id	sid	tid	token	lemma	pos
25944	1	1	Note	note	NN
25944	1	2	:	:	:
25944	1	3	Project	Project	NNP
25944	1	4	Gutenberg	Gutenberg	NNP
25944	1	5	also	also	RB
25944	1	6	has	have	VBZ
25944	1	7	an	an	DT
25944	1	8	HTML	html	NN
25944	1	9	version	version	NN
25944	1	10	of	of	IN
25944	1	11	this	this	DT
25944	1	12	file	file	NN
25944	1	13	which	which	WDT
25944	1	14	includes	include	VBZ
25944	1	15	the	the	DT
25944	1	16	original	original	JJ
25944	1	17	illustrations	illustration	NNS
25944	1	18	.	.	.
25944	2	1	See	see	VB
25944	2	2	25944-h.htm	25944-h.htm	CD
25944	2	3	or	or	CC
25944	2	4	25944-h.zip	25944-h.zip	CD
25944	2	5	:	:	:
25944	2	6	(	(	-LRB-
25944	2	7	http://www.gutenberg.net/dirs/2/5/9/4/25944/25944-h/25944-h.htm	http://www.gutenberg.net/dirs/2/5/9/4/25944/25944-h/25944-h.htm	CD
25944	2	8	)	)	-RRB-
25944	2	9	or	or	CC
25944	2	10	(	(	-LRB-
25944	2	11	http://www.gutenberg.net/dirs/2/5/9/4/25944/25944-h.zip	http://www.gutenberg.net/dirs/2/5/9/4/25944/25944-h.zip	NN
25944	2	12	)	)	-RRB-
25944	2	13	Transcriber	Transcriber	NNP
25944	2	14	's	's	POS
25944	2	15	note	note	NN
25944	2	16	:	:	:
25944	2	17	This	this	DT
25944	2	18	book	book	NN
25944	2	19	contains	contain	VBZ
25944	2	20	many	many	JJ
25944	2	21	characters	character	NNS
25944	2	22	not	not	RB
25944	2	23	displayed	display	VBN
25944	2	24	by	by	IN
25944	2	25	ASCII	ASCII	NNP
25944	2	26	or	or	CC
25944	2	27	iso-8859	iso-8859	NN
25944	2	28	-	-	HYPH
25944	2	29	1	1	CD
25944	2	30	(	(	-LRB-
25944	2	31	Latin1	Latin1	NNP
25944	2	32	)	)	-RRB-
25944	2	33	character	character	NN
25944	2	34	sets	set	NNS
25944	2	35	.	.	.
25944	3	1	In	in	IN
25944	3	2	the	the	DT
25944	3	3	text	text	NN
25944	3	4	file	file	NN
25944	3	5	these	these	DT
25944	3	6	characters	character	NNS
25944	3	7	have	have	VBP
25944	3	8	been	be	VBN
25944	3	9	denoted	denote	VBN
25944	3	10	by	by	IN
25944	3	11	enclosing	enclose	VBG
25944	3	12	explanatory	explanatory	JJ
25944	3	13	text	text	NN
25944	3	14	within	within	IN
25944	3	15	square	square	JJ
25944	3	16	brackets	bracket	NNS
25944	3	17	.	.	.
25944	4	1	Two	two	CD
25944	4	2	of	of	IN
25944	4	3	the	the	DT
25944	4	4	more	more	RBR
25944	4	5	commonly	commonly	RB
25944	4	6	occurring	occur	VBG
25944	4	7	such	such	JJ
25944	4	8	characters	character	NNS
25944	4	9	are	be	VBP
25944	4	10	the	the	DT
25944	4	11	oe	oe	JJ
25944	4	12	-	-	HYPH
25944	4	13	ligature	ligature	NN
25944	4	14	(	(	-LRB-
25944	4	15	denoted	denote	VBN
25944	4	16	by	by	IN
25944	4	17	[	[	-LRB-
25944	4	18	oe	oe	NN
25944	4	19	]	]	-RRB-
25944	4	20	or	or	CC
25944	4	21	[	[	-LRB-
25944	4	22	OE	OE	NNP
25944	4	23	]	]	-RRB-
25944	4	24	)	)	-RRB-
25944	4	25	and	and	CC
25944	4	26	a	a	DT
25944	4	27	-	-	HYPH
25944	4	28	macron	macron	NNP
25944	4	29	(	(	-LRB-
25944	4	30	denoted	denote	VBN
25944	4	31	by	by	IN
25944	4	32	[	[	-LRB-
25944	4	33	=	=	SYM
25944	4	34	a	a	LS
25944	4	35	]	]	-RRB-
25944	4	36	.	.	.
25944	5	1	Some	some	DT
25944	5	2	,	,	,
25944	5	3	but	but	CC
25944	5	4	not	not	RB
25944	5	5	all	all	DT
25944	5	6	,	,	,
25944	5	7	of	of	IN
25944	5	8	the	the	DT
25944	5	9	other	other	JJ
25944	5	10	such	such	JJ
25944	5	11	characters	character	NNS
25944	5	12	display	display	VBP
25944	5	13	properly	properly	RB
25944	5	14	in	in	IN
25944	5	15	the	the	DT
25944	5	16	html	html	NNP
25944	5	17	version	version	NN
25944	5	18	.	.	.
25944	6	1	Text	text	NN
25944	6	2	enclosed	enclose	VBD
25944	6	3	between	between	IN
25944	6	4	pound	pound	NN
25944	6	5	signs	sign	NNS
25944	6	6	was	be	VBD
25944	6	7	in	in	IN
25944	6	8	bold	bold	JJ
25944	6	9	face	face	NN
25944	6	10	in	in	IN
25944	6	11	the	the	DT
25944	6	12	original	original	NN
25944	6	13	(	(	-LRB-
25944	6	14	#	#	RB
25944	6	15	bold	bold	JJ
25944	6	16	face	face	NN
25944	6	17	#	#	NN
25944	6	18	)	)	-RRB-
25944	6	19	.	.	.
25944	7	1	A	a	DT
25944	7	2	detailed	detailed	JJ
25944	7	3	transcriber	transcriber	NN
25944	7	4	's	's	POS
25944	7	5	note	note	NN
25944	7	6	is	be	VBZ
25944	7	7	at	at	IN
25944	7	8	the	the	DT
25944	7	9	end	end	NN
25944	7	10	of	of	IN
25944	7	11	the	the	DT
25944	7	12	e	e	NN
25944	7	13	-	-	NN
25944	7	14	text	text	NN
25944	7	15	.	.	.
25944	8	1	ESSENTIALS	essential	NNS
25944	8	2	OF	of	IN
25944	8	3	DISEASES	disease	NNS
25944	8	4	OF	of	IN
25944	8	5	THE	the	DT
25944	8	6	SKIN	skin	NN
25944	8	7	Including	include	VBG
25944	8	8	the	the	DT
25944	8	9	Syphilodermata	Syphilodermata	NNP
25944	8	10	Arranged	arrange	VBN
25944	8	11	in	in	IN
25944	8	12	the	the	DT
25944	8	13	Form	Form	NNP
25944	8	14	of	of	IN
25944	8	15	Questions	Questions	NNPS
25944	8	16	and	and	CC
25944	8	17	Answers	Answers	NNPS
25944	8	18	Prepared	prepare	VBN
25944	8	19	Especially	especially	RB
25944	8	20	for	for	IN
25944	8	21	Students	student	NNS
25944	8	22	of	of	IN
25944	8	23	Medicine	Medicine	NNP
25944	8	24	by	by	IN
25944	8	25	HENRY	HENRY	NNP
25944	8	26	W.	W.	NNP
25944	8	27	STELWAGON	STELWAGON	NNP
25944	8	28	,	,	,
25944	8	29	M.D.	M.D.	NNP
25944	8	30	,	,	,
25944	8	31	PH.D.	ph.d.	CD
25944	8	32	*	*	NFP
25944	8	33	*	*	NFP
25944	8	34	*	*	NFP
25944	8	35	*	*	NFP
25944	8	36	*	*	NFP
25944	8	37	Get	get	VB
25944	8	38	the	the	DT
25944	8	39	Best	good	JJS
25944	8	40	The	the	DT
25944	8	41	New	New	NNP
25944	8	42	Standard	Standard	NNP
25944	8	43	DORLAND	DORLAND	NNP
25944	8	44	'S	's	POS
25944	8	45	AMERICAN	AMERICAN	NNP
25944	8	46	ILLUSTRATED	ILLUSTRATED	NNP
25944	8	47	MEDICAL	MEDICAL	NNP
25944	8	48	DICTIONARY	DICTIONARY	NNP
25944	8	49	For	for	IN
25944	8	50	Students	student	NNS
25944	8	51	and	and	CC
25944	8	52	Practitioners	Practitioners	NNPS
25944	8	53	A	a	DT
25944	8	54	New	New	NNP
25944	8	55	and	and	CC
25944	8	56	Complete	Complete	NNP
25944	8	57	Dictionary	Dictionary	NNP
25944	8	58	of	of	IN
25944	8	59	the	the	DT
25944	8	60	terms	term	NNS
25944	8	61	used	use	VBN
25944	8	62	in	in	IN
25944	8	63	Medicine	Medicine	NNP
25944	8	64	,	,	,
25944	8	65	Surgery	Surgery	NNP
25944	8	66	,	,	,
25944	8	67	Dentistry	Dentistry	NNP
25944	8	68	,	,	,
25944	8	69	Pharmacy	Pharmacy	NNP
25944	8	70	,	,	,
25944	8	71	Chemistry	Chemistry	NNP
25944	8	72	,	,	,
25944	8	73	and	and	CC
25944	8	74	kindred	kindred	JJ
25944	8	75	branches	branch	NNS
25944	8	76	;	;	:
25944	8	77	together	together	RB
25944	8	78	with	with	IN
25944	8	79	new	new	JJ
25944	8	80	and	and	CC
25944	8	81	elaborate	elaborate	JJ
25944	8	82	Tables	table	NNS
25944	8	83	of	of	IN
25944	8	84	Arteries	Arteries	NNPS
25944	8	85	,	,	,
25944	8	86	Muscles	Muscles	NNPS
25944	8	87	,	,	,
25944	8	88	Nerves	Nerves	NNPS
25944	8	89	,	,	,
25944	8	90	Veins	vein	NNS
25944	8	91	,	,	,
25944	8	92	etc	etc	FW
25944	8	93	.	.	.
25944	9	1	;	;	:
25944	9	2	of	of	IN
25944	9	3	Bacilli	Bacilli	NNP
25944	9	4	,	,	,
25944	9	5	Bacteria	Bacteria	NNP
25944	9	6	,	,	,
25944	9	7	Micrococci	Micrococci	NNP
25944	9	8	,	,	,
25944	9	9	etc	etc	FW
25944	9	10	.	.	.
25944	10	1	;	;	:
25944	10	2	Eponymic	Eponymic	NNP
25944	10	3	Tables	Tables	NNPS
25944	10	4	of	of	IN
25944	10	5	Diseases	Diseases	NNPS
25944	10	6	,	,	,
25944	10	7	Operations	Operations	NNPS
25944	10	8	,	,	,
25944	10	9	Signs	Signs	NNPS
25944	10	10	and	and	CC
25944	10	11	Symptoms	Symptoms	NNPS
25944	10	12	,	,	,
25944	10	13	Stains	Stains	NNPS
25944	10	14	,	,	,
25944	10	15	Tests	Tests	NNPS
25944	10	16	,	,	,
25944	10	17	Methods	Methods	NNPS
25944	10	18	of	of	IN
25944	10	19	Treatment	Treatment	NNP
25944	10	20	,	,	,
25944	10	21	etc	etc	FW
25944	10	22	.	.	.
25944	11	1	By	by	IN
25944	11	2	W.A.N.	W.A.N.	NNP
25944	12	1	Dorland	Dorland	NNP
25944	12	2	,	,	,
25944	12	3	M.D.	M.D.	NNP
25944	12	4	,	,	,
25944	12	5	Editor	Editor	NNP
25944	12	6	of	of	IN
25944	12	7	the	the	DT
25944	12	8	American	American	NNP
25944	12	9	Pocket	Pocket	NNP
25944	12	10	Medical	Medical	NNP
25944	12	11	Dictionary	Dictionary	NNP
25944	12	12	.	.	.
25944	13	1	Large	large	JJ
25944	13	2	octavo	octavo	NN
25944	13	3	,	,	,
25944	13	4	nearly	nearly	RB
25944	13	5	800	800	CD
25944	13	6	pages	page	NNS
25944	13	7	,	,	,
25944	13	8	bound	bind	VBN
25944	13	9	in	in	IN
25944	13	10	full	full	JJ
25944	13	11	flexible	flexible	JJ
25944	13	12	leather	leather	NN
25944	13	13	.	.	.
25944	14	1	Price	price	NN
25944	14	2	,	,	,
25944	14	3	$	$	$
25944	14	4	4.50	4.50	CD
25944	14	5	net	net	NN
25944	14	6	;	;	:
25944	14	7	with	with	IN
25944	14	8	thumb	thumb	NN
25944	14	9	index	index	NN
25944	14	10	,	,	,
25944	14	11	$	$	$
25944	14	12	5.00	5.00	CD
25944	14	13	net	net	NN
25944	14	14	.	.	.
25944	15	1	JUST	just	RB
25944	15	2	ISSUED	ISSUED	NNP
25944	15	3	--	--	:
25944	15	4	NEW	NEW	NNP
25944	15	5	(	(	-LRB-
25944	15	6	4	4	CD
25944	15	7	)	)	-RRB-
25944	15	8	REVISED	REVISED	NNP
25944	15	9	EDITION--2000	EDITION--2000	NNP
25944	15	10	NEW	new	JJ
25944	15	11	WORDS	word	NNS
25944	15	12	_	_	VBD
25944	15	13	It	-PRON-	PRP
25944	15	14	contains	contain	VBZ
25944	15	15	a	a	DT
25944	15	16	maximum	maximum	JJ
25944	15	17	amount	amount	NN
25944	15	18	of	of	IN
25944	15	19	matter	matter	NN
25944	15	20	in	in	IN
25944	15	21	a	a	DT
25944	15	22	minimum	minimum	JJ
25944	15	23	space	space	NN
25944	15	24	and	and	CC
25944	15	25	at	at	IN
25944	15	26	the	the	DT
25944	15	27	lowest	low	JJS
25944	15	28	possible	possible	JJ
25944	15	29	cost	cost	NN
25944	15	30	.	.	.
25944	15	31	_	_	NNP
25944	15	32	This	this	DT
25944	15	33	book	book	NN
25944	15	34	contains	contain	VBZ
25944	15	35	#	#	$
25944	15	36	double	double	PDT
25944	15	37	the	the	DT
25944	15	38	material	material	NN
25944	15	39	in	in	IN
25944	15	40	the	the	DT
25944	15	41	ordinary	ordinary	JJ
25944	15	42	students	student	NNS
25944	15	43	'	'	POS
25944	15	44	dictionary	dictionary	JJ
25944	15	45	#	#	NN
25944	15	46	,	,	,
25944	15	47	and	and	CC
25944	15	48	yet	yet	RB
25944	15	49	,	,	,
25944	15	50	by	by	IN
25944	15	51	the	the	DT
25944	15	52	use	use	NN
25944	15	53	of	of	IN
25944	15	54	a	a	DT
25944	15	55	clear	clear	JJ
25944	15	56	,	,	,
25944	15	57	condensed	condense	VBN
25944	15	58	type	type	NN
25944	15	59	and	and	CC
25944	15	60	thin	thin	JJ
25944	15	61	paper	paper	NN
25944	15	62	of	of	IN
25944	15	63	the	the	DT
25944	15	64	finest	fine	JJS
25944	15	65	quality	quality	NN
25944	15	66	,	,	,
25944	15	67	is	be	VBZ
25944	15	68	only	only	RB
25944	15	69	1	1	CD
25944	15	70	-	-	SYM
25944	15	71	3/4	3/4	CD
25944	15	72	inches	inch	NNS
25944	15	73	in	in	IN
25944	15	74	thickness	thickness	NN
25944	15	75	.	.	.
25944	16	1	It	-PRON-	PRP
25944	16	2	is	be	VBZ
25944	16	3	bound	bind	VBN
25944	16	4	in	in	IN
25944	16	5	full	full	JJ
25944	16	6	flexible	flexible	JJ
25944	16	7	leather	leather	NN
25944	16	8	,	,	,
25944	16	9	and	and	CC
25944	16	10	is	be	VBZ
25944	16	11	just	just	RB
25944	16	12	the	the	DT
25944	16	13	kind	kind	NN
25944	16	14	of	of	IN
25944	16	15	a	a	DT
25944	16	16	book	book	NN
25944	16	17	that	that	WDT
25944	16	18	a	a	DT
25944	16	19	man	man	NN
25944	16	20	will	will	MD
25944	16	21	want	want	VB
25944	16	22	to	to	TO
25944	16	23	keep	keep	VB
25944	16	24	on	on	IN
25944	16	25	his	-PRON-	PRP$
25944	16	26	desk	desk	NN
25944	16	27	for	for	IN
25944	16	28	constant	constant	JJ
25944	16	29	reference	reference	NN
25944	16	30	.	.	.
25944	17	1	The	the	DT
25944	17	2	book	book	NN
25944	17	3	makes	make	VBZ
25944	17	4	a	a	DT
25944	17	5	special	special	JJ
25944	17	6	feature	feature	NN
25944	17	7	of	of	IN
25944	17	8	#	#	$
25944	17	9	the	the	DT
25944	17	10	newer	new	JJR
25944	17	11	words	word	NNS
25944	17	12	#	#	$
25944	17	13	,	,	,
25944	17	14	and	and	CC
25944	17	15	defines	define	VBZ
25944	17	16	hundreds	hundred	NNS
25944	17	17	of	of	IN
25944	17	18	important	important	JJ
25944	17	19	terms	term	NNS
25944	17	20	not	not	RB
25944	17	21	to	to	TO
25944	17	22	be	be	VB
25944	17	23	found	find	VBN
25944	17	24	in	in	IN
25944	17	25	any	any	DT
25944	17	26	other	other	JJ
25944	17	27	dictionary	dictionary	NN
25944	17	28	.	.	.
25944	18	1	It	-PRON-	PRP
25944	18	2	is	be	VBZ
25944	18	3	especially	especially	RB
25944	18	4	#	#	VBN
25944	18	5	full	full	JJ
25944	18	6	in	in	IN
25944	18	7	the	the	DT
25944	18	8	matter	matter	NN
25944	18	9	of	of	IN
25944	18	10	tables	table	NNS
25944	18	11	#	#	$
25944	18	12	,	,	,
25944	18	13	containing	contain	VBG
25944	18	14	more	more	JJR
25944	18	15	than	than	IN
25944	18	16	a	a	DT
25944	18	17	hundred	hundred	CD
25944	18	18	of	of	IN
25944	18	19	great	great	JJ
25944	18	20	practical	practical	JJ
25944	18	21	value	value	NN
25944	18	22	,	,	,
25944	18	23	including	include	VBG
25944	18	24	new	new	JJ
25944	18	25	tables	table	NNS
25944	18	26	of	of	IN
25944	18	27	Tests	Tests	NNPS
25944	18	28	,	,	,
25944	18	29	Stains	Stains	NNPS
25944	18	30	and	and	CC
25944	18	31	Staining	Staining	NNP
25944	18	32	Methods	method	NNS
25944	18	33	.	.	.
25944	19	1	A	a	DT
25944	19	2	new	new	JJ
25944	19	3	feature	feature	NN
25944	19	4	is	be	VBZ
25944	19	5	the	the	DT
25944	19	6	inclusion	inclusion	NN
25944	19	7	of	of	IN
25944	19	8	numerous	numerous	JJ
25944	19	9	handsome	handsome	JJ
25944	19	10	illustrations	illustration	NNS
25944	19	11	,	,	,
25944	19	12	many	many	JJ
25944	19	13	of	of	IN
25944	19	14	them	-PRON-	PRP
25944	19	15	in	in	IN
25944	19	16	colors	color	NNS
25944	19	17	,	,	,
25944	19	18	drawn	draw	VBN
25944	19	19	and	and	CC
25944	19	20	engraved	engrave	VBD
25944	19	21	specially	specially	RB
25944	19	22	for	for	IN
25944	19	23	this	this	DT
25944	19	24	book	book	NN
25944	19	25	.	.	.
25944	20	1	"	"	``
25944	20	2	I	-PRON-	PRP
25944	20	3	must	must	MD
25944	20	4	acknowledge	acknowledge	VB
25944	20	5	my	-PRON-	PRP$
25944	20	6	astonishment	astonishment	NN
25944	20	7	at	at	IN
25944	20	8	seeing	see	VBG
25944	20	9	how	how	WRB
25944	20	10	much	much	JJ
25944	20	11	he	-PRON-	PRP
25944	20	12	has	have	VBZ
25944	20	13	condensed	condense	VBN
25944	20	14	within	within	IN
25944	20	15	relatively	relatively	RB
25944	20	16	small	small	JJ
25944	20	17	space	space	NN
25944	20	18	.	.	.
25944	21	1	I	-PRON-	PRP
25944	21	2	find	find	VBP
25944	21	3	nothing	nothing	NN
25944	21	4	to	to	TO
25944	21	5	criticise	criticise	VB
25944	21	6	,	,	,
25944	21	7	very	very	RB
25944	21	8	much	much	RB
25944	21	9	to	to	TO
25944	21	10	commend	commend	VB
25944	21	11	,	,	,
25944	21	12	and	and	CC
25944	21	13	was	be	VBD
25944	21	14	interested	interested	JJ
25944	21	15	in	in	IN
25944	21	16	finding	find	VBG
25944	21	17	some	some	DT
25944	21	18	of	of	IN
25944	21	19	the	the	DT
25944	21	20	new	new	JJ
25944	21	21	words	word	NNS
25944	21	22	which	which	WDT
25944	21	23	are	be	VBP
25944	21	24	not	not	RB
25944	21	25	in	in	IN
25944	21	26	other	other	JJ
25944	21	27	recent	recent	JJ
25944	21	28	dictionaries	dictionary	NNS
25944	21	29	.	.	.
25944	21	30	"	"	''
25944	22	1	--Roswell	--Roswell	:
25944	22	2	Park	Park	NNP
25944	22	3	,	,	,
25944	22	4	_	_	NNP
25944	22	5	Professor	Professor	NNP
25944	22	6	of	of	IN
25944	22	7	Principles	Principles	NNPS
25944	22	8	and	and	CC
25944	22	9	Practice	Practice	NNP
25944	22	10	of	of	IN
25944	22	11	Surgery	Surgery	NNP
25944	22	12	and	and	CC
25944	22	13	Clinical	Clinical	NNP
25944	22	14	Surgery	Surgery	NNP
25944	22	15	,	,	,
25944	22	16	University	University	NNP
25944	22	17	of	of	IN
25944	22	18	Buffalo	Buffalo	NNP
25944	22	19	_	_	NNP
25944	22	20	.	.	.
25944	23	1	"	"	``
25944	23	2	Dr.	Dr.	NNP
25944	23	3	Dorland	Dorland	NNP
25944	23	4	's	's	POS
25944	23	5	Dictionary	Dictionary	NNP
25944	23	6	is	be	VBZ
25944	23	7	admirable	admirable	JJ
25944	23	8	.	.	.
25944	24	1	It	-PRON-	PRP
25944	24	2	is	be	VBZ
25944	24	3	so	so	RB
25944	24	4	well	well	RB
25944	24	5	gotten	get	VBN
25944	24	6	up	up	RP
25944	24	7	and	and	CC
25944	24	8	of	of	IN
25944	24	9	such	such	JJ
25944	24	10	convenient	convenient	JJ
25944	24	11	size	size	NN
25944	24	12	.	.	.
25944	25	1	No	no	DT
25944	25	2	errors	error	NNS
25944	25	3	have	have	VBP
25944	25	4	been	be	VBN
25944	25	5	found	find	VBN
25944	25	6	in	in	IN
25944	25	7	my	-PRON-	PRP$
25944	25	8	use	use	NN
25944	25	9	of	of	IN
25944	25	10	it	-PRON-	PRP
25944	25	11	.	.	.
25944	25	12	"	"	''
25944	26	1	--Howard	--Howard	:
25944	26	2	A.	A.	NNP
25944	26	3	Kelly	Kelly	NNP
25944	26	4	,	,	,
25944	26	5	_	_	NNP
25944	26	6	Professor	Professor	NNP
25944	26	7	of	of	IN
25944	26	8	Gynecology	Gynecology	NNP
25944	26	9	,	,	,
25944	26	10	Johns	Johns	NNP
25944	26	11	Hopkins	Hopkins	NNP
25944	26	12	University	University	NNP
25944	26	13	,	,	,
25944	26	14	Baltimore	Baltimore	NNP
25944	26	15	_	_	NNP
25944	26	16	.	.	.
25944	27	1	W.	W.	NNP
25944	27	2	B.	B.	NNP
25944	27	3	SAUNDERS	SAUNDERS	NNP
25944	27	4	COMPANY	COMPANY	NNP
25944	27	5	,	,	,
25944	27	6	925	925	CD
25944	27	7	Walnut	Walnut	NNP
25944	27	8	St.	St.	NNP
25944	27	9	,	,	,
25944	27	10	Phila	Phila	NNP
25944	27	11	.	.	.
25944	28	1	London	London	NNP
25944	28	2	:	:	:
25944	28	3	9	9	CD
25944	28	4	,	,	,
25944	28	5	Henrietta	Henrietta	NNP
25944	28	6	Street	Street	NNP
25944	28	7	,	,	,
25944	28	8	Covent	Covent	NNP
25944	28	9	Garden	Garden	NNP
25944	28	10	Fifth	Fifth	NNP
25944	28	11	Edition	Edition	NNP
25944	28	12	,	,	,
25944	28	13	Just	just	RB
25944	28	14	Ready	ready	JJ
25944	28	15	With	with	IN
25944	28	16	Complete	Complete	NNP
25944	28	17	Vocabulary	Vocabulary	NNP
25944	28	18	THE	the	DT
25944	28	19	AMERICAN	AMERICAN	NNP
25944	28	20	POCKET	POCKET	NNP
25944	28	21	MEDICAL	MEDICAL	NNS
25944	28	22	DICTIONARY	DICTIONARY	NNP
25944	28	23	EDITED	edit	VBN
25944	28	24	BY	by	IN
25944	28	25	W.A.	W.A.	NNP
25944	29	1	NEWMAN	NEWMAN	NNP
25944	29	2	DORLAND	DORLAND	NNP
25944	29	3	,	,	,
25944	29	4	A.M.	A.M.	NNP
25944	29	5	,	,	,
25944	29	6	M.D.	M.D.	NNP
25944	29	7	,	,	,
25944	29	8	Assistant	Assistant	NNP
25944	29	9	Demonstrator	Demonstrator	NNP
25944	29	10	of	of	IN
25944	29	11	Obstetrics	Obstetrics	NNP
25944	29	12	,	,	,
25944	29	13	University	University	NNP
25944	29	14	of	of	IN
25944	29	15	Pennsylvania	Pennsylvania	NNP
25944	29	16	.	.	.
25944	30	1	HUNDREDS	HUNDREDS	NNP
25944	30	2	OF	of	IN
25944	30	3	NEW	new	JJ
25944	30	4	TERMS	term	NNS
25944	30	5	Bound	bind	VBN
25944	30	6	in	in	IN
25944	30	7	Full	Full	NNP
25944	30	8	Leather	Leather	NNP
25944	30	9	,	,	,
25944	30	10	Limp	Limp	NNP
25944	30	11	,	,	,
25944	30	12	with	with	IN
25944	30	13	Gold	Gold	NNP
25944	30	14	Edges	Edges	NNP
25944	30	15	.	.	.
25944	31	1	Price	price	NN
25944	31	2	,	,	,
25944	31	3	$	$	$
25944	31	4	1.00	1.00	CD
25944	31	5	net	net	NN
25944	31	6	;	;	:
25944	31	7	with	with	IN
25944	31	8	Patent	Patent	NNP
25944	31	9	Thumb	Thumb	NNP
25944	31	10	Index	Index	NNP
25944	31	11	,	,	,
25944	31	12	$	$	$
25944	31	13	1.25	1.25	CD
25944	31	14	net	net	NN
25944	31	15	.	.	.
25944	32	1	The	the	DT
25944	32	2	book	book	NN
25944	32	3	is	be	VBZ
25944	32	4	an	an	DT
25944	32	5	#	#	$
25944	32	6	absolutely	absolutely	RB
25944	32	7	new	new	JJ
25944	32	8	one	one	CD
25944	32	9	#	#	$
25944	32	10	.	.	.
25944	33	1	It	-PRON-	PRP
25944	33	2	is	be	VBZ
25944	33	3	not	not	RB
25944	33	4	a	a	DT
25944	33	5	revision	revision	NN
25944	33	6	of	of	IN
25944	33	7	any	any	DT
25944	33	8	old	old	JJ
25944	33	9	work	work	NN
25944	33	10	,	,	,
25944	33	11	but	but	CC
25944	33	12	it	-PRON-	PRP
25944	33	13	has	have	VBZ
25944	33	14	been	be	VBN
25944	33	15	written	write	VBN
25944	33	16	entirely	entirely	RB
25944	33	17	anew	anew	RB
25944	33	18	and	and	CC
25944	33	19	is	be	VBZ
25944	33	20	constructed	construct	VBN
25944	33	21	on	on	IN
25944	33	22	lines	line	NNS
25944	33	23	that	that	WDT
25944	33	24	experience	experience	NN
25944	33	25	has	have	VBZ
25944	33	26	shown	show	VBN
25944	33	27	to	to	TO
25944	33	28	be	be	VB
25944	33	29	the	the	DT
25944	33	30	most	most	RBS
25944	33	31	practical	practical	JJ
25944	33	32	for	for	IN
25944	33	33	a	a	DT
25944	33	34	work	work	NN
25944	33	35	of	of	IN
25944	33	36	this	this	DT
25944	33	37	kind	kind	NN
25944	33	38	.	.	.
25944	34	1	It	-PRON-	PRP
25944	34	2	aims	aim	VBZ
25944	34	3	to	to	TO
25944	34	4	be	be	VB
25944	34	5	#	#	$
25944	34	6	complete	complete	JJ
25944	34	7	#	#	NN
25944	34	8	,	,	,
25944	34	9	and	and	CC
25944	34	10	to	to	IN
25944	34	11	that	that	DT
25944	34	12	end	end	NN
25944	34	13	contains	contain	VBZ
25944	34	14	practically	practically	RB
25944	34	15	all	all	PDT
25944	34	16	the	the	DT
25944	34	17	terms	term	NNS
25944	34	18	of	of	IN
25944	34	19	modern	modern	JJ
25944	34	20	medicine	medicine	NN
25944	34	21	.	.	.
25944	35	1	This	this	DT
25944	35	2	makes	make	VBZ
25944	35	3	an	an	DT
25944	35	4	unusually	unusually	RB
25944	35	5	large	large	JJ
25944	35	6	vocabulary	vocabulary	NN
25944	35	7	.	.	.
25944	36	1	Besides	besides	IN
25944	36	2	the	the	DT
25944	36	3	ordinary	ordinary	JJ
25944	36	4	dictionary	dictionary	JJ
25944	36	5	terms	term	NNS
25944	36	6	the	the	DT
25944	36	7	book	book	NN
25944	36	8	contains	contain	VBZ
25944	36	9	a	a	DT
25944	36	10	wealth	wealth	NN
25944	36	11	of	of	IN
25944	36	12	#	#	$
25944	36	13	anatomical	anatomical	JJ
25944	36	14	and	and	CC
25944	36	15	other	other	JJ
25944	36	16	tables	table	NNS
25944	36	17	#	#	$
25944	36	18	.	.	.
25944	37	1	This	this	DT
25944	37	2	matter	matter	NN
25944	37	3	is	be	VBZ
25944	37	4	of	of	IN
25944	37	5	particular	particular	JJ
25944	37	6	value	value	NN
25944	37	7	to	to	IN
25944	37	8	students	student	NNS
25944	37	9	for	for	IN
25944	37	10	memorizing	memorize	VBG
25944	37	11	in	in	IN
25944	37	12	preparation	preparation	NN
25944	37	13	for	for	IN
25944	37	14	examination	examination	NN
25944	37	15	.	.	.
25944	38	1	"	"	``
25944	38	2	I	-PRON-	PRP
25944	38	3	am	be	VBP
25944	38	4	struck	strike	VBN
25944	38	5	at	at	IN
25944	38	6	once	once	RB
25944	38	7	with	with	IN
25944	38	8	admiration	admiration	NN
25944	38	9	at	at	IN
25944	38	10	the	the	DT
25944	38	11	compact	compact	JJ
25944	38	12	size	size	NN
25944	38	13	and	and	CC
25944	38	14	attractive	attractive	JJ
25944	38	15	exterior	exterior	NN
25944	38	16	.	.	.
25944	39	1	I	-PRON-	PRP
25944	39	2	can	can	MD
25944	39	3	recommend	recommend	VB
25944	39	4	it	-PRON-	PRP
25944	39	5	to	to	IN
25944	39	6	our	-PRON-	PRP$
25944	39	7	students	student	NNS
25944	39	8	without	without	IN
25944	39	9	reserve	reserve	NN
25944	39	10	.	.	.
25944	39	11	"	"	''
25944	40	1	--James	--James	:
25944	40	2	W.	W.	NNP
25944	40	3	Holland	Holland	NNP
25944	40	4	,	,	,
25944	40	5	M.D.	M.D.	NNP
25944	40	6	,	,	,
25944	40	7	_	_	NNP
25944	40	8	of	of	IN
25944	40	9	Jefferson	Jefferson	NNP
25944	40	10	Medical	Medical	NNP
25944	40	11	College	College	NNP
25944	40	12	_	_	NNP
25944	40	13	.	.	.
25944	41	1	"	"	``
25944	41	2	This	this	DT
25944	41	3	is	be	VBZ
25944	41	4	a	a	DT
25944	41	5	handy	handy	JJ
25944	41	6	pocket	pocket	NN
25944	41	7	dictionary	dictionary	NN
25944	41	8	,	,	,
25944	41	9	which	which	WDT
25944	41	10	is	be	VBZ
25944	41	11	so	so	RB
25944	41	12	full	full	JJ
25944	41	13	and	and	CC
25944	41	14	complete	complete	JJ
25944	41	15	that	that	IN
25944	41	16	it	-PRON-	PRP
25944	41	17	puts	put	VBZ
25944	41	18	to	to	TO
25944	41	19	shame	shame	VB
25944	41	20	some	some	DT
25944	41	21	of	of	IN
25944	41	22	the	the	DT
25944	41	23	more	more	RBR
25944	41	24	pretentious	pretentious	JJ
25944	41	25	volumes	volume	NNS
25944	41	26	.	.	.
25944	41	27	"	"	''
25944	42	1	--_Journal	--_Journal	NNP
25944	42	2	of	of	IN
25944	42	3	the	the	DT
25944	42	4	American	American	NNP
25944	42	5	Medical	Medical	NNP
25944	42	6	Association	Association	NNP
25944	42	7	.	.	.
25944	42	8	_	_	NNP
25944	42	9	"	"	``
25944	42	10	We	-PRON-	PRP
25944	42	11	have	have	VBP
25944	42	12	consulted	consult	VBN
25944	42	13	it	-PRON-	PRP
25944	42	14	for	for	IN
25944	42	15	the	the	DT
25944	42	16	meaning	meaning	NN
25944	42	17	of	of	IN
25944	42	18	many	many	JJ
25944	42	19	new	new	JJ
25944	42	20	and	and	CC
25944	42	21	rare	rare	JJ
25944	42	22	terms	term	NNS
25944	42	23	,	,	,
25944	42	24	and	and	CC
25944	42	25	have	have	VBP
25944	42	26	not	not	RB
25944	42	27	met	meet	VBN
25944	42	28	with	with	IN
25944	42	29	a	a	DT
25944	42	30	disappointment	disappointment	NN
25944	42	31	.	.	.
25944	43	1	The	the	DT
25944	43	2	definitions	definition	NNS
25944	43	3	are	be	VBP
25944	43	4	exquisitely	exquisitely	RB
25944	43	5	clear	clear	JJ
25944	43	6	and	and	CC
25944	43	7	concise	concise	JJ
25944	43	8	.	.	.
25944	44	1	We	-PRON-	PRP
25944	44	2	have	have	VBP
25944	44	3	never	never	RB
25944	44	4	found	find	VBN
25944	44	5	so	so	RB
25944	44	6	much	much	JJ
25944	44	7	information	information	NN
25944	44	8	in	in	IN
25944	44	9	so	so	RB
25944	44	10	small	small	JJ
25944	44	11	a	a	DT
25944	44	12	space	space	NN
25944	44	13	.	.	.
25944	44	14	"	"	''
25944	45	1	--_Dublin	--_Dublin	:
25944	45	2	Journal	Journal	NNP
25944	45	3	of	of	IN
25944	45	4	Medical	Medical	NNP
25944	45	5	Science	Science	NNP
25944	45	6	.	.	.
25944	45	7	_	_	NNP
25944	45	8	"	"	``
25944	45	9	This	this	DT
25944	45	10	is	be	VBZ
25944	45	11	a	a	DT
25944	45	12	handy	handy	JJ
25944	45	13	little	little	JJ
25944	45	14	volume	volume	NN
25944	45	15	that	that	IN
25944	45	16	,	,	,
25944	45	17	upon	upon	IN
25944	45	18	examination	examination	NN
25944	45	19	,	,	,
25944	45	20	seems	seem	VBZ
25944	45	21	fairly	fairly	RB
25944	45	22	to	to	TO
25944	45	23	fulfil	fulfil	VB
25944	45	24	the	the	DT
25944	45	25	promise	promise	NN
25944	45	26	of	of	IN
25944	45	27	its	-PRON-	PRP$
25944	45	28	title	title	NN
25944	45	29	,	,	,
25944	45	30	and	and	CC
25944	45	31	to	to	TO
25944	45	32	contain	contain	VB
25944	45	33	a	a	DT
25944	45	34	vast	vast	JJ
25944	45	35	amount	amount	NN
25944	45	36	of	of	IN
25944	45	37	information	information	NN
25944	45	38	in	in	IN
25944	45	39	a	a	DT
25944	45	40	very	very	RB
25944	45	41	small	small	JJ
25944	45	42	space	space	NN
25944	45	43	....	....	.
25944	46	1	It	-PRON-	PRP
25944	46	2	is	be	VBZ
25944	46	3	somewhat	somewhat	RB
25944	46	4	surprising	surprising	JJ
25944	46	5	that	that	IN
25944	46	6	it	-PRON-	PRP
25944	46	7	contains	contain	VBZ
25944	46	8	so	so	RB
25944	46	9	many	many	JJ
25944	46	10	of	of	IN
25944	46	11	the	the	DT
25944	46	12	rarer	rare	JJR
25944	46	13	terms	term	NNS
25944	46	14	used	use	VBN
25944	46	15	in	in	IN
25944	46	16	medicine	medicine	NN
25944	46	17	.	.	.
25944	46	18	"	"	''
25944	47	1	--_Bulletin	--_Bulletin	:
25944	47	2	Johns	Johns	NNP
25944	47	3	Hopkins	Hopkins	NNP
25944	47	4	Hospital	Hospital	NNP
25944	47	5	_	_	NNP
25944	47	6	,	,	,
25944	47	7	Baltimore	Baltimore	NNP
25944	47	8	.	.	.
25944	48	1	W.	W.	NNP
25944	48	2	B.	B.	NNP
25944	48	3	SAUNDERS	SAUNDERS	NNP
25944	48	4	COMPANY	COMPANY	NNP
25944	48	5	,	,	,
25944	48	6	925	925	CD
25944	48	7	Walnut	Walnut	NNP
25944	48	8	St.	St.	NNP
25944	48	9	,	,	,
25944	48	10	Phila	Phila	NNP
25944	48	11	.	.	.
25944	49	1	London	London	NNP
25944	49	2	:	:	:
25944	49	3	9	9	CD
25944	49	4	,	,	,
25944	49	5	Henrietta	Henrietta	NNP
25944	49	6	Street	Street	NNP
25944	49	7	,	,	,
25944	49	8	Covent	Covent	NNP
25944	49	9	Garden	Garden	NNP
25944	49	10	*	*	NFP
25944	49	11	*	*	NFP
25944	49	12	*	*	NFP
25944	49	13	*	*	NFP
25944	49	14	*	*	NFP
25944	49	15	ESSENTIALS	essential	NNS
25944	49	16	OF	of	IN
25944	49	17	DISEASES	disease	NNS
25944	49	18	OF	of	IN
25944	49	19	THE	the	DT
25944	49	20	SKIN	skin	NN
25944	49	21	.	.	.
25944	50	1	Since	since	IN
25944	50	2	the	the	DT
25944	50	3	issue	issue	NN
25944	50	4	of	of	IN
25944	50	5	the	the	DT
25944	50	6	first	first	JJ
25944	50	7	volume	volume	NN
25944	50	8	of	of	IN
25944	50	9	the	the	DT
25944	50	10	#	#	$
25944	50	11	Saunders	Saunders	NNPS
25944	50	12	Question	Question	NNP
25944	50	13	-	-	HYPH
25944	50	14	Compends	compends	NN
25944	50	15	#	#	NN
25944	50	16	,	,	,
25944	50	17	OVER	over	IN
25944	50	18	290,000	290,000	CD
25944	50	19	COPIES	copy	NNS
25944	50	20	of	of	IN
25944	50	21	these	these	DT
25944	50	22	unrivalled	unrivalled	JJ
25944	50	23	publications	publication	NNS
25944	50	24	have	have	VBP
25944	50	25	been	be	VBN
25944	50	26	sold	sell	VBN
25944	50	27	.	.	.
25944	51	1	This	this	DT
25944	51	2	enormous	enormous	JJ
25944	51	3	sale	sale	NN
25944	51	4	is	be	VBZ
25944	51	5	indisputable	indisputable	JJ
25944	51	6	evidence	evidence	NN
25944	51	7	of	of	IN
25944	51	8	the	the	DT
25944	51	9	value	value	NN
25944	51	10	of	of	IN
25944	51	11	these	these	DT
25944	51	12	self	self	NN
25944	51	13	-	-	HYPH
25944	51	14	helps	help	NNS
25944	51	15	to	to	IN
25944	51	16	students	student	NNS
25944	51	17	and	and	CC
25944	51	18	physicians	physician	NNS
25944	51	19	.	.	.
25944	52	1	Saunders	saunder	NNS
25944	52	2	'	'	POS
25944	52	3	Question	question	NN
25944	52	4	-	-	HYPH
25944	52	5	Compends	compends	NN
25944	52	6	.	.	.
25944	53	1	No	no	UH
25944	53	2	.	.	.
25944	54	1	11	11	CD
25944	54	2	.	.	.
25944	55	1	ESSENTIALS	essential	NNS
25944	55	2	OF	of	IN
25944	55	3	DISEASES	disease	NNS
25944	55	4	OF	of	IN
25944	55	5	THE	the	DT
25944	55	6	SKIN	skin	NN
25944	55	7	Including	include	VBG
25944	55	8	the	the	DT
25944	55	9	Syphilodermata	Syphilodermata	NNP
25944	55	10	Arranged	arrange	VBN
25944	55	11	in	in	IN
25944	55	12	the	the	DT
25944	55	13	Form	Form	NNP
25944	55	14	of	of	IN
25944	55	15	Questions	Questions	NNPS
25944	55	16	and	and	CC
25944	55	17	Answers	Answers	NNPS
25944	55	18	Prepared	prepare	VBN
25944	55	19	Especially	especially	RB
25944	55	20	for	for	IN
25944	55	21	Students	student	NNS
25944	55	22	of	of	IN
25944	55	23	Medicine	Medicine	NNP
25944	55	24	by	by	IN
25944	55	25	HENRY	HENRY	NNP
25944	55	26	W.	W.	NNP
25944	55	27	STELWAGON	STELWAGON	NNP
25944	55	28	,	,	,
25944	55	29	M.D.	M.D.	NNP
25944	55	30	,	,	,
25944	55	31	PH.D.	ph.d.	XX
25944	56	1	Professor	Professor	NNP
25944	56	2	of	of	IN
25944	56	3	Dermatology	Dermatology	NNP
25944	56	4	in	in	IN
25944	56	5	the	the	DT
25944	56	6	Jefferson	Jefferson	NNP
25944	56	7	Medical	Medical	NNP
25944	56	8	College	College	NNP
25944	56	9	,	,	,
25944	56	10	Philadelphia	Philadelphia	NNP
25944	56	11	;	;	:
25944	56	12	Dermatologist	dermatologist	IN
25944	56	13	to	to	IN
25944	56	14	the	the	DT
25944	56	15	Howard	Howard	NNP
25944	56	16	and	and	CC
25944	56	17	Philadelphia	Philadelphia	NNP
25944	56	18	Hospitals	Hospitals	NNPS
25944	56	19	,	,	,
25944	56	20	etc	etc	FW
25944	56	21	.	.	.
25944	57	1	Seventh	Seventh	NNP
25944	57	2	Edition	Edition	NNP
25944	57	3	,	,	,
25944	57	4	Thoroughly	Thoroughly	NNP
25944	57	5	Revised	Revised	NNP
25944	57	6	Illustrated	Illustrated	NNP
25944	57	7	Philadelphia	Philadelphia	NNP
25944	57	8	and	and	CC
25944	57	9	London	London	NNP
25944	57	10	W.	W.	NNP
25944	57	11	B.	B.	NNP
25944	57	12	Saunders	Saunders	NNP
25944	57	13	Company	Company	NNP
25944	57	14	1909	1909	CD
25944	57	15	Set	Set	VBN
25944	57	16	up	up	RP
25944	57	17	,	,	,
25944	57	18	electrotyped	electrotype	VBN
25944	57	19	,	,	,
25944	57	20	printed	print	VBN
25944	57	21	,	,	,
25944	57	22	1890	1890	CD
25944	57	23	.	.	.
25944	58	1	Reprinted	Reprinted	NNP
25944	58	2	July	July	NNP
25944	58	3	,	,	,
25944	58	4	1891	1891	CD
25944	58	5	.	.	.
25944	59	1	Revised	revise	VBN
25944	59	2	,	,	,
25944	59	3	reprinted	reprint	VBN
25944	59	4	,	,	,
25944	59	5	June	June	NNP
25944	59	6	,	,	,
25944	59	7	1894	1894	CD
25944	59	8	.	.	.
25944	60	1	Reprinted	Reprinted	NNP
25944	60	2	March	March	NNP
25944	60	3	,	,	,
25944	60	4	1897	1897	CD
25944	60	5	.	.	.
25944	61	1	Revised	revise	VBN
25944	61	2	,	,	,
25944	61	3	reprinted	reprint	VBN
25944	61	4	,	,	,
25944	61	5	August	August	NNP
25944	61	6	,	,	,
25944	61	7	1899	1899	CD
25944	61	8	.	.	.
25944	62	1	Reprinted	Reprinted	NNP
25944	62	2	September	September	NNP
25944	62	3	,	,	,
25944	62	4	1901	1901	CD
25944	62	5	,	,	,
25944	62	6	May	May	NNP
25944	62	7	,	,	,
25944	62	8	1902	1902	CD
25944	62	9	,	,	,
25944	62	10	September	September	NNP
25944	62	11	,	,	,
25944	62	12	1903	1903	CD
25944	62	13	.	.	.
25944	63	1	Revised	revise	VBN
25944	63	2	,	,	,
25944	63	3	reprinted	reprint	VBN
25944	63	4	January	January	NNP
25944	63	5	,	,	,
25944	63	6	1905	1905	CD
25944	63	7	.	.	.
25944	64	1	Reprinted	Reprinted	NNP
25944	64	2	March	March	NNP
25944	64	3	,	,	,
25944	64	4	1906	1906	CD
25944	64	5	.	.	.
25944	65	1	Revised	revise	VBN
25944	65	2	,	,	,
25944	65	3	reprinted	reprint	VBN
25944	65	4	March	March	NNP
25944	65	5	,	,	,
25944	65	6	1909	1909	CD
25944	65	7	.	.	.
25944	66	1	Printed	Printed	NNP
25944	66	2	in	in	IN
25944	66	3	America	America	NNP
25944	66	4	Press	Press	NNP
25944	66	5	of	of	IN
25944	66	6	W.	W.	NNP
25944	66	7	B.	B.	NNP
25944	66	8	Saunders	Saunders	NNP
25944	66	9	Company	Company	NNP
25944	66	10	Philadelphia	Philadelphia	NNP
25944	66	11	PREFACE	PREFACE	NNP
25944	66	12	TO	to	IN
25944	66	13	SEVENTH	SEVENTH	NNP
25944	66	14	EDITION	EDITION	NNP
25944	66	15	.	.	.
25944	67	1	In	in	IN
25944	67	2	the	the	DT
25944	67	3	present	present	JJ
25944	67	4	--	--	:
25944	67	5	seventh	seventh	JJ
25944	67	6	--	--	:
25944	67	7	edition	edition	NN
25944	67	8	the	the	DT
25944	67	9	subject	subject	JJ
25944	67	10	matter	matter	NN
25944	67	11	,	,	,
25944	67	12	especially	especially	RB
25944	67	13	as	as	IN
25944	67	14	regards	regard	VBZ
25944	67	15	the	the	DT
25944	67	16	practical	practical	JJ
25944	67	17	part	part	NN
25944	67	18	,	,	,
25944	67	19	has	have	VBZ
25944	67	20	been	be	VBN
25944	67	21	gone	go	VBN
25944	67	22	over	over	RB
25944	67	23	carefully	carefully	RB
25944	67	24	and	and	CC
25944	67	25	the	the	DT
25944	67	26	necessary	necessary	JJ
25944	67	27	corrections	correction	NNS
25944	67	28	and	and	CC
25944	67	29	additions	addition	NNS
25944	67	30	made	make	VBD
25944	67	31	.	.	.
25944	68	1	Nineteen	nineteen	CD
25944	68	2	new	new	JJ
25944	68	3	illustrations	illustration	NNS
25944	68	4	have	have	VBP
25944	68	5	been	be	VBN
25944	68	6	added	add	VBN
25944	68	7	,	,	,
25944	68	8	a	a	DT
25944	68	9	few	few	JJ
25944	68	10	of	of	IN
25944	68	11	the	the	DT
25944	68	12	old	old	JJ
25944	68	13	ones	one	NNS
25944	68	14	being	be	VBG
25944	68	15	eliminated	eliminate	VBN
25944	68	16	.	.	.
25944	69	1	It	-PRON-	PRP
25944	69	2	is	be	VBZ
25944	69	3	hoped	hope	VBN
25944	69	4	that	that	IN
25944	69	5	the	the	DT
25944	69	6	continued	continue	VBN
25944	69	7	demand	demand	NN
25944	69	8	for	for	IN
25944	69	9	this	this	DT
25944	69	10	compend	compend	NN
25944	69	11	means	mean	VBZ
25944	69	12	a	a	DT
25944	69	13	widening	widen	VBG
25944	69	14	interest	interest	NN
25944	69	15	in	in	IN
25944	69	16	the	the	DT
25944	69	17	study	study	NN
25944	69	18	of	of	IN
25944	69	19	diseases	disease	NNS
25944	69	20	of	of	IN
25944	69	21	the	the	DT
25944	69	22	skin	skin	NN
25944	69	23	,	,	,
25944	69	24	sufficiently	sufficiently	RB
25944	69	25	keen	keen	JJ
25944	69	26	as	as	IN
25944	69	27	to	to	TO
25944	69	28	lead	lead	VB
25944	69	29	to	to	IN
25944	69	30	the	the	DT
25944	69	31	desire	desire	NN
25944	69	32	for	for	IN
25944	69	33	a	a	DT
25944	69	34	still	still	RB
25944	69	35	greater	great	JJR
25944	69	36	knowledge	knowledge	NN
25944	69	37	.	.	.
25944	70	1	H.W.S.	H.W.S.	NNP
25944	71	1	PREFACE	preface	VB
25944	71	2	TO	to	IN
25944	71	3	FIRST	FIRST	NNP
25944	71	4	EDITION	EDITION	NNP
25944	71	5	.	.	.
25944	72	1	Much	much	JJ
25944	72	2	of	of	IN
25944	72	3	the	the	DT
25944	72	4	present	present	JJ
25944	72	5	volume	volume	NN
25944	72	6	is	be	VBZ
25944	72	7	,	,	,
25944	72	8	in	in	IN
25944	72	9	a	a	DT
25944	72	10	measure	measure	NN
25944	72	11	,	,	,
25944	72	12	the	the	DT
25944	72	13	outcome	outcome	NN
25944	72	14	of	of	IN
25944	72	15	a	a	DT
25944	72	16	thorough	thorough	JJ
25944	72	17	revision	revision	NN
25944	72	18	,	,	,
25944	72	19	remodelling	remodelling	NN
25944	72	20	and	and	CC
25944	72	21	simplification	simplification	NN
25944	72	22	of	of	IN
25944	72	23	the	the	DT
25944	72	24	various	various	JJ
25944	72	25	articles	article	NNS
25944	72	26	contributed	contribute	VBN
25944	72	27	by	by	IN
25944	72	28	the	the	DT
25944	72	29	author	author	NN
25944	72	30	to	to	IN
25944	72	31	Pepper	Pepper	NNP
25944	72	32	's	's	POS
25944	72	33	System	System	NNP
25944	72	34	of	of	IN
25944	72	35	Medicine	Medicine	NNP
25944	72	36	,	,	,
25944	72	37	Buck	Buck	NNP
25944	72	38	's	's	POS
25944	72	39	Reference	Reference	NNP
25944	72	40	Handbook	Handbook	NNP
25944	72	41	of	of	IN
25944	72	42	the	the	DT
25944	72	43	Medical	Medical	NNP
25944	72	44	Sciences	Sciences	NNPS
25944	72	45	,	,	,
25944	72	46	and	and	CC
25944	72	47	Keating	Keating	NNP
25944	72	48	's	's	POS
25944	72	49	Cyclopædia	Cyclopædia	NNP
25944	72	50	of	of	IN
25944	72	51	the	the	DT
25944	72	52	Diseases	Diseases	NNPS
25944	72	53	of	of	IN
25944	72	54	Children	Children	NNP
25944	72	55	.	.	.
25944	73	1	Moreover	moreover	RB
25944	73	2	,	,	,
25944	73	3	in	in	IN
25944	73	4	the	the	DT
25944	73	5	endeavor	endeavor	NN
25944	73	6	to	to	TO
25944	73	7	present	present	VB
25944	73	8	the	the	DT
25944	73	9	subject	subject	NN
25944	73	10	as	as	IN
25944	73	11	tersely	tersely	RB
25944	73	12	and	and	CC
25944	73	13	briefly	briefly	RB
25944	73	14	as	as	IN
25944	73	15	compatible	compatible	JJ
25944	73	16	with	with	IN
25944	73	17	clear	clear	JJ
25944	73	18	understanding	understanding	NN
25944	73	19	,	,	,
25944	73	20	the	the	DT
25944	73	21	several	several	JJ
25944	73	22	standard	standard	JJ
25944	73	23	treatises	treatise	NNS
25944	73	24	on	on	IN
25944	73	25	diseases	disease	NNS
25944	73	26	of	of	IN
25944	73	27	the	the	DT
25944	73	28	skin	skin	NN
25944	73	29	by	by	IN
25944	73	30	Tilbury	Tilbury	NNP
25944	73	31	Fox	Fox	NNP
25944	73	32	,	,	,
25944	73	33	Duhring	Duhring	NNP
25944	73	34	,	,	,
25944	73	35	Hyde	Hyde	NNP
25944	73	36	,	,	,
25944	73	37	Robinson	Robinson	NNP
25944	73	38	,	,	,
25944	73	39	Anderson	Anderson	NNP
25944	73	40	,	,	,
25944	73	41	and	and	CC
25944	73	42	Crocker	Crocker	NNP
25944	73	43	,	,	,
25944	73	44	have	have	VBP
25944	73	45	been	be	VBN
25944	73	46	freely	freely	RB
25944	73	47	consulted	consult	VBN
25944	73	48	,	,	,
25944	73	49	that	that	DT
25944	73	50	of	of	IN
25944	73	51	the	the	DT
25944	73	52	last	last	RB
25944	73	53	-	-	HYPH
25944	73	54	named	name	VBN
25944	73	55	author	author	NN
25944	73	56	suggesting	suggest	VBG
25944	73	57	the	the	DT
25944	73	58	pictorial	pictorial	JJ
25944	73	59	presentation	presentation	NN
25944	73	60	of	of	IN
25944	73	61	the	the	DT
25944	73	62	"	"	``
25944	73	63	Anatomy	Anatomy	NNP
25944	73	64	of	of	IN
25944	73	65	the	the	DT
25944	73	66	Skin	skin	NN
25944	73	67	.	.	.
25944	73	68	"	"	''
25944	74	1	The	the	DT
25944	74	2	space	space	NN
25944	74	3	allotted	allot	VBD
25944	74	4	to	to	IN
25944	74	5	each	each	DT
25944	74	6	disease	disease	NN
25944	74	7	has	have	VBZ
25944	74	8	been	be	VBN
25944	74	9	based	base	VBN
25944	74	10	upon	upon	IN
25944	74	11	relative	relative	JJ
25944	74	12	importance	importance	NN
25944	74	13	.	.	.
25944	75	1	As	as	IN
25944	75	2	to	to	IN
25944	75	3	treatment	treatment	NN
25944	75	4	,	,	,
25944	75	5	the	the	DT
25944	75	6	best	good	JJS
25944	75	7	and	and	CC
25944	75	8	approved	approve	VBN
25944	75	9	methods	method	NNS
25944	75	10	only	only	RB
25944	75	11	--	--	:
25944	75	12	those	those	DT
25944	75	13	which	which	WDT
25944	75	14	are	be	VBP
25944	75	15	founded	found	VBN
25944	75	16	upon	upon	IN
25944	75	17	the	the	DT
25944	75	18	aggregate	aggregate	JJ
25944	75	19	experience	experience	NN
25944	75	20	of	of	IN
25944	75	21	dermatologists	dermatologist	NNS
25944	75	22	--	--	:
25944	75	23	are	be	VBP
25944	75	24	referred	refer	VBN
25944	75	25	to	to	IN
25944	75	26	.	.	.
25944	76	1	For	for	IN
25944	76	2	general	general	JJ
25944	76	3	information	information	NN
25944	76	4	a	a	DT
25944	76	5	statistical	statistical	JJ
25944	76	6	table	table	NN
25944	76	7	from	from	IN
25944	76	8	the	the	DT
25944	76	9	Transactions	transaction	NNS
25944	76	10	of	of	IN
25944	76	11	the	the	DT
25944	76	12	American	American	NNP
25944	76	13	Dermatological	Dermatological	NNP
25944	76	14	Association	Association	NNP
25944	76	15	is	be	VBZ
25944	76	16	appended	append	VBN
25944	76	17	.	.	.
25944	77	1	H.W.S.	H.W.S.	NNP
25944	78	1	CONTENTS	content	NNS
25944	78	2	.	.	.
25944	79	1	PAGE	page	NN
25944	79	2	ANATOMY	anatomy	VBP
25944	79	3	OF	of	IN
25944	79	4	THE	the	DT
25944	79	5	SKIN	skin	NN
25944	79	6	17	17	CD
25944	79	7	The	the	DT
25944	79	8	Epidermis	Epidermis	NNP
25944	79	9	18	18	CD
25944	79	10	The	the	DT
25944	79	11	Blood	blood	NN
25944	79	12	-	-	HYPH
25944	79	13	vessels	vessel	NNS
25944	79	14	19	19	CD
25944	79	15	The	the	DT
25944	79	16	Nervous	nervous	JJ
25944	79	17	and	and	CC
25944	79	18	Vascular	vascular	JJ
25944	79	19	Papillæ	Papillæ	NNP
25944	79	20	20	20	CD
25944	79	21	The	the	DT
25944	79	22	Hair	Hair	NNP
25944	79	23	and	and	CC
25944	79	24	Hair	Hair	NNP
25944	79	25	-	-	HYPH
25944	79	26	follicle	follicle	NNP
25944	79	27	21	21	CD
25944	79	28	SYMPTOMATOLOGY	symptomatology	NN
25944	79	29	22	22	CD
25944	79	30	Primary	Primary	NNP
25944	79	31	Lesions	Lesions	NNP
25944	79	32	22	22	CD
25944	79	33	Secondary	Secondary	NNP
25944	79	34	Lesions	Lesions	NNP
25944	79	35	23	23	CD
25944	79	36	Distribution	distribution	NN
25944	79	37	and	and	CC
25944	79	38	Configuration	Configuration	NNP
25944	79	39	24	24	CD
25944	79	40	Relative	Relative	NNP
25944	79	41	Frequency	Frequency	NNP
25944	79	42	26	26	CD
25944	79	43	Contagiousness	Contagiousness	NNP
25944	79	44	27	27	CD
25944	79	45	Rapidity	rapidity	NN
25944	79	46	of	of	IN
25944	79	47	Cure	Cure	NNP
25944	79	48	27	27	CD
25944	79	49	Ointment	ointment	NN
25944	79	50	Bases	basis	NNS
25944	79	51	27	27	CD
25944	79	52	CLASS	class	NN
25944	79	53	I.--DISORDERS	I.--DISORDERS	:
25944	79	54	OF	of	IN
25944	79	55	THE	the	DT
25944	79	56	GLANDS	GLANDS	NNP
25944	79	57	28	28	CD
25944	79	58	Hyperidrosis	Hyperidrosis	NNP
25944	79	59	28	28	CD
25944	79	60	Sudamen	Sudamen	NNP
25944	79	61	30	30	CD
25944	79	62	Hydrocystoma	hydrocystoma	NN
25944	79	63	31	31	CD
25944	79	64	Anidrosis	Anidrosis	NNP
25944	79	65	31	31	CD
25944	79	66	Bromidrosis	Bromidrosis	NNP
25944	79	67	32	32	CD
25944	79	68	Chromidrosis	Chromidrosis	NNP
25944	79	69	32	32	CD
25944	79	70	Uridrosis	Uridrosis	NNP
25944	79	71	33	33	CD
25944	79	72	Phosphoridrosis	Phosphoridrosis	NNP
25944	79	73	33	33	CD
25944	79	74	Seborrh[oe]a	seborrh[oe]a	CD
25944	79	75	(	(	-LRB-
25944	79	76	Eczema	Eczema	NNP
25944	79	77	Seborrhoicum	Seborrhoicum	NNP
25944	79	78	)	)	-RRB-
25944	79	79	33	33	CD
25944	79	80	Comedo	Comedo	NNP
25944	79	81	38	38	CD
25944	79	82	Milium	Milium	NNP
25944	79	83	42	42	CD
25944	79	84	Steatoma	Steatoma	NNP
25944	79	85	43	43	CD
25944	79	86	CLASS	clas	NNS
25944	79	87	II.--INFLAMMATIONS	ii.--inflammations	CD
25944	79	88	44	44	CD
25944	79	89	Erythema	Erythema	NNP
25944	79	90	Simplex	Simplex	NNP
25944	79	91	44	44	CD
25944	79	92	Erythema	Erythema	NNP
25944	79	93	Intertrigo	Intertrigo	NNP
25944	79	94	45	45	CD
25944	79	95	Erythema	Erythema	NNP
25944	79	96	Multiforme	Multiforme	NNP
25944	79	97	46	46	CD
25944	79	98	Erythema	Erythema	NNP
25944	79	99	Nodosum	Nodosum	NNP
25944	79	100	50	50	CD
25944	79	101	Erythema	Erythema	NNP
25944	79	102	Induratum	Induratum	NNP
25944	79	103	51	51	CD
25944	79	104	Urticaria	Urticaria	NNP
25944	79	105	52	52	CD
25944	79	106	Urticaria	Urticaria	NNP
25944	79	107	Pigmentosa	Pigmentosa	NNP
25944	79	108	56	56	CD
25944	79	109	Dermatitis	Dermatitis	NNP
25944	79	110	58	58	CD
25944	79	111	Dermatitis	Dermatitis	NNP
25944	79	112	Medicamentosa	Medicamentosa	NNP
25944	79	113	60	60	CD
25944	79	114	X	X	NNP
25944	79	115	-	-	HYPH
25944	79	116	Ray	Ray	NNP
25944	79	117	Dermatitis	Dermatitis	NNP
25944	79	118	63	63	NNP
25944	79	119	Dermatitis	Dermatitis	NNP
25944	79	120	Factitia	Factitia	NNP
25944	79	121	64	64	CD
25944	79	122	Dermatitis	Dermatitis	NNP
25944	79	123	Gangrænosa	Gangrænosa	NNP
25944	79	124	65	65	CD
25944	79	125	Erysipelas	Erysipelas	NNP
25944	79	126	66	66	CD
25944	79	127	Phlegmona	Phlegmona	NNP
25944	79	128	Diffusa	Diffusa	NNP
25944	79	129	68	68	CD
25944	79	130	Furunculus	Furunculus	NNP
25944	79	131	68	68	CD
25944	79	132	Carbunculus	Carbunculus	NNP
25944	79	133	70	70	CD
25944	79	134	Pustula	Pustula	NNP
25944	79	135	Maligna	Maligna	NNP
25944	79	136	72	72	CD
25944	79	137	Post	post	NN
25944	79	138	-	-	JJ
25944	79	139	mortem	mortem	JJ
25944	79	140	Pustule	Pustule	NNP
25944	79	141	73	73	CD
25944	79	142	Framb[oe]sia	framb[oe]sia	$
25944	79	143	73	73	CD
25944	79	144	Verruga	Verruga	NNP
25944	79	145	Peruana	Peruana	NNP
25944	79	146	73	73	CD
25944	79	147	Equinia	Equinia	NNP
25944	79	148	74	74	CD
25944	79	149	Miliaria	Miliaria	NNP
25944	79	150	74	74	CD
25944	79	151	Pompholyx	Pompholyx	NNP
25944	79	152	76	76	CD
25944	79	153	Herpes	Herpes	NNP
25944	79	154	Simplex	Simplex	NNP
25944	79	155	78	78	CD
25944	79	156	Hydroa	Hydroa	NNP
25944	79	157	Vacciniforme	Vacciniforme	NNP
25944	79	158	80	80	CD
25944	79	159	Epidermolysis	Epidermolysis	NNP
25944	79	160	Bullosa	Bullosa	NNP
25944	79	161	80	80	CD
25944	79	162	Dermatitis	Dermatitis	NNP
25944	79	163	Repens	Repens	NNP
25944	79	164	81	81	CD
25944	79	165	Herpes	herpe	NNS
25944	79	166	Zoster	Zoster	NNP
25944	79	167	81	81	CD
25944	79	168	Dermatitis	Dermatitis	NNP
25944	79	169	Herpetiformis	Herpetiformis	NNP
25944	79	170	83	83	CD
25944	79	171	Psoriasis	psoriasis	NN
25944	79	172	86	86	CD
25944	79	173	Pityriasis	Pityriasis	NNP
25944	79	174	Rosea	Rosea	NNP
25944	79	175	95	95	CD
25944	79	176	Dermatitis	Dermatitis	NNP
25944	79	177	Exfoliativa	Exfoliativa	NNP
25944	79	178	96	96	CD
25944	79	179	Lichen	Lichen	NNP
25944	79	180	Planus	Planus	NNP
25944	79	181	98	98	CD
25944	79	182	Pityriasis	Pityriasis	NNP
25944	79	183	Rubra	Rubra	NNP
25944	79	184	Pilaris	Pilaris	NNP
25944	79	185	99	99	CD
25944	79	186	Lichen	Lichen	NNP
25944	79	187	Scrofulosus	Scrofulosus	NNP
25944	79	188	100	100	CD
25944	79	189	Eczema	eczema	NN
25944	79	190	100	100	CD
25944	79	191	Prurigo	Prurigo	NNS
25944	79	192	118	118	CD
25944	79	193	Acne	Acne	NNP
25944	79	194	119	119	CD
25944	79	195	Acne	Acne	NNP
25944	79	196	Rosacea	Rosacea	NNP
25944	79	197	126	126	CD
25944	79	198	Sycosis	Sycosis	NNP
25944	79	199	130	130	CD
25944	79	200	Dermatitis	Dermatitis	NNP
25944	79	201	Papillaris	Papillaris	NNP
25944	79	202	Capillitii	Capillitii	NNP
25944	79	203	135	135	CD
25944	79	204	Impetigo	Impetigo	NNP
25944	79	205	Contagiosa	Contagiosa	NNP
25944	79	206	136	136	CD
25944	79	207	Impetigo	Impetigo	NNP
25944	79	208	Herpetiformis	Herpetiformis	NNP
25944	79	209	138	138	CD
25944	79	210	Ecthyma	Ecthyma	NNP
25944	79	211	138	138	CD
25944	79	212	Pemphigus	Pemphigus	NNP
25944	79	213	140	140	CD
25944	79	214	CLASS	CLASS	NNP
25944	79	215	III.--HEMORRHAGES	III.--HEMORRHAGES	NNP
25944	79	216	144	144	CD
25944	79	217	Purpura	Purpura	NNP
25944	79	218	144	144	CD
25944	79	219	Scorbutus	Scorbutus	NNP
25944	79	220	146	146	CD
25944	79	221	CLASS	class	NN
25944	79	222	IV.--HYPERTROPHIES	iv.--hypertrophies	CD
25944	79	223	148	148	CD
25944	79	224	Lentigo	Lentigo	NNP
25944	79	225	148	148	CD
25944	79	226	Chloasma	Chloasma	NNP
25944	79	227	149	149	CD
25944	79	228	Keratosis	Keratosis	NNP
25944	79	229	Pilaris	Pilaris	NNP
25944	79	230	151	151	CD
25944	79	231	Keratosis	Keratosis	NNP
25944	79	232	Follicularis	Follicularis	NNP
25944	79	233	153	153	CD
25944	79	234	Molluscum	Molluscum	NNP
25944	79	235	Epitheliale	Epitheliale	NNP
25944	79	236	153	153	CD
25944	79	237	Callositas	Callositas	NNP
25944	79	238	155	155	CD
25944	79	239	Clavus	Clavus	NNP
25944	79	240	156	156	CD
25944	79	241	Cornu	Cornu	NNP
25944	79	242	Cutaneum	Cutaneum	NNP
25944	79	243	158	158	CD
25944	79	244	Verruca	verruca	NN
25944	79	245	160	160	CD
25944	79	246	Nævus	Nævus	NNP
25944	79	247	Pigmentosus	Pigmentosus	NNP
25944	79	248	162	162	CD
25944	79	249	Ichthyosis	Ichthyosis	NNP
25944	79	250	165	165	CD
25944	79	251	Onychauxis	Onychauxis	NNP
25944	79	252	167	167	CD
25944	79	253	Hypertrichosis	hypertrichosis	NN
25944	79	254	168	168	CD
25944	79	255	[	[	-LRB-
25944	79	256	OE]dema	OE]dema	NNP
25944	79	257	Neonatorum	Neonatorum	NNP
25944	79	258	170	170	CD
25944	79	259	Sclerema	Sclerema	NNP
25944	79	260	Neonatorum	Neonatorum	NNP
25944	79	261	171	171	CD
25944	79	262	Scleroderma	Scleroderma	NNP
25944	79	263	172	172	CD
25944	79	264	Elephantiasis	Elephantiasis	NNP
25944	79	265	174	174	CD
25944	79	266	Dermatolysis	Dermatolysis	NNP
25944	79	267	176	176	CD
25944	79	268	CLASS	clas	NNS
25944	79	269	V.--ATROPHIES	v.--atrophies	ADD
25944	79	270	177	177	CD
25944	79	271	Albinismus	Albinismus	NNP
25944	79	272	177	177	CD
25944	79	273	Vitiligo	Vitiligo	NNS
25944	79	274	178	178	CD
25944	79	275	Canities	canitie	NNS
25944	79	276	180	180	CD
25944	79	277	Alopecia	alopecia	NN
25944	79	278	181	181	CD
25944	79	279	Alopecia	Alopecia	NNP
25944	79	280	Areata	Areata	NNP
25944	79	281	183	183	CD
25944	79	282	Atrophia	Atrophia	NNP
25944	79	283	Pilorum	Pilorum	NNP
25944	79	284	Propria	Propria	NNP
25944	79	285	187	187	CD
25944	79	286	Atrophia	Atrophia	NNP
25944	79	287	Unguis	Unguis	NNP
25944	79	288	188	188	CD
25944	79	289	Atrophia	Atrophia	NNP
25944	79	290	Cutis	Cutis	NNP
25944	79	291	189	189	CD
25944	79	292	CLASS	class	NN
25944	79	293	VI.--NEW	VI.--NEW	NNS
25944	79	294	GROWTHS	growths	NN
25944	79	295	191	191	CD
25944	79	296	Keloid	Keloid	NNP
25944	79	297	191	191	CD
25944	79	298	Fibroma	Fibroma	NNP
25944	79	299	192	192	CD
25944	79	300	Neuroma	Neuroma	NNP
25944	79	301	194	194	CD
25944	79	302	Xanthoma	Xanthoma	NNP
25944	79	303	195	195	CD
25944	79	304	Myoma	Myoma	NNP
25944	79	305	196	196	CD
25944	79	306	Angioma	angioma	NN
25944	79	307	196	196	CD
25944	79	308	Telangiectasis	Telangiectasis	NNP
25944	79	309	197	197	CD
25944	79	310	Lymphangioma	Lymphangioma	NNP
25944	79	311	198	198	CD
25944	79	312	Rhinoscleroma	Rhinoscleroma	NNP
25944	79	313	198	198	CD
25944	79	314	Lupus	Lupus	NNP
25944	79	315	Erythematosus	Erythematosus	NNP
25944	79	316	199	199	CD
25944	79	317	Lupus	Lupus	NNP
25944	79	318	Vulgaris	Vulgaris	NNP
25944	79	319	203	203	CD
25944	79	320	Tuberculosis	Tuberculosis	NNP
25944	79	321	Cutis	Cutis	NNP
25944	79	322	209	209	CD
25944	79	323	Ainhum	Ainhum	NNP
25944	79	324	212	212	CD
25944	79	325	Mycetoma	Mycetoma	NNP
25944	79	326	212	212	CD
25944	79	327	Perforating	Perforating	NNP
25944	79	328	Ulcer	Ulcer	NNP
25944	79	329	of	of	IN
25944	79	330	the	the	DT
25944	79	331	Foot	Foot	NNP
25944	79	332	213	213	CD
25944	79	333	Syphilis	Syphilis	NNP
25944	79	334	Cutanea	Cutanea	NNP
25944	79	335	213	213	CD
25944	79	336	Lepra	Lepra	NNP
25944	79	337	231	231	CD
25944	79	338	Pellagra	Pellagra	NNP
25944	79	339	235	235	CD
25944	79	340	Epithelioma	Epithelioma	NNP
25944	79	341	236	236	CD
25944	79	342	Paget	Paget	NNP
25944	79	343	's	's	POS
25944	79	344	Disease	Disease	NNP
25944	79	345	of	of	IN
25944	79	346	the	the	DT
25944	79	347	Nipple	Nipple	NNP
25944	79	348	240	240	CD
25944	79	349	Sarcoma	Sarcoma	NNP
25944	79	350	241	241	CD
25944	79	351	Granuloma	Granuloma	NNP
25944	79	352	Fungoides	fungoide	NNS
25944	79	353	242	242	CD
25944	79	354	CLASS	class	NN
25944	79	355	VII.--NEUROSES	VII.--NEUROSES	NNP
25944	79	356	244	244	CD
25944	79	357	Hyperæsthesia	Hyperæsthesia	NNP
25944	79	358	244	244	CD
25944	79	359	Dermatalgia	Dermatalgia	NNP
25944	79	360	244	244	CD
25944	79	361	Anæsthesia	Anæsthesia	NNP
25944	79	362	244	244	CD
25944	79	363	Pruritus	Pruritus	NNP
25944	79	364	244	244	CD
25944	79	365	CLASS	class	NN
25944	79	366	VIII.--PARASITIC	viii.--parasitic	NN
25944	79	367	AFFECTIONS	affection	NNS
25944	79	368	247	247	CD
25944	79	369	Tinea	Tinea	NNP
25944	79	370	Favosa	Favosa	NNP
25944	79	371	247	247	CD
25944	79	372	Tinea	Tinea	NNP
25944	79	373	Trichophytina	Trichophytina	NNP
25944	79	374	251	251	CD
25944	79	375	Tinea	Tinea	NNP
25944	79	376	Imbricata	imbricata	NN
25944	79	377	261	261	CD
25944	79	378	Tinea	Tinea	NNP
25944	79	379	Versicolor	Versicolor	NNP
25944	79	380	262	262	CD
25944	79	381	Erythrasma	Erythrasma	NNP
25944	79	382	265	265	CD
25944	79	383	Actinomycosis	Actinomycosis	NNP
25944	79	384	266	266	CD
25944	79	385	Blastomycetic	Blastomycetic	NNP
25944	79	386	Dermatitis	Dermatitis	NNP
25944	79	387	266	266	CD
25944	79	388	Scabies	scabie	NNS
25944	79	389	267	267	CD
25944	79	390	Pediculosis	Pediculosis	NNP
25944	79	391	271	271	CD
25944	79	392	Pediculosis	Pediculosis	NNP
25944	79	393	Capitis	Capitis	NNP
25944	79	394	272	272	CD
25944	79	395	Pediculosis	Pediculosis	NNP
25944	79	396	Corporis	Corporis	NNP
25944	79	397	274	274	CD
25944	79	398	Pediculosis	Pediculosis	NNP
25944	79	399	Pubis	Pubis	NNP
25944	79	400	275	275	CD
25944	79	401	Cysticercus	Cysticercus	NNP
25944	79	402	Cellulosæ	Cellulosæ	NNP
25944	79	403	276	276	CD
25944	79	404	Filaria	Filaria	NNP
25944	79	405	Medinensis	Medinensis	NNP
25944	79	406	277	277	CD
25944	79	407	Ixodes	ixode	NNS
25944	79	408	277	277	CD
25944	79	409	Leptus	Leptus	NNP
25944	79	410	277	277	CD
25944	79	411	[	[	-LRB-
25944	79	412	OE]strus	OE]strus	NNP
25944	79	413	278	278	CD
25944	79	414	Pulex	Pulex	NNP
25944	79	415	Penetrans	Penetrans	NNP
25944	79	416	278	278	CD
25944	79	417	Cimex	Cimex	NNP
25944	79	418	Lectularius	Lectularius	NNP
25944	79	419	278	278	CD
25944	79	420	Culex	Culex	NNP
25944	79	421	279	279	CD
25944	79	422	Pulex	Pulex	NNP
25944	79	423	Irritans	Irritans	NNP
25944	79	424	279	279	CD
25944	79	425	TABLE	TABLE	NNS
25944	79	426	showing	show	VBG
25944	79	427	Relative	Relative	NNP
25944	79	428	Frequency	Frequency	NNP
25944	79	429	of	of	IN
25944	79	430	the	the	DT
25944	79	431	Various	Various	NNP
25944	79	432	Diseases	Diseases	NNPS
25944	79	433	of	of	IN
25944	79	434	the	the	DT
25944	79	435	Skin	skin	NN
25944	79	436	280	280	CD
25944	79	437	DISEASES	disease	NNS
25944	79	438	OF	of	IN
25944	79	439	THE	the	DT
25944	79	440	SKIN	skin	NN
25944	79	441	.	.	.
25944	80	1	#	#	VBG
25944	80	2	ANATOMY	anatomy	VBP
25944	80	3	OF	of	IN
25944	80	4	THE	the	DT
25944	80	5	SKIN	skin	NN
25944	80	6	.	.	.
25944	80	7	#	#	$
25944	80	8	[	[	-LRB-
25944	80	9	Illustration	illustration	NN
25944	80	10	:	:	:
25944	80	11	Fig	Fig	NNP
25944	80	12	.	.	.
25944	81	1	I.	I.	NNP
25944	81	2	Vertical	vertical	JJ
25944	81	3	section	section	NN
25944	81	4	of	of	IN
25944	81	5	the	the	DT
25944	81	6	skin	skin	NN
25944	81	7	--	--	:
25944	81	8	Diagrammatic	diagrammatic	JJ
25944	81	9	.	.	.
25944	82	1	(	(	-LRB-
25944	82	2	_	_	NNP
25944	82	3	After	after	IN
25944	82	4	Heitsmann	Heitsmann	NNP
25944	82	5	.	.	.
25944	82	6	_	_	NNP
25944	82	7	)	)	-RRB-
25944	82	8	]	]	-RRB-
25944	82	9	#	#	$
25944	82	10	The	the	DT
25944	82	11	Epidermis	Epidermis	NNP
25944	82	12	.	.	.
25944	82	13	#	#	$
25944	82	14	[	[	-LRB-
25944	82	15	Illustration	illustration	NN
25944	82	16	:	:	:
25944	82	17	Fig	Fig	NNP
25944	82	18	.	.	.
25944	83	1	2	2	LS
25944	83	2	.	.	.
25944	84	1	_	_	NNP
25944	84	2	c	c	NNP
25944	84	3	_	_	NNP
25944	84	4	,	,	,
25944	84	5	corneous	corneous	JJ
25944	84	6	(	(	-LRB-
25944	84	7	horny	horny	NN
25944	84	8	)	)	-RRB-
25944	84	9	layer	layer	NN
25944	84	10	;	;	:
25944	84	11	_	_	NNP
25944	84	12	g	g	NNP
25944	84	13	_	_	NNP
25944	84	14	,	,	,
25944	84	15	granular	granular	JJ
25944	84	16	layer	layer	NN
25944	84	17	;	;	:
25944	84	18	_	_	NNP
25944	84	19	m	m	NNP
25944	84	20	_	_	NNP
25944	84	21	,	,	,
25944	84	22	mucous	mucous	JJ
25944	84	23	layer	layer	NN
25944	84	24	(	(	-LRB-
25944	84	25	rete	rete	NN
25944	84	26	Malpighii	Malpighii	NNP
25944	84	27	)	)	-RRB-
25944	84	28	.	.	.
25944	85	1	The	the	DT
25944	85	2	stratum	stratum	JJ
25944	85	3	lucidum	lucidum	NN
25944	85	4	is	be	VBZ
25944	85	5	the	the	DT
25944	85	6	layer	layer	NN
25944	85	7	just	just	RB
25944	85	8	above	above	IN
25944	85	9	the	the	DT
25944	85	10	granular	granular	JJ
25944	85	11	layer	layer	NN
25944	85	12	.	.	.
25944	86	1	Nerve	Nerve	NNP
25944	86	2	terminations--_n	terminations--_n	NNP
25944	86	3	_	_	NNP
25944	86	4	,	,	,
25944	86	5	afferent	afferent	NN
25944	86	6	nerve	nerve	NN
25944	86	7	;	;	:
25944	86	8	_	_	NNP
25944	86	9	b	b	NNP
25944	86	10	_	_	NNP
25944	86	11	,	,	,
25944	86	12	terminal	terminal	JJ
25944	86	13	nerve	nerve	NN
25944	86	14	bulbs	bulb	NNS
25944	86	15	;	;	:
25944	86	16	_	_	NNP
25944	86	17	l	l	NNP
25944	86	18	_	_	NNP
25944	86	19	,	,	,
25944	86	20	cell	cell	NN
25944	86	21	of	of	IN
25944	86	22	Langerhans	Langerhans	NNPS
25944	86	23	.	.	.
25944	87	1	(	(	-LRB-
25944	87	2	_	_	NNP
25944	87	3	After	after	IN
25944	87	4	Ranvier	Ranvier	NNP
25944	87	5	.	.	.
25944	87	6	_	_	NNP
25944	87	7	)	)	-RRB-
25944	87	8	]	]	-RRB-
25944	87	9	#	#	$
25944	87	10	The	the	DT
25944	87	11	Blood	blood	NN
25944	87	12	-	-	HYPH
25944	87	13	vessels	vessel	NNS
25944	87	14	.	.	.
25944	87	15	#	#	$
25944	87	16	[	[	-LRB-
25944	87	17	Illustration	illustration	NN
25944	87	18	:	:	:
25944	87	19	Fig	Fig	NNP
25944	87	20	.	.	.
25944	88	1	3	3	LS
25944	88	2	.	.	.
25944	89	1	_	_	NNP
25944	89	2	C	C	NNP
25944	89	3	_	_	NNP
25944	89	4	,	,	,
25944	89	5	epidermis	epidermis	NN
25944	89	6	;	;	:
25944	89	7	_	_	NNP
25944	89	8	D	D	NNP
25944	89	9	_	_	NNP
25944	89	10	,	,	,
25944	89	11	corium	corium	NN
25944	89	12	;	;	:
25944	89	13	_	_	NNP
25944	89	14	P	P	NNP
25944	89	15	_	_	NNP
25944	89	16	,	,	,
25944	89	17	papillæ	papillæ	NN
25944	89	18	;	;	:
25944	89	19	_	_	NNP
25944	89	20	S	S	NNP
25944	89	21	_	_	NNP
25944	89	22	,	,	,
25944	89	23	sweat	sweat	NN
25944	89	24	-	-	HYPH
25944	89	25	gland	gland	NN
25944	89	26	duct	duct	NN
25944	89	27	.	.	.
25944	90	1	_	_	NNP
25944	90	2	v	v	NNP
25944	90	3	_	_	NNP
25944	90	4	,	,	,
25944	90	5	arterial	arterial	JJ
25944	90	6	and	and	CC
25944	90	7	venous	venous	JJ
25944	90	8	capillaries	capillary	NNS
25944	90	9	(	(	-LRB-
25944	90	10	superficial	superficial	JJ
25944	90	11	,	,	,
25944	90	12	or	or	CC
25944	90	13	papillary	papillary	JJ
25944	90	14	plexus	plexus	NN
25944	90	15	)	)	-RRB-
25944	90	16	of	of	IN
25944	90	17	the	the	DT
25944	90	18	papillæ	papillæ	NN
25944	90	19	.	.	.
25944	91	1	Deep	deep	JJ
25944	91	2	plexus	plexus	NN
25944	91	3	is	be	VBZ
25944	91	4	partly	partly	RB
25944	91	5	shown	show	VBN
25944	91	6	at	at	IN
25944	91	7	lower	low	JJR
25944	91	8	margin	margin	NN
25944	91	9	of	of	IN
25944	91	10	the	the	DT
25944	91	11	diagram	diagram	NN
25944	91	12	;	;	:
25944	91	13	_	_	NNP
25944	91	14	vs_--an	vs_--an	NNS
25944	91	15	intermediate	intermediate	NNP
25944	91	16	plexus	plexus	NNP
25944	91	17	,	,	,
25944	91	18	an	an	DT
25944	91	19	outgrowth	outgrowth	NN
25944	91	20	from	from	IN
25944	91	21	the	the	DT
25944	91	22	deep	deep	JJ
25944	91	23	plexus	plexus	NN
25944	91	24	,	,	,
25944	91	25	supplying	supply	VBG
25944	91	26	sweat	sweat	NN
25944	91	27	-	-	HYPH
25944	91	28	glands	gland	NNS
25944	91	29	,	,	,
25944	91	30	and	and	CC
25944	91	31	giving	give	VBG
25944	91	32	a	a	DT
25944	91	33	loop	loop	NN
25944	91	34	to	to	IN
25944	91	35	hair	hair	NN
25944	91	36	papilla	papilla	NN
25944	91	37	.	.	.
25944	92	1	(	(	-LRB-
25944	92	2	_	_	NNP
25944	92	3	After	after	IN
25944	92	4	Ranvier	Ranvier	NNP
25944	92	5	.	.	.
25944	92	6	_	_	NNP
25944	92	7	)	)	-RRB-
25944	92	8	]	]	-RRB-
25944	92	9	#	#	$
25944	92	10	The	the	DT
25944	92	11	Nervous	nervous	JJ
25944	92	12	and	and	CC
25944	92	13	Vascular	Vascular	NNP
25944	92	14	Papillæ	Papillæ	NNP
25944	92	15	.	.	.
25944	92	16	#	#	$
25944	92	17	[	[	-LRB-
25944	92	18	Illustration	illustration	NN
25944	92	19	:	:	:
25944	92	20	Fig	Fig	NNP
25944	92	21	.	.	.
25944	93	1	4	4	LS
25944	93	2	.	.	.
25944	94	1	_	_	NNP
25944	94	2	a	a	DT
25944	94	3	_	_	NNP
25944	94	4	,	,	,
25944	94	5	a	a	DT
25944	94	6	vascular	vascular	JJ
25944	94	7	papilla	papilla	NN
25944	94	8	;	;	:
25944	94	9	_	_	NNP
25944	94	10	b	b	NNP
25944	94	11	_	_	NNP
25944	94	12	,	,	,
25944	94	13	a	a	DT
25944	94	14	nervous	nervous	JJ
25944	94	15	papilla	papilla	NN
25944	94	16	;	;	:
25944	94	17	_	_	NNP
25944	94	18	c	c	NNP
25944	94	19	_	_	NNP
25944	94	20	,	,	,
25944	94	21	a	a	DT
25944	94	22	blood	blood	NN
25944	94	23	-	-	HYPH
25944	94	24	vessel	vessel	NN
25944	94	25	;	;	:
25944	94	26	_	_	NNP
25944	94	27	d	d	NNP
25944	94	28	_	_	NNP
25944	94	29	,	,	,
25944	94	30	a	a	DT
25944	94	31	nerve	nerve	NN
25944	94	32	fibre	fibre	NN
25944	94	33	;	;	:
25944	94	34	_	_	NNP
25944	94	35	e	e	NNP
25944	94	36	_	_	NNP
25944	94	37	,	,	,
25944	94	38	a	a	DT
25944	94	39	tactile	tactile	NN
25944	94	40	corpuscle	corpuscle	NN
25944	94	41	.	.	.
25944	95	1	(	(	-LRB-
25944	95	2	_	_	NNP
25944	95	3	After	after	IN
25944	95	4	Biesiadecki	Biesiadecki	NNP
25944	95	5	.	.	.
25944	95	6	_	_	NNP
25944	95	7	)	)	-RRB-
25944	95	8	]	]	-RRB-
25944	95	9	#	#	$
25944	95	10	The	the	DT
25944	95	11	Hair	Hair	NNP
25944	95	12	and	and	CC
25944	95	13	Hair	Hair	NNP
25944	95	14	-	-	HYPH
25944	95	15	Follicle	Follicle	NNP
25944	95	16	.	.	.
25944	95	17	#	#	$
25944	95	18	[	[	-LRB-
25944	95	19	Illustration	illustration	NN
25944	95	20	:	:	:
25944	95	21	Fig	Fig	NNP
25944	95	22	.	.	.
25944	96	1	5	5	CD
25944	96	2	.	.	.
25944	97	1	_	_	NNP
25944	97	2	A	A	NNP
25944	97	3	_	_	NNP
25944	97	4	,	,	,
25944	97	5	shaft	shaft	NN
25944	97	6	of	of	IN
25944	97	7	the	the	DT
25944	97	8	hair	hair	NN
25944	97	9	;	;	:
25944	97	10	_	_	NNP
25944	97	11	B	B	NNP
25944	97	12	_	_	NNP
25944	97	13	,	,	,
25944	97	14	root	root	NN
25944	97	15	of	of	IN
25944	97	16	the	the	DT
25944	97	17	hair	hair	NN
25944	97	18	;	;	:
25944	97	19	_	_	NNP
25944	97	20	C	C	NNP
25944	97	21	_	_	NNP
25944	97	22	,	,	,
25944	97	23	cuticle	cuticle	NN
25944	97	24	of	of	IN
25944	97	25	the	the	DT
25944	97	26	hair	hair	NN
25944	97	27	;	;	:
25944	97	28	_	_	NNP
25944	97	29	D	D	NNP
25944	97	30	_	_	NNP
25944	97	31	,	,	,
25944	97	32	medullary	medullary	JJ
25944	97	33	substance	substance	NN
25944	97	34	of	of	IN
25944	97	35	the	the	DT
25944	97	36	hair	hair	NN
25944	97	37	.	.	.
25944	98	1	_	_	NNP
25944	98	2	E	E	NNP
25944	98	3	_	_	NNP
25944	98	4	,	,	,
25944	98	5	external	external	JJ
25944	98	6	layer	layer	NN
25944	98	7	of	of	IN
25944	98	8	the	the	DT
25944	98	9	hair	hair	NN
25944	98	10	-	-	HYPH
25944	98	11	follicle	follicle	NN
25944	98	12	;	;	:
25944	98	13	_	_	NNP
25944	98	14	F	F	NNP
25944	98	15	_	_	NNP
25944	98	16	,	,	,
25944	98	17	middle	middle	JJ
25944	98	18	layer	layer	NN
25944	98	19	of	of	IN
25944	98	20	the	the	DT
25944	98	21	hair	hair	NN
25944	98	22	-	-	HYPH
25944	98	23	follicle	follicle	NN
25944	98	24	;	;	:
25944	98	25	_	_	NNP
25944	98	26	G	G	NNP
25944	98	27	_	_	NNP
25944	98	28	,	,	,
25944	98	29	internal	internal	JJ
25944	98	30	layer	layer	NN
25944	98	31	of	of	IN
25944	98	32	the	the	DT
25944	98	33	hair	hair	NN
25944	98	34	-	-	HYPH
25944	98	35	follicle	follicle	NN
25944	98	36	;	;	:
25944	98	37	_	_	NNP
25944	98	38	H	H	NNP
25944	98	39	_	_	NNP
25944	98	40	,	,	,
25944	98	41	papilla	papilla	NN
25944	98	42	of	of	IN
25944	98	43	the	the	DT
25944	98	44	hair	hair	NN
25944	98	45	;	;	:
25944	98	46	_	_	NNP
25944	98	47	I	-PRON-	PRP
25944	98	48	_	_	NNP
25944	98	49	,	,	,
25944	98	50	external	external	JJ
25944	98	51	root	root	NN
25944	98	52	-	-	HYPH
25944	98	53	sheath	sheath	NN
25944	98	54	;	;	:
25944	98	55	_	_	NNP
25944	98	56	J	J	NNP
25944	98	57	_	_	NNP
25944	98	58	,	,	,
25944	98	59	outer	outer	JJ
25944	98	60	layer	layer	NN
25944	98	61	of	of	IN
25944	98	62	the	the	DT
25944	98	63	internal	internal	JJ
25944	98	64	root	root	NN
25944	98	65	-	-	HYPH
25944	98	66	sheath	sheath	NN
25944	98	67	;	;	:
25944	98	68	_	_	NNP
25944	98	69	K	K	NNP
25944	98	70	_	_	NNP
25944	98	71	,	,	,
25944	98	72	internal	internal	JJ
25944	98	73	layer	layer	NN
25944	98	74	of	of	IN
25944	98	75	the	the	DT
25944	98	76	internal	internal	JJ
25944	98	77	root	root	NN
25944	98	78	-	-	HYPH
25944	98	79	sheath	sheath	NN
25944	98	80	.	.	.
25944	99	1	(	(	-LRB-
25944	99	2	_	_	NNP
25944	99	3	After	after	IN
25944	99	4	Duhring	Duhring	NNP
25944	99	5	.	.	.
25944	99	6	_	_	NNP
25944	99	7	)	)	-RRB-
25944	99	8	]	]	-RRB-
25944	99	9	#	#	$
25944	99	10	SYMPTOMATOLOGY	SYMPTOMATOLOGY	NNP
25944	99	11	.	.	.
25944	99	12	#	#	$
25944	99	13	The	the	DT
25944	99	14	symptoms	symptom	NNS
25944	99	15	of	of	IN
25944	99	16	cutaneous	cutaneous	JJ
25944	99	17	disease	disease	NN
25944	99	18	may	may	MD
25944	99	19	be	be	VB
25944	99	20	objective	objective	JJ
25944	99	21	,	,	,
25944	99	22	subjective	subjective	JJ
25944	99	23	or	or	CC
25944	99	24	both	both	DT
25944	99	25	;	;	:
25944	99	26	and	and	CC
25944	99	27	in	in	IN
25944	99	28	some	some	DT
25944	99	29	diseases	disease	NNS
25944	99	30	,	,	,
25944	99	31	also	also	RB
25944	99	32	,	,	,
25944	99	33	there	there	EX
25944	99	34	may	may	MD
25944	99	35	be	be	VB
25944	99	36	systemic	systemic	JJ
25944	99	37	disturbance	disturbance	NN
25944	99	38	.	.	.
25944	100	1	#	#	LS
25944	100	2	What	what	WP
25944	100	3	do	do	VBP
25944	100	4	you	-PRON-	PRP
25944	100	5	mean	mean	VB
25944	100	6	by	by	IN
25944	100	7	objective	objective	JJ
25944	100	8	symptoms	symptom	NNS
25944	100	9	?	?	.
25944	100	10	#	#	$
25944	100	11	Those	those	DT
25944	100	12	symptoms	symptom	NNS
25944	100	13	visible	visible	JJ
25944	100	14	to	to	IN
25944	100	15	the	the	DT
25944	100	16	eye	eye	NN
25944	100	17	or	or	CC
25944	100	18	touch	touch	NN
25944	100	19	.	.	.
25944	101	1	#	#	LS
25944	101	2	What	what	WP
25944	101	3	do	do	VBP
25944	101	4	you	-PRON-	PRP
25944	101	5	understand	understand	VB
25944	101	6	by	by	IN
25944	101	7	subjective	subjective	JJ
25944	101	8	symptoms	symptom	NNS
25944	101	9	?	?	.
25944	101	10	#	#	$
25944	101	11	Those	those	DT
25944	101	12	which	which	WDT
25944	101	13	relate	relate	VBP
25944	101	14	to	to	IN
25944	101	15	sensation	sensation	NN
25944	101	16	,	,	,
25944	101	17	such	such	JJ
25944	101	18	as	as	IN
25944	101	19	itching	itching	NN
25944	101	20	,	,	,
25944	101	21	tingling	tingle	VBG
25944	101	22	,	,	,
25944	101	23	burning	burning	NN
25944	101	24	,	,	,
25944	101	25	pain	pain	NN
25944	101	26	,	,	,
25944	101	27	tenderness	tenderness	NN
25944	101	28	,	,	,
25944	101	29	heat	heat	NN
25944	101	30	,	,	,
25944	101	31	anæsthesia	anæsthesia	NNP
25944	101	32	,	,	,
25944	101	33	and	and	CC
25944	101	34	hyperæsthesia	hyperæsthesia	NNP
25944	101	35	.	.	.
25944	102	1	#	#	LS
25944	102	2	What	what	WP
25944	102	3	do	do	VBP
25944	102	4	you	-PRON-	PRP
25944	102	5	mean	mean	VB
25944	102	6	by	by	IN
25944	102	7	systemic	systemic	JJ
25944	102	8	symptoms	symptom	NNS
25944	102	9	?	?	.
25944	102	10	#	#	$
25944	102	11	Those	those	DT
25944	102	12	general	general	JJ
25944	102	13	symptoms	symptom	NNS
25944	102	14	,	,	,
25944	102	15	slight	slight	JJ
25944	102	16	or	or	CC
25944	102	17	profound	profound	JJ
25944	102	18	,	,	,
25944	102	19	which	which	WDT
25944	102	20	are	be	VBP
25944	102	21	sometimes	sometimes	RB
25944	102	22	associated	associate	VBN
25944	102	23	,	,	,
25944	102	24	primarily	primarily	RB
25944	102	25	or	or	CC
25944	102	26	secondarily	secondarily	RB
25944	102	27	,	,	,
25944	102	28	with	with	IN
25944	102	29	the	the	DT
25944	102	30	cutaneous	cutaneous	JJ
25944	102	31	disease	disease	NN
25944	102	32	,	,	,
25944	102	33	as	as	IN
25944	102	34	,	,	,
25944	102	35	for	for	IN
25944	102	36	example	example	NN
25944	102	37	,	,	,
25944	102	38	the	the	DT
25944	102	39	systemic	systemic	JJ
25944	102	40	disturbance	disturbance	NN
25944	102	41	in	in	IN
25944	102	42	leprosy	leprosy	NN
25944	102	43	,	,	,
25944	102	44	pemphigus	pemphigus	NNP
25944	102	45	,	,	,
25944	102	46	and	and	CC
25944	102	47	purpura	purpura	NNP
25944	102	48	hemorrhagica	hemorrhagica	NNP
25944	102	49	.	.	.
25944	103	1	#	#	$
25944	103	2	Into	into	IN
25944	103	3	what	what	WP
25944	103	4	two	two	CD
25944	103	5	classes	class	NNS
25944	103	6	of	of	IN
25944	103	7	lesions	lesion	NNS
25944	103	8	are	be	VBP
25944	103	9	the	the	DT
25944	103	10	objective	objective	JJ
25944	103	11	symptoms	symptom	NNS
25944	103	12	commonly	commonly	RB
25944	103	13	divided	divide	VBN
25944	103	14	?	?	.
25944	103	15	#	#	NN
25944	103	16	Primary	Primary	NNP
25944	103	17	(	(	-LRB-
25944	103	18	or	or	CC
25944	103	19	elementary	elementary	JJ
25944	103	20	)	)	-RRB-
25944	103	21	,	,	,
25944	103	22	and	and	CC
25944	103	23	Secondary	secondary	JJ
25944	103	24	(	(	-LRB-
25944	103	25	or	or	CC
25944	103	26	consecutive	consecutive	JJ
25944	103	27	)	)	-RRB-
25944	103	28	.	.	.
25944	104	1	#	#	NNP
25944	104	2	Primary	Primary	NNP
25944	104	3	Lesions	Lesions	NNP
25944	104	4	.	.	.
25944	104	5	#	#	$
25944	104	6	#	#	$
25944	104	7	What	what	WP
25944	104	8	are	be	VBP
25944	104	9	primary	primary	JJ
25944	104	10	lesions	lesion	NNS
25944	104	11	?	?	.
25944	104	12	#	#	$
25944	104	13	Those	those	DT
25944	104	14	objective	objective	JJ
25944	104	15	lesions	lesion	NNS
25944	104	16	with	with	IN
25944	104	17	which	which	WDT
25944	104	18	cutaneous	cutaneous	JJ
25944	104	19	diseases	disease	NNS
25944	104	20	begin	begin	VBP
25944	104	21	.	.	.
25944	105	1	They	-PRON-	PRP
25944	105	2	may	may	MD
25944	105	3	continue	continue	VB
25944	105	4	as	as	RB
25944	105	5	such	such	JJ
25944	105	6	or	or	CC
25944	105	7	may	may	MD
25944	105	8	undergo	undergo	VB
25944	105	9	modification	modification	NN
25944	105	10	,	,	,
25944	105	11	passing	pass	VBG
25944	105	12	into	into	IN
25944	105	13	the	the	DT
25944	105	14	secondary	secondary	JJ
25944	105	15	or	or	CC
25944	105	16	consecutive	consecutive	JJ
25944	105	17	lesions	lesion	NNS
25944	105	18	.	.	.
25944	106	1	#	#	LS
25944	106	2	Enumerate	enumerate	VB
25944	106	3	the	the	DT
25944	106	4	primary	primary	JJ
25944	106	5	lesions	lesion	NNS
25944	106	6	.	.	.
25944	106	7	#	#	$
25944	106	8	Macules	Macules	NNP
25944	106	9	,	,	,
25944	106	10	papules	papule	NNS
25944	106	11	,	,	,
25944	106	12	tubercles	tubercle	NNS
25944	106	13	,	,	,
25944	106	14	wheals	wheal	NNS
25944	106	15	,	,	,
25944	106	16	tumors	tumor	NNS
25944	106	17	,	,	,
25944	106	18	vesicles	vesicle	NNS
25944	106	19	,	,	,
25944	106	20	blebs	blebs	NN
25944	106	21	and	and	CC
25944	106	22	pustules	pustule	NNS
25944	106	23	.	.	.
25944	107	1	#	#	LS
25944	107	2	What	what	WP
25944	107	3	are	be	VBP
25944	107	4	macules	macule	NNS
25944	107	5	(	(	-LRB-
25944	107	6	maculæ	maculæ	NNP
25944	107	7	)	)	-RRB-
25944	107	8	?	?	.
25944	107	9	#	#	$
25944	107	10	Variously	variously	RB
25944	107	11	-	-	HYPH
25944	107	12	sized	sized	JJ
25944	107	13	,	,	,
25944	107	14	shaped	shaped	JJ
25944	107	15	and	and	CC
25944	107	16	tinted	tint	VBN
25944	107	17	spots	spot	NNS
25944	107	18	and	and	CC
25944	107	19	discolorations	discoloration	NNS
25944	107	20	,	,	,
25944	107	21	without	without	IN
25944	107	22	elevation	elevation	NN
25944	107	23	or	or	CC
25944	107	24	depression	depression	NN
25944	107	25	;	;	:
25944	107	26	as	as	IN
25944	107	27	,	,	,
25944	107	28	for	for	IN
25944	107	29	example	example	NN
25944	107	30	,	,	,
25944	107	31	freckles	freckle	NNS
25944	107	32	,	,	,
25944	107	33	spots	spot	NNS
25944	107	34	of	of	IN
25944	107	35	purpura	purpura	NNP
25944	107	36	,	,	,
25944	107	37	macules	macule	NNS
25944	107	38	of	of	IN
25944	107	39	cutaneous	cutaneous	JJ
25944	107	40	syphilis	syphili	NNS
25944	107	41	.	.	.
25944	108	1	#	#	LS
25944	108	2	What	what	WP
25944	108	3	are	be	VBP
25944	108	4	papules	papule	NNS
25944	108	5	(	(	-LRB-
25944	108	6	papulæ	papulæ	NN
25944	108	7	)	)	-RRB-
25944	108	8	?	?	.
25944	108	9	#	#	NN
25944	108	10	Small	Small	NNP
25944	108	11	,	,	,
25944	108	12	circumscribed	circumscribe	VBN
25944	108	13	,	,	,
25944	108	14	solid	solid	JJ
25944	108	15	elevations	elevation	NNS
25944	108	16	,	,	,
25944	108	17	rarely	rarely	RB
25944	108	18	exceeding	exceed	VBG
25944	108	19	the	the	DT
25944	108	20	size	size	NN
25944	108	21	of	of	IN
25944	108	22	a	a	DT
25944	108	23	split	split	NN
25944	108	24	-	-	HYPH
25944	108	25	pea	pea	NN
25944	108	26	,	,	,
25944	108	27	and	and	CC
25944	108	28	usually	usually	RB
25944	108	29	superficially	superficially	RB
25944	108	30	seated	seated	JJ
25944	108	31	;	;	:
25944	108	32	as	as	IN
25944	108	33	,	,	,
25944	108	34	for	for	IN
25944	108	35	example	example	NN
25944	108	36	,	,	,
25944	108	37	the	the	DT
25944	108	38	papules	papule	NNS
25944	108	39	of	of	IN
25944	108	40	eczema	eczema	NN
25944	108	41	,	,	,
25944	108	42	of	of	IN
25944	108	43	acne	acne	NNP
25944	108	44	,	,	,
25944	108	45	and	and	CC
25944	108	46	of	of	IN
25944	108	47	cutaneous	cutaneous	JJ
25944	108	48	syphilis	syphili	NNS
25944	108	49	.	.	.
25944	109	1	#	#	LS
25944	109	2	What	what	WP
25944	109	3	are	be	VBP
25944	109	4	tubercles	tubercle	NNS
25944	109	5	(	(	-LRB-
25944	109	6	tubercula	tubercula	NN
25944	109	7	)	)	-RRB-
25944	109	8	?	?	.
25944	109	9	#	#	$
25944	109	10	Circumscribed	Circumscribed	NNP
25944	109	11	,	,	,
25944	109	12	solid	solid	JJ
25944	109	13	elevations	elevation	NNS
25944	109	14	,	,	,
25944	109	15	commonly	commonly	RB
25944	109	16	pea	pea	JJ
25944	109	17	-	-	HYPH
25944	109	18	sized	sized	JJ
25944	109	19	and	and	CC
25944	109	20	usually	usually	RB
25944	109	21	deep	deep	JJ
25944	109	22	-	-	HYPH
25944	109	23	seated	seated	JJ
25944	109	24	;	;	:
25944	109	25	as	as	IN
25944	109	26	,	,	,
25944	109	27	for	for	IN
25944	109	28	example	example	NN
25944	109	29	,	,	,
25944	109	30	the	the	DT
25944	109	31	tubercles	tubercle	NNS
25944	109	32	of	of	IN
25944	109	33	syphilis	syphilis	NNP
25944	109	34	,	,	,
25944	109	35	of	of	IN
25944	109	36	leprosy	leprosy	NN
25944	109	37	,	,	,
25944	109	38	and	and	CC
25944	109	39	of	of	IN
25944	109	40	lupus	lupus	NN
25944	109	41	.	.	.
25944	110	1	#	#	$
25944	110	2	What	what	WP
25944	110	3	are	be	VBP
25944	110	4	wheals	wheal	NNS
25944	110	5	(	(	-LRB-
25944	110	6	pomphi	pomphi	NNP
25944	110	7	)	)	-RRB-
25944	110	8	?	?	.
25944	110	9	#	#	$
25944	110	10	Variously	variously	RB
25944	110	11	-	-	HYPH
25944	110	12	sized	sized	JJ
25944	110	13	and	and	CC
25944	110	14	shaped	shaped	JJ
25944	110	15	,	,	,
25944	110	16	whitish	whitish	JJ
25944	110	17	,	,	,
25944	110	18	pinkish	pinkish	JJ
25944	110	19	or	or	CC
25944	110	20	reddish	reddish	JJ
25944	110	21	elevations	elevation	NNS
25944	110	22	,	,	,
25944	110	23	of	of	IN
25944	110	24	an	an	DT
25944	110	25	evanescent	evanescent	JJ
25944	110	26	character	character	NN
25944	110	27	;	;	:
25944	110	28	as	as	IN
25944	110	29	,	,	,
25944	110	30	for	for	IN
25944	110	31	example	example	NN
25944	110	32	,	,	,
25944	110	33	the	the	DT
25944	110	34	lesions	lesion	NNS
25944	110	35	of	of	IN
25944	110	36	urticaria	urticaria	NNP
25944	110	37	,	,	,
25944	110	38	the	the	DT
25944	110	39	lesions	lesion	NNS
25944	110	40	produced	produce	VBN
25944	110	41	by	by	IN
25944	110	42	the	the	DT
25944	110	43	bite	bite	NN
25944	110	44	of	of	IN
25944	110	45	a	a	DT
25944	110	46	mosquito	mosquito	NN
25944	110	47	or	or	CC
25944	110	48	by	by	IN
25944	110	49	the	the	DT
25944	110	50	sting	sting	NN
25944	110	51	of	of	IN
25944	110	52	a	a	DT
25944	110	53	nettle	nettle	NN
25944	110	54	.	.	.
25944	111	1	#	#	LS
25944	111	2	What	what	WP
25944	111	3	are	be	VBP
25944	111	4	tumors	tumor	NNS
25944	111	5	(	(	-LRB-
25944	111	6	tumores	tumore	NNS
25944	111	7	)	)	-RRB-
25944	111	8	?	?	.
25944	111	9	#	#	$
25944	111	10	Soft	soft	JJ
25944	111	11	or	or	CC
25944	111	12	firm	firm	JJ
25944	111	13	elevations	elevation	NNS
25944	111	14	,	,	,
25944	111	15	usually	usually	RB
25944	111	16	large	large	JJ
25944	111	17	and	and	CC
25944	111	18	prominent	prominent	JJ
25944	111	19	,	,	,
25944	111	20	and	and	CC
25944	111	21	having	have	VBG
25944	111	22	their	-PRON-	PRP$
25944	111	23	seat	seat	NN
25944	111	24	in	in	IN
25944	111	25	the	the	DT
25944	111	26	corium	corium	NN
25944	111	27	and	and	CC
25944	111	28	subcutaneous	subcutaneous	JJ
25944	111	29	tissue	tissue	NN
25944	111	30	;	;	:
25944	111	31	as	as	IN
25944	111	32	,	,	,
25944	111	33	for	for	IN
25944	111	34	example	example	NN
25944	111	35	,	,	,
25944	111	36	sebaceous	sebaceous	JJ
25944	111	37	tumors	tumor	NNS
25944	111	38	,	,	,
25944	111	39	gummata	gumma	NNS
25944	111	40	,	,	,
25944	111	41	and	and	CC
25944	111	42	the	the	DT
25944	111	43	lesions	lesion	NNS
25944	111	44	of	of	IN
25944	111	45	fibroma	fibroma	NNP
25944	111	46	.	.	.
25944	112	1	#	#	LS
25944	112	2	What	what	WP
25944	112	3	are	be	VBP
25944	112	4	vesicles	vesicle	NNS
25944	112	5	(	(	-LRB-
25944	112	6	vesiculæ	vesiculæ	NN
25944	112	7	)	)	-RRB-
25944	112	8	?	?	.
25944	112	9	#	#	$
25944	112	10	Pin	pin	NN
25944	112	11	-	-	HYPH
25944	112	12	head	head	NN
25944	112	13	to	to	IN
25944	112	14	pea	pea	JJ
25944	112	15	-	-	HYPH
25944	112	16	sized	sized	JJ
25944	112	17	,	,	,
25944	112	18	circumscribed	circumscribe	VBD
25944	112	19	epidermal	epidermal	JJ
25944	112	20	elevations	elevation	NNS
25944	112	21	,	,	,
25944	112	22	containing	contain	VBG
25944	112	23	serous	serous	JJ
25944	112	24	fluid	fluid	NN
25944	112	25	;	;	:
25944	112	26	as	as	IN
25944	112	27	,	,	,
25944	112	28	for	for	IN
25944	112	29	example	example	NN
25944	112	30	,	,	,
25944	112	31	the	the	DT
25944	112	32	so	so	RB
25944	112	33	-	-	HYPH
25944	112	34	called	call	VBN
25944	112	35	fever	fever	NN
25944	112	36	-	-	HYPH
25944	112	37	blisters	blister	NNS
25944	112	38	,	,	,
25944	112	39	the	the	DT
25944	112	40	lesions	lesion	NNS
25944	112	41	of	of	IN
25944	112	42	herpes	herpe	NNS
25944	112	43	zoster	zoster	NNP
25944	112	44	,	,	,
25944	112	45	and	and	CC
25944	112	46	of	of	IN
25944	112	47	vesicular	vesicular	JJ
25944	112	48	eczema	eczema	NN
25944	112	49	.	.	.
25944	113	1	#	#	LS
25944	113	2	What	what	WP
25944	113	3	are	be	VBP
25944	113	4	blebs	blebs	NN
25944	113	5	(	(	-LRB-
25944	113	6	bullæ	bullæ	NN
25944	113	7	)	)	-RRB-
25944	113	8	?	?	.
25944	113	9	#	#	NN
25944	113	10	Rounded	rounded	JJ
25944	113	11	or	or	CC
25944	113	12	irregularly	irregularly	RB
25944	113	13	-	-	HYPH
25944	113	14	shaped	shape	VBN
25944	113	15	,	,	,
25944	113	16	pea	pea	JJ
25944	113	17	to	to	IN
25944	113	18	egg	egg	NN
25944	113	19	-	-	HYPH
25944	113	20	sized	sized	JJ
25944	113	21	epidermic	epidermic	JJ
25944	113	22	elevations	elevation	NNS
25944	113	23	,	,	,
25944	113	24	with	with	IN
25944	113	25	fluid	fluid	JJ
25944	113	26	contents	content	NNS
25944	113	27	;	;	:
25944	113	28	in	in	IN
25944	113	29	short	short	JJ
25944	113	30	,	,	,
25944	113	31	they	-PRON-	PRP
25944	113	32	are	be	VBP
25944	113	33	essentially	essentially	RB
25944	113	34	the	the	DT
25944	113	35	same	same	JJ
25944	113	36	as	as	IN
25944	113	37	vesicles	vesicle	NNS
25944	113	38	and	and	CC
25944	113	39	pustules	pustule	NNS
25944	113	40	except	except	IN
25944	113	41	as	as	IN
25944	113	42	to	to	IN
25944	113	43	size	size	NN
25944	113	44	;	;	:
25944	113	45	as	as	IN
25944	113	46	,	,	,
25944	113	47	for	for	IN
25944	113	48	example	example	NN
25944	113	49	,	,	,
25944	113	50	the	the	DT
25944	113	51	blebs	blebs	NN
25944	113	52	of	of	IN
25944	113	53	pemphigus	pemphigus	NNP
25944	113	54	,	,	,
25944	113	55	rhus	rhu	NNS
25944	113	56	poisoning	poisoning	NN
25944	113	57	,	,	,
25944	113	58	and	and	CC
25944	113	59	syphilis	syphilis	NNP
25944	113	60	.	.	.
25944	114	1	#	#	LS
25944	114	2	What	what	WP
25944	114	3	are	be	VBP
25944	114	4	pustules	pustule	NNS
25944	114	5	(	(	-LRB-
25944	114	6	pustulæ	pustulæ	NN
25944	114	7	)	)	-RRB-
25944	114	8	?	?	.
25944	114	9	#	#	$
25944	114	10	Circumscribed	circumscribe	VBN
25944	114	11	epidermic	epidermic	JJ
25944	114	12	elevations	elevation	NNS
25944	114	13	containing	contain	VBG
25944	114	14	pus	pus	NN
25944	114	15	;	;	:
25944	114	16	as	as	IN
25944	114	17	,	,	,
25944	114	18	for	for	IN
25944	114	19	example	example	NN
25944	114	20	,	,	,
25944	114	21	the	the	DT
25944	114	22	pustules	pustule	NNS
25944	114	23	of	of	IN
25944	114	24	acne	acne	NNP
25944	114	25	,	,	,
25944	114	26	of	of	IN
25944	114	27	impetigo	impetigo	NNP
25944	114	28	,	,	,
25944	114	29	and	and	CC
25944	114	30	of	of	IN
25944	114	31	sycosis	sycosis	NN
25944	114	32	.	.	.
25944	115	1	#	#	NNP
25944	115	2	Secondary	Secondary	NNP
25944	115	3	Lesions	Lesions	NNPS
25944	115	4	.	.	.
25944	115	5	#	#	$
25944	115	6	#	#	$
25944	115	7	What	what	WP
25944	115	8	are	be	VBP
25944	115	9	secondary	secondary	JJ
25944	115	10	lesions	lesion	NNS
25944	115	11	?	?	.
25944	115	12	#	#	$
25944	115	13	Those	those	DT
25944	115	14	lesions	lesion	NNS
25944	115	15	resulting	result	VBG
25944	115	16	from	from	IN
25944	115	17	accidental	accidental	JJ
25944	115	18	or	or	CC
25944	115	19	natural	natural	JJ
25944	115	20	change	change	NN
25944	115	21	,	,	,
25944	115	22	modification	modification	NN
25944	115	23	or	or	CC
25944	115	24	termination	termination	NN
25944	115	25	of	of	IN
25944	115	26	the	the	DT
25944	115	27	primary	primary	JJ
25944	115	28	lesions	lesion	NNS
25944	115	29	.	.	.
25944	116	1	#	#	LS
25944	116	2	Enumerate	enumerate	VB
25944	116	3	the	the	DT
25944	116	4	secondary	secondary	JJ
25944	116	5	lesions	lesion	NNS
25944	116	6	.	.	.
25944	116	7	#	#	$
25944	116	8	Scales	Scales	NNP
25944	116	9	,	,	,
25944	116	10	crusts	crust	NNS
25944	116	11	,	,	,
25944	116	12	excoriations	excoriation	NNS
25944	116	13	,	,	,
25944	116	14	fissures	fissure	NNS
25944	116	15	,	,	,
25944	116	16	ulcers	ulcer	NNS
25944	116	17	,	,	,
25944	116	18	scars	scar	NNS
25944	116	19	and	and	CC
25944	116	20	stains	stain	NNS
25944	116	21	.	.	.
25944	117	1	#	#	LS
25944	117	2	What	what	WP
25944	117	3	are	be	VBP
25944	117	4	scales	scale	NNS
25944	117	5	(	(	-LRB-
25944	117	6	squamæ	squamæ	NNP
25944	117	7	)	)	-RRB-
25944	117	8	?	?	.
25944	117	9	#	#	NNP
25944	117	10	Dry	Dry	NNP
25944	117	11	,	,	,
25944	117	12	laminated	laminate	VBN
25944	117	13	,	,	,
25944	117	14	epidermal	epidermal	JJ
25944	117	15	exfoliations	exfoliation	NNS
25944	117	16	;	;	:
25944	117	17	as	as	IN
25944	117	18	,	,	,
25944	117	19	for	for	IN
25944	117	20	example	example	NN
25944	117	21	,	,	,
25944	117	22	the	the	DT
25944	117	23	scales	scale	NNS
25944	117	24	of	of	IN
25944	117	25	psoriasis	psoriasis	NN
25944	117	26	,	,	,
25944	117	27	ichthyosis	ichthyosis	NN
25944	117	28	,	,	,
25944	117	29	and	and	CC
25944	117	30	eczema	eczema	NN
25944	117	31	.	.	.
25944	118	1	#	#	LS
25944	118	2	What	what	WP
25944	118	3	are	be	VBP
25944	118	4	crusts	crust	NNS
25944	118	5	(	(	-LRB-
25944	118	6	crustæ	crustæ	NNP
25944	118	7	)	)	-RRB-
25944	118	8	?	?	.
25944	118	9	#	#	$
25944	118	10	Dried	dry	VBN
25944	118	11	effete	effete	JJ
25944	118	12	masses	masse	NNS
25944	118	13	of	of	IN
25944	118	14	exudation	exudation	NN
25944	118	15	;	;	:
25944	118	16	as	as	IN
25944	118	17	,	,	,
25944	118	18	for	for	IN
25944	118	19	example	example	NN
25944	118	20	,	,	,
25944	118	21	the	the	DT
25944	118	22	crusts	crust	NNS
25944	118	23	of	of	IN
25944	118	24	impetigo	impetigo	NNS
25944	118	25	,	,	,
25944	118	26	of	of	IN
25944	118	27	eczema	eczema	NN
25944	118	28	,	,	,
25944	118	29	and	and	CC
25944	118	30	of	of	IN
25944	118	31	the	the	DT
25944	118	32	pustular	pustular	NN
25944	118	33	and	and	CC
25944	118	34	ulcerating	ulcerating	JJ
25944	118	35	syphilodermata	syphilodermata	NNS
25944	118	36	.	.	.
25944	119	1	#	#	LS
25944	119	2	What	what	WP
25944	119	3	are	be	VBP
25944	119	4	excoriations	excoriation	NNS
25944	119	5	(	(	-LRB-
25944	119	6	excoriationes	excoriatione	NNS
25944	119	7	)	)	-RRB-
25944	119	8	?	?	.
25944	119	9	#	#	NNP
25944	119	10	Superficial	Superficial	NNP
25944	119	11	,	,	,
25944	119	12	usually	usually	RB
25944	119	13	epidermal	epidermal	JJ
25944	119	14	,	,	,
25944	119	15	linear	linear	JJ
25944	119	16	or	or	CC
25944	119	17	punctate	punctate	NN
25944	119	18	loss	loss	NN
25944	119	19	of	of	IN
25944	119	20	tissue	tissue	NN
25944	119	21	;	;	:
25944	119	22	as	as	IN
25944	119	23	,	,	,
25944	119	24	for	for	IN
25944	119	25	example	example	NN
25944	119	26	,	,	,
25944	119	27	ordinary	ordinary	JJ
25944	119	28	scratch	scratch	NN
25944	119	29	-	-	HYPH
25944	119	30	marks	mark	NNS
25944	119	31	.	.	.
25944	120	1	#	#	LS
25944	120	2	What	what	WP
25944	120	3	are	be	VBP
25944	120	4	fissures	fissure	NNS
25944	120	5	(	(	-LRB-
25944	120	6	rhagades	rhagade	NNS
25944	120	7	)	)	-RRB-
25944	120	8	?	?	.
25944	120	9	#	#	$
25944	120	10	Linear	linear	JJ
25944	120	11	cracks	crack	NNS
25944	120	12	or	or	CC
25944	120	13	wounds	wound	NNS
25944	120	14	,	,	,
25944	120	15	involving	involve	VBG
25944	120	16	the	the	DT
25944	120	17	epidermis	epidermis	NN
25944	120	18	,	,	,
25944	120	19	or	or	CC
25944	120	20	epidermis	epidermis	NNP
25944	120	21	and	and	CC
25944	120	22	corium	corium	NN
25944	120	23	;	;	:
25944	120	24	as	as	IN
25944	120	25	,	,	,
25944	120	26	for	for	IN
25944	120	27	example	example	NN
25944	120	28	,	,	,
25944	120	29	the	the	DT
25944	120	30	cracks	crack	NNS
25944	120	31	which	which	WDT
25944	120	32	often	often	RB
25944	120	33	occur	occur	VBP
25944	120	34	in	in	IN
25944	120	35	eczema	eczema	NN
25944	120	36	when	when	WRB
25944	120	37	seated	seat	VBN
25944	120	38	about	about	IN
25944	120	39	the	the	DT
25944	120	40	joints	joint	NNS
25944	120	41	,	,	,
25944	120	42	the	the	DT
25944	120	43	cracks	crack	NNS
25944	120	44	of	of	IN
25944	120	45	chapped	chap	VBN
25944	120	46	lips	lip	NNS
25944	120	47	and	and	CC
25944	120	48	hands	hand	NNS
25944	120	49	.	.	.
25944	121	1	#	#	LS
25944	121	2	What	what	WP
25944	121	3	are	be	VBP
25944	121	4	ulcers	ulcer	NNS
25944	121	5	(	(	-LRB-
25944	121	6	ulcera	ulcera	NNP
25944	121	7	)	)	-RRB-
25944	121	8	?	?	.
25944	121	9	#	#	NN
25944	121	10	Rounded	rounded	JJ
25944	121	11	or	or	CC
25944	121	12	irregularly	irregularly	RB
25944	121	13	-	-	HYPH
25944	121	14	shaped	shape	VBN
25944	121	15	and	and	CC
25944	121	16	sized	sized	JJ
25944	121	17	loss	loss	NN
25944	121	18	of	of	IN
25944	121	19	skin	skin	NN
25944	121	20	and	and	CC
25944	121	21	subcutaneous	subcutaneous	JJ
25944	121	22	tissue	tissue	NN
25944	121	23	resulting	result	VBG
25944	121	24	from	from	IN
25944	121	25	disease	disease	NN
25944	121	26	;	;	:
25944	121	27	as	as	IN
25944	121	28	,	,	,
25944	121	29	for	for	IN
25944	121	30	example	example	NN
25944	121	31	,	,	,
25944	121	32	the	the	DT
25944	121	33	ulcers	ulcer	NNS
25944	121	34	of	of	IN
25944	121	35	syphilis	syphilis	NNP
25944	121	36	and	and	CC
25944	121	37	of	of	IN
25944	121	38	cancer	cancer	NN
25944	121	39	.	.	.
25944	122	1	#	#	LS
25944	122	2	What	what	WP
25944	122	3	are	be	VBP
25944	122	4	scars	scar	NNS
25944	122	5	(	(	-LRB-
25944	122	6	cicatrices	cicatrix	NNS
25944	122	7	)	)	-RRB-
25944	122	8	?	?	.
25944	122	9	#	#	NNP
25944	122	10	Connective	connective	JJ
25944	122	11	-	-	HYPH
25944	122	12	tissue	tissue	NN
25944	122	13	new	new	JJ
25944	122	14	formations	formation	NNS
25944	122	15	replacing	replace	VBG
25944	122	16	loss	loss	NN
25944	122	17	of	of	IN
25944	122	18	substance	substance	NN
25944	122	19	.	.	.
25944	123	1	#	#	LS
25944	123	2	What	what	WP
25944	123	3	are	be	VBP
25944	123	4	stains	stain	NNS
25944	123	5	?	?	.
25944	123	6	#	#	$
25944	123	7	Discolorations	discoloration	NNS
25944	123	8	left	leave	VBN
25944	123	9	by	by	IN
25944	123	10	cutaneous	cutaneous	JJ
25944	123	11	disease	disease	NN
25944	123	12	,	,	,
25944	123	13	which	which	WDT
25944	123	14	stains	stain	NNS
25944	123	15	may	may	MD
25944	123	16	be	be	VB
25944	123	17	transitory	transitory	JJ
25944	123	18	or	or	CC
25944	123	19	permanent	permanent	JJ
25944	123	20	.	.	.
25944	124	1	#	#	NNP
25944	124	2	Distribution	Distribution	NNP
25944	124	3	and	and	CC
25944	124	4	Configuration	Configuration	NNP
25944	124	5	.	.	.
25944	124	6	#	#	$
25944	124	7	#	#	$
25944	124	8	What	what	WP
25944	124	9	do	do	VBP
25944	124	10	you	-PRON-	PRP
25944	124	11	mean	mean	VB
25944	124	12	by	by	IN
25944	124	13	a	a	DT
25944	124	14	patch	patch	NN
25944	124	15	of	of	IN
25944	124	16	eruption	eruption	NN
25944	124	17	?	?	.
25944	124	18	#	#	$
25944	124	19	A	a	DT
25944	124	20	single	single	JJ
25944	124	21	group	group	NN
25944	124	22	or	or	CC
25944	124	23	aggregation	aggregation	NN
25944	124	24	of	of	IN
25944	124	25	lesions	lesion	NNS
25944	124	26	or	or	CC
25944	124	27	an	an	DT
25944	124	28	area	area	NN
25944	124	29	of	of	IN
25944	124	30	disease	disease	NN
25944	124	31	.	.	.
25944	125	1	#	#	NNP
25944	125	2	When	when	WRB
25944	125	3	is	be	VBZ
25944	125	4	an	an	DT
25944	125	5	eruption	eruption	NN
25944	125	6	said	say	VBD
25944	125	7	to	to	TO
25944	125	8	be	be	VB
25944	125	9	limited	limit	VBN
25944	125	10	or	or	CC
25944	125	11	localized	localize	VBN
25944	125	12	?	?	.
25944	125	13	#	#	NN
25944	125	14	When	when	WRB
25944	125	15	it	-PRON-	PRP
25944	125	16	is	be	VBZ
25944	125	17	confined	confine	VBN
25944	125	18	to	to	IN
25944	125	19	one	one	CD
25944	125	20	part	part	NN
25944	125	21	or	or	CC
25944	125	22	region	region	NN
25944	125	23	.	.	.
25944	126	1	#	#	NNP
25944	126	2	When	when	WRB
25944	126	3	is	be	VBZ
25944	126	4	an	an	DT
25944	126	5	eruption	eruption	NN
25944	126	6	said	say	VBD
25944	126	7	to	to	TO
25944	126	8	be	be	VB
25944	126	9	general	general	JJ
25944	126	10	or	or	CC
25944	126	11	generalized	generalize	VBN
25944	126	12	?	?	.
25944	126	13	#	#	NN
25944	126	14	When	when	WRB
25944	126	15	it	-PRON-	PRP
25944	126	16	is	be	VBZ
25944	126	17	scattered	scatter	VBN
25944	126	18	,	,	,
25944	126	19	uniformly	uniformly	RB
25944	126	20	or	or	CC
25944	126	21	irregularly	irregularly	RB
25944	126	22	,	,	,
25944	126	23	over	over	IN
25944	126	24	the	the	DT
25944	126	25	entire	entire	JJ
25944	126	26	surface	surface	NN
25944	126	27	.	.	.
25944	127	1	#	#	NNP
25944	127	2	When	when	WRB
25944	127	3	is	be	VBZ
25944	127	4	an	an	DT
25944	127	5	eruption	eruption	NN
25944	127	6	universal	universal	JJ
25944	127	7	?	?	.
25944	127	8	#	#	NN
25944	127	9	When	when	WRB
25944	127	10	the	the	DT
25944	127	11	whole	whole	JJ
25944	127	12	integument	integument	NN
25944	127	13	is	be	VBZ
25944	127	14	involved	involve	VBN
25944	127	15	,	,	,
25944	127	16	without	without	IN
25944	127	17	any	any	DT
25944	127	18	intervening	intervene	VBG
25944	127	19	healthy	healthy	JJ
25944	127	20	skin	skin	NN
25944	127	21	.	.	.
25944	128	1	#	#	NNP
25944	128	2	When	when	WRB
25944	128	3	is	be	VBZ
25944	128	4	an	an	DT
25944	128	5	eruption	eruption	NN
25944	128	6	said	say	VBD
25944	128	7	to	to	TO
25944	128	8	be	be	VB
25944	128	9	discrete	discrete	JJ
25944	128	10	?	?	.
25944	128	11	#	#	$
25944	128	12	When	when	WRB
25944	128	13	the	the	DT
25944	128	14	lesions	lesion	NNS
25944	128	15	constituting	constitute	VBG
25944	128	16	the	the	DT
25944	128	17	eruption	eruption	NN
25944	128	18	are	be	VBP
25944	128	19	isolated	isolate	VBN
25944	128	20	,	,	,
25944	128	21	having	have	VBG
25944	128	22	more	more	RBR
25944	128	23	or	or	CC
25944	128	24	less	less	RBR
25944	128	25	intervening	intervene	VBG
25944	128	26	normal	normal	JJ
25944	128	27	skin	skin	NN
25944	128	28	.	.	.
25944	129	1	#	#	NNP
25944	129	2	When	when	WRB
25944	129	3	is	be	VBZ
25944	129	4	an	an	DT
25944	129	5	eruption	eruption	NN
25944	129	6	confluent	confluent	NN
25944	129	7	?	?	.
25944	129	8	#	#	NN
25944	129	9	When	when	WRB
25944	129	10	the	the	DT
25944	129	11	lesions	lesion	NNS
25944	129	12	constituting	constitute	VBG
25944	129	13	the	the	DT
25944	129	14	eruption	eruption	NN
25944	129	15	are	be	VBP
25944	129	16	so	so	RB
25944	129	17	closely	closely	RB
25944	129	18	crowded	crowded	JJ
25944	129	19	that	that	IN
25944	129	20	a	a	DT
25944	129	21	solid	solid	JJ
25944	129	22	sheet	sheet	NN
25944	129	23	results	result	NNS
25944	129	24	.	.	.
25944	130	1	#	#	NNP
25944	130	2	When	when	WRB
25944	130	3	is	be	VBZ
25944	130	4	an	an	DT
25944	130	5	eruption	eruption	NN
25944	130	6	uniform	uniform	NN
25944	130	7	?	?	.
25944	130	8	#	#	NN
25944	130	9	When	when	WRB
25944	130	10	the	the	DT
25944	130	11	lesions	lesion	NNS
25944	130	12	constituting	constitute	VBG
25944	130	13	the	the	DT
25944	130	14	eruption	eruption	NN
25944	130	15	are	be	VBP
25944	130	16	all	all	DT
25944	130	17	of	of	IN
25944	130	18	one	one	CD
25944	130	19	type	type	NN
25944	130	20	or	or	CC
25944	130	21	character	character	NN
25944	130	22	.	.	.
25944	131	1	#	#	NNP
25944	131	2	When	when	WRB
25944	131	3	is	be	VBZ
25944	131	4	an	an	DT
25944	131	5	eruption	eruption	NN
25944	131	6	multiform	multiform	NN
25944	131	7	?	?	.
25944	131	8	#	#	NN
25944	131	9	When	when	WRB
25944	131	10	the	the	DT
25944	131	11	lesions	lesion	NNS
25944	131	12	constituting	constitute	VBG
25944	131	13	the	the	DT
25944	131	14	eruption	eruption	NN
25944	131	15	are	be	VBP
25944	131	16	of	of	IN
25944	131	17	two	two	CD
25944	131	18	or	or	CC
25944	131	19	more	more	JJR
25944	131	20	types	type	NNS
25944	131	21	or	or	CC
25944	131	22	characters	character	NNS
25944	131	23	.	.	.
25944	132	1	#	#	NNP
25944	132	2	When	when	WRB
25944	132	3	are	be	VBP
25944	132	4	lesions	lesion	NNS
25944	132	5	said	say	VBN
25944	132	6	to	to	TO
25944	132	7	be	be	VB
25944	132	8	aggregated	aggregate	VBN
25944	132	9	?	?	.
25944	132	10	#	#	NN
25944	132	11	When	when	WRB
25944	132	12	they	-PRON-	PRP
25944	132	13	tend	tend	VBP
25944	132	14	to	to	TO
25944	132	15	form	form	VB
25944	132	16	groups	group	NNS
25944	132	17	or	or	CC
25944	132	18	closely	closely	RB
25944	132	19	-	-	HYPH
25944	132	20	crowded	crowded	JJ
25944	132	21	patches	patch	NNS
25944	132	22	.	.	.
25944	133	1	#	#	NNP
25944	133	2	When	when	WRB
25944	133	3	are	be	VBP
25944	133	4	lesions	lesion	NNS
25944	133	5	disseminated	disseminate	VBN
25944	133	6	?	?	.
25944	133	7	#	#	NN
25944	133	8	When	when	WRB
25944	133	9	they	-PRON-	PRP
25944	133	10	are	be	VBP
25944	133	11	irregularly	irregularly	RB
25944	133	12	scattered	scatter	VBN
25944	133	13	,	,	,
25944	133	14	with	with	IN
25944	133	15	no	no	DT
25944	133	16	tendency	tendency	NN
25944	133	17	to	to	TO
25944	133	18	form	form	VB
25944	133	19	groups	group	NNS
25944	133	20	or	or	CC
25944	133	21	patches	patch	NNS
25944	133	22	.	.	.
25944	134	1	#	#	NNP
25944	134	2	When	when	WRB
25944	134	3	is	be	VBZ
25944	134	4	a	a	DT
25944	134	5	patch	patch	NN
25944	134	6	of	of	IN
25944	134	7	eruption	eruption	NN
25944	134	8	said	say	VBD
25944	134	9	to	to	TO
25944	134	10	be	be	VB
25944	134	11	circinate	circinate	JJ
25944	134	12	?	?	.
25944	134	13	#	#	NN
25944	134	14	When	when	WRB
25944	134	15	it	-PRON-	PRP
25944	134	16	presents	present	VBZ
25944	134	17	a	a	DT
25944	134	18	rounded	round	VBN
25944	134	19	form	form	NN
25944	134	20	,	,	,
25944	134	21	and	and	CC
25944	134	22	usually	usually	RB
25944	134	23	tending	tend	VBG
25944	134	24	to	to	TO
25944	134	25	clear	clear	VB
25944	134	26	in	in	IN
25944	134	27	the	the	DT
25944	134	28	centre	centre	NN
25944	134	29	;	;	:
25944	134	30	as	as	IN
25944	134	31	,	,	,
25944	134	32	for	for	IN
25944	134	33	example	example	NN
25944	134	34	,	,	,
25944	134	35	a	a	DT
25944	134	36	patch	patch	NN
25944	134	37	of	of	IN
25944	134	38	ringworm	ringworm	NN
25944	134	39	.	.	.
25944	135	1	#	#	NNP
25944	135	2	When	when	WRB
25944	135	3	is	be	VBZ
25944	135	4	a	a	DT
25944	135	5	patch	patch	NN
25944	135	6	of	of	IN
25944	135	7	eruption	eruption	NN
25944	135	8	said	say	VBD
25944	135	9	to	to	TO
25944	135	10	be	be	VB
25944	135	11	annular	annular	JJ
25944	135	12	?	?	.
25944	135	13	#	#	NN
25944	135	14	When	when	WRB
25944	135	15	it	-PRON-	PRP
25944	135	16	is	be	VBZ
25944	135	17	ring	ring	NN
25944	135	18	-	-	HYPH
25944	135	19	shaped	shape	VBN
25944	135	20	,	,	,
25944	135	21	the	the	DT
25944	135	22	central	central	JJ
25944	135	23	portion	portion	NN
25944	135	24	being	be	VBG
25944	135	25	clear	clear	JJ
25944	135	26	;	;	:
25944	135	27	as	as	IN
25944	135	28	,	,	,
25944	135	29	for	for	IN
25944	135	30	example	example	NN
25944	135	31	,	,	,
25944	135	32	in	in	IN
25944	135	33	erythema	erythema	NNP
25944	135	34	annulare	annulare	NNP
25944	135	35	.	.	.
25944	136	1	#	#	NN
25944	136	2	What	what	WDT
25944	136	3	meaning	meaning	NN
25944	136	4	is	be	VBZ
25944	136	5	conveyed	convey	VBN
25944	136	6	by	by	IN
25944	136	7	the	the	DT
25944	136	8	term	term	NN
25944	136	9	"	"	``
25944	136	10	iris	iris	JJ
25944	136	11	"	"	''
25944	136	12	?	?	.
25944	136	13	#	#	$
25944	136	14	The	the	DT
25944	136	15	patch	patch	NN
25944	136	16	of	of	IN
25944	136	17	eruption	eruption	NN
25944	136	18	is	be	VBZ
25944	136	19	made	make	VBN
25944	136	20	up	up	RP
25944	136	21	of	of	IN
25944	136	22	several	several	JJ
25944	136	23	concentric	concentric	JJ
25944	136	24	rings	ring	NNS
25944	136	25	.	.	.
25944	137	1	Difference	difference	NN
25944	137	2	of	of	IN
25944	137	3	duration	duration	NN
25944	137	4	of	of	IN
25944	137	5	the	the	DT
25944	137	6	individual	individual	JJ
25944	137	7	rings	ring	NNS
25944	137	8	,	,	,
25944	137	9	usually	usually	RB
25944	137	10	slight	slight	JJ
25944	137	11	,	,	,
25944	137	12	tends	tend	VBZ
25944	137	13	to	to	TO
25944	137	14	give	give	VB
25944	137	15	the	the	DT
25944	137	16	patch	patch	NN
25944	137	17	variegated	variegate	VBN
25944	137	18	coloration	coloration	NN
25944	137	19	;	;	:
25944	137	20	as	as	IN
25944	137	21	,	,	,
25944	137	22	for	for	IN
25944	137	23	example	example	NN
25944	137	24	,	,	,
25944	137	25	in	in	IN
25944	137	26	erythema	erythema	NNP
25944	137	27	iris	iris	NNP
25944	137	28	and	and	CC
25944	137	29	herpes	herpes	NNP
25944	137	30	iris	iris	NNP
25944	137	31	.	.	.
25944	138	1	#	#	NN
25944	138	2	What	what	WDT
25944	138	3	meaning	meaning	NN
25944	138	4	is	be	VBZ
25944	138	5	conveyed	convey	VBN
25944	138	6	by	by	IN
25944	138	7	the	the	DT
25944	138	8	term	term	NN
25944	138	9	"	"	``
25944	138	10	marginate	marginate	NN
25944	138	11	"	"	''
25944	138	12	?	?	.
25944	138	13	#	#	$
25944	138	14	The	the	DT
25944	138	15	sheet	sheet	NN
25944	138	16	of	of	IN
25944	138	17	eruption	eruption	NN
25944	138	18	is	be	VBZ
25944	138	19	sharply	sharply	RB
25944	138	20	defined	define	VBN
25944	138	21	against	against	IN
25944	138	22	the	the	DT
25944	138	23	healthy	healthy	JJ
25944	138	24	skin	skin	NN
25944	138	25	;	;	:
25944	138	26	as	as	IN
25944	138	27	,	,	,
25944	138	28	for	for	IN
25944	138	29	example	example	NN
25944	138	30	,	,	,
25944	138	31	in	in	IN
25944	138	32	erythema	erythema	NNP
25944	138	33	marginatum	marginatum	NNP
25944	138	34	,	,	,
25944	138	35	eczema	eczema	NN
25944	138	36	marginatum	marginatum	NN
25944	138	37	.	.	.
25944	139	1	#	#	NN
25944	139	2	What	what	WDT
25944	139	3	meaning	meaning	NN
25944	139	4	is	be	VBZ
25944	139	5	conveyed	convey	VBN
25944	139	6	by	by	IN
25944	139	7	the	the	DT
25944	139	8	qualifying	qualifying	NN
25944	139	9	term	term	NN
25944	139	10	"	"	``
25944	139	11	circumscribed	circumscribe	VBN
25944	139	12	"	"	''
25944	139	13	?	?	.
25944	139	14	#	#	$
25944	139	15	The	the	DT
25944	139	16	term	term	NN
25944	139	17	is	be	VBZ
25944	139	18	applied	apply	VBN
25944	139	19	to	to	IN
25944	139	20	small	small	JJ
25944	139	21	,	,	,
25944	139	22	usually	usually	RB
25944	139	23	more	more	RBR
25944	139	24	or	or	CC
25944	139	25	less	less	RBR
25944	139	26	rounded	rounded	JJ
25944	139	27	,	,	,
25944	139	28	patches	patch	NNS
25944	139	29	,	,	,
25944	139	30	when	when	WRB
25944	139	31	sharply	sharply	RB
25944	139	32	defined	define	VBN
25944	139	33	;	;	:
25944	139	34	as	as	IN
25944	139	35	,	,	,
25944	139	36	for	for	IN
25944	139	37	example	example	NN
25944	139	38	,	,	,
25944	139	39	the	the	DT
25944	139	40	typical	typical	JJ
25944	139	41	patches	patch	NNS
25944	139	42	of	of	IN
25944	139	43	psoriasis	psoriasis	NN
25944	139	44	.	.	.
25944	140	1	#	#	NNP
25944	140	2	When	when	WRB
25944	140	3	is	be	VBZ
25944	140	4	the	the	DT
25944	140	5	qualifying	qualifying	NN
25944	140	6	term	term	NN
25944	140	7	"	"	``
25944	140	8	gyrate	gyrate	NN
25944	140	9	"	"	''
25944	140	10	employed	employ	VBN
25944	140	11	?	?	.
25944	140	12	#	#	NN
25944	140	13	When	when	WRB
25944	140	14	the	the	DT
25944	140	15	patches	patch	NNS
25944	140	16	arrange	arrange	VBP
25944	140	17	themselves	-PRON-	PRP
25944	140	18	in	in	IN
25944	140	19	an	an	DT
25944	140	20	irregular	irregular	JJ
25944	140	21	winding	winding	NN
25944	140	22	or	or	CC
25944	140	23	festoon	festoon	NN
25944	140	24	-	-	HYPH
25944	140	25	like	like	JJ
25944	140	26	manner	manner	NN
25944	140	27	;	;	:
25944	140	28	as	as	IN
25944	140	29	,	,	,
25944	140	30	for	for	IN
25944	140	31	instance	instance	NN
25944	140	32	,	,	,
25944	140	33	in	in	IN
25944	140	34	some	some	DT
25944	140	35	cases	case	NNS
25944	140	36	of	of	IN
25944	140	37	psoriasis	psoriasis	NN
25944	140	38	.	.	.
25944	141	1	It	-PRON-	PRP
25944	141	2	results	result	VBZ
25944	141	3	,	,	,
25944	141	4	usually	usually	RB
25944	141	5	,	,	,
25944	141	6	from	from	IN
25944	141	7	the	the	DT
25944	141	8	coalescence	coalescence	NN
25944	141	9	of	of	IN
25944	141	10	several	several	JJ
25944	141	11	rings	ring	NNS
25944	141	12	,	,	,
25944	141	13	the	the	DT
25944	141	14	eruption	eruption	NN
25944	141	15	disappearing	disappear	VBG
25944	141	16	at	at	IN
25944	141	17	the	the	DT
25944	141	18	points	point	NNS
25944	141	19	of	of	IN
25944	141	20	contact	contact	NN
25944	141	21	.	.	.
25944	142	1	#	#	NNP
25944	142	2	When	when	WRB
25944	142	3	is	be	VBZ
25944	142	4	an	an	DT
25944	142	5	eruption	eruption	NN
25944	142	6	said	say	VBD
25944	142	7	to	to	TO
25944	142	8	be	be	VB
25944	142	9	serpiginous	serpiginous	JJ
25944	142	10	?	?	.
25944	142	11	#	#	$
25944	142	12	When	when	WRB
25944	142	13	the	the	DT
25944	142	14	eruption	eruption	NN
25944	142	15	spreads	spread	VBZ
25944	142	16	at	at	IN
25944	142	17	the	the	DT
25944	142	18	border	border	NN
25944	142	19	,	,	,
25944	142	20	clearing	clear	VBG
25944	142	21	up	up	RP
25944	142	22	at	at	IN
25944	142	23	the	the	DT
25944	142	24	older	old	JJR
25944	142	25	part	part	NN
25944	142	26	;	;	:
25944	142	27	as	as	IN
25944	142	28	,	,	,
25944	142	29	for	for	IN
25944	142	30	instance	instance	NN
25944	142	31	,	,	,
25944	142	32	in	in	IN
25944	142	33	the	the	DT
25944	142	34	serpiginous	serpiginous	JJ
25944	142	35	syphiloderm	syphiloderm	NN
25944	142	36	.	.	.
25944	143	1	#	#	$
25944	143	2	RELATIVE	relative	NN
25944	143	3	FREQUENCY	FREQUENCY	VBD
25944	143	4	.	.	.
25944	143	5	#	#	$
25944	143	6	#	#	$
25944	143	7	Name	name	VB
25944	143	8	the	the	DT
25944	143	9	more	more	RBR
25944	143	10	common	common	JJ
25944	143	11	cutaneous	cutaneous	JJ
25944	143	12	diseases	disease	NNS
25944	143	13	and	and	CC
25944	143	14	state	state	NN
25944	143	15	approximately	approximately	RB
25944	143	16	their	-PRON-	PRP$
25944	143	17	frequency	frequency	NN
25944	143	18	.	.	.
25944	143	19	#	#	NNP
25944	143	20	Eczema	Eczema	NNP
25944	143	21	,	,	,
25944	143	22	30.4	30.4	CD
25944	143	23	%	%	NN
25944	143	24	;	;	,
25944	143	25	syphilis	syphilis	NNP
25944	143	26	cutanea	cutanea	NNP
25944	143	27	,	,	,
25944	143	28	11.2	11.2	CD
25944	143	29	%	%	NN
25944	143	30	;	;	,
25944	143	31	acne	acne	NNP
25944	143	32	,	,	,
25944	143	33	7.3	7.3	CD
25944	143	34	%	%	NN
25944	143	35	;	;	,
25944	143	36	pediculosis	pediculosis	NN
25944	143	37	,	,	,
25944	143	38	4	4	CD
25944	143	39	%	%	NN
25944	143	40	;	;	,
25944	143	41	psoriasis	psoriasis	NN
25944	143	42	,	,	,
25944	143	43	3.3	3.3	CD
25944	143	44	%	%	NN
25944	143	45	;	;	:
25944	143	46	ringworm	ringworm	NN
25944	143	47	,	,	,
25944	143	48	3.2	3.2	CD
25944	143	49	%	%	NN
25944	143	50	;	;	,
25944	143	51	dermatitis	dermatitis	NN
25944	143	52	,	,	,
25944	143	53	2.6	2.6	CD
25944	143	54	%	%	NN
25944	143	55	;	;	,
25944	143	56	scabies	scabie	NNS
25944	143	57	,	,	,
25944	143	58	2.6	2.6	CD
25944	143	59	%	%	NN
25944	143	60	;	;	,
25944	143	61	urticaria	urticaria	NNP
25944	143	62	,	,	,
25944	143	63	2.5	2.5	CD
25944	143	64	%	%	NN
25944	143	65	;	;	,
25944	143	66	pruritus	pruritus	NNP
25944	143	67	,	,	,
25944	143	68	2.1	2.1	CD
25944	143	69	%	%	NN
25944	143	70	;	;	:
25944	143	71	seborrh[oe]a	seborrh[oe]a	NNP
25944	143	72	,	,	,
25944	143	73	2.1	2.1	CD
25944	143	74	%	%	NN
25944	143	75	;	;	:
25944	143	76	herpes	herpes	NNP
25944	143	77	simplex	simplex	NNP
25944	143	78	,	,	,
25944	143	79	1.7	1.7	CD
25944	143	80	%	%	NN
25944	143	81	;	;	:
25944	143	82	favus	favus	NNP
25944	143	83	,	,	,
25944	143	84	1.7	1.7	CD
25944	143	85	%	%	NN
25944	143	86	;	;	,
25944	143	87	impetigo	impetigo	NNP
25944	143	88	,	,	,
25944	143	89	1.4	1.4	CD
25944	143	90	%	%	NN
25944	143	91	;	;	:
25944	143	92	herpes	herpes	NNP
25944	143	93	zoster	zoster	NNP
25944	143	94	,	,	,
25944	143	95	1.2	1.2	CD
25944	143	96	%	%	NN
25944	143	97	;	;	,
25944	143	98	verruca	verruca	NNP
25944	143	99	,	,	,
25944	143	100	1.1	1.1	CD
25944	143	101	%	%	NN
25944	143	102	;	;	,
25944	143	103	tinea	tinea	NNP
25944	143	104	versicolor	versicolor	NN
25944	143	105	,	,	,
25944	143	106	1	1	CD
25944	143	107	%	%	NN
25944	143	108	.	.	.
25944	144	1	Total	total	JJ
25944	144	2	:	:	:
25944	144	3	eighteen	eighteen	CD
25944	144	4	diseases	disease	NNS
25944	144	5	,	,	,
25944	144	6	representing	represent	VBG
25944	144	7	81	81	CD
25944	144	8	per	per	NN
25944	144	9	cent	cent	NN
25944	144	10	.	.	.
25944	145	1	of	of	IN
25944	145	2	all	all	DT
25944	145	3	cases	case	NNS
25944	145	4	met	meet	VBD
25944	145	5	with	with	IN
25944	145	6	.	.	.
25944	146	1	(	(	-LRB-
25944	146	2	These	these	DT
25944	146	3	percentages	percentage	NNS
25944	146	4	are	be	VBP
25944	146	5	based	base	VBN
25944	146	6	upon	upon	IN
25944	146	7	statistics	statistic	NNS
25944	146	8	,	,	,
25944	146	9	public	public	JJ
25944	146	10	and	and	CC
25944	146	11	private	private	JJ
25944	146	12	,	,	,
25944	146	13	of	of	IN
25944	146	14	the	the	DT
25944	146	15	American	American	NNP
25944	146	16	Dermatological	Dermatological	NNP
25944	146	17	Association	Association	NNP
25944	146	18	,	,	,
25944	146	19	covering	cover	VBG
25944	146	20	a	a	DT
25944	146	21	period	period	NN
25944	146	22	of	of	IN
25944	146	23	ten	ten	CD
25944	146	24	years	year	NNS
25944	146	25	.	.	.
25944	147	1	In	in	IN
25944	147	2	private	private	JJ
25944	147	3	practice	practice	NN
25944	147	4	the	the	DT
25944	147	5	proportion	proportion	NN
25944	147	6	of	of	IN
25944	147	7	cases	case	NNS
25944	147	8	of	of	IN
25944	147	9	pediculosis	pediculosis	NN
25944	147	10	,	,	,
25944	147	11	scabies	scabie	NNS
25944	147	12	,	,	,
25944	147	13	favus	favus	NNP
25944	147	14	,	,	,
25944	147	15	and	and	CC
25944	147	16	impetigo	impetigo	NNP
25944	147	17	is	be	VBZ
25944	147	18	much	much	RB
25944	147	19	smaller	small	JJR
25944	147	20	,	,	,
25944	147	21	while	while	IN
25944	147	22	acne	acne	NNP
25944	147	23	,	,	,
25944	147	24	acne	acne	NNP
25944	147	25	rosacea	rosacea	NNP
25944	147	26	,	,	,
25944	147	27	seborrh[oe]a	seborrh[oe]a	NNP
25944	147	28	,	,	,
25944	147	29	epithelioma	epithelioma	NNP
25944	147	30	,	,	,
25944	147	31	and	and	CC
25944	147	32	lupus	lupus	NNP
25944	147	33	are	be	VBP
25944	147	34	relatively	relatively	RB
25944	147	35	more	more	RBR
25944	147	36	frequent	frequent	JJ
25944	147	37	.	.	.
25944	147	38	)	)	-RRB-
25944	148	1	#	#	NNP
25944	148	2	CONTAGIOUSNESS	CONTAGIOUSNESS	NNP
25944	148	3	.	.	.
25944	148	4	#	#	$
25944	148	5	#	#	$
25944	148	6	Name	name	VB
25944	148	7	the	the	DT
25944	148	8	more	more	RBR
25944	148	9	actively	actively	RB
25944	148	10	contagious	contagious	JJ
25944	148	11	skin	skin	NN
25944	148	12	diseases	disease	NNS
25944	148	13	.	.	.
25944	148	14	#	#	$
25944	148	15	Impetigo	Impetigo	NNP
25944	148	16	contagiosa	contagiosa	VBP
25944	148	17	,	,	,
25944	148	18	ringworm	ringworm	NN
25944	148	19	,	,	,
25944	148	20	favus	favus	NNP
25944	148	21	,	,	,
25944	148	22	scabies	scabie	NNS
25944	148	23	and	and	CC
25944	148	24	pediculosis	pediculosis	NN
25944	148	25	;	;	:
25944	148	26	excluding	exclude	VBG
25944	148	27	the	the	DT
25944	148	28	exanthemata	exanthemata	NN
25944	148	29	,	,	,
25944	148	30	erysipelas	erysipelas	NNP
25944	148	31	,	,	,
25944	148	32	syphilis	syphilis	NNP
25944	148	33	and	and	CC
25944	148	34	certain	certain	JJ
25944	148	35	rare	rare	JJ
25944	148	36	and	and	CC
25944	148	37	doubtful	doubtful	JJ
25944	148	38	diseases	disease	NNS
25944	148	39	.	.	.
25944	149	1	[	[	-LRB-
25944	149	2	At	at	IN
25944	149	3	the	the	DT
25944	149	4	present	present	JJ
25944	149	5	time	time	NN
25944	149	6	when	when	WRB
25944	149	7	most	most	JJS
25944	149	8	diseases	disease	NNS
25944	149	9	are	be	VBP
25944	149	10	presumed	presume	VBN
25944	149	11	to	to	TO
25944	149	12	be	be	VB
25944	149	13	due	due	IN
25944	149	14	to	to	IN
25944	149	15	bacteria	bacteria	NNS
25944	149	16	or	or	CC
25944	149	17	parasites	parasite	NNS
25944	149	18	the	the	DT
25944	149	19	belief	belief	NN
25944	149	20	in	in	IN
25944	149	21	contagiousness	contagiousness	JJ
25944	149	22	,	,	,
25944	149	23	under	under	IN
25944	149	24	certain	certain	JJ
25944	149	25	conditions	condition	NNS
25944	149	26	,	,	,
25944	149	27	has	have	VBZ
25944	149	28	considerably	considerably	RB
25944	149	29	broadened	broaden	VBN
25944	149	30	.	.	.
25944	149	31	]	]	-RRB-
25944	150	1	#	#	NN
25944	150	2	RAPIDITY	RAPIDITY	NNP
25944	150	3	OF	of	IN
25944	150	4	CURE	CURE	NNP
25944	150	5	.	.	.
25944	150	6	#	#	$
25944	150	7	#	#	$
25944	150	8	Is	be	VBZ
25944	150	9	the	the	DT
25944	150	10	rapid	rapid	JJ
25944	150	11	cure	cure	NN
25944	150	12	of	of	IN
25944	150	13	a	a	DT
25944	150	14	skin	skin	NN
25944	150	15	disease	disease	NN
25944	150	16	fraught	fraught	RB
25944	150	17	with	with	IN
25944	150	18	any	any	DT
25944	150	19	danger	danger	NN
25944	150	20	to	to	IN
25944	150	21	the	the	DT
25944	150	22	patient	patient	NN
25944	150	23	?	?	.
25944	150	24	#	#	NN
25944	150	25	No	no	UH
25944	150	26	.	.	.
25944	151	1	It	-PRON-	PRP
25944	151	2	was	be	VBD
25944	151	3	formerly	formerly	RB
25944	151	4	so	so	RB
25944	151	5	considered	consider	VBN
25944	151	6	,	,	,
25944	151	7	especially	especially	RB
25944	151	8	by	by	IN
25944	151	9	the	the	DT
25944	151	10	public	public	JJ
25944	151	11	and	and	CC
25944	151	12	general	general	JJ
25944	151	13	profession	profession	NN
25944	151	14	,	,	,
25944	151	15	and	and	CC
25944	151	16	the	the	DT
25944	151	17	impression	impression	NN
25944	151	18	still	still	RB
25944	151	19	holds	hold	VBZ
25944	151	20	to	to	IN
25944	151	21	some	some	DT
25944	151	22	extent	extent	NN
25944	151	23	,	,	,
25944	151	24	but	but	CC
25944	151	25	it	-PRON-	PRP
25944	151	26	is	be	VBZ
25944	151	27	not	not	RB
25944	151	28	in	in	IN
25944	151	29	accord	accord	NN
25944	151	30	with	with	IN
25944	151	31	dermatological	dermatological	JJ
25944	151	32	experience	experience	NN
25944	151	33	.	.	.
25944	152	1	#	#	NN
25944	152	2	OINTMENT	OINTMENT	NNP
25944	152	3	BASES	basis	NNS
25944	152	4	.	.	.
25944	152	5	#	#	$
25944	152	6	#	#	$
25944	152	7	Name	name	VB
25944	152	8	the	the	DT
25944	152	9	several	several	JJ
25944	152	10	fats	fat	NNS
25944	152	11	in	in	IN
25944	152	12	common	common	JJ
25944	152	13	use	use	NN
25944	152	14	for	for	IN
25944	152	15	ointment	ointment	NN
25944	152	16	bases	basis	NNS
25944	152	17	.	.	.
25944	152	18	#	#	$
25944	152	19	Lard	Lard	NNP
25944	152	20	,	,	,
25944	152	21	petrolatum	petrolatum	NN
25944	152	22	(	(	-LRB-
25944	152	23	or	or	CC
25944	152	24	cosmoline	cosmoline	NN
25944	152	25	or	or	CC
25944	152	26	vaseline	vaseline	NN
25944	152	27	)	)	-RRB-
25944	152	28	,	,	,
25944	152	29	cold	cold	JJ
25944	152	30	cream	cream	NN
25944	152	31	and	and	CC
25944	152	32	lanolin	lanolin	NN
25944	152	33	.	.	.
25944	153	1	#	#	JJR
25944	153	2	State	state	NN
25944	153	3	the	the	DT
25944	153	4	relative	relative	JJ
25944	153	5	advantages	advantage	NNS
25944	153	6	of	of	IN
25944	153	7	these	these	DT
25944	153	8	several	several	JJ
25944	153	9	bases	basis	NNS
25944	153	10	.	.	.
25944	153	11	#	#	$
25944	153	12	_	_	NNP
25944	153	13	Lard	Lard	NNP
25944	153	14	_	_	NNP
25944	153	15	is	be	VBZ
25944	153	16	the	the	DT
25944	153	17	best	good	JJS
25944	153	18	all	all	RB
25944	153	19	-	-	HYPH
25944	153	20	around	around	RB
25944	153	21	base	base	NN
25944	153	22	,	,	,
25944	153	23	possessing	possess	VBG
25944	153	24	penetrating	penetrating	NN
25944	153	25	properties	property	NNS
25944	153	26	scarcely	scarcely	RB
25944	153	27	exceeded	exceed	VBN
25944	153	28	by	by	IN
25944	153	29	any	any	DT
25944	153	30	other	other	JJ
25944	153	31	fat	fat	NN
25944	153	32	.	.	.
25944	154	1	_	_	NNP
25944	154	2	Petrolatum	Petrolatum	NNP
25944	154	3	_	_	NNP
25944	154	4	is	be	VBZ
25944	154	5	also	also	RB
25944	154	6	valuable	valuable	JJ
25944	154	7	,	,	,
25944	154	8	having	have	VBG
25944	154	9	little	little	JJ
25944	154	10	,	,	,
25944	154	11	if	if	IN
25944	154	12	any	any	DT
25944	154	13	,	,	,
25944	154	14	tendency	tendency	NN
25944	154	15	to	to	TO
25944	154	16	change	change	VB
25944	154	17	;	;	:
25944	154	18	it	-PRON-	PRP
25944	154	19	is	be	VBZ
25944	154	20	useful	useful	JJ
25944	154	21	as	as	IN
25944	154	22	a	a	DT
25944	154	23	protective	protective	NN
25944	154	24	,	,	,
25944	154	25	but	but	CC
25944	154	26	is	be	VBZ
25944	154	27	lacking	lack	VBG
25944	154	28	in	in	IN
25944	154	29	its	-PRON-	PRP$
25944	154	30	power	power	NN
25944	154	31	of	of	IN
25944	154	32	penetration	penetration	NN
25944	154	33	.	.	.
25944	155	1	_	_	NNP
25944	155	2	Cold	Cold	NNP
25944	155	3	Cream	Cream	NNP
25944	155	4	_	_	NNP
25944	155	5	(	(	-LRB-
25944	155	6	ungt	ungt	UH
25944	155	7	.	.	.
25944	156	1	aquæ	aquæ	JJ
25944	156	2	rosæ	rosæ	NNP
25944	156	3	)	)	-RRB-
25944	156	4	is	be	VBZ
25944	156	5	soothing	soothing	JJ
25944	156	6	and	and	CC
25944	156	7	cooling	cooling	JJ
25944	156	8	,	,	,
25944	156	9	and	and	CC
25944	156	10	may	may	MD
25944	156	11	often	often	RB
25944	156	12	be	be	VB
25944	156	13	used	use	VBN
25944	156	14	when	when	WRB
25944	156	15	other	other	JJ
25944	156	16	fatty	fatty	NN
25944	156	17	applications	application	NNS
25944	156	18	disagree	disagree	VBP
25944	156	19	.	.	.
25944	157	1	_	_	NNP
25944	157	2	Lanolin	Lanolin	NNP
25944	157	3	_	_	NNP
25944	157	4	is	be	VBZ
25944	157	5	said	say	VBN
25944	157	6	to	to	TO
25944	157	7	surpass	surpass	VB
25944	157	8	in	in	IN
25944	157	9	its	-PRON-	PRP$
25944	157	10	power	power	NN
25944	157	11	of	of	IN
25944	157	12	penetration	penetration	NN
25944	157	13	all	all	DT
25944	157	14	other	other	JJ
25944	157	15	bases	basis	NNS
25944	157	16	,	,	,
25944	157	17	but	but	CC
25944	157	18	this	this	DT
25944	157	19	is	be	VBZ
25944	157	20	not	not	RB
25944	157	21	borne	bear	VBN
25944	157	22	out	out	RP
25944	157	23	by	by	IN
25944	157	24	experience	experience	NN
25944	157	25	.	.	.
25944	158	1	It	-PRON-	PRP
25944	158	2	is	be	VBZ
25944	158	3	an	an	DT
25944	158	4	unsatisfactory	unsatisfactory	JJ
25944	158	5	base	base	NN
25944	158	6	when	when	WRB
25944	158	7	used	use	VBN
25944	158	8	alone	alone	RB
25944	158	9	.	.	.
25944	159	1	It	-PRON-	PRP
25944	159	2	should	should	MD
25944	159	3	be	be	VB
25944	159	4	mixed	mix	VBN
25944	159	5	with	with	IN
25944	159	6	another	another	DT
25944	159	7	base	base	NN
25944	159	8	in	in	IN
25944	159	9	about	about	IN
25944	159	10	the	the	DT
25944	159	11	proportion	proportion	NN
25944	159	12	of	of	IN
25944	159	13	25	25	CD
25944	159	14	%	%	NN
25944	159	15	to	to	IN
25944	159	16	50	50	CD
25944	159	17	%	%	NN
25944	159	18	.	.	.
25944	160	1	These	these	DT
25944	160	2	several	several	JJ
25944	160	3	bases	basis	NNS
25944	160	4	may	may	MD
25944	160	5	,	,	,
25944	160	6	and	and	CC
25944	160	7	often	often	RB
25944	160	8	with	with	IN
25944	160	9	advantage	advantage	NN
25944	160	10	,	,	,
25944	160	11	be	be	VB
25944	160	12	variously	variously	RB
25944	160	13	combined	combine	VBN
25944	160	14	.	.	.
25944	161	1	#	#	LS
25944	161	2	What	what	WP
25944	161	3	is	be	VBZ
25944	161	4	to	to	TO
25944	161	5	be	be	VB
25944	161	6	added	add	VBN
25944	161	7	to	to	IN
25944	161	8	these	these	DT
25944	161	9	several	several	JJ
25944	161	10	bases	basis	NNS
25944	161	11	if	if	IN
25944	161	12	a	a	DT
25944	161	13	stiffer	stiff	JJR
25944	161	14	ointment	ointment	NN
25944	161	15	is	be	VBZ
25944	161	16	required	require	VBN
25944	161	17	?	?	.
25944	161	18	#	#	$
25944	161	19	Simple	simple	JJ
25944	161	20	cerate	cerate	NN
25944	161	21	,	,	,
25944	161	22	wax	wax	NN
25944	161	23	,	,	,
25944	161	24	spermaceti	spermaceti	NNP
25944	161	25	,	,	,
25944	161	26	or	or	CC
25944	161	27	suet	suet	JJ
25944	161	28	;	;	:
25944	161	29	or	or	CC
25944	161	30	in	in	IN
25944	161	31	some	some	DT
25944	161	32	instances	instance	NNS
25944	161	33	,	,	,
25944	161	34	a	a	DT
25944	161	35	pulverulent	pulverulent	JJ
25944	161	36	substance	substance	NN
25944	161	37	,	,	,
25944	161	38	such	such	JJ
25944	161	39	as	as	IN
25944	161	40	starch	starch	NN
25944	161	41	,	,	,
25944	161	42	boric	boric	NN
25944	161	43	acid	acid	NN
25944	161	44	,	,	,
25944	161	45	and	and	CC
25944	161	46	zinc	zinc	NN
25944	161	47	oxide	oxide	NN
25944	161	48	.	.	.
25944	162	1	#	#	$
25944	162	2	CLASS	class	NN
25944	162	3	I.--DISORDERS	I.--DISORDERS	:
25944	162	4	OF	of	IN
25944	162	5	THE	the	DT
25944	162	6	GLANDS	gland	NNS
25944	162	7	.	.	.
25944	162	8	#	#	$
25944	162	9	#	#	NNP
25944	162	10	Hyperidrosis	Hyperidrosis	NNP
25944	162	11	.	.	.
25944	162	12	#	#	$
25944	162	13	[	[	-LRB-
25944	162	14	Illustration	illustration	NN
25944	162	15	:	:	:
25944	162	16	Fig	Fig	NNP
25944	162	17	.	.	.
25944	163	1	6	6	CD
25944	163	2	.	.	.
25944	164	1	A	a	DT
25944	164	2	normal	normal	JJ
25944	164	3	sweat	sweat	NN
25944	164	4	-	-	HYPH
25944	164	5	gland	gland	NN
25944	164	6	,	,	,
25944	164	7	highly	highly	RB
25944	164	8	magnified	magnify	VBN
25944	164	9	.	.	.
25944	165	1	(	(	-LRB-
25944	165	2	_	_	NNP
25944	165	3	After	after	IN
25944	165	4	Neumann	Neumann	NNP
25944	165	5	.	.	.
25944	165	6	_	_	NNP
25944	165	7	)	)	-RRB-
25944	165	8	_	_	NNP
25944	165	9	a	a	DT
25944	165	10	_	_	NNP
25944	165	11	,	,	,
25944	165	12	Sweat	Sweat	NNP
25944	165	13	-	-	HYPH
25944	165	14	coil	coil	NNP
25944	165	15	:	:	:
25944	165	16	_	_	NNP
25944	165	17	b	b	NNP
25944	165	18	_	_	NNP
25944	165	19	,	,	,
25944	165	20	sweat	sweat	NN
25944	165	21	-	-	HYPH
25944	165	22	duct	duct	NN
25944	165	23	;	;	:
25944	165	24	_	_	NNP
25944	165	25	c	c	NNP
25944	165	26	_	_	NNP
25944	165	27	,	,	,
25944	165	28	lumen	luman	NNS
25944	165	29	of	of	IN
25944	165	30	duct	duct	NN
25944	165	31	;	;	:
25944	165	32	_	_	NNP
25944	165	33	d	d	NNP
25944	165	34	_	_	NNP
25944	165	35	,	,	,
25944	165	36	connective	connective	JJ
25944	165	37	-	-	HYPH
25944	165	38	tissue	tissue	NN
25944	165	39	capsule	capsule	NN
25944	165	40	;	;	:
25944	165	41	_	_	NNP
25944	165	42	e	e	NNP
25944	165	43	_	_	NNP
25944	165	44	and	and	CC
25944	165	45	_	_	NNP
25944	165	46	f	f	NNP
25944	165	47	_	_	NNP
25944	165	48	,	,	,
25944	165	49	arterial	arterial	JJ
25944	165	50	trunk	trunk	NN
25944	165	51	and	and	CC
25944	165	52	capillaries	capillary	NNS
25944	165	53	.	.	.
25944	165	54	]	]	-RRB-
25944	166	1	#	#	LS
25944	166	2	What	what	WP
25944	166	3	is	be	VBZ
25944	166	4	hyperidrosis	hyperidrosis	NN
25944	166	5	?	?	.
25944	166	6	#	#	$
25944	166	7	Hyperidrosis	Hyperidrosis	NNP
25944	166	8	is	be	VBZ
25944	166	9	a	a	DT
25944	166	10	functional	functional	JJ
25944	166	11	disturbance	disturbance	NN
25944	166	12	of	of	IN
25944	166	13	the	the	DT
25944	166	14	sweat	sweat	NN
25944	166	15	-	-	HYPH
25944	166	16	glands	gland	NNS
25944	166	17	,	,	,
25944	166	18	characterized	characterize	VBN
25944	166	19	by	by	IN
25944	166	20	an	an	DT
25944	166	21	increased	increase	VBN
25944	166	22	production	production	NN
25944	166	23	of	of	IN
25944	166	24	sweat	sweat	NN
25944	166	25	.	.	.
25944	167	1	This	this	DT
25944	167	2	increase	increase	NN
25944	167	3	may	may	MD
25944	167	4	be	be	VB
25944	167	5	slight	slight	JJ
25944	167	6	or	or	CC
25944	167	7	excessive	excessive	JJ
25944	167	8	,	,	,
25944	167	9	local	local	JJ
25944	167	10	or	or	CC
25944	167	11	general	general	JJ
25944	167	12	.	.	.
25944	168	1	#	#	NNP
25944	168	2	As	as	IN
25944	168	3	a	a	DT
25944	168	4	local	local	JJ
25944	168	5	affection	affection	NN
25944	168	6	,	,	,
25944	168	7	what	what	WDT
25944	168	8	parts	part	NNS
25944	168	9	are	be	VBP
25944	168	10	most	most	RBS
25944	168	11	commonly	commonly	RB
25944	168	12	involved	involve	VBN
25944	168	13	?	?	.
25944	168	14	#	#	$
25944	168	15	The	the	DT
25944	168	16	hands	hand	NNS
25944	168	17	,	,	,
25944	168	18	feet	foot	NNS
25944	168	19	,	,	,
25944	168	20	especially	especially	RB
25944	168	21	the	the	DT
25944	168	22	palmar	palmar	NNP
25944	168	23	and	and	CC
25944	168	24	plantar	plantar	NNP
25944	168	25	surfaces	surface	NNS
25944	168	26	,	,	,
25944	168	27	the	the	DT
25944	168	28	axillæ	axillæ	NN
25944	168	29	and	and	CC
25944	168	30	the	the	DT
25944	168	31	genitalia	genitalia	NNP
25944	168	32	.	.	.
25944	169	1	#	#	NNP
25944	169	2	Describe	describe	VB
25944	169	3	the	the	DT
25944	169	4	symptoms	symptom	NNS
25944	169	5	of	of	IN
25944	169	6	the	the	DT
25944	169	7	local	local	JJ
25944	169	8	forms	form	NNS
25944	169	9	of	of	IN
25944	169	10	hyperidrosis	hyperidrosis	NN
25944	169	11	.	.	.
25944	169	12	#	#	$
25944	169	13	The	the	DT
25944	169	14	essential	essential	JJ
25944	169	15	,	,	,
25944	169	16	and	and	CC
25944	169	17	frequently	frequently	RB
25944	169	18	the	the	DT
25944	169	19	sole	sole	JJ
25944	169	20	symptom	symptom	NN
25944	169	21	,	,	,
25944	169	22	is	be	VBZ
25944	169	23	more	more	RBR
25944	169	24	or	or	CC
25944	169	25	less	less	JJR
25944	169	26	profuse	profuse	NN
25944	169	27	sweating	sweating	NN
25944	169	28	.	.	.
25944	170	1	If	if	IN
25944	170	2	the	the	DT
25944	170	3	hands	hand	NNS
25944	170	4	are	be	VBP
25944	170	5	the	the	DT
25944	170	6	parts	part	NNS
25944	170	7	involved	involve	VBN
25944	170	8	,	,	,
25944	170	9	they	-PRON-	PRP
25944	170	10	are	be	VBP
25944	170	11	noted	note	VBN
25944	170	12	to	to	TO
25944	170	13	be	be	VB
25944	170	14	wet	wet	JJ
25944	170	15	,	,	,
25944	170	16	clammy	clammy	JJ
25944	170	17	and	and	CC
25944	170	18	sometimes	sometimes	RB
25944	170	19	cold	cold	JJ
25944	170	20	.	.	.
25944	171	1	If	if	IN
25944	171	2	involving	involve	VBG
25944	171	3	the	the	DT
25944	171	4	soles	sol	NNS
25944	171	5	,	,	,
25944	171	6	the	the	DT
25944	171	7	skin	skin	NN
25944	171	8	often	often	RB
25944	171	9	becomes	become	VBZ
25944	171	10	more	more	RBR
25944	171	11	or	or	CC
25944	171	12	less	less	RBR
25944	171	13	macerated	macerate	VBN
25944	171	14	and	and	CC
25944	171	15	sodden	sodden	JJ
25944	171	16	in	in	IN
25944	171	17	appearance	appearance	NN
25944	171	18	,	,	,
25944	171	19	and	and	CC
25944	171	20	as	as	IN
25944	171	21	a	a	DT
25944	171	22	result	result	NN
25944	171	23	of	of	IN
25944	171	24	this	this	DT
25944	171	25	maceration	maceration	NN
25944	171	26	and	and	CC
25944	171	27	continued	continued	JJ
25944	171	28	irritation	irritation	NN
25944	171	29	they	-PRON-	PRP
25944	171	30	may	may	MD
25944	171	31	become	become	VB
25944	171	32	inflamed	inflamed	JJ
25944	171	33	,	,	,
25944	171	34	especially	especially	RB
25944	171	35	about	about	IN
25944	171	36	the	the	DT
25944	171	37	borders	border	NNS
25944	171	38	of	of	IN
25944	171	39	the	the	DT
25944	171	40	affected	affect	VBN
25944	171	41	parts	part	NNS
25944	171	42	,	,	,
25944	171	43	and	and	CC
25944	171	44	present	present	VB
25944	171	45	a	a	DT
25944	171	46	pinkish	pinkish	NN
25944	171	47	or	or	CC
25944	171	48	pinkish	pinkish	NN
25944	171	49	-	-	HYPH
25944	171	50	red	red	JJ
25944	171	51	color	color	NN
25944	171	52	,	,	,
25944	171	53	having	have	VBG
25944	171	54	a	a	DT
25944	171	55	violaceous	violaceous	JJ
25944	171	56	tinge	tinge	NN
25944	171	57	.	.	.
25944	172	1	The	the	DT
25944	172	2	sweat	sweat	NN
25944	172	3	undergoes	undergoe	NNS
25944	172	4	change	change	VBP
25944	172	5	and	and	CC
25944	172	6	becomes	become	VBZ
25944	172	7	offensive	offensive	JJ
25944	172	8	.	.	.
25944	173	1	#	#	$
25944	173	2	Is	be	VBZ
25944	173	3	hyperidrosis	hyperidrosis	NN
25944	173	4	acute	acute	JJ
25944	173	5	or	or	CC
25944	173	6	chronic	chronic	JJ
25944	173	7	?	?	.
25944	173	8	#	#	NN
25944	173	9	Usually	usually	RB
25944	173	10	chronic	chronic	JJ
25944	173	11	,	,	,
25944	173	12	although	although	IN
25944	173	13	it	-PRON-	PRP
25944	173	14	may	may	MD
25944	173	15	also	also	RB
25944	173	16	occur	occur	VB
25944	173	17	as	as	IN
25944	173	18	an	an	DT
25944	173	19	acute	acute	JJ
25944	173	20	affection	affection	NN
25944	173	21	.	.	.
25944	174	1	#	#	LS
25944	174	2	What	what	WP
25944	174	3	is	be	VBZ
25944	174	4	the	the	DT
25944	174	5	etiology	etiology	NN
25944	174	6	of	of	IN
25944	174	7	hyperidrosis	hyperidrosis	NN
25944	174	8	?	?	.
25944	174	9	#	#	$
25944	174	10	Debility	Debility	NNP
25944	174	11	is	be	VBZ
25944	174	12	commonly	commonly	RB
25944	174	13	the	the	DT
25944	174	14	cause	cause	NN
25944	174	15	in	in	IN
25944	174	16	general	general	JJ
25944	174	17	hyperidrosis	hyperidrosis	NN
25944	174	18	;	;	:
25944	174	19	the	the	DT
25944	174	20	local	local	JJ
25944	174	21	forms	form	NNS
25944	174	22	are	be	VBP
25944	174	23	probably	probably	RB
25944	174	24	neurotic	neurotic	JJ
25944	174	25	in	in	IN
25944	174	26	origin	origin	NN
25944	174	27	.	.	.
25944	175	1	#	#	LS
25944	175	2	What	what	WP
25944	175	3	is	be	VBZ
25944	175	4	the	the	DT
25944	175	5	prognosis	prognosis	NN
25944	175	6	?	?	.
25944	175	7	#	#	$
25944	175	8	The	the	DT
25944	175	9	disease	disease	NN
25944	175	10	is	be	VBZ
25944	175	11	usually	usually	RB
25944	175	12	persistent	persistent	JJ
25944	175	13	and	and	CC
25944	175	14	often	often	RB
25944	175	15	rebellious	rebellious	JJ
25944	175	16	to	to	IN
25944	175	17	treatment	treatment	NN
25944	175	18	;	;	:
25944	175	19	in	in	IN
25944	175	20	many	many	JJ
25944	175	21	instances	instance	NNS
25944	175	22	a	a	DT
25944	175	23	permanent	permanent	JJ
25944	175	24	cure	cure	NN
25944	175	25	is	be	VBZ
25944	175	26	possible	possible	JJ
25944	175	27	,	,	,
25944	175	28	in	in	IN
25944	175	29	others	other	NNS
25944	175	30	palliation	palliation	NN
25944	175	31	.	.	.
25944	176	1	Relapses	relapse	NNS
25944	176	2	are	be	VBP
25944	176	3	not	not	RB
25944	176	4	uncommon	uncommon	JJ
25944	176	5	.	.	.
25944	177	1	#	#	DT
25944	177	2	What	what	WDT
25944	177	3	systemic	systemic	JJ
25944	177	4	remedies	remedy	NNS
25944	177	5	are	be	VBP
25944	177	6	employed	employ	VBN
25944	177	7	in	in	IN
25944	177	8	hyperidrosis	hyperidrosis	NN
25944	177	9	?	?	.
25944	177	10	#	#	NN
25944	177	11	Ergot	Ergot	NNP
25944	177	12	,	,	,
25944	177	13	belladonna	belladonna	NN
25944	177	14	,	,	,
25944	177	15	gallic	gallic	JJ
25944	177	16	acid	acid	NNP
25944	177	17	,	,	,
25944	177	18	mineral	mineral	NN
25944	177	19	acids	acid	NNS
25944	177	20	,	,	,
25944	177	21	and	and	CC
25944	177	22	tonics	tonic	NNS
25944	177	23	.	.	.
25944	178	1	Constitutional	constitutional	JJ
25944	178	2	treatment	treatment	NN
25944	178	3	is	be	VBZ
25944	178	4	rarely	rarely	RB
25944	178	5	of	of	IN
25944	178	6	benefit	benefit	NN
25944	178	7	in	in	IN
25944	178	8	the	the	DT
25944	178	9	local	local	JJ
25944	178	10	forms	form	NNS
25944	178	11	of	of	IN
25944	178	12	hyperidrosis	hyperidrosis	NN
25944	178	13	,	,	,
25944	178	14	and	and	CC
25944	178	15	external	external	JJ
25944	178	16	applications	application	NNS
25944	178	17	are	be	VBP
25944	178	18	seldom	seldom	RB
25944	178	19	of	of	IN
25944	178	20	service	service	NN
25944	178	21	in	in	IN
25944	178	22	general	general	JJ
25944	178	23	hyperidrosis	hyperidrosis	NN
25944	178	24	.	.	.
25944	179	1	Precipitated	precipitate	VBN
25944	179	2	sulphur	sulphur	NNP
25944	179	3	,	,	,
25944	179	4	a	a	DT
25944	179	5	teaspoonful	teaspoonful	JJ
25944	179	6	twice	twice	RB
25944	179	7	daily	daily	JJ
25944	179	8	,	,	,
25944	179	9	is	be	VBZ
25944	179	10	also	also	RB
25944	179	11	well	well	RB
25944	179	12	spoken	speak	VBN
25944	179	13	of	of	IN
25944	179	14	,	,	,
25944	179	15	combined	combine	VBN
25944	179	16	,	,	,
25944	179	17	if	if	IN
25944	179	18	necessary	necessary	JJ
25944	179	19	,	,	,
25944	179	20	with	with	IN
25944	179	21	an	an	DT
25944	179	22	astringent	astringent	NN
25944	179	23	.	.	.
25944	180	1	#	#	$
25944	180	2	What	what	WDT
25944	180	3	external	external	JJ
25944	180	4	remedies	remedy	NNS
25944	180	5	are	be	VBP
25944	180	6	employed	employ	VBN
25944	180	7	in	in	IN
25944	180	8	the	the	DT
25944	180	9	local	local	JJ
25944	180	10	forms	form	NNS
25944	180	11	?	?	.
25944	180	12	#	#	JJR
25944	180	13	Astringent	astringent	JJ
25944	180	14	lotions	lotion	NNS
25944	180	15	of	of	IN
25944	180	16	zinc	zinc	NN
25944	180	17	sulphate	sulphate	NN
25944	180	18	,	,	,
25944	180	19	tannin	tannin	NN
25944	180	20	and	and	CC
25944	180	21	alum	alum	NN
25944	180	22	,	,	,
25944	180	23	applied	apply	VBD
25944	180	24	several	several	JJ
25944	180	25	times	time	NNS
25944	180	26	daily	daily	RB
25944	180	27	,	,	,
25944	180	28	with	with	IN
25944	180	29	or	or	CC
25944	180	30	without	without	IN
25944	180	31	the	the	DT
25944	180	32	supplementary	supplementary	JJ
25944	180	33	use	use	NN
25944	180	34	of	of	IN
25944	180	35	dusting	dusting	NN
25944	180	36	-	-	HYPH
25944	180	37	powders	powder	NNS
25944	180	38	.	.	.
25944	181	1	Weak	weak	JJ
25944	181	2	solutions	solution	NNS
25944	181	3	of	of	IN
25944	181	4	formaldehyde	formaldehyde	NN
25944	181	5	,	,	,
25944	181	6	one	one	CD
25944	181	7	to	to	IN
25944	181	8	one	one	CD
25944	181	9	hundred	hundred	CD
25944	181	10	,	,	,
25944	181	11	are	be	VBP
25944	181	12	sometimes	sometimes	RB
25944	181	13	of	of	IN
25944	181	14	value	value	NN
25944	181	15	.	.	.
25944	182	1	Dusting	dusting	NN
25944	182	2	-	-	HYPH
25944	182	3	powders	powder	NNS
25944	182	4	of	of	IN
25944	182	5	boric	boric	NN
25944	182	6	acid	acid	NN
25944	182	7	and	and	CC
25944	182	8	zinc	zinc	NN
25944	182	9	oxide	oxide	NN
25944	182	10	,	,	,
25944	182	11	to	to	TO
25944	182	12	which	which	WDT
25944	182	13	may	may	MD
25944	182	14	be	be	VB
25944	182	15	added	add	VBN
25944	182	16	from	from	IN
25944	182	17	ten	ten	CD
25944	182	18	to	to	IN
25944	182	19	thirty	thirty	CD
25944	182	20	grains	grain	NNS
25944	182	21	of	of	IN
25944	182	22	salicylic	salicylic	JJ
25944	182	23	acid	acid	NN
25944	182	24	to	to	IN
25944	182	25	the	the	DT
25944	182	26	ounce	ounce	NN
25944	182	27	,	,	,
25944	182	28	to	to	TO
25944	182	29	be	be	VB
25944	182	30	used	use	VBN
25944	182	31	freely	freely	RB
25944	182	32	and	and	CC
25944	182	33	often:--	often:--	ADD
25944	182	34	[	[	-LRB-
25944	182	35	Rx	Rx	NNP
25944	182	36	]	]	-RRB-
25944	182	37	Pulv	Pulv	NNP
25944	182	38	.	.	.
25944	183	1	ac	ac	NNP
25944	183	2	.	.	.
25944	184	1	salicylici	salicylici	NNP
25944	184	2	.................	.................	.
25944	184	3	gr	gr	NNP
25944	184	4	.	.	.
25944	185	1	x	x	LS
25944	185	2	-	-	:
25944	185	3	xxx	xxx	NNP
25944	185	4	.	.	.
25944	186	1	Pulv	pulv	FW
25944	186	2	.	.	.
25944	187	1	ac	ac	NNP
25944	187	2	.	.	.
25944	188	1	borici	borici	NNP
25944	188	2	.....................	.....................	NFP
25944	188	3	[	[	-LRB-
25944	188	4	dram]v	dram]v	NNP
25944	188	5	.	.	.
25944	188	6	Pulv	Pulv	NNP
25944	188	7	.	.	.
25944	189	1	zinci	zinci	NNP
25944	189	2	oxidi	oxidi	NNP
25944	189	3	....................	....................	NFP
25944	189	4	[	[	-LRB-
25944	189	5	dram]iij	dram]iij	NNP
25944	189	6	M.	M.	NNP
25944	189	7	Diachylon	Diachylon	NNP
25944	189	8	ointment	ointment	NN
25944	189	9	,	,	,
25944	189	10	and	and	CC
25944	189	11	an	an	DT
25944	189	12	ointment	ointment	NN
25944	189	13	containing	contain	VBG
25944	189	14	a	a	DT
25944	189	15	drachm	drachm	NN
25944	189	16	of	of	IN
25944	189	17	tannin	tannin	NN
25944	189	18	to	to	IN
25944	189	19	the	the	DT
25944	189	20	ounce	ounce	NN
25944	189	21	;	;	:
25944	189	22	more	more	RBR
25944	189	23	especially	especially	RB
25944	189	24	applicable	applicable	JJ
25944	189	25	in	in	IN
25944	189	26	hyperidrosis	hyperidrosis	NN
25944	189	27	of	of	IN
25944	189	28	the	the	DT
25944	189	29	feet	foot	NNS
25944	189	30	.	.	.
25944	190	1	The	the	DT
25944	190	2	parts	part	NNS
25944	190	3	are	be	VBP
25944	190	4	first	first	RB
25944	190	5	thoroughly	thoroughly	RB
25944	190	6	washed	wash	VBN
25944	190	7	,	,	,
25944	190	8	rubbed	rub	VBD
25944	190	9	dry	dry	JJ
25944	190	10	with	with	IN
25944	190	11	towels	towel	NNS
25944	190	12	and	and	CC
25944	190	13	dusting	dusting	NN
25944	190	14	-	-	HYPH
25944	190	15	powder	powder	NN
25944	190	16	,	,	,
25944	190	17	and	and	CC
25944	190	18	the	the	DT
25944	190	19	ointment	ointment	NN
25944	190	20	applied	apply	VBD
25944	190	21	on	on	IN
25944	190	22	strips	strip	NNS
25944	190	23	of	of	IN
25944	190	24	muslin	muslin	NN
25944	190	25	or	or	CC
25944	190	26	lint	lint	NN
25944	190	27	and	and	CC
25944	190	28	bound	bind	VBN
25944	190	29	on	on	RP
25944	190	30	;	;	:
25944	190	31	the	the	DT
25944	190	32	dressing	dressing	NN
25944	190	33	is	be	VBZ
25944	190	34	renewed	renew	VBN
25944	190	35	twice	twice	RB
25944	190	36	daily	daily	RB
25944	190	37	,	,	,
25944	190	38	the	the	DT
25944	190	39	parts	part	NNS
25944	190	40	each	each	DT
25944	190	41	time	time	NN
25944	190	42	being	be	VBG
25944	190	43	rubbed	rub	VBN
25944	190	44	dry	dry	JJ
25944	190	45	with	with	IN
25944	190	46	soft	soft	JJ
25944	190	47	towels	towel	NNS
25944	190	48	and	and	CC
25944	190	49	dusting	dusting	NN
25944	190	50	-	-	HYPH
25944	190	51	powder	powder	NN
25944	190	52	,	,	,
25944	190	53	and	and	CC
25944	190	54	the	the	DT
25944	190	55	treatment	treatment	NN
25944	190	56	continued	continue	VBD
25944	190	57	for	for	IN
25944	190	58	ten	ten	CD
25944	190	59	days	day	NNS
25944	190	60	to	to	IN
25944	190	61	two	two	CD
25944	190	62	weeks	week	NNS
25944	190	63	,	,	,
25944	190	64	after	after	IN
25944	190	65	which	which	WDT
25944	190	66	the	the	DT
25944	190	67	dusting	dusting	NN
25944	190	68	-	-	HYPH
25944	190	69	powder	powder	NN
25944	190	70	is	be	VBZ
25944	190	71	to	to	TO
25944	190	72	be	be	VB
25944	190	73	used	use	VBN
25944	190	74	alone	alone	RB
25944	190	75	for	for	IN
25944	190	76	several	several	JJ
25944	190	77	weeks	week	NNS
25944	190	78	.	.	.
25944	191	1	No	no	DT
25944	191	2	water	water	NN
25944	191	3	is	be	VBZ
25944	191	4	to	to	TO
25944	191	5	be	be	VB
25944	191	6	used	use	VBN
25944	191	7	after	after	IN
25944	191	8	the	the	DT
25944	191	9	first	first	JJ
25944	191	10	washing	washing	NN
25944	191	11	until	until	IN
25944	191	12	the	the	DT
25944	191	13	ointment	ointment	NN
25944	191	14	is	be	VBZ
25944	191	15	discontinued	discontinue	VBN
25944	191	16	.	.	.
25944	192	1	One	one	CD
25944	192	2	such	such	JJ
25944	192	3	course	course	NN
25944	192	4	will	will	MD
25944	192	5	occasionally	occasionally	RB
25944	192	6	suffice	suffice	VB
25944	192	7	,	,	,
25944	192	8	but	but	CC
25944	192	9	not	not	RB
25944	192	10	infrequently	infrequently	RB
25944	192	11	a	a	DT
25944	192	12	repetition	repetition	NN
25944	192	13	is	be	VBZ
25944	192	14	necessary	necessary	JJ
25944	192	15	.	.	.
25944	193	1	Faradization	faradization	NN
25944	193	2	and	and	CC
25944	193	3	galvanization	galvanization	NN
25944	193	4	are	be	VBP
25944	193	5	sometimes	sometimes	RB
25944	193	6	serviceable	serviceable	JJ
25944	193	7	.	.	.
25944	194	1	Repeated	repeat	VBN
25944	194	2	mild	mild	JJ
25944	194	3	exposures	exposure	NNS
25944	194	4	to	to	IN
25944	194	5	the	the	DT
25944	194	6	Röntgen	Röntgen	NNP
25944	194	7	rays	ray	NNS
25944	194	8	have	have	VBP
25944	194	9	a	a	DT
25944	194	10	favorable	favorable	JJ
25944	194	11	influence	influence	NN
25944	194	12	in	in	IN
25944	194	13	some	some	DT
25944	194	14	instances	instance	NNS
25944	194	15	.	.	.
25944	195	1	#	#	NNP
25944	195	2	Sudamen	Sudamen	NNP
25944	195	3	.	.	.
25944	195	4	#	#	NNP
25944	195	5	(	(	-LRB-
25944	195	6	_	_	NNP
25944	195	7	Synonym	Synonym	NNP
25944	195	8	:	:	:
25944	195	9	_	_	NNP
25944	195	10	Miliaria	Miliaria	NNP
25944	195	11	crystallina	crystallina	NNP
25944	195	12	.	.	.
25944	195	13	)	)	-RRB-
25944	196	1	#	#	LS
25944	196	2	What	what	WP
25944	196	3	is	be	VBZ
25944	196	4	sudamen	sudaman	NNS
25944	196	5	?	?	.
25944	196	6	#	#	$
25944	196	7	Sudamen	Sudamen	NNPS
25944	196	8	is	be	VBZ
25944	196	9	a	a	DT
25944	196	10	non	non	JJ
25944	196	11	-	-	JJ
25944	196	12	inflammatory	inflammatory	JJ
25944	196	13	disorder	disorder	NN
25944	196	14	of	of	IN
25944	196	15	the	the	DT
25944	196	16	sweat	sweat	NN
25944	196	17	-	-	HYPH
25944	196	18	glands	gland	NNS
25944	196	19	,	,	,
25944	196	20	characterized	characterize	VBN
25944	196	21	by	by	IN
25944	196	22	pin	pin	NN
25944	196	23	-	-	HYPH
25944	196	24	point	point	NN
25944	196	25	to	to	IN
25944	196	26	pin	pin	NN
25944	196	27	-	-	HYPH
25944	196	28	head	head	NN
25944	196	29	-	-	HYPH
25944	196	30	sized	sized	JJ
25944	196	31	,	,	,
25944	196	32	discrete	discrete	JJ
25944	196	33	but	but	CC
25944	196	34	thickly	thickly	RB
25944	196	35	-	-	HYPH
25944	196	36	set	set	VBN
25944	196	37	,	,	,
25944	196	38	superficial	superficial	JJ
25944	196	39	,	,	,
25944	196	40	translucent	translucent	JJ
25944	196	41	whitish	whitish	JJ
25944	196	42	vesicles	vesicle	NNS
25944	196	43	.	.	.
25944	197	1	#	#	NNP
25944	197	2	Describe	describe	VB
25944	197	3	the	the	DT
25944	197	4	clinical	clinical	JJ
25944	197	5	characters	character	NNS
25944	197	6	.	.	.
25944	197	7	#	#	$
25944	197	8	The	the	DT
25944	197	9	lesions	lesion	NNS
25944	197	10	develop	develop	VBP
25944	197	11	rapidly	rapidly	RB
25944	197	12	and	and	CC
25944	197	13	in	in	IN
25944	197	14	great	great	JJ
25944	197	15	numbers	number	NNS
25944	197	16	,	,	,
25944	197	17	either	either	CC
25944	197	18	irregularly	irregularly	RB
25944	197	19	or	or	CC
25944	197	20	in	in	IN
25944	197	21	crops	crop	NNS
25944	197	22	,	,	,
25944	197	23	and	and	CC
25944	197	24	are	be	VBP
25944	197	25	usually	usually	RB
25944	197	26	to	to	TO
25944	197	27	be	be	VB
25944	197	28	seen	see	VBN
25944	197	29	as	as	IN
25944	197	30	discrete	discrete	JJ
25944	197	31	,	,	,
25944	197	32	closely	closely	RB
25944	197	33	-	-	HYPH
25944	197	34	crowded	crowded	JJ
25944	197	35	,	,	,
25944	197	36	whitish	whitish	JJ
25944	197	37	,	,	,
25944	197	38	or	or	CC
25944	197	39	pearl	pearl	NN
25944	197	40	-	-	HYPH
25944	197	41	colored	colored	JJ
25944	197	42	minute	minute	NN
25944	197	43	elevations	elevation	NNS
25944	197	44	,	,	,
25944	197	45	occurring	occur	VBG
25944	197	46	most	most	RBS
25944	197	47	abundantly	abundantly	RB
25944	197	48	upon	upon	IN
25944	197	49	the	the	DT
25944	197	50	trunk	trunk	NN
25944	197	51	.	.	.
25944	198	1	In	in	IN
25944	198	2	appearance	appearance	NN
25944	198	3	they	-PRON-	PRP
25944	198	4	resemble	resemble	VBP
25944	198	5	minute	minute	NN
25944	198	6	dew	dew	NN
25944	198	7	-	-	HYPH
25944	198	8	drops	drop	NNS
25944	198	9	.	.	.
25944	199	1	They	-PRON-	PRP
25944	199	2	are	be	VBP
25944	199	3	non	non	JJ
25944	199	4	-	-	JJ
25944	199	5	inflammatory	inflammatory	JJ
25944	199	6	,	,	,
25944	199	7	without	without	IN
25944	199	8	areola	areola	NNP
25944	199	9	,	,	,
25944	199	10	never	never	RB
25944	199	11	become	become	VB
25944	199	12	purulent	purulent	JJ
25944	199	13	,	,	,
25944	199	14	and	and	CC
25944	199	15	evince	evince	VB
25944	199	16	no	no	DT
25944	199	17	tendency	tendency	NN
25944	199	18	to	to	TO
25944	199	19	rupture	rupture	VB
25944	199	20	,	,	,
25944	199	21	the	the	DT
25944	199	22	fluid	fluid	JJ
25944	199	23	disappearing	disappearing	NN
25944	199	24	by	by	IN
25944	199	25	absorption	absorption	NN
25944	199	26	,	,	,
25944	199	27	and	and	CC
25944	199	28	the	the	DT
25944	199	29	epidermal	epidermal	JJ
25944	199	30	covering	covering	NN
25944	199	31	by	by	IN
25944	199	32	desquamation	desquamation	NN
25944	199	33	.	.	.
25944	200	1	#	#	NN
25944	200	2	Give	give	VB
25944	200	3	the	the	DT
25944	200	4	course	course	NN
25944	200	5	and	and	CC
25944	200	6	duration	duration	NN
25944	200	7	of	of	IN
25944	200	8	sudamen	sudaman	NNS
25944	200	9	.	.	.
25944	200	10	#	#	$
25944	200	11	New	new	JJ
25944	200	12	crops	crop	NNS
25944	200	13	may	may	MD
25944	200	14	appear	appear	VB
25944	200	15	as	as	IN
25944	200	16	the	the	DT
25944	200	17	older	old	JJR
25944	200	18	lesions	lesion	NNS
25944	200	19	are	be	VBP
25944	200	20	disappearing	disappear	VBG
25944	200	21	,	,	,
25944	200	22	and	and	CC
25944	200	23	the	the	DT
25944	200	24	affection	affection	NN
25944	200	25	persist	persist	VBP
25944	200	26	for	for	IN
25944	200	27	some	some	DT
25944	200	28	time	time	NN
25944	200	29	,	,	,
25944	200	30	or	or	CC
25944	200	31	,	,	,
25944	200	32	on	on	IN
25944	200	33	the	the	DT
25944	200	34	other	other	JJ
25944	200	35	hand	hand	NN
25944	200	36	,	,	,
25944	200	37	the	the	DT
25944	200	38	whole	whole	JJ
25944	200	39	process	process	NN
25944	200	40	may	may	MD
25944	200	41	come	come	VB
25944	200	42	to	to	IN
25944	200	43	an	an	DT
25944	200	44	end	end	NN
25944	200	45	in	in	IN
25944	200	46	several	several	JJ
25944	200	47	days	day	NNS
25944	200	48	or	or	CC
25944	200	49	a	a	DT
25944	200	50	week	week	NN
25944	200	51	.	.	.
25944	201	1	In	in	IN
25944	201	2	short	short	JJ
25944	201	3	,	,	,
25944	201	4	the	the	DT
25944	201	5	course	course	NN
25944	201	6	and	and	CC
25944	201	7	duration	duration	NN
25944	201	8	depend	depend	VBP
25944	201	9	upon	upon	IN
25944	201	10	the	the	DT
25944	201	11	subsidence	subsidence	NN
25944	201	12	or	or	CC
25944	201	13	persistence	persistence	NN
25944	201	14	of	of	IN
25944	201	15	the	the	DT
25944	201	16	cause	cause	NN
25944	201	17	.	.	.
25944	202	1	#	#	LS
25944	202	2	What	what	WP
25944	202	3	is	be	VBZ
25944	202	4	the	the	DT
25944	202	5	anatomical	anatomical	JJ
25944	202	6	seat	seat	NN
25944	202	7	of	of	IN
25944	202	8	sudamen	sudaman	NNS
25944	202	9	?	?	.
25944	202	10	#	#	$
25944	202	11	The	the	DT
25944	202	12	lesions	lesion	NNS
25944	202	13	are	be	VBP
25944	202	14	formed	form	VBN
25944	202	15	between	between	IN
25944	202	16	the	the	DT
25944	202	17	lamellæ	lamellæ	NN
25944	202	18	of	of	IN
25944	202	19	the	the	DT
25944	202	20	corneous	corneous	JJ
25944	202	21	layer	layer	NN
25944	202	22	,	,	,
25944	202	23	usually	usually	RB
25944	202	24	the	the	DT
25944	202	25	upper	upper	JJ
25944	202	26	part	part	NN
25944	202	27	;	;	:
25944	202	28	and	and	CC
25944	202	29	are	be	VBP
25944	202	30	thought	think	VBN
25944	202	31	to	to	TO
25944	202	32	be	be	VB
25944	202	33	due	due	IN
25944	202	34	to	to	IN
25944	202	35	some	some	DT
25944	202	36	change	change	NN
25944	202	37	in	in	IN
25944	202	38	the	the	DT
25944	202	39	character	character	NN
25944	202	40	of	of	IN
25944	202	41	the	the	DT
25944	202	42	epithelial	epithelial	JJ
25944	202	43	cells	cell	NNS
25944	202	44	of	of	IN
25944	202	45	this	this	DT
25944	202	46	layer	layer	NN
25944	202	47	,	,	,
25944	202	48	probably	probably	RB
25944	202	49	from	from	IN
25944	202	50	high	high	JJ
25944	202	51	temperature	temperature	NN
25944	202	52	,	,	,
25944	202	53	giving	give	VBG
25944	202	54	rise	rise	NN
25944	202	55	to	to	IN
25944	202	56	a	a	DT
25944	202	57	blocking	blocking	NN
25944	202	58	up	up	RP
25944	202	59	of	of	IN
25944	202	60	the	the	DT
25944	202	61	surface	surface	NN
25944	202	62	outlet	outlet	NN
25944	202	63	.	.	.
25944	203	1	#	#	LS
25944	203	2	What	what	WP
25944	203	3	is	be	VBZ
25944	203	4	the	the	DT
25944	203	5	cause	cause	NN
25944	203	6	of	of	IN
25944	203	7	sudamen	sudaman	NNS
25944	203	8	?	?	.
25944	203	9	#	#	$
25944	203	10	Debility	debility	NN
25944	203	11	,	,	,
25944	203	12	especially	especially	RB
25944	203	13	when	when	WRB
25944	203	14	associated	associate	VBN
25944	203	15	with	with	IN
25944	203	16	high	high	JJ
25944	203	17	fever	fever	NN
25944	203	18	.	.	.
25944	204	1	The	the	DT
25944	204	2	eruption	eruption	NN
25944	204	3	is	be	VBZ
25944	204	4	often	often	RB
25944	204	5	seen	see	VBN
25944	204	6	in	in	IN
25944	204	7	the	the	DT
25944	204	8	course	course	NN
25944	204	9	of	of	IN
25944	204	10	typhus	typhus	NN
25944	204	11	,	,	,
25944	204	12	typhoid	typhoid	NN
25944	204	13	and	and	CC
25944	204	14	rheumatic	rheumatic	JJ
25944	204	15	fevers	fever	NNS
25944	204	16	.	.	.
25944	205	1	#	#	NNP
25944	205	2	How	how	WRB
25944	205	3	would	would	MD
25944	205	4	you	-PRON-	PRP
25944	205	5	treat	treat	VB
25944	205	6	sudamen	sudaman	NNS
25944	205	7	?	?	.
25944	205	8	#	#	NN
25944	205	9	By	by	IN
25944	205	10	constitutional	constitutional	JJ
25944	205	11	remedies	remedy	NNS
25944	205	12	directed	direct	VBN
25944	205	13	against	against	IN
25944	205	14	the	the	DT
25944	205	15	predisposing	predispose	VBG
25944	205	16	factor	factor	NN
25944	205	17	or	or	CC
25944	205	18	factors	factor	NNS
25944	205	19	,	,	,
25944	205	20	and	and	CC
25944	205	21	the	the	DT
25944	205	22	application	application	NN
25944	205	23	of	of	IN
25944	205	24	cooling	cool	VBG
25944	205	25	lotions	lotion	NNS
25944	205	26	of	of	IN
25944	205	27	vinegar	vinegar	NN
25944	205	28	or	or	CC
25944	205	29	alcohol	alcohol	NN
25944	205	30	and	and	CC
25944	205	31	water	water	NN
25944	205	32	,	,	,
25944	205	33	or	or	CC
25944	205	34	dusting	dusting	NN
25944	205	35	-	-	HYPH
25944	205	36	powders	powder	NNS
25944	205	37	of	of	IN
25944	205	38	starch	starch	NN
25944	205	39	and	and	CC
25944	205	40	lycopodium	lycopodium	NN
25944	205	41	.	.	.
25944	206	1	#	#	NNP
25944	206	2	Hydrocystoma	Hydrocystoma	NNP
25944	206	3	.	.	.
25944	206	4	#	#	$
25944	206	5	#	#	$
25944	206	6	Describe	Describe	NNP
25944	206	7	hydrocystoma	hydrocystoma	NNP
25944	206	8	.	.	.
25944	206	9	#	#	$
25944	206	10	Hydrocystoma	Hydrocystoma	NNP
25944	206	11	is	be	VBZ
25944	206	12	a	a	DT
25944	206	13	cystic	cystic	JJ
25944	206	14	affection	affection	NN
25944	206	15	of	of	IN
25944	206	16	the	the	DT
25944	206	17	sweat	sweat	NN
25944	206	18	-	-	HYPH
25944	206	19	gland	gland	NN
25944	206	20	ducts	duct	NNS
25944	206	21	,	,	,
25944	206	22	seated	seat	VBN
25944	206	23	upon	upon	IN
25944	206	24	the	the	DT
25944	206	25	face	face	NN
25944	206	26	.	.	.
25944	207	1	The	the	DT
25944	207	2	lesions	lesion	NNS
25944	207	3	may	may	MD
25944	207	4	be	be	VB
25944	207	5	present	present	JJ
25944	207	6	in	in	IN
25944	207	7	scant	scant	JJ
25944	207	8	numbers	number	NNS
25944	207	9	or	or	CC
25944	207	10	in	in	IN
25944	207	11	more	more	JJR
25944	207	12	or	or	CC
25944	207	13	less	less	JJR
25944	207	14	profusion	profusion	NN
25944	207	15	.	.	.
25944	208	1	They	-PRON-	PRP
25944	208	2	have	have	VBP
25944	208	3	the	the	DT
25944	208	4	appearance	appearance	NN
25944	208	5	of	of	IN
25944	208	6	boiled	boil	VBN
25944	208	7	sago	sago	JJ
25944	208	8	grains	grain	NNS
25944	208	9	imbedded	imbed	VBN
25944	208	10	in	in	IN
25944	208	11	the	the	DT
25944	208	12	skin	skin	NN
25944	208	13	;	;	:
25944	208	14	the	the	DT
25944	208	15	larger	large	JJR
25944	208	16	lesions	lesion	NNS
25944	208	17	may	may	MD
25944	208	18	have	have	VB
25944	208	19	a	a	DT
25944	208	20	bluish	bluish	JJ
25944	208	21	color	color	NN
25944	208	22	,	,	,
25944	208	23	especially	especially	RB
25944	208	24	about	about	IN
25944	208	25	the	the	DT
25944	208	26	periphery	periphery	NN
25944	208	27	.	.	.
25944	209	1	It	-PRON-	PRP
25944	209	2	is	be	VBZ
25944	209	3	not	not	RB
25944	209	4	common	common	JJ
25944	209	5	,	,	,
25944	209	6	and	and	CC
25944	209	7	is	be	VBZ
25944	209	8	usually	usually	RB
25944	209	9	seen	see	VBN
25944	209	10	in	in	IN
25944	209	11	washerwomen	washerwoman	NNS
25944	209	12	and	and	CC
25944	209	13	laundresses	laundress	NNS
25944	209	14	,	,	,
25944	209	15	or	or	CC
25944	209	16	those	those	DT
25944	209	17	exposed	expose	VBN
25944	209	18	to	to	IN
25944	209	19	moist	moist	JJ
25944	209	20	heat	heat	NN
25944	209	21	.	.	.
25944	210	1	In	in	IN
25944	210	2	some	some	DT
25944	210	3	cases	case	NNS
25944	210	4	it	-PRON-	PRP
25944	210	5	tends	tend	VBZ
25944	210	6	to	to	TO
25944	210	7	disappear	disappear	VB
25944	210	8	during	during	IN
25944	210	9	the	the	DT
25944	210	10	winter	winter	NN
25944	210	11	months	month	NNS
25944	210	12	.	.	.
25944	211	1	There	there	EX
25944	211	2	are	be	VBP
25944	211	3	no	no	DT
25944	211	4	subjective	subjective	JJ
25944	211	5	symptoms	symptom	NNS
25944	211	6	.	.	.
25944	212	1	Treatment	treatment	NN
25944	212	2	consists	consist	VBZ
25944	212	3	of	of	IN
25944	212	4	puncturing	puncture	VBG
25944	212	5	the	the	DT
25944	212	6	lesions	lesion	NNS
25944	212	7	and	and	CC
25944	212	8	application	application	NN
25944	212	9	of	of	IN
25944	212	10	dusting	dusting	NN
25944	212	11	-	-	HYPH
25944	212	12	powder	powder	NN
25944	212	13	.	.	.
25944	213	1	Avoidance	avoidance	NN
25944	213	2	of	of	IN
25944	213	3	the	the	DT
25944	213	4	exciting	exciting	JJ
25944	213	5	cause	cause	NN
25944	213	6	(	(	-LRB-
25944	213	7	moist	moist	NNP
25944	213	8	heat	heat	NNP
25944	213	9	)	)	-RRB-
25944	213	10	is	be	VBZ
25944	213	11	important	important	JJ
25944	213	12	.	.	.
25944	214	1	#	#	NNP
25944	214	2	Anidrosis	Anidrosis	NNP
25944	214	3	.	.	.
25944	214	4	#	#	$
25944	214	5	#	#	$
25944	214	6	Describe	Describe	NNP
25944	214	7	anidrosis	anidrosis	NN
25944	214	8	.	.	.
25944	214	9	#	#	$
25944	214	10	It	-PRON-	PRP
25944	214	11	is	be	VBZ
25944	214	12	the	the	DT
25944	214	13	opposite	opposite	JJ
25944	214	14	condition	condition	NN
25944	214	15	of	of	IN
25944	214	16	hyperidrosis	hyperidrosis	NN
25944	214	17	,	,	,
25944	214	18	and	and	CC
25944	214	19	is	be	VBZ
25944	214	20	characterized	characterize	VBN
25944	214	21	by	by	IN
25944	214	22	diminution	diminution	NN
25944	214	23	or	or	CC
25944	214	24	suppression	suppression	NN
25944	214	25	of	of	IN
25944	214	26	the	the	DT
25944	214	27	sweat	sweat	NN
25944	214	28	secretion	secretion	NN
25944	214	29	.	.	.
25944	215	1	It	-PRON-	PRP
25944	215	2	occurs	occur	VBZ
25944	215	3	to	to	IN
25944	215	4	some	some	DT
25944	215	5	extent	extent	NN
25944	215	6	in	in	IN
25944	215	7	certain	certain	JJ
25944	215	8	systemic	systemic	JJ
25944	215	9	diseases	disease	NNS
25944	215	10	and	and	CC
25944	215	11	also	also	RB
25944	215	12	in	in	IN
25944	215	13	some	some	DT
25944	215	14	affections	affection	NNS
25944	215	15	of	of	IN
25944	215	16	the	the	DT
25944	215	17	skin	skin	NN
25944	215	18	,	,	,
25944	215	19	such	such	JJ
25944	215	20	as	as	IN
25944	215	21	ichthyosis	ichthyosis	NN
25944	215	22	;	;	:
25944	215	23	nerve	nerve	NN
25944	215	24	-	-	HYPH
25944	215	25	injuries	injury	NNS
25944	215	26	may	may	MD
25944	215	27	give	give	VB
25944	215	28	rise	rise	NN
25944	215	29	to	to	IN
25944	215	30	localized	localized	JJ
25944	215	31	sweat	sweat	NN
25944	215	32	-	-	HYPH
25944	215	33	suppression	suppression	NN
25944	215	34	.	.	.
25944	216	1	Treatment	treatment	NN
25944	216	2	is	be	VBZ
25944	216	3	based	base	VBN
25944	216	4	upon	upon	IN
25944	216	5	general	general	JJ
25944	216	6	principles	principle	NNS
25944	216	7	;	;	:
25944	216	8	friction	friction	NN
25944	216	9	,	,	,
25944	216	10	warm	warm	JJ
25944	216	11	and	and	CC
25944	216	12	hot	hot	JJ
25944	216	13	-	-	HYPH
25944	216	14	vapor	vapor	NN
25944	216	15	baths	bath	NNS
25944	216	16	,	,	,
25944	216	17	electricity	electricity	NN
25944	216	18	and	and	CC
25944	216	19	similar	similar	JJ
25944	216	20	measures	measure	NNS
25944	216	21	are	be	VBP
25944	216	22	of	of	IN
25944	216	23	service	service	NN
25944	216	24	.	.	.
25944	217	1	#	#	NNP
25944	217	2	Bromidrosis	Bromidrosis	NNP
25944	217	3	.	.	.
25944	217	4	#	#	NNP
25944	217	5	(	(	-LRB-
25944	217	6	_	_	NNP
25944	217	7	Synonym	Synonym	NNP
25944	217	8	:	:	:
25944	217	9	_	_	NNP
25944	217	10	Osmidrosis	Osmidrosis	NNP
25944	217	11	.	.	.
25944	217	12	)	)	-RRB-
25944	218	1	#	#	NNP
25944	218	2	Describe	Describe	NNP
25944	218	3	bromidrosis	bromidrosis	NN
25944	218	4	.	.	.
25944	218	5	#	#	$
25944	218	6	Bromidrosis	Bromidrosis	NNP
25944	218	7	is	be	VBZ
25944	218	8	a	a	DT
25944	218	9	functional	functional	JJ
25944	218	10	disturbance	disturbance	NN
25944	218	11	of	of	IN
25944	218	12	the	the	DT
25944	218	13	sweat	sweat	NN
25944	218	14	-	-	HYPH
25944	218	15	glands	gland	NNS
25944	218	16	characterized	characterize	VBN
25944	218	17	by	by	IN
25944	218	18	a	a	DT
25944	218	19	sweat	sweat	NN
25944	218	20	secretion	secretion	NN
25944	218	21	of	of	IN
25944	218	22	an	an	DT
25944	218	23	offensive	offensive	JJ
25944	218	24	odor	odor	NN
25944	218	25	.	.	.
25944	219	1	The	the	DT
25944	219	2	sweat	sweat	NN
25944	219	3	production	production	NN
25944	219	4	may	may	MD
25944	219	5	be	be	VB
25944	219	6	normal	normal	JJ
25944	219	7	in	in	IN
25944	219	8	quantity	quantity	NN
25944	219	9	or	or	CC
25944	219	10	more	more	JJR
25944	219	11	or	or	CC
25944	219	12	less	less	RBR
25944	219	13	excessive	excessive	JJ
25944	219	14	,	,	,
25944	219	15	usually	usually	RB
25944	219	16	the	the	DT
25944	219	17	latter	latter	JJ
25944	219	18	.	.	.
25944	220	1	The	the	DT
25944	220	2	condition	condition	NN
25944	220	3	may	may	MD
25944	220	4	be	be	VB
25944	220	5	local	local	JJ
25944	220	6	or	or	CC
25944	220	7	general	general	JJ
25944	220	8	,	,	,
25944	220	9	commonly	commonly	RB
25944	220	10	the	the	DT
25944	220	11	former	former	JJ
25944	220	12	.	.	.
25944	221	1	It	-PRON-	PRP
25944	221	2	is	be	VBZ
25944	221	3	closely	closely	RB
25944	221	4	allied	ally	VBN
25944	221	5	to	to	IN
25944	221	6	hyperidrosis	hyperidrosis	NN
25944	221	7	,	,	,
25944	221	8	and	and	CC
25944	221	9	may	may	MD
25944	221	10	often	often	RB
25944	221	11	be	be	VB
25944	221	12	considered	consider	VBN
25944	221	13	identical	identical	JJ
25944	221	14	,	,	,
25944	221	15	the	the	DT
25944	221	16	odor	odor	NN
25944	221	17	resulting	result	VBG
25944	221	18	from	from	IN
25944	221	19	rapid	rapid	JJ
25944	221	20	decomposition	decomposition	NN
25944	221	21	of	of	IN
25944	221	22	the	the	DT
25944	221	23	sweat	sweat	NN
25944	221	24	secretion	secretion	NN
25944	221	25	.	.	.
25944	222	1	The	the	DT
25944	222	2	decomposition	decomposition	NN
25944	222	3	and	and	CC
25944	222	4	resulting	result	VBG
25944	222	5	odor	odor	NN
25944	222	6	have	have	VBP
25944	222	7	been	be	VBN
25944	222	8	thought	think	VBN
25944	222	9	due	due	IN
25944	222	10	to	to	IN
25944	222	11	the	the	DT
25944	222	12	presence	presence	NN
25944	222	13	of	of	IN
25944	222	14	bacteria	bacteria	NNS
25944	222	15	.	.	.
25944	223	1	#	#	LS
25944	223	2	What	what	WDT
25944	223	3	parts	part	NNS
25944	223	4	are	be	VBP
25944	223	5	most	most	RBS
25944	223	6	commonly	commonly	RB
25944	223	7	affected	affect	VBN
25944	223	8	in	in	IN
25944	223	9	bromidrosis	bromidrosis	NN
25944	223	10	?	?	.
25944	223	11	#	#	$
25944	223	12	The	the	DT
25944	223	13	feet	foot	NNS
25944	223	14	and	and	CC
25944	223	15	the	the	DT
25944	223	16	axillæ	axillæ	NN
25944	223	17	.	.	.
25944	224	1	#	#	LS
25944	224	2	What	what	WP
25944	224	3	is	be	VBZ
25944	224	4	the	the	DT
25944	224	5	treatment	treatment	NN
25944	224	6	of	of	IN
25944	224	7	bromidrosis	bromidrosis	NN
25944	224	8	?	?	.
25944	224	9	#	#	$
25944	224	10	It	-PRON-	PRP
25944	224	11	is	be	VBZ
25944	224	12	essentially	essentially	RB
25944	224	13	the	the	DT
25944	224	14	same	same	JJ
25944	224	15	as	as	IN
25944	224	16	that	that	DT
25944	224	17	of	of	IN
25944	224	18	hyperidrosis	hyperidrosis	NN
25944	224	19	(	(	-LRB-
25944	224	20	_	_	NNP
25944	224	21	q	q	NNP
25944	224	22	.	.	.
25944	225	1	v.	v.	NNP
25944	225	2	_	_	NNP
25944	225	3	)	)	-RRB-
25944	225	4	,	,	,
25944	225	5	consisting	consist	VBG
25944	225	6	of	of	IN
25944	225	7	applications	application	NNS
25944	225	8	of	of	IN
25944	225	9	astringent	astringent	JJ
25944	225	10	lotions	lotion	NNS
25944	225	11	,	,	,
25944	225	12	dusting	dusting	NN
25944	225	13	-	-	HYPH
25944	225	14	powders	powder	NNS
25944	225	15	,	,	,
25944	225	16	especially	especially	RB
25944	225	17	those	those	DT
25944	225	18	containing	contain	VBG
25944	225	19	boric	boric	NN
25944	225	20	acid	acid	NN
25944	225	21	and	and	CC
25944	225	22	salicylic	salicylic	JJ
25944	225	23	acid	acid	NN
25944	225	24	,	,	,
25944	225	25	and	and	CC
25944	225	26	the	the	DT
25944	225	27	continuous	continuous	JJ
25944	225	28	application	application	NN
25944	225	29	of	of	IN
25944	225	30	diachylon	diachylon	NN
25944	225	31	ointment	ointment	NN
25944	225	32	.	.	.
25944	226	1	In	in	IN
25944	226	2	obstinate	obstinate	NN
25944	226	3	cases	case	NNS
25944	226	4	weak	weak	JJ
25944	226	5	formaldehyde	formaldehyde	NN
25944	226	6	solutions	solution	NNS
25944	226	7	,	,	,
25944	226	8	Röntgen	Röntgen	NNP
25944	226	9	rays	ray	NNS
25944	226	10	,	,	,
25944	226	11	and	and	CC
25944	226	12	high	high	JJ
25944	226	13	-	-	HYPH
25944	226	14	frequency	frequency	NN
25944	226	15	currents	current	NNS
25944	226	16	can	can	MD
25944	226	17	be	be	VB
25944	226	18	tried	try	VBN
25944	226	19	.	.	.
25944	227	1	#	#	NNP
25944	227	2	Chromidrosis	Chromidrosis	NNP
25944	227	3	.	.	.
25944	227	4	#	#	$
25944	227	5	#	#	$
25944	227	6	Describe	Describe	NNP
25944	227	7	chromidrosis	chromidrosis	NN
25944	227	8	.	.	.
25944	227	9	#	#	$
25944	227	10	This	this	DT
25944	227	11	is	be	VBZ
25944	227	12	a	a	DT
25944	227	13	functional	functional	JJ
25944	227	14	disorder	disorder	NN
25944	227	15	of	of	IN
25944	227	16	the	the	DT
25944	227	17	sweat	sweat	NN
25944	227	18	-	-	HYPH
25944	227	19	glands	gland	NNS
25944	227	20	characterized	characterize	VBN
25944	227	21	by	by	IN
25944	227	22	a	a	DT
25944	227	23	secretion	secretion	NN
25944	227	24	variously	variously	RB
25944	227	25	colored	color	VBN
25944	227	26	,	,	,
25944	227	27	and	and	CC
25944	227	28	usually	usually	RB
25944	227	29	increased	increase	VBN
25944	227	30	in	in	IN
25944	227	31	quantity	quantity	NN
25944	227	32	.	.	.
25944	228	1	It	-PRON-	PRP
25944	228	2	is	be	VBZ
25944	228	3	,	,	,
25944	228	4	as	as	IN
25944	228	5	a	a	DT
25944	228	6	rule	rule	NN
25944	228	7	,	,	,
25944	228	8	limited	limit	VBN
25944	228	9	to	to	IN
25944	228	10	a	a	DT
25944	228	11	circumscribed	circumscribe	VBN
25944	228	12	area	area	NN
25944	228	13	.	.	.
25944	229	1	The	the	DT
25944	229	2	most	most	RBS
25944	229	3	common	common	JJ
25944	229	4	color	color	NN
25944	229	5	is	be	VBZ
25944	229	6	red	red	JJ
25944	229	7	.	.	.
25944	230	1	The	the	DT
25944	230	2	condition	condition	NN
25944	230	3	is	be	VBZ
25944	230	4	probably	probably	RB
25944	230	5	of	of	IN
25944	230	6	neurotic	neurotic	JJ
25944	230	7	origin	origin	NN
25944	230	8	and	and	CC
25944	230	9	tends	tend	VBZ
25944	230	10	to	to	TO
25944	230	11	recur	recur	VB
25944	230	12	.	.	.
25944	231	1	(	(	-LRB-
25944	231	2	True	true	JJ
25944	231	3	chromidrosis	chromidrosis	NN
25944	231	4	is	be	VBZ
25944	231	5	extremely	extremely	RB
25944	231	6	rare	rare	JJ
25944	231	7	;	;	:
25944	231	8	most	most	JJS
25944	231	9	of	of	IN
25944	231	10	the	the	DT
25944	231	11	cases	case	NNS
25944	231	12	formerly	formerly	RB
25944	231	13	thought	think	VBN
25944	231	14	to	to	TO
25944	231	15	be	be	VB
25944	231	16	such	such	JJ
25944	231	17	are	be	VBP
25944	231	18	now	now	RB
25944	231	19	known	know	VBN
25944	231	20	to	to	TO
25944	231	21	be	be	VB
25944	231	22	examples	example	NNS
25944	231	23	of	of	IN
25944	231	24	pseudochromidrosis	pseudochromidrosis	NN
25944	231	25	.	.	.
25944	231	26	)	)	-RRB-
25944	232	1	Treatment	treatment	NN
25944	232	2	should	should	MD
25944	232	3	be	be	VB
25944	232	4	invigorating	invigorate	VBG
25944	232	5	and	and	CC
25944	232	6	tonic	tonic	NN
25944	232	7	,	,	,
25944	232	8	with	with	IN
25944	232	9	special	special	JJ
25944	232	10	reference	reference	NN
25944	232	11	toward	toward	IN
25944	232	12	the	the	DT
25944	232	13	nervous	nervous	JJ
25944	232	14	system	system	NN
25944	232	15	.	.	.
25944	233	1	The	the	DT
25944	233	2	various	various	JJ
25944	233	3	methods	method	NNS
25944	233	4	of	of	IN
25944	233	5	local	local	JJ
25944	233	6	electrization	electrization	NN
25944	233	7	should	should	MD
25944	233	8	also	also	RB
25944	233	9	be	be	VB
25944	233	10	resorted	resort	VBN
25944	233	11	to	to	IN
25944	233	12	.	.	.
25944	234	1	Mild	mild	JJ
25944	234	2	antiseptic	antiseptic	JJ
25944	234	3	and	and	CC
25944	234	4	astringent	astringent	JJ
25944	234	5	lotions	lotion	NNS
25944	234	6	or	or	CC
25944	234	7	dusting	dusting	NN
25944	234	8	powders	powder	NNS
25944	234	9	should	should	MD
25944	234	10	also	also	RB
25944	234	11	be	be	VB
25944	234	12	advised	advise	VBN
25944	234	13	.	.	.
25944	235	1	_	_	NNP
25944	235	2	Red	Red	NNP
25944	235	3	chromidrosis	chromidrosis	NN
25944	235	4	_	_	NNP
25944	235	5	or	or	CC
25944	235	6	_	_	NNP
25944	235	7	Pseudochromidrosis	Pseudochromidrosis	NNP
25944	235	8	_	_	NNP
25944	235	9	is	be	VBZ
25944	235	10	a	a	DT
25944	235	11	condition	condition	NN
25944	235	12	in	in	IN
25944	235	13	which	which	WDT
25944	235	14	the	the	DT
25944	235	15	coloring	coloring	NN
25944	235	16	of	of	IN
25944	235	17	the	the	DT
25944	235	18	sweat	sweat	NN
25944	235	19	occurs	occur	VBZ
25944	235	20	after	after	IN
25944	235	21	its	-PRON-	PRP$
25944	235	22	excretion	excretion	NN
25944	235	23	and	and	CC
25944	235	24	is	be	VBZ
25944	235	25	due	due	JJ
25944	235	26	to	to	IN
25944	235	27	the	the	DT
25944	235	28	presence	presence	NN
25944	235	29	of	of	IN
25944	235	30	chromatogenous	chromatogenous	JJ
25944	235	31	bacteria	bacteria	NNS
25944	235	32	which	which	WDT
25944	235	33	are	be	VBP
25944	235	34	found	find	VBN
25944	235	35	attached	attach	VBN
25944	235	36	to	to	IN
25944	235	37	the	the	DT
25944	235	38	hairs	hair	NNS
25944	235	39	of	of	IN
25944	235	40	the	the	DT
25944	235	41	part	part	NN
25944	235	42	in	in	IN
25944	235	43	agglutinated	agglutinate	VBN
25944	235	44	masses	masse	NNS
25944	235	45	.	.	.
25944	236	1	The	the	DT
25944	236	2	axilla	axilla	NN
25944	236	3	is	be	VBZ
25944	236	4	the	the	DT
25944	236	5	favorite	favorite	JJ
25944	236	6	site	site	NN
25944	236	7	.	.	.
25944	237	1	Treatment	treatment	NN
25944	237	2	consists	consist	VBZ
25944	237	3	of	of	IN
25944	237	4	frequent	frequent	JJ
25944	237	5	soap	soap	NN
25944	237	6	-	-	HYPH
25944	237	7	and	and	CC
25944	237	8	-	-	HYPH
25944	237	9	water	water	NN
25944	237	10	washings	washing	NNS
25944	237	11	,	,	,
25944	237	12	and	and	CC
25944	237	13	the	the	DT
25944	237	14	application	application	NN
25944	237	15	of	of	IN
25944	237	16	boric	boric	NN
25944	237	17	acid	acid	NN
25944	237	18	,	,	,
25944	237	19	resorcin	resorcin	NNS
25944	237	20	,	,	,
25944	237	21	and	and	CC
25944	237	22	corrosive	corrosive	JJ
25944	237	23	sublimate	sublimate	NN
25944	237	24	lotions	lotion	NNS
25944	237	25	.	.	.
25944	238	1	#	#	NNP
25944	238	2	Uridrosis	Uridrosis	NNP
25944	238	3	.	.	.
25944	238	4	#	#	$
25944	238	5	#	#	$
25944	238	6	Describe	Describe	NNP
25944	238	7	uridrosis	uridrosis	NN
25944	238	8	.	.	.
25944	238	9	#	#	$
25944	238	10	Uridrosis	Uridrosis	NNP
25944	238	11	is	be	VBZ
25944	238	12	a	a	DT
25944	238	13	rare	rare	JJ
25944	238	14	condition	condition	NN
25944	238	15	in	in	IN
25944	238	16	which	which	WDT
25944	238	17	the	the	DT
25944	238	18	sweat	sweat	NN
25944	238	19	secretion	secretion	NN
25944	238	20	contains	contain	VBZ
25944	238	21	the	the	DT
25944	238	22	elements	element	NNS
25944	238	23	of	of	IN
25944	238	24	the	the	DT
25944	238	25	urine	urine	NN
25944	238	26	,	,	,
25944	238	27	especially	especially	RB
25944	238	28	urea	urea	NNP
25944	238	29	.	.	.
25944	239	1	In	in	IN
25944	239	2	marked	marked	JJ
25944	239	3	cases	case	NNS
25944	239	4	the	the	DT
25944	239	5	salt	salt	NN
25944	239	6	may	may	MD
25944	239	7	be	be	VB
25944	239	8	noticeable	noticeable	JJ
25944	239	9	upon	upon	IN
25944	239	10	the	the	DT
25944	239	11	skin	skin	NN
25944	239	12	as	as	IN
25944	239	13	a	a	DT
25944	239	14	colorless	colorless	JJ
25944	239	15	or	or	CC
25944	239	16	whitish	whitish	JJ
25944	239	17	crystalline	crystalline	NN
25944	239	18	deposit	deposit	NN
25944	239	19	.	.	.
25944	240	1	In	in	IN
25944	240	2	most	most	JJS
25944	240	3	instances	instance	NNS
25944	240	4	it	-PRON-	PRP
25944	240	5	has	have	VBZ
25944	240	6	been	be	VBN
25944	240	7	preceded	precede	VBN
25944	240	8	or	or	CC
25944	240	9	accompanied	accompany	VBN
25944	240	10	by	by	IN
25944	240	11	partial	partial	JJ
25944	240	12	or	or	CC
25944	240	13	complete	complete	JJ
25944	240	14	suppression	suppression	NN
25944	240	15	of	of	IN
25944	240	16	the	the	DT
25944	240	17	renal	renal	JJ
25944	240	18	functions	function	NNS
25944	240	19	.	.	.
25944	241	1	#	#	NNP
25944	241	2	Phosphoridrosis	Phosphoridrosis	NNP
25944	241	3	.	.	.
25944	241	4	#	#	$
25944	241	5	#	#	$
25944	241	6	Describe	Describe	NNP
25944	241	7	phosphoridrosis	phosphoridrosis	NN
25944	241	8	.	.	.
25944	241	9	#	#	$
25944	241	10	Phosphoridrosis	Phosphoridrosis	NNP
25944	241	11	is	be	VBZ
25944	241	12	a	a	DT
25944	241	13	rare	rare	JJ
25944	241	14	condition	condition	NN
25944	241	15	,	,	,
25944	241	16	in	in	IN
25944	241	17	which	which	WDT
25944	241	18	the	the	DT
25944	241	19	sweat	sweat	NN
25944	241	20	is	be	VBZ
25944	241	21	phosphorescent	phosphorescent	JJ
25944	241	22	.	.	.
25944	242	1	It	-PRON-	PRP
25944	242	2	has	have	VBZ
25944	242	3	been	be	VBN
25944	242	4	observed	observe	VBN
25944	242	5	in	in	IN
25944	242	6	the	the	DT
25944	242	7	later	later	JJ
25944	242	8	stages	stage	NNS
25944	242	9	of	of	IN
25944	242	10	phthisis	phthisis	NN
25944	242	11	,	,	,
25944	242	12	in	in	IN
25944	242	13	miliaria	miliaria	NNP
25944	242	14	,	,	,
25944	242	15	and	and	CC
25944	242	16	in	in	IN
25944	242	17	those	those	DT
25944	242	18	who	who	WP
25944	242	19	have	have	VBP
25944	242	20	eaten	eat	VBN
25944	242	21	of	of	IN
25944	242	22	putrid	putrid	JJ
25944	242	23	fish	fish	NN
25944	242	24	.	.	.
25944	243	1	#	#	$
25944	243	2	Seborrh[oe]a	seborrh[oe]a	CD
25944	243	3	(	(	-LRB-
25944	243	4	Eczema	Eczema	NNP
25944	243	5	Seborrhoicum	Seborrhoicum	NNP
25944	243	6	)	)	-RRB-
25944	243	7	.	.	.
25944	243	8	#	#	$
25944	243	9	_	_	NNP
25944	243	10	Synonyms	Synonyms	NNP
25944	243	11	:	:	:
25944	243	12	_	_	NNP
25944	243	13	(	(	-LRB-
25944	243	14	Steatorrh[oe]a	steatorrh[oe]a	CD
25944	243	15	;	;	:
25944	243	16	Acne	Acne	NNP
25944	243	17	sebacea	sebacea	NNP
25944	243	18	;	;	:
25944	243	19	Ichthyosis	ichthyosis	NN
25944	243	20	sebacea	sebacea	NN
25944	243	21	;	;	:
25944	243	22	Dandruff	Dandruff	NNP
25944	243	23	.	.	.
25944	243	24	)	)	-RRB-
25944	244	1	#	#	LS
25944	244	2	What	what	WP
25944	244	3	is	be	VBZ
25944	244	4	seborrh[oe]a	seborrh[oe]a	NNP
25944	244	5	?	?	.
25944	244	6	#	#	NNP
25944	244	7	Seborrh[oe]a	seborrh[oe]a	CD
25944	244	8	is	be	VBZ
25944	244	9	a	a	DT
25944	244	10	disease	disease	NN
25944	244	11	of	of	IN
25944	244	12	the	the	DT
25944	244	13	sebaceous	sebaceous	JJ
25944	244	14	glands	gland	NNS
25944	244	15	,	,	,
25944	244	16	characterized	characterize	VBN
25944	244	17	by	by	IN
25944	244	18	an	an	DT
25944	244	19	excessive	excessive	JJ
25944	244	20	and	and	CC
25944	244	21	abnormal	abnormal	JJ
25944	244	22	secretion	secretion	NN
25944	244	23	of	of	IN
25944	244	24	sebaceous	sebaceous	JJ
25944	244	25	matter	matter	NN
25944	244	26	,	,	,
25944	244	27	appearing	appear	VBG
25944	244	28	on	on	IN
25944	244	29	the	the	DT
25944	244	30	skin	skin	NN
25944	244	31	as	as	IN
25944	244	32	an	an	DT
25944	244	33	oily	oily	JJ
25944	244	34	coating	coating	NN
25944	244	35	,	,	,
25944	244	36	crusts	crust	NNS
25944	244	37	,	,	,
25944	244	38	or	or	CC
25944	244	39	scales	scale	NNS
25944	244	40	.	.	.
25944	245	1	In	in	IN
25944	245	2	many	many	JJ
25944	245	3	cases	case	NNS
25944	245	4	the	the	DT
25944	245	5	sweat	sweat	NN
25944	245	6	-	-	HYPH
25944	245	7	glands	gland	NNS
25944	245	8	are	be	VBP
25944	245	9	likewise	likewise	RB
25944	245	10	implicated	implicate	VBN
25944	245	11	,	,	,
25944	245	12	and	and	CC
25944	245	13	the	the	DT
25944	245	14	process	process	NN
25944	245	15	may	may	MD
25944	245	16	also	also	RB
25944	245	17	be	be	VB
25944	245	18	distinctly	distinctly	RB
25944	245	19	,	,	,
25944	245	20	although	although	IN
25944	245	21	usually	usually	RB
25944	245	22	mildly	mildly	RB
25944	245	23	,	,	,
25944	245	24	inflammatory	inflammatory	JJ
25944	245	25	.	.	.
25944	246	1	#	#	$
25944	246	2	At	at	IN
25944	246	3	what	what	WDT
25944	246	4	age	age	NN
25944	246	5	is	be	VBZ
25944	246	6	seborrh[oe]a	seborrh[oe]a	NNP
25944	246	7	usually	usually	RB
25944	246	8	observed	observe	VBN
25944	246	9	?	?	.
25944	246	10	#	#	$
25944	246	11	Between	between	IN
25944	246	12	fifteen	fifteen	CD
25944	246	13	and	and	CC
25944	246	14	forty	forty	CD
25944	246	15	.	.	.
25944	247	1	It	-PRON-	PRP
25944	247	2	may	may	MD
25944	247	3	,	,	,
25944	247	4	however	however	RB
25944	247	5	,	,	,
25944	247	6	occur	occur	VBP
25944	247	7	at	at	IN
25944	247	8	any	any	DT
25944	247	9	age	age	NN
25944	247	10	.	.	.
25944	248	1	#	#	JJR
25944	248	2	Name	name	VB
25944	248	3	the	the	DT
25944	248	4	parts	part	NNS
25944	248	5	most	most	RBS
25944	248	6	commonly	commonly	RB
25944	248	7	affected	affect	VBN
25944	248	8	.	.	.
25944	248	9	#	#	$
25944	248	10	The	the	DT
25944	248	11	scalp	scalp	NN
25944	248	12	,	,	,
25944	248	13	face	face	NN
25944	248	14	,	,	,
25944	248	15	and	and	CC
25944	248	16	(	(	-LRB-
25944	248	17	less	less	RBR
25944	248	18	frequently	frequently	RB
25944	248	19	)	)	-RRB-
25944	248	20	the	the	DT
25944	248	21	sternal	sternal	JJ
25944	248	22	and	and	CC
25944	248	23	interscapular	interscapular	JJ
25944	248	24	regions	region	NNS
25944	248	25	of	of	IN
25944	248	26	the	the	DT
25944	248	27	trunk	trunk	NN
25944	248	28	.	.	.
25944	249	1	It	-PRON-	PRP
25944	249	2	is	be	VBZ
25944	249	3	sometimes	sometimes	RB
25944	249	4	seen	see	VBN
25944	249	5	on	on	IN
25944	249	6	other	other	JJ
25944	249	7	parts	part	NNS
25944	249	8	.	.	.
25944	250	1	#	#	LS
25944	250	2	What	what	WDT
25944	250	3	varieties	variety	NNS
25944	250	4	of	of	IN
25944	250	5	seborrh[oe]a	seborrh[oe]a	NNP
25944	250	6	are	be	VBP
25944	250	7	encountered	encounter	VBN
25944	250	8	?	?	.
25944	250	9	#	#	$
25944	250	10	Seborrh[oe]a	seborrh[oe]a	CD
25944	250	11	oleosa	oleosa	NNP
25944	250	12	and	and	CC
25944	250	13	seborrh[oe]a	seborrh[oe]a	NNP
25944	250	14	sicca	sicca	NN
25944	250	15	;	;	:
25944	250	16	not	not	RB
25944	250	17	infrequently	infrequently	RB
25944	250	18	the	the	DT
25944	250	19	disease	disease	NN
25944	250	20	is	be	VBZ
25944	250	21	of	of	IN
25944	250	22	a	a	DT
25944	250	23	mixed	mixed	JJ
25944	250	24	type	type	NN
25944	250	25	.	.	.
25944	251	1	#	#	LS
25944	251	2	What	what	WP
25944	251	3	are	be	VBP
25944	251	4	the	the	DT
25944	251	5	symptoms	symptom	NNS
25944	251	6	of	of	IN
25944	251	7	seborrh[oe]a	seborrh[oe]a	NNP
25944	251	8	oleosa	oleosa	NNP
25944	251	9	?	?	.
25944	251	10	#	#	$
25944	251	11	The	the	DT
25944	251	12	sole	sole	JJ
25944	251	13	symptom	symptom	NN
25944	251	14	is	be	VBZ
25944	251	15	an	an	DT
25944	251	16	unnatural	unnatural	JJ
25944	251	17	oiliness	oiliness	NN
25944	251	18	,	,	,
25944	251	19	variable	variable	JJ
25944	251	20	as	as	IN
25944	251	21	to	to	IN
25944	251	22	degree	degree	NN
25944	251	23	.	.	.
25944	252	1	Its	-PRON-	PRP$
25944	252	2	most	most	RBS
25944	252	3	common	common	JJ
25944	252	4	sites	site	NNS
25944	252	5	are	be	VBP
25944	252	6	the	the	DT
25944	252	7	regions	region	NNS
25944	252	8	of	of	IN
25944	252	9	the	the	DT
25944	252	10	scalp	scalp	NN
25944	252	11	,	,	,
25944	252	12	nose	nose	NN
25944	252	13	,	,	,
25944	252	14	and	and	CC
25944	252	15	forehead	forehead	NN
25944	252	16	.	.	.
25944	253	1	In	in	IN
25944	253	2	many	many	JJ
25944	253	3	instances	instance	NNS
25944	253	4	mild	mild	JJ
25944	253	5	rosacea	rosacea	JJ
25944	253	6	coexists	coexist	NNS
25944	253	7	with	with	IN
25944	253	8	oily	oily	JJ
25944	253	9	seborrh[oe]a	seborrh[oe]a	NNP
25944	253	10	of	of	IN
25944	253	11	the	the	DT
25944	253	12	nose	nose	NN
25944	253	13	.	.	.
25944	254	1	#	#	NN
25944	254	2	Give	give	VBP
25944	254	3	the	the	DT
25944	254	4	symptoms	symptom	NNS
25944	254	5	of	of	IN
25944	254	6	seborrh[oe]a	seborrh[oe]a	NNP
25944	254	7	sicca	sicca	NN
25944	254	8	.	.	.
25944	254	9	#	#	$
25944	254	10	A	a	DT
25944	254	11	variable	variable	JJ
25944	254	12	degree	degree	NN
25944	254	13	of	of	IN
25944	254	14	greasy	greasy	JJ
25944	254	15	scalines	scaline	NNS
25944	254	16	,	,	,
25944	254	17	which	which	WDT
25944	254	18	may	may	MD
25944	254	19	be	be	VB
25944	254	20	seated	seat	VBN
25944	254	21	upon	upon	IN
25944	254	22	a	a	DT
25944	254	23	pale	pale	JJ
25944	254	24	,	,	,
25944	254	25	hyperæmic	hyperæmic	JJ
25944	254	26	or	or	CC
25944	254	27	mildly	mildly	RB
25944	254	28	inflammatory	inflammatory	JJ
25944	254	29	surface	surface	NN
25944	254	30	.	.	.
25944	255	1	The	the	DT
25944	255	2	parts	part	NNS
25944	255	3	affected	affect	VBN
25944	255	4	are	be	VBP
25944	255	5	covered	cover	VBN
25944	255	6	scantily	scantily	RB
25944	255	7	or	or	CC
25944	255	8	more	more	RBR
25944	255	9	or	or	CC
25944	255	10	less	less	RBR
25944	255	11	abundantly	abundantly	RB
25944	255	12	with	with	IN
25944	255	13	somewhat	somewhat	RB
25944	255	14	greasy	greasy	JJ
25944	255	15	,	,	,
25944	255	16	grayish	grayish	NN
25944	255	17	,	,	,
25944	255	18	or	or	CC
25944	255	19	brownish	brownish	JJ
25944	255	20	-	-	HYPH
25944	255	21	gray	gray	JJ
25944	255	22	scales	scale	NNS
25944	255	23	.	.	.
25944	256	1	If	if	IN
25944	256	2	upon	upon	IN
25944	256	3	the	the	DT
25944	256	4	scalp	scalp	NN
25944	256	5	(	(	-LRB-
25944	256	6	_	_	NNP
25944	256	7	dandruff	dandruff	NN
25944	256	8	_	_	NNP
25944	256	9	,	,	,
25944	256	10	_	_	NNP
25944	256	11	pityriasis	pityriasis	NN
25944	256	12	capitis	capitis	NN
25944	256	13	_	_	NNP
25944	256	14	)	)	-RRB-
25944	256	15	,	,	,
25944	256	16	small	small	JJ
25944	256	17	particles	particle	NNS
25944	256	18	of	of	IN
25944	256	19	scales	scale	NNS
25944	256	20	are	be	VBP
25944	256	21	found	find	VBN
25944	256	22	scattered	scatter	VBN
25944	256	23	through	through	IN
25944	256	24	the	the	DT
25944	256	25	hair	hair	NN
25944	256	26	,	,	,
25944	256	27	and	and	CC
25944	256	28	when	when	WRB
25944	256	29	the	the	DT
25944	256	30	latter	latter	NN
25944	256	31	is	be	VBZ
25944	256	32	brushed	brush	VBN
25944	256	33	or	or	CC
25944	256	34	combed	comb	VBN
25944	256	35	,	,	,
25944	256	36	fall	fall	VB
25944	256	37	over	over	IN
25944	256	38	the	the	DT
25944	256	39	shoulders	shoulder	NNS
25944	256	40	.	.	.
25944	257	1	If	if	IN
25944	257	2	upon	upon	IN
25944	257	3	the	the	DT
25944	257	4	face	face	NN
25944	257	5	,	,	,
25944	257	6	in	in	IN
25944	257	7	addition	addition	NN
25944	257	8	to	to	IN
25944	257	9	the	the	DT
25944	257	10	scaliness	scaliness	NN
25944	257	11	,	,	,
25944	257	12	the	the	DT
25944	257	13	sebaceous	sebaceous	JJ
25944	257	14	ducts	duct	NNS
25944	257	15	are	be	VBP
25944	257	16	usually	usually	RB
25944	257	17	seen	see	VBN
25944	257	18	to	to	TO
25944	257	19	be	be	VB
25944	257	20	enlarged	enlarge	VBN
25944	257	21	and	and	CC
25944	257	22	filled	fill	VBN
25944	257	23	with	with	IN
25944	257	24	sebaceous	sebaceous	JJ
25944	257	25	matter	matter	NN
25944	257	26	.	.	.
25944	258	1	#	#	NNP
25944	258	2	Describe	describe	VB
25944	258	3	the	the	DT
25944	258	4	symptoms	symptom	NNS
25944	258	5	of	of	IN
25944	258	6	the	the	DT
25944	258	7	ordinary	ordinary	JJ
25944	258	8	or	or	CC
25944	258	9	mixed	mixed	JJ
25944	258	10	type	type	NN
25944	258	11	.	.	.
25944	258	12	#	#	$
25944	258	13	It	-PRON-	PRP
25944	258	14	is	be	VBZ
25944	258	15	common	common	JJ
25944	258	16	upon	upon	IN
25944	258	17	the	the	DT
25944	258	18	scalp	scalp	NN
25944	258	19	.	.	.
25944	259	1	The	the	DT
25944	259	2	skin	skin	NN
25944	259	3	is	be	VBZ
25944	259	4	covered	cover	VBN
25944	259	5	with	with	IN
25944	259	6	irregularly	irregularly	RB
25944	259	7	diffused	diffuse	VBN
25944	259	8	,	,	,
25944	259	9	greasy	greasy	JJ
25944	259	10	,	,	,
25944	259	11	grayish	grayish	NN
25944	259	12	or	or	CC
25944	259	13	brownish	brownish	NN
25944	259	14	scales	scale	NNS
25944	259	15	and	and	CC
25944	259	16	crusts	crust	NNS
25944	259	17	,	,	,
25944	259	18	in	in	IN
25944	259	19	some	some	DT
25944	259	20	cases	case	NNS
25944	259	21	moderate	moderate	VBP
25944	259	22	in	in	IN
25944	259	23	quantity	quantity	NN
25944	259	24	,	,	,
25944	259	25	in	in	IN
25944	259	26	others	other	NNS
25944	259	27	so	so	RB
25944	259	28	great	great	JJ
25944	259	29	that	that	IN
25944	259	30	large	large	JJ
25944	259	31	irregular	irregular	JJ
25944	259	32	masses	masse	NNS
25944	259	33	are	be	VBP
25944	259	34	formed	form	VBN
25944	259	35	,	,	,
25944	259	36	pasting	paste	VBG
25944	259	37	the	the	DT
25944	259	38	hair	hair	NN
25944	259	39	to	to	IN
25944	259	40	the	the	DT
25944	259	41	scalp	scalp	NN
25944	259	42	.	.	.
25944	260	1	If	if	IN
25944	260	2	removed	remove	VBN
25944	260	3	,	,	,
25944	260	4	the	the	DT
25944	260	5	scales	scale	NNS
25944	260	6	and	and	CC
25944	260	7	crusts	crust	NNS
25944	260	8	rapidly	rapidly	RB
25944	260	9	re	re	VBP
25944	260	10	-	-	NN
25944	260	11	form	form	NN
25944	260	12	.	.	.
25944	261	1	The	the	DT
25944	261	2	skin	skin	NN
25944	261	3	beneath	beneath	RB
25944	261	4	is	be	VBZ
25944	261	5	found	find	VBN
25944	261	6	slate	slate	NN
25944	261	7	-	-	HYPH
25944	261	8	colored	colored	JJ
25944	261	9	,	,	,
25944	261	10	hyperæmic	hyperæmic	JJ
25944	261	11	or	or	CC
25944	261	12	mildly	mildly	RB
25944	261	13	inflammatory	inflammatory	JJ
25944	261	14	,	,	,
25944	261	15	and	and	CC
25944	261	16	exceptionally	exceptionally	RB
25944	261	17	it	-PRON-	PRP
25944	261	18	has	have	VBZ
25944	261	19	in	in	IN
25944	261	20	places	place	NNS
25944	261	21	an	an	DT
25944	261	22	eczematous	eczematous	JJ
25944	261	23	aspect	aspect	NN
25944	261	24	(	(	-LRB-
25944	261	25	_	_	NNP
25944	261	26	eczema	eczema	NN
25944	261	27	seborrhoicum	seborrhoicum	NN
25944	261	28	_	_	NNP
25944	261	29	)	)	-RRB-
25944	261	30	.	.	.
25944	262	1	Extraneous	extraneous	JJ
25944	262	2	matter	matter	NN
25944	262	3	,	,	,
25944	262	4	such	such	JJ
25944	262	5	as	as	IN
25944	262	6	dust	dust	NN
25944	262	7	and	and	CC
25944	262	8	dirt	dirt	NN
25944	262	9	,	,	,
25944	262	10	collects	collect	VBZ
25944	262	11	upon	upon	IN
25944	262	12	the	the	DT
25944	262	13	parts	part	NNS
25944	262	14	,	,	,
25944	262	15	and	and	CC
25944	262	16	the	the	DT
25944	262	17	whole	whole	JJ
25944	262	18	mass	mass	NN
25944	262	19	may	may	MD
25944	262	20	become	become	VB
25944	262	21	more	more	RBR
25944	262	22	or	or	CC
25944	262	23	less	less	RBR
25944	262	24	offensive	offensive	JJ
25944	262	25	.	.	.
25944	263	1	There	there	EX
25944	263	2	is	be	VBZ
25944	263	3	a	a	DT
25944	263	4	strong	strong	JJ
25944	263	5	tendency	tendency	NN
25944	263	6	to	to	IN
25944	263	7	falling	fall	VBG
25944	263	8	-	-	HYPH
25944	263	9	out	out	IN
25944	263	10	of	of	IN
25944	263	11	the	the	DT
25944	263	12	hair	hair	NN
25944	263	13	.	.	.
25944	264	1	Itching	itching	NN
25944	264	2	may	may	MD
25944	264	3	or	or	CC
25944	264	4	may	may	MD
25944	264	5	not	not	RB
25944	264	6	be	be	VB
25944	264	7	present	present	JJ
25944	264	8	.	.	.
25944	265	1	[	[	-LRB-
25944	265	2	Illustration	illustration	NN
25944	265	3	:	:	:
25944	265	4	Seborrh[oe]a	seborrh[oe]a	CD
25944	265	5	(	(	-LRB-
25944	265	6	Eczema	Eczema	NNP
25944	265	7	Seborrhoicum	Seborrhoicum	NNP
25944	265	8	)	)	-RRB-
25944	265	9	.	.	.
25944	265	10	]	]	-RRB-
25944	266	1	#	#	NNP
25944	266	2	Describe	describe	VB
25944	266	3	the	the	DT
25944	266	4	symptoms	symptom	NNS
25944	266	5	of	of	IN
25944	266	6	seborrh[oe]a	seborrh[oe]a	NNP
25944	266	7	of	of	IN
25944	266	8	the	the	DT
25944	266	9	trunk	trunk	NN
25944	266	10	and	and	CC
25944	266	11	other	other	JJ
25944	266	12	parts	part	NNS
25944	266	13	.	.	.
25944	266	14	#	#	$
25944	266	15	[	[	-LRB-
25944	266	16	Illustration	illustration	NN
25944	266	17	:	:	:
25944	266	18	Fig	Fig	NNP
25944	266	19	.	.	.
25944	267	1	7	7	LS
25944	267	2	.	.	.
25944	268	1	A	a	DT
25944	268	2	normal	normal	JJ
25944	268	3	sebaceous	sebaceous	JJ
25944	268	4	gland	gland	NN
25944	268	5	in	in	IN
25944	268	6	connection	connection	NN
25944	268	7	with	with	IN
25944	268	8	a	a	DT
25944	268	9	lanugo	lanugo	NN
25944	268	10	hair	hair	NN
25944	268	11	.	.	.
25944	269	1	(	(	-LRB-
25944	269	2	_	_	NNP
25944	269	3	After	after	IN
25944	269	4	Neumann	Neumann	NNP
25944	269	5	.	.	.
25944	269	6	_	_	NNP
25944	269	7	)	)	-RRB-
25944	269	8	_	_	NNP
25944	269	9	a	a	DT
25944	269	10	_	_	NNP
25944	269	11	,	,	,
25944	269	12	Capsule	Capsule	NNP
25944	269	13	;	;	:
25944	269	14	_	_	NNP
25944	269	15	b	b	NNP
25944	269	16	_	_	NNP
25944	269	17	,	,	,
25944	269	18	fatty	fatty	NN
25944	269	19	secretion	secretion	NN
25944	269	20	;	;	:
25944	269	21	_	_	NNP
25944	269	22	c	c	NNP
25944	269	23	_	_	NNP
25944	269	24	,	,	,
25944	269	25	_	_	NNP
25944	269	26	h	h	NNP
25944	269	27	_	_	NNP
25944	269	28	,	,	,
25944	269	29	secreting	secrete	VBG
25944	269	30	cells	cell	NNS
25944	269	31	;	;	:
25944	269	32	_	_	NNP
25944	269	33	d	d	NNP
25944	269	34	_	_	NNP
25944	269	35	,	,	,
25944	269	36	root	root	NN
25944	269	37	of	of	IN
25944	269	38	lanugo	lanugo	NNS
25944	269	39	hair	hair	NN
25944	269	40	;	;	:
25944	269	41	_	_	NNP
25944	269	42	e	e	NNP
25944	269	43	_	_	NNP
25944	269	44	,	,	,
25944	269	45	hair	hair	NN
25944	269	46	-	-	HYPH
25944	269	47	sac	sac	NN
25944	269	48	;	;	:
25944	269	49	_	_	NNP
25944	269	50	f	f	NNP
25944	269	51	_	_	NNP
25944	269	52	,	,	,
25944	269	53	hair	hair	NN
25944	269	54	-	-	HYPH
25944	269	55	shaft	shaft	NN
25944	269	56	;	;	:
25944	269	57	_	_	NNP
25944	269	58	g	g	NNP
25944	269	59	_	_	NNP
25944	269	60	,	,	,
25944	269	61	acini	acini	NN
25944	269	62	of	of	IN
25944	269	63	sebaceous	sebaceous	JJ
25944	269	64	gland	gland	NN
25944	269	65	.	.	.
25944	269	66	]	]	-RRB-
25944	270	1	Seborrh[oe]a	seborrh[oe]a	CD
25944	270	2	corporis	corporis	NNP
25944	270	3	differs	differ	VBZ
25944	270	4	in	in	IN
25944	270	5	a	a	DT
25944	270	6	measure	measure	NN
25944	270	7	,	,	,
25944	270	8	in	in	IN
25944	270	9	its	-PRON-	PRP$
25944	270	10	symptoms	symptom	NNS
25944	270	11	,	,	,
25944	270	12	from	from	IN
25944	270	13	seborrh[oe]a	seborrh[oe]a	NNP
25944	270	14	of	of	IN
25944	270	15	the	the	DT
25944	270	16	scalp	scalp	NN
25944	270	17	and	and	CC
25944	270	18	is	be	VBZ
25944	270	19	usually	usually	RB
25944	270	20	illustrative	illustrative	JJ
25944	270	21	of	of	IN
25944	270	22	the	the	DT
25944	270	23	variety	variety	NN
25944	270	24	known	know	VBN
25944	270	25	as	as	IN
25944	270	26	eczema	eczema	NN
25944	270	27	seborrhoicum	seborrhoicum	NN
25944	270	28	;	;	:
25944	270	29	it	-PRON-	PRP
25944	270	30	occurs	occur	VBZ
25944	270	31	as	as	IN
25944	270	32	one	one	CD
25944	270	33	or	or	CC
25944	270	34	several	several	JJ
25944	270	35	irregular	irregular	JJ
25944	270	36	or	or	CC
25944	270	37	circinate	circinate	JJ
25944	270	38	,	,	,
25944	270	39	slightly	slightly	RB
25944	270	40	hyperæmic	hyperæmic	JJ
25944	270	41	or	or	CC
25944	270	42	moderately	moderately	RB
25944	270	43	inflammatory	inflammatory	JJ
25944	270	44	patches	patch	NNS
25944	270	45	,	,	,
25944	270	46	covered	cover	VBN
25944	270	47	with	with	IN
25944	270	48	dirty	dirty	JJ
25944	270	49	or	or	CC
25944	270	50	grayish	grayish	NN
25944	270	51	-	-	HYPH
25944	270	52	looking	look	VBG
25944	270	53	greasy	greasy	NN
25944	270	54	scales	scale	NNS
25944	270	55	or	or	CC
25944	270	56	crusts	crust	NNS
25944	270	57	,	,	,
25944	270	58	usually	usually	RB
25944	270	59	moderate	moderate	JJ
25944	270	60	in	in	IN
25944	270	61	quantity	quantity	NN
25944	270	62	,	,	,
25944	270	63	and	and	CC
25944	270	64	upon	upon	IN
25944	270	65	removal	removal	NN
25944	270	66	are	be	VBP
25944	270	67	found	find	VBN
25944	270	68	to	to	TO
25944	270	69	have	have	VB
25944	270	70	projections	projection	NNS
25944	270	71	into	into	IN
25944	270	72	the	the	DT
25944	270	73	sebaceous	sebaceous	JJ
25944	270	74	ducts	duct	NNS
25944	270	75	.	.	.
25944	271	1	It	-PRON-	PRP
25944	271	2	is	be	VBZ
25944	271	3	commonly	commonly	RB
25944	271	4	seen	see	VBN
25944	271	5	upon	upon	IN
25944	271	6	the	the	DT
25944	271	7	sternal	sternal	JJ
25944	271	8	and	and	CC
25944	271	9	interscapular	interscapular	JJ
25944	271	10	regions	region	NNS
25944	271	11	.	.	.
25944	272	1	It	-PRON-	PRP
25944	272	2	rarely	rarely	RB
25944	272	3	exists	exist	VBZ
25944	272	4	independently	independently	RB
25944	272	5	in	in	IN
25944	272	6	these	these	DT
25944	272	7	regions	region	NNS
25944	272	8	,	,	,
25944	272	9	being	be	VBG
25944	272	10	usually	usually	RB
25944	272	11	associated	associate	VBN
25944	272	12	with	with	IN
25944	272	13	and	and	CC
25944	272	14	following	follow	VBG
25944	272	15	the	the	DT
25944	272	16	disease	disease	NN
25944	272	17	on	on	IN
25944	272	18	the	the	DT
25944	272	19	scalp	scalp	NN
25944	272	20	.	.	.
25944	273	1	It	-PRON-	PRP
25944	273	2	may	may	MD
25944	273	3	also	also	RB
25944	273	4	invade	invade	VB
25944	273	5	the	the	DT
25944	273	6	axillæ	axillæ	NN
25944	273	7	,	,	,
25944	273	8	genitocrural	genitocrural	JJ
25944	273	9	,	,	,
25944	273	10	and	and	CC
25944	273	11	other	other	JJ
25944	273	12	regions	region	NNS
25944	273	13	.	.	.
25944	274	1	#	#	LS
25944	274	2	What	what	WP
25944	274	3	is	be	VBZ
25944	274	4	the	the	DT
25944	274	5	usual	usual	JJ
25944	274	6	course	course	NN
25944	274	7	of	of	IN
25944	274	8	seborrh[oe]a	seborrh[oe]a	NNP
25944	274	9	?	?	.
25944	274	10	#	#	$
25944	274	11	Essentially	essentially	RB
25944	274	12	chronic	chronic	JJ
25944	274	13	,	,	,
25944	274	14	the	the	DT
25944	274	15	disease	disease	NN
25944	274	16	varying	vary	VBG
25944	274	17	in	in	IN
25944	274	18	intensity	intensity	NN
25944	274	19	from	from	IN
25944	274	20	time	time	NN
25944	274	21	to	to	IN
25944	274	22	time	time	NN
25944	274	23	.	.	.
25944	275	1	In	in	IN
25944	275	2	occasional	occasional	JJ
25944	275	3	instances	instance	NNS
25944	275	4	it	-PRON-	PRP
25944	275	5	disappears	disappear	VBZ
25944	275	6	spontaneously	spontaneously	RB
25944	275	7	.	.	.
25944	276	1	#	#	NN
25944	276	2	Give	give	VB
25944	276	3	the	the	DT
25944	276	4	cause	cause	NN
25944	276	5	or	or	CC
25944	276	6	causes	cause	NNS
25944	276	7	of	of	IN
25944	276	8	seborrh[oe]a	seborrh[oe]a	NNP
25944	276	9	.	.	.
25944	276	10	#	#	NNP
25944	276	11	General	general	JJ
25944	276	12	debility	debility	NN
25944	276	13	,	,	,
25944	276	14	anæmia	anæmia	NN
25944	276	15	,	,	,
25944	276	16	chlorosis	chlorosis	NN
25944	276	17	,	,	,
25944	276	18	dyspepsia	dyspepsia	NN
25944	276	19	,	,	,
25944	276	20	and	and	CC
25944	276	21	similar	similar	JJ
25944	276	22	conditions	condition	NNS
25944	276	23	are	be	VBP
25944	276	24	to	to	TO
25944	276	25	be	be	VB
25944	276	26	variously	variously	RB
25944	276	27	looked	look	VBN
25944	276	28	upon	upon	IN
25944	276	29	as	as	IN
25944	276	30	predisposing	predisposing	NN
25944	276	31	.	.	.
25944	277	1	In	in	IN
25944	277	2	some	some	DT
25944	277	3	instances	instance	NNS
25944	277	4	,	,	,
25944	277	5	however	however	RB
25944	277	6	,	,	,
25944	277	7	the	the	DT
25944	277	8	disease	disease	NN
25944	277	9	seems	seem	VBZ
25944	277	10	to	to	TO
25944	277	11	be	be	VB
25944	277	12	purely	purely	RB
25944	277	13	local	local	JJ
25944	277	14	in	in	IN
25944	277	15	character	character	NN
25944	277	16	,	,	,
25944	277	17	and	and	CC
25944	277	18	to	to	TO
25944	277	19	be	be	VB
25944	277	20	entirely	entirely	RB
25944	277	21	independent	independent	JJ
25944	277	22	of	of	IN
25944	277	23	any	any	DT
25944	277	24	constitutional	constitutional	JJ
25944	277	25	or	or	CC
25944	277	26	predisposing	predispose	VBG
25944	277	27	condition	condition	NN
25944	277	28	.	.	.
25944	278	1	The	the	DT
25944	278	2	view	view	NN
25944	278	3	recently	recently	RB
25944	278	4	advanced	advance	VBD
25944	278	5	that	that	IN
25944	278	6	the	the	DT
25944	278	7	disease	disease	NN
25944	278	8	is	be	VBZ
25944	278	9	of	of	IN
25944	278	10	parasitic	parasitic	JJ
25944	278	11	nature	nature	NN
25944	278	12	and	and	CC
25944	278	13	contagious	contagious	JJ
25944	278	14	has	have	VBZ
25944	278	15	been	be	VBN
25944	278	16	steadily	steadily	RB
25944	278	17	gaining	gain	VBG
25944	278	18	ground	ground	NN
25944	278	19	.	.	.
25944	279	1	#	#	LS
25944	279	2	What	what	WP
25944	279	3	is	be	VBZ
25944	279	4	the	the	DT
25944	279	5	pathology	pathology	NN
25944	279	6	of	of	IN
25944	279	7	seborrh[oe]a	seborrh[oe]a	NNP
25944	279	8	?	?	.
25944	279	9	#	#	NNP
25944	279	10	Seborrh[oe]a	seborrh[oe]a	CD
25944	279	11	is	be	VBZ
25944	279	12	a	a	DT
25944	279	13	disease	disease	NN
25944	279	14	of	of	IN
25944	279	15	the	the	DT
25944	279	16	sebaceous	sebaceous	JJ
25944	279	17	glands	gland	NNS
25944	279	18	,	,	,
25944	279	19	and	and	CC
25944	279	20	probably	probably	RB
25944	279	21	often	often	RB
25944	279	22	involving	involve	VBG
25944	279	23	the	the	DT
25944	279	24	sweat	sweat	NN
25944	279	25	-	-	HYPH
25944	279	26	glands	gland	NNS
25944	279	27	also	also	RB
25944	279	28	;	;	:
25944	279	29	its	-PRON-	PRP$
25944	279	30	products	product	NNS
25944	279	31	,	,	,
25944	279	32	as	as	IN
25944	279	33	found	find	VBN
25944	279	34	upon	upon	IN
25944	279	35	the	the	DT
25944	279	36	skin	skin	NN
25944	279	37	,	,	,
25944	279	38	consisting	consist	VBG
25944	279	39	of	of	IN
25944	279	40	the	the	DT
25944	279	41	sebaceous	sebaceous	JJ
25944	279	42	secretion	secretion	NN
25944	279	43	,	,	,
25944	279	44	epithelial	epithelial	JJ
25944	279	45	cells	cell	NNS
25944	279	46	from	from	IN
25944	279	47	the	the	DT
25944	279	48	glands	gland	NNS
25944	279	49	and	and	CC
25944	279	50	ducts	duct	NNS
25944	279	51	,	,	,
25944	279	52	and	and	CC
25944	279	53	more	more	RBR
25944	279	54	or	or	CC
25944	279	55	less	less	RBR
25944	279	56	extraneous	extraneous	JJ
25944	279	57	matter	matter	NN
25944	279	58	.	.	.
25944	280	1	Not	not	RB
25944	280	2	infrequently	infrequently	RB
25944	280	3	evidences	evidence	NNS
25944	280	4	of	of	IN
25944	280	5	superficial	superficial	JJ
25944	280	6	inflammatory	inflammatory	JJ
25944	280	7	action	action	NN
25944	280	8	are	be	VBP
25944	280	9	also	also	RB
25944	280	10	to	to	TO
25944	280	11	be	be	VB
25944	280	12	found	find	VBN
25944	280	13	,	,	,
25944	280	14	and	and	CC
25944	280	15	it	-PRON-	PRP
25944	280	16	is	be	VBZ
25944	280	17	especially	especially	RB
25944	280	18	for	for	IN
25944	280	19	this	this	DT
25944	280	20	type	type	NN
25944	280	21	that	that	WDT
25944	280	22	the	the	DT
25944	280	23	name	name	NN
25944	280	24	eczema	eczema	NNP
25944	280	25	seborrhoicum	seborrhoicum	NNP
25944	280	26	is	be	VBZ
25944	280	27	most	most	RBS
25944	280	28	appropriate	appropriate	JJ
25944	280	29	.	.	.
25944	281	1	In	in	IN
25944	281	2	long	long	RB
25944	281	3	-	-	HYPH
25944	281	4	continued	continue	VBN
25944	281	5	and	and	CC
25944	281	6	neglected	neglect	VBN
25944	281	7	cases	case	NNS
25944	281	8	slight	slight	JJ
25944	281	9	atrophy	atrophy	NN
25944	281	10	of	of	IN
25944	281	11	the	the	DT
25944	281	12	gland	gland	NN
25944	281	13	-	-	HYPH
25944	281	14	structures	structure	NNS
25944	281	15	may	may	MD
25944	281	16	occur	occur	VB
25944	281	17	.	.	.
25944	282	1	#	#	$
25944	282	2	With	with	IN
25944	282	3	what	what	WP
25944	282	4	diseases	disease	NNS
25944	282	5	are	be	VBP
25944	282	6	you	-PRON-	PRP
25944	282	7	likely	likely	JJ
25944	282	8	to	to	TO
25944	282	9	confound	confound	VB
25944	282	10	seborrh[oe]a	seborrh[oe]a	NNP
25944	282	11	?	?	.
25944	282	12	#	#	NNP
25944	282	13	Upon	upon	IN
25944	282	14	the	the	DT
25944	282	15	scalp	scalp	NN
25944	282	16	,	,	,
25944	282	17	with	with	IN
25944	282	18	eczema	eczema	NN
25944	282	19	and	and	CC
25944	282	20	psoriasis	psoriasis	NN
25944	282	21	;	;	:
25944	282	22	upon	upon	IN
25944	282	23	the	the	DT
25944	282	24	face	face	NN
25944	282	25	,	,	,
25944	282	26	with	with	IN
25944	282	27	lupus	lupus	NN
25944	282	28	erythematosus	erythematosus	NN
25944	282	29	and	and	CC
25944	282	30	eczema	eczema	NN
25944	282	31	;	;	:
25944	282	32	and	and	CC
25944	282	33	upon	upon	IN
25944	282	34	the	the	DT
25944	282	35	trunk	trunk	NN
25944	282	36	,	,	,
25944	282	37	with	with	IN
25944	282	38	psoriasis	psoriasis	NN
25944	282	39	and	and	CC
25944	282	40	ringworm	ringworm	NN
25944	282	41	.	.	.
25944	283	1	As	as	IN
25944	283	2	a	a	DT
25944	283	3	rule	rule	NN
25944	283	4	,	,	,
25944	283	5	the	the	DT
25944	283	6	clinical	clinical	JJ
25944	283	7	features	feature	NNS
25944	283	8	of	of	IN
25944	283	9	seborrh[oe]a	seborrh[oe]a	NNP
25944	283	10	are	be	VBP
25944	283	11	sufficiently	sufficiently	RB
25944	283	12	characteristic	characteristic	JJ
25944	283	13	to	to	TO
25944	283	14	prevent	prevent	VB
25944	283	15	error	error	NN
25944	283	16	.	.	.
25944	284	1	#	#	LS
25944	284	2	What	what	WP
25944	284	3	are	be	VBP
25944	284	4	the	the	DT
25944	284	5	differential	differential	JJ
25944	284	6	points	point	NNS
25944	284	7	?	?	.
25944	284	8	#	#	NNP
25944	284	9	Eczema	Eczema	NNP
25944	284	10	,	,	,
25944	284	11	psoriasis	psoriasis	NN
25944	284	12	,	,	,
25944	284	13	and	and	CC
25944	284	14	lupus	lupus	NNP
25944	284	15	erythematosus	erythematosus	NN
25944	284	16	are	be	VBP
25944	284	17	diseases	disease	NNS
25944	284	18	in	in	IN
25944	284	19	which	which	WDT
25944	284	20	there	there	EX
25944	284	21	are	be	VBP
25944	284	22	distinct	distinct	JJ
25944	284	23	_	_	NNP
25944	284	24	inflammatory	inflammatory	JJ
25944	284	25	symptoms	symptom	NNS
25944	284	26	_	_	NNP
25944	284	27	,	,	,
25944	284	28	such	such	JJ
25944	284	29	as	as	IN
25944	284	30	thickening	thickening	NN
25944	284	31	and	and	CC
25944	284	32	infiltration	infiltration	NN
25944	284	33	and	and	CC
25944	284	34	redness	redness	NN
25944	284	35	;	;	:
25944	284	36	moreover	moreover	RB
25944	284	37	,	,	,
25944	284	38	psoriasis	psoriasis	NN
25944	284	39	,	,	,
25944	284	40	and	and	CC
25944	284	41	this	this	DT
25944	284	42	holds	hold	VBZ
25944	284	43	true	true	JJ
25944	284	44	as	as	IN
25944	284	45	to	to	TO
25944	284	46	ringworm	ringworm	VB
25944	284	47	also	also	RB
25944	284	48	,	,	,
25944	284	49	occurs	occur	VBZ
25944	284	50	in	in	IN
25944	284	51	sharply	sharply	RB
25944	284	52	-	-	HYPH
25944	284	53	defined	define	VBN
25944	284	54	,	,	,
25944	284	55	circumscribed	circumscribe	VBN
25944	284	56	patches	patch	NNS
25944	284	57	,	,	,
25944	284	58	and	and	CC
25944	284	59	lupus	lupus	NNP
25944	284	60	erythematosus	erythematosus	NNP
25944	284	61	has	have	VBZ
25944	284	62	a	a	DT
25944	284	63	peculiar	peculiar	JJ
25944	284	64	violaceous	violaceous	JJ
25944	284	65	tint	tint	NN
25944	284	66	and	and	CC
25944	284	67	an	an	DT
25944	284	68	elevated	elevated	JJ
25944	284	69	and	and	CC
25944	284	70	marginate	marginate	JJ
25944	284	71	border	border	NN
25944	284	72	.	.	.
25944	285	1	A	a	DT
25944	285	2	microscopic	microscopic	JJ
25944	285	3	examination	examination	NN
25944	285	4	of	of	IN
25944	285	5	the	the	DT
25944	285	6	epidermic	epidermic	JJ
25944	285	7	scrapings	scraping	NNS
25944	285	8	would	would	MD
25944	285	9	be	be	VB
25944	285	10	of	of	IN
25944	285	11	crucial	crucial	JJ
25944	285	12	value	value	NN
25944	285	13	in	in	IN
25944	285	14	differentiating	differentiate	VBG
25944	285	15	from	from	IN
25944	285	16	ringworm	ringworm	NN
25944	285	17	.	.	.
25944	286	1	Quite	quite	RB
25944	286	2	frequently	frequently	RB
25944	286	3	,	,	,
25944	286	4	especially	especially	RB
25944	286	5	in	in	IN
25944	286	6	the	the	DT
25944	286	7	interscapular	interscapular	JJ
25944	286	8	and	and	CC
25944	286	9	sternal	sternal	JJ
25944	286	10	regions	region	NNS
25944	286	11	,	,	,
25944	286	12	the	the	DT
25944	286	13	segmental	segmental	JJ
25944	286	14	configuration	configuration	NN
25944	286	15	constitutes	constitute	VBZ
25944	286	16	an	an	DT
25944	286	17	important	important	JJ
25944	286	18	feature	feature	NN
25944	286	19	of	of	IN
25944	286	20	seborrh[oe]a	seborrh[oe]a	NN
25944	286	21	--	--	:
25944	286	22	of	of	IN
25944	286	23	the	the	DT
25944	286	24	eczema	eczema	NN
25944	286	25	seborrhoicum	seborrhoicum	NN
25944	286	26	variety	variety	NN
25944	286	27	.	.	.
25944	287	1	#	#	LS
25944	287	2	What	what	WP
25944	287	3	is	be	VBZ
25944	287	4	the	the	DT
25944	287	5	prognosis	prognosis	NN
25944	287	6	in	in	IN
25944	287	7	seborrh[oe]a	seborrh[oe]a	NNP
25944	287	8	?	?	.
25944	287	9	#	#	:
25944	287	10	Favorable	favorable	JJ
25944	287	11	.	.	.
25944	288	1	All	all	DT
25944	288	2	types	type	NNS
25944	288	3	are	be	VBP
25944	288	4	curable	curable	JJ
25944	288	5	,	,	,
25944	288	6	and	and	CC
25944	288	7	when	when	WRB
25944	288	8	upon	upon	IN
25944	288	9	the	the	DT
25944	288	10	non	non	JJ
25944	288	11	-	-	JJ
25944	288	12	hairy	hairy	JJ
25944	288	13	regions	region	NNS
25944	288	14	,	,	,
25944	288	15	usually	usually	RB
25944	288	16	readily	readily	RB
25944	288	17	so	so	RB
25944	288	18	;	;	:
25944	288	19	upon	upon	IN
25944	288	20	the	the	DT
25944	288	21	scalp	scalp	NN
25944	288	22	it	-PRON-	PRP
25944	288	23	is	be	VBZ
25944	288	24	often	often	RB
25944	288	25	obstinate	obstinate	JJ
25944	288	26	.	.	.
25944	289	1	Relapses	relapse	NNS
25944	289	2	are	be	VBP
25944	289	3	not	not	RB
25944	289	4	uncommon	uncommon	JJ
25944	289	5	.	.	.
25944	290	1	In	in	IN
25944	290	2	those	those	DT
25944	290	3	cases	case	NNS
25944	290	4	of	of	IN
25944	290	5	seborrh[oe]a	seborrh[oe]a	NNP
25944	290	6	capitis	capitis	NN
25944	290	7	which	which	WDT
25944	290	8	have	have	VBP
25944	290	9	been	be	VBN
25944	290	10	long	long	RB
25944	290	11	-	-	HYPH
25944	290	12	continued	continue	VBN
25944	290	13	or	or	CC
25944	290	14	neglected	neglect	VBN
25944	290	15	,	,	,
25944	290	16	and	and	CC
25944	290	17	attended	attend	VBN
25944	290	18	with	with	IN
25944	290	19	loss	loss	NN
25944	290	20	of	of	IN
25944	290	21	hair	hair	NN
25944	290	22	,	,	,
25944	290	23	this	this	DT
25944	290	24	loss	loss	NN
25944	290	25	may	may	MD
25944	290	26	be	be	VB
25944	290	27	more	more	RBR
25944	290	28	or	or	CC
25944	290	29	less	less	RBR
25944	290	30	permanent	permanent	JJ
25944	290	31	,	,	,
25944	290	32	although	although	IN
25944	290	33	ordinarily	ordinarily	RB
25944	290	34	much	much	JJ
25944	290	35	can	can	MD
25944	290	36	be	be	VB
25944	290	37	done	do	VBN
25944	290	38	to	to	TO
25944	290	39	promote	promote	VB
25944	290	40	a	a	DT
25944	290	41	regrowth	regrowth	NN
25944	290	42	(	(	-LRB-
25944	290	43	see	see	VB
25944	290	44	_	_	NNP
25944	290	45	Treatment	Treatment	NNP
25944	290	46	of	of	IN
25944	290	47	Alopecia	Alopecia	NNP
25944	290	48	_	_	NNP
25944	290	49	)	)	-RRB-
25944	290	50	.	.	.
25944	291	1	#	#	NNP
25944	291	2	How	how	WRB
25944	291	3	would	would	MD
25944	291	4	you	-PRON-	PRP
25944	291	5	treat	treat	VB
25944	291	6	seborrh[oe]a	seborrh[oe]a	NNP
25944	291	7	of	of	IN
25944	291	8	the	the	DT
25944	291	9	scalp	scalp	NN
25944	291	10	?	?	.
25944	291	11	#	#	NN
25944	291	12	By	by	IN
25944	291	13	constitutional	constitutional	JJ
25944	291	14	(	(	-LRB-
25944	291	15	if	if	IN
25944	291	16	indicated	indicate	VBN
25944	291	17	)	)	-RRB-
25944	291	18	and	and	CC
25944	291	19	local	local	JJ
25944	291	20	remedies	remedy	NNS
25944	291	21	;	;	:
25944	291	22	the	the	DT
25944	291	23	former	former	JJ
25944	291	24	having	having	NN
25944	291	25	in	in	IN
25944	291	26	view	view	NN
25944	291	27	correction	correction	NN
25944	291	28	or	or	CC
25944	291	29	modification	modification	NN
25944	291	30	of	of	IN
25944	291	31	the	the	DT
25944	291	32	predisposing	predispose	VBG
25944	291	33	factor	factor	NN
25944	291	34	or	or	CC
25944	291	35	factors	factor	NNS
25944	291	36	,	,	,
25944	291	37	and	and	CC
25944	291	38	the	the	DT
25944	291	39	latter	latter	JJ
25944	291	40	removal	removal	NN
25944	291	41	of	of	IN
25944	291	42	the	the	DT
25944	291	43	sebaceous	sebaceous	JJ
25944	291	44	accumulations	accumulation	NNS
25944	291	45	and	and	CC
25944	291	46	the	the	DT
25944	291	47	application	application	NN
25944	291	48	of	of	IN
25944	291	49	mildly	mildly	RB
25944	291	50	stimulating	stimulate	VBG
25944	291	51	antiseptic	antiseptic	JJ
25944	291	52	ointments	ointment	NNS
25944	291	53	or	or	CC
25944	291	54	lotions	lotion	NNS
25944	291	55	.	.	.
25944	292	1	#	#	JJR
25944	292	2	What	what	WDT
25944	292	3	constitutional	constitutional	JJ
25944	292	4	remedies	remedy	NNS
25944	292	5	are	be	VBP
25944	292	6	commonly	commonly	RB
25944	292	7	employed	employ	VBN
25944	292	8	?	?	.
25944	292	9	#	#	$
25944	292	10	The	the	DT
25944	292	11	various	various	JJ
25944	292	12	tonics	tonic	NNS
25944	292	13	,	,	,
25944	292	14	such	such	JJ
25944	292	15	as	as	IN
25944	292	16	iron	iron	NN
25944	292	17	,	,	,
25944	292	18	quinine	quinine	NNP
25944	292	19	,	,	,
25944	292	20	strychnia	strychnia	NNP
25944	292	21	,	,	,
25944	292	22	cod	cod	NN
25944	292	23	-	-	HYPH
25944	292	24	liver	liver	NN
25944	292	25	oil	oil	NN
25944	292	26	,	,	,
25944	292	27	arsenic	arsenic	JJ
25944	292	28	,	,	,
25944	292	29	the	the	DT
25944	292	30	vegetable	vegetable	NN
25944	292	31	bitters	bitter	NNS
25944	292	32	,	,	,
25944	292	33	laxatives	laxative	NNS
25944	292	34	,	,	,
25944	292	35	malt	malt	NN
25944	292	36	and	and	CC
25944	292	37	similar	similar	JJ
25944	292	38	preparations	preparation	NNS
25944	292	39	.	.	.
25944	293	1	The	the	DT
25944	293	2	line	line	NN
25944	293	3	of	of	IN
25944	293	4	treatment	treatment	NN
25944	293	5	is	be	VBZ
25944	293	6	to	to	TO
25944	293	7	be	be	VB
25944	293	8	based	base	VBN
25944	293	9	upon	upon	IN
25944	293	10	indications	indication	NNS
25944	293	11	.	.	.
25944	294	1	#	#	NNP
25944	294	2	How	how	WRB
25944	294	3	do	do	VBP
25944	294	4	you	-PRON-	PRP
25944	294	5	free	free	VB
25944	294	6	the	the	DT
25944	294	7	scalp	scalp	NN
25944	294	8	of	of	IN
25944	294	9	the	the	DT
25944	294	10	sebaceous	sebaceous	JJ
25944	294	11	accumulations	accumulation	NNS
25944	294	12	?	?	.
25944	294	13	#	#	$
25944	294	14	In	in	IN
25944	294	15	mild	mild	JJ
25944	294	16	types	type	NNS
25944	294	17	of	of	IN
25944	294	18	the	the	DT
25944	294	19	disease	disease	NN
25944	294	20	shampooing	shampoo	VBG
25944	294	21	with	with	IN
25944	294	22	simple	simple	JJ
25944	294	23	Castile	castile	JJ
25944	294	24	soap	soap	NN
25944	294	25	(	(	-LRB-
25944	294	26	or	or	CC
25944	294	27	any	any	DT
25944	294	28	other	other	JJ
25944	294	29	good	good	JJ
25944	294	30	toilet	toilet	NN
25944	294	31	soap	soap	NN
25944	294	32	)	)	-RRB-
25944	294	33	and	and	CC
25944	294	34	hot	hot	JJ
25944	294	35	water	water	NN
25944	294	36	will	will	MD
25944	294	37	suffice	suffice	VB
25944	294	38	;	;	:
25944	294	39	in	in	IN
25944	294	40	those	those	DT
25944	294	41	cases	case	NNS
25944	294	42	in	in	IN
25944	294	43	which	which	WDT
25944	294	44	there	there	EX
25944	294	45	is	be	VBZ
25944	294	46	considerable	considerable	JJ
25944	294	47	scale	scale	NN
25944	294	48	-	-	HYPH
25944	294	49	and	and	CC
25944	294	50	crust	crust	NN
25944	294	51	-	-	HYPH
25944	294	52	formation	formation	NN
25944	294	53	the	the	DT
25944	294	54	tincture	tincture	NN
25944	294	55	of	of	IN
25944	294	56	green	green	JJ
25944	294	57	soap	soap	NN
25944	294	58	(	(	-LRB-
25944	294	59	tinct	tinct	FW
25944	294	60	.	.	.
25944	295	1	saponis	saponis	NNP
25944	295	2	viridis	viridis	NNP
25944	295	3	)	)	-RRB-
25944	295	4	is	be	VBZ
25944	295	5	to	to	TO
25944	295	6	be	be	VB
25944	295	7	employed	employ	VBN
25944	295	8	in	in	IN
25944	295	9	place	place	NN
25944	295	10	of	of	IN
25944	295	11	the	the	DT
25944	295	12	toilet	toilet	NN
25944	295	13	soap	soap	NN
25944	295	14	,	,	,
25944	295	15	and	and	CC
25944	295	16	in	in	IN
25944	295	17	some	some	DT
25944	295	18	of	of	IN
25944	295	19	these	these	DT
25944	295	20	latter	latter	JJ
25944	295	21	cases	case	NNS
25944	295	22	it	-PRON-	PRP
25944	295	23	may	may	MD
25944	295	24	be	be	VB
25944	295	25	necessary	necessary	JJ
25944	295	26	to	to	TO
25944	295	27	soften	soften	VB
25944	295	28	the	the	DT
25944	295	29	crusts	crust	NNS
25944	295	30	with	with	IN
25944	295	31	a	a	DT
25944	295	32	previous	previous	JJ
25944	295	33	soaking	soaking	NN
25944	295	34	with	with	IN
25944	295	35	olive	olive	JJ
25944	295	36	oil	oil	NN
25944	295	37	.	.	.
25944	296	1	The	the	DT
25944	296	2	frequency	frequency	NN
25944	296	3	of	of	IN
25944	296	4	the	the	DT
25944	296	5	shampoo	shampoo	NN
25944	296	6	depends	depend	VBZ
25944	296	7	upon	upon	IN
25944	296	8	the	the	DT
25944	296	9	conditions	condition	NNS
25944	296	10	.	.	.
25944	297	1	In	in	IN
25944	297	2	mild	mild	JJ
25944	297	3	cases	case	NNS
25944	297	4	once	once	RB
25944	297	5	in	in	IN
25944	297	6	five	five	CD
25944	297	7	or	or	CC
25944	297	8	ten	ten	CD
25944	297	9	days	day	NNS
25944	297	10	will	will	MD
25944	297	11	be	be	VB
25944	297	12	sufficiently	sufficiently	RB
25944	297	13	frequent	frequent	JJ
25944	297	14	to	to	TO
25944	297	15	keep	keep	VB
25944	297	16	the	the	DT
25944	297	17	parts	part	NNS
25944	297	18	clean	clean	JJ
25944	297	19	,	,	,
25944	297	20	but	but	CC
25944	297	21	in	in	IN
25944	297	22	those	those	DT
25944	297	23	cases	case	NNS
25944	297	24	in	in	IN
25944	297	25	which	which	WDT
25944	297	26	there	there	EX
25944	297	27	is	be	VBZ
25944	297	28	rapid	rapid	JJ
25944	297	29	scale	scale	NN
25944	297	30	-	-	HYPH
25944	297	31	or	or	CC
25944	297	32	crust	crust	NN
25944	297	33	-	-	HYPH
25944	297	34	production	production	NN
25944	297	35	once	once	RB
25944	297	36	daily	daily	RB
25944	297	37	or	or	CC
25944	297	38	every	every	DT
25944	297	39	second	second	JJ
25944	297	40	day	day	NN
25944	297	41	may	may	MD
25944	297	42	at	at	IN
25944	297	43	first	first	RB
25944	297	44	be	be	VB
25944	297	45	demanded	demand	VBN
25944	297	46	.	.	.
25944	298	1	#	#	JJR
25944	298	2	Name	name	VB
25944	298	3	the	the	DT
25944	298	4	most	most	RBS
25944	298	5	effectual	effectual	JJ
25944	298	6	applications	application	NNS
25944	298	7	in	in	IN
25944	298	8	seborrh[oe]a	seborrh[oe]a	NNP
25944	298	9	capitis	capitis	NN
25944	298	10	.	.	.
25944	298	11	#	#	NNP
25944	298	12	Sulphur	Sulphur	NNP
25944	298	13	,	,	,
25944	298	14	ammoniated	ammoniate	VBD
25944	298	15	mercury	mercury	NN
25944	298	16	,	,	,
25944	298	17	salicylic	salicylic	JJ
25944	298	18	acid	acid	NNP
25944	298	19	,	,	,
25944	298	20	resorcin	resorcin	NNS
25944	298	21	,	,	,
25944	298	22	and	and	CC
25944	298	23	carbolic	carbolic	JJ
25944	298	24	acid	acid	NN
25944	298	25	.	.	.
25944	299	1	Sulphur	Sulphur	NNP
25944	299	2	is	be	VBZ
25944	299	3	used	use	VBN
25944	299	4	in	in	IN
25944	299	5	the	the	DT
25944	299	6	form	form	NN
25944	299	7	of	of	IN
25944	299	8	an	an	DT
25944	299	9	ointment	ointment	NN
25944	299	10	,	,	,
25944	299	11	from	from	IN
25944	299	12	twenty	twenty	CD
25944	299	13	grains	grain	NNS
25944	299	14	to	to	IN
25944	299	15	one	one	CD
25944	299	16	drachm	drachm	NN
25944	299	17	in	in	IN
25944	299	18	the	the	DT
25944	299	19	ounce	ounce	NN
25944	299	20	.	.	.
25944	300	1	Ammoniated	ammoniate	VBN
25944	300	2	mercury	mercury	NN
25944	300	3	,	,	,
25944	300	4	in	in	IN
25944	300	5	the	the	DT
25944	300	6	form	form	NN
25944	300	7	of	of	IN
25944	300	8	an	an	DT
25944	300	9	ointment	ointment	NN
25944	300	10	,	,	,
25944	300	11	ten	ten	CD
25944	300	12	to	to	TO
25944	300	13	sixty	sixty	CD
25944	300	14	grains	grain	NNS
25944	300	15	to	to	IN
25944	300	16	the	the	DT
25944	300	17	ounce	ounce	NN
25944	300	18	.	.	.
25944	301	1	Salicylic	salicylic	JJ
25944	301	2	acid	acid	NN
25944	301	3	,	,	,
25944	301	4	either	either	RB
25944	301	5	alone	alone	RB
25944	301	6	as	as	IN
25944	301	7	an	an	DT
25944	301	8	ointment	ointment	NN
25944	301	9	,	,	,
25944	301	10	ten	ten	CD
25944	301	11	to	to	IN
25944	301	12	thirty	thirty	CD
25944	301	13	grains	grain	NNS
25944	301	14	to	to	IN
25944	301	15	the	the	DT
25944	301	16	ounce	ounce	NN
25944	301	17	;	;	:
25944	301	18	or	or	CC
25944	301	19	it	-PRON-	PRP
25944	301	20	may	may	MD
25944	301	21	often	often	RB
25944	301	22	be	be	VB
25944	301	23	added	add	VBN
25944	301	24	with	with	IN
25944	301	25	advantage	advantage	NN
25944	301	26	,	,	,
25944	301	27	in	in	IN
25944	301	28	the	the	DT
25944	301	29	same	same	JJ
25944	301	30	proportion	proportion	NN
25944	301	31	,	,	,
25944	301	32	to	to	IN
25944	301	33	the	the	DT
25944	301	34	sulphur	sulphur	NN
25944	301	35	or	or	CC
25944	301	36	ammoniated	ammoniate	VBD
25944	301	37	mercury	mercury	NNP
25944	301	38	ointment	ointment	NN
25944	301	39	above	above	IN
25944	301	40	named	name	VBN
25944	301	41	.	.	.
25944	302	1	Resorcin	Resorcin	NNP
25944	302	2	,	,	,
25944	302	3	either	either	CC
25944	302	4	as	as	IN
25944	302	5	an	an	DT
25944	302	6	ointment	ointment	NN
25944	302	7	,	,	,
25944	302	8	ten	ten	CD
25944	302	9	to	to	IN
25944	302	10	thirty	thirty	CD
25944	302	11	grains	grain	NNS
25944	302	12	to	to	IN
25944	302	13	the	the	DT
25944	302	14	ounce	ounce	NN
25944	302	15	,	,	,
25944	302	16	or	or	CC
25944	302	17	as	as	IN
25944	302	18	an	an	DT
25944	302	19	alcoholic	alcoholic	JJ
25944	302	20	or	or	CC
25944	302	21	aqueous	aqueous	JJ
25944	302	22	lotion	lotion	NN
25944	302	23	,	,	,
25944	302	24	as	as	IN
25944	302	25	the	the	DT
25944	302	26	following:--	following:--	NN
25944	302	27	[	[	-LRB-
25944	302	28	Rx	Rx	NNP
25944	302	29	]	]	-RRB-
25944	302	30	Resorcini	Resorcini	NNP
25944	302	31	............................	............................	NFP
25944	302	32	[	[	-LRB-
25944	302	33	dram]j-[dram]iss	dram]j-[dram]iss	CD
25944	302	34	.	.	.
25944	303	1	Ol	old	RB
25944	303	2	.	.	.
25944	304	1	ricini	ricini	NNP
25944	304	2	...........................	...........................	NFP
25944	304	3	[	[	-LRB-
25944	304	4	minim]xxx	minim]xxx	NN
25944	304	5	-	-	HYPH
25944	304	6	f[dram]ij	f[dram]ij	NNP
25944	304	7	.	.	.
25944	305	1	Alcoholis	Alcoholis	NNP
25944	305	2	............................	............................	.
25944	305	3	f[Oz]iv	f[oz]iv	XX
25944	305	4	.	.	.
25944	306	1	M.	M.	NNP
25944	306	2	Carbolic	Carbolic	NNP
25944	306	3	acid	acid	NN
25944	306	4	,	,	,
25944	306	5	to	to	IN
25944	306	6	the	the	DT
25944	306	7	amount	amount	NN
25944	306	8	of	of	IN
25944	306	9	ten	ten	CD
25944	306	10	to	to	IN
25944	306	11	thirty	thirty	CD
25944	306	12	grains	grain	NNS
25944	306	13	,	,	,
25944	306	14	can	can	MD
25944	306	15	be	be	VB
25944	306	16	added	add	VBN
25944	306	17	to	to	IN
25944	306	18	this	this	DT
25944	306	19	.	.	.
25944	307	1	If	if	IN
25944	307	2	an	an	DT
25944	307	3	aqueous	aqueous	JJ
25944	307	4	lotion	lotion	NN
25944	307	5	is	be	VBZ
25944	307	6	desirable	desirable	JJ
25944	307	7	,	,	,
25944	307	8	then	then	RB
25944	307	9	in	in	IN
25944	307	10	the	the	DT
25944	307	11	above	above	JJ
25944	307	12	formula	formula	NN
25944	307	13	the	the	DT
25944	307	14	oleum	oleum	NN
25944	307	15	ricini	ricini	NNP
25944	307	16	is	be	VBZ
25944	307	17	replaced	replace	VBN
25944	307	18	with	with	IN
25944	307	19	glycerine	glycerine	NN
25944	307	20	,	,	,
25944	307	21	and	and	CC
25944	307	22	the	the	DT
25944	307	23	alcohol	alcohol	NN
25944	307	24	with	with	IN
25944	307	25	water	water	NN
25944	307	26	;	;	:
25944	307	27	three	three	CD
25944	307	28	to	to	TO
25944	307	29	five	five	CD
25944	307	30	minims	minim	NNS
25944	307	31	of	of	IN
25944	307	32	glycerine	glycerine	NN
25944	307	33	in	in	IN
25944	307	34	each	each	DT
25944	307	35	ounce	ounce	NN
25944	307	36	is	be	VBZ
25944	307	37	usually	usually	RB
25944	307	38	sufficient	sufficient	JJ
25944	307	39	,	,	,
25944	307	40	as	as	IN
25944	307	41	a	a	DT
25944	307	42	greater	great	JJR
25944	307	43	quantity	quantity	NN
25944	307	44	makes	make	VBZ
25944	307	45	the	the	DT
25944	307	46	resulting	result	VBG
25944	307	47	lotion	lotion	NN
25944	307	48	sticky	sticky	NN
25944	307	49	.	.	.
25944	308	1	Petrolatum	petrolatum	NN
25944	308	2	alone	alone	RB
25944	308	3	,	,	,
25944	308	4	or	or	CC
25944	308	5	with	with	IN
25944	308	6	10	10	CD
25944	308	7	to	to	TO
25944	308	8	30	30	CD
25944	308	9	per	per	NN
25944	308	10	cent	cent	NN
25944	308	11	.	.	.
25944	309	1	lanolin	lanolin	NNP
25944	309	2	,	,	,
25944	309	3	is	be	VBZ
25944	309	4	usually	usually	RB
25944	309	5	the	the	DT
25944	309	6	most	most	RBS
25944	309	7	satisfactory	satisfactory	JJ
25944	309	8	base	base	NN
25944	309	9	for	for	IN
25944	309	10	the	the	DT
25944	309	11	ointments	ointment	NNS
25944	309	12	.	.	.
25944	310	1	In	in	IN
25944	310	2	some	some	DT
25944	310	3	cases	case	NNS
25944	310	4	of	of	IN
25944	310	5	the	the	DT
25944	310	6	inflammatory	inflammatory	JJ
25944	310	7	variety	variety	NN
25944	310	8	the	the	DT
25944	310	9	skin	skin	NN
25944	310	10	is	be	VBZ
25944	310	11	found	find	VBN
25944	310	12	quite	quite	RB
25944	310	13	irritable	irritable	JJ
25944	310	14	,	,	,
25944	310	15	and	and	CC
25944	310	16	the	the	DT
25944	310	17	mildest	mild	JJS
25944	310	18	applications	application	NNS
25944	310	19	are	be	VBP
25944	310	20	at	at	IN
25944	310	21	first	first	JJ
25944	310	22	only	only	RB
25944	310	23	admissible	admissible	JJ
25944	310	24	.	.	.
25944	311	1	#	#	NNP
25944	311	2	How	how	WRB
25944	311	3	are	be	VBP
25944	311	4	the	the	DT
25944	311	5	remedies	remedy	NNS
25944	311	6	to	to	TO
25944	311	7	be	be	VB
25944	311	8	applied	apply	VBN
25944	311	9	?	?	.
25944	311	10	#	#	$
25944	311	11	A	a	DT
25944	311	12	small	small	JJ
25944	311	13	quantity	quantity	NN
25944	311	14	of	of	IN
25944	311	15	the	the	DT
25944	311	16	lotion	lotion	NN
25944	311	17	,	,	,
25944	311	18	ointment	ointment	NN
25944	311	19	,	,	,
25944	311	20	or	or	CC
25944	311	21	oil	oil	NN
25944	311	22	is	be	VBZ
25944	311	23	gently	gently	RB
25944	311	24	applied	apply	VBN
25944	311	25	to	to	IN
25944	311	26	the	the	DT
25944	311	27	skin	skin	NN
25944	311	28	;	;	:
25944	311	29	when	when	WRB
25944	311	30	to	to	IN
25944	311	31	the	the	DT
25944	311	32	scalp	scalp	NN
25944	311	33	,	,	,
25944	311	34	a	a	DT
25944	311	35	lotion	lotion	NN
25944	311	36	or	or	CC
25944	311	37	oil	oil	NN
25944	311	38	can	can	MD
25944	311	39	be	be	VB
25944	311	40	conveniently	conveniently	RB
25944	311	41	applied	apply	VBN
25944	311	42	by	by	IN
25944	311	43	means	mean	NNS
25944	311	44	of	of	IN
25944	311	45	an	an	DT
25944	311	46	eye	eye	NN
25944	311	47	-	-	HYPH
25944	311	48	dropper	dropper	NN
25944	311	49	.	.	.
25944	312	1	In	in	IN
25944	312	2	the	the	DT
25944	312	3	beginning	beginning	NN
25944	312	4	of	of	IN
25944	312	5	the	the	DT
25944	312	6	treatment	treatment	NN
25944	312	7	an	an	DT
25944	312	8	application	application	NN
25944	312	9	once	once	RB
25944	312	10	or	or	CC
25944	312	11	twice	twice	RB
25944	312	12	daily	daily	JJ
25944	312	13	is	be	VBZ
25944	312	14	ordered	order	VBN
25944	312	15	;	;	:
25944	312	16	later	later	RB
25944	312	17	,	,	,
25944	312	18	as	as	IN
25944	312	19	the	the	DT
25944	312	20	disease	disease	NN
25944	312	21	becomes	become	VBZ
25944	312	22	less	less	RBR
25944	312	23	active	active	JJ
25944	312	24	,	,	,
25944	312	25	once	once	RB
25944	312	26	every	every	DT
25944	312	27	second	second	JJ
25944	312	28	or	or	CC
25944	312	29	third	third	JJ
25944	312	30	day	day	NN
25944	312	31	.	.	.
25944	313	1	#	#	NNP
25944	313	2	How	how	WRB
25944	313	3	is	be	VBZ
25944	313	4	seborrh[oe]a	seborrh[oe]a	NNP
25944	313	5	upon	upon	IN
25944	313	6	other	other	JJ
25944	313	7	parts	part	NNS
25944	313	8	to	to	TO
25944	313	9	be	be	VB
25944	313	10	treated	treat	VBN
25944	313	11	?	?	.
25944	313	12	#	#	NN
25944	313	13	In	in	IN
25944	313	14	the	the	DT
25944	313	15	same	same	JJ
25944	313	16	general	general	JJ
25944	313	17	manner	manner	NN
25944	313	18	as	as	IN
25944	313	19	seborrh[oe]a	seborrh[oe]a	NNP
25944	313	20	of	of	IN
25944	313	21	the	the	DT
25944	313	22	scalp	scalp	NN
25944	313	23	,	,	,
25944	313	24	except	except	IN
25944	313	25	that	that	IN
25944	313	26	the	the	DT
25944	313	27	local	local	JJ
25944	313	28	applications	application	NNS
25944	313	29	must	must	MD
25944	313	30	be	be	VB
25944	313	31	somewhat	somewhat	RB
25944	313	32	weaker	weak	JJR
25944	313	33	.	.	.
25944	314	1	The	the	DT
25944	314	2	several	several	JJ
25944	314	3	sulphur	sulphur	NN
25944	314	4	lotions	lotion	NNS
25944	314	5	employed	employ	VBN
25944	314	6	in	in	IN
25944	314	7	the	the	DT
25944	314	8	treatment	treatment	NN
25944	314	9	of	of	IN
25944	314	10	acne	acne	NNP
25944	314	11	(	(	-LRB-
25944	314	12	_	_	NNP
25944	314	13	q	q	NNP
25944	314	14	.	.	.
25944	315	1	v.	v.	NNP
25944	315	2	_	_	NNP
25944	315	3	)	)	-RRB-
25944	315	4	may	may	MD
25944	315	5	also	also	RB
25944	315	6	be	be	VB
25944	315	7	used	use	VBN
25944	315	8	when	when	WRB
25944	315	9	the	the	DT
25944	315	10	disease	disease	NN
25944	315	11	is	be	VBZ
25944	315	12	upon	upon	IN
25944	315	13	these	these	DT
25944	315	14	parts	part	NNS
25944	315	15	.	.	.
25944	316	1	In	in	IN
25944	316	2	obstinate	obstinate	JJ
25944	316	3	patchy	patchy	NN
25944	316	4	cases	case	NNS
25944	316	5	occasional	occasional	JJ
25944	316	6	paintings	painting	NNS
25944	316	7	with	with	IN
25944	316	8	a	a	DT
25944	316	9	20	20	CD
25944	316	10	to	to	TO
25944	316	11	50	50	CD
25944	316	12	per	per	IN
25944	316	13	cent	cent	NN
25944	316	14	alcoholic	alcoholic	JJ
25944	316	15	solution	solution	NN
25944	316	16	of	of	IN
25944	316	17	resorcin	resorcin	NNS
25944	316	18	is	be	VBZ
25944	316	19	curative	curative	JJ
25944	316	20	;	;	:
25944	316	21	following	follow	VBG
25944	316	22	the	the	DT
25944	316	23	painting	painting	NN
25944	316	24	a	a	DT
25944	316	25	mild	mild	JJ
25944	316	26	salve	salve	NN
25944	316	27	should	should	MD
25944	316	28	be	be	VB
25944	316	29	used	use	VBN
25944	316	30	.	.	.
25944	317	1	#	#	NNP
25944	317	2	Comedo	Comedo	NNP
25944	317	3	.	.	.
25944	317	4	#	#	NNP
25944	317	5	(	(	-LRB-
25944	317	6	_	_	NNP
25944	317	7	Synonyms	Synonyms	NNP
25944	317	8	:	:	:
25944	317	9	_	_	NNP
25944	317	10	Blackheads	Blackheads	NNP
25944	317	11	;	;	:
25944	317	12	Flesh	Flesh	NNP
25944	317	13	-	-	HYPH
25944	317	14	worms	worm	NNS
25944	317	15	.	.	.
25944	317	16	)	)	-RRB-
25944	318	1	#	#	LS
25944	318	2	What	what	WP
25944	318	3	is	be	VBZ
25944	318	4	comedo	comedo	NN
25944	318	5	?	?	.
25944	318	6	#	#	NNP
25944	318	7	Comedo	Comedo	NNP
25944	318	8	is	be	VBZ
25944	318	9	a	a	DT
25944	318	10	disorder	disorder	NN
25944	318	11	of	of	IN
25944	318	12	the	the	DT
25944	318	13	sebaceous	sebaceous	JJ
25944	318	14	glands	gland	NNS
25944	318	15	,	,	,
25944	318	16	characterized	characterize	VBN
25944	318	17	by	by	IN
25944	318	18	yellowish	yellowish	JJ
25944	318	19	or	or	CC
25944	318	20	blackish	blackish	VB
25944	318	21	pin	pin	NN
25944	318	22	-	-	HYPH
25944	318	23	point	point	NN
25944	318	24	or	or	CC
25944	318	25	pin	pin	NN
25944	318	26	-	-	HYPH
25944	318	27	head	head	NN
25944	318	28	-	-	HYPH
25944	318	29	sized	sized	JJ
25944	318	30	puncta	puncta	NN
25944	318	31	or	or	CC
25944	318	32	elevations	elevation	NNS
25944	318	33	corresponding	correspond	VBG
25944	318	34	to	to	IN
25944	318	35	the	the	DT
25944	318	36	gland	gland	NN
25944	318	37	-	-	HYPH
25944	318	38	orifices	orifice	NNS
25944	318	39	.	.	.
25944	319	1	#	#	$
25944	319	2	At	at	IN
25944	319	3	what	what	WDT
25944	319	4	age	age	NN
25944	319	5	and	and	CC
25944	319	6	upon	upon	IN
25944	319	7	what	what	WP
25944	319	8	parts	part	NNS
25944	319	9	are	be	VBP
25944	319	10	comedones	comedo	NNS
25944	319	11	found	find	VBN
25944	319	12	?	?	.
25944	319	13	#	#	NN
25944	319	14	Usually	usually	RB
25944	319	15	between	between	IN
25944	319	16	fifteen	fifteen	CD
25944	319	17	and	and	CC
25944	319	18	thirty	thirty	CD
25944	319	19	,	,	,
25944	319	20	and	and	CC
25944	319	21	upon	upon	IN
25944	319	22	the	the	DT
25944	319	23	face	face	NN
25944	319	24	and	and	CC
25944	319	25	upper	upper	JJ
25944	319	26	part	part	NN
25944	319	27	of	of	IN
25944	319	28	the	the	DT
25944	319	29	trunk	trunk	NN
25944	319	30	,	,	,
25944	319	31	where	where	WRB
25944	319	32	they	-PRON-	PRP
25944	319	33	may	may	MD
25944	319	34	exist	exist	VB
25944	319	35	sparsely	sparsely	RB
25944	319	36	or	or	CC
25944	319	37	in	in	IN
25944	319	38	great	great	JJ
25944	319	39	numbers	number	NNS
25944	319	40	.	.	.
25944	320	1	They	-PRON-	PRP
25944	320	2	are	be	VBP
25944	320	3	occasionally	occasionally	RB
25944	320	4	associated	associate	VBN
25944	320	5	with	with	IN
25944	320	6	oily	oily	JJ
25944	320	7	seborrh[oe]a	seborrh[oe]a	NNP
25944	320	8	,	,	,
25944	320	9	the	the	DT
25944	320	10	parts	part	NNS
25944	320	11	presenting	present	VBG
25944	320	12	a	a	DT
25944	320	13	greasy	greasy	NN
25944	320	14	or	or	CC
25944	320	15	soiled	soil	VBN
25944	320	16	appearance	appearance	NN
25944	320	17	.	.	.
25944	321	1	Exceptionally	exceptionally	RB
25944	321	2	they	-PRON-	PRP
25944	321	3	occur	occur	VBP
25944	321	4	as	as	RB
25944	321	5	distinct	distinct	JJ
25944	321	6	,	,	,
25944	321	7	and	and	CC
25944	321	8	usually	usually	RB
25944	321	9	symmetrical	symmetrical	JJ
25944	321	10	,	,	,
25944	321	11	groups	group	NNS
25944	321	12	upon	upon	IN
25944	321	13	the	the	DT
25944	321	14	forehead	forehead	NN
25944	321	15	or	or	CC
25944	321	16	the	the	DT
25944	321	17	cheeks	cheek	NNS
25944	321	18	.	.	.
25944	322	1	On	on	IN
25944	322	2	the	the	DT
25944	322	3	upper	upper	JJ
25944	322	4	trunk	trunk	NN
25944	322	5	so	so	RB
25944	322	6	-	-	HYPH
25944	322	7	called	call	VBN
25944	322	8	double	double	JJ
25944	322	9	and	and	CC
25944	322	10	multiple	multiple	JJ
25944	322	11	comedo	comedo	NNS
25944	322	12	have	have	VBP
25944	322	13	been	be	VBN
25944	322	14	noted	note	VBN
25944	322	15	--	--	:
25944	322	16	the	the	DT
25944	322	17	two	two	CD
25944	322	18	,	,	,
25944	322	19	three	three	CD
25944	322	20	,	,	,
25944	322	21	or	or	CC
25944	322	22	even	even	RB
25944	322	23	four	four	CD
25944	322	24	closely	closely	RB
25944	322	25	-	-	HYPH
25944	322	26	contiguous	contiguous	JJ
25944	322	27	blackheads	blackhead	NNS
25944	322	28	are	be	VBP
25944	322	29	,	,	,
25944	322	30	beneath	beneath	IN
25944	322	31	the	the	DT
25944	322	32	surface	surface	NN
25944	322	33	,	,	,
25944	322	34	intercommunicable	intercommunicable	JJ
25944	322	35	,	,	,
25944	322	36	the	the	DT
25944	322	37	dividing	divide	VBG
25944	322	38	duct	duct	NN
25944	322	39	-	-	HYPH
25944	322	40	walls	wall	NNS
25944	322	41	having	have	VBG
25944	322	42	apparently	apparently	RB
25944	322	43	disappeared	disappear	VBN
25944	322	44	by	by	IN
25944	322	45	fusion	fusion	NN
25944	322	46	.	.	.
25944	323	1	#	#	NNP
25944	323	2	Describe	describe	VB
25944	323	3	an	an	DT
25944	323	4	individual	individual	JJ
25944	323	5	lesion	lesion	NN
25944	323	6	.	.	.
25944	323	7	#	#	$
25944	323	8	It	-PRON-	PRP
25944	323	9	is	be	VBZ
25944	323	10	pin	pin	NN
25944	323	11	-	-	HYPH
25944	323	12	point	point	NN
25944	323	13	to	to	IN
25944	323	14	pin	pin	NN
25944	323	15	-	-	HYPH
25944	323	16	head	head	NN
25944	323	17	in	in	IN
25944	323	18	size	size	NN
25944	323	19	,	,	,
25944	323	20	dark	dark	JJ
25944	323	21	yellowish	yellowish	NN
25944	323	22	,	,	,
25944	323	23	and	and	CC
25944	323	24	usually	usually	RB
25944	323	25	with	with	IN
25944	323	26	a	a	DT
25944	323	27	central	central	JJ
25944	323	28	blackish	blackish	JJ
25944	323	29	point	point	NN
25944	323	30	(	(	-LRB-
25944	323	31	hence	hence	RB
25944	323	32	the	the	DT
25944	323	33	name	name	NN
25944	323	34	_	_	NNP
25944	323	35	blackheads	blackhead	VBZ
25944	323	36	_	_	NNP
25944	323	37	)	)	-RRB-
25944	323	38	.	.	.
25944	324	1	There	there	EX
25944	324	2	is	be	VBZ
25944	324	3	scarcely	scarcely	RB
25944	324	4	perceptible	perceptible	JJ
25944	324	5	elevation	elevation	NN
25944	324	6	,	,	,
25944	324	7	unless	unless	IN
25944	324	8	the	the	DT
25944	324	9	amount	amount	NN
25944	324	10	of	of	IN
25944	324	11	retained	retain	VBN
25944	324	12	secretion	secretion	NN
25944	324	13	is	be	VBZ
25944	324	14	excessive	excessive	JJ
25944	324	15	.	.	.
25944	325	1	Upon	upon	IN
25944	325	2	pressure	pressure	NN
25944	325	3	this	this	DT
25944	325	4	may	may	MD
25944	325	5	be	be	VB
25944	325	6	ejected	eject	VBN
25944	325	7	,	,	,
25944	325	8	the	the	DT
25944	325	9	small	small	JJ
25944	325	10	,	,	,
25944	325	11	rounded	rounded	JJ
25944	325	12	orifice	orifice	NN
25944	325	13	through	through	IN
25944	325	14	which	which	WDT
25944	325	15	it	-PRON-	PRP
25944	325	16	is	be	VBZ
25944	325	17	expressed	express	VBN
25944	325	18	giving	give	VBG
25944	325	19	it	-PRON-	PRP
25944	325	20	a	a	DT
25944	325	21	thread	thread	NN
25944	325	22	-	-	HYPH
25944	325	23	like	like	JJ
25944	325	24	shape	shape	NN
25944	325	25	(	(	-LRB-
25944	325	26	hence	hence	RB
25944	325	27	the	the	DT
25944	325	28	name	name	NN
25944	325	29	_	_	NNP
25944	325	30	flesh	flesh	NN
25944	325	31	-	-	HYPH
25944	325	32	worms	worm	NNS
25944	325	33	_	_	NNP
25944	325	34	)	)	-RRB-
25944	325	35	.	.	.
25944	326	1	#	#	LS
25944	326	2	What	what	WP
25944	326	3	is	be	VBZ
25944	326	4	the	the	DT
25944	326	5	usual	usual	JJ
25944	326	6	course	course	NN
25944	326	7	of	of	IN
25944	326	8	comedo	comedo	NN
25944	326	9	?	?	.
25944	326	10	#	#	NN
25944	326	11	Chronic	chronic	JJ
25944	326	12	.	.	.
25944	327	1	The	the	DT
25944	327	2	lesions	lesion	NNS
25944	327	3	may	may	MD
25944	327	4	persist	persist	VB
25944	327	5	indefinitely	indefinitely	RB
25944	327	6	or	or	CC
25944	327	7	the	the	DT
25944	327	8	condition	condition	NN
25944	327	9	may	may	MD
25944	327	10	be	be	VB
25944	327	11	somewhat	somewhat	RB
25944	327	12	variable	variable	JJ
25944	327	13	.	.	.
25944	328	1	In	in	IN
25944	328	2	many	many	JJ
25944	328	3	instances	instance	NNS
25944	328	4	,	,	,
25944	328	5	either	either	CC
25944	328	6	as	as	IN
25944	328	7	a	a	DT
25944	328	8	result	result	NN
25944	328	9	of	of	IN
25944	328	10	pressure	pressure	NN
25944	328	11	or	or	CC
25944	328	12	in	in	IN
25944	328	13	consequence	consequence	NN
25944	328	14	of	of	IN
25944	328	15	chemical	chemical	NN
25944	328	16	change	change	NN
25944	328	17	in	in	IN
25944	328	18	the	the	DT
25944	328	19	sebaceous	sebaceous	JJ
25944	328	20	plugs	plug	NNS
25944	328	21	or	or	CC
25944	328	22	of	of	IN
25944	328	23	the	the	DT
25944	328	24	addition	addition	NN
25944	328	25	of	of	IN
25944	328	26	a	a	DT
25944	328	27	microbic	microbic	JJ
25944	328	28	factor	factor	NN
25944	328	29	,	,	,
25944	328	30	inflammation	inflammation	NN
25944	328	31	is	be	VBZ
25944	328	32	excited	excited	JJ
25944	328	33	and	and	CC
25944	328	34	acne	acne	JJ
25944	328	35	results	result	NNS
25944	328	36	.	.	.
25944	329	1	The	the	DT
25944	329	2	two	two	CD
25944	329	3	conditions	condition	NNS
25944	329	4	are	be	VBP
25944	329	5	,	,	,
25944	329	6	in	in	IN
25944	329	7	fact	fact	NN
25944	329	8	,	,	,
25944	329	9	usually	usually	RB
25944	329	10	associated	associate	VBN
25944	329	11	.	.	.
25944	330	1	[	[	-LRB-
25944	330	2	Illustration	illustration	NN
25944	330	3	:	:	:
25944	330	4	Fig	Fig	NNP
25944	330	5	.	.	.
25944	331	1	8	8	LS
25944	331	2	.	.	.
25944	332	1	Demodex	Demodex	NNP
25944	332	2	Folliculorum	Folliculorum	NNP
25944	332	3	,	,	,
25944	332	4	X	X	NNP
25944	332	5	300	300	CD
25944	332	6	.	.	.
25944	333	1	Ventral	ventral	JJ
25944	333	2	surface	surface	NN
25944	333	3	.	.	.
25944	334	1	(	(	-LRB-
25944	334	2	_	_	NNP
25944	334	3	After	after	IN
25944	334	4	Simon	Simon	NNP
25944	334	5	.	.	.
25944	334	6	_	_	NNP
25944	334	7	)	)	-RRB-
25944	334	8	]	]	-RRB-
25944	334	9	#	#	$
25944	334	10	To	to	IN
25944	334	11	what	what	WP
25944	334	12	may	may	MD
25944	334	13	comedo	comedo	VB
25944	334	14	often	often	RB
25944	334	15	be	be	VB
25944	334	16	ascribed	ascribe	VBN
25944	334	17	?	?	.
25944	334	18	#	#	NN
25944	334	19	To	to	IN
25944	334	20	disorders	disorder	NNS
25944	334	21	of	of	IN
25944	334	22	digestion	digestion	NN
25944	334	23	,	,	,
25944	334	24	constipation	constipation	NN
25944	334	25	,	,	,
25944	334	26	chlorosis	chlorosis	NN
25944	334	27	,	,	,
25944	334	28	menstrual	menstrual	JJ
25944	334	29	disturbance	disturbance	NN
25944	334	30	,	,	,
25944	334	31	lack	lack	NN
25944	334	32	of	of	IN
25944	334	33	tone	tone	NN
25944	334	34	in	in	IN
25944	334	35	the	the	DT
25944	334	36	muscular	muscular	JJ
25944	334	37	fibres	fibre	NNS
25944	334	38	of	of	IN
25944	334	39	the	the	DT
25944	334	40	skin	skin	NN
25944	334	41	,	,	,
25944	334	42	the	the	DT
25944	334	43	infrequent	infrequent	JJ
25944	334	44	use	use	NN
25944	334	45	of	of	IN
25944	334	46	soap	soap	NN
25944	334	47	,	,	,
25944	334	48	and	and	CC
25944	334	49	working	work	VBG
25944	334	50	in	in	IN
25944	334	51	a	a	DT
25944	334	52	dirty	dirty	JJ
25944	334	53	or	or	CC
25944	334	54	dusty	dusty	JJ
25944	334	55	atmosphere	atmosphere	NN
25944	334	56	.	.	.
25944	335	1	A	a	DT
25944	335	2	small	small	JJ
25944	335	3	parasite	parasite	NN
25944	335	4	(	(	-LRB-
25944	335	5	_	_	NNP
25944	335	6	demodex	demodex	NN
25944	335	7	folliculorum	folliculorum	NN
25944	335	8	_	_	NNP
25944	335	9	,	,	,
25944	335	10	_	_	NNP
25944	335	11	acarus	acarus	NNP
25944	335	12	folliculorum	folliculorum	NNP
25944	335	13	_	_	NNP
25944	335	14	)	)	-RRB-
25944	335	15	is	be	VBZ
25944	335	16	sometimes	sometimes	RB
25944	335	17	found	find	VBN
25944	335	18	in	in	IN
25944	335	19	the	the	DT
25944	335	20	sebaceous	sebaceous	JJ
25944	335	21	mass	mass	NN
25944	335	22	,	,	,
25944	335	23	but	but	CC
25944	335	24	its	-PRON-	PRP$
25944	335	25	presence	presence	NN
25944	335	26	is	be	VBZ
25944	335	27	without	without	IN
25944	335	28	etiological	etiological	JJ
25944	335	29	significance	significance	NN
25944	335	30	,	,	,
25944	335	31	as	as	IN
25944	335	32	it	-PRON-	PRP
25944	335	33	is	be	VBZ
25944	335	34	also	also	RB
25944	335	35	found	find	VBN
25944	335	36	in	in	IN
25944	335	37	healthy	healthy	JJ
25944	335	38	follicles	follicle	NNS
25944	335	39	.	.	.
25944	336	1	A	a	DT
25944	336	2	microbacillus	microbacillus	NN
25944	336	3	has	have	VBZ
25944	336	4	been	be	VBN
25944	336	5	found	find	VBN
25944	336	6	by	by	IN
25944	336	7	several	several	JJ
25944	336	8	observers	observer	NNS
25944	336	9	,	,	,
25944	336	10	and	and	CC
25944	336	11	credited	credit	VBN
25944	336	12	with	with	IN
25944	336	13	etiological	etiological	JJ
25944	336	14	influence	influence	NN
25944	336	15	.	.	.
25944	337	1	#	#	LS
25944	337	2	What	what	WP
25944	337	3	is	be	VBZ
25944	337	4	the	the	DT
25944	337	5	pathology	pathology	NN
25944	337	6	of	of	IN
25944	337	7	comedo	comedo	NN
25944	337	8	?	?	.
25944	337	9	#	#	$
25944	337	10	The	the	DT
25944	337	11	sebaceous	sebaceous	JJ
25944	337	12	ducts	duct	NNS
25944	337	13	or	or	CC
25944	337	14	glands	gland	NNS
25944	337	15	,	,	,
25944	337	16	or	or	CC
25944	337	17	both	both	DT
25944	337	18	,	,	,
25944	337	19	become	become	VBN
25944	337	20	blocked	block	VBN
25944	337	21	up	up	RP
25944	337	22	with	with	IN
25944	337	23	retained	retained	JJ
25944	337	24	secretion	secretion	NN
25944	337	25	and	and	CC
25944	337	26	epithelial	epithelial	JJ
25944	337	27	cells	cell	NNS
25944	337	28	.	.	.
25944	338	1	The	the	DT
25944	338	2	dark	dark	JJ
25944	338	3	points	point	NNS
25944	338	4	which	which	WDT
25944	338	5	usually	usually	RB
25944	338	6	mark	mark	VBP
25944	338	7	the	the	DT
25944	338	8	lesions	lesion	NNS
25944	338	9	are	be	VBP
25944	338	10	probably	probably	RB
25944	338	11	due	due	JJ
25944	338	12	to	to	IN
25944	338	13	accumulation	accumulation	NN
25944	338	14	of	of	IN
25944	338	15	dirt	dirt	NN
25944	338	16	,	,	,
25944	338	17	but	but	CC
25944	338	18	may	may	MD
25944	338	19	,	,	,
25944	338	20	as	as	IN
25944	338	21	some	some	DT
25944	338	22	writers	writer	NNS
25944	338	23	maintain	maintain	VBP
25944	338	24	,	,	,
25944	338	25	be	be	VB
25944	338	26	due	due	IN
25944	338	27	to	to	IN
25944	338	28	the	the	DT
25944	338	29	presence	presence	NN
25944	338	30	of	of	IN
25944	338	31	pigment	pigment	NN
25944	338	32	-	-	HYPH
25944	338	33	granules	granule	NNS
25944	338	34	resulting	result	VBG
25944	338	35	from	from	IN
25944	338	36	chemical	chemical	JJ
25944	338	37	change	change	NN
25944	338	38	in	in	IN
25944	338	39	the	the	DT
25944	338	40	sebaceous	sebaceous	JJ
25944	338	41	matter	matter	NN
25944	338	42	.	.	.
25944	339	1	#	#	$
25944	339	2	Is	be	VBZ
25944	339	3	there	there	EX
25944	339	4	any	any	DT
25944	339	5	difficulty	difficulty	NN
25944	339	6	in	in	IN
25944	339	7	the	the	DT
25944	339	8	diagnosis	diagnosis	NN
25944	339	9	of	of	IN
25944	339	10	comedo	comedo	NNP
25944	339	11	?	?	.
25944	339	12	#	#	NN
25944	339	13	No	no	UH
25944	339	14	.	.	.
25944	340	1	It	-PRON-	PRP
25944	340	2	can	can	MD
25944	340	3	scarcely	scarcely	RB
25944	340	4	be	be	VB
25944	340	5	confounded	confound	VBN
25944	340	6	with	with	IN
25944	340	7	milium	milium	NN
25944	340	8	,	,	,
25944	340	9	as	as	IN
25944	340	10	in	in	IN
25944	340	11	this	this	DT
25944	340	12	latter	latter	JJ
25944	340	13	disease	disease	NN
25944	340	14	the	the	DT
25944	340	15	lesion	lesion	NN
25944	340	16	has	have	VBZ
25944	340	17	no	no	DT
25944	340	18	open	open	JJ
25944	340	19	outlet	outlet	NN
25944	340	20	,	,	,
25944	340	21	no	no	DT
25944	340	22	black	black	JJ
25944	340	23	point	point	NN
25944	340	24	,	,	,
25944	340	25	and	and	CC
25944	340	26	the	the	DT
25944	340	27	contents	content	NNS
25944	340	28	can	can	MD
25944	340	29	not	not	RB
25944	340	30	be	be	VB
25944	340	31	squeezed	squeeze	VBN
25944	340	32	out	out	RP
25944	340	33	.	.	.
25944	341	1	#	#	NN
25944	341	2	Give	give	VB
25944	341	3	the	the	DT
25944	341	4	prognosis	prognosis	NN
25944	341	5	of	of	IN
25944	341	6	comedo	comedo	NN
25944	341	7	.	.	.
25944	341	8	#	#	$
25944	341	9	The	the	DT
25944	341	10	result	result	NN
25944	341	11	of	of	IN
25944	341	12	treatment	treatment	NN
25944	341	13	is	be	VBZ
25944	341	14	usually	usually	RB
25944	341	15	favorable	favorable	JJ
25944	341	16	,	,	,
25944	341	17	although	although	IN
25944	341	18	the	the	DT
25944	341	19	disease	disease	NN
25944	341	20	is	be	VBZ
25944	341	21	often	often	RB
25944	341	22	rebellious	rebellious	JJ
25944	341	23	.	.	.
25944	342	1	Relapses	relapse	NNS
25944	342	2	are	be	VBP
25944	342	3	not	not	RB
25944	342	4	uncommon	uncommon	JJ
25944	342	5	.	.	.
25944	343	1	#	#	NNP
25944	343	2	How	how	WRB
25944	343	3	would	would	MD
25944	343	4	you	-PRON-	PRP
25944	343	5	treat	treat	VB
25944	343	6	a	a	DT
25944	343	7	case	case	NN
25944	343	8	of	of	IN
25944	343	9	comedo	comedo	NN
25944	343	10	?	?	.
25944	343	11	#	#	NN
25944	343	12	By	by	IN
25944	343	13	systemic	systemic	NN
25944	343	14	(	(	-LRB-
25944	343	15	if	if	IN
25944	343	16	indicated	indicate	VBN
25944	343	17	)	)	-RRB-
25944	343	18	and	and	CC
25944	343	19	local	local	JJ
25944	343	20	measures	measure	NNS
25944	343	21	.	.	.
25944	344	1	The	the	DT
25944	344	2	constitutional	constitutional	JJ
25944	344	3	treatment	treatment	NN
25944	344	4	aims	aim	VBZ
25944	344	5	at	at	IN
25944	344	6	correction	correction	NN
25944	344	7	or	or	CC
25944	344	8	palliation	palliation	NN
25944	344	9	of	of	IN
25944	344	10	the	the	DT
25944	344	11	predisposing	predisposing	NN
25944	344	12	conditions	condition	NNS
25944	344	13	,	,	,
25944	344	14	and	and	CC
25944	344	15	the	the	DT
25944	344	16	external	external	JJ
25944	344	17	applications	application	NNS
25944	344	18	have	have	VBP
25944	344	19	in	in	IN
25944	344	20	view	view	NN
25944	344	21	a	a	DT
25944	344	22	removal	removal	NN
25944	344	23	of	of	IN
25944	344	24	the	the	DT
25944	344	25	sebaceous	sebaceous	JJ
25944	344	26	plugs	plug	NNS
25944	344	27	and	and	CC
25944	344	28	stimulation	stimulation	NN
25944	344	29	of	of	IN
25944	344	30	the	the	DT
25944	344	31	glands	gland	NNS
25944	344	32	and	and	CC
25944	344	33	skin	skin	NN
25944	344	34	to	to	TO
25944	344	35	healthy	healthy	JJ
25944	344	36	action	action	NN
25944	344	37	.	.	.
25944	345	1	[	[	-LRB-
25944	345	2	Illustration	illustration	NN
25944	345	3	:	:	:
25944	345	4	Fig	Fig	NNP
25944	345	5	.	.	.
25944	346	1	9	9	CD
25944	346	2	.	.	.
25944	347	1	Comedo	Comedo	NNP
25944	347	2	Extractor	Extractor	NNP
25944	347	3	.	.	.
25944	347	4	]	]	-RRB-
25944	348	1	#	#	JJR
25944	348	2	Name	name	VB
25944	348	3	the	the	DT
25944	348	4	systemic	systemic	JJ
25944	348	5	remedies	remedy	NNS
25944	348	6	commonly	commonly	RB
25944	348	7	employed	employ	VBN
25944	348	8	.	.	.
25944	348	9	#	#	NNP
25944	348	10	Cod	cod	NN
25944	348	11	-	-	HYPH
25944	348	12	liver	liver	NN
25944	348	13	oil	oil	NN
25944	348	14	,	,	,
25944	348	15	iron	iron	NN
25944	348	16	,	,	,
25944	348	17	quinine	quinine	JJ
25944	348	18	,	,	,
25944	348	19	arsenic	arsenic	JJ
25944	348	20	,	,	,
25944	348	21	nux	nux	NN
25944	348	22	vomica	vomica	NNP
25944	348	23	and	and	CC
25944	348	24	other	other	JJ
25944	348	25	tonics	tonic	NNS
25944	348	26	;	;	,
25944	348	27	ergot	ergot	JJ
25944	348	28	in	in	IN
25944	348	29	those	those	DT
25944	348	30	cases	case	NNS
25944	348	31	in	in	IN
25944	348	32	which	which	WDT
25944	348	33	there	there	EX
25944	348	34	is	be	VBZ
25944	348	35	lack	lack	NN
25944	348	36	of	of	IN
25944	348	37	muscular	muscular	JJ
25944	348	38	tone	tone	NN
25944	348	39	,	,	,
25944	348	40	salines	saline	NNS
25944	348	41	and	and	CC
25944	348	42	aperient	aperient	NN
25944	348	43	pills	pill	NNS
25944	348	44	in	in	IN
25944	348	45	constipation	constipation	NN
25944	348	46	.	.	.
25944	349	1	The	the	DT
25944	349	2	digestion	digestion	NN
25944	349	3	is	be	VBZ
25944	349	4	to	to	TO
25944	349	5	be	be	VB
25944	349	6	looked	look	VBN
25944	349	7	after	after	IN
25944	349	8	and	and	CC
25944	349	9	the	the	DT
25944	349	10	bowels	bowel	NNS
25944	349	11	kept	keep	VBN
25944	349	12	regular	regular	JJ
25944	349	13	;	;	:
25944	349	14	indigestible	indigestible	JJ
25944	349	15	food	food	NN
25944	349	16	of	of	IN
25944	349	17	all	all	DT
25944	349	18	kinds	kind	NNS
25944	349	19	is	be	VBZ
25944	349	20	to	to	TO
25944	349	21	be	be	VB
25944	349	22	interdicted	interdict	VBN
25944	349	23	.	.	.
25944	350	1	Hygienic	hygienic	JJ
25944	350	2	measures	measure	NNS
25944	350	3	,	,	,
25944	350	4	such	such	JJ
25944	350	5	as	as	IN
25944	350	6	general	general	JJ
25944	350	7	and	and	CC
25944	350	8	local	local	JJ
25944	350	9	bathing	bathing	NN
25944	350	10	,	,	,
25944	350	11	local	local	JJ
25944	350	12	massage	massage	NN
25944	350	13	,	,	,
25944	350	14	calisthenics	calisthenic	NNS
25944	350	15	,	,	,
25944	350	16	and	and	CC
25944	350	17	open	open	JJ
25944	350	18	-	-	HYPH
25944	350	19	air	air	NN
25944	350	20	exercise	exercise	NN
25944	350	21	,	,	,
25944	350	22	are	be	VBP
25944	350	23	of	of	IN
25944	350	24	service	service	NN
25944	350	25	.	.	.
25944	351	1	#	#	NNP
25944	351	2	Describe	describe	VB
25944	351	3	the	the	DT
25944	351	4	local	local	JJ
25944	351	5	treatment	treatment	NN
25944	351	6	.	.	.
25944	351	7	#	#	LS
25944	351	8	Steaming	steam	VBG
25944	351	9	the	the	DT
25944	351	10	face	face	NN
25944	351	11	or	or	CC
25944	351	12	prolonged	prolonged	JJ
25944	351	13	applications	application	NNS
25944	351	14	of	of	IN
25944	351	15	hot	hot	JJ
25944	351	16	water	water	NN
25944	351	17	;	;	:
25944	351	18	washing	wash	VBG
25944	351	19	with	with	IN
25944	351	20	ordinary	ordinary	JJ
25944	351	21	toilet	toilet	NN
25944	351	22	soap	soap	NN
25944	351	23	and	and	CC
25944	351	24	hot	hot	JJ
25944	351	25	water	water	NN
25944	351	26	,	,	,
25944	351	27	or	or	CC
25944	351	28	,	,	,
25944	351	29	in	in	IN
25944	351	30	sluggish	sluggish	JJ
25944	351	31	cases	case	NNS
25944	351	32	,	,	,
25944	351	33	using	use	VBG
25944	351	34	tincture	tincture	NN
25944	351	35	of	of	IN
25944	351	36	green	green	JJ
25944	351	37	soap	soap	NN
25944	351	38	(	(	-LRB-
25944	351	39	tinct	tinct	FW
25944	351	40	.	.	.
25944	352	1	saponis	saponis	NNP
25944	352	2	viridis	viridis	NNP
25944	352	3	)	)	-RRB-
25944	352	4	instead	instead	RB
25944	352	5	of	of	IN
25944	352	6	the	the	DT
25944	352	7	toilet	toilet	NN
25944	352	8	soap	soap	NN
25944	352	9	;	;	:
25944	352	10	removal	removal	NN
25944	352	11	of	of	IN
25944	352	12	the	the	DT
25944	352	13	sebaceous	sebaceous	JJ
25944	352	14	plugs	plug	NNS
25944	352	15	by	by	IN
25944	352	16	mechanical	mechanical	JJ
25944	352	17	means	mean	NNS
25944	352	18	,	,	,
25944	352	19	such	such	JJ
25944	352	20	as	as	IN
25944	352	21	lateral	lateral	JJ
25944	352	22	pressure	pressure	NN
25944	352	23	with	with	IN
25944	352	24	the	the	DT
25944	352	25	finger	finger	NN
25944	352	26	ends	end	VBZ
25944	352	27	or	or	CC
25944	352	28	perpendicular	perpendicular	JJ
25944	352	29	pressure	pressure	NN
25944	352	30	with	with	IN
25944	352	31	a	a	DT
25944	352	32	watch	watch	NN
25944	352	33	-	-	HYPH
25944	352	34	key	key	NN
25944	352	35	with	with	IN
25944	352	36	rounded	rounded	JJ
25944	352	37	edges	edge	NNS
25944	352	38	,	,	,
25944	352	39	or	or	CC
25944	352	40	with	with	IN
25944	352	41	an	an	DT
25944	352	42	instrument	instrument	NN
25944	352	43	specially	specially	RB
25944	352	44	contrived	contrive	VBN
25944	352	45	for	for	IN
25944	352	46	this	this	DT
25944	352	47	purpose	purpose	NN
25944	352	48	;	;	:
25944	352	49	and	and	CC
25944	352	50	after	after	IN
25944	352	51	these	these	DT
25944	352	52	preliminary	preliminary	JJ
25944	352	53	measures	measure	NNS
25944	352	54	,	,	,
25944	352	55	which	which	WDT
25944	352	56	should	should	MD
25944	352	57	be	be	VB
25944	352	58	carried	carry	VBN
25944	352	59	out	out	RP
25944	352	60	every	every	DT
25944	352	61	night	night	NN
25944	352	62	,	,	,
25944	352	63	a	a	DT
25944	352	64	stimulating	stimulate	VBG
25944	352	65	sulphur	sulphur	NN
25944	352	66	ointment	ointment	NN
25944	352	67	or	or	CC
25944	352	68	lotion	lotion	NN
25944	352	69	,	,	,
25944	352	70	such	such	JJ
25944	352	71	as	as	IN
25944	352	72	employed	employ	VBN
25944	352	73	in	in	IN
25944	352	74	the	the	DT
25944	352	75	treatment	treatment	NN
25944	352	76	of	of	IN
25944	352	77	acne	acne	NNP
25944	352	78	(	(	-LRB-
25944	352	79	_	_	NNP
25944	352	80	q	q	NNP
25944	352	81	.	.	.
25944	353	1	v.	v.	NNP
25944	353	2	_	_	NNP
25944	353	3	)	)	-RRB-
25944	353	4	,	,	,
25944	353	5	is	be	VBZ
25944	353	6	to	to	TO
25944	353	7	be	be	VB
25944	353	8	thoroughly	thoroughly	RB
25944	353	9	applied	apply	VBN
25944	353	10	.	.	.
25944	354	1	The	the	DT
25944	354	2	following	follow	VBG
25944	354	3	is	be	VBZ
25944	354	4	valuable:--	valuable:--	NNP
25944	354	5	[	[	-LRB-
25944	354	6	Rx	Rx	NNP
25944	354	7	]	]	-RRB-
25944	354	8	Zinci	Zinci	NNP
25944	354	9	sulphatis	sulphatis	NN
25944	354	10	,	,	,
25944	354	11	Potassi	Potassi	NNP
25944	354	12	sulphureti	sulphureti	NN
25944	354	13	,	,	,
25944	354	14	.	.	.
25944	355	1	[	[	-LRB-
25944	355	2	=	=	SYM
25944	355	3	a][=a	a][=a	CD
25944	355	4	]	]	-RRB-
25944	355	5	.......	.......	.
25944	355	6	[	[	-LRB-
25944	355	7	dram]j-[dram]iv	dram]j-[dram]iv	NN
25944	355	8	.	.	.
25944	356	1	Alcoholi	Alcoholi	NNP
25944	356	2	.............................	.............................	NFP
25944	356	3	f[Oz]ss	f[oz]s	NNS
25944	356	4	.	.	.
25944	357	1	Aquæ	Aquæ	NNP
25944	357	2	,	,	,
25944	357	3	.................	.................	NFP
25944	357	4	q.s	q.s	NNP
25944	357	5	.	.	.
25944	358	1	ad	ad	NN
25944	358	2	......	......	NFP
25944	358	3	f[Oz]iv	f[Oz]iv	NNP
25944	358	4	.	.	.
25944	359	1	M.	M.	NNP
25944	359	2	Should	Should	NNP
25944	359	3	slight	slight	JJ
25944	359	4	scaliness	scaliness	NN
25944	359	5	or	or	CC
25944	359	6	a	a	DT
25944	359	7	mild	mild	JJ
25944	359	8	degree	degree	NN
25944	359	9	of	of	IN
25944	359	10	irritation	irritation	NN
25944	359	11	of	of	IN
25944	359	12	the	the	DT
25944	359	13	skin	skin	NN
25944	359	14	be	be	VB
25944	359	15	brought	bring	VBN
25944	359	16	about	about	RP
25944	359	17	,	,	,
25944	359	18	active	active	JJ
25944	359	19	external	external	JJ
25944	359	20	treatment	treatment	NN
25944	359	21	is	be	VBZ
25944	359	22	to	to	TO
25944	359	23	be	be	VB
25944	359	24	discontinued	discontinue	VBN
25944	359	25	for	for	IN
25944	359	26	a	a	DT
25944	359	27	few	few	JJ
25944	359	28	days	day	NNS
25944	359	29	and	and	CC
25944	359	30	soothing	soothe	VBG
25944	359	31	applications	application	NNS
25944	359	32	made	make	VBN
25944	359	33	.	.	.
25944	360	1	Resorcin	Resorcin	NNP
25944	360	2	,	,	,
25944	360	3	in	in	IN
25944	360	4	lotion	lotion	NN
25944	360	5	,	,	,
25944	360	6	3	3	CD
25944	360	7	to	to	IN
25944	360	8	25	25	CD
25944	360	9	per	per	NN
25944	360	10	cent	cent	NN
25944	360	11	strength	strength	NN
25944	360	12	,	,	,
25944	360	13	is	be	VBZ
25944	360	14	through	through	IN
25944	360	15	the	the	DT
25944	360	16	exfoliation	exfoliation	NN
25944	360	17	it	-PRON-	PRP
25944	360	18	provokes	provoke	VBZ
25944	360	19	,	,	,
25944	360	20	frequently	frequently	RB
25944	360	21	of	of	IN
25944	360	22	value	value	NN
25944	360	23	;	;	:
25944	360	24	the	the	DT
25944	360	25	resorcin	resorcin	NNPS
25944	360	26	paste	paste	NN
25944	360	27	referred	refer	VBD
25944	360	28	to	to	IN
25944	360	29	in	in	IN
25944	360	30	acne	acne	NNP
25944	360	31	can	can	MD
25944	360	32	also	also	RB
25944	360	33	be	be	VB
25944	360	34	used	use	VBN
25944	360	35	for	for	IN
25944	360	36	this	this	DT
25944	360	37	purpose	purpose	NN
25944	360	38	.	.	.
25944	361	1	Moderately	moderately	RB
25944	361	2	strong	strong	JJ
25944	361	3	applications	application	NNS
25944	361	4	of	of	IN
25944	361	5	the	the	DT
25944	361	6	Faradic	Faradic	NNP
25944	361	7	current	current	NN
25944	361	8	,	,	,
25944	361	9	repeated	repeat	VBD
25944	361	10	once	once	RB
25944	361	11	or	or	CC
25944	361	12	twice	twice	RB
25944	361	13	weekly	weekly	JJ
25944	361	14	,	,	,
25944	361	15	are	be	VBP
25944	361	16	sometimes	sometimes	RB
25944	361	17	of	of	IN
25944	361	18	service	service	NN
25944	361	19	;	;	:
25944	361	20	also	also	RB
25944	361	21	weak	weak	JJ
25944	361	22	to	to	TO
25944	361	23	moderately	moderately	RB
25944	361	24	strong	strong	JJ
25944	361	25	applications	application	NNS
25944	361	26	of	of	IN
25944	361	27	the	the	DT
25944	361	28	continuous	continuous	JJ
25944	361	29	and	and	CC
25944	361	30	high	high	JJ
25944	361	31	-	-	HYPH
25944	361	32	frequency	frequency	NN
25944	361	33	currents	current	NNS
25944	361	34	.	.	.
25944	362	1	Röntgen	Röntgen	NNP
25944	362	2	-	-	HYPH
25944	362	3	ray	ray	NN
25944	362	4	treatment	treatment	NN
25944	362	5	can	can	MD
25944	362	6	also	also	RB
25944	362	7	be	be	VB
25944	362	8	resorted	resort	VBN
25944	362	9	to	to	IN
25944	362	10	in	in	IN
25944	362	11	extremely	extremely	RB
25944	362	12	obstinate	obstinate	JJ
25944	362	13	cases	case	NNS
25944	362	14	.	.	.
25944	363	1	In	in	IN
25944	363	2	occasional	occasional	JJ
25944	363	3	instances	instance	NNS
25944	363	4	sulphur	sulphur	NN
25944	363	5	preparations	preparation	NNS
25944	363	6	not	not	RB
25944	363	7	only	only	RB
25944	363	8	fail	fail	VBP
25944	363	9	to	to	TO
25944	363	10	do	do	VB
25944	363	11	good	good	NN
25944	363	12	,	,	,
25944	363	13	but	but	CC
25944	363	14	materially	materially	RB
25944	363	15	aggravate	aggravate	VBP
25944	363	16	the	the	DT
25944	363	17	condition	condition	NN
25944	363	18	.	.	.
25944	364	1	In	in	IN
25944	364	2	such	such	JJ
25944	364	3	cases	case	NNS
25944	364	4	,	,	,
25944	364	5	if	if	IN
25944	364	6	resorcin	resorcin	JJ
25944	364	7	preparations	preparation	NNS
25944	364	8	also	also	RB
25944	364	9	fail	fail	VBP
25944	364	10	,	,	,
25944	364	11	the	the	DT
25944	364	12	mercurial	mercurial	JJ
25944	364	13	lotion	lotion	NN
25944	364	14	and	and	CC
25944	364	15	ointment	ointment	NN
25944	364	16	employed	employ	VBN
25944	364	17	in	in	IN
25944	364	18	acne	acne	NNP
25944	364	19	may	may	MD
25944	364	20	be	be	VB
25944	364	21	prescribed	prescribe	VBN
25944	364	22	.	.	.
25944	365	1	Mercurial	mercurial	JJ
25944	365	2	and	and	CC
25944	365	3	sulphur	sulphur	NN
25944	365	4	applications	application	NNS
25944	365	5	should	should	MD
25944	365	6	not	not	RB
25944	365	7	be	be	VB
25944	365	8	used	use	VBN
25944	365	9	,	,	,
25944	365	10	it	-PRON-	PRP
25944	365	11	need	nee	MD
25944	365	12	scarcely	scarcely	RB
25944	365	13	be	be	VB
25944	365	14	said	say	VBN
25944	365	15	,	,	,
25944	365	16	within	within	IN
25944	365	17	a	a	DT
25944	365	18	week	week	NN
25944	365	19	or	or	CC
25944	365	20	ten	ten	CD
25944	365	21	days	day	NNS
25944	365	22	of	of	IN
25944	365	23	each	each	DT
25944	365	24	other	other	JJ
25944	365	25	,	,	,
25944	365	26	otherwise	otherwise	RB
25944	365	27	an	an	DT
25944	365	28	increase	increase	NN
25944	365	29	in	in	IN
25944	365	30	the	the	DT
25944	365	31	comedones	comedo	NNS
25944	365	32	and	and	CC
25944	365	33	a	a	DT
25944	365	34	slight	slight	JJ
25944	365	35	darkening	darkening	NN
25944	365	36	of	of	IN
25944	365	37	the	the	DT
25944	365	38	skin	skin	NN
25944	365	39	result	result	VBP
25944	365	40	from	from	IN
25944	365	41	the	the	DT
25944	365	42	formation	formation	NN
25944	365	43	of	of	IN
25944	365	44	the	the	DT
25944	365	45	black	black	JJ
25944	365	46	sulphuret	sulphuret	NN
25944	365	47	of	of	IN
25944	365	48	mercury	mercury	NNP
25944	365	49	.	.	.
25944	366	1	#	#	NNP
25944	366	2	Milium	Milium	NNP
25944	366	3	.	.	.
25944	366	4	#	#	NNP
25944	366	5	(	(	-LRB-
25944	366	6	_	_	NNP
25944	366	7	Synonyms	Synonyms	NNP
25944	366	8	:	:	:
25944	366	9	_	_	NNP
25944	366	10	Grutum	Grutum	NNP
25944	366	11	;	;	:
25944	366	12	Strophulus	Strophulus	NNP
25944	366	13	Albidus	Albidus	NNP
25944	366	14	.	.	.
25944	366	15	)	)	-RRB-
25944	367	1	#	#	LS
25944	367	2	What	what	WP
25944	367	3	is	be	VBZ
25944	367	4	milium	milium	NN
25944	367	5	?	?	.
25944	367	6	#	#	NNP
25944	367	7	Milium	Milium	NNP
25944	367	8	consists	consist	VBZ
25944	367	9	in	in	IN
25944	367	10	the	the	DT
25944	367	11	formation	formation	NN
25944	367	12	of	of	IN
25944	367	13	small	small	JJ
25944	367	14	,	,	,
25944	367	15	whitish	whitish	JJ
25944	367	16	or	or	CC
25944	367	17	yellowish	yellowish	JJ
25944	367	18	,	,	,
25944	367	19	rounded	rounded	JJ
25944	367	20	,	,	,
25944	367	21	pearly	pearly	RB
25944	367	22	,	,	,
25944	367	23	non	non	JJ
25944	367	24	-	-	JJ
25944	367	25	inflammatory	inflammatory	JJ
25944	367	26	elevations	elevation	NNS
25944	367	27	situated	situate	VBN
25944	367	28	in	in	IN
25944	367	29	the	the	DT
25944	367	30	upper	upper	JJ
25944	367	31	part	part	NN
25944	367	32	of	of	IN
25944	367	33	the	the	DT
25944	367	34	corium	corium	NN
25944	367	35	.	.	.
25944	368	1	#	#	NNP
25944	368	2	Describe	describe	VB
25944	368	3	the	the	DT
25944	368	4	clinical	clinical	JJ
25944	368	5	appearances	appearance	NNS
25944	368	6	.	.	.
25944	368	7	#	#	$
25944	368	8	The	the	DT
25944	368	9	lesions	lesion	NNS
25944	368	10	are	be	VBP
25944	368	11	usually	usually	RB
25944	368	12	pin	pin	NN
25944	368	13	-	-	HYPH
25944	368	14	head	head	NN
25944	368	15	in	in	IN
25944	368	16	size	size	NN
25944	368	17	,	,	,
25944	368	18	whitish	whitish	JJ
25944	368	19	or	or	CC
25944	368	20	yellowish	yellowish	JJ
25944	368	21	,	,	,
25944	368	22	seemingly	seemingly	RB
25944	368	23	more	more	RBR
25944	368	24	or	or	CC
25944	368	25	less	less	RBR
25944	368	26	translucent	translucent	JJ
25944	368	27	,	,	,
25944	368	28	rounded	rounded	JJ
25944	368	29	or	or	CC
25944	368	30	acuminated	acuminate	VBN
25944	368	31	,	,	,
25944	368	32	without	without	IN
25944	368	33	aperture	aperture	NN
25944	368	34	or	or	CC
25944	368	35	duct	duct	NN
25944	368	36	,	,	,
25944	368	37	are	be	VBP
25944	368	38	superficially	superficially	RB
25944	368	39	seated	seat	VBN
25944	368	40	in	in	IN
25944	368	41	the	the	DT
25944	368	42	skin	skin	NN
25944	368	43	,	,	,
25944	368	44	and	and	CC
25944	368	45	project	project	NN
25944	368	46	slightly	slightly	RB
25944	368	47	above	above	IN
25944	368	48	the	the	DT
25944	368	49	surface	surface	NN
25944	368	50	.	.	.
25944	369	1	They	-PRON-	PRP
25944	369	2	appear	appear	VBP
25944	369	3	about	about	IN
25944	369	4	the	the	DT
25944	369	5	face	face	NN
25944	369	6	,	,	,
25944	369	7	especially	especially	RB
25944	369	8	about	about	IN
25944	369	9	the	the	DT
25944	369	10	eyelids	eyelid	NNS
25944	369	11	;	;	:
25944	369	12	they	-PRON-	PRP
25944	369	13	may	may	MD
25944	369	14	occur	occur	VB
25944	369	15	also	also	RB
25944	369	16	,	,	,
25944	369	17	although	although	IN
25944	369	18	rarely	rarely	RB
25944	369	19	,	,	,
25944	369	20	upon	upon	IN
25944	369	21	other	other	JJ
25944	369	22	parts	part	NNS
25944	369	23	.	.	.
25944	370	1	But	but	CC
25944	370	2	one	one	CD
25944	370	3	or	or	CC
25944	370	4	several	several	JJ
25944	370	5	may	may	MD
25944	370	6	be	be	VB
25944	370	7	present	present	JJ
25944	370	8	,	,	,
25944	370	9	or	or	CC
25944	370	10	they	-PRON-	PRP
25944	370	11	may	may	MD
25944	370	12	exist	exist	VB
25944	370	13	in	in	IN
25944	370	14	numbers	number	NNS
25944	370	15	.	.	.
25944	371	1	#	#	LS
25944	371	2	What	what	WP
25944	371	3	is	be	VBZ
25944	371	4	the	the	DT
25944	371	5	course	course	NN
25944	371	6	of	of	IN
25944	371	7	milium	milium	NN
25944	371	8	?	?	.
25944	371	9	#	#	$
25944	371	10	The	the	DT
25944	371	11	lesions	lesion	NNS
25944	371	12	develop	develop	VBP
25944	371	13	slowly	slowly	RB
25944	371	14	,	,	,
25944	371	15	and	and	CC
25944	371	16	may	may	MD
25944	371	17	then	then	RB
25944	371	18	remain	remain	VB
25944	371	19	stationary	stationary	JJ
25944	371	20	for	for	IN
25944	371	21	years	year	NNS
25944	371	22	.	.	.
25944	372	1	Their	-PRON-	PRP$
25944	372	2	presence	presence	NN
25944	372	3	gives	give	VBZ
25944	372	4	rise	rise	VB
25944	372	5	to	to	IN
25944	372	6	no	no	DT
25944	372	7	disturbance	disturbance	NN
25944	372	8	,	,	,
25944	372	9	and	and	CC
25944	372	10	,	,	,
25944	372	11	unless	unless	IN
25944	372	12	they	-PRON-	PRP
25944	372	13	are	be	VBP
25944	372	14	large	large	JJ
25944	372	15	in	in	IN
25944	372	16	size	size	NN
25944	372	17	or	or	CC
25944	372	18	exist	exist	VB
25944	372	19	in	in	IN
25944	372	20	numbers	number	NNS
25944	372	21	,	,	,
25944	372	22	causes	cause	NNS
25944	372	23	but	but	CC
25944	372	24	slight	slight	JJ
25944	372	25	disfigurement	disfigurement	NN
25944	372	26	.	.	.
25944	373	1	[	[	-LRB-
25944	373	2	Illustration	illustration	NN
25944	373	3	:	:	:
25944	373	4	Fig	Fig	NNP
25944	373	5	.	.	.
25944	374	1	10	10	CD
25944	374	2	.	.	.
25944	375	1	Milium	Milium	NNP
25944	375	2	Needle	Needle	NNP
25944	375	3	.	.	.
25944	375	4	]	]	-RRB-
25944	376	1	In	in	IN
25944	376	2	rare	rare	JJ
25944	376	3	instances	instance	NNS
25944	376	4	they	-PRON-	PRP
25944	376	5	may	may	MD
25944	376	6	undergo	undergo	VB
25944	376	7	calcareous	calcareous	JJ
25944	376	8	metamorphosis	metamorphosis	NN
25944	376	9	,	,	,
25944	376	10	constituting	constitute	VBG
25944	376	11	the	the	DT
25944	376	12	so	so	RB
25944	376	13	-	-	HYPH
25944	376	14	called	call	VBN
25944	376	15	_	_	NNP
25944	376	16	cutaneous	cutaneous	JJ
25944	376	17	calculi	calculus	NNS
25944	376	18	_	_	NNP
25944	376	19	.	.	.
25944	377	1	#	#	LS
25944	377	2	What	what	WP
25944	377	3	is	be	VBZ
25944	377	4	the	the	DT
25944	377	5	anatomical	anatomical	JJ
25944	377	6	seat	seat	NN
25944	377	7	of	of	IN
25944	377	8	milium	milium	NN
25944	377	9	?	?	.
25944	377	10	#	#	$
25944	377	11	The	the	DT
25944	377	12	sebaceous	sebaceous	JJ
25944	377	13	gland	gland	NN
25944	377	14	(	(	-LRB-
25944	377	15	probably	probably	RB
25944	377	16	one	one	CD
25944	377	17	or	or	CC
25944	377	18	several	several	JJ
25944	377	19	of	of	IN
25944	377	20	the	the	DT
25944	377	21	superficially	superficially	RB
25944	377	22	-	-	HYPH
25944	377	23	situated	situate	VBN
25944	377	24	acini	acini	NNP
25944	377	25	)	)	-RRB-
25944	377	26	,	,	,
25944	377	27	the	the	DT
25944	377	28	duct	duct	NN
25944	377	29	of	of	IN
25944	377	30	which	which	WDT
25944	377	31	is	be	VBZ
25944	377	32	in	in	IN
25944	377	33	some	some	DT
25944	377	34	manner	manner	NN
25944	377	35	obliterated	obliterate	VBN
25944	377	36	,	,	,
25944	377	37	the	the	DT
25944	377	38	sebaceous	sebaceous	JJ
25944	377	39	matter	matter	NN
25944	377	40	collects	collect	VBZ
25944	377	41	,	,	,
25944	377	42	becomes	become	VBZ
25944	377	43	inspissated	inspissated	JJ
25944	377	44	and	and	CC
25944	377	45	calcareous	calcareous	JJ
25944	377	46	,	,	,
25944	377	47	forming	form	VBG
25944	377	48	the	the	DT
25944	377	49	pin	pin	NN
25944	377	50	-	-	HYPH
25944	377	51	head	head	NN
25944	377	52	lesion	lesion	NN
25944	377	53	.	.	.
25944	378	1	The	the	DT
25944	378	2	epidermis	epidermis	NN
25944	378	3	is	be	VBZ
25944	378	4	the	the	DT
25944	378	5	external	external	JJ
25944	378	6	covering	covering	NN
25944	378	7	.	.	.
25944	379	1	#	#	LS
25944	379	2	What	what	WP
25944	379	3	is	be	VBZ
25944	379	4	the	the	DT
25944	379	5	treatment	treatment	NN
25944	379	6	?	?	.
25944	379	7	#	#	$
25944	379	8	The	the	DT
25944	379	9	usual	usual	JJ
25944	379	10	plan	plan	NN
25944	379	11	is	be	VBZ
25944	379	12	to	to	TO
25944	379	13	prick	prick	VB
25944	379	14	or	or	CC
25944	379	15	incise	incise	VB
25944	379	16	each	each	DT
25944	379	17	lesion	lesion	NN
25944	379	18	and	and	CC
25944	379	19	press	press	VB
25944	379	20	out	out	RP
25944	379	21	the	the	DT
25944	379	22	contents	content	NNS
25944	379	23	.	.	.
25944	380	1	In	in	IN
25944	380	2	some	some	DT
25944	380	3	milia	milium	NNS
25944	380	4	it	-PRON-	PRP
25944	380	5	may	may	MD
25944	380	6	be	be	VB
25944	380	7	necessary	necessary	JJ
25944	380	8	also	also	RB
25944	380	9	,	,	,
25944	380	10	in	in	IN
25944	380	11	order	order	NN
25944	380	12	to	to	TO
25944	380	13	prevent	prevent	VB
25944	380	14	a	a	DT
25944	380	15	return	return	NN
25944	380	16	,	,	,
25944	380	17	to	to	TO
25944	380	18	touch	touch	VB
25944	380	19	the	the	DT
25944	380	20	base	base	NN
25944	380	21	of	of	IN
25944	380	22	the	the	DT
25944	380	23	excavation	excavation	NN
25944	380	24	with	with	IN
25944	380	25	tincture	tincture	NN
25944	380	26	of	of	IN
25944	380	27	iodine	iodine	NN
25944	380	28	or	or	CC
25944	380	29	with	with	IN
25944	380	30	silver	silver	NN
25944	380	31	nitrate	nitrate	JJ
25944	380	32	.	.	.
25944	381	1	Electrolysis	electrolysis	NN
25944	381	2	is	be	VBZ
25944	381	3	also	also	RB
25944	381	4	effectual	effectual	JJ
25944	381	5	.	.	.
25944	382	1	In	in	IN
25944	382	2	those	those	DT
25944	382	3	cases	case	NNS
25944	382	4	where	where	WRB
25944	382	5	the	the	DT
25944	382	6	lesions	lesion	NNS
25944	382	7	are	be	VBP
25944	382	8	numerous	numerous	JJ
25944	382	9	the	the	DT
25944	382	10	production	production	NN
25944	382	11	of	of	IN
25944	382	12	exfoliation	exfoliation	NN
25944	382	13	of	of	IN
25944	382	14	the	the	DT
25944	382	15	epiderm	epiderm	NN
25944	382	16	by	by	IN
25944	382	17	means	mean	NNS
25944	382	18	of	of	IN
25944	382	19	resorcin	resorcin	NNPS
25944	382	20	applications	application	NNS
25944	382	21	(	(	-LRB-
25944	382	22	see	see	VB
25944	382	23	acne	acne	NNP
25944	382	24	)	)	-RRB-
25944	382	25	is	be	VBZ
25944	382	26	a	a	DT
25944	382	27	good	good	JJ
25944	382	28	plan	plan	NN
25944	382	29	.	.	.
25944	383	1	#	#	NNP
25944	383	2	Steatoma	Steatoma	NNP
25944	383	3	.	.	.
25944	383	4	#	#	NNP
25944	383	5	(	(	-LRB-
25944	383	6	_	_	NNP
25944	383	7	Synonyms	Synonyms	NNP
25944	383	8	:	:	:
25944	383	9	_	_	NNP
25944	383	10	Sebaceous	Sebaceous	NNP
25944	383	11	Cyst	Cyst	NNP
25944	383	12	;	;	:
25944	383	13	Sebaceous	Sebaceous	NNP
25944	383	14	Tumor	Tumor	NNP
25944	383	15	;	;	:
25944	383	16	Wen	Wen	NNP
25944	383	17	.	.	.
25944	383	18	)	)	-RRB-
25944	384	1	#	#	NNP
25944	384	2	Describe	Describe	NNP
25944	384	3	steatoma	steatoma	NN
25944	384	4	.	.	.
25944	384	5	#	#	NNP
25944	384	6	Steatoma	Steatoma	NNP
25944	384	7	,	,	,
25944	384	8	or	or	CC
25944	384	9	sebaceous	sebaceous	JJ
25944	384	10	cyst	cyst	NN
25944	384	11	,	,	,
25944	384	12	appears	appear	VBZ
25944	384	13	as	as	IN
25944	384	14	a	a	DT
25944	384	15	variously	variously	RB
25944	384	16	-	-	HYPH
25944	384	17	sized	sized	JJ
25944	384	18	,	,	,
25944	384	19	elevated	elevated	JJ
25944	384	20	,	,	,
25944	384	21	rounded	rounded	JJ
25944	384	22	or	or	CC
25944	384	23	semi	semi	JJ
25944	384	24	-	-	JJ
25944	384	25	globular	globular	JJ
25944	384	26	,	,	,
25944	384	27	soft	soft	JJ
25944	384	28	or	or	CC
25944	384	29	firm	firm	JJ
25944	384	30	tumor	tumor	NN
25944	384	31	,	,	,
25944	384	32	freely	freely	RB
25944	384	33	movable	movable	JJ
25944	384	34	and	and	CC
25944	384	35	painless	painless	JJ
25944	384	36	,	,	,
25944	384	37	and	and	CC
25944	384	38	having	have	VBG
25944	384	39	its	-PRON-	PRP$
25944	384	40	seat	seat	NN
25944	384	41	in	in	IN
25944	384	42	the	the	DT
25944	384	43	corium	corium	NN
25944	384	44	or	or	CC
25944	384	45	subcutaneous	subcutaneous	JJ
25944	384	46	tissue	tissue	NN
25944	384	47	.	.	.
25944	385	1	The	the	DT
25944	385	2	overlying	overlying	NN
25944	385	3	skin	skin	NN
25944	385	4	is	be	VBZ
25944	385	5	normal	normal	JJ
25944	385	6	in	in	IN
25944	385	7	color	color	NN
25944	385	8	,	,	,
25944	385	9	or	or	CC
25944	385	10	it	-PRON-	PRP
25944	385	11	may	may	MD
25944	385	12	be	be	VB
25944	385	13	whitish	whitish	JJ
25944	385	14	or	or	CC
25944	385	15	pale	pale	JJ
25944	385	16	from	from	IN
25944	385	17	distention	distention	NN
25944	385	18	;	;	:
25944	385	19	in	in	IN
25944	385	20	some	some	DT
25944	385	21	a	a	DT
25944	385	22	gland	gland	NN
25944	385	23	-	-	HYPH
25944	385	24	duct	duct	NN
25944	385	25	orifice	orifice	NN
25944	385	26	may	may	MD
25944	385	27	be	be	VB
25944	385	28	seen	see	VBN
25944	385	29	,	,	,
25944	385	30	but	but	CC
25944	385	31	,	,	,
25944	385	32	as	as	IN
25944	385	33	a	a	DT
25944	385	34	rule	rule	NN
25944	385	35	,	,	,
25944	385	36	this	this	DT
25944	385	37	is	be	VBZ
25944	385	38	absent	absent	JJ
25944	385	39	.	.	.
25944	386	1	#	#	LS
25944	386	2	What	what	WP
25944	386	3	are	be	VBP
25944	386	4	the	the	DT
25944	386	5	favorite	favorite	JJ
25944	386	6	regions	region	NNS
25944	386	7	for	for	IN
25944	386	8	the	the	DT
25944	386	9	development	development	NN
25944	386	10	of	of	IN
25944	386	11	steatoma	steatoma	NNP
25944	386	12	?	?	.
25944	386	13	#	#	$
25944	386	14	The	the	DT
25944	386	15	scalp	scalp	NN
25944	386	16	,	,	,
25944	386	17	face	face	NN
25944	386	18	and	and	CC
25944	386	19	back	back	NN
25944	386	20	.	.	.
25944	387	1	One	one	CD
25944	387	2	or	or	CC
25944	387	3	several	several	JJ
25944	387	4	may	may	MD
25944	387	5	be	be	VB
25944	387	6	present	present	JJ
25944	387	7	.	.	.
25944	388	1	#	#	LS
25944	388	2	What	what	WP
25944	388	3	is	be	VBZ
25944	388	4	the	the	DT
25944	388	5	course	course	NN
25944	388	6	of	of	IN
25944	388	7	sebaceous	sebaceous	JJ
25944	388	8	cysts	cyst	NNS
25944	388	9	?	?	.
25944	388	10	#	#	$
25944	388	11	Their	-PRON-	PRP$
25944	388	12	growth	growth	NN
25944	388	13	is	be	VBZ
25944	388	14	slow	slow	JJ
25944	388	15	,	,	,
25944	388	16	and	and	CC
25944	388	17	,	,	,
25944	388	18	after	after	IN
25944	388	19	attaining	attain	VBG
25944	388	20	a	a	DT
25944	388	21	variable	variable	JJ
25944	388	22	size	size	NN
25944	388	23	,	,	,
25944	388	24	may	may	MD
25944	388	25	remain	remain	VB
25944	388	26	stationary	stationary	JJ
25944	388	27	.	.	.
25944	389	1	They	-PRON-	PRP
25944	389	2	may	may	MD
25944	389	3	exist	exist	VB
25944	389	4	indefinitely	indefinitely	RB
25944	389	5	without	without	IN
25944	389	6	causing	cause	VBG
25944	389	7	any	any	DT
25944	389	8	inconvenience	inconvenience	NN
25944	389	9	beyond	beyond	IN
25944	389	10	the	the	DT
25944	389	11	disfigurement	disfigurement	NN
25944	389	12	.	.	.
25944	390	1	Exceptionally	exceptionally	RB
25944	390	2	,	,	,
25944	390	3	in	in	IN
25944	390	4	enormously	enormously	RB
25944	390	5	distended	distend	VBN
25944	390	6	growths	growth	NNS
25944	390	7	,	,	,
25944	390	8	suppuration	suppuration	NN
25944	390	9	and	and	CC
25944	390	10	ulceration	ulceration	NN
25944	390	11	result	result	NN
25944	390	12	.	.	.
25944	391	1	#	#	LS
25944	391	2	What	what	WP
25944	391	3	is	be	VBZ
25944	391	4	the	the	DT
25944	391	5	pathology	pathology	NN
25944	391	6	?	?	.
25944	391	7	#	#	$
25944	391	8	A	a	DT
25944	391	9	steatoma	steatoma	NN
25944	391	10	is	be	VBZ
25944	391	11	a	a	DT
25944	391	12	cyst	cyst	NN
25944	391	13	of	of	IN
25944	391	14	the	the	DT
25944	391	15	sebaceous	sebaceous	JJ
25944	391	16	gland	gland	NN
25944	391	17	and	and	CC
25944	391	18	duct	duct	NN
25944	391	19	,	,	,
25944	391	20	produced	produce	VBN
25944	391	21	by	by	IN
25944	391	22	retained	retain	VBN
25944	391	23	secretion	secretion	NN
25944	391	24	.	.	.
25944	392	1	The	the	DT
25944	392	2	contents	content	NNS
25944	392	3	may	may	MD
25944	392	4	be	be	VB
25944	392	5	hard	hard	JJ
25944	392	6	and	and	CC
25944	392	7	friable	friable	JJ
25944	392	8	,	,	,
25944	392	9	soft	soft	JJ
25944	392	10	and	and	CC
25944	392	11	cheesy	cheesy	JJ
25944	392	12	,	,	,
25944	392	13	or	or	CC
25944	392	14	even	even	RB
25944	392	15	fluid	fluid	JJ
25944	392	16	,	,	,
25944	392	17	of	of	IN
25944	392	18	a	a	DT
25944	392	19	grayish	grayish	NN
25944	392	20	,	,	,
25944	392	21	whitish	whitish	JJ
25944	392	22	or	or	CC
25944	392	23	yellowish	yellowish	JJ
25944	392	24	color	color	NN
25944	392	25	,	,	,
25944	392	26	and	and	CC
25944	392	27	with	with	IN
25944	392	28	or	or	CC
25944	392	29	without	without	IN
25944	392	30	a	a	DT
25944	392	31	fetid	fetid	JJ
25944	392	32	odor	odor	NN
25944	392	33	;	;	:
25944	392	34	the	the	DT
25944	392	35	mass	mass	NN
25944	392	36	consisting	consist	VBG
25944	392	37	of	of	IN
25944	392	38	fat	fat	NN
25944	392	39	-	-	HYPH
25944	392	40	drops	drop	NNS
25944	392	41	,	,	,
25944	392	42	epidermic	epidermic	JJ
25944	392	43	cells	cell	NNS
25944	392	44	,	,	,
25944	392	45	cholesterin	cholesterin	NNP
25944	392	46	,	,	,
25944	392	47	and	and	CC
25944	392	48	sometimes	sometimes	RB
25944	392	49	hairs	hair	NNS
25944	392	50	.	.	.
25944	393	1	#	#	NN
25944	393	2	Are	be	VBP
25944	393	3	sebaceous	sebaceous	JJ
25944	393	4	cysts	cyst	NNS
25944	393	5	likely	likely	JJ
25944	393	6	to	to	TO
25944	393	7	be	be	VB
25944	393	8	confounded	confound	VBN
25944	393	9	with	with	IN
25944	393	10	gummata	gumma	NNS
25944	393	11	?	?	.
25944	393	12	#	#	$
25944	393	13	No	no	UH
25944	393	14	.	.	.
25944	394	1	Gummata	gumma	NNS
25944	394	2	grow	grow	VBP
25944	394	3	more	more	RBR
25944	394	4	rapidly	rapidly	RB
25944	394	5	,	,	,
25944	394	6	are	be	VBP
25944	394	7	usually	usually	RB
25944	394	8	painful	painful	JJ
25944	394	9	to	to	IN
25944	394	10	the	the	DT
25944	394	11	touch	touch	NN
25944	394	12	,	,	,
25944	394	13	are	be	VBP
25944	394	14	not	not	RB
25944	394	15	freely	freely	RB
25944	394	16	movable	movable	JJ
25944	394	17	,	,	,
25944	394	18	and	and	CC
25944	394	19	tend	tend	VB
25944	394	20	to	to	TO
25944	394	21	break	break	VB
25944	394	22	down	down	RP
25944	394	23	and	and	CC
25944	394	24	ulcerate	ulcerate	JJ
25944	394	25	.	.	.
25944	395	1	#	#	NNP
25944	395	2	Describe	describe	VB
25944	395	3	the	the	DT
25944	395	4	treatment	treatment	NN
25944	395	5	of	of	IN
25944	395	6	steatoma	steatoma	NN
25944	395	7	.	.	.
25944	395	8	#	#	$
25944	395	9	A	a	DT
25944	395	10	linear	linear	JJ
25944	395	11	incision	incision	NN
25944	395	12	is	be	VBZ
25944	395	13	made	make	VBN
25944	395	14	,	,	,
25944	395	15	and	and	CC
25944	395	16	the	the	DT
25944	395	17	mass	mass	NN
25944	395	18	and	and	CC
25944	395	19	enveloping	envelop	VBG
25944	395	20	sac	sac	NN
25944	395	21	dissected	dissect	VBD
25944	395	22	out	out	RP
25944	395	23	.	.	.
25944	396	1	If	if	IN
25944	396	2	the	the	DT
25944	396	3	sac	sac	NN
25944	396	4	is	be	VBZ
25944	396	5	permitted	permit	VBN
25944	396	6	to	to	TO
25944	396	7	remain	remain	VB
25944	396	8	,	,	,
25944	396	9	reproduction	reproduction	NN
25944	396	10	almost	almost	RB
25944	396	11	invariably	invariably	RB
25944	396	12	takes	take	VBZ
25944	396	13	place	place	NN
25944	396	14	.	.	.
25944	397	1	#	#	NN
25944	397	2	CLASS	CLASS	NNP
25944	397	3	II.--INFLAMMATIONS	ii.--inflammations	JJ
25944	397	4	.	.	.
25944	397	5	#	#	$
25944	397	6	#	#	NN
25944	397	7	Erythema	Erythema	NNP
25944	397	8	Simplex	Simplex	NNP
25944	397	9	.	.	.
25944	397	10	#	#	$
25944	397	11	#	#	$
25944	397	12	What	what	WP
25944	397	13	do	do	VBP
25944	397	14	you	-PRON-	PRP
25944	397	15	understand	understand	VB
25944	397	16	by	by	IN
25944	397	17	erythema	erythema	NNP
25944	397	18	simplex	simplex	NNP
25944	397	19	?	?	.
25944	397	20	#	#	NNP
25944	397	21	Erythema	Erythema	NNP
25944	397	22	simplex	simplex	NN
25944	397	23	is	be	VBZ
25944	397	24	a	a	DT
25944	397	25	hyperæmic	hyperæmic	JJ
25944	397	26	disorder	disorder	NN
25944	397	27	characterized	characterize	VBN
25944	397	28	by	by	IN
25944	397	29	redness	redness	NN
25944	397	30	,	,	,
25944	397	31	occurring	occur	VBG
25944	397	32	in	in	IN
25944	397	33	the	the	DT
25944	397	34	form	form	NN
25944	397	35	of	of	IN
25944	397	36	variously	variously	RB
25944	397	37	-	-	HYPH
25944	397	38	sized	sized	JJ
25944	397	39	and	and	CC
25944	397	40	shaped	shaped	JJ
25944	397	41	,	,	,
25944	397	42	diffused	diffused	JJ
25944	397	43	or	or	CC
25944	397	44	circumscribed	circumscribe	VBN
25944	397	45	,	,	,
25944	397	46	non	non	JJ
25944	397	47	-	-	JJ
25944	397	48	elevated	elevated	JJ
25944	397	49	patches	patch	NNS
25944	397	50	.	.	.
25944	398	1	#	#	NNP
25944	398	2	Name	name	VB
25944	398	3	the	the	DT
25944	398	4	two	two	CD
25944	398	5	general	general	JJ
25944	398	6	classes	class	NNS
25944	398	7	into	into	IN
25944	398	8	which	which	WDT
25944	398	9	the	the	DT
25944	398	10	simple	simple	JJ
25944	398	11	erythemata	erythemata	NN
25944	398	12	are	be	VBP
25944	398	13	divided	divided	JJ
25944	398	14	.	.	.
25944	398	15	#	#	$
25944	398	16	Idiopathic	idiopathic	JJ
25944	398	17	and	and	CC
25944	398	18	symptomatic	symptomatic	JJ
25944	398	19	.	.	.
25944	399	1	#	#	LS
25944	399	2	What	what	WP
25944	399	3	do	do	VBP
25944	399	4	you	-PRON-	PRP
25944	399	5	include	include	VB
25944	399	6	in	in	IN
25944	399	7	the	the	DT
25944	399	8	idiopathic	idiopathic	JJ
25944	399	9	class	class	NN
25944	399	10	?	?	.
25944	399	11	#	#	$
25944	399	12	Those	those	DT
25944	399	13	erythemas	erythema	NNS
25944	399	14	due	due	IN
25944	399	15	to	to	IN
25944	399	16	external	external	JJ
25944	399	17	causes	cause	NNS
25944	399	18	,	,	,
25944	399	19	such	such	JJ
25944	399	20	as	as	IN
25944	399	21	cold	cold	JJ
25944	399	22	and	and	CC
25944	399	23	heat	heat	NN
25944	399	24	(	(	-LRB-
25944	399	25	_	_	NNP
25944	399	26	erythema	erythema	NNP
25944	399	27	caloricum	caloricum	NNP
25944	399	28	_	_	NNP
25944	399	29	)	)	-RRB-
25944	399	30	,	,	,
25944	399	31	the	the	DT
25944	399	32	action	action	NN
25944	399	33	of	of	IN
25944	399	34	the	the	DT
25944	399	35	sun	sun	NN
25944	399	36	(	(	-LRB-
25944	399	37	_	_	NNP
25944	399	38	erythema	erythema	NNP
25944	399	39	solare	solare	NNP
25944	399	40	_	_	NNP
25944	399	41	)	)	-RRB-
25944	399	42	,	,	,
25944	399	43	traumatism	traumatism	NN
25944	399	44	(	(	-LRB-
25944	399	45	_	_	NNP
25944	399	46	erythema	erythema	NNP
25944	399	47	traumaticum	traumaticum	NNP
25944	399	48	_	_	NNP
25944	399	49	)	)	-RRB-
25944	399	50	,	,	,
25944	399	51	and	and	CC
25944	399	52	the	the	DT
25944	399	53	various	various	JJ
25944	399	54	poisons	poison	NNS
25944	399	55	or	or	CC
25944	399	56	chemical	chemical	NN
25944	399	57	irritants	irritant	NNS
25944	399	58	(	(	-LRB-
25944	399	59	_	_	NNP
25944	399	60	erythema	erythema	NNP
25944	399	61	venenatum	venenatum	NNP
25944	399	62	_	_	NNP
25944	399	63	)	)	-RRB-
25944	399	64	.	.	.
25944	400	1	#	#	LS
25944	400	2	What	what	WP
25944	400	3	do	do	VBP
25944	400	4	you	-PRON-	PRP
25944	400	5	include	include	VB
25944	400	6	in	in	IN
25944	400	7	the	the	DT
25944	400	8	symptomatic	symptomatic	JJ
25944	400	9	class	class	NN
25944	400	10	?	?	.
25944	400	11	#	#	$
25944	400	12	Those	those	DT
25944	400	13	rashes	rash	NNS
25944	400	14	often	often	RB
25944	400	15	preceding	precede	VBG
25944	400	16	or	or	CC
25944	400	17	accompanying	accompany	VBG
25944	400	18	certain	certain	JJ
25944	400	19	of	of	IN
25944	400	20	the	the	DT
25944	400	21	systemic	systemic	JJ
25944	400	22	diseases	disease	NNS
25944	400	23	,	,	,
25944	400	24	and	and	CC
25944	400	25	those	those	DT
25944	400	26	due	due	IN
25944	400	27	to	to	IN
25944	400	28	disorders	disorder	NNS
25944	400	29	of	of	IN
25944	400	30	the	the	DT
25944	400	31	digestive	digestive	JJ
25944	400	32	tract	tract	NN
25944	400	33	,	,	,
25944	400	34	stomachic	stomachic	JJ
25944	400	35	and	and	CC
25944	400	36	intestinal	intestinal	JJ
25944	400	37	toxins	toxin	NNS
25944	400	38	,	,	,
25944	400	39	to	to	IN
25944	400	40	the	the	DT
25944	400	41	ingestion	ingestion	NN
25944	400	42	of	of	IN
25944	400	43	certain	certain	JJ
25944	400	44	drugs	drug	NNS
25944	400	45	,	,	,
25944	400	46	and	and	CC
25944	400	47	to	to	TO
25944	400	48	use	use	VB
25944	400	49	of	of	IN
25944	400	50	the	the	DT
25944	400	51	therapeutic	therapeutic	JJ
25944	400	52	serums	serum	NNS
25944	400	53	.	.	.
25944	401	1	#	#	NNP
25944	401	2	Describe	describe	VB
25944	401	3	the	the	DT
25944	401	4	symptoms	symptom	NNS
25944	401	5	of	of	IN
25944	401	6	erythema	erythema	NNP
25944	401	7	simplex	simplex	NNP
25944	401	8	.	.	.
25944	401	9	#	#	$
25944	401	10	The	the	DT
25944	401	11	essential	essential	JJ
25944	401	12	symptom	symptom	NN
25944	401	13	is	be	VBZ
25944	401	14	redness	redness	JJ
25944	401	15	--	--	:
25944	401	16	simple	simple	JJ
25944	401	17	hyperæmia	hyperæmia	NN
25944	401	18	--	--	:
25944	401	19	without	without	IN
25944	401	20	elevation	elevation	NN
25944	401	21	or	or	CC
25944	401	22	infiltration	infiltration	NN
25944	401	23	,	,	,
25944	401	24	disappearing	disappear	VBG
25944	401	25	under	under	IN
25944	401	26	pressure	pressure	NN
25944	401	27	,	,	,
25944	401	28	and	and	CC
25944	401	29	sometimes	sometimes	RB
25944	401	30	attended	attend	VBN
25944	401	31	by	by	IN
25944	401	32	slight	slight	JJ
25944	401	33	heat	heat	NN
25944	401	34	or	or	CC
25944	401	35	burning	burn	VBG
25944	401	36	;	;	:
25944	401	37	it	-PRON-	PRP
25944	401	38	may	may	MD
25944	401	39	be	be	VB
25944	401	40	patchy	patchy	JJ
25944	401	41	or	or	CC
25944	401	42	diffused	diffuse	VBN
25944	401	43	.	.	.
25944	402	1	In	in	IN
25944	402	2	the	the	DT
25944	402	3	idiopathic	idiopathic	JJ
25944	402	4	class	class	NN
25944	402	5	,	,	,
25944	402	6	if	if	IN
25944	402	7	the	the	DT
25944	402	8	cause	cause	NN
25944	402	9	is	be	VBZ
25944	402	10	continued	continue	VBN
25944	402	11	,	,	,
25944	402	12	dermatitis	dermatitis	NN
25944	402	13	may	may	MD
25944	402	14	result	result	VB
25944	402	15	.	.	.
25944	403	1	#	#	LS
25944	403	2	What	what	WP
25944	403	3	is	be	VBZ
25944	403	4	to	to	TO
25944	403	5	be	be	VB
25944	403	6	said	say	VBN
25944	403	7	about	about	IN
25944	403	8	the	the	DT
25944	403	9	distribution	distribution	NN
25944	403	10	of	of	IN
25944	403	11	the	the	DT
25944	403	12	simple	simple	JJ
25944	403	13	erythemata	erythemata	NN
25944	403	14	?	?	.
25944	403	15	#	#	$
25944	403	16	The	the	DT
25944	403	17	idiopathic	idiopathic	JJ
25944	403	18	rashes	rash	NNS
25944	403	19	,	,	,
25944	403	20	as	as	IN
25944	403	21	inferred	infer	VBN
25944	403	22	from	from	IN
25944	403	23	the	the	DT
25944	403	24	nature	nature	NN
25944	403	25	of	of	IN
25944	403	26	the	the	DT
25944	403	27	causes	cause	NNS
25944	403	28	,	,	,
25944	403	29	are	be	VBP
25944	403	30	usually	usually	RB
25944	403	31	limited	limited	JJ
25944	403	32	.	.	.
25944	404	1	The	the	DT
25944	404	2	symptomatic	symptomatic	JJ
25944	404	3	erythemas	erythema	NNS
25944	404	4	are	be	VBP
25944	404	5	more	more	RBR
25944	404	6	or	or	CC
25944	404	7	less	less	RBR
25944	404	8	generalized	generalize	VBN
25944	404	9	;	;	:
25944	404	10	desquamation	desquamation	NN
25944	404	11	sometimes	sometimes	RB
25944	404	12	follows	follow	VBZ
25944	404	13	.	.	.
25944	405	1	#	#	NNP
25944	405	2	Describe	describe	VB
25944	405	3	the	the	DT
25944	405	4	treatment	treatment	NN
25944	405	5	of	of	IN
25944	405	6	the	the	DT
25944	405	7	simple	simple	JJ
25944	405	8	erythemata	erythemata	NN
25944	405	9	.	.	.
25944	405	10	#	#	$
25944	405	11	A	a	DT
25944	405	12	removal	removal	NN
25944	405	13	of	of	IN
25944	405	14	the	the	DT
25944	405	15	cause	cause	NN
25944	405	16	in	in	IN
25944	405	17	idiopathic	idiopathic	JJ
25944	405	18	rashes	rash	NNS
25944	405	19	is	be	VBZ
25944	405	20	all	all	DT
25944	405	21	that	that	WDT
25944	405	22	is	be	VBZ
25944	405	23	needed	need	VBN
25944	405	24	,	,	,
25944	405	25	the	the	DT
25944	405	26	erythema	erythema	NN
25944	405	27	sooner	soon	RBR
25944	405	28	or	or	CC
25944	405	29	later	later	RBR
25944	405	30	subsiding	subsiding	JJ
25944	405	31	.	.	.
25944	406	1	The	the	DT
25944	406	2	same	same	JJ
25944	406	3	may	may	MD
25944	406	4	be	be	VB
25944	406	5	stated	state	VBN
25944	406	6	of	of	IN
25944	406	7	the	the	DT
25944	406	8	symptomatic	symptomatic	JJ
25944	406	9	erythemata	erythemata	NN
25944	406	10	,	,	,
25944	406	11	but	but	CC
25944	406	12	in	in	IN
25944	406	13	these	these	DT
25944	406	14	there	there	EX
25944	406	15	is	be	VBZ
25944	406	16	at	at	IN
25944	406	17	times	time	NNS
25944	406	18	difficulty	difficulty	NN
25944	406	19	in	in	IN
25944	406	20	recognizing	recognize	VBG
25944	406	21	the	the	DT
25944	406	22	etiological	etiological	JJ
25944	406	23	factor	factor	NN
25944	406	24	;	;	,
25944	406	25	constitutional	constitutional	JJ
25944	406	26	treatment	treatment	NN
25944	406	27	,	,	,
25944	406	28	if	if	IN
25944	406	29	necessary	necessary	JJ
25944	406	30	,	,	,
25944	406	31	is	be	VBZ
25944	406	32	to	to	TO
25944	406	33	be	be	VB
25944	406	34	based	base	VBN
25944	406	35	upon	upon	IN
25944	406	36	general	general	JJ
25944	406	37	principles	principle	NNS
25944	406	38	.	.	.
25944	407	1	Intestinal	intestinal	JJ
25944	407	2	antiseptics	antiseptic	NNS
25944	407	3	are	be	VBP
25944	407	4	useful	useful	JJ
25944	407	5	in	in	IN
25944	407	6	some	some	DT
25944	407	7	instances	instance	NNS
25944	407	8	.	.	.
25944	408	1	Local	local	JJ
25944	408	2	treatment	treatment	NN
25944	408	3	,	,	,
25944	408	4	which	which	WDT
25944	408	5	is	be	VBZ
25944	408	6	rarely	rarely	RB
25944	408	7	needed	need	VBN
25944	408	8	,	,	,
25944	408	9	consists	consist	VBZ
25944	408	10	of	of	IN
25944	408	11	the	the	DT
25944	408	12	use	use	NN
25944	408	13	of	of	IN
25944	408	14	dusting	dusting	NN
25944	408	15	-	-	HYPH
25944	408	16	powders	powder	NNS
25944	408	17	or	or	CC
25944	408	18	mild	mild	JJ
25944	408	19	cooling	cooling	JJ
25944	408	20	and	and	CC
25944	408	21	astringent	astringent	JJ
25944	408	22	lotions	lotion	NNS
25944	408	23	,	,	,
25944	408	24	such	such	JJ
25944	408	25	as	as	IN
25944	408	26	are	be	VBP
25944	408	27	employed	employ	VBN
25944	408	28	in	in	IN
25944	408	29	the	the	DT
25944	408	30	treatment	treatment	NN
25944	408	31	of	of	IN
25944	408	32	acute	acute	JJ
25944	408	33	eczema	eczema	NNP
25944	408	34	(	(	-LRB-
25944	408	35	q.	q.	NNP
25944	408	36	v.	v.	NNP
25944	408	37	)	)	-RRB-
25944	408	38	.	.	.
25944	409	1	#	#	NNP
25944	409	2	Erythema	Erythema	NNP
25944	409	3	Intertrigo	Intertrigo	NNP
25944	409	4	.	.	.
25944	409	5	#	#	NNP
25944	409	6	(	(	-LRB-
25944	409	7	_	_	NNP
25944	409	8	Synonym	Synonym	NNP
25944	409	9	:	:	:
25944	409	10	_	_	NNP
25944	409	11	Chafing	Chafing	NNP
25944	409	12	.	.	.
25944	409	13	)	)	-RRB-
25944	410	1	#	#	LS
25944	410	2	What	what	WP
25944	410	3	do	do	VBP
25944	410	4	you	-PRON-	PRP
25944	410	5	understand	understand	VB
25944	410	6	by	by	IN
25944	410	7	erythema	erythema	NNP
25944	410	8	intertrigo	intertrigo	NNP
25944	410	9	?	?	.
25944	410	10	#	#	NNP
25944	410	11	Erythema	Erythema	NNP
25944	410	12	intertrigo	intertrigo	NNS
25944	410	13	is	be	VBZ
25944	410	14	a	a	DT
25944	410	15	hyperæmic	hyperæmic	JJ
25944	410	16	disorder	disorder	NN
25944	410	17	occurring	occur	VBG
25944	410	18	on	on	IN
25944	410	19	parts	part	NNS
25944	410	20	where	where	WRB
25944	410	21	the	the	DT
25944	410	22	natural	natural	JJ
25944	410	23	folds	fold	NNS
25944	410	24	of	of	IN
25944	410	25	the	the	DT
25944	410	26	skin	skin	NN
25944	410	27	come	come	VBP
25944	410	28	in	in	IN
25944	410	29	contact	contact	NN
25944	410	30	,	,	,
25944	410	31	and	and	CC
25944	410	32	is	be	VBZ
25944	410	33	characterized	characterize	VBN
25944	410	34	by	by	IN
25944	410	35	redness	redness	NN
25944	410	36	,	,	,
25944	410	37	to	to	TO
25944	410	38	which	which	WDT
25944	410	39	may	may	MD
25944	410	40	be	be	VB
25944	410	41	added	add	VBN
25944	410	42	an	an	DT
25944	410	43	abraded	abrade	VBN
25944	410	44	surface	surface	NN
25944	410	45	and	and	CC
25944	410	46	maceration	maceration	NN
25944	410	47	of	of	IN
25944	410	48	the	the	DT
25944	410	49	epidermis	epidermis	NN
25944	410	50	.	.	.
25944	411	1	#	#	NNP
25944	411	2	Describe	describe	VB
25944	411	3	the	the	DT
25944	411	4	symptoms	symptom	NNS
25944	411	5	of	of	IN
25944	411	6	erythema	erythema	NNP
25944	411	7	intertrigo	intertrigo	NNP
25944	411	8	.	.	.
25944	411	9	#	#	$
25944	411	10	The	the	DT
25944	411	11	skin	skin	NN
25944	411	12	of	of	IN
25944	411	13	the	the	DT
25944	411	14	involved	involved	JJ
25944	411	15	region	region	NN
25944	411	16	gradually	gradually	RB
25944	411	17	becomes	become	VBZ
25944	411	18	hyperæmic	hyperæmic	JJ
25944	411	19	,	,	,
25944	411	20	but	but	CC
25944	411	21	is	be	VBZ
25944	411	22	without	without	IN
25944	411	23	elevation	elevation	NN
25944	411	24	or	or	CC
25944	411	25	infiltration	infiltration	NN
25944	411	26	;	;	,
25944	411	27	a	a	DT
25944	411	28	feeling	feeling	NN
25944	411	29	of	of	IN
25944	411	30	heat	heat	NN
25944	411	31	and	and	CC
25944	411	32	soreness	soreness	NN
25944	411	33	is	be	VBZ
25944	411	34	usually	usually	RB
25944	411	35	experienced	experience	VBN
25944	411	36	.	.	.
25944	412	1	If	if	IN
25944	412	2	the	the	DT
25944	412	3	condition	condition	NN
25944	412	4	continue	continue	VBP
25944	412	5	,	,	,
25944	412	6	the	the	DT
25944	412	7	increased	increase	VBN
25944	412	8	perspiration	perspiration	NN
25944	412	9	and	and	CC
25944	412	10	moisture	moisture	NN
25944	412	11	of	of	IN
25944	412	12	the	the	DT
25944	412	13	parts	part	NNS
25944	412	14	give	give	VBP
25944	412	15	rise	rise	NN
25944	412	16	to	to	IN
25944	412	17	maceration	maceration	NN
25944	412	18	of	of	IN
25944	412	19	the	the	DT
25944	412	20	epidermis	epidermis	NNP
25944	412	21	and	and	CC
25944	412	22	a	a	DT
25944	412	23	mucoid	mucoid	NN
25944	412	24	discharge	discharge	NN
25944	412	25	;	;	:
25944	412	26	actual	actual	JJ
25944	412	27	inflammation	inflammation	NN
25944	412	28	may	may	MD
25944	412	29	eventually	eventually	RB
25944	412	30	result	result	VB
25944	412	31	.	.	.
25944	413	1	#	#	LS
25944	413	2	What	what	WP
25944	413	3	is	be	VBZ
25944	413	4	the	the	DT
25944	413	5	course	course	NN
25944	413	6	of	of	IN
25944	413	7	erythema	erythema	JJ
25944	413	8	intertrigo	intertrigo	NNS
25944	413	9	?	?	.
25944	413	10	#	#	$
25944	413	11	The	the	DT
25944	413	12	affection	affection	NN
25944	413	13	may	may	MD
25944	413	14	pass	pass	VB
25944	413	15	away	away	RB
25944	413	16	in	in	IN
25944	413	17	a	a	DT
25944	413	18	few	few	JJ
25944	413	19	days	day	NNS
25944	413	20	or	or	CC
25944	413	21	persist	persist	VB
25944	413	22	several	several	JJ
25944	413	23	weeks	week	NNS
25944	413	24	,	,	,
25944	413	25	the	the	DT
25944	413	26	duration	duration	NN
25944	413	27	depending	depend	VBG
25944	413	28	,	,	,
25944	413	29	in	in	IN
25944	413	30	a	a	DT
25944	413	31	great	great	JJ
25944	413	32	measure	measure	NN
25944	413	33	,	,	,
25944	413	34	upon	upon	IN
25944	413	35	the	the	DT
25944	413	36	cause	cause	NN
25944	413	37	.	.	.
25944	414	1	#	#	$
25944	414	2	Mention	mention	VB
25944	414	3	the	the	DT
25944	414	4	causes	cause	NNS
25944	414	5	of	of	IN
25944	414	6	erythema	erythema	NNP
25944	414	7	intertrigo	intertrigo	NNP
25944	414	8	.	.	.
25944	414	9	#	#	$
25944	414	10	The	the	DT
25944	414	11	causes	cause	NNS
25944	414	12	are	be	VBP
25944	414	13	usually	usually	RB
25944	414	14	local	local	JJ
25944	414	15	.	.	.
25944	415	1	It	-PRON-	PRP
25944	415	2	is	be	VBZ
25944	415	3	seen	see	VBN
25944	415	4	chiefly	chiefly	RB
25944	415	5	in	in	IN
25944	415	6	children	child	NNS
25944	415	7	,	,	,
25944	415	8	especially	especially	RB
25944	415	9	in	in	IN
25944	415	10	fat	fat	JJ
25944	415	11	subjects	subject	NNS
25944	415	12	,	,	,
25944	415	13	in	in	IN
25944	415	14	whom	whom	WP
25944	415	15	friction	friction	NN
25944	415	16	and	and	CC
25944	415	17	moisture	moisture	NN
25944	415	18	of	of	IN
25944	415	19	contiguous	contiguous	JJ
25944	415	20	parts	part	NNS
25944	415	21	of	of	IN
25944	415	22	the	the	DT
25944	415	23	body	body	NN
25944	415	24	,	,	,
25944	415	25	usually	usually	RB
25944	415	26	the	the	DT
25944	415	27	region	region	NN
25944	415	28	of	of	IN
25944	415	29	the	the	DT
25944	415	30	neck	neck	NN
25944	415	31	,	,	,
25944	415	32	buttocks	buttock	NNS
25944	415	33	and	and	CC
25944	415	34	genitalia	genitalia	NNP
25944	415	35	,	,	,
25944	415	36	are	be	VBP
25944	415	37	more	more	RBR
25944	415	38	common	common	JJ
25944	415	39	;	;	:
25944	415	40	in	in	IN
25944	415	41	such	such	JJ
25944	415	42	,	,	,
25944	415	43	uncleanliness	uncleanliness	NN
25944	415	44	or	or	CC
25944	415	45	the	the	DT
25944	415	46	too	too	RB
25944	415	47	free	free	JJ
25944	415	48	use	use	NN
25944	415	49	of	of	IN
25944	415	50	soap	soap	NN
25944	415	51	washings	washing	NNS
25944	415	52	will	will	MD
25944	415	53	often	often	RB
25944	415	54	act	act	VB
25944	415	55	as	as	IN
25944	415	56	the	the	DT
25944	415	57	exciting	exciting	JJ
25944	415	58	factor	factor	NN
25944	415	59	.	.	.
25944	416	1	Disorders	disorder	NNS
25944	416	2	of	of	IN
25944	416	3	the	the	DT
25944	416	4	stomach	stomach	NN
25944	416	5	or	or	CC
25944	416	6	intestinal	intestinal	JJ
25944	416	7	canal	canal	NN
25944	416	8	apparently	apparently	RB
25944	416	9	have	have	VBP
25944	416	10	a	a	DT
25944	416	11	predisposing	predisposing	JJ
25944	416	12	influence	influence	NN
25944	416	13	.	.	.
25944	417	1	#	#	LS
25944	417	2	What	what	WDT
25944	417	3	treatment	treatment	NN
25944	417	4	would	would	MD
25944	417	5	you	-PRON-	PRP
25944	417	6	advise	advise	VB
25944	417	7	in	in	IN
25944	417	8	erythema	erythema	NNP
25944	417	9	intertrigo	intertrigo	NNP
25944	417	10	?	?	.
25944	417	11	#	#	$
25944	417	12	The	the	DT
25944	417	13	folds	fold	NNS
25944	417	14	or	or	CC
25944	417	15	parts	part	NNS
25944	417	16	are	be	VBP
25944	417	17	to	to	TO
25944	417	18	be	be	VB
25944	417	19	kept	keep	VBN
25944	417	20	from	from	IN
25944	417	21	contact	contact	NN
25944	417	22	by	by	IN
25944	417	23	means	mean	NNS
25944	417	24	of	of	IN
25944	417	25	lint	lint	NN
25944	417	26	or	or	CC
25944	417	27	absorbent	absorbent	NN
25944	417	28	cotton	cotton	NN
25944	417	29	;	;	,
25944	417	30	thin	thin	JJ
25944	417	31	,	,	,
25944	417	32	flat	flat	JJ
25944	417	33	bags	bag	NNS
25944	417	34	of	of	IN
25944	417	35	cheese	cheese	NN
25944	417	36	cloth	cloth	NN
25944	417	37	or	or	CC
25944	417	38	similar	similar	JJ
25944	417	39	material	material	NN
25944	417	40	partly	partly	RB
25944	417	41	filled	fill	VBN
25944	417	42	with	with	IN
25944	417	43	dusting	dusting	NN
25944	417	44	-	-	HYPH
25944	417	45	powder	powder	NN
25944	417	46	,	,	,
25944	417	47	and	and	CC
25944	417	48	kept	keep	VBD
25944	417	49	clean	clean	JJ
25944	417	50	by	by	IN
25944	417	51	frequent	frequent	JJ
25944	417	52	changes	change	NNS
25944	417	53	,	,	,
25944	417	54	are	be	VBP
25944	417	55	excellent	excellent	JJ
25944	417	56	for	for	IN
25944	417	57	this	this	DT
25944	417	58	purpose	purpose	NN
25944	417	59	,	,	,
25944	417	60	and	and	CC
25944	417	61	usually	usually	RB
25944	417	62	curative	curative	JJ
25944	417	63	.	.	.
25944	418	1	Cleanliness	cleanliness	NN
25944	418	2	is	be	VBZ
25944	418	3	essential	essential	JJ
25944	418	4	,	,	,
25944	418	5	but	but	CC
25944	418	6	it	-PRON-	PRP
25944	418	7	is	be	VBZ
25944	418	8	to	to	TO
25944	418	9	be	be	VB
25944	418	10	kept	keep	VBN
25944	418	11	within	within	IN
25944	418	12	the	the	DT
25944	418	13	bounds	bound	NNS
25944	418	14	of	of	IN
25944	418	15	common	common	JJ
25944	418	16	sense	sense	NN
25944	418	17	.	.	.
25944	419	1	Dusting	dusting	NN
25944	419	2	-	-	HYPH
25944	419	3	powders	powder	NNS
25944	419	4	and	and	CC
25944	419	5	cooling	cooling	NN
25944	419	6	and	and	CC
25944	419	7	astringent	astringent	JJ
25944	419	8	lotions	lotion	NNS
25944	419	9	,	,	,
25944	419	10	such	such	JJ
25944	419	11	as	as	IN
25944	419	12	are	be	VBP
25944	419	13	employed	employ	VBN
25944	419	14	in	in	IN
25944	419	15	the	the	DT
25944	419	16	treatment	treatment	NN
25944	419	17	of	of	IN
25944	419	18	acute	acute	JJ
25944	419	19	eczema	eczema	NN
25944	419	20	(	(	-LRB-
25944	419	21	_	_	NNP
25944	419	22	q	q	NNP
25944	419	23	.	.	.
25944	420	1	v.	v.	NNP
25944	420	2	_	_	NNP
25944	420	3	)	)	-RRB-
25944	420	4	,	,	,
25944	420	5	can	can	MD
25944	420	6	also	also	RB
25944	420	7	be	be	VB
25944	420	8	advised	advise	VBN
25944	420	9	.	.	.
25944	421	1	The	the	DT
25944	421	2	following	follow	VBG
25944	421	3	lotion	lotion	NN
25944	421	4	is	be	VBZ
25944	421	5	valuable:--	valuable:--	NNP
25944	421	6	[	[	-LRB-
25944	421	7	Rx	Rx	NNP
25944	421	8	]	]	-RRB-
25944	421	9	Pulv	Pulv	NNP
25944	421	10	.	.	.
25944	422	1	calaminæ	calaminæ	NNP
25944	422	2	,	,	,
25944	422	3	Pulv	Pulv	NNP
25944	422	4	.	.	.
25944	423	1	zinci	zinci	NNP
25944	423	2	oxidi	oxidi	NNP
25944	423	3	,	,	,
25944	423	4	..	..	NFP
25944	423	5	[	[	-LRB-
25944	423	6	=	=	SYM
25944	423	7	a][=a	a][=a	CD
25944	423	8	]	]	-RRB-
25944	423	9	......	......	NFP
25944	423	10	[	[	-LRB-
25944	423	11	dram]iss	dram]iss	NNP
25944	423	12	.	.	.
25944	424	1	Glycerinæ	Glycerinæ	NNP
25944	424	2	,	,	,
25944	424	3	..........................	..........................	NFP
25944	424	4	[	[	-LRB-
25944	424	5	minum]xxx	minum]xxx	NNP
25944	424	6	Alcoholis	Alcoholis	NNP
25944	424	7	,	,	,
25944	424	8	..........................	..........................	.
25944	424	9	f[dram]ij	f[dram]ij	NFP
25944	424	10	Aquæ	Aquæ	NNP
25944	424	11	,	,	,
25944	424	12	...............................	...............................	NFP
25944	424	13	Oss	oss	NN
25944	424	14	.	.	.
25944	425	1	M.	M.	NNP
25944	425	2	Exceptionally	exceptionally	RB
25944	425	3	a	a	DT
25944	425	4	mild	mild	JJ
25944	425	5	ointment	ointment	NN
25944	425	6	,	,	,
25944	425	7	alone	alone	JJ
25944	425	8	or	or	CC
25944	425	9	supplementary	supplementary	JJ
25944	425	10	to	to	IN
25944	425	11	a	a	DT
25944	425	12	lotion	lotion	NN
25944	425	13	,	,	,
25944	425	14	acts	act	VBZ
25944	425	15	more	more	RBR
25944	425	16	satisfactorily	satisfactorily	RB
25944	425	17	.	.	.
25944	426	1	In	in	IN
25944	426	2	persistent	persistent	JJ
25944	426	3	or	or	CC
25944	426	4	obstinate	obstinate	NN
25944	426	5	cases	case	NNS
25944	426	6	attention	attention	NN
25944	426	7	should	should	MD
25944	426	8	also	also	RB
25944	426	9	be	be	VB
25944	426	10	directed	direct	VBN
25944	426	11	to	to	IN
25944	426	12	the	the	DT
25944	426	13	state	state	NN
25944	426	14	of	of	IN
25944	426	15	the	the	DT
25944	426	16	general	general	JJ
25944	426	17	health	health	NN
25944	426	18	,	,	,
25944	426	19	especially	especially	RB
25944	426	20	as	as	IN
25944	426	21	regards	regard	VBZ
25944	426	22	the	the	DT
25944	426	23	digestive	digestive	JJ
25944	426	24	tract	tract	NN
25944	426	25	.	.	.
25944	427	1	#	#	NNP
25944	427	2	Erythema	Erythema	NNP
25944	427	3	Multiforme	Multiforme	NNP
25944	427	4	.	.	.
25944	427	5	#	#	$
25944	427	6	#	#	$
25944	427	7	What	what	WP
25944	427	8	is	be	VBZ
25944	427	9	erythema	erythema	NNP
25944	427	10	multiforme	multiforme	NN
25944	427	11	?	?	.
25944	427	12	#	#	NNP
25944	427	13	Erythema	Erythema	NNP
25944	427	14	multiforme	multiforme	NN
25944	427	15	is	be	VBZ
25944	427	16	an	an	DT
25944	427	17	acute	acute	JJ
25944	427	18	,	,	,
25944	427	19	inflammatory	inflammatory	JJ
25944	427	20	disease	disease	NN
25944	427	21	,	,	,
25944	427	22	characterized	characterize	VBN
25944	427	23	by	by	IN
25944	427	24	reddish	reddish	JJ
25944	427	25	,	,	,
25944	427	26	more	more	RBR
25944	427	27	or	or	CC
25944	427	28	less	less	RBR
25944	427	29	variegated	variegated	JJ
25944	427	30	macules	macule	NNS
25944	427	31	,	,	,
25944	427	32	papules	papule	NNS
25944	427	33	,	,	,
25944	427	34	and	and	CC
25944	427	35	tubercles	tubercle	NNS
25944	427	36	,	,	,
25944	427	37	occurring	occur	VBG
25944	427	38	as	as	IN
25944	427	39	discrete	discrete	JJ
25944	427	40	lesions	lesion	NNS
25944	427	41	or	or	CC
25944	427	42	in	in	IN
25944	427	43	patches	patch	NNS
25944	427	44	of	of	IN
25944	427	45	various	various	JJ
25944	427	46	size	size	NN
25944	427	47	and	and	CC
25944	427	48	shape	shape	NN
25944	427	49	.	.	.
25944	428	1	#	#	NN
25944	428	2	Upon	upon	IN
25944	428	3	what	what	WP
25944	428	4	parts	part	NNS
25944	428	5	of	of	IN
25944	428	6	the	the	DT
25944	428	7	body	body	NN
25944	428	8	does	do	VBZ
25944	428	9	the	the	DT
25944	428	10	eruption	eruption	NN
25944	428	11	appear	appear	VB
25944	428	12	?	?	.
25944	428	13	#	#	$
25944	428	14	Usually	usually	RB
25944	428	15	upon	upon	IN
25944	428	16	the	the	DT
25944	428	17	extremities	extremity	NNS
25944	428	18	,	,	,
25944	428	19	especially	especially	RB
25944	428	20	the	the	DT
25944	428	21	dorsal	dorsal	NN
25944	428	22	aspect	aspect	NN
25944	428	23	,	,	,
25944	428	24	from	from	IN
25944	428	25	the	the	DT
25944	428	26	knees	knee	NNS
25944	428	27	and	and	CC
25944	428	28	elbows	elbow	VBZ
25944	428	29	down	down	RB
25944	428	30	,	,	,
25944	428	31	and	and	CC
25944	428	32	about	about	IN
25944	428	33	the	the	DT
25944	428	34	face	face	NN
25944	428	35	and	and	CC
25944	428	36	neck	neck	NN
25944	428	37	;	;	:
25944	428	38	it	-PRON-	PRP
25944	428	39	may	may	MD
25944	428	40	,	,	,
25944	428	41	however	however	RB
25944	428	42	,	,	,
25944	428	43	be	be	VB
25944	428	44	more	more	RBR
25944	428	45	or	or	CC
25944	428	46	less	less	RBR
25944	428	47	general	general	JJ
25944	428	48	.	.	.
25944	429	1	#	#	NNP
25944	429	2	Describe	describe	VB
25944	429	3	the	the	DT
25944	429	4	symptoms	symptom	NNS
25944	429	5	of	of	IN
25944	429	6	erythema	erythema	NNP
25944	429	7	multiforme	multiforme	NNP
25944	429	8	.	.	.
25944	429	9	#	#	$
25944	429	10	With	with	IN
25944	429	11	or	or	CC
25944	429	12	without	without	IN
25944	429	13	precursory	precursory	JJ
25944	429	14	symptoms	symptom	NNS
25944	429	15	of	of	IN
25944	429	16	malaise	malaise	NN
25944	429	17	,	,	,
25944	429	18	gastric	gastric	JJ
25944	429	19	uneasiness	uneasiness	NN
25944	429	20	or	or	CC
25944	429	21	rheumatic	rheumatic	JJ
25944	429	22	pains	pain	NNS
25944	429	23	,	,	,
25944	429	24	the	the	DT
25944	429	25	eruption	eruption	NN
25944	429	26	suddenly	suddenly	RB
25944	429	27	makes	make	VBZ
25944	429	28	its	-PRON-	PRP$
25944	429	29	appearance	appearance	NN
25944	429	30	,	,	,
25944	429	31	assuming	assume	VBG
25944	429	32	an	an	DT
25944	429	33	erythematous	erythematous	JJ
25944	429	34	,	,	,
25944	429	35	papular	papular	JJ
25944	429	36	,	,	,
25944	429	37	tubercular	tubercular	JJ
25944	429	38	or	or	CC
25944	429	39	mixed	mixed	JJ
25944	429	40	character	character	NN
25944	429	41	;	;	,
25944	429	42	as	as	IN
25944	429	43	a	a	DT
25944	429	44	rule	rule	NN
25944	429	45	,	,	,
25944	429	46	one	one	CD
25944	429	47	type	type	NN
25944	429	48	of	of	IN
25944	429	49	lesion	lesion	NN
25944	429	50	predominates	predominate	VBZ
25944	429	51	.	.	.
25944	430	1	The	the	DT
25944	430	2	lesions	lesion	NNS
25944	430	3	tend	tend	VBP
25944	430	4	to	to	TO
25944	430	5	increase	increase	VB
25944	430	6	in	in	IN
25944	430	7	size	size	NN
25944	430	8	and	and	CC
25944	430	9	intensity	intensity	NN
25944	430	10	,	,	,
25944	430	11	remain	remain	VBP
25944	430	12	stationary	stationary	JJ
25944	430	13	for	for	IN
25944	430	14	several	several	JJ
25944	430	15	days	day	NNS
25944	430	16	or	or	CC
25944	430	17	a	a	DT
25944	430	18	week	week	NN
25944	430	19	,	,	,
25944	430	20	and	and	CC
25944	430	21	then	then	RB
25944	430	22	gradually	gradually	RB
25944	430	23	fade	fade	VB
25944	430	24	;	;	:
25944	430	25	during	during	IN
25944	430	26	this	this	DT
25944	430	27	time	time	NN
25944	430	28	there	there	EX
25944	430	29	may	may	MD
25944	430	30	have	have	VB
25944	430	31	been	be	VBN
25944	430	32	outbreaks	outbreak	NNS
25944	430	33	of	of	IN
25944	430	34	new	new	JJ
25944	430	35	lesions	lesion	NNS
25944	430	36	.	.	.
25944	431	1	In	in	IN
25944	431	2	color	color	NN
25944	431	3	they	-PRON-	PRP
25944	431	4	are	be	VBP
25944	431	5	pink	pink	JJ
25944	431	6	,	,	,
25944	431	7	red	red	JJ
25944	431	8	,	,	,
25944	431	9	or	or	CC
25944	431	10	violaceous	violaceous	JJ
25944	431	11	.	.	.
25944	432	1	Slight	slight	JJ
25944	432	2	itching	itching	NN
25944	432	3	may	may	MD
25944	432	4	or	or	CC
25944	432	5	may	may	MD
25944	432	6	not	not	RB
25944	432	7	be	be	VB
25944	432	8	present	present	JJ
25944	432	9	.	.	.
25944	433	1	Exceptionally	exceptionally	RB
25944	433	2	,	,	,
25944	433	3	in	in	IN
25944	433	4	general	general	JJ
25944	433	5	cases	case	NNS
25944	433	6	,	,	,
25944	433	7	the	the	DT
25944	433	8	eruption	eruption	NN
25944	433	9	partakes	partake	NNS
25944	433	10	of	of	IN
25944	433	11	the	the	DT
25944	433	12	nature	nature	NN
25944	433	13	of	of	IN
25944	433	14	both	both	CC
25944	433	15	urticaria	urticaria	NNP
25944	433	16	and	and	CC
25944	433	17	erythema	erythema	NNP
25944	433	18	multiforme	multiforme	NN
25944	433	19	,	,	,
25944	433	20	and	and	CC
25944	433	21	itching	itching	NN
25944	433	22	may	may	MD
25944	433	23	be	be	VB
25944	433	24	quite	quite	PDT
25944	433	25	a	a	DT
25944	433	26	decided	decide	VBN
25944	433	27	symptom	symptom	NN
25944	433	28	.	.	.
25944	434	1	In	in	IN
25944	434	2	some	some	DT
25944	434	3	instances	instance	NNS
25944	434	4	there	there	RB
25944	434	5	is	be	VBZ
25944	434	6	preceding	precede	VBG
25944	434	7	and	and	CC
25944	434	8	accompanying	accompany	VBG
25944	434	9	febrile	febrile	NN
25944	434	10	action	action	NN
25944	434	11	,	,	,
25944	434	12	usually	usually	RB
25944	434	13	slight	slight	JJ
25944	434	14	in	in	IN
25944	434	15	character	character	NN
25944	434	16	;	;	:
25944	434	17	in	in	IN
25944	434	18	others	other	NNS
25944	434	19	there	there	RB
25944	434	20	may	may	MD
25944	434	21	be	be	VB
25944	434	22	some	some	DT
25944	434	23	rheumatic	rheumatic	JJ
25944	434	24	swelling	swelling	NN
25944	434	25	of	of	IN
25944	434	26	one	one	CD
25944	434	27	or	or	CC
25944	434	28	more	more	JJR
25944	434	29	joints	joint	NNS
25944	434	30	.	.	.
25944	435	1	[	[	-LRB-
25944	435	2	Illustration	illustration	NN
25944	435	3	:	:	:
25944	435	4	Fig	Fig	NNP
25944	435	5	.	.	.
25944	436	1	11	11	CD
25944	436	2	.	.	.
25944	437	1	Erythema	Erythema	NNP
25944	437	2	Multiforme	Multiforme	NNP
25944	437	3	,	,	,
25944	437	4	in	in	IN
25944	437	5	which	which	WDT
25944	437	6	many	many	JJ
25944	437	7	of	of	IN
25944	437	8	the	the	DT
25944	437	9	lesions	lesion	NNS
25944	437	10	have	have	VBP
25944	437	11	become	become	VBN
25944	437	12	bullous	bullous	JJ
25944	437	13	--	--	:
25944	437	14	Erythema	Erythema	NNP
25944	437	15	Bullosum	Bullosum	NNP
25944	437	16	.	.	.
25944	437	17	]	]	-RRB-
25944	438	1	#	#	$
25944	438	2	What	what	WDT
25944	438	3	type	type	NN
25944	438	4	of	of	IN
25944	438	5	the	the	DT
25944	438	6	eruption	eruption	NN
25944	438	7	is	be	VBZ
25944	438	8	most	most	RBS
25944	438	9	common	common	JJ
25944	438	10	?	?	.
25944	438	11	#	#	$
25944	438	12	The	the	DT
25944	438	13	papular	papular	JJ
25944	438	14	,	,	,
25944	438	15	appearing	appear	VBG
25944	438	16	usually	usually	RB
25944	438	17	upon	upon	IN
25944	438	18	the	the	DT
25944	438	19	backs	back	NNS
25944	438	20	of	of	IN
25944	438	21	the	the	DT
25944	438	22	hands	hand	NNS
25944	438	23	and	and	CC
25944	438	24	forearms	forearm	NNS
25944	438	25	,	,	,
25944	438	26	and	and	CC
25944	438	27	not	not	RB
25944	438	28	infrequently	infrequently	RB
25944	438	29	,	,	,
25944	438	30	also	also	RB
25944	438	31	,	,	,
25944	438	32	upon	upon	IN
25944	438	33	the	the	DT
25944	438	34	face	face	NN
25944	438	35	,	,	,
25944	438	36	legs	leg	NNS
25944	438	37	and	and	CC
25944	438	38	feet	foot	NNS
25944	438	39	.	.	.
25944	439	1	The	the	DT
25944	439	2	papules	papule	NNS
25944	439	3	are	be	VBP
25944	439	4	usually	usually	RB
25944	439	5	pea	pea	JJ
25944	439	6	-	-	HYPH
25944	439	7	sized	sized	JJ
25944	439	8	,	,	,
25944	439	9	flattened	flatten	VBD
25944	439	10	,	,	,
25944	439	11	and	and	CC
25944	439	12	of	of	IN
25944	439	13	a	a	DT
25944	439	14	dark	dark	JJ
25944	439	15	red	red	JJ
25944	439	16	or	or	CC
25944	439	17	violaceous	violaceous	JJ
25944	439	18	color	color	NN
25944	439	19	.	.	.
25944	440	1	#	#	NNP
25944	440	2	Describe	describe	VB
25944	440	3	the	the	DT
25944	440	4	various	various	JJ
25944	440	5	shapes	shape	NNS
25944	440	6	which	which	WDT
25944	440	7	the	the	DT
25944	440	8	erythematous	erythematous	JJ
25944	440	9	lesions	lesion	NNS
25944	440	10	may	may	MD
25944	440	11	assume	assume	VB
25944	440	12	.	.	.
25944	440	13	#	#	$
25944	440	14	Often	often	RB
25944	440	15	the	the	DT
25944	440	16	patches	patch	NNS
25944	440	17	are	be	VBP
25944	440	18	distinctly	distinctly	RB
25944	440	19	ring	re	VBG
25944	440	20	-	-	HYPH
25944	440	21	shaped	shaped	JJ
25944	440	22	,	,	,
25944	440	23	with	with	IN
25944	440	24	a	a	DT
25944	440	25	clear	clear	JJ
25944	440	26	centre--_erythema	centre--_erythema	NNP
25944	440	27	annulare	annulare	NNP
25944	440	28	_	_	NNP
25944	440	29	;	;	:
25944	440	30	or	or	CC
25944	440	31	they	-PRON-	PRP
25944	440	32	are	be	VBP
25944	440	33	made	make	VBN
25944	440	34	up	up	RP
25944	440	35	of	of	IN
25944	440	36	several	several	JJ
25944	440	37	concentric	concentric	JJ
25944	440	38	rings	ring	NNS
25944	440	39	,	,	,
25944	440	40	presenting	present	VBG
25944	440	41	variegated	variegate	VBN
25944	440	42	coloring--_erythema	coloring--_erythema	NNP
25944	440	43	iris	iris	NNP
25944	440	44	_	_	NNP
25944	440	45	;	;	:
25944	440	46	or	or	CC
25944	440	47	a	a	DT
25944	440	48	more	more	RBR
25944	440	49	or	or	CC
25944	440	50	less	less	RBR
25944	440	51	extensive	extensive	JJ
25944	440	52	patch	patch	NN
25944	440	53	may	may	MD
25944	440	54	spread	spread	VB
25944	440	55	with	with	IN
25944	440	56	a	a	DT
25944	440	57	sharply	sharply	RB
25944	440	58	-	-	HYPH
25944	440	59	defined	define	VBN
25944	440	60	border	border	NN
25944	440	61	,	,	,
25944	440	62	the	the	DT
25944	440	63	older	old	JJR
25944	440	64	part	part	NN
25944	440	65	tending	tend	VBG
25944	440	66	to	to	IN
25944	440	67	fade--_erythema	fade--_erythema	CD
25944	440	68	marginatum	marginatum	JJ
25944	440	69	_	_	NNP
25944	440	70	;	;	:
25944	440	71	or	or	CC
25944	440	72	several	several	JJ
25944	440	73	rings	ring	NNS
25944	440	74	may	may	MD
25944	440	75	coalesce	coalesce	VB
25944	440	76	,	,	,
25944	440	77	with	with	IN
25944	440	78	a	a	DT
25944	440	79	disappearance	disappearance	NN
25944	440	80	of	of	IN
25944	440	81	the	the	DT
25944	440	82	coalescing	coalescing	NN
25944	440	83	parts	part	NNS
25944	440	84	,	,	,
25944	440	85	and	and	CC
25944	440	86	serpentine	serpentine	NN
25944	440	87	lines	line	NNS
25944	440	88	or	or	CC
25944	440	89	bands	band	NNS
25944	440	90	result--_erythema	result--_erythema	ADD
25944	440	91	gyratum	gyratum	NN
25944	440	92	_	_	NNP
25944	440	93	.	.	.
25944	441	1	#	#	NNP
25944	441	2	Does	do	VBZ
25944	441	3	the	the	DT
25944	441	4	eruption	eruption	NN
25944	441	5	of	of	IN
25944	441	6	erythema	erythema	NNP
25944	441	7	multiforme	multiforme	NNP
25944	441	8	ever	ever	RB
25944	441	9	assume	assume	VBP
25944	441	10	a	a	DT
25944	441	11	vesicular	vesicular	JJ
25944	441	12	or	or	CC
25944	441	13	bullous	bullous	JJ
25944	441	14	character	character	NN
25944	441	15	?	?	.
25944	441	16	#	#	NN
25944	441	17	Yes	yes	UH
25944	441	18	.	.	.
25944	442	1	In	in	IN
25944	442	2	exceptional	exceptional	JJ
25944	442	3	instances	instance	NNS
25944	442	4	,	,	,
25944	442	5	the	the	DT
25944	442	6	inflammatory	inflammatory	JJ
25944	442	7	process	process	NN
25944	442	8	may	may	MD
25944	442	9	be	be	VB
25944	442	10	sufficiently	sufficiently	RB
25944	442	11	intense	intense	JJ
25944	442	12	to	to	TO
25944	442	13	produce	produce	VB
25944	442	14	vesiculation	vesiculation	NN
25944	442	15	,	,	,
25944	442	16	usually	usually	RB
25944	442	17	at	at	IN
25944	442	18	the	the	DT
25944	442	19	summits	summit	NNS
25944	442	20	of	of	IN
25944	442	21	the	the	DT
25944	442	22	papules--_erythema	papules--_erythema	NNP
25944	442	23	vesiculosum	vesiculosum	NNP
25944	442	24	_	_	NNP
25944	442	25	;	;	:
25944	442	26	and	and	CC
25944	442	27	in	in	IN
25944	442	28	some	some	DT
25944	442	29	instances	instance	NNS
25944	442	30	,	,	,
25944	442	31	blebs	blebs	NN
25944	442	32	may	may	MD
25944	442	33	be	be	VB
25944	442	34	formed--_erythema	formed--_erythema	NNP
25944	442	35	bullosum	bullosum	NNP
25944	442	36	_	_	NNP
25944	442	37	.	.	.
25944	443	1	A	a	DT
25944	443	2	vesicular	vesicular	JJ
25944	443	3	or	or	CC
25944	443	4	bullous	bullous	JJ
25944	443	5	lesion	lesion	NN
25944	443	6	may	may	MD
25944	443	7	become	become	VB
25944	443	8	immediately	immediately	RB
25944	443	9	surrounded	surround	VBN
25944	443	10	by	by	IN
25944	443	11	a	a	DT
25944	443	12	ring	ring	NN
25944	443	13	-	-	HYPH
25944	443	14	like	like	JJ
25944	443	15	vesicle	vesicle	NN
25944	443	16	or	or	CC
25944	443	17	bleb	bleb	NN
25944	443	18	,	,	,
25944	443	19	and	and	CC
25944	443	20	outside	outside	IN
25944	443	21	of	of	IN
25944	443	22	this	this	DT
25944	443	23	another	another	DT
25944	443	24	form	form	NN
25944	443	25	;	;	:
25944	443	26	a	a	DT
25944	443	27	patch	patch	NN
25944	443	28	may	may	MD
25944	443	29	be	be	VB
25944	443	30	made	make	VBN
25944	443	31	up	up	RP
25944	443	32	of	of	IN
25944	443	33	as	as	RB
25944	443	34	many	many	JJ
25944	443	35	as	as	IN
25944	443	36	several	several	JJ
25944	443	37	such	such	JJ
25944	443	38	rings--_herpes	rings--_herpes	-LRB-
25944	443	39	iris	iris	NNP
25944	443	40	_	_	NNP
25944	443	41	.	.	.
25944	444	1	In	in	IN
25944	444	2	the	the	DT
25944	444	3	vesicular	vesicular	JJ
25944	444	4	and	and	CC
25944	444	5	bullous	bullous	JJ
25944	444	6	cases	case	NNS
25944	444	7	the	the	DT
25944	444	8	lips	lip	NNS
25944	444	9	and	and	CC
25944	444	10	the	the	DT
25944	444	11	mucous	mucous	JJ
25944	444	12	membranes	membrane	NNS
25944	444	13	of	of	IN
25944	444	14	the	the	DT
25944	444	15	mouth	mouth	NN
25944	444	16	and	and	CC
25944	444	17	nose	nose	NN
25944	444	18	also	also	RB
25944	444	19	may	may	MD
25944	444	20	be	be	VB
25944	444	21	the	the	DT
25944	444	22	seat	seat	NN
25944	444	23	of	of	IN
25944	444	24	similar	similar	JJ
25944	444	25	lesions	lesion	NNS
25944	444	26	.	.	.
25944	445	1	#	#	LS
25944	445	2	What	what	WP
25944	445	3	is	be	VBZ
25944	445	4	the	the	DT
25944	445	5	course	course	NN
25944	445	6	of	of	IN
25944	445	7	erythema	erythema	NNP
25944	445	8	multiforme	multiforme	NN
25944	445	9	?	?	.
25944	445	10	#	#	RBR
25944	445	11	Acute	acute	RB
25944	445	12	,	,	,
25944	445	13	the	the	DT
25944	445	14	symptoms	symptom	NNS
25944	445	15	disappearing	disappear	VBG
25944	445	16	spontaneously	spontaneously	RB
25944	445	17	,	,	,
25944	445	18	usually	usually	RB
25944	445	19	in	in	IN
25944	445	20	one	one	CD
25944	445	21	to	to	IN
25944	445	22	three	three	CD
25944	445	23	or	or	CC
25944	445	24	four	four	CD
25944	445	25	weeks	week	NNS
25944	445	26	.	.	.
25944	446	1	In	in	IN
25944	446	2	some	some	DT
25944	446	3	instances	instance	NNS
25944	446	4	the	the	DT
25944	446	5	recurrences	recurrence	NNS
25944	446	6	take	take	VB
25944	446	7	place	place	NN
25944	446	8	so	so	RB
25944	446	9	rapidly	rapidly	RB
25944	446	10	that	that	IN
25944	446	11	the	the	DT
25944	446	12	disease	disease	NN
25944	446	13	assumes	assume	VBZ
25944	446	14	a	a	DT
25944	446	15	chronic	chronic	JJ
25944	446	16	aspect	aspect	NN
25944	446	17	;	;	:
25944	446	18	it	-PRON-	PRP
25944	446	19	is	be	VBZ
25944	446	20	possible	possible	JJ
25944	446	21	that	that	IN
25944	446	22	such	such	JJ
25944	446	23	cases	case	NNS
25944	446	24	are	be	VBP
25944	446	25	midway	midway	NN
25944	446	26	cases	case	NNS
25944	446	27	between	between	IN
25944	446	28	this	this	DT
25944	446	29	disease	disease	NN
25944	446	30	and	and	CC
25944	446	31	dermatitis	dermatitis	NN
25944	446	32	herpetiformis	herpetiformis	NNP
25944	446	33	.	.	.
25944	447	1	#	#	$
25944	447	2	Mention	mention	VB
25944	447	3	the	the	DT
25944	447	4	etiological	etiological	JJ
25944	447	5	factors	factor	NNS
25944	447	6	in	in	IN
25944	447	7	erythema	erythema	NNP
25944	447	8	multiforme	multiforme	NN
25944	447	9	.	.	.
25944	447	10	#	#	$
25944	447	11	The	the	DT
25944	447	12	causes	cause	NNS
25944	447	13	are	be	VBP
25944	447	14	obscure	obscure	JJ
25944	447	15	.	.	.
25944	448	1	Digestive	digestive	JJ
25944	448	2	disturbance	disturbance	NN
25944	448	3	,	,	,
25944	448	4	rheumatic	rheumatic	JJ
25944	448	5	conditions	condition	NNS
25944	448	6	,	,	,
25944	448	7	and	and	CC
25944	448	8	the	the	DT
25944	448	9	ingestion	ingestion	NN
25944	448	10	of	of	IN
25944	448	11	certain	certain	JJ
25944	448	12	drugs	drug	NNS
25944	448	13	are	be	VBP
25944	448	14	at	at	IN
25944	448	15	times	time	NNS
25944	448	16	influential	influential	JJ
25944	448	17	.	.	.
25944	449	1	Intestinal	intestinal	JJ
25944	449	2	toxins	toxin	NNS
25944	449	3	are	be	VBP
25944	449	4	doubtless	doubtless	RB
25944	449	5	important	important	JJ
25944	449	6	etiological	etiological	JJ
25944	449	7	factors	factor	NNS
25944	449	8	in	in	IN
25944	449	9	some	some	DT
25944	449	10	cases	case	NNS
25944	449	11	.	.	.
25944	450	1	Certain	certain	JJ
25944	450	2	foods	food	NNS
25944	450	3	,	,	,
25944	450	4	such	such	JJ
25944	450	5	as	as	IN
25944	450	6	are	be	VBP
25944	450	7	apt	apt	JJ
25944	450	8	to	to	TO
25944	450	9	undergo	undergo	VB
25944	450	10	rapid	rapid	JJ
25944	450	11	putrefactive	putrefactive	JJ
25944	450	12	or	or	CC
25944	450	13	fermentative	fermentative	JJ
25944	450	14	change	change	NN
25944	450	15	,	,	,
25944	450	16	especially	especially	RB
25944	450	17	pork	pork	NN
25944	450	18	meats	meat	NNS
25944	450	19	,	,	,
25944	450	20	oysters	oyster	NNS
25944	450	21	,	,	,
25944	450	22	fish	fish	NN
25944	450	23	,	,	,
25944	450	24	crabs	crab	NNS
25944	450	25	,	,	,
25944	450	26	lobsters	lobster	NNS
25944	450	27	,	,	,
25944	450	28	etc	etc	FW
25944	450	29	.	.	.
25944	450	30	,	,	,
25944	450	31	are	be	VBP
25944	450	32	,	,	,
25944	450	33	therefore	therefore	RB
25944	450	34	,	,	,
25944	450	35	not	not	RB
25944	450	36	infrequently	infrequently	RB
25944	450	37	of	of	IN
25944	450	38	apparent	apparent	JJ
25944	450	39	causative	causative	JJ
25944	450	40	influence	influence	NN
25944	450	41	.	.	.
25944	451	1	It	-PRON-	PRP
25944	451	2	is	be	VBZ
25944	451	3	most	most	RBS
25944	451	4	frequently	frequently	RB
25944	451	5	observed	observe	VBN
25944	451	6	in	in	IN
25944	451	7	spring	spring	NN
25944	451	8	and	and	CC
25944	451	9	autumn	autumn	NN
25944	451	10	months	month	NNS
25944	451	11	,	,	,
25944	451	12	and	and	CC
25944	451	13	in	in	IN
25944	451	14	early	early	JJ
25944	451	15	adult	adult	NN
25944	451	16	life	life	NN
25944	451	17	.	.	.
25944	452	1	The	the	DT
25944	452	2	disease	disease	NN
25944	452	3	is	be	VBZ
25944	452	4	not	not	RB
25944	452	5	uncommon	uncommon	JJ
25944	452	6	.	.	.
25944	453	1	#	#	LS
25944	453	2	What	what	WP
25944	453	3	is	be	VBZ
25944	453	4	the	the	DT
25944	453	5	pathology	pathology	NN
25944	453	6	of	of	IN
25944	453	7	erythema	erythema	NNP
25944	453	8	multiforme	multiforme	NN
25944	453	9	?	?	.
25944	453	10	#	#	$
25944	453	11	It	-PRON-	PRP
25944	453	12	is	be	VBZ
25944	453	13	a	a	DT
25944	453	14	mildly	mildly	RB
25944	453	15	inflammatory	inflammatory	JJ
25944	453	16	disorder	disorder	NN
25944	453	17	,	,	,
25944	453	18	somewhat	somewhat	RB
25944	453	19	similar	similar	JJ
25944	453	20	to	to	IN
25944	453	21	urticaria	urticaria	JJ
25944	453	22	,	,	,
25944	453	23	and	and	CC
25944	453	24	presumably	presumably	RB
25944	453	25	due	due	IN
25944	453	26	to	to	IN
25944	453	27	vasomotor	vasomotor	NN
25944	453	28	disturbance	disturbance	NN
25944	453	29	;	;	:
25944	453	30	the	the	DT
25944	453	31	amount	amount	NN
25944	453	32	of	of	IN
25944	453	33	exudation	exudation	NN
25944	453	34	,	,	,
25944	453	35	which	which	WDT
25944	453	36	is	be	VBZ
25944	453	37	variable	variable	JJ
25944	453	38	,	,	,
25944	453	39	determines	determine	VBZ
25944	453	40	the	the	DT
25944	453	41	character	character	NN
25944	453	42	of	of	IN
25944	453	43	the	the	DT
25944	453	44	lesions	lesion	NNS
25944	453	45	.	.	.
25944	454	1	#	#	JJR
25944	454	2	Name	name	VB
25944	454	3	the	the	DT
25944	454	4	diagnostic	diagnostic	JJ
25944	454	5	points	point	NNS
25944	454	6	of	of	IN
25944	454	7	erythema	erythema	NNP
25944	454	8	multiforme	multiforme	NN
25944	454	9	.	.	.
25944	454	10	#	#	$
25944	454	11	The	the	DT
25944	454	12	multiformity	multiformity	NN
25944	454	13	of	of	IN
25944	454	14	the	the	DT
25944	454	15	eruption	eruption	NN
25944	454	16	,	,	,
25944	454	17	the	the	DT
25944	454	18	size	size	NN
25944	454	19	of	of	IN
25944	454	20	the	the	DT
25944	454	21	papules	papule	NNS
25944	454	22	,	,	,
25944	454	23	often	often	RB
25944	454	24	its	-PRON-	PRP$
25944	454	25	limitation	limitation	NN
25944	454	26	to	to	IN
25944	454	27	certain	certain	JJ
25944	454	28	parts	part	NNS
25944	454	29	,	,	,
25944	454	30	its	-PRON-	PRP$
25944	454	31	course	course	NN
25944	454	32	and	and	CC
25944	454	33	the	the	DT
25944	454	34	entire	entire	JJ
25944	454	35	or	or	CC
25944	454	36	comparative	comparative	JJ
25944	454	37	absence	absence	NN
25944	454	38	of	of	IN
25944	454	39	itching	itching	NN
25944	454	40	.	.	.
25944	455	1	It	-PRON-	PRP
25944	455	2	resembles	resemble	VBZ
25944	455	3	urticaria	urticaria	JJ
25944	455	4	at	at	IN
25944	455	5	times	time	NNS
25944	455	6	,	,	,
25944	455	7	but	but	CC
25944	455	8	the	the	DT
25944	455	9	lesions	lesion	NNS
25944	455	10	of	of	IN
25944	455	11	this	this	DT
25944	455	12	latter	latter	JJ
25944	455	13	disease	disease	NN
25944	455	14	are	be	VBP
25944	455	15	evanescent	evanescent	JJ
25944	455	16	,	,	,
25944	455	17	disappearing	disappear	VBG
25944	455	18	and	and	CC
25944	455	19	reappearing	reappear	VBG
25944	455	20	usually	usually	RB
25944	455	21	in	in	IN
25944	455	22	the	the	DT
25944	455	23	most	most	RBS
25944	455	24	capricious	capricious	JJ
25944	455	25	manner	manner	NN
25944	455	26	,	,	,
25944	455	27	are	be	VBP
25944	455	28	commonly	commonly	RB
25944	455	29	seated	seat	VBN
25944	455	30	about	about	IN
25944	455	31	the	the	DT
25944	455	32	trunk	trunk	NN
25944	455	33	,	,	,
25944	455	34	and	and	CC
25944	455	35	are	be	VBP
25944	455	36	exceedingly	exceedingly	RB
25944	455	37	itchy	itchy	JJ
25944	455	38	.	.	.
25944	456	1	In	in	IN
25944	456	2	the	the	DT
25944	456	3	vesicular	vesicular	JJ
25944	456	4	and	and	CC
25944	456	5	bullous	bullous	JJ
25944	456	6	types	type	NNS
25944	456	7	the	the	DT
25944	456	8	acute	acute	JJ
25944	456	9	character	character	NN
25944	456	10	of	of	IN
25944	456	11	the	the	DT
25944	456	12	outbreak	outbreak	NN
25944	456	13	,	,	,
25944	456	14	the	the	DT
25944	456	15	often	often	RB
25944	456	16	segmental	segmental	JJ
25944	456	17	and	and	CC
25944	456	18	ring	ring	JJ
25944	456	19	-	-	HYPH
25944	456	20	like	like	JJ
25944	456	21	shape	shape	NN
25944	456	22	,	,	,
25944	456	23	their	-PRON-	PRP$
25944	456	24	frequent	frequent	JJ
25944	456	25	origin	origin	NN
25944	456	26	from	from	IN
25944	456	27	erythematous	erythematous	JJ
25944	456	28	papules	papule	NNS
25944	456	29	,	,	,
25944	456	30	and	and	CC
25944	456	31	the	the	DT
25944	456	32	distribution	distribution	NN
25944	456	33	and	and	CC
25944	456	34	association	association	NN
25944	456	35	with	with	IN
25944	456	36	the	the	DT
25944	456	37	more	more	RBR
25944	456	38	common	common	JJ
25944	456	39	manifestations	manifestation	NNS
25944	456	40	,	,	,
25944	456	41	are	be	VBP
25944	456	42	always	always	RB
25944	456	43	suggestive	suggestive	JJ
25944	456	44	.	.	.
25944	457	1	#	#	LS
25944	457	2	What	what	WDT
25944	457	3	prognosis	prognosis	NN
25944	457	4	would	would	MD
25944	457	5	you	-PRON-	PRP
25944	457	6	give	give	VB
25944	457	7	in	in	IN
25944	457	8	erythema	erythema	NNP
25944	457	9	multiforme	multiforme	NN
25944	457	10	?	?	.
25944	457	11	#	#	$
25944	457	12	Always	always	RB
25944	457	13	favorable	favorable	JJ
25944	457	14	;	;	:
25944	457	15	the	the	DT
25944	457	16	eruption	eruption	NN
25944	457	17	usually	usually	RB
25944	457	18	disappears	disappear	VBZ
25944	457	19	in	in	IN
25944	457	20	ten	ten	CD
25944	457	21	days	day	NNS
25944	457	22	to	to	IN
25944	457	23	three	three	CD
25944	457	24	weeks	week	NNS
25944	457	25	,	,	,
25944	457	26	although	although	IN
25944	457	27	in	in	IN
25944	457	28	rare	rare	JJ
25944	457	29	instances	instance	NNS
25944	457	30	new	new	JJ
25944	457	31	crops	crop	NNS
25944	457	32	may	may	MD
25944	457	33	appear	appear	VB
25944	457	34	from	from	IN
25944	457	35	day	day	NN
25944	457	36	to	to	IN
25944	457	37	day	day	NN
25944	457	38	or	or	CC
25944	457	39	week	week	NN
25944	457	40	to	to	IN
25944	457	41	week	week	NN
25944	457	42	,	,	,
25944	457	43	and	and	CC
25944	457	44	the	the	DT
25944	457	45	process	process	NN
25944	457	46	last	last	JJ
25944	457	47	one	one	CD
25944	457	48	or	or	CC
25944	457	49	two	two	CD
25944	457	50	months	month	NNS
25944	457	51	.	.	.
25944	458	1	One	one	CD
25944	458	2	or	or	CC
25944	458	3	more	more	JJR
25944	458	4	recurrences	recurrence	NNS
25944	458	5	in	in	IN
25944	458	6	succeeding	succeed	VBG
25944	458	7	years	year	NNS
25944	458	8	are	be	VBP
25944	458	9	not	not	RB
25944	458	10	uncommon	uncommon	JJ
25944	458	11	.	.	.
25944	459	1	Those	those	DT
25944	459	2	rare	rare	JJ
25944	459	3	cases	case	NNS
25944	459	4	in	in	IN
25944	459	5	which	which	WDT
25944	459	6	vesicular	vesicular	JJ
25944	459	7	or	or	CC
25944	459	8	bullous	bullous	JJ
25944	459	9	lesions	lesion	NNS
25944	459	10	are	be	VBP
25944	459	11	also	also	RB
25944	459	12	seen	see	VBN
25944	459	13	on	on	IN
25944	459	14	the	the	DT
25944	459	15	lips	lip	NNS
25944	459	16	and	and	CC
25944	459	17	in	in	IN
25944	459	18	the	the	DT
25944	459	19	mouth	mouth	NN
25944	459	20	,	,	,
25944	459	21	are	be	VBP
25944	459	22	more	more	RBR
25944	459	23	prone	prone	JJ
25944	459	24	to	to	IN
25944	459	25	longer	long	JJR
25944	459	26	duration	duration	NN
25944	459	27	and	and	CC
25944	459	28	to	to	IN
25944	459	29	more	more	RBR
25944	459	30	frequent	frequent	JJ
25944	459	31	recurrences	recurrence	NNS
25944	459	32	.	.	.
25944	460	1	#	#	$
25944	460	2	What	what	WDT
25944	460	3	remedies	remedy	NNS
25944	460	4	are	be	VBP
25944	460	5	commonly	commonly	RB
25944	460	6	prescribed	prescribe	VBN
25944	460	7	in	in	IN
25944	460	8	erythema	erythema	NNP
25944	460	9	multiforme	multiforme	NNP
25944	460	10	?	?	.
25944	460	11	#	#	NNP
25944	460	12	Quinin	Quinin	NNP
25944	460	13	,	,	,
25944	460	14	and	and	CC
25944	460	15	,	,	,
25944	460	16	if	if	IN
25944	460	17	constipation	constipation	NN
25944	460	18	is	be	VBZ
25944	460	19	present	present	JJ
25944	460	20	,	,	,
25944	460	21	saline	saline	VB
25944	460	22	laxatives	laxative	NNS
25944	460	23	.	.	.
25944	461	1	Calcined	calcine	VBN
25944	461	2	magnesia	magnesia	NNP
25944	461	3	is	be	VBZ
25944	461	4	valuable	valuable	JJ
25944	461	5	as	as	IN
25944	461	6	a	a	DT
25944	461	7	laxative	laxative	NN
25944	461	8	.	.	.
25944	462	1	Intestinal	intestinal	JJ
25944	462	2	antiseptics	antiseptic	NNS
25944	462	3	,	,	,
25944	462	4	such	such	JJ
25944	462	5	as	as	IN
25944	462	6	salol	salol	NN
25944	462	7	,	,	,
25944	462	8	thymol	thymol	NN
25944	462	9	,	,	,
25944	462	10	and	and	CC
25944	462	11	sodium	sodium	NN
25944	462	12	salicylate	salicylate	NN
25944	462	13	,	,	,
25944	462	14	are	be	VBP
25944	462	15	valuable	valuable	JJ
25944	462	16	in	in	IN
25944	462	17	cases	case	NNS
25944	462	18	probably	probably	RB
25944	462	19	due	due	IN
25944	462	20	to	to	IN
25944	462	21	intestinal	intestinal	JJ
25944	462	22	toxins	toxin	NNS
25944	462	23	.	.	.
25944	463	1	In	in	IN
25944	463	2	those	those	DT
25944	463	3	exceptional	exceptional	JJ
25944	463	4	instances	instance	NNS
25944	463	5	in	in	IN
25944	463	6	which	which	WDT
25944	463	7	there	there	EX
25944	463	8	may	may	MD
25944	463	9	be	be	VB
25944	463	10	associated	associate	VBN
25944	463	11	febrile	febrile	NN
25944	463	12	action	action	NN
25944	463	13	and	and	CC
25944	463	14	rheumatic	rheumatic	JJ
25944	463	15	swelling	swelling	NN
25944	463	16	of	of	IN
25944	463	17	the	the	DT
25944	463	18	joints	joint	NNS
25944	463	19	,	,	,
25944	463	20	the	the	DT
25944	463	21	patient	patient	NN
25944	463	22	should	should	MD
25944	463	23	be	be	VB
25944	463	24	kept	keep	VBN
25944	463	25	in	in	IN
25944	463	26	bed	bed	NN
25944	463	27	till	till	IN
25944	463	28	these	these	DT
25944	463	29	symptoms	symptom	NNS
25944	463	30	subside	subside	VBP
25944	463	31	.	.	.
25944	464	1	Local	local	JJ
25944	464	2	applications	application	NNS
25944	464	3	are	be	VBP
25944	464	4	rarely	rarely	RB
25944	464	5	required	require	VBN
25944	464	6	,	,	,
25944	464	7	but	but	CC
25944	464	8	in	in	IN
25944	464	9	those	those	DT
25944	464	10	exceptional	exceptional	JJ
25944	464	11	cases	case	NNS
25944	464	12	in	in	IN
25944	464	13	which	which	WDT
25944	464	14	itching	itch	VBG
25944	464	15	or	or	CC
25944	464	16	burning	burning	NN
25944	464	17	is	be	VBZ
25944	464	18	present	present	JJ
25944	464	19	,	,	,
25944	464	20	cooling	cool	VBG
25944	464	21	lotions	lotion	NNS
25944	464	22	of	of	IN
25944	464	23	alcohol	alcohol	NN
25944	464	24	and	and	CC
25944	464	25	water	water	NN
25944	464	26	or	or	CC
25944	464	27	vinegar	vinegar	NN
25944	464	28	and	and	CC
25944	464	29	water	water	NN
25944	464	30	are	be	VBP
25944	464	31	to	to	TO
25944	464	32	be	be	VB
25944	464	33	prescribed	prescribe	VBN
25944	464	34	.	.	.
25944	465	1	The	the	DT
25944	465	2	vesicular	vesicular	JJ
25944	465	3	and	and	CC
25944	465	4	bullous	bullous	JJ
25944	465	5	types	type	NNS
25944	465	6	demand	demand	VBP
25944	465	7	mild	mild	JJ
25944	465	8	protective	protective	JJ
25944	465	9	applications	application	NNS
25944	465	10	,	,	,
25944	465	11	such	such	JJ
25944	465	12	as	as	IN
25944	465	13	used	use	VBN
25944	465	14	in	in	IN
25944	465	15	eczema	eczema	NN
25944	465	16	and	and	CC
25944	465	17	pemphigus	pemphigus	NN
25944	465	18	.	.	.
25944	466	1	#	#	NNP
25944	466	2	Erythema	Erythema	NNP
25944	466	3	Nodosum	Nodosum	NNP
25944	466	4	.	.	.
25944	466	5	#	#	NNP
25944	466	6	(	(	-LRB-
25944	466	7	_	_	NNP
25944	466	8	Synonym	Synonym	NNP
25944	466	9	:	:	:
25944	466	10	_	_	NNP
25944	466	11	Dermatitis	Dermatitis	NNP
25944	466	12	contusiformis	contusiformis	NN
25944	466	13	.	.	.
25944	466	14	)	)	-RRB-
25944	467	1	#	#	LS
25944	467	2	What	what	WP
25944	467	3	is	be	VBZ
25944	467	4	erythema	erythema	NNP
25944	467	5	nodosum	nodosum	NN
25944	467	6	?	?	.
25944	467	7	#	#	NNP
25944	467	8	Erythema	Erythema	NNP
25944	467	9	nodosum	nodosum	NN
25944	467	10	is	be	VBZ
25944	467	11	an	an	DT
25944	467	12	inflammatory	inflammatory	JJ
25944	467	13	affection	affection	NN
25944	467	14	,	,	,
25944	467	15	of	of	IN
25944	467	16	an	an	DT
25944	467	17	acute	acute	JJ
25944	467	18	type	type	NN
25944	467	19	,	,	,
25944	467	20	characterized	characterize	VBN
25944	467	21	by	by	IN
25944	467	22	the	the	DT
25944	467	23	formation	formation	NN
25944	467	24	of	of	IN
25944	467	25	variously	variously	RB
25944	467	26	-	-	HYPH
25944	467	27	sized	sized	JJ
25944	467	28	,	,	,
25944	467	29	roundish	roundish	JJ
25944	467	30	,	,	,
25944	467	31	more	more	RBR
25944	467	32	or	or	CC
25944	467	33	less	less	RBR
25944	467	34	elevated	elevated	JJ
25944	467	35	erythematous	erythematous	JJ
25944	467	36	nodes	node	NNS
25944	467	37	.	.	.
25944	468	1	#	#	$
25944	468	2	Is	be	VBZ
25944	468	3	there	there	EX
25944	468	4	any	any	DT
25944	468	5	special	special	JJ
25944	468	6	region	region	NN
25944	468	7	of	of	IN
25944	468	8	predilection	predilection	NN
25944	468	9	for	for	IN
25944	468	10	the	the	DT
25944	468	11	eruption	eruption	NN
25944	468	12	of	of	IN
25944	468	13	erythema	erythema	NNP
25944	468	14	nodosum	nodosum	NNP
25944	468	15	?	?	.
25944	468	16	#	#	NN
25944	468	17	Yes	yes	UH
25944	468	18	.	.	.
25944	469	1	The	the	DT
25944	469	2	tibial	tibial	NN
25944	469	3	surfaces	surface	NNS
25944	469	4	,	,	,
25944	469	5	to	to	TO
25944	469	6	which	which	WDT
25944	469	7	the	the	DT
25944	469	8	eruption	eruption	NN
25944	469	9	is	be	VBZ
25944	469	10	often	often	RB
25944	469	11	limited	limited	JJ
25944	469	12	;	;	:
25944	469	13	not	not	RB
25944	469	14	infrequently	infrequently	RB
25944	469	15	,	,	,
25944	469	16	however	however	RB
25944	469	17	,	,	,
25944	469	18	other	other	JJ
25944	469	19	parts	part	NNS
25944	469	20	may	may	MD
25944	469	21	be	be	VB
25944	469	22	involved	involve	VBN
25944	469	23	,	,	,
25944	469	24	more	more	RBR
25944	469	25	especially	especially	RB
25944	469	26	the	the	DT
25944	469	27	arms	arm	NNS
25944	469	28	and	and	CC
25944	469	29	forearms	forearm	NNS
25944	469	30	.	.	.
25944	470	1	#	#	NNP
25944	470	2	Describe	describe	VB
25944	470	3	the	the	DT
25944	470	4	symptoms	symptom	NNS
25944	470	5	of	of	IN
25944	470	6	erythema	erythema	NNP
25944	470	7	nodosum	nodosum	NNP
25944	470	8	.	.	.
25944	470	9	#	#	$
25944	470	10	The	the	DT
25944	470	11	eruption	eruption	NN
25944	470	12	makes	make	VBZ
25944	470	13	its	-PRON-	PRP$
25944	470	14	appearance	appearance	NN
25944	470	15	suddenly	suddenly	RB
25944	470	16	,	,	,
25944	470	17	and	and	CC
25944	470	18	is	be	VBZ
25944	470	19	usually	usually	RB
25944	470	20	ushered	usher	VBN
25944	470	21	in	in	RB
25944	470	22	with	with	IN
25944	470	23	febrile	febrile	NN
25944	470	24	disturbance	disturbance	NN
25944	470	25	,	,	,
25944	470	26	gastric	gastric	JJ
25944	470	27	uneasiness	uneasiness	NN
25944	470	28	,	,	,
25944	470	29	malaise	malaise	NN
25944	470	30	,	,	,
25944	470	31	and	and	CC
25944	470	32	rheumatic	rheumatic	JJ
25944	470	33	pains	pain	NNS
25944	470	34	and	and	CC
25944	470	35	swelling	swell	VBG
25944	470	36	about	about	IN
25944	470	37	the	the	DT
25944	470	38	joints	joint	NNS
25944	470	39	.	.	.
25944	471	1	The	the	DT
25944	471	2	lesions	lesion	NNS
25944	471	3	vary	vary	VBP
25944	471	4	in	in	IN
25944	471	5	size	size	NN
25944	471	6	from	from	IN
25944	471	7	a	a	DT
25944	471	8	cherry	cherry	NN
25944	471	9	to	to	IN
25944	471	10	a	a	DT
25944	471	11	hen	hen	NN
25944	471	12	's	's	POS
25944	471	13	egg	egg	NN
25944	471	14	,	,	,
25944	471	15	are	be	VBP
25944	471	16	rounded	rounded	JJ
25944	471	17	or	or	CC
25944	471	18	ovalish	ovalish	JJ
25944	471	19	,	,	,
25944	471	20	tender	tender	NN
25944	471	21	and	and	CC
25944	471	22	painful	painful	JJ
25944	471	23	,	,	,
25944	471	24	have	have	VBP
25944	471	25	a	a	DT
25944	471	26	glistening	glistening	NN
25944	471	27	and	and	CC
25944	471	28	tense	tense	JJ
25944	471	29	look	look	NN
25944	471	30	,	,	,
25944	471	31	and	and	CC
25944	471	32	are	be	VBP
25944	471	33	of	of	IN
25944	471	34	a	a	DT
25944	471	35	bright	bright	JJ
25944	471	36	red	red	JJ
25944	471	37	,	,	,
25944	471	38	erysipelatous	erysipelatous	JJ
25944	471	39	color	color	NN
25944	471	40	which	which	WDT
25944	471	41	merges	merge	VBZ
25944	471	42	gradually	gradually	RB
25944	471	43	into	into	IN
25944	471	44	the	the	DT
25944	471	45	sound	sound	JJ
25944	471	46	skin	skin	NN
25944	471	47	.	.	.
25944	472	1	At	at	IN
25944	472	2	first	first	RB
25944	472	3	they	-PRON-	PRP
25944	472	4	are	be	VBP
25944	472	5	somewhat	somewhat	RB
25944	472	6	hard	hard	JJ
25944	472	7	,	,	,
25944	472	8	but	but	CC
25944	472	9	later	later	RB
25944	472	10	they	-PRON-	PRP
25944	472	11	soften	soften	VBP
25944	472	12	and	and	CC
25944	472	13	appear	appear	VBP
25944	472	14	as	as	IN
25944	472	15	if	if	IN
25944	472	16	about	about	IN
25944	472	17	to	to	TO
25944	472	18	break	break	VB
25944	472	19	down	down	RP
25944	472	20	,	,	,
25944	472	21	but	but	CC
25944	472	22	this	this	DT
25944	472	23	,	,	,
25944	472	24	however	however	RB
25944	472	25	,	,	,
25944	472	26	never	never	RB
25944	472	27	occurs	occur	VBZ
25944	472	28	,	,	,
25944	472	29	absorption	absorption	NN
25944	472	30	invariably	invariably	RB
25944	472	31	taking	take	VBG
25944	472	32	place	place	NN
25944	472	33	.	.	.
25944	473	1	In	in	IN
25944	473	2	occasional	occasional	JJ
25944	473	3	instances	instance	NNS
25944	473	4	they	-PRON-	PRP
25944	473	5	are	be	VBP
25944	473	6	hemorrhagic	hemorrhagic	JJ
25944	473	7	.	.	.
25944	474	1	Exceptionally	exceptionally	RB
25944	474	2	the	the	DT
25944	474	3	lesions	lesion	NNS
25944	474	4	of	of	IN
25944	474	5	erythema	erythema	NNP
25944	474	6	multiforme	multiforme	NNP
25944	474	7	are	be	VBP
25944	474	8	also	also	RB
25944	474	9	present	present	JJ
25944	474	10	.	.	.
25944	475	1	Lymphangitis	Lymphangitis	NNP
25944	475	2	is	be	VBZ
25944	475	3	sometimes	sometimes	RB
25944	475	4	observed	observe	VBN
25944	475	5	.	.	.
25944	476	1	In	in	IN
25944	476	2	rare	rare	JJ
25944	476	3	instances	instance	NNS
25944	476	4	symptoms	symptom	NNS
25944	476	5	pointing	point	VBG
25944	476	6	to	to	IN
25944	476	7	visceral	visceral	JJ
25944	476	8	involvement	involvement	NN
25944	476	9	,	,	,
25944	476	10	to	to	IN
25944	476	11	cerebral	cerebral	JJ
25944	476	12	invasion	invasion	NN
25944	476	13	,	,	,
25944	476	14	and	and	CC
25944	476	15	to	to	IN
25944	476	16	heart	heart	NN
25944	476	17	complications	complication	NNS
25944	476	18	have	have	VBP
25944	476	19	been	be	VBN
25944	476	20	observed	observe	VBN
25944	476	21	.	.	.
25944	477	1	#	#	NN
25944	477	2	Are	be	VBP
25944	477	3	the	the	DT
25944	477	4	lesions	lesion	NNS
25944	477	5	in	in	IN
25944	477	6	erythema	erythema	NNP
25944	477	7	nodosum	nodosum	NNP
25944	477	8	usually	usually	RB
25944	477	9	numerous	numerous	JJ
25944	477	10	?	?	.
25944	477	11	#	#	$
25944	477	12	No	no	UH
25944	477	13	.	.	.
25944	478	1	As	as	IN
25944	478	2	a	a	DT
25944	478	3	rule	rule	NN
25944	478	4	not	not	RB
25944	478	5	more	more	JJR
25944	478	6	than	than	IN
25944	478	7	five	five	CD
25944	478	8	to	to	TO
25944	478	9	twenty	twenty	CD
25944	478	10	nodes	node	NNS
25944	478	11	are	be	VBP
25944	478	12	present	present	JJ
25944	478	13	.	.	.
25944	479	1	#	#	LS
25944	479	2	What	what	WP
25944	479	3	is	be	VBZ
25944	479	4	the	the	DT
25944	479	5	course	course	NN
25944	479	6	of	of	IN
25944	479	7	erythema	erythema	NNP
25944	479	8	nodosum	nodosum	NNP
25944	479	9	?	?	.
25944	479	10	#	#	NNP
25944	479	11	Acute	Acute	NNP
25944	479	12	.	.	.
25944	480	1	The	the	DT
25944	480	2	disease	disease	NN
25944	480	3	terminating	terminate	VBG
25944	480	4	usually	usually	RB
25944	480	5	in	in	IN
25944	480	6	one	one	CD
25944	480	7	to	to	TO
25944	480	8	three	three	CD
25944	480	9	weeks	week	NNS
25944	480	10	.	.	.
25944	481	1	As	as	IN
25944	481	2	the	the	DT
25944	481	3	lesions	lesion	NNS
25944	481	4	are	be	VBP
25944	481	5	disappearing	disappear	VBG
25944	481	6	they	-PRON-	PRP
25944	481	7	present	present	VBP
25944	481	8	the	the	DT
25944	481	9	various	various	JJ
25944	481	10	changes	change	NNS
25944	481	11	of	of	IN
25944	481	12	color	color	NN
25944	481	13	observed	observe	VBN
25944	481	14	in	in	IN
25944	481	15	an	an	DT
25944	481	16	ordinary	ordinary	JJ
25944	481	17	bruise	bruise	NN
25944	481	18	.	.	.
25944	482	1	#	#	LS
25944	482	2	What	what	WP
25944	482	3	is	be	VBZ
25944	482	4	known	know	VBN
25944	482	5	in	in	IN
25944	482	6	regard	regard	NN
25944	482	7	to	to	IN
25944	482	8	the	the	DT
25944	482	9	etiology	etiology	NN
25944	482	10	?	?	.
25944	482	11	#	#	$
25944	482	12	The	the	DT
25944	482	13	affection	affection	NN
25944	482	14	is	be	VBZ
25944	482	15	closely	closely	RB
25944	482	16	allied	ally	VBN
25944	482	17	to	to	IN
25944	482	18	erythema	erythema	NNP
25944	482	19	multiforme	multiforme	NNP
25944	482	20	,	,	,
25944	482	21	and	and	CC
25944	482	22	is	be	VBZ
25944	482	23	,	,	,
25944	482	24	indeed	indeed	RB
25944	482	25	,	,	,
25944	482	26	by	by	IN
25944	482	27	some	some	DT
25944	482	28	considered	consider	VBN
25944	482	29	a	a	DT
25944	482	30	form	form	NN
25944	482	31	of	of	IN
25944	482	32	that	that	DT
25944	482	33	disease	disease	NN
25944	482	34	.	.	.
25944	483	1	It	-PRON-	PRP
25944	483	2	occurs	occur	VBZ
25944	483	3	most	most	RBS
25944	483	4	frequently	frequently	RB
25944	483	5	in	in	IN
25944	483	6	children	child	NNS
25944	483	7	and	and	CC
25944	483	8	young	young	JJ
25944	483	9	adults	adult	NNS
25944	483	10	,	,	,
25944	483	11	and	and	CC
25944	483	12	usually	usually	RB
25944	483	13	in	in	IN
25944	483	14	the	the	DT
25944	483	15	spring	spring	NN
25944	483	16	and	and	CC
25944	483	17	autumn	autumn	NN
25944	483	18	months	month	NNS
25944	483	19	.	.	.
25944	484	1	Intestinal	intestinal	JJ
25944	484	2	toxins	toxin	NNS
25944	484	3	are	be	VBP
25944	484	4	thought	think	VBN
25944	484	5	responsible	responsible	JJ
25944	484	6	in	in	IN
25944	484	7	some	some	DT
25944	484	8	cases	case	NNS
25944	484	9	.	.	.
25944	485	1	Digestive	digestive	JJ
25944	485	2	disturbance	disturbance	NN
25944	485	3	and	and	CC
25944	485	4	rheumatic	rheumatic	JJ
25944	485	5	pain	pain	NN
25944	485	6	and	and	CC
25944	485	7	swellings	swelling	NNS
25944	485	8	are	be	VBP
25944	485	9	often	often	RB
25944	485	10	associated	associate	VBN
25944	485	11	with	with	IN
25944	485	12	it	-PRON-	PRP
25944	485	13	.	.	.
25944	486	1	By	by	IN
25944	486	2	many	many	JJ
25944	486	3	the	the	DT
25944	486	4	malady	malady	NN
25944	486	5	is	be	VBZ
25944	486	6	thought	think	VBN
25944	486	7	to	to	TO
25944	486	8	be	be	VB
25944	486	9	a	a	DT
25944	486	10	specific	specific	JJ
25944	486	11	infection	infection	NN
25944	486	12	.	.	.
25944	487	1	#	#	LS
25944	487	2	What	what	WP
25944	487	3	is	be	VBZ
25944	487	4	the	the	DT
25944	487	5	pathology	pathology	NN
25944	487	6	of	of	IN
25944	487	7	erythema	erythema	NNP
25944	487	8	nodosum	nodosum	NNP
25944	487	9	?	?	.
25944	487	10	#	#	$
25944	487	11	The	the	DT
25944	487	12	disease	disease	NN
25944	487	13	is	be	VBZ
25944	487	14	to	to	TO
25944	487	15	be	be	VB
25944	487	16	viewed	view	VBN
25944	487	17	as	as	IN
25944	487	18	an	an	DT
25944	487	19	inflammatory	inflammatory	JJ
25944	487	20	[	[	-LRB-
25944	487	21	oe]dema	oe]dema	JJ
25944	487	22	,	,	,
25944	487	23	probably	probably	RB
25944	487	24	resulting	result	VBG
25944	487	25	,	,	,
25944	487	26	in	in	IN
25944	487	27	some	some	DT
25944	487	28	instances	instance	NNS
25944	487	29	at	at	IN
25944	487	30	least	least	JJS
25944	487	31	,	,	,
25944	487	32	from	from	IN
25944	487	33	an	an	DT
25944	487	34	inflammation	inflammation	NN
25944	487	35	of	of	IN
25944	487	36	the	the	DT
25944	487	37	lymphatics	lymphatic	NNS
25944	487	38	or	or	CC
25944	487	39	an	an	DT
25944	487	40	embolism	embolism	NN
25944	487	41	of	of	IN
25944	487	42	the	the	DT
25944	487	43	cutaneous	cutaneous	JJ
25944	487	44	vessels	vessel	NNS
25944	487	45	.	.	.
25944	488	1	#	#	NNP
25944	488	2	What	what	WDT
25944	488	3	diseases	disease	NNS
25944	488	4	may	may	MD
25944	488	5	erythema	erythema	VB
25944	488	6	nodosum	nodosum	NNP
25944	488	7	resemble	resemble	NNP
25944	488	8	?	?	.
25944	488	9	#	#	NNP
25944	488	10	Bruises	Bruises	NNP
25944	488	11	,	,	,
25944	488	12	abscesses	abscess	NNS
25944	488	13	,	,	,
25944	488	14	and	and	CC
25944	488	15	gummata	gummata	JJ
25944	488	16	.	.	.
25944	489	1	#	#	NNP
25944	489	2	How	how	WRB
25944	489	3	are	be	VBP
25944	489	4	the	the	DT
25944	489	5	lesions	lesion	NNS
25944	489	6	of	of	IN
25944	489	7	erythema	erythema	NNP
25944	489	8	nodosum	nodosum	NNP
25944	489	9	to	to	TO
25944	489	10	be	be	VB
25944	489	11	distinguished	distinguish	VBN
25944	489	12	from	from	IN
25944	489	13	these	these	DT
25944	489	14	several	several	JJ
25944	489	15	conditions	condition	NNS
25944	489	16	?	?	.
25944	489	17	#	#	$
25944	489	18	By	by	IN
25944	489	19	the	the	DT
25944	489	20	bright	bright	JJ
25944	489	21	red	red	JJ
25944	489	22	or	or	CC
25944	489	23	rosy	rosy	JJ
25944	489	24	tint	tint	NN
25944	489	25	,	,	,
25944	489	26	the	the	DT
25944	489	27	apparently	apparently	RB
25944	489	28	violent	violent	JJ
25944	489	29	character	character	NN
25944	489	30	of	of	IN
25944	489	31	the	the	DT
25944	489	32	process	process	NN
25944	489	33	,	,	,
25944	489	34	the	the	DT
25944	489	35	number	number	NN
25944	489	36	,	,	,
25944	489	37	situation	situation	NN
25944	489	38	and	and	CC
25944	489	39	course	course	NN
25944	489	40	of	of	IN
25944	489	41	the	the	DT
25944	489	42	lesions	lesion	NNS
25944	489	43	.	.	.
25944	490	1	#	#	JJR
25944	490	2	State	state	NN
25944	490	3	the	the	DT
25944	490	4	prognosis	prognosis	NN
25944	490	5	of	of	IN
25944	490	6	erythema	erythema	NNP
25944	490	7	nodosum	nodosum	NNP
25944	490	8	.	.	.
25944	490	9	#	#	NNP
25944	490	10	Favorable	favorable	JJ
25944	490	11	,	,	,
25944	490	12	recovery	recovery	NN
25944	490	13	usually	usually	RB
25944	490	14	taking	take	VBG
25944	490	15	place	place	NN
25944	490	16	in	in	IN
25944	490	17	ten	ten	CD
25944	490	18	days	day	NNS
25944	490	19	to	to	IN
25944	490	20	several	several	JJ
25944	490	21	weeks	week	NNS
25944	490	22	.	.	.
25944	491	1	#	#	JJR
25944	491	2	State	state	NN
25944	491	3	the	the	DT
25944	491	4	treatment	treatment	NN
25944	491	5	to	to	TO
25944	491	6	be	be	VB
25944	491	7	advised	advise	VBN
25944	491	8	in	in	IN
25944	491	9	erythema	erythema	NNP
25944	491	10	nodosum	nodosum	NNP
25944	491	11	.	.	.
25944	491	12	#	#	NNP
25944	491	13	Rest	rest	NN
25944	491	14	,	,	,
25944	491	15	relative	relative	JJ
25944	491	16	or	or	CC
25944	491	17	absolute	absolute	JJ
25944	491	18	,	,	,
25944	491	19	depending	depend	VBG
25944	491	20	upon	upon	IN
25944	491	21	the	the	DT
25944	491	22	severity	severity	NN
25944	491	23	of	of	IN
25944	491	24	the	the	DT
25944	491	25	case	case	NN
25944	491	26	,	,	,
25944	491	27	and	and	CC
25944	491	28	an	an	DT
25944	491	29	unstimulating	unstimulating	JJ
25944	491	30	diet	diet	NN
25944	491	31	;	;	:
25944	491	32	internally	internally	RB
25944	491	33	intestinal	intestinal	JJ
25944	491	34	antiseptics	antiseptic	NNS
25944	491	35	,	,	,
25944	491	36	quinin	quinin	VB
25944	491	37	and	and	CC
25944	491	38	saline	saline	VB
25944	491	39	laxatives	laxative	NNS
25944	491	40	,	,	,
25944	491	41	and	and	CC
25944	491	42	locally	locally	RB
25944	491	43	applications	application	NNS
25944	491	44	of	of	IN
25944	491	45	lead	lead	NN
25944	491	46	-	-	HYPH
25944	491	47	water	water	NN
25944	491	48	and	and	CC
25944	491	49	laudanum	laudanum	NN
25944	491	50	.	.	.
25944	492	1	#	#	NNP
25944	492	2	Erythema	Erythema	NNP
25944	492	3	Induratum	Induratum	NNP
25944	492	4	.	.	.
25944	492	5	#	#	NNP
25944	492	6	(	(	-LRB-
25944	492	7	_	_	NNP
25944	492	8	Synonym	Synonym	NNP
25944	492	9	:	:	:
25944	492	10	_	_	NNP
25944	492	11	Erythema	Erythema	NNP
25944	492	12	induratum	induratum	NN
25944	492	13	scrofulosorum	scrofulosorum	NN
25944	492	14	.	.	.
25944	492	15	)	)	-RRB-
25944	493	1	#	#	LS
25944	493	2	What	what	WP
25944	493	3	do	do	VBP
25944	493	4	you	-PRON-	PRP
25944	493	5	understand	understand	VB
25944	493	6	by	by	IN
25944	493	7	erythema	erythema	NNP
25944	493	8	induratum	induratum	NNP
25944	493	9	?	?	.
25944	493	10	#	#	$
25944	493	11	A	a	DT
25944	493	12	rare	rare	JJ
25944	493	13	disease	disease	NN
25944	493	14	characterized	characterize	VBN
25944	493	15	in	in	IN
25944	493	16	the	the	DT
25944	493	17	beginning	beginning	NN
25944	493	18	by	by	IN
25944	493	19	one	one	CD
25944	493	20	or	or	CC
25944	493	21	more	more	JJR
25944	493	22	usually	usually	RB
25944	493	23	deep	deep	RB
25944	493	24	-	-	HYPH
25944	493	25	seated	seat	VBN
25944	493	26	nodules	nodule	NNS
25944	493	27	,	,	,
25944	493	28	and	and	CC
25944	493	29	,	,	,
25944	493	30	as	as	IN
25944	493	31	a	a	DT
25944	493	32	rule	rule	NN
25944	493	33	,	,	,
25944	493	34	seated	seat	VBN
25944	493	35	in	in	IN
25944	493	36	the	the	DT
25944	493	37	legs	leg	NNS
25944	493	38	,	,	,
25944	493	39	especially	especially	RB
25944	493	40	the	the	DT
25944	493	41	calf	calf	NN
25944	493	42	region	region	NN
25944	493	43	.	.	.
25944	494	1	The	the	DT
25944	494	2	nodules	nodule	NNS
25944	494	3	gradually	gradually	RB
25944	494	4	enlarge	enlarge	VBP
25944	494	5	,	,	,
25944	494	6	the	the	DT
25944	494	7	skin	skin	NN
25944	494	8	becomes	become	VBZ
25944	494	9	reddish	reddish	JJ
25944	494	10	,	,	,
25944	494	11	violaceous	violaceous	JJ
25944	494	12	or	or	CC
25944	494	13	livid	livid	JJ
25944	494	14	in	in	IN
25944	494	15	color	color	NN
25944	494	16	.	.	.
25944	495	1	Absorption	absorption	NN
25944	495	2	may	may	MD
25944	495	3	take	take	VB
25944	495	4	place	place	NN
25944	495	5	slowly	slowly	RB
25944	495	6	,	,	,
25944	495	7	or	or	CC
25944	495	8	the	the	DT
25944	495	9	indurations	induration	NNS
25944	495	10	may	may	MD
25944	495	11	break	break	VB
25944	495	12	down	down	RP
25944	495	13	,	,	,
25944	495	14	resulting	result	VBG
25944	495	15	in	in	IN
25944	495	16	an	an	DT
25944	495	17	indolent	indolent	NN
25944	495	18	,	,	,
25944	495	19	rather	rather	RB
25944	495	20	deep	deep	RB
25944	495	21	-	-	HYPH
25944	495	22	seated	seat	VBN
25944	495	23	ulcer	ulcer	NN
25944	495	24	,	,	,
25944	495	25	closely	closely	RB
25944	495	26	resembling	resemble	VBG
25944	495	27	a	a	DT
25944	495	28	gummatous	gummatous	JJ
25944	495	29	ulcer	ulcer	NN
25944	495	30	.	.	.
25944	496	1	The	the	DT
25944	496	2	disease	disease	NN
25944	496	3	is	be	VBZ
25944	496	4	slow	slow	JJ
25944	496	5	and	and	CC
25944	496	6	persistent	persistent	JJ
25944	496	7	,	,	,
25944	496	8	and	and	CC
25944	496	9	is	be	VBZ
25944	496	10	commonly	commonly	RB
25944	496	11	met	meet	VBN
25944	496	12	with	with	IN
25944	496	13	in	in	IN
25944	496	14	girls	girl	NNS
25944	496	15	and	and	CC
25944	496	16	young	young	JJ
25944	496	17	women	woman	NNS
25944	496	18	,	,	,
25944	496	19	usually	usually	RB
25944	496	20	of	of	IN
25944	496	21	strumous	strumous	JJ
25944	496	22	type	type	NN
25944	496	23	.	.	.
25944	497	1	It	-PRON-	PRP
25944	497	2	suggests	suggest	VBZ
25944	497	3	a	a	DT
25944	497	4	tuberculous	tuberculous	JJ
25944	497	5	origin	origin	NN
25944	497	6	.	.	.
25944	498	1	Treatment	treatment	NN
25944	498	2	consists	consist	VBZ
25944	498	3	in	in	IN
25944	498	4	administration	administration	NN
25944	498	5	of	of	IN
25944	498	6	cod	cod	NN
25944	498	7	-	-	HYPH
25944	498	8	liver	liver	NN
25944	498	9	oil	oil	NN
25944	498	10	,	,	,
25944	498	11	phosphorus	phosphorus	NN
25944	498	12	and	and	CC
25944	498	13	other	other	JJ
25944	498	14	tonics	tonic	NNS
25944	498	15	.	.	.
25944	499	1	Rest	rest	NN
25944	499	2	is	be	VBZ
25944	499	3	of	of	IN
25944	499	4	service	service	NN
25944	499	5	.	.	.
25944	500	1	Locally	locally	RB
25944	500	2	antiseptic	antiseptic	JJ
25944	500	3	applications	application	NNS
25944	500	4	,	,	,
25944	500	5	and	and	CC
25944	500	6	support	support	NN
25944	500	7	with	with	IN
25944	500	8	roller	roller	NN
25944	500	9	bandage	bandage	NN
25944	500	10	are	be	VBP
25944	500	11	to	to	TO
25944	500	12	be	be	VB
25944	500	13	advised	advise	VBN
25944	500	14	.	.	.
25944	501	1	#	#	NNP
25944	501	2	Urticaria	Urticaria	NNP
25944	501	3	.	.	.
25944	501	4	#	#	NNP
25944	501	5	(	(	-LRB-
25944	501	6	_	_	NNP
25944	501	7	Synonyms	Synonyms	NNP
25944	501	8	:	:	:
25944	501	9	_	_	NNP
25944	501	10	Hives	hive	NNS
25944	501	11	;	;	:
25944	501	12	Nettlerash	Nettlerash	NNP
25944	501	13	.	.	.
25944	501	14	)	)	-RRB-
25944	502	1	#	#	NN
25944	502	2	Give	give	VB
25944	502	3	a	a	DT
25944	502	4	definition	definition	NN
25944	502	5	of	of	IN
25944	502	6	urticaria	urticaria	NN
25944	502	7	.	.	.
25944	502	8	#	#	NNP
25944	502	9	Urticaria	Urticaria	NNP
25944	502	10	is	be	VBZ
25944	502	11	an	an	DT
25944	502	12	inflammatory	inflammatory	JJ
25944	502	13	affection	affection	NN
25944	502	14	characterized	characterize	VBN
25944	502	15	by	by	IN
25944	502	16	evanescent	evanescent	JJ
25944	502	17	whitish	whitish	NN
25944	502	18	,	,	,
25944	502	19	pinkish	pinkish	JJ
25944	502	20	or	or	CC
25944	502	21	reddish	reddish	JJ
25944	502	22	elevations	elevation	NNS
25944	502	23	,	,	,
25944	502	24	or	or	CC
25944	502	25	wheals	wheal	NNS
25944	502	26	,	,	,
25944	502	27	variable	variable	JJ
25944	502	28	as	as	IN
25944	502	29	to	to	IN
25944	502	30	size	size	NN
25944	502	31	and	and	CC
25944	502	32	shape	shape	NN
25944	502	33	,	,	,
25944	502	34	and	and	CC
25944	502	35	attended	attend	VBN
25944	502	36	by	by	IN
25944	502	37	itching	itch	VBG
25944	502	38	,	,	,
25944	502	39	stinging	stinging	JJ
25944	502	40	or	or	CC
25944	502	41	pricking	prick	VBG
25944	502	42	sensations	sensation	NNS
25944	502	43	.	.	.
25944	503	1	#	#	NNP
25944	503	2	Describe	describe	VB
25944	503	3	the	the	DT
25944	503	4	symptoms	symptom	NNS
25944	503	5	of	of	IN
25944	503	6	urticaria	urticaria	NNP
25944	503	7	.	.	.
25944	503	8	#	#	$
25944	503	9	The	the	DT
25944	503	10	eruption	eruption	NN
25944	503	11	,	,	,
25944	503	12	erythematous	erythematous	JJ
25944	503	13	in	in	IN
25944	503	14	character	character	NN
25944	503	15	and	and	CC
25944	503	16	consisting	consisting	NN
25944	503	17	of	of	IN
25944	503	18	isolated	isolated	JJ
25944	503	19	pea	pea	NN
25944	503	20	or	or	CC
25944	503	21	bean	bean	NN
25944	503	22	-	-	HYPH
25944	503	23	sized	sized	JJ
25944	503	24	elevations	elevation	NNS
25944	503	25	or	or	CC
25944	503	26	of	of	IN
25944	503	27	linear	linear	JJ
25944	503	28	streaks	streak	NNS
25944	503	29	or	or	CC
25944	503	30	irregular	irregular	JJ
25944	503	31	patches	patch	NNS
25944	503	32	,	,	,
25944	503	33	limited	limited	JJ
25944	503	34	or	or	CC
25944	503	35	more	more	RBR
25944	503	36	or	or	CC
25944	503	37	less	less	RBR
25944	503	38	general	general	JJ
25944	503	39	,	,	,
25944	503	40	and	and	CC
25944	503	41	usually	usually	RB
25944	503	42	intensely	intensely	RB
25944	503	43	itchy	itchy	JJ
25944	503	44	,	,	,
25944	503	45	makes	make	VBZ
25944	503	46	its	-PRON-	PRP$
25944	503	47	appearance	appearance	NN
25944	503	48	suddenly	suddenly	RB
25944	503	49	,	,	,
25944	503	50	with	with	IN
25944	503	51	or	or	CC
25944	503	52	without	without	IN
25944	503	53	symptoms	symptom	NNS
25944	503	54	of	of	IN
25944	503	55	preceding	precede	VBG
25944	503	56	gastric	gastric	JJ
25944	503	57	derangement	derangement	NN
25944	503	58	.	.	.
25944	504	1	The	the	DT
25944	504	2	lesions	lesion	NNS
25944	504	3	are	be	VBP
25944	504	4	soft	soft	JJ
25944	504	5	or	or	CC
25944	504	6	firm	firm	JJ
25944	504	7	,	,	,
25944	504	8	reddish	reddish	JJ
25944	504	9	or	or	CC
25944	504	10	pinkish	pinkish	NN
25944	504	11	-	-	HYPH
25944	504	12	white	white	JJ
25944	504	13	,	,	,
25944	504	14	with	with	IN
25944	504	15	the	the	DT
25944	504	16	peripheral	peripheral	JJ
25944	504	17	portion	portion	NN
25944	504	18	of	of	IN
25944	504	19	a	a	DT
25944	504	20	bright	bright	JJ
25944	504	21	red	red	JJ
25944	504	22	color	color	NN
25944	504	23	,	,	,
25944	504	24	and	and	CC
25944	504	25	are	be	VBP
25944	504	26	fugacious	fugacious	JJ
25944	504	27	in	in	IN
25944	504	28	character	character	NN
25944	504	29	,	,	,
25944	504	30	disappearing	disappear	VBG
25944	504	31	and	and	CC
25944	504	32	reappearing	reappearing	NN
25944	504	33	in	in	IN
25944	504	34	the	the	DT
25944	504	35	most	most	RBS
25944	504	36	capricious	capricious	JJ
25944	504	37	manner	manner	NN
25944	504	38	.	.	.
25944	505	1	In	in	IN
25944	505	2	many	many	JJ
25944	505	3	cases	case	NNS
25944	505	4	simply	simply	RB
25944	505	5	drawing	draw	VBG
25944	505	6	the	the	DT
25944	505	7	finger	finger	NN
25944	505	8	over	over	IN
25944	505	9	the	the	DT
25944	505	10	skin	skin	NN
25944	505	11	will	will	MD
25944	505	12	bring	bring	VB
25944	505	13	out	out	RP
25944	505	14	irregular	irregular	JJ
25944	505	15	and	and	CC
25944	505	16	linear	linear	JJ
25944	505	17	wheals	wheal	NNS
25944	505	18	.	.	.
25944	506	1	In	in	IN
25944	506	2	exceptional	exceptional	JJ
25944	506	3	cases	case	NNS
25944	506	4	this	this	DT
25944	506	5	peculiar	peculiar	JJ
25944	506	6	property	property	NN
25944	506	7	is	be	VBZ
25944	506	8	so	so	RB
25944	506	9	pronounced	pronounced	JJ
25944	506	10	and	and	CC
25944	506	11	constant	constant	JJ
25944	506	12	that	that	IN
25944	506	13	at	at	IN
25944	506	14	any	any	DT
25944	506	15	time	time	NN
25944	506	16	letters	letter	NNS
25944	506	17	and	and	CC
25944	506	18	other	other	JJ
25944	506	19	symbols	symbol	NNS
25944	506	20	may	may	MD
25944	506	21	be	be	VB
25944	506	22	produced	produce	VBN
25944	506	23	at	at	IN
25944	506	24	will	will	NN
25944	506	25	,	,	,
25944	506	26	even	even	RB
25944	506	27	when	when	WRB
25944	506	28	such	such	JJ
25944	506	29	subjects	subject	NNS
25944	506	30	are	be	VBP
25944	506	31	free	free	JJ
25944	506	32	from	from	IN
25944	506	33	the	the	DT
25944	506	34	ordinary	ordinary	JJ
25944	506	35	urticarial	urticarial	JJ
25944	506	36	lesions	lesion	NNS
25944	506	37	(	(	-LRB-
25944	506	38	_	_	NNP
25944	506	39	urticaria	urticaria	NNP
25944	506	40	factitia	factitia	NNP
25944	506	41	_	_	NNP
25944	506	42	,	,	,
25944	506	43	_	_	NNP
25944	506	44	dermatographism	dermatographism	NN
25944	506	45	_	_	NNP
25944	506	46	,	,	,
25944	506	47	_	_	NNP
25944	506	48	autographism	autographism	NN
25944	506	49	_	_	NNP
25944	506	50	)	)	-RRB-
25944	506	51	.	.	.
25944	507	1	The	the	DT
25944	507	2	mucous	mucous	JJ
25944	507	3	membrane	membrane	NN
25944	507	4	of	of	IN
25944	507	5	the	the	DT
25944	507	6	mouth	mouth	NN
25944	507	7	and	and	CC
25944	507	8	throat	throat	NN
25944	507	9	may	may	MD
25944	507	10	also	also	RB
25944	507	11	be	be	VB
25944	507	12	the	the	DT
25944	507	13	seat	seat	NN
25944	507	14	of	of	IN
25944	507	15	wheals	wheal	NNS
25944	507	16	and	and	CC
25944	507	17	urticarial	urticarial	JJ
25944	507	18	swellings	swelling	NNS
25944	507	19	.	.	.
25944	508	1	#	#	LS
25944	508	2	What	what	WP
25944	508	3	is	be	VBZ
25944	508	4	the	the	DT
25944	508	5	ordinary	ordinary	JJ
25944	508	6	course	course	NN
25944	508	7	of	of	IN
25944	508	8	urticaria	urticaria	NNP
25944	508	9	?	?	.
25944	508	10	#	#	NNP
25944	508	11	Acute	acute	JJ
25944	508	12	.	.	.
25944	509	1	The	the	DT
25944	509	2	disease	disease	NN
25944	509	3	is	be	VBZ
25944	509	4	usually	usually	RB
25944	509	5	at	at	IN
25944	509	6	an	an	DT
25944	509	7	end	end	NN
25944	509	8	in	in	IN
25944	509	9	several	several	JJ
25944	509	10	hours	hour	NNS
25944	509	11	or	or	CC
25944	509	12	days	day	NNS
25944	509	13	.	.	.
25944	510	1	#	#	NN
25944	510	2	Does	do	VBZ
25944	510	3	urticaria	urticaria	VB
25944	510	4	always	always	RB
25944	510	5	pursue	pursue	VB
25944	510	6	an	an	DT
25944	510	7	acute	acute	JJ
25944	510	8	course	course	NN
25944	510	9	?	?	.
25944	510	10	#	#	$
25944	510	11	No	no	UH
25944	510	12	.	.	.
25944	511	1	In	in	IN
25944	511	2	exceptional	exceptional	JJ
25944	511	3	instances	instance	NNS
25944	511	4	the	the	DT
25944	511	5	disease	disease	NN
25944	511	6	is	be	VBZ
25944	511	7	chronic	chronic	JJ
25944	511	8	,	,	,
25944	511	9	in	in	IN
25944	511	10	the	the	DT
25944	511	11	sense	sense	NN
25944	511	12	that	that	IN
25944	511	13	new	new	JJ
25944	511	14	lesions	lesion	NNS
25944	511	15	continue	continue	VBP
25944	511	16	to	to	TO
25944	511	17	appear	appear	VB
25944	511	18	and	and	CC
25944	511	19	disappear	disappear	VB
25944	511	20	irregularly	irregularly	RB
25944	511	21	from	from	IN
25944	511	22	time	time	NN
25944	511	23	to	to	IN
25944	511	24	time	time	NN
25944	511	25	for	for	IN
25944	511	26	months	month	NNS
25944	511	27	or	or	CC
25944	511	28	several	several	JJ
25944	511	29	years	year	NNS
25944	511	30	,	,	,
25944	511	31	the	the	DT
25944	511	32	skin	skin	NN
25944	511	33	rarely	rarely	RB
25944	511	34	being	be	VBG
25944	511	35	entirely	entirely	RB
25944	511	36	free	free	JJ
25944	511	37	(	(	-LRB-
25944	511	38	_	_	NNP
25944	511	39	chronic	chronic	JJ
25944	511	40	urticaria	urticaria	NN
25944	511	41	_	_	NNP
25944	511	42	)	)	-RRB-
25944	511	43	.	.	.
25944	512	1	[	[	-LRB-
25944	512	2	Illustration	illustration	NN
25944	512	3	:	:	:
25944	512	4	Fig	Fig	NNP
25944	512	5	.	.	.
25944	513	1	12	12	CD
25944	513	2	.	.	.
25944	514	1	Dermatographism	dermatographism	NN
25944	514	2	.	.	.
25944	515	1	(	(	-LRB-
25944	515	2	_	_	NNP
25944	515	3	After	after	IN
25944	515	4	C.N.	C.N.	NNP
25944	516	1	Davis	Davis	NNP
25944	516	2	.	.	.
25944	516	3	_	_	NNP
25944	516	4	)	)	-RRB-
25944	516	5	]	]	-RRB-
25944	516	6	#	#	$
25944	516	7	Are	be	VBP
25944	516	8	subjective	subjective	JJ
25944	516	9	symptoms	symptom	NNS
25944	516	10	always	always	RB
25944	516	11	present	present	JJ
25944	516	12	in	in	IN
25944	516	13	urticaria	urticaria	NNP
25944	516	14	?	?	.
25944	516	15	#	#	NN
25944	516	16	Yes	yes	UH
25944	516	17	.	.	.
25944	517	1	Itching	itching	NN
25944	517	2	is	be	VBZ
25944	517	3	commonly	commonly	RB
25944	517	4	a	a	DT
25944	517	5	conspicuous	conspicuous	JJ
25944	517	6	symptom	symptom	NN
25944	517	7	,	,	,
25944	517	8	although	although	IN
25944	517	9	at	at	IN
25944	517	10	times	time	NNS
25944	517	11	pricking	prick	VBG
25944	517	12	,	,	,
25944	517	13	stinging	stinging	JJ
25944	517	14	or	or	CC
25944	517	15	a	a	DT
25944	517	16	feeling	feeling	NN
25944	517	17	of	of	IN
25944	517	18	burning	burning	NN
25944	517	19	constitutes	constitute	VBZ
25944	517	20	the	the	DT
25944	517	21	chief	chief	JJ
25944	517	22	sensation	sensation	NN
25944	517	23	.	.	.
25944	518	1	#	#	$
25944	518	2	In	in	IN
25944	518	3	what	what	WDT
25944	518	4	way	way	NN
25944	518	5	may	may	MD
25944	518	6	the	the	DT
25944	518	7	eruption	eruption	NN
25944	518	8	be	be	VB
25944	518	9	atypical	atypical	JJ
25944	518	10	?	?	.
25944	518	11	#	#	$
25944	518	12	Exceptionally	exceptionally	RB
25944	518	13	the	the	DT
25944	518	14	wheals	wheal	NNS
25944	518	15	,	,	,
25944	518	16	or	or	CC
25944	518	17	lesions	lesion	NNS
25944	518	18	,	,	,
25944	518	19	are	be	VBP
25944	518	20	peculiar	peculiar	JJ
25944	518	21	as	as	IN
25944	518	22	to	to	IN
25944	518	23	formation	formation	NN
25944	518	24	,	,	,
25944	518	25	or	or	CC
25944	518	26	another	another	DT
25944	518	27	condition	condition	NN
25944	518	28	or	or	CC
25944	518	29	disease	disease	NN
25944	518	30	may	may	MD
25944	518	31	be	be	VB
25944	518	32	associated	associate	VBN
25944	518	33	,	,	,
25944	518	34	hence	hence	RB
25944	518	35	the	the	DT
25944	518	36	varieties	variety	NNS
25944	518	37	known	know	VBN
25944	518	38	as	as	IN
25944	518	39	urticaria	urticaria	NNP
25944	518	40	papulosa	papulosa	NNP
25944	518	41	,	,	,
25944	518	42	urticaria	urticaria	NNP
25944	518	43	hæmorrhagica	hæmorrhagica	NNP
25944	518	44	,	,	,
25944	518	45	urticaria	urticaria	NNP
25944	518	46	tuberosa	tuberosa	NNP
25944	518	47	,	,	,
25944	518	48	and	and	CC
25944	518	49	urticaria	urticaria	NNP
25944	518	50	bullosa	bullosa	NNP
25944	518	51	.	.	.
25944	519	1	#	#	NNP
25944	519	2	Describe	Describe	NNP
25944	519	3	urticaria	urticaria	JJ
25944	519	4	papulosa	papulosa	NNP
25944	519	5	.	.	.
25944	519	6	#	#	NNP
25944	519	7	Urticaria	Urticaria	NNP
25944	519	8	papulosa	papulosa	NNP
25944	519	9	(	(	-LRB-
25944	519	10	formerly	formerly	RB
25944	519	11	called	call	VBN
25944	519	12	_	_	NNP
25944	519	13	lichen	lichen	NNP
25944	519	14	urticatus	urticatus	NNP
25944	519	15	_	_	NNP
25944	519	16	)	)	-RRB-
25944	519	17	is	be	VBZ
25944	519	18	a	a	DT
25944	519	19	variety	variety	NN
25944	519	20	in	in	IN
25944	519	21	which	which	WDT
25944	519	22	the	the	DT
25944	519	23	lesions	lesion	NNS
25944	519	24	are	be	VBP
25944	519	25	small	small	JJ
25944	519	26	and	and	CC
25944	519	27	papular	papular	JJ
25944	519	28	,	,	,
25944	519	29	developing	develop	VBG
25944	519	30	usually	usually	RB
25944	519	31	out	out	IN
25944	519	32	of	of	IN
25944	519	33	the	the	DT
25944	519	34	ordinary	ordinary	JJ
25944	519	35	wheals	wheal	NNS
25944	519	36	.	.	.
25944	520	1	They	-PRON-	PRP
25944	520	2	appear	appear	VBP
25944	520	3	as	as	IN
25944	520	4	a	a	DT
25944	520	5	rule	rule	NN
25944	520	6	suddenly	suddenly	RB
25944	520	7	,	,	,
25944	520	8	rarely	rarely	RB
25944	520	9	in	in	IN
25944	520	10	great	great	JJ
25944	520	11	numbers	number	NNS
25944	520	12	,	,	,
25944	520	13	are	be	VBP
25944	520	14	scattered	scatter	VBN
25944	520	15	,	,	,
25944	520	16	and	and	CC
25944	520	17	after	after	IN
25944	520	18	a	a	DT
25944	520	19	few	few	JJ
25944	520	20	hours	hour	NNS
25944	520	21	or	or	CC
25944	520	22	,	,	,
25944	520	23	more	more	RBR
25944	520	24	commonly	commonly	RB
25944	520	25	,	,	,
25944	520	26	days	day	NNS
25944	520	27	gradually	gradually	RB
25944	520	28	disappear	disappear	VBP
25944	520	29	.	.	.
25944	521	1	The	the	DT
25944	521	2	itching	itching	NN
25944	521	3	is	be	VBZ
25944	521	4	intense	intense	JJ
25944	521	5	,	,	,
25944	521	6	and	and	CC
25944	521	7	in	in	IN
25944	521	8	consequence	consequence	NN
25944	521	9	their	-PRON-	PRP$
25944	521	10	apices	apex	NNS
25944	521	11	are	be	VBP
25944	521	12	excoriated	excoriate	VBN
25944	521	13	.	.	.
25944	522	1	Sometimes	sometimes	RB
25944	522	2	the	the	DT
25944	522	3	papules	papule	NNS
25944	522	4	are	be	VBP
25944	522	5	capped	cap	VBN
25944	522	6	with	with	IN
25944	522	7	a	a	DT
25944	522	8	small	small	JJ
25944	522	9	vesicle	vesicle	NN
25944	522	10	(	(	-LRB-
25944	522	11	vesicular	vesicular	JJ
25944	522	12	urticaria	urticaria	NNP
25944	522	13	)	)	-RRB-
25944	522	14	.	.	.
25944	523	1	It	-PRON-	PRP
25944	523	2	is	be	VBZ
25944	523	3	seen	see	VBN
25944	523	4	more	more	RBR
25944	523	5	particularly	particularly	RB
25944	523	6	in	in	IN
25944	523	7	ill	ill	RB
25944	523	8	-	-	HYPH
25944	523	9	cared	care	VBN
25944	523	10	for	for	IN
25944	523	11	and	and	CC
25944	523	12	badly	badly	RB
25944	523	13	-	-	HYPH
25944	523	14	nourished	nourish	VBN
25944	523	15	young	young	JJ
25944	523	16	children	child	NNS
25944	523	17	.	.	.
25944	524	1	#	#	NNP
25944	524	2	Describe	Describe	NNP
25944	524	3	urticaria	urticaria	JJ
25944	524	4	hæmorrhagica	hæmorrhagica	NN
25944	524	5	.	.	.
25944	524	6	#	#	$
25944	524	7	Urticaria	Urticaria	NNP
25944	524	8	hæmorrhagica	hæmorrhagica	NNP
25944	524	9	is	be	VBZ
25944	524	10	characterized	characterize	VBN
25944	524	11	by	by	IN
25944	524	12	lesions	lesion	NNS
25944	524	13	similar	similar	JJ
25944	524	14	to	to	IN
25944	524	15	ordinary	ordinary	JJ
25944	524	16	wheals	wheal	NNS
25944	524	17	,	,	,
25944	524	18	except	except	IN
25944	524	19	that	that	IN
25944	524	20	they	-PRON-	PRP
25944	524	21	are	be	VBP
25944	524	22	somewhat	somewhat	RB
25944	524	23	hemorrhagic	hemorrhagic	JJ
25944	524	24	,	,	,
25944	524	25	partaking	partaking	JJ
25944	524	26	,	,	,
25944	524	27	in	in	IN
25944	524	28	fact	fact	NN
25944	524	29	,	,	,
25944	524	30	of	of	IN
25944	524	31	the	the	DT
25944	524	32	nature	nature	NN
25944	524	33	of	of	IN
25944	524	34	both	both	CC
25944	524	35	urticaria	urticaria	NNP
25944	524	36	and	and	CC
25944	524	37	purpura	purpura	NNP
25944	524	38	.	.	.
25944	525	1	#	#	NNP
25944	525	2	Describe	Describe	NNP
25944	525	3	urticaria	urticaria	JJ
25944	525	4	tuberosa	tuberosa	NNP
25944	525	5	.	.	.
25944	525	6	#	#	NNP
25944	525	7	In	in	IN
25944	525	8	urticaria	urticaria	NNP
25944	525	9	tuberosa	tuberosa	VBZ
25944	525	10	the	the	DT
25944	525	11	lesions	lesion	NNS
25944	525	12	,	,	,
25944	525	13	instead	instead	RB
25944	525	14	of	of	IN
25944	525	15	being	be	VBG
25944	525	16	pea-	pea-	NNS
25944	525	17	or	or	CC
25944	525	18	bean	bean	NN
25944	525	19	-	-	HYPH
25944	525	20	sized	sized	JJ
25944	525	21	,	,	,
25944	525	22	as	as	IN
25944	525	23	in	in	IN
25944	525	24	typical	typical	JJ
25944	525	25	urticaria	urticaria	NN
25944	525	26	,	,	,
25944	525	27	are	be	VBP
25944	525	28	large	large	JJ
25944	525	29	and	and	CC
25944	525	30	node	node	JJ
25944	525	31	-	-	HYPH
25944	525	32	like	like	JJ
25944	525	33	(	(	-LRB-
25944	525	34	also	also	RB
25944	525	35	called	call	VBN
25944	525	36	_	_	NNP
25944	525	37	giant	giant	NN
25944	525	38	urticaria	urticaria	NNP
25944	525	39	_	_	NNP
25944	525	40	)	)	-RRB-
25944	525	41	.	.	.
25944	526	1	#	#	LS
25944	526	2	What	what	WP
25944	526	3	is	be	VBZ
25944	526	4	acute	acute	RB
25944	526	5	-	-	HYPH
25944	526	6	circumscribed	circumscribed	JJ
25944	526	7	[	[	-LRB-
25944	526	8	oe]dema	oe]dema	ADD
25944	526	9	?	?	.
25944	526	10	#	#	$
25944	526	11	In	in	IN
25944	526	12	rare	rare	JJ
25944	526	13	instances	instance	NNS
25944	526	14	there	there	RB
25944	526	15	occurs	occur	VBZ
25944	526	16	,	,	,
25944	526	17	along	along	IN
25944	526	18	with	with	IN
25944	526	19	the	the	DT
25944	526	20	ordinary	ordinary	JJ
25944	526	21	lesions	lesion	NNS
25944	526	22	of	of	IN
25944	526	23	the	the	DT
25944	526	24	disease	disease	NN
25944	526	25	or	or	CC
25944	526	26	as	as	IN
25944	526	27	its	-PRON-	PRP$
25944	526	28	sole	sole	JJ
25944	526	29	manifestation	manifestation	NN
25944	526	30	,	,	,
25944	526	31	sudden	sudden	JJ
25944	526	32	and	and	CC
25944	526	33	evanescent	evanescent	JJ
25944	526	34	swelling	swelling	NN
25944	526	35	of	of	IN
25944	526	36	the	the	DT
25944	526	37	eyelids	eyelid	NNS
25944	526	38	,	,	,
25944	526	39	ears	ear	NNS
25944	526	40	,	,	,
25944	526	41	lips	lip	NNS
25944	526	42	,	,	,
25944	526	43	tongue	tongue	NN
25944	526	44	,	,	,
25944	526	45	hands	hand	NNS
25944	526	46	,	,	,
25944	526	47	fingers	finger	NNS
25944	526	48	,	,	,
25944	526	49	or	or	CC
25944	526	50	feet	foot	NNS
25944	526	51	(	(	-LRB-
25944	526	52	_	_	NNP
25944	526	53	urticaria	urticaria	NNP
25944	526	54	[	[	-LRB-
25944	526	55	oe]dematosa	oe]dematosa	NNP
25944	526	56	_	_	NNP
25944	526	57	,	,	,
25944	526	58	_	_	NNP
25944	526	59	acute	acute	NN
25944	526	60	_	_	NNP
25944	526	61	_	_	NNP
25944	526	62	circumscribed	circumscribe	VBD
25944	526	63	[	[	-LRB-
25944	526	64	oe]dema	oe]dema	NNP
25944	526	65	_	_	NNP
25944	526	66	,	,	,
25944	526	67	_	_	NNP
25944	526	68	angioneurotic	angioneurotic	NN
25944	526	69	[	[	-LRB-
25944	526	70	oe]dema	oe]dema	NNP
25944	526	71	_	_	NNP
25944	526	72	)	)	-RRB-
25944	526	73	.	.	.
25944	527	1	One	one	CD
25944	527	2	or	or	CC
25944	527	3	several	several	JJ
25944	527	4	of	of	IN
25944	527	5	these	these	DT
25944	527	6	parts	part	NNS
25944	527	7	only	only	RB
25944	527	8	may	may	MD
25944	527	9	be	be	VB
25944	527	10	affected	affect	VBN
25944	527	11	at	at	IN
25944	527	12	the	the	DT
25944	527	13	one	one	CD
25944	527	14	attack	attack	NN
25944	527	15	;	;	:
25944	527	16	in	in	IN
25944	527	17	recurrences	recurrence	NNS
25944	527	18	,	,	,
25944	527	19	so	so	RB
25944	527	20	usual	usual	JJ
25944	527	21	in	in	IN
25944	527	22	this	this	DT
25944	527	23	variety	variety	NN
25944	527	24	,	,	,
25944	527	25	the	the	DT
25944	527	26	same	same	JJ
25944	527	27	or	or	CC
25944	527	28	other	other	JJ
25944	527	29	parts	part	NNS
25944	527	30	may	may	MD
25944	527	31	exhibit	exhibit	VB
25944	527	32	the	the	DT
25944	527	33	manifestation	manifestation	NN
25944	527	34	.	.	.
25944	528	1	(	(	-LRB-
25944	528	2	These	these	DT
25944	528	3	[	[	-LRB-
25944	528	4	oe]dematous	oe]dematous	JJ
25944	528	5	swellings	swelling	NNS
25944	528	6	occurring	occur	VBG
25944	528	7	alone	alone	RB
25944	528	8	might	may	MD
25944	528	9	be	be	VB
25944	528	10	looked	look	VBN
25944	528	11	upon	upon	IN
25944	528	12	,	,	,
25944	528	13	as	as	IN
25944	528	14	they	-PRON-	PRP
25944	528	15	are	be	VBP
25944	528	16	by	by	IN
25944	528	17	most	most	JJS
25944	528	18	observers	observer	NNS
25944	528	19	,	,	,
25944	528	20	as	as	IN
25944	528	21	an	an	DT
25944	528	22	independent	independent	JJ
25944	528	23	affection	affection	NN
25944	528	24	,	,	,
25944	528	25	but	but	CC
25944	528	26	its	-PRON-	PRP$
25944	528	27	close	close	JJ
25944	528	28	relationship	relationship	NN
25944	528	29	to	to	IN
25944	528	30	ordinary	ordinary	JJ
25944	528	31	urticaria	urticaria	NN
25944	528	32	is	be	VBZ
25944	528	33	often	often	RB
25944	528	34	evident	evident	JJ
25944	528	35	.	.	.
25944	528	36	)	)	-RRB-
25944	529	1	#	#	NNP
25944	529	2	Describe	Describe	NNP
25944	529	3	urticaria	urticaria	JJ
25944	529	4	bullosa	bullosa	NNP
25944	529	5	.	.	.
25944	529	6	#	#	NNP
25944	529	7	Urticaria	Urticaria	NNP
25944	529	8	bullosa	bullosa	NNP
25944	529	9	is	be	VBZ
25944	529	10	a	a	DT
25944	529	11	variety	variety	NN
25944	529	12	in	in	IN
25944	529	13	which	which	WDT
25944	529	14	the	the	DT
25944	529	15	inflammatory	inflammatory	JJ
25944	529	16	action	action	NN
25944	529	17	has	have	VBZ
25944	529	18	been	be	VBN
25944	529	19	sufficiently	sufficiently	RB
25944	529	20	great	great	JJ
25944	529	21	to	to	TO
25944	529	22	give	give	VB
25944	529	23	rise	rise	NN
25944	529	24	to	to	IN
25944	529	25	fluid	fluid	JJ
25944	529	26	exudation	exudation	NN
25944	529	27	,	,	,
25944	529	28	the	the	DT
25944	529	29	wheals	wheal	NNS
25944	529	30	resulting	result	VBG
25944	529	31	in	in	IN
25944	529	32	the	the	DT
25944	529	33	formation	formation	NN
25944	529	34	of	of	IN
25944	529	35	blebs	blebs	NN
25944	529	36	.	.	.
25944	530	1	#	#	LS
25944	530	2	What	what	WP
25944	530	3	is	be	VBZ
25944	530	4	the	the	DT
25944	530	5	etiology	etiology	NN
25944	530	6	of	of	IN
25944	530	7	urticaria	urticaria	NNP
25944	530	8	?	?	.
25944	530	9	#	#	$
25944	530	10	Any	any	DT
25944	530	11	irritation	irritation	NN
25944	530	12	from	from	IN
25944	530	13	disease	disease	NN
25944	530	14	,	,	,
25944	530	15	functional	functional	JJ
25944	530	16	or	or	CC
25944	530	17	organic	organic	JJ
25944	530	18	,	,	,
25944	530	19	of	of	IN
25944	530	20	any	any	DT
25944	530	21	internal	internal	JJ
25944	530	22	organ	organ	NN
25944	530	23	,	,	,
25944	530	24	may	may	MD
25944	530	25	give	give	VB
25944	530	26	rise	rise	NN
25944	530	27	to	to	IN
25944	530	28	the	the	DT
25944	530	29	eruption	eruption	NN
25944	530	30	in	in	IN
25944	530	31	those	those	DT
25944	530	32	predisposed	predispose	VBN
25944	530	33	.	.	.
25944	531	1	Gastric	gastric	JJ
25944	531	2	derangement	derangement	NN
25944	531	3	from	from	IN
25944	531	4	indigestible	indigestible	JJ
25944	531	5	or	or	CC
25944	531	6	peculiar	peculiar	JJ
25944	531	7	articles	article	NNS
25944	531	8	of	of	IN
25944	531	9	food	food	NN
25944	531	10	,	,	,
25944	531	11	intestinal	intestinal	JJ
25944	531	12	toxins	toxin	NNS
25944	531	13	,	,	,
25944	531	14	and	and	CC
25944	531	15	the	the	DT
25944	531	16	ingestion	ingestion	NN
25944	531	17	of	of	IN
25944	531	18	certain	certain	JJ
25944	531	19	drugs	drug	NNS
25944	531	20	are	be	VBP
25944	531	21	often	often	RB
25944	531	22	provocative	provocative	JJ
25944	531	23	.	.	.
25944	532	1	The	the	DT
25944	532	2	so	so	RB
25944	532	3	-	-	HYPH
25944	532	4	called	call	VBN
25944	532	5	"	"	``
25944	532	6	shell	shell	NN
25944	532	7	-	-	HYPH
25944	532	8	fish	fish	NN
25944	532	9	"	"	''
25944	532	10	group	group	NN
25944	532	11	of	of	IN
25944	532	12	foods	food	NNS
25944	532	13	play	play	VBP
25944	532	14	an	an	DT
25944	532	15	important	important	JJ
25944	532	16	etiological	etiological	JJ
25944	532	17	part	part	NN
25944	532	18	in	in	IN
25944	532	19	some	some	DT
25944	532	20	cases	case	NNS
25944	532	21	.	.	.
25944	533	1	Idiosyncrasy	idiosyncrasy	JJ
25944	533	2	to	to	IN
25944	533	3	certain	certain	JJ
25944	533	4	articles	article	NNS
25944	533	5	of	of	IN
25944	533	6	food	food	NN
25944	533	7	is	be	VBZ
25944	533	8	also	also	RB
25944	533	9	responsible	responsible	JJ
25944	533	10	in	in	IN
25944	533	11	occasional	occasional	JJ
25944	533	12	instances	instance	NNS
25944	533	13	.	.	.
25944	534	1	Various	various	JJ
25944	534	2	rheumatic	rheumatic	JJ
25944	534	3	and	and	CC
25944	534	4	nervous	nervous	JJ
25944	534	5	disorders	disorder	NNS
25944	534	6	are	be	VBP
25944	534	7	not	not	RB
25944	534	8	infrequently	infrequently	RB
25944	534	9	associated	associate	VBN
25944	534	10	with	with	IN
25944	534	11	it	-PRON-	PRP
25944	534	12	,	,	,
25944	534	13	and	and	CC
25944	534	14	are	be	VBP
25944	534	15	doubtless	doubtless	RB
25944	534	16	of	of	IN
25944	534	17	etiological	etiological	JJ
25944	534	18	significance	significance	NN
25944	534	19	.	.	.
25944	535	1	External	external	JJ
25944	535	2	irritants	irritant	NNS
25944	535	3	,	,	,
25944	535	4	also	also	RB
25944	535	5	,	,	,
25944	535	6	in	in	IN
25944	535	7	predisposed	predisposed	JJ
25944	535	8	subjects	subject	NNS
25944	535	9	,	,	,
25944	535	10	are	be	VBP
25944	535	11	at	at	IN
25944	535	12	times	time	NNS
25944	535	13	responsible	responsible	JJ
25944	535	14	.	.	.
25944	536	1	#	#	LS
25944	536	2	What	what	WP
25944	536	3	is	be	VBZ
25944	536	4	the	the	DT
25944	536	5	pathology	pathology	NN
25944	536	6	of	of	IN
25944	536	7	urticaria	urticaria	NNP
25944	536	8	?	?	.
25944	536	9	#	#	$
25944	536	10	Anatomically	anatomically	RB
25944	536	11	a	a	DT
25944	536	12	wheal	wheal	NN
25944	536	13	is	be	VBZ
25944	536	14	seen	see	VBN
25944	536	15	to	to	TO
25944	536	16	be	be	VB
25944	536	17	a	a	DT
25944	536	18	more	more	RBR
25944	536	19	or	or	CC
25944	536	20	less	less	RBR
25944	536	21	firm	firm	JJ
25944	536	22	elevation	elevation	NN
25944	536	23	consisting	consist	VBG
25944	536	24	of	of	IN
25944	536	25	a	a	DT
25944	536	26	circumscribed	circumscribe	VBN
25944	536	27	or	or	CC
25944	536	28	somewhat	somewhat	RB
25944	536	29	diffused	diffused	JJ
25944	536	30	collection	collection	NN
25944	536	31	of	of	IN
25944	536	32	semi	semi	JJ
25944	536	33	-	-	JJ
25944	536	34	fluid	fluid	JJ
25944	536	35	material	material	NN
25944	536	36	in	in	IN
25944	536	37	the	the	DT
25944	536	38	upper	upper	JJ
25944	536	39	layers	layer	NNS
25944	536	40	of	of	IN
25944	536	41	the	the	DT
25944	536	42	skin	skin	NN
25944	536	43	.	.	.
25944	537	1	The	the	DT
25944	537	2	vasomotor	vasomotor	NN
25944	537	3	nervous	nervous	JJ
25944	537	4	system	system	NN
25944	537	5	is	be	VBZ
25944	537	6	probably	probably	RB
25944	537	7	the	the	DT
25944	537	8	main	main	JJ
25944	537	9	factor	factor	NN
25944	537	10	in	in	IN
25944	537	11	its	-PRON-	PRP$
25944	537	12	production	production	NN
25944	537	13	;	;	:
25944	537	14	dilatation	dilatation	NN
25944	537	15	following	follow	VBG
25944	537	16	spasm	spasm	NN
25944	537	17	of	of	IN
25944	537	18	the	the	DT
25944	537	19	vessels	vessel	NNS
25944	537	20	results	result	NNS
25944	537	21	in	in	IN
25944	537	22	effusion	effusion	NN
25944	537	23	,	,	,
25944	537	24	and	and	CC
25944	537	25	in	in	IN
25944	537	26	consequence	consequence	NNP
25944	537	27	,	,	,
25944	537	28	the	the	DT
25944	537	29	overfilled	overfill	VBN
25944	537	30	vessels	vessel	NNS
25944	537	31	of	of	IN
25944	537	32	the	the	DT
25944	537	33	central	central	JJ
25944	537	34	portion	portion	NN
25944	537	35	are	be	VBP
25944	537	36	emptied	empty	VBN
25944	537	37	by	by	IN
25944	537	38	pressure	pressure	NN
25944	537	39	of	of	IN
25944	537	40	the	the	DT
25944	537	41	exudation	exudation	NN
25944	537	42	and	and	CC
25944	537	43	the	the	DT
25944	537	44	central	central	JJ
25944	537	45	paleness	paleness	NN
25944	537	46	results	result	NNS
25944	537	47	,	,	,
25944	537	48	while	while	IN
25944	537	49	the	the	DT
25944	537	50	pressed	press	VBN
25944	537	51	-	-	HYPH
25944	537	52	back	back	RP
25944	537	53	blood	blood	NN
25944	537	54	gives	give	VBZ
25944	537	55	rise	rise	VB
25944	537	56	to	to	IN
25944	537	57	the	the	DT
25944	537	58	bright	bright	JJ
25944	537	59	red	red	JJ
25944	537	60	periphery	periphery	NN
25944	537	61	.	.	.
25944	538	1	#	#	$
25944	538	2	From	from	IN
25944	538	3	what	what	WP
25944	538	4	diseases	disease	NNS
25944	538	5	is	be	VBZ
25944	538	6	urticaria	urticaria	JJ
25944	538	7	to	to	TO
25944	538	8	be	be	VB
25944	538	9	differentiated	differentiate	VBN
25944	538	10	?	?	.
25944	538	11	#	#	$
25944	538	12	From	from	IN
25944	538	13	erythema	erythema	NNP
25944	538	14	simplex	simplex	NNP
25944	538	15	,	,	,
25944	538	16	erythema	erythema	NNP
25944	538	17	multiforme	multiforme	NNP
25944	538	18	,	,	,
25944	538	19	erythema	erythema	NNP
25944	538	20	nodosum	nodosum	NNP
25944	538	21	,	,	,
25944	538	22	and	and	CC
25944	538	23	erysipelas	erysipela	NNS
25944	538	24	.	.	.
25944	539	1	#	#	$
25944	539	2	Mention	mention	VB
25944	539	3	the	the	DT
25944	539	4	diagnostic	diagnostic	JJ
25944	539	5	points	point	NNS
25944	539	6	of	of	IN
25944	539	7	urticaria	urticaria	NNP
25944	539	8	.	.	.
25944	539	9	#	#	$
25944	539	10	The	the	DT
25944	539	11	acuteness	acuteness	NN
25944	539	12	,	,	,
25944	539	13	character	character	NN
25944	539	14	of	of	IN
25944	539	15	the	the	DT
25944	539	16	lesions	lesion	NNS
25944	539	17	,	,	,
25944	539	18	their	-PRON-	PRP$
25944	539	19	evanescent	evanescent	JJ
25944	539	20	nature	nature	NN
25944	539	21	,	,	,
25944	539	22	the	the	DT
25944	539	23	irregular	irregular	JJ
25944	539	24	or	or	CC
25944	539	25	general	general	JJ
25944	539	26	distribution	distribution	NN
25944	539	27	,	,	,
25944	539	28	and	and	CC
25944	539	29	the	the	DT
25944	539	30	intense	intense	JJ
25944	539	31	itching	itching	NN
25944	539	32	.	.	.
25944	540	1	#	#	LS
25944	540	2	What	what	WP
25944	540	3	is	be	VBZ
25944	540	4	the	the	DT
25944	540	5	prognosis	prognosis	NN
25944	540	6	in	in	IN
25944	540	7	urticaria	urticaria	NNP
25944	540	8	?	?	.
25944	540	9	#	#	$
25944	540	10	The	the	DT
25944	540	11	acute	acute	JJ
25944	540	12	disease	disease	NN
25944	540	13	is	be	VBZ
25944	540	14	usually	usually	RB
25944	540	15	of	of	IN
25944	540	16	short	short	JJ
25944	540	17	duration	duration	NN
25944	540	18	,	,	,
25944	540	19	disappearing	disappear	VBG
25944	540	20	spontaneously	spontaneously	RB
25944	540	21	or	or	CC
25944	540	22	as	as	IN
25944	540	23	the	the	DT
25944	540	24	result	result	NN
25944	540	25	of	of	IN
25944	540	26	treatment	treatment	NN
25944	540	27	,	,	,
25944	540	28	in	in	IN
25944	540	29	several	several	JJ
25944	540	30	hours	hour	NNS
25944	540	31	or	or	CC
25944	540	32	days	day	NNS
25944	540	33	;	;	:
25944	540	34	it	-PRON-	PRP
25944	540	35	may	may	MD
25944	540	36	recur	recur	VB
25944	540	37	upon	upon	IN
25944	540	38	exposure	exposure	NN
25944	540	39	to	to	IN
25944	540	40	the	the	DT
25944	540	41	exciting	exciting	JJ
25944	540	42	cause	cause	NN
25944	540	43	.	.	.
25944	541	1	The	the	DT
25944	541	2	prognosis	prognosis	NN
25944	541	3	of	of	IN
25944	541	4	chronic	chronic	JJ
25944	541	5	urticaria	urticaria	NN
25944	541	6	is	be	VBZ
25944	541	7	to	to	TO
25944	541	8	be	be	VB
25944	541	9	guarded	guard	VBN
25944	541	10	,	,	,
25944	541	11	and	and	CC
25944	541	12	will	will	MD
25944	541	13	depend	depend	VB
25944	541	14	upon	upon	IN
25944	541	15	the	the	DT
25944	541	16	ability	ability	NN
25944	541	17	to	to	TO
25944	541	18	discover	discover	VB
25944	541	19	and	and	CC
25944	541	20	remove	remove	VB
25944	541	21	or	or	CC
25944	541	22	modify	modify	VB
25944	541	23	the	the	DT
25944	541	24	predisposing	predisposing	NN
25944	541	25	condition	condition	NN
25944	541	26	.	.	.
25944	542	1	#	#	LS
25944	542	2	What	what	WDT
25944	542	3	systemic	systemic	JJ
25944	542	4	measures	measure	NNS
25944	542	5	are	be	VBP
25944	542	6	to	to	TO
25944	542	7	be	be	VB
25944	542	8	prescribed	prescribe	VBN
25944	542	9	in	in	IN
25944	542	10	acute	acute	JJ
25944	542	11	urticaria	urticaria	NNP
25944	542	12	?	?	.
25944	542	13	#	#	NNP
25944	542	14	Removal	removal	NN
25944	542	15	of	of	IN
25944	542	16	the	the	DT
25944	542	17	etiological	etiological	JJ
25944	542	18	factor	factor	NN
25944	542	19	is	be	VBZ
25944	542	20	of	of	IN
25944	542	21	first	first	JJ
25944	542	22	importance	importance	NN
25944	542	23	.	.	.
25944	543	1	This	this	DT
25944	543	2	will	will	MD
25944	543	3	be	be	VB
25944	543	4	found	find	VBN
25944	543	5	in	in	IN
25944	543	6	most	most	JJS
25944	543	7	cases	case	NNS
25944	543	8	to	to	TO
25944	543	9	be	be	VB
25944	543	10	gastric	gastric	JJ
25944	543	11	disturbance	disturbance	NN
25944	543	12	from	from	IN
25944	543	13	the	the	DT
25944	543	14	ingestion	ingestion	NN
25944	543	15	of	of	IN
25944	543	16	improper	improper	JJ
25944	543	17	or	or	CC
25944	543	18	indigestible	indigestible	JJ
25944	543	19	food	food	NN
25944	543	20	,	,	,
25944	543	21	and	and	CC
25944	543	22	in	in	IN
25944	543	23	such	such	JJ
25944	543	24	cases	case	NNS
25944	543	25	a	a	DT
25944	543	26	saline	saline	JJ
25944	543	27	purgative	purgative	JJ
25944	543	28	is	be	VBZ
25944	543	29	to	to	TO
25944	543	30	be	be	VB
25944	543	31	given	give	VBN
25944	543	32	,	,	,
25944	543	33	probably	probably	RB
25944	543	34	the	the	DT
25944	543	35	best	good	JJS
25944	543	36	for	for	IN
25944	543	37	this	this	DT
25944	543	38	purpose	purpose	NN
25944	543	39	being	be	VBG
25944	543	40	the	the	DT
25944	543	41	laxative	laxative	NN
25944	543	42	antacid	antacid	JJ
25944	543	43	,	,	,
25944	543	44	magnesia	magnesia	NNP
25944	543	45	;	;	:
25944	543	46	or	or	CC
25944	543	47	if	if	IN
25944	543	48	the	the	DT
25944	543	49	case	case	NN
25944	543	50	is	be	VBZ
25944	543	51	severe	severe	JJ
25944	543	52	and	and	CC
25944	543	53	food	food	NN
25944	543	54	is	be	VBZ
25944	543	55	still	still	RB
25944	543	56	in	in	IN
25944	543	57	the	the	DT
25944	543	58	stomach	stomach	NN
25944	543	59	,	,	,
25944	543	60	an	an	DT
25944	543	61	emetic	emetic	JJ
25944	543	62	,	,	,
25944	543	63	such	such	JJ
25944	543	64	as	as	IN
25944	543	65	mustard	mustard	NN
25944	543	66	or	or	CC
25944	543	67	ipecac	ipecac	NNS
25944	543	68	,	,	,
25944	543	69	will	will	MD
25944	543	70	act	act	VB
25944	543	71	more	more	RBR
25944	543	72	promptly	promptly	RB
25944	543	73	.	.	.
25944	544	1	Alkalies	alkali	NNS
25944	544	2	,	,	,
25944	544	3	especially	especially	RB
25944	544	4	sodium	sodium	NN
25944	544	5	salicylate	salicylate	NN
25944	544	6	,	,	,
25944	544	7	and	and	CC
25944	544	8	intestinal	intestinal	JJ
25944	544	9	antiseptics	antiseptic	NNS
25944	544	10	are	be	VBP
25944	544	11	useful	useful	JJ
25944	544	12	.	.	.
25944	545	1	Calcium	calcium	NN
25944	545	2	chloride	chloride	NN
25944	545	3	in	in	IN
25944	545	4	doses	dose	NNS
25944	545	5	of	of	IN
25944	545	6	five	five	CD
25944	545	7	to	to	TO
25944	545	8	twenty	twenty	CD
25944	545	9	grains	grain	NNS
25944	545	10	should	should	MD
25944	545	11	be	be	VB
25944	545	12	tried	try	VBN
25944	545	13	in	in	IN
25944	545	14	obstinate	obstinate	NN
25944	545	15	cases	case	NNS
25944	545	16	.	.	.
25944	546	1	The	the	DT
25944	546	2	diet	diet	NN
25944	546	3	should	should	MD
25944	546	4	be	be	VB
25944	546	5	,	,	,
25944	546	6	for	for	IN
25944	546	7	the	the	DT
25944	546	8	time	time	NN
25944	546	9	,	,	,
25944	546	10	of	of	IN
25944	546	11	a	a	DT
25944	546	12	simple	simple	JJ
25944	546	13	character	character	NN
25944	546	14	.	.	.
25944	547	1	#	#	LS
25944	547	2	What	what	WDT
25944	547	3	systemic	systemic	JJ
25944	547	4	measures	measure	NNS
25944	547	5	are	be	VBP
25944	547	6	to	to	TO
25944	547	7	be	be	VB
25944	547	8	prescribed	prescribe	VBN
25944	547	9	in	in	IN
25944	547	10	chronic	chronic	JJ
25944	547	11	and	and	CC
25944	547	12	recurrent	recurrent	JJ
25944	547	13	urticaria	urticaria	JJ
25944	547	14	?	?	.
25944	547	15	#	#	$
25944	547	16	The	the	DT
25944	547	17	cause	cause	NN
25944	547	18	must	must	MD
25944	547	19	be	be	VB
25944	547	20	sought	seek	VBN
25944	547	21	for	for	IN
25944	547	22	and	and	CC
25944	547	23	treatment	treatment	NN
25944	547	24	directed	direct	VBN
25944	547	25	toward	toward	IN
25944	547	26	its	-PRON-	PRP$
25944	547	27	removal	removal	NN
25944	547	28	or	or	CC
25944	547	29	modification	modification	NN
25944	547	30	.	.	.
25944	548	1	Treatment	treatment	NN
25944	548	2	will	will	MD
25944	548	3	,	,	,
25944	548	4	therefore	therefore	RB
25944	548	5	,	,	,
25944	548	6	depend	depend	VBP
25944	548	7	upon	upon	IN
25944	548	8	indications	indication	NNS
25944	548	9	.	.	.
25944	549	1	In	in	IN
25944	549	2	obscure	obscure	JJ
25944	549	3	cases	case	NNS
25944	549	4	,	,	,
25944	549	5	quinine	quinine	JJ
25944	549	6	,	,	,
25944	549	7	sodium	sodium	NN
25944	549	8	salicylate	salicylate	NN
25944	549	9	,	,	,
25944	549	10	arsenic	arsenic	JJ
25944	549	11	,	,	,
25944	549	12	pilocarpine	pilocarpine	NN
25944	549	13	,	,	,
25944	549	14	_	_	NNP
25944	549	15	atropia	atropia	NNP
25944	549	16	_	_	NNP
25944	549	17	,	,	,
25944	549	18	potassium	potassium	NN
25944	549	19	bromide	bromide	NN
25944	549	20	,	,	,
25944	549	21	calcium	calcium	NN
25944	549	22	chloride	chloride	NN
25944	549	23	,	,	,
25944	549	24	and	and	CC
25944	549	25	ichthyol	ichthyol	NN
25944	549	26	are	be	VBP
25944	549	27	to	to	TO
25944	549	28	be	be	VB
25944	549	29	variously	variously	RB
25944	549	30	tried	try	VBN
25944	549	31	;	;	:
25944	549	32	general	general	JJ
25944	549	33	galvanization	galvanization	NN
25944	549	34	is	be	VBZ
25944	549	35	at	at	IN
25944	549	36	times	time	NNS
25944	549	37	useful	useful	JJ
25944	549	38	,	,	,
25944	549	39	as	as	IN
25944	549	40	is	be	VBZ
25944	549	41	also	also	RB
25944	549	42	a	a	DT
25944	549	43	change	change	NN
25944	549	44	of	of	IN
25944	549	45	scene	scene	NN
25944	549	46	and	and	CC
25944	549	47	climate	climate	NN
25944	549	48	.	.	.
25944	550	1	A	a	DT
25944	550	2	proper	proper	JJ
25944	550	3	dietary	dietary	NN
25944	550	4	and	and	CC
25944	550	5	the	the	DT
25944	550	6	maintenance	maintenance	NN
25944	550	7	of	of	IN
25944	550	8	free	free	JJ
25944	550	9	action	action	NN
25944	550	10	of	of	IN
25944	550	11	the	the	DT
25944	550	12	bowels	bowel	NNS
25944	550	13	,	,	,
25944	550	14	preferably	preferably	RB
25944	550	15	,	,	,
25944	550	16	as	as	IN
25944	550	17	a	a	DT
25944	550	18	rule	rule	NN
25944	550	19	,	,	,
25944	550	20	with	with	IN
25944	550	21	a	a	DT
25944	550	22	saline	saline	JJ
25944	550	23	laxative	laxative	NN
25944	550	24	,	,	,
25944	550	25	is	be	VBZ
25944	550	26	of	of	IN
25944	550	27	great	great	JJ
25944	550	28	importance	importance	NN
25944	550	29	in	in	IN
25944	550	30	these	these	DT
25944	550	31	chronic	chronic	JJ
25944	550	32	cases	case	NNS
25944	550	33	.	.	.
25944	551	1	In	in	IN
25944	551	2	acute	acute	JJ
25944	551	3	circumscribed	circumscribe	VBN
25944	551	4	[	[	-LRB-
25944	551	5	oe]dema	oe]dema	``
25944	551	6	treatment	treatment	NN
25944	551	7	is	be	VBZ
25944	551	8	essentially	essentially	RB
25944	551	9	that	that	DT
25944	551	10	of	of	IN
25944	551	11	urticaria	urticaria	NNP
25944	551	12	,	,	,
25944	551	13	the	the	DT
25944	551	14	diet	diet	NN
25944	551	15	being	be	VBG
25944	551	16	given	give	VBN
25944	551	17	special	special	JJ
25944	551	18	attention	attention	NN
25944	551	19	.	.	.
25944	552	1	#	#	$
25944	552	2	What	what	WDT
25944	552	3	external	external	JJ
25944	552	4	applications	application	NNS
25944	552	5	would	would	MD
25944	552	6	you	-PRON-	PRP
25944	552	7	advise	advise	VB
25944	552	8	for	for	IN
25944	552	9	the	the	DT
25944	552	10	relief	relief	NN
25944	552	11	of	of	IN
25944	552	12	the	the	DT
25944	552	13	subjective	subjective	JJ
25944	552	14	symptoms	symptom	NNS
25944	552	15	?	?	.
25944	552	16	#	#	$
25944	552	17	Cooling	cooling	JJ
25944	552	18	lotions	lotion	NNS
25944	552	19	of	of	IN
25944	552	20	alcohol	alcohol	NN
25944	552	21	and	and	CC
25944	552	22	water	water	NN
25944	552	23	or	or	CC
25944	552	24	vinegar	vinegar	NN
25944	552	25	and	and	CC
25944	552	26	water	water	NN
25944	552	27	;	;	:
25944	552	28	lotions	lotion	NNS
25944	552	29	of	of	IN
25944	552	30	carbolic	carbolic	JJ
25944	552	31	acid	acid	NNP
25944	552	32	,	,	,
25944	552	33	one	one	CD
25944	552	34	to	to	TO
25944	552	35	three	three	CD
25944	552	36	drachms	drachm	NNS
25944	552	37	to	to	IN
25944	552	38	the	the	DT
25944	552	39	pint	pint	NN
25944	552	40	;	;	:
25944	552	41	of	of	IN
25944	552	42	thymol	thymol	NN
25944	552	43	,	,	,
25944	552	44	one	one	CD
25944	552	45	-	-	HYPH
25944	552	46	fourth	fourth	NN
25944	552	47	to	to	IN
25944	552	48	one	one	CD
25944	552	49	drachm	drachm	NN
25944	552	50	to	to	IN
25944	552	51	the	the	DT
25944	552	52	pint	pint	NN
25944	552	53	of	of	IN
25944	552	54	alcohol	alcohol	NN
25944	552	55	and	and	CC
25944	552	56	water	water	NN
25944	552	57	;	;	,
25944	552	58	of	of	IN
25944	552	59	liquor	liquor	NN
25944	552	60	carbonis	carbonis	NN
25944	552	61	detergens	detergen	NNS
25944	552	62	,	,	,
25944	552	63	one	one	CD
25944	552	64	to	to	TO
25944	552	65	three	three	CD
25944	552	66	ounces	ounce	NNS
25944	552	67	to	to	IN
25944	552	68	the	the	DT
25944	552	69	pint	pint	NN
25944	552	70	of	of	IN
25944	552	71	water	water	NN
25944	552	72	,	,	,
25944	552	73	or	or	CC
25944	552	74	the	the	DT
25944	552	75	following:--	following:--	NN
25944	552	76	[	[	-LRB-
25944	552	77	Rx	Rx	NNP
25944	552	78	]	]	-RRB-
25944	552	79	Acidi	Acidi	NNP
25944	552	80	carbolici	carbolici	NNS
25944	552	81	,	,	,
25944	552	82	.....................	.....................	NFP
25944	552	83	[	[	-LRB-
25944	552	84	dram]j-[dram]iij	dram]j-[dram]iij	NN
25944	552	85	Acidi	acidi	NN
25944	552	86	borici	borici	NN
25944	552	87	,	,	,
25944	552	88	........................	........................	NFP
25944	552	89	[	[	-LRB-
25944	552	90	dram]iv	dram]iv	NNP
25944	552	91	Glycerinæ	Glycerinæ	NNP
25944	552	92	,	,	,
25944	552	93	...........................	...........................	NFP
25944	552	94	f[dram]j	f[dram]j	NNP
25944	552	95	Alcoholis	Alcoholis	NNP
25944	552	96	,	,	,
25944	552	97	...........................	...........................	.
25944	552	98	f[Oz]ij	f[Oz]ij	NNP
25944	552	99	Aquæ	Aquæ	NNP
25944	552	100	,	,	,
25944	552	101	................................	................................	.
25944	552	102	f[Oz]xiv	f[Oz]xiv	NNP
25944	552	103	.	.	.
25944	553	1	M.	M.	NNP
25944	553	2	Alkaline	Alkaline	NNP
25944	553	3	baths	bath	NNS
25944	553	4	are	be	VBP
25944	553	5	also	also	RB
25944	553	6	useful	useful	JJ
25944	553	7	,	,	,
25944	553	8	and	and	CC
25944	553	9	may	may	MD
25944	553	10	advantageously	advantageously	RB
25944	553	11	be	be	VB
25944	553	12	followed	follow	VBN
25944	553	13	by	by	IN
25944	553	14	dusting	dusting	NN
25944	553	15	-	-	HYPH
25944	553	16	powders	powder	NNS
25944	553	17	of	of	IN
25944	553	18	starch	starch	NN
25944	553	19	and	and	CC
25944	553	20	zinc	zinc	NN
25944	553	21	oxide	oxide	RB
25944	553	22	.	.	.
25944	554	1	#	#	NNP
25944	554	2	Urticaria	Urticaria	NNP
25944	554	3	Pigmentosa	Pigmentosa	NNP
25944	554	4	.	.	.
25944	554	5	#	#	NNP
25944	554	6	(	(	-LRB-
25944	554	7	_	_	NNP
25944	554	8	Synonym	Synonym	NNP
25944	554	9	:	:	:
25944	554	10	_	_	NNP
25944	554	11	Xanthelasmoidea	Xanthelasmoidea	NNP
25944	554	12	.	.	.
25944	554	13	)	)	-RRB-
25944	555	1	#	#	NNP
25944	555	2	Describe	Describe	NNP
25944	555	3	urticaria	urticaria	JJ
25944	555	4	pigmentosa	pigmentosa	NNP
25944	555	5	.	.	.
25944	555	6	#	#	NNP
25944	555	7	Urticaria	Urticaria	NNP
25944	555	8	pigmentosa	pigmentosa	NNP
25944	555	9	is	be	VBZ
25944	555	10	a	a	DT
25944	555	11	rare	rare	JJ
25944	555	12	disease	disease	NN
25944	555	13	,	,	,
25944	555	14	variously	variously	RB
25944	555	15	viewed	view	VBN
25944	555	16	as	as	IN
25944	555	17	an	an	DT
25944	555	18	unusual	unusual	JJ
25944	555	19	form	form	NN
25944	555	20	of	of	IN
25944	555	21	urticaria	urticaria	JJ
25944	555	22	and	and	CC
25944	555	23	as	as	IN
25944	555	24	an	an	DT
25944	555	25	urticaria	urticaria	JJ
25944	555	26	-	-	HYPH
25944	555	27	like	like	JJ
25944	555	28	eruption	eruption	NN
25944	555	29	in	in	IN
25944	555	30	which	which	WDT
25944	555	31	there	there	EX
25944	555	32	is	be	VBZ
25944	555	33	an	an	DT
25944	555	34	element	element	NN
25944	555	35	of	of	IN
25944	555	36	new	new	JJ
25944	555	37	growth	growth	NN
25944	555	38	in	in	IN
25944	555	39	the	the	DT
25944	555	40	lesions	lesion	NNS
25944	555	41	.	.	.
25944	556	1	It	-PRON-	PRP
25944	556	2	begins	begin	VBZ
25944	556	3	usually	usually	RB
25944	556	4	in	in	IN
25944	556	5	infancy	infancy	NN
25944	556	6	or	or	CC
25944	556	7	early	early	JJ
25944	556	8	childhood	childhood	NN
25944	556	9	and	and	CC
25944	556	10	continues	continue	VBZ
25944	556	11	for	for	IN
25944	556	12	months	month	NNS
25944	556	13	or	or	CC
25944	556	14	years	year	NNS
25944	556	15	,	,	,
25944	556	16	and	and	CC
25944	556	17	is	be	VBZ
25944	556	18	characterized	characterize	VBN
25944	556	19	by	by	IN
25944	556	20	slightly	slightly	RB
25944	556	21	,	,	,
25944	556	22	moderately	moderately	RB
25944	556	23	,	,	,
25944	556	24	or	or	CC
25944	556	25	intensely	intensely	RB
25944	556	26	itchy	itchy	JJ
25944	556	27	,	,	,
25944	556	28	wheal	wheal	NN
25944	556	29	-	-	HYPH
25944	556	30	like	like	JJ
25944	556	31	elevations	elevation	NNS
25944	556	32	,	,	,
25944	556	33	which	which	WDT
25944	556	34	are	be	VBP
25944	556	35	more	more	RBR
25944	556	36	or	or	CC
25944	556	37	less	less	RBR
25944	556	38	persistent	persistent	JJ
25944	556	39	and	and	CC
25944	556	40	leave	leave	VB
25944	556	41	yellowish	yellowish	JJ
25944	556	42	,	,	,
25944	556	43	orange	orange	JJ
25944	556	44	-	-	HYPH
25944	556	45	colored	colored	JJ
25944	556	46	,	,	,
25944	556	47	greenish	greenish	JJ
25944	556	48	or	or	CC
25944	556	49	brownish	brownish	NN
25944	556	50	stains	stain	NNS
25944	556	51	.	.	.
25944	557	1	Exceptionally	exceptionally	RB
25944	557	2	subjective	subjective	JJ
25944	557	3	symptoms	symptom	NNS
25944	557	4	are	be	VBP
25944	557	5	almost	almost	RB
25944	557	6	entirely	entirely	RB
25944	557	7	absent	absent	JJ
25944	557	8	.	.	.
25944	558	1	Anatomical	anatomical	JJ
25944	558	2	studies	study	NNS
25944	558	3	show	show	VBP
25944	558	4	that	that	IN
25944	558	5	the	the	DT
25944	558	6	lesion	lesion	NN
25944	558	7	has	have	VBZ
25944	558	8	in	in	IN
25944	558	9	some	some	DT
25944	558	10	respects	respect	NNS
25944	558	11	the	the	DT
25944	558	12	structure	structure	NN
25944	558	13	of	of	IN
25944	558	14	an	an	DT
25944	558	15	ordinary	ordinary	JJ
25944	558	16	wheal	wheal	NN
25944	558	17	,	,	,
25944	558	18	with	with	IN
25944	558	19	[	[	-LRB-
25944	558	20	oe]dema	oe]dema	NN
25944	558	21	and	and	CC
25944	558	22	pigment	pigment	NN
25944	558	23	deposit	deposit	NN
25944	558	24	in	in	IN
25944	558	25	the	the	DT
25944	558	26	epidermal	epidermal	JJ
25944	558	27	portion	portion	NN
25944	558	28	,	,	,
25944	558	29	and	and	CC
25944	558	30	cellular	cellular	JJ
25944	558	31	infiltration	infiltration	NN
25944	558	32	made	make	VBD
25944	558	33	up	up	RP
25944	558	34	principally	principally	RB
25944	558	35	of	of	IN
25944	558	36	mast	mast	NN
25944	558	37	-	-	HYPH
25944	558	38	cells	cell	NNS
25944	558	39	.	.	.
25944	559	1	[	[	-LRB-
25944	559	2	Illustration	illustration	NN
25944	559	3	:	:	:
25944	559	4	Fig	Fig	NNP
25944	559	5	.	.	.
25944	560	1	13	13	CD
25944	560	2	.	.	.
25944	561	1	Urticaria	Urticaria	NNP
25944	561	2	Pigmentosa	Pigmentosa	NNP
25944	561	3	.	.	.
25944	561	4	]	]	-RRB-
25944	562	1	The	the	DT
25944	562	2	nature	nature	NN
25944	562	3	of	of	IN
25944	562	4	the	the	DT
25944	562	5	disease	disease	NN
25944	562	6	is	be	VBZ
25944	562	7	obscure	obscure	JJ
25944	562	8	and	and	CC
25944	562	9	treatment	treatment	NN
25944	562	10	unsatisfactory	unsatisfactory	JJ
25944	562	11	.	.	.
25944	563	1	Ordinarily	ordinarily	RB
25944	563	2	as	as	IN
25944	563	3	early	early	JJ
25944	563	4	youth	youth	NN
25944	563	5	or	or	CC
25944	563	6	adult	adult	NN
25944	563	7	life	life	NN
25944	563	8	is	be	VBZ
25944	563	9	reached	reach	VBN
25944	563	10	it	-PRON-	PRP
25944	563	11	spontaneously	spontaneously	RB
25944	563	12	disappears	disappear	VBZ
25944	563	13	.	.	.
25944	564	1	The	the	DT
25944	564	2	treatment	treatment	NN
25944	564	3	advised	advise	VBN
25944	564	4	is	be	VBZ
25944	564	5	usually	usually	RB
25944	564	6	on	on	IN
25944	564	7	the	the	DT
25944	564	8	same	same	JJ
25944	564	9	lines	line	NNS
25944	564	10	as	as	IN
25944	564	11	that	that	DT
25944	564	12	of	of	IN
25944	564	13	chronic	chronic	JJ
25944	564	14	urticaria	urticaria	NN
25944	564	15	.	.	.
25944	565	1	#	#	NNP
25944	565	2	Dermatitis	Dermatitis	NNP
25944	565	3	.	.	.
25944	565	4	#	#	$
25944	565	5	#	#	$
25944	565	6	What	what	WP
25944	565	7	is	be	VBZ
25944	565	8	implied	imply	VBN
25944	565	9	by	by	IN
25944	565	10	the	the	DT
25944	565	11	term	term	NN
25944	565	12	dermatitis	dermatitis	NN
25944	565	13	?	?	.
25944	565	14	#	#	$
25944	565	15	Dermatitis	dermatitis	NN
25944	565	16	,	,	,
25944	565	17	or	or	CC
25944	565	18	inflammation	inflammation	NN
25944	565	19	of	of	IN
25944	565	20	the	the	DT
25944	565	21	skin	skin	NN
25944	565	22	,	,	,
25944	565	23	is	be	VBZ
25944	565	24	a	a	DT
25944	565	25	term	term	NN
25944	565	26	employed	employ	VBN
25944	565	27	to	to	TO
25944	565	28	designate	designate	VB
25944	565	29	those	those	DT
25944	565	30	cases	case	NNS
25944	565	31	of	of	IN
25944	565	32	cutaneous	cutaneous	JJ
25944	565	33	disturbance	disturbance	NN
25944	565	34	,	,	,
25944	565	35	usually	usually	RB
25944	565	36	acute	acute	JJ
25944	565	37	in	in	IN
25944	565	38	character	character	NN
25944	565	39	,	,	,
25944	565	40	which	which	WDT
25944	565	41	are	be	VBP
25944	565	42	due	due	JJ
25944	565	43	to	to	IN
25944	565	44	the	the	DT
25944	565	45	action	action	NN
25944	565	46	of	of	IN
25944	565	47	irritants	irritant	NNS
25944	565	48	.	.	.
25944	566	1	#	#	$
25944	566	2	Mention	mention	VB
25944	566	3	some	some	DT
25944	566	4	examples	example	NNS
25944	566	5	of	of	IN
25944	566	6	cutaneous	cutaneous	JJ
25944	566	7	disturbance	disturbance	NN
25944	566	8	to	to	TO
25944	566	9	which	which	WDT
25944	566	10	this	this	DT
25944	566	11	term	term	NN
25944	566	12	is	be	VBZ
25944	566	13	applied	apply	VBN
25944	566	14	.	.	.
25944	566	15	#	#	$
25944	566	16	The	the	DT
25944	566	17	dermatic	dermatic	JJ
25944	566	18	inflammation	inflammation	NN
25944	566	19	due	due	IN
25944	566	20	to	to	IN
25944	566	21	the	the	DT
25944	566	22	action	action	NN
25944	566	23	of	of	IN
25944	566	24	excessive	excessive	JJ
25944	566	25	heat	heat	NN
25944	566	26	or	or	CC
25944	566	27	cold	cold	JJ
25944	566	28	,	,	,
25944	566	29	to	to	IN
25944	566	30	caustics	caustic	NNS
25944	566	31	and	and	CC
25944	566	32	other	other	JJ
25944	566	33	chemical	chemical	NN
25944	566	34	irritants	irritant	NNS
25944	566	35	,	,	,
25944	566	36	and	and	CC
25944	566	37	to	to	IN
25944	566	38	the	the	DT
25944	566	39	ingestion	ingestion	NN
25944	566	40	of	of	IN
25944	566	41	certain	certain	JJ
25944	566	42	drugs	drug	NNS
25944	566	43	.	.	.
25944	567	1	#	#	$
25944	567	2	What	what	WDT
25944	567	3	several	several	JJ
25944	567	4	varieties	variety	NNS
25944	567	5	are	be	VBP
25944	567	6	commonly	commonly	RB
25944	567	7	described	describe	VBN
25944	567	8	?	?	.
25944	567	9	#	#	NNP
25944	567	10	Dermatitis	Dermatitis	NNP
25944	567	11	traumatica	traumatica	NNP
25944	567	12	,	,	,
25944	567	13	dermatitis	dermatitis	NN
25944	567	14	calorica	calorica	NNP
25944	567	15	,	,	,
25944	567	16	dermatitis	dermatitis	NN
25944	567	17	venenata	venenata	NNP
25944	567	18	,	,	,
25944	567	19	and	and	CC
25944	567	20	dermatitis	dermatitis	NNP
25944	567	21	medicamentosa	medicamentosa	NNP
25944	567	22	.	.	.
25944	568	1	#	#	NNP
25944	568	2	Describe	Describe	NNP
25944	568	3	dermatitis	dermatitis	NN
25944	568	4	traumatica	traumatica	NN
25944	568	5	.	.	.
25944	568	6	#	#	$
25944	568	7	Under	under	IN
25944	568	8	this	this	DT
25944	568	9	head	head	NN
25944	568	10	are	be	VBP
25944	568	11	included	include	VBN
25944	568	12	all	all	DT
25944	568	13	forms	form	NNS
25944	568	14	of	of	IN
25944	568	15	cutaneous	cutaneous	JJ
25944	568	16	inflammation	inflammation	NN
25944	568	17	due	due	JJ
25944	568	18	to	to	IN
25944	568	19	traumatism	traumatism	NN
25944	568	20	.	.	.
25944	569	1	To	to	IN
25944	569	2	the	the	DT
25944	569	3	dermatologist	dermatologist	NN
25944	569	4	the	the	DT
25944	569	5	most	most	RBS
25944	569	6	common	common	JJ
25944	569	7	met	meet	VBD
25944	569	8	with	with	IN
25944	569	9	is	be	VBZ
25944	569	10	that	that	DT
25944	569	11	produced	produce	VBN
25944	569	12	by	by	IN
25944	569	13	the	the	DT
25944	569	14	various	various	JJ
25944	569	15	animal	animal	NN
25944	569	16	parasites	parasite	NNS
25944	569	17	and	and	CC
25944	569	18	from	from	IN
25944	569	19	continued	continued	JJ
25944	569	20	scratching	scratching	NN
25944	569	21	;	;	:
25944	569	22	in	in	IN
25944	569	23	such	such	JJ
25944	569	24	,	,	,
25944	569	25	if	if	IN
25944	569	26	the	the	DT
25944	569	27	cause	cause	NN
25944	569	28	has	have	VBZ
25944	569	29	been	be	VBN
25944	569	30	long	long	RB
25944	569	31	-	-	HYPH
25944	569	32	continued	continued	JJ
25944	569	33	and	and	CC
25944	569	34	persistent	persistent	JJ
25944	569	35	,	,	,
25944	569	36	a	a	DT
25944	569	37	variable	variable	JJ
25944	569	38	degree	degree	NN
25944	569	39	of	of	IN
25944	569	40	inflammatory	inflammatory	JJ
25944	569	41	thickening	thickening	NN
25944	569	42	of	of	IN
25944	569	43	the	the	DT
25944	569	44	skin	skin	NN
25944	569	45	and	and	CC
25944	569	46	pigmentation	pigmentation	NN
25944	569	47	result	result	NN
25944	569	48	,	,	,
25944	569	49	the	the	DT
25944	569	50	latter	latter	JJ
25944	569	51	not	not	RB
25944	569	52	infrequently	infrequently	RB
25944	569	53	being	be	VBG
25944	569	54	more	more	RBR
25944	569	55	or	or	CC
25944	569	56	less	less	RBR
25944	569	57	permanent	permanent	JJ
25944	569	58	.	.	.
25944	570	1	The	the	DT
25944	570	2	inflammation	inflammation	NN
25944	570	3	due	due	IN
25944	570	4	to	to	IN
25944	570	5	tight	tight	RB
25944	570	6	-	-	HYPH
25944	570	7	fitting	fit	VBG
25944	570	8	garments	garment	NNS
25944	570	9	,	,	,
25944	570	10	bandages	bandage	NNS
25944	570	11	,	,	,
25944	570	12	to	to	IN
25944	570	13	constant	constant	JJ
25944	570	14	pressure	pressure	NN
25944	570	15	(	(	-LRB-
25944	570	16	as	as	IN
25944	570	17	bed	bed	NN
25944	570	18	-	-	HYPH
25944	570	19	sores	sore	NNS
25944	570	20	)	)	-RRB-
25944	570	21	,	,	,
25944	570	22	etc	etc	FW
25944	570	23	.	.	.
25944	570	24	,	,	,
25944	570	25	also	also	RB
25944	570	26	illustrates	illustrate	VBZ
25944	570	27	this	this	DT
25944	570	28	class	class	NN
25944	570	29	.	.	.
25944	571	1	#	#	LS
25944	571	2	What	what	WP
25944	571	3	is	be	VBZ
25944	571	4	the	the	DT
25944	571	5	treatment	treatment	NN
25944	571	6	of	of	IN
25944	571	7	dermatitis	dermatitis	NN
25944	571	8	traumatica	traumatica	NNP
25944	571	9	?	?	.
25944	571	10	#	#	NNP
25944	571	11	Removal	removal	NN
25944	571	12	of	of	IN
25944	571	13	the	the	DT
25944	571	14	cause	cause	NN
25944	571	15	,	,	,
25944	571	16	and	and	CC
25944	571	17	,	,	,
25944	571	18	if	if	IN
25944	571	19	necessary	necessary	JJ
25944	571	20	,	,	,
25944	571	21	the	the	DT
25944	571	22	application	application	NN
25944	571	23	of	of	IN
25944	571	24	soothing	soothe	VBG
25944	571	25	ointments	ointment	NNS
25944	571	26	or	or	CC
25944	571	27	lotions	lotion	NNS
25944	571	28	;	;	:
25944	571	29	in	in	IN
25944	571	30	bed	bed	NN
25944	571	31	-	-	HYPH
25944	571	32	sores	sore	NNS
25944	571	33	,	,	,
25944	571	34	soap	soap	NN
25944	571	35	plaster	plaster	NN
25944	571	36	,	,	,
25944	571	37	plain	plain	JJ
25944	571	38	or	or	CC
25944	571	39	with	with	IN
25944	571	40	one	one	CD
25944	571	41	to	to	TO
25944	571	42	five	five	CD
25944	571	43	per	per	NN
25944	571	44	cent	cent	NN
25944	571	45	.	.	.
25944	572	1	of	of	IN
25944	572	2	ichthyol	ichthyol	NNP
25944	572	3	.	.	.
25944	573	1	#	#	LS
25944	573	2	What	what	WP
25944	573	3	is	be	VBZ
25944	573	4	dermatitis	dermatitis	NN
25944	573	5	calorica	calorica	NN
25944	573	6	?	?	.
25944	573	7	#	#	NN
25944	573	8	Cutaneous	cutaneous	JJ
25944	573	9	inflammation	inflammation	NN
25944	573	10	,	,	,
25944	573	11	varying	vary	VBG
25944	573	12	from	from	IN
25944	573	13	a	a	DT
25944	573	14	slight	slight	JJ
25944	573	15	erythematous	erythematous	JJ
25944	573	16	to	to	IN
25944	573	17	a	a	DT
25944	573	18	gangrenous	gangrenous	JJ
25944	573	19	character	character	NN
25944	573	20	,	,	,
25944	573	21	produced	produce	VBN
25944	573	22	by	by	IN
25944	573	23	excessive	excessive	JJ
25944	573	24	heat	heat	NN
25944	573	25	(	(	-LRB-
25944	573	26	_	_	NNP
25944	573	27	dermatitis	dermatitis	NN
25944	573	28	ambustionis	ambustionis	NNP
25944	573	29	_	_	NNP
25944	573	30	,	,	,
25944	573	31	_	_	NNP
25944	573	32	burns	burn	NNS
25944	573	33	_	_	NNP
25944	573	34	)	)	-RRB-
25944	573	35	or	or	CC
25944	573	36	cold	cold	JJ
25944	573	37	(	(	-LRB-
25944	573	38	_	_	NNP
25944	573	39	dermatitis	dermatitis	NN
25944	573	40	congelationis	congelationis	NNP
25944	573	41	_	_	NNP
25944	573	42	,	,	,
25944	573	43	_	_	NNP
25944	573	44	frostbite	frostbite	NN
25944	573	45	_	_	NNP
25944	573	46	)	)	-RRB-
25944	573	47	.	.	.
25944	574	1	#	#	NN
25944	574	2	Give	give	VBP
25944	574	3	the	the	DT
25944	574	4	treatment	treatment	NN
25944	574	5	of	of	IN
25944	574	6	dermatitis	dermatitis	NN
25944	574	7	calorica	calorica	NNP
25944	574	8	.	.	.
25944	574	9	#	#	NNP
25944	574	10	In	in	IN
25944	574	11	burns	burn	NNS
25944	574	12	,	,	,
25944	574	13	if	if	IN
25944	574	14	of	of	IN
25944	574	15	a	a	DT
25944	574	16	mild	mild	JJ
25944	574	17	degree	degree	NN
25944	574	18	,	,	,
25944	574	19	the	the	DT
25944	574	20	application	application	NN
25944	574	21	of	of	IN
25944	574	22	sodium	sodium	NN
25944	574	23	bicarbonate	bicarbonate	NN
25944	574	24	,	,	,
25944	574	25	as	as	IN
25944	574	26	a	a	DT
25944	574	27	powder	powder	NN
25944	574	28	or	or	CC
25944	574	29	saturated	saturate	VBN
25944	574	30	solution	solution	NN
25944	574	31	,	,	,
25944	574	32	is	be	VBZ
25944	574	33	useful	useful	JJ
25944	574	34	;	;	:
25944	574	35	in	in	IN
25944	574	36	the	the	DT
25944	574	37	more	more	RBR
25944	574	38	severe	severe	JJ
25944	574	39	grade	grade	NN
25944	574	40	,	,	,
25944	574	41	a	a	DT
25944	574	42	two-	two-	NN
25944	574	43	to	to	TO
25944	574	44	five	five	CD
25944	574	45	-	-	HYPH
25944	574	46	per	per	IN
25944	574	47	-	-	HYPH
25944	574	48	cent	cent	NN
25944	574	49	.	.	.
25944	575	1	solution	solution	NN
25944	575	2	will	will	MD
25944	575	3	probably	probably	RB
25944	575	4	be	be	VB
25944	575	5	found	find	VBN
25944	575	6	of	of	IN
25944	575	7	greater	great	JJR
25944	575	8	advantage	advantage	NN
25944	575	9	.	.	.
25944	576	1	Other	other	JJ
25944	576	2	soothing	soothing	JJ
25944	576	3	applications	application	NNS
25944	576	4	may	may	MD
25944	576	5	also	also	RB
25944	576	6	be	be	VB
25944	576	7	employed	employ	VBN
25944	576	8	.	.	.
25944	577	1	In	in	IN
25944	577	2	recent	recent	JJ
25944	577	3	years	year	NNS
25944	577	4	a	a	DT
25944	577	5	one	one	CD
25944	577	6	-	-	HYPH
25944	577	7	per	per	IN
25944	577	8	-	-	HYPH
25944	577	9	cent	cent	NN
25944	577	10	.	.	.
25944	578	1	solution	solution	NN
25944	578	2	of	of	IN
25944	578	3	picric	picric	JJ
25944	578	4	acid	acid	NN
25944	578	5	has	have	VBZ
25944	578	6	been	be	VBN
25944	578	7	commended	commend	VBN
25944	578	8	for	for	IN
25944	578	9	the	the	DT
25944	578	10	slighter	slighter	JJ
25944	578	11	burns	burn	NNS
25944	578	12	of	of	IN
25944	578	13	limited	limited	JJ
25944	578	14	extent	extent	NN
25944	578	15	.	.	.
25944	579	1	Upon	upon	IN
25944	579	2	the	the	DT
25944	579	3	whole	whole	NN
25944	579	4	,	,	,
25944	579	5	there	there	EX
25944	579	6	is	be	VBZ
25944	579	7	nothing	nothing	NN
25944	579	8	yet	yet	RB
25944	579	9	so	so	RB
25944	579	10	generally	generally	RB
25944	579	11	useful	useful	JJ
25944	579	12	and	and	CC
25944	579	13	soothing	soothing	JJ
25944	579	14	in	in	IN
25944	579	15	these	these	DT
25944	579	16	cases	case	NNS
25944	579	17	as	as	IN
25944	579	18	the	the	DT
25944	579	19	so	so	RB
25944	579	20	-	-	HYPH
25944	579	21	called	call	VBN
25944	579	22	Carron	Carron	NNP
25944	579	23	oil	oil	NN
25944	579	24	;	;	:
25944	579	25	in	in	IN
25944	579	26	some	some	DT
25944	579	27	cases	case	NNS
25944	579	28	more	more	RBR
25944	579	29	valuable	valuable	JJ
25944	579	30	with	with	IN
25944	579	31	1/2	1/2	CD
25944	579	32	to	to	IN
25944	579	33	1	1	CD
25944	579	34	minim	minim	NN
25944	579	35	of	of	IN
25944	579	36	carbolic	carbolic	JJ
25944	579	37	acid	acid	NN
25944	579	38	added	add	VBN
25944	579	39	to	to	IN
25944	579	40	each	each	DT
25944	579	41	ounce	ounce	NN
25944	579	42	.	.	.
25944	580	1	In	in	IN
25944	580	2	frostbite	frostbite	JJ
25944	580	3	,	,	,
25944	580	4	seen	see	VBN
25944	580	5	immediately	immediately	RB
25944	580	6	after	after	IN
25944	580	7	exposure	exposure	NN
25944	580	8	,	,	,
25944	580	9	the	the	DT
25944	580	10	parts	part	NNS
25944	580	11	are	be	VBP
25944	580	12	to	to	TO
25944	580	13	be	be	VB
25944	580	14	brought	bring	VBN
25944	580	15	gradually	gradually	RB
25944	580	16	back	back	RB
25944	580	17	to	to	IN
25944	580	18	a	a	DT
25944	580	19	normal	normal	JJ
25944	580	20	temperature	temperature	NN
25944	580	21	,	,	,
25944	580	22	at	at	IN
25944	580	23	first	first	RB
25944	580	24	by	by	IN
25944	580	25	rubbing	rub	VBG
25944	580	26	with	with	IN
25944	580	27	snow	snow	NN
25944	580	28	or	or	CC
25944	580	29	applying	apply	VBG
25944	580	30	cold	cold	JJ
25944	580	31	water	water	NN
25944	580	32	.	.	.
25944	581	1	Subsequently	subsequently	RB
25944	581	2	,	,	,
25944	581	3	in	in	IN
25944	581	4	ordinary	ordinary	JJ
25944	581	5	chilblains	chilblain	NNS
25944	581	6	,	,	,
25944	581	7	stimulating	stimulating	JJ
25944	581	8	applications	application	NNS
25944	581	9	,	,	,
25944	581	10	such	such	JJ
25944	581	11	as	as	IN
25944	581	12	oil	oil	NN
25944	581	13	of	of	IN
25944	581	14	turpentine	turpentine	NN
25944	581	15	,	,	,
25944	581	16	balsam	balsam	NN
25944	581	17	of	of	IN
25944	581	18	Peru	Peru	NNP
25944	581	19	,	,	,
25944	581	20	tincture	tincture	NN
25944	581	21	of	of	IN
25944	581	22	iodine	iodine	NN
25944	581	23	,	,	,
25944	581	24	ichthyol	ichthyol	JJ
25944	581	25	,	,	,
25944	581	26	and	and	CC
25944	581	27	strongly	strongly	RB
25944	581	28	carbolized	carbolize	VBN
25944	581	29	ointments	ointment	NNS
25944	581	30	are	be	VBP
25944	581	31	of	of	IN
25944	581	32	most	most	JJS
25944	581	33	benefit	benefit	NN
25944	581	34	.	.	.
25944	582	1	If	if	IN
25944	582	2	the	the	DT
25944	582	3	frostbite	frostbite	NN
25944	582	4	is	be	VBZ
25944	582	5	of	of	IN
25944	582	6	a	a	DT
25944	582	7	vesicular	vesicular	JJ
25944	582	8	,	,	,
25944	582	9	pustular	pustular	JJ
25944	582	10	,	,	,
25944	582	11	bullous	bullous	JJ
25944	582	12	,	,	,
25944	582	13	or	or	CC
25944	582	14	escharotic	escharotic	JJ
25944	582	15	character	character	NN
25944	582	16	,	,	,
25944	582	17	the	the	DT
25944	582	18	treatment	treatment	NN
25944	582	19	consists	consist	VBZ
25944	582	20	in	in	IN
25944	582	21	the	the	DT
25944	582	22	application	application	NN
25944	582	23	of	of	IN
25944	582	24	soothing	soothe	VBG
25944	582	25	remedies	remedy	NNS
25944	582	26	,	,	,
25944	582	27	such	such	JJ
25944	582	28	as	as	IN
25944	582	29	are	be	VBP
25944	582	30	employed	employ	VBN
25944	582	31	in	in	IN
25944	582	32	other	other	JJ
25944	582	33	like	like	IN
25944	582	34	inflammatory	inflammatory	JJ
25944	582	35	conditions	condition	NNS
25944	582	36	.	.	.
25944	583	1	#	#	LS
25944	583	2	What	what	WP
25944	583	3	do	do	VBP
25944	583	4	you	-PRON-	PRP
25944	583	5	understand	understand	VB
25944	583	6	by	by	IN
25944	583	7	dermatitis	dermatitis	NN
25944	583	8	venenata	venenata	NNP
25944	583	9	?	?	.
25944	583	10	#	#	$
25944	583	11	All	all	DT
25944	583	12	inflammatory	inflammatory	JJ
25944	583	13	conditions	condition	NNS
25944	583	14	of	of	IN
25944	583	15	the	the	DT
25944	583	16	skin	skin	NN
25944	583	17	due	due	IN
25944	583	18	to	to	IN
25944	583	19	contact	contact	NN
25944	583	20	with	with	IN
25944	583	21	deleterious	deleterious	JJ
25944	583	22	substances	substance	NNS
25944	583	23	such	such	JJ
25944	583	24	as	as	IN
25944	583	25	caustic	caustic	JJ
25944	583	26	,	,	,
25944	583	27	chemical	chemical	JJ
25944	583	28	irritants	irritant	NNS
25944	583	29	,	,	,
25944	583	30	iodoform	iodoform	NN
25944	583	31	,	,	,
25944	583	32	etc	etc	FW
25944	583	33	.	.	.
25944	583	34	,	,	,
25944	583	35	are	be	VBP
25944	583	36	included	include	VBN
25944	583	37	under	under	IN
25944	583	38	this	this	DT
25944	583	39	head	head	NN
25944	583	40	,	,	,
25944	583	41	but	but	CC
25944	583	42	the	the	DT
25944	583	43	most	most	RBS
25944	583	44	common	common	JJ
25944	583	45	causes	cause	NNS
25944	583	46	are	be	VBP
25944	583	47	the	the	DT
25944	583	48	rhus	rhus	NN
25944	583	49	plants--_poison	plants--_poison	NNP
25944	583	50	ivy	ivy	NNP
25944	583	51	_	_	NNP
25944	583	52	(	(	-LRB-
25944	583	53	or	or	CC
25944	583	54	_	_	NNP
25944	583	55	poison	poison	NN
25944	583	56	oak	oak	NNP
25944	583	57	_	_	NNP
25944	583	58	)	)	-RRB-
25944	583	59	and	and	CC
25944	583	60	_	_	NNP
25944	583	61	poison	poison	NN
25944	583	62	sumach	sumach	NN
25944	583	63	_	_	NNP
25944	583	64	(	(	-LRB-
25944	583	65	_	_	NNP
25944	583	66	poison	poison	NN
25944	583	67	dogwood	dogwood	NN
25944	583	68	_	_	NNP
25944	583	69	)	)	-RRB-
25944	583	70	.	.	.
25944	584	1	Mere	mere	JJ
25944	584	2	proximity	proximity	NN
25944	584	3	to	to	IN
25944	584	4	these	these	DT
25944	584	5	plants	plant	NNS
25944	584	6	will	will	MD
25944	584	7	,	,	,
25944	584	8	in	in	IN
25944	584	9	some	some	DT
25944	584	10	individuals	individual	NNS
25944	584	11	,	,	,
25944	584	12	provoke	provoke	VB
25944	584	13	cutaneous	cutaneous	JJ
25944	584	14	disturbance	disturbance	NN
25944	584	15	(	(	-LRB-
25944	584	16	_	_	NNP
25944	584	17	rhus	rhus	NN
25944	584	18	poisoning	poison	VBG
25944	584	19	_	_	NNP
25944	584	20	,	,	,
25944	584	21	_	_	NNP
25944	584	22	ivy	ivy	NN
25944	584	23	poisoning	poisoning	NN
25944	584	24	_	_	NNP
25944	584	25	)	)	-RRB-
25944	584	26	,	,	,
25944	584	27	although	although	IN
25944	584	28	they	-PRON-	PRP
25944	584	29	may	may	MD
25944	584	30	be	be	VB
25944	584	31	handled	handle	VBN
25944	584	32	by	by	IN
25944	584	33	others	other	NNS
25944	584	34	with	with	IN
25944	584	35	impunity	impunity	NN
25944	584	36	.	.	.
25944	585	1	Many	many	JJ
25944	585	2	other	other	JJ
25944	585	3	plants	plant	NNS
25944	585	4	are	be	VBP
25944	585	5	also	also	RB
25944	585	6	known	know	VBN
25944	585	7	to	to	TO
25944	585	8	produce	produce	VB
25944	585	9	cutaneous	cutaneous	JJ
25944	585	10	irritation	irritation	NN
25944	585	11	in	in	IN
25944	585	12	certain	certain	JJ
25944	585	13	subjects	subject	NNS
25944	585	14	;	;	:
25944	585	15	among	among	IN
25944	585	16	these	these	DT
25944	585	17	may	may	MD
25944	585	18	be	be	VB
25944	585	19	mentioned	mention	VBN
25944	585	20	the	the	DT
25944	585	21	nettle	nettle	NN
25944	585	22	,	,	,
25944	585	23	primrose	primrose	NN
25944	585	24	,	,	,
25944	585	25	cowhage	cowhage	NN
25944	585	26	,	,	,
25944	585	27	smartweed	smartweed	NN
25944	585	28	,	,	,
25944	585	29	balm	balm	NN
25944	585	30	of	of	IN
25944	585	31	Gilead	Gilead	NNP
25944	585	32	,	,	,
25944	585	33	oleander	oleander	NN
25944	585	34	,	,	,
25944	585	35	and	and	CC
25944	585	36	rue	rue	FW
25944	585	37	.	.	.
25944	586	1	The	the	DT
25944	586	2	local	local	JJ
25944	586	3	action	action	NN
25944	586	4	of	of	IN
25944	586	5	iodoform	iodoform	NN
25944	586	6	(	(	-LRB-
25944	586	7	_	_	NNP
25944	586	8	iodoform	iodoform	NNP
25944	586	9	dermatitis	dermatitis	NN
25944	586	10	_	_	NNP
25944	586	11	)	)	-RRB-
25944	586	12	in	in	IN
25944	586	13	some	some	DT
25944	586	14	individuals	individual	NNS
25944	586	15	is	be	VBZ
25944	586	16	that	that	DT
25944	586	17	of	of	IN
25944	586	18	a	a	DT
25944	586	19	decided	decide	VBN
25944	586	20	irritant	irritant	NN
25944	586	21	,	,	,
25944	586	22	bringing	bring	VBG
25944	586	23	about	about	RP
25944	586	24	a	a	DT
25944	586	25	dermatitis	dermatitis	NN
25944	586	26	,	,	,
25944	586	27	which	which	WDT
25944	586	28	often	often	RB
25944	586	29	spreads	spread	VBZ
25944	586	30	much	much	RB
25944	586	31	beyond	beyond	IN
25944	586	32	the	the	DT
25944	586	33	parts	part	NNS
25944	586	34	of	of	IN
25944	586	35	application	application	NN
25944	586	36	,	,	,
25944	586	37	and	and	CC
25944	586	38	which	which	WDT
25944	586	39	in	in	IN
25944	586	40	those	those	DT
25944	586	41	eczematously	eczematously	RB
25944	586	42	inclined	inclined	JJ
25944	586	43	may	may	MD
25944	586	44	result	result	VB
25944	586	45	in	in	IN
25944	586	46	a	a	DT
25944	586	47	veritable	veritable	JJ
25944	586	48	and	and	CC
25944	586	49	persistent	persistent	JJ
25944	586	50	eczema	eczema	NN
25944	586	51	.	.	.
25944	587	1	#	#	NNP
25944	587	2	Describe	describe	VB
25944	587	3	the	the	DT
25944	587	4	symptoms	symptom	NNS
25944	587	5	of	of	IN
25944	587	6	rhus	rhu	NNS
25944	587	7	poisoning	poisoning	NN
25944	587	8	.	.	.
25944	587	9	#	#	$
25944	587	10	The	the	DT
25944	587	11	symptoms	symptom	NNS
25944	587	12	appear	appear	VBP
25944	587	13	usually	usually	RB
25944	587	14	soon	soon	RB
25944	587	15	after	after	IN
25944	587	16	exposure	exposure	NN
25944	587	17	,	,	,
25944	587	18	and	and	CC
25944	587	19	consist	consist	VB
25944	587	20	of	of	IN
25944	587	21	an	an	DT
25944	587	22	inflammatory	inflammatory	JJ
25944	587	23	condition	condition	NN
25944	587	24	of	of	IN
25944	587	25	the	the	DT
25944	587	26	skin	skin	NN
25944	587	27	of	of	IN
25944	587	28	an	an	DT
25944	587	29	eczematous	eczematous	JJ
25944	587	30	nature	nature	NN
25944	587	31	,	,	,
25944	587	32	varying	vary	VBG
25944	587	33	in	in	IN
25944	587	34	degree	degree	NN
25944	587	35	from	from	IN
25944	587	36	an	an	DT
25944	587	37	erythematous	erythematous	JJ
25944	587	38	to	to	IN
25944	587	39	a	a	DT
25944	587	40	bullous	bullous	JJ
25944	587	41	character	character	NN
25944	587	42	,	,	,
25944	587	43	and	and	CC
25944	587	44	with	with	IN
25944	587	45	or	or	CC
25944	587	46	without	without	IN
25944	587	47	[	[	-LRB-
25944	587	48	oe]dema	oe]dema	''
25944	587	49	and	and	CC
25944	587	50	swelling	swell	VBG
25944	587	51	.	.	.
25944	588	1	As	as	IN
25944	588	2	a	a	DT
25944	588	3	rule	rule	NN
25944	588	4	,	,	,
25944	588	5	marked	mark	VBD
25944	588	6	itching	itching	NN
25944	588	7	and	and	CC
25944	588	8	burning	burning	NN
25944	588	9	are	be	VBP
25944	588	10	present	present	JJ
25944	588	11	.	.	.
25944	589	1	The	the	DT
25944	589	2	face	face	NN
25944	589	3	,	,	,
25944	589	4	hands	hand	NNS
25944	589	5	,	,	,
25944	589	6	forearms	forearm	NNS
25944	589	7	and	and	CC
25944	589	8	genitalia	genitalia	NNP
25944	589	9	are	be	VBP
25944	589	10	favorite	favorite	JJ
25944	589	11	parts	part	NNS
25944	589	12	,	,	,
25944	589	13	although	although	IN
25944	589	14	it	-PRON-	PRP
25944	589	15	may	may	MD
25944	589	16	in	in	IN
25944	589	17	many	many	JJ
25944	589	18	instances	instance	NNS
25944	589	19	involve	involve	VBP
25944	589	20	a	a	DT
25944	589	21	greater	great	JJR
25944	589	22	portion	portion	NN
25944	589	23	of	of	IN
25944	589	24	the	the	DT
25944	589	25	whole	whole	JJ
25944	589	26	surface	surface	NN
25944	589	27	.	.	.
25944	590	1	#	#	LS
25944	590	2	What	what	WP
25944	590	3	is	be	VBZ
25944	590	4	the	the	DT
25944	590	5	course	course	NN
25944	590	6	of	of	IN
25944	590	7	rhus	rhus	NN
25944	590	8	poisoning	poisoning	NN
25944	590	9	?	?	.
25944	590	10	#	#	NNP
25944	590	11	It	-PRON-	PRP
25944	590	12	runs	run	VBZ
25944	590	13	an	an	DT
25944	590	14	acute	acute	JJ
25944	590	15	course	course	NN
25944	590	16	,	,	,
25944	590	17	terminating	terminate	VBG
25944	590	18	in	in	IN
25944	590	19	recovery	recovery	NN
25944	590	20	in	in	IN
25944	590	21	one	one	CD
25944	590	22	to	to	TO
25944	590	23	six	six	CD
25944	590	24	weeks	week	NNS
25944	590	25	.	.	.
25944	591	1	In	in	IN
25944	591	2	those	those	DT
25944	591	3	eczematously	eczematously	RB
25944	591	4	inclined	incline	VBN
25944	591	5	,	,	,
25944	591	6	however	however	RB
25944	591	7	,	,	,
25944	591	8	it	-PRON-	PRP
25944	591	9	may	may	MD
25944	591	10	result	result	VB
25944	591	11	in	in	IN
25944	591	12	a	a	DT
25944	591	13	veritable	veritable	JJ
25944	591	14	and	and	CC
25944	591	15	persistent	persistent	JJ
25944	591	16	form	form	NN
25944	591	17	of	of	IN
25944	591	18	that	that	DT
25944	591	19	disease	disease	NN
25944	591	20	.	.	.
25944	592	1	#	#	NNP
25944	592	2	How	how	WRB
25944	592	3	would	would	MD
25944	592	4	you	-PRON-	PRP
25944	592	5	treat	treat	VB
25944	592	6	rhus	rhu	NNS
25944	592	7	poisoning	poisoning	NN
25944	592	8	?	?	.
25944	592	9	#	#	$
25944	592	10	By	by	IN
25944	592	11	soothing	soothing	JJ
25944	592	12	and	and	CC
25944	592	13	astringent	astringent	JJ
25944	592	14	applications	application	NNS
25944	592	15	,	,	,
25944	592	16	such	such	JJ
25944	592	17	as	as	IN
25944	592	18	are	be	VBP
25944	592	19	employed	employ	VBN
25944	592	20	in	in	IN
25944	592	21	acute	acute	JJ
25944	592	22	eczema	eczema	NN
25944	592	23	(	(	-LRB-
25944	592	24	_	_	NNP
25944	592	25	q	q	NNP
25944	592	26	.	.	.
25944	593	1	v.	v.	NNP
25944	593	2	_	_	NNP
25944	593	3	)	)	-RRB-
25944	593	4	,	,	,
25944	593	5	which	which	WDT
25944	593	6	are	be	VBP
25944	593	7	to	to	TO
25944	593	8	be	be	VB
25944	593	9	used	use	VBN
25944	593	10	freely	freely	RB
25944	593	11	.	.	.
25944	594	1	Among	among	IN
25944	594	2	the	the	DT
25944	594	3	most	most	RBS
25944	594	4	valuable	valuable	JJ
25944	594	5	are	be	VBP
25944	594	6	:	:	:
25944	594	7	a	a	DT
25944	594	8	lotion	lotion	NN
25944	594	9	of	of	IN
25944	594	10	fluid	fluid	JJ
25944	594	11	extract	extract	NN
25944	594	12	of	of	IN
25944	594	13	grindelia	grindelia	NNP
25944	594	14	robusta	robusta	NNP
25944	594	15	,	,	,
25944	594	16	one	one	CD
25944	594	17	to	to	TO
25944	594	18	two	two	CD
25944	594	19	drachms	drachm	NNS
25944	594	20	to	to	IN
25944	594	21	four	four	CD
25944	594	22	ounces	ounce	NNS
25944	594	23	of	of	IN
25944	594	24	water	water	NN
25944	594	25	;	;	:
25944	594	26	lotio	lotio	VB
25944	594	27	nigra	nigra	NNP
25944	594	28	,	,	,
25944	594	29	either	either	CC
25944	594	30	alone	alone	RB
25944	594	31	or	or	CC
25944	594	32	followed	follow	VBN
25944	594	33	by	by	IN
25944	594	34	the	the	DT
25944	594	35	oxide	oxide	NN
25944	594	36	-	-	HYPH
25944	594	37	of	of	IN
25944	594	38	-	-	HYPH
25944	594	39	zinc	zinc	NN
25944	594	40	ointment	ointment	NN
25944	594	41	;	;	:
25944	594	42	a	a	DT
25944	594	43	saturated	saturate	VBN
25944	594	44	solution	solution	NN
25944	594	45	of	of	IN
25944	594	46	boric	boric	NN
25944	594	47	acid	acid	NN
25944	594	48	,	,	,
25944	594	49	with	with	IN
25944	594	50	a	a	DT
25944	594	51	half	half	NN
25944	594	52	to	to	TO
25944	594	53	two	two	CD
25944	594	54	drachms	drachm	NNS
25944	594	55	of	of	IN
25944	594	56	carbolic	carbolic	JJ
25944	594	57	acid	acid	NN
25944	594	58	to	to	IN
25944	594	59	the	the	DT
25944	594	60	pint	pint	NN
25944	594	61	;	;	:
25944	594	62	a	a	DT
25944	594	63	lotion	lotion	NN
25944	594	64	of	of	IN
25944	594	65	zinc	zinc	NN
25944	594	66	sulphate	sulphate	NN
25944	594	67	,	,	,
25944	594	68	a	a	DT
25944	594	69	half	half	NN
25944	594	70	to	to	TO
25944	594	71	four	four	CD
25944	594	72	grains	grain	NNS
25944	594	73	to	to	IN
25944	594	74	the	the	DT
25944	594	75	ounce	ounce	NN
25944	594	76	;	;	,
25944	594	77	weak	weak	JJ
25944	594	78	alkaline	alkaline	NN
25944	594	79	lotions	lotion	NNS
25944	594	80	;	;	,
25944	594	81	cold	cold	JJ
25944	594	82	cream	cream	NN
25944	594	83	,	,	,
25944	594	84	petrolatum	petrolatum	NN
25944	594	85	,	,	,
25944	594	86	and	and	CC
25944	594	87	oxide	oxide	NN
25944	594	88	-	-	HYPH
25944	594	89	of	of	IN
25944	594	90	-	-	HYPH
25944	594	91	zinc	zinc	NN
25944	594	92	ointments	ointment	NNS
25944	594	93	.	.	.
25944	595	1	#	#	NNP
25944	595	2	How	how	WRB
25944	595	3	would	would	MD
25944	595	4	you	-PRON-	PRP
25944	595	5	treat	treat	VB
25944	595	6	the	the	DT
25944	595	7	dermatitis	dermatitis	NN
25944	595	8	due	due	IN
25944	595	9	to	to	IN
25944	595	10	other	other	JJ
25944	595	11	deleterious	deleterious	JJ
25944	595	12	substances	substance	NNS
25944	595	13	of	of	IN
25944	595	14	this	this	DT
25944	595	15	class	class	NN
25944	595	16	?	?	.
25944	595	17	#	#	NN
25944	595	18	By	by	IN
25944	595	19	applications	application	NNS
25944	595	20	of	of	IN
25944	595	21	a	a	DT
25944	595	22	soothing	soothing	JJ
25944	595	23	and	and	CC
25944	595	24	protective	protective	JJ
25944	595	25	character	character	NN
25944	595	26	,	,	,
25944	595	27	similar	similar	JJ
25944	595	28	to	to	IN
25944	595	29	those	those	DT
25944	595	30	used	use	VBN
25944	595	31	in	in	IN
25944	595	32	eczema	eczema	NN
25944	595	33	and	and	CC
25944	595	34	burns	burn	NNS
25944	595	35	.	.	.
25944	596	1	#	#	NNP
25944	596	2	Dermatitis	Dermatitis	NNP
25944	596	3	Medicamentosa	Medicamentosa	NNP
25944	596	4	.	.	.
25944	596	5	#	#	$
25944	596	6	#	#	$
25944	596	7	What	what	WP
25944	596	8	do	do	VBP
25944	596	9	you	-PRON-	PRP
25944	596	10	understand	understand	VB
25944	596	11	by	by	IN
25944	596	12	dermatitis	dermatitis	NNP
25944	596	13	medicamentosa	medicamentosa	NNP
25944	596	14	?	?	.
25944	596	15	#	#	$
25944	596	16	Under	under	IN
25944	596	17	this	this	DT
25944	596	18	head	head	NN
25944	596	19	are	be	VBP
25944	596	20	included	include	VBN
25944	596	21	all	all	DT
25944	596	22	eruptions	eruption	NNS
25944	596	23	due	due	JJ
25944	596	24	to	to	IN
25944	596	25	the	the	DT
25944	596	26	ingestion	ingestion	NN
25944	596	27	or	or	CC
25944	596	28	absorption	absorption	NN
25944	596	29	of	of	IN
25944	596	30	certain	certain	JJ
25944	596	31	drugs	drug	NNS
25944	596	32	.	.	.
25944	597	1	In	in	IN
25944	597	2	rare	rare	JJ
25944	597	3	instances	instance	NNS
25944	597	4	one	one	CD
25944	597	5	dose	dose	NN
25944	597	6	will	will	MD
25944	597	7	have	have	VB
25944	597	8	such	such	JJ
25944	597	9	effect	effect	NN
25944	597	10	;	;	:
25944	597	11	commonly	commonly	RB
25944	597	12	,	,	,
25944	597	13	however	however	RB
25944	597	14	,	,	,
25944	597	15	it	-PRON-	PRP
25944	597	16	results	result	VBZ
25944	597	17	only	only	RB
25944	597	18	after	after	IN
25944	597	19	several	several	JJ
25944	597	20	days	day	NNS
25944	597	21	'	'	POS
25944	597	22	or	or	CC
25944	597	23	weeks	week	NNS
25944	597	24	'	'	POS
25944	597	25	continued	continue	VBN
25944	597	26	administration	administration	NN
25944	597	27	.	.	.
25944	598	1	With	with	IN
25944	598	2	some	some	DT
25944	598	3	drugs	drug	NNS
25944	598	4	such	such	JJ
25944	598	5	effect	effect	NN
25944	598	6	is	be	VBZ
25944	598	7	the	the	DT
25944	598	8	rule	rule	NN
25944	598	9	,	,	,
25944	598	10	with	with	IN
25944	598	11	others	other	NNS
25944	598	12	it	-PRON-	PRP
25944	598	13	is	be	VBZ
25944	598	14	exceptional	exceptional	JJ
25944	598	15	,	,	,
25944	598	16	nor	nor	CC
25944	598	17	are	be	VBP
25944	598	18	all	all	DT
25944	598	19	individuals	individual	NNS
25944	598	20	equally	equally	RB
25944	598	21	susceptible	susceptible	JJ
25944	598	22	.	.	.
25944	599	1	#	#	NNP
25944	599	2	How	how	WRB
25944	599	3	is	be	VBZ
25944	599	4	the	the	DT
25944	599	5	eruption	eruption	NN
25944	599	6	produced	produce	VBN
25944	599	7	in	in	IN
25944	599	8	dermatitis	dermatitis	NN
25944	599	9	medicamentosa	medicamentosa	NNP
25944	599	10	?	?	.
25944	599	11	#	#	NN
25944	599	12	In	in	IN
25944	599	13	some	some	DT
25944	599	14	instances	instance	NNS
25944	599	15	it	-PRON-	PRP
25944	599	16	is	be	VBZ
25944	599	17	probably	probably	RB
25944	599	18	due	due	IN
25944	599	19	to	to	IN
25944	599	20	the	the	DT
25944	599	21	elimination	elimination	NN
25944	599	22	of	of	IN
25944	599	23	the	the	DT
25944	599	24	drug	drug	NN
25944	599	25	through	through	IN
25944	599	26	the	the	DT
25944	599	27	cutaneous	cutaneous	JJ
25944	599	28	structures	structure	NNS
25944	599	29	;	;	:
25944	599	30	in	in	IN
25944	599	31	others	other	NNS
25944	599	32	,	,	,
25944	599	33	to	to	IN
25944	599	34	the	the	DT
25944	599	35	action	action	NN
25944	599	36	of	of	IN
25944	599	37	the	the	DT
25944	599	38	drug	drug	NN
25944	599	39	upon	upon	IN
25944	599	40	the	the	DT
25944	599	41	nervous	nervous	JJ
25944	599	42	system	system	NN
25944	599	43	.	.	.
25944	600	1	The	the	DT
25944	600	2	view	view	NN
25944	600	3	that	that	IN
25944	600	4	the	the	DT
25944	600	5	drug	drug	NN
25944	600	6	acts	act	VBZ
25944	600	7	as	as	IN
25944	600	8	a	a	DT
25944	600	9	toxin	toxin	NN
25944	600	10	or	or	CC
25944	600	11	generates	generate	VBZ
25944	600	12	some	some	DT
25944	600	13	toxin	toxin	NN
25944	600	14	or	or	CC
25944	600	15	irritant	irritant	JJ
25944	600	16	material	material	NN
25944	600	17	in	in	IN
25944	600	18	the	the	DT
25944	600	19	blood	blood	NN
25944	600	20	,	,	,
25944	600	21	to	to	TO
25944	600	22	which	which	WDT
25944	600	23	the	the	DT
25944	600	24	eruptive	eruptive	JJ
25944	600	25	phenomena	phenomenon	NNS
25944	600	26	may	may	MD
25944	600	27	be	be	VB
25944	600	28	due	due	JJ
25944	600	29	,	,	,
25944	600	30	has	have	VBZ
25944	600	31	also	also	RB
25944	600	32	been	be	VBN
25944	600	33	advanced	advance	VBN
25944	600	34	.	.	.
25944	601	1	[	[	-LRB-
25944	601	2	Illustration	illustration	NN
25944	601	3	:	:	:
25944	601	4	Dermatitis	Dermatitis	NNP
25944	601	5	medicamentosa	medicamentosa	NNP
25944	601	6	.	.	.
25944	602	1	Bullous	bullous	JJ
25944	602	2	dermatitis	dermatitis	NN
25944	602	3	from	from	IN
25944	602	4	iodide	iodide	NN
25944	602	5	of	of	IN
25944	602	6	potassium	potassium	NN
25944	602	7	.	.	.
25944	602	8	]	]	-RRB-
25944	603	1	#	#	LS
25944	603	2	What	what	WP
25944	603	3	is	be	VBZ
25944	603	4	the	the	DT
25944	603	5	character	character	NN
25944	603	6	of	of	IN
25944	603	7	the	the	DT
25944	603	8	eruption	eruption	NN
25944	603	9	in	in	IN
25944	603	10	dermatitis	dermatitis	NNP
25944	603	11	medicamentosa	medicamentosa	NNP
25944	603	12	?	?	.
25944	603	13	#	#	NN
25944	603	14	It	-PRON-	PRP
25944	603	15	may	may	MD
25944	603	16	be	be	VB
25944	603	17	erythematous	erythematous	JJ
25944	603	18	,	,	,
25944	603	19	papular	papular	JJ
25944	603	20	,	,	,
25944	603	21	urticarial	urticarial	JJ
25944	603	22	,	,	,
25944	603	23	vesicular	vesicular	JJ
25944	603	24	,	,	,
25944	603	25	pustular	pustular	JJ
25944	603	26	or	or	CC
25944	603	27	bullous	bullous	JJ
25944	603	28	,	,	,
25944	603	29	and	and	CC
25944	603	30	,	,	,
25944	603	31	if	if	IN
25944	603	32	the	the	DT
25944	603	33	administration	administration	NN
25944	603	34	of	of	IN
25944	603	35	the	the	DT
25944	603	36	drug	drug	NN
25944	603	37	is	be	VBZ
25944	603	38	continued	continue	VBN
25944	603	39	,	,	,
25944	603	40	even	even	RB
25944	603	41	gangrenous	gangrenous	JJ
25944	603	42	.	.	.
25944	604	1	#	#	$
25944	604	2	Name	name	VB
25944	604	3	the	the	DT
25944	604	4	more	more	RBR
25944	604	5	common	common	JJ
25944	604	6	drugs	drug	NNS
25944	604	7	having	have	VBG
25944	604	8	such	such	JJ
25944	604	9	action	action	NN
25944	604	10	.	.	.
25944	604	11	#	#	NNP
25944	604	12	Antipyrin	Antipyrin	NNP
25944	604	13	,	,	,
25944	604	14	arsenic	arsenic	JJ
25944	604	15	,	,	,
25944	604	16	atropia	atropia	NNP
25944	604	17	(	(	-LRB-
25944	604	18	or	or	CC
25944	604	19	belladonna	belladonna	NNP
25944	604	20	)	)	-RRB-
25944	604	21	,	,	,
25944	604	22	bromides	bromide	NNS
25944	604	23	,	,	,
25944	604	24	chloral	chloral	JJ
25944	604	25	,	,	,
25944	604	26	copaiba	copaiba	NNS
25944	604	27	,	,	,
25944	604	28	cubebs	cubebs	NNP
25944	604	29	,	,	,
25944	604	30	digitalis	digitalis	NNP
25944	604	31	,	,	,
25944	604	32	iodides	iodide	NNS
25944	604	33	,	,	,
25944	604	34	mercury	mercury	NN
25944	604	35	,	,	,
25944	604	36	opium	opium	NN
25944	604	37	(	(	-LRB-
25944	604	38	or	or	CC
25944	604	39	morphia	morphia	NNP
25944	604	40	)	)	-RRB-
25944	604	41	,	,	,
25944	604	42	quinine	quinine	JJ
25944	604	43	,	,	,
25944	604	44	salicylic	salicylic	JJ
25944	604	45	acid	acid	NN
25944	604	46	,	,	,
25944	604	47	stramonium	stramonium	NN
25944	604	48	,	,	,
25944	604	49	acetanilid	acetanilid	NN
25944	604	50	,	,	,
25944	604	51	sulphonal	sulphonal	JJ
25944	604	52	,	,	,
25944	604	53	phenacetin	phenacetin	NN
25944	604	54	,	,	,
25944	604	55	turpentine	turpentine	NN
25944	604	56	,	,	,
25944	604	57	many	many	JJ
25944	604	58	of	of	IN
25944	604	59	the	the	DT
25944	604	60	new	new	JJ
25944	604	61	coal	coal	NN
25944	604	62	-	-	HYPH
25944	604	63	tar	tar	NN
25944	604	64	derivatives	derivative	NNS
25944	604	65	,	,	,
25944	604	66	etc	etc	FW
25944	604	67	.	.	.
25944	605	1	#	#	JJR
25944	605	2	State	state	NN
25944	605	3	frequency	frequency	NN
25944	605	4	and	and	CC
25944	605	5	types	type	NNS
25944	605	6	of	of	IN
25944	605	7	eruption	eruption	NN
25944	605	8	due	due	IN
25944	605	9	to	to	IN
25944	605	10	the	the	DT
25944	605	11	ingestion	ingestion	NN
25944	605	12	of	of	IN
25944	605	13	antipyrin	antipyrin	NNP
25944	605	14	.	.	.
25944	605	15	#	#	$
25944	605	16	Not	not	RB
25944	605	17	uncommon	uncommon	JJ
25944	605	18	.	.	.
25944	606	1	_	_	NNP
25944	606	2	Erythematous	Erythematous	NNP
25944	606	3	_	_	NNP
25944	606	4	,	,	,
25944	606	5	morbilliform	morbilliform	NN
25944	606	6	and	and	CC
25944	606	7	erythemato	erythemato	NN
25944	606	8	-	-	HYPH
25944	606	9	papular	papular	JJ
25944	606	10	;	;	:
25944	606	11	itching	itching	NN
25944	606	12	is	be	VBZ
25944	606	13	usually	usually	RB
25944	606	14	present	present	JJ
25944	606	15	and	and	CC
25944	606	16	moderate	moderate	JJ
25944	606	17	desquamation	desquamation	NN
25944	606	18	may	may	MD
25944	606	19	follow	follow	VB
25944	606	20	.	.	.
25944	607	1	Acetanilid	acetanilid	JJ
25944	607	2	,	,	,
25944	607	3	sulphonal	sulphonal	JJ
25944	607	4	,	,	,
25944	607	5	phenacetin	phenacetin	NN
25944	607	6	,	,	,
25944	607	7	and	and	CC
25944	607	8	other	other	JJ
25944	607	9	drugs	drug	NNS
25944	607	10	of	of	IN
25944	607	11	this	this	DT
25944	607	12	class	class	NN
25944	607	13	may	may	MD
25944	607	14	provoke	provoke	VB
25944	607	15	like	like	IN
25944	607	16	eruptions	eruption	NNS
25944	607	17	.	.	.
25944	608	1	#	#	$
25944	608	2	Mention	mention	VBP
25944	608	3	frequency	frequency	NN
25944	608	4	and	and	CC
25944	608	5	types	type	NNS
25944	608	6	of	of	IN
25944	608	7	eruption	eruption	NN
25944	608	8	due	due	IN
25944	608	9	to	to	IN
25944	608	10	the	the	DT
25944	608	11	ingestion	ingestion	NN
25944	608	12	of	of	IN
25944	608	13	arsenic	arsenic	JJ
25944	608	14	.	.	.
25944	608	15	#	#	NNP
25944	608	16	Rare	Rare	NNP
25944	608	17	.	.	.
25944	609	1	Erythematous	erythematous	JJ
25944	609	2	,	,	,
25944	609	3	erythemato	erythemato	JJ
25944	609	4	-	-	HYPH
25944	609	5	papular	papular	NN
25944	609	6	;	;	:
25944	609	7	exceptionally	exceptionally	RB
25944	609	8	,	,	,
25944	609	9	herpetic	herpetic	JJ
25944	609	10	,	,	,
25944	609	11	and	and	CC
25944	609	12	pigmentary	pigmentary	NN
25944	609	13	.	.	.
25944	610	1	Herpes	Herpes	NNP
25944	610	2	zoster	zoster	NN
25944	610	3	has	have	VBZ
25944	610	4	been	be	VBN
25944	610	5	thought	think	VBN
25944	610	6	to	to	TO
25944	610	7	follow	follow	VB
25944	610	8	its	-PRON-	PRP$
25944	610	9	use	use	NN
25944	610	10	.	.	.
25944	611	1	Keratosis	Keratosis	NNP
25944	611	2	of	of	IN
25944	611	3	the	the	DT
25944	611	4	palms	palm	NNS
25944	611	5	and	and	CC
25944	611	6	soles	sol	NNS
25944	611	7	has	have	VBZ
25944	611	8	also	also	RB
25944	611	9	been	be	VBN
25944	611	10	occasionally	occasionally	RB
25944	611	11	observed	observe	VBN
25944	611	12	,	,	,
25944	611	13	which	which	WDT
25944	611	14	,	,	,
25944	611	15	in	in	IN
25944	611	16	rare	rare	JJ
25944	611	17	instances	instance	NNS
25944	611	18	,	,	,
25944	611	19	has	have	VBZ
25944	611	20	developed	develop	VBN
25944	611	21	into	into	IN
25944	611	22	epithelioma	epithelioma	NN
25944	611	23	.	.	.
25944	612	1	#	#	$
25944	612	2	Mention	mention	VBP
25944	612	3	frequency	frequency	NN
25944	612	4	and	and	CC
25944	612	5	types	type	NNS
25944	612	6	of	of	IN
25944	612	7	eruption	eruption	NN
25944	612	8	due	due	IN
25944	612	9	to	to	IN
25944	612	10	the	the	DT
25944	612	11	ingestion	ingestion	NN
25944	612	12	of	of	IN
25944	612	13	atropia	atropia	NNP
25944	612	14	(	(	-LRB-
25944	612	15	or	or	CC
25944	612	16	belladonna	belladonna	NNP
25944	612	17	)	)	-RRB-
25944	612	18	.	.	.
25944	612	19	#	#	NN
25944	612	20	Not	not	RB
25944	612	21	uncommon	uncommon	JJ
25944	612	22	.	.	.
25944	613	1	_	_	NNP
25944	613	2	Erythematous	Erythematous	NNP
25944	613	3	_	_	NNP
25944	613	4	and	and	CC
25944	613	5	_	_	NNP
25944	613	6	scarlatinoid	scarlatinoid	NN
25944	613	7	_	_	NNP
25944	613	8	;	;	:
25944	613	9	usually	usually	RB
25944	613	10	no	no	DT
25944	613	11	febrile	febrile	NN
25944	613	12	disturbance	disturbance	NN
25944	613	13	,	,	,
25944	613	14	and	and	CC
25944	613	15	desquamation	desquamation	NN
25944	613	16	seldom	seldom	RB
25944	613	17	follows	follow	VBZ
25944	613	18	.	.	.
25944	614	1	#	#	NN
25944	614	2	Give	give	VBP
25944	614	3	frequency	frequency	NN
25944	614	4	and	and	CC
25944	614	5	types	type	NNS
25944	614	6	of	of	IN
25944	614	7	cutaneous	cutaneous	JJ
25944	614	8	disturbance	disturbance	NN
25944	614	9	following	follow	VBG
25944	614	10	the	the	DT
25944	614	11	administration	administration	NN
25944	614	12	of	of	IN
25944	614	13	the	the	DT
25944	614	14	bromides	bromide	NNS
25944	614	15	(	(	-LRB-
25944	614	16	bromine	bromine	NN
25944	614	17	)	)	-RRB-
25944	614	18	.	.	.
25944	614	19	#	#	$
25944	614	20	Common	Common	NNP
25944	614	21	.	.	.
25944	615	1	_	_	NNP
25944	615	2	Pustular	Pustular	NNP
25944	615	3	_	_	NNP
25944	615	4	,	,	,
25944	615	5	sometimes	sometimes	RB
25944	615	6	furuncular	furuncular	NNP
25944	615	7	and	and	CC
25944	615	8	carbuncular	carbuncular	NNP
25944	615	9	and	and	CC
25944	615	10	superficially	superficially	RB
25944	615	11	ulcerative	ulcerative	JJ
25944	615	12	.	.	.
25944	616	1	In	in	IN
25944	616	2	exceptional	exceptional	JJ
25944	616	3	instances	instance	NNS
25944	616	4	papillomatous	papillomatous	JJ
25944	616	5	or	or	CC
25944	616	6	vegetating	vegetate	VBG
25944	616	7	lesions	lesion	NNS
25944	616	8	have	have	VBP
25944	616	9	been	be	VBN
25944	616	10	observed	observe	VBN
25944	616	11	.	.	.
25944	617	1	Co	co	NN
25944	617	2	-	-	NN
25944	617	3	administration	administration	NN
25944	617	4	of	of	IN
25944	617	5	arsenic	arsenic	JJ
25944	617	6	or	or	CC
25944	617	7	potassium	potassium	NN
25944	617	8	bitartrate	bitartrate	NN
25944	617	9	is	be	VBZ
25944	617	10	thought	think	VBN
25944	617	11	to	to	TO
25944	617	12	have	have	VB
25944	617	13	a	a	DT
25944	617	14	preventive	preventive	JJ
25944	617	15	influence	influence	NN
25944	617	16	in	in	IN
25944	617	17	some	some	DT
25944	617	18	cases	case	NNS
25944	617	19	.	.	.
25944	618	1	#	#	JJR
25944	618	2	State	state	NN
25944	618	3	frequency	frequency	NN
25944	618	4	and	and	CC
25944	618	5	types	type	NNS
25944	618	6	of	of	IN
25944	618	7	cutaneous	cutaneous	JJ
25944	618	8	disturbance	disturbance	NN
25944	618	9	due	due	IN
25944	618	10	to	to	IN
25944	618	11	the	the	DT
25944	618	12	administration	administration	NN
25944	618	13	of	of	IN
25944	618	14	chloral	chloral	NN
25944	618	15	.	.	.
25944	618	16	#	#	NNP
25944	618	17	Occasional	Occasional	NNP
25944	618	18	.	.	.
25944	619	1	Scarlatinoid	scarlatinoid	JJ
25944	619	2	and	and	CC
25944	619	3	urticarial	urticarial	JJ
25944	619	4	,	,	,
25944	619	5	and	and	CC
25944	619	6	exceptionally	exceptionally	RB
25944	619	7	purpuric	purpuric	JJ
25944	619	8	;	;	:
25944	619	9	in	in	IN
25944	619	10	rare	rare	JJ
25944	619	11	instances	instance	NNS
25944	619	12	,	,	,
25944	619	13	if	if	IN
25944	619	14	drug	drug	NN
25944	619	15	is	be	VBZ
25944	619	16	continued	continue	VBN
25944	619	17	,	,	,
25944	619	18	eruption	eruption	NN
25944	619	19	becomes	become	VBZ
25944	619	20	vesicular	vesicular	JJ
25944	619	21	,	,	,
25944	619	22	hemorrhagic	hemorrhagic	JJ
25944	619	23	,	,	,
25944	619	24	ulcerative	ulcerative	JJ
25944	619	25	and	and	CC
25944	619	26	even	even	RB
25944	619	27	gangrenous	gangrenous	JJ
25944	619	28	.	.	.
25944	620	1	#	#	JJR
25944	620	2	State	state	NN
25944	620	3	frequency	frequency	NN
25944	620	4	and	and	CC
25944	620	5	types	type	NNS
25944	620	6	of	of	IN
25944	620	7	eruption	eruption	NN
25944	620	8	following	follow	VBG
25944	620	9	the	the	DT
25944	620	10	administration	administration	NN
25944	620	11	of	of	IN
25944	620	12	copaiba	copaiba	NNP
25944	620	13	.	.	.
25944	620	14	#	#	NN
25944	620	15	Not	not	RB
25944	620	16	uncommon	uncommon	JJ
25944	620	17	.	.	.
25944	621	1	_	_	NNP
25944	621	2	Urticarial	Urticarial	NNP
25944	621	3	_	_	NNP
25944	621	4	,	,	,
25944	621	5	erythemato	erythemato	NNP
25944	621	6	-	-	HYPH
25944	621	7	papular	papular	NN
25944	621	8	and	and	CC
25944	621	9	_	_	NNP
25944	621	10	scarlatinoid	scarlatinoid	NN
25944	621	11	_	_	NNP
25944	621	12	.	.	.
25944	622	1	#	#	$
25944	622	2	Mention	mention	VBP
25944	622	3	frequency	frequency	NN
25944	622	4	and	and	CC
25944	622	5	types	type	NNS
25944	622	6	of	of	IN
25944	622	7	eruption	eruption	NN
25944	622	8	resulting	result	VBG
25944	622	9	from	from	IN
25944	622	10	the	the	DT
25944	622	11	ingestion	ingestion	NN
25944	622	12	of	of	IN
25944	622	13	cubebs	cubeb	NNS
25944	622	14	.	.	.
25944	622	15	#	#	NNP
25944	622	16	Uncommon	Uncommon	NNP
25944	622	17	.	.	.
25944	623	1	Erythematous	erythematous	JJ
25944	623	2	and	and	CC
25944	623	3	small	small	JJ
25944	623	4	papular	papular	NN
25944	623	5	.	.	.
25944	624	1	[	[	-LRB-
25944	624	2	Illustration	illustration	NN
25944	624	3	:	:	:
25944	624	4	Fig	Fig	NNP
25944	624	5	.	.	.
25944	625	1	14	14	CD
25944	625	2	.	.	.
25944	626	1	A	a	DT
25944	626	2	somewhat	somewhat	RB
25944	626	3	rare	rare	JJ
25944	626	4	form	form	NN
25944	626	5	of	of	IN
25944	626	6	eruption	eruption	NN
25944	626	7	from	from	IN
25944	626	8	the	the	DT
25944	626	9	ingestion	ingestion	NN
25944	626	10	of	of	IN
25944	626	11	iodine	iodine	JJ
25944	626	12	compounds	compound	NNS
25944	626	13	.	.	.
25944	627	1	(	(	-LRB-
25944	627	2	_	_	NNP
25944	627	3	After	after	IN
25944	627	4	J.C.	J.C.	NNP
25944	627	5	McGuire	McGuire	NNP
25944	627	6	.	.	.
25944	627	7	_	_	NNP
25944	627	8	)	)	-RRB-
25944	627	9	]	]	-RRB-
25944	627	10	#	#	$
25944	627	11	Mention	mention	VBP
25944	627	12	frequency	frequency	NN
25944	627	13	and	and	CC
25944	627	14	types	type	NNS
25944	627	15	of	of	IN
25944	627	16	eruption	eruption	NN
25944	627	17	resulting	result	VBG
25944	627	18	from	from	IN
25944	627	19	the	the	DT
25944	627	20	administration	administration	NN
25944	627	21	of	of	IN
25944	627	22	digitalis	digitalis	NNP
25944	627	23	.	.	.
25944	627	24	#	#	NNP
25944	627	25	Exceptional	exceptional	JJ
25944	627	26	.	.	.
25944	628	1	Scarlatinoid	scarlatinoid	JJ
25944	628	2	and	and	CC
25944	628	3	papular	papular	JJ
25944	628	4	.	.	.
25944	629	1	#	#	JJR
25944	629	2	State	state	NN
25944	629	3	frequency	frequency	NN
25944	629	4	and	and	CC
25944	629	5	types	type	NNS
25944	629	6	of	of	IN
25944	629	7	eruption	eruption	NN
25944	629	8	resulting	result	VBG
25944	629	9	from	from	IN
25944	629	10	the	the	DT
25944	629	11	iodides	iodide	NNS
25944	629	12	(	(	-LRB-
25944	629	13	iodine	iodine	NNP
25944	629	14	)	)	-RRB-
25944	629	15	.	.	.
25944	629	16	#	#	$
25944	629	17	Common	Common	NNP
25944	629	18	.	.	.
25944	630	1	_	_	NNP
25944	630	2	Pustular	Pustular	NNP
25944	630	3	_	_	NNP
25944	630	4	,	,	,
25944	630	5	but	but	CC
25944	630	6	may	may	MD
25944	630	7	be	be	VB
25944	630	8	erythematous	erythematous	JJ
25944	630	9	,	,	,
25944	630	10	papular	papular	JJ
25944	630	11	,	,	,
25944	630	12	vesicular	vesicular	JJ
25944	630	13	,	,	,
25944	630	14	bullous	bullous	JJ
25944	630	15	,	,	,
25944	630	16	tuberous	tuberous	JJ
25944	630	17	,	,	,
25944	630	18	purpuric	purpuric	JJ
25944	630	19	and	and	CC
25944	630	20	hemorrhagic	hemorrhagic	JJ
25944	630	21	.	.	.
25944	631	1	Co	co	NN
25944	631	2	-	-	NN
25944	631	3	administration	administration	NN
25944	631	4	of	of	IN
25944	631	5	arsenic	arsenic	JJ
25944	631	6	or	or	CC
25944	631	7	potassium	potassium	NN
25944	631	8	bitartrate	bitartrate	NN
25944	631	9	is	be	VBZ
25944	631	10	thought	think	VBN
25944	631	11	to	to	TO
25944	631	12	have	have	VB
25944	631	13	a	a	DT
25944	631	14	preventive	preventive	JJ
25944	631	15	influence	influence	NN
25944	631	16	in	in	IN
25944	631	17	some	some	DT
25944	631	18	cases	case	NNS
25944	631	19	.	.	.
25944	632	1	#	#	NN
25944	632	2	Give	give	VBP
25944	632	3	the	the	DT
25944	632	4	frequency	frequency	NN
25944	632	5	and	and	CC
25944	632	6	types	type	NNS
25944	632	7	of	of	IN
25944	632	8	eruption	eruption	NN
25944	632	9	observed	observe	VBN
25944	632	10	to	to	TO
25944	632	11	follow	follow	VB
25944	632	12	the	the	DT
25944	632	13	administration	administration	NNP
25944	632	14	of	of	IN
25944	632	15	mercury	mercury	NNP
25944	632	16	.	.	.
25944	632	17	#	#	NNP
25944	632	18	Exceptional	exceptional	JJ
25944	632	19	.	.	.
25944	633	1	Erythematous	erythematous	JJ
25944	633	2	and	and	CC
25944	633	3	erysipelatous	erysipelatous	JJ
25944	633	4	.	.	.
25944	634	1	#	#	NN
25944	634	2	Give	give	VBP
25944	634	3	the	the	DT
25944	634	4	frequency	frequency	NN
25944	634	5	and	and	CC
25944	634	6	types	type	NNS
25944	634	7	of	of	IN
25944	634	8	the	the	DT
25944	634	9	cutaneous	cutaneous	JJ
25944	634	10	disturbance	disturbance	NN
25944	634	11	following	follow	VBG
25944	634	12	the	the	DT
25944	634	13	ingestion	ingestion	NN
25944	634	14	of	of	IN
25944	634	15	opium	opium	NN
25944	634	16	(	(	-LRB-
25944	634	17	or	or	CC
25944	634	18	morphia	morphia	NN
25944	634	19	)	)	-RRB-
25944	634	20	.	.	.
25944	634	21	#	#	NN
25944	634	22	Not	not	RB
25944	634	23	uncommon	uncommon	JJ
25944	634	24	.	.	.
25944	635	1	Erythematous	erythematous	JJ
25944	635	2	and	and	CC
25944	635	3	_	_	NNP
25944	635	4	scarlatinoid	scarlatinoid	NN
25944	635	5	_	_	NNP
25944	635	6	,	,	,
25944	635	7	and	and	CC
25944	635	8	sometimes	sometimes	RB
25944	635	9	urticarial	urticarial	JJ
25944	635	10	.	.	.
25944	636	1	#	#	$
25944	636	2	Mention	mention	VB
25944	636	3	the	the	DT
25944	636	4	frequency	frequency	NN
25944	636	5	and	and	CC
25944	636	6	the	the	DT
25944	636	7	types	type	NNS
25944	636	8	of	of	IN
25944	636	9	eruption	eruption	NN
25944	636	10	following	follow	VBG
25944	636	11	the	the	DT
25944	636	12	administration	administration	NN
25944	636	13	of	of	IN
25944	636	14	quinine	quinine	NNP
25944	636	15	.	.	.
25944	636	16	#	#	NN
25944	636	17	Not	not	RB
25944	636	18	infrequent	infrequent	JJ
25944	636	19	.	.	.
25944	637	1	Usually	usually	RB
25944	637	2	_	_	NNP
25944	637	3	erythematous	erythematous	JJ
25944	637	4	_	_	NNP
25944	637	5	,	,	,
25944	637	6	but	but	CC
25944	637	7	may	may	MD
25944	637	8	be	be	VB
25944	637	9	urticarial	urticarial	JJ
25944	637	10	,	,	,
25944	637	11	erythemato	erythemato	JJ
25944	637	12	-	-	HYPH
25944	637	13	papular	papular	JJ
25944	637	14	,	,	,
25944	637	15	and	and	CC
25944	637	16	even	even	RB
25944	637	17	purpuric	purpuric	NN
25944	637	18	.	.	.
25944	638	1	There	there	EX
25944	638	2	is	be	VBZ
25944	638	3	,	,	,
25944	638	4	in	in	IN
25944	638	5	some	some	DT
25944	638	6	instances	instance	NNS
25944	638	7	,	,	,
25944	638	8	preceding	precede	VBG
25944	638	9	or	or	CC
25944	638	10	accompanying	accompany	VBG
25944	638	11	systemic	systemic	JJ
25944	638	12	disturbance	disturbance	NN
25944	638	13	.	.	.
25944	639	1	Furfuraceous	furfuraceous	JJ
25944	639	2	or	or	CC
25944	639	3	lamellar	lamellar	JJ
25944	639	4	desquamation	desquamation	NN
25944	639	5	often	often	RB
25944	639	6	follows	follow	VBZ
25944	639	7	.	.	.
25944	640	1	#	#	JJR
25944	640	2	State	state	NN
25944	640	3	frequency	frequency	NN
25944	640	4	and	and	CC
25944	640	5	types	type	NNS
25944	640	6	of	of	IN
25944	640	7	eruption	eruption	NN
25944	640	8	resulting	result	VBG
25944	640	9	from	from	IN
25944	640	10	the	the	DT
25944	640	11	ingestion	ingestion	NN
25944	640	12	of	of	IN
25944	640	13	salicylic	salicylic	JJ
25944	640	14	acid	acid	NN
25944	640	15	.	.	.
25944	640	16	#	#	$
25944	640	17	Not	not	RB
25944	640	18	common	common	JJ
25944	640	19	.	.	.
25944	641	1	Erythematous	erythematous	JJ
25944	641	2	and	and	CC
25944	641	3	urticarial	urticarial	JJ
25944	641	4	;	;	:
25944	641	5	exceptionally	exceptionally	RB
25944	641	6	,	,	,
25944	641	7	vesicular	vesicular	JJ
25944	641	8	,	,	,
25944	641	9	pustular	pustular	JJ
25944	641	10	,	,	,
25944	641	11	bullous	bullous	JJ
25944	641	12	,	,	,
25944	641	13	and	and	CC
25944	641	14	ecchymotic	ecchymotic	JJ
25944	641	15	.	.	.
25944	642	1	#	#	NN
25944	642	2	Give	give	VBP
25944	642	3	frequency	frequency	NN
25944	642	4	and	and	CC
25944	642	5	type	type	NN
25944	642	6	of	of	IN
25944	642	7	cutaneous	cutaneous	JJ
25944	642	8	disturbance	disturbance	NN
25944	642	9	due	due	IN
25944	642	10	to	to	IN
25944	642	11	the	the	DT
25944	642	12	administration	administration	NN
25944	642	13	of	of	IN
25944	642	14	stramonium	stramonium	NN
25944	642	15	.	.	.
25944	642	16	#	#	$
25944	642	17	Not	not	RB
25944	642	18	common	common	JJ
25944	642	19	.	.	.
25944	643	1	Erythematous	erythematous	JJ
25944	643	2	.	.	.
25944	644	1	#	#	JJR
25944	644	2	State	state	NN
25944	644	3	frequency	frequency	NN
25944	644	4	and	and	CC
25944	644	5	types	type	NNS
25944	644	6	of	of	IN
25944	644	7	eruption	eruption	NN
25944	644	8	resulting	result	VBG
25944	644	9	from	from	IN
25944	644	10	the	the	DT
25944	644	11	administration	administration	NN
25944	644	12	of	of	IN
25944	644	13	turpentine	turpentine	NN
25944	644	14	.	.	.
25944	644	15	#	#	$
25944	644	16	Not	not	RB
25944	644	17	uncommon	uncommon	JJ
25944	644	18	.	.	.
25944	645	1	_	_	NNP
25944	645	2	Erythematous	Erythematous	NNP
25944	645	3	_	_	NNP
25944	645	4	,	,	,
25944	645	5	and	and	CC
25944	645	6	small	small	JJ
25944	645	7	-	-	HYPH
25944	645	8	papular	papular	JJ
25944	645	9	;	;	:
25944	645	10	exceptionally	exceptionally	RB
25944	645	11	vesicular	vesicular	JJ
25944	645	12	.	.	.
25944	646	1	#	#	NNP
25944	646	2	X	X	NNP
25944	646	3	-	-	HYPH
25944	646	4	Ray	Ray	NNP
25944	646	5	Dermatitis	Dermatitis	NNP
25944	646	6	.	.	.
25944	646	7	#	#	$
25944	646	8	#	#	$
25944	646	9	What	what	WDT
25944	646	10	several	several	JJ
25944	646	11	grades	grade	NNS
25944	646	12	of	of	IN
25944	646	13	x	x	SYM
25944	646	14	-	-	NN
25944	646	15	ray	ray	NN
25944	646	16	dermatitis	dermatitis	NN
25944	646	17	(	(	-LRB-
25944	646	18	x	x	NN
25944	646	19	-	-	NN
25944	646	20	ray	ray	NN
25944	646	21	burns	burn	NNS
25944	646	22	,	,	,
25944	646	23	Rontgen	Rontgen	NNP
25944	646	24	-	-	HYPH
25944	646	25	ray	ray	NNP
25944	646	26	burns	burn	NNS
25944	646	27	)	)	-RRB-
25944	646	28	are	be	VBP
25944	646	29	observed	observe	VBN
25944	646	30	?	?	.
25944	646	31	#	#	$
25944	646	32	Three	three	CD
25944	646	33	grades	grade	NNS
25944	646	34	are	be	VBP
25944	646	35	usually	usually	RB
25944	646	36	described	describe	VBN
25944	646	37	:	:	:
25944	646	38	erythema	erythema	NNP
25944	646	39	,	,	,
25944	646	40	superficial	superficial	JJ
25944	646	41	vesication	vesication	NN
25944	646	42	,	,	,
25944	646	43	and	and	CC
25944	646	44	necrosis	necrosis	NN
25944	646	45	.	.	.
25944	647	1	The	the	DT
25944	647	2	first	first	JJ
25944	647	3	and	and	CC
25944	647	4	second	second	JJ
25944	647	5	may	may	MD
25944	647	6	come	come	VB
25944	647	7	on	on	RP
25944	647	8	shortly	shortly	RB
25944	647	9	--	--	:
25944	647	10	a	a	DT
25944	647	11	few	few	JJ
25944	647	12	hours	hour	NNS
25944	647	13	to	to	IN
25944	647	14	several	several	JJ
25944	647	15	days	day	NNS
25944	647	16	--	--	:
25944	647	17	after	after	IN
25944	647	18	exposure	exposure	NN
25944	647	19	;	;	:
25944	647	20	occasionally	occasionally	RB
25944	647	21	later	later	RB
25944	647	22	.	.	.
25944	648	1	The	the	DT
25944	648	2	third	third	JJ
25944	648	3	grade	grade	NN
25944	648	4	may	may	MD
25944	648	5	present	present	VB
25944	648	6	also	also	RB
25944	648	7	in	in	IN
25944	648	8	the	the	DT
25944	648	9	first	first	JJ
25944	648	10	several	several	JJ
25944	648	11	days	day	NNS
25944	648	12	,	,	,
25944	648	13	but	but	CC
25944	648	14	in	in	IN
25944	648	15	many	many	JJ
25944	648	16	cases	case	NNS
25944	648	17	one	one	PRP
25944	648	18	to	to	IN
25944	648	19	several	several	JJ
25944	648	20	weeks	week	NNS
25944	648	21	may	may	MD
25944	648	22	elapse	elapse	VB
25944	648	23	before	before	IN
25944	648	24	it	-PRON-	PRP
25944	648	25	appears	appear	VBZ
25944	648	26	;	;	:
25944	648	27	it	-PRON-	PRP
25944	648	28	is	be	VBZ
25944	648	29	quite	quite	RB
25944	648	30	commonly	commonly	RB
25944	648	31	preceded	precede	VBN
25944	648	32	by	by	IN
25944	648	33	erythema	erythema	NNP
25944	648	34	and	and	CC
25944	648	35	vesication	vesication	NN
25944	648	36	.	.	.
25944	649	1	The	the	DT
25944	649	2	necrosis	necrosis	NN
25944	649	3	may	may	MD
25944	649	4	be	be	VB
25944	649	5	superficial	superficial	JJ
25944	649	6	or	or	CC
25944	649	7	deep	deep	JJ
25944	649	8	,	,	,
25944	649	9	and	and	CC
25944	649	10	quite	quite	RB
25944	649	11	usually	usually	RB
25944	649	12	results	result	VBZ
25944	649	13	in	in	IN
25944	649	14	a	a	DT
25944	649	15	persistent	persistent	JJ
25944	649	16	ulcer	ulcer	NN
25944	649	17	covered	cover	VBN
25944	649	18	by	by	IN
25944	649	19	a	a	DT
25944	649	20	leathery	leathery	NN
25944	649	21	coating	coating	NN
25944	649	22	;	;	:
25944	649	23	it	-PRON-	PRP
25944	649	24	is	be	VBZ
25944	649	25	usually	usually	RB
25944	649	26	painful	painful	JJ
25944	649	27	.	.	.
25944	650	1	[	[	-LRB-
25944	650	2	Illustration	illustration	NN
25944	650	3	:	:	:
25944	650	4	Fig	Fig	NNP
25944	650	5	.	.	.
25944	651	1	15	15	CD
25944	651	2	.	.	.
25944	652	1	_	_	NNP
25944	652	2	x_-ray	x_-ray	NNP
25944	652	3	burn	burn	NN
25944	652	4	]	]	-RRB-
25944	652	5	#	#	NN
25944	652	6	Give	give	VB
25944	652	7	the	the	DT
25944	652	8	prognosis	prognosis	NN
25944	652	9	and	and	CC
25944	652	10	treatment	treatment	NN
25944	652	11	of	of	IN
25944	652	12	x	x	NNP
25944	652	13	-	-	NN
25944	652	14	ray	ray	NN
25944	652	15	dermatitis	dermatitis	NN
25944	652	16	.	.	.
25944	652	17	#	#	$
25944	652	18	The	the	DT
25944	652	19	first	first	JJ
25944	652	20	grade	grade	NN
25944	652	21	--	--	:
25944	652	22	the	the	DT
25944	652	23	erythematous	erythematous	JJ
25944	652	24	--	--	:
25944	652	25	usually	usually	RB
25944	652	26	disappears	disappear	VBZ
25944	652	27	in	in	IN
25944	652	28	one	one	CD
25944	652	29	to	to	TO
25944	652	30	ten	ten	CD
25944	652	31	days	day	NNS
25944	652	32	;	;	:
25944	652	33	the	the	DT
25944	652	34	second	second	JJ
25944	652	35	grade	grade	NN
25944	652	36	requires	require	VBZ
25944	652	37	one	one	CD
25944	652	38	to	to	IN
25944	652	39	several	several	JJ
25944	652	40	weeks	week	NNS
25944	652	41	,	,	,
25944	652	42	and	and	CC
25944	652	43	may	may	MD
25944	652	44	be	be	VB
25944	652	45	quite	quite	RB
25944	652	46	sore	sore	JJ
25944	652	47	and	and	CC
25944	652	48	tender	tender	JJ
25944	652	49	;	;	:
25944	652	50	the	the	DT
25944	652	51	severe	severe	JJ
25944	652	52	or	or	CC
25944	652	53	necrotic	necrotic	JJ
25944	652	54	burns	burn	NNS
25944	652	55	are	be	VBP
25944	652	56	persistent	persistent	JJ
25944	652	57	,	,	,
25944	652	58	sometimes	sometimes	RB
25944	652	59	lasting	last	VBG
25944	652	60	for	for	IN
25944	652	61	months	month	NNS
25944	652	62	and	and	CC
25944	652	63	several	several	JJ
25944	652	64	years	year	NNS
25944	652	65	,	,	,
25944	652	66	with	with	IN
25944	652	67	little	little	JJ
25944	652	68	tendency	tendency	NN
25944	652	69	to	to	IN
25944	652	70	spontaneous	spontaneous	JJ
25944	652	71	disappearance	disappearance	NN
25944	652	72	,	,	,
25944	652	73	and	and	CC
25944	652	74	rebellious	rebellious	JJ
25944	652	75	to	to	IN
25944	652	76	treatment	treatment	NN
25944	652	77	.	.	.
25944	653	1	Treatment	treatment	NN
25944	653	2	of	of	IN
25944	653	3	the	the	DT
25944	653	4	milder	milder	NN
25944	653	5	types	type	NNS
25944	653	6	is	be	VBZ
25944	653	7	that	that	DT
25944	653	8	of	of	IN
25944	653	9	erythema	erythema	NNP
25944	653	10	(	(	-LRB-
25944	653	11	_	_	NNP
25944	653	12	q	q	NNP
25944	653	13	.	.	.
25944	654	1	v.	v.	NNP
25944	654	2	_	_	NNP
25944	654	3	)	)	-RRB-
25944	654	4	;	;	:
25944	654	5	the	the	DT
25944	654	6	necrotic	necrotic	JJ
25944	654	7	type	type	NN
25944	654	8	occasionally	occasionally	RB
25944	654	9	demands	demand	VBZ
25944	654	10	thorough	thorough	JJ
25944	654	11	curetting	curet	VBG
25944	654	12	and	and	CC
25944	654	13	skin	skin	NN
25944	654	14	-	-	HYPH
25944	654	15	grafting	graft	VBG
25944	654	16	before	before	IN
25944	654	17	it	-PRON-	PRP
25944	654	18	will	will	MD
25944	654	19	heal	heal	VB
25944	654	20	.	.	.
25944	655	1	#	#	NNP
25944	655	2	Dermatitis	Dermatitis	NNP
25944	655	3	Factitia	Factitia	NNP
25944	655	4	.	.	.
25944	655	5	#	#	NNP
25944	655	6	(	(	-LRB-
25944	655	7	_	_	NNP
25944	655	8	Synonym	Synonym	NNP
25944	655	9	:	:	:
25944	655	10	_	_	NNP
25944	655	11	Feigned	Feigned	NNP
25944	655	12	Eruptions	Eruptions	NNPS
25944	655	13	.	.	.
25944	655	14	)	)	-RRB-
25944	656	1	#	#	LS
25944	656	2	What	what	WP
25944	656	3	do	do	VBP
25944	656	4	you	-PRON-	PRP
25944	656	5	understand	understand	VB
25944	656	6	by	by	IN
25944	656	7	feigned	feigned	JJ
25944	656	8	eruptions	eruption	NNS
25944	656	9	?	?	.
25944	656	10	#	#	$
25944	656	11	Feigned	feign	VBN
25944	656	12	,	,	,
25944	656	13	or	or	CC
25944	656	14	artificial	artificial	JJ
25944	656	15	,	,	,
25944	656	16	eruptions	eruption	NNS
25944	656	17	,	,	,
25944	656	18	occasionally	occasionally	RB
25944	656	19	met	meet	VBD
25944	656	20	with	with	IN
25944	656	21	in	in	IN
25944	656	22	hysterical	hysterical	JJ
25944	656	23	females	female	NNS
25944	656	24	and	and	CC
25944	656	25	in	in	IN
25944	656	26	others	other	NNS
25944	656	27	,	,	,
25944	656	28	are	be	VBP
25944	656	29	produced	produce	VBN
25944	656	30	,	,	,
25944	656	31	for	for	IN
25944	656	32	the	the	DT
25944	656	33	purpose	purpose	NN
25944	656	34	of	of	IN
25944	656	35	exciting	exciting	JJ
25944	656	36	sympathy	sympathy	NN
25944	656	37	or	or	CC
25944	656	38	of	of	IN
25944	656	39	deception	deception	NN
25944	656	40	,	,	,
25944	656	41	by	by	IN
25944	656	42	the	the	DT
25944	656	43	action	action	NN
25944	656	44	of	of	IN
25944	656	45	friction	friction	NN
25944	656	46	,	,	,
25944	656	47	cantharides	cantharide	NNS
25944	656	48	,	,	,
25944	656	49	acids	acid	NNS
25944	656	50	or	or	CC
25944	656	51	strong	strong	JJ
25944	656	52	alkalies	alkali	NNS
25944	656	53	;	;	:
25944	656	54	the	the	DT
25944	656	55	cutaneous	cutaneous	JJ
25944	656	56	disturbance	disturbance	NN
25944	656	57	may	may	MD
25944	656	58	,	,	,
25944	656	59	therefore	therefore	RB
25944	656	60	,	,	,
25944	656	61	be	be	VB
25944	656	62	erythematous	erythematous	JJ
25944	656	63	,	,	,
25944	656	64	vesicular	vesicular	JJ
25944	656	65	,	,	,
25944	656	66	bullous	bullous	JJ
25944	656	67	,	,	,
25944	656	68	or	or	CC
25944	656	69	gangrenous	gangrenous	JJ
25944	656	70	.	.	.
25944	657	1	It	-PRON-	PRP
25944	657	2	is	be	VBZ
25944	657	3	usually	usually	RB
25944	657	4	limited	limited	JJ
25944	657	5	in	in	IN
25944	657	6	extent	extent	NN
25944	657	7	,	,	,
25944	657	8	and	and	CC
25944	657	9	,	,	,
25944	657	10	as	as	IN
25944	657	11	a	a	DT
25944	657	12	rule	rule	NN
25944	657	13	,	,	,
25944	657	14	seen	see	VBN
25944	657	15	only	only	RB
25944	657	16	on	on	IN
25944	657	17	parts	part	NNS
25944	657	18	easily	easily	RB
25944	657	19	reached	reach	VBN
25944	657	20	by	by	IN
25944	657	21	the	the	DT
25944	657	22	hands	hand	NNS
25944	657	23	.	.	.
25944	658	1	[	[	-LRB-
25944	658	2	Illustration	illustration	NN
25944	658	3	:	:	:
25944	658	4	Fig	Fig	NNP
25944	658	5	.	.	.
25944	659	1	16	16	CD
25944	659	2	.	.	.
25944	660	1	Dermatitis	Dermatitis	NNP
25944	660	2	Factitia	Factitia	NNP
25944	660	3	--	--	:
25944	660	4	note	note	VB
25944	660	5	the	the	DT
25944	660	6	unusually	unusually	RB
25944	660	7	uniform	uniform	JJ
25944	660	8	and	and	CC
25944	660	9	regular	regular	JJ
25944	660	10	character	character	NN
25944	660	11	and	and	CC
25944	660	12	arrangement	arrangement	NN
25944	660	13	of	of	IN
25944	660	14	the	the	DT
25944	660	15	lesions	lesion	NNS
25944	660	16	.	.	.
25944	660	17	]	]	-RRB-
25944	661	1	#	#	NNP
25944	661	2	Dermatitis	Dermatitis	NNP
25944	661	3	Gangrænosa	Gangrænosa	NNP
25944	661	4	.	.	.
25944	661	5	#	#	$
25944	661	6	#	#	$
25944	661	7	What	what	WP
25944	661	8	do	do	VBP
25944	661	9	you	-PRON-	PRP
25944	661	10	understand	understand	VB
25944	661	11	by	by	IN
25944	661	12	dermatitis	dermatitis	JJ
25944	661	13	gangrænosa	gangrænosa	NNP
25944	661	14	?	?	.
25944	661	15	#	#	NNP
25944	661	16	Dermatitis	Dermatitis	NNP
25944	661	17	gangrænosa	gangrænosa	NNS
25944	661	18	(	(	-LRB-
25944	661	19	_	_	NNP
25944	661	20	erythema	erythema	NNP
25944	661	21	gangrænosum	gangrænosum	NN
25944	661	22	_	_	NNP
25944	661	23	,	,	,
25944	661	24	_	_	NNP
25944	661	25	Raynaud	Raynaud	NNP
25944	661	26	's	's	POS
25944	661	27	disease	disease	NN
25944	661	28	_	_	NNP
25944	661	29	,	,	,
25944	661	30	_	_	NNP
25944	661	31	spontaneous	spontaneous	JJ
25944	661	32	gangrene	gangrene	NN
25944	661	33	_	_	NNP
25944	661	34	)	)	-RRB-
25944	661	35	is	be	VBZ
25944	661	36	an	an	DT
25944	661	37	exceedingly	exceedingly	RB
25944	661	38	rare	rare	JJ
25944	661	39	affection	affection	NN
25944	661	40	,	,	,
25944	661	41	characterized	characterize	VBN
25944	661	42	by	by	IN
25944	661	43	the	the	DT
25944	661	44	formation	formation	NN
25944	661	45	of	of	IN
25944	661	46	gangrenous	gangrenous	JJ
25944	661	47	spots	spot	NNS
25944	661	48	and	and	CC
25944	661	49	patches	patch	NNS
25944	661	50	.	.	.
25944	662	1	It	-PRON-	PRP
25944	662	2	may	may	MD
25944	662	3	be	be	VB
25944	662	4	idiopathic	idiopathic	JJ
25944	662	5	or	or	CC
25944	662	6	symptomatic	symptomatic	JJ
25944	662	7	.	.	.
25944	663	1	Some	some	DT
25944	663	2	of	of	IN
25944	663	3	these	these	DT
25944	663	4	cases	case	NNS
25944	663	5	,	,	,
25944	663	6	especially	especially	RB
25944	663	7	in	in	IN
25944	663	8	hysterical	hysterical	JJ
25944	663	9	subjects	subject	NNS
25944	663	10	,	,	,
25944	663	11	belong	belong	VBP
25944	663	12	under	under	IN
25944	663	13	the	the	DT
25944	663	14	"	"	``
25944	663	15	feigned	feigned	JJ
25944	663	16	eruptions	eruption	NNS
25944	663	17	,	,	,
25944	663	18	"	"	''
25944	663	19	being	be	VBG
25944	663	20	self	self	NN
25944	663	21	-	-	HYPH
25944	663	22	produced	produce	VBN
25944	663	23	.	.	.
25944	664	1	As	as	IN
25944	664	2	an	an	DT
25944	664	3	idiopathic	idiopathic	JJ
25944	664	4	disease	disease	NN
25944	664	5	,	,	,
25944	664	6	it	-PRON-	PRP
25944	664	7	begins	begin	VBZ
25944	664	8	as	as	RB
25944	664	9	erythematous	erythematous	JJ
25944	664	10	,	,	,
25944	664	11	dark	dark	JJ
25944	664	12	-	-	HYPH
25944	664	13	red	red	JJ
25944	664	14	spots	spot	NNS
25944	664	15	--	--	:
25944	664	16	usually	usually	RB
25944	664	17	preceded	precede	VBN
25944	664	18	and	and	CC
25944	664	19	accompanied	accompany	VBN
25944	664	20	by	by	IN
25944	664	21	mild	mild	JJ
25944	664	22	or	or	CC
25944	664	23	grave	grave	JJ
25944	664	24	systemic	systemic	JJ
25944	664	25	disturbance	disturbance	NN
25944	664	26	--	--	:
25944	664	27	which	which	WDT
25944	664	28	gradually	gradually	RB
25944	664	29	pass	pass	VBP
25944	664	30	into	into	IN
25944	664	31	gangrene	gangrene	NN
25944	664	32	and	and	CC
25944	664	33	sloughing	sloughing	NN
25944	664	34	;	;	:
25944	664	35	the	the	DT
25944	664	36	eventual	eventual	JJ
25944	664	37	termination	termination	NN
25944	664	38	may	may	MD
25944	664	39	be	be	VB
25944	664	40	fatal	fatal	JJ
25944	664	41	,	,	,
25944	664	42	or	or	CC
25944	664	43	recovery	recovery	NN
25944	664	44	may	may	MD
25944	664	45	take	take	VB
25944	664	46	place	place	NN
25944	664	47	.	.	.
25944	665	1	As	as	IN
25944	665	2	a	a	DT
25944	665	3	symptomatic	symptomatic	JJ
25944	665	4	disease	disease	NN
25944	665	5	,	,	,
25944	665	6	it	-PRON-	PRP
25944	665	7	is	be	VBZ
25944	665	8	occasionally	occasionally	RB
25944	665	9	met	meet	VBN
25944	665	10	with	with	IN
25944	665	11	in	in	IN
25944	665	12	diabetes	diabetes	NN
25944	665	13	and	and	CC
25944	665	14	in	in	IN
25944	665	15	grave	grave	JJ
25944	665	16	cerebral	cerebral	JJ
25944	665	17	and	and	CC
25944	665	18	spinal	spinal	JJ
25944	665	19	affections	affection	NNS
25944	665	20	.	.	.
25944	666	1	In	in	IN
25944	666	2	Raynaud	Raynaud	NNP
25944	666	3	's	's	POS
25944	666	4	disease	disease	NN
25944	666	5	(	(	-LRB-
25944	666	6	symmetric	symmetric	JJ
25944	666	7	gangrene	gangrene	NN
25944	666	8	)	)	-RRB-
25944	666	9	the	the	DT
25944	666	10	parts	part	NNS
25944	666	11	affected	affect	VBN
25944	666	12	are	be	VBP
25944	666	13	the	the	DT
25944	666	14	extremities	extremity	NNS
25944	666	15	,	,	,
25944	666	16	such	such	JJ
25944	666	17	as	as	IN
25944	666	18	fingers	finger	NNS
25944	666	19	and	and	CC
25944	666	20	toes	toe	NNS
25944	666	21	,	,	,
25944	666	22	the	the	DT
25944	666	23	ears	ear	NNS
25944	666	24	and	and	CC
25944	666	25	nose	nose	NN
25944	666	26	,	,	,
25944	666	27	only	only	RB
25944	666	28	occasionally	occasionally	RB
25944	666	29	other	other	JJ
25944	666	30	parts	part	NNS
25944	666	31	.	.	.
25944	667	1	The	the	DT
25944	667	2	first	first	JJ
25944	667	3	symptoms	symptom	NNS
25944	667	4	observed	observe	VBN
25944	667	5	are	be	VBP
25944	667	6	coldness	coldness	NN
25944	667	7	and	and	CC
25944	667	8	paleness	paleness	NN
25944	667	9	of	of	IN
25944	667	10	the	the	DT
25944	667	11	part	part	NN
25944	667	12	;	;	,
25944	667	13	followed	follow	VBD
25944	667	14	sooner	soon	RBR
25944	667	15	or	or	CC
25944	667	16	later	later	RB
25944	667	17	by	by	IN
25944	667	18	congestion	congestion	NN
25944	667	19	of	of	IN
25944	667	20	a	a	DT
25944	667	21	dark	dark	JJ
25944	667	22	red	red	JJ
25944	667	23	,	,	,
25944	667	24	livid	livid	NNP
25944	667	25	,	,	,
25944	667	26	or	or	CC
25944	667	27	bluish	bluish	JJ
25944	667	28	color	color	NN
25944	667	29	,	,	,
25944	667	30	with	with	IN
25944	667	31	sometimes	sometimes	RB
25944	667	32	swelling	swell	VBG
25944	667	33	,	,	,
25944	667	34	and	and	CC
25944	667	35	tenderness	tenderness	NN
25944	667	36	and	and	CC
25944	667	37	shooting	shooting	NN
25944	667	38	pains	pain	NNS
25944	667	39	.	.	.
25944	668	1	The	the	DT
25944	668	2	termination	termination	NN
25944	668	3	is	be	VBZ
25944	668	4	usually	usually	RB
25944	668	5	in	in	IN
25944	668	6	gangrene	gangrene	NN
25944	668	7	of	of	IN
25944	668	8	a	a	DT
25944	668	9	dry	dry	JJ
25944	668	10	character	character	NN
25944	668	11	,	,	,
25944	668	12	with	with	IN
25944	668	13	,	,	,
25944	668	14	in	in	IN
25944	668	15	some	some	DT
25944	668	16	instances	instance	NNS
25944	668	17	,	,	,
25944	668	18	vesicles	vesicle	NNS
25944	668	19	and	and	CC
25944	668	20	blebs	blebs	NN
25944	668	21	along	along	IN
25944	668	22	the	the	DT
25944	668	23	edges	edge	NNS
25944	668	24	;	;	:
25944	668	25	in	in	IN
25944	668	26	other	other	JJ
25944	668	27	cases	case	NNS
25944	668	28	the	the	DT
25944	668	29	parts	part	NNS
25944	668	30	become	become	VBP
25944	668	31	atrophied	atrophy	VBN
25944	668	32	,	,	,
25944	668	33	withered	withered	JJ
25944	668	34	,	,	,
25944	668	35	and	and	CC
25944	668	36	indurated	indurate	VBD
25944	668	37	.	.	.
25944	669	1	Treatment	treatment	NN
25944	669	2	is	be	VBZ
25944	669	3	based	base	VBN
25944	669	4	upon	upon	IN
25944	669	5	general	general	JJ
25944	669	6	principles	principle	NNS
25944	669	7	.	.	.
25944	670	1	#	#	NNP
25944	670	2	Erysipelas	Erysipelas	NNP
25944	670	3	.	.	.
25944	670	4	#	#	$
25944	670	5	#	#	$
25944	670	6	What	what	WP
25944	670	7	is	be	VBZ
25944	670	8	erysipelas	erysipela	NNS
25944	670	9	?	?	.
25944	670	10	#	#	NNP
25944	670	11	Erysipelas	Erysipelas	NNP
25944	670	12	is	be	VBZ
25944	670	13	an	an	DT
25944	670	14	acute	acute	JJ
25944	670	15	specific	specific	JJ
25944	670	16	inflammation	inflammation	NN
25944	670	17	of	of	IN
25944	670	18	the	the	DT
25944	670	19	skin	skin	NN
25944	670	20	and	and	CC
25944	670	21	subcutaneous	subcutaneous	JJ
25944	670	22	tissue	tissue	NN
25944	670	23	,	,	,
25944	670	24	commonly	commonly	RB
25944	670	25	of	of	IN
25944	670	26	the	the	DT
25944	670	27	face	face	NN
25944	670	28	,	,	,
25944	670	29	characterized	characterize	VBN
25944	670	30	by	by	IN
25944	670	31	shining	shine	VBG
25944	670	32	redness	redness	NN
25944	670	33	,	,	,
25944	670	34	swelling	swell	VBG
25944	670	35	,	,	,
25944	670	36	[	[	-LRB-
25944	670	37	oe]dema	oe]dema	NNP
25944	670	38	,	,	,
25944	670	39	heat	heat	NN
25944	670	40	,	,	,
25944	670	41	and	and	CC
25944	670	42	a	a	DT
25944	670	43	tendency	tendency	NN
25944	670	44	in	in	IN
25944	670	45	some	some	DT
25944	670	46	cases	case	NNS
25944	670	47	to	to	IN
25944	670	48	vesicle-	vesicle-	NN
25944	670	49	and	and	CC
25944	670	50	bleb	bleb	NN
25944	670	51	-	-	HYPH
25944	670	52	formation	formation	NN
25944	670	53	,	,	,
25944	670	54	and	and	CC
25944	670	55	accompanied	accompany	VBN
25944	670	56	by	by	IN
25944	670	57	more	more	JJR
25944	670	58	or	or	CC
25944	670	59	less	less	JJR
25944	670	60	febrile	febrile	NN
25944	670	61	disturbance	disturbance	NN
25944	670	62	.	.	.
25944	671	1	#	#	NNP
25944	671	2	Describe	describe	VB
25944	671	3	the	the	DT
25944	671	4	symptoms	symptom	NNS
25944	671	5	and	and	CC
25944	671	6	course	course	NN
25944	671	7	of	of	IN
25944	671	8	erysipelas	erysipela	NNS
25944	671	9	.	.	.
25944	671	10	#	#	$
25944	671	11	A	a	DT
25944	671	12	decided	decide	VBN
25944	671	13	rigor	rigor	NN
25944	671	14	or	or	CC
25944	671	15	a	a	DT
25944	671	16	feeling	feeling	NN
25944	671	17	of	of	IN
25944	671	18	chilliness	chilliness	NN
25944	671	19	followed	follow	VBN
25944	671	20	by	by	IN
25944	671	21	febrile	febrile	NN
25944	671	22	action	action	NN
25944	671	23	usually	usually	RB
25944	671	24	ushers	usher	VBZ
25944	671	25	in	in	IN
25944	671	26	the	the	DT
25944	671	27	cutaneous	cutaneous	JJ
25944	671	28	disturbance	disturbance	NN
25944	671	29	.	.	.
25944	672	1	The	the	DT
25944	672	2	skin	skin	NN
25944	672	3	at	at	IN
25944	672	4	a	a	DT
25944	672	5	certain	certain	JJ
25944	672	6	point	point	NN
25944	672	7	or	or	CC
25944	672	8	part	part	NN
25944	672	9	,	,	,
25944	672	10	commonly	commonly	RB
25944	672	11	where	where	WRB
25944	672	12	there	there	EX
25944	672	13	is	be	VBZ
25944	672	14	a	a	DT
25944	672	15	lesion	lesion	NN
25944	672	16	of	of	IN
25944	672	17	continuity	continuity	NN
25944	672	18	,	,	,
25944	672	19	becomes	become	VBZ
25944	672	20	bright	bright	JJ
25944	672	21	red	red	JJ
25944	672	22	and	and	CC
25944	672	23	swollen	swollen	JJ
25944	672	24	;	;	:
25944	672	25	this	this	DT
25944	672	26	spreads	spread	VBZ
25944	672	27	by	by	IN
25944	672	28	peripheral	peripheral	JJ
25944	672	29	extension	extension	NN
25944	672	30	,	,	,
25944	672	31	and	and	CC
25944	672	32	in	in	IN
25944	672	33	the	the	DT
25944	672	34	course	course	NN
25944	672	35	of	of	IN
25944	672	36	several	several	JJ
25944	672	37	hours	hour	NNS
25944	672	38	involves	involve	VBZ
25944	672	39	a	a	DT
25944	672	40	portion	portion	NN
25944	672	41	or	or	CC
25944	672	42	the	the	DT
25944	672	43	whole	whole	JJ
25944	672	44	region	region	NN
25944	672	45	.	.	.
25944	673	1	The	the	DT
25944	673	2	parts	part	NNS
25944	673	3	are	be	VBP
25944	673	4	shining	shine	VBG
25944	673	5	red	red	JJ
25944	673	6	,	,	,
25944	673	7	swollen	swollen	JJ
25944	673	8	,	,	,
25944	673	9	of	of	IN
25944	673	10	an	an	DT
25944	673	11	elevated	elevated	JJ
25944	673	12	temperature	temperature	NN
25944	673	13	,	,	,
25944	673	14	and	and	CC
25944	673	15	sharply	sharply	RB
25944	673	16	defined	define	VBN
25944	673	17	against	against	IN
25944	673	18	the	the	DT
25944	673	19	sound	sound	JJ
25944	673	20	skin	skin	NN
25944	673	21	.	.	.
25944	674	1	After	after	IN
25944	674	2	several	several	JJ
25944	674	3	days	day	NNS
25944	674	4	or	or	CC
25944	674	5	a	a	DT
25944	674	6	week	week	NN
25944	674	7	,	,	,
25944	674	8	during	during	IN
25944	674	9	which	which	WDT
25944	674	10	time	time	NN
25944	674	11	there	there	EX
25944	674	12	is	be	VBZ
25944	674	13	usually	usually	RB
25944	674	14	continued	continue	VBN
25944	674	15	mild	mild	JJ
25944	674	16	or	or	CC
25944	674	17	severe	severe	JJ
25944	674	18	febrile	febrile	NN
25944	674	19	action	action	NN
25944	674	20	,	,	,
25944	674	21	the	the	DT
25944	674	22	process	process	NN
25944	674	23	begins	begin	VBZ
25944	674	24	to	to	TO
25944	674	25	subside	subside	VB
25944	674	26	,	,	,
25944	674	27	and	and	CC
25944	674	28	is	be	VBZ
25944	674	29	followed	follow	VBN
25944	674	30	by	by	IN
25944	674	31	epidermic	epidermic	JJ
25944	674	32	desquamation	desquamation	NN
25944	674	33	.	.	.
25944	675	1	In	in	IN
25944	675	2	some	some	DT
25944	675	3	cases	case	NNS
25944	675	4	vesicles	vesicle	NNS
25944	675	5	and	and	CC
25944	675	6	blebs	blebs	NN
25944	675	7	may	may	MD
25944	675	8	be	be	VB
25944	675	9	present	present	JJ
25944	675	10	;	;	:
25944	675	11	in	in	IN
25944	675	12	other	other	JJ
25944	675	13	cases	case	NNS
25944	675	14	the	the	DT
25944	675	15	disease	disease	NN
25944	675	16	seriously	seriously	RB
25944	675	17	involves	involve	VBZ
25944	675	18	the	the	DT
25944	675	19	deeper	deep	JJR
25944	675	20	parts	part	NNS
25944	675	21	,	,	,
25944	675	22	and	and	CC
25944	675	23	is	be	VBZ
25944	675	24	accompanied	accompany	VBN
25944	675	25	by	by	IN
25944	675	26	grave	grave	JJ
25944	675	27	constitutional	constitutional	JJ
25944	675	28	symptoms	symptom	NNS
25944	675	29	.	.	.
25944	676	1	In	in	IN
25944	676	2	exceptional	exceptional	JJ
25944	676	3	instances	instance	NNS
25944	676	4	sloughing	slough	VBG
25944	676	5	takes	take	VBZ
25944	676	6	place	place	NN
25944	676	7	.	.	.
25944	677	1	A	a	DT
25944	677	2	mild	mild	JJ
25944	677	3	,	,	,
25944	677	4	transitory	transitory	JJ
25944	677	5	,	,	,
25944	677	6	limited	limited	JJ
25944	677	7	,	,	,
25944	677	8	and	and	CC
25944	677	9	often	often	RB
25944	677	10	recurrent	recurrent	VBP
25944	677	11	erysipelatous	erysipelatous	JJ
25944	677	12	condition	condition	NN
25944	677	13	of	of	IN
25944	677	14	the	the	DT
25944	677	15	outlet	outlet	NN
25944	677	16	and	and	CC
25944	677	17	immediate	immediate	JJ
25944	677	18	neighborhood	neighborhood	NN
25944	677	19	of	of	IN
25944	677	20	one	one	CD
25944	677	21	or	or	CC
25944	677	22	both	both	DT
25944	677	23	nostrils	nostril	NNS
25944	677	24	is	be	VBZ
25944	677	25	met	meet	VBN
25944	677	26	with	with	IN
25944	677	27	,	,	,
25944	677	28	taking	take	VBG
25944	677	29	its	-PRON-	PRP$
25944	677	30	origin	origin	NN
25944	677	31	from	from	IN
25944	677	32	an	an	DT
25944	677	33	inflammation	inflammation	NN
25944	677	34	of	of	IN
25944	677	35	the	the	DT
25944	677	36	hair	hair	NN
25944	677	37	-	-	HYPH
25944	677	38	follicles	follicle	NNS
25944	677	39	just	just	RB
25944	677	40	inside	inside	IN
25944	677	41	the	the	DT
25944	677	42	margin	margin	NN
25944	677	43	of	of	IN
25944	677	44	the	the	DT
25944	677	45	nose	nose	NN
25944	677	46	;	;	,
25944	677	47	constitutional	constitutional	JJ
25944	677	48	symptoms	symptom	NNS
25944	677	49	are	be	VBP
25944	677	50	usually	usually	RB
25944	677	51	wanting	want	VBG
25944	677	52	.	.	.
25944	678	1	Somewhat	somewhat	RB
25944	678	2	similar	similar	JJ
25944	678	3	,	,	,
25944	678	4	doubtless	doubtless	JJ
25944	678	5	,	,	,
25944	678	6	is	be	VBZ
25944	678	7	the	the	DT
25944	678	8	erysipelatous	erysipelatous	JJ
25944	678	9	inflammation	inflammation	NN
25944	678	10	(	(	-LRB-
25944	678	11	_	_	NNP
25944	678	12	erysipeloid	erysipeloid	NN
25944	678	13	_	_	NNP
25944	678	14	)	)	-RRB-
25944	678	15	observed	observe	VBN
25944	678	16	on	on	IN
25944	678	17	the	the	DT
25944	678	18	fingers	finger	NNS
25944	678	19	and	and	CC
25944	678	20	hands	hand	NNS
25944	678	21	of	of	IN
25944	678	22	butchers	butcher	NNS
25944	678	23	,	,	,
25944	678	24	etc	etc	FW
25944	678	25	.	.	FW
25944	678	26	,	,	,
25944	678	27	starting	start	VBG
25944	678	28	from	from	IN
25944	678	29	a	a	DT
25944	678	30	wound	wound	NN
25944	678	31	,	,	,
25944	678	32	apparently	apparently	RB
25944	678	33	as	as	IN
25944	678	34	a	a	DT
25944	678	35	result	result	NN
25944	678	36	of	of	IN
25944	678	37	infection	infection	NN
25944	678	38	from	from	IN
25944	678	39	putrid	putrid	JJ
25944	678	40	meat	meat	NN
25944	678	41	or	or	CC
25944	678	42	fish	fish	NN
25944	678	43	.	.	.
25944	679	1	#	#	LS
25944	679	2	What	what	WP
25944	679	3	is	be	VBZ
25944	679	4	erysipelas	erysipelas	NNP
25944	679	5	migrans	migrans	NNPS
25944	679	6	(	(	-LRB-
25944	679	7	or	or	CC
25944	679	8	erysipelas	erysipelas	NNP
25944	679	9	ambulans	ambulans	NNPS
25944	679	10	)	)	-RRB-
25944	679	11	?	?	.
25944	679	12	#	#	$
25944	679	13	A	a	DT
25944	679	14	variety	variety	NN
25944	679	15	of	of	IN
25944	679	16	erysipelas	erysipela	NNS
25944	679	17	which	which	WDT
25944	679	18	,	,	,
25944	679	19	after	after	IN
25944	679	20	a	a	DT
25944	679	21	few	few	JJ
25944	679	22	hours	hour	NNS
25944	679	23	or	or	CC
25944	679	24	days	day	NNS
25944	679	25	,	,	,
25944	679	26	disappears	disappear	VBZ
25944	679	27	at	at	IN
25944	679	28	one	one	CD
25944	679	29	region	region	NN
25944	679	30	and	and	CC
25944	679	31	appears	appear	VBZ
25944	679	32	at	at	IN
25944	679	33	another	another	DT
25944	679	34	,	,	,
25944	679	35	and	and	CC
25944	679	36	so	so	RB
25944	679	37	continues	continue	VBZ
25944	679	38	for	for	IN
25944	679	39	one	one	CD
25944	679	40	or	or	CC
25944	679	41	several	several	JJ
25944	679	42	weeks	week	NNS
25944	679	43	.	.	.
25944	680	1	#	#	LS
25944	680	2	What	what	WP
25944	680	3	is	be	VBZ
25944	680	4	the	the	DT
25944	680	5	cause	cause	NN
25944	680	6	of	of	IN
25944	680	7	erysipelas	erysipela	NNS
25944	680	8	?	?	.
25944	680	9	#	#	$
25944	680	10	The	the	DT
25944	680	11	disease	disease	NN
25944	680	12	is	be	VBZ
25944	680	13	due	due	JJ
25944	680	14	to	to	IN
25944	680	15	a	a	DT
25944	680	16	specific	specific	JJ
25944	680	17	streptococcus	streptococcus	NN
25944	680	18	--	--	:
25944	680	19	the	the	DT
25944	680	20	streptococcus	streptococcus	NN
25944	680	21	of	of	IN
25944	680	22	Fehleisen	Fehleisen	NNP
25944	680	23	.	.	.
25944	681	1	Depression	depression	NN
25944	681	2	of	of	IN
25944	681	3	the	the	DT
25944	681	4	vital	vital	JJ
25944	681	5	forces	force	NNS
25944	681	6	and	and	CC
25944	681	7	local	local	JJ
25944	681	8	abrasions	abrasion	NNS
25944	681	9	are	be	VBP
25944	681	10	predisposing	predispose	VBG
25944	681	11	factors	factor	NNS
25944	681	12	.	.	.
25944	682	1	#	#	JJR
25944	682	2	State	state	NN
25944	682	3	the	the	DT
25944	682	4	diagnostic	diagnostic	JJ
25944	682	5	points	point	NNS
25944	682	6	.	.	.
25944	682	7	#	#	$
25944	682	8	The	the	DT
25944	682	9	character	character	NN
25944	682	10	of	of	IN
25944	682	11	the	the	DT
25944	682	12	onset	onset	NN
25944	682	13	,	,	,
25944	682	14	the	the	DT
25944	682	15	shining	shine	VBG
25944	682	16	redness	redness	NN
25944	682	17	and	and	CC
25944	682	18	swelling	swelling	NN
25944	682	19	,	,	,
25944	682	20	the	the	DT
25944	682	21	sharply	sharply	RB
25944	682	22	-	-	HYPH
25944	682	23	defined	define	VBN
25944	682	24	border	border	NN
25944	682	25	,	,	,
25944	682	26	and	and	CC
25944	682	27	the	the	DT
25944	682	28	accompanying	accompany	VBG
25944	682	29	febrile	febrile	NN
25944	682	30	disturbance	disturbance	NN
25944	682	31	.	.	.
25944	683	1	#	#	LS
25944	683	2	What	what	WP
25944	683	3	is	be	VBZ
25944	683	4	the	the	DT
25944	683	5	prognosis	prognosis	NN
25944	683	6	in	in	IN
25944	683	7	erysipelas	erysipela	NNS
25944	683	8	?	?	.
25944	683	9	#	#	$
25944	683	10	In	in	IN
25944	683	11	most	most	JJS
25944	683	12	instances	instance	NNS
25944	683	13	the	the	DT
25944	683	14	disease	disease	NN
25944	683	15	runs	run	VBZ
25944	683	16	a	a	DT
25944	683	17	favorable	favorable	JJ
25944	683	18	course	course	NN
25944	683	19	,	,	,
25944	683	20	terminating	terminate	VBG
25944	683	21	in	in	IN
25944	683	22	recovery	recovery	NN
25944	683	23	in	in	IN
25944	683	24	one	one	CD
25944	683	25	to	to	TO
25944	683	26	three	three	CD
25944	683	27	weeks	week	NNS
25944	683	28	.	.	.
25944	684	1	Exceptionally	exceptionally	RB
25944	684	2	,	,	,
25944	684	3	in	in	IN
25944	684	4	severe	severe	JJ
25944	684	5	cases	case	NNS
25944	684	6	,	,	,
25944	684	7	a	a	DT
25944	684	8	fatal	fatal	JJ
25944	684	9	termination	termination	NN
25944	684	10	ensues	ensue	NNS
25944	684	11	.	.	.
25944	685	1	#	#	LS
25944	685	2	What	what	WP
25944	685	3	is	be	VBZ
25944	685	4	the	the	DT
25944	685	5	treatment	treatment	NN
25944	685	6	of	of	IN
25944	685	7	erysipelas	erysipela	NNS
25944	685	8	?	?	.
25944	685	9	#	#	$
25944	685	10	_	_	NNP
25944	685	11	Internally	internally	RB
25944	685	12	_	_	NNP
25944	685	13	,	,	,
25944	685	14	a	a	DT
25944	685	15	purge	purge	NN
25944	685	16	,	,	,
25944	685	17	followed	follow	VBN
25944	685	18	by	by	IN
25944	685	19	the	the	DT
25944	685	20	tincture	tincture	NN
25944	685	21	of	of	IN
25944	685	22	the	the	DT
25944	685	23	chloride	chloride	NN
25944	685	24	of	of	IN
25944	685	25	iron	iron	NN
25944	685	26	and	and	CC
25944	685	27	quinia	quinia	NNP
25944	685	28	,	,	,
25944	685	29	and	and	CC
25944	685	30	stimulants	stimulant	NNS
25944	685	31	if	if	IN
25944	685	32	needed	need	VBN
25944	685	33	.	.	.
25944	686	1	_	_	NNP
25944	686	2	Locally	Locally	NNP
25944	686	3	_	_	NNP
25944	686	4	,	,	,
25944	686	5	one	one	CD
25944	686	6	to	to	TO
25944	686	7	three	three	CD
25944	686	8	per	per	IN
25944	686	9	cent	cent	NN
25944	686	10	.	.	.
25944	687	1	carbolic	carbolic	JJ
25944	687	2	-	-	HYPH
25944	687	3	acid	acid	NN
25944	687	4	lotion	lotion	NN
25944	687	5	or	or	CC
25944	687	6	ointment	ointment	NN
25944	687	7	,	,	,
25944	687	8	a	a	DT
25944	687	9	saturated	saturate	VBN
25944	687	10	solution	solution	NN
25944	687	11	of	of	IN
25944	687	12	boric	boric	NN
25944	687	13	acid	acid	NN
25944	687	14	,	,	,
25944	687	15	or	or	CC
25944	687	16	a	a	DT
25944	687	17	ten-	ten-	NN
25944	687	18	to	to	TO
25944	687	19	twenty	twenty	CD
25944	687	20	-	-	HYPH
25944	687	21	per	per	IN
25944	687	22	-	-	HYPH
25944	687	23	cent	cent	NN
25944	687	24	.	.	.
25944	688	1	aqueous	aqueous	JJ
25944	688	2	solution	solution	NN
25944	688	3	or	or	CC
25944	688	4	ointment	ointment	NN
25944	688	5	of	of	IN
25944	688	6	ichthyol	ichthyol	NN
25944	688	7	may	may	MD
25944	688	8	be	be	VB
25944	688	9	employed	employ	VBN
25944	688	10	.	.	.
25944	689	1	In	in	IN
25944	689	2	some	some	DT
25944	689	3	cases	case	NNS
25944	689	4	the	the	DT
25944	689	5	spread	spread	NN
25944	689	6	of	of	IN
25944	689	7	the	the	DT
25944	689	8	disease	disease	NN
25944	689	9	is	be	VBZ
25944	689	10	apparently	apparently	RB
25944	689	11	controlled	control	VBN
25944	689	12	by	by	IN
25944	689	13	painting	paint	VBG
25944	689	14	the	the	DT
25944	689	15	bordering	bordering	NN
25944	689	16	healthy	healthy	JJ
25944	689	17	skin	skin	NN
25944	689	18	with	with	IN
25944	689	19	a	a	DT
25944	689	20	ring	ring	NN
25944	689	21	of	of	IN
25944	689	22	tincture	tincture	NN
25944	689	23	of	of	IN
25944	689	24	iodine	iodine	NN
25944	689	25	or	or	CC
25944	689	26	strong	strong	JJ
25944	689	27	solution	solution	NN
25944	689	28	of	of	IN
25944	689	29	nitrate	nitrate	NN
25944	689	30	of	of	IN
25944	689	31	silver	silver	NN
25944	689	32	.	.	.
25944	690	1	#	#	NNP
25944	690	2	Phlegmona	Phlegmona	NNP
25944	690	3	Diffusa	Diffusa	NNP
25944	690	4	.	.	.
25944	690	5	#	#	$
25944	690	6	#	#	$
25944	690	7	What	what	WP
25944	690	8	do	do	VBP
25944	690	9	you	-PRON-	PRP
25944	690	10	understand	understand	VB
25944	690	11	by	by	IN
25944	690	12	phlegmona	phlegmona	NN
25944	690	13	diffusa	diffusa	RB
25944	690	14	?	?	.
25944	690	15	#	#	$
25944	690	16	Phlegmona	Phlegmona	NNP
25944	690	17	diffusa	diffusa	VBP
25944	690	18	is	be	VBZ
25944	690	19	a	a	DT
25944	690	20	more	more	RBR
25944	690	21	or	or	CC
25944	690	22	less	less	RBR
25944	690	23	extensive	extensive	JJ
25944	690	24	inflammation	inflammation	NN
25944	690	25	of	of	IN
25944	690	26	the	the	DT
25944	690	27	cutaneous	cutaneous	JJ
25944	690	28	and	and	CC
25944	690	29	subcutaneous	subcutaneous	JJ
25944	690	30	tissues	tissue	NNS
25944	690	31	presenting	present	VBG
25944	690	32	symptoms	symptom	NNS
25944	690	33	partaking	partake	VBG
25944	690	34	of	of	IN
25944	690	35	the	the	DT
25944	690	36	nature	nature	NN
25944	690	37	of	of	IN
25944	690	38	both	both	CC
25944	690	39	deep	deep	JJ
25944	690	40	erysipelas	erysipela	NNS
25944	690	41	and	and	CC
25944	690	42	flat	flat	JJ
25944	690	43	carbuncles	carbuncle	NNS
25944	690	44	,	,	,
25944	690	45	and	and	CC
25944	690	46	usually	usually	RB
25944	690	47	attended	attend	VBN
25944	690	48	with	with	IN
25944	690	49	varying	vary	VBG
25944	690	50	constitutional	constitutional	JJ
25944	690	51	disturbance	disturbance	NN
25944	690	52	.	.	.
25944	691	1	Suppuration	suppuration	NN
25944	691	2	at	at	IN
25944	691	3	several	several	JJ
25944	691	4	points	point	NNS
25944	691	5	takes	take	VBZ
25944	691	6	place	place	NN
25944	691	7	,	,	,
25944	691	8	and	and	CC
25944	691	9	sloughing	sloughing	NN
25944	691	10	may	may	MD
25944	691	11	ensue	ensue	VB
25944	691	12	.	.	.
25944	692	1	Recovery	recovery	NN
25944	692	2	usually	usually	RB
25944	692	3	finally	finally	RB
25944	692	4	results	result	VBZ
25944	692	5	,	,	,
25944	692	6	but	but	CC
25944	692	7	a	a	DT
25944	692	8	fatal	fatal	JJ
25944	692	9	issue	issue	NN
25944	692	10	is	be	VBZ
25944	692	11	possible	possible	JJ
25944	692	12	.	.	.
25944	693	1	Treatment	treatment	NN
25944	693	2	is	be	VBZ
25944	693	3	based	base	VBN
25944	693	4	upon	upon	IN
25944	693	5	general	general	JJ
25944	693	6	principles	principle	NNS
25944	693	7	.	.	.
25944	694	1	#	#	NNP
25944	694	2	Furunculus	Furunculus	NNP
25944	694	3	.	.	.
25944	694	4	#	#	NNP
25944	694	5	(	(	-LRB-
25944	694	6	_	_	NNP
25944	694	7	Synonyms	Synonyms	NNP
25944	694	8	:	:	:
25944	694	9	_	_	NNP
25944	694	10	Furuncle	Furuncle	NNP
25944	694	11	;	;	:
25944	694	12	Boil	Boil	NNP
25944	694	13	.	.	.
25944	694	14	)	)	-RRB-
25944	695	1	#	#	$
25944	695	2	Define	Define	NNP
25944	695	3	furunculus	furunculus	NN
25944	695	4	.	.	.
25944	695	5	#	#	$
25944	695	6	Furunculus	Furunculus	NNP
25944	695	7	,	,	,
25944	695	8	or	or	CC
25944	695	9	boil	boil	NN
25944	695	10	,	,	,
25944	695	11	is	be	VBZ
25944	695	12	an	an	DT
25944	695	13	acute	acute	JJ
25944	695	14	,	,	,
25944	695	15	deep	deep	JJ
25944	695	16	-	-	HYPH
25944	695	17	seated	seated	JJ
25944	695	18	,	,	,
25944	695	19	inflammatory	inflammatory	JJ
25944	695	20	,	,	,
25944	695	21	circumscribed	circumscribe	VBN
25944	695	22	,	,	,
25944	695	23	rounded	round	VBD
25944	695	24	or	or	CC
25944	695	25	more	more	RBR
25944	695	26	or	or	CC
25944	695	27	less	less	RBR
25944	695	28	acuminated	acuminated	JJ
25944	695	29	,	,	,
25944	695	30	firm	firm	JJ
25944	695	31	,	,	,
25944	695	32	painful	painful	JJ
25944	695	33	formation	formation	NN
25944	695	34	,	,	,
25944	695	35	usually	usually	RB
25944	695	36	terminating	terminate	VBG
25944	695	37	in	in	IN
25944	695	38	central	central	JJ
25944	695	39	suppuration	suppuration	NN
25944	695	40	.	.	.
25944	696	1	#	#	NNP
25944	696	2	Describe	describe	VB
25944	696	3	the	the	DT
25944	696	4	symptoms	symptom	NNS
25944	696	5	and	and	CC
25944	696	6	course	course	NN
25944	696	7	.	.	.
25944	696	8	#	#	$
25944	696	9	A	a	DT
25944	696	10	boil	boil	NN
25944	696	11	begins	begin	VBZ
25944	696	12	as	as	IN
25944	696	13	a	a	DT
25944	696	14	small	small	JJ
25944	696	15	,	,	,
25944	696	16	rounded	rounded	JJ
25944	696	17	or	or	CC
25944	696	18	imperfectly	imperfectly	RB
25944	696	19	defined	define	VBN
25944	696	20	reddish	reddish	JJ
25944	696	21	spot	spot	NN
25944	696	22	,	,	,
25944	696	23	or	or	CC
25944	696	24	as	as	IN
25944	696	25	a	a	DT
25944	696	26	small	small	JJ
25944	696	27	,	,	,
25944	696	28	superficial	superficial	JJ
25944	696	29	pustule	pustule	NN
25944	696	30	;	;	:
25944	696	31	it	-PRON-	PRP
25944	696	32	increases	increase	VBZ
25944	696	33	in	in	IN
25944	696	34	size	size	NN
25944	696	35	,	,	,
25944	696	36	and	and	CC
25944	696	37	when	when	WRB
25944	696	38	well	well	RB
25944	696	39	advanced	advanced	JJ
25944	696	40	appears	appear	VBZ
25944	696	41	as	as	IN
25944	696	42	a	a	DT
25944	696	43	pea	pea	NN
25944	696	44	or	or	CC
25944	696	45	cherry	cherry	NN
25944	696	46	-	-	HYPH
25944	696	47	sized	sized	JJ
25944	696	48	,	,	,
25944	696	49	circumscribed	circumscribe	VBN
25944	696	50	,	,	,
25944	696	51	reddish	reddish	JJ
25944	696	52	elevation	elevation	NN
25944	696	53	,	,	,
25944	696	54	with	with	IN
25944	696	55	more	more	RBR
25944	696	56	or	or	CC
25944	696	57	less	less	RBR
25944	696	58	surrounding	surround	VBG
25944	696	59	hyperæmia	hyperæmia	NN
25944	696	60	and	and	CC
25944	696	61	swelling	swelling	NN
25944	696	62	;	;	:
25944	696	63	it	-PRON-	PRP
25944	696	64	is	be	VBZ
25944	696	65	painful	painful	JJ
25944	696	66	and	and	CC
25944	696	67	tender	tender	JJ
25944	696	68	,	,	,
25944	696	69	and	and	CC
25944	696	70	ends	end	VBZ
25944	696	71	,	,	,
25944	696	72	in	in	IN
25944	696	73	the	the	DT
25944	696	74	course	course	NN
25944	696	75	of	of	IN
25944	696	76	several	several	JJ
25944	696	77	days	day	NNS
25944	696	78	or	or	CC
25944	696	79	a	a	DT
25944	696	80	week	week	NN
25944	696	81	,	,	,
25944	696	82	in	in	IN
25944	696	83	the	the	DT
25944	696	84	formation	formation	NN
25944	696	85	of	of	IN
25944	696	86	a	a	DT
25944	696	87	central	central	JJ
25944	696	88	slough	slough	NN
25944	696	89	or	or	CC
25944	696	90	"	"	``
25944	696	91	_	_	NNP
25944	696	92	core	core	NN
25944	696	93	_	_	NNP
25944	696	94	,	,	,
25944	696	95	"	"	''
25944	696	96	which	which	WDT
25944	696	97	finally	finally	RB
25944	696	98	involves	involve	VBZ
25944	696	99	the	the	DT
25944	696	100	central	central	JJ
25944	696	101	overlying	overlying	NN
25944	696	102	skin	skin	NN
25944	696	103	(	(	-LRB-
25944	696	104	_	_	NNP
25944	696	105	pointing	point	VBG
25944	696	106	_	_	NNP
25944	696	107	)	)	-RRB-
25944	696	108	.	.	.
25944	697	1	One	one	CD
25944	697	2	or	or	CC
25944	697	3	several	several	JJ
25944	697	4	may	may	MD
25944	697	5	be	be	VB
25944	697	6	present	present	JJ
25944	697	7	,	,	,
25944	697	8	gradually	gradually	RB
25944	697	9	maturing	mature	VBG
25944	697	10	and	and	CC
25944	697	11	disappearing	disappear	VBG
25944	697	12	.	.	.
25944	698	1	Insignificant	insignificant	JJ
25944	698	2	scarring	scarring	NN
25944	698	3	may	may	MD
25944	698	4	remain	remain	VB
25944	698	5	.	.	.
25944	699	1	In	in	IN
25944	699	2	some	some	DT
25944	699	3	cases	case	NNS
25944	699	4	sympathetic	sympathetic	JJ
25944	699	5	constitutional	constitutional	JJ
25944	699	6	disturbance	disturbance	NN
25944	699	7	is	be	VBZ
25944	699	8	noticed	notice	VBN
25944	699	9	.	.	.
25944	700	1	#	#	LS
25944	700	2	What	what	WP
25944	700	3	is	be	VBZ
25944	700	4	a	a	DT
25944	700	5	blind	blind	JJ
25944	700	6	boil	boil	NN
25944	700	7	?	?	.
25944	700	8	#	#	$
25944	700	9	A	a	DT
25944	700	10	sluggish	sluggish	JJ
25944	700	11	boil	boil	NN
25944	700	12	exhibiting	exhibit	VBG
25944	700	13	little	little	JJ
25944	700	14	,	,	,
25944	700	15	if	if	IN
25944	700	16	any	any	DT
25944	700	17	,	,	,
25944	700	18	tendency	tendency	NN
25944	700	19	to	to	TO
25944	700	20	point	point	VB
25944	700	21	or	or	CC
25944	700	22	break	break	VB
25944	700	23	.	.	.
25944	701	1	#	#	LS
25944	701	2	What	what	WP
25944	701	3	is	be	VBZ
25944	701	4	furunculosis	furunculosis	NN
25944	701	5	?	?	.
25944	701	6	#	#	NNP
25944	701	7	Furunculosis	Furunculosis	NNP
25944	701	8	is	be	VBZ
25944	701	9	that	that	DT
25944	701	10	condition	condition	NN
25944	701	11	in	in	IN
25944	701	12	which	which	WDT
25944	701	13	boils	boil	VBZ
25944	701	14	,	,	,
25944	701	15	singly	singly	RB
25944	701	16	or	or	CC
25944	701	17	in	in	IN
25944	701	18	crops	crop	NNS
25944	701	19	,	,	,
25944	701	20	continue	continue	VBP
25944	701	21	to	to	TO
25944	701	22	appear	appear	VB
25944	701	23	,	,	,
25944	701	24	irregularly	irregularly	RB
25944	701	25	,	,	,
25944	701	26	for	for	IN
25944	701	27	weeks	week	NNS
25944	701	28	or	or	CC
25944	701	29	months	month	NNS
25944	701	30	.	.	.
25944	702	1	#	#	NNP
25944	702	2	State	state	NN
25944	702	3	the	the	DT
25944	702	4	etiology	etiology	NN
25944	702	5	of	of	IN
25944	702	6	furuncle	furuncle	NN
25944	702	7	.	.	.
25944	702	8	#	#	$
25944	702	9	A	a	DT
25944	702	10	depraved	depraved	JJ
25944	702	11	state	state	NN
25944	702	12	of	of	IN
25944	702	13	the	the	DT
25944	702	14	general	general	JJ
25944	702	15	health	health	NN
25944	702	16	is	be	VBZ
25944	702	17	often	often	RB
25944	702	18	to	to	TO
25944	702	19	be	be	VB
25944	702	20	considered	consider	VBN
25944	702	21	as	as	IN
25944	702	22	a	a	DT
25944	702	23	predisposing	predisposing	NN
25944	702	24	factor	factor	NN
25944	702	25	.	.	.
25944	703	1	Persistent	persistent	JJ
25944	703	2	furunculosis	furunculosis	NN
25944	703	3	is	be	VBZ
25944	703	4	not	not	RB
25944	703	5	infrequent	infrequent	JJ
25944	703	6	in	in	IN
25944	703	7	diabetes	diabetes	NN
25944	703	8	mellitus	mellitus	NN
25944	703	9	.	.	.
25944	704	1	The	the	DT
25944	704	2	immediate	immediate	JJ
25944	704	3	exciting	exciting	JJ
25944	704	4	cause	cause	NN
25944	704	5	is	be	VBZ
25944	704	6	the	the	DT
25944	704	7	entrance	entrance	NN
25944	704	8	into	into	IN
25944	704	9	the	the	DT
25944	704	10	follicle	follicle	NN
25944	704	11	of	of	IN
25944	704	12	a	a	DT
25944	704	13	microbe	microbe	NN
25944	704	14	,	,	,
25944	704	15	the	the	DT
25944	704	16	staphylococcus	staphylococcus	NN
25944	704	17	pyogenes	pyogene	VBZ
25944	704	18	aureus	aureus	NNP
25944	704	19	.	.	.
25944	705	1	It	-PRON-	PRP
25944	705	2	is	be	VBZ
25944	705	3	not	not	RB
25944	705	4	improbable	improbable	JJ
25944	705	5	,	,	,
25944	705	6	however	however	RB
25944	705	7	,	,	,
25944	705	8	that	that	IN
25944	705	9	boils	boils	NNP
25944	705	10	may	may	MD
25944	705	11	also	also	RB
25944	705	12	be	be	VB
25944	705	13	due	due	JJ
25944	705	14	to	to	IN
25944	705	15	other	other	JJ
25944	705	16	pus	pus	NN
25944	705	17	-	-	HYPH
25944	705	18	producing	produce	VBG
25944	705	19	organisms	organism	NNS
25944	705	20	.	.	.
25944	706	1	Workmen	workman	NNS
25944	706	2	in	in	IN
25944	706	3	paraffin	paraffin	NN
25944	706	4	oils	oil	NNS
25944	706	5	or	or	CC
25944	706	6	other	other	JJ
25944	706	7	petroleum	petroleum	NN
25944	706	8	products	product	NNS
25944	706	9	often	often	RB
25944	706	10	present	present	VBP
25944	706	11	numerous	numerous	JJ
25944	706	12	furuncles	furuncle	NNS
25944	706	13	and	and	CC
25944	706	14	cutaneous	cutaneous	JJ
25944	706	15	abscesses	abscess	NNS
25944	706	16	.	.	.
25944	707	1	Conditions	condition	NNS
25944	707	2	favoring	favor	VBG
25944	707	3	a	a	DT
25944	707	4	persistent	persistent	JJ
25944	707	5	miliaria	miliaria	NN
25944	707	6	have	have	VBP
25944	707	7	also	also	RB
25944	707	8	a	a	DT
25944	707	9	causative	causative	JJ
25944	707	10	influence	influence	NN
25944	707	11	,	,	,
25944	707	12	especially	especially	RB
25944	707	13	observed	observe	VBN
25944	707	14	in	in	IN
25944	707	15	infants	infant	NNS
25944	707	16	and	and	CC
25944	707	17	young	young	JJ
25944	707	18	children	child	NNS
25944	707	19	.	.	.
25944	708	1	In	in	IN
25944	708	2	these	these	DT
25944	708	3	latter	latter	JJ
25944	708	4	,	,	,
25944	708	5	especially	especially	RB
25944	708	6	among	among	IN
25944	708	7	the	the	DT
25944	708	8	poorer	poor	JJR
25944	708	9	classes	class	NNS
25944	708	10	,	,	,
25944	708	11	sluggish	sluggish	JJ
25944	708	12	boils	boil	NNS
25944	708	13	or	or	CC
25944	708	14	subcutaneous	subcutaneous	JJ
25944	708	15	abscesses	abscess	NNS
25944	708	16	about	about	IN
25944	708	17	the	the	DT
25944	708	18	scalp	scalp	NN
25944	708	19	in	in	IN
25944	708	20	hot	hot	JJ
25944	708	21	weather	weather	NN
25944	708	22	,	,	,
25944	708	23	are	be	VBP
25944	708	24	not	not	RB
25944	708	25	at	at	RB
25944	708	26	all	all	RB
25944	708	27	infrequent	infrequent	NN
25944	708	28	.	.	.
25944	709	1	#	#	LS
25944	709	2	What	what	WP
25944	709	3	is	be	VBZ
25944	709	4	the	the	DT
25944	709	5	pathology	pathology	NN
25944	709	6	of	of	IN
25944	709	7	furuncle	furuncle	NN
25944	709	8	?	?	.
25944	709	9	#	#	$
25944	709	10	A	a	DT
25944	709	11	boil	boil	NN
25944	709	12	is	be	VBZ
25944	709	13	an	an	DT
25944	709	14	inflammatory	inflammatory	JJ
25944	709	15	formation	formation	NN
25944	709	16	having	have	VBG
25944	709	17	its	-PRON-	PRP$
25944	709	18	starting	starting	NN
25944	709	19	point	point	NN
25944	709	20	in	in	IN
25944	709	21	a	a	DT
25944	709	22	sebaceous	sebaceous	JJ
25944	709	23	-	-	HYPH
25944	709	24	gland	gland	NN
25944	709	25	,	,	,
25944	709	26	sweat	sweat	NN
25944	709	27	-	-	HYPH
25944	709	28	gland	gland	NN
25944	709	29	,	,	,
25944	709	30	or	or	CC
25944	709	31	hair	hair	NN
25944	709	32	-	-	HYPH
25944	709	33	follicle	follicle	NN
25944	709	34	.	.	.
25944	710	1	The	the	DT
25944	710	2	core	core	NN
25944	710	3	,	,	,
25944	710	4	or	or	CC
25944	710	5	central	central	JJ
25944	710	6	slough	slough	NN
25944	710	7	,	,	,
25944	710	8	is	be	VBZ
25944	710	9	composed	compose	VBN
25944	710	10	of	of	IN
25944	710	11	pus	pus	NN
25944	710	12	and	and	CC
25944	710	13	of	of	IN
25944	710	14	the	the	DT
25944	710	15	tissue	tissue	NN
25944	710	16	of	of	IN
25944	710	17	the	the	DT
25944	710	18	gland	gland	NN
25944	710	19	in	in	IN
25944	710	20	which	which	WDT
25944	710	21	it	-PRON-	PRP
25944	710	22	had	have	VBD
25944	710	23	its	-PRON-	PRP$
25944	710	24	origin	origin	NN
25944	710	25	.	.	.
25944	711	1	#	#	NNP
25944	711	2	How	how	WRB
25944	711	3	would	would	MD
25944	711	4	you	-PRON-	PRP
25944	711	5	distinguish	distinguish	VB
25944	711	6	a	a	DT
25944	711	7	boil	boil	NN
25944	711	8	from	from	IN
25944	711	9	a	a	DT
25944	711	10	carbuncle	carbuncle	NN
25944	711	11	?	?	.
25944	711	12	#	#	$
25944	711	13	A	a	DT
25944	711	14	boil	boil	NN
25944	711	15	is	be	VBZ
25944	711	16	comparatively	comparatively	RB
25944	711	17	small	small	JJ
25944	711	18	,	,	,
25944	711	19	rounded	rounded	JJ
25944	711	20	or	or	CC
25944	711	21	acuminate	acuminate	NN
25944	711	22	,	,	,
25944	711	23	and	and	CC
25944	711	24	has	have	VBZ
25944	711	25	but	but	CC
25944	711	26	one	one	CD
25944	711	27	point	point	NN
25944	711	28	of	of	IN
25944	711	29	suppuration	suppuration	NN
25944	711	30	;	;	:
25944	711	31	a	a	DT
25944	711	32	carbuncle	carbuncle	NN
25944	711	33	is	be	VBZ
25944	711	34	large	large	JJ
25944	711	35	,	,	,
25944	711	36	flattened	flatten	VBN
25944	711	37	,	,	,
25944	711	38	intensely	intensely	RB
25944	711	39	painful	painful	JJ
25944	711	40	,	,	,
25944	711	41	often	often	RB
25944	711	42	with	with	IN
25944	711	43	grave	grave	JJ
25944	711	44	systemic	systemic	JJ
25944	711	45	disturbance	disturbance	NN
25944	711	46	,	,	,
25944	711	47	and	and	CC
25944	711	48	has	have	VBZ
25944	711	49	,	,	,
25944	711	50	moreover	moreover	RB
25944	711	51	,	,	,
25944	711	52	several	several	JJ
25944	711	53	centres	centre	NNS
25944	711	54	of	of	IN
25944	711	55	suppuration	suppuration	NN
25944	711	56	.	.	.
25944	712	1	#	#	JJR
25944	712	2	State	state	NN
25944	712	3	the	the	DT
25944	712	4	prognosis	prognosis	NN
25944	712	5	.	.	.
25944	712	6	#	#	NN
25944	712	7	When	when	WRB
25944	712	8	occurring	occur	VBG
25944	712	9	in	in	IN
25944	712	10	crops	crop	NNS
25944	712	11	(	(	-LRB-
25944	712	12	furunculosis	furunculosis	NN
25944	712	13	)	)	-RRB-
25944	712	14	the	the	DT
25944	712	15	affection	affection	NN
25944	712	16	is	be	VBZ
25944	712	17	often	often	RB
25944	712	18	rebellious	rebellious	JJ
25944	712	19	;	;	:
25944	712	20	recovery	recovery	NN
25944	712	21	,	,	,
25944	712	22	however	however	RB
25944	712	23	,	,	,
25944	712	24	finally	finally	RB
25944	712	25	resulting	result	VBG
25944	712	26	.	.	.
25944	713	1	#	#	LS
25944	713	2	What	what	WP
25944	713	3	is	be	VBZ
25944	713	4	the	the	DT
25944	713	5	method	method	NN
25944	713	6	of	of	IN
25944	713	7	treatment	treatment	NN
25944	713	8	of	of	IN
25944	713	9	furunculus	furunculus	NN
25944	713	10	?	?	.
25944	713	11	#	#	$
25944	713	12	If	if	IN
25944	713	13	there	there	EX
25944	713	14	be	be	VBP
25944	713	15	but	but	CC
25944	713	16	one	one	CD
25944	713	17	lesion	lesion	NN
25944	713	18	,	,	,
25944	713	19	with	with	IN
25944	713	20	no	no	DT
25944	713	21	tendency	tendency	NN
25944	713	22	to	to	IN
25944	713	23	the	the	DT
25944	713	24	appearance	appearance	NN
25944	713	25	of	of	IN
25944	713	26	others	other	NNS
25944	713	27	,	,	,
25944	713	28	local	local	JJ
25944	713	29	treatment	treatment	NN
25944	713	30	alone	alone	RB
25944	713	31	is	be	VBZ
25944	713	32	usually	usually	RB
25944	713	33	employed	employ	VBN
25944	713	34	.	.	.
25944	714	1	If	if	IN
25944	714	2	,	,	,
25944	714	3	however	however	RB
25944	714	4	,	,	,
25944	714	5	several	several	JJ
25944	714	6	or	or	CC
25944	714	7	more	more	JJR
25944	714	8	are	be	VBP
25944	714	9	present	present	JJ
25944	714	10	,	,	,
25944	714	11	or	or	CC
25944	714	12	if	if	IN
25944	714	13	there	there	EX
25944	714	14	is	be	VBZ
25944	714	15	a	a	DT
25944	714	16	tendency	tendency	NN
25944	714	17	to	to	IN
25944	714	18	successive	successive	JJ
25944	714	19	development	development	NN
25944	714	20	,	,	,
25944	714	21	both	both	CC
25944	714	22	constitutional	constitutional	JJ
25944	714	23	and	and	CC
25944	714	24	local	local	JJ
25944	714	25	measures	measure	NNS
25944	714	26	are	be	VBP
25944	714	27	demanded	demand	VBN
25944	714	28	.	.	.
25944	715	1	#	#	$
25944	715	2	Name	name	VB
25944	715	3	the	the	DT
25944	715	4	internal	internal	JJ
25944	715	5	remedies	remedy	NNS
25944	715	6	employed	employ	VBN
25944	715	7	.	.	.
25944	715	8	#	#	$
25944	715	9	Such	such	JJ
25944	715	10	nutrients	nutrient	NNS
25944	715	11	and	and	CC
25944	715	12	tonics	tonic	NNS
25944	715	13	as	as	IN
25944	715	14	cod	cod	NN
25944	715	15	-	-	HYPH
25944	715	16	liver	liver	NN
25944	715	17	oil	oil	NN
25944	715	18	,	,	,
25944	715	19	malt	malt	NN
25944	715	20	,	,	,
25944	715	21	quinine	quinine	NNP
25944	715	22	,	,	,
25944	715	23	strychnia	strychnia	NNP
25944	715	24	,	,	,
25944	715	25	iron	iron	NN
25944	715	26	and	and	CC
25944	715	27	arsenic	arsenic	JJ
25944	715	28	;	;	:
25944	715	29	in	in	IN
25944	715	30	some	some	DT
25944	715	31	instances	instance	NNS
25944	715	32	calx	calx	VBP
25944	715	33	sulphurata	sulphurata	NN
25944	715	34	,	,	,
25944	715	35	one	one	CD
25944	715	36	-	-	HYPH
25944	715	37	tenth-	tenth-	NN
25944	715	38	to	to	IN
25944	715	39	one	one	CD
25944	715	40	-	-	HYPH
25944	715	41	fourth	fourth	JJ
25944	715	42	-	-	HYPH
25944	715	43	grain	grain	NN
25944	715	44	doses	dose	NNS
25944	715	45	every	every	DT
25944	715	46	three	three	CD
25944	715	47	or	or	CC
25944	715	48	four	four	CD
25944	715	49	hours	hour	NNS
25944	715	50	has	have	VBZ
25944	715	51	been	be	VBN
25944	715	52	thought	think	VBN
25944	715	53	to	to	TO
25944	715	54	be	be	VB
25944	715	55	of	of	IN
25944	715	56	service	service	NN
25944	715	57	.	.	.
25944	716	1	Brewers	brewer	NNS
25944	716	2	'	'	POS
25944	716	3	yeast	yeast	NN
25944	716	4	has	have	VBZ
25944	716	5	been	be	VBN
25944	716	6	recently	recently	RB
25944	716	7	again	again	RB
25944	716	8	brought	bring	VBN
25944	716	9	forward	forward	RB
25944	716	10	as	as	IN
25944	716	11	a	a	DT
25944	716	12	remedy	remedy	NN
25944	716	13	of	of	IN
25944	716	14	value	value	NN
25944	716	15	.	.	.
25944	717	1	#	#	LS
25944	717	2	What	what	WP
25944	717	3	is	be	VBZ
25944	717	4	the	the	DT
25944	717	5	external	external	JJ
25944	717	6	treatment	treatment	NN
25944	717	7	?	?	.
25944	717	8	#	#	$
25944	717	9	Local	local	JJ
25944	717	10	treatment	treatment	NN
25944	717	11	consists	consist	VBZ
25944	717	12	in	in	IN
25944	717	13	the	the	DT
25944	717	14	beginning	beginning	NN
25944	717	15	,	,	,
25944	717	16	with	with	IN
25944	717	17	the	the	DT
25944	717	18	hope	hope	NN
25944	717	19	of	of	IN
25944	717	20	aborting	abort	VBG
25944	717	21	the	the	DT
25944	717	22	lesion	lesion	NN
25944	717	23	,	,	,
25944	717	24	of	of	IN
25944	717	25	the	the	DT
25944	717	26	application	application	NN
25944	717	27	of	of	IN
25944	717	28	carbolic	carbolic	JJ
25944	717	29	acid	acid	NN
25944	717	30	to	to	IN
25944	717	31	the	the	DT
25944	717	32	central	central	JJ
25944	717	33	portion	portion	NN
25944	717	34	,	,	,
25944	717	35	or	or	CC
25944	717	36	the	the	DT
25944	717	37	use	use	NN
25944	717	38	of	of	IN
25944	717	39	a	a	DT
25944	717	40	twenty	twenty	CD
25944	717	41	-	-	HYPH
25944	717	42	five	five	CD
25944	717	43	-	-	HYPH
25944	717	44	per	per	IN
25944	717	45	-	-	HYPH
25944	717	46	cent	cent	NN
25944	717	47	.	.	.
25944	718	1	ointment	ointment	NN
25944	718	2	of	of	IN
25944	718	3	ichthyol	ichthyol	NNP
25944	718	4	applied	apply	VBN
25944	718	5	as	as	IN
25944	718	6	a	a	DT
25944	718	7	plaster:--	plaster:--	NN
25944	718	8	[	[	-LRB-
25944	718	9	Rx	Rx	NNP
25944	718	10	]	]	-RRB-
25944	718	11	Ichthyol	Ichthyol	NNP
25944	718	12	,	,	,
25944	718	13	............................	............................	NFP
25944	718	14	[	[	-LRB-
25944	718	15	dram]j	dram]j	NNP
25944	718	16	Emp	Emp	NNP
25944	718	17	.	.	.
25944	719	1	plumbi	plumbi	NNP
25944	719	2	,	,	,
25944	719	3	...........................	...........................	NFP
25944	719	4	[	[	-LRB-
25944	719	5	dram]ij	dram]ij	NN
25944	719	6	Emp	Emp	NNP
25944	719	7	.	.	.
25944	720	1	resinæ	resinæ	NNP
25944	720	2	,	,	,
25944	720	3	...........................	...........................	NFP
25944	720	4	[	[	-LRB-
25944	720	5	dram]j	dram]j	NNP
25944	720	6	.	.	.
25944	720	7	M.	M.	NNP
25944	720	8	Or	or	CC
25944	720	9	the	the	DT
25944	720	10	injection	injection	NN
25944	720	11	of	of	IN
25944	720	12	a	a	DT
25944	720	13	five	five	CD
25944	720	14	-	-	HYPH
25944	720	15	per	per	IN
25944	720	16	-	-	HYPH
25944	720	17	cent	cent	NN
25944	720	18	.	.	.
25944	721	1	solution	solution	NN
25944	721	2	of	of	IN
25944	721	3	carbolic	carbolic	JJ
25944	721	4	acid	acid	NN
25944	721	5	into	into	IN
25944	721	6	the	the	DT
25944	721	7	apex	apex	NN
25944	721	8	of	of	IN
25944	721	9	the	the	DT
25944	721	10	boil	boil	NN
25944	721	11	may	may	MD
25944	721	12	be	be	VB
25944	721	13	tried	try	VBN
25944	721	14	if	if	IN
25944	721	15	the	the	DT
25944	721	16	formation	formation	NN
25944	721	17	is	be	VBZ
25944	721	18	more	more	RBR
25944	721	19	advanced	advanced	JJ
25944	721	20	.	.	.
25944	722	1	If	if	IN
25944	722	2	suppuration	suppuration	NN
25944	722	3	is	be	VBZ
25944	722	4	fully	fully	RB
25944	722	5	established	establish	VBN
25944	722	6	,	,	,
25944	722	7	evacuation	evacuation	NN
25944	722	8	of	of	IN
25944	722	9	the	the	DT
25944	722	10	contents	content	NNS
25944	722	11	,	,	,
25944	722	12	followed	follow	VBN
25944	722	13	by	by	IN
25944	722	14	antiseptic	antiseptic	JJ
25944	722	15	applications	application	NNS
25944	722	16	,	,	,
25944	722	17	constitutes	constitute	VBZ
25944	722	18	the	the	DT
25944	722	19	best	good	JJS
25944	722	20	method	method	NN
25944	722	21	.	.	.
25944	723	1	A	a	DT
25944	723	2	saturated	saturate	VBN
25944	723	3	solution	solution	NN
25944	723	4	of	of	IN
25944	723	5	boric	boric	NN
25944	723	6	acid	acid	NN
25944	723	7	or	or	CC
25944	723	8	a	a	DT
25944	723	9	lotion	lotion	NN
25944	723	10	of	of	IN
25944	723	11	corrosive	corrosive	JJ
25944	723	12	sublimate	sublimate	NN
25944	723	13	(	(	-LRB-
25944	723	14	one	one	CD
25944	723	15	to	to	TO
25944	723	16	three	three	CD
25944	723	17	grains	grain	NNS
25944	723	18	to	to	IN
25944	723	19	the	the	DT
25944	723	20	ounce	ounce	NN
25944	723	21	)	)	-RRB-
25944	723	22	applied	apply	VBD
25944	723	23	to	to	IN
25944	723	24	the	the	DT
25944	723	25	immediate	immediate	JJ
25944	723	26	neighborhood	neighborhood	NN
25944	723	27	of	of	IN
25944	723	28	the	the	DT
25944	723	29	boil	boil	NN
25944	723	30	or	or	CC
25944	723	31	boils	boil	VBZ
25944	723	32	tends	tend	VBZ
25944	723	33	to	to	TO
25944	723	34	prevent	prevent	VB
25944	723	35	the	the	DT
25944	723	36	formation	formation	NN
25944	723	37	of	of	IN
25944	723	38	new	new	JJ
25944	723	39	lesions	lesion	NNS
25944	723	40	.	.	.
25944	724	1	Frequent	frequent	JJ
25944	724	2	washing	washing	NN
25944	724	3	of	of	IN
25944	724	4	the	the	DT
25944	724	5	parts	part	NNS
25944	724	6	with	with	IN
25944	724	7	soap	soap	NN
25944	724	8	and	and	CC
25944	724	9	water	water	NN
25944	724	10	or	or	CC
25944	724	11	tincture	tincture	NN
25944	724	12	of	of	IN
25944	724	13	green	green	JJ
25944	724	14	soap	soap	NN
25944	724	15	and	and	CC
25944	724	16	water	water	NN
25944	724	17	is	be	VBZ
25944	724	18	also	also	RB
25944	724	19	a	a	DT
25944	724	20	preventive	preventive	JJ
25944	724	21	measure	measure	NN
25944	724	22	of	of	IN
25944	724	23	value	value	NN
25944	724	24	.	.	.
25944	725	1	In	in	IN
25944	725	2	repeatedly	repeatedly	RB
25944	725	3	infected	infect	VBN
25944	725	4	areas	area	NNS
25944	725	5	,	,	,
25944	725	6	mild	mild	JJ
25944	725	7	exposures	exposure	NNS
25944	725	8	to	to	IN
25944	725	9	_	_	NNP
25944	725	10	x_-rays	x_-rays	NNP
25944	725	11	,	,	,
25944	725	12	at	at	IN
25944	725	13	intervals	interval	NNS
25944	725	14	of	of	IN
25944	725	15	a	a	DT
25944	725	16	few	few	JJ
25944	725	17	days	day	NNS
25944	725	18	,	,	,
25944	725	19	will	will	MD
25944	725	20	often	often	RB
25944	725	21	prove	prove	VB
25944	725	22	of	of	IN
25944	725	23	curative	curative	JJ
25944	725	24	value	value	NN
25944	725	25	.	.	.
25944	726	1	#	#	NNP
25944	726	2	Carbunculus	Carbunculus	NNP
25944	726	3	.	.	.
25944	726	4	#	#	NNP
25944	726	5	(	(	-LRB-
25944	726	6	_	_	NNP
25944	726	7	Synonyms	Synonyms	NNP
25944	726	8	:	:	:
25944	726	9	_	_	NNP
25944	726	10	Anthrax	Anthrax	NNP
25944	726	11	;	;	:
25944	726	12	Carbuncle	Carbuncle	NNP
25944	726	13	.	.	.
25944	726	14	)	)	-RRB-
25944	727	1	#	#	LS
25944	727	2	What	what	WP
25944	727	3	is	be	VBZ
25944	727	4	carbuncle	carbuncle	NN
25944	727	5	?	?	.
25944	727	6	#	#	$
25944	727	7	A	a	DT
25944	727	8	carbuncle	carbuncle	NN
25944	727	9	is	be	VBZ
25944	727	10	an	an	DT
25944	727	11	acute	acute	NN
25944	727	12	,	,	,
25944	727	13	usually	usually	RB
25944	727	14	egg	egg	NN
25944	727	15	to	to	IN
25944	727	16	palm	palm	NN
25944	727	17	-	-	HYPH
25944	727	18	sized	sized	JJ
25944	727	19	,	,	,
25944	727	20	circumscribed	circumscribe	VBN
25944	727	21	,	,	,
25944	727	22	phlegmonous	phlegmonous	JJ
25944	727	23	inflammation	inflammation	NN
25944	727	24	of	of	IN
25944	727	25	the	the	DT
25944	727	26	skin	skin	NN
25944	727	27	and	and	CC
25944	727	28	subcutaneous	subcutaneous	JJ
25944	727	29	structures	structure	NNS
25944	727	30	,	,	,
25944	727	31	terminating	terminate	VBG
25944	727	32	in	in	IN
25944	727	33	a	a	DT
25944	727	34	slough	slough	NN
25944	727	35	.	.	.
25944	728	1	#	#	$
25944	728	2	At	at	IN
25944	728	3	what	what	WDT
25944	728	4	age	age	NN
25944	728	5	and	and	CC
25944	728	6	upon	upon	IN
25944	728	7	what	what	WP
25944	728	8	parts	part	NNS
25944	728	9	is	be	VBZ
25944	728	10	carbuncle	carbuncle	NN
25944	728	11	usually	usually	RB
25944	728	12	observed	observe	VBN
25944	728	13	?	?	.
25944	728	14	#	#	$
25944	728	15	In	in	IN
25944	728	16	middle	middle	JJ
25944	728	17	and	and	CC
25944	728	18	advanced	advanced	JJ
25944	728	19	life	life	NN
25944	728	20	,	,	,
25944	728	21	and	and	CC
25944	728	22	more	more	RBR
25944	728	23	commonly	commonly	RB
25944	728	24	in	in	IN
25944	728	25	men	man	NNS
25944	728	26	.	.	.
25944	729	1	It	-PRON-	PRP
25944	729	2	is	be	VBZ
25944	729	3	seen	see	VBN
25944	729	4	most	most	RBS
25944	729	5	frequently	frequently	RB
25944	729	6	at	at	IN
25944	729	7	the	the	DT
25944	729	8	nape	nape	NN
25944	729	9	of	of	IN
25944	729	10	the	the	DT
25944	729	11	neck	neck	NN
25944	729	12	and	and	CC
25944	729	13	upon	upon	IN
25944	729	14	the	the	DT
25944	729	15	upper	upper	JJ
25944	729	16	part	part	NN
25944	729	17	of	of	IN
25944	729	18	the	the	DT
25944	729	19	back	back	NN
25944	729	20	.	.	.
25944	730	1	#	#	LS
25944	730	2	What	what	WP
25944	730	3	are	be	VBP
25944	730	4	the	the	DT
25944	730	5	symptoms	symptom	NNS
25944	730	6	and	and	CC
25944	730	7	course	course	NN
25944	730	8	of	of	IN
25944	730	9	carbuncle	carbuncle	NN
25944	730	10	?	?	.
25944	730	11	#	#	$
25944	730	12	There	there	EX
25944	730	13	is	be	VBZ
25944	730	14	rarely	rarely	RB
25944	730	15	more	more	JJR
25944	730	16	than	than	IN
25944	730	17	one	one	CD
25944	730	18	lesion	lesion	NN
25944	730	19	present	present	JJ
25944	730	20	.	.	.
25944	731	1	It	-PRON-	PRP
25944	731	2	begins	begin	VBZ
25944	731	3	,	,	,
25944	731	4	usually	usually	RB
25944	731	5	with	with	IN
25944	731	6	preceding	precede	VBG
25944	731	7	and	and	CC
25944	731	8	accompanying	accompany	VBG
25944	731	9	malaise	malaise	NN
25944	731	10	,	,	,
25944	731	11	chilliness	chilliness	NN
25944	731	12	and	and	CC
25944	731	13	febrile	febrile	NN
25944	731	14	disturbance	disturbance	NN
25944	731	15	,	,	,
25944	731	16	as	as	IN
25944	731	17	a	a	DT
25944	731	18	firm	firm	JJ
25944	731	19	,	,	,
25944	731	20	flat	flat	JJ
25944	731	21	,	,	,
25944	731	22	inflammatory	inflammatory	JJ
25944	731	23	infiltration	infiltration	NN
25944	731	24	in	in	IN
25944	731	25	the	the	DT
25944	731	26	deeper	deep	JJR
25944	731	27	skin	skin	NN
25944	731	28	and	and	CC
25944	731	29	subcutaneous	subcutaneous	JJ
25944	731	30	tissue	tissue	NN
25944	731	31	,	,	,
25944	731	32	spreading	spread	VBG
25944	731	33	laterally	laterally	RB
25944	731	34	and	and	CC
25944	731	35	finally	finally	RB
25944	731	36	involving	involve	VBG
25944	731	37	an	an	DT
25944	731	38	area	area	NN
25944	731	39	of	of	IN
25944	731	40	one	one	CD
25944	731	41	to	to	IN
25944	731	42	several	several	JJ
25944	731	43	inches	inch	NNS
25944	731	44	in	in	IN
25944	731	45	diameter	diameter	NN
25944	731	46	.	.	.
25944	732	1	The	the	DT
25944	732	2	infiltration	infiltration	NN
25944	732	3	and	and	CC
25944	732	4	swelling	swell	VBG
25944	732	5	increase	increase	NN
25944	732	6	,	,	,
25944	732	7	the	the	DT
25944	732	8	skin	skin	NN
25944	732	9	becomes	become	VBZ
25944	732	10	of	of	IN
25944	732	11	dark	dark	JJ
25944	732	12	red	red	JJ
25944	732	13	color	color	NN
25944	732	14	,	,	,
25944	732	15	and	and	CC
25944	732	16	sooner	soon	RBR
25944	732	17	or	or	CC
25944	732	18	later	later	RBR
25944	732	19	,	,	,
25944	732	20	usually	usually	RB
25944	732	21	at	at	IN
25944	732	22	the	the	DT
25944	732	23	end	end	NN
25944	732	24	of	of	IN
25944	732	25	ten	ten	CD
25944	732	26	days	day	NNS
25944	732	27	or	or	CC
25944	732	28	two	two	CD
25944	732	29	weeks	week	NNS
25944	732	30	,	,	,
25944	732	31	softening	soften	VBG
25944	732	32	and	and	CC
25944	732	33	suppuration	suppuration	NN
25944	732	34	begin	begin	VBP
25944	732	35	to	to	TO
25944	732	36	take	take	VB
25944	732	37	place	place	NN
25944	732	38	,	,	,
25944	732	39	the	the	DT
25944	732	40	skin	skin	NN
25944	732	41	finally	finally	RB
25944	732	42	giving	give	VBG
25944	732	43	away	away	RP
25944	732	44	at	at	IN
25944	732	45	several	several	JJ
25944	732	46	points	point	NNS
25944	732	47	,	,	,
25944	732	48	through	through	IN
25944	732	49	which	which	WDT
25944	732	50	sanious	sanious	JJ
25944	732	51	pus	pus	NN
25944	732	52	exudes	exude	NNS
25944	732	53	;	;	:
25944	732	54	the	the	DT
25944	732	55	whole	whole	JJ
25944	732	56	mass	mass	NN
25944	732	57	finally	finally	RB
25944	732	58	sloughs	slough	VBZ
25944	732	59	away	away	RB
25944	732	60	either	either	CC
25944	732	61	in	in	IN
25944	732	62	portions	portion	NNS
25944	732	63	or	or	CC
25944	732	64	in	in	IN
25944	732	65	its	-PRON-	PRP$
25944	732	66	entirety	entirety	NN
25944	732	67	,	,	,
25944	732	68	resulting	result	VBG
25944	732	69	in	in	IN
25944	732	70	a	a	DT
25944	732	71	deep	deep	JJ
25944	732	72	ulcer	ulcer	NN
25944	732	73	,	,	,
25944	732	74	which	which	WDT
25944	732	75	slowly	slowly	RB
25944	732	76	heals	heal	VBZ
25944	732	77	and	and	CC
25944	732	78	leaves	leave	VBZ
25944	732	79	a	a	DT
25944	732	80	permanent	permanent	JJ
25944	732	81	cicatrix	cicatrix	NN
25944	732	82	.	.	.
25944	733	1	In	in	IN
25944	733	2	some	some	DT
25944	733	3	cases	case	NNS
25944	733	4	,	,	,
25944	733	5	especially	especially	RB
25944	733	6	in	in	IN
25944	733	7	old	old	JJ
25944	733	8	people	people	NNS
25944	733	9	,	,	,
25944	733	10	constitutional	constitutional	JJ
25944	733	11	disturbance	disturbance	NN
25944	733	12	of	of	IN
25944	733	13	a	a	DT
25944	733	14	grave	grave	JJ
25944	733	15	character	character	NN
25944	733	16	is	be	VBZ
25944	733	17	noted	note	VBN
25944	733	18	,	,	,
25944	733	19	septicæmia	septicæmia	NN
25944	733	20	is	be	VBZ
25944	733	21	developed	develop	VBN
25944	733	22	,	,	,
25944	733	23	and	and	CC
25944	733	24	a	a	DT
25944	733	25	fatal	fatal	JJ
25944	733	26	result	result	NN
25944	733	27	may	may	MD
25944	733	28	ensue	ensue	VB
25944	733	29	.	.	.
25944	734	1	#	#	LS
25944	734	2	What	what	WP
25944	734	3	is	be	VBZ
25944	734	4	the	the	DT
25944	734	5	cause	cause	NN
25944	734	6	of	of	IN
25944	734	7	carbuncle	carbuncle	NN
25944	734	8	?	?	.
25944	734	9	#	#	$
25944	734	10	The	the	DT
25944	734	11	same	same	JJ
25944	734	12	causes	cause	NNS
25944	734	13	are	be	VBP
25944	734	14	considered	consider	VBN
25944	734	15	to	to	TO
25944	734	16	be	be	VB
25944	734	17	operative	operative	JJ
25944	734	18	in	in	IN
25944	734	19	carbunculus	carbunculus	NN
25944	734	20	as	as	IN
25944	734	21	in	in	IN
25944	734	22	furuncle	furuncle	NN
25944	734	23	;	;	:
25944	734	24	general	general	JJ
25944	734	25	debility	debility	NN
25944	734	26	and	and	CC
25944	734	27	depression	depression	NN
25944	734	28	,	,	,
25944	734	29	from	from	IN
25944	734	30	whatever	whatever	WDT
25944	734	31	cause	cause	NN
25944	734	32	,	,	,
25944	734	33	predisposing	predispose	VBG
25944	734	34	to	to	IN
25944	734	35	its	-PRON-	PRP$
25944	734	36	formation	formation	NN
25944	734	37	,	,	,
25944	734	38	and	and	CC
25944	734	39	the	the	DT
25944	734	40	introduction	introduction	NN
25944	734	41	of	of	IN
25944	734	42	a	a	DT
25944	734	43	microbe	microbe	NN
25944	734	44	,	,	,
25944	734	45	probably	probably	RB
25944	734	46	the	the	DT
25944	734	47	same	same	JJ
25944	734	48	as	as	IN
25944	734	49	in	in	IN
25944	734	50	furunculus	furunculus	NN
25944	734	51	,	,	,
25944	734	52	being	be	VBG
25944	734	53	at	at	IN
25944	734	54	present	present	NN
25944	734	55	looked	look	VBN
25944	734	56	upon	upon	IN
25944	734	57	as	as	IN
25944	734	58	the	the	DT
25944	734	59	exciting	exciting	JJ
25944	734	60	factor	factor	NN
25944	734	61	.	.	.
25944	735	1	#	#	LS
25944	735	2	What	what	WP
25944	735	3	is	be	VBZ
25944	735	4	the	the	DT
25944	735	5	pathology	pathology	NN
25944	735	6	?	?	.
25944	735	7	#	#	$
25944	735	8	The	the	DT
25944	735	9	inflammation	inflammation	NN
25944	735	10	starts	start	VBZ
25944	735	11	simultaneously	simultaneously	RB
25944	735	12	from	from	IN
25944	735	13	numerous	numerous	JJ
25944	735	14	points	point	NNS
25944	735	15	,	,	,
25944	735	16	from	from	IN
25944	735	17	the	the	DT
25944	735	18	hair	hair	NN
25944	735	19	-	-	HYPH
25944	735	20	follicles	follicle	NNS
25944	735	21	,	,	,
25944	735	22	sweat	sweat	NN
25944	735	23	-	-	HYPH
25944	735	24	glands	gland	NNS
25944	735	25	or	or	CC
25944	735	26	sebaceous	sebaceous	JJ
25944	735	27	glands	gland	NNS
25944	735	28	.	.	.
25944	736	1	The	the	DT
25944	736	2	inflammatory	inflammatory	JJ
25944	736	3	centres	centre	NNS
25944	736	4	break	break	VBP
25944	736	5	down	down	RP
25944	736	6	,	,	,
25944	736	7	and	and	CC
25944	736	8	the	the	DT
25944	736	9	pus	pus	NNP
25944	736	10	finds	find	VBZ
25944	736	11	its	-PRON-	PRP$
25944	736	12	way	way	NN
25944	736	13	to	to	IN
25944	736	14	the	the	DT
25944	736	15	surface	surface	NN
25944	736	16	;	;	:
25944	736	17	finally	finally	RB
25944	736	18	the	the	DT
25944	736	19	process	process	NN
25944	736	20	ends	end	VBZ
25944	736	21	in	in	IN
25944	736	22	gangrene	gangrene	NN
25944	736	23	of	of	IN
25944	736	24	the	the	DT
25944	736	25	whole	whole	JJ
25944	736	26	area	area	NN
25944	736	27	.	.	.
25944	737	1	#	#	NNP
25944	737	2	How	how	WRB
25944	737	3	would	would	MD
25944	737	4	you	-PRON-	PRP
25944	737	5	distinguish	distinguish	VB
25944	737	6	carbuncle	carbuncle	NN
25944	737	7	from	from	IN
25944	737	8	a	a	DT
25944	737	9	boil	boil	NN
25944	737	10	?	?	.
25944	737	11	#	#	NN
25944	737	12	By	by	IN
25944	737	13	its	-PRON-	PRP$
25944	737	14	flat	flat	JJ
25944	737	15	character	character	NN
25944	737	16	,	,	,
25944	737	17	greater	great	JJR
25944	737	18	size	size	NN
25944	737	19	,	,	,
25944	737	20	and	and	CC
25944	737	21	multiple	multiple	JJ
25944	737	22	points	point	NNS
25944	737	23	of	of	IN
25944	737	24	suppuration	suppuration	NN
25944	737	25	.	.	.
25944	738	1	#	#	LS
25944	738	2	What	what	WP
25944	738	3	is	be	VBZ
25944	738	4	the	the	DT
25944	738	5	prognosis	prognosis	NN
25944	738	6	of	of	IN
25944	738	7	carbuncle	carbuncle	NN
25944	738	8	?	?	.
25944	738	9	#	#	$
25944	738	10	Occurring	occur	VBG
25944	738	11	in	in	IN
25944	738	12	those	those	DT
25944	738	13	greatly	greatly	RB
25944	738	14	debilitated	debilitated	JJ
25944	738	15	or	or	CC
25944	738	16	in	in	IN
25944	738	17	late	late	JJ
25944	738	18	life	life	NN
25944	738	19	,	,	,
25944	738	20	and	and	CC
25944	738	21	in	in	IN
25944	738	22	those	those	DT
25944	738	23	cases	case	NNS
25944	738	24	in	in	IN
25944	738	25	which	which	WDT
25944	738	26	two	two	CD
25944	738	27	or	or	CC
25944	738	28	more	more	JJR
25944	738	29	lesions	lesion	NNS
25944	738	30	exist	exist	VBP
25944	738	31	,	,	,
25944	738	32	or	or	CC
25944	738	33	when	when	WRB
25944	738	34	seated	seat	VBN
25944	738	35	about	about	IN
25944	738	36	the	the	DT
25944	738	37	head	head	NN
25944	738	38	,	,	,
25944	738	39	the	the	DT
25944	738	40	prognosis	prognosis	NN
25944	738	41	is	be	VBZ
25944	738	42	always	always	RB
25944	738	43	to	to	TO
25944	738	44	be	be	VB
25944	738	45	guarded	guard	VBN
25944	738	46	,	,	,
25944	738	47	as	as	IN
25944	738	48	a	a	DT
25944	738	49	fatal	fatal	JJ
25944	738	50	result	result	NN
25944	738	51	is	be	VBZ
25944	738	52	not	not	RB
25944	738	53	uncommon	uncommon	JJ
25944	738	54	.	.	.
25944	739	1	In	in	IN
25944	739	2	fact	fact	NN
25944	739	3	,	,	,
25944	739	4	in	in	IN
25944	739	5	every	every	DT
25944	739	6	instance	instance	NN
25944	739	7	the	the	DT
25944	739	8	disease	disease	NN
25944	739	9	is	be	VBZ
25944	739	10	to	to	TO
25944	739	11	be	be	VB
25944	739	12	considered	consider	VBN
25944	739	13	of	of	IN
25944	739	14	possible	possible	JJ
25944	739	15	serious	serious	JJ
25944	739	16	import	import	NN
25944	739	17	.	.	.
25944	740	1	#	#	LS
25944	740	2	What	what	WDT
25944	740	3	constitutional	constitutional	JJ
25944	740	4	treatment	treatment	NN
25944	740	5	is	be	VBZ
25944	740	6	usually	usually	RB
25944	740	7	employed	employ	VBN
25944	740	8	in	in	IN
25944	740	9	carbuncle	carbuncle	NN
25944	740	10	?	?	.
25944	740	11	#	#	$
25944	740	12	A	a	DT
25944	740	13	full	full	JJ
25944	740	14	nutritious	nutritious	JJ
25944	740	15	diet	diet	NN
25944	740	16	,	,	,
25944	740	17	the	the	DT
25944	740	18	use	use	NN
25944	740	19	of	of	IN
25944	740	20	such	such	JJ
25944	740	21	remedies	remedy	NNS
25944	740	22	as	as	IN
25944	740	23	iron	iron	NN
25944	740	24	,	,	,
25944	740	25	quinia	quinia	NNP
25944	740	26	,	,	,
25944	740	27	nux	nux	NN
25944	740	28	vomica	vomica	NNP
25944	740	29	,	,	,
25944	740	30	with	with	IN
25944	740	31	malt	malt	NN
25944	740	32	and	and	CC
25944	740	33	stimulants	stimulant	NNS
25944	740	34	,	,	,
25944	740	35	if	if	IN
25944	740	36	indicated	indicate	VBN
25944	740	37	.	.	.
25944	741	1	Calx	calx	NN
25944	741	2	sulphurata	sulphurata	NN
25944	741	3	,	,	,
25944	741	4	one	one	CD
25944	741	5	-	-	HYPH
25944	741	6	tenth	tenth	NN
25944	741	7	to	to	IN
25944	741	8	one	one	CD
25944	741	9	-	-	HYPH
25944	741	10	fourth	fourth	NN
25944	741	11	grain	grain	NN
25944	741	12	every	every	DT
25944	741	13	two	two	CD
25944	741	14	or	or	CC
25944	741	15	three	three	CD
25944	741	16	hours	hour	NNS
25944	741	17	,	,	,
25944	741	18	appears	appear	VBZ
25944	741	19	,	,	,
25944	741	20	in	in	IN
25944	741	21	some	some	DT
25944	741	22	instances	instance	NNS
25944	741	23	,	,	,
25944	741	24	to	to	TO
25944	741	25	have	have	VB
25944	741	26	a	a	DT
25944	741	27	beneficial	beneficial	JJ
25944	741	28	effect	effect	NN
25944	741	29	.	.	.
25944	742	1	If	if	IN
25944	742	2	the	the	DT
25944	742	3	pain	pain	NN
25944	742	4	is	be	VBZ
25944	742	5	severe	severe	JJ
25944	742	6	,	,	,
25944	742	7	morphia	morphia	JJ
25944	742	8	or	or	CC
25944	742	9	chloral	chloral	JJ
25944	742	10	should	should	MD
25944	742	11	be	be	VB
25944	742	12	given	give	VBN
25944	742	13	.	.	.
25944	743	1	#	#	$
25944	743	2	What	what	WDT
25944	743	3	external	external	JJ
25944	743	4	measures	measure	NNS
25944	743	5	are	be	VBP
25944	743	6	employed	employ	VBN
25944	743	7	?	?	.
25944	743	8	#	#	$
25944	743	9	In	in	IN
25944	743	10	the	the	DT
25944	743	11	early	early	JJ
25944	743	12	part	part	NN
25944	743	13	of	of	IN
25944	743	14	the	the	DT
25944	743	15	formation	formation	NN
25944	743	16	,	,	,
25944	743	17	injection	injection	NN
25944	743	18	of	of	IN
25944	743	19	a	a	DT
25944	743	20	five	five	CD
25944	743	21	or	or	CC
25944	743	22	ten	ten	CD
25944	743	23	per	per	IN
25944	743	24	cent	cent	NN
25944	743	25	.	.	.
25944	744	1	carbolic	carbolic	NNP
25944	744	2	acid	acid	NNP
25944	744	3	solution	solution	NN
25944	744	4	,	,	,
25944	744	5	or	or	CC
25944	744	6	covering	cover	VBG
25944	744	7	the	the	DT
25944	744	8	whole	whole	JJ
25944	744	9	area	area	NN
25944	744	10	with	with	IN
25944	744	11	a	a	DT
25944	744	12	twenty	twenty	CD
25944	744	13	-	-	HYPH
25944	744	14	five	five	CD
25944	744	15	per	per	IN
25944	744	16	cent	cent	NN
25944	744	17	.	.	.
25944	745	1	ichthyol	ichthyol	JJ
25944	745	2	ointment	ointment	NN
25944	745	3	,	,	,
25944	745	4	may	may	MD
25944	745	5	be	be	VB
25944	745	6	employed	employ	VBN
25944	745	7	.	.	.
25944	746	1	When	when	WRB
25944	746	2	it	-PRON-	PRP
25944	746	3	has	have	VBZ
25944	746	4	broken	break	VBN
25944	746	5	down	down	RP
25944	746	6	the	the	DT
25944	746	7	pus	pus	NN
25944	746	8	may	may	MD
25944	746	9	be	be	VB
25944	746	10	drawn	draw	VBN
25944	746	11	out	out	RP
25944	746	12	with	with	IN
25944	746	13	a	a	DT
25944	746	14	cupping	cup	VBG
25944	746	15	-	-	HYPH
25944	746	16	glass	glass	NN
25944	746	17	,	,	,
25944	746	18	and	and	CC
25944	746	19	carbolized	carbolize	VBD
25944	746	20	glycerine	glycerine	JJ
25944	746	21	or	or	CC
25944	746	22	carbolized	carbolize	VBN
25944	746	23	water	water	NN
25944	746	24	introduced	introduce	VBN
25944	746	25	into	into	IN
25944	746	26	each	each	DT
25944	746	27	opening	opening	NN
25944	746	28	,	,	,
25944	746	29	and	and	CC
25944	746	30	the	the	DT
25944	746	31	ichthyol	ichthyol	JJ
25944	746	32	ointment	ointment	NN
25944	746	33	superimposed	superimpose	VBD
25944	746	34	.	.	.
25944	747	1	If	if	IN
25944	747	2	the	the	DT
25944	747	3	whole	whole	JJ
25944	747	4	part	part	NN
25944	747	5	has	have	VBZ
25944	747	6	sloughed	slough	VBN
25944	747	7	,	,	,
25944	747	8	it	-PRON-	PRP
25944	747	9	should	should	MD
25944	747	10	be	be	VB
25944	747	11	removed	remove	VBN
25944	747	12	as	as	RB
25944	747	13	rapidly	rapidly	RB
25944	747	14	as	as	IN
25944	747	15	possible	possible	JJ
25944	747	16	,	,	,
25944	747	17	and	and	CC
25944	747	18	antiseptic	antiseptic	JJ
25944	747	19	dressings	dressing	NNS
25944	747	20	used	use	VBN
25944	747	21	.	.	.
25944	748	1	Or	or	CC
25944	748	2	,	,	,
25944	748	3	if	if	IN
25944	748	4	its	-PRON-	PRP$
25944	748	5	progress	progress	NN
25944	748	6	is	be	VBZ
25944	748	7	slow	slow	JJ
25944	748	8	,	,	,
25944	748	9	and	and	CC
25944	748	10	grave	grave	JJ
25944	748	11	systemic	systemic	JJ
25944	748	12	disturbance	disturbance	NN
25944	748	13	be	be	VB
25944	748	14	present	present	JJ
25944	748	15	,	,	,
25944	748	16	the	the	DT
25944	748	17	whole	whole	JJ
25944	748	18	part	part	NN
25944	748	19	may	may	MD
25944	748	20	be	be	VB
25944	748	21	incised	incise	VBN
25944	748	22	and	and	CC
25944	748	23	curetted	curet	VBN
25944	748	24	,	,	,
25944	748	25	and	and	CC
25944	748	26	then	then	RB
25944	748	27	treated	treat	VBN
25944	748	28	antiseptically	antiseptically	RB
25944	748	29	.	.	.
25944	749	1	Mild	mild	JJ
25944	749	2	exposure	exposure	NN
25944	749	3	to	to	IN
25944	749	4	the	the	DT
25944	749	5	_	_	NNP
25944	749	6	x_-rays	x_-rays	NNP
25944	749	7	is	be	VBZ
25944	749	8	also	also	RB
25944	749	9	to	to	TO
25944	749	10	be	be	VB
25944	749	11	commended	commend	VBN
25944	749	12	.	.	.
25944	750	1	#	#	NNP
25944	750	2	Pustula	Pustula	NNP
25944	750	3	Maligna	Maligna	NNPS
25944	750	4	.	.	.
25944	750	5	#	#	NNP
25944	750	6	(	(	-LRB-
25944	750	7	_	_	NNP
25944	750	8	Synonyms	Synonyms	NNP
25944	750	9	:	:	:
25944	750	10	_	_	NNP
25944	750	11	Anthrax	Anthrax	NNP
25944	750	12	;	;	:
25944	750	13	Malignant	Malignant	NNP
25944	750	14	Pustule	Pustule	NNP
25944	750	15	.	.	.
25944	750	16	)	)	-RRB-
25944	751	1	#	#	LS
25944	751	2	What	what	WP
25944	751	3	is	be	VBZ
25944	751	4	malignant	malignant	JJ
25944	751	5	pustule	pustule	NN
25944	751	6	?	?	.
25944	751	7	#	#	$
25944	751	8	Malignant	malignant	JJ
25944	751	9	pustule	pustule	NN
25944	751	10	is	be	VBZ
25944	751	11	a	a	DT
25944	751	12	furuncle-	furuncle-	NN
25944	751	13	or	or	CC
25944	751	14	carbuncle	carbuncle	NN
25944	751	15	-	-	HYPH
25944	751	16	like	like	JJ
25944	751	17	lesion	lesion	NN
25944	751	18	resulting	result	VBG
25944	751	19	from	from	IN
25944	751	20	inoculation	inoculation	NN
25944	751	21	of	of	IN
25944	751	22	the	the	DT
25944	751	23	virus	virus	NN
25944	751	24	generated	generate	VBN
25944	751	25	in	in	IN
25944	751	26	animals	animal	NNS
25944	751	27	suffering	suffer	VBG
25944	751	28	from	from	IN
25944	751	29	splenic	splenic	JJ
25944	751	30	fever	fever	NN
25944	751	31	,	,	,
25944	751	32	or	or	CC
25944	751	33	"	"	``
25944	751	34	charbon	charbon	NN
25944	751	35	,	,	,
25944	751	36	"	"	''
25944	751	37	and	and	CC
25944	751	38	is	be	VBZ
25944	751	39	accompanied	accompany	VBN
25944	751	40	by	by	IN
25944	751	41	constitutional	constitutional	JJ
25944	751	42	symptoms	symptom	NNS
25944	751	43	of	of	IN
25944	751	44	more	more	JJR
25944	751	45	or	or	CC
25944	751	46	less	less	JJR
25944	751	47	gravity	gravity	NN
25944	751	48	.	.	.
25944	752	1	A	a	DT
25944	752	2	fatal	fatal	JJ
25944	752	3	termination	termination	NN
25944	752	4	is	be	VBZ
25944	752	5	not	not	RB
25944	752	6	unusual	unusual	JJ
25944	752	7	.	.	.
25944	753	1	#	#	LS
25944	753	2	What	what	WP
25944	753	3	is	be	VBZ
25944	753	4	the	the	DT
25944	753	5	cause	cause	NN
25944	753	6	of	of	IN
25944	753	7	pustula	pustula	NN
25944	753	8	maligna	maligna	NNS
25944	753	9	?	?	.
25944	753	10	#	#	$
25944	753	11	The	the	DT
25944	753	12	disease	disease	NN
25944	753	13	is	be	VBZ
25944	753	14	due	due	JJ
25944	753	15	to	to	IN
25944	753	16	the	the	DT
25944	753	17	presence	presence	NN
25944	753	18	of	of	IN
25944	753	19	the	the	DT
25944	753	20	bacillus	bacillus	NN
25944	753	21	anthracis	anthracis	RB
25944	753	22	.	.	.
25944	754	1	#	#	LS
25944	754	2	What	what	WP
25944	754	3	is	be	VBZ
25944	754	4	the	the	DT
25944	754	5	treatment	treatment	NN
25944	754	6	of	of	IN
25944	754	7	malignant	malignant	JJ
25944	754	8	pustule	pustule	NN
25944	754	9	?	?	.
25944	754	10	#	#	$
25944	754	11	Early	early	JJ
25944	754	12	excision	excision	NN
25944	754	13	or	or	CC
25944	754	14	destruction	destruction	NN
25944	754	15	with	with	IN
25944	754	16	caustic	caustic	JJ
25944	754	17	potash	potash	NN
25944	754	18	,	,	,
25944	754	19	with	with	IN
25944	754	20	subsequent	subsequent	JJ
25944	754	21	antiseptic	antiseptic	JJ
25944	754	22	dressings	dressing	NNS
25944	754	23	;	;	:
25944	754	24	and	and	CC
25944	754	25	internally	internally	RB
25944	754	26	the	the	DT
25944	754	27	free	free	JJ
25944	754	28	use	use	NN
25944	754	29	of	of	IN
25944	754	30	stimulants	stimulant	NNS
25944	754	31	and	and	CC
25944	754	32	tonics	tonic	NNS
25944	754	33	.	.	.
25944	755	1	#	#	NNP
25944	755	2	Post	post	JJ
25944	755	3	-	-	JJ
25944	755	4	mortem	mortem	JJ
25944	755	5	Pustule	Pustule	NNP
25944	755	6	.	.	.
25944	755	7	#	#	NNP
25944	755	8	(	(	-LRB-
25944	755	9	_	_	NNP
25944	755	10	Synonym	Synonym	NNP
25944	755	11	:	:	:
25944	755	12	_	_	NNP
25944	755	13	Dissection	Dissection	NNP
25944	755	14	Wound	Wound	NNP
25944	755	15	.	.	.
25944	755	16	)	)	-RRB-
25944	756	1	#	#	NNP
25944	756	2	Describe	Describe	NNP
25944	756	3	post	post	JJ
25944	756	4	-	-	JJ
25944	756	5	mortem	mortem	JJ
25944	756	6	pustule	pustule	NN
25944	756	7	.	.	.
25944	756	8	#	#	NNP
25944	756	9	Post	post	JJ
25944	756	10	-	-	JJ
25944	756	11	mortem	mortem	JJ
25944	756	12	pustule	pustule	NN
25944	756	13	develops	develop	VBZ
25944	756	14	at	at	IN
25944	756	15	the	the	DT
25944	756	16	point	point	NN
25944	756	17	of	of	IN
25944	756	18	inoculation	inoculation	NN
25944	756	19	,	,	,
25944	756	20	beginning	begin	VBG
25944	756	21	as	as	IN
25944	756	22	an	an	DT
25944	756	23	itchy	itchy	JJ
25944	756	24	red	red	JJ
25944	756	25	spot	spot	NN
25944	756	26	,	,	,
25944	756	27	becoming	become	VBG
25944	756	28	vesico	vesico	NN
25944	756	29	-	-	HYPH
25944	756	30	pustular	pustular	NN
25944	756	31	,	,	,
25944	756	32	and	and	CC
25944	756	33	later	later	RB
25944	756	34	pustular	pustular	JJ
25944	756	35	,	,	,
25944	756	36	with	with	IN
25944	756	37	usually	usually	RB
25944	756	38	a	a	DT
25944	756	39	broad	broad	JJ
25944	756	40	inflammatory	inflammatory	JJ
25944	756	41	base	base	NN
25944	756	42	,	,	,
25944	756	43	and	and	CC
25944	756	44	accompanied	accompany	VBN
25944	756	45	with	with	IN
25944	756	46	more	more	JJR
25944	756	47	or	or	CC
25944	756	48	less	less	JJR
25944	756	49	pain	pain	NN
25944	756	50	and	and	CC
25944	756	51	redness	redness	NN
25944	756	52	and	and	CC
25944	756	53	not	not	RB
25944	756	54	infrequently	infrequently	RB
25944	756	55	lymphangitis	lymphangitis	VB
25944	756	56	,	,	,
25944	756	57	erysipelatous	erysipelatous	JJ
25944	756	58	swelling	swelling	NN
25944	756	59	,	,	,
25944	756	60	and	and	CC
25944	756	61	slight	slight	JJ
25944	756	62	or	or	CC
25944	756	63	severe	severe	JJ
25944	756	64	sympathetic	sympathetic	JJ
25944	756	65	constitutional	constitutional	JJ
25944	756	66	disturbance	disturbance	NN
25944	756	67	.	.	.
25944	757	1	#	#	LS
25944	757	2	What	what	WP
25944	757	3	is	be	VBZ
25944	757	4	the	the	DT
25944	757	5	treatment	treatment	NN
25944	757	6	of	of	IN
25944	757	7	post	post	JJ
25944	757	8	-	-	JJ
25944	757	9	mortem	mortem	JJ
25944	757	10	pustule	pustule	NN
25944	757	11	?	?	.
25944	757	12	#	#	$
25944	757	13	Treatment	Treatment	NNP
25944	757	14	consists	consist	VBZ
25944	757	15	in	in	IN
25944	757	16	opening	open	VBG
25944	757	17	the	the	DT
25944	757	18	pustule	pustule	NN
25944	757	19	and	and	CC
25944	757	20	thorough	thorough	JJ
25944	757	21	cauterization	cauterization	NN
25944	757	22	,	,	,
25944	757	23	and	and	CC
25944	757	24	the	the	DT
25944	757	25	subsequent	subsequent	JJ
25944	757	26	use	use	NN
25944	757	27	of	of	IN
25944	757	28	antiseptic	antiseptic	JJ
25944	757	29	applications	application	NNS
25944	757	30	or	or	CC
25944	757	31	dressings	dressing	NNS
25944	757	32	.	.	.
25944	758	1	_	_	NNP
25944	758	2	Internally	internally	RB
25944	758	3	_	_	NNP
25944	758	4	quinia	quinia	NN
25944	758	5	and	and	CC
25944	758	6	stimulants	stimulant	NNS
25944	758	7	if	if	IN
25944	758	8	indicated	indicate	VBN
25944	758	9	.	.	.
25944	759	1	#	#	NNP
25944	759	2	Framb[oe]sia	Framb[oe]sia	NNP
25944	759	3	.	.	.
25944	759	4	#	#	NNP
25944	759	5	(	(	-LRB-
25944	759	6	_	_	NNP
25944	759	7	Synonyms	Synonyms	NNP
25944	759	8	:	:	:
25944	759	9	_	_	NNP
25944	759	10	Yaws	Yaws	NNP
25944	759	11	;	;	:
25944	759	12	Pian	Pian	NNP
25944	759	13	.	.	.
25944	759	14	)	)	-RRB-
25944	760	1	#	#	NNP
25944	760	2	Describe	Describe	NNP
25944	760	3	framb[oe]sia	framb[oe]sia	NNP
25944	760	4	.	.	.
25944	760	5	#	#	NNP
25944	760	6	Framb[oe]sia	Framb[oe]sia	NNP
25944	760	7	is	be	VBZ
25944	760	8	an	an	DT
25944	760	9	endemic	endemic	JJ
25944	760	10	,	,	,
25944	760	11	contagious	contagious	JJ
25944	760	12	disease	disease	NN
25944	760	13	met	meet	VBD
25944	760	14	with	with	IN
25944	760	15	in	in	IN
25944	760	16	tropical	tropical	JJ
25944	760	17	countries	country	NNS
25944	760	18	,	,	,
25944	760	19	characterized	characterize	VBN
25944	760	20	by	by	IN
25944	760	21	the	the	DT
25944	760	22	appearance	appearance	NN
25944	760	23	of	of	IN
25944	760	24	variously	variously	RB
25944	760	25	-	-	HYPH
25944	760	26	sized	sized	JJ
25944	760	27	papules	papule	NNS
25944	760	28	,	,	,
25944	760	29	tubercles	tubercle	NNS
25944	760	30	,	,	,
25944	760	31	and	and	CC
25944	760	32	tumors	tumor	NNS
25944	760	33	,	,	,
25944	760	34	which	which	WDT
25944	760	35	,	,	,
25944	760	36	when	when	WRB
25944	760	37	developed	develop	VBN
25944	760	38	,	,	,
25944	760	39	resemble	resemble	VB
25944	760	40	currants	currant	NNS
25944	760	41	and	and	CC
25944	760	42	small	small	JJ
25944	760	43	raspberries	raspberry	NNS
25944	760	44	,	,	,
25944	760	45	and	and	CC
25944	760	46	finally	finally	RB
25944	760	47	break	break	VB
25944	760	48	down	down	RP
25944	760	49	and	and	CC
25944	760	50	ulcerate	ulcerate	JJ
25944	760	51	.	.	.
25944	761	1	It	-PRON-	PRP
25944	761	2	is	be	VBZ
25944	761	3	accompanied	accompany	VBN
25944	761	4	by	by	IN
25944	761	5	constitutional	constitutional	JJ
25944	761	6	symptoms	symptom	NNS
25944	761	7	of	of	IN
25944	761	8	variable	variable	JJ
25944	761	9	severity	severity	NN
25944	761	10	.	.	.
25944	762	1	Hygienic	hygienic	JJ
25944	762	2	measures	measure	NNS
25944	762	3	,	,	,
25944	762	4	good	good	JJ
25944	762	5	food	food	NN
25944	762	6	,	,	,
25944	762	7	tonics	tonic	NNS
25944	762	8	,	,	,
25944	762	9	and	and	CC
25944	762	10	antiseptic	antiseptic	JJ
25944	762	11	and	and	CC
25944	762	12	stimulating	stimulating	JJ
25944	762	13	applications	application	NNS
25944	762	14	are	be	VBP
25944	762	15	curative	curative	JJ
25944	762	16	.	.	.
25944	763	1	#	#	NNP
25944	763	2	Verruga	Verruga	NNP
25944	763	3	Peruana	Peruana	NNP
25944	763	4	.	.	.
25944	763	5	#	#	NNP
25944	763	6	(	(	-LRB-
25944	763	7	_	_	NNP
25944	763	8	Synonyms	Synonyms	NNP
25944	763	9	:	:	:
25944	763	10	_	_	NNP
25944	763	11	Peruvian	Peruvian	NNP
25944	763	12	Warts	Warts	NNPS
25944	763	13	;	;	:
25944	763	14	Carrion	Carrion	NNP
25944	763	15	's	's	POS
25944	763	16	Disease	Disease	NNP
25944	763	17	;	;	:
25944	763	18	Oroya	Oroya	NNP
25944	763	19	Fever	Fever	NNP
25944	763	20	.	.	.
25944	763	21	)	)	-RRB-
25944	764	1	#	#	$
25944	764	2	Describe	Describe	NNP
25944	764	3	verruga	verruga	NN
25944	764	4	peruana	peruana	NNS
25944	764	5	.	.	.
25944	764	6	#	#	$
25944	764	7	A	a	DT
25944	764	8	specific	specific	JJ
25944	764	9	inoculable	inoculable	JJ
25944	764	10	affection	affection	NN
25944	764	11	endemic	endemic	NN
25944	764	12	in	in	IN
25944	764	13	some	some	DT
25944	764	14	valleys	valley	NNS
25944	764	15	of	of	IN
25944	764	16	the	the	DT
25944	764	17	Western	Western	NNP
25944	764	18	Andes	Andes	NNP
25944	764	19	,	,	,
25944	764	20	in	in	IN
25944	764	21	Peru	Peru	NNP
25944	764	22	,	,	,
25944	764	23	and	and	CC
25944	764	24	characterized	characterize	VBN
25944	764	25	by	by	IN
25944	764	26	a	a	DT
25944	764	27	prodromal	prodromal	JJ
25944	764	28	febrile	febrile	NN
25944	764	29	period	period	NN
25944	764	30	and	and	CC
25944	764	31	subsequent	subsequent	JJ
25944	764	32	outbreak	outbreak	NN
25944	764	33	of	of	IN
25944	764	34	peculiar	peculiar	JJ
25944	764	35	pin	pin	NN
25944	764	36	-	-	HYPH
25944	764	37	head-	head-	NN
25944	764	38	to	to	IN
25944	764	39	pea	pea	JJ
25944	764	40	-	-	HYPH
25944	764	41	sized	sized	JJ
25944	764	42	,	,	,
25944	764	43	or	or	CC
25944	764	44	larger	large	JJR
25944	764	45	,	,	,
25944	764	46	bright	bright	JJ
25944	764	47	reddish	reddish	JJ
25944	764	48	,	,	,
25944	764	49	rounded	round	VBD
25944	764	50	,	,	,
25944	764	51	wart	wart	JJ
25944	764	52	-	-	HYPH
25944	764	53	like	like	JJ
25944	764	54	elevations	elevation	NNS
25944	764	55	.	.	.
25944	765	1	The	the	DT
25944	765	2	prodromal	prodromal	JJ
25944	765	3	symptoms	symptom	NNS
25944	765	4	,	,	,
25944	765	5	of	of	IN
25944	765	6	an	an	DT
25944	765	7	irregular	irregular	JJ
25944	765	8	malarial	malarial	JJ
25944	765	9	or	or	CC
25944	765	10	typhoid	typhoid	NN
25944	765	11	type	type	NN
25944	765	12	,	,	,
25944	765	13	with	with	IN
25944	765	14	associated	associate	VBN
25944	765	15	rheumatic	rheumatic	JJ
25944	765	16	and	and	CC
25944	765	17	muscular	muscular	JJ
25944	765	18	pains	pain	NNS
25944	765	19	,	,	,
25944	765	20	may	may	MD
25944	765	21	last	last	VB
25944	765	22	for	for	IN
25944	765	23	weeks	week	NNS
25944	765	24	or	or	CC
25944	765	25	several	several	JJ
25944	765	26	months	month	NNS
25944	765	27	,	,	,
25944	765	28	usually	usually	RB
25944	765	29	abating	abate	VBG
25944	765	30	when	when	WRB
25944	765	31	eruption	eruption	NN
25944	765	32	presents	present	VBZ
25944	765	33	.	.	.
25944	766	1	The	the	DT
25944	766	2	lesions	lesion	NNS
25944	766	3	may	may	MD
25944	766	4	be	be	VB
25944	766	5	crowded	crowd	VBN
25944	766	6	together	together	RB
25944	766	7	in	in	IN
25944	766	8	great	great	JJ
25944	766	9	bunches	bunche	NNS
25944	766	10	.	.	.
25944	767	1	The	the	DT
25944	767	2	face	face	NN
25944	767	3	and	and	CC
25944	767	4	limbs	limb	NNS
25944	767	5	are	be	VBP
25944	767	6	favorite	favorite	JJ
25944	767	7	localities	locality	NNS
25944	767	8	.	.	.
25944	768	1	The	the	DT
25944	768	2	disease	disease	NN
25944	768	3	is	be	VBZ
25944	768	4	inoculable	inoculable	JJ
25944	768	5	and	and	CC
25944	768	6	thought	think	VBN
25944	768	7	to	to	TO
25944	768	8	be	be	VB
25944	768	9	due	due	IN
25944	768	10	to	to	IN
25944	768	11	a	a	DT
25944	768	12	bacillus	bacillus	NN
25944	768	13	.	.	.
25944	769	1	The	the	DT
25944	769	2	fatality	fatality	NN
25944	769	3	varies	vary	VBZ
25944	769	4	between	between	IN
25944	769	5	10	10	CD
25944	769	6	and	and	CC
25944	769	7	20	20	CD
25944	769	8	per	per	NN
25944	769	9	cent	cent	NN
25944	769	10	.	.	.
25944	770	1	Tonics	tonic	NNS
25944	770	2	and	and	CC
25944	770	3	stimulants	stimulant	NNS
25944	770	4	are	be	VBP
25944	770	5	prescribed	prescribe	VBN
25944	770	6	.	.	.
25944	771	1	#	#	NNP
25944	771	2	Equinia	Equinia	NNP
25944	771	3	.	.	.
25944	771	4	#	#	NNP
25944	771	5	(	(	-LRB-
25944	771	6	_	_	NNP
25944	771	7	Synonyms	Synonyms	NNP
25944	771	8	:	:	:
25944	771	9	_	_	NNP
25944	771	10	Farcy	Farcy	NNP
25944	771	11	;	;	:
25944	771	12	Glanders	Glanders	NNPS
25944	771	13	.	.	.
25944	771	14	)	)	-RRB-
25944	772	1	#	#	LS
25944	772	2	What	what	WP
25944	772	3	is	be	VBZ
25944	772	4	equinia	equinia	NNP
25944	772	5	,	,	,
25944	772	6	or	or	CC
25944	772	7	glanders	glander	NNS
25944	772	8	?	?	.
25944	772	9	#	#	$
25944	772	10	A	a	DT
25944	772	11	rare	rare	JJ
25944	772	12	contagious	contagious	JJ
25944	772	13	specific	specific	JJ
25944	772	14	disease	disease	NN
25944	772	15	of	of	IN
25944	772	16	a	a	DT
25944	772	17	malignant	malignant	JJ
25944	772	18	type	type	NN
25944	772	19	,	,	,
25944	772	20	derived	derive	VBN
25944	772	21	from	from	IN
25944	772	22	the	the	DT
25944	772	23	horse	horse	NN
25944	772	24	,	,	,
25944	772	25	and	and	CC
25944	772	26	characterized	characterize	VBN
25944	772	27	by	by	IN
25944	772	28	grave	grave	JJ
25944	772	29	constitutional	constitutional	JJ
25944	772	30	symptoms	symptom	NNS
25944	772	31	,	,	,
25944	772	32	inflammation	inflammation	NN
25944	772	33	of	of	IN
25944	772	34	the	the	DT
25944	772	35	nasal	nasal	NN
25944	772	36	and	and	CC
25944	772	37	respiratory	respiratory	JJ
25944	772	38	passages	passage	NNS
25944	772	39	,	,	,
25944	772	40	and	and	CC
25944	772	41	a	a	DT
25944	772	42	deep	deep	RB
25944	772	43	-	-	HYPH
25944	772	44	seated	seat	VBN
25944	772	45	papulo	papulo	JJ
25944	772	46	-	-	HYPH
25944	772	47	pustular	pustular	NN
25944	772	48	,	,	,
25944	772	49	or	or	CC
25944	772	50	tubercular	tubercular	JJ
25944	772	51	,	,	,
25944	772	52	nodular	nodular	JJ
25944	772	53	(	(	-LRB-
25944	772	54	_	_	NNP
25944	772	55	farcy	farcy	NN
25944	772	56	buds	bud	NNS
25944	772	57	_	_	NNP
25944	772	58	)	)	-RRB-
25944	772	59	,	,	,
25944	772	60	ulcerative	ulcerative	JJ
25944	772	61	eruption	eruption	NN
25944	772	62	.	.	.
25944	773	1	A	a	DT
25944	773	2	fatal	fatal	JJ
25944	773	3	issue	issue	NN
25944	773	4	is	be	VBZ
25944	773	5	not	not	RB
25944	773	6	uncommon	uncommon	JJ
25944	773	7	.	.	.
25944	774	1	It	-PRON-	PRP
25944	774	2	is	be	VBZ
25944	774	3	due	due	JJ
25944	774	4	to	to	IN
25944	774	5	a	a	DT
25944	774	6	micro	micro	NN
25944	774	7	-	-	HYPH
25944	774	8	organism	organism	NN
25944	774	9	.	.	.
25944	775	1	Treatment	treatment	NN
25944	775	2	,	,	,
25944	775	3	both	both	CC
25944	775	4	local	local	JJ
25944	775	5	and	and	CC
25944	775	6	constitutional	constitutional	JJ
25944	775	7	,	,	,
25944	775	8	is	be	VBZ
25944	775	9	based	base	VBN
25944	775	10	upon	upon	IN
25944	775	11	general	general	JJ
25944	775	12	principles	principle	NNS
25944	775	13	.	.	.
25944	776	1	#	#	NNP
25944	776	2	Miliaria	Miliaria	NNP
25944	776	3	.	.	.
25944	776	4	#	#	NNP
25944	776	5	(	(	-LRB-
25944	776	6	_	_	NNP
25944	776	7	Synonyms	Synonyms	NNP
25944	776	8	:	:	:
25944	776	9	_	_	NNP
25944	776	10	Prickly	Prickly	NNP
25944	776	11	Heat	Heat	NNP
25944	776	12	;	;	:
25944	776	13	Heat	Heat	NNP
25944	776	14	Rash	Rash	NNP
25944	776	15	;	;	:
25944	776	16	Lichen	Lichen	NNP
25944	776	17	Tropicus	Tropicus	NNP
25944	776	18	;	;	:
25944	776	19	Red	Red	NNP
25944	776	20	Gum	Gum	NNP
25944	776	21	;	;	:
25944	776	22	Strophulus	Strophulus	NNP
25944	776	23	.	.	.
25944	776	24	)	)	-RRB-
25944	777	1	#	#	LS
25944	777	2	What	what	WP
25944	777	3	do	do	VBP
25944	777	4	you	-PRON-	PRP
25944	777	5	understand	understand	VB
25944	777	6	by	by	IN
25944	777	7	miliaria	miliaria	NNP
25944	777	8	?	?	.
25944	777	9	#	#	$
25944	777	10	An	an	DT
25944	777	11	acute	acute	JJ
25944	777	12	mildly	mildly	RB
25944	777	13	inflammatory	inflammatory	JJ
25944	777	14	disorder	disorder	NN
25944	777	15	of	of	IN
25944	777	16	the	the	DT
25944	777	17	sweat	sweat	NN
25944	777	18	-	-	HYPH
25944	777	19	glands	gland	NNS
25944	777	20	,	,	,
25944	777	21	characterized	characterize	VBN
25944	777	22	by	by	IN
25944	777	23	the	the	DT
25944	777	24	appearance	appearance	NN
25944	777	25	of	of	IN
25944	777	26	minute	minute	NN
25944	777	27	,	,	,
25944	777	28	discrete	discrete	JJ
25944	777	29	but	but	CC
25944	777	30	closely	closely	RB
25944	777	31	crowded	crowded	JJ
25944	777	32	papules	papule	NNS
25944	777	33	,	,	,
25944	777	34	vesico	vesico	NN
25944	777	35	-	-	HYPH
25944	777	36	papules	papule	NNS
25944	777	37	,	,	,
25944	777	38	and	and	CC
25944	777	39	vesicles	vesicle	NNS
25944	777	40	.	.	.
25944	778	1	#	#	NNP
25944	778	2	Describe	describe	VB
25944	778	3	the	the	DT
25944	778	4	symptoms	symptom	NNS
25944	778	5	of	of	IN
25944	778	6	miliaria	miliaria	NNP
25944	778	7	.	.	.
25944	778	8	#	#	$
25944	778	9	The	the	DT
25944	778	10	eruption	eruption	NN
25944	778	11	,	,	,
25944	778	12	consisting	consist	VBG
25944	778	13	of	of	IN
25944	778	14	pin	pin	NN
25944	778	15	-	-	HYPH
25944	778	16	point	point	NN
25944	778	17	to	to	IN
25944	778	18	millet	millet	JJ
25944	778	19	-	-	HYPH
25944	778	20	seed	seed	NN
25944	778	21	-	-	HYPH
25944	778	22	sized	sized	JJ
25944	778	23	papules	papule	NNS
25944	778	24	,	,	,
25944	778	25	vesico	vesico	NN
25944	778	26	-	-	HYPH
25944	778	27	papules	papule	NNS
25944	778	28	,	,	,
25944	778	29	vesicles	vesicle	NNS
25944	778	30	,	,	,
25944	778	31	or	or	CC
25944	778	32	a	a	DT
25944	778	33	mixture	mixture	NN
25944	778	34	of	of	IN
25944	778	35	these	these	DT
25944	778	36	lesions	lesion	NNS
25944	778	37	,	,	,
25944	778	38	discrete	discrete	JJ
25944	778	39	but	but	CC
25944	778	40	usually	usually	RB
25944	778	41	numerous	numerous	JJ
25944	778	42	and	and	CC
25944	778	43	closely	closely	RB
25944	778	44	crowded	crowded	JJ
25944	778	45	,	,	,
25944	778	46	appears	appear	VBZ
25944	778	47	suddenly	suddenly	RB
25944	778	48	,	,	,
25944	778	49	occurring	occur	VBG
25944	778	50	upon	upon	IN
25944	778	51	a	a	DT
25944	778	52	limited	limited	JJ
25944	778	53	portion	portion	NN
25944	778	54	of	of	IN
25944	778	55	the	the	DT
25944	778	56	surface	surface	NN
25944	778	57	,	,	,
25944	778	58	or	or	CC
25944	778	59	,	,	,
25944	778	60	as	as	IN
25944	778	61	commonly	commonly	RB
25944	778	62	observed	observe	VBN
25944	778	63	,	,	,
25944	778	64	involving	involve	VBG
25944	778	65	a	a	DT
25944	778	66	greater	great	JJR
25944	778	67	part	part	NN
25944	778	68	or	or	CC
25944	778	69	the	the	DT
25944	778	70	whole	whole	JJ
25944	778	71	integument	integument	NN
25944	778	72	.	.	.
25944	779	1	The	the	DT
25944	779	2	trunk	trunk	NN
25944	779	3	is	be	VBZ
25944	779	4	a	a	DT
25944	779	5	favorite	favorite	JJ
25944	779	6	locality	locality	NN
25944	779	7	.	.	.
25944	780	1	The	the	DT
25944	780	2	papular	papular	JJ
25944	780	3	lesions	lesion	NNS
25944	780	4	are	be	VBP
25944	780	5	pinkish	pinkish	JJ
25944	780	6	or	or	CC
25944	780	7	reddish	reddish	JJ
25944	780	8	,	,	,
25944	780	9	and	and	CC
25944	780	10	the	the	DT
25944	780	11	vesicles	vesicle	NNS
25944	780	12	whitish	whitish	VBP
25944	780	13	or	or	CC
25944	780	14	yellowish	yellowish	JJ
25944	780	15	,	,	,
25944	780	16	surrounded	surround	VBN
25944	780	17	by	by	IN
25944	780	18	inflammatory	inflammatory	JJ
25944	780	19	areola	areola	NNP
25944	780	20	,	,	,
25944	780	21	thus	thus	RB
25944	780	22	giving	give	VBG
25944	780	23	the	the	DT
25944	780	24	whole	whole	JJ
25944	780	25	eruption	eruption	NN
25944	780	26	a	a	DT
25944	780	27	bright	bright	JJ
25944	780	28	red	red	JJ
25944	780	29	appearance--_miliaria	appearance--_miliaria	NNP
25944	780	30	rubra	rubra	NNP
25944	780	31	_	_	NNP
25944	780	32	.	.	.
25944	781	1	Later	later	RB
25944	781	2	,	,	,
25944	781	3	the	the	DT
25944	781	4	areolæ	areolæ	NNP
25944	781	5	fade	fade	NN
25944	781	6	,	,	,
25944	781	7	the	the	DT
25944	781	8	transparent	transparent	JJ
25944	781	9	contents	content	NNS
25944	781	10	of	of	IN
25944	781	11	the	the	DT
25944	781	12	vesicles	vesicle	NNS
25944	781	13	become	become	VBP
25944	781	14	somewhat	somewhat	RB
25944	781	15	opaque	opaque	JJ
25944	781	16	and	and	CC
25944	781	17	yellowish	yellowish	JJ
25944	781	18	-	-	HYPH
25944	781	19	white	white	JJ
25944	781	20	,	,	,
25944	781	21	and	and	CC
25944	781	22	the	the	DT
25944	781	23	eruption	eruption	NN
25944	781	24	has	have	VBZ
25944	781	25	a	a	DT
25944	781	26	whitish	whitish	JJ
25944	781	27	or	or	CC
25944	781	28	yellowish	yellowish	JJ
25944	781	29	cast--_miliaria	cast--_miliaria	NN
25944	781	30	alba	alba	VBZ
25944	781	31	_	_	NNP
25944	781	32	.	.	.
25944	782	1	In	in	IN
25944	782	2	long	long	RB
25944	782	3	-	-	HYPH
25944	782	4	continued	continue	VBN
25944	782	5	cases	case	NNS
25944	782	6	,	,	,
25944	782	7	especially	especially	RB
25944	782	8	in	in	IN
25944	782	9	children	child	NNS
25944	782	10	,	,	,
25944	782	11	boils	boil	NNS
25944	782	12	and	and	CC
25944	782	13	cutaneous	cutaneous	JJ
25944	782	14	abscesses	abscess	NNS
25944	782	15	sometimes	sometimes	RB
25944	782	16	develop	develop	VBP
25944	782	17	;	;	:
25944	782	18	and	and	CC
25944	782	19	it	-PRON-	PRP
25944	782	20	may	may	MD
25944	782	21	also	also	RB
25944	782	22	develop	develop	VB
25944	782	23	into	into	IN
25944	782	24	a	a	DT
25944	782	25	true	true	JJ
25944	782	26	eczema	eczema	NN
25944	782	27	.	.	.
25944	783	1	Itching	itching	NN
25944	783	2	,	,	,
25944	783	3	or	or	CC
25944	783	4	a	a	DT
25944	783	5	feeling	feeling	NN
25944	783	6	of	of	IN
25944	783	7	burning	burning	NN
25944	783	8	,	,	,
25944	783	9	slight	slight	JJ
25944	783	10	or	or	CC
25944	783	11	intense	intense	JJ
25944	783	12	,	,	,
25944	783	13	is	be	VBZ
25944	783	14	usually	usually	RB
25944	783	15	present	present	JJ
25944	783	16	.	.	.
25944	784	1	#	#	LS
25944	784	2	What	what	WP
25944	784	3	is	be	VBZ
25944	784	4	the	the	DT
25944	784	5	course	course	NN
25944	784	6	of	of	IN
25944	784	7	the	the	DT
25944	784	8	eruption	eruption	NN
25944	784	9	?	?	.
25944	784	10	#	#	$
25944	784	11	The	the	DT
25944	784	12	vesicles	vesicle	NNS
25944	784	13	show	show	VBP
25944	784	14	no	no	DT
25944	784	15	disposition	disposition	NN
25944	784	16	to	to	TO
25944	784	17	rupture	rupture	VB
25944	784	18	,	,	,
25944	784	19	but	but	CC
25944	784	20	dry	dry	VB
25944	784	21	up	up	RP
25944	784	22	in	in	IN
25944	784	23	a	a	DT
25944	784	24	few	few	JJ
25944	784	25	days	day	NNS
25944	784	26	or	or	CC
25944	784	27	a	a	DT
25944	784	28	week	week	NN
25944	784	29	,	,	,
25944	784	30	disappearing	disappear	VBG
25944	784	31	by	by	IN
25944	784	32	absorption	absorption	NN
25944	784	33	and	and	CC
25944	784	34	with	with	IN
25944	784	35	slight	slight	JJ
25944	784	36	subsequent	subsequent	JJ
25944	784	37	desquamation	desquamation	NN
25944	784	38	;	;	:
25944	784	39	the	the	DT
25944	784	40	papular	papular	JJ
25944	784	41	lesions	lesion	NNS
25944	784	42	gradually	gradually	RB
25944	784	43	fade	fade	VB
25944	784	44	away	away	RB
25944	784	45	,	,	,
25944	784	46	and	and	CC
25944	784	47	the	the	DT
25944	784	48	affection	affection	NN
25944	784	49	,	,	,
25944	784	50	if	if	IN
25944	784	51	the	the	DT
25944	784	52	exciting	exciting	JJ
25944	784	53	cause	cause	NN
25944	784	54	has	have	VBZ
25944	784	55	ceased	cease	VBN
25944	784	56	to	to	TO
25944	784	57	act	act	VB
25944	784	58	,	,	,
25944	784	59	terminates	terminate	NNS
25944	784	60	.	.	.
25944	785	1	#	#	LS
25944	785	2	What	what	WP
25944	785	3	is	be	VBZ
25944	785	4	the	the	DT
25944	785	5	cause	cause	NN
25944	785	6	of	of	IN
25944	785	7	miliaria	miliaria	NN
25944	785	8	?	?	.
25944	785	9	#	#	$
25944	785	10	Excessive	excessive	JJ
25944	785	11	heat	heat	NN
25944	785	12	.	.	.
25944	786	1	Debilitated	debilitate	VBN
25944	786	2	individuals	individual	NNS
25944	786	3	,	,	,
25944	786	4	especially	especially	RB
25944	786	5	children	child	NNS
25944	786	6	,	,	,
25944	786	7	are	be	VBP
25944	786	8	more	more	RBR
25944	786	9	prone	prone	JJ
25944	786	10	to	to	IN
25944	786	11	an	an	DT
25944	786	12	attack	attack	NN
25944	786	13	.	.	.
25944	787	1	Being	be	VBG
25944	787	2	too	too	RB
25944	787	3	warmly	warmly	RB
25944	787	4	clad	clothe	VBN
25944	787	5	is	be	VBZ
25944	787	6	often	often	RB
25944	787	7	causative	causative	JJ
25944	787	8	.	.	.
25944	788	1	#	#	LS
25944	788	2	What	what	WP
25944	788	3	is	be	VBZ
25944	788	4	the	the	DT
25944	788	5	nature	nature	NN
25944	788	6	of	of	IN
25944	788	7	the	the	DT
25944	788	8	disease	disease	NN
25944	788	9	?	?	.
25944	788	10	#	#	$
25944	788	11	The	the	DT
25944	788	12	affection	affection	NN
25944	788	13	is	be	VBZ
25944	788	14	considered	consider	VBN
25944	788	15	to	to	TO
25944	788	16	be	be	VB
25944	788	17	due	due	JJ
25944	788	18	to	to	IN
25944	788	19	sweat	sweat	NN
25944	788	20	-	-	HYPH
25944	788	21	obstruction	obstruction	NN
25944	788	22	,	,	,
25944	788	23	with	with	IN
25944	788	24	mild	mild	JJ
25944	788	25	inflammatory	inflammatory	JJ
25944	788	26	symptoms	symptom	NNS
25944	788	27	as	as	IN
25944	788	28	a	a	DT
25944	788	29	cause	cause	NN
25944	788	30	or	or	CC
25944	788	31	consequence	consequence	NN
25944	788	32	,	,	,
25944	788	33	congestion	congestion	NN
25944	788	34	and	and	CC
25944	788	35	exudation	exudation	NN
25944	788	36	taking	take	VBG
25944	788	37	place	place	NN
25944	788	38	about	about	IN
25944	788	39	the	the	DT
25944	788	40	ducts	duct	NNS
25944	788	41	,	,	,
25944	788	42	giving	give	VBG
25944	788	43	rise	rise	NN
25944	788	44	to	to	IN
25944	788	45	papules	papule	NNS
25944	788	46	or	or	CC
25944	788	47	vesicles	vesicle	NNS
25944	788	48	,	,	,
25944	788	49	according	accord	VBG
25944	788	50	to	to	IN
25944	788	51	the	the	DT
25944	788	52	intensity	intensity	NN
25944	788	53	of	of	IN
25944	788	54	the	the	DT
25944	788	55	process	process	NN
25944	788	56	.	.	.
25944	789	1	#	#	NNP
25944	789	2	How	how	WRB
25944	789	3	would	would	MD
25944	789	4	you	-PRON-	PRP
25944	789	5	distinguish	distinguish	VB
25944	789	6	miliaria	miliaria	NN
25944	789	7	from	from	IN
25944	789	8	papular	papular	JJ
25944	789	9	and	and	CC
25944	789	10	vesicular	vesicular	JJ
25944	789	11	eczema	eczema	NN
25944	789	12	,	,	,
25944	789	13	and	and	CC
25944	789	14	from	from	IN
25944	789	15	sudamen	sudaman	NNS
25944	789	16	?	?	.
25944	789	17	#	#	$
25944	789	18	The	the	DT
25944	789	19	papules	papule	NNS
25944	789	20	of	of	IN
25944	789	21	eczema	eczema	NN
25944	789	22	are	be	VBP
25944	789	23	larger	large	JJR
25944	789	24	,	,	,
25944	789	25	more	more	RBR
25944	789	26	elevated	elevated	JJ
25944	789	27	,	,	,
25944	789	28	firmer	firm	JJR
25944	789	29	,	,	,
25944	789	30	slower	slow	JJR
25944	789	31	in	in	IN
25944	789	32	their	-PRON-	PRP$
25944	789	33	evolution	evolution	NN
25944	789	34	,	,	,
25944	789	35	of	of	IN
25944	789	36	longer	long	JJR
25944	789	37	duration	duration	NN
25944	789	38	,	,	,
25944	789	39	and	and	CC
25944	789	40	are	be	VBP
25944	789	41	markedly	markedly	RB
25944	789	42	itchy	itchy	JJ
25944	789	43	.	.	.
25944	790	1	The	the	DT
25944	790	2	vesicles	vesicle	NNS
25944	790	3	of	of	IN
25944	790	4	eczema	eczema	NN
25944	790	5	are	be	VBP
25944	790	6	usually	usually	RB
25944	790	7	larger	large	JJR
25944	790	8	,	,	,
25944	790	9	tend	tend	VBP
25944	790	10	to	to	TO
25944	790	11	become	become	VB
25944	790	12	confluent	confluent	JJ
25944	790	13	,	,	,
25944	790	14	and	and	CC
25944	790	15	also	also	RB
25944	790	16	to	to	TO
25944	790	17	rupture	rupture	VB
25944	790	18	and	and	CC
25944	790	19	become	become	VB
25944	790	20	crusted	crusted	JJ
25944	790	21	;	;	:
25944	790	22	there	there	EX
25944	790	23	is	be	VBZ
25944	790	24	marked	mark	VBN
25944	790	25	itchiness	itchiness	NN
25944	790	26	,	,	,
25944	790	27	and	and	CC
25944	790	28	the	the	DT
25944	790	29	inflammatory	inflammatory	JJ
25944	790	30	action	action	NN
25944	790	31	is	be	VBZ
25944	790	32	usually	usually	RB
25944	790	33	severe	severe	JJ
25944	790	34	and	and	CC
25944	790	35	persistent	persistent	JJ
25944	790	36	.	.	.
25944	791	1	In	in	IN
25944	791	2	sudamen	sudaman	NNS
25944	791	3	there	there	EX
25944	791	4	is	be	VBZ
25944	791	5	absence	absence	NN
25944	791	6	of	of	IN
25944	791	7	inflammatory	inflammatory	JJ
25944	791	8	symptoms	symptom	NNS
25944	791	9	.	.	.
25944	792	1	#	#	LS
25944	792	2	What	what	WP
25944	792	3	is	be	VBZ
25944	792	4	the	the	DT
25944	792	5	prognosis	prognosis	NN
25944	792	6	of	of	IN
25944	792	7	miliaria	miliaria	NN
25944	792	8	?	?	.
25944	792	9	#	#	$
25944	792	10	The	the	DT
25944	792	11	affection	affection	NN
25944	792	12	,	,	,
25944	792	13	under	under	IN
25944	792	14	favorable	favorable	JJ
25944	792	15	circumstances	circumstance	NNS
25944	792	16	,	,	,
25944	792	17	disappears	disappear	VBZ
25944	792	18	in	in	IN
25944	792	19	a	a	DT
25944	792	20	few	few	JJ
25944	792	21	days	day	NNS
25944	792	22	or	or	CC
25944	792	23	weeks	week	NNS
25944	792	24	.	.	.
25944	793	1	If	if	IN
25944	793	2	the	the	DT
25944	793	3	cause	cause	NN
25944	793	4	persists	persist	VBZ
25944	793	5	,	,	,
25944	793	6	as	as	IN
25944	793	7	for	for	IN
25944	793	8	instance	instance	NN
25944	793	9	,	,	,
25944	793	10	in	in	IN
25944	793	11	infants	infant	NNS
25944	793	12	or	or	CC
25944	793	13	young	young	JJ
25944	793	14	children	child	NNS
25944	793	15	too	too	RB
25944	793	16	warmly	warmly	RB
25944	793	17	clad	clothe	VBN
25944	793	18	,	,	,
25944	793	19	it	-PRON-	PRP
25944	793	20	may	may	MD
25944	793	21	result	result	VB
25944	793	22	in	in	IN
25944	793	23	eczema	eczema	NN
25944	793	24	.	.	.
25944	794	1	#	#	LS
25944	794	2	What	what	WP
25944	794	3	is	be	VBZ
25944	794	4	the	the	DT
25944	794	5	treatment	treatment	NN
25944	794	6	of	of	IN
25944	794	7	miliaria	miliaria	NNP
25944	794	8	?	?	.
25944	794	9	#	#	NNP
25944	794	10	Removal	removal	NN
25944	794	11	of	of	IN
25944	794	12	the	the	DT
25944	794	13	cause	cause	NN
25944	794	14	,	,	,
25944	794	15	and	and	CC
25944	794	16	in	in	IN
25944	794	17	debilitated	debilitate	VBN
25944	794	18	subjects	subject	NNS
25944	794	19	the	the	DT
25944	794	20	administration	administration	NN
25944	794	21	of	of	IN
25944	794	22	tonics	tonic	NNS
25944	794	23	;	;	,
25944	794	24	together	together	RB
25944	794	25	with	with	IN
25944	794	26	the	the	DT
25944	794	27	application	application	NN
25944	794	28	of	of	IN
25944	794	29	cooling	cooling	NN
25944	794	30	and	and	CC
25944	794	31	astringent	astringent	JJ
25944	794	32	lotions	lotion	NNS
25944	794	33	,	,	,
25944	794	34	as	as	IN
25944	794	35	the	the	DT
25944	794	36	following:--	following:--	NN
25944	794	37	[	[	-LRB-
25944	794	38	Rx	Rx	NNP
25944	794	39	]	]	-RRB-
25944	794	40	Aeidi	Aeidi	NNP
25944	794	41	carbolici	carbolici	VBZ
25944	794	42	,	,	,
25944	794	43	.....................	.....................	NFP
25944	794	44	[	[	-LRB-
25944	794	45	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	794	46	Acidi	Acidi	NNP
25944	794	47	borici	borici	NN
25944	794	48	,	,	,
25944	794	49	........................	........................	NFP
25944	794	50	[	[	-LRB-
25944	794	51	dram]iv	dram]iv	NNP
25944	794	52	Glycerinæ	Glycerinæ	NNP
25944	794	53	,	,	,
25944	794	54	...........................	...........................	NFP
25944	794	55	f[dram]j	f[dram]j	NNP
25944	794	56	Alcoholis	Alcoholis	NNP
25944	794	57	,	,	,
25944	794	58	...........................	...........................	.
25944	794	59	f[Oz]ij	f[Oz]ij	NNP
25944	794	60	Aquæ	Aquæ	NNP
25944	794	61	,	,	,
25944	794	62	................................	................................	NFP
25944	794	63	[	[	-LRB-
25944	794	64	Oz]xiv	Oz]xiv	NNS
25944	794	65	.	.	.
25944	795	1	M.	M.	NNP
25944	795	2	This	This	NNP
25944	795	3	is	be	VBZ
25944	795	4	sometimes	sometimes	RB
25944	795	5	more	more	RBR
25944	795	6	efficient	efficient	JJ
25944	795	7	if	if	IN
25944	795	8	zinc	zinc	NN
25944	795	9	oxide	oxide	NN
25944	795	10	,	,	,
25944	795	11	six	six	CD
25944	795	12	to	to	TO
25944	795	13	eight	eight	CD
25944	795	14	drachms	drachm	NNS
25944	795	15	,	,	,
25944	795	16	is	be	VBZ
25944	795	17	added	add	VBN
25944	795	18	.	.	.
25944	796	1	Lotions	lotion	NNS
25944	796	2	of	of	IN
25944	796	3	alcohol	alcohol	NN
25944	796	4	and	and	CC
25944	796	5	water	water	NN
25944	796	6	or	or	CC
25944	796	7	vinegar	vinegar	NN
25944	796	8	and	and	CC
25944	796	9	water	water	NN
25944	796	10	,	,	,
25944	796	11	and	and	CC
25944	796	12	also	also	RB
25944	796	13	the	the	DT
25944	796	14	various	various	JJ
25944	796	15	lotions	lotion	NNS
25944	796	16	used	use	VBN
25944	796	17	in	in	IN
25944	796	18	acute	acute	JJ
25944	796	19	eczema	eczema	NN
25944	796	20	,	,	,
25944	796	21	are	be	VBP
25944	796	22	often	often	RB
25944	796	23	employed	employ	VBN
25944	796	24	with	with	IN
25944	796	25	relief	relief	NN
25944	796	26	.	.	.
25944	797	1	Dusting	dusting	NN
25944	797	2	-	-	HYPH
25944	797	3	powders	powder	NNS
25944	797	4	of	of	IN
25944	797	5	starch	starch	NN
25944	797	6	,	,	,
25944	797	7	boric	boric	NN
25944	797	8	acid	acid	NN
25944	797	9	,	,	,
25944	797	10	lycopodium	lycopodium	NN
25944	797	11	,	,	,
25944	797	12	talc	talc	NN
25944	797	13	,	,	,
25944	797	14	and	and	CC
25944	797	15	zinc	zinc	NN
25944	797	16	oxide	oxide	NN
25944	797	17	are	be	VBP
25944	797	18	also	also	RB
25944	797	19	valuable	valuable	JJ
25944	797	20	;	;	:
25944	797	21	the	the	DT
25944	797	22	following	follow	VBG
25944	797	23	combination	combination	NN
25944	797	24	is	be	VBZ
25944	797	25	satisfactory:--	satisfactory:--	NN
25944	797	26	[	[	-LRB-
25944	797	27	Rx	Rx	NNP
25944	797	28	]	]	-RRB-
25944	797	29	Pulv	Pulv	NNP
25944	797	30	.	.	.
25944	798	1	acidi	acidi	NN
25944	798	2	borici	borici	NNP
25944	798	3	,	,	,
25944	798	4	Pulv	Pulv	NNP
25944	798	5	.	.	.
25944	799	1	talci	talci	NNP
25944	799	2	veneti	veneti	NNP
25944	799	3	,	,	,
25944	799	4	Pulv	Pulv	NNP
25944	799	5	.	.	.
25944	800	1	zinci	zinci	JJ
25944	800	2	oxidi	oxidi	NN
25944	800	3	,	,	,
25944	800	4	Pulv	Pulv	NNP
25944	800	5	.	.	.
25944	801	1	amyli	amyli	VB
25944	801	2	,	,	,
25944	801	3	.............	.............	NFP
25944	801	4	[	[	-LRB-
25944	801	5	=	=	SYM
25944	801	6	a][=a]	a][=a]	UH
25944	801	7	.....	.....	.
25944	801	8	[dram]ij	[dram]ij	XX
25944	801	9	.	.	.
25944	802	1	M.	M.	NNP
25944	802	2	Probably	probably	RB
25944	802	3	the	the	DT
25944	802	4	best	good	JJS
25944	802	5	plan	plan	NN
25944	802	6	is	be	VBZ
25944	802	7	to	to	TO
25944	802	8	use	use	VB
25944	802	9	a	a	DT
25944	802	10	lotion	lotion	NN
25944	802	11	and	and	CC
25944	802	12	a	a	DT
25944	802	13	dusting	dusting	NN
25944	802	14	-	-	HYPH
25944	802	15	powder	powder	NN
25944	802	16	conjointly	conjointly	RB
25944	802	17	;	;	:
25944	802	18	dabbing	dab	VBG
25944	802	19	on	on	IN
25944	802	20	the	the	DT
25944	802	21	wash	wash	NN
25944	802	22	freely	freely	RB
25944	802	23	,	,	,
25944	802	24	allowing	allow	VBG
25944	802	25	it	-PRON-	PRP
25944	802	26	to	to	TO
25944	802	27	dry	dry	VB
25944	802	28	,	,	,
25944	802	29	and	and	CC
25944	802	30	then	then	RB
25944	802	31	dusting	dust	VBG
25944	802	32	over	over	RP
25944	802	33	with	with	IN
25944	802	34	the	the	DT
25944	802	35	powder	powder	NN
25944	802	36	.	.	.
25944	803	1	#	#	NNP
25944	803	2	Pompholyx	Pompholyx	NNP
25944	803	3	.	.	.
25944	803	4	#	#	NNP
25944	803	5	(	(	-LRB-
25944	803	6	_	_	NNP
25944	803	7	Synonyms	Synonyms	NNP
25944	803	8	:	:	:
25944	803	9	_	_	NNP
25944	803	10	Dysidrosis	Dysidrosis	NNP
25944	803	11	;	;	:
25944	803	12	Cheiro	Cheiro	NNP
25944	803	13	-	-	HYPH
25944	803	14	pompholyx	pompholyx	NNP
25944	803	15	.	.	.
25944	803	16	)	)	-RRB-
25944	804	1	#	#	LS
25944	804	2	What	what	WP
25944	804	3	is	be	VBZ
25944	804	4	pompholyx	pompholyx	NN
25944	804	5	?	?	.
25944	804	6	#	#	NNP
25944	804	7	Pompholyx	Pompholyx	NNP
25944	804	8	is	be	VBZ
25944	804	9	a	a	DT
25944	804	10	rare	rare	JJ
25944	804	11	disease	disease	NN
25944	804	12	of	of	IN
25944	804	13	the	the	DT
25944	804	14	skin	skin	NN
25944	804	15	of	of	IN
25944	804	16	a	a	DT
25944	804	17	vesicular	vesicular	JJ
25944	804	18	and	and	CC
25944	804	19	bullous	bullous	JJ
25944	804	20	character	character	NN
25944	804	21	,	,	,
25944	804	22	and	and	CC
25944	804	23	limited	limit	VBN
25944	804	24	to	to	IN
25944	804	25	the	the	DT
25944	804	26	hands	hand	NNS
25944	804	27	and	and	CC
25944	804	28	feet	foot	NNS
25944	804	29	.	.	.
25944	805	1	#	#	NNP
25944	805	2	Describe	describe	VB
25944	805	3	the	the	DT
25944	805	4	symptoms	symptom	NNS
25944	805	5	of	of	IN
25944	805	6	pompholyx	pompholyx	NN
25944	805	7	.	.	.
25944	805	8	#	#	$
25944	805	9	In	in	IN
25944	805	10	most	most	JJS
25944	805	11	instances	instance	NNS
25944	805	12	the	the	DT
25944	805	13	hands	hand	NNS
25944	805	14	only	only	RB
25944	805	15	are	be	VBP
25944	805	16	affected	affect	VBN
25944	805	17	.	.	.
25944	806	1	It	-PRON-	PRP
25944	806	2	begins	begin	VBZ
25944	806	3	usually	usually	RB
25944	806	4	with	with	IN
25944	806	5	a	a	DT
25944	806	6	feeling	feeling	NN
25944	806	7	of	of	IN
25944	806	8	burning	burning	NN
25944	806	9	,	,	,
25944	806	10	tingling	tingling	NN
25944	806	11	or	or	CC
25944	806	12	tenderness	tenderness	NN
25944	806	13	of	of	IN
25944	806	14	the	the	DT
25944	806	15	parts	part	NNS
25944	806	16	,	,	,
25944	806	17	followed	follow	VBD
25944	806	18	rapidly	rapidly	RB
25944	806	19	by	by	IN
25944	806	20	the	the	DT
25944	806	21	appearance	appearance	NN
25944	806	22	of	of	IN
25944	806	23	deeply	deeply	RB
25944	806	24	-	-	HYPH
25944	806	25	seated	seat	VBN
25944	806	26	vesicles	vesicle	NNS
25944	806	27	,	,	,
25944	806	28	especially	especially	RB
25944	806	29	between	between	IN
25944	806	30	the	the	DT
25944	806	31	fingers	finger	NNS
25944	806	32	and	and	CC
25944	806	33	on	on	IN
25944	806	34	the	the	DT
25944	806	35	palmar	palmar	NNP
25944	806	36	aspect	aspect	NN
25944	806	37	.	.	.
25944	807	1	These	these	DT
25944	807	2	beginning	begin	VBG
25944	807	3	lesions	lesion	NNS
25944	807	4	look	look	VBP
25944	807	5	not	not	RB
25944	807	6	unlike	unlike	IN
25944	807	7	sago	sago	JJ
25944	807	8	grains	grain	NNS
25944	807	9	imbedded	imbed	VBN
25944	807	10	in	in	IN
25944	807	11	the	the	DT
25944	807	12	skin	skin	NN
25944	807	13	.	.	.
25944	808	1	In	in	IN
25944	808	2	some	some	DT
25944	808	3	instances	instance	NNS
25944	808	4	the	the	DT
25944	808	5	disease	disease	NN
25944	808	6	does	do	VBZ
25944	808	7	not	not	RB
25944	808	8	extend	extend	VB
25944	808	9	beyond	beyond	IN
25944	808	10	this	this	DT
25944	808	11	stage	stage	NN
25944	808	12	,	,	,
25944	808	13	the	the	DT
25944	808	14	vesicles	vesicle	NNS
25944	808	15	disappearing	disappear	VBG
25944	808	16	after	after	IN
25944	808	17	a	a	DT
25944	808	18	few	few	JJ
25944	808	19	days	day	NNS
25944	808	20	or	or	CC
25944	808	21	weeks	week	NNS
25944	808	22	by	by	IN
25944	808	23	absorption	absorption	NN
25944	808	24	,	,	,
25944	808	25	and	and	CC
25944	808	26	usually	usually	RB
25944	808	27	without	without	IN
25944	808	28	desquamation	desquamation	NN
25944	808	29	.	.	.
25944	809	1	Ordinarily	ordinarily	RB
25944	809	2	,	,	,
25944	809	3	however	however	RB
25944	809	4	,	,	,
25944	809	5	the	the	DT
25944	809	6	lesions	lesion	NNS
25944	809	7	increase	increase	VBP
25944	809	8	in	in	IN
25944	809	9	size	size	NN
25944	809	10	,	,	,
25944	809	11	new	new	JJ
25944	809	12	ones	one	NNS
25944	809	13	arise	arise	VBP
25944	809	14	,	,	,
25944	809	15	become	become	VBP
25944	809	16	confluent	confluent	JJ
25944	809	17	,	,	,
25944	809	18	and	and	CC
25944	809	19	blebs	blebs	NN
25944	809	20	result	result	NN
25944	809	21	,	,	,
25944	809	22	the	the	DT
25944	809	23	skin	skin	NN
25944	809	24	in	in	IN
25944	809	25	places	place	NNS
25944	809	26	appearing	appear	VBG
25944	809	27	as	as	IN
25944	809	28	if	if	IN
25944	809	29	undermined	undermine	VBN
25944	809	30	with	with	IN
25944	809	31	serous	serous	JJ
25944	809	32	exudation	exudation	NN
25944	809	33	.	.	.
25944	810	1	The	the	DT
25944	810	2	parts	part	NNS
25944	810	3	are	be	VBP
25944	810	4	commonly	commonly	RB
25944	810	5	inflamed	inflame	VBN
25944	810	6	to	to	IN
25944	810	7	a	a	DT
25944	810	8	slight	slight	JJ
25944	810	9	or	or	CC
25944	810	10	marked	marked	JJ
25944	810	11	degree	degree	NN
25944	810	12	.	.	.
25944	811	1	The	the	DT
25944	811	2	skin	skin	NN
25944	811	3	comes	come	VBZ
25944	811	4	off	off	RP
25944	811	5	in	in	IN
25944	811	6	flakes	flake	NNS
25944	811	7	,	,	,
25944	811	8	new	new	JJ
25944	811	9	lesions	lesion	NNS
25944	811	10	may	may	MD
25944	811	11	appear	appear	VB
25944	811	12	for	for	IN
25944	811	13	several	several	JJ
25944	811	14	days	day	NNS
25944	811	15	or	or	CC
25944	811	16	two	two	CD
25944	811	17	or	or	CC
25944	811	18	three	three	CD
25944	811	19	weeks	week	NNS
25944	811	20	,	,	,
25944	811	21	and	and	CC
25944	811	22	the	the	DT
25944	811	23	process	process	NN
25944	811	24	then	then	RB
25944	811	25	declines	decline	VBZ
25944	811	26	,	,	,
25944	811	27	recovery	recovery	NN
25944	811	28	gradually	gradually	RB
25944	811	29	taking	take	VBG
25944	811	30	place	place	NN
25944	811	31	.	.	.
25944	812	1	There	there	EX
25944	812	2	are	be	VBP
25944	812	3	no	no	DT
25944	812	4	constitutional	constitutional	JJ
25944	812	5	symptoms	symptom	NNS
25944	812	6	,	,	,
25944	812	7	although	although	IN
25944	812	8	it	-PRON-	PRP
25944	812	9	is	be	VBZ
25944	812	10	usually	usually	RB
25944	812	11	noticed	notice	VBN
25944	812	12	that	that	IN
25944	812	13	the	the	DT
25944	812	14	general	general	JJ
25944	812	15	health	health	NN
25944	812	16	is	be	VBZ
25944	812	17	below	below	IN
25944	812	18	par	par	NN
25944	812	19	.	.	.
25944	813	1	#	#	LS
25944	813	2	What	what	WP
25944	813	3	is	be	VBZ
25944	813	4	the	the	DT
25944	813	5	character	character	NN
25944	813	6	of	of	IN
25944	813	7	the	the	DT
25944	813	8	subjective	subjective	JJ
25944	813	9	symptoms	symptom	NNS
25944	813	10	in	in	IN
25944	813	11	pompholyx	pompholyx	NN
25944	813	12	?	?	.
25944	813	13	#	#	$
25944	813	14	The	the	DT
25944	813	15	subjective	subjective	JJ
25944	813	16	symptoms	symptom	NNS
25944	813	17	consist	consist	VBP
25944	813	18	of	of	IN
25944	813	19	a	a	DT
25944	813	20	feeling	feeling	NN
25944	813	21	of	of	IN
25944	813	22	tension	tension	NN
25944	813	23	,	,	,
25944	813	24	burning	burning	NN
25944	813	25	and	and	CC
25944	813	26	tenderness	tenderness	NN
25944	813	27	,	,	,
25944	813	28	and	and	CC
25944	813	29	sometimes	sometimes	RB
25944	813	30	itching	itch	VBG
25944	813	31	.	.	.
25944	814	1	Not	not	RB
25944	814	2	infrequently	infrequently	RB
25944	814	3	,	,	,
25944	814	4	also	also	RB
25944	814	5	there	there	EX
25944	814	6	is	be	VBZ
25944	814	7	neuralgic	neuralgic	JJ
25944	814	8	pain	pain	NN
25944	814	9	.	.	.
25944	815	1	#	#	LS
25944	815	2	What	what	WP
25944	815	3	is	be	VBZ
25944	815	4	the	the	DT
25944	815	5	cause	cause	NN
25944	815	6	of	of	IN
25944	815	7	pompholyx	pompholyx	NN
25944	815	8	?	?	.
25944	815	9	#	#	$
25944	815	10	The	the	DT
25944	815	11	eruption	eruption	NN
25944	815	12	is	be	VBZ
25944	815	13	thought	think	VBN
25944	815	14	to	to	TO
25944	815	15	be	be	VB
25944	815	16	due	due	IN
25944	815	17	to	to	IN
25944	815	18	a	a	DT
25944	815	19	depressed	depressed	JJ
25944	815	20	state	state	NN
25944	815	21	of	of	IN
25944	815	22	the	the	DT
25944	815	23	nervous	nervous	JJ
25944	815	24	system	system	NN
25944	815	25	.	.	.
25944	816	1	It	-PRON-	PRP
25944	816	2	is	be	VBZ
25944	816	3	more	more	RBR
25944	816	4	common	common	JJ
25944	816	5	in	in	IN
25944	816	6	women	woman	NNS
25944	816	7	,	,	,
25944	816	8	and	and	CC
25944	816	9	is	be	VBZ
25944	816	10	met	meet	VBN
25944	816	11	with	with	IN
25944	816	12	chiefly	chiefly	NNP
25944	816	13	in	in	IN
25944	816	14	adult	adult	NN
25944	816	15	and	and	CC
25944	816	16	middle	middle	JJ
25944	816	17	life	life	NN
25944	816	18	.	.	.
25944	817	1	#	#	LS
25944	817	2	What	what	WP
25944	817	3	is	be	VBZ
25944	817	4	the	the	DT
25944	817	5	pathology	pathology	NN
25944	817	6	?	?	.
25944	817	7	#	#	$
25944	817	8	Opinion	opinion	NN
25944	817	9	is	be	VBZ
25944	817	10	divided	divide	VBN
25944	817	11	;	;	:
25944	817	12	some	some	DT
25944	817	13	considering	consider	VBG
25944	817	14	it	-PRON-	PRP
25944	817	15	a	a	DT
25944	817	16	disease	disease	NN
25944	817	17	of	of	IN
25944	817	18	the	the	DT
25944	817	19	sweat	sweat	NN
25944	817	20	-	-	HYPH
25944	817	21	glands	gland	NNS
25944	817	22	and	and	CC
25944	817	23	others	other	NNS
25944	817	24	an	an	DT
25944	817	25	inflammatory	inflammatory	JJ
25944	817	26	disease	disease	NN
25944	817	27	independent	independent	NN
25944	817	28	of	of	IN
25944	817	29	these	these	DT
25944	817	30	structures	structure	NNS
25944	817	31	.	.	.
25944	818	1	#	#	JJR
25944	818	2	State	state	NN
25944	818	3	the	the	DT
25944	818	4	diagnostic	diagnostic	JJ
25944	818	5	features	feature	NNS
25944	818	6	of	of	IN
25944	818	7	pompholyx	pompholyx	NN
25944	818	8	.	.	.
25944	818	9	#	#	$
25944	818	10	The	the	DT
25944	818	11	distribution	distribution	NN
25944	818	12	and	and	CC
25944	818	13	the	the	DT
25944	818	14	peculiar	peculiar	JJ
25944	818	15	characters	character	NNS
25944	818	16	and	and	CC
25944	818	17	course	course	NN
25944	818	18	of	of	IN
25944	818	19	the	the	DT
25944	818	20	eruption	eruption	NN
25944	818	21	.	.	.
25944	819	1	It	-PRON-	PRP
25944	819	2	is	be	VBZ
25944	819	3	to	to	TO
25944	819	4	be	be	VB
25944	819	5	differentiated	differentiate	VBN
25944	819	6	from	from	IN
25944	819	7	eczema	eczema	NN
25944	819	8	.	.	.
25944	820	1	#	#	LS
25944	820	2	What	what	WP
25944	820	3	is	be	VBZ
25944	820	4	the	the	DT
25944	820	5	prognosis	prognosis	NN
25944	820	6	?	?	.
25944	820	7	#	#	$
25944	820	8	For	for	IN
25944	820	9	the	the	DT
25944	820	10	immediate	immediate	JJ
25944	820	11	attack	attack	NN
25944	820	12	,	,	,
25944	820	13	favorable	favorable	JJ
25944	820	14	,	,	,
25944	820	15	recovery	recovery	NN
25944	820	16	taking	take	VBG
25944	820	17	place	place	NN
25944	820	18	in	in	IN
25944	820	19	several	several	JJ
25944	820	20	weeks	week	NNS
25944	820	21	or	or	CC
25944	820	22	a	a	DT
25944	820	23	few	few	JJ
25944	820	24	months	month	NNS
25944	820	25	.	.	.
25944	821	1	Recurrences	recurrence	NNS
25944	821	2	at	at	IN
25944	821	3	irregular	irregular	JJ
25944	821	4	intervals	interval	NNS
25944	821	5	are	be	VBP
25944	821	6	not	not	RB
25944	821	7	uncommon	uncommon	JJ
25944	821	8	.	.	.
25944	822	1	#	#	LS
25944	822	2	What	what	WP
25944	822	3	is	be	VBZ
25944	822	4	the	the	DT
25944	822	5	treatment	treatment	NN
25944	822	6	of	of	IN
25944	822	7	pompholyx	pompholyx	NN
25944	822	8	?	?	.
25944	822	9	#	#	$
25944	822	10	The	the	DT
25944	822	11	general	general	JJ
25944	822	12	health	health	NN
25944	822	13	is	be	VBZ
25944	822	14	to	to	TO
25944	822	15	be	be	VB
25944	822	16	looked	look	VBN
25944	822	17	after	after	IN
25944	822	18	,	,	,
25944	822	19	and	and	CC
25944	822	20	the	the	DT
25944	822	21	patient	patient	NN
25944	822	22	placed	place	VBN
25944	822	23	under	under	IN
25944	822	24	good	good	JJ
25944	822	25	hygienic	hygienic	JJ
25944	822	26	conditions	condition	NNS
25944	822	27	.	.	.
25944	823	1	Remedies	remedy	NNS
25944	823	2	of	of	IN
25944	823	3	a	a	DT
25944	823	4	tonic	tonic	NN
25944	823	5	nature	nature	NN
25944	823	6	,	,	,
25944	823	7	directed	direct	VBD
25944	823	8	especially	especially	RB
25944	823	9	toward	toward	IN
25944	823	10	improving	improve	VBG
25944	823	11	the	the	DT
25944	823	12	state	state	NN
25944	823	13	of	of	IN
25944	823	14	the	the	DT
25944	823	15	nervous	nervous	JJ
25944	823	16	system	system	NN
25944	823	17	,	,	,
25944	823	18	are	be	VBP
25944	823	19	to	to	TO
25944	823	20	be	be	VB
25944	823	21	prescribed	prescribe	VBN
25944	823	22	.	.	.
25944	824	1	_	_	NNP
25944	824	2	Locally	Locally	NNP
25944	824	3	_	_	NNP
25944	824	4	,	,	,
25944	824	5	soothing	soothing	JJ
25944	824	6	and	and	CC
25944	824	7	anodyne	anodyne	NN
25944	824	8	applications	application	NNS
25944	824	9	,	,	,
25944	824	10	such	such	JJ
25944	824	11	as	as	IN
25944	824	12	lead	lead	NN
25944	824	13	-	-	HYPH
25944	824	14	water	water	NN
25944	824	15	and	and	CC
25944	824	16	laudanum	laudanum	NN
25944	824	17	,	,	,
25944	824	18	boric	boric	NN
25944	824	19	-	-	HYPH
25944	824	20	acid	acid	NN
25944	824	21	lotion	lotion	NN
25944	824	22	,	,	,
25944	824	23	oxide	oxide	NN
25944	824	24	-	-	HYPH
25944	824	25	of	of	IN
25944	824	26	-	-	HYPH
25944	824	27	zinc	zinc	NN
25944	824	28	,	,	,
25944	824	29	boric	boric	NN
25944	824	30	-	-	HYPH
25944	824	31	acid	acid	NN
25944	824	32	and	and	CC
25944	824	33	diachylon	diachylon	NN
25944	824	34	ointments	ointment	NNS
25944	824	35	,	,	,
25944	824	36	are	be	VBP
25944	824	37	most	most	RBS
25944	824	38	suitable	suitable	JJ
25944	824	39	;	;	:
25944	824	40	or	or	CC
25944	824	41	the	the	DT
25944	824	42	parts	part	NNS
25944	824	43	may	may	MD
25944	824	44	be	be	VB
25944	824	45	enveloped	envelop	VBN
25944	824	46	with	with	IN
25944	824	47	the	the	DT
25944	824	48	following:--	following:--	NN
25944	824	49	[	[	-LRB-
25944	824	50	Rx	Rx	NNP
25944	824	51	]	]	-RRB-
25944	824	52	Pulv	Pulv	NNP
25944	824	53	.	.	.
25944	825	1	ac	ac	NNP
25944	825	2	.	.	.
25944	826	1	salicylici	salicylici	NNP
25944	826	2	,	,	,
25944	826	3	................	................	NFP
25944	826	4	gr	gr	FW
25944	826	5	.	.	.
25944	827	1	x	x	LS
25944	827	2	Pulv	Pulv	NNP
25944	827	3	.	.	.
25944	828	1	ac	ac	NNP
25944	828	2	.	.	.
25944	829	1	borici	borici	NNP
25944	829	2	,	,	,
25944	829	3	Pulv	Pulv	NNP
25944	829	4	.	.	.
25944	830	1	amyli	amyli	VB
25944	830	2	,	,	,
25944	830	3	..........	..........	NFP
25944	830	4	[	[	-LRB-
25944	830	5	=	=	SYM
25944	830	6	a][=a	a][=a	CD
25944	830	7	]	]	-RRB-
25944	830	8	.....	.....	.
25944	830	9	[	[	-LRB-
25944	830	10	dram]ij	dram]ij	NNP
25944	830	11	Petrolati	Petrolati	NNP
25944	830	12	,	,	,
25944	830	13	...........................	...........................	NFP
25944	830	14	[	[	-LRB-
25944	830	15	dram]iv	dram]iv	NNS
25944	830	16	.	.	.
25944	831	1	M.	M.	NNP
25944	831	2	In	In	NNP
25944	831	3	fact	fact	NN
25944	831	4	,	,	,
25944	831	5	the	the	DT
25944	831	6	external	external	JJ
25944	831	7	treatment	treatment	NN
25944	831	8	is	be	VBZ
25944	831	9	similar	similar	JJ
25944	831	10	to	to	IN
25944	831	11	that	that	DT
25944	831	12	employed	employ	VBN
25944	831	13	in	in	IN
25944	831	14	acute	acute	JJ
25944	831	15	eczema	eczema	NN
25944	831	16	.	.	.
25944	832	1	#	#	NNP
25944	832	2	Herpes	Herpes	NNP
25944	832	3	Simplex	Simplex	NNP
25944	832	4	.	.	.
25944	832	5	#	#	NNP
25944	832	6	(	(	-LRB-
25944	832	7	_	_	NNP
25944	832	8	Synonym	Synonym	NNP
25944	832	9	:	:	:
25944	832	10	_	_	NNP
25944	832	11	Fever	Fever	NNP
25944	832	12	Blisters	Blisters	NNPS
25944	832	13	.	.	.
25944	832	14	)	)	-RRB-
25944	833	1	#	#	LS
25944	833	2	What	what	WP
25944	833	3	is	be	VBZ
25944	833	4	herpes	herpe	NNS
25944	833	5	simplex	simplex	NN
25944	833	6	?	?	.
25944	833	7	#	#	$
25944	833	8	An	an	DT
25944	833	9	acute	acute	JJ
25944	833	10	inflammatory	inflammatory	JJ
25944	833	11	disease	disease	NN
25944	833	12	,	,	,
25944	833	13	characterized	characterize	VBN
25944	833	14	by	by	IN
25944	833	15	the	the	DT
25944	833	16	formation	formation	NN
25944	833	17	of	of	IN
25944	833	18	pin	pin	NN
25944	833	19	-	-	HYPH
25944	833	20	head	head	NN
25944	833	21	to	to	IN
25944	833	22	pea	pea	JJ
25944	833	23	-	-	HYPH
25944	833	24	sized	sized	JJ
25944	833	25	vesicles	vesicle	NNS
25944	833	26	,	,	,
25944	833	27	arranged	arrange	VBN
25944	833	28	in	in	IN
25944	833	29	groups	group	NNS
25944	833	30	,	,	,
25944	833	31	and	and	CC
25944	833	32	occurring	occur	VBG
25944	833	33	for	for	IN
25944	833	34	the	the	DT
25944	833	35	most	most	JJS
25944	833	36	part	part	NN
25944	833	37	about	about	IN
25944	833	38	the	the	DT
25944	833	39	face	face	NN
25944	833	40	and	and	CC
25944	833	41	genitalia	genitalia	NNP
25944	833	42	.	.	.
25944	834	1	#	#	NNP
25944	834	2	Describe	describe	VB
25944	834	3	the	the	DT
25944	834	4	symptoms	symptom	NNS
25944	834	5	of	of	IN
25944	834	6	herpes	herpe	NNS
25944	834	7	simplex	simplex	NN
25944	834	8	.	.	.
25944	834	9	#	#	$
25944	834	10	In	in	IN
25944	834	11	severe	severe	JJ
25944	834	12	cases	case	NNS
25944	834	13	,	,	,
25944	834	14	malaise	malaise	NN
25944	834	15	and	and	CC
25944	834	16	pyrexia	pyrexia	NNP
25944	834	17	may	may	MD
25944	834	18	precede	precede	VB
25944	834	19	the	the	DT
25944	834	20	eruption	eruption	NN
25944	834	21	,	,	,
25944	834	22	but	but	CC
25944	834	23	usually	usually	RB
25944	834	24	it	-PRON-	PRP
25944	834	25	appears	appear	VBZ
25944	834	26	without	without	IN
25944	834	27	any	any	DT
25944	834	28	precursory	precursory	NN
25944	834	29	or	or	CC
25944	834	30	constitutional	constitutional	JJ
25944	834	31	symptoms	symptom	NNS
25944	834	32	.	.	.
25944	835	1	A	a	DT
25944	835	2	feeling	feeling	NN
25944	835	3	of	of	IN
25944	835	4	heat	heat	NN
25944	835	5	and	and	CC
25944	835	6	burning	burn	VBG
25944	835	7	in	in	IN
25944	835	8	the	the	DT
25944	835	9	parts	part	NNS
25944	835	10	is	be	VBZ
25944	835	11	often	often	RB
25944	835	12	complained	complain	VBN
25944	835	13	of	of	IN
25944	835	14	.	.	.
25944	836	1	The	the	DT
25944	836	2	vesicles	vesicle	NNS
25944	836	3	,	,	,
25944	836	4	which	which	WDT
25944	836	5	are	be	VBP
25944	836	6	commonly	commonly	RB
25944	836	7	pin	pin	NN
25944	836	8	-	-	HYPH
25944	836	9	head	head	NN
25944	836	10	in	in	IN
25944	836	11	size	size	NN
25944	836	12	,	,	,
25944	836	13	are	be	VBP
25944	836	14	usually	usually	RB
25944	836	15	upon	upon	IN
25944	836	16	a	a	DT
25944	836	17	hyperæmic	hyperæmic	JJ
25944	836	18	or	or	CC
25944	836	19	inflammatory	inflammatory	JJ
25944	836	20	base	base	NN
25944	836	21	,	,	,
25944	836	22	and	and	CC
25944	836	23	tend	tend	VBP
25944	836	24	to	to	TO
25944	836	25	occur	occur	VB
25944	836	26	in	in	IN
25944	836	27	groups	group	NNS
25944	836	28	or	or	CC
25944	836	29	clusters	cluster	NNS
25944	836	30	.	.	.
25944	837	1	Their	-PRON-	PRP$
25944	837	2	contents	content	NNS
25944	837	3	are	be	VBP
25944	837	4	usually	usually	RB
25944	837	5	clear	clear	JJ
25944	837	6	,	,	,
25944	837	7	subsequently	subsequently	RB
25944	837	8	becoming	become	VBG
25944	837	9	more	more	RBR
25944	837	10	or	or	CC
25944	837	11	less	less	RBR
25944	837	12	milky	milky	NNP
25944	837	13	or	or	CC
25944	837	14	puriform	puriform	NN
25944	837	15	.	.	.
25944	838	1	There	there	EX
25944	838	2	is	be	VBZ
25944	838	3	no	no	DT
25944	838	4	tendency	tendency	NN
25944	838	5	to	to	IN
25944	838	6	spontaneous	spontaneous	JJ
25944	838	7	rupture	rupture	NN
25944	838	8	,	,	,
25944	838	9	but	but	CC
25944	838	10	should	should	MD
25944	838	11	they	-PRON-	PRP
25944	838	12	be	be	VB
25944	838	13	broken	break	VBN
25944	838	14	a	a	DT
25944	838	15	superficial	superficial	JJ
25944	838	16	excoriation	excoriation	NN
25944	838	17	results	result	NNS
25944	838	18	.	.	.
25944	839	1	In	in	IN
25944	839	2	a	a	DT
25944	839	3	short	short	JJ
25944	839	4	time	time	NN
25944	839	5	they	-PRON-	PRP
25944	839	6	dry	dry	VBP
25944	839	7	to	to	IN
25944	839	8	crusts	crust	NNS
25944	839	9	which	which	WDT
25944	839	10	soon	soon	RB
25944	839	11	fall	fall	VBP
25944	839	12	off	off	RP
25944	839	13	,	,	,
25944	839	14	leaving	leave	VBG
25944	839	15	no	no	DT
25944	839	16	permanent	permanent	JJ
25944	839	17	trace	trace	NN
25944	839	18	.	.	.
25944	840	1	#	#	$
25944	840	2	Is	be	VBZ
25944	840	3	the	the	DT
25944	840	4	eruption	eruption	NN
25944	840	5	in	in	IN
25944	840	6	herpes	herpes	NNP
25944	840	7	simplex	simplex	NN
25944	840	8	abundant	abundant	JJ
25944	840	9	?	?	.
25944	840	10	#	#	$
25944	840	11	No	no	UH
25944	840	12	.	.	.
25944	841	1	As	as	IN
25944	841	2	a	a	DT
25944	841	3	rule	rule	NN
25944	841	4	not	not	RB
25944	841	5	more	more	JJR
25944	841	6	than	than	IN
25944	841	7	one	one	CD
25944	841	8	or	or	CC
25944	841	9	two	two	CD
25944	841	10	clusters	cluster	NNS
25944	841	11	or	or	CC
25944	841	12	groups	group	NNS
25944	841	13	are	be	VBP
25944	841	14	observed	observe	VBN
25944	841	15	.	.	.
25944	842	1	#	#	NN
25944	842	2	Upon	upon	IN
25944	842	3	what	what	WP
25944	842	4	parts	part	NNS
25944	842	5	does	do	VBZ
25944	842	6	the	the	DT
25944	842	7	eruption	eruption	NN
25944	842	8	occur	occur	VB
25944	842	9	?	?	.
25944	842	10	#	#	NN
25944	842	11	Usually	usually	RB
25944	842	12	about	about	IN
25944	842	13	the	the	DT
25944	842	14	face	face	NN
25944	842	15	(	(	-LRB-
25944	842	16	_	_	NNP
25944	842	17	herpes	herpes	NNP
25944	842	18	facialis	facialis	NNP
25944	842	19	_	_	NNP
25944	842	20	)	)	-RRB-
25944	842	21	,	,	,
25944	842	22	and	and	CC
25944	842	23	most	most	RBS
25944	842	24	frequently	frequently	RB
25944	842	25	about	about	IN
25944	842	26	the	the	DT
25944	842	27	lips	lip	NNS
25944	842	28	(	(	-LRB-
25944	842	29	_	_	NNP
25944	842	30	herpes	herpes	NNP
25944	842	31	labialis	labialis	NNP
25944	842	32	_	_	NNP
25944	842	33	)	)	-RRB-
25944	842	34	;	;	:
25944	842	35	on	on	IN
25944	842	36	the	the	DT
25944	842	37	genitalia	genitalia	NNP
25944	842	38	(	(	-LRB-
25944	842	39	_	_	NNP
25944	842	40	herpes	herpe	NNS
25944	842	41	progenitalis	progenitalis	NNP
25944	842	42	_	_	NNP
25944	842	43	)	)	-RRB-
25944	842	44	,	,	,
25944	842	45	the	the	DT
25944	842	46	lesions	lesion	NNS
25944	842	47	are	be	VBP
25944	842	48	commonly	commonly	RB
25944	842	49	found	find	VBN
25944	842	50	on	on	IN
25944	842	51	the	the	DT
25944	842	52	prepuce	prepuce	NN
25944	842	53	(	(	-LRB-
25944	842	54	_	_	NNP
25944	842	55	herpes	herpes	NNP
25944	842	56	præputialis	præputialis	NNP
25944	842	57	_	_	NNP
25944	842	58	)	)	-RRB-
25944	842	59	in	in	IN
25944	842	60	the	the	DT
25944	842	61	male	male	NN
25944	842	62	,	,	,
25944	842	63	and	and	CC
25944	842	64	on	on	IN
25944	842	65	the	the	DT
25944	842	66	labia	labia	NNP
25944	842	67	minora	minora	NNP
25944	842	68	and	and	CC
25944	842	69	labia	labia	NNP
25944	842	70	majora	majora	NNP
25944	842	71	in	in	IN
25944	842	72	the	the	DT
25944	842	73	female	female	NN
25944	842	74	.	.	.
25944	843	1	#	#	JJR
25944	843	2	State	state	NN
25944	843	3	the	the	DT
25944	843	4	causes	cause	NNS
25944	843	5	of	of	IN
25944	843	6	herpes	herpe	NNS
25944	843	7	simplex	simplex	NN
25944	843	8	.	.	.
25944	843	9	#	#	NNP
25944	843	10	Herpes	Herpes	NNP
25944	843	11	facialis	facialis	NNP
25944	843	12	is	be	VBZ
25944	843	13	often	often	RB
25944	843	14	observed	observe	VBN
25944	843	15	in	in	IN
25944	843	16	association	association	NN
25944	843	17	with	with	IN
25944	843	18	colds	cold	NNS
25944	843	19	and	and	CC
25944	843	20	febrile	febrile	NN
25944	843	21	and	and	CC
25944	843	22	lung	lung	NN
25944	843	23	diseases	disease	NNS
25944	843	24	.	.	.
25944	844	1	Malaria	Malaria	NNP
25944	844	2	,	,	,
25944	844	3	digestive	digestive	JJ
25944	844	4	disturbance	disturbance	NN
25944	844	5	,	,	,
25944	844	6	and	and	CC
25944	844	7	nervous	nervous	JJ
25944	844	8	disorders	disorder	NNS
25944	844	9	are	be	VBP
25944	844	10	not	not	RB
25944	844	11	infrequently	infrequently	RB
25944	844	12	predisposing	predispose	VBG
25944	844	13	factors	factor	NNS
25944	844	14	.	.	.
25944	845	1	Herpes	Herpes	NNP
25944	845	2	progenitalis	progenitalis	NNP
25944	845	3	is	be	VBZ
25944	845	4	said	say	VBN
25944	845	5	to	to	TO
25944	845	6	occur	occur	VB
25944	845	7	more	more	RBR
25944	845	8	frequently	frequently	RB
25944	845	9	in	in	IN
25944	845	10	those	those	DT
25944	845	11	who	who	WP
25944	845	12	have	have	VBP
25944	845	13	previously	previously	RB
25944	845	14	had	have	VBN
25944	845	15	some	some	DT
25944	845	16	venereal	venereal	JJ
25944	845	17	disease	disease	NN
25944	845	18	,	,	,
25944	845	19	especially	especially	RB
25944	845	20	gonorrh[oe]a	gonorrh[oe]a	NNP
25944	845	21	,	,	,
25944	845	22	but	but	CC
25944	845	23	this	this	DT
25944	845	24	is	be	VBZ
25944	845	25	questionable	questionable	JJ
25944	845	26	.	.	.
25944	846	1	It	-PRON-	PRP
25944	846	2	is	be	VBZ
25944	846	3	probably	probably	RB
25944	846	4	often	often	RB
25944	846	5	purely	purely	RB
25944	846	6	neurotic	neurotic	JJ
25944	846	7	.	.	.
25944	847	1	#	#	LS
25944	847	2	What	what	WP
25944	847	3	are	be	VBP
25944	847	4	the	the	DT
25944	847	5	diagnostic	diagnostic	JJ
25944	847	6	points	point	NNS
25944	847	7	?	?	.
25944	847	8	#	#	$
25944	847	9	The	the	DT
25944	847	10	appearance	appearance	NN
25944	847	11	of	of	IN
25944	847	12	one	one	CD
25944	847	13	or	or	CC
25944	847	14	several	several	JJ
25944	847	15	vesicular	vesicular	JJ
25944	847	16	groups	group	NNS
25944	847	17	or	or	CC
25944	847	18	clusters	cluster	NNS
25944	847	19	about	about	IN
25944	847	20	the	the	DT
25944	847	21	face	face	NN
25944	847	22	,	,	,
25944	847	23	and	and	CC
25944	847	24	especially	especially	RB
25944	847	25	about	about	IN
25944	847	26	the	the	DT
25944	847	27	lips	lip	NNS
25944	847	28	,	,	,
25944	847	29	is	be	VBZ
25944	847	30	usually	usually	RB
25944	847	31	sufficiently	sufficiently	RB
25944	847	32	characteristic	characteristic	JJ
25944	847	33	.	.	.
25944	848	1	The	the	DT
25944	848	2	same	same	JJ
25944	848	3	holds	hold	VBZ
25944	848	4	true	true	JJ
25944	848	5	ordinarily	ordinarily	RB
25944	848	6	when	when	WRB
25944	848	7	the	the	DT
25944	848	8	eruption	eruption	NN
25944	848	9	is	be	VBZ
25944	848	10	seen	see	VBN
25944	848	11	on	on	IN
25944	848	12	the	the	DT
25944	848	13	prepuce	prepuce	NN
25944	848	14	or	or	CC
25944	848	15	other	other	JJ
25944	848	16	parts	part	NNS
25944	848	17	of	of	IN
25944	848	18	the	the	DT
25944	848	19	genitalia	genitalia	NNP
25944	848	20	;	;	:
25944	848	21	it	-PRON-	PRP
25944	848	22	is	be	VBZ
25944	848	23	only	only	RB
25944	848	24	when	when	WRB
25944	848	25	the	the	DT
25944	848	26	vesicles	vesicle	NNS
25944	848	27	become	become	VBP
25944	848	28	rubbed	rubbed	JJ
25944	848	29	or	or	CC
25944	848	30	abraded	abrade	VBN
25944	848	31	and	and	CC
25944	848	32	irritated	irritate	VBD
25944	848	33	that	that	IN
25944	848	34	it	-PRON-	PRP
25944	848	35	might	may	MD
25944	848	36	be	be	VB
25944	848	37	mistaken	mistake	VBN
25944	848	38	for	for	IN
25944	848	39	a	a	DT
25944	848	40	venereal	venereal	JJ
25944	848	41	sore	sore	JJ
25944	848	42	,	,	,
25944	848	43	but	but	CC
25944	848	44	the	the	DT
25944	848	45	history	history	NN
25944	848	46	,	,	,
25944	848	47	course	course	NN
25944	848	48	and	and	CC
25944	848	49	duration	duration	NN
25944	848	50	will	will	MD
25944	848	51	usually	usually	RB
25944	848	52	serve	serve	VB
25944	848	53	to	to	TO
25944	848	54	differentiate	differentiate	VB
25944	848	55	.	.	.
25944	849	1	#	#	NN
25944	849	2	Give	give	VB
25944	849	3	the	the	DT
25944	849	4	prognosis	prognosis	NN
25944	849	5	.	.	.
25944	849	6	#	#	$
25944	849	7	The	the	DT
25944	849	8	eruption	eruption	NN
25944	849	9	will	will	MD
25944	849	10	usually	usually	RB
25944	849	11	disappear	disappear	VB
25944	849	12	in	in	IN
25944	849	13	several	several	JJ
25944	849	14	days	day	NNS
25944	849	15	or	or	CC
25944	849	16	one	one	CD
25944	849	17	or	or	CC
25944	849	18	two	two	CD
25944	849	19	weeks	week	NNS
25944	849	20	without	without	IN
25944	849	21	treatment	treatment	NN
25944	849	22	.	.	.
25944	850	1	Remedial	remedial	JJ
25944	850	2	applications	application	NNS
25944	850	3	,	,	,
25944	850	4	however	however	RB
25944	850	5	,	,	,
25944	850	6	exert	exert	VB
25944	850	7	a	a	DT
25944	850	8	favorable	favorable	JJ
25944	850	9	influence	influence	NN
25944	850	10	.	.	.
25944	851	1	Herpes	Herpes	NNP
25944	851	2	progenitalis	progenitalis	NNP
25944	851	3	exhibits	exhibit	VBZ
25944	851	4	a	a	DT
25944	851	5	strong	strong	JJ
25944	851	6	disposition	disposition	NN
25944	851	7	to	to	TO
25944	851	8	recurrence	recurrence	VB
25944	851	9	.	.	.
25944	852	1	#	#	LS
25944	852	2	What	what	WP
25944	852	3	is	be	VBZ
25944	852	4	the	the	DT
25944	852	5	treatment	treatment	NN
25944	852	6	of	of	IN
25944	852	7	herpes	herpes	NNP
25944	852	8	facialis	facialis	NNP
25944	852	9	?	?	.
25944	852	10	#	#	NNP
25944	852	11	Anointing	anoint	VBG
25944	852	12	the	the	DT
25944	852	13	parts	part	NNS
25944	852	14	with	with	IN
25944	852	15	camphorated	camphorated	JJ
25944	852	16	cold	cold	JJ
25944	852	17	cream	cream	NN
25944	852	18	,	,	,
25944	852	19	with	with	IN
25944	852	20	spirits	spirit	NNS
25944	852	21	of	of	IN
25944	852	22	camphor	camphor	NNP
25944	852	23	or	or	CC
25944	852	24	similar	similar	JJ
25944	852	25	evaporating	evaporating	NN
25944	852	26	and	and	CC
25944	852	27	stimulating	stimulate	VBG
25944	852	28	applications	application	NNS
25944	852	29	will	will	MD
25944	852	30	at	at	IN
25944	852	31	times	time	NNS
25944	852	32	afford	afford	VB
25944	852	33	relief	relief	NN
25944	852	34	to	to	IN
25944	852	35	the	the	DT
25944	852	36	burning	burning	NN
25944	852	37	,	,	,
25944	852	38	and	and	CC
25944	852	39	shorten	shorten	VB
25944	852	40	the	the	DT
25944	852	41	course	course	NN
25944	852	42	.	.	.
25944	853	1	#	#	LS
25944	853	2	What	what	WP
25944	853	3	is	be	VBZ
25944	853	4	the	the	DT
25944	853	5	treatment	treatment	NN
25944	853	6	of	of	IN
25944	853	7	herpes	herpe	NNS
25944	853	8	progenitalis	progenitalis	NNP
25944	853	9	?	?	.
25944	853	10	#	#	$
25944	853	11	In	in	IN
25944	853	12	herpes	herpe	NNS
25944	853	13	about	about	IN
25944	853	14	the	the	DT
25944	853	15	genitalia	genitalia	NNP
25944	853	16	cleanliness	cleanliness	NNP
25944	853	17	is	be	VBZ
25944	853	18	of	of	IN
25944	853	19	first	first	JJ
25944	853	20	importance	importance	NN
25944	853	21	.	.	.
25944	854	1	A	a	DT
25944	854	2	saturated	saturate	VBN
25944	854	3	solution	solution	NN
25944	854	4	of	of	IN
25944	854	5	boric	boric	NN
25944	854	6	acid	acid	NN
25944	854	7	,	,	,
25944	854	8	a	a	DT
25944	854	9	dusting	dusting	NN
25944	854	10	-	-	HYPH
25944	854	11	powder	powder	NN
25944	854	12	of	of	IN
25944	854	13	calomel	calomel	NN
25944	854	14	or	or	CC
25944	854	15	oxide	oxide	NN
25944	854	16	of	of	IN
25944	854	17	zinc	zinc	NN
25944	854	18	,	,	,
25944	854	19	and	and	CC
25944	854	20	the	the	DT
25944	854	21	following	follow	VBG
25944	854	22	lotion	lotion	NN
25944	854	23	,	,	,
25944	854	24	containing	contain	VBG
25944	854	25	calamine	calamine	NN
25944	854	26	and	and	CC
25944	854	27	oxide	oxide	NN
25944	854	28	of	of	IN
25944	854	29	zinc	zinc	NN
25944	854	30	,	,	,
25944	854	31	are	be	VBP
25944	854	32	valuable:--	valuable:--	JJR
25944	854	33	[	[	-LRB-
25944	854	34	Rx	Rx	NNP
25944	854	35	]	]	-RRB-
25944	854	36	Zinci	Zinci	NNP
25944	854	37	oxidi	oxidi	NN
25944	854	38	,	,	,
25944	854	39	Calaminæ	Calaminæ	NNP
25944	854	40	,	,	,
25944	854	41	..........	..........	NFP
25944	854	42	[	[	-LRB-
25944	854	43	=	=	SYM
25944	854	44	a][=a	a][=a	CD
25944	854	45	]	]	-RRB-
25944	854	46	........	........	.
25944	854	47	gr	gr	NNP
25944	854	48	.	.	.
25944	855	1	v	v	LS
25944	855	2	Glycerinæ	Glycerinæ	NNP
25944	855	3	,	,	,
25944	855	4	Alcoholis	Alcoholis	NNP
25944	855	5	,	,	,
25944	855	6	.........	.........	NFP
25944	855	7	[	[	-LRB-
25944	855	8	=	=	SYM
25944	855	9	a][=a	a][=a	CD
25944	855	10	]	]	-RRB-
25944	855	11	........	........	.
25944	855	12	[	[	-LRB-
25944	855	13	minim]vj	minim]vj	NNP
25944	855	14	Aquæ	Aquæ	NNP
25944	855	15	,	,	,
25944	855	16	................................	................................	NFP
25944	855	17	[	[	-LRB-
25944	855	18	Oz]j	Oz]j	.
25944	855	19	M.	M.	NNP
25944	855	20	In	In	NNP
25944	855	21	obstinate	obstinate	JJ
25944	855	22	recurrent	recurrent	JJ
25944	855	23	cases	case	NNS
25944	855	24	,	,	,
25944	855	25	frequent	frequent	JJ
25944	855	26	applications	application	NNS
25944	855	27	of	of	IN
25944	855	28	a	a	DT
25944	855	29	mild	mild	JJ
25944	855	30	galvanic	galvanic	JJ
25944	855	31	current	current	NN
25944	855	32	will	will	MD
25944	855	33	have	have	VB
25944	855	34	a	a	DT
25944	855	35	favorable	favorable	JJ
25944	855	36	influence	influence	NN
25944	855	37	.	.	.
25944	856	1	#	#	$
25944	856	2	Hydroa	Hydroa	NNP
25944	856	3	Vacciniforme	Vacciniforme	NNP
25944	856	4	.	.	.
25944	856	5	#	#	NN
25944	856	6	(	(	-LRB-
25944	856	7	_	_	NNP
25944	856	8	Synonyms	Synonyms	NNP
25944	856	9	:	:	:
25944	856	10	_	_	NNP
25944	856	11	Recurrent	Recurrent	NNP
25944	856	12	Summer	Summer	NNP
25944	856	13	Eruption	eruption	NN
25944	856	14	;	;	:
25944	856	15	Hydroa	Hydroa	NNP
25944	856	16	Puerorum	Puerorum	NNP
25944	856	17	;	;	:
25944	856	18	Hydroa	Hydroa	NNP
25944	856	19	Aestivale	Aestivale	NNP
25944	856	20	.	.	.
25944	856	21	)	)	-RRB-
25944	857	1	#	#	NNP
25944	857	2	Describe	describe	VB
25944	857	3	hydroa	hydroa	NN
25944	857	4	vacciniforme	vacciniforme	NN
25944	857	5	.	.	.
25944	857	6	#	#	WRB
25944	857	7	It	-PRON-	PRP
25944	857	8	is	be	VBZ
25944	857	9	a	a	DT
25944	857	10	rare	rare	JJ
25944	857	11	vesicular	vesicular	JJ
25944	857	12	disease	disease	NN
25944	857	13	usually	usually	RB
25944	857	14	seen	see	VBN
25944	857	15	in	in	IN
25944	857	16	boys	boy	NNS
25944	857	17	(	(	-LRB-
25944	857	18	only	only	RB
25944	857	19	two	two	CD
25944	857	20	or	or	CC
25944	857	21	three	three	CD
25944	857	22	exceptions	exception	NNS
25944	857	23	)	)	-RRB-
25944	857	24	,	,	,
25944	857	25	occurring	occur	VBG
25944	857	26	upon	upon	IN
25944	857	27	uncovered	uncovered	JJ
25944	857	28	parts	part	NNS
25944	857	29	,	,	,
25944	857	30	especially	especially	RB
25944	857	31	the	the	DT
25944	857	32	nose	nose	NN
25944	857	33	,	,	,
25944	857	34	cheeks	cheek	NNS
25944	857	35	,	,	,
25944	857	36	and	and	CC
25944	857	37	ears	ear	NNS
25944	857	38	.	.	.
25944	858	1	The	the	DT
25944	858	2	lesions	lesion	NNS
25944	858	3	begin	begin	VBP
25944	858	4	as	as	IN
25944	858	5	red	red	JJ
25944	858	6	spots	spot	NNS
25944	858	7	,	,	,
25944	858	8	discrete	discrete	JJ
25944	858	9	or	or	CC
25944	858	10	in	in	IN
25944	858	11	groups	group	NNS
25944	858	12	,	,	,
25944	858	13	rapidly	rapidly	RB
25944	858	14	exhibit	exhibit	VBP
25944	858	15	vesiculation	vesiculation	NN
25944	858	16	,	,	,
25944	858	17	and	and	CC
25944	858	18	later	later	RB
25944	858	19	umbilication	umbilication	NN
25944	858	20	;	;	:
25944	858	21	the	the	DT
25944	858	22	contents	content	NNS
25944	858	23	become	become	VBP
25944	858	24	milky	milky	NNP
25944	858	25	,	,	,
25944	858	26	dry	dry	JJ
25944	858	27	to	to	IN
25944	858	28	crusts	crust	NNS
25944	858	29	,	,	,
25944	858	30	which	which	WDT
25944	858	31	fall	fall	VBP
25944	858	32	off	off	RP
25944	858	33	and	and	CC
25944	858	34	leave	leave	VB
25944	858	35	small	small	JJ
25944	858	36	pit	pit	NN
25944	858	37	-	-	HYPH
25944	858	38	like	like	JJ
25944	858	39	scars	scar	NNS
25944	858	40	.	.	.
25944	859	1	Fresh	fresh	JJ
25944	859	2	outbreaks	outbreak	NNS
25944	859	3	may	may	MD
25944	859	4	take	take	VB
25944	859	5	place	place	NN
25944	859	6	almost	almost	RB
25944	859	7	continuously	continuously	RB
25944	859	8	,	,	,
25944	859	9	and	and	CC
25944	859	10	the	the	DT
25944	859	11	process	process	NN
25944	859	12	go	go	VB
25944	859	13	on	on	RP
25944	859	14	indefinitely	indefinitely	RB
25944	859	15	,	,	,
25944	859	16	at	at	IN
25944	859	17	least	least	RBS
25944	859	18	up	up	RB
25944	859	19	to	to	IN
25944	859	20	youth	youth	NN
25944	859	21	or	or	CC
25944	859	22	manhood	manhood	NN
25944	859	23	,	,	,
25944	859	24	when	when	WRB
25944	859	25	the	the	DT
25944	859	26	tendency	tendency	NN
25944	859	27	subsides	subside	NNS
25944	859	28	.	.	.
25944	860	1	Its	-PRON-	PRP$
25944	860	2	activity	activity	NN
25944	860	3	is	be	VBZ
25944	860	4	usually	usually	RB
25944	860	5	limited	limit	VBN
25944	860	6	to	to	IN
25944	860	7	the	the	DT
25944	860	8	warm	warm	JJ
25944	860	9	season	season	NN
25944	860	10	.	.	.
25944	861	1	Arthritic	arthritic	JJ
25944	861	2	symptoms	symptom	NNS
25944	861	3	and	and	CC
25944	861	4	general	general	JJ
25944	861	5	disturbance	disturbance	NN
25944	861	6	are	be	VBP
25944	861	7	sometimes	sometimes	RB
25944	861	8	noted	note	VBN
25944	861	9	in	in	IN
25944	861	10	severe	severe	JJ
25944	861	11	cases	case	NNS
25944	861	12	.	.	.
25944	862	1	It	-PRON-	PRP
25944	862	2	is	be	VBZ
25944	862	3	doubtless	doubtless	RB
25944	862	4	a	a	DT
25944	862	5	vasomotor	vasomotor	NN
25944	862	6	neurosis	neurosis	NN
25944	862	7	.	.	.
25944	863	1	Exposure	exposure	NN
25944	863	2	to	to	TO
25944	863	3	sun	sun	NN
25944	863	4	and	and	CC
25944	863	5	wind	wind	NN
25944	863	6	is	be	VBZ
25944	863	7	an	an	DT
25944	863	8	important	important	JJ
25944	863	9	,	,	,
25944	863	10	if	if	IN
25944	863	11	not	not	RB
25944	863	12	essential	essential	JJ
25944	863	13	,	,	,
25944	863	14	etiological	etiological	JJ
25944	863	15	factor	factor	NN
25944	863	16	.	.	.
25944	864	1	Primarily	primarily	RB
25944	864	2	the	the	DT
25944	864	3	lesion	lesion	NN
25944	864	4	begins	begin	VBZ
25944	864	5	in	in	IN
25944	864	6	the	the	DT
25944	864	7	rete	rete	NN
25944	864	8	middle	middle	JJ
25944	864	9	layers	layer	NNS
25944	864	10	,	,	,
25944	864	11	and	and	CC
25944	864	12	is	be	VBZ
25944	864	13	purely	purely	RB
25944	864	14	vesicular	vesicular	JJ
25944	864	15	in	in	IN
25944	864	16	character	character	NN
25944	864	17	;	;	:
25944	864	18	later	later	RB
25944	864	19	,	,	,
25944	864	20	necrosis	necrosis	NN
25944	864	21	of	of	IN
25944	864	22	the	the	DT
25944	864	23	rete	rete	NN
25944	864	24	and	and	CC
25944	864	25	extending	extend	VBG
25944	864	26	deep	deep	RB
25944	864	27	in	in	IN
25944	864	28	the	the	DT
25944	864	29	corium	corium	NN
25944	864	30	is	be	VBZ
25944	864	31	observed	observe	VBN
25944	864	32	.	.	.
25944	865	1	Treatment	treatment	NN
25944	865	2	so	so	RB
25944	865	3	far	far	RB
25944	865	4	has	have	VBZ
25944	865	5	only	only	RB
25944	865	6	been	be	VBN
25944	865	7	palliative	palliative	JJ
25944	865	8	,	,	,
25944	865	9	consisting	consist	VBG
25944	865	10	of	of	IN
25944	865	11	the	the	DT
25944	865	12	applications	application	NNS
25944	865	13	employed	employ	VBN
25944	865	14	in	in	IN
25944	865	15	similar	similar	JJ
25944	865	16	conditions	condition	NNS
25944	865	17	.	.	.
25944	866	1	Constitutional	constitutional	JJ
25944	866	2	medication	medication	NN
25944	866	3	is	be	VBZ
25944	866	4	based	base	VBN
25944	866	5	upon	upon	IN
25944	866	6	general	general	JJ
25944	866	7	principles	principle	NNS
25944	866	8	.	.	.
25944	867	1	The	the	DT
25944	867	2	patient	patient	NN
25944	867	3	should	should	MD
25944	867	4	avoid	avoid	VB
25944	867	5	exposure	exposure	NN
25944	867	6	to	to	IN
25944	867	7	the	the	DT
25944	867	8	sun	sun	NN
25944	867	9	,	,	,
25944	867	10	strong	strong	JJ
25944	867	11	wind	wind	NN
25944	867	12	and	and	CC
25944	867	13	excessive	excessive	JJ
25944	867	14	artificial	artificial	JJ
25944	867	15	heat	heat	NN
25944	867	16	.	.	.
25944	868	1	#	#	NNP
25944	868	2	Epidermolysis	Epidermolysis	NNP
25944	868	3	Bullosa	Bullosa	NNP
25944	868	4	.	.	.
25944	868	5	#	#	$
25944	868	6	#	#	$
25944	868	7	Describe	Describe	NNP
25944	868	8	epidermolysis	epidermolysis	NN
25944	868	9	bullosa	bullosa	FW
25944	868	10	.	.	.
25944	868	11	#	#	$
25944	868	12	This	this	DT
25944	868	13	is	be	VBZ
25944	868	14	a	a	DT
25944	868	15	rare	rare	JJ
25944	868	16	,	,	,
25944	868	17	usually	usually	RB
25944	868	18	hereditary	hereditary	JJ
25944	868	19	,	,	,
25944	868	20	disease	disease	NN
25944	868	21	or	or	CC
25944	868	22	condition	condition	NN
25944	868	23	,	,	,
25944	868	24	characterized	characterize	VBN
25944	868	25	by	by	IN
25944	868	26	the	the	DT
25944	868	27	formation	formation	NN
25944	868	28	of	of	IN
25944	868	29	vesicles	vesicle	NNS
25944	868	30	and	and	CC
25944	868	31	blebs	blebs	NN
25944	868	32	on	on	IN
25944	868	33	any	any	DT
25944	868	34	part	part	NN
25944	868	35	subjected	subject	VBN
25944	868	36	to	to	IN
25944	868	37	slight	slight	JJ
25944	868	38	rubbing	rubbing	NN
25944	868	39	or	or	CC
25944	868	40	irritation	irritation	NN
25944	868	41	.	.	.
25944	869	1	No	no	DT
25944	869	2	scarring	scar	VBG
25944	869	3	is	be	VBZ
25944	869	4	left	leave	VBN
25944	869	5	,	,	,
25944	869	6	and	and	CC
25944	869	7	no	no	DT
25944	869	8	pigmentation	pigmentation	NN
25944	869	9	noted	note	VBD
25944	869	10	.	.	.
25944	870	1	The	the	DT
25944	870	2	predisposition	predisposition	NN
25944	870	3	to	to	IN
25944	870	4	these	these	DT
25944	870	5	lesions	lesion	NNS
25944	870	6	persists	persist	VBZ
25944	870	7	indefinitely	indefinitely	RB
25944	870	8	.	.	.
25944	871	1	The	the	DT
25944	871	2	general	general	JJ
25944	871	3	health	health	NN
25944	871	4	is	be	VBZ
25944	871	5	not	not	RB
25944	871	6	involved	involve	VBN
25944	871	7	.	.	.
25944	872	1	The	the	DT
25944	872	2	nature	nature	NN
25944	872	3	of	of	IN
25944	872	4	the	the	DT
25944	872	5	disease	disease	NN
25944	872	6	is	be	VBZ
25944	872	7	obscure	obscure	JJ
25944	872	8	.	.	.
25944	873	1	Treatment	treatment	NN
25944	873	2	has	have	VBZ
25944	873	3	no	no	DT
25944	873	4	influence	influence	NN
25944	873	5	in	in	IN
25944	873	6	modifying	modify	VBG
25944	873	7	or	or	CC
25944	873	8	lessening	lessen	VBG
25944	873	9	this	this	DT
25944	873	10	tendency	tendency	NN
25944	873	11	.	.	.
25944	874	1	The	the	DT
25944	874	2	vulnerable	vulnerable	JJ
25944	874	3	parts	part	NNS
25944	874	4	should	should	MD
25944	874	5	so	so	RB
25944	874	6	far	far	RB
25944	874	7	as	as	IN
25944	874	8	possible	possible	JJ
25944	874	9	be	be	VB
25944	874	10	protected	protect	VBN
25944	874	11	from	from	IN
25944	874	12	knocks	knock	NNS
25944	874	13	and	and	CC
25944	874	14	undue	undue	JJ
25944	874	15	friction	friction	NN
25944	874	16	.	.	.
25944	875	1	#	#	NNP
25944	875	2	Dermatitis	Dermatitis	NNP
25944	875	3	Repens	Repens	NNP
25944	875	4	.	.	.
25944	875	5	#	#	$
25944	875	6	#	#	$
25944	875	7	What	what	WP
25944	875	8	do	do	VBP
25944	875	9	you	-PRON-	PRP
25944	875	10	understand	understand	VB
25944	875	11	by	by	IN
25944	875	12	dermatitis	dermatitis	NN
25944	875	13	repens	repen	NNS
25944	875	14	?	?	.
25944	875	15	#	#	NN
25944	875	16	It	-PRON-	PRP
25944	875	17	is	be	VBZ
25944	875	18	a	a	DT
25944	875	19	rare	rare	JJ
25944	875	20	spreading	spread	VBG
25944	875	21	dermatitis	dermatitis	NN
25944	875	22	starting	start	VBG
25944	875	23	from	from	IN
25944	875	24	an	an	DT
25944	875	25	injury	injury	NN
25944	875	26	,	,	,
25944	875	27	extending	extend	VBG
25944	875	28	by	by	IN
25944	875	29	a	a	DT
25944	875	30	serous	serous	JJ
25944	875	31	undermining	undermining	NN
25944	875	32	of	of	IN
25944	875	33	the	the	DT
25944	875	34	epidermis	epidermis	NN
25944	875	35	,	,	,
25944	875	36	and	and	CC
25944	875	37	usually	usually	RB
25944	875	38	occurring	occur	VBG
25944	875	39	upon	upon	IN
25944	875	40	the	the	DT
25944	875	41	upper	upper	JJ
25944	875	42	extremities	extremity	NNS
25944	875	43	.	.	.
25944	876	1	It	-PRON-	PRP
25944	876	2	usually	usually	RB
25944	876	3	begins	begin	VBZ
25944	876	4	shortly	shortly	RB
25944	876	5	after	after	IN
25944	876	6	an	an	DT
25944	876	7	injury	injury	NN
25944	876	8	,	,	,
25944	876	9	and	and	CC
25944	876	10	,	,	,
25944	876	11	as	as	IN
25944	876	12	a	a	DT
25944	876	13	rule	rule	NN
25944	876	14	,	,	,
25944	876	15	presents	present	VBZ
25944	876	16	itself	-PRON-	PRP
25944	876	17	by	by	IN
25944	876	18	redness	redness	JJ
25944	876	19	and	and	CC
25944	876	20	serous	serous	JJ
25944	876	21	exudation	exudation	NN
25944	876	22	.	.	.
25944	877	1	The	the	DT
25944	877	2	overlying	overlying	NN
25944	877	3	epidermis	epidermis	NN
25944	877	4	breaks	break	VBZ
25944	877	5	,	,	,
25944	877	6	and	and	CC
25944	877	7	the	the	DT
25944	877	8	area	area	NN
25944	877	9	of	of	IN
25944	877	10	disease	disease	NNP
25944	877	11	gradually	gradually	RB
25944	877	12	progresses	progress	VBZ
25944	877	13	by	by	IN
25944	877	14	an	an	DT
25944	877	15	extension	extension	NN
25944	877	16	of	of	IN
25944	877	17	the	the	DT
25944	877	18	serous	serous	JJ
25944	877	19	undermining	undermining	NN
25944	877	20	process	process	NN
25944	877	21	,	,	,
25944	877	22	the	the	DT
25944	877	23	denuded	denuded	JJ
25944	877	24	part	part	NN
25944	877	25	looking	look	VBG
25944	877	26	red	red	JJ
25944	877	27	and	and	CC
25944	877	28	raw	raw	JJ
25944	877	29	,	,	,
25944	877	30	with	with	IN
25944	877	31	usually	usually	RB
25944	877	32	an	an	DT
25944	877	33	oozing	oozing	NN
25944	877	34	surface	surface	NN
25944	877	35	.	.	.
25944	878	1	As	as	IN
25944	878	2	the	the	DT
25944	878	3	disease	disease	NN
25944	878	4	spreads	spread	VBZ
25944	878	5	the	the	DT
25944	878	6	oldest	old	JJS
25944	878	7	part	part	NN
25944	878	8	becomes	become	VBZ
25944	878	9	dry	dry	JJ
25944	878	10	and	and	CC
25944	878	11	heals	heal	NNS
25944	878	12	,	,	,
25944	878	13	the	the	DT
25944	878	14	new	new	JJ
25944	878	15	epidermal	epidermal	JJ
25944	878	16	covering	covering	NN
25944	878	17	being	be	VBG
25944	878	18	thin	thin	JJ
25944	878	19	and	and	CC
25944	878	20	atrophic	atrophic	JJ
25944	878	21	in	in	IN
25944	878	22	appearance	appearance	NN
25944	878	23	.	.	.
25944	879	1	Its	-PRON-	PRP$
25944	879	2	most	most	RBS
25944	879	3	usual	usual	JJ
25944	879	4	beginning	beginning	NN
25944	879	5	is	be	VBZ
25944	879	6	on	on	IN
25944	879	7	some	some	DT
25944	879	8	part	part	NN
25944	879	9	of	of	IN
25944	879	10	the	the	DT
25944	879	11	hand	hand	NN
25944	879	12	,	,	,
25944	879	13	and	and	CC
25944	879	14	from	from	IN
25944	879	15	here	here	RB
25944	879	16	it	-PRON-	PRP
25944	879	17	may	may	MD
25944	879	18	spread	spread	VB
25944	879	19	up	up	RP
25944	879	20	the	the	DT
25944	879	21	arm	arm	NN
25944	879	22	and	and	CC
25944	879	23	involve	involve	VBP
25944	879	24	considerable	considerable	JJ
25944	879	25	area	area	NN
25944	879	26	.	.	.
25944	880	1	The	the	DT
25944	880	2	injury	injury	NN
25944	880	3	from	from	IN
25944	880	4	which	which	WDT
25944	880	5	it	-PRON-	PRP
25944	880	6	starts	start	VBZ
25944	880	7	may	may	MD
25944	880	8	be	be	VB
25944	880	9	extremely	extremely	RB
25944	880	10	insignificant	insignificant	JJ
25944	880	11	,	,	,
25944	880	12	apparently	apparently	RB
25944	880	13	affording	afford	VBG
25944	880	14	an	an	DT
25944	880	15	opening	opening	NN
25944	880	16	for	for	IN
25944	880	17	the	the	DT
25944	880	18	introduction	introduction	NN
25944	880	19	of	of	IN
25944	880	20	the	the	DT
25944	880	21	causative	causative	JJ
25944	880	22	factor	factor	NN
25944	880	23	,	,	,
25944	880	24	doubtless	doubtless	RB
25944	880	25	parasitic	parasitic	JJ
25944	880	26	.	.	.
25944	881	1	Beyond	beyond	IN
25944	881	2	a	a	DT
25944	881	3	feeling	feeling	NN
25944	881	4	of	of	IN
25944	881	5	soreness	soreness	NN
25944	881	6	there	there	EX
25944	881	7	seem	seem	VBP
25944	881	8	to	to	TO
25944	881	9	be	be	VB
25944	881	10	no	no	DT
25944	881	11	special	special	JJ
25944	881	12	subjective	subjective	JJ
25944	881	13	symptoms	symptom	NNS
25944	881	14	.	.	.
25944	882	1	#	#	NN
25944	882	2	Give	give	VB
25944	882	3	the	the	DT
25944	882	4	prognosis	prognosis	NN
25944	882	5	and	and	CC
25944	882	6	treatment	treatment	NN
25944	882	7	.	.	.
25944	882	8	#	#	$
25944	882	9	The	the	DT
25944	882	10	malady	malady	JJ
25944	882	11	shows	show	NNS
25944	882	12	but	but	CC
25944	882	13	little	little	JJ
25944	882	14	tendency	tendency	NN
25944	882	15	to	to	IN
25944	882	16	spontaneous	spontaneous	JJ
25944	882	17	cure	cure	NN
25944	882	18	.	.	.
25944	883	1	The	the	DT
25944	883	2	frequent	frequent	JJ
25944	883	3	or	or	CC
25944	883	4	constant	constant	JJ
25944	883	5	application	application	NN
25944	883	6	of	of	IN
25944	883	7	a	a	DT
25944	883	8	mild	mild	JJ
25944	883	9	antiseptic	antiseptic	JJ
25944	883	10	lotion	lotion	NN
25944	883	11	,	,	,
25944	883	12	such	such	JJ
25944	883	13	as	as	IN
25944	883	14	boric	boric	NN
25944	883	15	acid	acid	NN
25944	883	16	and	and	CC
25944	883	17	resorcin	resorcin	NNS
25944	883	18	,	,	,
25944	883	19	or	or	CC
25944	883	20	of	of	IN
25944	883	21	a	a	DT
25944	883	22	mild	mild	JJ
25944	883	23	parasiticide	parasiticide	NN
25944	883	24	ointment	ointment	NN
25944	883	25	will	will	MD
25944	883	26	generally	generally	RB
25944	883	27	bring	bring	VB
25944	883	28	the	the	DT
25944	883	29	disease	disease	NN
25944	883	30	gradually	gradually	RB
25944	883	31	to	to	IN
25944	883	32	an	an	DT
25944	883	33	end	end	NN
25944	883	34	.	.	.
25944	884	1	#	#	NNP
25944	884	2	Herpes	Herpes	NNP
25944	884	3	Zoster	Zoster	NNP
25944	884	4	.	.	.
25944	884	5	#	#	NNP
25944	884	6	(	(	-LRB-
25944	884	7	_	_	NNP
25944	884	8	Synonyms	Synonyms	NNP
25944	884	9	:	:	:
25944	884	10	_	_	NNP
25944	884	11	Zoster	Zoster	NNP
25944	884	12	;	;	:
25944	884	13	Zona	Zona	NNP
25944	884	14	;	;	:
25944	884	15	Shingles	Shingles	NNP
25944	884	16	.	.	.
25944	884	17	)	)	-RRB-
25944	885	1	#	#	NN
25944	885	2	Give	give	VB
25944	885	3	a	a	DT
25944	885	4	definition	definition	NN
25944	885	5	of	of	IN
25944	885	6	herpes	herpe	NNS
25944	885	7	zoster	zoster	NN
25944	885	8	.	.	.
25944	885	9	#	#	NNP
25944	885	10	Herpes	Herpes	NNP
25944	885	11	zoster	zoster	NN
25944	885	12	is	be	VBZ
25944	885	13	an	an	DT
25944	885	14	acute	acute	JJ
25944	885	15	,	,	,
25944	885	16	self	self	NN
25944	885	17	-	-	HYPH
25944	885	18	limited	limited	JJ
25944	885	19	,	,	,
25944	885	20	inflammatory	inflammatory	JJ
25944	885	21	disease	disease	NN
25944	885	22	,	,	,
25944	885	23	characterized	characterize	VBN
25944	885	24	by	by	IN
25944	885	25	groups	group	NNS
25944	885	26	of	of	IN
25944	885	27	vesicles	vesicle	NNS
25944	885	28	upon	upon	IN
25944	885	29	inflammatory	inflammatory	JJ
25944	885	30	bases	basis	NNS
25944	885	31	,	,	,
25944	885	32	situated	situate	VBN
25944	885	33	over	over	IN
25944	885	34	or	or	CC
25944	885	35	along	along	IN
25944	885	36	a	a	DT
25944	885	37	nerve	nerve	NN
25944	885	38	tract	tract	NN
25944	885	39	.	.	.
25944	886	1	#	#	NN
25944	886	2	Upon	upon	IN
25944	886	3	what	what	WP
25944	886	4	parts	part	NNS
25944	886	5	of	of	IN
25944	886	6	the	the	DT
25944	886	7	body	body	NN
25944	886	8	may	may	MD
25944	886	9	the	the	DT
25944	886	10	eruption	eruption	NN
25944	886	11	appear	appear	VB
25944	886	12	?	?	.
25944	886	13	#	#	$
25944	886	14	It	-PRON-	PRP
25944	886	15	may	may	MD
25944	886	16	appear	appear	VB
25944	886	17	upon	upon	IN
25944	886	18	any	any	DT
25944	886	19	part	part	NN
25944	886	20	,	,	,
25944	886	21	following	follow	VBG
25944	886	22	the	the	DT
25944	886	23	course	course	NN
25944	886	24	of	of	IN
25944	886	25	a	a	DT
25944	886	26	nerve	nerve	NN
25944	886	27	;	;	:
25944	886	28	it	-PRON-	PRP
25944	886	29	is	be	VBZ
25944	886	30	therefore	therefore	RB
25944	886	31	always	always	RB
25944	886	32	limited	limited	JJ
25944	886	33	in	in	IN
25944	886	34	extent	extent	NN
25944	886	35	,	,	,
25944	886	36	and	and	CC
25944	886	37	confined	confine	VBN
25944	886	38	to	to	IN
25944	886	39	one	one	CD
25944	886	40	side	side	NN
25944	886	41	of	of	IN
25944	886	42	the	the	DT
25944	886	43	body	body	NN
25944	886	44	.	.	.
25944	887	1	It	-PRON-	PRP
25944	887	2	is	be	VBZ
25944	887	3	probably	probably	RB
25944	887	4	most	most	RBS
25944	887	5	common	common	JJ
25944	887	6	about	about	IN
25944	887	7	the	the	DT
25944	887	8	intercostal	intercostal	JJ
25944	887	9	,	,	,
25944	887	10	lumbar	lumbar	NNP
25944	887	11	and	and	CC
25944	887	12	supra	supra	NN
25944	887	13	-	-	HYPH
25944	887	14	orbital	orbital	JJ
25944	887	15	regions	region	NNS
25944	887	16	.	.	.
25944	888	1	In	in	IN
25944	888	2	rare	rare	JJ
25944	888	3	instances	instance	NNS
25944	888	4	the	the	DT
25944	888	5	eruption	eruption	NN
25944	888	6	has	have	VBZ
25944	888	7	been	be	VBN
25944	888	8	observed	observe	VBN
25944	888	9	to	to	TO
25944	888	10	be	be	VB
25944	888	11	bilateral	bilateral	JJ
25944	888	12	.	.	.
25944	889	1	#	#	NN
25944	889	2	Are	be	VBP
25944	889	3	there	there	EX
25944	889	4	any	any	DT
25944	889	5	subjective	subjective	JJ
25944	889	6	or	or	CC
25944	889	7	constitutional	constitutional	JJ
25944	889	8	symptoms	symptom	NNS
25944	889	9	?	?	.
25944	889	10	#	#	NN
25944	889	11	Yes	yes	UH
25944	889	12	;	;	:
25944	889	13	there	there	EX
25944	889	14	is	be	VBZ
25944	889	15	,	,	,
25944	889	16	as	as	IN
25944	889	17	a	a	DT
25944	889	18	rule	rule	NN
25944	889	19	,	,	,
25944	889	20	neuralgic	neuralgic	JJ
25944	889	21	pain	pain	NN
25944	889	22	preceding	precede	VBG
25944	889	23	,	,	,
25944	889	24	during	during	IN
25944	889	25	and	and	CC
25944	889	26	following	follow	VBG
25944	889	27	the	the	DT
25944	889	28	eruption	eruption	NN
25944	889	29	;	;	,
25944	889	30	and	and	CC
25944	889	31	in	in	IN
25944	889	32	some	some	DT
25944	889	33	cases	case	NNS
25944	889	34	,	,	,
25944	889	35	also	also	RB
25944	889	36	,	,	,
25944	889	37	there	there	EX
25944	889	38	may	may	MD
25944	889	39	be	be	VB
25944	889	40	in	in	IN
25944	889	41	the	the	DT
25944	889	42	beginning	begin	VBG
25944	889	43	mild	mild	JJ
25944	889	44	febrile	febrile	NN
25944	889	45	disturbance	disturbance	NN
25944	889	46	.	.	.
25944	890	1	There	there	EX
25944	890	2	is	be	VBZ
25944	890	3	also	also	RB
25944	890	4	a	a	DT
25944	890	5	variable	variable	JJ
25944	890	6	degree	degree	NN
25944	890	7	of	of	IN
25944	890	8	tenderness	tenderness	NN
25944	890	9	and	and	CC
25944	890	10	pain	pain	NN
25944	890	11	.	.	.
25944	891	1	#	#	LS
25944	891	2	What	what	WP
25944	891	3	are	be	VBP
25944	891	4	the	the	DT
25944	891	5	characters	character	NNS
25944	891	6	of	of	IN
25944	891	7	the	the	DT
25944	891	8	eruption	eruption	NN
25944	891	9	?	?	.
25944	891	10	#	#	$
25944	891	11	Several	several	JJ
25944	891	12	or	or	CC
25944	891	13	more	more	RBR
25944	891	14	hyperæmic	hyperæmic	JJ
25944	891	15	or	or	CC
25944	891	16	inflammatory	inflammatory	JJ
25944	891	17	patches	patch	NNS
25944	891	18	over	over	IN
25944	891	19	a	a	DT
25944	891	20	nerve	nerve	NN
25944	891	21	course	course	NN
25944	891	22	appear	appear	VBP
25944	891	23	,	,	,
25944	891	24	upon	upon	IN
25944	891	25	which	which	WDT
25944	891	26	are	be	VBP
25944	891	27	seated	seat	VBN
25944	891	28	vesico	vesico	NN
25944	891	29	-	-	HYPH
25944	891	30	papules	papule	NNS
25944	891	31	irregularly	irregularly	RB
25944	891	32	grouped	group	VBD
25944	891	33	;	;	:
25944	891	34	these	these	DT
25944	891	35	vesico	vesico	NN
25944	891	36	-	-	HYPH
25944	891	37	papules	papule	NNS
25944	891	38	become	become	VBP
25944	891	39	distinct	distinct	JJ
25944	891	40	vesicles	vesicle	NNS
25944	891	41	,	,	,
25944	891	42	of	of	IN
25944	891	43	size	size	NN
25944	891	44	from	from	IN
25944	891	45	a	a	DT
25944	891	46	pin	pin	NN
25944	891	47	-	-	HYPH
25944	891	48	head	head	NN
25944	891	49	to	to	IN
25944	891	50	a	a	DT
25944	891	51	pea	pea	NN
25944	891	52	,	,	,
25944	891	53	and	and	CC
25944	891	54	soon	soon	RB
25944	891	55	dry	dry	JJ
25944	891	56	and	and	CC
25944	891	57	give	give	VB
25944	891	58	rise	rise	NN
25944	891	59	to	to	IN
25944	891	60	thin	thin	JJ
25944	891	61	,	,	,
25944	891	62	yellowish	yellowish	JJ
25944	891	63	or	or	CC
25944	891	64	brownish	brownish	JJ
25944	891	65	crusts	crust	NNS
25944	891	66	,	,	,
25944	891	67	which	which	WDT
25944	891	68	drop	drop	VBP
25944	891	69	off	off	RP
25944	891	70	,	,	,
25944	891	71	leaving	leave	VBG
25944	891	72	in	in	IN
25944	891	73	most	most	JJS
25944	891	74	instances	instance	NNS
25944	891	75	no	no	DT
25944	891	76	permanent	permanent	JJ
25944	891	77	trace	trace	NN
25944	891	78	,	,	,
25944	891	79	in	in	IN
25944	891	80	others	other	NNS
25944	891	81	more	more	RBR
25944	891	82	or	or	CC
25944	891	83	less	less	RBR
25944	891	84	scarring	scar	VBG
25944	891	85	.	.	.
25944	892	1	In	in	IN
25944	892	2	some	some	DT
25944	892	3	cases	case	NNS
25944	892	4	the	the	DT
25944	892	5	lesions	lesion	NNS
25944	892	6	may	may	MD
25944	892	7	become	become	VB
25944	892	8	pustular	pustular	JJ
25944	892	9	and	and	CC
25944	892	10	,	,	,
25944	892	11	on	on	IN
25944	892	12	the	the	DT
25944	892	13	other	other	JJ
25944	892	14	hand	hand	NN
25944	892	15	,	,	,
25944	892	16	the	the	DT
25944	892	17	eruption	eruption	NN
25944	892	18	may	may	MD
25944	892	19	be	be	VB
25944	892	20	abortive	abortive	JJ
25944	892	21	,	,	,
25944	892	22	stopping	stop	VBG
25944	892	23	short	short	RB
25944	892	24	of	of	IN
25944	892	25	full	full	JJ
25944	892	26	vesiculation	vesiculation	NN
25944	892	27	.	.	.
25944	893	1	#	#	LS
25944	893	2	What	what	WP
25944	893	3	is	be	VBZ
25944	893	4	known	know	VBN
25944	893	5	in	in	IN
25944	893	6	regard	regard	NN
25944	893	7	to	to	IN
25944	893	8	the	the	DT
25944	893	9	nature	nature	NN
25944	893	10	of	of	IN
25944	893	11	the	the	DT
25944	893	12	disease	disease	NN
25944	893	13	?	?	.
25944	893	14	#	#	$
25944	893	15	An	an	DT
25944	893	16	inflamed	inflamed	JJ
25944	893	17	and	and	CC
25944	893	18	irritable	irritable	JJ
25944	893	19	state	state	NN
25944	893	20	of	of	IN
25944	893	21	the	the	DT
25944	893	22	spinal	spinal	NNP
25944	893	23	ganglia	ganglia	NNP
25944	893	24	,	,	,
25944	893	25	nerve	nerve	NN
25944	893	26	tract	tract	NN
25944	893	27	,	,	,
25944	893	28	or	or	CC
25944	893	29	peripheral	peripheral	JJ
25944	893	30	branches	branch	NNS
25944	893	31	is	be	VBZ
25944	893	32	directly	directly	RB
25944	893	33	responsible	responsible	JJ
25944	893	34	for	for	IN
25944	893	35	the	the	DT
25944	893	36	eruption	eruption	NN
25944	893	37	,	,	,
25944	893	38	and	and	CC
25944	893	39	this	this	DT
25944	893	40	state	state	NN
25944	893	41	may	may	MD
25944	893	42	be	be	VB
25944	893	43	due	due	IN
25944	893	44	to	to	IN
25944	893	45	atmospheric	atmospheric	JJ
25944	893	46	changes	change	NNS
25944	893	47	,	,	,
25944	893	48	cold	cold	JJ
25944	893	49	,	,	,
25944	893	50	nerve	nerve	NN
25944	893	51	-	-	HYPH
25944	893	52	injuries	injury	NNS
25944	893	53	and	and	CC
25944	893	54	similar	similar	JJ
25944	893	55	influences	influence	NNS
25944	893	56	.	.	.
25944	894	1	The	the	DT
25944	894	2	view	view	NN
25944	894	3	has	have	VBZ
25944	894	4	also	also	RB
25944	894	5	been	be	VBN
25944	894	6	advanced	advance	VBN
25944	894	7	that	that	IN
25944	894	8	the	the	DT
25944	894	9	disease	disease	NN
25944	894	10	is	be	VBZ
25944	894	11	of	of	IN
25944	894	12	specific	specific	JJ
25944	894	13	and	and	CC
25944	894	14	infectious	infectious	JJ
25944	894	15	character	character	NN
25944	894	16	.	.	.
25944	895	1	#	#	NN
25944	895	2	Give	give	VB
25944	895	3	the	the	DT
25944	895	4	chief	chief	JJ
25944	895	5	diagnostic	diagnostic	JJ
25944	895	6	features	feature	NNS
25944	895	7	of	of	IN
25944	895	8	herpes	herpe	NNS
25944	895	9	zoster	zoster	NN
25944	895	10	.	.	.
25944	895	11	#	#	$
25944	895	12	The	the	DT
25944	895	13	prodromic	prodromic	JJ
25944	895	14	neuralgic	neuralgic	JJ
25944	895	15	pain	pain	NN
25944	895	16	,	,	,
25944	895	17	the	the	DT
25944	895	18	appearance	appearance	NN
25944	895	19	of	of	IN
25944	895	20	grouped	group	VBN
25944	895	21	vesicles	vesicle	NNS
25944	895	22	upon	upon	IN
25944	895	23	inflammatory	inflammatory	JJ
25944	895	24	bases	basis	NNS
25944	895	25	following	follow	VBG
25944	895	26	the	the	DT
25944	895	27	course	course	NN
25944	895	28	of	of	IN
25944	895	29	a	a	DT
25944	895	30	nerve	nerve	NN
25944	895	31	tract	tract	NN
25944	895	32	,	,	,
25944	895	33	and	and	CC
25944	895	34	the	the	DT
25944	895	35	limitation	limitation	NN
25944	895	36	of	of	IN
25944	895	37	the	the	DT
25944	895	38	eruption	eruption	NN
25944	895	39	to	to	IN
25944	895	40	one	one	CD
25944	895	41	side	side	NN
25944	895	42	of	of	IN
25944	895	43	the	the	DT
25944	895	44	body	body	NN
25944	895	45	.	.	.
25944	896	1	#	#	LS
25944	896	2	What	what	WP
25944	896	3	is	be	VBZ
25944	896	4	the	the	DT
25944	896	5	prognosis	prognosis	NN
25944	896	6	?	?	.
25944	896	7	#	#	:
25944	896	8	Favorable	favorable	JJ
25944	896	9	;	;	:
25944	896	10	the	the	DT
25944	896	11	symptoms	symptom	NNS
25944	896	12	usually	usually	RB
25944	896	13	disappearing	disappear	VBG
25944	896	14	in	in	IN
25944	896	15	two	two	CD
25944	896	16	to	to	TO
25944	896	17	four	four	CD
25944	896	18	weeks	week	NNS
25944	896	19	.	.	.
25944	897	1	In	in	IN
25944	897	2	some	some	DT
25944	897	3	instances	instance	NNS
25944	897	4	,	,	,
25944	897	5	however	however	RB
25944	897	6	,	,	,
25944	897	7	the	the	DT
25944	897	8	neuralgic	neuralgic	JJ
25944	897	9	pains	pain	NNS
25944	897	10	may	may	MD
25944	897	11	be	be	VB
25944	897	12	persistent	persistent	JJ
25944	897	13	,	,	,
25944	897	14	and	and	CC
25944	897	15	in	in	IN
25944	897	16	zoster	zoster	NN
25944	897	17	of	of	IN
25944	897	18	the	the	DT
25944	897	19	supra	supra	NNP
25944	897	20	-	-	HYPH
25944	897	21	orbital	orbital	JJ
25944	897	22	region	region	NN
25944	897	23	the	the	DT
25944	897	24	eye	eye	NN
25944	897	25	may	may	MD
25944	897	26	suffer	suffer	VB
25944	897	27	permanent	permanent	JJ
25944	897	28	damage	damage	NN
25944	897	29	.	.	.
25944	898	1	#	#	NNP
25944	898	2	How	how	WRB
25944	898	3	would	would	MD
25944	898	4	you	-PRON-	PRP
25944	898	5	treat	treat	VB
25944	898	6	herpes	herpe	NNS
25944	898	7	zoster	zoster	NNP
25944	898	8	?	?	.
25944	898	9	#	#	$
25944	898	10	_	_	NNP
25944	898	11	Constitutional	constitutional	JJ
25944	898	12	treatment	treatment	NN
25944	898	13	_	_	NNP
25944	898	14	,	,	,
25944	898	15	usually	usually	RB
25944	898	16	tonic	tonic	NN
25944	898	17	in	in	IN
25944	898	18	character	character	NN
25944	898	19	,	,	,
25944	898	20	is	be	VBZ
25944	898	21	to	to	TO
25944	898	22	be	be	VB
25944	898	23	based	base	VBN
25944	898	24	upon	upon	IN
25944	898	25	general	general	JJ
25944	898	26	principles	principle	NNS
25944	898	27	;	;	,
25944	898	28	moderate	moderate	JJ
25944	898	29	doses	dose	NNS
25944	898	30	of	of	IN
25944	898	31	quinia	quinia	NNP
25944	898	32	,	,	,
25944	898	33	with	with	IN
25944	898	34	one	one	CD
25944	898	35	-	-	HYPH
25944	898	36	sixth	sixth	JJ
25944	898	37	grain	grain	NN
25944	898	38	of	of	IN
25944	898	39	zinc	zinc	NN
25944	898	40	phosphide	phosphide	NNP
25944	898	41	,	,	,
25944	898	42	four	four	CD
25944	898	43	or	or	CC
25944	898	44	five	five	CD
25944	898	45	times	time	NNS
25944	898	46	daily	daily	RB
25944	898	47	,	,	,
25944	898	48	appear	appear	VBP
25944	898	49	in	in	IN
25944	898	50	some	some	DT
25944	898	51	cases	case	NNS
25944	898	52	to	to	TO
25944	898	53	have	have	VB
25944	898	54	a	a	DT
25944	898	55	special	special	JJ
25944	898	56	value	value	NN
25944	898	57	.	.	.
25944	899	1	The	the	DT
25944	899	2	accompanying	accompany	VBG
25944	899	3	neuralgic	neuralgic	JJ
25944	899	4	pain	pain	NN
25944	899	5	may	may	MD
25944	899	6	be	be	VB
25944	899	7	so	so	RB
25944	899	8	intense	intense	JJ
25944	899	9	as	as	IN
25944	899	10	to	to	TO
25944	899	11	require	require	VB
25944	899	12	anodynes	anodyne	NNS
25944	899	13	.	.	.
25944	900	1	_	_	NNP
25944	900	2	Local	local	JJ
25944	900	3	treatment	treatment	NN
25944	900	4	_	_	NNP
25944	900	5	should	should	MD
25944	900	6	be	be	VB
25944	900	7	of	of	IN
25944	900	8	a	a	DT
25944	900	9	soothing	soothing	JJ
25944	900	10	and	and	CC
25944	900	11	protective	protective	JJ
25944	900	12	character	character	NN
25944	900	13	.	.	.
25944	901	1	A	a	DT
25944	901	2	dusting	dusting	NN
25944	901	3	-	-	HYPH
25944	901	4	powder	powder	NN
25944	901	5	of	of	IN
25944	901	6	oxide	oxide	NN
25944	901	7	of	of	IN
25944	901	8	zinc	zinc	NN
25944	901	9	and	and	CC
25944	901	10	starch	starch	NN
25944	901	11	(	(	-LRB-
25944	901	12	to	to	IN
25944	901	13	the	the	DT
25944	901	14	ounce	ounce	NN
25944	901	15	of	of	IN
25944	901	16	which	which	WDT
25944	901	17	twenty	twenty	CD
25944	901	18	to	to	IN
25944	901	19	thirty	thirty	CD
25944	901	20	grains	grain	NNS
25944	901	21	of	of	IN
25944	901	22	camphor	camphor	NNP
25944	901	23	may	may	MD
25944	901	24	be	be	VB
25944	901	25	added	add	VBN
25944	901	26	)	)	-RRB-
25944	901	27	proves	prove	VBZ
25944	901	28	useful	useful	JJ
25944	901	29	;	;	:
25944	901	30	and	and	CC
25944	901	31	over	over	IN
25944	901	32	this	this	DT
25944	901	33	,	,	,
25944	901	34	in	in	IN
25944	901	35	order	order	NN
25944	901	36	that	that	IN
25944	901	37	the	the	DT
25944	901	38	parts	part	NNS
25944	901	39	be	be	VB
25944	901	40	further	further	RB
25944	901	41	protected	protect	VBN
25944	901	42	,	,	,
25944	901	43	a	a	DT
25944	901	44	bandage	bandage	NN
25944	901	45	or	or	CC
25944	901	46	a	a	DT
25944	901	47	layer	layer	NN
25944	901	48	of	of	IN
25944	901	49	cotton	cotton	NN
25944	901	50	batting	batting	NN
25944	901	51	.	.	.
25944	902	1	Oxide	oxide	NN
25944	902	2	-	-	HYPH
25944	902	3	of	of	IN
25944	902	4	-	-	HYPH
25944	902	5	zinc	zinc	NN
25944	902	6	ointment	ointment	NN
25944	902	7	,	,	,
25944	902	8	and	and	CC
25944	902	9	in	in	IN
25944	902	10	those	those	DT
25944	902	11	cases	case	NNS
25944	902	12	in	in	IN
25944	902	13	which	which	WDT
25944	902	14	there	there	EX
25944	902	15	is	be	VBZ
25944	902	16	much	much	JJ
25944	902	17	pain	pain	NN
25944	902	18	,	,	,
25944	902	19	ointments	ointment	NNS
25944	902	20	containing	contain	VBG
25944	902	21	powdered	powder	VBN
25944	902	22	opium	opium	NN
25944	902	23	or	or	CC
25944	902	24	belladonna	belladonna	NN
25944	902	25	,	,	,
25944	902	26	or	or	CC
25944	902	27	orthoform	orthoform	NN
25944	902	28	,	,	,
25944	902	29	may	may	MD
25944	902	30	be	be	VB
25944	902	31	used	use	VBN
25944	902	32	.	.	.
25944	903	1	A	a	DT
25944	903	2	mild	mild	JJ
25944	903	3	galvanic	galvanic	JJ
25944	903	4	current	current	NN
25944	903	5	applied	apply	VBN
25944	903	6	daily	daily	RB
25944	903	7	to	to	IN
25944	903	8	the	the	DT
25944	903	9	parts	part	NNS
25944	903	10	is	be	VBZ
25944	903	11	often	often	RB
25944	903	12	of	of	IN
25944	903	13	great	great	JJ
25944	903	14	advantage	advantage	NN
25944	903	15	,	,	,
25944	903	16	both	both	DT
25944	903	17	in	in	IN
25944	903	18	its	-PRON-	PRP$
25944	903	19	influence	influence	NN
25944	903	20	upon	upon	IN
25944	903	21	the	the	DT
25944	903	22	course	course	NN
25944	903	23	of	of	IN
25944	903	24	the	the	DT
25944	903	25	eruption	eruption	NN
25944	903	26	and	and	CC
25944	903	27	upon	upon	IN
25944	903	28	the	the	DT
25944	903	29	neuralgic	neuralgic	JJ
25944	903	30	pain	pain	NN
25944	903	31	.	.	.
25944	904	1	The	the	DT
25944	904	2	plan	plan	NN
25944	904	3	,	,	,
25944	904	4	so	so	RB
25944	904	5	often	often	RB
25944	904	6	advised	advise	VBN
25944	904	7	,	,	,
25944	904	8	of	of	IN
25944	904	9	painting	paint	VBG
25944	904	10	the	the	DT
25944	904	11	parts	part	NNS
25944	904	12	with	with	IN
25944	904	13	flexible	flexible	JJ
25944	904	14	collodion	collodion	NN
25944	904	15	is	be	VBZ
25944	904	16	not	not	RB
25944	904	17	to	to	TO
25944	904	18	be	be	VB
25944	904	19	commended	commend	VBN
25944	904	20	.	.	.
25944	905	1	#	#	NNP
25944	905	2	Dermatitis	Dermatitis	NNP
25944	905	3	Herpetiformis	Herpetiformis	NNP
25944	905	4	.	.	.
25944	905	5	#	#	NNP
25944	905	6	(	(	-LRB-
25944	905	7	_	_	NNP
25944	905	8	Synonyms	Synonyms	NNP
25944	905	9	:	:	:
25944	905	10	_	_	NNP
25944	905	11	Hydroa	Hydroa	NNP
25944	905	12	Herpetiforme	Herpetiforme	NNP
25944	905	13	(	(	-LRB-
25944	905	14	Tilbury	Tilbury	NNP
25944	905	15	Fox	Fox	NNP
25944	905	16	)	)	-RRB-
25944	905	17	;	;	:
25944	905	18	Herpes	Herpes	NNP
25944	905	19	Gestationis	Gestationis	NNP
25944	905	20	(	(	-LRB-
25944	905	21	Bulkley	Bulkley	NNP
25944	905	22	)	)	-RRB-
25944	905	23	;	;	:
25944	905	24	Pemphigus	Pemphigus	NNP
25944	905	25	Prurigiuosus	Prurigiuosus	NNP
25944	905	26	;	;	:
25944	905	27	Duhring	Duhring	NNP
25944	905	28	's	's	POS
25944	905	29	Disease	Disease	NNP
25944	905	30	.	.	.
25944	905	31	)	)	-RRB-
25944	906	1	#	#	NN
25944	906	2	Give	give	VB
25944	906	3	a	a	DT
25944	906	4	definition	definition	NN
25944	906	5	of	of	IN
25944	906	6	dermatitis	dermatitis	NN
25944	906	7	herpetiformis	herpetiformis	NN
25944	906	8	.	.	.
25944	906	9	#	#	NNP
25944	906	10	Dermatitis	Dermatitis	NNP
25944	906	11	herpetiformis	herpetiformis	NNP
25944	906	12	is	be	VBZ
25944	906	13	a	a	DT
25944	906	14	somewhat	somewhat	RB
25944	906	15	rare	rare	JJ
25944	906	16	inflammatory	inflammatory	JJ
25944	906	17	disease	disease	NN
25944	906	18	,	,	,
25944	906	19	characterized	characterize	VBN
25944	906	20	by	by	IN
25944	906	21	an	an	DT
25944	906	22	eruption	eruption	NN
25944	906	23	of	of	IN
25944	906	24	an	an	DT
25944	906	25	erythematous	erythematous	JJ
25944	906	26	,	,	,
25944	906	27	papular	papular	JJ
25944	906	28	,	,	,
25944	906	29	vesicular	vesicular	JJ
25944	906	30	,	,	,
25944	906	31	pustular	pustular	JJ
25944	906	32	,	,	,
25944	906	33	bullous	bullous	JJ
25944	906	34	or	or	CC
25944	906	35	mixed	mixed	JJ
25944	906	36	type	type	NN
25944	906	37	,	,	,
25944	906	38	with	with	IN
25944	906	39	a	a	DT
25944	906	40	decided	decide	VBN
25944	906	41	disposition	disposition	NN
25944	906	42	toward	toward	IN
25944	906	43	grouping	grouping	NN
25944	906	44	,	,	,
25944	906	45	accompanied	accompany	VBN
25944	906	46	by	by	IN
25944	906	47	itching	itch	VBG
25944	906	48	and	and	CC
25944	906	49	burning	burn	VBG
25944	906	50	sensations	sensation	NNS
25944	906	51	,	,	,
25944	906	52	with	with	IN
25944	906	53	,	,	,
25944	906	54	as	as	IN
25944	906	55	a	a	DT
25944	906	56	rule	rule	NN
25944	906	57	,	,	,
25944	906	58	more	more	RBR
25944	906	59	or	or	CC
25944	906	60	less	less	RBR
25944	906	61	consequent	consequent	JJ
25944	906	62	pigmentation	pigmentation	NN
25944	906	63	,	,	,
25944	906	64	and	and	CC
25944	906	65	pursuing	pursue	VBG
25944	906	66	usually	usually	RB
25944	906	67	a	a	DT
25944	906	68	chronic	chronic	JJ
25944	906	69	course	course	NN
25944	906	70	with	with	IN
25944	906	71	remissions	remission	NNS
25944	906	72	.	.	.
25944	907	1	#	#	NNP
25944	907	2	Describe	describe	VB
25944	907	3	the	the	DT
25944	907	4	erythematous	erythematous	JJ
25944	907	5	type	type	NN
25944	907	6	of	of	IN
25944	907	7	dermatitis	dermatitis	NN
25944	907	8	herpetiformis	herpetiformis	NN
25944	907	9	.	.	.
25944	907	10	#	#	$
25944	907	11	The	the	DT
25944	907	12	character	character	NN
25944	907	13	of	of	IN
25944	907	14	the	the	DT
25944	907	15	eruption	eruption	NN
25944	907	16	in	in	IN
25944	907	17	the	the	DT
25944	907	18	erythematous	erythematous	JJ
25944	907	19	type	type	NN
25944	907	20	resembles	resemble	VBZ
25944	907	21	closely	closely	RB
25944	907	22	that	that	DT
25944	907	23	of	of	IN
25944	907	24	erythema	erythema	NNP
25944	907	25	multiforme	multiforme	NNP
25944	907	26	and	and	CC
25944	907	27	of	of	IN
25944	907	28	urticaria	urticaria	NNP
25944	907	29	,	,	,
25944	907	30	especially	especially	RB
25944	907	31	the	the	DT
25944	907	32	former	former	JJ
25944	907	33	.	.	.
25944	908	1	The	the	DT
25944	908	2	efflorescences	efflorescence	NNS
25944	908	3	usually	usually	RB
25944	908	4	make	make	VBP
25944	908	5	their	-PRON-	PRP$
25944	908	6	appearance	appearance	NN
25944	908	7	in	in	IN
25944	908	8	crops	crop	NNS
25944	908	9	,	,	,
25944	908	10	and	and	CC
25944	908	11	are	be	VBP
25944	908	12	more	more	RBR
25944	908	13	or	or	CC
25944	908	14	less	less	RBR
25944	908	15	persistent	persistent	JJ
25944	908	16	;	;	:
25944	908	17	fading	fade	VBG
25944	908	18	sooner	soon	RBR
25944	908	19	or	or	CC
25944	908	20	later	later	RB
25944	908	21	,	,	,
25944	908	22	however	however	RB
25944	908	23	,	,	,
25944	908	24	and	and	CC
25944	908	25	giving	give	VBG
25944	908	26	place	place	NN
25944	908	27	to	to	IN
25944	908	28	new	new	JJ
25944	908	29	outbreaks	outbreak	NNS
25944	908	30	.	.	.
25944	909	1	Vesicles	vesicle	NNS
25944	909	2	are	be	VBP
25944	909	3	often	often	RB
25944	909	4	intermingled	intermingle	VBN
25944	909	5	,	,	,
25944	909	6	developing	develop	VBG
25944	909	7	from	from	IN
25944	909	8	erythematous	erythematous	JJ
25944	909	9	and	and	CC
25944	909	10	erythemato	erythemato	JJ
25944	909	11	-	-	HYPH
25944	909	12	papular	papular	JJ
25944	909	13	lesions	lesion	NNS
25944	909	14	or	or	CC
25944	909	15	arising	arise	VBG
25944	909	16	from	from	IN
25944	909	17	apparently	apparently	RB
25944	909	18	normal	normal	JJ
25944	909	19	skin	skin	NN
25944	909	20	.	.	.
25944	910	1	It	-PRON-	PRP
25944	910	2	may	may	MD
25944	910	3	continue	continue	VB
25944	910	4	in	in	IN
25944	910	5	the	the	DT
25944	910	6	same	same	JJ
25944	910	7	type	type	NN
25944	910	8	,	,	,
25944	910	9	or	or	CC
25944	910	10	change	change	NN
25944	910	11	to	to	IN
25944	910	12	the	the	DT
25944	910	13	vesicular	vesicular	JJ
25944	910	14	,	,	,
25944	910	15	bullous	bullous	JJ
25944	910	16	or	or	CC
25944	910	17	other	other	JJ
25944	910	18	variety	variety	NN
25944	910	19	.	.	.
25944	911	1	#	#	NNP
25944	911	2	Describe	describe	VB
25944	911	3	the	the	DT
25944	911	4	papular	papular	JJ
25944	911	5	type	type	NN
25944	911	6	of	of	IN
25944	911	7	dermatitis	dermatitis	NN
25944	911	8	herpetiformis	herpetiformis	NN
25944	911	9	.	.	.
25944	911	10	#	#	$
25944	911	11	This	this	DT
25944	911	12	is	be	VBZ
25944	911	13	rarely	rarely	RB
25944	911	14	seen	see	VBN
25944	911	15	as	as	IN
25944	911	16	consisting	consist	VBG
25944	911	17	purely	purely	RB
25944	911	18	of	of	IN
25944	911	19	papular	papular	JJ
25944	911	20	lesions	lesion	NNS
25944	911	21	,	,	,
25944	911	22	but	but	CC
25944	911	23	is	be	VBZ
25944	911	24	commonly	commonly	RB
25944	911	25	associated	associate	VBN
25944	911	26	with	with	IN
25944	911	27	the	the	DT
25944	911	28	erythematous	erythematous	JJ
25944	911	29	and	and	CC
25944	911	30	vesicular	vesicular	JJ
25944	911	31	varieties	variety	NNS
25944	911	32	.	.	.
25944	912	1	In	in	IN
25944	912	2	a	a	DT
25944	912	3	measure	measure	NN
25944	912	4	it	-PRON-	PRP
25944	912	5	resembles	resemble	VBZ
25944	912	6	the	the	DT
25944	912	7	papular	papular	JJ
25944	912	8	manifestations	manifestation	NNS
25944	912	9	of	of	IN
25944	912	10	erythema	erythema	NNP
25944	912	11	multiforme	multiforme	NNP
25944	912	12	,	,	,
25944	912	13	with	with	IN
25944	912	14	a	a	DT
25944	912	15	distinct	distinct	JJ
25944	912	16	disposition	disposition	NN
25944	912	17	toward	toward	IN
25944	912	18	group	group	NN
25944	912	19	formation	formation	NN
25944	912	20	.	.	.
25944	913	1	The	the	DT
25944	913	2	papules	papule	NNS
25944	913	3	tend	tend	VBP
25944	913	4	,	,	,
25944	913	5	sooner	sooner	RB
25944	913	6	or	or	CC
25944	913	7	later	later	RB
25944	913	8	,	,	,
25944	913	9	to	to	TO
25944	913	10	develop	develop	VB
25944	913	11	into	into	IN
25944	913	12	vesicles	vesicle	NNS
25944	913	13	,	,	,
25944	913	14	new	new	JJ
25944	913	15	papular	papular	JJ
25944	913	16	outbreaks	outbreak	NNS
25944	913	17	occurring	occur	VBG
25944	913	18	from	from	IN
25944	913	19	time	time	NN
25944	913	20	to	to	IN
25944	913	21	time	time	NN
25944	913	22	;	;	:
25944	913	23	or	or	CC
25944	913	24	the	the	DT
25944	913	25	whole	whole	JJ
25944	913	26	eruption	eruption	NN
25944	913	27	changes	change	VBZ
25944	913	28	to	to	IN
25944	913	29	the	the	DT
25944	913	30	vesicular	vesicular	JJ
25944	913	31	or	or	CC
25944	913	32	other	other	JJ
25944	913	33	type	type	NN
25944	913	34	of	of	IN
25944	913	35	the	the	DT
25944	913	36	disease	disease	NN
25944	913	37	.	.	.
25944	914	1	It	-PRON-	PRP
25944	914	2	is	be	VBZ
25944	914	3	not	not	RB
25944	914	4	a	a	DT
25944	914	5	common	common	JJ
25944	914	6	type	type	NN
25944	914	7	.	.	.
25944	915	1	#	#	NNP
25944	915	2	Describe	describe	VB
25944	915	3	the	the	DT
25944	915	4	vesicular	vesicular	JJ
25944	915	5	type	type	NN
25944	915	6	of	of	IN
25944	915	7	dermatitis	dermatitis	NN
25944	915	8	herpetiformis	herpetiformis	NN
25944	915	9	.	.	.
25944	915	10	#	#	$
25944	915	11	This	this	DT
25944	915	12	is	be	VBZ
25944	915	13	the	the	DT
25944	915	14	common	common	JJ
25944	915	15	clinical	clinical	JJ
25944	915	16	type	type	NN
25944	915	17	of	of	IN
25944	915	18	the	the	DT
25944	915	19	disease	disease	NN
25944	915	20	,	,	,
25944	915	21	and	and	CC
25944	915	22	is	be	VBZ
25944	915	23	characterized	characterize	VBN
25944	915	24	by	by	IN
25944	915	25	pin	pin	NN
25944	915	26	-	-	HYPH
25944	915	27	head	head	NN
25944	915	28	to	to	IN
25944	915	29	pea	pea	JJ
25944	915	30	-	-	HYPH
25944	915	31	sized	sized	JJ
25944	915	32	,	,	,
25944	915	33	rounded	rounded	JJ
25944	915	34	or	or	CC
25944	915	35	irregularly	irregularly	RB
25944	915	36	-	-	HYPH
25944	915	37	shaped	shape	VBN
25944	915	38	,	,	,
25944	915	39	distended	distend	VBN
25944	915	40	or	or	CC
25944	915	41	flattened	flatten	VBN
25944	915	42	and	and	CC
25944	915	43	stellate	stellate	VB
25944	915	44	vesicles	vesicle	NNS
25944	915	45	,	,	,
25944	915	46	occurring	occur	VBG
25944	915	47	,	,	,
25944	915	48	for	for	IN
25944	915	49	the	the	DT
25944	915	50	most	most	JJS
25944	915	51	part	part	NN
25944	915	52	,	,	,
25944	915	53	in	in	IN
25944	915	54	irregular	irregular	JJ
25944	915	55	and	and	CC
25944	915	56	segmental	segmental	JJ
25944	915	57	groups	group	NNS
25944	915	58	of	of	IN
25944	915	59	three	three	CD
25944	915	60	or	or	CC
25944	915	61	more	more	JJR
25944	915	62	lesions	lesion	NNS
25944	915	63	,	,	,
25944	915	64	seated	seat	VBN
25944	915	65	either	either	CC
25944	915	66	upon	upon	IN
25944	915	67	apparently	apparently	RB
25944	915	68	normal	normal	JJ
25944	915	69	integument	integument	NN
25944	915	70	or	or	CC
25944	915	71	upon	upon	IN
25944	915	72	hyperæmic	hyperæmic	JJ
25944	915	73	or	or	CC
25944	915	74	inflammatory	inflammatory	JJ
25944	915	75	skin	skin	NN
25944	915	76	.	.	.
25944	916	1	They	-PRON-	PRP
25944	916	2	exhibit	exhibit	VBP
25944	916	3	no	no	DT
25944	916	4	tendency	tendency	NN
25944	916	5	to	to	IN
25944	916	6	spontaneous	spontaneous	JJ
25944	916	7	rupture	rupture	NN
25944	916	8	,	,	,
25944	916	9	but	but	CC
25944	916	10	after	after	IN
25944	916	11	remaining	remain	VBG
25944	916	12	a	a	DT
25944	916	13	shorter	short	JJR
25944	916	14	or	or	CC
25944	916	15	longer	long	JJR
25944	916	16	time	time	NN
25944	916	17	,	,	,
25944	916	18	are	be	VBP
25944	916	19	broken	break	VBN
25944	916	20	or	or	CC
25944	916	21	disappear	disappear	VB
25944	916	22	by	by	IN
25944	916	23	absorption	absorption	NN
25944	916	24	.	.	.
25944	917	1	The	the	DT
25944	917	2	lesions	lesion	NNS
25944	917	3	tend	tend	VBP
25944	917	4	to	to	TO
25944	917	5	appear	appear	VB
25944	917	6	in	in	IN
25944	917	7	crops	crop	NNS
25944	917	8	.	.	.
25944	918	1	It	-PRON-	PRP
25944	918	2	may	may	MD
25944	918	3	,	,	,
25944	918	4	as	as	IN
25944	918	5	it	-PRON-	PRP
25944	918	6	not	not	RB
25944	918	7	infrequently	infrequently	RB
25944	918	8	does	do	VBZ
25944	918	9	,	,	,
25944	918	10	continue	continue	VB
25944	918	11	in	in	IN
25944	918	12	the	the	DT
25944	918	13	same	same	JJ
25944	918	14	type	type	NN
25944	918	15	,	,	,
25944	918	16	or	or	CC
25944	918	17	it	-PRON-	PRP
25944	918	18	may	may	MD
25944	918	19	become	become	VB
25944	918	20	more	more	RBR
25944	918	21	or	or	CC
25944	918	22	less	less	RBR
25944	918	23	erythematous	erythematous	JJ
25944	918	24	or	or	CC
25944	918	25	bullous	bullous	JJ
25944	918	26	in	in	IN
25944	918	27	character	character	NN
25944	918	28	.	.	.
25944	919	1	In	in	IN
25944	919	2	not	not	RB
25944	919	3	a	a	DT
25944	919	4	few	few	JJ
25944	919	5	instances	instance	NNS
25944	919	6	pustules	pustule	NNS
25944	919	7	,	,	,
25944	919	8	few	few	JJ
25944	919	9	or	or	CC
25944	919	10	in	in	IN
25944	919	11	numbers	number	NNS
25944	919	12	,	,	,
25944	919	13	are	be	VBP
25944	919	14	at	at	IN
25944	919	15	times	time	NNS
25944	919	16	intermingled	intermingle	VBN
25944	919	17	.	.	.
25944	920	1	#	#	NNP
25944	920	2	Describe	describe	VB
25944	920	3	the	the	DT
25944	920	4	pustular	pustular	JJ
25944	920	5	type	type	NN
25944	920	6	of	of	IN
25944	920	7	dermatitis	dermatitis	NN
25944	920	8	herpetiformis	herpetiformis	NN
25944	920	9	.	.	.
25944	920	10	#	#	$
25944	920	11	This	this	DT
25944	920	12	is	be	VBZ
25944	920	13	rare	rare	JJ
25944	920	14	.	.	.
25944	921	1	It	-PRON-	PRP
25944	921	2	is	be	VBZ
25944	921	3	similar	similar	JJ
25944	921	4	in	in	IN
25944	921	5	its	-PRON-	PRP$
25944	921	6	clinical	clinical	JJ
25944	921	7	characters	character	NNS
25944	921	8	to	to	IN
25944	921	9	the	the	DT
25944	921	10	vesicular	vesicular	JJ
25944	921	11	type	type	NN
25944	921	12	,	,	,
25944	921	13	except	except	IN
25944	921	14	that	that	IN
25944	921	15	the	the	DT
25944	921	16	lesions	lesion	NNS
25944	921	17	are	be	VBP
25944	921	18	pustular	pustular	JJ
25944	921	19	.	.	.
25944	922	1	It	-PRON-	PRP
25944	922	2	is	be	VBZ
25944	922	3	met	meet	VBN
25944	922	4	with	with	IN
25944	922	5	,	,	,
25944	922	6	as	as	IN
25944	922	7	a	a	DT
25944	922	8	rule	rule	NN
25944	922	9	,	,	,
25944	922	10	in	in	IN
25944	922	11	association	association	NN
25944	922	12	with	with	IN
25944	922	13	the	the	DT
25944	922	14	vesicular	vesicular	JJ
25944	922	15	and	and	CC
25944	922	16	bullous	bullous	JJ
25944	922	17	varieties	variety	NNS
25944	922	18	of	of	IN
25944	922	19	the	the	DT
25944	922	20	disease	disease	NN
25944	922	21	.	.	.
25944	923	1	#	#	NNP
25944	923	2	Describe	describe	VB
25944	923	3	the	the	DT
25944	923	4	bullous	bullous	JJ
25944	923	5	type	type	NN
25944	923	6	of	of	IN
25944	923	7	dermatitis	dermatitis	NN
25944	923	8	herpetiformis	herpetiformis	NN
25944	923	9	.	.	.
25944	923	10	#	#	$
25944	923	11	The	the	DT
25944	923	12	bullous	bullous	JJ
25944	923	13	expression	expression	NN
25944	923	14	of	of	IN
25944	923	15	the	the	DT
25944	923	16	disease	disease	NN
25944	923	17	is	be	VBZ
25944	923	18	usually	usually	RB
25944	923	19	of	of	IN
25944	923	20	a	a	DT
25944	923	21	markedly	markedly	RB
25944	923	22	inflammatory	inflammatory	JJ
25944	923	23	nature	nature	NN
25944	923	24	,	,	,
25944	923	25	often	often	RB
25944	923	26	innumerable	innumerable	JJ
25944	923	27	blebs	blebs	NN
25944	923	28	,	,	,
25944	923	29	small	small	JJ
25944	923	30	and	and	CC
25944	923	31	large	large	JJ
25944	923	32	,	,	,
25944	923	33	appearing	appear	VBG
25944	923	34	almost	almost	RB
25944	923	35	continuously	continuously	RB
25944	923	36	,	,	,
25944	923	37	and	and	CC
25944	923	38	in	in	IN
25944	923	39	some	some	DT
25944	923	40	instances	instance	NNS
25944	923	41	involving	involve	VBG
25944	923	42	the	the	DT
25944	923	43	greater	great	JJR
25944	923	44	part	part	NN
25944	923	45	of	of	IN
25944	923	46	the	the	DT
25944	923	47	surface	surface	NN
25944	923	48	.	.	.
25944	924	1	The	the	DT
25944	924	2	lesions	lesion	NNS
25944	924	3	arise	arise	VBP
25944	924	4	from	from	IN
25944	924	5	erythematous	erythematous	JJ
25944	924	6	skin	skin	NN
25944	924	7	,	,	,
25944	924	8	from	from	IN
25944	924	9	preëxisting	preëxiste	VBG
25944	924	10	vesicles	vesicle	NNS
25944	924	11	or	or	CC
25944	924	12	vesicular	vesicular	JJ
25944	924	13	groups	group	NNS
25944	924	14	,	,	,
25944	924	15	or	or	CC
25944	924	16	from	from	IN
25944	924	17	apparently	apparently	RB
25944	924	18	normal	normal	JJ
25944	924	19	integument	integument	NN
25944	924	20	.	.	.
25944	925	1	There	there	EX
25944	925	2	is	be	VBZ
25944	925	3	a	a	DT
25944	925	4	marked	marked	JJ
25944	925	5	disposition	disposition	NN
25944	925	6	to	to	TO
25944	925	7	appear	appear	VB
25944	925	8	in	in	IN
25944	925	9	clusters	cluster	NNS
25944	925	10	.	.	.
25944	926	1	A	a	DT
25944	926	2	change	change	NN
25944	926	3	of	of	IN
25944	926	4	type	type	NN
25944	926	5	to	to	IN
25944	926	6	the	the	DT
25944	926	7	erythematous	erythematous	JJ
25944	926	8	or	or	CC
25944	926	9	vesicular	vesicular	JJ
25944	926	10	varieties	variety	NNS
25944	926	11	is	be	VBZ
25944	926	12	not	not	RB
25944	926	13	unusual	unusual	JJ
25944	926	14	.	.	.
25944	927	1	#	#	NNP
25944	927	2	Describe	describe	VB
25944	927	3	the	the	DT
25944	927	4	mixed	mixed	JJ
25944	927	5	type	type	NN
25944	927	6	of	of	IN
25944	927	7	dermatitis	dermatitis	NN
25944	927	8	herpetiformis	herpetiformis	NN
25944	927	9	.	.	.
25944	927	10	#	#	$
25944	927	11	In	in	IN
25944	927	12	this	this	DT
25944	927	13	type	type	NN
25944	927	14	the	the	DT
25944	927	15	eruption	eruption	NN
25944	927	16	is	be	VBZ
25944	927	17	made	make	VBN
25944	927	18	up	up	RP
25944	927	19	of	of	IN
25944	927	20	erythematous	erythematous	JJ
25944	927	21	patches	patch	NNS
25944	927	22	,	,	,
25944	927	23	vesicles	vesicle	NNS
25944	927	24	,	,	,
25944	927	25	bullæ	bullæ	NNP
25944	927	26	,	,	,
25944	927	27	and	and	CC
25944	927	28	often	often	RB
25944	927	29	with	with	IN
25944	927	30	pustules	pustule	NNS
25944	927	31	intermingled	intermingle	VBN
25944	927	32	,	,	,
25944	927	33	appearing	appear	VBG
25944	927	34	irregularly	irregularly	RB
25944	927	35	or	or	CC
25944	927	36	in	in	IN
25944	927	37	crops	crop	NNS
25944	927	38	,	,	,
25944	927	39	and	and	CC
25944	927	40	with	with	IN
25944	927	41	a	a	DT
25944	927	42	tendency	tendency	NN
25944	927	43	to	to	TO
25944	927	44	patch	patch	VB
25944	927	45	or	or	CC
25944	927	46	group	group	NN
25944	927	47	formation	formation	NN
25944	927	48	.	.	.
25944	928	1	#	#	NNP
25944	928	2	Describe	describe	VB
25944	928	3	the	the	DT
25944	928	4	characters	character	NNS
25944	928	5	of	of	IN
25944	928	6	the	the	DT
25944	928	7	vesicles	vesicle	NNS
25944	928	8	,	,	,
25944	928	9	pustules	pustule	NNS
25944	928	10	and	and	CC
25944	928	11	blebs	blebs	NN
25944	928	12	.	.	.
25944	928	13	#	#	$
25944	928	14	As	as	IN
25944	928	15	a	a	DT
25944	928	16	rule	rule	NN
25944	928	17	,	,	,
25944	928	18	these	these	DT
25944	928	19	several	several	JJ
25944	928	20	lesions	lesion	NNS
25944	928	21	,	,	,
25944	928	22	especially	especially	RB
25944	928	23	the	the	DT
25944	928	24	vesicles	vesicle	NNS
25944	928	25	and	and	CC
25944	928	26	blebs	blebs	NN
25944	928	27	,	,	,
25944	928	28	are	be	VBP
25944	928	29	somewhat	somewhat	RB
25944	928	30	peculiar	peculiar	JJ
25944	928	31	:	:	:
25944	928	32	they	-PRON-	PRP
25944	928	33	are	be	VBP
25944	928	34	usually	usually	RB
25944	928	35	of	of	IN
25944	928	36	a	a	DT
25944	928	37	strikingly	strikingly	RB
25944	928	38	irregular	irregular	JJ
25944	928	39	outline	outline	NN
25944	928	40	,	,	,
25944	928	41	oblong	oblong	NNP
25944	928	42	,	,	,
25944	928	43	stellate	stellate	JJ
25944	928	44	,	,	,
25944	928	45	quadrate	quadrate	JJ
25944	928	46	,	,	,
25944	928	47	and	and	CC
25944	928	48	when	when	WRB
25944	928	49	drying	drying	NN
25944	928	50	are	be	VBP
25944	928	51	apt	apt	JJ
25944	928	52	to	to	TO
25944	928	53	have	have	VB
25944	928	54	a	a	DT
25944	928	55	puckered	puckered	JJ
25944	928	56	appearance	appearance	NN
25944	928	57	.	.	.
25944	929	1	They	-PRON-	PRP
25944	929	2	are	be	VBP
25944	929	3	herpetic	herpetic	JJ
25944	929	4	in	in	IN
25944	929	5	that	that	DT
25944	929	6	they	-PRON-	PRP
25944	929	7	show	show	VBP
25944	929	8	little	little	JJ
25944	929	9	disposition	disposition	NN
25944	929	10	to	to	IN
25944	929	11	spontaneous	spontaneous	JJ
25944	929	12	rupture	rupture	NN
25944	929	13	,	,	,
25944	929	14	occur	occur	VBP
25944	929	15	in	in	IN
25944	929	16	groups	group	NNS
25944	929	17	,	,	,
25944	929	18	and	and	CC
25944	929	19	are	be	VBP
25944	929	20	usually	usually	RB
25944	929	21	seated	seat	VBN
25944	929	22	upon	upon	IN
25944	929	23	erythematous	erythematous	JJ
25944	929	24	or	or	CC
25944	929	25	inflammatory	inflammatory	JJ
25944	929	26	skin	skin	NN
25944	929	27	--	--	:
25944	929	28	in	in	IN
25944	929	29	some	some	DT
25944	929	30	respects	respect	NNS
25944	929	31	similar	similar	JJ
25944	929	32	to	to	IN
25944	929	33	the	the	DT
25944	929	34	groups	group	NNS
25944	929	35	of	of	IN
25944	929	36	simple	simple	JJ
25944	929	37	herpes	herpe	NNS
25944	929	38	and	and	CC
25944	929	39	herpes	herpe	NNS
25944	929	40	zoster	zoster	NNP
25944	929	41	.	.	.
25944	930	1	#	#	LS
25944	930	2	What	what	WP
25944	930	3	is	be	VBZ
25944	930	4	to	to	TO
25944	930	5	be	be	VB
25944	930	6	said	say	VBN
25944	930	7	in	in	IN
25944	930	8	regard	regard	NN
25944	930	9	to	to	IN
25944	930	10	the	the	DT
25944	930	11	subjective	subjective	JJ
25944	930	12	symptoms	symptom	NNS
25944	930	13	?	?	.
25944	930	14	#	#	$
25944	930	15	The	the	DT
25944	930	16	subjective	subjective	JJ
25944	930	17	symptoms	symptom	NNS
25944	930	18	are	be	VBP
25944	930	19	usually	usually	RB
25944	930	20	the	the	DT
25944	930	21	most	most	RBS
25944	930	22	troublesome	troublesome	JJ
25944	930	23	feature	feature	NN
25944	930	24	of	of	IN
25944	930	25	the	the	DT
25944	930	26	disease	disease	NN
25944	930	27	,	,	,
25944	930	28	consisting	consist	VBG
25944	930	29	of	of	IN
25944	930	30	intense	intense	JJ
25944	930	31	and	and	CC
25944	930	32	persistent	persistent	JJ
25944	930	33	itching	itching	NN
25944	930	34	and	and	CC
25944	930	35	a	a	DT
25944	930	36	feeling	feeling	NN
25944	930	37	of	of	IN
25944	930	38	heat	heat	NN
25944	930	39	and	and	CC
25944	930	40	burning	burn	VBG
25944	930	41	.	.	.
25944	931	1	#	#	NN
25944	931	2	Are	be	VBP
25944	931	3	there	there	EX
25944	931	4	any	any	DT
25944	931	5	constitutional	constitutional	JJ
25944	931	6	symptoms	symptom	NNS
25944	931	7	in	in	IN
25944	931	8	dermatitis	dermatitis	NN
25944	931	9	herpetiformis	herpetiformis	NN
25944	931	10	?	?	.
25944	931	11	#	#	$
25944	931	12	As	as	IN
25944	931	13	a	a	DT
25944	931	14	rule	rule	NN
25944	931	15	,	,	,
25944	931	16	not	not	RB
25944	931	17	,	,	,
25944	931	18	excepting	except	VBG
25944	931	19	the	the	DT
25944	931	20	distress	distress	NN
25944	931	21	and	and	CC
25944	931	22	depression	depression	NN
25944	931	23	necessarily	necessarily	RB
25944	931	24	consequent	consequent	JJ
25944	931	25	upon	upon	IN
25944	931	26	the	the	DT
25944	931	27	intense	intense	JJ
25944	931	28	itchiness	itchiness	NN
25944	931	29	and	and	CC
25944	931	30	loss	loss	NN
25944	931	31	of	of	IN
25944	931	32	sleep	sleep	NN
25944	931	33	.	.	.
25944	932	1	In	in	IN
25944	932	2	the	the	DT
25944	932	3	pustular	pustular	JJ
25944	932	4	and	and	CC
25944	932	5	bullous	bullous	JJ
25944	932	6	varieties	variety	NNS
25944	932	7	there	there	EX
25944	932	8	may	may	MD
25944	932	9	be	be	VB
25944	932	10	mild	mild	JJ
25944	932	11	or	or	CC
25944	932	12	grave	grave	JJ
25944	932	13	systemic	systemic	JJ
25944	932	14	symptoms	symptom	NNS
25944	932	15	,	,	,
25944	932	16	but	but	CC
25944	932	17	even	even	RB
25944	932	18	in	in	IN
25944	932	19	these	these	DT
25944	932	20	types	type	NNS
25944	932	21	the	the	DT
25944	932	22	constitutional	constitutional	JJ
25944	932	23	involvement	involvement	NN
25944	932	24	is	be	VBZ
25944	932	25	,	,	,
25944	932	26	in	in	IN
25944	932	27	most	most	JJS
25944	932	28	instances	instance	NNS
25944	932	29	,	,	,
25944	932	30	slight	slight	JJ
25944	932	31	in	in	IN
25944	932	32	comparison	comparison	NN
25944	932	33	to	to	IN
25944	932	34	the	the	DT
25944	932	35	intensity	intensity	NN
25944	932	36	of	of	IN
25944	932	37	the	the	DT
25944	932	38	cutaneous	cutaneous	JJ
25944	932	39	disturbance	disturbance	NN
25944	932	40	.	.	.
25944	933	1	#	#	LS
25944	933	2	What	what	WP
25944	933	3	is	be	VBZ
25944	933	4	the	the	DT
25944	933	5	course	course	NN
25944	933	6	of	of	IN
25944	933	7	dermatitis	dermatitis	NN
25944	933	8	herpetiformis	herpetiformis	NN
25944	933	9	?	?	.
25944	933	10	#	#	$
25944	933	11	Extremely	extremely	RB
25944	933	12	chronic	chronic	JJ
25944	933	13	,	,	,
25944	933	14	in	in	IN
25944	933	15	most	most	JJS
25944	933	16	instances	instance	NNS
25944	933	17	lasting	last	VBG
25944	933	18	,	,	,
25944	933	19	with	with	IN
25944	933	20	remissions	remission	NNS
25944	933	21	,	,	,
25944	933	22	indefinitely	indefinitely	RB
25944	933	23	.	.	.
25944	934	1	The	the	DT
25944	934	2	skin	skin	NN
25944	934	3	is	be	VBZ
25944	934	4	rarely	rarely	RB
25944	934	5	entirely	entirely	RB
25944	934	6	free	free	JJ
25944	934	7	.	.	.
25944	935	1	From	from	IN
25944	935	2	time	time	NN
25944	935	3	to	to	IN
25944	935	4	time	time	NN
25944	935	5	the	the	DT
25944	935	6	type	type	NN
25944	935	7	of	of	IN
25944	935	8	the	the	DT
25944	935	9	disease	disease	NN
25944	935	10	may	may	MD
25944	935	11	undergo	undergo	VB
25944	935	12	change	change	NN
25944	935	13	.	.	.
25944	936	1	From	from	IN
25944	936	2	the	the	DT
25944	936	3	continued	continue	VBN
25944	936	4	irritation	irritation	NN
25944	936	5	and	and	CC
25944	936	6	scratching	scratch	VBG
25944	936	7	more	more	RBR
25944	936	8	or	or	CC
25944	936	9	less	less	JJR
25944	936	10	pigmentation	pigmentation	NN
25944	936	11	results	result	NNS
25944	936	12	.	.	.
25944	937	1	#	#	LS
25944	937	2	What	what	WP
25944	937	3	is	be	VBZ
25944	937	4	to	to	TO
25944	937	5	be	be	VB
25944	937	6	said	say	VBN
25944	937	7	in	in	IN
25944	937	8	regard	regard	NN
25944	937	9	to	to	IN
25944	937	10	the	the	DT
25944	937	11	etiology	etiology	NN
25944	937	12	?	?	.
25944	937	13	#	#	$
25944	937	14	The	the	DT
25944	937	15	disease	disease	NN
25944	937	16	is	be	VBZ
25944	937	17	in	in	IN
25944	937	18	many	many	JJ
25944	937	19	instances	instance	NNS
25944	937	20	essentially	essentially	RB
25944	937	21	neurotic	neurotic	JJ
25944	937	22	,	,	,
25944	937	23	and	and	CC
25944	937	24	in	in	IN
25944	937	25	exceptional	exceptional	JJ
25944	937	26	instances	instance	NNS
25944	937	27	septicæmic	septicæmic	VBP
25944	937	28	.	.	.
25944	938	1	Pregnancy	Pregnancy	NNP
25944	938	2	and	and	CC
25944	938	3	the	the	DT
25944	938	4	parturient	parturient	NN
25944	938	5	state	state	NN
25944	938	6	are	be	VBP
25944	938	7	factors	factor	NNS
25944	938	8	in	in	IN
25944	938	9	some	some	DT
25944	938	10	instances	instance	NNS
25944	938	11	(	(	-LRB-
25944	938	12	so	so	RB
25944	938	13	-	-	HYPH
25944	938	14	called	call	VBN
25944	938	15	herpes	herpes	NNP
25944	938	16	gestationis	gestationis	NNP
25944	938	17	)	)	-RRB-
25944	938	18	.	.	.
25944	939	1	It	-PRON-	PRP
25944	939	2	is	be	VBZ
25944	939	3	possible	possible	JJ
25944	939	4	in	in	IN
25944	939	5	some	some	DT
25944	939	6	instances	instance	NNS
25944	939	7	that	that	IN
25944	939	8	the	the	DT
25944	939	9	eruption	eruption	NN
25944	939	10	may	may	MD
25944	939	11	be	be	VB
25944	939	12	an	an	DT
25944	939	13	expression	expression	NN
25944	939	14	of	of	IN
25944	939	15	a	a	DT
25944	939	16	mild	mild	JJ
25944	939	17	toxemia	toxemia	NN
25944	939	18	of	of	IN
25944	939	19	gastro	gastro	NNP
25944	939	20	-	-	HYPH
25944	939	21	intestinal	intestinal	JJ
25944	939	22	origin	origin	NN
25944	939	23	.	.	.
25944	940	1	In	in	IN
25944	940	2	some	some	DT
25944	940	3	cases	case	NNS
25944	940	4	no	no	DT
25944	940	5	cause	cause	NN
25944	940	6	can	can	MD
25944	940	7	be	be	VB
25944	940	8	assigned	assign	VBN
25944	940	9	.	.	.
25944	941	1	In	in	IN
25944	941	2	the	the	DT
25944	941	3	majority	majority	NN
25944	941	4	of	of	IN
25944	941	5	patients	patient	NNS
25944	941	6	the	the	DT
25944	941	7	general	general	JJ
25944	941	8	health	health	NN
25944	941	9	,	,	,
25944	941	10	considering	consider	VBG
25944	941	11	the	the	DT
25944	941	12	violence	violence	NN
25944	941	13	of	of	IN
25944	941	14	the	the	DT
25944	941	15	eruptive	eruptive	JJ
25944	941	16	phenomena	phenomenon	NNS
25944	941	17	,	,	,
25944	941	18	remains	remain	VBZ
25944	941	19	comparatively	comparatively	RB
25944	941	20	undisturbed	undisturbed	JJ
25944	941	21	.	.	.
25944	942	1	Nervous	nervous	JJ
25944	942	2	shock	shock	NN
25944	942	3	and	and	CC
25944	942	4	mental	mental	JJ
25944	942	5	worry	worry	NN
25944	942	6	are	be	VBP
25944	942	7	factors	factor	NNS
25944	942	8	in	in	IN
25944	942	9	some	some	DT
25944	942	10	cases	case	NNS
25944	942	11	.	.	.
25944	943	1	Polyuria	Polyuria	NNP
25944	943	2	,	,	,
25944	943	3	with	with	IN
25944	943	4	sugar	sugar	NN
25944	943	5	in	in	IN
25944	943	6	the	the	DT
25944	943	7	urine	urine	NN
25944	943	8	,	,	,
25944	943	9	has	have	VBZ
25944	943	10	occasionally	occasionally	RB
25944	943	11	been	be	VBN
25944	943	12	noted	note	VBN
25944	943	13	.	.	.
25944	944	1	Eosinophile	eosinophile	JJ
25944	944	2	cells	cell	NNS
25944	944	3	have	have	VBP
25944	944	4	been	be	VBN
25944	944	5	found	find	VBN
25944	944	6	both	both	DT
25944	944	7	in	in	IN
25944	944	8	the	the	DT
25944	944	9	vesicles	vesicle	NNS
25944	944	10	and	and	CC
25944	944	11	the	the	DT
25944	944	12	blood	blood	NN
25944	944	13	.	.	.
25944	945	1	In	in	IN
25944	945	2	some	some	DT
25944	945	3	instances	instance	NNS
25944	945	4	--	--	:
25944	945	5	exceptionally	exceptionally	RB
25944	945	6	,	,	,
25944	945	7	it	-PRON-	PRP
25944	945	8	is	be	VBZ
25944	945	9	true	true	JJ
25944	945	10	--	--	:
25944	945	11	the	the	DT
25944	945	12	disease	disease	NN
25944	945	13	has	have	VBZ
25944	945	14	appeared	appear	VBN
25944	945	15	shortly	shortly	RB
25944	945	16	after	after	IN
25944	945	17	vaccination	vaccination	NN
25944	945	18	.	.	.
25944	946	1	#	#	$
25944	946	2	Mention	mention	VB
25944	946	3	the	the	DT
25944	946	4	diagnostic	diagnostic	JJ
25944	946	5	features	feature	NNS
25944	946	6	of	of	IN
25944	946	7	dermatitis	dermatitis	NN
25944	946	8	herpetiformis	herpetiformis	NN
25944	946	9	.	.	.
25944	946	10	#	#	$
25944	946	11	The	the	DT
25944	946	12	multiformity	multiformity	NN
25944	946	13	of	of	IN
25944	946	14	the	the	DT
25944	946	15	eruption	eruption	NN
25944	946	16	,	,	,
25944	946	17	the	the	DT
25944	946	18	characters	character	NNS
25944	946	19	of	of	IN
25944	946	20	the	the	DT
25944	946	21	lesions	lesion	NNS
25944	946	22	,	,	,
25944	946	23	the	the	DT
25944	946	24	disposition	disposition	NN
25944	946	25	to	to	IN
25944	946	26	grouping	group	VBG
25944	946	27	,	,	,
25944	946	28	the	the	DT
25944	946	29	absence	absence	NN
25944	946	30	of	of	IN
25944	946	31	tendency	tendency	NN
25944	946	32	to	to	TO
25944	946	33	form	form	VB
25944	946	34	solid	solid	JJ
25944	946	35	sheets	sheet	NNS
25944	946	36	of	of	IN
25944	946	37	eruption	eruption	NN
25944	946	38	(	(	-LRB-
25944	946	39	as	as	IN
25944	946	40	in	in	IN
25944	946	41	eczema	eczema	NN
25944	946	42	)	)	-RRB-
25944	946	43	,	,	,
25944	946	44	the	the	DT
25944	946	45	intense	intense	JJ
25944	946	46	itching	itching	NN
25944	946	47	,	,	,
25944	946	48	history	history	NN
25944	946	49	,	,	,
25944	946	50	chronicity	chronicity	NN
25944	946	51	and	and	CC
25944	946	52	course	course	NN
25944	946	53	.	.	.
25944	947	1	In	in	IN
25944	947	2	doubtful	doubtful	JJ
25944	947	3	cases	case	NNS
25944	947	4	,	,	,
25944	947	5	an	an	DT
25944	947	6	observation	observation	NN
25944	947	7	of	of	IN
25944	947	8	several	several	JJ
25944	947	9	weeks	week	NNS
25944	947	10	will	will	MD
25944	947	11	always	always	RB
25944	947	12	suffice	suffice	VB
25944	947	13	to	to	TO
25944	947	14	distinguish	distinguish	VB
25944	947	15	it	-PRON-	PRP
25944	947	16	from	from	IN
25944	947	17	eczema	eczema	NN
25944	947	18	,	,	,
25944	947	19	erythema	erythema	NNP
25944	947	20	multiforme	multiforme	NNP
25944	947	21	,	,	,
25944	947	22	herpes	herpes	NNP
25944	947	23	iris	iris	NNP
25944	947	24	and	and	CC
25944	947	25	pemphigus	pemphigus	JJ
25944	947	26	,	,	,
25944	947	27	diseases	disease	NNS
25944	947	28	to	to	TO
25944	947	29	which	which	WDT
25944	947	30	it	-PRON-	PRP
25944	947	31	at	at	IN
25944	947	32	times	time	NNS
25944	947	33	bears	bear	VBZ
25944	947	34	strong	strong	JJ
25944	947	35	resemblance	resemblance	NN
25944	947	36	.	.	.
25944	948	1	#	#	NN
25944	948	2	Give	give	VB
25944	948	3	the	the	DT
25944	948	4	prognosis	prognosis	NN
25944	948	5	of	of	IN
25944	948	6	dermatitis	dermatitis	NN
25944	948	7	herpetiformis	herpetiformis	NN
25944	948	8	.	.	.
25944	948	9	#	#	$
25944	948	10	An	an	DT
25944	948	11	opinion	opinion	NN
25944	948	12	as	as	IN
25944	948	13	to	to	IN
25944	948	14	the	the	DT
25944	948	15	outcome	outcome	NN
25944	948	16	of	of	IN
25944	948	17	the	the	DT
25944	948	18	disease	disease	NN
25944	948	19	should	should	MD
25944	948	20	be	be	VB
25944	948	21	guarded	guard	VBN
25944	948	22	.	.	.
25944	949	1	It	-PRON-	PRP
25944	949	2	is	be	VBZ
25944	949	3	exceedingly	exceedingly	RB
25944	949	4	rebellious	rebellious	JJ
25944	949	5	to	to	IN
25944	949	6	treatment	treatment	NN
25944	949	7	,	,	,
25944	949	8	and	and	CC
25944	949	9	relapses	relapse	NNS
25944	949	10	are	be	VBP
25944	949	11	the	the	DT
25944	949	12	rule	rule	NN
25944	949	13	.	.	.
25944	950	1	Exceptionally	exceptionally	RB
25944	950	2	the	the	DT
25944	950	3	bullous	bullous	JJ
25944	950	4	and	and	CC
25944	950	5	pustular	pustular	JJ
25944	950	6	varieties	variety	NNS
25944	950	7	prove	prove	VBP
25944	950	8	eventually	eventually	RB
25944	950	9	fatal	fatal	JJ
25944	950	10	.	.	.
25944	951	1	The	the	DT
25944	951	2	erythematous	erythematous	JJ
25944	951	3	and	and	CC
25944	951	4	vesicular	vesicular	JJ
25944	951	5	varieties	variety	NNS
25944	951	6	are	be	VBP
25944	951	7	the	the	DT
25944	951	8	most	most	RBS
25944	951	9	favorable	favorable	JJ
25944	951	10	.	.	.
25944	952	1	#	#	JJR
25944	952	2	State	state	NN
25944	952	3	the	the	DT
25944	952	4	treatment	treatment	NN
25944	952	5	to	to	TO
25944	952	6	be	be	VB
25944	952	7	advised	advise	VBN
25944	952	8	.	.	.
25944	952	9	#	#	$
25944	952	10	There	there	EX
25944	952	11	are	be	VBP
25944	952	12	no	no	DT
25944	952	13	special	special	JJ
25944	952	14	remedies	remedy	NNS
25944	952	15	.	.	.
25944	953	1	Constitutional	constitutional	JJ
25944	953	2	treatment	treatment	NN
25944	953	3	must	must	MD
25944	953	4	be	be	VB
25944	953	5	conducted	conduct	VBN
25944	953	6	upon	upon	IN
25944	953	7	general	general	JJ
25944	953	8	principles	principle	NNS
25944	953	9	.	.	.
25944	954	1	A	a	DT
25944	954	2	free	free	JJ
25944	954	3	action	action	NN
25944	954	4	of	of	IN
25944	954	5	the	the	DT
25944	954	6	bowels	bowel	NNS
25944	954	7	is	be	VBZ
25944	954	8	to	to	TO
25944	954	9	be	be	VB
25944	954	10	maintained	maintain	VBN
25944	954	11	.	.	.
25944	955	1	In	in	IN
25944	955	2	occasional	occasional	JJ
25944	955	3	instances	instance	NNS
25944	955	4	arsenic	arsenic	JJ
25944	955	5	in	in	IN
25944	955	6	progressive	progressive	JJ
25944	955	7	doses	dose	NNS
25944	955	8	seems	seem	VBZ
25944	955	9	of	of	IN
25944	955	10	value	value	NN
25944	955	11	.	.	.
25944	956	1	Externally	externally	RB
25944	956	2	protective	protective	JJ
25944	956	3	and	and	CC
25944	956	4	antipruritic	antipruritic	JJ
25944	956	5	applications	application	NNS
25944	956	6	,	,	,
25944	956	7	such	such	JJ
25944	956	8	as	as	IN
25944	956	9	are	be	VBP
25944	956	10	employed	employ	VBN
25944	956	11	in	in	IN
25944	956	12	the	the	DT
25944	956	13	treatment	treatment	NN
25944	956	14	of	of	IN
25944	956	15	eczema	eczema	NN
25944	956	16	and	and	CC
25944	956	17	pemphigus	pemphigus	NN
25944	956	18	,	,	,
25944	956	19	are	be	VBP
25944	956	20	to	to	TO
25944	956	21	be	be	VB
25944	956	22	employed:--	employed:--	.
25944	956	23	[	[	-LRB-
25944	956	24	Rx	Rx	NNP
25944	956	25	]	]	-RRB-
25944	956	26	Ac	Ac	NNP
25944	956	27	.	.	.
25944	957	1	carbolici	carbolici	NNS
25944	957	2	,	,	,
25944	957	3	.......................	.......................	NFP
25944	957	4	[	[	-LRB-
25944	957	5	dram]j-[dram]ij	dram]j-[dram]ij	NNP
25944	957	6	Thymol	Thymol	NNP
25944	957	7	,	,	,
25944	957	8	..............................	..............................	NFP
25944	957	9	gr	gr	NNP
25944	957	10	.	.	.
25944	958	1	xvj	xvj	NNP
25944	958	2	.	.	.
25944	959	1	Glycerinæ	Glycerinæ	NNP
25944	959	2	,	,	,
25944	959	3	...........................	...........................	NFP
25944	959	4	[	[	-LRB-
25944	959	5	Oz]ss-[Oz]j	Oz]ss-[Oz]j	NNP
25944	959	6	Alcoholis	Alcoholis	NNP
25944	959	7	,	,	,
25944	959	8	...........................	...........................	.
25944	959	9	f[Oz]ij	f[Oz]ij	NNP
25944	959	10	Aquæ	Aquæ	NNP
25944	959	11	,	,	,
25944	959	12	q.s	q.s	NNP
25944	959	13	.	.	NNP
25944	959	14	,	,	,
25944	959	15	.........	.........	NFP
25944	959	16	ad	ad	NN
25944	959	17	.............	.............	.
25944	959	18	Oj	oj	UH
25944	959	19	.	.	.
25944	960	1	M.	M.	NNP
25944	960	2	Other	other	JJ
25944	960	3	valuable	valuable	JJ
25944	960	4	applications	application	NNS
25944	960	5	are	be	VBP
25944	960	6	:	:	:
25944	960	7	lotions	lotion	NNS
25944	960	8	of	of	IN
25944	960	9	carbolic	carbolic	JJ
25944	960	10	acid	acid	NN
25944	960	11	,	,	,
25944	960	12	of	of	IN
25944	960	13	liquor	liquor	NN
25944	960	14	carbonis	carbonis	NN
25944	960	15	detergens	detergen	NNS
25944	960	16	,	,	,
25944	960	17	of	of	IN
25944	960	18	boric	boric	NN
25944	960	19	acid	acid	NN
25944	960	20	;	;	:
25944	960	21	alkaline	alkaline	NN
25944	960	22	baths	bath	NNS
25944	960	23	,	,	,
25944	960	24	mild	mild	JJ
25944	960	25	sulphur	sulphur	NNP
25944	960	26	ointment	ointment	NN
25944	960	27	and	and	CC
25944	960	28	carbolized	carbolize	VBN
25944	960	29	oxide	oxide	NN
25944	960	30	-	-	HYPH
25944	960	31	of	of	IN
25944	960	32	-	-	HYPH
25944	960	33	zinc	zinc	NN
25944	960	34	ointment	ointment	NN
25944	960	35	,	,	,
25944	960	36	and	and	CC
25944	960	37	dusting	dusting	NN
25944	960	38	-	-	HYPH
25944	960	39	powders	powder	NNS
25944	960	40	of	of	IN
25944	960	41	starch	starch	NN
25944	960	42	,	,	,
25944	960	43	zinc	zinc	NN
25944	960	44	oxide	oxide	NN
25944	960	45	,	,	,
25944	960	46	talc	talc	NN
25944	960	47	and	and	CC
25944	960	48	boric	boric	NN
25944	960	49	acid	acid	NN
25944	960	50	.	.	.
25944	961	1	A	a	DT
25944	961	2	two-	two-	NN
25944	961	3	to	to	IN
25944	961	4	ten	ten	CD
25944	961	5	-	-	HYPH
25944	961	6	per	per	IN
25944	961	7	-	-	HYPH
25944	961	8	cent	cent	NN
25944	961	9	.	.	.
25944	962	1	ichthyol	ichthyol	JJ
25944	962	2	lotion	lotion	NN
25944	962	3	or	or	CC
25944	962	4	ointment	ointment	NN
25944	962	5	is	be	VBZ
25944	962	6	sometimes	sometimes	RB
25944	962	7	of	of	IN
25944	962	8	advantage	advantage	NN
25944	962	9	;	;	:
25944	962	10	thiol	thiol	NN
25944	962	11	employed	employ	VBN
25944	962	12	in	in	IN
25944	962	13	the	the	DT
25944	962	14	same	same	JJ
25944	962	15	manner	manner	NN
25944	962	16	has	have	VBZ
25944	962	17	also	also	RB
25944	962	18	been	be	VBN
25944	962	19	commended	commend	VBN
25944	962	20	.	.	.
25944	963	1	#	#	NNP
25944	963	2	Psoriasis	Psoriasis	NNP
25944	963	3	.	.	.
25944	963	4	#	#	$
25944	963	5	#	#	$
25944	963	6	Give	give	VB
25944	963	7	a	a	DT
25944	963	8	definition	definition	NN
25944	963	9	of	of	IN
25944	963	10	psoriasis	psoriasis	NN
25944	963	11	.	.	.
25944	963	12	#	#	$
25944	963	13	Psoriasis	Psoriasis	NNP
25944	963	14	is	be	VBZ
25944	963	15	a	a	DT
25944	963	16	chronic	chronic	JJ
25944	963	17	,	,	,
25944	963	18	inflammatory	inflammatory	JJ
25944	963	19	disease	disease	NN
25944	963	20	,	,	,
25944	963	21	characterized	characterize	VBN
25944	963	22	by	by	IN
25944	963	23	dry	dry	JJ
25944	963	24	,	,	,
25944	963	25	reddish	reddish	JJ
25944	963	26	,	,	,
25944	963	27	variously	variously	RB
25944	963	28	-	-	HYPH
25944	963	29	sized	sized	JJ
25944	963	30	,	,	,
25944	963	31	rounded	rounded	JJ
25944	963	32	,	,	,
25944	963	33	sharply	sharply	RB
25944	963	34	-	-	HYPH
25944	963	35	defined	define	VBN
25944	963	36	,	,	,
25944	963	37	more	more	RBR
25944	963	38	or	or	CC
25944	963	39	less	less	RBR
25944	963	40	infiltrated	infiltrated	JJ
25944	963	41	,	,	,
25944	963	42	scaly	scaly	NNP
25944	963	43	patches	patch	NNS
25944	963	44	.	.	.
25944	964	1	[	[	-LRB-
25944	964	2	Illustration	illustration	NN
25944	964	3	:	:	:
25944	964	4	Psoriasis	Psoriasis	NNP
25944	964	5	.	.	.
25944	964	6	]	]	-RRB-
25944	965	1	#	#	$
25944	965	2	At	at	IN
25944	965	3	what	what	WDT
25944	965	4	age	age	NN
25944	965	5	does	do	VBZ
25944	965	6	psoriasis	psoriasis	NN
25944	965	7	usually	usually	RB
25944	965	8	first	first	RB
25944	965	9	make	make	VB
25944	965	10	its	-PRON-	PRP$
25944	965	11	appearance	appearance	NN
25944	965	12	?	?	.
25944	965	13	#	#	NN
25944	965	14	Most	most	RBS
25944	965	15	commonly	commonly	RB
25944	965	16	between	between	IN
25944	965	17	the	the	DT
25944	965	18	ages	age	NNS
25944	965	19	of	of	IN
25944	965	20	fifteen	fifteen	CD
25944	965	21	and	and	CC
25944	965	22	thirty	thirty	CD
25944	965	23	.	.	.
25944	966	1	It	-PRON-	PRP
25944	966	2	is	be	VBZ
25944	966	3	rarely	rarely	RB
25944	966	4	seen	see	VBN
25944	966	5	before	before	IN
25944	966	6	the	the	DT
25944	966	7	tenth	tenth	JJ
25944	966	8	year	year	NN
25944	966	9	,	,	,
25944	966	10	and	and	CC
25944	966	11	a	a	DT
25944	966	12	first	first	JJ
25944	966	13	attack	attack	NN
25944	966	14	is	be	VBZ
25944	966	15	uncommon	uncommon	JJ
25944	966	16	after	after	IN
25944	966	17	the	the	DT
25944	966	18	age	age	NN
25944	966	19	of	of	IN
25944	966	20	forty	forty	CD
25944	966	21	.	.	.
25944	967	1	#	#	NNP
25944	967	2	Has	have	VBZ
25944	967	3	psoriasis	psoriasis	NN
25944	967	4	any	any	DT
25944	967	5	special	special	JJ
25944	967	6	parts	part	NNS
25944	967	7	of	of	IN
25944	967	8	predilection	predilection	NN
25944	967	9	?	?	.
25944	967	10	#	#	$
25944	967	11	The	the	DT
25944	967	12	extensor	extensor	NN
25944	967	13	surfaces	surface	NNS
25944	967	14	of	of	IN
25944	967	15	the	the	DT
25944	967	16	limbs	limb	NNS
25944	967	17	,	,	,
25944	967	18	especially	especially	RB
25944	967	19	the	the	DT
25944	967	20	elbows	elbow	NNS
25944	967	21	and	and	CC
25944	967	22	knees	knee	NNS
25944	967	23	,	,	,
25944	967	24	are	be	VBP
25944	967	25	favorite	favorite	JJ
25944	967	26	localities	locality	NNS
25944	967	27	,	,	,
25944	967	28	and	and	CC
25944	967	29	even	even	RB
25944	967	30	when	when	WRB
25944	967	31	the	the	DT
25944	967	32	eruption	eruption	NN
25944	967	33	is	be	VBZ
25944	967	34	more	more	RBR
25944	967	35	or	or	CC
25944	967	36	less	less	RBR
25944	967	37	general	general	JJ
25944	967	38	,	,	,
25944	967	39	these	these	DT
25944	967	40	regions	region	NNS
25944	967	41	are	be	VBP
25944	967	42	usually	usually	RB
25944	967	43	most	most	RBS
25944	967	44	conspicuously	conspicuously	RB
25944	967	45	involved	involve	VBN
25944	967	46	.	.	.
25944	968	1	The	the	DT
25944	968	2	face	face	NN
25944	968	3	often	often	RB
25944	968	4	escapes	escape	VBZ
25944	968	5	,	,	,
25944	968	6	and	and	CC
25944	968	7	the	the	DT
25944	968	8	palms	palm	NNS
25944	968	9	and	and	CC
25944	968	10	soles	sol	NNS
25944	968	11	,	,	,
25944	968	12	likewise	likewise	RB
25944	968	13	the	the	DT
25944	968	14	nails	nail	NNS
25944	968	15	,	,	,
25944	968	16	are	be	VBP
25944	968	17	rarely	rarely	RB
25944	968	18	involved	involve	VBN
25944	968	19	.	.	.
25944	969	1	In	in	IN
25944	969	2	exceptional	exceptional	JJ
25944	969	3	instances	instance	NNS
25944	969	4	,	,	,
25944	969	5	the	the	DT
25944	969	6	eruption	eruption	NN
25944	969	7	is	be	VBZ
25944	969	8	limited	limit	VBN
25944	969	9	almost	almost	RB
25944	969	10	exclusively	exclusively	RB
25944	969	11	to	to	IN
25944	969	12	the	the	DT
25944	969	13	scalp	scalp	NN
25944	969	14	.	.	.
25944	970	1	#	#	NN
25944	970	2	Are	be	VBP
25944	970	3	there	there	EX
25944	970	4	any	any	DT
25944	970	5	constitutional	constitutional	JJ
25944	970	6	or	or	CC
25944	970	7	subjective	subjective	JJ
25944	970	8	symptoms	symptom	NNS
25944	970	9	in	in	IN
25944	970	10	psoriasis	psoriasis	NN
25944	970	11	?	?	.
25944	970	12	#	#	$
25944	970	13	There	there	EX
25944	970	14	is	be	VBZ
25944	970	15	no	no	DT
25944	970	16	systemic	systemic	JJ
25944	970	17	disturbance	disturbance	NN
25944	970	18	;	;	:
25944	970	19	but	but	CC
25944	970	20	a	a	DT
25944	970	21	variable	variable	JJ
25944	970	22	amount	amount	NN
25944	970	23	of	of	IN
25944	970	24	itching	itching	NN
25944	970	25	may	may	MD
25944	970	26	be	be	VB
25944	970	27	present	present	JJ
25944	970	28	,	,	,
25944	970	29	although	although	IN
25944	970	30	,	,	,
25944	970	31	as	as	IN
25944	970	32	a	a	DT
25944	970	33	rule	rule	NN
25944	970	34	,	,	,
25944	970	35	it	-PRON-	PRP
25944	970	36	is	be	VBZ
25944	970	37	not	not	RB
25944	970	38	a	a	DT
25944	970	39	troublesome	troublesome	JJ
25944	970	40	symptom	symptom	NN
25944	970	41	.	.	.
25944	971	1	#	#	NNP
25944	971	2	Describe	describe	VB
25944	971	3	the	the	DT
25944	971	4	clinical	clinical	JJ
25944	971	5	appearances	appearance	NNS
25944	971	6	of	of	IN
25944	971	7	a	a	DT
25944	971	8	typical	typical	JJ
25944	971	9	,	,	,
25944	971	10	well	well	RB
25944	971	11	developed	developed	JJ
25944	971	12	case	case	NN
25944	971	13	.	.	.
25944	971	14	#	#	$
25944	971	15	Twenty	twenty	CD
25944	971	16	or	or	CC
25944	971	17	a	a	DT
25944	971	18	hundred	hundred	CD
25944	971	19	or	or	CC
25944	971	20	more	more	JJR
25944	971	21	lesions	lesion	NNS
25944	971	22	,	,	,
25944	971	23	varying	vary	VBG
25944	971	24	in	in	IN
25944	971	25	size	size	NN
25944	971	26	from	from	IN
25944	971	27	a	a	DT
25944	971	28	pin	pin	NN
25944	971	29	-	-	HYPH
25944	971	30	head	head	NN
25944	971	31	to	to	IN
25944	971	32	a	a	DT
25944	971	33	silver	silver	JJ
25944	971	34	dollar	dollar	NN
25944	971	35	,	,	,
25944	971	36	are	be	VBP
25944	971	37	usually	usually	RB
25944	971	38	present	present	JJ
25944	971	39	.	.	.
25944	972	1	They	-PRON-	PRP
25944	972	2	are	be	VBP
25944	972	3	sharply	sharply	RB
25944	972	4	defined	define	VBN
25944	972	5	against	against	IN
25944	972	6	the	the	DT
25944	972	7	sound	sound	JJ
25944	972	8	skin	skin	NN
25944	972	9	,	,	,
25944	972	10	are	be	VBP
25944	972	11	reddish	reddish	JJ
25944	972	12	,	,	,
25944	972	13	slightly	slightly	RB
25944	972	14	elevated	elevated	JJ
25944	972	15	and	and	CC
25944	972	16	infiltrated	infiltrate	VBN
25944	972	17	,	,	,
25944	972	18	and	and	CC
25944	972	19	more	more	RBR
25944	972	20	or	or	CC
25944	972	21	less	less	RBR
25944	972	22	abundantly	abundantly	RB
25944	972	23	covered	cover	VBN
25944	972	24	with	with	IN
25944	972	25	whitish	whitish	JJ
25944	972	26	,	,	,
25944	972	27	grayish	grayish	NN
25944	972	28	or	or	CC
25944	972	29	mother	mother	NN
25944	972	30	-	-	HYPH
25944	972	31	of	of	IN
25944	972	32	-	-	HYPH
25944	972	33	pearl	pearl	NN
25944	972	34	colored	color	VBN
25944	972	35	scales	scale	NNS
25944	972	36	.	.	.
25944	973	1	The	the	DT
25944	973	2	patches	patch	NNS
25944	973	3	are	be	VBP
25944	973	4	usually	usually	RB
25944	973	5	scattered	scatter	VBN
25944	973	6	over	over	IN
25944	973	7	the	the	DT
25944	973	8	general	general	JJ
25944	973	9	surface	surface	NN
25944	973	10	,	,	,
25944	973	11	but	but	CC
25944	973	12	are	be	VBP
25944	973	13	frequently	frequently	RB
25944	973	14	more	more	RBR
25944	973	15	numerous	numerous	JJ
25944	973	16	on	on	IN
25944	973	17	the	the	DT
25944	973	18	extensor	extensor	NN
25944	973	19	surfaces	surface	NNS
25944	973	20	of	of	IN
25944	973	21	the	the	DT
25944	973	22	arms	arm	NNS
25944	973	23	and	and	CC
25944	973	24	legs	leg	NNS
25944	973	25	,	,	,
25944	973	26	especially	especially	RB
25944	973	27	about	about	IN
25944	973	28	the	the	DT
25944	973	29	elbows	elbow	NNS
25944	973	30	and	and	CC
25944	973	31	knees	knee	NNS
25944	973	32	.	.	.
25944	974	1	Several	several	JJ
25944	974	2	closely	closely	RB
25944	974	3	-	-	HYPH
25944	974	4	lying	lie	VBG
25944	974	5	lesions	lesion	NNS
25944	974	6	may	may	MD
25944	974	7	coalesce	coalesce	VB
25944	974	8	and	and	CC
25944	974	9	a	a	DT
25944	974	10	large	large	JJ
25944	974	11	,	,	,
25944	974	12	irregular	irregular	JJ
25944	974	13	patch	patch	NN
25944	974	14	be	be	VB
25944	974	15	formed	form	VBN
25944	974	16	;	;	:
25944	974	17	some	some	DT
25944	974	18	of	of	IN
25944	974	19	the	the	DT
25944	974	20	patches	patch	NNS
25944	974	21	,	,	,
25944	974	22	also	also	RB
25944	974	23	,	,	,
25944	974	24	may	may	MD
25944	974	25	be	be	VB
25944	974	26	more	more	RBR
25944	974	27	or	or	CC
25944	974	28	less	less	RBR
25944	974	29	circinate	circinate	JJ
25944	974	30	,	,	,
25944	974	31	the	the	DT
25944	974	32	central	central	JJ
25944	974	33	portion	portion	NN
25944	974	34	having	have	VBG
25944	974	35	,	,	,
25944	974	36	in	in	IN
25944	974	37	a	a	DT
25944	974	38	measure	measure	NN
25944	974	39	or	or	CC
25944	974	40	completely	completely	RB
25944	974	41	,	,	,
25944	974	42	disappeared	disappear	VBD
25944	974	43	.	.	.
25944	975	1	#	#	NN
25944	975	2	Give	give	VB
25944	975	3	the	the	DT
25944	975	4	development	development	NN
25944	975	5	and	and	CC
25944	975	6	history	history	NN
25944	975	7	of	of	IN
25944	975	8	a	a	DT
25944	975	9	single	single	JJ
25944	975	10	lesion	lesion	NN
25944	975	11	.	.	.
25944	975	12	#	#	$
25944	975	13	Every	every	DT
25944	975	14	single	single	JJ
25944	975	15	patch	patch	NN
25944	975	16	of	of	IN
25944	975	17	psoriasis	psoriasis	NN
25944	975	18	begins	begin	VBZ
25944	975	19	as	as	IN
25944	975	20	a	a	DT
25944	975	21	pin	pin	NN
25944	975	22	-	-	HYPH
25944	975	23	point	point	NN
25944	975	24	or	or	CC
25944	975	25	pin	pin	NN
25944	975	26	-	-	HYPH
25944	975	27	head	head	NN
25944	975	28	-	-	HYPH
25944	975	29	sized	sized	JJ
25944	975	30	,	,	,
25944	975	31	hyperæmic	hyperæmic	JJ
25944	975	32	,	,	,
25944	975	33	scaly	scaly	NNP
25944	975	34	,	,	,
25944	975	35	slightly	slightly	RB
25944	975	36	-	-	HYPH
25944	975	37	elevated	elevated	JJ
25944	975	38	lesion	lesion	NN
25944	975	39	;	;	:
25944	975	40	it	-PRON-	PRP
25944	975	41	increases	increase	VBZ
25944	975	42	gradually	gradually	RB
25944	975	43	,	,	,
25944	975	44	and	and	CC
25944	975	45	in	in	IN
25944	975	46	the	the	DT
25944	975	47	course	course	NN
25944	975	48	of	of	IN
25944	975	49	several	several	JJ
25944	975	50	days	day	NNS
25944	975	51	or	or	CC
25944	975	52	weeks	week	NNS
25944	975	53	usually	usually	RB
25944	975	54	reaches	reach	VBZ
25944	975	55	the	the	DT
25944	975	56	size	size	NN
25944	975	57	of	of	IN
25944	975	58	a	a	DT
25944	975	59	dime	dime	NN
25944	975	60	or	or	CC
25944	975	61	larger	large	JJR
25944	975	62	,	,	,
25944	975	63	and	and	CC
25944	975	64	then	then	RB
25944	975	65	may	may	MD
25944	975	66	remain	remain	VB
25944	975	67	stationary	stationary	JJ
25944	975	68	;	;	:
25944	975	69	or	or	CC
25944	975	70	involution	involution	NN
25944	975	71	begins	begin	VBZ
25944	975	72	to	to	TO
25944	975	73	take	take	VB
25944	975	74	place	place	NN
25944	975	75	,	,	,
25944	975	76	usually	usually	RB
25944	975	77	by	by	IN
25944	975	78	a	a	DT
25944	975	79	disappearance	disappearance	NN
25944	975	80	,	,	,
25944	975	81	partially	partially	RB
25944	975	82	or	or	CC
25944	975	83	completely	completely	RB
25944	975	84	,	,	,
25944	975	85	of	of	IN
25944	975	86	the	the	DT
25944	975	87	central	central	JJ
25944	975	88	portion	portion	NN
25944	975	89	,	,	,
25944	975	90	and	and	CC
25944	975	91	finally	finally	RB
25944	975	92	of	of	IN
25944	975	93	the	the	DT
25944	975	94	whole	whole	JJ
25944	975	95	patch	patch	NN
25944	975	96	.	.	.
25944	976	1	#	#	NNP
25944	976	2	Describe	describe	VB
25944	976	3	the	the	DT
25944	976	4	so	so	RB
25944	976	5	-	-	HYPH
25944	976	6	called	call	VBN
25944	976	7	clinical	clinical	JJ
25944	976	8	varieties	variety	NNS
25944	976	9	of	of	IN
25944	976	10	psoriasis	psoriasis	NN
25944	976	11	.	.	.
25944	976	12	#	#	$
25944	976	13	As	as	RB
25944	976	14	clinically	clinically	RB
25944	976	15	met	meet	VBN
25944	976	16	with	with	IN
25944	976	17	,	,	,
25944	976	18	the	the	DT
25944	976	19	patches	patch	NNS
25944	976	20	present	present	JJ
25944	976	21	are	be	VBP
25944	976	22	,	,	,
25944	976	23	as	as	IN
25944	976	24	a	a	DT
25944	976	25	rule	rule	NN
25944	976	26	,	,	,
25944	976	27	in	in	IN
25944	976	28	all	all	DT
25944	976	29	stages	stage	NNS
25944	976	30	of	of	IN
25944	976	31	development	development	NN
25944	976	32	.	.	.
25944	977	1	In	in	IN
25944	977	2	some	some	DT
25944	977	3	instances	instance	NNS
25944	977	4	,	,	,
25944	977	5	however	however	RB
25944	977	6	,	,	,
25944	977	7	the	the	DT
25944	977	8	lesions	lesion	NNS
25944	977	9	,	,	,
25944	977	10	or	or	CC
25944	977	11	the	the	DT
25944	977	12	most	most	JJS
25944	977	13	of	of	IN
25944	977	14	them	-PRON-	PRP
25944	977	15	,	,	,
25944	977	16	progress	progress	VBP
25944	977	17	no	no	RB
25944	977	18	further	further	RB
25944	977	19	than	than	IN
25944	977	20	pin	pin	NN
25944	977	21	-	-	HYPH
25944	977	22	head	head	NN
25944	977	23	in	in	IN
25944	977	24	size	size	NN
25944	977	25	,	,	,
25944	977	26	and	and	CC
25944	977	27	then	then	RB
25944	977	28	remain	remain	VB
25944	977	29	stationary	stationary	JJ
25944	977	30	,	,	,
25944	977	31	constituting	constitute	VBG
25944	977	32	_	_	NNP
25944	977	33	psoriasis	psoriasis	NN
25944	977	34	punctata	punctata	NNP
25944	977	35	_	_	NNP
25944	977	36	;	;	:
25944	977	37	in	in	IN
25944	977	38	other	other	JJ
25944	977	39	cases	case	NNS
25944	977	40	,	,	,
25944	977	41	they	-PRON-	PRP
25944	977	42	may	may	MD
25944	977	43	stop	stop	VB
25944	977	44	short	short	JJ
25944	977	45	after	after	IN
25944	977	46	having	have	VBG
25944	977	47	reached	reach	VBN
25944	977	48	the	the	DT
25944	977	49	size	size	NN
25944	977	50	of	of	IN
25944	977	51	drops--_psoriasis	drops--_psoriasis	``
25944	977	52	guttata	guttata	NNP
25944	977	53	_	_	NNP
25944	977	54	;	;	:
25944	977	55	in	in	IN
25944	977	56	others	other	NNS
25944	977	57	(	(	-LRB-
25944	977	58	and	and	CC
25944	977	59	this	this	DT
25944	977	60	is	be	VBZ
25944	977	61	the	the	DT
25944	977	62	usual	usual	JJ
25944	977	63	clinical	clinical	JJ
25944	977	64	type	type	NN
25944	977	65	)	)	-RRB-
25944	977	66	the	the	DT
25944	977	67	patches	patch	NNS
25944	977	68	develop	develop	VBP
25944	977	69	to	to	IN
25944	977	70	the	the	DT
25944	977	71	size	size	NN
25944	977	72	of	of	IN
25944	977	73	coins--_psoriasis	coins--_psoriasis	NNP
25944	977	74	nummularis	nummularis	NNP
25944	977	75	_	_	NNP
25944	977	76	.	.	.
25944	978	1	In	in	IN
25944	978	2	some	some	DT
25944	978	3	cases	case	NNS
25944	978	4	there	there	EX
25944	978	5	is	be	VBZ
25944	978	6	a	a	DT
25944	978	7	strong	strong	JJ
25944	978	8	tendency	tendency	NN
25944	978	9	for	for	IN
25944	978	10	the	the	DT
25944	978	11	central	central	JJ
25944	978	12	part	part	NN
25944	978	13	of	of	IN
25944	978	14	the	the	DT
25944	978	15	lesions	lesion	NNS
25944	978	16	to	to	TO
25944	978	17	disappear	disappear	VB
25944	978	18	,	,	,
25944	978	19	and	and	CC
25944	978	20	the	the	DT
25944	978	21	process	process	NN
25944	978	22	then	then	RB
25944	978	23	remain	remain	VBP
25944	978	24	stationary	stationary	JJ
25944	978	25	,	,	,
25944	978	26	the	the	DT
25944	978	27	patches	patch	NNS
25944	978	28	being	be	VBG
25944	978	29	ring	ring	NN
25944	978	30	-	-	HYPH
25944	978	31	shaped--_psoriasis	shaped--_psoriasis	NN
25944	978	32	circinata	circinata	NNP
25944	978	33	_	_	NNP
25944	978	34	;	;	:
25944	978	35	and	and	CC
25944	978	36	occasionally	occasionally	RB
25944	978	37	several	several	JJ
25944	978	38	such	such	JJ
25944	978	39	rings	ring	NNS
25944	978	40	coalesce	coalesce	NN
25944	978	41	,	,	,
25944	978	42	the	the	DT
25944	978	43	coalescing	coalesce	VBG
25944	978	44	portions	portion	NNS
25944	978	45	disappearing	disappear	VBG
25944	978	46	and	and	CC
25944	978	47	the	the	DT
25944	978	48	eruption	eruption	NN
25944	978	49	be	be	VB
25944	978	50	more	more	RBR
25944	978	51	or	or	CC
25944	978	52	less	less	JJR
25944	978	53	serpentine--_psoriasis	serpentine--_psoriasis	CC
25944	978	54	gyrata	gyrata	NN
25944	978	55	_	_	NNP
25944	978	56	.	.	.
25944	979	1	Or	or	CC
25944	979	2	,	,	,
25944	979	3	in	in	IN
25944	979	4	other	other	JJ
25944	979	5	instances	instance	NNS
25944	979	6	,	,	,
25944	979	7	several	several	JJ
25944	979	8	large	large	JJ
25944	979	9	contiguous	contiguous	JJ
25944	979	10	lesions	lesion	NNS
25944	979	11	may	may	MD
25944	979	12	coalesce	coalesce	VB
25944	979	13	and	and	CC
25944	979	14	a	a	DT
25944	979	15	diffused	diffused	JJ
25944	979	16	,	,	,
25944	979	17	infiltrated	infiltrated	JJ
25944	979	18	patch	patch	NN
25944	979	19	covering	cover	VBG
25944	979	20	considerable	considerable	JJ
25944	979	21	surface	surface	NN
25944	979	22	results--_psoriasis	results--_psoriasis	CD
25944	979	23	diffusa	diffusa	VBN
25944	979	24	,	,	,
25944	979	25	psoriasis	psoriasis	NN
25944	979	26	inveterata	inveterata	NNP
25944	979	27	_	_	NNP
25944	979	28	.	.	.
25944	980	1	[	[	-LRB-
25944	980	2	Illustration	illustration	NN
25944	980	3	:	:	:
25944	980	4	Fig	Fig	NNP
25944	980	5	.	.	.
25944	981	1	17	17	CD
25944	981	2	.	.	.
25944	982	1	Psoriasis	psoriasis	NN
25944	982	2	.	.	.
25944	982	3	]	]	-RRB-
25944	983	1	#	#	$
25944	983	2	Is	be	VBZ
25944	983	3	the	the	DT
25944	983	4	eruption	eruption	NN
25944	983	5	of	of	IN
25944	983	6	psoriasis	psoriasis	NN
25944	983	7	always	always	RB
25944	983	8	dry	dry	JJ
25944	983	9	?	?	.
25944	983	10	#	#	NN
25944	983	11	Yes	yes	UH
25944	983	12	.	.	.
25944	984	1	#	#	LS
25944	984	2	What	what	WDT
25944	984	3	course	course	NN
25944	984	4	does	do	VBZ
25944	984	5	psoriasis	psoriasis	NN
25944	984	6	pursue	pursue	VB
25944	984	7	?	?	.
25944	984	8	#	#	$
25944	984	9	As	as	IN
25944	984	10	a	a	DT
25944	984	11	rule	rule	NN
25944	984	12	,	,	,
25944	984	13	eminently	eminently	RB
25944	984	14	chronic	chronic	JJ
25944	984	15	.	.	.
25944	985	1	Patches	patch	NNS
25944	985	2	may	may	MD
25944	985	3	remain	remain	VB
25944	985	4	almost	almost	RB
25944	985	5	indefinitely	indefinitely	RB
25944	985	6	,	,	,
25944	985	7	or	or	CC
25944	985	8	may	may	MD
25944	985	9	gradually	gradually	RB
25944	985	10	disappear	disappear	VB
25944	985	11	and	and	CC
25944	985	12	new	new	JJ
25944	985	13	lesions	lesion	NNS
25944	985	14	appear	appear	VBP
25944	985	15	elsewhere	elsewhere	RB
25944	985	16	,	,	,
25944	985	17	and	and	CC
25944	985	18	so	so	RB
25944	985	19	the	the	DT
25944	985	20	disease	disease	NN
25944	985	21	may	may	MD
25944	985	22	continue	continue	VB
25944	985	23	for	for	IN
25944	985	24	months	month	NNS
25944	985	25	and	and	CC
25944	985	26	,	,	,
25944	985	27	sometimes	sometimes	RB
25944	985	28	,	,	,
25944	985	29	for	for	IN
25944	985	30	years	year	NNS
25944	985	31	;	;	:
25944	985	32	or	or	CC
25944	985	33	,	,	,
25944	985	34	after	after	IN
25944	985	35	continuing	continue	VBG
25944	985	36	for	for	IN
25944	985	37	a	a	DT
25944	985	38	longer	long	JJR
25944	985	39	or	or	CC
25944	985	40	shorter	short	JJR
25944	985	41	period	period	NN
25944	985	42	,	,	,
25944	985	43	may	may	MD
25944	985	44	subside	subside	VB
25944	985	45	and	and	CC
25944	985	46	the	the	DT
25944	985	47	skin	skin	NN
25944	985	48	remain	remain	VBP
25944	985	49	free	free	JJ
25944	985	50	for	for	IN
25944	985	51	several	several	JJ
25944	985	52	months	month	NNS
25944	985	53	or	or	CC
25944	985	54	one	one	CD
25944	985	55	or	or	CC
25944	985	56	two	two	CD
25944	985	57	years	year	NNS
25944	985	58	,	,	,
25944	985	59	and	and	CC
25944	985	60	,	,	,
25944	985	61	in	in	IN
25944	985	62	rare	rare	JJ
25944	985	63	instances	instance	NNS
25944	985	64	,	,	,
25944	985	65	may	may	MD
25944	985	66	never	never	RB
25944	985	67	return	return	VB
25944	985	68	.	.	.
25944	986	1	[	[	-LRB-
25944	986	2	Illustration	illustration	NN
25944	986	3	:	:	:
25944	986	4	Fig	Fig	NNP
25944	986	5	.	.	.
25944	987	1	18	18	CD
25944	987	2	.	.	.
25944	988	1	Psoriasis	psoriasis	NN
25944	988	2	.	.	.
25944	988	3	]	]	-RRB-
25944	989	1	#	#	$
25944	989	2	Is	be	VBZ
25944	989	3	the	the	DT
25944	989	4	course	course	NN
25944	989	5	of	of	IN
25944	989	6	psoriasis	psoriasis	NN
25944	989	7	influenced	influence	VBN
25944	989	8	by	by	IN
25944	989	9	the	the	DT
25944	989	10	seasons	season	NNS
25944	989	11	?	?	.
25944	989	12	#	#	$
25944	989	13	As	as	IN
25944	989	14	a	a	DT
25944	989	15	rule	rule	NN
25944	989	16	,	,	,
25944	989	17	yes	yes	UH
25944	989	18	;	;	:
25944	989	19	there	there	EX
25944	989	20	is	be	VBZ
25944	989	21	a	a	DT
25944	989	22	natural	natural	JJ
25944	989	23	tendency	tendency	NN
25944	989	24	for	for	IN
25944	989	25	the	the	DT
25944	989	26	disease	disease	NN
25944	989	27	to	to	TO
25944	989	28	become	become	VB
25944	989	29	less	less	RBR
25944	989	30	active	active	JJ
25944	989	31	or	or	CC
25944	989	32	to	to	TO
25944	989	33	disappear	disappear	VB
25944	989	34	altogether	altogether	RB
25944	989	35	during	during	IN
25944	989	36	the	the	DT
25944	989	37	warm	warm	JJ
25944	989	38	months	month	NNS
25944	989	39	.	.	.
25944	990	1	#	#	LS
25944	990	2	What	what	WP
25944	990	3	is	be	VBZ
25944	990	4	known	know	VBN
25944	990	5	in	in	IN
25944	990	6	regard	regard	NN
25944	990	7	to	to	IN
25944	990	8	the	the	DT
25944	990	9	etiology	etiology	NN
25944	990	10	of	of	IN
25944	990	11	psoriasis	psoriasis	NN
25944	990	12	?	?	.
25944	990	13	#	#	$
25944	990	14	The	the	DT
25944	990	15	causes	cause	NNS
25944	990	16	of	of	IN
25944	990	17	the	the	DT
25944	990	18	disease	disease	NN
25944	990	19	are	be	VBP
25944	990	20	always	always	RB
25944	990	21	more	more	RBR
25944	990	22	or	or	CC
25944	990	23	less	less	RBR
25944	990	24	obscure	obscure	JJ
25944	990	25	.	.	.
25944	991	1	There	there	EX
25944	991	2	is	be	VBZ
25944	991	3	often	often	RB
25944	991	4	a	a	DT
25944	991	5	hereditary	hereditary	JJ
25944	991	6	tendency	tendency	NN
25944	991	7	,	,	,
25944	991	8	and	and	CC
25944	991	9	the	the	DT
25944	991	10	gouty	gouty	NN
25944	991	11	and	and	CC
25944	991	12	rheumatic	rheumatic	JJ
25944	991	13	diathesis	diathesis	NN
25944	991	14	must	must	MD
25944	991	15	occasionally	occasionally	RB
25944	991	16	be	be	VB
25944	991	17	considered	consider	VBN
25944	991	18	potential	potential	JJ
25944	991	19	.	.	.
25944	992	1	In	in	IN
25944	992	2	some	some	DT
25944	992	3	instances	instance	NNS
25944	992	4	it	-PRON-	PRP
25944	992	5	is	be	VBZ
25944	992	6	apparently	apparently	RB
25944	992	7	influenced	influence	VBN
25944	992	8	by	by	IN
25944	992	9	the	the	DT
25944	992	10	state	state	NN
25944	992	11	of	of	IN
25944	992	12	the	the	DT
25944	992	13	general	general	JJ
25944	992	14	health	health	NN
25944	992	15	.	.	.
25944	993	1	It	-PRON-	PRP
25944	993	2	is	be	VBZ
25944	993	3	a	a	DT
25944	993	4	rather	rather	RB
25944	993	5	common	common	JJ
25944	993	6	disease	disease	NN
25944	993	7	and	and	CC
25944	993	8	is	be	VBZ
25944	993	9	met	meet	VBN
25944	993	10	with	with	IN
25944	993	11	in	in	IN
25944	993	12	all	all	DT
25944	993	13	walks	walk	NNS
25944	993	14	of	of	IN
25944	993	15	life	life	NN
25944	993	16	.	.	.
25944	994	1	#	#	$
25944	994	2	Is	be	VBZ
25944	994	3	psoriasis	psoriasis	NN
25944	994	4	contagious	contagious	JJ
25944	994	5	?	?	.
25944	994	6	#	#	$
25944	994	7	No	no	UH
25944	994	8	.	.	.
25944	995	1	In	in	IN
25944	995	2	recent	recent	JJ
25944	995	3	years	year	NNS
25944	995	4	the	the	DT
25944	995	5	fact	fact	NN
25944	995	6	of	of	IN
25944	995	7	its	-PRON-	PRP$
25944	995	8	exhibiting	exhibit	VBG
25944	995	9	a	a	DT
25944	995	10	family	family	NN
25944	995	11	tendency	tendency	NN
25944	995	12	has	have	VBZ
25944	995	13	been	be	VBN
25944	995	14	thought	think	VBN
25944	995	15	as	as	IN
25944	995	16	much	much	JJ
25944	995	17	suggestive	suggestive	NN
25944	995	18	of	of	IN
25944	995	19	contagiousness	contagiousness	NN
25944	995	20	as	as	IN
25944	995	21	of	of	IN
25944	995	22	heredity	heredity	NN
25944	995	23	.	.	.
25944	996	1	#	#	LS
25944	996	2	What	what	WP
25944	996	3	is	be	VBZ
25944	996	4	the	the	DT
25944	996	5	pathology	pathology	NN
25944	996	6	?	?	.
25944	996	7	#	#	$
25944	996	8	According	accord	VBG
25944	996	9	to	to	IN
25944	996	10	modern	modern	JJ
25944	996	11	investigations	investigation	NNS
25944	996	12	,	,	,
25944	996	13	it	-PRON-	PRP
25944	996	14	is	be	VBZ
25944	996	15	an	an	DT
25944	996	16	inflammation	inflammation	NN
25944	996	17	induced	induce	VBN
25944	996	18	by	by	IN
25944	996	19	hyperplasia	hyperplasia	NNP
25944	996	20	of	of	IN
25944	996	21	the	the	DT
25944	996	22	rete	rete	NN
25944	996	23	mucosum	mucosum	NN
25944	996	24	;	;	:
25944	996	25	and	and	CC
25944	996	26	it	-PRON-	PRP
25944	996	27	is	be	VBZ
25944	996	28	beginning	begin	VBG
25944	996	29	to	to	TO
25944	996	30	be	be	VB
25944	996	31	believed	believe	VBN
25944	996	32	that	that	IN
25944	996	33	this	this	DT
25944	996	34	hyperplasia	hyperplasia	NNP
25944	996	35	may	may	MD
25944	996	36	have	have	VB
25944	996	37	a	a	DT
25944	996	38	parasitic	parasitic	JJ
25944	996	39	factor	factor	NN
25944	996	40	as	as	IN
25944	996	41	the	the	DT
25944	996	42	starting	starting	NN
25944	996	43	-	-	HYPH
25944	996	44	cause	cause	NN
25944	996	45	.	.	.
25944	997	1	#	#	$
25944	997	2	With	with	IN
25944	997	3	what	what	WP
25944	997	4	diseases	disease	NNS
25944	997	5	are	be	VBP
25944	997	6	you	-PRON-	PRP
25944	997	7	likely	likely	JJ
25944	997	8	to	to	TO
25944	997	9	confound	confound	VB
25944	997	10	psoriasis	psoriasis	NN
25944	997	11	?	?	.
25944	997	12	#	#	NN
25944	997	13	Chiefly	Chiefly	NNP
25944	997	14	with	with	IN
25944	997	15	squamous	squamous	JJ
25944	997	16	eczema	eczema	NN
25944	997	17	and	and	CC
25944	997	18	the	the	DT
25944	997	19	papulo	papulo	JJ
25944	997	20	-	-	HYPH
25944	997	21	squamous	squamous	JJ
25944	997	22	syphiloderm	syphiloderm	NN
25944	997	23	;	;	,
25944	997	24	and	and	CC
25944	997	25	on	on	IN
25944	997	26	the	the	DT
25944	997	27	scalp	scalp	NN
25944	997	28	,	,	,
25944	997	29	also	also	RB
25944	997	30	with	with	IN
25944	997	31	seborrh[oe]a	seborrh[oe]a	NNP
25944	997	32	.	.	.
25944	998	1	It	-PRON-	PRP
25944	998	2	can	can	MD
25944	998	3	scarcely	scarcely	RB
25944	998	4	be	be	VB
25944	998	5	confounded	confound	VBN
25944	998	6	with	with	IN
25944	998	7	ringworm	ringworm	NN
25944	998	8	.	.	.
25944	999	1	#	#	NNP
25944	999	2	How	how	WRB
25944	999	3	is	be	VBZ
25944	999	4	psoriasis	psoriasis	NN
25944	999	5	to	to	TO
25944	999	6	be	be	VB
25944	999	7	distinguished	distinguish	VBN
25944	999	8	from	from	IN
25944	999	9	squamous	squamous	JJ
25944	999	10	eczema	eczema	NN
25944	999	11	?	?	.
25944	999	12	#	#	NN
25944	999	13	By	by	IN
25944	999	14	the	the	DT
25944	999	15	sharply	sharply	RB
25944	999	16	-	-	HYPH
25944	999	17	defined	define	VBN
25944	999	18	,	,	,
25944	999	19	circumscribed	circumscribe	VBN
25944	999	20	,	,	,
25944	999	21	scattered	scatter	VBN
25944	999	22	,	,	,
25944	999	23	scaly	scaly	NNP
25944	999	24	patches	patch	NNS
25944	999	25	,	,	,
25944	999	26	and	and	CC
25944	999	27	by	by	IN
25944	999	28	the	the	DT
25944	999	29	history	history	NN
25944	999	30	and	and	CC
25944	999	31	course	course	NN
25944	999	32	of	of	IN
25944	999	33	the	the	DT
25944	999	34	individual	individual	JJ
25944	999	35	lesions	lesion	NNS
25944	999	36	.	.	.
25944	1000	1	#	#	$
25944	1000	2	In	in	IN
25944	1000	3	what	what	WDT
25944	1000	4	respects	respect	VBZ
25944	1000	5	does	do	VBZ
25944	1000	6	the	the	DT
25944	1000	7	papulo	papulo	JJ
25944	1000	8	-	-	HYPH
25944	1000	9	squamous	squamous	JJ
25944	1000	10	syphiloderm	syphiloderm	NN
25944	1000	11	differ	differ	VBP
25944	1000	12	from	from	IN
25944	1000	13	psoriasis	psoriasis	NN
25944	1000	14	?	?	.
25944	1000	15	#	#	$
25944	1000	16	The	the	DT
25944	1000	17	scales	scale	NNS
25944	1000	18	of	of	IN
25944	1000	19	the	the	DT
25944	1000	20	squamous	squamous	JJ
25944	1000	21	syphilide	syphilide	NN
25944	1000	22	are	be	VBP
25944	1000	23	usually	usually	RB
25944	1000	24	dirty	dirty	JJ
25944	1000	25	gray	gray	NN
25944	1000	26	in	in	IN
25944	1000	27	color	color	NN
25944	1000	28	and	and	CC
25944	1000	29	more	more	RBR
25944	1000	30	or	or	CC
25944	1000	31	less	less	JJR
25944	1000	32	scanty	scanty	NN
25944	1000	33	;	;	:
25944	1000	34	the	the	DT
25944	1000	35	patches	patch	NNS
25944	1000	36	are	be	VBP
25944	1000	37	coppery	coppery	NN
25944	1000	38	in	in	IN
25944	1000	39	hue	hue	NNP
25944	1000	40	,	,	,
25944	1000	41	and	and	CC
25944	1000	42	usually	usually	RB
25944	1000	43	several	several	JJ
25944	1000	44	or	or	CC
25944	1000	45	more	more	RBR
25944	1000	46	characteristic	characteristic	JJ
25944	1000	47	scaleless	scaleless	NN
25944	1000	48	,	,	,
25944	1000	49	infiltrated	infiltrated	JJ
25944	1000	50	papules	papule	NNS
25944	1000	51	are	be	VBP
25944	1000	52	to	to	TO
25944	1000	53	be	be	VB
25944	1000	54	found	find	VBN
25944	1000	55	.	.	.
25944	1001	1	The	the	DT
25944	1001	2	face	face	NN
25944	1001	3	,	,	,
25944	1001	4	palms	palm	NNS
25944	1001	5	,	,	,
25944	1001	6	and	and	CC
25944	1001	7	soles	sol	NNS
25944	1001	8	are	be	VBP
25944	1001	9	often	often	RB
25944	1001	10	the	the	DT
25944	1001	11	seat	seat	NN
25944	1001	12	of	of	IN
25944	1001	13	the	the	DT
25944	1001	14	syphilitic	syphilitic	JJ
25944	1001	15	eruption	eruption	NN
25944	1001	16	;	;	,
25944	1001	17	and	and	CC
25944	1001	18	,	,	,
25944	1001	19	moreover	moreover	RB
25944	1001	20	,	,	,
25944	1001	21	_	_	NNP
25944	1001	22	concomitant	concomitant	JJ
25944	1001	23	symptoms	symptom	NNS
25944	1001	24	of	of	IN
25944	1001	25	syphilis	syphilis	NNP
25944	1001	26	_	_	NNP
25944	1001	27	,	,	,
25944	1001	28	such	such	JJ
25944	1001	29	as	as	IN
25944	1001	30	sore	sore	JJ
25944	1001	31	throat	throat	NN
25944	1001	32	,	,	,
25944	1001	33	mucous	mucous	JJ
25944	1001	34	patches	patch	NNS
25944	1001	35	,	,	,
25944	1001	36	glandular	glandular	JJ
25944	1001	37	enlargement	enlargement	NN
25944	1001	38	,	,	,
25944	1001	39	rheumatic	rheumatic	JJ
25944	1001	40	pains	pain	NNS
25944	1001	41	,	,	,
25944	1001	42	falling	fall	VBG
25944	1001	43	out	out	IN
25944	1001	44	of	of	IN
25944	1001	45	the	the	DT
25944	1001	46	hair	hair	NN
25944	1001	47	,	,	,
25944	1001	48	together	together	RB
25944	1001	49	with	with	IN
25944	1001	50	the	the	DT
25944	1001	51	history	history	NN
25944	1001	52	of	of	IN
25944	1001	53	the	the	DT
25944	1001	54	initial	initial	JJ
25944	1001	55	lesion	lesion	NN
25944	1001	56	,	,	,
25944	1001	57	are	be	VBP
25944	1001	58	one	one	CD
25944	1001	59	,	,	,
25944	1001	60	several	several	JJ
25944	1001	61	,	,	,
25944	1001	62	or	or	CC
25944	1001	63	all	all	DT
25944	1001	64	usually	usually	RB
25944	1001	65	present	present	JJ
25944	1001	66	.	.	.
25944	1002	1	#	#	NNP
25944	1002	2	How	how	WRB
25944	1002	3	does	do	VBZ
25944	1002	4	seborrh[oe]a	seborrh[oe]a	NNP
25944	1002	5	differ	differ	VB
25944	1002	6	from	from	IN
25944	1002	7	psoriasis	psoriasis	NN
25944	1002	8	?	?	.
25944	1002	9	#	#	$
25944	1002	10	Seborrh[oe]a	seborrh[oe]a	CD
25944	1002	11	of	of	IN
25944	1002	12	the	the	DT
25944	1002	13	scalp	scalp	NN
25944	1002	14	is	be	VBZ
25944	1002	15	usually	usually	RB
25944	1002	16	diffused	diffuse	VBN
25944	1002	17	,	,	,
25944	1002	18	with	with	IN
25944	1002	19	but	but	CC
25944	1002	20	little	little	JJ
25944	1002	21	redness	redness	NN
25944	1002	22	and	and	CC
25944	1002	23	no	no	DT
25944	1002	24	infiltration	infiltration	NN
25944	1002	25	;	;	,
25944	1002	26	moreover	moreover	RB
25944	1002	27	,	,	,
25944	1002	28	the	the	DT
25944	1002	29	scales	scale	NNS
25944	1002	30	of	of	IN
25944	1002	31	seborrh[oe]a	seborrh[oe]a	NNP
25944	1002	32	are	be	VBP
25944	1002	33	greasy	greasy	JJ
25944	1002	34	,	,	,
25944	1002	35	dirty	dirty	JJ
25944	1002	36	gray	gray	NN
25944	1002	37	or	or	CC
25944	1002	38	brownish	brownish	NN
25944	1002	39	,	,	,
25944	1002	40	while	while	IN
25944	1002	41	those	those	DT
25944	1002	42	of	of	IN
25944	1002	43	psoriasis	psoriasis	NN
25944	1002	44	are	be	VBP
25944	1002	45	dry	dry	JJ
25944	1002	46	and	and	CC
25944	1002	47	comonly	comonly	RB
25944	1002	48	whitish	whitish	NN
25944	1002	49	or	or	CC
25944	1002	50	mother	mother	NN
25944	1002	51	-	-	HYPH
25944	1002	52	of	of	IN
25944	1002	53	-	-	HYPH
25944	1002	54	pearl	pearl	NN
25944	1002	55	colored	color	VBN
25944	1002	56	.	.	.
25944	1003	1	Psoriasis	psoriasis	NN
25944	1003	2	of	of	IN
25944	1003	3	the	the	DT
25944	1003	4	scalp	scalp	NN
25944	1003	5	rarely	rarely	RB
25944	1003	6	exists	exist	VBZ
25944	1003	7	independently	independently	RB
25944	1003	8	of	of	IN
25944	1003	9	other	other	JJ
25944	1003	10	patches	patch	NNS
25944	1003	11	elsewhere	elsewhere	RB
25944	1003	12	on	on	IN
25944	1003	13	the	the	DT
25944	1003	14	general	general	JJ
25944	1003	15	surface	surface	NN
25944	1003	16	.	.	.
25944	1004	1	That	that	DT
25944	1004	2	variety	variety	NN
25944	1004	3	of	of	IN
25944	1004	4	seborrh[oe]a	seborrh[oe]a	NNP
25944	1004	5	,	,	,
25944	1004	6	commonly	commonly	RB
25944	1004	7	known	know	VBN
25944	1004	8	as	as	IN
25944	1004	9	eczema	eczema	NN
25944	1004	10	seborrhoicum	seborrhoicum	NN
25944	1004	11	,	,	,
25944	1004	12	presents	present	VBZ
25944	1004	13	at	at	IN
25944	1004	14	times	time	NNS
25944	1004	15	,	,	,
25944	1004	16	both	both	CC
25944	1004	17	on	on	IN
25944	1004	18	scalp	scalp	NNP
25944	1004	19	and	and	CC
25944	1004	20	general	general	JJ
25944	1004	21	surface	surface	NN
25944	1004	22	,	,	,
25944	1004	23	a	a	DT
25944	1004	24	strong	strong	JJ
25944	1004	25	resemblance	resemblance	NN
25944	1004	26	to	to	IN
25944	1004	27	psoriasis	psoriasis	NN
25944	1004	28	,	,	,
25944	1004	29	but	but	CC
25944	1004	30	the	the	DT
25944	1004	31	character	character	NN
25944	1004	32	of	of	IN
25944	1004	33	the	the	DT
25944	1004	34	scales	scale	NNS
25944	1004	35	and	and	CC
25944	1004	36	distribution	distribution	NN
25944	1004	37	of	of	IN
25944	1004	38	psoriasis	psoriasis	NN
25944	1004	39	,	,	,
25944	1004	40	as	as	IN
25944	1004	41	above	above	IN
25944	1004	42	stated	state	VBN
25944	1004	43	,	,	,
25944	1004	44	are	be	VBP
25944	1004	45	distinguishing	distinguish	VBG
25944	1004	46	points	point	NNS
25944	1004	47	;	;	:
25944	1004	48	seborrh[oe]a	seborrh[oe]a	NNP
25944	1004	49	,	,	,
25944	1004	50	moreover	moreover	RB
25944	1004	51	,	,	,
25944	1004	52	favors	favor	VBZ
25944	1004	53	hairy	hairy	JJ
25944	1004	54	surfaces	surface	NNS
25944	1004	55	and	and	CC
25944	1004	56	in	in	IN
25944	1004	57	extensive	extensive	JJ
25944	1004	58	examples	example	NNS
25944	1004	59	the	the	DT
25944	1004	60	scalp	scalp	NN
25944	1004	61	,	,	,
25944	1004	62	eyebrows	eyebrow	NNS
25944	1004	63	,	,	,
25944	1004	64	sternal	sternal	JJ
25944	1004	65	,	,	,
25944	1004	66	and	and	CC
25944	1004	67	pubic	pubic	JJ
25944	1004	68	regions	region	NNS
25944	1004	69	rarely	rarely	RB
25944	1004	70	escape	escape	VBP
25944	1004	71	.	.	.
25944	1005	1	#	#	NN
25944	1005	2	How	how	WRB
25944	1005	3	does	do	VBZ
25944	1005	4	psoriasis	psoriasis	NN
25944	1005	5	differ	differ	VB
25944	1005	6	from	from	IN
25944	1005	7	ringworm	ringworm	NN
25944	1005	8	?	?	.
25944	1005	9	#	#	NN
25944	1005	10	By	by	IN
25944	1005	11	its	-PRON-	PRP$
25944	1005	12	greater	great	JJR
25944	1005	13	scaliness	scaliness	NN
25944	1005	14	,	,	,
25944	1005	15	by	by	IN
25944	1005	16	its	-PRON-	PRP$
25944	1005	17	higher	high	JJR
25944	1005	18	degree	degree	NN
25944	1005	19	of	of	IN
25944	1005	20	inflammatory	inflammatory	JJ
25944	1005	21	action	action	NN
25944	1005	22	,	,	,
25944	1005	23	and	and	CC
25944	1005	24	by	by	IN
25944	1005	25	its	-PRON-	PRP$
25944	1005	26	larger	large	JJR
25944	1005	27	number	number	NN
25944	1005	28	of	of	IN
25944	1005	29	patches	patch	NNS
25944	1005	30	,	,	,
25944	1005	31	as	as	RB
25944	1005	32	also	also	RB
25944	1005	33	by	by	IN
25944	1005	34	its	-PRON-	PRP$
25944	1005	35	history	history	NN
25944	1005	36	.	.	.
25944	1006	1	In	in	IN
25944	1006	2	ringworm	ringworm	NN
25944	1006	3	_	_	NNP
25944	1006	4	all	all	DT
25944	1006	5	_	_	NNP
25944	1006	6	the	the	DT
25944	1006	7	patches	patch	NNS
25944	1006	8	tend	tend	VBP
25944	1006	9	to	to	TO
25944	1006	10	clear	clear	VB
25944	1006	11	up	up	RP
25944	1006	12	in	in	IN
25944	1006	13	the	the	DT
25944	1006	14	centre	centre	NN
25944	1006	15	;	;	:
25944	1006	16	in	in	IN
25944	1006	17	psoriasis	psoriasis	NN
25944	1006	18	this	this	DT
25944	1006	19	is	be	VBZ
25944	1006	20	rarely	rarely	RB
25944	1006	21	,	,	,
25944	1006	22	if	if	IN
25944	1006	23	ever	ever	RB
25944	1006	24	,	,	,
25944	1006	25	so	so	RB
25944	1006	26	.	.	.
25944	1007	1	If	if	IN
25944	1007	2	there	there	EX
25944	1007	3	is	be	VBZ
25944	1007	4	still	still	RB
25944	1007	5	any	any	DT
25944	1007	6	doubt	doubt	NN
25944	1007	7	,	,	,
25944	1007	8	microscopic	microscopic	JJ
25944	1007	9	examination	examination	NN
25944	1007	10	of	of	IN
25944	1007	11	the	the	DT
25944	1007	12	scrapings	scraping	NNS
25944	1007	13	will	will	MD
25944	1007	14	determine	determine	VB
25944	1007	15	.	.	.
25944	1008	1	#	#	NN
25944	1008	2	Give	give	VB
25944	1008	3	the	the	DT
25944	1008	4	prognosis	prognosis	NN
25944	1008	5	of	of	IN
25944	1008	6	psoriasis	psoriasis	NN
25944	1008	7	.	.	.
25944	1008	8	#	#	$
25944	1008	9	The	the	DT
25944	1008	10	prognosis	prognosis	NN
25944	1008	11	is	be	VBZ
25944	1008	12	usually	usually	RB
25944	1008	13	favorable	favorable	JJ
25944	1008	14	,	,	,
25944	1008	15	so	so	RB
25944	1008	16	far	far	RB
25944	1008	17	as	as	IN
25944	1008	18	concerns	concern	NNS
25944	1008	19	the	the	DT
25944	1008	20	immediate	immediate	JJ
25944	1008	21	eruption	eruption	NN
25944	1008	22	,	,	,
25944	1008	23	but	but	CC
25944	1008	24	as	as	IN
25944	1008	25	to	to	IN
25944	1008	26	recurrences	recurrence	NNS
25944	1008	27	,	,	,
25944	1008	28	nothing	nothing	NN
25944	1008	29	positive	positive	JJ
25944	1008	30	can	can	MD
25944	1008	31	be	be	VB
25944	1008	32	stated	state	VBN
25944	1008	33	.	.	.
25944	1009	1	In	in	IN
25944	1009	2	rare	rare	JJ
25944	1009	3	instances	instance	NNS
25944	1009	4	,	,	,
25944	1009	5	however	however	RB
25944	1009	6	,	,	,
25944	1009	7	the	the	DT
25944	1009	8	cure	cure	NN
25944	1009	9	remains	remain	VBZ
25944	1009	10	permanent	permanent	JJ
25944	1009	11	.	.	.
25944	1010	1	#	#	NNP
25944	1010	2	How	how	WRB
25944	1010	3	is	be	VBZ
25944	1010	4	psoriasis	psoriasis	NN
25944	1010	5	treated	treat	VBN
25944	1010	6	?	?	.
25944	1010	7	#	#	$
25944	1010	8	Both	both	CC
25944	1010	9	constitutional	constitutional	JJ
25944	1010	10	and	and	CC
25944	1010	11	local	local	JJ
25944	1010	12	remedies	remedy	NNS
25944	1010	13	are	be	VBP
25944	1010	14	demanded	demand	VBN
25944	1010	15	in	in	IN
25944	1010	16	most	most	JJS
25944	1010	17	cases	case	NNS
25944	1010	18	.	.	.
25944	1011	1	#	#	JJR
25944	1011	2	Do	do	VBP
25944	1011	3	dietary	dietary	JJ
25944	1011	4	measures	measure	NNS
25944	1011	5	exert	exert	VB
25944	1011	6	any	any	DT
25944	1011	7	influence	influence	NN
25944	1011	8	?	?	.
25944	1011	9	#	#	$
25944	1011	10	As	as	IN
25944	1011	11	a	a	DT
25944	1011	12	rule	rule	NN
25944	1011	13	,	,	,
25944	1011	14	no	no	UH
25944	1011	15	;	;	:
25944	1011	16	but	but	CC
25944	1011	17	the	the	DT
25944	1011	18	food	food	NN
25944	1011	19	should	should	MD
25944	1011	20	be	be	VB
25944	1011	21	plain	plain	JJ
25944	1011	22	,	,	,
25944	1011	23	and	and	CC
25944	1011	24	an	an	DT
25944	1011	25	excess	excess	NN
25944	1011	26	of	of	IN
25944	1011	27	meat	meat	NN
25944	1011	28	avoided	avoid	VBN
25944	1011	29	.	.	.
25944	1012	1	#	#	$
25944	1012	2	Name	name	VB
25944	1012	3	the	the	DT
25944	1012	4	important	important	JJ
25944	1012	5	constitutional	constitutional	JJ
25944	1012	6	remedies	remedy	NNS
25944	1012	7	usually	usually	RB
25944	1012	8	employed	employ	VBN
25944	1012	9	in	in	IN
25944	1012	10	psoriasis	psoriasis	NN
25944	1012	11	.	.	.
25944	1012	12	#	#	$
25944	1012	13	_	_	NNP
25944	1012	14	Arsenic	Arsenic	NNP
25944	1012	15	_	_	NNP
25944	1012	16	is	be	VBZ
25944	1012	17	of	of	IN
25944	1012	18	first	first	JJ
25944	1012	19	importance	importance	NN
25944	1012	20	.	.	.
25944	1013	1	It	-PRON-	PRP
25944	1013	2	is	be	VBZ
25944	1013	3	not	not	RB
25944	1013	4	suitable	suitable	JJ
25944	1013	5	in	in	IN
25944	1013	6	acute	acute	JJ
25944	1013	7	or	or	CC
25944	1013	8	markedly	markedly	RB
25944	1013	9	inflammatory	inflammatory	JJ
25944	1013	10	types	type	NNS
25944	1013	11	;	;	:
25944	1013	12	but	but	CC
25944	1013	13	is	be	VBZ
25944	1013	14	most	most	RBS
25944	1013	15	useful	useful	JJ
25944	1013	16	in	in	IN
25944	1013	17	the	the	DT
25944	1013	18	sluggish	sluggish	JJ
25944	1013	19	,	,	,
25944	1013	20	chronic	chronic	JJ
25944	1013	21	forms	form	NNS
25944	1013	22	of	of	IN
25944	1013	23	the	the	DT
25944	1013	24	disease	disease	NN
25944	1013	25	.	.	.
25944	1014	1	The	the	DT
25944	1014	2	dose	dose	NN
25944	1014	3	should	should	MD
25944	1014	4	never	never	RB
25944	1014	5	be	be	VB
25944	1014	6	pushed	push	VBN
25944	1014	7	beyond	beyond	IN
25944	1014	8	slight	slight	JJ
25944	1014	9	physiological	physiological	JJ
25944	1014	10	action	action	NN
25944	1014	11	.	.	.
25944	1015	1	It	-PRON-	PRP
25944	1015	2	may	may	MD
25944	1015	3	be	be	VB
25944	1015	4	given	give	VBN
25944	1015	5	as	as	IN
25944	1015	6	arsenious	arsenious	JJ
25944	1015	7	acid	acid	NN
25944	1015	8	in	in	IN
25944	1015	9	pill	pill	NN
25944	1015	10	form	form	NN
25944	1015	11	,	,	,
25944	1015	12	one	one	CD
25944	1015	13	-	-	HYPH
25944	1015	14	fiftieth	fiftieth	NN
25944	1015	15	to	to	IN
25944	1015	16	one	one	CD
25944	1015	17	-	-	HYPH
25944	1015	18	tenth	tenth	NN
25944	1015	19	of	of	IN
25944	1015	20	a	a	DT
25944	1015	21	grain	grain	NN
25944	1015	22	three	three	CD
25944	1015	23	times	time	NNS
25944	1015	24	daily	daily	RB
25944	1015	25	,	,	,
25944	1015	26	or	or	CC
25944	1015	27	as	as	IN
25944	1015	28	Fowler	Fowler	NNP
25944	1015	29	's	's	POS
25944	1015	30	solution	solution	NN
25944	1015	31	,	,	,
25944	1015	32	three	three	CD
25944	1015	33	to	to	TO
25944	1015	34	ten	ten	CD
25944	1015	35	minims	minim	NNS
25944	1015	36	at	at	IN
25944	1015	37	a	a	DT
25944	1015	38	dose	dose	NN
25944	1015	39	.	.	.
25944	1016	1	_	_	NNP
25944	1016	2	Alkalies	Alkalies	NNP
25944	1016	3	_	_	NNP
25944	1016	4	,	,	,
25944	1016	5	of	of	IN
25944	1016	6	which	which	WDT
25944	1016	7	liquor	liquor	NN
25944	1016	8	potassæ	potassæ	NNP
25944	1016	9	is	be	VBZ
25944	1016	10	the	the	DT
25944	1016	11	most	most	RBS
25944	1016	12	eligible	eligible	JJ
25944	1016	13	.	.	.
25944	1017	1	It	-PRON-	PRP
25944	1017	2	is	be	VBZ
25944	1017	3	to	to	TO
25944	1017	4	be	be	VB
25944	1017	5	given	give	VBN
25944	1017	6	in	in	IN
25944	1017	7	ten	ten	CD
25944	1017	8	to	to	TO
25944	1017	9	twenty	twenty	CD
25944	1017	10	minim	minim	NN
25944	1017	11	doses	dose	NNS
25944	1017	12	,	,	,
25944	1017	13	largely	largely	RB
25944	1017	14	diluted	diluted	JJ
25944	1017	15	.	.	.
25944	1018	1	It	-PRON-	PRP
25944	1018	2	is	be	VBZ
25944	1018	3	valuable	valuable	JJ
25944	1018	4	in	in	IN
25944	1018	5	robust	robust	JJ
25944	1018	6	,	,	,
25944	1018	7	plethoric	plethoric	JJ
25944	1018	8	,	,	,
25944	1018	9	rheumatic	rheumatic	JJ
25944	1018	10	or	or	CC
25944	1018	11	gouty	gouty	JJ
25944	1018	12	individuals	individual	NNS
25944	1018	13	with	with	IN
25944	1018	14	psoriasis	psoriasis	NN
25944	1018	15	of	of	IN
25944	1018	16	an	an	DT
25944	1018	17	acute	acute	JJ
25944	1018	18	or	or	CC
25944	1018	19	markedly	markedly	RB
25944	1018	20	inflammatory	inflammatory	JJ
25944	1018	21	type	type	NN
25944	1018	22	;	;	:
25944	1018	23	it	-PRON-	PRP
25944	1018	24	is	be	VBZ
25944	1018	25	not	not	RB
25944	1018	26	to	to	TO
25944	1018	27	be	be	VB
25944	1018	28	given	give	VBN
25944	1018	29	to	to	IN
25944	1018	30	debilitated	debilitated	JJ
25944	1018	31	or	or	CC
25944	1018	32	anæmic	anæmic	JJ
25944	1018	33	subjects	subject	NNS
25944	1018	34	.	.	.
25944	1019	1	_	_	NNP
25944	1019	2	Salicin	Salicin	NNP
25944	1019	3	_	_	NNP
25944	1019	4	,	,	,
25944	1019	5	sodium	sodium	NN
25944	1019	6	salicylate	salicylate	NN
25944	1019	7	,	,	,
25944	1019	8	and	and	CC
25944	1019	9	salophen	salophen	NNP
25944	1019	10	in	in	IN
25944	1019	11	moderately	moderately	RB
25944	1019	12	full	full	JJ
25944	1019	13	doses	dose	NNS
25944	1019	14	act	act	VBP
25944	1019	15	well	well	RB
25944	1019	16	in	in	IN
25944	1019	17	some	some	DT
25944	1019	18	cases	case	NNS
25944	1019	19	.	.	.
25944	1020	1	Occasionally	occasionally	RB
25944	1020	2	thyroid	thyroid	NN
25944	1020	3	preparations	preparation	NNS
25944	1020	4	have	have	VBP
25944	1020	5	a	a	DT
25944	1020	6	good	good	JJ
25944	1020	7	effect	effect	NN
25944	1020	8	.	.	.
25944	1021	1	_	_	NNP
25944	1021	2	Potassium	Potassium	NNP
25944	1021	3	Iodide	Iodide	NNP
25944	1021	4	_	_	NNP
25944	1021	5	,	,	,
25944	1021	6	in	in	IN
25944	1021	7	doses	dose	NNS
25944	1021	8	of	of	IN
25944	1021	9	thirty	thirty	CD
25944	1021	10	to	to	IN
25944	1021	11	one	one	CD
25944	1021	12	hundred	hundred	CD
25944	1021	13	grains	grain	NNS
25944	1021	14	,	,	,
25944	1021	15	t.d	t.d	NNP
25944	1021	16	.	.	NNP
25944	1021	17	,	,	,
25944	1021	18	acts	act	VBZ
25944	1021	19	favorably	favorably	RB
25944	1021	20	in	in	IN
25944	1021	21	some	some	DT
25944	1021	22	instances	instance	NNS
25944	1021	23	;	;	:
25944	1021	24	there	there	EX
25944	1021	25	are	be	VBP
25944	1021	26	no	no	DT
25944	1021	27	special	special	JJ
25944	1021	28	indications	indication	NNS
25944	1021	29	pointing	point	VBG
25944	1021	30	toward	toward	IN
25944	1021	31	its	-PRON-	PRP$
25944	1021	32	selection	selection	NN
25944	1021	33	,	,	,
25944	1021	34	unless	unless	IN
25944	1021	35	it	-PRON-	PRP
25944	1021	36	be	be	VB
25944	1021	37	the	the	DT
25944	1021	38	existence	existence	NN
25944	1021	39	of	of	IN
25944	1021	40	a	a	DT
25944	1021	41	gouty	gouty	JJ
25944	1021	42	or	or	CC
25944	1021	43	rheumatic	rheumatic	JJ
25944	1021	44	diathesis	diathesis	NN
25944	1021	45	.	.	.
25944	1022	1	Oil	oil	NN
25944	1022	2	of	of	IN
25944	1022	3	copaiba	copaiba	NNS
25944	1022	4	,	,	,
25944	1022	5	potassium	potassium	NN
25944	1022	6	acetate	acetate	NN
25944	1022	7	,	,	,
25944	1022	8	oil	oil	NN
25944	1022	9	of	of	IN
25944	1022	10	turpentine	turpentine	NN
25944	1022	11	,	,	,
25944	1022	12	oil	oil	NN
25944	1022	13	of	of	IN
25944	1022	14	juniper	juniper	NN
25944	1022	15	,	,	,
25944	1022	16	and	and	CC
25944	1022	17	other	other	JJ
25944	1022	18	diuretics	diuretic	NNS
25944	1022	19	are	be	VBP
25944	1022	20	valuable	valuable	JJ
25944	1022	21	in	in	IN
25944	1022	22	some	some	DT
25944	1022	23	instances	instance	NNS
25944	1022	24	,	,	,
25944	1022	25	and	and	CC
25944	1022	26	,	,	,
25944	1022	27	while	while	IN
25944	1022	28	often	often	RB
25944	1022	29	failing	fail	VBG
25944	1022	30	,	,	,
25944	1022	31	sometimes	sometimes	RB
25944	1022	32	exert	exert	VB
25944	1022	33	a	a	DT
25944	1022	34	rapid	rapid	JJ
25944	1022	35	influence	influence	NN
25944	1022	36	,	,	,
25944	1022	37	especially	especially	RB
25944	1022	38	in	in	IN
25944	1022	39	those	those	DT
25944	1022	40	cases	case	NNS
25944	1022	41	in	in	IN
25944	1022	42	which	which	WDT
25944	1022	43	the	the	DT
25944	1022	44	disease	disease	NN
25944	1022	45	is	be	VBZ
25944	1022	46	extensive	extensive	JJ
25944	1022	47	and	and	CC
25944	1022	48	inflammatory	inflammatory	JJ
25944	1022	49	.	.	.
25944	1023	1	Wine	wine	NN
25944	1023	2	of	of	IN
25944	1023	3	antimony	antimony	NN
25944	1023	4	,	,	,
25944	1023	5	given	give	VBN
25944	1023	6	cautiously	cautiously	RB
25944	1023	7	,	,	,
25944	1023	8	is	be	VBZ
25944	1023	9	also	also	RB
25944	1023	10	sometimes	sometimes	RB
25944	1023	11	of	of	IN
25944	1023	12	service	service	NN
25944	1023	13	in	in	IN
25944	1023	14	the	the	DT
25944	1023	15	acute	acute	JJ
25944	1023	16	inflammatory	inflammatory	JJ
25944	1023	17	type	type	NN
25944	1023	18	in	in	IN
25944	1023	19	robust	robust	JJ
25944	1023	20	subjects	subject	NNS
25944	1023	21	.	.	.
25944	1024	1	#	#	NN
25944	1024	2	Are	be	VBP
25944	1024	3	such	such	JJ
25944	1024	4	remedies	remedy	NNS
25944	1024	5	as	as	IN
25944	1024	6	iron	iron	NN
25944	1024	7	,	,	,
25944	1024	8	quinine	quinine	JJ
25944	1024	9	,	,	,
25944	1024	10	nux	nux	NN
25944	1024	11	vomica	vomica	NN
25944	1024	12	and	and	CC
25944	1024	13	cod	cod	NN
25944	1024	14	-	-	HYPH
25944	1024	15	liver	liver	NN
25944	1024	16	oil	oil	NN
25944	1024	17	ever	ever	RB
25944	1024	18	useful	useful	JJ
25944	1024	19	in	in	IN
25944	1024	20	psoriasis	psoriasis	NN
25944	1024	21	?	?	.
25944	1024	22	#	#	NN
25944	1024	23	Yes	yes	UH
25944	1024	24	.	.	.
25944	1025	1	In	in	IN
25944	1025	2	debilitated	debilitated	JJ
25944	1025	3	subjects	subject	NNS
25944	1025	4	the	the	DT
25944	1025	5	administration	administration	NN
25944	1025	6	of	of	IN
25944	1025	7	such	such	JJ
25944	1025	8	remedies	remedy	NNS
25944	1025	9	is	be	VBZ
25944	1025	10	at	at	IN
25944	1025	11	times	time	NNS
25944	1025	12	attended	attend	VBN
25944	1025	13	with	with	IN
25944	1025	14	improvement	improvement	NN
25944	1025	15	in	in	IN
25944	1025	16	the	the	DT
25944	1025	17	cutaneous	cutaneous	JJ
25944	1025	18	eruption	eruption	NN
25944	1025	19	.	.	.
25944	1026	1	#	#	LS
25944	1026	2	What	what	WP
25944	1026	3	are	be	VBP
25944	1026	4	the	the	DT
25944	1026	5	indications	indication	NNS
25944	1026	6	as	as	IN
25944	1026	7	regards	regard	VBZ
25944	1026	8	the	the	DT
25944	1026	9	external	external	JJ
25944	1026	10	measures	measure	NNS
25944	1026	11	?	?	.
25944	1026	12	#	#	$
25944	1026	13	Removal	removal	NN
25944	1026	14	of	of	IN
25944	1026	15	the	the	DT
25944	1026	16	scales	scale	NNS
25944	1026	17	,	,	,
25944	1026	18	and	and	CC
25944	1026	19	the	the	DT
25944	1026	20	use	use	NN
25944	1026	21	of	of	IN
25944	1026	22	soothing	soothe	VBG
25944	1026	23	or	or	CC
25944	1026	24	stimulating	stimulating	JJ
25944	1026	25	applications	application	NNS
25944	1026	26	,	,	,
25944	1026	27	according	accord	VBG
25944	1026	28	to	to	IN
25944	1026	29	the	the	DT
25944	1026	30	individual	individual	JJ
25944	1026	31	case	case	NN
25944	1026	32	.	.	.
25944	1027	1	#	#	NNP
25944	1027	2	How	how	WRB
25944	1027	3	are	be	VBP
25944	1027	4	the	the	DT
25944	1027	5	scales	scale	NNS
25944	1027	6	removed	remove	VBN
25944	1027	7	?	?	.
25944	1027	8	#	#	NN
25944	1027	9	In	in	IN
25944	1027	10	ordinary	ordinary	JJ
25944	1027	11	cases	case	NNS
25944	1027	12	,	,	,
25944	1027	13	either	either	CC
25944	1027	14	by	by	IN
25944	1027	15	warm	warm	JJ
25944	1027	16	,	,	,
25944	1027	17	plain	plain	JJ
25944	1027	18	,	,	,
25944	1027	19	or	or	CC
25944	1027	20	alkaline	alkaline	NN
25944	1027	21	baths	bath	NNS
25944	1027	22	,	,	,
25944	1027	23	or	or	CC
25944	1027	24	hot	hot	JJ
25944	1027	25	-	-	HYPH
25944	1027	26	water	water	NN
25944	1027	27	-	-	HYPH
25944	1027	28	and	and	CC
25944	1027	29	-	-	HYPH
25944	1027	30	soap	soap	NN
25944	1027	31	washings	washing	NNS
25944	1027	32	;	;	:
25944	1027	33	in	in	IN
25944	1027	34	those	those	DT
25944	1027	35	cases	case	NNS
25944	1027	36	in	in	IN
25944	1027	37	which	which	WDT
25944	1027	38	the	the	DT
25944	1027	39	scaling	scaling	NN
25944	1027	40	is	be	VBZ
25944	1027	41	abundant	abundant	JJ
25944	1027	42	and	and	CC
25944	1027	43	adherent	adherent	JJ
25944	1027	44	,	,	,
25944	1027	45	washing	wash	VBG
25944	1027	46	with	with	IN
25944	1027	47	sapo	sapo	JJ
25944	1027	48	viridis	viridis	NN
25944	1027	49	and	and	CC
25944	1027	50	hot	hot	JJ
25944	1027	51	water	water	NN
25944	1027	52	may	may	MD
25944	1027	53	be	be	VB
25944	1027	54	required	require	VBN
25944	1027	55	.	.	.
25944	1028	1	Baths	bath	NNS
25944	1028	2	of	of	IN
25944	1028	3	sal	sal	NNP
25944	1028	4	ammoniac	ammoniac	NN
25944	1028	5	,	,	,
25944	1028	6	two	two	CD
25944	1028	7	to	to	TO
25944	1028	8	six	six	CD
25944	1028	9	ounces	ounce	NNS
25944	1028	10	to	to	IN
25944	1028	11	the	the	DT
25944	1028	12	bath	bath	NN
25944	1028	13	are	be	VBP
25944	1028	14	also	also	RB
25944	1028	15	valuable	valuable	JJ
25944	1028	16	in	in	IN
25944	1028	17	removing	remove	VBG
25944	1028	18	the	the	DT
25944	1028	19	scaliness	scaliness	NN
25944	1028	20	.	.	.
25944	1029	1	The	the	DT
25944	1029	2	tincture	tincture	NN
25944	1029	3	of	of	IN
25944	1029	4	green	green	JJ
25944	1029	5	soap	soap	NN
25944	1029	6	(	(	-LRB-
25944	1029	7	tinctura	tinctura	NNP
25944	1029	8	saponis	saponis	NNP
25944	1029	9	viridis	viridis	NNP
25944	1029	10	)	)	-RRB-
25944	1029	11	is	be	VBZ
25944	1029	12	especially	especially	RB
25944	1029	13	valuable	valuable	JJ
25944	1029	14	for	for	IN
25944	1029	15	cleansing	cleanse	VBG
25944	1029	16	purposes	purpose	NNS
25944	1029	17	in	in	IN
25944	1029	18	psoriasis	psoriasis	NN
25944	1029	19	of	of	IN
25944	1029	20	the	the	DT
25944	1029	21	scalp	scalp	NN
25944	1029	22	.	.	.
25944	1030	1	The	the	DT
25944	1030	2	hot	hot	JJ
25944	1030	3	vapor	vapor	NN
25944	1030	4	bath	bath	NN
25944	1030	5	once	once	RB
25944	1030	6	or	or	CC
25944	1030	7	twice	twice	RB
25944	1030	8	weekly	weekly	JJ
25944	1030	9	is	be	VBZ
25944	1030	10	serviceable	serviceable	JJ
25944	1030	11	in	in	IN
25944	1030	12	keeping	keep	VBG
25944	1030	13	the	the	DT
25944	1030	14	scaliness	scaliness	NN
25944	1030	15	in	in	IN
25944	1030	16	abeyance	abeyance	NN
25944	1030	17	,	,	,
25944	1030	18	and	and	CC
25944	1030	19	has	have	VBZ
25944	1030	20	,	,	,
25944	1030	21	moreover	moreover	RB
25944	1030	22	,	,	,
25944	1030	23	in	in	IN
25944	1030	24	some	some	DT
25944	1030	25	cases	case	NNS
25944	1030	26	,	,	,
25944	1030	27	a	a	DT
25944	1030	28	therapeutic	therapeutic	JJ
25944	1030	29	value	value	NN
25944	1030	30	.	.	.
25944	1031	1	The	the	DT
25944	1031	2	frequency	frequency	NN
25944	1031	3	of	of	IN
25944	1031	4	the	the	DT
25944	1031	5	baths	bath	NNS
25944	1031	6	or	or	CC
25944	1031	7	washings	washing	NNS
25944	1031	8	will	will	MD
25944	1031	9	depend	depend	VB
25944	1031	10	upon	upon	IN
25944	1031	11	the	the	DT
25944	1031	12	rapidity	rapidity	NN
25944	1031	13	with	with	IN
25944	1031	14	which	which	WDT
25944	1031	15	the	the	DT
25944	1031	16	scales	scale	NNS
25944	1031	17	are	be	VBP
25944	1031	18	reproduced	reproduce	VBN
25944	1031	19	.	.	.
25944	1032	1	#	#	NN
25944	1032	2	Are	be	VBP
25944	1032	3	soothing	soothe	VBG
25944	1032	4	applications	application	NNS
25944	1032	5	often	often	RB
25944	1032	6	demanded	demand	VBD
25944	1032	7	in	in	IN
25944	1032	8	psoriasis	psoriasis	NN
25944	1032	9	?	?	.
25944	1032	10	#	#	$
25944	1032	11	In	in	IN
25944	1032	12	exceptional	exceptional	JJ
25944	1032	13	cases	case	NNS
25944	1032	14	;	;	:
25944	1032	15	in	in	IN
25944	1032	16	those	those	DT
25944	1032	17	in	in	IN
25944	1032	18	which	which	WDT
25944	1032	19	the	the	DT
25944	1032	20	disease	disease	NN
25944	1032	21	is	be	VBZ
25944	1032	22	acute	acute	JJ
25944	1032	23	,	,	,
25944	1032	24	markedly	markedly	RB
25944	1032	25	inflammatory	inflammatory	JJ
25944	1032	26	and	and	CC
25944	1032	27	rapidly	rapidly	RB
25944	1032	28	progressing	progress	VBG
25944	1032	29	,	,	,
25944	1032	30	mild	mild	JJ
25944	1032	31	,	,	,
25944	1032	32	soothing	soothing	JJ
25944	1032	33	applications	application	NNS
25944	1032	34	must	must	MD
25944	1032	35	be	be	VB
25944	1032	36	temporarily	temporarily	RB
25944	1032	37	employed	employ	VBN
25944	1032	38	,	,	,
25944	1032	39	such	such	JJ
25944	1032	40	as	as	IN
25944	1032	41	plain	plain	JJ
25944	1032	42	or	or	CC
25944	1032	43	bran	bran	NN
25944	1032	44	baths	bath	NNS
25944	1032	45	,	,	,
25944	1032	46	with	with	IN
25944	1032	47	the	the	DT
25944	1032	48	use	use	NN
25944	1032	49	of	of	IN
25944	1032	50	some	some	DT
25944	1032	51	bland	bland	JJ
25944	1032	52	oil	oil	NN
25944	1032	53	or	or	CC
25944	1032	54	ointment	ointment	NN
25944	1032	55	.	.	.
25944	1033	1	As	as	IN
25944	1033	2	a	a	DT
25944	1033	3	rule	rule	NN
25944	1033	4	,	,	,
25944	1033	5	however	however	RB
25944	1033	6	,	,	,
25944	1033	7	the	the	DT
25944	1033	8	conditions	condition	NNS
25944	1033	9	,	,	,
25944	1033	10	when	when	WRB
25944	1033	11	coming	come	VBG
25944	1033	12	under	under	IN
25944	1033	13	observation	observation	NN
25944	1033	14	,	,	,
25944	1033	15	are	be	VBP
25944	1033	16	such	such	JJ
25944	1033	17	as	as	IN
25944	1033	18	to	to	TO
25944	1033	19	permit	permit	VB
25944	1033	20	of	of	IN
25944	1033	21	stimulating	stimulating	JJ
25944	1033	22	applications	application	NNS
25944	1033	23	from	from	IN
25944	1033	24	the	the	DT
25944	1033	25	start	start	NN
25944	1033	26	.	.	.
25944	1034	1	The	the	DT
25944	1034	2	most	most	RBS
25944	1034	3	efficient	efficient	JJ
25944	1034	4	soothing	soothing	JJ
25944	1034	5	applications	application	NNS
25944	1034	6	are	be	VBP
25944	1034	7	the	the	DT
25944	1034	8	mild	mild	JJ
25944	1034	9	lotions	lotion	NNS
25944	1034	10	and	and	CC
25944	1034	11	ointments	ointment	NNS
25944	1034	12	employed	employ	VBN
25944	1034	13	in	in	IN
25944	1034	14	eczema	eczema	NN
25944	1034	15	of	of	IN
25944	1034	16	acute	acute	JJ
25944	1034	17	type	type	NN
25944	1034	18	.	.	.
25944	1035	1	#	#	NNP
25944	1035	2	How	how	WRB
25944	1035	3	are	be	VBP
25944	1035	4	the	the	DT
25944	1035	5	stimulating	stimulating	JJ
25944	1035	6	remedies	remedy	NNS
25944	1035	7	employed	employ	VBN
25944	1035	8	in	in	IN
25944	1035	9	psoriasis	psoriasis	NN
25944	1035	10	applied	apply	VBN
25944	1035	11	?	?	.
25944	1035	12	#	#	NNP
25944	1035	13	As	as	IN
25944	1035	14	ointments	ointment	NNS
25944	1035	15	,	,	,
25944	1035	16	oils	oil	NNS
25944	1035	17	,	,	,
25944	1035	18	and	and	CC
25944	1035	19	paints	paint	NNS
25944	1035	20	(	(	-LRB-
25944	1035	21	pigmenta	pigmenta	NNP
25944	1035	22	)	)	-RRB-
25944	1035	23	.	.	.
25944	1036	1	An	an	DT
25944	1036	2	ointment	ointment	NN
25944	1036	3	,	,	,
25944	1036	4	if	if	IN
25944	1036	5	employed	employ	VBN
25944	1036	6	,	,	,
25944	1036	7	is	be	VBZ
25944	1036	8	to	to	TO
25944	1036	9	be	be	VB
25944	1036	10	thoroughly	thoroughly	RB
25944	1036	11	rubbed	rub	VBN
25944	1036	12	in	in	IN
25944	1036	13	the	the	DT
25944	1036	14	diseased	disease	VBN
25944	1036	15	areas	area	NNS
25944	1036	16	once	once	RB
25944	1036	17	or	or	CC
25944	1036	18	twice	twice	RB
25944	1036	19	daily	daily	RB
25944	1036	20	.	.	.
25944	1037	1	The	the	DT
25944	1037	2	same	same	JJ
25944	1037	3	may	may	MD
25944	1037	4	be	be	VB
25944	1037	5	said	say	VBN
25944	1037	6	of	of	IN
25944	1037	7	the	the	DT
25944	1037	8	oily	oily	JJ
25944	1037	9	applications	application	NNS
25944	1037	10	.	.	.
25944	1038	1	The	the	DT
25944	1038	2	paints	paint	NNS
25944	1038	3	(	(	-LRB-
25944	1038	4	medicated	medicate	VBN
25944	1038	5	collodion	collodion	NN
25944	1038	6	and	and	CC
25944	1038	7	gutta	gutta	NN
25944	1038	8	-	-	HYPH
25944	1038	9	percha	percha	NN
25944	1038	10	solution	solution	NN
25944	1038	11	)	)	-RRB-
25944	1038	12	are	be	VBP
25944	1038	13	applied	apply	VBN
25944	1038	14	with	with	IN
25944	1038	15	a	a	DT
25944	1038	16	brush	brush	NN
25944	1038	17	,	,	,
25944	1038	18	once	once	RB
25944	1038	19	daily	daily	RB
25944	1038	20	,	,	,
25944	1038	21	or	or	CC
25944	1038	22	every	every	DT
25944	1038	23	second	second	JJ
25944	1038	24	or	or	CC
25944	1038	25	third	third	JJ
25944	1038	26	day	day	NN
25944	1038	27	,	,	,
25944	1038	28	depending	depend	VBG
25944	1038	29	mainly	mainly	RB
25944	1038	30	upon	upon	IN
25944	1038	31	the	the	DT
25944	1038	32	length	length	NN
25944	1038	33	of	of	IN
25944	1038	34	time	time	NN
25944	1038	35	the	the	DT
25944	1038	36	film	film	NN
25944	1038	37	remains	remain	VBZ
25944	1038	38	intact	intact	JJ
25944	1038	39	and	and	CC
25944	1038	40	adherent	adherent	JJ
25944	1038	41	.	.	.
25944	1039	1	#	#	$
25944	1039	2	Name	name	VB
25944	1039	3	the	the	DT
25944	1039	4	several	several	JJ
25944	1039	5	important	important	JJ
25944	1039	6	external	external	JJ
25944	1039	7	remedies	remedy	NNS
25944	1039	8	.	.	.
25944	1039	9	#	#	NNP
25944	1039	10	Chrysarobin	Chrysarobin	NNP
25944	1039	11	,	,	,
25944	1039	12	pyrogallol	pyrogallol	NN
25944	1039	13	,	,	,
25944	1039	14	tar	tar	NNP
25944	1039	15	,	,	,
25944	1039	16	ammoniated	ammoniate	VBD
25944	1039	17	mercury	mercury	NNP
25944	1039	18	,	,	,
25944	1039	19	[	[	-LRB-
25944	1039	20	beta]-naphthol	beta]-naphthol	NNP
25944	1039	21	,	,	,
25944	1039	22	and	and	CC
25944	1039	23	resorcin	resorcin	NNS
25944	1039	24	.	.	.
25944	1040	1	#	#	NN
25944	1040	2	Are	be	VBP
25944	1040	3	these	these	DT
25944	1040	4	several	several	JJ
25944	1040	5	external	external	JJ
25944	1040	6	remedies	remedy	NNS
25944	1040	7	equally	equally	RB
25944	1040	8	serviceable	serviceable	JJ
25944	1040	9	in	in	IN
25944	1040	10	all	all	DT
25944	1040	11	cases	case	NNS
25944	1040	12	?	?	.
25944	1040	13	#	#	$
25944	1040	14	No	no	UH
25944	1040	15	.	.	.
25944	1041	1	Their	-PRON-	PRP$
25944	1041	2	action	action	NN
25944	1041	3	differs	differ	VBZ
25944	1041	4	slightly	slightly	RB
25944	1041	5	or	or	CC
25944	1041	6	greatly	greatly	RB
25944	1041	7	according	accord	VBG
25944	1041	8	to	to	IN
25944	1041	9	the	the	DT
25944	1041	10	case	case	NN
25944	1041	11	and	and	CC
25944	1041	12	individual	individual	NN
25944	1041	13	.	.	.
25944	1042	1	A	a	DT
25944	1042	2	change	change	NN
25944	1042	3	from	from	IN
25944	1042	4	one	one	CD
25944	1042	5	to	to	IN
25944	1042	6	another	another	DT
25944	1042	7	is	be	VBZ
25944	1042	8	often	often	RB
25944	1042	9	necessary	necessary	JJ
25944	1042	10	.	.	.
25944	1043	1	#	#	$
25944	1043	2	In	in	IN
25944	1043	3	what	what	WDT
25944	1043	4	forms	form	NNS
25944	1043	5	and	and	CC
25944	1043	6	strength	strength	NN
25944	1043	7	are	be	VBP
25944	1043	8	these	these	DT
25944	1043	9	remedies	remedy	NNS
25944	1043	10	to	to	TO
25944	1043	11	be	be	VB
25944	1043	12	applied	apply	VBN
25944	1043	13	?	?	.
25944	1043	14	#	#	$
25944	1043	15	_	_	NNP
25944	1043	16	Chrysarobin	Chrysarobin	NNP
25944	1043	17	_	_	NNP
25944	1043	18	is	be	VBZ
25944	1043	19	applied	apply	VBN
25944	1043	20	in	in	IN
25944	1043	21	several	several	JJ
25944	1043	22	ways	way	NNS
25944	1043	23	:	:	:
25944	1043	24	as	as	IN
25944	1043	25	an	an	DT
25944	1043	26	ointment	ointment	NN
25944	1043	27	,	,	,
25944	1043	28	twenty	twenty	CD
25944	1043	29	to	to	TO
25944	1043	30	sixty	sixty	CD
25944	1043	31	grains	grain	NNS
25944	1043	32	to	to	IN
25944	1043	33	the	the	DT
25944	1043	34	ounce	ounce	NN
25944	1043	35	,	,	,
25944	1043	36	rubbed	rub	VBN
25944	1043	37	in	in	IN
25944	1043	38	once	once	RB
25944	1043	39	or	or	CC
25944	1043	40	twice	twice	RB
25944	1043	41	daily	daily	RB
25944	1043	42	;	;	:
25944	1043	43	this	this	DT
25944	1043	44	is	be	VBZ
25944	1043	45	the	the	DT
25944	1043	46	most	most	RBS
25944	1043	47	rapid	rapid	JJ
25944	1043	48	but	but	CC
25944	1043	49	least	least	JJS
25944	1043	50	cleanly	cleanly	JJ
25944	1043	51	and	and	CC
25944	1043	52	eligible	eligible	JJ
25944	1043	53	method	method	NN
25944	1043	54	.	.	.
25944	1044	1	As	as	IN
25944	1044	2	a	a	DT
25944	1044	3	pigment	pigment	NN
25944	1044	4	,	,	,
25944	1044	5	or	or	CC
25944	1044	6	paint	paint	NN
25944	1044	7	,	,	,
25944	1044	8	as	as	IN
25944	1044	9	in	in	IN
25944	1044	10	the	the	DT
25944	1044	11	following:--	following:--	NN
25944	1044	12	[	[	-LRB-
25944	1044	13	Rx	Rx	NNP
25944	1044	14	]	]	-RRB-
25944	1044	15	Chrysarobini	Chrysarobini	NNP
25944	1044	16	,	,	,
25944	1044	17	........................	........................	NFP
25944	1044	18	[	[	-LRB-
25944	1044	19	dram]j	dram]j	JJ
25944	1044	20	Acidi	Acidi	NNP
25944	1044	21	salicylici	salicylici	NN
25944	1044	22	,	,	,
25944	1044	23	....................	....................	NFP
25944	1044	24	gr	gr	NNP
25944	1044	25	.	.	.
25944	1045	1	xx	xx	IN
25944	1045	2	Etheris	Etheris	NNP
25944	1045	3	,	,	,
25944	1045	4	.............................	.............................	NFP
25944	1045	5	f[dram]j	f[dram]j	VBZ
25944	1045	6	Ol	old	RB
25944	1045	7	.	.	.
25944	1046	1	ricini	ricini	NNP
25944	1046	2	,	,	,
25944	1046	3	..........................	..........................	NFP
25944	1046	4	[	[	-LRB-
25944	1046	5	minim]x	minim]x	NNP
25944	1046	6	Collodii	Collodii	NNP
25944	1046	7	,	,	,
25944	1046	8	............................	............................	NFP
25944	1046	9	f[dram]vij	f[dram]vij	NNS
25944	1046	10	.	.	.
25944	1047	1	M.	M.	NNP
25944	1047	2	Or	or	CC
25944	1047	3	it	-PRON-	PRP
25944	1047	4	may	may	MD
25944	1047	5	be	be	VB
25944	1047	6	used	use	VBN
25944	1047	7	in	in	IN
25944	1047	8	liquor	liquor	NNP
25944	1047	9	gutta	gutta	NNP
25944	1047	10	-	-	HYPH
25944	1047	11	perchæ	perchæ	NNP
25944	1047	12	(	(	-LRB-
25944	1047	13	traumaticin	traumaticin	NNP
25944	1047	14	)	)	-RRB-
25944	1047	15	,	,	,
25944	1047	16	a	a	DT
25944	1047	17	drachm	drachm	NN
25944	1047	18	to	to	IN
25944	1047	19	the	the	DT
25944	1047	20	ounce	ounce	NN
25944	1047	21	.	.	.
25944	1048	1	It	-PRON-	PRP
25944	1048	2	may	may	MD
25944	1048	3	also	also	RB
25944	1048	4	be	be	VB
25944	1048	5	employed	employ	VBN
25944	1048	6	in	in	IN
25944	1048	7	chloroform	chloroform	NN
25944	1048	8	,	,	,
25944	1048	9	a	a	DT
25944	1048	10	drachm	drachm	NN
25944	1048	11	to	to	IN
25944	1048	12	the	the	DT
25944	1048	13	ounce	ounce	NN
25944	1048	14	;	;	:
25944	1048	15	this	this	DT
25944	1048	16	is	be	VBZ
25944	1048	17	painted	paint	VBN
25944	1048	18	on	on	IN
25944	1048	19	,	,	,
25944	1048	20	the	the	DT
25944	1048	21	chloroform	chloroform	NN
25944	1048	22	evaporating	evaporating	NN
25944	1048	23	,	,	,
25944	1048	24	leaving	leave	VBG
25944	1048	25	a	a	DT
25944	1048	26	thin	thin	JJ
25944	1048	27	film	film	NN
25944	1048	28	of	of	IN
25944	1048	29	chrysarobin	chrysarobin	NNP
25944	1048	30	;	;	:
25944	1048	31	over	over	IN
25944	1048	32	this	this	DT
25944	1048	33	is	be	VBZ
25944	1048	34	painted	paint	VBN
25944	1048	35	flexible	flexible	JJ
25944	1048	36	collodion	collodion	NN
25944	1048	37	.	.	.
25944	1049	1	If	if	IN
25944	1049	2	the	the	DT
25944	1049	3	patches	patch	NNS
25944	1049	4	are	be	VBP
25944	1049	5	few	few	JJ
25944	1049	6	and	and	CC
25944	1049	7	large	large	JJ
25944	1049	8	,	,	,
25944	1049	9	chrysarobin	chrysarobin	NNP
25944	1049	10	rubber	rubber	NN
25944	1049	11	-	-	HYPH
25944	1049	12	plaster	plaster	NN
25944	1049	13	may	may	MD
25944	1049	14	be	be	VB
25944	1049	15	used	use	VBN
25944	1049	16	.	.	.
25944	1050	1	Chrysarobin	Chrysarobin	NNP
25944	1050	2	is	be	VBZ
25944	1050	3	usually	usually	RB
25944	1050	4	rapid	rapid	JJ
25944	1050	5	in	in	IN
25944	1050	6	its	-PRON-	PRP$
25944	1050	7	effect	effect	NN
25944	1050	8	,	,	,
25944	1050	9	but	but	CC
25944	1050	10	it	-PRON-	PRP
25944	1050	11	has	have	VBZ
25944	1050	12	certain	certain	JJ
25944	1050	13	disadvantages	disadvantage	NNS
25944	1050	14	;	;	:
25944	1050	15	it	-PRON-	PRP
25944	1050	16	may	may	MD
25944	1050	17	cause	cause	VB
25944	1050	18	an	an	DT
25944	1050	19	inflammation	inflammation	NN
25944	1050	20	of	of	IN
25944	1050	21	the	the	DT
25944	1050	22	surrounding	surround	VBG
25944	1050	23	skin	skin	NN
25944	1050	24	,	,	,
25944	1050	25	and	and	CC
25944	1050	26	,	,	,
25944	1050	27	if	if	IN
25944	1050	28	used	use	VBN
25944	1050	29	near	near	IN
25944	1050	30	the	the	DT
25944	1050	31	eyes	eye	NNS
25944	1050	32	,	,	,
25944	1050	33	may	may	MD
25944	1050	34	give	give	VB
25944	1050	35	rise	rise	NN
25944	1050	36	to	to	IN
25944	1050	37	conjunctivitis	conjunctivitis	NNP
25944	1050	38	.	.	.
25944	1051	1	As	as	IN
25944	1051	2	a	a	DT
25944	1051	3	rule	rule	NN
25944	1051	4	,	,	,
25944	1051	5	it	-PRON-	PRP
25944	1051	6	should	should	MD
25944	1051	7	not	not	RB
25944	1051	8	be	be	VB
25944	1051	9	employed	employ	VBN
25944	1051	10	about	about	IN
25944	1051	11	the	the	DT
25944	1051	12	head	head	NN
25944	1051	13	.	.	.
25944	1052	1	Moreover	moreover	RB
25944	1052	2	,	,	,
25944	1052	3	it	-PRON-	PRP
25944	1052	4	stains	stain	VBZ
25944	1052	5	the	the	DT
25944	1052	6	linen	linen	NN
25944	1052	7	permanently	permanently	RB
25944	1052	8	and	and	CC
25944	1052	9	the	the	DT
25944	1052	10	skin	skin	NN
25944	1052	11	temporarily	temporarily	RB
25944	1052	12	.	.	.
25944	1053	1	_	_	NNP
25944	1053	2	Pyrogallol	Pyrogallol	NNP
25944	1053	3	_	_	NNP
25944	1053	4	is	be	VBZ
25944	1053	5	valuable	valuable	JJ
25944	1053	6	,	,	,
25944	1053	7	and	and	CC
25944	1053	8	is	be	VBZ
25944	1053	9	employed	employ	VBN
25944	1053	10	in	in	IN
25944	1053	11	the	the	DT
25944	1053	12	same	same	JJ
25944	1053	13	manner	manner	NN
25944	1053	14	and	and	CC
25944	1053	15	strength	strength	NN
25944	1053	16	as	as	IN
25944	1053	17	chrysarobin	chrysarobin	NNP
25944	1053	18	.	.	.
25944	1054	1	In	in	IN
25944	1054	2	collodion	collodion	NN
25944	1054	3	it	-PRON-	PRP
25944	1054	4	should	should	MD
25944	1054	5	at	at	IN
25944	1054	6	first	first	RB
25944	1054	7	not	not	RB
25944	1054	8	be	be	VB
25944	1054	9	used	use	VBN
25944	1054	10	of	of	IN
25944	1054	11	greater	great	JJR
25944	1054	12	strength	strength	NN
25944	1054	13	than	than	IN
25944	1054	14	three	three	CD
25944	1054	15	to	to	TO
25944	1054	16	four	four	CD
25944	1054	17	per	per	IN
25944	1054	18	cent	cent	NN
25944	1054	19	.	.	.
25944	1054	20	,	,	,
25944	1054	21	as	as	IN
25944	1054	22	in	in	IN
25944	1054	23	this	this	DT
25944	1054	24	form	form	NN
25944	1054	25	pyrogallol	pyrogallol	NN
25944	1054	26	sometimes	sometimes	RB
25944	1054	27	acts	act	VBZ
25944	1054	28	with	with	IN
25944	1054	29	unexpected	unexpected	JJ
25944	1054	30	energy	energy	NN
25944	1054	31	.	.	.
25944	1055	1	It	-PRON-	PRP
25944	1055	2	is	be	VBZ
25944	1055	3	less	less	RBR
25944	1055	4	rapid	rapid	JJ
25944	1055	5	than	than	IN
25944	1055	6	chrysarobin	chrysarobin	NNP
25944	1055	7	,	,	,
25944	1055	8	but	but	CC
25944	1055	9	it	-PRON-	PRP
25944	1055	10	rarely	rarely	RB
25944	1055	11	inflames	inflame	VBZ
25944	1055	12	the	the	DT
25944	1055	13	surrounding	surround	VBG
25944	1055	14	integument	integument	NN
25944	1055	15	.	.	.
25944	1056	1	It	-PRON-	PRP
25944	1056	2	stains	stain	VBZ
25944	1056	3	the	the	DT
25944	1056	4	linen	linen	NN
25944	1056	5	a	a	DT
25944	1056	6	light	light	JJ
25944	1056	7	brown	brown	NN
25944	1056	8	,	,	,
25944	1056	9	however	however	RB
25944	1056	10	,	,	,
25944	1056	11	and	and	CC
25944	1056	12	is	be	VBZ
25944	1056	13	not	not	RB
25944	1056	14	to	to	TO
25944	1056	15	be	be	VB
25944	1056	16	used	use	VBN
25944	1056	17	over	over	IN
25944	1056	18	an	an	DT
25944	1056	19	extensive	extensive	JJ
25944	1056	20	surface	surface	NN
25944	1056	21	for	for	IN
25944	1056	22	fear	fear	NN
25944	1056	23	of	of	IN
25944	1056	24	absorption	absorption	NN
25944	1056	25	and	and	CC
25944	1056	26	toxic	toxic	JJ
25944	1056	27	effect	effect	NN
25944	1056	28	.	.	.
25944	1057	1	Oxidized	oxidize	VBN
25944	1057	2	pyrogallic	pyrogallic	NN
25944	1057	3	acid	acid	NN
25944	1057	4	,	,	,
25944	1057	5	a	a	DT
25944	1057	6	somewhat	somewhat	RB
25944	1057	7	milder	milder	JJ
25944	1057	8	drug	drug	NN
25944	1057	9	in	in	IN
25944	1057	10	its	-PRON-	PRP$
25944	1057	11	effect	effect	NN
25944	1057	12	,	,	,
25944	1057	13	has	have	VBZ
25944	1057	14	been	be	VBN
25944	1057	15	highly	highly	RB
25944	1057	16	commended	commend	VBN
25944	1057	17	,	,	,
25944	1057	18	and	and	CC
25944	1057	19	has	have	VBZ
25944	1057	20	the	the	DT
25944	1057	21	alleged	allege	VBN
25944	1057	22	advantage	advantage	NN
25944	1057	23	of	of	IN
25944	1057	24	being	be	VBG
25944	1057	25	free	free	JJ
25944	1057	26	from	from	IN
25944	1057	27	toxic	toxic	JJ
25944	1057	28	action	action	NN
25944	1057	29	.	.	.
25944	1058	1	_	_	NNP
25944	1058	2	Tar	Tar	NNP
25944	1058	3	_	_	NNP
25944	1058	4	is	be	VBZ
25944	1058	5	,	,	,
25944	1058	6	all	all	DT
25944	1058	7	things	thing	NNS
25944	1058	8	considered	consider	VBN
25944	1058	9	,	,	,
25944	1058	10	the	the	DT
25944	1058	11	most	most	RBS
25944	1058	12	important	important	JJ
25944	1058	13	external	external	JJ
25944	1058	14	remedy	remedy	NN
25944	1058	15	.	.	.
25944	1059	1	It	-PRON-	PRP
25944	1059	2	is	be	VBZ
25944	1059	3	comparatively	comparatively	RB
25944	1059	4	slow	slow	JJ
25944	1059	5	in	in	IN
25944	1059	6	its	-PRON-	PRP$
25944	1059	7	action	action	NN
25944	1059	8	,	,	,
25944	1059	9	but	but	CC
25944	1059	10	is	be	VBZ
25944	1059	11	useful	useful	JJ
25944	1059	12	in	in	IN
25944	1059	13	almost	almost	RB
25944	1059	14	all	all	DT
25944	1059	15	cases	case	NNS
25944	1059	16	.	.	.
25944	1060	1	As	as	IN
25944	1060	2	employed	employ	VBN
25944	1060	3	usually	usually	RB
25944	1060	4	it	-PRON-	PRP
25944	1060	5	is	be	VBZ
25944	1060	6	prescribed	prescribe	VBN
25944	1060	7	in	in	IN
25944	1060	8	ointment	ointment	NN
25944	1060	9	form	form	NN
25944	1060	10	,	,	,
25944	1060	11	either	either	CC
25944	1060	12	as	as	IN
25944	1060	13	the	the	DT
25944	1060	14	official	official	JJ
25944	1060	15	tar	tar	NN
25944	1060	16	ointment	ointment	NN
25944	1060	17	,	,	,
25944	1060	18	full	full	JJ
25944	1060	19	strength	strength	NN
25944	1060	20	or	or	CC
25944	1060	21	weakened	weaken	VBN
25944	1060	22	with	with	IN
25944	1060	23	lard	lard	NN
25944	1060	24	or	or	CC
25944	1060	25	petrolatum	petrolatum	NN
25944	1060	26	.	.	.
25944	1061	1	It	-PRON-	PRP
25944	1061	2	may	may	MD
25944	1061	3	also	also	RB
25944	1061	4	be	be	VB
25944	1061	5	used	use	VBN
25944	1061	6	as	as	IN
25944	1061	7	pix	pix	NNP
25944	1061	8	liquida	liquida	NNP
25944	1061	9	,	,	,
25944	1061	10	with	with	IN
25944	1061	11	equal	equal	JJ
25944	1061	12	part	part	NN
25944	1061	13	of	of	IN
25944	1061	14	alcohol	alcohol	NN
25944	1061	15	.	.	.
25944	1062	1	Or	or	CC
25944	1062	2	the	the	DT
25944	1062	3	tar	tar	NN
25944	1062	4	oils	oil	NNS
25944	1062	5	,	,	,
25944	1062	6	oil	oil	NN
25944	1062	7	of	of	IN
25944	1062	8	cade	cade	NNP
25944	1062	9	(	(	-LRB-
25944	1062	10	ol	old	NNP
25944	1062	11	.	.	.
25944	1063	1	cadini	cadini	NNP
25944	1063	2	)	)	-RRB-
25944	1063	3	,	,	,
25944	1063	4	and	and	CC
25944	1063	5	oil	oil	NN
25944	1063	6	of	of	IN
25944	1063	7	birch	birch	NNP
25944	1063	8	(	(	-LRB-
25944	1063	9	ol	old	JJ
25944	1063	10	.	.	.
25944	1064	1	rusci	rusci	NNP
25944	1064	2	)	)	-RRB-
25944	1064	3	may	may	MD
25944	1064	4	be	be	VB
25944	1064	5	employed	employ	VBN
25944	1064	6	,	,	,
25944	1064	7	either	either	CC
25944	1064	8	as	as	IN
25944	1064	9	oily	oily	JJ
25944	1064	10	applications	application	NNS
25944	1064	11	or	or	CC
25944	1064	12	incorporated	incorporate	VBN
25944	1064	13	with	with	IN
25944	1064	14	ointment	ointment	NN
25944	1064	15	or	or	CC
25944	1064	16	with	with	IN
25944	1064	17	alcohol	alcohol	NN
25944	1064	18	.	.	.
25944	1065	1	Liquor	liquor	NN
25944	1065	2	carbonis	carbonis	NN
25944	1065	3	detergens	detergen	NNS
25944	1065	4	,	,	,
25944	1065	5	in	in	IN
25944	1065	6	ointment	ointment	NN
25944	1065	7	,	,	,
25944	1065	8	one	one	CD
25944	1065	9	to	to	TO
25944	1065	10	three	three	CD
25944	1065	11	drachms	drachm	NNS
25944	1065	12	to	to	IN
25944	1065	13	the	the	DT
25944	1065	14	ounce	ounce	NN
25944	1065	15	of	of	IN
25944	1065	16	simple	simple	JJ
25944	1065	17	cerate	cerate	NN
25944	1065	18	and	and	CC
25944	1065	19	lanolin	lanolin	NN
25944	1065	20	is	be	VBZ
25944	1065	21	a	a	DT
25944	1065	22	mild	mild	JJ
25944	1065	23	tarry	tarry	NN
25944	1065	24	application	application	NN
25944	1065	25	which	which	WDT
25944	1065	26	is	be	VBZ
25944	1065	27	often	often	RB
25944	1065	28	useful	useful	JJ
25944	1065	29	.	.	.
25944	1066	1	In	in	IN
25944	1066	2	stubborn	stubborn	JJ
25944	1066	3	patches	patch	NNS
25944	1066	4	an	an	DT
25944	1066	5	occasional	occasional	JJ
25944	1066	6	thorough	thorough	NN
25944	1066	7	rubbing	rub	VBG
25944	1066	8	with	with	IN
25944	1066	9	a	a	DT
25944	1066	10	mixture	mixture	NN
25944	1066	11	of	of	IN
25944	1066	12	equal	equal	JJ
25944	1066	13	parts	part	NNS
25944	1066	14	of	of	IN
25944	1066	15	liquor	liquor	NN
25944	1066	16	carbonis	carbonis	NN
25944	1066	17	detergens	detergen	NNS
25944	1066	18	and	and	CC
25944	1066	19	Vleminckx	Vleminckx	NNP
25944	1066	20	's	's	POS
25944	1066	21	solution	solution	NN
25944	1066	22	,	,	,
25944	1066	23	followed	follow	VBN
25944	1066	24	by	by	IN
25944	1066	25	a	a	DT
25944	1066	26	mild	mild	JJ
25944	1066	27	ointment	ointment	NN
25944	1066	28	,	,	,
25944	1066	29	sometimes	sometimes	RB
25944	1066	30	proves	prove	VBZ
25944	1066	31	of	of	IN
25944	1066	32	value	value	NN
25944	1066	33	.	.	.
25944	1067	1	In	in	IN
25944	1067	2	whatsoever	whatsoever	JJ
25944	1067	3	form	form	NN
25944	1067	4	tar	tar	NN
25944	1067	5	is	be	VBZ
25944	1067	6	employed	employ	VBN
25944	1067	7	it	-PRON-	PRP
25944	1067	8	should	should	MD
25944	1067	9	be	be	VB
25944	1067	10	thoroughly	thoroughly	RB
25944	1067	11	rubbed	rub	VBN
25944	1067	12	in	in	IN
25944	1067	13	,	,	,
25944	1067	14	once	once	RB
25944	1067	15	or	or	CC
25944	1067	16	twice	twice	RB
25944	1067	17	daily	daily	RB
25944	1067	18	,	,	,
25944	1067	19	the	the	DT
25944	1067	20	excess	excess	NN
25944	1067	21	wiped	wipe	VBN
25944	1067	22	off	off	RP
25944	1067	23	,	,	,
25944	1067	24	and	and	CC
25944	1067	25	the	the	DT
25944	1067	26	parts	part	NNS
25944	1067	27	then	then	RB
25944	1067	28	dusted	dust	VBD
25944	1067	29	with	with	IN
25944	1067	30	starch	starch	NN
25944	1067	31	or	or	CC
25944	1067	32	similar	similar	JJ
25944	1067	33	powder	powder	NN
25944	1067	34	.	.	.
25944	1068	1	_	_	NNP
25944	1068	2	Ammoniated	Ammoniated	NNP
25944	1068	3	mercury	mercury	NN
25944	1068	4	_	_	NNP
25944	1068	5	is	be	VBZ
25944	1068	6	applied	apply	VBN
25944	1068	7	in	in	IN
25944	1068	8	ointment	ointment	NN
25944	1068	9	form	form	NN
25944	1068	10	,	,	,
25944	1068	11	twenty	twenty	CD
25944	1068	12	to	to	TO
25944	1068	13	sixty	sixty	CD
25944	1068	14	grains	grain	NNS
25944	1068	15	to	to	IN
25944	1068	16	the	the	DT
25944	1068	17	ounce	ounce	NN
25944	1068	18	.	.	.
25944	1069	1	Compared	compare	VBN
25944	1069	2	to	to	IN
25944	1069	3	other	other	JJ
25944	1069	4	remedies	remedy	NNS
25944	1069	5	it	-PRON-	PRP
25944	1069	6	is	be	VBZ
25944	1069	7	clean	clean	JJ
25944	1069	8	and	and	CC
25944	1069	9	free	free	JJ
25944	1069	10	from	from	IN
25944	1069	11	staining	stain	VBG
25944	1069	12	,	,	,
25944	1069	13	although	although	IN
25944	1069	14	,	,	,
25944	1069	15	as	as	IN
25944	1069	16	a	a	DT
25944	1069	17	rule	rule	NN
25944	1069	18	,	,	,
25944	1069	19	not	not	RB
25944	1069	20	so	so	RB
25944	1069	21	uniformly	uniformly	RB
25944	1069	22	efficacious	efficacious	JJ
25944	1069	23	.	.	.
25944	1070	1	It	-PRON-	PRP
25944	1070	2	is	be	VBZ
25944	1070	3	especially	especially	RB
25944	1070	4	useful	useful	JJ
25944	1070	5	for	for	IN
25944	1070	6	application	application	NN
25944	1070	7	to	to	IN
25944	1070	8	the	the	DT
25944	1070	9	scalp	scalp	NN
25944	1070	10	and	and	CC
25944	1070	11	exposed	expose	VBN
25944	1070	12	parts	part	NNS
25944	1070	13	.	.	.
25944	1071	1	It	-PRON-	PRP
25944	1071	2	should	should	MD
25944	1071	3	not	not	RB
25944	1071	4	be	be	VB
25944	1071	5	used	use	VBN
25944	1071	6	over	over	IN
25944	1071	7	extensive	extensive	JJ
25944	1071	8	surface	surface	NN
25944	1071	9	for	for	IN
25944	1071	10	fear	fear	NN
25944	1071	11	of	of	IN
25944	1071	12	absorption	absorption	NN
25944	1071	13	.	.	.
25944	1072	1	_	_	NNP
25944	1072	2	[	[	-LRB-
25944	1072	3	beta]-Naphthol	beta]-Naphthol	NNP
25944	1072	4	_	_	NNP
25944	1072	5	and	and	CC
25944	1072	6	_	_	NNP
25944	1072	7	resorcin	resorcin	NNPS
25944	1072	8	_	_	NNP
25944	1072	9	are	be	VBP
25944	1072	10	applied	apply	VBN
25944	1072	11	as	as	IN
25944	1072	12	ointments	ointment	NNS
25944	1072	13	,	,	,
25944	1072	14	thirty	thirty	CD
25944	1072	15	to	to	TO
25944	1072	16	sixty	sixty	CD
25944	1072	17	grains	grain	NNS
25944	1072	18	to	to	IN
25944	1072	19	the	the	DT
25944	1072	20	ounce	ounce	NN
25944	1072	21	,	,	,
25944	1072	22	and	and	CC
25944	1072	23	as	as	IN
25944	1072	24	they	-PRON-	PRP
25944	1072	25	are	be	VBP
25944	1072	26	(	(	-LRB-
25944	1072	27	especially	especially	RB
25944	1072	28	the	the	DT
25944	1072	29	former	former	JJ
25944	1072	30	)	)	-RRB-
25944	1072	31	practically	practically	RB
25944	1072	32	free	free	JJ
25944	1072	33	from	from	IN
25944	1072	34	staining	stain	VBG
25944	1072	35	,	,	,
25944	1072	36	may	may	MD
25944	1072	37	be	be	VB
25944	1072	38	used	use	VBN
25944	1072	39	for	for	IN
25944	1072	40	exposed	expose	VBN
25944	1072	41	surfaces	surface	NNS
25944	1072	42	.	.	.
25944	1073	1	Gallacetophenone	Gallacetophenone	NNP
25944	1073	2	and	and	CC
25944	1073	3	aristol	aristol	NNP
25944	1073	4	also	also	RB
25944	1073	5	act	act	VBP
25944	1073	6	well	well	RB
25944	1073	7	in	in	IN
25944	1073	8	some	some	DT
25944	1073	9	cases	case	NNS
25944	1073	10	,	,	,
25944	1073	11	applied	apply	VBN
25944	1073	12	in	in	IN
25944	1073	13	five-	five-	JJ
25944	1073	14	to	to	IN
25944	1073	15	ten	ten	CD
25944	1073	16	-	-	HYPH
25944	1073	17	per	per	IN
25944	1073	18	-	-	HYPH
25944	1073	19	cent	cent	NN
25944	1073	20	.	.	.
25944	1074	1	strength	strength	NN
25944	1074	2	,	,	,
25944	1074	3	as	as	IN
25944	1074	4	ointments	ointment	NNS
25944	1074	5	.	.	.
25944	1075	1	In	in	IN
25944	1075	2	obstinate	obstinate	NN
25944	1075	3	patches	patch	VBZ
25944	1075	4	the	the	DT
25944	1075	5	_	_	NNP
25944	1075	6	x_-ray	x_-ray	NN
25944	1075	7	may	may	MD
25944	1075	8	be	be	VB
25944	1075	9	resorted	resort	VBN
25944	1075	10	to	to	IN
25944	1075	11	,	,	,
25944	1075	12	employing	employ	VBG
25944	1075	13	it	-PRON-	PRP
25944	1075	14	with	with	IN
25944	1075	15	caution	caution	NN
25944	1075	16	and	and	CC
25944	1075	17	in	in	IN
25944	1075	18	the	the	DT
25944	1075	19	same	same	JJ
25944	1075	20	manner	manner	NN
25944	1075	21	as	as	IN
25944	1075	22	in	in	IN
25944	1075	23	other	other	JJ
25944	1075	24	diseases	disease	NNS
25944	1075	25	.	.	.
25944	1076	1	#	#	NNP
25944	1076	2	Pityriasis	Pityriasis	NNP
25944	1076	3	Rosea	Rosea	NNP
25944	1076	4	.	.	.
25944	1076	5	#	#	NNP
25944	1076	6	(	(	-LRB-
25944	1076	7	_	_	NNP
25944	1076	8	Synonym	Synonym	NNP
25944	1076	9	:	:	:
25944	1076	10	_	_	NNP
25944	1076	11	Pityriasis	Pityriasis	NNP
25944	1076	12	Maculata	Maculata	NNP
25944	1076	13	et	et	NNP
25944	1076	14	Circinata	Circinata	NNP
25944	1076	15	.	.	.
25944	1076	16	)	)	-RRB-
25944	1077	1	#	#	LS
25944	1077	2	What	what	WP
25944	1077	3	do	do	VBP
25944	1077	4	you	-PRON-	PRP
25944	1077	5	understand	understand	VB
25944	1077	6	by	by	IN
25944	1077	7	pityriasis	pityriasis	NN
25944	1077	8	rosea	rosea	NN
25944	1077	9	?	?	.
25944	1077	10	#	#	$
25944	1077	11	Pityriasis	Pityriasis	NNP
25944	1077	12	rosea	rosea	NN
25944	1077	13	is	be	VBZ
25944	1077	14	a	a	DT
25944	1077	15	disease	disease	NN
25944	1077	16	of	of	IN
25944	1077	17	a	a	DT
25944	1077	18	mildly	mildly	RB
25944	1077	19	inflammatory	inflammatory	JJ
25944	1077	20	nature	nature	NN
25944	1077	21	,	,	,
25944	1077	22	characterized	characterize	VBN
25944	1077	23	by	by	IN
25944	1077	24	discrete	discrete	JJ
25944	1077	25	,	,	,
25944	1077	26	and	and	CC
25944	1077	27	later	later	RB
25944	1077	28	frequently	frequently	RB
25944	1077	29	confluent	confluent	JJ
25944	1077	30	,	,	,
25944	1077	31	variously	variously	RB
25944	1077	32	sized	sized	JJ
25944	1077	33	,	,	,
25944	1077	34	slightly	slightly	RB
25944	1077	35	raised	raise	VBN
25944	1077	36	scaly	scaly	IN
25944	1077	37	macules	macule	NNS
25944	1077	38	of	of	IN
25944	1077	39	a	a	DT
25944	1077	40	pinkish	pinkish	NN
25944	1077	41	to	to	IN
25944	1077	42	rosy	rosy	JJ
25944	1077	43	-	-	HYPH
25944	1077	44	red	red	JJ
25944	1077	45	,	,	,
25944	1077	46	often	often	RB
25944	1077	47	salmon	salmon	NN
25944	1077	48	-	-	HYPH
25944	1077	49	tinged	tinge	VBN
25944	1077	50	,	,	,
25944	1077	51	color	color	NN
25944	1077	52	.	.	.
25944	1078	1	#	#	NN
25944	1078	2	Upon	upon	IN
25944	1078	3	what	what	WP
25944	1078	4	part	part	NN
25944	1078	5	of	of	IN
25944	1078	6	the	the	DT
25944	1078	7	body	body	NN
25944	1078	8	is	be	VBZ
25944	1078	9	the	the	DT
25944	1078	10	eruption	eruption	NN
25944	1078	11	usually	usually	RB
25944	1078	12	found	find	VBN
25944	1078	13	?	?	.
25944	1078	14	#	#	$
25944	1078	15	The	the	DT
25944	1078	16	trunk	trunk	NN
25944	1078	17	is	be	VBZ
25944	1078	18	the	the	DT
25944	1078	19	chief	chief	JJ
25944	1078	20	seat	seat	NN
25944	1078	21	of	of	IN
25944	1078	22	the	the	DT
25944	1078	23	eruption	eruption	NN
25944	1078	24	,	,	,
25944	1078	25	although	although	IN
25944	1078	26	not	not	RB
25944	1078	27	infrequently	infrequently	RB
25944	1078	28	it	-PRON-	PRP
25944	1078	29	is	be	VBZ
25944	1078	30	more	more	RBR
25944	1078	31	or	or	CC
25944	1078	32	less	less	RBR
25944	1078	33	general	general	JJ
25944	1078	34	.	.	.
25944	1079	1	#	#	NNP
25944	1079	2	Describe	describe	VB
25944	1079	3	the	the	DT
25944	1079	4	symptoms	symptom	NNS
25944	1079	5	of	of	IN
25944	1079	6	pityriasis	pityriasis	NN
25944	1079	7	rosea	rosea	NN
25944	1079	8	.	.	.
25944	1079	9	#	#	$
25944	1079	10	The	the	DT
25944	1079	11	lesions	lesion	NNS
25944	1079	12	,	,	,
25944	1079	13	which	which	WDT
25944	1079	14	appear	appear	VBP
25944	1079	15	rapidly	rapidly	RB
25944	1079	16	or	or	CC
25944	1079	17	slowly	slowly	RB
25944	1079	18	,	,	,
25944	1079	19	are	be	VBP
25944	1079	20	but	but	CC
25944	1079	21	slightly	slightly	RB
25944	1079	22	elevated	elevated	JJ
25944	1079	23	,	,	,
25944	1079	24	somewhat	somewhat	RB
25944	1079	25	scaly	scaly	NNP
25944	1079	26	,	,	,
25944	1079	27	usually	usually	RB
25944	1079	28	rounded	round	VBN
25944	1079	29	,	,	,
25944	1079	30	except	except	IN
25944	1079	31	when	when	WRB
25944	1079	32	several	several	JJ
25944	1079	33	coalesce	coalesce	NN
25944	1079	34	,	,	,
25944	1079	35	when	when	WRB
25944	1079	36	an	an	DT
25944	1079	37	irregularly	irregularly	RB
25944	1079	38	outlined	outline	VBN
25944	1079	39	patch	patch	NN
25944	1079	40	results	result	NNS
25944	1079	41	.	.	.
25944	1080	1	At	at	IN
25944	1080	2	first	first	RB
25944	1080	3	they	-PRON-	PRP
25944	1080	4	are	be	VBP
25944	1080	5	pale	pale	JJ
25944	1080	6	or	or	CC
25944	1080	7	bright	bright	JJ
25944	1080	8	pink	pink	JJ
25944	1080	9	or	or	CC
25944	1080	10	reddish	reddish	JJ
25944	1080	11	,	,	,
25944	1080	12	later	later	RB
25944	1080	13	a	a	DT
25944	1080	14	salmon	salmon	NN
25944	1080	15	tint	tint	NN
25944	1080	16	(	(	-LRB-
25944	1080	17	which	which	WDT
25944	1080	18	is	be	VBZ
25944	1080	19	often	often	RB
25944	1080	20	characteristic	characteristic	JJ
25944	1080	21	)	)	-RRB-
25944	1080	22	is	be	VBZ
25944	1080	23	noticed	notice	VBN
25944	1080	24	.	.	.
25944	1081	1	The	the	DT
25944	1081	2	scaliness	scaliness	NN
25944	1081	3	is	be	VBZ
25944	1081	4	bran	bran	NN
25944	1081	5	-	-	HYPH
25944	1081	6	like	like	JJ
25944	1081	7	or	or	CC
25944	1081	8	flaky	flaky	JJ
25944	1081	9	,	,	,
25944	1081	10	of	of	IN
25944	1081	11	a	a	DT
25944	1081	12	dirty	dirty	JJ
25944	1081	13	gray	gray	JJ
25944	1081	14	color	color	NN
25944	1081	15	,	,	,
25944	1081	16	and	and	CC
25944	1081	17	,	,	,
25944	1081	18	as	as	IN
25944	1081	19	a	a	DT
25944	1081	20	rule	rule	NN
25944	1081	21	,	,	,
25944	1081	22	less	less	RBR
25944	1081	23	marked	mark	VBN
25944	1081	24	in	in	IN
25944	1081	25	the	the	DT
25944	1081	26	central	central	JJ
25944	1081	27	portion	portion	NN
25944	1081	28	;	;	:
25944	1081	29	it	-PRON-	PRP
25944	1081	30	is	be	VBZ
25944	1081	31	never	never	RB
25944	1081	32	abundant	abundant	JJ
25944	1081	33	.	.	.
25944	1082	1	The	the	DT
25944	1082	2	skin	skin	NN
25944	1082	3	is	be	VBZ
25944	1082	4	rarely	rarely	RB
25944	1082	5	thickened	thicken	VBN
25944	1082	6	,	,	,
25944	1082	7	the	the	DT
25944	1082	8	process	process	NN
25944	1082	9	being	be	VBG
25944	1082	10	usually	usually	RB
25944	1082	11	exceedingly	exceedingly	RB
25944	1082	12	superficial	superficial	JJ
25944	1082	13	.	.	.
25944	1083	1	#	#	LS
25944	1083	2	What	what	WDT
25944	1083	3	course	course	NN
25944	1083	4	does	do	VBZ
25944	1083	5	pityriasis	pityriasis	NN
25944	1083	6	rosea	rosea	NN
25944	1083	7	pursue	pursue	NN
25944	1083	8	?	?	.
25944	1083	9	#	#	$
25944	1083	10	The	the	DT
25944	1083	11	eruption	eruption	NN
25944	1083	12	makes	make	VBZ
25944	1083	13	its	-PRON-	PRP$
25944	1083	14	appearance	appearance	NN
25944	1083	15	,	,	,
25944	1083	16	as	as	IN
25944	1083	17	a	a	DT
25944	1083	18	rule	rule	NN
25944	1083	19	,	,	,
25944	1083	20	somewhat	somewhat	RB
25944	1083	21	rapidly	rapidly	RB
25944	1083	22	,	,	,
25944	1083	23	usually	usually	RB
25944	1083	24	attaining	attain	VBG
25944	1083	25	its	-PRON-	PRP$
25944	1083	26	full	full	JJ
25944	1083	27	development	development	NN
25944	1083	28	in	in	IN
25944	1083	29	the	the	DT
25944	1083	30	course	course	NN
25944	1083	31	of	of	IN
25944	1083	32	one	one	CD
25944	1083	33	or	or	CC
25944	1083	34	two	two	CD
25944	1083	35	weeks	week	NNS
25944	1083	36	,	,	,
25944	1083	37	and	and	CC
25944	1083	38	then	then	RB
25944	1083	39	begins	begin	VBZ
25944	1083	40	gradually	gradually	RB
25944	1083	41	to	to	TO
25944	1083	42	decline	decline	VB
25944	1083	43	,	,	,
25944	1083	44	the	the	DT
25944	1083	45	whole	whole	JJ
25944	1083	46	process	process	NN
25944	1083	47	occupying	occupy	VBG
25944	1083	48	one	one	CD
25944	1083	49	or	or	CC
25944	1083	50	two	two	CD
25944	1083	51	months	month	NNS
25944	1083	52	.	.	.
25944	1084	1	#	#	JJR
25944	1084	2	To	to	IN
25944	1084	3	what	what	WP
25944	1084	4	is	be	VBZ
25944	1084	5	pityriasis	pityriasis	NN
25944	1084	6	rosea	rosea	NN
25944	1084	7	to	to	TO
25944	1084	8	be	be	VB
25944	1084	9	attributed	attribute	VBN
25944	1084	10	?	?	.
25944	1084	11	#	#	$
25944	1084	12	The	the	DT
25944	1084	13	cause	cause	NN
25944	1084	14	is	be	VBZ
25944	1084	15	not	not	RB
25944	1084	16	known	know	VBN
25944	1084	17	;	;	:
25944	1084	18	it	-PRON-	PRP
25944	1084	19	is	be	VBZ
25944	1084	20	variously	variously	RB
25944	1084	21	considered	consider	VBN
25944	1084	22	as	as	IN
25944	1084	23	allied	allied	JJ
25944	1084	24	to	to	IN
25944	1084	25	seborrh[oe]a	seborrh[oe]a	NNP
25944	1084	26	(	(	-LRB-
25944	1084	27	eczema	eczema	NNP
25944	1084	28	seborrhoicum	seborrhoicum	JJ
25944	1084	29	)	)	-RRB-
25944	1084	30	,	,	,
25944	1084	31	as	as	IN
25944	1084	32	being	be	VBG
25944	1084	33	of	of	IN
25944	1084	34	a	a	DT
25944	1084	35	vegetable	vegetable	NN
25944	1084	36	-	-	HYPH
25944	1084	37	parasitic	parasitic	JJ
25944	1084	38	origin	origin	NN
25944	1084	39	,	,	,
25944	1084	40	and	and	CC
25944	1084	41	as	as	IN
25944	1084	42	a	a	DT
25944	1084	43	mildly	mildly	RB
25944	1084	44	inflammatory	inflammatory	JJ
25944	1084	45	affection	affection	NN
25944	1084	46	somewhat	somewhat	RB
25944	1084	47	similar	similar	JJ
25944	1084	48	to	to	IN
25944	1084	49	psoriasis	psoriasis	NN
25944	1084	50	.	.	.
25944	1085	1	It	-PRON-	PRP
25944	1085	2	is	be	VBZ
25944	1085	3	not	not	RB
25944	1085	4	a	a	DT
25944	1085	5	frequent	frequent	JJ
25944	1085	6	disease	disease	NN
25944	1085	7	.	.	.
25944	1086	1	#	#	NNP
25944	1086	2	How	how	WRB
25944	1086	3	is	be	VBZ
25944	1086	4	pityriasis	pityriasis	NN
25944	1086	5	rosea	rosea	NN
25944	1086	6	distinguished	distinguish	VBN
25944	1086	7	from	from	IN
25944	1086	8	ringworm	ringworm	NN
25944	1086	9	,	,	,
25944	1086	10	psoriasis	psoriasis	NN
25944	1086	11	and	and	CC
25944	1086	12	the	the	DT
25944	1086	13	squamous	squamous	JJ
25944	1086	14	syphiloderm	syphiloderm	NN
25944	1086	15	?	?	.
25944	1086	16	#	#	$
25944	1086	17	From	from	TO
25944	1086	18	ringworm	ringworm	VB
25944	1086	19	,	,	,
25944	1086	20	by	by	IN
25944	1086	21	its	-PRON-	PRP$
25944	1086	22	rapid	rapid	JJ
25944	1086	23	appearance	appearance	NN
25944	1086	24	,	,	,
25944	1086	25	its	-PRON-	PRP$
25944	1086	26	distribution	distribution	NN
25944	1086	27	,	,	,
25944	1086	28	the	the	DT
25944	1086	29	number	number	NN
25944	1086	30	of	of	IN
25944	1086	31	patches	patch	NNS
25944	1086	32	,	,	,
25944	1086	33	and	and	CC
25944	1086	34	,	,	,
25944	1086	35	if	if	IN
25944	1086	36	necessary	necessary	JJ
25944	1086	37	,	,	,
25944	1086	38	by	by	IN
25944	1086	39	microscopic	microscopic	JJ
25944	1086	40	examination	examination	NN
25944	1086	41	of	of	IN
25944	1086	42	the	the	DT
25944	1086	43	scrapings	scraping	NNS
25944	1086	44	.	.	.
25944	1087	1	Psoriasis	psoriasis	NN
25944	1087	2	is	be	VBZ
25944	1087	3	a	a	DT
25944	1087	4	more	more	RBR
25944	1087	5	inflammatory	inflammatory	JJ
25944	1087	6	disease	disease	NN
25944	1087	7	,	,	,
25944	1087	8	is	be	VBZ
25944	1087	9	seen	see	VBN
25944	1087	10	usually	usually	RB
25944	1087	11	more	more	RBR
25944	1087	12	abundantly	abundantly	RB
25944	1087	13	upon	upon	IN
25944	1087	14	the	the	DT
25944	1087	15	limbs	limb	NNS
25944	1087	16	,	,	,
25944	1087	17	the	the	DT
25944	1087	18	scales	scale	NNS
25944	1087	19	are	be	VBP
25944	1087	20	profuse	profuse	NN
25944	1087	21	and	and	CC
25944	1087	22	silvery	silvery	JJ
25944	1087	23	,	,	,
25944	1087	24	and	and	CC
25944	1087	25	the	the	DT
25944	1087	26	underlying	underlie	VBG
25944	1087	27	skin	skin	NN
25944	1087	28	is	be	VBZ
25944	1087	29	red	red	JJ
25944	1087	30	and	and	CC
25944	1087	31	has	have	VBZ
25944	1087	32	a	a	DT
25944	1087	33	glazed	glaze	VBN
25944	1087	34	look	look	NN
25944	1087	35	;	;	:
25944	1087	36	moreover	moreover	RB
25944	1087	37	,	,	,
25944	1087	38	psoriasis	psoriasis	NN
25944	1087	39	,	,	,
25944	1087	40	as	as	IN
25944	1087	41	a	a	DT
25944	1087	42	rule	rule	NN
25944	1087	43	,	,	,
25944	1087	44	appears	appear	VBZ
25944	1087	45	slowly	slowly	RB
25944	1087	46	and	and	CC
25944	1087	47	runs	run	VBZ
25944	1087	48	a	a	DT
25944	1087	49	chronic	chronic	JJ
25944	1087	50	course	course	NN
25944	1087	51	.	.	.
25944	1088	1	The	the	DT
25944	1088	2	squamous	squamous	JJ
25944	1088	3	syphiloderm	syphiloderm	NN
25944	1088	4	differs	differ	NNS
25944	1088	5	in	in	IN
25944	1088	6	its	-PRON-	PRP$
25944	1088	7	history	history	NN
25944	1088	8	,	,	,
25944	1088	9	distribution	distribution	NN
25944	1088	10	,	,	,
25944	1088	11	and	and	CC
25944	1088	12	above	above	IN
25944	1088	13	all	all	DT
25944	1088	14	,	,	,
25944	1088	15	by	by	IN
25944	1088	16	the	the	DT
25944	1088	17	presence	presence	NN
25944	1088	18	of	of	IN
25944	1088	19	concomitant	concomitant	JJ
25944	1088	20	symptoms	symptom	NNS
25944	1088	21	of	of	IN
25944	1088	22	syphilis	syphilis	NNP
25944	1088	23	,	,	,
25944	1088	24	such	such	JJ
25944	1088	25	as	as	IN
25944	1088	26	glandular	glandular	JJ
25944	1088	27	enlargement	enlargement	NN
25944	1088	28	,	,	,
25944	1088	29	sore	sore	JJ
25944	1088	30	throat	throat	NN
25944	1088	31	,	,	,
25944	1088	32	mucous	mucous	JJ
25944	1088	33	patches	patch	NNS
25944	1088	34	,	,	,
25944	1088	35	rheumatic	rheumatic	JJ
25944	1088	36	pains	pain	NNS
25944	1088	37	,	,	,
25944	1088	38	and	and	CC
25944	1088	39	falling	fall	VBG
25944	1088	40	out	out	IN
25944	1088	41	of	of	IN
25944	1088	42	the	the	DT
25944	1088	43	hair	hair	NN
25944	1088	44	.	.	.
25944	1089	1	#	#	JJR
25944	1089	2	State	state	NN
25944	1089	3	the	the	DT
25944	1089	4	prognosis	prognosis	NN
25944	1089	5	of	of	IN
25944	1089	6	pityriasis	pityriasis	NN
25944	1089	7	rosea	rosea	NN
25944	1089	8	.	.	.
25944	1089	9	#	#	$
25944	1089	10	It	-PRON-	PRP
25944	1089	11	is	be	VBZ
25944	1089	12	favorable	favorable	JJ
25944	1089	13	,	,	,
25944	1089	14	the	the	DT
25944	1089	15	disease	disease	NN
25944	1089	16	tending	tend	VBG
25944	1089	17	to	to	IN
25944	1089	18	spontaneous	spontaneous	JJ
25944	1089	19	disappearance	disappearance	NN
25944	1089	20	,	,	,
25944	1089	21	usually	usually	RB
25944	1089	22	in	in	IN
25944	1089	23	the	the	DT
25944	1089	24	course	course	NN
25944	1089	25	of	of	IN
25944	1089	26	several	several	JJ
25944	1089	27	weeks	week	NNS
25944	1089	28	or	or	CC
25944	1089	29	one	one	CD
25944	1089	30	or	or	CC
25944	1089	31	two	two	CD
25944	1089	32	months	month	NNS
25944	1089	33	.	.	.
25944	1090	1	#	#	LS
25944	1090	2	What	what	WDT
25944	1090	3	treatment	treatment	NN
25944	1090	4	is	be	VBZ
25944	1090	5	to	to	TO
25944	1090	6	be	be	VB
25944	1090	7	advised	advise	VBN
25944	1090	8	in	in	IN
25944	1090	9	pityriasis	pityriasis	NN
25944	1090	10	rosea	rosea	NN
25944	1090	11	?	?	.
25944	1090	12	#	#	$
25944	1090	13	Laxatives	Laxatives	NNPS
25944	1090	14	and	and	CC
25944	1090	15	intestinal	intestinal	JJ
25944	1090	16	antiseptics	antiseptic	NNS
25944	1090	17	,	,	,
25944	1090	18	and	and	CC
25944	1090	19	ointments	ointment	NNS
25944	1090	20	of	of	IN
25944	1090	21	salicylic	salicylic	JJ
25944	1090	22	acid	acid	NN
25944	1090	23	(	(	-LRB-
25944	1090	24	5	5	CD
25944	1090	25	-	-	SYM
25944	1090	26	15	15	CD
25944	1090	27	grains	grain	NNS
25944	1090	28	to	to	IN
25944	1090	29	the	the	DT
25944	1090	30	ounce	ounce	NN
25944	1090	31	)	)	-RRB-
25944	1090	32	,	,	,
25944	1090	33	of	of	IN
25944	1090	34	sulphur	sulphur	NNP
25944	1090	35	(	(	-LRB-
25944	1090	36	10	10	CD
25944	1090	37	-	-	SYM
25944	1090	38	40	40	CD
25944	1090	39	grains	grain	NNS
25944	1090	40	to	to	IN
25944	1090	41	the	the	DT
25944	1090	42	ounce	ounce	NN
25944	1090	43	)	)	-RRB-
25944	1090	44	;	;	:
25944	1090	45	or	or	CC
25944	1090	46	a	a	DT
25944	1090	47	compound	compound	NN
25944	1090	48	ointment	ointment	NN
25944	1090	49	containing	contain	VBG
25944	1090	50	both	both	CC
25944	1090	51	these	these	DT
25944	1090	52	ingredients	ingredient	NNS
25944	1090	53	can	can	MD
25944	1090	54	be	be	VB
25944	1090	55	prescribed	prescribe	VBN
25944	1090	56	.	.	.
25944	1091	1	The	the	DT
25944	1091	2	ointment	ointment	NN
25944	1091	3	base	base	NN
25944	1091	4	can	can	MD
25944	1091	5	be	be	VB
25944	1091	6	equal	equal	JJ
25944	1091	7	parts	part	NNS
25944	1091	8	of	of	IN
25944	1091	9	white	white	NNP
25944	1091	10	vaselin	vaselin	NNP
25944	1091	11	and	and	CC
25944	1091	12	cold	cold	JJ
25944	1091	13	cream	cream	NN
25944	1091	14	;	;	:
25944	1091	15	in	in	IN
25944	1091	16	some	some	DT
25944	1091	17	instances	instance	NNS
25944	1091	18	Lassar	Lassar	NNP
25944	1091	19	's	's	POS
25944	1091	20	paste	paste	NN
25944	1091	21	(	(	-LRB-
25944	1091	22	starch	starch	NN
25944	1091	23	powder	powder	NN
25944	1091	24	,	,	,
25944	1091	25	zinc	zinc	NN
25944	1091	26	oxid	oxid	NN
25944	1091	27	powder	powder	NN
25944	1091	28	,	,	,
25944	1091	29	each	each	DT
25944	1091	30	,	,	,
25944	1091	31	[	[	-LRB-
25944	1091	32	dram]ij	dram]ij	NN
25944	1091	33	;	;	:
25944	1091	34	vaselin	vaselin	NNP
25944	1091	35	,	,	,
25944	1091	36	[	[	-LRB-
25944	1091	37	dram]iv	dram]iv	NNP
25944	1091	38	)	)	-RRB-
25944	1091	39	seems	seem	VBZ
25944	1091	40	more	more	RBR
25944	1091	41	satisfactory	satisfactory	JJ
25944	1091	42	.	.	.
25944	1092	1	#	#	NNP
25944	1092	2	Dermatitis	Dermatitis	NNP
25944	1092	3	Exfoliativa	Exfoliativa	NNP
25944	1092	4	.	.	.
25944	1092	5	#	#	NNP
25944	1092	6	(	(	-LRB-
25944	1092	7	_	_	NNP
25944	1092	8	Synonyms	Synonyms	NNP
25944	1092	9	:	:	:
25944	1092	10	_	_	NNP
25944	1092	11	General	General	NNP
25944	1092	12	Exfoliative	Exfoliative	NNP
25944	1092	13	Dermatitis	Dermatitis	NNP
25944	1092	14	;	;	:
25944	1092	15	Recurrent	recurrent	JJ
25944	1092	16	Exfoliative	exfoliative	JJ
25944	1092	17	Dermatitis	dermatitis	NN
25944	1092	18	;	;	:
25944	1092	19	Desquamative	desquamative	JJ
25944	1092	20	Scarlatiniform	Scarlatiniform	NNP
25944	1092	21	Erythema	Erythema	NNP
25944	1092	22	;	;	:
25944	1092	23	Acute	Acute	NNP
25944	1092	24	General	General	NNP
25944	1092	25	Dermatitis	Dermatitis	NNP
25944	1092	26	;	;	:
25944	1092	27	Recurrent	Recurrent	NNP
25944	1092	28	Exfoliative	Exfoliative	NNP
25944	1092	29	Erythema	erythema	NN
25944	1092	30	;	;	:
25944	1092	31	Pityriasis	Pityriasis	NNP
25944	1092	32	Rubra	Rubra	NNP
25944	1092	33	.	.	.
25944	1092	34	)	)	-RRB-
25944	1093	1	#	#	NNP
25944	1093	2	Describe	Describe	NNP
25944	1093	3	dermatitis	dermatitis	NN
25944	1093	4	exfoliativa	exfoliativa	NN
25944	1093	5	.	.	.
25944	1093	6	#	#	NNP
25944	1093	7	Dermatitis	Dermatitis	NNP
25944	1093	8	exfoliativa	exfoliativa	NN
25944	1093	9	is	be	VBZ
25944	1093	10	an	an	DT
25944	1093	11	inflammatory	inflammatory	JJ
25944	1093	12	disease	disease	NN
25944	1093	13	of	of	IN
25944	1093	14	an	an	DT
25944	1093	15	acute	acute	JJ
25944	1093	16	type	type	NN
25944	1093	17	,	,	,
25944	1093	18	characterized	characterize	VBN
25944	1093	19	by	by	IN
25944	1093	20	a	a	DT
25944	1093	21	more	more	RBR
25944	1093	22	or	or	CC
25944	1093	23	less	less	RBR
25944	1093	24	general	general	JJ
25944	1093	25	erythematous	erythematous	JJ
25944	1093	26	inflammation	inflammation	NN
25944	1093	27	,	,	,
25944	1093	28	in	in	IN
25944	1093	29	exceptional	exceptional	JJ
25944	1093	30	instances	instance	NNS
25944	1093	31	vesicular	vesicular	JJ
25944	1093	32	or	or	CC
25944	1093	33	bullous	bullous	JJ
25944	1093	34	,	,	,
25944	1093	35	with	with	IN
25944	1093	36	epidermic	epidermic	JJ
25944	1093	37	desquamation	desquamation	NN
25944	1093	38	or	or	CC
25944	1093	39	exfoliation	exfoliation	NN
25944	1093	40	accompanying	accompany	VBG
25944	1093	41	or	or	CC
25944	1093	42	following	follow	VBG
25944	1093	43	its	-PRON-	PRP$
25944	1093	44	development	development	NN
25944	1093	45	.	.	.
25944	1094	1	Constitutional	constitutional	JJ
25944	1094	2	disturbance	disturbance	NN
25944	1094	3	,	,	,
25944	1094	4	which	which	WDT
25944	1094	5	may	may	MD
25944	1094	6	be	be	VB
25944	1094	7	of	of	IN
25944	1094	8	a	a	DT
25944	1094	9	serious	serious	JJ
25944	1094	10	character	character	NN
25944	1094	11	,	,	,
25944	1094	12	is	be	VBZ
25944	1094	13	sometimes	sometimes	RB
25944	1094	14	present	present	JJ
25944	1094	15	.	.	.
25944	1095	1	It	-PRON-	PRP
25944	1095	2	is	be	VBZ
25944	1095	3	a	a	DT
25944	1095	4	rare	rare	JJ
25944	1095	5	and	and	CC
25944	1095	6	obscure	obscure	JJ
25944	1095	7	affection	affection	NN
25944	1095	8	,	,	,
25944	1095	9	running	run	VBG
25944	1095	10	its	-PRON-	PRP$
25944	1095	11	course	course	NN
25944	1095	12	usually	usually	RB
25944	1095	13	in	in	IN
25944	1095	14	several	several	JJ
25944	1095	15	weeks	week	NNS
25944	1095	16	or	or	CC
25944	1095	17	months	month	NNS
25944	1095	18	,	,	,
25944	1095	19	but	but	CC
25944	1095	20	exhibiting	exhibit	VBG
25944	1095	21	a	a	DT
25944	1095	22	decided	decided	JJ
25944	1095	23	tendency	tendency	NN
25944	1095	24	to	to	TO
25944	1095	25	relapse	relapse	VB
25944	1095	26	and	and	CC
25944	1095	27	recurrence	recurrence	VB
25944	1095	28	.	.	.
25944	1096	1	In	in	IN
25944	1096	2	many	many	JJ
25944	1096	3	cases	case	NNS
25944	1096	4	it	-PRON-	PRP
25944	1096	5	is	be	VBZ
25944	1096	6	persistently	persistently	RB
25944	1096	7	chronic	chronic	JJ
25944	1096	8	,	,	,
25944	1096	9	with	with	IN
25944	1096	10	exacerbations	exacerbation	NNS
25944	1096	11	and	and	CC
25944	1096	12	remissions	remission	NNS
25944	1096	13	.	.	.
25944	1097	1	In	in	IN
25944	1097	2	some	some	DT
25944	1097	3	instances	instance	NNS
25944	1097	4	it	-PRON-	PRP
25944	1097	5	develops	develop	VBZ
25944	1097	6	from	from	IN
25944	1097	7	a	a	DT
25944	1097	8	long	long	RB
25944	1097	9	-	-	HYPH
25944	1097	10	continued	continue	VBN
25944	1097	11	and	and	CC
25944	1097	12	more	more	RBR
25944	1097	13	or	or	CC
25944	1097	14	less	less	RBR
25944	1097	15	generalized	generalize	VBN
25944	1097	16	eczema	eczema	NN
25944	1097	17	or	or	CC
25944	1097	18	psoriasis	psoriasis	NN
25944	1097	19	,	,	,
25944	1097	20	and	and	CC
25944	1097	21	in	in	IN
25944	1097	22	exceptional	exceptional	JJ
25944	1097	23	cases	case	NNS
25944	1097	24	it	-PRON-	PRP
25944	1097	25	is	be	VBZ
25944	1097	26	started	start	VBN
25944	1097	27	by	by	IN
25944	1097	28	the	the	DT
25944	1097	29	careless	careless	JJ
25944	1097	30	use	use	NN
25944	1097	31	of	of	IN
25944	1097	32	mercurial	mercurial	JJ
25944	1097	33	ointment	ointment	NN
25944	1097	34	and	and	CC
25944	1097	35	of	of	IN
25944	1097	36	chrysarobin	chrysarobin	NNP
25944	1097	37	ointment	ointment	NNP
25944	1097	38	.	.	.
25944	1098	1	[	[	-LRB-
25944	1098	2	Illustration	illustration	NN
25944	1098	3	:	:	:
25944	1098	4	Fig	Fig	NNP
25944	1098	5	.	.	.
25944	1099	1	19	19	CD
25944	1099	2	.	.	.
25944	1100	1	Dermatitis	Dermatitis	NNP
25944	1100	2	Exfoliativa	Exfoliativa	NNP
25944	1100	3	.	.	.
25944	1100	4	]	]	-RRB-
25944	1101	1	In	in	IN
25944	1101	2	another	another	DT
25944	1101	3	type	type	NN
25944	1101	4	of	of	IN
25944	1101	5	the	the	DT
25944	1101	6	disease	disease	NN
25944	1101	7	,	,	,
25944	1101	8	formerly	formerly	RB
25944	1101	9	described	describe	VBN
25944	1101	10	as	as	IN
25944	1101	11	_	_	NNP
25944	1101	12	pityriasis	pityriasis	NN
25944	1101	13	rubra	rubra	NNP
25944	1101	14	_	_	NNP
25944	1101	15	,	,	,
25944	1101	16	the	the	DT
25944	1101	17	skin	skin	NN
25944	1101	18	is	be	VBZ
25944	1101	19	pale	pale	JJ
25944	1101	20	red	red	JJ
25944	1101	21	or	or	CC
25944	1101	22	violaceous	violaceous	JJ
25944	1101	23	-	-	HYPH
25944	1101	24	red	red	JJ
25944	1101	25	,	,	,
25944	1101	26	but	but	CC
25944	1101	27	is	be	VBZ
25944	1101	28	rarely	rarely	RB
25944	1101	29	thickened	thicken	VBN
25944	1101	30	,	,	,
25944	1101	31	continued	continue	VBN
25944	1101	32	exfoliation	exfoliation	NN
25944	1101	33	in	in	IN
25944	1101	34	the	the	DT
25944	1101	35	form	form	NN
25944	1101	36	of	of	IN
25944	1101	37	thin	thin	JJ
25944	1101	38	plates	plate	NNS
25944	1101	39	taking	take	VBG
25944	1101	40	place	place	NN
25944	1101	41	.	.	.
25944	1102	1	Its	-PRON-	PRP$
25944	1102	2	course	course	NN
25944	1102	3	is	be	VBZ
25944	1102	4	variable	variable	JJ
25944	1102	5	,	,	,
25944	1102	6	lasting	last	VBG
25944	1102	7	for	for	IN
25944	1102	8	years	year	NNS
25944	1102	9	,	,	,
25944	1102	10	with	with	IN
25944	1102	11	remissions	remission	NNS
25944	1102	12	.	.	.
25944	1103	1	An	an	DT
25944	1103	2	exfoliating	exfoliate	VBG
25944	1103	3	generalized	generalize	VBN
25944	1103	4	dermatitis	dermatitis	NN
25944	1103	5	is	be	VBZ
25944	1103	6	exceptionally	exceptionally	RB
25944	1103	7	observed	observe	VBN
25944	1103	8	in	in	IN
25944	1103	9	the	the	DT
25944	1103	10	first	first	JJ
25944	1103	11	weeks	week	NNS
25944	1103	12	of	of	IN
25944	1103	13	life	life	NN
25944	1103	14	(	(	-LRB-
25944	1103	15	_	_	NNP
25944	1103	16	dermatitis	dermatitis	NN
25944	1103	17	exfoliativa	exfoliativa	NNP
25944	1103	18	neonatorum	neonatorum	NNP
25944	1103	19	_	_	NNP
25944	1103	20	)	)	-RRB-
25944	1103	21	,	,	,
25944	1103	22	lasting	last	VBG
25944	1103	23	some	some	DT
25944	1103	24	weeks	week	NNS
25944	1103	25	,	,	,
25944	1103	26	and	and	CC
25944	1103	27	in	in	IN
25944	1103	28	most	most	JJS
25944	1103	29	cases	case	NNS
25944	1103	30	followed	follow	VBN
25944	1103	31	by	by	IN
25944	1103	32	recovery	recovery	NN
25944	1103	33	.	.	.
25944	1104	1	There	there	EX
25944	1104	2	are	be	VBP
25944	1104	3	no	no	DT
25944	1104	4	special	special	JJ
25944	1104	5	constitutional	constitutional	JJ
25944	1104	6	symptoms	symptom	NNS
25944	1104	7	,	,	,
25944	1104	8	the	the	DT
25944	1104	9	fatal	fatal	JJ
25944	1104	10	cases	case	NNS
25944	1104	11	usually	usually	RB
25944	1104	12	dying	die	VBG
25944	1104	13	of	of	IN
25944	1104	14	marasmus	marasmus	NNP
25944	1104	15	.	.	.
25944	1105	1	As	as	IN
25944	1105	2	will	will	MD
25944	1105	3	be	be	VB
25944	1105	4	seen	see	VBN
25944	1105	5	dermatitis	dermatitis	NN
25944	1105	6	exfoliativa	exfoliativa	NNP
25944	1105	7	varies	vary	VBZ
25944	1105	8	considerably	considerably	RB
25944	1105	9	in	in	IN
25944	1105	10	degree	degree	NN
25944	1105	11	;	;	:
25944	1105	12	it	-PRON-	PRP
25944	1105	13	may	may	MD
25944	1105	14	be	be	VB
25944	1105	15	extremely	extremely	RB
25944	1105	16	mild	mild	JJ
25944	1105	17	,	,	,
25944	1105	18	resembling	resemble	VBG
25944	1105	19	in	in	IN
25944	1105	20	appearance	appearance	NN
25944	1105	21	the	the	DT
25944	1105	22	scarlet	scarlet	JJ
25944	1105	23	-	-	HYPH
25944	1105	24	fever	fever	NN
25944	1105	25	eruption	eruption	NN
25944	1105	26	(	(	-LRB-
25944	1105	27	erythema	erythema	NNP
25944	1105	28	scarlatiniforme	scarlatiniforme	NNP
25944	1105	29	)	)	-RRB-
25944	1105	30	and	and	CC
25944	1105	31	running	run	VBG
25944	1105	32	a	a	DT
25944	1105	33	rapid	rapid	JJ
25944	1105	34	course	course	NN
25944	1105	35	;	;	:
25944	1105	36	or	or	CC
25944	1105	37	the	the	DT
25944	1105	38	skin	skin	NN
25944	1105	39	-	-	HYPH
25944	1105	40	condition	condition	NN
25944	1105	41	and	and	CC
25944	1105	42	the	the	DT
25944	1105	43	systemic	systemic	JJ
25944	1105	44	symptoms	symptom	NNS
25944	1105	45	may	may	MD
25944	1105	46	be	be	VB
25944	1105	47	of	of	IN
25944	1105	48	grave	grave	JJ
25944	1105	49	and	and	CC
25944	1105	50	persistent	persistent	JJ
25944	1105	51	character	character	NN
25944	1105	52	.	.	.
25944	1106	1	#	#	NN
25944	1106	2	Give	give	VBP
25944	1106	3	the	the	DT
25944	1106	4	treatment	treatment	NN
25944	1106	5	of	of	IN
25944	1106	6	dermatitis	dermatitis	NN
25944	1106	7	exfoliativa	exfoliativa	NN
25944	1106	8	.	.	.
25944	1106	9	#	#	NNP
25944	1106	10	General	general	JJ
25944	1106	11	treatment	treatment	NN
25944	1106	12	is	be	VBZ
25944	1106	13	based	base	VBN
25944	1106	14	upon	upon	IN
25944	1106	15	indications	indication	NNS
25944	1106	16	,	,	,
25944	1106	17	and	and	CC
25944	1106	18	externally	externally	RB
25944	1106	19	soothing	soothing	JJ
25944	1106	20	applications	application	NNS
25944	1106	21	,	,	,
25944	1106	22	such	such	JJ
25944	1106	23	as	as	IN
25944	1106	24	are	be	VBP
25944	1106	25	employed	employ	VBN
25944	1106	26	in	in	IN
25944	1106	27	acute	acute	JJ
25944	1106	28	and	and	CC
25944	1106	29	subacute	subacute	NN
25944	1106	30	eczema	eczema	NN
25944	1106	31	,	,	,
25944	1106	32	are	be	VBP
25944	1106	33	to	to	TO
25944	1106	34	be	be	VB
25944	1106	35	used	use	VBN
25944	1106	36	.	.	.
25944	1107	1	#	#	NNP
25944	1107	2	Lichen	Lichen	NNP
25944	1107	3	Planus	Planus	NNP
25944	1107	4	.	.	.
25944	1107	5	#	#	$
25944	1107	6	#	#	$
25944	1107	7	What	what	WP
25944	1107	8	is	be	VBZ
25944	1107	9	lichen	lichen	NNP
25944	1107	10	planus	planus	JJ
25944	1107	11	?	?	.
25944	1107	12	#	#	NNP
25944	1107	13	Lichen	Lichen	NNP
25944	1107	14	planus	planus	NN
25944	1107	15	is	be	VBZ
25944	1107	16	an	an	DT
25944	1107	17	inflammatory	inflammatory	JJ
25944	1107	18	disease	disease	NN
25944	1107	19	characterized	characterize	VBN
25944	1107	20	by	by	IN
25944	1107	21	small	small	JJ
25944	1107	22	,	,	,
25944	1107	23	flat	flat	JJ
25944	1107	24	and	and	CC
25944	1107	25	angular	angular	JJ
25944	1107	26	,	,	,
25944	1107	27	smooth	smooth	JJ
25944	1107	28	and	and	CC
25944	1107	29	shining	shine	VBG
25944	1107	30	,	,	,
25944	1107	31	or	or	CC
25944	1107	32	scaly	scaly	NNP
25944	1107	33	,	,	,
25944	1107	34	discrete	discrete	JJ
25944	1107	35	or	or	CC
25944	1107	36	confluent	confluent	JJ
25944	1107	37	,	,	,
25944	1107	38	red	red	JJ
25944	1107	39	or	or	CC
25944	1107	40	violaceous	violaceous	JJ
25944	1107	41	-	-	HYPH
25944	1107	42	red	red	JJ
25944	1107	43	papules	papule	NNS
25944	1107	44	,	,	,
25944	1107	45	having	have	VBG
25944	1107	46	a	a	DT
25944	1107	47	distinctly	distinctly	RB
25944	1107	48	papular	papular	JJ
25944	1107	49	or	or	CC
25944	1107	50	papulo	papulo	JJ
25944	1107	51	-	-	HYPH
25944	1107	52	squamous	squamous	JJ
25944	1107	53	course	course	NN
25944	1107	54	,	,	,
25944	1107	55	and	and	CC
25944	1107	56	attended	attend	VBD
25944	1107	57	with	with	IN
25944	1107	58	more	more	JJR
25944	1107	59	or	or	CC
25944	1107	60	less	less	RBR
25944	1107	61	itching	itching	NN
25944	1107	62	.	.	.
25944	1108	1	#	#	NNP
25944	1108	2	Describe	describe	VB
25944	1108	3	the	the	DT
25944	1108	4	symptoms	symptom	NNS
25944	1108	5	of	of	IN
25944	1108	6	lichen	lichen	NNP
25944	1108	7	planus	planus	NNP
25944	1108	8	.	.	.
25944	1108	9	#	#	$
25944	1108	10	The	the	DT
25944	1108	11	eruption	eruption	NN
25944	1108	12	,	,	,
25944	1108	13	as	as	IN
25944	1108	14	a	a	DT
25944	1108	15	rule	rule	NN
25944	1108	16	,	,	,
25944	1108	17	begins	begin	VBZ
25944	1108	18	slowly	slowly	RB
25944	1108	19	,	,	,
25944	1108	20	usually	usually	RB
25944	1108	21	showing	show	VBG
25944	1108	22	itself	-PRON-	PRP
25944	1108	23	upon	upon	IN
25944	1108	24	the	the	DT
25944	1108	25	extremities	extremity	NNS
25944	1108	26	;	;	:
25944	1108	27	the	the	DT
25944	1108	28	forearms	forearm	NNS
25944	1108	29	,	,	,
25944	1108	30	wrists	wrist	NNS
25944	1108	31	and	and	CC
25944	1108	32	legs	leg	NNS
25944	1108	33	being	be	VBG
25944	1108	34	favorite	favorite	JJ
25944	1108	35	localities	locality	NNS
25944	1108	36	.	.	.
25944	1109	1	It	-PRON-	PRP
25944	1109	2	may	may	MD
25944	1109	3	appear	appear	VB
25944	1109	4	as	as	IN
25944	1109	5	one	one	CD
25944	1109	6	or	or	CC
25944	1109	7	more	more	JJR
25944	1109	8	groups	group	NNS
25944	1109	9	or	or	CC
25944	1109	10	in	in	IN
25944	1109	11	the	the	DT
25944	1109	12	form	form	NN
25944	1109	13	of	of	IN
25944	1109	14	short	short	JJ
25944	1109	15	or	or	CC
25944	1109	16	long	long	JJ
25944	1109	17	bands	band	NNS
25944	1109	18	.	.	.
25944	1110	1	Occasionally	occasionally	RB
25944	1110	2	its	-PRON-	PRP$
25944	1110	3	evolution	evolution	NN
25944	1110	4	is	be	VBZ
25944	1110	5	rapid	rapid	JJ
25944	1110	6	and	and	CC
25944	1110	7	a	a	DT
25944	1110	8	considerable	considerable	JJ
25944	1110	9	part	part	NN
25944	1110	10	of	of	IN
25944	1110	11	the	the	DT
25944	1110	12	surface	surface	NN
25944	1110	13	may	may	MD
25944	1110	14	be	be	VB
25944	1110	15	invaded	invade	VBN
25944	1110	16	.	.	.
25944	1111	1	The	the	DT
25944	1111	2	lesions	lesion	NNS
25944	1111	3	are	be	VBP
25944	1111	4	pin	pin	NN
25944	1111	5	-	-	HYPH
25944	1111	6	head	head	NN
25944	1111	7	to	to	IN
25944	1111	8	small	small	JJ
25944	1111	9	pea	pea	JJ
25944	1111	10	-	-	HYPH
25944	1111	11	sized	sized	JJ
25944	1111	12	,	,	,
25944	1111	13	irregularly	irregularly	RB
25944	1111	14	grouped	group	VBN
25944	1111	15	or	or	CC
25944	1111	16	so	so	RB
25944	1111	17	closely	closely	RB
25944	1111	18	crowded	crowded	JJ
25944	1111	19	together	together	RB
25944	1111	20	as	as	IN
25944	1111	21	to	to	TO
25944	1111	22	form	form	VB
25944	1111	23	solid	solid	JJ
25944	1111	24	patches	patch	NNS
25944	1111	25	;	;	:
25944	1111	26	they	-PRON-	PRP
25944	1111	27	are	be	VBP
25944	1111	28	quadrangular	quadrangular	JJ
25944	1111	29	or	or	CC
25944	1111	30	polygonal	polygonal	JJ
25944	1111	31	in	in	IN
25944	1111	32	shape	shape	NN
25944	1111	33	,	,	,
25944	1111	34	usually	usually	RB
25944	1111	35	flat	flat	JJ
25944	1111	36	,	,	,
25944	1111	37	with	with	IN
25944	1111	38	central	central	JJ
25944	1111	39	depression	depression	NN
25944	1111	40	or	or	CC
25944	1111	41	umbilication	umbilication	NN
25944	1111	42	,	,	,
25944	1111	43	and	and	CC
25944	1111	44	are	be	VBP
25944	1111	45	reddish	reddish	JJ
25944	1111	46	or	or	CC
25944	1111	47	violaceous	violaceous	JJ
25944	1111	48	in	in	IN
25944	1111	49	color	color	NN
25944	1111	50	.	.	.
25944	1112	1	At	at	IN
25944	1112	2	first	first	RB
25944	1112	3	they	-PRON-	PRP
25944	1112	4	have	have	VBP
25944	1112	5	a	a	DT
25944	1112	6	glazed	glaze	VBN
25944	1112	7	or	or	CC
25944	1112	8	shining	shine	VBG
25944	1112	9	appearance	appearance	NN
25944	1112	10	;	;	:
25944	1112	11	later	later	RB
25944	1112	12	,	,	,
25944	1112	13	becoming	become	VBG
25944	1112	14	slightly	slightly	RB
25944	1112	15	scaly	scaly	JJ
25944	1112	16	,	,	,
25944	1112	17	the	the	DT
25944	1112	18	scaliness	scaliness	NN
25944	1112	19	being	be	VBG
25944	1112	20	more	more	RBR
25944	1112	21	marked	marked	JJ
25944	1112	22	where	where	WRB
25944	1112	23	solid	solid	JJ
25944	1112	24	patches	patch	NNS
25944	1112	25	have	have	VBP
25944	1112	26	resulted	result	VBN
25944	1112	27	.	.	.
25944	1113	1	New	new	JJ
25944	1113	2	papules	papule	NNS
25944	1113	3	may	may	MD
25944	1113	4	appear	appear	VB
25944	1113	5	from	from	IN
25944	1113	6	time	time	NN
25944	1113	7	to	to	IN
25944	1113	8	time	time	NN
25944	1113	9	,	,	,
25944	1113	10	the	the	DT
25944	1113	11	older	old	JJR
25944	1113	12	lesions	lesion	NNS
25944	1113	13	disappearing	disappear	VBG
25944	1113	14	and	and	CC
25944	1113	15	leaving	leave	VBG
25944	1113	16	persistent	persistent	JJ
25944	1113	17	reddish	reddish	JJ
25944	1113	18	or	or	CC
25944	1113	19	brownish	brownish	JJ
25944	1113	20	pigmentation	pigmentation	NN
25944	1113	21	.	.	.
25944	1114	1	Exceptionally	exceptionally	RB
25944	1114	2	the	the	DT
25944	1114	3	eruption	eruption	NN
25944	1114	4	presents	present	VBZ
25944	1114	5	in	in	IN
25944	1114	6	bands	band	NNS
25944	1114	7	or	or	CC
25944	1114	8	lines	line	NNS
25944	1114	9	,	,	,
25944	1114	10	like	like	IN
25944	1114	11	rows	row	NNS
25944	1114	12	of	of	IN
25944	1114	13	beads	bead	NNS
25944	1114	14	(	(	-LRB-
25944	1114	15	_	_	NNP
25944	1114	16	lichen	lichen	NNP
25944	1114	17	moniliformis	moniliformis	NNP
25944	1114	18	_	_	NNP
25944	1114	19	)	)	-RRB-
25944	1114	20	.	.	.
25944	1115	1	Very	very	RB
25944	1115	2	exceptionally	exceptionally	RB
25944	1115	3	a	a	DT
25944	1115	4	vesicular	vesicular	JJ
25944	1115	5	or	or	CC
25944	1115	6	bleb	bleb	JJ
25944	1115	7	tendency	tendency	NN
25944	1115	8	in	in	IN
25944	1115	9	some	some	DT
25944	1115	10	of	of	IN
25944	1115	11	the	the	DT
25944	1115	12	lesions	lesion	NNS
25944	1115	13	has	have	VBZ
25944	1115	14	been	be	VBN
25944	1115	15	noted	note	VBN
25944	1115	16	;	;	:
25944	1115	17	doubtless	doubtless	RB
25944	1115	18	,	,	,
25944	1115	19	in	in	IN
25944	1115	20	most	most	JJS
25944	1115	21	instances	instance	NNS
25944	1115	22	at	at	IN
25944	1115	23	least	least	JJS
25944	1115	24	,	,	,
25944	1115	25	this	this	DT
25944	1115	26	has	have	VBZ
25944	1115	27	been	be	VBN
25944	1115	28	due	due	JJ
25944	1115	29	to	to	IN
25944	1115	30	the	the	DT
25944	1115	31	arsenic	arsenic	JJ
25944	1115	32	so	so	RB
25944	1115	33	generally	generally	RB
25944	1115	34	administered	administer	VBN
25944	1115	35	in	in	IN
25944	1115	36	this	this	DT
25944	1115	37	disease	disease	NN
25944	1115	38	.	.	.
25944	1116	1	In	in	IN
25944	1116	2	rare	rare	JJ
25944	1116	3	instances	instance	NNS
25944	1116	4	lichen	lichen	NNP
25944	1116	5	planus	planus	NN
25944	1116	6	lesions	lesion	NNS
25944	1116	7	are	be	VBP
25944	1116	8	also	also	RB
25944	1116	9	seen	see	VBN
25944	1116	10	on	on	IN
25944	1116	11	the	the	DT
25944	1116	12	glans	glans	NNPS
25944	1116	13	penis	penis	NN
25944	1116	14	and	and	CC
25944	1116	15	on	on	IN
25944	1116	16	the	the	DT
25944	1116	17	buccal	buccal	JJ
25944	1116	18	mucous	mucous	JJ
25944	1116	19	membrane	membrane	NN
25944	1116	20	.	.	.
25944	1117	1	In	in	IN
25944	1117	2	some	some	DT
25944	1117	3	cases	case	NNS
25944	1117	4	,	,	,
25944	1117	5	especially	especially	RB
25944	1117	6	in	in	IN
25944	1117	7	the	the	DT
25944	1117	8	region	region	NN
25944	1117	9	of	of	IN
25944	1117	10	the	the	DT
25944	1117	11	ankle	ankle	NN
25944	1117	12	,	,	,
25944	1117	13	the	the	DT
25944	1117	14	papules	papule	NNS
25944	1117	15	become	become	VBP
25944	1117	16	quite	quite	RB
25944	1117	17	large	large	JJ
25944	1117	18	(	(	-LRB-
25944	1117	19	_	_	NNP
25944	1117	20	lichen	lichen	NNP
25944	1117	21	planus	planus	NNP
25944	1117	22	hypertrophicus	hypertrophicus	NNP
25944	1117	23	_	_	NNP
25944	1117	24	)	)	-RRB-
25944	1117	25	,	,	,
25944	1117	26	and	and	CC
25944	1117	27	in	in	IN
25944	1117	28	occasional	occasional	JJ
25944	1117	29	cases	case	NNS
25944	1117	30	there	there	EX
25944	1117	31	is	be	VBZ
25944	1117	32	a	a	DT
25944	1117	33	tendency	tendency	NN
25944	1117	34	in	in	IN
25944	1117	35	some	some	DT
25944	1117	36	of	of	IN
25944	1117	37	the	the	DT
25944	1117	38	lesions	lesion	NNS
25944	1117	39	or	or	CC
25944	1117	40	patches	patch	NNS
25944	1117	41	to	to	TO
25944	1117	42	clear	clear	VB
25944	1117	43	up	up	RP
25944	1117	44	centrally	centrally	RB
25944	1117	45	.	.	.
25944	1118	1	There	there	EX
25944	1118	2	is	be	VBZ
25944	1118	3	,	,	,
25944	1118	4	as	as	IN
25944	1118	5	a	a	DT
25944	1118	6	rule	rule	NN
25944	1118	7	,	,	,
25944	1118	8	considerable	considerable	JJ
25944	1118	9	itching	itching	NN
25944	1118	10	.	.	.
25944	1119	1	There	there	EX
25944	1119	2	are	be	VBP
25944	1119	3	no	no	DT
25944	1119	4	constitutional	constitutional	JJ
25944	1119	5	symptoms	symptom	NNS
25944	1119	6	.	.	.
25944	1120	1	#	#	LS
25944	1120	2	What	what	WP
25944	1120	3	is	be	VBZ
25944	1120	4	the	the	DT
25944	1120	5	etiology	etiology	NN
25944	1120	6	of	of	IN
25944	1120	7	lichen	lichen	NNP
25944	1120	8	planus	planus	NNP
25944	1120	9	?	?	.
25944	1120	10	#	#	NNP
25944	1120	11	In	in	IN
25944	1120	12	some	some	DT
25944	1120	13	cases	case	NNS
25944	1120	14	the	the	DT
25944	1120	15	disease	disease	NN
25944	1120	16	is	be	VBZ
25944	1120	17	distinctly	distinctly	RB
25944	1120	18	neurotic	neurotic	JJ
25944	1120	19	in	in	IN
25944	1120	20	character	character	NN
25944	1120	21	,	,	,
25944	1120	22	in	in	IN
25944	1120	23	others	other	NNS
25944	1120	24	no	no	UH
25944	1120	25	cause	cause	NN
25944	1120	26	can	can	MD
25944	1120	27	be	be	VB
25944	1120	28	assigned	assign	VBN
25944	1120	29	.	.	.
25944	1121	1	It	-PRON-	PRP
25944	1121	2	is	be	VBZ
25944	1121	3	more	more	RBR
25944	1121	4	especially	especially	RB
25944	1121	5	met	meet	VBN
25944	1121	6	with	with	IN
25944	1121	7	at	at	IN
25944	1121	8	middle	middle	JJ
25944	1121	9	age	age	NN
25944	1121	10	,	,	,
25944	1121	11	and	and	CC
25944	1121	12	among	among	IN
25944	1121	13	the	the	DT
25944	1121	14	wealthier	wealthy	JJR
25944	1121	15	,	,	,
25944	1121	16	professional	professional	JJ
25944	1121	17	,	,	,
25944	1121	18	and	and	CC
25944	1121	19	luxurious	luxurious	JJ
25944	1121	20	classes	class	NNS
25944	1121	21	.	.	.
25944	1122	1	Pathologically	pathologically	RB
25944	1122	2	the	the	DT
25944	1122	3	first	first	JJ
25944	1122	4	change	change	NN
25944	1122	5	noted	note	VBN
25944	1122	6	in	in	IN
25944	1122	7	the	the	DT
25944	1122	8	epidermis	epidermis	NN
25944	1122	9	is	be	VBZ
25944	1122	10	thought	think	VBN
25944	1122	11	to	to	TO
25944	1122	12	be	be	VB
25944	1122	13	an	an	DT
25944	1122	14	acanthosis	acanthosis	NN
25944	1122	15	,	,	,
25944	1122	16	followed	follow	VBN
25944	1122	17	by	by	IN
25944	1122	18	epithelial	epithelial	JJ
25944	1122	19	atrophy	atrophy	NN
25944	1122	20	,	,	,
25944	1122	21	and	and	CC
25944	1122	22	a	a	DT
25944	1122	23	hyperkeratosis	hyperkeratosis	NN
25944	1122	24	,	,	,
25944	1122	25	intercellular	intercellular	JJ
25944	1122	26	edema	edema	NN
25944	1122	27	,	,	,
25944	1122	28	and	and	CC
25944	1122	29	colloid	colloid	NN
25944	1122	30	degeneration	degeneration	NN
25944	1122	31	of	of	IN
25944	1122	32	the	the	DT
25944	1122	33	prickle	prickle	JJ
25944	1122	34	cells	cell	NNS
25944	1122	35	.	.	.
25944	1123	1	#	#	NNP
25944	1123	2	Does	do	VBZ
25944	1123	3	the	the	DT
25944	1123	4	disease	disease	NN
25944	1123	5	bear	bear	VB
25944	1123	6	any	any	DT
25944	1123	7	resemblance	resemblance	NN
25944	1123	8	to	to	IN
25944	1123	9	the	the	DT
25944	1123	10	miliary	miliary	JJ
25944	1123	11	papular	papular	JJ
25944	1123	12	syphilide	syphilide	NN
25944	1123	13	,	,	,
25944	1123	14	psoriasis	psoriasis	NN
25944	1123	15	,	,	,
25944	1123	16	and	and	CC
25944	1123	17	papular	papular	JJ
25944	1123	18	eczema	eczema	NN
25944	1123	19	?	?	.
25944	1123	20	#	#	$
25944	1123	21	In	in	IN
25944	1123	22	some	some	DT
25944	1123	23	instances	instance	NNS
25944	1123	24	it	-PRON-	PRP
25944	1123	25	does	do	VBZ
25944	1123	26	,	,	,
25944	1123	27	but	but	CC
25944	1123	28	the	the	DT
25944	1123	29	irregular	irregular	JJ
25944	1123	30	and	and	CC
25944	1123	31	angular	angular	JJ
25944	1123	32	outline	outline	NN
25944	1123	33	,	,	,
25944	1123	34	the	the	DT
25944	1123	35	slightly	slightly	RB
25944	1123	36	-	-	HYPH
25944	1123	37	umbilicated	umbilicated	JJ
25944	1123	38	,	,	,
25944	1123	39	flattened	flatten	VBD
25944	1123	40	,	,	,
25944	1123	41	smooth	smooth	JJ
25944	1123	42	or	or	CC
25944	1123	43	scaly	scaly	NN
25944	1123	44	summits	summit	NNS
25944	1123	45	,	,	,
25944	1123	46	and	and	CC
25944	1123	47	the	the	DT
25944	1123	48	dull	dull	JJ
25944	1123	49	-	-	HYPH
25944	1123	50	red	red	JJ
25944	1123	51	or	or	CC
25944	1123	52	violaceous	violaceous	JJ
25944	1123	53	color	color	NN
25944	1123	54	,	,	,
25944	1123	55	the	the	DT
25944	1123	56	history	history	NN
25944	1123	57	and	and	CC
25944	1123	58	course	course	NN
25944	1123	59	,	,	,
25944	1123	60	of	of	IN
25944	1123	61	lichen	lichen	NNP
25944	1123	62	planus	planus	NNP
25944	1123	63	,	,	,
25944	1123	64	will	will	MD
25944	1123	65	serve	serve	VB
25944	1123	66	to	to	TO
25944	1123	67	differentiate	differentiate	VB
25944	1123	68	.	.	.
25944	1124	1	#	#	JJR
25944	1124	2	State	state	NN
25944	1124	3	the	the	DT
25944	1124	4	prognosis	prognosis	NN
25944	1124	5	.	.	.
25944	1124	6	#	#	$
25944	1124	7	Under	under	IN
25944	1124	8	proper	proper	JJ
25944	1124	9	management	management	NN
25944	1124	10	the	the	DT
25944	1124	11	eruption	eruption	NN
25944	1124	12	,	,	,
25944	1124	13	although	although	IN
25944	1124	14	often	often	RB
25944	1124	15	obstinate	obstinate	VBP
25944	1124	16	,	,	,
25944	1124	17	yields	yield	NNS
25944	1124	18	to	to	IN
25944	1124	19	treatment	treatment	NN
25944	1124	20	.	.	.
25944	1125	1	#	#	LS
25944	1125	2	What	what	WDT
25944	1125	3	treatment	treatment	NN
25944	1125	4	would	would	MD
25944	1125	5	you	-PRON-	PRP
25944	1125	6	prescribe	prescribe	VB
25944	1125	7	in	in	IN
25944	1125	8	lichen	lichen	NNP
25944	1125	9	planus	planus	NNP
25944	1125	10	?	?	.
25944	1125	11	#	#	$
25944	1125	12	A	a	DT
25944	1125	13	general	general	JJ
25944	1125	14	tonic	tonic	NN
25944	1125	15	plan	plan	NN
25944	1125	16	of	of	IN
25944	1125	17	medication	medication	NN
25944	1125	18	is	be	VBZ
25944	1125	19	indicated	indicate	VBN
25944	1125	20	in	in	IN
25944	1125	21	most	most	JJS
25944	1125	22	cases	case	NNS
25944	1125	23	,	,	,
25944	1125	24	with	with	IN
25944	1125	25	such	such	JJ
25944	1125	26	remedies	remedy	NNS
25944	1125	27	as	as	IN
25944	1125	28	iron	iron	NN
25944	1125	29	,	,	,
25944	1125	30	quinine	quinine	JJ
25944	1125	31	,	,	,
25944	1125	32	nux	nux	NN
25944	1125	33	vomica	vomica	NN
25944	1125	34	,	,	,
25944	1125	35	and	and	CC
25944	1125	36	cod	cod	NN
25944	1125	37	-	-	HYPH
25944	1125	38	liver	liver	NN
25944	1125	39	oil	oil	NN
25944	1125	40	and	and	CC
25944	1125	41	other	other	JJ
25944	1125	42	nutrients	nutrient	NNS
25944	1125	43	.	.	.
25944	1126	1	In	in	IN
25944	1126	2	many	many	JJ
25944	1126	3	instances	instance	NNS
25944	1126	4	arsenic	arsenic	JJ
25944	1126	5	exerts	exert	NNS
25944	1126	6	a	a	DT
25944	1126	7	special	special	JJ
25944	1126	8	influence	influence	NN
25944	1126	9	,	,	,
25944	1126	10	and	and	CC
25944	1126	11	should	should	MD
25944	1126	12	always	always	RB
25944	1126	13	be	be	VB
25944	1126	14	tried	try	VBN
25944	1126	15	.	.	.
25944	1127	1	Mercurials	mercurial	NNS
25944	1127	2	in	in	IN
25944	1127	3	moderate	moderate	JJ
25944	1127	4	dosage	dosage	NN
25944	1127	5	have	have	VBP
25944	1127	6	also	also	RB
25944	1127	7	a	a	DT
25944	1127	8	favorable	favorable	JJ
25944	1127	9	action	action	NN
25944	1127	10	in	in	IN
25944	1127	11	most	most	JJS
25944	1127	12	cases	case	NNS
25944	1127	13	.	.	.
25944	1128	1	Locally	locally	RB
25944	1128	2	,	,	,
25944	1128	3	antipruritic	antipruritic	JJ
25944	1128	4	and	and	CC
25944	1128	5	stimulating	stimulating	JJ
25944	1128	6	applications	application	NNS
25944	1128	7	,	,	,
25944	1128	8	such	such	JJ
25944	1128	9	as	as	IN
25944	1128	10	are	be	VBP
25944	1128	11	used	use	VBN
25944	1128	12	in	in	IN
25944	1128	13	the	the	DT
25944	1128	14	treatment	treatment	NN
25944	1128	15	of	of	IN
25944	1128	16	eczema	eczema	NN
25944	1128	17	,	,	,
25944	1128	18	are	be	VBP
25944	1128	19	to	to	TO
25944	1128	20	be	be	VB
25944	1128	21	employed	employ	VBN
25944	1128	22	,	,	,
25944	1128	23	alkaline	alkaline	NN
25944	1128	24	baths	bath	NNS
25944	1128	25	and	and	CC
25944	1128	26	tarry	tarry	NN
25944	1128	27	applications	application	NNS
25944	1128	28	deserving	deserve	VBG
25944	1128	29	special	special	JJ
25944	1128	30	mention	mention	NN
25944	1128	31	.	.	.
25944	1129	1	Liquor	liquor	NN
25944	1129	2	carbonis	carbonis	NN
25944	1129	3	detergens	detergen	NNS
25944	1129	4	,	,	,
25944	1129	5	applied	apply	VBD
25944	1129	6	weakened	weaken	VBD
25944	1129	7	with	with	IN
25944	1129	8	several	several	JJ
25944	1129	9	parts	part	NNS
25944	1129	10	water	water	NN
25944	1129	11	,	,	,
25944	1129	12	is	be	VBZ
25944	1129	13	a	a	DT
25944	1129	14	valuable	valuable	JJ
25944	1129	15	application	application	NN
25944	1129	16	.	.	.
25944	1130	1	In	in	IN
25944	1130	2	some	some	DT
25944	1130	3	cases	case	NNS
25944	1130	4	,	,	,
25944	1130	5	particularly	particularly	RB
25944	1130	6	if	if	IN
25944	1130	7	the	the	DT
25944	1130	8	disease	disease	NN
25944	1130	9	is	be	VBZ
25944	1130	10	limited	limited	JJ
25944	1130	11	,	,	,
25944	1130	12	external	external	JJ
25944	1130	13	applications	application	NNS
25944	1130	14	alone	alone	RB
25944	1130	15	often	often	RB
25944	1130	16	suffice	suffice	VBP
25944	1130	17	to	to	TO
25944	1130	18	bring	bring	VB
25944	1130	19	about	about	RP
25944	1130	20	a	a	DT
25944	1130	21	cure	cure	NN
25944	1130	22	.	.	.
25944	1131	1	#	#	NNP
25944	1131	2	Pityriasis	Pityriasis	NNP
25944	1131	3	Rubra	Rubra	NNP
25944	1131	4	Pilaris	Pilaris	NNP
25944	1131	5	.	.	.
25944	1131	6	#	#	NNP
25944	1131	7	(	(	-LRB-
25944	1131	8	_	_	NNP
25944	1131	9	Synonyms	Synonyms	NNP
25944	1131	10	:	:	:
25944	1131	11	_	_	NNP
25944	1131	12	Lichen	Lichen	NNP
25944	1131	13	Ruber	Ruber	NNP
25944	1131	14	;	;	:
25944	1131	15	Lichen	Lichen	NNP
25944	1131	16	Ruber	Ruber	NNP
25944	1131	17	Acuminatus	Acuminatus	NNP
25944	1131	18	.	.	.
25944	1131	19	)	)	-RRB-
25944	1132	1	#	#	NNP
25944	1132	2	Describe	Describe	NNP
25944	1132	3	pityriasis	pityriasis	NN
25944	1132	4	rubra	rubra	NNP
25944	1132	5	pilaris	pilaris	NNP
25944	1132	6	.	.	.
25944	1132	7	#	#	NNP
25944	1132	8	Pityriasis	Pityriasis	NNP
25944	1132	9	rubra	rubra	NNP
25944	1132	10	pilaris	pilaris	NNP
25944	1132	11	is	be	VBZ
25944	1132	12	an	an	DT
25944	1132	13	extremely	extremely	RB
25944	1132	14	rare	rare	JJ
25944	1132	15	disease	disease	NN
25944	1132	16	,	,	,
25944	1132	17	usually	usually	RB
25944	1132	18	of	of	IN
25944	1132	19	a	a	DT
25944	1132	20	mildly	mildly	RB
25944	1132	21	inflammatory	inflammatory	JJ
25944	1132	22	nature	nature	NN
25944	1132	23	,	,	,
25944	1132	24	characterized	characterize	VBN
25944	1132	25	by	by	IN
25944	1132	26	grayish	grayish	NN
25944	1132	27	,	,	,
25944	1132	28	pale	pale	JJ
25944	1132	29	-	-	HYPH
25944	1132	30	red	red	JJ
25944	1132	31	or	or	CC
25944	1132	32	reddish	reddish	JJ
25944	1132	33	-	-	HYPH
25944	1132	34	brown	brown	JJ
25944	1132	35	follicular	follicular	JJ
25944	1132	36	papules	papule	NNS
25944	1132	37	with	with	IN
25944	1132	38	somewhat	somewhat	RB
25944	1132	39	hard	hard	JJ
25944	1132	40	or	or	CC
25944	1132	41	horny	horny	JJ
25944	1132	42	centres	centre	NNS
25944	1132	43	;	;	,
25944	1132	44	discrete	discrete	JJ
25944	1132	45	and	and	CC
25944	1132	46	confluent	confluent	JJ
25944	1132	47	,	,	,
25944	1132	48	and	and	CC
25944	1132	49	covering	cover	VBG
25944	1132	50	a	a	DT
25944	1132	51	part	part	NN
25944	1132	52	or	or	CC
25944	1132	53	the	the	DT
25944	1132	54	entire	entire	JJ
25944	1132	55	surface	surface	NN
25944	1132	56	.	.	.
25944	1133	1	The	the	DT
25944	1133	2	skin	skin	NN
25944	1133	3	is	be	VBZ
25944	1133	4	harsh	harsh	JJ
25944	1133	5	,	,	,
25944	1133	6	dry	dry	JJ
25944	1133	7	and	and	CC
25944	1133	8	rough	rough	JJ
25944	1133	9	,	,	,
25944	1133	10	feeling	feel	VBG
25944	1133	11	to	to	IN
25944	1133	12	the	the	DT
25944	1133	13	touch	touch	NN
25944	1133	14	somewhat	somewhat	RB
25944	1133	15	like	like	IN
25944	1133	16	the	the	DT
25944	1133	17	surface	surface	NN
25944	1133	18	of	of	IN
25944	1133	19	a	a	DT
25944	1133	20	nutmeg	nutmeg	NN
25944	1133	21	-	-	HYPH
25944	1133	22	grater	grater	NN
25944	1133	23	or	or	CC
25944	1133	24	a	a	DT
25944	1133	25	coarse	coarse	JJ
25944	1133	26	file	file	NN
25944	1133	27	.	.	.
25944	1134	1	More	More	JJR
25944	1134	2	or	or	CC
25944	1134	3	less	less	RBR
25944	1134	4	scaliness	scaliness	NN
25944	1134	5	is	be	VBZ
25944	1134	6	usually	usually	RB
25944	1134	7	present	present	JJ
25944	1134	8	in	in	IN
25944	1134	9	the	the	DT
25944	1134	10	confluent	confluent	NN
25944	1134	11	patches	patch	NNS
25944	1134	12	and	and	CC
25944	1134	13	on	on	IN
25944	1134	14	the	the	DT
25944	1134	15	palms	palm	NNS
25944	1134	16	and	and	CC
25944	1134	17	soles	sol	NNS
25944	1134	18	;	;	:
25944	1134	19	in	in	IN
25944	1134	20	these	these	DT
25944	1134	21	latter	latter	JJ
25944	1134	22	regions	region	NNS
25944	1134	23	the	the	DT
25944	1134	24	papules	papule	NNS
25944	1134	25	are	be	VBP
25944	1134	26	rarely	rarely	RB
25944	1134	27	seen	see	VBN
25944	1134	28	.	.	.
25944	1135	1	The	the	DT
25944	1135	2	duration	duration	NN
25944	1135	3	of	of	IN
25944	1135	4	the	the	DT
25944	1135	5	disease	disease	NN
25944	1135	6	is	be	VBZ
25944	1135	7	variable	variable	JJ
25944	1135	8	,	,	,
25944	1135	9	and	and	CC
25944	1135	10	relapses	relapse	NNS
25944	1135	11	are	be	VBP
25944	1135	12	common	common	JJ
25944	1135	13	.	.	.
25944	1136	1	It	-PRON-	PRP
25944	1136	2	bears	bear	VBZ
25944	1136	3	resemblance	resemblance	NN
25944	1136	4	at	at	IN
25944	1136	5	times	time	NNS
25944	1136	6	to	to	IN
25944	1136	7	keratosis	keratosis	NNP
25944	1136	8	pilaris	pilaris	NNP
25944	1136	9	,	,	,
25944	1136	10	ichthyosis	ichthyosis	NN
25944	1136	11	,	,	,
25944	1136	12	dermatitis	dermatitis	NN
25944	1136	13	exfoliativa	exfoliativa	NNP
25944	1136	14	;	;	:
25944	1136	15	it	-PRON-	PRP
25944	1136	16	is	be	VBZ
25944	1136	17	considered	consider	VBN
25944	1136	18	identical	identical	JJ
25944	1136	19	with	with	IN
25944	1136	20	the	the	DT
25944	1136	21	lichen	lichen	NNP
25944	1136	22	ruber	ruber	NNP
25944	1136	23	acuminatus	acuminatus	NN
25944	1136	24	of	of	IN
25944	1136	25	Kaposi	Kaposi	NNP
25944	1136	26	,	,	,
25944	1136	27	and	and	CC
25944	1136	28	by	by	IN
25944	1136	29	many	many	JJ
25944	1136	30	also	also	RB
25944	1136	31	with	with	IN
25944	1136	32	the	the	DT
25944	1136	33	lichen	lichen	NNP
25944	1136	34	ruber	ruber	NNP
25944	1136	35	of	of	IN
25944	1136	36	Hebra	Hebra	NNP
25944	1136	37	.	.	.
25944	1137	1	The	the	DT
25944	1137	2	etiology	etiology	NN
25944	1137	3	is	be	VBZ
25944	1137	4	obscure	obscure	JJ
25944	1137	5	.	.	.
25944	1138	1	Treatment	treatment	NN
25944	1138	2	,	,	,
25944	1138	3	both	both	CC
25944	1138	4	constitutional	constitutional	JJ
25944	1138	5	and	and	CC
25944	1138	6	local	local	JJ
25944	1138	7	,	,	,
25944	1138	8	is	be	VBZ
25944	1138	9	to	to	TO
25944	1138	10	be	be	VB
25944	1138	11	based	base	VBN
25944	1138	12	upon	upon	IN
25944	1138	13	general	general	JJ
25944	1138	14	principles	principle	NNS
25944	1138	15	;	;	,
25944	1138	16	stimulating	stimulate	VBG
25944	1138	17	applications	application	NNS
25944	1138	18	,	,	,
25944	1138	19	with	with	IN
25944	1138	20	frequent	frequent	JJ
25944	1138	21	baths	bath	NNS
25944	1138	22	,	,	,
25944	1138	23	such	such	JJ
25944	1138	24	as	as	IN
25944	1138	25	are	be	VBP
25944	1138	26	advised	advise	VBN
25944	1138	27	in	in	IN
25944	1138	28	psoriasis	psoriasis	NN
25944	1138	29	,	,	,
25944	1138	30	are	be	VBP
25944	1138	31	the	the	DT
25944	1138	32	most	most	RBS
25944	1138	33	satisfactory	satisfactory	JJ
25944	1138	34	.	.	.
25944	1139	1	It	-PRON-	PRP
25944	1139	2	is	be	VBZ
25944	1139	3	rebellious	rebellious	JJ
25944	1139	4	,	,	,
25944	1139	5	and	and	CC
25944	1139	6	not	not	RB
25944	1139	7	much	much	RB
25944	1139	8	more	more	JJR
25944	1139	9	than	than	IN
25944	1139	10	palliation	palliation	NN
25944	1139	11	can	can	MD
25944	1139	12	be	be	VB
25944	1139	13	effected	effect	VBN
25944	1139	14	in	in	IN
25944	1139	15	some	some	DT
25944	1139	16	cases	case	NNS
25944	1139	17	,	,	,
25944	1139	18	in	in	IN
25944	1139	19	others	other	NNS
25944	1139	20	the	the	DT
25944	1139	21	outlook	outlook	NN
25944	1139	22	is	be	VBZ
25944	1139	23	more	more	RBR
25944	1139	24	hopeful	hopeful	JJ
25944	1139	25	.	.	.
25944	1140	1	#	#	NNP
25944	1140	2	Lichen	Lichen	NNP
25944	1140	3	Scrofulosus	Scrofulosus	NNP
25944	1140	4	.	.	.
25944	1140	5	#	#	$
25944	1140	6	#	#	$
25944	1140	7	Describe	Describe	NNP
25944	1140	8	lichen	lichen	NNP
25944	1140	9	scrofulosus	scrofulosus	NNP
25944	1140	10	.	.	.
25944	1140	11	#	#	NNP
25944	1140	12	Lichen	Lichen	NNP
25944	1140	13	scrofulosus	scrofulosus	NNP
25944	1140	14	is	be	VBZ
25944	1140	15	a	a	DT
25944	1140	16	chronic	chronic	JJ
25944	1140	17	,	,	,
25944	1140	18	inflammatory	inflammatory	JJ
25944	1140	19	disease	disease	NN
25944	1140	20	,	,	,
25944	1140	21	characterized	characterize	VBN
25944	1140	22	by	by	IN
25944	1140	23	millet	millet	NN
25944	1140	24	-	-	HYPH
25944	1140	25	seed	seed	NN
25944	1140	26	-	-	HYPH
25944	1140	27	sized	sized	JJ
25944	1140	28	,	,	,
25944	1140	29	rounded	rounded	JJ
25944	1140	30	or	or	CC
25944	1140	31	flat	flat	JJ
25944	1140	32	,	,	,
25944	1140	33	reddish	reddish	JJ
25944	1140	34	or	or	CC
25944	1140	35	yellowish	yellowish	JJ
25944	1140	36	,	,	,
25944	1140	37	more	more	RBR
25944	1140	38	or	or	CC
25944	1140	39	less	less	RBR
25944	1140	40	grouped	group	VBN
25944	1140	41	,	,	,
25944	1140	42	desquamating	desquamate	VBG
25944	1140	43	papules	papule	NNS
25944	1140	44	.	.	.
25944	1141	1	The	the	DT
25944	1141	2	lesions	lesion	NNS
25944	1141	3	have	have	VBP
25944	1141	4	their	-PRON-	PRP$
25944	1141	5	start	start	NN
25944	1141	6	about	about	IN
25944	1141	7	the	the	DT
25944	1141	8	hair	hair	NN
25944	1141	9	-	-	HYPH
25944	1141	10	follicles	follicle	NNS
25944	1141	11	,	,	,
25944	1141	12	occur	occur	VBP
25944	1141	13	usually	usually	RB
25944	1141	14	upon	upon	IN
25944	1141	15	the	the	DT
25944	1141	16	trunk	trunk	NN
25944	1141	17	,	,	,
25944	1141	18	tend	tend	VB
25944	1141	19	to	to	TO
25944	1141	20	group	group	VB
25944	1141	21	and	and	CC
25944	1141	22	form	form	NN
25944	1141	23	patches	patch	NNS
25944	1141	24	,	,	,
25944	1141	25	and	and	CC
25944	1141	26	sooner	soon	RBR
25944	1141	27	or	or	CC
25944	1141	28	later	later	RB
25944	1141	29	become	become	VBP
25944	1141	30	covered	covered	JJ
25944	1141	31	with	with	IN
25944	1141	32	minute	minute	JJ
25944	1141	33	scales	scale	NNS
25944	1141	34	.	.	.
25944	1142	1	As	as	IN
25944	1142	2	a	a	DT
25944	1142	3	rule	rule	NN
25944	1142	4	,	,	,
25944	1142	5	there	there	EX
25944	1142	6	is	be	VBZ
25944	1142	7	no	no	DT
25944	1142	8	itching	itching	NN
25944	1142	9	.	.	.
25944	1143	1	It	-PRON-	PRP
25944	1143	2	is	be	VBZ
25944	1143	3	a	a	DT
25944	1143	4	rare	rare	JJ
25944	1143	5	disease	disease	NN
25944	1143	6	,	,	,
25944	1143	7	and	and	CC
25944	1143	8	but	but	CC
25944	1143	9	seldom	seldom	RB
25944	1143	10	met	meet	VBD
25944	1143	11	with	with	IN
25944	1143	12	in	in	IN
25944	1143	13	America	America	NNP
25944	1143	14	;	;	:
25944	1143	15	it	-PRON-	PRP
25944	1143	16	is	be	VBZ
25944	1143	17	seen	see	VBN
25944	1143	18	chiefly	chiefly	RB
25944	1143	19	in	in	IN
25944	1143	20	children	child	NNS
25944	1143	21	and	and	CC
25944	1143	22	young	young	JJ
25944	1143	23	people	people	NNS
25944	1143	24	of	of	IN
25944	1143	25	a	a	DT
25944	1143	26	scrofulous	scrofulous	JJ
25944	1143	27	diathesis	diathesis	NN
25944	1143	28	.	.	.
25944	1144	1	Scarring	scar	VBG
25944	1144	2	,	,	,
25944	1144	3	slight	slight	JJ
25944	1144	4	in	in	IN
25944	1144	5	character	character	NN
25944	1144	6	,	,	,
25944	1144	7	may	may	MD
25944	1144	8	or	or	CC
25944	1144	9	may	may	MD
25944	1144	10	not	not	RB
25944	1144	11	follow	follow	VB
25944	1144	12	.	.	.
25944	1145	1	#	#	LS
25944	1145	2	What	what	WP
25944	1145	3	is	be	VBZ
25944	1145	4	the	the	DT
25944	1145	5	treatment	treatment	NN
25944	1145	6	of	of	IN
25944	1145	7	lichen	lichen	NNP
25944	1145	8	scrofulosus	scrofulosus	NNP
25944	1145	9	?	?	.
25944	1145	10	#	#	$
25944	1145	11	The	the	DT
25944	1145	12	condition	condition	NN
25944	1145	13	responds	respond	VBZ
25944	1145	14	to	to	IN
25944	1145	15	tonics	tonic	NNS
25944	1145	16	and	and	CC
25944	1145	17	anti	anti	JJ
25944	1145	18	-	-	JJ
25944	1145	19	strumous	strumous	JJ
25944	1145	20	remedies	remedy	NNS
25944	1145	21	.	.	.
25944	1146	1	#	#	NNP
25944	1146	2	Eczema	Eczema	NNP
25944	1146	3	.	.	.
25944	1146	4	#	#	NNP
25944	1146	5	(	(	-LRB-
25944	1146	6	_	_	NNP
25944	1146	7	Synonym	Synonym	NNP
25944	1146	8	:	:	:
25944	1146	9	_	_	NNP
25944	1146	10	Tetter	Tetter	NNP
25944	1146	11	;	;	:
25944	1146	12	Salt	Salt	NNP
25944	1146	13	Rheum	Rheum	NNP
25944	1146	14	.	.	.
25944	1146	15	)	)	-RRB-
25944	1147	1	#	#	LS
25944	1147	2	What	what	WP
25944	1147	3	is	be	VBZ
25944	1147	4	eczema	eczema	NN
25944	1147	5	?	?	.
25944	1147	6	#	#	$
25944	1147	7	An	an	DT
25944	1147	8	acute	acute	JJ
25944	1147	9	,	,	,
25944	1147	10	subacute	subacute	JJ
25944	1147	11	or	or	CC
25944	1147	12	chronic	chronic	JJ
25944	1147	13	inflammatory	inflammatory	JJ
25944	1147	14	disease	disease	NN
25944	1147	15	,	,	,
25944	1147	16	characterized	characterize	VBN
25944	1147	17	in	in	IN
25944	1147	18	the	the	DT
25944	1147	19	beginning	beginning	NN
25944	1147	20	by	by	IN
25944	1147	21	the	the	DT
25944	1147	22	appearance	appearance	NN
25944	1147	23	of	of	IN
25944	1147	24	erythema	erythema	NNP
25944	1147	25	,	,	,
25944	1147	26	papules	papule	NNS
25944	1147	27	,	,	,
25944	1147	28	vesicles	vesicle	NNS
25944	1147	29	or	or	CC
25944	1147	30	pustules	pustule	NNS
25944	1147	31	,	,	,
25944	1147	32	or	or	CC
25944	1147	33	a	a	DT
25944	1147	34	combination	combination	NN
25944	1147	35	of	of	IN
25944	1147	36	these	these	DT
25944	1147	37	lesions	lesion	NNS
25944	1147	38	,	,	,
25944	1147	39	with	with	IN
25944	1147	40	a	a	DT
25944	1147	41	variable	variable	JJ
25944	1147	42	amount	amount	NN
25944	1147	43	of	of	IN
25944	1147	44	infiltration	infiltration	NN
25944	1147	45	and	and	CC
25944	1147	46	thickening	thickening	NN
25944	1147	47	,	,	,
25944	1147	48	terminating	terminate	VBG
25944	1147	49	either	either	CC
25944	1147	50	in	in	IN
25944	1147	51	discharge	discharge	NN
25944	1147	52	with	with	IN
25944	1147	53	the	the	DT
25944	1147	54	formation	formation	NN
25944	1147	55	of	of	IN
25944	1147	56	crusts	crust	NNS
25944	1147	57	,	,	,
25944	1147	58	in	in	IN
25944	1147	59	absorption	absorption	NN
25944	1147	60	,	,	,
25944	1147	61	or	or	CC
25944	1147	62	in	in	IN
25944	1147	63	desquamation	desquamation	NN
25944	1147	64	,	,	,
25944	1147	65	and	and	CC
25944	1147	66	accompanied	accompany	VBN
25944	1147	67	by	by	IN
25944	1147	68	more	more	JJR
25944	1147	69	or	or	CC
25944	1147	70	less	less	RBR
25944	1147	71	intense	intense	JJ
25944	1147	72	itching	itching	NN
25944	1147	73	and	and	CC
25944	1147	74	a	a	DT
25944	1147	75	feeling	feeling	NN
25944	1147	76	of	of	IN
25944	1147	77	heat	heat	NN
25944	1147	78	or	or	CC
25944	1147	79	burning	burn	VBG
25944	1147	80	.	.	.
25944	1148	1	#	#	LS
25944	1148	2	What	what	WP
25944	1148	3	are	be	VBP
25944	1148	4	the	the	DT
25944	1148	5	several	several	JJ
25944	1148	6	primary	primary	JJ
25944	1148	7	types	type	NNS
25944	1148	8	of	of	IN
25944	1148	9	eczema	eczema	NN
25944	1148	10	?	?	.
25944	1148	11	#	#	NNP
25944	1148	12	Erythematous	erythematous	JJ
25944	1148	13	,	,	,
25944	1148	14	papular	papular	JJ
25944	1148	15	,	,	,
25944	1148	16	vesicular	vesicular	JJ
25944	1148	17	and	and	CC
25944	1148	18	pustular	pustular	JJ
25944	1148	19	;	;	:
25944	1148	20	all	all	DT
25944	1148	21	cases	case	NNS
25944	1148	22	begin	begin	VBP
25944	1148	23	as	as	IN
25944	1148	24	one	one	CD
25944	1148	25	or	or	CC
25944	1148	26	more	more	JJR
25944	1148	27	of	of	IN
25944	1148	28	these	these	DT
25944	1148	29	types	type	NNS
25944	1148	30	,	,	,
25944	1148	31	but	but	CC
25944	1148	32	not	not	RB
25944	1148	33	infrequently	infrequently	RB
25944	1148	34	lose	lose	VBP
25944	1148	35	these	these	DT
25944	1148	36	characters	character	NNS
25944	1148	37	and	and	CC
25944	1148	38	develop	develop	VB
25944	1148	39	into	into	IN
25944	1148	40	the	the	DT
25944	1148	41	common	common	JJ
25944	1148	42	clinical	clinical	JJ
25944	1148	43	or	or	CC
25944	1148	44	secondary	secondary	JJ
25944	1148	45	types	type	NNS
25944	1148	46	--	--	:
25944	1148	47	eczema	eczema	NN
25944	1148	48	rubrum	rubrum	NN
25944	1148	49	and	and	CC
25944	1148	50	eczema	eczema	NN
25944	1148	51	squamosum	squamosum	NN
25944	1148	52	.	.	.
25944	1149	1	[	[	-LRB-
25944	1149	2	Illustration	illustration	NN
25944	1149	3	:	:	:
25944	1149	4	Fig	Fig	NNP
25944	1149	5	.	.	.
25944	1150	1	20	20	CD
25944	1150	2	.	.	.
25944	1151	1	Papular	Papular	NNP
25944	1151	2	Eczema	Eczema	NNP
25944	1151	3	(	(	-LRB-
25944	1151	4	leg	leg	NN
25944	1151	5	)	)	-RRB-
25944	1151	6	.	.	.
25944	1151	7	]	]	-RRB-
25944	1152	1	#	#	$
25944	1152	2	What	what	WDT
25944	1152	3	other	other	JJ
25944	1152	4	types	type	NNS
25944	1152	5	are	be	VBP
25944	1152	6	met	meet	VBN
25944	1152	7	with	with	IN
25944	1152	8	clinically	clinically	RB
25944	1152	9	?	?	.
25944	1152	10	#	#	$
25944	1152	11	Eczema	Eczema	NNP
25944	1152	12	rubrum	rubrum	NN
25944	1152	13	,	,	,
25944	1152	14	eczema	eczema	NN
25944	1152	15	squamosum	squamosum	NN
25944	1152	16	,	,	,
25944	1152	17	eczema	eczema	NN
25944	1152	18	fissum	fissum	NN
25944	1152	19	,	,	,
25944	1152	20	eczema	eczema	NN
25944	1152	21	sclerosum	sclerosum	NN
25944	1152	22	and	and	CC
25944	1152	23	eczema	eczema	NN
25944	1152	24	verrucosum	verrucosum	NN
25944	1152	25	.	.	.
25944	1153	1	Eczema	eczema	NN
25944	1153	2	seborrhoicum	seborrhoicum	NN
25944	1153	3	is	be	VBZ
25944	1153	4	probably	probably	RB
25944	1153	5	a	a	DT
25944	1153	6	closely	closely	RB
25944	1153	7	allied	ally	VBN
25944	1153	8	disease	disease	NN
25944	1153	9	,	,	,
25944	1153	10	occupying	occupy	VBG
25944	1153	11	a	a	DT
25944	1153	12	middle	middle	JJ
25944	1153	13	position	position	NN
25944	1153	14	between	between	IN
25944	1153	15	ordinary	ordinary	JJ
25944	1153	16	eczema	eczema	NN
25944	1153	17	and	and	CC
25944	1153	18	seborrh[oe]a	seborrh[oe]a	NNP
25944	1153	19	.	.	.
25944	1154	1	#	#	NNP
25944	1154	2	Describe	describe	VB
25944	1154	3	the	the	DT
25944	1154	4	symptoms	symptom	NNS
25944	1154	5	of	of	IN
25944	1154	6	erythematous	erythematous	JJ
25944	1154	7	eczema	eczema	NN
25944	1154	8	.	.	.
25944	1154	9	#	#	JJR
25944	1154	10	Erythematous	erythematous	JJ
25944	1154	11	eczema	eczema	NN
25944	1154	12	(	(	-LRB-
25944	1154	13	_	_	NNP
25944	1154	14	eczema	eczema	NN
25944	1154	15	erythematosum	erythematosum	NNP
25944	1154	16	_	_	NNP
25944	1154	17	)	)	-RRB-
25944	1154	18	begins	begin	VBZ
25944	1154	19	as	as	IN
25944	1154	20	one	one	CD
25944	1154	21	or	or	CC
25944	1154	22	more	more	JJR
25944	1154	23	small	small	JJ
25944	1154	24	or	or	CC
25944	1154	25	large	large	JJ
25944	1154	26	,	,	,
25944	1154	27	irregularly	irregularly	RB
25944	1154	28	outlined	outline	VBN
25944	1154	29	hyperæmic	hyperæmic	JJ
25944	1154	30	macules	macule	NNS
25944	1154	31	or	or	CC
25944	1154	32	patches	patch	NNS
25944	1154	33	,	,	,
25944	1154	34	with	with	IN
25944	1154	35	or	or	CC
25944	1154	36	without	without	IN
25944	1154	37	slight	slight	JJ
25944	1154	38	or	or	CC
25944	1154	39	marked	mark	VBN
25944	1154	40	swelling	swelling	NN
25944	1154	41	,	,	,
25944	1154	42	and	and	CC
25944	1154	43	with	with	IN
25944	1154	44	more	more	JJR
25944	1154	45	or	or	CC
25944	1154	46	less	less	RBR
25944	1154	47	itching	itch	VBG
25944	1154	48	or	or	CC
25944	1154	49	burning	burning	NN
25944	1154	50	.	.	.
25944	1155	1	At	at	IN
25944	1155	2	first	first	RB
25944	1155	3	it	-PRON-	PRP
25944	1155	4	may	may	MD
25944	1155	5	be	be	VB
25944	1155	6	ill	ill	RB
25944	1155	7	-	-	HYPH
25944	1155	8	defined	define	VBN
25944	1155	9	,	,	,
25944	1155	10	but	but	CC
25944	1155	11	it	-PRON-	PRP
25944	1155	12	tends	tend	VBZ
25944	1155	13	to	to	TO
25944	1155	14	spread	spread	VB
25944	1155	15	and	and	CC
25944	1155	16	its	-PRON-	PRP$
25944	1155	17	features	feature	NNS
25944	1155	18	to	to	TO
25944	1155	19	become	become	VB
25944	1155	20	more	more	RBR
25944	1155	21	pronounced	pronounced	JJ
25944	1155	22	.	.	.
25944	1156	1	It	-PRON-	PRP
25944	1156	2	may	may	MD
25944	1156	3	be	be	VB
25944	1156	4	limited	limit	VBN
25944	1156	5	to	to	IN
25944	1156	6	a	a	DT
25944	1156	7	certain	certain	JJ
25944	1156	8	region	region	NN
25944	1156	9	,	,	,
25944	1156	10	or	or	CC
25944	1156	11	it	-PRON-	PRP
25944	1156	12	may	may	MD
25944	1156	13	be	be	VB
25944	1156	14	more	more	RBR
25944	1156	15	or	or	CC
25944	1156	16	less	less	RBR
25944	1156	17	general	general	JJ
25944	1156	18	.	.	.
25944	1157	1	When	when	WRB
25944	1157	2	fully	fully	RB
25944	1157	3	developed	develop	VBN
25944	1157	4	,	,	,
25944	1157	5	the	the	DT
25944	1157	6	skin	skin	NN
25944	1157	7	is	be	VBZ
25944	1157	8	harsh	harsh	JJ
25944	1157	9	and	and	CC
25944	1157	10	dry	dry	JJ
25944	1157	11	,	,	,
25944	1157	12	of	of	IN
25944	1157	13	a	a	DT
25944	1157	14	mottled	mottled	JJ
25944	1157	15	,	,	,
25944	1157	16	reddish	reddish	JJ
25944	1157	17	or	or	CC
25944	1157	18	violaceous	violaceous	JJ
25944	1157	19	color	color	NN
25944	1157	20	,	,	,
25944	1157	21	thickened	thicken	VBD
25944	1157	22	,	,	,
25944	1157	23	infiltrated	infiltrate	VBN
25944	1157	24	and	and	CC
25944	1157	25	usually	usually	RB
25944	1157	26	slightly	slightly	RB
25944	1157	27	scaly	scaly	VBP
25944	1157	28	,	,	,
25944	1157	29	with	with	IN
25944	1157	30	,	,	,
25944	1157	31	at	at	IN
25944	1157	32	times	time	NNS
25944	1157	33	,	,	,
25944	1157	34	a	a	DT
25944	1157	35	tendency	tendency	NN
25944	1157	36	toward	toward	IN
25944	1157	37	the	the	DT
25944	1157	38	formation	formation	NN
25944	1157	39	of	of	IN
25944	1157	40	oozing	oozing	NN
25944	1157	41	areas	area	NNS
25944	1157	42	.	.	.
25944	1158	1	Punctate	punctate	NN
25944	1158	2	and	and	CC
25944	1158	3	linear	linear	JJ
25944	1158	4	scratch	scratch	NN
25944	1158	5	-	-	HYPH
25944	1158	6	marks	mark	NNS
25944	1158	7	may	may	MD
25944	1158	8	usually	usually	RB
25944	1158	9	be	be	VB
25944	1158	10	seen	see	VBN
25944	1158	11	scattered	scatter	VBN
25944	1158	12	over	over	IN
25944	1158	13	the	the	DT
25944	1158	14	affected	affected	JJ
25944	1158	15	region	region	NN
25944	1158	16	.	.	.
25944	1159	1	[	[	-LRB-
25944	1159	2	Illustration	illustration	NN
25944	1159	3	:	:	:
25944	1159	4	Fig	Fig	NNP
25944	1159	5	.	.	.
25944	1160	1	21	21	CD
25944	1160	2	.	.	.
25944	1161	1	Eczema	Eczema	NNP
25944	1161	2	Rubrum	Rubrum	NNP
25944	1161	3	.	.	.
25944	1161	4	]	]	-RRB-
25944	1162	1	Its	-PRON-	PRP$
25944	1162	2	most	most	RBS
25944	1162	3	common	common	JJ
25944	1162	4	site	site	NN
25944	1162	5	is	be	VBZ
25944	1162	6	the	the	DT
25944	1162	7	face	face	NN
25944	1162	8	,	,	,
25944	1162	9	but	but	CC
25944	1162	10	it	-PRON-	PRP
25944	1162	11	is	be	VBZ
25944	1162	12	not	not	RB
25944	1162	13	infrequent	infrequent	JJ
25944	1162	14	upon	upon	IN
25944	1162	15	other	other	JJ
25944	1162	16	parts	part	NNS
25944	1162	17	.	.	.
25944	1163	1	#	#	LS
25944	1163	2	What	what	WDT
25944	1163	3	course	course	NN
25944	1163	4	does	do	VBZ
25944	1163	5	erythematous	erythematous	JJ
25944	1163	6	eczema	eczema	NN
25944	1163	7	pursue	pursue	NN
25944	1163	8	?	?	.
25944	1163	9	#	#	$
25944	1163	10	It	-PRON-	PRP
25944	1163	11	tends	tend	VBZ
25944	1163	12	to	to	IN
25944	1163	13	chronicity	chronicity	NN
25944	1163	14	,	,	,
25944	1163	15	continuing	continue	VBG
25944	1163	16	as	as	IN
25944	1163	17	the	the	DT
25944	1163	18	erythematous	erythematous	JJ
25944	1163	19	form	form	NN
25944	1163	20	,	,	,
25944	1163	21	or	or	CC
25944	1163	22	the	the	DT
25944	1163	23	skin	skin	NN
25944	1163	24	may	may	MD
25944	1163	25	become	become	VB
25944	1163	26	considerably	considerably	RB
25944	1163	27	thickened	thicken	VBN
25944	1163	28	and	and	CC
25944	1163	29	markedly	markedly	RB
25944	1163	30	scaly	scaly	NNP
25944	1163	31	,	,	,
25944	1163	32	constituting	constitute	VBG
25944	1163	33	eczema	eczema	NN
25944	1163	34	squamosum	squamosum	NN
25944	1163	35	;	;	:
25944	1163	36	or	or	CC
25944	1163	37	a	a	DT
25944	1163	38	moist	moist	JJ
25944	1163	39	oozing	oozing	NN
25944	1163	40	surface	surface	NN
25944	1163	41	,	,	,
25944	1163	42	with	with	IN
25944	1163	43	more	more	RBR
25944	1163	44	or	or	CC
25944	1163	45	less	less	RBR
25944	1163	46	crusting	crusting	NN
25944	1163	47	,	,	,
25944	1163	48	may	may	MD
25944	1163	49	take	take	VB
25944	1163	50	its	-PRON-	PRP$
25944	1163	51	place	place	NN
25944	1163	52	--	--	:
25944	1163	53	eczema	eczema	NN
25944	1163	54	rubrum	rubrum	NN
25944	1163	55	.	.	.
25944	1164	1	#	#	NNP
25944	1164	2	Describe	describe	VB
25944	1164	3	the	the	DT
25944	1164	4	symptoms	symptom	NNS
25944	1164	5	of	of	IN
25944	1164	6	papular	papular	JJ
25944	1164	7	eczema	eczema	NN
25944	1164	8	.	.	.
25944	1164	9	#	#	$
25944	1164	10	Papular	Papular	NNP
25944	1164	11	eczema	eczema	NN
25944	1164	12	(	(	-LRB-
25944	1164	13	_	_	NNP
25944	1164	14	eczema	eczema	NN
25944	1164	15	papulosum	papulosum	NN
25944	1164	16	_	_	NNP
25944	1164	17	)	)	-RRB-
25944	1164	18	is	be	VBZ
25944	1164	19	characterized	characterize	VBN
25944	1164	20	by	by	IN
25944	1164	21	the	the	DT
25944	1164	22	appearance	appearance	NN
25944	1164	23	,	,	,
25944	1164	24	usually	usually	RB
25944	1164	25	in	in	IN
25944	1164	26	numbers	number	NNS
25944	1164	27	,	,	,
25944	1164	28	of	of	IN
25944	1164	29	discrete	discrete	JJ
25944	1164	30	,	,	,
25944	1164	31	aggregated	aggregated	JJ
25944	1164	32	or	or	CC
25944	1164	33	closely	closely	RB
25944	1164	34	-	-	HYPH
25944	1164	35	crowded	crowded	JJ
25944	1164	36	,	,	,
25944	1164	37	reddish	reddish	JJ
25944	1164	38	,	,	,
25944	1164	39	pin	pin	NN
25944	1164	40	-	-	HYPH
25944	1164	41	head	head	NN
25944	1164	42	-	-	HYPH
25944	1164	43	sized	sized	JJ
25944	1164	44	acuminated	acuminated	JJ
25944	1164	45	or	or	CC
25944	1164	46	rounded	rounded	JJ
25944	1164	47	papules	papule	NNS
25944	1164	48	.	.	.
25944	1165	1	Vesicles	vesicle	NNS
25944	1165	2	and	and	CC
25944	1165	3	vesico	vesico	NN
25944	1165	4	-	-	HYPH
25944	1165	5	papules	papule	NNS
25944	1165	6	are	be	VBP
25944	1165	7	often	often	RB
25944	1165	8	intermingled	intermingle	VBN
25944	1165	9	.	.	.
25944	1166	1	The	the	DT
25944	1166	2	itching	itching	NN
25944	1166	3	is	be	VBZ
25944	1166	4	commonly	commonly	RB
25944	1166	5	intense	intense	JJ
25944	1166	6	,	,	,
25944	1166	7	as	as	RB
25944	1166	8	often	often	RB
25944	1166	9	attested	attest	VBN
25944	1166	10	by	by	IN
25944	1166	11	the	the	DT
25944	1166	12	presence	presence	NN
25944	1166	13	of	of	IN
25944	1166	14	scratch	scratch	NN
25944	1166	15	-	-	HYPH
25944	1166	16	marks	mark	NNS
25944	1166	17	and	and	CC
25944	1166	18	blood	blood	NN
25944	1166	19	crusts	crust	NNS
25944	1166	20	.	.	.
25944	1167	1	[	[	-LRB-
25944	1167	2	Illustration	illustration	NN
25944	1167	3	:	:	:
25944	1167	4	Fig	Fig	NNP
25944	1167	5	.	.	.
25944	1168	1	22	22	CD
25944	1168	2	.	.	.
25944	1169	1	Eczema	Eczema	NNP
25944	1169	2	Squamosum	Squamosum	NNP
25944	1169	3	et	et	NNP
25944	1169	4	tissum	tissum	NN
25944	1169	5	.	.	.
25944	1169	6	]	]	-RRB-
25944	1170	1	It	-PRON-	PRP
25944	1170	2	is	be	VBZ
25944	1170	3	seen	see	VBN
25944	1170	4	most	most	RBS
25944	1170	5	frequently	frequently	RB
25944	1170	6	upon	upon	IN
25944	1170	7	the	the	DT
25944	1170	8	extremities	extremity	NNS
25944	1170	9	,	,	,
25944	1170	10	especially	especially	RB
25944	1170	11	the	the	DT
25944	1170	12	flexor	flexor	NN
25944	1170	13	surfaces	surface	NNS
25944	1170	14	.	.	.
25944	1171	1	#	#	LS
25944	1171	2	What	what	WDT
25944	1171	3	course	course	NN
25944	1171	4	does	do	VBZ
25944	1171	5	papular	papular	JJ
25944	1171	6	eczema	eczema	NN
25944	1171	7	pursue	pursue	VB
25944	1171	8	?	?	.
25944	1171	9	#	#	$
25944	1171	10	The	the	DT
25944	1171	11	lesions	lesion	NNS
25944	1171	12	tend	tend	VBP
25944	1171	13	,	,	,
25944	1171	14	sooner	sooner	RB
25944	1171	15	or	or	CC
25944	1171	16	later	later	RB
25944	1171	17	,	,	,
25944	1171	18	to	to	TO
25944	1171	19	disappear	disappear	VB
25944	1171	20	,	,	,
25944	1171	21	but	but	CC
25944	1171	22	are	be	VBP
25944	1171	23	usually	usually	RB
25944	1171	24	replaced	replace	VBN
25944	1171	25	by	by	IN
25944	1171	26	others	other	NNS
25944	1171	27	,	,	,
25944	1171	28	the	the	DT
25944	1171	29	disease	disease	NN
25944	1171	30	thus	thus	RB
25944	1171	31	persisting	persist	VBG
25944	1171	32	for	for	IN
25944	1171	33	weeks	week	NNS
25944	1171	34	or	or	CC
25944	1171	35	months	month	NNS
25944	1171	36	;	;	:
25944	1171	37	in	in	IN
25944	1171	38	places	place	NNS
25944	1171	39	where	where	WRB
25944	1171	40	closely	closely	RB
25944	1171	41	crowded	crowded	JJ
25944	1171	42	,	,	,
25944	1171	43	a	a	DT
25944	1171	44	solid	solid	JJ
25944	1171	45	,	,	,
25944	1171	46	thickened	thicken	VBN
25944	1171	47	,	,	,
25944	1171	48	scaly	scaly	NNP
25944	1171	49	sheet	sheet	NN
25944	1171	50	of	of	IN
25944	1171	51	eruption	eruption	NN
25944	1171	52	may	may	MD
25944	1171	53	result	result	VB
25944	1171	54	--	--	:
25944	1171	55	eczema	eczema	NN
25944	1171	56	squamosum	squamosum	NN
25944	1171	57	.	.	.
25944	1172	1	#	#	NNP
25944	1172	2	Describe	describe	VB
25944	1172	3	the	the	DT
25944	1172	4	symptoms	symptom	NNS
25944	1172	5	of	of	IN
25944	1172	6	vesicular	vesicular	JJ
25944	1172	7	eczema	eczema	NN
25944	1172	8	.	.	.
25944	1172	9	#	#	$
25944	1172	10	Vesicular	Vesicular	NNP
25944	1172	11	eczema	eczema	NN
25944	1172	12	(	(	-LRB-
25944	1172	13	_	_	NNP
25944	1172	14	Eczema	Eczema	NNP
25944	1172	15	vesiculosum	vesiculosum	NN
25944	1172	16	_	_	NNP
25944	1172	17	)	)	-RRB-
25944	1172	18	usually	usually	RB
25944	1172	19	appears	appear	VBZ
25944	1172	20	,	,	,
25944	1172	21	on	on	IN
25944	1172	22	one	one	CD
25944	1172	23	or	or	CC
25944	1172	24	several	several	JJ
25944	1172	25	regions	region	NNS
25944	1172	26	,	,	,
25944	1172	27	as	as	IN
25944	1172	28	more	more	RBR
25944	1172	29	or	or	CC
25944	1172	30	less	less	RBR
25944	1172	31	diffused	diffused	JJ
25944	1172	32	inflammatory	inflammatory	JJ
25944	1172	33	reddened	redden	VBN
25944	1172	34	patches	patch	NNS
25944	1172	35	,	,	,
25944	1172	36	upon	upon	IN
25944	1172	37	which	which	WDT
25944	1172	38	rapidly	rapidly	RB
25944	1172	39	develop	develop	VBP
25944	1172	40	numerous	numerous	JJ
25944	1172	41	closely	closely	RB
25944	1172	42	-	-	HYPH
25944	1172	43	crowded	crowded	JJ
25944	1172	44	pin	pin	NN
25944	1172	45	-	-	HYPH
25944	1172	46	point	point	NN
25944	1172	47	to	to	IN
25944	1172	48	pin	pin	NN
25944	1172	49	-	-	HYPH
25944	1172	50	head	head	NN
25944	1172	51	-	-	HYPH
25944	1172	52	sized	sized	JJ
25944	1172	53	vesicles	vesicle	NNS
25944	1172	54	,	,	,
25944	1172	55	which	which	WDT
25944	1172	56	tend	tend	VBP
25944	1172	57	to	to	TO
25944	1172	58	become	become	VB
25944	1172	59	confluent	confluent	NN
25944	1172	60	and	and	CC
25944	1172	61	form	form	VB
25944	1172	62	a	a	DT
25944	1172	63	solid	solid	JJ
25944	1172	64	sheet	sheet	NN
25944	1172	65	of	of	IN
25944	1172	66	eruption	eruption	NN
25944	1172	67	.	.	.
25944	1173	1	The	the	DT
25944	1173	2	vesicles	vesicle	NNS
25944	1173	3	soon	soon	RB
25944	1173	4	mature	mature	VBP
25944	1173	5	and	and	CC
25944	1173	6	rupture	rupture	VB
25944	1173	7	,	,	,
25944	1173	8	the	the	DT
25944	1173	9	discharge	discharge	NN
25944	1173	10	drying	dry	VBG
25944	1173	11	to	to	IN
25944	1173	12	yellowish	yellowish	JJ
25944	1173	13	,	,	,
25944	1173	14	honeycomb	honeycomb	NN
25944	1173	15	-	-	HYPH
25944	1173	16	like	like	JJ
25944	1173	17	crusts	crust	NNS
25944	1173	18	.	.	.
25944	1174	1	The	the	DT
25944	1174	2	oozing	oozing	NN
25944	1174	3	is	be	VBZ
25944	1174	4	usually	usually	RB
25944	1174	5	more	more	RBR
25944	1174	6	or	or	CC
25944	1174	7	less	less	RBR
25944	1174	8	continuous	continuous	JJ
25944	1174	9	,	,	,
25944	1174	10	or	or	CC
25944	1174	11	the	the	DT
25944	1174	12	disease	disease	NN
25944	1174	13	may	may	MD
25944	1174	14	decline	decline	VB
25944	1174	15	,	,	,
25944	1174	16	the	the	DT
25944	1174	17	crusts	crust	NNS
25944	1174	18	be	be	VB
25944	1174	19	cast	cast	VBN
25944	1174	20	off	off	RP
25944	1174	21	,	,	,
25944	1174	22	to	to	TO
25944	1174	23	be	be	VB
25944	1174	24	quickly	quickly	RB
25944	1174	25	followed	follow	VBN
25944	1174	26	by	by	IN
25944	1174	27	a	a	DT
25944	1174	28	new	new	JJ
25944	1174	29	crop	crop	NN
25944	1174	30	of	of	IN
25944	1174	31	vesicles	vesicle	NNS
25944	1174	32	.	.	.
25944	1175	1	In	in	IN
25944	1175	2	those	those	DT
25944	1175	3	cases	case	NNS
25944	1175	4	in	in	IN
25944	1175	5	which	which	WDT
25944	1175	6	the	the	DT
25944	1175	7	process	process	NN
25944	1175	8	is	be	VBZ
25944	1175	9	markedly	markedly	RB
25944	1175	10	acute	acute	JJ
25944	1175	11	,	,	,
25944	1175	12	considerable	considerable	JJ
25944	1175	13	swelling	swelling	NN
25944	1175	14	and	and	CC
25944	1175	15	[	[	-LRB-
25944	1175	16	oe]dema	oe]dema	NNS
25944	1175	17	are	be	VBP
25944	1175	18	present	present	JJ
25944	1175	19	.	.	.
25944	1176	1	Scattered	scatter	VBN
25944	1176	2	papules	papule	NNS
25944	1176	3	,	,	,
25944	1176	4	vesico	vesico	NN
25944	1176	5	-	-	HYPH
25944	1176	6	papules	papule	NNS
25944	1176	7	and	and	CC
25944	1176	8	pustules	pustule	NNS
25944	1176	9	may	may	MD
25944	1176	10	usually	usually	RB
25944	1176	11	be	be	VB
25944	1176	12	seen	see	VBN
25944	1176	13	upon	upon	IN
25944	1176	14	the	the	DT
25944	1176	15	involved	involved	JJ
25944	1176	16	area	area	NN
25944	1176	17	or	or	CC
25944	1176	18	about	about	IN
25944	1176	19	the	the	DT
25944	1176	20	border	border	NN
25944	1176	21	.	.	.
25944	1177	1	The	the	DT
25944	1177	2	face	face	NN
25944	1177	3	in	in	IN
25944	1177	4	infants	infant	NNS
25944	1177	5	(	(	-LRB-
25944	1177	6	_	_	NNP
25944	1177	7	crusta	crusta	NNP
25944	1177	8	lactea	lactea	NNP
25944	1177	9	_	_	NNP
25944	1177	10	,	,	,
25944	1177	11	or	or	CC
25944	1177	12	_	_	NNP
25944	1177	13	milk	milk	NN
25944	1177	14	crust	crust	NN
25944	1177	15	_	_	NNP
25944	1177	16	,	,	,
25944	1177	17	of	of	IN
25944	1177	18	older	old	JJR
25944	1177	19	writers	writer	NNS
25944	1177	20	)	)	-RRB-
25944	1177	21	,	,	,
25944	1177	22	the	the	DT
25944	1177	23	neck	neck	NN
25944	1177	24	,	,	,
25944	1177	25	flexor	flexor	NN
25944	1177	26	surfaces	surface	NNS
25944	1177	27	and	and	CC
25944	1177	28	the	the	DT
25944	1177	29	fingers	finger	NNS
25944	1177	30	are	be	VBP
25944	1177	31	its	-PRON-	PRP$
25944	1177	32	favorite	favorite	JJ
25944	1177	33	localities	locality	NNS
25944	1177	34	.	.	.
25944	1178	1	#	#	LS
25944	1178	2	What	what	WDT
25944	1178	3	course	course	NN
25944	1178	4	does	do	VBZ
25944	1178	5	vesicular	vesicular	JJ
25944	1178	6	eczema	eczema	NN
25944	1178	7	pursue	pursue	NN
25944	1178	8	?	?	.
25944	1178	9	#	#	NN
25944	1178	10	Usually	usually	RB
25944	1178	11	chronic	chronic	JJ
25944	1178	12	,	,	,
25944	1178	13	with	with	IN
25944	1178	14	acute	acute	JJ
25944	1178	15	exacerbations	exacerbation	NNS
25944	1178	16	.	.	.
25944	1179	1	Not	not	RB
25944	1179	2	infrequently	infrequently	RB
25944	1179	3	it	-PRON-	PRP
25944	1179	4	passes	pass	VBZ
25944	1179	5	into	into	IN
25944	1179	6	eczema	eczema	NN
25944	1179	7	rubrum	rubrum	NN
25944	1179	8	.	.	.
25944	1180	1	#	#	NNP
25944	1180	2	Describe	describe	VB
25944	1180	3	the	the	DT
25944	1180	4	symptoms	symptom	NNS
25944	1180	5	of	of	IN
25944	1180	6	pustular	pustular	JJ
25944	1180	7	eczema	eczema	NN
25944	1180	8	.	.	.
25944	1180	9	#	#	$
25944	1180	10	Pustular	Pustular	NNP
25944	1180	11	eczema	eczema	NN
25944	1180	12	(	(	-LRB-
25944	1180	13	_	_	NNP
25944	1180	14	eczema	eczema	NNP
25944	1180	15	pustulosum	pustulosum	NN
25944	1180	16	_	_	NNP
25944	1180	17	,	,	,
25944	1180	18	_	_	NNP
25944	1180	19	eczema	eczema	NN
25944	1180	20	impetiginosum	impetiginosum	NN
25944	1180	21	_	_	NNP
25944	1180	22	)	)	-RRB-
25944	1180	23	is	be	VBZ
25944	1180	24	probably	probably	RB
25944	1180	25	the	the	DT
25944	1180	26	least	least	JJS
25944	1180	27	common	common	JJ
25944	1180	28	of	of	IN
25944	1180	29	all	all	PDT
25944	1180	30	the	the	DT
25944	1180	31	varieties	variety	NNS
25944	1180	32	.	.	.
25944	1181	1	It	-PRON-	PRP
25944	1181	2	is	be	VBZ
25944	1181	3	similar	similar	JJ
25944	1181	4	,	,	,
25944	1181	5	although	although	IN
25944	1181	6	usually	usually	RB
25944	1181	7	less	less	RBR
25944	1181	8	actively	actively	RB
25944	1181	9	inflammatory	inflammatory	JJ
25944	1181	10	,	,	,
25944	1181	11	in	in	IN
25944	1181	12	its	-PRON-	PRP$
25944	1181	13	symptoms	symptom	NNS
25944	1181	14	to	to	IN
25944	1181	15	eczema	eczema	NNP
25944	1181	16	vesiculosum	vesiculosum	NN
25944	1181	17	,	,	,
25944	1181	18	the	the	DT
25944	1181	19	lesions	lesion	NNS
25944	1181	20	being	be	VBG
25944	1181	21	pustular	pustular	JJ
25944	1181	22	from	from	IN
25944	1181	23	the	the	DT
25944	1181	24	start	start	NN
25944	1181	25	or	or	CC
25944	1181	26	developing	develop	VBG
25944	1181	27	from	from	IN
25944	1181	28	preëxisting	preëxiste	VBG
25944	1181	29	vesicles	vesicle	NNS
25944	1181	30	;	;	:
25944	1181	31	not	not	RB
25944	1181	32	infrequently	infrequently	RB
25944	1181	33	the	the	DT
25944	1181	34	eruption	eruption	NN
25944	1181	35	is	be	VBZ
25944	1181	36	mixed	mixed	JJ
25944	1181	37	,	,	,
25944	1181	38	the	the	DT
25944	1181	39	pustules	pustule	NNS
25944	1181	40	predominating	predominate	VBG
25944	1181	41	.	.	.
25944	1182	1	There	there	EX
25944	1182	2	is	be	VBZ
25944	1182	3	a	a	DT
25944	1182	4	marked	marked	JJ
25944	1182	5	tendency	tendency	NN
25944	1182	6	to	to	IN
25944	1182	7	rupturing	rupture	VBG
25944	1182	8	of	of	IN
25944	1182	9	the	the	DT
25944	1182	10	lesions	lesion	NNS
25944	1182	11	,	,	,
25944	1182	12	the	the	DT
25944	1182	13	discharge	discharge	NN
25944	1182	14	drying	dry	VBG
25944	1182	15	to	to	IN
25944	1182	16	thick	thick	JJ
25944	1182	17	,	,	,
25944	1182	18	yellowish	yellowish	JJ
25944	1182	19	,	,	,
25944	1182	20	brownish	brownish	JJ
25944	1182	21	or	or	CC
25944	1182	22	greenish	greenish	JJ
25944	1182	23	crusts	crust	NNS
25944	1182	24	.	.	.
25944	1183	1	Its	-PRON-	PRP$
25944	1183	2	most	most	RBS
25944	1183	3	common	common	JJ
25944	1183	4	sites	site	NNS
25944	1183	5	are	be	VBP
25944	1183	6	the	the	DT
25944	1183	7	scalp	scalp	NN
25944	1183	8	and	and	CC
25944	1183	9	face	face	NN
25944	1183	10	,	,	,
25944	1183	11	especially	especially	RB
25944	1183	12	in	in	IN
25944	1183	13	young	young	JJ
25944	1183	14	people	people	NNS
25944	1183	15	and	and	CC
25944	1183	16	in	in	IN
25944	1183	17	those	those	DT
25944	1183	18	who	who	WP
25944	1183	19	are	be	VBP
25944	1183	20	ill	ill	RB
25944	1183	21	-	-	HYPH
25944	1183	22	nourished	nourished	JJ
25944	1183	23	and	and	CC
25944	1183	24	strumous	strumous	JJ
25944	1183	25	.	.	.
25944	1184	1	#	#	LS
25944	1184	2	What	what	WDT
25944	1184	3	course	course	NN
25944	1184	4	does	do	VBZ
25944	1184	5	pustular	pustular	JJ
25944	1184	6	eczema	eczema	NN
25944	1184	7	pursue	pursue	NN
25944	1184	8	?	?	.
25944	1184	9	#	#	NN
25944	1184	10	Usually	usually	RB
25944	1184	11	chronic	chronic	JJ
25944	1184	12	,	,	,
25944	1184	13	continuing	continue	VBG
25944	1184	14	as	as	IN
25944	1184	15	the	the	DT
25944	1184	16	same	same	JJ
25944	1184	17	type	type	NN
25944	1184	18	,	,	,
25944	1184	19	or	or	CC
25944	1184	20	passing	pass	VBG
25944	1184	21	into	into	IN
25944	1184	22	eczema	eczema	NN
25944	1184	23	rubrum	rubrum	NN
25944	1184	24	.	.	.
25944	1185	1	#	#	NNP
25944	1185	2	Describe	describe	VB
25944	1185	3	the	the	DT
25944	1185	4	symptoms	symptom	NNS
25944	1185	5	of	of	IN
25944	1185	6	squamous	squamous	JJ
25944	1185	7	eczema	eczema	NN
25944	1185	8	.	.	.
25944	1185	9	#	#	JJR
25944	1185	10	Squamous	squamous	JJ
25944	1185	11	eczema	eczema	NN
25944	1185	12	(	(	-LRB-
25944	1185	13	_	_	NNP
25944	1185	14	eczema	eczema	NN
25944	1185	15	squamosum	squamosum	NN
25944	1185	16	_	_	NNP
25944	1185	17	)	)	-RRB-
25944	1185	18	may	may	MD
25944	1185	19	be	be	VB
25944	1185	20	defined	define	VBN
25944	1185	21	as	as	IN
25944	1185	22	a	a	DT
25944	1185	23	clinical	clinical	JJ
25944	1185	24	variety	variety	NN
25944	1185	25	,	,	,
25944	1185	26	the	the	DT
25944	1185	27	chief	chief	JJ
25944	1185	28	symptoms	symptom	NNS
25944	1185	29	of	of	IN
25944	1185	30	which	which	WDT
25944	1185	31	are	be	VBP
25944	1185	32	a	a	DT
25944	1185	33	variable	variable	JJ
25944	1185	34	degree	degree	NN
25944	1185	35	of	of	IN
25944	1185	36	scaliness	scaliness	NN
25944	1185	37	,	,	,
25944	1185	38	more	more	RBR
25944	1185	39	or	or	CC
25944	1185	40	less	less	RBR
25944	1185	41	thickening	thickening	NN
25944	1185	42	,	,	,
25944	1185	43	infiltration	infiltration	NN
25944	1185	44	,	,	,
25944	1185	45	and	and	CC
25944	1185	46	redness	redness	NN
25944	1185	47	,	,	,
25944	1185	48	with	with	IN
25944	1185	49	commonly	commonly	RB
25944	1185	50	a	a	DT
25944	1185	51	tendency	tendency	NN
25944	1185	52	to	to	IN
25944	1185	53	cracking	crack	VBG
25944	1185	54	or	or	CC
25944	1185	55	fissuring	fissuring	NN
25944	1185	56	of	of	IN
25944	1185	57	the	the	DT
25944	1185	58	skin	skin	NN
25944	1185	59	,	,	,
25944	1185	60	especially	especially	RB
25944	1185	61	when	when	WRB
25944	1185	62	the	the	DT
25944	1185	63	disease	disease	NN
25944	1185	64	is	be	VBZ
25944	1185	65	seated	seat	VBN
25944	1185	66	about	about	IN
25944	1185	67	the	the	DT
25944	1185	68	joints	joint	NNS
25944	1185	69	.	.	.
25944	1186	1	It	-PRON-	PRP
25944	1186	2	is	be	VBZ
25944	1186	3	developed	develop	VBN
25944	1186	4	,	,	,
25944	1186	5	as	as	IN
25944	1186	6	a	a	DT
25944	1186	7	rule	rule	NN
25944	1186	8	,	,	,
25944	1186	9	from	from	IN
25944	1186	10	the	the	DT
25944	1186	11	erythematous	erythematous	JJ
25944	1186	12	or	or	CC
25944	1186	13	papular	papular	JJ
25944	1186	14	type	type	NN
25944	1186	15	.	.	.
25944	1187	1	Itching	itching	NN
25944	1187	2	is	be	VBZ
25944	1187	3	slight	slight	JJ
25944	1187	4	or	or	CC
25944	1187	5	intense	intense	JJ
25944	1187	6	.	.	.
25944	1188	1	The	the	DT
25944	1188	2	disease	disease	NN
25944	1188	3	is	be	VBZ
25944	1188	4	not	not	RB
25944	1188	5	uncommon	uncommon	JJ
25944	1188	6	upon	upon	IN
25944	1188	7	the	the	DT
25944	1188	8	scalp	scalp	NN
25944	1188	9	.	.	.
25944	1189	1	#	#	LS
25944	1189	2	What	what	WP
25944	1189	3	is	be	VBZ
25944	1189	4	the	the	DT
25944	1189	5	course	course	NN
25944	1189	6	of	of	IN
25944	1189	7	squamous	squamous	JJ
25944	1189	8	eczema	eczema	NN
25944	1189	9	?	?	.
25944	1189	10	#	#	$
25944	1189	11	Essentially	essentially	RB
25944	1189	12	chronic	chronic	JJ
25944	1189	13	.	.	.
25944	1190	1	[	[	-LRB-
25944	1190	2	Illustration	illustration	NN
25944	1190	3	:	:	:
25944	1190	4	Fig	Fig	NNP
25944	1190	5	.	.	.
25944	1191	1	23	23	CD
25944	1191	2	.	.	.
25944	1192	1	Eczema	eczema	NN
25944	1192	2	of	of	IN
25944	1192	3	the	the	DT
25944	1192	4	Face	Face	NNP
25944	1192	5	and	and	CC
25944	1192	6	Scalp	Scalp	NNP
25944	1192	7	.	.	.
25944	1192	8	]	]	-RRB-
25944	1193	1	#	#	NNP
25944	1193	2	Describe	describe	VB
25944	1193	3	the	the	DT
25944	1193	4	symptoms	symptom	NNS
25944	1193	5	of	of	IN
25944	1193	6	eczema	eczema	NN
25944	1193	7	rubrum	rubrum	NN
25944	1193	8	.	.	.
25944	1193	9	#	#	$
25944	1193	10	Eczema	Eczema	NNP
25944	1193	11	rubrum	rubrum	NN
25944	1193	12	is	be	VBZ
25944	1193	13	characterized	characterize	VBN
25944	1193	14	by	by	IN
25944	1193	15	a	a	DT
25944	1193	16	red	red	JJ
25944	1193	17	,	,	,
25944	1193	18	raw	raw	JJ
25944	1193	19	-	-	HYPH
25944	1193	20	looking	look	VBG
25944	1193	21	,	,	,
25944	1193	22	weeping	weeping	NN
25944	1193	23	,	,	,
25944	1193	24	oozing	oozing	NN
25944	1193	25	or	or	CC
25944	1193	26	discharging	discharging	NN
25944	1193	27	surface	surface	NN
25944	1193	28	,	,	,
25944	1193	29	attended	attend	VBD
25944	1193	30	with	with	IN
25944	1193	31	more	more	JJR
25944	1193	32	or	or	CC
25944	1193	33	less	less	RBR
25944	1193	34	inflammatory	inflammatory	JJ
25944	1193	35	thickening	thickening	NN
25944	1193	36	,	,	,
25944	1193	37	infiltration	infiltration	NN
25944	1193	38	and	and	CC
25944	1193	39	swelling	swelling	NN
25944	1193	40	;	;	:
25944	1193	41	the	the	DT
25944	1193	42	exudation	exudation	NN
25944	1193	43	,	,	,
25944	1193	44	consisting	consist	VBG
25944	1193	45	of	of	IN
25944	1193	46	serum	serum	NN
25944	1193	47	,	,	,
25944	1193	48	sometimes	sometimes	RB
25944	1193	49	bloody	bloody	JJ
25944	1193	50	,	,	,
25944	1193	51	dries	dry	NNS
25944	1193	52	into	into	IN
25944	1193	53	thick	thick	JJ
25944	1193	54	yellowish	yellowish	JJ
25944	1193	55	or	or	CC
25944	1193	56	reddish	reddish	JJ
25944	1193	57	-	-	HYPH
25944	1193	58	brown	brown	JJ
25944	1193	59	crusts	crust	NNS
25944	1193	60	.	.	.
25944	1194	1	At	at	IN
25944	1194	2	one	one	CD
25944	1194	3	time	time	NN
25944	1194	4	the	the	DT
25944	1194	5	whole	whole	JJ
25944	1194	6	diseased	diseased	JJ
25944	1194	7	area	area	NN
25944	1194	8	may	may	MD
25944	1194	9	be	be	VB
25944	1194	10	hidden	hide	VBN
25944	1194	11	under	under	IN
25944	1194	12	a	a	DT
25944	1194	13	mass	mass	NN
25944	1194	14	of	of	IN
25944	1194	15	crusting	crusting	NN
25944	1194	16	,	,	,
25944	1194	17	at	at	IN
25944	1194	18	other	other	JJ
25944	1194	19	times	time	NNS
25944	1194	20	a	a	DT
25944	1194	21	red	red	JJ
25944	1194	22	,	,	,
25944	1194	23	raw	raw	JJ
25944	1194	24	-	-	HYPH
25944	1194	25	looking	look	VBG
25944	1194	26	,	,	,
25944	1194	27	weeping	weeping	NN
25944	1194	28	surface	surface	NN
25944	1194	29	(	(	-LRB-
25944	1194	30	_	_	NNP
25944	1194	31	eczema	eczema	NN
25944	1194	32	madidans	madidan	NNS
25944	1194	33	_	_	NNP
25944	1194	34	)	)	-RRB-
25944	1194	35	is	be	VBZ
25944	1194	36	the	the	DT
25944	1194	37	most	most	RBS
25944	1194	38	striking	striking	JJ
25944	1194	39	feature	feature	NN
25944	1194	40	.	.	.
25944	1195	1	Itching	itching	NN
25944	1195	2	is	be	VBZ
25944	1195	3	slight	slight	JJ
25944	1195	4	or	or	CC
25944	1195	5	intense	intense	JJ
25944	1195	6	,	,	,
25944	1195	7	or	or	CC
25944	1195	8	the	the	DT
25944	1195	9	subjective	subjective	JJ
25944	1195	10	symptom	symptom	NN
25944	1195	11	may	may	MD
25944	1195	12	be	be	VB
25944	1195	13	a	a	DT
25944	1195	14	feeling	feeling	NN
25944	1195	15	of	of	IN
25944	1195	16	burning	burning	NN
25944	1195	17	.	.	.
25944	1196	1	It	-PRON-	PRP
25944	1196	2	is	be	VBZ
25944	1196	3	an	an	DT
25944	1196	4	important	important	JJ
25944	1196	5	clinical	clinical	JJ
25944	1196	6	type	type	NN
25944	1196	7	,	,	,
25944	1196	8	usually	usually	RB
25944	1196	9	developing	develop	VBG
25944	1196	10	from	from	IN
25944	1196	11	the	the	DT
25944	1196	12	vesicular	vesicular	JJ
25944	1196	13	,	,	,
25944	1196	14	pustular	pustular	JJ
25944	1196	15	or	or	CC
25944	1196	16	other	other	JJ
25944	1196	17	primary	primary	JJ
25944	1196	18	variety	variety	NN
25944	1196	19	.	.	.
25944	1197	1	It	-PRON-	PRP
25944	1197	2	is	be	VBZ
25944	1197	3	common	common	JJ
25944	1197	4	about	about	IN
25944	1197	5	the	the	DT
25944	1197	6	face	face	NN
25944	1197	7	and	and	CC
25944	1197	8	scalp	scalp	NN
25944	1197	9	in	in	IN
25944	1197	10	children	child	NNS
25944	1197	11	,	,	,
25944	1197	12	and	and	CC
25944	1197	13	the	the	DT
25944	1197	14	middle	middle	JJ
25944	1197	15	and	and	CC
25944	1197	16	lower	low	JJR
25944	1197	17	part	part	NN
25944	1197	18	of	of	IN
25944	1197	19	the	the	DT
25944	1197	20	leg	leg	NN
25944	1197	21	in	in	IN
25944	1197	22	elderly	elderly	JJ
25944	1197	23	people	people	NNS
25944	1197	24	.	.	.
25944	1198	1	#	#	LS
25944	1198	2	What	what	WP
25944	1198	3	is	be	VBZ
25944	1198	4	the	the	DT
25944	1198	5	course	course	NN
25944	1198	6	of	of	IN
25944	1198	7	eczema	eczema	NN
25944	1198	8	rubrum	rubrum	NN
25944	1198	9	?	?	.
25944	1198	10	#	#	$
25944	1198	11	Chronic	chronic	JJ
25944	1198	12	,	,	,
25944	1198	13	varying	vary	VBG
25944	1198	14	in	in	IN
25944	1198	15	intensity	intensity	NN
25944	1198	16	from	from	IN
25944	1198	17	time	time	NN
25944	1198	18	to	to	IN
25944	1198	19	time	time	NN
25944	1198	20	.	.	.
25944	1199	1	#	#	NNP
25944	1199	2	Describe	describe	VB
25944	1199	3	the	the	DT
25944	1199	4	symptoms	symptom	NNS
25944	1199	5	of	of	IN
25944	1199	6	fissured	fissure	VBN
25944	1199	7	eczema	eczema	NN
25944	1199	8	.	.	.
25944	1199	9	#	#	$
25944	1199	10	The	the	DT
25944	1199	11	conspicuous	conspicuous	JJ
25944	1199	12	symptom	symptom	NN
25944	1199	13	is	be	VBZ
25944	1199	14	a	a	DT
25944	1199	15	marked	marked	JJ
25944	1199	16	tendency	tendency	NN
25944	1199	17	to	to	IN
25944	1199	18	fissuring	fissure	VBG
25944	1199	19	or	or	CC
25944	1199	20	cracking	crack	VBG
25944	1199	21	of	of	IN
25944	1199	22	the	the	DT
25944	1199	23	skin	skin	NN
25944	1199	24	(	(	-LRB-
25944	1199	25	_	_	NNP
25944	1199	26	eczema	eczema	NN
25944	1199	27	fissum	fissum	NN
25944	1199	28	_	_	NNP
25944	1199	29	;	;	:
25944	1199	30	_	_	NNP
25944	1199	31	eczema	eczema	NN
25944	1199	32	rimosum	rimosum	NN
25944	1199	33	_	_	NNP
25944	1199	34	)	)	-RRB-
25944	1199	35	.	.	.
25944	1200	1	This	this	DT
25944	1200	2	tendency	tendency	NN
25944	1200	3	is	be	VBZ
25944	1200	4	usually	usually	RB
25944	1200	5	a	a	DT
25944	1200	6	part	part	NN
25944	1200	7	of	of	IN
25944	1200	8	an	an	DT
25944	1200	9	erythematous	erythematous	JJ
25944	1200	10	or	or	CC
25944	1200	11	squamous	squamous	JJ
25944	1200	12	eczema	eczema	NN
25944	1200	13	,	,	,
25944	1200	14	the	the	DT
25944	1200	15	fissuring	fissuring	NN
25944	1200	16	constituting	constitute	VBG
25944	1200	17	the	the	DT
25944	1200	18	most	most	RBS
25944	1200	19	conspicuous	conspicuous	JJ
25944	1200	20	and	and	CC
25944	1200	21	troublesome	troublesome	JJ
25944	1200	22	symptom	symptom	NN
25944	1200	23	.	.	.
25944	1201	1	_	_	NNP
25944	1201	2	Chapping	Chapping	NNP
25944	1201	3	_	_	NNP
25944	1201	4	is	be	VBZ
25944	1201	5	an	an	DT
25944	1201	6	extremely	extremely	RB
25944	1201	7	mild	mild	JJ
25944	1201	8	but	but	CC
25944	1201	9	familiar	familiar	JJ
25944	1201	10	example	example	NN
25944	1201	11	of	of	IN
25944	1201	12	this	this	DT
25944	1201	13	type	type	NN
25944	1201	14	.	.	.
25944	1202	1	It	-PRON-	PRP
25944	1202	2	is	be	VBZ
25944	1202	3	especially	especially	RB
25944	1202	4	common	common	JJ
25944	1202	5	about	about	IN
25944	1202	6	the	the	DT
25944	1202	7	hands	hand	NNS
25944	1202	8	and	and	CC
25944	1202	9	fingers	finger	NNS
25944	1202	10	.	.	.
25944	1203	1	#	#	LS
25944	1203	2	What	what	WP
25944	1203	3	is	be	VBZ
25944	1203	4	the	the	DT
25944	1203	5	course	course	NN
25944	1203	6	of	of	IN
25944	1203	7	fissured	fissure	VBN
25944	1203	8	eczema	eczema	NN
25944	1203	9	?	?	.
25944	1203	10	#	#	$
25944	1203	11	It	-PRON-	PRP
25944	1203	12	is	be	VBZ
25944	1203	13	more	more	RBR
25944	1203	14	or	or	CC
25944	1203	15	less	less	RBR
25944	1203	16	persistent	persistent	JJ
25944	1203	17	,	,	,
25944	1203	18	the	the	DT
25944	1203	19	tendency	tendency	NN
25944	1203	20	to	to	IN
25944	1203	21	fissuring	fissure	VBG
25944	1203	22	varying	vary	VBG
25944	1203	23	considerably	considerably	RB
25944	1203	24	according	accord	VBG
25944	1203	25	to	to	IN
25944	1203	26	the	the	DT
25944	1203	27	state	state	NN
25944	1203	28	of	of	IN
25944	1203	29	the	the	DT
25944	1203	30	weather	weather	NN
25944	1203	31	,	,	,
25944	1203	32	often	often	RB
25944	1203	33	disappearing	disappear	VBG
25944	1203	34	spontaneously	spontaneously	RB
25944	1203	35	in	in	IN
25944	1203	36	the	the	DT
25944	1203	37	summer	summer	NN
25944	1203	38	months	month	NNS
25944	1203	39	.	.	.
25944	1204	1	#	#	NNP
25944	1204	2	Describe	Describe	NNP
25944	1204	3	eczema	eczema	NN
25944	1204	4	sclerosum	sclerosum	NN
25944	1204	5	and	and	CC
25944	1204	6	eczema	eczema	NN
25944	1204	7	verrucosum	verrucosum	NN
25944	1204	8	.	.	.
25944	1204	9	#	#	$
25944	1204	10	In	in	IN
25944	1204	11	eczema	eczema	NN
25944	1204	12	sclerosum	sclerosum	VBD
25944	1204	13	the	the	DT
25944	1204	14	skin	skin	NN
25944	1204	15	is	be	VBZ
25944	1204	16	thickened	thicken	VBN
25944	1204	17	,	,	,
25944	1204	18	infiltrated	infiltrate	VBN
25944	1204	19	,	,	,
25944	1204	20	hard	hard	RB
25944	1204	21	,	,	,
25944	1204	22	and	and	CC
25944	1204	23	almost	almost	RB
25944	1204	24	horny	horny	JJ
25944	1204	25	.	.	.
25944	1205	1	Eczema	eczema	NN
25944	1205	2	verrucosum	verrucosum	NN
25944	1205	3	presents	present	VBZ
25944	1205	4	similar	similar	JJ
25944	1205	5	conditions	condition	NNS
25944	1205	6	,	,	,
25944	1205	7	but	but	CC
25944	1205	8	,	,	,
25944	1205	9	in	in	IN
25944	1205	10	addition	addition	NN
25944	1205	11	,	,	,
25944	1205	12	displays	display	VBZ
25944	1205	13	a	a	DT
25944	1205	14	tendency	tendency	NN
25944	1205	15	to	to	IN
25944	1205	16	papillary	papillary	NN
25944	1205	17	or	or	CC
25944	1205	18	wart	wart	JJ
25944	1205	19	-	-	HYPH
25944	1205	20	like	like	JJ
25944	1205	21	hypertrophy	hypertrophy	NN
25944	1205	22	.	.	.
25944	1206	1	In	in	IN
25944	1206	2	both	both	DT
25944	1206	3	varieties	variety	NNS
25944	1206	4	the	the	DT
25944	1206	5	disease	disease	NN
25944	1206	6	is	be	VBZ
25944	1206	7	usually	usually	RB
25944	1206	8	seated	seat	VBN
25944	1206	9	about	about	IN
25944	1206	10	the	the	DT
25944	1206	11	ankle	ankle	NN
25944	1206	12	or	or	CC
25944	1206	13	the	the	DT
25944	1206	14	foot	foot	NN
25944	1206	15	,	,	,
25944	1206	16	developing	develop	VBG
25944	1206	17	from	from	IN
25944	1206	18	the	the	DT
25944	1206	19	papular	papular	JJ
25944	1206	20	or	or	CC
25944	1206	21	squamous	squamous	JJ
25944	1206	22	type	type	NN
25944	1206	23	.	.	.
25944	1207	1	They	-PRON-	PRP
25944	1207	2	are	be	VBP
25944	1207	3	uncommon	uncommon	JJ
25944	1207	4	,	,	,
25944	1207	5	and	and	CC
25944	1207	6	obstinately	obstinately	RB
25944	1207	7	chronic	chronic	JJ
25944	1207	8	.	.	.
25944	1208	1	#	#	JJR
25944	1208	2	State	state	NN
25944	1208	3	the	the	DT
25944	1208	4	nature	nature	NN
25944	1208	5	of	of	IN
25944	1208	6	the	the	DT
25944	1208	7	subjective	subjective	JJ
25944	1208	8	symptoms	symptom	NNS
25944	1208	9	in	in	IN
25944	1208	10	eczema	eczema	NN
25944	1208	11	.	.	.
25944	1208	12	#	#	$
25944	1208	13	Itching	itching	NN
25944	1208	14	,	,	,
25944	1208	15	commonly	commonly	RB
25944	1208	16	intense	intense	JJ
25944	1208	17	,	,	,
25944	1208	18	is	be	VBZ
25944	1208	19	usually	usually	RB
25944	1208	20	a	a	DT
25944	1208	21	conspicuous	conspicuous	JJ
25944	1208	22	symptom	symptom	NN
25944	1208	23	;	;	:
25944	1208	24	it	-PRON-	PRP
25944	1208	25	may	may	MD
25944	1208	26	be	be	VB
25944	1208	27	more	more	RBR
25944	1208	28	or	or	CC
25944	1208	29	less	less	RBR
25944	1208	30	paroxysmal	paroxysmal	JJ
25944	1208	31	.	.	.
25944	1209	1	In	in	IN
25944	1209	2	some	some	DT
25944	1209	3	cases	case	NNS
25944	1209	4	burning	burn	VBG
25944	1209	5	and	and	CC
25944	1209	6	heat	heat	NN
25944	1209	7	constitute	constitute	VBP
25944	1209	8	the	the	DT
25944	1209	9	main	main	JJ
25944	1209	10	subjective	subjective	JJ
25944	1209	11	phenomena	phenomena	NN
25944	1209	12	.	.	.
25944	1210	1	#	#	$
25944	1210	2	Is	be	VBZ
25944	1210	3	eczema	eczema	NN
25944	1210	4	accompanied	accompany	VBN
25944	1210	5	by	by	IN
25944	1210	6	febrile	febrile	NN
25944	1210	7	or	or	CC
25944	1210	8	systemic	systemic	JJ
25944	1210	9	symptoms	symptom	NNS
25944	1210	10	?	?	.
25944	1210	11	#	#	$
25944	1210	12	No	no	UH
25944	1210	13	.	.	.
25944	1211	1	In	in	IN
25944	1211	2	rare	rare	JJ
25944	1211	3	instances	instance	NNS
25944	1211	4	,	,	,
25944	1211	5	in	in	IN
25944	1211	6	acute	acute	JJ
25944	1211	7	universal	universal	JJ
25944	1211	8	eczema	eczema	NNP
25944	1211	9	,	,	,
25944	1211	10	slight	slight	JJ
25944	1211	11	febrile	febrile	NN
25944	1211	12	action	action	NN
25944	1211	13	,	,	,
25944	1211	14	or	or	CC
25944	1211	15	other	other	JJ
25944	1211	16	systemic	systemic	JJ
25944	1211	17	disturbance	disturbance	NN
25944	1211	18	,	,	,
25944	1211	19	may	may	MD
25944	1211	20	be	be	VB
25944	1211	21	noted	note	VBN
25944	1211	22	at	at	IN
25944	1211	23	the	the	DT
25944	1211	24	time	time	NN
25944	1211	25	of	of	IN
25944	1211	26	the	the	DT
25944	1211	27	outbreak	outbreak	NN
25944	1211	28	.	.	.
25944	1212	1	#	#	$
25944	1212	2	Is	be	VBZ
25944	1212	3	the	the	DT
25944	1212	4	eczematous	eczematous	JJ
25944	1212	5	eruption	eruption	NN
25944	1212	6	(	(	-LRB-
25944	1212	7	patch	patch	NN
25944	1212	8	or	or	CC
25944	1212	9	patches	patch	NNS
25944	1212	10	)	)	-RRB-
25944	1212	11	sharply	sharply	RB
25944	1212	12	defined	define	VBN
25944	1212	13	against	against	IN
25944	1212	14	the	the	DT
25944	1212	15	neighboring	neighboring	JJ
25944	1212	16	sound	sound	NN
25944	1212	17	skin	skin	NN
25944	1212	18	?	?	.
25944	1212	19	#	#	$
25944	1212	20	No	no	UH
25944	1212	21	.	.	.
25944	1213	1	In	in	IN
25944	1213	2	almost	almost	RB
25944	1213	3	all	all	DT
25944	1213	4	instances	instance	NNS
25944	1213	5	the	the	DT
25944	1213	6	diseased	diseased	JJ
25944	1213	7	area	area	NN
25944	1213	8	merges	merge	NNS
25944	1213	9	gradually	gradually	RB
25944	1213	10	and	and	CC
25944	1213	11	imperceptibly	imperceptibly	RB
25944	1213	12	into	into	IN
25944	1213	13	the	the	DT
25944	1213	14	surrounding	surround	VBG
25944	1213	15	healthy	healthy	JJ
25944	1213	16	integument	integument	NN
25944	1213	17	.	.	.
25944	1214	1	#	#	LS
25944	1214	2	What	what	WP
25944	1214	3	is	be	VBZ
25944	1214	4	the	the	DT
25944	1214	5	character	character	NN
25944	1214	6	of	of	IN
25944	1214	7	eczema	eczema	NN
25944	1214	8	as	as	IN
25944	1214	9	regards	regard	VBZ
25944	1214	10	the	the	DT
25944	1214	11	degree	degree	NN
25944	1214	12	of	of	IN
25944	1214	13	inflammatory	inflammatory	JJ
25944	1214	14	action	action	NN
25944	1214	15	?	?	.
25944	1214	16	#	#	$
25944	1214	17	The	the	DT
25944	1214	18	inflammatory	inflammatory	JJ
25944	1214	19	action	action	NN
25944	1214	20	may	may	MD
25944	1214	21	be	be	VB
25944	1214	22	acute	acute	JJ
25944	1214	23	,	,	,
25944	1214	24	subacute	subacute	JJ
25944	1214	25	or	or	CC
25944	1214	26	sluggish	sluggish	JJ
25944	1214	27	in	in	IN
25944	1214	28	character	character	NN
25944	1214	29	,	,	,
25944	1214	30	and	and	CC
25944	1214	31	may	may	MD
25944	1214	32	be	be	VB
25944	1214	33	so	so	RB
25944	1214	34	from	from	IN
25944	1214	35	the	the	DT
25944	1214	36	start	start	NN
25944	1214	37	and	and	CC
25944	1214	38	so	so	RB
25944	1214	39	continue	continue	VB
25944	1214	40	throughout	throughout	IN
25944	1214	41	its	-PRON-	PRP$
25944	1214	42	whole	whole	JJ
25944	1214	43	course	course	NN
25944	1214	44	;	;	:
25944	1214	45	or	or	CC
25944	1214	46	it	-PRON-	PRP
25944	1214	47	may	may	MD
25944	1214	48	,	,	,
25944	1214	49	as	as	IN
25944	1214	50	is	be	VBZ
25944	1214	51	usually	usually	RB
25944	1214	52	the	the	DT
25944	1214	53	case	case	NN
25944	1214	54	,	,	,
25944	1214	55	vary	vary	VBP
25944	1214	56	in	in	IN
25944	1214	57	intensity	intensity	NN
25944	1214	58	from	from	IN
25944	1214	59	time	time	NN
25944	1214	60	to	to	IN
25944	1214	61	time	time	NN
25944	1214	62	.	.	.
25944	1215	1	#	#	NNP
25944	1215	2	State	state	NN
25944	1215	3	the	the	DT
25944	1215	4	character	character	NN
25944	1215	5	of	of	IN
25944	1215	6	eczema	eczema	NN
25944	1215	7	as	as	IN
25944	1215	8	regards	regard	VBZ
25944	1215	9	duration	duration	NN
25944	1215	10	.	.	.
25944	1215	11	#	#	$
25944	1215	12	As	as	IN
25944	1215	13	a	a	DT
25944	1215	14	rule	rule	NN
25944	1215	15	,	,	,
25944	1215	16	it	-PRON-	PRP
25944	1215	17	is	be	VBZ
25944	1215	18	a	a	DT
25944	1215	19	persistent	persistent	JJ
25944	1215	20	disease	disease	NN
25944	1215	21	,	,	,
25944	1215	22	showing	show	VBG
25944	1215	23	little	little	JJ
25944	1215	24	,	,	,
25944	1215	25	if	if	IN
25944	1215	26	any	any	DT
25944	1215	27	,	,	,
25944	1215	28	tendency	tendency	NN
25944	1215	29	to	to	IN
25944	1215	30	spontaneous	spontaneous	JJ
25944	1215	31	disappearance	disappearance	NN
25944	1215	32	.	.	.
25944	1216	1	#	#	$
25944	1216	2	Is	be	VBZ
25944	1216	3	eczema	eczema	NN
25944	1216	4	influenced	influence	VBN
25944	1216	5	by	by	IN
25944	1216	6	the	the	DT
25944	1216	7	seasons	season	NNS
25944	1216	8	?	?	.
25944	1216	9	#	#	NN
25944	1216	10	Yes	yes	UH
25944	1216	11	.	.	.
25944	1217	1	With	with	IN
25944	1217	2	comparatively	comparatively	RB
25944	1217	3	few	few	JJ
25944	1217	4	exceptions	exception	NNS
25944	1217	5	the	the	DT
25944	1217	6	disease	disease	NN
25944	1217	7	is	be	VBZ
25944	1217	8	most	most	RBS
25944	1217	9	common	common	JJ
25944	1217	10	and	and	CC
25944	1217	11	much	much	RB
25944	1217	12	worse	bad	JJR
25944	1217	13	in	in	IN
25944	1217	14	cold	cold	JJ
25944	1217	15	,	,	,
25944	1217	16	windy	windy	JJ
25944	1217	17	,	,	,
25944	1217	18	winter	winter	NN
25944	1217	19	weather	weather	NN
25944	1217	20	.	.	.
25944	1218	1	#	#	JJR
25944	1218	2	To	to	IN
25944	1218	3	what	what	WP
25944	1218	4	may	may	MD
25944	1218	5	eczema	eczema	VB
25944	1218	6	be	be	VB
25944	1218	7	ascribed	ascribe	VBN
25944	1218	8	?	?	.
25944	1218	9	#	#	$
25944	1218	10	Eczema	Eczema	NNP
25944	1218	11	may	may	MD
25944	1218	12	be	be	VB
25944	1218	13	due	due	JJ
25944	1218	14	to	to	IN
25944	1218	15	constitutional	constitutional	JJ
25944	1218	16	or	or	CC
25944	1218	17	local	local	JJ
25944	1218	18	causes	cause	NNS
25944	1218	19	,	,	,
25944	1218	20	or	or	CC
25944	1218	21	to	to	IN
25944	1218	22	both	both	DT
25944	1218	23	.	.	.
25944	1219	1	It	-PRON-	PRP
25944	1219	2	may	may	MD
25944	1219	3	be	be	VB
25944	1219	4	considered	consider	VBN
25944	1219	5	,	,	,
25944	1219	6	in	in	IN
25944	1219	7	fact	fact	NN
25944	1219	8	,	,	,
25944	1219	9	as	as	IN
25944	1219	10	a	a	DT
25944	1219	11	reaction	reaction	NN
25944	1219	12	of	of	IN
25944	1219	13	the	the	DT
25944	1219	14	skin	skin	NN
25944	1219	15	tissues	tissue	NNS
25944	1219	16	against	against	IN
25944	1219	17	some	some	DT
25944	1219	18	irritant	irritant	NN
25944	1219	19	,	,	,
25944	1219	20	and	and	CC
25944	1219	21	the	the	DT
25944	1219	22	latter	latter	JJ
25944	1219	23	may	may	MD
25944	1219	24	have	have	VB
25944	1219	25	its	-PRON-	PRP$
25944	1219	26	origin	origin	NN
25944	1219	27	from	from	IN
25944	1219	28	within	within	IN
25944	1219	29	or	or	CC
25944	1219	30	without	without	IN
25944	1219	31	.	.	.
25944	1220	1	#	#	JJR
25944	1220	2	Name	name	VB
25944	1220	3	some	some	DT
25944	1220	4	of	of	IN
25944	1220	5	the	the	DT
25944	1220	6	important	important	JJ
25944	1220	7	constitutional	constitutional	JJ
25944	1220	8	or	or	CC
25944	1220	9	predisposing	predispose	VBG
25944	1220	10	causes	cause	NNS
25944	1220	11	.	.	.
25944	1220	12	#	#	$
25944	1220	13	Gouty	gouty	JJ
25944	1220	14	diathesis	diathesis	NN
25944	1220	15	,	,	,
25944	1220	16	rheumatic	rheumatic	JJ
25944	1220	17	diathesis	diathesis	NN
25944	1220	18	,	,	,
25944	1220	19	disorders	disorder	NNS
25944	1220	20	of	of	IN
25944	1220	21	the	the	DT
25944	1220	22	digestive	digestive	JJ
25944	1220	23	tract	tract	NN
25944	1220	24	,	,	,
25944	1220	25	general	general	JJ
25944	1220	26	debility	debility	NN
25944	1220	27	or	or	CC
25944	1220	28	lack	lack	NN
25944	1220	29	of	of	IN
25944	1220	30	tone	tone	NN
25944	1220	31	,	,	,
25944	1220	32	an	an	DT
25944	1220	33	exhausted	exhausted	JJ
25944	1220	34	state	state	NN
25944	1220	35	of	of	IN
25944	1220	36	the	the	DT
25944	1220	37	nervous	nervous	JJ
25944	1220	38	system	system	NN
25944	1220	39	,	,	,
25944	1220	40	dentition	dentition	NN
25944	1220	41	and	and	CC
25944	1220	42	struma	struma	NN
25944	1220	43	.	.	.
25944	1221	1	#	#	$
25944	1221	2	Is	be	VBZ
25944	1221	3	a	a	DT
25944	1221	4	constitutional	constitutional	JJ
25944	1221	5	cause	cause	NN
25944	1221	6	sufficient	sufficient	JJ
25944	1221	7	to	to	TO
25944	1221	8	provoke	provoke	VB
25944	1221	9	an	an	DT
25944	1221	10	attack	attack	NN
25944	1221	11	?	?	.
25944	1221	12	#	#	NN
25944	1221	13	Yes	yes	UH
25944	1221	14	;	;	:
25944	1221	15	but	but	CC
25944	1221	16	often	often	RB
25944	1221	17	the	the	DT
25944	1221	18	attack	attack	NN
25944	1221	19	is	be	VBZ
25944	1221	20	brought	bring	VBN
25944	1221	21	about	about	RP
25944	1221	22	in	in	IN
25944	1221	23	those	those	DT
25944	1221	24	so	so	RB
25944	1221	25	predisposed	predispose	VBN
25944	1221	26	by	by	IN
25944	1221	27	some	some	DT
25944	1221	28	local	local	JJ
25944	1221	29	or	or	CC
25944	1221	30	external	external	JJ
25944	1221	31	irritant	irritant	NN
25944	1221	32	.	.	.
25944	1222	1	#	#	$
25944	1222	2	Mention	mention	VB
25944	1222	3	some	some	DT
25944	1222	4	of	of	IN
25944	1222	5	the	the	DT
25944	1222	6	external	external	JJ
25944	1222	7	causes	cause	NNS
25944	1222	8	.	.	.
25944	1222	9	#	#	NNP
25944	1222	10	Heat	Heat	NNP
25944	1222	11	and	and	CC
25944	1222	12	cold	cold	JJ
25944	1222	13	,	,	,
25944	1222	14	sharp	sharp	JJ
25944	1222	15	,	,	,
25944	1222	16	biting	bite	VBG
25944	1222	17	winds	wind	NNS
25944	1222	18	,	,	,
25944	1222	19	excessive	excessive	JJ
25944	1222	20	use	use	NN
25944	1222	21	of	of	IN
25944	1222	22	water	water	NN
25944	1222	23	,	,	,
25944	1222	24	strong	strong	JJ
25944	1222	25	soaps	soap	NNS
25944	1222	26	,	,	,
25944	1222	27	vaccination	vaccination	NN
25944	1222	28	,	,	,
25944	1222	29	dyes	dye	NNS
25944	1222	30	and	and	CC
25944	1222	31	dyestuffs	dyestuff	NNS
25944	1222	32	,	,	,
25944	1222	33	chemical	chemical	NN
25944	1222	34	irritants	irritant	NNS
25944	1222	35	,	,	,
25944	1222	36	and	and	CC
25944	1222	37	the	the	DT
25944	1222	38	like	like	JJ
25944	1222	39	.	.	.
25944	1223	1	There	there	EX
25944	1223	2	is	be	VBZ
25944	1223	3	a	a	DT
25944	1223	4	growing	grow	VBG
25944	1223	5	belief	belief	NN
25944	1223	6	that	that	IN
25944	1223	7	some	some	DT
25944	1223	8	cases	case	NNS
25944	1223	9	presenting	present	VBG
25944	1223	10	eczematous	eczematous	JJ
25944	1223	11	aspects	aspect	NNS
25944	1223	12	are	be	VBP
25944	1223	13	probably	probably	RB
25944	1223	14	parasitic	parasitic	JJ
25944	1223	15	in	in	IN
25944	1223	16	origin	origin	NN
25944	1223	17	.	.	.
25944	1224	1	In	in	IN
25944	1224	2	fact	fact	NN
25944	1224	3	,	,	,
25944	1224	4	some	some	DT
25944	1224	5	observers	observer	NNS
25944	1224	6	hold	hold	VBP
25944	1224	7	to	to	IN
25944	1224	8	the	the	DT
25944	1224	9	microbic	microbic	JJ
25944	1224	10	view	view	NN
25944	1224	11	of	of	IN
25944	1224	12	all	all	DT
25944	1224	13	cases	case	NNS
25944	1224	14	of	of	IN
25944	1224	15	eczema	eczema	NN
25944	1224	16	.	.	.
25944	1225	1	Contact	contact	NN
25944	1225	2	with	with	IN
25944	1225	3	the	the	DT
25944	1225	4	rhus	rhu	NNS
25944	1225	5	plants	plant	NNS
25944	1225	6	,	,	,
25944	1225	7	while	while	IN
25944	1225	8	producing	produce	VBG
25944	1225	9	a	a	DT
25944	1225	10	peculiar	peculiar	JJ
25944	1225	11	dermatitis	dermatitis	NN
25944	1225	12	,	,	,
25944	1225	13	usually	usually	RB
25944	1225	14	running	run	VBG
25944	1225	15	an	an	DT
25944	1225	16	acute	acute	JJ
25944	1225	17	course	course	NN
25944	1225	18	terminating	terminate	VBG
25944	1225	19	in	in	IN
25944	1225	20	recovery	recovery	NN
25944	1225	21	,	,	,
25944	1225	22	may	may	MD
25944	1225	23	,	,	,
25944	1225	24	in	in	IN
25944	1225	25	those	those	DT
25944	1225	26	predisposed	predispose	VBN
25944	1225	27	,	,	,
25944	1225	28	provoke	provoke	VB
25944	1225	29	a	a	DT
25944	1225	30	veritable	veritable	JJ
25944	1225	31	and	and	CC
25944	1225	32	persistent	persistent	JJ
25944	1225	33	eczema	eczema	NN
25944	1225	34	.	.	.
25944	1226	1	In	in	IN
25944	1226	2	fact	fact	NN
25944	1226	3	,	,	,
25944	1226	4	in	in	IN
25944	1226	5	our	-PRON-	PRP$
25944	1226	6	examination	examination	NN
25944	1226	7	as	as	IN
25944	1226	8	to	to	IN
25944	1226	9	causes	cause	NNS
25944	1226	10	in	in	IN
25944	1226	11	a	a	DT
25944	1226	12	given	give	VBN
25944	1226	13	case	case	NN
25944	1226	14	,	,	,
25944	1226	15	especially	especially	RB
25944	1226	16	of	of	IN
25944	1226	17	the	the	DT
25944	1226	18	hands	hand	NNS
25944	1226	19	and	and	CC
25944	1226	20	face	face	VB
25944	1226	21	,	,	,
25944	1226	22	all	all	DT
25944	1226	23	possible	possible	JJ
25944	1226	24	exciting	exciting	JJ
25944	1226	25	factors	factor	NNS
25944	1226	26	should	should	MD
25944	1226	27	be	be	VB
25944	1226	28	inquired	inquire	VBN
25944	1226	29	into	into	IN
25944	1226	30	,	,	,
25944	1226	31	such	such	JJ
25944	1226	32	as	as	IN
25944	1226	33	the	the	DT
25944	1226	34	handling	handling	NN
25944	1226	35	of	of	IN
25944	1226	36	plants	plant	NNS
25944	1226	37	,	,	,
25944	1226	38	chemicals	chemical	NNS
25944	1226	39	,	,	,
25944	1226	40	dyes	dye	NNS
25944	1226	41	,	,	,
25944	1226	42	etc	etc	FW
25944	1226	43	.	.	.
25944	1227	1	[	[	-LRB-
25944	1227	2	Illustration	illustration	NN
25944	1227	3	:	:	:
25944	1227	4	Fig	Fig	NNP
25944	1227	5	.	.	.
25944	1228	1	24	24	CD
25944	1228	2	.	.	.
25944	1229	1	Eczema	Eczema	NNP
25944	1229	2	of	of	IN
25944	1229	3	Face	Face	NNP
25944	1229	4	.	.	.
25944	1229	5	]	]	-RRB-
25944	1230	1	#	#	$
25944	1230	2	Is	be	VBZ
25944	1230	3	eczema	eczema	NN
25944	1230	4	contagious	contagious	JJ
25944	1230	5	?	?	.
25944	1230	6	#	#	NN
25944	1230	7	No	no	UH
25944	1230	8	.	.	.
25944	1231	1	The	the	DT
25944	1231	2	acceptance	acceptance	NN
25944	1231	3	of	of	IN
25944	1231	4	a	a	DT
25944	1231	5	parasitic	parasitic	JJ
25944	1231	6	cause	cause	NN
25944	1231	7	for	for	IN
25944	1231	8	the	the	DT
25944	1231	9	disease	disease	NN
25944	1231	10	,	,	,
25944	1231	11	however	however	RB
25944	1231	12	,	,	,
25944	1231	13	necessarily	necessarily	RB
25944	1231	14	carries	carry	VBZ
25944	1231	15	with	with	IN
25944	1231	16	it	-PRON-	PRP
25944	1231	17	the	the	DT
25944	1231	18	possibility	possibility	NN
25944	1231	19	of	of	IN
25944	1231	20	contagiousness	contagiousness	NN
25944	1231	21	under	under	IN
25944	1231	22	favoring	favor	VBG
25944	1231	23	conditions	condition	NNS
25944	1231	24	.	.	.
25944	1232	1	Such	such	JJ
25944	1232	2	is	be	VBZ
25944	1232	3	not	not	RB
25944	1232	4	supported	support	VBN
25944	1232	5	,	,	,
25944	1232	6	however	however	RB
25944	1232	7	,	,	,
25944	1232	8	by	by	IN
25944	1232	9	practical	practical	JJ
25944	1232	10	experience	experience	NN
25944	1232	11	.	.	.
25944	1233	1	#	#	LS
25944	1233	2	What	what	WP
25944	1233	3	is	be	VBZ
25944	1233	4	the	the	DT
25944	1233	5	pathology	pathology	NN
25944	1233	6	?	?	.
25944	1233	7	#	#	$
25944	1233	8	The	the	DT
25944	1233	9	process	process	NN
25944	1233	10	is	be	VBZ
25944	1233	11	an	an	DT
25944	1233	12	inflammatory	inflammatory	JJ
25944	1233	13	one	one	NN
25944	1233	14	,	,	,
25944	1233	15	characterized	characterize	VBN
25944	1233	16	in	in	IN
25944	1233	17	all	all	DT
25944	1233	18	cases	case	NNS
25944	1233	19	by	by	IN
25944	1233	20	hyperæmia	hyperæmia	NN
25944	1233	21	and	and	CC
25944	1233	22	exudation	exudation	NN
25944	1233	23	,	,	,
25944	1233	24	varying	vary	VBG
25944	1233	25	in	in	IN
25944	1233	26	degree	degree	NN
25944	1233	27	according	accord	VBG
25944	1233	28	to	to	IN
25944	1233	29	the	the	DT
25944	1233	30	intensity	intensity	NN
25944	1233	31	and	and	CC
25944	1233	32	duration	duration	NN
25944	1233	33	of	of	IN
25944	1233	34	the	the	DT
25944	1233	35	disease	disease	NN
25944	1233	36	.	.	.
25944	1234	1	The	the	DT
25944	1234	2	rete	rete	NN
25944	1234	3	and	and	CC
25944	1234	4	papillary	papillary	JJ
25944	1234	5	layer	layer	NN
25944	1234	6	are	be	VBP
25944	1234	7	especially	especially	RB
25944	1234	8	involved	involve	VBN
25944	1234	9	,	,	,
25944	1234	10	although	although	IN
25944	1234	11	in	in	IN
25944	1234	12	severe	severe	JJ
25944	1234	13	and	and	CC
25944	1234	14	chronic	chronic	JJ
25944	1234	15	cases	case	NNS
25944	1234	16	the	the	DT
25944	1234	17	lower	low	JJR
25944	1234	18	part	part	NN
25944	1234	19	of	of	IN
25944	1234	20	the	the	DT
25944	1234	21	corium	corium	NN
25944	1234	22	and	and	CC
25944	1234	23	even	even	RB
25944	1234	24	the	the	DT
25944	1234	25	subcutaneous	subcutaneous	JJ
25944	1234	26	tissue	tissue	NN
25944	1234	27	may	may	MD
25944	1234	28	share	share	VB
25944	1234	29	in	in	IN
25944	1234	30	the	the	DT
25944	1234	31	process	process	NN
25944	1234	32	.	.	.
25944	1235	1	#	#	$
25944	1235	2	Do	do	VBP
25944	1235	3	the	the	DT
25944	1235	4	cutaneous	cutaneous	JJ
25944	1235	5	manifestations	manifestation	NNS
25944	1235	6	of	of	IN
25944	1235	7	the	the	DT
25944	1235	8	eruptive	eruptive	JJ
25944	1235	9	fevers	fever	NNS
25944	1235	10	bear	bear	VBP
25944	1235	11	resemblance	resemblance	NN
25944	1235	12	to	to	IN
25944	1235	13	the	the	DT
25944	1235	14	erythematous	erythematous	JJ
25944	1235	15	type	type	NN
25944	1235	16	of	of	IN
25944	1235	17	eczema	eczema	NN
25944	1235	18	?	?	.
25944	1235	19	#	#	NNP
25944	1235	20	Scarlatina	Scarlatina	NNP
25944	1235	21	and	and	CC
25944	1235	22	erysipelas	erysipela	NNS
25944	1235	23	may	may	MD
25944	1235	24	,	,	,
25944	1235	25	to	to	IN
25944	1235	26	a	a	DT
25944	1235	27	slight	slight	JJ
25944	1235	28	extent	extent	NN
25944	1235	29	,	,	,
25944	1235	30	but	but	CC
25944	1235	31	the	the	DT
25944	1235	32	presence	presence	NN
25944	1235	33	or	or	CC
25944	1235	34	absence	absence	NN
25944	1235	35	of	of	IN
25944	1235	36	febrile	febrile	NN
25944	1235	37	and	and	CC
25944	1235	38	other	other	JJ
25944	1235	39	constitutional	constitutional	JJ
25944	1235	40	symptoms	symptom	NNS
25944	1235	41	will	will	MD
25944	1235	42	usually	usually	RB
25944	1235	43	serve	serve	VB
25944	1235	44	to	to	TO
25944	1235	45	differentiate	differentiate	VB
25944	1235	46	.	.	.
25944	1236	1	#	#	LS
25944	1236	2	What	what	WDT
25944	1236	3	common	common	JJ
25944	1236	4	skin	skin	NN
25944	1236	5	diseases	disease	NNS
25944	1236	6	resemble	resemble	VBP
25944	1236	7	some	some	DT
25944	1236	8	phases	phase	NNS
25944	1236	9	of	of	IN
25944	1236	10	eczema	eczema	NN
25944	1236	11	?	?	.
25944	1236	12	#	#	NNP
25944	1236	13	Psoriasis	Psoriasis	NNP
25944	1236	14	,	,	,
25944	1236	15	seborrh[oe]a	seborrh[oe]a	NNP
25944	1236	16	,	,	,
25944	1236	17	sycosis	sycosis	NN
25944	1236	18	,	,	,
25944	1236	19	scabies	scabie	NNS
25944	1236	20	and	and	CC
25944	1236	21	ringworm	ringworm	NN
25944	1236	22	.	.	.
25944	1237	1	#	#	NNP
25944	1237	2	How	how	WRB
25944	1237	3	would	would	MD
25944	1237	4	you	-PRON-	PRP
25944	1237	5	exclude	exclude	VB
25944	1237	6	psoriasis	psoriasis	NN
25944	1237	7	in	in	IN
25944	1237	8	a	a	DT
25944	1237	9	suspected	suspect	VBN
25944	1237	10	case	case	NN
25944	1237	11	of	of	IN
25944	1237	12	eczema	eczema	NN
25944	1237	13	(	(	-LRB-
25944	1237	14	squamous	squamous	JJ
25944	1237	15	eczema	eczema	NN
25944	1237	16	)	)	-RRB-
25944	1237	17	?	?	.
25944	1237	18	#	#	$
25944	1237	19	Psoriasis	Psoriasis	NNP
25944	1237	20	occurs	occur	VBZ
25944	1237	21	in	in	IN
25944	1237	22	variously	variously	RB
25944	1237	23	-	-	HYPH
25944	1237	24	sized	sized	JJ
25944	1237	25	,	,	,
25944	1237	26	rounded	rounded	JJ
25944	1237	27	,	,	,
25944	1237	28	_	_	NNP
25944	1237	29	sharply	sharply	RB
25944	1237	30	-	-	HYPH
25944	1237	31	defined	define	VBN
25944	1237	32	_	_	NNP
25944	1237	33	patches	patch	NNS
25944	1237	34	,	,	,
25944	1237	35	usually	usually	RB
25944	1237	36	scattered	scatter	VBN
25944	1237	37	irregularly	irregularly	RB
25944	1237	38	over	over	IN
25944	1237	39	the	the	DT
25944	1237	40	general	general	JJ
25944	1237	41	surface	surface	NN
25944	1237	42	,	,	,
25944	1237	43	with	with	IN
25944	1237	44	special	special	JJ
25944	1237	45	predilection	predilection	NN
25944	1237	46	for	for	IN
25944	1237	47	the	the	DT
25944	1237	48	elbows	elbow	NNS
25944	1237	49	and	and	CC
25944	1237	50	knees	knee	NNS
25944	1237	51	.	.	.
25944	1238	1	They	-PRON-	PRP
25944	1238	2	are	be	VBP
25944	1238	3	covered	cover	VBN
25944	1238	4	more	more	RBR
25944	1238	5	or	or	CC
25944	1238	6	less	less	RBR
25944	1238	7	abundantly	abundantly	RB
25944	1238	8	with	with	IN
25944	1238	9	whitish	whitish	JJ
25944	1238	10	,	,	,
25944	1238	11	silvery	silvery	JJ
25944	1238	12	or	or	CC
25944	1238	13	mother	mother	NN
25944	1238	14	-	-	HYPH
25944	1238	15	of	of	IN
25944	1238	16	-	-	HYPH
25944	1238	17	pearl	pearl	NN
25944	1238	18	colored	colored	JJ
25944	1238	19	imbricated	imbricated	JJ
25944	1238	20	scales	scale	NNS
25944	1238	21	.	.	.
25944	1239	1	The	the	DT
25944	1239	2	patches	patch	NNS
25944	1239	3	are	be	VBP
25944	1239	4	always	always	RB
25944	1239	5	dry	dry	JJ
25944	1239	6	,	,	,
25944	1239	7	and	and	CC
25944	1239	8	itching	itching	NN
25944	1239	9	is	be	VBZ
25944	1239	10	,	,	,
25944	1239	11	as	as	IN
25944	1239	12	a	a	DT
25944	1239	13	rule	rule	NN
25944	1239	14	,	,	,
25944	1239	15	slight	slight	JJ
25944	1239	16	,	,	,
25944	1239	17	or	or	CC
25944	1239	18	may	may	MD
25944	1239	19	be	be	VB
25944	1239	20	entirely	entirely	RB
25944	1239	21	absent	absent	JJ
25944	1239	22	.	.	.
25944	1240	1	Eczema	Eczema	NNP
25944	1240	2	,	,	,
25944	1240	3	on	on	IN
25944	1240	4	the	the	DT
25944	1240	5	contrary	contrary	NN
25944	1240	6	,	,	,
25944	1240	7	is	be	VBZ
25944	1240	8	often	often	RB
25944	1240	9	localized	localize	VBN
25944	1240	10	,	,	,
25944	1240	11	appearing	appear	VBG
25944	1240	12	as	as	IN
25944	1240	13	one	one	CD
25944	1240	14	or	or	CC
25944	1240	15	more	more	RBR
25944	1240	16	large	large	JJ
25944	1240	17	,	,	,
25944	1240	18	irregularly	irregularly	RB
25944	1240	19	diffused	diffuse	VBN
25944	1240	20	patches	patch	NNS
25944	1240	21	;	;	:
25944	1240	22	it	-PRON-	PRP
25944	1240	23	merges	merge	VBZ
25944	1240	24	imperceptibly	imperceptibly	RB
25944	1240	25	into	into	IN
25944	1240	26	the	the	DT
25944	1240	27	sound	sound	NN
25944	1240	28	skin	skin	NN
25944	1240	29	,	,	,
25944	1240	30	and	and	CC
25944	1240	31	there	there	EX
25944	1240	32	is	be	VBZ
25944	1240	33	often	often	RB
25944	1240	34	a	a	DT
25944	1240	35	history	history	NN
25944	1240	36	of	of	IN
25944	1240	37	characteristic	characteristic	JJ
25944	1240	38	serous	serous	JJ
25944	1240	39	or	or	CC
25944	1240	40	gummy	gummy	JJ
25944	1240	41	oozing	oozing	NN
25944	1240	42	;	;	:
25944	1240	43	the	the	DT
25944	1240	44	scaling	scaling	NN
25944	1240	45	is	be	VBZ
25944	1240	46	usually	usually	RB
25944	1240	47	slight	slight	JJ
25944	1240	48	and	and	CC
25944	1240	49	itching	itch	VBG
25944	1240	50	almost	almost	RB
25944	1240	51	invariably	invariably	RB
25944	1240	52	a	a	DT
25944	1240	53	prominent	prominent	JJ
25944	1240	54	symptom	symptom	NN
25944	1240	55	.	.	.
25944	1241	1	#	#	NNP
25944	1241	2	How	how	WRB
25944	1241	3	would	would	MD
25944	1241	4	you	-PRON-	PRP
25944	1241	5	exclude	exclude	VB
25944	1241	6	seborrh[oe]a	seborrh[oe]a	NNP
25944	1241	7	(	(	-LRB-
25944	1241	8	eczema	eczema	NNP
25944	1241	9	seborrhoicum	seborrhoicum	JJ
25944	1241	10	)	)	-RRB-
25944	1241	11	in	in	IN
25944	1241	12	a	a	DT
25944	1241	13	suspected	suspect	VBN
25944	1241	14	case	case	NN
25944	1241	15	of	of	IN
25944	1241	16	eczema	eczema	NN
25944	1241	17	?	?	.
25944	1241	18	#	#	$
25944	1241	19	Seborrh[oe]a	seborrh[oe]a	CD
25944	1241	20	of	of	IN
25944	1241	21	the	the	DT
25944	1241	22	scalp	scalp	NN
25944	1241	23	is	be	VBZ
25944	1241	24	more	more	RBR
25944	1241	25	commonly	commonly	RB
25944	1241	26	over	over	IN
25944	1241	27	the	the	DT
25944	1241	28	whole	whole	NN
25944	1241	29	of	of	IN
25944	1241	30	that	that	DT
25944	1241	31	region	region	NN
25944	1241	32	and	and	CC
25944	1241	33	is	be	VBZ
25944	1241	34	relatively	relatively	RB
25944	1241	35	free	free	JJ
25944	1241	36	from	from	IN
25944	1241	37	inflammatory	inflammatory	JJ
25944	1241	38	symptoms	symptom	NNS
25944	1241	39	;	;	:
25944	1241	40	the	the	DT
25944	1241	41	scales	scale	NNS
25944	1241	42	are	be	VBP
25944	1241	43	of	of	IN
25944	1241	44	a	a	DT
25944	1241	45	greasy	greasy	JJ
25944	1241	46	character	character	NN
25944	1241	47	and	and	CC
25944	1241	48	the	the	DT
25944	1241	49	itching	itching	NN
25944	1241	50	is	be	VBZ
25944	1241	51	usually	usually	RB
25944	1241	52	slight	slight	JJ
25944	1241	53	or	or	CC
25944	1241	54	nil	nil	NN
25944	1241	55	.	.	.
25944	1242	1	On	on	IN
25944	1242	2	the	the	DT
25944	1242	3	other	other	JJ
25944	1242	4	hand	hand	NN
25944	1242	5	,	,	,
25944	1242	6	in	in	IN
25944	1242	7	eczema	eczema	NN
25944	1242	8	of	of	IN
25944	1242	9	this	this	DT
25944	1242	10	region	region	NN
25944	1242	11	the	the	DT
25944	1242	12	parts	part	NNS
25944	1242	13	are	be	VBP
25944	1242	14	rarely	rarely	RB
25944	1242	15	invaded	invade	VBN
25944	1242	16	in	in	IN
25944	1242	17	their	-PRON-	PRP$
25944	1242	18	entirety	entirety	NN
25944	1242	19	;	;	:
25944	1242	20	there	there	EX
25944	1242	21	may	may	MD
25944	1242	22	be	be	VB
25944	1242	23	at	at	IN
25944	1242	24	times	time	NNS
25944	1242	25	the	the	DT
25944	1242	26	characteristic	characteristic	JJ
25944	1242	27	serous	serous	JJ
25944	1242	28	or	or	CC
25944	1242	29	gummy	gummy	JJ
25944	1242	30	oozing	oozing	NN
25944	1242	31	;	;	,
25944	1242	32	inflammatory	inflammatory	JJ
25944	1242	33	symptoms	symptom	NNS
25944	1242	34	are	be	VBP
25944	1242	35	usually	usually	RB
25944	1242	36	well	well	RB
25944	1242	37	-	-	HYPH
25944	1242	38	marked	mark	VBN
25944	1242	39	,	,	,
25944	1242	40	the	the	DT
25944	1242	41	scales	scale	NNS
25944	1242	42	are	be	VBP
25944	1242	43	dry	dry	JJ
25944	1242	44	and	and	CC
25944	1242	45	the	the	DT
25944	1242	46	itching	itching	NN
25944	1242	47	is	be	VBZ
25944	1242	48	,	,	,
25944	1242	49	as	as	IN
25944	1242	50	a	a	DT
25944	1242	51	rule	rule	NN
25944	1242	52	,	,	,
25944	1242	53	a	a	DT
25944	1242	54	prominent	prominent	JJ
25944	1242	55	symptom	symptom	NN
25944	1242	56	.	.	.
25944	1243	1	These	these	DT
25944	1243	2	same	same	JJ
25944	1243	3	differences	difference	NNS
25944	1243	4	serve	serve	VBP
25944	1243	5	to	to	TO
25944	1243	6	differentiate	differentiate	VB
25944	1243	7	the	the	DT
25944	1243	8	diseases	disease	NNS
25944	1243	9	in	in	IN
25944	1243	10	other	other	JJ
25944	1243	11	regions	region	NNS
25944	1243	12	.	.	.
25944	1244	1	#	#	NNP
25944	1244	2	How	how	WRB
25944	1244	3	does	do	VBZ
25944	1244	4	scabies	scabie	NNS
25944	1244	5	differ	differ	VB
25944	1244	6	from	from	IN
25944	1244	7	eczema	eczema	NN
25944	1244	8	?	?	.
25944	1244	9	#	#	$
25944	1244	10	Scabies	Scabies	NNP
25944	1244	11	differs	differ	VBZ
25944	1244	12	from	from	IN
25944	1244	13	eczema	eczema	NN
25944	1244	14	in	in	IN
25944	1244	15	its	-PRON-	PRP$
25944	1244	16	peculiar	peculiar	JJ
25944	1244	17	distribution	distribution	NN
25944	1244	18	,	,	,
25944	1244	19	the	the	DT
25944	1244	20	presence	presence	NN
25944	1244	21	of	of	IN
25944	1244	22	the	the	DT
25944	1244	23	burrows	burrow	NNS
25944	1244	24	,	,	,
25944	1244	25	the	the	DT
25944	1244	26	absence	absence	NN
25944	1244	27	of	of	IN
25944	1244	28	any	any	DT
25944	1244	29	tendency	tendency	NN
25944	1244	30	to	to	TO
25944	1244	31	patch	patch	VB
25944	1244	32	formation	formation	NN
25944	1244	33	,	,	,
25944	1244	34	and	and	CC
25944	1244	35	usually	usually	RB
25944	1244	36	by	by	IN
25944	1244	37	a	a	DT
25944	1244	38	clear	clear	JJ
25944	1244	39	history	history	NN
25944	1244	40	of	of	IN
25944	1244	41	contagion	contagion	NN
25944	1244	42	.	.	.
25944	1245	1	#	#	NNP
25944	1245	2	How	how	WRB
25944	1245	3	would	would	MD
25944	1245	4	you	-PRON-	PRP
25944	1245	5	exclude	exclude	VB
25944	1245	6	ringworm	ringworm	NN
25944	1245	7	in	in	IN
25944	1245	8	a	a	DT
25944	1245	9	suspected	suspect	VBN
25944	1245	10	case	case	NN
25944	1245	11	of	of	IN
25944	1245	12	eczema	eczema	NN
25944	1245	13	?	?	.
25944	1245	14	#	#	NNP
25944	1245	15	Ringworm	ringworm	NN
25944	1245	16	is	be	VBZ
25944	1245	17	to	to	TO
25944	1245	18	be	be	VB
25944	1245	19	distinguished	distinguish	VBN
25944	1245	20	by	by	IN
25944	1245	21	its	-PRON-	PRP$
25944	1245	22	circular	circular	JJ
25944	1245	23	form	form	NN
25944	1245	24	,	,	,
25944	1245	25	its	-PRON-	PRP$
25944	1245	26	fading	fading	NN
25944	1245	27	in	in	IN
25944	1245	28	the	the	DT
25944	1245	29	centre	centre	NN
25944	1245	30	,	,	,
25944	1245	31	and	and	CC
25944	1245	32	in	in	IN
25944	1245	33	doubtful	doubtful	JJ
25944	1245	34	cases	case	NNS
25944	1245	35	by	by	IN
25944	1245	36	microscopic	microscopic	JJ
25944	1245	37	examination	examination	NN
25944	1245	38	of	of	IN
25944	1245	39	the	the	DT
25944	1245	40	scrapings	scraping	NNS
25944	1245	41	.	.	.
25944	1246	1	#	#	NN
25944	1246	2	How	how	WRB
25944	1246	3	does	do	VBZ
25944	1246	4	eczema	eczema	VB
25944	1246	5	differ	differ	VB
25944	1246	6	from	from	IN
25944	1246	7	sycosis	sycosis	NN
25944	1246	8	?	?	.
25944	1246	9	#	#	$
25944	1246	10	Sycosis	Sycosis	NNP
25944	1246	11	is	be	VBZ
25944	1246	12	limited	limit	VBN
25944	1246	13	to	to	IN
25944	1246	14	the	the	DT
25944	1246	15	hairy	hairy	JJ
25944	1246	16	region	region	NN
25944	1246	17	of	of	IN
25944	1246	18	the	the	DT
25944	1246	19	face	face	NN
25944	1246	20	,	,	,
25944	1246	21	is	be	VBZ
25944	1246	22	distinctly	distinctly	RB
25944	1246	23	a	a	DT
25944	1246	24	follicular	follicular	JJ
25944	1246	25	inflammation	inflammation	NN
25944	1246	26	,	,	,
25944	1246	27	and	and	CC
25944	1246	28	is	be	VBZ
25944	1246	29	rarely	rarely	RB
25944	1246	30	very	very	RB
25944	1246	31	itchy	itchy	JJ
25944	1246	32	;	;	:
25944	1246	33	eczema	eczema	NN
25944	1246	34	is	be	VBZ
25944	1246	35	diffused	diffuse	VBN
25944	1246	36	,	,	,
25944	1246	37	usually	usually	RB
25944	1246	38	involves	involve	VBZ
25944	1246	39	other	other	JJ
25944	1246	40	parts	part	NNS
25944	1246	41	of	of	IN
25944	1246	42	the	the	DT
25944	1246	43	face	face	NN
25944	1246	44	,	,	,
25944	1246	45	and	and	CC
25944	1246	46	itching	itching	NN
25944	1246	47	is	be	VBZ
25944	1246	48	an	an	DT
25944	1246	49	annoying	annoying	JJ
25944	1246	50	symptom	symptom	NN
25944	1246	51	.	.	.
25944	1247	1	#	#	NNP
25944	1247	2	State	state	NN
25944	1247	3	the	the	DT
25944	1247	4	general	general	JJ
25944	1247	5	prognosis	prognosis	NN
25944	1247	6	of	of	IN
25944	1247	7	eczema	eczema	NN
25944	1247	8	.	.	.
25944	1247	9	#	#	$
25944	1247	10	The	the	DT
25944	1247	11	disease	disease	NN
25944	1247	12	is	be	VBZ
25944	1247	13	,	,	,
25944	1247	14	under	under	IN
25944	1247	15	favorable	favorable	JJ
25944	1247	16	circumstances	circumstance	NNS
25944	1247	17	,	,	,
25944	1247	18	curable	curable	JJ
25944	1247	19	,	,	,
25944	1247	20	some	some	DT
25944	1247	21	cases	case	NNS
25944	1247	22	yielding	yield	VBG
25944	1247	23	more	more	RBR
25944	1247	24	or	or	CC
25944	1247	25	less	less	RBR
25944	1247	26	readily	readily	RB
25944	1247	27	,	,	,
25944	1247	28	others	other	NNS
25944	1247	29	proving	prove	VBG
25944	1247	30	exceedingly	exceedingly	RB
25944	1247	31	rebellious	rebellious	JJ
25944	1247	32	.	.	.
25944	1248	1	The	the	DT
25944	1248	2	length	length	NN
25944	1248	3	of	of	IN
25944	1248	4	time	time	NN
25944	1248	5	to	to	TO
25944	1248	6	bring	bring	VB
25944	1248	7	about	about	RP
25944	1248	8	a	a	DT
25944	1248	9	result	result	NN
25944	1248	10	is	be	VBZ
25944	1248	11	always	always	RB
25944	1248	12	uncertain	uncertain	JJ
25944	1248	13	,	,	,
25944	1248	14	and	and	CC
25944	1248	15	an	an	DT
25944	1248	16	opinion	opinion	NN
25944	1248	17	on	on	IN
25944	1248	18	this	this	DT
25944	1248	19	point	point	NN
25944	1248	20	should	should	MD
25944	1248	21	be	be	VB
25944	1248	22	guarded	guard	VBN
25944	1248	23	.	.	.
25944	1249	1	#	#	NN
25944	1249	2	Upon	upon	IN
25944	1249	3	what	what	WP
25944	1249	4	would	would	MD
25944	1249	5	you	-PRON-	PRP
25944	1249	6	base	base	VB
25944	1249	7	your	-PRON-	PRP$
25944	1249	8	prognosis	prognosis	NN
25944	1249	9	in	in	IN
25944	1249	10	the	the	DT
25944	1249	11	individual	individual	JJ
25944	1249	12	case	case	NN
25944	1249	13	?	?	.
25944	1249	14	#	#	$
25944	1249	15	The	the	DT
25944	1249	16	extent	extent	NN
25944	1249	17	of	of	IN
25944	1249	18	disease	disease	NN
25944	1249	19	,	,	,
25944	1249	20	its	-PRON-	PRP$
25944	1249	21	duration	duration	NN
25944	1249	22	and	and	CC
25944	1249	23	previous	previous	JJ
25944	1249	24	behavior	behavior	NN
25944	1249	25	,	,	,
25944	1249	26	the	the	DT
25944	1249	27	removability	removability	NN
25944	1249	28	of	of	IN
25944	1249	29	the	the	DT
25944	1249	30	exciting	exciting	JJ
25944	1249	31	and	and	CC
25944	1249	32	predisposing	predisposing	JJ
25944	1249	33	causes	cause	NNS
25944	1249	34	,	,	,
25944	1249	35	and	and	CC
25944	1249	36	the	the	DT
25944	1249	37	attention	attention	NN
25944	1249	38	the	the	DT
25944	1249	39	patient	patient	NN
25944	1249	40	can	can	MD
25944	1249	41	give	give	VB
25944	1249	42	to	to	IN
25944	1249	43	the	the	DT
25944	1249	44	treatment	treatment	NN
25944	1249	45	.	.	.
25944	1250	1	In	in	IN
25944	1250	2	eczema	eczema	NN
25944	1250	3	involving	involve	VBG
25944	1250	4	the	the	DT
25944	1250	5	lips	lip	NNS
25944	1250	6	,	,	,
25944	1250	7	face	face	NN
25944	1250	8	,	,	,
25944	1250	9	scrotum	scrotum	NN
25944	1250	10	,	,	,
25944	1250	11	and	and	CC
25944	1250	12	leg	leg	NN
25944	1250	13	,	,	,
25944	1250	14	and	and	CC
25944	1250	15	especially	especially	RB
25944	1250	16	when	when	WRB
25944	1250	17	this	this	DT
25944	1250	18	last	last	RB
25944	1250	19	-	-	HYPH
25944	1250	20	named	name	VBN
25944	1250	21	exhibits	exhibit	VBZ
25944	1250	22	a	a	DT
25944	1250	23	varicose	varicose	JJ
25944	1250	24	condition	condition	NN
25944	1250	25	of	of	IN
25944	1250	26	the	the	DT
25944	1250	27	veins	vein	NNS
25944	1250	28	,	,	,
25944	1250	29	a	a	DT
25944	1250	30	cure	cure	NN
25944	1250	31	is	be	VBZ
25944	1250	32	effected	effect	VBN
25944	1250	33	,	,	,
25944	1250	34	as	as	IN
25944	1250	35	a	a	DT
25944	1250	36	rule	rule	NN
25944	1250	37	,	,	,
25944	1250	38	only	only	RB
25944	1250	39	through	through	IN
25944	1250	40	persistent	persistent	NN
25944	1250	41	and	and	CC
25944	1250	42	prolonged	prolonged	JJ
25944	1250	43	treatment	treatment	NN
25944	1250	44	.	.	.
25944	1251	1	#	#	NN
25944	1251	2	Does	do	VBZ
25944	1251	3	eczema	eczema	NN
25944	1251	4	ever	ever	RB
25944	1251	5	leave	leave	VB
25944	1251	6	scars	scar	NNS
25944	1251	7	?	?	.
25944	1251	8	#	#	$
25944	1251	9	No	no	UH
25944	1251	10	.	.	.
25944	1252	1	Upon	upon	IN
25944	1252	2	the	the	DT
25944	1252	3	legs	leg	NNS
25944	1252	4	,	,	,
25944	1252	5	in	in	IN
25944	1252	6	long	long	RB
25944	1252	7	-	-	HYPH
25944	1252	8	continued	continue	VBN
25944	1252	9	cases	case	NNS
25944	1252	10	,	,	,
25944	1252	11	more	more	RBR
25944	1252	12	or	or	CC
25944	1252	13	less	less	JJR
25944	1252	14	pigmentation	pigmentation	NN
25944	1252	15	usually	usually	RB
25944	1252	16	remains	remain	VBZ
25944	1252	17	.	.	.
25944	1253	1	#	#	NNP
25944	1253	2	How	how	WRB
25944	1253	3	is	be	VBZ
25944	1253	4	eczema	eczema	NN
25944	1253	5	treated	treat	VBN
25944	1253	6	?	?	.
25944	1253	7	#	#	NNP
25944	1253	8	As	as	IN
25944	1253	9	a	a	DT
25944	1253	10	rule	rule	NN
25944	1253	11	,	,	,
25944	1253	12	eczema	eczema	NN
25944	1253	13	requires	require	VBZ
25944	1253	14	for	for	IN
25944	1253	15	its	-PRON-	PRP$
25944	1253	16	removal	removal	NN
25944	1253	17	both	both	CC
25944	1253	18	constitutional	constitutional	JJ
25944	1253	19	and	and	CC
25944	1253	20	external	external	JJ
25944	1253	21	treatment	treatment	NN
25944	1253	22	.	.	.
25944	1254	1	Certain	certain	JJ
25944	1254	2	cases	case	NNS
25944	1254	3	,	,	,
25944	1254	4	however	however	RB
25944	1254	5	,	,	,
25944	1254	6	seem	seem	VBP
25944	1254	7	to	to	TO
25944	1254	8	be	be	VB
25944	1254	9	entirely	entirely	RB
25944	1254	10	local	local	JJ
25944	1254	11	in	in	IN
25944	1254	12	their	-PRON-	PRP$
25944	1254	13	nature	nature	NN
25944	1254	14	,	,	,
25944	1254	15	and	and	CC
25944	1254	16	in	in	IN
25944	1254	17	these	these	DT
25944	1254	18	cases	case	NNS
25944	1254	19	external	external	JJ
25944	1254	20	treatment	treatment	NN
25944	1254	21	alone	alone	RB
25944	1254	22	will	will	MD
25944	1254	23	have	have	VB
25944	1254	24	satisfactory	satisfactory	JJ
25944	1254	25	results	result	NNS
25944	1254	26	.	.	.
25944	1255	1	#	#	$
25944	1255	2	What	what	WDT
25944	1255	3	general	general	JJ
25944	1255	4	measures	measure	NNS
25944	1255	5	as	as	IN
25944	1255	6	to	to	TO
25944	1255	7	hygiene	hygiene	VB
25944	1255	8	and	and	CC
25944	1255	9	diet	diet	NN
25944	1255	10	are	be	VBP
25944	1255	11	commonly	commonly	RB
25944	1255	12	advisable	advisable	JJ
25944	1255	13	?	?	.
25944	1255	14	#	#	$
25944	1255	15	Fresh	fresh	JJ
25944	1255	16	air	air	NN
25944	1255	17	,	,	,
25944	1255	18	exercise	exercise	NN
25944	1255	19	,	,	,
25944	1255	20	moderate	moderate	JJ
25944	1255	21	indulgence	indulgence	NN
25944	1255	22	in	in	IN
25944	1255	23	calisthenics	calisthenic	NNS
25944	1255	24	,	,	,
25944	1255	25	regular	regular	JJ
25944	1255	26	habits	habit	NNS
25944	1255	27	,	,	,
25944	1255	28	a	a	DT
25944	1255	29	plain	plain	JJ
25944	1255	30	,	,	,
25944	1255	31	nutritious	nutritious	JJ
25944	1255	32	diet	diet	NN
25944	1255	33	;	;	:
25944	1255	34	abstention	abstention	NN
25944	1255	35	from	from	IN
25944	1255	36	such	such	JJ
25944	1255	37	articles	article	NNS
25944	1255	38	of	of	IN
25944	1255	39	food	food	NN
25944	1255	40	as	as	IN
25944	1255	41	pork	pork	NN
25944	1255	42	,	,	,
25944	1255	43	salted	salt	VBN
25944	1255	44	meat	meat	NN
25944	1255	45	,	,	,
25944	1255	46	acid	acid	JJ
25944	1255	47	fruits	fruit	NNS
25944	1255	48	,	,	,
25944	1255	49	pastry	pastry	NN
25944	1255	50	,	,	,
25944	1255	51	gravies	gravy	NNS
25944	1255	52	,	,	,
25944	1255	53	sauces	sauce	NNS
25944	1255	54	,	,	,
25944	1255	55	cheese	cheese	NN
25944	1255	56	,	,	,
25944	1255	57	pickles	pickle	NNS
25944	1255	58	,	,	,
25944	1255	59	condiments	condiment	NNS
25944	1255	60	,	,	,
25944	1255	61	excessive	excessive	JJ
25944	1255	62	coffee	coffee	NN
25944	1255	63	or	or	CC
25944	1255	64	tea	tea	NN
25944	1255	65	drinking	drinking	NN
25944	1255	66	,	,	,
25944	1255	67	etc	etc	FW
25944	1255	68	.	.	.
25944	1256	1	As	as	IN
25944	1256	2	a	a	DT
25944	1256	3	rule	rule	NN
25944	1256	4	,	,	,
25944	1256	5	also	also	RB
25944	1256	6	,	,	,
25944	1256	7	beer	beer	NN
25944	1256	8	,	,	,
25944	1256	9	wine	wine	NN
25944	1256	10	,	,	,
25944	1256	11	and	and	CC
25944	1256	12	other	other	JJ
25944	1256	13	stimulants	stimulant	NNS
25944	1256	14	are	be	VBP
25944	1256	15	to	to	TO
25944	1256	16	be	be	VB
25944	1256	17	interdicted	interdict	VBN
25944	1256	18	.	.	.
25944	1257	1	#	#	NN
25944	1257	2	Upon	upon	IN
25944	1257	3	what	what	WP
25944	1257	4	grounds	ground	NNS
25944	1257	5	is	be	VBZ
25944	1257	6	the	the	DT
25944	1257	7	line	line	NN
25944	1257	8	or	or	CC
25944	1257	9	plan	plan	NN
25944	1257	10	of	of	IN
25944	1257	11	constitutional	constitutional	JJ
25944	1257	12	treatment	treatment	NN
25944	1257	13	to	to	TO
25944	1257	14	be	be	VB
25944	1257	15	based	base	VBN
25944	1257	16	?	?	.
25944	1257	17	#	#	NN
25944	1257	18	Upon	upon	IN
25944	1257	19	indications	indication	NNS
25944	1257	20	in	in	IN
25944	1257	21	the	the	DT
25944	1257	22	individual	individual	JJ
25944	1257	23	case	case	NN
25944	1257	24	.	.	.
25944	1258	1	A	a	DT
25944	1258	2	careful	careful	JJ
25944	1258	3	examination	examination	NN
25944	1258	4	into	into	IN
25944	1258	5	the	the	DT
25944	1258	6	patient	patient	NN
25944	1258	7	's	's	POS
25944	1258	8	general	general	JJ
25944	1258	9	health	health	NN
25944	1258	10	will	will	MD
25944	1258	11	usually	usually	RB
25944	1258	12	give	give	VB
25944	1258	13	the	the	DT
25944	1258	14	cue	cue	NN
25944	1258	15	to	to	IN
25944	1258	16	the	the	DT
25944	1258	17	line	line	NN
25944	1258	18	of	of	IN
25944	1258	19	treatment	treatment	NN
25944	1258	20	to	to	TO
25944	1258	21	be	be	VB
25944	1258	22	adopted	adopt	VBN
25944	1258	23	.	.	.
25944	1259	1	#	#	$
25944	1259	2	Mention	mention	VB
25944	1259	3	the	the	DT
25944	1259	4	important	important	JJ
25944	1259	5	remedies	remedy	NNS
25944	1259	6	variously	variously	RB
25944	1259	7	employed	employ	VBN
25944	1259	8	in	in	IN
25944	1259	9	the	the	DT
25944	1259	10	constitutional	constitutional	JJ
25944	1259	11	treatment	treatment	NN
25944	1259	12	.	.	.
25944	1259	13	#	#	$
25944	1259	14	_	_	NNP
25944	1259	15	Tonics_--such	Tonics_--such	NNP
25944	1259	16	as	as	IN
25944	1259	17	cod	cod	NN
25944	1259	18	-	-	HYPH
25944	1259	19	liver	liver	NN
25944	1259	20	oil	oil	NN
25944	1259	21	,	,	,
25944	1259	22	quinine	quinine	JJ
25944	1259	23	,	,	,
25944	1259	24	nux	nux	NN
25944	1259	25	vomica	vomica	NNP
25944	1259	26	,	,	,
25944	1259	27	the	the	DT
25944	1259	28	vegetable	vegetable	NN
25944	1259	29	bitters	bitter	NNS
25944	1259	30	,	,	,
25944	1259	31	iron	iron	NN
25944	1259	32	,	,	,
25944	1259	33	arsenic	arsenic	JJ
25944	1259	34	,	,	,
25944	1259	35	malt	malt	NN
25944	1259	36	,	,	,
25944	1259	37	etc	etc	FW
25944	1259	38	.	.	.
25944	1260	1	_	_	NNP
25944	1260	2	Alkalies_--sodium	alkalies_--sodium	JJ
25944	1260	3	salicylate	salicylate	NN
25944	1260	4	,	,	,
25944	1260	5	potassium	potassium	NN
25944	1260	6	bicarbonate	bicarbonate	NN
25944	1260	7	,	,	,
25944	1260	8	liquor	liquor	NN
25944	1260	9	potassæ	potassæ	NN
25944	1260	10	,	,	,
25944	1260	11	and	and	CC
25944	1260	12	lithium	lithium	NN
25944	1260	13	carbonate	carbonate	NN
25944	1260	14	.	.	.
25944	1261	1	_	_	NNP
25944	1261	2	Alteratives_--calomel	Alteratives_--calomel	NNP
25944	1261	3	,	,	,
25944	1261	4	colchicum	colchicum	NNP
25944	1261	5	,	,	,
25944	1261	6	arsenic	arsenic	JJ
25944	1261	7	,	,	,
25944	1261	8	and	and	CC
25944	1261	9	potassium	potassium	NN
25944	1261	10	iodide	iodide	NN
25944	1261	11	.	.	.
25944	1262	1	_	_	NNP
25944	1262	2	Diuretics_--potassium	Diuretics_--potassium	NNP
25944	1262	3	acetate	acetate	NNP
25944	1262	4	,	,	,
25944	1262	5	potassium	potassium	NN
25944	1262	6	citrate	citrate	NN
25944	1262	7	,	,	,
25944	1262	8	and	and	CC
25944	1262	9	oil	oil	NN
25944	1262	10	of	of	IN
25944	1262	11	copaiba	copaiba	NNS
25944	1262	12	.	.	.
25944	1263	1	_	_	NNP
25944	1263	2	Laxatives_--the	laxatives_--the	DT
25944	1263	3	various	various	JJ
25944	1263	4	salines	saline	NNS
25944	1263	5	,	,	,
25944	1263	6	aperient	aperient	NNP
25944	1263	7	spring	spring	NN
25944	1263	8	waters	water	NNS
25944	1263	9	,	,	,
25944	1263	10	castor	castor	NN
25944	1263	11	oil	oil	NN
25944	1263	12	,	,	,
25944	1263	13	cascara	cascara	NNP
25944	1263	14	sagrada	sagrada	NNP
25944	1263	15	,	,	,
25944	1263	16	aloes	aloe	NNS
25944	1263	17	and	and	CC
25944	1263	18	other	other	JJ
25944	1263	19	vegetable	vegetable	NN
25944	1263	20	cathartics	cathartic	NNS
25944	1263	21	.	.	.
25944	1264	1	_	_	NNP
25944	1264	2	Digestives_--pepsin	Digestives_--pepsin	NNP
25944	1264	3	,	,	,
25944	1264	4	pancreatin	pancreatin	NNP
25944	1264	5	,	,	,
25944	1264	6	muriatic	muriatic	JJ
25944	1264	7	acid	acid	NN
25944	1264	8	and	and	CC
25944	1264	9	the	the	DT
25944	1264	10	various	various	JJ
25944	1264	11	bitter	bitter	JJ
25944	1264	12	tonics	tonic	NNS
25944	1264	13	.	.	.
25944	1265	1	#	#	NN
25944	1265	2	Are	be	VBP
25944	1265	3	there	there	EX
25944	1265	4	any	any	DT
25944	1265	5	remedies	remedy	NNS
25944	1265	6	which	which	WDT
25944	1265	7	have	have	VBP
25944	1265	8	a	a	DT
25944	1265	9	specific	specific	JJ
25944	1265	10	influence	influence	NN
25944	1265	11	?	?	.
25944	1265	12	#	#	$
25944	1265	13	No	no	UH
25944	1265	14	;	;	:
25944	1265	15	although	although	IN
25944	1265	16	arsenic	arsenic	JJ
25944	1265	17	,	,	,
25944	1265	18	in	in	IN
25944	1265	19	exceptional	exceptional	JJ
25944	1265	20	instances	instance	NNS
25944	1265	21	,	,	,
25944	1265	22	seems	seem	VBZ
25944	1265	23	to	to	TO
25944	1265	24	exert	exert	VB
25944	1265	25	a	a	DT
25944	1265	26	special	special	JJ
25944	1265	27	action	action	NN
25944	1265	28	.	.	.
25944	1266	1	Cod	cod	VB
25944	1266	2	-	-	HYPH
25944	1266	3	liver	liver	NN
25944	1266	4	oil	oil	NN
25944	1266	5	is	be	VBZ
25944	1266	6	also	also	RB
25944	1266	7	of	of	IN
25944	1266	8	great	great	JJ
25944	1266	9	value	value	NN
25944	1266	10	in	in	IN
25944	1266	11	some	some	DT
25944	1266	12	cases	case	NNS
25944	1266	13	.	.	.
25944	1267	1	Upon	upon	IN
25944	1267	2	the	the	DT
25944	1267	3	whole	whole	NN
25944	1267	4	the	the	DT
25944	1267	5	most	most	RBS
25944	1267	6	important	important	JJ
25944	1267	7	remedies	remedy	NNS
25944	1267	8	are	be	VBP
25944	1267	9	those	those	DT
25944	1267	10	which	which	WDT
25944	1267	11	keep	keep	VBP
25944	1267	12	in	in	IN
25944	1267	13	view	view	NN
25944	1267	14	the	the	DT
25944	1267	15	maintenance	maintenance	NN
25944	1267	16	of	of	IN
25944	1267	17	a	a	DT
25944	1267	18	proper	proper	JJ
25944	1267	19	and	and	CC
25944	1267	20	healthful	healthful	JJ
25944	1267	21	condition	condition	NN
25944	1267	22	of	of	IN
25944	1267	23	the	the	DT
25944	1267	24	gastro	gastro	JJ
25944	1267	25	-	-	HYPH
25944	1267	26	intestinal	intestinal	JJ
25944	1267	27	tract	tract	NN
25944	1267	28	,	,	,
25944	1267	29	and	and	CC
25944	1267	30	especially	especially	RB
25944	1267	31	with	with	IN
25944	1267	32	regular	regular	JJ
25944	1267	33	and	and	CC
25944	1267	34	rather	rather	RB
25944	1267	35	free	free	JJ
25944	1267	36	action	action	NN
25944	1267	37	of	of	IN
25944	1267	38	the	the	DT
25944	1267	39	bowels	bowel	NNS
25944	1267	40	.	.	.
25944	1268	1	#	#	$
25944	1268	2	In	in	IN
25944	1268	3	what	what	WDT
25944	1268	4	class	class	NN
25944	1268	5	of	of	IN
25944	1268	6	cases	case	NNS
25944	1268	7	does	do	VBZ
25944	1268	8	arsenic	arsenic	JJ
25944	1268	9	often	often	RB
25944	1268	10	prove	prove	VB
25944	1268	11	of	of	IN
25944	1268	12	service	service	NN
25944	1268	13	?	?	.
25944	1268	14	#	#	$
25944	1268	15	In	in	IN
25944	1268	16	the	the	DT
25944	1268	17	sluggish	sluggish	JJ
25944	1268	18	,	,	,
25944	1268	19	dry	dry	JJ
25944	1268	20	,	,	,
25944	1268	21	erythematous	erythematous	JJ
25944	1268	22	,	,	,
25944	1268	23	scaly	scaly	JJ
25944	1268	24	and	and	CC
25944	1268	25	papular	papular	JJ
25944	1268	26	types	type	NNS
25944	1268	27	.	.	.
25944	1269	1	#	#	$
25944	1269	2	In	in	IN
25944	1269	3	what	what	WP
25944	1269	4	cases	case	NNS
25944	1269	5	is	be	VBZ
25944	1269	6	arsenic	arsenic	JJ
25944	1269	7	usually	usually	RB
25944	1269	8	contraindicated	contraindicated	JJ
25944	1269	9	?	?	.
25944	1269	10	#	#	NN
25944	1269	11	It	-PRON-	PRP
25944	1269	12	should	should	MD
25944	1269	13	never	never	RB
25944	1269	14	be	be	VB
25944	1269	15	employed	employ	VBN
25944	1269	16	in	in	IN
25944	1269	17	acute	acute	JJ
25944	1269	18	cases	case	NNS
25944	1269	19	;	;	:
25944	1269	20	nor	nor	CC
25944	1269	21	in	in	IN
25944	1269	22	any	any	DT
25944	1269	23	instance	instance	NN
25944	1269	24	(	(	-LRB-
25944	1269	25	unless	unless	IN
25944	1269	26	its	-PRON-	PRP$
25944	1269	27	action	action	NN
25944	1269	28	is	be	VBZ
25944	1269	29	watched	watch	VBN
25944	1269	30	)	)	-RRB-
25944	1269	31	,	,	,
25944	1269	32	in	in	IN
25944	1269	33	which	which	WDT
25944	1269	34	the	the	DT
25944	1269	35	degree	degree	NN
25944	1269	36	of	of	IN
25944	1269	37	inflammatory	inflammatory	JJ
25944	1269	38	action	action	NN
25944	1269	39	is	be	VBZ
25944	1269	40	marked	mark	VBN
25944	1269	41	,	,	,
25944	1269	42	as	as	IN
25944	1269	43	an	an	DT
25944	1269	44	aggravation	aggravation	NN
25944	1269	45	of	of	IN
25944	1269	46	the	the	DT
25944	1269	47	disease	disease	NN
25944	1269	48	usually	usually	RB
25944	1269	49	results	result	VBZ
25944	1269	50	.	.	.
25944	1270	1	#	#	$
25944	1270	2	What	what	WP
25944	1270	3	should	should	MD
25944	1270	4	be	be	VB
25944	1270	5	the	the	DT
25944	1270	6	character	character	NN
25944	1270	7	of	of	IN
25944	1270	8	the	the	DT
25944	1270	9	external	external	JJ
25944	1270	10	treatment	treatment	NN
25944	1270	11	?	?	.
25944	1270	12	#	#	$
25944	1270	13	It	-PRON-	PRP
25944	1270	14	depends	depend	VBZ
25944	1270	15	mainly	mainly	RB
25944	1270	16	upon	upon	IN
25944	1270	17	the	the	DT
25944	1270	18	degree	degree	NN
25944	1270	19	of	of	IN
25944	1270	20	inflammatory	inflammatory	JJ
25944	1270	21	action	action	NN
25944	1270	22	;	;	:
25944	1270	23	but	but	CC
25944	1270	24	the	the	DT
25944	1270	25	stage	stage	NN
25944	1270	26	of	of	IN
25944	1270	27	the	the	DT
25944	1270	28	disease	disease	NN
25944	1270	29	,	,	,
25944	1270	30	the	the	DT
25944	1270	31	extent	extent	NN
25944	1270	32	involved	involve	VBN
25944	1270	33	,	,	,
25944	1270	34	and	and	CC
25944	1270	35	the	the	DT
25944	1270	36	ability	ability	NN
25944	1270	37	of	of	IN
25944	1270	38	the	the	DT
25944	1270	39	patient	patient	NN
25944	1270	40	to	to	TO
25944	1270	41	carry	carry	VB
25944	1270	42	out	out	RP
25944	1270	43	the	the	DT
25944	1270	44	details	detail	NNS
25944	1270	45	of	of	IN
25944	1270	46	treatment	treatment	NN
25944	1270	47	,	,	,
25944	1270	48	also	also	RB
25944	1270	49	have	have	VB
25944	1270	50	a	a	DT
25944	1270	51	bearing	bearing	NN
25944	1270	52	upon	upon	IN
25944	1270	53	the	the	DT
25944	1270	54	selection	selection	NN
25944	1270	55	of	of	IN
25944	1270	56	the	the	DT
25944	1270	57	plan	plan	NN
25944	1270	58	to	to	TO
25944	1270	59	be	be	VB
25944	1270	60	advised	advise	VBN
25944	1270	61	.	.	.
25944	1271	1	#	#	LS
25944	1271	2	What	what	WP
25944	1271	3	is	be	VBZ
25944	1271	4	to	to	TO
25944	1271	5	be	be	VB
25944	1271	6	said	say	VBN
25944	1271	7	about	about	IN
25944	1271	8	the	the	DT
25944	1271	9	use	use	NN
25944	1271	10	of	of	IN
25944	1271	11	soap	soap	NN
25944	1271	12	and	and	CC
25944	1271	13	water	water	NN
25944	1271	14	in	in	IN
25944	1271	15	eczema	eczema	NN
25944	1271	16	?	?	.
25944	1271	17	#	#	$
25944	1271	18	In	in	IN
25944	1271	19	acute	acute	JJ
25944	1271	20	and	and	CC
25944	1271	21	subacute	subacute	JJ
25944	1271	22	conditions	condition	NNS
25944	1271	23	soap	soap	NN
25944	1271	24	and	and	CC
25944	1271	25	water	water	NN
25944	1271	26	are	be	VBP
25944	1271	27	to	to	TO
25944	1271	28	be	be	VB
25944	1271	29	employed	employ	VBN
25944	1271	30	,	,	,
25944	1271	31	as	as	IN
25944	1271	32	a	a	DT
25944	1271	33	rule	rule	NN
25944	1271	34	,	,	,
25944	1271	35	as	as	RB
25944	1271	36	infrequently	infrequently	RB
25944	1271	37	and	and	CC
25944	1271	38	as	as	RB
25944	1271	39	sparingly	sparingly	RB
25944	1271	40	as	as	IN
25944	1271	41	possible	possible	JJ
25944	1271	42	,	,	,
25944	1271	43	as	as	IN
25944	1271	44	the	the	DT
25944	1271	45	disease	disease	NN
25944	1271	46	is	be	VBZ
25944	1271	47	often	often	RB
25944	1271	48	aggravated	aggravate	VBN
25944	1271	49	by	by	IN
25944	1271	50	their	-PRON-	PRP$
25944	1271	51	too	too	RB
25944	1271	52	free	free	JJ
25944	1271	53	use	use	NN
25944	1271	54	.	.	.
25944	1272	1	Washing	washing	NN
25944	1272	2	is	be	VBZ
25944	1272	3	necessary	necessary	JJ
25944	1272	4	,	,	,
25944	1272	5	however	however	RB
25944	1272	6	,	,	,
25944	1272	7	for	for	IN
25944	1272	8	cleanliness	cleanliness	NN
25944	1272	9	and	and	CC
25944	1272	10	occasionally	occasionally	RB
25944	1272	11	,	,	,
25944	1272	12	also	also	RB
25944	1272	13	,	,	,
25944	1272	14	for	for	IN
25944	1272	15	the	the	DT
25944	1272	16	removal	removal	NN
25944	1272	17	of	of	IN
25944	1272	18	the	the	DT
25944	1272	19	crusts	crust	NNS
25944	1272	20	.	.	.
25944	1273	1	On	on	IN
25944	1273	2	the	the	DT
25944	1273	3	other	other	JJ
25944	1273	4	hand	hand	NN
25944	1273	5	,	,	,
25944	1273	6	in	in	IN
25944	1273	7	chronic	chronic	JJ
25944	1273	8	,	,	,
25944	1273	9	sluggish	sluggish	JJ
25944	1273	10	types	type	NNS
25944	1273	11	the	the	DT
25944	1273	12	use	use	NN
25944	1273	13	of	of	IN
25944	1273	14	soap	soap	NN
25944	1273	15	and	and	CC
25944	1273	16	water	water	NN
25944	1273	17	frequently	frequently	RB
25944	1273	18	has	have	VBZ
25944	1273	19	a	a	DT
25944	1273	20	therapeutic	therapeutic	JJ
25944	1273	21	value	value	NN
25944	1273	22	.	.	.
25944	1274	1	#	#	NN
25944	1274	2	How	how	WRB
25944	1274	3	often	often	RB
25944	1274	4	should	should	MD
25944	1274	5	remedial	remedial	JJ
25944	1274	6	applications	application	NNS
25944	1274	7	be	be	VB
25944	1274	8	made	make	VBN
25944	1274	9	?	?	.
25944	1274	10	#	#	$
25944	1274	11	Usually	usually	RB
25944	1274	12	twice	twice	RB
25944	1274	13	daily	daily	JJ
25944	1274	14	,	,	,
25944	1274	15	although	although	IN
25944	1274	16	in	in	IN
25944	1274	17	some	some	DT
25944	1274	18	case	case	NN
25944	1274	19	,	,	,
25944	1274	20	and	and	CC
25944	1274	21	especially	especially	RB
25944	1274	22	those	those	DT
25944	1274	23	of	of	IN
25944	1274	24	an	an	DT
25944	1274	25	acute	acute	JJ
25944	1274	26	type	type	NN
25944	1274	27	,	,	,
25944	1274	28	applications	application	NNS
25944	1274	29	should	should	MD
25944	1274	30	be	be	VB
25944	1274	31	made	make	VBN
25944	1274	32	every	every	DT
25944	1274	33	few	few	JJ
25944	1274	34	hours	hour	NNS
25944	1274	35	.	.	.
25944	1275	1	#	#	$
25944	1275	2	Mention	mention	VB
25944	1275	3	several	several	JJ
25944	1275	4	remedies	remedy	NNS
25944	1275	5	or	or	CC
25944	1275	6	plans	plan	NNS
25944	1275	7	of	of	IN
25944	1275	8	treatment	treatment	NN
25944	1275	9	to	to	TO
25944	1275	10	be	be	VB
25944	1275	11	used	use	VBN
25944	1275	12	in	in	IN
25944	1275	13	the	the	DT
25944	1275	14	acute	acute	NN
25944	1275	15	or	or	CC
25944	1275	16	actively	actively	RB
25944	1275	17	inflammatory	inflammatory	JJ
25944	1275	18	cases	case	NNS
25944	1275	19	.	.	.
25944	1275	20	#	#	$
25944	1275	21	Black	black	JJ
25944	1275	22	wash	wash	NN
25944	1275	23	and	and	CC
25944	1275	24	oxide	oxide	NN
25944	1275	25	-	-	HYPH
25944	1275	26	of	of	IN
25944	1275	27	-	-	HYPH
25944	1275	28	zinc	zinc	NN
25944	1275	29	ointment	ointment	NN
25944	1275	30	conjointly	conjointly	RB
25944	1275	31	,	,	,
25944	1275	32	the	the	DT
25944	1275	33	wash	wash	NN
25944	1275	34	thoroughly	thoroughly	RB
25944	1275	35	dabbed	dab	VBN
25944	1275	36	on	on	IN
25944	1275	37	,	,	,
25944	1275	38	allowed	allow	VBN
25944	1275	39	to	to	TO
25944	1275	40	dry	dry	VB
25944	1275	41	,	,	,
25944	1275	42	the	the	DT
25944	1275	43	parts	part	NNS
25944	1275	44	gently	gently	RB
25944	1275	45	smeared	smear	VBD
25944	1275	46	with	with	IN
25944	1275	47	ointment	ointment	NN
25944	1275	48	;	;	:
25944	1275	49	or	or	CC
25944	1275	50	the	the	DT
25944	1275	51	ointment	ointment	NN
25944	1275	52	may	may	MD
25944	1275	53	be	be	VB
25944	1275	54	applied	apply	VBN
25944	1275	55	spread	spread	NN
25944	1275	56	on	on	IN
25944	1275	57	lint	lint	NN
25944	1275	58	as	as	IN
25944	1275	59	a	a	DT
25944	1275	60	plaster	plaster	NN
25944	1275	61	.	.	.
25944	1276	1	Boric	boric	NN
25944	1276	2	-	-	HYPH
25944	1276	3	acid	acid	JJ
25944	1276	4	wash	wash	NN
25944	1276	5	(	(	-LRB-
25944	1276	6	15	15	CD
25944	1276	7	grains	grain	NNS
25944	1276	8	to	to	IN
25944	1276	9	the	the	DT
25944	1276	10	ounce	ounce	NN
25944	1276	11	)	)	-RRB-
25944	1276	12	and	and	CC
25944	1276	13	oxide	oxide	NN
25944	1276	14	-	-	HYPH
25944	1276	15	of	of	IN
25944	1276	16	-	-	HYPH
25944	1276	17	zinc	zinc	NN
25944	1276	18	ointment	ointment	NN
25944	1276	19	,	,	,
25944	1276	20	applied	apply	VBD
25944	1276	21	in	in	IN
25944	1276	22	the	the	DT
25944	1276	23	same	same	JJ
25944	1276	24	manner	manner	NN
25944	1276	25	as	as	IN
25944	1276	26	the	the	DT
25944	1276	27	above	above	JJ
25944	1276	28	.	.	.
25944	1277	1	A	a	DT
25944	1277	2	lotion	lotion	NN
25944	1277	3	containing	contain	VBG
25944	1277	4	calamine	calamine	NN
25944	1277	5	and	and	CC
25944	1277	6	zinc	zinc	NN
25944	1277	7	oxide	oxide	NN
25944	1277	8	,	,	,
25944	1277	9	the	the	DT
25944	1277	10	sediment	sediment	NN
25944	1277	11	drying	drying	NN
25944	1277	12	and	and	CC
25944	1277	13	coating	coat	VBG
25944	1277	14	over	over	IN
25944	1277	15	the	the	DT
25944	1277	16	affected	affect	VBN
25944	1277	17	surface:--	surface:--	CD
25944	1277	18	[	[	-LRB-
25944	1277	19	Rx	Rx	NNP
25944	1277	20	]	]	-RRB-
25944	1277	21	Calaminæ	Calaminæ	NNP
25944	1277	22	,	,	,
25944	1277	23	Zinci	Zinci	NNP
25944	1277	24	oxidi	oxidi	NN
25944	1277	25	,	,	,
25944	1277	26	...	...	NFP
25944	1277	27	[	[	-LRB-
25944	1277	28	=	=	SYM
25944	1277	29	a][=a	a][=a	CD
25944	1277	30	]	]	-RRB-
25944	1277	31	.........	.........	.
25944	1277	32	[	[	-LRB-
25944	1277	33	dram]ij-[dram]iij	dram]ij-[dram]iij	.
25944	1277	34	Glycerinæ	Glycerinæ	NNP
25944	1277	35	,	,	,
25944	1277	36	Alcoholis	Alcoholis	NNP
25944	1277	37	,	,	,
25944	1277	38	.....	.....	NFP
25944	1277	39	[	[	-LRB-
25944	1277	40	=	=	SYM
25944	1277	41	a][=a	a][=a	CD
25944	1277	42	]	]	-RRB-
25944	1277	43	.........	.........	NFP
25944	1277	44	f[dram]ss	f[dram]ss	NFP
25944	1277	45	Liq	liq	XX
25944	1277	46	.	.	.
25944	1278	1	calcis	calcis	NNP
25944	1278	2	,	,	,
25944	1278	3	......................	......................	.
25944	1278	4	f[Oz]ij	f[Oz]ij	NNP
25944	1278	5	Aquæ	Aquæ	NNP
25944	1278	6	,	,	,
25944	1278	7	..........	..........	NFP
25944	1278	8	q.s	q.s	NNP
25944	1278	9	.	.	.
25944	1279	1	ad	ad	NN
25944	1279	2	..........	..........	.
25944	1279	3	f[Oz]vj	f[Oz]vj	NNP
25944	1279	4	.	.	.
25944	1280	1	M.	M.	NNP
25944	1280	2	Another	another	DT
25944	1280	3	excellent	excellent	JJ
25944	1280	4	lotion	lotion	NN
25944	1280	5	somewhat	somewhat	RB
25944	1280	6	similar	similar	JJ
25944	1280	7	to	to	IN
25944	1280	8	the	the	DT
25944	1280	9	last	last	JJ
25944	1280	10	,	,	,
25944	1280	11	but	but	CC
25944	1280	12	of	of	IN
25944	1280	13	oily	oily	JJ
25944	1280	14	character	character	NN
25944	1280	15	,	,	,
25944	1280	16	is	be	VBZ
25944	1280	17	made	make	VBN
25944	1280	18	up	up	RP
25944	1280	19	of	of	IN
25944	1280	20	three	three	CD
25944	1280	21	drachms	drachm	NNS
25944	1280	22	each	each	DT
25944	1280	23	of	of	IN
25944	1280	24	calamine	calamine	NN
25944	1280	25	and	and	CC
25944	1280	26	zinc	zinc	NN
25944	1280	27	oxide	oxide	NN
25944	1280	28	,	,	,
25944	1280	29	one	one	CD
25944	1280	30	drachm	drachm	NN
25944	1280	31	of	of	IN
25944	1280	32	boric	boric	NN
25944	1280	33	acid	acid	NN
25944	1280	34	,	,	,
25944	1280	35	ten	ten	CD
25944	1280	36	to	to	IN
25944	1280	37	thirty	thirty	CD
25944	1280	38	drops	drop	NNS
25944	1280	39	of	of	IN
25944	1280	40	carbolic	carbolic	JJ
25944	1280	41	acid	acid	NN
25944	1280	42	,	,	,
25944	1280	43	and	and	CC
25944	1280	44	three	three	CD
25944	1280	45	ounces	ounce	NNS
25944	1280	46	each	each	DT
25944	1280	47	of	of	IN
25944	1280	48	lime	lime	NN
25944	1280	49	-	-	HYPH
25944	1280	50	water	water	NN
25944	1280	51	and	and	CC
25944	1280	52	oil	oil	NN
25944	1280	53	of	of	IN
25944	1280	54	sweet	sweet	JJ
25944	1280	55	almonds	almond	NNS
25944	1280	56	.	.	.
25944	1281	1	Carbolic	carbolic	JJ
25944	1281	2	-	-	HYPH
25944	1281	3	acid	acid	NN
25944	1281	4	lotion	lotion	NN
25944	1281	5	,	,	,
25944	1281	6	about	about	RB
25944	1281	7	two	two	CD
25944	1281	8	drachms	drachm	NNS
25944	1281	9	to	to	IN
25944	1281	10	the	the	DT
25944	1281	11	pint	pint	NN
25944	1281	12	of	of	IN
25944	1281	13	water	water	NN
25944	1281	14	,	,	,
25944	1281	15	to	to	TO
25944	1281	16	which	which	WDT
25944	1281	17	may	may	MD
25944	1281	18	be	be	VB
25944	1281	19	added	add	VBN
25944	1281	20	two	two	CD
25944	1281	21	or	or	CC
25944	1281	22	three	three	CD
25944	1281	23	drachms	drachm	NNS
25944	1281	24	each	each	DT
25944	1281	25	of	of	IN
25944	1281	26	glycerin	glycerin	NN
25944	1281	27	and	and	CC
25944	1281	28	alcohol	alcohol	NN
25944	1281	29	;	;	:
25944	1281	30	or	or	CC
25944	1281	31	,	,	,
25944	1281	32	if	if	IN
25944	1281	33	there	there	EX
25944	1281	34	is	be	VBZ
25944	1281	35	intense	intense	JJ
25944	1281	36	itching	itching	NN
25944	1281	37	,	,	,
25944	1281	38	carbolic	carbolic	JJ
25944	1281	39	acid	acid	NN
25944	1281	40	may	may	MD
25944	1281	41	be	be	VB
25944	1281	42	added	add	VBN
25944	1281	43	to	to	IN
25944	1281	44	the	the	DT
25944	1281	45	several	several	JJ
25944	1281	46	washes	wash	NNS
25944	1281	47	already	already	RB
25944	1281	48	mentioned	mention	VBN
25944	1281	49	.	.	.
25944	1282	1	A	a	DT
25944	1282	2	lotion	lotion	NN
25944	1282	3	made	make	VBN
25944	1282	4	of	of	IN
25944	1282	5	one	one	CD
25944	1282	6	or	or	CC
25944	1282	7	two	two	CD
25944	1282	8	drachms	drachm	NNS
25944	1282	9	of	of	IN
25944	1282	10	liquor	liquor	NN
25944	1282	11	carbonis	carbonis	NNP
25944	1282	12	detergens[A	detergens[A	NNP
25944	1282	13	]	]	-RRB-
25944	1282	14	to	to	IN
25944	1282	15	four	four	CD
25944	1282	16	ounces	ounce	NNS
25944	1282	17	of	of	IN
25944	1282	18	water	water	NN
25944	1282	19	.	.	.
25944	1283	1	The	the	DT
25944	1283	2	following	following	JJ
25944	1283	3	wash	wash	NN
25944	1283	4	,	,	,
25944	1283	5	especially	especially	RB
25944	1283	6	in	in	IN
25944	1283	7	the	the	DT
25944	1283	8	dry	dry	JJ
25944	1283	9	form	form	NN
25944	1283	10	of	of	IN
25944	1283	11	the	the	DT
25944	1283	12	disease:--	disease:--	NN
25944	1283	13	[	[	-LRB-
25944	1283	14	Rx	Rx	NNP
25944	1283	15	]	]	-RRB-
25944	1283	16	Ac	Ac	NNP
25944	1283	17	.	.	.
25944	1284	1	borici	borici	NNP
25944	1284	2	,	,	,
25944	1284	3	..........................	..........................	NFP
25944	1284	4	[	[	-LRB-
25944	1284	5	dram]iv	dram]iv	NNS
25944	1284	6	Ac	Ac	NNP
25944	1284	7	.	.	.
25944	1285	1	carbolici	carbolici	NNS
25944	1285	2	,	,	,
25944	1285	3	.......................	.......................	NFP
25944	1285	4	[	[	-LRB-
25944	1285	5	dram]j	dram]j	NNP
25944	1285	6	Glycerinæ	Glycerinæ	NNP
25944	1285	7	,	,	,
25944	1285	8	...........................	...........................	NFP
25944	1285	9	[	[	-LRB-
25944	1285	10	dram]ij	dram]ij	FW
25944	1285	11	Alcoholis	Alcoholis	NNP
25944	1285	12	,	,	,
25944	1285	13	...........................	...........................	NFP
25944	1285	14	[	[	-LRB-
25944	1285	15	dram]ij	dram]ij	NNP
25944	1285	16	Aquæ	Aquæ	NNP
25944	1285	17	,	,	,
25944	1285	18	.............	.............	NFP
25944	1285	19	q.s	q.s	NNP
25944	1285	20	.	.	.
25944	1286	1	ad	ad	NN
25944	1286	2	..........	..........	.
25944	1286	3	Oj	oj	UH
25944	1286	4	.	.	.
25944	1287	1	M.	M.	NNP
25944	1287	2	[	[	-LRB-
25944	1287	3	Footnote	Footnote	NNP
25944	1287	4	A	A	NNP
25944	1287	5	:	:	:
25944	1287	6	Liquor	liquor	NN
25944	1287	7	carbonis	carbonis	NN
25944	1287	8	detergens	detergen	NNS
25944	1287	9	is	be	VBZ
25944	1287	10	made	make	VBN
25944	1287	11	by	by	IN
25944	1287	12	mixing	mix	VBG
25944	1287	13	together	together	RB
25944	1287	14	nine	nine	CD
25944	1287	15	ounces	ounce	NNS
25944	1287	16	of	of	IN
25944	1287	17	tincture	tincture	NN
25944	1287	18	soap	soap	NN
25944	1287	19	bark	bark	NN
25944	1287	20	and	and	CC
25944	1287	21	four	four	CD
25944	1287	22	ounces	ounce	NNS
25944	1287	23	of	of	IN
25944	1287	24	coal	coal	NN
25944	1287	25	tar	tar	NN
25944	1287	26	,	,	,
25944	1287	27	allowing	allow	VBG
25944	1287	28	to	to	TO
25944	1287	29	digest	digest	VB
25944	1287	30	for	for	IN
25944	1287	31	eight	eight	CD
25944	1287	32	days	day	NNS
25944	1287	33	,	,	,
25944	1287	34	and	and	CC
25944	1287	35	filtering	filter	VBG
25944	1287	36	.	.	.
25944	1288	1	The	the	DT
25944	1288	2	tincture	tincture	NN
25944	1288	3	of	of	IN
25944	1288	4	soap	soap	NN
25944	1288	5	bark	bark	NN
25944	1288	6	used	use	VBN
25944	1288	7	is	be	VBZ
25944	1288	8	made	make	VBN
25944	1288	9	with	with	IN
25944	1288	10	one	one	CD
25944	1288	11	pound	pound	NN
25944	1288	12	of	of	IN
25944	1288	13	soap	soap	NN
25944	1288	14	bark	bark	NN
25944	1288	15	to	to	IN
25944	1288	16	one	one	CD
25944	1288	17	gallon	gallon	NN
25944	1288	18	of	of	IN
25944	1288	19	95	95	CD
25944	1288	20	per	per	NN
25944	1288	21	cent	cent	NN
25944	1288	22	.	.	.
25944	1289	1	alcohol	alcohol	NNP
25944	1289	2	,	,	,
25944	1289	3	digesting	digest	VBG
25944	1289	4	for	for	IN
25944	1289	5	a	a	DT
25944	1289	6	week	week	NN
25944	1289	7	or	or	CC
25944	1289	8	so	so	RB
25944	1289	9	.	.	.
25944	1290	1	Instead	instead	RB
25944	1290	2	of	of	IN
25944	1290	3	the	the	DT
25944	1290	4	proprietary	proprietary	JJ
25944	1290	5	name	name	NN
25944	1290	6	above	above	RB
25944	1290	7	,	,	,
25944	1290	8	Prof.	Prof.	NNP
25944	1290	9	Duhring	Duhring	NNP
25944	1290	10	has	have	VBZ
25944	1290	11	suggested	suggest	VBN
25944	1290	12	that	that	IN
25944	1290	13	of	of	IN
25944	1290	14	tinctura	tinctura	NN
25944	1290	15	picis	picis	NNP
25944	1290	16	mineralis	mineralis	NNP
25944	1290	17	comp	comp	NNP
25944	1290	18	.	.	.
25944	1290	19	]	]	-RRB-
25944	1291	1	Dusting	dusting	NN
25944	1291	2	-	-	HYPH
25944	1291	3	powders	powder	NNS
25944	1291	4	,	,	,
25944	1291	5	of	of	IN
25944	1291	6	starch	starch	NN
25944	1291	7	,	,	,
25944	1291	8	zinc	zinc	NN
25944	1291	9	oxide	oxide	NN
25944	1291	10	and	and	CC
25944	1291	11	Venetian	venetian	JJ
25944	1291	12	talc	talc	NN
25944	1291	13	,	,	,
25944	1291	14	alone	alone	JJ
25944	1291	15	or	or	CC
25944	1291	16	severally	severally	RB
25944	1291	17	combined	combine	VBN
25944	1291	18	,	,	,
25944	1291	19	applied	apply	VBD
25944	1291	20	freely	freely	RB
25944	1291	21	and	and	CC
25944	1291	22	often	often	RB
25944	1291	23	,	,	,
25944	1291	24	so	so	IN
25944	1291	25	as	as	IN
25944	1291	26	to	to	TO
25944	1291	27	afford	afford	VB
25944	1291	28	protection	protection	NN
25944	1291	29	to	to	IN
25944	1291	30	the	the	DT
25944	1291	31	inflamed	inflame	VBN
25944	1291	32	surface:--	surface:--	.
25944	1291	33	[	[	-LRB-
25944	1291	34	Rx	Rx	NNP
25944	1291	35	]	]	-RRB-
25944	1291	36	Talci	Talci	NNP
25944	1291	37	venet	venet	NN
25944	1291	38	,	,	,
25944	1291	39	Zinci	Zinci	NNP
25944	1291	40	oxidi	oxidi	NN
25944	1291	41	,	,	,
25944	1291	42	.......	.......	NFP
25944	1291	43	[	[	-LRB-
25944	1291	44	=	=	SYM
25944	1291	45	a][=a	a][=a	CD
25944	1291	46	]	]	-RRB-
25944	1291	47	........	........	.
25944	1291	48	[	[	-LRB-
25944	1291	49	dram]iv	dram]iv	NNP
25944	1291	50	Amyli	amyli	VB
25944	1291	51	,	,	,
25944	1291	52	...............................	...............................	NFP
25944	1291	53	[	[	-LRB-
25944	1291	54	Oz]j	Oz]j	.
25944	1291	55	M.	M.	NNP
25944	1291	56	If	if	IN
25944	1291	57	washes	wash	NNS
25944	1291	58	or	or	CC
25944	1291	59	dusting	dusting	NN
25944	1291	60	-	-	HYPH
25944	1291	61	powders	powder	NNS
25944	1291	62	should	should	MD
25944	1291	63	disagree	disagree	VB
25944	1291	64	or	or	CC
25944	1291	65	are	be	VBP
25944	1291	66	not	not	RB
25944	1291	67	desirable	desirable	JJ
25944	1291	68	or	or	CC
25944	1291	69	practicable	practicable	JJ
25944	1291	70	,	,	,
25944	1291	71	ointments	ointment	NNS
25944	1291	72	may	may	MD
25944	1291	73	be	be	VB
25944	1291	74	employed	employ	VBN
25944	1291	75	,	,	,
25944	1291	76	such	such	JJ
25944	1291	77	as--	as--	NNP
25944	1291	78	Oxide	Oxide	NNP
25944	1291	79	-	-	HYPH
25944	1291	80	of	of	IN
25944	1291	81	-	-	HYPH
25944	1291	82	zinc	zinc	NN
25944	1291	83	ointment	ointment	NN
25944	1291	84	,	,	,
25944	1291	85	cold	cold	JJ
25944	1291	86	cream	cream	NN
25944	1291	87	,	,	,
25944	1291	88	petrolatum	petrolatum	NN
25944	1291	89	,	,	,
25944	1291	90	plain	plain	JJ
25944	1291	91	or	or	CC
25944	1291	92	carbolated	carbolate	VBN
25944	1291	93	,	,	,
25944	1291	94	diachylon	diachylon	NNP
25944	1291	95	ointment	ointment	NN
25944	1291	96	(	(	-LRB-
25944	1291	97	if	if	IN
25944	1291	98	fresh	fresh	JJ
25944	1291	99	and	and	CC
25944	1291	100	well	well	RB
25944	1291	101	prepared	prepared	JJ
25944	1291	102	)	)	-RRB-
25944	1291	103	,	,	,
25944	1291	104	and	and	CC
25944	1291	105	a	a	DT
25944	1291	106	paste	paste	NN
25944	1291	107	-	-	HYPH
25944	1291	108	like	like	JJ
25944	1291	109	ointment	ointment	NN
25944	1291	110	,	,	,
25944	1291	111	as	as	IN
25944	1291	112	the	the	DT
25944	1291	113	following	following	NN
25944	1291	114	,	,	,
25944	1291	115	usually	usually	RB
25944	1291	116	called	call	VBN
25944	1291	117	"	"	``
25944	1291	118	salicylic	salicylic	JJ
25944	1291	119	-	-	HYPH
25944	1291	120	acid	acid	NN
25944	1291	121	paste	paste	NN
25944	1291	122	"	"	''
25944	1291	123	;	;	,
25944	1291	124	in	in	IN
25944	1291	125	markedly	markedly	RB
25944	1291	126	itchy	itchy	JJ
25944	1291	127	cases	case	NNS
25944	1291	128	,	,	,
25944	1291	129	five	five	CD
25944	1291	130	to	to	TO
25944	1291	131	fifteen	fifteen	CD
25944	1291	132	grains	grain	NNS
25944	1291	133	of	of	IN
25944	1291	134	carbolic	carbolic	NNP
25944	1291	135	may	may	MD
25944	1291	136	be	be	VB
25944	1291	137	added	add	VBN
25944	1291	138	to	to	IN
25944	1291	139	each	each	DT
25944	1291	140	ounce	ounce	NN
25944	1291	141	:	:	:
25944	1291	142	[	[	-LRB-
25944	1291	143	Rx	Rx	NNP
25944	1291	144	]	]	-RRB-
25944	1291	145	Ac	Ac	NNP
25944	1291	146	.	.	.
25944	1292	1	salicylici	salicylici	NNP
25944	1292	2	,	,	,
25944	1292	3	......................	......................	NFP
25944	1292	4	gr	gr	NNP
25944	1292	5	.	.	.
25944	1293	1	v	v	LS
25944	1293	2	-	-	:
25944	1293	3	x	x	SYM
25944	1293	4	Pulv	Pulv	NNP
25944	1293	5	.	.	.
25944	1294	1	amyli	amyli	VB
25944	1294	2	,	,	,
25944	1294	3	Pulv	Pulv	NNP
25944	1294	4	.	.	.
25944	1295	1	zinci	zinci	NNP
25944	1295	2	oxidi	oxidi	NNP
25944	1295	3	,	,	,
25944	1295	4	....	....	NFP
25944	1295	5	[	[	-LRB-
25944	1295	6	=	=	SYM
25944	1295	7	a][=a	a][=a	CD
25944	1295	8	]	]	-RRB-
25944	1295	9	.....	.....	.
25944	1295	10	[	[	-LRB-
25944	1295	11	dram]ij	dram]ij	NNP
25944	1295	12	Petrolati	Petrolati	NNP
25944	1295	13	,	,	,
25944	1295	14	...........................	...........................	NFP
25944	1295	15	[	[	-LRB-
25944	1295	16	dram]iv	dram]iv	NNP
25944	1295	17	M.	M.	NNP
25944	1295	18	Or	or	CC
25944	1295	19	the	the	DT
25944	1295	20	following	follow	VBG
25944	1295	21	ointment:--	ointment:--	''
25944	1295	22	[	[	-LRB-
25944	1295	23	Rx	Rx	NNP
25944	1295	24	]	]	-RRB-
25944	1295	25	Calaminæ	Calaminæ	NNP
25944	1295	26	,	,	,
25944	1295	27	............................	............................	NFP
25944	1295	28	[	[	-LRB-
25944	1295	29	dram]j	dram]j	NNP
25944	1295	30	Ungt	Ungt	NNP
25944	1295	31	.	.	.
25944	1296	1	zinci	zinci	NNP
25944	1296	2	oxidi	oxidi	NNP
25944	1296	3	,	,	,
25944	1296	4	...................	...................	NFP
25944	1296	5	[	[	-LRB-
25944	1296	6	dram]vij	dram]vij	NNP
25944	1296	7	.	.	.
25944	1297	1	M.	M.	NNP
25944	1297	2	#	#	NNP
25944	1297	3	Name	Name	NNP
25944	1297	4	several	several	JJ
25944	1297	5	external	external	JJ
25944	1297	6	remedies	remedy	NNS
25944	1297	7	and	and	CC
25944	1297	8	combinations	combination	NNS
25944	1297	9	useful	useful	JJ
25944	1297	10	in	in	IN
25944	1297	11	eczema	eczema	NN
25944	1297	12	of	of	IN
25944	1297	13	a	a	DT
25944	1297	14	subacute	subacute	NN
25944	1297	15	or	or	CC
25944	1297	16	mildly	mildly	RB
25944	1297	17	inflammatory	inflammatory	JJ
25944	1297	18	type	type	NN
25944	1297	19	.	.	.
25944	1297	20	#	#	$
25944	1297	21	The	the	DT
25944	1297	22	various	various	JJ
25944	1297	23	remedies	remedy	NNS
25944	1297	24	and	and	CC
25944	1297	25	combinations	combination	NNS
25944	1297	26	useful	useful	JJ
25944	1297	27	when	when	WRB
25944	1297	28	the	the	DT
25944	1297	29	symptoms	symptom	NNS
25944	1297	30	are	be	VBP
25944	1297	31	acute	acute	JJ
25944	1297	32	or	or	CC
25944	1297	33	markedly	markedly	RB
25944	1297	34	inflammatory	inflammatory	JJ
25944	1297	35	(	(	-LRB-
25944	1297	36	mentioned	mention	VBN
25944	1297	37	above	above	RB
25944	1297	38	)	)	-RRB-
25944	1297	39	,	,	,
25944	1297	40	and	and	CC
25944	1297	41	more	more	RBR
25944	1297	42	especially	especially	RB
25944	1297	43	the	the	DT
25944	1297	44	several	several	JJ
25944	1297	45	following:--	following:--	CD
25944	1297	46	[	[	-LRB-
25944	1297	47	Rx	Rx	NNP
25944	1297	48	]	]	-RRB-
25944	1297	49	Zinci	Zinci	NNP
25944	1297	50	oxidi	oxidi	NN
25944	1297	51	,	,	,
25944	1297	52	.........................	.........................	NFP
25944	1297	53	[	[	-LRB-
25944	1297	54	dram]ij	dram]ij	UH
25944	1297	55	Liq	Liq	NNP
25944	1297	56	.	.	.
25944	1298	1	plumbi	plumbi	NNP
25944	1298	2	subacetat	subacetat	NNP
25944	1298	3	.	.	.
25944	1299	1	dilut	dilut	NNP
25944	1299	2	.	.	.
25944	1299	3	,	,	,
25944	1299	4	.......	.......	.
25944	1299	5	f[dram]vj	f[dram]vj	NFP
25944	1299	6	Glycerinæ	Glycerinæ	NNP
25944	1299	7	,	,	,
25944	1299	8	...........................	...........................	NFP
25944	1299	9	f[dram]ij	f[dram]ij	NFP
25944	1299	10	Infus	infu	NNS
25944	1299	11	.	.	.
25944	1300	1	picis	picis	NNP
25944	1300	2	liq	liq	NNP
25944	1300	3	.	.	NNP
25944	1300	4	,	,	,
25944	1300	5	...................	...................	.
25944	1300	6	f[Oz]iij	f[Oz]iij	NNP
25944	1300	7	M.	M.	NNP
25944	1300	8	A	A	NNP
25944	1300	9	lotion	lotion	NN
25944	1300	10	containing	contain	VBG
25944	1300	11	resorcin	resorcin	NNS
25944	1300	12	,	,	,
25944	1300	13	five	five	CD
25944	1300	14	to	to	TO
25944	1300	15	thirty	thirty	CD
25944	1300	16	grains	grain	NNS
25944	1300	17	to	to	IN
25944	1300	18	the	the	DT
25944	1300	19	ounce	ounce	NN
25944	1300	20	.	.	.
25944	1301	1	Solution	solution	NN
25944	1301	2	of	of	IN
25944	1301	3	zinc	zinc	NN
25944	1301	4	sulphate	sulphate	NN
25944	1301	5	,	,	,
25944	1301	6	one	one	CD
25944	1301	7	-	-	HYPH
25944	1301	8	half	half	NN
25944	1301	9	to	to	IN
25944	1301	10	three	three	CD
25944	1301	11	grains	grain	NNS
25944	1301	12	to	to	IN
25944	1301	13	the	the	DT
25944	1301	14	ounce	ounce	NN
25944	1301	15	.	.	.
25944	1302	1	An	an	DT
25944	1302	2	ointment	ointment	NN
25944	1302	3	containing	contain	VBG
25944	1302	4	calomel	calomel	NN
25944	1302	5	or	or	CC
25944	1302	6	ammoniated	ammoniated	JJ
25944	1302	7	mercury	mercury	NN
25944	1302	8	,	,	,
25944	1302	9	as	as	IN
25944	1302	10	in	in	IN
25944	1302	11	the	the	DT
25944	1302	12	annexed	annex	VBN
25944	1302	13	formula:--	formula:--	NN
25944	1302	14	[	[	-LRB-
25944	1302	15	Rx	Rx	NNP
25944	1302	16	]	]	-RRB-
25944	1302	17	Hydrargyri	Hydrargyri	NNP
25944	1302	18	ammoniat	ammoniat	NNP
25944	1302	19	.	.	.
25944	1303	1	seu	seu	NNP
25944	1303	2	Hydrargyri	Hydrargyri	NNP
25944	1303	3	chloridi	chloridi	NN
25944	1303	4	mit	mit	NN
25944	1303	5	.	.	NNP
25944	1303	6	,	,	,
25944	1303	7	...................	...................	NFP
25944	1303	8	gr	gr	NNP
25944	1303	9	.	.	.
25944	1304	1	x	x	LS
25944	1304	2	-	-	:
25944	1304	3	xxx	xxx	NNP
25944	1304	4	Ac	Ac	NNP
25944	1304	5	.	.	.
25944	1305	1	carbolici	carbolici	NNP
25944	1305	2	,	,	,
25944	1305	3	.....................	.....................	.
25944	1305	4	gr	gr	NNP
25944	1305	5	.	.	.
25944	1306	1	v	v	LS
25944	1306	2	-	-	HYPH
25944	1306	3	x	x	NNP
25944	1306	4	Ungt	Ungt	NNP
25944	1306	5	.	.	.
25944	1307	1	zinci	zinci	NNP
25944	1307	2	oxidi	oxidi	NNP
25944	1307	3	,	,	,
25944	1307	4	.................	.................	NFP
25944	1307	5	[	[	-LRB-
25944	1307	6	Oz]j	Oz]j	.
25944	1307	7	M.	M.	NNP
25944	1307	8	Another	Another	NNP
25944	1307	9	formula	formula	NN
25944	1307	10	,	,	,
25944	1307	11	more	more	RBR
25944	1307	12	especially	especially	RB
25944	1307	13	useful	useful	JJ
25944	1307	14	in	in	IN
25944	1307	15	eczema	eczema	NN
25944	1307	16	of	of	IN
25944	1307	17	the	the	DT
25944	1307	18	hands	hand	NNS
25944	1307	19	and	and	CC
25944	1307	20	legs	leg	NNS
25944	1307	21	,	,	,
25944	1307	22	is	be	VBZ
25944	1307	23	the	the	DT
25944	1307	24	following:--	following:--	NN
25944	1307	25	[	[	-LRB-
25944	1307	26	Rx	Rx	NNP
25944	1307	27	]	]	-RRB-
25944	1307	28	Ac	Ac	NNP
25944	1307	29	.	.	.
25944	1308	1	salicylici	salicylici	NNP
25944	1308	2	,	,	,
25944	1308	3	......................	......................	NFP
25944	1308	4	gr	gr	NNP
25944	1308	5	.	.	.
25944	1309	1	xxx	xxx	NNP
25944	1309	2	Emp	Emp	NNP
25944	1309	3	.	.	.
25944	1310	1	plumbi	plumbi	NNP
25944	1310	2	,	,	,
25944	1310	3	Emp	Emp	NNP
25944	1310	4	.	.	.
25944	1311	1	saponis	saponis	NNP
25944	1311	2	,	,	,
25944	1311	3	Petrolati	Petrolati	NNP
25944	1311	4	,	,	,
25944	1311	5	......	......	NFP
25944	1311	6	[	[	-LRB-
25944	1311	7	=	=	SYM
25944	1311	8	a][=a	a][=a	CD
25944	1311	9	]	]	-RRB-
25944	1311	10	...........	...........	NFP
25944	1311	11	[	[	-LRB-
25944	1311	12	Oz]j	Oz]j	NNP
25944	1311	13	.	.	.
25944	1311	14	M.	M.	NNP
25944	1311	15	(	(	-LRB-
25944	1311	16	This	this	DT
25944	1311	17	is	be	VBZ
25944	1311	18	to	to	TO
25944	1311	19	be	be	VB
25944	1311	20	applied	apply	VBN
25944	1311	21	as	as	IN
25944	1311	22	a	a	DT
25944	1311	23	plaster	plaster	NN
25944	1311	24	,	,	,
25944	1311	25	spread	spread	VBD
25944	1311	26	on	on	IN
25944	1311	27	strips	strip	NNS
25944	1311	28	of	of	IN
25944	1311	29	lint	lint	NN
25944	1311	30	,	,	,
25944	1311	31	and	and	CC
25944	1311	32	changed	change	VBD
25944	1311	33	every	every	DT
25944	1311	34	twelve	twelve	CD
25944	1311	35	or	or	CC
25944	1311	36	twenty	twenty	CD
25944	1311	37	-	-	HYPH
25944	1311	38	four	four	CD
25944	1311	39	hours	hour	NNS
25944	1311	40	.	.	.
25944	1311	41	)	)	-RRB-
25944	1312	1	The	the	DT
25944	1312	2	paste	paste	NN
25944	1312	3	-	-	HYPH
25944	1312	4	like	like	JJ
25944	1312	5	ointment	ointment	NN
25944	1312	6	,	,	,
25944	1312	7	referred	refer	VBD
25944	1312	8	to	to	IN
25944	1312	9	as	as	RB
25944	1312	10	useful	useful	JJ
25944	1312	11	in	in	IN
25944	1312	12	acute	acute	JJ
25944	1312	13	eczema	eczema	NN
25944	1312	14	,	,	,
25944	1312	15	may	may	MD
25944	1312	16	also	also	RB
25944	1312	17	be	be	VB
25944	1312	18	used	use	VBN
25944	1312	19	with	with	IN
25944	1312	20	a	a	DT
25944	1312	21	larger	large	JJR
25944	1312	22	proportion	proportion	NN
25944	1312	23	(	(	-LRB-
25944	1312	24	20	20	CD
25944	1312	25	to	to	TO
25944	1312	26	60	60	CD
25944	1312	27	grains	grain	NNS
25944	1312	28	to	to	IN
25944	1312	29	the	the	DT
25944	1312	30	ounce	ounce	NN
25944	1312	31	)	)	-RRB-
25944	1312	32	of	of	IN
25944	1312	33	salicylic	salicylic	JJ
25944	1312	34	acid	acid	NN
25944	1312	35	.	.	.
25944	1313	1	The	the	DT
25944	1313	2	following	follow	VBG
25944	1313	3	,	,	,
25944	1313	4	containing	contain	VBG
25944	1313	5	tar	tar	NN
25944	1313	6	,	,	,
25944	1313	7	may	may	MD
25944	1313	8	often	often	RB
25944	1313	9	be	be	VB
25944	1313	10	employed	employ	VBN
25944	1313	11	with	with	IN
25944	1313	12	advantage:--	advantage:--	NNP
25944	1313	13	[	[	-LRB-
25944	1313	14	Rx	Rx	NNP
25944	1313	15	]	]	-RRB-
25944	1313	16	Ungt	Ungt	NNP
25944	1313	17	.	.	.
25944	1314	1	picis	picis	NNP
25944	1314	2	liq	liq	NNP
25944	1314	3	.	.	NNP
25944	1314	4	,	,	,
25944	1314	5	....................	....................	NFP
25944	1314	6	[	[	-LRB-
25944	1314	7	dram]j	dram]j	NNP
25944	1314	8	Ungt	Ungt	NNP
25944	1314	9	.	.	.
25944	1315	1	zinci	zinci	NNP
25944	1315	2	oxidi	oxidi	NNP
25944	1315	3	,	,	,
25944	1315	4	...................	...................	NFP
25944	1315	5	[	[	-LRB-
25944	1315	6	dram]vij	dram]vij	NNP
25944	1315	7	.	.	.
25944	1316	1	M.	M.	NNP
25944	1316	2	#	#	NNP
25944	1316	3	What	what	WP
25944	1316	4	is	be	VBZ
25944	1316	5	to	to	TO
25944	1316	6	be	be	VB
25944	1316	7	said	say	VBN
25944	1316	8	in	in	IN
25944	1316	9	regard	regard	NN
25944	1316	10	to	to	IN
25944	1316	11	the	the	DT
25944	1316	12	use	use	NN
25944	1316	13	of	of	IN
25944	1316	14	tarry	tarry	NN
25944	1316	15	applications	application	NNS
25944	1316	16	?	?	.
25944	1316	17	#	#	$
25944	1316	18	Ointments	Ointments	NNPS
25944	1316	19	or	or	CC
25944	1316	20	lotions	lotion	NNS
25944	1316	21	containing	contain	VBG
25944	1316	22	tar	tar	NN
25944	1316	23	should	should	MD
25944	1316	24	always	always	RB
25944	1316	25	be	be	VB
25944	1316	26	tried	try	VBN
25944	1316	27	at	at	IN
25944	1316	28	first	first	RB
25944	1316	29	upon	upon	IN
25944	1316	30	a	a	DT
25944	1316	31	limited	limit	VBN
25944	1316	32	surface	surface	NN
25944	1316	33	,	,	,
25944	1316	34	as	as	IN
25944	1316	35	occasionally	occasionally	RB
25944	1316	36	skins	skin	NNS
25944	1316	37	are	be	VBP
25944	1316	38	met	meet	VBN
25944	1316	39	with	with	IN
25944	1316	40	upon	upon	IN
25944	1316	41	which	which	WDT
25944	1316	42	this	this	DT
25944	1316	43	remedy	remedy	NN
25944	1316	44	acts	act	VBZ
25944	1316	45	as	as	IN
25944	1316	46	a	a	DT
25944	1316	47	more	more	RBR
25944	1316	48	or	or	CC
25944	1316	49	less	less	RBR
25944	1316	50	violent	violent	JJ
25944	1316	51	irritant	irritant	NN
25944	1316	52	.	.	.
25944	1317	1	The	the	DT
25944	1317	2	coal	coal	NN
25944	1317	3	tar	tar	NN
25944	1317	4	lotion	lotion	NN
25944	1317	5	(	(	-LRB-
25944	1317	6	liquor	liquor	NN
25944	1317	7	carbonis	carbonis	NN
25944	1317	8	detergens	detergen	NNS
25944	1317	9	)	)	-RRB-
25944	1317	10	is	be	VBZ
25944	1317	11	the	the	DT
25944	1317	12	least	least	RBS
25944	1317	13	likely	likely	JJ
25944	1317	14	to	to	TO
25944	1317	15	disagree	disagree	VB
25944	1317	16	and	and	CC
25944	1317	17	may	may	MD
25944	1317	18	be	be	VB
25944	1317	19	used	use	VBN
25944	1317	20	as	as	IN
25944	1317	21	a	a	DT
25944	1317	22	mild	mild	JJ
25944	1317	23	ointment	ointment	NN
25944	1317	24	,	,	,
25944	1317	25	one	one	CD
25944	1317	26	or	or	CC
25944	1317	27	two	two	CD
25944	1317	28	drachms	drachm	NNS
25944	1317	29	to	to	IN
25944	1317	30	the	the	DT
25944	1317	31	ounce	ounce	NN
25944	1317	32	,	,	,
25944	1317	33	or	or	CC
25944	1317	34	it	-PRON-	PRP
25944	1317	35	may	may	MD
25944	1317	36	be	be	VB
25944	1317	37	diluted	dilute	VBN
25944	1317	38	and	and	CC
25944	1317	39	used	use	VBN
25944	1317	40	as	as	IN
25944	1317	41	a	a	DT
25944	1317	42	weak	weak	JJ
25944	1317	43	lotion	lotion	NN
25944	1317	44	as	as	IN
25944	1317	45	already	already	RB
25944	1317	46	referred	refer	VBN
25944	1317	47	to	to	IN
25944	1317	48	.	.	.
25944	1318	1	#	#	$
25944	1318	2	What	what	WDT
25944	1318	3	external	external	JJ
25944	1318	4	remedies	remedy	NNS
25944	1318	5	are	be	VBP
25944	1318	6	to	to	TO
25944	1318	7	be	be	VB
25944	1318	8	employed	employ	VBN
25944	1318	9	in	in	IN
25944	1318	10	eczema	eczema	NN
25944	1318	11	of	of	IN
25944	1318	12	a	a	DT
25944	1318	13	sluggish	sluggish	JJ
25944	1318	14	type	type	NN
25944	1318	15	?	?	.
25944	1318	16	#	#	$
25944	1318	17	The	the	DT
25944	1318	18	various	various	JJ
25944	1318	19	remedies	remedy	NNS
25944	1318	20	and	and	CC
25944	1318	21	combinations	combination	NNS
25944	1318	22	(	(	-LRB-
25944	1318	23	mentioned	mention	VBN
25944	1318	24	above	above	RB
25944	1318	25	)	)	-RRB-
25944	1318	26	useful	useful	JJ
25944	1318	27	in	in	IN
25944	1318	28	acute	acute	JJ
25944	1318	29	and	and	CC
25944	1318	30	subacute	subacute	NN
25944	1318	31	eczema	eczema	NN
25944	1318	32	may	may	MD
25944	1318	33	often	often	RB
25944	1318	34	be	be	VB
25944	1318	35	employed	employ	VBN
25944	1318	36	with	with	IN
25944	1318	37	benefit	benefit	NN
25944	1318	38	,	,	,
25944	1318	39	but	but	CC
25944	1318	40	,	,	,
25944	1318	41	as	as	IN
25944	1318	42	a	a	DT
25944	1318	43	rule	rule	NN
25944	1318	44	,	,	,
25944	1318	45	stronger	strong	JJR
25944	1318	46	applications	application	NNS
25944	1318	47	are	be	VBP
25944	1318	48	necessary	necessary	JJ
25944	1318	49	,	,	,
25944	1318	50	especially	especially	RB
25944	1318	51	in	in	IN
25944	1318	52	the	the	DT
25944	1318	53	thick	thick	JJ
25944	1318	54	and	and	CC
25944	1318	55	leathery	leathery	JJ
25944	1318	56	patches	patch	NNS
25944	1318	57	.	.	.
25944	1319	1	The	the	DT
25944	1319	2	following	follow	VBG
25944	1319	3	are	be	VBP
25944	1319	4	the	the	DT
25944	1319	5	most	most	JJS
25944	1319	6	valuable:--	valuable:--	NN
25944	1319	7	An	an	DT
25944	1319	8	ointment	ointment	NN
25944	1319	9	of	of	IN
25944	1319	10	calomel	calomel	NN
25944	1319	11	or	or	CC
25944	1319	12	ammoniated	ammoniated	JJ
25944	1319	13	mercury	mercury	NN
25944	1319	14	;	;	,
25944	1319	15	forty	forty	CD
25944	1319	16	to	to	TO
25944	1319	17	sixty	sixty	CD
25944	1319	18	grains	grain	NNS
25944	1319	19	to	to	IN
25944	1319	20	the	the	DT
25944	1319	21	ounce	ounce	NN
25944	1319	22	.	.	.
25944	1320	1	Strong	strong	JJ
25944	1320	2	salicylic	salicylic	JJ
25944	1320	3	-	-	HYPH
25944	1320	4	acid	acid	NN
25944	1320	5	ointment	ointment	NN
25944	1320	6	;	;	:
25944	1320	7	a	a	DT
25944	1320	8	half	half	NN
25944	1320	9	to	to	IN
25944	1320	10	one	one	CD
25944	1320	11	drachm	drachm	NN
25944	1320	12	of	of	IN
25944	1320	13	salicylic	salicylic	JJ
25944	1320	14	acid	acid	NN
25944	1320	15	to	to	IN
25944	1320	16	the	the	DT
25944	1320	17	ounce	ounce	NN
25944	1320	18	of	of	IN
25944	1320	19	lard	lard	NN
25944	1320	20	.	.	.
25944	1321	1	Tar	tar	NN
25944	1321	2	ointment	ointment	NN
25944	1321	3	,	,	,
25944	1321	4	official	official	JJ
25944	1321	5	strength	strength	NN
25944	1321	6	;	;	:
25944	1321	7	or	or	CC
25944	1321	8	the	the	DT
25944	1321	9	various	various	JJ
25944	1321	10	tar	tar	NN
25944	1321	11	oils	oil	NNS
25944	1321	12	,	,	,
25944	1321	13	alone	alone	RB
25944	1321	14	or	or	CC
25944	1321	15	with	with	IN
25944	1321	16	alcohol	alcohol	NN
25944	1321	17	,	,	,
25944	1321	18	as	as	IN
25944	1321	19	a	a	DT
25944	1321	20	lotion	lotion	NN
25944	1321	21	,	,	,
25944	1321	22	or	or	CC
25944	1321	23	in	in	IN
25944	1321	24	ointment	ointment	NN
25944	1321	25	form	form	NN
25944	1321	26	.	.	.
25944	1322	1	Liquor	liquor	NN
25944	1322	2	picis	picis	NN
25944	1322	3	alkalinus[B	alkalinus[b	NN
25944	1322	4	]	]	-RRB-
25944	1322	5	is	be	VBZ
25944	1322	6	a	a	DT
25944	1322	7	valuable	valuable	JJ
25944	1322	8	remedy	remedy	NN
25944	1322	9	in	in	IN
25944	1322	10	chronic	chronic	JJ
25944	1322	11	_	_	NNP
25944	1322	12	thickened	thicken	VBD
25944	1322	13	_	_	NNP
25944	1322	14	,	,	,
25944	1322	15	_	_	NNP
25944	1322	16	hard	hard	JJ
25944	1322	17	_	_	NNP
25944	1322	18	and	and	CC
25944	1322	19	_	_	NNP
25944	1322	20	verrucous	verrucous	JJ
25944	1322	21	_	_	NNP
25944	1322	22	patches	patch	NNS
25944	1322	23	,	,	,
25944	1322	24	but	but	CC
25944	1322	25	is	be	VBZ
25944	1322	26	a	a	DT
25944	1322	27	strong	strong	JJ
25944	1322	28	preparation	preparation	NN
25944	1322	29	and	and	CC
25944	1322	30	must	must	MD
25944	1322	31	be	be	VB
25944	1322	32	used	use	VBN
25944	1322	33	with	with	IN
25944	1322	34	caution	caution	NN
25944	1322	35	.	.	.
25944	1323	1	It	-PRON-	PRP
25944	1323	2	is	be	VBZ
25944	1323	3	applied	apply	VBN
25944	1323	4	diluted	diluted	JJ
25944	1323	5	,	,	,
25944	1323	6	one	one	CD
25944	1323	7	part	part	NN
25944	1323	8	with	with	IN
25944	1323	9	from	from	IN
25944	1323	10	eight	eight	CD
25944	1323	11	to	to	TO
25944	1323	12	thirty	thirty	CD
25944	1323	13	-	-	HYPH
25944	1323	14	two	two	CD
25944	1323	15	parts	part	NNS
25944	1323	16	of	of	IN
25944	1323	17	water	water	NN
25944	1323	18	;	;	:
25944	1323	19	or	or	CC
25944	1323	20	in	in	IN
25944	1323	21	ointment	ointment	NN
25944	1323	22	,	,	,
25944	1323	23	one	one	CD
25944	1323	24	or	or	CC
25944	1323	25	two	two	CD
25944	1323	26	drachms	drachm	NNS
25944	1323	27	to	to	IN
25944	1323	28	the	the	DT
25944	1323	29	ounce	ounce	NN
25944	1323	30	.	.	.
25944	1324	1	In	in	IN
25944	1324	2	such	such	JJ
25944	1324	3	cases	case	NNS
25944	1324	4	,	,	,
25944	1324	5	also	also	RB
25944	1324	6	,	,	,
25944	1324	7	the	the	DT
25944	1324	8	following	follow	VBG
25944	1324	9	is	be	VBZ
25944	1324	10	useful:--	useful:--	CD
25944	1324	11	[	[	-LRB-
25944	1324	12	Rx	Rx	NNP
25944	1324	13	]	]	-RRB-
25944	1324	14	Saponis	Saponis	NNP
25944	1324	15	viridis	viridis	NN
25944	1324	16	,	,	,
25944	1324	17	Picis	Picis	NNP
25944	1324	18	liq	liq	NNP
25944	1324	19	.	.	NNP
25944	1324	20	,	,	,
25944	1324	21	Alcoholis	Alcoholis	NNP
25944	1324	22	,	,	,
25944	1324	23	..........	..........	NFP
25944	1324	24	[	[	-LRB-
25944	1324	25	=	=	SYM
25944	1324	26	a][=a	a][=a	CD
25944	1324	27	]	]	-RRB-
25944	1324	28	.......	.......	.
25944	1324	29	[	[	-LRB-
25944	1324	30	dram]iij	dram]iij	NNP
25944	1324	31	.	.	.
25944	1325	1	M.	M.	NNP
25944	1325	2	SIG	SIG	NNP
25944	1325	3	.	.	.
25944	1326	1	To	to	TO
25944	1326	2	be	be	VB
25944	1326	3	well	well	RB
25944	1326	4	rubbed	rub	VBN
25944	1326	5	in	in	IN
25944	1326	6	.	.	.
25944	1327	1	[	[	-LRB-
25944	1327	2	Footnote	Footnote	NNP
25944	1327	3	B	b	NN
25944	1327	4	:	:	:
25944	1327	5	[	[	-LRB-
25944	1327	6	Rx	Rx	NNP
25944	1327	7	]	]	-RRB-
25944	1327	8	Potassæ	Potassæ	NNP
25944	1327	9	,	,	,
25944	1327	10	.............................	.............................	NFP
25944	1327	11	[	[	-LRB-
25944	1327	12	dram]j	dram]j	NNP
25944	1327	13	Picis	Picis	NNP
25944	1327	14	liq	liq	NNP
25944	1327	15	.	.	NNP
25944	1327	16	,	,	,
25944	1327	17	..........................	..........................	NFP
25944	1327	18	[	[	-LRB-
25944	1327	19	dram]ij	dram]ij	NNP
25944	1327	20	Aquæ	Aquæ	NNP
25944	1327	21	,	,	,
25944	1327	22	................................	................................	NFP
25944	1327	23	[	[	-LRB-
25944	1327	24	dram]v	dram]v	NNP
25944	1327	25	.	.	.
25944	1327	26	Dissolve	dissolve	VB
25944	1327	27	the	the	DT
25944	1327	28	potash	potash	NN
25944	1327	29	in	in	IN
25944	1327	30	the	the	DT
25944	1327	31	water	water	NN
25944	1327	32	,	,	,
25944	1327	33	and	and	CC
25944	1327	34	gradually	gradually	RB
25944	1327	35	add	add	VB
25944	1327	36	to	to	IN
25944	1327	37	the	the	DT
25944	1327	38	tar	tar	NN
25944	1327	39	in	in	IN
25944	1327	40	a	a	DT
25944	1327	41	mortar	mortar	NN
25944	1327	42	,	,	,
25944	1327	43	with	with	IN
25944	1327	44	thorough	thorough	JJ
25944	1327	45	stirring	stirring	NN
25944	1327	46	.	.	.
25944	1327	47	]	]	-RRB-
25944	1328	1	In	in	IN
25944	1328	2	similar	similar	JJ
25944	1328	3	cases	case	NNS
25944	1328	4	,	,	,
25944	1328	5	also	also	RB
25944	1328	6	,	,	,
25944	1328	7	the	the	DT
25944	1328	8	parts	part	NNS
25944	1328	9	may	may	MD
25944	1328	10	be	be	VB
25944	1328	11	thoroughly	thoroughly	RB
25944	1328	12	washed	wash	VBN
25944	1328	13	or	or	CC
25944	1328	14	scrubbed	scrub	VBN
25944	1328	15	with	with	IN
25944	1328	16	sapo	sapo	JJ
25944	1328	17	viridis	viridis	NN
25944	1328	18	and	and	CC
25944	1328	19	hot	hot	JJ
25944	1328	20	water	water	NN
25944	1328	21	until	until	IN
25944	1328	22	somewhat	somewhat	RB
25944	1328	23	tender	tender	JJ
25944	1328	24	,	,	,
25944	1328	25	rinsed	rinse	VBD
25944	1328	26	off	off	RP
25944	1328	27	,	,	,
25944	1328	28	dried	dry	VBN
25944	1328	29	,	,	,
25944	1328	30	and	and	CC
25944	1328	31	a	a	DT
25944	1328	32	mild	mild	JJ
25944	1328	33	ointment	ointment	NN
25944	1328	34	applied	apply	VBD
25944	1328	35	as	as	IN
25944	1328	36	a	a	DT
25944	1328	37	plaster	plaster	NN
25944	1328	38	.	.	.
25944	1329	1	Lactic	lactic	JJ
25944	1329	2	acid	acid	NN
25944	1329	3	,	,	,
25944	1329	4	applied	apply	VBD
25944	1329	5	with	with	IN
25944	1329	6	one	one	CD
25944	1329	7	to	to	TO
25944	1329	8	ten	ten	CD
25944	1329	9	or	or	CC
25944	1329	10	more	more	JJR
25944	1329	11	parts	part	NNS
25944	1329	12	of	of	IN
25944	1329	13	water	water	NN
25944	1329	14	is	be	VBZ
25944	1329	15	also	also	RB
25944	1329	16	of	of	IN
25944	1329	17	value	value	NN
25944	1329	18	in	in	IN
25944	1329	19	the	the	DT
25944	1329	20	sclerous	sclerous	JJ
25944	1329	21	and	and	CC
25944	1329	22	verrucous	verrucous	JJ
25944	1329	23	types	type	NNS
25944	1329	24	.	.	.
25944	1330	1	Caustic	caustic	JJ
25944	1330	2	potash	potash	NN
25944	1330	3	solutions	solution	NNS
25944	1330	4	,	,	,
25944	1330	5	used	use	VBD
25944	1330	6	cautiously	cautiously	RB
25944	1330	7	,	,	,
25944	1330	8	may	may	MD
25944	1330	9	also	also	RB
25944	1330	10	be	be	VB
25944	1330	11	occasionally	occasionally	RB
25944	1330	12	employed	employ	VBN
25944	1330	13	to	to	TO
25944	1330	14	advantage	advantage	VB
25944	1330	15	in	in	IN
25944	1330	16	these	these	DT
25944	1330	17	cases	case	NNS
25944	1330	18	.	.	.
25944	1331	1	Another	another	DT
25944	1331	2	remedy	remedy	NN
25944	1331	3	of	of	IN
25944	1331	4	value	value	NN
25944	1331	5	in	in	IN
25944	1331	6	these	these	DT
25944	1331	7	cases	case	NNS
25944	1331	8	,	,	,
25944	1331	9	as	as	RB
25944	1331	10	well	well	RB
25944	1331	11	as	as	IN
25944	1331	12	in	in	IN
25944	1331	13	others	other	NNS
25944	1331	14	of	of	IN
25944	1331	15	more	more	RBR
25944	1331	16	or	or	CC
25944	1331	17	less	less	RBR
25944	1331	18	limited	limited	JJ
25944	1331	19	nature	nature	NN
25944	1331	20	,	,	,
25944	1331	21	is	be	VBZ
25944	1331	22	the	the	DT
25944	1331	23	_	_	NNP
25944	1331	24	x_-ray	x_-ray	NN
25944	1331	25	.	.	.
25944	1332	1	Exposures	exposure	NNS
25944	1332	2	every	every	DT
25944	1332	3	few	few	JJ
25944	1332	4	days	day	NNS
25944	1332	5	,	,	,
25944	1332	6	of	of	IN
25944	1332	7	short	short	JJ
25944	1332	8	duration	duration	NN
25944	1332	9	and	and	CC
25944	1332	10	4	4	CD
25944	1332	11	to	to	TO
25944	1332	12	10	10	CD
25944	1332	13	inches	inch	NNS
25944	1332	14	distance	distance	NN
25944	1332	15	,	,	,
25944	1332	16	with	with	IN
25944	1332	17	medium	medium	JJ
25944	1332	18	vacuum	vacuum	NN
25944	1332	19	tube	tube	NN
25944	1332	20	.	.	.
25944	1333	1	This	this	DT
25944	1333	2	method	method	NN
25944	1333	3	has	have	VBZ
25944	1333	4	served	serve	VBN
25944	1333	5	me	-PRON-	PRP
25944	1333	6	well	well	RB
25944	1333	7	in	in	IN
25944	1333	8	occasional	occasional	JJ
25944	1333	9	cases	case	NNS
25944	1333	10	;	;	:
25944	1333	11	caution	caution	NN
25944	1333	12	is	be	VBZ
25944	1333	13	necessary	necessary	JJ
25944	1333	14	,	,	,
25944	1333	15	and	and	CC
25944	1333	16	it	-PRON-	PRP
25944	1333	17	should	should	MD
25944	1333	18	not	not	RB
25944	1333	19	be	be	VB
25944	1333	20	pushed	push	VBN
25944	1333	21	further	further	RB
25944	1333	22	than	than	IN
25944	1333	23	the	the	DT
25944	1333	24	production	production	NN
25944	1333	25	of	of	IN
25944	1333	26	the	the	DT
25944	1333	27	mildest	mild	JJS
25944	1333	28	reaction	reaction	NN
25944	1333	29	.	.	.
25944	1334	1	The	the	DT
25944	1334	2	repeated	repeat	VBN
25944	1334	3	application	application	NN
25944	1334	4	of	of	IN
25944	1334	5	a	a	DT
25944	1334	6	high	high	JJ
25944	1334	7	-	-	HYPH
25944	1334	8	frequency	frequency	NN
25944	1334	9	current	current	NN
25944	1334	10	,	,	,
25944	1334	11	by	by	IN
25944	1334	12	means	mean	NNS
25944	1334	13	of	of	IN
25944	1334	14	the	the	DT
25944	1334	15	vacuum	vacuum	NN
25944	1334	16	electrodes	electrode	NNS
25944	1334	17	,	,	,
25944	1334	18	is	be	VBZ
25944	1334	19	a	a	DT
25944	1334	20	safer	safe	JJR
25944	1334	21	and	and	CC
25944	1334	22	sometimes	sometimes	RB
25944	1334	23	an	an	DT
25944	1334	24	equally	equally	RB
25944	1334	25	beneficial	beneficial	JJ
25944	1334	26	method	method	NN
25944	1334	27	.	.	.
25944	1335	1	#	#	$
25944	1335	2	Is	be	VBZ
25944	1335	3	there	there	EX
25944	1335	4	any	any	DT
25944	1335	5	method	method	NN
25944	1335	6	of	of	IN
25944	1335	7	treating	treat	VBG
25944	1335	8	eczema	eczema	NN
25944	1335	9	with	with	IN
25944	1335	10	fixed	fix	VBN
25944	1335	11	dressings	dressing	NNS
25944	1335	12	?	?	.
25944	1335	13	#	#	$
25944	1335	14	Several	several	JJ
25944	1335	15	plans	plan	NNS
25944	1335	16	have	have	VBP
25944	1335	17	been	be	VBN
25944	1335	18	advised	advise	VBN
25944	1335	19	from	from	IN
25944	1335	20	time	time	NN
25944	1335	21	to	to	IN
25944	1335	22	time	time	NN
25944	1335	23	;	;	:
25944	1335	24	some	some	DT
25944	1335	25	are	be	VBP
25944	1335	26	costly	costly	JJ
25944	1335	27	,	,	,
25944	1335	28	and	and	CC
25944	1335	29	some	some	DT
25944	1335	30	require	require	VBP
25944	1335	31	too	too	RB
25944	1335	32	great	great	JJ
25944	1335	33	attention	attention	NN
25944	1335	34	to	to	IN
25944	1335	35	details	detail	NNS
25944	1335	36	,	,	,
25944	1335	37	and	and	CC
25944	1335	38	are	be	VBP
25944	1335	39	therefore	therefore	RB
25944	1335	40	impracticable	impracticable	JJ
25944	1335	41	for	for	IN
25944	1335	42	general	general	JJ
25944	1335	43	employment	employment	NN
25944	1335	44	.	.	.
25944	1336	1	The	the	DT
25944	1336	2	following	follow	VBG
25944	1336	3	are	be	VBP
25944	1336	4	those	those	DT
25944	1336	5	in	in	IN
25944	1336	6	more	more	RBR
25944	1336	7	common	common	JJ
25944	1336	8	use:--	use:--	NNP
25944	1336	9	The	the	DT
25944	1336	10	_	_	NNP
25944	1336	11	gelatin	gelatin	NN
25944	1336	12	dressing	dress	VBG
25944	1336	13	_	_	NNP
25944	1336	14	,	,	,
25944	1336	15	as	as	RB
25944	1336	16	originally	originally	RB
25944	1336	17	ordered	order	VBN
25944	1336	18	,	,	,
25944	1336	19	is	be	VBZ
25944	1336	20	made	make	VBN
25944	1336	21	by	by	IN
25944	1336	22	melting	melt	VBG
25944	1336	23	over	over	IN
25944	1336	24	a	a	DT
25944	1336	25	water	water	NN
25944	1336	26	-	-	HYPH
25944	1336	27	bath	bath	NN
25944	1336	28	one	one	CD
25944	1336	29	part	part	NN
25944	1336	30	of	of	IN
25944	1336	31	gelatin	gelatin	NN
25944	1336	32	in	in	IN
25944	1336	33	two	two	CD
25944	1336	34	parts	part	NNS
25944	1336	35	of	of	IN
25944	1336	36	water	water	NN
25944	1336	37	--	--	:
25944	1336	38	quickly	quickly	RB
25944	1336	39	painting	paint	VBG
25944	1336	40	it	-PRON-	PRP
25944	1336	41	over	over	IN
25944	1336	42	the	the	DT
25944	1336	43	diseased	diseased	JJ
25944	1336	44	area	area	NN
25944	1336	45	;	;	:
25944	1336	46	it	-PRON-	PRP
25944	1336	47	dries	dry	VBZ
25944	1336	48	rapidly	rapidly	RB
25944	1336	49	,	,	,
25944	1336	50	and	and	CC
25944	1336	51	to	to	TO
25944	1336	52	prevent	prevent	VB
25944	1336	53	cracking	crack	VBG
25944	1336	54	glycerine	glycerine	NN
25944	1336	55	is	be	VBZ
25944	1336	56	brushed	brush	VBN
25944	1336	57	over	over	IN
25944	1336	58	the	the	DT
25944	1336	59	surface	surface	NN
25944	1336	60	.	.	.
25944	1337	1	Or	or	CC
25944	1337	2	the	the	DT
25944	1337	3	glycerine	glycerine	NN
25944	1337	4	may	may	MD
25944	1337	5	be	be	VB
25944	1337	6	incorporated	incorporate	VBN
25944	1337	7	with	with	IN
25944	1337	8	the	the	DT
25944	1337	9	gelatin	gelatin	NN
25944	1337	10	and	and	CC
25944	1337	11	water	water	NN
25944	1337	12	in	in	IN
25944	1337	13	the	the	DT
25944	1337	14	following	following	JJ
25944	1337	15	proportion	proportion	NN
25944	1337	16	:	:	:
25944	1337	17	glycerine	glycerine	NNP
25944	1337	18	,	,	,
25944	1337	19	one	one	CD
25944	1337	20	part	part	NN
25944	1337	21	;	;	:
25944	1337	22	gelatin	gelatin	NN
25944	1337	23	,	,	,
25944	1337	24	four	four	CD
25944	1337	25	parts	part	NNS
25944	1337	26	,	,	,
25944	1337	27	and	and	CC
25944	1337	28	water	water	NN
25944	1337	29	eight	eight	CD
25944	1337	30	parts	part	NNS
25944	1337	31	.	.	.
25944	1338	1	Medicinal	medicinal	JJ
25944	1338	2	substances	substance	NNS
25944	1338	3	may	may	MD
25944	1338	4	be	be	VB
25944	1338	5	incorporated	incorporate	VBN
25944	1338	6	with	with	IN
25944	1338	7	the	the	DT
25944	1338	8	gelatin	gelatin	NN
25944	1338	9	mixture	mixture	NN
25944	1338	10	.	.	.
25944	1339	1	A	a	DT
25944	1339	2	good	good	JJ
25944	1339	3	formula	formula	NN
25944	1339	4	is	be	VBZ
25944	1339	5	the	the	DT
25944	1339	6	following:--	following:--	NN
25944	1339	7	[	[	-LRB-
25944	1339	8	Rx	Rx	NNP
25944	1339	9	]	]	-RRB-
25944	1339	10	Gelatin	Gelatin	NNP
25944	1339	11	,	,	,
25944	1339	12	.............................	.............................	NFP
25944	1339	13	[	[	-LRB-
25944	1339	14	Oz]j	oz]j	CD
25944	1339	15	Zinci	zinci	JJ
25944	1339	16	oxidi	oxidi	NN
25944	1339	17	,	,	,
25944	1339	18	.........................	.........................	NFP
25944	1339	19	[	[	-LRB-
25944	1339	20	Oz]ss	Oz]ss	NNP
25944	1339	21	Glycerini	Glycerini	NNP
25944	1339	22	,	,	,
25944	1339	23	...........................	...........................	NFP
25944	1339	24	[	[	-LRB-
25944	1339	25	Oz]iss	oz]iss	JJ
25944	1339	26	Aquæ	Aquæ	NNP
25944	1339	27	,	,	,
25944	1339	28	................................	................................	NFP
25944	1339	29	[	[	-LRB-
25944	1339	30	Oz]ii-[Oz]iij	oz]ii-[oz]iij	NN
25944	1339	31	.	.	.
25944	1340	1	This	this	DT
25944	1340	2	should	should	MD
25944	1340	3	be	be	VB
25944	1340	4	prepared	prepare	VBN
25944	1340	5	over	over	IN
25944	1340	6	a	a	DT
25944	1340	7	water	water	NN
25944	1340	8	-	-	HYPH
25944	1340	9	bath	bath	NN
25944	1340	10	,	,	,
25944	1340	11	and	and	CC
25944	1340	12	two	two	CD
25944	1340	13	per	per	NN
25944	1340	14	cent	cent	NN
25944	1340	15	.	.	.
25944	1341	1	ichthyol	ichthyol	NNP
25944	1341	2	added	add	VBD
25944	1341	3	.	.	.
25944	1342	1	A	a	DT
25944	1342	2	thin	thin	JJ
25944	1342	3	gauze	gauze	NN
25944	1342	4	bandage	bandage	NN
25944	1342	5	can	can	MD
25944	1342	6	be	be	VB
25944	1342	7	applied	apply	VBN
25944	1342	8	to	to	IN
25944	1342	9	the	the	DT
25944	1342	10	parts	part	NNS
25944	1342	11	over	over	IN
25944	1342	12	which	which	WDT
25944	1342	13	this	this	DT
25944	1342	14	dressing	dressing	NN
25944	1342	15	is	be	VBZ
25944	1342	16	painted	paint	VBN
25944	1342	17	,	,	,
25944	1342	18	before	before	IN
25944	1342	19	it	-PRON-	PRP
25944	1342	20	is	be	VBZ
25944	1342	21	completely	completely	RB
25944	1342	22	dry	dry	JJ
25944	1342	23	;	;	:
25944	1342	24	it	-PRON-	PRP
25944	1342	25	makes	make	VBZ
25944	1342	26	a	a	DT
25944	1342	27	comfortable	comfortable	JJ
25944	1342	28	fixed	fix	VBN
25944	1342	29	dressing	dressing	NN
25944	1342	30	and	and	CC
25944	1342	31	may	may	MD
25944	1342	32	remain	remain	VB
25944	1342	33	on	on	IN
25944	1342	34	several	several	JJ
25944	1342	35	days	day	NNS
25944	1342	36	.	.	.
25944	1343	1	_	_	NNP
25944	1343	2	Plaster	Plaster	NNP
25944	1343	3	-	-	HYPH
25944	1343	4	mull	mull	NNP
25944	1343	5	_	_	NNP
25944	1343	6	and	and	CC
25944	1343	7	_	_	NNP
25944	1343	8	gutta	gutta	NN
25944	1343	9	-	-	HYPH
25944	1343	10	percha	percha	NN
25944	1343	11	plaster	plaster	NNP
25944	1343	12	_	_	NNP
25944	1343	13	.	.	.
25944	1344	1	The	the	DT
25944	1344	2	plaster	plaster	NN
25944	1344	3	-	-	HYPH
25944	1344	4	mull	mull	NN
25944	1344	5	,	,	,
25944	1344	6	consisting	consist	VBG
25944	1344	7	of	of	IN
25944	1344	8	muslin	muslin	NNP
25944	1344	9	incorporated	incorporate	VBN
25944	1344	10	with	with	IN
25944	1344	11	a	a	DT
25944	1344	12	layer	layer	NN
25944	1344	13	of	of	IN
25944	1344	14	stiff	stiff	JJ
25944	1344	15	ointment	ointment	NN
25944	1344	16	,	,	,
25944	1344	17	and	and	CC
25944	1344	18	the	the	DT
25944	1344	19	gutta	gutta	NN
25944	1344	20	-	-	HYPH
25944	1344	21	percha	percha	NN
25944	1344	22	plaster	plaster	NN
25944	1344	23	,	,	,
25944	1344	24	consisting	consist	VBG
25944	1344	25	of	of	IN
25944	1344	26	muslin	muslin	NNP
25944	1344	27	faced	face	VBN
25944	1344	28	with	with	IN
25944	1344	29	a	a	DT
25944	1344	30	thin	thin	JJ
25944	1344	31	layer	layer	NN
25944	1344	32	of	of	IN
25944	1344	33	India	India	NNP
25944	1344	34	-	-	HYPH
25944	1344	35	rubber	rubber	NNP
25944	1344	36	,	,	,
25944	1344	37	the	the	DT
25944	1344	38	medication	medication	NN
25944	1344	39	being	be	VBG
25944	1344	40	spread	spread	VBN
25944	1344	41	upon	upon	IN
25944	1344	42	the	the	DT
25944	1344	43	rubber	rubber	NN
25944	1344	44	coating	coating	NN
25944	1344	45	.	.	.
25944	1345	1	_	_	NNP
25944	1345	2	Rubber	Rubber	NNP
25944	1345	3	plasters	plaster	NNS
25944	1345	4	.	.	.
25944	1345	5	_	_	NNP
25944	1345	6	These	these	DT
25944	1345	7	are	be	VBP
25944	1345	8	medicated	medicate	VBN
25944	1345	9	with	with	IN
25944	1345	10	the	the	DT
25944	1345	11	various	various	JJ
25944	1345	12	drugs	drug	NNS
25944	1345	13	used	use	VBN
25944	1345	14	in	in	IN
25944	1345	15	the	the	DT
25944	1345	16	external	external	JJ
25944	1345	17	treatment	treatment	NN
25944	1345	18	of	of	IN
25944	1345	19	skin	skin	NN
25944	1345	20	diseases	disease	NNS
25944	1345	21	,	,	,
25944	1345	22	and	and	CC
25944	1345	23	are	be	VBP
25944	1345	24	often	often	RB
25944	1345	25	of	of	IN
25944	1345	26	service	service	NN
25944	1345	27	in	in	IN
25944	1345	28	chronic	chronic	JJ
25944	1345	29	patches	patch	NNS
25944	1345	30	.	.	.
25944	1346	1	Two	two	CD
25944	1346	2	new	new	JJ
25944	1346	3	excipients	excipient	NNS
25944	1346	4	for	for	IN
25944	1346	5	fixed	fix	VBN
25944	1346	6	dressings	dressing	NNS
25944	1346	7	have	have	VBP
25944	1346	8	recently	recently	RB
25944	1346	9	been	be	VBN
25944	1346	10	introduced	introduce	VBN
25944	1346	11	--	--	:
25944	1346	12	bassorin	bassorin	NN
25944	1346	13	and	and	CC
25944	1346	14	plasment	plasment	NN
25944	1346	15	;	;	:
25944	1346	16	the	the	DT
25944	1346	17	former	former	JJ
25944	1346	18	is	be	VBZ
25944	1346	19	made	make	VBN
25944	1346	20	from	from	IN
25944	1346	21	gum	gum	NN
25944	1346	22	tragacanth	tragacanth	NN
25944	1346	23	,	,	,
25944	1346	24	and	and	CC
25944	1346	25	the	the	DT
25944	1346	26	latter	latter	JJ
25944	1346	27	from	from	IN
25944	1346	28	Irish	irish	JJ
25944	1346	29	moss	moss	NN
25944	1346	30	.	.	.
25944	1347	1	The	the	DT
25944	1347	2	following	follow	VBG
25944	1347	3	is	be	VBZ
25944	1347	4	a	a	DT
25944	1347	5	satisfactory	satisfactory	JJ
25944	1347	6	formula	formula	NN
25944	1347	7	for	for	IN
25944	1347	8	a	a	DT
25944	1347	9	tragacanth	tragacanth	JJ
25944	1347	10	dressing	dressing	NN
25944	1347	11	:	:	:
25944	1347	12	[	[	-LRB-
25944	1347	13	Rx	Rx	NNP
25944	1347	14	]	]	-RRB-
25944	1347	15	Tragacanth	Tragacanth	NNP
25944	1347	16	,	,	,
25944	1347	17	..........................	..........................	NFP
25944	1347	18	gr	gr	NNP
25944	1347	19	.	.	.
25944	1348	1	lxxv	lxxv	NNP
25944	1348	2	Glycerini	Glycerini	NNP
25944	1348	3	,	,	,
25944	1348	4	...........................	...........................	NFP
25944	1348	5	[	[	-LRB-
25944	1348	6	minim	minim	NN
25944	1348	7	]	]	-RRB-
25944	1348	8	xxx	xxx	NNP
25944	1348	9	Ac	Ac	NNP
25944	1348	10	.	.	.
25944	1349	1	carbolici	carbolici	NNP
25944	1349	2	,	,	,
25944	1349	3	.......................	.......................	NFP
25944	1349	4	gr	gr	NNP
25944	1349	5	.	.	.
25944	1350	1	x	x	LS
25944	1350	2	-	-	:
25944	1350	3	xx	xx	CD
25944	1350	4	Zinci	Zinci	NNP
25944	1350	5	oxidi	oxidi	NN
25944	1350	6	,	,	,
25944	1350	7	.........................	.........................	NFP
25944	1350	8	[	[	-LRB-
25944	1350	9	dram]iss-[dram]iiss	dram]iss-[dram]iiss	NNP
25944	1350	10	.	.	.
25944	1351	1	M.	M.	NNP
25944	1351	2	This	This	NNP
25944	1351	3	is	be	VBZ
25944	1351	4	painted	paint	VBN
25944	1351	5	over	over	IN
25944	1351	6	the	the	DT
25944	1351	7	parts	part	NNS
25944	1351	8	and	and	CC
25944	1351	9	allowed	allow	VBN
25944	1351	10	to	to	TO
25944	1351	11	dry	dry	VB
25944	1351	12	,	,	,
25944	1351	13	and	and	CC
25944	1351	14	a	a	DT
25944	1351	15	mild	mild	JJ
25944	1351	16	dusting	dusting	NN
25944	1351	17	powder	powder	NN
25944	1351	18	sprinkled	sprinkle	VBN
25944	1351	19	over	over	RP
25944	1351	20	.	.	.
25944	1352	1	It	-PRON-	PRP
25944	1352	2	can	can	MD
25944	1352	3	not	not	RB
25944	1352	4	be	be	VB
25944	1352	5	used	use	VBN
25944	1352	6	in	in	IN
25944	1352	7	warm	warm	JJ
25944	1352	8	weather	weather	NN
25944	1352	9	or	or	CC
25944	1352	10	in	in	IN
25944	1352	11	folds	fold	NNS
25944	1352	12	,	,	,
25944	1352	13	as	as	IN
25944	1352	14	it	-PRON-	PRP
25944	1352	15	is	be	VBZ
25944	1352	16	apt	apt	JJ
25944	1352	17	to	to	TO
25944	1352	18	get	get	VB
25944	1352	19	sticky	sticky	JJ
25944	1352	20	.	.	.
25944	1353	1	The	the	DT
25944	1353	2	following	follow	VBG
25944	1353	3	is	be	VBZ
25944	1353	4	a	a	DT
25944	1353	5	bassorin	bassorin	NN
25944	1353	6	paste	paste	NN
25944	1353	7	which	which	WDT
25944	1353	8	may	may	MD
25944	1353	9	be	be	VB
25944	1353	10	variously	variously	RB
25944	1353	11	medicated	medicate	VBN
25944	1353	12	.	.	.
25944	1354	1	[	[	-LRB-
25944	1354	2	Rx	Rx	NNP
25944	1354	3	]	]	-RRB-
25944	1354	4	Bassorin	Bassorin	NNP
25944	1354	5	,	,	,
25944	1354	6	............................	............................	NFP
25944	1354	7	[	[	-LRB-
25944	1354	8	dram]x	dram]x	NNP
25944	1354	9	Dextrin	Dextrin	NNP
25944	1354	10	,	,	,
25944	1354	11	.............................	.............................	NFP
25944	1354	12	[	[	-LRB-
25944	1354	13	dram]vj	dram]vj	IN
25944	1354	14	Glycerini	Glycerini	NNP
25944	1354	15	,	,	,
25944	1354	16	...........................	...........................	NFP
25944	1354	17	[	[	-LRB-
25944	1354	18	Oz]ij	oz]ij	NN
25944	1354	19	.	.	.
25944	1355	1	Aquæ	Aquæ	NNP
25944	1355	2	,	,	,
25944	1355	3	.......................	.......................	NFP
25944	1355	4	q.s	q.s	NNP
25944	1355	5	.	.	.
25944	1356	1	ad	ad	NN
25944	1356	2	.	.	.
25944	1357	1	[	[	-LRB-
25944	1357	2	Oz]iij	Oz]iij	NNP
25944	1357	3	.	.	.
25944	1358	1	It	-PRON-	PRP
25944	1358	2	should	should	MD
25944	1358	3	be	be	VB
25944	1358	4	prepared	prepare	VBN
25944	1358	5	cold	cold	JJ
25944	1358	6	.	.	.
25944	1359	1	Another	another	DT
25944	1359	2	"	"	``
25944	1359	3	drying	drying	NN
25944	1359	4	dressing	dressing	NN
25944	1359	5	"	"	''
25944	1359	6	which	which	WDT
25944	1359	7	may	may	MD
25944	1359	8	be	be	VB
25944	1359	9	used	use	VBN
25944	1359	10	in	in	IN
25944	1359	11	cool	cool	JJ
25944	1359	12	weather	weather	NN
25944	1359	13	is	be	VBZ
25944	1359	14	:	:	:
25944	1359	15	[	[	-LRB-
25944	1359	16	Rx	Rx	NNP
25944	1359	17	]	]	-RRB-
25944	1359	18	Zinci	Zinci	NNP
25944	1359	19	oxidi	oxidi	NN
25944	1359	20	,	,	,
25944	1359	21	.........................	.........................	NFP
25944	1359	22	[	[	-LRB-
25944	1359	23	Oz]j	Oz]j	.
25944	1359	24	Glycerini	Glycerini	NNP
25944	1359	25	,	,	,
25944	1359	26	...........................	...........................	NFP
25944	1359	27	[	[	-LRB-
25944	1359	28	Oz]ss	Oz]ss	NNP
25944	1359	29	Mucilag	Mucilag	NNP
25944	1359	30	.	.	.
25944	1360	1	acaciæ	acaciæ	NNP
25944	1360	2	,	,	,
25944	1360	3	.....................	.....................	.
25944	1360	4	[	[	-LRB-
25944	1360	5	Oz]ii-[Oz]iv	oz]ii-[oz]iv	NN
25944	1360	6	.	.	.
25944	1361	1	It	-PRON-	PRP
25944	1361	2	may	may	MD
25944	1361	3	be	be	VB
25944	1361	4	variously	variously	RB
25944	1361	5	medicated	medicate	VBN
25944	1361	6	.	.	.
25944	1362	1	The	the	DT
25944	1362	2	plaster	plaster	NN
25944	1362	3	-	-	HYPH
25944	1362	4	mull	mull	NN
25944	1362	5	is	be	VBZ
25944	1362	6	used	use	VBN
25944	1362	7	in	in	IN
25944	1362	8	all	all	DT
25944	1362	9	types	type	NNS
25944	1362	10	,	,	,
25944	1362	11	especially	especially	RB
25944	1362	12	the	the	DT
25944	1362	13	acute	acute	NN
25944	1362	14	;	;	:
25944	1362	15	the	the	DT
25944	1362	16	gelatin	gelatin	NN
25944	1362	17	dressing	dressing	NN
25944	1362	18	,	,	,
25944	1362	19	and	and	CC
25944	1362	20	the	the	DT
25944	1362	21	gutta	gutta	NN
25944	1362	22	-	-	HYPH
25944	1362	23	percha	percha	NN
25944	1362	24	plaster	plaster	NN
25944	1362	25	,	,	,
25944	1362	26	in	in	IN
25944	1362	27	the	the	DT
25944	1362	28	subacute	subacute	NN
25944	1362	29	and	and	CC
25944	1362	30	chronic	chronic	JJ
25944	1362	31	;	;	:
25944	1362	32	and	and	CC
25944	1362	33	the	the	DT
25944	1362	34	rubber	rubber	NN
25944	1362	35	plaster	plaster	NN
25944	1362	36	in	in	IN
25944	1362	37	chronic	chronic	JJ
25944	1362	38	,	,	,
25944	1362	39	sluggish	sluggish	JJ
25944	1362	40	patches	patch	NNS
25944	1362	41	only	only	RB
25944	1362	42	.	.	.
25944	1363	1	Acacia	Acacia	NNP
25944	1363	2	,	,	,
25944	1363	3	tragacanth	tragacanth	NN
25944	1363	4	,	,	,
25944	1363	5	bassorin	bassorin	NN
25944	1363	6	and	and	CC
25944	1363	7	plasment	plasment	NN
25944	1363	8	applications	application	NNS
25944	1363	9	are	be	VBP
25944	1363	10	used	use	VBN
25944	1363	11	in	in	IN
25944	1363	12	cases	case	NNS
25944	1363	13	of	of	IN
25944	1363	14	a	a	DT
25944	1363	15	subacute	subacute	NN
25944	1363	16	and	and	CC
25944	1363	17	chronic	chronic	JJ
25944	1363	18	character	character	NN
25944	1363	19	.	.	.
25944	1364	1	#	#	NNP
25944	1364	2	Prurigo	Prurigo	NNP
25944	1364	3	.	.	.
25944	1364	4	#	#	$
25944	1364	5	#	#	$
25944	1364	6	Define	Define	NNP
25944	1364	7	prurigo	prurigo	VBZ
25944	1364	8	.	.	.
25944	1364	9	#	#	$
25944	1364	10	Prurigo	Prurigo	NNP
25944	1364	11	is	be	VBZ
25944	1364	12	a	a	DT
25944	1364	13	chronic	chronic	JJ
25944	1364	14	,	,	,
25944	1364	15	inflammatory	inflammatory	JJ
25944	1364	16	disease	disease	NN
25944	1364	17	,	,	,
25944	1364	18	characterized	characterize	VBN
25944	1364	19	by	by	IN
25944	1364	20	discrete	discrete	JJ
25944	1364	21	,	,	,
25944	1364	22	pin	pin	NN
25944	1364	23	-	-	HYPH
25944	1364	24	head-	head-	NN
25944	1364	25	to	to	IN
25944	1364	26	small	small	JJ
25944	1364	27	pea	pea	JJ
25944	1364	28	-	-	HYPH
25944	1364	29	sized	sized	JJ
25944	1364	30	,	,	,
25944	1364	31	solid	solid	JJ
25944	1364	32	,	,	,
25944	1364	33	firmly	firmly	RB
25944	1364	34	-	-	HYPH
25944	1364	35	seated	seat	VBN
25944	1364	36	,	,	,
25944	1364	37	slightly	slightly	RB
25944	1364	38	raised	raise	VBN
25944	1364	39	,	,	,
25944	1364	40	pale	pale	JJ
25944	1364	41	-	-	HYPH
25944	1364	42	red	red	JJ
25944	1364	43	papules	papule	NNS
25944	1364	44	,	,	,
25944	1364	45	accompanied	accompany	VBN
25944	1364	46	by	by	IN
25944	1364	47	itching	itch	VBG
25944	1364	48	and	and	CC
25944	1364	49	more	more	RBR
25944	1364	50	or	or	CC
25944	1364	51	less	less	RBR
25944	1364	52	general	general	JJ
25944	1364	53	thickening	thickening	NN
25944	1364	54	of	of	IN
25944	1364	55	the	the	DT
25944	1364	56	affected	affected	JJ
25944	1364	57	skin	skin	NN
25944	1364	58	.	.	.
25944	1365	1	#	#	NNP
25944	1365	2	Describe	describe	VB
25944	1365	3	the	the	DT
25944	1365	4	symptoms	symptom	NNS
25944	1365	5	and	and	CC
25944	1365	6	course	course	NN
25944	1365	7	of	of	IN
25944	1365	8	prurigo	prurigo	NNS
25944	1365	9	.	.	.
25944	1365	10	#	#	$
25944	1365	11	The	the	DT
25944	1365	12	disease	disease	NN
25944	1365	13	first	first	RB
25944	1365	14	appears	appear	VBZ
25944	1365	15	upon	upon	IN
25944	1365	16	the	the	DT
25944	1365	17	tibial	tibial	JJ
25944	1365	18	regions	region	NNS
25944	1365	19	,	,	,
25944	1365	20	and	and	CC
25944	1365	21	its	-PRON-	PRP$
25944	1365	22	earliest	early	JJS
25944	1365	23	manifestation	manifestation	NN
25944	1365	24	may	may	MD
25944	1365	25	be	be	VB
25944	1365	26	urticarial	urticarial	JJ
25944	1365	27	,	,	,
25944	1365	28	but	but	CC
25944	1365	29	there	there	EX
25944	1365	30	soon	soon	RB
25944	1365	31	develop	develop	VBP
25944	1365	32	the	the	DT
25944	1365	33	characteristic	characteristic	JJ
25944	1365	34	small	small	JJ
25944	1365	35	,	,	,
25944	1365	36	millet	millet	JJ
25944	1365	37	-	-	HYPH
25944	1365	38	seed	seed	NN
25944	1365	39	-	-	HYPH
25944	1365	40	sized	sized	JJ
25944	1365	41	,	,	,
25944	1365	42	or	or	CC
25944	1365	43	larger	large	JJR
25944	1365	44	,	,	,
25944	1365	45	firm	firm	JJ
25944	1365	46	elevations	elevation	NNS
25944	1365	47	,	,	,
25944	1365	48	which	which	WDT
25944	1365	49	may	may	MD
25944	1365	50	be	be	VB
25944	1365	51	of	of	IN
25944	1365	52	the	the	DT
25944	1365	53	natural	natural	JJ
25944	1365	54	color	color	NN
25944	1365	55	of	of	IN
25944	1365	56	the	the	DT
25944	1365	57	skin	skin	NN
25944	1365	58	or	or	CC
25944	1365	59	of	of	IN
25944	1365	60	a	a	DT
25944	1365	61	pinkish	pinkish	JJ
25944	1365	62	tinge	tinge	NN
25944	1365	63	.	.	.
25944	1366	1	The	the	DT
25944	1366	2	lesions	lesion	NNS
25944	1366	3	,	,	,
25944	1366	4	whilst	whilst	IN
25944	1366	5	discrete	discrete	JJ
25944	1366	6	,	,	,
25944	1366	7	are	be	VBP
25944	1366	8	in	in	IN
25944	1366	9	great	great	JJ
25944	1366	10	numbers	number	NNS
25944	1366	11	,	,	,
25944	1366	12	and	and	CC
25944	1366	13	closely	closely	RB
25944	1366	14	crowded	crowded	JJ
25944	1366	15	.	.	.
25944	1367	1	The	the	DT
25944	1367	2	overlying	overlying	NN
25944	1367	3	skin	skin	NN
25944	1367	4	is	be	VBZ
25944	1367	5	dry	dry	JJ
25944	1367	6	,	,	,
25944	1367	7	rough	rough	JJ
25944	1367	8	and	and	CC
25944	1367	9	harsh	harsh	JJ
25944	1367	10	;	;	:
25944	1367	11	itching	itching	NN
25944	1367	12	is	be	VBZ
25944	1367	13	intense	intense	JJ
25944	1367	14	,	,	,
25944	1367	15	and	and	CC
25944	1367	16	,	,	,
25944	1367	17	as	as	IN
25944	1367	18	a	a	DT
25944	1367	19	result	result	NN
25944	1367	20	of	of	IN
25944	1367	21	the	the	DT
25944	1367	22	scratching	scratching	NN
25944	1367	23	,	,	,
25944	1367	24	excoriations	excoriation	NNS
25944	1367	25	and	and	CC
25944	1367	26	blood	blood	NN
25944	1367	27	crusts	crust	NNS
25944	1367	28	are	be	VBP
25944	1367	29	commonly	commonly	RB
25944	1367	30	present	present	JJ
25944	1367	31	.	.	.
25944	1368	1	In	in	IN
25944	1368	2	consequence	consequence	NN
25944	1368	3	of	of	IN
25944	1368	4	the	the	DT
25944	1368	5	irritation	irritation	NN
25944	1368	6	,	,	,
25944	1368	7	the	the	DT
25944	1368	8	inguinal	inguinal	JJ
25944	1368	9	glands	gland	NNS
25944	1368	10	are	be	VBP
25944	1368	11	enlarged	enlarge	VBN
25944	1368	12	.	.	.
25944	1369	1	Sooner	soon	RBR
25944	1369	2	or	or	CC
25944	1369	3	later	later	RBR
25944	1369	4	the	the	DT
25944	1369	5	integument	integument	NN
25944	1369	6	becomes	become	VBZ
25944	1369	7	considerably	considerably	RB
25944	1369	8	thickened	thicken	VBN
25944	1369	9	,	,	,
25944	1369	10	hard	hard	JJ
25944	1369	11	and	and	CC
25944	1369	12	rough	rough	JJ
25944	1369	13	.	.	.
25944	1370	1	Eczematous	eczematous	JJ
25944	1370	2	symptoms	symptom	NNS
25944	1370	3	may	may	MD
25944	1370	4	be	be	VB
25944	1370	5	superadded	superadde	VBN
25944	1370	6	.	.	.
25944	1371	1	In	in	IN
25944	1371	2	severe	severe	JJ
25944	1371	3	cases	case	NNS
25944	1371	4	the	the	DT
25944	1371	5	entire	entire	JJ
25944	1371	6	extensor	extensor	NN
25944	1371	7	surfaces	surface	NNS
25944	1371	8	of	of	IN
25944	1371	9	the	the	DT
25944	1371	10	legs	leg	NNS
25944	1371	11	and	and	CC
25944	1371	12	arms	arm	NNS
25944	1371	13	,	,	,
25944	1371	14	and	and	CC
25944	1371	15	in	in	IN
25944	1371	16	some	some	DT
25944	1371	17	instances	instance	NNS
25944	1371	18	the	the	DT
25944	1371	19	trunk	trunk	NN
25944	1371	20	also	also	RB
25944	1371	21	,	,	,
25944	1371	22	are	be	VBP
25944	1371	23	invaded	invade	VBN
25944	1371	24	.	.	.
25944	1372	1	It	-PRON-	PRP
25944	1372	2	is	be	VBZ
25944	1372	3	worse	bad	JJR
25944	1372	4	in	in	IN
25944	1372	5	the	the	DT
25944	1372	6	winter	winter	NN
25944	1372	7	season	season	NN
25944	1372	8	.	.	.
25944	1373	1	#	#	LS
25944	1373	2	What	what	WP
25944	1373	3	is	be	VBZ
25944	1373	4	known	know	VBN
25944	1373	5	in	in	IN
25944	1373	6	regard	regard	NN
25944	1373	7	to	to	IN
25944	1373	8	etiology	etiology	NN
25944	1373	9	and	and	CC
25944	1373	10	pathology	pathology	NN
25944	1373	11	?	?	.
25944	1373	12	#	#	$
25944	1373	13	It	-PRON-	PRP
25944	1373	14	is	be	VBZ
25944	1373	15	a	a	DT
25944	1373	16	disease	disease	NN
25944	1373	17	of	of	IN
25944	1373	18	the	the	DT
25944	1373	19	ill	ill	RB
25944	1373	20	-	-	HYPH
25944	1373	21	fed	fed	NNP
25944	1373	22	and	and	CC
25944	1373	23	neglected	neglect	VBN
25944	1373	24	,	,	,
25944	1373	25	usually	usually	RB
25944	1373	26	developing	develop	VBG
25944	1373	27	in	in	IN
25944	1373	28	early	early	JJ
25944	1373	29	childhood	childhood	NN
25944	1373	30	,	,	,
25944	1373	31	and	and	CC
25944	1373	32	persisting	persist	VBG
25944	1373	33	throughout	throughout	IN
25944	1373	34	life	life	NN
25944	1373	35	.	.	.
25944	1374	1	It	-PRON-	PRP
25944	1374	2	is	be	VBZ
25944	1374	3	extremely	extremely	RB
25944	1374	4	rare	rare	JJ
25944	1374	5	,	,	,
25944	1374	6	even	even	RB
25944	1374	7	in	in	IN
25944	1374	8	its	-PRON-	PRP$
25944	1374	9	milder	milder	NN
25944	1374	10	types	type	NNS
25944	1374	11	,	,	,
25944	1374	12	in	in	IN
25944	1374	13	this	this	DT
25944	1374	14	country	country	NN
25944	1374	15	.	.	.
25944	1375	1	Clinically	clinically	RB
25944	1375	2	and	and	CC
25944	1375	3	pathologically	pathologically	RB
25944	1375	4	it	-PRON-	PRP
25944	1375	5	bears	bear	VBZ
25944	1375	6	some	some	DT
25944	1375	7	resemblance	resemblance	NN
25944	1375	8	to	to	IN
25944	1375	9	papular	papular	JJ
25944	1375	10	eczema	eczema	NN
25944	1375	11	.	.	.
25944	1376	1	#	#	NN
25944	1376	2	Give	give	VB
25944	1376	3	the	the	DT
25944	1376	4	prognosis	prognosis	NN
25944	1376	5	and	and	CC
25944	1376	6	treatment	treatment	NN
25944	1376	7	of	of	IN
25944	1376	8	prurigo	prurigo	NNS
25944	1376	9	.	.	.
25944	1376	10	#	#	$
25944	1376	11	The	the	DT
25944	1376	12	disease	disease	NN
25944	1376	13	,	,	,
25944	1376	14	in	in	IN
25944	1376	15	its	-PRON-	PRP$
25944	1376	16	severer	severer	NN
25944	1376	17	types	type	NNS
25944	1376	18	is	be	VBZ
25944	1376	19	,	,	,
25944	1376	20	as	as	IN
25944	1376	21	a	a	DT
25944	1376	22	rule	rule	NN
25944	1376	23	,	,	,
25944	1376	24	incurable	incurable	JJ
25944	1376	25	,	,	,
25944	1376	26	but	but	CC
25944	1376	27	much	much	JJ
25944	1376	28	can	can	MD
25944	1376	29	be	be	VB
25944	1376	30	done	do	VBN
25944	1376	31	to	to	TO
25944	1376	32	alleviate	alleviate	VB
25944	1376	33	the	the	DT
25944	1376	34	condition	condition	NN
25944	1376	35	.	.	.
25944	1377	1	Good	good	JJ
25944	1377	2	,	,	,
25944	1377	3	nourishing	nourish	VBG
25944	1377	4	food	food	NN
25944	1377	5	,	,	,
25944	1377	6	pure	pure	JJ
25944	1377	7	air	air	NN
25944	1377	8	and	and	CC
25944	1377	9	exercise	exercise	NN
25944	1377	10	are	be	VBP
25944	1377	11	of	of	IN
25944	1377	12	importance	importance	NN
25944	1377	13	.	.	.
25944	1378	1	Tonics	tonic	NNS
25944	1378	2	and	and	CC
25944	1378	3	cod	cod	NN
25944	1378	4	-	-	HYPH
25944	1378	5	liver	liver	NN
25944	1378	6	oil	oil	NN
25944	1378	7	are	be	VBP
25944	1378	8	usually	usually	RB
25944	1378	9	beneficial	beneficial	JJ
25944	1378	10	.	.	.
25944	1379	1	The	the	DT
25944	1379	2	local	local	JJ
25944	1379	3	management	management	NN
25944	1379	4	is	be	VBZ
25944	1379	5	similar	similar	JJ
25944	1379	6	to	to	IN
25944	1379	7	that	that	DT
25944	1379	8	employed	employ	VBN
25944	1379	9	in	in	IN
25944	1379	10	chronic	chronic	JJ
25944	1379	11	eczema	eczema	NN
25944	1379	12	.	.	.
25944	1380	1	An	an	DT
25944	1380	2	ointment	ointment	NN
25944	1380	3	of	of	IN
25944	1380	4	[	[	-LRB-
25944	1380	5	beta]-naphthol	beta]-naphthol	NNP
25944	1380	6	,	,	,
25944	1380	7	one	one	CD
25944	1380	8	-	-	HYPH
25944	1380	9	half	half	NN
25944	1380	10	to	to	TO
25944	1380	11	five	five	CD
25944	1380	12	per	per	NN
25944	1380	13	cent	cent	NN
25944	1380	14	.	.	.
25944	1381	1	strength	strength	NN
25944	1381	2	,	,	,
25944	1381	3	is	be	VBZ
25944	1381	4	highly	highly	RB
25944	1381	5	extolled	extoll	VBN
25944	1381	6	.	.	.
25944	1382	1	#	#	NNP
25944	1382	2	Acne	Acne	NNP
25944	1382	3	.	.	.
25944	1382	4	#	#	$
25944	1382	5	#	#	NN
25944	1382	6	Give	give	VB
25944	1382	7	a	a	DT
25944	1382	8	definition	definition	NN
25944	1382	9	of	of	IN
25944	1382	10	acne	acne	NNP
25944	1382	11	.	.	.
25944	1382	12	#	#	$
25944	1382	13	Acne	Acne	NNP
25944	1382	14	is	be	VBZ
25944	1382	15	an	an	DT
25944	1382	16	inflammatory	inflammatory	JJ
25944	1382	17	,	,	,
25944	1382	18	usually	usually	RB
25944	1382	19	chronic	chronic	JJ
25944	1382	20	,	,	,
25944	1382	21	disease	disease	NN
25944	1382	22	of	of	IN
25944	1382	23	the	the	DT
25944	1382	24	sebaceous	sebaceous	JJ
25944	1382	25	glands	gland	NNS
25944	1382	26	,	,	,
25944	1382	27	characterized	characterize	VBN
25944	1382	28	by	by	IN
25944	1382	29	papules	papule	NNS
25944	1382	30	,	,	,
25944	1382	31	tubercles	tubercle	NNS
25944	1382	32	,	,	,
25944	1382	33	or	or	CC
25944	1382	34	pustules	pustule	NNS
25944	1382	35	,	,	,
25944	1382	36	or	or	CC
25944	1382	37	a	a	DT
25944	1382	38	mixture	mixture	NN
25944	1382	39	of	of	IN
25944	1382	40	these	these	DT
25944	1382	41	lesions	lesion	NNS
25944	1382	42	,	,	,
25944	1382	43	and	and	CC
25944	1382	44	seated	seat	VBN
25944	1382	45	usually	usually	RB
25944	1382	46	about	about	IN
25944	1382	47	the	the	DT
25944	1382	48	face	face	NN
25944	1382	49	.	.	.
25944	1383	1	#	#	$
25944	1383	2	At	at	IN
25944	1383	3	what	what	WDT
25944	1383	4	age	age	NN
25944	1383	5	does	do	VBZ
25944	1383	6	acne	acne	NNS
25944	1383	7	usually	usually	RB
25944	1383	8	occur	occur	VB
25944	1383	9	?	?	.
25944	1383	10	#	#	NN
25944	1383	11	Between	between	IN
25944	1383	12	the	the	DT
25944	1383	13	ages	age	NNS
25944	1383	14	of	of	IN
25944	1383	15	fifteen	fifteen	CD
25944	1383	16	and	and	CC
25944	1383	17	thirty	thirty	CD
25944	1383	18	,	,	,
25944	1383	19	at	at	IN
25944	1383	20	which	which	WDT
25944	1383	21	time	time	NN
25944	1383	22	the	the	DT
25944	1383	23	glandular	glandular	JJ
25944	1383	24	structures	structure	NNS
25944	1383	25	are	be	VBP
25944	1383	26	naturally	naturally	RB
25944	1383	27	more	more	RBR
25944	1383	28	or	or	CC
25944	1383	29	less	less	RBR
25944	1383	30	active	active	JJ
25944	1383	31	.	.	.
25944	1384	1	#	#	NNP
25944	1384	2	Describe	describe	VB
25944	1384	3	the	the	DT
25944	1384	4	symptoms	symptom	NNS
25944	1384	5	of	of	IN
25944	1384	6	acne	acne	NNP
25944	1384	7	.	.	.
25944	1384	8	#	#	$
25944	1384	9	Irregularly	irregularly	RB
25944	1384	10	scattered	scatter	VBN
25944	1384	11	over	over	IN
25944	1384	12	the	the	DT
25944	1384	13	face	face	NN
25944	1384	14	,	,	,
25944	1384	15	and	and	CC
25944	1384	16	in	in	IN
25944	1384	17	some	some	DT
25944	1384	18	cases	case	NNS
25944	1384	19	also	also	RB
25944	1384	20	over	over	IN
25944	1384	21	the	the	DT
25944	1384	22	neck	neck	NN
25944	1384	23	,	,	,
25944	1384	24	shoulders	shoulder	NNS
25944	1384	25	and	and	CC
25944	1384	26	upper	upper	JJ
25944	1384	27	part	part	NN
25944	1384	28	of	of	IN
25944	1384	29	the	the	DT
25944	1384	30	trunk	trunk	NN
25944	1384	31	,	,	,
25944	1384	32	are	be	VBP
25944	1384	33	to	to	TO
25944	1384	34	be	be	VB
25944	1384	35	seen	see	VBN
25944	1384	36	several	several	JJ
25944	1384	37	,	,	,
25944	1384	38	fifty	fifty	CD
25944	1384	39	or	or	CC
25944	1384	40	more	more	JJR
25944	1384	41	,	,	,
25944	1384	42	pin	pin	NN
25944	1384	43	-	-	HYPH
25944	1384	44	head-	head-	NN
25944	1384	45	to	to	IN
25944	1384	46	pea	pea	JJ
25944	1384	47	-	-	HYPH
25944	1384	48	sized	sized	JJ
25944	1384	49	papules	papule	NNS
25944	1384	50	,	,	,
25944	1384	51	tubercles	tubercle	NNS
25944	1384	52	or	or	CC
25944	1384	53	pustules	pustule	NNS
25944	1384	54	;	;	,
25944	1384	55	commonly	commonly	RB
25944	1384	56	the	the	DT
25944	1384	57	eruption	eruption	NN
25944	1384	58	is	be	VBZ
25944	1384	59	of	of	IN
25944	1384	60	a	a	DT
25944	1384	61	mixed	mixed	JJ
25944	1384	62	type	type	NN
25944	1384	63	(	(	-LRB-
25944	1384	64	_	_	NNP
25944	1384	65	acne	acne	NNP
25944	1384	66	vulgaris	vulgaris	NNP
25944	1384	67	_	_	NNP
25944	1384	68	)	)	-RRB-
25944	1384	69	,	,	,
25944	1384	70	the	the	DT
25944	1384	71	several	several	JJ
25944	1384	72	kinds	kind	NNS
25944	1384	73	of	of	IN
25944	1384	74	lesions	lesion	NNS
25944	1384	75	in	in	IN
25944	1384	76	all	all	DT
25944	1384	77	stages	stage	NNS
25944	1384	78	of	of	IN
25944	1384	79	evolution	evolution	NN
25944	1384	80	and	and	CC
25944	1384	81	subsidence	subsidence	NN
25944	1384	82	presenting	present	VBG
25944	1384	83	in	in	IN
25944	1384	84	the	the	DT
25944	1384	85	single	single	JJ
25944	1384	86	case	case	NN
25944	1384	87	.	.	.
25944	1385	1	Interspersed	Interspersed	NNP
25944	1385	2	may	may	MD
25944	1385	3	generally	generally	RB
25944	1385	4	be	be	VB
25944	1385	5	seen	see	VBN
25944	1385	6	blackheads	blackhead	NNS
25944	1385	7	,	,	,
25944	1385	8	or	or	CC
25944	1385	9	comedones	comedo	NNS
25944	1385	10	.	.	.
25944	1386	1	The	the	DT
25944	1386	2	lesions	lesion	NNS
25944	1386	3	may	may	MD
25944	1386	4	be	be	VB
25944	1386	5	sluggish	sluggish	JJ
25944	1386	6	in	in	IN
25944	1386	7	character	character	NN
25944	1386	8	,	,	,
25944	1386	9	or	or	CC
25944	1386	10	they	-PRON-	PRP
25944	1386	11	may	may	MD
25944	1386	12	be	be	VB
25944	1386	13	markedly	markedly	RB
25944	1386	14	inflammatory	inflammatory	JJ
25944	1386	15	,	,	,
25944	1386	16	with	with	IN
25944	1386	17	hard	hard	JJ
25944	1386	18	and	and	CC
25944	1386	19	indurated	indurated	JJ
25944	1386	20	bases	basis	NNS
25944	1386	21	.	.	.
25944	1387	1	In	in	IN
25944	1387	2	the	the	DT
25944	1387	3	course	course	NN
25944	1387	4	of	of	IN
25944	1387	5	several	several	JJ
25944	1387	6	days	day	NNS
25944	1387	7	or	or	CC
25944	1387	8	weeks	week	NNS
25944	1387	9	,	,	,
25944	1387	10	the	the	DT
25944	1387	11	papules	papule	NNS
25944	1387	12	and	and	CC
25944	1387	13	tubercles	tubercle	NNS
25944	1387	14	tend	tend	VBP
25944	1387	15	gradually	gradually	RB
25944	1387	16	to	to	TO
25944	1387	17	disappear	disappear	VB
25944	1387	18	by	by	IN
25944	1387	19	absorption	absorption	NN
25944	1387	20	;	;	:
25944	1387	21	or	or	CC
25944	1387	22	,	,	,
25944	1387	23	and	and	CC
25944	1387	24	as	as	IN
25944	1387	25	commonly	commonly	RB
25944	1387	26	the	the	DT
25944	1387	27	case	case	NN
25944	1387	28	,	,	,
25944	1387	29	they	-PRON-	PRP
25944	1387	30	become	become	VBP
25944	1387	31	pustular	pustular	JJ
25944	1387	32	,	,	,
25944	1387	33	discharge	discharge	VBP
25944	1387	34	their	-PRON-	PRP$
25944	1387	35	contents	content	NNS
25944	1387	36	,	,	,
25944	1387	37	or	or	CC
25944	1387	38	dry	dry	JJ
25944	1387	39	and	and	CC
25944	1387	40	slowly	slowly	RB
25944	1387	41	or	or	CC
25944	1387	42	rapidly	rapidly	RB
25944	1387	43	disappear	disappear	VB
25944	1387	44	,	,	,
25944	1387	45	with	with	IN
25944	1387	46	or	or	CC
25944	1387	47	without	without	IN
25944	1387	48	leaving	leave	VBG
25944	1387	49	a	a	DT
25944	1387	50	permanent	permanent	JJ
25944	1387	51	trace	trace	NN
25944	1387	52	,	,	,
25944	1387	53	new	new	JJ
25944	1387	54	lesions	lesion	NNS
25944	1387	55	arising	arise	VBG
25944	1387	56	,	,	,
25944	1387	57	here	here	RB
25944	1387	58	and	and	CC
25944	1387	59	there	there	RB
25944	1387	60	,	,	,
25944	1387	61	to	to	TO
25944	1387	62	take	take	VB
25944	1387	63	their	-PRON-	PRP$
25944	1387	64	place	place	NN
25944	1387	65	.	.	.
25944	1388	1	In	in	IN
25944	1388	2	exceptional	exceptional	JJ
25944	1388	3	instances	instance	NNS
25944	1388	4	the	the	DT
25944	1388	5	eruption	eruption	NN
25944	1388	6	is	be	VBZ
25944	1388	7	limited	limit	VBN
25944	1388	8	to	to	IN
25944	1388	9	the	the	DT
25944	1388	10	back	back	NN
25944	1388	11	,	,	,
25944	1388	12	and	and	CC
25944	1388	13	in	in	IN
25944	1388	14	these	these	DT
25944	1388	15	cases	case	NNS
25944	1388	16	the	the	DT
25944	1388	17	eruption	eruption	NN
25944	1388	18	is	be	VBZ
25944	1388	19	usually	usually	RB
25944	1388	20	extensive	extensive	JJ
25944	1388	21	and	and	CC
25944	1388	22	persistent	persistent	JJ
25944	1388	23	,	,	,
25944	1388	24	and	and	CC
25944	1388	25	not	not	RB
25944	1388	26	infrequently	infrequently	RB
25944	1388	27	leaves	leave	VBZ
25944	1388	28	scars	scar	NNS
25944	1388	29	.	.	.
25944	1389	1	#	#	LS
25944	1389	2	What	what	WP
25944	1389	3	do	do	VBP
25944	1389	4	you	-PRON-	PRP
25944	1389	5	understand	understand	VB
25944	1389	6	by	by	IN
25944	1389	7	acne	acne	NNP
25944	1389	8	punctata	punctata	NNP
25944	1389	9	,	,	,
25944	1389	10	acne	acne	NNP
25944	1389	11	papulosa	papulosa	NNP
25944	1389	12	,	,	,
25944	1389	13	acne	acne	NNP
25944	1389	14	pustulosa	pustulosa	NNP
25944	1389	15	,	,	,
25944	1389	16	acne	acne	NNP
25944	1389	17	indurata	indurata	NNP
25944	1389	18	,	,	,
25944	1389	19	acne	acne	NNP
25944	1389	20	atrophica	atrophica	NNP
25944	1389	21	,	,	,
25944	1389	22	acne	acne	NNP
25944	1389	23	hypertrophica	hypertrophica	NNP
25944	1389	24	,	,	,
25944	1389	25	and	and	CC
25944	1389	26	acne	acne	NNP
25944	1389	27	cachecticorum	cachecticorum	NNP
25944	1389	28	?	?	.
25944	1389	29	#	#	$
25944	1389	30	These	these	DT
25944	1389	31	several	several	JJ
25944	1389	32	terms	term	NNS
25944	1389	33	indicate	indicate	VBP
25944	1389	34	that	that	IN
25944	1389	35	the	the	DT
25944	1389	36	lesions	lesion	NNS
25944	1389	37	present	present	JJ
25944	1389	38	are	be	VBP
25944	1389	39	,	,	,
25944	1389	40	for	for	IN
25944	1389	41	the	the	DT
25944	1389	42	most	most	JJS
25944	1389	43	part	part	NN
25944	1389	44	,	,	,
25944	1389	45	of	of	IN
25944	1389	46	one	one	CD
25944	1389	47	particular	particular	JJ
25944	1389	48	character	character	NN
25944	1389	49	or	or	CC
25944	1389	50	variety	variety	NN
25944	1389	51	.	.	.
25944	1390	1	#	#	NNP
25944	1390	2	Describe	describe	VB
25944	1390	3	the	the	DT
25944	1390	4	lesions	lesion	NNS
25944	1390	5	giving	give	VBG
25944	1390	6	rise	rise	NN
25944	1390	7	to	to	IN
25944	1390	8	the	the	DT
25944	1390	9	names	name	NNS
25944	1390	10	of	of	IN
25944	1390	11	these	these	DT
25944	1390	12	various	various	JJ
25944	1390	13	types	type	NNS
25944	1390	14	.	.	.
25944	1390	15	#	#	$
25944	1390	16	Blocking	block	VBG
25944	1390	17	up	up	RP
25944	1390	18	of	of	IN
25944	1390	19	the	the	DT
25944	1390	20	outlet	outlet	NN
25944	1390	21	of	of	IN
25944	1390	22	the	the	DT
25944	1390	23	sebaceous	sebaceous	JJ
25944	1390	24	gland	gland	NNP
25944	1390	25	(	(	-LRB-
25944	1390	26	comedo	comedo	NNP
25944	1390	27	)	)	-RRB-
25944	1390	28	,	,	,
25944	1390	29	which	which	WDT
25944	1390	30	is	be	VBZ
25944	1390	31	usually	usually	RB
25944	1390	32	the	the	DT
25944	1390	33	beginning	beginning	NN
25944	1390	34	of	of	IN
25944	1390	35	an	an	DT
25944	1390	36	acne	acne	NNP
25944	1390	37	lesion	lesion	NN
25944	1390	38	,	,	,
25944	1390	39	may	may	MD
25944	1390	40	cause	cause	VB
25944	1390	41	a	a	DT
25944	1390	42	moderate	moderate	JJ
25944	1390	43	degree	degree	NN
25944	1390	44	of	of	IN
25944	1390	45	hyperæmia	hyperæmia	NN
25944	1390	46	and	and	CC
25944	1390	47	inflammation	inflammation	NN
25944	1390	48	,	,	,
25944	1390	49	and	and	CC
25944	1390	50	a	a	DT
25944	1390	51	slight	slight	JJ
25944	1390	52	elevation	elevation	NN
25944	1390	53	,	,	,
25944	1390	54	with	with	IN
25944	1390	55	a	a	DT
25944	1390	56	central	central	JJ
25944	1390	57	yellowish	yellowish	JJ
25944	1390	58	or	or	CC
25944	1390	59	blackish	blackish	JJ
25944	1390	60	point	point	NN
25944	1390	61	results	result	NNS
25944	1390	62	--	--	:
25944	1390	63	the	the	DT
25944	1390	64	lesion	lesion	NN
25944	1390	65	of	of	IN
25944	1390	66	_	_	NNP
25944	1390	67	acne	acne	NNP
25944	1390	68	punctata	punctata	NNP
25944	1390	69	_	_	NNP
25944	1390	70	;	;	:
25944	1390	71	if	if	IN
25944	1390	72	the	the	DT
25944	1390	73	inflammation	inflammation	NN
25944	1390	74	is	be	VBZ
25944	1390	75	of	of	IN
25944	1390	76	a	a	DT
25944	1390	77	higher	high	JJR
25944	1390	78	grade	grade	NN
25944	1390	79	or	or	CC
25944	1390	80	progresses	progress	NNS
25944	1390	81	,	,	,
25944	1390	82	the	the	DT
25944	1390	83	elevation	elevation	NN
25944	1390	84	is	be	VBZ
25944	1390	85	reddened	redden	VBN
25944	1390	86	and	and	CC
25944	1390	87	more	more	JJR
25944	1390	88	prominent--_acne	prominent--_acne	NNP
25944	1390	89	papulosa	papulosa	NNP
25944	1390	90	_	_	NNP
25944	1390	91	;	;	:
25944	1390	92	if	if	IN
25944	1390	93	the	the	DT
25944	1390	94	inflammatory	inflammatory	JJ
25944	1390	95	action	action	NN
25944	1390	96	continues	continue	VBZ
25944	1390	97	,	,	,
25944	1390	98	the	the	DT
25944	1390	99	interior	interior	JJ
25944	1390	100	or	or	CC
25944	1390	101	central	central	JJ
25944	1390	102	portion	portion	NN
25944	1390	103	of	of	IN
25944	1390	104	the	the	DT
25944	1390	105	papule	papule	NNP
25944	1390	106	suppurates	suppurate	NNS
25944	1390	107	and	and	CC
25944	1390	108	a	a	DT
25944	1390	109	pustule	pustule	NN
25944	1390	110	results--_acne	results--_acne	.
25944	1390	111	pustulosa	pustulosa	NNP
25944	1390	112	_	_	NNP
25944	1390	113	;	;	:
25944	1390	114	the	the	DT
25944	1390	115	pustule	pustule	NN
25944	1390	116	,	,	,
25944	1390	117	in	in	IN
25944	1390	118	some	some	DT
25944	1390	119	cases	case	NNS
25944	1390	120	,	,	,
25944	1390	121	may	may	MD
25944	1390	122	have	have	VB
25944	1390	123	a	a	DT
25944	1390	124	markedly	markedly	RB
25944	1390	125	inflammatory	inflammatory	JJ
25944	1390	126	and	and	CC
25944	1390	127	hard	hard	JJ
25944	1390	128	base--_acne	base--_acne	''
25944	1390	129	indurata	indurata	NNP
25944	1390	130	_	_	NNP
25944	1390	131	;	;	:
25944	1390	132	and	and	CC
25944	1390	133	not	not	RB
25944	1390	134	infrequently	infrequently	RB
25944	1390	135	the	the	DT
25944	1390	136	lesions	lesion	NNS
25944	1390	137	in	in	IN
25944	1390	138	disappearing	disappear	VBG
25944	1390	139	may	may	MD
25944	1390	140	leave	leave	VB
25944	1390	141	a	a	DT
25944	1390	142	pit	pit	NN
25944	1390	143	-	-	HYPH
25944	1390	144	like	like	JJ
25944	1390	145	atrophy	atrophy	NN
25944	1390	146	or	or	CC
25944	1390	147	depression--_acne	depression--_acne	NNP
25944	1390	148	atrophica	atrophica	NNP
25944	1390	149	_	_	NNP
25944	1390	150	;	;	:
25944	1390	151	or	or	CC
25944	1390	152	,	,	,
25944	1390	153	on	on	IN
25944	1390	154	the	the	DT
25944	1390	155	contrary	contrary	JJ
25944	1390	156	,	,	,
25944	1390	157	connective	connective	JJ
25944	1390	158	-	-	HYPH
25944	1390	159	tissue	tissue	NN
25944	1390	160	new	new	JJ
25944	1390	161	growth	growth	NN
25944	1390	162	may	may	MD
25944	1390	163	follow	follow	VB
25944	1390	164	their	-PRON-	PRP$
25944	1390	165	disappearance--_acne	disappearance--_acne	NNP
25944	1390	166	hypertrophica	hypertrophica	NNP
25944	1390	167	_	_	NNP
25944	1390	168	;	;	:
25944	1390	169	and	and	CC
25944	1390	170	,	,	,
25944	1390	171	in	in	IN
25944	1390	172	strumous	strumous	JJ
25944	1390	173	or	or	CC
25944	1390	174	cachectic	cachectic	JJ
25944	1390	175	individuals	individual	NNS
25944	1390	176	,	,	,
25944	1390	177	the	the	DT
25944	1390	178	lesions	lesion	NNS
25944	1390	179	may	may	MD
25944	1390	180	be	be	VB
25944	1390	181	more	more	RBR
25944	1390	182	or	or	CC
25944	1390	183	less	less	RBR
25944	1390	184	furuncular	furuncular	JJ
25944	1390	185	in	in	IN
25944	1390	186	type	type	NN
25944	1390	187	,	,	,
25944	1390	188	often	often	RB
25944	1390	189	of	of	IN
25944	1390	190	the	the	DT
25944	1390	191	nature	nature	NN
25944	1390	192	of	of	IN
25944	1390	193	dermic	dermic	NN
25944	1390	194	abscesses	abscess	NNS
25944	1390	195	,	,	,
25944	1390	196	usually	usually	RB
25944	1390	197	of	of	IN
25944	1390	198	a	a	DT
25944	1390	199	cold	cold	JJ
25944	1390	200	or	or	CC
25944	1390	201	sluggish	sluggish	JJ
25944	1390	202	character	character	NN
25944	1390	203	,	,	,
25944	1390	204	and	and	CC
25944	1390	205	of	of	IN
25944	1390	206	more	more	JJR
25944	1390	207	general	general	JJ
25944	1390	208	distribution--_acne	distribution--_acne	JJ
25944	1390	209	cachecticorum	cachecticorum	NN
25944	1390	210	_	_	NNP
25944	1390	211	.	.	.
25944	1391	1	#	#	LS
25944	1391	2	What	what	WP
25944	1391	3	is	be	VBZ
25944	1391	4	acne	acne	RB
25944	1391	5	artificialis	artificialis	RB
25944	1391	6	?	?	.
25944	1391	7	#	#	$
25944	1391	8	Acne	Acne	NNP
25944	1391	9	artificialis	artificialis	RB
25944	1391	10	is	be	VBZ
25944	1391	11	a	a	DT
25944	1391	12	term	term	NN
25944	1391	13	applied	apply	VBN
25944	1391	14	to	to	IN
25944	1391	15	an	an	DT
25944	1391	16	acne	acne	NNP
25944	1391	17	or	or	CC
25944	1391	18	acne	acne	NNP
25944	1391	19	-	-	HYPH
25944	1391	20	like	like	JJ
25944	1391	21	eruption	eruption	NN
25944	1391	22	produced	produce	VBN
25944	1391	23	by	by	IN
25944	1391	24	the	the	DT
25944	1391	25	ingestion	ingestion	NN
25944	1391	26	of	of	IN
25944	1391	27	certain	certain	JJ
25944	1391	28	drugs	drug	NNS
25944	1391	29	,	,	,
25944	1391	30	as	as	IN
25944	1391	31	the	the	DT
25944	1391	32	bromides	bromide	NNS
25944	1391	33	and	and	CC
25944	1391	34	iodides	iodide	NNS
25944	1391	35	,	,	,
25944	1391	36	and	and	CC
25944	1391	37	by	by	IN
25944	1391	38	the	the	DT
25944	1391	39	external	external	JJ
25944	1391	40	use	use	NN
25944	1391	41	of	of	IN
25944	1391	42	tar	tar	NN
25944	1391	43	;	;	:
25944	1391	44	this	this	DT
25944	1391	45	is	be	VBZ
25944	1391	46	also	also	RB
25944	1391	47	called	call	VBN
25944	1391	48	_	_	NNP
25944	1391	49	tar	tar	NN
25944	1391	50	acne	acne	NNP
25944	1391	51	_	_	NNP
25944	1391	52	.	.	.
25944	1392	1	#	#	LS
25944	1392	2	What	what	WDT
25944	1392	3	course	course	NN
25944	1392	4	does	do	VBZ
25944	1392	5	acne	acne	NNP
25944	1392	6	pursue	pursue	VB
25944	1392	7	?	?	.
25944	1392	8	#	#	$
25944	1392	9	Essentially	essentially	RB
25944	1392	10	chronic	chronic	JJ
25944	1392	11	.	.	.
25944	1393	1	The	the	DT
25944	1393	2	individual	individual	JJ
25944	1393	3	lesions	lesion	NNS
25944	1393	4	usually	usually	RB
25944	1393	5	run	run	VBP
25944	1393	6	their	-PRON-	PRP$
25944	1393	7	course	course	NN
25944	1393	8	in	in	IN
25944	1393	9	several	several	JJ
25944	1393	10	days	day	NNS
25944	1393	11	or	or	CC
25944	1393	12	one	one	CD
25944	1393	13	or	or	CC
25944	1393	14	two	two	CD
25944	1393	15	weeks	week	NNS
25944	1393	16	,	,	,
25944	1393	17	but	but	CC
25944	1393	18	new	new	JJ
25944	1393	19	lesions	lesion	NNS
25944	1393	20	continue	continue	VBP
25944	1393	21	to	to	TO
25944	1393	22	appear	appear	VB
25944	1393	23	from	from	IN
25944	1393	24	time	time	NN
25944	1393	25	to	to	IN
25944	1393	26	time	time	NN
25944	1393	27	,	,	,
25944	1393	28	and	and	CC
25944	1393	29	the	the	DT
25944	1393	30	disease	disease	NN
25944	1393	31	thus	thus	RB
25944	1393	32	persists	persist	VBZ
25944	1393	33	,	,	,
25944	1393	34	with	with	IN
25944	1393	35	more	more	JJR
25944	1393	36	or	or	CC
25944	1393	37	less	less	JJR
25944	1393	38	variation	variation	NN
25944	1393	39	,	,	,
25944	1393	40	for	for	IN
25944	1393	41	months	month	NNS
25944	1393	42	or	or	CC
25944	1393	43	years	year	NNS
25944	1393	44	.	.	.
25944	1394	1	In	in	IN
25944	1394	2	many	many	JJ
25944	1394	3	cases	case	NNS
25944	1394	4	there	there	EX
25944	1394	5	is	be	VBZ
25944	1394	6	,	,	,
25944	1394	7	toward	toward	IN
25944	1394	8	the	the	DT
25944	1394	9	age	age	NN
25944	1394	10	of	of	IN
25944	1394	11	twenty	twenty	CD
25944	1394	12	-	-	HYPH
25944	1394	13	five	five	CD
25944	1394	14	or	or	CC
25944	1394	15	thirty	thirty	CD
25944	1394	16	,	,	,
25944	1394	17	a	a	DT
25944	1394	18	tendency	tendency	NN
25944	1394	19	to	to	IN
25944	1394	20	spontaneous	spontaneous	JJ
25944	1394	21	disappearance	disappearance	NN
25944	1394	22	of	of	IN
25944	1394	23	the	the	DT
25944	1394	24	disease	disease	NN
25944	1394	25	.	.	.
25944	1395	1	[	[	-LRB-
25944	1395	2	Illustration	illustration	NN
25944	1395	3	:	:	:
25944	1395	4	Acne	Acne	NNP
25944	1395	5	.	.	.
25944	1395	6	]	]	-RRB-
25944	1396	1	#	#	$
25944	1396	2	Is	be	VBZ
25944	1396	3	the	the	DT
25944	1396	4	eruption	eruption	NN
25944	1396	5	in	in	IN
25944	1396	6	acne	acne	NNP
25944	1396	7	usually	usually	RB
25944	1396	8	abundant	abundant	JJ
25944	1396	9	?	?	.
25944	1396	10	#	#	WRB
25944	1396	11	It	-PRON-	PRP
25944	1396	12	varies	vary	VBZ
25944	1396	13	in	in	IN
25944	1396	14	different	different	JJ
25944	1396	15	cases	case	NNS
25944	1396	16	and	and	CC
25944	1396	17	at	at	IN
25944	1396	18	different	different	JJ
25944	1396	19	periods	period	NNS
25944	1396	20	in	in	IN
25944	1396	21	the	the	DT
25944	1396	22	same	same	JJ
25944	1396	23	case	case	NN
25944	1396	24	.	.	.
25944	1397	1	In	in	IN
25944	1397	2	some	some	DT
25944	1397	3	instances	instance	NNS
25944	1397	4	,	,	,
25944	1397	5	not	not	RB
25944	1397	6	more	more	JJR
25944	1397	7	than	than	IN
25944	1397	8	five	five	CD
25944	1397	9	or	or	CC
25944	1397	10	ten	ten	CD
25944	1397	11	papules	papule	NNS
25944	1397	12	and	and	CC
25944	1397	13	pustules	pustule	NNS
25944	1397	14	are	be	VBP
25944	1397	15	present	present	JJ
25944	1397	16	at	at	IN
25944	1397	17	one	one	CD
25944	1397	18	time	time	NN
25944	1397	19	;	;	:
25944	1397	20	in	in	IN
25944	1397	21	others	other	NNS
25944	1397	22	they	-PRON-	PRP
25944	1397	23	may	may	MD
25944	1397	24	be	be	VB
25944	1397	25	numerous	numerous	JJ
25944	1397	26	.	.	.
25944	1398	1	Not	not	RB
25944	1398	2	infrequently	infrequently	RB
25944	1398	3	several	several	JJ
25944	1398	4	lesions	lesion	NNS
25944	1398	5	make	make	VBP
25944	1398	6	their	-PRON-	PRP$
25944	1398	7	appearance	appearance	NN
25944	1398	8	,	,	,
25944	1398	9	gradually	gradually	RB
25944	1398	10	run	run	VB
25944	1398	11	their	-PRON-	PRP$
25944	1398	12	course	course	NN
25944	1398	13	,	,	,
25944	1398	14	and	and	CC
25944	1398	15	the	the	DT
25944	1398	16	face	face	NN
25944	1398	17	continues	continue	VBZ
25944	1398	18	free	free	JJ
25944	1398	19	for	for	IN
25944	1398	20	days	day	NNS
25944	1398	21	or	or	CC
25944	1398	22	one	one	CD
25944	1398	23	or	or	CC
25944	1398	24	two	two	CD
25944	1398	25	weeks	week	NNS
25944	1398	26	.	.	.
25944	1399	1	#	#	NNP
25944	1399	2	Does	do	VBZ
25944	1399	3	the	the	DT
25944	1399	4	eruption	eruption	NN
25944	1399	5	in	in	IN
25944	1399	6	acne	acne	NNP
25944	1399	7	disappear	disappear	VB
25944	1399	8	without	without	IN
25944	1399	9	leaving	leave	VBG
25944	1399	10	a	a	DT
25944	1399	11	trace	trace	NN
25944	1399	12	?	?	.
25944	1399	13	#	#	$
25944	1399	14	In	in	IN
25944	1399	15	many	many	JJ
25944	1399	16	instances	instance	NNS
25944	1399	17	no	no	DT
25944	1399	18	permanent	permanent	JJ
25944	1399	19	trace	trace	NN
25944	1399	20	remains	remain	VBZ
25944	1399	21	,	,	,
25944	1399	22	but	but	CC
25944	1399	23	in	in	IN
25944	1399	24	others	other	NNS
25944	1399	25	slight	slight	JJ
25944	1399	26	or	or	CC
25944	1399	27	conspicuous	conspicuous	JJ
25944	1399	28	scarring	scarring	NN
25944	1399	29	is	be	VBZ
25944	1399	30	left	leave	VBN
25944	1399	31	to	to	TO
25944	1399	32	mark	mark	VB
25944	1399	33	the	the	DT
25944	1399	34	site	site	NN
25944	1399	35	of	of	IN
25944	1399	36	the	the	DT
25944	1399	37	lesions	lesion	NNS
25944	1399	38	.	.	.
25944	1400	1	#	#	NN
25944	1400	2	Are	be	VBP
25944	1400	3	there	there	EX
25944	1400	4	any	any	DT
25944	1400	5	subjective	subjective	JJ
25944	1400	6	symptoms	symptom	NNS
25944	1400	7	in	in	IN
25944	1400	8	acne	acne	NNP
25944	1400	9	?	?	.
25944	1400	10	#	#	$
25944	1400	11	As	as	IN
25944	1400	12	a	a	DT
25944	1400	13	rule	rule	NN
25944	1400	14	,	,	,
25944	1400	15	not	not	RB
25944	1400	16	;	;	:
25944	1400	17	but	but	CC
25944	1400	18	markedly	markedly	RB
25944	1400	19	inflammatory	inflammatory	JJ
25944	1400	20	lesions	lesion	NNS
25944	1400	21	are	be	VBP
25944	1400	22	painful	painful	JJ
25944	1400	23	.	.	.
25944	1401	1	#	#	JJR
25944	1401	2	State	state	NN
25944	1401	3	the	the	DT
25944	1401	4	immediate	immediate	JJ
25944	1401	5	or	or	CC
25944	1401	6	direct	direct	JJ
25944	1401	7	cause	cause	NN
25944	1401	8	of	of	IN
25944	1401	9	an	an	DT
25944	1401	10	acne	acne	NNP
25944	1401	11	lesion	lesion	NN
25944	1401	12	.	.	.
25944	1401	13	#	#	$
25944	1401	14	Hypersecretion	hypersecretion	NN
25944	1401	15	or	or	CC
25944	1401	16	retention	retention	NN
25944	1401	17	of	of	IN
25944	1401	18	sebaceous	sebaceous	JJ
25944	1401	19	matter	matter	NN
25944	1401	20	.	.	.
25944	1402	1	Recent	recent	JJ
25944	1402	2	investigations	investigation	NNS
25944	1402	3	point	point	VBP
25944	1402	4	to	to	IN
25944	1402	5	the	the	DT
25944	1402	6	possibility	possibility	NN
25944	1402	7	of	of	IN
25944	1402	8	a	a	DT
25944	1402	9	special	special	JJ
25944	1402	10	bacillus	bacillus	NN
25944	1402	11	being	be	VBG
25944	1402	12	the	the	DT
25944	1402	13	exciting	exciting	JJ
25944	1402	14	cause	cause	NN
25944	1402	15	,	,	,
25944	1402	16	in	in	IN
25944	1402	17	some	some	DT
25944	1402	18	instances	instance	NNS
25944	1402	19	at	at	IN
25944	1402	20	least	least	JJS
25944	1402	21	.	.	.
25944	1403	1	The	the	DT
25944	1403	2	pyogenic	pyogenic	JJ
25944	1403	3	cocci	coccus	NNS
25944	1403	4	are	be	VBP
25944	1403	5	added	add	VBN
25944	1403	6	factors	factor	NNS
25944	1403	7	in	in	IN
25944	1403	8	the	the	DT
25944	1403	9	pustular	pustular	NN
25944	1403	10	and	and	CC
25944	1403	11	furuncular	furuncular	JJ
25944	1403	12	cases	case	NNS
25944	1403	13	.	.	.
25944	1404	1	#	#	$
25944	1404	2	Name	name	VB
25944	1404	3	the	the	DT
25944	1404	4	indirect	indirect	NN
25944	1404	5	or	or	CC
25944	1404	6	predisposing	predispose	VBG
25944	1404	7	causes	cause	NNS
25944	1404	8	of	of	IN
25944	1404	9	acne	acne	NNS
25944	1404	10	.	.	.
25944	1404	11	#	#	$
25944	1404	12	Digestive	digestive	JJ
25944	1404	13	disturbance	disturbance	NN
25944	1404	14	,	,	,
25944	1404	15	constipation	constipation	NN
25944	1404	16	,	,	,
25944	1404	17	menstrual	menstrual	JJ
25944	1404	18	irregularities	irregularity	NNS
25944	1404	19	,	,	,
25944	1404	20	chlorosis	chlorosis	NN
25944	1404	21	,	,	,
25944	1404	22	general	general	JJ
25944	1404	23	debility	debility	NN
25944	1404	24	,	,	,
25944	1404	25	lack	lack	NN
25944	1404	26	of	of	IN
25944	1404	27	tone	tone	NN
25944	1404	28	in	in	IN
25944	1404	29	the	the	DT
25944	1404	30	muscular	muscular	JJ
25944	1404	31	fibres	fibre	NNS
25944	1404	32	of	of	IN
25944	1404	33	the	the	DT
25944	1404	34	skin	skin	NN
25944	1404	35	,	,	,
25944	1404	36	scrofulosis	scrofulosis	NN
25944	1404	37	;	;	,
25944	1404	38	and	and	CC
25944	1404	39	medicinal	medicinal	JJ
25944	1404	40	substances	substance	NNS
25944	1404	41	such	such	JJ
25944	1404	42	as	as	IN
25944	1404	43	the	the	DT
25944	1404	44	iodides	iodide	NNS
25944	1404	45	and	and	CC
25944	1404	46	bromides	bromide	VBZ
25944	1404	47	internally	internally	RB
25944	1404	48	,	,	,
25944	1404	49	and	and	CC
25944	1404	50	tar	tar	NN
25944	1404	51	externally	externally	RB
25944	1404	52	.	.	.
25944	1405	1	Working	work	VBG
25944	1405	2	in	in	IN
25944	1405	3	a	a	DT
25944	1405	4	dusty	dusty	JJ
25944	1405	5	or	or	CC
25944	1405	6	dirty	dirty	JJ
25944	1405	7	atmosphere	atmosphere	NN
25944	1405	8	is	be	VBZ
25944	1405	9	often	often	RB
25944	1405	10	influential	influential	JJ
25944	1405	11	,	,	,
25944	1405	12	resulting	result	VBG
25944	1405	13	in	in	IN
25944	1405	14	a	a	DT
25944	1405	15	blocking	blocking	NN
25944	1405	16	-	-	HYPH
25944	1405	17	up	up	NN
25944	1405	18	of	of	IN
25944	1405	19	the	the	DT
25944	1405	20	gland	gland	NN
25944	1405	21	ducts	duct	NNS
25944	1405	22	.	.	.
25944	1406	1	Workmen	workman	NNS
25944	1406	2	in	in	IN
25944	1406	3	paraffin	paraffin	NN
25944	1406	4	oils	oil	NNS
25944	1406	5	or	or	CC
25944	1406	6	other	other	JJ
25944	1406	7	petroleum	petroleum	NN
25944	1406	8	products	product	NNS
25944	1406	9	often	often	RB
25944	1406	10	present	present	VBP
25944	1406	11	a	a	DT
25944	1406	12	furuncle	furuncle	NN
25944	1406	13	-	-	HYPH
25944	1406	14	like	like	JJ
25944	1406	15	acne	acne	NNP
25944	1406	16	.	.	.
25944	1407	1	The	the	DT
25944	1407	2	disease	disease	NN
25944	1407	3	is	be	VBZ
25944	1407	4	more	more	RBR
25944	1407	5	common	common	JJ
25944	1407	6	in	in	IN
25944	1407	7	individuals	individual	NNS
25944	1407	8	of	of	IN
25944	1407	9	light	light	JJ
25944	1407	10	complexion	complexion	NN
25944	1407	11	.	.	.
25944	1408	1	#	#	$
25944	1408	2	Is	be	VBZ
25944	1408	3	there	there	EX
25944	1408	4	any	any	DT
25944	1408	5	difficulty	difficulty	NN
25944	1408	6	in	in	IN
25944	1408	7	the	the	DT
25944	1408	8	diagnosis	diagnosis	NN
25944	1408	9	of	of	IN
25944	1408	10	acne	acne	NNP
25944	1408	11	?	?	.
25944	1408	12	#	#	NN
25944	1408	13	Not	not	RB
25944	1408	14	if	if	IN
25944	1408	15	it	-PRON-	PRP
25944	1408	16	be	be	VB
25944	1408	17	remembered	remember	VBN
25944	1408	18	that	that	IN
25944	1408	19	acne	acne	NNP
25944	1408	20	eruption	eruption	NN
25944	1408	21	is	be	VBZ
25944	1408	22	limited	limit	VBN
25944	1408	23	to	to	IN
25944	1408	24	certain	certain	JJ
25944	1408	25	parts	part	NNS
25944	1408	26	and	and	CC
25944	1408	27	is	be	VBZ
25944	1408	28	always	always	RB
25944	1408	29	follicular	follicular	JJ
25944	1408	30	,	,	,
25944	1408	31	and	and	CC
25944	1408	32	that	that	IN
25944	1408	33	the	the	DT
25944	1408	34	several	several	JJ
25944	1408	35	stages	stage	NNS
25944	1408	36	,	,	,
25944	1408	37	from	from	IN
25944	1408	38	the	the	DT
25944	1408	39	comedo	comedo	NN
25944	1408	40	to	to	IN
25944	1408	41	the	the	DT
25944	1408	42	matured	matured	JJ
25944	1408	43	lesion	lesion	NN
25944	1408	44	,	,	,
25944	1408	45	are	be	VBP
25944	1408	46	usually	usually	RB
25944	1408	47	to	to	TO
25944	1408	48	be	be	VB
25944	1408	49	seen	see	VBN
25944	1408	50	in	in	IN
25944	1408	51	the	the	DT
25944	1408	52	individual	individual	JJ
25944	1408	53	case	case	NN
25944	1408	54	.	.	.
25944	1409	1	#	#	$
25944	1409	2	In	in	IN
25944	1409	3	what	what	WDT
25944	1409	4	respect	respect	NN
25944	1409	5	does	do	VBZ
25944	1409	6	the	the	DT
25944	1409	7	pustular	pustular	JJ
25944	1409	8	syphiloderm	syphiloderm	NN
25944	1409	9	differ	differ	VB
25944	1409	10	from	from	IN
25944	1409	11	acne	acne	NNP
25944	1409	12	?	?	.
25944	1409	13	#	#	NN
25944	1409	14	By	by	IN
25944	1409	15	its	-PRON-	PRP$
25944	1409	16	general	general	JJ
25944	1409	17	distribution	distribution	NN
25944	1409	18	,	,	,
25944	1409	19	the	the	DT
25944	1409	20	longer	long	JJR
25944	1409	21	duration	duration	NN
25944	1409	22	of	of	IN
25944	1409	23	the	the	DT
25944	1409	24	individual	individual	JJ
25944	1409	25	lesions	lesion	NNS
25944	1409	26	,	,	,
25944	1409	27	the	the	DT
25944	1409	28	darker	dark	JJR
25944	1409	29	color	color	NN
25944	1409	30	,	,	,
25944	1409	31	and	and	CC
25944	1409	32	the	the	DT
25944	1409	33	presence	presence	NN
25944	1409	34	of	of	IN
25944	1409	35	concomitant	concomitant	JJ
25944	1409	36	symptoms	symptom	NNS
25944	1409	37	of	of	IN
25944	1409	38	syphilis	syphilis	NNP
25944	1409	39	.	.	.
25944	1410	1	#	#	LS
25944	1410	2	What	what	WP
25944	1410	3	is	be	VBZ
25944	1410	4	the	the	DT
25944	1410	5	pathology	pathology	NN
25944	1410	6	of	of	IN
25944	1410	7	acne	acne	NNP
25944	1410	8	?	?	.
25944	1410	9	#	#	$
25944	1410	10	Primarily	primarily	RB
25944	1410	11	,	,	,
25944	1410	12	acne	acne	NNP
25944	1410	13	is	be	VBZ
25944	1410	14	a	a	DT
25944	1410	15	folliculitis	folliculitis	NN
25944	1410	16	,	,	,
25944	1410	17	due	due	IN
25944	1410	18	to	to	IN
25944	1410	19	retention	retention	NN
25944	1410	20	or	or	CC
25944	1410	21	decomposition	decomposition	NN
25944	1410	22	of	of	IN
25944	1410	23	the	the	DT
25944	1410	24	sebaceous	sebaceous	JJ
25944	1410	25	secretion	secretion	NN
25944	1410	26	or	or	CC
25944	1410	27	to	to	IN
25944	1410	28	the	the	DT
25944	1410	29	introduction	introduction	NN
25944	1410	30	of	of	IN
25944	1410	31	a	a	DT
25944	1410	32	micro	micro	JJ
25944	1410	33	-	-	HYPH
25944	1410	34	organism	organism	NN
25944	1410	35	;	;	:
25944	1410	36	subsequently	subsequently	RB
25944	1410	37	,	,	,
25944	1410	38	the	the	DT
25944	1410	39	tissue	tissue	NN
25944	1410	40	immediately	immediately	RB
25944	1410	41	surrounding	surround	VBG
25944	1410	42	becoming	become	VBG
25944	1410	43	involved	involve	VBN
25944	1410	44	,	,	,
25944	1410	45	with	with	IN
25944	1410	46	the	the	DT
25944	1410	47	possible	possible	JJ
25944	1410	48	destruction	destruction	NN
25944	1410	49	of	of	IN
25944	1410	50	the	the	DT
25944	1410	51	sebaceous	sebaceous	JJ
25944	1410	52	follicle	follicle	NN
25944	1410	53	as	as	IN
25944	1410	54	a	a	DT
25944	1410	55	result	result	NN
25944	1410	56	.	.	.
25944	1411	1	The	the	DT
25944	1411	2	degree	degree	NN
25944	1411	3	of	of	IN
25944	1411	4	inflammatory	inflammatory	JJ
25944	1411	5	action	action	NN
25944	1411	6	determines	determine	VBZ
25944	1411	7	the	the	DT
25944	1411	8	character	character	NN
25944	1411	9	of	of	IN
25944	1411	10	the	the	DT
25944	1411	11	lesions	lesion	NNS
25944	1411	12	.	.	.
25944	1412	1	#	#	JJR
25944	1412	2	State	state	NN
25944	1412	3	the	the	DT
25944	1412	4	prognosis	prognosis	NN
25944	1412	5	of	of	IN
25944	1412	6	acne	acne	NNP
25944	1412	7	.	.	.
25944	1412	8	#	#	$
25944	1412	9	It	-PRON-	PRP
25944	1412	10	is	be	VBZ
25944	1412	11	usually	usually	RB
25944	1412	12	an	an	DT
25944	1412	13	obstinate	obstinate	NN
25944	1412	14	disease	disease	NN
25944	1412	15	,	,	,
25944	1412	16	but	but	CC
25944	1412	17	curable	curable	JJ
25944	1412	18	.	.	.
25944	1413	1	Some	some	DT
25944	1413	2	cases	case	NNS
25944	1413	3	yield	yield	VBP
25944	1413	4	readily	readily	RB
25944	1413	5	,	,	,
25944	1413	6	others	other	NNS
25944	1413	7	are	be	VBP
25944	1413	8	exceedingly	exceedingly	RB
25944	1413	9	rebellious	rebellious	JJ
25944	1413	10	,	,	,
25944	1413	11	especially	especially	RB
25944	1413	12	acne	acne	NNS
25944	1413	13	of	of	IN
25944	1413	14	the	the	DT
25944	1413	15	back	back	NN
25944	1413	16	.	.	.
25944	1414	1	Success	success	NN
25944	1414	2	depends	depend	VBZ
25944	1414	3	in	in	IN
25944	1414	4	a	a	DT
25944	1414	5	great	great	JJ
25944	1414	6	measure	measure	NN
25944	1414	7	upon	upon	IN
25944	1414	8	a	a	DT
25944	1414	9	recognition	recognition	NN
25944	1414	10	and	and	CC
25944	1414	11	removal	removal	NN
25944	1414	12	of	of	IN
25944	1414	13	the	the	DT
25944	1414	14	predisposing	predisposing	NN
25944	1414	15	condition	condition	NN
25944	1414	16	.	.	.
25944	1415	1	Treatment	treatment	NN
25944	1415	2	is	be	VBZ
25944	1415	3	ordinarily	ordinarily	RB
25944	1415	4	a	a	DT
25944	1415	5	matter	matter	NN
25944	1415	6	of	of	IN
25944	1415	7	months	month	NNS
25944	1415	8	.	.	.
25944	1416	1	#	#	LS
25944	1416	2	What	what	WDT
25944	1416	3	measures	measure	NNS
25944	1416	4	of	of	IN
25944	1416	5	treatment	treatment	NN
25944	1416	6	are	be	VBP
25944	1416	7	usually	usually	RB
25944	1416	8	demanded	demand	VBN
25944	1416	9	in	in	IN
25944	1416	10	acne	acne	NNP
25944	1416	11	?	?	.
25944	1416	12	#	#	$
25944	1416	13	Constitutional	constitutional	JJ
25944	1416	14	and	and	CC
25944	1416	15	local	local	JJ
25944	1416	16	measures	measure	NNS
25944	1416	17	;	;	:
25944	1416	18	the	the	DT
25944	1416	19	former	former	JJ
25944	1416	20	when	when	WRB
25944	1416	21	indicated	indicate	VBN
25944	1416	22	,	,	,
25944	1416	23	the	the	DT
25944	1416	24	latter	latter	JJ
25944	1416	25	always	always	RB
25944	1416	26	.	.	.
25944	1417	1	#	#	NN
25944	1417	2	Upon	upon	IN
25944	1417	3	what	what	WP
25944	1417	4	is	be	VBZ
25944	1417	5	the	the	DT
25944	1417	6	constitutional	constitutional	JJ
25944	1417	7	treatment	treatment	NN
25944	1417	8	based	base	VBN
25944	1417	9	?	?	.
25944	1417	10	#	#	NNP
25944	1417	11	Upon	upon	IN
25944	1417	12	indications	indication	NNS
25944	1417	13	.	.	.
25944	1418	1	Diet	diet	NN
25944	1418	2	and	and	CC
25944	1418	3	hygienic	hygienic	JJ
25944	1418	4	measures	measure	NNS
25944	1418	5	are	be	VBP
25944	1418	6	important	important	JJ
25944	1418	7	.	.	.
25944	1419	1	In	in	IN
25944	1419	2	dyspepsia	dyspepsia	NNP
25944	1419	3	and	and	CC
25944	1419	4	constipation	constipation	NN
25944	1419	5	,	,	,
25944	1419	6	bitter	bitter	JJ
25944	1419	7	tonics	tonic	NNS
25944	1419	8	,	,	,
25944	1419	9	alkalies	alkali	NNS
25944	1419	10	,	,	,
25944	1419	11	acids	acid	NNS
25944	1419	12	,	,	,
25944	1419	13	pepsin	pepsin	NNP
25944	1419	14	,	,	,
25944	1419	15	saline	saline	NN
25944	1419	16	and	and	CC
25944	1419	17	vegetable	vegetable	NN
25944	1419	18	laxatives	laxative	NNS
25944	1419	19	,	,	,
25944	1419	20	are	be	VBP
25944	1419	21	variously	variously	RB
25944	1419	22	prescribed	prescribe	VBN
25944	1419	23	.	.	.
25944	1420	1	Special	special	JJ
25944	1420	2	mention	mention	NN
25944	1420	3	may	may	MD
25944	1420	4	be	be	VB
25944	1420	5	made	make	VBN
25944	1420	6	of	of	IN
25944	1420	7	the	the	DT
25944	1420	8	following:--	following:--	NN
25944	1420	9	[	[	-LRB-
25944	1420	10	Rx	Rx	NNP
25944	1420	11	]	]	-RRB-
25944	1420	12	Ext	Ext	NNP
25944	1420	13	.	.	.
25944	1421	1	rhamni	rhamni	NNP
25944	1421	2	pursh	pursh	NNP
25944	1421	3	.	.	.
25944	1422	1	fl	fl	NNP
25944	1422	2	.	.	NNP
25944	1422	3	,	,	,
25944	1422	4	..............	..............	NFP
25944	1422	5	f[dram]ij	f[dram]ij	NFP
25944	1422	6	-	-	:
25944	1422	7	f[dram]iv	f[dram]iv	NNS
25944	1422	8	Tinct	tinct	FW
25944	1422	9	.	.	.
25944	1423	1	nucis	nucis	NNP
25944	1423	2	vom	vom	NNP
25944	1423	3	.	.	NNP
25944	1423	4	,	,	,
25944	1423	5	...................	...................	NFP
25944	1423	6	f[dram]iij	f[dram]iij	NNP
25944	1423	7	Tinct	Tinct	NNP
25944	1423	8	.	.	.
25944	1424	1	cardamomi	cardamomi	NNP
25944	1424	2	comp	comp	NNP
25944	1424	3	.	.	.
25944	1424	4	,	,	,
25944	1424	5	.......	.......	NFP
25944	1424	6	q.s	q.s	NNP
25944	1424	7	.	.	.
25944	1425	1	ad	ad	NN
25944	1425	2	[	[	-LRB-
25944	1425	3	Oz]iij	Oz]iij	NNP
25944	1425	4	.	.	.
25944	1426	1	M.	M.	NNP
25944	1427	1	SIG.--f[dram]t.d	SIG.--f[dram]t.d	NNP
25944	1427	2	.	.	.
25944	1428	1	Or	or	CC
25944	1428	2	Hunyadi	Hunyadi	NNP
25944	1428	3	Janos	Janos	NNP
25944	1428	4	or	or	CC
25944	1428	5	Friedrichshall	Friedrichshall	NNP
25944	1428	6	water	water	NN
25944	1428	7	may	may	MD
25944	1428	8	be	be	VB
25944	1428	9	employed	employ	VBN
25944	1428	10	for	for	IN
25944	1428	11	a	a	DT
25944	1428	12	laxative	laxative	JJ
25944	1428	13	purpose	purpose	NN
25944	1428	14	.	.	.
25944	1429	1	In	in	IN
25944	1429	2	chlorotic	chlorotic	JJ
25944	1429	3	and	and	CC
25944	1429	4	anæmic	anæmic	JJ
25944	1429	5	cases	case	NNS
25944	1429	6	the	the	DT
25944	1429	7	ferruginous	ferruginous	JJ
25944	1429	8	preparations	preparation	NNS
25944	1429	9	are	be	VBP
25944	1429	10	of	of	IN
25944	1429	11	advantage	advantage	NN
25944	1429	12	.	.	.
25944	1430	1	Cod	cod	VB
25944	1430	2	-	-	HYPH
25944	1430	3	liver	liver	NN
25944	1430	4	oil	oil	NN
25944	1430	5	is	be	VBZ
25944	1430	6	often	often	RB
25944	1430	7	a	a	DT
25944	1430	8	remedy	remedy	NN
25944	1430	9	of	of	IN
25944	1430	10	great	great	JJ
25944	1430	11	value	value	NN
25944	1430	12	,	,	,
25944	1430	13	and	and	CC
25944	1430	14	is	be	VBZ
25944	1430	15	especially	especially	RB
25944	1430	16	useful	useful	JJ
25944	1430	17	in	in	IN
25944	1430	18	strumous	strumous	JJ
25944	1430	19	and	and	CC
25944	1430	20	debilitated	debilitated	JJ
25944	1430	21	subjects	subject	NNS
25944	1430	22	.	.	.
25944	1431	1	Calx	Calx	NNP
25944	1431	2	sulphurata	sulphurata	NNS
25944	1431	3	in	in	IN
25944	1431	4	pill	pill	NN
25944	1431	5	form	form	NN
25944	1431	6	,	,	,
25944	1431	7	one	one	CD
25944	1431	8	-	-	HYPH
25944	1431	9	tenth	tenth	NN
25944	1431	10	to	to	IN
25944	1431	11	one	one	CD
25944	1431	12	-	-	HYPH
25944	1431	13	fourth	fourth	NN
25944	1431	14	grain	grain	NN
25944	1431	15	four	four	CD
25944	1431	16	or	or	CC
25944	1431	17	five	five	CD
25944	1431	18	times	time	NNS
25944	1431	19	daily	daily	RB
25944	1431	20	,	,	,
25944	1431	21	is	be	VBZ
25944	1431	22	said	say	VBN
25944	1431	23	,	,	,
25944	1431	24	acts	act	VBZ
25944	1431	25	well	well	RB
25944	1431	26	in	in	IN
25944	1431	27	the	the	DT
25944	1431	28	pustular	pustular	JJ
25944	1431	29	variety	variety	NN
25944	1431	30	.	.	.
25944	1432	1	In	in	IN
25944	1432	2	some	some	DT
25944	1432	3	instances	instance	NNS
25944	1432	4	,	,	,
25944	1432	5	more	more	RBR
25944	1432	6	particularly	particularly	RB
25944	1432	7	in	in	IN
25944	1432	8	sluggish	sluggish	JJ
25944	1432	9	papular	papular	JJ
25944	1432	10	acne	acne	NNS
25944	1432	11	,	,	,
25944	1432	12	arsenic	arsenic	JJ
25944	1432	13	,	,	,
25944	1432	14	especially	especially	RB
25944	1432	15	the	the	DT
25944	1432	16	sulphide	sulphide	NN
25944	1432	17	of	of	IN
25944	1432	18	arsenic	arsenic	JJ
25944	1432	19	,	,	,
25944	1432	20	acts	act	VBZ
25944	1432	21	favorably	favorably	RB
25944	1432	22	.	.	.
25944	1433	1	Upon	upon	IN
25944	1433	2	the	the	DT
25944	1433	3	whole	whole	NN
25944	1433	4	,	,	,
25944	1433	5	the	the	DT
25944	1433	6	line	line	NN
25944	1433	7	of	of	IN
25944	1433	8	treatment	treatment	NN
25944	1433	9	that	that	WDT
25944	1433	10	keeps	keep	VBZ
25944	1433	11	in	in	IN
25944	1433	12	view	view	NN
25944	1433	13	proper	proper	JJ
25944	1433	14	and	and	CC
25944	1433	15	healthy	healthy	JJ
25944	1433	16	action	action	NN
25944	1433	17	of	of	IN
25944	1433	18	the	the	DT
25944	1433	19	gastro	gastro	JJ
25944	1433	20	-	-	HYPH
25944	1433	21	intestinal	intestinal	JJ
25944	1433	22	canal	canal	NN
25944	1433	23	is	be	VBZ
25944	1433	24	the	the	DT
25944	1433	25	most	most	RBS
25944	1433	26	successful	successful	JJ
25944	1433	27	.	.	.
25944	1434	1	[	[	-LRB-
25944	1434	2	Illustration	illustration	NN
25944	1434	3	:	:	:
25944	1434	4	Acne	Acne	NNS
25944	1434	5	of	of	IN
25944	1434	6	back	back	NN
25944	1434	7	.	.	.
25944	1434	8	]	]	-RRB-
25944	1435	1	In	in	IN
25944	1435	2	inflammatory	inflammatory	JJ
25944	1435	3	cases	case	NNS
25944	1435	4	occurring	occur	VBG
25944	1435	5	in	in	IN
25944	1435	6	robust	robust	JJ
25944	1435	7	individuals	individual	NNS
25944	1435	8	the	the	DT
25944	1435	9	following	follow	VBG
25944	1435	10	is	be	VBZ
25944	1435	11	often	often	RB
25944	1435	12	of	of	IN
25944	1435	13	service:--	service:--	''
25944	1435	14	[	[	-LRB-
25944	1435	15	Rx	Rx	NNP
25944	1435	16	]	]	-RRB-
25944	1435	17	Potassii	Potassii	NNP
25944	1435	18	acetat	acetat	NN
25944	1435	19	.	.	.
25944	1435	20	,	,	,
25944	1435	21	....................	....................	NFP
25944	1435	22	[	[	-LRB-
25944	1435	23	dram]iv	dram]iv	NNP
25944	1435	24	Liq	Liq	NNP
25944	1435	25	.	.	.
25944	1436	1	potassæ	potassæ	NNP
25944	1436	2	,	,	,
25944	1436	3	........................	........................	.
25944	1436	4	f[dram]ij	f[dram]ij	NFP
25944	1436	5	Liq	liq	NN
25944	1436	6	.	.	.
25944	1437	1	ammonii	ammonii	NNP
25944	1437	2	acetat	acetat	NNP
25944	1437	3	.	.	.
25944	1437	4	,	,	,
25944	1437	5	....	....	NFP
25944	1437	6	q.s	q.s	NNP
25944	1437	7	.	.	.
25944	1438	1	ad	ad	NN
25944	1438	2	...	...	:
25944	1438	3	f[Oz]iij	f[Oz]iij	NNP
25944	1438	4	.	.	.
25944	1439	1	M.	M.	NNP
25944	1440	1	SIG.--f[dram]j	SIG.--f[dram]j	NNP
25944	1440	2	-	-	HYPH
25944	1440	3	f[dram]ij	f[dram]ij	NNP
25944	1440	4	t.d	t.d	NNP
25944	1440	5	.	.	NNP
25944	1440	6	,	,	,
25944	1440	7	largely	largely	RB
25944	1440	8	diluted	diluted	JJ
25944	1440	9	.	.	.
25944	1441	1	#	#	NNP
25944	1441	2	State	state	NN
25944	1441	3	the	the	DT
25944	1441	4	character	character	NN
25944	1441	5	of	of	IN
25944	1441	6	the	the	DT
25944	1441	7	local	local	JJ
25944	1441	8	treatment	treatment	NN
25944	1441	9	in	in	IN
25944	1441	10	acne	acne	NNP
25944	1441	11	.	.	.
25944	1441	12	#	#	$
25944	1441	13	This	this	DT
25944	1441	14	must	must	MD
25944	1441	15	vary	vary	VB
25944	1441	16	somewhat	somewhat	RB
25944	1441	17	with	with	IN
25944	1441	18	the	the	DT
25944	1441	19	local	local	JJ
25944	1441	20	conditions	condition	NNS
25944	1441	21	.	.	.
25944	1442	1	Cases	case	NNS
25944	1442	2	which	which	WDT
25944	1442	3	are	be	VBP
25944	1442	4	acute	acute	JJ
25944	1442	5	in	in	IN
25944	1442	6	character	character	NN
25944	1442	7	,	,	,
25944	1442	8	in	in	IN
25944	1442	9	the	the	DT
25944	1442	10	sense	sense	NN
25944	1442	11	that	that	IN
25944	1442	12	the	the	DT
25944	1442	13	lesions	lesion	NNS
25944	1442	14	are	be	VBP
25944	1442	15	markedly	markedly	RB
25944	1442	16	hyperæmic	hyperæmic	JJ
25944	1442	17	,	,	,
25944	1442	18	tender	tender	JJ
25944	1442	19	and	and	CC
25944	1442	20	painful	painful	JJ
25944	1442	21	,	,	,
25944	1442	22	require	require	VB
25944	1442	23	milder	milder	NN
25944	1442	24	applications	application	NNS
25944	1442	25	,	,	,
25944	1442	26	and	and	CC
25944	1442	27	in	in	IN
25944	1442	28	exceptional	exceptional	JJ
25944	1442	29	instances	instance	NNS
25944	1442	30	soothing	soothe	VBG
25944	1442	31	remedies	remedy	NNS
25944	1442	32	are	be	VBP
25944	1442	33	to	to	TO
25944	1442	34	be	be	VB
25944	1442	35	prescribed	prescribe	VBN
25944	1442	36	.	.	.
25944	1443	1	As	as	IN
25944	1443	2	a	a	DT
25944	1443	3	rule	rule	NN
25944	1443	4	,	,	,
25944	1443	5	however	however	RB
25944	1443	6	,	,	,
25944	1443	7	stimulating	stimulating	JJ
25944	1443	8	applications	application	NNS
25944	1443	9	may	may	MD
25944	1443	10	be	be	VB
25944	1443	11	employed	employ	VBN
25944	1443	12	from	from	IN
25944	1443	13	the	the	DT
25944	1443	14	start	start	NN
25944	1443	15	.	.	.
25944	1444	1	The	the	DT
25944	1444	2	remedies	remedy	NNS
25944	1444	3	are	be	VBP
25944	1444	4	,	,	,
25944	1444	5	for	for	IN
25944	1444	6	obvious	obvious	JJ
25944	1444	7	reasons	reason	NNS
25944	1444	8	,	,	,
25944	1444	9	most	most	RBS
25944	1444	10	conveniently	conveniently	RB
25944	1444	11	applied	apply	VBN
25944	1444	12	at	at	IN
25944	1444	13	bedtime	bedtime	NNP
25944	1444	14	.	.	.
25944	1445	1	#	#	JJS
25944	1445	2	What	what	WDT
25944	1445	3	preliminary	preliminary	JJ
25944	1445	4	measures	measure	NNS
25944	1445	5	are	be	VBP
25944	1445	6	to	to	TO
25944	1445	7	be	be	VB
25944	1445	8	advised	advise	VBN
25944	1445	9	in	in	IN
25944	1445	10	ordinary	ordinary	JJ
25944	1445	11	acne	acne	NNS
25944	1445	12	cases	case	NNS
25944	1445	13	?	?	.
25944	1445	14	#	#	$
25944	1445	15	Washing	wash	VBG
25944	1445	16	the	the	DT
25944	1445	17	parts	part	NNS
25944	1445	18	gently	gently	RB
25944	1445	19	or	or	CC
25944	1445	20	vigorously	vigorously	RB
25944	1445	21	,	,	,
25944	1445	22	according	accord	VBG
25944	1445	23	to	to	IN
25944	1445	24	the	the	DT
25944	1445	25	irritability	irritability	NN
25944	1445	26	of	of	IN
25944	1445	27	the	the	DT
25944	1445	28	skin	skin	NN
25944	1445	29	,	,	,
25944	1445	30	with	with	IN
25944	1445	31	warm	warm	JJ
25944	1445	32	water	water	NN
25944	1445	33	and	and	CC
25944	1445	34	soap	soap	NN
25944	1445	35	;	;	,
25944	1445	36	subsequently	subsequently	RB
25944	1445	37	rinsing	rinse	VBG
25944	1445	38	,	,	,
25944	1445	39	and	and	CC
25944	1445	40	sponging	sponge	VBG
25944	1445	41	for	for	IN
25944	1445	42	several	several	JJ
25944	1445	43	minutes	minute	NNS
25944	1445	44	with	with	IN
25944	1445	45	hot	hot	JJ
25944	1445	46	water	water	NN
25944	1445	47	,	,	,
25944	1445	48	and	and	CC
25944	1445	49	rubbing	rub	VBG
25944	1445	50	dry	dry	JJ
25944	1445	51	with	with	IN
25944	1445	52	a	a	DT
25944	1445	53	soft	soft	JJ
25944	1445	54	towel	towel	NN
25944	1445	55	;	;	:
25944	1445	56	after	after	IN
25944	1445	57	which	which	WDT
25944	1445	58	the	the	DT
25944	1445	59	remedial	remedial	JJ
25944	1445	60	application	application	NN
25944	1445	61	is	be	VBZ
25944	1445	62	made	make	VBN
25944	1445	63	.	.	.
25944	1446	1	In	in	IN
25944	1446	2	sluggish	sluggish	JJ
25944	1446	3	and	and	CC
25944	1446	4	non	non	JJ
25944	1446	5	-	-	JJ
25944	1446	6	irritable	irritable	JJ
25944	1446	7	cases	case	NNS
25944	1446	8	sapo	sapo	IN
25944	1446	9	viridis	viridi	NNS
25944	1446	10	or	or	CC
25944	1446	11	its	-PRON-	PRP$
25944	1446	12	tincture	tincture	NN
25944	1446	13	may	may	MD
25944	1446	14	often	often	RB
25944	1446	15	be	be	VB
25944	1446	16	advantageously	advantageously	RB
25944	1446	17	used	use	VBN
25944	1446	18	in	in	IN
25944	1446	19	place	place	NN
25944	1446	20	of	of	IN
25944	1446	21	the	the	DT
25944	1446	22	ordinary	ordinary	JJ
25944	1446	23	toilet	toilet	NN
25944	1446	24	soap	soap	NN
25944	1446	25	.	.	.
25944	1447	1	The	the	DT
25944	1447	2	blackheads	blackhead	NNS
25944	1447	3	,	,	,
25944	1447	4	so	so	RB
25944	1447	5	far	far	RB
25944	1447	6	as	as	IN
25944	1447	7	practicable	practicable	JJ
25944	1447	8	,	,	,
25944	1447	9	are	be	VBP
25944	1447	10	to	to	TO
25944	1447	11	be	be	VB
25944	1447	12	removed	remove	VBN
25944	1447	13	by	by	IN
25944	1447	14	pressure	pressure	NN
25944	1447	15	with	with	IN
25944	1447	16	the	the	DT
25944	1447	17	fingers	finger	NNS
25944	1447	18	or	or	CC
25944	1447	19	with	with	IN
25944	1447	20	a	a	DT
25944	1447	21	suitable	suitable	JJ
25944	1447	22	instrument	instrument	NN
25944	1447	23	(	(	-LRB-
25944	1447	24	see	see	VB
25944	1447	25	Comedo	Comedo	NNP
25944	1447	26	)	)	-RRB-
25944	1447	27	,	,	,
25944	1447	28	and	and	CC
25944	1447	29	the	the	DT
25944	1447	30	superficial	superficial	JJ
25944	1447	31	pustules	pustule	NNS
25944	1447	32	punctured	puncture	VBN
25944	1447	33	and	and	CC
25944	1447	34	the	the	DT
25944	1447	35	contents	content	NNS
25944	1447	36	pressed	press	VBD
25944	1447	37	out	out	RP
25944	1447	38	.	.	.
25944	1448	1	Scraping	scrape	VBG
25944	1448	2	the	the	DT
25944	1448	3	affected	affected	JJ
25944	1448	4	parts	part	NNS
25944	1448	5	with	with	IN
25944	1448	6	a	a	DT
25944	1448	7	blunt	blunt	JJ
25944	1448	8	curette	curette	NN
25944	1448	9	is	be	VBZ
25944	1448	10	a	a	DT
25944	1448	11	valuable	valuable	JJ
25944	1448	12	measure	measure	NN
25944	1448	13	,	,	,
25944	1448	14	but	but	CC
25944	1448	15	is	be	VBZ
25944	1448	16	temporarily	temporarily	RB
25944	1448	17	disfiguring	disfigure	VBG
25944	1448	18	.	.	.
25944	1449	1	As	as	IN
25944	1449	2	a	a	DT
25944	1449	3	rule	rule	NN
25944	1449	4	,	,	,
25944	1449	5	however	however	RB
25944	1449	6	,	,	,
25944	1449	7	cases	case	NNS
25944	1449	8	do	do	VBP
25944	1449	9	just	just	RB
25944	1449	10	as	as	RB
25944	1449	11	well	well	RB
25944	1449	12	without	without	IN
25944	1449	13	puncturing	puncturing	NN
25944	1449	14	and	and	CC
25944	1449	15	scraping	scraping	NN
25944	1449	16	,	,	,
25944	1449	17	and	and	CC
25944	1449	18	these	these	DT
25944	1449	19	methods	method	NNS
25944	1449	20	sometimes	sometimes	RB
25944	1449	21	leave	leave	VBP
25944	1449	22	behind	behind	RB
25944	1449	23	scarring	scar	VBG
25944	1449	24	.	.	.
25944	1450	1	#	#	JJR
25944	1450	2	State	state	NN
25944	1450	3	the	the	DT
25944	1450	4	methods	method	NNS
25944	1450	5	of	of	IN
25944	1450	6	external	external	JJ
25944	1450	7	medication	medication	NN
25944	1450	8	commonly	commonly	RB
25944	1450	9	employed	employ	VBN
25944	1450	10	.	.	.
25944	1450	11	#	#	$
25944	1450	12	By	by	IN
25944	1450	13	ointments	ointment	NNS
25944	1450	14	and	and	CC
25944	1450	15	lotions	lotion	NNS
25944	1450	16	.	.	.
25944	1451	1	If	if	IN
25944	1451	2	an	an	DT
25944	1451	3	ointment	ointment	NN
25944	1451	4	is	be	VBZ
25944	1451	5	used	use	VBN
25944	1451	6	,	,	,
25944	1451	7	it	-PRON-	PRP
25944	1451	8	is	be	VBZ
25944	1451	9	to	to	TO
25944	1451	10	be	be	VB
25944	1451	11	thoroughly	thoroughly	RB
25944	1451	12	rubbed	rub	VBN
25944	1451	13	in	in	IN
25944	1451	14	,	,	,
25944	1451	15	in	in	IN
25944	1451	16	small	small	JJ
25944	1451	17	quantity	quantity	NN
25944	1451	18	;	;	:
25944	1451	19	if	if	IN
25944	1451	20	a	a	DT
25944	1451	21	lotion	lotion	NN
25944	1451	22	is	be	VBZ
25944	1451	23	employed	employ	VBN
25944	1451	24	,	,	,
25944	1451	25	it	-PRON-	PRP
25944	1451	26	is	be	VBZ
25944	1451	27	to	to	TO
25944	1451	28	be	be	VB
25944	1451	29	well	well	RB
25944	1451	30	shaken	shake	VBN
25944	1451	31	,	,	,
25944	1451	32	the	the	DT
25944	1451	33	parts	part	NNS
25944	1451	34	freely	freely	RB
25944	1451	35	dabbed	dab	VBD
25944	1451	36	with	with	IN
25944	1451	37	it	-PRON-	PRP
25944	1451	38	for	for	IN
25944	1451	39	several	several	JJ
25944	1451	40	minutes	minute	NNS
25944	1451	41	and	and	CC
25944	1451	42	then	then	RB
25944	1451	43	allowed	allow	VBN
25944	1451	44	to	to	TO
25944	1451	45	dry	dry	VB
25944	1451	46	on	on	IN
25944	1451	47	.	.	.
25944	1452	1	#	#	JJR
25944	1452	2	State	state	NN
25944	1452	3	the	the	DT
25944	1452	4	object	object	NN
25944	1452	5	in	in	IN
25944	1452	6	view	view	NN
25944	1452	7	in	in	IN
25944	1452	8	local	local	JJ
25944	1452	9	medication	medication	NN
25944	1452	10	.	.	.
25944	1452	11	#	#	$
25944	1452	12	To	to	TO
25944	1452	13	hasten	hasten	VB
25944	1452	14	the	the	DT
25944	1452	15	maturation	maturation	NN
25944	1452	16	and	and	CC
25944	1452	17	disappearance	disappearance	NN
25944	1452	18	of	of	IN
25944	1452	19	the	the	DT
25944	1452	20	existing	exist	VBG
25944	1452	21	lesions	lesion	NNS
25944	1452	22	,	,	,
25944	1452	23	and	and	CC
25944	1452	24	to	to	TO
25944	1452	25	stimulate	stimulate	VB
25944	1452	26	the	the	DT
25944	1452	27	skin	skin	NN
25944	1452	28	and	and	CC
25944	1452	29	glands	gland	VBZ
25944	1452	30	to	to	TO
25944	1452	31	healthy	healthy	JJ
25944	1452	32	action	action	NN
25944	1452	33	.	.	.
25944	1453	1	If	if	IN
25944	1453	2	slight	slight	JJ
25944	1453	3	irritation	irritation	NN
25944	1453	4	or	or	CC
25944	1453	5	scaliness	scaliness	JJ
25944	1453	6	results	result	NNS
25944	1453	7	,	,	,
25944	1453	8	the	the	DT
25944	1453	9	application	application	NN
25944	1453	10	is	be	VBZ
25944	1453	11	to	to	TO
25944	1453	12	be	be	VB
25944	1453	13	intermitted	intermit	VBN
25944	1453	14	one	one	CD
25944	1453	15	or	or	CC
25944	1453	16	two	two	CD
25944	1453	17	nights	night	NNS
25944	1453	18	;	;	:
25944	1453	19	in	in	IN
25944	1453	20	the	the	DT
25944	1453	21	meantime	meantime	NN
25944	1453	22	nothing	nothing	NN
25944	1453	23	except	except	IN
25944	1453	24	the	the	DT
25944	1453	25	hot	hot	JJ
25944	1453	26	-	-	HYPH
25944	1453	27	water	water	NN
25944	1453	28	sponging	sponging	NN
25944	1453	29	,	,	,
25944	1453	30	with	with	IN
25944	1453	31	or	or	CC
25944	1453	32	without	without	IN
25944	1453	33	the	the	DT
25944	1453	34	application	application	NN
25944	1453	35	of	of	IN
25944	1453	36	a	a	DT
25944	1453	37	mild	mild	JJ
25944	1453	38	soothing	soothing	JJ
25944	1453	39	ointment	ointment	NN
25944	1453	40	,	,	,
25944	1453	41	is	be	VBZ
25944	1453	42	to	to	TO
25944	1453	43	be	be	VB
25944	1453	44	employed	employ	VBN
25944	1453	45	.	.	.
25944	1454	1	#	#	$
25944	1454	2	Is	be	VBZ
25944	1454	3	it	-PRON-	PRP
25944	1454	4	usually	usually	RB
25944	1454	5	necessary	necessary	JJ
25944	1454	6	to	to	TO
25944	1454	7	change	change	VB
25944	1454	8	from	from	IN
25944	1454	9	one	one	CD
25944	1454	10	external	external	JJ
25944	1454	11	remedy	remedy	NN
25944	1454	12	to	to	IN
25944	1454	13	another	another	DT
25944	1454	14	in	in	IN
25944	1454	15	the	the	DT
25944	1454	16	course	course	NN
25944	1454	17	of	of	IN
25944	1454	18	treatment	treatment	NN
25944	1454	19	?	?	.
25944	1454	20	#	#	$
25944	1454	21	Yes	yes	UH
25944	1454	22	.	.	.
25944	1455	1	After	after	IN
25944	1455	2	a	a	DT
25944	1455	3	certain	certain	JJ
25944	1455	4	time	time	NN
25944	1455	5	one	one	CD
25944	1455	6	remedy	remedy	NN
25944	1455	7	,	,	,
25944	1455	8	as	as	IN
25944	1455	9	a	a	DT
25944	1455	10	rule	rule	NN
25944	1455	11	,	,	,
25944	1455	12	loses	lose	VBZ
25944	1455	13	its	-PRON-	PRP$
25944	1455	14	effect	effect	NN
25944	1455	15	,	,	,
25944	1455	16	and	and	CC
25944	1455	17	a	a	DT
25944	1455	18	change	change	NN
25944	1455	19	from	from	IN
25944	1455	20	lotion	lotion	NN
25944	1455	21	to	to	IN
25944	1455	22	ointment	ointment	NN
25944	1455	23	or	or	CC
25944	1455	24	the	the	DT
25944	1455	25	reverse	reverse	NN
25944	1455	26	,	,	,
25944	1455	27	and	and	CC
25944	1455	28	from	from	IN
25944	1455	29	one	one	CD
25944	1455	30	lotion	lotion	NN
25944	1455	31	or	or	CC
25944	1455	32	ointment	ointment	NN
25944	1455	33	to	to	IN
25944	1455	34	another	another	DT
25944	1455	35	,	,	,
25944	1455	36	will	will	MD
25944	1455	37	often	often	RB
25944	1455	38	be	be	VB
25944	1455	39	found	find	VBN
25944	1455	40	necessary	necessary	JJ
25944	1455	41	in	in	IN
25944	1455	42	order	order	NN
25944	1455	43	to	to	TO
25944	1455	44	bring	bring	VB
25944	1455	45	about	about	RP
25944	1455	46	continuous	continuous	JJ
25944	1455	47	improvement	improvement	NN
25944	1455	48	.	.	.
25944	1456	1	#	#	$
25944	1456	2	Name	name	VB
25944	1456	3	the	the	DT
25944	1456	4	various	various	JJ
25944	1456	5	important	important	JJ
25944	1456	6	remedies	remedy	NNS
25944	1456	7	and	and	CC
25944	1456	8	combinations	combination	NNS
25944	1456	9	employed	employ	VBN
25944	1456	10	in	in	IN
25944	1456	11	the	the	DT
25944	1456	12	external	external	JJ
25944	1456	13	treatment	treatment	NN
25944	1456	14	of	of	IN
25944	1456	15	acne	acne	NNP
25944	1456	16	.	.	.
25944	1456	17	#	#	NNP
25944	1456	18	Sulphur	Sulphur	NNP
25944	1456	19	is	be	VBZ
25944	1456	20	the	the	DT
25944	1456	21	most	most	RBS
25944	1456	22	valuable	valuable	JJ
25944	1456	23	.	.	.
25944	1457	1	It	-PRON-	PRP
25944	1457	2	may	may	MD
25944	1457	3	often	often	RB
25944	1457	4	be	be	VB
25944	1457	5	applied	apply	VBN
25944	1457	6	with	with	IN
25944	1457	7	benefit	benefit	NN
25944	1457	8	as	as	IN
25944	1457	9	a	a	DT
25944	1457	10	simple	simple	JJ
25944	1457	11	ointment:--	ointment:--	CD
25944	1457	12	[	[	-LRB-
25944	1457	13	Rx	Rx	NNP
25944	1457	14	]	]	-RRB-
25944	1457	15	Sulphur	Sulphur	NNP
25944	1457	16	,	,	,
25944	1457	17	præcip	præcip	NN
25944	1457	18	.	.	.
25944	1457	19	,	,	,
25944	1457	20	....................	....................	NFP
25944	1457	21	[	[	-LRB-
25944	1457	22	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	1457	23	Adipis	Adipis	NNP
25944	1457	24	benz	benz	NN
25944	1457	25	.	.	.
25944	1458	1	Lanolin	lanolin	NN
25944	1458	2	,	,	,
25944	1458	3	............	............	NFP
25944	1458	4	[	[	-LRB-
25944	1458	5	=	=	SYM
25944	1458	6	a][=a	a][=a	CD
25944	1458	7	]	]	-RRB-
25944	1458	8	.......	.......	.
25944	1458	9	[	[	-LRB-
25944	1458	10	dram]ij	dram]ij	NN
25944	1458	11	.	.	.
25944	1459	1	Or	or	CC
25944	1459	2	it	-PRON-	PRP
25944	1459	3	may	may	MD
25944	1459	4	be	be	VB
25944	1459	5	used	use	VBN
25944	1459	6	as	as	IN
25944	1459	7	a	a	DT
25944	1459	8	lotion	lotion	NN
25944	1459	9	,	,	,
25944	1459	10	as	as	IN
25944	1459	11	in	in	IN
25944	1459	12	the	the	DT
25944	1459	13	annexed	annex	VBN
25944	1459	14	formula:--	formula:--	NN
25944	1459	15	[	[	-LRB-
25944	1459	16	Rx	Rx	NNP
25944	1459	17	]	]	-RRB-
25944	1459	18	Sulphur	Sulphur	NNP
25944	1459	19	,	,	,
25944	1459	20	præcip	præcip	NN
25944	1459	21	.	.	.
25944	1459	22	,	,	,
25944	1459	23	....................	....................	NFP
25944	1459	24	[	[	-LRB-
25944	1459	25	dram]iss	dram]iss	NNP
25944	1459	26	Pulv	Pulv	NNP
25944	1459	27	.	.	.
25944	1460	1	tragacanthæ	tragacanthæ	NNP
25944	1460	2	,	,	,
25944	1460	3	...................	...................	NFP
25944	1460	4	gr	gr	NNP
25944	1460	5	.	.	.
25944	1461	1	x1	x1	NNP
25944	1461	2	Pulv	Pulv	NNP
25944	1461	3	.	.	.
25944	1462	1	camphoræ	camphoræ	NNP
25944	1462	2	,	,	,
25944	1462	3	......................	......................	NFP
25944	1462	4	gr	gr	NNP
25944	1462	5	.	.	.
25944	1463	1	xx	xx	IN
25944	1463	2	Liq	Liq	NNP
25944	1463	3	.	.	.
25944	1464	1	calcis	calcis	NNP
25944	1464	2	,	,	,
25944	1464	3	........	........	.
25944	1464	4	q.s	q.s	NNP
25944	1464	5	.	.	.
25944	1465	1	ad	ad	NN
25944	1465	2	........	........	.
25944	1465	3	f[Oz]iv	f[oz]iv	NN
25944	1465	4	.	.	.
25944	1466	1	M.	M.	NNP
25944	1466	2	Another	another	DT
25944	1466	3	lotion	lotion	NN
25944	1466	4	,	,	,
25944	1466	5	especially	especially	RB
25944	1466	6	useful	useful	JJ
25944	1466	7	in	in	IN
25944	1466	8	those	those	DT
25944	1466	9	cases	case	NNS
25944	1466	10	in	in	IN
25944	1466	11	which	which	WDT
25944	1466	12	an	an	DT
25944	1466	13	oily	oily	JJ
25944	1466	14	condition	condition	NN
25944	1466	15	of	of	IN
25944	1466	16	the	the	DT
25944	1466	17	skin	skin	NN
25944	1466	18	is	be	VBZ
25944	1466	19	present	present	JJ
25944	1466	20	,	,	,
25944	1466	21	is	be	VBZ
25944	1466	22	the	the	DT
25944	1466	23	following:--	following:--	NN
25944	1466	24	[	[	-LRB-
25944	1466	25	Rx	Rx	NNP
25944	1466	26	]	]	-RRB-
25944	1466	27	Sulphur	Sulphur	NNP
25944	1466	28	,	,	,
25944	1466	29	præcip	præcip	NN
25944	1466	30	.	.	.
25944	1466	31	,	,	,
25944	1466	32	....................	....................	NFP
25944	1466	33	[	[	-LRB-
25944	1466	34	dram]iss	dram]iss	NNP
25944	1466	35	Etheris	Etheris	NNP
25944	1466	36	,	,	,
25944	1466	37	.............................	.............................	NFP
25944	1466	38	f[dram]iv	f[dram]iv	NFP
25944	1466	39	Alcoholis	Alcoholis	NNP
25944	1466	40	,	,	,
25944	1466	41	...........................	...........................	.
25944	1466	42	f[Oz]iijss	f[oz]iijss	NN
25944	1466	43	.	.	.
25944	1467	1	M.	M.	NNP
25944	1467	2	A	A	NNP
25944	1467	3	compound	compound	NN
25944	1467	4	lotion	lotion	NN
25944	1467	5	containing	contain	VBG
25944	1467	6	sulphur	sulphur	NNP
25944	1467	7	in	in	IN
25944	1467	8	one	one	CD
25944	1467	9	of	of	IN
25944	1467	10	its	-PRON-	PRP$
25944	1467	11	combinations	combination	NNS
25944	1467	12	is	be	VBZ
25944	1467	13	also	also	RB
25944	1467	14	valuable	valuable	JJ
25944	1467	15	in	in	IN
25944	1467	16	many	many	JJ
25944	1467	17	cases:--	cases:--	:
25944	1467	18	[	[	-LRB-
25944	1467	19	Rx	Rx	NNP
25944	1467	20	]	]	-RRB-
25944	1467	21	Zinci	Zinci	NNP
25944	1467	22	sulphatis	sulphatis	NN
25944	1467	23	,	,	,
25944	1467	24	Potassii	Potassii	NNP
25944	1467	25	sulphureti	sulphureti	NN
25944	1467	26	,	,	,
25944	1467	27	....	....	NFP
25944	1467	28	[	[	-LRB-
25944	1467	29	=	=	SYM
25944	1467	30	a][=a	a][=a	CD
25944	1467	31	]	]	-RRB-
25944	1467	32	...	...	.
25944	1467	33	[	[	-LRB-
25944	1467	34	dram]ss-[dram]iv	dram]ss-[dram]iv	NNP
25944	1467	35	Aquæ	Aquæ	NNP
25944	1467	36	,	,	,
25944	1467	37	................................	................................	NFP
25944	1467	38	[	[	-LRB-
25944	1467	39	Oz]iv	oz]iv	NN
25944	1467	40	.	.	.
25944	1468	1	M.	M.	NNP
25944	1468	2	(	(	-LRB-
25944	1468	3	The	the	DT
25944	1468	4	salts	salt	NNS
25944	1468	5	should	should	MD
25944	1468	6	be	be	VB
25944	1468	7	dissolved	dissolve	VBN
25944	1468	8	separately	separately	RB
25944	1468	9	and	and	CC
25944	1468	10	then	then	RB
25944	1468	11	mixed	mixed	JJ
25944	1468	12	;	;	:
25944	1468	13	reaction	reaction	NN
25944	1468	14	takes	take	VBZ
25944	1468	15	place	place	NN
25944	1468	16	and	and	CC
25944	1468	17	the	the	DT
25944	1468	18	resulting	result	VBG
25944	1468	19	lotion	lotion	NN
25944	1468	20	,	,	,
25944	1468	21	when	when	WRB
25944	1468	22	shaken	shake	VBN
25944	1468	23	,	,	,
25944	1468	24	is	be	VBZ
25944	1468	25	milky	milky	NNP
25944	1468	26	in	in	IN
25944	1468	27	appearance	appearance	NN
25944	1468	28	,	,	,
25944	1468	29	and	and	CC
25944	1468	30	free	free	JJ
25944	1468	31	from	from	IN
25944	1468	32	odor	odor	NN
25944	1468	33	;	;	:
25944	1468	34	allowed	allow	VBN
25944	1468	35	to	to	TO
25944	1468	36	stand	stand	VB
25944	1468	37	the	the	DT
25944	1468	38	particles	particle	NNS
25944	1468	39	settle	settle	VB
25944	1468	40	,	,	,
25944	1468	41	the	the	DT
25944	1468	42	sediment	sediment	NN
25944	1468	43	constituting	constitute	VBG
25944	1468	44	about	about	RB
25944	1468	45	one	one	CD
25944	1468	46	-	-	HYPH
25944	1468	47	fourth	fourth	NN
25944	1468	48	to	to	TO
25944	1468	49	three	three	CD
25944	1468	50	-	-	HYPH
25944	1468	51	fourths	fourth	NNS
25944	1468	52	of	of	IN
25944	1468	53	the	the	DT
25944	1468	54	whole	whole	JJ
25944	1468	55	bulk	bulk	NN
25944	1468	56	)	)	-RRB-
25944	1468	57	.	.	.
25944	1469	1	At	at	IN
25944	1469	2	times	time	NNS
25944	1469	3	the	the	DT
25944	1469	4	addition	addition	NN
25944	1469	5	to	to	IN
25944	1469	6	this	this	DT
25944	1469	7	formula	formula	NN
25944	1469	8	of	of	IN
25944	1469	9	several	several	JJ
25944	1469	10	drachms	drachm	NNS
25944	1469	11	of	of	IN
25944	1469	12	alcohol	alcohol	NN
25944	1469	13	and	and	CC
25944	1469	14	of	of	IN
25944	1469	15	five	five	CD
25944	1469	16	to	to	TO
25944	1469	17	ten	ten	CD
25944	1469	18	minims	minim	NNS
25944	1469	19	of	of	IN
25944	1469	20	glycerin	glycerin	NN
25944	1469	21	is	be	VBZ
25944	1469	22	of	of	IN
25944	1469	23	advantage	advantage	NN
25944	1469	24	.	.	.
25944	1470	1	An	an	DT
25944	1470	2	external	external	JJ
25944	1470	3	remedy	remedy	NN
25944	1470	4	,	,	,
25944	1470	5	often	often	RB
25944	1470	6	valuable	valuable	JJ
25944	1470	7	,	,	,
25944	1470	8	is	be	VBZ
25944	1470	9	ichthyol	ichthyol	JJ
25944	1470	10	.	.	.
25944	1471	1	It	-PRON-	PRP
25944	1471	2	is	be	VBZ
25944	1471	3	thus	thus	RB
25944	1471	4	prescribed:--	prescribed:--	CD
25944	1471	5	[	[	-LRB-
25944	1471	6	Rx	Rx	NNP
25944	1471	7	]	]	-RRB-
25944	1471	8	Ichthyol	Ichthyol	NNP
25944	1471	9	,	,	,
25944	1471	10	............................	............................	NFP
25944	1471	11	[	[	-LRB-
25944	1471	12	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	1471	13	Cerat	Cerat	NNP
25944	1471	14	.	.	.
25944	1472	1	simp	simp	NNP
25944	1472	2	.	.	.
25944	1472	3	,	,	,
25944	1472	4	........................	........................	NFP
25944	1472	5	[	[	-LRB-
25944	1472	6	dram]iv	dram]iv	NNS
25944	1472	7	.	.	.
25944	1473	1	M.	M.	NNP
25944	1473	2	The	the	DT
25944	1473	3	various	various	JJ
25944	1473	4	mercurial	mercurial	JJ
25944	1473	5	ointments	ointment	NNS
25944	1473	6	,	,	,
25944	1473	7	especially	especially	RB
25944	1473	8	one	one	CD
25944	1473	9	of	of	IN
25944	1473	10	white	white	JJ
25944	1473	11	precipitate	precipitate	NN
25944	1473	12	,	,	,
25944	1473	13	five	five	CD
25944	1473	14	to	to	TO
25944	1473	15	fifteen	fifteen	CD
25944	1473	16	per	per	IN
25944	1473	17	cent	cent	NN
25944	1473	18	.	.	.
25944	1474	1	strength	strength	NN
25944	1474	2	,	,	,
25944	1474	3	are	be	VBP
25944	1474	4	sometimes	sometimes	RB
25944	1474	5	beneficial	beneficial	JJ
25944	1474	6	.	.	.
25944	1475	1	A	a	DT
25944	1475	2	compound	compound	NN
25944	1475	3	lotion	lotion	NN
25944	1475	4	,	,	,
25944	1475	5	containing	contain	VBG
25944	1475	6	mercury	mercury	NN
25944	1475	7	,	,	,
25944	1475	8	which	which	WDT
25944	1475	9	frequently	frequently	RB
25944	1475	10	proves	prove	VBZ
25944	1475	11	serviceable	serviceable	JJ
25944	1475	12	,	,	,
25944	1475	13	is:--	is:--	ADD
25944	1475	14	[	[	-LRB-
25944	1475	15	Rx	Rx	NNP
25944	1475	16	]	]	-RRB-
25944	1475	17	Hydrarg	Hydrarg	NNP
25944	1475	18	.	.	.
25944	1476	1	chlorid	chlorid	NNP
25944	1476	2	.	.	.
25944	1477	1	corros	corros	NNP
25944	1477	2	.	.	NNP
25944	1477	3	,	,	,
25944	1477	4	...........	...........	NFP
25944	1477	5	gr	gr	NNP
25944	1477	6	.	.	.
25944	1478	1	ii	ii	LS
25944	1478	2	-	-	HYPH
25944	1478	3	viij	viij	NN
25944	1478	4	Zinci	Zinci	NNP
25944	1478	5	sulphatis	sulphatis	NN
25944	1478	6	,	,	,
25944	1478	7	.....................	.....................	NFP
25944	1478	8	gr	gr	NNP
25944	1478	9	.	.	.
25944	1479	1	x	x	LS
25944	1479	2	-	-	:
25944	1479	3	xx	xx	NNP
25944	1479	4	Tinct	Tinct	NNP
25944	1479	5	.	.	.
25944	1480	1	benzoini	benzoini	NNP
25944	1480	2	,	,	,
25944	1480	3	.....................	.....................	.
25944	1480	4	f[dram]ij	f[dram]ij	NNP
25944	1480	5	Aquæ	Aquæ	NNP
25944	1480	6	,	,	,
25944	1480	7	............	............	NFP
25944	1480	8	q.s	q.s	NNP
25944	1480	9	.	.	.
25944	1481	1	ad	ad	NN
25944	1481	2	...........	...........	.
25944	1481	3	f[Oz]iv	f[oz]iv	NN
25944	1481	4	.	.	.
25944	1482	1	In	in	IN
25944	1482	2	extremely	extremely	RB
25944	1482	3	sluggish	sluggish	JJ
25944	1482	4	cases	case	NNS
25944	1482	5	the	the	DT
25944	1482	6	following	following	NN
25944	1482	7	,	,	,
25944	1482	8	used	use	VBN
25944	1482	9	cautiously	cautiously	RB
25944	1482	10	,	,	,
25944	1482	11	is	be	VBZ
25944	1482	12	of	of	IN
25944	1482	13	value:--	value:--	.
25944	1482	14	[	[	-LRB-
25944	1482	15	Rx	Rx	NNP
25944	1482	16	]	]	-RRB-
25944	1482	17	Ichthyol	Ichthyol	NNP
25944	1482	18	,	,	,
25944	1482	19	Saponis	Saponis	NNP
25944	1482	20	viridis	viridis	NN
25944	1482	21	,	,	,
25944	1482	22	Sulphur	Sulphur	NNP
25944	1482	23	,	,	,
25944	1482	24	præcip	præcip	NN
25944	1482	25	.	.	.
25944	1482	26	,	,	,
25944	1482	27	Lanolin	Lanolin	NNP
25944	1482	28	,	,	,
25944	1482	29	.............	.............	NFP
25944	1482	30	[	[	-LRB-
25944	1482	31	=	=	SYM
25944	1482	32	a][=a	a][=a	CD
25944	1482	33	]	]	-RRB-
25944	1482	34	......	......	NFP
25944	1482	35	[	[	-LRB-
25944	1482	36	dram]j	dram]j	NNP
25944	1482	37	.	.	.
25944	1483	1	In	in	IN
25944	1483	2	such	such	JJ
25944	1483	3	instances	instance	NNS
25944	1483	4	the	the	DT
25944	1483	5	application	application	NN
25944	1483	6	of	of	IN
25944	1483	7	a	a	DT
25944	1483	8	strong	strong	JJ
25944	1483	9	alcoholic	alcoholic	JJ
25944	1483	10	resorcin	resorcin	NNS
25944	1483	11	lotion	lotion	NN
25944	1483	12	,	,	,
25944	1483	13	ten	ten	CD
25944	1483	14	to	to	TO
25944	1483	15	twenty	twenty	CD
25944	1483	16	-	-	HYPH
25944	1483	17	five	five	CD
25944	1483	18	per	per	IN
25944	1483	19	cent	cent	NN
25944	1483	20	.	.	.
25944	1484	1	strength	strength	NN
25944	1484	2	,	,	,
25944	1484	3	repeated	repeat	VBD
25944	1484	4	several	several	JJ
25944	1484	5	times	time	NNS
25944	1484	6	daily	daily	RB
25944	1484	7	till	till	IN
25944	1484	8	marked	mark	VBN
25944	1484	9	irritation	irritation	NN
25944	1484	10	and	and	CC
25944	1484	11	exfoliation	exfoliation	NN
25944	1484	12	occur	occur	VBP
25944	1484	13	(	(	-LRB-
25944	1484	14	a	a	DT
25944	1484	15	matter	matter	NN
25944	1484	16	usually	usually	RB
25944	1484	17	of	of	IN
25944	1484	18	one	one	CD
25944	1484	19	to	to	TO
25944	1484	20	three	three	CD
25944	1484	21	days	day	NNS
25944	1484	22	)	)	-RRB-
25944	1484	23	,	,	,
25944	1484	24	will	will	MD
25944	1484	25	sometimes	sometimes	RB
25944	1484	26	be	be	VB
25944	1484	27	followed	follow	VBN
25944	1484	28	by	by	IN
25944	1484	29	marked	mark	VBN
25944	1484	30	improvement	improvement	NN
25944	1484	31	.	.	.
25944	1485	1	Acne	Acne	NNS
25944	1485	2	of	of	IN
25944	1485	3	the	the	DT
25944	1485	4	back	back	NN
25944	1485	5	is	be	VBZ
25944	1485	6	treated	treat	VBN
25944	1485	7	with	with	IN
25944	1485	8	the	the	DT
25944	1485	9	same	same	JJ
25944	1485	10	applications	application	NNS
25944	1485	11	,	,	,
25944	1485	12	but	but	CC
25944	1485	13	usually	usually	RB
25944	1485	14	stronger	strong	JJR
25944	1485	15	;	;	,
25944	1485	16	in	in	IN
25944	1485	17	this	this	DT
25944	1485	18	region	region	NN
25944	1485	19	applications	application	NNS
25944	1485	20	of	of	IN
25944	1485	21	Vleminckx	Vleminckx	NNP
25944	1485	22	's	's	POS
25944	1485	23	solution	solution	NN
25944	1485	24	and	and	CC
25944	1485	25	formaldehyde	formaldehyde	NN
25944	1485	26	solution	solution	NN
25944	1485	27	,	,	,
25944	1485	28	weakened	weaken	VBD
25944	1485	29	considerably	considerably	RB
25944	1485	30	,	,	,
25944	1485	31	at	at	IN
25944	1485	32	first	first	RB
25944	1485	33	at	at	IN
25944	1485	34	least	least	JJS
25944	1485	35	,	,	,
25944	1485	36	prove	prove	NN
25944	1485	37	of	of	IN
25944	1485	38	value	value	NN
25944	1485	39	.	.	.
25944	1486	1	_	_	NNP
25944	1486	2	Obstinate	Obstinate	NNP
25944	1486	3	and	and	CC
25944	1486	4	indurated	indurate	VBD
25944	1486	5	lesions	lesion	NNS
25944	1486	6	_	_	NNP
25944	1486	7	may	may	MD
25944	1486	8	be	be	VB
25944	1486	9	incised	incise	VBN
25944	1486	10	,	,	,
25944	1486	11	the	the	DT
25944	1486	12	contents	content	NNS
25944	1486	13	pressed	press	VBD
25944	1486	14	out	out	RP
25944	1486	15	,	,	,
25944	1486	16	and	and	CC
25944	1486	17	the	the	DT
25944	1486	18	interior	interior	NNP
25944	1486	19	touched	touch	VBN
25944	1486	20	with	with	IN
25944	1486	21	carbolic	carbolic	JJ
25944	1486	22	acid	acid	NN
25944	1486	23	by	by	IN
25944	1486	24	means	mean	NNS
25944	1486	25	of	of	IN
25944	1486	26	a	a	DT
25944	1486	27	pointed	pointed	JJ
25944	1486	28	stick	stick	NN
25944	1486	29	.	.	.
25944	1487	1	The	the	DT
25944	1487	2	_	_	NNP
25944	1487	3	x_-ray	x_-ray	NN
25944	1487	4	has	have	VBZ
25944	1487	5	proved	prove	VBN
25944	1487	6	a	a	DT
25944	1487	7	most	most	RBS
25944	1487	8	valuable	valuable	JJ
25944	1487	9	addition	addition	NN
25944	1487	10	to	to	IN
25944	1487	11	our	-PRON-	PRP$
25944	1487	12	resources	resource	NNS
25944	1487	13	in	in	IN
25944	1487	14	the	the	DT
25944	1487	15	treatment	treatment	NN
25944	1487	16	of	of	IN
25944	1487	17	acne	acne	NNP
25944	1487	18	,	,	,
25944	1487	19	and	and	CC
25944	1487	20	is	be	VBZ
25944	1487	21	especially	especially	RB
25944	1487	22	serviceable	serviceable	JJ
25944	1487	23	in	in	IN
25944	1487	24	extensive	extensive	JJ
25944	1487	25	and	and	CC
25944	1487	26	obstinate	obstinate	JJ
25944	1487	27	cases	case	NNS
25944	1487	28	.	.	.
25944	1488	1	An	an	DT
25944	1488	2	exposure	exposure	NN
25944	1488	3	should	should	MD
25944	1488	4	be	be	VB
25944	1488	5	made	make	VBN
25944	1488	6	about	about	IN
25944	1488	7	twice	twice	RB
25944	1488	8	weekly	weekly	JJ
25944	1488	9	,	,	,
25944	1488	10	at	at	IN
25944	1488	11	a	a	DT
25944	1488	12	distance	distance	NN
25944	1488	13	of	of	IN
25944	1488	14	five	five	CD
25944	1488	15	to	to	TO
25944	1488	16	ten	ten	CD
25944	1488	17	inches	inch	NNS
25944	1488	18	and	and	CC
25944	1488	19	for	for	IN
25944	1488	20	from	from	IN
25944	1488	21	three	three	CD
25944	1488	22	to	to	TO
25944	1488	23	ten	ten	CD
25944	1488	24	minutes	minute	NNS
25944	1488	25	,	,	,
25944	1488	26	and	and	CC
25944	1488	27	a	a	DT
25944	1488	28	tube	tube	NN
25944	1488	29	of	of	IN
25944	1488	30	medium	medium	JJ
25944	1488	31	vacuum	vacuum	NN
25944	1488	32	used	use	VBN
25944	1488	33	.	.	.
25944	1489	1	It	-PRON-	PRP
25944	1489	2	must	must	MD
25944	1489	3	be	be	VB
25944	1489	4	used	use	VBN
25944	1489	5	with	with	IN
25944	1489	6	great	great	JJ
25944	1489	7	caution	caution	NN
25944	1489	8	and	and	CC
25944	1489	9	never	never	RB
25944	1489	10	beyond	beyond	IN
25944	1489	11	the	the	DT
25944	1489	12	production	production	NN
25944	1489	13	of	of	IN
25944	1489	14	the	the	DT
25944	1489	15	mildest	mild	JJS
25944	1489	16	erythema	erythema	NN
25944	1489	17	.	.	.
25944	1490	1	The	the	DT
25944	1490	2	hair	hair	NN
25944	1490	3	,	,	,
25944	1490	4	eyes	eye	NNS
25944	1490	5	,	,	,
25944	1490	6	and	and	CC
25944	1490	7	lips	lip	NNS
25944	1490	8	should	should	MD
25944	1490	9	be	be	VB
25944	1490	10	protected	protect	VBN
25944	1490	11	.	.	.
25944	1491	1	The	the	DT
25944	1491	2	_	_	NNP
25944	1491	3	x_-ray	x_-ray	NN
25944	1491	4	treatment	treatment	NN
25944	1491	5	is	be	VBZ
25944	1491	6	best	well	RBS
25944	1491	7	reserved	reserved	JJ
25944	1491	8	for	for	IN
25944	1491	9	obstinate	obstinate	NN
25944	1491	10	cases	case	NNS
25944	1491	11	,	,	,
25944	1491	12	and	and	CC
25944	1491	13	then	then	RB
25944	1491	14	used	use	VBD
25944	1491	15	mildly	mildly	RB
25944	1491	16	,	,	,
25944	1491	17	and	and	CC
25944	1491	18	rather	rather	RB
25944	1491	19	as	as	IN
25944	1491	20	an	an	DT
25944	1491	21	adjuvant	adjuvant	NN
25944	1491	22	to	to	IN
25944	1491	23	the	the	DT
25944	1491	24	ordinary	ordinary	JJ
25944	1491	25	methods	method	NNS
25944	1491	26	than	than	IN
25944	1491	27	as	as	IN
25944	1491	28	the	the	DT
25944	1491	29	sole	sole	JJ
25944	1491	30	measure	measure	NN
25944	1491	31	.	.	.
25944	1492	1	#	#	$
25944	1492	2	What	what	WDT
25944	1492	3	precaution	precaution	NN
25944	1492	4	is	be	VBZ
25944	1492	5	to	to	TO
25944	1492	6	be	be	VB
25944	1492	7	taken	take	VBN
25944	1492	8	in	in	IN
25944	1492	9	advising	advise	VBG
25944	1492	10	a	a	DT
25944	1492	11	change	change	NN
25944	1492	12	from	from	IN
25944	1492	13	a	a	DT
25944	1492	14	sulphur	sulphur	NN
25944	1492	15	to	to	IN
25944	1492	16	a	a	DT
25944	1492	17	mercurial	mercurial	JJ
25944	1492	18	preparation	preparation	NN
25944	1492	19	or	or	CC
25944	1492	20	the	the	DT
25944	1492	21	reverse	reverse	NN
25944	1492	22	?	?	.
25944	1492	23	#	#	$
25944	1492	24	Several	several	JJ
25944	1492	25	days	day	NNS
25944	1492	26	should	should	MD
25944	1492	27	be	be	VB
25944	1492	28	allowed	allow	VBN
25944	1492	29	to	to	TO
25944	1492	30	intervene	intervene	VB
25944	1492	31	,	,	,
25944	1492	32	otherwise	otherwise	RB
25944	1492	33	a	a	DT
25944	1492	34	disagreeable	disagreeable	NN
25944	1492	35	,	,	,
25944	1492	36	although	although	IN
25944	1492	37	temporary	temporary	JJ
25944	1492	38	,	,	,
25944	1492	39	staining	stain	VBG
25944	1492	40	or	or	CC
25944	1492	41	darkening	darken	VBG
25944	1492	42	of	of	IN
25944	1492	43	the	the	DT
25944	1492	44	skin	skin	NN
25944	1492	45	results	result	NNS
25944	1492	46	--	--	:
25944	1492	47	from	from	IN
25944	1492	48	the	the	DT
25944	1492	49	formation	formation	NN
25944	1492	50	of	of	IN
25944	1492	51	the	the	DT
25944	1492	52	black	black	JJ
25944	1492	53	sulphuret	sulphuret	NN
25944	1492	54	of	of	IN
25944	1492	55	mercury	mercury	NNP
25944	1492	56	.	.	.
25944	1493	1	#	#	NNP
25944	1493	2	Acne	Acne	NNP
25944	1493	3	Rosacea	Rosacea	NNP
25944	1493	4	.	.	.
25944	1493	5	#	#	$
25944	1493	6	#	#	$
25944	1493	7	Give	give	VB
25944	1493	8	a	a	DT
25944	1493	9	descriptive	descriptive	JJ
25944	1493	10	definition	definition	NN
25944	1493	11	of	of	IN
25944	1493	12	acne	acne	NNP
25944	1493	13	rosacea	rosacea	NNP
25944	1493	14	.	.	.
25944	1493	15	#	#	$
25944	1493	16	Acne	Acne	NNP
25944	1493	17	rosacea	rosacea	NNP
25944	1493	18	is	be	VBZ
25944	1493	19	a	a	DT
25944	1493	20	chronic	chronic	JJ
25944	1493	21	,	,	,
25944	1493	22	hyperæmic	hyperæmic	JJ
25944	1493	23	or	or	CC
25944	1493	24	inflammatory	inflammatory	JJ
25944	1493	25	disease	disease	NN
25944	1493	26	,	,	,
25944	1493	27	limited	limit	VBN
25944	1493	28	to	to	IN
25944	1493	29	the	the	DT
25944	1493	30	face	face	NN
25944	1493	31	,	,	,
25944	1493	32	especially	especially	RB
25944	1493	33	to	to	IN
25944	1493	34	the	the	DT
25944	1493	35	nose	nose	NN
25944	1493	36	and	and	CC
25944	1493	37	cheeks	cheek	NNS
25944	1493	38	,	,	,
25944	1493	39	characterized	characterize	VBN
25944	1493	40	by	by	IN
25944	1493	41	redness	redness	NN
25944	1493	42	,	,	,
25944	1493	43	dilatation	dilatation	NN
25944	1493	44	and	and	CC
25944	1493	45	enlargement	enlargement	NN
25944	1493	46	of	of	IN
25944	1493	47	the	the	DT
25944	1493	48	bloodvessels	bloodvessel	NNS
25944	1493	49	,	,	,
25944	1493	50	more	more	RBR
25944	1493	51	or	or	CC
25944	1493	52	less	less	JJR
25944	1493	53	acne	acne	NNP
25944	1493	54	and	and	CC
25944	1493	55	hypertrophy	hypertrophy	NN
25944	1493	56	.	.	.
25944	1494	1	#	#	NNP
25944	1494	2	Describe	describe	VB
25944	1494	3	the	the	DT
25944	1494	4	symptoms	symptom	NNS
25944	1494	5	of	of	IN
25944	1494	6	acne	acne	NNP
25944	1494	7	rosacea	rosacea	NNP
25944	1494	8	.	.	.
25944	1494	9	#	#	$
25944	1494	10	The	the	DT
25944	1494	11	disease	disease	NN
25944	1494	12	may	may	MD
25944	1494	13	be	be	VB
25944	1494	14	slight	slight	JJ
25944	1494	15	or	or	CC
25944	1494	16	well	well	RB
25944	1494	17	-	-	HYPH
25944	1494	18	marked	mark	VBN
25944	1494	19	.	.	.
25944	1495	1	Redness	redness	JJ
25944	1495	2	,	,	,
25944	1495	3	capillary	capillary	JJ
25944	1495	4	dilatation	dilatation	NN
25944	1495	5	,	,	,
25944	1495	6	and	and	CC
25944	1495	7	acne	acne	NNP
25944	1495	8	lesions	lesion	NNS
25944	1495	9	seated	seat	VBN
25944	1495	10	on	on	IN
25944	1495	11	the	the	DT
25944	1495	12	nose	nose	NN
25944	1495	13	and	and	CC
25944	1495	14	cheeks	cheek	NNS
25944	1495	15	,	,	,
25944	1495	16	and	and	CC
25944	1495	17	sometimes	sometimes	RB
25944	1495	18	on	on	IN
25944	1495	19	chin	chin	NN
25944	1495	20	and	and	CC
25944	1495	21	forehead	forehead	NNP
25944	1495	22	also	also	RB
25944	1495	23	,	,	,
25944	1495	24	constitute	constitute	VB
25944	1495	25	in	in	IN
25944	1495	26	most	most	JJS
25944	1495	27	cases	case	NNS
25944	1495	28	the	the	DT
25944	1495	29	entire	entire	JJ
25944	1495	30	symptomatology	symptomatology	NN
25944	1495	31	.	.	.
25944	1496	1	A	a	DT
25944	1496	2	mild	mild	JJ
25944	1496	3	variety	variety	NN
25944	1496	4	consists	consist	VBZ
25944	1496	5	in	in	IN
25944	1496	6	simple	simple	JJ
25944	1496	7	redness	redness	NN
25944	1496	8	or	or	CC
25944	1496	9	hyperæmia	hyperæmia	NN
25944	1496	10	,	,	,
25944	1496	11	involving	involve	VBG
25944	1496	12	the	the	DT
25944	1496	13	nose	nose	NN
25944	1496	14	chiefly	chiefly	RB
25944	1496	15	and	and	CC
25944	1496	16	often	often	RB
25944	1496	17	exclusively	exclusively	RB
25944	1496	18	,	,	,
25944	1496	19	and	and	CC
25944	1496	20	is	be	VBZ
25944	1496	21	to	to	TO
25944	1496	22	be	be	VB
25944	1496	23	looked	look	VBN
25944	1496	24	upon	upon	IN
25944	1496	25	as	as	IN
25944	1496	26	a	a	DT
25944	1496	27	passive	passive	JJ
25944	1496	28	congestion	congestion	NN
25944	1496	29	;	;	:
25944	1496	30	this	this	DT
25944	1496	31	is	be	VBZ
25944	1496	32	not	not	RB
25944	1496	33	uncommon	uncommon	JJ
25944	1496	34	in	in	IN
25944	1496	35	young	young	JJ
25944	1496	36	adults	adult	NNS
25944	1496	37	and	and	CC
25944	1496	38	is	be	VBZ
25944	1496	39	often	often	RB
25944	1496	40	associated	associate	VBN
25944	1496	41	with	with	IN
25944	1496	42	an	an	DT
25944	1496	43	oily	oily	JJ
25944	1496	44	seborrh[oe]a	seborrh[oe]a	NN
25944	1496	45	of	of	IN
25944	1496	46	the	the	DT
25944	1496	47	same	same	JJ
25944	1496	48	parts	part	NNS
25944	1496	49	.	.	.
25944	1497	1	In	in	IN
25944	1497	2	many	many	JJ
25944	1497	3	cases	case	NNS
25944	1497	4	the	the	DT
25944	1497	5	condition	condition	NN
25944	1497	6	does	do	VBZ
25944	1497	7	not	not	RB
25944	1497	8	progress	progress	VB
25944	1497	9	beyond	beyond	IN
25944	1497	10	this	this	DT
25944	1497	11	stage	stage	NN
25944	1497	12	.	.	.
25944	1498	1	In	in	IN
25944	1498	2	other	other	JJ
25944	1498	3	cases	case	NNS
25944	1498	4	,	,	,
25944	1498	5	however	however	RB
25944	1498	6	,	,	,
25944	1498	7	sooner	soon	RBR
25944	1498	8	or	or	CC
25944	1498	9	later	later	RBR
25944	1498	10	the	the	DT
25944	1498	11	dilated	dilate	VBN
25944	1498	12	capillaries	capillary	NNS
25944	1498	13	become	become	VBP
25944	1498	14	permanently	permanently	RB
25944	1498	15	enlarged	enlarged	JJ
25944	1498	16	(	(	-LRB-
25944	1498	17	_	_	NNP
25944	1498	18	telangiectasis	telangiectasis	NN
25944	1498	19	_	_	NNP
25944	1498	20	)	)	-RRB-
25944	1498	21	and	and	CC
25944	1498	22	acne	acne	NNP
25944	1498	23	lesions	lesion	NNS
25944	1498	24	are	be	VBP
25944	1498	25	often	often	RB
25944	1498	26	present	present	JJ
25944	1498	27	--	--	:
25944	1498	28	constituting	constitute	VBG
25944	1498	29	the	the	DT
25944	1498	30	middle	middle	JJ
25944	1498	31	stage	stage	NN
25944	1498	32	or	or	CC
25944	1498	33	grade	grade	NN
25944	1498	34	of	of	IN
25944	1498	35	the	the	DT
25944	1498	36	disease	disease	NN
25944	1498	37	;	;	:
25944	1498	38	this	this	DT
25944	1498	39	is	be	VBZ
25944	1498	40	the	the	DT
25944	1498	41	type	type	NN
25944	1498	42	most	most	RBS
25944	1498	43	frequently	frequently	RB
25944	1498	44	met	meet	VBD
25944	1498	45	with	with	IN
25944	1498	46	.	.	.
25944	1499	1	In	in	IN
25944	1499	2	exceptional	exceptional	JJ
25944	1499	3	instances	instance	NNS
25944	1499	4	,	,	,
25944	1499	5	still	still	RB
25944	1499	6	further	further	JJ
25944	1499	7	hypertrophy	hypertrophy	NN
25944	1499	8	of	of	IN
25944	1499	9	the	the	DT
25944	1499	10	bloodvessels	bloodvessel	NNS
25944	1499	11	ensues	ensue	NNS
25944	1499	12	,	,	,
25944	1499	13	the	the	DT
25944	1499	14	glands	gland	NNS
25944	1499	15	are	be	VBP
25944	1499	16	enlarged	enlarge	VBN
25944	1499	17	,	,	,
25944	1499	18	and	and	CC
25944	1499	19	a	a	DT
25944	1499	20	variable	variable	JJ
25944	1499	21	degree	degree	NN
25944	1499	22	of	of	IN
25944	1499	23	connective	connective	JJ
25944	1499	24	-	-	HYPH
25944	1499	25	tissue	tissue	NN
25944	1499	26	new	new	JJ
25944	1499	27	growth	growth	NN
25944	1499	28	is	be	VBZ
25944	1499	29	added	add	VBN
25944	1499	30	;	;	:
25944	1499	31	this	this	DT
25944	1499	32	latter	latter	NN
25944	1499	33	is	be	VBZ
25944	1499	34	usually	usually	RB
25944	1499	35	slight	slight	JJ
25944	1499	36	,	,	,
25944	1499	37	but	but	CC
25944	1499	38	may	may	MD
25944	1499	39	be	be	VB
25944	1499	40	excessive	excessive	JJ
25944	1499	41	,	,	,
25944	1499	42	the	the	DT
25944	1499	43	nose	nose	NN
25944	1499	44	presenting	present	VBG
25944	1499	45	an	an	DT
25944	1499	46	enlarged	enlarge	VBN
25944	1499	47	and	and	CC
25944	1499	48	lobulated	lobulate	VBN
25944	1499	49	appearance	appearance	NN
25944	1499	50	(	(	-LRB-
25944	1499	51	_	_	NNP
25944	1499	52	rhinophyma	rhinophyma	NN
25944	1499	53	_	_	NNP
25944	1499	54	)	)	-RRB-
25944	1499	55	.	.	.
25944	1500	1	[	[	-LRB-
25944	1500	2	Illustration	illustration	NN
25944	1500	3	:	:	:
25944	1500	4	Fig	Fig	NNP
25944	1500	5	.	.	.
25944	1501	1	25	25	CD
25944	1501	2	.	.	.
25944	1502	1	Acne	Acne	NNP
25944	1502	2	Rosacea	Rosacea	NNP
25944	1502	3	.	.	.
25944	1502	4	]	]	-RRB-
25944	1503	1	#	#	NN
25944	1503	2	Are	be	VBP
25944	1503	3	there	there	EX
25944	1503	4	any	any	DT
25944	1503	5	subjective	subjective	JJ
25944	1503	6	symptoms	symptom	NNS
25944	1503	7	in	in	IN
25944	1503	8	acne	acne	NNP
25944	1503	9	rosacea	rosacea	NNP
25944	1503	10	?	?	.
25944	1503	11	#	#	NN
25944	1503	12	As	as	IN
25944	1503	13	a	a	DT
25944	1503	14	rule	rule	NN
25944	1503	15	,	,	,
25944	1503	16	no	no	UH
25944	1503	17	.	.	.
25944	1504	1	Some	some	DT
25944	1504	2	of	of	IN
25944	1504	3	the	the	DT
25944	1504	4	acne	acne	NNP
25944	1504	5	lesions	lesion	NNS
25944	1504	6	may	may	MD
25944	1504	7	be	be	VB
25944	1504	8	tender	tender	JJ
25944	1504	9	and	and	CC
25944	1504	10	painful	painful	JJ
25944	1504	11	,	,	,
25944	1504	12	and	and	CC
25944	1504	13	at	at	IN
25944	1504	14	times	time	NNS
25944	1504	15	there	there	EX
25944	1504	16	is	be	VBZ
25944	1504	17	a	a	DT
25944	1504	18	feeling	feeling	NN
25944	1504	19	of	of	IN
25944	1504	20	heat	heat	NN
25944	1504	21	and	and	CC
25944	1504	22	burning	burn	VBG
25944	1504	23	.	.	.
25944	1505	1	#	#	LS
25944	1505	2	What	what	WP
25944	1505	3	do	do	VBP
25944	1505	4	you	-PRON-	PRP
25944	1505	5	know	know	VB
25944	1505	6	in	in	IN
25944	1505	7	regard	regard	NN
25944	1505	8	to	to	IN
25944	1505	9	the	the	DT
25944	1505	10	etiology	etiology	NN
25944	1505	11	?	?	.
25944	1505	12	#	#	$
25944	1505	13	In	in	IN
25944	1505	14	many	many	JJ
25944	1505	15	cases	case	NNS
25944	1505	16	the	the	DT
25944	1505	17	causes	cause	NNS
25944	1505	18	are	be	VBP
25944	1505	19	obscure	obscure	JJ
25944	1505	20	.	.	.
25944	1506	1	Chronic	chronic	JJ
25944	1506	2	digestive	digestive	JJ
25944	1506	3	and	and	CC
25944	1506	4	intestinal	intestinal	JJ
25944	1506	5	disorders	disorder	NNS
25944	1506	6	,	,	,
25944	1506	7	anæmia	anæmia	NN
25944	1506	8	,	,	,
25944	1506	9	chlorosis	chlorosis	NN
25944	1506	10	,	,	,
25944	1506	11	continued	continue	VBN
25944	1506	12	exposure	exposure	NN
25944	1506	13	to	to	TO
25944	1506	14	heat	heat	VB
25944	1506	15	or	or	CC
25944	1506	16	cold	cold	JJ
25944	1506	17	,	,	,
25944	1506	18	menstrual	menstrual	JJ
25944	1506	19	and	and	CC
25944	1506	20	uterine	uterine	JJ
25944	1506	21	irregularities	irregularity	NNS
25944	1506	22	,	,	,
25944	1506	23	and	and	CC
25944	1506	24	the	the	DT
25944	1506	25	too	too	RB
25944	1506	26	free	free	JJ
25944	1506	27	use	use	NN
25944	1506	28	of	of	IN
25944	1506	29	spirituous	spirituous	JJ
25944	1506	30	liquors	liquor	NNS
25944	1506	31	,	,	,
25944	1506	32	tea	tea	NN
25944	1506	33	,	,	,
25944	1506	34	etc	etc	FW
25944	1506	35	.	.	.
25944	1507	1	are	be	VBP
25944	1507	2	often	often	RB
25944	1507	3	responsible	responsible	JJ
25944	1507	4	factors	factor	NNS
25944	1507	5	.	.	.
25944	1508	1	It	-PRON-	PRP
25944	1508	2	is	be	VBZ
25944	1508	3	essentially	essentially	RB
25944	1508	4	a	a	DT
25944	1508	5	disease	disease	NN
25944	1508	6	of	of	IN
25944	1508	7	adult	adult	NN
25944	1508	8	life	life	NN
25944	1508	9	,	,	,
25944	1508	10	common	common	JJ
25944	1508	11	about	about	IN
25944	1508	12	middle	middle	JJ
25944	1508	13	age	age	NN
25944	1508	14	,	,	,
25944	1508	15	occurring	occur	VBG
25944	1508	16	in	in	IN
25944	1508	17	both	both	DT
25944	1508	18	sexes	sex	NNS
25944	1508	19	,	,	,
25944	1508	20	but	but	CC
25944	1508	21	rarely	rarely	RB
25944	1508	22	reaching	reach	VBG
25944	1508	23	the	the	DT
25944	1508	24	same	same	JJ
25944	1508	25	degree	degree	NN
25944	1508	26	of	of	IN
25944	1508	27	development	development	NN
25944	1508	28	in	in	IN
25944	1508	29	women	woman	NNS
25944	1508	30	as	as	IN
25944	1508	31	observed	observe	VBN
25944	1508	32	at	at	IN
25944	1508	33	times	time	NNS
25944	1508	34	in	in	IN
25944	1508	35	men	man	NNS
25944	1508	36	.	.	.
25944	1509	1	#	#	$
25944	1509	2	Is	be	VBZ
25944	1509	3	acne	acne	RB
25944	1509	4	rosacea	rosacea	FW
25944	1509	5	easily	easily	RB
25944	1509	6	recognized	recognize	VBN
25944	1509	7	?	?	.
25944	1509	8	#	#	NN
25944	1509	9	Yes	yes	UH
25944	1509	10	.	.	.
25944	1510	1	The	the	DT
25944	1510	2	redness	redness	NN
25944	1510	3	,	,	,
25944	1510	4	acne	acne	NNP
25944	1510	5	lesions	lesion	NNS
25944	1510	6	,	,	,
25944	1510	7	dilated	dilate	VBN
25944	1510	8	capillaries	capillary	NNS
25944	1510	9	,	,	,
25944	1510	10	and	and	CC
25944	1510	11	,	,	,
25944	1510	12	at	at	IN
25944	1510	13	times	time	NNS
25944	1510	14	,	,	,
25944	1510	15	the	the	DT
25944	1510	16	glandular	glandular	JJ
25944	1510	17	and	and	CC
25944	1510	18	connective	connective	JJ
25944	1510	19	-	-	HYPH
25944	1510	20	tissue	tissue	NN
25944	1510	21	hypertrophy	hypertrophy	NN
25944	1510	22	;	;	:
25944	1510	23	the	the	DT
25944	1510	24	limitation	limitation	NN
25944	1510	25	of	of	IN
25944	1510	26	the	the	DT
25944	1510	27	eruption	eruption	NN
25944	1510	28	to	to	IN
25944	1510	29	the	the	DT
25944	1510	30	face	face	NN
25944	1510	31	,	,	,
25944	1510	32	especially	especially	RB
25944	1510	33	the	the	DT
25944	1510	34	region	region	NN
25944	1510	35	of	of	IN
25944	1510	36	the	the	DT
25944	1510	37	nose	nose	NN
25944	1510	38	;	;	:
25944	1510	39	the	the	DT
25944	1510	40	evident	evident	JJ
25944	1510	41	involvement	involvement	NN
25944	1510	42	of	of	IN
25944	1510	43	the	the	DT
25944	1510	44	sebaceous	sebaceous	JJ
25944	1510	45	glands	gland	NNS
25944	1510	46	,	,	,
25944	1510	47	the	the	DT
25944	1510	48	absence	absence	NN
25944	1510	49	of	of	IN
25944	1510	50	ulceration	ulceration	NN
25944	1510	51	,	,	,
25944	1510	52	taken	take	VBN
25944	1510	53	with	with	IN
25944	1510	54	the	the	DT
25944	1510	55	history	history	NN
25944	1510	56	of	of	IN
25944	1510	57	the	the	DT
25944	1510	58	case	case	NN
25944	1510	59	,	,	,
25944	1510	60	are	be	VBP
25944	1510	61	characteristic	characteristic	JJ
25944	1510	62	.	.	.
25944	1511	1	It	-PRON-	PRP
25944	1511	2	is	be	VBZ
25944	1511	3	to	to	TO
25944	1511	4	be	be	VB
25944	1511	5	distinguished	distinguish	VBN
25944	1511	6	from	from	IN
25944	1511	7	the	the	DT
25944	1511	8	tubercular	tubercular	JJ
25944	1511	9	syphiloderm	syphiloderm	NNP
25944	1511	10	and	and	CC
25944	1511	11	lupus	lupus	NNP
25944	1511	12	vulgaris	vulgaris	NNP
25944	1511	13	,	,	,
25944	1511	14	diseases	disease	VBZ
25944	1511	15	to	to	TO
25944	1511	16	which	which	WDT
25944	1511	17	it	-PRON-	PRP
25944	1511	18	may	may	MD
25944	1511	19	bear	bear	VB
25944	1511	20	rough	rough	JJ
25944	1511	21	resemblance	resemblance	NN
25944	1511	22	.	.	.
25944	1512	1	#	#	JJR
25944	1512	2	State	state	NN
25944	1512	3	the	the	DT
25944	1512	4	prognosis	prognosis	NN
25944	1512	5	of	of	IN
25944	1512	6	acne	acne	NNP
25944	1512	7	rosacea	rosacea	NNP
25944	1512	8	.	.	.
25944	1512	9	#	#	$
25944	1512	10	All	all	DT
25944	1512	11	cases	case	NNS
25944	1512	12	may	may	MD
25944	1512	13	be	be	VB
25944	1512	14	favorably	favorably	RB
25944	1512	15	influenced	influence	VBN
25944	1512	16	by	by	IN
25944	1512	17	treatment	treatment	NN
25944	1512	18	;	;	:
25944	1512	19	the	the	DT
25944	1512	20	mild	mild	JJ
25944	1512	21	and	and	CC
25944	1512	22	moderately	moderately	RB
25944	1512	23	-	-	HYPH
25944	1512	24	developed	develop	VBN
25944	1512	25	types	type	NNS
25944	1512	26	are	be	VBP
25944	1512	27	,	,	,
25944	1512	28	as	as	IN
25944	1512	29	a	a	DT
25944	1512	30	rule	rule	NN
25944	1512	31	,	,	,
25944	1512	32	curable	curable	JJ
25944	1512	33	,	,	,
25944	1512	34	but	but	CC
25944	1512	35	usually	usually	RB
25944	1512	36	obstinate	obstinate	VBP
25944	1512	37	.	.	.
25944	1513	1	It	-PRON-	PRP
25944	1513	2	is	be	VBZ
25944	1513	3	a	a	DT
25944	1513	4	persistent	persistent	JJ
25944	1513	5	disease	disease	NN
25944	1513	6	,	,	,
25944	1513	7	showing	show	VBG
25944	1513	8	little	little	JJ
25944	1513	9	,	,	,
25944	1513	10	if	if	IN
25944	1513	11	any	any	DT
25944	1513	12	,	,	,
25944	1513	13	tendency	tendency	NN
25944	1513	14	to	to	TO
25944	1513	15	disappear	disappear	VB
25944	1513	16	spontaneously	spontaneously	RB
25944	1513	17	.	.	.
25944	1514	1	#	#	LS
25944	1514	2	What	what	WP
25944	1514	3	is	be	VBZ
25944	1514	4	the	the	DT
25944	1514	5	method	method	NN
25944	1514	6	of	of	IN
25944	1514	7	treatment	treatment	NN
25944	1514	8	?	?	.
25944	1514	9	#	#	$
25944	1514	10	Both	both	CC
25944	1514	11	constitutional	constitutional	JJ
25944	1514	12	and	and	CC
25944	1514	13	local	local	JJ
25944	1514	14	measures	measure	NNS
25944	1514	15	are	be	VBP
25944	1514	16	demanded	demand	VBN
25944	1514	17	in	in	IN
25944	1514	18	most	most	JJS
25944	1514	19	cases	case	NNS
25944	1514	20	.	.	.
25944	1515	1	#	#	NN
25944	1515	2	Upon	upon	IN
25944	1515	3	what	what	WP
25944	1515	4	is	be	VBZ
25944	1515	5	the	the	DT
25944	1515	6	constitutional	constitutional	JJ
25944	1515	7	treatment	treatment	NN
25944	1515	8	to	to	TO
25944	1515	9	be	be	VB
25944	1515	10	based	base	VBN
25944	1515	11	?	?	.
25944	1515	12	#	#	$
25944	1515	13	The	the	DT
25944	1515	14	constitutional	constitutional	JJ
25944	1515	15	treatment	treatment	NN
25944	1515	16	,	,	,
25944	1515	17	beyond	beyond	IN
25944	1515	18	a	a	DT
25944	1515	19	regulation	regulation	NN
25944	1515	20	of	of	IN
25944	1515	21	the	the	DT
25944	1515	22	diet	diet	NN
25944	1515	23	,	,	,
25944	1515	24	is	be	VBZ
25944	1515	25	to	to	TO
25944	1515	26	be	be	VB
25944	1515	27	based	base	VBN
25944	1515	28	upon	upon	IN
25944	1515	29	a	a	DT
25944	1515	30	correct	correct	JJ
25944	1515	31	appreciation	appreciation	NN
25944	1515	32	of	of	IN
25944	1515	33	the	the	DT
25944	1515	34	etiological	etiological	JJ
25944	1515	35	factors	factor	NNS
25944	1515	36	in	in	IN
25944	1515	37	the	the	DT
25944	1515	38	individual	individual	JJ
25944	1515	39	case	case	NN
25944	1515	40	.	.	.
25944	1516	1	There	there	EX
25944	1516	2	are	be	VBP
25944	1516	3	no	no	DT
25944	1516	4	special	special	JJ
25944	1516	5	remedies	remedy	NNS
25944	1516	6	.	.	.
25944	1517	1	Iron	iron	NN
25944	1517	2	,	,	,
25944	1517	3	cod	cod	NN
25944	1517	4	-	-	HYPH
25944	1517	5	liver	liver	NN
25944	1517	6	oil	oil	NN
25944	1517	7	,	,	,
25944	1517	8	tonics	tonic	NNS
25944	1517	9	,	,	,
25944	1517	10	ergot	ergot	NNS
25944	1517	11	,	,	,
25944	1517	12	alkalies	alkali	NNS
25944	1517	13	,	,	,
25944	1517	14	saline	saline	VBP
25944	1517	15	laxatives	laxative	NNS
25944	1517	16	,	,	,
25944	1517	17	and	and	CC
25944	1517	18	similar	similar	JJ
25944	1517	19	drugs	drug	NNS
25944	1517	20	are	be	VBP
25944	1517	21	to	to	TO
25944	1517	22	be	be	VB
25944	1517	23	variously	variously	RB
25944	1517	24	prescribed	prescribe	VBN
25944	1517	25	.	.	.
25944	1518	1	#	#	LS
25944	1518	2	What	what	WP
25944	1518	3	is	be	VBZ
25944	1518	4	the	the	DT
25944	1518	5	external	external	JJ
25944	1518	6	treatment	treatment	NN
25944	1518	7	?	?	.
25944	1518	8	#	#	$
25944	1518	9	In	in	IN
25944	1518	10	many	many	JJ
25944	1518	11	respects	respect	NNS
25944	1518	12	,	,	,
25944	1518	13	both	both	CC
25944	1518	14	as	as	IN
25944	1518	15	to	to	IN
25944	1518	16	the	the	DT
25944	1518	17	preliminary	preliminary	JJ
25944	1518	18	measures	measure	NNS
25944	1518	19	and	and	CC
25944	1518	20	remedies	remedy	NNS
25944	1518	21	,	,	,
25944	1518	22	essentially	essentially	RB
25944	1518	23	the	the	DT
25944	1518	24	same	same	JJ
25944	1518	25	as	as	IN
25944	1518	26	that	that	DT
25944	1518	27	employed	employ	VBN
25944	1518	28	in	in	IN
25944	1518	29	the	the	DT
25944	1518	30	treatment	treatment	NN
25944	1518	31	of	of	IN
25944	1518	32	simple	simple	JJ
25944	1518	33	acne	acne	NNP
25944	1518	34	(	(	-LRB-
25944	1518	35	_	_	NNP
25944	1518	36	q	q	NNP
25944	1518	37	.	.	.
25944	1519	1	v.	v.	NNP
25944	1519	2	_	_	NNP
25944	1519	3	)	)	-RRB-
25944	1519	4	.	.	.
25944	1520	1	The	the	DT
25944	1520	2	_	_	NNP
25944	1520	3	x_-ray	x_-ray	NN
25944	1520	4	treatment	treatment	NN
25944	1520	5	is	be	VBZ
25944	1520	6	not	not	RB
25944	1520	7	so	so	RB
25944	1520	8	efficient	efficient	JJ
25944	1520	9	in	in	IN
25944	1520	10	this	this	DT
25944	1520	11	disease	disease	NN
25944	1520	12	,	,	,
25944	1520	13	however	however	RB
25944	1520	14	,	,	,
25944	1520	15	as	as	IN
25944	1520	16	in	in	IN
25944	1520	17	acne	acne	NNP
25944	1520	18	.	.	.
25944	1521	1	In	in	IN
25944	1521	2	addition	addition	NN
25944	1521	3	to	to	IN
25944	1521	4	the	the	DT
25944	1521	5	treatment	treatment	NN
25944	1521	6	there	there	RB
25944	1521	7	found	find	VBN
25944	1521	8	,	,	,
25944	1521	9	several	several	JJ
25944	1521	10	other	other	JJ
25944	1521	11	applications	application	NNS
25944	1521	12	deserve	deserve	VBP
25944	1521	13	mention:--	mention:--	''
25944	1521	14	In	in	IN
25944	1521	15	many	many	JJ
25944	1521	16	cases	case	NNS
25944	1521	17	_	_	NNP
25944	1521	18	Vleminckx	Vleminckx	NNP
25944	1521	19	's	's	POS
25944	1521	20	solution_[C	solution_[c	NN
25944	1521	21	]	]	-RRB-
25944	1521	22	is	be	VBZ
25944	1521	23	valuable	valuable	JJ
25944	1521	24	,	,	,
25944	1521	25	applied	apply	VBD
25944	1521	26	diluted	diluted	JJ
25944	1521	27	with	with	IN
25944	1521	28	one	one	CD
25944	1521	29	to	to	TO
25944	1521	30	ten	ten	CD
25944	1521	31	parts	part	NNS
25944	1521	32	of	of	IN
25944	1521	33	water	water	NN
25944	1521	34	.	.	.
25944	1522	1	Also	also	RB
25944	1522	2	,	,	,
25944	1522	3	a	a	DT
25944	1522	4	mucilaginous	mucilaginous	JJ
25944	1522	5	paste	paste	NN
25944	1522	6	containing	contain	VBG
25944	1522	7	sulphur:--	sulphur:--	''
25944	1522	8	[	[	-LRB-
25944	1522	9	Rx	Rx	NNP
25944	1522	10	]	]	-RRB-
25944	1522	11	Mucilag	Mucilag	NNP
25944	1522	12	.	.	.
25944	1523	1	acaciæ	acaciæ	NNP
25944	1523	2	,	,	,
25944	1523	3	.....................	.....................	NFP
25944	1523	4	f[dram]iij	f[dram]iij	JJ
25944	1523	5	Glycerinæ	Glycerinæ	NNP
25944	1523	6	,	,	,
25944	1523	7	...........................	...........................	NFP
25944	1523	8	f[dram]ij	f[dram]ij	NFP
25944	1523	9	Sulphur	Sulphur	NNP
25944	1523	10	,	,	,
25944	1523	11	præcip	præcip	NN
25944	1523	12	.	.	.
25944	1523	13	,	,	,
25944	1523	14	....................	....................	NFP
25944	1523	15	[	[	-LRB-
25944	1523	16	dram]iij	dram]iij	NNP
25944	1523	17	.	.	.
25944	1524	1	M.	M.	NNP
25944	1524	2	[	[	-LRB-
25944	1524	3	Footnote	Footnote	NNP
25944	1524	4	C	C	NNP
25944	1524	5	:	:	:
25944	1524	6	[	[	-LRB-
25944	1524	7	Rx	Rx	NNP
25944	1524	8	]	]	-RRB-
25944	1524	9	Calcis	Calcis	NNP
25944	1524	10	,	,	,
25944	1524	11	..............................	..............................	NFP
25944	1524	12	[	[	-LRB-
25944	1524	13	Oz]ss	Oz]ss	NNP
25944	1524	14	Sulph	Sulph	NNP
25944	1524	15	.	.	.
25944	1525	1	sublimat	sublimat	NN
25944	1525	2	.	.	.
25944	1525	3	,	,	,
25944	1525	4	....................	....................	NFP
25944	1525	5	[	[	-LRB-
25944	1525	6	Oz]j	Oz]j	.
25944	1525	7	Aquæ	Aquæ	NNP
25944	1525	8	,	,	,
25944	1525	9	................................	................................	NFP
25944	1525	10	[	[	-LRB-
25944	1525	11	Oz]x	oz]x	NN
25944	1525	12	.	.	.
25944	1526	1	To	to	TO
25944	1526	2	be	be	VB
25944	1526	3	boiled	boil	VBN
25944	1526	4	down	down	RP
25944	1526	5	to	to	IN
25944	1526	6	[	[	-LRB-
25944	1526	7	Oz]vj	Oz]vj	NNP
25944	1526	8	and	and	CC
25944	1526	9	filtered	filter	VBN
25944	1526	10	.	.	.
25944	1526	11	]	]	-RRB-
25944	1527	1	Or	or	CC
25944	1527	2	a	a	DT
25944	1527	3	similar	similar	JJ
25944	1527	4	paste	paste	NN
25944	1527	5	with	with	IN
25944	1527	6	the	the	DT
25944	1527	7	glycerine	glycerine	NN
25944	1527	8	in	in	IN
25944	1527	9	the	the	DT
25944	1527	10	foregoing	foregoing	NN
25944	1527	11	replaced	replace	VBN
25944	1527	12	with	with	IN
25944	1527	13	ichthyol	ichthyol	NN
25944	1527	14	may	may	MD
25944	1527	15	be	be	VB
25944	1527	16	used	use	VBN
25944	1527	17	.	.	.
25944	1528	1	#	#	$
25944	1528	2	In	in	IN
25944	1528	3	what	what	WDT
25944	1528	4	manner	manner	NN
25944	1528	5	are	be	VBP
25944	1528	6	the	the	DT
25944	1528	7	dilated	dilated	JJ
25944	1528	8	bloodvessels	bloodvessel	NNS
25944	1528	9	and	and	CC
25944	1528	10	connective	connective	JJ
25944	1528	11	-	-	HYPH
25944	1528	12	tissue	tissue	NN
25944	1528	13	hypertrophy	hypertrophy	NN
25944	1528	14	to	to	TO
25944	1528	15	be	be	VB
25944	1528	16	treated	treat	VBN
25944	1528	17	?	?	.
25944	1528	18	#	#	$
25944	1528	19	The	the	DT
25944	1528	20	enlarged	enlarge	VBN
25944	1528	21	capillaries	capillary	NNS
25944	1528	22	are	be	VBP
25944	1528	23	to	to	TO
25944	1528	24	be	be	VB
25944	1528	25	destroyed	destroy	VBN
25944	1528	26	by	by	IN
25944	1528	27	incision	incision	NN
25944	1528	28	or	or	CC
25944	1528	29	by	by	IN
25944	1528	30	electrolysis	electrolysis	NN
25944	1528	31	.	.	.
25944	1529	1	Properly	properly	RB
25944	1529	2	managed	manage	VBD
25944	1529	3	the	the	DT
25944	1529	4	vessels	vessel	NNS
25944	1529	5	may	may	MD
25944	1529	6	be	be	VB
25944	1529	7	thus	thus	RB
25944	1529	8	destroyed	destroy	VBN
25944	1529	9	,	,	,
25944	1529	10	but	but	CC
25944	1529	11	unless	unless	IN
25944	1529	12	the	the	DT
25944	1529	13	predisposing	predispose	VBG
25944	1529	14	causes	cause	NNS
25944	1529	15	have	have	VBP
25944	1529	16	disappeared	disappear	VBN
25944	1529	17	or	or	CC
25944	1529	18	have	have	VBP
25944	1529	19	been	be	VBN
25944	1529	20	remedied	remedie	VBN
25944	1529	21	,	,	,
25944	1529	22	a	a	DT
25944	1529	23	new	new	JJ
25944	1529	24	growth	growth	NN
25944	1529	25	may	may	MD
25944	1529	26	take	take	VB
25944	1529	27	place	place	NN
25944	1529	28	.	.	.
25944	1530	1	If	if	IN
25944	1530	2	the	the	DT
25944	1530	3	knife	knife	NN
25944	1530	4	is	be	VBZ
25944	1530	5	employed	employ	VBN
25944	1530	6	,	,	,
25944	1530	7	the	the	DT
25944	1530	8	vessels	vessel	NNS
25944	1530	9	are	be	VBP
25944	1530	10	either	either	CC
25944	1530	11	slit	slit	VBN
25944	1530	12	in	in	IN
25944	1530	13	their	-PRON-	PRP$
25944	1530	14	length	length	NN
25944	1530	15	or	or	CC
25944	1530	16	cut	cut	VBN
25944	1530	17	transversely	transversely	RB
25944	1530	18	at	at	IN
25944	1530	19	several	several	JJ
25944	1530	20	points	point	NNS
25944	1530	21	.	.	.
25944	1531	1	The	the	DT
25944	1531	2	method	method	NN
25944	1531	3	by	by	IN
25944	1531	4	electrolysis	electrolysis	NN
25944	1531	5	is	be	VBZ
25944	1531	6	the	the	DT
25944	1531	7	same	same	JJ
25944	1531	8	as	as	IN
25944	1531	9	used	use	VBN
25944	1531	10	in	in	IN
25944	1531	11	the	the	DT
25944	1531	12	removal	removal	NN
25944	1531	13	of	of	IN
25944	1531	14	superfluous	superfluous	JJ
25944	1531	15	hair	hair	NN
25944	1531	16	(	(	-LRB-
25944	1531	17	_	_	NNP
25944	1531	18	q	q	NNP
25944	1531	19	.	.	.
25944	1532	1	v.	v.	NNP
25944	1532	2	_	_	NNP
25944	1532	3	)	)	-RRB-
25944	1532	4	.	.	.
25944	1533	1	;	;	:
25944	1533	2	the	the	DT
25944	1533	3	needle	needle	NN
25944	1533	4	may	may	MD
25944	1533	5	,	,	,
25944	1533	6	if	if	IN
25944	1533	7	the	the	DT
25944	1533	8	vessel	vessel	NN
25944	1533	9	is	be	VBZ
25944	1533	10	short	short	JJ
25944	1533	11	,	,	,
25944	1533	12	be	be	VB
25944	1533	13	inserted	insert	VBN
25944	1533	14	along	along	IN
25944	1533	15	its	-PRON-	PRP$
25944	1533	16	calibre	calibre	NN
25944	1533	17	,	,	,
25944	1533	18	or	or	CC
25944	1533	19	if	if	IN
25944	1533	20	long	long	JJ
25944	1533	21	,	,	,
25944	1533	22	may	may	MD
25944	1533	23	be	be	VB
25944	1533	24	inserted	insert	VBN
25944	1533	25	at	at	IN
25944	1533	26	several	several	JJ
25944	1533	27	points	point	NNS
25944	1533	28	in	in	IN
25944	1533	29	its	-PRON-	PRP$
25944	1533	30	length	length	NN
25944	1533	31	.	.	.
25944	1534	1	Excessive	excessive	JJ
25944	1534	2	connective	connective	JJ
25944	1534	3	-	-	HYPH
25944	1534	4	tissue	tissue	NN
25944	1534	5	growth	growth	NN
25944	1534	6	,	,	,
25944	1534	7	exceptionally	exceptionally	RB
25944	1534	8	met	meet	VBN
25944	1534	9	with	with	IN
25944	1534	10	,	,	,
25944	1534	11	is	be	VBZ
25944	1534	12	to	to	TO
25944	1534	13	be	be	VB
25944	1534	14	treated	treat	VBN
25944	1534	15	by	by	IN
25944	1534	16	ablation	ablation	NN
25944	1534	17	with	with	IN
25944	1534	18	the	the	DT
25944	1534	19	scissors	scissor	NNS
25944	1534	20	or	or	CC
25944	1534	21	knife	knife	NN
25944	1534	22	.	.	.
25944	1535	1	#	#	NNP
25944	1535	2	Acne	Acne	NNP
25944	1535	3	Varioliformis	Varioliformis	NNP
25944	1535	4	.	.	.
25944	1535	5	#	#	NNP
25944	1535	6	(	(	-LRB-
25944	1535	7	_	_	NNP
25944	1535	8	Synonyms	Synonyms	NNP
25944	1535	9	:	:	:
25944	1535	10	_	_	NNP
25944	1535	11	Acne	Acne	NNP
25944	1535	12	Frontalis	Frontalis	NNPS
25944	1535	13	;	;	:
25944	1535	14	Acne	Acne	NNP
25944	1535	15	Rodens	Rodens	NNPS
25944	1535	16	;	;	:
25944	1535	17	Acne	Acne	NNP
25944	1535	18	Necrotica	Necrotica	NNP
25944	1535	19	;	;	:
25944	1535	20	Lupoid	Lupoid	NNP
25944	1535	21	Acne	Acne	NNP
25944	1535	22	;	;	:
25944	1535	23	Necrotic	Necrotic	NNP
25944	1535	24	Granuloma	Granuloma	NNP
25944	1535	25	.	.	.
25944	1535	26	)	)	-RRB-
25944	1536	1	#	#	NNP
25944	1536	2	Describe	Describe	NNP
25944	1536	3	acne	acne	NNP
25944	1536	4	varioliformis	varioliformis	NN
25944	1536	5	.	.	.
25944	1536	6	#	#	$
25944	1536	7	Acne	Acne	NNP
25944	1536	8	varioliformis	varioliformis	NN
25944	1536	9	is	be	VBZ
25944	1536	10	characterized	characterize	VBN
25944	1536	11	by	by	IN
25944	1536	12	lesions	lesion	NNS
25944	1536	13	of	of	IN
25944	1536	14	a	a	DT
25944	1536	15	moderately	moderately	RB
25944	1536	16	superficial	superficial	JJ
25944	1536	17	papulo	papulo	JJ
25944	1536	18	-	-	HYPH
25944	1536	19	pustular	pustular	NN
25944	1536	20	type	type	NN
25944	1536	21	,	,	,
25944	1536	22	which	which	WDT
25944	1536	23	in	in	IN
25944	1536	24	disappearing	disappear	VBG
25944	1536	25	leave	leave	VBP
25944	1536	26	slight	slight	NN
25944	1536	27	or	or	CC
25944	1536	28	pit	pit	NN
25944	1536	29	-	-	HYPH
25944	1536	30	like	like	JJ
25944	1536	31	scars	scar	NNS
25944	1536	32	.	.	.
25944	1537	1	The	the	DT
25944	1537	2	forehead	forehead	NN
25944	1537	3	and	and	CC
25944	1537	4	scalp	scalp	NN
25944	1537	5	are	be	VBP
25944	1537	6	the	the	DT
25944	1537	7	favorite	favorite	JJ
25944	1537	8	sites	site	NNS
25944	1537	9	,	,	,
25944	1537	10	but	but	CC
25944	1537	11	they	-PRON-	PRP
25944	1537	12	may	may	MD
25944	1537	13	also	also	RB
25944	1537	14	occur	occur	VB
25944	1537	15	elsewhere	elsewhere	RB
25944	1537	16	.	.	.
25944	1538	1	The	the	DT
25944	1538	2	eruption	eruption	NN
25944	1538	3	is	be	VBZ
25944	1538	4	rather	rather	RB
25944	1538	5	scanty	scanty	NN
25944	1538	6	as	as	IN
25944	1538	7	a	a	DT
25944	1538	8	rule	rule	NN
25944	1538	9	,	,	,
25944	1538	10	consisting	consist	VBG
25944	1538	11	usually	usually	RB
25944	1538	12	of	of	IN
25944	1538	13	ten	ten	CD
25944	1538	14	to	to	IN
25944	1538	15	thirty	thirty	CD
25944	1538	16	lesions	lesion	NNS
25944	1538	17	.	.	.
25944	1539	1	They	-PRON-	PRP
25944	1539	2	begin	begin	VBP
25944	1539	3	as	as	RB
25944	1539	4	small	small	JJ
25944	1539	5	maculo	maculo	NN
25944	1539	6	-	-	HYPH
25944	1539	7	papules	papule	NNS
25944	1539	8	,	,	,
25944	1539	9	as	as	IN
25944	1539	10	papules	papule	NNS
25944	1539	11	,	,	,
25944	1539	12	or	or	CC
25944	1539	13	as	as	IN
25944	1539	14	minute	minute	NN
25944	1539	15	nodules	nodule	VBZ
25944	1539	16	in	in	IN
25944	1539	17	or	or	CC
25944	1539	18	on	on	IN
25944	1539	19	the	the	DT
25944	1539	20	skin	skin	NN
25944	1539	21	,	,	,
25944	1539	22	and	and	CC
25944	1539	23	gradually	gradually	RB
25944	1539	24	become	become	VB
25944	1539	25	small	small	JJ
25944	1539	26	pea	pea	JJ
25944	1539	27	-	-	HYPH
25944	1539	28	sized	sized	JJ
25944	1539	29	,	,	,
25944	1539	30	with	with	IN
25944	1539	31	a	a	DT
25944	1539	32	tendency	tendency	NN
25944	1539	33	to	to	IN
25944	1539	34	slight	slight	JJ
25944	1539	35	vesiculation	vesiculation	NN
25944	1539	36	or	or	CC
25944	1539	37	pustulation	pustulation	NN
25944	1539	38	at	at	IN
25944	1539	39	the	the	DT
25944	1539	40	central	central	JJ
25944	1539	41	part	part	NN
25944	1539	42	.	.	.
25944	1540	1	The	the	DT
25944	1540	2	lesion	lesion	NN
25944	1540	3	is	be	VBZ
25944	1540	4	sluggish	sluggish	JJ
25944	1540	5	in	in	IN
25944	1540	6	its	-PRON-	PRP$
25944	1540	7	course	course	NN
25944	1540	8	,	,	,
25944	1540	9	drying	dry	VBG
25944	1540	10	to	to	IN
25944	1540	11	a	a	DT
25944	1540	12	thin	thin	JJ
25944	1540	13	crust	crust	NN
25944	1540	14	,	,	,
25944	1540	15	which	which	WDT
25944	1540	16	finally	finally	RB
25944	1540	17	falls	fall	VBZ
25944	1540	18	off	off	RP
25944	1540	19	,	,	,
25944	1540	20	leaving	leave	VBG
25944	1540	21	a	a	DT
25944	1540	22	depressed	depressed	JJ
25944	1540	23	variola	variola	NN
25944	1540	24	-	-	HYPH
25944	1540	25	like	like	JJ
25944	1540	26	scar	scar	NN
25944	1540	27	.	.	.
25944	1541	1	New	new	JJ
25944	1541	2	lesions	lesion	NNS
25944	1541	3	arise	arise	VBP
25944	1541	4	from	from	IN
25944	1541	5	time	time	NN
25944	1541	6	to	to	IN
25944	1541	7	time	time	NN
25944	1541	8	,	,	,
25944	1541	9	and	and	CC
25944	1541	10	the	the	DT
25944	1541	11	disease	disease	NN
25944	1541	12	thus	thus	RB
25944	1541	13	continues	continue	VBZ
25944	1541	14	almost	almost	RB
25944	1541	15	indefinitely	indefinitely	RB
25944	1541	16	.	.	.
25944	1542	1	There	there	EX
25944	1542	2	may	may	MD
25944	1542	3	or	or	CC
25944	1542	4	may	may	MD
25944	1542	5	not	not	RB
25944	1542	6	be	be	VB
25944	1542	7	itching	itch	VBG
25944	1542	8	.	.	.
25944	1543	1	In	in	IN
25944	1543	2	what	what	WP
25944	1543	3	appears	appear	VBZ
25944	1543	4	to	to	TO
25944	1543	5	be	be	VB
25944	1543	6	a	a	DT
25944	1543	7	variety	variety	NN
25944	1543	8	of	of	IN
25944	1543	9	this	this	DT
25944	1543	10	disease	disease	NN
25944	1543	11	,	,	,
25944	1543	12	known	know	VBN
25944	1543	13	usually	usually	RB
25944	1543	14	as	as	IN
25944	1543	15	_	_	NNP
25944	1543	16	acne	acne	NNP
25944	1543	17	urticata	urticata	NNP
25944	1543	18	_	_	NNP
25944	1543	19	,	,	,
25944	1543	20	there	there	EX
25944	1543	21	is	be	VBZ
25944	1543	22	considerable	considerable	JJ
25944	1543	23	itching	itching	NN
25944	1543	24	just	just	RB
25944	1543	25	at	at	IN
25944	1543	26	the	the	DT
25944	1543	27	time	time	NN
25944	1543	28	the	the	DT
25944	1543	29	lesion	lesion	NN
25944	1543	30	is	be	VBZ
25944	1543	31	appearing	appear	VBG
25944	1543	32	.	.	.
25944	1544	1	The	the	DT
25944	1544	2	malady	malady	NN
25944	1544	3	is	be	VBZ
25944	1544	4	not	not	RB
25944	1544	5	frequent	frequent	JJ
25944	1544	6	,	,	,
25944	1544	7	but	but	CC
25944	1544	8	occurs	occur	VBZ
25944	1544	9	in	in	IN
25944	1544	10	both	both	DT
25944	1544	11	sexes	sex	NNS
25944	1544	12	,	,	,
25944	1544	13	usually	usually	RB
25944	1544	14	in	in	IN
25944	1544	15	those	those	DT
25944	1544	16	between	between	IN
25944	1544	17	the	the	DT
25944	1544	18	ages	age	NNS
25944	1544	19	of	of	IN
25944	1544	20	twenty	twenty	CD
25944	1544	21	and	and	CC
25944	1544	22	fifty	fifty	CD
25944	1544	23	.	.	.
25944	1545	1	It	-PRON-	PRP
25944	1545	2	seems	seem	VBZ
25944	1545	3	probable	probable	JJ
25944	1545	4	that	that	IN
25944	1545	5	the	the	DT
25944	1545	6	eruption	eruption	NN
25944	1545	7	is	be	VBZ
25944	1545	8	parasitic	parasitic	JJ
25944	1545	9	in	in	IN
25944	1545	10	origin	origin	NN
25944	1545	11	.	.	.
25944	1546	1	The	the	DT
25944	1546	2	maladies	malady	NNS
25944	1546	3	variously	variously	RB
25944	1546	4	known	know	VBN
25944	1546	5	as	as	IN
25944	1546	6	hydradenitis	hydradenitis	NN
25944	1546	7	suppurativa	suppurativa	NN
25944	1546	8	,	,	,
25944	1546	9	acnitis	acnitis	NN
25944	1546	10	,	,	,
25944	1546	11	spiradenitis	spiradenitis	NNP
25944	1546	12	,	,	,
25944	1546	13	folliclis	folliclis	NNP
25944	1546	14	,	,	,
25944	1546	15	granuloma	granuloma	NNP
25944	1546	16	necroticum	necroticum	NNP
25944	1546	17	,	,	,
25944	1546	18	etc	etc	FW
25944	1546	19	.	.	FW
25944	1546	20	,	,	,
25944	1546	21	in	in	IN
25944	1546	22	which	which	WDT
25944	1546	23	the	the	DT
25944	1546	24	lesions	lesion	NNS
25944	1546	25	,	,	,
25944	1546	26	primarily	primarily	RB
25944	1546	27	at	at	IN
25944	1546	28	least	least	JJS
25944	1546	29	,	,	,
25944	1546	30	are	be	VBP
25944	1546	31	somewhat	somewhat	RB
25944	1546	32	deeper	deeply	RBR
25944	1546	33	seated	seated	JJ
25944	1546	34	,	,	,
25944	1546	35	sluggish	sluggish	JJ
25944	1546	36	in	in	IN
25944	1546	37	their	-PRON-	PRP$
25944	1546	38	course	course	NN
25944	1546	39	,	,	,
25944	1546	40	and	and	CC
25944	1546	41	followed	follow	VBN
25944	1546	42	by	by	IN
25944	1546	43	scarring	scar	VBG
25944	1546	44	,	,	,
25944	1546	45	could	could	MD
25944	1546	46	be	be	VB
25944	1546	47	also	also	RB
25944	1546	48	included	include	VBN
25944	1546	49	under	under	IN
25944	1546	50	this	this	DT
25944	1546	51	head	head	NN
25944	1546	52	.	.	.
25944	1547	1	#	#	NN
25944	1547	2	Give	give	VB
25944	1547	3	the	the	DT
25944	1547	4	prognosis	prognosis	NN
25944	1547	5	and	and	CC
25944	1547	6	treatment	treatment	NN
25944	1547	7	.	.	.
25944	1547	8	#	#	$
25944	1547	9	The	the	DT
25944	1547	10	disease	disease	NN
25944	1547	11	is	be	VBZ
25944	1547	12	rebellious	rebellious	JJ
25944	1547	13	and	and	CC
25944	1547	14	tends	tend	VBZ
25944	1547	15	to	to	TO
25944	1547	16	recur	recur	VB
25944	1547	17	.	.	.
25944	1548	1	The	the	DT
25944	1548	2	most	most	RBS
25944	1548	3	efficient	efficient	JJ
25944	1548	4	applications	application	NNS
25944	1548	5	are	be	VBP
25944	1548	6	those	those	DT
25944	1548	7	of	of	IN
25944	1548	8	sulphur	sulphur	NNP
25944	1548	9	and	and	CC
25944	1548	10	resorcin	resorcin	NNP
25944	1548	11	,	,	,
25944	1548	12	the	the	DT
25944	1548	13	same	same	JJ
25944	1548	14	as	as	IN
25944	1548	15	prescribed	prescribe	VBN
25944	1548	16	in	in	IN
25944	1548	17	ordinary	ordinary	JJ
25944	1548	18	acne	acne	NNS
25944	1548	19	.	.	.
25944	1549	1	#	#	NNP
25944	1549	2	Sycosis	Sycosis	NNP
25944	1549	3	.	.	.
25944	1549	4	#	#	NNP
25944	1549	5	(	(	-LRB-
25944	1549	6	_	_	NNP
25944	1549	7	Synonyms	Synonyms	NNP
25944	1549	8	:	:	:
25944	1549	9	_	_	NNP
25944	1549	10	Sycosis	Sycosis	NNP
25944	1549	11	Vulgaris	Vulgaris	NNP
25944	1549	12	;	;	:
25944	1549	13	Sycosis	Sycosis	NNP
25944	1549	14	Non	Non	NNP
25944	1549	15	-	-	NN
25944	1549	16	parasitica	parasitica	NN
25944	1549	17	;	;	:
25944	1549	18	Folliculitis	Folliculitis	NNP
25944	1549	19	Barbæ	Barbæ	NNP
25944	1549	20	;	;	:
25944	1549	21	Sycosis	Sycosis	NNP
25944	1549	22	Coccogenica	Coccogenica	NNP
25944	1549	23	.	.	.
25944	1549	24	)	)	-RRB-
25944	1550	1	#	#	LS
25944	1550	2	What	what	WP
25944	1550	3	do	do	VBP
25944	1550	4	you	-PRON-	PRP
25944	1550	5	understand	understand	VB
25944	1550	6	by	by	IN
25944	1550	7	sycosis	sycosis	NN
25944	1550	8	?	?	.
25944	1550	9	#	#	$
25944	1550	10	Sycosis	Sycosis	NNP
25944	1550	11	is	be	VBZ
25944	1550	12	a	a	DT
25944	1550	13	chronic	chronic	JJ
25944	1550	14	,	,	,
25944	1550	15	inflammatory	inflammatory	JJ
25944	1550	16	affection	affection	NN
25944	1550	17	involving	involve	VBG
25944	1550	18	the	the	DT
25944	1550	19	hair	hair	NN
25944	1550	20	-	-	HYPH
25944	1550	21	follicles	follicle	NNS
25944	1550	22	,	,	,
25944	1550	23	usually	usually	RB
25944	1550	24	of	of	IN
25944	1550	25	the	the	DT
25944	1550	26	moustache	moustache	JJ
25944	1550	27	and	and	CC
25944	1550	28	bearded	bearded	JJ
25944	1550	29	regions	region	NNS
25944	1550	30	only	only	RB
25944	1550	31	,	,	,
25944	1550	32	and	and	CC
25944	1550	33	characterized	characterize	VBN
25944	1550	34	by	by	IN
25944	1550	35	papules	papule	NNS
25944	1550	36	,	,	,
25944	1550	37	tubercles	tubercle	NNS
25944	1550	38	,	,	,
25944	1550	39	and	and	CC
25944	1550	40	pustules	pustule	NNS
25944	1550	41	perforated	perforate	VBN
25944	1550	42	by	by	IN
25944	1550	43	hairs	hair	NNS
25944	1550	44	.	.	.
25944	1551	1	#	#	NNP
25944	1551	2	Describe	describe	VB
25944	1551	3	the	the	DT
25944	1551	4	symptoms	symptom	NNS
25944	1551	5	of	of	IN
25944	1551	6	sycosis	sycosis	NN
25944	1551	7	.	.	.
25944	1551	8	#	#	$
25944	1551	9	Sycosis	Sycosis	NNP
25944	1551	10	begins	begin	VBZ
25944	1551	11	by	by	IN
25944	1551	12	the	the	DT
25944	1551	13	formation	formation	NN
25944	1551	14	of	of	IN
25944	1551	15	papules	papule	NNS
25944	1551	16	and	and	CC
25944	1551	17	pustules	pustule	NNS
25944	1551	18	about	about	IN
25944	1551	19	the	the	DT
25944	1551	20	hair	hair	NN
25944	1551	21	-	-	HYPH
25944	1551	22	follicles	follicle	NNS
25944	1551	23	;	;	:
25944	1551	24	the	the	DT
25944	1551	25	lesions	lesion	NNS
25944	1551	26	occur	occur	VBP
25944	1551	27	in	in	IN
25944	1551	28	numbers	number	NNS
25944	1551	29	,	,	,
25944	1551	30	in	in	IN
25944	1551	31	close	close	JJ
25944	1551	32	proximity	proximity	NN
25944	1551	33	,	,	,
25944	1551	34	and	and	CC
25944	1551	35	together	together	RB
25944	1551	36	with	with	IN
25944	1551	37	the	the	DT
25944	1551	38	accompanying	accompany	VBG
25944	1551	39	inflammation	inflammation	NN
25944	1551	40	,	,	,
25944	1551	41	make	make	VB
25944	1551	42	up	up	RP
25944	1551	43	a	a	DT
25944	1551	44	small	small	JJ
25944	1551	45	or	or	CC
25944	1551	46	large	large	JJ
25944	1551	47	area	area	NN
25944	1551	48	.	.	.
25944	1552	1	The	the	DT
25944	1552	2	pustules	pustule	NNS
25944	1552	3	are	be	VBP
25944	1552	4	small	small	JJ
25944	1552	5	,	,	,
25944	1552	6	rounded	rounded	JJ
25944	1552	7	,	,	,
25944	1552	8	flat	flat	JJ
25944	1552	9	or	or	CC
25944	1552	10	acuminated	acuminated	JJ
25944	1552	11	,	,	,
25944	1552	12	discrete	discrete	JJ
25944	1552	13	,	,	,
25944	1552	14	and	and	CC
25944	1552	15	yellowish	yellowish	VB
25944	1552	16	in	in	IN
25944	1552	17	color	color	NN
25944	1552	18	;	;	:
25944	1552	19	they	-PRON-	PRP
25944	1552	20	are	be	VBP
25944	1552	21	perforated	perforate	VBN
25944	1552	22	by	by	IN
25944	1552	23	hairs	hair	NNS
25944	1552	24	,	,	,
25944	1552	25	show	show	VBP
25944	1552	26	no	no	DT
25944	1552	27	tendency	tendency	NN
25944	1552	28	to	to	TO
25944	1552	29	rupture	rupture	VB
25944	1552	30	,	,	,
25944	1552	31	and	and	CC
25944	1552	32	are	be	VBP
25944	1552	33	apt	apt	JJ
25944	1552	34	to	to	TO
25944	1552	35	occur	occur	VB
25944	1552	36	in	in	IN
25944	1552	37	crops	crop	NNS
25944	1552	38	,	,	,
25944	1552	39	drying	dry	VBG
25944	1552	40	to	to	IN
25944	1552	41	thin	thin	JJ
25944	1552	42	yellowish	yellowish	JJ
25944	1552	43	or	or	CC
25944	1552	44	brownish	brownish	JJ
25944	1552	45	crusts	crust	NNS
25944	1552	46	.	.	.
25944	1553	1	Papules	papule	NNS
25944	1553	2	and	and	CC
25944	1553	3	tubercles	tubercle	NNS
25944	1553	4	are	be	VBP
25944	1553	5	often	often	RB
25944	1553	6	intermingled	intermingle	VBN
25944	1553	7	.	.	.
25944	1554	1	More	more	RBR
25944	1554	2	or	or	CC
25944	1554	3	less	less	RBR
25944	1554	4	swelling	swelling	NN
25944	1554	5	and	and	CC
25944	1554	6	infiltration	infiltration	NN
25944	1554	7	are	be	VBP
25944	1554	8	noticeable	noticeable	JJ
25944	1554	9	.	.	.
25944	1555	1	[	[	-LRB-
25944	1555	2	Illustration	illustration	NN
25944	1555	3	:	:	:
25944	1555	4	Fig	Fig	NNP
25944	1555	5	.	.	.
25944	1556	1	26	26	CD
25944	1556	2	.	.	.
25944	1557	1	Sycosis	sycosis	NN
25944	1557	2	--	--	:
25944	1557	3	not	not	RB
25944	1557	4	infrequently	infrequently	RB
25944	1557	5	begins	begin	VBZ
25944	1557	6	in	in	RB
25944	1557	7	,	,	,
25944	1557	8	and	and	CC
25944	1557	9	sometimes	sometimes	RB
25944	1557	10	limited	limit	VBN
25944	1557	11	to	to	IN
25944	1557	12	,	,	,
25944	1557	13	this	this	DT
25944	1557	14	region	region	NN
25944	1557	15	.	.	.
25944	1557	16	]	]	-RRB-
25944	1558	1	The	the	DT
25944	1558	2	disease	disease	NN
25944	1558	3	is	be	VBZ
25944	1558	4	seen	see	VBN
25944	1558	5	,	,	,
25944	1558	6	as	as	IN
25944	1558	7	a	a	DT
25944	1558	8	rule	rule	NN
25944	1558	9	,	,	,
25944	1558	10	only	only	RB
25944	1558	11	on	on	IN
25944	1558	12	the	the	DT
25944	1558	13	bearded	bearded	JJ
25944	1558	14	part	part	NN
25944	1558	15	of	of	IN
25944	1558	16	the	the	DT
25944	1558	17	face	face	NN
25944	1558	18	,	,	,
25944	1558	19	either	either	CC
25944	1558	20	about	about	IN
25944	1558	21	the	the	DT
25944	1558	22	cheeks	cheek	NNS
25944	1558	23	,	,	,
25944	1558	24	chin	chin	NN
25944	1558	25	or	or	CC
25944	1558	26	upper	upper	JJ
25944	1558	27	lip	lip	NN
25944	1558	28	,	,	,
25944	1558	29	involving	involve	VBG
25944	1558	30	a	a	DT
25944	1558	31	small	small	JJ
25944	1558	32	portion	portion	NN
25944	1558	33	or	or	CC
25944	1558	34	the	the	DT
25944	1558	35	whole	whole	NN
25944	1558	36	of	of	IN
25944	1558	37	these	these	DT
25944	1558	38	parts	part	NNS
25944	1558	39	.	.	.
25944	1559	1	It	-PRON-	PRP
25944	1559	2	is	be	VBZ
25944	1559	3	also	also	RB
25944	1559	4	sometimes	sometimes	RB
25944	1559	5	met	meet	VBN
25944	1559	6	with	with	IN
25944	1559	7	involving	involve	VBG
25944	1559	8	the	the	DT
25944	1559	9	hair	hair	NN
25944	1559	10	follicles	follicle	NNS
25944	1559	11	just	just	RB
25944	1559	12	within	within	IN
25944	1559	13	the	the	DT
25944	1559	14	nasal	nasal	NN
25944	1559	15	orifice	orifice	NN
25944	1559	16	,	,	,
25944	1559	17	and	and	CC
25944	1559	18	may	may	MD
25944	1559	19	even	even	RB
25944	1559	20	be	be	VB
25944	1559	21	limited	limit	VBN
25944	1559	22	to	to	IN
25944	1559	23	this	this	DT
25944	1559	24	region	region	NN
25944	1559	25	.	.	.
25944	1560	1	Occasionally	occasionally	RB
25944	1560	2	a	a	DT
25944	1560	3	sycosiform	sycosiform	JJ
25944	1560	4	eruption	eruption	NN
25944	1560	5	,	,	,
25944	1560	6	usually	usually	RB
25944	1560	7	of	of	IN
25944	1560	8	the	the	DT
25944	1560	9	side	side	NN
25944	1560	10	of	of	IN
25944	1560	11	the	the	DT
25944	1560	12	bearded	bearded	JJ
25944	1560	13	region	region	NN
25944	1560	14	,	,	,
25944	1560	15	leaves	leave	VBZ
25944	1560	16	behind	behind	IN
25944	1560	17	a	a	DT
25944	1560	18	smooth	smooth	JJ
25944	1560	19	or	or	CC
25944	1560	20	keloidal	keloidal	NN
25944	1560	21	scar	scar	NN
25944	1560	22	,	,	,
25944	1560	23	the	the	DT
25944	1560	24	disease	disease	NN
25944	1560	25	gradually	gradually	RB
25944	1560	26	extending--_ulerythema	extending--_ulerythema	NNP
25944	1560	27	sycosiforme	sycosiforme	NNP
25944	1560	28	_	_	NNP
25944	1560	29	(	(	-LRB-
25944	1560	30	lupoid	lupoid	NNP
25944	1560	31	sycosis	sycosis	NNP
25944	1560	32	)	)	-RRB-
25944	1560	33	.	.	.
25944	1561	1	An	an	DT
25944	1561	2	inflammation	inflammation	NN
25944	1561	3	of	of	IN
25944	1561	4	the	the	DT
25944	1561	5	hair	hair	NN
25944	1561	6	-	-	HYPH
25944	1561	7	follicles	follicle	NNS
25944	1561	8	of	of	IN
25944	1561	9	the	the	DT
25944	1561	10	scalp	scalp	NN
25944	1561	11	apparently	apparently	RB
25944	1561	12	sycosiform	sycosiform	VBP
25944	1561	13	in	in	IN
25944	1561	14	character	character	NN
25944	1561	15	,	,	,
25944	1561	16	occurring	occur	VBG
25944	1561	17	as	as	IN
25944	1561	18	discrete	discrete	JJ
25944	1561	19	or	or	CC
25944	1561	20	aggregated	aggregated	JJ
25944	1561	21	lesions	lesion	NNS
25944	1561	22	,	,	,
25944	1561	23	is	be	VBZ
25944	1561	24	sometimes	sometimes	RB
25944	1561	25	observed	observe	VBN
25944	1561	26	,	,	,
25944	1561	27	the	the	DT
25944	1561	28	follicles	follicle	NNS
25944	1561	29	being	be	VBG
25944	1561	30	destroyed	destroy	VBN
25944	1561	31	and	and	CC
25944	1561	32	atrophy	atrophy	NN
25944	1561	33	or	or	CC
25944	1561	34	slight	slight	JJ
25944	1561	35	scarring	scar	VBG
25944	1561	36	resulting--_folliculitis	resulting--_folliculitis	JJR
25944	1561	37	decalvans	decalvan	NNS
25944	1561	38	_	_	NNP
25944	1561	39	.	.	.
25944	1562	1	#	#	NN
25944	1562	2	Does	do	VBZ
25944	1562	3	conspicuous	conspicuous	JJ
25944	1562	4	hair	hair	NN
25944	1562	5	loss	loss	NN
25944	1562	6	occur	occur	VB
25944	1562	7	in	in	IN
25944	1562	8	sycosis	sycosis	NN
25944	1562	9	?	?	.
25944	1562	10	#	#	$
25944	1562	11	Ordinarily	ordinarily	RB
25944	1562	12	not	not	RB
25944	1562	13	;	;	:
25944	1562	14	the	the	DT
25944	1562	15	hairs	hair	NNS
25944	1562	16	are	be	VBP
25944	1562	17	,	,	,
25944	1562	18	especially	especially	RB
25944	1562	19	at	at	IN
25944	1562	20	first	first	RB
25944	1562	21	,	,	,
25944	1562	22	usually	usually	RB
25944	1562	23	firmly	firmly	RB
25944	1562	24	seated	seated	JJ
25944	1562	25	,	,	,
25944	1562	26	but	but	CC
25944	1562	27	in	in	IN
25944	1562	28	those	those	DT
25944	1562	29	cases	case	NNS
25944	1562	30	in	in	IN
25944	1562	31	which	which	WDT
25944	1562	32	suppuration	suppuration	NN
25944	1562	33	is	be	VBZ
25944	1562	34	active	active	JJ
25944	1562	35	,	,	,
25944	1562	36	and	and	CC
25944	1562	37	has	have	VBZ
25944	1562	38	involved	involve	VBN
25944	1562	39	the	the	DT
25944	1562	40	follicles	follicle	NNS
25944	1562	41	,	,	,
25944	1562	42	they	-PRON-	PRP
25944	1562	43	may	may	MD
25944	1562	44	,	,	,
25944	1562	45	as	as	IN
25944	1562	46	a	a	DT
25944	1562	47	rule	rule	NN
25944	1562	48	,	,	,
25944	1562	49	be	be	VB
25944	1562	50	easily	easily	RB
25944	1562	51	extracted	extract	VBN
25944	1562	52	.	.	.
25944	1563	1	In	in	IN
25944	1563	2	some	some	DT
25944	1563	3	cases	case	NNS
25944	1563	4	destruction	destruction	NN
25944	1563	5	of	of	IN
25944	1563	6	the	the	DT
25944	1563	7	follicles	follicle	NNS
25944	1563	8	ensues	ensue	NNS
25944	1563	9	and	and	CC
25944	1563	10	slight	slight	JJ
25944	1563	11	scarring	scarring	NN
25944	1563	12	and	and	CC
25944	1563	13	permanent	permanent	JJ
25944	1563	14	hair	hair	NN
25944	1563	15	loss	loss	NN
25944	1563	16	result	result	NN
25944	1563	17	.	.	.
25944	1564	1	#	#	NNP
25944	1564	2	State	state	NN
25944	1564	3	the	the	DT
25944	1564	4	character	character	NN
25944	1564	5	of	of	IN
25944	1564	6	the	the	DT
25944	1564	7	subjective	subjective	JJ
25944	1564	8	symptoms	symptom	NNS
25944	1564	9	.	.	.
25944	1564	10	#	#	NNP
25944	1564	11	Pain	Pain	NNP
25944	1564	12	and	and	CC
25944	1564	13	itching	itching	NN
25944	1564	14	and	and	CC
25944	1564	15	a	a	DT
25944	1564	16	sense	sense	NN
25944	1564	17	of	of	IN
25944	1564	18	burning	burning	NN
25944	1564	19	,	,	,
25944	1564	20	variable	variable	JJ
25944	1564	21	as	as	IN
25944	1564	22	to	to	IN
25944	1564	23	degree	degree	NN
25944	1564	24	,	,	,
25944	1564	25	may	may	MD
25944	1564	26	be	be	VB
25944	1564	27	present	present	JJ
25944	1564	28	.	.	.
25944	1565	1	#	#	LS
25944	1565	2	What	what	WP
25944	1565	3	is	be	VBZ
25944	1565	4	the	the	DT
25944	1565	5	course	course	NN
25944	1565	6	of	of	IN
25944	1565	7	the	the	DT
25944	1565	8	disease	disease	NN
25944	1565	9	?	?	.
25944	1565	10	#	#	$
25944	1565	11	Essentially	essentially	RB
25944	1565	12	chronic	chronic	JJ
25944	1565	13	,	,	,
25944	1565	14	the	the	DT
25944	1565	15	inflammatory	inflammatory	JJ
25944	1565	16	action	action	NN
25944	1565	17	being	be	VBG
25944	1565	18	of	of	IN
25944	1565	19	a	a	DT
25944	1565	20	subacute	subacute	NN
25944	1565	21	or	or	CC
25944	1565	22	sluggish	sluggish	JJ
25944	1565	23	character	character	NN
25944	1565	24	,	,	,
25944	1565	25	with	with	IN
25944	1565	26	acute	acute	JJ
25944	1565	27	exacerbations	exacerbation	NNS
25944	1565	28	.	.	.
25944	1566	1	#	#	JJR
25944	1566	2	State	state	NN
25944	1566	3	the	the	DT
25944	1566	4	causes	cause	NNS
25944	1566	5	of	of	IN
25944	1566	6	sycosis	sycosis	NN
25944	1566	7	.	.	.
25944	1566	8	#	#	$
25944	1566	9	Upon	upon	IN
25944	1566	10	the	the	DT
25944	1566	11	upper	upper	JJ
25944	1566	12	lip	lip	NN
25944	1566	13	it	-PRON-	PRP
25944	1566	14	may	may	MD
25944	1566	15	have	have	VB
25944	1566	16	its	-PRON-	PRP$
25944	1566	17	origin	origin	NN
25944	1566	18	in	in	IN
25944	1566	19	a	a	DT
25944	1566	20	nasal	nasal	NN
25944	1566	21	catarrh	catarrh	NNP
25944	1566	22	.	.	.
25944	1567	1	Entrance	entrance	NN
25944	1567	2	into	into	IN
25944	1567	3	the	the	DT
25944	1567	4	follicles	follicle	NNS
25944	1567	5	of	of	IN
25944	1567	6	pyogenic	pyogenic	NNP
25944	1567	7	micrococci	micrococci	NN
25944	1567	8	is	be	VBZ
25944	1567	9	now	now	RB
25944	1567	10	regarded	regard	VBN
25944	1567	11	as	as	IN
25944	1567	12	the	the	DT
25944	1567	13	essential	essential	JJ
25944	1567	14	factor	factor	NN
25944	1567	15	.	.	.
25944	1568	1	This	this	DT
25944	1568	2	view	view	NN
25944	1568	3	being	be	VBG
25944	1568	4	accepted	accept	VBN
25944	1568	5	,	,	,
25944	1568	6	carries	carry	VBZ
25944	1568	7	with	with	IN
25944	1568	8	it	-PRON-	PRP
25944	1568	9	the	the	DT
25944	1568	10	possibility	possibility	NN
25944	1568	11	of	of	IN
25944	1568	12	contagiousness	contagiousness	NN
25944	1568	13	.	.	.
25944	1569	1	It	-PRON-	PRP
25944	1569	2	is	be	VBZ
25944	1569	3	seen	see	VBN
25944	1569	4	in	in	IN
25944	1569	5	the	the	DT
25944	1569	6	male	male	JJ
25944	1569	7	sex	sex	NN
25944	1569	8	only	only	RB
25944	1569	9	,	,	,
25944	1569	10	usually	usually	RB
25944	1569	11	in	in	IN
25944	1569	12	those	those	DT
25944	1569	13	between	between	IN
25944	1569	14	the	the	DT
25944	1569	15	ages	age	NNS
25944	1569	16	of	of	IN
25944	1569	17	twenty	twenty	CD
25944	1569	18	-	-	HYPH
25944	1569	19	five	five	CD
25944	1569	20	and	and	CC
25944	1569	21	fifty	fifty	CD
25944	1569	22	;	;	:
25944	1569	23	and	and	CC
25944	1569	24	is	be	VBZ
25944	1569	25	met	meet	VBN
25944	1569	26	with	with	IN
25944	1569	27	in	in	IN
25944	1569	28	those	those	DT
25944	1569	29	in	in	IN
25944	1569	30	good	good	JJ
25944	1569	31	and	and	CC
25944	1569	32	bad	bad	JJ
25944	1569	33	health	health	NN
25944	1569	34	,	,	,
25944	1569	35	and	and	CC
25944	1569	36	among	among	IN
25944	1569	37	rich	rich	JJ
25944	1569	38	and	and	CC
25944	1569	39	poor	poor	JJ
25944	1569	40	.	.	.
25944	1570	1	It	-PRON-	PRP
25944	1570	2	is	be	VBZ
25944	1570	3	comparatively	comparatively	RB
25944	1570	4	infrequent	infrequent	JJ
25944	1570	5	.	.	.
25944	1571	1	#	#	LS
25944	1571	2	What	what	WP
25944	1571	3	is	be	VBZ
25944	1571	4	the	the	DT
25944	1571	5	pathology	pathology	NN
25944	1571	6	of	of	IN
25944	1571	7	sycosis	sycosis	NN
25944	1571	8	?	?	.
25944	1571	9	#	#	$
25944	1571	10	The	the	DT
25944	1571	11	disease	disease	NN
25944	1571	12	is	be	VBZ
25944	1571	13	primarily	primarily	RB
25944	1571	14	a	a	DT
25944	1571	15	perifolliculitis	perifolliculitis	NN
25944	1571	16	,	,	,
25944	1571	17	the	the	DT
25944	1571	18	follicle	follicle	NN
25944	1571	19	and	and	CC
25944	1571	20	its	-PRON-	PRP$
25944	1571	21	sheath	sheath	NN
25944	1571	22	subsequently	subsequently	RB
25944	1571	23	becoming	become	VBG
25944	1571	24	involved	involved	JJ
25944	1571	25	in	in	IN
25944	1571	26	the	the	DT
25944	1571	27	inflammatory	inflammatory	JJ
25944	1571	28	process	process	NN
25944	1571	29	.	.	.
25944	1572	1	#	#	NNP
25944	1572	2	How	how	WRB
25944	1572	3	would	would	MD
25944	1572	4	you	-PRON-	PRP
25944	1572	5	distinguish	distinguish	VB
25944	1572	6	sycosis	sycosis	NN
25944	1572	7	from	from	IN
25944	1572	8	eczema	eczema	NN
25944	1572	9	?	?	.
25944	1572	10	#	#	NNP
25944	1572	11	Eczema	Eczema	NNP
25944	1572	12	is	be	VBZ
25944	1572	13	rarely	rarely	RB
25944	1572	14	sharply	sharply	RB
25944	1572	15	limited	limit	VBN
25944	1572	16	to	to	IN
25944	1572	17	the	the	DT
25944	1572	18	bearded	bearded	JJ
25944	1572	19	region	region	NN
25944	1572	20	,	,	,
25944	1572	21	but	but	CC
25944	1572	22	is	be	VBZ
25944	1572	23	apt	apt	JJ
25944	1572	24	to	to	TO
25944	1572	25	involve	involve	VB
25944	1572	26	other	other	JJ
25944	1572	27	parts	part	NNS
25944	1572	28	of	of	IN
25944	1572	29	the	the	DT
25944	1572	30	face	face	NN
25944	1572	31	;	;	:
25944	1572	32	moreover	moreover	RB
25944	1572	33	,	,	,
25944	1572	34	the	the	DT
25944	1572	35	lesions	lesion	NNS
25944	1572	36	are	be	VBP
25944	1572	37	usually	usually	RB
25944	1572	38	confluent	confluent	JJ
25944	1572	39	,	,	,
25944	1572	40	and	and	CC
25944	1572	41	there	there	EX
25944	1572	42	is	be	VBZ
25944	1572	43	either	either	CC
25944	1572	44	an	an	DT
25944	1572	45	oozing	oozing	NN
25944	1572	46	,	,	,
25944	1572	47	red	red	JJ
25944	1572	48	crusted	crust	VBN
25944	1572	49	surface	surface	NN
25944	1572	50	,	,	,
25944	1572	51	or	or	CC
25944	1572	52	it	-PRON-	PRP
25944	1572	53	is	be	VBZ
25944	1572	54	dry	dry	JJ
25944	1572	55	and	and	CC
25944	1572	56	scaly	scaly	NNP
25944	1572	57	.	.	.
25944	1573	1	#	#	NNP
25944	1573	2	How	how	WRB
25944	1573	3	would	would	MD
25944	1573	4	you	-PRON-	PRP
25944	1573	5	exclude	exclude	VB
25944	1573	6	tinea	tinea	NNP
25944	1573	7	sycosis	sycosis	NN
25944	1573	8	in	in	IN
25944	1573	9	the	the	DT
25944	1573	10	diagnosis	diagnosis	NN
25944	1573	11	?	?	.
25944	1573	12	#	#	$
25944	1573	13	In	in	IN
25944	1573	14	tinea	tinea	JJ
25944	1573	15	sycosis	sycosis	NN
25944	1573	16	,	,	,
25944	1573	17	or	or	CC
25944	1573	18	ringworm	ringworm	VB
25944	1573	19	sycosis	sycosis	NN
25944	1573	20	,	,	,
25944	1573	21	the	the	DT
25944	1573	22	history	history	NN
25944	1573	23	of	of	IN
25944	1573	24	the	the	DT
25944	1573	25	case	case	NN
25944	1573	26	is	be	VBZ
25944	1573	27	different	different	JJ
25944	1573	28	.	.	.
25944	1574	1	The	the	DT
25944	1574	2	parts	part	NNS
25944	1574	3	are	be	VBP
25944	1574	4	distinctly	distinctly	RB
25944	1574	5	lumpy	lumpy	JJ
25944	1574	6	and	and	CC
25944	1574	7	nodular	nodular	JJ
25944	1574	8	;	;	:
25944	1574	9	the	the	DT
25944	1574	10	hairs	hair	NNS
25944	1574	11	are	be	VBP
25944	1574	12	soon	soon	RB
25944	1574	13	involved	involve	VBN
25944	1574	14	and	and	CC
25944	1574	15	become	become	VB
25944	1574	16	dry	dry	JJ
25944	1574	17	,	,	,
25944	1574	18	brittle	brittle	JJ
25944	1574	19	,	,	,
25944	1574	20	loose	loose	JJ
25944	1574	21	,	,	,
25944	1574	22	and	and	CC
25944	1574	23	fall	fall	VB
25944	1574	24	out	out	RP
25944	1574	25	,	,	,
25944	1574	26	or	or	CC
25944	1574	27	they	-PRON-	PRP
25944	1574	28	may	may	MD
25944	1574	29	be	be	VB
25944	1574	30	readily	readily	RB
25944	1574	31	extracted	extract	VBN
25944	1574	32	.	.	.
25944	1575	1	The	the	DT
25944	1575	2	superficial	superficial	JJ
25944	1575	3	type	type	NN
25944	1575	4	of	of	IN
25944	1575	5	ringworm	ringworm	NN
25944	1575	6	sycosis	sycosis	NN
25944	1575	7	is	be	VBZ
25944	1575	8	readily	readily	RB
25944	1575	9	distinguished	distinguish	VBN
25944	1575	10	by	by	IN
25944	1575	11	the	the	DT
25944	1575	12	ring	ring	NN
25944	1575	13	-	-	HYPH
25944	1575	14	like	like	JJ
25944	1575	15	character	character	NN
25944	1575	16	of	of	IN
25944	1575	17	the	the	DT
25944	1575	18	patches	patch	NNS
25944	1575	19	.	.	.
25944	1576	1	In	in	IN
25944	1576	2	doubtful	doubtful	JJ
25944	1576	3	cases	case	NNS
25944	1576	4	,	,	,
25944	1576	5	microscopic	microscopic	JJ
25944	1576	6	examination	examination	NN
25944	1576	7	of	of	IN
25944	1576	8	the	the	DT
25944	1576	9	hairs	hair	NNS
25944	1576	10	may	may	MD
25944	1576	11	be	be	VB
25944	1576	12	resorted	resort	VBN
25944	1576	13	to	to	IN
25944	1576	14	.	.	.
25944	1577	1	#	#	NN
25944	1577	2	Give	give	VB
25944	1577	3	the	the	DT
25944	1577	4	prognosis	prognosis	NN
25944	1577	5	of	of	IN
25944	1577	6	sycosis	sycosis	NN
25944	1577	7	.	.	.
25944	1577	8	#	#	$
25944	1577	9	The	the	DT
25944	1577	10	disease	disease	NN
25944	1577	11	is	be	VBZ
25944	1577	12	curable	curable	JJ
25944	1577	13	,	,	,
25944	1577	14	but	but	CC
25944	1577	15	almost	almost	RB
25944	1577	16	invariably	invariably	RB
25944	1577	17	obstinate	obstinate	VBP
25944	1577	18	and	and	CC
25944	1577	19	rebellious	rebellious	JJ
25944	1577	20	to	to	IN
25944	1577	21	treatment	treatment	NN
25944	1577	22	.	.	.
25944	1578	1	The	the	DT
25944	1578	2	duration	duration	NN
25944	1578	3	,	,	,
25944	1578	4	extent	extent	NN
25944	1578	5	,	,	,
25944	1578	6	and	and	CC
25944	1578	7	character	character	NN
25944	1578	8	of	of	IN
25944	1578	9	the	the	DT
25944	1578	10	inflammatory	inflammatory	JJ
25944	1578	11	process	process	NN
25944	1578	12	must	must	MD
25944	1578	13	all	all	DT
25944	1578	14	be	be	VB
25944	1578	15	considered	consider	VBN
25944	1578	16	.	.	.
25944	1579	1	An	an	DT
25944	1579	2	expression	expression	NN
25944	1579	3	of	of	IN
25944	1579	4	an	an	DT
25944	1579	5	opinion	opinion	NN
25944	1579	6	as	as	IN
25944	1579	7	to	to	IN
25944	1579	8	the	the	DT
25944	1579	9	length	length	NN
25944	1579	10	of	of	IN
25944	1579	11	time	time	NN
25944	1579	12	required	require	VBN
25944	1579	13	for	for	IN
25944	1579	14	a	a	DT
25944	1579	15	cure	cure	NN
25944	1579	16	should	should	MD
25944	1579	17	always	always	RB
25944	1579	18	be	be	VB
25944	1579	19	guarded	guard	VBN
25944	1579	20	.	.	.
25944	1580	1	Ulerythema	Ulerythema	NNP
25944	1580	2	sycosiforme	sycosiforme	NNP
25944	1580	3	is	be	VBZ
25944	1580	4	extremely	extremely	RB
25944	1580	5	obstinate	obstinate	JJ
25944	1580	6	.	.	.
25944	1581	1	Folliculitis	folliculitis	JJ
25944	1581	2	decalvans	decalvan	NNS
25944	1581	3	is	be	VBZ
25944	1581	4	also	also	RB
25944	1581	5	rebellious	rebellious	JJ
25944	1581	6	.	.	.
25944	1582	1	#	#	NNP
25944	1582	2	How	how	WRB
25944	1582	3	is	be	VBZ
25944	1582	4	sycosis	sycosis	NN
25944	1582	5	to	to	TO
25944	1582	6	be	be	VB
25944	1582	7	treated	treat	VBN
25944	1582	8	?	?	.
25944	1582	9	#	#	NNP
25944	1582	10	Mainly	mainly	RB
25944	1582	11	,	,	,
25944	1582	12	and	and	CC
25944	1582	13	often	often	RB
25944	1582	14	exclusively	exclusively	RB
25944	1582	15	,	,	,
25944	1582	16	by	by	IN
25944	1582	17	external	external	JJ
25944	1582	18	applications	application	NNS
25944	1582	19	.	.	.
25944	1583	1	[	[	-LRB-
25944	1583	2	Illustration	illustration	NN
25944	1583	3	:	:	:
25944	1583	4	Fig	Fig	NNP
25944	1583	5	.	.	.
25944	1584	1	27	27	CD
25944	1584	2	.	.	.
25944	1585	1	Sycosis	Sycosis	NNP
25944	1585	2	.	.	.
25944	1585	3	]	]	-RRB-
25944	1586	1	#	#	$
25944	1586	2	Is	be	VBZ
25944	1586	3	constitutional	constitutional	JJ
25944	1586	4	treatment	treatment	NN
25944	1586	5	of	of	IN
25944	1586	6	no	no	DT
25944	1586	7	avail	avail	NN
25944	1586	8	in	in	IN
25944	1586	9	sycosis	sycosis	NN
25944	1586	10	?	?	.
25944	1586	11	#	#	$
25944	1586	12	In	in	IN
25944	1586	13	some	some	DT
25944	1586	14	instances	instance	NNS
25944	1586	15	;	;	:
25944	1586	16	but	but	CC
25944	1586	17	,	,	,
25944	1586	18	as	as	IN
25944	1586	19	a	a	DT
25944	1586	20	rule	rule	NN
25944	1586	21	,	,	,
25944	1586	22	it	-PRON-	PRP
25944	1586	23	is	be	VBZ
25944	1586	24	negative	negative	JJ
25944	1586	25	.	.	.
25944	1587	1	If	if	IN
25944	1587	2	indicated	indicate	VBN
25944	1587	3	,	,	,
25944	1587	4	such	such	JJ
25944	1587	5	remedies	remedy	NNS
25944	1587	6	as	as	IN
25944	1587	7	tonics	tonic	NNS
25944	1587	8	,	,	,
25944	1587	9	alteratives	alterative	NNS
25944	1587	10	,	,	,
25944	1587	11	cod	cod	NN
25944	1587	12	-	-	HYPH
25944	1587	13	liver	liver	NN
25944	1587	14	oil	oil	NN
25944	1587	15	and	and	CC
25944	1587	16	the	the	DT
25944	1587	17	like	like	JJ
25944	1587	18	are	be	VBP
25944	1587	19	to	to	TO
25944	1587	20	be	be	VB
25944	1587	21	prescribed	prescribe	VBN
25944	1587	22	.	.	.
25944	1588	1	#	#	NNP
25944	1588	2	Describe	describe	VB
25944	1588	3	the	the	DT
25944	1588	4	external	external	JJ
25944	1588	5	treatment	treatment	NN
25944	1588	6	.	.	.
25944	1588	7	#	#	NNP
25944	1588	8	Crusting	crusting	NN
25944	1588	9	,	,	,
25944	1588	10	if	if	IN
25944	1588	11	present	present	JJ
25944	1588	12	,	,	,
25944	1588	13	is	be	VBZ
25944	1588	14	to	to	TO
25944	1588	15	be	be	VB
25944	1588	16	removed	remove	VBN
25944	1588	17	by	by	IN
25944	1588	18	warm	warm	JJ
25944	1588	19	embrocations	embrocation	NNS
25944	1588	20	.	.	.
25944	1589	1	If	if	IN
25944	1589	2	the	the	DT
25944	1589	3	inflammation	inflammation	NN
25944	1589	4	is	be	VBZ
25944	1589	5	of	of	IN
25944	1589	6	a	a	DT
25944	1589	7	high	high	JJ
25944	1589	8	grade	grade	NN
25944	1589	9	,	,	,
25944	1589	10	and	and	CC
25944	1589	11	the	the	DT
25944	1589	12	parts	part	NNS
25944	1589	13	tender	tender	NN
25944	1589	14	and	and	CC
25944	1589	15	painful	painful	JJ
25944	1589	16	,	,	,
25944	1589	17	soothing	soothing	JJ
25944	1589	18	applications	application	NNS
25944	1589	19	,	,	,
25944	1589	20	such	such	JJ
25944	1589	21	as	as	IN
25944	1589	22	bland	bland	JJ
25944	1589	23	oils	oil	NNS
25944	1589	24	,	,	,
25944	1589	25	black	black	JJ
25944	1589	26	wash	wash	NN
25944	1589	27	and	and	CC
25944	1589	28	oxide	oxide	NN
25944	1589	29	-	-	HYPH
25944	1589	30	of	of	IN
25944	1589	31	-	-	HYPH
25944	1589	32	zinc	zinc	NN
25944	1589	33	ointment	ointment	NN
25944	1589	34	,	,	,
25944	1589	35	cold	cold	JJ
25944	1589	36	cream	cream	NN
25944	1589	37	and	and	CC
25944	1589	38	petrolatum	petrolatum	NN
25944	1589	39	,	,	,
25944	1589	40	are	be	VBP
25944	1589	41	to	to	TO
25944	1589	42	be	be	VB
25944	1589	43	used	use	VBN
25944	1589	44	;	;	:
25944	1589	45	boric	boric	NN
25944	1589	46	-	-	HYPH
25944	1589	47	acid	acid	NN
25944	1589	48	solution	solution	NN
25944	1589	49	,	,	,
25944	1589	50	fifteen	fifteen	CD
25944	1589	51	grains	grain	NNS
25944	1589	52	to	to	IN
25944	1589	53	the	the	DT
25944	1589	54	ounce	ounce	NN
25944	1589	55	,	,	,
25944	1589	56	may	may	MD
25944	1589	57	be	be	VB
25944	1589	58	advised	advise	VBN
25944	1589	59	in	in	IN
25944	1589	60	place	place	NN
25944	1589	61	of	of	IN
25944	1589	62	black	black	JJ
25944	1589	63	wash	wash	NN
25944	1589	64	.	.	.
25944	1590	1	In	in	IN
25944	1590	2	most	most	JJS
25944	1590	3	cases	case	NNS
25944	1590	4	,	,	,
25944	1590	5	however	however	RB
25944	1590	6	,	,	,
25944	1590	7	astringent	astringent	JJ
25944	1590	8	and	and	CC
25944	1590	9	stimulating	stimulating	JJ
25944	1590	10	remedies	remedy	NNS
25944	1590	11	are	be	VBP
25944	1590	12	demanded	demand	VBN
25944	1590	13	from	from	IN
25944	1590	14	the	the	DT
25944	1590	15	start	start	NN
25944	1590	16	,	,	,
25944	1590	17	such	such	JJ
25944	1590	18	as	as	IN
25944	1590	19	:	:	:
25944	1590	20	diachylon	diachylon	NN
25944	1590	21	ointment	ointment	NN
25944	1590	22	,	,	,
25944	1590	23	alone	alone	RB
25944	1590	24	or	or	CC
25944	1590	25	with	with	IN
25944	1590	26	ten	ten	CD
25944	1590	27	to	to	IN
25944	1590	28	thirty	thirty	CD
25944	1590	29	grains	grain	NNS
25944	1590	30	of	of	IN
25944	1590	31	calomel	calomel	NN
25944	1590	32	to	to	IN
25944	1590	33	the	the	DT
25944	1590	34	ounce	ounce	NN
25944	1590	35	;	;	:
25944	1590	36	oleate	oleate	NN
25944	1590	37	of	of	IN
25944	1590	38	mercury	mercury	NN
25944	1590	39	,	,	,
25944	1590	40	as	as	IN
25944	1590	41	a	a	DT
25944	1590	42	five-	five-	NN
25944	1590	43	to	to	TO
25944	1590	44	twenty	twenty	CD
25944	1590	45	-	-	HYPH
25944	1590	46	per	per	IN
25944	1590	47	-	-	HYPH
25944	1590	48	cent	cent	NN
25944	1590	49	.	.	.
25944	1591	1	ointment	ointment	NN
25944	1591	2	;	;	,
25944	1591	3	precipitated	precipitate	VBD
25944	1591	4	sulphur	sulphur	NNP
25944	1591	5	,	,	,
25944	1591	6	one	one	CD
25944	1591	7	to	to	TO
25944	1591	8	three	three	CD
25944	1591	9	drachms	drachm	NNS
25944	1591	10	to	to	IN
25944	1591	11	the	the	DT
25944	1591	12	ounce	ounce	NN
25944	1591	13	of	of	IN
25944	1591	14	benzoated	benzoate	VBN
25944	1591	15	lard	lard	NN
25944	1591	16	,	,	,
25944	1591	17	or	or	CC
25944	1591	18	lard	lard	NN
25944	1591	19	and	and	CC
25944	1591	20	lanolin	lanolin	NN
25944	1591	21	;	;	:
25944	1591	22	a	a	DT
25944	1591	23	ten-	ten-	NN
25944	1591	24	to	to	TO
25944	1591	25	twenty	twenty	CD
25944	1591	26	-	-	HYPH
25944	1591	27	five	five	CD
25944	1591	28	-	-	HYPH
25944	1591	29	per	per	IN
25944	1591	30	-	-	HYPH
25944	1591	31	cent	cent	NN
25944	1591	32	.	.	.
25944	1592	1	ichthyol	ichthyol	NNP
25944	1592	2	ointment	ointment	NNP
25944	1592	3	;	;	:
25944	1592	4	and	and	CC
25944	1592	5	resorcin	resorcin	JJ
25944	1592	6	lotion	lotion	NN
25944	1592	7	or	or	CC
25944	1592	8	ointment	ointment	NN
25944	1592	9	,	,	,
25944	1592	10	ten	ten	CD
25944	1592	11	to	to	TO
25944	1592	12	twenty	twenty	CD
25944	1592	13	per	per	IN
25944	1592	14	cent	cent	NN
25944	1592	15	.	.	.
25944	1593	1	strength	strength	NN
25944	1593	2	.	.	.
25944	1594	1	[	[	-LRB-
25944	1594	2	Illustration	illustration	NN
25944	1594	3	:	:	:
25944	1594	4	Fig	Fig	NNP
25944	1594	5	.	.	.
25944	1595	1	28	28	CD
25944	1595	2	.	.	.
25944	1596	1	Sycosis	Sycosis	NNP
25944	1596	2	.	.	.
25944	1596	3	]	]	-RRB-
25944	1597	1	A	a	DT
25944	1597	2	change	change	NN
25944	1597	3	from	from	IN
25944	1597	4	one	one	CD
25944	1597	5	application	application	NN
25944	1597	6	to	to	IN
25944	1597	7	another	another	DT
25944	1597	8	will	will	MD
25944	1597	9	be	be	VB
25944	1597	10	found	find	VBN
25944	1597	11	necessary	necessary	JJ
25944	1597	12	in	in	IN
25944	1597	13	almost	almost	RB
25944	1597	14	all	all	DT
25944	1597	15	cases	case	NNS
25944	1597	16	.	.	.
25944	1598	1	In	in	IN
25944	1598	2	obstinate	obstinate	NN
25944	1598	3	cases	case	VBZ
25944	1598	4	the	the	DT
25944	1598	5	x	x	NN
25944	1598	6	-	-	NN
25944	1598	7	ray	ray	NN
25944	1598	8	treatment	treatment	NN
25944	1598	9	can	can	MD
25944	1598	10	be	be	VB
25944	1598	11	used	use	VBN
25944	1598	12	,	,	,
25944	1598	13	as	as	IN
25944	1598	14	it	-PRON-	PRP
25944	1598	15	has	have	VBZ
25944	1598	16	proved	prove	VBN
25944	1598	17	itself	-PRON-	PRP
25944	1598	18	valuable	valuable	JJ
25944	1598	19	in	in	IN
25944	1598	20	some	some	DT
25944	1598	21	instances	instance	NNS
25944	1598	22	;	;	:
25944	1598	23	as	as	IN
25944	1598	24	in	in	IN
25944	1598	25	other	other	JJ
25944	1598	26	diseases	disease	NNS
25944	1598	27	,	,	,
25944	1598	28	it	-PRON-	PRP
25944	1598	29	should	should	MD
25944	1598	30	be	be	VB
25944	1598	31	employed	employ	VBN
25944	1598	32	cautiously	cautiously	RB
25944	1598	33	.	.	.
25944	1599	1	#	#	NNP
25944	1599	2	What	what	WP
25944	1599	3	would	would	MD
25944	1599	4	you	-PRON-	PRP
25944	1599	5	advise	advise	VB
25944	1599	6	in	in	IN
25944	1599	7	regard	regard	NN
25944	1599	8	to	to	IN
25944	1599	9	shaving	shaving	NN
25944	1599	10	?	?	.
25944	1599	11	#	#	NN
25944	1599	12	When	when	WRB
25944	1599	13	bearable	bearable	JJ
25944	1599	14	(	(	-LRB-
25944	1599	15	and	and	CC
25944	1599	16	after	after	IN
25944	1599	17	a	a	DT
25944	1599	18	few	few	JJ
25944	1599	19	days	day	NNS
25944	1599	20	'	'	POS
25944	1599	21	application	application	NN
25944	1599	22	of	of	IN
25944	1599	23	soothing	soothe	VBG
25944	1599	24	remedies	remedy	NNS
25944	1599	25	it	-PRON-	PRP
25944	1599	26	almost	almost	RB
25944	1599	27	always	always	RB
25944	1599	28	is	be	VBZ
25944	1599	29	)	)	-RRB-
25944	1599	30	,	,	,
25944	1599	31	it	-PRON-	PRP
25944	1599	32	is	be	VBZ
25944	1599	33	to	to	TO
25944	1599	34	be	be	VB
25944	1599	35	advised	advise	VBN
25944	1599	36	in	in	IN
25944	1599	37	all	all	DT
25944	1599	38	cases	case	NNS
25944	1599	39	,	,	,
25944	1599	40	as	as	IN
25944	1599	41	it	-PRON-	PRP
25944	1599	42	materially	materially	RB
25944	1599	43	aids	aid	VBZ
25944	1599	44	in	in	IN
25944	1599	45	the	the	DT
25944	1599	46	treatment	treatment	NN
25944	1599	47	.	.	.
25944	1600	1	After	after	IN
25944	1600	2	a	a	DT
25944	1600	3	cure	cure	NN
25944	1600	4	is	be	VBZ
25944	1600	5	effected	effect	VBN
25944	1600	6	it	-PRON-	PRP
25944	1600	7	should	should	MD
25944	1600	8	be	be	VB
25944	1600	9	continued	continue	VBN
25944	1600	10	for	for	IN
25944	1600	11	some	some	DT
25944	1600	12	months	month	NNS
25944	1600	13	,	,	,
25944	1600	14	until	until	IN
25944	1600	15	the	the	DT
25944	1600	16	healthy	healthy	JJ
25944	1600	17	condition	condition	NN
25944	1600	18	of	of	IN
25944	1600	19	the	the	DT
25944	1600	20	parts	part	NNS
25944	1600	21	is	be	VBZ
25944	1600	22	thoroughly	thoroughly	RB
25944	1600	23	established	establish	VBN
25944	1600	24	.	.	.
25944	1601	1	#	#	NNP
25944	1601	2	When	when	WRB
25944	1601	3	is	be	VBZ
25944	1601	4	depilation	depilation	NN
25944	1601	5	advisable	advisable	JJ
25944	1601	6	as	as	IN
25944	1601	7	a	a	DT
25944	1601	8	therapeutic	therapeutic	JJ
25944	1601	9	measure	measure	NN
25944	1601	10	?	?	.
25944	1601	11	#	#	NN
25944	1601	12	When	when	WRB
25944	1601	13	the	the	DT
25944	1601	14	suppurative	suppurative	NN
25944	1601	15	process	process	NN
25944	1601	16	is	be	VBZ
25944	1601	17	active	active	JJ
25944	1601	18	,	,	,
25944	1601	19	in	in	IN
25944	1601	20	order	order	NN
25944	1601	21	to	to	TO
25944	1601	22	save	save	VB
25944	1601	23	the	the	DT
25944	1601	24	follicles	follicle	NNS
25944	1601	25	from	from	IN
25944	1601	26	destruction	destruction	NN
25944	1601	27	;	;	,
25944	1601	28	incising	incise	VBG
25944	1601	29	or	or	CC
25944	1601	30	puncturing	puncture	VBG
25944	1601	31	the	the	DT
25944	1601	32	pustules	pustule	NNS
25944	1601	33	will	will	MD
25944	1601	34	often	often	RB
25944	1601	35	accomplish	accomplish	VB
25944	1601	36	the	the	DT
25944	1601	37	same	same	JJ
25944	1601	38	end	end	NN
25944	1601	39	.	.	.
25944	1602	1	Depilation	depilation	NN
25944	1602	2	is	be	VBZ
25944	1602	3	in	in	IN
25944	1602	4	all	all	DT
25944	1602	5	cases	case	NNS
25944	1602	6	a	a	DT
25944	1602	7	valuable	valuable	JJ
25944	1602	8	therapeutic	therapeutic	JJ
25944	1602	9	measure	measure	NN
25944	1602	10	,	,	,
25944	1602	11	but	but	CC
25944	1602	12	it	-PRON-	PRP
25944	1602	13	is	be	VBZ
25944	1602	14	painful	painful	JJ
25944	1602	15	;	;	:
25944	1602	16	as	as	IN
25944	1602	17	a	a	DT
25944	1602	18	routine	routine	JJ
25944	1602	19	practice	practice	NN
25944	1602	20	,	,	,
25944	1602	21	shaving	shaving	NN
25944	1602	22	is	be	VBZ
25944	1602	23	less	less	RBR
25944	1602	24	objectionable	objectionable	JJ
25944	1602	25	and	and	CC
25944	1602	26	,	,	,
25944	1602	27	upon	upon	IN
25944	1602	28	the	the	DT
25944	1602	29	whole	whole	NN
25944	1602	30	,	,	,
25944	1602	31	is	be	VBZ
25944	1602	32	probably	probably	RB
25944	1602	33	as	as	RB
25944	1602	34	satisfactory	satisfactory	JJ
25944	1602	35	.	.	.
25944	1603	1	Those	those	DT
25944	1603	2	who	who	WP
25944	1603	3	make	make	VBP
25944	1603	4	free	free	JJ
25944	1603	5	use	use	NN
25944	1603	6	of	of	IN
25944	1603	7	the	the	DT
25944	1603	8	x	x	NN
25944	1603	9	-	-	NN
25944	1603	10	ray	ray	NN
25944	1603	11	commonly	commonly	RB
25944	1603	12	push	push	VB
25944	1603	13	it	-PRON-	PRP
25944	1603	14	to	to	IN
25944	1603	15	the	the	DT
25944	1603	16	point	point	NN
25944	1603	17	of	of	IN
25944	1603	18	producing	produce	VBG
25944	1603	19	depilation	depilation	NN
25944	1603	20	.	.	.
25944	1604	1	#	#	NNP
25944	1604	2	Dermatitis	Dermatitis	NNP
25944	1604	3	Papillaris	Papillaris	NNP
25944	1604	4	Capillitii	Capillitii	NNP
25944	1604	5	.	.	.
25944	1604	6	#	#	NNP
25944	1604	7	(	(	-LRB-
25944	1604	8	_	_	NNP
25944	1604	9	Synonym	Synonym	NNP
25944	1604	10	:	:	:
25944	1604	11	_	_	NNP
25944	1604	12	Acne	Acne	NNP
25944	1604	13	Keloid	Keloid	NNP
25944	1604	14	.	.	.
25944	1604	15	)	)	-RRB-
25944	1605	1	[	[	-LRB-
25944	1605	2	Illustration	illustration	NN
25944	1605	3	:	:	:
25944	1605	4	Fig	Fig	NNP
25944	1605	5	.	.	.
25944	1606	1	29	29	CD
25944	1606	2	.	.	.
25944	1607	1	Dermatitis	Dermatitis	NNP
25944	1607	2	Papillaris	Papillaris	NNP
25944	1607	3	Capillitii	Capillitii	NNP
25944	1607	4	.	.	.
25944	1607	5	]	]	-RRB-
25944	1608	1	#	#	NNP
25944	1608	2	Describe	Describe	NNP
25944	1608	3	dermatitis	dermatitis	NN
25944	1608	4	papillaris	papillaris	NNP
25944	1608	5	capillitii	capillitii	NNP
25944	1608	6	.	.	.
25944	1608	7	#	#	$
25944	1608	8	This	this	DT
25944	1608	9	is	be	VBZ
25944	1608	10	a	a	DT
25944	1608	11	peculiar	peculiar	JJ
25944	1608	12	,	,	,
25944	1608	13	mildly	mildly	RB
25944	1608	14	inflammatory	inflammatory	JJ
25944	1608	15	,	,	,
25944	1608	16	sycosiform	sycosiform	VBP
25944	1608	17	,	,	,
25944	1608	18	keloidal	keloidal	NNP
25944	1608	19	,	,	,
25944	1608	20	acne	acne	NNP
25944	1608	21	-	-	HYPH
25944	1608	22	like	like	JJ
25944	1608	23	disease	disease	NN
25944	1608	24	of	of	IN
25944	1608	25	the	the	DT
25944	1608	26	hairy	hairy	JJ
25944	1608	27	border	border	NN
25944	1608	28	of	of	IN
25944	1608	29	the	the	DT
25944	1608	30	back	back	NN
25944	1608	31	of	of	IN
25944	1608	32	the	the	DT
25944	1608	33	neck	neck	NN
25944	1608	34	,	,	,
25944	1608	35	often	often	RB
25944	1608	36	extending	extend	VBG
25944	1608	37	upward	upward	RB
25944	1608	38	to	to	IN
25944	1608	39	the	the	DT
25944	1608	40	occipital	occipital	JJ
25944	1608	41	region	region	NN
25944	1608	42	;	;	:
25944	1608	43	partaking	partaking	NN
25944	1608	44	,	,	,
25944	1608	45	especially	especially	RB
25944	1608	46	later	later	RB
25944	1608	47	in	in	IN
25944	1608	48	its	-PRON-	PRP$
25944	1608	49	course	course	NN
25944	1608	50	,	,	,
25944	1608	51	somewhat	somewhat	RB
25944	1608	52	of	of	IN
25944	1608	53	the	the	DT
25944	1608	54	nature	nature	NN
25944	1608	55	of	of	IN
25944	1608	56	keloid	keloid	NNP
25944	1608	57	.	.	.
25944	1609	1	Several	several	JJ
25944	1609	2	or	or	CC
25944	1609	3	more	more	JJR
25944	1609	4	acne	acne	JJ
25944	1609	5	-	-	HYPH
25944	1609	6	like	like	JJ
25944	1609	7	lesions	lesion	NNS
25944	1609	8	,	,	,
25944	1609	9	papular	papular	JJ
25944	1609	10	and	and	CC
25944	1609	11	pustular	pustular	JJ
25944	1609	12	,	,	,
25944	1609	13	closely	closely	RB
25944	1609	14	grouped	group	VBN
25944	1609	15	or	or	CC
25944	1609	16	bunched	bunch	VBN
25944	1609	17	,	,	,
25944	1609	18	appear	appear	VB
25944	1609	19	,	,	,
25944	1609	20	developing	develop	VBG
25944	1609	21	slowly	slowly	RB
25944	1609	22	,	,	,
25944	1609	23	usually	usually	RB
25944	1609	24	to	to	IN
25944	1609	25	the	the	DT
25944	1609	26	size	size	NN
25944	1609	27	of	of	IN
25944	1609	28	peas	pea	NNS
25944	1609	29	;	;	:
25944	1609	30	are	be	VBP
25944	1609	31	red	red	JJ
25944	1609	32	,	,	,
25944	1609	33	pale	pale	JJ
25944	1609	34	red	red	JJ
25944	1609	35	,	,	,
25944	1609	36	or	or	CC
25944	1609	37	whitish	whitish	JJ
25944	1609	38	,	,	,
25944	1609	39	often	often	RB
25944	1609	40	enveloping	envelop	VBG
25944	1609	41	small	small	JJ
25944	1609	42	tufts	tuft	NNS
25944	1609	43	of	of	IN
25944	1609	44	hair	hair	NN
25944	1609	45	,	,	,
25944	1609	46	and	and	CC
25944	1609	47	attended	attend	VBD
25944	1609	48	with	with	IN
25944	1609	49	more	more	JJR
25944	1609	50	or	or	CC
25944	1609	51	less	less	JJR
25944	1609	52	hair	hair	NN
25944	1609	53	loss	loss	NN
25944	1609	54	.	.	.
25944	1610	1	Its	-PRON-	PRP$
25944	1610	2	course	course	NN
25944	1610	3	is	be	VBZ
25944	1610	4	gradual	gradual	JJ
25944	1610	5	and	and	CC
25944	1610	6	persistent	persistent	JJ
25944	1610	7	.	.	.
25944	1611	1	It	-PRON-	PRP
25944	1611	2	is	be	VBZ
25944	1611	3	an	an	DT
25944	1611	4	exceedingly	exceedingly	RB
25944	1611	5	rare	rare	JJ
25944	1611	6	condition	condition	NN
25944	1611	7	,	,	,
25944	1611	8	the	the	DT
25944	1611	9	exact	exact	JJ
25944	1611	10	nature	nature	NN
25944	1611	11	of	of	IN
25944	1611	12	which	which	WDT
25944	1611	13	is	be	VBZ
25944	1611	14	still	still	RB
25944	1611	15	obscure	obscure	JJ
25944	1611	16	.	.	.
25944	1612	1	#	#	NN
25944	1612	2	Give	give	VB
25944	1612	3	the	the	DT
25944	1612	4	treatment	treatment	NN
25944	1612	5	.	.	.
25944	1612	6	#	#	$
25944	1612	7	Treatment	Treatment	NNP
25944	1612	8	,	,	,
25944	1612	9	which	which	WDT
25944	1612	10	is	be	VBZ
25944	1612	11	usually	usually	RB
25944	1612	12	unsatisfactory	unsatisfactory	JJ
25944	1612	13	,	,	,
25944	1612	14	consists	consist	VBZ
25944	1612	15	of	of	IN
25944	1612	16	stimulating	stimulating	JJ
25944	1612	17	applications	application	NNS
25944	1612	18	--	--	:
25944	1612	19	the	the	DT
25944	1612	20	same	same	JJ
25944	1612	21	,	,	,
25944	1612	22	in	in	IN
25944	1612	23	fact	fact	NN
25944	1612	24	,	,	,
25944	1612	25	as	as	IN
25944	1612	26	employed	employ	VBN
25944	1612	27	in	in	IN
25944	1612	28	sycosis	sycosis	NNP
25944	1612	29	,	,	,
25944	1612	30	sulphur	sulphur	NNP
25944	1612	31	and	and	CC
25944	1612	32	ichthyol	ichthyol	NNP
25944	1612	33	deserving	deserve	VBG
25944	1612	34	special	special	JJ
25944	1612	35	mention	mention	NN
25944	1612	36	.	.	.
25944	1613	1	Depilation	depilation	NN
25944	1613	2	is	be	VBZ
25944	1613	3	essential	essential	JJ
25944	1613	4	.	.	.
25944	1614	1	#	#	NNP
25944	1614	2	Impetigo	Impetigo	NNPS
25944	1614	3	Contagiosa	Contagiosa	NNP
25944	1614	4	.	.	.
25944	1614	5	#	#	$
25944	1614	6	#	#	$
25944	1614	7	Give	give	VB
25944	1614	8	a	a	DT
25944	1614	9	descriptive	descriptive	JJ
25944	1614	10	definition	definition	NN
25944	1614	11	of	of	IN
25944	1614	12	impetigo	impetigo	NNP
25944	1614	13	contagiosa	contagiosa	NNP
25944	1614	14	.	.	.
25944	1614	15	#	#	$
25944	1614	16	Impetigo	Impetigo	NNP
25944	1614	17	contagiosa	contagiosa	VBP
25944	1614	18	is	be	VBZ
25944	1614	19	an	an	DT
25944	1614	20	acute	acute	JJ
25944	1614	21	,	,	,
25944	1614	22	contagious	contagious	JJ
25944	1614	23	,	,	,
25944	1614	24	inflammatory	inflammatory	JJ
25944	1614	25	disease	disease	NN
25944	1614	26	,	,	,
25944	1614	27	characterized	characterize	VBN
25944	1614	28	by	by	IN
25944	1614	29	the	the	DT
25944	1614	30	formation	formation	NN
25944	1614	31	of	of	IN
25944	1614	32	discrete	discrete	JJ
25944	1614	33	,	,	,
25944	1614	34	superficial	superficial	JJ
25944	1614	35	,	,	,
25944	1614	36	flat	flat	JJ
25944	1614	37	,	,	,
25944	1614	38	rounded	rounded	JJ
25944	1614	39	,	,	,
25944	1614	40	or	or	CC
25944	1614	41	ovalish	ovalish	VB
25944	1614	42	vesicles	vesicle	NNS
25944	1614	43	or	or	CC
25944	1614	44	blebs	blebs	NN
25944	1614	45	,	,	,
25944	1614	46	soon	soon	RB
25944	1614	47	becoming	become	VBG
25944	1614	48	vesico	vesico	NN
25944	1614	49	-	-	HYPH
25944	1614	50	pustular	pustular	NN
25944	1614	51	,	,	,
25944	1614	52	and	and	CC
25944	1614	53	drying	dry	VBG
25944	1614	54	to	to	IN
25944	1614	55	thin	thin	JJ
25944	1614	56	yellowish	yellowish	JJ
25944	1614	57	crusts	crust	NNS
25944	1614	58	.	.	.
25944	1615	1	#	#	NN
25944	1615	2	Upon	upon	IN
25944	1615	3	what	what	WP
25944	1615	4	parts	part	NNS
25944	1615	5	does	do	VBZ
25944	1615	6	the	the	DT
25944	1615	7	eruption	eruption	NN
25944	1615	8	commonly	commonly	RB
25944	1615	9	appear	appear	VB
25944	1615	10	?	?	.
25944	1615	11	#	#	NN
25944	1615	12	Upon	upon	IN
25944	1615	13	the	the	DT
25944	1615	14	face	face	NN
25944	1615	15	,	,	,
25944	1615	16	scalp	scalp	FW
25944	1615	17	,	,	,
25944	1615	18	and	and	CC
25944	1615	19	hands	hand	NNS
25944	1615	20	,	,	,
25944	1615	21	and	and	CC
25944	1615	22	exceptionally	exceptionally	RB
25944	1615	23	upon	upon	IN
25944	1615	24	other	other	JJ
25944	1615	25	regions	region	NNS
25944	1615	26	.	.	.
25944	1616	1	#	#	NNP
25944	1616	2	Describe	describe	VB
25944	1616	3	the	the	DT
25944	1616	4	symptoms	symptom	NNS
25944	1616	5	of	of	IN
25944	1616	6	impetigo	impetigo	NNP
25944	1616	7	contagiosa	contagiosa	NNP
25944	1616	8	.	.	.
25944	1616	9	#	#	$
25944	1616	10	One	one	CD
25944	1616	11	,	,	,
25944	1616	12	several	several	JJ
25944	1616	13	or	or	CC
25944	1616	14	more	more	RBR
25944	1616	15	small	small	JJ
25944	1616	16	pin	pin	NN
25944	1616	17	-	-	HYPH
25944	1616	18	head	head	NN
25944	1616	19	-	-	HYPH
25944	1616	20	sized	sized	JJ
25944	1616	21	papulo	papulo	NN
25944	1616	22	-	-	HYPH
25944	1616	23	vesicles	vesicle	NNS
25944	1616	24	or	or	CC
25944	1616	25	vesicles	vesicle	NNS
25944	1616	26	make	make	VBP
25944	1616	27	their	-PRON-	PRP$
25944	1616	28	appearance	appearance	NN
25944	1616	29	,	,	,
25944	1616	30	usually	usually	RB
25944	1616	31	upon	upon	IN
25944	1616	32	the	the	DT
25944	1616	33	face	face	NN
25944	1616	34	and	and	CC
25944	1616	35	fingers	finger	NNS
25944	1616	36	.	.	.
25944	1617	1	In	in	IN
25944	1617	2	the	the	DT
25944	1617	3	male	male	JJ
25944	1617	4	adult	adult	NN
25944	1617	5	the	the	DT
25944	1617	6	region	region	NN
25944	1617	7	of	of	IN
25944	1617	8	the	the	DT
25944	1617	9	neck	neck	NN
25944	1617	10	and	and	CC
25944	1617	11	beard	beard	NN
25944	1617	12	is	be	VBZ
25944	1617	13	a	a	DT
25944	1617	14	favorite	favorite	JJ
25944	1617	15	situation	situation	NN
25944	1617	16	.	.	.
25944	1618	1	They	-PRON-	PRP
25944	1618	2	increase	increase	VBP
25944	1618	3	in	in	IN
25944	1618	4	size	size	NN
25944	1618	5	by	by	IN
25944	1618	6	extending	extend	VBG
25944	1618	7	peripherally	peripherally	RB
25944	1618	8	,	,	,
25944	1618	9	but	but	CC
25944	1618	10	are	be	VBP
25944	1618	11	more	more	RBR
25944	1618	12	or	or	CC
25944	1618	13	less	less	RBR
25944	1618	14	flattened	flattened	JJ
25944	1618	15	and	and	CC
25944	1618	16	umbilicated	umbilicated	JJ
25944	1618	17	,	,	,
25944	1618	18	and	and	CC
25944	1618	19	are	be	VBP
25944	1618	20	without	without	IN
25944	1618	21	conspicuous	conspicuous	JJ
25944	1618	22	areola	areola	NN
25944	1618	23	.	.	.
25944	1619	1	The	the	DT
25944	1619	2	lesions	lesion	NNS
25944	1619	3	may	may	MD
25944	1619	4	attain	attain	VB
25944	1619	5	the	the	DT
25944	1619	6	size	size	NN
25944	1619	7	of	of	IN
25944	1619	8	a	a	DT
25944	1619	9	dime	dime	NN
25944	1619	10	or	or	CC
25944	1619	11	larger	large	JJR
25944	1619	12	,	,	,
25944	1619	13	and	and	CC
25944	1619	14	when	when	WRB
25944	1619	15	close	close	RB
25944	1619	16	together	together	RB
25944	1619	17	may	may	MD
25944	1619	18	coalesce	coalesce	VB
25944	1619	19	and	and	CC
25944	1619	20	form	form	VB
25944	1619	21	a	a	DT
25944	1619	22	large	large	JJ
25944	1619	23	patch	patch	NN
25944	1619	24	.	.	.
25944	1620	1	In	in	IN
25944	1620	2	some	some	DT
25944	1620	3	cases	case	NNS
25944	1620	4	distinct	distinct	JJ
25944	1620	5	blebs	blebs	NN
25944	1620	6	result	result	NN
25944	1620	7	,	,	,
25944	1620	8	and	and	CC
25944	1620	9	a	a	DT
25944	1620	10	picture	picture	NN
25944	1620	11	of	of	IN
25944	1620	12	pemphigus	pemphigus	JJ
25944	1620	13	eruption	eruption	NN
25944	1620	14	presented	present	VBD
25944	1620	15	;	;	:
25944	1620	16	it	-PRON-	PRP
25944	1620	17	is	be	VBZ
25944	1620	18	probable	probable	JJ
25944	1620	19	that	that	IN
25944	1620	20	many	many	JJ
25944	1620	21	of	of	IN
25944	1620	22	the	the	DT
25944	1620	23	cases	case	NNS
25944	1620	24	of	of	IN
25944	1620	25	"	"	``
25944	1620	26	contagious	contagious	JJ
25944	1620	27	pemphigus	pemphigus	NN
25944	1620	28	"	"	''
25944	1620	29	belong	belong	VBP
25944	1620	30	to	to	IN
25944	1620	31	this	this	DT
25944	1620	32	class	class	NN
25944	1620	33	.	.	.
25944	1621	1	New	new	JJ
25944	1621	2	lesions	lesion	NNS
25944	1621	3	may	may	MD
25944	1621	4	appear	appear	VB
25944	1621	5	for	for	IN
25944	1621	6	several	several	JJ
25944	1621	7	days	day	NNS
25944	1621	8	,	,	,
25944	1621	9	but	but	CC
25944	1621	10	finally	finally	RB
25944	1621	11	,	,	,
25944	1621	12	in	in	IN
25944	1621	13	the	the	DT
25944	1621	14	course	course	NN
25944	1621	15	of	of	IN
25944	1621	16	a	a	DT
25944	1621	17	week	week	NN
25944	1621	18	or	or	CC
25944	1621	19	ten	ten	CD
25944	1621	20	days	day	NNS
25944	1621	21	,	,	,
25944	1621	22	they	-PRON-	PRP
25944	1621	23	have	have	VBP
25944	1621	24	all	all	RB
25944	1621	25	dried	dry	VBN
25944	1621	26	to	to	IN
25944	1621	27	thin	thin	JJ
25944	1621	28	,	,	,
25944	1621	29	wafer	wafer	NN
25944	1621	30	-	-	HYPH
25944	1621	31	like	like	JJ
25944	1621	32	crusts	crust	NNS
25944	1621	33	,	,	,
25944	1621	34	of	of	IN
25944	1621	35	a	a	DT
25944	1621	36	straw	straw	NN
25944	1621	37	or	or	CC
25944	1621	38	light	light	JJ
25944	1621	39	-	-	HYPH
25944	1621	40	yellow	yellow	JJ
25944	1621	41	color	color	NN
25944	1621	42	,	,	,
25944	1621	43	but	but	CC
25944	1621	44	slightly	slightly	RB
25944	1621	45	adherent	adherent	JJ
25944	1621	46	,	,	,
25944	1621	47	and	and	CC
25944	1621	48	appearing	appear	VBG
25944	1621	49	as	as	IN
25944	1621	50	if	if	IN
25944	1621	51	stuck	stick	VBN
25944	1621	52	on	on	RB
25944	1621	53	;	;	,
25944	1621	54	these	these	DT
25944	1621	55	soon	soon	RB
25944	1621	56	drop	drop	VB
25944	1621	57	off	off	RP
25944	1621	58	,	,	,
25944	1621	59	leaving	leave	VBG
25944	1621	60	faint	faint	JJ
25944	1621	61	reddish	reddish	JJ
25944	1621	62	spots	spot	NNS
25944	1621	63	,	,	,
25944	1621	64	which	which	WDT
25944	1621	65	gradually	gradually	RB
25944	1621	66	fade	fade	VBP
25944	1621	67	.	.	.
25944	1622	1	In	in	IN
25944	1622	2	some	some	DT
25944	1622	3	cases	case	NNS
25944	1622	4	there	there	RB
25944	1622	5	is	be	VBZ
25944	1622	6	so	so	RB
25944	1622	7	decided	decide	VBN
25944	1622	8	a	a	DT
25944	1622	9	tendency	tendency	NN
25944	1622	10	to	to	TO
25944	1622	11	clear	clear	VB
25944	1622	12	and	and	CC
25944	1622	13	dry	dry	VB
25944	1622	14	up	up	RP
25944	1622	15	centrally	centrally	RB
25944	1622	16	while	while	IN
25944	1622	17	spreading	spread	VBG
25944	1622	18	peripherally	peripherally	RB
25944	1622	19	that	that	IN
25944	1622	20	the	the	DT
25944	1622	21	eruption	eruption	NN
25944	1622	22	has	have	VBZ
25944	1622	23	a	a	DT
25944	1622	24	ring	ring	NN
25944	1622	25	-	-	HYPH
25944	1622	26	like	like	JJ
25944	1622	27	aspect	aspect	NN
25944	1622	28	;	;	:
25944	1622	29	this	this	DT
25944	1622	30	seems	seem	VBZ
25944	1622	31	especially	especially	RB
25944	1622	32	so	so	RB
25944	1622	33	in	in	IN
25944	1622	34	the	the	DT
25944	1622	35	bearded	bearded	JJ
25944	1622	36	region	region	NN
25944	1622	37	of	of	IN
25944	1622	38	the	the	DT
25944	1622	39	male	male	JJ
25944	1622	40	adult	adult	NN
25944	1622	41	.	.	.
25944	1623	1	Instead	instead	RB
25944	1623	2	of	of	IN
25944	1623	3	presenting	present	VBG
25944	1623	4	as	as	IN
25944	1623	5	described	describe	VBN
25944	1623	6	,	,	,
25944	1623	7	it	-PRON-	PRP
25944	1623	8	may	may	MD
25944	1623	9	occur	occur	VB
25944	1623	10	as	as	IN
25944	1623	11	one	one	CD
25944	1623	12	or	or	CC
25944	1623	13	more	more	JJR
25944	1623	14	pea-	pea-	NNS
25944	1623	15	or	or	CC
25944	1623	16	finger	finger	NN
25944	1623	17	-	-	HYPH
25944	1623	18	nail	nail	NN
25944	1623	19	-	-	HYPH
25944	1623	20	sized	sized	JJ
25944	1623	21	,	,	,
25944	1623	22	rounded	rounded	JJ
25944	1623	23	and	and	CC
25944	1623	24	elevated	elevated	JJ
25944	1623	25	,	,	,
25944	1623	26	usually	usually	RB
25944	1623	27	firm	firm	JJ
25944	1623	28	,	,	,
25944	1623	29	discrete	discrete	JJ
25944	1623	30	pustules	pustule	NNS
25944	1623	31	,	,	,
25944	1623	32	scattered	scatter	VBN
25944	1623	33	over	over	IN
25944	1623	34	one	one	CD
25944	1623	35	part	part	NN
25944	1623	36	,	,	,
25944	1623	37	or	or	CC
25944	1623	38	more	more	RBR
25944	1623	39	commonly	commonly	RB
25944	1623	40	over	over	IN
25944	1623	41	various	various	JJ
25944	1623	42	regions	region	NNS
25944	1623	43	,	,	,
25944	1623	44	such	such	JJ
25944	1623	45	as	as	IN
25944	1623	46	the	the	DT
25944	1623	47	face	face	NN
25944	1623	48	,	,	,
25944	1623	49	hands	hand	NNS
25944	1623	50	,	,	,
25944	1623	51	feet	foot	NNS
25944	1623	52	and	and	CC
25944	1623	53	lower	low	JJR
25944	1623	54	extremities	extremity	NNS
25944	1623	55	.	.	.
25944	1624	1	The	the	DT
25944	1624	2	pustules	pustule	NNS
25944	1624	3	are	be	VBP
25944	1624	4	such	such	JJ
25944	1624	5	from	from	IN
25944	1624	6	the	the	DT
25944	1624	7	beginning	beginning	NN
25944	1624	8	,	,	,
25944	1624	9	and	and	CC
25944	1624	10	when	when	WRB
25944	1624	11	developed	develop	VBN
25944	1624	12	are	be	VBP
25944	1624	13	usually	usually	RB
25944	1624	14	of	of	IN
25944	1624	15	the	the	DT
25944	1624	16	size	size	NN
25944	1624	17	of	of	IN
25944	1624	18	a	a	DT
25944	1624	19	pea	pea	NN
25944	1624	20	or	or	CC
25944	1624	21	finger	finger	NN
25944	1624	22	-	-	HYPH
25944	1624	23	nail	nail	NN
25944	1624	24	,	,	,
25944	1624	25	elevated	elevated	JJ
25944	1624	26	,	,	,
25944	1624	27	semi	semi	JJ
25944	1624	28	-	-	JJ
25944	1624	29	globular	globular	JJ
25944	1624	30	or	or	CC
25944	1624	31	rounded	rounded	JJ
25944	1624	32	,	,	,
25944	1624	33	with	with	IN
25944	1624	34	somewhat	somewhat	RB
25944	1624	35	thick	thick	JJ
25944	1624	36	and	and	CC
25944	1624	37	tough	tough	JJ
25944	1624	38	walls	wall	NNS
25944	1624	39	,	,	,
25944	1624	40	and	and	CC
25944	1624	41	of	of	IN
25944	1624	42	a	a	DT
25944	1624	43	whitish	whitish	JJ
25944	1624	44	or	or	CC
25944	1624	45	yellowish	yellowish	JJ
25944	1624	46	color	color	NN
25944	1624	47	;	;	:
25944	1624	48	at	at	IN
25944	1624	49	first	first	RB
25944	1624	50	there	there	EX
25944	1624	51	may	may	MD
25944	1624	52	be	be	VB
25944	1624	53	a	a	DT
25944	1624	54	slight	slight	JJ
25944	1624	55	inflammatory	inflammatory	JJ
25944	1624	56	areola	areola	NN
25944	1624	57	,	,	,
25944	1624	58	but	but	CC
25944	1624	59	as	as	IN
25944	1624	60	the	the	DT
25944	1624	61	lesion	lesion	NN
25944	1624	62	matures	mature	VBZ
25944	1624	63	this	this	DT
25944	1624	64	almost	almost	RB
25944	1624	65	,	,	,
25944	1624	66	if	if	IN
25944	1624	67	not	not	RB
25944	1624	68	entirely	entirely	RB
25944	1624	69	,	,	,
25944	1624	70	disappears	disappear	VBZ
25944	1624	71	.	.	.
25944	1625	1	The	the	DT
25944	1625	2	pustules	pustule	NNS
25944	1625	3	show	show	VBP
25944	1625	4	no	no	DT
25944	1625	5	disposition	disposition	NN
25944	1625	6	to	to	IN
25944	1625	7	umbilication	umbilication	NN
25944	1625	8	,	,	,
25944	1625	9	rupture	rupture	NN
25944	1625	10	or	or	CC
25944	1625	11	coalescence	coalescence	NN
25944	1625	12	;	;	,
25944	1625	13	drying	dry	VBG
25944	1625	14	in	in	IN
25944	1625	15	the	the	DT
25944	1625	16	course	course	NN
25944	1625	17	of	of	IN
25944	1625	18	several	several	JJ
25944	1625	19	days	day	NNS
25944	1625	20	or	or	CC
25944	1625	21	a	a	DT
25944	1625	22	week	week	NN
25944	1625	23	to	to	TO
25944	1625	24	yellowish	yellowish	VB
25944	1625	25	or	or	CC
25944	1625	26	brownish	brownish	JJ
25944	1625	27	crusts	crust	NNS
25944	1625	28	,	,	,
25944	1625	29	which	which	WDT
25944	1625	30	soon	soon	RB
25944	1625	31	drop	drop	VBP
25944	1625	32	off	off	RP
25944	1625	33	,	,	,
25944	1625	34	leaving	leave	VBG
25944	1625	35	no	no	DT
25944	1625	36	permanent	permanent	JJ
25944	1625	37	trace	trace	NN
25944	1625	38	.	.	.
25944	1626	1	This	this	DT
25944	1626	2	variety	variety	NN
25944	1626	3	was	be	VBD
25944	1626	4	formerly	formerly	RB
25944	1626	5	thought	think	VBN
25944	1626	6	to	to	TO
25944	1626	7	be	be	VB
25944	1626	8	a	a	DT
25944	1626	9	distinct	distinct	JJ
25944	1626	10	disease	disease	NN
25944	1626	11	,	,	,
25944	1626	12	and	and	CC
25944	1626	13	was	be	VBD
25944	1626	14	described	describe	VBN
25944	1626	15	under	under	IN
25944	1626	16	the	the	DT
25944	1626	17	name	name	NN
25944	1626	18	of	of	IN
25944	1626	19	_	_	NNP
25944	1626	20	impetigo	impetigo	NNP
25944	1626	21	simplex	simplex	NNP
25944	1626	22	_	_	NNP
25944	1626	23	.	.	.
25944	1627	1	As	as	IN
25944	1627	2	a	a	DT
25944	1627	3	rule	rule	NN
25944	1627	4	there	there	EX
25944	1627	5	are	be	VBP
25944	1627	6	no	no	DT
25944	1627	7	constitutional	constitutional	JJ
25944	1627	8	symptoms	symptom	NNS
25944	1627	9	,	,	,
25944	1627	10	but	but	CC
25944	1627	11	in	in	IN
25944	1627	12	the	the	DT
25944	1627	13	more	more	RBR
25944	1627	14	severe	severe	JJ
25944	1627	15	cases	case	NNS
25944	1627	16	the	the	DT
25944	1627	17	eruption	eruption	NN
25944	1627	18	may	may	MD
25944	1627	19	be	be	VB
25944	1627	20	preceded	precede	VBN
25944	1627	21	by	by	IN
25944	1627	22	febrile	febrile	NN
25944	1627	23	disturbance	disturbance	NN
25944	1627	24	and	and	CC
25944	1627	25	malaise	malaise	NN
25944	1627	26	.	.	.
25944	1628	1	Itching	itching	NN
25944	1628	2	may	may	MD
25944	1628	3	or	or	CC
25944	1628	4	may	may	MD
25944	1628	5	not	not	RB
25944	1628	6	be	be	VB
25944	1628	7	present	present	JJ
25944	1628	8	.	.	.
25944	1629	1	#	#	JJR
25944	1629	2	State	state	NN
25944	1629	3	the	the	DT
25944	1629	4	cause	cause	NN
25944	1629	5	of	of	IN
25944	1629	6	the	the	DT
25944	1629	7	disease	disease	NN
25944	1629	8	.	.	.
25944	1629	9	#	#	$
25944	1629	10	It	-PRON-	PRP
25944	1629	11	is	be	VBZ
25944	1629	12	contagious	contagious	JJ
25944	1629	13	,	,	,
25944	1629	14	the	the	DT
25944	1629	15	contents	content	NNS
25944	1629	16	of	of	IN
25944	1629	17	the	the	DT
25944	1629	18	lesions	lesion	NNS
25944	1629	19	being	be	VBG
25944	1629	20	inoculable	inoculable	JJ
25944	1629	21	and	and	CC
25944	1629	22	auto	auto	NN
25944	1629	23	-	-	HYPH
25944	1629	24	inoculable	inoculable	JJ
25944	1629	25	.	.	.
25944	1630	1	At	at	IN
25944	1630	2	times	time	NNS
25944	1630	3	it	-PRON-	PRP
25944	1630	4	seems	seem	VBZ
25944	1630	5	to	to	TO
25944	1630	6	prevail	prevail	VB
25944	1630	7	in	in	IN
25944	1630	8	epidemic	epidemic	NN
25944	1630	9	form	form	NN
25944	1630	10	.	.	.
25944	1631	1	Pyogenic	pyogenic	JJ
25944	1631	2	microörganisms	microörganism	NNS
25944	1631	3	are	be	VBP
25944	1631	4	now	now	RB
25944	1631	5	regarded	regard	VBN
25944	1631	6	as	as	RB
25944	1631	7	causative	causative	JJ
25944	1631	8	.	.	.
25944	1632	1	A	a	DT
25944	1632	2	relationship	relationship	NN
25944	1632	3	to	to	IN
25944	1632	4	vaccination	vaccination	NN
25944	1632	5	has	have	VBZ
25944	1632	6	been	be	VBN
25944	1632	7	alleged	allege	VBN
25944	1632	8	by	by	IN
25944	1632	9	some	some	DT
25944	1632	10	observers	observer	NNS
25944	1632	11	.	.	.
25944	1633	1	It	-PRON-	PRP
25944	1633	2	is	be	VBZ
25944	1633	3	more	more	RBR
25944	1633	4	commonly	commonly	RB
25944	1633	5	observed	observe	VBN
25944	1633	6	in	in	IN
25944	1633	7	infants	infant	NNS
25944	1633	8	and	and	CC
25944	1633	9	young	young	JJ
25944	1633	10	children	child	NNS
25944	1633	11	.	.	.
25944	1634	1	#	#	$
25944	1634	2	From	from	IN
25944	1634	3	what	what	WP
25944	1634	4	diseases	disease	NNS
25944	1634	5	is	be	VBZ
25944	1634	6	impetigo	impetigo	NNP
25944	1634	7	contagiosa	contagiosa	NNP
25944	1634	8	to	to	TO
25944	1634	9	be	be	VB
25944	1634	10	differentiated	differentiate	VBN
25944	1634	11	?	?	.
25944	1634	12	#	#	$
25944	1634	13	From	from	IN
25944	1634	14	eczema	eczema	NN
25944	1634	15	,	,	,
25944	1634	16	pemphigus	pemphigus	NN
25944	1634	17	,	,	,
25944	1634	18	and	and	CC
25944	1634	19	ecthyma	ecthyma	NN
25944	1634	20	.	.	.
25944	1635	1	#	#	NNP
25944	1635	2	How	how	WRB
25944	1635	3	does	do	VBZ
25944	1635	4	impetigo	impetigo	NNP
25944	1635	5	contagiosa	contagiosa	VB
25944	1635	6	differ	differ	VB
25944	1635	7	from	from	IN
25944	1635	8	these	these	DT
25944	1635	9	several	several	JJ
25944	1635	10	diseases	disease	NNS
25944	1635	11	?	?	.
25944	1635	12	#	#	NN
25944	1635	13	By	by	IN
25944	1635	14	the	the	DT
25944	1635	15	character	character	NN
25944	1635	16	of	of	IN
25944	1635	17	the	the	DT
25944	1635	18	lesions	lesion	NNS
25944	1635	19	,	,	,
25944	1635	20	their	-PRON-	PRP$
25944	1635	21	growth	growth	NN
25944	1635	22	,	,	,
25944	1635	23	their	-PRON-	PRP$
25944	1635	24	superficial	superficial	JJ
25944	1635	25	nature	nature	NN
25944	1635	26	,	,	,
25944	1635	27	their	-PRON-	PRP$
25944	1635	28	course	course	NN
25944	1635	29	,	,	,
25944	1635	30	the	the	DT
25944	1635	31	absence	absence	NN
25944	1635	32	of	of	IN
25944	1635	33	an	an	DT
25944	1635	34	inflammatory	inflammatory	JJ
25944	1635	35	base	base	NN
25944	1635	36	and	and	CC
25944	1635	37	areola	areola	NNP
25944	1635	38	,	,	,
25944	1635	39	the	the	DT
25944	1635	40	thin	thin	JJ
25944	1635	41	,	,	,
25944	1635	42	yellowish	yellowish	JJ
25944	1635	43	,	,	,
25944	1635	44	wafer	wafer	NN
25944	1635	45	-	-	HYPH
25944	1635	46	like	like	JJ
25944	1635	47	crusts	crust	NNS
25944	1635	48	,	,	,
25944	1635	49	and	and	CC
25944	1635	50	usually	usually	RB
25944	1635	51	a	a	DT
25944	1635	52	history	history	NN
25944	1635	53	of	of	IN
25944	1635	54	contagion	contagion	NN
25944	1635	55	.	.	.
25944	1636	1	#	#	JJR
25944	1636	2	State	state	NN
25944	1636	3	the	the	DT
25944	1636	4	prognosis	prognosis	NN
25944	1636	5	.	.	.
25944	1636	6	#	#	$
25944	1636	7	The	the	DT
25944	1636	8	effect	effect	NN
25944	1636	9	of	of	IN
25944	1636	10	treatment	treatment	NN
25944	1636	11	is	be	VBZ
25944	1636	12	usually	usually	RB
25944	1636	13	prompt	prompt	JJ
25944	1636	14	.	.	.
25944	1637	1	The	the	DT
25944	1637	2	disease	disease	NN
25944	1637	3	,	,	,
25944	1637	4	indeed	indeed	RB
25944	1637	5	,	,	,
25944	1637	6	tends	tend	VBZ
25944	1637	7	to	to	IN
25944	1637	8	spontaneous	spontaneous	JJ
25944	1637	9	disappearance	disappearance	NN
25944	1637	10	in	in	IN
25944	1637	11	two	two	CD
25944	1637	12	to	to	TO
25944	1637	13	four	four	CD
25944	1637	14	weeks	week	NNS
25944	1637	15	;	;	:
25944	1637	16	in	in	IN
25944	1637	17	exceptional	exceptional	JJ
25944	1637	18	instances	instance	NNS
25944	1637	19	,	,	,
25944	1637	20	more	more	RBR
25944	1637	21	especially	especially	RB
25944	1637	22	in	in	IN
25944	1637	23	those	those	DT
25944	1637	24	cases	case	NNS
25944	1637	25	in	in	IN
25944	1637	26	which	which	WDT
25944	1637	27	itching	itching	NN
25944	1637	28	is	be	VBZ
25944	1637	29	present	present	JJ
25944	1637	30	,	,	,
25944	1637	31	the	the	DT
25944	1637	32	excoriations	excoriation	NNS
25944	1637	33	or	or	CC
25944	1637	34	scratch	scratch	NN
25944	1637	35	-	-	HYPH
25944	1637	36	marks	mark	NNS
25944	1637	37	become	become	VBP
25944	1637	38	inoculated	inoculated	JJ
25944	1637	39	,	,	,
25944	1637	40	and	and	CC
25944	1637	41	in	in	IN
25944	1637	42	this	this	DT
25944	1637	43	way	way	NN
25944	1637	44	it	-PRON-	PRP
25944	1637	45	may	may	MD
25944	1637	46	persist	persist	VB
25944	1637	47	several	several	JJ
25944	1637	48	weeks	week	NNS
25944	1637	49	.	.	.
25944	1638	1	#	#	LS
25944	1638	2	What	what	WP
25944	1638	3	is	be	VBZ
25944	1638	4	the	the	DT
25944	1638	5	treatment	treatment	NN
25944	1638	6	of	of	IN
25944	1638	7	impetigo	impetigo	NNP
25944	1638	8	contagiosa	contagiosa	NNP
25944	1638	9	?	?	.
25944	1638	10	#	#	$
25944	1638	11	Treatment	Treatment	NNP
25944	1638	12	consists	consist	VBZ
25944	1638	13	in	in	IN
25944	1638	14	the	the	DT
25944	1638	15	destruction	destruction	NN
25944	1638	16	of	of	IN
25944	1638	17	the	the	DT
25944	1638	18	auto	auto	NN
25944	1638	19	-	-	HYPH
25944	1638	20	inoculable	inoculable	JJ
25944	1638	21	properties	property	NNS
25944	1638	22	of	of	IN
25944	1638	23	the	the	DT
25944	1638	24	contents	content	NNS
25944	1638	25	of	of	IN
25944	1638	26	the	the	DT
25944	1638	27	lesions	lesion	NNS
25944	1638	28	;	;	:
25944	1638	29	this	this	DT
25944	1638	30	is	be	VBZ
25944	1638	31	effected	effect	VBN
25944	1638	32	by	by	IN
25944	1638	33	removing	remove	VBG
25944	1638	34	the	the	DT
25944	1638	35	crusts	crust	NNS
25944	1638	36	by	by	IN
25944	1638	37	means	mean	NNS
25944	1638	38	of	of	IN
25944	1638	39	warm	warm	JJ
25944	1638	40	water	water	NN
25944	1638	41	-	-	HYPH
25944	1638	42	and	and	CC
25944	1638	43	-	-	HYPH
25944	1638	44	soap	soap	NN
25944	1638	45	washings	washing	NNS
25944	1638	46	,	,	,
25944	1638	47	and	and	CC
25944	1638	48	subsequently	subsequently	RB
25944	1638	49	rubbing	rub	VBG
25944	1638	50	in	in	IN
25944	1638	51	an	an	DT
25944	1638	52	ointment	ointment	NN
25944	1638	53	of	of	IN
25944	1638	54	ammoniated	ammoniate	VBN
25944	1638	55	mercury	mercury	NNP
25944	1638	56	,	,	,
25944	1638	57	ten	ten	CD
25944	1638	58	to	to	TO
25944	1638	59	twenty	twenty	CD
25944	1638	60	grains	grain	NNS
25944	1638	61	to	to	IN
25944	1638	62	the	the	DT
25944	1638	63	ounce	ounce	NN
25944	1638	64	.	.	.
25944	1639	1	Some	some	DT
25944	1639	2	cases	case	NNS
25944	1639	3	respond	respond	VBP
25944	1639	4	more	more	RBR
25944	1639	5	rapidly	rapidly	RB
25944	1639	6	to	to	IN
25944	1639	7	the	the	DT
25944	1639	8	use	use	NN
25944	1639	9	of	of	IN
25944	1639	10	a	a	DT
25944	1639	11	drying	drying	NN
25944	1639	12	ointment	ointment	NN
25944	1639	13	,	,	,
25944	1639	14	such	such	JJ
25944	1639	15	as	as	IN
25944	1639	16	Lassar	Lassar	NNP
25944	1639	17	's	's	POS
25944	1639	18	paste	paste	NN
25944	1639	19	,	,	,
25944	1639	20	with	with	IN
25944	1639	21	ten	ten	CD
25944	1639	22	to	to	TO
25944	1639	23	twenty	twenty	CD
25944	1639	24	grains	grain	NNS
25944	1639	25	of	of	IN
25944	1639	26	white	white	JJ
25944	1639	27	precipitate	precipitate	NN
25944	1639	28	or	or	CC
25944	1639	29	sulphur	sulphur	NNP
25944	1639	30	to	to	IN
25944	1639	31	the	the	DT
25944	1639	32	ounce	ounce	NN
25944	1639	33	.	.	.
25944	1640	1	In	in	IN
25944	1640	2	itching	itch	VBG
25944	1640	3	cases	case	NNS
25944	1640	4	,	,	,
25944	1640	5	a	a	DT
25944	1640	6	saturated	saturate	VBN
25944	1640	7	solution	solution	NN
25944	1640	8	of	of	IN
25944	1640	9	boric	boric	NN
25944	1640	10	acid	acid	NN
25944	1640	11	,	,	,
25944	1640	12	or	or	CC
25944	1640	13	a	a	DT
25944	1640	14	carbolic	carbolic	JJ
25944	1640	15	-	-	HYPH
25944	1640	16	acid	acid	NN
25944	1640	17	lotion	lotion	NN
25944	1640	18	,	,	,
25944	1640	19	one	one	CD
25944	1640	20	to	to	TO
25944	1640	21	two	two	CD
25944	1640	22	drachms	drachm	NNS
25944	1640	23	to	to	IN
25944	1640	24	the	the	DT
25944	1640	25	pint	pint	NN
25944	1640	26	,	,	,
25944	1640	27	is	be	VBZ
25944	1640	28	to	to	TO
25944	1640	29	be	be	VB
25944	1640	30	employed	employ	VBN
25944	1640	31	for	for	IN
25944	1640	32	general	general	JJ
25944	1640	33	application	application	NN
25944	1640	34	.	.	.
25944	1641	1	#	#	NNP
25944	1641	2	Impetigo	Impetigo	NNP
25944	1641	3	Herpetiformis	Herpetiformis	NNP
25944	1641	4	.	.	.
25944	1641	5	#	#	$
25944	1641	6	#	#	$
25944	1641	7	Describe	Describe	NNP
25944	1641	8	impetigo	impetigo	NNP
25944	1641	9	herpetiformis	herpetiformis	NN
25944	1641	10	.	.	.
25944	1641	11	#	#	$
25944	1641	12	Impetigo	Impetigo	NNP
25944	1641	13	herpetiformis	herpetiformis	NNP
25944	1641	14	is	be	VBZ
25944	1641	15	an	an	DT
25944	1641	16	extremely	extremely	RB
25944	1641	17	rare	rare	JJ
25944	1641	18	disease	disease	NN
25944	1641	19	,	,	,
25944	1641	20	observed	observe	VBN
25944	1641	21	usually	usually	RB
25944	1641	22	in	in	IN
25944	1641	23	pregnant	pregnant	JJ
25944	1641	24	women	woman	NNS
25944	1641	25	,	,	,
25944	1641	26	and	and	CC
25944	1641	27	is	be	VBZ
25944	1641	28	characterized	characterize	VBN
25944	1641	29	by	by	IN
25944	1641	30	the	the	DT
25944	1641	31	appearance	appearance	NN
25944	1641	32	of	of	IN
25944	1641	33	numerous	numerous	JJ
25944	1641	34	isolated	isolated	JJ
25944	1641	35	and	and	CC
25944	1641	36	closely	closely	RB
25944	1641	37	-	-	HYPH
25944	1641	38	crowded	crowded	JJ
25944	1641	39	pin	pin	NN
25944	1641	40	-	-	HYPH
25944	1641	41	head	head	NN
25944	1641	42	-	-	HYPH
25944	1641	43	sized	sized	JJ
25944	1641	44	superficial	superficial	JJ
25944	1641	45	pustules	pustule	NNS
25944	1641	46	,	,	,
25944	1641	47	which	which	WDT
25944	1641	48	show	show	VBP
25944	1641	49	a	a	DT
25944	1641	50	decided	decide	VBN
25944	1641	51	disposition	disposition	NN
25944	1641	52	to	to	IN
25944	1641	53	the	the	DT
25944	1641	54	formation	formation	NN
25944	1641	55	of	of	IN
25944	1641	56	circular	circular	JJ
25944	1641	57	groups	group	NNS
25944	1641	58	or	or	CC
25944	1641	59	patches	patch	NNS
25944	1641	60	.	.	.
25944	1642	1	The	the	DT
25944	1642	2	central	central	JJ
25944	1642	3	portion	portion	NN
25944	1642	4	of	of	IN
25944	1642	5	these	these	DT
25944	1642	6	groups	group	NNS
25944	1642	7	dries	dry	VBZ
25944	1642	8	to	to	IN
25944	1642	9	crusts	crust	NNS
25944	1642	10	,	,	,
25944	1642	11	while	while	IN
25944	1642	12	new	new	JJ
25944	1642	13	pustules	pustule	NNS
25944	1642	14	appear	appear	VBP
25944	1642	15	at	at	IN
25944	1642	16	the	the	DT
25944	1642	17	peripheral	peripheral	JJ
25944	1642	18	portion	portion	NN
25944	1642	19	.	.	.
25944	1643	1	They	-PRON-	PRP
25944	1643	2	tend	tend	VBP
25944	1643	3	to	to	TO
25944	1643	4	coalesce	coalesce	VB
25944	1643	5	,	,	,
25944	1643	6	and	and	CC
25944	1643	7	in	in	IN
25944	1643	8	this	this	DT
25944	1643	9	manner	manner	NN
25944	1643	10	a	a	DT
25944	1643	11	greater	great	JJR
25944	1643	12	part	part	NN
25944	1643	13	of	of	IN
25944	1643	14	the	the	DT
25944	1643	15	whole	whole	JJ
25944	1643	16	surface	surface	NN
25944	1643	17	may	may	MD
25944	1643	18	,	,	,
25944	1643	19	in	in	IN
25944	1643	20	the	the	DT
25944	1643	21	course	course	NN
25944	1643	22	of	of	IN
25944	1643	23	weeks	week	NNS
25944	1643	24	or	or	CC
25944	1643	25	months	month	NNS
25944	1643	26	,	,	,
25944	1643	27	become	become	VBP
25944	1643	28	involved	involved	JJ
25944	1643	29	.	.	.
25944	1644	1	Profound	profound	JJ
25944	1644	2	constitutional	constitutional	JJ
25944	1644	3	disturbance	disturbance	NN
25944	1644	4	,	,	,
25944	1644	5	usually	usually	RB
25944	1644	6	of	of	IN
25944	1644	7	a	a	DT
25944	1644	8	septic	septic	JJ
25944	1644	9	character	character	NN
25944	1644	10	,	,	,
25944	1644	11	precedes	precede	NNS
25944	1644	12	and	and	CC
25944	1644	13	accompanies	accompany	VBZ
25944	1644	14	the	the	DT
25944	1644	15	disease	disease	NN
25944	1644	16	;	;	:
25944	1644	17	in	in	IN
25944	1644	18	almost	almost	RB
25944	1644	19	every	every	DT
25944	1644	20	instance	instance	NN
25944	1644	21	a	a	DT
25944	1644	22	fatal	fatal	JJ
25944	1644	23	termination	termination	NN
25944	1644	24	sooner	soon	RBR
25944	1644	25	or	or	CC
25944	1644	26	later	later	JJ
25944	1644	27	results	result	NNS
25944	1644	28	.	.	.
25944	1645	1	It	-PRON-	PRP
25944	1645	2	is	be	VBZ
25944	1645	3	possibly	possibly	RB
25944	1645	4	a	a	DT
25944	1645	5	grave	grave	JJ
25944	1645	6	type	type	NN
25944	1645	7	of	of	IN
25944	1645	8	dermatitis	dermatitis	NN
25944	1645	9	herpetiformis	herpetiformis	NN
25944	1645	10	.	.	.
25944	1646	1	#	#	NNP
25944	1646	2	Ecthyma	Ecthyma	NNP
25944	1646	3	.	.	.
25944	1646	4	#	#	$
25944	1646	5	#	#	NN
25944	1646	6	Give	give	VB
25944	1646	7	a	a	DT
25944	1646	8	descriptive	descriptive	JJ
25944	1646	9	definition	definition	NN
25944	1646	10	of	of	IN
25944	1646	11	ecthyma	ecthyma	NN
25944	1646	12	.	.	.
25944	1646	13	#	#	NNP
25944	1646	14	Ecthyma	Ecthyma	NNP
25944	1646	15	is	be	VBZ
25944	1646	16	a	a	DT
25944	1646	17	disease	disease	NN
25944	1646	18	characterized	characterize	VBN
25944	1646	19	by	by	IN
25944	1646	20	the	the	DT
25944	1646	21	appearance	appearance	NN
25944	1646	22	of	of	IN
25944	1646	23	one	one	CD
25944	1646	24	,	,	,
25944	1646	25	several	several	JJ
25944	1646	26	or	or	CC
25944	1646	27	more	more	RBR
25944	1646	28	discrete	discrete	JJ
25944	1646	29	,	,	,
25944	1646	30	finger	finger	NN
25944	1646	31	-	-	HYPH
25944	1646	32	nail	nail	NN
25944	1646	33	-	-	HYPH
25944	1646	34	sized	sized	JJ
25944	1646	35	,	,	,
25944	1646	36	flat	flat	JJ
25944	1646	37	,	,	,
25944	1646	38	usually	usually	RB
25944	1646	39	markedly	markedly	RB
25944	1646	40	inflammatory	inflammatory	JJ
25944	1646	41	pustules	pustule	NNS
25944	1646	42	.	.	.
25944	1647	1	#	#	NNP
25944	1647	2	Describe	describe	VB
25944	1647	3	the	the	DT
25944	1647	4	symptoms	symptom	NNS
25944	1647	5	and	and	CC
25944	1647	6	course	course	NN
25944	1647	7	of	of	IN
25944	1647	8	ecthyma	ecthyma	NN
25944	1647	9	.	.	.
25944	1647	10	#	#	$
25944	1647	11	The	the	DT
25944	1647	12	lesions	lesion	NNS
25944	1647	13	begin	begin	VBP
25944	1647	14	as	as	IN
25944	1647	15	small	small	JJ
25944	1647	16	,	,	,
25944	1647	17	usually	usually	RB
25944	1647	18	pea	pea	JJ
25944	1647	19	-	-	HYPH
25944	1647	20	sized	sized	JJ
25944	1647	21	,	,	,
25944	1647	22	pustules	pustule	NNS
25944	1647	23	;	;	:
25944	1647	24	increase	increase	VB
25944	1647	25	somewhat	somewhat	RB
25944	1647	26	in	in	IN
25944	1647	27	area	area	NN
25944	1647	28	,	,	,
25944	1647	29	and	and	CC
25944	1647	30	when	when	WRB
25944	1647	31	fully	fully	RB
25944	1647	32	developed	develop	VBN
25944	1647	33	are	be	VBP
25944	1647	34	dime	dime	NN
25944	1647	35	-	-	HYPH
25944	1647	36	sized	sized	JJ
25944	1647	37	,	,	,
25944	1647	38	or	or	CC
25944	1647	39	larger	large	JJR
25944	1647	40	,	,	,
25944	1647	41	somewhat	somewhat	RB
25944	1647	42	flat	flat	JJ
25944	1647	43	,	,	,
25944	1647	44	with	with	IN
25944	1647	45	a	a	DT
25944	1647	46	markedly	markedly	RB
25944	1647	47	inflammatory	inflammatory	JJ
25944	1647	48	base	base	NN
25944	1647	49	and	and	CC
25944	1647	50	areola	areola	NNP
25944	1647	51	.	.	.
25944	1648	1	At	at	IN
25944	1648	2	first	first	RB
25944	1648	3	yellowish	yellowish	UH
25944	1648	4	they	-PRON-	PRP
25944	1648	5	soon	soon	RB
25944	1648	6	become	become	VBP
25944	1648	7	,	,	,
25944	1648	8	from	from	IN
25944	1648	9	the	the	DT
25944	1648	10	admixture	admixture	NN
25944	1648	11	of	of	IN
25944	1648	12	blood	blood	NN
25944	1648	13	,	,	,
25944	1648	14	reddish	reddish	JJ
25944	1648	15	,	,	,
25944	1648	16	and	and	CC
25944	1648	17	dry	dry	JJ
25944	1648	18	to	to	IN
25944	1648	19	brownish	brownish	NNP
25944	1648	20	crusts	crust	NNS
25944	1648	21	,	,	,
25944	1648	22	beneath	beneath	IN
25944	1648	23	which	which	WDT
25944	1648	24	will	will	MD
25944	1648	25	be	be	VB
25944	1648	26	found	find	VBN
25944	1648	27	superficial	superficial	JJ
25944	1648	28	excoriations	excoriation	NNS
25944	1648	29	.	.	.
25944	1649	1	The	the	DT
25944	1649	2	individual	individual	JJ
25944	1649	3	pustules	pustule	NNS
25944	1649	4	are	be	VBP
25944	1649	5	usually	usually	RB
25944	1649	6	somewhat	somewhat	RB
25944	1649	7	acute	acute	JJ
25944	1649	8	in	in	IN
25944	1649	9	their	-PRON-	PRP$
25944	1649	10	course	course	NN
25944	1649	11	,	,	,
25944	1649	12	but	but	CC
25944	1649	13	new	new	JJ
25944	1649	14	lesions	lesion	NNS
25944	1649	15	may	may	MD
25944	1649	16	continue	continue	VB
25944	1649	17	to	to	TO
25944	1649	18	appear	appear	VB
25944	1649	19	from	from	IN
25944	1649	20	day	day	NN
25944	1649	21	to	to	IN
25944	1649	22	day	day	NN
25944	1649	23	or	or	CC
25944	1649	24	week	week	NN
25944	1649	25	to	to	IN
25944	1649	26	week	week	NN
25944	1649	27	.	.	.
25944	1650	1	As	as	IN
25944	1650	2	a	a	DT
25944	1650	3	rule	rule	NN
25944	1650	4	,	,	,
25944	1650	5	not	not	RB
25944	1650	6	more	more	JJR
25944	1650	7	than	than	IN
25944	1650	8	five	five	CD
25944	1650	9	to	to	TO
25944	1650	10	twenty	twenty	CD
25944	1650	11	are	be	VBP
25944	1650	12	present	present	JJ
25944	1650	13	at	at	IN
25944	1650	14	one	one	CD
25944	1650	15	time	time	NN
25944	1650	16	,	,	,
25944	1650	17	and	and	CC
25944	1650	18	in	in	IN
25944	1650	19	most	most	JJS
25944	1650	20	cases	case	NNS
25944	1650	21	they	-PRON-	PRP
25944	1650	22	are	be	VBP
25944	1650	23	seated	seat	VBN
25944	1650	24	on	on	IN
25944	1650	25	the	the	DT
25944	1650	26	legs	leg	NNS
25944	1650	27	.	.	.
25944	1651	1	More	More	JJR
25944	1651	2	or	or	CC
25944	1651	3	less	less	JJR
25944	1651	4	pigmentation	pigmentation	NN
25944	1651	5	,	,	,
25944	1651	6	and	and	CC
25944	1651	7	sometimes	sometimes	RB
25944	1651	8	superficial	superficial	JJ
25944	1651	9	scarring	scar	VBG
25944	1651	10	,	,	,
25944	1651	11	may	may	MD
25944	1651	12	remain	remain	VB
25944	1651	13	to	to	TO
25944	1651	14	mark	mark	VB
25944	1651	15	the	the	DT
25944	1651	16	site	site	NN
25944	1651	17	of	of	IN
25944	1651	18	the	the	DT
25944	1651	19	lesions	lesion	NNS
25944	1651	20	.	.	.
25944	1652	1	Itching	itching	NN
25944	1652	2	is	be	VBZ
25944	1652	3	rarely	rarely	RB
25944	1652	4	present	present	JJ
25944	1652	5	,	,	,
25944	1652	6	but	but	CC
25944	1652	7	there	there	EX
25944	1652	8	may	may	MD
25944	1652	9	be	be	VB
25944	1652	10	more	more	RBR
25944	1652	11	or	or	CC
25944	1652	12	less	less	JJR
25944	1652	13	pain	pain	NN
25944	1652	14	and	and	CC
25944	1652	15	tenderness	tenderness	NN
25944	1652	16	.	.	.
25944	1653	1	#	#	LS
25944	1653	2	What	what	WP
25944	1653	3	is	be	VBZ
25944	1653	4	the	the	DT
25944	1653	5	cause	cause	NN
25944	1653	6	of	of	IN
25944	1653	7	ecthyma	ecthyma	NN
25944	1653	8	?	?	.
25944	1653	9	#	#	$
25944	1653	10	It	-PRON-	PRP
25944	1653	11	is	be	VBZ
25944	1653	12	essentially	essentially	RB
25944	1653	13	a	a	DT
25944	1653	14	disease	disease	NN
25944	1653	15	of	of	IN
25944	1653	16	the	the	DT
25944	1653	17	poorly	poorly	RB
25944	1653	18	cared	care	VBN
25944	1653	19	-	-	HYPH
25944	1653	20	for	for	IN
25944	1653	21	and	and	CC
25944	1653	22	ill	ill	RB
25944	1653	23	-	-	HYPH
25944	1653	24	fed	fed	NNP
25944	1653	25	;	;	:
25944	1653	26	the	the	DT
25944	1653	27	direct	direct	JJ
25944	1653	28	exciting	exciting	JJ
25944	1653	29	cause	cause	NN
25944	1653	30	is	be	VBZ
25944	1653	31	the	the	DT
25944	1653	32	introduction	introduction	NN
25944	1653	33	of	of	IN
25944	1653	34	pyogenic	pyogenic	JJ
25944	1653	35	microörganisms	microörganism	NNS
25944	1653	36	into	into	IN
25944	1653	37	the	the	DT
25944	1653	38	follicular	follicular	JJ
25944	1653	39	openings	opening	NNS
25944	1653	40	.	.	.
25944	1654	1	It	-PRON-	PRP
25944	1654	2	is	be	VBZ
25944	1654	3	closely	closely	RB
25944	1654	4	allied	ally	VBN
25944	1654	5	to	to	IN
25944	1654	6	impetigo	impetigo	NNP
25944	1654	7	contagiosa	contagiosa	NNP
25944	1654	8	,	,	,
25944	1654	9	and	and	CC
25944	1654	10	may	may	MD
25944	1654	11	in	in	IN
25944	1654	12	fact	fact	NN
25944	1654	13	be	be	VB
25944	1654	14	regarded	regard	VBN
25944	1654	15	as	as	IN
25944	1654	16	a	a	DT
25944	1654	17	markedly	markedly	RB
25944	1654	18	inflammatory	inflammatory	JJ
25944	1654	19	form	form	NN
25944	1654	20	of	of	IN
25944	1654	21	the	the	DT
25944	1654	22	latter	latter	JJ
25944	1654	23	affection	affection	NN
25944	1654	24	.	.	.
25944	1655	1	It	-PRON-	PRP
25944	1655	2	seems	seem	VBZ
25944	1655	3	much	much	RB
25944	1655	4	less	less	RBR
25944	1655	5	contagious	contagious	JJ
25944	1655	6	,	,	,
25944	1655	7	however	however	RB
25944	1655	8	.	.	.
25944	1656	1	It	-PRON-	PRP
25944	1656	2	is	be	VBZ
25944	1656	3	commonly	commonly	RB
25944	1656	4	observed	observe	VBN
25944	1656	5	in	in	IN
25944	1656	6	male	male	JJ
25944	1656	7	adults	adult	NNS
25944	1656	8	.	.	.
25944	1657	1	#	#	$
25944	1657	2	From	from	IN
25944	1657	3	what	what	WP
25944	1657	4	diseases	disease	NNS
25944	1657	5	is	be	VBZ
25944	1657	6	ecthyma	ecthyma	NN
25944	1657	7	to	to	TO
25944	1657	8	be	be	VB
25944	1657	9	differentiated	differentiate	VBN
25944	1657	10	?	?	.
25944	1657	11	#	#	$
25944	1657	12	From	from	IN
25944	1657	13	impetigo	impetigo	NNP
25944	1657	14	contagiosa	contagiosa	NNP
25944	1657	15	,	,	,
25944	1657	16	and	and	CC
25944	1657	17	the	the	DT
25944	1657	18	flat	flat	JJ
25944	1657	19	pustular	pustular	JJ
25944	1657	20	syphiloderm	syphiloderm	NN
25944	1657	21	.	.	.
25944	1658	1	#	#	NNP
25944	1658	2	How	how	WRB
25944	1658	3	is	be	VBZ
25944	1658	4	it	-PRON-	PRP
25944	1658	5	distinguished	distinguish	VBN
25944	1658	6	from	from	IN
25944	1658	7	these	these	DT
25944	1658	8	several	several	JJ
25944	1658	9	diseases	disease	NNS
25944	1658	10	?	?	.
25944	1658	11	#	#	$
25944	1658	12	The	the	DT
25944	1658	13	size	size	NN
25944	1658	14	,	,	,
25944	1658	15	shape	shape	NN
25944	1658	16	,	,	,
25944	1658	17	inflammatory	inflammatory	JJ
25944	1658	18	action	action	NN
25944	1658	19	,	,	,
25944	1658	20	and	and	CC
25944	1658	21	the	the	DT
25944	1658	22	depraved	depraved	JJ
25944	1658	23	general	general	JJ
25944	1658	24	condition	condition	NN
25944	1658	25	,	,	,
25944	1658	26	the	the	DT
25944	1658	27	distribution	distribution	NN
25944	1658	28	and	and	CC
25944	1658	29	lesser	less	JJR
25944	1658	30	-	-	HYPH
25944	1658	31	contagiousness	contagiousness	RB
25944	1658	32	will	will	MD
25944	1658	33	distinguish	distinguish	VB
25944	1658	34	it	-PRON-	PRP
25944	1658	35	from	from	IN
25944	1658	36	impetigo	impetigo	NNP
25944	1658	37	contagiosa	contagiosa	NNP
25944	1658	38	;	;	:
25944	1658	39	and	and	CC
25944	1658	40	the	the	DT
25944	1658	41	absence	absence	NN
25944	1658	42	of	of	IN
25944	1658	43	concomitant	concomitant	JJ
25944	1658	44	symptoms	symptom	NNS
25944	1658	45	of	of	IN
25944	1658	46	syphilis	syphilis	NNP
25944	1658	47	,	,	,
25944	1658	48	and	and	CC
25944	1658	49	of	of	IN
25944	1658	50	positive	positive	JJ
25944	1658	51	ulceration	ulceration	NN
25944	1658	52	,	,	,
25944	1658	53	as	as	RB
25944	1658	54	well	well	RB
25944	1658	55	as	as	IN
25944	1658	56	its	-PRON-	PRP$
25944	1658	57	distribution	distribution	NN
25944	1658	58	and	and	CC
25944	1658	59	more	more	RBR
25944	1658	60	rapid	rapid	JJ
25944	1658	61	and	and	CC
25944	1658	62	inflammatory	inflammatory	JJ
25944	1658	63	course	course	NN
25944	1658	64	,	,	,
25944	1658	65	will	will	MD
25944	1658	66	exclude	exclude	VB
25944	1658	67	the	the	DT
25944	1658	68	pustular	pustular	JJ
25944	1658	69	syphiloderm	syphiloderm	NN
25944	1658	70	.	.	.
25944	1659	1	#	#	JJR
25944	1659	2	State	state	NN
25944	1659	3	the	the	DT
25944	1659	4	prognosis	prognosis	NN
25944	1659	5	.	.	.
25944	1659	6	#	#	$
25944	1659	7	The	the	DT
25944	1659	8	disease	disease	NN
25944	1659	9	is	be	VBZ
25944	1659	10	readily	readily	RB
25944	1659	11	curable	curable	JJ
25944	1659	12	,	,	,
25944	1659	13	disappearing	disappear	VBG
25944	1659	14	upon	upon	IN
25944	1659	15	the	the	DT
25944	1659	16	removal	removal	NN
25944	1659	17	of	of	IN
25944	1659	18	the	the	DT
25944	1659	19	predisposing	predisposing	NN
25944	1659	20	cause	cause	NN
25944	1659	21	and	and	CC
25944	1659	22	the	the	DT
25944	1659	23	employment	employment	NN
25944	1659	24	of	of	IN
25944	1659	25	local	local	JJ
25944	1659	26	antiseptic	antiseptic	JJ
25944	1659	27	applications	application	NNS
25944	1659	28	.	.	.
25944	1660	1	#	#	LS
25944	1660	2	What	what	WDT
25944	1660	3	treatment	treatment	NN
25944	1660	4	is	be	VBZ
25944	1660	5	to	to	TO
25944	1660	6	be	be	VB
25944	1660	7	advised	advise	VBN
25944	1660	8	?	?	.
25944	1660	9	#	#	$
25944	1660	10	Good	good	JJ
25944	1660	11	food	food	NN
25944	1660	12	,	,	,
25944	1660	13	proper	proper	JJ
25944	1660	14	hygiene	hygiene	NN
25944	1660	15	and	and	CC
25944	1660	16	tonic	tonic	NN
25944	1660	17	remedies	remedy	NNS
25944	1660	18	;	;	:
25944	1660	19	and	and	CC
25944	1660	20	,	,	,
25944	1660	21	locally	locally	RB
25944	1660	22	,	,	,
25944	1660	23	removal	removal	NN
25944	1660	24	of	of	IN
25944	1660	25	the	the	DT
25944	1660	26	crusts	crust	NNS
25944	1660	27	and	and	CC
25944	1660	28	stimulation	stimulation	NN
25944	1660	29	of	of	IN
25944	1660	30	the	the	DT
25944	1660	31	underlying	underlie	VBG
25944	1660	32	surface	surface	NN
25944	1660	33	with	with	IN
25944	1660	34	an	an	DT
25944	1660	35	ointment	ointment	NN
25944	1660	36	of	of	IN
25944	1660	37	ammoniated	ammoniate	VBN
25944	1660	38	mercury	mercury	NN
25944	1660	39	,	,	,
25944	1660	40	ten	ten	CD
25944	1660	41	to	to	IN
25944	1660	42	thirty	thirty	CD
25944	1660	43	grains	grain	NNS
25944	1660	44	to	to	IN
25944	1660	45	the	the	DT
25944	1660	46	ounce	ounce	NN
25944	1660	47	.	.	.
25944	1661	1	The	the	DT
25944	1661	2	following	follow	VBG
25944	1661	3	mild	mild	JJ
25944	1661	4	antiseptic	antiseptic	JJ
25944	1661	5	lotion	lotion	NN
25944	1661	6	,	,	,
25944	1661	7	which	which	WDT
25944	1661	8	materially	materially	RB
25944	1661	9	lessens	lessen	VBZ
25944	1661	10	the	the	DT
25944	1661	11	tendency	tendency	NN
25944	1661	12	to	to	IN
25944	1661	13	the	the	DT
25944	1661	14	formation	formation	NN
25944	1661	15	of	of	IN
25944	1661	16	new	new	JJ
25944	1661	17	lesions	lesion	NNS
25944	1661	18	,	,	,
25944	1661	19	may	may	MD
25944	1661	20	be	be	VB
25944	1661	21	applied	apply	VBN
25944	1661	22	to	to	IN
25944	1661	23	the	the	DT
25944	1661	24	affected	affected	JJ
25944	1661	25	region	region	NN
25944	1661	26	two	two	CD
25944	1661	27	or	or	CC
25944	1661	28	three	three	CD
25944	1661	29	times	time	NNS
25944	1661	30	daily:--	daily:--	.
25944	1661	31	[	[	-LRB-
25944	1661	32	Rx	Rx	NNP
25944	1661	33	]	]	-RRB-
25944	1661	34	Acidi	Acidi	NNP
25944	1661	35	borici	borici	NN
25944	1661	36	,	,	,
25944	1661	37	........................	........................	NFP
25944	1661	38	[	[	-LRB-
25944	1661	39	dram]iv	dram]iv	NNP
25944	1661	40	Resorcini	Resorcini	NNP
25944	1661	41	,	,	,
25944	1661	42	...........................	...........................	NFP
25944	1661	43	[	[	-LRB-
25944	1661	44	dram]ij	dram]ij	VBP
25944	1661	45	Glycerinæ	Glycerinæ	NNP
25944	1661	46	,	,	,
25944	1661	47	...........................	...........................	NFP
25944	1661	48	f[dram]ij	f[dram]ij	NFP
25944	1661	49	Alcoholis	Alcoholis	NNP
25944	1661	50	,	,	,
25944	1661	51	...........................	...........................	NFP
25944	1661	52	f[Oz]j	f[Oz]j	NNP
25944	1661	53	Aquæ	Aquæ	NNP
25944	1661	54	,	,	,
25944	1661	55	...........	...........	NFP
25944	1661	56	q.s	q.s	NNP
25944	1661	57	.	.	.
25944	1662	1	ad	ad	NN
25944	1662	2	............	............	.
25944	1662	3	Oj	oj	UH
25944	1662	4	.	.	.
25944	1663	1	M.	M.	NNP
25944	1663	2	A	a	DT
25944	1663	3	weak	weak	JJ
25944	1663	4	lotion	lotion	NN
25944	1663	5	of	of	IN
25944	1663	6	thymol	thymol	NN
25944	1663	7	,	,	,
25944	1663	8	corrosive	corrosive	JJ
25944	1663	9	sublimate	sublimate	NN
25944	1663	10	or	or	CC
25944	1663	11	ichthyol	ichthyol	NN
25944	1663	12	would	would	MD
25944	1663	13	doubtless	doubtless	RB
25944	1663	14	be	be	VB
25944	1663	15	equally	equally	RB
25944	1663	16	effectual	effectual	JJ
25944	1663	17	.	.	.
25944	1664	1	#	#	NNP
25944	1664	2	Pemphigus	Pemphigus	NNP
25944	1664	3	.	.	.
25944	1664	4	#	#	$
25944	1664	5	#	#	$
25944	1664	6	What	what	WP
25944	1664	7	do	do	VBP
25944	1664	8	you	-PRON-	PRP
25944	1664	9	understand	understand	VB
25944	1664	10	by	by	IN
25944	1664	11	pemphigus	pemphigus	NNP
25944	1664	12	?	?	.
25944	1664	13	#	#	NNP
25944	1664	14	Pemphigus	Pemphigus	NNP
25944	1664	15	is	be	VBZ
25944	1664	16	an	an	DT
25944	1664	17	acute	acute	JJ
25944	1664	18	or	or	CC
25944	1664	19	chronic	chronic	JJ
25944	1664	20	disease	disease	NN
25944	1664	21	characterized	characterize	VBN
25944	1664	22	by	by	IN
25944	1664	23	the	the	DT
25944	1664	24	successive	successive	JJ
25944	1664	25	formation	formation	NN
25944	1664	26	of	of	IN
25944	1664	27	irregularly	irregularly	RB
25944	1664	28	-	-	HYPH
25944	1664	29	scattered	scatter	VBN
25944	1664	30	,	,	,
25944	1664	31	variously	variously	RB
25944	1664	32	-	-	HYPH
25944	1664	33	sized	sized	JJ
25944	1664	34	blebs	blebs	NN
25944	1664	35	.	.	.
25944	1665	1	#	#	JJR
25944	1665	2	Name	name	VB
25944	1665	3	the	the	DT
25944	1665	4	varieties	variety	NNS
25944	1665	5	met	meet	VBD
25944	1665	6	with	with	IN
25944	1665	7	.	.	.
25944	1665	8	#	#	$
25944	1665	9	Two	two	CD
25944	1665	10	varieties	variety	NNS
25944	1665	11	are	be	VBP
25944	1665	12	usually	usually	RB
25944	1665	13	described	describe	VBN
25944	1665	14	--	--	:
25944	1665	15	pemphigus	pemphigus	NNP
25944	1665	16	vulgaris	vulgaris	NNP
25944	1665	17	and	and	CC
25944	1665	18	pemphigus	pemphigus	NNP
25944	1665	19	foliaceus	foliaceus	NNP
25944	1665	20	.	.	.
25944	1666	1	#	#	NNP
25944	1666	2	Describe	describe	VB
25944	1666	3	the	the	DT
25944	1666	4	symptoms	symptom	NNS
25944	1666	5	and	and	CC
25944	1666	6	course	course	NN
25944	1666	7	of	of	IN
25944	1666	8	pemphigus	pemphigus	NNP
25944	1666	9	vulgaris	vulgaris	NN
25944	1666	10	.	.	.
25944	1666	11	#	#	NNP
25944	1666	12	With	with	IN
25944	1666	13	or	or	CC
25944	1666	14	without	without	IN
25944	1666	15	precursory	precursory	JJ
25944	1666	16	symptoms	symptom	NNS
25944	1666	17	of	of	IN
25944	1666	18	systemic	systemic	JJ
25944	1666	19	disturbance	disturbance	NN
25944	1666	20	,	,	,
25944	1666	21	irregularly	irregularly	RB
25944	1666	22	scattered	scatter	VBN
25944	1666	23	blebs	blebs	NN
25944	1666	24	,	,	,
25944	1666	25	few	few	JJ
25944	1666	26	or	or	CC
25944	1666	27	in	in	IN
25944	1666	28	numbers	number	NNS
25944	1666	29	,	,	,
25944	1666	30	make	make	VB
25944	1666	31	their	-PRON-	PRP$
25944	1666	32	appearance	appearance	NN
25944	1666	33	,	,	,
25944	1666	34	arising	arise	VBG
25944	1666	35	from	from	IN
25944	1666	36	erythematous	erythematous	JJ
25944	1666	37	spots	spot	NNS
25944	1666	38	or	or	CC
25944	1666	39	from	from	IN
25944	1666	40	apparently	apparently	RB
25944	1666	41	normal	normal	JJ
25944	1666	42	skin	skin	NN
25944	1666	43	.	.	.
25944	1667	1	They	-PRON-	PRP
25944	1667	2	vary	vary	VBP
25944	1667	3	in	in	IN
25944	1667	4	size	size	NN
25944	1667	5	from	from	IN
25944	1667	6	a	a	DT
25944	1667	7	pea	pea	NN
25944	1667	8	to	to	IN
25944	1667	9	a	a	DT
25944	1667	10	large	large	JJ
25944	1667	11	egg	egg	NN
25944	1667	12	,	,	,
25944	1667	13	are	be	VBP
25944	1667	14	rounded	rounded	JJ
25944	1667	15	or	or	CC
25944	1667	16	ovalish	ovalish	JJ
25944	1667	17	,	,	,
25944	1667	18	usually	usually	RB
25944	1667	19	distended	distend	VBN
25944	1667	20	,	,	,
25944	1667	21	and	and	CC
25944	1667	22	contain	contain	VB
25944	1667	23	a	a	DT
25944	1667	24	yellowish	yellowish	JJ
25944	1667	25	fluid	fluid	NN
25944	1667	26	which	which	WDT
25944	1667	27	,	,	,
25944	1667	28	later	later	RB
25944	1667	29	,	,	,
25944	1667	30	becomes	become	VBZ
25944	1667	31	cloudy	cloudy	JJ
25944	1667	32	or	or	CC
25944	1667	33	puriform	puriform	NN
25944	1667	34	.	.	.
25944	1668	1	If	if	IN
25944	1668	2	ruptured	rupture	VBN
25944	1668	3	,	,	,
25944	1668	4	the	the	DT
25944	1668	5	rete	rete	NN
25944	1668	6	is	be	VBZ
25944	1668	7	exposed	expose	VBN
25944	1668	8	,	,	,
25944	1668	9	but	but	CC
25944	1668	10	the	the	DT
25944	1668	11	skin	skin	NN
25944	1668	12	soon	soon	RB
25944	1668	13	regains	regain	VBZ
25944	1668	14	its	-PRON-	PRP$
25944	1668	15	normal	normal	JJ
25944	1668	16	condition	condition	NN
25944	1668	17	;	;	:
25944	1668	18	if	if	IN
25944	1668	19	undisturbed	undisturbed	JJ
25944	1668	20	,	,	,
25944	1668	21	the	the	DT
25944	1668	22	fluid	fluid	NN
25944	1668	23	usually	usually	RB
25944	1668	24	disappears	disappear	VBZ
25944	1668	25	by	by	IN
25944	1668	26	absorption	absorption	NN
25944	1668	27	.	.	.
25944	1669	1	Each	each	DT
25944	1669	2	lesion	lesion	NN
25944	1669	3	runs	run	VBZ
25944	1669	4	its	-PRON-	PRP$
25944	1669	5	course	course	NN
25944	1669	6	in	in	IN
25944	1669	7	several	several	JJ
25944	1669	8	days	day	NNS
25944	1669	9	or	or	CC
25944	1669	10	a	a	DT
25944	1669	11	week	week	NN
25944	1669	12	.	.	.
25944	1670	1	A	a	DT
25944	1670	2	grave	grave	JJ
25944	1670	3	type	type	NN
25944	1670	4	of	of	IN
25944	1670	5	pemphigus	pemphigus	NN
25944	1670	6	is	be	VBZ
25944	1670	7	exceptionally	exceptionally	RB
25944	1670	8	observed	observe	VBN
25944	1670	9	in	in	IN
25944	1670	10	the	the	DT
25944	1670	11	newborn--_pemphigus	newborn--_pemphigus	NNP
25944	1670	12	neonatorum	neonatorum	NN
25944	1670	13	_	_	NNP
25944	1670	14	.	.	.
25944	1671	1	#	#	LS
25944	1671	2	What	what	WDT
25944	1671	3	course	course	NN
25944	1671	4	does	do	VBZ
25944	1671	5	pemphigus	pemphigus	NNP
25944	1671	6	vulgaris	vulgaris	NNP
25944	1671	7	pursue	pursue	NN
25944	1671	8	?	?	.
25944	1671	9	#	#	NN
25944	1671	10	Usually	usually	RB
25944	1671	11	chronic	chronic	JJ
25944	1671	12	.	.	.
25944	1672	1	The	the	DT
25944	1672	2	disease	disease	NN
25944	1672	3	may	may	MD
25944	1672	4	subside	subside	VB
25944	1672	5	in	in	IN
25944	1672	6	several	several	JJ
25944	1672	7	months	month	NNS
25944	1672	8	and	and	CC
25944	1672	9	the	the	DT
25944	1672	10	process	process	NN
25944	1672	11	come	come	VBD
25944	1672	12	to	to	IN
25944	1672	13	an	an	DT
25944	1672	14	end	end	NN
25944	1672	15	,	,	,
25944	1672	16	constituting	constitute	VBG
25944	1672	17	the	the	DT
25944	1672	18	acute	acute	JJ
25944	1672	19	type	type	NN
25944	1672	20	.	.	.
25944	1673	1	As	as	IN
25944	1673	2	a	a	DT
25944	1673	3	rule	rule	NN
25944	1673	4	,	,	,
25944	1673	5	however	however	RB
25944	1673	6	,	,	,
25944	1673	7	the	the	DT
25944	1673	8	disease	disease	NN
25944	1673	9	is	be	VBZ
25944	1673	10	chronic	chronic	JJ
25944	1673	11	,	,	,
25944	1673	12	new	new	JJ
25944	1673	13	blebs	blebs	NN
25944	1673	14	continuing	continue	VBG
25944	1673	15	to	to	TO
25944	1673	16	appear	appear	VB
25944	1673	17	from	from	IN
25944	1673	18	time	time	NN
25944	1673	19	to	to	IN
25944	1673	20	time	time	NN
25944	1673	21	for	for	IN
25944	1673	22	an	an	DT
25944	1673	23	indefinite	indefinite	JJ
25944	1673	24	period	period	NN
25944	1673	25	.	.	.
25944	1674	1	[	[	-LRB-
25944	1674	2	Illustration	illustration	NN
25944	1674	3	:	:	:
25944	1674	4	Fig	Fig	NNP
25944	1674	5	.	.	.
25944	1675	1	30	30	CD
25944	1675	2	.	.	.
25944	1676	1	Pemphigus	Pemphigus	NNP
25944	1676	2	(	(	-LRB-
25944	1676	3	mulatto	mulatto	NN
25944	1676	4	)	)	-RRB-
25944	1676	5	.	.	.
25944	1676	6	]	]	-RRB-
25944	1677	1	#	#	$
25944	1677	2	In	in	IN
25944	1677	3	what	what	WDT
25944	1677	4	respects	respect	VBZ
25944	1677	5	does	do	VBZ
25944	1677	6	the	the	DT
25944	1677	7	severe	severe	JJ
25944	1677	8	form	form	NN
25944	1677	9	of	of	IN
25944	1677	10	pemphigus	pemphigus	NNP
25944	1677	11	vulgaris	vulgaris	NNP
25944	1677	12	differ	differ	VBP
25944	1677	13	from	from	IN
25944	1677	14	the	the	DT
25944	1677	15	ordinary	ordinary	JJ
25944	1677	16	type	type	NN
25944	1677	17	?	?	.
25944	1677	18	#	#	$
25944	1677	19	In	in	IN
25944	1677	20	the	the	DT
25944	1677	21	severe	severe	JJ
25944	1677	22	or	or	CC
25944	1677	23	malignant	malignant	JJ
25944	1677	24	type	type	NN
25944	1677	25	the	the	DT
25944	1677	26	eruption	eruption	NN
25944	1677	27	is	be	VBZ
25944	1677	28	more	more	JJR
25944	1677	29	profuse	profuse	NN
25944	1677	30	;	;	:
25944	1677	31	there	there	EX
25944	1677	32	is	be	VBZ
25944	1677	33	marked	mark	VBN
25944	1677	34	,	,	,
25944	1677	35	and	and	CC
25944	1677	36	often	often	RB
25944	1677	37	grave	grave	JJ
25944	1677	38	,	,	,
25944	1677	39	systemic	systemic	JJ
25944	1677	40	depression	depression	NN
25944	1677	41	,	,	,
25944	1677	42	and	and	CC
25944	1677	43	the	the	DT
25944	1677	44	lesions	lesion	NNS
25944	1677	45	are	be	VBP
25944	1677	46	attended	attend	VBN
25944	1677	47	with	with	IN
25944	1677	48	ulcerative	ulcerative	JJ
25944	1677	49	action	action	NN
25944	1677	50	.	.	.
25944	1678	1	#	#	NNP
25944	1678	2	Describe	describe	VB
25944	1678	3	the	the	DT
25944	1678	4	symptoms	symptom	NNS
25944	1678	5	and	and	CC
25944	1678	6	course	course	NN
25944	1678	7	of	of	IN
25944	1678	8	pemphigus	pemphigus	JJ
25944	1678	9	foliaceus	foliaceus	NN
25944	1678	10	.	.	.
25944	1678	11	#	#	NNP
25944	1678	12	In	in	IN
25944	1678	13	this	this	DT
25944	1678	14	,	,	,
25944	1678	15	the	the	DT
25944	1678	16	grave	grave	JJ
25944	1678	17	type	type	NN
25944	1678	18	of	of	IN
25944	1678	19	the	the	DT
25944	1678	20	disease	disease	NN
25944	1678	21	,	,	,
25944	1678	22	the	the	DT
25944	1678	23	blebs	blebs	NN
25944	1678	24	are	be	VBP
25944	1678	25	loose	loose	JJ
25944	1678	26	and	and	CC
25944	1678	27	flaccid	flaccid	JJ
25944	1678	28	,	,	,
25944	1678	29	with	with	IN
25944	1678	30	milky	milky	NNP
25944	1678	31	or	or	CC
25944	1678	32	puriform	puriform	NN
25944	1678	33	contents	content	NNS
25944	1678	34	,	,	,
25944	1678	35	rupturing	rupture	VBG
25944	1678	36	and	and	CC
25944	1678	37	drying	dry	VBG
25944	1678	38	to	to	IN
25944	1678	39	crusts	crust	NNS
25944	1678	40	,	,	,
25944	1678	41	which	which	WDT
25944	1678	42	are	be	VBP
25944	1678	43	cast	cast	VBN
25944	1678	44	off	off	RP
25944	1678	45	,	,	,
25944	1678	46	disclosing	disclose	VBG
25944	1678	47	the	the	DT
25944	1678	48	reddened	redden	VBN
25944	1678	49	corium	corium	NN
25944	1678	50	.	.	.
25944	1679	1	New	new	JJ
25944	1679	2	blebs	blebs	NN
25944	1679	3	appear	appear	VB
25944	1679	4	on	on	IN
25944	1679	5	the	the	DT
25944	1679	6	sites	site	NNS
25944	1679	7	of	of	IN
25944	1679	8	disappearing	disappear	VBG
25944	1679	9	or	or	CC
25944	1679	10	half	half	RB
25944	1679	11	-	-	HYPH
25944	1679	12	ruptured	rupture	VBN
25944	1679	13	lesions	lesion	NNS
25944	1679	14	,	,	,
25944	1679	15	and	and	CC
25944	1679	16	the	the	DT
25944	1679	17	whole	whole	JJ
25944	1679	18	surface	surface	NN
25944	1679	19	may	may	MD
25944	1679	20	be	be	VB
25944	1679	21	thus	thus	RB
25944	1679	22	involved	involve	VBN
25944	1679	23	and	and	CC
25944	1679	24	the	the	DT
25944	1679	25	disease	disease	NN
25944	1679	26	continue	continue	VBP
25944	1679	27	for	for	IN
25944	1679	28	years	year	NNS
25944	1679	29	,	,	,
25944	1679	30	compromising	compromise	VBG
25944	1679	31	the	the	DT
25944	1679	32	general	general	JJ
25944	1679	33	health	health	NN
25944	1679	34	and	and	CC
25944	1679	35	eventually	eventually	RB
25944	1679	36	ending	end	VBG
25944	1679	37	fatally	fatally	RB
25944	1679	38	.	.	.
25944	1680	1	In	in	IN
25944	1680	2	some	some	DT
25944	1680	3	cases	case	NNS
25944	1680	4	of	of	IN
25944	1680	5	pemphigus	pemphigus	NNP
25944	1680	6	(	(	-LRB-
25944	1680	7	pemphigus	pemphigus	NNP
25944	1680	8	vegetans	vegetans	NNP
25944	1680	9	)	)	-RRB-
25944	1680	10	a	a	DT
25944	1680	11	vegetating	vegetate	VBG
25944	1680	12	or	or	CC
25944	1680	13	papillomatous	papillomatous	JJ
25944	1680	14	condition	condition	NN
25944	1680	15	develops	develop	VBZ
25944	1680	16	from	from	IN
25944	1680	17	the	the	DT
25944	1680	18	base	base	NN
25944	1680	19	of	of	IN
25944	1680	20	the	the	DT
25944	1680	21	lesion	lesion	NN
25944	1680	22	,	,	,
25944	1680	23	with	with	IN
25944	1680	24	an	an	DT
25944	1680	25	offensive	offensive	JJ
25944	1680	26	discharge	discharge	NN
25944	1680	27	;	;	:
25944	1680	28	it	-PRON-	PRP
25944	1680	29	is	be	VBZ
25944	1680	30	usually	usually	RB
25944	1680	31	a	a	DT
25944	1680	32	grave	grave	JJ
25944	1680	33	type	type	NN
25944	1680	34	of	of	IN
25944	1680	35	the	the	DT
25944	1680	36	malady	malady	NN
25944	1680	37	.	.	.
25944	1681	1	Exceptionally	exceptionally	RB
25944	1681	2	cases	case	NNS
25944	1681	3	(	(	-LRB-
25944	1681	4	dermatitis	dermatitis	NN
25944	1681	5	vegetans	vegetan	NNS
25944	1681	6	)	)	-RRB-
25944	1681	7	are	be	VBP
25944	1681	8	met	meet	VBN
25944	1681	9	with	with	IN
25944	1681	10	which	which	WDT
25944	1681	11	have	have	VBP
25944	1681	12	a	a	DT
25944	1681	13	close	close	JJ
25944	1681	14	similarity	similarity	NN
25944	1681	15	in	in	IN
25944	1681	16	their	-PRON-	PRP$
25944	1681	17	symptoms	symptom	NNS
25944	1681	18	to	to	IN
25944	1681	19	pemphigus	pemphigus	NNP
25944	1681	20	vegetans	vegetan	NNS
25944	1681	21	,	,	,
25944	1681	22	but	but	CC
25944	1681	23	in	in	IN
25944	1681	24	which	which	WDT
25944	1681	25	the	the	DT
25944	1681	26	eruption	eruption	NN
25944	1681	27	is	be	VBZ
25944	1681	28	more	more	RBR
25944	1681	29	or	or	CC
25944	1681	30	less	less	RBR
25944	1681	31	limited	limited	JJ
25944	1681	32	to	to	IN
25944	1681	33	the	the	DT
25944	1681	34	genitocrural	genitocrural	JJ
25944	1681	35	region	region	NN
25944	1681	36	.	.	.
25944	1682	1	The	the	DT
25944	1682	2	disorder	disorder	NN
25944	1682	3	is	be	VBZ
25944	1682	4	not	not	RB
25944	1682	5	malignant	malignant	JJ
25944	1682	6	and	and	CC
25944	1682	7	usually	usually	RB
25944	1682	8	yields	yield	VBZ
25944	1682	9	to	to	IN
25944	1682	10	cleanliness	cleanliness	NN
25944	1682	11	and	and	CC
25944	1682	12	antiseptics	antiseptic	NNS
25944	1682	13	.	.	.
25944	1683	1	#	#	LS
25944	1683	2	What	what	WP
25944	1683	3	is	be	VBZ
25944	1683	4	the	the	DT
25944	1683	5	character	character	NN
25944	1683	6	of	of	IN
25944	1683	7	the	the	DT
25944	1683	8	subjective	subjective	JJ
25944	1683	9	symptoms	symptom	NNS
25944	1683	10	in	in	IN
25944	1683	11	pemphigus	pemphigus	NNP
25944	1683	12	?	?	.
25944	1683	13	#	#	$
25944	1683	14	The	the	DT
25944	1683	15	subjective	subjective	JJ
25944	1683	16	symptoms	symptom	NNS
25944	1683	17	consist	consist	VBP
25944	1683	18	variously	variously	RB
25944	1683	19	of	of	IN
25944	1683	20	heat	heat	NN
25944	1683	21	,	,	,
25944	1683	22	tenderness	tenderness	NN
25944	1683	23	,	,	,
25944	1683	24	pain	pain	NN
25944	1683	25	,	,	,
25944	1683	26	burning	burning	NN
25944	1683	27	and	and	CC
25944	1683	28	itching	itching	NN
25944	1683	29	,	,	,
25944	1683	30	and	and	CC
25944	1683	31	may	may	MD
25944	1683	32	be	be	VB
25944	1683	33	slight	slight	JJ
25944	1683	34	or	or	CC
25944	1683	35	troublesome	troublesome	JJ
25944	1683	36	.	.	.
25944	1684	1	#	#	LS
25944	1684	2	What	what	WP
25944	1684	3	is	be	VBZ
25944	1684	4	known	know	VBN
25944	1684	5	in	in	IN
25944	1684	6	regard	regard	NN
25944	1684	7	to	to	IN
25944	1684	8	the	the	DT
25944	1684	9	etiology	etiology	NN
25944	1684	10	of	of	IN
25944	1684	11	pemphigus	pemphigus	NNP
25944	1684	12	?	?	.
25944	1684	13	#	#	$
25944	1684	14	The	the	DT
25944	1684	15	causes	cause	NNS
25944	1684	16	are	be	VBP
25944	1684	17	obscure	obscure	JJ
25944	1684	18	;	;	:
25944	1684	19	general	general	JJ
25944	1684	20	debility	debility	NN
25944	1684	21	,	,	,
25944	1684	22	overwork	overwork	NN
25944	1684	23	,	,	,
25944	1684	24	shock	shock	NN
25944	1684	25	,	,	,
25944	1684	26	nervous	nervous	JJ
25944	1684	27	exhaustion	exhaustion	NN
25944	1684	28	,	,	,
25944	1684	29	and	and	CC
25944	1684	30	septic	septic	NN
25944	1684	31	conditions	condition	NNS
25944	1684	32	(	(	-LRB-
25944	1684	33	microörganisms	microörganism	NNS
25944	1684	34	)	)	-RRB-
25944	1684	35	are	be	VBP
25944	1684	36	thought	think	VBN
25944	1684	37	to	to	TO
25944	1684	38	be	be	VB
25944	1684	39	of	of	IN
25944	1684	40	influence	influence	NN
25944	1684	41	.	.	.
25944	1685	1	There	there	EX
25944	1685	2	seems	seem	VBZ
25944	1685	3	no	no	DT
25944	1685	4	doubt	doubt	NN
25944	1685	5	that	that	IN
25944	1685	6	those	those	DT
25944	1685	7	who	who	WP
25944	1685	8	have	have	VBP
25944	1685	9	to	to	TO
25944	1685	10	do	do	VB
25944	1685	11	with	with	IN
25944	1685	12	cattle	cattle	NNS
25944	1685	13	products	product	NNS
25944	1685	14	,	,	,
25944	1685	15	especially	especially	RB
25944	1685	16	butchers	butcher	NNS
25944	1685	17	,	,	,
25944	1685	18	are	be	VBP
25944	1685	19	subjects	subject	NNS
25944	1685	20	of	of	IN
25944	1685	21	acute	acute	NN
25944	1685	22	and	and	CC
25944	1685	23	usually	usually	RB
25944	1685	24	grave	grave	VBP
25944	1685	25	pemphigus	pemphigus	NNP
25944	1685	26	.	.	.
25944	1686	1	Vaccination	Vaccination	NNP
25944	1686	2	has	have	VBZ
25944	1686	3	exceptionally	exceptionally	RB
25944	1686	4	been	be	VBN
25944	1686	5	responsible	responsible	JJ
25944	1686	6	for	for	IN
25944	1686	7	the	the	DT
25944	1686	8	disease	disease	NN
25944	1686	9	,	,	,
25944	1686	10	probably	probably	RB
25944	1686	11	through	through	IN
25944	1686	12	some	some	DT
25944	1686	13	coincidental	coincidental	JJ
25944	1686	14	infection	infection	NN
25944	1686	15	.	.	.
25944	1687	1	The	the	DT
25944	1687	2	disease	disease	NN
25944	1687	3	is	be	VBZ
25944	1687	4	not	not	RB
25944	1687	5	contagious	contagious	JJ
25944	1687	6	,	,	,
25944	1687	7	nor	nor	CC
25944	1687	8	is	be	VBZ
25944	1687	9	it	-PRON-	PRP
25944	1687	10	due	due	JJ
25944	1687	11	to	to	IN
25944	1687	12	syphilis	syphilis	NNP
25944	1687	13	.	.	.
25944	1688	1	It	-PRON-	PRP
25944	1688	2	may	may	MD
25944	1688	3	occur	occur	VB
25944	1688	4	at	at	IN
25944	1688	5	any	any	DT
25944	1688	6	age	age	NN
25944	1688	7	.	.	.
25944	1689	1	It	-PRON-	PRP
25944	1689	2	is	be	VBZ
25944	1689	3	a	a	DT
25944	1689	4	rare	rare	JJ
25944	1689	5	disease	disease	NN
25944	1689	6	,	,	,
25944	1689	7	especially	especially	RB
25944	1689	8	in	in	IN
25944	1689	9	this	this	DT
25944	1689	10	country	country	NN
25944	1689	11	.	.	.
25944	1690	1	Most	Most	JJS
25944	1690	2	of	of	IN
25944	1690	3	the	the	DT
25944	1690	4	cases	case	NNS
25944	1690	5	diagnosed	diagnose	VBN
25944	1690	6	as	as	IN
25944	1690	7	pemphigus	pemphigu	VBN
25944	1690	8	by	by	IN
25944	1690	9	the	the	DT
25944	1690	10	inexperienced	inexperienced	JJ
25944	1690	11	are	be	VBP
25944	1690	12	examples	example	NNS
25944	1690	13	of	of	IN
25944	1690	14	bullous	bullous	JJ
25944	1690	15	urticaria	urticaria	JJ
25944	1690	16	,	,	,
25944	1690	17	bullous	bullous	JJ
25944	1690	18	erythema	erythema	NNP
25944	1690	19	multiforme	multiforme	NNP
25944	1690	20	,	,	,
25944	1690	21	and	and	CC
25944	1690	22	impetigo	impetigo	NNP
25944	1690	23	contagiosa	contagiosa	NNP
25944	1690	24	.	.	.
25944	1691	1	#	#	LS
25944	1691	2	What	what	WP
25944	1691	3	is	be	VBZ
25944	1691	4	the	the	DT
25944	1691	5	pathology	pathology	NN
25944	1691	6	?	?	.
25944	1691	7	#	#	$
25944	1691	8	The	the	DT
25944	1691	9	lesions	lesion	NNS
25944	1691	10	are	be	VBP
25944	1691	11	superficially	superficially	RB
25944	1691	12	seated	seat	VBN
25944	1691	13	,	,	,
25944	1691	14	usually	usually	RB
25944	1691	15	between	between	IN
25944	1691	16	the	the	DT
25944	1691	17	horny	horny	JJ
25944	1691	18	layer	layer	NN
25944	1691	19	and	and	CC
25944	1691	20	upper	upper	JJ
25944	1691	21	part	part	NN
25944	1691	22	of	of	IN
25944	1691	23	the	the	DT
25944	1691	24	rete	rete	NN
25944	1691	25	.	.	.
25944	1692	1	Round	round	JJ
25944	1692	2	-	-	HYPH
25944	1692	3	cell	cell	NN
25944	1692	4	infiltration	infiltration	NN
25944	1692	5	and	and	CC
25944	1692	6	dilated	dilate	VBN
25944	1692	7	blood	blood	NN
25944	1692	8	vessels	vessel	NNS
25944	1692	9	are	be	VBP
25944	1692	10	found	find	VBN
25944	1692	11	about	about	IN
25944	1692	12	the	the	DT
25944	1692	13	papillæ	papillæ	NN
25944	1692	14	and	and	CC
25944	1692	15	in	in	IN
25944	1692	16	the	the	DT
25944	1692	17	subcutaneous	subcutaneous	JJ
25944	1692	18	tissue	tissue	NN
25944	1692	19	.	.	.
25944	1693	1	The	the	DT
25944	1693	2	contents	content	NNS
25944	1693	3	of	of	IN
25944	1693	4	the	the	DT
25944	1693	5	blebs	blebs	NN
25944	1693	6	,	,	,
25944	1693	7	always	always	RB
25944	1693	8	of	of	IN
25944	1693	9	alkaline	alkaline	NN
25944	1693	10	reaction	reaction	NN
25944	1693	11	,	,	,
25944	1693	12	are	be	VBP
25944	1693	13	at	at	IN
25944	1693	14	first	first	RB
25944	1693	15	serous	serous	JJ
25944	1693	16	,	,	,
25944	1693	17	later	later	RB
25944	1693	18	containing	contain	VBG
25944	1693	19	blood	blood	NN
25944	1693	20	corpuscles	corpuscle	NNS
25944	1693	21	,	,	,
25944	1693	22	pus	pus	NNP
25944	1693	23	,	,	,
25944	1693	24	fatty	fatty	NN
25944	1693	25	-	-	HYPH
25944	1693	26	acid	acid	NN
25944	1693	27	crystals	crystal	NNS
25944	1693	28	,	,	,
25944	1693	29	epithelial	epithelial	JJ
25944	1693	30	cells	cell	NNS
25944	1693	31	,	,	,
25944	1693	32	and	and	CC
25944	1693	33	occasionally	occasionally	RB
25944	1693	34	uric	uric	JJ
25944	1693	35	acid	acid	NN
25944	1693	36	crystals	crystal	NNS
25944	1693	37	and	and	CC
25944	1693	38	free	free	JJ
25944	1693	39	ammonia	ammonia	NN
25944	1693	40	.	.	.
25944	1694	1	#	#	$
25944	1694	2	From	from	IN
25944	1694	3	what	what	WP
25944	1694	4	diseases	disease	NNS
25944	1694	5	is	be	VBZ
25944	1694	6	pemphigus	pemphigus	JJ
25944	1694	7	to	to	TO
25944	1694	8	be	be	VB
25944	1694	9	differentiated	differentiate	VBN
25944	1694	10	?	?	.
25944	1694	11	#	#	$
25944	1694	12	From	from	IN
25944	1694	13	herpes	herpes	NNP
25944	1694	14	iris	iris	NNP
25944	1694	15	,	,	,
25944	1694	16	the	the	DT
25944	1694	17	bullous	bullous	NNP
25944	1694	18	syphiloderm	syphiloderm	NNP
25944	1694	19	,	,	,
25944	1694	20	impetigo	impetigo	NNP
25944	1694	21	contagiosa	contagiosa	NNP
25944	1694	22	and	and	CC
25944	1694	23	dermatitis	dermatitis	NNP
25944	1694	24	herpetiformis	herpetiformis	NNP
25944	1694	25	.	.	.
25944	1695	1	#	#	NNP
25944	1695	2	How	how	WRB
25944	1695	3	do	do	VBP
25944	1695	4	these	these	DT
25944	1695	5	several	several	JJ
25944	1695	6	diseases	disease	NNS
25944	1695	7	differ	differ	VBP
25944	1695	8	from	from	IN
25944	1695	9	pemphigus	pemphigus	NNP
25944	1695	10	?	?	.
25944	1695	11	#	#	$
25944	1695	12	The	the	DT
25944	1695	13	acute	acute	JJ
25944	1695	14	course	course	NN
25944	1695	15	,	,	,
25944	1695	16	small	small	JJ
25944	1695	17	lesions	lesion	NNS
25944	1695	18	,	,	,
25944	1695	19	concentric	concentric	JJ
25944	1695	20	arrangement	arrangement	NN
25944	1695	21	,	,	,
25944	1695	22	variegated	variegate	VBD
25944	1695	23	colors	color	NNS
25944	1695	24	,	,	,
25944	1695	25	and	and	CC
25944	1695	26	distribution	distribution	NN
25944	1695	27	,	,	,
25944	1695	28	in	in	IN
25944	1695	29	herpes	herpes	NNP
25944	1695	30	iris	iris	NNP
25944	1695	31	;	;	:
25944	1695	32	the	the	DT
25944	1695	33	thick	thick	JJ
25944	1695	34	,	,	,
25944	1695	35	bulky	bulky	JJ
25944	1695	36	,	,	,
25944	1695	37	greenish	greenish	JJ
25944	1695	38	crusts	crust	NNS
25944	1695	39	,	,	,
25944	1695	40	the	the	DT
25944	1695	41	underlying	underlie	VBG
25944	1695	42	ulceration	ulceration	NN
25944	1695	43	,	,	,
25944	1695	44	the	the	DT
25944	1695	45	course	course	NN
25944	1695	46	,	,	,
25944	1695	47	history	history	NN
25944	1695	48	,	,	,
25944	1695	49	and	and	CC
25944	1695	50	the	the	DT
25944	1695	51	presence	presence	NN
25944	1695	52	of	of	IN
25944	1695	53	concomitant	concomitant	JJ
25944	1695	54	symptoms	symptom	NNS
25944	1695	55	of	of	IN
25944	1695	56	syphilis	syphilis	NNP
25944	1695	57	,	,	,
25944	1695	58	in	in	IN
25944	1695	59	the	the	DT
25944	1695	60	bullous	bullous	JJ
25944	1695	61	syphiloderm	syphiloderm	NN
25944	1695	62	;	;	:
25944	1695	63	the	the	DT
25944	1695	64	history	history	NN
25944	1695	65	,	,	,
25944	1695	66	course	course	NN
25944	1695	67	,	,	,
25944	1695	68	distribution	distribution	NN
25944	1695	69	,	,	,
25944	1695	70	the	the	DT
25944	1695	71	character	character	NN
25944	1695	72	of	of	IN
25944	1695	73	the	the	DT
25944	1695	74	crusting	crusting	NN
25944	1695	75	,	,	,
25944	1695	76	and	and	CC
25944	1695	77	the	the	DT
25944	1695	78	contagious	contagious	JJ
25944	1695	79	and	and	CC
25944	1695	80	auto	auto	NN
25944	1695	81	-	-	HYPH
25944	1695	82	inoculable	inoculable	JJ
25944	1695	83	properties	property	NNS
25944	1695	84	of	of	IN
25944	1695	85	the	the	DT
25944	1695	86	contents	content	NNS
25944	1695	87	of	of	IN
25944	1695	88	the	the	DT
25944	1695	89	lesions	lesion	NNS
25944	1695	90	,	,	,
25944	1695	91	in	in	IN
25944	1695	92	impetigo	impetigo	NNP
25944	1695	93	contagiosa	contagiosa	NNP
25944	1695	94	;	;	:
25944	1695	95	the	the	DT
25944	1695	96	tendency	tendency	NN
25944	1695	97	to	to	TO
25944	1695	98	appear	appear	VB
25944	1695	99	in	in	IN
25944	1695	100	groups	group	NNS
25944	1695	101	,	,	,
25944	1695	102	the	the	DT
25944	1695	103	smaller	small	JJR
25944	1695	104	lesions	lesion	NNS
25944	1695	105	,	,	,
25944	1695	106	the	the	DT
25944	1695	107	intense	intense	JJ
25944	1695	108	itchiness	itchiness	NN
25944	1695	109	,	,	,
25944	1695	110	course	course	NN
25944	1695	111	,	,	,
25944	1695	112	multiform	multiform	NN
25944	1695	113	characters	character	NNS
25944	1695	114	of	of	IN
25944	1695	115	the	the	DT
25944	1695	116	eruption	eruption	NN
25944	1695	117	and	and	CC
25944	1695	118	the	the	DT
25944	1695	119	disposition	disposition	NN
25944	1695	120	to	to	TO
25944	1695	121	change	change	VB
25944	1695	122	of	of	IN
25944	1695	123	type	type	NN
25944	1695	124	in	in	IN
25944	1695	125	dermatitis	dermatitis	NN
25944	1695	126	herpetiformis,--will	herpetiformis,--will	NNP
25944	1695	127	serve	serve	VB
25944	1695	128	as	as	IN
25944	1695	129	differential	differential	NN
25944	1695	130	points	point	NNS
25944	1695	131	.	.	.
25944	1696	1	#	#	JJR
25944	1696	2	State	state	NN
25944	1696	3	the	the	DT
25944	1696	4	prognosis	prognosis	NN
25944	1696	5	of	of	IN
25944	1696	6	pemphigus	pemphigus	NN
25944	1696	7	.	.	.
25944	1696	8	#	#	$
25944	1696	9	Its	-PRON-	PRP$
25944	1696	10	duration	duration	NN
25944	1696	11	is	be	VBZ
25944	1696	12	uncertain	uncertain	JJ
25944	1696	13	,	,	,
25944	1696	14	and	and	CC
25944	1696	15	the	the	DT
25944	1696	16	issue	issue	NN
25944	1696	17	may	may	MD
25944	1696	18	in	in	IN
25944	1696	19	severe	severe	JJ
25944	1696	20	cases	case	NNS
25944	1696	21	be	be	VB
25944	1696	22	fatal	fatal	JJ
25944	1696	23	.	.	.
25944	1697	1	In	in	IN
25944	1697	2	the	the	DT
25944	1697	3	milder	milder	NN
25944	1697	4	types	type	NNS
25944	1697	5	,	,	,
25944	1697	6	after	after	IN
25944	1697	7	months	month	NNS
25944	1697	8	or	or	CC
25944	1697	9	several	several	JJ
25944	1697	10	years	year	NNS
25944	1697	11	,	,	,
25944	1697	12	recovery	recovery	NN
25944	1697	13	may	may	MD
25944	1697	14	take	take	VB
25944	1697	15	place	place	NN
25944	1697	16	.	.	.
25944	1698	1	The	the	DT
25944	1698	2	extent	extent	NN
25944	1698	3	and	and	CC
25944	1698	4	severity	severity	NN
25944	1698	5	of	of	IN
25944	1698	6	the	the	DT
25944	1698	7	disease	disease	NN
25944	1698	8	and	and	CC
25944	1698	9	the	the	DT
25944	1698	10	general	general	JJ
25944	1698	11	condition	condition	NN
25944	1698	12	of	of	IN
25944	1698	13	the	the	DT
25944	1698	14	patient	patient	NN
25944	1698	15	are	be	VBP
25944	1698	16	always	always	RB
25944	1698	17	to	to	TO
25944	1698	18	be	be	VB
25944	1698	19	considered	consider	VBN
25944	1698	20	before	before	IN
25944	1698	21	an	an	DT
25944	1698	22	opinion	opinion	NN
25944	1698	23	is	be	VBZ
25944	1698	24	expressed	express	VBN
25944	1698	25	.	.	.
25944	1699	1	Pemphigus	Pemphigus	NNP
25944	1699	2	neonatorum	neonatorum	NN
25944	1699	3	usually	usually	RB
25944	1699	4	ends	end	VBZ
25944	1699	5	fatally	fatally	RB
25944	1699	6	.	.	.
25944	1700	1	#	#	NN
25944	1700	2	Give	give	VB
25944	1700	3	the	the	DT
25944	1700	4	treatment	treatment	NN
25944	1700	5	of	of	IN
25944	1700	6	pemphigus	pemphigus	NNP
25944	1700	7	.	.	.
25944	1700	8	#	#	NN
25944	1700	9	Both	both	CC
25944	1700	10	constitutional	constitutional	JJ
25944	1700	11	and	and	CC
25944	1700	12	local	local	JJ
25944	1700	13	measures	measure	NNS
25944	1700	14	are	be	VBP
25944	1700	15	demanded	demand	VBN
25944	1700	16	.	.	.
25944	1701	1	Good	good	JJ
25944	1701	2	nutritious	nutritious	JJ
25944	1701	3	food	food	NN
25944	1701	4	and	and	CC
25944	1701	5	hygienic	hygienic	JJ
25944	1701	6	regulations	regulation	NNS
25944	1701	7	are	be	VBP
25944	1701	8	essential	essential	JJ
25944	1701	9	.	.	.
25944	1702	1	Arsenic	arsenic	JJ
25944	1702	2	and	and	CC
25944	1702	3	quinia	quinia	NNP
25944	1702	4	are	be	VBP
25944	1702	5	the	the	DT
25944	1702	6	most	most	RBS
25944	1702	7	valuable	valuable	JJ
25944	1702	8	remedies	remedy	NNS
25944	1702	9	.	.	.
25944	1703	1	The	the	DT
25944	1703	2	former	former	JJ
25944	1703	3	,	,	,
25944	1703	4	in	in	IN
25944	1703	5	occasional	occasional	JJ
25944	1703	6	instances	instance	NNS
25944	1703	7	,	,	,
25944	1703	8	seems	seem	VBZ
25944	1703	9	to	to	TO
25944	1703	10	have	have	VB
25944	1703	11	a	a	DT
25944	1703	12	specific	specific	JJ
25944	1703	13	influence	influence	NN
25944	1703	14	,	,	,
25944	1703	15	and	and	CC
25944	1703	16	should	should	MD
25944	1703	17	always	always	RB
25944	1703	18	be	be	VB
25944	1703	19	tried	try	VBN
25944	1703	20	,	,	,
25944	1703	21	beginning	begin	VBG
25944	1703	22	with	with	IN
25944	1703	23	small	small	JJ
25944	1703	24	doses	dose	NNS
25944	1703	25	and	and	CC
25944	1703	26	increasing	increase	VBG
25944	1703	27	gradually	gradually	RB
25944	1703	28	to	to	IN
25944	1703	29	the	the	DT
25944	1703	30	point	point	NN
25944	1703	31	of	of	IN
25944	1703	32	tolerance	tolerance	NN
25944	1703	33	and	and	CC
25944	1703	34	continued	continue	VBD
25944	1703	35	for	for	IN
25944	1703	36	several	several	JJ
25944	1703	37	weeks	week	NNS
25944	1703	38	or	or	CC
25944	1703	39	longer	long	JJR
25944	1703	40	.	.	.
25944	1704	1	The	the	DT
25944	1704	2	remedy	remedy	NN
25944	1704	3	should	should	MD
25944	1704	4	not	not	RB
25944	1704	5	be	be	VB
25944	1704	6	set	set	VBN
25944	1704	7	aside	aside	RB
25944	1704	8	as	as	RB
25944	1704	9	long	long	RB
25944	1704	10	as	as	IN
25944	1704	11	there	there	EX
25944	1704	12	are	be	VBP
25944	1704	13	signs	sign	NNS
25944	1704	14	of	of	IN
25944	1704	15	improvement	improvement	NN
25944	1704	16	,	,	,
25944	1704	17	unless	unless	IN
25944	1704	18	the	the	DT
25944	1704	19	supervention	supervention	NN
25944	1704	20	of	of	IN
25944	1704	21	stomachic	stomachic	JJ
25944	1704	22	,	,	,
25944	1704	23	intestinal	intestinal	JJ
25944	1704	24	or	or	CC
25944	1704	25	other	other	JJ
25944	1704	26	disturbance	disturbance	NN
25944	1704	27	demand	demand	VBP
25944	1704	28	its	-PRON-	PRP$
25944	1704	29	discontinuance	discontinuance	NN
25944	1704	30	.	.	.
25944	1705	1	Other	other	JJ
25944	1705	2	tonics	tonic	NNS
25944	1705	3	,	,	,
25944	1705	4	such	such	JJ
25944	1705	5	as	as	IN
25944	1705	6	iron	iron	NN
25944	1705	7	,	,	,
25944	1705	8	strychnia	strychnia	NNP
25944	1705	9	and	and	CC
25944	1705	10	cod	cod	NN
25944	1705	11	-	-	HYPH
25944	1705	12	liver	liver	NN
25944	1705	13	oil	oil	NN
25944	1705	14	,	,	,
25944	1705	15	are	be	VBP
25944	1705	16	also	also	RB
25944	1705	17	at	at	IN
25944	1705	18	times	time	NNS
25944	1705	19	of	of	IN
25944	1705	20	service	service	NN
25944	1705	21	.	.	.
25944	1706	1	The	the	DT
25944	1706	2	blebs	blebs	NN
25944	1706	3	should	should	MD
25944	1706	4	be	be	VB
25944	1706	5	opened	open	VBN
25944	1706	6	and	and	CC
25944	1706	7	the	the	DT
25944	1706	8	parts	part	NNS
25944	1706	9	anointed	anoint	VBN
25944	1706	10	or	or	CC
25944	1706	11	covered	cover	VBN
25944	1706	12	with	with	IN
25944	1706	13	a	a	DT
25944	1706	14	mild	mild	JJ
25944	1706	15	ointment	ointment	NN
25944	1706	16	.	.	.
25944	1707	1	In	in	IN
25944	1707	2	more	more	JJR
25944	1707	3	general	general	JJ
25944	1707	4	cases	case	NNS
25944	1707	5	bran	bran	NN
25944	1707	6	,	,	,
25944	1707	7	starch	starch	NN
25944	1707	8	and	and	CC
25944	1707	9	gelatin	gelatin	NN
25944	1707	10	baths	bath	NNS
25944	1707	11	,	,	,
25944	1707	12	and	and	CC
25944	1707	13	in	in	IN
25944	1707	14	severe	severe	JJ
25944	1707	15	cases	case	NNS
25944	1707	16	the	the	DT
25944	1707	17	continuous	continuous	JJ
25944	1707	18	bath	bath	NN
25944	1707	19	,	,	,
25944	1707	20	if	if	IN
25944	1707	21	practicable	practicable	JJ
25944	1707	22	,	,	,
25944	1707	23	are	be	VBP
25944	1707	24	to	to	TO
25944	1707	25	be	be	VB
25944	1707	26	used	use	VBN
25944	1707	27	.	.	.
25944	1708	1	#	#	$
25944	1708	2	CLASS	CLASS	NNP
25944	1708	3	III.--HEMORRHAGES	iii.--hemorrhages	NN
25944	1708	4	.	.	.
25944	1708	5	#	#	$
25944	1708	6	#	#	NNP
25944	1708	7	Purpura	Purpura	NNP
25944	1708	8	.	.	.
25944	1708	9	#	#	$
25944	1708	10	#	#	$
25944	1708	11	Define	Define	NNP
25944	1708	12	purpura	purpura	NN
25944	1708	13	.	.	.
25944	1708	14	#	#	$
25944	1708	15	Purpura	Purpura	NNP
25944	1708	16	is	be	VBZ
25944	1708	17	a	a	DT
25944	1708	18	hemorrhagic	hemorrhagic	JJ
25944	1708	19	affection	affection	NN
25944	1708	20	characterized	characterize	VBN
25944	1708	21	by	by	IN
25944	1708	22	the	the	DT
25944	1708	23	appearance	appearance	NN
25944	1708	24	of	of	IN
25944	1708	25	variously	variously	RB
25944	1708	26	-	-	HYPH
25944	1708	27	sized	sized	JJ
25944	1708	28	,	,	,
25944	1708	29	usually	usually	RB
25944	1708	30	non	non	JJ
25944	1708	31	-	-	JJ
25944	1708	32	elevated	elevated	JJ
25944	1708	33	,	,	,
25944	1708	34	smooth	smooth	JJ
25944	1708	35	,	,	,
25944	1708	36	reddish	reddish	JJ
25944	1708	37	or	or	CC
25944	1708	38	purplish	purplish	JJ
25944	1708	39	spots	spot	NNS
25944	1708	40	or	or	CC
25944	1708	41	patches	patch	NNS
25944	1708	42	,	,	,
25944	1708	43	not	not	RB
25944	1708	44	disappearing	disappear	VBG
25944	1708	45	under	under	IN
25944	1708	46	pressure	pressure	NN
25944	1708	47	.	.	.
25944	1709	1	#	#	$
25944	1709	2	Name	name	VB
25944	1709	3	the	the	DT
25944	1709	4	several	several	JJ
25944	1709	5	varieties	variety	NNS
25944	1709	6	met	meet	VBD
25944	1709	7	with	with	IN
25944	1709	8	.	.	.
25944	1709	9	#	#	$
25944	1709	10	Three	three	CD
25944	1709	11	--	--	:
25944	1709	12	purpura	purpura	NNP
25944	1709	13	simplex	simplex	NNP
25944	1709	14	,	,	,
25944	1709	15	purpura	purpura	NNP
25944	1709	16	rheumatica	rheumatica	NNP
25944	1709	17	and	and	CC
25944	1709	18	purpura	purpura	NNP
25944	1709	19	hæmorrhagica	hæmorrhagica	NNP
25944	1709	20	;	;	:
25944	1709	21	denoting	denoting	NN
25944	1709	22	,	,	,
25944	1709	23	respectively	respectively	RB
25944	1709	24	,	,	,
25944	1709	25	the	the	DT
25944	1709	26	mild	mild	JJ
25944	1709	27	,	,	,
25944	1709	28	moderate	moderate	JJ
25944	1709	29	and	and	CC
25944	1709	30	severe	severe	JJ
25944	1709	31	grade	grade	NN
25944	1709	32	of	of	IN
25944	1709	33	the	the	DT
25944	1709	34	disease	disease	NN
25944	1709	35	.	.	.
25944	1710	1	The	the	DT
25944	1710	2	division	division	NN
25944	1710	3	is	be	VBZ
25944	1710	4	,	,	,
25944	1710	5	to	to	IN
25944	1710	6	a	a	DT
25944	1710	7	great	great	JJ
25944	1710	8	extent	extent	NN
25944	1710	9	,	,	,
25944	1710	10	an	an	DT
25944	1710	11	arbitrary	arbitrary	JJ
25944	1710	12	one	one	CD
25944	1710	13	.	.	.
25944	1711	1	#	#	NNP
25944	1711	2	Describe	describe	VB
25944	1711	3	the	the	DT
25944	1711	4	clinical	clinical	JJ
25944	1711	5	appearance	appearance	NN
25944	1711	6	and	and	CC
25944	1711	7	course	course	NN
25944	1711	8	of	of	IN
25944	1711	9	an	an	DT
25944	1711	10	individual	individual	JJ
25944	1711	11	lesion	lesion	NN
25944	1711	12	of	of	IN
25944	1711	13	purpura	purpura	NNP
25944	1711	14	.	.	.
25944	1711	15	#	#	$
25944	1711	16	The	the	DT
25944	1711	17	spot	spot	NN
25944	1711	18	,	,	,
25944	1711	19	which	which	WDT
25944	1711	20	may	may	MD
25944	1711	21	be	be	VB
25944	1711	22	pin	pin	NN
25944	1711	23	-	-	HYPH
25944	1711	24	head	head	NN
25944	1711	25	,	,	,
25944	1711	26	pea-	pea-	NNS
25944	1711	27	,	,	,
25944	1711	28	bean	bean	NN
25944	1711	29	-	-	HYPH
25944	1711	30	sized	sized	JJ
25944	1711	31	or	or	CC
25944	1711	32	larger	large	JJR
25944	1711	33	,	,	,
25944	1711	34	appears	appear	VBZ
25944	1711	35	suddenly	suddenly	RB
25944	1711	36	,	,	,
25944	1711	37	and	and	CC
25944	1711	38	is	be	VBZ
25944	1711	39	of	of	IN
25944	1711	40	a	a	DT
25944	1711	41	bright	bright	JJ
25944	1711	42	red	red	JJ
25944	1711	43	or	or	CC
25944	1711	44	purplish	purplish	JJ
25944	1711	45	red	red	JJ
25944	1711	46	color	color	NN
25944	1711	47	.	.	.
25944	1712	1	Its	-PRON-	PRP$
25944	1712	2	brightness	brightness	NN
25944	1712	3	gradually	gradually	RB
25944	1712	4	fades	fade	VBZ
25944	1712	5	,	,	,
25944	1712	6	the	the	DT
25944	1712	7	color	color	NN
25944	1712	8	changing	change	VBG
25944	1712	9	to	to	IN
25944	1712	10	a	a	DT
25944	1712	11	bluish	bluish	JJ
25944	1712	12	,	,	,
25944	1712	13	bluish	bluish	JJ
25944	1712	14	-	-	HYPH
25944	1712	15	green	green	JJ
25944	1712	16	,	,	,
25944	1712	17	bluish-	bluish-	JJ
25944	1712	18	or	or	CC
25944	1712	19	greenish	greenish	NN
25944	1712	20	-	-	HYPH
25944	1712	21	yellow	yellow	JJ
25944	1712	22	,	,	,
25944	1712	23	dirty	dirty	JJ
25944	1712	24	yellowish	yellowish	JJ
25944	1712	25	,	,	,
25944	1712	26	yellowish	yellowish	JJ
25944	1712	27	-	-	HYPH
25944	1712	28	white	white	JJ
25944	1712	29	,	,	,
25944	1712	30	and	and	CC
25944	1712	31	finally	finally	RB
25944	1712	32	disappearing	disappear	VBG
25944	1712	33	;	;	:
25944	1712	34	varying	vary	VBG
25944	1712	35	in	in	IN
25944	1712	36	duration	duration	NN
25944	1712	37	from	from	IN
25944	1712	38	several	several	JJ
25944	1712	39	days	day	NNS
25944	1712	40	to	to	IN
25944	1712	41	several	several	JJ
25944	1712	42	weeks	week	NNS
25944	1712	43	.	.	.
25944	1713	1	#	#	NNP
25944	1713	2	Describe	describe	VB
25944	1713	3	the	the	DT
25944	1713	4	symptoms	symptom	NNS
25944	1713	5	of	of	IN
25944	1713	6	purpura	purpura	NNP
25944	1713	7	simplex	simplex	NN
25944	1713	8	.	.	.
25944	1713	9	#	#	$
25944	1713	10	Purpura	Purpura	NNP
25944	1713	11	simplex	simplex	NN
25944	1713	12	,	,	,
25944	1713	13	or	or	CC
25944	1713	14	the	the	DT
25944	1713	15	mild	mild	JJ
25944	1713	16	form	form	NN
25944	1713	17	,	,	,
25944	1713	18	shows	show	VBZ
25944	1713	19	itself	-PRON-	PRP
25944	1713	20	as	as	IN
25944	1713	21	pin	pin	NN
25944	1713	22	-	-	HYPH
25944	1713	23	point	point	NN
25944	1713	24	to	to	IN
25944	1713	25	pea-	pea-	NNS
25944	1713	26	or	or	CC
25944	1713	27	bean	bean	NN
25944	1713	28	-	-	HYPH
25944	1713	29	sized	sized	JJ
25944	1713	30	,	,	,
25944	1713	31	bright	bright	JJ
25944	1713	32	or	or	CC
25944	1713	33	dark	dark	JJ
25944	1713	34	-	-	HYPH
25944	1713	35	red	red	JJ
25944	1713	36	spots	spot	NNS
25944	1713	37	,	,	,
25944	1713	38	limited	limit	VBN
25944	1713	39	,	,	,
25944	1713	40	as	as	IN
25944	1713	41	a	a	DT
25944	1713	42	rule	rule	NN
25944	1713	43	,	,	,
25944	1713	44	to	to	IN
25944	1713	45	the	the	DT
25944	1713	46	limbs	limb	NNS
25944	1713	47	,	,	,
25944	1713	48	especially	especially	RB
25944	1713	49	the	the	DT
25944	1713	50	lower	low	JJR
25944	1713	51	extremities	extremity	NNS
25944	1713	52	;	;	,
25944	1713	53	fading	fade	VBG
25944	1713	54	gradually	gradually	RB
25944	1713	55	away	away	RB
25944	1713	56	and	and	CC
25944	1713	57	coming	come	VBG
25944	1713	58	to	to	IN
25944	1713	59	an	an	DT
25944	1713	60	end	end	NN
25944	1713	61	in	in	IN
25944	1713	62	a	a	DT
25944	1713	63	few	few	JJ
25944	1713	64	weeks	week	NNS
25944	1713	65	,	,	,
25944	1713	66	or	or	CC
25944	1713	67	new	new	JJ
25944	1713	68	crops	crop	NNS
25944	1713	69	appearing	appear	VBG
25944	1713	70	irregularly	irregularly	RB
25944	1713	71	for	for	IN
25944	1713	72	several	several	JJ
25944	1713	73	months	month	NNS
25944	1713	74	.	.	.
25944	1714	1	There	there	EX
25944	1714	2	is	be	VBZ
25944	1714	3	rarely	rarely	RB
25944	1714	4	any	any	DT
25944	1714	5	systemic	systemic	JJ
25944	1714	6	disturbance	disturbance	NN
25944	1714	7	,	,	,
25944	1714	8	and	and	CC
25944	1714	9	,	,	,
25944	1714	10	as	as	IN
25944	1714	11	a	a	DT
25944	1714	12	rule	rule	NN
25944	1714	13	,	,	,
25944	1714	14	no	no	DT
25944	1714	15	subjective	subjective	JJ
25944	1714	16	symptoms	symptom	NNS
25944	1714	17	;	;	:
25944	1714	18	in	in	IN
25944	1714	19	exceptional	exceptional	JJ
25944	1714	20	cases	case	NNS
25944	1714	21	an	an	DT
25944	1714	22	urticarial	urticarial	JJ
25944	1714	23	element	element	NN
25944	1714	24	is	be	VBZ
25944	1714	25	added--_purpura	added--_purpura	ADD
25944	1714	26	urticans	urticans	NNPS
25944	1714	27	_	_	NNP
25944	1714	28	.	.	.
25944	1715	1	#	#	NNP
25944	1715	2	Describe	describe	VB
25944	1715	3	the	the	DT
25944	1715	4	symptoms	symptom	NNS
25944	1715	5	of	of	IN
25944	1715	6	purpura	purpura	NNP
25944	1715	7	rheumatica	rheumatica	NNP
25944	1715	8	.	.	.
25944	1715	9	#	#	$
25944	1715	10	Purpura	Purpura	NNP
25944	1715	11	rheumatica	rheumatica	NNP
25944	1715	12	(	(	-LRB-
25944	1715	13	also	also	RB
25944	1715	14	called	call	VBN
25944	1715	15	_	_	NNP
25944	1715	16	peliosis	peliosis	NN
25944	1715	17	rheumatica	rheumatica	NNP
25944	1715	18	_	_	NNP
25944	1715	19	)	)	-RRB-
25944	1715	20	is	be	VBZ
25944	1715	21	usually	usually	RB
25944	1715	22	preceded	precede	VBN
25944	1715	23	by	by	IN
25944	1715	24	symptoms	symptom	NNS
25944	1715	25	of	of	IN
25944	1715	26	malaise	malaise	JJ
25944	1715	27	,	,	,
25944	1715	28	rheumatic	rheumatic	JJ
25944	1715	29	pains	pain	NNS
25944	1715	30	and	and	CC
25944	1715	31	sometimes	sometimes	RB
25944	1715	32	swelling	swell	VBG
25944	1715	33	about	about	IN
25944	1715	34	the	the	DT
25944	1715	35	joints	joint	NNS
25944	1715	36	;	;	:
25944	1715	37	these	these	DT
25944	1715	38	phenomena	phenomenon	NNS
25944	1715	39	abate	abate	VBP
25944	1715	40	and	and	CC
25944	1715	41	frequently	frequently	RB
25944	1715	42	disappear	disappear	VB
25944	1715	43	upon	upon	IN
25944	1715	44	the	the	DT
25944	1715	45	outbreak	outbreak	NN
25944	1715	46	of	of	IN
25944	1715	47	the	the	DT
25944	1715	48	eruption	eruption	NN
25944	1715	49	.	.	.
25944	1716	1	The	the	DT
25944	1716	2	lesions	lesion	NNS
25944	1716	3	are	be	VBP
25944	1716	4	pea-	pea-	NNS
25944	1716	5	to	to	IN
25944	1716	6	dime	dime	NN
25944	1716	7	-	-	HYPH
25944	1716	8	sized	sized	JJ
25944	1716	9	,	,	,
25944	1716	10	smooth	smooth	JJ
25944	1716	11	,	,	,
25944	1716	12	non	non	JJ
25944	1716	13	-	-	JJ
25944	1716	14	elevated	elevated	JJ
25944	1716	15	,	,	,
25944	1716	16	or	or	CC
25944	1716	17	slightly	slightly	RB
25944	1716	18	raised	raise	VBN
25944	1716	19	,	,	,
25944	1716	20	and	and	CC
25944	1716	21	of	of	IN
25944	1716	22	a	a	DT
25944	1716	23	reddish	reddish	JJ
25944	1716	24	or	or	CC
25944	1716	25	purplish	purplish	JJ
25944	1716	26	color	color	NN
25944	1716	27	;	;	:
25944	1716	28	the	the	DT
25944	1716	29	eruption	eruption	NN
25944	1716	30	may	may	MD
25944	1716	31	be	be	VB
25944	1716	32	more	more	RBR
25944	1716	33	or	or	CC
25944	1716	34	less	less	RBR
25944	1716	35	generalized	generalize	VBN
25944	1716	36	,	,	,
25944	1716	37	most	most	RBS
25944	1716	38	abundant	abundant	JJ
25944	1716	39	upon	upon	IN
25944	1716	40	the	the	DT
25944	1716	41	limbs	limb	NNS
25944	1716	42	,	,	,
25944	1716	43	or	or	CC
25944	1716	44	it	-PRON-	PRP
25944	1716	45	may	may	MD
25944	1716	46	be	be	VB
25944	1716	47	limited	limited	JJ
25944	1716	48	to	to	IN
25944	1716	49	these	these	DT
25944	1716	50	parts	part	NNS
25944	1716	51	.	.	.
25944	1717	1	It	-PRON-	PRP
25944	1717	2	may	may	MD
25944	1717	3	end	end	VB
25944	1717	4	in	in	IN
25944	1717	5	a	a	DT
25944	1717	6	few	few	JJ
25944	1717	7	weeks	week	NNS
25944	1717	8	,	,	,
25944	1717	9	or	or	CC
25944	1717	10	may	may	MD
25944	1717	11	persist	persist	VB
25944	1717	12	for	for	IN
25944	1717	13	several	several	JJ
25944	1717	14	months	month	NNS
25944	1717	15	,	,	,
25944	1717	16	new	new	JJ
25944	1717	17	spots	spot	NNS
25944	1717	18	appearing	appear	VBG
25944	1717	19	irregularly	irregularly	RB
25944	1717	20	or	or	CC
25944	1717	21	in	in	IN
25944	1717	22	the	the	DT
25944	1717	23	form	form	NN
25944	1717	24	of	of	IN
25944	1717	25	crops	crop	NNS
25944	1717	26	.	.	.
25944	1718	1	As	as	IN
25944	1718	2	somewhat	somewhat	RB
25944	1718	3	allied	allied	JJ
25944	1718	4	to	to	IN
25944	1718	5	this	this	DT
25944	1718	6	is	be	VBZ
25944	1718	7	another	another	DT
25944	1718	8	form	form	NN
25944	1718	9	(	(	-LRB-
25944	1718	10	_	_	NNP
25944	1718	11	Schönlein	Schönlein	NNP
25944	1718	12	's	's	POS
25944	1718	13	disease	disease	NN
25944	1718	14	_	_	NNP
25944	1718	15	)	)	-RRB-
25944	1718	16	,	,	,
25944	1718	17	quite	quite	RB
25944	1718	18	alarming	alarming	JJ
25944	1718	19	in	in	IN
25944	1718	20	its	-PRON-	PRP$
25944	1718	21	symptoms	symptom	NNS
25944	1718	22	.	.	.
25944	1719	1	It	-PRON-	PRP
25944	1719	2	is	be	VBZ
25944	1719	3	rare	rare	JJ
25944	1719	4	.	.	.
25944	1720	1	It	-PRON-	PRP
25944	1720	2	is	be	VBZ
25944	1720	3	characterized	characterize	VBN
25944	1720	4	by	by	IN
25944	1720	5	symptoms	symptom	NNS
25944	1720	6	partaking	partake	VBG
25944	1720	7	of	of	IN
25944	1720	8	the	the	DT
25944	1720	9	nature	nature	NN
25944	1720	10	of	of	IN
25944	1720	11	rheumatism	rheumatism	NN
25944	1720	12	,	,	,
25944	1720	13	purpuric	purpuric	NN
25944	1720	14	spots	spot	NNS
25944	1720	15	,	,	,
25944	1720	16	blotches	blotch	NNS
25944	1720	17	and	and	CC
25944	1720	18	ecchymoses	ecchymosis	NNS
25944	1720	19	,	,	,
25944	1720	20	erythema	erythema	NNP
25944	1720	21	multiforme	multiforme	NNP
25944	1720	22	,	,	,
25944	1720	23	and	and	CC
25944	1720	24	often	often	RB
25944	1720	25	associated	associate	VBN
25944	1720	26	with	with	IN
25944	1720	27	considerable	considerable	JJ
25944	1720	28	edema	edema	NN
25944	1720	29	.	.	.
25944	1721	1	The	the	DT
25944	1721	2	throat	throat	NN
25944	1721	3	is	be	VBZ
25944	1721	4	also	also	RB
25944	1721	5	usually	usually	RB
25944	1721	6	invaded	invade	VBN
25944	1721	7	,	,	,
25944	1721	8	and	and	CC
25944	1721	9	indeed	indeed	RB
25944	1721	10	the	the	DT
25944	1721	11	first	first	JJ
25944	1721	12	symptom	symptom	NN
25944	1721	13	is	be	VBZ
25944	1721	14	commonly	commonly	RB
25944	1721	15	in	in	IN
25944	1721	16	this	this	DT
25944	1721	17	region	region	NN
25944	1721	18	.	.	.
25944	1722	1	Considerable	considerable	JJ
25944	1722	2	constitutional	constitutional	JJ
25944	1722	3	disturbance	disturbance	NN
25944	1722	4	,	,	,
25944	1722	5	of	of	IN
25944	1722	6	a	a	DT
25944	1722	7	threatening	threatening	JJ
25944	1722	8	character	character	NN
25944	1722	9	,	,	,
25944	1722	10	is	be	VBZ
25944	1722	11	commonly	commonly	RB
25944	1722	12	observed	observe	VBN
25944	1722	13	.	.	.
25944	1723	1	Recovery	recovery	NN
25944	1723	2	usually	usually	RB
25944	1723	3	takes	take	VBZ
25944	1723	4	place	place	NN
25944	1723	5	.	.	.
25944	1724	1	_	_	NNP
25944	1724	2	Henoch	Henoch	NNP
25944	1724	3	's	's	POS
25944	1724	4	purpura	purpura	NN
25944	1724	5	_	_	NNP
25944	1724	6	,	,	,
25944	1724	7	observed	observe	VBN
25944	1724	8	chiefly	chiefly	RB
25944	1724	9	in	in	IN
25944	1724	10	children	child	NNS
25944	1724	11	,	,	,
25944	1724	12	resembles	resemble	VBZ
25944	1724	13	the	the	DT
25944	1724	14	above	above	JJ
25944	1724	15	,	,	,
25944	1724	16	with	with	IN
25944	1724	17	the	the	DT
25944	1724	18	erythema	erythema	NNP
25944	1724	19	multiforme	multiforme	NNP
25944	1724	20	character	character	NN
25944	1724	21	and	and	CC
25944	1724	22	the	the	DT
25944	1724	23	[	[	-LRB-
25944	1724	24	oe]dematous	oe]dematous	NNP
25944	1724	25	swellings	swelling	NNS
25944	1724	26	more	more	RBR
25944	1724	27	pronounced	pronounced	JJ
25944	1724	28	,	,	,
25944	1724	29	while	while	IN
25944	1724	30	the	the	DT
25944	1724	31	actual	actual	JJ
25944	1724	32	purpuric	purpuric	NN
25944	1724	33	symptoms	symptom	NNS
25944	1724	34	are	be	VBP
25944	1724	35	less	less	RBR
25944	1724	36	conspicuous	conspicuous	JJ
25944	1724	37	.	.	.
25944	1725	1	Gastric	gastric	JJ
25944	1725	2	and	and	CC
25944	1725	3	intestinal	intestinal	JJ
25944	1725	4	symptoms	symptom	NNS
25944	1725	5	and	and	CC
25944	1725	6	hemorrhages	hemorrhage	NNS
25944	1725	7	from	from	IN
25944	1725	8	the	the	DT
25944	1725	9	mucous	mucous	JJ
25944	1725	10	membrane	membrane	NN
25944	1725	11	are	be	VBP
25944	1725	12	commonly	commonly	RB
25944	1725	13	noted	note	VBN
25944	1725	14	.	.	.
25944	1726	1	It	-PRON-	PRP
25944	1726	2	is	be	VBZ
25944	1726	3	fatal	fatal	JJ
25944	1726	4	in	in	IN
25944	1726	5	about	about	RB
25944	1726	6	20	20	CD
25944	1726	7	per	per	NN
25944	1726	8	cent	cent	NN
25944	1726	9	.	.	.
25944	1727	1	of	of	IN
25944	1727	2	the	the	DT
25944	1727	3	cases	case	NNS
25944	1727	4	.	.	.
25944	1728	1	#	#	NNP
25944	1728	2	Describe	describe	VB
25944	1728	3	the	the	DT
25944	1728	4	symptoms	symptom	NNS
25944	1728	5	of	of	IN
25944	1728	6	purpura	purpura	NNP
25944	1728	7	hæmorrhagica	hæmorrhagica	NNP
25944	1728	8	.	.	.
25944	1728	9	#	#	$
25944	1728	10	Purpura	Purpura	NNP
25944	1728	11	hæmorrhagica	hæmorrhagica	NNP
25944	1728	12	(	(	-LRB-
25944	1728	13	also	also	RB
25944	1728	14	called	call	VBN
25944	1728	15	_	_	NNP
25944	1728	16	land	land	NN
25944	1728	17	scurvy	scurvy	NNP
25944	1728	18	_	_	NNP
25944	1728	19	)	)	-RRB-
25944	1728	20	is	be	VBZ
25944	1728	21	characterized	characterize	VBN
25944	1728	22	usually	usually	RB
25944	1728	23	by	by	IN
25944	1728	24	premonitory	premonitory	NN
25944	1728	25	,	,	,
25944	1728	26	and	and	CC
25944	1728	27	frequently	frequently	RB
25944	1728	28	accompanying	accompany	VBG
25944	1728	29	,	,	,
25944	1728	30	symptoms	symptom	NNS
25944	1728	31	of	of	IN
25944	1728	32	general	general	JJ
25944	1728	33	distress	distress	NN
25944	1728	34	,	,	,
25944	1728	35	and	and	CC
25944	1728	36	by	by	IN
25944	1728	37	the	the	DT
25944	1728	38	appearance	appearance	NN
25944	1728	39	of	of	IN
25944	1728	40	coin	coin	NN
25944	1728	41	to	to	IN
25944	1728	42	palm	palm	NN
25944	1728	43	-	-	HYPH
25944	1728	44	sized	sized	JJ
25944	1728	45	,	,	,
25944	1728	46	red	red	JJ
25944	1728	47	or	or	CC
25944	1728	48	purplish	purplish	JJ
25944	1728	49	hemorrhagic	hemorrhagic	JJ
25944	1728	50	spots	spot	NNS
25944	1728	51	or	or	CC
25944	1728	52	patches	patch	NNS
25944	1728	53	,	,	,
25944	1728	54	smooth	smooth	JJ
25944	1728	55	,	,	,
25944	1728	56	non	non	JJ
25944	1728	57	-	-	JJ
25944	1728	58	elevated	elevated	JJ
25944	1728	59	or	or	CC
25944	1728	60	raised	raise	VBN
25944	1728	61	.	.	.
25944	1729	1	Hemorrhage	hemorrhage	NN
25944	1729	2	from	from	IN
25944	1729	3	the	the	DT
25944	1729	4	mouth	mouth	NN
25944	1729	5	,	,	,
25944	1729	6	gums	gum	NNS
25944	1729	7	and	and	CC
25944	1729	8	other	other	JJ
25944	1729	9	parts	part	NNS
25944	1729	10	,	,	,
25944	1729	11	slight	slight	JJ
25944	1729	12	or	or	CC
25944	1729	13	serious	serious	JJ
25944	1729	14	in	in	IN
25944	1729	15	character	character	NN
25944	1729	16	,	,	,
25944	1729	17	may	may	MD
25944	1729	18	occur	occur	VB
25944	1729	19	.	.	.
25944	1730	1	New	new	JJ
25944	1730	2	lesions	lesion	NNS
25944	1730	3	continue	continue	VBP
25944	1730	4	to	to	TO
25944	1730	5	appear	appear	VB
25944	1730	6	for	for	IN
25944	1730	7	several	several	JJ
25944	1730	8	days	day	NNS
25944	1730	9	or	or	CC
25944	1730	10	weeks	week	NNS
25944	1730	11	;	;	:
25944	1730	12	and	and	CC
25944	1730	13	in	in	IN
25944	1730	14	exceptional	exceptional	JJ
25944	1730	15	instances	instance	NNS
25944	1730	16	,	,	,
25944	1730	17	repeated	repeat	VBN
25944	1730	18	relapses	relapse	NNS
25944	1730	19	take	take	VBP
25944	1730	20	place	place	NN
25944	1730	21	,	,	,
25944	1730	22	and	and	CC
25944	1730	23	the	the	DT
25944	1730	24	disease	disease	NN
25944	1730	25	thus	thus	RB
25944	1730	26	persists	persist	VBZ
25944	1730	27	for	for	IN
25944	1730	28	months	month	NNS
25944	1730	29	.	.	.
25944	1731	1	It	-PRON-	PRP
25944	1731	2	may	may	MD
25944	1731	3	end	end	VB
25944	1731	4	fatally	fatally	RB
25944	1731	5	.	.	.
25944	1732	1	#	#	NNP
25944	1732	2	State	state	NN
25944	1732	3	the	the	DT
25944	1732	4	etiology	etiology	NN
25944	1732	5	of	of	IN
25944	1732	6	purpura	purpura	NNP
25944	1732	7	.	.	.
25944	1732	8	#	#	$
25944	1732	9	In	in	IN
25944	1732	10	most	most	JJS
25944	1732	11	instances	instance	NNS
25944	1732	12	no	no	DT
25944	1732	13	cause	cause	NN
25944	1732	14	can	can	MD
25944	1732	15	be	be	VB
25944	1732	16	assigned	assign	VBN
25944	1732	17	.	.	.
25944	1733	1	The	the	DT
25944	1733	2	disease	disease	NN
25944	1733	3	occurs	occur	VBZ
25944	1733	4	at	at	IN
25944	1733	5	all	all	DT
25944	1733	6	ages	age	NNS
25944	1733	7	from	from	IN
25944	1733	8	childhood	childhood	NN
25944	1733	9	to	to	IN
25944	1733	10	advanced	advanced	JJ
25944	1733	11	life	life	NN
25944	1733	12	,	,	,
25944	1733	13	and	and	CC
25944	1733	14	in	in	IN
25944	1733	15	individuals	individual	NNS
25944	1733	16	,	,	,
25944	1733	17	apparently	apparently	RB
25944	1733	18	,	,	,
25944	1733	19	in	in	IN
25944	1733	20	good	good	JJ
25944	1733	21	and	and	CC
25944	1733	22	bad	bad	JJ
25944	1733	23	health	health	NN
25944	1733	24	alike	alike	RB
25944	1733	25	.	.	.
25944	1734	1	The	the	DT
25944	1734	2	hemorrhagic	hemorrhagic	JJ
25944	1734	3	type	type	NN
25944	1734	4	is	be	VBZ
25944	1734	5	oftener	oftener	RB
25944	1734	6	seen	see	VBN
25944	1734	7	in	in	IN
25944	1734	8	subjects	subject	NNS
25944	1734	9	debilitated	debilitate	VBN
25944	1734	10	or	or	CC
25944	1734	11	in	in	IN
25944	1734	12	a	a	DT
25944	1734	13	depraved	depraved	JJ
25944	1734	14	state	state	NN
25944	1734	15	of	of	IN
25944	1734	16	health	health	NN
25944	1734	17	.	.	.
25944	1735	1	A	a	DT
25944	1735	2	microörganism	microörganism	NN
25944	1735	3	is	be	VBZ
25944	1735	4	also	also	RB
25944	1735	5	looked	look	VBN
25944	1735	6	upon	upon	IN
25944	1735	7	as	as	IN
25944	1735	8	a	a	DT
25944	1735	9	factor	factor	NN
25944	1735	10	by	by	IN
25944	1735	11	some	some	DT
25944	1735	12	observers	observer	NNS
25944	1735	13	,	,	,
25944	1735	14	especially	especially	RB
25944	1735	15	in	in	IN
25944	1735	16	the	the	DT
25944	1735	17	grave	grave	JJ
25944	1735	18	type	type	NN
25944	1735	19	of	of	IN
25944	1735	20	disease	disease	NN
25944	1735	21	.	.	.
25944	1736	1	#	#	JJR
25944	1736	2	State	state	NN
25944	1736	3	the	the	DT
25944	1736	4	diagnostic	diagnostic	JJ
25944	1736	5	characters	character	NNS
25944	1736	6	of	of	IN
25944	1736	7	purpura	purpura	NNP
25944	1736	8	.	.	.
25944	1736	9	#	#	$
25944	1736	10	The	the	DT
25944	1736	11	appearance	appearance	NN
25944	1736	12	,	,	,
25944	1736	13	irregularly	irregularly	RB
25944	1736	14	or	or	CC
25944	1736	15	in	in	IN
25944	1736	16	crops	crop	NNS
25944	1736	17	,	,	,
25944	1736	18	of	of	IN
25944	1736	19	bright	bright	JJ
25944	1736	20	-	-	HYPH
25944	1736	21	red	red	JJ
25944	1736	22	or	or	CC
25944	1736	23	purplish	purplish	JJ
25944	1736	24	spots	spot	NNS
25944	1736	25	,	,	,
25944	1736	26	evidently	evidently	RB
25944	1736	27	of	of	IN
25944	1736	28	hemorrhagic	hemorrhagic	JJ
25944	1736	29	nature	nature	NN
25944	1736	30	,	,	,
25944	1736	31	and	and	CC
25944	1736	32	not	not	RB
25944	1736	33	_	_	NNP
25944	1736	34	disappearing	disappear	VBG
25944	1736	35	upon	upon	IN
25944	1736	36	pressure	pressure	NN
25944	1736	37	_	_	NNP
25944	1736	38	,	,	,
25944	1736	39	and	and	CC
25944	1736	40	as	as	IN
25944	1736	41	they	-PRON-	PRP
25944	1736	42	are	be	VBP
25944	1736	43	fading	fade	VBG
25944	1736	44	,	,	,
25944	1736	45	going	go	VBG
25944	1736	46	through	through	IN
25944	1736	47	the	the	DT
25944	1736	48	several	several	JJ
25944	1736	49	changes	change	NNS
25944	1736	50	of	of	IN
25944	1736	51	color	color	NN
25944	1736	52	usually	usually	RB
25944	1736	53	observed	observe	VBN
25944	1736	54	in	in	IN
25944	1736	55	any	any	DT
25944	1736	56	ecchymosis	ecchymosis	NN
25944	1736	57	.	.	.
25944	1737	1	#	#	NNP
25944	1737	2	How	how	WRB
25944	1737	3	does	do	VBZ
25944	1737	4	scurvy	scurvy	VB
25944	1737	5	(	(	-LRB-
25944	1737	6	scorbutus	scorbutus	NN
25944	1737	7	)	)	-RRB-
25944	1737	8	differ	differ	VBP
25944	1737	9	from	from	IN
25944	1737	10	purpura	purpura	NNP
25944	1737	11	?	?	.
25944	1737	12	#	#	NNP
25944	1737	13	Scurvy	Scurvy	NNP
25944	1737	14	,	,	,
25944	1737	15	which	which	WDT
25944	1737	16	may	may	MD
25944	1737	17	resemble	resemble	VB
25944	1737	18	the	the	DT
25944	1737	19	severe	severe	JJ
25944	1737	20	grade	grade	NN
25944	1737	21	of	of	IN
25944	1737	22	purpura	purpura	NNP
25944	1737	23	,	,	,
25944	1737	24	has	have	VBZ
25944	1737	25	a	a	DT
25944	1737	26	different	different	JJ
25944	1737	27	history	history	NN
25944	1737	28	,	,	,
25944	1737	29	a	a	DT
25944	1737	30	recognizable	recognizable	JJ
25944	1737	31	cause	cause	NN
25944	1737	32	,	,	,
25944	1737	33	usually	usually	RB
25944	1737	34	a	a	DT
25944	1737	35	peculiar	peculiar	JJ
25944	1737	36	distribution	distribution	NN
25944	1737	37	,	,	,
25944	1737	38	and	and	CC
25944	1737	39	is	be	VBZ
25944	1737	40	accompanied	accompany	VBN
25944	1737	41	with	with	IN
25944	1737	42	general	general	JJ
25944	1737	43	weakness	weakness	NN
25944	1737	44	and	and	CC
25944	1737	45	a	a	DT
25944	1737	46	spongy	spongy	JJ
25944	1737	47	,	,	,
25944	1737	48	soft	soft	JJ
25944	1737	49	and	and	CC
25944	1737	50	bleeding	bleeding	JJ
25944	1737	51	condition	condition	NN
25944	1737	52	of	of	IN
25944	1737	53	the	the	DT
25944	1737	54	gums	gum	NNS
25944	1737	55	.	.	.
25944	1738	1	#	#	LS
25944	1738	2	What	what	WP
25944	1738	3	is	be	VBZ
25944	1738	4	the	the	DT
25944	1738	5	pathology	pathology	NN
25944	1738	6	of	of	IN
25944	1738	7	purpura	purpura	NNP
25944	1738	8	?	?	.
25944	1738	9	#	#	$
25944	1738	10	The	the	DT
25944	1738	11	lesion	lesion	NN
25944	1738	12	of	of	IN
25944	1738	13	purpura	purpura	NNP
25944	1738	14	consists	consist	VBZ
25944	1738	15	essentially	essentially	RB
25944	1738	16	of	of	IN
25944	1738	17	a	a	DT
25944	1738	18	hemorrhage	hemorrhage	NN
25944	1738	19	into	into	IN
25944	1738	20	the	the	DT
25944	1738	21	cutaneous	cutaneous	JJ
25944	1738	22	tissues	tissue	NNS
25944	1738	23	.	.	.
25944	1739	1	The	the	DT
25944	1739	2	blood	blood	NN
25944	1739	3	is	be	VBZ
25944	1739	4	subsequently	subsequently	RB
25944	1739	5	absorbed	absorb	VBN
25944	1739	6	,	,	,
25944	1739	7	the	the	DT
25944	1739	8	hæmatin	hæmatin	NN
25944	1739	9	undergoing	undergo	VBG
25944	1739	10	changes	change	NNS
25944	1739	11	of	of	IN
25944	1739	12	color	color	NN
25944	1739	13	from	from	IN
25944	1739	14	a	a	DT
25944	1739	15	red	red	NN
25944	1739	16	to	to	IN
25944	1739	17	greenish	greenish	JJ
25944	1739	18	and	and	CC
25944	1739	19	pale	pale	JJ
25944	1739	20	yellow	yellow	JJ
25944	1739	21	,	,	,
25944	1739	22	and	and	CC
25944	1739	23	finally	finally	RB
25944	1739	24	fading	fade	VBG
25944	1739	25	away	away	RB
25944	1739	26	.	.	.
25944	1740	1	#	#	JJR
25944	1740	2	State	state	NN
25944	1740	3	the	the	DT
25944	1740	4	prognosis	prognosis	NN
25944	1740	5	#	#	$
25944	1740	6	The	the	DT
25944	1740	7	milder	milder	NN
25944	1740	8	varieties	variety	NNS
25944	1740	9	disappear	disappear	VBP
25944	1740	10	in	in	IN
25944	1740	11	the	the	DT
25944	1740	12	course	course	NN
25944	1740	13	of	of	IN
25944	1740	14	several	several	JJ
25944	1740	15	weeks	week	NNS
25944	1740	16	or	or	CC
25944	1740	17	months	month	NNS
25944	1740	18	,	,	,
25944	1740	19	and	and	CC
25944	1740	20	are	be	VBP
25944	1740	21	rarely	rarely	RB
25944	1740	22	of	of	IN
25944	1740	23	serious	serious	JJ
25944	1740	24	import	import	NN
25944	1740	25	;	;	:
25944	1740	26	the	the	DT
25944	1740	27	outcome	outcome	NN
25944	1740	28	of	of	IN
25944	1740	29	purpura	purpura	NNP
25944	1740	30	hæmorrhagica	hæmorrhagica	NNP
25944	1740	31	is	be	VBZ
25944	1740	32	somewhat	somewhat	RB
25944	1740	33	uncertain	uncertain	JJ
25944	1740	34	;	;	:
25944	1740	35	although	although	IN
25944	1740	36	usually	usually	RB
25944	1740	37	favorable	favorable	JJ
25944	1740	38	,	,	,
25944	1740	39	a	a	DT
25944	1740	40	fatal	fatal	JJ
25944	1740	41	result	result	NN
25944	1740	42	from	from	IN
25944	1740	43	internal	internal	JJ
25944	1740	44	hemorrhage	hemorrhage	NN
25944	1740	45	is	be	VBZ
25944	1740	46	possible	possible	JJ
25944	1740	47	.	.	.
25944	1741	1	The	the	DT
25944	1741	2	variety	variety	NN
25944	1741	3	known	know	VBN
25944	1741	4	as	as	IN
25944	1741	5	Schönlein	Schönlein	NNP
25944	1741	6	's	's	POS
25944	1741	7	disease	disease	NN
25944	1741	8	is	be	VBZ
25944	1741	9	alarming	alarming	JJ
25944	1741	10	,	,	,
25944	1741	11	but	but	CC
25944	1741	12	seldom	seldom	RB
25944	1741	13	fatal	fatal	JJ
25944	1741	14	.	.	.
25944	1742	1	Henoch	Henoch	NNP
25944	1742	2	's	's	POS
25944	1742	3	disease	disease	NN
25944	1742	4	is	be	VBZ
25944	1742	5	,	,	,
25944	1742	6	however	however	RB
25944	1742	7	,	,	,
25944	1742	8	always	always	RB
25944	1742	9	of	of	IN
25944	1742	10	grave	grave	JJ
25944	1742	11	import	import	NN
25944	1742	12	.	.	.
25944	1743	1	#	#	LS
25944	1743	2	What	what	WP
25944	1743	3	is	be	VBZ
25944	1743	4	the	the	DT
25944	1743	5	treatment	treatment	NN
25944	1743	6	of	of	IN
25944	1743	7	purpura	purpura	NNP
25944	1743	8	?	?	.
25944	1743	9	#	#	NNP
25944	1743	10	Hygienic	hygienic	JJ
25944	1743	11	and	and	CC
25944	1743	12	dietary	dietary	JJ
25944	1743	13	measures	measure	NNS
25944	1743	14	,	,	,
25944	1743	15	the	the	DT
25944	1743	16	administration	administration	NN
25944	1743	17	of	of	IN
25944	1743	18	tonics	tonic	NNS
25944	1743	19	and	and	CC
25944	1743	20	astringents	astringent	NNS
25944	1743	21	,	,	,
25944	1743	22	and	and	CC
25944	1743	23	,	,	,
25944	1743	24	in	in	IN
25944	1743	25	severe	severe	JJ
25944	1743	26	cases	case	NNS
25944	1743	27	,	,	,
25944	1743	28	by	by	IN
25944	1743	29	relative	relative	JJ
25944	1743	30	or	or	CC
25944	1743	31	absolute	absolute	JJ
25944	1743	32	rest	rest	NN
25944	1743	33	.	.	.
25944	1744	1	The	the	DT
25944	1744	2	drugs	drug	NNS
25944	1744	3	commonly	commonly	RB
25944	1744	4	prescribed	prescribe	VBN
25944	1744	5	are	be	VBP
25944	1744	6	:	:	:
25944	1744	7	ergot	ergot	NNP
25944	1744	8	,	,	,
25944	1744	9	oil	oil	NN
25944	1744	10	of	of	IN
25944	1744	11	erigeron	erigeron	NNP
25944	1744	12	,	,	,
25944	1744	13	oil	oil	NN
25944	1744	14	of	of	IN
25944	1744	15	turpentine	turpentine	NN
25944	1744	16	,	,	,
25944	1744	17	quinia	quinia	NNP
25944	1744	18	,	,	,
25944	1744	19	strychnia	strychnia	NNP
25944	1744	20	,	,	,
25944	1744	21	iron	iron	NN
25944	1744	22	,	,	,
25944	1744	23	mineral	mineral	NN
25944	1744	24	acids	acid	NNS
25944	1744	25	,	,	,
25944	1744	26	and	and	CC
25944	1744	27	gallic	gallic	JJ
25944	1744	28	acid	acid	NN
25944	1744	29	.	.	.
25944	1745	1	_	_	NNP
25944	1745	2	External	External	NNP
25944	1745	3	_	_	NNP
25944	1745	4	treatment	treatment	NN
25944	1745	5	is	be	VBZ
25944	1745	6	rarely	rarely	RB
25944	1745	7	called	call	VBN
25944	1745	8	for	for	IN
25944	1745	9	,	,	,
25944	1745	10	but	but	CC
25944	1745	11	if	if	IN
25944	1745	12	deemed	deem	VBN
25944	1745	13	advisable	advisable	JJ
25944	1745	14	,	,	,
25944	1745	15	astringent	astringent	JJ
25944	1745	16	lotions	lotion	NNS
25944	1745	17	may	may	MD
25944	1745	18	be	be	VB
25944	1745	19	employed	employ	VBN
25944	1745	20	.	.	.
25944	1746	1	#	#	NNP
25944	1746	2	Scorbutus	Scorbutus	NNP
25944	1746	3	.	.	.
25944	1746	4	#	#	NNP
25944	1746	5	(	(	-LRB-
25944	1746	6	_	_	NNP
25944	1746	7	Synonyms	Synonyms	NNP
25944	1746	8	:	:	:
25944	1746	9	_	_	NNP
25944	1746	10	Scurvy	Scurvy	NNP
25944	1746	11	;	;	:
25944	1746	12	Sea	Sea	NNP
25944	1746	13	Scurvy	Scurvy	NNP
25944	1746	14	;	;	:
25944	1746	15	Purpura	Purpura	NNP
25944	1746	16	Scorbutica	Scorbutica	NNP
25944	1746	17	.	.	.
25944	1746	18	)	)	-RRB-
25944	1747	1	#	#	$
25944	1747	2	Describe	Describe	NNP
25944	1747	3	scorbutus	scorbutus	NN
25944	1747	4	.	.	.
25944	1747	5	#	#	:
25944	1747	6	Scurvy	Scurvy	NNP
25944	1747	7	is	be	VBZ
25944	1747	8	a	a	DT
25944	1747	9	peculiar	peculiar	JJ
25944	1747	10	constitutional	constitutional	JJ
25944	1747	11	state	state	NN
25944	1747	12	,	,	,
25944	1747	13	developed	develop	VBN
25944	1747	14	in	in	IN
25944	1747	15	those	those	DT
25944	1747	16	living	live	VBG
25944	1747	17	under	under	IN
25944	1747	18	bad	bad	JJ
25944	1747	19	hygienic	hygienic	JJ
25944	1747	20	conditions	condition	NNS
25944	1747	21	,	,	,
25944	1747	22	and	and	CC
25944	1747	23	is	be	VBZ
25944	1747	24	characterized	characterize	VBN
25944	1747	25	by	by	IN
25944	1747	26	emaciation	emaciation	NN
25944	1747	27	,	,	,
25944	1747	28	general	general	JJ
25944	1747	29	febrile	febrile	NN
25944	1747	30	and	and	CC
25944	1747	31	asthenic	asthenic	JJ
25944	1747	32	symptoms	symptom	NNS
25944	1747	33	,	,	,
25944	1747	34	a	a	DT
25944	1747	35	more	more	RBR
25944	1747	36	or	or	CC
25944	1747	37	less	less	RBR
25944	1747	38	swollen	swollen	JJ
25944	1747	39	,	,	,
25944	1747	40	turgid	turgid	JJ
25944	1747	41	and	and	CC
25944	1747	42	spongy	spongy	JJ
25944	1747	43	and	and	CC
25944	1747	44	even	even	RB
25944	1747	45	gangrenous	gangrenous	JJ
25944	1747	46	condition	condition	NN
25944	1747	47	of	of	IN
25944	1747	48	the	the	DT
25944	1747	49	gums	gum	NNS
25944	1747	50	;	;	,
25944	1747	51	and	and	CC
25944	1747	52	concomitantly	concomitantly	RB
25944	1747	53	,	,	,
25944	1747	54	or	or	CC
25944	1747	55	sooner	sooner	RB
25944	1747	56	or	or	CC
25944	1747	57	later	later	RB
25944	1747	58	,	,	,
25944	1747	59	by	by	IN
25944	1747	60	the	the	DT
25944	1747	61	appearance	appearance	NN
25944	1747	62	,	,	,
25944	1747	63	usually	usually	RB
25944	1747	64	upon	upon	IN
25944	1747	65	the	the	DT
25944	1747	66	lower	low	JJR
25944	1747	67	portion	portion	NN
25944	1747	68	of	of	IN
25944	1747	69	the	the	DT
25944	1747	70	legs	leg	NNS
25944	1747	71	only	only	RB
25944	1747	72	,	,	,
25944	1747	73	of	of	IN
25944	1747	74	dark	dark	JJ
25944	1747	75	-	-	HYPH
25944	1747	76	colored	colored	JJ
25944	1747	77	hemorrhagic	hemorrhagic	JJ
25944	1747	78	patches	patch	NNS
25944	1747	79	or	or	CC
25944	1747	80	blotches	blotch	NNS
25944	1747	81	.	.	.
25944	1748	1	The	the	DT
25944	1748	2	skin	skin	NN
25944	1748	3	of	of	IN
25944	1748	4	the	the	DT
25944	1748	5	affected	affect	VBN
25944	1748	6	part	part	NN
25944	1748	7	may	may	MD
25944	1748	8	become	become	VB
25944	1748	9	brawny	brawny	JJ
25944	1748	10	and	and	CC
25944	1748	11	slightly	slightly	RB
25944	1748	12	scaly	scaly	NNP
25944	1748	13	,	,	,
25944	1748	14	and	and	CC
25944	1748	15	not	not	RB
25944	1748	16	infrequently	infrequently	RB
25944	1748	17	may	may	MD
25944	1748	18	break	break	VB
25944	1748	19	down	down	RP
25944	1748	20	and	and	CC
25944	1748	21	ulcerate	ulcerate	JJ
25944	1748	22	.	.	.
25944	1749	1	Hemorrhages	hemorrhage	NNS
25944	1749	2	from	from	IN
25944	1749	3	the	the	DT
25944	1749	4	various	various	JJ
25944	1749	5	mucous	mucous	JJ
25944	1749	6	surfaces	surface	NNS
25944	1749	7	,	,	,
25944	1749	8	slight	slight	JJ
25944	1749	9	or	or	CC
25944	1749	10	grave	grave	JJ
25944	1749	11	,	,	,
25944	1749	12	may	may	MD
25944	1749	13	also	also	RB
25944	1749	14	take	take	VB
25944	1749	15	place	place	NN
25944	1749	16	.	.	.
25944	1750	1	#	#	NNP
25944	1750	2	State	state	NN
25944	1750	3	the	the	DT
25944	1750	4	etiology	etiology	NN
25944	1750	5	of	of	IN
25944	1750	6	scurvy	scurvy	NNP
25944	1750	7	.	.	.
25944	1750	8	#	#	$
25944	1750	9	It	-PRON-	PRP
25944	1750	10	is	be	VBZ
25944	1750	11	due	due	JJ
25944	1750	12	to	to	IN
25944	1750	13	long	long	RB
25944	1750	14	-	-	HYPH
25944	1750	15	continued	continue	VBN
25944	1750	16	deprivation	deprivation	NN
25944	1750	17	of	of	IN
25944	1750	18	proper	proper	JJ
25944	1750	19	food	food	NN
25944	1750	20	,	,	,
25944	1750	21	especially	especially	RB
25944	1750	22	of	of	IN
25944	1750	23	fruits	fruit	NNS
25944	1750	24	and	and	CC
25944	1750	25	vegetables	vegetable	NNS
25944	1750	26	.	.	.
25944	1751	1	Other	other	JJ
25944	1751	2	bad	bad	JJ
25944	1751	3	hygienic	hygienic	JJ
25944	1751	4	conditions	condition	NNS
25944	1751	5	favor	favor	VBP
25944	1751	6	its	-PRON-	PRP$
25944	1751	7	development	development	NN
25944	1751	8	.	.	.
25944	1752	1	It	-PRON-	PRP
25944	1752	2	is	be	VBZ
25944	1752	3	seen	see	VBN
25944	1752	4	most	most	RBS
25944	1752	5	commonly	commonly	RB
25944	1752	6	in	in	IN
25944	1752	7	sailors	sailor	NNS
25944	1752	8	and	and	CC
25944	1752	9	others	other	NNS
25944	1752	10	taking	take	VBG
25944	1752	11	long	long	JJ
25944	1752	12	voyages	voyage	NNS
25944	1752	13	.	.	.
25944	1753	1	#	#	NNP
25944	1753	2	How	how	WRB
25944	1753	3	is	be	VBZ
25944	1753	4	scurvy	scurvy	JJ
25944	1753	5	to	to	TO
25944	1753	6	be	be	VB
25944	1753	7	distinguished	distinguish	VBN
25944	1753	8	from	from	IN
25944	1753	9	purpura	purpura	NNP
25944	1753	10	?	?	.
25944	1753	11	#	#	NN
25944	1753	12	By	by	IN
25944	1753	13	the	the	DT
25944	1753	14	asthenic	asthenic	JJ
25944	1753	15	and	and	CC
25944	1753	16	emaciated	emaciate	VBN
25944	1753	17	general	general	JJ
25944	1753	18	condition	condition	NN
25944	1753	19	and	and	CC
25944	1753	20	the	the	DT
25944	1753	21	peculiar	peculiar	JJ
25944	1753	22	puffy	puffy	NNP
25944	1753	23	,	,	,
25944	1753	24	spongy	spongy	JJ
25944	1753	25	state	state	NN
25944	1753	26	of	of	IN
25944	1753	27	the	the	DT
25944	1753	28	gums	gum	NNS
25944	1753	29	.	.	.
25944	1754	1	The	the	DT
25944	1754	2	cutaneous	cutaneous	JJ
25944	1754	3	manifestation	manifestation	NN
25944	1754	4	is	be	VBZ
25944	1754	5	more	more	RBR
25944	1754	6	diffused	diffused	JJ
25944	1754	7	,	,	,
25944	1754	8	forming	form	VBG
25944	1754	9	usually	usually	RB
25944	1754	10	large	large	JJ
25944	1754	11	palm	palm	NN
25944	1754	12	-	-	HYPH
25944	1754	13	sized	sized	JJ
25944	1754	14	patches	patch	NNS
25944	1754	15	,	,	,
25944	1754	16	and	and	CC
25944	1754	17	,	,	,
25944	1754	18	as	as	IN
25944	1754	19	a	a	DT
25944	1754	20	rule	rule	NN
25944	1754	21	,	,	,
25944	1754	22	limited	limit	VBN
25944	1754	23	to	to	IN
25944	1754	24	the	the	DT
25944	1754	25	region	region	NN
25944	1754	26	of	of	IN
25944	1754	27	the	the	DT
25944	1754	28	ankles	ankle	NNS
25944	1754	29	or	or	CC
25944	1754	30	lower	low	JJR
25944	1754	31	part	part	NN
25944	1754	32	of	of	IN
25944	1754	33	the	the	DT
25944	1754	34	legs	leg	NNS
25944	1754	35	.	.	.
25944	1755	1	#	#	NN
25944	1755	2	Give	give	VB
25944	1755	3	the	the	DT
25944	1755	4	prognosis	prognosis	NN
25944	1755	5	of	of	IN
25944	1755	6	scurvy	scurvy	NN
25944	1755	7	.	.	.
25944	1755	8	#	#	$
25944	1755	9	The	the	DT
25944	1755	10	disease	disease	NN
25944	1755	11	is	be	VBZ
25944	1755	12	remediable	remediable	JJ
25944	1755	13	,	,	,
25944	1755	14	and	and	CC
25944	1755	15	usually	usually	RB
25944	1755	16	rapidly	rapidly	RB
25944	1755	17	so	so	RB
25944	1755	18	.	.	.
25944	1756	1	In	in	IN
25944	1756	2	those	those	DT
25944	1756	3	instances	instance	NNS
25944	1756	4	in	in	IN
25944	1756	5	which	which	WDT
25944	1756	6	the	the	DT
25944	1756	7	same	same	JJ
25944	1756	8	bad	bad	JJ
25944	1756	9	hygienic	hygienic	JJ
25944	1756	10	conditions	condition	NNS
25944	1756	11	and	and	CC
25944	1756	12	the	the	DT
25944	1756	13	ingestion	ingestion	NN
25944	1756	14	of	of	IN
25944	1756	15	improper	improper	JJ
25944	1756	16	food	food	NN
25944	1756	17	are	be	VBP
25944	1756	18	continued	continued	JJ
25944	1756	19	,	,	,
25944	1756	20	death	death	NN
25944	1756	21	finally	finally	RB
25944	1756	22	results	result	VBZ
25944	1756	23	.	.	.
25944	1757	1	#	#	LS
25944	1757	2	What	what	WDT
25944	1757	3	treatment	treatment	NN
25944	1757	4	would	would	MD
25944	1757	5	you	-PRON-	PRP
25944	1757	6	advise	advise	VB
25944	1757	7	in	in	IN
25944	1757	8	scurvy	scurvy	NN
25944	1757	9	?	?	.
25944	1757	10	#	#	$
25944	1757	11	Proper	proper	JJ
25944	1757	12	food	food	NN
25944	1757	13	,	,	,
25944	1757	14	with	with	IN
25944	1757	15	an	an	DT
25944	1757	16	abundance	abundance	NN
25944	1757	17	of	of	IN
25944	1757	18	fruit	fruit	NN
25944	1757	19	and	and	CC
25944	1757	20	vegetables	vegetable	NNS
25944	1757	21	.	.	.
25944	1758	1	Lemon	lemon	NN
25944	1758	2	or	or	CC
25944	1758	3	lime	lime	NN
25944	1758	4	juice	juice	NN
25944	1758	5	is	be	VBZ
25944	1758	6	especially	especially	RB
25944	1758	7	valuable	valuable	JJ
25944	1758	8	,	,	,
25944	1758	9	and	and	CC
25944	1758	10	is	be	VBZ
25944	1758	11	to	to	TO
25944	1758	12	be	be	VB
25944	1758	13	taken	take	VBN
25944	1758	14	freely	freely	RB
25944	1758	15	.	.	.
25944	1759	1	If	if	IN
25944	1759	2	indicated	indicate	VBN
25944	1759	3	,	,	,
25944	1759	4	tonics	tonic	NNS
25944	1759	5	and	and	CC
25944	1759	6	stimulants	stimulant	NNS
25944	1759	7	are	be	VBP
25944	1759	8	also	also	RB
25944	1759	9	to	to	TO
25944	1759	10	be	be	VB
25944	1759	11	prescribed	prescribe	VBN
25944	1759	12	.	.	.
25944	1760	1	For	for	IN
25944	1760	2	the	the	DT
25944	1760	3	relief	relief	NN
25944	1760	4	of	of	IN
25944	1760	5	the	the	DT
25944	1760	6	tumid	tumid	NN
25944	1760	7	,	,	,
25944	1760	8	spongy	spongy	JJ
25944	1760	9	condition	condition	NN
25944	1760	10	of	of	IN
25944	1760	11	the	the	DT
25944	1760	12	gums	gum	NNS
25944	1760	13	,	,	,
25944	1760	14	astringent	astringent	JJ
25944	1760	15	and	and	CC
25944	1760	16	antiseptic	antiseptic	JJ
25944	1760	17	mouth	mouth	NN
25944	1760	18	washes	wash	NNS
25944	1760	19	are	be	VBP
25944	1760	20	to	to	TO
25944	1760	21	be	be	VB
25944	1760	22	employed	employ	VBN
25944	1760	23	.	.	.
25944	1761	1	The	the	DT
25944	1761	2	cutaneous	cutaneous	JJ
25944	1761	3	manifestations	manifestation	NNS
25944	1761	4	,	,	,
25944	1761	5	when	when	WRB
25944	1761	6	tending	tend	VBG
25944	1761	7	to	to	IN
25944	1761	8	ulceration	ulceration	NN
25944	1761	9	,	,	,
25944	1761	10	are	be	VBP
25944	1761	11	to	to	TO
25944	1761	12	be	be	VB
25944	1761	13	treated	treat	VBN
25944	1761	14	upon	upon	IN
25944	1761	15	general	general	JJ
25944	1761	16	principles	principle	NNS
25944	1761	17	.	.	.
25944	1762	1	#	#	$
25944	1762	2	CLASS	CLASS	NNP
25944	1762	3	IV.--HYPERTROPHIES	iv.--hypertrophies	CD
25944	1762	4	.	.	.
25944	1762	5	#	#	$
25944	1762	6	#	#	NNP
25944	1762	7	Lentigo	Lentigo	NNP
25944	1762	8	.	.	.
25944	1762	9	#	#	NNP
25944	1762	10	(	(	-LRB-
25944	1762	11	_	_	NNP
25944	1762	12	Synonym	Synonym	NNP
25944	1762	13	:	:	:
25944	1762	14	_	_	NNP
25944	1762	15	Freckle	Freckle	NNP
25944	1762	16	.	.	.
25944	1762	17	)	)	-RRB-
25944	1763	1	#	#	NNP
25944	1763	2	Describe	Describe	NNP
25944	1763	3	lentigo	lentigo	NNP
25944	1763	4	.	.	.
25944	1763	5	#	#	NNP
25944	1763	6	Lentigo	Lentigo	NNP
25944	1763	7	,	,	,
25944	1763	8	or	or	CC
25944	1763	9	freckle	freckle	NN
25944	1763	10	,	,	,
25944	1763	11	is	be	VBZ
25944	1763	12	characterized	characterize	VBN
25944	1763	13	by	by	IN
25944	1763	14	round	round	JJ
25944	1763	15	or	or	CC
25944	1763	16	irregular	irregular	JJ
25944	1763	17	,	,	,
25944	1763	18	pin	pin	NN
25944	1763	19	-	-	HYPH
25944	1763	20	head	head	NN
25944	1763	21	to	to	IN
25944	1763	22	pea	pea	JJ
25944	1763	23	-	-	HYPH
25944	1763	24	sized	sized	JJ
25944	1763	25	,	,	,
25944	1763	26	yellowish	yellowish	JJ
25944	1763	27	,	,	,
25944	1763	28	brownish	brownish	JJ
25944	1763	29	or	or	CC
25944	1763	30	blackish	blackish	JJ
25944	1763	31	spots	spot	NNS
25944	1763	32	,	,	,
25944	1763	33	occurring	occur	VBG
25944	1763	34	usually	usually	RB
25944	1763	35	about	about	IN
25944	1763	36	the	the	DT
25944	1763	37	face	face	NN
25944	1763	38	and	and	CC
25944	1763	39	the	the	DT
25944	1763	40	backs	back	NNS
25944	1763	41	of	of	IN
25944	1763	42	the	the	DT
25944	1763	43	hands	hand	NNS
25944	1763	44	.	.	.
25944	1764	1	It	-PRON-	PRP
25944	1764	2	is	be	VBZ
25944	1764	3	a	a	DT
25944	1764	4	common	common	JJ
25944	1764	5	affection	affection	NN
25944	1764	6	,	,	,
25944	1764	7	varying	vary	VBG
25944	1764	8	somewhat	somewhat	RB
25944	1764	9	in	in	IN
25944	1764	10	the	the	DT
25944	1764	11	degree	degree	NN
25944	1764	12	of	of	IN
25944	1764	13	development	development	NN
25944	1764	14	;	;	:
25944	1764	15	the	the	DT
25944	1764	16	freckles	freckle	NNS
25944	1764	17	present	present	NN
25944	1764	18	may	may	MD
25944	1764	19	be	be	VB
25944	1764	20	few	few	JJ
25944	1764	21	and	and	CC
25944	1764	22	insignificant	insignificant	JJ
25944	1764	23	,	,	,
25944	1764	24	or	or	CC
25944	1764	25	they	-PRON-	PRP
25944	1764	26	may	may	MD
25944	1764	27	exist	exist	VB
25944	1764	28	in	in	IN
25944	1764	29	profusion	profusion	NN
25944	1764	30	and	and	CC
25944	1764	31	be	be	VB
25944	1764	32	quite	quite	RB
25944	1764	33	disfiguring	disfigure	VBG
25944	1764	34	.	.	.
25944	1765	1	Heat	heat	NN
25944	1765	2	and	and	CC
25944	1765	3	exposure	exposure	NN
25944	1765	4	favor	favor	VBP
25944	1765	5	their	-PRON-	PRP$
25944	1765	6	development	development	NN
25944	1765	7	.	.	.
25944	1766	1	Those	those	DT
25944	1766	2	of	of	IN
25944	1766	3	light	light	JJ
25944	1766	4	complexion	complexion	NN
25944	1766	5	,	,	,
25944	1766	6	especially	especially	RB
25944	1766	7	those	those	DT
25944	1766	8	with	with	IN
25944	1766	9	red	red	JJ
25944	1766	10	hair	hair	NN
25944	1766	11	,	,	,
25944	1766	12	are	be	VBP
25944	1766	13	its	-PRON-	PRP$
25944	1766	14	most	most	RBS
25944	1766	15	common	common	JJ
25944	1766	16	subjects	subject	NNS
25944	1766	17	.	.	.
25944	1767	1	The	the	DT
25944	1767	2	color	color	NN
25944	1767	3	of	of	IN
25944	1767	4	the	the	DT
25944	1767	5	lesion	lesion	NN
25944	1767	6	is	be	VBZ
25944	1767	7	usually	usually	RB
25944	1767	8	a	a	DT
25944	1767	9	yellowish	yellowish	JJ
25944	1767	10	-	-	HYPH
25944	1767	11	brown	brown	JJ
25944	1767	12	.	.	.
25944	1768	1	It	-PRON-	PRP
25944	1768	2	is	be	VBZ
25944	1768	3	common	common	JJ
25944	1768	4	to	to	IN
25944	1768	5	all	all	DT
25944	1768	6	ages	age	NNS
25944	1768	7	,	,	,
25944	1768	8	but	but	CC
25944	1768	9	is	be	VBZ
25944	1768	10	generally	generally	RB
25944	1768	11	seen	see	VBN
25944	1768	12	in	in	IN
25944	1768	13	its	-PRON-	PRP$
25944	1768	14	greatest	great	JJS
25944	1768	15	development	development	NN
25944	1768	16	during	during	IN
25944	1768	17	adolescence	adolescence	NN
25944	1768	18	,	,	,
25944	1768	19	the	the	DT
25944	1768	20	disposition	disposition	NN
25944	1768	21	to	to	IN
25944	1768	22	its	-PRON-	PRP$
25944	1768	23	appearance	appearance	NN
25944	1768	24	becoming	become	VBG
25944	1768	25	less	less	RBR
25944	1768	26	marked	marked	JJ
25944	1768	27	as	as	IN
25944	1768	28	age	age	NN
25944	1768	29	advances	advance	NNS
25944	1768	30	.	.	.
25944	1769	1	#	#	LS
25944	1769	2	What	what	WP
25944	1769	3	is	be	VBZ
25944	1769	4	the	the	DT
25944	1769	5	pathology	pathology	NN
25944	1769	6	of	of	IN
25944	1769	7	lentigo	lentigo	NNP
25944	1769	8	?	?	.
25944	1769	9	#	#	NNP
25944	1769	10	Lentigo	Lentigo	NNP
25944	1769	11	consists	consist	VBZ
25944	1769	12	simply	simply	RB
25944	1769	13	of	of	IN
25944	1769	14	a	a	DT
25944	1769	15	circumscribed	circumscribe	VBN
25944	1769	16	deposit	deposit	NN
25944	1769	17	of	of	IN
25944	1769	18	pigment	pigment	NN
25944	1769	19	granules	granule	NNS
25944	1769	20	--	--	:
25944	1769	21	merely	merely	RB
25944	1769	22	a	a	DT
25944	1769	23	localized	localized	JJ
25944	1769	24	increase	increase	NN
25944	1769	25	of	of	IN
25944	1769	26	the	the	DT
25944	1769	27	normal	normal	JJ
25944	1769	28	pigment	pigment	NN
25944	1769	29	,	,	,
25944	1769	30	differing	differ	VBG
25944	1769	31	from	from	IN
25944	1769	32	chloasma	chloasma	NN
25944	1769	33	(	(	-LRB-
25944	1769	34	_	_	NNP
25944	1769	35	q	q	NNP
25944	1769	36	.	.	.
25944	1770	1	v.	v.	NNP
25944	1770	2	_	_	NNP
25944	1770	3	)	)	-RRB-
25944	1770	4	only	only	RB
25944	1770	5	in	in	IN
25944	1770	6	the	the	DT
25944	1770	7	size	size	NN
25944	1770	8	and	and	CC
25944	1770	9	shape	shape	NN
25944	1770	10	of	of	IN
25944	1770	11	the	the	DT
25944	1770	12	pigmentation	pigmentation	NN
25944	1770	13	.	.	.
25944	1771	1	#	#	JJR
25944	1771	2	State	state	NN
25944	1771	3	the	the	DT
25944	1771	4	prognosis	prognosis	NN
25944	1771	5	.	.	.
25944	1771	6	#	#	$
25944	1771	7	The	the	DT
25944	1771	8	blemishes	blemish	NNS
25944	1771	9	can	can	MD
25944	1771	10	be	be	VB
25944	1771	11	removed	remove	VBN
25944	1771	12	by	by	IN
25944	1771	13	treatment	treatment	NN
25944	1771	14	,	,	,
25944	1771	15	but	but	CC
25944	1771	16	their	-PRON-	PRP$
25944	1771	17	return	return	NN
25944	1771	18	is	be	VBZ
25944	1771	19	almost	almost	RB
25944	1771	20	certain	certain	JJ
25944	1771	21	.	.	.
25944	1772	1	#	#	$
25944	1772	2	Name	name	VB
25944	1772	3	the	the	DT
25944	1772	4	several	several	JJ
25944	1772	5	applications	application	NNS
25944	1772	6	commonly	commonly	RB
25944	1772	7	employed	employ	VBN
25944	1772	8	for	for	IN
25944	1772	9	their	-PRON-	PRP$
25944	1772	10	removal	removal	NN
25944	1772	11	.	.	.
25944	1772	12	#	#	$
25944	1772	13	An	an	DT
25944	1772	14	aqueous	aqueous	JJ
25944	1772	15	or	or	CC
25944	1772	16	alcoholic	alcoholic	JJ
25944	1772	17	solution	solution	NN
25944	1772	18	of	of	IN
25944	1772	19	corrosive	corrosive	JJ
25944	1772	20	sublimate	sublimate	NN
25944	1772	21	,	,	,
25944	1772	22	one	one	CD
25944	1772	23	-	-	HYPH
25944	1772	24	half	half	NN
25944	1772	25	to	to	IN
25944	1772	26	three	three	CD
25944	1772	27	grains	grain	NNS
25944	1772	28	to	to	IN
25944	1772	29	the	the	DT
25944	1772	30	ounce	ounce	NN
25944	1772	31	;	;	:
25944	1772	32	lactic	lactic	JJ
25944	1772	33	acid	acid	NN
25944	1772	34	,	,	,
25944	1772	35	one	one	CD
25944	1772	36	part	part	NN
25944	1772	37	to	to	IN
25944	1772	38	from	from	IN
25944	1772	39	six	six	CD
25944	1772	40	to	to	TO
25944	1772	41	twenty	twenty	CD
25944	1772	42	parts	part	NNS
25944	1772	43	of	of	IN
25944	1772	44	water	water	NN
25944	1772	45	;	;	:
25944	1772	46	and	and	CC
25944	1772	47	an	an	DT
25944	1772	48	ointment	ointment	NN
25944	1772	49	containing	contain	VBG
25944	1772	50	a	a	DT
25944	1772	51	drachm	drachm	NN
25944	1772	52	each	each	DT
25944	1772	53	of	of	IN
25944	1772	54	bismuth	bismuth	NNP
25944	1772	55	subnitrate	subnitrate	NN
25944	1772	56	and	and	CC
25944	1772	57	ammoniated	ammoniate	VBD
25944	1772	58	mercury	mercury	NN
25944	1772	59	to	to	IN
25944	1772	60	the	the	DT
25944	1772	61	ounce	ounce	NN
25944	1772	62	.	.	.
25944	1773	1	The	the	DT
25944	1773	2	applications	application	NNS
25944	1773	3	,	,	,
25944	1773	4	which	which	WDT
25944	1773	5	act	act	VBP
25944	1773	6	by	by	IN
25944	1773	7	removing	remove	VBG
25944	1773	8	the	the	DT
25944	1773	9	epidermal	epidermal	JJ
25944	1773	10	and	and	CC
25944	1773	11	rete	rete	NN
25944	1773	12	cells	cell	NNS
25944	1773	13	and	and	CC
25944	1773	14	with	with	IN
25944	1773	15	them	-PRON-	PRP
25944	1773	16	the	the	DT
25944	1773	17	pigment	pigment	NN
25944	1773	18	,	,	,
25944	1773	19	are	be	VBP
25944	1773	20	made	make	VBN
25944	1773	21	two	two	CD
25944	1773	22	or	or	CC
25944	1773	23	three	three	CD
25944	1773	24	times	time	NNS
25944	1773	25	daily	daily	RB
25944	1773	26	,	,	,
25944	1773	27	and	and	CC
25944	1773	28	their	-PRON-	PRP$
25944	1773	29	use	use	NN
25944	1773	30	intermitted	intermit	VBD
25944	1773	31	for	for	IN
25944	1773	32	a	a	DT
25944	1773	33	few	few	JJ
25944	1773	34	days	day	NNS
25944	1773	35	as	as	RB
25944	1773	36	soon	soon	RB
25944	1773	37	as	as	IN
25944	1773	38	the	the	DT
25944	1773	39	skin	skin	NN
25944	1773	40	becomes	become	VBZ
25944	1773	41	irritated	irritated	JJ
25944	1773	42	or	or	CC
25944	1773	43	scaly	scaly	NNP
25944	1773	44	.	.	.
25944	1774	1	Touching	touch	VBG
25944	1774	2	each	each	DT
25944	1774	3	freckle	freckle	NN
25944	1774	4	for	for	IN
25944	1774	5	a	a	DT
25944	1774	6	few	few	JJ
25944	1774	7	seconds	second	NNS
25944	1774	8	with	with	IN
25944	1774	9	the	the	DT
25944	1774	10	electric	electric	JJ
25944	1774	11	needle	needle	NN
25944	1774	12	,	,	,
25944	1774	13	just	just	RB
25944	1774	14	pricking	prick	VBG
25944	1774	15	the	the	DT
25944	1774	16	epidermis	epidermis	NNP
25944	1774	17	,	,	,
25944	1774	18	will	will	MD
25944	1774	19	occasionally	occasionally	RB
25944	1774	20	remove	remove	VB
25944	1774	21	the	the	DT
25944	1774	22	blemish	blemish	NN
25944	1774	23	.	.	.
25944	1775	1	#	#	NNP
25944	1775	2	Chloasma	Chloasma	NNP
25944	1775	3	.	.	.
25944	1775	4	#	#	$
25944	1775	5	#	#	$
25944	1775	6	What	what	WP
25944	1775	7	do	do	VBP
25944	1775	8	you	-PRON-	PRP
25944	1775	9	understand	understand	VB
25944	1775	10	by	by	IN
25944	1775	11	chloasma	chloasma	NN
25944	1775	12	?	?	.
25944	1775	13	#	#	NNP
25944	1775	14	Chloasma	Chloasma	NNP
25944	1775	15	consists	consist	VBZ
25944	1775	16	of	of	IN
25944	1775	17	an	an	DT
25944	1775	18	abnormal	abnormal	JJ
25944	1775	19	deposit	deposit	NN
25944	1775	20	of	of	IN
25944	1775	21	pigment	pigment	NN
25944	1775	22	,	,	,
25944	1775	23	occurring	occur	VBG
25944	1775	24	as	as	IN
25944	1775	25	variously	variously	RB
25944	1775	26	-	-	HYPH
25944	1775	27	sized	sized	JJ
25944	1775	28	and	and	CC
25944	1775	29	shaped	shaped	JJ
25944	1775	30	,	,	,
25944	1775	31	yellowish	yellowish	JJ
25944	1775	32	,	,	,
25944	1775	33	brownish	brownish	JJ
25944	1775	34	or	or	CC
25944	1775	35	blackish	blackish	JJ
25944	1775	36	patches	patch	NNS
25944	1775	37	.	.	.
25944	1776	1	#	#	NNP
25944	1776	2	Describe	describe	VB
25944	1776	3	the	the	DT
25944	1776	4	clinical	clinical	JJ
25944	1776	5	appearances	appearance	NNS
25944	1776	6	of	of	IN
25944	1776	7	chloasma	chloasma	NN
25944	1776	8	.	.	.
25944	1776	9	#	#	NNP
25944	1776	10	Chloasma	Chloasma	NNP
25944	1776	11	appears	appear	VBZ
25944	1776	12	either	either	CC
25944	1776	13	in	in	IN
25944	1776	14	ill	ill	RB
25944	1776	15	-	-	HYPH
25944	1776	16	defined	define	VBN
25944	1776	17	patches	patch	NNS
25944	1776	18	,	,	,
25944	1776	19	as	as	IN
25944	1776	20	is	be	VBZ
25944	1776	21	commonly	commonly	RB
25944	1776	22	the	the	DT
25944	1776	23	case	case	NN
25944	1776	24	,	,	,
25944	1776	25	or	or	CC
25944	1776	26	as	as	IN
25944	1776	27	a	a	DT
25944	1776	28	diffuse	diffuse	NN
25944	1776	29	discoloration	discoloration	NN
25944	1776	30	.	.	.
25944	1777	1	Its	-PRON-	PRP$
25944	1777	2	appearance	appearance	NN
25944	1777	3	is	be	VBZ
25944	1777	4	rapid	rapid	JJ
25944	1777	5	or	or	CC
25944	1777	6	gradual	gradual	JJ
25944	1777	7	,	,	,
25944	1777	8	generally	generally	RB
25944	1777	9	the	the	DT
25944	1777	10	latter	latter	JJ
25944	1777	11	.	.	.
25944	1778	1	The	the	DT
25944	1778	2	patches	patch	NNS
25944	1778	3	are	be	VBP
25944	1778	4	rounded	rounded	JJ
25944	1778	5	or	or	CC
25944	1778	6	irregular	irregular	JJ
25944	1778	7	,	,	,
25944	1778	8	and	and	CC
25944	1778	9	usually	usually	RB
25944	1778	10	shade	shade	VB
25944	1778	11	off	off	RP
25944	1778	12	into	into	IN
25944	1778	13	the	the	DT
25944	1778	14	sound	sound	JJ
25944	1778	15	skin	skin	NN
25944	1778	16	.	.	.
25944	1779	1	One	one	CD
25944	1779	2	,	,	,
25944	1779	3	several	several	JJ
25944	1779	4	or	or	CC
25944	1779	5	more	more	JJR
25944	1779	6	may	may	MD
25944	1779	7	be	be	VB
25944	1779	8	present	present	JJ
25944	1779	9	,	,	,
25944	1779	10	and	and	CC
25944	1779	11	coalescence	coalescence	NN
25944	1779	12	may	may	MD
25944	1779	13	take	take	VB
25944	1779	14	place	place	NN
25944	1779	15	,	,	,
25944	1779	16	resulting	result	VBG
25944	1779	17	in	in	IN
25944	1779	18	a	a	DT
25944	1779	19	large	large	JJ
25944	1779	20	irregular	irregular	JJ
25944	1779	21	pigmented	pigment	VBN
25944	1779	22	area	area	NN
25944	1779	23	.	.	.
25944	1780	1	The	the	DT
25944	1780	2	color	color	NN
25944	1780	3	is	be	VBZ
25944	1780	4	yellowish	yellowish	JJ
25944	1780	5	,	,	,
25944	1780	6	or	or	CC
25944	1780	7	brownish	brownish	NN
25944	1780	8	,	,	,
25944	1780	9	and	and	CC
25944	1780	10	may	may	MD
25944	1780	11	even	even	RB
25944	1780	12	be	be	VB
25944	1780	13	blackish	blackish	JJ
25944	1780	14	(	(	-LRB-
25944	1780	15	_	_	NNP
25944	1780	16	melasma	melasma	NN
25944	1780	17	_	_	NNP
25944	1780	18	,	,	,
25944	1780	19	_	_	NNP
25944	1780	20	melanoderma	melanoderma	NNP
25944	1780	21	_	_	NNP
25944	1780	22	)	)	-RRB-
25944	1780	23	.	.	.
25944	1781	1	The	the	DT
25944	1781	2	skin	skin	NN
25944	1781	3	is	be	VBZ
25944	1781	4	otherwise	otherwise	RB
25944	1781	5	normal	normal	JJ
25944	1781	6	.	.	.
25944	1782	1	The	the	DT
25944	1782	2	face	face	NN
25944	1782	3	is	be	VBZ
25944	1782	4	the	the	DT
25944	1782	5	most	most	RBS
25944	1782	6	common	common	JJ
25944	1782	7	site	site	NN
25944	1782	8	.	.	.
25944	1783	1	#	#	$
25944	1783	2	Into	into	IN
25944	1783	3	what	what	WP
25944	1783	4	two	two	CD
25944	1783	5	general	general	JJ
25944	1783	6	classes	class	NNS
25944	1783	7	may	may	MD
25944	1783	8	the	the	DT
25944	1783	9	various	various	JJ
25944	1783	10	examples	example	NNS
25944	1783	11	of	of	IN
25944	1783	12	chloasma	chloasma	NN
25944	1783	13	be	be	VB
25944	1783	14	grouped	group	VBN
25944	1783	15	?	?	.
25944	1783	16	#	#	$
25944	1783	17	Idiopathic	idiopathic	JJ
25944	1783	18	and	and	CC
25944	1783	19	symptomatic	symptomatic	JJ
25944	1783	20	.	.	.
25944	1784	1	#	#	LS
25944	1784	2	What	what	WDT
25944	1784	3	cases	case	NNS
25944	1784	4	of	of	IN
25944	1784	5	chloasma	chloasma	NN
25944	1784	6	are	be	VBP
25944	1784	7	included	include	VBN
25944	1784	8	in	in	IN
25944	1784	9	the	the	DT
25944	1784	10	idiopathic	idiopathic	JJ
25944	1784	11	group	group	NN
25944	1784	12	?	?	.
25944	1784	13	#	#	$
25944	1784	14	All	all	PDT
25944	1784	15	those	those	DT
25944	1784	16	cases	case	NNS
25944	1784	17	of	of	IN
25944	1784	18	pigmentation	pigmentation	NN
25944	1784	19	caused	cause	VBN
25944	1784	20	by	by	IN
25944	1784	21	external	external	JJ
25944	1784	22	agents	agent	NNS
25944	1784	23	,	,	,
25944	1784	24	such	such	JJ
25944	1784	25	as	as	IN
25944	1784	26	the	the	DT
25944	1784	27	sun	sun	NN
25944	1784	28	's	's	POS
25944	1784	29	rays	ray	NNS
25944	1784	30	,	,	,
25944	1784	31	sinapisms	sinapism	NNS
25944	1784	32	,	,	,
25944	1784	33	blisters	blister	NNS
25944	1784	34	,	,	,
25944	1784	35	continued	continue	VBD
25944	1784	36	cutaneous	cutaneous	JJ
25944	1784	37	hyperæmia	hyperæmia	NN
25944	1784	38	from	from	IN
25944	1784	39	scratching	scratching	NN
25944	1784	40	or	or	CC
25944	1784	41	any	any	DT
25944	1784	42	other	other	JJ
25944	1784	43	cause	cause	NN
25944	1784	44	,	,	,
25944	1784	45	etc	etc	FW
25944	1784	46	.	.	.
25944	1785	1	#	#	LS
25944	1785	2	What	what	WDT
25944	1785	3	cases	case	NNS
25944	1785	4	of	of	IN
25944	1785	5	chloasma	chloasma	NN
25944	1785	6	are	be	VBP
25944	1785	7	included	include	VBN
25944	1785	8	in	in	IN
25944	1785	9	the	the	DT
25944	1785	10	symptomatic	symptomatic	JJ
25944	1785	11	group	group	NN
25944	1785	12	?	?	.
25944	1785	13	#	#	$
25944	1785	14	All	all	DT
25944	1785	15	forms	form	NNS
25944	1785	16	of	of	IN
25944	1785	17	pigment	pigment	NN
25944	1785	18	deposit	deposit	NN
25944	1785	19	which	which	WDT
25944	1785	20	occur	occur	VBP
25944	1785	21	as	as	IN
25944	1785	22	a	a	DT
25944	1785	23	consequence	consequence	NN
25944	1785	24	of	of	IN
25944	1785	25	various	various	JJ
25944	1785	26	organic	organic	JJ
25944	1785	27	and	and	CC
25944	1785	28	systemic	systemic	JJ
25944	1785	29	diseases	disease	NNS
25944	1785	30	,	,	,
25944	1785	31	as	as	IN
25944	1785	32	the	the	DT
25944	1785	33	pigmentation	pigmentation	NN
25944	1785	34	,	,	,
25944	1785	35	for	for	IN
25944	1785	36	instance	instance	NN
25944	1785	37	,	,	,
25944	1785	38	seen	see	VBN
25944	1785	39	in	in	IN
25944	1785	40	association	association	NN
25944	1785	41	with	with	IN
25944	1785	42	tuberculosis	tuberculosis	NN
25944	1785	43	,	,	,
25944	1785	44	cancer	cancer	NN
25944	1785	45	,	,	,
25944	1785	46	malaria	malaria	NN
25944	1785	47	,	,	,
25944	1785	48	Addison	Addison	NNP
25944	1785	49	's	's	POS
25944	1785	50	disease	disease	NN
25944	1785	51	,	,	,
25944	1785	52	uterine	uterine	JJ
25944	1785	53	affections	affection	NNS
25944	1785	54	,	,	,
25944	1785	55	and	and	CC
25944	1785	56	the	the	DT
25944	1785	57	like	like	JJ
25944	1785	58	.	.	.
25944	1786	1	In	in	IN
25944	1786	2	such	such	JJ
25944	1786	3	cases	case	NNS
25944	1786	4	,	,	,
25944	1786	5	with	with	IN
25944	1786	6	few	few	JJ
25944	1786	7	exceptions	exception	NNS
25944	1786	8	,	,	,
25944	1786	9	the	the	DT
25944	1786	10	pigmentation	pigmentation	NN
25944	1786	11	is	be	VBZ
25944	1786	12	usually	usually	RB
25944	1786	13	more	more	RBR
25944	1786	14	or	or	CC
25944	1786	15	less	less	JJR
25944	1786	16	diffuse	diffuse	NN
25944	1786	17	.	.	.
25944	1787	1	#	#	LS
25944	1787	2	What	what	WP
25944	1787	3	is	be	VBZ
25944	1787	4	chloasma	chloasma	NN
25944	1787	5	uterinum	uterinum	RB
25944	1787	6	?	?	.
25944	1787	7	#	#	$
25944	1787	8	Chloasma	Chloasma	NNP
25944	1787	9	uterinum	uterinum	RB
25944	1787	10	is	be	VBZ
25944	1787	11	a	a	DT
25944	1787	12	term	term	NN
25944	1787	13	applied	apply	VBN
25944	1787	14	to	to	IN
25944	1787	15	the	the	DT
25944	1787	16	ill	ill	RB
25944	1787	17	-	-	HYPH
25944	1787	18	defined	define	VBN
25944	1787	19	patches	patch	NNS
25944	1787	20	of	of	IN
25944	1787	21	yellowish	yellowish	JJ
25944	1787	22	-	-	HYPH
25944	1787	23	brown	brown	JJ
25944	1787	24	pigmentation	pigmentation	NN
25944	1787	25	appearing	appear	VBG
25944	1787	26	upon	upon	IN
25944	1787	27	the	the	DT
25944	1787	28	faces	face	NNS
25944	1787	29	of	of	IN
25944	1787	30	women	woman	NNS
25944	1787	31	,	,	,
25944	1787	32	usually	usually	RB
25944	1787	33	between	between	IN
25944	1787	34	the	the	DT
25944	1787	35	ages	age	NNS
25944	1787	36	of	of	IN
25944	1787	37	twenty	twenty	CD
25944	1787	38	-	-	HYPH
25944	1787	39	five	five	CD
25944	1787	40	and	and	CC
25944	1787	41	fifty	fifty	CD
25944	1787	42	.	.	.
25944	1788	1	It	-PRON-	PRP
25944	1788	2	is	be	VBZ
25944	1788	3	most	most	RBS
25944	1788	4	commonly	commonly	RB
25944	1788	5	seen	see	VBN
25944	1788	6	during	during	IN
25944	1788	7	pregnancy	pregnancy	NN
25944	1788	8	,	,	,
25944	1788	9	but	but	CC
25944	1788	10	may	may	MD
25944	1788	11	occur	occur	VB
25944	1788	12	in	in	IN
25944	1788	13	connection	connection	NN
25944	1788	14	with	with	IN
25944	1788	15	any	any	DT
25944	1788	16	functional	functional	JJ
25944	1788	17	or	or	CC
25944	1788	18	organic	organic	JJ
25944	1788	19	disease	disease	NN
25944	1788	20	of	of	IN
25944	1788	21	the	the	DT
25944	1788	22	utero	utero	NNP
25944	1788	23	-	-	HYPH
25944	1788	24	ovarian	ovarian	JJ
25944	1788	25	apparatus	apparatus	NN
25944	1788	26	.	.	.
25944	1789	1	#	#	LS
25944	1789	2	What	what	WP
25944	1789	3	is	be	VBZ
25944	1789	4	argyria	argyria	NN
25944	1789	5	?	?	.
25944	1789	6	#	#	$
25944	1789	7	Argyria	Argyria	NNP
25944	1789	8	is	be	VBZ
25944	1789	9	the	the	DT
25944	1789	10	term	term	NN
25944	1789	11	applied	apply	VBN
25944	1789	12	to	to	IN
25944	1789	13	the	the	DT
25944	1789	14	slate	slate	NN
25944	1789	15	-	-	HYPH
25944	1789	16	like	like	JJ
25944	1789	17	discoloration	discoloration	NN
25944	1789	18	which	which	WDT
25944	1789	19	follows	follow	VBZ
25944	1789	20	the	the	DT
25944	1789	21	prolonged	prolonged	JJ
25944	1789	22	administration	administration	NN
25944	1789	23	of	of	IN
25944	1789	24	silver	silver	NNP
25944	1789	25	nitrate	nitrate	JJ
25944	1789	26	.	.	.
25944	1790	1	#	#	NNP
25944	1790	2	State	state	NN
25944	1790	3	the	the	DT
25944	1790	4	pathology	pathology	NN
25944	1790	5	of	of	IN
25944	1790	6	chloasma	chloasma	NN
25944	1790	7	.	.	.
25944	1790	8	#	#	$
25944	1790	9	The	the	DT
25944	1790	10	sole	sole	JJ
25944	1790	11	change	change	NN
25944	1790	12	consists	consist	VBZ
25944	1790	13	in	in	IN
25944	1790	14	an	an	DT
25944	1790	15	increased	increase	VBN
25944	1790	16	deposit	deposit	NN
25944	1790	17	of	of	IN
25944	1790	18	pigment	pigment	NN
25944	1790	19	.	.	.
25944	1791	1	#	#	NN
25944	1791	2	Give	give	VB
25944	1791	3	the	the	DT
25944	1791	4	prognosis	prognosis	NN
25944	1791	5	of	of	IN
25944	1791	6	chloasma	chloasma	NN
25944	1791	7	.	.	.
25944	1791	8	#	#	$
25944	1791	9	Unless	unless	IN
25944	1791	10	a	a	DT
25944	1791	11	removal	removal	NN
25944	1791	12	of	of	IN
25944	1791	13	the	the	DT
25944	1791	14	exciting	exciting	JJ
25944	1791	15	or	or	CC
25944	1791	16	predisposing	predisposing	JJ
25944	1791	17	cause	cause	NN
25944	1791	18	is	be	VBZ
25944	1791	19	possible	possible	JJ
25944	1791	20	,	,	,
25944	1791	21	the	the	DT
25944	1791	22	prognosis	prognosis	NN
25944	1791	23	is	be	VBZ
25944	1791	24	,	,	,
25944	1791	25	as	as	IN
25944	1791	26	a	a	DT
25944	1791	27	rule	rule	NN
25944	1791	28	,	,	,
25944	1791	29	unfavorable	unfavorable	JJ
25944	1791	30	,	,	,
25944	1791	31	and	and	CC
25944	1791	32	the	the	DT
25944	1791	33	relief	relief	NN
25944	1791	34	furnished	furnish	VBN
25944	1791	35	by	by	IN
25944	1791	36	local	local	JJ
25944	1791	37	applications	application	NNS
25944	1791	38	usually	usually	RB
25944	1791	39	but	but	CC
25944	1791	40	temporary	temporary	JJ
25944	1791	41	.	.	.
25944	1792	1	#	#	$
25944	1792	2	If	if	IN
25944	1792	3	constitutional	constitutional	JJ
25944	1792	4	treatment	treatment	NN
25944	1792	5	is	be	VBZ
25944	1792	6	advisable	advisable	JJ
25944	1792	7	,	,	,
25944	1792	8	upon	upon	IN
25944	1792	9	what	what	WP
25944	1792	10	is	be	VBZ
25944	1792	11	it	-PRON-	PRP
25944	1792	12	to	to	TO
25944	1792	13	be	be	VB
25944	1792	14	based	base	VBN
25944	1792	15	?	?	.
25944	1792	16	#	#	$
25944	1792	17	Upon	upon	IN
25944	1792	18	general	general	JJ
25944	1792	19	principles	principle	NNS
25944	1792	20	;	;	:
25944	1792	21	there	there	EX
25944	1792	22	are	be	VBP
25944	1792	23	no	no	DT
25944	1792	24	special	special	JJ
25944	1792	25	remedies	remedy	NNS
25944	1792	26	.	.	.
25944	1793	1	#	#	NNP
25944	1793	2	How	how	WRB
25944	1793	3	do	do	VBP
25944	1793	4	external	external	JJ
25944	1793	5	remedies	remedy	NNS
25944	1793	6	act	act	VB
25944	1793	7	?	?	.
25944	1793	8	#	#	NN
25944	1793	9	Mainly	mainly	RB
25944	1793	10	by	by	IN
25944	1793	11	removing	remove	VBG
25944	1793	12	the	the	DT
25944	1793	13	rete	rete	NN
25944	1793	14	cells	cell	NNS
25944	1793	15	and	and	CC
25944	1793	16	with	with	IN
25944	1793	17	them	-PRON-	PRP
25944	1793	18	the	the	DT
25944	1793	19	pigmentation	pigmentation	NN
25944	1793	20	;	;	,
25944	1793	21	and	and	CC
25944	1793	22	partly	partly	RB
25944	1793	23	,	,	,
25944	1793	24	also	also	RB
25944	1793	25	,	,	,
25944	1793	26	by	by	IN
25944	1793	27	stimulating	stimulate	VBG
25944	1793	28	the	the	DT
25944	1793	29	absorbents	absorbent	NNS
25944	1793	30	.	.	.
25944	1794	1	#	#	NN
25944	1794	2	Are	be	VBP
25944	1794	3	all	all	DT
25944	1794	4	external	external	JJ
25944	1794	5	remedies	remedy	NNS
25944	1794	6	which	which	WDT
25944	1794	7	tend	tend	VBP
25944	1794	8	to	to	TO
25944	1794	9	remove	remove	VB
25944	1794	10	the	the	DT
25944	1794	11	upper	upper	JJ
25944	1794	12	layers	layer	NNS
25944	1794	13	of	of	IN
25944	1794	14	the	the	DT
25944	1794	15	skin	skin	NN
25944	1794	16	equally	equally	RB
25944	1794	17	useful	useful	JJ
25944	1794	18	for	for	IN
25944	1794	19	this	this	DT
25944	1794	20	purpose	purpose	NN
25944	1794	21	?	?	.
25944	1794	22	#	#	NN
25944	1794	23	No	no	UH
25944	1794	24	;	;	:
25944	1794	25	on	on	IN
25944	1794	26	the	the	DT
25944	1794	27	contrary	contrary	NN
25944	1794	28	some	some	DT
25944	1794	29	such	such	JJ
25944	1794	30	applications	application	NNS
25944	1794	31	are	be	VBP
25944	1794	32	followed	follow	VBN
25944	1794	33	by	by	IN
25944	1794	34	an	an	DT
25944	1794	35	increase	increase	NN
25944	1794	36	in	in	IN
25944	1794	37	the	the	DT
25944	1794	38	pigment	pigment	NN
25944	1794	39	deposit	deposit	NN
25944	1794	40	.	.	.
25944	1795	1	#	#	$
25944	1795	2	Name	name	VB
25944	1795	3	the	the	DT
25944	1795	4	several	several	JJ
25944	1795	5	applications	application	NNS
25944	1795	6	commonly	commonly	RB
25944	1795	7	employed	employ	VBN
25944	1795	8	.	.	.
25944	1795	9	#	#	JJR
25944	1795	10	Corrosive	corrosive	JJ
25944	1795	11	sublimate	sublimate	NN
25944	1795	12	in	in	IN
25944	1795	13	solution	solution	NN
25944	1795	14	,	,	,
25944	1795	15	in	in	IN
25944	1795	16	the	the	DT
25944	1795	17	strength	strength	NN
25944	1795	18	of	of	IN
25944	1795	19	one	one	CD
25944	1795	20	to	to	TO
25944	1795	21	four	four	CD
25944	1795	22	grains	grain	NNS
25944	1795	23	to	to	IN
25944	1795	24	the	the	DT
25944	1795	25	ounce	ounce	NN
25944	1795	26	of	of	IN
25944	1795	27	alcohol	alcohol	NN
25944	1795	28	and	and	CC
25944	1795	29	water	water	NN
25944	1795	30	;	;	:
25944	1795	31	a	a	DT
25944	1795	32	lotion	lotion	NN
25944	1795	33	made	make	VBN
25944	1795	34	up	up	RP
25944	1795	35	as	as	IN
25944	1795	36	follows:--	follows:--	ADD
25944	1795	37	[	[	-LRB-
25944	1795	38	Rx	Rx	NNP
25944	1795	39	]	]	-RRB-
25944	1795	40	Hydrargyri	Hydrargyri	NNP
25944	1795	41	chlorid	chlorid	NN
25944	1795	42	.	.	.
25944	1796	1	corros	corros	NNP
25944	1796	2	.	.	NNP
25944	1796	3	,	,	,
25944	1796	4	.........	.........	NFP
25944	1796	5	gr	gr	NNP
25944	1796	6	.	.	.
25944	1797	1	iij	iij	NNP
25944	1797	2	-	-	HYPH
25944	1797	3	viij	viij	JJ
25944	1797	4	Ac	Ac	NNP
25944	1797	5	.	.	.
25944	1798	1	acet	acet	NNP
25944	1798	2	.	.	.
25944	1799	1	dilut	dilut	NNP
25944	1799	2	.	.	.
25944	1799	3	,	,	,
25944	1799	4	....................	....................	NFP
25944	1799	5	f[dram]ij	f[dram]ij	NFP
25944	1799	6	Sodii	sodii	VBP
25944	1799	7	borat	borat	NNP
25944	1799	8	.	.	.
25944	1799	9	,	,	,
25944	1799	10	........................	........................	NFP
25944	1799	11	[	[	-LRB-
25944	1799	12	scruple]ij	scruple]ij	NNP
25944	1799	13	Aquæ	Aquæ	NNP
25944	1799	14	rosæ	rosæ	NN
25944	1799	15	,	,	,
25944	1799	16	...........................	...........................	NFP
25944	1799	17	f[Oz]iv	f[Oz]iv	NNP
25944	1799	18	.	.	.
25944	1800	1	M.	M.	NNP
25944	1800	2	And	and	CC
25944	1800	3	also	also	RB
25944	1800	4	the	the	DT
25944	1800	5	following:--	following:--	NN
25944	1800	6	[	[	-LRB-
25944	1800	7	Rx	Rx	NNP
25944	1800	8	]	]	-RRB-
25944	1800	9	Hydrargyri	Hydrargyri	NNP
25944	1800	10	chlorid	chlorid	NN
25944	1800	11	.	.	.
25944	1801	1	corros	corros	NNP
25944	1801	2	.	.	NNP
25944	1801	3	,	,	,
25944	1801	4	.........	.........	NFP
25944	1801	5	gr	gr	NNP
25944	1801	6	.	.	.
25944	1802	1	iij	iij	NNP
25944	1802	2	-	-	HYPH
25944	1802	3	viij	viij	NN
25944	1802	4	Zinci	Zinci	NNP
25944	1802	5	sulphat	sulphat	NN
25944	1802	6	.	.	.
25944	1802	7	,	,	,
25944	1802	8	Plumbi	Plumbi	NNP
25944	1802	9	acetat	acetat	NNP
25944	1802	10	.	.	.
25944	1802	11	,	,	,
25944	1802	12	......	......	NFP
25944	1802	13	[	[	-LRB-
25944	1802	14	=	=	SYM
25944	1802	15	a][=a	a][=a	CD
25944	1802	16	]	]	-RRB-
25944	1802	17	......	......	NFP
25944	1802	18	[	[	-LRB-
25944	1802	19	dram]ss	dram]s	NNS
25944	1802	20	Aquæ	Aquæ	NNP
25944	1802	21	,	,	,
25944	1802	22	................................	................................	NFP
25944	1802	23	f[Oz]iv	f[oz]iv	XX
25944	1802	24	.	.	.
25944	1803	1	M.	M.	NNP
25944	1803	2	And	and	CC
25944	1803	3	lactic	lactic	JJ
25944	1803	4	acid	acid	NN
25944	1803	5	,	,	,
25944	1803	6	with	with	IN
25944	1803	7	from	from	IN
25944	1803	8	five	five	CD
25944	1803	9	to	to	TO
25944	1803	10	twenty	twenty	CD
25944	1803	11	parts	part	NNS
25944	1803	12	of	of	IN
25944	1803	13	water	water	NN
25944	1803	14	;	;	:
25944	1803	15	and	and	CC
25944	1803	16	an	an	DT
25944	1803	17	ointment	ointment	NN
25944	1803	18	containing	contain	VBG
25944	1803	19	a	a	DT
25944	1803	20	drachm	drachm	NN
25944	1803	21	each	each	DT
25944	1803	22	of	of	IN
25944	1803	23	bismuth	bismuth	NNP
25944	1803	24	subnitrate	subnitrate	NN
25944	1803	25	and	and	CC
25944	1803	26	white	white	JJ
25944	1803	27	precipitate	precipitate	NN
25944	1803	28	to	to	IN
25944	1803	29	the	the	DT
25944	1803	30	ounce	ounce	NN
25944	1803	31	.	.	.
25944	1804	1	Hydrogen	hydrogen	NN
25944	1804	2	peroxide	peroxide	NN
25944	1804	3	occasionally	occasionally	RB
25944	1804	4	acts	act	VBZ
25944	1804	5	well	well	RB
25944	1804	6	.	.	.
25944	1805	1	Trichloracetic	trichloracetic	JJ
25944	1805	2	acid	acid	NN
25944	1805	3	,	,	,
25944	1805	4	usually	usually	RB
25944	1805	5	weakened	weaken	VBN
25944	1805	6	with	with	IN
25944	1805	7	one	one	CD
25944	1805	8	or	or	CC
25944	1805	9	two	two	CD
25944	1805	10	parts	part	NNS
25944	1805	11	water	water	NN
25944	1805	12	,	,	,
25944	1805	13	may	may	MD
25944	1805	14	be	be	VB
25944	1805	15	cautiously	cautiously	RB
25944	1805	16	tried	try	VBN
25944	1805	17	.	.	.
25944	1806	1	The	the	DT
25944	1806	2	application	application	NN
25944	1806	3	of	of	IN
25944	1806	4	a	a	DT
25944	1806	5	strong	strong	JJ
25944	1806	6	alcoholic	alcoholic	JJ
25944	1806	7	solution	solution	NN
25944	1806	8	of	of	IN
25944	1806	9	resorcin	resorcin	NNS
25944	1806	10	,	,	,
25944	1806	11	twenty	twenty	CD
25944	1806	12	to	to	TO
25944	1806	13	fifty	fifty	CD
25944	1806	14	per	per	IN
25944	1806	15	cent	cent	NN
25944	1806	16	.	.	.
25944	1807	1	strength	strength	NN
25944	1807	2	,	,	,
25944	1807	3	is	be	VBZ
25944	1807	4	also	also	RB
25944	1807	5	valuable	valuable	JJ
25944	1807	6	,	,	,
25944	1807	7	as	as	IN
25944	1807	8	is	be	VBZ
25944	1807	9	also	also	RB
25944	1807	10	a	a	DT
25944	1807	11	two	two	CD
25944	1807	12	to	to	TO
25944	1807	13	ten	ten	CD
25944	1807	14	per	per	IN
25944	1807	15	cent	cent	NN
25944	1807	16	.	.	.
25944	1808	1	alcoholic	alcoholic	JJ
25944	1808	2	solution	solution	NN
25944	1808	3	of	of	IN
25944	1808	4	salicylic	salicylic	JJ
25944	1808	5	acid	acid	NN
25944	1808	6	.	.	.
25944	1809	1	(	(	-LRB-
25944	1809	2	Applications	application	NNS
25944	1809	3	are	be	VBP
25944	1809	4	made	make	VBN
25944	1809	5	two	two	CD
25944	1809	6	or	or	CC
25944	1809	7	three	three	CD
25944	1809	8	times	time	NNS
25944	1809	9	daily	daily	RB
25944	1809	10	,	,	,
25944	1809	11	and	and	CC
25944	1809	12	as	as	RB
25944	1809	13	soon	soon	RB
25944	1809	14	as	as	IN
25944	1809	15	slight	slight	JJ
25944	1809	16	scaliness	scaliness	NN
25944	1809	17	or	or	CC
25944	1809	18	irritation	irritation	NN
25944	1809	19	is	be	VBZ
25944	1809	20	produced	produce	VBN
25944	1809	21	are	be	VBP
25944	1809	22	to	to	TO
25944	1809	23	be	be	VB
25944	1809	24	discontinued	discontinue	VBN
25944	1809	25	for	for	IN
25944	1809	26	one	one	CD
25944	1809	27	or	or	CC
25944	1809	28	two	two	CD
25944	1809	29	days	day	NNS
25944	1809	30	.	.	.
25944	1809	31	)	)	-RRB-
25944	1810	1	_	_	NNP
25944	1810	2	Tattoo	Tattoo	NNP
25944	1810	3	-	-	HYPH
25944	1810	4	marks	mark	NNS
25944	1810	5	_	_	NNP
25944	1810	6	are	be	VBP
25944	1810	7	difficult	difficult	JJ
25944	1810	8	to	to	TO
25944	1810	9	remove	remove	VB
25944	1810	10	.	.	.
25944	1811	1	Excision	excision	NN
25944	1811	2	is	be	VBZ
25944	1811	3	the	the	DT
25944	1811	4	surest	sure	JJS
25944	1811	5	method	method	NN
25944	1811	6	.	.	.
25944	1812	1	Electrolysis	electrolysis	NN
25944	1812	2	,	,	,
25944	1812	3	applying	apply	VBG
25944	1812	4	the	the	DT
25944	1812	5	needle	needle	NN
25944	1812	6	at	at	IN
25944	1812	7	various	various	JJ
25944	1812	8	points	point	NNS
25944	1812	9	,	,	,
25944	1812	10	somewhat	somewhat	RB
25944	1812	11	close	close	JJ
25944	1812	12	together	together	RB
25944	1812	13	,	,	,
25944	1812	14	and	and	CC
25944	1812	15	using	use	VBG
25944	1812	16	a	a	DT
25944	1812	17	fairly	fairly	RB
25944	1812	18	strong	strong	JJ
25944	1812	19	current	current	NN
25944	1812	20	--	--	:
25944	1812	21	three	three	CD
25944	1812	22	to	to	TO
25944	1812	23	eight	eight	CD
25944	1812	24	milliampères	milliampère	NNS
25944	1812	25	--	--	:
25944	1812	26	will	will	MD
25944	1812	27	exceptionally	exceptionally	RB
25944	1812	28	,	,	,
25944	1812	29	especially	especially	RB
25944	1812	30	when	when	WRB
25944	1812	31	repeated	repeat	VBN
25944	1812	32	several	several	JJ
25944	1812	33	times	time	NNS
25944	1812	34	,	,	,
25944	1812	35	produce	produce	VB
25944	1812	36	a	a	DT
25944	1812	37	reactive	reactive	JJ
25944	1812	38	inflammation	inflammation	NN
25944	1812	39	and	and	CC
25944	1812	40	casting	casting	NN
25944	1812	41	-	-	HYPH
25944	1812	42	off	off	NN
25944	1812	43	of	of	IN
25944	1812	44	the	the	DT
25944	1812	45	tissue	tissue	NN
25944	1812	46	containing	contain	VBG
25944	1812	47	the	the	DT
25944	1812	48	pigment	pigment	NN
25944	1812	49	;	;	:
25944	1812	50	a	a	DT
25944	1812	51	scar	scar	NN
25944	1812	52	is	be	VBZ
25944	1812	53	left	leave	VBN
25944	1812	54	.	.	.
25944	1813	1	Several	several	JJ
25944	1813	2	writers	writer	NNS
25944	1813	3	claim	claim	VBP
25944	1813	4	good	good	JJ
25944	1813	5	results	result	NNS
25944	1813	6	with	with	IN
25944	1813	7	glycerole	glycerole	NN
25944	1813	8	of	of	IN
25944	1813	9	papain	papain	NN
25944	1813	10	,	,	,
25944	1813	11	pricking	prick	VBG
25944	1813	12	it	-PRON-	PRP
25944	1813	13	in	in	RP
25944	1813	14	in	in	IN
25944	1813	15	the	the	DT
25944	1813	16	same	same	JJ
25944	1813	17	manner	manner	NN
25944	1813	18	as	as	IN
25944	1813	19	in	in	IN
25944	1813	20	tattooing	tattooing	NN
25944	1813	21	.	.	.
25944	1814	1	_	_	NNP
25944	1814	2	Gun	Gun	NNP
25944	1814	3	-	-	HYPH
25944	1814	4	powder	powder	NNP
25944	1814	5	marks	mark	NNS
25944	1814	6	.	.	.
25944	1814	7	_	_	XX
25944	1814	8	If	if	IN
25944	1814	9	recent	recent	JJ
25944	1814	10	,	,	,
25944	1814	11	but	but	CC
25944	1814	12	a	a	DT
25944	1814	13	day	day	NN
25944	1814	14	or	or	CC
25944	1814	15	so	so	RB
25944	1814	16	after	after	IN
25944	1814	17	their	-PRON-	PRP$
25944	1814	18	occurrence	occurrence	NN
25944	1814	19	,	,	,
25944	1814	20	the	the	DT
25944	1814	21	larger	large	JJR
25944	1814	22	specks	speck	NNS
25944	1814	23	may	may	MD
25944	1814	24	be	be	VB
25944	1814	25	picked	pick	VBN
25944	1814	26	or	or	CC
25944	1814	27	scraped	scrape	VBN
25944	1814	28	out	out	RP
25944	1814	29	.	.	.
25944	1815	1	Later	later	RB
25944	1815	2	,	,	,
25944	1815	3	electrolysis	electrolysis	NN
25944	1815	4	,	,	,
25944	1815	5	using	use	VBG
25944	1815	6	a	a	DT
25944	1815	7	fairly	fairly	RB
25944	1815	8	strong	strong	JJ
25944	1815	9	current	current	NN
25944	1815	10	,	,	,
25944	1815	11	may	may	MD
25944	1815	12	result	result	VB
25944	1815	13	in	in	IN
25944	1815	14	their	-PRON-	PRP$
25944	1815	15	removal	removal	NN
25944	1815	16	.	.	.
25944	1816	1	Their	-PRON-	PRP$
25944	1816	2	removal	removal	NN
25944	1816	3	may	may	MD
25944	1816	4	also	also	RB
25944	1816	5	be	be	VB
25944	1816	6	satisfactorily	satisfactorily	RB
25944	1816	7	effected	effect	VBN
25944	1816	8	with	with	IN
25944	1816	9	a	a	DT
25944	1816	10	minute	minute	JJ
25944	1816	11	cutaneous	cutaneous	JJ
25944	1816	12	trephine	trephine	NN
25944	1816	13	.	.	.
25944	1817	1	#	#	NNP
25944	1817	2	Keratosis	Keratosis	NNP
25944	1817	3	Pilaris	Pilaris	NNP
25944	1817	4	.	.	.
25944	1817	5	#	#	NNP
25944	1817	6	(	(	-LRB-
25944	1817	7	_	_	NNP
25944	1817	8	Synonyms	Synonyms	NNP
25944	1817	9	:	:	:
25944	1817	10	_	_	NNP
25944	1817	11	Pityriasis	Pityriasis	NNP
25944	1817	12	Pilaris	Pilaris	NNP
25944	1817	13	;	;	:
25944	1817	14	Lichen	Lichen	NNP
25944	1817	15	Pilaris	Pilaris	NNP
25944	1817	16	.	.	.
25944	1817	17	)	)	-RRB-
25944	1818	1	#	#	LS
25944	1818	2	What	what	WP
25944	1818	3	is	be	VBZ
25944	1818	4	meant	mean	VBN
25944	1818	5	by	by	IN
25944	1818	6	keratosis	keratosis	NNP
25944	1818	7	pilaris	pilaris	NNP
25944	1818	8	?	?	.
25944	1818	9	#	#	NNP
25944	1818	10	Keratosis	Keratosis	NNP
25944	1818	11	pilaris	pilaris	NNP
25944	1818	12	may	may	MD
25944	1818	13	be	be	VB
25944	1818	14	defined	define	VBN
25944	1818	15	as	as	IN
25944	1818	16	a	a	DT
25944	1818	17	hypertrophic	hypertrophic	JJ
25944	1818	18	affection	affection	NN
25944	1818	19	characterized	characterize	VBN
25944	1818	20	by	by	IN
25944	1818	21	the	the	DT
25944	1818	22	formation	formation	NN
25944	1818	23	of	of	IN
25944	1818	24	pin	pin	NN
25944	1818	25	-	-	HYPH
25944	1818	26	head	head	NN
25944	1818	27	-	-	HYPH
25944	1818	28	sized	sized	JJ
25944	1818	29	,	,	,
25944	1818	30	conical	conical	JJ
25944	1818	31	,	,	,
25944	1818	32	epidermic	epidermic	JJ
25944	1818	33	elevations	elevation	NNS
25944	1818	34	seated	seat	VBN
25944	1818	35	about	about	IN
25944	1818	36	the	the	DT
25944	1818	37	apertures	aperture	NNS
25944	1818	38	of	of	IN
25944	1818	39	the	the	DT
25944	1818	40	hair	hair	NN
25944	1818	41	follicles	follicle	NNS
25944	1818	42	.	.	.
25944	1819	1	#	#	NNP
25944	1819	2	Describe	describe	VB
25944	1819	3	the	the	DT
25944	1819	4	clinical	clinical	JJ
25944	1819	5	appearances	appearance	NNS
25944	1819	6	of	of	IN
25944	1819	7	keratosis	keratosis	NNP
25944	1819	8	pilaris	pilaris	NNP
25944	1819	9	.	.	.
25944	1819	10	#	#	$
25944	1819	11	The	the	DT
25944	1819	12	lesions	lesion	NNS
25944	1819	13	are	be	VBP
25944	1819	14	usually	usually	RB
25944	1819	15	limited	limited	JJ
25944	1819	16	to	to	IN
25944	1819	17	the	the	DT
25944	1819	18	extensor	extensor	NN
25944	1819	19	surfaces	surface	NNS
25944	1819	20	of	of	IN
25944	1819	21	the	the	DT
25944	1819	22	thighs	thigh	NNS
25944	1819	23	and	and	CC
25944	1819	24	arms	arm	NNS
25944	1819	25	,	,	,
25944	1819	26	especially	especially	RB
25944	1819	27	the	the	DT
25944	1819	28	former	former	JJ
25944	1819	29	.	.	.
25944	1820	1	They	-PRON-	PRP
25944	1820	2	appear	appear	VBP
25944	1820	3	as	as	IN
25944	1820	4	pin	pin	NN
25944	1820	5	-	-	HYPH
25944	1820	6	head	head	NN
25944	1820	7	-	-	HYPH
25944	1820	8	sized	sized	JJ
25944	1820	9	,	,	,
25944	1820	10	whitish	whitish	JJ
25944	1820	11	or	or	CC
25944	1820	12	grayish	grayish	VB
25944	1820	13	elevations	elevation	NNS
25944	1820	14	,	,	,
25944	1820	15	consisting	consist	VBG
25944	1820	16	of	of	IN
25944	1820	17	accumulations	accumulation	NNS
25944	1820	18	of	of	IN
25944	1820	19	epithelial	epithelial	JJ
25944	1820	20	matter	matter	NN
25944	1820	21	about	about	IN
25944	1820	22	the	the	DT
25944	1820	23	apertures	aperture	NNS
25944	1820	24	of	of	IN
25944	1820	25	the	the	DT
25944	1820	26	hair	hair	NN
25944	1820	27	follicles	follicle	NNS
25944	1820	28	.	.	.
25944	1821	1	Each	each	DT
25944	1821	2	elevation	elevation	NN
25944	1821	3	is	be	VBZ
25944	1821	4	pierced	pierce	VBN
25944	1821	5	by	by	IN
25944	1821	6	a	a	DT
25944	1821	7	hair	hair	NN
25944	1821	8	,	,	,
25944	1821	9	or	or	CC
25944	1821	10	the	the	DT
25944	1821	11	hair	hair	NN
25944	1821	12	may	may	MD
25944	1821	13	be	be	VB
25944	1821	14	twisted	twist	VBN
25944	1821	15	and	and	CC
25944	1821	16	imprisoned	imprison	VBN
25944	1821	17	within	within	IN
25944	1821	18	the	the	DT
25944	1821	19	epithelial	epithelial	JJ
25944	1821	20	mass	mass	NN
25944	1821	21	;	;	:
25944	1821	22	or	or	CC
25944	1821	23	it	-PRON-	PRP
25944	1821	24	may	may	MD
25944	1821	25	be	be	VB
25944	1821	26	broken	break	VBN
25944	1821	27	off	off	RP
25944	1821	28	just	just	RB
25944	1821	29	at	at	IN
25944	1821	30	the	the	DT
25944	1821	31	point	point	NN
25944	1821	32	of	of	IN
25944	1821	33	emergence	emergence	NN
25944	1821	34	at	at	IN
25944	1821	35	the	the	DT
25944	1821	36	apex	apex	NN
25944	1821	37	of	of	IN
25944	1821	38	the	the	DT
25944	1821	39	papule	papule	NN
25944	1821	40	,	,	,
25944	1821	41	in	in	IN
25944	1821	42	which	which	WDT
25944	1821	43	event	event	NN
25944	1821	44	it	-PRON-	PRP
25944	1821	45	may	may	MD
25944	1821	46	be	be	VB
25944	1821	47	seen	see	VBN
25944	1821	48	as	as	IN
25944	1821	49	a	a	DT
25944	1821	50	dark	dark	JJ
25944	1821	51	,	,	,
25944	1821	52	central	central	JJ
25944	1821	53	speck	speck	NN
25944	1821	54	.	.	.
25944	1822	1	The	the	DT
25944	1822	2	skin	skin	NN
25944	1822	3	is	be	VBZ
25944	1822	4	usually	usually	RB
25944	1822	5	dry	dry	JJ
25944	1822	6	,	,	,
25944	1822	7	rough	rough	JJ
25944	1822	8	and	and	CC
25944	1822	9	harsh	harsh	JJ
25944	1822	10	,	,	,
25944	1822	11	and	and	CC
25944	1822	12	in	in	IN
25944	1822	13	marked	marked	JJ
25944	1822	14	cases	case	NNS
25944	1822	15	,	,	,
25944	1822	16	to	to	IN
25944	1822	17	the	the	DT
25944	1822	18	hand	hand	NN
25944	1822	19	passing	pass	VBG
25944	1822	20	over	over	IN
25944	1822	21	it	-PRON-	PRP
25944	1822	22	,	,	,
25944	1822	23	feels	feel	VBZ
25944	1822	24	not	not	RB
25944	1822	25	unlike	unlike	IN
25944	1822	26	a	a	DT
25944	1822	27	nutmeg	nutmeg	NN
25944	1822	28	-	-	HYPH
25944	1822	29	grater	grater	NN
25944	1822	30	.	.	.
25944	1823	1	The	the	DT
25944	1823	2	disease	disease	NN
25944	1823	3	varies	vary	VBZ
25944	1823	4	in	in	IN
25944	1823	5	its	-PRON-	PRP$
25944	1823	6	development	development	NN
25944	1823	7	,	,	,
25944	1823	8	in	in	IN
25944	1823	9	most	most	JJS
25944	1823	10	cases	case	NNS
25944	1823	11	being	be	VBG
25944	1823	12	so	so	RB
25944	1823	13	slight	slight	JJ
25944	1823	14	as	as	IN
25944	1823	15	to	to	TO
25944	1823	16	escape	escape	VB
25944	1823	17	attention	attention	NN
25944	1823	18	.	.	.
25944	1824	1	As	as	IN
25944	1824	2	a	a	DT
25944	1824	3	rule	rule	NN
25944	1824	4	,	,	,
25944	1824	5	it	-PRON-	PRP
25944	1824	6	is	be	VBZ
25944	1824	7	free	free	JJ
25944	1824	8	from	from	IN
25944	1824	9	itching	itch	VBG
25944	1824	10	.	.	.
25944	1825	1	#	#	LS
25944	1825	2	What	what	WDT
25944	1825	3	course	course	NN
25944	1825	4	does	do	VBZ
25944	1825	5	keratosis	keratosis	NNP
25944	1825	6	pilaris	pilaris	NNP
25944	1825	7	pursue	pursue	NNP
25944	1825	8	?	?	.
25944	1825	9	#	#	NNP
25944	1825	10	It	-PRON-	PRP
25944	1825	11	is	be	VBZ
25944	1825	12	sluggish	sluggish	JJ
25944	1825	13	and	and	CC
25944	1825	14	chronic	chronic	JJ
25944	1825	15	.	.	.
25944	1826	1	#	#	$
25944	1826	2	Mention	mention	VB
25944	1826	3	some	some	DT
25944	1826	4	of	of	IN
25944	1826	5	the	the	DT
25944	1826	6	etiological	etiological	JJ
25944	1826	7	factors	factor	NNS
25944	1826	8	.	.	.
25944	1826	9	#	#	$
25944	1826	10	It	-PRON-	PRP
25944	1826	11	is	be	VBZ
25944	1826	12	not	not	RB
25944	1826	13	an	an	DT
25944	1826	14	uncommon	uncommon	JJ
25944	1826	15	disease	disease	NN
25944	1826	16	,	,	,
25944	1826	17	and	and	CC
25944	1826	18	is	be	VBZ
25944	1826	19	seen	see	VBN
25944	1826	20	usually	usually	RB
25944	1826	21	in	in	IN
25944	1826	22	those	those	DT
25944	1826	23	who	who	WP
25944	1826	24	are	be	VBP
25944	1826	25	unaccustomed	unaccustomed	JJ
25944	1826	26	to	to	IN
25944	1826	27	frequent	frequent	JJ
25944	1826	28	bathing	bathing	NN
25944	1826	29	,	,	,
25944	1826	30	being	be	VBG
25944	1826	31	most	most	RBS
25944	1826	32	frequently	frequently	RB
25944	1826	33	met	meet	VBN
25944	1826	34	with	with	IN
25944	1826	35	during	during	IN
25944	1826	36	the	the	DT
25944	1826	37	winter	winter	NN
25944	1826	38	months	month	NNS
25944	1826	39	.	.	.
25944	1827	1	It	-PRON-	PRP
25944	1827	2	is	be	VBZ
25944	1827	3	chiefly	chiefly	RB
25944	1827	4	observed	observe	VBN
25944	1827	5	during	during	IN
25944	1827	6	early	early	JJ
25944	1827	7	adult	adult	NN
25944	1827	8	life	life	NN
25944	1827	9	.	.	.
25944	1828	1	#	#	$
25944	1828	2	Is	be	VBZ
25944	1828	3	there	there	EX
25944	1828	4	any	any	DT
25944	1828	5	difficulty	difficulty	NN
25944	1828	6	in	in	IN
25944	1828	7	the	the	DT
25944	1828	8	diagnosis	diagnosis	NN
25944	1828	9	?	?	.
25944	1828	10	#	#	$
25944	1828	11	No	no	UH
25944	1828	12	.	.	.
25944	1829	1	It	-PRON-	PRP
25944	1829	2	is	be	VBZ
25944	1829	3	thought	think	VBN
25944	1829	4	at	at	IN
25944	1829	5	times	time	NNS
25944	1829	6	to	to	TO
25944	1829	7	bear	bear	VB
25944	1829	8	some	some	DT
25944	1829	9	resemblance	resemblance	NN
25944	1829	10	to	to	IN
25944	1829	11	goose	goose	NN
25944	1829	12	-	-	HYPH
25944	1829	13	flesh	flesh	NN
25944	1829	14	(	(	-LRB-
25944	1829	15	cutis	cutis	NNP
25944	1829	16	anserina	anserina	NNP
25944	1829	17	)	)	-RRB-
25944	1829	18	,	,	,
25944	1829	19	the	the	DT
25944	1829	20	miliary	miliary	JJ
25944	1829	21	papular	papular	JJ
25944	1829	22	syphiloderm	syphiloderm	NN
25944	1829	23	in	in	IN
25944	1829	24	its	-PRON-	PRP$
25944	1829	25	desquamating	desquamating	JJ
25944	1829	26	stage	stage	NN
25944	1829	27	,	,	,
25944	1829	28	and	and	CC
25944	1829	29	lichen	lichen	NNP
25944	1829	30	scrofulosus	scrofulosus	NNP
25944	1829	31	.	.	.
25944	1830	1	In	in	IN
25944	1830	2	goose	goose	NN
25944	1830	3	-	-	HYPH
25944	1830	4	flesh	flesh	NN
25944	1830	5	the	the	DT
25944	1830	6	elevations	elevation	NNS
25944	1830	7	are	be	VBP
25944	1830	8	evanescent	evanescent	JJ
25944	1830	9	and	and	CC
25944	1830	10	of	of	IN
25944	1830	11	an	an	DT
25944	1830	12	entirely	entirely	RB
25944	1830	13	different	different	JJ
25944	1830	14	character	character	NN
25944	1830	15	;	;	:
25944	1830	16	the	the	DT
25944	1830	17	papules	papule	NNS
25944	1830	18	of	of	IN
25944	1830	19	the	the	DT
25944	1830	20	syphiloderm	syphiloderm	NN
25944	1830	21	are	be	VBP
25944	1830	22	usually	usually	RB
25944	1830	23	generalized	generalize	VBN
25944	1830	24	,	,	,
25944	1830	25	of	of	IN
25944	1830	26	a	a	DT
25944	1830	27	reddish	reddish	JJ
25944	1830	28	color	color	NN
25944	1830	29	,	,	,
25944	1830	30	tend	tend	VBP
25944	1830	31	to	to	TO
25944	1830	32	group	group	VB
25944	1830	33	,	,	,
25944	1830	34	are	be	VBP
25944	1830	35	more	more	RBR
25944	1830	36	solid	solid	JJ
25944	1830	37	and	and	CC
25944	1830	38	deeply	deeply	RB
25944	1830	39	-	-	HYPH
25944	1830	40	seated	seated	JJ
25944	1830	41	,	,	,
25944	1830	42	less	less	RBR
25944	1830	43	scaly	scaly	NNP
25944	1830	44	and	and	CC
25944	1830	45	are	be	VBP
25944	1830	46	accompanied	accompany	VBN
25944	1830	47	with	with	IN
25944	1830	48	other	other	JJ
25944	1830	49	symptoms	symptom	NNS
25944	1830	50	of	of	IN
25944	1830	51	syphilis	syphilis	NNP
25944	1830	52	;	;	:
25944	1830	53	in	in	IN
25944	1830	54	lichen	lichen	NNP
25944	1830	55	scrofulosus	scrofulosus	NNP
25944	1830	56	the	the	DT
25944	1830	57	papules	papule	NNS
25944	1830	58	are	be	VBP
25944	1830	59	larger	large	JJR
25944	1830	60	,	,	,
25944	1830	61	incline	incline	VBP
25944	1830	62	to	to	TO
25944	1830	63	occur	occur	VB
25944	1830	64	in	in	IN
25944	1830	65	groups	group	NNS
25944	1830	66	,	,	,
25944	1830	67	and	and	CC
25944	1830	68	appear	appear	VBP
25944	1830	69	usually	usually	RB
25944	1830	70	upon	upon	IN
25944	1830	71	the	the	DT
25944	1830	72	abdomen	abdomen	NNP
25944	1830	73	.	.	.
25944	1831	1	#	#	JJR
25944	1831	2	State	state	NN
25944	1831	3	the	the	DT
25944	1831	4	prognosis	prognosis	NN
25944	1831	5	.	.	.
25944	1831	6	#	#	$
25944	1831	7	The	the	DT
25944	1831	8	disease	disease	NN
25944	1831	9	yields	yield	VBZ
25944	1831	10	readily	readily	RB
25944	1831	11	to	to	IN
25944	1831	12	treatment	treatment	NN
25944	1831	13	.	.	.
25944	1832	1	#	#	NN
25944	1832	2	Give	give	VB
25944	1832	3	the	the	DT
25944	1832	4	treatment	treatment	NN
25944	1832	5	of	of	IN
25944	1832	6	keratosis	keratosis	NNP
25944	1832	7	pilaris	pilaris	NNP
25944	1832	8	.	.	.
25944	1832	9	#	#	$
25944	1832	10	Frequent	frequent	JJ
25944	1832	11	warm	warm	JJ
25944	1832	12	baths	bath	NNS
25944	1832	13	,	,	,
25944	1832	14	with	with	IN
25944	1832	15	the	the	DT
25944	1832	16	use	use	NN
25944	1832	17	of	of	IN
25944	1832	18	a	a	DT
25944	1832	19	toilet	toilet	NN
25944	1832	20	soap	soap	NN
25944	1832	21	or	or	CC
25944	1832	22	sapo	sapo	NN
25944	1832	23	viridis	viridi	NNS
25944	1832	24	,	,	,
25944	1832	25	will	will	MD
25944	1832	26	usually	usually	RB
25944	1832	27	be	be	VB
25944	1832	28	found	find	VBN
25944	1832	29	curative	curative	JJ
25944	1832	30	.	.	.
25944	1833	1	Alkaline	alkaline	NN
25944	1833	2	baths	bath	NNS
25944	1833	3	are	be	VBP
25944	1833	4	also	also	RB
25944	1833	5	useful	useful	JJ
25944	1833	6	.	.	.
25944	1834	1	In	in	IN
25944	1834	2	obstinate	obstinate	NN
25944	1834	3	cases	case	NNS
25944	1834	4	the	the	DT
25944	1834	5	ordinary	ordinary	JJ
25944	1834	6	mild	mild	JJ
25944	1834	7	ointments	ointment	NNS
25944	1834	8	,	,	,
25944	1834	9	glycerine	glycerine	JJ
25944	1834	10	,	,	,
25944	1834	11	etc	etc	FW
25944	1834	12	.	.	.
25944	1834	13	,	,	,
25944	1834	14	are	be	VBP
25944	1834	15	to	to	TO
25944	1834	16	be	be	VB
25944	1834	17	advised	advise	VBN
25944	1834	18	in	in	IN
25944	1834	19	conjunction	conjunction	NN
25944	1834	20	with	with	IN
25944	1834	21	the	the	DT
25944	1834	22	baths	bath	NNS
25944	1834	23	.	.	.
25944	1835	1	#	#	NNP
25944	1835	2	Keratosis	Keratosis	NNP
25944	1835	3	Follicularis	Follicularis	NNP
25944	1835	4	.	.	.
25944	1835	5	#	#	$
25944	1835	6	#	#	$
25944	1835	7	Describe	Describe	NNP
25944	1835	8	keratosis	keratosis	NN
25944	1835	9	follicularis	follicularis	NN
25944	1835	10	.	.	.
25944	1835	11	#	#	$
25944	1835	12	Keratosis	Keratosis	NNP
25944	1835	13	follicularis	follicularis	NN
25944	1835	14	(	(	-LRB-
25944	1835	15	_	_	NNP
25944	1835	16	Darier	Darier	NNP
25944	1835	17	's	's	POS
25944	1835	18	disease	disease	NN
25944	1835	19	_	_	NNP
25944	1835	20	,	,	,
25944	1835	21	_	_	NNP
25944	1835	22	ichthyosis	ichthyosis	NN
25944	1835	23	follicularis	follicularis	NNP
25944	1835	24	_	_	NNP
25944	1835	25	,	,	,
25944	1835	26	_	_	NNP
25944	1835	27	ichthyosis	ichthyosis	NN
25944	1835	28	sebacea	sebacea	NNP
25944	1835	29	cornea	cornea	NNP
25944	1835	30	_	_	NNP
25944	1835	31	,	,	,
25944	1835	32	_	_	NNP
25944	1835	33	psorospermosis	psorospermosis	NN
25944	1835	34	_	_	NNP
25944	1835	35	)	)	-RRB-
25944	1835	36	is	be	VBZ
25944	1835	37	a	a	DT
25944	1835	38	rare	rare	JJ
25944	1835	39	disease	disease	NN
25944	1835	40	characterized	characterize	VBN
25944	1835	41	by	by	IN
25944	1835	42	pin	pin	NN
25944	1835	43	-	-	HYPH
25944	1835	44	head	head	NN
25944	1835	45	to	to	IN
25944	1835	46	pea	pea	JJ
25944	1835	47	-	-	HYPH
25944	1835	48	sized	sized	JJ
25944	1835	49	pointed	pointed	JJ
25944	1835	50	,	,	,
25944	1835	51	rounded	round	VBD
25944	1835	52	,	,	,
25944	1835	53	or	or	CC
25944	1835	54	irregularly	irregularly	RB
25944	1835	55	-	-	HYPH
25944	1835	56	shaped	shape	VBN
25944	1835	57	grayish	grayish	NN
25944	1835	58	,	,	,
25944	1835	59	brownish	brownish	NN
25944	1835	60	,	,	,
25944	1835	61	red	red	JJ
25944	1835	62	or	or	CC
25944	1835	63	even	even	RB
25944	1835	64	black	black	JJ
25944	1835	65	,	,	,
25944	1835	66	horny	horny	JJ
25944	1835	67	papules	papule	NNS
25944	1835	68	or	or	CC
25944	1835	69	elevations	elevation	NNS
25944	1835	70	,	,	,
25944	1835	71	arising	arise	VBG
25944	1835	72	from	from	IN
25944	1835	73	the	the	DT
25944	1835	74	sebaceous	sebaceous	JJ
25944	1835	75	or	or	CC
25944	1835	76	hair	hair	NN
25944	1835	77	-	-	HYPH
25944	1835	78	follicles	follicle	NNS
25944	1835	79	.	.	.
25944	1836	1	They	-PRON-	PRP
25944	1836	2	are	be	VBP
25944	1836	3	,	,	,
25944	1836	4	for	for	IN
25944	1836	5	the	the	DT
25944	1836	6	most	most	JJS
25944	1836	7	part	part	NN
25944	1836	8	,	,	,
25944	1836	9	discrete	discrete	JJ
25944	1836	10	,	,	,
25944	1836	11	with	with	IN
25944	1836	12	a	a	DT
25944	1836	13	tendency	tendency	NN
25944	1836	14	here	here	RB
25944	1836	15	and	and	CC
25944	1836	16	there	there	RB
25944	1836	17	to	to	TO
25944	1836	18	form	form	VB
25944	1836	19	solid	solid	JJ
25944	1836	20	aggregations	aggregation	NNS
25944	1836	21	or	or	CC
25944	1836	22	areas	area	NNS
25944	1836	23	.	.	.
25944	1837	1	Many	many	JJ
25944	1837	2	of	of	IN
25944	1837	3	them	-PRON-	PRP
25944	1837	4	contain	contain	VBP
25944	1837	5	projecting	projecting	NN
25944	1837	6	cornified	cornifie	VBN
25944	1837	7	plugs	plug	NNS
25944	1837	8	which	which	WDT
25944	1837	9	may	may	MD
25944	1837	10	be	be	VB
25944	1837	11	squeezed	squeeze	VBN
25944	1837	12	out	out	RP
25944	1837	13	,	,	,
25944	1837	14	leaving	leave	VBG
25944	1837	15	pit	pit	NN
25944	1837	16	-	-	HYPH
25944	1837	17	like	like	JJ
25944	1837	18	depressions	depression	NNS
25944	1837	19	.	.	.
25944	1838	1	The	the	DT
25944	1838	2	face	face	NN
25944	1838	3	,	,	,
25944	1838	4	scalp	scalp	NNP
25944	1838	5	,	,	,
25944	1838	6	lower	low	JJR
25944	1838	7	trunk	trunk	NN
25944	1838	8	,	,	,
25944	1838	9	groins	groin	NNS
25944	1838	10	and	and	CC
25944	1838	11	flanks	flank	NNS
25944	1838	12	are	be	VBP
25944	1838	13	the	the	DT
25944	1838	14	parts	part	NNS
25944	1838	15	chiefly	chiefly	RB
25944	1838	16	affected	affect	VBD
25944	1838	17	.	.	.
25944	1839	1	The	the	DT
25944	1839	2	view	view	NN
25944	1839	3	advanced	advance	VBN
25944	1839	4	by	by	IN
25944	1839	5	Darier	Darier	NNP
25944	1839	6	,	,	,
25944	1839	7	that	that	IN
25944	1839	8	the	the	DT
25944	1839	9	malady	malady	NN
25944	1839	10	was	be	VBD
25944	1839	11	due	due	JJ
25944	1839	12	to	to	IN
25944	1839	13	psorosperms	psorosperm	NNS
25944	1839	14	,	,	,
25944	1839	15	is	be	VBZ
25944	1839	16	now	now	RB
25944	1839	17	denied	deny	VBN
25944	1839	18	,	,	,
25944	1839	19	the	the	DT
25944	1839	20	bodies	body	NNS
25944	1839	21	thought	think	VBD
25944	1839	22	to	to	TO
25944	1839	23	be	be	VB
25944	1839	24	such	such	JJ
25944	1839	25	having	have	VBG
25944	1839	26	been	be	VBN
25944	1839	27	demonstrated	demonstrate	VBN
25944	1839	28	to	to	TO
25944	1839	29	be	be	VB
25944	1839	30	due	due	IN
25944	1839	31	to	to	IN
25944	1839	32	cell	cell	NN
25944	1839	33	transformation	transformation	NN
25944	1839	34	.	.	.
25944	1840	1	As	as	IN
25944	1840	2	to	to	IN
25944	1840	3	treatment	treatment	NN
25944	1840	4	,	,	,
25944	1840	5	in	in	IN
25944	1840	6	one	one	CD
25944	1840	7	instance	instance	NN
25944	1840	8	the	the	DT
25944	1840	9	induction	induction	NN
25944	1840	10	of	of	IN
25944	1840	11	a	a	DT
25944	1840	12	substitutive	substitutive	JJ
25944	1840	13	dermatic	dermatic	JJ
25944	1840	14	inflammation	inflammation	NN
25944	1840	15	had	have	VBD
25944	1840	16	a	a	DT
25944	1840	17	favorable	favorable	JJ
25944	1840	18	influence	influence	NN
25944	1840	19	.	.	.
25944	1841	1	#	#	NNP
25944	1841	2	Molluscum	Molluscum	NNP
25944	1841	3	Epitheliale	Epitheliale	NNP
25944	1841	4	.	.	.
25944	1841	5	#	#	NNP
25944	1841	6	(	(	-LRB-
25944	1841	7	_	_	NNP
25944	1841	8	Synonyms	Synonyms	NNP
25944	1841	9	:	:	:
25944	1841	10	_	_	NNP
25944	1841	11	Molluscum	Molluscum	NNP
25944	1841	12	Contagiosum	Contagiosum	NNP
25944	1841	13	;	;	:
25944	1841	14	Molluscum	Molluscum	NNP
25944	1841	15	Sebaceum	Sebaceum	NNP
25944	1841	16	;	;	:
25944	1841	17	Epithelioma	Epithelioma	NNP
25944	1841	18	Molluscum	Molluscum	NNP
25944	1841	19	.	.	.
25944	1841	20	)	)	-RRB-
25944	1842	1	#	#	NN
25944	1842	2	Give	give	VB
25944	1842	3	a	a	DT
25944	1842	4	definition	definition	NN
25944	1842	5	of	of	IN
25944	1842	6	molluscum	molluscum	NNP
25944	1842	7	epitheliale	epitheliale	NNP
25944	1842	8	.	.	.
25944	1842	9	#	#	NNP
25944	1842	10	Molluscum	Molluscum	NNP
25944	1842	11	epitheliale	epitheliale	NN
25944	1842	12	is	be	VBZ
25944	1842	13	characterized	characterize	VBN
25944	1842	14	by	by	IN
25944	1842	15	pin	pin	NN
25944	1842	16	-	-	HYPH
25944	1842	17	head	head	NN
25944	1842	18	to	to	IN
25944	1842	19	pea	pea	JJ
25944	1842	20	-	-	HYPH
25944	1842	21	sized	sized	JJ
25944	1842	22	,	,	,
25944	1842	23	rounded	rounded	JJ
25944	1842	24	,	,	,
25944	1842	25	semi	semi	JJ
25944	1842	26	-	-	JJ
25944	1842	27	globular	globular	JJ
25944	1842	28	,	,	,
25944	1842	29	or	or	CC
25944	1842	30	flattened	flatten	VBN
25944	1842	31	,	,	,
25944	1842	32	pearl	pearl	NN
25944	1842	33	-	-	HYPH
25944	1842	34	like	like	JJ
25944	1842	35	elevations	elevation	NNS
25944	1842	36	,	,	,
25944	1842	37	of	of	IN
25944	1842	38	a	a	DT
25944	1842	39	whitish	whitish	JJ
25944	1842	40	or	or	CC
25944	1842	41	pinkish	pinkish	JJ
25944	1842	42	color	color	NN
25944	1842	43	.	.	.
25944	1843	1	#	#	NNP
25944	1843	2	Describe	describe	VB
25944	1843	3	the	the	DT
25944	1843	4	symptoms	symptom	NNS
25944	1843	5	and	and	CC
25944	1843	6	course	course	NN
25944	1843	7	of	of	IN
25944	1843	8	molluscum	molluscum	NNP
25944	1843	9	epitheliale	epitheliale	NNP
25944	1843	10	.	.	.
25944	1843	11	#	#	$
25944	1843	12	The	the	DT
25944	1843	13	usual	usual	JJ
25944	1843	14	seat	seat	NN
25944	1843	15	is	be	VBZ
25944	1843	16	the	the	DT
25944	1843	17	face	face	NN
25944	1843	18	;	;	:
25944	1843	19	not	not	RB
25944	1843	20	infrequently	infrequently	RB
25944	1843	21	,	,	,
25944	1843	22	however	however	RB
25944	1843	23	,	,	,
25944	1843	24	the	the	DT
25944	1843	25	growths	growth	NNS
25944	1843	26	occur	occur	VBP
25944	1843	27	on	on	IN
25944	1843	28	other	other	JJ
25944	1843	29	parts	part	NNS
25944	1843	30	.	.	.
25944	1844	1	The	the	DT
25944	1844	2	lesions	lesion	NNS
25944	1844	3	begin	begin	VBP
25944	1844	4	as	as	IN
25944	1844	5	pin	pin	NN
25944	1844	6	-	-	HYPH
25944	1844	7	head	head	NN
25944	1844	8	,	,	,
25944	1844	9	waxy	waxy	RB
25944	1844	10	-	-	HYPH
25944	1844	11	looking	look	VBG
25944	1844	12	,	,	,
25944	1844	13	rounded	rounded	JJ
25944	1844	14	or	or	CC
25944	1844	15	acuminated	acuminate	VBN
25944	1844	16	elevations	elevation	NNS
25944	1844	17	,	,	,
25944	1844	18	gradually	gradually	RB
25944	1844	19	attaining	attain	VBG
25944	1844	20	the	the	DT
25944	1844	21	size	size	NN
25944	1844	22	of	of	IN
25944	1844	23	small	small	JJ
25944	1844	24	peas	pea	NNS
25944	1844	25	.	.	.
25944	1845	1	They	-PRON-	PRP
25944	1845	2	have	have	VBP
25944	1845	3	a	a	DT
25944	1845	4	broad	broad	JJ
25944	1845	5	base	base	NN
25944	1845	6	or	or	CC
25944	1845	7	occasionally	occasionally	RB
25944	1845	8	may	may	MD
25944	1845	9	tend	tend	VB
25944	1845	10	to	to	TO
25944	1845	11	become	become	VB
25944	1845	12	pedunculated	pedunculate	VBN
25944	1845	13	.	.	.
25944	1846	1	They	-PRON-	PRP
25944	1846	2	rarely	rarely	RB
25944	1846	3	exist	exist	VBP
25944	1846	4	in	in	IN
25944	1846	5	profusion	profusion	NN
25944	1846	6	,	,	,
25944	1846	7	in	in	IN
25944	1846	8	most	most	JJS
25944	1846	9	cases	case	NNS
25944	1846	10	three	three	CD
25944	1846	11	to	to	TO
25944	1846	12	ten	ten	CD
25944	1846	13	or	or	CC
25944	1846	14	twelve	twelve	CD
25944	1846	15	lesions	lesion	NNS
25944	1846	16	being	be	VBG
25944	1846	17	present	present	JJ
25944	1846	18	.	.	.
25944	1847	1	When	when	WRB
25944	1847	2	fully	fully	RB
25944	1847	3	developed	develop	VBN
25944	1847	4	they	-PRON-	PRP
25944	1847	5	are	be	VBP
25944	1847	6	somewhat	somewhat	RB
25944	1847	7	flattened	flattened	JJ
25944	1847	8	and	and	CC
25944	1847	9	umbilicated	umbilicated	JJ
25944	1847	10	,	,	,
25944	1847	11	with	with	IN
25944	1847	12	a	a	DT
25944	1847	13	central	central	JJ
25944	1847	14	,	,	,
25944	1847	15	darkish	darkish	JJ
25944	1847	16	point	point	NN
25944	1847	17	representing	represent	VBG
25944	1847	18	the	the	DT
25944	1847	19	mouth	mouth	NN
25944	1847	20	of	of	IN
25944	1847	21	the	the	DT
25944	1847	22	follicle	follicle	NN
25944	1847	23	.	.	.
25944	1848	1	They	-PRON-	PRP
25944	1848	2	are	be	VBP
25944	1848	3	whitish	whitish	JJ
25944	1848	4	or	or	CC
25944	1848	5	pinkish	pinkish	JJ
25944	1848	6	,	,	,
25944	1848	7	and	and	CC
25944	1848	8	look	look	VB
25944	1848	9	not	not	RB
25944	1848	10	unlike	unlike	IN
25944	1848	11	drops	drop	NNS
25944	1848	12	of	of	IN
25944	1848	13	wax	wax	NN
25944	1848	14	or	or	CC
25944	1848	15	pearl	pearl	NN
25944	1848	16	buttons	button	NNS
25944	1848	17	.	.	.
25944	1849	1	At	at	IN
25944	1849	2	first	first	RB
25944	1849	3	they	-PRON-	PRP
25944	1849	4	are	be	VBP
25944	1849	5	firm	firm	JJ
25944	1849	6	,	,	,
25944	1849	7	but	but	CC
25944	1849	8	eventually	eventually	RB
25944	1849	9	,	,	,
25944	1849	10	in	in	IN
25944	1849	11	most	most	JJS
25944	1849	12	cases	case	NNS
25944	1849	13	,	,	,
25944	1849	14	tend	tend	VBP
25944	1849	15	to	to	TO
25944	1849	16	become	become	VB
25944	1849	17	soft	soft	JJ
25944	1849	18	and	and	CC
25944	1849	19	break	break	VB
25944	1849	20	down	down	RP
25944	1849	21	.	.	.
25944	1850	1	Not	not	RB
25944	1850	2	infrequently	infrequently	RB
25944	1850	3	,	,	,
25944	1850	4	however	however	RB
25944	1850	5	,	,	,
25944	1850	6	the	the	DT
25944	1850	7	lesions	lesion	NNS
25944	1850	8	disappear	disappear	VBP
25944	1850	9	slowly	slowly	RB
25944	1850	10	by	by	IN
25944	1850	11	absorption	absorption	NN
25944	1850	12	,	,	,
25944	1850	13	without	without	IN
25944	1850	14	apparent	apparent	JJ
25944	1850	15	previous	previous	JJ
25944	1850	16	softening	softening	NN
25944	1850	17	.	.	.
25944	1851	1	Their	-PRON-	PRP$
25944	1851	2	course	course	NN
25944	1851	3	is	be	VBZ
25944	1851	4	usually	usually	RB
25944	1851	5	chronic	chronic	JJ
25944	1851	6	.	.	.
25944	1852	1	The	the	DT
25944	1852	2	contents	content	NNS
25944	1852	3	,	,	,
25944	1852	4	a	a	DT
25944	1852	5	cheesy	cheesy	RB
25944	1852	6	-	-	HYPH
25944	1852	7	looking	look	VBG
25944	1852	8	mass	mass	NN
25944	1852	9	,	,	,
25944	1852	10	may	may	MD
25944	1852	11	commonly	commonly	RB
25944	1852	12	be	be	VB
25944	1852	13	pressed	press	VBN
25944	1852	14	out	out	RP
25944	1852	15	without	without	IN
25944	1852	16	difficulty	difficulty	NN
25944	1852	17	.	.	.
25944	1853	1	#	#	LS
25944	1853	2	What	what	WP
25944	1853	3	is	be	VBZ
25944	1853	4	the	the	DT
25944	1853	5	cause	cause	NN
25944	1853	6	of	of	IN
25944	1853	7	molluscum	molluscum	NNP
25944	1853	8	epitheliale	epitheliale	NNP
25944	1853	9	?	?	.
25944	1853	10	#	#	$
25944	1853	11	It	-PRON-	PRP
25944	1853	12	is	be	VBZ
25944	1853	13	now	now	RB
25944	1853	14	generally	generally	RB
25944	1853	15	accepted	accept	VBN
25944	1853	16	that	that	IN
25944	1853	17	the	the	DT
25944	1853	18	disease	disease	NN
25944	1853	19	is	be	VBZ
25944	1853	20	mildly	mildly	RB
25944	1853	21	contagious	contagious	JJ
25944	1853	22	.	.	.
25944	1854	1	It	-PRON-	PRP
25944	1854	2	occurs	occur	VBZ
25944	1854	3	chiefly	chiefly	RB
25944	1854	4	in	in	IN
25944	1854	5	children	child	NNS
25944	1854	6	,	,	,
25944	1854	7	and	and	CC
25944	1854	8	especially	especially	RB
25944	1854	9	among	among	IN
25944	1854	10	the	the	DT
25944	1854	11	poorer	poor	JJR
25944	1854	12	classes	class	NNS
25944	1854	13	.	.	.
25944	1855	1	The	the	DT
25944	1855	2	belief	belief	NN
25944	1855	3	in	in	IN
25944	1855	4	the	the	DT
25944	1855	5	parasitic	parasitic	JJ
25944	1855	6	nature	nature	NN
25944	1855	7	of	of	IN
25944	1855	8	the	the	DT
25944	1855	9	disease	disease	NN
25944	1855	10	is	be	VBZ
25944	1855	11	gaining	gain	VBG
25944	1855	12	ground	ground	NN
25944	1855	13	;	;	:
25944	1855	14	recently	recently	RB
25944	1855	15	the	the	DT
25944	1855	16	opinion	opinion	NN
25944	1855	17	has	have	VBZ
25944	1855	18	been	be	VBN
25944	1855	19	advanced	advance	VBN
25944	1855	20	that	that	IN
25944	1855	21	it	-PRON-	PRP
25944	1855	22	is	be	VBZ
25944	1855	23	due	due	JJ
25944	1855	24	to	to	IN
25944	1855	25	psorosperms	psorosperm	NNS
25944	1855	26	(	(	-LRB-
25944	1855	27	psorospermosis	psorospermosis	NN
25944	1855	28	)	)	-RRB-
25944	1855	29	;	;	:
25944	1855	30	but	but	CC
25944	1855	31	further	further	JJ
25944	1855	32	investigations	investigation	NNS
25944	1855	33	have	have	VBP
25944	1855	34	indicated	indicate	VBN
25944	1855	35	that	that	IN
25944	1855	36	these	these	DT
25944	1855	37	bodies	body	NNS
25944	1855	38	were	be	VBD
25944	1855	39	degenerated	degenerate	VBN
25944	1855	40	epithelia	epithelia	NNP
25944	1855	41	.	.	.
25944	1856	1	#	#	NNP
25944	1856	2	State	state	NN
25944	1856	3	the	the	DT
25944	1856	4	pathology	pathology	NN
25944	1856	5	.	.	.
25944	1856	6	#	#	$
25944	1856	7	[	[	-LRB-
25944	1856	8	Illustration	illustration	NN
25944	1856	9	:	:	:
25944	1856	10	Fig	Fig	NNP
25944	1856	11	.	.	.
25944	1857	1	31	31	CD
25944	1857	2	.	.	.
25944	1858	1	Molluscum	Molluscum	NNP
25944	1858	2	Epitheliale	Epitheliale	NNP
25944	1858	3	.	.	.
25944	1858	4	]	]	-RRB-
25944	1859	1	According	accord	VBG
25944	1859	2	to	to	IN
25944	1859	3	recent	recent	JJ
25944	1859	4	investigations	investigation	NNS
25944	1859	5	,	,	,
25944	1859	6	molluscum	molluscum	NNP
25944	1859	7	epitheliale	epitheliale	NNP
25944	1859	8	is	be	VBZ
25944	1859	9	to	to	TO
25944	1859	10	be	be	VB
25944	1859	11	regarded	regard	VBN
25944	1859	12	as	as	IN
25944	1859	13	a	a	DT
25944	1859	14	hyperplasia	hyperplasia	NN
25944	1859	15	of	of	IN
25944	1859	16	the	the	DT
25944	1859	17	rete	rete	NN
25944	1859	18	,	,	,
25944	1859	19	the	the	DT
25944	1859	20	growth	growth	NN
25944	1859	21	probably	probably	RB
25944	1859	22	beginning	begin	VBG
25944	1859	23	in	in	IN
25944	1859	24	the	the	DT
25944	1859	25	hair	hair	NN
25944	1859	26	-	-	HYPH
25944	1859	27	follicles	follicle	NNS
25944	1859	28	;	;	:
25944	1859	29	the	the	DT
25944	1859	30	so	so	RB
25944	1859	31	-	-	HYPH
25944	1859	32	called	call	VBN
25944	1859	33	molluscum	molluscum	NNP
25944	1859	34	bodies	body	NNS
25944	1859	35	--	--	:
25944	1859	36	peculiar	peculiar	JJ
25944	1859	37	,	,	,
25944	1859	38	rounded	rounded	JJ
25944	1859	39	or	or	CC
25944	1859	40	ovoidal	ovoidal	JJ
25944	1859	41	,	,	,
25944	1859	42	sharply	sharply	RB
25944	1859	43	-	-	HYPH
25944	1859	44	defined	define	VBN
25944	1859	45	,	,	,
25944	1859	46	fatty	fatty	NN
25944	1859	47	-	-	HYPH
25944	1859	48	looking	look	VBG
25944	1859	49	bodies	body	NNS
25944	1859	50	found	find	VBN
25944	1859	51	in	in	IN
25944	1859	52	microscopical	microscopical	JJ
25944	1859	53	examination	examination	NN
25944	1859	54	of	of	IN
25944	1859	55	the	the	DT
25944	1859	56	growth	growth	NN
25944	1859	57	--	--	:
25944	1859	58	are	be	VBP
25944	1859	59	to	to	TO
25944	1859	60	be	be	VB
25944	1859	61	viewed	view	VBN
25944	1859	62	as	as	IN
25944	1859	63	a	a	DT
25944	1859	64	form	form	NN
25944	1859	65	of	of	IN
25944	1859	66	epithelial	epithelial	JJ
25944	1859	67	degeneration	degeneration	NN
25944	1859	68	.	.	.
25944	1860	1	#	#	LS
25944	1860	2	What	what	WP
25944	1860	3	are	be	VBP
25944	1860	4	the	the	DT
25944	1860	5	diagnostic	diagnostic	JJ
25944	1860	6	points	point	NNS
25944	1860	7	in	in	IN
25944	1860	8	molluscum	molluscum	NNP
25944	1860	9	epitheliale	epitheliale	NNP
25944	1860	10	?	?	.
25944	1860	11	#	#	$
25944	1860	12	The	the	DT
25944	1860	13	size	size	NN
25944	1860	14	of	of	IN
25944	1860	15	the	the	DT
25944	1860	16	lesions	lesion	NNS
25944	1860	17	,	,	,
25944	1860	18	their	-PRON-	PRP$
25944	1860	19	waxy	waxy	NN
25944	1860	20	or	or	CC
25944	1860	21	glistening	glisten	VBG
25944	1860	22	appearance	appearance	NN
25944	1860	23	,	,	,
25944	1860	24	and	and	CC
25944	1860	25	the	the	DT
25944	1860	26	presence	presence	NN
25944	1860	27	of	of	IN
25944	1860	28	the	the	DT
25944	1860	29	central	central	JJ
25944	1860	30	orifice	orifice	NN
25944	1860	31	.	.	.
25944	1861	1	It	-PRON-	PRP
25944	1861	2	is	be	VBZ
25944	1861	3	to	to	TO
25944	1861	4	be	be	VB
25944	1861	5	differentiated	differentiate	VBN
25944	1861	6	from	from	IN
25944	1861	7	molluscum	molluscum	NNP
25944	1861	8	fibrosum	fibrosum	NNP
25944	1861	9	,	,	,
25944	1861	10	warts	wart	NNS
25944	1861	11	and	and	CC
25944	1861	12	acne	acne	NNP
25944	1861	13	.	.	.
25944	1862	1	#	#	JJR
25944	1862	2	State	state	NN
25944	1862	3	the	the	DT
25944	1862	4	prognosis	prognosis	NN
25944	1862	5	.	.	.
25944	1862	6	#	#	$
25944	1862	7	The	the	DT
25944	1862	8	growths	growth	NNS
25944	1862	9	are	be	VBP
25944	1862	10	amenable	amenable	JJ
25944	1862	11	to	to	IN
25944	1862	12	treatment	treatment	NN
25944	1862	13	.	.	.
25944	1863	1	In	in	IN
25944	1863	2	some	some	DT
25944	1863	3	instances	instance	NNS
25944	1863	4	the	the	DT
25944	1863	5	disease	disease	NN
25944	1863	6	,	,	,
25944	1863	7	after	after	IN
25944	1863	8	existing	exist	VBG
25944	1863	9	some	some	DT
25944	1863	10	weeks	week	NNS
25944	1863	11	,	,	,
25944	1863	12	tends	tend	VBZ
25944	1863	13	to	to	TO
25944	1863	14	disappear	disappear	VB
25944	1863	15	spontaneously	spontaneously	RB
25944	1863	16	.	.	.
25944	1864	1	#	#	LS
25944	1864	2	What	what	WP
25944	1864	3	is	be	VBZ
25944	1864	4	the	the	DT
25944	1864	5	treatment	treatment	NN
25944	1864	6	of	of	IN
25944	1864	7	molluscum	molluscum	NNP
25944	1864	8	epitheliale	epitheliale	NNP
25944	1864	9	?	?	.
25944	1864	10	#	#	JJR
25944	1864	11	Incision	incision	NN
25944	1864	12	and	and	CC
25944	1864	13	expression	expression	NN
25944	1864	14	of	of	IN
25944	1864	15	the	the	DT
25944	1864	16	contents	content	NNS
25944	1864	17	,	,	,
25944	1864	18	and	and	CC
25944	1864	19	touching	touch	VBG
25944	1864	20	the	the	DT
25944	1864	21	base	base	NN
25944	1864	22	of	of	IN
25944	1864	23	the	the	DT
25944	1864	24	cavity	cavity	NN
25944	1864	25	with	with	IN
25944	1864	26	silver	silver	NN
25944	1864	27	nitrate	nitrate	JJ
25944	1864	28	.	.	.
25944	1865	1	Pedunculated	pedunculate	VBN
25944	1865	2	growths	growth	NNS
25944	1865	3	may	may	MD
25944	1865	4	be	be	VB
25944	1865	5	ligated	ligate	VBN
25944	1865	6	.	.	.
25944	1866	1	In	in	IN
25944	1866	2	some	some	DT
25944	1866	3	cases	case	NNS
25944	1866	4	an	an	DT
25944	1866	5	ointment	ointment	NN
25944	1866	6	of	of	IN
25944	1866	7	ammoniated	ammoniate	VBN
25944	1866	8	mercury	mercury	NN
25944	1866	9	,	,	,
25944	1866	10	twenty	twenty	CD
25944	1866	11	to	to	TO
25944	1866	12	forty	forty	CD
25944	1866	13	grains	grain	NNS
25944	1866	14	to	to	IN
25944	1866	15	the	the	DT
25944	1866	16	ounce	ounce	NN
25944	1866	17	,	,	,
25944	1866	18	applied	apply	VBD
25944	1866	19	,	,	,
25944	1866	20	by	by	IN
25944	1866	21	gently	gently	RB
25944	1866	22	rubbing	rub	VBG
25944	1866	23	,	,	,
25944	1866	24	once	once	RB
25944	1866	25	or	or	CC
25944	1866	26	twice	twice	RB
25944	1866	27	daily	daily	RB
25944	1866	28	,	,	,
25944	1866	29	will	will	MD
25944	1866	30	bring	bring	VB
25944	1866	31	about	about	RP
25944	1866	32	a	a	DT
25944	1866	33	cure	cure	NN
25944	1866	34	.	.	.
25944	1867	1	#	#	NNP
25944	1867	2	Callositas	Callositas	NNP
25944	1867	3	.	.	.
25944	1867	4	#	#	NNP
25944	1867	5	(	(	-LRB-
25944	1867	6	_	_	NNP
25944	1867	7	Synonyms	Synonyms	NNP
25944	1867	8	:	:	:
25944	1867	9	_	_	NNP
25944	1867	10	Tylosis	Tylosis	NNP
25944	1867	11	;	;	:
25944	1867	12	Tyloma	Tyloma	NNP
25944	1867	13	;	;	:
25944	1867	14	Callus	Callus	NNP
25944	1867	15	;	;	:
25944	1867	16	Callous	callous	JJ
25944	1867	17	;	;	:
25944	1867	18	Callosity	callosity	NN
25944	1867	19	;	;	:
25944	1867	20	Keratoma	Keratoma	NNP
25944	1867	21	.	.	.
25944	1867	22	)	)	-RRB-
25944	1868	1	#	#	LS
25944	1868	2	What	what	WP
25944	1868	3	do	do	VBP
25944	1868	4	you	-PRON-	PRP
25944	1868	5	understand	understand	VB
25944	1868	6	by	by	IN
25944	1868	7	callositas	callositas	NNP
25944	1868	8	?	?	.
25944	1868	9	#	#	$
25944	1868	10	A	a	DT
25944	1868	11	hard	hard	JJ
25944	1868	12	,	,	,
25944	1868	13	thickened	thicken	VBN
25944	1868	14	,	,	,
25944	1868	15	horny	horny	NN
25944	1868	16	patch	patch	NN
25944	1868	17	made	make	VBN
25944	1868	18	up	up	RP
25944	1868	19	of	of	IN
25944	1868	20	the	the	DT
25944	1868	21	corneous	corneous	JJ
25944	1868	22	layers	layer	NNS
25944	1868	23	of	of	IN
25944	1868	24	the	the	DT
25944	1868	25	epidermis	epidermis	NN
25944	1868	26	.	.	.
25944	1869	1	#	#	NNP
25944	1869	2	Describe	describe	VB
25944	1869	3	the	the	DT
25944	1869	4	clinical	clinical	JJ
25944	1869	5	appearances	appearance	NNS
25944	1869	6	.	.	.
25944	1869	7	#	#	NNP
25944	1869	8	Callosities	Callosities	NNPS
25944	1869	9	are	be	VBP
25944	1869	10	most	most	RBS
25944	1869	11	common	common	JJ
25944	1869	12	about	about	IN
25944	1869	13	the	the	DT
25944	1869	14	hands	hand	NNS
25944	1869	15	and	and	CC
25944	1869	16	feet	foot	NNS
25944	1869	17	,	,	,
25944	1869	18	and	and	CC
25944	1869	19	consist	consist	VB
25944	1869	20	of	of	IN
25944	1869	21	small	small	JJ
25944	1869	22	or	or	CC
25944	1869	23	large	large	JJ
25944	1869	24	patches	patch	NNS
25944	1869	25	of	of	IN
25944	1869	26	dry	dry	JJ
25944	1869	27	,	,	,
25944	1869	28	grayish	grayish	NN
25944	1869	29	-	-	HYPH
25944	1869	30	yellow	yellow	JJ
25944	1869	31	looking	looking	NN
25944	1869	32	,	,	,
25944	1869	33	hard	hard	JJ
25944	1869	34	,	,	,
25944	1869	35	slight	slight	JJ
25944	1869	36	or	or	CC
25944	1869	37	excessive	excessive	JJ
25944	1869	38	epidermic	epidermic	JJ
25944	1869	39	accumulations	accumulation	NNS
25944	1869	40	.	.	.
25944	1870	1	They	-PRON-	PRP
25944	1870	2	are	be	VBP
25944	1870	3	somewhat	somewhat	RB
25944	1870	4	elevated	elevated	JJ
25944	1870	5	,	,	,
25944	1870	6	especially	especially	RB
25944	1870	7	at	at	IN
25944	1870	8	the	the	DT
25944	1870	9	central	central	JJ
25944	1870	10	portion	portion	NN
25944	1870	11	,	,	,
25944	1870	12	and	and	CC
25944	1870	13	gradually	gradually	RB
25944	1870	14	merge	merge	VB
25944	1870	15	into	into	IN
25944	1870	16	the	the	DT
25944	1870	17	healthy	healthy	JJ
25944	1870	18	skin	skin	NN
25944	1870	19	.	.	.
25944	1871	1	The	the	DT
25944	1871	2	natural	natural	JJ
25944	1871	3	surface	surface	NN
25944	1871	4	lines	line	NNS
25944	1871	5	are	be	VBP
25944	1871	6	in	in	IN
25944	1871	7	a	a	DT
25944	1871	8	great	great	JJ
25944	1871	9	measure	measure	NN
25944	1871	10	obliterated	obliterate	VBD
25944	1871	11	,	,	,
25944	1871	12	the	the	DT
25944	1871	13	patches	patch	NNS
25944	1871	14	usually	usually	RB
25944	1871	15	being	be	VBG
25944	1871	16	smooth	smooth	JJ
25944	1871	17	and	and	CC
25944	1871	18	horn	horn	NN
25944	1871	19	-	-	HYPH
25944	1871	20	like	like	JJ
25944	1871	21	.	.	.
25944	1872	1	_	_	NNP
25944	1872	2	Keratosis	Keratosis	NNP
25944	1872	3	palmaris	palmaris	NNP
25944	1872	4	et	et	NNP
25944	1872	5	plantaris	plantaris	NNP
25944	1872	6	_	_	NNP
25944	1872	7	(	(	-LRB-
25944	1872	8	symmetric	symmetric	NNP
25944	1872	9	keratodermia	keratodermia	NN
25944	1872	10	)	)	-RRB-
25944	1872	11	,	,	,
25944	1872	12	as	as	IN
25944	1872	13	regards	regard	VBZ
25944	1872	14	the	the	DT
25944	1872	15	local	local	JJ
25944	1872	16	condition	condition	NN
25944	1872	17	,	,	,
25944	1872	18	is	be	VBZ
25944	1872	19	a	a	DT
25944	1872	20	somewhat	somewhat	RB
25944	1872	21	similar	similar	JJ
25944	1872	22	affection	affection	NN
25944	1872	23	.	.	.
25944	1873	1	It	-PRON-	PRP
25944	1873	2	consists	consist	VBZ
25944	1873	3	of	of	IN
25944	1873	4	hypertrophy	hypertrophy	NN
25944	1873	5	of	of	IN
25944	1873	6	the	the	DT
25944	1873	7	corneous	corneous	JJ
25944	1873	8	layer	layer	NN
25944	1873	9	of	of	IN
25944	1873	10	the	the	DT
25944	1873	11	palm	palm	NN
25944	1873	12	and	and	CC
25944	1873	13	soles	sol	NNS
25944	1873	14	,	,	,
25944	1873	15	usually	usually	RB
25944	1873	16	of	of	IN
25944	1873	17	a	a	DT
25944	1873	18	more	more	RBR
25944	1873	19	or	or	CC
25944	1873	20	less	less	RBR
25944	1873	21	horny	horny	NN
25944	1873	22	and	and	CC
25944	1873	23	plate	plate	NN
25944	1873	24	-	-	HYPH
25944	1873	25	like	like	JJ
25944	1873	26	character	character	NN
25944	1873	27	,	,	,
25944	1873	28	but	but	CC
25944	1873	29	is	be	VBZ
25944	1873	30	congenital	congenital	JJ
25944	1873	31	or	or	CC
25944	1873	32	hereditary	hereditary	JJ
25944	1873	33	,	,	,
25944	1873	34	and	and	CC
25944	1873	35	not	not	RB
25944	1873	36	necessarily	necessarily	RB
25944	1873	37	dependent	dependent	JJ
25944	1873	38	upon	upon	IN
25944	1873	39	local	local	JJ
25944	1873	40	friction	friction	NN
25944	1873	41	or	or	CC
25944	1873	42	pressure	pressure	NN
25944	1873	43	.	.	.
25944	1874	1	#	#	NN
25944	1874	2	Are	be	VBP
25944	1874	3	there	there	EX
25944	1874	4	any	any	DT
25944	1874	5	inflammatory	inflammatory	JJ
25944	1874	6	symptoms	symptom	NNS
25944	1874	7	in	in	IN
25944	1874	8	callositas	callositas	NNP
25944	1874	9	?	?	.
25944	1874	10	#	#	NN
25944	1874	11	No	no	UH
25944	1874	12	;	;	:
25944	1874	13	but	but	CC
25944	1874	14	exceptionally	exceptionally	RB
25944	1874	15	,	,	,
25944	1874	16	from	from	IN
25944	1874	17	accidental	accidental	JJ
25944	1874	18	injury	injury	NN
25944	1874	19	,	,	,
25944	1874	20	the	the	DT
25944	1874	21	subjacent	subjacent	JJ
25944	1874	22	corium	corium	NN
25944	1874	23	becomes	become	VBZ
25944	1874	24	inflamed	inflame	VBN
25944	1874	25	,	,	,
25944	1874	26	suppurates	suppurate	NNS
25944	1874	27	,	,	,
25944	1874	28	and	and	CC
25944	1874	29	the	the	DT
25944	1874	30	thickened	thicken	VBN
25944	1874	31	mass	mass	NN
25944	1874	32	is	be	VBZ
25944	1874	33	cast	cast	VBN
25944	1874	34	off	off	RP
25944	1874	35	.	.	.
25944	1875	1	#	#	JJR
25944	1875	2	State	state	NN
25944	1875	3	the	the	DT
25944	1875	4	causes	cause	NNS
25944	1875	5	of	of	IN
25944	1875	6	callositas	callosita	NNS
25944	1875	7	.	.	.
25944	1875	8	#	#	$
25944	1875	9	Pressure	pressure	NN
25944	1875	10	and	and	CC
25944	1875	11	friction	friction	NN
25944	1875	12	;	;	:
25944	1875	13	for	for	IN
25944	1875	14	example	example	NN
25944	1875	15	,	,	,
25944	1875	16	on	on	IN
25944	1875	17	the	the	DT
25944	1875	18	hands	hand	NNS
25944	1875	19	,	,	,
25944	1875	20	from	from	IN
25944	1875	21	the	the	DT
25944	1875	22	use	use	NN
25944	1875	23	of	of	IN
25944	1875	24	various	various	JJ
25944	1875	25	tools	tool	NNS
25944	1875	26	and	and	CC
25944	1875	27	implements	implement	NNS
25944	1875	28	,	,	,
25944	1875	29	and	and	CC
25944	1875	30	on	on	IN
25944	1875	31	the	the	DT
25944	1875	32	feet	foot	NNS
25944	1875	33	from	from	IN
25944	1875	34	ill	ill	RB
25944	1875	35	-	-	HYPH
25944	1875	36	fitting	fitting	JJ
25944	1875	37	shoes	shoe	NNS
25944	1875	38	.	.	.
25944	1876	1	It	-PRON-	PRP
25944	1876	2	is	be	VBZ
25944	1876	3	,	,	,
25944	1876	4	indeed	indeed	RB
25944	1876	5	,	,	,
25944	1876	6	often	often	RB
25944	1876	7	to	to	TO
25944	1876	8	be	be	VB
25944	1876	9	looked	look	VBN
25944	1876	10	upon	upon	IN
25944	1876	11	as	as	IN
25944	1876	12	an	an	DT
25944	1876	13	effort	effort	NN
25944	1876	14	of	of	IN
25944	1876	15	nature	nature	NN
25944	1876	16	to	to	TO
25944	1876	17	protect	protect	VB
25944	1876	18	the	the	DT
25944	1876	19	more	more	RBR
25944	1876	20	delicate	delicate	JJ
25944	1876	21	corium	corium	NN
25944	1876	22	.	.	.
25944	1877	1	In	in	IN
25944	1877	2	exceptional	exceptional	JJ
25944	1877	3	instances	instance	NNS
25944	1877	4	it	-PRON-	PRP
25944	1877	5	arises	arise	VBZ
25944	1877	6	without	without	IN
25944	1877	7	apparent	apparent	JJ
25944	1877	8	cause	cause	NN
25944	1877	9	.	.	.
25944	1878	1	#	#	LS
25944	1878	2	What	what	WP
25944	1878	3	is	be	VBZ
25944	1878	4	the	the	DT
25944	1878	5	pathology	pathology	NN
25944	1878	6	?	?	.
25944	1878	7	#	#	$
25944	1878	8	The	the	DT
25944	1878	9	epidermis	epidermis	NN
25944	1878	10	alone	alone	RB
25944	1878	11	is	be	VBZ
25944	1878	12	involved	involve	VBN
25944	1878	13	;	;	:
25944	1878	14	it	-PRON-	PRP
25944	1878	15	consists	consist	VBZ
25944	1878	16	,	,	,
25944	1878	17	in	in	IN
25944	1878	18	fact	fact	NN
25944	1878	19	,	,	,
25944	1878	20	of	of	IN
25944	1878	21	a	a	DT
25944	1878	22	hyperplasia	hyperplasia	NN
25944	1878	23	of	of	IN
25944	1878	24	the	the	DT
25944	1878	25	horny	horny	JJ
25944	1878	26	layer	layer	NN
25944	1878	27	.	.	.
25944	1879	1	#	#	JJR
25944	1879	2	State	state	NN
25944	1879	3	the	the	DT
25944	1879	4	prognosis	prognosis	NN
25944	1879	5	of	of	IN
25944	1879	6	callositas	callosita	NNS
25944	1879	7	.	.	.
25944	1879	8	#	#	$
25944	1879	9	If	if	IN
25944	1879	10	the	the	DT
25944	1879	11	causes	cause	NNS
25944	1879	12	are	be	VBP
25944	1879	13	removed	remove	VBN
25944	1879	14	,	,	,
25944	1879	15	the	the	DT
25944	1879	16	accumulation	accumulation	NN
25944	1879	17	,	,	,
25944	1879	18	as	as	IN
25944	1879	19	a	a	DT
25944	1879	20	rule	rule	NN
25944	1879	21	,	,	,
25944	1879	22	gradually	gradually	RB
25944	1879	23	disappears	disappear	VBZ
25944	1879	24	.	.	.
25944	1880	1	The	the	DT
25944	1880	2	effect	effect	NN
25944	1880	3	of	of	IN
25944	1880	4	treatment	treatment	NN
25944	1880	5	is	be	VBZ
25944	1880	6	always	always	RB
25944	1880	7	rapid	rapid	JJ
25944	1880	8	and	and	CC
25944	1880	9	positive	positive	JJ
25944	1880	10	,	,	,
25944	1880	11	but	but	CC
25944	1880	12	unless	unless	IN
25944	1880	13	the	the	DT
25944	1880	14	etiological	etiological	JJ
25944	1880	15	factors	factor	NNS
25944	1880	16	have	have	VBP
25944	1880	17	ceased	cease	VBN
25944	1880	18	to	to	TO
25944	1880	19	act	act	VB
25944	1880	20	,	,	,
25944	1880	21	the	the	DT
25944	1880	22	result	result	NN
25944	1880	23	is	be	VBZ
25944	1880	24	usually	usually	RB
25944	1880	25	but	but	CC
25944	1880	26	temporary	temporary	JJ
25944	1880	27	.	.	.
25944	1881	1	#	#	NNP
25944	1881	2	How	how	WRB
25944	1881	3	is	be	VBZ
25944	1881	4	callositas	callositas	NNP
25944	1881	5	treated	treat	VBN
25944	1881	6	?	?	.
25944	1881	7	#	#	NN
25944	1881	8	When	when	WRB
25944	1881	9	treatment	treatment	NN
25944	1881	10	is	be	VBZ
25944	1881	11	deemed	deem	VBN
25944	1881	12	advisable	advisable	JJ
25944	1881	13	,	,	,
25944	1881	14	it	-PRON-	PRP
25944	1881	15	consists	consist	VBZ
25944	1881	16	in	in	IN
25944	1881	17	softening	soften	VBG
25944	1881	18	the	the	DT
25944	1881	19	parts	part	NNS
25944	1881	20	with	with	IN
25944	1881	21	hot	hot	JJ
25944	1881	22	-	-	HYPH
25944	1881	23	water	water	NN
25944	1881	24	soakings	soaking	NNS
25944	1881	25	or	or	CC
25944	1881	26	poultices	poultice	NNS
25944	1881	27	,	,	,
25944	1881	28	and	and	CC
25944	1881	29	subsequently	subsequently	RB
25944	1881	30	shaving	shave	VBG
25944	1881	31	or	or	CC
25944	1881	32	scraping	scrape	VBG
25944	1881	33	off	off	RP
25944	1881	34	the	the	DT
25944	1881	35	callous	callous	JJ
25944	1881	36	mass	mass	NN
25944	1881	37	.	.	.
25944	1882	1	The	the	DT
25944	1882	2	same	same	JJ
25944	1882	3	result	result	NN
25944	1882	4	may	may	MD
25944	1882	5	also	also	RB
25944	1882	6	be	be	VB
25944	1882	7	often	often	RB
25944	1882	8	effected	effect	VBN
25944	1882	9	by	by	IN
25944	1882	10	the	the	DT
25944	1882	11	continuous	continuous	JJ
25944	1882	12	application	application	NN
25944	1882	13	,	,	,
25944	1882	14	for	for	IN
25944	1882	15	several	several	JJ
25944	1882	16	days	day	NNS
25944	1882	17	or	or	CC
25944	1882	18	a	a	DT
25944	1882	19	week	week	NN
25944	1882	20	,	,	,
25944	1882	21	of	of	IN
25944	1882	22	a	a	DT
25944	1882	23	10	10	CD
25944	1882	24	to	to	TO
25944	1882	25	15	15	CD
25944	1882	26	per	per	NN
25944	1882	27	cent	cent	NN
25944	1882	28	.	.	.
25944	1883	1	salicylated	salicylate	VBN
25944	1883	2	plaster	plaster	NN
25944	1883	3	,	,	,
25944	1883	4	or	or	CC
25944	1883	5	the	the	DT
25944	1883	6	application	application	NN
25944	1883	7	of	of	IN
25944	1883	8	a	a	DT
25944	1883	9	salicylated	salicylate	VBN
25944	1883	10	collodion	collodion	NN
25944	1883	11	,	,	,
25944	1883	12	same	same	JJ
25944	1883	13	strength	strength	NN
25944	1883	14	;	;	:
25944	1883	15	it	-PRON-	PRP
25944	1883	16	is	be	VBZ
25944	1883	17	followed	follow	VBN
25944	1883	18	up	up	RP
25944	1883	19	by	by	IN
25944	1883	20	hot	hot	JJ
25944	1883	21	-	-	HYPH
25944	1883	22	water	water	NN
25944	1883	23	soaking	soaking	NN
25944	1883	24	,	,	,
25944	1883	25	the	the	DT
25944	1883	26	accumulation	accumulation	NN
25944	1883	27	,	,	,
25944	1883	28	as	as	IN
25944	1883	29	a	a	DT
25944	1883	30	rule	rule	NN
25944	1883	31	,	,	,
25944	1883	32	coming	come	VBG
25944	1883	33	readily	readily	RB
25944	1883	34	away	away	RB
25944	1883	35	.	.	.
25944	1884	1	#	#	NNP
25944	1884	2	Clavus	Clavus	NNP
25944	1884	3	.	.	.
25944	1884	4	#	#	NNP
25944	1884	5	(	(	-LRB-
25944	1884	6	_	_	NNP
25944	1884	7	Synonym	Synonym	NNP
25944	1884	8	:	:	:
25944	1884	9	_	_	NNP
25944	1884	10	Corn	Corn	NNP
25944	1884	11	.	.	.
25944	1884	12	)	)	-RRB-
25944	1885	1	#	#	LS
25944	1885	2	What	what	WP
25944	1885	3	is	be	VBZ
25944	1885	4	clavus	clavus	NN
25944	1885	5	?	?	.
25944	1885	6	#	#	NNP
25944	1885	7	Clavus	Clavus	NNP
25944	1885	8	,	,	,
25944	1885	9	or	or	CC
25944	1885	10	corn	corn	NN
25944	1885	11	,	,	,
25944	1885	12	is	be	VBZ
25944	1885	13	a	a	DT
25944	1885	14	small	small	JJ
25944	1885	15	,	,	,
25944	1885	16	circumscribed	circumscribe	VBN
25944	1885	17	,	,	,
25944	1885	18	flattened	flatten	VBD
25944	1885	19	,	,	,
25944	1885	20	deep	deep	JJ
25944	1885	21	-	-	HYPH
25944	1885	22	seated	seated	JJ
25944	1885	23	,	,	,
25944	1885	24	horny	horny	JJ
25944	1885	25	formation	formation	NN
25944	1885	26	usually	usually	RB
25944	1885	27	seated	seat	VBN
25944	1885	28	about	about	IN
25944	1885	29	the	the	DT
25944	1885	30	toes	toe	NNS
25944	1885	31	.	.	.
25944	1886	1	#	#	NNP
25944	1886	2	Describe	describe	VB
25944	1886	3	the	the	DT
25944	1886	4	clinical	clinical	JJ
25944	1886	5	appearances	appearance	NNS
25944	1886	6	.	.	.
25944	1886	7	#	#	$
25944	1886	8	Ordinarily	ordinarily	RB
25944	1886	9	a	a	DT
25944	1886	10	corn	corn	NN
25944	1886	11	has	have	VBZ
25944	1886	12	the	the	DT
25944	1886	13	appearance	appearance	NN
25944	1886	14	of	of	IN
25944	1886	15	a	a	DT
25944	1886	16	small	small	JJ
25944	1886	17	callosity	callosity	NN
25944	1886	18	;	;	:
25944	1886	19	the	the	DT
25944	1886	20	skin	skin	NN
25944	1886	21	is	be	VBZ
25944	1886	22	thickened	thicken	VBN
25944	1886	23	,	,	,
25944	1886	24	polished	polished	JJ
25944	1886	25	and	and	CC
25944	1886	26	horny	horny	NNP
25944	1886	27	.	.	.
25944	1887	1	Exceptionally	exceptionally	RB
25944	1887	2	,	,	,
25944	1887	3	however	however	RB
25944	1887	4	,	,	,
25944	1887	5	occurring	occur	VBG
25944	1887	6	on	on	IN
25944	1887	7	parts	part	NNS
25944	1887	8	that	that	WDT
25944	1887	9	are	be	VBP
25944	1887	10	naturally	naturally	RB
25944	1887	11	more	more	RBR
25944	1887	12	or	or	CC
25944	1887	13	less	less	RBR
25944	1887	14	moist	moist	JJ
25944	1887	15	,	,	,
25944	1887	16	as	as	IN
25944	1887	17	between	between	IN
25944	1887	18	the	the	DT
25944	1887	19	toes	toe	NNS
25944	1887	20	,	,	,
25944	1887	21	maceration	maceration	NN
25944	1887	22	takes	take	VBZ
25944	1887	23	place	place	NN
25944	1887	24	,	,	,
25944	1887	25	and	and	CC
25944	1887	26	the	the	DT
25944	1887	27	result	result	NN
25944	1887	28	is	be	VBZ
25944	1887	29	the	the	DT
25944	1887	30	so	so	RB
25944	1887	31	-	-	HYPH
25944	1887	32	called	call	VBN
25944	1887	33	_	_	NNP
25944	1887	34	soft	soft	JJ
25944	1887	35	corn	corn	NN
25944	1887	36	_	_	NNP
25944	1887	37	.	.	.
25944	1888	1	The	the	DT
25944	1888	2	dorsal	dorsal	NN
25944	1888	3	aspect	aspect	NN
25944	1888	4	of	of	IN
25944	1888	5	the	the	DT
25944	1888	6	toes	toe	NNS
25944	1888	7	is	be	VBZ
25944	1888	8	the	the	DT
25944	1888	9	common	common	JJ
25944	1888	10	site	site	NN
25944	1888	11	for	for	IN
25944	1888	12	the	the	DT
25944	1888	13	ordinary	ordinary	JJ
25944	1888	14	variety	variety	NN
25944	1888	15	.	.	.
25944	1889	1	The	the	DT
25944	1889	2	usual	usual	JJ
25944	1889	3	size	size	NN
25944	1889	4	is	be	VBZ
25944	1889	5	that	that	DT
25944	1889	6	of	of	IN
25944	1889	7	a	a	DT
25944	1889	8	small	small	JJ
25944	1889	9	pea	pea	NN
25944	1889	10	.	.	.
25944	1890	1	They	-PRON-	PRP
25944	1890	2	are	be	VBP
25944	1890	3	painful	painful	JJ
25944	1890	4	on	on	IN
25944	1890	5	pressure	pressure	NN
25944	1890	6	,	,	,
25944	1890	7	and	and	CC
25944	1890	8	,	,	,
25944	1890	9	at	at	IN
25944	1890	10	times	time	NNS
25944	1890	11	,	,	,
25944	1890	12	spontaneously	spontaneously	RB
25944	1890	13	so	so	RB
25944	1890	14	.	.	.
25944	1891	1	#	#	JJR
25944	1891	2	State	state	NN
25944	1891	3	the	the	DT
25944	1891	4	causes	cause	NNS
25944	1891	5	.	.	.
25944	1891	6	#	#	$
25944	1891	7	Corns	Corns	NNPS
25944	1891	8	are	be	VBP
25944	1891	9	caused	cause	VBN
25944	1891	10	by	by	IN
25944	1891	11	pressure	pressure	NN
25944	1891	12	and	and	CC
25944	1891	13	friction	friction	NN
25944	1891	14	,	,	,
25944	1891	15	and	and	CC
25944	1891	16	may	may	MD
25944	1891	17	usually	usually	RB
25944	1891	18	be	be	VB
25944	1891	19	referred	refer	VBN
25944	1891	20	to	to	IN
25944	1891	21	improperly	improperly	RB
25944	1891	22	fitting	fitting	JJ
25944	1891	23	shoes	shoe	NNS
25944	1891	24	.	.	.
25944	1892	1	#	#	LS
25944	1892	2	What	what	WP
25944	1892	3	is	be	VBZ
25944	1892	4	the	the	DT
25944	1892	5	pathology	pathology	NN
25944	1892	6	of	of	IN
25944	1892	7	clavus	clavu	NNS
25944	1892	8	?	?	.
25944	1892	9	#	#	$
25944	1892	10	It	-PRON-	PRP
25944	1892	11	is	be	VBZ
25944	1892	12	a	a	DT
25944	1892	13	hypertrophy	hypertrophy	NN
25944	1892	14	of	of	IN
25944	1892	15	the	the	DT
25944	1892	16	epiderm	epiderm	NN
25944	1892	17	.	.	.
25944	1893	1	Its	-PRON-	PRP$
25944	1893	2	shape	shape	NN
25944	1893	3	is	be	VBZ
25944	1893	4	conical	conical	JJ
25944	1893	5	,	,	,
25944	1893	6	with	with	IN
25944	1893	7	the	the	DT
25944	1893	8	base	base	NN
25944	1893	9	external	external	NNP
25944	1893	10	and	and	CC
25944	1893	11	the	the	DT
25944	1893	12	apex	apex	NN
25944	1893	13	pressing	press	VBG
25944	1893	14	upon	upon	IN
25944	1893	15	the	the	DT
25944	1893	16	papillæ	papillæ	NN
25944	1893	17	.	.	.
25944	1894	1	It	-PRON-	PRP
25944	1894	2	is	be	VBZ
25944	1894	3	,	,	,
25944	1894	4	in	in	IN
25944	1894	5	fact	fact	NN
25944	1894	6	,	,	,
25944	1894	7	a	a	DT
25944	1894	8	peculiarly	peculiarly	RB
25944	1894	9	-	-	HYPH
25944	1894	10	shaped	shape	VBN
25944	1894	11	callosity	callosity	NN
25944	1894	12	,	,	,
25944	1894	13	the	the	DT
25944	1894	14	central	central	JJ
25944	1894	15	portion	portion	NN
25944	1894	16	and	and	CC
25944	1894	17	apex	apex	NNP
25944	1894	18	being	be	VBG
25944	1894	19	dense	dense	JJ
25944	1894	20	and	and	CC
25944	1894	21	horny	horny	JJ
25944	1894	22	,	,	,
25944	1894	23	forming	form	VBG
25944	1894	24	the	the	DT
25944	1894	25	so	so	RB
25944	1894	26	-	-	HYPH
25944	1894	27	called	call	VBN
25944	1894	28	core	core	NN
25944	1894	29	.	.	.
25944	1895	1	#	#	NN
25944	1895	2	Give	give	VBP
25944	1895	3	the	the	DT
25944	1895	4	treatment	treatment	NN
25944	1895	5	of	of	IN
25944	1895	6	clavus	clavu	NNS
25944	1895	7	.	.	.
25944	1895	8	#	#	$
25944	1895	9	A	a	DT
25944	1895	10	simple	simple	JJ
25944	1895	11	method	method	NN
25944	1895	12	of	of	IN
25944	1895	13	treatment	treatment	NN
25944	1895	14	consists	consist	VBZ
25944	1895	15	in	in	IN
25944	1895	16	shaving	shave	VBG
25944	1895	17	off	off	RP
25944	1895	18	,	,	,
25944	1895	19	after	after	IN
25944	1895	20	a	a	DT
25944	1895	21	preliminary	preliminary	JJ
25944	1895	22	hot	hot	JJ
25944	1895	23	-	-	HYPH
25944	1895	24	water	water	NN
25944	1895	25	soaking	soaking	NN
25944	1895	26	,	,	,
25944	1895	27	the	the	DT
25944	1895	28	outer	outer	JJ
25944	1895	29	portion	portion	NN
25944	1895	30	,	,	,
25944	1895	31	and	and	CC
25944	1895	32	then	then	RB
25944	1895	33	applying	apply	VBG
25944	1895	34	a	a	DT
25944	1895	35	ring	ring	NN
25944	1895	36	of	of	IN
25944	1895	37	felt	feel	VBN
25944	1895	38	or	or	CC
25944	1895	39	like	like	IN
25944	1895	40	material	material	NN
25944	1895	41	,	,	,
25944	1895	42	with	with	IN
25944	1895	43	the	the	DT
25944	1895	44	hollow	hollow	JJ
25944	1895	45	part	part	NN
25944	1895	46	immediately	immediately	RB
25944	1895	47	over	over	IN
25944	1895	48	the	the	DT
25944	1895	49	site	site	NN
25944	1895	50	of	of	IN
25944	1895	51	the	the	DT
25944	1895	52	core	core	NN
25944	1895	53	;	;	:
25944	1895	54	this	this	DT
25944	1895	55	should	should	MD
25944	1895	56	be	be	VB
25944	1895	57	worn	wear	VBN
25944	1895	58	for	for	IN
25944	1895	59	several	several	JJ
25944	1895	60	weeks	week	NNS
25944	1895	61	.	.	.
25944	1896	1	It	-PRON-	PRP
25944	1896	2	is	be	VBZ
25944	1896	3	also	also	RB
25944	1896	4	possible	possible	JJ
25944	1896	5	in	in	IN
25944	1896	6	some	some	DT
25944	1896	7	cases	case	NNS
25944	1896	8	to	to	TO
25944	1896	9	extract	extract	VB
25944	1896	10	the	the	DT
25944	1896	11	whole	whole	JJ
25944	1896	12	corn	corn	NN
25944	1896	13	by	by	IN
25944	1896	14	gently	gently	RB
25944	1896	15	dissecting	dissect	VBG
25944	1896	16	it	-PRON-	PRP
25944	1896	17	out	out	RP
25944	1896	18	;	;	:
25944	1896	19	the	the	DT
25944	1896	20	after	after	IN
25944	1896	21	-	-	HYPH
25944	1896	22	treatment	treatment	NN
25944	1896	23	being	be	VBG
25944	1896	24	the	the	DT
25944	1896	25	same	same	JJ
25944	1896	26	as	as	IN
25944	1896	27	the	the	DT
25944	1896	28	above	above	JJ
25944	1896	29	.	.	.
25944	1897	1	Another	another	DT
25944	1897	2	method	method	NN
25944	1897	3	is	be	VBZ
25944	1897	4	by	by	IN
25944	1897	5	means	mean	NNS
25944	1897	6	of	of	IN
25944	1897	7	a	a	DT
25944	1897	8	ten-	ten-	NN
25944	1897	9	to	to	IN
25944	1897	10	fifteen	fifteen	CD
25944	1897	11	-	-	HYPH
25944	1897	12	per	per	IN
25944	1897	13	-	-	HYPH
25944	1897	14	cent	cent	NN
25944	1897	15	.	.	.
25944	1898	1	solution	solution	NN
25944	1898	2	of	of	IN
25944	1898	3	salicylic	salicylic	JJ
25944	1898	4	acid	acid	NN
25944	1898	5	,	,	,
25944	1898	6	in	in	IN
25944	1898	7	alcohol	alcohol	NN
25944	1898	8	or	or	CC
25944	1898	9	collodion	collodion	NN
25944	1898	10	,	,	,
25944	1898	11	or	or	CC
25944	1898	12	the	the	DT
25944	1898	13	following:--	following:--	NN
25944	1898	14	[	[	-LRB-
25944	1898	15	Rx	Rx	NNP
25944	1898	16	]	]	-RRB-
25944	1898	17	Ac	Ac	NNP
25944	1898	18	.	.	.
25944	1899	1	salicylici	salicylici	NNP
25944	1899	2	,	,	,
25944	1899	3	......................	......................	NFP
25944	1899	4	gr	gr	NNP
25944	1899	5	.	.	.
25944	1900	1	xxx	xxx	NNP
25944	1900	2	Ext	Ext	NNP
25944	1900	3	.	.	.
25944	1901	1	cannabis	cannabis	NNP
25944	1901	2	Ind.	Indiana	NNP
25944	1901	3	,	,	,
25944	1901	4	..................	..................	NFP
25944	1901	5	gr	gr	NNP
25944	1901	6	.	.	.
25944	1902	1	x	x	LS
25944	1902	2	Collodii	Collodii	NNP
25944	1902	3	,	,	,
25944	1902	4	............................	............................	NFP
25944	1902	5	f[dram]iv	f[dram]iv	:
25944	1902	6	.	.	.
25944	1903	1	M.	M.	NNP
25944	1903	2	This	This	NNP
25944	1903	3	is	be	VBZ
25944	1903	4	painted	paint	VBN
25944	1903	5	on	on	IN
25944	1903	6	the	the	DT
25944	1903	7	corn	corn	NN
25944	1903	8	night	night	NN
25944	1903	9	and	and	CC
25944	1903	10	morning	morning	NN
25944	1903	11	for	for	IN
25944	1903	12	several	several	JJ
25944	1903	13	days	day	NNS
25944	1903	14	,	,	,
25944	1903	15	at	at	IN
25944	1903	16	the	the	DT
25944	1903	17	end	end	NN
25944	1903	18	of	of	IN
25944	1903	19	which	which	WDT
25944	1903	20	time	time	NN
25944	1903	21	the	the	DT
25944	1903	22	parts	part	NNS
25944	1903	23	are	be	VBP
25944	1903	24	soaked	soak	VBN
25944	1903	25	in	in	IN
25944	1903	26	hot	hot	JJ
25944	1903	27	water	water	NN
25944	1903	28	,	,	,
25944	1903	29	and	and	CC
25944	1903	30	the	the	DT
25944	1903	31	mass	mass	NN
25944	1903	32	or	or	CC
25944	1903	33	a	a	DT
25944	1903	34	greater	great	JJR
25944	1903	35	part	part	NN
25944	1903	36	of	of	IN
25944	1903	37	it	-PRON-	PRP
25944	1903	38	,	,	,
25944	1903	39	will	will	MD
25944	1903	40	be	be	VB
25944	1903	41	found	find	VBN
25944	1903	42	,	,	,
25944	1903	43	as	as	IN
25944	1903	44	a	a	DT
25944	1903	45	rule	rule	NN
25944	1903	46	,	,	,
25944	1903	47	to	to	TO
25944	1903	48	come	come	VB
25944	1903	49	readily	readily	RB
25944	1903	50	away	away	RB
25944	1903	51	;	;	:
25944	1903	52	one	one	CD
25944	1903	53	or	or	CC
25944	1903	54	two	two	CD
25944	1903	55	repetitions	repetition	NNS
25944	1903	56	may	may	MD
25944	1903	57	be	be	VB
25944	1903	58	necessary	necessary	JJ
25944	1903	59	.	.	.
25944	1904	1	Lactic	lactic	JJ
25944	1904	2	acid	acid	NN
25944	1904	3	,	,	,
25944	1904	4	with	with	IN
25944	1904	5	one	one	CD
25944	1904	6	to	to	IN
25944	1904	7	several	several	JJ
25944	1904	8	parts	part	NNS
25944	1904	9	of	of	IN
25944	1904	10	water	water	NN
25944	1904	11	,	,	,
25944	1904	12	applied	apply	VBD
25944	1904	13	once	once	RB
25944	1904	14	or	or	CC
25944	1904	15	twice	twice	RB
25944	1904	16	daily	daily	RB
25944	1904	17	,	,	,
25944	1904	18	acts	act	VBZ
25944	1904	19	in	in	IN
25944	1904	20	a	a	DT
25944	1904	21	similar	similar	JJ
25944	1904	22	manner	manner	NN
25944	1904	23	.	.	.
25944	1905	1	Soft	soft	JJ
25944	1905	2	corns	corn	NNS
25944	1905	3	,	,	,
25944	1905	4	after	after	IN
25944	1905	5	the	the	DT
25944	1905	6	removal	removal	NN
25944	1905	7	of	of	IN
25944	1905	8	pressure	pressure	NN
25944	1905	9	,	,	,
25944	1905	10	may	may	MD
25944	1905	11	be	be	VB
25944	1905	12	treated	treat	VBN
25944	1905	13	with	with	IN
25944	1905	14	the	the	DT
25944	1905	15	solid	solid	JJ
25944	1905	16	stick	stick	NN
25944	1905	17	of	of	IN
25944	1905	18	nitrate	nitrate	JJ
25944	1905	19	of	of	IN
25944	1905	20	silver	silver	NN
25944	1905	21	,	,	,
25944	1905	22	or	or	CC
25944	1905	23	by	by	IN
25944	1905	24	any	any	DT
25944	1905	25	of	of	IN
25944	1905	26	the	the	DT
25944	1905	27	methods	method	NNS
25944	1905	28	already	already	RB
25944	1905	29	mentioned	mention	VBN
25944	1905	30	.	.	.
25944	1906	1	In	in	IN
25944	1906	2	order	order	NN
25944	1906	3	that	that	IN
25944	1906	4	treatment	treatment	NN
25944	1906	5	be	be	VB
25944	1906	6	permanently	permanently	RB
25944	1906	7	successful	successful	JJ
25944	1906	8	,	,	,
25944	1906	9	the	the	DT
25944	1906	10	feet	foot	NNS
25944	1906	11	are	be	VBP
25944	1906	12	to	to	TO
25944	1906	13	be	be	VB
25944	1906	14	properly	properly	RB
25944	1906	15	fitted	fit	VBN
25944	1906	16	.	.	.
25944	1907	1	If	if	IN
25944	1907	2	pressure	pressure	NN
25944	1907	3	is	be	VBZ
25944	1907	4	removed	remove	VBN
25944	1907	5	,	,	,
25944	1907	6	corns	corn	NNS
25944	1907	7	will	will	MD
25944	1907	8	commonly	commonly	RB
25944	1907	9	disappear	disappear	VB
25944	1907	10	spontaneously	spontaneously	RB
25944	1907	11	.	.	.
25944	1908	1	#	#	NNP
25944	1908	2	Cornu	Cornu	NNP
25944	1908	3	Cutaneum	Cutaneum	NNP
25944	1908	4	.	.	.
25944	1908	5	#	#	NN
25944	1908	6	(	(	-LRB-
25944	1908	7	_	_	NNP
25944	1908	8	Synonyms	Synonyms	NNP
25944	1908	9	:	:	:
25944	1908	10	_	_	NNP
25944	1908	11	Cornu	Cornu	NNP
25944	1908	12	Humanum	Humanum	NNP
25944	1908	13	;	;	:
25944	1908	14	Cutaneous	Cutaneous	NNP
25944	1908	15	Horn	Horn	NNP
25944	1908	16	.	.	.
25944	1908	17	)	)	-RRB-
25944	1909	1	#	#	LS
25944	1909	2	What	what	WP
25944	1909	3	is	be	VBZ
25944	1909	4	cornu	cornu	NNP
25944	1909	5	cutaneum	cutaneum	NNP
25944	1909	6	?	?	.
25944	1909	7	#	#	$
25944	1909	8	A	a	DT
25944	1909	9	cutaneous	cutaneous	JJ
25944	1909	10	horn	horn	NN
25944	1909	11	is	be	VBZ
25944	1909	12	a	a	DT
25944	1909	13	circumscribed	circumscribe	VBN
25944	1909	14	hypertrophy	hypertrophy	NN
25944	1909	15	of	of	IN
25944	1909	16	the	the	DT
25944	1909	17	epidermis	epidermis	NN
25944	1909	18	,	,	,
25944	1909	19	forming	form	VBG
25944	1909	20	an	an	DT
25944	1909	21	outgrowth	outgrowth	NN
25944	1909	22	of	of	IN
25944	1909	23	horny	horny	JJ
25944	1909	24	consistence	consistence	NN
25944	1909	25	and	and	CC
25944	1909	26	of	of	IN
25944	1909	27	variable	variable	JJ
25944	1909	28	size	size	NN
25944	1909	29	and	and	CC
25944	1909	30	shape	shape	NN
25944	1909	31	.	.	.
25944	1910	1	#	#	$
25944	1910	2	At	at	IN
25944	1910	3	what	what	WDT
25944	1910	4	age	age	NN
25944	1910	5	and	and	CC
25944	1910	6	upon	upon	IN
25944	1910	7	what	what	WP
25944	1910	8	parts	part	NNS
25944	1910	9	are	be	VBP
25944	1910	10	cutaneous	cutaneous	JJ
25944	1910	11	horns	horn	NNS
25944	1910	12	observed	observe	VBN
25944	1910	13	?	?	.
25944	1910	14	#	#	VBD
25944	1910	15	They	-PRON-	PRP
25944	1910	16	are	be	VBP
25944	1910	17	usually	usually	RB
25944	1910	18	met	meet	VBN
25944	1910	19	with	with	IN
25944	1910	20	late	late	JJ
25944	1910	21	in	in	IN
25944	1910	22	life	life	NN
25944	1910	23	,	,	,
25944	1910	24	and	and	CC
25944	1910	25	are	be	VBP
25944	1910	26	mostly	mostly	RB
25944	1910	27	seated	seat	VBN
25944	1910	28	upon	upon	IN
25944	1910	29	the	the	DT
25944	1910	30	face	face	NN
25944	1910	31	and	and	CC
25944	1910	32	scalp	scalp	NN
25944	1910	33	.	.	.
25944	1911	1	[	[	-LRB-
25944	1911	2	Illustration	illustration	NN
25944	1911	3	:	:	:
25944	1911	4	Fig	Fig	NNP
25944	1911	5	.	.	.
25944	1912	1	32	32	CD
25944	1912	2	.	.	.
25944	1913	1	Cutaneous	cutaneous	JJ
25944	1913	2	Horns	Horns	NNPS
25944	1913	3	.	.	.
25944	1914	1	Showing	show	VBG
25944	1914	2	beginning	begin	VBG
25944	1914	3	epitheliomatous	epitheliomatous	JJ
25944	1914	4	degeneration	degeneration	NN
25944	1914	5	of	of	IN
25944	1914	6	the	the	DT
25944	1914	7	base	base	NN
25944	1914	8	.	.	.
25944	1915	1	(	(	-LRB-
25944	1915	2	_	_	NNP
25944	1915	3	After	after	IN
25944	1915	4	Pancoast	Pancoast	NNP
25944	1915	5	.	.	.
25944	1915	6	_	_	NNP
25944	1915	7	)	)	-RRB-
25944	1915	8	]	]	-RRB-
25944	1915	9	#	#	$
25944	1915	10	Describe	describe	VB
25944	1915	11	the	the	DT
25944	1915	12	clinical	clinical	JJ
25944	1915	13	appearances	appearance	NNS
25944	1915	14	.	.	.
25944	1915	15	#	#	$
25944	1915	16	In	in	IN
25944	1915	17	appearance	appearance	NN
25944	1915	18	cutaneous	cutaneous	JJ
25944	1915	19	horns	horn	NNS
25944	1915	20	resemble	resemble	VBP
25944	1915	21	those	those	DT
25944	1915	22	seen	see	VBN
25944	1915	23	in	in	IN
25944	1915	24	the	the	DT
25944	1915	25	lower	low	JJR
25944	1915	26	animals	animal	NNS
25944	1915	27	,	,	,
25944	1915	28	differing	differ	VBG
25944	1915	29	,	,	,
25944	1915	30	if	if	IN
25944	1915	31	at	at	RB
25944	1915	32	all	all	RB
25944	1915	33	,	,	,
25944	1915	34	but	but	CC
25944	1915	35	slightly	slightly	RB
25944	1915	36	.	.	.
25944	1916	1	They	-PRON-	PRP
25944	1916	2	are	be	VBP
25944	1916	3	hard	hard	JJ
25944	1916	4	,	,	,
25944	1916	5	solid	solid	JJ
25944	1916	6	,	,	,
25944	1916	7	dry	dry	JJ
25944	1916	8	and	and	CC
25944	1916	9	somewhat	somewhat	RB
25944	1916	10	brittle	brittle	JJ
25944	1916	11	;	;	:
25944	1916	12	usually	usually	RB
25944	1916	13	tapering	taper	VBG
25944	1916	14	,	,	,
25944	1916	15	and	and	CC
25944	1916	16	may	may	MD
25944	1916	17	be	be	VB
25944	1916	18	either	either	CC
25944	1916	19	straight	straight	RB
25944	1916	20	,	,	,
25944	1916	21	curved	curved	JJ
25944	1916	22	or	or	CC
25944	1916	23	crooked	crooked	JJ
25944	1916	24	.	.	.
25944	1917	1	Their	-PRON-	PRP$
25944	1917	2	surface	surface	NN
25944	1917	3	is	be	VBZ
25944	1917	4	rough	rough	JJ
25944	1917	5	,	,	,
25944	1917	6	irregular	irregular	JJ
25944	1917	7	,	,	,
25944	1917	8	laminated	laminate	VBN
25944	1917	9	or	or	CC
25944	1917	10	fissured	fissure	VBN
25944	1917	11	,	,	,
25944	1917	12	the	the	DT
25944	1917	13	ends	end	NNS
25944	1917	14	pointed	point	VBD
25944	1917	15	,	,	,
25944	1917	16	blunt	blunt	JJ
25944	1917	17	or	or	CC
25944	1917	18	clubbed	club	VBN
25944	1917	19	.	.	.
25944	1918	1	The	the	DT
25944	1918	2	color	color	NN
25944	1918	3	varies	vary	VBZ
25944	1918	4	;	;	:
25944	1918	5	it	-PRON-	PRP
25944	1918	6	is	be	VBZ
25944	1918	7	usually	usually	RB
25944	1918	8	grayish	grayish	NN
25944	1918	9	-	-	HYPH
25944	1918	10	yellow	yellow	JJ
25944	1918	11	,	,	,
25944	1918	12	but	but	CC
25944	1918	13	may	may	MD
25944	1918	14	be	be	VB
25944	1918	15	even	even	RB
25944	1918	16	blackish	blackish	JJ
25944	1918	17	.	.	.
25944	1919	1	As	as	IN
25944	1919	2	commonly	commonly	RB
25944	1919	3	seen	see	VBN
25944	1919	4	they	-PRON-	PRP
25944	1919	5	are	be	VBP
25944	1919	6	small	small	JJ
25944	1919	7	in	in	IN
25944	1919	8	size	size	NN
25944	1919	9	,	,	,
25944	1919	10	a	a	DT
25944	1919	11	fraction	fraction	NN
25944	1919	12	of	of	IN
25944	1919	13	an	an	DT
25944	1919	14	inch	inch	NN
25944	1919	15	or	or	CC
25944	1919	16	an	an	DT
25944	1919	17	inch	inch	NN
25944	1919	18	or	or	CC
25944	1919	19	thereabouts	thereabout	NNS
25944	1919	20	in	in	IN
25944	1919	21	length	length	NN
25944	1919	22	,	,	,
25944	1919	23	but	but	CC
25944	1919	24	exceptionally	exceptionally	RB
25944	1919	25	attain	attain	VBP
25944	1919	26	considerable	considerable	JJ
25944	1919	27	proportions	proportion	NNS
25944	1919	28	.	.	.
25944	1920	1	The	the	DT
25944	1920	2	base	base	NN
25944	1920	3	,	,	,
25944	1920	4	which	which	WDT
25944	1920	5	rests	rest	VBZ
25944	1920	6	directly	directly	RB
25944	1920	7	upon	upon	IN
25944	1920	8	the	the	DT
25944	1920	9	skin	skin	NN
25944	1920	10	,	,	,
25944	1920	11	may	may	MD
25944	1920	12	be	be	VB
25944	1920	13	broad	broad	JJ
25944	1920	14	,	,	,
25944	1920	15	flattened	flatten	VBN
25944	1920	16	,	,	,
25944	1920	17	or	or	CC
25944	1920	18	concave	concave	NNP
25944	1920	19	,	,	,
25944	1920	20	with	with	IN
25944	1920	21	the	the	DT
25944	1920	22	underlying	underlying	JJ
25944	1920	23	and	and	CC
25944	1920	24	adjacent	adjacent	JJ
25944	1920	25	tissues	tissue	NNS
25944	1920	26	normal	normal	JJ
25944	1920	27	or	or	CC
25944	1920	28	the	the	DT
25944	1920	29	papillæ	papillæ	NN
25944	1920	30	hypertrophied	hypertrophied	JJ
25944	1920	31	;	;	:
25944	1920	32	and	and	CC
25944	1920	33	in	in	IN
25944	1920	34	some	some	DT
25944	1920	35	cases	case	NNS
25944	1920	36	there	there	EX
25944	1920	37	is	be	VBZ
25944	1920	38	more	more	RBR
25944	1920	39	or	or	CC
25944	1920	40	less	less	JJR
25944	1920	41	inflammation	inflammation	NN
25944	1920	42	,	,	,
25944	1920	43	which	which	WDT
25944	1920	44	may	may	MD
25944	1920	45	be	be	VB
25944	1920	46	followed	follow	VBN
25944	1920	47	by	by	IN
25944	1920	48	suppuration	suppuration	NN
25944	1920	49	.	.	.
25944	1921	1	They	-PRON-	PRP
25944	1921	2	are	be	VBP
25944	1921	3	usually	usually	RB
25944	1921	4	solitary	solitary	JJ
25944	1921	5	formations	formation	NNS
25944	1921	6	.	.	.
25944	1922	1	They	-PRON-	PRP
25944	1922	2	are	be	VBP
25944	1922	3	not	not	RB
25944	1922	4	,	,	,
25944	1922	5	as	as	IN
25944	1922	6	a	a	DT
25944	1922	7	rule	rule	NN
25944	1922	8	,	,	,
25944	1922	9	painful	painful	JJ
25944	1922	10	,	,	,
25944	1922	11	unless	unless	IN
25944	1922	12	knocked	knock	VBN
25944	1922	13	or	or	CC
25944	1922	14	irritated	irritated	JJ
25944	1922	15	.	.	.
25944	1923	1	#	#	LS
25944	1923	2	What	what	WDT
25944	1923	3	course	course	NN
25944	1923	4	do	do	VBP
25944	1923	5	cutaneous	cutaneous	JJ
25944	1923	6	horns	horn	NNS
25944	1923	7	pursue	pursue	VB
25944	1923	8	?	?	.
25944	1923	9	#	#	$
25944	1923	10	Their	-PRON-	PRP$
25944	1923	11	growth	growth	NN
25944	1923	12	is	be	VBZ
25944	1923	13	usually	usually	RB
25944	1923	14	slow	slow	JJ
25944	1923	15	,	,	,
25944	1923	16	and	and	CC
25944	1923	17	,	,	,
25944	1923	18	after	after	IN
25944	1923	19	having	have	VBG
25944	1923	20	attained	attain	VBN
25944	1923	21	a	a	DT
25944	1923	22	certain	certain	JJ
25944	1923	23	size	size	NN
25944	1923	24	,	,	,
25944	1923	25	they	-PRON-	PRP
25944	1923	26	not	not	RB
25944	1923	27	infrequently	infrequently	RB
25944	1923	28	become	become	VBP
25944	1923	29	loose	loose	JJ
25944	1923	30	and	and	CC
25944	1923	31	fall	fall	VB
25944	1923	32	off	off	RP
25944	1923	33	;	;	:
25944	1923	34	they	-PRON-	PRP
25944	1923	35	are	be	VBP
25944	1923	36	almost	almost	RB
25944	1923	37	always	always	RB
25944	1923	38	reproduced	reproduce	VBN
25944	1923	39	.	.	.
25944	1924	1	#	#	LS
25944	1924	2	What	what	WP
25944	1924	3	is	be	VBZ
25944	1924	4	the	the	DT
25944	1924	5	cause	cause	NN
25944	1924	6	of	of	IN
25944	1924	7	these	these	DT
25944	1924	8	horny	horny	JJ
25944	1924	9	growths	growth	NNS
25944	1924	10	?	?	.
25944	1924	11	#	#	$
25944	1924	12	The	the	DT
25944	1924	13	cause	cause	NN
25944	1924	14	is	be	VBZ
25944	1924	15	not	not	RB
25944	1924	16	known	know	VBN
25944	1924	17	;	;	:
25944	1924	18	appearing	appear	VBG
25944	1924	19	about	about	IN
25944	1924	20	the	the	DT
25944	1924	21	genitalia	genitalia	NNP
25944	1924	22	,	,	,
25944	1924	23	they	-PRON-	PRP
25944	1924	24	usually	usually	RB
25944	1924	25	develop	develop	VBP
25944	1924	26	from	from	IN
25944	1924	27	acuminated	acuminated	JJ
25944	1924	28	warts	wart	NNS
25944	1924	29	.	.	.
25944	1925	1	They	-PRON-	PRP
25944	1925	2	are	be	VBP
25944	1925	3	rare	rare	JJ
25944	1925	4	formations	formation	NNS
25944	1925	5	.	.	.
25944	1926	1	#	#	NNP
25944	1926	2	State	state	NN
25944	1926	3	the	the	DT
25944	1926	4	pathology	pathology	NN
25944	1926	5	of	of	IN
25944	1926	6	cornu	cornu	NNP
25944	1926	7	cutaneum	cutaneum	NNP
25944	1926	8	.	.	.
25944	1926	9	#	#	$
25944	1926	10	Horns	horn	NNS
25944	1926	11	consist	consist	VBP
25944	1926	12	of	of	IN
25944	1926	13	closely	closely	RB
25944	1926	14	agglutinated	agglutinate	VBN
25944	1926	15	epidermic	epidermic	JJ
25944	1926	16	cells	cell	NNS
25944	1926	17	,	,	,
25944	1926	18	forming	form	VBG
25944	1926	19	small	small	JJ
25944	1926	20	columns	column	NNS
25944	1926	21	or	or	CC
25944	1926	22	rods	rod	NNS
25944	1926	23	;	;	:
25944	1926	24	in	in	IN
25944	1926	25	the	the	DT
25944	1926	26	columns	column	NNS
25944	1926	27	themselves	-PRON-	PRP
25944	1926	28	the	the	DT
25944	1926	29	cells	cell	NNS
25944	1926	30	are	be	VBP
25944	1926	31	arranged	arrange	VBN
25944	1926	32	concentrically	concentrically	RB
25944	1926	33	.	.	.
25944	1927	1	In	in	IN
25944	1927	2	the	the	DT
25944	1927	3	base	base	NN
25944	1927	4	are	be	VBP
25944	1927	5	found	find	VBN
25944	1927	6	hypertrophic	hypertrophic	JJ
25944	1927	7	papillæ	papillæ	NN
25944	1927	8	and	and	CC
25944	1927	9	some	some	DT
25944	1927	10	bloodvessels	bloodvessel	NNS
25944	1927	11	.	.	.
25944	1928	1	They	-PRON-	PRP
25944	1928	2	have	have	VBP
25944	1928	3	their	-PRON-	PRP$
25944	1928	4	starting	starting	NN
25944	1928	5	-	-	HYPH
25944	1928	6	point	point	NN
25944	1928	7	in	in	IN
25944	1928	8	the	the	DT
25944	1928	9	rete	rete	NN
25944	1928	10	mucosum	mucosum	NN
25944	1928	11	,	,	,
25944	1928	12	either	either	CC
25944	1928	13	from	from	IN
25944	1928	14	that	that	DT
25944	1928	15	lying	lie	VBG
25944	1928	16	above	above	IN
25944	1928	17	the	the	DT
25944	1928	18	papillæ	papillæ	NN
25944	1928	19	or	or	CC
25944	1928	20	that	that	IN
25944	1928	21	lining	line	VBG
25944	1928	22	the	the	DT
25944	1928	23	follicles	follicle	NNS
25944	1928	24	and	and	CC
25944	1928	25	glands	gland	NNS
25944	1928	26	.	.	.
25944	1929	1	#	#	NN
25944	1929	2	Does	do	VBZ
25944	1929	3	epitheliomatous	epitheliomatous	JJ
25944	1929	4	degeneration	degeneration	NN
25944	1929	5	of	of	IN
25944	1929	6	the	the	DT
25944	1929	7	base	base	NN
25944	1929	8	ever	ever	RB
25944	1929	9	occur	occur	VB
25944	1929	10	?	?	.
25944	1929	11	#	#	NN
25944	1929	12	Yes	yes	UH
25944	1929	13	.	.	.
25944	1930	1	#	#	JJR
25944	1930	2	State	state	NN
25944	1930	3	the	the	DT
25944	1930	4	prognosis	prognosis	NN
25944	1930	5	.	.	.
25944	1930	6	#	#	JJR
25944	1930	7	Cutaneous	cutaneous	JJ
25944	1930	8	horns	horn	NNS
25944	1930	9	may	may	MD
25944	1930	10	be	be	VB
25944	1930	11	readily	readily	RB
25944	1930	12	and	and	CC
25944	1930	13	permanently	permanently	RB
25944	1930	14	removed	remove	VBN
25944	1930	15	.	.	.
25944	1931	1	#	#	LS
25944	1931	2	What	what	WP
25944	1931	3	is	be	VBZ
25944	1931	4	the	the	DT
25944	1931	5	treatment	treatment	NN
25944	1931	6	?	?	.
25944	1931	7	#	#	$
25944	1931	8	Treatment	Treatment	NNP
25944	1931	9	consists	consist	VBZ
25944	1931	10	in	in	IN
25944	1931	11	detachment	detachment	NN
25944	1931	12	,	,	,
25944	1931	13	and	and	CC
25944	1931	14	subsequent	subsequent	JJ
25944	1931	15	destruction	destruction	NN
25944	1931	16	of	of	IN
25944	1931	17	the	the	DT
25944	1931	18	base	base	NN
25944	1931	19	;	;	:
25944	1931	20	the	the	DT
25944	1931	21	former	former	JJ
25944	1931	22	is	be	VBZ
25944	1931	23	accomplished	accomplish	VBN
25944	1931	24	by	by	IN
25944	1931	25	dissecting	dissect	VBG
25944	1931	26	the	the	DT
25944	1931	27	horn	horn	NN
25944	1931	28	away	away	RB
25944	1931	29	from	from	IN
25944	1931	30	the	the	DT
25944	1931	31	base	base	NN
25944	1931	32	or	or	CC
25944	1931	33	forcibly	forcibly	RB
25944	1931	34	breaking	break	VBG
25944	1931	35	it	-PRON-	PRP
25944	1931	36	off	off	RP
25944	1931	37	,	,	,
25944	1931	38	the	the	DT
25944	1931	39	latter	latter	JJ
25944	1931	40	by	by	IN
25944	1931	41	means	mean	NNS
25944	1931	42	of	of	IN
25944	1931	43	any	any	DT
25944	1931	44	of	of	IN
25944	1931	45	the	the	DT
25944	1931	46	well	well	RB
25944	1931	47	-	-	HYPH
25944	1931	48	known	know	VBN
25944	1931	49	caustics	caustic	NNS
25944	1931	50	,	,	,
25944	1931	51	such	such	JJ
25944	1931	52	as	as	IN
25944	1931	53	caustic	caustic	JJ
25944	1931	54	potash	potash	NN
25944	1931	55	,	,	,
25944	1931	56	chloride	chloride	NN
25944	1931	57	of	of	IN
25944	1931	58	zinc	zinc	NN
25944	1931	59	and	and	CC
25944	1931	60	the	the	DT
25944	1931	61	galvano	galvano	NN
25944	1931	62	-	-	HYPH
25944	1931	63	cautery	cautery	NN
25944	1931	64	.	.	.
25944	1932	1	Another	another	DT
25944	1932	2	method	method	NN
25944	1932	3	is	be	VBZ
25944	1932	4	to	to	TO
25944	1932	5	excise	excise	VB
25944	1932	6	the	the	DT
25944	1932	7	base	base	NN
25944	1932	8	,	,	,
25944	1932	9	the	the	DT
25944	1932	10	horn	horn	NN
25944	1932	11	coming	come	VBG
25944	1932	12	away	away	RB
25944	1932	13	with	with	IN
25944	1932	14	it	-PRON-	PRP
25944	1932	15	;	;	:
25944	1932	16	this	this	DT
25944	1932	17	necessitates	necessitate	NNS
25944	1932	18	,	,	,
25944	1932	19	however	however	RB
25944	1932	20	,	,	,
25944	1932	21	considerable	considerable	JJ
25944	1932	22	loss	loss	NN
25944	1932	23	of	of	IN
25944	1932	24	tissue	tissue	NN
25944	1932	25	.	.	.
25944	1933	1	#	#	NNP
25944	1933	2	Verruca	Verruca	NNP
25944	1933	3	.	.	.
25944	1933	4	#	#	NNP
25944	1933	5	(	(	-LRB-
25944	1933	6	_	_	NNP
25944	1933	7	Synonym	Synonym	NNP
25944	1933	8	:	:	:
25944	1933	9	_	_	NNP
25944	1933	10	Wart	Wart	NNP
25944	1933	11	.	.	.
25944	1933	12	)	)	-RRB-
25944	1934	1	#	#	LS
25944	1934	2	What	what	WP
25944	1934	3	is	be	VBZ
25944	1934	4	verruca	verruca	NN
25944	1934	5	?	?	.
25944	1934	6	#	#	NNP
25944	1934	7	Verruca	Verruca	NNP
25944	1934	8	,	,	,
25944	1934	9	or	or	CC
25944	1934	10	wart	wart	JJ
25944	1934	11	,	,	,
25944	1934	12	is	be	VBZ
25944	1934	13	a	a	DT
25944	1934	14	hard	hard	JJ
25944	1934	15	or	or	CC
25944	1934	16	soft	soft	JJ
25944	1934	17	,	,	,
25944	1934	18	rounded	rounded	JJ
25944	1934	19	,	,	,
25944	1934	20	flat	flat	JJ
25944	1934	21	,	,	,
25944	1934	22	acuminated	acuminated	JJ
25944	1934	23	or	or	CC
25944	1934	24	filiform	filiform	NN
25944	1934	25	,	,	,
25944	1934	26	circumscribed	circumscribe	VBN
25944	1934	27	epidermal	epidermal	JJ
25944	1934	28	and	and	CC
25944	1934	29	papillary	papillary	JJ
25944	1934	30	growth	growth	NN
25944	1934	31	.	.	.
25944	1935	1	#	#	$
25944	1935	2	Name	name	VB
25944	1935	3	the	the	DT
25944	1935	4	several	several	JJ
25944	1935	5	varieties	variety	NNS
25944	1935	6	of	of	IN
25944	1935	7	warts	wart	NNS
25944	1935	8	met	meet	VBD
25944	1935	9	with	with	IN
25944	1935	10	.	.	.
25944	1935	11	#	#	JJR
25944	1935	12	Verruca	Verruca	NNP
25944	1935	13	vulgaris	vulgaris	NNP
25944	1935	14	,	,	,
25944	1935	15	verruca	verruca	NNP
25944	1935	16	plana	plana	NNP
25944	1935	17	,	,	,
25944	1935	18	verruca	verruca	NNP
25944	1935	19	plana	plana	NNP
25944	1935	20	juvenilis	juvenilis	NNP
25944	1935	21	,	,	,
25944	1935	22	verruca	verruca	NNP
25944	1935	23	digitata	digitata	NNP
25944	1935	24	,	,	,
25944	1935	25	verruca	verruca	NNP
25944	1935	26	filifortnis	filifortnis	NNP
25944	1935	27	and	and	CC
25944	1935	28	verruca	verruca	NNP
25944	1935	29	acuminata	acuminata	NNP
25944	1935	30	.	.	.
25944	1936	1	#	#	NNP
25944	1936	2	Describe	Describe	NNP
25944	1936	3	verruca	verruca	NN
25944	1936	4	vulgaris	vulgaris	NN
25944	1936	5	.	.	.
25944	1936	6	#	#	$
25944	1936	7	This	this	DT
25944	1936	8	is	be	VBZ
25944	1936	9	the	the	DT
25944	1936	10	common	common	JJ
25944	1936	11	wart	wart	NN
25944	1936	12	,	,	,
25944	1936	13	occurring	occur	VBG
25944	1936	14	mostly	mostly	RB
25944	1936	15	upon	upon	IN
25944	1936	16	the	the	DT
25944	1936	17	hands	hand	NNS
25944	1936	18	.	.	.
25944	1937	1	It	-PRON-	PRP
25944	1937	2	is	be	VBZ
25944	1937	3	rounded	rounded	JJ
25944	1937	4	,	,	,
25944	1937	5	elevated	elevated	JJ
25944	1937	6	,	,	,
25944	1937	7	circumscribed	circumscribe	VBN
25944	1937	8	,	,	,
25944	1937	9	hard	hard	JJ
25944	1937	10	and	and	CC
25944	1937	11	horny	horny	NNP
25944	1937	12	,	,	,
25944	1937	13	with	with	IN
25944	1937	14	a	a	DT
25944	1937	15	broad	broad	JJ
25944	1937	16	base	base	NN
25944	1937	17	,	,	,
25944	1937	18	and	and	CC
25944	1937	19	usually	usually	RB
25944	1937	20	the	the	DT
25944	1937	21	size	size	NN
25944	1937	22	of	of	IN
25944	1937	23	a	a	DT
25944	1937	24	pea	pea	NN
25944	1937	25	.	.	.
25944	1938	1	At	at	IN
25944	1938	2	first	first	RB
25944	1938	3	it	-PRON-	PRP
25944	1938	4	is	be	VBZ
25944	1938	5	smooth	smooth	JJ
25944	1938	6	and	and	CC
25944	1938	7	covered	cover	VBN
25944	1938	8	with	with	IN
25944	1938	9	slightly	slightly	RB
25944	1938	10	thickened	thicken	VBN
25944	1938	11	epidermis	epidermis	NN
25944	1938	12	,	,	,
25944	1938	13	but	but	CC
25944	1938	14	later	later	RBR
25944	1938	15	this	this	DT
25944	1938	16	disappears	disappear	VBZ
25944	1938	17	to	to	IN
25944	1938	18	some	some	DT
25944	1938	19	extent	extent	NN
25944	1938	20	,	,	,
25944	1938	21	the	the	DT
25944	1938	22	hypertrophied	hypertrophied	JJ
25944	1938	23	papillæ	papillæ	NN
25944	1938	24	,	,	,
25944	1938	25	appearing	appear	VBG
25944	1938	26	as	as	IN
25944	1938	27	minute	minute	JJ
25944	1938	28	elevations	elevation	NNS
25944	1938	29	,	,	,
25944	1938	30	making	make	VBG
25944	1938	31	up	up	RP
25944	1938	32	the	the	DT
25944	1938	33	growth	growth	NN
25944	1938	34	.	.	.
25944	1939	1	One	one	CD
25944	1939	2	,	,	,
25944	1939	3	several	several	JJ
25944	1939	4	or	or	CC
25944	1939	5	more	more	JJR
25944	1939	6	may	may	MD
25944	1939	7	be	be	VB
25944	1939	8	present	present	JJ
25944	1939	9	.	.	.
25944	1940	1	#	#	NNP
25944	1940	2	Describe	Describe	NNP
25944	1940	3	verruca	verruca	NN
25944	1940	4	plana	plana	NNS
25944	1940	5	.	.	.
25944	1940	6	#	#	$
25944	1940	7	This	this	DT
25944	1940	8	is	be	VBZ
25944	1940	9	the	the	DT
25944	1940	10	so	so	RB
25944	1940	11	-	-	HYPH
25944	1940	12	called	call	VBN
25944	1940	13	flat	flat	JJ
25944	1940	14	wart	wart	NN
25944	1940	15	,	,	,
25944	1940	16	and	and	CC
25944	1940	17	occurs	occur	VBZ
25944	1940	18	commonly	commonly	RB
25944	1940	19	upon	upon	IN
25944	1940	20	the	the	DT
25944	1940	21	back	back	NN
25944	1940	22	,	,	,
25944	1940	23	especially	especially	RB
25944	1940	24	in	in	IN
25944	1940	25	elderly	elderly	JJ
25944	1940	26	people	people	NNS
25944	1940	27	(	(	-LRB-
25944	1940	28	_	_	NNP
25944	1940	29	verruca	verruca	NNP
25944	1940	30	senilis	senilis	NNP
25944	1940	31	_	_	NNP
25944	1940	32	,	,	,
25944	1940	33	_	_	NNP
25944	1940	34	keratosis	keratosis	NNP
25944	1940	35	pigmentosa	pigmentosa	NNP
25944	1940	36	_	_	NNP
25944	1940	37	)	)	-RRB-
25944	1940	38	.	.	.
25944	1941	1	It	-PRON-	PRP
25944	1941	2	is	be	VBZ
25944	1941	3	,	,	,
25944	1941	4	as	as	IN
25944	1941	5	a	a	DT
25944	1941	6	rule	rule	NN
25944	1941	7	,	,	,
25944	1941	8	but	but	CC
25944	1941	9	slightly	slightly	RB
25944	1941	10	elevated	elevate	VBN
25944	1941	11	,	,	,
25944	1941	12	is	be	VBZ
25944	1941	13	usually	usually	RB
25944	1941	14	dark	dark	JJ
25944	1941	15	in	in	IN
25944	1941	16	color	color	NN
25944	1941	17	,	,	,
25944	1941	18	and	and	CC
25944	1941	19	of	of	IN
25944	1941	20	the	the	DT
25944	1941	21	size	size	NN
25944	1941	22	of	of	IN
25944	1941	23	a	a	DT
25944	1941	24	pea	pea	NN
25944	1941	25	or	or	CC
25944	1941	26	finger	finger	NN
25944	1941	27	-	-	HYPH
25944	1941	28	nail	nail	NN
25944	1941	29	.	.	.
25944	1942	1	#	#	NNP
25944	1942	2	Describe	Describe	NNP
25944	1942	3	verruca	verruca	NN
25944	1942	4	plana	plana	NNS
25944	1942	5	juvenilis	juvenilis	NNP
25944	1942	6	.	.	.
25944	1942	7	#	#	$
25944	1942	8	The	the	DT
25944	1942	9	warts	wart	NNS
25944	1942	10	are	be	VBP
25944	1942	11	mostly	mostly	RB
25944	1942	12	pin	pin	NN
25944	1942	13	-	-	HYPH
25944	1942	14	head	head	NN
25944	1942	15	in	in	IN
25944	1942	16	size	size	NN
25944	1942	17	,	,	,
25944	1942	18	flat	flat	JJ
25944	1942	19	,	,	,
25944	1942	20	but	but	CC
25944	1942	21	slightly	slightly	RB
25944	1942	22	elevated	elevated	JJ
25944	1942	23	,	,	,
25944	1942	24	rounded	rounded	JJ
25944	1942	25	,	,	,
25944	1942	26	irregular	irregular	JJ
25944	1942	27	or	or	CC
25944	1942	28	square	square	RB
25944	1942	29	-	-	HYPH
25944	1942	30	shaped	shaped	JJ
25944	1942	31	,	,	,
25944	1942	32	and	and	CC
25944	1942	33	of	of	IN
25944	1942	34	a	a	DT
25944	1942	35	light	light	JJ
25944	1942	36	yellowish	yellowish	JJ
25944	1942	37	-	-	HYPH
25944	1942	38	brown	brown	JJ
25944	1942	39	color	color	NN
25944	1942	40	.	.	.
25944	1943	1	They	-PRON-	PRP
25944	1943	2	bear	bear	VBP
25944	1943	3	resemblance	resemblance	NN
25944	1943	4	to	to	IN
25944	1943	5	lichen	lichen	NNP
25944	1943	6	planus	planus	NNP
25944	1943	7	papules	papule	NNS
25944	1943	8	.	.	.
25944	1944	1	They	-PRON-	PRP
25944	1944	2	are	be	VBP
25944	1944	3	apt	apt	JJ
25944	1944	4	to	to	TO
25944	1944	5	be	be	VB
25944	1944	6	numerous	numerous	JJ
25944	1944	7	,	,	,
25944	1944	8	often	often	RB
25944	1944	9	becoming	become	VBG
25944	1944	10	aggregated	aggregate	VBN
25944	1944	11	or	or	CC
25944	1944	12	fused	fuse	VBN
25944	1944	13	,	,	,
25944	1944	14	and	and	CC
25944	1944	15	occur	occur	VB
25944	1944	16	usually	usually	RB
25944	1944	17	in	in	IN
25944	1944	18	young	young	JJ
25944	1944	19	children	child	NNS
25944	1944	20	,	,	,
25944	1944	21	and	and	CC
25944	1944	22	,	,	,
25944	1944	23	as	as	IN
25944	1944	24	a	a	DT
25944	1944	25	rule	rule	NN
25944	1944	26	,	,	,
25944	1944	27	on	on	IN
25944	1944	28	the	the	DT
25944	1944	29	face	face	NN
25944	1944	30	and	and	CC
25944	1944	31	hands	hand	NNS
25944	1944	32	.	.	.
25944	1945	1	#	#	NNP
25944	1945	2	Describe	Describe	NNP
25944	1945	3	verruca	verruca	NN
25944	1945	4	filiformis	filiformis	NN
25944	1945	5	.	.	.
25944	1945	6	#	#	$
25944	1945	7	This	this	DT
25944	1945	8	is	be	VBZ
25944	1945	9	a	a	DT
25944	1945	10	thread	thread	NN
25944	1945	11	-	-	HYPH
25944	1945	12	like	like	JJ
25944	1945	13	growth	growth	NN
25944	1945	14	about	about	IN
25944	1945	15	an	an	DT
25944	1945	16	eighth	eighth	JJ
25944	1945	17	or	or	CC
25944	1945	18	fourth	fourth	JJ
25944	1945	19	of	of	IN
25944	1945	20	an	an	DT
25944	1945	21	inch	inch	NN
25944	1945	22	long	long	JJ
25944	1945	23	,	,	,
25944	1945	24	and	and	CC
25944	1945	25	occurring	occur	VBG
25944	1945	26	commonly	commonly	RB
25944	1945	27	about	about	IN
25944	1945	28	the	the	DT
25944	1945	29	face	face	NN
25944	1945	30	,	,	,
25944	1945	31	eyelids	eyelid	NNS
25944	1945	32	and	and	CC
25944	1945	33	neck	neck	NN
25944	1945	34	.	.	.
25944	1946	1	It	-PRON-	PRP
25944	1946	2	is	be	VBZ
25944	1946	3	usually	usually	RB
25944	1946	4	soft	soft	JJ
25944	1946	5	to	to	IN
25944	1946	6	the	the	DT
25944	1946	7	touch	touch	NN
25944	1946	8	and	and	CC
25944	1946	9	flexible	flexible	JJ
25944	1946	10	.	.	.
25944	1947	1	#	#	NNP
25944	1947	2	Describe	Describe	NNP
25944	1947	3	verruca	verruca	NN
25944	1947	4	digitata	digitata	NN
25944	1947	5	.	.	.
25944	1947	6	#	#	$
25944	1947	7	This	this	DT
25944	1947	8	is	be	VBZ
25944	1947	9	a	a	DT
25944	1947	10	variety	variety	NN
25944	1947	11	of	of	IN
25944	1947	12	wart	wart	JJ
25944	1947	13	,	,	,
25944	1947	14	which	which	WDT
25944	1947	15	,	,	,
25944	1947	16	especially	especially	RB
25944	1947	17	about	about	IN
25944	1947	18	the	the	DT
25944	1947	19	edges	edge	NNS
25944	1947	20	,	,	,
25944	1947	21	is	be	VBZ
25944	1947	22	marked	mark	VBN
25944	1947	23	by	by	IN
25944	1947	24	digitations	digitation	NNS
25944	1947	25	,	,	,
25944	1947	26	extending	extend	VBG
25944	1947	27	nearly	nearly	RB
25944	1947	28	or	or	CC
25944	1947	29	quite	quite	RB
25944	1947	30	down	down	RB
25944	1947	31	to	to	IN
25944	1947	32	the	the	DT
25944	1947	33	base	base	NN
25944	1947	34	.	.	.
25944	1948	1	It	-PRON-	PRP
25944	1948	2	is	be	VBZ
25944	1948	3	commonly	commonly	RB
25944	1948	4	seen	see	VBN
25944	1948	5	upon	upon	IN
25944	1948	6	the	the	DT
25944	1948	7	scalp	scalp	NN
25944	1948	8	.	.	.
25944	1949	1	#	#	NNP
25944	1949	2	Describe	Describe	NNP
25944	1949	3	verruca	verruca	NN
25944	1949	4	acuminata	acuminata	NN
25944	1949	5	.	.	.
25944	1949	6	#	#	$
25944	1949	7	This	this	DT
25944	1949	8	variety	variety	NN
25944	1949	9	(	(	-LRB-
25944	1949	10	_	_	NNP
25944	1949	11	venereal	venereal	RB
25944	1949	12	wart	wart	JJ
25944	1949	13	_	_	NNP
25944	1949	14	,	,	,
25944	1949	15	_	_	NNP
25944	1949	16	pointed	point	VBD
25944	1949	17	wart	wart	JJ
25944	1949	18	_	_	NNP
25944	1949	19	,	,	,
25944	1949	20	_	_	NNP
25944	1949	21	pointed	point	VBD
25944	1949	22	condyloma	condyloma	NNS
25944	1949	23	_	_	NNP
25944	1949	24	)	)	-RRB-
25944	1949	25	,	,	,
25944	1949	26	usually	usually	RB
25944	1949	27	occurs	occur	VBZ
25944	1949	28	about	about	IN
25944	1949	29	the	the	DT
25944	1949	30	genitalia	genitalia	NNP
25944	1949	31	,	,	,
25944	1949	32	especially	especially	RB
25944	1949	33	upon	upon	IN
25944	1949	34	the	the	DT
25944	1949	35	mucous	mucous	JJ
25944	1949	36	and	and	CC
25944	1949	37	muco	muco	NN
25944	1949	38	-	-	HYPH
25944	1949	39	cutaneous	cutaneous	JJ
25944	1949	40	surfaces	surface	NNS
25944	1949	41	.	.	.
25944	1950	1	It	-PRON-	PRP
25944	1950	2	consists	consist	VBZ
25944	1950	3	of	of	IN
25944	1950	4	one	one	CD
25944	1950	5	or	or	CC
25944	1950	6	more	more	JJR
25944	1950	7	groups	group	NNS
25944	1950	8	of	of	IN
25944	1950	9	acuminated	acuminate	VBN
25944	1950	10	,	,	,
25944	1950	11	pinkish	pinkish	NNP
25944	1950	12	or	or	CC
25944	1950	13	reddish	reddish	JJ
25944	1950	14	,	,	,
25944	1950	15	raspberry	raspberry	NN
25944	1950	16	-	-	HYPH
25944	1950	17	like	like	JJ
25944	1950	18	elevations	elevation	NNS
25944	1950	19	,	,	,
25944	1950	20	and	and	CC
25944	1950	21	,	,	,
25944	1950	22	according	accord	VBG
25944	1950	23	to	to	IN
25944	1950	24	the	the	DT
25944	1950	25	region	region	NN
25944	1950	26	,	,	,
25944	1950	27	may	may	MD
25944	1950	28	be	be	VB
25944	1950	29	dry	dry	JJ
25944	1950	30	or	or	CC
25944	1950	31	moist	moist	VB
25944	1950	32	;	;	:
25944	1950	33	if	if	IN
25944	1950	34	the	the	DT
25944	1950	35	latter	latter	JJ
25944	1950	36	,	,	,
25944	1950	37	the	the	DT
25944	1950	38	secretion	secretion	NN
25944	1950	39	,	,	,
25944	1950	40	which	which	WDT
25944	1950	41	is	be	VBZ
25944	1950	42	usually	usually	RB
25944	1950	43	yellowish	yellowish	JJ
25944	1950	44	and	and	CC
25944	1950	45	puriform	puriform	VBP
25944	1950	46	,	,	,
25944	1950	47	from	from	IN
25944	1950	48	rapid	rapid	JJ
25944	1950	49	decomposition	decomposition	NN
25944	1950	50	,	,	,
25944	1950	51	develops	develop	VBZ
25944	1950	52	an	an	DT
25944	1950	53	offensive	offensive	JJ
25944	1950	54	and	and	CC
25944	1950	55	penetrating	penetrating	NN
25944	1950	56	odor	odor	NN
25944	1950	57	.	.	.
25944	1951	1	The	the	DT
25944	1951	2	formation	formation	NN
25944	1951	3	may	may	MD
25944	1951	4	be	be	VB
25944	1951	5	the	the	DT
25944	1951	6	size	size	NN
25944	1951	7	of	of	IN
25944	1951	8	a	a	DT
25944	1951	9	small	small	JJ
25944	1951	10	pea	pea	NN
25944	1951	11	,	,	,
25944	1951	12	or	or	CC
25944	1951	13	may	may	MD
25944	1951	14	attain	attain	VB
25944	1951	15	the	the	DT
25944	1951	16	dimensions	dimension	NNS
25944	1951	17	of	of	IN
25944	1951	18	a	a	DT
25944	1951	19	fist	fist	NN
25944	1951	20	.	.	.
25944	1952	1	#	#	LS
25944	1952	2	What	what	WP
25944	1952	3	is	be	VBZ
25944	1952	4	the	the	DT
25944	1952	5	cause	cause	NN
25944	1952	6	of	of	IN
25944	1952	7	warts	wart	NNS
25944	1952	8	?	?	.
25944	1952	9	#	#	$
25944	1952	10	The	the	DT
25944	1952	11	etiology	etiology	NN
25944	1952	12	is	be	VBZ
25944	1952	13	not	not	RB
25944	1952	14	known	know	VBN
25944	1952	15	.	.	.
25944	1953	1	They	-PRON-	PRP
25944	1953	2	are	be	VBP
25944	1953	3	more	more	RBR
25944	1953	4	common	common	JJ
25944	1953	5	in	in	IN
25944	1953	6	adolescent	adolescent	JJ
25944	1953	7	and	and	CC
25944	1953	8	early	early	JJ
25944	1953	9	adult	adult	NN
25944	1953	10	life	life	NN
25944	1953	11	.	.	.
25944	1954	1	Irritating	irritate	VBG
25944	1954	2	secretions	secretion	NNS
25944	1954	3	are	be	VBP
25944	1954	4	thought	think	VBN
25944	1954	5	to	to	TO
25944	1954	6	be	be	VB
25944	1954	7	causative	causative	JJ
25944	1954	8	in	in	IN
25944	1954	9	the	the	DT
25944	1954	10	acuminated	acuminate	VBN
25944	1954	11	variety	variety	NN
25944	1954	12	.	.	.
25944	1955	1	It	-PRON-	PRP
25944	1955	2	is	be	VBZ
25944	1955	3	highly	highly	RB
25944	1955	4	probable	probable	JJ
25944	1955	5	that	that	IN
25944	1955	6	a	a	DT
25944	1955	7	parasitic	parasitic	JJ
25944	1955	8	factor	factor	NN
25944	1955	9	will	will	MD
25944	1955	10	finally	finally	RB
25944	1955	11	be	be	VB
25944	1955	12	demonstrated	demonstrate	VBN
25944	1955	13	.	.	.
25944	1956	1	They	-PRON-	PRP
25944	1956	2	are	be	VBP
25944	1956	3	doubtless	doubtless	RB
25944	1956	4	mildly	mildly	RB
25944	1956	5	contagious	contagious	JJ
25944	1956	6	.	.	.
25944	1957	1	[	[	-LRB-
25944	1957	2	Illustration	illustration	NN
25944	1957	3	:	:	:
25944	1957	4	Fig	Fig	NNP
25944	1957	5	.	.	.
25944	1958	1	33	33	CD
25944	1958	2	.	.	.
25944	1959	1	Verruca	Verruca	NNP
25944	1959	2	Acuminata	Acuminata	NNP
25944	1959	3	--	--	:
25944	1959	4	about	about	IN
25944	1959	5	the	the	DT
25944	1959	6	anus	anus	NN
25944	1959	7	.	.	.
25944	1960	1	(	(	-LRB-
25944	1960	2	_	_	NNP
25944	1960	3	After	after	IN
25944	1960	4	Ashton	Ashton	NNP
25944	1960	5	.	.	.
25944	1960	6	_	_	NNP
25944	1960	7	)	)	-RRB-
25944	1960	8	]	]	-RRB-
25944	1960	9	#	#	$
25944	1960	10	State	state	NN
25944	1960	11	the	the	DT
25944	1960	12	pathology	pathology	NN
25944	1960	13	of	of	IN
25944	1960	14	warts	wart	NNS
25944	1960	15	.	.	.
25944	1960	16	#	#	$
25944	1960	17	A	a	DT
25944	1960	18	wart	wart	NN
25944	1960	19	consists	consist	VBZ
25944	1960	20	of	of	IN
25944	1960	21	both	both	CC
25944	1960	22	epidermic	epidermic	JJ
25944	1960	23	and	and	CC
25944	1960	24	papillary	papillary	JJ
25944	1960	25	hypertrophy	hypertrophy	NN
25944	1960	26	,	,	,
25944	1960	27	the	the	DT
25944	1960	28	interior	interior	NN
25944	1960	29	of	of	IN
25944	1960	30	the	the	DT
25944	1960	31	growth	growth	NN
25944	1960	32	containing	contain	VBG
25944	1960	33	a	a	DT
25944	1960	34	vascular	vascular	JJ
25944	1960	35	loop	loop	NN
25944	1960	36	.	.	.
25944	1961	1	In	in	IN
25944	1961	2	the	the	DT
25944	1961	3	acuminated	acuminate	VBN
25944	1961	4	variety	variety	NN
25944	1961	5	there	there	EX
25944	1961	6	are	be	VBP
25944	1961	7	marked	mark	VBN
25944	1961	8	papillary	papillary	JJ
25944	1961	9	enlargement	enlargement	NN
25944	1961	10	,	,	,
25944	1961	11	excessive	excessive	JJ
25944	1961	12	development	development	NN
25944	1961	13	of	of	IN
25944	1961	14	the	the	DT
25944	1961	15	mucous	mucous	JJ
25944	1961	16	layer	layer	NN
25944	1961	17	,	,	,
25944	1961	18	and	and	CC
25944	1961	19	an	an	DT
25944	1961	20	abundant	abundant	JJ
25944	1961	21	vascular	vascular	JJ
25944	1961	22	supply	supply	NN
25944	1961	23	.	.	.
25944	1962	1	#	#	NN
25944	1962	2	Give	give	VB
25944	1962	3	the	the	DT
25944	1962	4	treatment	treatment	NN
25944	1962	5	of	of	IN
25944	1962	6	warts	wart	NNS
25944	1962	7	.	.	.
25944	1962	8	#	#	$
25944	1962	9	For	for	IN
25944	1962	10	ordinary	ordinary	JJ
25944	1962	11	warts	wart	NNS
25944	1962	12	,	,	,
25944	1962	13	excision	excision	NN
25944	1962	14	or	or	CC
25944	1962	15	destruction	destruction	NN
25944	1962	16	by	by	IN
25944	1962	17	caustics	caustic	NNS
25944	1962	18	.	.	.
25944	1963	1	The	the	DT
25944	1963	2	repeated	repeat	VBN
25944	1963	3	application	application	NN
25944	1963	4	of	of	IN
25944	1963	5	a	a	DT
25944	1963	6	saturated	saturate	VBN
25944	1963	7	alcoholic	alcoholic	JJ
25944	1963	8	solution	solution	NN
25944	1963	9	of	of	IN
25944	1963	10	salicylic	salicylic	JJ
25944	1963	11	acid	acid	NN
25944	1963	12	is	be	VBZ
25944	1963	13	often	often	RB
25944	1963	14	curative	curative	JJ
25944	1963	15	,	,	,
25944	1963	16	the	the	DT
25944	1963	17	upper	upper	JJ
25944	1963	18	portion	portion	NN
25944	1963	19	being	be	VBG
25944	1963	20	pared	pare	VBN
25944	1963	21	off	off	RP
25944	1963	22	from	from	IN
25944	1963	23	time	time	NN
25944	1963	24	to	to	IN
25944	1963	25	time	time	NN
25944	1963	26	.	.	.
25944	1964	1	The	the	DT
25944	1964	2	filiform	filiform	NN
25944	1964	3	and	and	CC
25944	1964	4	digitate	digitate	JJ
25944	1964	5	varieties	variety	NNS
25944	1964	6	may	may	MD
25944	1964	7	be	be	VB
25944	1964	8	snipped	snip	VBN
25944	1964	9	off	off	RP
25944	1964	10	with	with	IN
25944	1964	11	the	the	DT
25944	1964	12	scissors	scissor	NNS
25944	1964	13	,	,	,
25944	1964	14	and	and	CC
25944	1964	15	the	the	DT
25944	1964	16	base	base	NN
25944	1964	17	touched	touch	VBD
25944	1964	18	with	with	IN
25944	1964	19	nitrate	nitrate	NN
25944	1964	20	of	of	IN
25944	1964	21	silver	silver	NN
25944	1964	22	;	;	:
25944	1964	23	or	or	CC
25944	1964	24	a	a	DT
25944	1964	25	ligature	ligature	NN
25944	1964	26	may	may	MD
25944	1964	27	be	be	VB
25944	1964	28	used	use	VBN
25944	1964	29	.	.	.
25944	1965	1	Curetting	curetting	NN
25944	1965	2	is	be	VBZ
25944	1965	3	a	a	DT
25944	1965	4	valuable	valuable	JJ
25944	1965	5	operative	operative	JJ
25944	1965	6	method	method	NN
25944	1965	7	.	.	.
25944	1966	1	The	the	DT
25944	1966	2	growths	growth	NNS
25944	1966	3	may	may	MD
25944	1966	4	also	also	RB
25944	1966	5	be	be	VB
25944	1966	6	removed	remove	VBN
25944	1966	7	by	by	IN
25944	1966	8	electrolysis	electrolysis	NN
25944	1966	9	.	.	.
25944	1967	1	When	when	WRB
25944	1967	2	warts	wart	NNS
25944	1967	3	are	be	VBP
25944	1967	4	numerous	numerous	JJ
25944	1967	5	and	and	CC
25944	1967	6	close	close	JJ
25944	1967	7	together	together	RB
25944	1967	8	parasiticide	parasiticide	NN
25944	1967	9	applications	application	NNS
25944	1967	10	can	can	MD
25944	1967	11	be	be	VB
25944	1967	12	daily	daily	RB
25944	1967	13	made	make	VBN
25944	1967	14	to	to	IN
25944	1967	15	the	the	DT
25944	1967	16	whole	whole	JJ
25944	1967	17	affected	affected	JJ
25944	1967	18	region	region	NN
25944	1967	19	.	.	.
25944	1968	1	For	for	IN
25944	1968	2	this	this	DT
25944	1968	3	purpose	purpose	NN
25944	1968	4	a	a	DT
25944	1968	5	boric	boric	NN
25944	1968	6	acid	acid	NN
25944	1968	7	solution	solution	NN
25944	1968	8	,	,	,
25944	1968	9	containing	contain	VBG
25944	1968	10	five	five	CD
25944	1968	11	to	to	TO
25944	1968	12	thirty	thirty	CD
25944	1968	13	grains	grain	NNS
25944	1968	14	of	of	IN
25944	1968	15	resorcin	resorcin	NNS
25944	1968	16	to	to	IN
25944	1968	17	the	the	DT
25944	1968	18	ounce	ounce	NN
25944	1968	19	,	,	,
25944	1968	20	and	and	CC
25944	1968	21	Vleminckx	Vleminckx	NNP
25944	1968	22	's	's	POS
25944	1968	23	solution	solution	NN
25944	1968	24	,	,	,
25944	1968	25	at	at	IN
25944	1968	26	first	first	RB
25944	1968	27	diluted	dilute	VBN
25944	1968	28	,	,	,
25944	1968	29	prove	prove	VB
25944	1968	30	the	the	DT
25944	1968	31	most	most	RBS
25944	1968	32	valuable	valuable	JJ
25944	1968	33	.	.	.
25944	1969	1	Verruca	Verruca	NNP
25944	1969	2	acuminata	acuminata	NN
25944	1969	3	is	be	VBZ
25944	1969	4	to	to	TO
25944	1969	5	be	be	VB
25944	1969	6	treated	treat	VBN
25944	1969	7	by	by	IN
25944	1969	8	maintaining	maintain	VBG
25944	1969	9	absolute	absolute	JJ
25944	1969	10	cleanliness	cleanliness	NN
25944	1969	11	,	,	,
25944	1969	12	and	and	CC
25944	1969	13	the	the	DT
25944	1969	14	application	application	NN
25944	1969	15	of	of	IN
25944	1969	16	such	such	JJ
25944	1969	17	astringents	astringent	NNS
25944	1969	18	as	as	IN
25944	1969	19	liquor	liquor	NN
25944	1969	20	plumbi	plumbi	NNP
25944	1969	21	subacetatis	subacetatis	NNP
25944	1969	22	,	,	,
25944	1969	23	tincture	tincture	NN
25944	1969	24	of	of	IN
25944	1969	25	iron	iron	NN
25944	1969	26	,	,	,
25944	1969	27	powdered	powdered	JJ
25944	1969	28	alum	alum	NN
25944	1969	29	and	and	CC
25944	1969	30	boric	boric	NN
25944	1969	31	acid	acid	NN
25944	1969	32	.	.	.
25944	1970	1	The	the	DT
25944	1970	2	salicylic	salicylic	JJ
25944	1970	3	acid	acid	NN
25944	1970	4	solution	solution	NN
25944	1970	5	may	may	MD
25944	1970	6	also	also	RB
25944	1970	7	be	be	VB
25944	1970	8	used	use	VBN
25944	1970	9	.	.	.
25944	1971	1	In	in	IN
25944	1971	2	obstinate	obstinate	NN
25944	1971	3	cases	case	NNS
25944	1971	4	,	,	,
25944	1971	5	glacial	glacial	JJ
25944	1971	6	acetic	acetic	JJ
25944	1971	7	acid	acid	NN
25944	1971	8	or	or	CC
25944	1971	9	chromic	chromic	NN
25944	1971	10	acid	acid	NN
25944	1971	11	may	may	MD
25944	1971	12	be	be	VB
25944	1971	13	cautiously	cautiously	RB
25944	1971	14	employed	employ	VBN
25944	1971	15	.	.	.
25944	1972	1	#	#	NNP
25944	1972	2	Nævus	Nævus	NNP
25944	1972	3	Pigmentosus	Pigmentosus	NNP
25944	1972	4	.	.	.
25944	1972	5	#	#	NNP
25944	1972	6	(	(	-LRB-
25944	1972	7	_	_	NNP
25944	1972	8	Synonym	Synonym	NNP
25944	1972	9	:	:	:
25944	1972	10	_	_	NNP
25944	1972	11	Mole	Mole	NNP
25944	1972	12	.	.	.
25944	1972	13	)	)	-RRB-
25944	1973	1	#	#	NNP
25944	1973	2	Describe	describe	VB
25944	1973	3	nævus	nævu	VBN
25944	1973	4	pigmentosus	pigmentosus	NN
25944	1973	5	.	.	.
25944	1973	6	#	#	$
25944	1973	7	Nævus	Nævus	NNP
25944	1973	8	pigmentosus	pigmentosus	NN
25944	1973	9	,	,	,
25944	1973	10	commonly	commonly	RB
25944	1973	11	known	know	VBN
25944	1973	12	as	as	IN
25944	1973	13	mole	mole	NNP
25944	1973	14	,	,	,
25944	1973	15	may	may	MD
25944	1973	16	be	be	VB
25944	1973	17	defined	define	VBN
25944	1973	18	as	as	IN
25944	1973	19	a	a	DT
25944	1973	20	circumscribed	circumscribe	VBN
25944	1973	21	increase	increase	NN
25944	1973	22	in	in	IN
25944	1973	23	the	the	DT
25944	1973	24	pigment	pigment	NN
25944	1973	25	of	of	IN
25944	1973	26	the	the	DT
25944	1973	27	skin	skin	NN
25944	1973	28	,	,	,
25944	1973	29	usually	usually	RB
25944	1973	30	associated	associate	VBN
25944	1973	31	with	with	IN
25944	1973	32	hypertrophy	hypertrophy	NN
25944	1973	33	of	of	IN
25944	1973	34	one	one	CD
25944	1973	35	or	or	CC
25944	1973	36	all	all	DT
25944	1973	37	of	of	IN
25944	1973	38	the	the	DT
25944	1973	39	cutaneous	cutaneous	JJ
25944	1973	40	structures	structure	NNS
25944	1973	41	,	,	,
25944	1973	42	especially	especially	RB
25944	1973	43	of	of	IN
25944	1973	44	the	the	DT
25944	1973	45	connective	connective	JJ
25944	1973	46	tissue	tissue	NN
25944	1973	47	and	and	CC
25944	1973	48	hair	hair	NN
25944	1973	49	.	.	.
25944	1974	1	It	-PRON-	PRP
25944	1974	2	occurs	occur	VBZ
25944	1974	3	singly	singly	RB
25944	1974	4	or	or	CC
25944	1974	5	in	in	IN
25944	1974	6	numbers	number	NNS
25944	1974	7	;	;	:
25944	1974	8	is	be	VBZ
25944	1974	9	usually	usually	RB
25944	1974	10	pea-	pea-	NNS
25944	1974	11	,	,	,
25944	1974	12	bean	bean	NN
25944	1974	13	-	-	HYPH
25944	1974	14	sized	sized	JJ
25944	1974	15	or	or	CC
25944	1974	16	larger	large	JJR
25944	1974	17	,	,	,
25944	1974	18	rounded	rounded	JJ
25944	1974	19	or	or	CC
25944	1974	20	irregular	irregular	JJ
25944	1974	21	,	,	,
25944	1974	22	smooth	smooth	JJ
25944	1974	23	or	or	CC
25944	1974	24	rough	rough	JJ
25944	1974	25	,	,	,
25944	1974	26	flat	flat	JJ
25944	1974	27	or	or	CC
25944	1974	28	elevated	elevated	JJ
25944	1974	29	,	,	,
25944	1974	30	and	and	CC
25944	1974	31	of	of	IN
25944	1974	32	a	a	DT
25944	1974	33	color	color	NN
25944	1974	34	varying	varying	NN
25944	1974	35	from	from	IN
25944	1974	36	a	a	DT
25944	1974	37	light	light	JJ
25944	1974	38	brown	brown	JJ
25944	1974	39	to	to	IN
25944	1974	40	black	black	NN
25944	1974	41	;	;	:
25944	1974	42	the	the	DT
25944	1974	43	hair	hair	NN
25944	1974	44	found	find	VBD
25944	1974	45	thereon	thereon	NN
25944	1974	46	may	may	MD
25944	1974	47	be	be	VB
25944	1974	48	either	either	CC
25944	1974	49	colorless	colorless	JJ
25944	1974	50	or	or	CC
25944	1974	51	deeply	deeply	RB
25944	1974	52	pigmented	pigment	VBN
25944	1974	53	,	,	,
25944	1974	54	coarse	coarse	JJ
25944	1974	55	and	and	CC
25944	1974	56	of	of	IN
25944	1974	57	considerable	considerable	JJ
25944	1974	58	length	length	NN
25944	1974	59	.	.	.
25944	1975	1	It	-PRON-	PRP
25944	1975	2	is	be	VBZ
25944	1975	3	,	,	,
25944	1975	4	as	as	IN
25944	1975	5	a	a	DT
25944	1975	6	rule	rule	NN
25944	1975	7	,	,	,
25944	1975	8	a	a	DT
25944	1975	9	permanent	permanent	JJ
25944	1975	10	formation	formation	NN
25944	1975	11	.	.	.
25944	1976	1	#	#	$
25944	1976	2	Name	name	VB
25944	1976	3	the	the	DT
25944	1976	4	several	several	JJ
25944	1976	5	varieties	variety	NNS
25944	1976	6	of	of	IN
25944	1976	7	nævus	nævus	NNP
25944	1976	8	pigmentosus	pigmentosus	NN
25944	1976	9	met	meet	VBD
25944	1976	10	with	with	IN
25944	1976	11	.	.	.
25944	1976	12	#	#	$
25944	1976	13	Nævus	Nævus	NNP
25944	1976	14	spilus	spilus	JJ
25944	1976	15	,	,	,
25944	1976	16	nævus	nævus	NNP
25944	1976	17	pilosus	pilosus	NNP
25944	1976	18	,	,	,
25944	1976	19	nævus	nævus	NNP
25944	1976	20	verrucosus	verrucosus	NNP
25944	1976	21	,	,	,
25944	1976	22	and	and	CC
25944	1976	23	nævus	nævus	NNP
25944	1976	24	lipomatodes	lipomatode	NNS
25944	1976	25	.	.	.
25944	1977	1	So	so	RB
25944	1977	2	-	-	HYPH
25944	1977	3	called	call	VBN
25944	1977	4	linear	linear	NN
25944	1977	5	nævus	nævu	NNS
25944	1977	6	might	may	MD
25944	1977	7	also	also	RB
25944	1977	8	be	be	VB
25944	1977	9	considered	consider	VBN
25944	1977	10	as	as	IN
25944	1977	11	belonging	belong	VBG
25944	1977	12	in	in	IN
25944	1977	13	this	this	DT
25944	1977	14	group	group	NN
25944	1977	15	.	.	.
25944	1978	1	#	#	LS
25944	1978	2	What	what	WP
25944	1978	3	is	be	VBZ
25944	1978	4	nævus	nævu	VBN
25944	1978	5	spilus	spilus	JJ
25944	1978	6	?	?	.
25944	1978	7	#	#	$
25944	1978	8	A	a	DT
25944	1978	9	smooth	smooth	JJ
25944	1978	10	and	and	CC
25944	1978	11	flat	flat	JJ
25944	1978	12	nævus	nævu	NNS
25944	1978	13	,	,	,
25944	1978	14	consisting	consist	VBG
25944	1978	15	essentially	essentially	RB
25944	1978	16	of	of	IN
25944	1978	17	augmented	augment	VBN
25944	1978	18	pigmentation	pigmentation	NN
25944	1978	19	alone	alone	RB
25944	1978	20	.	.	.
25944	1979	1	[	[	-LRB-
25944	1979	2	Illustration	illustration	NN
25944	1979	3	:	:	:
25944	1979	4	Fig	Fig	NNP
25944	1979	5	.	.	.
25944	1980	1	34	34	CD
25944	1980	2	.	.	.
25944	1981	1	Linear	Linear	NNP
25944	1981	2	Nævus	Nævus	NNP
25944	1981	3	.	.	.
25944	1981	4	]	]	-RRB-
25944	1982	1	#	#	LS
25944	1982	2	What	what	WP
25944	1982	3	is	be	VBZ
25944	1982	4	nævus	nævu	VBN
25944	1982	5	pilosus	pilosus	JJ
25944	1982	6	?	?	.
25944	1982	7	#	#	$
25944	1982	8	A	a	DT
25944	1982	9	nævus	nævus	NN
25944	1982	10	upon	upon	IN
25944	1982	11	which	which	WDT
25944	1982	12	there	there	EX
25944	1982	13	is	be	VBZ
25944	1982	14	an	an	DT
25944	1982	15	abnormal	abnormal	JJ
25944	1982	16	growth	growth	NN
25944	1982	17	of	of	IN
25944	1982	18	hair	hair	NN
25944	1982	19	,	,	,
25944	1982	20	slight	slight	JJ
25944	1982	21	or	or	CC
25944	1982	22	excessive	excessive	JJ
25944	1982	23	.	.	.
25944	1983	1	#	#	LS
25944	1983	2	What	what	WP
25944	1983	3	is	be	VBZ
25944	1983	4	nævus	nævu	VBN
25944	1983	5	verrucosus	verrucosus	JJ
25944	1983	6	?	?	.
25944	1983	7	#	#	$
25944	1983	8	A	a	DT
25944	1983	9	nævus	nævus	NN
25944	1983	10	to	to	TO
25944	1983	11	which	which	WDT
25944	1983	12	is	be	VBZ
25944	1983	13	added	add	VBN
25944	1983	14	hypertrophy	hypertrophy	NN
25944	1983	15	of	of	IN
25944	1983	16	the	the	DT
25944	1983	17	papillæ	papillæ	NN
25944	1983	18	,	,	,
25944	1983	19	giving	give	VBG
25944	1983	20	rise	rise	NN
25944	1983	21	to	to	IN
25944	1983	22	a	a	DT
25944	1983	23	furrowed	furrowed	JJ
25944	1983	24	and	and	CC
25944	1983	25	uneven	uneven	JJ
25944	1983	26	surface	surface	NN
25944	1983	27	.	.	.
25944	1984	1	#	#	LS
25944	1984	2	What	what	WP
25944	1984	3	is	be	VBZ
25944	1984	4	linear	linear	JJ
25944	1984	5	nævus	nævus	IN
25944	1984	6	?	?	.
25944	1984	7	#	#	$
25944	1984	8	Linear	Linear	NNP
25944	1984	9	nævus	nævus	RB
25944	1984	10	is	be	VBZ
25944	1984	11	a	a	DT
25944	1984	12	formation	formation	NN
25944	1984	13	usually	usually	RB
25944	1984	14	of	of	IN
25944	1984	15	a	a	DT
25944	1984	16	verrucous	verrucous	JJ
25944	1984	17	character	character	NN
25944	1984	18	,	,	,
25944	1984	19	more	more	RBR
25944	1984	20	or	or	CC
25944	1984	21	less	less	RBR
25944	1984	22	pigmented	pigment	VBN
25944	1984	23	,	,	,
25944	1984	24	sometimes	sometimes	RB
25944	1984	25	slightly	slightly	RB
25944	1984	26	scaly	scaly	JJ
25944	1984	27	,	,	,
25944	1984	28	occurring	occur	VBG
25944	1984	29	in	in	IN
25944	1984	30	band	band	NN
25944	1984	31	-	-	HYPH
25944	1984	32	like	like	JJ
25944	1984	33	or	or	CC
25944	1984	34	zoster	zost	JJR
25944	1984	35	-	-	HYPH
25944	1984	36	like	like	JJ
25944	1984	37	areas	area	NNS
25944	1984	38	,	,	,
25944	1984	39	and	and	CC
25944	1984	40	,	,	,
25944	1984	41	as	as	IN
25944	1984	42	a	a	DT
25944	1984	43	rule	rule	NN
25944	1984	44	,	,	,
25944	1984	45	unilaterally	unilaterally	RB
25944	1984	46	.	.	.
25944	1985	1	#	#	LS
25944	1985	2	What	what	WP
25944	1985	3	is	be	VBZ
25944	1985	4	nævus	nævu	VBN
25944	1985	5	lipomatodes	lipomatode	NNS
25944	1985	6	?	?	.
25944	1985	7	#	#	$
25944	1985	8	A	a	DT
25944	1985	9	nævus	nævus	NN
25944	1985	10	with	with	IN
25944	1985	11	excessive	excessive	JJ
25944	1985	12	fat	fat	NN
25944	1985	13	and	and	CC
25944	1985	14	connective	connective	JJ
25944	1985	15	-	-	HYPH
25944	1985	16	tissue	tissue	NN
25944	1985	17	hypertrophy	hypertrophy	NN
25944	1985	18	.	.	.
25944	1986	1	#	#	NNP
25944	1986	2	State	state	NN
25944	1986	3	the	the	DT
25944	1986	4	etiology	etiology	NN
25944	1986	5	of	of	IN
25944	1986	6	nævus	nævus	NNP
25944	1986	7	pigmentosus	pigmentosus	NN
25944	1986	8	.	.	.
25944	1986	9	#	#	$
25944	1986	10	The	the	DT
25944	1986	11	causes	cause	NNS
25944	1986	12	are	be	VBP
25944	1986	13	obscure	obscure	JJ
25944	1986	14	.	.	.
25944	1987	1	The	the	DT
25944	1987	2	growths	growth	NNS
25944	1987	3	are	be	VBP
25944	1987	4	usually	usually	RB
25944	1987	5	congenital	congenital	JJ
25944	1987	6	;	;	:
25944	1987	7	but	but	CC
25944	1987	8	the	the	DT
25944	1987	9	smooth	smooth	JJ
25944	1987	10	,	,	,
25944	1987	11	non	non	JJ
25944	1987	12	-	-	JJ
25944	1987	13	hairy	hairy	JJ
25944	1987	14	moles	mole	NNS
25944	1987	15	may	may	MD
25944	1987	16	be	be	VB
25944	1987	17	acquired	acquire	VBN
25944	1987	18	.	.	.
25944	1988	1	#	#	NN
25944	1988	2	Give	give	VBP
25944	1988	3	the	the	DT
25944	1988	4	pathology	pathology	NN
25944	1988	5	of	of	IN
25944	1988	6	nævus	nævus	JJ
25944	1988	7	pigmentosus	pigmentosus	NN
25944	1988	8	.	.	.
25944	1988	9	#	#	$
25944	1988	10	Microscopical	microscopical	JJ
25944	1988	11	examination	examination	NN
25944	1988	12	shows	show	VBZ
25944	1988	13	a	a	DT
25944	1988	14	marked	marked	JJ
25944	1988	15	increase	increase	NN
25944	1988	16	in	in	IN
25944	1988	17	the	the	DT
25944	1988	18	pigment	pigment	NN
25944	1988	19	in	in	IN
25944	1988	20	the	the	DT
25944	1988	21	lowest	low	JJS
25944	1988	22	layers	layer	NNS
25944	1988	23	of	of	IN
25944	1988	24	the	the	DT
25944	1988	25	rete	rete	NN
25944	1988	26	mucosum	mucosum	NN
25944	1988	27	,	,	,
25944	1988	28	as	as	RB
25944	1988	29	well	well	RB
25944	1988	30	as	as	IN
25944	1988	31	more	more	RBR
25944	1988	32	or	or	CC
25944	1988	33	less	less	JJR
25944	1988	34	pigmentation	pigmentation	NN
25944	1988	35	in	in	IN
25944	1988	36	the	the	DT
25944	1988	37	corium	corium	NN
25944	1988	38	usually	usually	RB
25944	1988	39	following	follow	VBG
25944	1988	40	the	the	DT
25944	1988	41	course	course	NN
25944	1988	42	of	of	IN
25944	1988	43	the	the	DT
25944	1988	44	bloodvessels	bloodvessel	NNS
25944	1988	45	;	;	:
25944	1988	46	in	in	IN
25944	1988	47	the	the	DT
25944	1988	48	verrucous	verrucous	JJ
25944	1988	49	variety	variety	NN
25944	1988	50	the	the	DT
25944	1988	51	papillæ	papillæ	NN
25944	1988	52	are	be	VBP
25944	1988	53	greatly	greatly	RB
25944	1988	54	hypertrophied	hypertrophied	JJ
25944	1988	55	,	,	,
25944	1988	56	in	in	IN
25944	1988	57	addition	addition	NN
25944	1988	58	to	to	IN
25944	1988	59	the	the	DT
25944	1988	60	increased	increase	VBN
25944	1988	61	pigmentation	pigmentation	NN
25944	1988	62	.	.	.
25944	1989	1	There	there	EX
25944	1989	2	is	be	VBZ
25944	1989	3	,	,	,
25944	1989	4	as	as	IN
25944	1989	5	a	a	DT
25944	1989	6	rule	rule	NN
25944	1989	7	,	,	,
25944	1989	8	more	more	RBR
25944	1989	9	or	or	CC
25944	1989	10	less	less	RBR
25944	1989	11	connective	connective	JJ
25944	1989	12	-	-	HYPH
25944	1989	13	tissue	tissue	NN
25944	1989	14	hypertrophy	hypertrophy	NN
25944	1989	15	.	.	.
25944	1990	1	#	#	LS
25944	1990	2	What	what	WP
25944	1990	3	is	be	VBZ
25944	1990	4	the	the	DT
25944	1990	5	treatment	treatment	NN
25944	1990	6	of	of	IN
25944	1990	7	nævus	nævus	NNP
25944	1990	8	pigmentosus	pigmentosus	NN
25944	1990	9	?	?	.
25944	1990	10	#	#	$
25944	1990	11	In	in	IN
25944	1990	12	many	many	JJ
25944	1990	13	instances	instance	NNS
25944	1990	14	interference	interference	NN
25944	1990	15	is	be	VBZ
25944	1990	16	scarcely	scarcely	RB
25944	1990	17	called	call	VBN
25944	1990	18	for	for	IN
25944	1990	19	,	,	,
25944	1990	20	but	but	CC
25944	1990	21	when	when	WRB
25944	1990	22	demanded	demand	VBD
25944	1990	23	consists	consist	VBZ
25944	1990	24	in	in	IN
25944	1990	25	the	the	DT
25944	1990	26	removal	removal	NN
25944	1990	27	of	of	IN
25944	1990	28	the	the	DT
25944	1990	29	formation	formation	NN
25944	1990	30	either	either	CC
25944	1990	31	by	by	IN
25944	1990	32	the	the	DT
25944	1990	33	knife	knife	NN
25944	1990	34	,	,	,
25944	1990	35	by	by	IN
25944	1990	36	caustics	caustic	NNS
25944	1990	37	,	,	,
25944	1990	38	or	or	CC
25944	1990	39	by	by	IN
25944	1990	40	electrolysis	electrolysis	NN
25944	1990	41	.	.	.
25944	1991	1	This	this	DT
25944	1991	2	last	last	JJ
25944	1991	3	is	be	VBZ
25944	1991	4	,	,	,
25944	1991	5	in	in	IN
25944	1991	6	the	the	DT
25944	1991	7	milder	milder	NN
25944	1991	8	varieties	variety	NNS
25944	1991	9	at	at	IN
25944	1991	10	least	least	JJS
25944	1991	11	,	,	,
25944	1991	12	perhaps	perhaps	RB
25944	1991	13	the	the	DT
25944	1991	14	best	good	JJS
25944	1991	15	method	method	NN
25944	1991	16	,	,	,
25944	1991	17	as	as	IN
25944	1991	18	it	-PRON-	PRP
25944	1991	19	is	be	VBZ
25944	1991	20	less	less	RBR
25944	1991	21	likely	likely	JJ
25944	1991	22	to	to	TO
25944	1991	23	be	be	VB
25944	1991	24	followed	follow	VBN
25944	1991	25	by	by	IN
25944	1991	26	disfiguring	disfigure	VBG
25944	1991	27	cicatrices	cicatrix	NNS
25944	1991	28	.	.	.
25944	1992	1	In	in	IN
25944	1992	2	nævus	nævus	NNP
25944	1992	3	pilosus	pilosus	NNP
25944	1992	4	the	the	DT
25944	1992	5	removal	removal	NN
25944	1992	6	of	of	IN
25944	1992	7	the	the	DT
25944	1992	8	hairs	hair	NNS
25944	1992	9	alone	alone	RB
25944	1992	10	by	by	IN
25944	1992	11	electrolysis	electrolysis	NN
25944	1992	12	is	be	VBZ
25944	1992	13	not	not	RB
25944	1992	14	infrequently	infrequently	RB
25944	1992	15	followed	follow	VBN
25944	1992	16	by	by	IN
25944	1992	17	a	a	DT
25944	1992	18	decided	decide	VBN
25944	1992	19	diminution	diminution	NN
25944	1992	20	of	of	IN
25944	1992	21	the	the	DT
25944	1992	22	pigmentation	pigmentation	NN
25944	1992	23	.	.	.
25944	1993	1	In	in	IN
25944	1993	2	recent	recent	JJ
25944	1993	3	years	year	NNS
25944	1993	4	both	both	CC
25944	1993	5	liquid	liquid	JJ
25944	1993	6	air	air	NN
25944	1993	7	and	and	CC
25944	1993	8	carbon	carbon	NN
25944	1993	9	dioxide	dioxide	NN
25944	1993	10	have	have	VBP
25944	1993	11	also	also	RB
25944	1993	12	been	be	VBN
25944	1993	13	used	use	VBN
25944	1993	14	successfully	successfully	RB
25944	1993	15	in	in	IN
25944	1993	16	the	the	DT
25944	1993	17	removal	removal	NN
25944	1993	18	of	of	IN
25944	1993	19	these	these	DT
25944	1993	20	growths	growth	NNS
25944	1993	21	.	.	.
25944	1994	1	Pigmented	pigment	VBN
25944	1994	2	nævi	nævi	RB
25944	1994	3	,	,	,
25944	1994	4	which	which	WDT
25944	1994	5	show	show	VBP
25944	1994	6	the	the	DT
25944	1994	7	least	least	JJS
25944	1994	8	tendency	tendency	NN
25944	1994	9	to	to	TO
25944	1994	10	growth	growth	VB
25944	1994	11	or	or	CC
25944	1994	12	degenerative	degenerative	JJ
25944	1994	13	change	change	NN
25944	1994	14	,	,	,
25944	1994	15	should	should	MD
25944	1994	16	be	be	VB
25944	1994	17	radically	radically	RB
25944	1994	18	removed	remove	VBN
25944	1994	19	,	,	,
25944	1994	20	as	as	IN
25944	1994	21	they	-PRON-	PRP
25944	1994	22	not	not	RB
25944	1994	23	infrequently	infrequently	RB
25944	1994	24	lead	lead	VBP
25944	1994	25	to	to	IN
25944	1994	26	carcinomatous	carcinomatous	JJ
25944	1994	27	and	and	CC
25944	1994	28	sarcomatous	sarcomatous	JJ
25944	1994	29	growths	growth	NNS
25944	1994	30	.	.	.
25944	1995	1	#	#	NNP
25944	1995	2	Ichthyosis	Ichthyosis	NNP
25944	1995	3	.	.	.
25944	1995	4	#	#	NNP
25944	1995	5	(	(	-LRB-
25944	1995	6	_	_	NNP
25944	1995	7	Synonym	Synonym	NNP
25944	1995	8	:	:	:
25944	1995	9	_	_	NNP
25944	1995	10	Fish	fish	NN
25944	1995	11	-	-	HYPH
25944	1995	12	skin	skin	NN
25944	1995	13	Disease	Disease	NNP
25944	1995	14	.	.	.
25944	1995	15	)	)	-RRB-
25944	1996	1	#	#	NN
25944	1996	2	Give	give	VBP
25944	1996	3	a	a	DT
25944	1996	4	descriptive	descriptive	JJ
25944	1996	5	definition	definition	NN
25944	1996	6	of	of	IN
25944	1996	7	ichthyosis	ichthyosis	NN
25944	1996	8	.	.	.
25944	1996	9	#	#	NNP
25944	1996	10	Ichthyosis	Ichthyosis	NNP
25944	1996	11	is	be	VBZ
25944	1996	12	a	a	DT
25944	1996	13	chronic	chronic	JJ
25944	1996	14	,	,	,
25944	1996	15	hypertrophic	hypertrophic	JJ
25944	1996	16	disease	disease	NN
25944	1996	17	,	,	,
25944	1996	18	characterized	characterize	VBN
25944	1996	19	by	by	IN
25944	1996	20	dryness	dryness	NN
25944	1996	21	and	and	CC
25944	1996	22	scaliness	scaliness	NN
25944	1996	23	of	of	IN
25944	1996	24	the	the	DT
25944	1996	25	skin	skin	NN
25944	1996	26	,	,	,
25944	1996	27	with	with	IN
25944	1996	28	a	a	DT
25944	1996	29	variable	variable	JJ
25944	1996	30	amount	amount	NN
25944	1996	31	of	of	IN
25944	1996	32	papillary	papillary	JJ
25944	1996	33	growth	growth	NN
25944	1996	34	.	.	.
25944	1997	1	#	#	$
25944	1997	2	At	at	IN
25944	1997	3	what	what	WDT
25944	1997	4	age	age	NN
25944	1997	5	is	be	VBZ
25944	1997	6	ichthyosis	ichthyosis	NN
25944	1997	7	first	first	RB
25944	1997	8	observed	observe	VBN
25944	1997	9	?	?	.
25944	1997	10	#	#	$
25944	1997	11	It	-PRON-	PRP
25944	1997	12	is	be	VBZ
25944	1997	13	first	first	RB
25944	1997	14	noticed	notice	VBN
25944	1997	15	in	in	IN
25944	1997	16	infancy	infancy	NN
25944	1997	17	or	or	CC
25944	1997	18	early	early	JJ
25944	1997	19	childhood	childhood	NN
25944	1997	20	.	.	.
25944	1998	1	In	in	IN
25944	1998	2	rare	rare	JJ
25944	1998	3	instances	instance	NNS
25944	1998	4	it	-PRON-	PRP
25944	1998	5	is	be	VBZ
25944	1998	6	congenital	congenital	JJ
25944	1998	7	(	(	-LRB-
25944	1998	8	ichthyosis	ichthyosis	NNP
25944	1998	9	congenita	congenita	NNP
25944	1998	10	)	)	-RRB-
25944	1998	11	,	,	,
25944	1998	12	and	and	CC
25944	1998	13	in	in	IN
25944	1998	14	such	such	JJ
25944	1998	15	cases	case	NNS
25944	1998	16	it	-PRON-	PRP
25944	1998	17	is	be	VBZ
25944	1998	18	usually	usually	RB
25944	1998	19	severe	severe	JJ
25944	1998	20	,	,	,
25944	1998	21	and	and	CC
25944	1998	22	of	of	IN
25944	1998	23	a	a	DT
25944	1998	24	grave	grave	JJ
25944	1998	25	type	type	NN
25944	1998	26	;	;	:
25944	1998	27	the	the	DT
25944	1998	28	children	child	NNS
25944	1998	29	are	be	VBP
25944	1998	30	,	,	,
25944	1998	31	as	as	IN
25944	1998	32	a	a	DT
25944	1998	33	rule	rule	NN
25944	1998	34	,	,	,
25944	1998	35	prematurely	prematurely	RB
25944	1998	36	born	bear	VBN
25944	1998	37	,	,	,
25944	1998	38	and	and	CC
25944	1998	39	frequently	frequently	RB
25944	1998	40	do	do	VBP
25944	1998	41	not	not	RB
25944	1998	42	survive	survive	VB
25944	1998	43	many	many	JJ
25944	1998	44	days	day	NNS
25944	1998	45	or	or	CC
25944	1998	46	weeks	week	NNS
25944	1998	47	.	.	.
25944	1999	1	#	#	LS
25944	1999	2	What	what	WDT
25944	1999	3	extent	extent	NN
25944	1999	4	of	of	IN
25944	1999	5	surface	surface	NN
25944	1999	6	is	be	VBZ
25944	1999	7	involved	involve	VBN
25944	1999	8	?	?	.
25944	1999	9	#	#	NN
25944	1999	10	Usually	usually	RB
25944	1999	11	the	the	DT
25944	1999	12	whole	whole	JJ
25944	1999	13	surface	surface	NN
25944	1999	14	,	,	,
25944	1999	15	but	but	CC
25944	1999	16	it	-PRON-	PRP
25944	1999	17	is	be	VBZ
25944	1999	18	most	most	RBS
25944	1999	19	marked	mark	VBN
25944	1999	20	upon	upon	IN
25944	1999	21	the	the	DT
25944	1999	22	extensor	extensor	NN
25944	1999	23	surfaces	surface	NNS
25944	1999	24	of	of	IN
25944	1999	25	the	the	DT
25944	1999	26	arms	arm	NNS
25944	1999	27	and	and	CC
25944	1999	28	legs	leg	NNS
25944	1999	29	,	,	,
25944	1999	30	especially	especially	RB
25944	1999	31	at	at	IN
25944	1999	32	the	the	DT
25944	1999	33	elbows	elbow	NNS
25944	1999	34	and	and	CC
25944	1999	35	knees	knee	NNS
25944	1999	36	;	;	:
25944	1999	37	the	the	DT
25944	1999	38	face	face	NN
25944	1999	39	and	and	CC
25944	1999	40	scalp	scalp	NN
25944	1999	41	,	,	,
25944	1999	42	in	in	IN
25944	1999	43	mild	mild	JJ
25944	1999	44	cases	case	NNS
25944	1999	45	,	,	,
25944	1999	46	often	often	RB
25944	1999	47	remain	remain	VBP
25944	1999	48	free	free	JJ
25944	1999	49	.	.	.
25944	2000	1	#	#	NNP
25944	2000	2	Name	name	VB
25944	2000	3	the	the	DT
25944	2000	4	two	two	CD
25944	2000	5	varieties	variety	NNS
25944	2000	6	of	of	IN
25944	2000	7	ichthyosis	ichthyosis	NN
25944	2000	8	usually	usually	RB
25944	2000	9	described	describe	VBN
25944	2000	10	.	.	.
25944	2000	11	#	#	NNP
25944	2000	12	Ichthyosis	Ichthyosis	NNP
25944	2000	13	simplex	simplex	NN
25944	2000	14	and	and	CC
25944	2000	15	ichthyosis	ichthyosis	NN
25944	2000	16	hystrix	hystrix	NNP
25944	2000	17	,	,	,
25944	2000	18	terms	term	NNS
25944	2000	19	commonly	commonly	RB
25944	2000	20	employed	employ	VBN
25944	2000	21	to	to	TO
25944	2000	22	designate	designate	VB
25944	2000	23	the	the	DT
25944	2000	24	mild	mild	JJ
25944	2000	25	and	and	CC
25944	2000	26	severe	severe	JJ
25944	2000	27	forms	form	NNS
25944	2000	28	respectively	respectively	RB
25944	2000	29	.	.	.
25944	2001	1	#	#	NNP
25944	2001	2	Describe	describe	VB
25944	2001	3	the	the	DT
25944	2001	4	clinical	clinical	JJ
25944	2001	5	appearances	appearance	NNS
25944	2001	6	of	of	IN
25944	2001	7	ichthyosis	ichthyosis	NN
25944	2001	8	.	.	.
25944	2001	9	#	#	$
25944	2001	10	The	the	DT
25944	2001	11	milder	milder	NN
25944	2001	12	forms	form	NNS
25944	2001	13	of	of	IN
25944	2001	14	the	the	DT
25944	2001	15	disease	disease	NN
25944	2001	16	may	may	MD
25944	2001	17	be	be	VB
25944	2001	18	so	so	RB
25944	2001	19	slight	slight	JJ
25944	2001	20	as	as	IN
25944	2001	21	to	to	TO
25944	2001	22	give	give	VB
25944	2001	23	rise	rise	NN
25944	2001	24	to	to	IN
25944	2001	25	simple	simple	JJ
25944	2001	26	dryness	dryness	NN
25944	2001	27	or	or	CC
25944	2001	28	harshness	harshness	NN
25944	2001	29	of	of	IN
25944	2001	30	the	the	DT
25944	2001	31	skin	skin	NN
25944	2001	32	(	(	-LRB-
25944	2001	33	_	_	NNP
25944	2001	34	xeroderma	xeroderma	NNP
25944	2001	35	_	_	NNP
25944	2001	36	)	)	-RRB-
25944	2001	37	;	;	:
25944	2001	38	but	but	CC
25944	2001	39	as	as	IN
25944	2001	40	commonly	commonly	RB
25944	2001	41	met	meet	VBN
25944	2001	42	with	with	IN
25944	2001	43	it	-PRON-	PRP
25944	2001	44	is	be	VBZ
25944	2001	45	more	more	RBR
25944	2001	46	developed	developed	JJ
25944	2001	47	,	,	,
25944	2001	48	more	more	RBR
25944	2001	49	or	or	CC
25944	2001	50	less	less	RBR
25944	2001	51	marked	marked	JJ
25944	2001	52	scaliness	scaliness	NN
25944	2001	53	in	in	IN
25944	2001	54	the	the	DT
25944	2001	55	form	form	NN
25944	2001	56	of	of	IN
25944	2001	57	thin	thin	JJ
25944	2001	58	or	or	CC
25944	2001	59	somewhat	somewhat	RB
25944	2001	60	thick	thick	JJ
25944	2001	61	epidermal	epidermal	JJ
25944	2001	62	plates	plate	NNS
25944	2001	63	being	be	VBG
25944	2001	64	present	present	JJ
25944	2001	65	.	.	.
25944	2002	1	The	the	DT
25944	2002	2	papillæ	papillæ	NN
25944	2002	3	of	of	IN
25944	2002	4	the	the	DT
25944	2002	5	skin	skin	NN
25944	2002	6	are	be	VBP
25944	2002	7	often	often	RB
25944	2002	8	slightly	slightly	RB
25944	2002	9	hypertrophied	hypertrophy	VBN
25944	2002	10	.	.	.
25944	2003	1	In	in	IN
25944	2003	2	slight	slight	JJ
25944	2003	3	cases	case	NNS
25944	2003	4	the	the	DT
25944	2003	5	color	color	NN
25944	2003	6	of	of	IN
25944	2003	7	the	the	DT
25944	2003	8	scales	scale	NNS
25944	2003	9	is	be	VBZ
25944	2003	10	usually	usually	RB
25944	2003	11	light	light	JJ
25944	2003	12	and	and	CC
25944	2003	13	pearly	pearly	RB
25944	2003	14	;	;	:
25944	2003	15	in	in	IN
25944	2003	16	the	the	DT
25944	2003	17	more	more	RBR
25944	2003	18	marked	marked	JJ
25944	2003	19	examples	example	NNS
25944	2003	20	it	-PRON-	PRP
25944	2003	21	is	be	VBZ
25944	2003	22	dark	dark	JJ
25944	2003	23	gray	gray	JJ
25944	2003	24	,	,	,
25944	2003	25	olive	olive	JJ
25944	2003	26	green	green	JJ
25944	2003	27	or	or	CC
25944	2003	28	black	black	JJ
25944	2003	29	.	.	.
25944	2004	1	In	in	IN
25944	2004	2	the	the	DT
25944	2004	3	severe	severe	JJ
25944	2004	4	variety	variety	NN
25944	2004	5	--	--	:
25944	2004	6	ichthyosis	ichthyosis	NN
25944	2004	7	hystrix	hystrix	NN
25944	2004	8	--	--	:
25944	2004	9	in	in	IN
25944	2004	10	addition	addition	NN
25944	2004	11	to	to	TO
25944	2004	12	scaliness	scaliness	VB
25944	2004	13	there	there	EX
25944	2004	14	is	be	VBZ
25944	2004	15	marked	mark	VBN
25944	2004	16	papillary	papillary	JJ
25944	2004	17	hypertrophy	hypertrophy	NN
25944	2004	18	,	,	,
25944	2004	19	forming	form	VBG
25944	2004	20	warty	warty	CD
25944	2004	21	or	or	CC
25944	2004	22	spinous	spinous	JJ
25944	2004	23	patches	patch	NNS
25944	2004	24	.	.	.
25944	2005	1	This	this	DT
25944	2005	2	type	type	NN
25944	2005	3	is	be	VBZ
25944	2005	4	rare	rare	JJ
25944	2005	5	,	,	,
25944	2005	6	and	and	CC
25944	2005	7	,	,	,
25944	2005	8	as	as	IN
25944	2005	9	a	a	DT
25944	2005	10	rule	rule	NN
25944	2005	11	,	,	,
25944	2005	12	the	the	DT
25944	2005	13	surface	surface	NN
25944	2005	14	involved	involve	VBN
25944	2005	15	is	be	VBZ
25944	2005	16	more	more	RBR
25944	2005	17	or	or	CC
25944	2005	18	less	less	RBR
25944	2005	19	limited	limited	JJ
25944	2005	20	.	.	.
25944	2006	1	#	#	NN
25944	2006	2	Are	be	VBP
25944	2006	3	there	there	EX
25944	2006	4	any	any	DT
25944	2006	5	inflammatory	inflammatory	JJ
25944	2006	6	symptoms	symptom	NNS
25944	2006	7	in	in	IN
25944	2006	8	ichthyosis	ichthyosis	NN
25944	2006	9	?	?	.
25944	2006	10	#	#	$
25944	2006	11	No	no	UH
25944	2006	12	.	.	.
25944	2007	1	In	in	IN
25944	2007	2	fact	fact	NN
25944	2007	3	,	,	,
25944	2007	4	beyond	beyond	IN
25944	2007	5	the	the	DT
25944	2007	6	disfigurement	disfigurement	NN
25944	2007	7	,	,	,
25944	2007	8	the	the	DT
25944	2007	9	disease	disease	NN
25944	2007	10	causes	cause	VBZ
25944	2007	11	no	no	DT
25944	2007	12	inconvenience	inconvenience	NN
25944	2007	13	;	;	:
25944	2007	14	in	in	IN
25944	2007	15	those	those	DT
25944	2007	16	well	well	RB
25944	2007	17	-	-	HYPH
25944	2007	18	marked	mark	VBN
25944	2007	19	cases	case	NNS
25944	2007	20	,	,	,
25944	2007	21	however	however	RB
25944	2007	22	,	,	,
25944	2007	23	in	in	IN
25944	2007	24	which	which	WDT
25944	2007	25	the	the	DT
25944	2007	26	scales	scale	NNS
25944	2007	27	are	be	VBP
25944	2007	28	thick	thick	JJ
25944	2007	29	and	and	CC
25944	2007	30	more	more	RBR
25944	2007	31	or	or	CC
25944	2007	32	less	less	RBR
25944	2007	33	immovable	immovable	JJ
25944	2007	34	,	,	,
25944	2007	35	the	the	DT
25944	2007	36	natural	natural	JJ
25944	2007	37	mobility	mobility	NN
25944	2007	38	of	of	IN
25944	2007	39	the	the	DT
25944	2007	40	parts	part	NNS
25944	2007	41	is	be	VBZ
25944	2007	42	compromised	compromise	VBN
25944	2007	43	and	and	CC
25944	2007	44	fissuring	fissuring	NN
25944	2007	45	often	often	RB
25944	2007	46	occurs	occur	VBZ
25944	2007	47	.	.	.
25944	2008	1	In	in	IN
25944	2008	2	the	the	DT
25944	2008	3	winter	winter	NN
25944	2008	4	months	month	NNS
25944	2008	5	,	,	,
25944	2008	6	in	in	IN
25944	2008	7	the	the	DT
25944	2008	8	severer	severer	NN
25944	2008	9	cases	case	NNS
25944	2008	10	,	,	,
25944	2008	11	exposed	expose	VBN
25944	2008	12	parts	part	NNS
25944	2008	13	may	may	MD
25944	2008	14	become	become	VB
25944	2008	15	slightly	slightly	RB
25944	2008	16	eczematous	eczematous	JJ
25944	2008	17	.	.	.
25944	2009	1	#	#	NNP
25944	2009	2	Does	do	VBZ
25944	2009	3	ichthyosis	ichthyosis	NN
25944	2009	4	vary	vary	VBP
25944	2009	5	somewhat	somewhat	RB
25944	2009	6	with	with	IN
25944	2009	7	the	the	DT
25944	2009	8	season	season	NN
25944	2009	9	?	?	.
25944	2009	10	#	#	NN
25944	2009	11	Yes	yes	UH
25944	2009	12	.	.	.
25944	2010	1	In	in	IN
25944	2010	2	all	all	DT
25944	2010	3	cases	case	NNS
25944	2010	4	the	the	DT
25944	2010	5	disease	disease	NN
25944	2010	6	is	be	VBZ
25944	2010	7	better	well	JJR
25944	2010	8	in	in	IN
25944	2010	9	the	the	DT
25944	2010	10	warm	warm	JJ
25944	2010	11	months	month	NNS
25944	2010	12	,	,	,
25944	2010	13	and	and	CC
25944	2010	14	in	in	IN
25944	2010	15	the	the	DT
25944	2010	16	mild	mild	JJ
25944	2010	17	forms	form	NNS
25944	2010	18	may	may	MD
25944	2010	19	entirely	entirely	RB
25944	2010	20	disappear	disappear	VB
25944	2010	21	during	during	IN
25944	2010	22	this	this	DT
25944	2010	23	time	time	NN
25944	2010	24	.	.	.
25944	2011	1	This	this	DT
25944	2011	2	favorable	favorable	JJ
25944	2011	3	change	change	NN
25944	2011	4	is	be	VBZ
25944	2011	5	purely	purely	RB
25944	2011	6	mechanical	mechanical	JJ
25944	2011	7	--	--	:
25944	2011	8	due	due	IN
25944	2011	9	to	to	IN
25944	2011	10	the	the	DT
25944	2011	11	maceration	maceration	NN
25944	2011	12	to	to	TO
25944	2011	13	which	which	WDT
25944	2011	14	the	the	DT
25944	2011	15	increased	increase	VBN
25944	2011	16	activity	activity	NN
25944	2011	17	of	of	IN
25944	2011	18	the	the	DT
25944	2011	19	sweat	sweat	NN
25944	2011	20	glands	gland	NNS
25944	2011	21	gives	give	VBZ
25944	2011	22	rise	rise	VB
25944	2011	23	.	.	.
25944	2012	1	#	#	$
25944	2012	2	Is	be	VBZ
25944	2012	3	the	the	DT
25944	2012	4	general	general	JJ
25944	2012	5	health	health	NN
25944	2012	6	affected	affect	VBN
25944	2012	7	in	in	IN
25944	2012	8	ichthyosis	ichthyosis	NN
25944	2012	9	?	?	.
25944	2012	10	#	#	$
25944	2012	11	No	no	UH
25944	2012	12	.	.	.
25944	2013	1	#	#	LS
25944	2013	2	What	what	WDT
25944	2013	3	course	course	NN
25944	2013	4	does	do	VBZ
25944	2013	5	ichthyosis	ichthyosis	NN
25944	2013	6	pursue	pursue	VB
25944	2013	7	?	?	.
25944	2013	8	#	#	NN
25944	2013	9	Chronic	chronic	JJ
25944	2013	10	.	.	.
25944	2014	1	Beginning	begin	VBG
25944	2014	2	in	in	IN
25944	2014	3	early	early	JJ
25944	2014	4	infancy	infancy	NN
25944	2014	5	or	or	CC
25944	2014	6	childhood	childhood	NN
25944	2014	7	,	,	,
25944	2014	8	it	-PRON-	PRP
25944	2014	9	usually	usually	RB
25944	2014	10	becomes	become	VBZ
25944	2014	11	gradually	gradually	RB
25944	2014	12	more	more	RBR
25944	2014	13	marked	mark	VBN
25944	2014	14	until	until	IN
25944	2014	15	adult	adult	NN
25944	2014	16	age	age	NN
25944	2014	17	,	,	,
25944	2014	18	after	after	IN
25944	2014	19	which	which	WDT
25944	2014	20	time	time	NN
25944	2014	21	it	-PRON-	PRP
25944	2014	22	,	,	,
25944	2014	23	as	as	IN
25944	2014	24	a	a	DT
25944	2014	25	rule	rule	NN
25944	2014	26	,	,	,
25944	2014	27	remains	remain	VBZ
25944	2014	28	stationary	stationary	JJ
25944	2014	29	.	.	.
25944	2015	1	#	#	LS
25944	2015	2	What	what	WP
25944	2015	3	is	be	VBZ
25944	2015	4	the	the	DT
25944	2015	5	etiology	etiology	NN
25944	2015	6	?	?	.
25944	2015	7	#	#	$
25944	2015	8	Beyond	beyond	IN
25944	2015	9	a	a	DT
25944	2015	10	hereditary	hereditary	JJ
25944	2015	11	influence	influence	NN
25944	2015	12	,	,	,
25944	2015	13	which	which	WDT
25944	2015	14	is	be	VBZ
25944	2015	15	often	often	RB
25944	2015	16	a	a	DT
25944	2015	17	positive	positive	JJ
25944	2015	18	factor	factor	NN
25944	2015	19	,	,	,
25944	2015	20	the	the	DT
25944	2015	21	causes	cause	NNS
25944	2015	22	are	be	VBP
25944	2015	23	obscure	obscure	JJ
25944	2015	24	.	.	.
25944	2016	1	It	-PRON-	PRP
25944	2016	2	is	be	VBZ
25944	2016	3	not	not	RB
25944	2016	4	a	a	DT
25944	2016	5	common	common	JJ
25944	2016	6	disease	disease	NN
25944	2016	7	.	.	.
25944	2017	1	#	#	NNP
25944	2017	2	State	state	NN
25944	2017	3	the	the	DT
25944	2017	4	pathology	pathology	NN
25944	2017	5	.	.	.
25944	2017	6	#	#	$
25944	2017	7	Anatomically	anatomically	RB
25944	2017	8	the	the	DT
25944	2017	9	essential	essential	JJ
25944	2017	10	feature	feature	NN
25944	2017	11	is	be	VBZ
25944	2017	12	epidermic	epidermic	JJ
25944	2017	13	hypertrophy	hypertrophy	NN
25944	2017	14	,	,	,
25944	2017	15	with	with	IN
25944	2017	16	usually	usually	RB
25944	2017	17	a	a	DT
25944	2017	18	varying	varying	NN
25944	2017	19	degree	degree	NN
25944	2017	20	of	of	IN
25944	2017	21	papillary	papillary	JJ
25944	2017	22	hypertrophy	hypertrophy	NN
25944	2017	23	also	also	RB
25944	2017	24	.	.	.
25944	2018	1	#	#	$
25944	2018	2	Mention	mention	VB
25944	2018	3	the	the	DT
25944	2018	4	diagnostic	diagnostic	JJ
25944	2018	5	features	feature	NNS
25944	2018	6	of	of	IN
25944	2018	7	ichthyosis	ichthyosis	NN
25944	2018	8	.	.	.
25944	2018	9	#	#	$
25944	2018	10	The	the	DT
25944	2018	11	harsh	harsh	JJ
25944	2018	12	,	,	,
25944	2018	13	dry	dry	JJ
25944	2018	14	skin	skin	NN
25944	2018	15	,	,	,
25944	2018	16	epidermic	epidermic	JJ
25944	2018	17	and	and	CC
25944	2018	18	papillary	papillary	JJ
25944	2018	19	hypertrophy	hypertrophy	NN
25944	2018	20	,	,	,
25944	2018	21	the	the	DT
25944	2018	22	furfuraceous	furfuraceous	JJ
25944	2018	23	or	or	CC
25944	2018	24	plate	plate	NN
25944	2018	25	-	-	HYPH
25944	2018	26	like	like	JJ
25944	2018	27	scaliness	scaliness	NN
25944	2018	28	,	,	,
25944	2018	29	the	the	DT
25944	2018	30	greater	great	JJR
25944	2018	31	development	development	NN
25944	2018	32	upon	upon	IN
25944	2018	33	the	the	DT
25944	2018	34	extensor	extensor	NN
25944	2018	35	surfaces	surface	NNS
25944	2018	36	,	,	,
25944	2018	37	a	a	DT
25944	2018	38	history	history	NN
25944	2018	39	of	of	IN
25944	2018	40	the	the	DT
25944	2018	41	affection	affection	NN
25944	2018	42	dating	date	VBG
25944	2018	43	from	from	IN
25944	2018	44	early	early	JJ
25944	2018	45	childhood	childhood	NN
25944	2018	46	,	,	,
25944	2018	47	and	and	CC
25944	2018	48	the	the	DT
25944	2018	49	absence	absence	NN
25944	2018	50	of	of	IN
25944	2018	51	inflammatory	inflammatory	JJ
25944	2018	52	symptoms	symptom	NNS
25944	2018	53	.	.	.
25944	2019	1	#	#	NNP
25944	2019	2	How	how	WRB
25944	2019	3	is	be	VBZ
25944	2019	4	ichthyosis	ichthyosis	NN
25944	2019	5	to	to	TO
25944	2019	6	be	be	VB
25944	2019	7	distinguished	distinguish	VBN
25944	2019	8	from	from	IN
25944	2019	9	eczema	eczema	NN
25944	2019	10	,	,	,
25944	2019	11	psoriasis	psoriasis	NN
25944	2019	12	,	,	,
25944	2019	13	and	and	CC
25944	2019	14	other	other	JJ
25944	2019	15	scaly	scaly	NN
25944	2019	16	inflammatory	inflammatory	JJ
25944	2019	17	diseases	disease	NNS
25944	2019	18	?	?	.
25944	2019	19	#	#	NN
25944	2019	20	By	by	IN
25944	2019	21	the	the	DT
25944	2019	22	absence	absence	NN
25944	2019	23	of	of	IN
25944	2019	24	the	the	DT
25944	2019	25	inflammatory	inflammatory	JJ
25944	2019	26	element	element	NN
25944	2019	27	.	.	.
25944	2020	1	#	#	LS
25944	2020	2	What	what	WP
25944	2020	3	is	be	VBZ
25944	2020	4	the	the	DT
25944	2020	5	outlook	outlook	NN
25944	2020	6	for	for	IN
25944	2020	7	a	a	DT
25944	2020	8	case	case	NN
25944	2020	9	of	of	IN
25944	2020	10	ichthyosis	ichthyosis	NN
25944	2020	11	?	?	.
25944	2020	12	#	#	$
25944	2020	13	The	the	DT
25944	2020	14	prognosis	prognosis	NN
25944	2020	15	is	be	VBZ
25944	2020	16	unfavorable	unfavorable	JJ
25944	2020	17	as	as	IN
25944	2020	18	regards	regard	VBZ
25944	2020	19	a	a	DT
25944	2020	20	cure	cure	NN
25944	2020	21	,	,	,
25944	2020	22	but	but	CC
25944	2020	23	the	the	DT
25944	2020	24	process	process	NN
25944	2020	25	may	may	MD
25944	2020	26	usually	usually	RB
25944	2020	27	be	be	VB
25944	2020	28	kept	keep	VBN
25944	2020	29	in	in	IN
25944	2020	30	abeyance	abeyance	NN
25944	2020	31	or	or	CC
25944	2020	32	rendered	render	VBN
25944	2020	33	endurable	endurable	JJ
25944	2020	34	by	by	IN
25944	2020	35	proper	proper	JJ
25944	2020	36	measures	measure	NNS
25944	2020	37	.	.	.
25944	2021	1	#	#	LS
25944	2021	2	What	what	WDT
25944	2021	3	treatment	treatment	NN
25944	2021	4	would	would	MD
25944	2021	5	you	-PRON-	PRP
25944	2021	6	prescribe	prescribe	VB
25944	2021	7	for	for	IN
25944	2021	8	ichthyosis	ichthyosis	NN
25944	2021	9	?	?	.
25944	2021	10	#	#	$
25944	2021	11	Treatment	Treatment	NNP
25944	2021	12	that	that	WDT
25944	2021	13	has	have	VBZ
25944	2021	14	in	in	IN
25944	2021	15	view	view	NN
25944	2021	16	removal	removal	NN
25944	2021	17	of	of	IN
25944	2021	18	the	the	DT
25944	2021	19	scaliness	scaliness	NN
25944	2021	20	and	and	CC
25944	2021	21	the	the	DT
25944	2021	22	maintenance	maintenance	NN
25944	2021	23	of	of	IN
25944	2021	24	a	a	DT
25944	2021	25	soft	soft	JJ
25944	2021	26	and	and	CC
25944	2021	27	flexible	flexible	JJ
25944	2021	28	condition	condition	NN
25944	2021	29	of	of	IN
25944	2021	30	the	the	DT
25944	2021	31	skin	skin	NN
25944	2021	32	.	.	.
25944	2022	1	In	in	IN
25944	2022	2	mild	mild	JJ
25944	2022	3	cases	case	NNS
25944	2022	4	frequent	frequent	JJ
25944	2022	5	warm	warm	JJ
25944	2022	6	baths	bath	NNS
25944	2022	7	,	,	,
25944	2022	8	simple	simple	JJ
25944	2022	9	or	or	CC
25944	2022	10	alkaline	alkaline	NN
25944	2022	11	,	,	,
25944	2022	12	will	will	MD
25944	2022	13	suffice	suffice	VB
25944	2022	14	;	;	:
25944	2022	15	in	in	IN
25944	2022	16	others	other	NNS
25944	2022	17	an	an	DT
25944	2022	18	application	application	NN
25944	2022	19	of	of	IN
25944	2022	20	an	an	DT
25944	2022	21	oily	oily	JJ
25944	2022	22	or	or	CC
25944	2022	23	fatty	fatty	NN
25944	2022	24	substance	substance	NN
25944	2022	25	,	,	,
25944	2022	26	such	such	JJ
25944	2022	27	as	as	IN
25944	2022	28	the	the	DT
25944	2022	29	ordinary	ordinary	JJ
25944	2022	30	oils	oil	NNS
25944	2022	31	or	or	CC
25944	2022	32	ointments	ointment	NNS
25944	2022	33	,	,	,
25944	2022	34	made	make	VBD
25944	2022	35	several	several	JJ
25944	2022	36	hours	hour	NNS
25944	2022	37	or	or	CC
25944	2022	38	immediately	immediately	RB
25944	2022	39	before	before	IN
25944	2022	40	the	the	DT
25944	2022	41	bath	bath	NN
25944	2022	42	may	may	MD
25944	2022	43	be	be	VB
25944	2022	44	necessary	necessary	JJ
25944	2022	45	.	.	.
25944	2023	1	In	in	IN
25944	2023	2	moderately	moderately	RB
25944	2023	3	developed	develop	VBN
25944	2023	4	cases	case	NNS
25944	2023	5	the	the	DT
25944	2023	6	skin	skin	NN
25944	2023	7	is	be	VBZ
25944	2023	8	to	to	TO
25944	2023	9	be	be	VB
25944	2023	10	washed	wash	VBN
25944	2023	11	energetically	energetically	RB
25944	2023	12	with	with	IN
25944	2023	13	sapo	sapo	JJ
25944	2023	14	viridis	viridis	NN
25944	2023	15	and	and	CC
25944	2023	16	hot	hot	JJ
25944	2023	17	water	water	NN
25944	2023	18	,	,	,
25944	2023	19	followed	follow	VBN
25944	2023	20	by	by	IN
25944	2023	21	a	a	DT
25944	2023	22	warm	warm	JJ
25944	2023	23	bath	bath	NN
25944	2023	24	,	,	,
25944	2023	25	after	after	IN
25944	2023	26	which	which	WDT
25944	2023	27	an	an	DT
25944	2023	28	oily	oily	JJ
25944	2023	29	or	or	CC
25944	2023	30	fatty	fatty	NN
25944	2023	31	application	application	NN
25944	2023	32	is	be	VBZ
25944	2023	33	made	make	VBN
25944	2023	34	.	.	.
25944	2024	1	In	in	IN
25944	2024	2	some	some	DT
25944	2024	3	of	of	IN
25944	2024	4	the	the	DT
25944	2024	5	more	more	RBR
25944	2024	6	severe	severe	JJ
25944	2024	7	cases	case	NNS
25944	2024	8	the	the	DT
25944	2024	9	following	follow	VBG
25944	2024	10	plan	plan	NN
25944	2024	11	is	be	VBZ
25944	2024	12	often	often	RB
25944	2024	13	useful	useful	JJ
25944	2024	14	:	:	:
25944	2024	15	The	the	DT
25944	2024	16	parts	part	NNS
25944	2024	17	are	be	VBP
25944	2024	18	first	first	RB
25944	2024	19	rubbed	rub	VBN
25944	2024	20	with	with	IN
25944	2024	21	a	a	DT
25944	2024	22	soapy	soapy	NN
25944	2024	23	ointment	ointment	NN
25944	2024	24	consisting	consist	VBG
25944	2024	25	of	of	IN
25944	2024	26	one	one	CD
25944	2024	27	part	part	NN
25944	2024	28	of	of	IN
25944	2024	29	precipitated	precipitate	VBN
25944	2024	30	sulphur	sulphur	NNP
25944	2024	31	and	and	CC
25944	2024	32	seven	seven	CD
25944	2024	33	parts	part	NNS
25944	2024	34	of	of	IN
25944	2024	35	sapo	sapo	JJ
25944	2024	36	viridis	viridi	NNS
25944	2024	37	;	;	:
25944	2024	38	a	a	DT
25944	2024	39	bath	bath	NN
25944	2024	40	is	be	VBZ
25944	2024	41	then	then	RB
25944	2024	42	taken	take	VBN
25944	2024	43	,	,	,
25944	2024	44	the	the	DT
25944	2024	45	skin	skin	NN
25944	2024	46	wiped	wipe	VBD
25944	2024	47	dry	dry	JJ
25944	2024	48	,	,	,
25944	2024	49	and	and	CC
25944	2024	50	a	a	DT
25944	2024	51	one	one	CD
25944	2024	52	to	to	TO
25944	2024	53	five	five	CD
25944	2024	54	per	per	NN
25944	2024	55	cent	cent	NN
25944	2024	56	.	.	.
25944	2025	1	ointment	ointment	NNP
25944	2025	2	of	of	IN
25944	2025	3	salicylic	salicylic	NNP
25944	2025	4	acid	acid	NN
25944	2025	5	gently	gently	RB
25944	2025	6	rubbed	rub	VBD
25944	2025	7	in	in	IN
25944	2025	8	.	.	.
25944	2026	1	Glycerine	glycerine	JJ
25944	2026	2	lotions	lotion	NNS
25944	2026	3	,	,	,
25944	2026	4	one	one	CD
25944	2026	5	or	or	CC
25944	2026	6	two	two	CD
25944	2026	7	drachms	drachm	NNS
25944	2026	8	to	to	IN
25944	2026	9	the	the	DT
25944	2026	10	ounce	ounce	NN
25944	2026	11	of	of	IN
25944	2026	12	water	water	NN
25944	2026	13	,	,	,
25944	2026	14	are	be	VBP
25944	2026	15	also	also	RB
25944	2026	16	beneficial	beneficial	JJ
25944	2026	17	;	;	:
25944	2026	18	as	as	IN
25944	2026	19	also	also	RB
25944	2026	20	the	the	DT
25944	2026	21	following:--	following:--	NN
25944	2026	22	[	[	-LRB-
25944	2026	23	Rx	Rx	NNP
25944	2026	24	]	]	-RRB-
25944	2026	25	Ac	Ac	NNP
25944	2026	26	.	.	.
25944	2027	1	salicylici	salicylici	NNP
25944	2027	2	,	,	,
25944	2027	3	......................	......................	NFP
25944	2027	4	gr	gr	NNP
25944	2027	5	.	.	.
25944	2028	1	x	x	LS
25944	2028	2	-	-	:
25944	2028	3	xl	xl	NNP
25944	2028	4	Glycerini	Glycerini	NNP
25944	2028	5	,	,	,
25944	2028	6	...........................	...........................	NFP
25944	2028	7	[	[	-LRB-
25944	2028	8	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	2028	9	Lanolin	Lanolin	NNP
25944	2028	10	,	,	,
25944	2028	11	Petrolati	Petrolati	NNP
25944	2028	12	,	,	,
25944	2028	13	..................	..................	NFP
25944	2028	14	[	[	-LRB-
25944	2028	15	=	=	SYM
25944	2028	16	a][=a	a][=a	CD
25944	2028	17	]	]	-RRB-
25944	2028	18	[	[	-LRB-
25944	2028	19	Oz]ss	Oz]ss	NNP
25944	2028	20	In	in	IN
25944	2028	21	severe	severe	JJ
25944	2028	22	cases	case	NNS
25944	2028	23	of	of	IN
25944	2028	24	ichthyosis	ichthyosis	NN
25944	2028	25	hystrix	hystrix	NNP
25944	2028	26	it	-PRON-	PRP
25944	2028	27	may	may	MD
25944	2028	28	be	be	VB
25944	2028	29	necessary	necessary	JJ
25944	2028	30	,	,	,
25944	2028	31	also	also	RB
25944	2028	32	,	,	,
25944	2028	33	to	to	TO
25944	2028	34	employ	employ	VB
25944	2028	35	caustics	caustic	NNS
25944	2028	36	or	or	CC
25944	2028	37	the	the	DT
25944	2028	38	knife	knife	NN
25944	2028	39	.	.	.
25944	2029	1	#	#	LS
25944	2029	2	What	what	WDT
25944	2029	3	systemic	systemic	JJ
25944	2029	4	treatment	treatment	NN
25944	2029	5	would	would	MD
25944	2029	6	you	-PRON-	PRP
25944	2029	7	prescribe	prescribe	VB
25944	2029	8	?	?	.
25944	2029	9	#	#	$
25944	2029	10	Constitutional	constitutional	JJ
25944	2029	11	remedies	remedy	NNS
25944	2029	12	are	be	VBP
25944	2029	13	practically	practically	RB
25944	2029	14	powerless	powerless	JJ
25944	2029	15	;	;	:
25944	2029	16	occasionally	occasionally	RB
25944	2029	17	some	some	DT
25944	2029	18	good	good	JJ
25944	2029	19	is	be	VBZ
25944	2029	20	accomplished	accomplish	VBN
25944	2029	21	by	by	IN
25944	2029	22	the	the	DT
25944	2029	23	internal	internal	NNP
25944	2029	24	administration	administration	NNP
25944	2029	25	of	of	IN
25944	2029	26	linseed	linseed	NNP
25944	2029	27	oil	oil	NN
25944	2029	28	and	and	CC
25944	2029	29	jaborandi	jaborandi	NN
25944	2029	30	.	.	.
25944	2030	1	#	#	NNP
25944	2030	2	Onychauxis	Onychauxis	NNP
25944	2030	3	.	.	.
25944	2030	4	#	#	NNP
25944	2030	5	(	(	-LRB-
25944	2030	6	_	_	NNP
25944	2030	7	Synonym	Synonym	NNP
25944	2030	8	:	:	:
25944	2030	9	_	_	NNP
25944	2030	10	Hypertrophy	Hypertrophy	NNP
25944	2030	11	of	of	IN
25944	2030	12	the	the	DT
25944	2030	13	Nail	Nail	NNP
25944	2030	14	.	.	.
25944	2030	15	)	)	-RRB-
25944	2031	1	#	#	NNP
25944	2031	2	Describe	Describe	NNP
25944	2031	3	onychauxis	onychauxi	NNS
25944	2031	4	.	.	.
25944	2031	5	#	#	$
25944	2031	6	Onychauxis	Onychauxis	NNP
25944	2031	7	,	,	,
25944	2031	8	or	or	CC
25944	2031	9	hypertrophy	hypertrophy	NN
25944	2031	10	of	of	IN
25944	2031	11	the	the	DT
25944	2031	12	nail	nail	NN
25944	2031	13	,	,	,
25944	2031	14	may	may	MD
25944	2031	15	take	take	VB
25944	2031	16	place	place	NN
25944	2031	17	in	in	IN
25944	2031	18	one	one	CD
25944	2031	19	or	or	CC
25944	2031	20	all	all	DT
25944	2031	21	directions	direction	NNS
25944	2031	22	,	,	,
25944	2031	23	and	and	CC
25944	2031	24	this	this	DT
25944	2031	25	increase	increase	NN
25944	2031	26	may	may	MD
25944	2031	27	be	be	VB
25944	2031	28	,	,	,
25944	2031	29	and	and	CC
25944	2031	30	often	often	RB
25944	2031	31	is	be	VBZ
25944	2031	32	,	,	,
25944	2031	33	accompanied	accompany	VBN
25944	2031	34	by	by	IN
25944	2031	35	changes	change	NNS
25944	2031	36	in	in	IN
25944	2031	37	shape	shape	NN
25944	2031	38	,	,	,
25944	2031	39	color	color	NN
25944	2031	40	,	,	,
25944	2031	41	and	and	CC
25944	2031	42	direction	direction	NN
25944	2031	43	of	of	IN
25944	2031	44	growth	growth	NN
25944	2031	45	.	.	.
25944	2032	1	One	one	CD
25944	2032	2	or	or	CC
25944	2032	3	all	all	PDT
25944	2032	4	the	the	DT
25944	2032	5	nails	nail	NNS
25944	2032	6	may	may	MD
25944	2032	7	share	share	VB
25944	2032	8	in	in	IN
25944	2032	9	the	the	DT
25944	2032	10	process	process	NN
25944	2032	11	.	.	.
25944	2033	1	As	as	IN
25944	2033	2	the	the	DT
25944	2033	3	result	result	NN
25944	2033	4	of	of	IN
25944	2033	5	lateral	lateral	JJ
25944	2033	6	deviation	deviation	NN
25944	2033	7	of	of	IN
25944	2033	8	growth	growth	NN
25944	2033	9	,	,	,
25944	2033	10	the	the	DT
25944	2033	11	nail	nail	NN
25944	2033	12	presses	press	VBZ
25944	2033	13	upon	upon	IN
25944	2033	14	the	the	DT
25944	2033	15	surrounding	surround	VBG
25944	2033	16	tissues	tissue	NNS
25944	2033	17	,	,	,
25944	2033	18	producing	produce	VBG
25944	2033	19	a	a	DT
25944	2033	20	varying	varying	NN
25944	2033	21	degree	degree	NN
25944	2033	22	of	of	IN
25944	2033	23	inflammation--_paronychia	inflammation--_paronychia	``
25944	2033	24	_	_	NNP
25944	2033	25	.	.	.
25944	2034	1	#	#	LS
25944	2034	2	What	what	WP
25944	2034	3	is	be	VBZ
25944	2034	4	the	the	DT
25944	2034	5	etiology	etiology	NN
25944	2034	6	of	of	IN
25944	2034	7	hypertrophy	hypertrophy	NN
25944	2034	8	of	of	IN
25944	2034	9	the	the	DT
25944	2034	10	nail	nail	NN
25944	2034	11	?	?	.
25944	2034	12	#	#	$
25944	2034	13	The	the	DT
25944	2034	14	condition	condition	NN
25944	2034	15	may	may	MD
25944	2034	16	be	be	VB
25944	2034	17	either	either	CC
25944	2034	18	congenital	congenital	JJ
25944	2034	19	or	or	CC
25944	2034	20	acquired	acquire	VBN
25944	2034	21	.	.	.
25944	2035	1	In	in	IN
25944	2035	2	the	the	DT
25944	2035	3	latter	latter	JJ
25944	2035	4	instances	instance	NNS
25944	2035	5	it	-PRON-	PRP
25944	2035	6	is	be	VBZ
25944	2035	7	usually	usually	RB
25944	2035	8	the	the	DT
25944	2035	9	result	result	NN
25944	2035	10	of	of	IN
25944	2035	11	the	the	DT
25944	2035	12	extension	extension	NN
25944	2035	13	to	to	IN
25944	2035	14	the	the	DT
25944	2035	15	matrix	matrix	NN
25944	2035	16	of	of	IN
25944	2035	17	such	such	JJ
25944	2035	18	cutaneous	cutaneous	JJ
25944	2035	19	diseases	disease	NNS
25944	2035	20	as	as	IN
25944	2035	21	psoriasis	psoriasis	NN
25944	2035	22	and	and	CC
25944	2035	23	eczema	eczema	NN
25944	2035	24	;	;	:
25944	2035	25	or	or	CC
25944	2035	26	it	-PRON-	PRP
25944	2035	27	is	be	VBZ
25944	2035	28	produced	produce	VBN
25944	2035	29	by	by	IN
25944	2035	30	constitutional	constitutional	JJ
25944	2035	31	maladies	malady	NNS
25944	2035	32	,	,	,
25944	2035	33	such	such	JJ
25944	2035	34	as	as	IN
25944	2035	35	syphilis	syphilis	NNP
25944	2035	36	.	.	.
25944	2036	1	#	#	NN
25944	2036	2	Give	give	VBP
25944	2036	3	the	the	DT
25944	2036	4	treatment	treatment	NN
25944	2036	5	of	of	IN
25944	2036	6	hypertrophy	hypertrophy	NN
25944	2036	7	of	of	IN
25944	2036	8	the	the	DT
25944	2036	9	nail	nail	NN
25944	2036	10	.	.	.
25944	2036	11	#	#	$
25944	2036	12	Treatment	Treatment	NNP
25944	2036	13	consists	consist	VBZ
25944	2036	14	in	in	IN
25944	2036	15	the	the	DT
25944	2036	16	removal	removal	NN
25944	2036	17	of	of	IN
25944	2036	18	the	the	DT
25944	2036	19	redundant	redundant	JJ
25944	2036	20	nail	nail	NN
25944	2036	21	-	-	HYPH
25944	2036	22	tissue	tissue	NN
25944	2036	23	by	by	IN
25944	2036	24	means	mean	NNS
25944	2036	25	of	of	IN
25944	2036	26	the	the	DT
25944	2036	27	knife	knife	NN
25944	2036	28	or	or	CC
25944	2036	29	scissors	scissor	NNS
25944	2036	30	;	;	:
25944	2036	31	and	and	CC
25944	2036	32	,	,	,
25944	2036	33	when	when	WRB
25944	2036	34	dependent	dependent	JJ
25944	2036	35	upon	upon	IN
25944	2036	36	eczema	eczema	NN
25944	2036	37	or	or	CC
25944	2036	38	psoriasis	psoriasis	NN
25944	2036	39	,	,	,
25944	2036	40	the	the	DT
25944	2036	41	employment	employment	NN
25944	2036	42	of	of	IN
25944	2036	43	remedies	remedy	NNS
25944	2036	44	suitable	suitable	JJ
25944	2036	45	for	for	IN
25944	2036	46	these	these	DT
25944	2036	47	diseases	disease	NNS
25944	2036	48	.	.	.
25944	2037	1	When	when	WRB
25944	2037	2	it	-PRON-	PRP
25944	2037	3	is	be	VBZ
25944	2037	4	the	the	DT
25944	2037	5	result	result	NN
25944	2037	6	of	of	IN
25944	2037	7	syphilis	syphilis	NNP
25944	2037	8	,	,	,
25944	2037	9	the	the	DT
25944	2037	10	medication	medication	NN
25944	2037	11	appropriate	appropriate	JJ
25944	2037	12	to	to	IN
25944	2037	13	this	this	DT
25944	2037	14	disease	disease	NN
25944	2037	15	is	be	VBZ
25944	2037	16	to	to	TO
25944	2037	17	be	be	VB
25944	2037	18	employed	employ	VBN
25944	2037	19	.	.	.
25944	2038	1	In	in	IN
25944	2038	2	paronychia	paronychia	NN
25944	2038	3	the	the	DT
25944	2038	4	nail	nail	NN
25944	2038	5	should	should	MD
25944	2038	6	be	be	VB
25944	2038	7	frequently	frequently	RB
25944	2038	8	trimmed	trim	VBN
25944	2038	9	and	and	CC
25944	2038	10	a	a	DT
25944	2038	11	pledget	pledget	NN
25944	2038	12	of	of	IN
25944	2038	13	lint	lint	NN
25944	2038	14	or	or	CC
25944	2038	15	cotton	cotton	NN
25944	2038	16	be	be	VB
25944	2038	17	interposed	interpose	VBN
25944	2038	18	between	between	IN
25944	2038	19	the	the	DT
25944	2038	20	edge	edge	NN
25944	2038	21	of	of	IN
25944	2038	22	the	the	DT
25944	2038	23	nail	nail	NN
25944	2038	24	and	and	CC
25944	2038	25	the	the	DT
25944	2038	26	adjacent	adjacent	JJ
25944	2038	27	soft	soft	JJ
25944	2038	28	parts	part	NNS
25944	2038	29	;	;	,
25944	2038	30	astringent	astringent	JJ
25944	2038	31	powders	powder	NNS
25944	2038	32	and	and	CC
25944	2038	33	lotions	lotion	NNS
25944	2038	34	may	may	MD
25944	2038	35	often	often	RB
25944	2038	36	be	be	VB
25944	2038	37	employed	employ	VBN
25944	2038	38	with	with	IN
25944	2038	39	advantage	advantage	NN
25944	2038	40	;	;	:
25944	2038	41	and	and	CC
25944	2038	42	in	in	IN
25944	2038	43	severe	severe	JJ
25944	2038	44	and	and	CC
25944	2038	45	persistent	persistent	JJ
25944	2038	46	cases	case	NNS
25944	2038	47	excision	excision	NN
25944	2038	48	of	of	IN
25944	2038	49	the	the	DT
25944	2038	50	nail	nail	NN
25944	2038	51	,	,	,
25944	2038	52	partial	partial	JJ
25944	2038	53	or	or	CC
25944	2038	54	complete	complete	JJ
25944	2038	55	,	,	,
25944	2038	56	may	may	MD
25944	2038	57	be	be	VB
25944	2038	58	found	find	VBN
25944	2038	59	necessary	necessary	JJ
25944	2038	60	.	.	.
25944	2039	1	#	#	NNP
25944	2039	2	Hypertrichosis	hypertrichosis	NN
25944	2039	3	.	.	.
25944	2039	4	#	#	NNP
25944	2039	5	(	(	-LRB-
25944	2039	6	_	_	NNP
25944	2039	7	Synonyms	Synonyms	NNP
25944	2039	8	:	:	:
25944	2039	9	_	_	NNP
25944	2039	10	Hirsuties	Hirsuties	NNPS
25944	2039	11	;	;	:
25944	2039	12	Hypertrophy	Hypertrophy	NNP
25944	2039	13	of	of	IN
25944	2039	14	the	the	DT
25944	2039	15	Hair	Hair	NNP
25944	2039	16	;	;	:
25944	2039	17	Superfluous	superfluous	JJ
25944	2039	18	Hair	Hair	NNP
25944	2039	19	.	.	.
25944	2039	20	)	)	-RRB-
25944	2040	1	#	#	LS
25944	2040	2	What	what	WP
25944	2040	3	is	be	VBZ
25944	2040	4	meant	mean	VBN
25944	2040	5	by	by	IN
25944	2040	6	hypertrichosis	hypertrichosis	NN
25944	2040	7	?	?	.
25944	2040	8	#	#	$
25944	2040	9	Hypertrichosis	hypertrichosis	NN
25944	2040	10	is	be	VBZ
25944	2040	11	a	a	DT
25944	2040	12	term	term	NN
25944	2040	13	applied	apply	VBN
25944	2040	14	to	to	IN
25944	2040	15	excessive	excessive	JJ
25944	2040	16	growth	growth	NN
25944	2040	17	of	of	IN
25944	2040	18	hair	hair	NN
25944	2040	19	,	,	,
25944	2040	20	either	either	CC
25944	2040	21	as	as	IN
25944	2040	22	regards	regard	VBZ
25944	2040	23	region	region	NN
25944	2040	24	,	,	,
25944	2040	25	extent	extent	NN
25944	2040	26	,	,	,
25944	2040	27	age	age	NN
25944	2040	28	or	or	CC
25944	2040	29	sex	sex	NN
25944	2040	30	.	.	.
25944	2041	1	#	#	NNP
25944	2041	2	Describe	describe	VB
25944	2041	3	the	the	DT
25944	2041	4	several	several	JJ
25944	2041	5	conditions	condition	NNS
25944	2041	6	met	meet	VBD
25944	2041	7	with	with	IN
25944	2041	8	.	.	.
25944	2041	9	#	#	$
25944	2041	10	The	the	DT
25944	2041	11	unnatural	unnatural	JJ
25944	2041	12	hair	hair	NN
25944	2041	13	growth	growth	NN
25944	2041	14	may	may	MD
25944	2041	15	be	be	VB
25944	2041	16	slight	slight	JJ
25944	2041	17	,	,	,
25944	2041	18	as	as	IN
25944	2041	19	,	,	,
25944	2041	20	for	for	IN
25944	2041	21	instance	instance	NN
25944	2041	22	,	,	,
25944	2041	23	upon	upon	IN
25944	2041	24	a	a	DT
25944	2041	25	nævus	nævus	NN
25944	2041	26	(	(	-LRB-
25944	2041	27	_	_	NNP
25944	2041	28	nævus	nævus	NNP
25944	2041	29	pilosus	pilosus	NNP
25944	2041	30	_	_	NNP
25944	2041	31	)	)	-RRB-
25944	2041	32	;	;	:
25944	2041	33	or	or	CC
25944	2041	34	it	-PRON-	PRP
25944	2041	35	may	may	MD
25944	2041	36	be	be	VB
25944	2041	37	excessive	excessive	JJ
25944	2041	38	,	,	,
25944	2041	39	as	as	IN
25944	2041	40	in	in	IN
25944	2041	41	the	the	DT
25944	2041	42	so	so	RB
25944	2041	43	-	-	HYPH
25944	2041	44	called	call	VBN
25944	2041	45	hairy	hairy	JJ
25944	2041	46	people	people	NNS
25944	2041	47	(	(	-LRB-
25944	2041	48	_	_	NNP
25944	2041	49	homines	homines	NNP
25944	2041	50	pilosi	pilosi	NNP
25944	2041	51	_	_	NNP
25944	2041	52	)	)	-RRB-
25944	2041	53	;	;	:
25944	2041	54	or	or	CC
25944	2041	55	it	-PRON-	PRP
25944	2041	56	may	may	MD
25944	2041	57	also	also	RB
25944	2041	58	appear	appear	VB
25944	2041	59	on	on	IN
25944	2041	60	the	the	DT
25944	2041	61	face	face	NN
25944	2041	62	,	,	,
25944	2041	63	arms	arm	NNS
25944	2041	64	and	and	CC
25944	2041	65	other	other	JJ
25944	2041	66	parts	part	NNS
25944	2041	67	in	in	IN
25944	2041	68	females	female	NNS
25944	2041	69	,	,	,
25944	2041	70	resulting	result	VBG
25944	2041	71	from	from	IN
25944	2041	72	a	a	DT
25944	2041	73	hypertrophy	hypertrophy	NN
25944	2041	74	of	of	IN
25944	2041	75	the	the	DT
25944	2041	76	natural	natural	JJ
25944	2041	77	lanugo	lanugo	NNS
25944	2041	78	hairs	hair	NNS
25944	2041	79	.	.	.
25944	2042	1	#	#	JJR
25944	2042	2	State	state	NN
25944	2042	3	the	the	DT
25944	2042	4	causes	cause	NNS
25944	2042	5	of	of	IN
25944	2042	6	hypertrichosis	hypertrichosis	NN
25944	2042	7	.	.	.
25944	2042	8	#	#	$
25944	2042	9	Hereditary	hereditary	JJ
25944	2042	10	influence	influence	NN
25944	2042	11	is	be	VBZ
25944	2042	12	often	often	RB
25944	2042	13	a	a	DT
25944	2042	14	factor	factor	NN
25944	2042	15	;	;	:
25944	2042	16	the	the	DT
25944	2042	17	condition	condition	NN
25944	2042	18	may	may	MD
25944	2042	19	also	also	RB
25944	2042	20	be	be	VB
25944	2042	21	congenital	congenital	JJ
25944	2042	22	.	.	.
25944	2043	1	If	if	IN
25944	2043	2	acquired	acquire	VBN
25944	2043	3	,	,	,
25944	2043	4	the	the	DT
25944	2043	5	tendency	tendency	NN
25944	2043	6	manifests	manifest	VBZ
25944	2043	7	itself	-PRON-	PRP
25944	2043	8	usually	usually	RB
25944	2043	9	toward	toward	IN
25944	2043	10	middle	middle	JJ
25944	2043	11	life	life	NN
25944	2043	12	.	.	.
25944	2044	1	In	in	IN
25944	2044	2	women	woman	NNS
25944	2044	3	,	,	,
25944	2044	4	it	-PRON-	PRP
25944	2044	5	is	be	VBZ
25944	2044	6	not	not	RB
25944	2044	7	infrequently	infrequently	RB
25944	2044	8	associated	associate	VBN
25944	2044	9	with	with	IN
25944	2044	10	diseases	disease	NNS
25944	2044	11	of	of	IN
25944	2044	12	the	the	DT
25944	2044	13	utero	utero	JJ
25944	2044	14	-	-	HYPH
25944	2044	15	ovarian	ovarian	JJ
25944	2044	16	system	system	NN
25944	2044	17	;	;	:
25944	2044	18	in	in	IN
25944	2044	19	many	many	JJ
25944	2044	20	instances	instance	NNS
25944	2044	21	,	,	,
25944	2044	22	however	however	RB
25944	2044	23	,	,	,
25944	2044	24	there	there	EX
25944	2044	25	is	be	VBZ
25944	2044	26	no	no	DT
25944	2044	27	apparent	apparent	JJ
25944	2044	28	cause	cause	NN
25944	2044	29	.	.	.
25944	2045	1	Local	local	JJ
25944	2045	2	irritation	irritation	NN
25944	2045	3	or	or	CC
25944	2045	4	stimulation	stimulation	NN
25944	2045	5	has	have	VBZ
25944	2045	6	at	at	IN
25944	2045	7	times	time	NNS
25944	2045	8	a	a	DT
25944	2045	9	causative	causative	JJ
25944	2045	10	influence	influence	NN
25944	2045	11	.	.	.
25944	2046	1	#	#	NNP
25944	2046	2	How	how	WRB
25944	2046	3	is	be	VBZ
25944	2046	4	hypertrichosis	hypertrichosis	JJ
25944	2046	5	to	to	TO
25944	2046	6	be	be	VB
25944	2046	7	treated	treat	VBN
25944	2046	8	?	?	.
25944	2046	9	#	#	$
25944	2046	10	For	for	IN
25944	2046	11	general	general	JJ
25944	2046	12	hypertrichosis	hypertrichosis	NN
25944	2046	13	there	there	EX
25944	2046	14	is	be	VBZ
25944	2046	15	no	no	DT
25944	2046	16	remedy	remedy	NN
25944	2046	17	.	.	.
25944	2047	1	Small	small	JJ
25944	2047	2	hairy	hairy	NN
25944	2047	3	nævi	nævi	NN
25944	2047	4	may	may	MD
25944	2047	5	be	be	VB
25944	2047	6	excised	excise	VBN
25944	2047	7	,	,	,
25944	2047	8	or	or	CC
25944	2047	9	,	,	,
25944	2047	10	as	as	RB
25944	2047	11	also	also	RB
25944	2047	12	in	in	IN
25944	2047	13	the	the	DT
25944	2047	14	larger	large	JJR
25944	2047	15	hairy	hairy	JJ
25944	2047	16	moles	mole	NNS
25944	2047	17	,	,	,
25944	2047	18	the	the	DT
25944	2047	19	hairs	hair	NNS
25944	2047	20	may	may	MD
25944	2047	21	be	be	VB
25944	2047	22	removed	remove	VBN
25944	2047	23	by	by	IN
25944	2047	24	electrolysis	electrolysis	NN
25944	2047	25	.	.	.
25944	2048	1	On	on	IN
25944	2048	2	the	the	DT
25944	2048	3	faces	face	NNS
25944	2048	4	of	of	IN
25944	2048	5	women	woman	NNS
25944	2048	6	,	,	,
25944	2048	7	if	if	IN
25944	2048	8	the	the	DT
25944	2048	9	hairs	hair	NNS
25944	2048	10	are	be	VBP
25944	2048	11	coarse	coarse	JJ
25944	2048	12	or	or	CC
25944	2048	13	large	large	JJ
25944	2048	14	,	,	,
25944	2048	15	electrolysis	electrolysis	NN
25944	2048	16	constitutes	constitute	VBZ
25944	2048	17	the	the	DT
25944	2048	18	only	only	JJ
25944	2048	19	satisfactory	satisfactory	JJ
25944	2048	20	method	method	NN
25944	2048	21	;	;	:
25944	2048	22	if	if	IN
25944	2048	23	the	the	DT
25944	2048	24	hairs	hair	NNS
25944	2048	25	are	be	VBP
25944	2048	26	small	small	JJ
25944	2048	27	and	and	CC
25944	2048	28	lanugo	lanugo	JJ
25944	2048	29	-	-	HYPH
25944	2048	30	like	like	JJ
25944	2048	31	,	,	,
25944	2048	32	the	the	DT
25944	2048	33	operation	operation	NN
25944	2048	34	is	be	VBZ
25944	2048	35	not	not	RB
25944	2048	36	to	to	TO
25944	2048	37	be	be	VB
25944	2048	38	advised	advise	VBN
25944	2048	39	.	.	.
25944	2049	1	It	-PRON-	PRP
25944	2049	2	is	be	VBZ
25944	2049	3	somewhat	somewhat	RB
25944	2049	4	painful	painful	JJ
25944	2049	5	,	,	,
25944	2049	6	but	but	CC
25944	2049	7	never	never	RB
25944	2049	8	unbearable	unbearable	JJ
25944	2049	9	.	.	.
25944	2050	1	In	in	IN
25944	2050	2	the	the	DT
25944	2050	3	past	past	JJ
25944	2050	4	several	several	JJ
25944	2050	5	years	year	NNS
25944	2050	6	the	the	DT
25944	2050	7	_	_	NNP
25944	2050	8	x_-ray	x_-ray	NN
25944	2050	9	has	have	VBZ
25944	2050	10	been	be	VBN
25944	2050	11	advocated	advocate	VBN
25944	2050	12	by	by	IN
25944	2050	13	several	several	JJ
25944	2050	14	writers	writer	NNS
25944	2050	15	,	,	,
25944	2050	16	but	but	CC
25944	2050	17	it	-PRON-	PRP
25944	2050	18	requires	require	VBZ
25944	2050	19	usually	usually	RB
25944	2050	20	numerous	numerous	JJ
25944	2050	21	exposures	exposure	NNS
25944	2050	22	pushed	push	VBD
25944	2050	23	to	to	IN
25944	2050	24	the	the	DT
25944	2050	25	point	point	NN
25944	2050	26	of	of	IN
25944	2050	27	producing	produce	VBG
25944	2050	28	erythema	erythema	NNP
25944	2050	29	;	;	:
25944	2050	30	it	-PRON-	PRP
25944	2050	31	is	be	VBZ
25944	2050	32	not	not	RB
25944	2050	33	without	without	IN
25944	2050	34	risk	risk	NN
25944	2050	35	,	,	,
25944	2050	36	and	and	CC
25944	2050	37	the	the	DT
25944	2050	38	hairs	hair	NNS
25944	2050	39	are	be	VBP
25944	2050	40	said	say	VBN
25944	2050	41	to	to	TO
25944	2050	42	return	return	VB
25944	2050	43	in	in	IN
25944	2050	44	some	some	DT
25944	2050	45	months	month	NNS
25944	2050	46	.	.	.
25944	2051	1	#	#	LS
25944	2051	2	What	what	WDT
25944	2051	3	temporary	temporary	JJ
25944	2051	4	methods	method	NNS
25944	2051	5	are	be	VBP
25944	2051	6	usually	usually	RB
25944	2051	7	resorted	resorted	JJ
25944	2051	8	to	to	IN
25944	2051	9	for	for	IN
25944	2051	10	the	the	DT
25944	2051	11	removal	removal	NN
25944	2051	12	of	of	IN
25944	2051	13	superfluous	superfluous	JJ
25944	2051	14	hair	hair	NN
25944	2051	15	?	?	.
25944	2051	16	#	#	NN
25944	2051	17	Shaving	shaving	NN
25944	2051	18	,	,	,
25944	2051	19	extraction	extraction	NN
25944	2051	20	of	of	IN
25944	2051	21	the	the	DT
25944	2051	22	hairs	hair	NNS
25944	2051	23	and	and	CC
25944	2051	24	the	the	DT
25944	2051	25	use	use	NN
25944	2051	26	of	of	IN
25944	2051	27	depilatories	depilatory	NNS
25944	2051	28	.	.	.
25944	2052	1	As	as	IN
25944	2052	2	a	a	DT
25944	2052	3	depilatory	depilatory	NN
25944	2052	4	,	,	,
25944	2052	5	a	a	DT
25944	2052	6	powder	powder	NN
25944	2052	7	made	make	VBN
25944	2052	8	up	up	RP
25944	2052	9	of	of	IN
25944	2052	10	two	two	CD
25944	2052	11	drachms	drachm	NNS
25944	2052	12	of	of	IN
25944	2052	13	barium	barium	NN
25944	2052	14	sulphide	sulphide	NN
25944	2052	15	and	and	CC
25944	2052	16	three	three	CD
25944	2052	17	drachms	drachm	NNS
25944	2052	18	each	each	DT
25944	2052	19	of	of	IN
25944	2052	20	zinc	zinc	NN
25944	2052	21	oxide	oxide	NN
25944	2052	22	and	and	CC
25944	2052	23	starch	starch	NN
25944	2052	24	,	,	,
25944	2052	25	is	be	VBZ
25944	2052	26	commonly	commonly	RB
25944	2052	27	(	(	-LRB-
25944	2052	28	and	and	CC
25944	2052	29	cautiously	cautiously	RB
25944	2052	30	)	)	-RRB-
25944	2052	31	employed	employ	VBN
25944	2052	32	;	;	:
25944	2052	33	at	at	IN
25944	2052	34	the	the	DT
25944	2052	35	time	time	NN
25944	2052	36	of	of	IN
25944	2052	37	application	application	NN
25944	2052	38	enough	enough	JJ
25944	2052	39	water	water	NN
25944	2052	40	is	be	VBZ
25944	2052	41	added	add	VBN
25944	2052	42	to	to	IN
25944	2052	43	the	the	DT
25944	2052	44	powder	powder	NN
25944	2052	45	to	to	TO
25944	2052	46	make	make	VB
25944	2052	47	a	a	DT
25944	2052	48	paste	paste	NN
25944	2052	49	,	,	,
25944	2052	50	and	and	CC
25944	2052	51	it	-PRON-	PRP
25944	2052	52	is	be	VBZ
25944	2052	53	then	then	RB
25944	2052	54	spread	spread	VBN
25944	2052	55	thinly	thinly	RB
25944	2052	56	upon	upon	IN
25944	2052	57	the	the	DT
25944	2052	58	parts	part	NNS
25944	2052	59	,	,	,
25944	2052	60	allowed	allow	VBN
25944	2052	61	to	to	TO
25944	2052	62	remain	remain	VB
25944	2052	63	five	five	CD
25944	2052	64	to	to	TO
25944	2052	65	fifteen	fifteen	CD
25944	2052	66	minutes	minute	NNS
25944	2052	67	,	,	,
25944	2052	68	or	or	CC
25944	2052	69	until	until	IN
25944	2052	70	heat	heat	NN
25944	2052	71	of	of	IN
25944	2052	72	skin	skin	NN
25944	2052	73	or	or	CC
25944	2052	74	a	a	DT
25944	2052	75	burning	burn	VBG
25944	2052	76	sensation	sensation	NN
25944	2052	77	is	be	VBZ
25944	2052	78	felt	feel	VBN
25944	2052	79	,	,	,
25944	2052	80	washed	wash	VBN
25944	2052	81	off	off	RP
25944	2052	82	thoroughly	thoroughly	RB
25944	2052	83	,	,	,
25944	2052	84	and	and	CC
25944	2052	85	a	a	DT
25944	2052	86	soothing	soothe	VBG
25944	2052	87	ointment	ointment	NN
25944	2052	88	applied	apply	VBD
25944	2052	89	.	.	.
25944	2053	1	This	this	DT
25944	2053	2	preparation	preparation	NN
25944	2053	3	must	must	MD
25944	2053	4	be	be	VB
25944	2053	5	well	well	RB
25944	2053	6	prepared	prepared	JJ
25944	2053	7	to	to	TO
25944	2053	8	be	be	VB
25944	2053	9	efficient	efficient	JJ
25944	2053	10	.	.	.
25944	2054	1	#	#	NNP
25944	2054	2	Describe	describe	VB
25944	2054	3	the	the	DT
25944	2054	4	method	method	NN
25944	2054	5	of	of	IN
25944	2054	6	removal	removal	NN
25944	2054	7	of	of	IN
25944	2054	8	superfluous	superfluous	JJ
25944	2054	9	hair	hair	NN
25944	2054	10	by	by	IN
25944	2054	11	electrolysis	electrolysis	NN
25944	2054	12	.	.	.
25944	2054	13	#	#	$
25944	2054	14	A	a	DT
25944	2054	15	fine	fine	JJ
25944	2054	16	needle	needle	NN
25944	2054	17	in	in	IN
25944	2054	18	a	a	DT
25944	2054	19	suitable	suitable	JJ
25944	2054	20	handle	handle	NN
25944	2054	21	is	be	VBZ
25944	2054	22	attached	attach	VBN
25944	2054	23	to	to	IN
25944	2054	24	the	the	DT
25944	2054	25	_	_	NNP
25944	2054	26	negative	negative	JJ
25944	2054	27	_	_	NNP
25944	2054	28	pole	pole	NN
25944	2054	29	of	of	IN
25944	2054	30	a	a	DT
25944	2054	31	_	_	NNP
25944	2054	32	galvanic	galvanic	JJ
25944	2054	33	_	_	NNP
25944	2054	34	battery	battery	NN
25944	2054	35	,	,	,
25944	2054	36	introduced	introduce	VBN
25944	2054	37	into	into	IN
25944	2054	38	the	the	DT
25944	2054	39	hair	hair	NN
25944	2054	40	-	-	HYPH
25944	2054	41	follicle	follicle	NN
25944	2054	42	to	to	IN
25944	2054	43	the	the	DT
25944	2054	44	depth	depth	NN
25944	2054	45	of	of	IN
25944	2054	46	the	the	DT
25944	2054	47	papilla	papilla	NN
25944	2054	48	,	,	,
25944	2054	49	and	and	CC
25944	2054	50	the	the	DT
25944	2054	51	circuit	circuit	NN
25944	2054	52	completed	complete	VBN
25944	2054	53	by	by	IN
25944	2054	54	the	the	DT
25944	2054	55	patient	patient	NN
25944	2054	56	touching	touch	VBG
25944	2054	57	the	the	DT
25944	2054	58	positive	positive	JJ
25944	2054	59	electrode	electrode	NN
25944	2054	60	;	;	:
25944	2054	61	in	in	IN
25944	2054	62	several	several	JJ
25944	2054	63	seconds	second	NNS
25944	2054	64	slight	slight	JJ
25944	2054	65	blanching	blanching	NN
25944	2054	66	and	and	CC
25944	2054	67	frothing	frothing	NN
25944	2054	68	usually	usually	RB
25944	2054	69	appear	appear	VBP
25944	2054	70	at	at	IN
25944	2054	71	the	the	DT
25944	2054	72	point	point	NN
25944	2054	73	of	of	IN
25944	2054	74	insertion	insertion	NN
25944	2054	75	;	;	:
25944	2054	76	a	a	DT
25944	2054	77	few	few	JJ
25944	2054	78	seconds	second	NNS
25944	2054	79	later	later	RB
25944	2054	80	the	the	DT
25944	2054	81	current	current	NN
25944	2054	82	is	be	VBZ
25944	2054	83	broken	break	VBN
25944	2054	84	by	by	IN
25944	2054	85	release	release	NN
25944	2054	86	of	of	IN
25944	2054	87	the	the	DT
25944	2054	88	positive	positive	JJ
25944	2054	89	electrode	electrode	NN
25944	2054	90	,	,	,
25944	2054	91	and	and	CC
25944	2054	92	the	the	DT
25944	2054	93	needle	needle	NN
25944	2054	94	is	be	VBZ
25944	2054	95	then	then	RB
25944	2054	96	withdrawn	withdraw	VBN
25944	2054	97	.	.	.
25944	2055	1	Sometimes	sometimes	RB
25944	2055	2	a	a	DT
25944	2055	3	wheal	wheal	NN
25944	2055	4	-	-	HYPH
25944	2055	5	like	like	JJ
25944	2055	6	elevation	elevation	NN
25944	2055	7	arises	arise	NNS
25944	2055	8	,	,	,
25944	2055	9	remains	remain	VBZ
25944	2055	10	several	several	JJ
25944	2055	11	minutes	minute	NNS
25944	2055	12	or	or	CC
25944	2055	13	hours	hour	NNS
25944	2055	14	,	,	,
25944	2055	15	and	and	CC
25944	2055	16	then	then	RB
25944	2055	17	disappears	disappear	VBZ
25944	2055	18	;	;	:
25944	2055	19	or	or	CC
25944	2055	20	occasionally	occasionally	RB
25944	2055	21	,	,	,
25944	2055	22	probably	probably	RB
25944	2055	23	from	from	IN
25944	2055	24	secondary	secondary	JJ
25944	2055	25	infection	infection	NN
25944	2055	26	,	,	,
25944	2055	27	it	-PRON-	PRP
25944	2055	28	develops	develop	VBZ
25944	2055	29	into	into	IN
25944	2055	30	a	a	DT
25944	2055	31	pustule	pustule	NN
25944	2055	32	.	.	.
25944	2056	1	A	a	DT
25944	2056	2	strength	strength	NN
25944	2056	3	of	of	IN
25944	2056	4	current	current	NN
25944	2056	5	of	of	IN
25944	2056	6	a	a	DT
25944	2056	7	half	half	NN
25944	2056	8	to	to	TO
25944	2056	9	two	two	CD
25944	2056	10	milliamperes	milliampere	NNS
25944	2056	11	is	be	VBZ
25944	2056	12	usually	usually	RB
25944	2056	13	sufficient	sufficient	JJ
25944	2056	14	;	;	:
25944	2056	15	the	the	DT
25944	2056	16	time	time	NN
25944	2056	17	necessary	necessary	JJ
25944	2056	18	for	for	IN
25944	2056	19	the	the	DT
25944	2056	20	destruction	destruction	NN
25944	2056	21	of	of	IN
25944	2056	22	the	the	DT
25944	2056	23	papilla	papilla	NN
25944	2056	24	varying	varying	NN
25944	2056	25	from	from	IN
25944	2056	26	several	several	JJ
25944	2056	27	to	to	IN
25944	2056	28	thirty	thirty	CD
25944	2056	29	seconds	second	NNS
25944	2056	30	.	.	.
25944	2057	1	#	#	NNP
25944	2057	2	How	how	WRB
25944	2057	3	are	be	VBP
25944	2057	4	you	-PRON-	PRP
25944	2057	5	to	to	TO
25944	2057	6	know	know	VB
25944	2057	7	if	if	IN
25944	2057	8	the	the	DT
25944	2057	9	papilla	papilla	NN
25944	2057	10	has	have	VBZ
25944	2057	11	been	be	VBN
25944	2057	12	destroyed	destroy	VBN
25944	2057	13	?	?	.
25944	2057	14	#	#	$
25944	2057	15	The	the	DT
25944	2057	16	hair	hair	NN
25944	2057	17	will	will	MD
25944	2057	18	readily	readily	RB
25944	2057	19	come	come	VB
25944	2057	20	out	out	RP
25944	2057	21	with	with	IN
25944	2057	22	but	but	CC
25944	2057	23	little	little	JJ
25944	2057	24	,	,	,
25944	2057	25	if	if	IN
25944	2057	26	any	any	DT
25944	2057	27	,	,	,
25944	2057	28	traction	traction	NN
25944	2057	29	.	.	.
25944	2058	1	#	#	LS
25944	2058	2	What	what	WP
25944	2058	3	is	be	VBZ
25944	2058	4	the	the	DT
25944	2058	5	result	result	NN
25944	2058	6	if	if	IN
25944	2058	7	the	the	DT
25944	2058	8	current	current	NN
25944	2058	9	has	have	VBZ
25944	2058	10	been	be	VBN
25944	2058	11	too	too	RB
25944	2058	12	strong	strong	JJ
25944	2058	13	or	or	CC
25944	2058	14	too	too	RB
25944	2058	15	long	long	RB
25944	2058	16	continued	continued	JJ
25944	2058	17	?	?	.
25944	2058	18	#	#	$
25944	2058	19	The	the	DT
25944	2058	20	follicle	follicle	NN
25944	2058	21	suppurates	suppurate	VBZ
25944	2058	22	and	and	CC
25944	2058	23	a	a	DT
25944	2058	24	scar	scar	NN
25944	2058	25	results	result	NNS
25944	2058	26	.	.	.
25944	2059	1	#	#	NNP
25944	2059	2	Why	why	WRB
25944	2059	3	should	should	MD
25944	2059	4	contiguous	contiguous	JJ
25944	2059	5	hairs	hair	NNS
25944	2059	6	not	not	RB
25944	2059	7	be	be	VB
25944	2059	8	operated	operate	VBN
25944	2059	9	upon	upon	IN
25944	2059	10	at	at	IN
25944	2059	11	the	the	DT
25944	2059	12	same	same	JJ
25944	2059	13	sitting	sitting	NN
25944	2059	14	?	?	.
25944	2059	15	#	#	$
25944	2059	16	In	in	IN
25944	2059	17	order	order	NN
25944	2059	18	that	that	IN
25944	2059	19	the	the	DT
25944	2059	20	chances	chance	NNS
25944	2059	21	of	of	IN
25944	2059	22	marked	marked	JJ
25944	2059	23	inflammatory	inflammatory	JJ
25944	2059	24	action	action	NN
25944	2059	25	and	and	CC
25944	2059	26	scarring	scar	VBG
25944	2059	27	(	(	-LRB-
25944	2059	28	always	always	RB
25944	2059	29	possibilities	possibility	NNS
25944	2059	30	)	)	-RRB-
25944	2059	31	may	may	MD
25944	2059	32	be	be	VB
25944	2059	33	reduced	reduce	VBN
25944	2059	34	to	to	IN
25944	2059	35	a	a	DT
25944	2059	36	minimum	minimum	NN
25944	2059	37	.	.	.
25944	2060	1	#	#	$
25944	2060	2	In	in	IN
25944	2060	3	case	case	NN
25944	2060	4	of	of	IN
25944	2060	5	failure	failure	NN
25944	2060	6	to	to	TO
25944	2060	7	destroy	destroy	VB
25944	2060	8	an	an	DT
25944	2060	9	individual	individual	JJ
25944	2060	10	papilla	papilla	NN
25944	2060	11	,	,	,
25944	2060	12	should	should	MD
25944	2060	13	a	a	DT
25944	2060	14	second	second	JJ
25944	2060	15	attempt	attempt	NN
25944	2060	16	be	be	VB
25944	2060	17	made	make	VBN
25944	2060	18	at	at	IN
25944	2060	19	the	the	DT
25944	2060	20	same	same	JJ
25944	2060	21	sitting	sitting	NN
25944	2060	22	?	?	.
25944	2060	23	#	#	$
25944	2060	24	As	as	IN
25944	2060	25	a	a	DT
25944	2060	26	rule	rule	NN
25944	2060	27	not	not	RB
25944	2060	28	,	,	,
25944	2060	29	in	in	IN
25944	2060	30	order	order	NN
25944	2060	31	to	to	TO
25944	2060	32	avoid	avoid	VB
25944	2060	33	the	the	DT
25944	2060	34	possibility	possibility	NN
25944	2060	35	of	of	IN
25944	2060	36	too	too	RB
25944	2060	37	much	much	JJ
25944	2060	38	destructive	destructive	JJ
25944	2060	39	action	action	NN
25944	2060	40	,	,	,
25944	2060	41	and	and	CC
25944	2060	42	consequent	consequent	NN
25944	2060	43	scarring	scarring	NN
25944	2060	44	.	.	.
25944	2061	1	#	#	NN
25944	2061	2	Can	Can	MD
25944	2061	3	scarring	scar	VBG
25944	2061	4	always	always	RB
25944	2061	5	be	be	VB
25944	2061	6	prevented	prevent	VBN
25944	2061	7	?	?	.
25944	2061	8	#	#	NN
25944	2061	9	In	in	IN
25944	2061	10	the	the	DT
25944	2061	11	average	average	JJ
25944	2061	12	case	case	NN
25944	2061	13	,	,	,
25944	2061	14	with	with	IN
25944	2061	15	skill	skill	NN
25944	2061	16	and	and	CC
25944	2061	17	care	care	NN
25944	2061	18	,	,	,
25944	2061	19	the	the	DT
25944	2061	20	use	use	NN
25944	2061	21	of	of	IN
25944	2061	22	an	an	DT
25944	2061	23	exceedingly	exceedingly	RB
25944	2061	24	fine	fine	JJ
25944	2061	25	needle	needle	NN
25944	2061	26	and	and	CC
25944	2061	27	the	the	DT
25944	2061	28	avoidance	avoidance	NN
25944	2061	29	of	of	IN
25944	2061	30	too	too	RB
25944	2061	31	strong	strong	JJ
25944	2061	32	a	a	DT
25944	2061	33	current	current	NN
25944	2061	34	,	,	,
25944	2061	35	_	_	NNP
25944	2061	36	perceptible	perceptible	JJ
25944	2061	37	_	_	NNP
25944	2061	38	scarring	scar	VBG
25944	2061	39	(	(	-LRB-
25944	2061	40	scarring	scar	VBG
25944	2061	41	perceptible	perceptible	JJ
25944	2061	42	to	to	IN
25944	2061	43	the	the	DT
25944	2061	44	ordinary	ordinary	JJ
25944	2061	45	observer	observer	NN
25944	2061	46	or	or	CC
25944	2061	47	at	at	IN
25944	2061	48	ordinary	ordinary	JJ
25944	2061	49	distance	distance	NN
25944	2061	50	)	)	-RRB-
25944	2061	51	need	nee	MD
25944	2061	52	rarely	rarely	RB
25944	2061	53	occur	occur	VB
25944	2061	54	.	.	.
25944	2062	1	#	#	LS
25944	2062	2	What	what	WDT
25944	2062	3	measures	measure	NNS
25944	2062	4	are	be	VBP
25944	2062	5	to	to	TO
25944	2062	6	be	be	VB
25944	2062	7	advised	advise	VBN
25944	2062	8	for	for	IN
25944	2062	9	the	the	DT
25944	2062	10	irritation	irritation	NN
25944	2062	11	produced	produce	VBN
25944	2062	12	by	by	IN
25944	2062	13	the	the	DT
25944	2062	14	operation	operation	NN
25944	2062	15	?	?	.
25944	2062	16	#	#	$
25944	2062	17	Hot	hot	JJ
25944	2062	18	-	-	HYPH
25944	2062	19	water	water	NN
25944	2062	20	applications	application	NNS
25944	2062	21	and	and	CC
25944	2062	22	the	the	DT
25944	2062	23	use	use	NN
25944	2062	24	of	of	IN
25944	2062	25	an	an	DT
25944	2062	26	ointment	ointment	NN
25944	2062	27	made	make	VBN
25944	2062	28	of	of	IN
25944	2062	29	two	two	CD
25944	2062	30	drachms	drachms	NN
25944	2062	31	cold	cold	JJ
25944	2062	32	cream	cream	NN
25944	2062	33	and	and	CC
25944	2062	34	ten	ten	CD
25944	2062	35	grains	grain	NNS
25944	2062	36	of	of	IN
25944	2062	37	boric	boric	NN
25944	2062	38	acid	acid	NN
25944	2062	39	are	be	VBP
25944	2062	40	of	of	IN
25944	2062	41	advantage	advantage	NN
25944	2062	42	not	not	RB
25944	2062	43	only	only	RB
25944	2062	44	in	in	IN
25944	2062	45	reducing	reduce	VBG
25944	2062	46	the	the	DT
25944	2062	47	resulting	result	VBG
25944	2062	48	hyperæmia	hyperæmia	NN
25944	2062	49	,	,	,
25944	2062	50	but	but	CC
25944	2062	51	also	also	RB
25944	2062	52	in	in	IN
25944	2062	53	preventing	prevent	VBG
25944	2062	54	suppuration	suppuration	NN
25944	2062	55	and	and	CC
25944	2062	56	consequent	consequent	NN
25944	2062	57	scarring	scarring	NN
25944	2062	58	.	.	.
25944	2063	1	To	to	TO
25944	2063	2	lessen	lessen	VB
25944	2063	3	the	the	DT
25944	2063	4	chances	chance	NNS
25944	2063	5	of	of	IN
25944	2063	6	the	the	DT
25944	2063	7	latter	latter	JJ
25944	2063	8	,	,	,
25944	2063	9	cleansing	cleanse	VBG
25944	2063	10	the	the	DT
25944	2063	11	parts	part	NNS
25944	2063	12	with	with	IN
25944	2063	13	alcohol	alcohol	NN
25944	2063	14	just	just	RB
25944	2063	15	before	before	IN
25944	2063	16	and	and	CC
25944	2063	17	after	after	IN
25944	2063	18	the	the	DT
25944	2063	19	operation	operation	NN
25944	2063	20	is	be	VBZ
25944	2063	21	also	also	RB
25944	2063	22	of	of	IN
25944	2063	23	service	service	NN
25944	2063	24	.	.	.
25944	2064	1	#	#	$
25944	2064	2	[	[	-LRB-
25944	2064	3	OE]dema	OE]dema	NNP
25944	2064	4	Neonatorum	Neonatorum	NNP
25944	2064	5	.	.	.
25944	2064	6	#	#	$
25944	2064	7	#	#	NN
25944	2064	8	Describe	describe	VB
25944	2064	9	[	[	-LRB-
25944	2064	10	oe]dema	oe]dema	FW
25944	2064	11	neonatorum	neonatorum	NN
25944	2064	12	.	.	.
25944	2064	13	#	#	$
25944	2064	14	The	the	DT
25944	2064	15	essential	essential	JJ
25944	2064	16	symptoms	symptom	NNS
25944	2064	17	are	be	VBP
25944	2064	18	[	[	-LRB-
25944	2064	19	oe]dema	oe]dema	ADD
25944	2064	20	and	and	CC
25944	2064	21	a	a	DT
25944	2064	22	variable	variable	JJ
25944	2064	23	degree	degree	NN
25944	2064	24	of	of	IN
25944	2064	25	hardness	hardness	NN
25944	2064	26	and	and	CC
25944	2064	27	induration	induration	NN
25944	2064	28	.	.	.
25944	2065	1	It	-PRON-	PRP
25944	2065	2	develops	develop	VBZ
25944	2065	3	in	in	IN
25944	2065	4	the	the	DT
25944	2065	5	first	first	JJ
25944	2065	6	few	few	JJ
25944	2065	7	days	day	NNS
25944	2065	8	of	of	IN
25944	2065	9	life	life	NN
25944	2065	10	,	,	,
25944	2065	11	and	and	CC
25944	2065	12	usually	usually	RB
25944	2065	13	upon	upon	IN
25944	2065	14	the	the	DT
25944	2065	15	extremities	extremity	NNS
25944	2065	16	,	,	,
25944	2065	17	especially	especially	RB
25944	2065	18	the	the	DT
25944	2065	19	lower	low	JJR
25944	2065	20	.	.	.
25944	2066	1	It	-PRON-	PRP
25944	2066	2	may	may	MD
25944	2066	3	remain	remain	VB
25944	2066	4	more	more	RBR
25944	2066	5	or	or	CC
25944	2066	6	less	less	RBR
25944	2066	7	limited	limited	JJ
25944	2066	8	to	to	IN
25944	2066	9	these	these	DT
25944	2066	10	parts	part	NNS
25944	2066	11	,	,	,
25944	2066	12	but	but	CC
25944	2066	13	,	,	,
25944	2066	14	as	as	IN
25944	2066	15	a	a	DT
25944	2066	16	rule	rule	NN
25944	2066	17	,	,	,
25944	2066	18	slowly	slowly	RB
25944	2066	19	extends	extend	VBZ
25944	2066	20	.	.	.
25944	2067	1	The	the	DT
25944	2067	2	skin	skin	NN
25944	2067	3	is	be	VBZ
25944	2067	4	of	of	IN
25944	2067	5	a	a	DT
25944	2067	6	yellowish	yellowish	JJ
25944	2067	7	,	,	,
25944	2067	8	dusky	dusky	JJ
25944	2067	9	,	,	,
25944	2067	10	or	or	CC
25944	2067	11	livid	livid	JJ
25944	2067	12	color	color	NN
25944	2067	13	,	,	,
25944	2067	14	and	and	CC
25944	2067	15	sometimes	sometimes	RB
25944	2067	16	glossy	glossy	JJ
25944	2067	17	or	or	CC
25944	2067	18	shining	shine	VBG
25944	2067	19	.	.	.
25944	2068	1	There	there	EX
25944	2068	2	are	be	VBP
25944	2068	3	general	general	JJ
25944	2068	4	symptoms	symptom	NNS
25944	2068	5	of	of	IN
25944	2068	6	drowsiness	drowsiness	NN
25944	2068	7	,	,	,
25944	2068	8	subnormal	subnormal	JJ
25944	2068	9	temperature	temperature	NN
25944	2068	10	,	,	,
25944	2068	11	weakened	weakened	JJ
25944	2068	12	circulation	circulation	NN
25944	2068	13	,	,	,
25944	2068	14	and	and	CC
25944	2068	15	impaired	impair	VBN
25944	2068	16	respiration	respiration	NN
25944	2068	17	,	,	,
25944	2068	18	which	which	WDT
25944	2068	19	gradually	gradually	RB
25944	2068	20	increase	increase	VBP
25944	2068	21	,	,	,
25944	2068	22	and	and	CC
25944	2068	23	in	in	IN
25944	2068	24	eighty	eighty	CD
25944	2068	25	to	to	TO
25944	2068	26	ninety	ninety	CD
25944	2068	27	per	per	IN
25944	2068	28	cent	cent	NN
25944	2068	29	.	.	.
25944	2069	1	of	of	IN
25944	2069	2	the	the	DT
25944	2069	3	cases	case	NNS
25944	2069	4	lead	lead	VBP
25944	2069	5	to	to	IN
25944	2069	6	death	death	NN
25944	2069	7	.	.	.
25944	2070	1	It	-PRON-	PRP
25944	2070	2	is	be	VBZ
25944	2070	3	believed	believe	VBN
25944	2070	4	to	to	TO
25944	2070	5	be	be	VB
25944	2070	6	similar	similar	JJ
25944	2070	7	to	to	IN
25944	2070	8	anasarca	anasarca	NN
25944	2070	9	in	in	IN
25944	2070	10	the	the	DT
25944	2070	11	adult	adult	NN
25944	2070	12	and	and	CC
25944	2070	13	to	to	TO
25944	2070	14	be	be	VB
25944	2070	15	due	due	JJ
25944	2070	16	to	to	IN
25944	2070	17	like	like	JJ
25944	2070	18	causes	cause	NNS
25944	2070	19	.	.	.
25944	2071	1	Treatment	treatment	NN
25944	2071	2	consists	consist	VBZ
25944	2071	3	in	in	IN
25944	2071	4	maintaining	maintain	VBG
25944	2071	5	the	the	DT
25944	2071	6	body	body	NN
25944	2071	7	-	-	HYPH
25944	2071	8	heat	heat	NN
25944	2071	9	,	,	,
25944	2071	10	sufficient	sufficient	JJ
25944	2071	11	and	and	CC
25944	2071	12	proper	proper	JJ
25944	2071	13	nourishment	nourishment	NN
25944	2071	14	and	and	CC
25944	2071	15	stimulation	stimulation	NN
25944	2071	16	.	.	.
25944	2072	1	#	#	NNP
25944	2072	2	Sclerema	Sclerema	NNP
25944	2072	3	Neonatorum	Neonatorum	NNP
25944	2072	4	.	.	.
25944	2072	5	#	#	NNP
25944	2072	6	(	(	-LRB-
25944	2072	7	_	_	NNP
25944	2072	8	Synonyms	Synonyms	NNP
25944	2072	9	:	:	:
25944	2072	10	_	_	NNP
25944	2072	11	Scleroderma	Scleroderma	NNP
25944	2072	12	Neonatorum	Neonatorum	NNP
25944	2072	13	;	;	:
25944	2072	14	Sclerema	Sclerema	NNP
25944	2072	15	of	of	IN
25944	2072	16	the	the	DT
25944	2072	17	Newborn	Newborn	NNP
25944	2072	18	.	.	.
25944	2072	19	)	)	-RRB-
25944	2073	1	#	#	LS
25944	2073	2	What	what	WP
25944	2073	3	is	be	VBZ
25944	2073	4	sclerema	sclerema	NN
25944	2073	5	neonatorum	neonatorum	NN
25944	2073	6	?	?	.
25944	2073	7	#	#	NNP
25944	2073	8	Sclerema	Sclerema	NNP
25944	2073	9	neonatorum	neonatorum	NN
25944	2073	10	is	be	VBZ
25944	2073	11	a	a	DT
25944	2073	12	disease	disease	NN
25944	2073	13	of	of	IN
25944	2073	14	infancy	infancy	NN
25944	2073	15	,	,	,
25944	2073	16	showing	show	VBG
25944	2073	17	itself	-PRON-	PRP
25944	2073	18	usually	usually	RB
25944	2073	19	at	at	IN
25944	2073	20	or	or	CC
25944	2073	21	shortly	shortly	RB
25944	2073	22	after	after	IN
25944	2073	23	birth	birth	NN
25944	2073	24	,	,	,
25944	2073	25	and	and	CC
25944	2073	26	is	be	VBZ
25944	2073	27	characterized	characterize	VBN
25944	2073	28	by	by	IN
25944	2073	29	a	a	DT
25944	2073	30	diffuse	diffuse	NN
25944	2073	31	stiffness	stiffness	NN
25944	2073	32	and	and	CC
25944	2073	33	rigidity	rigidity	NN
25944	2073	34	of	of	IN
25944	2073	35	the	the	DT
25944	2073	36	integument	integument	NN
25944	2073	37	,	,	,
25944	2073	38	accompanied	accompany	VBN
25944	2073	39	by	by	IN
25944	2073	40	coldness	coldness	NN
25944	2073	41	,	,	,
25944	2073	42	[	[	-LRB-
25944	2073	43	oe]dema	oe]dema	NN
25944	2073	44	,	,	,
25944	2073	45	discoloration	discoloration	NN
25944	2073	46	,	,	,
25944	2073	47	lividity	lividity	NN
25944	2073	48	and	and	CC
25944	2073	49	general	general	JJ
25944	2073	50	circulatory	circulatory	JJ
25944	2073	51	disturbance	disturbance	NN
25944	2073	52	.	.	.
25944	2074	1	#	#	NNP
25944	2074	2	Describe	describe	VB
25944	2074	3	the	the	DT
25944	2074	4	symptoms	symptom	NNS
25944	2074	5	,	,	,
25944	2074	6	course	course	NN
25944	2074	7	,	,	,
25944	2074	8	nature	nature	NN
25944	2074	9	and	and	CC
25944	2074	10	treatment	treatment	NN
25944	2074	11	of	of	IN
25944	2074	12	sclerema	sclerema	NN
25944	2074	13	neonatorum	neonatorum	NNP
25944	2074	14	.	.	.
25944	2074	15	#	#	$
25944	2074	16	As	as	IN
25944	2074	17	a	a	DT
25944	2074	18	rule	rule	NN
25944	2074	19	the	the	DT
25944	2074	20	disease	disease	NN
25944	2074	21	first	first	RB
25944	2074	22	manifests	manifest	VBZ
25944	2074	23	itself	-PRON-	PRP
25944	2074	24	upon	upon	IN
25944	2074	25	the	the	DT
25944	2074	26	lower	low	JJR
25944	2074	27	extremities	extremity	NNS
25944	2074	28	,	,	,
25944	2074	29	and	and	CC
25944	2074	30	then	then	RB
25944	2074	31	gradually	gradually	RB
25944	2074	32	,	,	,
25944	2074	33	but	but	CC
25944	2074	34	usually	usually	RB
25944	2074	35	rapidly	rapidly	RB
25944	2074	36	,	,	,
25944	2074	37	invades	invade	VBZ
25944	2074	38	the	the	DT
25944	2074	39	trunk	trunk	NN
25944	2074	40	,	,	,
25944	2074	41	arms	arm	NNS
25944	2074	42	and	and	CC
25944	2074	43	face	face	NN
25944	2074	44	.	.	.
25944	2075	1	The	the	DT
25944	2075	2	surface	surface	NN
25944	2075	3	is	be	VBZ
25944	2075	4	cold	cold	JJ
25944	2075	5	.	.	.
25944	2076	1	The	the	DT
25944	2076	2	skin	skin	NN
25944	2076	3	,	,	,
25944	2076	4	which	which	WDT
25944	2076	5	is	be	VBZ
25944	2076	6	noted	note	VBN
25944	2076	7	to	to	TO
25944	2076	8	be	be	VB
25944	2076	9	reddish	reddish	JJ
25944	2076	10	,	,	,
25944	2076	11	purplish	purplish	JJ
25944	2076	12	or	or	CC
25944	2076	13	mottled	mottle	VBN
25944	2076	14	,	,	,
25944	2076	15	is	be	VBZ
25944	2076	16	[	[	-LRB-
25944	2076	17	oe]dematous	oe]dematous	JJ
25944	2076	18	,	,	,
25944	2076	19	stiff	stiff	JJ
25944	2076	20	and	and	CC
25944	2076	21	tense	tense	JJ
25944	2076	22	;	;	:
25944	2076	23	in	in	IN
25944	2076	24	consequence	consequence	NNP
25944	2076	25	the	the	DT
25944	2076	26	infant	infant	NN
25944	2076	27	is	be	VBZ
25944	2076	28	unable	unable	JJ
25944	2076	29	to	to	TO
25944	2076	30	move	move	VB
25944	2076	31	,	,	,
25944	2076	32	respires	respire	NNS
25944	2076	33	feebly	feebly	RB
25944	2076	34	and	and	CC
25944	2076	35	usually	usually	RB
25944	2076	36	perishes	perish	VBZ
25944	2076	37	in	in	IN
25944	2076	38	a	a	DT
25944	2076	39	few	few	JJ
25944	2076	40	days	day	NNS
25944	2076	41	or	or	CC
25944	2076	42	weeks	week	NNS
25944	2076	43	.	.	.
25944	2077	1	In	in	IN
25944	2077	2	extremely	extremely	RB
25944	2077	3	exceptional	exceptional	JJ
25944	2077	4	instances	instance	NNS
25944	2077	5	the	the	DT
25944	2077	6	disease	disease	NN
25944	2077	7	,	,	,
25944	2077	8	after	after	IN
25944	2077	9	involving	involve	VBG
25944	2077	10	a	a	DT
25944	2077	11	small	small	JJ
25944	2077	12	part	part	NN
25944	2077	13	,	,	,
25944	2077	14	may	may	MD
25944	2077	15	retrogress	retrogress	NN
25944	2077	16	and	and	CC
25944	2077	17	recovery	recovery	NN
25944	2077	18	take	take	VB
25944	2077	19	place	place	NN
25944	2077	20	.	.	.
25944	2078	1	The	the	DT
25944	2078	2	disease	disease	NN
25944	2078	3	is	be	VBZ
25944	2078	4	rare	rare	JJ
25944	2078	5	,	,	,
25944	2078	6	and	and	CC
25944	2078	7	in	in	IN
25944	2078	8	most	most	JJS
25944	2078	9	cases	case	NNS
25944	2078	10	is	be	VBZ
25944	2078	11	found	find	VBN
25944	2078	12	associated	associate	VBN
25944	2078	13	with	with	IN
25944	2078	14	pneumonia	pneumonia	NN
25944	2078	15	and	and	CC
25944	2078	16	with	with	IN
25944	2078	17	affections	affection	NNS
25944	2078	18	of	of	IN
25944	2078	19	the	the	DT
25944	2078	20	circulatory	circulatory	JJ
25944	2078	21	apparatus	apparatus	NN
25944	2078	22	.	.	.
25944	2079	1	Treatment	treatment	NN
25944	2079	2	should	should	MD
25944	2079	3	be	be	VB
25944	2079	4	directed	direct	VBN
25944	2079	5	toward	toward	IN
25944	2079	6	maintaining	maintain	VBG
25944	2079	7	warmth	warmth	NN
25944	2079	8	and	and	CC
25944	2079	9	proper	proper	JJ
25944	2079	10	alimentation	alimentation	NN
25944	2079	11	.	.	.
25944	2080	1	#	#	NNP
25944	2080	2	Scleroderma	Scleroderma	NNP
25944	2080	3	.	.	.
25944	2080	4	#	#	NNP
25944	2080	5	(	(	-LRB-
25944	2080	6	_	_	NNP
25944	2080	7	Synonyms	Synonyms	NNP
25944	2080	8	:	:	:
25944	2080	9	_	_	NNP
25944	2080	10	Sclerema	Sclerema	NNP
25944	2080	11	;	;	:
25944	2080	12	Scleriasis	scleriasis	NN
25944	2080	13	;	;	:
25944	2080	14	Dermatosclerosis	dermatosclerosis	NN
25944	2080	15	;	;	,
25944	2080	16	Morph[oe]a	morph[oe]a	CD
25944	2080	17	;	;	:
25944	2080	18	Keloid	Keloid	NNP
25944	2080	19	of	of	IN
25944	2080	20	Addison	Addison	NNP
25944	2080	21	.	.	.
25944	2080	22	)	)	-RRB-
25944	2081	1	#	#	LS
25944	2081	2	What	what	WP
25944	2081	3	is	be	VBZ
25944	2081	4	scleroderma	scleroderma	NN
25944	2081	5	?	?	.
25944	2081	6	#	#	NNP
25944	2081	7	Scleroderma	Scleroderma	NNP
25944	2081	8	is	be	VBZ
25944	2081	9	an	an	DT
25944	2081	10	acute	acute	JJ
25944	2081	11	or	or	CC
25944	2081	12	chronic	chronic	JJ
25944	2081	13	disease	disease	NN
25944	2081	14	of	of	IN
25944	2081	15	the	the	DT
25944	2081	16	skin	skin	NN
25944	2081	17	characterized	characterize	VBN
25944	2081	18	by	by	IN
25944	2081	19	a	a	DT
25944	2081	20	localized	localized	JJ
25944	2081	21	or	or	CC
25944	2081	22	general	general	JJ
25944	2081	23	,	,	,
25944	2081	24	more	more	RBR
25944	2081	25	or	or	CC
25944	2081	26	less	less	JJR
25944	2081	27	diffuse	diffuse	NN
25944	2081	28	,	,	,
25944	2081	29	usually	usually	RB
25944	2081	30	pigmented	pigment	VBN
25944	2081	31	,	,	,
25944	2081	32	rigid	rigid	JJ
25944	2081	33	,	,	,
25944	2081	34	stiffened	stiffen	VBD
25944	2081	35	,	,	,
25944	2081	36	indurated	indurate	VBD
25944	2081	37	or	or	CC
25944	2081	38	hide	hide	VB
25944	2081	39	-	-	HYPH
25944	2081	40	bound	bind	VBN
25944	2081	41	condition	condition	NN
25944	2081	42	.	.	.
25944	2082	1	Morph[oe]a	Morph[oe]a	NNP
25944	2082	2	,	,	,
25944	2082	3	by	by	IN
25944	2082	4	some	some	DT
25944	2082	5	formerly	formerly	RB
25944	2082	6	thought	think	VBN
25944	2082	7	to	to	TO
25944	2082	8	be	be	VB
25944	2082	9	a	a	DT
25944	2082	10	distinct	distinct	JJ
25944	2082	11	affection	affection	NN
25944	2082	12	,	,	,
25944	2082	13	is	be	VBZ
25944	2082	14	now	now	RB
25944	2082	15	believed	believe	VBN
25944	2082	16	to	to	TO
25944	2082	17	be	be	VB
25944	2082	18	a	a	DT
25944	2082	19	form	form	NN
25944	2082	20	of	of	IN
25944	2082	21	scleroderma	scleroderma	NN
25944	2082	22	;	;	:
25944	2082	23	as	as	RB
25944	2082	24	typically	typically	RB
25944	2082	25	met	meet	VBD
25944	2082	26	with	with	IN
25944	2082	27	it	-PRON-	PRP
25944	2082	28	is	be	VBZ
25944	2082	29	characterized	characterize	VBN
25944	2082	30	by	by	IN
25944	2082	31	one	one	CD
25944	2082	32	or	or	CC
25944	2082	33	more	more	RBR
25944	2082	34	rounded	rounded	JJ
25944	2082	35	,	,	,
25944	2082	36	oval	oval	NN
25944	2082	37	,	,	,
25944	2082	38	or	or	CC
25944	2082	39	elongate	elongate	VB
25944	2082	40	,	,	,
25944	2082	41	coin-	coin-	NN
25944	2082	42	to	to	IN
25944	2082	43	palm	palm	NN
25944	2082	44	-	-	HYPH
25944	2082	45	sized	sized	JJ
25944	2082	46	,	,	,
25944	2082	47	pinkish	pinkish	NN
25944	2082	48	,	,	,
25944	2082	49	or	or	CC
25944	2082	50	whitish	whitish	JJ
25944	2082	51	ivory	ivory	NN
25944	2082	52	-	-	HYPH
25944	2082	53	looking	look	VBG
25944	2082	54	patches	patch	NNS
25944	2082	55	.	.	.
25944	2083	1	In	in	IN
25944	2083	2	some	some	DT
25944	2083	3	instances	instance	NNS
25944	2083	4	such	such	JJ
25944	2083	5	patches	patch	NNS
25944	2083	6	are	be	VBP
25944	2083	7	seen	see	VBN
25944	2083	8	in	in	IN
25944	2083	9	association	association	NN
25944	2083	10	with	with	IN
25944	2083	11	the	the	DT
25944	2083	12	more	more	RBR
25944	2083	13	classic	classic	JJ
25944	2083	14	type	type	NN
25944	2083	15	of	of	IN
25944	2083	16	scleroderma	scleroderma	NN
25944	2083	17	just	just	RB
25944	2083	18	defined	define	VBN
25944	2083	19	.	.	.
25944	2084	1	#	#	NNP
25944	2084	2	Describe	describe	VB
25944	2084	3	the	the	DT
25944	2084	4	symptoms	symptom	NNS
25944	2084	5	of	of	IN
25944	2084	6	ordinary	ordinary	JJ
25944	2084	7	scleroderma	scleroderma	NN
25944	2084	8	.	.	.
25944	2084	9	#	#	$
25944	2084	10	The	the	DT
25944	2084	11	disease	disease	NN
25944	2084	12	may	may	MD
25944	2084	13	be	be	VB
25944	2084	14	acute	acute	JJ
25944	2084	15	or	or	CC
25944	2084	16	chronic	chronic	JJ
25944	2084	17	,	,	,
25944	2084	18	usually	usually	RB
25944	2084	19	the	the	DT
25944	2084	20	latter	latter	JJ
25944	2084	21	.	.	.
25944	2085	1	A	a	DT
25944	2085	2	portion	portion	NN
25944	2085	3	or	or	CC
25944	2085	4	almost	almost	RB
25944	2085	5	the	the	DT
25944	2085	6	entire	entire	JJ
25944	2085	7	surface	surface	NN
25944	2085	8	may	may	MD
25944	2085	9	be	be	VB
25944	2085	10	involved	involve	VBN
25944	2085	11	,	,	,
25944	2085	12	or	or	CC
25944	2085	13	it	-PRON-	PRP
25944	2085	14	may	may	MD
25944	2085	15	occupy	occupy	VB
25944	2085	16	variously	variously	RB
25944	2085	17	sized	sized	JJ
25944	2085	18	and	and	CC
25944	2085	19	shaped	shaped	JJ
25944	2085	20	areas	area	NNS
25944	2085	21	.	.	.
25944	2086	1	The	the	DT
25944	2086	2	integument	integument	NN
25944	2086	3	becomes	become	VBZ
25944	2086	4	more	more	RBR
25944	2086	5	or	or	CC
25944	2086	6	less	less	RBR
25944	2086	7	rigid	rigid	JJ
25944	2086	8	and	and	CC
25944	2086	9	indurated	indurated	JJ
25944	2086	10	,	,	,
25944	2086	11	hard	hard	RB
25944	2086	12	to	to	IN
25944	2086	13	the	the	DT
25944	2086	14	touch	touch	NN
25944	2086	15	,	,	,
25944	2086	16	hide	hide	NN
25944	2086	17	-	-	HYPH
25944	2086	18	bound	bind	VBN
25944	2086	19	,	,	,
25944	2086	20	and	and	CC
25944	2086	21	in	in	IN
25944	2086	22	marked	marked	JJ
25944	2086	23	cases	case	NNS
25944	2086	24	immobile	immobile	JJ
25944	2086	25	.	.	.
25944	2087	1	[	[	-LRB-
25944	2087	2	OE]dema	OE]dema	NNP
25944	2087	3	may	may	MD
25944	2087	4	,	,	,
25944	2087	5	especially	especially	RB
25944	2087	6	in	in	IN
25944	2087	7	the	the	DT
25944	2087	8	more	more	RBR
25944	2087	9	acute	acute	JJ
25944	2087	10	cases	case	NNS
25944	2087	11	,	,	,
25944	2087	12	precede	precede	VBP
25944	2087	13	the	the	DT
25944	2087	14	induration	induration	NN
25944	2087	15	.	.	.
25944	2088	1	Pigmentation	pigmentation	NN
25944	2088	2	,	,	,
25944	2088	3	of	of	IN
25944	2088	4	a	a	DT
25944	2088	5	yellowish	yellowish	JJ
25944	2088	6	or	or	CC
25944	2088	7	brownish	brownish	JJ
25944	2088	8	color	color	NN
25944	2088	9	,	,	,
25944	2088	10	is	be	VBZ
25944	2088	11	often	often	RB
25944	2088	12	a	a	DT
25944	2088	13	precursory	precursory	NN
25944	2088	14	and	and	CC
25944	2088	15	accompanying	accompany	VBG
25944	2088	16	symptom	symptom	NN
25944	2088	17	.	.	.
25944	2089	1	The	the	DT
25944	2089	2	skin	skin	NN
25944	2089	3	feels	feel	VBZ
25944	2089	4	tight	tight	JJ
25944	2089	5	and	and	CC
25944	2089	6	contracted	contract	VBN
25944	2089	7	,	,	,
25944	2089	8	and	and	CC
25944	2089	9	in	in	IN
25944	2089	10	some	some	DT
25944	2089	11	instances	instance	NNS
25944	2089	12	numbness	numbness	NN
25944	2089	13	and	and	CC
25944	2089	14	cramp	cramp	NN
25944	2089	15	-	-	HYPH
25944	2089	16	like	like	JJ
25944	2089	17	pains	pain	NNS
25944	2089	18	are	be	VBP
25944	2089	19	complained	complain	VBN
25944	2089	20	of	of	IN
25944	2089	21	.	.	.
25944	2090	1	#	#	NNP
25944	2090	2	Describe	describe	VB
25944	2090	3	the	the	DT
25944	2090	4	variety	variety	NN
25944	2090	5	known	know	VBN
25944	2090	6	as	as	IN
25944	2090	7	morph[oe]a	morph[oe]a	NNP
25944	2090	8	.	.	.
25944	2090	9	#	#	$
25944	2090	10	The	the	DT
25944	2090	11	patches	patch	NNS
25944	2090	12	(	(	-LRB-
25944	2090	13	one	one	CD
25944	2090	14	,	,	,
25944	2090	15	several	several	JJ
25944	2090	16	,	,	,
25944	2090	17	or	or	CC
25944	2090	18	more	more	JJR
25944	2090	19	)	)	-RRB-
25944	2090	20	,	,	,
25944	2090	21	occurring	occur	VBG
25944	2090	22	most	most	RBS
25944	2090	23	frequently	frequently	RB
25944	2090	24	about	about	IN
25944	2090	25	the	the	DT
25944	2090	26	trunk	trunk	NN
25944	2090	27	,	,	,
25944	2090	28	are	be	VBP
25944	2090	29	in	in	IN
25944	2090	30	the	the	DT
25944	2090	31	beginning	beginning	NN
25944	2090	32	usually	usually	RB
25944	2090	33	slightly	slightly	RB
25944	2090	34	hyperæmic	hyperæmic	JJ
25944	2090	35	,	,	,
25944	2090	36	later	later	RB
25944	2090	37	becoming	become	VBG
25944	2090	38	pale	pale	JJ
25944	2090	39	-	-	HYPH
25944	2090	40	yellowish	yellowish	JJ
25944	2090	41	or	or	CC
25944	2090	42	white	white	JJ
25944	2090	43	,	,	,
25944	2090	44	and	and	CC
25944	2090	45	having	have	VBG
25944	2090	46	a	a	DT
25944	2090	47	pinkish	pinkish	NN
25944	2090	48	or	or	CC
25944	2090	49	lilac	lilac	NNS
25944	2090	50	border	border	NN
25944	2090	51	made	make	VBD
25944	2090	52	up	up	RP
25944	2090	53	of	of	IN
25944	2090	54	minute	minute	JJ
25944	2090	55	capillaries	capillary	NNS
25944	2090	56	.	.	.
25944	2091	1	They	-PRON-	PRP
25944	2091	2	are	be	VBP
25944	2091	3	,	,	,
25944	2091	4	as	as	IN
25944	2091	5	a	a	DT
25944	2091	6	rule	rule	NN
25944	2091	7	,	,	,
25944	2091	8	sharply	sharply	RB
25944	2091	9	defined	define	VBN
25944	2091	10	,	,	,
25944	2091	11	with	with	IN
25944	2091	12	a	a	DT
25944	2091	13	smooth	smooth	JJ
25944	2091	14	,	,	,
25944	2091	15	often	often	RB
25944	2091	16	shining	shine	VBG
25944	2091	17	and	and	CC
25944	2091	18	atrophic	atrophic	JJ
25944	2091	19	-	-	HYPH
25944	2091	20	looking	look	VBG
25944	2091	21	surface	surface	NN
25944	2091	22	;	;	:
25944	2091	23	are	be	VBP
25944	2091	24	soft	soft	JJ
25944	2091	25	,	,	,
25944	2091	26	fine	fine	JJ
25944	2091	27	or	or	CC
25944	2091	28	leathery	leathery	NN
25944	2091	29	to	to	IN
25944	2091	30	the	the	DT
25944	2091	31	touch	touch	NN
25944	2091	32	,	,	,
25944	2091	33	on	on	IN
25944	2091	34	a	a	DT
25944	2091	35	level	level	NN
25944	2091	36	or	or	CC
25944	2091	37	somewhat	somewhat	RB
25944	2091	38	depressed	depressed	JJ
25944	2091	39	,	,	,
25944	2091	40	and	and	CC
25944	2091	41	appearing	appear	VBG
25944	2091	42	not	not	RB
25944	2091	43	unlike	unlike	IN
25944	2091	44	a	a	DT
25944	2091	45	piece	piece	NN
25944	2091	46	of	of	IN
25944	2091	47	bacon	bacon	NN
25944	2091	48	or	or	CC
25944	2091	49	ivory	ivory	NN
25944	2091	50	laid	lay	VBN
25944	2091	51	in	in	IN
25944	2091	52	the	the	DT
25944	2091	53	skin	skin	NN
25944	2091	54	.	.	.
25944	2092	1	Occasionally	occasionally	RB
25944	2092	2	the	the	DT
25944	2092	3	patches	patch	NNS
25944	2092	4	are	be	VBP
25944	2092	5	noted	note	VBN
25944	2092	6	to	to	TO
25944	2092	7	occur	occur	VB
25944	2092	8	over	over	IN
25944	2092	9	nerve	nerve	NN
25944	2092	10	-	-	HYPH
25944	2092	11	tracts	tract	NNS
25944	2092	12	.	.	.
25944	2093	1	The	the	DT
25944	2093	2	adjacent	adjacent	JJ
25944	2093	3	skin	skin	NN
25944	2093	4	may	may	MD
25944	2093	5	be	be	VB
25944	2093	6	normal	normal	JJ
25944	2093	7	or	or	CC
25944	2093	8	there	there	EX
25944	2093	9	may	may	MD
25944	2093	10	be	be	VB
25944	2093	11	more	more	RBR
25944	2093	12	or	or	CC
25944	2093	13	less	less	RBR
25944	2093	14	yellowish	yellowish	JJ
25944	2093	15	or	or	CC
25944	2093	16	brownish	brownish	JJ
25944	2093	17	mottling	mottling	NN
25944	2093	18	.	.	.
25944	2094	1	The	the	DT
25944	2094	2	subjective	subjective	JJ
25944	2094	3	symptoms	symptom	NNS
25944	2094	4	of	of	IN
25944	2094	5	tingling	tingling	NN
25944	2094	6	,	,	,
25944	2094	7	itching	itching	NN
25944	2094	8	,	,	,
25944	2094	9	numbness	numbness	NN
25944	2094	10	,	,	,
25944	2094	11	and	and	CC
25944	2094	12	even	even	RB
25944	2094	13	pain	pain	NN
25944	2094	14	,	,	,
25944	2094	15	may	may	MD
25944	2094	16	or	or	CC
25944	2094	17	may	may	MD
25944	2094	18	not	not	RB
25944	2094	19	be	be	VB
25944	2094	20	present	present	JJ
25944	2094	21	.	.	.
25944	2095	1	#	#	LS
25944	2095	2	What	what	WP
25944	2095	3	is	be	VBZ
25944	2095	4	the	the	DT
25944	2095	5	course	course	NN
25944	2095	6	of	of	IN
25944	2095	7	the	the	DT
25944	2095	8	disease	disease	NN
25944	2095	9	?	?	.
25944	2095	10	#	#	$
25944	2095	11	Sooner	soon	RBR
25944	2095	12	or	or	CC
25944	2095	13	later	later	RBR
25944	2095	14	,	,	,
25944	2095	15	usually	usually	RB
25944	2095	16	after	after	IN
25944	2095	17	months	month	NNS
25944	2095	18	or	or	CC
25944	2095	19	years	year	NNS
25944	2095	20	,	,	,
25944	2095	21	the	the	DT
25944	2095	22	disease	disease	NN
25944	2095	23	ends	end	VBZ
25944	2095	24	in	in	IN
25944	2095	25	resolution	resolution	NN
25944	2095	26	and	and	CC
25944	2095	27	recovery	recovery	NN
25944	2095	28	,	,	,
25944	2095	29	or	or	CC
25944	2095	30	in	in	IN
25944	2095	31	marked	mark	VBN
25944	2095	32	atrophic	atrophic	JJ
25944	2095	33	changes	change	NNS
25944	2095	34	,	,	,
25944	2095	35	causing	cause	VBG
25944	2095	36	contraction	contraction	NN
25944	2095	37	and	and	CC
25944	2095	38	deformity	deformity	NN
25944	2095	39	.	.	.
25944	2096	1	As	as	IN
25944	2096	2	a	a	DT
25944	2096	3	rule	rule	NN
25944	2096	4	,	,	,
25944	2096	5	the	the	DT
25944	2096	6	general	general	JJ
25944	2096	7	health	health	NN
25944	2096	8	remains	remain	VBZ
25944	2096	9	good	good	JJ
25944	2096	10	.	.	.
25944	2097	1	#	#	JJR
25944	2097	2	State	state	NN
25944	2097	3	the	the	DT
25944	2097	4	causes	cause	NNS
25944	2097	5	of	of	IN
25944	2097	6	scleroderma	scleroderma	NNP
25944	2097	7	.	.	.
25944	2097	8	#	#	$
25944	2097	9	The	the	DT
25944	2097	10	condition	condition	NN
25944	2097	11	is	be	VBZ
25944	2097	12	to	to	TO
25944	2097	13	be	be	VB
25944	2097	14	considered	consider	VBN
25944	2097	15	as	as	RB
25944	2097	16	probably	probably	RB
25944	2097	17	of	of	IN
25944	2097	18	neurotic	neurotic	JJ
25944	2097	19	origin	origin	NN
25944	2097	20	.	.	.
25944	2098	1	Exposure	exposure	NN
25944	2098	2	and	and	CC
25944	2098	3	shock	shock	NN
25944	2098	4	to	to	IN
25944	2098	5	the	the	DT
25944	2098	6	nervous	nervous	JJ
25944	2098	7	system	system	NN
25944	2098	8	are	be	VBP
25944	2098	9	to	to	TO
25944	2098	10	be	be	VB
25944	2098	11	looked	look	VBN
25944	2098	12	upon	upon	IN
25944	2098	13	as	as	IN
25944	2098	14	influential	influential	JJ
25944	2098	15	.	.	.
25944	2099	1	It	-PRON-	PRP
25944	2099	2	is	be	VBZ
25944	2099	3	a	a	DT
25944	2099	4	rare	rare	JJ
25944	2099	5	disease	disease	NN
25944	2099	6	,	,	,
25944	2099	7	observed	observe	VBN
25944	2099	8	usually	usually	RB
25944	2099	9	in	in	IN
25944	2099	10	early	early	JJ
25944	2099	11	adult	adult	NN
25944	2099	12	or	or	CC
25944	2099	13	middle	middle	JJ
25944	2099	14	life	life	NN
25944	2099	15	,	,	,
25944	2099	16	and	and	CC
25944	2099	17	is	be	VBZ
25944	2099	18	more	more	RBR
25944	2099	19	frequent	frequent	JJ
25944	2099	20	in	in	IN
25944	2099	21	women	woman	NNS
25944	2099	22	than	than	IN
25944	2099	23	in	in	IN
25944	2099	24	men	man	NNS
25944	2099	25	.	.	.
25944	2100	1	#	#	LS
25944	2100	2	What	what	WP
25944	2100	3	is	be	VBZ
25944	2100	4	the	the	DT
25944	2100	5	pathology	pathology	NN
25944	2100	6	?	?	.
25944	2100	7	#	#	$
25944	2100	8	In	in	IN
25944	2100	9	typical	typical	JJ
25944	2100	10	and	and	CC
25944	2100	11	advanced	advanced	JJ
25944	2100	12	cases	case	NNS
25944	2100	13	both	both	CC
25944	2100	14	the	the	DT
25944	2100	15	true	true	JJ
25944	2100	16	skin	skin	NN
25944	2100	17	and	and	CC
25944	2100	18	the	the	DT
25944	2100	19	subcutaneous	subcutaneous	JJ
25944	2100	20	connective	connective	JJ
25944	2100	21	tissue	tissue	NN
25944	2100	22	show	show	VBP
25944	2100	23	a	a	DT
25944	2100	24	marked	marked	JJ
25944	2100	25	increase	increase	NN
25944	2100	26	of	of	IN
25944	2100	27	connective	connective	JJ
25944	2100	28	tissue	tissue	NN
25944	2100	29	-	-	HYPH
25944	2100	30	element	element	NN
25944	2100	31	,	,	,
25944	2100	32	with	with	IN
25944	2100	33	thickening	thickening	NN
25944	2100	34	and	and	CC
25944	2100	35	condensation	condensation	NN
25944	2100	36	of	of	IN
25944	2100	37	the	the	DT
25944	2100	38	fibers	fiber	NNS
25944	2100	39	.	.	.
25944	2101	1	#	#	$
25944	2101	2	Is	be	VBZ
25944	2101	3	there	there	EX
25944	2101	4	any	any	DT
25944	2101	5	difficulty	difficulty	NN
25944	2101	6	in	in	IN
25944	2101	7	reaching	reach	VBG
25944	2101	8	a	a	DT
25944	2101	9	diagnosis	diagnosis	NN
25944	2101	10	in	in	IN
25944	2101	11	scleroderma	scleroderma	NNP
25944	2101	12	?	?	.
25944	2101	13	#	#	NN
25944	2101	14	As	as	IN
25944	2101	15	a	a	DT
25944	2101	16	rule	rule	NN
25944	2101	17	,	,	,
25944	2101	18	no	no	UH
25944	2101	19	.	.	.
25944	2102	1	The	the	DT
25944	2102	2	characters	character	NNS
25944	2102	3	--	--	:
25944	2102	4	rigidity	rigidity	NN
25944	2102	5	,	,	,
25944	2102	6	stiffness	stiffness	NN
25944	2102	7	,	,	,
25944	2102	8	hardness	hardness	NN
25944	2102	9	,	,	,
25944	2102	10	and	and	CC
25944	2102	11	hide	hide	VB
25944	2102	12	-	-	HYPH
25944	2102	13	bound	bind	VBN
25944	2102	14	condition	condition	NN
25944	2102	15	of	of	IN
25944	2102	16	the	the	DT
25944	2102	17	skin	skin	NN
25944	2102	18	--	--	:
25944	2102	19	are	be	VBP
25944	2102	20	always	always	RB
25944	2102	21	distinctive	distinctive	JJ
25944	2102	22	.	.	.
25944	2103	1	The	the	DT
25944	2103	2	peculiar	peculiar	JJ
25944	2103	3	appearance	appearance	NN
25944	2103	4	,	,	,
25944	2103	5	the	the	DT
25944	2103	6	course	course	NN
25944	2103	7	and	and	CC
25944	2103	8	character	character	NN
25944	2103	9	of	of	IN
25944	2103	10	the	the	DT
25944	2103	11	patches	patch	NNS
25944	2103	12	,	,	,
25944	2103	13	of	of	IN
25944	2103	14	morph[oe]a	morph[oe]a	NNP
25944	2103	15	are	be	VBP
25944	2103	16	quite	quite	RB
25944	2103	17	distinctive	distinctive	JJ
25944	2103	18	.	.	.
25944	2104	1	#	#	NN
25944	2104	2	Give	give	VB
25944	2104	3	the	the	DT
25944	2104	4	prognosis	prognosis	NN
25944	2104	5	of	of	IN
25944	2104	6	scleroderma	scleroderma	NN
25944	2104	7	.	.	.
25944	2104	8	#	#	WRB
25944	2104	9	It	-PRON-	PRP
25944	2104	10	should	should	MD
25944	2104	11	always	always	RB
25944	2104	12	be	be	VB
25944	2104	13	guarded	guard	VBN
25944	2104	14	.	.	.
25944	2105	1	In	in	IN
25944	2105	2	many	many	JJ
25944	2105	3	instances	instance	NNS
25944	2105	4	recovery	recovery	NN
25944	2105	5	takes	take	VBZ
25944	2105	6	place	place	NN
25944	2105	7	,	,	,
25944	2105	8	whilst	whilst	IN
25944	2105	9	in	in	IN
25944	2105	10	others	other	NNS
25944	2105	11	the	the	DT
25944	2105	12	disease	disease	NN
25944	2105	13	is	be	VBZ
25944	2105	14	rebellious	rebellious	JJ
25944	2105	15	,	,	,
25944	2105	16	lasting	last	VBG
25944	2105	17	indefinitely	indefinitely	RB
25944	2105	18	.	.	.
25944	2106	1	The	the	DT
25944	2106	2	prognosis	prognosis	NN
25944	2106	3	of	of	IN
25944	2106	4	the	the	DT
25944	2106	5	variety	variety	NN
25944	2106	6	known	know	VBN
25944	2106	7	as	as	IN
25944	2106	8	morph[oe]a	morph[oe]a	NNP
25944	2106	9	is	be	VBZ
25944	2106	10	less	less	RBR
25944	2106	11	unfavorable	unfavorable	JJ
25944	2106	12	than	than	IN
25944	2106	13	general	general	JJ
25944	2106	14	scleroderma	scleroderma	NNP
25944	2106	15	,	,	,
25944	2106	16	and	and	CC
25944	2106	17	recovery	recovery	NN
25944	2106	18	more	more	RBR
25944	2106	19	frequent	frequent	JJ
25944	2106	20	.	.	.
25944	2107	1	#	#	LS
25944	2107	2	What	what	WP
25944	2107	3	is	be	VBZ
25944	2107	4	the	the	DT
25944	2107	5	treatment	treatment	NN
25944	2107	6	of	of	IN
25944	2107	7	scleroderma	scleroderma	NNP
25944	2107	8	?	?	.
25944	2107	9	#	#	NN
25944	2107	10	Tonics	Tonics	NNPS
25944	2107	11	,	,	,
25944	2107	12	such	such	JJ
25944	2107	13	as	as	IN
25944	2107	14	arsenic	arsenic	JJ
25944	2107	15	,	,	,
25944	2107	16	quinia	quinia	NNP
25944	2107	17	,	,	,
25944	2107	18	nux	nux	NN
25944	2107	19	vomica	vomica	NN
25944	2107	20	,	,	,
25944	2107	21	and	and	CC
25944	2107	22	cod	cod	NN
25944	2107	23	-	-	HYPH
25944	2107	24	liver	liver	NN
25944	2107	25	oil	oil	NN
25944	2107	26	;	;	:
25944	2107	27	conjointly	conjointly	RB
25944	2107	28	with	with	IN
25944	2107	29	the	the	DT
25944	2107	30	local	local	JJ
25944	2107	31	employment	employment	NN
25944	2107	32	of	of	IN
25944	2107	33	stimulating	stimulating	NN
25944	2107	34	,	,	,
25944	2107	35	oily	oily	RB
25944	2107	36	or	or	CC
25944	2107	37	fatty	fatty	NN
25944	2107	38	applications	application	NNS
25944	2107	39	,	,	,
25944	2107	40	friction	friction	NN
25944	2107	41	,	,	,
25944	2107	42	and	and	CC
25944	2107	43	electricity	electricity	NN
25944	2107	44	.	.	.
25944	2108	1	Röntgen	Röntgen	NNP
25944	2108	2	-	-	HYPH
25944	2108	3	ray	ray	NN
25944	2108	4	treatment	treatment	NN
25944	2108	5	is	be	VBZ
25944	2108	6	often	often	RB
25944	2108	7	of	of	IN
25944	2108	8	value	value	NN
25944	2108	9	,	,	,
25944	2108	10	more	more	RBR
25944	2108	11	especially	especially	RB
25944	2108	12	in	in	IN
25944	2108	13	the	the	DT
25944	2108	14	morph[oe]a	morph[oe]a	NNP
25944	2108	15	type	type	NN
25944	2108	16	.	.	.
25944	2109	1	#	#	NNP
25944	2109	2	Elephantiasis	Elephantiasis	NNP
25944	2109	3	.	.	.
25944	2109	4	#	#	NNP
25944	2109	5	(	(	-LRB-
25944	2109	6	_	_	NNP
25944	2109	7	Synonyms	Synonyms	NNP
25944	2109	8	:	:	:
25944	2109	9	_	_	NNP
25944	2109	10	Elephantiasis	Elephantiasis	NNP
25944	2109	11	Arabum	Arabum	NNP
25944	2109	12	;	;	:
25944	2109	13	Pachydermia	pachydermia	NN
25944	2109	14	;	;	:
25944	2109	15	Barbadoes	Barbadoes	NNPS
25944	2109	16	Leg	Leg	NNP
25944	2109	17	;	;	:
25944	2109	18	Elephant	Elephant	NNP
25944	2109	19	Leg	Leg	NNP
25944	2109	20	.	.	.
25944	2109	21	)	)	-RRB-
25944	2110	1	#	#	NN
25944	2110	2	Give	give	VBP
25944	2110	3	a	a	DT
25944	2110	4	descriptive	descriptive	JJ
25944	2110	5	definition	definition	NN
25944	2110	6	of	of	IN
25944	2110	7	elephantiasis	elephantiasis	NN
25944	2110	8	.	.	.
25944	2110	9	#	#	NNP
25944	2110	10	Elephantiasis	Elephantiasis	NNP
25944	2110	11	is	be	VBZ
25944	2110	12	a	a	DT
25944	2110	13	chronic	chronic	JJ
25944	2110	14	hypertrophic	hypertrophic	JJ
25944	2110	15	disease	disease	NN
25944	2110	16	of	of	IN
25944	2110	17	the	the	DT
25944	2110	18	skin	skin	NN
25944	2110	19	and	and	CC
25944	2110	20	subcutaneous	subcutaneous	JJ
25944	2110	21	tissue	tissue	NN
25944	2110	22	characterized	characterize	VBN
25944	2110	23	by	by	IN
25944	2110	24	enlargement	enlargement	NN
25944	2110	25	and	and	CC
25944	2110	26	deformity	deformity	NN
25944	2110	27	,	,	,
25944	2110	28	lymphangitis	lymphangitis	NNP
25944	2110	29	,	,	,
25944	2110	30	swelling	swell	VBG
25944	2110	31	,	,	,
25944	2110	32	[	[	-LRB-
25944	2110	33	oe]dema	oe]dema	NNS
25944	2110	34	,	,	,
25944	2110	35	thickening	thickening	NN
25944	2110	36	,	,	,
25944	2110	37	induration	induration	NN
25944	2110	38	,	,	,
25944	2110	39	pigmentation	pigmentation	NN
25944	2110	40	,	,	,
25944	2110	41	and	and	CC
25944	2110	42	more	more	RBR
25944	2110	43	or	or	CC
25944	2110	44	less	less	JJR
25944	2110	45	papillary	papillary	JJ
25944	2110	46	growth	growth	NN
25944	2110	47	.	.	.
25944	2111	1	[	[	-LRB-
25944	2111	2	Illustration	illustration	NN
25944	2111	3	:	:	:
25944	2111	4	Fig	Fig	NNP
25944	2111	5	.	.	.
25944	2112	1	35	35	CD
25944	2112	2	.	.	.
25944	2113	1	Elephantiasis	Elephantiasis	NNP
25944	2113	2	of	of	IN
25944	2113	3	moderate	moderate	JJ
25944	2113	4	development	development	NN
25944	2113	5	.	.	.
25944	2113	6	]	]	-RRB-
25944	2114	1	#	#	LS
25944	2114	2	What	what	WDT
25944	2114	3	parts	part	NNS
25944	2114	4	are	be	VBP
25944	2114	5	commonly	commonly	RB
25944	2114	6	involved	involve	VBN
25944	2114	7	in	in	IN
25944	2114	8	elephantiasis	elephantiasis	NN
25944	2114	9	?	?	.
25944	2114	10	#	#	NN
25944	2114	11	Usually	usually	RB
25944	2114	12	one	one	CD
25944	2114	13	or	or	CC
25944	2114	14	both	both	DT
25944	2114	15	legs	leg	NNS
25944	2114	16	;	;	:
25944	2114	17	occasionally	occasionally	RB
25944	2114	18	the	the	DT
25944	2114	19	genitalia	genitalia	NNP
25944	2114	20	;	;	:
25944	2114	21	other	other	JJ
25944	2114	22	parts	part	NNS
25944	2114	23	are	be	VBP
25944	2114	24	seldom	seldom	RB
25944	2114	25	affected	affected	JJ
25944	2114	26	.	.	.
25944	2115	1	#	#	NNP
25944	2115	2	Describe	describe	VB
25944	2115	3	the	the	DT
25944	2115	4	symptoms	symptom	NNS
25944	2115	5	of	of	IN
25944	2115	6	elephantiasis	elephantiasis	NN
25944	2115	7	.	.	.
25944	2115	8	#	#	$
25944	2115	9	The	the	DT
25944	2115	10	disease	disease	NN
25944	2115	11	usually	usually	RB
25944	2115	12	begins	begin	VBZ
25944	2115	13	with	with	IN
25944	2115	14	recurrent	recurrent	NN
25944	2115	15	(	(	-LRB-
25944	2115	16	at	at	IN
25944	2115	17	intervals	interval	NNS
25944	2115	18	of	of	IN
25944	2115	19	months	month	NNS
25944	2115	20	or	or	CC
25944	2115	21	years	year	NNS
25944	2115	22	)	)	-RRB-
25944	2115	23	erysipelatous	erysipelatous	JJ
25944	2115	24	inflammation	inflammation	NN
25944	2115	25	,	,	,
25944	2115	26	with	with	IN
25944	2115	27	swelling	swelling	NN
25944	2115	28	,	,	,
25944	2115	29	pain	pain	NN
25944	2115	30	,	,	,
25944	2115	31	heat	heat	NN
25944	2115	32	,	,	,
25944	2115	33	redness	redness	NN
25944	2115	34	and	and	CC
25944	2115	35	lymphangitis	lymphangitis	NNP
25944	2115	36	;	;	,
25944	2115	37	after	after	IN
25944	2115	38	each	each	DT
25944	2115	39	attack	attack	NN
25944	2115	40	the	the	DT
25944	2115	41	parts	part	NNS
25944	2115	42	remain	remain	VBP
25944	2115	43	somewhat	somewhat	RB
25944	2115	44	increased	increased	JJ
25944	2115	45	in	in	IN
25944	2115	46	size	size	NN
25944	2115	47	,	,	,
25944	2115	48	although	although	IN
25944	2115	49	at	at	IN
25944	2115	50	first	first	RB
25944	2115	51	not	not	RB
25944	2115	52	noticeably	noticeably	RB
25944	2115	53	so	so	RB
25944	2115	54	.	.	.
25944	2116	1	After	after	IN
25944	2116	2	months	month	NNS
25944	2116	3	or	or	CC
25944	2116	4	one	one	CD
25944	2116	5	or	or	CC
25944	2116	6	two	two	CD
25944	2116	7	years	year	NNS
25944	2116	8	the	the	DT
25944	2116	9	enlargement	enlargement	NN
25944	2116	10	or	or	CC
25944	2116	11	hypertrophy	hypertrophy	NN
25944	2116	12	becomes	become	VBZ
25944	2116	13	conspicuous	conspicuous	JJ
25944	2116	14	,	,	,
25944	2116	15	the	the	DT
25944	2116	16	part	part	NN
25944	2116	17	is	be	VBZ
25944	2116	18	chronically	chronically	RB
25944	2116	19	swollen	swollen	JJ
25944	2116	20	,	,	,
25944	2116	21	[	[	-LRB-
25944	2116	22	oe]dematous	oe]dematous	JJ
25944	2116	23	and	and	CC
25944	2116	24	hard	hard	JJ
25944	2116	25	;	;	:
25944	2116	26	the	the	DT
25944	2116	27	skin	skin	NN
25944	2116	28	is	be	VBZ
25944	2116	29	thickened	thicken	VBN
25944	2116	30	,	,	,
25944	2116	31	the	the	DT
25944	2116	32	normal	normal	JJ
25944	2116	33	lines	line	NNS
25944	2116	34	and	and	CC
25944	2116	35	folds	fold	NNS
25944	2116	36	exaggerated	exaggerate	VBD
25944	2116	37	,	,	,
25944	2116	38	the	the	DT
25944	2116	39	papillæ	papillæ	NN
25944	2116	40	enlarged	enlarge	VBN
25944	2116	41	and	and	CC
25944	2116	42	prominent	prominent	JJ
25944	2116	43	,	,	,
25944	2116	44	and	and	CC
25944	2116	45	with	with	IN
25944	2116	46	more	more	RBR
25944	2116	47	or	or	CC
25944	2116	48	less	less	RBR
25944	2116	49	fissuring	fissuring	NN
25944	2116	50	and	and	CC
25944	2116	51	pigmentation	pigmentation	NN
25944	2116	52	.	.	.
25944	2117	1	#	#	LS
25944	2117	2	What	what	WP
25944	2117	3	is	be	VBZ
25944	2117	4	the	the	DT
25944	2117	5	further	further	JJ
25944	2117	6	course	course	NN
25944	2117	7	of	of	IN
25944	2117	8	the	the	DT
25944	2117	9	disease	disease	NN
25944	2117	10	?	?	.
25944	2117	11	#	#	$
25944	2117	12	There	there	EX
25944	2117	13	is	be	VBZ
25944	2117	14	gradual	gradual	JJ
25944	2117	15	increase	increase	NN
25944	2117	16	in	in	IN
25944	2117	17	size	size	NN
25944	2117	18	,	,	,
25944	2117	19	the	the	DT
25944	2117	20	parts	part	NNS
25944	2117	21	in	in	IN
25944	2117	22	some	some	DT
25944	2117	23	instances	instance	NNS
25944	2117	24	reaching	reach	VBG
25944	2117	25	enormous	enormous	JJ
25944	2117	26	proportions	proportion	NNS
25944	2117	27	;	;	:
25944	2117	28	the	the	DT
25944	2117	29	skin	skin	NN
25944	2117	30	becomes	become	VBZ
25944	2117	31	rough	rough	JJ
25944	2117	32	and	and	CC
25944	2117	33	warty	warty	JJ
25944	2117	34	,	,	,
25944	2117	35	eczematous	eczematous	JJ
25944	2117	36	inflammation	inflammation	NN
25944	2117	37	is	be	VBZ
25944	2117	38	often	often	RB
25944	2117	39	superadded	superadde	VBN
25944	2117	40	,	,	,
25944	2117	41	and	and	CC
25944	2117	42	,	,	,
25944	2117	43	sooner	sooner	RB
25944	2117	44	or	or	CC
25944	2117	45	later	later	RBR
25944	2117	46	,	,	,
25944	2117	47	ulcers	ulcer	NNS
25944	2117	48	,	,	,
25944	2117	49	superficial	superficial	JJ
25944	2117	50	or	or	CC
25944	2117	51	deep	deep	JJ
25944	2117	52	,	,	,
25944	2117	53	form	form	NN
25944	2117	54	--	--	:
25944	2117	55	which	which	WDT
25944	2117	56	,	,	,
25944	2117	57	together	together	RB
25944	2117	58	with	with	IN
25944	2117	59	the	the	DT
25944	2117	60	crusting	crust	VBG
25944	2117	61	and	and	CC
25944	2117	62	moderate	moderate	JJ
25944	2117	63	scaliness	scaliness	NN
25944	2117	64	,	,	,
25944	2117	65	present	present	VB
25944	2117	66	a	a	DT
25944	2117	67	striking	striking	JJ
25944	2117	68	picture	picture	NN
25944	2117	69	.	.	.
25944	2118	1	There	there	EX
25944	2118	2	may	may	MD
25944	2118	3	be	be	VB
25944	2118	4	periods	period	NNS
25944	2118	5	of	of	IN
25944	2118	6	comparative	comparative	JJ
25944	2118	7	inactivity	inactivity	NN
25944	2118	8	,	,	,
25944	2118	9	or	or	CC
25944	2118	10	,	,	,
25944	2118	11	after	after	IN
25944	2118	12	reaching	reach	VBG
25944	2118	13	a	a	DT
25944	2118	14	certain	certain	JJ
25944	2118	15	development	development	NN
25944	2118	16	,	,	,
25944	2118	17	the	the	DT
25944	2118	18	disease	disease	NN
25944	2118	19	may	may	MD
25944	2118	20	,	,	,
25944	2118	21	for	for	IN
25944	2118	22	a	a	DT
25944	2118	23	time	time	NN
25944	2118	24	at	at	IN
25944	2118	25	least	least	JJS
25944	2118	26	,	,	,
25944	2118	27	remain	remain	VB
25944	2118	28	stationary	stationary	JJ
25944	2118	29	.	.	.
25944	2119	1	#	#	NN
25944	2119	2	Are	be	VBP
25944	2119	3	there	there	EX
25944	2119	4	any	any	DT
25944	2119	5	subjective	subjective	JJ
25944	2119	6	symptoms	symptom	NNS
25944	2119	7	?	?	.
25944	2119	8	#	#	$
25944	2119	9	A	a	DT
25944	2119	10	variable	variable	JJ
25944	2119	11	degree	degree	NN
25944	2119	12	of	of	IN
25944	2119	13	pain	pain	NN
25944	2119	14	is	be	VBZ
25944	2119	15	often	often	RB
25944	2119	16	noted	note	VBN
25944	2119	17	,	,	,
25944	2119	18	especially	especially	RB
25944	2119	19	marked	mark	VBN
25944	2119	20	during	during	IN
25944	2119	21	the	the	DT
25944	2119	22	inflammatory	inflammatory	JJ
25944	2119	23	attacks	attack	NNS
25944	2119	24	.	.	.
25944	2120	1	The	the	DT
25944	2120	2	general	general	JJ
25944	2120	3	health	health	NN
25944	2120	4	is	be	VBZ
25944	2120	5	not	not	RB
25944	2120	6	involved	involve	VBN
25944	2120	7	.	.	.
25944	2121	1	#	#	JJR
25944	2121	2	State	state	NN
25944	2121	3	the	the	DT
25944	2121	4	cause	cause	NN
25944	2121	5	of	of	IN
25944	2121	6	elephantiasis	elephantiasis	NN
25944	2121	7	.	.	.
25944	2121	8	#	#	$
25944	2121	9	The	the	DT
25944	2121	10	etiology	etiology	NN
25944	2121	11	is	be	VBZ
25944	2121	12	obscure	obscure	JJ
25944	2121	13	.	.	.
25944	2122	1	The	the	DT
25944	2122	2	disease	disease	NN
25944	2122	3	rarely	rarely	RB
25944	2122	4	occurs	occur	VBZ
25944	2122	5	before	before	IN
25944	2122	6	puberty	puberty	NN
25944	2122	7	.	.	.
25944	2123	1	It	-PRON-	PRP
25944	2123	2	is	be	VBZ
25944	2123	3	most	most	RBS
25944	2123	4	common	common	JJ
25944	2123	5	in	in	IN
25944	2123	6	tropical	tropical	JJ
25944	2123	7	countries	country	NNS
25944	2123	8	,	,	,
25944	2123	9	more	more	RBR
25944	2123	10	especially	especially	RB
25944	2123	11	among	among	IN
25944	2123	12	the	the	DT
25944	2123	13	poor	poor	JJ
25944	2123	14	and	and	CC
25944	2123	15	neglected	neglect	VBD
25944	2123	16	.	.	.
25944	2124	1	It	-PRON-	PRP
25944	2124	2	is	be	VBZ
25944	2124	3	not	not	RB
25944	2124	4	hereditary	hereditary	JJ
25944	2124	5	,	,	,
25944	2124	6	nor	nor	CC
25944	2124	7	can	can	MD
25944	2124	8	it	-PRON-	PRP
25944	2124	9	be	be	VB
25944	2124	10	said	say	VBN
25944	2124	11	to	to	TO
25944	2124	12	be	be	VB
25944	2124	13	contagious	contagious	JJ
25944	2124	14	.	.	.
25944	2125	1	Inflammation	inflammation	NN
25944	2125	2	and	and	CC
25944	2125	3	obstruction	obstruction	NN
25944	2125	4	of	of	IN
25944	2125	5	the	the	DT
25944	2125	6	lymphatics	lymphatic	NNS
25944	2125	7	,	,	,
25944	2125	8	probably	probably	RB
25944	2125	9	due	due	JJ
25944	2125	10	,	,	,
25944	2125	11	according	accord	VBG
25944	2125	12	to	to	IN
25944	2125	13	late	late	JJ
25944	2125	14	investigations	investigation	NNS
25944	2125	15	,	,	,
25944	2125	16	to	to	IN
25944	2125	17	the	the	DT
25944	2125	18	presence	presence	NN
25944	2125	19	of	of	IN
25944	2125	20	large	large	JJ
25944	2125	21	numbers	number	NNS
25944	2125	22	of	of	IN
25944	2125	23	filaria	filaria	NNP
25944	2125	24	(	(	-LRB-
25944	2125	25	microscopic	microscopic	JJ
25944	2125	26	thread	thread	NN
25944	2125	27	-	-	HYPH
25944	2125	28	worms	worm	NNS
25944	2125	29	)	)	-RRB-
25944	2125	30	in	in	IN
25944	2125	31	the	the	DT
25944	2125	32	lymph	lymph	NN
25944	2125	33	channels	channel	NNS
25944	2125	34	and	and	CC
25944	2125	35	bloodvessels	bloodvessel	NNS
25944	2125	36	,	,	,
25944	2125	37	is	be	VBZ
25944	2125	38	to	to	TO
25944	2125	39	be	be	VB
25944	2125	40	looked	look	VBN
25944	2125	41	upon	upon	IN
25944	2125	42	as	as	IN
25944	2125	43	the	the	DT
25944	2125	44	immediate	immediate	JJ
25944	2125	45	cause	cause	NN
25944	2125	46	.	.	.
25944	2126	1	#	#	LS
25944	2126	2	What	what	WP
25944	2126	3	is	be	VBZ
25944	2126	4	the	the	DT
25944	2126	5	pathology	pathology	NN
25944	2126	6	?	?	.
25944	2126	7	#	#	$
25944	2126	8	All	all	DT
25944	2126	9	parts	part	NNS
25944	2126	10	of	of	IN
25944	2126	11	the	the	DT
25944	2126	12	skin	skin	NN
25944	2126	13	and	and	CC
25944	2126	14	subcutaneous	subcutaneous	JJ
25944	2126	15	connective	connective	JJ
25944	2126	16	-	-	HYPH
25944	2126	17	tissue	tissue	NN
25944	2126	18	are	be	VBP
25944	2126	19	hypertrophied	hypertrophied	JJ
25944	2126	20	,	,	,
25944	2126	21	the	the	DT
25944	2126	22	lymphatic	lymphatic	JJ
25944	2126	23	glands	gland	NNS
25944	2126	24	are	be	VBP
25944	2126	25	swollen	swollen	JJ
25944	2126	26	,	,	,
25944	2126	27	the	the	DT
25944	2126	28	lymph	lymph	NN
25944	2126	29	channels	channel	NNS
25944	2126	30	and	and	CC
25944	2126	31	bloodvessels	bloodvessel	NNS
25944	2126	32	enlarged	enlarge	VBD
25944	2126	33	,	,	,
25944	2126	34	and	and	CC
25944	2126	35	there	there	EX
25944	2126	36	is	be	VBZ
25944	2126	37	more	more	RBR
25944	2126	38	or	or	CC
25944	2126	39	less	less	JJR
25944	2126	40	inflammation	inflammation	NN
25944	2126	41	,	,	,
25944	2126	42	with	with	IN
25944	2126	43	[	[	-LRB-
25944	2126	44	oe]dema	oe]dema	NN
25944	2126	45	.	.	.
25944	2127	1	Secondarily	secondarily	RB
25944	2127	2	,	,	,
25944	2127	3	from	from	IN
25944	2127	4	pressure	pressure	NN
25944	2127	5	,	,	,
25944	2127	6	atrophy	atrophy	NN
25944	2127	7	and	and	CC
25944	2127	8	destruction	destruction	NN
25944	2127	9	of	of	IN
25944	2127	10	the	the	DT
25944	2127	11	skin	skin	NN
25944	2127	12	-	-	HYPH
25944	2127	13	glands	gland	NNS
25944	2127	14	,	,	,
25944	2127	15	and	and	CC
25944	2127	16	atrophic	atrophic	JJ
25944	2127	17	degeneration	degeneration	NN
25944	2127	18	of	of	IN
25944	2127	19	the	the	DT
25944	2127	20	fat	fat	NN
25944	2127	21	and	and	CC
25944	2127	22	muscles	muscle	NNS
25944	2127	23	result	result	VBP
25944	2127	24	.	.	.
25944	2128	1	#	#	LS
25944	2128	2	What	what	WP
25944	2128	3	are	be	VBP
25944	2128	4	the	the	DT
25944	2128	5	diagnostic	diagnostic	JJ
25944	2128	6	characters	character	NNS
25944	2128	7	of	of	IN
25944	2128	8	beginning	begin	VBG
25944	2128	9	elephantiasis	elephantiasis	NN
25944	2128	10	?	?	.
25944	2128	11	#	#	$
25944	2128	12	Recurrent	recurrent	JJ
25944	2128	13	erysipelatous	erysipelatous	JJ
25944	2128	14	inflammation	inflammation	NN
25944	2128	15	,	,	,
25944	2128	16	attended	attend	VBN
25944	2128	17	with	with	IN
25944	2128	18	gradual	gradual	JJ
25944	2128	19	enlargement	enlargement	NN
25944	2128	20	of	of	IN
25944	2128	21	the	the	DT
25944	2128	22	parts	part	NNS
25944	2128	23	.	.	.
25944	2129	1	The	the	DT
25944	2129	2	appearances	appearance	NNS
25944	2129	3	,	,	,
25944	2129	4	later	later	RB
25944	2129	5	in	in	IN
25944	2129	6	the	the	DT
25944	2129	7	course	course	NN
25944	2129	8	of	of	IN
25944	2129	9	the	the	DT
25944	2129	10	disease	disease	NN
25944	2129	11	,	,	,
25944	2129	12	are	be	VBP
25944	2129	13	so	so	RB
25944	2129	14	characteristic	characteristic	JJ
25944	2129	15	that	that	IN
25944	2129	16	a	a	DT
25944	2129	17	mistake	mistake	NN
25944	2129	18	is	be	VBZ
25944	2129	19	scarcely	scarcely	RB
25944	2129	20	possible	possible	JJ
25944	2129	21	.	.	.
25944	2130	1	#	#	NN
25944	2130	2	Give	give	VB
25944	2130	3	the	the	DT
25944	2130	4	prognosis	prognosis	NN
25944	2130	5	of	of	IN
25944	2130	6	elephantiasis	elephantiasis	NN
25944	2130	7	.	.	.
25944	2130	8	#	#	$
25944	2130	9	If	if	IN
25944	2130	10	the	the	DT
25944	2130	11	case	case	NN
25944	2130	12	comes	come	VBZ
25944	2130	13	under	under	IN
25944	2130	14	treatment	treatment	NN
25944	2130	15	in	in	IN
25944	2130	16	the	the	DT
25944	2130	17	first	first	JJ
25944	2130	18	months	month	NNS
25944	2130	19	of	of	IN
25944	2130	20	its	-PRON-	PRP$
25944	2130	21	development	development	NN
25944	2130	22	,	,	,
25944	2130	23	the	the	DT
25944	2130	24	process	process	NN
25944	2130	25	may	may	MD
25944	2130	26	probably	probably	RB
25944	2130	27	be	be	VB
25944	2130	28	checked	check	VBN
25944	2130	29	or	or	CC
25944	2130	30	held	hold	VBN
25944	2130	31	in	in	IN
25944	2130	32	abeyance	abeyance	NN
25944	2130	33	;	;	:
25944	2130	34	when	when	WRB
25944	2130	35	well	well	RB
25944	2130	36	established	establish	VBN
25944	2130	37	,	,	,
25944	2130	38	rarely	rarely	RB
25944	2130	39	more	more	JJR
25944	2130	40	than	than	IN
25944	2130	41	palliation	palliation	NN
25944	2130	42	is	be	VBZ
25944	2130	43	possible	possible	JJ
25944	2130	44	.	.	.
25944	2131	1	#	#	LS
25944	2131	2	What	what	WP
25944	2131	3	is	be	VBZ
25944	2131	4	the	the	DT
25944	2131	5	treatment	treatment	NN
25944	2131	6	of	of	IN
25944	2131	7	elephantiasis	elephantiasis	NN
25944	2131	8	?	?	.
25944	2131	9	#	#	$
25944	2131	10	The	the	DT
25944	2131	11	inflammatory	inflammatory	JJ
25944	2131	12	attacks	attack	NNS
25944	2131	13	are	be	VBP
25944	2131	14	to	to	TO
25944	2131	15	be	be	VB
25944	2131	16	treated	treat	VBN
25944	2131	17	on	on	IN
25944	2131	18	general	general	JJ
25944	2131	19	principles	principle	NNS
25944	2131	20	.	.	.
25944	2132	1	Quinia	Quinia	NNP
25944	2132	2	,	,	,
25944	2132	3	potassium	potassium	NN
25944	2132	4	iodide	iodide	NN
25944	2132	5	,	,	,
25944	2132	6	iron	iron	NN
25944	2132	7	and	and	CC
25944	2132	8	other	other	JJ
25944	2132	9	tonics	tonic	NNS
25944	2132	10	are	be	VBP
25944	2132	11	occasionally	occasionally	RB
25944	2132	12	useful	useful	JJ
25944	2132	13	;	;	:
25944	2132	14	and	and	CC
25944	2132	15	,	,	,
25944	2132	16	especially	especially	RB
25944	2132	17	in	in	IN
25944	2132	18	the	the	DT
25944	2132	19	earlier	early	JJR
25944	2132	20	stages	stage	NNS
25944	2132	21	,	,	,
25944	2132	22	climatic	climatic	JJ
25944	2132	23	change	change	NN
25944	2132	24	is	be	VBZ
25944	2132	25	often	often	RB
25944	2132	26	of	of	IN
25944	2132	27	value	value	NN
25944	2132	28	.	.	.
25944	2133	1	Between	between	IN
25944	2133	2	the	the	DT
25944	2133	3	inflammatory	inflammatory	JJ
25944	2133	4	attacks	attack	NNS
25944	2133	5	the	the	DT
25944	2133	6	parts	part	NNS
25944	2133	7	are	be	VBP
25944	2133	8	to	to	TO
25944	2133	9	be	be	VB
25944	2133	10	rubbed	rub	VBN
25944	2133	11	with	with	IN
25944	2133	12	an	an	DT
25944	2133	13	ointment	ointment	NN
25944	2133	14	of	of	IN
25944	2133	15	iodine	iodine	NN
25944	2133	16	or	or	CC
25944	2133	17	mercury	mercury	NN
25944	2133	18	,	,	,
25944	2133	19	together	together	RB
25944	2133	20	with	with	IN
25944	2133	21	galvanization	galvanization	NN
25944	2133	22	of	of	IN
25944	2133	23	the	the	DT
25944	2133	24	involved	involved	JJ
25944	2133	25	part	part	NN
25944	2133	26	.	.	.
25944	2134	1	In	in	IN
25944	2134	2	elephantiasis	elephantiasis	NN
25944	2134	3	of	of	IN
25944	2134	4	the	the	DT
25944	2134	5	leg	leg	NN
25944	2134	6	,	,	,
25944	2134	7	a	a	DT
25944	2134	8	roller	roller	NN
25944	2134	9	or	or	CC
25944	2134	10	rubber	rubber	NN
25944	2134	11	bandage	bandage	NN
25944	2134	12	,	,	,
25944	2134	13	or	or	CC
25944	2134	14	the	the	DT
25944	2134	15	gum	gum	NN
25944	2134	16	stocking	stocking	NN
25944	2134	17	,	,	,
25944	2134	18	is	be	VBZ
25944	2134	19	to	to	TO
25944	2134	20	be	be	VB
25944	2134	21	worn	wear	VBN
25944	2134	22	;	;	:
25944	2134	23	compression	compression	NN
25944	2134	24	and	and	CC
25944	2134	25	ligation	ligation	NN
25944	2134	26	of	of	IN
25944	2134	27	the	the	DT
25944	2134	28	main	main	JJ
25944	2134	29	artery	artery	NN
25944	2134	30	,	,	,
25944	2134	31	and	and	CC
25944	2134	32	even	even	RB
25944	2134	33	excision	excision	NN
25944	2134	34	of	of	IN
25944	2134	35	the	the	DT
25944	2134	36	sciatic	sciatic	JJ
25944	2134	37	nerve	nerve	NN
25944	2134	38	,	,	,
25944	2134	39	have	have	VBP
25944	2134	40	all	all	DT
25944	2134	41	been	be	VBN
25944	2134	42	employed	employ	VBN
25944	2134	43	,	,	,
25944	2134	44	with	with	IN
25944	2134	45	more	more	RBR
25944	2134	46	or	or	CC
25944	2134	47	less	less	JJR
25944	2134	48	diminution	diminution	NN
25944	2134	49	in	in	IN
25944	2134	50	size	size	NN
25944	2134	51	as	as	IN
25944	2134	52	a	a	DT
25944	2134	53	result	result	NN
25944	2134	54	.	.	.
25944	2135	1	In	in	IN
25944	2135	2	elephantiasis	elephantiasis	NN
25944	2135	3	of	of	IN
25944	2135	4	the	the	DT
25944	2135	5	genitalia	genitalia	NNP
25944	2135	6	,	,	,
25944	2135	7	if	if	IN
25944	2135	8	the	the	DT
25944	2135	9	disease	disease	NN
25944	2135	10	is	be	VBZ
25944	2135	11	well	well	RB
25944	2135	12	advanced	advanced	JJ
25944	2135	13	,	,	,
25944	2135	14	excision	excision	NN
25944	2135	15	or	or	CC
25944	2135	16	amputation	amputation	NN
25944	2135	17	of	of	IN
25944	2135	18	the	the	DT
25944	2135	19	parts	part	NNS
25944	2135	20	is	be	VBZ
25944	2135	21	to	to	TO
25944	2135	22	be	be	VB
25944	2135	23	practised	practise	VBN
25944	2135	24	.	.	.
25944	2136	1	Eczematous	eczematous	JJ
25944	2136	2	inflammation	inflammation	NN
25944	2136	3	,	,	,
25944	2136	4	if	if	IN
25944	2136	5	present	present	JJ
25944	2136	6	,	,	,
25944	2136	7	is	be	VBZ
25944	2136	8	to	to	TO
25944	2136	9	be	be	VB
25944	2136	10	treated	treat	VBN
25944	2136	11	with	with	IN
25944	2136	12	the	the	DT
25944	2136	13	ordinary	ordinary	JJ
25944	2136	14	remedies	remedy	NNS
25944	2136	15	.	.	.
25944	2137	1	#	#	NNP
25944	2137	2	Dermatolysis	Dermatolysis	NNP
25944	2137	3	.	.	.
25944	2137	4	#	#	NNP
25944	2137	5	(	(	-LRB-
25944	2137	6	_	_	NNP
25944	2137	7	Synonym	Synonym	NNP
25944	2137	8	:	:	:
25944	2137	9	_	_	NNP
25944	2137	10	Cutis	Cutis	NNP
25944	2137	11	Pendula	Pendula	NNP
25944	2137	12	.	.	.
25944	2137	13	)	)	-RRB-
25944	2138	1	#	#	NN
25944	2138	2	Give	give	VBP
25944	2138	3	a	a	DT
25944	2138	4	descriptive	descriptive	JJ
25944	2138	5	definition	definition	NN
25944	2138	6	of	of	IN
25944	2138	7	dermatolysis	dermatolysis	NN
25944	2138	8	.	.	.
25944	2138	9	#	#	NNP
25944	2138	10	Dermatolysis	Dermatolysis	NNP
25944	2138	11	is	be	VBZ
25944	2138	12	a	a	DT
25944	2138	13	rare	rare	JJ
25944	2138	14	disease	disease	NN
25944	2138	15	,	,	,
25944	2138	16	consisting	consist	VBG
25944	2138	17	of	of	IN
25944	2138	18	hypertrophy	hypertrophy	NN
25944	2138	19	and	and	CC
25944	2138	20	looseness	looseness	NN
25944	2138	21	of	of	IN
25944	2138	22	the	the	DT
25944	2138	23	skin	skin	NN
25944	2138	24	and	and	CC
25944	2138	25	subcutaneous	subcutaneous	JJ
25944	2138	26	connective	connective	JJ
25944	2138	27	tissue	tissue	NN
25944	2138	28	,	,	,
25944	2138	29	with	with	IN
25944	2138	30	a	a	DT
25944	2138	31	tendency	tendency	NN
25944	2138	32	to	to	TO
25944	2138	33	hang	hang	VB
25944	2138	34	in	in	IN
25944	2138	35	folds	fold	NNS
25944	2138	36	.	.	.
25944	2139	1	#	#	NNP
25944	2139	2	Describe	describe	VB
25944	2139	3	the	the	DT
25944	2139	4	symptoms	symptom	NNS
25944	2139	5	and	and	CC
25944	2139	6	course	course	NN
25944	2139	7	of	of	IN
25944	2139	8	dermatolysis	dermatolysis	NN
25944	2139	9	.	.	.
25944	2139	10	#	#	$
25944	2139	11	It	-PRON-	PRP
25944	2139	12	may	may	MD
25944	2139	13	be	be	VB
25944	2139	14	congenital	congenital	JJ
25944	2139	15	or	or	CC
25944	2139	16	acquired	acquire	VBN
25944	2139	17	,	,	,
25944	2139	18	and	and	CC
25944	2139	19	maybe	maybe	RB
25944	2139	20	limited	limit	VBN
25944	2139	21	to	to	IN
25944	2139	22	a	a	DT
25944	2139	23	small	small	JJ
25944	2139	24	or	or	CC
25944	2139	25	large	large	JJ
25944	2139	26	area	area	NN
25944	2139	27	,	,	,
25944	2139	28	or	or	CC
25944	2139	29	develop	develop	VB
25944	2139	30	simultaneously	simultaneously	RB
25944	2139	31	at	at	IN
25944	2139	32	several	several	JJ
25944	2139	33	regions	region	NNS
25944	2139	34	.	.	.
25944	2140	1	All	all	DT
25944	2140	2	parts	part	NNS
25944	2140	3	of	of	IN
25944	2140	4	the	the	DT
25944	2140	5	skin	skin	NN
25944	2140	6	,	,	,
25944	2140	7	including	include	VBG
25944	2140	8	the	the	DT
25944	2140	9	follicles	follicle	NNS
25944	2140	10	,	,	,
25944	2140	11	glands	gland	NNS
25944	2140	12	and	and	CC
25944	2140	13	subcutaneous	subcutaneous	JJ
25944	2140	14	connective	connective	JJ
25944	2140	15	and	and	CC
25944	2140	16	areolar	areolar	JJ
25944	2140	17	tissue	tissue	NN
25944	2140	18	,	,	,
25944	2140	19	share	share	VB
25944	2140	20	in	in	IN
25944	2140	21	the	the	DT
25944	2140	22	hypertrophy	hypertrophy	NN
25944	2140	23	;	;	:
25944	2140	24	and	and	CC
25944	2140	25	this	this	DT
25944	2140	26	in	in	IN
25944	2140	27	exceptional	exceptional	JJ
25944	2140	28	instances	instance	NNS
25944	2140	29	may	may	MD
25944	2140	30	be	be	VB
25944	2140	31	so	so	RB
25944	2140	32	extensive	extensive	JJ
25944	2140	33	that	that	IN
25944	2140	34	the	the	DT
25944	2140	35	integument	integument	NN
25944	2140	36	hangs	hang	VBZ
25944	2140	37	in	in	IN
25944	2140	38	folds	fold	NNS
25944	2140	39	.	.	.
25944	2141	1	The	the	DT
25944	2141	2	enlargement	enlargement	NN
25944	2141	3	of	of	IN
25944	2141	4	the	the	DT
25944	2141	5	follicles	follicle	NNS
25944	2141	6	,	,	,
25944	2141	7	natural	natural	JJ
25944	2141	8	folds	fold	NNS
25944	2141	9	and	and	CC
25944	2141	10	rugæ	rugæ	NNP
25944	2141	11	gives	give	VBZ
25944	2141	12	rise	rise	NN
25944	2141	13	to	to	IN
25944	2141	14	an	an	DT
25944	2141	15	uneven	uneven	JJ
25944	2141	16	surface	surface	NN
25944	2141	17	,	,	,
25944	2141	18	but	but	CC
25944	2141	19	the	the	DT
25944	2141	20	skin	skin	NN
25944	2141	21	remains	remain	VBZ
25944	2141	22	soft	soft	JJ
25944	2141	23	and	and	CC
25944	2141	24	pliable	pliable	JJ
25944	2141	25	.	.	.
25944	2142	1	There	there	EX
25944	2142	2	is	be	VBZ
25944	2142	3	also	also	RB
25944	2142	4	increased	increase	VBN
25944	2142	5	pigmentation	pigmentation	NN
25944	2142	6	,	,	,
25944	2142	7	the	the	DT
25944	2142	8	integument	integument	NN
25944	2142	9	becoming	become	VBG
25944	2142	10	more	more	RBR
25944	2142	11	or	or	CC
25944	2142	12	less	less	RBR
25944	2142	13	brownish	brownish	JJ
25944	2142	14	.	.	.
25944	2143	1	#	#	LS
25944	2143	2	What	what	WDT
25944	2143	3	course	course	NN
25944	2143	4	does	do	VBZ
25944	2143	5	dermatolysis	dermatolysis	NN
25944	2143	6	pursue	pursue	VB
25944	2143	7	?	?	.
25944	2143	8	#	#	$
25944	2143	9	Its	-PRON-	PRP$
25944	2143	10	development	development	NN
25944	2143	11	is	be	VBZ
25944	2143	12	slow	slow	JJ
25944	2143	13	and	and	CC
25944	2143	14	usually	usually	RB
25944	2143	15	progressive	progressive	JJ
25944	2143	16	.	.	.
25944	2144	1	It	-PRON-	PRP
25944	2144	2	gives	give	VBZ
25944	2144	3	rise	rise	NN
25944	2144	4	to	to	IN
25944	2144	5	no	no	DT
25944	2144	6	further	further	JJ
25944	2144	7	inconvenience	inconvenience	NN
25944	2144	8	than	than	IN
25944	2144	9	its	-PRON-	PRP$
25944	2144	10	weight	weight	NN
25944	2144	11	and	and	CC
25944	2144	12	consequent	consequent	JJ
25944	2144	13	discomfort	discomfort	NN
25944	2144	14	.	.	.
25944	2145	1	#	#	NN
25944	2145	2	Give	give	VB
25944	2145	3	the	the	DT
25944	2145	4	etiology	etiology	NN
25944	2145	5	.	.	.
25944	2145	6	#	#	$
25944	2145	7	The	the	DT
25944	2145	8	etiology	etiology	NN
25944	2145	9	is	be	VBZ
25944	2145	10	obscure	obscure	JJ
25944	2145	11	.	.	.
25944	2146	1	It	-PRON-	PRP
25944	2146	2	is	be	VBZ
25944	2146	3	considered	consider	VBN
25944	2146	4	by	by	IN
25944	2146	5	some	some	DT
25944	2146	6	authors	author	NNS
25944	2146	7	as	as	IN
25944	2146	8	allied	ally	VBN
25944	2146	9	to	to	IN
25944	2146	10	molluscum	molluscum	NNP
25944	2146	11	fibrosum	fibrosum	NNP
25944	2146	12	,	,	,
25944	2146	13	and	and	CC
25944	2146	14	,	,	,
25944	2146	15	in	in	IN
25944	2146	16	fact	fact	NN
25944	2146	17	,	,	,
25944	2146	18	as	as	IN
25944	2146	19	a	a	DT
25944	2146	20	manifestation	manifestation	NN
25944	2146	21	of	of	IN
25944	2146	22	that	that	DT
25944	2146	23	disease	disease	NN
25944	2146	24	,	,	,
25944	2146	25	ordinary	ordinary	JJ
25944	2146	26	molluscum	molluscum	JJ
25944	2146	27	tumors	tumor	NNS
25944	2146	28	sometimes	sometimes	RB
25944	2146	29	being	be	VBG
25944	2146	30	associated	associate	VBN
25944	2146	31	with	with	IN
25944	2146	32	it	-PRON-	PRP
25944	2146	33	.	.	.
25944	2147	1	It	-PRON-	PRP
25944	2147	2	is	be	VBZ
25944	2147	3	not	not	RB
25944	2147	4	malignant	malignant	JJ
25944	2147	5	.	.	.
25944	2148	1	#	#	LS
25944	2148	2	What	what	WP
25944	2148	3	is	be	VBZ
25944	2148	4	the	the	DT
25944	2148	5	pathology	pathology	NN
25944	2148	6	?	?	.
25944	2148	7	#	#	$
25944	2148	8	The	the	DT
25944	2148	9	disease	disease	NN
25944	2148	10	consists	consist	VBZ
25944	2148	11	of	of	IN
25944	2148	12	a	a	DT
25944	2148	13	simple	simple	JJ
25944	2148	14	hypertrophy	hypertrophy	NN
25944	2148	15	of	of	IN
25944	2148	16	all	all	PDT
25944	2148	17	the	the	DT
25944	2148	18	skin	skin	NN
25944	2148	19	structures	structure	NNS
25944	2148	20	and	and	CC
25944	2148	21	the	the	DT
25944	2148	22	subcutaneous	subcutaneous	JJ
25944	2148	23	connective	connective	JJ
25944	2148	24	tissue	tissue	NN
25944	2148	25	.	.	.
25944	2149	1	#	#	LS
25944	2149	2	What	what	WP
25944	2149	3	is	be	VBZ
25944	2149	4	the	the	DT
25944	2149	5	treatment	treatment	NN
25944	2149	6	of	of	IN
25944	2149	7	dermatolysis	dermatolysis	NN
25944	2149	8	?	?	.
25944	2149	9	#	#	NN
25944	2149	10	Excision	excision	NN
25944	2149	11	when	when	WRB
25944	2149	12	advisable	advisable	JJ
25944	2149	13	and	and	CC
25944	2149	14	practicable	practicable	JJ
25944	2149	15	.	.	.
25944	2150	1	#	#	$
25944	2150	2	CLASS	CLASS	NNP
25944	2150	3	V.--ATROPHIES	v.--atrophies	ADD
25944	2150	4	.	.	.
25944	2150	5	#	#	$
25944	2150	6	#	#	NNP
25944	2150	7	Albinismus	Albinismus	NNP
25944	2150	8	.	.	.
25944	2150	9	#	#	$
25944	2150	10	#	#	$
25944	2150	11	What	what	WP
25944	2150	12	do	do	VBP
25944	2150	13	you	-PRON-	PRP
25944	2150	14	understand	understand	VB
25944	2150	15	by	by	IN
25944	2150	16	albinismus	albinismus	NNP
25944	2150	17	?	?	.
25944	2150	18	#	#	$
25944	2150	19	Congenital	congenital	JJ
25944	2150	20	absence	absence	NN
25944	2150	21	,	,	,
25944	2150	22	either	either	CC
25944	2150	23	partial	partial	JJ
25944	2150	24	or	or	CC
25944	2150	25	complete	complete	JJ
25944	2150	26	,	,	,
25944	2150	27	of	of	IN
25944	2150	28	the	the	DT
25944	2150	29	pigment	pigment	NN
25944	2150	30	normally	normally	RB
25944	2150	31	present	present	JJ
25944	2150	32	in	in	IN
25944	2150	33	the	the	DT
25944	2150	34	skin	skin	NN
25944	2150	35	,	,	,
25944	2150	36	hair	hair	NN
25944	2150	37	and	and	CC
25944	2150	38	eyes	eye	NNS
25944	2150	39	.	.	.
25944	2151	1	#	#	NN
25944	2151	2	Describe	Describe	NNP
25944	2151	3	complete	complete	JJ
25944	2151	4	albinismus	albinismus	NN
25944	2151	5	.	.	.
25944	2151	6	#	#	$
25944	2151	7	In	in	IN
25944	2151	8	complete	complete	JJ
25944	2151	9	albinismus	albinismus	NN
25944	2151	10	the	the	DT
25944	2151	11	skin	skin	NN
25944	2151	12	of	of	IN
25944	2151	13	the	the	DT
25944	2151	14	entire	entire	JJ
25944	2151	15	body	body	NN
25944	2151	16	is	be	VBZ
25944	2151	17	white	white	JJ
25944	2151	18	,	,	,
25944	2151	19	the	the	DT
25944	2151	20	hair	hair	NN
25944	2151	21	very	very	RB
25944	2151	22	fine	fine	JJ
25944	2151	23	,	,	,
25944	2151	24	soft	soft	JJ
25944	2151	25	and	and	CC
25944	2151	26	white	white	JJ
25944	2151	27	or	or	CC
25944	2151	28	whitish	whitish	NN
25944	2151	29	-	-	HYPH
25944	2151	30	yellow	yellow	JJ
25944	2151	31	in	in	IN
25944	2151	32	color	color	NN
25944	2151	33	,	,	,
25944	2151	34	the	the	DT
25944	2151	35	irides	iris	NNS
25944	2151	36	are	be	VBP
25944	2151	37	colorless	colorless	JJ
25944	2151	38	or	or	CC
25944	2151	39	light	light	JJ
25944	2151	40	blue	blue	NN
25944	2151	41	,	,	,
25944	2151	42	and	and	CC
25944	2151	43	the	the	DT
25944	2151	44	pupils	pupil	NNS
25944	2151	45	,	,	,
25944	2151	46	owing	owe	VBG
25944	2151	47	to	to	IN
25944	2151	48	the	the	DT
25944	2151	49	absence	absence	NN
25944	2151	50	of	of	IN
25944	2151	51	pigment	pigment	NN
25944	2151	52	in	in	IN
25944	2151	53	the	the	DT
25944	2151	54	choroid	choroid	NN
25944	2151	55	,	,	,
25944	2151	56	are	be	VBP
25944	2151	57	red	red	JJ
25944	2151	58	;	;	:
25944	2151	59	this	this	DT
25944	2151	60	absence	absence	NN
25944	2151	61	of	of	IN
25944	2151	62	pigment	pigment	NN
25944	2151	63	in	in	IN
25944	2151	64	the	the	DT
25944	2151	65	eyes	eye	NNS
25944	2151	66	gives	give	VBZ
25944	2151	67	rise	rise	NN
25944	2151	68	to	to	IN
25944	2151	69	photophobia	photophobia	NNP
25944	2151	70	and	and	CC
25944	2151	71	nystagmus	nystagmus	NN
25944	2151	72	.	.	.
25944	2152	1	_	_	NNP
25944	2152	2	Albinos_--a	Albinos_--a	NNP
25944	2152	3	term	term	NN
25944	2152	4	applied	apply	VBN
25944	2152	5	to	to	IN
25944	2152	6	such	such	JJ
25944	2152	7	individuals	individual	NNS
25944	2152	8	--	--	:
25944	2152	9	are	be	VBP
25944	2152	10	commonly	commonly	RB
25944	2152	11	of	of	IN
25944	2152	12	feeble	feeble	JJ
25944	2152	13	constitution	constitution	NN
25944	2152	14	,	,	,
25944	2152	15	and	and	CC
25944	2152	16	may	may	MD
25944	2152	17	exhibit	exhibit	VB
25944	2152	18	imperfect	imperfect	JJ
25944	2152	19	mental	mental	JJ
25944	2152	20	development	development	NN
25944	2152	21	.	.	.
25944	2153	1	#	#	NNP
25944	2153	2	Describe	Describe	NNP
25944	2153	3	partial	partial	JJ
25944	2153	4	albinismus	albinismus	NN
25944	2153	5	.	.	.
25944	2153	6	#	#	$
25944	2153	7	Partial	Partial	NNP
25944	2153	8	albinismus	albinismus	NN
25944	2153	9	is	be	VBZ
25944	2153	10	met	meet	VBN
25944	2153	11	with	with	IN
25944	2153	12	most	most	RBS
25944	2153	13	frequently	frequently	RB
25944	2153	14	in	in	IN
25944	2153	15	the	the	DT
25944	2153	16	colored	colored	JJ
25944	2153	17	race	race	NN
25944	2153	18	.	.	.
25944	2154	1	In	in	IN
25944	2154	2	this	this	DT
25944	2154	3	form	form	NN
25944	2154	4	of	of	IN
25944	2154	5	the	the	DT
25944	2154	6	affection	affection	NN
25944	2154	7	the	the	DT
25944	2154	8	pigment	pigment	NN
25944	2154	9	is	be	VBZ
25944	2154	10	absent	absent	JJ
25944	2154	11	in	in	IN
25944	2154	12	one	one	CD
25944	2154	13	,	,	,
25944	2154	14	several	several	JJ
25944	2154	15	or	or	CC
25944	2154	16	more	more	RBR
25944	2154	17	variously	variously	RB
25944	2154	18	-	-	HYPH
25944	2154	19	sized	sized	JJ
25944	2154	20	patches	patch	NNS
25944	2154	21	;	;	:
25944	2154	22	usually	usually	RB
25944	2154	23	the	the	DT
25944	2154	24	hairs	hair	NNS
25944	2154	25	growing	grow	VBG
25944	2154	26	thereon	thereon	NN
25944	2154	27	are	be	VBP
25944	2154	28	likewise	likewise	RB
25944	2154	29	colorless	colorless	NN
25944	2154	30	.	.	.
25944	2155	1	#	#	$
25944	2155	2	Is	be	VBZ
25944	2155	3	there	there	EX
25944	2155	4	any	any	DT
25944	2155	5	structural	structural	JJ
25944	2155	6	change	change	NN
25944	2155	7	in	in	IN
25944	2155	8	the	the	DT
25944	2155	9	skin	skin	NN
25944	2155	10	?	?	.
25944	2155	11	#	#	$
25944	2155	12	No	no	UH
25944	2155	13	.	.	.
25944	2156	1	The	the	DT
25944	2156	2	functions	function	NNS
25944	2156	3	of	of	IN
25944	2156	4	the	the	DT
25944	2156	5	skin	skin	NN
25944	2156	6	are	be	VBP
25944	2156	7	performed	perform	VBN
25944	2156	8	in	in	IN
25944	2156	9	a	a	DT
25944	2156	10	perfectly	perfectly	RB
25944	2156	11	natural	natural	JJ
25944	2156	12	manner	manner	NN
25944	2156	13	,	,	,
25944	2156	14	and	and	CC
25944	2156	15	microscopical	microscopical	JJ
25944	2156	16	examination	examination	NN
25944	2156	17	shows	show	VBZ
25944	2156	18	no	no	DT
25944	2156	19	departure	departure	NN
25944	2156	20	from	from	IN
25944	2156	21	normal	normal	JJ
25944	2156	22	structure	structure	NN
25944	2156	23	save	save	IN
25944	2156	24	the	the	DT
25944	2156	25	complete	complete	JJ
25944	2156	26	absence	absence	NN
25944	2156	27	of	of	IN
25944	2156	28	pigment	pigment	NN
25944	2156	29	.	.	.
25944	2157	1	#	#	LS
25944	2157	2	What	what	WP
25944	2157	3	is	be	VBZ
25944	2157	4	known	know	VBN
25944	2157	5	in	in	IN
25944	2157	6	regard	regard	NN
25944	2157	7	to	to	IN
25944	2157	8	the	the	DT
25944	2157	9	etiology	etiology	NN
25944	2157	10	?	?	.
25944	2157	11	#	#	$
25944	2157	12	Nothing	nothing	NN
25944	2157	13	is	be	VBZ
25944	2157	14	known	know	VBN
25944	2157	15	of	of	IN
25944	2157	16	the	the	DT
25944	2157	17	causes	cause	NNS
25944	2157	18	producing	produce	VBG
25944	2157	19	albinismus	albinismus	NNP
25944	2157	20	beyond	beyond	IN
25944	2157	21	the	the	DT
25944	2157	22	single	single	JJ
25944	2157	23	fact	fact	NN
25944	2157	24	that	that	IN
25944	2157	25	it	-PRON-	PRP
25944	2157	26	is	be	VBZ
25944	2157	27	frequently	frequently	RB
25944	2157	28	hereditary	hereditary	JJ
25944	2157	29	.	.	.
25944	2158	1	#	#	NNP
25944	2158	2	Does	do	VBZ
25944	2158	3	albinismus	albinismus	NNP
25944	2158	4	admit	admit	VB
25944	2158	5	of	of	IN
25944	2158	6	treatment	treatment	NN
25944	2158	7	?	?	.
25944	2158	8	#	#	$
25944	2158	9	No	no	UH
25944	2158	10	;	;	:
25944	2158	11	the	the	DT
25944	2158	12	condition	condition	NN
25944	2158	13	is	be	VBZ
25944	2158	14	without	without	IN
25944	2158	15	remedy	remedy	NN
25944	2158	16	.	.	.
25944	2159	1	#	#	JJR
25944	2159	2	Vitiligo	Vitiligo	NNP
25944	2159	3	.	.	.
25944	2159	4	#	#	NN
25944	2159	5	(	(	-LRB-
25944	2159	6	_	_	NNP
25944	2159	7	Synonyms	Synonyms	NNP
25944	2159	8	:	:	:
25944	2159	9	_	_	NNP
25944	2159	10	Leucoderma	Leucoderma	NNP
25944	2159	11	;	;	:
25944	2159	12	Leucopathia	Leucopathia	NNP
25944	2159	13	.	.	.
25944	2159	14	)	)	-RRB-
25944	2160	1	#	#	NN
25944	2160	2	Give	give	VB
25944	2160	3	a	a	DT
25944	2160	4	definition	definition	NN
25944	2160	5	of	of	IN
25944	2160	6	vitiligo	vitiligo	NNS
25944	2160	7	.	.	.
25944	2160	8	#	#	$
25944	2160	9	Vitiligo	Vitiligo	NNS
25944	2160	10	may	may	MD
25944	2160	11	be	be	VB
25944	2160	12	defined	define	VBN
25944	2160	13	as	as	IN
25944	2160	14	a	a	DT
25944	2160	15	disease	disease	NN
25944	2160	16	involving	involve	VBG
25944	2160	17	the	the	DT
25944	2160	18	pigment	pigment	NN
25944	2160	19	of	of	IN
25944	2160	20	the	the	DT
25944	2160	21	skin	skin	NN
25944	2160	22	alone	alone	RB
25944	2160	23	,	,	,
25944	2160	24	characterized	characterize	VBN
25944	2160	25	by	by	IN
25944	2160	26	several	several	JJ
25944	2160	27	or	or	CC
25944	2160	28	more	more	RBR
25944	2160	29	progressive	progressive	JJ
25944	2160	30	,	,	,
25944	2160	31	milky	milky	JJ
25944	2160	32	-	-	HYPH
25944	2160	33	white	white	JJ
25944	2160	34	patches	patch	NNS
25944	2160	35	surrounded	surround	VBN
25944	2160	36	by	by	IN
25944	2160	37	increased	increase	VBN
25944	2160	38	pigmentation	pigmentation	NN
25944	2160	39	.	.	.
25944	2161	1	#	#	NNP
25944	2161	2	Describe	describe	VB
25944	2161	3	the	the	DT
25944	2161	4	symptoms	symptom	NNS
25944	2161	5	of	of	IN
25944	2161	6	vitiligo	vitiligo	NNS
25944	2161	7	.	.	.
25944	2161	8	#	#	$
25944	2161	9	The	the	DT
25944	2161	10	disease	disease	NN
25944	2161	11	may	may	MD
25944	2161	12	begin	begin	VB
25944	2161	13	at	at	IN
25944	2161	14	one	one	CD
25944	2161	15	or	or	CC
25944	2161	16	more	more	JJR
25944	2161	17	regions	region	NNS
25944	2161	18	,	,	,
25944	2161	19	the	the	DT
25944	2161	20	backs	back	NNS
25944	2161	21	of	of	IN
25944	2161	22	the	the	DT
25944	2161	23	hands	hand	NNS
25944	2161	24	,	,	,
25944	2161	25	trunk	trunk	NN
25944	2161	26	and	and	CC
25944	2161	27	face	face	NN
25944	2161	28	being	be	VBG
25944	2161	29	favorite	favorite	JJ
25944	2161	30	parts	part	NNS
25944	2161	31	;	;	:
25944	2161	32	its	-PRON-	PRP$
25944	2161	33	appearance	appearance	NN
25944	2161	34	is	be	VBZ
25944	2161	35	usually	usually	RB
25944	2161	36	insidious	insidious	JJ
25944	2161	37	,	,	,
25944	2161	38	and	and	CC
25944	2161	39	the	the	DT
25944	2161	40	spots	spot	NNS
25944	2161	41	may	may	MD
25944	2161	42	not	not	RB
25944	2161	43	be	be	VB
25944	2161	44	especially	especially	RB
25944	2161	45	noticeable	noticeable	JJ
25944	2161	46	until	until	IN
25944	2161	47	they	-PRON-	PRP
25944	2161	48	are	be	VBP
25944	2161	49	the	the	DT
25944	2161	50	size	size	NN
25944	2161	51	of	of	IN
25944	2161	52	a	a	DT
25944	2161	53	pea	pea	NN
25944	2161	54	or	or	CC
25944	2161	55	larger	large	JJR
25944	2161	56	.	.	.
25944	2162	1	The	the	DT
25944	2162	2	patches	patch	NNS
25944	2162	3	grow	grow	VBP
25944	2162	4	slowly	slowly	RB
25944	2162	5	,	,	,
25944	2162	6	are	be	VBP
25944	2162	7	milky	milky	JJ
25944	2162	8	or	or	CC
25944	2162	9	dead	dead	JJ
25944	2162	10	white	white	JJ
25944	2162	11	,	,	,
25944	2162	12	smooth	smooth	JJ
25944	2162	13	,	,	,
25944	2162	14	non	non	JJ
25944	2162	15	-	-	JJ
25944	2162	16	elevated	elevated	JJ
25944	2162	17	,	,	,
25944	2162	18	and	and	CC
25944	2162	19	of	of	IN
25944	2162	20	rounded	rounded	JJ
25944	2162	21	outline	outline	NN
25944	2162	22	;	;	:
25944	2162	23	the	the	DT
25944	2162	24	bordering	bordering	NN
25944	2162	25	skin	skin	NN
25944	2162	26	is	be	VBZ
25944	2162	27	darker	dark	JJR
25944	2162	28	than	than	IN
25944	2162	29	normal	normal	JJ
25944	2162	30	,	,	,
25944	2162	31	showing	show	VBG
25944	2162	32	increased	increase	VBN
25944	2162	33	pigmentation	pigmentation	NN
25944	2162	34	.	.	.
25944	2163	1	Several	several	JJ
25944	2163	2	contiguous	contiguous	JJ
25944	2163	3	spots	spot	NNS
25944	2163	4	may	may	MD
25944	2163	5	coalesce	coalesce	VB
25944	2163	6	and	and	CC
25944	2163	7	form	form	VB
25944	2163	8	a	a	DT
25944	2163	9	large	large	JJ
25944	2163	10	,	,	,
25944	2163	11	irregularly	irregularly	RB
25944	2163	12	-	-	HYPH
25944	2163	13	shaped	shape	VBN
25944	2163	14	patch	patch	NN
25944	2163	15	.	.	.
25944	2164	1	Hair	hair	NN
25944	2164	2	growing	grow	VBG
25944	2164	3	on	on	IN
25944	2164	4	the	the	DT
25944	2164	5	involved	involved	JJ
25944	2164	6	skin	skin	NN
25944	2164	7	may	may	MD
25944	2164	8	or	or	CC
25944	2164	9	may	may	MD
25944	2164	10	not	not	RB
25944	2164	11	be	be	VB
25944	2164	12	blanched	blanch	VBN
25944	2164	13	.	.	.
25944	2165	1	There	there	EX
25944	2165	2	are	be	VBP
25944	2165	3	no	no	DT
25944	2165	4	subjective	subjective	JJ
25944	2165	5	symptoms	symptom	NNS
25944	2165	6	.	.	.
25944	2166	1	#	#	LS
25944	2166	2	What	what	WDT
25944	2166	3	course	course	NN
25944	2166	4	does	do	VBZ
25944	2166	5	vitiligo	vitiligo	RB
25944	2166	6	pursue	pursue	VB
25944	2166	7	?	?	.
25944	2166	8	#	#	$
25944	2166	9	The	the	DT
25944	2166	10	course	course	NN
25944	2166	11	of	of	IN
25944	2166	12	the	the	DT
25944	2166	13	disease	disease	NN
25944	2166	14	is	be	VBZ
25944	2166	15	slow	slow	JJ
25944	2166	16	,	,	,
25944	2166	17	months	month	NNS
25944	2166	18	and	and	CC
25944	2166	19	sometimes	sometimes	RB
25944	2166	20	years	year	NNS
25944	2166	21	elapsing	elapsing	JJ
25944	2166	22	before	before	IN
25944	2166	23	it	-PRON-	PRP
25944	2166	24	reaches	reach	VBZ
25944	2166	25	conspicuous	conspicuous	JJ
25944	2166	26	development	development	NN
25944	2166	27	.	.	.
25944	2167	1	It	-PRON-	PRP
25944	2167	2	may	may	MD
25944	2167	3	after	after	IN
25944	2167	4	a	a	DT
25944	2167	5	time	time	NN
25944	2167	6	remain	remain	VBP
25944	2167	7	stationary	stationary	JJ
25944	2167	8	,	,	,
25944	2167	9	or	or	CC
25944	2167	10	,	,	,
25944	2167	11	in	in	IN
25944	2167	12	rare	rare	JJ
25944	2167	13	instances	instance	NNS
25944	2167	14	,	,	,
25944	2167	15	retrogress	retrogress	NN
25944	2167	16	;	;	:
25944	2167	17	as	as	IN
25944	2167	18	a	a	DT
25944	2167	19	rule	rule	NN
25944	2167	20	,	,	,
25944	2167	21	however	however	RB
25944	2167	22	,	,	,
25944	2167	23	it	-PRON-	PRP
25944	2167	24	is	be	VBZ
25944	2167	25	progressive	progressive	JJ
25944	2167	26	.	.	.
25944	2168	1	Exceptionally	exceptionally	RB
25944	2168	2	,	,	,
25944	2168	3	the	the	DT
25944	2168	4	greater	great	JJR
25944	2168	5	part	part	NN
25944	2168	6	,	,	,
25944	2168	7	or	or	CC
25944	2168	8	even	even	RB
25944	2168	9	the	the	DT
25944	2168	10	whole	whole	JJ
25944	2168	11	surface	surface	NN
25944	2168	12	may	may	MD
25944	2168	13	eventually	eventually	RB
25944	2168	14	be	be	VB
25944	2168	15	involved	involve	VBN
25944	2168	16	.	.	.
25944	2169	1	#	#	NN
25944	2169	2	Give	give	VB
25944	2169	3	the	the	DT
25944	2169	4	etiology	etiology	NN
25944	2169	5	of	of	IN
25944	2169	6	vitiligo	vitiligo	NNS
25944	2169	7	.	.	.
25944	2169	8	#	#	$
25944	2169	9	Disturbed	disturb	VBN
25944	2169	10	innervation	innervation	NN
25944	2169	11	is	be	VBZ
25944	2169	12	thought	think	VBN
25944	2169	13	to	to	TO
25944	2169	14	be	be	VB
25944	2169	15	influential	influential	JJ
25944	2169	16	.	.	.
25944	2170	1	The	the	DT
25944	2170	2	disease	disease	NN
25944	2170	3	develops	develop	VBZ
25944	2170	4	often	often	RB
25944	2170	5	without	without	IN
25944	2170	6	apparent	apparent	JJ
25944	2170	7	cause	cause	NN
25944	2170	8	.	.	.
25944	2171	1	Alopecia	Alopecia	NNP
25944	2171	2	areata	areata	NNP
25944	2171	3	and	and	CC
25944	2171	4	morph[oe]a	morph[oe]a	NNP
25944	2171	5	have	have	VBP
25944	2171	6	been	be	VBN
25944	2171	7	observed	observe	VBN
25944	2171	8	associated	associate	VBN
25944	2171	9	with	with	IN
25944	2171	10	it	-PRON-	PRP
25944	2171	11	.	.	.
25944	2172	1	[	[	-LRB-
25944	2172	2	Illustration	illustration	NN
25944	2172	3	:	:	:
25944	2172	4	Fig	Fig	NNP
25944	2172	5	.	.	.
25944	2173	1	36	36	CD
25944	2173	2	.	.	.
25944	2174	1	Vitiligo	Vitiligo	NNS
25944	2174	2	.	.	.
25944	2174	3	]	]	-RRB-
25944	2175	1	#	#	NNP
25944	2175	2	State	state	NN
25944	2175	3	the	the	DT
25944	2175	4	pathology	pathology	NN
25944	2175	5	of	of	IN
25944	2175	6	vitiligo	vitiligo	NNS
25944	2175	7	.	.	.
25944	2175	8	#	#	$
25944	2175	9	The	the	DT
25944	2175	10	disease	disease	NN
25944	2175	11	consists	consist	VBZ
25944	2175	12	,	,	,
25944	2175	13	anatomically	anatomically	RB
25944	2175	14	,	,	,
25944	2175	15	of	of	IN
25944	2175	16	both	both	DT
25944	2175	17	a	a	DT
25944	2175	18	diminution	diminution	NN
25944	2175	19	and	and	CC
25944	2175	20	increase	increase	NN
25944	2175	21	of	of	IN
25944	2175	22	the	the	DT
25944	2175	23	pigment	pigment	NN
25944	2175	24	--	--	:
25944	2175	25	the	the	DT
25944	2175	26	white	white	JJ
25944	2175	27	patch	patch	NN
25944	2175	28	resulting	result	VBG
25944	2175	29	from	from	IN
25944	2175	30	the	the	DT
25944	2175	31	former	former	JJ
25944	2175	32	,	,	,
25944	2175	33	and	and	CC
25944	2175	34	the	the	DT
25944	2175	35	pigmented	pigment	VBN
25944	2175	36	borders	border	NNS
25944	2175	37	from	from	IN
25944	2175	38	the	the	DT
25944	2175	39	latter	latter	JJ
25944	2175	40	.	.	.
25944	2176	1	There	there	EX
25944	2176	2	is	be	VBZ
25944	2176	3	no	no	DT
25944	2176	4	textural	textural	JJ
25944	2176	5	change	change	NN
25944	2176	6	,	,	,
25944	2176	7	the	the	DT
25944	2176	8	skin	skin	NN
25944	2176	9	in	in	IN
25944	2176	10	other	other	JJ
25944	2176	11	respects	respect	NNS
25944	2176	12	being	be	VBG
25944	2176	13	normal	normal	JJ
25944	2176	14	.	.	.
25944	2177	1	#	#	$
25944	2177	2	From	from	IN
25944	2177	3	what	what	WP
25944	2177	4	diseases	disease	NNS
25944	2177	5	is	be	VBZ
25944	2177	6	vitiligo	vitiligo	NNS
25944	2177	7	to	to	TO
25944	2177	8	be	be	VB
25944	2177	9	differentiated	differentiate	VBN
25944	2177	10	?	?	.
25944	2177	11	#	#	$
25944	2177	12	From	from	IN
25944	2177	13	morph[oe]a	morph[oe]a	NNP
25944	2177	14	and	and	CC
25944	2177	15	from	from	IN
25944	2177	16	the	the	DT
25944	2177	17	anæsthetic	anæsthetic	JJ
25944	2177	18	patches	patch	NNS
25944	2177	19	of	of	IN
25944	2177	20	leprosy	leprosy	NN
25944	2177	21	.	.	.
25944	2178	1	#	#	$
25944	2178	2	In	in	IN
25944	2178	3	what	what	WDT
25944	2178	4	respects	respect	NNS
25944	2178	5	do	do	VBP
25944	2178	6	these	these	DT
25944	2178	7	diseases	disease	NNS
25944	2178	8	differ	differ	VB
25944	2178	9	from	from	IN
25944	2178	10	vitiligo	vitiligo	NNS
25944	2178	11	?	?	.
25944	2178	12	#	#	$
25944	2178	13	In	in	IN
25944	2178	14	morph[oe]a	morph[oe]a	NNP
25944	2178	15	there	there	EX
25944	2178	16	is	be	VBZ
25944	2178	17	textural	textural	JJ
25944	2178	18	change	change	NN
25944	2178	19	,	,	,
25944	2178	20	and	and	CC
25944	2178	21	in	in	IN
25944	2178	22	leprosy	leprosy	NN
25944	2178	23	both	both	CC
25944	2178	24	textural	textural	JJ
25944	2178	25	change	change	NN
25944	2178	26	and	and	CC
25944	2178	27	constitutional	constitutional	JJ
25944	2178	28	or	or	CC
25944	2178	29	other	other	JJ
25944	2178	30	symptoms	symptom	NNS
25944	2178	31	.	.	.
25944	2179	1	#	#	LS
25944	2179	2	What	what	WDT
25944	2179	3	prognosis	prognosis	NN
25944	2179	4	is	be	VBZ
25944	2179	5	to	to	TO
25944	2179	6	be	be	VB
25944	2179	7	given	give	VBN
25944	2179	8	?	?	.
25944	2179	9	#	#	$
25944	2179	10	It	-PRON-	PRP
25944	2179	11	should	should	MD
25944	2179	12	always	always	RB
25944	2179	13	be	be	VB
25944	2179	14	guarded	guard	VBN
25944	2179	15	,	,	,
25944	2179	16	the	the	DT
25944	2179	17	disease	disease	NN
25944	2179	18	in	in	IN
25944	2179	19	almost	almost	RB
25944	2179	20	all	all	DT
25944	2179	21	cases	case	NNS
25944	2179	22	being	be	VBG
25944	2179	23	irresponsive	irresponsive	JJ
25944	2179	24	to	to	IN
25944	2179	25	treatment	treatment	NN
25944	2179	26	.	.	.
25944	2180	1	#	#	LS
25944	2180	2	What	what	WP
25944	2180	3	is	be	VBZ
25944	2180	4	the	the	DT
25944	2180	5	treatment	treatment	NN
25944	2180	6	of	of	IN
25944	2180	7	vitiligo	vitiligo	NNS
25944	2180	8	?	?	.
25944	2180	9	#	#	$
25944	2180	10	The	the	DT
25944	2180	11	general	general	JJ
25944	2180	12	health	health	NN
25944	2180	13	is	be	VBZ
25944	2180	14	to	to	TO
25944	2180	15	be	be	VB
25944	2180	16	looked	look	VBN
25944	2180	17	after	after	IN
25944	2180	18	,	,	,
25944	2180	19	and	and	CC
25944	2180	20	remedies	remedy	NNS
25944	2180	21	directed	direct	VBD
25944	2180	22	especially	especially	RB
25944	2180	23	toward	toward	IN
25944	2180	24	the	the	DT
25944	2180	25	nervous	nervous	JJ
25944	2180	26	system	system	NN
25944	2180	27	to	to	TO
25944	2180	28	be	be	VB
25944	2180	29	employed	employ	VBN
25944	2180	30	.	.	.
25944	2181	1	Arsenic	arsenic	JJ
25944	2181	2	,	,	,
25944	2181	3	in	in	IN
25944	2181	4	small	small	JJ
25944	2181	5	and	and	CC
25944	2181	6	continued	continued	JJ
25944	2181	7	doses	dose	NNS
25944	2181	8	,	,	,
25944	2181	9	seems	seem	VBZ
25944	2181	10	at	at	IN
25944	2181	11	times	time	NNS
25944	2181	12	to	to	TO
25944	2181	13	have	have	VB
25944	2181	14	an	an	DT
25944	2181	15	influence	influence	NN
25944	2181	16	;	;	:
25944	2181	17	when	when	WRB
25944	2181	18	there	there	EX
25944	2181	19	is	be	VBZ
25944	2181	20	lack	lack	NN
25944	2181	21	of	of	IN
25944	2181	22	general	general	JJ
25944	2181	23	tone	tone	NN
25944	2181	24	it	-PRON-	PRP
25944	2181	25	may	may	MD
25944	2181	26	be	be	VB
25944	2181	27	prescribed	prescribe	VBN
25944	2181	28	as	as	IN
25944	2181	29	follows:--	follows:--	ADD
25944	2181	30	[	[	-LRB-
25944	2181	31	Rx	Rx	NNP
25944	2181	32	]	]	-RRB-
25944	2181	33	Liq	Liq	NNP
25944	2181	34	.	.	.
25944	2182	1	potassii	potassii	NNP
25944	2182	2	arsenitis	arsenitis	NNP
25944	2182	3	,	,	,
25944	2182	4	.............	.............	NFP
25944	2182	5	f[dram]j	f[dram]j	NNS
25944	2182	6	Tinct	Tinct	NNP
25944	2182	7	.	.	.
25944	2183	1	nucis	nucis	NNP
25944	2183	2	vom	vom	NNP
25944	2183	3	.	.	NNP
25944	2183	4	,	,	,
25944	2183	5	...................	...................	NFP
25944	2183	6	f[dram]iij	f[dram]iij	JJ
25944	2183	7	Elix	Elix	NNP
25944	2183	8	.	.	.
25944	2184	1	calisayæ	calisayæ	NNP
25944	2184	2	,	,	,
25944	2184	3	.......	.......	NFP
25944	2184	4	q.	q.	NNP
25944	2184	5	s.	s.	NNP
25944	2184	6	ad	ad	NNP
25944	2184	7	.....	.....	.
25944	2184	8	f[Oz]iv	f[oz]iv	NN
25944	2184	9	.	.	.
25944	2185	1	M.	M.	NNP
25944	2186	1	SIG.--f[dram]j	SIG.--f[dram]j	NNP
25944	2186	2	t.	t.	NNP
25944	2186	3	d.	d.	NNP
25944	2186	4	Suprarenal	Suprarenal	NNP
25944	2186	5	-	-	HYPH
25944	2186	6	gland	gland	NN
25944	2186	7	preparations	preparation	NNS
25944	2186	8	in	in	IN
25944	2186	9	moderate	moderate	JJ
25944	2186	10	dosage	dosage	NN
25944	2186	11	long	long	RB
25944	2186	12	continued	continue	VBN
25944	2186	13	has	have	VBZ
25944	2186	14	appeared	appear	VBN
25944	2186	15	in	in	IN
25944	2186	16	a	a	DT
25944	2186	17	few	few	JJ
25944	2186	18	instances	instance	NNS
25944	2186	19	to	to	TO
25944	2186	20	be	be	VB
25944	2186	21	of	of	IN
25944	2186	22	some	some	DT
25944	2186	23	benefit	benefit	NN
25944	2186	24	.	.	.
25944	2187	1	When	when	WRB
25944	2187	2	upon	upon	IN
25944	2187	3	exposed	exposed	JJ
25944	2187	4	parts	part	NNS
25944	2187	5	,	,	,
25944	2187	6	stimulation	stimulation	NN
25944	2187	7	of	of	IN
25944	2187	8	the	the	DT
25944	2187	9	patches	patch	NNS
25944	2187	10	,	,	,
25944	2187	11	with	with	IN
25944	2187	12	the	the	DT
25944	2187	13	view	view	NN
25944	2187	14	of	of	IN
25944	2187	15	producing	produce	VBG
25944	2187	16	hyperæmia	hyperæmia	NN
25944	2187	17	and	and	CC
25944	2187	18	consequent	consequent	JJ
25944	2187	19	pigment	pigment	NN
25944	2187	20	deposit	deposit	NN
25944	2187	21	;	;	:
25944	2187	22	conjoined	conjoin	VBN
25944	2187	23	with	with	IN
25944	2187	24	suitable	suitable	JJ
25944	2187	25	applications	application	NNS
25944	2187	26	to	to	IN
25944	2187	27	the	the	DT
25944	2187	28	surrounding	surround	VBG
25944	2187	29	pigmented	pigment	VBN
25944	2187	30	skin	skin	NN
25944	2187	31	,	,	,
25944	2187	32	with	with	IN
25944	2187	33	a	a	DT
25944	2187	34	view	view	NN
25944	2187	35	to	to	TO
25944	2187	36	lessen	lessen	VB
25944	2187	37	the	the	DT
25944	2187	38	coloration	coloration	NN
25944	2187	39	(	(	-LRB-
25944	2187	40	see	see	VB
25944	2187	41	_	_	NNP
25944	2187	42	treatment	treatment	NN
25944	2187	43	of	of	IN
25944	2187	44	chloasma	chloasma	NNP
25944	2187	45	_	_	NNP
25944	2187	46	)	)	-RRB-
25944	2187	47	,	,	,
25944	2187	48	will	will	MD
25944	2187	49	be	be	VB
25944	2187	50	of	of	IN
25944	2187	51	aid	aid	NN
25944	2187	52	in	in	IN
25944	2187	53	rendering	render	VBG
25944	2187	54	the	the	DT
25944	2187	55	disease	disease	NN
25944	2187	56	less	less	RBR
25944	2187	57	conspicuous	conspicuous	JJ
25944	2187	58	.	.	.
25944	2188	1	Or	or	CC
25944	2188	2	the	the	DT
25944	2188	3	condition	condition	NN
25944	2188	4	may	may	MD
25944	2188	5	be	be	VB
25944	2188	6	,	,	,
25944	2188	7	in	in	IN
25944	2188	8	a	a	DT
25944	2188	9	measure	measure	NN
25944	2188	10	,	,	,
25944	2188	11	masked	mask	VBN
25944	2188	12	by	by	IN
25944	2188	13	staining	stain	VBG
25944	2188	14	the	the	DT
25944	2188	15	patches	patch	NNS
25944	2188	16	with	with	IN
25944	2188	17	walnut	walnut	NNP
25944	2188	18	juice	juice	NN
25944	2188	19	or	or	CC
25944	2188	20	similar	similar	JJ
25944	2188	21	pigment	pigment	NN
25944	2188	22	.	.	.
25944	2189	1	#	#	NNP
25944	2189	2	Canities	Canities	NNP
25944	2189	3	.	.	.
25944	2189	4	#	#	NNP
25944	2189	5	(	(	-LRB-
25944	2189	6	_	_	NNP
25944	2189	7	Synonym	Synonym	NNP
25944	2189	8	:	:	:
25944	2189	9	_	_	NNP
25944	2189	10	Grayness	Grayness	NNP
25944	2189	11	of	of	IN
25944	2189	12	the	the	DT
25944	2189	13	Hair	Hair	NNP
25944	2189	14	.	.	.
25944	2189	15	)	)	-RRB-
25944	2190	1	#	#	NNP
25944	2190	2	Describe	Describe	NNP
25944	2190	3	canities	canitie	NNS
25944	2190	4	.	.	.
25944	2190	5	#	#	$
25944	2190	6	Canities	canitie	NNS
25944	2190	7	,	,	,
25944	2190	8	or	or	CC
25944	2190	9	graying	graying	NN
25944	2190	10	of	of	IN
25944	2190	11	the	the	DT
25944	2190	12	hair	hair	NN
25944	2190	13	,	,	,
25944	2190	14	may	may	MD
25944	2190	15	occur	occur	VB
25944	2190	16	in	in	IN
25944	2190	17	localized	localized	JJ
25944	2190	18	areas	area	NNS
25944	2190	19	or	or	CC
25944	2190	20	it	-PRON-	PRP
25944	2190	21	may	may	MD
25944	2190	22	be	be	VB
25944	2190	23	more	more	RBR
25944	2190	24	or	or	CC
25944	2190	25	less	less	RBR
25944	2190	26	general	general	JJ
25944	2190	27	;	;	:
25944	2190	28	the	the	DT
25944	2190	29	blanching	blanching	NN
25944	2190	30	may	may	MD
25944	2190	31	be	be	VB
25944	2190	32	slight	slight	JJ
25944	2190	33	,	,	,
25944	2190	34	scarcely	scarcely	RB
25944	2190	35	amounting	amount	VBG
25944	2190	36	to	to	IN
25944	2190	37	slight	slight	JJ
25944	2190	38	grayness	grayness	NN
25944	2190	39	,	,	,
25944	2190	40	or	or	CC
25944	2190	41	it	-PRON-	PRP
25944	2190	42	may	may	MD
25944	2190	43	be	be	VB
25944	2190	44	complete	complete	JJ
25944	2190	45	.	.	.
25944	2191	1	It	-PRON-	PRP
25944	2191	2	is	be	VBZ
25944	2191	3	common	common	JJ
25944	2191	4	to	to	IN
25944	2191	5	advancing	advance	VBG
25944	2191	6	years	year	NNS
25944	2191	7	(	(	-LRB-
25944	2191	8	_	_	NNP
25944	2191	9	canities	canitie	NNS
25944	2191	10	senilis	senilis	NNPS
25944	2191	11	_	_	NNP
25944	2191	12	)	)	-RRB-
25944	2191	13	;	;	:
25944	2191	14	it	-PRON-	PRP
25944	2191	15	is	be	VBZ
25944	2191	16	seen	see	VBN
25944	2191	17	also	also	RB
25944	2191	18	exceptionally	exceptionally	RB
25944	2191	19	in	in	IN
25944	2191	20	early	early	JJ
25944	2191	21	life	life	NN
25944	2191	22	(	(	-LRB-
25944	2191	23	_	_	NNP
25944	2191	24	canities	canitie	NNS
25944	2191	25	præmatura	præmatura	NNP
25944	2191	26	_	_	NNP
25944	2191	27	)	)	-RRB-
25944	2191	28	.	.	.
25944	2192	1	The	the	DT
25944	2192	2	condition	condition	NN
25944	2192	3	is	be	VBZ
25944	2192	4	usually	usually	RB
25944	2192	5	permanent	permanent	JJ
25944	2192	6	.	.	.
25944	2193	1	The	the	DT
25944	2193	2	loss	loss	NN
25944	2193	3	of	of	IN
25944	2193	4	pigment	pigment	NN
25944	2193	5	takes	take	VBZ
25944	2193	6	place	place	NN
25944	2193	7	,	,	,
25944	2193	8	as	as	IN
25944	2193	9	a	a	DT
25944	2193	10	rule	rule	NN
25944	2193	11	,	,	,
25944	2193	12	slowly	slowly	RB
25944	2193	13	,	,	,
25944	2193	14	but	but	CC
25944	2193	15	several	several	JJ
25944	2193	16	apparently	apparently	RB
25944	2193	17	authentic	authentic	JJ
25944	2193	18	cases	case	NNS
25944	2193	19	have	have	VBP
25944	2193	20	been	be	VBN
25944	2193	21	reported	report	VBN
25944	2193	22	in	in	IN
25944	2193	23	which	which	WDT
25944	2193	24	the	the	DT
25944	2193	25	change	change	NN
25944	2193	26	occurred	occur	VBD
25944	2193	27	in	in	IN
25944	2193	28	the	the	DT
25944	2193	29	course	course	NN
25944	2193	30	of	of	IN
25944	2193	31	a	a	DT
25944	2193	32	night	night	NN
25944	2193	33	or	or	CC
25944	2193	34	in	in	IN
25944	2193	35	a	a	DT
25944	2193	36	few	few	JJ
25944	2193	37	days	day	NNS
25944	2193	38	.	.	.
25944	2194	1	#	#	LS
25944	2194	2	What	what	WP
25944	2194	3	is	be	VBZ
25944	2194	4	the	the	DT
25944	2194	5	etiology	etiology	NN
25944	2194	6	of	of	IN
25944	2194	7	canities	canitie	NNS
25944	2194	8	?	?	.
25944	2194	9	#	#	$
25944	2194	10	The	the	DT
25944	2194	11	causes	cause	NNS
25944	2194	12	are	be	VBP
25944	2194	13	obscure	obscure	JJ
25944	2194	14	.	.	.
25944	2195	1	Heredity	heredity	NN
25944	2195	2	is	be	VBZ
25944	2195	3	usually	usually	RB
25944	2195	4	an	an	DT
25944	2195	5	influential	influential	JJ
25944	2195	6	factor	factor	NN
25944	2195	7	,	,	,
25944	2195	8	and	and	CC
25944	2195	9	conditions	condition	NNS
25944	2195	10	which	which	WDT
25944	2195	11	impair	impair	VBP
25944	2195	12	the	the	DT
25944	2195	13	general	general	JJ
25944	2195	14	nutrition	nutrition	NN
25944	2195	15	have	have	VBP
25944	2195	16	at	at	IN
25944	2195	17	times	time	NNS
25944	2195	18	an	an	DT
25944	2195	19	etiological	etiological	JJ
25944	2195	20	bearing	bearing	NN
25944	2195	21	.	.	.
25944	2196	1	Intense	intense	JJ
25944	2196	2	anxiety	anxiety	NN
25944	2196	3	,	,	,
25944	2196	4	fright	fright	NN
25944	2196	5	,	,	,
25944	2196	6	and	and	CC
25944	2196	7	other	other	JJ
25944	2196	8	profound	profound	JJ
25944	2196	9	nervous	nervous	JJ
25944	2196	10	shock	shock	NN
25944	2196	11	are	be	VBP
25944	2196	12	looked	look	VBN
25944	2196	13	upon	upon	IN
25944	2196	14	as	as	RB
25944	2196	15	causative	causative	JJ
25944	2196	16	in	in	IN
25944	2196	17	sudden	sudden	JJ
25944	2196	18	graying	graying	NN
25944	2196	19	of	of	IN
25944	2196	20	the	the	DT
25944	2196	21	hair	hair	NN
25944	2196	22	.	.	.
25944	2197	1	#	#	NN
25944	2197	2	Give	give	VB
25944	2197	3	the	the	DT
25944	2197	4	treatment	treatment	NN
25944	2197	5	.	.	.
25944	2197	6	#	#	$
25944	2197	7	Canities	Canities	NNP
25944	2197	8	is	be	VBZ
25944	2197	9	without	without	IN
25944	2197	10	remedy	remedy	NN
25944	2197	11	.	.	.
25944	2198	1	Dyeing	Dyeing	NNP
25944	2198	2	,	,	,
25944	2198	3	although	although	IN
25944	2198	4	not	not	RB
25944	2198	5	to	to	TO
25944	2198	6	be	be	VB
25944	2198	7	advised	advise	VBN
25944	2198	8	,	,	,
25944	2198	9	is	be	VBZ
25944	2198	10	often	often	RB
25944	2198	11	practised	practise	VBN
25944	2198	12	,	,	,
25944	2198	13	and	and	CC
25944	2198	14	the	the	DT
25944	2198	15	condition	condition	NN
25944	2198	16	thus	thus	RB
25944	2198	17	masked	mask	VBD
25944	2198	18	.	.	.
25944	2199	1	#	#	NNP
25944	2199	2	Alopecia	Alopecia	NNP
25944	2199	3	.	.	.
25944	2199	4	#	#	NNP
25944	2199	5	(	(	-LRB-
25944	2199	6	_	_	NNP
25944	2199	7	Synonym	Synonym	NNP
25944	2199	8	:	:	:
25944	2199	9	_	_	NNP
25944	2199	10	Baldness	Baldness	NNP
25944	2199	11	.	.	.
25944	2199	12	)	)	-RRB-
25944	2200	1	#	#	LS
25944	2200	2	What	what	WP
25944	2200	3	do	do	VBP
25944	2200	4	you	-PRON-	PRP
25944	2200	5	understand	understand	VB
25944	2200	6	by	by	IN
25944	2200	7	alopecia	alopecia	NNP
25944	2200	8	?	?	.
25944	2200	9	#	#	NN
25944	2200	10	By	by	IN
25944	2200	11	alopecia	alopecia	NN
25944	2200	12	is	be	VBZ
25944	2200	13	meant	mean	VBN
25944	2200	14	loss	loss	NN
25944	2200	15	of	of	IN
25944	2200	16	hair	hair	NN
25944	2200	17	,	,	,
25944	2200	18	either	either	CC
25944	2200	19	partial	partial	JJ
25944	2200	20	or	or	CC
25944	2200	21	complete	complete	JJ
25944	2200	22	.	.	.
25944	2201	1	#	#	$
25944	2201	2	Name	name	VB
25944	2201	3	the	the	DT
25944	2201	4	several	several	JJ
25944	2201	5	varieties	variety	NNS
25944	2201	6	of	of	IN
25944	2201	7	alopecia	alopecia	NN
25944	2201	8	.	.	.
25944	2201	9	#	#	$
25944	2201	10	The	the	DT
25944	2201	11	so	so	RB
25944	2201	12	-	-	HYPH
25944	2201	13	called	call	VBN
25944	2201	14	varieties	variety	NNS
25944	2201	15	are	be	VBP
25944	2201	16	based	base	VBN
25944	2201	17	mainly	mainly	RB
25944	2201	18	upon	upon	IN
25944	2201	19	the	the	DT
25944	2201	20	etiology	etiology	NN
25944	2201	21	,	,	,
25944	2201	22	and	and	CC
25944	2201	23	are	be	VBP
25944	2201	24	named	name	VBN
25944	2201	25	congenital	congenital	JJ
25944	2201	26	alopecia	alopecia	NN
25944	2201	27	,	,	,
25944	2201	28	premature	premature	JJ
25944	2201	29	alopecia	alopecia	NN
25944	2201	30	and	and	CC
25944	2201	31	senile	senile	JJ
25944	2201	32	alopecia	alopecia	NN
25944	2201	33	.	.	.
25944	2202	1	#	#	$
25944	2202	2	Describe	describe	JJ
25944	2202	3	congenital	congenital	JJ
25944	2202	4	alopecia	alopecia	NN
25944	2202	5	.	.	.
25944	2202	6	#	#	$
25944	2202	7	Congenital	congenital	JJ
25944	2202	8	alopecia	alopecia	NN
25944	2202	9	is	be	VBZ
25944	2202	10	a	a	DT
25944	2202	11	rare	rare	JJ
25944	2202	12	condition	condition	NN
25944	2202	13	,	,	,
25944	2202	14	in	in	IN
25944	2202	15	which	which	WDT
25944	2202	16	the	the	DT
25944	2202	17	hair	hair	NN
25944	2202	18	-	-	HYPH
25944	2202	19	loss	loss	NN
25944	2202	20	is	be	VBZ
25944	2202	21	usually	usually	RB
25944	2202	22	noted	note	VBN
25944	2202	23	to	to	TO
25944	2202	24	be	be	VB
25944	2202	25	patchy	patchy	JJ
25944	2202	26	,	,	,
25944	2202	27	or	or	CC
25944	2202	28	the	the	DT
25944	2202	29	general	general	JJ
25944	2202	30	hair	hair	NN
25944	2202	31	-	-	HYPH
25944	2202	32	growth	growth	NN
25944	2202	33	may	may	MD
25944	2202	34	simply	simply	RB
25944	2202	35	be	be	VB
25944	2202	36	scanty	scanty	NN
25944	2202	37	.	.	.
25944	2203	1	In	in	IN
25944	2203	2	rare	rare	JJ
25944	2203	3	instances	instance	NNS
25944	2203	4	the	the	DT
25944	2203	5	hair	hair	NN
25944	2203	6	has	have	VBZ
25944	2203	7	been	be	VBN
25944	2203	8	entirely	entirely	RB
25944	2203	9	wanting	want	VBG
25944	2203	10	;	;	:
25944	2203	11	in	in	IN
25944	2203	12	such	such	JJ
25944	2203	13	cases	case	NNS
25944	2203	14	there	there	EX
25944	2203	15	is	be	VBZ
25944	2203	16	usually	usually	RB
25944	2203	17	defective	defective	JJ
25944	2203	18	development	development	NN
25944	2203	19	of	of	IN
25944	2203	20	other	other	JJ
25944	2203	21	structures	structure	NNS
25944	2203	22	,	,	,
25944	2203	23	such	such	JJ
25944	2203	24	as	as	IN
25944	2203	25	the	the	DT
25944	2203	26	teeth	tooth	NNS
25944	2203	27	.	.	.
25944	2204	1	#	#	JJR
25944	2204	2	Describe	describe	VB
25944	2204	3	premature	premature	JJ
25944	2204	4	alopecia	alopecia	NN
25944	2204	5	.	.	.
25944	2204	6	#	#	$
25944	2204	7	Loss	loss	NN
25944	2204	8	of	of	IN
25944	2204	9	hair	hair	NN
25944	2204	10	occurring	occur	VBG
25944	2204	11	in	in	IN
25944	2204	12	early	early	JJ
25944	2204	13	and	and	CC
25944	2204	14	middle	middle	JJ
25944	2204	15	adult	adult	NN
25944	2204	16	life	life	NN
25944	2204	17	is	be	VBZ
25944	2204	18	not	not	RB
25944	2204	19	uncommon	uncommon	JJ
25944	2204	20	,	,	,
25944	2204	21	and	and	CC
25944	2204	22	may	may	MD
25944	2204	23	consist	consist	VB
25944	2204	24	of	of	IN
25944	2204	25	a	a	DT
25944	2204	26	simple	simple	JJ
25944	2204	27	thinning	thinning	NN
25944	2204	28	or	or	CC
25944	2204	29	of	of	IN
25944	2204	30	more	more	JJR
25944	2204	31	or	or	CC
25944	2204	32	less	less	RBR
25944	2204	33	complete	complete	JJ
25944	2204	34	baldness	baldness	NN
25944	2204	35	of	of	IN
25944	2204	36	the	the	DT
25944	2204	37	whole	whole	JJ
25944	2204	38	or	or	CC
25944	2204	39	greater	great	JJR
25944	2204	40	part	part	NN
25944	2204	41	of	of	IN
25944	2204	42	the	the	DT
25944	2204	43	scalp	scalp	NN
25944	2204	44	.	.	.
25944	2205	1	It	-PRON-	PRP
25944	2205	2	usually	usually	RB
25944	2205	3	develops	develop	VBZ
25944	2205	4	slowly	slowly	RB
25944	2205	5	,	,	,
25944	2205	6	some	some	DT
25944	2205	7	months	month	NNS
25944	2205	8	or	or	CC
25944	2205	9	several	several	JJ
25944	2205	10	years	year	NNS
25944	2205	11	passing	pass	VBG
25944	2205	12	before	before	IN
25944	2205	13	the	the	DT
25944	2205	14	condition	condition	NN
25944	2205	15	is	be	VBZ
25944	2205	16	well	well	RB
25944	2205	17	established	establish	VBN
25944	2205	18	.	.	.
25944	2206	1	It	-PRON-	PRP
25944	2206	2	is	be	VBZ
25944	2206	3	often	often	RB
25944	2206	4	idiopathic	idiopathic	JJ
25944	2206	5	,	,	,
25944	2206	6	and	and	CC
25944	2206	7	without	without	IN
25944	2206	8	apparent	apparent	JJ
25944	2206	9	cause	cause	NN
25944	2206	10	further	far	RBR
25944	2206	11	than	than	IN
25944	2206	12	probably	probably	RB
25944	2206	13	a	a	DT
25944	2206	14	hereditary	hereditary	JJ
25944	2206	15	predisposition	predisposition	NN
25944	2206	16	.	.	.
25944	2207	1	It	-PRON-	PRP
25944	2207	2	may	may	MD
25944	2207	3	also	also	RB
25944	2207	4	be	be	VB
25944	2207	5	symptomatic	symptomatic	JJ
25944	2207	6	,	,	,
25944	2207	7	as	as	IN
25944	2207	8	,	,	,
25944	2207	9	for	for	IN
25944	2207	10	example	example	NN
25944	2207	11	,	,	,
25944	2207	12	the	the	DT
25944	2207	13	loss	loss	NN
25944	2207	14	of	of	IN
25944	2207	15	hair	hair	NN
25944	2207	16	,	,	,
25944	2207	17	usually	usually	RB
25944	2207	18	rapid	rapid	JJ
25944	2207	19	(	(	-LRB-
25944	2207	20	_	_	NNP
25944	2207	21	defluvium	defluvium	NN
25944	2207	22	capillorum	capillorum	NN
25944	2207	23	_	_	NNP
25944	2207	24	)	)	-RRB-
25944	2207	25	,	,	,
25944	2207	26	following	follow	VBG
25944	2207	27	systemic	systemic	JJ
25944	2207	28	diseases	disease	NNS
25944	2207	29	,	,	,
25944	2207	30	such	such	JJ
25944	2207	31	as	as	IN
25944	2207	32	the	the	DT
25944	2207	33	various	various	JJ
25944	2207	34	fevers	fever	NNS
25944	2207	35	,	,	,
25944	2207	36	and	and	CC
25944	2207	37	syphilis	syphilis	NNP
25944	2207	38	;	;	:
25944	2207	39	or	or	CC
25944	2207	40	as	as	IN
25944	2207	41	a	a	DT
25944	2207	42	result	result	NN
25944	2207	43	of	of	IN
25944	2207	44	a	a	DT
25944	2207	45	long	long	RB
25944	2207	46	-	-	HYPH
25944	2207	47	continued	continue	VBN
25944	2207	48	seborrh[oe]a	seborrh[oe]a	NNP
25944	2207	49	or	or	CC
25944	2207	50	seborrh[oe]ic	seborrh[oe]ic	NNP
25944	2207	51	eczema	eczema	NN
25944	2207	52	(	(	-LRB-
25944	2207	53	_	_	NNP
25944	2207	54	alopecia	alopecia	NNP
25944	2207	55	furfuracea	furfuracea	NNP
25944	2207	56	_	_	NNP
25944	2207	57	)	)	-RRB-
25944	2207	58	.	.	.
25944	2208	1	#	#	NNP
25944	2208	2	Describe	describe	VBP
25944	2208	3	senile	senile	JJ
25944	2208	4	alopecia	alopecia	NN
25944	2208	5	.	.	.
25944	2208	6	#	#	$
25944	2208	7	This	this	DT
25944	2208	8	is	be	VBZ
25944	2208	9	the	the	DT
25944	2208	10	baldness	baldness	NN
25944	2208	11	so	so	RB
25944	2208	12	frequently	frequently	RB
25944	2208	13	seen	see	VBN
25944	2208	14	developing	develop	VBG
25944	2208	15	with	with	IN
25944	2208	16	advancing	advance	VBG
25944	2208	17	years	year	NNS
25944	2208	18	,	,	,
25944	2208	19	and	and	CC
25944	2208	20	may	may	MD
25944	2208	21	consist	consist	VB
25944	2208	22	merely	merely	RB
25944	2208	23	of	of	IN
25944	2208	24	a	a	DT
25944	2208	25	general	general	JJ
25944	2208	26	thinning	thinning	NN
25944	2208	27	,	,	,
25944	2208	28	or	or	CC
25944	2208	29	,	,	,
25944	2208	30	more	more	RBR
25944	2208	31	commonly	commonly	RB
25944	2208	32	a	a	DT
25944	2208	33	general	general	JJ
25944	2208	34	thinning	thinning	NN
25944	2208	35	with	with	IN
25944	2208	36	a	a	DT
25944	2208	37	more	more	RBR
25944	2208	38	or	or	CC
25944	2208	39	less	less	RBR
25944	2208	40	complete	complete	JJ
25944	2208	41	baldness	baldness	NN
25944	2208	42	of	of	IN
25944	2208	43	the	the	DT
25944	2208	44	temporal	temporal	JJ
25944	2208	45	and	and	CC
25944	2208	46	anterior	anterior	JJ
25944	2208	47	portion	portion	NN
25944	2208	48	or	or	CC
25944	2208	49	of	of	IN
25944	2208	50	the	the	DT
25944	2208	51	vertex	vertex	NNP
25944	2208	52	of	of	IN
25944	2208	53	the	the	DT
25944	2208	54	scalp	scalp	NN
25944	2208	55	.	.	.
25944	2209	1	#	#	LS
25944	2209	2	What	what	WP
25944	2209	3	is	be	VBZ
25944	2209	4	the	the	DT
25944	2209	5	prognosis	prognosis	NN
25944	2209	6	in	in	IN
25944	2209	7	the	the	DT
25944	2209	8	various	various	JJ
25944	2209	9	varieties	variety	NNS
25944	2209	10	of	of	IN
25944	2209	11	alopecia	alopecia	NN
25944	2209	12	?	?	.
25944	2209	13	#	#	NN
25944	2209	14	In	in	IN
25944	2209	15	those	those	DT
25944	2209	16	cases	case	NNS
25944	2209	17	in	in	IN
25944	2209	18	which	which	WDT
25944	2209	19	there	there	EX
25944	2209	20	is	be	VBZ
25944	2209	21	a	a	DT
25944	2209	22	positive	positive	JJ
25944	2209	23	cause	cause	NN
25944	2209	24	,	,	,
25944	2209	25	as	as	IN
25944	2209	26	,	,	,
25944	2209	27	for	for	IN
25944	2209	28	instance	instance	NN
25944	2209	29	,	,	,
25944	2209	30	in	in	IN
25944	2209	31	symptomatic	symptomatic	JJ
25944	2209	32	alopecia	alopecia	NN
25944	2209	33	,	,	,
25944	2209	34	the	the	DT
25944	2209	35	prognosis	prognosis	NN
25944	2209	36	is	be	VBZ
25944	2209	37	,	,	,
25944	2209	38	as	as	IN
25944	2209	39	a	a	DT
25944	2209	40	rule	rule	NN
25944	2209	41	,	,	,
25944	2209	42	favorable	favorable	JJ
25944	2209	43	,	,	,
25944	2209	44	especially	especially	RB
25944	2209	45	if	if	IN
25944	2209	46	no	no	DT
25944	2209	47	family	family	NN
25944	2209	48	predisposition	predisposition	NN
25944	2209	49	exists	exist	VBZ
25944	2209	50	.	.	.
25944	2210	1	In	in	IN
25944	2210	2	the	the	DT
25944	2210	3	congenital	congenital	JJ
25944	2210	4	and	and	CC
25944	2210	5	senile	senile	JJ
25944	2210	6	varieties	variety	NNS
25944	2210	7	the	the	DT
25944	2210	8	condition	condition	NN
25944	2210	9	is	be	VBZ
25944	2210	10	usually	usually	RB
25944	2210	11	irremediable	irremediable	JJ
25944	2210	12	.	.	.
25944	2211	1	In	in	IN
25944	2211	2	idiopathic	idiopathic	JJ
25944	2211	3	premature	premature	JJ
25944	2211	4	alopecia	alopecia	NN
25944	2211	5	,	,	,
25944	2211	6	the	the	DT
25944	2211	7	prognosis	prognosis	NN
25944	2211	8	should	should	MD
25944	2211	9	be	be	VB
25944	2211	10	extremely	extremely	RB
25944	2211	11	guarded	guard	VBN
25944	2211	12	.	.	.
25944	2212	1	#	#	NNP
25944	2212	2	How	how	WRB
25944	2212	3	would	would	MD
25944	2212	4	you	-PRON-	PRP
25944	2212	5	treat	treat	VB
25944	2212	6	alopecia	alopecia	NNP
25944	2212	7	?	?	.
25944	2212	8	#	#	NN
25944	2212	9	By	by	IN
25944	2212	10	removing	remove	VBG
25944	2212	11	or	or	CC
25944	2212	12	modifying	modify	VBG
25944	2212	13	the	the	DT
25944	2212	14	predisposing	predisposing	NN
25944	2212	15	factors	factor	NNS
25944	2212	16	by	by	IN
25944	2212	17	appropriate	appropriate	JJ
25944	2212	18	constitutional	constitutional	JJ
25944	2212	19	remedies	remedy	NNS
25944	2212	20	,	,	,
25944	2212	21	and	and	CC
25944	2212	22	by	by	IN
25944	2212	23	the	the	DT
25944	2212	24	external	external	JJ
25944	2212	25	use	use	NN
25944	2212	26	of	of	IN
25944	2212	27	stimulating	stimulating	JJ
25944	2212	28	applications	application	NNS
25944	2212	29	.	.	.
25944	2213	1	#	#	$
25944	2213	2	Name	name	VB
25944	2213	3	several	several	JJ
25944	2213	4	remedies	remedy	NNS
25944	2213	5	or	or	CC
25944	2213	6	combinations	combination	NNS
25944	2213	7	usually	usually	RB
25944	2213	8	employed	employ	VBN
25944	2213	9	in	in	IN
25944	2213	10	the	the	DT
25944	2213	11	local	local	JJ
25944	2213	12	treatment	treatment	NN
25944	2213	13	.	.	.
25944	2213	14	#	#	NNP
25944	2213	15	Sulphur	Sulphur	NNP
25944	2213	16	ointment	ointment	NN
25944	2213	17	,	,	,
25944	2213	18	full	full	JJ
25944	2213	19	strength	strength	NN
25944	2213	20	or	or	CC
25944	2213	21	weakened	weaken	VBN
25944	2213	22	with	with	IN
25944	2213	23	lard	lard	NN
25944	2213	24	or	or	CC
25944	2213	25	vaseline	vaseline	NN
25944	2213	26	;	;	:
25944	2213	27	a	a	DT
25944	2213	28	lotion	lotion	NN
25944	2213	29	of	of	IN
25944	2213	30	resorcin	resorcin	NNS
25944	2213	31	consisting	consist	VBG
25944	2213	32	of	of	IN
25944	2213	33	one	one	CD
25944	2213	34	or	or	CC
25944	2213	35	two	two	CD
25944	2213	36	drachms	drachm	NNS
25944	2213	37	to	to	IN
25944	2213	38	four	four	CD
25944	2213	39	ounces	ounce	NNS
25944	2213	40	of	of	IN
25944	2213	41	alcohol	alcohol	NN
25944	2213	42	,	,	,
25944	2213	43	to	to	TO
25944	2213	44	which	which	WDT
25944	2213	45	is	be	VBZ
25944	2213	46	added	add	VBN
25944	2213	47	ten	ten	CD
25944	2213	48	to	to	IN
25944	2213	49	thirty	thirty	CD
25944	2213	50	minims	minim	NNS
25944	2213	51	of	of	IN
25944	2213	52	castor	castor	NN
25944	2213	53	oil	oil	NN
25944	2213	54	;	;	:
25944	2213	55	and	and	CC
25944	2213	56	a	a	DT
25944	2213	57	lotion	lotion	NN
25944	2213	58	made	make	VBN
25944	2213	59	up	up	RP
25944	2213	60	as	as	IN
25944	2213	61	follows:--	follows:--	ADD
25944	2213	62	[	[	-LRB-
25944	2213	63	Rx	Rx	NNP
25944	2213	64	]	]	-RRB-
25944	2213	65	Tinct	tinct	FW
25944	2213	66	.	.	.
25944	2214	1	cantharidis	cantharidis	NNP
25944	2214	2	,	,	,
25944	2214	3	..................	..................	NFP
25944	2214	4	f[dram]iv	f[dram]iv	NFP
25944	2214	5	Tinct	tinct	FW
25944	2214	6	.	.	.
25944	2215	1	capsici	capsici	NNP
25944	2215	2	,	,	,
25944	2215	3	......................	......................	NFP
25944	2215	4	f[Oz]j	f[Oz]j	.
25944	2215	5	Ol	old	NNP
25944	2215	6	.	.	.
25944	2216	1	ricini	ricini	NNP
25944	2216	2	,	,	,
25944	2216	3	..........................	..........................	NFP
25944	2216	4	f[dram]ss	f[dram]ss	NFP
25944	2216	5	-	-	HYPH
25944	2216	6	f[dram]j	f[dram]j	NNS
25944	2216	7	Alcoholis	Alcoholis	NNP
25944	2216	8	,	,	,
25944	2216	9	....	....	NFP
25944	2216	10	q.	q.	NNP
25944	2216	11	s.	s.	NNP
25944	2216	12	ad	ad	NNP
25944	2216	13	.............	.............	.
25944	2216	14	f[Oz]iv	f[oz]iv	NN
25944	2216	15	.	.	.
25944	2217	1	M.	M.	NNP
25944	2217	2	The	the	DT
25944	2217	3	following	follow	VBG
25944	2217	4	is	be	VBZ
25944	2217	5	sometimes	sometimes	RB
25944	2217	6	beneficial:--	beneficial:--	:
25944	2217	7	[	[	-LRB-
25944	2217	8	Rx	Rx	NNP
25944	2217	9	]	]	-RRB-
25944	2217	10	Resorcin	Resorcin	NNP
25944	2217	11	,	,	,
25944	2217	12	............................	............................	NFP
25944	2217	13	gr	gr	FW
25944	2217	14	.	.	.
25944	2218	1	lxxx	lxxx	NNP
25944	2218	2	Quininæ	Quininæ	NNP
25944	2218	3	(	(	-LRB-
25944	2218	4	alkaloid	alkaloid	NNP
25944	2218	5	)	)	-RRB-
25944	2218	6	,	,	,
25944	2218	7	..................	..................	NFP
25944	2218	8	gr	gr	NNP
25944	2218	9	.	.	.
25944	2219	1	xv	xv	NNP
25944	2219	2	Ol	old	NNP
25944	2219	3	.	.	.
25944	2220	1	ricini	ricini	NNP
25944	2220	2	,	,	,
25944	2220	3	..........................	..........................	NFP
25944	2220	4	[	[	-LRB-
25944	2220	5	minim]v-[minim]xx	minim]v-[minim]xx	NNP
25944	2220	6	Alcoholis	Alcoholis	NNP
25944	2220	7	,	,	,
25944	2220	8	...........................	...........................	.
25944	2221	1	f[Oz]iv.--M.	f[Oz]iv.--M.	NNP
25944	2222	1	Another	another	DT
25944	2222	2	excellent	excellent	JJ
25944	2222	3	formula	formula	NN
25944	2222	4	is	be	VBZ
25944	2222	5	:	:	:
25944	2222	6	[	[	-LRB-
25944	2222	7	Rx	Rx	NNP
25944	2222	8	]	]	-RRB-
25944	2222	9	Resorcin	Resorcin	NNP
25944	2222	10	,	,	,
25944	2222	11	............................	............................	NFP
25944	2222	12	gr	gr	FW
25944	2222	13	.	.	.
25944	2223	1	lxxx	lxxx	NNP
25944	2223	2	-	-	HYPH
25944	2223	3	cxx	cxx	NNP
25944	2223	4	Ac	Ac	NNP
25944	2223	5	.	.	.
25944	2224	1	carbolici	carbolici	NNP
25944	2224	2	cryst	cryst	NNP
25944	2224	3	.	.	.
25944	2224	4	,	,	,
25944	2224	5	................	................	NFP
25944	2224	6	gr	gr	FW
25944	2224	7	.	.	.
25944	2225	1	xx	xx	IN
25944	2225	2	Spts	Spts	NNP
25944	2225	3	.	.	.
25944	2226	1	myrciæ	myrciæ	NNP
25944	2226	2	,	,	,
25944	2226	3	........................	........................	.
25944	2227	1	f[Oz]iv.--M.	f[Oz]iv.--M.	NNP
25944	2228	1	And	and	CC
25944	2228	2	also	also	RB
25944	2228	3	the	the	DT
25944	2228	4	various	various	JJ
25944	2228	5	other	other	JJ
25944	2228	6	stimulating	stimulating	JJ
25944	2228	7	applications	application	NNS
25944	2228	8	employed	employ	VBN
25944	2228	9	in	in	IN
25944	2228	10	alopecia	alopecia	NNP
25944	2228	11	areata	areata	NNP
25944	2228	12	(	(	-LRB-
25944	2228	13	_	_	NNP
25944	2228	14	q	q	NNP
25944	2228	15	.	.	.
25944	2229	1	v.	v.	NNP
25944	2229	2	_	_	NNP
25944	2229	3	)	)	-RRB-
25944	2229	4	.	.	.
25944	2230	1	Other	other	JJ
25944	2230	2	measures	measure	NNS
25944	2230	3	of	of	IN
25944	2230	4	value	value	NN
25944	2230	5	are	be	VBP
25944	2230	6	:	:	:
25944	2230	7	Faradic	Faradic	NNP
25944	2230	8	electricity	electricity	NN
25944	2230	9	applied	apply	VBD
25944	2230	10	daily	daily	RB
25944	2230	11	for	for	IN
25944	2230	12	five	five	CD
25944	2230	13	minutes	minute	NNS
25944	2230	14	with	with	IN
25944	2230	15	a	a	DT
25944	2230	16	metallic	metallic	JJ
25944	2230	17	brush	brush	NN
25944	2230	18	or	or	CC
25944	2230	19	comb	comb	NN
25944	2230	20	;	;	:
25944	2230	21	daily	daily	JJ
25944	2230	22	massage	massage	NN
25944	2230	23	,	,	,
25944	2230	24	with	with	IN
25944	2230	25	the	the	DT
25944	2230	26	object	object	NN
25944	2230	27	of	of	IN
25944	2230	28	loosening	loosen	VBG
25944	2230	29	the	the	DT
25944	2230	30	skin	skin	NN
25944	2230	31	and	and	CC
25944	2230	32	giving	give	VBG
25944	2230	33	more	more	JJR
25944	2230	34	freedom	freedom	NN
25944	2230	35	to	to	IN
25944	2230	36	cutaneous	cutaneous	JJ
25944	2230	37	and	and	CC
25944	2230	38	subcutaneous	subcutaneous	JJ
25944	2230	39	circulation	circulation	NN
25944	2230	40	;	;	:
25944	2230	41	and	and	CC
25944	2230	42	the	the	DT
25944	2230	43	application	application	NN
25944	2230	44	,	,	,
25944	2230	45	two	two	CD
25944	2230	46	or	or	CC
25944	2230	47	three	three	CD
25944	2230	48	times	time	NNS
25944	2230	49	weekly	weekly	JJ
25944	2230	50	,	,	,
25944	2230	51	of	of	IN
25944	2230	52	static	static	JJ
25944	2230	53	electricity	electricity	NN
25944	2230	54	by	by	IN
25944	2230	55	means	mean	NNS
25944	2230	56	of	of	IN
25944	2230	57	the	the	DT
25944	2230	58	static	static	JJ
25944	2230	59	crown	crown	NN
25944	2230	60	electrode	electrode	NNP
25944	2230	61	.	.	.
25944	2231	1	(	(	-LRB-
25944	2231	2	The	the	DT
25944	2231	3	application	application	NN
25944	2231	4	selected	select	VBN
25944	2231	5	should	should	MD
25944	2231	6	be	be	VB
25944	2231	7	gently	gently	RB
25944	2231	8	--	--	:
25944	2231	9	not	not	RB
25944	2231	10	rubbing	rub	VBG
25944	2231	11	--	--	:
25944	2231	12	applied	apply	VBN
25944	2231	13	daily	daily	RB
25944	2231	14	or	or	CC
25944	2231	15	every	every	DT
25944	2231	16	second	second	JJ
25944	2231	17	or	or	CC
25944	2231	18	third	third	JJ
25944	2231	19	day	day	NN
25944	2231	20	,	,	,
25944	2231	21	according	accord	VBG
25944	2231	22	to	to	IN
25944	2231	23	the	the	DT
25944	2231	24	case	case	NN
25944	2231	25	;	;	:
25944	2231	26	if	if	IN
25944	2231	27	a	a	DT
25944	2231	28	lotion	lotion	NN
25944	2231	29	,	,	,
25944	2231	30	moistening	moisten	VBG
25944	2231	31	the	the	DT
25944	2231	32	parts	part	NNS
25944	2231	33	with	with	IN
25944	2231	34	it	-PRON-	PRP
25944	2231	35	;	;	:
25944	2231	36	if	if	IN
25944	2231	37	an	an	DT
25944	2231	38	ointment	ointment	NN
25944	2231	39	,	,	,
25944	2231	40	merely	merely	RB
25944	2231	41	greasing	grease	VBG
25944	2231	42	the	the	DT
25944	2231	43	parts	part	NNS
25944	2231	44	.	.	.
25944	2232	1	Shampooing	shampoo	VBG
25944	2232	2	every	every	DT
25944	2232	3	one	one	CD
25944	2232	4	to	to	TO
25944	2232	5	three	three	CD
25944	2232	6	weeks	week	NNS
25944	2232	7	,	,	,
25944	2232	8	according	accord	VBG
25944	2232	9	to	to	IN
25944	2232	10	circumstances	circumstance	NNS
25944	2232	11	.	.	.
25944	2232	12	)	)	-RRB-
25944	2233	1	#	#	$
25944	2233	2	Alopecia	Alopecia	NNP
25944	2233	3	Areata	Areata	NNP
25944	2233	4	.	.	.
25944	2233	5	#	#	NNP
25944	2233	6	(	(	-LRB-
25944	2233	7	_	_	NNP
25944	2233	8	Synonyms	Synonyms	NNP
25944	2233	9	:	:	:
25944	2233	10	_	_	NNP
25944	2233	11	Area	Area	NNP
25944	2233	12	Celsi	Celsi	NNP
25944	2233	13	;	;	:
25944	2233	14	Alopecia	Alopecia	NNP
25944	2233	15	Circumscripta	Circumscripta	NNP
25944	2233	16	.	.	.
25944	2233	17	)	)	-RRB-
25944	2234	1	#	#	LS
25944	2234	2	What	what	WP
25944	2234	3	do	do	VBP
25944	2234	4	you	-PRON-	PRP
25944	2234	5	understand	understand	VB
25944	2234	6	by	by	IN
25944	2234	7	alopecia	alopecia	NNP
25944	2234	8	areata	areata	NNP
25944	2234	9	?	?	.
25944	2234	10	#	#	NNP
25944	2234	11	[	[	-LRB-
25944	2234	12	Illustration	illustration	NN
25944	2234	13	:	:	:
25944	2234	14	Fig	Fig	NNP
25944	2234	15	.	.	.
25944	2235	1	37	37	CD
25944	2235	2	.	.	.
25944	2236	1	Alopecia	Alopecia	NNP
25944	2236	2	Areata	Areata	NNP
25944	2236	3	.	.	.
25944	2236	4	]	]	-RRB-
25944	2237	1	Alopecia	Alopecia	NNP
25944	2237	2	areata	areata	NNP
25944	2237	3	is	be	VBZ
25944	2237	4	an	an	DT
25944	2237	5	affection	affection	NN
25944	2237	6	of	of	IN
25944	2237	7	the	the	DT
25944	2237	8	hairy	hairy	JJ
25944	2237	9	system	system	NN
25944	2237	10	,	,	,
25944	2237	11	in	in	IN
25944	2237	12	which	which	WDT
25944	2237	13	occur	occur	VBP
25944	2237	14	one	one	CD
25944	2237	15	or	or	CC
25944	2237	16	more	more	JJR
25944	2237	17	circumscribed	circumscribe	VBN
25944	2237	18	,	,	,
25944	2237	19	round	round	JJ
25944	2237	20	or	or	CC
25944	2237	21	oval	oval	JJ
25944	2237	22	patches	patch	NNS
25944	2237	23	of	of	IN
25944	2237	24	complete	complete	JJ
25944	2237	25	baldness	baldness	NN
25944	2237	26	unattended	unattende	VBN
25944	2237	27	by	by	IN
25944	2237	28	any	any	DT
25944	2237	29	marked	marked	JJ
25944	2237	30	alteration	alteration	NN
25944	2237	31	in	in	IN
25944	2237	32	the	the	DT
25944	2237	33	skin	skin	NN
25944	2237	34	.	.	.
25944	2238	1	#	#	NN
25944	2238	2	Upon	upon	IN
25944	2238	3	what	what	WP
25944	2238	4	parts	part	NNS
25944	2238	5	and	and	CC
25944	2238	6	at	at	IN
25944	2238	7	what	what	WDT
25944	2238	8	age	age	NN
25944	2238	9	does	do	VBZ
25944	2238	10	the	the	DT
25944	2238	11	disease	disease	NN
25944	2238	12	occur	occur	VB
25944	2238	13	?	?	.
25944	2238	14	#	#	NN
25944	2238	15	In	in	IN
25944	2238	16	the	the	DT
25944	2238	17	large	large	JJ
25944	2238	18	majority	majority	NN
25944	2238	19	of	of	IN
25944	2238	20	cases	case	NNS
25944	2238	21	the	the	DT
25944	2238	22	disease	disease	NN
25944	2238	23	is	be	VBZ
25944	2238	24	limited	limit	VBN
25944	2238	25	to	to	IN
25944	2238	26	the	the	DT
25944	2238	27	scalp	scalp	NN
25944	2238	28	;	;	:
25944	2238	29	but	but	CC
25944	2238	30	it	-PRON-	PRP
25944	2238	31	may	may	MD
25944	2238	32	invade	invade	VB
25944	2238	33	other	other	JJ
25944	2238	34	portions	portion	NNS
25944	2238	35	of	of	IN
25944	2238	36	the	the	DT
25944	2238	37	body	body	NN
25944	2238	38	,	,	,
25944	2238	39	as	as	IN
25944	2238	40	the	the	DT
25944	2238	41	bearded	bearded	JJ
25944	2238	42	region	region	NN
25944	2238	43	,	,	,
25944	2238	44	eyebrows	eyebrow	NNS
25944	2238	45	,	,	,
25944	2238	46	eyelashes	eyelash	NNS
25944	2238	47	,	,	,
25944	2238	48	and	and	CC
25944	2238	49	,	,	,
25944	2238	50	in	in	IN
25944	2238	51	rare	rare	JJ
25944	2238	52	instances	instance	NNS
25944	2238	53	,	,	,
25944	2238	54	the	the	DT
25944	2238	55	entire	entire	JJ
25944	2238	56	integument	integument	NN
25944	2238	57	.	.	.
25944	2239	1	It	-PRON-	PRP
25944	2239	2	is	be	VBZ
25944	2239	3	most	most	RBS
25944	2239	4	common	common	JJ
25944	2239	5	between	between	IN
25944	2239	6	the	the	DT
25944	2239	7	ages	age	NNS
25944	2239	8	of	of	IN
25944	2239	9	ten	ten	CD
25944	2239	10	and	and	CC
25944	2239	11	forty	forty	CD
25944	2239	12	.	.	.
25944	2240	1	#	#	NNP
25944	2240	2	Describe	describe	VB
25944	2240	3	the	the	DT
25944	2240	4	symptoms	symptom	NNS
25944	2240	5	of	of	IN
25944	2240	6	alopecia	alopecia	NNP
25944	2240	7	areata	areata	NNP
25944	2240	8	.	.	.
25944	2240	9	#	#	$
25944	2240	10	The	the	DT
25944	2240	11	disease	disease	NN
25944	2240	12	begins	begin	VBZ
25944	2240	13	either	either	CC
25944	2240	14	suddenly	suddenly	RB
25944	2240	15	,	,	,
25944	2240	16	without	without	IN
25944	2240	17	premonitory	premonitory	JJ
25944	2240	18	symptoms	symptom	NNS
25944	2240	19	,	,	,
25944	2240	20	one	one	CD
25944	2240	21	or	or	CC
25944	2240	22	several	several	JJ
25944	2240	23	patches	patch	NNS
25944	2240	24	being	be	VBG
25944	2240	25	formed	form	VBN
25944	2240	26	in	in	IN
25944	2240	27	a	a	DT
25944	2240	28	few	few	JJ
25944	2240	29	hours	hour	NNS
25944	2240	30	;	;	:
25944	2240	31	or	or	CC
25944	2240	32	,	,	,
25944	2240	33	and	and	CC
25944	2240	34	as	as	IN
25944	2240	35	is	be	VBZ
25944	2240	36	more	more	JJR
25944	2240	37	usually	usually	RB
25944	2240	38	the	the	DT
25944	2240	39	case	case	NN
25944	2240	40	,	,	,
25944	2240	41	several	several	JJ
25944	2240	42	days	day	NNS
25944	2240	43	or	or	CC
25944	2240	44	weeks	week	NNS
25944	2240	45	elapse	elapse	VBN
25944	2240	46	before	before	IN
25944	2240	47	the	the	DT
25944	2240	48	bald	bald	JJ
25944	2240	49	area	area	NN
25944	2240	50	or	or	CC
25944	2240	51	areas	area	NNS
25944	2240	52	are	be	VBP
25944	2240	53	sufficiently	sufficiently	RB
25944	2240	54	large	large	JJ
25944	2240	55	to	to	TO
25944	2240	56	become	become	VB
25944	2240	57	noticeable	noticeable	JJ
25944	2240	58	.	.	.
25944	2241	1	The	the	DT
25944	2241	2	patches	patch	NNS
25944	2241	3	continue	continue	VBP
25944	2241	4	to	to	TO
25944	2241	5	extend	extend	VB
25944	2241	6	peripherally	peripherally	RB
25944	2241	7	for	for	IN
25944	2241	8	a	a	DT
25944	2241	9	variable	variable	JJ
25944	2241	10	period	period	NN
25944	2241	11	,	,	,
25944	2241	12	and	and	CC
25944	2241	13	then	then	RB
25944	2241	14	remain	remain	VB
25944	2241	15	stationary	stationary	JJ
25944	2241	16	,	,	,
25944	2241	17	or	or	CC
25944	2241	18	several	several	DT
25944	2241	19	gradually	gradually	RB
25944	2241	20	coalesce	coalesce	NN
25944	2241	21	and	and	CC
25944	2241	22	form	form	VB
25944	2241	23	a	a	DT
25944	2241	24	large	large	JJ
25944	2241	25	,	,	,
25944	2241	26	irregular	irregular	JJ
25944	2241	27	area	area	NN
25944	2241	28	involving	involve	VBG
25944	2241	29	the	the	DT
25944	2241	30	entire	entire	JJ
25944	2241	31	or	or	CC
25944	2241	32	a	a	DT
25944	2241	33	greater	great	JJR
25944	2241	34	portion	portion	NN
25944	2241	35	of	of	IN
25944	2241	36	the	the	DT
25944	2241	37	scalp	scalp	NN
25944	2241	38	.	.	.
25944	2242	1	The	the	DT
25944	2242	2	skin	skin	NN
25944	2242	3	of	of	IN
25944	2242	4	the	the	DT
25944	2242	5	affected	affected	JJ
25944	2242	6	regions	region	NNS
25944	2242	7	is	be	VBZ
25944	2242	8	smooth	smooth	JJ
25944	2242	9	,	,	,
25944	2242	10	faintly	faintly	RB
25944	2242	11	pink	pink	JJ
25944	2242	12	or	or	CC
25944	2242	13	milky	milky	JJ
25944	2242	14	white	white	NNP
25944	2242	15	,	,	,
25944	2242	16	and	and	CC
25944	2242	17	at	at	IN
25944	2242	18	first	first	JJ
25944	2242	19	presents	present	NNS
25944	2242	20	no	no	DT
25944	2242	21	departure	departure	NN
25944	2242	22	from	from	IN
25944	2242	23	the	the	DT
25944	2242	24	normal	normal	JJ
25944	2242	25	;	;	:
25944	2242	26	sooner	sooner	RB
25944	2242	27	or	or	CC
25944	2242	28	later	later	RBR
25944	2242	29	,	,	,
25944	2242	30	however	however	RB
25944	2242	31	,	,	,
25944	2242	32	the	the	DT
25944	2242	33	follicles	follicle	NNS
25944	2242	34	become	become	VBP
25944	2242	35	less	less	RBR
25944	2242	36	prominent	prominent	JJ
25944	2242	37	,	,	,
25944	2242	38	and	and	CC
25944	2242	39	slight	slight	JJ
25944	2242	40	atrophy	atrophy	NN
25944	2242	41	or	or	CC
25944	2242	42	thinning	thinning	NN
25944	2242	43	may	may	MD
25944	2242	44	occur	occur	VB
25944	2242	45	,	,	,
25944	2242	46	the	the	DT
25944	2242	47	bald	bald	JJ
25944	2242	48	plaques	plaque	NNS
25944	2242	49	being	be	VBG
25944	2242	50	slightly	slightly	RB
25944	2242	51	depressed	depress	VBN
25944	2242	52	.	.	.
25944	2243	1	[	[	-LRB-
25944	2243	2	Illustration	illustration	NN
25944	2243	3	:	:	:
25944	2243	4	Fig	Fig	NNP
25944	2243	5	.	.	.
25944	2244	1	38	38	CD
25944	2244	2	.	.	.
25944	2245	1	Alopecia	Alopecia	NNP
25944	2245	2	Areata	Areata	NNP
25944	2245	3	--	--	:
25944	2245	4	complete	complete	JJ
25944	2245	5	hair	hair	NN
25944	2245	6	loss	loss	NN
25944	2245	7	.	.	.
25944	2245	8	]	]	-RRB-
25944	2246	1	Occasionally	occasionally	RB
25944	2246	2	,	,	,
25944	2246	3	usually	usually	RB
25944	2246	4	about	about	IN
25944	2246	5	the	the	DT
25944	2246	6	periphery	periphery	NN
25944	2246	7	and	and	CC
25944	2246	8	in	in	IN
25944	2246	9	the	the	DT
25944	2246	10	early	early	JJ
25944	2246	11	stages	stage	NNS
25944	2246	12	,	,	,
25944	2246	13	a	a	DT
25944	2246	14	few	few	JJ
25944	2246	15	hair	hair	NN
25944	2246	16	-	-	HYPH
25944	2246	17	stumps	stump	NNS
25944	2246	18	may	may	MD
25944	2246	19	be	be	VB
25944	2246	20	seen	see	VBN
25944	2246	21	.	.	.
25944	2247	1	#	#	LS
25944	2247	2	What	what	WDT
25944	2247	3	course	course	NN
25944	2247	4	does	do	VBZ
25944	2247	5	alopecia	alopecia	NNP
25944	2247	6	areata	areata	NNP
25944	2247	7	pursue	pursue	NNP
25944	2247	8	?	?	.
25944	2247	9	#	#	$
25944	2247	10	Almost	almost	RB
25944	2247	11	invariably	invariably	RB
25944	2247	12	chronic	chronic	JJ
25944	2247	13	.	.	.
25944	2248	1	After	after	IN
25944	2248	2	the	the	DT
25944	2248	3	lapse	lapse	NN
25944	2248	4	of	of	IN
25944	2248	5	a	a	DT
25944	2248	6	variable	variable	JJ
25944	2248	7	period	period	NN
25944	2248	8	the	the	DT
25944	2248	9	patches	patch	NNS
25944	2248	10	cease	cease	VBP
25944	2248	11	to	to	TO
25944	2248	12	extend	extend	VB
25944	2248	13	,	,	,
25944	2248	14	the	the	DT
25944	2248	15	hairs	hair	NNS
25944	2248	16	at	at	IN
25944	2248	17	the	the	DT
25944	2248	18	margins	margin	NNS
25944	2248	19	of	of	IN
25944	2248	20	the	the	DT
25944	2248	21	bald	bald	JJ
25944	2248	22	areas	area	NNS
25944	2248	23	being	be	VBG
25944	2248	24	firmly	firmly	RB
25944	2248	25	fixed	fix	VBN
25944	2248	26	in	in	IN
25944	2248	27	the	the	DT
25944	2248	28	follicles	follicle	NNS
25944	2248	29	;	;	:
25944	2248	30	sooner	sooner	RB
25944	2248	31	or	or	CC
25944	2248	32	later	later	RB
25944	2248	33	a	a	DT
25944	2248	34	fine	fine	JJ
25944	2248	35	,	,	,
25944	2248	36	colorless	colorless	JJ
25944	2248	37	lanugo	lanugo	NNS
25944	2248	38	or	or	CC
25944	2248	39	down	down	RB
25944	2248	40	shows	show	VBZ
25944	2248	41	itself	-PRON-	PRP
25944	2248	42	,	,	,
25944	2248	43	which	which	WDT
25944	2248	44	may	may	MD
25944	2248	45	continue	continue	VB
25944	2248	46	to	to	TO
25944	2248	47	grow	grow	VB
25944	2248	48	until	until	IN
25944	2248	49	it	-PRON-	PRP
25944	2248	50	is	be	VBZ
25944	2248	51	about	about	RB
25944	2248	52	a	a	DT
25944	2248	53	half	half	JJ
25944	2248	54	-	-	HYPH
25944	2248	55	inch	inch	NN
25944	2248	56	or	or	CC
25944	2248	57	so	so	RB
25944	2248	58	in	in	IN
25944	2248	59	length	length	NN
25944	2248	60	and	and	CC
25944	2248	61	then	then	RB
25944	2248	62	drop	drop	VB
25944	2248	63	out	out	RP
25944	2248	64	;	;	:
25944	2248	65	or	or	CC
25944	2248	66	it	-PRON-	PRP
25944	2248	67	may	may	MD
25944	2248	68	remain	remain	VB
25944	2248	69	,	,	,
25944	2248	70	become	become	VBP
25944	2248	71	coarser	coarser	NN
25944	2248	72	and	and	CC
25944	2248	73	pigmented	pigment	VBD
25944	2248	74	,	,	,
25944	2248	75	and	and	CC
25944	2248	76	the	the	DT
25944	2248	77	parts	part	NNS
25944	2248	78	resume	resume	VBP
25944	2248	79	their	-PRON-	PRP$
25944	2248	80	normal	normal	JJ
25944	2248	81	condition	condition	NN
25944	2248	82	.	.	.
25944	2249	1	Not	not	RB
25944	2249	2	infrequently	infrequently	RB
25944	2249	3	,	,	,
25944	2249	4	however	however	RB
25944	2249	5	,	,	,
25944	2249	6	after	after	IN
25944	2249	7	growing	grow	VBG
25944	2249	8	for	for	IN
25944	2249	9	a	a	DT
25944	2249	10	time	time	NN
25944	2249	11	,	,	,
25944	2249	12	the	the	DT
25944	2249	13	new	new	JJ
25944	2249	14	hair	hair	NN
25944	2249	15	falls	fall	VBZ
25944	2249	16	out	out	RP
25944	2249	17	,	,	,
25944	2249	18	and	and	CC
25944	2249	19	this	this	DT
25944	2249	20	may	may	MD
25944	2249	21	happen	happen	VB
25944	2249	22	several	several	JJ
25944	2249	23	times	time	NNS
25944	2249	24	before	before	IN
25944	2249	25	the	the	DT
25944	2249	26	termination	termination	NN
25944	2249	27	of	of	IN
25944	2249	28	the	the	DT
25944	2249	29	disease	disease	NN
25944	2249	30	.	.	.
25944	2250	1	#	#	NN
25944	2250	2	Are	be	VBP
25944	2250	3	there	there	EX
25944	2250	4	any	any	DT
25944	2250	5	subjective	subjective	JJ
25944	2250	6	symptoms	symptom	NNS
25944	2250	7	in	in	IN
25944	2250	8	alopecia	alopecia	NNP
25944	2250	9	areata	areata	NNP
25944	2250	10	?	?	.
25944	2250	11	#	#	NNP
25944	2250	12	As	as	IN
25944	2250	13	a	a	DT
25944	2250	14	rule	rule	NN
25944	2250	15	,	,	,
25944	2250	16	not	not	RB
25944	2250	17	;	;	:
25944	2250	18	but	but	CC
25944	2250	19	occasionally	occasionally	RB
25944	2250	20	the	the	DT
25944	2250	21	appearance	appearance	NN
25944	2250	22	of	of	IN
25944	2250	23	the	the	DT
25944	2250	24	patches	patch	NNS
25944	2250	25	is	be	VBZ
25944	2250	26	preceded	precede	VBN
25944	2250	27	by	by	IN
25944	2250	28	severe	severe	JJ
25944	2250	29	headache	headache	NNP
25944	2250	30	,	,	,
25944	2250	31	itching	itch	VBG
25944	2250	32	or	or	CC
25944	2250	33	burning	burning	NN
25944	2250	34	,	,	,
25944	2250	35	or	or	CC
25944	2250	36	other	other	JJ
25944	2250	37	manifestations	manifestation	NNS
25944	2250	38	of	of	IN
25944	2250	39	disturbed	disturbed	JJ
25944	2250	40	innervation	innervation	NN
25944	2250	41	.	.	.
25944	2251	1	#	#	JJR
25944	2251	2	State	state	NN
25944	2251	3	the	the	DT
25944	2251	4	cause	cause	NN
25944	2251	5	of	of	IN
25944	2251	6	alopecia	alopecia	NNP
25944	2251	7	areata	areata	NNP
25944	2251	8	.	.	.
25944	2251	9	#	#	$
25944	2251	10	The	the	DT
25944	2251	11	etiology	etiology	NN
25944	2251	12	is	be	VBZ
25944	2251	13	obscure	obscure	JJ
25944	2251	14	.	.	.
25944	2252	1	Two	two	CD
25944	2252	2	theories	theory	NNS
25944	2252	3	as	as	IN
25944	2252	4	to	to	IN
25944	2252	5	the	the	DT
25944	2252	6	cause	cause	NN
25944	2252	7	of	of	IN
25944	2252	8	the	the	DT
25944	2252	9	disease	disease	NN
25944	2252	10	exist	exist	VBP
25944	2252	11	:	:	:
25944	2252	12	one	one	CD
25944	2252	13	of	of	IN
25944	2252	14	these	these	DT
25944	2252	15	regards	regard	VBZ
25944	2252	16	it	-PRON-	PRP
25944	2252	17	as	as	IN
25944	2252	18	parasitic	parasitic	JJ
25944	2252	19	,	,	,
25944	2252	20	and	and	CC
25944	2252	21	the	the	DT
25944	2252	22	other	other	JJ
25944	2252	23	considers	consider	VBZ
25944	2252	24	it	-PRON-	PRP
25944	2252	25	to	to	TO
25944	2252	26	be	be	VB
25944	2252	27	trophoneurotic	trophoneurotic	JJ
25944	2252	28	.	.	.
25944	2253	1	Doubtless	doubtless	RB
25944	2253	2	both	both	DT
25944	2253	3	are	be	VBP
25944	2253	4	right	right	JJ
25944	2253	5	,	,	,
25944	2253	6	as	as	IN
25944	2253	7	a	a	DT
25944	2253	8	study	study	NN
25944	2253	9	of	of	IN
25944	2253	10	the	the	DT
25944	2253	11	literature	literature	NN
25944	2253	12	would	would	MD
25944	2253	13	indicate	indicate	VB
25944	2253	14	that	that	IN
25944	2253	15	there	there	EX
25944	2253	16	are	be	VBP
25944	2253	17	,	,	,
25944	2253	18	as	as	IN
25944	2253	19	regards	regard	VBZ
25944	2253	20	etiology	etiology	NN
25944	2253	21	,	,	,
25944	2253	22	really	really	RB
25944	2253	23	two	two	CD
25944	2253	24	varieties	variety	NNS
25944	2253	25	--	--	:
25944	2253	26	the	the	DT
25944	2253	27	contagious	contagious	JJ
25944	2253	28	and	and	CC
25944	2253	29	the	the	DT
25944	2253	30	non	non	JJ
25944	2253	31	-	-	JJ
25944	2253	32	contagious	contagious	JJ
25944	2253	33	.	.	.
25944	2254	1	In	in	IN
25944	2254	2	America	America	NNP
25944	2254	3	examples	example	NNS
25944	2254	4	of	of	IN
25944	2254	5	the	the	DT
25944	2254	6	contagious	contagious	JJ
25944	2254	7	variety	variety	NN
25944	2254	8	are	be	VBP
25944	2254	9	uncommon	uncommon	JJ
25944	2254	10	.	.	.
25944	2255	1	#	#	NN
25944	2255	2	Does	do	VBZ
25944	2255	3	the	the	DT
25944	2255	4	skin	skin	NN
25944	2255	5	undergo	undergo	VB
25944	2255	6	any	any	DT
25944	2255	7	alterative	alterative	JJ
25944	2255	8	or	or	CC
25944	2255	9	destructive	destructive	JJ
25944	2255	10	changes	change	NNS
25944	2255	11	?	?	.
25944	2255	12	#	#	NN
25944	2255	13	Microscopical	microscopical	JJ
25944	2255	14	examination	examination	NN
25944	2255	15	of	of	IN
25944	2255	16	the	the	DT
25944	2255	17	skin	skin	NN
25944	2255	18	of	of	IN
25944	2255	19	the	the	DT
25944	2255	20	diseased	diseased	JJ
25944	2255	21	area	area	NN
25944	2255	22	shows	show	VBZ
25944	2255	23	little	little	JJ
25944	2255	24	or	or	CC
25944	2255	25	no	no	DT
25944	2255	26	alteration	alteration	NN
25944	2255	27	in	in	IN
25944	2255	28	its	-PRON-	PRP$
25944	2255	29	structure	structure	NN
25944	2255	30	beyond	beyond	IN
25944	2255	31	slight	slight	JJ
25944	2255	32	thinning	thinning	NN
25944	2255	33	.	.	.
25944	2256	1	#	#	NNP
25944	2256	2	How	how	WRB
25944	2256	3	do	do	VBP
25944	2256	4	you	-PRON-	PRP
25944	2256	5	distinguish	distinguish	VB
25944	2256	6	alopecia	alopecia	NNP
25944	2256	7	areata	areata	NNP
25944	2256	8	from	from	IN
25944	2256	9	ringworm	ringworm	NN
25944	2256	10	?	?	.
25944	2256	11	#	#	$
25944	2256	12	The	the	DT
25944	2256	13	plaques	plaque	NNS
25944	2256	14	of	of	IN
25944	2256	15	alopecia	alopecia	NNP
25944	2256	16	areata	areata	NNP
25944	2256	17	are	be	VBP
25944	2256	18	smooth	smooth	JJ
25944	2256	19	,	,	,
25944	2256	20	often	often	RB
25944	2256	21	completely	completely	RB
25944	2256	22	devoid	devoid	JJ
25944	2256	23	of	of	IN
25944	2256	24	hair	hair	NN
25944	2256	25	,	,	,
25944	2256	26	and	and	CC
25944	2256	27	free	free	JJ
25944	2256	28	from	from	IN
25944	2256	29	scales	scale	NNS
25944	2256	30	;	;	:
25944	2256	31	while	while	IN
25944	2256	32	those	those	DT
25944	2256	33	of	of	IN
25944	2256	34	ringworm	ringworm	JJ
25944	2256	35	show	show	NN
25944	2256	36	numerous	numerous	JJ
25944	2256	37	broken	broken	JJ
25944	2256	38	hairs	hair	NNS
25944	2256	39	and	and	CC
25944	2256	40	stumps	stump	NNS
25944	2256	41	,	,	,
25944	2256	42	desquamation	desquamation	NN
25944	2256	43	,	,	,
25944	2256	44	and	and	CC
25944	2256	45	usually	usually	RB
25944	2256	46	symptoms	symptom	NNS
25944	2256	47	of	of	IN
25944	2256	48	mild	mild	JJ
25944	2256	49	inflammatory	inflammatory	JJ
25944	2256	50	action	action	NN
25944	2256	51	.	.	.
25944	2257	1	In	in	IN
25944	2257	2	doubtful	doubtful	JJ
25944	2257	3	cases	case	NNS
25944	2257	4	recourse	recourse	VBP
25944	2257	5	should	should	MD
25944	2257	6	be	be	VB
25944	2257	7	had	have	VBN
25944	2257	8	to	to	IN
25944	2257	9	the	the	DT
25944	2257	10	microscope	microscope	NN
25944	2257	11	.	.	.
25944	2258	1	#	#	LS
25944	2258	2	What	what	WP
25944	2258	3	is	be	VBZ
25944	2258	4	the	the	DT
25944	2258	5	prognosis	prognosis	NN
25944	2258	6	in	in	IN
25944	2258	7	alopecia	alopecia	NNP
25944	2258	8	areata	areata	NNP
25944	2258	9	?	?	.
25944	2258	10	#	#	$
25944	2258	11	The	the	DT
25944	2258	12	disease	disease	NN
25944	2258	13	is	be	VBZ
25944	2258	14	often	often	RB
25944	2258	15	rebellious	rebellious	JJ
25944	2258	16	,	,	,
25944	2258	17	but	but	CC
25944	2258	18	in	in	IN
25944	2258	19	children	child	NNS
25944	2258	20	and	and	CC
25944	2258	21	young	young	JJ
25944	2258	22	adults	adult	NNS
25944	2258	23	the	the	DT
25944	2258	24	prognosis	prognosis	NN
25944	2258	25	is	be	VBZ
25944	2258	26	almost	almost	RB
25944	2258	27	invariably	invariably	RB
25944	2258	28	favorable	favorable	JJ
25944	2258	29	,	,	,
25944	2258	30	permanent	permanent	JJ
25944	2258	31	loss	loss	NN
25944	2258	32	of	of	IN
25944	2258	33	hair	hair	NN
25944	2258	34	being	be	VBG
25944	2258	35	uncommon	uncommon	JJ
25944	2258	36	.	.	.
25944	2259	1	The	the	DT
25944	2259	2	same	same	JJ
25944	2259	3	holds	hold	VBZ
25944	2259	4	true	true	JJ
25944	2259	5	,	,	,
25944	2259	6	but	but	CC
25944	2259	7	to	to	IN
25944	2259	8	a	a	DT
25944	2259	9	much	much	RB
25944	2259	10	less	less	JJR
25944	2259	11	extent	extent	NN
25944	2259	12	,	,	,
25944	2259	13	with	with	IN
25944	2259	14	the	the	DT
25944	2259	15	disease	disease	NN
25944	2259	16	as	as	IN
25944	2259	17	occurring	occur	VBG
25944	2259	18	in	in	IN
25944	2259	19	those	those	DT
25944	2259	20	of	of	IN
25944	2259	21	more	more	RBR
25944	2259	22	advanced	advanced	JJ
25944	2259	23	age	age	NN
25944	2259	24	.	.	.
25944	2260	1	In	in	IN
25944	2260	2	extensive	extensive	JJ
25944	2260	3	cases	case	NNS
25944	2260	4	--	--	:
25944	2260	5	those	those	DT
25944	2260	6	in	in	IN
25944	2260	7	which	which	WDT
25944	2260	8	the	the	DT
25944	2260	9	hair	hair	NN
25944	2260	10	of	of	IN
25944	2260	11	the	the	DT
25944	2260	12	entire	entire	JJ
25944	2260	13	scalp	scalp	NN
25944	2260	14	finally	finally	RB
25944	2260	15	entirely	entirely	RB
25944	2260	16	disappears	disappear	VBZ
25944	2260	17	,	,	,
25944	2260	18	and	and	CC
25944	2260	19	sometimes	sometimes	RB
25944	2260	20	involves	involve	VBZ
25944	2260	21	all	all	DT
25944	2260	22	hairy	hairy	JJ
25944	2260	23	parts	part	NNS
25944	2260	24	--	--	:
25944	2260	25	the	the	DT
25944	2260	26	prognosis	prognosis	NN
25944	2260	27	is	be	VBZ
25944	2260	28	unfavorable	unfavorable	JJ
25944	2260	29	.	.	.
25944	2261	1	Only	only	RB
25944	2261	2	exceptionally	exceptionally	RB
25944	2261	3	does	do	VBZ
25944	2261	4	recovery	recovery	NN
25944	2261	5	ensue	ensue	NN
25944	2261	6	in	in	IN
25944	2261	7	such	such	JJ
25944	2261	8	instances	instance	NNS
25944	2261	9	.	.	.
25944	2262	1	The	the	DT
25944	2262	2	uncertain	uncertain	JJ
25944	2262	3	duration	duration	NN
25944	2262	4	,	,	,
25944	2262	5	however	however	RB
25944	2262	6	,	,	,
25944	2262	7	must	must	MD
25944	2262	8	be	be	VB
25944	2262	9	borne	bear	VBN
25944	2262	10	in	in	IN
25944	2262	11	mind	mind	NN
25944	2262	12	;	;	,
25944	2262	13	months	month	NNS
25944	2262	14	,	,	,
25944	2262	15	and	and	CC
25944	2262	16	in	in	IN
25944	2262	17	some	some	DT
25944	2262	18	instances	instance	NNS
25944	2262	19	several	several	JJ
25944	2262	20	years	year	NNS
25944	2262	21	,	,	,
25944	2262	22	may	may	MD
25944	2262	23	elapse	elapse	VB
25944	2262	24	before	before	IN
25944	2262	25	complete	complete	JJ
25944	2262	26	restoration	restoration	NN
25944	2262	27	of	of	IN
25944	2262	28	hair	hair	NN
25944	2262	29	takes	take	VBZ
25944	2262	30	place	place	NN
25944	2262	31	.	.	.
25944	2263	1	Relapses	relapse	NNS
25944	2263	2	are	be	VBP
25944	2263	3	not	not	RB
25944	2263	4	uncommon	uncommon	JJ
25944	2263	5	.	.	.
25944	2264	1	#	#	NNP
25944	2264	2	How	how	WRB
25944	2264	3	is	be	VBZ
25944	2264	4	alopecia	alopecia	NNP
25944	2264	5	areata	areata	NNP
25944	2264	6	treated	treat	VBN
25944	2264	7	?	?	.
25944	2264	8	#	#	NN
25944	2264	9	By	by	IN
25944	2264	10	both	both	CC
25944	2264	11	constitutional	constitutional	JJ
25944	2264	12	and	and	CC
25944	2264	13	local	local	JJ
25944	2264	14	measures	measure	NNS
25944	2264	15	,	,	,
25944	2264	16	the	the	DT
25944	2264	17	former	former	JJ
25944	2264	18	having	having	NN
25944	2264	19	in	in	IN
25944	2264	20	view	view	NN
25944	2264	21	the	the	DT
25944	2264	22	invigoration	invigoration	NN
25944	2264	23	of	of	IN
25944	2264	24	the	the	DT
25944	2264	25	nervous	nervous	JJ
25944	2264	26	system	system	NN
25944	2264	27	,	,	,
25944	2264	28	and	and	CC
25944	2264	29	the	the	DT
25944	2264	30	latter	latter	JJ
25944	2264	31	a	a	DT
25944	2264	32	stimulating	stimulating	JJ
25944	2264	33	and	and	CC
25944	2264	34	parasiticidal	parasiticidal	JJ
25944	2264	35	action	action	NN
25944	2264	36	of	of	IN
25944	2264	37	the	the	DT
25944	2264	38	affected	affect	VBN
25944	2264	39	areas	area	NNS
25944	2264	40	.	.	.
25944	2265	1	#	#	NN
25944	2265	2	Give	give	VB
25944	2265	3	the	the	DT
25944	2265	4	constitutional	constitutional	JJ
25944	2265	5	treatment	treatment	NN
25944	2265	6	.	.	.
25944	2265	7	#	#	NFP
25944	2265	8	Arsenic	Arsenic	NNP
25944	2265	9	is	be	VBZ
25944	2265	10	perhaps	perhaps	RB
25944	2265	11	the	the	DT
25944	2265	12	most	most	RBS
25944	2265	13	valuable	valuable	JJ
25944	2265	14	remedy	remedy	NN
25944	2265	15	,	,	,
25944	2265	16	while	while	IN
25944	2265	17	quinine	quinine	JJ
25944	2265	18	,	,	,
25944	2265	19	nux	nux	NN
25944	2265	20	vomica	vomica	NN
25944	2265	21	,	,	,
25944	2265	22	pilocarpine	pilocarpine	NN
25944	2265	23	,	,	,
25944	2265	24	cod	cod	NN
25944	2265	25	-	-	HYPH
25944	2265	26	liver	liver	NN
25944	2265	27	oil	oil	NN
25944	2265	28	and	and	CC
25944	2265	29	ferruginous	ferruginous	JJ
25944	2265	30	tonics	tonic	NNS
25944	2265	31	may	may	MD
25944	2265	32	,	,	,
25944	2265	33	in	in	IN
25944	2265	34	suitable	suitable	JJ
25944	2265	35	cases	case	NNS
25944	2265	36	,	,	,
25944	2265	37	often	often	RB
25944	2265	38	be	be	VB
25944	2265	39	administered	administer	VBN
25944	2265	40	with	with	IN
25944	2265	41	benefit	benefit	NN
25944	2265	42	.	.	.
25944	2266	1	#	#	$
25944	2266	2	Name	name	VB
25944	2266	3	several	several	JJ
25944	2266	4	remedies	remedy	NNS
25944	2266	5	or	or	CC
25944	2266	6	combinations	combination	NNS
25944	2266	7	employed	employ	VBN
25944	2266	8	in	in	IN
25944	2266	9	the	the	DT
25944	2266	10	external	external	JJ
25944	2266	11	treatment	treatment	NN
25944	2266	12	of	of	IN
25944	2266	13	alopecia	alopecia	NNP
25944	2266	14	areata	areata	NNP
25944	2266	15	.	.	.
25944	2266	16	#	#	$
25944	2266	17	Ointments	Ointments	NNP
25944	2266	18	of	of	IN
25944	2266	19	tar	tar	NNP
25944	2266	20	and	and	CC
25944	2266	21	sulphur	sulphur	NNP
25944	2266	22	of	of	IN
25944	2266	23	varying	varying	NN
25944	2266	24	strength	strength	NN
25944	2266	25	;	;	:
25944	2266	26	the	the	DT
25944	2266	27	various	various	JJ
25944	2266	28	mercurial	mercurial	JJ
25944	2266	29	ointments	ointment	NNS
25944	2266	30	;	;	:
25944	2266	31	the	the	DT
25944	2266	32	tar	tar	NN
25944	2266	33	oils	oil	NNS
25944	2266	34	,	,	,
25944	2266	35	either	either	CC
25944	2266	36	pure	pure	JJ
25944	2266	37	or	or	CC
25944	2266	38	with	with	IN
25944	2266	39	alcohol	alcohol	NN
25944	2266	40	;	;	:
25944	2266	41	stimulating	stimulate	VBG
25944	2266	42	lotions	lotion	NNS
25944	2266	43	,	,	,
25944	2266	44	containing	contain	VBG
25944	2266	45	varying	varying	NN
25944	2266	46	proportions	proportion	NNS
25944	2266	47	,	,	,
25944	2266	48	singly	singly	RB
25944	2266	49	or	or	CC
25944	2266	50	in	in	IN
25944	2266	51	combination	combination	NN
25944	2266	52	,	,	,
25944	2266	53	of	of	IN
25944	2266	54	tincture	tincture	NN
25944	2266	55	of	of	IN
25944	2266	56	capsicum	capsicum	NN
25944	2266	57	,	,	,
25944	2266	58	tincture	tincture	NN
25944	2266	59	of	of	IN
25944	2266	60	cantharides	cantharide	NNS
25944	2266	61	,	,	,
25944	2266	62	aqua	aqua	NNP
25944	2266	63	ammoniæ	ammoniæ	NNP
25944	2266	64	,	,	,
25944	2266	65	and	and	CC
25944	2266	66	oil	oil	NN
25944	2266	67	of	of	IN
25944	2266	68	turpentine	turpentine	NN
25944	2266	69	.	.	.
25944	2267	1	The	the	DT
25944	2267	2	following	follow	VBG
25944	2267	3	is	be	VBZ
25944	2267	4	a	a	DT
25944	2267	5	safe	safe	JJ
25944	2267	6	formula	formula	NN
25944	2267	7	,	,	,
25944	2267	8	especially	especially	RB
25944	2267	9	in	in	IN
25944	2267	10	dispensary	dispensary	JJ
25944	2267	11	and	and	CC
25944	2267	12	ignorant	ignorant	JJ
25944	2267	13	class	class	NN
25944	2267	14	practice	practice	NN
25944	2267	15	:	:	:
25944	2267	16	[	[	-LRB-
25944	2267	17	Rx	rx	NN
25944	2267	18	]	]	-RRB-
25944	2267	19	[	[	-LRB-
25944	2267	20	beta]-naphthol	beta]-naphthol	NNP
25944	2267	21	,	,	,
25944	2267	22	.....................	.....................	.
25944	2267	23	[	[	-LRB-
25944	2267	24	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	2267	25	Ol	old	NNP
25944	2267	26	.	.	.
25944	2268	1	cadini	cadini	NNP
25944	2268	2	,	,	,
25944	2268	3	..........................	..........................	NFP
25944	2268	4	[	[	-LRB-
25944	2268	5	dram]j	dram]j	NNP
25944	2268	6	Ungt	Ungt	NNP
25944	2268	7	.	.	.
25944	2269	1	sulphuris	sulphuris	NNP
25944	2269	2	,	,	,
25944	2269	3	..........	..........	NFP
25944	2269	4	q.	q.	NNP
25944	2269	5	s.	s.	NNP
25944	2269	6	ad	ad	NNP
25944	2269	7	...	...	:
25944	2269	8	[	[	-LRB-
25944	2269	9	Oz]j	Oz]j	.
25944	2269	10	M.	M.	NNP
25944	2269	11	The	the	DT
25944	2269	12	cautious	cautious	JJ
25944	2269	13	use	use	NN
25944	2269	14	of	of	IN
25944	2269	15	a	a	DT
25944	2269	16	five	five	CD
25944	2269	17	to	to	TO
25944	2269	18	twenty	twenty	CD
25944	2269	19	per	per	IN
25944	2269	20	cent	cent	NN
25944	2269	21	.	.	.
25944	2270	1	chrysarobin	chrysarobin	NNP
25944	2270	2	ointment	ointment	NNP
25944	2270	3	is	be	VBZ
25944	2270	4	of	of	IN
25944	2270	5	value	value	NN
25944	2270	6	.	.	.
25944	2271	1	Painting	paint	VBG
25944	2271	2	the	the	DT
25944	2271	3	patches	patch	NNS
25944	2271	4	with	with	IN
25944	2271	5	pure	pure	JJ
25944	2271	6	carbolic	carbolic	JJ
25944	2271	7	acid	acid	NN
25944	2271	8	or	or	CC
25944	2271	9	trikresol	trikresol	NN
25944	2271	10	every	every	DT
25944	2271	11	ten	ten	CD
25944	2271	12	days	day	NNS
25944	2271	13	or	or	CC
25944	2271	14	two	two	CD
25944	2271	15	weeks	week	NNS
25944	2271	16	sometimes	sometimes	RB
25944	2271	17	acts	act	VBZ
25944	2271	18	well	well	RB
25944	2271	19	;	;	:
25944	2271	20	it	-PRON-	PRP
25944	2271	21	should	should	MD
25944	2271	22	not	not	RB
25944	2271	23	be	be	VB
25944	2271	24	applied	apply	VBN
25944	2271	25	over	over	IN
25944	2271	26	large	large	JJ
25944	2271	27	areas	area	NNS
25944	2271	28	nor	nor	CC
25944	2271	29	used	use	VBN
25944	2271	30	in	in	IN
25944	2271	31	young	young	JJ
25944	2271	32	children	child	NNS
25944	2271	33	.	.	.
25944	2272	1	Galvanization	galvanization	NN
25944	2272	2	or	or	CC
25944	2272	3	faradization	faradization	NN
25944	2272	4	of	of	IN
25944	2272	5	the	the	DT
25944	2272	6	affected	affected	JJ
25944	2272	7	parts	part	NNS
25944	2272	8	may	may	MD
25944	2272	9	also	also	RB
25944	2272	10	be	be	VB
25944	2272	11	employed	employ	VBN
25944	2272	12	,	,	,
25944	2272	13	and	and	CC
25944	2272	14	with	with	IN
25944	2272	15	,	,	,
25944	2272	16	occasionally	occasionally	RB
25944	2272	17	,	,	,
25944	2272	18	beneficial	beneficial	JJ
25944	2272	19	effect	effect	NN
25944	2272	20	.	.	.
25944	2273	1	Stimulation	stimulation	NN
25944	2273	2	with	with	IN
25944	2273	3	the	the	DT
25944	2273	4	high	high	JJ
25944	2273	5	-	-	HYPH
25944	2273	6	frequency	frequency	NN
25944	2273	7	current	current	NN
25944	2273	8	by	by	IN
25944	2273	9	means	mean	NNS
25944	2273	10	of	of	IN
25944	2273	11	the	the	DT
25944	2273	12	vacuum	vacuum	NN
25944	2273	13	electrode	electrode	NN
25944	2273	14	is	be	VBZ
25944	2273	15	also	also	RB
25944	2273	16	of	of	IN
25944	2273	17	value	value	NN
25944	2273	18	.	.	.
25944	2274	1	When	when	WRB
25944	2274	2	practicable	practicable	JJ
25944	2274	3	,	,	,
25944	2274	4	the	the	DT
25944	2274	5	Finsen	Finsen	NNP
25944	2274	6	light	light	NN
25944	2274	7	can	can	MD
25944	2274	8	be	be	VB
25944	2274	9	applied	apply	VBN
25944	2274	10	with	with	IN
25944	2274	11	hope	hope	NN
25944	2274	12	of	of	IN
25944	2274	13	benefit	benefit	NN
25944	2274	14	and	and	CC
25944	2274	15	cure	cure	NN
25944	2274	16	.	.	.
25944	2275	1	#	#	NNP
25944	2275	2	Atrophia	Atrophia	NNP
25944	2275	3	Pilorum	Pilorum	NNP
25944	2275	4	Propria	Propria	NNP
25944	2275	5	.	.	.
25944	2275	6	#	#	NNP
25944	2275	7	(	(	-LRB-
25944	2275	8	_	_	NNP
25944	2275	9	Synonym	Synonym	NNP
25944	2275	10	:	:	:
25944	2275	11	_	_	NNP
25944	2275	12	Atrophy	Atrophy	NNP
25944	2275	13	of	of	IN
25944	2275	14	the	the	DT
25944	2275	15	Hair	Hair	NNP
25944	2275	16	.	.	.
25944	2275	17	)	)	-RRB-
25944	2276	1	#	#	LS
25944	2276	2	What	what	WP
25944	2276	3	do	do	VBP
25944	2276	4	you	-PRON-	PRP
25944	2276	5	understand	understand	VB
25944	2276	6	by	by	IN
25944	2276	7	atrophy	atrophy	NN
25944	2276	8	of	of	IN
25944	2276	9	the	the	DT
25944	2276	10	hair	hair	NN
25944	2276	11	?	?	.
25944	2276	12	#	#	$
25944	2276	13	An	an	DT
25944	2276	14	atrophic	atrophic	JJ
25944	2276	15	,	,	,
25944	2276	16	brittle	brittle	JJ
25944	2276	17	,	,	,
25944	2276	18	dry	dry	JJ
25944	2276	19	condition	condition	NN
25944	2276	20	of	of	IN
25944	2276	21	the	the	DT
25944	2276	22	hair	hair	NN
25944	2276	23	,	,	,
25944	2276	24	and	and	CC
25944	2276	25	which	which	WDT
25944	2276	26	may	may	MD
25944	2276	27	be	be	VB
25944	2276	28	either	either	CC
25944	2276	29	symptomatic	symptomatic	JJ
25944	2276	30	or	or	CC
25944	2276	31	idiopathic	idiopathic	JJ
25944	2276	32	.	.	.
25944	2277	1	#	#	NNP
25944	2277	2	Describe	describe	VB
25944	2277	3	the	the	DT
25944	2277	4	several	several	JJ
25944	2277	5	conditions	condition	NNS
25944	2277	6	met	meet	VBD
25944	2277	7	with	with	IN
25944	2277	8	.	.	.
25944	2277	9	#	#	$
25944	2277	10	As	as	IN
25944	2277	11	a	a	DT
25944	2277	12	symptomatic	symptomatic	JJ
25944	2277	13	affection	affection	NN
25944	2277	14	,	,	,
25944	2277	15	the	the	DT
25944	2277	16	dry	dry	JJ
25944	2277	17	,	,	,
25944	2277	18	brittle	brittle	JJ
25944	2277	19	condition	condition	NN
25944	2277	20	of	of	IN
25944	2277	21	the	the	DT
25944	2277	22	hair	hair	NN
25944	2277	23	met	meet	VBN
25944	2277	24	with	with	IN
25944	2277	25	in	in	IN
25944	2277	26	seborrh[oe]a	seborrh[oe]a	NNP
25944	2277	27	,	,	,
25944	2277	28	in	in	IN
25944	2277	29	severe	severe	JJ
25944	2277	30	constitutional	constitutional	JJ
25944	2277	31	diseases	disease	NNS
25944	2277	32	,	,	,
25944	2277	33	and	and	CC
25944	2277	34	in	in	IN
25944	2277	35	the	the	DT
25944	2277	36	various	various	JJ
25944	2277	37	vegetable	vegetable	NN
25944	2277	38	parasitic	parasitic	JJ
25944	2277	39	affections	affection	NNS
25944	2277	40	,	,	,
25944	2277	41	may	may	MD
25944	2277	42	be	be	VB
25944	2277	43	referred	refer	VBN
25944	2277	44	to	to	IN
25944	2277	45	.	.	.
25944	2278	1	As	as	IN
25944	2278	2	an	an	DT
25944	2278	3	idiopathic	idiopathic	JJ
25944	2278	4	disease	disease	NN
25944	2278	5	it	-PRON-	PRP
25944	2278	6	is	be	VBZ
25944	2278	7	rare	rare	JJ
25944	2278	8	,	,	,
25944	2278	9	consisting	consist	VBG
25944	2278	10	simply	simply	RB
25944	2278	11	of	of	IN
25944	2278	12	a	a	DT
25944	2278	13	brittleness	brittleness	NN
25944	2278	14	and	and	CC
25944	2278	15	an	an	DT
25944	2278	16	uneven	uneven	JJ
25944	2278	17	and	and	CC
25944	2278	18	irregular	irregular	JJ
25944	2278	19	formation	formation	NN
25944	2278	20	of	of	IN
25944	2278	21	the	the	DT
25944	2278	22	hair	hair	NN
25944	2278	23	-	-	HYPH
25944	2278	24	shaft	shaft	NN
25944	2278	25	,	,	,
25944	2278	26	with	with	IN
25944	2278	27	a	a	DT
25944	2278	28	tendency	tendency	NN
25944	2278	29	to	to	TO
25944	2278	30	split	split	VB
25944	2278	31	up	up	RP
25944	2278	32	into	into	IN
25944	2278	33	filaments	filament	NNS
25944	2278	34	(	(	-LRB-
25944	2278	35	_	_	NNP
25944	2278	36	fragilitas	fragilitas	NNP
25944	2278	37	crinium	crinium	NNP
25944	2278	38	_	_	NNP
25944	2278	39	)	)	-RRB-
25944	2278	40	;	;	:
25944	2278	41	or	or	CC
25944	2278	42	there	there	EX
25944	2278	43	may	may	MD
25944	2278	44	be	be	VB
25944	2278	45	localized	localize	VBN
25944	2278	46	swelling	swell	VBG
25944	2278	47	and	and	CC
25944	2278	48	bursting	bursting	NN
25944	2278	49	of	of	IN
25944	2278	50	the	the	DT
25944	2278	51	hair	hair	NN
25944	2278	52	-	-	HYPH
25944	2278	53	shaft	shaft	NN
25944	2278	54	,	,	,
25944	2278	55	the	the	DT
25944	2278	56	nodes	node	NNS
25944	2278	57	thus	thus	RB
25944	2278	58	produced	produce	VBD
25944	2278	59	having	have	VBG
25944	2278	60	a	a	DT
25944	2278	61	shining	shining	JJ
25944	2278	62	,	,	,
25944	2278	63	semi	semi	JJ
25944	2278	64	-	-	JJ
25944	2278	65	transparent	transparent	JJ
25944	2278	66	appearance	appearance	NN
25944	2278	67	(	(	-LRB-
25944	2278	68	_	_	NNP
25944	2278	69	trichorrhexis	trichorrhexis	NNP
25944	2278	70	nodosa	nodosa	NNP
25944	2278	71	_	_	NNP
25944	2278	72	)	)	-RRB-
25944	2278	73	.	.	.
25944	2279	1	This	this	DT
25944	2279	2	latter	latter	NN
25944	2279	3	usually	usually	RB
25944	2279	4	occurs	occur	VBZ
25944	2279	5	upon	upon	IN
25944	2279	6	the	the	DT
25944	2279	7	beard	beard	NN
25944	2279	8	and	and	CC
25944	2279	9	moustache	moustache	NNP
25944	2279	10	.	.	.
25944	2280	1	#	#	JJR
25944	2280	2	State	state	NN
25944	2280	3	the	the	DT
25944	2280	4	causes	cause	NNS
25944	2280	5	of	of	IN
25944	2280	6	atrophy	atrophy	NN
25944	2280	7	of	of	IN
25944	2280	8	the	the	DT
25944	2280	9	hair	hair	NN
25944	2280	10	.	.	.
25944	2280	11	#	#	$
25944	2280	12	The	the	DT
25944	2280	13	causes	cause	NNS
25944	2280	14	of	of	IN
25944	2280	15	the	the	DT
25944	2280	16	symptomatic	symptomatic	JJ
25944	2280	17	variety	variety	NN
25944	2280	18	are	be	VBP
25944	2280	19	usually	usually	RB
25944	2280	20	evident	evident	JJ
25944	2280	21	;	;	:
25944	2280	22	the	the	DT
25944	2280	23	etiology	etiology	NN
25944	2280	24	of	of	IN
25944	2280	25	idiopathic	idiopathic	JJ
25944	2280	26	atrophy	atrophy	NN
25944	2280	27	is	be	VBZ
25944	2280	28	obscure	obscure	JJ
25944	2280	29	,	,	,
25944	2280	30	but	but	CC
25944	2280	31	by	by	IN
25944	2280	32	many	many	JJ
25944	2280	33	is	be	VBZ
25944	2280	34	thought	think	VBN
25944	2280	35	due	due	IN
25944	2280	36	to	to	IN
25944	2280	37	parasitism	parasitism	NN
25944	2280	38	.	.	.
25944	2281	1	[	[	-LRB-
25944	2281	2	Illustration	illustration	NN
25944	2281	3	:	:	:
25944	2281	4	Fig	Fig	NNP
25944	2281	5	.	.	.
25944	2282	1	39	39	CD
25944	2282	2	.	.	.
25944	2283	1	Trichorrhexis	Trichorrhexis	NNP
25944	2283	2	Nodosa	Nodosa	NNP
25944	2283	3	.	.	.
25944	2284	1	(	(	-LRB-
25944	2284	2	_	_	NNP
25944	2284	3	After	after	IN
25944	2284	4	Michelson	Michelson	NNP
25944	2284	5	.	.	.
25944	2284	6	_	_	NNP
25944	2284	7	)	)	-RRB-
25944	2284	8	]	]	-RRB-
25944	2284	9	#	#	$
25944	2284	10	What	what	WP
25944	2284	11	would	would	MD
25944	2284	12	be	be	VB
25944	2284	13	your	-PRON-	PRP$
25944	2284	14	prognosis	prognosis	NN
25944	2284	15	and	and	CC
25944	2284	16	treatment	treatment	NN
25944	2284	17	in	in	IN
25944	2284	18	atrophy	atrophy	NN
25944	2284	19	of	of	IN
25944	2284	20	the	the	DT
25944	2284	21	hair	hair	NN
25944	2284	22	?	?	.
25944	2284	23	#	#	$
25944	2284	24	Symptomatic	symptomatic	JJ
25944	2284	25	atrophy	atrophy	NN
25944	2284	26	usually	usually	RB
25944	2284	27	responds	respond	VBZ
25944	2284	28	to	to	IN
25944	2284	29	proper	proper	JJ
25944	2284	30	measures	measure	NNS
25944	2284	31	,	,	,
25944	2284	32	but	but	CC
25944	2284	33	always	always	RB
25944	2284	34	slowly	slowly	RB
25944	2284	35	;	;	:
25944	2284	36	treatment	treatment	NN
25944	2284	37	is	be	VBZ
25944	2284	38	based	base	VBN
25944	2284	39	upon	upon	IN
25944	2284	40	the	the	DT
25944	2284	41	etiological	etiological	JJ
25944	2284	42	factors	factor	NNS
25944	2284	43	.	.	.
25944	2285	1	For	for	IN
25944	2285	2	the	the	DT
25944	2285	3	idiopathic	idiopathic	JJ
25944	2285	4	disease	disease	NN
25944	2285	5	little	little	JJ
25944	2285	6	,	,	,
25944	2285	7	as	as	IN
25944	2285	8	a	a	DT
25944	2285	9	rule	rule	NN
25944	2285	10	,	,	,
25944	2285	11	can	can	MD
25944	2285	12	be	be	VB
25944	2285	13	done	do	VBN
25944	2285	14	;	;	:
25944	2285	15	repeated	repeat	VBN
25944	2285	16	shaving	shaving	NN
25944	2285	17	or	or	CC
25944	2285	18	cutting	cut	VBG
25944	2285	19	the	the	DT
25944	2285	20	hair	hair	NN
25944	2285	21	has	have	VBZ
25944	2285	22	,	,	,
25944	2285	23	in	in	IN
25944	2285	24	exceptional	exceptional	JJ
25944	2285	25	instances	instance	NNS
25944	2285	26	,	,	,
25944	2285	27	been	be	VBN
25944	2285	28	followed	follow	VBN
25944	2285	29	by	by	IN
25944	2285	30	favorable	favorable	JJ
25944	2285	31	results	result	NNS
25944	2285	32	.	.	.
25944	2286	1	#	#	NNP
25944	2286	2	Atrophia	Atrophia	NNP
25944	2286	3	Unguis	Unguis	NNP
25944	2286	4	.	.	.
25944	2286	5	#	#	NNP
25944	2286	6	(	(	-LRB-
25944	2286	7	_	_	NNP
25944	2286	8	Synonyms	Synonyms	NNP
25944	2286	9	:	:	:
25944	2286	10	_	_	NNP
25944	2286	11	Atrophy	Atrophy	NNP
25944	2286	12	of	of	IN
25944	2286	13	the	the	DT
25944	2286	14	Nails	Nails	NNP
25944	2286	15	;	;	:
25944	2286	16	Onychatrophia	Onychatrophia	NNP
25944	2286	17	.	.	.
25944	2286	18	)	)	-RRB-
25944	2287	1	#	#	NNP
25944	2287	2	Describe	Describe	NNP
25944	2287	3	atrophy	atrophy	NN
25944	2287	4	of	of	IN
25944	2287	5	the	the	DT
25944	2287	6	nails	nail	NNS
25944	2287	7	.	.	.
25944	2287	8	#	#	$
25944	2287	9	The	the	DT
25944	2287	10	nails	nail	NNS
25944	2287	11	are	be	VBP
25944	2287	12	soft	soft	JJ
25944	2287	13	,	,	,
25944	2287	14	thin	thin	JJ
25944	2287	15	and	and	CC
25944	2287	16	brittle	brittle	JJ
25944	2287	17	,	,	,
25944	2287	18	splitting	split	VBG
25944	2287	19	easily	easily	RB
25944	2287	20	,	,	,
25944	2287	21	and	and	CC
25944	2287	22	are	be	VBP
25944	2287	23	often	often	RB
25944	2287	24	opaque	opaque	JJ
25944	2287	25	and	and	CC
25944	2287	26	lustreless	lustreless	VBP
25944	2287	27	,	,	,
25944	2287	28	and	and	CC
25944	2287	29	may	may	MD
25944	2287	30	have	have	VB
25944	2287	31	a	a	DT
25944	2287	32	worm	worm	NN
25944	2287	33	-	-	HYPH
25944	2287	34	eaten	eat	VBN
25944	2287	35	appearance	appearance	NN
25944	2287	36	.	.	.
25944	2288	1	Several	several	JJ
25944	2288	2	or	or	CC
25944	2288	3	more	more	JJR
25944	2288	4	are	be	VBP
25944	2288	5	usually	usually	RB
25944	2288	6	affected	affect	VBN
25944	2288	7	.	.	.
25944	2289	1	#	#	JJR
25944	2289	2	State	state	NN
25944	2289	3	the	the	DT
25944	2289	4	causes	cause	NNS
25944	2289	5	of	of	IN
25944	2289	6	atrophy	atrophy	NN
25944	2289	7	of	of	IN
25944	2289	8	the	the	DT
25944	2289	9	nails	nail	NNS
25944	2289	10	.	.	.
25944	2289	11	#	#	$
25944	2289	12	The	the	DT
25944	2289	13	condition	condition	NN
25944	2289	14	may	may	MD
25944	2289	15	be	be	VB
25944	2289	16	congenital	congenital	JJ
25944	2289	17	or	or	CC
25944	2289	18	acquired	acquire	VBN
25944	2289	19	,	,	,
25944	2289	20	usually	usually	RB
25944	2289	21	the	the	DT
25944	2289	22	latter	latter	JJ
25944	2289	23	.	.	.
25944	2290	1	It	-PRON-	PRP
25944	2290	2	may	may	MD
25944	2290	3	result	result	VB
25944	2290	4	from	from	IN
25944	2290	5	trauma	trauma	NN
25944	2290	6	,	,	,
25944	2290	7	or	or	CC
25944	2290	8	be	be	VB
25944	2290	9	produced	produce	VBN
25944	2290	10	by	by	IN
25944	2290	11	certain	certain	JJ
25944	2290	12	cutaneous	cutaneous	JJ
25944	2290	13	diseases	disease	NNS
25944	2290	14	,	,	,
25944	2290	15	notably	notably	RB
25944	2290	16	eczema	eczema	NN
25944	2290	17	and	and	CC
25944	2290	18	psoriasis	psoriasis	NN
25944	2290	19	;	;	:
25944	2290	20	or	or	CC
25944	2290	21	it	-PRON-	PRP
25944	2290	22	may	may	MD
25944	2290	23	follow	follow	VB
25944	2290	24	injuries	injury	NNS
25944	2290	25	or	or	CC
25944	2290	26	diseases	disease	NNS
25944	2290	27	of	of	IN
25944	2290	28	the	the	DT
25944	2290	29	nerves	nerve	NNS
25944	2290	30	.	.	.
25944	2291	1	Syphilis	Syphilis	NNP
25944	2291	2	and	and	CC
25944	2291	3	chronic	chronic	JJ
25944	2291	4	wasting	waste	VBG
25944	2291	5	constitutional	constitutional	JJ
25944	2291	6	diseases	disease	NNS
25944	2291	7	may	may	MD
25944	2291	8	also	also	RB
25944	2291	9	interfere	interfere	VB
25944	2291	10	with	with	IN
25944	2291	11	the	the	DT
25944	2291	12	normal	normal	JJ
25944	2291	13	growth	growth	NN
25944	2291	14	of	of	IN
25944	2291	15	the	the	DT
25944	2291	16	nail	nail	NN
25944	2291	17	-	-	HYPH
25944	2291	18	substance	substance	NN
25944	2291	19	,	,	,
25944	2291	20	producing	produce	VBG
25944	2291	21	varying	vary	VBG
25944	2291	22	degrees	degree	NNS
25944	2291	23	of	of	IN
25944	2291	24	atrophy	atrophy	NN
25944	2291	25	.	.	.
25944	2292	1	The	the	DT
25944	2292	2	fungi	fungi	NN
25944	2292	3	of	of	IN
25944	2292	4	tinea	tinea	NNP
25944	2292	5	trichophytina	trichophytina	NNP
25944	2292	6	and	and	CC
25944	2292	7	tinea	tinea	NNP
25944	2292	8	favosa	favosa	NNS
25944	2292	9	at	at	IN
25944	2292	10	times	time	NNS
25944	2292	11	invade	invade	VBP
25944	2292	12	these	these	DT
25944	2292	13	structures	structure	NNS
25944	2292	14	and	and	CC
25944	2292	15	lead	lead	VBP
25944	2292	16	to	to	IN
25944	2292	17	more	more	RBR
25944	2292	18	or	or	CC
25944	2292	19	less	less	RBR
25944	2292	20	complete	complete	JJ
25944	2292	21	disintegration--_onychomycosis	disintegration--_onychomycosis	NNP
25944	2292	22	_	_	NNP
25944	2292	23	.	.	.
25944	2293	1	[	[	-LRB-
25944	2293	2	Illustration	illustration	NN
25944	2293	3	:	:	:
25944	2293	4	Fig	Fig	NNP
25944	2293	5	.	.	.
25944	2294	1	40	40	CD
25944	2294	2	.	.	.
25944	2295	1	Atrophy	Atrophy	NNP
25944	2295	2	of	of	IN
25944	2295	3	the	the	DT
25944	2295	4	Nails	Nails	NNP
25944	2295	5	.	.	.
25944	2295	6	]	]	-RRB-
25944	2296	1	#	#	LS
25944	2296	2	What	what	WP
25944	2296	3	is	be	VBZ
25944	2296	4	the	the	DT
25944	2296	5	treatment	treatment	NN
25944	2296	6	of	of	IN
25944	2296	7	atrophy	atrophy	NN
25944	2296	8	of	of	IN
25944	2296	9	the	the	DT
25944	2296	10	nails	nail	NNS
25944	2296	11	?	?	.
25944	2296	12	#	#	$
25944	2296	13	Treatment	Treatment	NNP
25944	2296	14	will	will	MD
25944	2296	15	depend	depend	VB
25944	2296	16	upon	upon	IN
25944	2296	17	the	the	DT
25944	2296	18	cause	cause	NN
25944	2296	19	.	.	.
25944	2297	1	When	when	WRB
25944	2297	2	it	-PRON-	PRP
25944	2297	3	is	be	VBZ
25944	2297	4	due	due	JJ
25944	2297	5	to	to	IN
25944	2297	6	eczema	eczema	NN
25944	2297	7	or	or	CC
25944	2297	8	psoriasis	psoriasis	NN
25944	2297	9	,	,	,
25944	2297	10	appropriate	appropriate	JJ
25944	2297	11	constitutional	constitutional	JJ
25944	2297	12	and	and	CC
25944	2297	13	local	local	JJ
25944	2297	14	remedies	remedy	NNS
25944	2297	15	should	should	MD
25944	2297	16	be	be	VB
25944	2297	17	prescribed	prescribe	VBN
25944	2297	18	.	.	.
25944	2298	1	If	if	IN
25944	2298	2	it	-PRON-	PRP
25944	2298	3	is	be	VBZ
25944	2298	4	the	the	DT
25944	2298	5	result	result	NN
25944	2298	6	of	of	IN
25944	2298	7	syphilis	syphilis	NNP
25944	2298	8	,	,	,
25944	2298	9	mercury	mercury	NN
25944	2298	10	and	and	CC
25944	2298	11	potassium	potassium	NN
25944	2298	12	iodide	iodide	NN
25944	2298	13	are	be	VBP
25944	2298	14	to	to	TO
25944	2298	15	be	be	VB
25944	2298	16	advised	advise	VBN
25944	2298	17	.	.	.
25944	2299	1	In	in	IN
25944	2299	2	onychomycosis	onychomycosis	NN
25944	2299	3	--	--	:
25944	2299	4	an	an	DT
25944	2299	5	exceedingly	exceedingly	JJ
25944	2299	6	obstinate	obstinate	NN
25944	2299	7	affection	affection	NN
25944	2299	8	--	--	:
25944	2299	9	the	the	DT
25944	2299	10	nails	nail	NNS
25944	2299	11	should	should	MD
25944	2299	12	be	be	VB
25944	2299	13	kept	keep	VBN
25944	2299	14	closely	closely	RB
25944	2299	15	cut	cut	VBN
25944	2299	16	and	and	CC
25944	2299	17	pared	pare	VBN
25944	2299	18	,	,	,
25944	2299	19	and	and	CC
25944	2299	20	a	a	DT
25944	2299	21	one-	one-	NN
25944	2299	22	to	to	TO
25944	2299	23	five	five	CD
25944	2299	24	-	-	HYPH
25944	2299	25	grain	grain	NN
25944	2299	26	solution	solution	NN
25944	2299	27	of	of	IN
25944	2299	28	corrosive	corrosive	JJ
25944	2299	29	sublimate	sublimate	NN
25944	2299	30	applied	apply	VBD
25944	2299	31	several	several	JJ
25944	2299	32	times	time	NNS
25944	2299	33	a	a	DT
25944	2299	34	day	day	NN
25944	2299	35	;	;	:
25944	2299	36	a	a	DT
25944	2299	37	lotion	lotion	NN
25944	2299	38	of	of	IN
25944	2299	39	sodium	sodium	NN
25944	2299	40	hyposulphite	hyposulphite	NN
25944	2299	41	,	,	,
25944	2299	42	a	a	DT
25944	2299	43	drachm	drachm	NN
25944	2299	44	to	to	IN
25944	2299	45	the	the	DT
25944	2299	46	ounce	ounce	NN
25944	2299	47	,	,	,
25944	2299	48	is	be	VBZ
25944	2299	49	also	also	RB
25944	2299	50	a	a	DT
25944	2299	51	valuable	valuable	JJ
25944	2299	52	and	and	CC
25944	2299	53	safe	safe	JJ
25944	2299	54	application	application	NN
25944	2299	55	.	.	.
25944	2300	1	#	#	NNP
25944	2300	2	Atrophia	Atrophia	NNP
25944	2300	3	Cutis	Cutis	NNP
25944	2300	4	.	.	.
25944	2300	5	#	#	NNP
25944	2300	6	(	(	-LRB-
25944	2300	7	_	_	NNP
25944	2300	8	Synonyms	Synonyms	NNP
25944	2300	9	:	:	:
25944	2300	10	_	_	NNP
25944	2300	11	Atrophoderma	Atrophoderma	NNP
25944	2300	12	;	;	:
25944	2300	13	Atrophy	Atrophy	NNP
25944	2300	14	of	of	IN
25944	2300	15	the	the	DT
25944	2300	16	Skin	skin	NN
25944	2300	17	.	.	.
25944	2300	18	)	)	-RRB-
25944	2301	1	#	#	LS
25944	2301	2	What	what	WP
25944	2301	3	do	do	VBP
25944	2301	4	you	-PRON-	PRP
25944	2301	5	understand	understand	VB
25944	2301	6	by	by	IN
25944	2301	7	atrophy	atrophy	NN
25944	2301	8	of	of	IN
25944	2301	9	the	the	DT
25944	2301	10	skin	skin	NN
25944	2301	11	?	?	.
25944	2301	12	#	#	NN
25944	2301	13	By	by	IN
25944	2301	14	atrophy	atrophy	NN
25944	2301	15	of	of	IN
25944	2301	16	the	the	DT
25944	2301	17	skin	skin	NN
25944	2301	18	is	be	VBZ
25944	2301	19	meant	mean	VBN
25944	2301	20	an	an	DT
25944	2301	21	idiopathic	idiopathic	JJ
25944	2301	22	or	or	CC
25944	2301	23	symptomatic	symptomatic	JJ
25944	2301	24	wasting	wasting	NN
25944	2301	25	or	or	CC
25944	2301	26	degeneration	degeneration	NN
25944	2301	27	of	of	IN
25944	2301	28	its	-PRON-	PRP$
25944	2301	29	component	component	NN
25944	2301	30	elements	element	NNS
25944	2301	31	.	.	.
25944	2302	1	#	#	NNP
25944	2302	2	State	state	NN
25944	2302	3	the	the	DT
25944	2302	4	several	several	JJ
25944	2302	5	conditions	condition	NNS
25944	2302	6	met	meet	VBD
25944	2302	7	with	with	IN
25944	2302	8	.	.	.
25944	2302	9	#	#	$
25944	2302	10	Glossy	glossy	JJ
25944	2302	11	skin	skin	NN
25944	2302	12	,	,	,
25944	2302	13	general	general	JJ
25944	2302	14	idiopathic	idiopathic	JJ
25944	2302	15	atrophy	atrophy	NN
25944	2302	16	of	of	IN
25944	2302	17	the	the	DT
25944	2302	18	skin	skin	NN
25944	2302	19	,	,	,
25944	2302	20	parchment	parchment	NN
25944	2302	21	skin	skin	NN
25944	2302	22	,	,	,
25944	2302	23	atrophic	atrophic	JJ
25944	2302	24	lines	line	NNS
25944	2302	25	and	and	CC
25944	2302	26	spots	spot	NNS
25944	2302	27	,	,	,
25944	2302	28	senile	senile	JJ
25944	2302	29	atrophy	atrophy	NN
25944	2302	30	,	,	,
25944	2302	31	and	and	CC
25944	2302	32	the	the	DT
25944	2302	33	atrophy	atrophy	NN
25944	2302	34	following	follow	VBG
25944	2302	35	certain	certain	JJ
25944	2302	36	cutaneous	cutaneous	JJ
25944	2302	37	diseases	disease	NNS
25944	2302	38	.	.	.
25944	2303	1	#	#	NN
25944	2303	2	Describe	describe	VBP
25944	2303	3	glossy	glossy	JJ
25944	2303	4	skin	skin	NN
25944	2303	5	(	(	-LRB-
25944	2303	6	atrophoderma	atrophoderma	NNP
25944	2303	7	neuriticum	neuriticum	NNP
25944	2303	8	)	)	-RRB-
25944	2303	9	,	,	,
25944	2303	10	and	and	CC
25944	2303	11	state	state	VB
25944	2303	12	the	the	DT
25944	2303	13	treatment	treatment	NN
25944	2303	14	.	.	.
25944	2303	15	#	#	$
25944	2303	16	Glossy	glossy	JJ
25944	2303	17	skin	skin	NN
25944	2303	18	is	be	VBZ
25944	2303	19	a	a	DT
25944	2303	20	rare	rare	JJ
25944	2303	21	condition	condition	NN
25944	2303	22	following	follow	VBG
25944	2303	23	an	an	DT
25944	2303	24	injury	injury	NN
25944	2303	25	or	or	CC
25944	2303	26	disease	disease	NN
25944	2303	27	of	of	IN
25944	2303	28	the	the	DT
25944	2303	29	nerve	nerve	NN
25944	2303	30	.	.	.
25944	2304	1	It	-PRON-	PRP
25944	2304	2	is	be	VBZ
25944	2304	3	usually	usually	RB
25944	2304	4	seen	see	VBN
25944	2304	5	about	about	IN
25944	2304	6	the	the	DT
25944	2304	7	fingers	finger	NNS
25944	2304	8	.	.	.
25944	2305	1	The	the	DT
25944	2305	2	skin	skin	NN
25944	2305	3	is	be	VBZ
25944	2305	4	hairless	hairless	NN
25944	2305	5	,	,	,
25944	2305	6	faintly	faintly	RB
25944	2305	7	reddish	reddish	JJ
25944	2305	8	,	,	,
25944	2305	9	smooth	smooth	JJ
25944	2305	10	and	and	CC
25944	2305	11	shining	shine	VBG
25944	2305	12	,	,	,
25944	2305	13	with	with	IN
25944	2305	14	a	a	DT
25944	2305	15	varnished	varnished	JJ
25944	2305	16	and	and	CC
25944	2305	17	thin	thin	JJ
25944	2305	18	appearance	appearance	NN
25944	2305	19	,	,	,
25944	2305	20	and	and	CC
25944	2305	21	with	with	IN
25944	2305	22	a	a	DT
25944	2305	23	tendency	tendency	NN
25944	2305	24	to	to	IN
25944	2305	25	fissuring	fissuring	NN
25944	2305	26	.	.	.
25944	2306	1	More	more	RBR
25944	2306	2	or	or	CC
25944	2306	3	less	less	RBR
25944	2306	4	severe	severe	JJ
25944	2306	5	and	and	CC
25944	2306	6	persistent	persistent	JJ
25944	2306	7	burning	burn	VBG
25944	2306	8	pain	pain	NN
25944	2306	9	precedes	precede	NNS
25944	2306	10	and	and	CC
25944	2306	11	accompanies	accompany	VBZ
25944	2306	12	the	the	DT
25944	2306	13	atrophy	atrophy	NN
25944	2306	14	.	.	.
25944	2307	1	Protective	protective	JJ
25944	2307	2	applications	application	NNS
25944	2307	3	are	be	VBP
25944	2307	4	called	call	VBN
25944	2307	5	for	for	IN
25944	2307	6	,	,	,
25944	2307	7	the	the	DT
25944	2307	8	disease	disease	NN
25944	2307	9	tending	tend	VBG
25944	2307	10	slowly	slowly	RB
25944	2307	11	to	to	IN
25944	2307	12	spontaneous	spontaneous	JJ
25944	2307	13	disappearance	disappearance	NN
25944	2307	14	.	.	.
25944	2308	1	#	#	$
25944	2308	2	Describe	Describe	NNP
25944	2308	3	general	general	JJ
25944	2308	4	idiopathic	idiopathic	JJ
25944	2308	5	atrophy	atrophy	NN
25944	2308	6	of	of	IN
25944	2308	7	the	the	DT
25944	2308	8	skin	skin	NN
25944	2308	9	,	,	,
25944	2308	10	and	and	CC
25944	2308	11	give	give	VB
25944	2308	12	the	the	DT
25944	2308	13	treatment	treatment	NN
25944	2308	14	.	.	.
25944	2308	15	#	#	$
25944	2308	16	General	general	JJ
25944	2308	17	idiopathic	idiopathic	JJ
25944	2308	18	atrophy	atrophy	NN
25944	2308	19	of	of	IN
25944	2308	20	the	the	DT
25944	2308	21	skin	skin	NN
25944	2308	22	is	be	VBZ
25944	2308	23	extremely	extremely	RB
25944	2308	24	rare	rare	JJ
25944	2308	25	,	,	,
25944	2308	26	and	and	CC
25944	2308	27	is	be	VBZ
25944	2308	28	characterized	characterize	VBN
25944	2308	29	by	by	IN
25944	2308	30	a	a	DT
25944	2308	31	gradual	gradual	JJ
25944	2308	32	,	,	,
25944	2308	33	more	more	RBR
25944	2308	34	or	or	CC
25944	2308	35	less	less	RBR
25944	2308	36	general	general	JJ
25944	2308	37	,	,	,
25944	2308	38	degenerative	degenerative	JJ
25944	2308	39	and	and	CC
25944	2308	40	quantitative	quantitative	JJ
25944	2308	41	atrophy	atrophy	NN
25944	2308	42	of	of	IN
25944	2308	43	the	the	DT
25944	2308	44	skin	skin	NN
25944	2308	45	structures	structure	NNS
25944	2308	46	,	,	,
25944	2308	47	accompanied	accompany	VBN
25944	2308	48	usually	usually	RB
25944	2308	49	with	with	IN
25944	2308	50	more	more	JJR
25944	2308	51	or	or	CC
25944	2308	52	less	less	JJR
25944	2308	53	discoloration	discoloration	NN
25944	2308	54	and	and	CC
25944	2308	55	pigmentation	pigmentation	NN
25944	2308	56	.	.	.
25944	2309	1	Treatment	treatment	NN
25944	2309	2	is	be	VBZ
25944	2309	3	palliative	palliative	JJ
25944	2309	4	and	and	CC
25944	2309	5	based	base	VBN
25944	2309	6	upon	upon	IN
25944	2309	7	indications	indication	NNS
25944	2309	8	.	.	.
25944	2310	1	#	#	NNP
25944	2310	2	Describe	Describe	NNP
25944	2310	3	parchment	parchment	NN
25944	2310	4	skin	skin	NN
25944	2310	5	,	,	,
25944	2310	6	and	and	CC
25944	2310	7	state	state	VB
25944	2310	8	the	the	DT
25944	2310	9	treatment	treatment	NN
25944	2310	10	.	.	.
25944	2310	11	#	#	JJR
25944	2310	12	Parchment	Parchment	NNP
25944	2310	13	skin	skin	NN
25944	2310	14	(	(	-LRB-
25944	2310	15	_	_	NNP
25944	2310	16	xeroderma	xeroderma	NNP
25944	2310	17	pigmentosum	pigmentosum	NNP
25944	2310	18	_	_	NNP
25944	2310	19	,	,	,
25944	2310	20	_	_	NNP
25944	2310	21	angioma	angioma	NNP
25944	2310	22	pigmentosum	pigmentosum	NNP
25944	2310	23	et	et	NNP
25944	2310	24	atrophicum	atrophicum	NNP
25944	2310	25	_	_	NNP
25944	2310	26	)	)	-RRB-
25944	2310	27	is	be	VBZ
25944	2310	28	a	a	DT
25944	2310	29	rare	rare	JJ
25944	2310	30	disease	disease	NN
25944	2310	31	,	,	,
25944	2310	32	the	the	DT
25944	2310	33	exact	exact	JJ
25944	2310	34	nature	nature	NN
25944	2310	35	of	of	IN
25944	2310	36	which	which	WDT
25944	2310	37	is	be	VBZ
25944	2310	38	not	not	RB
25944	2310	39	understood	understand	VBN
25944	2310	40	.	.	.
25944	2311	1	It	-PRON-	PRP
25944	2311	2	is	be	VBZ
25944	2311	3	characterized	characterize	VBN
25944	2311	4	by	by	IN
25944	2311	5	the	the	DT
25944	2311	6	appearance	appearance	NN
25944	2311	7	of	of	IN
25944	2311	8	numerous	numerous	JJ
25944	2311	9	disseminated	disseminate	VBN
25944	2311	10	,	,	,
25944	2311	11	freckle	freckle	NN
25944	2311	12	-	-	HYPH
25944	2311	13	like	like	JJ
25944	2311	14	pigment	pigment	NN
25944	2311	15	-	-	HYPH
25944	2311	16	spots	spot	NNS
25944	2311	17	,	,	,
25944	2311	18	telangiectases	telangiectasis	NNS
25944	2311	19	,	,	,
25944	2311	20	atrophied	atrophy	VBN
25944	2311	21	muscles	muscle	NNS
25944	2311	22	,	,	,
25944	2311	23	more	more	RBR
25944	2311	24	or	or	CC
25944	2311	25	less	less	RBR
25944	2311	26	shrinking	shrink	VBG
25944	2311	27	and	and	CC
25944	2311	28	contraction	contraction	NN
25944	2311	29	of	of	IN
25944	2311	30	the	the	DT
25944	2311	31	integument	integument	NN
25944	2311	32	,	,	,
25944	2311	33	and	and	CC
25944	2311	34	followed	follow	VBD
25944	2311	35	,	,	,
25944	2311	36	in	in	IN
25944	2311	37	most	most	JJS
25944	2311	38	instances	instance	NNS
25944	2311	39	,	,	,
25944	2311	40	by	by	IN
25944	2311	41	epitheliomatous	epitheliomatous	JJ
25944	2311	42	tumors	tumor	NNS
25944	2311	43	and	and	CC
25944	2311	44	ulceration	ulceration	NN
25944	2311	45	,	,	,
25944	2311	46	and	and	CC
25944	2311	47	finally	finally	RB
25944	2311	48	death	death	NN
25944	2311	49	.	.	.
25944	2312	1	It	-PRON-	PRP
25944	2312	2	is	be	VBZ
25944	2312	3	usually	usually	RB
25944	2312	4	slow	slow	JJ
25944	2312	5	in	in	IN
25944	2312	6	its	-PRON-	PRP$
25944	2312	7	course	course	NN
25944	2312	8	,	,	,
25944	2312	9	beginning	begin	VBG
25944	2312	10	in	in	IN
25944	2312	11	childhood	childhood	NN
25944	2312	12	and	and	CC
25944	2312	13	lasting	last	VBG
25944	2312	14	for	for	IN
25944	2312	15	years	year	NNS
25944	2312	16	.	.	.
25944	2313	1	It	-PRON-	PRP
25944	2313	2	is	be	VBZ
25944	2313	3	not	not	RB
25944	2313	4	infrequently	infrequently	RB
25944	2313	5	seen	see	VBN
25944	2313	6	in	in	IN
25944	2313	7	several	several	JJ
25944	2313	8	children	child	NNS
25944	2313	9	of	of	IN
25944	2313	10	the	the	DT
25944	2313	11	same	same	JJ
25944	2313	12	family	family	NN
25944	2313	13	.	.	.
25944	2314	1	Treatment	treatment	NN
25944	2314	2	is	be	VBZ
25944	2314	3	palliative	palliative	JJ
25944	2314	4	,	,	,
25944	2314	5	consisting	consist	VBG
25944	2314	6	,	,	,
25944	2314	7	if	if	IN
25944	2314	8	necessary	necessary	JJ
25944	2314	9	,	,	,
25944	2314	10	of	of	IN
25944	2314	11	the	the	DT
25944	2314	12	use	use	NN
25944	2314	13	of	of	IN
25944	2314	14	protective	protective	JJ
25944	2314	15	applications	application	NNS
25944	2314	16	and	and	CC
25944	2314	17	of	of	IN
25944	2314	18	the	the	DT
25944	2314	19	administration	administration	NN
25944	2314	20	of	of	IN
25944	2314	21	tonics	tonic	NNS
25944	2314	22	and	and	CC
25944	2314	23	nutrients	nutrient	NNS
25944	2314	24	.	.	.
25944	2315	1	#	#	NN
25944	2315	2	Describe	Describe	NNP
25944	2315	3	atrophic	atrophic	JJ
25944	2315	4	lines	line	NNS
25944	2315	5	and	and	CC
25944	2315	6	spots	spot	NNS
25944	2315	7	.	.	.
25944	2315	8	#	#	$
25944	2315	9	Atrophic	atrophic	JJ
25944	2315	10	lines	line	NNS
25944	2315	11	and	and	CC
25944	2315	12	spots	spot	NNS
25944	2315	13	(	(	-LRB-
25944	2315	14	_	_	NNP
25944	2315	15	striæ	striæ	NNP
25944	2315	16	et	et	NNP
25944	2315	17	maculæ	maculæ	NN
25944	2315	18	atrophicæ	atrophicæ	NNP
25944	2315	19	_	_	NNP
25944	2315	20	)	)	-RRB-
25944	2315	21	may	may	MD
25944	2315	22	be	be	VB
25944	2315	23	idiopathic	idiopathic	JJ
25944	2315	24	or	or	CC
25944	2315	25	symptomatic	symptomatic	JJ
25944	2315	26	,	,	,
25944	2315	27	the	the	DT
25944	2315	28	lesions	lesion	NNS
25944	2315	29	consisting	consist	VBG
25944	2315	30	of	of	IN
25944	2315	31	scar	scar	NN
25944	2315	32	-	-	HYPH
25944	2315	33	like	like	JJ
25944	2315	34	or	or	CC
25944	2315	35	atrophic	atrophic	NN
25944	2315	36	-	-	HYPH
25944	2315	37	looking	look	VBG
25944	2315	38	,	,	,
25944	2315	39	whitish	whitish	JJ
25944	2315	40	lines	line	NNS
25944	2315	41	and	and	CC
25944	2315	42	macules	macule	NNS
25944	2315	43	,	,	,
25944	2315	44	most	most	RBS
25944	2315	45	commonly	commonly	RB
25944	2315	46	seen	see	VBN
25944	2315	47	on	on	IN
25944	2315	48	the	the	DT
25944	2315	49	trunk	trunk	NN
25944	2315	50	.	.	.
25944	2316	1	They	-PRON-	PRP
25944	2316	2	are	be	VBP
25944	2316	3	smooth	smooth	JJ
25944	2316	4	and	and	CC
25944	2316	5	glistening	glisten	VBG
25944	2316	6	.	.	.
25944	2317	1	Slight	slight	JJ
25944	2317	2	hyperæmia	hyperæmia	NN
25944	2317	3	usually	usually	RB
25944	2317	4	precedes	precede	VBZ
25944	2317	5	their	-PRON-	PRP$
25944	2317	6	formation	formation	NN
25944	2317	7	.	.	.
25944	2318	1	As	as	IN
25944	2318	2	an	an	DT
25944	2318	3	idiopathic	idiopathic	JJ
25944	2318	4	disease	disease	NN
25944	2318	5	its	-PRON-	PRP$
25944	2318	6	course	course	NN
25944	2318	7	is	be	VBZ
25944	2318	8	insidious	insidious	JJ
25944	2318	9	and	and	CC
25944	2318	10	slow	slow	JJ
25944	2318	11	,	,	,
25944	2318	12	and	and	CC
25944	2318	13	its	-PRON-	PRP$
25944	2318	14	progress	progress	NN
25944	2318	15	eventually	eventually	RB
25944	2318	16	stayed	stay	VBD
25944	2318	17	.	.	.
25944	2319	1	The	the	DT
25944	2319	2	so	so	RB
25944	2319	3	-	-	HYPH
25944	2319	4	called	call	VBN
25944	2319	5	_	_	NNP
25944	2319	6	lineæ	lineæ	NN
25944	2319	7	albicantes	albicante	VBZ
25944	2319	8	_	_	NNP
25944	2319	9	,	,	,
25944	2319	10	resulting	result	VBG
25944	2319	11	from	from	IN
25944	2319	12	the	the	DT
25944	2319	13	stretching	stretching	NN
25944	2319	14	of	of	IN
25944	2319	15	the	the	DT
25944	2319	16	skin	skin	NN
25944	2319	17	produced	produce	VBN
25944	2319	18	by	by	IN
25944	2319	19	pregnancy	pregnancy	NN
25944	2319	20	or	or	CC
25944	2319	21	tumors	tumor	NNS
25944	2319	22	,	,	,
25944	2319	23	and	and	CC
25944	2319	24	from	from	IN
25944	2319	25	rapid	rapid	JJ
25944	2319	26	development	development	NN
25944	2319	27	of	of	IN
25944	2319	28	fat	fat	NN
25944	2319	29	,	,	,
25944	2319	30	may	may	MD
25944	2319	31	be	be	VB
25944	2319	32	mentioned	mention	VBN
25944	2319	33	as	as	IN
25944	2319	34	illustrating	illustrate	VBG
25944	2319	35	the	the	DT
25944	2319	36	symptomatic	symptomatic	JJ
25944	2319	37	variety	variety	NN
25944	2319	38	.	.	.
25944	2320	1	In	in	IN
25944	2320	2	course	course	NN
25944	2320	3	of	of	IN
25944	2320	4	time	time	NN
25944	2320	5	the	the	DT
25944	2320	6	atrophy	atrophy	NN
25944	2320	7	becomes	become	VBZ
25944	2320	8	less	less	RBR
25944	2320	9	conspicuous	conspicuous	JJ
25944	2320	10	.	.	.
25944	2321	1	#	#	NNP
25944	2321	2	Describe	describe	VBP
25944	2321	3	senile	senile	JJ
25944	2321	4	atrophy	atrophy	NN
25944	2321	5	.	.	.
25944	2321	6	#	#	$
25944	2321	7	Senile	senile	JJ
25944	2321	8	atrophy	atrophy	NN
25944	2321	9	is	be	VBZ
25944	2321	10	not	not	RB
25944	2321	11	uncommon	uncommon	JJ
25944	2321	12	,	,	,
25944	2321	13	the	the	DT
25944	2321	14	atrophy	atrophy	NN
25944	2321	15	resulting	result	VBG
25944	2321	16	,	,	,
25944	2321	17	as	as	IN
25944	2321	18	the	the	DT
25944	2321	19	name	name	NN
25944	2321	20	inferentially	inferentially	RB
25944	2321	21	implies	imply	VBZ
25944	2321	22	,	,	,
25944	2321	23	from	from	IN
25944	2321	24	advancing	advance	VBG
25944	2321	25	age	age	NN
25944	2321	26	.	.	.
25944	2322	1	It	-PRON-	PRP
25944	2322	2	is	be	VBZ
25944	2322	3	characterized	characterize	VBN
25944	2322	4	by	by	IN
25944	2322	5	thinning	thin	VBG
25944	2322	6	and	and	CC
25944	2322	7	wasting	waste	VBG
25944	2322	8	,	,	,
25944	2322	9	dryness	dryness	NN
25944	2322	10	,	,	,
25944	2322	11	and	and	CC
25944	2322	12	a	a	DT
25944	2322	13	wrinkled	wrinkle	VBN
25944	2322	14	condition	condition	NN
25944	2322	15	,	,	,
25944	2322	16	with	with	IN
25944	2322	17	more	more	JJR
25944	2322	18	or	or	CC
25944	2322	19	less	less	JJR
25944	2322	20	pigmentation	pigmentation	NN
25944	2322	21	and	and	CC
25944	2322	22	loss	loss	NN
25944	2322	23	of	of	IN
25944	2322	24	hair	hair	NN
25944	2322	25	.	.	.
25944	2323	1	Circumscribed	circumscribe	VBN
25944	2323	2	pigmentary	pigmentary	NN
25944	2323	3	deposits	deposit	NNS
25944	2323	4	and	and	CC
25944	2323	5	seborrh[oe]a	seborrh[oe]a	NNP
25944	2323	6	,	,	,
25944	2323	7	with	with	IN
25944	2323	8	degeneration	degeneration	NN
25944	2323	9	,	,	,
25944	2323	10	are	be	VBP
25944	2323	11	also	also	RB
25944	2323	12	noted	note	VBN
25944	2323	13	.	.	.
25944	2324	1	#	#	$
25944	2324	2	What	what	WDT
25944	2324	3	several	several	JJ
25944	2324	4	diseases	disease	NNS
25944	2324	5	of	of	IN
25944	2324	6	the	the	DT
25944	2324	7	skin	skin	NN
25944	2324	8	are	be	VBP
25944	2324	9	commonly	commonly	RB
25944	2324	10	followed	follow	VBN
25944	2324	11	by	by	IN
25944	2324	12	atrophic	atrophic	JJ
25944	2324	13	changes	change	NNS
25944	2324	14	?	?	.
25944	2324	15	#	#	NNP
25944	2324	16	Favus	Favus	NNP
25944	2324	17	,	,	,
25944	2324	18	lupus	lupus	NN
25944	2324	19	,	,	,
25944	2324	20	syphilis	syphilis	NNP
25944	2324	21	,	,	,
25944	2324	22	leprosy	leprosy	NN
25944	2324	23	,	,	,
25944	2324	24	scleroderma	scleroderma	NNP
25944	2324	25	and	and	CC
25944	2324	26	morph[oe]a	morph[oe]a	NNP
25944	2324	27	.	.	.
25944	2325	1	#	#	$
25944	2325	2	CLASS	class	NN
25944	2325	3	VI.--NEW	VI.--NEW	NNS
25944	2325	4	GROWTHS	GROWTHS	NNP
25944	2325	5	.	.	.
25944	2325	6	#	#	$
25944	2325	7	#	#	$
25944	2325	8	Keloid	Keloid	NNP
25944	2325	9	.	.	.
25944	2325	10	#	#	NNP
25944	2325	11	(	(	-LRB-
25944	2325	12	_	_	NNP
25944	2325	13	Synonyms	Synonyms	NNP
25944	2325	14	:	:	:
25944	2325	15	_	_	NNP
25944	2325	16	Keloid	Keloid	NNP
25944	2325	17	of	of	IN
25944	2325	18	Alibert	Alibert	NNP
25944	2325	19	;	;	:
25944	2325	20	Cheloid	Cheloid	NNP
25944	2325	21	.	.	.
25944	2325	22	)	)	-RRB-
25944	2326	1	#	#	NN
25944	2326	2	Give	give	VBP
25944	2326	3	a	a	DT
25944	2326	4	descriptive	descriptive	JJ
25944	2326	5	definition	definition	NN
25944	2326	6	of	of	IN
25944	2326	7	keloid	keloid	NN
25944	2326	8	.	.	.
25944	2326	9	#	#	NNP
25944	2326	10	Keloid	Keloid	NNP
25944	2326	11	is	be	VBZ
25944	2326	12	a	a	DT
25944	2326	13	fibro	fibro	JJ
25944	2326	14	-	-	HYPH
25944	2326	15	cellular	cellular	JJ
25944	2326	16	new	new	JJ
25944	2326	17	growth	growth	NN
25944	2326	18	of	of	IN
25944	2326	19	the	the	DT
25944	2326	20	corium	corium	NN
25944	2326	21	appearing	appear	VBG
25944	2326	22	as	as	IN
25944	2326	23	one	one	CD
25944	2326	24	or	or	CC
25944	2326	25	several	several	JJ
25944	2326	26	variously	variously	RB
25944	2326	27	-	-	HYPH
25944	2326	28	sized	sized	JJ
25944	2326	29	,	,	,
25944	2326	30	irregularly	irregularly	RB
25944	2326	31	-	-	HYPH
25944	2326	32	shaped	shape	VBN
25944	2326	33	,	,	,
25944	2326	34	elevated	elevated	JJ
25944	2326	35	,	,	,
25944	2326	36	smooth	smooth	JJ
25944	2326	37	,	,	,
25944	2326	38	firm	firm	JJ
25944	2326	39	,	,	,
25944	2326	40	pinkish	pinkish	JJ
25944	2326	41	or	or	CC
25944	2326	42	pale	pale	JJ
25944	2326	43	-	-	HYPH
25944	2326	44	reddish	reddish	JJ
25944	2326	45	cicatriform	cicatriform	JJ
25944	2326	46	lesions	lesion	NNS
25944	2326	47	.	.	.
25944	2327	1	#	#	NNP
25944	2327	2	Describe	describe	VB
25944	2327	3	the	the	DT
25944	2327	4	clinical	clinical	JJ
25944	2327	5	appearance	appearance	NN
25944	2327	6	of	of	IN
25944	2327	7	keloid	keloid	NNP
25944	2327	8	.	.	.
25944	2327	9	#	#	$
25944	2327	10	The	the	DT
25944	2327	11	growth	growth	NN
25944	2327	12	begins	begin	VBZ
25944	2327	13	as	as	IN
25944	2327	14	a	a	DT
25944	2327	15	small	small	JJ
25944	2327	16	,	,	,
25944	2327	17	hard	hard	JJ
25944	2327	18	,	,	,
25944	2327	19	elevated	elevated	JJ
25944	2327	20	,	,	,
25944	2327	21	pinkish	pinkish	JJ
25944	2327	22	or	or	CC
25944	2327	23	reddish	reddish	JJ
25944	2327	24	tubercle	tubercle	NN
25944	2327	25	,	,	,
25944	2327	26	increasing	increase	VBG
25944	2327	27	gradually	gradually	RB
25944	2327	28	,	,	,
25944	2327	29	several	several	JJ
25944	2327	30	months	month	NNS
25944	2327	31	or	or	CC
25944	2327	32	years	year	NNS
25944	2327	33	usually	usually	RB
25944	2327	34	elapsing	elapse	VBG
25944	2327	35	before	before	IN
25944	2327	36	the	the	DT
25944	2327	37	tumor	tumor	NN
25944	2327	38	reaches	reach	VBZ
25944	2327	39	conspicuous	conspicuous	JJ
25944	2327	40	size	size	NN
25944	2327	41	.	.	.
25944	2328	1	When	when	WRB
25944	2328	2	developed	develop	VBN
25944	2328	3	,	,	,
25944	2328	4	it	-PRON-	PRP
25944	2328	5	is	be	VBZ
25944	2328	6	one	one	CD
25944	2328	7	or	or	CC
25944	2328	8	more	more	JJR
25944	2328	9	inches	inch	NNS
25944	2328	10	in	in	IN
25944	2328	11	diameter	diameter	NN
25944	2328	12	,	,	,
25944	2328	13	is	be	VBZ
25944	2328	14	sharply	sharply	RB
25944	2328	15	defined	define	VBN
25944	2328	16	,	,	,
25944	2328	17	elevated	elevated	JJ
25944	2328	18	,	,	,
25944	2328	19	hard	hard	RB
25944	2328	20	,	,	,
25944	2328	21	rounded	rounded	JJ
25944	2328	22	or	or	CC
25944	2328	23	oval	oval	JJ
25944	2328	24	,	,	,
25944	2328	25	fungoid	fungoid	JJ
25944	2328	26	or	or	CC
25944	2328	27	crab	crab	NN
25944	2328	28	-	-	HYPH
25944	2328	29	shaped	shape	VBN
25944	2328	30	,	,	,
25944	2328	31	and	and	CC
25944	2328	32	firmly	firmly	RB
25944	2328	33	implanted	implant	VBD
25944	2328	34	in	in	IN
25944	2328	35	the	the	DT
25944	2328	36	skin	skin	NN
25944	2328	37	.	.	.
25944	2329	1	It	-PRON-	PRP
25944	2329	2	is	be	VBZ
25944	2329	3	usually	usually	RB
25944	2329	4	pinkish	pinkish	JJ
25944	2329	5	,	,	,
25944	2329	6	pearl	pearl	NN
25944	2329	7	-	-	HYPH
25944	2329	8	white	white	JJ
25944	2329	9	,	,	,
25944	2329	10	or	or	CC
25944	2329	11	reddish	reddish	JJ
25944	2329	12	,	,	,
25944	2329	13	commonly	commonly	RB
25944	2329	14	devoid	devoid	JJ
25944	2329	15	of	of	IN
25944	2329	16	hair	hair	NN
25944	2329	17	,	,	,
25944	2329	18	with	with	IN
25944	2329	19	no	no	DT
25944	2329	20	tendency	tendency	NN
25944	2329	21	to	to	TO
25944	2329	22	scaliness	scaliness	VB
25944	2329	23	,	,	,
25944	2329	24	and	and	CC
25944	2329	25	with	with	IN
25944	2329	26	,	,	,
25944	2329	27	usually	usually	RB
25944	2329	28	,	,	,
25944	2329	29	several	several	JJ
25944	2329	30	vessels	vessel	NNS
25944	2329	31	coursing	course	VBG
25944	2329	32	over	over	IN
25944	2329	33	it	-PRON-	PRP
25944	2329	34	.	.	.
25944	2330	1	In	in	IN
25944	2330	2	some	some	DT
25944	2330	3	instances	instance	NNS
25944	2330	4	it	-PRON-	PRP
25944	2330	5	is	be	VBZ
25944	2330	6	tender	tender	JJ
25944	2330	7	,	,	,
25944	2330	8	and	and	CC
25944	2330	9	it	-PRON-	PRP
25944	2330	10	may	may	MD
25944	2330	11	be	be	VB
25944	2330	12	spontaneously	spontaneously	RB
25944	2330	13	painful	painful	JJ
25944	2330	14	.	.	.
25944	2331	1	The	the	DT
25944	2331	2	breast	breast	NN
25944	2331	3	,	,	,
25944	2331	4	especially	especially	RB
25944	2331	5	over	over	IN
25944	2331	6	the	the	DT
25944	2331	7	sternal	sternal	JJ
25944	2331	8	region	region	NN
25944	2331	9	,	,	,
25944	2331	10	is	be	VBZ
25944	2331	11	a	a	DT
25944	2331	12	favorite	favorite	JJ
25944	2331	13	site	site	NN
25944	2331	14	for	for	IN
25944	2331	15	its	-PRON-	PRP$
25944	2331	16	appearance	appearance	NN
25944	2331	17	.	.	.
25944	2332	1	One	one	CD
25944	2332	2	,	,	,
25944	2332	3	several	several	JJ
25944	2332	4	or	or	CC
25944	2332	5	more	more	JJR
25944	2332	6	may	may	MD
25944	2332	7	be	be	VB
25944	2332	8	present	present	JJ
25944	2332	9	in	in	IN
25944	2332	10	the	the	DT
25944	2332	11	single	single	JJ
25944	2332	12	case	case	NN
25944	2332	13	.	.	.
25944	2333	1	#	#	LS
25944	2333	2	What	what	WDT
25944	2333	3	course	course	NN
25944	2333	4	does	do	VBZ
25944	2333	5	keloid	keloid	VB
25944	2333	6	pursue	pursue	VB
25944	2333	7	?	?	.
25944	2333	8	#	#	NN
25944	2333	9	Chronic	chronic	JJ
25944	2333	10	;	;	:
25944	2333	11	usually	usually	RB
25944	2333	12	lasting	last	VBG
25944	2333	13	throughout	throughout	IN
25944	2333	14	life	life	NN
25944	2333	15	.	.	.
25944	2334	1	In	in	IN
25944	2334	2	rare	rare	JJ
25944	2334	3	instances	instance	NNS
25944	2334	4	spontaneous	spontaneous	JJ
25944	2334	5	involution	involution	NN
25944	2334	6	takes	take	VBZ
25944	2334	7	place	place	NN
25944	2334	8	.	.	.
25944	2335	1	#	#	NNP
25944	2335	2	State	state	NN
25944	2335	3	the	the	DT
25944	2335	4	etiology	etiology	NN
25944	2335	5	of	of	IN
25944	2335	6	keloid	keloid	NNP
25944	2335	7	.	.	.
25944	2335	8	#	#	$
25944	2335	9	The	the	DT
25944	2335	10	causes	cause	NNS
25944	2335	11	are	be	VBP
25944	2335	12	obscure	obscure	JJ
25944	2335	13	.	.	.
25944	2336	1	The	the	DT
25944	2336	2	growth	growth	NN
25944	2336	3	usually	usually	RB
25944	2336	4	takes	take	VBZ
25944	2336	5	its	-PRON-	PRP$
25944	2336	6	start	start	NN
25944	2336	7	from	from	IN
25944	2336	8	some	some	DT
25944	2336	9	injury	injury	NN
25944	2336	10	or	or	CC
25944	2336	11	lesion	lesion	NN
25944	2336	12	of	of	IN
25944	2336	13	continuity	continuity	NN
25944	2336	14	;	;	:
25944	2336	15	for	for	IN
25944	2336	16	instance	instance	NN
25944	2336	17	,	,	,
25944	2336	18	at	at	IN
25944	2336	19	the	the	DT
25944	2336	20	site	site	NN
25944	2336	21	of	of	IN
25944	2336	22	burns	burn	NNS
25944	2336	23	,	,	,
25944	2336	24	cuts	cut	NNS
25944	2336	25	,	,	,
25944	2336	26	acne	acne	NNS
25944	2336	27	and	and	CC
25944	2336	28	smallpox	smallpox	NN
25944	2336	29	scars	scar	NNS
25944	2336	30	,	,	,
25944	2336	31	etc.--_cicatricial	etc.--_cicatricial	.
25944	2336	32	keloid	keloid	NNP
25944	2336	33	,	,	,
25944	2336	34	false	false	JJ
25944	2336	35	keloid	keloid	NN
25944	2336	36	_	_	NNP
25944	2336	37	;	;	:
25944	2336	38	or	or	CC
25944	2336	39	it	-PRON-	PRP
25944	2336	40	may	may	MD
25944	2336	41	also	also	RB
25944	2336	42	,	,	,
25944	2336	43	so	so	CC
25944	2336	44	it	-PRON-	PRP
25944	2336	45	is	be	VBZ
25944	2336	46	thought	think	VBN
25944	2336	47	,	,	,
25944	2336	48	originate	originate	VBP
25944	2336	49	in	in	IN
25944	2336	50	normal	normal	JJ
25944	2336	51	skin--_spontaneous	skin--_spontaneous	JJ
25944	2336	52	keloid	keloid	NN
25944	2336	53	,	,	,
25944	2336	54	true	true	JJ
25944	2336	55	keloid	keloid	NNP
25944	2336	56	_	_	NNP
25944	2336	57	.	.	.
25944	2337	1	#	#	LS
25944	2337	2	What	what	WP
25944	2337	3	is	be	VBZ
25944	2337	4	the	the	DT
25944	2337	5	pathology	pathology	NN
25944	2337	6	of	of	IN
25944	2337	7	keloid	keloid	NN
25944	2337	8	?	?	.
25944	2337	9	#	#	$
25944	2337	10	The	the	DT
25944	2337	11	lesion	lesion	NN
25944	2337	12	is	be	VBZ
25944	2337	13	a	a	DT
25944	2337	14	connective	connective	JJ
25944	2337	15	-	-	HYPH
25944	2337	16	tissue	tissue	NN
25944	2337	17	new	new	JJ
25944	2337	18	growth	growth	NN
25944	2337	19	having	have	VBG
25944	2337	20	its	-PRON-	PRP$
25944	2337	21	seat	seat	NN
25944	2337	22	in	in	IN
25944	2337	23	the	the	DT
25944	2337	24	corium	corium	NN
25944	2337	25	.	.	.
25944	2338	1	#	#	$
25944	2338	2	Is	be	VBZ
25944	2338	3	there	there	EX
25944	2338	4	any	any	DT
25944	2338	5	difficulty	difficulty	NN
25944	2338	6	in	in	IN
25944	2338	7	the	the	DT
25944	2338	8	diagnosis	diagnosis	NN
25944	2338	9	of	of	IN
25944	2338	10	keloid	keloid	NNP
25944	2338	11	?	?	.
25944	2338	12	#	#	NN
25944	2338	13	No	no	UH
25944	2338	14	.	.	.
25944	2339	1	It	-PRON-	PRP
25944	2339	2	resembles	resemble	VBZ
25944	2339	3	hypertrophic	hypertrophic	JJ
25944	2339	4	scar	scar	NN
25944	2339	5	;	;	:
25944	2339	6	but	but	CC
25944	2339	7	this	this	DT
25944	2339	8	latter	latter	JJ
25944	2339	9	,	,	,
25944	2339	10	which	which	WDT
25944	2339	11	is	be	VBZ
25944	2339	12	essentially	essentially	RB
25944	2339	13	keloidal	keloidal	NNP
25944	2339	14	,	,	,
25944	2339	15	never	never	RB
25944	2339	16	extends	extend	VBZ
25944	2339	17	beyond	beyond	IN
25944	2339	18	the	the	DT
25944	2339	19	line	line	NN
25944	2339	20	of	of	IN
25944	2339	21	injury	injury	NN
25944	2339	22	.	.	.
25944	2340	1	#	#	NN
25944	2340	2	Give	give	VB
25944	2340	3	the	the	DT
25944	2340	4	prognosis	prognosis	NN
25944	2340	5	.	.	.
25944	2340	6	#	#	$
25944	2340	7	The	the	DT
25944	2340	8	growth	growth	NN
25944	2340	9	is	be	VBZ
25944	2340	10	persistent	persistent	JJ
25944	2340	11	and	and	CC
25944	2340	12	usually	usually	RB
25944	2340	13	irresponsive	irresponsive	JJ
25944	2340	14	to	to	IN
25944	2340	15	treatment	treatment	NN
25944	2340	16	.	.	.
25944	2341	1	In	in	IN
25944	2341	2	some	some	DT
25944	2341	3	cases	case	NNS
25944	2341	4	,	,	,
25944	2341	5	however	however	RB
25944	2341	6	,	,	,
25944	2341	7	there	there	EX
25944	2341	8	is	be	VBZ
25944	2341	9	eventually	eventually	RB
25944	2341	10	a	a	DT
25944	2341	11	tendency	tendency	NN
25944	2341	12	to	to	IN
25944	2341	13	spontaneous	spontaneous	JJ
25944	2341	14	retrogression	retrogression	NN
25944	2341	15	,	,	,
25944	2341	16	up	up	IN
25944	2341	17	to	to	IN
25944	2341	18	a	a	DT
25944	2341	19	certain	certain	JJ
25944	2341	20	point	point	NN
25944	2341	21	at	at	IN
25944	2341	22	least	least	JJS
25944	2341	23	.	.	.
25944	2342	1	#	#	LS
25944	2342	2	What	what	WP
25944	2342	3	is	be	VBZ
25944	2342	4	the	the	DT
25944	2342	5	treatment	treatment	NN
25944	2342	6	of	of	IN
25944	2342	7	keloid	keloid	NN
25944	2342	8	?	?	.
25944	2342	9	#	#	NN
25944	2342	10	Usually	usually	RB
25944	2342	11	palliative	palliative	JJ
25944	2342	12	,	,	,
25944	2342	13	consisting	consist	VBG
25944	2342	14	of	of	IN
25944	2342	15	the	the	DT
25944	2342	16	continuous	continuous	JJ
25944	2342	17	application	application	NN
25944	2342	18	of	of	IN
25944	2342	19	an	an	DT
25944	2342	20	ointment	ointment	NN
25944	2342	21	such	such	JJ
25944	2342	22	as	as	IN
25944	2342	23	the	the	DT
25944	2342	24	following:--	following:--	NN
25944	2342	25	[	[	-LRB-
25944	2342	26	Rx	Rx	NNP
25944	2342	27	]	]	-RRB-
25944	2342	28	Acidi	Acidi	NNP
25944	2342	29	salicylici	salicylici	NNS
25944	2342	30	,	,	,
25944	2342	31	....................	....................	NFP
25944	2342	32	gr	gr	NNP
25944	2342	33	.	.	.
25944	2343	1	x	x	LS
25944	2343	2	-	-	:
25944	2343	3	xx	xx	NNP
25944	2343	4	Emplast	Emplast	NNP
25944	2343	5	.	.	.
25944	2344	1	plumbi	plumbi	NNP
25944	2344	2	,	,	,
25944	2344	3	Emplast	Emplast	NNP
25944	2344	4	.	.	.
25944	2345	1	saponis	saponis	NNP
25944	2345	2	,	,	,
25944	2345	3	...	...	NFP
25944	2345	4	[	[	-LRB-
25944	2345	5	=	=	SYM
25944	2345	6	a][=a	a][=a	CD
25944	2345	7	]	]	-RRB-
25944	2345	8	.......	.......	.
25944	2345	9	[	[	-LRB-
25944	2345	10	dram]iij	dram]iij	NNP
25944	2345	11	Petrolati	Petrolati	NNP
25944	2345	12	,	,	,
25944	2345	13	...........................	...........................	NFP
25944	2345	14	[	[	-LRB-
25944	2345	15	dram]ij	dram]ij	NN
25944	2345	16	.	.	.
25944	2346	1	M.	M.	NNP
25944	2346	2	An	An	NNP
25944	2346	3	ointment	ointment	NN
25944	2346	4	of	of	IN
25944	2346	5	ichthyol	ichthyol	JJ
25944	2346	6	,	,	,
25944	2346	7	twenty	twenty	CD
25944	2346	8	-	-	HYPH
25944	2346	9	five	five	CD
25944	2346	10	per	per	IN
25944	2346	11	cent	cent	NN
25944	2346	12	.	.	.
25944	2347	1	strength	strength	NN
25944	2347	2	,	,	,
25944	2347	3	rubbed	rub	VBN
25944	2347	4	in	in	IN
25944	2347	5	once	once	RB
25944	2347	6	or	or	CC
25944	2347	7	twice	twice	RB
25944	2347	8	daily	daily	RB
25944	2347	9	,	,	,
25944	2347	10	is	be	VBZ
25944	2347	11	sometimes	sometimes	RB
25944	2347	12	beneficial	beneficial	JJ
25944	2347	13	.	.	.
25944	2348	1	Operative	operative	JJ
25944	2348	2	measures	measure	NNS
25944	2348	3	,	,	,
25944	2348	4	such	such	JJ
25944	2348	5	as	as	IN
25944	2348	6	punctate	punctate	NN
25944	2348	7	and	and	CC
25944	2348	8	linear	linear	JJ
25944	2348	9	scarification	scarification	NN
25944	2348	10	,	,	,
25944	2348	11	electrolysis	electrolysis	NN
25944	2348	12	and	and	CC
25944	2348	13	excision	excision	NN
25944	2348	14	,	,	,
25944	2348	15	are	be	VBP
25944	2348	16	occasionally	occasionally	RB
25944	2348	17	practised	practise	VBN
25944	2348	18	,	,	,
25944	2348	19	but	but	CC
25944	2348	20	the	the	DT
25944	2348	21	results	result	NNS
25944	2348	22	are	be	VBP
25944	2348	23	rarely	rarely	RB
25944	2348	24	satisfactory	satisfactory	JJ
25944	2348	25	and	and	CC
25944	2348	26	permanent	permanent	JJ
25944	2348	27	;	;	:
25944	2348	28	not	not	RB
25944	2348	29	infrequently	infrequently	RB
25944	2348	30	,	,	,
25944	2348	31	indeed	indeed	RB
25944	2348	32	,	,	,
25944	2348	33	renewed	renew	VBN
25944	2348	34	activity	activity	NN
25944	2348	35	in	in	IN
25944	2348	36	the	the	DT
25944	2348	37	progress	progress	NN
25944	2348	38	of	of	IN
25944	2348	39	the	the	DT
25944	2348	40	growth	growth	NN
25944	2348	41	is	be	VBZ
25944	2348	42	noted	note	VBN
25944	2348	43	to	to	TO
25944	2348	44	follow	follow	VB
25944	2348	45	.	.	.
25944	2349	1	The	the	DT
25944	2349	2	_	_	NNP
25944	2349	3	x_-ray	x_-ray	NN
25944	2349	4	can	can	MD
25944	2349	5	be	be	VB
25944	2349	6	tried	try	VBN
25944	2349	7	with	with	IN
25944	2349	8	some	some	DT
25944	2349	9	hope	hope	NN
25944	2349	10	of	of	IN
25944	2349	11	improvement	improvement	NN
25944	2349	12	.	.	.
25944	2350	1	The	the	DT
25944	2350	2	administration	administration	NN
25944	2350	3	of	of	IN
25944	2350	4	thyroid	thyroid	NNP
25944	2350	5	has	have	VBZ
25944	2350	6	been	be	VBN
25944	2350	7	thought	think	VBN
25944	2350	8	to	to	TO
25944	2350	9	have	have	VB
25944	2350	10	a	a	DT
25944	2350	11	possible	possible	JJ
25944	2350	12	influence	influence	NN
25944	2350	13	in	in	IN
25944	2350	14	some	some	DT
25944	2350	15	instances	instance	NNS
25944	2350	16	.	.	.
25944	2351	1	#	#	NNP
25944	2351	2	Fibroma	Fibroma	NNP
25944	2351	3	.	.	.
25944	2351	4	#	#	NNP
25944	2351	5	(	(	-LRB-
25944	2351	6	_	_	NNP
25944	2351	7	Synonyms	Synonyms	NNP
25944	2351	8	:	:	:
25944	2351	9	_	_	NNP
25944	2351	10	Molluscum	Molluscum	NNP
25944	2351	11	Fibrosum	Fibrosum	NNP
25944	2351	12	;	;	:
25944	2351	13	Fibroma	Fibroma	NNP
25944	2351	14	Molluscum	Molluscum	NNP
25944	2351	15	.	.	.
25944	2351	16	)	)	-RRB-
25944	2352	1	#	#	LS
25944	2352	2	What	what	WP
25944	2352	3	do	do	VBP
25944	2352	4	you	-PRON-	PRP
25944	2352	5	understand	understand	VB
25944	2352	6	by	by	IN
25944	2352	7	fibroma	fibroma	NNP
25944	2352	8	?	?	.
25944	2352	9	#	#	$
25944	2352	10	Fibroma	Fibroma	NNP
25944	2352	11	is	be	VBZ
25944	2352	12	a	a	DT
25944	2352	13	connective	connective	JJ
25944	2352	14	-	-	HYPH
25944	2352	15	tissue	tissue	NN
25944	2352	16	new	new	JJ
25944	2352	17	growth	growth	NN
25944	2352	18	characterized	characterize	VBN
25944	2352	19	by	by	IN
25944	2352	20	one	one	CD
25944	2352	21	or	or	CC
25944	2352	22	more	more	JJR
25944	2352	23	sessile	sessile	JJ
25944	2352	24	or	or	CC
25944	2352	25	pedunculated	pedunculate	VBN
25944	2352	26	,	,	,
25944	2352	27	pea-	pea-	RB
25944	2352	28	to	to	IN
25944	2352	29	egg	egg	NN
25944	2352	30	-	-	HYPH
25944	2352	31	sized	sized	JJ
25944	2352	32	or	or	CC
25944	2352	33	larger	large	JJR
25944	2352	34	,	,	,
25944	2352	35	soft	soft	JJ
25944	2352	36	or	or	CC
25944	2352	37	firm	firm	JJ
25944	2352	38	,	,	,
25944	2352	39	rounded	rounded	JJ
25944	2352	40	,	,	,
25944	2352	41	painless	painless	JJ
25944	2352	42	tumors	tumor	NNS
25944	2352	43	,	,	,
25944	2352	44	seated	seat	VBN
25944	2352	45	beneath	beneath	IN
25944	2352	46	and	and	CC
25944	2352	47	in	in	IN
25944	2352	48	the	the	DT
25944	2352	49	skin	skin	NN
25944	2352	50	.	.	.
25944	2353	1	#	#	NNP
25944	2353	2	Describe	describe	VB
25944	2353	3	the	the	DT
25944	2353	4	clinical	clinical	JJ
25944	2353	5	appearances	appearance	NNS
25944	2353	6	of	of	IN
25944	2353	7	fibroma	fibroma	NN
25944	2353	8	.	.	.
25944	2353	9	#	#	$
25944	2353	10	The	the	DT
25944	2353	11	growth	growth	NN
25944	2353	12	may	may	MD
25944	2353	13	be	be	VB
25944	2353	14	single	single	JJ
25944	2353	15	,	,	,
25944	2353	16	in	in	IN
25944	2353	17	which	which	WDT
25944	2353	18	case	case	NN
25944	2353	19	it	-PRON-	PRP
25944	2353	20	is	be	VBZ
25944	2353	21	apt	apt	JJ
25944	2353	22	to	to	TO
25944	2353	23	be	be	VB
25944	2353	24	pedunculated	pedunculate	VBN
25944	2353	25	or	or	CC
25944	2353	26	pendulous	pendulous	JJ
25944	2353	27	,	,	,
25944	2353	28	and	and	CC
25944	2353	29	attain	attain	VB
25944	2353	30	considerable	considerable	JJ
25944	2353	31	dimensions	dimension	NNS
25944	2353	32	;	;	:
25944	2353	33	as	as	IN
25944	2353	34	a	a	DT
25944	2353	35	result	result	NN
25944	2353	36	of	of	IN
25944	2353	37	weight	weight	NN
25944	2353	38	or	or	CC
25944	2353	39	pressure	pressure	NN
25944	2353	40	surface	surface	NN
25944	2353	41	-	-	HYPH
25944	2353	42	ulceration	ulceration	NN
25944	2353	43	may	may	MD
25944	2353	44	occur	occur	VB
25944	2353	45	.	.	.
25944	2354	1	Or	or	CC
25944	2354	2	,	,	,
25944	2354	3	as	as	IN
25944	2354	4	commonly	commonly	RB
25944	2354	5	met	meet	VBN
25944	2354	6	with	with	IN
25944	2354	7	,	,	,
25944	2354	8	the	the	DT
25944	2354	9	lesions	lesion	NNS
25944	2354	10	are	be	VBP
25944	2354	11	numerous	numerous	JJ
25944	2354	12	,	,	,
25944	2354	13	scattered	scatter	VBN
25944	2354	14	over	over	IN
25944	2354	15	large	large	JJ
25944	2354	16	surface	surface	NN
25944	2354	17	,	,	,
25944	2354	18	and	and	CC
25944	2354	19	vary	vary	VBP
25944	2354	20	in	in	IN
25944	2354	21	size	size	NN
25944	2354	22	from	from	IN
25944	2354	23	a	a	DT
25944	2354	24	pea	pea	NN
25944	2354	25	to	to	IN
25944	2354	26	a	a	DT
25944	2354	27	cherry	cherry	NN
25944	2354	28	;	;	:
25944	2354	29	the	the	DT
25944	2354	30	overlying	overlying	NN
25944	2354	31	skin	skin	NN
25944	2354	32	being	be	VBG
25944	2354	33	normal	normal	JJ
25944	2354	34	,	,	,
25944	2354	35	pinkish	pinkish	JJ
25944	2354	36	or	or	CC
25944	2354	37	reddish	reddish	JJ
25944	2354	38	,	,	,
25944	2354	39	loose	loose	JJ
25944	2354	40	,	,	,
25944	2354	41	stretched	stretched	JJ
25944	2354	42	,	,	,
25944	2354	43	hypertrophied	hypertrophied	JJ
25944	2354	44	or	or	CC
25944	2354	45	atrophied	atrophy	VBN
25944	2354	46	.	.	.
25944	2355	1	The	the	DT
25944	2355	2	tumors	tumor	NNS
25944	2355	3	are	be	VBP
25944	2355	4	painless	painless	JJ
25944	2355	5	.	.	.
25944	2356	1	The	the	DT
25944	2356	2	general	general	JJ
25944	2356	3	health	health	NN
25944	2356	4	is	be	VBZ
25944	2356	5	not	not	RB
25944	2356	6	involved	involve	VBN
25944	2356	7	.	.	.
25944	2357	1	[	[	-LRB-
25944	2357	2	Illustration	illustration	NN
25944	2357	3	:	:	:
25944	2357	4	Fig	Fig	NNP
25944	2357	5	.	.	.
25944	2358	1	41	41	CD
25944	2358	2	.	.	.
25944	2359	1	Fibroma	Fibroma	NNP
25944	2359	2	.	.	.
25944	2360	1	(	(	-LRB-
25944	2360	2	_	_	NNP
25944	2360	3	After	after	IN
25944	2360	4	Octerlony	Octerlony	NNP
25944	2360	5	.	.	.
25944	2360	6	_	_	NNP
25944	2360	7	)	)	-RRB-
25944	2360	8	]	]	-RRB-
25944	2360	9	#	#	$
25944	2360	10	What	what	WP
25944	2360	11	is	be	VBZ
25944	2360	12	the	the	DT
25944	2360	13	course	course	NN
25944	2360	14	of	of	IN
25944	2360	15	fibroma	fibroma	NN
25944	2360	16	?	?	.
25944	2360	17	#	#	$
25944	2360	18	Chronic	chronic	JJ
25944	2360	19	and	and	CC
25944	2360	20	persistent	persistent	JJ
25944	2360	21	.	.	.
25944	2361	1	#	#	LS
25944	2361	2	What	what	WP
25944	2361	3	is	be	VBZ
25944	2361	4	the	the	DT
25944	2361	5	etiology	etiology	NN
25944	2361	6	of	of	IN
25944	2361	7	fibroma	fibroma	NNP
25944	2361	8	?	?	.
25944	2361	9	#	#	$
25944	2361	10	The	the	DT
25944	2361	11	cause	cause	NN
25944	2361	12	is	be	VBZ
25944	2361	13	not	not	RB
25944	2361	14	known	know	VBN
25944	2361	15	.	.	.
25944	2362	1	Heredity	heredity	NN
25944	2362	2	is	be	VBZ
25944	2362	3	often	often	RB
25944	2362	4	noted	note	VBN
25944	2362	5	.	.	.
25944	2363	1	The	the	DT
25944	2363	2	affection	affection	NN
25944	2363	3	is	be	VBZ
25944	2363	4	not	not	RB
25944	2363	5	common	common	JJ
25944	2363	6	.	.	.
25944	2364	1	#	#	NNP
25944	2364	2	State	state	NN
25944	2364	3	the	the	DT
25944	2364	4	pathology	pathology	NN
25944	2364	5	of	of	IN
25944	2364	6	fibroma	fibroma	NN
25944	2364	7	.	.	.
25944	2364	8	#	#	$
25944	2364	9	The	the	DT
25944	2364	10	growths	growth	NNS
25944	2364	11	are	be	VBP
25944	2364	12	variously	variously	RB
25944	2364	13	thought	think	VBN
25944	2364	14	to	to	TO
25944	2364	15	have	have	VB
25944	2364	16	their	-PRON-	PRP$
25944	2364	17	origin	origin	NN
25944	2364	18	in	in	IN
25944	2364	19	the	the	DT
25944	2364	20	connective	connective	JJ
25944	2364	21	tissue	tissue	NN
25944	2364	22	of	of	IN
25944	2364	23	the	the	DT
25944	2364	24	corium	corium	NN
25944	2364	25	,	,	,
25944	2364	26	or	or	CC
25944	2364	27	in	in	IN
25944	2364	28	that	that	DT
25944	2364	29	of	of	IN
25944	2364	30	the	the	DT
25944	2364	31	walls	wall	NNS
25944	2364	32	of	of	IN
25944	2364	33	the	the	DT
25944	2364	34	hair	hair	NN
25944	2364	35	-	-	HYPH
25944	2364	36	sac	sac	NN
25944	2364	37	,	,	,
25944	2364	38	or	or	CC
25944	2364	39	in	in	IN
25944	2364	40	the	the	DT
25944	2364	41	connective	connective	JJ
25944	2364	42	-	-	HYPH
25944	2364	43	tissue	tissue	NN
25944	2364	44	framework	framework	NN
25944	2364	45	of	of	IN
25944	2364	46	the	the	DT
25944	2364	47	fatty	fatty	NN
25944	2364	48	tissue	tissue	NN
25944	2364	49	.	.	.
25944	2365	1	Recent	recent	JJ
25944	2365	2	tumors	tumor	NNS
25944	2365	3	are	be	VBP
25944	2365	4	composed	compose	VBN
25944	2365	5	of	of	IN
25944	2365	6	gelatinous	gelatinous	JJ
25944	2365	7	,	,	,
25944	2365	8	newly	newly	RB
25944	2365	9	-	-	HYPH
25944	2365	10	formed	form	VBN
25944	2365	11	connective	connective	JJ
25944	2365	12	tissue	tissue	NN
25944	2365	13	,	,	,
25944	2365	14	and	and	CC
25944	2365	15	the	the	DT
25944	2365	16	older	old	JJR
25944	2365	17	growths	growth	NNS
25944	2365	18	of	of	IN
25944	2365	19	a	a	DT
25944	2365	20	dense	dense	JJ
25944	2365	21	,	,	,
25944	2365	22	firmly	firmly	RB
25944	2365	23	-	-	HYPH
25944	2365	24	packed	pack	VBN
25944	2365	25	,	,	,
25944	2365	26	fibrous	fibrous	JJ
25944	2365	27	tissue	tissue	NN
25944	2365	28	.	.	.
25944	2366	1	#	#	$
25944	2366	2	From	from	IN
25944	2366	3	what	what	WP
25944	2366	4	growths	growth	NNS
25944	2366	5	is	be	VBZ
25944	2366	6	fibroma	fibroma	NN
25944	2366	7	to	to	TO
25944	2366	8	be	be	VB
25944	2366	9	differentiated	differentiate	VBN
25944	2366	10	?	?	.
25944	2366	11	#	#	$
25944	2366	12	From	from	IN
25944	2366	13	molluscum	molluscum	NNP
25944	2366	14	contagiosum	contagiosum	NN
25944	2366	15	,	,	,
25944	2366	16	neuroma	neuroma	NN
25944	2366	17	and	and	CC
25944	2366	18	lipoma	lipoma	NNP
25944	2366	19	;	;	:
25944	2366	20	the	the	DT
25944	2366	21	first	first	JJ
25944	2366	22	is	be	VBZ
25944	2366	23	differentiated	differentiate	VBN
25944	2366	24	by	by	IN
25944	2366	25	its	-PRON-	PRP$
25944	2366	26	central	central	JJ
25944	2366	27	aperture	aperture	NN
25944	2366	28	or	or	CC
25944	2366	29	depression	depression	NN
25944	2366	30	,	,	,
25944	2366	31	neuroma	neuroma	NN
25944	2366	32	by	by	IN
25944	2366	33	its	-PRON-	PRP$
25944	2366	34	painfulness	painfulness	NN
25944	2366	35	,	,	,
25944	2366	36	and	and	CC
25944	2366	37	lipoma	lipoma	NNS
25944	2366	38	by	by	IN
25944	2366	39	its	-PRON-	PRP$
25944	2366	40	lobulated	lobulate	VBN
25944	2366	41	character	character	NN
25944	2366	42	and	and	CC
25944	2366	43	soft	soft	JJ
25944	2366	44	feel	feel	NN
25944	2366	45	.	.	.
25944	2367	1	#	#	NN
25944	2367	2	Give	give	VB
25944	2367	3	the	the	DT
25944	2367	4	prognosis	prognosis	NN
25944	2367	5	of	of	IN
25944	2367	6	fibroma	fibroma	NN
25944	2367	7	.	.	.
25944	2367	8	#	#	$
25944	2367	9	The	the	DT
25944	2367	10	disease	disease	NN
25944	2367	11	is	be	VBZ
25944	2367	12	persistent	persistent	JJ
25944	2367	13	,	,	,
25944	2367	14	and	and	CC
25944	2367	15	irresponsive	irresponsive	JJ
25944	2367	16	to	to	IN
25944	2367	17	all	all	DT
25944	2367	18	treatment	treatment	NN
25944	2367	19	save	save	VB
25944	2367	20	operative	operative	JJ
25944	2367	21	measures	measure	NNS
25944	2367	22	.	.	.
25944	2368	1	#	#	LS
25944	2368	2	What	what	WP
25944	2368	3	is	be	VBZ
25944	2368	4	the	the	DT
25944	2368	5	treatment	treatment	NN
25944	2368	6	of	of	IN
25944	2368	7	fibroma	fibroma	NN
25944	2368	8	?	?	.
25944	2368	9	#	#	$
25944	2368	10	Treatment	Treatment	NNP
25944	2368	11	consists	consist	VBZ
25944	2368	12	,	,	,
25944	2368	13	when	when	WRB
25944	2368	14	desired	desire	VBN
25944	2368	15	and	and	CC
25944	2368	16	practicable	practicable	JJ
25944	2368	17	,	,	,
25944	2368	18	in	in	IN
25944	2368	19	the	the	DT
25944	2368	20	removal	removal	NN
25944	2368	21	of	of	IN
25944	2368	22	the	the	DT
25944	2368	23	growths	growth	NNS
25944	2368	24	by	by	IN
25944	2368	25	the	the	DT
25944	2368	26	knife	knife	NN
25944	2368	27	,	,	,
25944	2368	28	or	or	CC
25944	2368	29	in	in	IN
25944	2368	30	large	large	JJ
25944	2368	31	and	and	CC
25944	2368	32	pedunculated	pedunculate	VBN
25944	2368	33	tumors	tumor	NNS
25944	2368	34	by	by	IN
25944	2368	35	the	the	DT
25944	2368	36	ligature	ligature	NN
25944	2368	37	or	or	CC
25944	2368	38	by	by	IN
25944	2368	39	the	the	DT
25944	2368	40	galvano	galvano	NN
25944	2368	41	-	-	HYPH
25944	2368	42	cautery	cautery	NN
25944	2368	43	.	.	.
25944	2369	1	#	#	NNP
25944	2369	2	Neuroma	Neuroma	NNP
25944	2369	3	.	.	.
25944	2369	4	#	#	$
25944	2369	5	#	#	$
25944	2369	6	Describe	Describe	NNP
25944	2369	7	neuroma	neuroma	NN
25944	2369	8	.	.	.
25944	2369	9	#	#	$
25944	2369	10	Neuroma	Neuroma	NNP
25944	2369	11	of	of	IN
25944	2369	12	the	the	DT
25944	2369	13	skin	skin	NN
25944	2369	14	is	be	VBZ
25944	2369	15	an	an	DT
25944	2369	16	exceedingly	exceedingly	RB
25944	2369	17	rare	rare	JJ
25944	2369	18	disease	disease	NN
25944	2369	19	,	,	,
25944	2369	20	characterized	characterize	VBN
25944	2369	21	by	by	IN
25944	2369	22	the	the	DT
25944	2369	23	formation	formation	NN
25944	2369	24	of	of	IN
25944	2369	25	variously	variously	RB
25944	2369	26	-	-	HYPH
25944	2369	27	sized	sized	JJ
25944	2369	28	,	,	,
25944	2369	29	usually	usually	RB
25944	2369	30	numerous	numerous	JJ
25944	2369	31	,	,	,
25944	2369	32	firm	firm	JJ
25944	2369	33	,	,	,
25944	2369	34	immovable	immovable	JJ
25944	2369	35	and	and	CC
25944	2369	36	elastic	elastic	JJ
25944	2369	37	fibrous	fibrous	JJ
25944	2369	38	tubercles	tubercle	NNS
25944	2369	39	containing	contain	VBG
25944	2369	40	new	new	JJ
25944	2369	41	nerve	nerve	NN
25944	2369	42	-	-	HYPH
25944	2369	43	elements	element	NNS
25944	2369	44	,	,	,
25944	2369	45	and	and	CC
25944	2369	46	accompanied	accompany	VBN
25944	2369	47	by	by	IN
25944	2369	48	violent	violent	JJ
25944	2369	49	,	,	,
25944	2369	50	paroxysmal	paroxysmal	JJ
25944	2369	51	pain	pain	NN
25944	2369	52	.	.	.
25944	2370	1	Their	-PRON-	PRP$
25944	2370	2	growth	growth	NN
25944	2370	3	is	be	VBZ
25944	2370	4	slow	slow	JJ
25944	2370	5	and	and	CC
25944	2370	6	usually	usually	RB
25944	2370	7	progressive	progressive	JJ
25944	2370	8	.	.	.
25944	2371	1	Later	later	RB
25944	2371	2	they	-PRON-	PRP
25944	2371	3	are	be	VBP
25944	2371	4	painful	painful	JJ
25944	2371	5	upon	upon	IN
25944	2371	6	pressure	pressure	NN
25944	2371	7	.	.	.
25944	2372	1	They	-PRON-	PRP
25944	2372	2	are	be	VBP
25944	2372	3	limited	limit	VBN
25944	2372	4	to	to	IN
25944	2372	5	one	one	CD
25944	2372	6	region	region	NN
25944	2372	7	.	.	.
25944	2373	1	The	the	DT
25944	2373	2	tumors	tumor	NNS
25944	2373	3	are	be	VBP
25944	2373	4	seated	seat	VBN
25944	2373	5	in	in	IN
25944	2373	6	the	the	DT
25944	2373	7	corium	corium	NN
25944	2373	8	,	,	,
25944	2373	9	extending	extend	VBG
25944	2373	10	into	into	IN
25944	2373	11	the	the	DT
25944	2373	12	deeper	deep	JJR
25944	2373	13	structure	structure	NN
25944	2373	14	,	,	,
25944	2373	15	and	and	CC
25944	2373	16	consist	consist	VB
25944	2373	17	of	of	IN
25944	2373	18	nerve	nerve	NN
25944	2373	19	-	-	HYPH
25944	2373	20	fibres	fibre	NNS
25944	2373	21	,	,	,
25944	2373	22	yellow	yellow	JJ
25944	2373	23	elastic	elastic	JJ
25944	2373	24	tissue	tissue	NN
25944	2373	25	,	,	,
25944	2373	26	blood	blood	NN
25944	2373	27	vessels	vessel	NNS
25944	2373	28	and	and	CC
25944	2373	29	lymphoid	lymphoid	JJ
25944	2373	30	cells	cell	NNS
25944	2373	31	.	.	.
25944	2374	1	In	in	IN
25944	2374	2	the	the	DT
25944	2374	3	two	two	CD
25944	2374	4	cases	case	NNS
25944	2374	5	reported	report	VBN
25944	2374	6	,	,	,
25944	2374	7	excision	excision	NN
25944	2374	8	of	of	IN
25944	2374	9	the	the	DT
25944	2374	10	nerve	nerve	NN
25944	2374	11	-	-	HYPH
25944	2374	12	trunk	trunk	NN
25944	2374	13	gave	give	VBD
25944	2374	14	,	,	,
25944	2374	15	in	in	IN
25944	2374	16	one	one	CD
25944	2374	17	instance	instance	NN
25944	2374	18	,	,	,
25944	2374	19	permanent	permanent	JJ
25944	2374	20	relief	relief	NN
25944	2374	21	;	;	:
25944	2374	22	in	in	IN
25944	2374	23	the	the	DT
25944	2374	24	other	other	JJ
25944	2374	25	the	the	DT
25944	2374	26	effect	effect	NN
25944	2374	27	was	be	VBD
25944	2374	28	only	only	RB
25944	2374	29	temporary	temporary	JJ
25944	2374	30	.	.	.
25944	2375	1	#	#	NNP
25944	2375	2	Xanthoma	Xanthoma	NNP
25944	2375	3	.	.	.
25944	2375	4	#	#	NNP
25944	2375	5	(	(	-LRB-
25944	2375	6	_	_	NNP
25944	2375	7	Synonyms	Synonyms	NNP
25944	2375	8	:	:	:
25944	2375	9	_	_	NNP
25944	2375	10	Vitiligoidea	Vitiligoidea	NNP
25944	2375	11	;	;	:
25944	2375	12	Xanthelasma	Xanthelasma	NNP
25944	2375	13	.	.	.
25944	2375	14	)	)	-RRB-
25944	2376	1	#	#	LS
25944	2376	2	What	what	WP
25944	2376	3	is	be	VBZ
25944	2376	4	xanthoma	xanthoma	NNP
25944	2376	5	?	?	.
25944	2376	6	#	#	NNP
25944	2376	7	Xanthoma	Xanthoma	NNP
25944	2376	8	is	be	VBZ
25944	2376	9	a	a	DT
25944	2376	10	connective	connective	JJ
25944	2376	11	-	-	HYPH
25944	2376	12	tissue	tissue	NN
25944	2376	13	new	new	JJ
25944	2376	14	growth	growth	NN
25944	2376	15	characterized	characterize	VBN
25944	2376	16	by	by	IN
25944	2376	17	the	the	DT
25944	2376	18	formation	formation	NN
25944	2376	19	of	of	IN
25944	2376	20	yellowish	yellowish	JJ
25944	2376	21	,	,	,
25944	2376	22	circumscribed	circumscribe	VBN
25944	2376	23	,	,	,
25944	2376	24	irregularly	irregularly	RB
25944	2376	25	-	-	HYPH
25944	2376	26	shaped	shaped	JJ
25944	2376	27	,	,	,
25944	2376	28	variously	variously	RB
25944	2376	29	-	-	HYPH
25944	2376	30	sized	sized	JJ
25944	2376	31	,	,	,
25944	2376	32	non	non	JJ
25944	2376	33	-	-	JJ
25944	2376	34	indurated	indurated	JJ
25944	2376	35	,	,	,
25944	2376	36	flat	flat	JJ
25944	2376	37	or	or	CC
25944	2376	38	raised	raise	VBN
25944	2376	39	patches	patch	NNS
25944	2376	40	or	or	CC
25944	2376	41	tubercles	tubercle	NNS
25944	2376	42	.	.	.
25944	2377	1	#	#	NNP
25944	2377	2	Name	name	VB
25944	2377	3	the	the	DT
25944	2377	4	two	two	CD
25944	2377	5	varieties	variety	NNS
25944	2377	6	met	meet	VBD
25944	2377	7	with	with	IN
25944	2377	8	.	.	.
25944	2377	9	#	#	$
25944	2377	10	The	the	DT
25944	2377	11	macular	macular	JJ
25944	2377	12	or	or	CC
25944	2377	13	flat	flat	JJ
25944	2377	14	(	(	-LRB-
25944	2377	15	_	_	NNP
25944	2377	16	xanthoma	xanthoma	NNP
25944	2377	17	planum	planum	NNP
25944	2377	18	_	_	NNP
25944	2377	19	)	)	-RRB-
25944	2377	20	and	and	CC
25944	2377	21	the	the	DT
25944	2377	22	tubercular	tubercular	NN
25944	2377	23	(	(	-LRB-
25944	2377	24	_	_	NNP
25944	2377	25	xanthoma	xanthoma	NNP
25944	2377	26	tuberculatum	tuberculatum	NNP
25944	2377	27	_	_	NNP
25944	2377	28	or	or	CC
25944	2377	29	_	_	NNP
25944	2377	30	tuberosum	tuberosum	NN
25944	2377	31	_	_	NNP
25944	2377	32	)	)	-RRB-
25944	2377	33	.	.	.
25944	2378	1	In	in	IN
25944	2378	2	some	some	DT
25944	2378	3	instances	instance	NNS
25944	2378	4	both	both	DT
25944	2378	5	varieties	variety	NNS
25944	2378	6	(	(	-LRB-
25944	2378	7	_	_	NNP
25944	2378	8	xanthoma	xanthoma	NNP
25944	2378	9	multiplex	multiplex	NNP
25944	2378	10	_	_	NNP
25944	2378	11	)	)	-RRB-
25944	2378	12	are	be	VBP
25944	2378	13	seen	see	VBN
25944	2378	14	in	in	IN
25944	2378	15	the	the	DT
25944	2378	16	same	same	JJ
25944	2378	17	individual	individual	NN
25944	2378	18	.	.	.
25944	2379	1	#	#	NNP
25944	2379	2	Describe	describe	VB
25944	2379	3	the	the	DT
25944	2379	4	clinical	clinical	JJ
25944	2379	5	appearances	appearance	NNS
25944	2379	6	of	of	IN
25944	2379	7	xanthoma	xanthoma	NNP
25944	2379	8	planum	planum	NNP
25944	2379	9	.	.	.
25944	2379	10	#	#	$
25944	2379	11	The	the	DT
25944	2379	12	macular	macular	JJ
25944	2379	13	or	or	CC
25944	2379	14	flat	flat	JJ
25944	2379	15	variety	variety	NN
25944	2379	16	is	be	VBZ
25944	2379	17	usually	usually	RB
25944	2379	18	seen	see	VBN
25944	2379	19	about	about	IN
25944	2379	20	the	the	DT
25944	2379	21	eyelids	eyelid	NNS
25944	2379	22	.	.	.
25944	2380	1	It	-PRON-	PRP
25944	2380	2	consists	consist	VBZ
25944	2380	3	of	of	IN
25944	2380	4	one	one	CD
25944	2380	5	,	,	,
25944	2380	6	several	several	JJ
25944	2380	7	or	or	CC
25944	2380	8	more	more	RBR
25944	2380	9	small	small	JJ
25944	2380	10	or	or	CC
25944	2380	11	large	large	JJ
25944	2380	12	,	,	,
25944	2380	13	smooth	smooth	JJ
25944	2380	14	,	,	,
25944	2380	15	opaque	opaque	JJ
25944	2380	16	,	,	,
25944	2380	17	sharply	sharply	RB
25944	2380	18	-	-	HYPH
25944	2380	19	defined	define	VBN
25944	2380	20	,	,	,
25944	2380	21	often	often	RB
25944	2380	22	slightly	slightly	RB
25944	2380	23	raised	raise	VBN
25944	2380	24	,	,	,
25944	2380	25	yellowish	yellowish	JJ
25944	2380	26	patches	patch	NNS
25944	2380	27	,	,	,
25944	2380	28	looking	look	VBG
25944	2380	29	not	not	RB
25944	2380	30	unlike	unlike	IN
25944	2380	31	pieces	piece	NNS
25944	2380	32	of	of	IN
25944	2380	33	chamois	chamois	NNP
25944	2380	34	-	-	HYPH
25944	2380	35	skin	skin	NN
25944	2380	36	implanted	implant	VBD
25944	2380	37	in	in	IN
25944	2380	38	the	the	DT
25944	2380	39	skin	skin	NN
25944	2380	40	.	.	.
25944	2381	1	#	#	NNP
25944	2381	2	Describe	describe	VB
25944	2381	3	the	the	DT
25944	2381	4	clinical	clinical	JJ
25944	2381	5	appearances	appearance	NNS
25944	2381	6	of	of	IN
25944	2381	7	xanthoma	xanthoma	NNP
25944	2381	8	tuberosum	tuberosum	NN
25944	2381	9	.	.	.
25944	2381	10	#	#	$
25944	2381	11	The	the	DT
25944	2381	12	tubercular	tubercular	JJ
25944	2381	13	variety	variety	NN
25944	2381	14	is	be	VBZ
25944	2381	15	commonly	commonly	RB
25944	2381	16	met	meet	VBN
25944	2381	17	with	with	IN
25944	2381	18	upon	upon	IN
25944	2381	19	the	the	DT
25944	2381	20	neck	neck	NN
25944	2381	21	,	,	,
25944	2381	22	trunk	trunk	NN
25944	2381	23	and	and	CC
25944	2381	24	extremities	extremity	NNS
25944	2381	25	.	.	.
25944	2382	1	It	-PRON-	PRP
25944	2382	2	occurs	occur	VBZ
25944	2382	3	as	as	RB
25944	2382	4	small	small	JJ
25944	2382	5	,	,	,
25944	2382	6	raised	raise	VBN
25944	2382	7	,	,	,
25944	2382	8	isolated	isolated	JJ
25944	2382	9	,	,	,
25944	2382	10	yellowish	yellowish	JJ
25944	2382	11	nodules	nodule	NNS
25944	2382	12	,	,	,
25944	2382	13	or	or	CC
25944	2382	14	as	as	IN
25944	2382	15	patches	patch	NNS
25944	2382	16	made	make	VBN
25944	2382	17	up	up	RP
25944	2382	18	of	of	IN
25944	2382	19	aggregations	aggregation	NNS
25944	2382	20	of	of	IN
25944	2382	21	millet	millet	NN
25944	2382	22	-	-	HYPH
25944	2382	23	seed	seed	NN
25944	2382	24	-	-	HYPH
25944	2382	25	sized	sized	JJ
25944	2382	26	or	or	CC
25944	2382	27	larger	large	JJR
25944	2382	28	tubercles	tubercle	NNS
25944	2382	29	.	.	.
25944	2383	1	The	the	DT
25944	2383	2	lesions	lesion	NNS
25944	2383	3	may	may	MD
25944	2383	4	be	be	VB
25944	2383	5	few	few	JJ
25944	2383	6	or	or	CC
25944	2383	7	they	-PRON-	PRP
25944	2383	8	may	may	MD
25944	2383	9	exist	exist	VB
25944	2383	10	in	in	IN
25944	2383	11	great	great	JJ
25944	2383	12	numbers	number	NNS
25944	2383	13	.	.	.
25944	2384	1	#	#	LS
25944	2384	2	What	what	WP
25944	2384	3	is	be	VBZ
25944	2384	4	the	the	DT
25944	2384	5	course	course	NN
25944	2384	6	of	of	IN
25944	2384	7	xanthoma	xanthoma	NNP
25944	2384	8	?	?	.
25944	2384	9	#	#	$
25944	2384	10	Extremely	extremely	RB
25944	2384	11	slow	slow	JJ
25944	2384	12	;	;	:
25944	2384	13	after	after	IN
25944	2384	14	reaching	reach	VBG
25944	2384	15	a	a	DT
25944	2384	16	certain	certain	JJ
25944	2384	17	development	development	NN
25944	2384	18	the	the	DT
25944	2384	19	growths	growth	NNS
25944	2384	20	may	may	MD
25944	2384	21	remain	remain	VB
25944	2384	22	stationary	stationary	JJ
25944	2384	23	.	.	.
25944	2385	1	#	#	NNP
25944	2385	2	State	state	NN
25944	2385	3	the	the	DT
25944	2385	4	etiology	etiology	NN
25944	2385	5	of	of	IN
25944	2385	6	xanthoma	xanthoma	NNP
25944	2385	7	.	.	.
25944	2385	8	#	#	$
25944	2385	9	The	the	DT
25944	2385	10	causes	cause	NNS
25944	2385	11	are	be	VBP
25944	2385	12	obscure	obscure	JJ
25944	2385	13	.	.	.
25944	2386	1	Jaundice	Jaundice	NNS
25944	2386	2	not	not	RB
25944	2386	3	infrequently	infrequently	RB
25944	2386	4	precedes	precede	VBZ
25944	2386	5	and	and	CC
25944	2386	6	accompanies	accompany	VBZ
25944	2386	7	its	-PRON-	PRP$
25944	2386	8	development	development	NN
25944	2386	9	,	,	,
25944	2386	10	especially	especially	RB
25944	2386	11	in	in	IN
25944	2386	12	the	the	DT
25944	2386	13	tubercular	tubercular	JJ
25944	2386	14	variety	variety	NN
25944	2386	15	.	.	.
25944	2387	1	The	the	DT
25944	2387	2	disease	disease	NN
25944	2387	3	is	be	VBZ
25944	2387	4	uncommon	uncommon	JJ
25944	2387	5	,	,	,
25944	2387	6	and	and	CC
25944	2387	7	is	be	VBZ
25944	2387	8	usually	usually	RB
25944	2387	9	seen	see	VBN
25944	2387	10	in	in	IN
25944	2387	11	middle	middle	JJ
25944	2387	12	and	and	CC
25944	2387	13	advanced	advanced	JJ
25944	2387	14	life	life	NN
25944	2387	15	,	,	,
25944	2387	16	and	and	CC
25944	2387	17	more	more	RBR
25944	2387	18	frequently	frequently	RB
25944	2387	19	in	in	IN
25944	2387	20	women	woman	NNS
25944	2387	21	.	.	.
25944	2388	1	In	in	IN
25944	2388	2	some	some	DT
25944	2388	3	cases	case	NNS
25944	2388	4	(	(	-LRB-
25944	2388	5	_	_	NNP
25944	2388	6	xanthoma	xanthoma	NNP
25944	2388	7	diabeticorum	diabeticorum	NNP
25944	2388	8	_	_	NNP
25944	2388	9	)	)	-RRB-
25944	2388	10	of	of	IN
25944	2388	11	general	general	NNP
25944	2388	12	xanthoma	xanthoma	NNP
25944	2388	13	diabetes	diabetes	NN
25944	2388	14	is	be	VBZ
25944	2388	15	the	the	DT
25944	2388	16	causative	causative	JJ
25944	2388	17	factor	factor	NN
25944	2388	18	.	.	.
25944	2389	1	#	#	LS
25944	2389	2	What	what	WP
25944	2389	3	is	be	VBZ
25944	2389	4	the	the	DT
25944	2389	5	pathology	pathology	NN
25944	2389	6	of	of	IN
25944	2389	7	xanthoma	xanthoma	NNP
25944	2389	8	?	?	.
25944	2389	9	#	#	$
25944	2389	10	It	-PRON-	PRP
25944	2389	11	is	be	VBZ
25944	2389	12	a	a	DT
25944	2389	13	benign	benign	JJ
25944	2389	14	,	,	,
25944	2389	15	connective	connective	JJ
25944	2389	16	-	-	HYPH
25944	2389	17	tissue	tissue	NN
25944	2389	18	new	new	JJ
25944	2389	19	growth	growth	NN
25944	2389	20	,	,	,
25944	2389	21	with	with	IN
25944	2389	22	concomitant	concomitant	JJ
25944	2389	23	or	or	CC
25944	2389	24	subsequent	subsequent	JJ
25944	2389	25	,	,	,
25944	2389	26	but	but	CC
25944	2389	27	usually	usually	RB
25944	2389	28	partial	partial	JJ
25944	2389	29	,	,	,
25944	2389	30	fatty	fatty	NN
25944	2389	31	degeneration	degeneration	NN
25944	2389	32	.	.	.
25944	2390	1	#	#	NN
25944	2390	2	Give	give	VB
25944	2390	3	the	the	DT
25944	2390	4	prognosis	prognosis	NN
25944	2390	5	of	of	IN
25944	2390	6	xanthoma	xanthoma	NNP
25944	2390	7	.	.	.
25944	2390	8	#	#	$
25944	2390	9	The	the	DT
25944	2390	10	condition	condition	NN
25944	2390	11	is	be	VBZ
25944	2390	12	persistent	persistent	JJ
25944	2390	13	,	,	,
25944	2390	14	and	and	CC
25944	2390	15	usually	usually	RB
25944	2390	16	irresponsive	irresponsive	JJ
25944	2390	17	to	to	IN
25944	2390	18	all	all	DT
25944	2390	19	treatment	treatment	NN
25944	2390	20	save	save	VB
25944	2390	21	destructive	destructive	JJ
25944	2390	22	or	or	CC
25944	2390	23	operative	operative	JJ
25944	2390	24	measures	measure	NNS
25944	2390	25	.	.	.
25944	2391	1	#	#	LS
25944	2391	2	What	what	WP
25944	2391	3	is	be	VBZ
25944	2391	4	the	the	DT
25944	2391	5	treatment	treatment	NN
25944	2391	6	of	of	IN
25944	2391	7	xanthoma	xanthoma	NNP
25944	2391	8	?	?	.
25944	2391	9	#	#	$
25944	2391	10	Treatment	Treatment	NNP
25944	2391	11	consists	consist	VBZ
25944	2391	12	,	,	,
25944	2391	13	in	in	IN
25944	2391	14	suitable	suitable	JJ
25944	2391	15	cases	case	NNS
25944	2391	16	,	,	,
25944	2391	17	of	of	IN
25944	2391	18	excision	excision	NN
25944	2391	19	;	;	:
25944	2391	20	in	in	IN
25944	2391	21	some	some	DT
25944	2391	22	instances	instance	NNS
25944	2391	23	,	,	,
25944	2391	24	electrolysis	electrolysis	NN
25944	2391	25	is	be	VBZ
25944	2391	26	serviceable	serviceable	JJ
25944	2391	27	.	.	.
25944	2392	1	Applications	application	NNS
25944	2392	2	of	of	IN
25944	2392	3	trichloracetic	trichloracetic	JJ
25944	2392	4	acid	acid	NN
25944	2392	5	cautiously	cautiously	RB
25944	2392	6	made	make	VBN
25944	2392	7	are	be	VBP
25944	2392	8	sometimes	sometimes	RB
25944	2392	9	of	of	IN
25944	2392	10	value	value	NN
25944	2392	11	.	.	.
25944	2393	1	In	in	IN
25944	2393	2	that	that	DT
25944	2393	3	form	form	NN
25944	2393	4	of	of	IN
25944	2393	5	general	general	JJ
25944	2393	6	xanthoma	xanthoma	NNP
25944	2393	7	due	due	IN
25944	2393	8	to	to	IN
25944	2393	9	diabetes	diabetes	NN
25944	2393	10	the	the	DT
25944	2393	11	treatment	treatment	NN
25944	2393	12	of	of	IN
25944	2393	13	this	this	DT
25944	2393	14	latter	latter	JJ
25944	2393	15	condition	condition	NN
25944	2393	16	will	will	MD
25944	2393	17	materially	materially	RB
25944	2393	18	and	and	CC
25944	2393	19	sometimes	sometimes	RB
25944	2393	20	completely	completely	RB
25944	2393	21	remove	remove	VB
25944	2393	22	the	the	DT
25944	2393	23	eruption	eruption	NN
25944	2393	24	.	.	.
25944	2394	1	#	#	NNP
25944	2394	2	Myoma	Myoma	NNP
25944	2394	3	.	.	.
25944	2394	4	#	#	NNP
25944	2394	5	(	(	-LRB-
25944	2394	6	_	_	NNP
25944	2394	7	Synonyms	Synonyms	NNP
25944	2394	8	:	:	:
25944	2394	9	_	_	NNP
25944	2394	10	Myoma	Myoma	NNP
25944	2394	11	Cutis	Cutis	NNP
25944	2394	12	;	;	:
25944	2394	13	Dermatomyoma	Dermatomyoma	NNP
25944	2394	14	;	;	:
25944	2394	15	Liomyoma	Liomyoma	NNP
25944	2394	16	Cutis	Cutis	NNP
25944	2394	17	.	.	.
25944	2394	18	)	)	-RRB-
25944	2395	1	#	#	$
25944	2395	2	Describe	Describe	NNP
25944	2395	3	myoma	myoma	NN
25944	2395	4	.	.	.
25944	2395	5	#	#	$
25944	2395	6	The	the	DT
25944	2395	7	disease	disease	NN
25944	2395	8	is	be	VBZ
25944	2395	9	rare	rare	JJ
25944	2395	10	,	,	,
25944	2395	11	and	and	CC
25944	2395	12	consists	consist	VBZ
25944	2395	13	usually	usually	RB
25944	2395	14	of	of	IN
25944	2395	15	one	one	CD
25944	2395	16	or	or	CC
25944	2395	17	several	several	JJ
25944	2395	18	(	(	-LRB-
25944	2395	19	exceptionally	exceptionally	RB
25944	2395	20	numerous	numerous	JJ
25944	2395	21	)	)	-RRB-
25944	2395	22	,	,	,
25944	2395	23	variously	variously	RB
25944	2395	24	-	-	HYPH
25944	2395	25	sized	sized	JJ
25944	2395	26	tumors	tumor	NNS
25944	2395	27	of	of	IN
25944	2395	28	the	the	DT
25944	2395	29	skin	skin	NN
25944	2395	30	,	,	,
25944	2395	31	made	make	VBN
25944	2395	32	up	up	RP
25944	2395	33	of	of	IN
25944	2395	34	smooth	smooth	JJ
25944	2395	35	muscular	muscular	JJ
25944	2395	36	fibres	fibre	NNS
25944	2395	37	.	.	.
25944	2396	1	They	-PRON-	PRP
25944	2396	2	are	be	VBP
25944	2396	3	flat	flat	JJ
25944	2396	4	,	,	,
25944	2396	5	rounded	rounded	JJ
25944	2396	6	,	,	,
25944	2396	7	oval	oval	RB
25944	2396	8	or	or	CC
25944	2396	9	pedunculated	pedunculate	VBN
25944	2396	10	,	,	,
25944	2396	11	and	and	CC
25944	2396	12	have	have	VB
25944	2396	13	a	a	DT
25944	2396	14	smooth	smooth	JJ
25944	2396	15	surface	surface	NN
25944	2396	16	and	and	CC
25944	2396	17	a	a	DT
25944	2396	18	pale	pale	JJ
25944	2396	19	-	-	HYPH
25944	2396	20	red	red	JJ
25944	2396	21	color	color	NN
25944	2396	22	;	;	:
25944	2396	23	as	as	IN
25944	2396	24	a	a	DT
25944	2396	25	rule	rule	NN
25944	2396	26	,	,	,
25944	2396	27	they	-PRON-	PRP
25944	2396	28	are	be	VBP
25944	2396	29	painless	painless	JJ
25944	2396	30	.	.	.
25944	2397	1	The	the	DT
25944	2397	2	growth	growth	NN
25944	2397	3	is	be	VBZ
25944	2397	4	benign	benign	JJ
25944	2397	5	,	,	,
25944	2397	6	and	and	CC
25944	2397	7	consists	consist	VBZ
25944	2397	8	essentially	essentially	RB
25944	2397	9	of	of	IN
25944	2397	10	a	a	DT
25944	2397	11	new	new	JJ
25944	2397	12	formation	formation	NN
25944	2397	13	of	of	IN
25944	2397	14	unstriped	unstriped	JJ
25944	2397	15	muscular	muscular	JJ
25944	2397	16	fibres	fibre	NNS
25944	2397	17	;	;	:
25944	2397	18	but	but	CC
25944	2397	19	it	-PRON-	PRP
25944	2397	20	may	may	MD
25944	2397	21	also	also	RB
25944	2397	22	be	be	VB
25944	2397	23	composed	compose	VBN
25944	2397	24	largely	largely	RB
25944	2397	25	of	of	IN
25944	2397	26	connective	connective	JJ
25944	2397	27	tissue	tissue	NN
25944	2397	28	(	(	-LRB-
25944	2397	29	_	_	NNP
25944	2397	30	fibromyoma	fibromyoma	NNP
25944	2397	31	_	_	NNP
25944	2397	32	)	)	-RRB-
25944	2397	33	;	;	:
25944	2397	34	or	or	CC
25944	2397	35	it	-PRON-	PRP
25944	2397	36	may	may	MD
25944	2397	37	contain	contain	VB
25944	2397	38	an	an	DT
25944	2397	39	abundance	abundance	NN
25944	2397	40	of	of	IN
25944	2397	41	bloodvessels	bloodvessel	NNS
25944	2397	42	(	(	-LRB-
25944	2397	43	_	_	NNP
25944	2397	44	myoma	myoma	NNP
25944	2397	45	telangiectodes	telangiectode	VBZ
25944	2397	46	_	_	NNP
25944	2397	47	,	,	,
25944	2397	48	_	_	NNP
25944	2397	49	angiomyoma	angiomyoma	NNP
25944	2397	50	_	_	NNP
25944	2397	51	)	)	-RRB-
25944	2397	52	;	;	:
25944	2397	53	or	or	CC
25944	2397	54	there	there	EX
25944	2397	55	may	may	MD
25944	2397	56	be	be	VB
25944	2397	57	lymphatic	lymphatic	JJ
25944	2397	58	involvement	involvement	NN
25944	2397	59	(	(	-LRB-
25944	2397	60	_	_	NNP
25944	2397	61	lymphangiomyoma	lymphangiomyoma	NN
25944	2397	62	_	_	NNP
25944	2397	63	)	)	-RRB-
25944	2397	64	.	.	.
25944	2398	1	#	#	NNP
25944	2398	2	Angioma	Angioma	NNP
25944	2398	3	.	.	.
25944	2398	4	#	#	NNP
25944	2398	5	(	(	-LRB-
25944	2398	6	_	_	NNP
25944	2398	7	Synonyms	Synonyms	NNP
25944	2398	8	:	:	:
25944	2398	9	_	_	NNP
25944	2398	10	Nævus	Nævus	NNP
25944	2398	11	Vasculosus	Vasculosus	NNP
25944	2398	12	;	;	:
25944	2398	13	Nævus	Nævus	NNP
25944	2398	14	Sanguineus	Sanguineus	NNP
25944	2398	15	.	.	.
25944	2398	16	)	)	-RRB-
25944	2399	1	#	#	NN
25944	2399	2	Give	give	VB
25944	2399	3	a	a	DT
25944	2399	4	definition	definition	NN
25944	2399	5	of	of	IN
25944	2399	6	angioma	angioma	NN
25944	2399	7	.	.	.
25944	2399	8	#	#	$
25944	2399	9	Angioma	Angioma	NNP
25944	2399	10	is	be	VBZ
25944	2399	11	a	a	DT
25944	2399	12	congenital	congenital	JJ
25944	2399	13	hypertrophy	hypertrophy	NN
25944	2399	14	of	of	IN
25944	2399	15	the	the	DT
25944	2399	16	vascular	vascular	JJ
25944	2399	17	tissues	tissue	NNS
25944	2399	18	of	of	IN
25944	2399	19	the	the	DT
25944	2399	20	corium	corium	NN
25944	2399	21	and	and	CC
25944	2399	22	subcutaneous	subcutaneous	JJ
25944	2399	23	tissue	tissue	NN
25944	2399	24	.	.	.
25944	2400	1	Exceptionally	exceptionally	RB
25944	2400	2	it	-PRON-	PRP
25944	2400	3	makes	make	VBZ
25944	2400	4	its	-PRON-	PRP$
25944	2400	5	appearance	appearance	NN
25944	2400	6	a	a	DT
25944	2400	7	few	few	JJ
25944	2400	8	weeks	week	NNS
25944	2400	9	or	or	CC
25944	2400	10	a	a	DT
25944	2400	11	month	month	NN
25944	2400	12	after	after	IN
25944	2400	13	birth	birth	NN
25944	2400	14	.	.	.
25944	2401	1	#	#	$
25944	2401	2	Into	into	IN
25944	2401	3	what	what	WP
25944	2401	4	two	two	CD
25944	2401	5	classes	class	NNS
25944	2401	6	may	may	MD
25944	2401	7	angiomata	angiomata	NN
25944	2401	8	be	be	VB
25944	2401	9	roughly	roughly	RB
25944	2401	10	grouped	group	VBN
25944	2401	11	?	?	.
25944	2401	12	#	#	$
25944	2401	13	The	the	DT
25944	2401	14	flat	flat	JJ
25944	2401	15	(	(	-LRB-
25944	2401	16	or	or	CC
25944	2401	17	non	non	JJ
25944	2401	18	-	-	JJ
25944	2401	19	elevated	elevated	JJ
25944	2401	20	)	)	-RRB-
25944	2401	21	and	and	CC
25944	2401	22	the	the	DT
25944	2401	23	prominent	prominent	JJ
25944	2401	24	(	(	-LRB-
25944	2401	25	or	or	CC
25944	2401	26	elevated	elevate	VBN
25944	2401	27	)	)	-RRB-
25944	2401	28	.	.	.
25944	2402	1	#	#	NNP
25944	2402	2	Describe	describe	VB
25944	2402	3	the	the	DT
25944	2402	4	flat	flat	JJ
25944	2402	5	,	,	,
25944	2402	6	or	or	CC
25944	2402	7	non	non	JJ
25944	2402	8	-	-	JJ
25944	2402	9	elevated	elevated	JJ
25944	2402	10	,	,	,
25944	2402	11	variety	variety	NN
25944	2402	12	of	of	IN
25944	2402	13	angioma	angioma	NN
25944	2402	14	.	.	.
25944	2402	15	#	#	$
25944	2402	16	The	the	DT
25944	2402	17	flat	flat	JJ
25944	2402	18	,	,	,
25944	2402	19	or	or	CC
25944	2402	20	non	non	JJ
25944	2402	21	-	-	JJ
25944	2402	22	elevated	elevated	JJ
25944	2402	23	,	,	,
25944	2402	24	angioma	angioma	NNP
25944	2402	25	(	(	-LRB-
25944	2402	26	_	_	NNP
25944	2402	27	nævus	nævu	VBN
25944	2402	28	flammeus	flammeus	NNP
25944	2402	29	_	_	NNP
25944	2402	30	,	,	,
25944	2402	31	_	_	NNP
25944	2402	32	nævus	nævus	NNP
25944	2402	33	simplex	simplex	NNP
25944	2402	34	_	_	NNP
25944	2402	35	,	,	,
25944	2402	36	_	_	NNP
25944	2402	37	angioma	angioma	NN
25944	2402	38	simplex	simplex	NNP
25944	2402	39	_	_	NNP
25944	2402	40	,	,	,
25944	2402	41	_	_	NNP
25944	2402	42	capillary	capillary	JJ
25944	2402	43	nævus	nævus	NNP
25944	2402	44	_	_	NNP
25944	2402	45	)	)	-RRB-
25944	2402	46	may	may	MD
25944	2402	47	be	be	VB
25944	2402	48	pin	pin	NN
25944	2402	49	-	-	HYPH
25944	2402	50	head-	head-	NN
25944	2402	51	to	to	IN
25944	2402	52	bean	bean	NN
25944	2402	53	-	-	HYPH
25944	2402	54	sized	sized	JJ
25944	2402	55	;	;	:
25944	2402	56	or	or	CC
25944	2402	57	it	-PRON-	PRP
25944	2402	58	may	may	MD
25944	2402	59	involve	involve	VB
25944	2402	60	an	an	DT
25944	2402	61	area	area	NN
25944	2402	62	of	of	IN
25944	2402	63	several	several	JJ
25944	2402	64	inches	inch	NNS
25944	2402	65	in	in	IN
25944	2402	66	diameter	diameter	NN
25944	2402	67	,	,	,
25944	2402	68	and	and	CC
25944	2402	69	,	,	,
25944	2402	70	exceptionally	exceptionally	RB
25944	2402	71	,	,	,
25944	2402	72	a	a	DT
25944	2402	73	whole	whole	JJ
25944	2402	74	region	region	NN
25944	2402	75	.	.	.
25944	2403	1	It	-PRON-	PRP
25944	2403	2	is	be	VBZ
25944	2403	3	of	of	IN
25944	2403	4	a	a	DT
25944	2403	5	bright-	bright-	JJ
25944	2403	6	or	or	CC
25944	2403	7	dark	dark	JJ
25944	2403	8	-	-	HYPH
25944	2403	9	red	red	JJ
25944	2403	10	color	color	NN
25944	2403	11	,	,	,
25944	2403	12	and	and	CC
25944	2403	13	is	be	VBZ
25944	2403	14	met	meet	VBN
25944	2403	15	with	with	IN
25944	2403	16	most	most	RBS
25944	2403	17	frequently	frequently	RB
25944	2403	18	about	about	IN
25944	2403	19	the	the	DT
25944	2403	20	face	face	NN
25944	2403	21	.	.	.
25944	2404	1	In	in	IN
25944	2404	2	some	some	DT
25944	2404	3	instances	instance	NNS
25944	2404	4	it	-PRON-	PRP
25944	2404	5	extends	extend	VBZ
25944	2404	6	after	after	IN
25944	2404	7	birth	birth	NN
25944	2404	8	,	,	,
25944	2404	9	reaches	reach	VBZ
25944	2404	10	a	a	DT
25944	2404	11	certain	certain	JJ
25944	2404	12	size	size	NN
25944	2404	13	and	and	CC
25944	2404	14	then	then	RB
25944	2404	15	remains	remain	VBZ
25944	2404	16	stationary	stationary	JJ
25944	2404	17	;	;	:
25944	2404	18	occasionally	occasionally	RB
25944	2404	19	,	,	,
25944	2404	20	when	when	WRB
25944	2404	21	involving	involve	VBG
25944	2404	22	a	a	DT
25944	2404	23	small	small	JJ
25944	2404	24	area	area	NN
25944	2404	25	,	,	,
25944	2404	26	it	-PRON-	PRP
25944	2404	27	undergoes	undergo	VBZ
25944	2404	28	involution	involution	NN
25944	2404	29	and	and	CC
25944	2404	30	disappears	disappear	NNS
25944	2404	31	.	.	.
25944	2405	1	The	the	DT
25944	2405	2	so	so	RB
25944	2405	3	-	-	HYPH
25944	2405	4	called	call	VBN
25944	2405	5	_	_	NNP
25944	2405	6	port	port	NN
25944	2405	7	-	-	HYPH
25944	2405	8	wine	wine	NN
25944	2405	9	mark	mark	NNP
25944	2405	10	_	_	NNP
25944	2405	11	is	be	VBZ
25944	2405	12	included	include	VBN
25944	2405	13	in	in	IN
25944	2405	14	this	this	DT
25944	2405	15	group	group	NN
25944	2405	16	.	.	.
25944	2406	1	#	#	NNP
25944	2406	2	Describe	describe	VB
25944	2406	3	the	the	DT
25944	2406	4	prominent	prominent	JJ
25944	2406	5	,	,	,
25944	2406	6	or	or	CC
25944	2406	7	elevated	elevated	JJ
25944	2406	8	,	,	,
25944	2406	9	variety	variety	NN
25944	2406	10	of	of	IN
25944	2406	11	angioma	angioma	NN
25944	2406	12	.	.	.
25944	2406	13	#	#	$
25944	2406	14	The	the	DT
25944	2406	15	prominent	prominent	JJ
25944	2406	16	variety	variety	NN
25944	2406	17	(	(	-LRB-
25944	2406	18	_	_	NNP
25944	2406	19	venous	venous	JJ
25944	2406	20	n[oe]vus	n[oe]vus	NNP
25944	2406	21	_	_	NNP
25944	2406	22	,	,	,
25944	2406	23	_	_	NNP
25944	2406	24	angioma	angioma	NNP
25944	2406	25	cavernosum	cavernosum	NNP
25944	2406	26	_	_	NNP
25944	2406	27	,	,	,
25944	2406	28	_	_	NNP
25944	2406	29	n[oe]vus	n[oe]vus	NNP
25944	2406	30	tuberosus	tuberosus	JJ
25944	2406	31	_	_	NNP
25944	2406	32	)	)	-RRB-
25944	2406	33	is	be	VBZ
25944	2406	34	variously	variously	RB
25944	2406	35	-	-	HYPH
25944	2406	36	sized	sized	JJ
25944	2406	37	,	,	,
25944	2406	38	often	often	RB
25944	2406	39	considerably	considerably	RB
25944	2406	40	elevated	elevate	VBN
25944	2406	41	,	,	,
25944	2406	42	clearly	clearly	RB
25944	2406	43	-	-	HYPH
25944	2406	44	defined	define	VBN
25944	2406	45	,	,	,
25944	2406	46	compressible	compressible	JJ
25944	2406	47	,	,	,
25944	2406	48	smooth	smooth	JJ
25944	2406	49	or	or	CC
25944	2406	50	lobulated	lobulate	VBD
25944	2406	51	,	,	,
25944	2406	52	and	and	CC
25944	2406	53	of	of	IN
25944	2406	54	a	a	DT
25944	2406	55	dark	dark	JJ
25944	2406	56	,	,	,
25944	2406	57	purple	purple	JJ
25944	2406	58	color	color	NN
25944	2406	59	;	;	:
25944	2406	60	it	-PRON-	PRP
25944	2406	61	may	may	MD
25944	2406	62	,	,	,
25944	2406	63	also	also	RB
25944	2406	64	,	,	,
25944	2406	65	be	be	VB
25944	2406	66	erectile	erectile	JJ
25944	2406	67	and	and	CC
25944	2406	68	pulsating	pulsate	VBG
25944	2406	69	.	.	.
25944	2407	1	The	the	DT
25944	2407	2	growth	growth	NN
25944	2407	3	is	be	VBZ
25944	2407	4	usually	usually	RB
25944	2407	5	a	a	DT
25944	2407	6	single	single	JJ
25944	2407	7	formation	formation	NN
25944	2407	8	,	,	,
25944	2407	9	and	and	CC
25944	2407	10	is	be	VBZ
25944	2407	11	met	meet	VBN
25944	2407	12	with	with	IN
25944	2407	13	upon	upon	IN
25944	2407	14	all	all	DT
25944	2407	15	parts	part	NNS
25944	2407	16	of	of	IN
25944	2407	17	the	the	DT
25944	2407	18	body	body	NN
25944	2407	19	.	.	.
25944	2408	1	#	#	LS
25944	2408	2	What	what	WP
25944	2408	3	is	be	VBZ
25944	2408	4	the	the	DT
25944	2408	5	pathology	pathology	NN
25944	2408	6	of	of	IN
25944	2408	7	angioma	angioma	NN
25944	2408	8	?	?	.
25944	2408	9	#	#	$
25944	2408	10	It	-PRON-	PRP
25944	2408	11	is	be	VBZ
25944	2408	12	a	a	DT
25944	2408	13	new	new	JJ
25944	2408	14	growth	growth	NN
25944	2408	15	,	,	,
25944	2408	16	consisting	consist	VBG
25944	2408	17	of	of	IN
25944	2408	18	a	a	DT
25944	2408	19	variable	variable	JJ
25944	2408	20	hypertrophy	hypertrophy	NN
25944	2408	21	of	of	IN
25944	2408	22	the	the	DT
25944	2408	23	cutaneous	cutaneous	JJ
25944	2408	24	and	and	CC
25944	2408	25	subcutaneous	subcutaneous	JJ
25944	2408	26	arterial	arterial	JJ
25944	2408	27	and	and	CC
25944	2408	28	venous	venous	JJ
25944	2408	29	bloodvessels	bloodvessel	NNS
25944	2408	30	,	,	,
25944	2408	31	with	with	IN
25944	2408	32	or	or	CC
25944	2408	33	without	without	IN
25944	2408	34	an	an	DT
25944	2408	35	increase	increase	NN
25944	2408	36	of	of	IN
25944	2408	37	the	the	DT
25944	2408	38	connective	connective	JJ
25944	2408	39	tissue	tissue	NN
25944	2408	40	.	.	.
25944	2409	1	#	#	NN
25944	2409	2	Give	give	VB
25944	2409	3	the	the	DT
25944	2409	4	treatment	treatment	NN
25944	2409	5	of	of	IN
25944	2409	6	angioma	angioma	NN
25944	2409	7	.	.	.
25944	2409	8	#	#	$
25944	2409	9	In	in	IN
25944	2409	10	some	some	DT
25944	2409	11	instances	instance	NNS
25944	2409	12	,	,	,
25944	2409	13	especially	especially	RB
25944	2409	14	in	in	IN
25944	2409	15	infants	infant	NNS
25944	2409	16	,	,	,
25944	2409	17	painting	paint	VBG
25944	2409	18	the	the	DT
25944	2409	19	parts	part	NNS
25944	2409	20	repeatedly	repeatedly	RB
25944	2409	21	with	with	IN
25944	2409	22	collodion	collodion	NN
25944	2409	23	or	or	CC
25944	2409	24	liquor	liquor	NN
25944	2409	25	plumbi	plumbi	NNP
25944	2409	26	subacetatis	subacetatis	NNP
25944	2409	27	will	will	MD
25944	2409	28	act	act	VB
25944	2409	29	favorably	favorably	RB
25944	2409	30	.	.	.
25944	2410	1	For	for	IN
25944	2410	2	well	well	RB
25944	2410	3	-	-	HYPH
25944	2410	4	established	establish	VBN
25944	2410	5	,	,	,
25944	2410	6	small	small	JJ
25944	2410	7	,	,	,
25944	2410	8	capillary	capillary	JJ
25944	2410	9	nævi	nævi	JJ
25944	2410	10	electrolysis	electrolysis	NN
25944	2410	11	or	or	CC
25944	2410	12	puncturing	puncture	VBG
25944	2410	13	with	with	IN
25944	2410	14	a	a	DT
25944	2410	15	red	red	JJ
25944	2410	16	-	-	HYPH
25944	2410	17	hot	hot	JJ
25944	2410	18	needle	needle	NN
25944	2410	19	or	or	CC
25944	2410	20	with	with	IN
25944	2410	21	a	a	DT
25944	2410	22	needle	needle	NN
25944	2410	23	charged	charge	VBN
25944	2410	24	with	with	IN
25944	2410	25	nitric	nitric	JJ
25944	2410	26	acid	acid	NN
25944	2410	27	may	may	MD
25944	2410	28	be	be	VB
25944	2410	29	employed	employ	VBN
25944	2410	30	;	;	:
25944	2410	31	for	for	IN
25944	2410	32	"	"	``
25944	2410	33	port	port	NN
25944	2410	34	-	-	HYPH
25944	2410	35	wine	wine	NN
25944	2410	36	mark	mark	NN
25944	2410	37	"	"	''
25944	2410	38	frequent	frequent	JJ
25944	2410	39	and	and	CC
25944	2410	40	closely	closely	RB
25944	2410	41	contiguous	contiguous	JJ
25944	2410	42	electrolytic	electrolytic	JJ
25944	2410	43	punctures	puncture	NNS
25944	2410	44	are	be	VBP
25944	2410	45	occasionally	occasionally	RB
25944	2410	46	followed	follow	VBN
25944	2410	47	by	by	IN
25944	2410	48	a	a	DT
25944	2410	49	slight	slight	JJ
25944	2410	50	diminution	diminution	NN
25944	2410	51	in	in	IN
25944	2410	52	color	color	NN
25944	2410	53	.	.	.
25944	2411	1	For	for	IN
25944	2411	2	the	the	DT
25944	2411	3	_	_	NNP
25944	2411	4	prominent	prominent	JJ
25944	2411	5	growths	growth	NNS
25944	2411	6	_	_	NNP
25944	2411	7	,	,	,
25944	2411	8	vaccination	vaccination	NN
25944	2411	9	,	,	,
25944	2411	10	the	the	DT
25944	2411	11	ligature	ligature	NN
25944	2411	12	,	,	,
25944	2411	13	puncturing	puncture	VBG
25944	2411	14	with	with	IN
25944	2411	15	the	the	DT
25944	2411	16	galvano	galvano	NN
25944	2411	17	-	-	HYPH
25944	2411	18	cautery	cautery	NN
25944	2411	19	,	,	,
25944	2411	20	and	and	CC
25944	2411	21	excision	excision	NN
25944	2411	22	are	be	VBP
25944	2411	23	variously	variously	RB
25944	2411	24	resorted	resort	VBN
25944	2411	25	to	to	IN
25944	2411	26	.	.	.
25944	2412	1	In	in	IN
25944	2412	2	recent	recent	JJ
25944	2412	3	years	year	NNS
25944	2412	4	applications	application	NNS
25944	2412	5	of	of	IN
25944	2412	6	liquid	liquid	JJ
25944	2412	7	air	air	NN
25944	2412	8	and	and	CC
25944	2412	9	carbon	carbon	NN
25944	2412	10	dioxide	dioxide	NN
25944	2412	11	have	have	VBP
25944	2412	12	proved	prove	VBN
25944	2412	13	of	of	IN
25944	2412	14	service	service	NN
25944	2412	15	in	in	IN
25944	2412	16	some	some	DT
25944	2412	17	cases	case	NNS
25944	2412	18	.	.	.
25944	2413	1	#	#	NNP
25944	2413	2	Telangiectasis	Telangiectasis	NNP
25944	2413	3	.	.	.
25944	2413	4	#	#	$
25944	2413	5	#	#	$
25944	2413	6	Describe	Describe	NNP
25944	2413	7	telangiectasis	telangiectasis	NN
25944	2413	8	.	.	.
25944	2413	9	#	#	$
25944	2413	10	Telangiectasis	Telangiectasis	NNP
25944	2413	11	consists	consist	VBZ
25944	2413	12	of	of	IN
25944	2413	13	a	a	DT
25944	2413	14	new	new	JJ
25944	2413	15	growth	growth	NN
25944	2413	16	or	or	CC
25944	2413	17	enlargement	enlargement	NN
25944	2413	18	of	of	IN
25944	2413	19	the	the	DT
25944	2413	20	cutaneous	cutaneous	JJ
25944	2413	21	capillaries	capillary	NNS
25944	2413	22	,	,	,
25944	2413	23	usually	usually	RB
25944	2413	24	appearing	appear	VBG
25944	2413	25	during	during	IN
25944	2413	26	middle	middle	JJ
25944	2413	27	adult	adult	NN
25944	2413	28	life	life	NN
25944	2413	29	,	,	,
25944	2413	30	and	and	CC
25944	2413	31	seated	seat	VBN
25944	2413	32	,	,	,
25944	2413	33	for	for	IN
25944	2413	34	the	the	DT
25944	2413	35	most	most	JJS
25944	2413	36	part	part	NN
25944	2413	37	,	,	,
25944	2413	38	about	about	IN
25944	2413	39	the	the	DT
25944	2413	40	face	face	NN
25944	2413	41	.	.	.
25944	2414	1	#	#	$
25944	2414	2	To	to	TO
25944	2414	3	what	what	WDT
25944	2414	4	extent	extent	NN
25944	2414	5	may	may	MD
25944	2414	6	telangiectasis	telangiectasis	VB
25944	2414	7	develop	develop	VB
25944	2414	8	?	?	.
25944	2414	9	#	#	$
25944	2414	10	It	-PRON-	PRP
25944	2414	11	may	may	MD
25944	2414	12	be	be	VB
25944	2414	13	limited	limit	VBN
25944	2414	14	to	to	IN
25944	2414	15	a	a	DT
25944	2414	16	red	red	JJ
25944	2414	17	dot	dot	NN
25944	2414	18	or	or	CC
25944	2414	19	point	point	NN
25944	2414	20	,	,	,
25944	2414	21	with	with	IN
25944	2414	22	several	several	JJ
25944	2414	23	small	small	JJ
25944	2414	24	radiating	radiate	VBG
25944	2414	25	capillaries	capillary	NNS
25944	2414	26	(	(	-LRB-
25944	2414	27	_	_	NNP
25944	2414	28	nævus	nævus	NNP
25944	2414	29	araneus	araneus	NNP
25944	2414	30	_	_	NNP
25944	2414	31	,	,	,
25944	2414	32	_	_	NNP
25944	2414	33	spider	spider	NN
25944	2414	34	nævus	nævus	RB
25944	2414	35	_	_	NNP
25944	2414	36	)	)	-RRB-
25944	2414	37	,	,	,
25944	2414	38	or	or	CC
25944	2414	39	a	a	DT
25944	2414	40	whole	whole	JJ
25944	2414	41	region	region	NN
25944	2414	42	,	,	,
25944	2414	43	usually	usually	RB
25944	2414	44	the	the	DT
25944	2414	45	face	face	NN
25944	2414	46	,	,	,
25944	2414	47	may	may	MD
25944	2414	48	show	show	VB
25944	2414	49	numerous	numerous	JJ
25944	2414	50	scattered	scatter	VBN
25944	2414	51	or	or	CC
25944	2414	52	closely	closely	RB
25944	2414	53	-	-	HYPH
25944	2414	54	set	set	VBN
25944	2414	55	capillary	capillary	JJ
25944	2414	56	enlargements	enlargement	NNS
25944	2414	57	or	or	CC
25944	2414	58	new	new	JJ
25944	2414	59	formations	formation	NNS
25944	2414	60	(	(	-LRB-
25944	2414	61	_	_	NNP
25944	2414	62	rosacea	rosacea	NNP
25944	2414	63	_	_	NNP
25944	2414	64	)	)	-RRB-
25944	2414	65	.	.	.
25944	2415	1	The	the	DT
25944	2415	2	latter	latter	JJ
25944	2415	3	is	be	VBZ
25944	2415	4	frequently	frequently	RB
25944	2415	5	associated	associate	VBN
25944	2415	6	with	with	IN
25944	2415	7	acne	acne	NNP
25944	2415	8	(	(	-LRB-
25944	2415	9	_	_	NNP
25944	2415	10	acne	acne	NNP
25944	2415	11	rosacea	rosacea	NNP
25944	2415	12	_	_	NNP
25944	2415	13	)	)	-RRB-
25944	2415	14	.	.	.
25944	2416	1	The	the	DT
25944	2416	2	etiology	etiology	NN
25944	2416	3	is	be	VBZ
25944	2416	4	obscure	obscure	JJ
25944	2416	5	.	.	.
25944	2417	1	#	#	LS
25944	2417	2	What	what	WP
25944	2417	3	is	be	VBZ
25944	2417	4	the	the	DT
25944	2417	5	treatment	treatment	NN
25944	2417	6	of	of	IN
25944	2417	7	telangiectasis	telangiectasis	NN
25944	2417	8	?	?	.
25944	2417	9	#	#	$
25944	2417	10	Destruction	destruction	NN
25944	2417	11	of	of	IN
25944	2417	12	the	the	DT
25944	2417	13	vessels	vessel	NNS
25944	2417	14	by	by	IN
25944	2417	15	electrolysis	electrolysis	NN
25944	2417	16	or	or	CC
25944	2417	17	by	by	IN
25944	2417	18	the	the	DT
25944	2417	19	knife	knife	NN
25944	2417	20	.	.	.
25944	2418	1	(	(	-LRB-
25944	2418	2	See	see	VB
25944	2418	3	treatment	treatment	NN
25944	2418	4	of	of	IN
25944	2418	5	acne	acne	NNP
25944	2418	6	rosacea	rosacea	NNP
25944	2418	7	.	.	.
25944	2418	8	)	)	-RRB-
25944	2419	1	#	#	NNP
25944	2419	2	Lymphangioma	Lymphangioma	NNP
25944	2419	3	.	.	.
25944	2419	4	#	#	NNP
25944	2419	5	(	(	-LRB-
25944	2419	6	_	_	NNP
25944	2419	7	Synonym	Synonym	NNP
25944	2419	8	:	:	:
25944	2419	9	_	_	NNP
25944	2419	10	Lymphangiectodes	Lymphangiectodes	NNP
25944	2419	11	.	.	.
25944	2419	12	)	)	-RRB-
25944	2420	1	#	#	NNP
25944	2420	2	Describe	Describe	NNP
25944	2420	3	lymphangioma	lymphangioma	NNS
25944	2420	4	.	.	.
25944	2420	5	#	#	$
25944	2420	6	Lymphangioma	Lymphangioma	NNP
25944	2420	7	is	be	VBZ
25944	2420	8	a	a	DT
25944	2420	9	rare	rare	JJ
25944	2420	10	disease	disease	NN
25944	2420	11	,	,	,
25944	2420	12	consisting	consist	VBG
25944	2420	13	of	of	IN
25944	2420	14	localized	localized	JJ
25944	2420	15	dilatations	dilatation	NNS
25944	2420	16	of	of	IN
25944	2420	17	the	the	DT
25944	2420	18	lymphatic	lymphatic	JJ
25944	2420	19	vessels	vessel	NNS
25944	2420	20	,	,	,
25944	2420	21	appearing	appear	VBG
25944	2420	22	as	as	IN
25944	2420	23	discrete	discrete	JJ
25944	2420	24	or	or	CC
25944	2420	25	aggregated	aggregate	VBN
25944	2420	26	pin	pin	NN
25944	2420	27	-	-	HYPH
25944	2420	28	head	head	NN
25944	2420	29	or	or	CC
25944	2420	30	pea	pea	NN
25944	2420	31	-	-	HYPH
25944	2420	32	sized	sized	JJ
25944	2420	33	,	,	,
25944	2420	34	compressible	compressible	JJ
25944	2420	35	,	,	,
25944	2420	36	hollow	hollow	JJ
25944	2420	37	,	,	,
25944	2420	38	tubercle	tubercle	NN
25944	2420	39	-	-	HYPH
25944	2420	40	like	like	JJ
25944	2420	41	elevations	elevation	NNS
25944	2420	42	,	,	,
25944	2420	43	of	of	IN
25944	2420	44	a	a	DT
25944	2420	45	pinkish	pinkish	NN
25944	2420	46	or	or	CC
25944	2420	47	faint	faint	JJ
25944	2420	48	lilac	lilac	NNS
25944	2420	49	color	color	NN
25944	2420	50	,	,	,
25944	2420	51	and	and	CC
25944	2420	52	occurring	occur	VBG
25944	2420	53	for	for	IN
25944	2420	54	the	the	DT
25944	2420	55	most	most	JJS
25944	2420	56	part	part	NN
25944	2420	57	about	about	IN
25944	2420	58	the	the	DT
25944	2420	59	trunk	trunk	NN
25944	2420	60	.	.	.
25944	2421	1	It	-PRON-	PRP
25944	2421	2	is	be	VBZ
25944	2421	3	of	of	IN
25944	2421	4	slow	slow	JJ
25944	2421	5	but	but	CC
25944	2421	6	usually	usually	RB
25944	2421	7	progressive	progressive	JJ
25944	2421	8	development	development	NN
25944	2421	9	,	,	,
25944	2421	10	and	and	CC
25944	2421	11	is	be	VBZ
25944	2421	12	unaccompanied	unaccompanied	JJ
25944	2421	13	by	by	IN
25944	2421	14	subjective	subjective	JJ
25944	2421	15	symptoms	symptom	NNS
25944	2421	16	.	.	.
25944	2422	1	A	a	DT
25944	2422	2	rare	rare	JJ
25944	2422	3	condition	condition	NN
25944	2422	4	,	,	,
25944	2422	5	Kaposi	Kaposi	NNP
25944	2422	6	described	describe	VBD
25944	2422	7	as	as	IN
25944	2422	8	lymphangioma	lymphangioma	NNP
25944	2422	9	tuberosum	tuberosum	NN
25944	2422	10	multiplex	multiplex	NNP
25944	2422	11	,	,	,
25944	2422	12	characterized	characterize	VBN
25944	2422	13	by	by	IN
25944	2422	14	more	more	RBR
25944	2422	15	or	or	CC
25944	2422	16	less	less	RBR
25944	2422	17	solid	solid	JJ
25944	2422	18	,	,	,
25944	2422	19	somewhat	somewhat	RB
25944	2422	20	cystic	cystic	JJ
25944	2422	21	,	,	,
25944	2422	22	pearly	pearly	RB
25944	2422	23	to	to	TO
25944	2422	24	pinkish	pinkish	VB
25944	2422	25	red	red	NN
25944	2422	26	,	,	,
25944	2422	27	sometimes	sometimes	RB
25944	2422	28	crowded	crowd	VBD
25944	2422	29	lesions	lesion	NNS
25944	2422	30	,	,	,
25944	2422	31	is	be	VBZ
25944	2422	32	now	now	RB
25944	2422	33	known	know	VBN
25944	2422	34	to	to	TO
25944	2422	35	be	be	VB
25944	2422	36	"	"	``
25944	2422	37	benign	benign	JJ
25944	2422	38	cystic	cystic	JJ
25944	2422	39	epithelioma	epithelioma	NN
25944	2422	40	"	"	''
25944	2422	41	;	;	:
25944	2422	42	its	-PRON-	PRP$
25944	2422	43	most	most	RBS
25944	2422	44	common	common	JJ
25944	2422	45	site	site	NN
25944	2422	46	is	be	VBZ
25944	2422	47	the	the	DT
25944	2422	48	face	face	NN
25944	2422	49	.	.	.
25944	2423	1	While	while	IN
25944	2423	2	called	call	VBN
25944	2423	3	"	"	``
25944	2423	4	benign	benign	JJ
25944	2423	5	,	,	,
25944	2423	6	"	"	''
25944	2423	7	ulcerative	ulcerative	JJ
25944	2423	8	action	action	NN
25944	2423	9	may	may	MD
25944	2423	10	eventually	eventually	RB
25944	2423	11	ensue	ensue	VB
25944	2423	12	.	.	.
25944	2424	1	Treatment	treatment	NN
25944	2424	2	,	,	,
25944	2424	3	when	when	WRB
25944	2424	4	demanded	demand	VBD
25944	2424	5	,	,	,
25944	2424	6	consists	consist	VBZ
25944	2424	7	of	of	IN
25944	2424	8	operative	operative	JJ
25944	2424	9	measures	measure	NNS
25944	2424	10	.	.	.
25944	2425	1	#	#	NNP
25944	2425	2	Rhinoscleroma	Rhinoscleroma	NNP
25944	2425	3	.	.	.
25944	2425	4	#	#	$
25944	2425	5	#	#	$
25944	2425	6	Describe	Describe	NNP
25944	2425	7	rhinoscleroma	rhinoscleroma	NN
25944	2425	8	.	.	.
25944	2425	9	#	#	$
25944	2425	10	Rhinoscleroma	Rhinoscleroma	NNP
25944	2425	11	is	be	VBZ
25944	2425	12	a	a	DT
25944	2425	13	rare	rare	JJ
25944	2425	14	and	and	CC
25944	2425	15	obscure	obscure	JJ
25944	2425	16	disease	disease	NN
25944	2425	17	,	,	,
25944	2425	18	slow	slow	JJ
25944	2425	19	but	but	CC
25944	2425	20	progressive	progressive	JJ
25944	2425	21	in	in	IN
25944	2425	22	its	-PRON-	PRP$
25944	2425	23	course	course	NN
25944	2425	24	,	,	,
25944	2425	25	characterized	characterize	VBN
25944	2425	26	by	by	IN
25944	2425	27	the	the	DT
25944	2425	28	development	development	NN
25944	2425	29	of	of	IN
25944	2425	30	an	an	DT
25944	2425	31	irregular	irregular	JJ
25944	2425	32	,	,	,
25944	2425	33	dense	dense	JJ
25944	2425	34	and	and	CC
25944	2425	35	hard	hard	JJ
25944	2425	36	,	,	,
25944	2425	37	flattened	flatten	VBD
25944	2425	38	,	,	,
25944	2425	39	tubercular	tubercular	JJ
25944	2425	40	,	,	,
25944	2425	41	non	non	JJ
25944	2425	42	-	-	JJ
25944	2425	43	ulcerating	ulcerating	JJ
25944	2425	44	,	,	,
25944	2425	45	cellular	cellular	JJ
25944	2425	46	new	new	JJ
25944	2425	47	growth	growth	NN
25944	2425	48	,	,	,
25944	2425	49	having	have	VBG
25944	2425	50	its	-PRON-	PRP$
25944	2425	51	seat	seat	NN
25944	2425	52	about	about	IN
25944	2425	53	the	the	DT
25944	2425	54	nose	nose	NN
25944	2425	55	and	and	CC
25944	2425	56	contiguous	contiguous	JJ
25944	2425	57	parts	part	NNS
25944	2425	58	.	.	.
25944	2426	1	The	the	DT
25944	2426	2	overlying	overlying	NN
25944	2426	3	skin	skin	NN
25944	2426	4	is	be	VBZ
25944	2426	5	normal	normal	JJ
25944	2426	6	in	in	IN
25944	2426	7	color	color	NN
25944	2426	8	,	,	,
25944	2426	9	or	or	CC
25944	2426	10	it	-PRON-	PRP
25944	2426	11	may	may	MD
25944	2426	12	be	be	VB
25944	2426	13	light-	light-	JJ
25944	2426	14	or	or	CC
25944	2426	15	dark	dark	JJ
25944	2426	16	-	-	HYPH
25944	2426	17	brown	brown	JJ
25944	2426	18	or	or	CC
25944	2426	19	reddish	reddish	JJ
25944	2426	20	.	.	.
25944	2427	1	Marked	mark	VBN
25944	2427	2	disfigurement	disfigurement	NN
25944	2427	3	and	and	CC
25944	2427	4	closure	closure	NN
25944	2427	5	,	,	,
25944	2427	6	partial	partial	JJ
25944	2427	7	or	or	CC
25944	2427	8	complete	complete	JJ
25944	2427	9	,	,	,
25944	2427	10	of	of	IN
25944	2427	11	the	the	DT
25944	2427	12	nasal	nasal	NN
25944	2427	13	orifices	orifice	NNS
25944	2427	14	gradually	gradually	RB
25944	2427	15	results	result	VBZ
25944	2427	16	.	.	.
25944	2428	1	It	-PRON-	PRP
25944	2428	2	is	be	VBZ
25944	2428	3	met	meet	VBN
25944	2428	4	with	with	IN
25944	2428	5	chiefly	chiefly	NNP
25944	2428	6	in	in	IN
25944	2428	7	Austria	Austria	NNP
25944	2428	8	and	and	CC
25944	2428	9	Germany	Germany	NNP
25944	2428	10	.	.	.
25944	2429	1	Treatment	treatment	NN
25944	2429	2	,	,	,
25944	2429	3	consisting	consist	VBG
25944	2429	4	of	of	IN
25944	2429	5	partial	partial	JJ
25944	2429	6	or	or	CC
25944	2429	7	complete	complete	JJ
25944	2429	8	extirpation	extirpation	NN
25944	2429	9	,	,	,
25944	2429	10	is	be	VBZ
25944	2429	11	rarely	rarely	RB
25944	2429	12	permanent	permanent	JJ
25944	2429	13	in	in	IN
25944	2429	14	its	-PRON-	PRP$
25944	2429	15	results	result	NNS
25944	2429	16	,	,	,
25944	2429	17	the	the	DT
25944	2429	18	disease	disease	NN
25944	2429	19	tending	tend	VBG
25944	2429	20	to	to	TO
25944	2429	21	recur	recur	VB
25944	2429	22	.	.	.
25944	2430	1	#	#	NNP
25944	2430	2	Lupus	Lupus	NNP
25944	2430	3	Erythematosus	Erythematosus	NNP
25944	2430	4	.	.	.
25944	2430	5	#	#	NNP
25944	2430	6	(	(	-LRB-
25944	2430	7	_	_	NNP
25944	2430	8	Synonyms	Synonyms	NNP
25944	2430	9	:	:	:
25944	2430	10	_	_	NNP
25944	2430	11	Lupus	Lupus	NNP
25944	2430	12	Erythematodes	Erythematodes	NNPS
25944	2430	13	;	;	:
25944	2430	14	Lupus	Lupus	NNP
25944	2430	15	Sebaceus	Sebaceus	NNP
25944	2430	16	;	;	:
25944	2430	17	Seborrh[oe]a	seborrh[oe]a	CD
25944	2430	18	Congestiva	Congestiva	NNP
25944	2430	19	.	.	.
25944	2430	20	)	)	-RRB-
25944	2431	1	#	#	LS
25944	2431	2	What	what	WP
25944	2431	3	is	be	VBZ
25944	2431	4	lupus	lupus	NN
25944	2431	5	erythematosus	erythematosus	NN
25944	2431	6	?	?	.
25944	2431	7	#	#	NNP
25944	2431	8	Lupus	Lupus	NNP
25944	2431	9	erythematosus	erythematosus	NN
25944	2431	10	may	may	MD
25944	2431	11	be	be	VB
25944	2431	12	roughly	roughly	RB
25944	2431	13	defined	define	VBN
25944	2431	14	as	as	IN
25944	2431	15	a	a	DT
25944	2431	16	mildly	mildly	RB
25944	2431	17	to	to	IN
25944	2431	18	moderately	moderately	RB
25944	2431	19	inflammatory	inflammatory	JJ
25944	2431	20	superficial	superficial	JJ
25944	2431	21	new	new	JJ
25944	2431	22	-	-	HYPH
25944	2431	23	growth	growth	NN
25944	2431	24	formation	formation	NN
25944	2431	25	,	,	,
25944	2431	26	characterized	characterize	VBN
25944	2431	27	by	by	IN
25944	2431	28	one	one	CD
25944	2431	29	,	,	,
25944	2431	30	several	several	JJ
25944	2431	31	,	,	,
25944	2431	32	or	or	CC
25944	2431	33	more	more	RBR
25944	2431	34	circumscribed	circumscribed	JJ
25944	2431	35	,	,	,
25944	2431	36	variously	variously	RB
25944	2431	37	sized	sized	JJ
25944	2431	38	and	and	CC
25944	2431	39	shaped	shaped	JJ
25944	2431	40	,	,	,
25944	2431	41	pinkish	pinkish	JJ
25944	2431	42	or	or	CC
25944	2431	43	dark	dark	JJ
25944	2431	44	red	red	JJ
25944	2431	45	patches	patch	NNS
25944	2431	46	,	,	,
25944	2431	47	covered	cover	VBN
25944	2431	48	slightly	slightly	RB
25944	2431	49	,	,	,
25944	2431	50	and	and	CC
25944	2431	51	more	more	RBR
25944	2431	52	or	or	CC
25944	2431	53	less	less	RBR
25944	2431	54	irregularly	irregularly	RB
25944	2431	55	,	,	,
25944	2431	56	with	with	IN
25944	2431	57	adherent	adherent	JJ
25944	2431	58	grayish	grayish	NN
25944	2431	59	or	or	CC
25944	2431	60	yellowish	yellowish	JJ
25944	2431	61	scales	scale	NNS
25944	2431	62	.	.	.
25944	2432	1	#	#	NN
25944	2432	2	Upon	upon	IN
25944	2432	3	what	what	WP
25944	2432	4	parts	part	NNS
25944	2432	5	is	be	VBZ
25944	2432	6	lupus	lupus	NNP
25944	2432	7	erythematosus	erythematosu	VBG
25944	2432	8	observed	observe	VBN
25944	2432	9	?	?	.
25944	2432	10	#	#	$
25944	2432	11	Its	-PRON-	PRP$
25944	2432	12	common	common	JJ
25944	2432	13	site	site	NN
25944	2432	14	is	be	VBZ
25944	2432	15	the	the	DT
25944	2432	16	face	face	NN
25944	2432	17	,	,	,
25944	2432	18	usually	usually	RB
25944	2432	19	the	the	DT
25944	2432	20	nose	nose	NN
25944	2432	21	and	and	CC
25944	2432	22	cheeks	cheek	NNS
25944	2432	23	,	,	,
25944	2432	24	with	with	IN
25944	2432	25	a	a	DT
25944	2432	26	tendency	tendency	NN
25944	2432	27	toward	toward	IN
25944	2432	28	symmetry	symmetry	NN
25944	2432	29	;	;	:
25944	2432	30	it	-PRON-	PRP
25944	2432	31	is	be	VBZ
25944	2432	32	often	often	RB
25944	2432	33	limited	limited	JJ
25944	2432	34	to	to	IN
25944	2432	35	these	these	DT
25944	2432	36	parts	part	NNS
25944	2432	37	,	,	,
25944	2432	38	but	but	CC
25944	2432	39	may	may	MD
25944	2432	40	occasionally	occasionally	RB
25944	2432	41	be	be	VB
25944	2432	42	seen	see	VBN
25944	2432	43	upon	upon	IN
25944	2432	44	other	other	JJ
25944	2432	45	regions	region	NNS
25944	2432	46	,	,	,
25944	2432	47	more	more	RBR
25944	2432	48	especially	especially	RB
25944	2432	49	the	the	DT
25944	2432	50	lips	lip	NNS
25944	2432	51	,	,	,
25944	2432	52	ears	ear	NNS
25944	2432	53	,	,	,
25944	2432	54	and	and	CC
25944	2432	55	scalp	scalp	NNP
25944	2432	56	.	.	.
25944	2433	1	In	in	IN
25944	2433	2	rare	rare	JJ
25944	2433	3	instances	instance	NNS
25944	2433	4	a	a	DT
25944	2433	5	great	great	JJ
25944	2433	6	part	part	NN
25944	2433	7	of	of	IN
25944	2433	8	the	the	DT
25944	2433	9	general	general	JJ
25944	2433	10	surface	surface	NN
25944	2433	11	may	may	MD
25944	2433	12	become	become	VB
25944	2433	13	involved	involved	JJ
25944	2433	14	.	.	.
25944	2434	1	#	#	NNP
25944	2434	2	Describe	describe	VB
25944	2434	3	the	the	DT
25944	2434	4	symptoms	symptom	NNS
25944	2434	5	of	of	IN
25944	2434	6	lupus	lupus	NNP
25944	2434	7	erythematosus	erythematosus	NNP
25944	2434	8	.	.	.
25944	2434	9	#	#	$
25944	2434	10	Usually	usually	RB
25944	2434	11	the	the	DT
25944	2434	12	disease	disease	NN
25944	2434	13	begins	begin	VBZ
25944	2434	14	as	as	IN
25944	2434	15	one	one	CD
25944	2434	16	or	or	CC
25944	2434	17	several	several	JJ
25944	2434	18	rounded	rounded	JJ
25944	2434	19	,	,	,
25944	2434	20	circumscribed	circumscribe	VBN
25944	2434	21	,	,	,
25944	2434	22	pin	pin	NN
25944	2434	23	-	-	HYPH
25944	2434	24	head-	head-	NN
25944	2434	25	to	to	IN
25944	2434	26	pea	pea	JJ
25944	2434	27	-	-	HYPH
25944	2434	28	sized	sized	JJ
25944	2434	29	lesions	lesion	NNS
25944	2434	30	;	;	:
25944	2434	31	slightly	slightly	RB
25944	2434	32	scaly	scaly	NNP
25944	2434	33	,	,	,
25944	2434	34	somewhat	somewhat	RB
25944	2434	35	elevated	elevated	JJ
25944	2434	36	,	,	,
25944	2434	37	and	and	CC
25944	2434	38	of	of	IN
25944	2434	39	a	a	DT
25944	2434	40	pinkish	pinkish	JJ
25944	2434	41	,	,	,
25944	2434	42	reddish	reddish	JJ
25944	2434	43	or	or	CC
25944	2434	44	violaceous	violaceous	JJ
25944	2434	45	color	color	NN
25944	2434	46	.	.	.
25944	2435	1	They	-PRON-	PRP
25944	2435	2	slowly	slowly	RB
25944	2435	3	,	,	,
25944	2435	4	or	or	CC
25944	2435	5	somewhat	somewhat	RB
25944	2435	6	rapidly	rapidly	RB
25944	2435	7	,	,	,
25944	2435	8	increase	increase	VBP
25944	2435	9	in	in	IN
25944	2435	10	area	area	NN
25944	2435	11	,	,	,
25944	2435	12	and	and	CC
25944	2435	13	after	after	IN
25944	2435	14	attaining	attain	VBG
25944	2435	15	variable	variable	JJ
25944	2435	16	size	size	NN
25944	2435	17	remain	remain	VBP
25944	2435	18	stationary	stationary	JJ
25944	2435	19	;	;	:
25944	2435	20	or	or	CC
25944	2435	21	they	-PRON-	PRP
25944	2435	22	may	may	MD
25944	2435	23	progress	progress	VB
25944	2435	24	and	and	CC
25944	2435	25	coalesce	coalesce	NN
25944	2435	26	,	,	,
25944	2435	27	and	and	CC
25944	2435	28	in	in	IN
25944	2435	29	this	this	DT
25944	2435	30	manner	manner	NN
25944	2435	31	sooner	soon	RBR
25944	2435	32	or	or	CC
25944	2435	33	later	later	RB
25944	2435	34	involve	involve	VBP
25944	2435	35	considerable	considerable	JJ
25944	2435	36	surface	surface	NN
25944	2435	37	.	.	.
25944	2436	1	The	the	DT
25944	2436	2	patches	patch	NNS
25944	2436	3	are	be	VBP
25944	2436	4	sharply	sharply	RB
25944	2436	5	defined	define	VBN
25944	2436	6	against	against	IN
25944	2436	7	the	the	DT
25944	2436	8	sound	sound	JJ
25944	2436	9	skin	skin	NN
25944	2436	10	by	by	IN
25944	2436	11	an	an	DT
25944	2436	12	elevated	elevated	JJ
25944	2436	13	border	border	NN
25944	2436	14	,	,	,
25944	2436	15	while	while	IN
25944	2436	16	the	the	DT
25944	2436	17	central	central	JJ
25944	2436	18	portion	portion	NN
25944	2436	19	is	be	VBZ
25944	2436	20	somewhat	somewhat	RB
25944	2436	21	depressed	depressed	JJ
25944	2436	22	and	and	CC
25944	2436	23	usually	usually	RB
25944	2436	24	atrophic	atrophic	JJ
25944	2436	25	.	.	.
25944	2437	1	More	more	RBR
25944	2437	2	or	or	CC
25944	2437	3	less	less	RBR
25944	2437	4	thickening	thickening	NN
25944	2437	5	and	and	CC
25944	2437	6	infiltration	infiltration	NN
25944	2437	7	are	be	VBP
25944	2437	8	observed	observe	VBN
25944	2437	9	.	.	.
25944	2438	1	_	_	NNP
25944	2438	2	There	there	EX
25944	2438	3	is	be	VBZ
25944	2438	4	no	no	DT
25944	2438	5	tendency	tendency	NN
25944	2438	6	to	to	TO
25944	2438	7	ulceration	ulceration	NN
25944	2438	8	_	_	NNP
25944	2438	9	.	.	.
25944	2439	1	The	the	DT
25944	2439	2	scaliness	scaliness	NN
25944	2439	3	is	be	VBZ
25944	2439	4	,	,	,
25944	2439	5	as	as	IN
25944	2439	6	a	a	DT
25944	2439	7	rule	rule	NN
25944	2439	8	,	,	,
25944	2439	9	scanty	scanty	NN
25944	2439	10	.	.	.
25944	2440	1	The	the	DT
25944	2440	2	gland	gland	NN
25944	2440	3	-	-	HYPH
25944	2440	4	ducts	duct	NNS
25944	2440	5	are	be	VBP
25944	2440	6	enlarged	enlarge	VBN
25944	2440	7	,	,	,
25944	2440	8	patulous	patulous	JJ
25944	2440	9	or	or	CC
25944	2440	10	plugged	plug	VBN
25944	2440	11	with	with	IN
25944	2440	12	sebaceous	sebaceous	JJ
25944	2440	13	and	and	CC
25944	2440	14	epithelial	epithelial	JJ
25944	2440	15	matter	matter	NN
25944	2440	16	.	.	.
25944	2441	1	The	the	DT
25944	2441	2	subjective	subjective	JJ
25944	2441	3	symptoms	symptom	NNS
25944	2441	4	of	of	IN
25944	2441	5	burning	burning	NN
25944	2441	6	and	and	CC
25944	2441	7	itching	itching	NN
25944	2441	8	are	be	VBP
25944	2441	9	usually	usually	RB
25944	2441	10	slight	slight	JJ
25944	2441	11	and	and	CC
25944	2441	12	often	often	RB
25944	2441	13	wanting	want	VBG
25944	2441	14	.	.	.
25944	2442	1	#	#	LS
25944	2442	2	What	what	WDT
25944	2442	3	course	course	NN
25944	2442	4	does	do	VBZ
25944	2442	5	lupus	lupus	NNP
25944	2442	6	erythematosus	erythematosus	NNP
25944	2442	7	pursue	pursue	VB
25944	2442	8	?	?	.
25944	2442	9	#	#	NN
25944	2442	10	As	as	IN
25944	2442	11	a	a	DT
25944	2442	12	rule	rule	NN
25944	2442	13	,	,	,
25944	2442	14	the	the	DT
25944	2442	15	disease	disease	NN
25944	2442	16	is	be	VBZ
25944	2442	17	persistent	persistent	JJ
25944	2442	18	,	,	,
25944	2442	19	although	although	IN
25944	2442	20	somewhat	somewhat	RB
25944	2442	21	variable	variable	JJ
25944	2442	22	.	.	.
25944	2443	1	At	at	IN
25944	2443	2	times	time	NNS
25944	2443	3	the	the	DT
25944	2443	4	patches	patch	NNS
25944	2443	5	retrogress	retrogress	NN
25944	2443	6	,	,	,
25944	2443	7	involution	involution	NN
25944	2443	8	taking	take	VBG
25944	2443	9	place	place	NN
25944	2443	10	with	with	IN
25944	2443	11	or	or	CC
25944	2443	12	without	without	IN
25944	2443	13	slight	slight	JJ
25944	2443	14	sieve	sieve	NN
25944	2443	15	-	-	HYPH
25944	2443	16	like	like	JJ
25944	2443	17	atrophy	atrophy	NN
25944	2443	18	or	or	CC
25944	2443	19	scarring	scar	VBG
25944	2443	20	.	.	.
25944	2444	1	#	#	JJR
25944	2444	2	State	state	NN
25944	2444	3	the	the	DT
25944	2444	4	causes	cause	NNS
25944	2444	5	of	of	IN
25944	2444	6	lupus	lupus	NNP
25944	2444	7	erythematosus	erythematosus	NN
25944	2444	8	.	.	.
25944	2444	9	#	#	$
25944	2444	10	The	the	DT
25944	2444	11	etiology	etiology	NN
25944	2444	12	is	be	VBZ
25944	2444	13	obscure	obscure	JJ
25944	2444	14	.	.	.
25944	2445	1	Some	some	DT
25944	2445	2	observers	observer	NNS
25944	2445	3	believe	believe	VBP
25944	2445	4	it	-PRON-	PRP
25944	2445	5	to	to	TO
25944	2445	6	be	be	VB
25944	2445	7	a	a	DT
25944	2445	8	variety	variety	NN
25944	2445	9	of	of	IN
25944	2445	10	cutaneous	cutaneous	JJ
25944	2445	11	tuberculosis	tuberculosis	NN
25944	2445	12	.	.	.
25944	2446	1	It	-PRON-	PRP
25944	2446	2	is	be	VBZ
25944	2446	3	essentially	essentially	RB
25944	2446	4	a	a	DT
25944	2446	5	disease	disease	NN
25944	2446	6	of	of	IN
25944	2446	7	adult	adult	NN
25944	2446	8	and	and	CC
25944	2446	9	middle	middle	JJ
25944	2446	10	age	age	NN
25944	2446	11	;	;	:
25944	2446	12	is	be	VBZ
25944	2446	13	more	more	RBR
25944	2446	14	common	common	JJ
25944	2446	15	in	in	IN
25944	2446	16	women	woman	NNS
25944	2446	17	,	,	,
25944	2446	18	and	and	CC
25944	2446	19	more	more	RBR
25944	2446	20	frequent	frequent	JJ
25944	2446	21	in	in	IN
25944	2446	22	those	those	DT
25944	2446	23	having	have	VBG
25944	2446	24	a	a	DT
25944	2446	25	tendency	tendency	NN
25944	2446	26	to	to	IN
25944	2446	27	disorders	disorder	NNS
25944	2446	28	of	of	IN
25944	2446	29	the	the	DT
25944	2446	30	sebaceous	sebaceous	JJ
25944	2446	31	glands	gland	NNS
25944	2446	32	.	.	.
25944	2447	1	It	-PRON-	PRP
25944	2447	2	may	may	MD
25944	2447	3	,	,	,
25944	2447	4	in	in	IN
25944	2447	5	fact	fact	NN
25944	2447	6	,	,	,
25944	2447	7	begin	begin	VB
25944	2447	8	as	as	IN
25944	2447	9	a	a	DT
25944	2447	10	seborrh[oe]a	seborrh[oe]a	NNP
25944	2447	11	.	.	.
25944	2448	1	#	#	LS
25944	2448	2	What	what	WP
25944	2448	3	is	be	VBZ
25944	2448	4	the	the	DT
25944	2448	5	pathology	pathology	NN
25944	2448	6	?	?	.
25944	2448	7	#	#	$
25944	2448	8	It	-PRON-	PRP
25944	2448	9	was	be	VBD
25944	2448	10	formerly	formerly	RB
25944	2448	11	considered	consider	VBN
25944	2448	12	a	a	DT
25944	2448	13	new	new	JJ
25944	2448	14	growth	growth	NN
25944	2448	15	,	,	,
25944	2448	16	but	but	CC
25944	2448	17	recent	recent	JJ
25944	2448	18	opinion	opinion	NN
25944	2448	19	tends	tend	VBZ
25944	2448	20	toward	toward	IN
25944	2448	21	regarding	regard	VBG
25944	2448	22	it	-PRON-	PRP
25944	2448	23	as	as	IN
25944	2448	24	a	a	DT
25944	2448	25	chronic	chronic	JJ
25944	2448	26	inflammation	inflammation	NN
25944	2448	27	of	of	IN
25944	2448	28	the	the	DT
25944	2448	29	cutis	cutis	NN
25944	2448	30	,	,	,
25944	2448	31	superinducing	superinduce	VBG
25944	2448	32	degenerative	degenerative	JJ
25944	2448	33	and	and	CC
25944	2448	34	atrophic	atrophic	JJ
25944	2448	35	changes	change	NNS
25944	2448	36	.	.	.
25944	2449	1	Variable	variable	JJ
25944	2449	2	[	[	-LRB-
25944	2449	3	oe]dema	oe]dema	JJ
25944	2449	4	of	of	IN
25944	2449	5	the	the	DT
25944	2449	6	prickle	prickle	JJ
25944	2449	7	layer	layer	NN
25944	2449	8	and	and	CC
25944	2449	9	of	of	IN
25944	2449	10	the	the	DT
25944	2449	11	cutis	cutis	NN
25944	2449	12	is	be	VBZ
25944	2449	13	found	find	VBN
25944	2449	14	.	.	.
25944	2450	1	There	there	EX
25944	2450	2	is	be	VBZ
25944	2450	3	no	no	DT
25944	2450	4	tendency	tendency	NN
25944	2450	5	to	to	TO
25944	2450	6	pus	pus	VB
25944	2450	7	formation	formation	NN
25944	2450	8	.	.	.
25944	2451	1	[	[	-LRB-
25944	2451	2	Illustration	illustration	NN
25944	2451	3	:	:	:
25944	2451	4	Fig	Fig	NNP
25944	2451	5	.	.	.
25944	2452	1	42	42	CD
25944	2452	2	.	.	.
25944	2453	1	Lupus	Lupus	NNP
25944	2453	2	Erythematosus	Erythematosus	NNP
25944	2453	3	.	.	.
25944	2453	4	]	]	-RRB-
25944	2454	1	#	#	$
25944	2454	2	Is	be	VBZ
25944	2454	3	there	there	EX
25944	2454	4	any	any	DT
25944	2454	5	difficulty	difficulty	NN
25944	2454	6	in	in	IN
25944	2454	7	the	the	DT
25944	2454	8	diagnosis	diagnosis	NN
25944	2454	9	of	of	IN
25944	2454	10	lupus	lupus	NNP
25944	2454	11	erythematosus	erythematosus	NN
25944	2454	12	?	?	.
25944	2454	13	#	#	$
25944	2454	14	As	as	IN
25944	2454	15	a	a	DT
25944	2454	16	rule	rule	NN
25944	2454	17	,	,	,
25944	2454	18	not	not	RB
25944	2454	19	,	,	,
25944	2454	20	as	as	IN
25944	2454	21	the	the	DT
25944	2454	22	features	feature	NNS
25944	2454	23	of	of	IN
25944	2454	24	the	the	DT
25944	2454	25	disease	disease	NN
25944	2454	26	--	--	:
25944	2454	27	the	the	DT
25944	2454	28	sharply	sharply	RB
25944	2454	29	circumscribed	circumscribe	VBN
25944	2454	30	outline	outline	NN
25944	2454	31	,	,	,
25944	2454	32	the	the	DT
25944	2454	33	reddish	reddish	JJ
25944	2454	34	or	or	CC
25944	2454	35	violaceous	violaceous	JJ
25944	2454	36	color	color	NN
25944	2454	37	,	,	,
25944	2454	38	the	the	DT
25944	2454	39	elevated	elevated	JJ
25944	2454	40	border	border	NN
25944	2454	41	,	,	,
25944	2454	42	the	the	DT
25944	2454	43	tendency	tendency	NN
25944	2454	44	to	to	IN
25944	2454	45	central	central	JJ
25944	2454	46	depression	depression	NN
25944	2454	47	and	and	CC
25944	2454	48	atrophy	atrophy	NN
25944	2454	49	,	,	,
25944	2454	50	the	the	DT
25944	2454	51	plugged	plug	VBN
25944	2454	52	up	up	RP
25944	2454	53	or	or	CC
25944	2454	54	patulous	patulous	JJ
25944	2454	55	sebaceous	sebaceous	JJ
25944	2454	56	ducts	duct	NNS
25944	2454	57	,	,	,
25944	2454	58	the	the	DT
25944	2454	59	adherent	adherent	JJ
25944	2454	60	grayish	grayish	NN
25944	2454	61	or	or	CC
25944	2454	62	yellowish	yellowish	JJ
25944	2454	63	scales	scale	NNS
25944	2454	64	,	,	,
25944	2454	65	together	together	RB
25944	2454	66	with	with	IN
25944	2454	67	the	the	DT
25944	2454	68	region	region	NN
25944	2454	69	attacked	attack	VBN
25944	2454	70	(	(	-LRB-
25944	2454	71	usually	usually	RB
25944	2454	72	the	the	DT
25944	2454	73	nose	nose	NN
25944	2454	74	and	and	CC
25944	2454	75	cheeks)--are	cheeks)--are	JJ
25944	2454	76	characteristic	characteristic	JJ
25944	2454	77	.	.	.
25944	2455	1	#	#	JJR
25944	2455	2	State	state	NN
25944	2455	3	the	the	DT
25944	2455	4	prognosis	prognosis	NN
25944	2455	5	of	of	IN
25944	2455	6	lupus	lupus	NN
25944	2455	7	erythematosus	erythematosus	NN
25944	2455	8	.	.	.
25944	2455	9	#	#	$
25944	2455	10	The	the	DT
25944	2455	11	disease	disease	NN
25944	2455	12	is	be	VBZ
25944	2455	13	often	often	RB
25944	2455	14	capricious	capricious	JJ
25944	2455	15	and	and	CC
25944	2455	16	extremely	extremely	RB
25944	2455	17	rebellious	rebellious	JJ
25944	2455	18	to	to	IN
25944	2455	19	treatment	treatment	NN
25944	2455	20	;	;	:
25944	2455	21	some	some	DT
25944	2455	22	cases	case	NNS
25944	2455	23	,	,	,
25944	2455	24	up	up	IN
25944	2455	25	to	to	IN
25944	2455	26	a	a	DT
25944	2455	27	certain	certain	JJ
25944	2455	28	point	point	NN
25944	2455	29	at	at	IN
25944	2455	30	least	least	JJS
25944	2455	31	,	,	,
25944	2455	32	yield	yield	VB
25944	2455	33	readily	readily	RB
25944	2455	34	,	,	,
25944	2455	35	and	and	CC
25944	2455	36	occasionally	occasionally	RB
25944	2455	37	a	a	DT
25944	2455	38	tendency	tendency	NN
25944	2455	39	to	to	IN
25944	2455	40	spontaneous	spontaneous	JJ
25944	2455	41	disappearance	disappearance	NN
25944	2455	42	is	be	VBZ
25944	2455	43	observed	observe	VBN
25944	2455	44	;	;	:
25944	2455	45	a	a	DT
25944	2455	46	complete	complete	JJ
25944	2455	47	cure	cure	NN
25944	2455	48	is	be	VBZ
25944	2455	49	,	,	,
25944	2455	50	however	however	RB
25944	2455	51	,	,	,
25944	2455	52	it	-PRON-	PRP
25944	2455	53	must	must	MD
25944	2455	54	be	be	VB
25944	2455	55	confessed	confess	VBN
25944	2455	56	,	,	,
25944	2455	57	rather	rather	RB
25944	2455	58	rare	rare	JJ
25944	2455	59	.	.	.
25944	2456	1	The	the	DT
25944	2456	2	disease	disease	NN
25944	2456	3	in	in	IN
25944	2456	4	nowise	nowise	NN
25944	2456	5	compromises	compromise	VBZ
25944	2456	6	the	the	DT
25944	2456	7	general	general	JJ
25944	2456	8	health	health	NN
25944	2456	9	.	.	.
25944	2457	1	In	in	IN
25944	2457	2	those	those	DT
25944	2457	3	rare	rare	JJ
25944	2457	4	instances	instance	NNS
25944	2457	5	of	of	IN
25944	2457	6	generalized	generalize	VBN
25944	2457	7	disease	disease	NN
25944	2457	8	the	the	DT
25944	2457	9	patient	patient	NN
25944	2457	10	has	have	VBZ
25944	2457	11	usually	usually	RB
25944	2457	12	died	die	VBN
25944	2457	13	from	from	IN
25944	2457	14	an	an	DT
25944	2457	15	intercurrent	intercurrent	NN
25944	2457	16	tuberculosis	tuberculosis	NN
25944	2457	17	.	.	.
25944	2458	1	#	#	NNP
25944	2458	2	How	how	WRB
25944	2458	3	is	be	VBZ
25944	2458	4	lupus	lupus	NNP
25944	2458	5	erythematosus	erythematosus	NN
25944	2458	6	to	to	TO
25944	2458	7	be	be	VB
25944	2458	8	treated	treat	VBN
25944	2458	9	?	?	.
25944	2458	10	#	#	$
25944	2458	11	The	the	DT
25944	2458	12	general	general	JJ
25944	2458	13	health	health	NN
25944	2458	14	is	be	VBZ
25944	2458	15	to	to	TO
25944	2458	16	be	be	VB
25944	2458	17	looked	look	VBN
25944	2458	18	after	after	IN
25944	2458	19	and	and	CC
25944	2458	20	systemic	systemic	JJ
25944	2458	21	treatment	treatment	NN
25944	2458	22	prescribed	prescribe	VBN
25944	2458	23	,	,	,
25944	2458	24	if	if	IN
25944	2458	25	indicated	indicate	VBN
25944	2458	26	.	.	.
25944	2459	1	As	as	IN
25944	2459	2	a	a	DT
25944	2459	3	rule	rule	NN
25944	2459	4	,	,	,
25944	2459	5	constitutional	constitutional	JJ
25944	2459	6	remedies	remedy	NNS
25944	2459	7	exert	exert	VBP
25944	2459	8	little	little	JJ
25944	2459	9	,	,	,
25944	2459	10	if	if	IN
25944	2459	11	any	any	DT
25944	2459	12	,	,	,
25944	2459	13	influence	influence	NN
25944	2459	14	,	,	,
25944	2459	15	but	but	CC
25944	2459	16	exceptionally	exceptionally	RB
25944	2459	17	,	,	,
25944	2459	18	cod	cod	NN
25944	2459	19	-	-	HYPH
25944	2459	20	liver	liver	NN
25944	2459	21	oil	oil	NN
25944	2459	22	,	,	,
25944	2459	23	arsenic	arsenic	JJ
25944	2459	24	,	,	,
25944	2459	25	phosphorus	phosphorus	NN
25944	2459	26	,	,	,
25944	2459	27	salicin	salicin	JJ
25944	2459	28	,	,	,
25944	2459	29	quinine	quinine	JJ
25944	2459	30	,	,	,
25944	2459	31	or	or	CC
25944	2459	32	potassium	potassium	NN
25944	2459	33	iodide	iodide	NN
25944	2459	34	proves	prof	NNS
25944	2459	35	of	of	IN
25944	2459	36	service	service	NN
25944	2459	37	.	.	.
25944	2460	1	Locally	locally	RB
25944	2460	2	,	,	,
25944	2460	3	according	accord	VBG
25944	2460	4	to	to	IN
25944	2460	5	the	the	DT
25944	2460	6	case	case	NN
25944	2460	7	,	,	,
25944	2460	8	soothing	soothe	VBG
25944	2460	9	remedies	remedy	NNS
25944	2460	10	,	,	,
25944	2460	11	stimulating	stimulate	VBG
25944	2460	12	applications	application	NNS
25944	2460	13	and	and	CC
25944	2460	14	destruction	destruction	NN
25944	2460	15	of	of	IN
25944	2460	16	the	the	DT
25944	2460	17	growth	growth	NN
25944	2460	18	by	by	IN
25944	2460	19	caustics	caustic	NNS
25944	2460	20	or	or	CC
25944	2460	21	operative	operative	JJ
25944	2460	22	measures	measure	NNS
25944	2460	23	are	be	VBP
25944	2460	24	to	to	TO
25944	2460	25	be	be	VB
25944	2460	26	employed	employ	VBN
25944	2460	27	.	.	.
25944	2461	1	(	(	-LRB-
25944	2461	2	_	_	NNP
25944	2461	3	Try	try	VB
25944	2461	4	the	the	DT
25944	2461	5	milder	milder	NN
25944	2461	6	applications	application	NNS
25944	2461	7	first	first	RB
25944	2461	8	.	.	.
25944	2461	9	_	_	NNP
25944	2461	10	)	)	-RRB-
25944	2461	11	#	#	$
25944	2461	12	Mention	mention	VB
25944	2461	13	the	the	DT
25944	2461	14	stimulating	stimulating	JJ
25944	2461	15	applications	application	NNS
25944	2461	16	commonly	commonly	RB
25944	2461	17	employed	employ	VBN
25944	2461	18	.	.	.
25944	2461	19	#	#	$
25944	2461	20	Washing	wash	VBG
25944	2461	21	the	the	DT
25944	2461	22	parts	part	NNS
25944	2461	23	energetically	energetically	RB
25944	2461	24	with	with	IN
25944	2461	25	tincture	tincture	NN
25944	2461	26	of	of	IN
25944	2461	27	sapo	sapo	JJ
25944	2461	28	viridis	viridi	NNS
25944	2461	29	,	,	,
25944	2461	30	rinsing	rinse	VBG
25944	2461	31	and	and	CC
25944	2461	32	applying	apply	VBG
25944	2461	33	a	a	DT
25944	2461	34	soothing	soothing	JJ
25944	2461	35	ointment	ointment	NN
25944	2461	36	,	,	,
25944	2461	37	such	such	JJ
25944	2461	38	as	as	IN
25944	2461	39	cold	cold	JJ
25944	2461	40	cream	cream	NN
25944	2461	41	or	or	CC
25944	2461	42	vaseline	vaseline	NN
25944	2461	43	.	.	.
25944	2462	1	A	a	DT
25944	2462	2	lotion	lotion	NN
25944	2462	3	containing	contain	VBG
25944	2462	4	zinc	zinc	NN
25944	2462	5	sulphate	sulphate	NN
25944	2462	6	and	and	CC
25944	2462	7	potassium	potassium	NN
25944	2462	8	sulphuret	sulphuret	NN
25944	2462	9	thoroughly	thoroughly	RB
25944	2462	10	dabbed	dab	VBN
25944	2462	11	on	on	IN
25944	2462	12	the	the	DT
25944	2462	13	parts	part	NNS
25944	2462	14	morning	morning	NN
25944	2462	15	and	and	CC
25944	2462	16	evening:--	evening:--	ADD
25944	2462	17	[	[	-LRB-
25944	2462	18	Rx	Rx	NNP
25944	2462	19	]	]	-RRB-
25944	2462	20	Zinci	Zinci	NNP
25944	2462	21	sulphatis	sulphatis	NN
25944	2462	22	,	,	,
25944	2462	23	Potassii	Potassii	NNP
25944	2462	24	sulphurati	sulphurati	NNP
25944	2462	25	,	,	,
25944	2462	26	....	....	NFP
25944	2462	27	[	[	-LRB-
25944	2462	28	=	=	SYM
25944	2462	29	a][=a	a][=a	CD
25944	2462	30	]	]	-RRB-
25944	2462	31	...	...	.
25944	2462	32	[	[	-LRB-
25944	2462	33	dram]i-[dram]iv	dram]i-[dram]iv	NNP
25944	2462	34	Glycerinæ	Glycerinæ	NNP
25944	2462	35	,	,	,
25944	2462	36	...........................	...........................	NFP
25944	2462	37	[	[	-LRB-
25944	2462	38	minim]iv	minim]iv	NNP
25944	2462	39	Aquæ	Aquæ	NNP
25944	2462	40	,	,	,
25944	2462	41	................................	................................	NFP
25944	2462	42	f[Oz]iv	f[oz]iv	XX
25944	2462	43	.	.	.
25944	2463	1	M.	M.	NNP
25944	2463	2	The	the	DT
25944	2463	3	calamine	calamine	NN
25944	2463	4	-	-	HYPH
25944	2463	5	and	and	CC
25944	2463	6	-	-	HYPH
25944	2463	7	zinc	zinc	NN
25944	2463	8	oxide	oxide	NN
25944	2463	9	lotion	lotion	NN
25944	2463	10	used	use	VBN
25944	2463	11	in	in	IN
25944	2463	12	acute	acute	JJ
25944	2463	13	eczema	eczema	NN
25944	2463	14	is	be	VBZ
25944	2463	15	also	also	RB
25944	2463	16	often	often	RB
25944	2463	17	extremely	extremely	RB
25944	2463	18	valuable	valuable	JJ
25944	2463	19	.	.	.
25944	2464	1	Lotions	lotion	NNS
25944	2464	2	of	of	IN
25944	2464	3	ichthyol	ichthyol	NN
25944	2464	4	and	and	CC
25944	2464	5	of	of	IN
25944	2464	6	resorcin	resorcin	NNS
25944	2464	7	,	,	,
25944	2464	8	five	five	CD
25944	2464	9	to	to	TO
25944	2464	10	sixty	sixty	CD
25944	2464	11	grains	grain	NNS
25944	2464	12	to	to	IN
25944	2464	13	the	the	DT
25944	2464	14	ounce	ounce	NN
25944	2464	15	;	;	:
25944	2464	16	ichthyol	ichthyol	NNP
25944	2464	17	in	in	IN
25944	2464	18	ointment	ointment	NN
25944	2464	19	,	,	,
25944	2464	20	five-	five-	JJ
25944	2464	21	to	to	IN
25944	2464	22	twenty	twenty	CD
25944	2464	23	-	-	HYPH
25944	2464	24	per	per	IN
25944	2464	25	-	-	HYPH
25944	2464	26	cent	cent	NN
25944	2464	27	.	.	.
25944	2465	1	strength	strength	NN
25944	2465	2	,	,	,
25944	2465	3	is	be	VBZ
25944	2465	4	also	also	RB
25944	2465	5	useful	useful	JJ
25944	2465	6	.	.	.
25944	2466	1	Painting	paint	VBG
25944	2466	2	the	the	DT
25944	2466	3	patches	patch	NNS
25944	2466	4	with	with	IN
25944	2466	5	pure	pure	JJ
25944	2466	6	carbolic	carbolic	JJ
25944	2466	7	acid	acid	NN
25944	2466	8	;	;	:
25944	2466	9	repeating	repeat	VBG
25944	2466	10	a	a	DT
25944	2466	11	day	day	NN
25944	2466	12	or	or	CC
25944	2466	13	two	two	CD
25944	2466	14	after	after	IN
25944	2466	15	the	the	DT
25944	2466	16	crusts	crust	NNS
25944	2466	17	have	have	VBP
25944	2466	18	fallen	fall	VBN
25944	2466	19	off	off	RP
25944	2466	20	.	.	.
25944	2467	1	The	the	DT
25944	2467	2	continuous	continuous	JJ
25944	2467	3	application	application	NN
25944	2467	4	of	of	IN
25944	2467	5	mercurial	mercurial	JJ
25944	2467	6	plaster	plaster	NN
25944	2467	7	.	.	.
25944	2468	1	Sulphur	Sulphur	NNP
25944	2468	2	and	and	CC
25944	2468	3	tar	tar	NN
25944	2468	4	ointments	ointment	NNS
25944	2468	5	,	,	,
25944	2468	6	officinal	officinal	JJ
25944	2468	7	strength	strength	NN
25944	2468	8	or	or	CC
25944	2468	9	weakened	weaken	VBN
25944	2468	10	with	with	IN
25944	2468	11	lard	lard	NN
25944	2468	12	,	,	,
25944	2468	13	and	and	CC
25944	2468	14	also	also	RB
25944	2468	15	the	the	DT
25944	2468	16	following:--	following:--	NN
25944	2468	17	[	[	-LRB-
25944	2468	18	Rx	Rx	NNP
25944	2468	19	]	]	-RRB-
25944	2468	20	Ol	old	NNP
25944	2468	21	.	.	.
25944	2469	1	cadini	cadini	NNP
25944	2469	2	,	,	,
25944	2469	3	Alcoholis	Alcoholis	NNP
25944	2469	4	,	,	,
25944	2469	5	Saponis	Saponis	NNP
25944	2469	6	viridis	viridis	NN
25944	2469	7	,	,	,
25944	2469	8	.....	.....	NFP
25944	2469	9	[	[	-LRB-
25944	2469	10	=	=	SYM
25944	2469	11	a][=a	a][=a	CD
25944	2469	12	]	]	-RRB-
25944	2469	13	......	......	NFP
25944	2469	14	[	[	-LRB-
25944	2469	15	dram]iiss	dram]iis	NNS
25944	2469	16	.	.	.
25944	2470	1	M.	M.	NNP
25944	2470	2	(	(	-LRB-
25944	2470	3	This	this	DT
25944	2470	4	is	be	VBZ
25944	2470	5	to	to	TO
25944	2470	6	be	be	VB
25944	2470	7	rubbed	rub	VBN
25944	2470	8	in	in	IN
25944	2470	9	,	,	,
25944	2470	10	in	in	IN
25944	2470	11	small	small	JJ
25944	2470	12	quantity	quantity	NN
25944	2470	13	,	,	,
25944	2470	14	once	once	RB
25944	2470	15	or	or	CC
25944	2470	16	twice	twice	RB
25944	2470	17	daily	daily	RB
25944	2470	18	,	,	,
25944	2470	19	and	and	CC
25944	2470	20	later	later	RB
25944	2470	21	a	a	DT
25944	2470	22	soothing	soothe	VBG
25944	2470	23	remedy	remedy	NN
25944	2470	24	applied	apply	VBD
25944	2470	25	.	.	.
25944	2470	26	)	)	-RRB-
25944	2471	1	In	in	IN
25944	2471	2	recent	recent	JJ
25944	2471	3	years	year	NNS
25944	2471	4	both	both	CC
25944	2471	5	the	the	DT
25944	2471	6	_	_	NNP
25944	2471	7	x_-ray	x_-ray	NN
25944	2471	8	and	and	CC
25944	2471	9	Finsen	Finsen	NNP
25944	2471	10	light	light	NN
25944	2471	11	have	have	VBP
25944	2471	12	been	be	VBN
25944	2471	13	used	use	VBN
25944	2471	14	with	with	IN
25944	2471	15	variable	variable	JJ
25944	2471	16	success	success	NN
25944	2471	17	.	.	.
25944	2472	1	Repeated	repeat	VBN
25944	2472	2	applications	application	NNS
25944	2472	3	of	of	IN
25944	2472	4	the	the	DT
25944	2472	5	high	high	JJ
25944	2472	6	-	-	HYPH
25944	2472	7	frequency	frequency	NN
25944	2472	8	current	current	NN
25944	2472	9	,	,	,
25944	2472	10	with	with	IN
25944	2472	11	the	the	DT
25944	2472	12	vacuum	vacuum	NN
25944	2472	13	electrode	electrode	NN
25944	2472	14	,	,	,
25944	2472	15	have	have	VBP
25944	2472	16	also	also	RB
25944	2472	17	proved	prove	VBN
25944	2472	18	serviceable	serviceable	JJ
25944	2472	19	.	.	.
25944	2473	1	Cautious	cautious	JJ
25944	2473	2	applications	application	NNS
25944	2473	3	of	of	IN
25944	2473	4	liquid	liquid	JJ
25944	2473	5	air	air	NN
25944	2473	6	or	or	CC
25944	2473	7	carbon	carbon	NN
25944	2473	8	dioxide	dioxide	NN
25944	2473	9	have	have	VBP
25944	2473	10	also	also	RB
25944	2473	11	been	be	VBN
25944	2473	12	used	use	VBN
25944	2473	13	with	with	IN
25944	2473	14	some	some	DT
25944	2473	15	success	success	NN
25944	2473	16	in	in	IN
25944	2473	17	the	the	DT
25944	2473	18	past	past	JJ
25944	2473	19	few	few	JJ
25944	2473	20	years	year	NNS
25944	2473	21	.	.	.
25944	2474	1	#	#	NNP
25944	2474	2	When	when	WRB
25944	2474	3	are	be	VBP
25944	2474	4	destructive	destructive	JJ
25944	2474	5	and	and	CC
25944	2474	6	operative	operative	JJ
25944	2474	7	measures	measure	NNS
25944	2474	8	justifiable	justifiable	JJ
25944	2474	9	?	?	.
25944	2474	10	#	#	$
25944	2474	11	In	in	IN
25944	2474	12	obstinate	obstinate	NN
25944	2474	13	,	,	,
25944	2474	14	sluggish	sluggish	JJ
25944	2474	15	,	,	,
25944	2474	16	and	and	CC
25944	2474	17	long	long	JJ
25944	2474	18	-	-	HYPH
25944	2474	19	persistent	persistent	JJ
25944	2474	20	patches	patch	NNS
25944	2474	21	,	,	,
25944	2474	22	and	and	CC
25944	2474	23	then	then	RB
25944	2474	24	only	only	RB
25944	2474	25	after	after	IN
25944	2474	26	other	other	JJ
25944	2474	27	methods	method	NNS
25944	2474	28	of	of	IN
25944	2474	29	treatment	treatment	NN
25944	2474	30	have	have	VBP
25944	2474	31	failed	fail	VBN
25944	2474	32	.	.	.
25944	2475	1	(	(	-LRB-
25944	2475	2	Remember	remember	VB
25944	2475	3	that	that	IN
25944	2475	4	a	a	DT
25944	2475	5	patch	patch	NN
25944	2475	6	or	or	CC
25944	2475	7	patches	patch	NNS
25944	2475	8	of	of	IN
25944	2475	9	the	the	DT
25944	2475	10	disease	disease	NN
25944	2475	11	_	_	NNP
25944	2475	12	may	may	MD
25944	2475	13	_	_	NNP
25944	2475	14	disappear	disappear	VB
25944	2475	15	in	in	IN
25944	2475	16	course	course	NN
25944	2475	17	of	of	IN
25944	2475	18	time	time	NN
25944	2475	19	spontaneously	spontaneously	RB
25944	2475	20	,	,	,
25944	2475	21	and	and	CC
25944	2475	22	occasionally	occasionally	RB
25944	2475	23	_	_	NNP
25944	2475	24	without	without	IN
25944	2475	25	leaving	leave	VBG
25944	2475	26	a	a	DT
25944	2475	27	scar	scar	NN
25944	2475	28	_	_	NNP
25944	2475	29	.	.	.
25944	2475	30	)	)	-RRB-
25944	2476	1	#	#	JJR
25944	2476	2	State	state	NN
25944	2476	3	the	the	DT
25944	2476	4	methods	method	NNS
25944	2476	5	of	of	IN
25944	2476	6	treatment	treatment	NN
25944	2476	7	commonly	commonly	RB
25944	2476	8	used	use	VBN
25944	2476	9	in	in	IN
25944	2476	10	obstinate	obstinate	NN
25944	2476	11	,	,	,
25944	2476	12	sluggish	sluggish	JJ
25944	2476	13	and	and	CC
25944	2476	14	persistent	persistent	JJ
25944	2476	15	patches	patch	NNS
25944	2476	16	of	of	IN
25944	2476	17	lupus	lupus	NN
25944	2476	18	erythematosus	erythematosus	NN
25944	2476	19	.	.	.
25944	2476	20	#	#	$
25944	2476	21	Cauterization	Cauterization	NNP
25944	2476	22	--	--	:
25944	2476	23	with	with	IN
25944	2476	24	nitrate	nitrate	NN
25944	2476	25	of	of	IN
25944	2476	26	silver	silver	NN
25944	2476	27	,	,	,
25944	2476	28	with	with	IN
25944	2476	29	applications	application	NNS
25944	2476	30	of	of	IN
25944	2476	31	pyrogallic	pyrogallic	NN
25944	2476	32	acid	acid	NN
25944	2476	33	in	in	IN
25944	2476	34	ointment	ointment	NN
25944	2476	35	or	or	CC
25944	2476	36	in	in	IN
25944	2476	37	liquor	liquor	NNP
25944	2476	38	gutta	gutta	NNP
25944	2476	39	-	-	HYPH
25944	2476	40	perchæ	perchæ	NNP
25944	2476	41	,	,	,
25944	2476	42	fifteen	fifteen	CD
25944	2476	43	to	to	TO
25944	2476	44	thirty	thirty	CD
25944	2476	45	per	per	IN
25944	2476	46	cent	cent	NN
25944	2476	47	.	.	.
25944	2477	1	strength	strength	NN
25944	2477	2	,	,	,
25944	2477	3	and	and	CC
25944	2477	4	with	with	IN
25944	2477	5	solutions	solution	NNS
25944	2477	6	(	(	-LRB-
25944	2477	7	cautiously	cautiously	RB
25944	2477	8	employed	employ	VBN
25944	2477	9	)	)	-RRB-
25944	2477	10	of	of	IN
25944	2477	11	caustic	caustic	JJ
25944	2477	12	potash	potash	NN
25944	2477	13	,	,	,
25944	2477	14	and	and	CC
25944	2477	15	exceptionally	exceptionally	RB
25944	2477	16	with	with	IN
25944	2477	17	the	the	DT
25944	2477	18	galvano	galvano	NN
25944	2477	19	-	-	HYPH
25944	2477	20	cautery	cautery	NN
25944	2477	21	.	.	.
25944	2478	1	[	[	-LRB-
25944	2478	2	Illustration	illustration	NN
25944	2478	3	:	:	:
25944	2478	4	Fig	Fig	NNP
25944	2478	5	.	.	.
25944	2479	1	43	43	CD
25944	2479	2	.	.	.
25944	2480	1	Single	Single	NNP
25944	2480	2	Scarifier	Scarifier	NNP
25944	2480	3	.	.	.
25944	2480	4	]	]	-RRB-
25944	2481	1	[	[	-LRB-
25944	2481	2	Illustration	illustration	NN
25944	2481	3	:	:	:
25944	2481	4	Fig	Fig	NNP
25944	2481	5	.	.	.
25944	2482	1	44	44	CD
25944	2482	2	.	.	.
25944	2483	1	Multiple	Multiple	NNP
25944	2483	2	Scarifier	Scarifier	NNP
25944	2483	3	.	.	.
25944	2484	1	(	(	-LRB-
25944	2484	2	_	_	NNP
25944	2484	3	As	as	IN
25944	2484	4	modified	modify	VBN
25944	2484	5	by	by	IN
25944	2484	6	Van	Van	NNP
25944	2484	7	Harlingen	Harlingen	NNP
25944	2484	8	.	.	.
25944	2484	9	_	_	NNP
25944	2484	10	)	)	-RRB-
25944	2484	11	]	]	-RRB-
25944	2484	12	Operative	operative	JJ
25944	2484	13	--	--	:
25944	2484	14	scarification	scarification	NN
25944	2484	15	,	,	,
25944	2484	16	either	either	CC
25944	2484	17	punctate	punctate	NN
25944	2484	18	or	or	CC
25944	2484	19	linear	linear	JJ
25944	2484	20	,	,	,
25944	2484	21	and	and	CC
25944	2484	22	erosion	erosion	NN
25944	2484	23	with	with	IN
25944	2484	24	the	the	DT
25944	2484	25	curette	curette	NN
25944	2484	26	.	.	.
25944	2485	1	(	(	-LRB-
25944	2485	2	See	see	VB
25944	2485	3	treatment	treatment	NN
25944	2485	4	of	of	IN
25944	2485	5	lupus	lupus	NNP
25944	2485	6	vulgaris	vulgaris	NNP
25944	2485	7	.	.	.
25944	2485	8	)	)	-RRB-
25944	2486	1	#	#	NNP
25944	2486	2	Lupus	Lupus	NNP
25944	2486	3	Vulgaris	Vulgaris	NNP
25944	2486	4	.	.	.
25944	2486	5	#	#	NNP
25944	2486	6	(	(	-LRB-
25944	2486	7	_	_	NNP
25944	2486	8	Synonyms	Synonyms	NNP
25944	2486	9	:	:	:
25944	2486	10	_	_	NNP
25944	2486	11	Lupus	Lupus	NNP
25944	2486	12	;	;	:
25944	2486	13	Lupus	Lupus	NNP
25944	2486	14	Exedens	Exedens	NNPS
25944	2486	15	;	;	:
25944	2486	16	Lupus	Lupus	NNP
25944	2486	17	Vorax	Vorax	NNP
25944	2486	18	;	;	:
25944	2486	19	Tuberculosis	tuberculosis	NN
25944	2486	20	of	of	IN
25944	2486	21	the	the	DT
25944	2486	22	Skin	skin	NN
25944	2486	23	.	.	.
25944	2486	24	)	)	-RRB-
25944	2487	1	#	#	LS
25944	2487	2	What	what	WP
25944	2487	3	do	do	VBP
25944	2487	4	you	-PRON-	PRP
25944	2487	5	understand	understand	VB
25944	2487	6	by	by	IN
25944	2487	7	lupus	lupus	NNP
25944	2487	8	vulgaris	vulgaris	NNP
25944	2487	9	?	?	.
25944	2487	10	#	#	NNP
25944	2487	11	Lupus	Lupus	NNP
25944	2487	12	vulgaris	vulgaris	NN
25944	2487	13	is	be	VBZ
25944	2487	14	a	a	DT
25944	2487	15	cellular	cellular	JJ
25944	2487	16	new	new	JJ
25944	2487	17	growth	growth	NN
25944	2487	18	,	,	,
25944	2487	19	characterized	characterize	VBN
25944	2487	20	by	by	IN
25944	2487	21	variously	variously	RB
25944	2487	22	-	-	HYPH
25944	2487	23	sized	sized	JJ
25944	2487	24	,	,	,
25944	2487	25	soft	soft	JJ
25944	2487	26	,	,	,
25944	2487	27	reddish	reddish	JJ
25944	2487	28	-	-	HYPH
25944	2487	29	brown	brown	JJ
25944	2487	30	,	,	,
25944	2487	31	papular	papular	JJ
25944	2487	32	,	,	,
25944	2487	33	tubercular	tubercular	JJ
25944	2487	34	and	and	CC
25944	2487	35	infiltrated	infiltrated	JJ
25944	2487	36	patches	patch	NNS
25944	2487	37	,	,	,
25944	2487	38	usually	usually	RB
25944	2487	39	terminating	terminate	VBG
25944	2487	40	in	in	IN
25944	2487	41	ulceration	ulceration	NN
25944	2487	42	and	and	CC
25944	2487	43	scarring	scar	VBG
25944	2487	44	.	.	.
25944	2488	1	#	#	NN
25944	2488	2	Upon	upon	IN
25944	2488	3	what	what	WDT
25944	2488	4	region	region	NN
25944	2488	5	is	be	VBZ
25944	2488	6	lupus	lupus	NNP
25944	2488	7	vulgaris	vulgaris	NNP
25944	2488	8	usually	usually	RB
25944	2488	9	observed	observe	VBN
25944	2488	10	?	?	.
25944	2488	11	#	#	$
25944	2488	12	The	the	DT
25944	2488	13	face	face	NN
25944	2488	14	,	,	,
25944	2488	15	especially	especially	RB
25944	2488	16	the	the	DT
25944	2488	17	nose	nose	NN
25944	2488	18	,	,	,
25944	2488	19	but	but	CC
25944	2488	20	any	any	DT
25944	2488	21	part	part	NN
25944	2488	22	may	may	MD
25944	2488	23	be	be	VB
25944	2488	24	invaded	invade	VBN
25944	2488	25	.	.	.
25944	2489	1	The	the	DT
25944	2489	2	area	area	NN
25944	2489	3	involved	involve	VBN
25944	2489	4	may	may	MD
25944	2489	5	be	be	VB
25944	2489	6	small	small	JJ
25944	2489	7	or	or	CC
25944	2489	8	quite	quite	RB
25944	2489	9	extensive	extensive	JJ
25944	2489	10	,	,	,
25944	2489	11	usually	usually	RB
25944	2489	12	the	the	DT
25944	2489	13	former	former	JJ
25944	2489	14	.	.	.
25944	2490	1	#	#	$
25944	2490	2	At	at	IN
25944	2490	3	what	what	WDT
25944	2490	4	age	age	NN
25944	2490	5	is	be	VBZ
25944	2490	6	the	the	DT
25944	2490	7	disease	disease	NN
25944	2490	8	noted	note	VBN
25944	2490	9	?	?	.
25944	2490	10	#	#	$
25944	2490	11	In	in	IN
25944	2490	12	many	many	JJ
25944	2490	13	cases	case	NNS
25944	2490	14	it	-PRON-	PRP
25944	2490	15	begins	begin	VBZ
25944	2490	16	in	in	IN
25944	2490	17	childhood	childhood	NN
25944	2490	18	or	or	CC
25944	2490	19	early	early	JJ
25944	2490	20	adult	adult	NN
25944	2490	21	life	life	NN
25944	2490	22	,	,	,
25944	2490	23	but	but	CC
25944	2490	24	as	as	IN
25944	2490	25	it	-PRON-	PRP
25944	2490	26	is	be	VBZ
25944	2490	27	persistent	persistent	JJ
25944	2490	28	and	and	CC
25944	2490	29	tends	tend	VBZ
25944	2490	30	to	to	TO
25944	2490	31	relapse	relapse	VB
25944	2490	32	,	,	,
25944	2490	33	it	-PRON-	PRP
25944	2490	34	may	may	MD
25944	2490	35	be	be	VB
25944	2490	36	met	meet	VBN
25944	2490	37	with	with	IN
25944	2490	38	at	at	IN
25944	2490	39	any	any	DT
25944	2490	40	age	age	NN
25944	2490	41	.	.	.
25944	2491	1	#	#	NNP
25944	2491	2	Describe	describe	VB
25944	2491	3	the	the	DT
25944	2491	4	earlier	early	JJR
25944	2491	5	symptoms	symptom	NNS
25944	2491	6	of	of	IN
25944	2491	7	lupus	lupus	NNP
25944	2491	8	vulgaris	vulgaris	NNP
25944	2491	9	.	.	.
25944	2491	10	#	#	$
25944	2491	11	The	the	DT
25944	2491	12	disease	disease	NN
25944	2491	13	begins	begin	VBZ
25944	2491	14	by	by	IN
25944	2491	15	the	the	DT
25944	2491	16	development	development	NN
25944	2491	17	of	of	IN
25944	2491	18	several	several	JJ
25944	2491	19	or	or	CC
25944	2491	20	more	more	JJR
25944	2491	21	pin	pin	NN
25944	2491	22	-	-	HYPH
25944	2491	23	head	head	NN
25944	2491	24	to	to	IN
25944	2491	25	small	small	JJ
25944	2491	26	pea	pea	JJ
25944	2491	27	-	-	HYPH
25944	2491	28	sized	sized	JJ
25944	2491	29	,	,	,
25944	2491	30	deep	deep	JJ
25944	2491	31	-	-	HYPH
25944	2491	32	seated	seated	JJ
25944	2491	33	,	,	,
25944	2491	34	brownish	brownish	NN
25944	2491	35	-	-	HYPH
25944	2491	36	red	red	JJ
25944	2491	37	or	or	CC
25944	2491	38	yellowish	yellowish	JJ
25944	2491	39	tubercles	tubercle	NNS
25944	2491	40	,	,	,
25944	2491	41	having	have	VBG
25944	2491	42	their	-PRON-	PRP$
25944	2491	43	seat	seat	NN
25944	2491	44	in	in	IN
25944	2491	45	the	the	DT
25944	2491	46	deeper	deep	JJR
25944	2491	47	part	part	NN
25944	2491	48	of	of	IN
25944	2491	49	the	the	DT
25944	2491	50	corium	corium	NN
25944	2491	51	,	,	,
25944	2491	52	and	and	CC
25944	2491	53	which	which	WDT
25944	2491	54	are	be	VBP
25944	2491	55	somewhat	somewhat	RB
25944	2491	56	softer	soft	JJR
25944	2491	57	and	and	CC
25944	2491	58	looser	loose	JJR
25944	2491	59	in	in	IN
25944	2491	60	texture	texture	NN
25944	2491	61	than	than	IN
25944	2491	62	normal	normal	JJ
25944	2491	63	tissue	tissue	NN
25944	2491	64	.	.	.
25944	2492	1	As	as	IN
25944	2492	2	the	the	DT
25944	2492	3	disease	disease	NN
25944	2492	4	progresses	progress	VBZ
25944	2492	5	,	,	,
25944	2492	6	variously	variously	RB
25944	2492	7	-	-	HYPH
25944	2492	8	sized	sized	JJ
25944	2492	9	and	and	CC
25944	2492	10	shaped	shaped	JJ
25944	2492	11	aggregations	aggregation	NNS
25944	2492	12	or	or	CC
25944	2492	13	patches	patch	NNS
25944	2492	14	result	result	VBP
25944	2492	15	,	,	,
25944	2492	16	covered	cover	VBN
25944	2492	17	with	with	IN
25944	2492	18	thin	thin	JJ
25944	2492	19	and	and	CC
25944	2492	20	imperfectly	imperfectly	RB
25944	2492	21	-	-	HYPH
25944	2492	22	formed	form	VBN
25944	2492	23	epidermis	epidermis	NN
25944	2492	24	.	.	.
25944	2493	1	#	#	$
25944	2493	2	What	what	WDT
25944	2493	3	changes	change	NNS
25944	2493	4	do	do	VBP
25944	2493	5	the	the	DT
25944	2493	6	lupus	lupus	JJ
25944	2493	7	tubercles	tubercle	NNS
25944	2493	8	or	or	CC
25944	2493	9	infiltrations	infiltration	NNS
25944	2493	10	undergo	undergo	VBP
25944	2493	11	?	?	.
25944	2493	12	#	#	$
25944	2493	13	The	the	DT
25944	2493	14	lesions	lesion	NNS
25944	2493	15	,	,	,
25944	2493	16	having	have	VBG
25944	2493	17	attained	attain	VBN
25944	2493	18	a	a	DT
25944	2493	19	certain	certain	JJ
25944	2493	20	size	size	NN
25944	2493	21	or	or	CC
25944	2493	22	development	development	NN
25944	2493	23	,	,	,
25944	2493	24	may	may	MD
25944	2493	25	remain	remain	VB
25944	2493	26	so	so	RB
25944	2493	27	for	for	IN
25944	2493	28	a	a	DT
25944	2493	29	time	time	NN
25944	2493	30	,	,	,
25944	2493	31	but	but	CC
25944	2493	32	sooner	soon	RBR
25944	2493	33	or	or	CC
25944	2493	34	later	later	RB
25944	2493	35	retrogressive	retrogressive	JJ
25944	2493	36	changes	change	NNS
25944	2493	37	occur	occur	VBP
25944	2493	38	:	:	:
25944	2493	39	the	the	DT
25944	2493	40	matured	mature	VBN
25944	2493	41	papules	papule	NNS
25944	2493	42	or	or	CC
25944	2493	43	tubercles	tubercle	NNS
25944	2493	44	,	,	,
25944	2493	45	or	or	CC
25944	2493	46	infiltrated	infiltrated	JJ
25944	2493	47	patches	patch	NNS
25944	2493	48	,	,	,
25944	2493	49	slowly	slowly	RB
25944	2493	50	disappear	disappear	VBP
25944	2493	51	by	by	IN
25944	2493	52	absorption	absorption	NN
25944	2493	53	,	,	,
25944	2493	54	fatty	fatty	NN
25944	2493	55	degeneration	degeneration	NN
25944	2493	56	,	,	,
25944	2493	57	and	and	CC
25944	2493	58	exfoliation	exfoliation	NN
25944	2493	59	,	,	,
25944	2493	60	leaving	leave	VBG
25944	2493	61	a	a	DT
25944	2493	62	yellowish	yellowish	JJ
25944	2493	63	or	or	CC
25944	2493	64	brownish	brownish	JJ
25944	2493	65	pigmentation	pigmentation	NN
25944	2493	66	,	,	,
25944	2493	67	usually	usually	RB
25944	2493	68	with	with	IN
25944	2493	69	more	more	JJR
25944	2493	70	or	or	CC
25944	2493	71	less	less	JJR
25944	2493	72	atrophy	atrophy	NN
25944	2493	73	or	or	CC
25944	2493	74	cicatricial	cicatricial	JJ
25944	2493	75	-	-	HYPH
25944	2493	76	tissue	tissue	NN
25944	2493	77	formation--_lupus	formation--_lupus	NNP
25944	2493	78	exfoliativus	exfoliativus	NNP
25944	2493	79	_	_	NNP
25944	2493	80	;	;	:
25944	2493	81	or	or	CC
25944	2493	82	disintegration	disintegration	NN
25944	2493	83	and	and	CC
25944	2493	84	destruction	destruction	NN
25944	2493	85	result	result	NN
25944	2493	86	,	,	,
25944	2493	87	terminating	terminate	VBG
25944	2493	88	in	in	IN
25944	2493	89	ulceration--_lupus	ulceration--_lupus	JJ
25944	2493	90	exedens	exeden	NNS
25944	2493	91	,	,	,
25944	2493	92	lupus	lupus	NNP
25944	2493	93	exulcerans	exulcerans	NNPS
25944	2493	94	_	_	NNP
25944	2493	95	.	.	.
25944	2494	1	This	this	DT
25944	2494	2	latter	latter	NN
25944	2494	3	is	be	VBZ
25944	2494	4	the	the	DT
25944	2494	5	more	more	RBR
25944	2494	6	usual	usual	JJ
25944	2494	7	course	course	NN
25944	2494	8	.	.	.
25944	2495	1	#	#	NNP
25944	2495	2	Describe	describe	VB
25944	2495	3	the	the	DT
25944	2495	4	clinical	clinical	JJ
25944	2495	5	appearances	appearance	NNS
25944	2495	6	and	and	CC
25944	2495	7	behavior	behavior	NN
25944	2495	8	of	of	IN
25944	2495	9	the	the	DT
25944	2495	10	lupus	lupus	NNP
25944	2495	11	ulcerations	ulceration	NNS
25944	2495	12	.	.	.
25944	2495	13	#	#	$
25944	2495	14	They	-PRON-	PRP
25944	2495	15	are	be	VBP
25944	2495	16	rounded	rounded	JJ
25944	2495	17	,	,	,
25944	2495	18	shallow	shallow	JJ
25944	2495	19	excavations	excavation	NNS
25944	2495	20	,	,	,
25944	2495	21	with	with	IN
25944	2495	22	soft	soft	JJ
25944	2495	23	and	and	CC
25944	2495	24	reddish	reddish	JJ
25944	2495	25	borders	border	NNS
25944	2495	26	.	.	.
25944	2496	1	In	in	IN
25944	2496	2	exceptional	exceptional	JJ
25944	2496	3	instances	instance	NNS
25944	2496	4	exuberant	exuberant	JJ
25944	2496	5	granulations	granulation	NNS
25944	2496	6	appear--_lupus	appear--_lupus	NNP
25944	2496	7	hypertrophicus	hypertrophicus	NNP
25944	2496	8	_	_	NNP
25944	2496	9	;	;	:
25944	2496	10	or	or	CC
25944	2496	11	papillary	papillary	JJ
25944	2496	12	outgrowths	outgrowth	NNS
25944	2496	13	are	be	VBP
25944	2496	14	noted--_lupus	noted--_lupus	NNP
25944	2496	15	verrucosus	verrucosus	NNP
25944	2496	16	_	_	NNP
25944	2496	17	.	.	.
25944	2497	1	The	the	DT
25944	2497	2	ulcerations	ulceration	NNS
25944	2497	3	secrete	secrete	VBP
25944	2497	4	a	a	DT
25944	2497	5	variable	variable	JJ
25944	2497	6	amount	amount	NN
25944	2497	7	of	of	IN
25944	2497	8	pus	pus	NN
25944	2497	9	,	,	,
25944	2497	10	usually	usually	RB
25944	2497	11	slight	slight	JJ
25944	2497	12	in	in	IN
25944	2497	13	quantity	quantity	NN
25944	2497	14	,	,	,
25944	2497	15	which	which	WDT
25944	2497	16	leads	lead	VBZ
25944	2497	17	to	to	IN
25944	2497	18	more	more	RBR
25944	2497	19	or	or	CC
25944	2497	20	less	less	JJR
25944	2497	21	crust	crust	NN
25944	2497	22	formation	formation	NN
25944	2497	23	;	;	:
25944	2497	24	later	later	RB
25944	2497	25	,	,	,
25944	2497	26	however	however	RB
25944	2497	27	,	,	,
25944	2497	28	cicatricial	cicatricial	JJ
25944	2497	29	tissue	tissue	NN
25944	2497	30	,	,	,
25944	2497	31	generally	generally	RB
25944	2497	32	of	of	IN
25944	2497	33	a	a	DT
25944	2497	34	_	_	NNP
25944	2497	35	firm	firm	NN
25944	2497	36	and	and	CC
25944	2497	37	fibrous	fibrous	JJ
25944	2497	38	_	_	NNP
25944	2497	39	character	character	NN
25944	2497	40	,	,	,
25944	2497	41	results	result	NNS
25944	2497	42	.	.	.
25944	2498	1	[	[	-LRB-
25944	2498	2	Illustration	illustration	NN
25944	2498	3	:	:	:
25944	2498	4	Fig	Fig	NNP
25944	2498	5	.	.	.
25944	2499	1	45	45	CD
25944	2499	2	.	.	.
25944	2500	1	Lupus	Lupus	NNP
25944	2500	2	of	of	IN
25944	2500	3	Arm	Arm	NNP
25944	2500	4	.	.	.
25944	2500	5	]	]	-RRB-
25944	2501	1	#	#	$
25944	2501	2	In	in	IN
25944	2501	3	what	what	WDT
25944	2501	4	manner	manner	NN
25944	2501	5	does	do	VBZ
25944	2501	6	the	the	DT
25944	2501	7	disease	disease	NN
25944	2501	8	spread	spread	VB
25944	2501	9	?	?	.
25944	2501	10	#	#	$
25944	2501	11	The	the	DT
25944	2501	12	patches	patch	NNS
25944	2501	13	spread	spread	VBN
25944	2501	14	by	by	IN
25944	2501	15	the	the	DT
25944	2501	16	appearance	appearance	NN
25944	2501	17	of	of	IN
25944	2501	18	new	new	JJ
25944	2501	19	tubercles	tubercle	NNS
25944	2501	20	,	,	,
25944	2501	21	or	or	CC
25944	2501	22	infiltrations	infiltration	NNS
25944	2501	23	at	at	IN
25944	2501	24	the	the	DT
25944	2501	25	peripheral	peripheral	JJ
25944	2501	26	portion	portion	NN
25944	2501	27	.	.	.
25944	2502	1	New	new	JJ
25944	2502	2	islets	islet	NNS
25944	2502	3	and	and	CC
25944	2502	4	areas	area	NNS
25944	2502	5	of	of	IN
25944	2502	6	disease	disease	NN
25944	2502	7	may	may	MD
25944	2502	8	continue	continue	VB
25944	2502	9	to	to	TO
25944	2502	10	make	make	VB
25944	2502	11	their	-PRON-	PRP$
25944	2502	12	appearance	appearance	NN
25944	2502	13	from	from	IN
25944	2502	14	time	time	NN
25944	2502	15	to	to	IN
25944	2502	16	time	time	NN
25944	2502	17	,	,	,
25944	2502	18	usually	usually	RB
25944	2502	19	upon	upon	IN
25944	2502	20	contiguous	contiguous	JJ
25944	2502	21	parts	part	NNS
25944	2502	22	.	.	.
25944	2503	1	#	#	NN
25944	2503	2	Are	be	VBP
25944	2503	3	the	the	DT
25944	2503	4	mucous	mucous	JJ
25944	2503	5	membranes	membrane	NNS
25944	2503	6	of	of	IN
25944	2503	7	the	the	DT
25944	2503	8	mouth	mouth	NN
25944	2503	9	,	,	,
25944	2503	10	throat	throat	NNP
25944	2503	11	and	and	CC
25944	2503	12	larynx	larynx	NNP
25944	2503	13	ever	ever	RB
25944	2503	14	involved	involve	VBN
25944	2503	15	?	?	.
25944	2503	16	#	#	NN
25944	2503	17	In	in	IN
25944	2503	18	some	some	DT
25944	2503	19	instances	instance	NNS
25944	2503	20	,	,	,
25944	2503	21	and	and	CC
25944	2503	22	either	either	CC
25944	2503	23	primarily	primarily	RB
25944	2503	24	or	or	CC
25944	2503	25	secondarily	secondarily	RB
25944	2503	26	.	.	.
25944	2504	1	[	[	-LRB-
25944	2504	2	Illustration	illustration	NN
25944	2504	3	:	:	:
25944	2504	4	Lupus	Lupus	NNP
25944	2504	5	Vulgaris	Vulgaris	NNP
25944	2504	6	.	.	.
25944	2504	7	]	]	-RRB-
25944	2505	1	[	[	-LRB-
25944	2505	2	Illustration	illustration	NN
25944	2505	3	:	:	:
25944	2505	4	Lupus	Lupus	NNP
25944	2505	5	Vulgaris	Vulgaris	NNP
25944	2505	6	.	.	.
25944	2505	7	]	]	-RRB-
25944	2506	1	#	#	$
25944	2506	2	Is	be	VBZ
25944	2506	3	the	the	DT
25944	2506	4	bone	bone	NN
25944	2506	5	tissue	tissue	NN
25944	2506	6	ever	ever	RB
25944	2506	7	involved	involve	VBN
25944	2506	8	in	in	IN
25944	2506	9	lupus	lupus	NNP
25944	2506	10	vulgaris	vulgaris	NNP
25944	2506	11	?	?	.
25944	2506	12	#	#	NN
25944	2506	13	No	no	UH
25944	2506	14	.	.	.
25944	2507	1	#	#	LS
25944	2507	2	What	what	WDT
25944	2507	3	course	course	NN
25944	2507	4	does	do	VBZ
25944	2507	5	lupus	lupus	NNP
25944	2507	6	vulgaris	vulgaris	NNP
25944	2507	7	pursue	pursue	NNP
25944	2507	8	?	?	.
25944	2507	9	#	#	NNP
25944	2507	10	It	-PRON-	PRP
25944	2507	11	is	be	VBZ
25944	2507	12	slowly	slowly	RB
25944	2507	13	but	but	CC
25944	2507	14	,	,	,
25944	2507	15	as	as	IN
25944	2507	16	a	a	DT
25944	2507	17	rule	rule	NN
25944	2507	18	,	,	,
25944	2507	19	steadily	steadily	RB
25944	2507	20	progressive	progressive	JJ
25944	2507	21	.	.	.
25944	2508	1	Several	several	JJ
25944	2508	2	years	year	NNS
25944	2508	3	or	or	CC
25944	2508	4	more	more	JJR
25944	2508	5	may	may	MD
25944	2508	6	elapse	elapse	VB
25944	2508	7	before	before	IN
25944	2508	8	the	the	DT
25944	2508	9	area	area	NN
25944	2508	10	of	of	IN
25944	2508	11	disease	disease	NN
25944	2508	12	is	be	VBZ
25944	2508	13	conspicuous	conspicuous	JJ
25944	2508	14	.	.	.
25944	2509	1	#	#	LS
25944	2509	2	What	what	WP
25944	2509	3	is	be	VBZ
25944	2509	4	the	the	DT
25944	2509	5	cause	cause	NN
25944	2509	6	of	of	IN
25944	2509	7	lupus	lupus	NNP
25944	2509	8	vulgaris	vulgaris	NNP
25944	2509	9	?	?	.
25944	2509	10	#	#	WRB
25944	2509	11	It	-PRON-	PRP
25944	2509	12	is	be	VBZ
25944	2509	13	now	now	RB
25944	2509	14	known	know	VBN
25944	2509	15	to	to	TO
25944	2509	16	be	be	VB
25944	2509	17	due	due	IN
25944	2509	18	to	to	IN
25944	2509	19	the	the	DT
25944	2509	20	invasion	invasion	NN
25944	2509	21	of	of	IN
25944	2509	22	the	the	DT
25944	2509	23	cutaneous	cutaneous	JJ
25944	2509	24	structures	structure	NNS
25944	2509	25	by	by	IN
25944	2509	26	the	the	DT
25944	2509	27	tubercle	tubercle	NN
25944	2509	28	bacillus	bacillus	NN
25944	2509	29	;	;	:
25944	2509	30	in	in	IN
25944	2509	31	short	short	JJ
25944	2509	32	,	,	,
25944	2509	33	a	a	DT
25944	2509	34	tuberculosis	tuberculosis	NN
25944	2509	35	of	of	IN
25944	2509	36	the	the	DT
25944	2509	37	skin	skin	NN
25944	2509	38	.	.	.
25944	2510	1	It	-PRON-	PRP
25944	2510	2	is	be	VBZ
25944	2510	3	not	not	RB
25944	2510	4	infrequently	infrequently	RB
25944	2510	5	observed	observe	VBN
25944	2510	6	in	in	IN
25944	2510	7	the	the	DT
25944	2510	8	strumous	strumous	JJ
25944	2510	9	and	and	CC
25944	2510	10	debilitated	debilitate	VBN
25944	2510	11	.	.	.
25944	2511	1	It	-PRON-	PRP
25944	2511	2	is	be	VBZ
25944	2511	3	entirely	entirely	RB
25944	2511	4	independent	independent	JJ
25944	2511	5	of	of	IN
25944	2511	6	syphilis	syphilis	NNP
25944	2511	7	.	.	.
25944	2512	1	#	#	LS
25944	2512	2	What	what	WP
25944	2512	3	is	be	VBZ
25944	2512	4	the	the	DT
25944	2512	5	pathology	pathology	NN
25944	2512	6	of	of	IN
25944	2512	7	lupus	lupus	NNP
25944	2512	8	vulgaris	vulgaris	NN
25944	2512	9	?	?	.
25944	2512	10	#	#	$
25944	2512	11	According	accord	VBG
25944	2512	12	to	to	IN
25944	2512	13	recent	recent	JJ
25944	2512	14	investigations	investigation	NNS
25944	2512	15	,	,	,
25944	2512	16	the	the	DT
25944	2512	17	infiltrations	infiltration	NNS
25944	2512	18	of	of	IN
25944	2512	19	lupus	lupu	NNS
25944	2512	20	are	be	VBP
25944	2512	21	due	due	JJ
25944	2512	22	chiefly	chiefly	RB
25944	2512	23	to	to	IN
25944	2512	24	cell	cell	NN
25944	2512	25	-	-	HYPH
25944	2512	26	proliferation	proliferation	NN
25944	2512	27	and	and	CC
25944	2512	28	outgrowth	outgrowth	NN
25944	2512	29	from	from	IN
25944	2512	30	the	the	DT
25944	2512	31	protoplasmic	protoplasmic	JJ
25944	2512	32	walls	wall	NNS
25944	2512	33	and	and	CC
25944	2512	34	adventitia	adventitia	NN
25944	2512	35	of	of	IN
25944	2512	36	the	the	DT
25944	2512	37	bloodvessels	bloodvessel	NNS
25944	2512	38	and	and	CC
25944	2512	39	lymphatics	lymphatic	NNS
25944	2512	40	.	.	.
25944	2513	1	The	the	DT
25944	2513	2	fibrous	fibrous	JJ
25944	2513	3	-	-	HYPH
25944	2513	4	tissue	tissue	NN
25944	2513	5	network	network	NN
25944	2513	6	,	,	,
25944	2513	7	vessels	vessel	NNS
25944	2513	8	and	and	CC
25944	2513	9	a	a	DT
25944	2513	10	portion	portion	NN
25944	2513	11	of	of	IN
25944	2513	12	the	the	DT
25944	2513	13	cell	cell	NN
25944	2513	14	infiltration	infiltration	NN
25944	2513	15	are	be	VBP
25944	2513	16	thus	thus	RB
25944	2513	17	produced	produce	VBN
25944	2513	18	,	,	,
25944	2513	19	the	the	DT
25944	2513	20	fixed	fixed	JJ
25944	2513	21	and	and	CC
25944	2513	22	wandering	wander	VBG
25944	2513	23	connective	connective	JJ
25944	2513	24	-	-	HYPH
25944	2513	25	tissue	tissue	NN
25944	2513	26	cells	cell	NNS
25944	2513	27	of	of	IN
25944	2513	28	the	the	DT
25944	2513	29	inflamed	inflame	VBN
25944	2513	30	stroma	stroma	NNP
25944	2513	31	of	of	IN
25944	2513	32	the	the	DT
25944	2513	33	cutis	cutis	JJ
25944	2513	34	being	be	VBG
25944	2513	35	responsible	responsible	JJ
25944	2513	36	for	for	IN
25944	2513	37	the	the	DT
25944	2513	38	other	other	JJ
25944	2513	39	portion	portion	NN
25944	2513	40	of	of	IN
25944	2513	41	the	the	DT
25944	2513	42	new	new	JJ
25944	2513	43	growth	growth	NN
25944	2513	44	(	(	-LRB-
25944	2513	45	Robinson	Robinson	NNP
25944	2513	46	)	)	-RRB-
25944	2513	47	.	.	.
25944	2514	1	#	#	JJR
25944	2514	2	State	state	NN
25944	2514	3	the	the	DT
25944	2514	4	diagnostic	diagnostic	JJ
25944	2514	5	features	feature	NNS
25944	2514	6	of	of	IN
25944	2514	7	lupus	lupus	NNP
25944	2514	8	vulgaris	vulgaris	NNP
25944	2514	9	.	.	.
25944	2514	10	#	#	$
25944	2514	11	In	in	IN
25944	2514	12	a	a	DT
25944	2514	13	typical	typical	JJ
25944	2514	14	,	,	,
25944	2514	15	developed	developed	JJ
25944	2514	16	patch	patch	NN
25944	2514	17	of	of	IN
25944	2514	18	lupus	lupus	NN
25944	2514	19	are	be	VBP
25944	2514	20	to	to	TO
25944	2514	21	be	be	VB
25944	2514	22	seen:--cicatricial	seen:--cicatricial	CD
25944	2514	23	formation	formation	NN
25944	2514	24	,	,	,
25944	2514	25	usually	usually	RB
25944	2514	26	of	of	IN
25944	2514	27	a	a	DT
25944	2514	28	fibrous	fibrous	JJ
25944	2514	29	and	and	CC
25944	2514	30	tough	tough	JJ
25944	2514	31	character	character	NN
25944	2514	32	;	;	,
25944	2514	33	ulcerations	ulceration	NNS
25944	2514	34	;	;	:
25944	2514	35	the	the	DT
25944	2514	36	yellowish	yellowish	JJ
25944	2514	37	-	-	HYPH
25944	2514	38	brown	brown	JJ
25944	2514	39	tubercles	tubercle	NNS
25944	2514	40	and	and	CC
25944	2514	41	infiltration	infiltration	NN
25944	2514	42	;	;	,
25944	2514	43	and	and	CC
25944	2514	44	the	the	DT
25944	2514	45	characteristic	characteristic	JJ
25944	2514	46	soft	soft	JJ
25944	2514	47	,	,	,
25944	2514	48	small	small	JJ
25944	2514	49	,	,	,
25944	2514	50	yellowish	yellowish	JJ
25944	2514	51	or	or	CC
25944	2514	52	reddish	reddish	JJ
25944	2514	53	-	-	HYPH
25944	2514	54	brown	brown	JJ
25944	2514	55	,	,	,
25944	2514	56	cutaneous	cutaneous	JJ
25944	2514	57	and	and	CC
25944	2514	58	subcutaneous	subcutaneous	JJ
25944	2514	59	points	point	NNS
25944	2514	60	and	and	CC
25944	2514	61	tubercles	tubercle	NNS
25944	2514	62	.	.	.
25944	2515	1	#	#	NNP
25944	2515	2	How	how	WRB
25944	2515	3	does	do	VBZ
25944	2515	4	the	the	DT
25944	2515	5	tubercular	tubercular	JJ
25944	2515	6	syphiloderm	syphiloderm	NN
25944	2515	7	differ	differ	VB
25944	2515	8	from	from	IN
25944	2515	9	lupus	lupus	NNP
25944	2515	10	vulgaris	vulgaris	NNP
25944	2515	11	?	?	.
25944	2515	12	#	#	$
25944	2515	13	The	the	DT
25944	2515	14	tubercular	tubercular	JJ
25944	2515	15	syphiloderm	syphiloderm	NN
25944	2515	16	is	be	VBZ
25944	2515	17	much	much	RB
25944	2515	18	more	more	RBR
25944	2515	19	rapid	rapid	JJ
25944	2515	20	in	in	IN
25944	2515	21	its	-PRON-	PRP$
25944	2515	22	course	course	NN
25944	2515	23	,	,	,
25944	2515	24	the	the	DT
25944	2515	25	ulceration	ulceration	NN
25944	2515	26	is	be	VBZ
25944	2515	27	deeper	deep	JJR
25944	2515	28	and	and	CC
25944	2515	29	the	the	DT
25944	2515	30	discharge	discharge	NN
25944	2515	31	copious	copious	JJ
25944	2515	32	and	and	CC
25944	2515	33	often	often	RB
25944	2515	34	offensive	offensive	JJ
25944	2515	35	;	;	:
25944	2515	36	the	the	DT
25944	2515	37	scarring	scarring	NN
25944	2515	38	is	be	VBZ
25944	2515	39	soft	soft	JJ
25944	2515	40	,	,	,
25944	2515	41	and	and	CC
25944	2515	42	,	,	,
25944	2515	43	compared	compare	VBN
25944	2515	44	to	to	IN
25944	2515	45	the	the	DT
25944	2515	46	amount	amount	NN
25944	2515	47	of	of	IN
25944	2515	48	ulceration	ulceration	NN
25944	2515	49	,	,	,
25944	2515	50	but	but	CC
25944	2515	51	slightly	slightly	RB
25944	2515	52	disfiguring	disfigure	VBG
25944	2515	53	;	;	:
25944	2515	54	and	and	CC
25944	2515	55	it	-PRON-	PRP
25944	2515	56	is	be	VBZ
25944	2515	57	,	,	,
25944	2515	58	for	for	IN
25944	2515	59	obvious	obvious	JJ
25944	2515	60	reasons	reason	NNS
25944	2515	61	,	,	,
25944	2515	62	a	a	DT
25944	2515	63	disease	disease	NN
25944	2515	64	of	of	IN
25944	2515	65	adult	adult	NN
25944	2515	66	or	or	CC
25944	2515	67	late	late	JJ
25944	2515	68	life	life	NN
25944	2515	69	.	.	.
25944	2516	1	The	the	DT
25944	2516	2	history	history	NN
25944	2516	3	,	,	,
25944	2516	4	together	together	RB
25944	2516	5	with	with	IN
25944	2516	6	other	other	JJ
25944	2516	7	evidences	evidence	NNS
25944	2516	8	of	of	IN
25944	2516	9	previous	previous	JJ
25944	2516	10	or	or	CC
25944	2516	11	concomitant	concomitant	JJ
25944	2516	12	symptoms	symptom	NNS
25944	2516	13	of	of	IN
25944	2516	14	syphilis	syphilis	NNP
25944	2516	15	,	,	,
25944	2516	16	will	will	MD
25944	2516	17	often	often	RB
25944	2516	18	aid	aid	VB
25944	2516	19	in	in	IN
25944	2516	20	the	the	DT
25944	2516	21	differentiation	differentiation	NN
25944	2516	22	.	.	.
25944	2517	1	#	#	NN
25944	2517	2	How	how	WRB
25944	2517	3	does	do	VBZ
25944	2517	4	epithelioma	epithelioma	NN
25944	2517	5	differ	differ	VB
25944	2517	6	from	from	IN
25944	2517	7	lupus	lupus	NNP
25944	2517	8	vulgaris	vulgaris	NNP
25944	2517	9	?	?	.
25944	2517	10	#	#	$
25944	2517	11	The	the	DT
25944	2517	12	edges	edge	NNS
25944	2517	13	of	of	IN
25944	2517	14	the	the	DT
25944	2517	15	epitheliomatous	epitheliomatous	JJ
25944	2517	16	ulcer	ulcer	NN
25944	2517	17	are	be	VBP
25944	2517	18	hard	hard	JJ
25944	2517	19	,	,	,
25944	2517	20	elevated	elevated	JJ
25944	2517	21	and	and	CC
25944	2517	22	waxy	waxy	RB
25944	2517	23	;	;	:
25944	2517	24	the	the	DT
25944	2517	25	base	base	NN
25944	2517	26	is	be	VBZ
25944	2517	27	uneven	uneven	JJ
25944	2517	28	,	,	,
25944	2517	29	the	the	DT
25944	2517	30	secretion	secretion	NN
25944	2517	31	thin	thin	JJ
25944	2517	32	,	,	,
25944	2517	33	scanty	scanty	NN
25944	2517	34	and	and	CC
25944	2517	35	apt	apt	NN
25944	2517	36	to	to	TO
25944	2517	37	be	be	VB
25944	2517	38	streaked	streak	VBN
25944	2517	39	with	with	IN
25944	2517	40	blood	blood	NN
25944	2517	41	;	;	:
25944	2517	42	the	the	DT
25944	2517	43	ulceration	ulceration	NN
25944	2517	44	usually	usually	RB
25944	2517	45	starts	start	VBZ
25944	2517	46	from	from	IN
25944	2517	47	one	one	CD
25944	2517	48	point	point	NN
25944	2517	49	,	,	,
25944	2517	50	and	and	CC
25944	2517	51	is	be	VBZ
25944	2517	52	often	often	RB
25944	2517	53	painful	painful	JJ
25944	2517	54	;	;	:
25944	2517	55	the	the	DT
25944	2517	56	tissue	tissue	NN
25944	2517	57	destruction	destruction	NN
25944	2517	58	may	may	MD
25944	2517	59	be	be	VB
25944	2517	60	considerable	considerable	JJ
25944	2517	61	;	;	:
25944	2517	62	there	there	EX
25944	2517	63	is	be	VBZ
25944	2517	64	little	little	JJ
25944	2517	65	,	,	,
25944	2517	66	if	if	IN
25944	2517	67	any	any	DT
25944	2517	68	,	,	,
25944	2517	69	tendency	tendency	NN
25944	2517	70	to	to	IN
25944	2517	71	the	the	DT
25944	2517	72	formation	formation	NN
25944	2517	73	of	of	IN
25944	2517	74	cicatricial	cicatricial	JJ
25944	2517	75	tissue	tissue	NN
25944	2517	76	;	;	:
25944	2517	77	and	and	CC
25944	2517	78	,	,	,
25944	2517	79	finally	finally	RB
25944	2517	80	,	,	,
25944	2517	81	it	-PRON-	PRP
25944	2517	82	is	be	VBZ
25944	2517	83	usually	usually	RB
25944	2517	84	a	a	DT
25944	2517	85	disease	disease	NN
25944	2517	86	of	of	IN
25944	2517	87	advanced	advanced	JJ
25944	2517	88	age	age	NN
25944	2517	89	.	.	.
25944	2518	1	#	#	$
25944	2518	2	In	in	IN
25944	2518	3	what	what	WDT
25944	2518	4	respects	respect	NNS
25944	2518	5	does	do	VBZ
25944	2518	6	lupus	lupus	NNP
25944	2518	7	erythematosus	erythematosus	NNP
25944	2518	8	differ	differ	VB
25944	2518	9	from	from	IN
25944	2518	10	lupus	lupus	NNP
25944	2518	11	vulgaris	vulgaris	NNP
25944	2518	12	?	?	.
25944	2518	13	#	#	NNP
25944	2518	14	Lupus	Lupus	NNP
25944	2518	15	erythematosus	erythematosus	NN
25944	2518	16	has	have	VBZ
25944	2518	17	no	no	DT
25944	2518	18	papules	papule	NNS
25944	2518	19	,	,	,
25944	2518	20	tubercles	tubercle	NNS
25944	2518	21	or	or	CC
25944	2518	22	ulceration	ulceration	NN
25944	2518	23	.	.	.
25944	2519	1	#	#	NNP
25944	2519	2	How	how	WRB
25944	2519	3	does	do	VBZ
25944	2519	4	acne	acne	NNP
25944	2519	5	rosacea	rosacea	NNP
25944	2519	6	differ	differ	VB
25944	2519	7	from	from	IN
25944	2519	8	lupus	lupus	NNP
25944	2519	9	vulgaris	vulgaris	NNP
25944	2519	10	?	?	.
25944	2519	11	#	#	$
25944	2519	12	Acne	Acne	NNP
25944	2519	13	rosacea	rosacea	NNP
25944	2519	14	is	be	VBZ
25944	2519	15	characterized	characterize	VBN
25944	2519	16	by	by	IN
25944	2519	17	hyperæmia	hyperæmia	NN
25944	2519	18	,	,	,
25944	2519	19	dilated	dilate	VBN
25944	2519	20	vessels	vessel	NNS
25944	2519	21	,	,	,
25944	2519	22	papules	papule	NNS
25944	2519	23	,	,	,
25944	2519	24	pustules	pustule	NNS
25944	2519	25	,	,	,
25944	2519	26	the	the	DT
25944	2519	27	absence	absence	NN
25944	2519	28	of	of	IN
25944	2519	29	ulceration	ulceration	NN
25944	2519	30	,	,	,
25944	2519	31	and	and	CC
25944	2519	32	a	a	DT
25944	2519	33	different	different	JJ
25944	2519	34	history	history	NN
25944	2519	35	.	.	.
25944	2520	1	#	#	JJR
25944	2520	2	State	state	NN
25944	2520	3	the	the	DT
25944	2520	4	prognosis	prognosis	NN
25944	2520	5	of	of	IN
25944	2520	6	lupus	lupus	NNP
25944	2520	7	vulgaris	vulgaris	NNP
25944	2520	8	.	.	.
25944	2520	9	#	#	NNP
25944	2520	10	Lupus	Lupus	NNP
25944	2520	11	vulgaris	vulgaris	NN
25944	2520	12	is	be	VBZ
25944	2520	13	always	always	RB
25944	2520	14	a	a	DT
25944	2520	15	chronic	chronic	JJ
25944	2520	16	disease	disease	NN
25944	2520	17	,	,	,
25944	2520	18	often	often	RB
25944	2520	19	exceedingly	exceedingly	RB
25944	2520	20	rebellious	rebellious	JJ
25944	2520	21	to	to	IN
25944	2520	22	treatment	treatment	NN
25944	2520	23	,	,	,
25944	2520	24	and	and	CC
25944	2520	25	one	one	CD
25944	2520	26	that	that	WDT
25944	2520	27	calls	call	VBZ
25944	2520	28	for	for	IN
25944	2520	29	a	a	DT
25944	2520	30	guarded	guard	VBN
25944	2520	31	opinion	opinion	NN
25944	2520	32	.	.	.
25944	2521	1	Relapses	relapse	NNS
25944	2521	2	are	be	VBP
25944	2521	3	not	not	RB
25944	2521	4	uncommon	uncommon	JJ
25944	2521	5	.	.	.
25944	2522	1	[	[	-LRB-
25944	2522	2	Illustration	illustration	NN
25944	2522	3	:	:	:
25944	2522	4	Fig	Fig	NNP
25944	2522	5	.	.	.
25944	2523	1	46	46	CD
25944	2523	2	.	.	.
25944	2524	1	Galvano	galvano	JJ
25944	2524	2	-	-	HYPH
25944	2524	3	cautery	cautery	NN
25944	2524	4	Needle	Needle	NNP
25944	2524	5	,	,	,
25944	2524	6	Knife	Knife	NNP
25944	2524	7	and	and	CC
25944	2524	8	Spiral	Spiral	NNP
25944	2524	9	Points	Points	NNPS
25944	2524	10	.	.	.
25944	2525	1	(	(	-LRB-
25944	2525	2	_	_	NNP
25944	2525	3	As	as	IN
25944	2525	4	devised	devise	VBN
25944	2525	5	by	by	IN
25944	2525	6	Bésnier	Bésnier	NNP
25944	2525	7	.	.	.
25944	2525	8	_	_	NNP
25944	2525	9	)	)	-RRB-
25944	2525	10	]	]	-RRB-
25944	2525	11	The	the	DT
25944	2525	12	general	general	JJ
25944	2525	13	health	health	NN
25944	2525	14	usually	usually	RB
25944	2525	15	remains	remain	VBZ
25944	2525	16	good	good	JJ
25944	2525	17	,	,	,
25944	2525	18	but	but	CC
25944	2525	19	in	in	IN
25944	2525	20	some	some	DT
25944	2525	21	instances	instance	NNS
25944	2525	22	death	death	NN
25944	2525	23	by	by	IN
25944	2525	24	tuberculosis	tuberculosis	NN
25944	2525	25	of	of	IN
25944	2525	26	the	the	DT
25944	2525	27	lungs	lung	NNS
25944	2525	28	has	have	VBZ
25944	2525	29	been	be	VBN
25944	2525	30	noted	note	VBN
25944	2525	31	.	.	.
25944	2526	1	#	#	$
25944	2526	2	Is	be	VBZ
25944	2526	3	external	external	JJ
25944	2526	4	or	or	CC
25944	2526	5	internal	internal	JJ
25944	2526	6	treatment	treatment	NN
25944	2526	7	called	call	VBD
25944	2526	8	for	for	IN
25944	2526	9	in	in	IN
25944	2526	10	lupus	lupus	NNP
25944	2526	11	vulgaris	vulgaris	NNP
25944	2526	12	?	?	.
25944	2526	13	#	#	$
25944	2526	14	Always	always	RB
25944	2526	15	external	external	JJ
25944	2526	16	,	,	,
25944	2526	17	and	and	CC
25944	2526	18	not	not	RB
25944	2526	19	infrequently	infrequently	RB
25944	2526	20	constitutional	constitutional	JJ
25944	2526	21	also	also	RB
25944	2526	22	.	.	.
25944	2527	1	#	#	LS
25944	2527	2	What	what	WP
25944	2527	3	is	be	VBZ
25944	2527	4	the	the	DT
25944	2527	5	constitutional	constitutional	JJ
25944	2527	6	treatment	treatment	NN
25944	2527	7	?	?	.
25944	2527	8	#	#	$
25944	2527	9	The	the	DT
25944	2527	10	general	general	JJ
25944	2527	11	health	health	NN
25944	2527	12	must	must	MD
25944	2527	13	be	be	VB
25944	2527	14	cared	care	VBN
25944	2527	15	for	for	IN
25944	2527	16	;	;	:
25944	2527	17	good	good	JJ
25944	2527	18	,	,	,
25944	2527	19	nutritious	nutritious	JJ
25944	2527	20	food	food	NN
25944	2527	21	,	,	,
25944	2527	22	fresh	fresh	JJ
25944	2527	23	air	air	NN
25944	2527	24	and	and	CC
25944	2527	25	out	out	JJ
25944	2527	26	-	-	HYPH
25944	2527	27	door	door	NN
25944	2527	28	exercise	exercise	NN
25944	2527	29	,	,	,
25944	2527	30	together	together	RB
25944	2527	31	with	with	IN
25944	2527	32	,	,	,
25944	2527	33	in	in	IN
25944	2527	34	many	many	JJ
25944	2527	35	cases	case	NNS
25944	2527	36	,	,	,
25944	2527	37	the	the	DT
25944	2527	38	administration	administration	NN
25944	2527	39	of	of	IN
25944	2527	40	such	such	JJ
25944	2527	41	remedies	remedy	NNS
25944	2527	42	as	as	IN
25944	2527	43	cod	cod	NN
25944	2527	44	-	-	HYPH
25944	2527	45	liver	liver	NN
25944	2527	46	oil	oil	NN
25944	2527	47	,	,	,
25944	2527	48	potassium	potassium	NN
25944	2527	49	iodide	iodide	NN
25944	2527	50	,	,	,
25944	2527	51	iron	iron	NN
25944	2527	52	and	and	CC
25944	2527	53	quinine	quinine	NN
25944	2527	54	,	,	,
25944	2527	55	are	be	VBP
25944	2527	56	of	of	IN
25944	2527	57	therapeutic	therapeutic	JJ
25944	2527	58	importance	importance	NN
25944	2527	59	.	.	.
25944	2528	1	Tuberculin	tuberculin	NN
25944	2528	2	may	may	MD
25944	2528	3	be	be	VB
25944	2528	4	tried	try	VBN
25944	2528	5	in	in	IN
25944	2528	6	severe	severe	JJ
25944	2528	7	and	and	CC
25944	2528	8	obstinate	obstinate	JJ
25944	2528	9	cases	case	NNS
25944	2528	10	,	,	,
25944	2528	11	but	but	CC
25944	2528	12	its	-PRON-	PRP$
25944	2528	13	use	use	NN
25944	2528	14	is	be	VBZ
25944	2528	15	not	not	RB
25944	2528	16	without	without	IN
25944	2528	17	danger	danger	NN
25944	2528	18	.	.	.
25944	2529	1	#	#	JJR
25944	2529	2	State	state	NN
25944	2529	3	the	the	DT
25944	2529	4	object	object	NN
25944	2529	5	of	of	IN
25944	2529	6	local	local	JJ
25944	2529	7	treatment	treatment	NN
25944	2529	8	.	.	.
25944	2529	9	#	#	$
25944	2529	10	The	the	DT
25944	2529	11	destruction	destruction	NN
25944	2529	12	or	or	CC
25944	2529	13	removal	removal	NN
25944	2529	14	of	of	IN
25944	2529	15	the	the	DT
25944	2529	16	diseased	diseased	JJ
25944	2529	17	tissue	tissue	NN
25944	2529	18	.	.	.
25944	2530	1	#	#	NN
25944	2530	2	May	May	MD
25944	2530	3	milder	milder	NN
25944	2530	4	methods	method	NNS
25944	2530	5	of	of	IN
25944	2530	6	treatment	treatment	NN
25944	2530	7	sometimes	sometimes	RB
25944	2530	8	prove	prove	VBP
25944	2530	9	beneficial	beneficial	JJ
25944	2530	10	and	and	CC
25944	2530	11	even	even	RB
25944	2530	12	curative	curative	JJ
25944	2530	13	?	?	.
25944	2530	14	#	#	NN
25944	2530	15	Exceptionally	exceptionally	RB
25944	2530	16	,	,	,
25944	2530	17	mercurial	mercurial	JJ
25944	2530	18	plaster	plaster	NN
25944	2530	19	,	,	,
25944	2530	20	corrosive	corrosive	JJ
25944	2530	21	-	-	HYPH
25944	2530	22	sublimate	sublimate	NN
25944	2530	23	lotion	lotion	NN
25944	2530	24	and	and	CC
25944	2530	25	ointment	ointment	NN
25944	2530	26	(	(	-LRB-
25944	2530	27	gr	gr	NNP
25944	2530	28	.	.	.
25944	2531	1	j	j	NNP
25944	2531	2	to	to	IN
25944	2531	3	[	[	-LRB-
25944	2531	4	Oz]j	Oz]j	NNP
25944	2531	5	)	)	-RRB-
25944	2531	6	,	,	,
25944	2531	7	a	a	DT
25944	2531	8	plaster	plaster	NN
25944	2531	9	containing	contain	VBG
25944	2531	10	five	five	CD
25944	2531	11	to	to	TO
25944	2531	12	fifteen	fifteen	CD
25944	2531	13	per	per	IN
25944	2531	14	cent	cent	NN
25944	2531	15	.	.	.
25944	2532	1	of	of	IN
25944	2532	2	salicylic	salicylic	JJ
25944	2532	3	acid	acid	NNP
25944	2532	4	and	and	CC
25944	2532	5	creasote	creasote	NN
25944	2532	6	,	,	,
25944	2532	7	repeated	repeat	VBD
25944	2532	8	paintings	painting	NNS
25944	2532	9	with	with	IN
25944	2532	10	carbolic	carbolic	JJ
25944	2532	11	acid	acid	NN
25944	2532	12	,	,	,
25944	2532	13	and	and	CC
25944	2532	14	the	the	DT
25944	2532	15	constant	constant	JJ
25944	2532	16	application	application	NN
25944	2532	17	of	of	IN
25944	2532	18	lead	lead	NN
25944	2532	19	plaster	plaster	NN
25944	2532	20	containing	contain	VBG
25944	2532	21	twenty	twenty	CD
25944	2532	22	per	per	IN
25944	2532	23	cent	cent	NN
25944	2532	24	.	.	.
25944	2533	1	of	of	IN
25944	2533	2	ichthyol	ichthyol	NNP
25944	2533	3	,	,	,
25944	2533	4	are	be	VBP
25944	2533	5	valuable	valuable	JJ
25944	2533	6	.	.	.
25944	2534	1	[	[	-LRB-
25944	2534	2	Illustration	illustration	NN
25944	2534	3	:	:	:
25944	2534	4	Fig	Fig	NNP
25944	2534	5	.	.	.
25944	2535	1	47	47	CD
25944	2535	2	.	.	.
25944	2536	1	Double	double	JJ
25944	2536	2	Curette	Curette	NNP
25944	2536	3	.	.	.
25944	2536	4	]	]	-RRB-
25944	2537	1	Of	of	IN
25944	2537	2	the	the	DT
25944	2537	3	milder	milder	NN
25944	2537	4	methods	method	NNS
25944	2537	5	,	,	,
25944	2537	6	those	those	DT
25944	2537	7	most	most	RBS
25944	2537	8	in	in	IN
25944	2537	9	vogue	vogue	NN
25944	2537	10	to	to	NN
25944	2537	11	-	-	HYPH
25944	2537	12	day	day	NN
25944	2537	13	are	be	VBP
25944	2537	14	the	the	DT
25944	2537	15	_	_	NNP
25944	2537	16	Finsen	Finsen	NNP
25944	2537	17	light	light	NN
25944	2537	18	_	_	NNP
25944	2537	19	and	and	CC
25944	2537	20	_	_	NNP
25944	2537	21	x	x	NNP
25944	2537	22	-	-	NN
25944	2537	23	ray	ray	NNP
25944	2537	24	_	_	NNP
25944	2537	25	.	.	.
25944	2538	1	Either	either	CC
25944	2538	2	proves	prove	VBZ
25944	2538	3	extremely	extremely	RB
25944	2538	4	valuable	valuable	JJ
25944	2538	5	in	in	IN
25944	2538	6	some	some	DT
25944	2538	7	cases	case	NNS
25944	2538	8	,	,	,
25944	2538	9	but	but	CC
25944	2538	10	the	the	DT
25944	2538	11	Finsen	Finsen	NNP
25944	2538	12	method	method	NN
25944	2538	13	is	be	VBZ
25944	2538	14	the	the	DT
25944	2538	15	favorite	favorite	JJ
25944	2538	16	method	method	NN
25944	2538	17	.	.	.
25944	2539	1	#	#	NN
25944	2539	2	What	what	WDT
25944	2539	3	methods	method	NNS
25944	2539	4	are	be	VBP
25944	2539	5	commonly	commonly	RB
25944	2539	6	employed	employ	VBN
25944	2539	7	for	for	IN
25944	2539	8	the	the	DT
25944	2539	9	rapid	rapid	JJ
25944	2539	10	removal	removal	NN
25944	2539	11	or	or	CC
25944	2539	12	destruction	destruction	NN
25944	2539	13	of	of	IN
25944	2539	14	lupus	lupus	JJ
25944	2539	15	tissue	tissue	NN
25944	2539	16	?	?	.
25944	2539	17	#	#	$
25944	2539	18	Cauterization	cauterization	NN
25944	2539	19	,	,	,
25944	2539	20	scarification	scarification	NN
25944	2539	21	,	,	,
25944	2539	22	erasion	erasion	NN
25944	2539	23	and	and	CC
25944	2539	24	excision	excision	NN
25944	2539	25	are	be	VBP
25944	2539	26	variously	variously	RB
25944	2539	27	practised	practise	VBN
25944	2539	28	;	;	:
25944	2539	29	the	the	DT
25944	2539	30	particular	particular	JJ
25944	2539	31	method	method	NN
25944	2539	32	depending	depend	VBG
25944	2539	33	,	,	,
25944	2539	34	in	in	IN
25944	2539	35	great	great	JJ
25944	2539	36	measure	measure	NN
25944	2539	37	,	,	,
25944	2539	38	upon	upon	IN
25944	2539	39	the	the	DT
25944	2539	40	extent	extent	NN
25944	2539	41	of	of	IN
25944	2539	42	the	the	DT
25944	2539	43	disease	disease	NN
25944	2539	44	,	,	,
25944	2539	45	the	the	DT
25944	2539	46	part	part	NN
25944	2539	47	involved	involve	VBN
25944	2539	48	,	,	,
25944	2539	49	and	and	CC
25944	2539	50	other	other	JJ
25944	2539	51	circumstances	circumstance	NNS
25944	2539	52	.	.	.
25944	2540	1	#	#	$
25944	2540	2	Name	name	VB
25944	2540	3	the	the	DT
25944	2540	4	several	several	JJ
25944	2540	5	caustics	caustic	NNS
25944	2540	6	,	,	,
25944	2540	7	and	and	CC
25944	2540	8	state	state	NN
25944	2540	9	how	how	WRB
25944	2540	10	they	-PRON-	PRP
25944	2540	11	are	be	VBP
25944	2540	12	employed	employ	VBN
25944	2540	13	.	.	.
25944	2540	14	#	#	$
25944	2540	15	_	_	NNP
25944	2540	16	Pyrogallic	Pyrogallic	NNP
25944	2540	17	acid	acid	NN
25944	2540	18	_	_	NNP
25944	2540	19	,	,	,
25944	2540	20	used	use	VBN
25944	2540	21	as	as	IN
25944	2540	22	an	an	DT
25944	2540	23	ointment:--	ointment:--	JJ
25944	2540	24	[	[	-LRB-
25944	2540	25	Rx	Rx	NNP
25944	2540	26	]	]	-RRB-
25944	2540	27	Ac	Ac	NNP
25944	2540	28	.	.	.
25944	2541	1	pyrogallici	pyrogallici	NNP
25944	2541	2	,	,	,
25944	2541	3	.....................	.....................	NFP
25944	2541	4	[	[	-LRB-
25944	2541	5	dram]ij	dram]ij	VBP
25944	2541	6	Emplast	Emplast	NNP
25944	2541	7	.	.	.
25944	2542	1	plumbi	plumbi	NNP
25944	2542	2	,	,	,
25944	2542	3	.....................	.....................	NFP
25944	2542	4	[	[	-LRB-
25944	2542	5	dram]j	dram]j	NNP
25944	2542	6	Cerat	Cerat	NNP
25944	2542	7	.	.	.
25944	2543	1	resinsæ	resinsæ	NNS
25944	2543	2	,	,	,
25944	2543	3	......................	......................	NFP
25944	2543	4	[	[	-LRB-
25944	2543	5	dram]v	dram]v	NNP
25944	2543	6	.	.	.
25944	2543	7	M.	M.	NNP
25944	2543	8	It	-PRON-	PRP
25944	2543	9	is	be	VBZ
25944	2543	10	applied	apply	VBN
25944	2543	11	for	for	IN
25944	2543	12	one	one	CD
25944	2543	13	or	or	CC
25944	2543	14	two	two	CD
25944	2543	15	weeks	week	NNS
25944	2543	16	.	.	.
25944	2544	1	Every	every	DT
25944	2544	2	several	several	JJ
25944	2544	3	days	day	NNS
25944	2544	4	the	the	DT
25944	2544	5	parts	part	NNS
25944	2544	6	are	be	VBP
25944	2544	7	poulticed	poultice	VBN
25944	2544	8	,	,	,
25944	2544	9	the	the	DT
25944	2544	10	slough	slough	NN
25944	2544	11	thus	thus	RB
25944	2544	12	removed	remove	VBD
25944	2544	13	,	,	,
25944	2544	14	and	and	CC
25944	2544	15	the	the	DT
25944	2544	16	ointment	ointment	NN
25944	2544	17	reapplied	reapplie	VBD
25944	2544	18	,	,	,
25944	2544	19	and	and	CC
25944	2544	20	so	so	RB
25944	2544	21	on	on	RB
25944	2544	22	until	until	IN
25944	2544	23	the	the	DT
25944	2544	24	diseased	diseased	JJ
25944	2544	25	tissue	tissue	NN
25944	2544	26	has	have	VBZ
25944	2544	27	been	be	VBN
25944	2544	28	destroyed	destroy	VBN
25944	2544	29	.	.	.
25944	2545	1	It	-PRON-	PRP
25944	2545	2	is	be	VBZ
25944	2545	3	useful	useful	JJ
25944	2545	4	in	in	IN
25944	2545	5	those	those	DT
25944	2545	6	cases	case	NNS
25944	2545	7	in	in	IN
25944	2545	8	which	which	WDT
25944	2545	9	a	a	DT
25944	2545	10	mild	mild	JJ
25944	2545	11	and	and	CC
25944	2545	12	comparatively	comparatively	RB
25944	2545	13	painless	painless	JJ
25944	2545	14	caustic	caustic	JJ
25944	2545	15	is	be	VBZ
25944	2545	16	advisable	advisable	JJ
25944	2545	17	.	.	.
25944	2546	1	In	in	IN
25944	2546	2	most	most	JJS
25944	2546	3	cases	case	NNS
25944	2546	4	several	several	JJ
25944	2546	5	repetitions	repetition	NNS
25944	2546	6	of	of	IN
25944	2546	7	this	this	DT
25944	2546	8	plan	plan	NN
25944	2546	9	are	be	VBP
25944	2546	10	necessary	necessary	JJ
25944	2546	11	.	.	.
25944	2547	1	_	_	NNP
25944	2547	2	Arsenious	arsenious	JJ
25944	2547	3	acid	acid	NN
25944	2547	4	_	_	NNP
25944	2547	5	,	,	,
25944	2547	6	employed	employ	VBN
25944	2547	7	as	as	IN
25944	2547	8	an	an	DT
25944	2547	9	ointment--	ointment--	NNP
25944	2547	10	[	[	-LRB-
25944	2547	11	Rx	Rx	NNP
25944	2547	12	]	]	-RRB-
25944	2547	13	Ac	Ac	NNP
25944	2547	14	.	.	.
25944	2548	1	arseniosi	arseniosi	NNP
25944	2548	2	,	,	,
25944	2548	3	......................	......................	.
25944	2548	4	gr	gr	FW
25944	2548	5	.	.	.
25944	2549	1	xx	xx	IN
25944	2549	2	Hydrarg	Hydrarg	NNP
25944	2549	3	.	.	.
25944	2550	1	sulphid	sulphid	NNP
25944	2550	2	.	.	.
25944	2551	1	rub	rub	NNP
25944	2551	2	.	.	NNP
25944	2551	3	,	,	,
25944	2551	4	.............	.............	NFP
25944	2551	5	gr	gr	NNP
25944	2551	6	.	.	.
25944	2552	1	lx	lx	NNP
25944	2552	2	Ungt	Ungt	NNP
25944	2552	3	.	.	.
25944	2553	1	aquæ	aquæ	NNP
25944	2553	2	rosæ	rosæ	NNP
25944	2553	3	,	,	,
25944	2553	4	....................	....................	.
25944	2554	1	[	[	-LRB-
25944	2554	2	Oz]i.--M.	Oz]i.--M.	NNP
25944	2555	1	It	-PRON-	PRP
25944	2555	2	is	be	VBZ
25944	2555	3	painful	painful	JJ
25944	2555	4	but	but	CC
25944	2555	5	thorough	thorough	JJ
25944	2555	6	;	;	:
25944	2555	7	it	-PRON-	PRP
25944	2555	8	is	be	VBZ
25944	2555	9	spread	spread	VBN
25944	2555	10	on	on	IN
25944	2555	11	lint	lint	NN
25944	2555	12	and	and	CC
25944	2555	13	renewed	renew	VBN
25944	2555	14	daily	daily	RB
25944	2555	15	.	.	.
25944	2556	1	The	the	DT
25944	2556	2	action	action	NN
25944	2556	3	is	be	VBZ
25944	2556	4	usually	usually	RB
25944	2556	5	sufficient	sufficient	JJ
25944	2556	6	in	in	IN
25944	2556	7	three	three	CD
25944	2556	8	days	day	NNS
25944	2556	9	,	,	,
25944	2556	10	and	and	CC
25944	2556	11	the	the	DT
25944	2556	12	parts	part	NNS
25944	2556	13	are	be	VBP
25944	2556	14	then	then	RB
25944	2556	15	poulticed	poultice	VBN
25944	2556	16	until	until	IN
25944	2556	17	the	the	DT
25944	2556	18	slough	slough	NN
25944	2556	19	comes	come	VBZ
25944	2556	20	away	away	RB
25944	2556	21	,	,	,
25944	2556	22	after	after	IN
25944	2556	23	which	which	WDT
25944	2556	24	a	a	DT
25944	2556	25	simple	simple	JJ
25944	2556	26	dressing	dressing	NN
25944	2556	27	is	be	VBZ
25944	2556	28	employed	employ	VBN
25944	2556	29	.	.	.
25944	2557	1	Its	-PRON-	PRP$
25944	2557	2	application	application	NN
25944	2557	3	is	be	VBZ
25944	2557	4	advisable	advisable	JJ
25944	2557	5	for	for	IN
25944	2557	6	a	a	DT
25944	2557	7	small	small	JJ
25944	2557	8	area	area	NN
25944	2557	9	only	only	RB
25944	2557	10	--	--	:
25944	2557	11	not	not	RB
25944	2557	12	more	more	JJR
25944	2557	13	than	than	IN
25944	2557	14	four	four	CD
25944	2557	15	square	square	JJ
25944	2557	16	inches	inch	NNS
25944	2557	17	--	--	:
25944	2557	18	as	as	IN
25944	2557	19	absorption	absorption	NN
25944	2557	20	is	be	VBZ
25944	2557	21	possible	possible	JJ
25944	2557	22	.	.	.
25944	2558	1	_	_	NNP
25944	2558	2	Galvano	Galvano	NNP
25944	2558	3	-	-	HYPH
25944	2558	4	cautery._--The	cautery._--the	NN
25944	2558	5	diseased	diseased	JJ
25944	2558	6	tissue	tissue	NN
25944	2558	7	is	be	VBZ
25944	2558	8	destroyed	destroy	VBN
25944	2558	9	by	by	IN
25944	2558	10	numerous	numerous	JJ
25944	2558	11	punctures	puncture	NNS
25944	2558	12	with	with	IN
25944	2558	13	a	a	DT
25944	2558	14	red	red	JJ
25944	2558	15	-	-	HYPH
25944	2558	16	heated	heated	JJ
25944	2558	17	point	point	NN
25944	2558	18	or	or	CC
25944	2558	19	by	by	IN
25944	2558	20	linear	linear	JJ
25944	2558	21	incision	incision	NN
25944	2558	22	with	with	IN
25944	2558	23	a	a	DT
25944	2558	24	red	red	JJ
25944	2558	25	-	-	HYPH
25944	2558	26	heated	heated	JJ
25944	2558	27	knife	knife	NN
25944	2558	28	.	.	.
25944	2559	1	It	-PRON-	PRP
25944	2559	2	is	be	VBZ
25944	2559	3	often	often	RB
25944	2559	4	a	a	DT
25944	2559	5	practicable	practicable	JJ
25944	2559	6	and	and	CC
25944	2559	7	satisfactory	satisfactory	JJ
25944	2559	8	method	method	NN
25944	2559	9	.	.	.
25944	2560	1	The	the	DT
25944	2560	2	Paquelin	Paquelin	NNP
25944	2560	3	cautery	cautery	NN
25944	2560	4	and	and	CC
25944	2560	5	liquid	liquid	JJ
25944	2560	6	air	air	NN
25944	2560	7	and	and	CC
25944	2560	8	carbon	carbon	NN
25944	2560	9	dioxide	dioxide	NN
25944	2560	10	also	also	RB
25944	2560	11	have	have	VBP
25944	2560	12	their	-PRON-	PRP$
25944	2560	13	advocates	advocate	NNS
25944	2560	14	.	.	.
25944	2561	1	#	#	NNP
25944	2561	2	Describe	describe	VB
25944	2561	3	the	the	DT
25944	2561	4	operative	operative	JJ
25944	2561	5	measures	measure	NNS
25944	2561	6	employed	employ	VBN
25944	2561	7	in	in	IN
25944	2561	8	the	the	DT
25944	2561	9	removal	removal	NN
25944	2561	10	of	of	IN
25944	2561	11	lupus	lupus	NNP
25944	2561	12	tissue	tissue	NN
25944	2561	13	.	.	.
25944	2561	14	#	#	$
25944	2561	15	_	_	NNP
25944	2561	16	Linear	Linear	NNP
25944	2561	17	Scarification._--The	Scarification._--The	NNP
25944	2561	18	parts	part	NNS
25944	2561	19	are	be	VBP
25944	2561	20	thoroughly	thoroughly	RB
25944	2561	21	cross	cross	JJ
25944	2561	22	-	-	JJ
25944	2561	23	tracked	tracked	JJ
25944	2561	24	,	,	,
25944	2561	25	cutting	cut	VBG
25944	2561	26	through	through	IN
25944	2561	27	the	the	DT
25944	2561	28	diseased	diseased	JJ
25944	2561	29	tissue	tissue	NN
25944	2561	30	,	,	,
25944	2561	31	and	and	CC
25944	2561	32	subsequently	subsequently	RB
25944	2561	33	a	a	DT
25944	2561	34	simple	simple	JJ
25944	2561	35	salicylated	salicylate	VBN
25944	2561	36	ointment	ointment	NN
25944	2561	37	applied	apply	VBN
25944	2561	38	.	.	.
25944	2562	1	The	the	DT
25944	2562	2	operation	operation	NN
25944	2562	3	is	be	VBZ
25944	2562	4	repeated	repeat	VBN
25944	2562	5	from	from	IN
25944	2562	6	time	time	NN
25944	2562	7	to	to	IN
25944	2562	8	time	time	NN
25944	2562	9	,	,	,
25944	2562	10	and	and	CC
25944	2562	11	as	as	IN
25944	2562	12	a	a	DT
25944	2562	13	result	result	NN
25944	2562	14	the	the	DT
25944	2562	15	new	new	JJ
25944	2562	16	growth	growth	NN
25944	2562	17	undergoes	undergo	VBZ
25944	2562	18	retrogressive	retrogressive	JJ
25944	2562	19	changes	change	NNS
25944	2562	20	,	,	,
25944	2562	21	and	and	CC
25944	2562	22	cicatrization	cicatrization	NN
25944	2562	23	takes	take	VBZ
25944	2562	24	place	place	NN
25944	2562	25	.	.	.
25944	2563	1	_	_	NNP
25944	2563	2	Punctate	Punctate	NNP
25944	2563	3	Scarification._--By	scarification._--by	NN
25944	2563	4	means	mean	NNS
25944	2563	5	of	of	IN
25944	2563	6	a	a	DT
25944	2563	7	simple	simple	JJ
25944	2563	8	or	or	CC
25944	2563	9	multiple	multiple	JJ
25944	2563	10	-	-	HYPH
25944	2563	11	pointed	pointed	JJ
25944	2563	12	instrument	instrument	NN
25944	2563	13	numerous	numerous	JJ
25944	2563	14	closely	closely	RB
25944	2563	15	-	-	HYPH
25944	2563	16	set	set	VBN
25944	2563	17	punctures	puncture	NNS
25944	2563	18	are	be	VBP
25944	2563	19	made	make	VBN
25944	2563	20	,	,	,
25944	2563	21	and	and	CC
25944	2563	22	repeated	repeat	VBN
25944	2563	23	from	from	IN
25944	2563	24	time	time	NN
25944	2563	25	to	to	IN
25944	2563	26	time	time	NN
25944	2563	27	,	,	,
25944	2563	28	usually	usually	RB
25944	2563	29	with	with	IN
25944	2563	30	the	the	DT
25944	2563	31	same	same	JJ
25944	2563	32	action	action	NN
25944	2563	33	and	and	CC
25944	2563	34	result	result	VB
25944	2563	35	as	as	IN
25944	2563	36	from	from	IN
25944	2563	37	linear	linear	JJ
25944	2563	38	scarification	scarification	NN
25944	2563	39	.	.	.
25944	2564	1	_	_	NNP
25944	2564	2	Erasion._--The	Erasion._--The	NNP
25944	2564	3	parts	part	NNS
25944	2564	4	are	be	VBP
25944	2564	5	thoroughly	thoroughly	RB
25944	2564	6	scraped	scrape	VBN
25944	2564	7	with	with	IN
25944	2564	8	a	a	DT
25944	2564	9	curette	curette	NN
25944	2564	10	,	,	,
25944	2564	11	and	and	CC
25944	2564	12	a	a	DT
25944	2564	13	supplementary	supplementary	JJ
25944	2564	14	caustic	caustic	JJ
25944	2564	15	application	application	NN
25944	2564	16	made	make	VBN
25944	2564	17	,	,	,
25944	2564	18	either	either	CC
25944	2564	19	with	with	IN
25944	2564	20	caustic	caustic	JJ
25944	2564	21	potash	potash	NN
25944	2564	22	or	or	CC
25944	2564	23	several	several	JJ
25944	2564	24	days	day	NNS
25944	2564	25	'	'	POS
25944	2564	26	use	use	NN
25944	2564	27	of	of	IN
25944	2564	28	the	the	DT
25944	2564	29	pyrogallic	pyrogallic	JJ
25944	2564	30	-	-	HYPH
25944	2564	31	acid	acid	NN
25944	2564	32	ointment	ointment	NN
25944	2564	33	.	.	.
25944	2565	1	The	the	DT
25944	2565	2	result	result	NN
25944	2565	3	is	be	VBZ
25944	2565	4	usually	usually	RB
25944	2565	5	satisfactory	satisfactory	JJ
25944	2565	6	.	.	.
25944	2566	1	The	the	DT
25944	2566	2	dental	dental	NN
25944	2566	3	-	-	HYPH
25944	2566	4	burr	burr	NN
25944	2566	5	is	be	VBZ
25944	2566	6	also	also	RB
25944	2566	7	useful	useful	JJ
25944	2566	8	in	in	IN
25944	2566	9	breaking	break	VBG
25944	2566	10	up	up	RP
25944	2566	11	discrete	discrete	JJ
25944	2566	12	tubercles	tubercle	NNS
25944	2566	13	.	.	.
25944	2567	1	_	_	NNP
25944	2567	2	Excision._--This	Excision._--This	NNP
25944	2567	3	is	be	VBZ
25944	2567	4	an	an	DT
25944	2567	5	effective	effective	JJ
25944	2567	6	method	method	NN
25944	2567	7	if	if	IN
25944	2567	8	the	the	DT
25944	2567	9	disease	disease	NN
25944	2567	10	consists	consist	VBZ
25944	2567	11	of	of	IN
25944	2567	12	a	a	DT
25944	2567	13	small	small	JJ
25944	2567	14	pea-	pea-	NNS
25944	2567	15	or	or	CC
25944	2567	16	bean	bean	NN
25944	2567	17	-	-	HYPH
25944	2567	18	sized	sized	JJ
25944	2567	19	circumscribed	circumscribed	JJ
25944	2567	20	patch	patch	NN
25944	2567	21	.	.	.
25944	2568	1	Of	of	IN
25944	2568	2	these	these	DT
25944	2568	3	various	various	JJ
25944	2568	4	operative	operative	JJ
25944	2568	5	methods	method	NNS
25944	2568	6	those	those	DT
25944	2568	7	now	now	RB
25944	2568	8	most	most	RBS
25944	2568	9	favored	favor	VBN
25944	2568	10	are	be	VBP
25944	2568	11	erasion	erasion	NN
25944	2568	12	and	and	CC
25944	2568	13	excision	excision	NN
25944	2568	14	,	,	,
25944	2568	15	punctate	punctate	VB
25944	2568	16	and	and	CC
25944	2568	17	linear	linear	JJ
25944	2568	18	scarification	scarification	NN
25944	2568	19	methods	method	NNS
25944	2568	20	are	be	VBP
25944	2568	21	now	now	RB
25944	2568	22	rarely	rarely	RB
25944	2568	23	employed	employ	VBN
25944	2568	24	.	.	.
25944	2569	1	#	#	$
25944	2569	2	Tuberculosis	Tuberculosis	NNP
25944	2569	3	Cutis.#[D	cutis.#[d	NN
25944	2569	4	]	]	-RRB-
25944	2569	5	(	(	-LRB-
25944	2569	6	_	_	NNP
25944	2569	7	Synonym	Synonym	NNP
25944	2569	8	:	:	:
25944	2569	9	_	_	NNP
25944	2569	10	Scrofuloderma	Scrofuloderma	NNP
25944	2569	11	.	.	.
25944	2569	12	)	)	-RRB-
25944	2570	1	[	[	-LRB-
25944	2570	2	Footnote	footnote	NN
25944	2570	3	D	d	NN
25944	2570	4	:	:	:
25944	2570	5	The	the	DT
25944	2570	6	most	most	RBS
25944	2570	7	important	important	JJ
25944	2570	8	clinical	clinical	JJ
25944	2570	9	variety	variety	NN
25944	2570	10	of	of	IN
25944	2570	11	this	this	DT
25944	2570	12	class	class	NN
25944	2570	13	is	be	VBZ
25944	2570	14	lupus	lupus	NNP
25944	2570	15	vulgaris	vulgaris	NNP
25944	2570	16	,	,	,
25944	2570	17	which	which	WDT
25944	2570	18	is	be	VBZ
25944	2570	19	considered	consider	VBN
25944	2570	20	above	above	RB
25944	2570	21	,	,	,
25944	2570	22	separately	separately	RB
25944	2570	23	,	,	,
25944	2570	24	at	at	IN
25944	2570	25	some	some	DT
25944	2570	26	length	length	NN
25944	2570	27	.	.	.
25944	2570	28	]	]	-RRB-
25944	2571	1	#	#	LS
25944	2571	2	What	what	WP
25944	2571	3	do	do	VBP
25944	2571	4	you	-PRON-	PRP
25944	2571	5	understand	understand	VB
25944	2571	6	by	by	IN
25944	2571	7	tuberculosis	tuberculosis	NN
25944	2571	8	cutis	cutis	RB
25944	2571	9	?	?	.
25944	2571	10	#	#	$
25944	2571	11	The	the	DT
25944	2571	12	term	term	NN
25944	2571	13	is	be	VBZ
25944	2571	14	applied	apply	VBN
25944	2571	15	to	to	IN
25944	2571	16	those	those	DT
25944	2571	17	peculiar	peculiar	JJ
25944	2571	18	suppurative	suppurative	NN
25944	2571	19	and	and	CC
25944	2571	20	ulcerative	ulcerative	JJ
25944	2571	21	conditions	condition	NNS
25944	2571	22	of	of	IN
25944	2571	23	the	the	DT
25944	2571	24	skin	skin	NN
25944	2571	25	due	due	IN
25944	2571	26	to	to	IN
25944	2571	27	the	the	DT
25944	2571	28	tubercle	tubercle	NN
25944	2571	29	bacilli	bacilli	NNP
25944	2571	30	.	.	.
25944	2572	1	#	#	NNP
25944	2572	2	How	how	WRB
25944	2572	3	does	do	VBZ
25944	2572	4	the	the	DT
25944	2572	5	common	common	JJ
25944	2572	6	type	type	NN
25944	2572	7	of	of	IN
25944	2572	8	tuberculosis	tuberculosis	NN
25944	2572	9	cutis	cutis	JJ
25944	2572	10	begin	begin	VB
25944	2572	11	?	?	.
25944	2572	12	#	#	$
25944	2572	13	The	the	DT
25944	2572	14	most	most	RBS
25944	2572	15	common	common	JJ
25944	2572	16	type	type	NN
25944	2572	17	of	of	IN
25944	2572	18	tuberculous	tuberculous	JJ
25944	2572	19	ulceration	ulceration	NN
25944	2572	20	or	or	CC
25944	2572	21	involvement	involvement	NN
25944	2572	22	of	of	IN
25944	2572	23	the	the	DT
25944	2572	24	skin	skin	NN
25944	2572	25	usually	usually	RB
25944	2572	26	results	result	VBZ
25944	2572	27	by	by	IN
25944	2572	28	extension	extension	NN
25944	2572	29	from	from	IN
25944	2572	30	an	an	DT
25944	2572	31	underlying	underlying	JJ
25944	2572	32	caseating	caseating	NN
25944	2572	33	and	and	CC
25944	2572	34	suppurating	suppurate	VBG
25944	2572	35	lymphatic	lymphatic	JJ
25944	2572	36	gland	gland	NN
25944	2572	37	;	;	:
25944	2572	38	or	or	CC
25944	2572	39	it	-PRON-	PRP
25944	2572	40	may	may	MD
25944	2572	41	have	have	VB
25944	2572	42	its	-PRON-	PRP$
25944	2572	43	origin	origin	NN
25944	2572	44	as	as	IN
25944	2572	45	subcutaneous	subcutaneous	JJ
25944	2572	46	tubercles	tubercle	NNS
25944	2572	47	independently	independently	RB
25944	2572	48	of	of	IN
25944	2572	49	these	these	DT
25944	2572	50	structures	structure	NNS
25944	2572	51	.	.	.
25944	2573	1	It	-PRON-	PRP
25944	2573	2	tends	tend	VBZ
25944	2573	3	to	to	TO
25944	2573	4	spread	spread	VB
25944	2573	5	,	,	,
25944	2573	6	and	and	CC
25944	2573	7	may	may	MD
25944	2573	8	involve	involve	VB
25944	2573	9	an	an	DT
25944	2573	10	area	area	NN
25944	2573	11	of	of	IN
25944	2573	12	one	one	CD
25944	2573	13	or	or	CC
25944	2573	14	several	several	JJ
25944	2573	15	inches	inch	NNS
25944	2573	16	.	.	.
25944	2574	1	[	[	-LRB-
25944	2574	2	Illustration	illustration	NN
25944	2574	3	:	:	:
25944	2574	4	Fig	Fig	NNP
25944	2574	5	.	.	.
25944	2575	1	48	48	CD
25944	2575	2	.	.	.
25944	2576	1	Tuberculosis	Tuberculosis	NNP
25944	2576	2	Verrucosa	Verrucosa	NNP
25944	2576	3	Cutis	Cutis	NNP
25944	2576	4	(	(	-LRB-
25944	2576	5	Negro	Negro	NNP
25944	2576	6	)	)	-RRB-
25944	2576	7	.	.	.
25944	2576	8	]	]	-RRB-
25944	2577	1	#	#	LS
25944	2577	2	What	what	WP
25944	2577	3	are	be	VBP
25944	2577	4	the	the	DT
25944	2577	5	clinical	clinical	JJ
25944	2577	6	appearances	appearance	NNS
25944	2577	7	and	and	CC
25944	2577	8	behavior	behavior	NN
25944	2577	9	of	of	IN
25944	2577	10	this	this	DT
25944	2577	11	type	type	NN
25944	2577	12	of	of	IN
25944	2577	13	tuberculous	tuberculous	JJ
25944	2577	14	ulceration	ulceration	NN
25944	2577	15	?	?	.
25944	2577	16	#	#	$
25944	2577	17	It	-PRON-	PRP
25944	2577	18	is	be	VBZ
25944	2577	19	usually	usually	RB
25944	2577	20	superficial	superficial	JJ
25944	2577	21	,	,	,
25944	2577	22	has	have	VBZ
25944	2577	23	thin	thin	JJ
25944	2577	24	,	,	,
25944	2577	25	red	red	JJ
25944	2577	26	,	,	,
25944	2577	27	undermined	undermine	VBD
25944	2577	28	edges	edge	NNS
25944	2577	29	of	of	IN
25944	2577	30	a	a	DT
25944	2577	31	violaceous	violaceous	JJ
25944	2577	32	color	color	NN
25944	2577	33	,	,	,
25944	2577	34	and	and	CC
25944	2577	35	an	an	DT
25944	2577	36	irregular	irregular	JJ
25944	2577	37	base	base	NN
25944	2577	38	with	with	IN
25944	2577	39	granulations	granulation	NNS
25944	2577	40	covered	cover	VBN
25944	2577	41	scantily	scantily	RB
25944	2577	42	with	with	IN
25944	2577	43	pus	pus	NNP
25944	2577	44	.	.	.
25944	2578	1	As	as	IN
25944	2578	2	a	a	DT
25944	2578	3	rule	rule	NN
25944	2578	4	,	,	,
25944	2578	5	it	-PRON-	PRP
25944	2578	6	spreads	spread	VBZ
25944	2578	7	gradually	gradually	RB
25944	2578	8	as	as	IN
25944	2578	9	a	a	DT
25944	2578	10	simple	simple	JJ
25944	2578	11	ulceration	ulceration	NN
25944	2578	12	,	,	,
25944	2578	13	with	with	IN
25944	2578	14	but	but	CC
25944	2578	15	slight	slight	JJ
25944	2578	16	,	,	,
25944	2578	17	if	if	IN
25944	2578	18	any	any	DT
25944	2578	19	,	,	,
25944	2578	20	outlying	outlying	JJ
25944	2578	21	infiltration	infiltration	NN
25944	2578	22	.	.	.
25944	2579	1	Subjective	subjective	JJ
25944	2579	2	symptoms	symptom	NNS
25944	2579	3	of	of	IN
25944	2579	4	a	a	DT
25944	2579	5	painful	painful	JJ
25944	2579	6	or	or	CC
25944	2579	7	troublesome	troublesome	JJ
25944	2579	8	character	character	NN
25944	2579	9	are	be	VBP
25944	2579	10	rarely	rarely	RB
25944	2579	11	present	present	JJ
25944	2579	12	.	.	.
25944	2580	1	Its	-PRON-	PRP$
25944	2580	2	course	course	NN
25944	2580	3	is	be	VBZ
25944	2580	4	usually	usually	RB
25944	2580	5	progressive	progressive	JJ
25944	2580	6	but	but	CC
25944	2580	7	slow	slow	JJ
25944	2580	8	and	and	CC
25944	2580	9	chronic	chronic	JJ
25944	2580	10	.	.	.
25944	2581	1	Other	other	JJ
25944	2581	2	symptoms	symptom	NNS
25944	2581	3	of	of	IN
25944	2581	4	tuberculosis	tuberculosis	NN
25944	2581	5	are	be	VBP
25944	2581	6	commonly	commonly	RB
25944	2581	7	to	to	TO
25944	2581	8	be	be	VB
25944	2581	9	found	find	VBN
25944	2581	10	.	.	.
25944	2582	1	#	#	NN
25944	2582	2	Are	be	VBP
25944	2582	3	other	other	JJ
25944	2582	4	forms	form	NNS
25944	2582	5	of	of	IN
25944	2582	6	tuberculosis	tuberculosis	NN
25944	2582	7	cutis	cutis	JJ
25944	2582	8	met	meet	VBD
25944	2582	9	with	with	IN
25944	2582	10	?	?	.
25944	2582	11	#	#	$
25944	2582	12	A	a	DT
25944	2582	13	papulo	papulo	JJ
25944	2582	14	-	-	HYPH
25944	2582	15	pustular	pustular	NN
25944	2582	16	eruption	eruption	NN
25944	2582	17	is	be	VBZ
25944	2582	18	sometimes	sometimes	RB
25944	2582	19	observed	observe	VBN
25944	2582	20	,	,	,
25944	2582	21	especially	especially	RB
25944	2582	22	on	on	IN
25944	2582	23	the	the	DT
25944	2582	24	upper	upper	JJ
25944	2582	25	extremities	extremity	NNS
25944	2582	26	and	and	CC
25944	2582	27	face	face	NN
25944	2582	28	;	;	:
25944	2582	29	sluggish	sluggish	JJ
25944	2582	30	and	and	CC
25944	2582	31	chronic	chronic	JJ
25944	2582	32	in	in	IN
25944	2582	33	character	character	NN
25944	2582	34	and	and	CC
25944	2582	35	leaving	leave	VBG
25944	2582	36	small	small	JJ
25944	2582	37	pit	pit	NN
25944	2582	38	-	-	HYPH
25944	2582	39	like	like	JJ
25944	2582	40	scars	scar	NNS
25944	2582	41	;	;	,
25944	2582	42	has	have	VBZ
25944	2582	43	been	be	VBN
25944	2582	44	known	know	VBN
25944	2582	45	as	as	IN
25944	2582	46	the	the	DT
25944	2582	47	_	_	NNP
25944	2582	48	small	small	JJ
25944	2582	49	pustular	pustular	JJ
25944	2582	50	scrofuloderma	scrofuloderma	NNP
25944	2582	51	_	_	NNP
25944	2582	52	.	.	.
25944	2583	1	[	[	-LRB-
25944	2583	2	Illustration	illustration	NN
25944	2583	3	:	:	:
25944	2583	4	Fig	Fig	NNP
25944	2583	5	.	.	.
25944	2584	1	49	49	CD
25944	2584	2	.	.	.
25944	2585	1	Tuberculosis	Tuberculosis	NNP
25944	2585	2	Verrucosa	Verrucosa	NNP
25944	2585	3	Cutis	Cutis	NNP
25944	2585	4	(	(	-LRB-
25944	2585	5	patient	patient	JJ
25944	2585	6	had	have	VBD
25944	2585	7	a	a	DT
25944	2585	8	coexistent	coexistent	NN
25944	2585	9	pulmonary	pulmonary	JJ
25944	2585	10	tuberculosis	tuberculosis	NN
25944	2585	11	)	)	-RRB-
25944	2585	12	.	.	.
25944	2585	13	]	]	-RRB-
25944	2586	1	An	an	DT
25944	2586	2	ulcerative	ulcerative	JJ
25944	2586	3	papillomatous	papillomatous	JJ
25944	2586	4	or	or	CC
25944	2586	5	verrucous	verrucous	JJ
25944	2586	6	tuberculosis	tuberculosis	NN
25944	2586	7	of	of	IN
25944	2586	8	the	the	DT
25944	2586	9	skin	skin	NN
25944	2586	10	(	(	-LRB-
25944	2586	11	tuberculosis	tuberculosis	NNP
25944	2586	12	verrucosa	verrucosa	NNP
25944	2586	13	cutis	cutis	NNP
25944	2586	14	)	)	-RRB-
25944	2586	15	is	be	VBZ
25944	2586	16	also	also	RB
25944	2586	17	occasionally	occasionally	RB
25944	2586	18	noted	note	VBN
25944	2586	19	,	,	,
25944	2586	20	most	most	RBS
25944	2586	21	commonly	commonly	RB
25944	2586	22	seated	seat	VBN
25944	2586	23	upon	upon	IN
25944	2586	24	the	the	DT
25944	2586	25	lower	low	JJR
25944	2586	26	leg	leg	NN
25944	2586	27	or	or	CC
25944	2586	28	the	the	DT
25944	2586	29	back	back	NN
25944	2586	30	of	of	IN
25944	2586	31	the	the	DT
25944	2586	32	hand	hand	NN
25944	2586	33	.	.	.
25944	2587	1	It	-PRON-	PRP
25944	2587	2	may	may	MD
25944	2587	3	be	be	VB
25944	2587	4	slight	slight	JJ
25944	2587	5	or	or	CC
25944	2587	6	extensive	extensive	JJ
25944	2587	7	.	.	.
25944	2588	1	Its	-PRON-	PRP$
25944	2588	2	mildest	mildest	JJ
25944	2588	3	phase	phase	NN
25944	2588	4	is	be	VBZ
25944	2588	5	the	the	DT
25944	2588	6	so	so	RB
25944	2588	7	-	-	HYPH
25944	2588	8	called	call	VBN
25944	2588	9	verruca	verruca	NNP
25944	2588	10	necrogenica	necrogenica	NNP
25944	2588	11	.	.	.
25944	2589	1	#	#	NNP
25944	2589	2	Describe	Describe	NNP
25944	2589	3	verruca	verruca	NN
25944	2589	4	necrogenica	necrogenica	NNP
25944	2589	5	.	.	.
25944	2589	6	#	#	NNP
25944	2589	7	Verruca	Verruca	NNP
25944	2589	8	necrogenica	necrogenica	NNP
25944	2589	9	is	be	VBZ
25944	2589	10	a	a	DT
25944	2589	11	rare	rare	JJ
25944	2589	12	,	,	,
25944	2589	13	localized	localize	VBN
25944	2589	14	,	,	,
25944	2589	15	papillary	papillary	JJ
25944	2589	16	or	or	CC
25944	2589	17	wart	wart	JJ
25944	2589	18	-	-	HYPH
25944	2589	19	like	like	JJ
25944	2589	20	formation	formation	NN
25944	2589	21	,	,	,
25944	2589	22	occurring	occur	VBG
25944	2589	23	usually	usually	RB
25944	2589	24	about	about	IN
25944	2589	25	the	the	DT
25944	2589	26	knuckles	knuckle	NNS
25944	2589	27	or	or	CC
25944	2589	28	other	other	JJ
25944	2589	29	parts	part	NNS
25944	2589	30	of	of	IN
25944	2589	31	the	the	DT
25944	2589	32	hand	hand	NN
25944	2589	33	.	.	.
25944	2590	1	It	-PRON-	PRP
25944	2590	2	begins	begin	VBZ
25944	2590	3	,	,	,
25944	2590	4	as	as	IN
25944	2590	5	a	a	DT
25944	2590	6	rule	rule	NN
25944	2590	7	,	,	,
25944	2590	8	as	as	IN
25944	2590	9	a	a	DT
25944	2590	10	small	small	JJ
25944	2590	11	,	,	,
25944	2590	12	papule	papule	JJ
25944	2590	13	-	-	HYPH
25944	2590	14	like	like	JJ
25944	2590	15	growth	growth	NN
25944	2590	16	,	,	,
25944	2590	17	increasing	increase	VBG
25944	2590	18	gradually	gradually	RB
25944	2590	19	in	in	IN
25944	2590	20	area	area	NN
25944	2590	21	,	,	,
25944	2590	22	and	and	CC
25944	2590	23	when	when	WRB
25944	2590	24	well	well	RB
25944	2590	25	advanced	advanced	JJ
25944	2590	26	appears	appear	VBZ
25944	2590	27	as	as	IN
25944	2590	28	a	a	DT
25944	2590	29	pea	pea	NN
25944	2590	30	,	,	,
25944	2590	31	dime	dime	NN
25944	2590	32	-	-	HYPH
25944	2590	33	sized	sized	JJ
25944	2590	34	or	or	CC
25944	2590	35	larger	large	JJR
25944	2590	36	,	,	,
25944	2590	37	somewhat	somewhat	RB
25944	2590	38	inflammatory	inflammatory	JJ
25944	2590	39	,	,	,
25944	2590	40	elevated	elevated	JJ
25944	2590	41	,	,	,
25944	2590	42	flat	flat	JJ
25944	2590	43	,	,	,
25944	2590	44	warty	warty	JJ
25944	2590	45	mass	mass	NN
25944	2590	46	,	,	,
25944	2590	47	with	with	IN
25944	2590	48	usually	usually	RB
25944	2590	49	a	a	DT
25944	2590	50	tendency	tendency	NN
25944	2590	51	to	to	IN
25944	2590	52	slight	slight	JJ
25944	2590	53	pus	pus	NN
25944	2590	54	-	-	HYPH
25944	2590	55	formation	formation	NN
25944	2590	56	between	between	IN
25944	2590	57	the	the	DT
25944	2590	58	hypertrophied	hypertrophied	JJ
25944	2590	59	papillæ	papillæ	NN
25944	2590	60	;	;	:
25944	2590	61	the	the	DT
25944	2590	62	surface	surface	NN
25944	2590	63	may	may	MD
25944	2590	64	be	be	VB
25944	2590	65	horny	horny	JJ
25944	2590	66	or	or	CC
25944	2590	67	it	-PRON-	PRP
25944	2590	68	may	may	MD
25944	2590	69	be	be	VB
25944	2590	70	crusted	crust	VBN
25944	2590	71	.	.	.
25944	2591	1	It	-PRON-	PRP
25944	2591	2	tends	tend	VBZ
25944	2591	3	to	to	TO
25944	2591	4	enlarge	enlarge	VB
25944	2591	5	slowly	slowly	RB
25944	2591	6	and	and	CC
25944	2591	7	is	be	VBZ
25944	2591	8	usually	usually	RB
25944	2591	9	persistent	persistent	JJ
25944	2591	10	,	,	,
25944	2591	11	but	but	CC
25944	2591	12	it	-PRON-	PRP
25944	2591	13	at	at	IN
25944	2591	14	times	time	NNS
25944	2591	15	undergoes	undergo	VBZ
25944	2591	16	involution	involution	NN
25944	2591	17	.	.	.
25944	2592	1	[	[	-LRB-
25944	2592	2	Illustration	illustration	NN
25944	2592	3	:	:	:
25944	2592	4	Fig	Fig	NNP
25944	2592	5	.	.	.
25944	2593	1	50	50	CD
25944	2593	2	.	.	.
25944	2594	1	Tuberculosis	Tuberculosis	NNP
25944	2594	2	Cutis	Cutis	NNP
25944	2594	3	(	(	-LRB-
25944	2594	4	Verruca	Verruca	NNP
25944	2594	5	Necrogenica	Necrogenica	NNP
25944	2594	6	)	)	-RRB-
25944	2594	7	.	.	.
25944	2595	1	(	(	-LRB-
25944	2595	2	_	_	NNP
25944	2595	3	After	after	IN
25944	2595	4	Model	Model	NNP
25944	2595	5	in	in	IN
25944	2595	6	Guy	Guy	NNP
25944	2595	7	's	's	POS
25944	2595	8	Museum	Museum	NNP
25944	2595	9	.	.	.
25944	2595	10	_	_	NNP
25944	2595	11	)	)	-RRB-
25944	2595	12	]	]	-RRB-
25944	2595	13	#	#	$
25944	2595	14	State	state	NN
25944	2595	15	the	the	DT
25944	2595	16	etiology	etiology	NN
25944	2595	17	.	.	.
25944	2595	18	#	#	$
25944	2595	19	Heredity	heredity	NN
25944	2595	20	,	,	,
25944	2595	21	insufficient	insufficient	JJ
25944	2595	22	and	and	CC
25944	2595	23	unwholesome	unwholesome	JJ
25944	2595	24	food	food	NN
25944	2595	25	,	,	,
25944	2595	26	impure	impure	NN
25944	2595	27	air	air	NN
25944	2595	28	,	,	,
25944	2595	29	and	and	CC
25944	2595	30	the	the	DT
25944	2595	31	like	like	JJ
25944	2595	32	are	be	VBP
25944	2595	33	predisposing	predispose	VBG
25944	2595	34	.	.	.
25944	2596	1	The	the	DT
25944	2596	2	tubercle	tubercle	NN
25944	2596	3	bacillus	bacillus	NN
25944	2596	4	is	be	VBZ
25944	2596	5	the	the	DT
25944	2596	6	immediate	immediate	JJ
25944	2596	7	exciting	exciting	JJ
25944	2596	8	cause	cause	NN
25944	2596	9	.	.	.
25944	2597	1	The	the	DT
25944	2597	2	disease	disease	NN
25944	2597	3	usually	usually	RB
25944	2597	4	appears	appear	VBZ
25944	2597	5	in	in	IN
25944	2597	6	childhood	childhood	NN
25944	2597	7	or	or	CC
25944	2597	8	early	early	JJ
25944	2597	9	adult	adult	NN
25944	2597	10	life	life	NN
25944	2597	11	,	,	,
25944	2597	12	and	and	CC
25944	2597	13	not	not	RB
25944	2597	14	infrequently	infrequently	RB
25944	2597	15	follows	follow	VBZ
25944	2597	16	in	in	IN
25944	2597	17	the	the	DT
25944	2597	18	wake	wake	NN
25944	2597	19	of	of	IN
25944	2597	20	some	some	DT
25944	2597	21	severe	severe	JJ
25944	2597	22	systemic	systemic	JJ
25944	2597	23	disease	disease	NN
25944	2597	24	.	.	.
25944	2598	1	Etiologically	etiologically	RB
25944	2598	2	it	-PRON-	PRP
25944	2598	3	is	be	VBZ
25944	2598	4	identical	identical	JJ
25944	2598	5	in	in	IN
25944	2598	6	nature	nature	NN
25944	2598	7	with	with	IN
25944	2598	8	lupus	lupus	NNP
25944	2598	9	.	.	.
25944	2599	1	#	#	NNP
25944	2599	2	How	how	WRB
25944	2599	3	is	be	VBZ
25944	2599	4	the	the	DT
25944	2599	5	tuberculous	tuberculous	JJ
25944	2599	6	ulcer	ulcer	NN
25944	2599	7	to	to	TO
25944	2599	8	be	be	VB
25944	2599	9	differentiated	differentiate	VBN
25944	2599	10	from	from	IN
25944	2599	11	syphilis	syphilis	NNP
25944	2599	12	?	?	.
25944	2599	13	#	#	NN
25944	2599	14	By	by	IN
25944	2599	15	the	the	DT
25944	2599	16	peculiar	peculiar	JJ
25944	2599	17	character	character	NN
25944	2599	18	of	of	IN
25944	2599	19	the	the	DT
25944	2599	20	tuberculous	tuberculous	JJ
25944	2599	21	ulceration	ulceration	NN
25944	2599	22	,	,	,
25944	2599	23	the	the	DT
25944	2599	24	absence	absence	NN
25944	2599	25	of	of	IN
25944	2599	26	outlying	outlying	JJ
25944	2599	27	tubercles	tubercle	NNS
25944	2599	28	and	and	CC
25944	2599	29	infiltration	infiltration	NN
25944	2599	30	,	,	,
25944	2599	31	together	together	RB
25944	2599	32	with	with	IN
25944	2599	33	its	-PRON-	PRP$
25944	2599	34	history	history	NN
25944	2599	35	,	,	,
25944	2599	36	course	course	NN
25944	2599	37	,	,	,
25944	2599	38	and	and	CC
25944	2599	39	often	often	RB
25944	2599	40	the	the	DT
25944	2599	41	presence	presence	NN
25944	2599	42	of	of	IN
25944	2599	43	other	other	JJ
25944	2599	44	tuberculous	tuberculous	JJ
25944	2599	45	symptoms	symptom	NNS
25944	2599	46	.	.	.
25944	2600	1	#	#	JJR
25944	2600	2	State	state	NN
25944	2600	3	the	the	DT
25944	2600	4	prognosis	prognosis	NN
25944	2600	5	.	.	.
25944	2600	6	#	#	$
25944	2600	7	These	these	DT
25944	2600	8	various	various	JJ
25944	2600	9	types	type	NNS
25944	2600	10	of	of	IN
25944	2600	11	tuberculosis	tuberculosis	NN
25944	2600	12	cutis	cutis	NN
25944	2600	13	are	be	VBP
25944	2600	14	,	,	,
25944	2600	15	as	as	IN
25944	2600	16	a	a	DT
25944	2600	17	rule	rule	NN
25944	2600	18	,	,	,
25944	2600	19	more	more	RBR
25944	2600	20	amenable	amenable	JJ
25944	2600	21	to	to	IN
25944	2600	22	treatment	treatment	NN
25944	2600	23	than	than	IN
25944	2600	24	that	that	DT
25944	2600	25	form	form	NN
25944	2600	26	known	know	VBN
25944	2600	27	as	as	IN
25944	2600	28	lupus	lupus	NNP
25944	2600	29	vulgaris	vulgaris	NNP
25944	2600	30	(	(	-LRB-
25944	2600	31	_	_	NNP
25944	2600	32	q	q	NNP
25944	2600	33	.	.	.
25944	2601	1	v.	v.	NNP
25944	2601	2	_	_	NNP
25944	2601	3	)	)	-RRB-
25944	2601	4	.	.	.
25944	2602	1	#	#	LS
25944	2602	2	What	what	WP
25944	2602	3	is	be	VBZ
25944	2602	4	the	the	DT
25944	2602	5	treatment	treatment	NN
25944	2602	6	of	of	IN
25944	2602	7	these	these	DT
25944	2602	8	forms	form	NNS
25944	2602	9	of	of	IN
25944	2602	10	tuberculosis	tuberculosis	NN
25944	2602	11	cutis	cutis	JJ
25944	2602	12	?	?	.
25944	2602	13	#	#	$
25944	2602	14	Constitutional	constitutional	JJ
25944	2602	15	remedies	remedy	NNS
25944	2602	16	,	,	,
25944	2602	17	such	such	JJ
25944	2602	18	as	as	IN
25944	2602	19	cod	cod	NN
25944	2602	20	-	-	HYPH
25944	2602	21	liver	liver	NN
25944	2602	22	oil	oil	NN
25944	2602	23	,	,	,
25944	2602	24	iodide	iodide	NN
25944	2602	25	of	of	IN
25944	2602	26	iron	iron	NN
25944	2602	27	or	or	CC
25944	2602	28	other	other	JJ
25944	2602	29	ferruginous	ferruginous	JJ
25944	2602	30	tonics	tonic	NNS
25944	2602	31	,	,	,
25944	2602	32	together	together	RB
25944	2602	33	with	with	IN
25944	2602	34	good	good	JJ
25944	2602	35	food	food	NN
25944	2602	36	and	and	CC
25944	2602	37	pure	pure	JJ
25944	2602	38	air	air	NN
25944	2602	39	;	;	:
25944	2602	40	phosphorus	phosphorus	NN
25944	2602	41	one	one	CD
25944	2602	42	-	-	HYPH
25944	2602	43	hundredth	hundredth	NN
25944	2602	44	to	to	IN
25944	2602	45	one	one	CD
25944	2602	46	-	-	HYPH
25944	2602	47	fiftieth	fiftieth	NN
25944	2602	48	of	of	IN
25944	2602	49	a	a	DT
25944	2602	50	grain	grain	NN
25944	2602	51	three	three	CD
25944	2602	52	times	time	NNS
25944	2602	53	daily	daily	NNP
25944	2602	54	is	be	VBZ
25944	2602	55	also	also	RB
25944	2602	56	of	of	IN
25944	2602	57	benefit	benefit	NN
25944	2602	58	in	in	IN
25944	2602	59	some	some	DT
25944	2602	60	cases	case	NNS
25944	2602	61	.	.	.
25944	2603	1	The	the	DT
25944	2603	2	local	local	JJ
25944	2603	3	treatment	treatment	NN
25944	2603	4	consists	consist	VBZ
25944	2603	5	in	in	IN
25944	2603	6	thorough	thorough	JJ
25944	2603	7	curetting	curetting	NN
25944	2603	8	and	and	CC
25944	2603	9	the	the	DT
25944	2603	10	subsequent	subsequent	JJ
25944	2603	11	application	application	NN
25944	2603	12	of	of	IN
25944	2603	13	a	a	DT
25944	2603	14	mildly	mildly	RB
25944	2603	15	stimulating	stimulating	JJ
25944	2603	16	ointment	ointment	NN
25944	2603	17	.	.	.
25944	2604	1	The	the	DT
25944	2604	2	several	several	JJ
25944	2604	3	other	other	JJ
25944	2604	4	plans	plan	NNS
25944	2604	5	of	of	IN
25944	2604	6	external	external	JJ
25944	2604	7	treatment	treatment	NN
25944	2604	8	employed	employ	VBN
25944	2604	9	in	in	IN
25944	2604	10	lupus	lupus	NNP
25944	2604	11	(	(	-LRB-
25944	2604	12	_	_	NNP
25944	2604	13	q	q	NNP
25944	2604	14	.	.	.
25944	2605	1	v.	v.	NNP
25944	2605	2	_	_	NNP
25944	2605	3	)	)	-RRB-
25944	2605	4	are	be	VBP
25944	2605	5	also	also	RB
25944	2605	6	variously	variously	RB
25944	2605	7	practised	practise	VBN
25944	2605	8	.	.	.
25944	2606	1	In	in	IN
25944	2606	2	recent	recent	JJ
25944	2606	3	years	year	NNS
25944	2606	4	the	the	DT
25944	2606	5	_	_	NNP
25944	2606	6	x_-ray	x_-ray	NN
25944	2606	7	and	and	CC
25944	2606	8	Finsen	Finsen	NNP
25944	2606	9	light	light	JJ
25944	2606	10	plans	plan	NNS
25944	2606	11	have	have	VBP
25944	2606	12	,	,	,
25944	2606	13	in	in	IN
25944	2606	14	a	a	DT
25944	2606	15	measure	measure	NN
25944	2606	16	,	,	,
25944	2606	17	supplanted	supplant	VBD
25944	2606	18	the	the	DT
25944	2606	19	previous	previous	JJ
25944	2606	20	methods	method	NNS
25944	2606	21	of	of	IN
25944	2606	22	treatment	treatment	NN
25944	2606	23	.	.	.
25944	2607	1	They	-PRON-	PRP
25944	2607	2	are	be	VBP
25944	2607	3	slow	slow	JJ
25944	2607	4	,	,	,
25944	2607	5	however	however	RB
25944	2607	6	,	,	,
25944	2607	7	and	and	CC
25944	2607	8	might	may	MD
25944	2607	9	be	be	VB
25944	2607	10	,	,	,
25944	2607	11	especially	especially	RB
25944	2607	12	the	the	DT
25944	2607	13	_	_	NNP
25944	2607	14	x_-ray	x_-ray	NN
25944	2607	15	,	,	,
25944	2607	16	more	more	RBR
25944	2607	17	satisfactorily	satisfactorily	RB
25944	2607	18	employed	employ	VBN
25944	2607	19	as	as	IN
25944	2607	20	a	a	DT
25944	2607	21	supplementary	supplementary	JJ
25944	2607	22	measure	measure	NN
25944	2607	23	.	.	.
25944	2608	1	#	#	NNP
25944	2608	2	Ainhum	Ainhum	NNP
25944	2608	3	.	.	.
25944	2608	4	#	#	$
25944	2608	5	#	#	$
25944	2608	6	Describe	Describe	NNP
25944	2608	7	ainhum	ainhum	NN
25944	2608	8	.	.	.
25944	2608	9	#	#	$
25944	2608	10	Ainhum	Ainhum	NNP
25944	2608	11	is	be	VBZ
25944	2608	12	a	a	DT
25944	2608	13	disease	disease	NN
25944	2608	14	of	of	IN
25944	2608	15	the	the	DT
25944	2608	16	African	african	JJ
25944	2608	17	race	race	NN
25944	2608	18	,	,	,
25944	2608	19	met	meet	VBD
25944	2608	20	with	with	IN
25944	2608	21	chiefly	chiefly	NNP
25944	2608	22	in	in	IN
25944	2608	23	Brazil	Brazil	NNP
25944	2608	24	,	,	,
25944	2608	25	the	the	DT
25944	2608	26	West	West	NNP
25944	2608	27	Indies	Indies	NNPS
25944	2608	28	,	,	,
25944	2608	29	and	and	CC
25944	2608	30	Africa	Africa	NNP
25944	2608	31	,	,	,
25944	2608	32	and	and	CC
25944	2608	33	consists	consist	VBZ
25944	2608	34	of	of	IN
25944	2608	35	a	a	DT
25944	2608	36	slow	slow	JJ
25944	2608	37	but	but	CC
25944	2608	38	gradual	gradual	JJ
25944	2608	39	linear	linear	JJ
25944	2608	40	strangulation	strangulation	NN
25944	2608	41	of	of	IN
25944	2608	42	one	one	CD
25944	2608	43	or	or	CC
25944	2608	44	more	more	JJR
25944	2608	45	of	of	IN
25944	2608	46	the	the	DT
25944	2608	47	toes	toe	NNS
25944	2608	48	,	,	,
25944	2608	49	especially	especially	RB
25944	2608	50	the	the	DT
25944	2608	51	smallest	small	JJS
25944	2608	52	,	,	,
25944	2608	53	resulting	result	VBG
25944	2608	54	,	,	,
25944	2608	55	eventually	eventually	RB
25944	2608	56	,	,	,
25944	2608	57	in	in	IN
25944	2608	58	spontaneous	spontaneous	JJ
25944	2608	59	amputation	amputation	NN
25944	2608	60	.	.	.
25944	2609	1	The	the	DT
25944	2609	2	affected	affected	JJ
25944	2609	3	toes	toe	NNS
25944	2609	4	themselves	-PRON-	PRP
25944	2609	5	undergo	undergo	VBP
25944	2609	6	fatty	fatty	NN
25944	2609	7	degeneration	degeneration	NN
25944	2609	8	,	,	,
25944	2609	9	often	often	RB
25944	2609	10	with	with	IN
25944	2609	11	increase	increase	NN
25944	2609	12	in	in	IN
25944	2609	13	size	size	NN
25944	2609	14	,	,	,
25944	2609	15	and	and	CC
25944	2609	16	are	be	VBP
25944	2609	17	,	,	,
25944	2609	18	when	when	WRB
25944	2609	19	strangulation	strangulation	NN
25944	2609	20	is	be	VBZ
25944	2609	21	well	well	RB
25944	2609	22	advanced	advanced	JJ
25944	2609	23	,	,	,
25944	2609	24	considerably	considerably	RB
25944	2609	25	misshapen	misshapen	JJ
25944	2609	26	.	.	.
25944	2610	1	The	the	DT
25944	2610	2	nature	nature	NN
25944	2610	3	of	of	IN
25944	2610	4	the	the	DT
25944	2610	5	disease	disease	NN
25944	2610	6	is	be	VBZ
25944	2610	7	obscure	obscure	JJ
25944	2610	8	.	.	.
25944	2611	1	_	_	NNP
25944	2611	2	Treatment	Treatment	NNP
25944	2611	3	_	_	NNP
25944	2611	4	consists	consist	VBZ
25944	2611	5	,	,	,
25944	2611	6	in	in	IN
25944	2611	7	the	the	DT
25944	2611	8	early	early	JJ
25944	2611	9	stages	stage	NNS
25944	2611	10	,	,	,
25944	2611	11	of	of	IN
25944	2611	12	incision	incision	NN
25944	2611	13	through	through	IN
25944	2611	14	the	the	DT
25944	2611	15	constricting	constrict	VBG
25944	2611	16	band	band	NN
25944	2611	17	;	;	:
25944	2611	18	when	when	WRB
25944	2611	19	the	the	DT
25944	2611	20	disease	disease	NN
25944	2611	21	is	be	VBZ
25944	2611	22	well	well	RB
25944	2611	23	advanced	advanced	JJ
25944	2611	24	,	,	,
25944	2611	25	amputation	amputation	NN
25944	2611	26	is	be	VBZ
25944	2611	27	the	the	DT
25944	2611	28	sole	sole	JJ
25944	2611	29	recourse	recourse	NN
25944	2611	30	.	.	.
25944	2612	1	#	#	NNP
25944	2612	2	Mycetoma	Mycetoma	NNP
25944	2612	3	.	.	.
25944	2612	4	#	#	NNP
25944	2612	5	(	(	-LRB-
25944	2612	6	_	_	NNP
25944	2612	7	Synonyms	Synonyms	NNP
25944	2612	8	:	:	:
25944	2612	9	_	_	NNP
25944	2612	10	Fungous	Fungous	NNP
25944	2612	11	Foot	Foot	NNP
25944	2612	12	of	of	IN
25944	2612	13	India	India	NNP
25944	2612	14	;	;	:
25944	2612	15	Madura	Madura	NNP
25944	2612	16	Foot	Foot	NNP
25944	2612	17	;	;	:
25944	2612	18	Podelcoma	Podelcoma	NNP
25944	2612	19	.	.	.
25944	2612	20	)	)	-RRB-
25944	2613	1	#	#	NNP
25944	2613	2	Decribe	Decribe	NNP
25944	2613	3	mycetoma	mycetoma	NN
25944	2613	4	.	.	.
25944	2613	5	#	#	$
25944	2613	6	It	-PRON-	PRP
25944	2613	7	is	be	VBZ
25944	2613	8	a	a	DT
25944	2613	9	disease	disease	NN
25944	2613	10	involving	involve	VBG
25944	2613	11	usually	usually	RB
25944	2613	12	the	the	DT
25944	2613	13	foot	foot	NN
25944	2613	14	,	,	,
25944	2613	15	and	and	CC
25944	2613	16	is	be	VBZ
25944	2613	17	met	meet	VBN
25944	2613	18	with	with	IN
25944	2613	19	chiefly	chiefly	NNP
25944	2613	20	in	in	IN
25944	2613	21	India	India	NNP
25944	2613	22	.	.	.
25944	2614	1	It	-PRON-	PRP
25944	2614	2	is	be	VBZ
25944	2614	3	characterized	characterize	VBN
25944	2614	4	by	by	IN
25944	2614	5	swelling	swell	VBG
25944	2614	6	and	and	CC
25944	2614	7	the	the	DT
25944	2614	8	formation	formation	NN
25944	2614	9	of	of	IN
25944	2614	10	tubercular	tubercular	JJ
25944	2614	11	or	or	CC
25944	2614	12	nodular	nodular	JJ
25944	2614	13	lesions	lesion	NNS
25944	2614	14	which	which	WDT
25944	2614	15	break	break	VBP
25944	2614	16	down	down	RP
25944	2614	17	and	and	CC
25944	2614	18	form	form	VB
25944	2614	19	the	the	DT
25944	2614	20	external	external	JJ
25944	2614	21	openings	opening	NNS
25944	2614	22	of	of	IN
25944	2614	23	sinuses	sinus	NNS
25944	2614	24	which	which	WDT
25944	2614	25	lead	lead	VBP
25944	2614	26	to	to	IN
25944	2614	27	the	the	DT
25944	2614	28	interior	interior	NN
25944	2614	29	of	of	IN
25944	2614	30	the	the	DT
25944	2614	31	affected	affected	JJ
25944	2614	32	part	part	NN
25944	2614	33	.	.	.
25944	2615	1	These	these	DT
25944	2615	2	discharge	discharge	VBP
25944	2615	3	,	,	,
25944	2615	4	and	and	CC
25944	2615	5	are	be	VBP
25944	2615	6	studded	stud	VBN
25944	2615	7	with	with	IN
25944	2615	8	,	,	,
25944	2615	9	whitish	whitish	JJ
25944	2615	10	granules	granule	NNS
25944	2615	11	or	or	CC
25944	2615	12	black	black	JJ
25944	2615	13	,	,	,
25944	2615	14	roe	roe	JJ
25944	2615	15	-	-	HYPH
25944	2615	16	like	like	JJ
25944	2615	17	masses	masse	NNS
25944	2615	18	,	,	,
25944	2615	19	mixed	mix	VBN
25944	2615	20	with	with	IN
25944	2615	21	a	a	DT
25944	2615	22	sanious	sanious	JJ
25944	2615	23	or	or	CC
25944	2615	24	sero	sero	NN
25944	2615	25	-	-	HYPH
25944	2615	26	purulent	purulent	NN
25944	2615	27	fluid	fluid	NN
25944	2615	28	.	.	.
25944	2616	1	The	the	DT
25944	2616	2	whole	whole	JJ
25944	2616	3	part	part	NN
25944	2616	4	is	be	VBZ
25944	2616	5	gradually	gradually	RB
25944	2616	6	disintegrated	disintegrate	VBN
25944	2616	7	,	,	,
25944	2616	8	the	the	DT
25944	2616	9	process	process	NN
25944	2616	10	lasting	last	VBG
25944	2616	11	indefinitely	indefinitely	RB
25944	2616	12	.	.	.
25944	2617	1	Its	-PRON-	PRP$
25944	2617	2	nature	nature	NN
25944	2617	3	is	be	VBZ
25944	2617	4	obscure	obscure	JJ
25944	2617	5	;	;	:
25944	2617	6	it	-PRON-	PRP
25944	2617	7	is	be	VBZ
25944	2617	8	thought	think	VBN
25944	2617	9	to	to	TO
25944	2617	10	be	be	VB
25944	2617	11	due	due	IN
25944	2617	12	to	to	IN
25944	2617	13	a	a	DT
25944	2617	14	fungus	fungus	NN
25944	2617	15	.	.	.
25944	2618	1	_	_	NNP
25944	2618	2	Treatment	Treatment	NNP
25944	2618	3	_	_	NNP
25944	2618	4	consists	consist	VBZ
25944	2618	5	in	in	IN
25944	2618	6	the	the	DT
25944	2618	7	early	early	JJ
25944	2618	8	stages	stage	NNS
25944	2618	9	,	,	,
25944	2618	10	when	when	WRB
25944	2618	11	the	the	DT
25944	2618	12	disease	disease	NN
25944	2618	13	is	be	VBZ
25944	2618	14	limited	limited	JJ
25944	2618	15	,	,	,
25944	2618	16	of	of	IN
25944	2618	17	thorough	thorough	JJ
25944	2618	18	curetting	curetting	NN
25944	2618	19	and	and	CC
25944	2618	20	cauterization	cauterization	NN
25944	2618	21	;	;	:
25944	2618	22	later	later	RB
25944	2618	23	,	,	,
25944	2618	24	after	after	IN
25944	2618	25	the	the	DT
25944	2618	26	part	part	NN
25944	2618	27	is	be	VBZ
25944	2618	28	more	more	RBR
25944	2618	29	or	or	CC
25944	2618	30	less	less	RBR
25944	2618	31	involved	involved	JJ
25944	2618	32	,	,	,
25944	2618	33	amputation	amputation	NN
25944	2618	34	,	,	,
25944	2618	35	at	at	IN
25944	2618	36	a	a	DT
25944	2618	37	point	point	NN
25944	2618	38	well	well	RB
25944	2618	39	up	up	RP
25944	2618	40	beyond	beyond	IN
25944	2618	41	the	the	DT
25944	2618	42	disease	disease	NN
25944	2618	43	,	,	,
25944	2618	44	becomes	become	VBZ
25944	2618	45	necessary	necessary	JJ
25944	2618	46	.	.	.
25944	2619	1	Potassium	potassium	NN
25944	2619	2	iodide	iodide	NN
25944	2619	3	internally	internally	RB
25944	2619	4	may	may	MD
25944	2619	5	exert	exert	VB
25944	2619	6	a	a	DT
25944	2619	7	favorable	favorable	JJ
25944	2619	8	influence	influence	NN
25944	2619	9	.	.	.
25944	2620	1	#	#	NNP
25944	2620	2	Perforating	perforate	VBG
25944	2620	3	Ulcer	Ulcer	NNP
25944	2620	4	of	of	IN
25944	2620	5	the	the	DT
25944	2620	6	Foot	Foot	NNP
25944	2620	7	.	.	.
25944	2620	8	#	#	$
25944	2620	9	#	#	$
25944	2620	10	Describe	Describe	NNP
25944	2620	11	perforating	perforate	VBG
25944	2620	12	ulcer	ulcer	NN
25944	2620	13	of	of	IN
25944	2620	14	the	the	DT
25944	2620	15	foot	foot	NN
25944	2620	16	.	.	.
25944	2620	17	#	#	$
25944	2620	18	Perforating	perforate	VBG
25944	2620	19	ulcer	ulcer	NN
25944	2620	20	of	of	IN
25944	2620	21	the	the	DT
25944	2620	22	foot	foot	NN
25944	2620	23	is	be	VBZ
25944	2620	24	a	a	DT
25944	2620	25	rare	rare	JJ
25944	2620	26	disease	disease	NN
25944	2620	27	,	,	,
25944	2620	28	consisting	consist	VBG
25944	2620	29	of	of	IN
25944	2620	30	an	an	DT
25944	2620	31	indolent	indolent	NN
25944	2620	32	and	and	CC
25944	2620	33	usually	usually	RB
25944	2620	34	painless	painless	VBP
25944	2620	35	sinus	sinus	NN
25944	2620	36	leading	lead	VBG
25944	2620	37	down	down	RB
25944	2620	38	to	to	IN
25944	2620	39	diseased	diseased	JJ
25944	2620	40	bone	bone	NN
25944	2620	41	.	.	.
25944	2621	1	The	the	DT
25944	2621	2	external	external	JJ
25944	2621	3	opening	opening	NN
25944	2621	4	,	,	,
25944	2621	5	which	which	WDT
25944	2621	6	is	be	VBZ
25944	2621	7	through	through	IN
25944	2621	8	the	the	DT
25944	2621	9	centre	centre	NN
25944	2621	10	of	of	IN
25944	2621	11	a	a	DT
25944	2621	12	corn	corn	NN
25944	2621	13	-	-	HYPH
25944	2621	14	like	like	JJ
25944	2621	15	formation	formation	NN
25944	2621	16	,	,	,
25944	2621	17	is	be	VBZ
25944	2621	18	small	small	JJ
25944	2621	19	,	,	,
25944	2621	20	and	and	CC
25944	2621	21	may	may	MD
25944	2621	22	or	or	CC
25944	2621	23	may	may	MD
25944	2621	24	not	not	RB
25944	2621	25	show	show	VB
25944	2621	26	the	the	DT
25944	2621	27	presence	presence	NN
25944	2621	28	of	of	IN
25944	2621	29	granulations	granulation	NNS
25944	2621	30	.	.	.
25944	2622	1	The	the	DT
25944	2622	2	affected	affected	JJ
25944	2622	3	part	part	NN
25944	2622	4	is	be	VBZ
25944	2622	5	commonly	commonly	RB
25944	2622	6	more	more	RBR
25944	2622	7	or	or	CC
25944	2622	8	less	less	RBR
25944	2622	9	anæsthetic	anæsthetic	JJ
25944	2622	10	and	and	CC
25944	2622	11	of	of	IN
25944	2622	12	subnormal	subnormal	JJ
25944	2622	13	temperature	temperature	NN
25944	2622	14	.	.	.
25944	2623	1	One	one	CD
25944	2623	2	or	or	CC
25944	2623	3	several	several	JJ
25944	2623	4	may	may	MD
25944	2623	5	be	be	VB
25944	2623	6	present	present	JJ
25944	2623	7	,	,	,
25944	2623	8	either	either	CC
25944	2623	9	on	on	IN
25944	2623	10	one	one	CD
25944	2623	11	or	or	CC
25944	2623	12	both	both	DT
25944	2623	13	feet	foot	NNS
25944	2623	14	.	.	.
25944	2624	1	The	the	DT
25944	2624	2	most	most	RBS
25944	2624	3	common	common	JJ
25944	2624	4	site	site	NN
25944	2624	5	is	be	VBZ
25944	2624	6	over	over	IN
25944	2624	7	the	the	DT
25944	2624	8	articulation	articulation	NN
25944	2624	9	of	of	IN
25944	2624	10	the	the	DT
25944	2624	11	metatarsal	metatarsal	NN
25944	2624	12	bone	bone	NN
25944	2624	13	with	with	IN
25944	2624	14	the	the	DT
25944	2624	15	phalanx	phalanx	NN
25944	2624	16	of	of	IN
25944	2624	17	the	the	DT
25944	2624	18	first	first	JJ
25944	2624	19	or	or	CC
25944	2624	20	last	last	JJ
25944	2624	21	toe	toe	NN
25944	2624	22	.	.	.
25944	2625	1	The	the	DT
25944	2625	2	disease	disease	NN
25944	2625	3	is	be	VBZ
25944	2625	4	dependent	dependent	JJ
25944	2625	5	upon	upon	IN
25944	2625	6	impairment	impairment	NN
25944	2625	7	or	or	CC
25944	2625	8	degeneration	degeneration	NN
25944	2625	9	of	of	IN
25944	2625	10	the	the	DT
25944	2625	11	central	central	JJ
25944	2625	12	,	,	,
25944	2625	13	truncal	truncal	JJ
25944	2625	14	or	or	CC
25944	2625	15	peripheral	peripheral	JJ
25944	2625	16	nerves	nerve	NNS
25944	2625	17	.	.	.
25944	2626	1	#	#	LS
25944	2626	2	What	what	WP
25944	2626	3	is	be	VBZ
25944	2626	4	to	to	TO
25944	2626	5	be	be	VB
25944	2626	6	said	say	VBN
25944	2626	7	in	in	IN
25944	2626	8	regard	regard	NN
25944	2626	9	to	to	IN
25944	2626	10	the	the	DT
25944	2626	11	prognosis	prognosis	NN
25944	2626	12	and	and	CC
25944	2626	13	treatment	treatment	NN
25944	2626	14	?	?	.
25944	2626	15	#	#	$
25944	2626	16	Treatment	Treatment	NNP
25944	2626	17	,	,	,
25944	2626	18	which	which	WDT
25944	2626	19	is	be	VBZ
25944	2626	20	,	,	,
25944	2626	21	as	as	IN
25944	2626	22	a	a	DT
25944	2626	23	rule	rule	NN
25944	2626	24	,	,	,
25944	2626	25	unsatisfactory	unsatisfactory	JJ
25944	2626	26	,	,	,
25944	2626	27	consists	consist	VBZ
25944	2626	28	in	in	IN
25944	2626	29	the	the	DT
25944	2626	30	maintenance	maintenance	NN
25944	2626	31	of	of	IN
25944	2626	32	absolute	absolute	JJ
25944	2626	33	rest	rest	NN
25944	2626	34	,	,	,
25944	2626	35	and	and	CC
25944	2626	36	the	the	DT
25944	2626	37	use	use	NN
25944	2626	38	of	of	IN
25944	2626	39	antiseptic	antiseptic	NN
25944	2626	40	and	and	CC
25944	2626	41	stimulating	stimulating	JJ
25944	2626	42	applications	application	NNS
25944	2626	43	.	.	.
25944	2627	1	Amputation	amputation	NN
25944	2627	2	is	be	VBZ
25944	2627	3	also	also	RB
25944	2627	4	resorted	resort	VBN
25944	2627	5	to	to	IN
25944	2627	6	,	,	,
25944	2627	7	but	but	CC
25944	2627	8	even	even	RB
25944	2627	9	this	this	DT
25944	2627	10	is	be	VBZ
25944	2627	11	at	at	IN
25944	2627	12	times	time	NNS
25944	2627	13	futile	futile	JJ
25944	2627	14	,	,	,
25944	2627	15	as	as	IN
25944	2627	16	a	a	DT
25944	2627	17	new	new	JJ
25944	2627	18	sinus	sinus	NN
25944	2627	19	may	may	MD
25944	2627	20	appear	appear	VB
25944	2627	21	upon	upon	IN
25944	2627	22	the	the	DT
25944	2627	23	stump	stump	NN
25944	2627	24	.	.	.
25944	2628	1	#	#	NNP
25944	2628	2	Syphilis	Syphilis	NNP
25944	2628	3	Cutanea	Cutanea	NNP
25944	2628	4	.	.	.
25944	2628	5	#	#	NNP
25944	2628	6	(	(	-LRB-
25944	2628	7	_	_	NNP
25944	2628	8	Synonyms	Synonyms	NNP
25944	2628	9	:	:	:
25944	2628	10	_	_	NNP
25944	2628	11	Syphiloderma	Syphiloderma	NNP
25944	2628	12	;	;	:
25944	2628	13	Dermatosyphilis	Dermatosyphilis	NNP
25944	2628	14	;	;	,
25944	2628	15	Syphilis	Syphilis	NNP
25944	2628	16	of	of	IN
25944	2628	17	the	the	DT
25944	2628	18	Skin	skin	NN
25944	2628	19	.	.	.
25944	2628	20	)	)	-RRB-
25944	2629	1	#	#	$
25944	2629	2	In	in	IN
25944	2629	3	what	what	WP
25944	2629	4	various	various	JJ
25944	2629	5	types	type	NNS
25944	2629	6	may	may	MD
25944	2629	7	syphilis	syphilis	VB
25944	2629	8	manifest	manifest	VB
25944	2629	9	itself	-PRON-	PRP
25944	2629	10	upon	upon	IN
25944	2629	11	the	the	DT
25944	2629	12	integument	integument	NN
25944	2629	13	?	?	.
25944	2629	14	#	#	NNP
25944	2629	15	Syphilis	Syphilis	NNP
25944	2629	16	may	may	MD
25944	2629	17	show	show	VB
25944	2629	18	itself	-PRON-	PRP
25944	2629	19	as	as	IN
25944	2629	20	a	a	DT
25944	2629	21	macular	macular	JJ
25944	2629	22	,	,	,
25944	2629	23	papular	papular	JJ
25944	2629	24	(	(	-LRB-
25944	2629	25	rarely	rarely	RB
25944	2629	26	vesicular	vesicular	JJ
25944	2629	27	)	)	-RRB-
25944	2629	28	,	,	,
25944	2629	29	pustular	pustular	JJ
25944	2629	30	,	,	,
25944	2629	31	bullous	bullous	JJ
25944	2629	32	,	,	,
25944	2629	33	tubercular	tubercular	JJ
25944	2629	34	and	and	CC
25944	2629	35	gummatous	gummatous	JJ
25944	2629	36	eruption	eruption	NN
25944	2629	37	;	;	:
25944	2629	38	or	or	CC
25944	2629	39	the	the	DT
25944	2629	40	eruption	eruption	NN
25944	2629	41	may	may	MD
25944	2629	42	be	be	VB
25944	2629	43	,	,	,
25944	2629	44	in	in	IN
25944	2629	45	a	a	DT
25944	2629	46	measure	measure	NN
25944	2629	47	,	,	,
25944	2629	48	of	of	IN
25944	2629	49	a	a	DT
25944	2629	50	mixed	mixed	JJ
25944	2629	51	type	type	NN
25944	2629	52	.	.	.
25944	2630	1	#	#	$
25944	2630	2	In	in	IN
25944	2630	3	what	what	WDT
25944	2630	4	respects	respect	NNS
25944	2630	5	do	do	VBP
25944	2630	6	the	the	DT
25944	2630	7	early	early	JJ
25944	2630	8	(	(	-LRB-
25944	2630	9	or	or	CC
25944	2630	10	secondary	secondary	JJ
25944	2630	11	)	)	-RRB-
25944	2630	12	eruptions	eruption	NNS
25944	2630	13	of	of	IN
25944	2630	14	syphilis	syphili	NNS
25944	2630	15	differ	differ	VBP
25944	2630	16	from	from	IN
25944	2630	17	those	those	DT
25944	2630	18	following	follow	VBG
25944	2630	19	several	several	JJ
25944	2630	20	years	year	NNS
25944	2630	21	or	or	CC
25944	2630	22	more	more	JJR
25944	2630	23	after	after	IN
25944	2630	24	the	the	DT
25944	2630	25	contraction	contraction	NN
25944	2630	26	of	of	IN
25944	2630	27	the	the	DT
25944	2630	28	disease	disease	NN
25944	2630	29	?	?	.
25944	2630	30	#	#	$
25944	2630	31	The	the	DT
25944	2630	32	early	early	JJ
25944	2630	33	or	or	CC
25944	2630	34	secondary	secondary	JJ
25944	2630	35	eruptions	eruption	NNS
25944	2630	36	are	be	VBP
25944	2630	37	more	more	RBR
25944	2630	38	or	or	CC
25944	2630	39	less	less	RBR
25944	2630	40	generalized	generalize	VBN
25944	2630	41	,	,	,
25944	2630	42	with	with	IN
25944	2630	43	rarely	rarely	RB
25944	2630	44	any	any	DT
25944	2630	45	attempt	attempt	NN
25944	2630	46	at	at	IN
25944	2630	47	special	special	JJ
25944	2630	48	configuration	configuration	NN
25944	2630	49	.	.	.
25944	2631	1	Their	-PRON-	PRP$
25944	2631	2	appearance	appearance	NN
25944	2631	3	is	be	VBZ
25944	2631	4	often	often	RB
25944	2631	5	preceded	precede	VBN
25944	2631	6	by	by	IN
25944	2631	7	symptoms	symptom	NNS
25944	2631	8	of	of	IN
25944	2631	9	systemic	systemic	JJ
25944	2631	10	disturbance	disturbance	NN
25944	2631	11	,	,	,
25944	2631	12	such	such	JJ
25944	2631	13	as	as	IN
25944	2631	14	fever	fever	NN
25944	2631	15	,	,	,
25944	2631	16	loss	loss	NN
25944	2631	17	of	of	IN
25944	2631	18	appetite	appetite	NN
25944	2631	19	,	,	,
25944	2631	20	muscular	muscular	JJ
25944	2631	21	pains	pain	NNS
25944	2631	22	and	and	CC
25944	2631	23	headache	headache	NN
25944	2631	24	;	;	,
25944	2631	25	and	and	CC
25944	2631	26	accompanied	accompany	VBN
25944	2631	27	by	by	IN
25944	2631	28	concomitant	concomitant	JJ
25944	2631	29	signs	sign	NNS
25944	2631	30	of	of	IN
25944	2631	31	the	the	DT
25944	2631	32	disease	disease	NN
25944	2631	33	,	,	,
25944	2631	34	such	such	JJ
25944	2631	35	as	as	IN
25944	2631	36	enlargement	enlargement	NN
25944	2631	37	of	of	IN
25944	2631	38	the	the	DT
25944	2631	39	lymphatic	lymphatic	JJ
25944	2631	40	glands	gland	NNS
25944	2631	41	,	,	,
25944	2631	42	sore	sore	JJ
25944	2631	43	throat	throat	NN
25944	2631	44	,	,	,
25944	2631	45	mucous	mucous	JJ
25944	2631	46	patches	patch	NNS
25944	2631	47	,	,	,
25944	2631	48	falling	fall	VBG
25944	2631	49	of	of	IN
25944	2631	50	the	the	DT
25944	2631	51	hair	hair	NN
25944	2631	52	and	and	CC
25944	2631	53	rheumatic	rheumatic	JJ
25944	2631	54	pains	pain	NNS
25944	2631	55	.	.	.
25944	2632	1	#	#	JJR
25944	2632	2	State	state	NN
25944	2632	3	the	the	DT
25944	2632	4	distinguishing	distinguish	VBG
25944	2632	5	characters	character	NNS
25944	2632	6	of	of	IN
25944	2632	7	the	the	DT
25944	2632	8	late	late	JJ
25944	2632	9	eruptions	eruption	NNS
25944	2632	10	.	.	.
25944	2632	11	#	#	$
25944	2632	12	The	the	DT
25944	2632	13	late	late	JJ
25944	2632	14	eruptions	eruption	NNS
25944	2632	15	(	(	-LRB-
25944	2632	16	those	those	DT
25944	2632	17	following	follow	VBG
25944	2632	18	one	one	CD
25944	2632	19	or	or	CC
25944	2632	20	more	more	JJR
25944	2632	21	years	year	NNS
25944	2632	22	after	after	IN
25944	2632	23	the	the	DT
25944	2632	24	contraction	contraction	NN
25944	2632	25	of	of	IN
25944	2632	26	the	the	DT
25944	2632	27	disease	disease	NN
25944	2632	28	)	)	-RRB-
25944	2632	29	are	be	VBP
25944	2632	30	usually	usually	RB
25944	2632	31	of	of	IN
25944	2632	32	tubercular	tubercular	JJ
25944	2632	33	,	,	,
25944	2632	34	gummatous	gummatous	JJ
25944	2632	35	or	or	CC
25944	2632	36	ulcerative	ulcerative	JJ
25944	2632	37	type	type	NN
25944	2632	38	;	;	:
25944	2632	39	are	be	VBP
25944	2632	40	limited	limited	JJ
25944	2632	41	in	in	IN
25944	2632	42	extent	extent	NN
25944	2632	43	,	,	,
25944	2632	44	and	and	CC
25944	2632	45	have	have	VBP
25944	2632	46	a	a	DT
25944	2632	47	marked	marked	JJ
25944	2632	48	tendency	tendency	NN
25944	2632	49	to	to	TO
25944	2632	50	appear	appear	VB
25944	2632	51	in	in	IN
25944	2632	52	circular	circular	JJ
25944	2632	53	,	,	,
25944	2632	54	semicircular	semicircular	JJ
25944	2632	55	or	or	CC
25944	2632	56	crescentic	crescentic	JJ
25944	2632	57	forms	form	NNS
25944	2632	58	or	or	CC
25944	2632	59	groups	group	NNS
25944	2632	60	.	.	.
25944	2633	1	Pain	pain	NN
25944	2633	2	in	in	IN
25944	2633	3	the	the	DT
25944	2633	4	bones	bone	NNS
25944	2633	5	,	,	,
25944	2633	6	bone	bone	NN
25944	2633	7	lesions	lesion	NNS
25944	2633	8	and	and	CC
25944	2633	9	other	other	JJ
25944	2633	10	symptoms	symptom	NNS
25944	2633	11	may	may	MD
25944	2633	12	or	or	CC
25944	2633	13	may	may	MD
25944	2633	14	not	not	RB
25944	2633	15	be	be	VB
25944	2633	16	present	present	JJ
25944	2633	17	.	.	.
25944	2634	1	#	#	LS
25944	2634	2	What	what	WP
25944	2634	3	is	be	VBZ
25944	2634	4	the	the	DT
25944	2634	5	color	color	NN
25944	2634	6	of	of	IN
25944	2634	7	syphilitic	syphilitic	JJ
25944	2634	8	lesions	lesion	NNS
25944	2634	9	?	?	.
25944	2634	10	#	#	NNP
25944	2634	11	Usually	usually	RB
25944	2634	12	,	,	,
25944	2634	13	a	a	DT
25944	2634	14	dull	dull	JJ
25944	2634	15	brownish	brownish	NN
25944	2634	16	-	-	HYPH
25944	2634	17	red	red	NN
25944	2634	18	or	or	CC
25944	2634	19	ham	ham	NN
25944	2634	20	-	-	HYPH
25944	2634	21	red	red	JJ
25944	2634	22	,	,	,
25944	2634	23	with	with	IN
25944	2634	24	at	at	IN
25944	2634	25	times	time	NNS
25944	2634	26	a	a	DT
25944	2634	27	yellowish	yellowish	JJ
25944	2634	28	cast	cast	NN
25944	2634	29	.	.	.
25944	2635	1	#	#	NN
25944	2635	2	Are	be	VBP
25944	2635	3	there	there	EX
25944	2635	4	any	any	DT
25944	2635	5	subjective	subjective	JJ
25944	2635	6	symptoms	symptom	NNS
25944	2635	7	in	in	IN
25944	2635	8	syphilitic	syphilitic	JJ
25944	2635	9	eruptions	eruption	NNS
25944	2635	10	?	?	.
25944	2635	11	#	#	NN
25944	2635	12	As	as	IN
25944	2635	13	a	a	DT
25944	2635	14	rule	rule	NN
25944	2635	15	,	,	,
25944	2635	16	no	no	UH
25944	2635	17	;	;	:
25944	2635	18	but	but	CC
25944	2635	19	in	in	IN
25944	2635	20	exceptional	exceptional	JJ
25944	2635	21	instances	instance	NNS
25944	2635	22	of	of	IN
25944	2635	23	the	the	DT
25944	2635	24	generalized	generalized	JJ
25944	2635	25	eruptions	eruption	NNS
25944	2635	26	,	,	,
25944	2635	27	more	more	RBR
25944	2635	28	especially	especially	RB
25944	2635	29	in	in	IN
25944	2635	30	negroes	negro	NNS
25944	2635	31	,	,	,
25944	2635	32	there	there	EX
25944	2635	33	may	may	MD
25944	2635	34	be	be	VB
25944	2635	35	slight	slight	JJ
25944	2635	36	itching	itching	NN
25944	2635	37	.	.	.
25944	2636	1	#	#	NNP
25944	2636	2	Describe	describe	VB
25944	2636	3	the	the	DT
25944	2636	4	macular	macular	JJ
25944	2636	5	,	,	,
25944	2636	6	or	or	CC
25944	2636	7	erythematous	erythematous	JJ
25944	2636	8	,	,	,
25944	2636	9	eruption	eruption	NN
25944	2636	10	of	of	IN
25944	2636	11	syphilis	syphilis	NNP
25944	2636	12	.	.	.
25944	2636	13	#	#	$
25944	2636	14	The	the	DT
25944	2636	15	_	_	NNP
25944	2636	16	macular	macular	JJ
25944	2636	17	syphiloderm	syphiloderm	NNP
25944	2636	18	_	_	NNP
25944	2636	19	is	be	VBZ
25944	2636	20	a	a	DT
25944	2636	21	general	general	JJ
25944	2636	22	eruption	eruption	NN
25944	2636	23	,	,	,
25944	2636	24	showing	show	VBG
25944	2636	25	itself	-PRON-	PRP
25944	2636	26	usually	usually	RB
25944	2636	27	six	six	CD
25944	2636	28	or	or	CC
25944	2636	29	eight	eight	CD
25944	2636	30	weeks	week	NNS
25944	2636	31	after	after	IN
25944	2636	32	the	the	DT
25944	2636	33	appearance	appearance	NN
25944	2636	34	of	of	IN
25944	2636	35	the	the	DT
25944	2636	36	chancre	chancre	NN
25944	2636	37	.	.	.
25944	2637	1	It	-PRON-	PRP
25944	2637	2	consists	consist	VBZ
25944	2637	3	of	of	IN
25944	2637	4	small	small	JJ
25944	2637	5	or	or	CC
25944	2637	6	large	large	JJ
25944	2637	7	,	,	,
25944	2637	8	commonly	commonly	RB
25944	2637	9	pea-	pea-	NNS
25944	2637	10	or	or	CC
25944	2637	11	bean	bean	NN
25944	2637	12	-	-	HYPH
25944	2637	13	sized	sized	JJ
25944	2637	14	,	,	,
25944	2637	15	rounded	rounded	JJ
25944	2637	16	or	or	CC
25944	2637	17	irregularly	irregularly	RB
25944	2637	18	-	-	HYPH
25944	2637	19	shaped	shaped	JJ
25944	2637	20	,	,	,
25944	2637	21	not	not	RB
25944	2637	22	infrequently	infrequently	RB
25944	2637	23	slightly	slightly	RB
25944	2637	24	raised	raise	VBN
25944	2637	25	,	,	,
25944	2637	26	macules	macule	NNS
25944	2637	27	.	.	.
25944	2638	1	When	when	WRB
25944	2638	2	well	well	RB
25944	2638	3	established	establish	VBN
25944	2638	4	they	-PRON-	PRP
25944	2638	5	do	do	VBP
25944	2638	6	not	not	RB
25944	2638	7	entirely	entirely	RB
25944	2638	8	disappear	disappear	VB
25944	2638	9	under	under	IN
25944	2638	10	pressure	pressure	NN
25944	2638	11	.	.	.
25944	2639	1	At	at	IN
25944	2639	2	first	first	RB
25944	2639	3	a	a	DT
25944	2639	4	pale	pale	JJ
25944	2639	5	-	-	HYPH
25944	2639	6	pink	pink	JJ
25944	2639	7	or	or	CC
25944	2639	8	dull	dull	JJ
25944	2639	9	,	,	,
25944	2639	10	violaceous	violaceous	JJ
25944	2639	11	red	red	NN
25944	2639	12	,	,	,
25944	2639	13	they	-PRON-	PRP
25944	2639	14	later	later	RB
25944	2639	15	become	become	VBP
25944	2639	16	yellowish	yellowish	JJ
25944	2639	17	or	or	CC
25944	2639	18	coppery	coppery	NN
25944	2639	19	.	.	.
25944	2640	1	The	the	DT
25944	2640	2	eruption	eruption	NN
25944	2640	3	is	be	VBZ
25944	2640	4	generally	generally	RB
25944	2640	5	profuse	profuse	NN
25944	2640	6	;	;	:
25944	2640	7	the	the	DT
25944	2640	8	face	face	NN
25944	2640	9	,	,	,
25944	2640	10	backs	back	NNS
25944	2640	11	of	of	IN
25944	2640	12	the	the	DT
25944	2640	13	hands	hand	NNS
25944	2640	14	and	and	CC
25944	2640	15	feet	foot	NNS
25944	2640	16	may	may	MD
25944	2640	17	escape	escape	VB
25944	2640	18	.	.	.
25944	2641	1	It	-PRON-	PRP
25944	2641	2	persists	persist	VBZ
25944	2641	3	several	several	JJ
25944	2641	4	weeks	week	NNS
25944	2641	5	or	or	CC
25944	2641	6	one	one	CD
25944	2641	7	or	or	CC
25944	2641	8	two	two	CD
25944	2641	9	months	month	NNS
25944	2641	10	;	;	:
25944	2641	11	as	as	IN
25944	2641	12	a	a	DT
25944	2641	13	rule	rule	NN
25944	2641	14	,	,	,
25944	2641	15	it	-PRON-	PRP
25944	2641	16	is	be	VBZ
25944	2641	17	rapidly	rapidly	RB
25944	2641	18	responsive	responsive	JJ
25944	2641	19	to	to	IN
25944	2641	20	treatment	treatment	NN
25944	2641	21	.	.	.
25944	2642	1	#	#	NNP
25944	2642	2	How	how	WRB
25944	2642	3	would	would	MD
25944	2642	4	you	-PRON-	PRP
25944	2642	5	distinguish	distinguish	VB
25944	2642	6	the	the	DT
25944	2642	7	macular	macular	JJ
25944	2642	8	syphiloderm	syphiloderm	NN
25944	2642	9	from	from	IN
25944	2642	10	measles	measle	NNS
25944	2642	11	,	,	,
25944	2642	12	rötheln	rötheln	NN
25944	2642	13	and	and	CC
25944	2642	14	tinea	tinea	NN
25944	2642	15	versicolor	versicolor	NN
25944	2642	16	?	?	.
25944	2642	17	#	#	NNP
25944	2642	18	Measles	Measles	NNP
25944	2642	19	is	be	VBZ
25944	2642	20	to	to	TO
25944	2642	21	be	be	VB
25944	2642	22	differentiated	differentiate	VBN
25944	2642	23	by	by	IN
25944	2642	24	its	-PRON-	PRP$
25944	2642	25	catarrhal	catarrhal	NN
25944	2642	26	symptoms	symptom	NNS
25944	2642	27	,	,	,
25944	2642	28	fever	fever	NN
25944	2642	29	,	,	,
25944	2642	30	form	form	NN
25944	2642	31	and	and	CC
25944	2642	32	situation	situation	NN
25944	2642	33	of	of	IN
25944	2642	34	the	the	DT
25944	2642	35	eruption	eruption	NN
25944	2642	36	;	;	:
25944	2642	37	rötheln	rötheln	NN
25944	2642	38	,	,	,
25944	2642	39	by	by	IN
25944	2642	40	its	-PRON-	PRP$
25944	2642	41	small	small	JJ
25944	2642	42	,	,	,
25944	2642	43	roundish	roundish	JJ
25944	2642	44	,	,	,
25944	2642	45	confluent	confluent	NN
25944	2642	46	pinkish	pinkish	NN
25944	2642	47	or	or	CC
25944	2642	48	reddish	reddish	JJ
25944	2642	49	patches	patch	NNS
25944	2642	50	,	,	,
25944	2642	51	its	-PRON-	PRP$
25944	2642	52	precursory	precursory	JJ
25944	2642	53	pyrexic	pyrexic	JJ
25944	2642	54	symptoms	symptom	NNS
25944	2642	55	,	,	,
25944	2642	56	its	-PRON-	PRP$
25944	2642	57	epidemic	epidemic	NN
25944	2642	58	nature	nature	NN
25944	2642	59	,	,	,
25944	2642	60	and	and	CC
25944	2642	61	short	short	JJ
25944	2642	62	duration	duration	NN
25944	2642	63	;	;	,
25944	2642	64	tinea	tinea	NNP
25944	2642	65	versicolor	versicolor	NN
25944	2642	66	by	by	IN
25944	2642	67	its	-PRON-	PRP$
25944	2642	68	scaliness	scaliness	NN
25944	2642	69	,	,	,
25944	2642	70	peripheral	peripheral	JJ
25944	2642	71	growth	growth	NN
25944	2642	72	,	,	,
25944	2642	73	distribution	distribution	NN
25944	2642	74	and	and	CC
25944	2642	75	history	history	NN
25944	2642	76	.	.	.
25944	2643	1	And	and	CC
25944	2643	2	,	,	,
25944	2643	3	finally	finally	RB
25944	2643	4	,	,	,
25944	2643	5	by	by	IN
25944	2643	6	the	the	DT
25944	2643	7	absence	absence	NN
25944	2643	8	or	or	CC
25944	2643	9	presence	presence	NN
25944	2643	10	of	of	IN
25944	2643	11	other	other	JJ
25944	2643	12	symptoms	symptom	NNS
25944	2643	13	of	of	IN
25944	2643	14	syphilis	syphilis	NNP
25944	2643	15	.	.	.
25944	2644	1	[	[	-LRB-
25944	2644	2	Illustration	illustration	NN
25944	2644	3	:	:	:
25944	2644	4	Fig	Fig	NNP
25944	2644	5	.	.	.
25944	2645	1	51	51	CD
25944	2645	2	.	.	.
25944	2646	1	Macular	Macular	NNP
25944	2646	2	Syphiloderm	Syphiloderm	NNP
25944	2646	3	.	.	.
25944	2646	4	]	]	-RRB-
25944	2647	1	#	#	$
25944	2647	2	What	what	WDT
25944	2647	3	several	several	JJ
25944	2647	4	varieties	variety	NNS
25944	2647	5	of	of	IN
25944	2647	6	the	the	DT
25944	2647	7	papular	papular	JJ
25944	2647	8	eruption	eruption	NN
25944	2647	9	of	of	IN
25944	2647	10	syphilis	syphili	NNS
25944	2647	11	are	be	VBP
25944	2647	12	met	meet	VBN
25944	2647	13	with	with	IN
25944	2647	14	?	?	.
25944	2647	15	#	#	$
25944	2647	16	There	there	EX
25944	2647	17	are	be	VBP
25944	2647	18	two	two	CD
25944	2647	19	forms	form	NNS
25944	2647	20	of	of	IN
25944	2647	21	the	the	DT
25944	2647	22	papular	papular	JJ
25944	2647	23	eruption	eruption	NN
25944	2647	24	--	--	:
25944	2647	25	the	the	DT
25944	2647	26	small	small	JJ
25944	2647	27	and	and	CC
25944	2647	28	large	large	JJ
25944	2647	29	;	;	:
25944	2647	30	those	those	DT
25944	2647	31	of	of	IN
25944	2647	32	the	the	DT
25944	2647	33	latter	latter	JJ
25944	2647	34	type	type	NN
25944	2647	35	may	may	MD
25944	2647	36	undergo	undergo	VB
25944	2647	37	various	various	JJ
25944	2647	38	modifications	modification	NNS
25944	2647	39	.	.	.
25944	2648	1	#	#	NNP
25944	2648	2	Describe	describe	VB
25944	2648	3	the	the	DT
25944	2648	4	small	small	JJ
25944	2648	5	-	-	HYPH
25944	2648	6	papular	papular	JJ
25944	2648	7	eruption	eruption	NN
25944	2648	8	of	of	IN
25944	2648	9	syphilis	syphilis	NNP
25944	2648	10	.	.	.
25944	2648	11	#	#	$
25944	2648	12	The	the	DT
25944	2648	13	_	_	NNP
25944	2648	14	small	small	JJ
25944	2648	15	-	-	HYPH
25944	2648	16	papular	papular	JJ
25944	2648	17	syphiloderm	syphiloderm	NN
25944	2648	18	_	_	NNP
25944	2648	19	(	(	-LRB-
25944	2648	20	_	_	NNP
25944	2648	21	miliary	miliary	JJ
25944	2648	22	papular	papular	JJ
25944	2648	23	syphiloderm	syphiloderm	NNP
25944	2648	24	_	_	NNP
25944	2648	25	)	)	-RRB-
25944	2648	26	usually	usually	RB
25944	2648	27	shows	show	VBZ
25944	2648	28	itself	-PRON-	PRP
25944	2648	29	in	in	IN
25944	2648	30	the	the	DT
25944	2648	31	third	third	JJ
25944	2648	32	or	or	CC
25944	2648	33	fourth	fourth	JJ
25944	2648	34	month	month	NN
25944	2648	35	of	of	IN
25944	2648	36	the	the	DT
25944	2648	37	disease	disease	NN
25944	2648	38	,	,	,
25944	2648	39	and	and	CC
25944	2648	40	consists	consist	VBZ
25944	2648	41	of	of	IN
25944	2648	42	a	a	DT
25944	2648	43	more	more	RBR
25944	2648	44	or	or	CC
25944	2648	45	less	less	RBR
25944	2648	46	generalized	generalized	JJ
25944	2648	47	eruption	eruption	NN
25944	2648	48	of	of	IN
25944	2648	49	disseminated	disseminate	VBN
25944	2648	50	or	or	CC
25944	2648	51	grouped	group	VBN
25944	2648	52	,	,	,
25944	2648	53	firm	firm	JJ
25944	2648	54	,	,	,
25944	2648	55	rounded	rounded	JJ
25944	2648	56	or	or	CC
25944	2648	57	acuminated	acuminate	VBN
25944	2648	58	pin	pin	NN
25944	2648	59	-	-	HYPH
25944	2648	60	head	head	NN
25944	2648	61	to	to	IN
25944	2648	62	millet	millet	JJ
25944	2648	63	-	-	HYPH
25944	2648	64	seed	seed	NN
25944	2648	65	-	-	HYPH
25944	2648	66	sized	sized	JJ
25944	2648	67	papules	papule	NNS
25944	2648	68	,	,	,
25944	2648	69	with	with	IN
25944	2648	70	smooth	smooth	JJ
25944	2648	71	or	or	CC
25944	2648	72	slightly	slightly	RB
25944	2648	73	scaly	scaly	CC
25944	2648	74	summits	summit	NNS
25944	2648	75	,	,	,
25944	2648	76	and	and	CC
25944	2648	77	in	in	IN
25944	2648	78	some	some	DT
25944	2648	79	lesions	lesion	NNS
25944	2648	80	showing	show	VBG
25944	2648	81	pointed	pointed	JJ
25944	2648	82	pustulation	pustulation	NN
25944	2648	83	.	.	.
25944	2649	1	Scattered	scatter	VBN
25944	2649	2	minute	minute	NN
25944	2649	3	pustules	pustule	NNS
25944	2649	4	and	and	CC
25944	2649	5	some	some	DT
25944	2649	6	large	large	JJ
25944	2649	7	papules	papule	NNS
25944	2649	8	are	be	VBP
25944	2649	9	usually	usually	RB
25944	2649	10	present	present	JJ
25944	2649	11	.	.	.
25944	2650	1	The	the	DT
25944	2650	2	eruption	eruption	NN
25944	2650	3	is	be	VBZ
25944	2650	4	profuse	profuse	NN
25944	2650	5	,	,	,
25944	2650	6	most	most	RBS
25944	2650	7	abundant	abundant	JJ
25944	2650	8	upon	upon	IN
25944	2650	9	the	the	DT
25944	2650	10	trunk	trunk	NN
25944	2650	11	and	and	CC
25944	2650	12	limbs	limb	NNS
25944	2650	13	;	;	:
25944	2650	14	and	and	CC
25944	2650	15	in	in	IN
25944	2650	16	the	the	DT
25944	2650	17	early	early	JJ
25944	2650	18	part	part	NN
25944	2650	19	of	of	IN
25944	2650	20	the	the	DT
25944	2650	21	outbreak	outbreak	NN
25944	2650	22	is	be	VBZ
25944	2650	23	of	of	IN
25944	2650	24	a	a	DT
25944	2650	25	bright-	bright-	NN
25944	2650	26	or	or	CC
25944	2650	27	dull	dull	JJ
25944	2650	28	-	-	HYPH
25944	2650	29	red	red	JJ
25944	2650	30	color	color	NN
25944	2650	31	,	,	,
25944	2650	32	later	later	RB
25944	2650	33	assuming	assume	VBG
25944	2650	34	a	a	DT
25944	2650	35	violaceous	violaceous	JJ
25944	2650	36	or	or	CC
25944	2650	37	brownish	brownish	JJ
25944	2650	38	tint	tint	NN
25944	2650	39	.	.	.
25944	2651	1	It	-PRON-	PRP
25944	2651	2	runs	run	VBZ
25944	2651	3	a	a	DT
25944	2651	4	chronic	chronic	JJ
25944	2651	5	course	course	NN
25944	2651	6	,	,	,
25944	2651	7	is	be	VBZ
25944	2651	8	somewhat	somewhat	RB
25944	2651	9	rebellious	rebellious	JJ
25944	2651	10	to	to	IN
25944	2651	11	treatment	treatment	NN
25944	2651	12	,	,	,
25944	2651	13	and	and	CC
25944	2651	14	displays	display	VBZ
25944	2651	15	a	a	DT
25944	2651	16	tendency	tendency	NN
25944	2651	17	to	to	TO
25944	2651	18	relapse	relapse	VB
25944	2651	19	.	.	.
25944	2652	1	[	[	-LRB-
25944	2652	2	Illustration	illustration	NN
25944	2652	3	:	:	:
25944	2652	4	Fig	Fig	NNP
25944	2652	5	.	.	.
25944	2653	1	52	52	CD
25944	2653	2	.	.	.
25944	2654	1	Moist	Moist	NNP
25944	2654	2	Papules	Papules	NNP
25944	2654	3	.	.	.
25944	2655	1	(	(	-LRB-
25944	2655	2	_	_	NNP
25944	2655	3	After	after	IN
25944	2655	4	Miller	Miller	NNP
25944	2655	5	.	.	.
25944	2655	6	_	_	NNP
25944	2655	7	)	)	-RRB-
25944	2655	8	]	]	-RRB-
25944	2655	9	#	#	NN
25944	2655	10	How	how	WRB
25944	2655	11	would	would	MD
25944	2655	12	you	-PRON-	PRP
25944	2655	13	distinguish	distinguish	VB
25944	2655	14	the	the	DT
25944	2655	15	small	small	JJ
25944	2655	16	-	-	HYPH
25944	2655	17	papular	papular	JJ
25944	2655	18	syphiloderm	syphiloderm	NN
25944	2655	19	from	from	IN
25944	2655	20	keratosis	keratosis	NNP
25944	2655	21	pilaris	pilaris	NNP
25944	2655	22	,	,	,
25944	2655	23	psoriasis	psoriasis	NNP
25944	2655	24	punctata	punctata	NNP
25944	2655	25	,	,	,
25944	2655	26	papular	papular	JJ
25944	2655	27	eczema	eczema	NN
25944	2655	28	,	,	,
25944	2655	29	and	and	CC
25944	2655	30	lichen	lichen	NNP
25944	2655	31	ruber	ruber	NNP
25944	2655	32	?	?	.
25944	2655	33	#	#	$
25944	2655	34	The	the	DT
25944	2655	35	distribution	distribution	NN
25944	2655	36	and	and	CC
25944	2655	37	extent	extent	NN
25944	2655	38	of	of	IN
25944	2655	39	the	the	DT
25944	2655	40	eruption	eruption	NN
25944	2655	41	,	,	,
25944	2655	42	the	the	DT
25944	2655	43	color	color	NN
25944	2655	44	,	,	,
25944	2655	45	the	the	DT
25944	2655	46	grouping	grouping	NN
25944	2655	47	,	,	,
25944	2655	48	with	with	IN
25944	2655	49	usually	usually	RB
25944	2655	50	the	the	DT
25944	2655	51	presence	presence	NN
25944	2655	52	of	of	IN
25944	2655	53	pustules	pustule	NNS
25944	2655	54	and	and	CC
25944	2655	55	large	large	JJ
25944	2655	56	papules	papule	NNS
25944	2655	57	and	and	CC
25944	2655	58	other	other	JJ
25944	2655	59	concomitant	concomitant	JJ
25944	2655	60	symptoms	symptom	NNS
25944	2655	61	of	of	IN
25944	2655	62	syphilis	syphilis	NNP
25944	2655	63	,	,	,
25944	2655	64	are	be	VBP
25944	2655	65	points	point	NNS
25944	2655	66	of	of	IN
25944	2655	67	difference	difference	NN
25944	2655	68	.	.	.
25944	2656	1	Pustules	pustule	NNS
25944	2656	2	never	never	RB
25944	2656	3	occur	occur	VBP
25944	2656	4	in	in	IN
25944	2656	5	the	the	DT
25944	2656	6	several	several	JJ
25944	2656	7	diseases	disease	NNS
25944	2656	8	named	name	VBN
25944	2656	9	,	,	,
25944	2656	10	except	except	IN
25944	2656	11	in	in	IN
25944	2656	12	eczema	eczema	NN
25944	2656	13	.	.	.
25944	2657	1	#	#	NNP
25944	2657	2	Describe	describe	VB
25944	2657	3	the	the	DT
25944	2657	4	large	large	JJ
25944	2657	5	-	-	HYPH
25944	2657	6	papular	papular	JJ
25944	2657	7	eruption	eruption	NN
25944	2657	8	of	of	IN
25944	2657	9	syphilis	syphilis	NNP
25944	2657	10	.	.	.
25944	2657	11	#	#	$
25944	2657	12	The	the	DT
25944	2657	13	_	_	NNP
25944	2657	14	large	large	JJ
25944	2657	15	-	-	HYPH
25944	2657	16	papular	papular	JJ
25944	2657	17	syphiloderm	syphiloderm	NN
25944	2657	18	_	_	NNP
25944	2657	19	(	(	-LRB-
25944	2657	20	or	or	CC
25944	2657	21	_	_	NNP
25944	2657	22	lenticular	lenticular	NN
25944	2657	23	syphiloderm	syphiloderm	NN
25944	2657	24	_	_	NNP
25944	2657	25	)	)	-RRB-
25944	2657	26	is	be	VBZ
25944	2657	27	a	a	DT
25944	2657	28	common	common	JJ
25944	2657	29	form	form	NN
25944	2657	30	of	of	IN
25944	2657	31	cutaneous	cutaneous	JJ
25944	2657	32	syphilis	syphili	NNS
25944	2657	33	,	,	,
25944	2657	34	appearing	appear	VBG
25944	2657	35	usually	usually	RB
25944	2657	36	in	in	IN
25944	2657	37	the	the	DT
25944	2657	38	first	first	JJ
25944	2657	39	six	six	CD
25944	2657	40	or	or	CC
25944	2657	41	eight	eight	CD
25944	2657	42	months	month	NNS
25944	2657	43	,	,	,
25944	2657	44	and	and	CC
25944	2657	45	consists	consist	VBZ
25944	2657	46	of	of	IN
25944	2657	47	a	a	DT
25944	2657	48	more	more	RBR
25944	2657	49	or	or	CC
25944	2657	50	less	less	RBR
25944	2657	51	generalized	generalized	JJ
25944	2657	52	eruption	eruption	NN
25944	2657	53	of	of	IN
25944	2657	54	pea-	pea-	NNS
25944	2657	55	to	to	IN
25944	2657	56	dime	dime	NN
25944	2657	57	-	-	HYPH
25944	2657	58	sized	sized	JJ
25944	2657	59	or	or	CC
25944	2657	60	larger	large	JJR
25944	2657	61	,	,	,
25944	2657	62	flat	flat	JJ
25944	2657	63	,	,	,
25944	2657	64	rounded	rounded	JJ
25944	2657	65	or	or	CC
25944	2657	66	oval	oval	NN
25944	2657	67	,	,	,
25944	2657	68	firmly	firmly	RB
25944	2657	69	seated	seated	JJ
25944	2657	70	,	,	,
25944	2657	71	more	more	RBR
25944	2657	72	or	or	CC
25944	2657	73	less	less	RBR
25944	2657	74	raised	raise	VBN
25944	2657	75	,	,	,
25944	2657	76	dull	dull	JJ
25944	2657	77	-	-	HYPH
25944	2657	78	red	red	JJ
25944	2657	79	papules	papule	NNS
25944	2657	80	;	;	:
25944	2657	81	with	with	IN
25944	2657	82	at	at	IN
25944	2657	83	first	first	RB
25944	2657	84	a	a	DT
25944	2657	85	smooth	smooth	JJ
25944	2657	86	surface	surface	NN
25944	2657	87	,	,	,
25944	2657	88	which	which	WDT
25944	2657	89	later	later	RB
25944	2657	90	usually	usually	RB
25944	2657	91	becomes	become	VBZ
25944	2657	92	covered	cover	VBN
25944	2657	93	with	with	IN
25944	2657	94	a	a	DT
25944	2657	95	film	film	NN
25944	2657	96	of	of	IN
25944	2657	97	exfoliating	exfoliate	VBG
25944	2657	98	epidermis	epidermis	NNP
25944	2657	99	.	.	.
25944	2658	1	The	the	DT
25944	2658	2	papules	papule	NNS
25944	2658	3	,	,	,
25944	2658	4	as	as	IN
25944	2658	5	a	a	DT
25944	2658	6	rule	rule	NN
25944	2658	7	,	,	,
25944	2658	8	develop	develop	VB
25944	2658	9	slowly	slowly	RB
25944	2658	10	,	,	,
25944	2658	11	remain	remain	VBP
25944	2658	12	stationary	stationary	JJ
25944	2658	13	several	several	JJ
25944	2658	14	weeks	week	NNS
25944	2658	15	or	or	CC
25944	2658	16	a	a	DT
25944	2658	17	few	few	JJ
25944	2658	18	months	month	NNS
25944	2658	19	,	,	,
25944	2658	20	and	and	CC
25944	2658	21	then	then	RB
25944	2658	22	pass	pass	VB
25944	2658	23	away	away	RP
25944	2658	24	by	by	IN
25944	2658	25	absorption	absorption	NN
25944	2658	26	,	,	,
25944	2658	27	leaving	leave	VBG
25944	2658	28	slight	slight	JJ
25944	2658	29	pigmentation	pigmentation	NN
25944	2658	30	,	,	,
25944	2658	31	which	which	WDT
25944	2658	32	gradually	gradually	RB
25944	2658	33	fades	fade	VBZ
25944	2658	34	;	;	:
25944	2658	35	or	or	CC
25944	2658	36	they	-PRON-	PRP
25944	2658	37	may	may	MD
25944	2658	38	undergo	undergo	VB
25944	2658	39	certain	certain	JJ
25944	2658	40	modifications	modification	NNS
25944	2658	41	.	.	.
25944	2659	1	In	in	IN
25944	2659	2	most	most	JJS
25944	2659	3	cases	case	NNS
25944	2659	4	it	-PRON-	PRP
25944	2659	5	responds	respond	VBZ
25944	2659	6	rapidly	rapidly	RB
25944	2659	7	to	to	IN
25944	2659	8	treatment	treatment	NN
25944	2659	9	.	.	.
25944	2660	1	[	[	-LRB-
25944	2660	2	Illustration	illustration	NN
25944	2660	3	:	:	:
25944	2660	4	Small	small	JJ
25944	2660	5	-	-	HYPH
25944	2660	6	papular	papular	JJ
25944	2660	7	Syphiloderm	Syphiloderm	NNP
25944	2660	8	.	.	.
25944	2660	9	]	]	-RRB-
25944	2661	1	[	[	-LRB-
25944	2661	2	Illustration	illustration	NN
25944	2661	3	:	:	:
25944	2661	4	Fig	Fig	NNP
25944	2661	5	.	.	.
25944	2662	1	53	53	CD
25944	2662	2	.	.	.
25944	2663	1	Palmar	Palmar	NNP
25944	2663	2	Syphiloderm	Syphiloderm	NNP
25944	2663	3	.	.	.
25944	2663	4	]	]	-RRB-
25944	2664	1	#	#	$
25944	2664	2	What	what	WDT
25944	2664	3	modifications	modification	NNS
25944	2664	4	do	do	VBP
25944	2664	5	the	the	DT
25944	2664	6	papules	papule	NNS
25944	2664	7	of	of	IN
25944	2664	8	the	the	DT
25944	2664	9	large	large	JJ
25944	2664	10	-	-	HYPH
25944	2664	11	papular	papular	JJ
25944	2664	12	syphiloderm	syphiloderm	NN
25944	2664	13	sometimes	sometimes	RB
25944	2664	14	undergo	undergo	VB
25944	2664	15	?	?	.
25944	2664	16	#	#	NN
25944	2664	17	They	-PRON-	PRP
25944	2664	18	may	may	MD
25944	2664	19	change	change	VB
25944	2664	20	into	into	IN
25944	2664	21	the	the	DT
25944	2664	22	moist	moist	NN
25944	2664	23	papule	papule	JJ
25944	2664	24	and	and	CC
25944	2664	25	squamous	squamous	JJ
25944	2664	26	papule	papule	NN
25944	2664	27	.	.	.
25944	2665	1	#	#	NNP
25944	2665	2	Describe	describe	VB
25944	2665	3	the	the	DT
25944	2665	4	moist	moist	NN
25944	2665	5	papule	papule	NN
25944	2665	6	of	of	IN
25944	2665	7	syphilis	syphilis	NNP
25944	2665	8	.	.	.
25944	2665	9	#	#	$
25944	2665	10	The	the	DT
25944	2665	11	change	change	NN
25944	2665	12	into	into	IN
25944	2665	13	the	the	DT
25944	2665	14	moist	moist	NN
25944	2665	15	papule	papule	NN
25944	2665	16	(	(	-LRB-
25944	2665	17	also	also	RB
25944	2665	18	called	call	VBN
25944	2665	19	_	_	NNP
25944	2665	20	mucous	mucous	JJ
25944	2665	21	patch	patch	NN
25944	2665	22	,	,	,
25944	2665	23	flat	flat	JJ
25944	2665	24	condyloma	condyloma	NNS
25944	2665	25	_	_	NNP
25944	2665	26	)	)	-RRB-
25944	2665	27	is	be	VBZ
25944	2665	28	not	not	RB
25944	2665	29	uncommon	uncommon	JJ
25944	2665	30	where	where	WRB
25944	2665	31	opposing	oppose	VBG
25944	2665	32	surfaces	surface	NNS
25944	2665	33	and	and	CC
25944	2665	34	natural	natural	JJ
25944	2665	35	folds	fold	NNS
25944	2665	36	of	of	IN
25944	2665	37	skin	skin	NN
25944	2665	38	are	be	VBP
25944	2665	39	subjected	subject	VBN
25944	2665	40	to	to	IN
25944	2665	41	more	more	RBR
25944	2665	42	or	or	CC
25944	2665	43	less	less	JJR
25944	2665	44	contact	contact	NN
25944	2665	45	,	,	,
25944	2665	46	as	as	IN
25944	2665	47	about	about	IN
25944	2665	48	the	the	DT
25944	2665	49	anus	anus	NN
25944	2665	50	,	,	,
25944	2665	51	the	the	DT
25944	2665	52	scroto	scroto	JJ
25944	2665	53	-	-	HYPH
25944	2665	54	femoral	femoral	JJ
25944	2665	55	regions	region	NNS
25944	2665	56	,	,	,
25944	2665	57	umbilicus	umbilicus	NNP
25944	2665	58	,	,	,
25944	2665	59	axillæ	axillæ	RB
25944	2665	60	and	and	CC
25944	2665	61	beneath	beneath	IN
25944	2665	62	the	the	DT
25944	2665	63	mammæ	mammæ	NN
25944	2665	64	.	.	.
25944	2666	1	The	the	DT
25944	2666	2	dry	dry	JJ
25944	2666	3	,	,	,
25944	2666	4	flat	flat	JJ
25944	2666	5	papules	papule	NNS
25944	2666	6	gradually	gradually	RB
25944	2666	7	become	become	VBP
25944	2666	8	moist	moist	JJ
25944	2666	9	and	and	CC
25944	2666	10	covered	cover	VBN
25944	2666	11	with	with	IN
25944	2666	12	a	a	DT
25944	2666	13	grayish	grayish	NN
25944	2666	14	,	,	,
25944	2666	15	sticky	sticky	JJ
25944	2666	16	,	,	,
25944	2666	17	mucoid	mucoid	NNP
25944	2666	18	secretion	secretion	NN
25944	2666	19	;	;	:
25944	2666	20	several	several	JJ
25944	2666	21	may	may	MD
25944	2666	22	coalesce	coalesce	VB
25944	2666	23	and	and	CC
25944	2666	24	form	form	VB
25944	2666	25	large	large	JJ
25944	2666	26	,	,	,
25944	2666	27	flat	flat	JJ
25944	2666	28	patches	patch	NNS
25944	2666	29	.	.	.
25944	2667	1	They	-PRON-	PRP
25944	2667	2	may	may	MD
25944	2667	3	so	so	RB
25944	2667	4	remain	remain	VB
25944	2667	5	,	,	,
25944	2667	6	or	or	CC
25944	2667	7	they	-PRON-	PRP
25944	2667	8	may	may	MD
25944	2667	9	become	become	VB
25944	2667	10	hypertrophic	hypertrophic	JJ
25944	2667	11	,	,	,
25944	2667	12	warty	warty	JJ
25944	2667	13	or	or	CC
25944	2667	14	papillomatous	papillomatous	JJ
25944	2667	15	,	,	,
25944	2667	16	with	with	IN
25944	2667	17	more	more	JJR
25944	2667	18	or	or	CC
25944	2667	19	less	less	JJR
25944	2667	20	crust	crust	NN
25944	2667	21	formation	formation	NN
25944	2667	22	(	(	-LRB-
25944	2667	23	_	_	NNP
25944	2667	24	vegetating	vegetate	VBG
25944	2667	25	syphiloderm	syphiloderm	NNP
25944	2667	26	_	_	NNP
25944	2667	27	)	)	-RRB-
25944	2667	28	.	.	.
25944	2668	1	[	[	-LRB-
25944	2668	2	Illustration	illustration	NN
25944	2668	3	:	:	:
25944	2668	4	Fig	Fig	NNP
25944	2668	5	.	.	.
25944	2669	1	54	54	CD
25944	2669	2	.	.	.
25944	2670	1	Annular	Annular	NNP
25944	2670	2	Syphiloderm	Syphiloderm	NNP
25944	2670	3	.	.	.
25944	2671	1	(	(	-LRB-
25944	2671	2	_	_	NNP
25944	2671	3	After	after	IN
25944	2671	4	I.E.	I.E.	NNP
25944	2672	1	Atkinson	Atkinson	NNP
25944	2672	2	.	.	.
25944	2672	3	_	_	NNP
25944	2672	4	)	)	-RRB-
25944	2672	5	]	]	-RRB-
25944	2672	6	#	#	$
25944	2672	7	Describe	describe	VB
25944	2672	8	the	the	DT
25944	2672	9	squamous	squamous	JJ
25944	2672	10	papule	papule	NN
25944	2672	11	of	of	IN
25944	2672	12	syphilis	syphilis	NNP
25944	2672	13	.	.	.
25944	2672	14	#	#	$
25944	2672	15	This	this	DT
25944	2672	16	tendency	tendency	NN
25944	2672	17	of	of	IN
25944	2672	18	the	the	DT
25944	2672	19	large	large	JJ
25944	2672	20	-	-	HYPH
25944	2672	21	papular	papular	JJ
25944	2672	22	eruption	eruption	NN
25944	2672	23	to	to	TO
25944	2672	24	become	become	VB
25944	2672	25	scaly	scaly	NNP
25944	2672	26	,	,	,
25944	2672	27	when	when	WRB
25944	2672	28	exhibited	exhibit	VBN
25944	2672	29	,	,	,
25944	2672	30	is	be	VBZ
25944	2672	31	more	more	RBR
25944	2672	32	or	or	CC
25944	2672	33	less	less	RBR
25944	2672	34	common	common	JJ
25944	2672	35	to	to	IN
25944	2672	36	all	all	DT
25944	2672	37	papules	papule	NNS
25944	2672	38	,	,	,
25944	2672	39	and	and	CC
25944	2672	40	constitutes	constitute	VBZ
25944	2672	41	the	the	DT
25944	2672	42	_	_	NNP
25944	2672	43	squamous	squamous	JJ
25944	2672	44	_	_	NNP
25944	2672	45	or	or	CC
25944	2672	46	_	_	NNP
25944	2672	47	papulo	papulo	JJ
25944	2672	48	-	-	HYPH
25944	2672	49	squamous	squamous	JJ
25944	2672	50	syphiloderm	syphiloderm	NN
25944	2672	51	_	_	NNP
25944	2672	52	(	(	-LRB-
25944	2672	53	improperly	improperly	RB
25944	2672	54	called	call	VBN
25944	2672	55	_	_	NNP
25944	2672	56	psoriasis	psoriasis	NN
25944	2672	57	syphilitica	syphilitica	NNP
25944	2672	58	_	_	NNP
25944	2672	59	)	)	-RRB-
25944	2672	60	.	.	.
25944	2673	1	The	the	DT
25944	2673	2	papules	papule	NNS
25944	2673	3	become	become	VBP
25944	2673	4	somewhat	somewhat	RB
25944	2673	5	flattened	flattened	JJ
25944	2673	6	and	and	CC
25944	2673	7	are	be	VBP
25944	2673	8	covered	cover	VBN
25944	2673	9	with	with	IN
25944	2673	10	dry	dry	JJ
25944	2673	11	,	,	,
25944	2673	12	grayish	grayish	NN
25944	2673	13	or	or	CC
25944	2673	14	dirty	dirty	JJ
25944	2673	15	-	-	HYPH
25944	2673	16	gray	gray	JJ
25944	2673	17	,	,	,
25944	2673	18	somewhat	somewhat	RB
25944	2673	19	adherent	adherent	JJ
25944	2673	20	scales	scale	VBZ
25944	2673	21	.	.	.
25944	2674	1	The	the	DT
25944	2674	2	scaling	scaling	NN
25944	2674	3	,	,	,
25944	2674	4	as	as	IN
25944	2674	5	compared	compare	VBN
25944	2674	6	to	to	IN
25944	2674	7	that	that	DT
25944	2674	8	of	of	IN
25944	2674	9	psoriasis	psoriasis	NN
25944	2674	10	,	,	,
25944	2674	11	is	be	VBZ
25944	2674	12	,	,	,
25944	2674	13	as	as	IN
25944	2674	14	a	a	DT
25944	2674	15	rule	rule	NN
25944	2674	16	,	,	,
25944	2674	17	relatively	relatively	RB
25944	2674	18	slight	slight	JJ
25944	2674	19	.	.	.
25944	2675	1	The	the	DT
25944	2675	2	eruption	eruption	NN
25944	2675	3	may	may	MD
25944	2675	4	be	be	VB
25944	2675	5	general	general	JJ
25944	2675	6	,	,	,
25944	2675	7	as	as	IN
25944	2675	8	usually	usually	RB
25944	2675	9	the	the	DT
25944	2675	10	case	case	NN
25944	2675	11	in	in	IN
25944	2675	12	the	the	DT
25944	2675	13	earlier	early	JJR
25944	2675	14	months	month	NNS
25944	2675	15	of	of	IN
25944	2675	16	the	the	DT
25944	2675	17	disease	disease	NN
25944	2675	18	,	,	,
25944	2675	19	or	or	CC
25944	2675	20	it	-PRON-	PRP
25944	2675	21	may	may	MD
25944	2675	22	appear	appear	VB
25944	2675	23	as	as	IN
25944	2675	24	a	a	DT
25944	2675	25	relapse	relapse	NN
25944	2675	26	or	or	CC
25944	2675	27	a	a	DT
25944	2675	28	later	later	JJ
25944	2675	29	manifestation	manifestation	NN
25944	2675	30	,	,	,
25944	2675	31	and	and	CC
25944	2675	32	be	be	VB
25944	2675	33	limited	limit	VBN
25944	2675	34	in	in	IN
25944	2675	35	extent	extent	NN
25944	2675	36	.	.	.
25944	2676	1	As	as	IN
25944	2676	2	a	a	DT
25944	2676	3	limited	limited	JJ
25944	2676	4	eruption	eruption	NN
25944	2676	5	it	-PRON-	PRP
25944	2676	6	is	be	VBZ
25944	2676	7	most	most	RBS
25944	2676	8	frequently	frequently	RB
25944	2676	9	seen	see	VBN
25944	2676	10	on	on	IN
25944	2676	11	the	the	DT
25944	2676	12	palms	palm	NNS
25944	2676	13	and	and	CC
25944	2676	14	soles	sol	NNS
25944	2676	15	--	--	:
25944	2676	16	the	the	DT
25944	2676	17	_	_	NNP
25944	2676	18	palmar	palmar	NNP
25944	2676	19	and	and	CC
25944	2676	20	plantar	plantar	NNP
25944	2676	21	syphiloderm	syphiloderm	NNP
25944	2676	22	_	_	NNP
25944	2676	23	.	.	.
25944	2677	1	Occurring	occur	VBG
25944	2677	2	on	on	IN
25944	2677	3	these	these	DT
25944	2677	4	parts	part	NNS
25944	2677	5	it	-PRON-	PRP
25944	2677	6	is	be	VBZ
25944	2677	7	often	often	RB
25944	2677	8	rebellious	rebellious	JJ
25944	2677	9	to	to	IN
25944	2677	10	treatment	treatment	NN
25944	2677	11	.	.	.
25944	2678	1	[	[	-LRB-
25944	2678	2	Illustration	illustration	NN
25944	2678	3	:	:	:
25944	2678	4	Maculo	maculo	NN
25944	2678	5	-	-	HYPH
25944	2678	6	papular	papular	JJ
25944	2678	7	syphiloderm	syphiloderm	NN
25944	2678	8	.	.	.
25944	2678	9	]	]	-RRB-
25944	2679	1	#	#	NNP
25944	2679	2	How	how	WRB
25944	2679	3	are	be	VBP
25944	2679	4	you	-PRON-	PRP
25944	2679	5	to	to	TO
25944	2679	6	distinguish	distinguish	VB
25944	2679	7	the	the	DT
25944	2679	8	papulo	papulo	JJ
25944	2679	9	-	-	HYPH
25944	2679	10	squamous	squamous	JJ
25944	2679	11	syphiloderm	syphiloderm	NN
25944	2679	12	from	from	IN
25944	2679	13	psoriasis	psoriasis	NN
25944	2679	14	?	?	.
25944	2679	15	#	#	$
25944	2679	16	In	in	IN
25944	2679	17	psoriasis	psoriasis	NN
25944	2679	18	the	the	DT
25944	2679	19	eruption	eruption	NN
25944	2679	20	is	be	VBZ
25944	2679	21	more	more	RBR
25944	2679	22	inflammatory	inflammatory	JJ
25944	2679	23	,	,	,
25944	2679	24	and	and	CC
25944	2679	25	usually	usually	RB
25944	2679	26	bright	bright	JJ
25944	2679	27	red	red	JJ
25944	2679	28	;	;	:
25944	2679	29	the	the	DT
25944	2679	30	scales	scale	NNS
25944	2679	31	whitish	whitish	NNP
25944	2679	32	or	or	CC
25944	2679	33	pearl	pearl	NN
25944	2679	34	-	-	HYPH
25944	2679	35	colored	colored	JJ
25944	2679	36	and	and	CC
25944	2679	37	,	,	,
25944	2679	38	as	as	IN
25944	2679	39	a	a	DT
25944	2679	40	rule	rule	NN
25944	2679	41	,	,	,
25944	2679	42	abundant	abundant	JJ
25944	2679	43	.	.	.
25944	2680	1	It	-PRON-	PRP
25944	2680	2	is	be	VBZ
25944	2680	3	generally	generally	RB
25944	2680	4	seen	see	VBN
25944	2680	5	in	in	IN
25944	2680	6	greater	great	JJR
25944	2680	7	profusion	profusion	NN
25944	2680	8	upon	upon	IN
25944	2680	9	certain	certain	JJ
25944	2680	10	parts	part	NNS
25944	2680	11	,	,	,
25944	2680	12	as	as	IN
25944	2680	13	,	,	,
25944	2680	14	for	for	IN
25944	2680	15	instance	instance	NN
25944	2680	16	,	,	,
25944	2680	17	the	the	DT
25944	2680	18	extensor	extensor	NN
25944	2680	19	surfaces	surface	VBZ
25944	2680	20	,	,	,
25944	2680	21	especially	especially	RB
25944	2680	22	of	of	IN
25944	2680	23	the	the	DT
25944	2680	24	elbows	elbow	NNS
25944	2680	25	and	and	CC
25944	2680	26	knees	knee	NNS
25944	2680	27	.	.	.
25944	2681	1	It	-PRON-	PRP
25944	2681	2	is	be	VBZ
25944	2681	3	not	not	RB
25944	2681	4	infrequently	infrequently	RB
25944	2681	5	itchy	itchy	JJ
25944	2681	6	,	,	,
25944	2681	7	and	and	CC
25944	2681	8	,	,	,
25944	2681	9	moreover	moreover	RB
25944	2681	10	,	,	,
25944	2681	11	presents	present	VBZ
25944	2681	12	a	a	DT
25944	2681	13	different	different	JJ
25944	2681	14	history	history	NN
25944	2681	15	.	.	.
25944	2682	1	In	in	IN
25944	2682	2	the	the	DT
25944	2682	3	syphilitic	syphilitic	JJ
25944	2682	4	eruption	eruption	NN
25944	2682	5	some	some	DT
25944	2682	6	of	of	IN
25944	2682	7	the	the	DT
25944	2682	8	papules	papule	NNS
25944	2682	9	almost	almost	RB
25944	2682	10	invariably	invariably	RB
25944	2682	11	remain	remain	VBP
25944	2682	12	perfectly	perfectly	RB
25944	2682	13	free	free	JJ
25944	2682	14	from	from	IN
25944	2682	15	any	any	DT
25944	2682	16	tendency	tendency	NN
25944	2682	17	to	to	TO
25944	2682	18	scale	scale	VB
25944	2682	19	formation	formation	NN
25944	2682	20	;	;	:
25944	2682	21	there	there	EX
25944	2682	22	is	be	VBZ
25944	2682	23	distinct	distinct	JJ
25944	2682	24	deposit	deposit	NN
25944	2682	25	or	or	CC
25944	2682	26	infiltration	infiltration	NN
25944	2682	27	,	,	,
25944	2682	28	and	and	CC
25944	2682	29	the	the	DT
25944	2682	30	lesions	lesion	NNS
25944	2682	31	are	be	VBP
25944	2682	32	of	of	IN
25944	2682	33	a	a	DT
25944	2682	34	dark	dark	JJ
25944	2682	35	,	,	,
25944	2682	36	sluggish	sluggish	JJ
25944	2682	37	red	red	JJ
25944	2682	38	or	or	CC
25944	2682	39	ham	ham	NN
25944	2682	40	tint	tint	NN
25944	2682	41	;	;	:
25944	2682	42	and	and	CC
25944	2682	43	,	,	,
25944	2682	44	moreover	moreover	RB
25944	2682	45	,	,	,
25944	2682	46	concomitant	concomitant	JJ
25944	2682	47	symptoms	symptom	NNS
25944	2682	48	of	of	IN
25944	2682	49	syphilis	syphili	NNS
25944	2682	50	are	be	VBP
25944	2682	51	usually	usually	RB
25944	2682	52	present	present	JJ
25944	2682	53	.	.	.
25944	2683	1	#	#	NNP
25944	2683	2	Describe	describe	VB
25944	2683	3	the	the	DT
25944	2683	4	annular	annular	JJ
25944	2683	5	eruption	eruption	NN
25944	2683	6	of	of	IN
25944	2683	7	syphilis	syphilis	NNP
25944	2683	8	.	.	.
25944	2683	9	#	#	$
25944	2683	10	The	the	DT
25944	2683	11	_	_	NNP
25944	2683	12	annular	annular	NN
25944	2683	13	syphiloderm	syphiloderm	NN
25944	2683	14	_	_	NNP
25944	2683	15	(	(	-LRB-
25944	2683	16	_	_	NNP
25944	2683	17	circinate	circinate	NNP
25944	2683	18	syphiloderm	syphiloderm	NNP
25944	2683	19	_	_	NNP
25944	2683	20	)	)	-RRB-
25944	2683	21	is	be	VBZ
25944	2683	22	observed	observe	VBN
25944	2683	23	usually	usually	RB
25944	2683	24	in	in	IN
25944	2683	25	association	association	NN
25944	2683	26	with	with	IN
25944	2683	27	the	the	DT
25944	2683	28	large	large	JJ
25944	2683	29	-	-	HYPH
25944	2683	30	papular	papular	JJ
25944	2683	31	eruption	eruption	NN
25944	2683	32	,	,	,
25944	2683	33	and	and	CC
25944	2683	34	consists	consist	VBZ
25944	2683	35	of	of	IN
25944	2683	36	several	several	JJ
25944	2683	37	or	or	CC
25944	2683	38	more	more	RBR
25944	2683	39	variously	variously	RB
25944	2683	40	sized	sized	JJ
25944	2683	41	,	,	,
25944	2683	42	ring	ring	NN
25944	2683	43	-	-	HYPH
25944	2683	44	like	like	JJ
25944	2683	45	lesions	lesion	NNS
25944	2683	46	,	,	,
25944	2683	47	with	with	IN
25944	2683	48	a	a	DT
25944	2683	49	distinctly	distinctly	RB
25944	2683	50	elevated	elevated	JJ
25944	2683	51	solid	solid	JJ
25944	2683	52	ridge	ridge	NN
25944	2683	53	or	or	CC
25944	2683	54	wall	wall	NN
25944	2683	55	peripherally	peripherally	RB
25944	2683	56	and	and	CC
25944	2683	57	a	a	DT
25944	2683	58	more	more	RBR
25944	2683	59	or	or	CC
25944	2683	60	less	less	RBR
25944	2683	61	flattened	flatten	VBD
25944	2683	62	centre	centre	NN
25944	2683	63	.	.	.
25944	2684	1	It	-PRON-	PRP
25944	2684	2	is	be	VBZ
25944	2684	3	commonly	commonly	RB
25944	2684	4	seen	see	VBN
25944	2684	5	about	about	IN
25944	2684	6	the	the	DT
25944	2684	7	mouth	mouth	NN
25944	2684	8	,	,	,
25944	2684	9	forehead	forehead	NN
25944	2684	10	and	and	CC
25944	2684	11	neck	neck	NN
25944	2684	12	.	.	.
25944	2685	1	The	the	DT
25944	2685	2	lesion	lesion	NN
25944	2685	3	appears	appear	VBZ
25944	2685	4	to	to	TO
25944	2685	5	have	have	VB
25944	2685	6	its	-PRON-	PRP$
25944	2685	7	origin	origin	NN
25944	2685	8	from	from	IN
25944	2685	9	an	an	DT
25944	2685	10	ordinary	ordinary	JJ
25944	2685	11	,	,	,
25944	2685	12	usually	usually	RB
25944	2685	13	scaleless	scaleless	JJ
25944	2685	14	or	or	CC
25944	2685	15	slightly	slightly	RB
25944	2685	16	scaly	scaly	JJ
25944	2685	17	,	,	,
25944	2685	18	large	large	JJ
25944	2685	19	papule	papule	NN
25944	2685	20	,	,	,
25944	2685	21	the	the	DT
25944	2685	22	central	central	JJ
25944	2685	23	portion	portion	NN
25944	2685	24	of	of	IN
25944	2685	25	which	which	WDT
25944	2685	26	has	have	VBZ
25944	2685	27	been	be	VBN
25944	2685	28	incompletely	incompletely	RB
25944	2685	29	formed	form	VBN
25944	2685	30	or	or	CC
25944	2685	31	has	have	VBZ
25944	2685	32	become	become	VBN
25944	2685	33	sunken	sink	VBN
25944	2685	34	and	and	CC
25944	2685	35	flattened	flattened	JJ
25944	2685	36	.	.	.
25944	2686	1	The	the	DT
25944	2686	2	manifestation	manifestation	NN
25944	2686	3	is	be	VBZ
25944	2686	4	rare	rare	JJ
25944	2686	5	,	,	,
25944	2686	6	and	and	CC
25944	2686	7	is	be	VBZ
25944	2686	8	seen	see	VBN
25944	2686	9	most	most	RBS
25944	2686	10	frequently	frequently	RB
25944	2686	11	in	in	IN
25944	2686	12	the	the	DT
25944	2686	13	negro	negro	NNS
25944	2686	14	.	.	.
25944	2687	1	#	#	$
25944	2687	2	What	what	WDT
25944	2687	3	several	several	JJ
25944	2687	4	varieties	variety	NNS
25944	2687	5	of	of	IN
25944	2687	6	the	the	DT
25944	2687	7	pustular	pustular	JJ
25944	2687	8	syphiloderm	syphiloderm	NN
25944	2687	9	are	be	VBP
25944	2687	10	met	meet	VBN
25944	2687	11	with	with	IN
25944	2687	12	?	?	.
25944	2687	13	#	#	$
25944	2687	14	The	the	DT
25944	2687	15	small	small	JJ
25944	2687	16	acuminated	acuminate	VBN
25944	2687	17	-	-	HYPH
25944	2687	18	pustular	pustular	JJ
25944	2687	19	syphiloderm	syphiloderm	NN
25944	2687	20	,	,	,
25944	2687	21	the	the	DT
25944	2687	22	large	large	JJ
25944	2687	23	acuminated	acuminate	VBN
25944	2687	24	-	-	HYPH
25944	2687	25	pustular	pustular	JJ
25944	2687	26	syphiloderm	syphiloderm	NN
25944	2687	27	,	,	,
25944	2687	28	the	the	DT
25944	2687	29	small	small	JJ
25944	2687	30	flat	flat	JJ
25944	2687	31	-	-	HYPH
25944	2687	32	pustular	pustular	JJ
25944	2687	33	syphiloderm	syphiloderm	NN
25944	2687	34	,	,	,
25944	2687	35	and	and	CC
25944	2687	36	the	the	DT
25944	2687	37	large	large	JJ
25944	2687	38	flat	flat	JJ
25944	2687	39	-	-	HYPH
25944	2687	40	pustular	pustular	JJ
25944	2687	41	syphiloderm	syphiloderm	NN
25944	2687	42	.	.	.
25944	2688	1	#	#	NNP
25944	2688	2	Describe	describe	VB
25944	2688	3	the	the	DT
25944	2688	4	small	small	JJ
25944	2688	5	acuminated	acuminate	VBN
25944	2688	6	-	-	HYPH
25944	2688	7	pustular	pustular	JJ
25944	2688	8	eruption	eruption	NN
25944	2688	9	of	of	IN
25944	2688	10	syphilis	syphilis	NNP
25944	2688	11	.	.	.
25944	2688	12	#	#	$
25944	2688	13	The	the	DT
25944	2688	14	_	_	NNP
25944	2688	15	small	small	JJ
25944	2688	16	acuminated	acuminate	VBN
25944	2688	17	-	-	HYPH
25944	2688	18	pustular	pustular	JJ
25944	2688	19	syphiloderm	syphiloderm	NN
25944	2688	20	_	_	NNP
25944	2688	21	(	(	-LRB-
25944	2688	22	_	_	NNP
25944	2688	23	miliary	miliary	JJ
25944	2688	24	pustular	pustular	NN
25944	2688	25	syphiloderm	syphiloderm	NNP
25944	2688	26	_	_	NNP
25944	2688	27	)	)	-RRB-
25944	2688	28	is	be	VBZ
25944	2688	29	an	an	DT
25944	2688	30	early	early	JJ
25944	2688	31	or	or	CC
25944	2688	32	late	late	JJ
25944	2688	33	secondary	secondary	JJ
25944	2688	34	eruption	eruption	NN
25944	2688	35	,	,	,
25944	2688	36	commonly	commonly	RB
25944	2688	37	encountered	encounter	VBN
25944	2688	38	in	in	IN
25944	2688	39	the	the	DT
25944	2688	40	first	first	JJ
25944	2688	41	six	six	CD
25944	2688	42	or	or	CC
25944	2688	43	eight	eight	CD
25944	2688	44	months	month	NNS
25944	2688	45	of	of	IN
25944	2688	46	the	the	DT
25944	2688	47	disease	disease	NN
25944	2688	48	.	.	.
25944	2689	1	It	-PRON-	PRP
25944	2689	2	consists	consist	VBZ
25944	2689	3	of	of	IN
25944	2689	4	a	a	DT
25944	2689	5	more	more	RBR
25944	2689	6	or	or	CC
25944	2689	7	less	less	RBR
25944	2689	8	generalized	generalize	VBN
25944	2689	9	,	,	,
25944	2689	10	disseminated	disseminate	VBN
25944	2689	11	or	or	CC
25944	2689	12	grouped	group	VBN
25944	2689	13	,	,	,
25944	2689	14	millet	millet	NN
25944	2689	15	-	-	HYPH
25944	2689	16	seed	seed	NN
25944	2689	17	-	-	HYPH
25944	2689	18	sized	sized	JJ
25944	2689	19	,	,	,
25944	2689	20	acuminated	acuminate	VBN
25944	2689	21	pustules	pustule	NNS
25944	2689	22	,	,	,
25944	2689	23	usually	usually	RB
25944	2689	24	seated	seat	VBN
25944	2689	25	upon	upon	IN
25944	2689	26	dull	dull	JJ
25944	2689	27	-	-	HYPH
25944	2689	28	red	red	JJ
25944	2689	29	,	,	,
25944	2689	30	papular	papular	JJ
25944	2689	31	elevations	elevation	NNS
25944	2689	32	.	.	.
25944	2690	1	The	the	DT
25944	2690	2	eruption	eruption	NN
25944	2690	3	is	be	VBZ
25944	2690	4	,	,	,
25944	2690	5	as	as	IN
25944	2690	6	a	a	DT
25944	2690	7	rule	rule	NN
25944	2690	8	,	,	,
25944	2690	9	profuse	profuse	NN
25944	2690	10	,	,	,
25944	2690	11	and	and	CC
25944	2690	12	usually	usually	RB
25944	2690	13	involves	involve	VBZ
25944	2690	14	the	the	DT
25944	2690	15	hair	hair	NN
25944	2690	16	-	-	HYPH
25944	2690	17	follicles	follicle	NNS
25944	2690	18	.	.	.
25944	2691	1	The	the	DT
25944	2691	2	pustules	pustule	NNS
25944	2691	3	dry	dry	VBP
25944	2691	4	to	to	IN
25944	2691	5	crusts	crust	NNS
25944	2691	6	,	,	,
25944	2691	7	which	which	WDT
25944	2691	8	fall	fall	VBP
25944	2691	9	off	off	RP
25944	2691	10	and	and	CC
25944	2691	11	are	be	VBP
25944	2691	12	often	often	RB
25944	2691	13	followed	follow	VBN
25944	2691	14	by	by	IN
25944	2691	15	a	a	DT
25944	2691	16	slight	slight	JJ
25944	2691	17	,	,	,
25944	2691	18	fringe	fringe	NN
25944	2691	19	-	-	HYPH
25944	2691	20	like	like	JJ
25944	2691	21	exfoliation	exfoliation	NN
25944	2691	22	around	around	IN
25944	2691	23	the	the	DT
25944	2691	24	base	base	NN
25944	2691	25	,	,	,
25944	2691	26	constituting	constitute	VBG
25944	2691	27	a	a	DT
25944	2691	28	grayish	grayish	NN
25944	2691	29	ring	ring	NN
25944	2691	30	or	or	CC
25944	2691	31	collar	collar	NN
25944	2691	32	.	.	.
25944	2692	1	Minute	minute	JJ
25944	2692	2	pin	pin	NN
25944	2692	3	-	-	HYPH
25944	2692	4	point	point	NN
25944	2692	5	atrophic	atrophic	JJ
25944	2692	6	depressions	depression	NNS
25944	2692	7	or	or	CC
25944	2692	8	stains	stain	NNS
25944	2692	9	are	be	VBP
25944	2692	10	left	leave	VBN
25944	2692	11	,	,	,
25944	2692	12	which	which	WDT
25944	2692	13	gradually	gradually	RB
25944	2692	14	become	become	VBP
25944	2692	15	less	less	RBR
25944	2692	16	distinct	distinct	JJ
25944	2692	17	.	.	.
25944	2693	1	Scattered	scatter	VBN
25944	2693	2	large	large	JJ
25944	2693	3	pustules	pustule	NNS
25944	2693	4	,	,	,
25944	2693	5	and	and	CC
25944	2693	6	sometimes	sometimes	RB
25944	2693	7	papules	papule	NNS
25944	2693	8	,	,	,
25944	2693	9	are	be	VBP
25944	2693	10	not	not	RB
25944	2693	11	infrequently	infrequently	RB
25944	2693	12	present	present	JJ
25944	2693	13	.	.	.
25944	2694	1	#	#	NNP
25944	2694	2	Describe	describe	VB
25944	2694	3	the	the	DT
25944	2694	4	large	large	JJ
25944	2694	5	acuminated	acuminate	VBN
25944	2694	6	-	-	HYPH
25944	2694	7	pustular	pustular	JJ
25944	2694	8	eruption	eruption	NN
25944	2694	9	of	of	IN
25944	2694	10	syphilis	syphilis	NNP
25944	2694	11	.	.	.
25944	2694	12	#	#	$
25944	2694	13	The	the	DT
25944	2694	14	_	_	NNP
25944	2694	15	large	large	JJ
25944	2694	16	acuminated	acuminate	VBN
25944	2694	17	-	-	HYPH
25944	2694	18	pustular	pustular	JJ
25944	2694	19	syphiloderm	syphiloderm	NN
25944	2694	20	_	_	NNP
25944	2694	21	(	(	-LRB-
25944	2694	22	_	_	NNP
25944	2694	23	acne	acne	NNP
25944	2694	24	-	-	HYPH
25944	2694	25	form	form	NN
25944	2694	26	syphiloderm	syphiloderm	NNP
25944	2694	27	_	_	NNP
25944	2694	28	,	,	,
25944	2694	29	_	_	NNP
25944	2694	30	variola	variola	NNP
25944	2694	31	-	-	HYPH
25944	2694	32	form	form	NN
25944	2694	33	syphiloderm	syphiloderm	NNP
25944	2694	34	_	_	NNP
25944	2694	35	)	)	-RRB-
25944	2694	36	is	be	VBZ
25944	2694	37	a	a	DT
25944	2694	38	more	more	RBR
25944	2694	39	or	or	CC
25944	2694	40	less	less	RBR
25944	2694	41	generalized	generalized	JJ
25944	2694	42	eruption	eruption	NN
25944	2694	43	,	,	,
25944	2694	44	occurring	occur	VBG
25944	2694	45	usually	usually	RB
25944	2694	46	in	in	IN
25944	2694	47	the	the	DT
25944	2694	48	first	first	JJ
25944	2694	49	six	six	CD
25944	2694	50	or	or	CC
25944	2694	51	eight	eight	CD
25944	2694	52	months	month	NNS
25944	2694	53	of	of	IN
25944	2694	54	the	the	DT
25944	2694	55	disease	disease	NN
25944	2694	56	.	.	.
25944	2695	1	It	-PRON-	PRP
25944	2695	2	consists	consist	VBZ
25944	2695	3	of	of	IN
25944	2695	4	small	small	JJ
25944	2695	5	or	or	CC
25944	2695	6	large	large	JJ
25944	2695	7	pea	pea	JJ
25944	2695	8	-	-	HYPH
25944	2695	9	sized	sized	JJ
25944	2695	10	,	,	,
25944	2695	11	disseminated	disseminate	VBN
25944	2695	12	or	or	CC
25944	2695	13	grouped	group	VBN
25944	2695	14	,	,	,
25944	2695	15	acuminated	acuminated	JJ
25944	2695	16	or	or	CC
25944	2695	17	rounded	rounded	JJ
25944	2695	18	pustules	pustule	NNS
25944	2695	19	,	,	,
25944	2695	20	resembling	resemble	VBG
25944	2695	21	the	the	DT
25944	2695	22	lesions	lesion	NNS
25944	2695	23	of	of	IN
25944	2695	24	acne	acne	NNP
25944	2695	25	and	and	CC
25944	2695	26	variola	variola	NNP
25944	2695	27	.	.	.
25944	2696	1	They	-PRON-	PRP
25944	2696	2	develop	develop	VBP
25944	2696	3	slowly	slowly	RB
25944	2696	4	or	or	CC
25944	2696	5	rapidly	rapidly	RB
25944	2696	6	,	,	,
25944	2696	7	and	and	CC
25944	2696	8	at	at	IN
25944	2696	9	first	first	RB
25944	2696	10	may	may	MD
25944	2696	11	appear	appear	VB
25944	2696	12	more	more	RBR
25944	2696	13	or	or	CC
25944	2696	14	less	less	RBR
25944	2696	15	papular	papular	JJ
25944	2696	16	.	.	.
25944	2697	1	They	-PRON-	PRP
25944	2697	2	dry	dry	VBP
25944	2697	3	to	to	IN
25944	2697	4	somewhat	somewhat	RB
25944	2697	5	thick	thick	JJ
25944	2697	6	crusts	crust	NNS
25944	2697	7	,	,	,
25944	2697	8	and	and	CC
25944	2697	9	are	be	VBP
25944	2697	10	seated	seat	VBN
25944	2697	11	upon	upon	IN
25944	2697	12	superficially	superficially	RB
25944	2697	13	ulcerated	ulcerated	JJ
25944	2697	14	bases	basis	NNS
25944	2697	15	.	.	.
25944	2698	1	It	-PRON-	PRP
25944	2698	2	pursues	pursue	VBZ
25944	2698	3	,	,	,
25944	2698	4	as	as	IN
25944	2698	5	a	a	DT
25944	2698	6	rule	rule	NN
25944	2698	7	,	,	,
25944	2698	8	a	a	DT
25944	2698	9	comparatively	comparatively	RB
25944	2698	10	rapid	rapid	JJ
25944	2698	11	and	and	CC
25944	2698	12	benign	benign	JJ
25944	2698	13	course	course	NN
25944	2698	14	.	.	.
25944	2699	1	In	in	IN
25944	2699	2	relapses	relapse	VBZ
25944	2699	3	the	the	DT
25944	2699	4	eruption	eruption	NN
25944	2699	5	is	be	VBZ
25944	2699	6	usually	usually	RB
25944	2699	7	more	more	RBR
25944	2699	8	or	or	CC
25944	2699	9	less	less	RBR
25944	2699	10	localized	localized	JJ
25944	2699	11	.	.	.
25944	2700	1	#	#	NNP
25944	2700	2	How	how	WRB
25944	2700	3	would	would	MD
25944	2700	4	you	-PRON-	PRP
25944	2700	5	distinguish	distinguish	VB
25944	2700	6	the	the	DT
25944	2700	7	large	large	JJ
25944	2700	8	acuminated	acuminate	VBN
25944	2700	9	-	-	HYPH
25944	2700	10	pustular	pustular	JJ
25944	2700	11	syphiloderm	syphiloderm	NN
25944	2700	12	from	from	IN
25944	2700	13	acne	acne	NNP
25944	2700	14	and	and	CC
25944	2700	15	variola	variola	NNP
25944	2700	16	?	?	.
25944	2700	17	#	#	$
25944	2700	18	In	in	IN
25944	2700	19	acne	acne	NNP
25944	2700	20	the	the	DT
25944	2700	21	usual	usual	JJ
25944	2700	22	limitation	limitation	NN
25944	2700	23	of	of	IN
25944	2700	24	the	the	DT
25944	2700	25	lesions	lesion	NNS
25944	2700	26	to	to	IN
25944	2700	27	the	the	DT
25944	2700	28	face	face	NN
25944	2700	29	or	or	CC
25944	2700	30	face	face	NN
25944	2700	31	and	and	CC
25944	2700	32	shoulders	shoulder	NNS
25944	2700	33	,	,	,
25944	2700	34	the	the	DT
25944	2700	35	origin	origin	NN
25944	2700	36	,	,	,
25944	2700	37	more	more	RBR
25944	2700	38	rapid	rapid	JJ
25944	2700	39	formation	formation	NN
25944	2700	40	and	and	CC
25944	2700	41	evolution	evolution	NN
25944	2700	42	of	of	IN
25944	2700	43	the	the	DT
25944	2700	44	individual	individual	JJ
25944	2700	45	lesions	lesion	NNS
25944	2700	46	,	,	,
25944	2700	47	and	and	CC
25944	2700	48	the	the	DT
25944	2700	49	chronic	chronic	JJ
25944	2700	50	character	character	NN
25944	2700	51	of	of	IN
25944	2700	52	the	the	DT
25944	2700	53	disease	disease	NN
25944	2700	54	,	,	,
25944	2700	55	are	be	VBP
25944	2700	56	usually	usually	RB
25944	2700	57	distinctive	distinctive	JJ
25944	2700	58	points	point	NNS
25944	2700	59	.	.	.
25944	2701	1	In	in	IN
25944	2701	2	variola	variola	NNP
25944	2701	3	,	,	,
25944	2701	4	the	the	DT
25944	2701	5	intensity	intensity	NN
25944	2701	6	of	of	IN
25944	2701	7	the	the	DT
25944	2701	8	general	general	JJ
25944	2701	9	symptoms	symptom	NNS
25944	2701	10	,	,	,
25944	2701	11	the	the	DT
25944	2701	12	shot	shot	NN
25944	2701	13	-	-	HYPH
25944	2701	14	like	like	JJ
25944	2701	15	beginning	beginning	NN
25944	2701	16	of	of	IN
25944	2701	17	the	the	DT
25944	2701	18	lesions	lesion	NNS
25944	2701	19	,	,	,
25944	2701	20	their	-PRON-	PRP$
25944	2701	21	course	course	NN
25944	2701	22	,	,	,
25944	2701	23	the	the	DT
25944	2701	24	umbilication	umbilication	NN
25944	2701	25	,	,	,
25944	2701	26	and	and	CC
25944	2701	27	the	the	DT
25944	2701	28	definite	definite	JJ
25944	2701	29	duration	duration	NN
25944	2701	30	,	,	,
25944	2701	31	are	be	VBP
25944	2701	32	to	to	TO
25944	2701	33	be	be	VB
25944	2701	34	considered	consider	VBN
25944	2701	35	.	.	.
25944	2702	1	The	the	DT
25944	2702	2	presence	presence	NN
25944	2702	3	or	or	CC
25944	2702	4	absence	absence	NN
25944	2702	5	of	of	IN
25944	2702	6	other	other	JJ
25944	2702	7	symptoms	symptom	NNS
25944	2702	8	of	of	IN
25944	2702	9	syphilis	syphilis	NNP
25944	2702	10	has	have	VBZ
25944	2702	11	,	,	,
25944	2702	12	in	in	IN
25944	2702	13	obscure	obscure	JJ
25944	2702	14	cases	case	NNS
25944	2702	15	,	,	,
25944	2702	16	an	an	DT
25944	2702	17	important	important	JJ
25944	2702	18	diagnostic	diagnostic	JJ
25944	2702	19	bearing	bearing	NN
25944	2702	20	.	.	.
25944	2703	1	#	#	NNP
25944	2703	2	Describe	describe	VB
25944	2703	3	the	the	DT
25944	2703	4	small	small	JJ
25944	2703	5	flat	flat	JJ
25944	2703	6	-	-	HYPH
25944	2703	7	pustular	pustular	JJ
25944	2703	8	eruption	eruption	NN
25944	2703	9	of	of	IN
25944	2703	10	syphilis	syphilis	NNP
25944	2703	11	.	.	.
25944	2703	12	#	#	$
25944	2703	13	The	the	DT
25944	2703	14	_	_	NNP
25944	2703	15	small	small	JJ
25944	2703	16	flat	flat	JJ
25944	2703	17	-	-	HYPH
25944	2703	18	pustular	pustular	JJ
25944	2703	19	syphiloderm	syphiloderm	NN
25944	2703	20	_	_	NNP
25944	2703	21	(	(	-LRB-
25944	2703	22	_	_	NNP
25944	2703	23	impetigo	impetigo	NNP
25944	2703	24	-	-	HYPH
25944	2703	25	form	form	NN
25944	2703	26	syphiloderm	syphiloderm	NNP
25944	2703	27	_	_	NNP
25944	2703	28	)	)	-RRB-
25944	2703	29	consists	consist	VBZ
25944	2703	30	of	of	IN
25944	2703	31	a	a	DT
25944	2703	32	more	more	RBR
25944	2703	33	or	or	CC
25944	2703	34	less	less	RBR
25944	2703	35	generalized	generalized	JJ
25944	2703	36	,	,	,
25944	2703	37	pea	pea	JJ
25944	2703	38	-	-	HYPH
25944	2703	39	sized	sized	JJ
25944	2703	40	,	,	,
25944	2703	41	flat	flat	JJ
25944	2703	42	or	or	CC
25944	2703	43	raised	raise	VBN
25944	2703	44	,	,	,
25944	2703	45	discrete	discrete	JJ
25944	2703	46	,	,	,
25944	2703	47	irregularly	irregularly	RB
25944	2703	48	-	-	HYPH
25944	2703	49	grouped	group	VBN
25944	2703	50	,	,	,
25944	2703	51	or	or	CC
25944	2703	52	in	in	IN
25944	2703	53	places	place	NNS
25944	2703	54	confluent	confluent	NN
25944	2703	55	,	,	,
25944	2703	56	pustules	pustule	NNS
25944	2703	57	,	,	,
25944	2703	58	appearing	appear	VBG
25944	2703	59	usually	usually	RB
25944	2703	60	in	in	IN
25944	2703	61	the	the	DT
25944	2703	62	first	first	JJ
25944	2703	63	year	year	NN
25944	2703	64	of	of	IN
25944	2703	65	the	the	DT
25944	2703	66	disease	disease	NN
25944	2703	67	.	.	.
25944	2704	1	The	the	DT
25944	2704	2	pustules	pustule	NNS
25944	2704	3	dry	dry	VBP
25944	2704	4	rapidly	rapidly	RB
25944	2704	5	to	to	IN
25944	2704	6	yellow	yellow	NN
25944	2704	7	,	,	,
25944	2704	8	greenish	greenish	NN
25944	2704	9	-	-	HYPH
25944	2704	10	yellow	yellow	JJ
25944	2704	11	,	,	,
25944	2704	12	or	or	CC
25944	2704	13	brownish	brownish	NNP
25944	2704	14	,	,	,
25944	2704	15	more	more	RBR
25944	2704	16	or	or	CC
25944	2704	17	less	less	RBR
25944	2704	18	adherent	adherent	JJ
25944	2704	19	,	,	,
25944	2704	20	thick	thick	JJ
25944	2704	21	,	,	,
25944	2704	22	uneven	uneven	JJ
25944	2704	23	,	,	,
25944	2704	24	somewhat	somewhat	RB
25944	2704	25	granular	granular	JJ
25944	2704	26	crusts	crust	NNS
25944	2704	27	,	,	,
25944	2704	28	beneath	beneath	IN
25944	2704	29	which	which	WDT
25944	2704	30	there	there	EX
25944	2704	31	may	may	MD
25944	2704	32	be	be	VB
25944	2704	33	superficial	superficial	JJ
25944	2704	34	or	or	CC
25944	2704	35	deep	deep	JJ
25944	2704	36	ulceration	ulceration	NN
25944	2704	37	;	;	:
25944	2704	38	where	where	WRB
25944	2704	39	the	the	DT
25944	2704	40	lesions	lesion	NNS
25944	2704	41	are	be	VBP
25944	2704	42	confluent	confluent	JJ
25944	2704	43	a	a	DT
25944	2704	44	continuous	continuous	JJ
25944	2704	45	sheet	sheet	NN
25944	2704	46	of	of	IN
25944	2704	47	crusting	crust	VBG
25944	2704	48	forms	form	NNS
25944	2704	49	.	.	.
25944	2705	1	The	the	DT
25944	2705	2	eruption	eruption	NN
25944	2705	3	is	be	VBZ
25944	2705	4	often	often	RB
25944	2705	5	scanty	scanty	NN
25944	2705	6	.	.	.
25944	2706	1	It	-PRON-	PRP
25944	2706	2	is	be	VBZ
25944	2706	3	most	most	RBS
25944	2706	4	frequently	frequently	RB
25944	2706	5	observed	observe	VBN
25944	2706	6	about	about	IN
25944	2706	7	the	the	DT
25944	2706	8	nose	nose	NN
25944	2706	9	,	,	,
25944	2706	10	mouth	mouth	NN
25944	2706	11	,	,	,
25944	2706	12	hairy	hairy	JJ
25944	2706	13	parts	part	NNS
25944	2706	14	of	of	IN
25944	2706	15	the	the	DT
25944	2706	16	face	face	NN
25944	2706	17	and	and	CC
25944	2706	18	scalp	scalp	NN
25944	2706	19	,	,	,
25944	2706	20	and	and	CC
25944	2706	21	about	about	IN
25944	2706	22	the	the	DT
25944	2706	23	genitalia	genitalia	NNP
25944	2706	24	,	,	,
25944	2706	25	frequently	frequently	RB
25944	2706	26	in	in	IN
25944	2706	27	association	association	NN
25944	2706	28	with	with	IN
25944	2706	29	papules	papule	NNS
25944	2706	30	on	on	IN
25944	2706	31	other	other	JJ
25944	2706	32	parts	part	NNS
25944	2706	33	.	.	.
25944	2707	1	#	#	NN
25944	2707	2	Are	be	VBP
25944	2707	3	you	-PRON-	PRP
25944	2707	4	likely	likely	JJ
25944	2707	5	to	to	TO
25944	2707	6	mistake	mistake	VB
25944	2707	7	the	the	DT
25944	2707	8	small	small	JJ
25944	2707	9	flat	flat	JJ
25944	2707	10	-	-	HYPH
25944	2707	11	pustular	pustular	JJ
25944	2707	12	syphiloderm	syphiloderm	NN
25944	2707	13	for	for	IN
25944	2707	14	any	any	DT
25944	2707	15	other	other	JJ
25944	2707	16	eruption	eruption	NN
25944	2707	17	?	?	.
25944	2707	18	#	#	NN
25944	2707	19	Scarcely	scarcely	RB
25944	2707	20	;	;	:
25944	2707	21	but	but	CC
25944	2707	22	when	when	WRB
25944	2707	23	upon	upon	IN
25944	2707	24	the	the	DT
25944	2707	25	scalp	scalp	NN
25944	2707	26	,	,	,
25944	2707	27	it	-PRON-	PRP
25944	2707	28	may	may	MD
25944	2707	29	bear	bear	VB
25944	2707	30	rough	rough	JJ
25944	2707	31	resemblance	resemblance	NN
25944	2707	32	to	to	IN
25944	2707	33	pustular	pustular	JJ
25944	2707	34	eczema	eczema	NN
25944	2707	35	,	,	,
25944	2707	36	but	but	CC
25944	2707	37	the	the	DT
25944	2707	38	erosion	erosion	NN
25944	2707	39	or	or	CC
25944	2707	40	ulceration	ulceration	NN
25944	2707	41	will	will	MD
25944	2707	42	serve	serve	VB
25944	2707	43	to	to	TO
25944	2707	44	differentiate	differentiate	VB
25944	2707	45	.	.	.
25944	2708	1	Moreover	moreover	RB
25944	2708	2	,	,	,
25944	2708	3	concomitant	concomitant	JJ
25944	2708	4	symptoms	symptom	NNS
25944	2708	5	of	of	IN
25944	2708	6	syphilis	syphili	NNS
25944	2708	7	are	be	VBP
25944	2708	8	to	to	TO
25944	2708	9	be	be	VB
25944	2708	10	looked	look	VBN
25944	2708	11	for	for	IN
25944	2708	12	.	.	.
25944	2709	1	#	#	NNP
25944	2709	2	Describe	describe	VB
25944	2709	3	the	the	DT
25944	2709	4	large	large	JJ
25944	2709	5	flat	flat	JJ
25944	2709	6	-	-	HYPH
25944	2709	7	pustular	pustular	JJ
25944	2709	8	eruption	eruption	NN
25944	2709	9	of	of	IN
25944	2709	10	syphilis	syphilis	NNP
25944	2709	11	.	.	.
25944	2709	12	#	#	$
25944	2709	13	The	the	DT
25944	2709	14	_	_	NNP
25944	2709	15	large	large	JJ
25944	2709	16	flat	flat	JJ
25944	2709	17	-	-	HYPH
25944	2709	18	pustular	pustular	JJ
25944	2709	19	syphiloderm	syphiloderm	NN
25944	2709	20	_	_	NNP
25944	2709	21	(	(	-LRB-
25944	2709	22	_	_	NNP
25944	2709	23	ecthyma	ecthyma	NN
25944	2709	24	-	-	HYPH
25944	2709	25	form	form	NN
25944	2709	26	syphiloderm	syphiloderm	NN
25944	2709	27	_	_	NNP
25944	2709	28	)	)	-RRB-
25944	2709	29	consists	consist	VBZ
25944	2709	30	of	of	IN
25944	2709	31	a	a	DT
25944	2709	32	more	more	RBR
25944	2709	33	or	or	CC
25944	2709	34	less	less	RBR
25944	2709	35	generalized	generalize	VBN
25944	2709	36	,	,	,
25944	2709	37	scattered	scattered	JJ
25944	2709	38	eruption	eruption	NN
25944	2709	39	,	,	,
25944	2709	40	of	of	IN
25944	2709	41	large	large	JJ
25944	2709	42	pea-	pea-	NNS
25944	2709	43	or	or	CC
25944	2709	44	dime	dime	NN
25944	2709	45	-	-	HYPH
25944	2709	46	sized	sized	JJ
25944	2709	47	,	,	,
25944	2709	48	flat	flat	JJ
25944	2709	49	pustules	pustule	NNS
25944	2709	50	.	.	.
25944	2710	1	They	-PRON-	PRP
25944	2710	2	dry	dry	VBP
25944	2710	3	rapidly	rapidly	RB
25944	2710	4	to	to	IN
25944	2710	5	crusts	crust	NNS
25944	2710	6	.	.	.
25944	2711	1	The	the	DT
25944	2711	2	bases	basis	NNS
25944	2711	3	of	of	IN
25944	2711	4	the	the	DT
25944	2711	5	lesions	lesion	NNS
25944	2711	6	are	be	VBP
25944	2711	7	a	a	DT
25944	2711	8	deep	deep	JJ
25944	2711	9	-	-	HYPH
25944	2711	10	red	red	NN
25944	2711	11	or	or	CC
25944	2711	12	copper	copper	NN
25944	2711	13	color	color	NN
25944	2711	14	.	.	.
25944	2712	1	Two	two	CD
25944	2712	2	types	type	NNS
25944	2712	3	of	of	IN
25944	2712	4	the	the	DT
25944	2712	5	eruption	eruption	NN
25944	2712	6	are	be	VBP
25944	2712	7	met	meet	VBN
25944	2712	8	with	with	IN
25944	2712	9	.	.	.
25944	2713	1	In	in	IN
25944	2713	2	one	one	CD
25944	2713	3	type	type	NN
25944	2713	4	--	--	:
25944	2713	5	the	the	DT
25944	2713	6	superficial	superficial	JJ
25944	2713	7	variety	variety	NN
25944	2713	8	--	--	:
25944	2713	9	the	the	DT
25944	2713	10	crust	crust	NN
25944	2713	11	is	be	VBZ
25944	2713	12	flat	flat	JJ
25944	2713	13	,	,	,
25944	2713	14	rounded	rounded	JJ
25944	2713	15	or	or	CC
25944	2713	16	ovalish	ovalish	JJ
25944	2713	17	,	,	,
25944	2713	18	of	of	IN
25944	2713	19	a	a	DT
25944	2713	20	yellowish	yellowish	JJ
25944	2713	21	-	-	HYPH
25944	2713	22	brown	brown	JJ
25944	2713	23	or	or	CC
25944	2713	24	dark	dark	JJ
25944	2713	25	-	-	HYPH
25944	2713	26	brown	brown	JJ
25944	2713	27	color	color	NN
25944	2713	28	,	,	,
25944	2713	29	and	and	CC
25944	2713	30	seated	seat	VBN
25944	2713	31	upon	upon	IN
25944	2713	32	a	a	DT
25944	2713	33	superficial	superficial	JJ
25944	2713	34	erosion	erosion	NN
25944	2713	35	or	or	CC
25944	2713	36	ulcer	ulcer	NN
25944	2713	37	.	.	.
25944	2714	1	The	the	DT
25944	2714	2	lesions	lesion	NNS
25944	2714	3	are	be	VBP
25944	2714	4	usually	usually	RB
25944	2714	5	numerous	numerous	JJ
25944	2714	6	,	,	,
25944	2714	7	and	and	CC
25944	2714	8	most	most	RBS
25944	2714	9	abundant	abundant	JJ
25944	2714	10	on	on	IN
25944	2714	11	the	the	DT
25944	2714	12	back	back	NN
25944	2714	13	,	,	,
25944	2714	14	shoulders	shoulder	NNS
25944	2714	15	and	and	CC
25944	2714	16	extremities	extremity	NNS
25944	2714	17	.	.	.
25944	2715	1	It	-PRON-	PRP
25944	2715	2	appears	appear	VBZ
25944	2715	3	,	,	,
25944	2715	4	as	as	IN
25944	2715	5	a	a	DT
25944	2715	6	rule	rule	NN
25944	2715	7	,	,	,
25944	2715	8	within	within	IN
25944	2715	9	the	the	DT
25944	2715	10	first	first	JJ
25944	2715	11	year	year	NN
25944	2715	12	,	,	,
25944	2715	13	and	and	CC
25944	2715	14	generally	generally	RB
25944	2715	15	runs	run	VBZ
25944	2715	16	a	a	DT
25944	2715	17	benign	benign	JJ
25944	2715	18	course	course	NN
25944	2715	19	.	.	.
25944	2716	1	[	[	-LRB-
25944	2716	2	Illustration	illustration	NN
25944	2716	3	:	:	:
25944	2716	4	Fig	Fig	NNP
25944	2716	5	.	.	.
25944	2717	1	55	55	CD
25944	2717	2	.	.	.
25944	2718	1	Rupia	Rupia	NNP
25944	2718	2	.	.	.
25944	2719	1	(	(	-LRB-
25944	2719	2	_	_	NNP
25944	2719	3	After	after	IN
25944	2719	4	Tilbury	Tilbury	NNP
25944	2719	5	Fox	Fox	NNP
25944	2719	6	.	.	.
25944	2719	7	_	_	NNP
25944	2719	8	)	)	-RRB-
25944	2719	9	]	]	-RRB-
25944	2719	10	In	in	IN
25944	2719	11	the	the	DT
25944	2719	12	other	other	JJ
25944	2719	13	type	type	NN
25944	2719	14	--	--	:
25944	2719	15	the	the	DT
25944	2719	16	deep	deep	JJ
25944	2719	17	variety	variety	NN
25944	2719	18	--	--	:
25944	2719	19	the	the	DT
25944	2719	20	crust	crust	NN
25944	2719	21	is	be	VBZ
25944	2719	22	greenish	greenish	JJ
25944	2719	23	or	or	CC
25944	2719	24	blackish	blackish	NN
25944	2719	25	,	,	,
25944	2719	26	is	be	VBZ
25944	2719	27	raised	raise	VBN
25944	2719	28	and	and	CC
25944	2719	29	more	more	JJR
25944	2719	30	bulky	bulky	JJ
25944	2719	31	,	,	,
25944	2719	32	often	often	RB
25944	2719	33	conical	conical	JJ
25944	2719	34	and	and	CC
25944	2719	35	stratified	stratified	JJ
25944	2719	36	,	,	,
25944	2719	37	like	like	IN
25944	2719	38	an	an	DT
25944	2719	39	oyster	oyster	NN
25944	2719	40	shell--_rupia	shell--_rupia	NNP
25944	2719	41	_	_	NNP
25944	2719	42	;	;	:
25944	2719	43	beneath	beneath	IN
25944	2719	44	the	the	DT
25944	2719	45	crusts	crust	NNS
25944	2719	46	may	may	MD
25944	2719	47	be	be	VB
25944	2719	48	seen	see	VBN
25944	2719	49	rounded	rounded	JJ
25944	2719	50	or	or	CC
25944	2719	51	irregular	irregular	JJ
25944	2719	52	-	-	HYPH
25944	2719	53	shaped	shape	VBN
25944	2719	54	ulcers	ulcer	NNS
25944	2719	55	,	,	,
25944	2719	56	having	have	VBG
25944	2719	57	a	a	DT
25944	2719	58	greenish	greenish	NN
25944	2719	59	-	-	HYPH
25944	2719	60	yellow	yellow	JJ
25944	2719	61	,	,	,
25944	2719	62	puriform	puriform	NN
25944	2719	63	secretion	secretion	NN
25944	2719	64	.	.	.
25944	2720	1	It	-PRON-	PRP
25944	2720	2	is	be	VBZ
25944	2720	3	usually	usually	RB
25944	2720	4	a	a	DT
25944	2720	5	late	late	JJ
25944	2720	6	and	and	CC
25944	2720	7	malignant	malignant	JJ
25944	2720	8	manifestation	manifestation	NN
25944	2720	9	.	.	.
25944	2721	1	#	#	NNP
25944	2721	2	How	how	WRB
25944	2721	3	would	would	MD
25944	2721	4	you	-PRON-	PRP
25944	2721	5	differentiate	differentiate	VB
25944	2721	6	the	the	DT
25944	2721	7	large	large	JJ
25944	2721	8	flat	flat	JJ
25944	2721	9	-	-	HYPH
25944	2721	10	pustular	pustular	JJ
25944	2721	11	syphiloderm	syphiloderm	NN
25944	2721	12	from	from	IN
25944	2721	13	ecthyma	ecthyma	NN
25944	2721	14	?	?	.
25944	2721	15	#	#	$
25944	2721	16	The	the	DT
25944	2721	17	syphilitic	syphilitic	JJ
25944	2721	18	lesions	lesion	NNS
25944	2721	19	are	be	VBP
25944	2721	20	more	more	RBR
25944	2721	21	numerous	numerous	JJ
25944	2721	22	,	,	,
25944	2721	23	are	be	VBP
25944	2721	24	scattered	scatter	VBN
25944	2721	25	,	,	,
25944	2721	26	are	be	VBP
25944	2721	27	attended	attend	VBN
25944	2721	28	with	with	IN
25944	2721	29	superficial	superficial	JJ
25944	2721	30	or	or	CC
25944	2721	31	deep	deep	JJ
25944	2721	32	ulceration	ulceration	NN
25944	2721	33	,	,	,
25944	2721	34	and	and	CC
25944	2721	35	followed	follow	VBN
25944	2721	36	by	by	IN
25944	2721	37	more	more	JJR
25944	2721	38	or	or	CC
25944	2721	39	less	less	JJR
25944	2721	40	scar	scar	NN
25944	2721	41	-	-	HYPH
25944	2721	42	formation	formation	NN
25944	2721	43	.	.	.
25944	2722	1	Moreover	moreover	RB
25944	2722	2	,	,	,
25944	2722	3	the	the	DT
25944	2722	4	history	history	NN
25944	2722	5	,	,	,
25944	2722	6	and	and	CC
25944	2722	7	presence	presence	NN
25944	2722	8	or	or	CC
25944	2722	9	absence	absence	NN
25944	2722	10	of	of	IN
25944	2722	11	other	other	JJ
25944	2722	12	symptoms	symptom	NNS
25944	2722	13	of	of	IN
25944	2722	14	syphilis	syphilis	NNP
25944	2722	15	have	have	VBP
25944	2722	16	an	an	DT
25944	2722	17	important	important	JJ
25944	2722	18	diagnostic	diagnostic	JJ
25944	2722	19	value	value	NN
25944	2722	20	.	.	.
25944	2723	1	[	[	-LRB-
25944	2723	2	Illustration	illustration	NN
25944	2723	3	:	:	:
25944	2723	4	Fig	Fig	NNP
25944	2723	5	.	.	.
25944	2724	1	56	56	CD
25944	2724	2	.	.	.
25944	2725	1	Ulcerating	ulcerate	VBG
25944	2725	2	Tubercular	Tubercular	NNP
25944	2725	3	Syphiloderm	Syphiloderm	NNP
25944	2725	4	.	.	.
25944	2725	5	]	]	-RRB-
25944	2726	1	#	#	NNP
25944	2726	2	Describe	describe	VB
25944	2726	3	the	the	DT
25944	2726	4	bullous	bullous	JJ
25944	2726	5	eruption	eruption	NN
25944	2726	6	of	of	IN
25944	2726	7	syphilis	syphilis	NNP
25944	2726	8	.	.	.
25944	2726	9	#	#	$
25944	2726	10	The	the	DT
25944	2726	11	_	_	NNP
25944	2726	12	bullous	bullous	JJ
25944	2726	13	syphiloderm	syphiloderm	NN
25944	2726	14	_	_	NNP
25944	2726	15	,	,	,
25944	2726	16	(	(	-LRB-
25944	2726	17	of	of	IN
25944	2726	18	acquired	acquire	VBN
25944	2726	19	syphilis	syphilis	NNP
25944	2726	20	)	)	-RRB-
25944	2726	21	is	be	VBZ
25944	2726	22	a	a	DT
25944	2726	23	rare	rare	JJ
25944	2726	24	and	and	CC
25944	2726	25	usually	usually	RB
25944	2726	26	late	late	JJ
25944	2726	27	eruption	eruption	NN
25944	2726	28	,	,	,
25944	2726	29	appearing	appear	VBG
25944	2726	30	in	in	IN
25944	2726	31	the	the	DT
25944	2726	32	form	form	NN
25944	2726	33	of	of	IN
25944	2726	34	discrete	discrete	JJ
25944	2726	35	,	,	,
25944	2726	36	disseminated	disseminate	VBN
25944	2726	37	,	,	,
25944	2726	38	rounded	rounded	JJ
25944	2726	39	or	or	CC
25944	2726	40	ovalish	ovalish	JJ
25944	2726	41	,	,	,
25944	2726	42	pea-	pea-	RB
25944	2726	43	to	to	IN
25944	2726	44	walnut	walnut	NN
25944	2726	45	-	-	HYPH
25944	2726	46	sized	sized	JJ
25944	2726	47	,	,	,
25944	2726	48	partially	partially	RB
25944	2726	49	or	or	CC
25944	2726	50	fully	fully	RB
25944	2726	51	distended	distend	VBN
25944	2726	52	,	,	,
25944	2726	53	blebs	blebs	NN
25944	2726	54	.	.	.
25944	2727	1	The	the	DT
25944	2727	2	serous	serous	JJ
25944	2727	3	contents	content	NNS
25944	2727	4	soon	soon	RB
25944	2727	5	become	become	VBP
25944	2727	6	cloudy	cloudy	JJ
25944	2727	7	and	and	CC
25944	2727	8	puriform	puriform	NN
25944	2727	9	.	.	.
25944	2728	1	In	in	IN
25944	2728	2	some	some	DT
25944	2728	3	cases	case	NNS
25944	2728	4	the	the	DT
25944	2728	5	lesions	lesion	NNS
25944	2728	6	are	be	VBP
25944	2728	7	distinctly	distinctly	RB
25944	2728	8	pustular	pustular	JJ
25944	2728	9	from	from	IN
25944	2728	10	the	the	DT
25944	2728	11	beginning	beginning	NN
25944	2728	12	.	.	.
25944	2729	1	The	the	DT
25944	2729	2	crust	crust	NN
25944	2729	3	,	,	,
25944	2729	4	which	which	WDT
25944	2729	5	soon	soon	RB
25944	2729	6	forms	form	VBZ
25944	2729	7	,	,	,
25944	2729	8	is	be	VBZ
25944	2729	9	of	of	IN
25944	2729	10	a	a	DT
25944	2729	11	yellowish	yellowish	JJ
25944	2729	12	-	-	HYPH
25944	2729	13	brown	brown	JJ
25944	2729	14	or	or	CC
25944	2729	15	dark	dark	JJ
25944	2729	16	green	green	JJ
25944	2729	17	color	color	NN
25944	2729	18	,	,	,
25944	2729	19	and	and	CC
25944	2729	20	may	may	MD
25944	2729	21	be	be	VB
25944	2729	22	thick	thick	JJ
25944	2729	23	and	and	CC
25944	2729	24	stratified	stratified	JJ
25944	2729	25	(	(	-LRB-
25944	2729	26	_	_	NNP
25944	2729	27	rupia	rupia	NN
25944	2729	28	_	_	NNP
25944	2729	29	)	)	-RRB-
25944	2729	30	,	,	,
25944	2729	31	as	as	IN
25944	2729	32	in	in	IN
25944	2729	33	the	the	DT
25944	2729	34	deep	deep	JJ
25944	2729	35	variety	variety	NN
25944	2729	36	of	of	IN
25944	2729	37	the	the	DT
25944	2729	38	large	large	JJ
25944	2729	39	flat	flat	JJ
25944	2729	40	-	-	HYPH
25944	2729	41	pustular	pustular	JJ
25944	2729	42	syphiloderm	syphiloderm	NN
25944	2729	43	.	.	.
25944	2730	1	The	the	DT
25944	2730	2	erosions	erosion	NNS
25944	2730	3	or	or	CC
25944	2730	4	ulcers	ulcer	NNS
25944	2730	5	beneath	beneath	IN
25944	2730	6	the	the	DT
25944	2730	7	crusts	crust	NNS
25944	2730	8	secrete	secrete	VBP
25944	2730	9	a	a	DT
25944	2730	10	greenish	greenish	JJ
25944	2730	11	-	-	HYPH
25944	2730	12	yellow	yellow	JJ
25944	2730	13	fluid	fluid	NN
25944	2730	14	.	.	.
25944	2731	1	It	-PRON-	PRP
25944	2731	2	is	be	VBZ
25944	2731	3	a	a	DT
25944	2731	4	malignant	malignant	JJ
25944	2731	5	type	type	NN
25944	2731	6	of	of	IN
25944	2731	7	eruption	eruption	NN
25944	2731	8	,	,	,
25944	2731	9	and	and	CC
25944	2731	10	is	be	VBZ
25944	2731	11	usually	usually	RB
25944	2731	12	seen	see	VBN
25944	2731	13	in	in	IN
25944	2731	14	broken	break	VBN
25944	2731	15	-	-	HYPH
25944	2731	16	down	down	RP
25944	2731	17	subjects	subject	NNS
25944	2731	18	.	.	.
25944	2732	1	It	-PRON-	PRP
25944	2732	2	is	be	VBZ
25944	2732	3	not	not	RB
25944	2732	4	an	an	DT
25944	2732	5	uncommon	uncommon	JJ
25944	2732	6	manifestation	manifestation	NN
25944	2732	7	of	of	IN
25944	2732	8	hereditary	hereditary	JJ
25944	2732	9	syphilis	syphilis	NNP
25944	2732	10	(	(	-LRB-
25944	2732	11	_	_	NNP
25944	2732	12	q	q	NNP
25944	2732	13	.	.	.
25944	2733	1	v.	v.	NNP
25944	2733	2	_	_	NNP
25944	2733	3	)	)	-RRB-
25944	2733	4	in	in	IN
25944	2733	5	the	the	DT
25944	2733	6	newborn	newborn	JJ
25944	2733	7	.	.	.
25944	2734	1	[	[	-LRB-
25944	2734	2	Illustration	illustration	NN
25944	2734	3	:	:	:
25944	2734	4	Fig	Fig	NNP
25944	2734	5	.	.	.
25944	2735	1	57	57	CD
25944	2735	2	.	.	.
25944	2736	1	Tubercular	Tubercular	NNP
25944	2736	2	Syphiloderm	Syphiloderm	NNP
25944	2736	3	.	.	.
25944	2736	4	]	]	-RRB-
25944	2737	1	#	#	NNP
25944	2737	2	How	how	WRB
25944	2737	3	is	be	VBZ
25944	2737	4	the	the	DT
25944	2737	5	bullous	bullous	JJ
25944	2737	6	syphiloderm	syphiloderm	NN
25944	2737	7	to	to	TO
25944	2737	8	be	be	VB
25944	2737	9	differentiated	differentiate	VBN
25944	2737	10	from	from	IN
25944	2737	11	other	other	JJ
25944	2737	12	pemphigoid	pemphigoid	JJ
25944	2737	13	eruptions	eruption	NNS
25944	2737	14	?	?	.
25944	2737	15	#	#	NN
25944	2737	16	By	by	IN
25944	2737	17	the	the	DT
25944	2737	18	gravity	gravity	NN
25944	2737	19	of	of	IN
25944	2737	20	the	the	DT
25944	2737	21	disease	disease	NN
25944	2737	22	,	,	,
25944	2737	23	the	the	DT
25944	2737	24	accompanying	accompany	VBG
25944	2737	25	ulceration	ulceration	NN
25944	2737	26	,	,	,
25944	2737	27	the	the	DT
25944	2737	28	course	course	NN
25944	2737	29	and	and	CC
25944	2737	30	history	history	NN
25944	2737	31	;	;	,
25944	2737	32	and	and	CC
25944	2737	33	by	by	IN
25944	2737	34	other	other	JJ
25944	2737	35	evidences	evidence	NNS
25944	2737	36	,	,	,
25944	2737	37	past	past	JJ
25944	2737	38	or	or	CC
25944	2737	39	present	present	JJ
25944	2737	40	,	,	,
25944	2737	41	of	of	IN
25944	2737	42	syphilis	syphilis	NNP
25944	2737	43	.	.	.
25944	2738	1	#	#	NNP
25944	2738	2	Describe	describe	VB
25944	2738	3	the	the	DT
25944	2738	4	tubercular	tubercular	JJ
25944	2738	5	eruption	eruption	NN
25944	2738	6	of	of	IN
25944	2738	7	syphilis	syphilis	NNP
25944	2738	8	.	.	.
25944	2738	9	#	#	$
25944	2738	10	The	the	DT
25944	2738	11	_	_	NNP
25944	2738	12	tubercular	tubercular	JJ
25944	2738	13	syphiloderm	syphiloderm	NN
25944	2738	14	_	_	NNP
25944	2738	15	(	(	-LRB-
25944	2738	16	_	_	NNP
25944	2738	17	syphiloderma	syphiloderma	NNP
25944	2738	18	tuberculosum	tuberculosum	NNP
25944	2738	19	_	_	NNP
25944	2738	20	)	)	-RRB-
25944	2738	21	may	may	MD
25944	2738	22	exceptionally	exceptionally	RB
25944	2738	23	occur	occur	VB
25944	2738	24	within	within	IN
25944	2738	25	the	the	DT
25944	2738	26	first	first	JJ
25944	2738	27	year	year	NN
25944	2738	28	as	as	IN
25944	2738	29	a	a	DT
25944	2738	30	more	more	RBR
25944	2738	31	or	or	CC
25944	2738	32	less	less	RBR
25944	2738	33	generalized	generalized	JJ
25944	2738	34	eruption	eruption	NN
25944	2738	35	.	.	.
25944	2739	1	As	as	IN
25944	2739	2	a	a	DT
25944	2739	3	rule	rule	NN
25944	2739	4	,	,	,
25944	2739	5	however	however	RB
25944	2739	6	,	,	,
25944	2739	7	it	-PRON-	PRP
25944	2739	8	is	be	VBZ
25944	2739	9	a	a	DT
25944	2739	10	late	late	JJ
25944	2739	11	manifestation	manifestation	NN
25944	2739	12	,	,	,
25944	2739	13	at	at	IN
25944	2739	14	times	time	NNS
25944	2739	15	appearing	appear	VBG
25944	2739	16	many	many	JJ
25944	2739	17	years	year	NNS
25944	2739	18	after	after	IN
25944	2739	19	the	the	DT
25944	2739	20	initial	initial	JJ
25944	2739	21	lesion	lesion	NN
25944	2739	22	;	;	:
25944	2739	23	is	be	VBZ
25944	2739	24	limited	limit	VBN
25944	2739	25	in	in	IN
25944	2739	26	extent	extent	NN
25944	2739	27	,	,	,
25944	2739	28	and	and	CC
25944	2739	29	shows	show	VBZ
25944	2739	30	a	a	DT
25944	2739	31	decided	decided	JJ
25944	2739	32	tendency	tendency	NN
25944	2739	33	to	to	TO
25944	2739	34	occur	occur	VB
25944	2739	35	in	in	IN
25944	2739	36	groups	group	NNS
25944	2739	37	,	,	,
25944	2739	38	often	often	RB
25944	2739	39	forming	form	VBG
25944	2739	40	segments	segment	NNS
25944	2739	41	of	of	IN
25944	2739	42	circles	circle	NNS
25944	2739	43	and	and	CC
25944	2739	44	circular	circular	JJ
25944	2739	45	areas	area	NNS
25944	2739	46	,	,	,
25944	2739	47	clearing	clear	VBG
25944	2739	48	in	in	IN
25944	2739	49	the	the	DT
25944	2739	50	centre	centre	NN
25944	2739	51	and	and	CC
25944	2739	52	spreading	spread	VBG
25944	2739	53	peripherally	peripherally	RB
25944	2739	54	.	.	.
25944	2740	1	It	-PRON-	PRP
25944	2740	2	consists	consist	VBZ
25944	2740	3	(	(	-LRB-
25944	2740	4	as	as	IN
25944	2740	5	a	a	DT
25944	2740	6	late	late	JJ
25944	2740	7	,	,	,
25944	2740	8	limited	limited	JJ
25944	2740	9	manifestation	manifestation	NN
25944	2740	10	)	)	-RRB-
25944	2740	11	of	of	IN
25944	2740	12	several	several	JJ
25944	2740	13	or	or	CC
25944	2740	14	more	more	RBR
25944	2740	15	firm	firm	JJ
25944	2740	16	,	,	,
25944	2740	17	circumscribed	circumscribe	VBN
25944	2740	18	,	,	,
25944	2740	19	deeply	deeply	RB
25944	2740	20	-	-	HYPH
25944	2740	21	seated	seated	JJ
25944	2740	22	,	,	,
25944	2740	23	smooth	smooth	JJ
25944	2740	24	,	,	,
25944	2740	25	glistening	glistening	NN
25944	2740	26	or	or	CC
25944	2740	27	slightly	slightly	RB
25944	2740	28	scaly	scaly	IN
25944	2740	29	elevations	elevation	NNS
25944	2740	30	;	;	,
25944	2740	31	rounded	rounded	JJ
25944	2740	32	or	or	CC
25944	2740	33	acuminated	acuminate	VBN
25944	2740	34	in	in	IN
25944	2740	35	shape	shape	NN
25944	2740	36	,	,	,
25944	2740	37	of	of	IN
25944	2740	38	a	a	DT
25944	2740	39	yellowish	yellowish	JJ
25944	2740	40	-	-	HYPH
25944	2740	41	red	red	JJ
25944	2740	42	,	,	,
25944	2740	43	brownish	brownish	NN
25944	2740	44	-	-	HYPH
25944	2740	45	red	red	JJ
25944	2740	46	or	or	CC
25944	2740	47	coppery	coppery	NN
25944	2740	48	color	color	NN
25944	2740	49	and	and	CC
25944	2740	50	usually	usually	RB
25944	2740	51	of	of	IN
25944	2740	52	the	the	DT
25944	2740	53	size	size	NN
25944	2740	54	of	of	IN
25944	2740	55	small	small	JJ
25944	2740	56	or	or	CC
25944	2740	57	large	large	JJ
25944	2740	58	peas	pea	NNS
25944	2740	59	.	.	.
25944	2741	1	Several	several	JJ
25944	2741	2	groups	group	NNS
25944	2741	3	may	may	MD
25944	2741	4	coalesce	coalesce	VB
25944	2741	5	,	,	,
25944	2741	6	and	and	CC
25944	2741	7	a	a	DT
25944	2741	8	serpiginous	serpiginous	JJ
25944	2741	9	tract	tract	NN
25944	2741	10	result	result	NN
25944	2741	11	(	(	-LRB-
25944	2741	12	_	_	NNP
25944	2741	13	serpiginous	serpiginous	JJ
25944	2741	14	tubercular	tubercular	JJ
25944	2741	15	syphiloderm	syphiloderm	NN
25944	2741	16	_	_	NNP
25944	2741	17	)	)	-RRB-
25944	2741	18	.	.	.
25944	2742	1	The	the	DT
25944	2742	2	lesions	lesion	NNS
25944	2742	3	develop	develop	VBP
25944	2742	4	slowly	slowly	RB
25944	2742	5	,	,	,
25944	2742	6	and	and	CC
25944	2742	7	are	be	VBP
25944	2742	8	sluggish	sluggish	JJ
25944	2742	9	in	in	IN
25944	2742	10	their	-PRON-	PRP$
25944	2742	11	course	course	NN
25944	2742	12	,	,	,
25944	2742	13	remaining	remain	VBG
25944	2742	14	,	,	,
25944	2742	15	at	at	IN
25944	2742	16	times	time	NNS
25944	2742	17	,	,	,
25944	2742	18	for	for	IN
25944	2742	19	weeks	week	NNS
25944	2742	20	or	or	CC
25944	2742	21	months	month	NNS
25944	2742	22	,	,	,
25944	2742	23	with	with	IN
25944	2742	24	but	but	CC
25944	2742	25	little	little	JJ
25944	2742	26	change	change	NN
25944	2742	27	.	.	.
25944	2743	1	As	as	IN
25944	2743	2	a	a	DT
25944	2743	3	rule	rule	NN
25944	2743	4	,	,	,
25944	2743	5	however	however	RB
25944	2743	6	,	,	,
25944	2743	7	they	-PRON-	PRP
25944	2743	8	terminate	terminate	VBP
25944	2743	9	sooner	soon	RBR
25944	2743	10	or	or	CC
25944	2743	11	later	later	RBR
25944	2743	12	,	,	,
25944	2743	13	either	either	CC
25944	2743	14	by	by	IN
25944	2743	15	absorption	absorption	NN
25944	2743	16	,	,	,
25944	2743	17	leaving	leave	VBG
25944	2743	18	a	a	DT
25944	2743	19	more	more	RBR
25944	2743	20	or	or	CC
25944	2743	21	less	less	RBR
25944	2743	22	permanent	permanent	JJ
25944	2743	23	pigment	pigment	NN
25944	2743	24	stain	stain	NN
25944	2743	25	with	with	IN
25944	2743	26	or	or	CC
25944	2743	27	without	without	IN
25944	2743	28	slight	slight	JJ
25944	2743	29	atrophy	atrophy	NN
25944	2743	30	(	(	-LRB-
25944	2743	31	_	_	NNP
25944	2743	32	non	non	JJ
25944	2743	33	-	-	JJ
25944	2743	34	ulcerating	ulcerating	JJ
25944	2743	35	tubercular	tubercular	JJ
25944	2743	36	syphiloderm	syphiloderm	NN
25944	2743	37	_	_	NNP
25944	2743	38	)	)	-RRB-
25944	2743	39	,	,	,
25944	2743	40	or	or	CC
25944	2743	41	by	by	IN
25944	2743	42	ulceration	ulceration	NN
25944	2743	43	(	(	-LRB-
25944	2743	44	_	_	NNP
25944	2743	45	ulcerating	ulcerate	VBG
25944	2743	46	tubercular	tubercular	JJ
25944	2743	47	syphiloderm	syphiloderm	NN
25944	2743	48	_	_	NNP
25944	2743	49	)	)	-RRB-
25944	2743	50	.	.	.
25944	2744	1	[	[	-LRB-
25944	2744	2	Illustration	illustration	NN
25944	2744	3	:	:	:
25944	2744	4	Fig	Fig	NNP
25944	2744	5	.	.	.
25944	2745	1	58	58	CD
25944	2745	2	.	.	.
25944	2746	1	Ulcerating	ulcerate	VBG
25944	2746	2	Tubercular	Tubercular	NNP
25944	2746	3	Syphiloderm	Syphiloderm	NNP
25944	2746	4	.	.	.
25944	2746	5	]	]	-RRB-
25944	2747	1	#	#	NNP
25944	2747	2	Describe	describe	VB
25944	2747	3	the	the	DT
25944	2747	4	ulcerating	ulcerating	JJ
25944	2747	5	tubercular	tubercular	JJ
25944	2747	6	syphiloderm	syphiloderm	NN
25944	2747	7	.	.	.
25944	2747	8	#	#	$
25944	2747	9	The	the	DT
25944	2747	10	ulceration	ulceration	NN
25944	2747	11	may	may	MD
25944	2747	12	be	be	VB
25944	2747	13	superficial	superficial	JJ
25944	2747	14	or	or	CC
25944	2747	15	deep	deep	JJ
25944	2747	16	in	in	IN
25944	2747	17	character	character	NN
25944	2747	18	,	,	,
25944	2747	19	and	and	CC
25944	2747	20	involve	involve	VBP
25944	2747	21	several	several	JJ
25944	2747	22	or	or	CC
25944	2747	23	all	all	DT
25944	2747	24	of	of	IN
25944	2747	25	the	the	DT
25944	2747	26	lesions	lesion	NNS
25944	2747	27	forming	form	VBG
25944	2747	28	the	the	DT
25944	2747	29	group	group	NN
25944	2747	30	.	.	.
25944	2748	1	The	the	DT
25944	2748	2	patch	patch	NN
25944	2748	3	may	may	MD
25944	2748	4	consist	consist	VB
25944	2748	5	,	,	,
25944	2748	6	therefore	therefore	RB
25944	2748	7	,	,	,
25944	2748	8	of	of	IN
25944	2748	9	small	small	JJ
25944	2748	10	,	,	,
25944	2748	11	discrete	discrete	JJ
25944	2748	12	,	,	,
25944	2748	13	punched	punch	VBN
25944	2748	14	-	-	HYPH
25944	2748	15	out	out	RP
25944	2748	16	ulcers	ulcer	NNS
25944	2748	17	,	,	,
25944	2748	18	or	or	CC
25944	2748	19	of	of	IN
25944	2748	20	one	one	CD
25944	2748	21	or	or	CC
25944	2748	22	more	more	JJR
25944	2748	23	continuous	continuous	JJ
25944	2748	24	ulcers	ulcer	NNS
25944	2748	25	,	,	,
25944	2748	26	segmented	segmented	JJ
25944	2748	27	,	,	,
25944	2748	28	crescentic	crescentic	JJ
25944	2748	29	or	or	CC
25944	2748	30	serpiginous	serpiginous	JJ
25944	2748	31	in	in	IN
25944	2748	32	shape	shape	NN
25944	2748	33	.	.	.
25944	2749	1	They	-PRON-	PRP
25944	2749	2	are	be	VBP
25944	2749	3	covered	cover	VBN
25944	2749	4	with	with	IN
25944	2749	5	a	a	DT
25944	2749	6	gummy	gummy	JJ
25944	2749	7	,	,	,
25944	2749	8	grayish	grayish	NN
25944	2749	9	-	-	HYPH
25944	2749	10	yellow	yellow	JJ
25944	2749	11	deposit	deposit	NN
25944	2749	12	or	or	CC
25944	2749	13	they	-PRON-	PRP
25944	2749	14	may	may	MD
25944	2749	15	be	be	VB
25944	2749	16	crusted	crust	VBN
25944	2749	17	.	.	.
25944	2750	1	As	as	IN
25944	2750	2	the	the	DT
25944	2750	3	ulcerative	ulcerative	JJ
25944	2750	4	changes	change	NNS
25944	2750	5	take	take	VBP
25944	2750	6	place	place	NN
25944	2750	7	,	,	,
25944	2750	8	new	new	JJ
25944	2750	9	lesions	lesion	NNS
25944	2750	10	,	,	,
25944	2750	11	especially	especially	RB
25944	2750	12	about	about	IN
25944	2750	13	the	the	DT
25944	2750	14	periphery	periphery	NN
25944	2750	15	of	of	IN
25944	2750	16	the	the	DT
25944	2750	17	group	group	NN
25944	2750	18	or	or	CC
25944	2750	19	patch	patch	NN
25944	2750	20	,	,	,
25944	2750	21	may	may	MD
25944	2750	22	appear	appear	VB
25944	2750	23	from	from	IN
25944	2750	24	time	time	NN
25944	2750	25	to	to	IN
25944	2750	26	time	time	NN
25944	2750	27	.	.	.
25944	2751	1	[	[	-LRB-
25944	2751	2	Illustration	illustration	NN
25944	2751	3	:	:	:
25944	2751	4	Tubercular	Tubercular	NNP
25944	2751	5	Syphiloderm	Syphiloderm	NNP
25944	2751	6	.	.	.
25944	2751	7	]	]	-RRB-
25944	2752	1	[	[	-LRB-
25944	2752	2	Illustration	illustration	NN
25944	2752	3	:	:	:
25944	2752	4	Large	large	JJ
25944	2752	5	-	-	HYPH
25944	2752	6	pustular	pustular	NN
25944	2752	7	Syphiloderm	Syphiloderm	NNP
25944	2752	8	.	.	.
25944	2752	9	]	]	-RRB-
25944	2753	1	In	in	IN
25944	2753	2	some	some	DT
25944	2753	3	instances	instance	NNS
25944	2753	4	,	,	,
25944	2753	5	more	more	RBR
25944	2753	6	especially	especially	RB
25944	2753	7	about	about	IN
25944	2753	8	the	the	DT
25944	2753	9	scalp	scalp	NN
25944	2753	10	,	,	,
25944	2753	11	the	the	DT
25944	2753	12	surface	surface	NN
25944	2753	13	of	of	IN
25944	2753	14	the	the	DT
25944	2753	15	ulcerations	ulceration	NNS
25944	2753	16	becomes	become	VBZ
25944	2753	17	papillary	papillary	JJ
25944	2753	18	or	or	CC
25944	2753	19	wart	wart	JJ
25944	2753	20	-	-	HYPH
25944	2753	21	like	like	JJ
25944	2753	22	,	,	,
25944	2753	23	with	with	IN
25944	2753	24	an	an	DT
25944	2753	25	offensive	offensive	JJ
25944	2753	26	,	,	,
25944	2753	27	yellowish	yellowish	JJ
25944	2753	28	,	,	,
25944	2753	29	puriform	puriform	NN
25944	2753	30	secretion	secretion	NN
25944	2753	31	(	(	-LRB-
25944	2753	32	_	_	NNP
25944	2753	33	syphilis	syphilis	NNP
25944	2753	34	cutanea	cutanea	NNP
25944	2753	35	papillomatosa	papillomatosa	NNP
25944	2753	36	_	_	NNP
25944	2753	37	)	)	-RRB-
25944	2753	38	.	.	.
25944	2754	1	#	#	$
25944	2754	2	From	from	IN
25944	2754	3	what	what	WP
25944	2754	4	diseases	disease	NNS
25944	2754	5	is	be	VBZ
25944	2754	6	the	the	DT
25944	2754	7	tubercular	tubercular	JJ
25944	2754	8	syphiloderm	syphiloderm	NN
25944	2754	9	to	to	TO
25944	2754	10	be	be	VB
25944	2754	11	differentiated	differentiate	VBN
25944	2754	12	?	?	.
25944	2754	13	#	#	$
25944	2754	14	From	from	IN
25944	2754	15	tubercular	tubercular	JJ
25944	2754	16	leprosy	leprosy	NN
25944	2754	17	,	,	,
25944	2754	18	epithelioma	epithelioma	NNP
25944	2754	19	and	and	CC
25944	2754	20	lupus	lupus	NNP
25944	2754	21	vulgaris	vulgaris	NNP
25944	2754	22	,	,	,
25944	2754	23	especially	especially	RB
25944	2754	24	the	the	DT
25944	2754	25	last	last	RB
25944	2754	26	-	-	HYPH
25944	2754	27	named	name	VBN
25944	2754	28	.	.	.
25944	2755	1	#	#	LS
25944	2755	2	What	what	WP
25944	2755	3	are	be	VBP
25944	2755	4	the	the	DT
25944	2755	5	chief	chief	JJ
25944	2755	6	diagnostic	diagnostic	JJ
25944	2755	7	characters	character	NNS
25944	2755	8	of	of	IN
25944	2755	9	the	the	DT
25944	2755	10	tubercular	tubercular	JJ
25944	2755	11	syphiloderm	syphiloderm	NN
25944	2755	12	?	?	.
25944	2755	13	#	#	$
25944	2755	14	The	the	DT
25944	2755	15	tendency	tendency	NN
25944	2755	16	to	to	TO
25944	2755	17	form	form	VB
25944	2755	18	segments	segment	NNS
25944	2755	19	,	,	,
25944	2755	20	crescents	crescent	NNS
25944	2755	21	and	and	CC
25944	2755	22	circles	circle	NNS
25944	2755	23	,	,	,
25944	2755	24	the	the	DT
25944	2755	25	color	color	NN
25944	2755	26	,	,	,
25944	2755	27	the	the	DT
25944	2755	28	pigmentation	pigmentation	NN
25944	2755	29	and	and	CC
25944	2755	30	ulceration	ulceration	NN
25944	2755	31	,	,	,
25944	2755	32	the	the	DT
25944	2755	33	history	history	NN
25944	2755	34	,	,	,
25944	2755	35	and	and	CC
25944	2755	36	not	not	RB
25944	2755	37	infrequently	infrequently	RB
25944	2755	38	marks	mark	NNS
25944	2755	39	or	or	CC
25944	2755	40	scars	scar	NNS
25944	2755	41	of	of	IN
25944	2755	42	former	former	JJ
25944	2755	43	eruptions	eruption	NNS
25944	2755	44	.	.	.
25944	2756	1	[	[	-LRB-
25944	2756	2	Illustration	illustration	NN
25944	2756	3	:	:	:
25944	2756	4	Fig	Fig	NNP
25944	2756	5	.	.	.
25944	2757	1	59	59	CD
25944	2757	2	.	.	.
25944	2758	1	Tubercular	Tubercular	NNP
25944	2758	2	Syphiloderm	Syphiloderm	NNP
25944	2758	3	.	.	.
25944	2758	4	]	]	-RRB-
25944	2759	1	#	#	NNP
25944	2759	2	Describe	describe	VB
25944	2759	3	the	the	DT
25944	2759	4	gummatous	gummatous	JJ
25944	2759	5	eruption	eruption	NN
25944	2759	6	of	of	IN
25944	2759	7	syphilis	syphilis	NNP
25944	2759	8	.	.	.
25944	2759	9	#	#	$
25944	2759	10	The	the	DT
25944	2759	11	_	_	NNP
25944	2759	12	gummatous	gummatous	JJ
25944	2759	13	syphiloderm	syphiloderm	NNP
25944	2759	14	_	_	NNP
25944	2759	15	(	(	-LRB-
25944	2759	16	_	_	NNP
25944	2759	17	syphiloderma	syphiloderma	NNP
25944	2759	18	gummatosum	gummatosum	NNP
25944	2759	19	_	_	NNP
25944	2759	20	,	,	,
25944	2759	21	_	_	NNP
25944	2759	22	gumma	gumma	NN
25944	2759	23	_	_	NNP
25944	2759	24	,	,	,
25944	2759	25	_	_	NNP
25944	2759	26	syphiloma	syphiloma	NNP
25944	2759	27	_	_	NNP
25944	2759	28	)	)	-RRB-
25944	2759	29	is	be	VBZ
25944	2759	30	usually	usually	RB
25944	2759	31	a	a	DT
25944	2759	32	late	late	JJ
25944	2759	33	manifestation	manifestation	NN
25944	2759	34	,	,	,
25944	2759	35	showing	show	VBG
25944	2759	36	itself	-PRON-	PRP
25944	2759	37	as	as	IN
25944	2759	38	one	one	CD
25944	2759	39	,	,	,
25944	2759	40	several	several	JJ
25944	2759	41	or	or	CC
25944	2759	42	more	more	RBR
25944	2759	43	painless	painless	JJ
25944	2759	44	or	or	CC
25944	2759	45	slightly	slightly	RB
25944	2759	46	painful	painful	JJ
25944	2759	47	,	,	,
25944	2759	48	rounded	rounded	JJ
25944	2759	49	or	or	CC
25944	2759	50	flat	flat	JJ
25944	2759	51	,	,	,
25944	2759	52	more	more	RBR
25944	2759	53	or	or	CC
25944	2759	54	less	less	RBR
25944	2759	55	circumscribed	circumscribe	VBN
25944	2759	56	tumors	tumor	NNS
25944	2759	57	;	;	:
25944	2759	58	they	-PRON-	PRP
25944	2759	59	are	be	VBP
25944	2759	60	slightly	slightly	RB
25944	2759	61	raised	raise	VBN
25944	2759	62	,	,	,
25944	2759	63	moderately	moderately	RB
25944	2759	64	firm	firm	JJ
25944	2759	65	,	,	,
25944	2759	66	and	and	CC
25944	2759	67	have	have	VBP
25944	2759	68	their	-PRON-	PRP$
25944	2759	69	seat	seat	NN
25944	2759	70	in	in	IN
25944	2759	71	the	the	DT
25944	2759	72	subcutaneous	subcutaneous	JJ
25944	2759	73	tissue	tissue	NN
25944	2759	74	.	.	.
25944	2760	1	They	-PRON-	PRP
25944	2760	2	tend	tend	VBP
25944	2760	3	to	to	TO
25944	2760	4	break	break	VB
25944	2760	5	down	down	RP
25944	2760	6	and	and	CC
25944	2760	7	ulcerate	ulcerate	JJ
25944	2760	8	.	.	.
25944	2761	1	The	the	DT
25944	2761	2	lesion	lesion	NN
25944	2761	3	begins	begin	VBZ
25944	2761	4	usually	usually	RB
25944	2761	5	as	as	IN
25944	2761	6	a	a	DT
25944	2761	7	pea	pea	JJ
25944	2761	8	-	-	HYPH
25944	2761	9	sized	sized	JJ
25944	2761	10	deposit	deposit	NN
25944	2761	11	or	or	CC
25944	2761	12	infiltration	infiltration	NN
25944	2761	13	,	,	,
25944	2761	14	and	and	CC
25944	2761	15	grows	grow	VBZ
25944	2761	16	slowly	slowly	RB
25944	2761	17	or	or	CC
25944	2761	18	rapidly	rapidly	RB
25944	2761	19	;	;	:
25944	2761	20	when	when	WRB
25944	2761	21	fully	fully	RB
25944	2761	22	developed	develop	VBD
25944	2761	23	it	-PRON-	PRP
25944	2761	24	may	may	MD
25944	2761	25	be	be	VB
25944	2761	26	the	the	DT
25944	2761	27	size	size	NN
25944	2761	28	of	of	IN
25944	2761	29	a	a	DT
25944	2761	30	walnut	walnut	NN
25944	2761	31	,	,	,
25944	2761	32	or	or	CC
25944	2761	33	even	even	RB
25944	2761	34	larger	large	JJR
25944	2761	35	.	.	.
25944	2762	1	The	the	DT
25944	2762	2	overlying	overlying	NN
25944	2762	3	skin	skin	NN
25944	2762	4	becomes	become	VBZ
25944	2762	5	gradually	gradually	RB
25944	2762	6	reddish	reddish	JJ
25944	2762	7	.	.	.
25944	2763	1	At	at	IN
25944	2763	2	first	first	JJ
25944	2763	3	firm	firm	NN
25944	2763	4	,	,	,
25944	2763	5	it	-PRON-	PRP
25944	2763	6	is	be	VBZ
25944	2763	7	later	later	RBR
25944	2763	8	soft	soft	JJ
25944	2763	9	and	and	CC
25944	2763	10	doughy	doughy	NN
25944	2763	11	.	.	.
25944	2764	1	It	-PRON-	PRP
25944	2764	2	may	may	MD
25944	2764	3	,	,	,
25944	2764	4	even	even	RB
25944	2764	5	when	when	WRB
25944	2764	6	well	well	RB
25944	2764	7	advanced	advanced	JJ
25944	2764	8	,	,	,
25944	2764	9	disappear	disappear	VB
25944	2764	10	by	by	IN
25944	2764	11	absorption	absorption	NN
25944	2764	12	,	,	,
25944	2764	13	but	but	CC
25944	2764	14	usually	usually	RB
25944	2764	15	tends	tend	VBZ
25944	2764	16	to	to	TO
25944	2764	17	break	break	VB
25944	2764	18	down	down	RP
25944	2764	19	,	,	,
25944	2764	20	terminating	terminate	VBG
25944	2764	21	in	in	IN
25944	2764	22	a	a	DT
25944	2764	23	small	small	JJ
25944	2764	24	or	or	CC
25944	2764	25	large	large	JJ
25944	2764	26	,	,	,
25944	2764	27	deep	deep	JJ
25944	2764	28	,	,	,
25944	2764	29	punched	punch	VBN
25944	2764	30	-	-	HYPH
25944	2764	31	out	out	RP
25944	2764	32	ulcer	ulcer	NN
25944	2764	33	.	.	.
25944	2765	1	[	[	-LRB-
25944	2765	2	Illustration	illustration	NN
25944	2765	3	:	:	:
25944	2765	4	Fig	Fig	NNP
25944	2765	5	.	.	.
25944	2766	1	60	60	CD
25944	2766	2	.	.	.
25944	2767	1	Tubercular	Tubercular	NNP
25944	2767	2	Syphiloderm	Syphiloderm	NNP
25944	2767	3	.	.	.
25944	2767	4	]	]	-RRB-
25944	2768	1	#	#	NN
25944	2768	2	Does	do	VBZ
25944	2768	3	the	the	DT
25944	2768	4	gummatous	gummatous	JJ
25944	2768	5	syphiloderm	syphiloderm	NN
25944	2768	6	invariably	invariably	RB
25944	2768	7	appear	appear	VBP
25944	2768	8	as	as	IN
25944	2768	9	a	a	DT
25944	2768	10	rounded	rounded	JJ
25944	2768	11	well	well	RB
25944	2768	12	-	-	HYPH
25944	2768	13	defined	define	VBN
25944	2768	14	tumor	tumor	NN
25944	2768	15	?	?	.
25944	2768	16	#	#	$
25944	2768	17	No	no	UH
25944	2768	18	.	.	.
25944	2769	1	Exceptionally	exceptionally	RB
25944	2769	2	,	,	,
25944	2769	3	instead	instead	RB
25944	2769	4	of	of	IN
25944	2769	5	a	a	DT
25944	2769	6	well	well	RB
25944	2769	7	-	-	HYPH
25944	2769	8	defined	define	VBN
25944	2769	9	tumor	tumor	NN
25944	2769	10	,	,	,
25944	2769	11	it	-PRON-	PRP
25944	2769	12	may	may	MD
25944	2769	13	appear	appear	VB
25944	2769	14	as	as	IN
25944	2769	15	a	a	DT
25944	2769	16	more	more	RBR
25944	2769	17	or	or	CC
25944	2769	18	less	less	RBR
25944	2769	19	diffused	diffused	JJ
25944	2769	20	patch	patch	NN
25944	2769	21	of	of	IN
25944	2769	22	infiltration	infiltration	NN
25944	2769	23	,	,	,
25944	2769	24	leading	lead	VBG
25944	2769	25	eventually	eventually	RB
25944	2769	26	to	to	IN
25944	2769	27	extensive	extensive	JJ
25944	2769	28	superficial	superficial	JJ
25944	2769	29	or	or	CC
25944	2769	30	deep	deep	JJ
25944	2769	31	ulceration	ulceration	NN
25944	2769	32	.	.	.
25944	2770	1	#	#	$
25944	2770	2	From	from	IN
25944	2770	3	what	what	WDT
25944	2770	4	formations	formation	NNS
25944	2770	5	is	be	VBZ
25944	2770	6	the	the	DT
25944	2770	7	gummatous	gummatous	JJ
25944	2770	8	syphiloderm	syphiloderm	NN
25944	2770	9	to	to	TO
25944	2770	10	be	be	VB
25944	2770	11	differentiated	differentiate	VBN
25944	2770	12	?	?	.
25944	2770	13	#	#	$
25944	2770	14	From	from	IN
25944	2770	15	furuncle	furuncle	NN
25944	2770	16	,	,	,
25944	2770	17	abscess	abscess	NN
25944	2770	18	,	,	,
25944	2770	19	and	and	CC
25944	2770	20	sebaceous	sebaceous	JJ
25944	2770	21	,	,	,
25944	2770	22	fatty	fatty	NN
25944	2770	23	and	and	CC
25944	2770	24	fibroid	fibroid	JJ
25944	2770	25	tumors	tumor	NNS
25944	2770	26	.	.	.
25944	2771	1	Attention	attention	NN
25944	2771	2	to	to	IN
25944	2771	3	the	the	DT
25944	2771	4	origin	origin	NN
25944	2771	5	,	,	,
25944	2771	6	course	course	NN
25944	2771	7	,	,	,
25944	2771	8	and	and	CC
25944	2771	9	behavior	behavior	NN
25944	2771	10	of	of	IN
25944	2771	11	the	the	DT
25944	2771	12	lesion	lesion	NN
25944	2771	13	,	,	,
25944	2771	14	together	together	RB
25944	2771	15	with	with	IN
25944	2771	16	a	a	DT
25944	2771	17	history	history	NN
25944	2771	18	,	,	,
25944	2771	19	must	must	MD
25944	2771	20	all	all	DT
25944	2771	21	be	be	VB
25944	2771	22	considered	consider	VBN
25944	2771	23	in	in	IN
25944	2771	24	doubtful	doubtful	JJ
25944	2771	25	cases	case	NNS
25944	2771	26	.	.	.
25944	2772	1	[	[	-LRB-
25944	2772	2	Illustration	illustration	NN
25944	2772	3	:	:	:
25944	2772	4	Fig	Fig	NNP
25944	2772	5	.	.	.
25944	2773	1	61	61	CD
25944	2773	2	.	.	.
25944	2774	1	Large	large	JJ
25944	2774	2	Pustular	Pustular	NNP
25944	2774	3	Syphiloderm	Syphiloderm	NNP
25944	2774	4	.	.	.
25944	2774	5	]	]	-RRB-
25944	2775	1	#	#	LS
25944	2775	2	What	what	WP
25944	2775	3	is	be	VBZ
25944	2775	4	to	to	TO
25944	2775	5	be	be	VB
25944	2775	6	said	say	VBN
25944	2775	7	in	in	IN
25944	2775	8	regard	regard	NN
25944	2775	9	to	to	IN
25944	2775	10	the	the	DT
25944	2775	11	character	character	NN
25944	2775	12	and	and	CC
25944	2775	13	time	time	NN
25944	2775	14	of	of	IN
25944	2775	15	appearance	appearance	NN
25944	2775	16	of	of	IN
25944	2775	17	the	the	DT
25944	2775	18	cutaneous	cutaneous	JJ
25944	2775	19	manifestations	manifestation	NNS
25944	2775	20	of	of	IN
25944	2775	21	hereditary	hereditary	JJ
25944	2775	22	syphilis	syphili	NNS
25944	2775	23	?	?	.
25944	2775	24	#	#	$
25944	2775	25	In	in	IN
25944	2775	26	a	a	DT
25944	2775	27	great	great	JJ
25944	2775	28	measure	measure	NN
25944	2775	29	the	the	DT
25944	2775	30	cutaneous	cutaneous	JJ
25944	2775	31	manifestations	manifestation	NNS
25944	2775	32	of	of	IN
25944	2775	33	hereditary	hereditary	JJ
25944	2775	34	syphilis	syphili	NNS
25944	2775	35	are	be	VBP
25944	2775	36	essentially	essentially	RB
25944	2775	37	the	the	DT
25944	2775	38	same	same	JJ
25944	2775	39	as	as	IN
25944	2775	40	observed	observe	VBN
25944	2775	41	in	in	IN
25944	2775	42	acquired	acquire	VBN
25944	2775	43	syphilis	syphilis	NNP
25944	2775	44	.	.	.
25944	2776	1	They	-PRON-	PRP
25944	2776	2	are	be	VBP
25944	2776	3	usually	usually	RB
25944	2776	4	noted	note	VBN
25944	2776	5	to	to	TO
25944	2776	6	occur	occur	VB
25944	2776	7	within	within	IN
25944	2776	8	the	the	DT
25944	2776	9	first	first	JJ
25944	2776	10	three	three	CD
25944	2776	11	months	month	NNS
25944	2776	12	of	of	IN
25944	2776	13	extra	extra	JJ
25944	2776	14	-	-	HYPH
25944	2776	15	uterine	uterine	JJ
25944	2776	16	life	life	NN
25944	2776	17	.	.	.
25944	2777	1	The	the	DT
25944	2777	2	macular	macular	JJ
25944	2777	3	,	,	,
25944	2777	4	papular	papular	JJ
25944	2777	5	,	,	,
25944	2777	6	and	and	CC
25944	2777	7	bullous	bullous	JJ
25944	2777	8	eruptions	eruption	NNS
25944	2777	9	are	be	VBP
25944	2777	10	most	most	RBS
25944	2777	11	common	common	JJ
25944	2777	12	.	.	.
25944	2778	1	#	#	NNP
25944	2778	2	Describe	describe	VB
25944	2778	3	these	these	DT
25944	2778	4	several	several	JJ
25944	2778	5	cutaneous	cutaneous	JJ
25944	2778	6	manifestations	manifestation	NNS
25944	2778	7	of	of	IN
25944	2778	8	hereditary	hereditary	JJ
25944	2778	9	syphilis	syphili	NNS
25944	2778	10	.	.	.
25944	2778	11	#	#	$
25944	2778	12	The	the	DT
25944	2778	13	_	_	NNP
25944	2778	14	macular	macular	JJ
25944	2778	15	_	_	NNP
25944	2778	16	(	(	-LRB-
25944	2778	17	erythematous	erythematous	JJ
25944	2778	18	)	)	-RRB-
25944	2778	19	eruption	eruption	NN
25944	2778	20	begins	begin	VBZ
25944	2778	21	as	as	RB
25944	2778	22	large	large	JJ
25944	2778	23	or	or	CC
25944	2778	24	small	small	JJ
25944	2778	25	,	,	,
25944	2778	26	bright-	bright-	JJ
25944	2778	27	or	or	CC
25944	2778	28	dark	dark	JJ
25944	2778	29	-	-	HYPH
25944	2778	30	red	red	JJ
25944	2778	31	macules	macule	NNS
25944	2778	32	,	,	,
25944	2778	33	later	later	RB
25944	2778	34	presenting	present	VBG
25944	2778	35	a	a	DT
25944	2778	36	ham	ham	NN
25944	2778	37	or	or	CC
25944	2778	38	café	café	NN
25944	2778	39	-	-	HYPH
25944	2778	40	au	au	NNP
25944	2778	41	-	-	HYPH
25944	2778	42	lait	lait	JJ
25944	2778	43	appearance	appearance	NN
25944	2778	44	.	.	.
25944	2779	1	At	at	IN
25944	2779	2	first	first	RB
25944	2779	3	they	-PRON-	PRP
25944	2779	4	disappear	disappear	VBP
25944	2779	5	upon	upon	IN
25944	2779	6	pressure	pressure	NN
25944	2779	7	.	.	.
25944	2780	1	The	the	DT
25944	2780	2	lesions	lesion	NNS
25944	2780	3	are	be	VBP
25944	2780	4	more	more	RBR
25944	2780	5	or	or	CC
25944	2780	6	less	less	RBR
25944	2780	7	numerous	numerous	JJ
25944	2780	8	,	,	,
25944	2780	9	usually	usually	RB
25944	2780	10	become	become	VBP
25944	2780	11	confluent	confluent	JJ
25944	2780	12	,	,	,
25944	2780	13	especially	especially	RB
25944	2780	14	about	about	IN
25944	2780	15	the	the	DT
25944	2780	16	folds	fold	NNS
25944	2780	17	of	of	IN
25944	2780	18	the	the	DT
25944	2780	19	neck	neck	NN
25944	2780	20	,	,	,
25944	2780	21	about	about	IN
25944	2780	22	the	the	DT
25944	2780	23	genitalia	genitalia	NNP
25944	2780	24	and	and	CC
25944	2780	25	buttocks	buttock	NNS
25944	2780	26	;	;	:
25944	2780	27	in	in	IN
25944	2780	28	these	these	DT
25944	2780	29	regions	region	NNS
25944	2780	30	resembling	resemble	VBG
25944	2780	31	somewhat	somewhat	RB
25944	2780	32	erythema	erythema	NNP
25944	2780	33	intertrigo	intertrigo	NNS
25944	2780	34	.	.	.
25944	2781	1	The	the	DT
25944	2781	2	_	_	NNP
25944	2781	3	papular	papular	JJ
25944	2781	4	_	_	NNP
25944	2781	5	eruption	eruption	NN
25944	2781	6	is	be	VBZ
25944	2781	7	observed	observe	VBN
25944	2781	8	in	in	IN
25944	2781	9	conjunction	conjunction	NN
25944	2781	10	with	with	IN
25944	2781	11	the	the	DT
25944	2781	12	erythematous	erythematous	JJ
25944	2781	13	manifestation	manifestation	NN
25944	2781	14	,	,	,
25944	2781	15	or	or	CC
25944	2781	16	it	-PRON-	PRP
25944	2781	17	occurs	occur	VBZ
25944	2781	18	alone	alone	RB
25944	2781	19	.	.	.
25944	2782	1	The	the	DT
25944	2782	2	lesions	lesion	NNS
25944	2782	3	are	be	VBP
25944	2782	4	but	but	CC
25944	2782	5	slightly	slightly	RB
25944	2782	6	elevated	elevated	JJ
25944	2782	7	,	,	,
25944	2782	8	and	and	CC
25944	2782	9	seem	seem	VBP
25944	2782	10	to	to	TO
25944	2782	11	partake	partake	VB
25944	2782	12	of	of	IN
25944	2782	13	the	the	DT
25944	2782	14	nature	nature	NN
25944	2782	15	of	of	IN
25944	2782	16	both	both	DT
25944	2782	17	macules	macule	NNS
25944	2782	18	and	and	CC
25944	2782	19	papules	papule	NNS
25944	2782	20	.	.	.
25944	2783	1	They	-PRON-	PRP
25944	2783	2	are	be	VBP
25944	2783	3	usually	usually	RB
25944	2783	4	discrete	discrete	JJ
25944	2783	5	,	,	,
25944	2783	6	and	and	CC
25944	2783	7	rarely	rarely	RB
25944	2783	8	abundant	abundant	JJ
25944	2783	9	;	;	:
25944	2783	10	they	-PRON-	PRP
25944	2783	11	may	may	MD
25944	2783	12	become	become	VB
25944	2783	13	decked	deck	VBN
25944	2783	14	with	with	IN
25944	2783	15	a	a	DT
25944	2783	16	film	film	NN
25944	2783	17	-	-	HYPH
25944	2783	18	like	like	JJ
25944	2783	19	scale	scale	NN
25944	2783	20	,	,	,
25944	2783	21	and	and	CC
25944	2783	22	at	at	IN
25944	2783	23	the	the	DT
25944	2783	24	various	various	JJ
25944	2783	25	points	point	NNS
25944	2783	26	of	of	IN
25944	2783	27	junction	junction	NN
25944	2783	28	of	of	IN
25944	2783	29	skin	skin	NN
25944	2783	30	and	and	CC
25944	2783	31	mucous	mucous	JJ
25944	2783	32	membrane	membrane	NN
25944	2783	33	,	,	,
25944	2783	34	and	and	CC
25944	2783	35	in	in	IN
25944	2783	36	the	the	DT
25944	2783	37	folds	fold	NNS
25944	2783	38	,	,	,
25944	2783	39	they	-PRON-	PRP
25944	2783	40	become	become	VBP
25944	2783	41	abraded	abraded	JJ
25944	2783	42	and	and	CC
25944	2783	43	macerated	macerate	VBN
25944	2783	44	,	,	,
25944	2783	45	developing	develop	VBG
25944	2783	46	into	into	IN
25944	2783	47	_	_	NNP
25944	2783	48	moist	moist	NN
25944	2783	49	papules	papule	NNS
25944	2783	50	_	_	NNP
25944	2783	51	.	.	.
25944	2784	1	The	the	DT
25944	2784	2	_	_	NNP
25944	2784	3	bullous	bullous	JJ
25944	2784	4	_	_	NNP
25944	2784	5	eruption	eruption	NN
25944	2784	6	consists	consist	VBZ
25944	2784	7	of	of	IN
25944	2784	8	variously	variously	RB
25944	2784	9	-	-	HYPH
25944	2784	10	sized	sized	JJ
25944	2784	11	,	,	,
25944	2784	12	more	more	RBR
25944	2784	13	or	or	CC
25944	2784	14	less	less	RBR
25944	2784	15	purulent	purulent	NN
25944	2784	16	blebs	blebs	NN
25944	2784	17	,	,	,
25944	2784	18	and	and	CC
25944	2784	19	is	be	VBZ
25944	2784	20	usually	usually	RB
25944	2784	21	met	meet	VBN
25944	2784	22	with	with	IN
25944	2784	23	at	at	IN
25944	2784	24	or	or	CC
25944	2784	25	immediately	immediately	RB
25944	2784	26	following	follow	VBG
25944	2784	27	birth	birth	NN
25944	2784	28	.	.	.
25944	2785	1	It	-PRON-	PRP
25944	2785	2	is	be	VBZ
25944	2785	3	most	most	RBS
25944	2785	4	abundant	abundant	JJ
25944	2785	5	about	about	IN
25944	2785	6	the	the	DT
25944	2785	7	hands	hand	NNS
25944	2785	8	and	and	CC
25944	2785	9	feet	foot	NNS
25944	2785	10	.	.	.
25944	2786	1	Macules	macule	NNS
25944	2786	2	and	and	CC
25944	2786	3	papules	papule	NNS
25944	2786	4	are	be	VBP
25944	2786	5	often	often	RB
25944	2786	6	interspersed	intersperse	VBN
25944	2786	7	.	.	.
25944	2787	1	There	there	EX
25944	2787	2	may	may	MD
25944	2787	3	be	be	VB
25944	2787	4	superficial	superficial	JJ
25944	2787	5	or	or	CC
25944	2787	6	deep	deep	JJ
25944	2787	7	ulceration	ulceration	NN
25944	2787	8	underlying	underlie	VBG
25944	2787	9	the	the	DT
25944	2787	10	bullæ	bullæ	NN
25944	2787	11	.	.	.
25944	2788	1	#	#	$
25944	2788	2	What	what	WDT
25944	2788	3	other	other	JJ
25944	2788	4	symptoms	symptom	NNS
25944	2788	5	in	in	IN
25944	2788	6	addition	addition	NN
25944	2788	7	to	to	IN
25944	2788	8	the	the	DT
25944	2788	9	cutaneous	cutaneous	JJ
25944	2788	10	manifestations	manifestation	NNS
25944	2788	11	are	be	VBP
25944	2788	12	noted	note	VBN
25944	2788	13	in	in	IN
25944	2788	14	hereditary	hereditary	JJ
25944	2788	15	syphilis	syphili	NNS
25944	2788	16	in	in	IN
25944	2788	17	the	the	DT
25944	2788	18	newborn	newborn	JJ
25944	2788	19	?	?	.
25944	2788	20	#	#	$
25944	2788	21	Mucous	mucous	JJ
25944	2788	22	patches	patch	NNS
25944	2788	23	,	,	,
25944	2788	24	and	and	CC
25944	2788	25	sometimes	sometimes	RB
25944	2788	26	ulcers	ulcer	NNS
25944	2788	27	,	,	,
25944	2788	28	in	in	IN
25944	2788	29	the	the	DT
25944	2788	30	mouth	mouth	NN
25944	2788	31	and	and	CC
25944	2788	32	throat	throat	NN
25944	2788	33	;	;	:
25944	2788	34	hoarseness	hoarseness	JJ
25944	2788	35	,	,	,
25944	2788	36	as	as	IN
25944	2788	37	shown	show	VBN
25944	2788	38	by	by	IN
25944	2788	39	the	the	DT
25944	2788	40	peculiar	peculiar	JJ
25944	2788	41	cry	cry	NN
25944	2788	42	,	,	,
25944	2788	43	and	and	CC
25944	2788	44	indicating	indicate	VBG
25944	2788	45	involvement	involvement	NN
25944	2788	46	of	of	IN
25944	2788	47	the	the	DT
25944	2788	48	larynx	larynx	NN
25944	2788	49	;	;	:
25944	2788	50	snuffles	snuffle	NNS
25944	2788	51	,	,	,
25944	2788	52	a	a	DT
25944	2788	53	sallow	sallow	JJ
25944	2788	54	and	and	CC
25944	2788	55	dirty	dirty	JJ
25944	2788	56	appearance	appearance	NN
25944	2788	57	of	of	IN
25944	2788	58	the	the	DT
25944	2788	59	skin	skin	NN
25944	2788	60	,	,	,
25944	2788	61	loss	loss	NN
25944	2788	62	of	of	IN
25944	2788	63	flesh	flesh	NN
25944	2788	64	and	and	CC
25944	2788	65	often	often	RB
25944	2788	66	a	a	DT
25944	2788	67	shriveled	shriveled	JJ
25944	2788	68	or	or	CC
25944	2788	69	senile	senile	JJ
25944	2788	70	look	look	NN
25944	2788	71	.	.	.
25944	2789	1	#	#	LS
25944	2789	2	What	what	WP
25944	2789	3	is	be	VBZ
25944	2789	4	the	the	DT
25944	2789	5	pathology	pathology	NN
25944	2789	6	of	of	IN
25944	2789	7	cutaneous	cutaneous	JJ
25944	2789	8	syphilis	syphili	NNS
25944	2789	9	?	?	.
25944	2789	10	#	#	$
25944	2789	11	The	the	DT
25944	2789	12	syphilitic	syphilitic	JJ
25944	2789	13	deposit	deposit	NN
25944	2789	14	consists	consist	VBZ
25944	2789	15	of	of	IN
25944	2789	16	round	round	JJ
25944	2789	17	-	-	HYPH
25944	2789	18	cell	cell	NN
25944	2789	19	infiltration	infiltration	NN
25944	2789	20	.	.	.
25944	2790	1	The	the	DT
25944	2790	2	mucous	mucous	JJ
25944	2790	3	layer	layer	NN
25944	2790	4	,	,	,
25944	2790	5	the	the	DT
25944	2790	6	corium	corium	NN
25944	2790	7	,	,	,
25944	2790	8	and	and	CC
25944	2790	9	in	in	IN
25944	2790	10	the	the	DT
25944	2790	11	deep	deep	JJ
25944	2790	12	lesions	lesion	NNS
25944	2790	13	the	the	DT
25944	2790	14	subcutaneous	subcutaneous	JJ
25944	2790	15	connective	connective	JJ
25944	2790	16	tissues	tissue	NNS
25944	2790	17	also	also	RB
25944	2790	18	,	,	,
25944	2790	19	are	be	VBP
25944	2790	20	involved	involve	VBN
25944	2790	21	in	in	IN
25944	2790	22	the	the	DT
25944	2790	23	process	process	NN
25944	2790	24	.	.	.
25944	2791	1	The	the	DT
25944	2791	2	infiltration	infiltration	NN
25944	2791	3	disappears	disappear	VBZ
25944	2791	4	by	by	IN
25944	2791	5	absorption	absorption	NN
25944	2791	6	or	or	CC
25944	2791	7	ulceration	ulceration	NN
25944	2791	8	.	.	.
25944	2792	1	The	the	DT
25944	2792	2	factor	factor	NN
25944	2792	3	now	now	RB
25944	2792	4	believed	believe	VBN
25944	2792	5	to	to	TO
25944	2792	6	be	be	VB
25944	2792	7	responsible	responsible	JJ
25944	2792	8	for	for	IN
25944	2792	9	the	the	DT
25944	2792	10	disease	disease	NN
25944	2792	11	and	and	CC
25944	2792	12	the	the	DT
25944	2792	13	pathological	pathological	JJ
25944	2792	14	changes	change	NNS
25944	2792	15	is	be	VBZ
25944	2792	16	the	the	DT
25944	2792	17	Spirochæta	Spirochæta	NNP
25944	2792	18	pallida	pallida	NN
25944	2792	19	,	,	,
25944	2792	20	discovered	discover	VBN
25944	2792	21	by	by	IN
25944	2792	22	Schaudinn	Schaudinn	NNP
25944	2792	23	and	and	CC
25944	2792	24	Hoffmann	Hoffmann	NNP
25944	2792	25	,	,	,
25944	2792	26	and	and	CC
25944	2792	27	usually	usually	RB
25944	2792	28	found	find	VBN
25944	2792	29	in	in	IN
25944	2792	30	numbers	number	NNS
25944	2792	31	in	in	IN
25944	2792	32	the	the	DT
25944	2792	33	tissues	tissue	NNS
25944	2792	34	.	.	.
25944	2793	1	#	#	NN
25944	2793	2	Give	give	VB
25944	2793	3	the	the	DT
25944	2793	4	prognosis	prognosis	NN
25944	2793	5	of	of	IN
25944	2793	6	cutaneous	cutaneous	JJ
25944	2793	7	syphilis	syphili	NNS
25944	2793	8	.	.	.
25944	2793	9	#	#	NNP
25944	2793	10	In	in	IN
25944	2793	11	_	_	NNP
25944	2793	12	acquired	acquire	VBD
25944	2793	13	syphilis	syphilis	NNP
25944	2793	14	_	_	NNP
25944	2793	15	,	,	,
25944	2793	16	favorable	favorable	JJ
25944	2793	17	;	;	:
25944	2793	18	sooner	sooner	RB
25944	2793	19	or	or	CC
25944	2793	20	later	later	RBR
25944	2793	21	,	,	,
25944	2793	22	unless	unless	IN
25944	2793	23	the	the	DT
25944	2793	24	whole	whole	JJ
25944	2793	25	system	system	NN
25944	2793	26	is	be	VBZ
25944	2793	27	so	so	RB
25944	2793	28	profoundly	profoundly	RB
25944	2793	29	affected	affect	VBN
25944	2793	30	by	by	IN
25944	2793	31	the	the	DT
25944	2793	32	syphilitic	syphilitic	JJ
25944	2793	33	poison	poison	NN
25944	2793	34	that	that	WDT
25944	2793	35	a	a	DT
25944	2793	36	fatal	fatal	JJ
25944	2793	37	ending	end	VBG
25944	2793	38	ensues	ensue	NNS
25944	2793	39	,	,	,
25944	2793	40	the	the	DT
25944	2793	41	cutaneous	cutaneous	JJ
25944	2793	42	manifestations	manifestation	NNS
25944	2793	43	disappear	disappear	VBP
25944	2793	44	,	,	,
25944	2793	45	either	either	CC
25944	2793	46	spontaneously	spontaneously	RB
25944	2793	47	or	or	CC
25944	2793	48	as	as	IN
25944	2793	49	the	the	DT
25944	2793	50	result	result	NN
25944	2793	51	of	of	IN
25944	2793	52	treatment	treatment	NN
25944	2793	53	.	.	.
25944	2794	1	The	the	DT
25944	2794	2	earlier	early	JJR
25944	2794	3	eruptions	eruption	NNS
25944	2794	4	will	will	MD
25944	2794	5	often	often	RB
25944	2794	6	pass	pass	VB
25944	2794	7	away	away	RB
25944	2794	8	without	without	IN
25944	2794	9	medication	medication	NN
25944	2794	10	,	,	,
25944	2794	11	but	but	CC
25944	2794	12	treatment	treatment	NN
25944	2794	13	is	be	VBZ
25944	2794	14	of	of	IN
25944	2794	15	material	material	JJ
25944	2794	16	aid	aid	NN
25944	2794	17	in	in	IN
25944	2794	18	moderating	moderate	VBG
25944	2794	19	their	-PRON-	PRP$
25944	2794	20	severity	severity	NN
25944	2794	21	and	and	CC
25944	2794	22	hastening	hasten	VBG
25944	2794	23	their	-PRON-	PRP$
25944	2794	24	disappearance	disappearance	NN
25944	2794	25	,	,	,
25944	2794	26	and	and	CC
25944	2794	27	is	be	VBZ
25944	2794	28	to	to	TO
25944	2794	29	be	be	VB
25944	2794	30	looked	look	VBN
25944	2794	31	upon	upon	IN
25944	2794	32	as	as	IN
25944	2794	33	essential	essential	JJ
25944	2794	34	;	;	:
25944	2794	35	in	in	IN
25944	2794	36	the	the	DT
25944	2794	37	late	late	JJ
25944	2794	38	syphilodermata	syphilodermata	NN
25944	2794	39	treatment	treatment	NN
25944	2794	40	is	be	VBZ
25944	2794	41	indispensable	indispensable	JJ
25944	2794	42	.	.	.
25944	2795	1	In	in	IN
25944	2795	2	the	the	DT
25944	2795	3	large	large	JJ
25944	2795	4	pustular	pustular	NN
25944	2795	5	,	,	,
25944	2795	6	the	the	DT
25944	2795	7	tubercular	tubercular	JJ
25944	2795	8	and	and	CC
25944	2795	9	gummatous	gummatous	JJ
25944	2795	10	lesions	lesion	NNS
25944	2795	11	,	,	,
25944	2795	12	considerable	considerable	JJ
25944	2795	13	destruction	destruction	NN
25944	2795	14	of	of	IN
25944	2795	15	tissue	tissue	NN
25944	2795	16	may	may	MD
25944	2795	17	take	take	VB
25944	2795	18	place	place	NN
25944	2795	19	,	,	,
25944	2795	20	and	and	CC
25944	2795	21	in	in	IN
25944	2795	22	consequence	consequence	NN
25944	2795	23	scarring	scar	VBG
25944	2795	24	result	result	NN
25944	2795	25	.	.	.
25944	2796	1	Ill	Ill	NNP
25944	2796	2	-	-	HYPH
25944	2796	3	health	health	NN
25944	2796	4	from	from	IN
25944	2796	5	any	any	DT
25944	2796	6	cause	cause	NN
25944	2796	7	predisposes	predispose	NNS
25944	2796	8	to	to	IN
25944	2796	9	a	a	DT
25944	2796	10	relapse	relapse	NN
25944	2796	11	,	,	,
25944	2796	12	and	and	CC
25944	2796	13	also	also	RB
25944	2796	14	adds	add	VBZ
25944	2796	15	to	to	IN
25944	2796	16	the	the	DT
25944	2796	17	gravity	gravity	NN
25944	2796	18	of	of	IN
25944	2796	19	the	the	DT
25944	2796	20	case	case	NN
25944	2796	21	.	.	.
25944	2797	1	In	in	IN
25944	2797	2	_	_	NNP
25944	2797	3	hereditary	hereditary	JJ
25944	2797	4	infantile	infantile	NN
25944	2797	5	syphilis	syphilis	NNP
25944	2797	6	_	_	NNP
25944	2797	7	,	,	,
25944	2797	8	the	the	DT
25944	2797	9	prognosis	prognosis	NN
25944	2797	10	is	be	VBZ
25944	2797	11	always	always	RB
25944	2797	12	uncertain	uncertain	JJ
25944	2797	13	:	:	:
25944	2797	14	the	the	DT
25944	2797	15	more	more	RBR
25944	2797	16	distant	distant	JJ
25944	2797	17	from	from	IN
25944	2797	18	the	the	DT
25944	2797	19	time	time	NN
25944	2797	20	of	of	IN
25944	2797	21	birth	birth	NN
25944	2797	22	the	the	DT
25944	2797	23	manifestations	manifestation	NNS
25944	2797	24	appear	appear	VBP
25944	2797	25	the	the	DT
25944	2797	26	more	more	RBR
25944	2797	27	favorable	favorable	JJ
25944	2797	28	usually	usually	RB
25944	2797	29	is	be	VBZ
25944	2797	30	the	the	DT
25944	2797	31	outcome	outcome	NN
25944	2797	32	.	.	.
25944	2798	1	#	#	NNP
25944	2798	2	How	how	WRB
25944	2798	3	is	be	VBZ
25944	2798	4	cutaneous	cutaneous	JJ
25944	2798	5	syphilis	syphili	NNS
25944	2798	6	to	to	TO
25944	2798	7	be	be	VB
25944	2798	8	treated	treat	VBN
25944	2798	9	?	?	.
25944	2798	10	#	#	$
25944	2798	11	Always	always	RB
25944	2798	12	with	with	IN
25944	2798	13	constitutional	constitutional	JJ
25944	2798	14	remedies	remedy	NNS
25944	2798	15	;	;	:
25944	2798	16	and	and	CC
25944	2798	17	in	in	IN
25944	2798	18	the	the	DT
25944	2798	19	graver	graver	JJ
25944	2798	20	eruptions	eruption	NNS
25944	2798	21	,	,	,
25944	2798	22	and	and	CC
25944	2798	23	especially	especially	RB
25944	2798	24	in	in	IN
25944	2798	25	those	those	DT
25944	2798	26	more	more	RBR
25944	2798	27	or	or	CC
25944	2798	28	less	less	RBR
25944	2798	29	limited	limited	JJ
25944	2798	30	,	,	,
25944	2798	31	with	with	IN
25944	2798	32	local	local	JJ
25944	2798	33	applications	application	NNS
25944	2798	34	also	also	RB
25944	2798	35	.	.	.
25944	2799	1	#	#	JJR
25944	2799	2	What	what	WDT
25944	2799	3	constitutional	constitutional	JJ
25944	2799	4	and	and	CC
25944	2799	5	local	local	JJ
25944	2799	6	remedies	remedy	NNS
25944	2799	7	are	be	VBP
25944	2799	8	commonly	commonly	RB
25944	2799	9	employed	employ	VBN
25944	2799	10	in	in	IN
25944	2799	11	cutaneous	cutaneous	JJ
25944	2799	12	syphilis	syphili	NNS
25944	2799	13	?	?	.
25944	2799	14	#	#	$
25944	2799	15	_	_	NNP
25944	2799	16	Constitutional	Constitutional	NNP
25944	2799	17	Remedies._--Mercury	remedies._--mercury	NN
25944	2799	18	and	and	CC
25944	2799	19	potassium	potassium	NN
25944	2799	20	iodide	iodide	NN
25944	2799	21	;	;	:
25944	2799	22	tonics	tonic	NNS
25944	2799	23	and	and	CC
25944	2799	24	nutrients	nutrient	NNS
25944	2799	25	are	be	VBP
25944	2799	26	necessary	necessary	JJ
25944	2799	27	in	in	IN
25944	2799	28	some	some	DT
25944	2799	29	cases	case	NNS
25944	2799	30	.	.	.
25944	2800	1	_	_	NNP
25944	2800	2	Local	local	JJ
25944	2800	3	Remedies._--Mercurial	remedies._--mercurial	JJ
25944	2800	4	ointments	ointment	NNS
25944	2800	5	,	,	,
25944	2800	6	lotions	lotion	NNS
25944	2800	7	and	and	CC
25944	2800	8	baths	bath	NNS
25944	2800	9	,	,	,
25944	2800	10	and	and	CC
25944	2800	11	iodol	iodol	NN
25944	2800	12	in	in	IN
25944	2800	13	ointment	ointment	NN
25944	2800	14	or	or	CC
25944	2800	15	in	in	IN
25944	2800	16	(	(	-LRB-
25944	2800	17	and	and	CC
25944	2800	18	also	also	RB
25944	2800	19	calomel	calomel	VB
25944	2800	20	)	)	-RRB-
25944	2800	21	powder	powder	NN
25944	2800	22	form	form	NN
25944	2800	23	.	.	.
25944	2801	1	#	#	NN
25944	2801	2	Give	give	VB
25944	2801	3	the	the	DT
25944	2801	4	constitutional	constitutional	JJ
25944	2801	5	treatment	treatment	NN
25944	2801	6	of	of	IN
25944	2801	7	the	the	DT
25944	2801	8	earlier	early	JJR
25944	2801	9	,	,	,
25944	2801	10	or	or	CC
25944	2801	11	secondary	secondary	JJ
25944	2801	12	,	,	,
25944	2801	13	eruptions	eruption	NNS
25944	2801	14	of	of	IN
25944	2801	15	syphilis	syphilis	NNP
25944	2801	16	.	.	.
25944	2801	17	#	#	$
25944	2801	18	In	in	IN
25944	2801	19	secondary	secondary	JJ
25944	2801	20	or	or	CC
25944	2801	21	early	early	JJ
25944	2801	22	eruptions	eruption	NNS
25944	2801	23	mercury	mercury	NN
25944	2801	24	alone	alone	RB
25944	2801	25	in	in	IN
25944	2801	26	almost	almost	RB
25944	2801	27	every	every	DT
25944	2801	28	case	case	NN
25944	2801	29	;	;	:
25944	2801	30	with	with	IN
25944	2801	31	tonics	tonic	NNS
25944	2801	32	,	,	,
25944	2801	33	if	if	IN
25944	2801	34	called	call	VBD
25944	2801	35	for	for	IN
25944	2801	36	.	.	.
25944	2802	1	If	if	IN
25944	2802	2	mercury	mercury	NN
25944	2802	3	is	be	VBZ
25944	2802	4	contraindicated	contraindicate	VBN
25944	2802	5	(	(	-LRB-
25944	2802	6	extremely	extremely	RB
25944	2802	7	rare	rare	JJ
25944	2802	8	)	)	-RRB-
25944	2802	9	,	,	,
25944	2802	10	potassium	potassium	NN
25944	2802	11	iodide	iodide	NN
25944	2802	12	may	may	MD
25944	2802	13	be	be	VB
25944	2802	14	substituted	substitute	VBN
25944	2802	15	.	.	.
25944	2803	1	#	#	NNP
25944	2803	2	How	how	WRB
25944	2803	3	is	be	VBZ
25944	2803	4	mercury	mercury	NN
25944	2803	5	usually	usually	RB
25944	2803	6	administered	administer	VBN
25944	2803	7	in	in	IN
25944	2803	8	the	the	DT
25944	2803	9	eruptions	eruption	NNS
25944	2803	10	of	of	IN
25944	2803	11	secondary	secondary	JJ
25944	2803	12	syphilis	syphili	NNS
25944	2803	13	?	?	.
25944	2803	14	#	#	NN
25944	2803	15	By	by	IN
25944	2803	16	the	the	DT
25944	2803	17	mouth	mouth	NN
25944	2803	18	,	,	,
25944	2803	19	chiefly	chiefly	RB
25944	2803	20	as	as	IN
25944	2803	21	the	the	DT
25944	2803	22	protiodide	protiodide	NN
25944	2803	23	,	,	,
25944	2803	24	calomel	calomel	NN
25944	2803	25	and	and	CC
25944	2803	26	blue	blue	JJ
25944	2803	27	mass	mass	NNP
25944	2803	28	,	,	,
25944	2803	29	in	in	IN
25944	2803	30	dosage	dosage	NN
25944	2803	31	just	just	RB
25944	2803	32	short	short	RB
25944	2803	33	of	of	IN
25944	2803	34	mild	mild	JJ
25944	2803	35	physiological	physiological	JJ
25944	2803	36	action	action	NN
25944	2803	37	;	;	:
25944	2803	38	by	by	IN
25944	2803	39	_	_	NNP
25944	2803	40	inunction	inunction	NN
25944	2803	41	_	_	NNP
25944	2803	42	,	,	,
25944	2803	43	in	in	IN
25944	2803	44	the	the	DT
25944	2803	45	form	form	NN
25944	2803	46	of	of	IN
25944	2803	47	blue	blue	JJ
25944	2803	48	ointment	ointment	NN
25944	2803	49	;	;	:
25944	2803	50	by	by	IN
25944	2803	51	_	_	NNP
25944	2803	52	hypodermic	hypodermic	JJ
25944	2803	53	injection	injection	NN
25944	2803	54	_	_	NNP
25944	2803	55	,	,	,
25944	2803	56	usually	usually	RB
25944	2803	57	as	as	IN
25944	2803	58	corrosive	corrosive	JJ
25944	2803	59	sublimate	sublimate	NN
25944	2803	60	solution	solution	NN
25944	2803	61	.	.	.
25944	2804	1	The	the	DT
25944	2804	2	method	method	NN
25944	2804	3	by	by	IN
25944	2804	4	_	_	NNP
25944	2804	5	fumigation	fumigation	NN
25944	2804	6	_	_	NNP
25944	2804	7	,	,	,
25944	2804	8	with	with	IN
25944	2804	9	calomel	calomel	NN
25944	2804	10	or	or	CC
25944	2804	11	bisulphuret	bisulphuret	NN
25944	2804	12	,	,	,
25944	2804	13	is	be	VBZ
25944	2804	14	now	now	RB
25944	2804	15	rarely	rarely	RB
25944	2804	16	employed	employ	VBN
25944	2804	17	.	.	.
25944	2805	1	The	the	DT
25944	2805	2	method	method	NN
25944	2805	3	by	by	IN
25944	2805	4	the	the	DT
25944	2805	5	mouth	mouth	NN
25944	2805	6	is	be	VBZ
25944	2805	7	the	the	DT
25944	2805	8	common	common	JJ
25944	2805	9	one	one	NN
25944	2805	10	,	,	,
25944	2805	11	and	and	CC
25944	2805	12	it	-PRON-	PRP
25944	2805	13	is	be	VBZ
25944	2805	14	only	only	RB
25944	2805	15	in	in	IN
25944	2805	16	rare	rare	JJ
25944	2805	17	instances	instance	NNS
25944	2805	18	that	that	IN
25944	2805	19	any	any	DT
25944	2805	20	other	other	JJ
25944	2805	21	method	method	NN
25944	2805	22	is	be	VBZ
25944	2805	23	necessary	necessary	JJ
25944	2805	24	or	or	CC
25944	2805	25	advisable	advisable	JJ
25944	2805	26	.	.	.
25944	2806	1	#	#	JJR
25944	2806	2	What	what	WDT
25944	2806	3	local	local	JJ
25944	2806	4	applications	application	NNS
25944	2806	5	are	be	VBP
25944	2806	6	usually	usually	RB
25944	2806	7	advised	advise	VBN
25944	2806	8	in	in	IN
25944	2806	9	the	the	DT
25944	2806	10	eruptions	eruption	NNS
25944	2806	11	of	of	IN
25944	2806	12	secondary	secondary	JJ
25944	2806	13	syphilis	syphili	NNS
25944	2806	14	?	?	.
25944	2806	15	#	#	$
25944	2806	16	If	if	IN
25944	2806	17	the	the	DT
25944	2806	18	eruption	eruption	NN
25944	2806	19	is	be	VBZ
25944	2806	20	extensive	extensive	JJ
25944	2806	21	,	,	,
25944	2806	22	and	and	CC
25944	2806	23	more	more	RBR
25944	2806	24	especially	especially	RB
25944	2806	25	in	in	IN
25944	2806	26	the	the	DT
25944	2806	27	pustular	pustular	JJ
25944	2806	28	types	type	NNS
25944	2806	29	,	,	,
25944	2806	30	baths	bath	NNS
25944	2806	31	of	of	IN
25944	2806	32	corrosive	corrosive	JJ
25944	2806	33	sublimate	sublimate	NN
25944	2806	34	(	(	-LRB-
25944	2806	35	[	[	-LRB-
25944	2806	36	dram	dram	NNP
25944	2806	37	ii	ii	NNP
25944	2806	38	-	-	HYPH
25944	2806	39	dram	dram	NNP
25944	2806	40	-	-	HYPH
25944	2806	41	iv	iv	NNP
25944	2806	42	]	]	-RRB-
25944	2806	43	to	to	IN
25944	2806	44	Cong	Cong	NNP
25944	2806	45	.	.	.
25944	2807	1	xxx	xxx	NNP
25944	2807	2	)	)	-RRB-
25944	2807	3	may	may	MD
25944	2807	4	be	be	VB
25944	2807	5	used	use	VBN
25944	2807	6	;	;	:
25944	2807	7	and	and	CC
25944	2807	8	ointment	ointment	NN
25944	2807	9	of	of	IN
25944	2807	10	ammoniated	ammoniate	VBN
25944	2807	11	mercury	mercury	NNP
25944	2807	12	,	,	,
25944	2807	13	twenty	twenty	CD
25944	2807	14	to	to	TO
25944	2807	15	sixty	sixty	CD
25944	2807	16	grains	grain	NNS
25944	2807	17	to	to	IN
25944	2807	18	the	the	DT
25944	2807	19	ounce	ounce	NN
25944	2807	20	,	,	,
25944	2807	21	blue	blue	JJ
25944	2807	22	ointment	ointment	NN
25944	2807	23	,	,	,
25944	2807	24	and	and	CC
25944	2807	25	the	the	DT
25944	2807	26	ten	ten	CD
25944	2807	27	per	per	IN
25944	2807	28	cent	cent	NN
25944	2807	29	.	.	.
25944	2808	1	oleate	oleate	NN
25944	2808	2	of	of	IN
25944	2808	3	mercury	mercury	NN
25944	2808	4	alone	alone	JJ
25944	2808	5	or	or	CC
25944	2808	6	with	with	IN
25944	2808	7	an	an	DT
25944	2808	8	equal	equal	JJ
25944	2808	9	quantity	quantity	NN
25944	2808	10	of	of	IN
25944	2808	11	any	any	DT
25944	2808	12	ointment	ointment	NN
25944	2808	13	base	base	NN
25944	2808	14	.	.	.
25944	2809	1	The	the	DT
25944	2809	2	same	same	JJ
25944	2809	3	applications	application	NNS
25944	2809	4	or	or	CC
25944	2809	5	a	a	DT
25944	2809	6	dusting	dusting	NN
25944	2809	7	powder	powder	NN
25944	2809	8	of	of	IN
25944	2809	9	calomel	calomel	NN
25944	2809	10	may	may	MD
25944	2809	11	also	also	RB
25944	2809	12	be	be	VB
25944	2809	13	used	use	VBN
25944	2809	14	on	on	IN
25944	2809	15	moist	moist	JJ
25944	2809	16	papules	papule	NNS
25944	2809	17	.	.	.
25944	2810	1	#	#	NN
25944	2810	2	How	how	WRB
25944	2810	3	long	long	JJ
25944	2810	4	is	be	VBZ
25944	2810	5	mercury	mercury	NN
25944	2810	6	to	to	TO
25944	2810	7	be	be	VB
25944	2810	8	actively	actively	RB
25944	2810	9	continued	continue	VBN
25944	2810	10	in	in	IN
25944	2810	11	cases	case	NNS
25944	2810	12	of	of	IN
25944	2810	13	early	early	JJ
25944	2810	14	(	(	-LRB-
25944	2810	15	secondary	secondary	JJ
25944	2810	16	)	)	-RRB-
25944	2810	17	syphilis	syphilis	NNP
25944	2810	18	?	?	.
25944	2810	19	#	#	NN
25944	2810	20	Until	until	IN
25944	2810	21	one	one	CD
25944	2810	22	or	or	CC
25944	2810	23	two	two	CD
25944	2810	24	months	month	NNS
25944	2810	25	after	after	IN
25944	2810	26	all	all	DT
25944	2810	27	manifestations	manifestation	NNS
25944	2810	28	(	(	-LRB-
25944	2810	29	cutaneous	cutaneous	JJ
25944	2810	30	or	or	CC
25944	2810	31	other	other	JJ
25944	2810	32	)	)	-RRB-
25944	2810	33	have	have	VBP
25944	2810	34	disappeared	disappear	VBN
25944	2810	35	,	,	,
25944	2810	36	and	and	CC
25944	2810	37	then	then	RB
25944	2810	38	,	,	,
25944	2810	39	as	as	IN
25944	2810	40	a	a	DT
25944	2810	41	general	general	JJ
25944	2810	42	rule	rule	NN
25944	2810	43	,	,	,
25944	2810	44	continued	continue	VBD
25944	2810	45	,	,	,
25944	2810	46	as	as	IN
25944	2810	47	a	a	DT
25944	2810	48	small	small	JJ
25944	2810	49	daily	daily	NN
25944	2810	50	dose	dose	NN
25944	2810	51	(	(	-LRB-
25944	2810	52	about	about	RB
25944	2810	53	one	one	CD
25944	2810	54	-	-	HYPH
25944	2810	55	quarter	quarter	NN
25944	2810	56	to	to	IN
25944	2810	57	one	one	CD
25944	2810	58	-	-	HYPH
25944	2810	59	third	third	NN
25944	2810	60	of	of	IN
25944	2810	61	that	that	DT
25944	2810	62	prescribed	prescribe	VBN
25944	2810	63	during	during	IN
25944	2810	64	the	the	DT
25944	2810	65	active	active	JJ
25944	2810	66	treatment	treatment	NN
25944	2810	67	)	)	-RRB-
25944	2810	68	for	for	IN
25944	2810	69	a	a	DT
25944	2810	70	period	period	NN
25944	2810	71	of	of	IN
25944	2810	72	two	two	CD
25944	2810	73	or	or	CC
25944	2810	74	three	three	CD
25944	2810	75	months	month	NNS
25944	2810	76	;	;	:
25944	2810	77	then	then	RB
25944	2810	78	another	another	DT
25944	2810	79	cycle	cycle	NN
25944	2810	80	of	of	IN
25944	2810	81	the	the	DT
25944	2810	82	active	active	JJ
25944	2810	83	dosage	dosage	NN
25944	2810	84	for	for	IN
25944	2810	85	a	a	DT
25944	2810	86	period	period	NN
25944	2810	87	of	of	IN
25944	2810	88	four	four	CD
25944	2810	89	to	to	TO
25944	2810	90	six	six	CD
25944	2810	91	weeks	week	NNS
25944	2810	92	;	;	:
25944	2810	93	then	then	RB
25944	2810	94	a	a	DT
25944	2810	95	resumption	resumption	NN
25944	2810	96	of	of	IN
25944	2810	97	the	the	DT
25944	2810	98	smaller	small	JJR
25944	2810	99	daily	daily	RB
25944	2810	100	dose	dose	NN
25944	2810	101	for	for	IN
25944	2810	102	another	another	DT
25944	2810	103	two	two	CD
25944	2810	104	or	or	CC
25944	2810	105	three	three	CD
25944	2810	106	months	month	NNS
25944	2810	107	;	;	:
25944	2810	108	and	and	CC
25944	2810	109	so	so	RB
25944	2810	110	on	on	RB
25944	2810	111	,	,	,
25944	2810	112	for	for	IN
25944	2810	113	a	a	DT
25944	2810	114	period	period	NN
25944	2810	115	of	of	IN
25944	2810	116	at	at	RB
25944	2810	117	least	least	RBS
25944	2810	118	two	two	CD
25944	2810	119	years	year	NNS
25944	2810	120	.	.	.
25944	2811	1	(	(	-LRB-
25944	2811	2	Almost	almost	RB
25944	2811	3	all	all	DT
25944	2811	4	authorities	authority	NNS
25944	2811	5	are	be	VBP
25944	2811	6	agreed	agree	VBN
25944	2811	7	as	as	IN
25944	2811	8	to	to	IN
25944	2811	9	the	the	DT
25944	2811	10	importance	importance	NN
25944	2811	11	of	of	IN
25944	2811	12	prolonged	prolonged	JJ
25944	2811	13	treatment	treatment	NN
25944	2811	14	,	,	,
25944	2811	15	but	but	CC
25944	2811	16	differ	differ	VBP
25944	2811	17	somewhat	somewhat	RB
25944	2811	18	on	on	IN
25944	2811	19	the	the	DT
25944	2811	20	question	question	NN
25944	2811	21	of	of	IN
25944	2811	22	intermittent	intermittent	JJ
25944	2811	23	or	or	CC
25944	2811	24	uninterrupted	uninterrupted	JJ
25944	2811	25	administration	administration	NN
25944	2811	26	.	.	.
25944	2811	27	)	)	-RRB-
25944	2812	1	#	#	NN
25944	2812	2	Give	give	VB
25944	2812	3	the	the	DT
25944	2812	4	constitutional	constitutional	JJ
25944	2812	5	treatment	treatment	NN
25944	2812	6	of	of	IN
25944	2812	7	the	the	DT
25944	2812	8	late	late	JJ
25944	2812	9	,	,	,
25944	2812	10	or	or	CC
25944	2812	11	localized	localize	VBN
25944	2812	12	,	,	,
25944	2812	13	syphilodermata	syphilodermata	NNS
25944	2812	14	.	.	.
25944	2812	15	#	#	NNP
25944	2812	16	Mercury	Mercury	NNP
25944	2812	17	always	always	RB
25944	2812	18	,	,	,
25944	2812	19	usually	usually	RB
25944	2812	20	in	in	IN
25944	2812	21	small	small	JJ
25944	2812	22	or	or	CC
25944	2812	23	moderate	moderate	JJ
25944	2812	24	dosage	dosage	NN
25944	2812	25	,	,	,
25944	2812	26	as	as	IN
25944	2812	27	the	the	DT
25944	2812	28	biniodide	biniodide	NN
25944	2812	29	or	or	CC
25944	2812	30	corrosive	corrosive	JJ
25944	2812	31	chloride	chloride	NN
25944	2812	32	,	,	,
25944	2812	33	and	and	CC
25944	2812	34	potassium	potassium	NN
25944	2812	35	iodide	iodide	NN
25944	2812	36	;	;	:
25944	2812	37	the	the	DT
25944	2812	38	latter	latter	JJ
25944	2812	39	in	in	IN
25944	2812	40	dose	dose	VBD
25944	2812	41	varying	varying	NN
25944	2812	42	from	from	IN
25944	2812	43	two	two	CD
25944	2812	44	grains	grain	NNS
25944	2812	45	to	to	IN
25944	2812	46	two	two	CD
25944	2812	47	drachms	drachm	NNS
25944	2812	48	or	or	CC
25944	2812	49	more	more	JJR
25944	2812	50	,	,	,
25944	2812	51	t.d	t.d	NNP
25944	2812	52	.	.	NNP
25944	2812	53	,	,	,
25944	2812	54	depending	depend	VBG
25944	2812	55	upon	upon	IN
25944	2812	56	its	-PRON-	PRP$
25944	2812	57	action	action	NN
25944	2812	58	and	and	CC
25944	2812	59	the	the	DT
25944	2812	60	urgency	urgency	NN
25944	2812	61	of	of	IN
25944	2812	62	the	the	DT
25944	2812	63	case	case	NN
25944	2812	64	.	.	.
25944	2813	1	#	#	NN
25944	2813	2	How	how	WRB
25944	2813	3	long	long	JJ
25944	2813	4	is	be	VBZ
25944	2813	5	constitutional	constitutional	JJ
25944	2813	6	treatment	treatment	NN
25944	2813	7	to	to	TO
25944	2813	8	be	be	VB
25944	2813	9	continued	continue	VBN
25944	2813	10	in	in	IN
25944	2813	11	cases	case	NNS
25944	2813	12	of	of	IN
25944	2813	13	the	the	DT
25944	2813	14	late	late	JJ
25944	2813	15	syphilodermata	syphilodermata	NNS
25944	2813	16	?	?	.
25944	2813	17	#	#	NN
25944	2813	18	Actively	actively	RB
25944	2813	19	for	for	IN
25944	2813	20	several	several	JJ
25944	2813	21	weeks	week	NNS
25944	2813	22	after	after	IN
25944	2813	23	the	the	DT
25944	2813	24	disappearance	disappearance	NN
25944	2813	25	of	of	IN
25944	2813	26	all	all	DT
25944	2813	27	symptoms	symptom	NNS
25944	2813	28	,	,	,
25944	2813	29	and	and	CC
25944	2813	30	then	then	RB
25944	2813	31	(	(	-LRB-
25944	2813	32	especially	especially	RB
25944	2813	33	the	the	DT
25944	2813	34	mercury	mercury	NN
25944	2813	35	)	)	-RRB-
25944	2813	36	continued	continue	VBD
25944	2813	37	in	in	IN
25944	2813	38	smaller	small	JJR
25944	2813	39	dosage	dosage	NN
25944	2813	40	(	(	-LRB-
25944	2813	41	about	about	RB
25944	2813	42	one	one	CD
25944	2813	43	-	-	HYPH
25944	2813	44	third	third	NN
25944	2813	45	)	)	-RRB-
25944	2813	46	for	for	IN
25944	2813	47	several	several	JJ
25944	2813	48	months	month	NNS
25944	2813	49	longer	long	RBR
25944	2813	50	.	.	.
25944	2814	1	#	#	NNP
25944	2814	2	What	what	WDT
25944	2814	3	applications	application	NNS
25944	2814	4	are	be	VBP
25944	2814	5	usually	usually	RB
25944	2814	6	advised	advise	VBN
25944	2814	7	in	in	IN
25944	2814	8	the	the	DT
25944	2814	9	late	late	JJ
25944	2814	10	,	,	,
25944	2814	11	or	or	CC
25944	2814	12	localized	localize	VBN
25944	2814	13	,	,	,
25944	2814	14	syphilodermata	syphilodermata	NNS
25944	2814	15	?	?	.
25944	2814	16	#	#	NNP
25944	2814	17	Ointment	Ointment	NNP
25944	2814	18	of	of	IN
25944	2814	19	ammoniated	ammoniated	JJ
25944	2814	20	mercury	mercury	NN
25944	2814	21	,	,	,
25944	2814	22	twenty	twenty	CD
25944	2814	23	to	to	TO
25944	2814	24	sixty	sixty	CD
25944	2814	25	grains	grain	NNS
25944	2814	26	to	to	IN
25944	2814	27	the	the	DT
25944	2814	28	ounce	ounce	NN
25944	2814	29	;	;	:
25944	2814	30	oleate	oleate	NN
25944	2814	31	of	of	IN
25944	2814	32	mercury	mercury	NNP
25944	2814	33	,	,	,
25944	2814	34	five	five	CD
25944	2814	35	to	to	TO
25944	2814	36	ten	ten	CD
25944	2814	37	per	per	IN
25944	2814	38	cent	cent	NN
25944	2814	39	.	.	.
25944	2815	1	strength	strength	NN
25944	2815	2	;	;	:
25944	2815	3	mercurial	mercurial	JJ
25944	2815	4	plaster	plaster	NN
25944	2815	5	,	,	,
25944	2815	6	full	full	JJ
25944	2815	7	strength	strength	NN
25944	2815	8	or	or	CC
25944	2815	9	weakened	weaken	VBN
25944	2815	10	with	with	IN
25944	2815	11	lard	lard	NN
25944	2815	12	or	or	CC
25944	2815	13	petrolatum	petrolatum	NN
25944	2815	14	;	;	:
25944	2815	15	a	a	DT
25944	2815	16	two	two	CD
25944	2815	17	to	to	TO
25944	2815	18	twenty	twenty	CD
25944	2815	19	per	per	IN
25944	2815	20	cent	cent	NN
25944	2815	21	.	.	.
25944	2816	1	ointment	ointment	NN
25944	2816	2	of	of	IN
25944	2816	3	iodol	iodol	NNP
25944	2816	4	;	;	,
25944	2816	5	resorcin	resorcin	NNPS
25944	2816	6	,	,	,
25944	2816	7	twenty	twenty	CD
25944	2816	8	to	to	TO
25944	2816	9	sixty	sixty	CD
25944	2816	10	grains	grain	NNS
25944	2816	11	to	to	IN
25944	2816	12	the	the	DT
25944	2816	13	ounce	ounce	NN
25944	2816	14	of	of	IN
25944	2816	15	ointment	ointment	NN
25944	2816	16	base	base	NN
25944	2816	17	;	;	:
25944	2816	18	and	and	CC
25944	2816	19	lotions	lotion	NNS
25944	2816	20	of	of	IN
25944	2816	21	corrosive	corrosive	JJ
25944	2816	22	sublimate	sublimate	NN
25944	2816	23	,	,	,
25944	2816	24	one	one	CD
25944	2816	25	-	-	HYPH
25944	2816	26	half	half	NN
25944	2816	27	to	to	IN
25944	2816	28	three	three	CD
25944	2816	29	grains	grain	NNS
25944	2816	30	to	to	IN
25944	2816	31	the	the	DT
25944	2816	32	ounce	ounce	NN
25944	2816	33	.	.	.
25944	2817	1	The	the	DT
25944	2817	2	following	follow	VBG
25944	2817	3	is	be	VBZ
25944	2817	4	valuable	valuable	JJ
25944	2817	5	in	in	IN
25944	2817	6	offensive	offensive	JJ
25944	2817	7	and	and	CC
25944	2817	8	obstinate	obstinate	NN
25944	2817	9	ulcerations:--	ulcerations:--	JJ
25944	2817	10	[	[	-LRB-
25944	2817	11	Rx	Rx	NNP
25944	2817	12	]	]	-RRB-
25944	2817	13	Hydrarg	Hydrarg	NNP
25944	2817	14	.	.	.
25944	2818	1	chlorid	chlorid	NNP
25944	2818	2	.	.	.
25944	2819	1	corros	corros	NNP
25944	2819	2	.	.	NNP
25944	2819	3	,	,	,
25944	2819	4	...........	...........	NFP
25944	2819	5	gr	gr	NNP
25944	2819	6	.	.	.
25944	2820	1	iv	iv	NNP
25944	2820	2	-	-	HYPH
25944	2820	3	gr	gr	NNP
25944	2820	4	.	.	.
25944	2821	1	viij	viij	NNP
25944	2821	2	Ac	Ac	NNP
25944	2821	3	.	.	.
25944	2822	1	carbolici	carbolici	NNP
25944	2822	2	,	,	,
25944	2822	3	.......................	.......................	NFP
25944	2822	4	gr	gr	NNP
25944	2822	5	.	.	.
25944	2823	1	x	x	LS
25944	2823	2	-	-	:
25944	2823	3	xx	xx	NNP
25944	2823	4	Alcoholis	Alcoholis	NNP
25944	2823	5	,	,	,
25944	2823	6	...........................	...........................	.
25944	2823	7	f[dram]iv	f[dram]iv	NFP
25944	2823	8	Glycerinæ	Glycerinæ	NNP
25944	2823	9	,	,	,
25944	2823	10	...........................	...........................	NFP
25944	2823	11	f[dram]j	f[dram]j	NNP
25944	2823	12	Aquæ	Aquæ	NNP
25944	2823	13	,	,	,
25944	2823	14	............	............	NFP
25944	2823	15	q.s	q.s	NNP
25944	2823	16	.	.	.
25944	2824	1	ad	ad	NN
25944	2824	2	...........	...........	.
25944	2824	3	[	[	-LRB-
25944	2824	4	Oz]iv	oz]iv	NN
25944	2824	5	.	.	.
25944	2825	1	M.	M.	NNP
25944	2825	2	Ointments	Ointments	NNP
25944	2825	3	are	be	VBP
25944	2825	4	to	to	TO
25944	2825	5	be	be	VB
25944	2825	6	rubbed	rub	VBN
25944	2825	7	in	in	IN
25944	2825	8	or	or	CC
25944	2825	9	applied	apply	VBN
25944	2825	10	as	as	IN
25944	2825	11	a	a	DT
25944	2825	12	plaster	plaster	NN
25944	2825	13	;	;	:
25944	2825	14	lotions	lotion	NNS
25944	2825	15	,	,	,
25944	2825	16	employed	employ	VBN
25944	2825	17	chiefly	chiefly	RB
25944	2825	18	in	in	IN
25944	2825	19	ulcers	ulcer	NNS
25944	2825	20	and	and	CC
25944	2825	21	ulcerations	ulceration	NNS
25944	2825	22	,	,	,
25944	2825	23	are	be	VBP
25944	2825	24	to	to	TO
25944	2825	25	be	be	VB
25944	2825	26	thoroughly	thoroughly	RB
25944	2825	27	dabbed	dab	VBN
25944	2825	28	on	on	IN
25944	2825	29	,	,	,
25944	2825	30	and	and	CC
25944	2825	31	usually	usually	RB
25944	2825	32	supplemented	supplement	VBN
25944	2825	33	by	by	IN
25944	2825	34	the	the	DT
25944	2825	35	application	application	NN
25944	2825	36	of	of	IN
25944	2825	37	an	an	DT
25944	2825	38	ointment	ointment	NN
25944	2825	39	.	.	.
25944	2826	1	Iodol	Iodol	NNP
25944	2826	2	may	may	MD
25944	2826	3	also	also	RB
25944	2826	4	be	be	VB
25944	2826	5	applied	apply	VBN
25944	2826	6	to	to	IN
25944	2826	7	ulcers	ulcer	NNS
25944	2826	8	as	as	IN
25944	2826	9	a	a	DT
25944	2826	10	dusting	dusting	NN
25944	2826	11	-	-	HYPH
25944	2826	12	powder	powder	NN
25944	2826	13	,	,	,
25944	2826	14	usually	usually	RB
25944	2826	15	mixed	mix	VBN
25944	2826	16	with	with	IN
25944	2826	17	one	one	CD
25944	2826	18	to	to	IN
25944	2826	19	several	several	JJ
25944	2826	20	parts	part	NNS
25944	2826	21	of	of	IN
25944	2826	22	zinc	zinc	NN
25944	2826	23	oxide	oxide	NN
25944	2826	24	or	or	CC
25944	2826	25	boric	boric	NN
25944	2826	26	acid	acid	NN
25944	2826	27	.	.	.
25944	2827	1	#	#	NN
25944	2827	2	Give	give	VB
25944	2827	3	the	the	DT
25944	2827	4	treatment	treatment	NN
25944	2827	5	of	of	IN
25944	2827	6	hereditary	hereditary	JJ
25944	2827	7	infantile	infantile	NN
25944	2827	8	syphilis	syphilis	NNP
25944	2827	9	.	.	.
25944	2827	10	#	#	NN
25944	2827	11	It	-PRON-	PRP
25944	2827	12	is	be	VBZ
25944	2827	13	essentially	essentially	RB
25944	2827	14	the	the	DT
25944	2827	15	same	same	JJ
25944	2827	16	(	(	-LRB-
25944	2827	17	but	but	CC
25944	2827	18	much	much	RB
25944	2827	19	smaller	small	JJR
25944	2827	20	dosage	dosage	NN
25944	2827	21	)	)	-RRB-
25944	2827	22	as	as	IN
25944	2827	23	employed	employ	VBN
25944	2827	24	in	in	IN
25944	2827	25	acquired	acquire	VBN
25944	2827	26	syphilis	syphilis	NNP
25944	2827	27	.	.	.
25944	2828	1	Attention	attention	NN
25944	2828	2	to	to	IN
25944	2828	3	proper	proper	JJ
25944	2828	4	feeding	feeding	NN
25944	2828	5	and	and	CC
25944	2828	6	hygiene	hygiene	NN
25944	2828	7	is	be	VBZ
25944	2828	8	of	of	IN
25944	2828	9	first	first	JJ
25944	2828	10	importance	importance	NN
25944	2828	11	.	.	.
25944	2829	1	Mercury	Mercury	NNP
25944	2829	2	may	may	MD
25944	2829	3	be	be	VB
25944	2829	4	given	give	VBN
25944	2829	5	by	by	IN
25944	2829	6	the	the	DT
25944	2829	7	mouth	mouth	NN
25944	2829	8	,	,	,
25944	2829	9	as	as	IN
25944	2829	10	mercury	mercury	NN
25944	2829	11	with	with	IN
25944	2829	12	chalk	chalk	NNP
25944	2829	13	(	(	-LRB-
25944	2829	14	gr	gr	NNP
25944	2829	15	.	.	.
25944	2830	1	ss	ss	NNP
25944	2830	2	-	-	HYPH
25944	2830	3	gr	gr	NNP
25944	2830	4	.	.	.
25944	2831	1	ij	ij	NNP
25944	2831	2	,	,	,
25944	2831	3	t.d	t.d	NNP
25944	2831	4	.	.	.
25944	2832	1	)	)	-RRB-
25944	2832	2	;	;	:
25944	2832	3	as	as	IN
25944	2832	4	calomel	calomel	NNP
25944	2832	5	(	(	-LRB-
25944	2832	6	gr	gr	NNP
25944	2832	7	.	.	.
25944	2833	1	1/20-gr	1/20-gr	NN
25944	2833	2	.	.	.
25944	2834	1	1/6	1/6	LS
25944	2834	2	,	,	,
25944	2834	3	t.d	t.d	NNP
25944	2834	4	.	.	.
25944	2835	1	)	)	-RRB-
25944	2835	2	;	;	:
25944	2835	3	and	and	CC
25944	2835	4	as	as	IN
25944	2835	5	a	a	DT
25944	2835	6	solution	solution	NN
25944	2835	7	of	of	IN
25944	2835	8	corrosive	corrosive	JJ
25944	2835	9	sublimate	sublimate	NN
25944	2835	10	(	(	-LRB-
25944	2835	11	gr	gr	NNP
25944	2835	12	.	.	.
25944	2836	1	ss-[Oz]vj	ss-[Oz]vj	NNP
25944	2836	2	,	,	,
25944	2836	3	[	[	-LRB-
25944	2836	4	dram]j	dram]j	NNP
25944	2836	5	,	,	,
25944	2836	6	t.d	t.d	NNP
25944	2836	7	.	.	.
25944	2836	8	)	)	-RRB-
25944	2836	9	.	.	.
25944	2837	1	If	if	IN
25944	2837	2	mercury	mercury	NN
25944	2837	3	is	be	VBZ
25944	2837	4	not	not	RB
25944	2837	5	well	well	RB
25944	2837	6	borne	bear	VBN
25944	2837	7	by	by	IN
25944	2837	8	the	the	DT
25944	2837	9	stomach	stomach	NN
25944	2837	10	,	,	,
25944	2837	11	it	-PRON-	PRP
25944	2837	12	may	may	MD
25944	2837	13	be	be	VB
25944	2837	14	administered	administer	VBN
25944	2837	15	by	by	IN
25944	2837	16	inunction	inunction	NN
25944	2837	17	;	;	,
25944	2837	18	for	for	IN
25944	2837	19	this	this	DT
25944	2837	20	purpose	purpose	NN
25944	2837	21	,	,	,
25944	2837	22	blue	blue	JJ
25944	2837	23	ointment	ointment	NN
25944	2837	24	is	be	VBZ
25944	2837	25	mixed	mix	VBN
25944	2837	26	with	with	IN
25944	2837	27	one	one	CD
25944	2837	28	or	or	CC
25944	2837	29	two	two	CD
25944	2837	30	parts	part	NNS
25944	2837	31	of	of	IN
25944	2837	32	lard	lard	NN
25944	2837	33	and	and	CC
25944	2837	34	spread	spread	NN
25944	2837	35	(	(	-LRB-
25944	2837	36	about	about	IN
25944	2837	37	a	a	DT
25944	2837	38	drachm	drachm	NN
25944	2837	39	)	)	-RRB-
25944	2837	40	upon	upon	IN
25944	2837	41	an	an	DT
25944	2837	42	abdominal	abdominal	JJ
25944	2837	43	bandage	bandage	NN
25944	2837	44	and	and	CC
25944	2837	45	applied	apply	VBD
25944	2837	46	,	,	,
25944	2837	47	being	be	VBG
25944	2837	48	renewed	renew	VBN
25944	2837	49	daily	daily	RB
25944	2837	50	.	.	.
25944	2838	1	Treatment	treatment	NN
25944	2838	2	by	by	IN
25944	2838	3	means	mean	NNS
25944	2838	4	of	of	IN
25944	2838	5	baths	bath	NNS
25944	2838	6	(	(	-LRB-
25944	2838	7	gr	gr	NNP
25944	2838	8	.	.	.
25944	2839	1	x	x	LS
25944	2839	2	-	-	:
25944	2839	3	xxx	xxx	NNP
25944	2839	4	to	to	IN
25944	2839	5	the	the	DT
25944	2839	6	bath	bath	NN
25944	2839	7	)	)	-RRB-
25944	2839	8	of	of	IN
25944	2839	9	corrosive	corrosive	JJ
25944	2839	10	sublimate	sublimate	NN
25944	2839	11	is	be	VBZ
25944	2839	12	,	,	,
25944	2839	13	at	at	IN
25944	2839	14	times	time	NNS
25944	2839	15	,	,	,
25944	2839	16	a	a	DT
25944	2839	17	serviceable	serviceable	JJ
25944	2839	18	method	method	NN
25944	2839	19	.	.	.
25944	2840	1	Potassium	potassium	NN
25944	2840	2	iodide	iodide	NN
25944	2840	3	,	,	,
25944	2840	4	if	if	IN
25944	2840	5	exceptionally	exceptionally	RB
25944	2840	6	deemed	deem	VBN
25944	2840	7	preferable	preferable	JJ
25944	2840	8	,	,	,
25944	2840	9	may	may	MD
25944	2840	10	be	be	VB
25944	2840	11	given	give	VBN
25944	2840	12	in	in	IN
25944	2840	13	the	the	DT
25944	2840	14	dose	dose	NN
25944	2840	15	of	of	IN
25944	2840	16	a	a	DT
25944	2840	17	fractional	fractional	JJ
25944	2840	18	part	part	NN
25944	2840	19	of	of	IN
25944	2840	20	a	a	DT
25944	2840	21	grain	grain	NN
25944	2840	22	to	to	IN
25944	2840	23	two	two	CD
25944	2840	24	or	or	CC
25944	2840	25	three	three	CD
25944	2840	26	grains	grain	NNS
25944	2840	27	three	three	CD
25944	2840	28	times	time	NNS
25944	2840	29	daily	daily	RB
25944	2840	30	.	.	.
25944	2841	1	#	#	JJR
25944	2841	2	What	what	WDT
25944	2841	3	local	local	JJ
25944	2841	4	measures	measure	NNS
25944	2841	5	are	be	VBP
25944	2841	6	to	to	TO
25944	2841	7	be	be	VB
25944	2841	8	advised	advise	VBN
25944	2841	9	in	in	IN
25944	2841	10	cutaneous	cutaneous	JJ
25944	2841	11	syphilis	syphili	NNS
25944	2841	12	of	of	IN
25944	2841	13	the	the	DT
25944	2841	14	newborn	newborn	JJ
25944	2841	15	?	?	.
25944	2841	16	#	#	$
25944	2841	17	If	if	IN
25944	2841	18	demanded	demand	VBN
25944	2841	19	,	,	,
25944	2841	20	applications	application	NNS
25944	2841	21	similar	similar	JJ
25944	2841	22	to	to	IN
25944	2841	23	those	those	DT
25944	2841	24	employed	employ	VBN
25944	2841	25	in	in	IN
25944	2841	26	eruptions	eruption	NNS
25944	2841	27	of	of	IN
25944	2841	28	acquired	acquire	VBN
25944	2841	29	syphilis	syphilis	NNP
25944	2841	30	,	,	,
25944	2841	31	but	but	CC
25944	2841	32	not	not	RB
25944	2841	33	more	more	JJR
25944	2841	34	than	than	IN
25944	2841	35	one	one	CD
25944	2841	36	-	-	HYPH
25944	2841	37	third	third	NN
25944	2841	38	to	to	IN
25944	2841	39	one	one	CD
25944	2841	40	-	-	HYPH
25944	2841	41	half	half	NN
25944	2841	42	the	the	DT
25944	2841	43	strength	strength	NN
25944	2841	44	.	.	.
25944	2842	1	#	#	NNP
25944	2842	2	Lepra	Lepra	NNP
25944	2842	3	.	.	.
25944	2842	4	#	#	NNP
25944	2842	5	(	(	-LRB-
25944	2842	6	_	_	NNP
25944	2842	7	Synonyms	Synonyms	NNP
25944	2842	8	:	:	:
25944	2842	9	_	_	NNP
25944	2842	10	Leprosy	Leprosy	NNP
25944	2842	11	;	;	:
25944	2842	12	Elephantiasis	Elephantiasis	NNP
25944	2842	13	Græcorum	Græcorum	NNP
25944	2842	14	.	.	.
25944	2842	15	)	)	-RRB-
25944	2843	1	#	#	LS
25944	2843	2	What	what	WP
25944	2843	3	do	do	VBP
25944	2843	4	you	-PRON-	PRP
25944	2843	5	understand	understand	VB
25944	2843	6	by	by	IN
25944	2843	7	leprosy	leprosy	NN
25944	2843	8	?	?	.
25944	2843	9	#	#	NNP
25944	2843	10	Lepra	Lepra	NNP
25944	2843	11	,	,	,
25944	2843	12	or	or	CC
25944	2843	13	leprosy	leprosy	NN
25944	2843	14	,	,	,
25944	2843	15	is	be	VBZ
25944	2843	16	an	an	DT
25944	2843	17	endemic	endemic	JJ
25944	2843	18	,	,	,
25944	2843	19	chronic	chronic	JJ
25944	2843	20	,	,	,
25944	2843	21	malignant	malignant	JJ
25944	2843	22	constitutional	constitutional	JJ
25944	2843	23	disease	disease	NN
25944	2843	24	,	,	,
25944	2843	25	characterized	characterize	VBN
25944	2843	26	by	by	IN
25944	2843	27	alterations	alteration	NNS
25944	2843	28	in	in	IN
25944	2843	29	the	the	DT
25944	2843	30	cutaneous	cutaneous	JJ
25944	2843	31	,	,	,
25944	2843	32	nerve	nerve	NN
25944	2843	33	,	,	,
25944	2843	34	and	and	CC
25944	2843	35	bone	bone	NN
25944	2843	36	structures	structure	NNS
25944	2843	37	;	;	,
25944	2843	38	varying	vary	VBG
25944	2843	39	in	in	IN
25944	2843	40	its	-PRON-	PRP$
25944	2843	41	morbid	morbid	NN
25944	2843	42	manifestations	manifestation	NNS
25944	2843	43	according	accord	VBG
25944	2843	44	to	to	IN
25944	2843	45	whether	whether	IN
25944	2843	46	the	the	DT
25944	2843	47	skin	skin	NN
25944	2843	48	,	,	,
25944	2843	49	nerves	nerve	NNS
25944	2843	50	or	or	CC
25944	2843	51	other	other	JJ
25944	2843	52	tissues	tissue	NNS
25944	2843	53	are	be	VBP
25944	2843	54	predominantly	predominantly	RB
25944	2843	55	involved	involve	VBN
25944	2843	56	.	.	.
25944	2844	1	#	#	LS
25944	2844	2	What	what	WP
25944	2844	3	is	be	VBZ
25944	2844	4	the	the	DT
25944	2844	5	nature	nature	NN
25944	2844	6	of	of	IN
25944	2844	7	the	the	DT
25944	2844	8	premonitory	premonitory	JJ
25944	2844	9	symptoms	symptom	NNS
25944	2844	10	of	of	IN
25944	2844	11	leprosy	leprosy	NN
25944	2844	12	?	?	.
25944	2844	13	#	#	$
25944	2844	14	In	in	IN
25944	2844	15	some	some	DT
25944	2844	16	instances	instance	NNS
25944	2844	17	the	the	DT
25944	2844	18	active	active	JJ
25944	2844	19	manifestations	manifestation	NNS
25944	2844	20	appear	appear	VBP
25944	2844	21	without	without	IN
25944	2844	22	premonition	premonition	NN
25944	2844	23	,	,	,
25944	2844	24	but	but	CC
25944	2844	25	in	in	IN
25944	2844	26	the	the	DT
25944	2844	27	majority	majority	NN
25944	2844	28	of	of	IN
25944	2844	29	cases	case	NNS
25944	2844	30	symptoms	symptom	NNS
25944	2844	31	,	,	,
25944	2844	32	slight	slight	JJ
25944	2844	33	or	or	CC
25944	2844	34	severe	severe	JJ
25944	2844	35	in	in	IN
25944	2844	36	character	character	NN
25944	2844	37	,	,	,
25944	2844	38	pointing	point	VBG
25944	2844	39	toward	toward	IN
25944	2844	40	profound	profound	JJ
25944	2844	41	constitutional	constitutional	JJ
25944	2844	42	disturbance	disturbance	NN
25944	2844	43	,	,	,
25944	2844	44	such	such	JJ
25944	2844	45	as	as	IN
25944	2844	46	mental	mental	JJ
25944	2844	47	depression	depression	NN
25944	2844	48	,	,	,
25944	2844	49	malaise	malaise	NNP
25944	2844	50	,	,	,
25944	2844	51	chills	chill	NNS
25944	2844	52	,	,	,
25944	2844	53	febrile	febrile	NN
25944	2844	54	attacks	attack	NNS
25944	2844	55	,	,	,
25944	2844	56	digestive	digestive	JJ
25944	2844	57	derangements	derangement	NNS
25944	2844	58	and	and	CC
25944	2844	59	bone	bone	NN
25944	2844	60	pains	pain	NNS
25944	2844	61	,	,	,
25944	2844	62	are	be	VBP
25944	2844	63	noticed	notice	VBN
25944	2844	64	for	for	IN
25944	2844	65	weeks	week	NNS
25944	2844	66	,	,	,
25944	2844	67	months	month	NNS
25944	2844	68	,	,	,
25944	2844	69	or	or	CC
25944	2844	70	several	several	JJ
25944	2844	71	years	year	NNS
25944	2844	72	preceding	precede	VBG
25944	2844	73	the	the	DT
25944	2844	74	outbreak	outbreak	NN
25944	2844	75	.	.	.
25944	2845	1	#	#	$
25944	2845	2	What	what	WDT
25944	2845	3	several	several	JJ
25944	2845	4	varieties	variety	NNS
25944	2845	5	of	of	IN
25944	2845	6	leprosy	leprosy	NN
25944	2845	7	are	be	VBP
25944	2845	8	observed	observe	VBN
25944	2845	9	?	?	.
25944	2845	10	#	#	$
25944	2845	11	Two	two	CD
25944	2845	12	definite	definite	JJ
25944	2845	13	forms	form	NNS
25944	2845	14	are	be	VBP
25944	2845	15	usually	usually	RB
25944	2845	16	described	describe	VBN
25944	2845	17	--	--	:
25944	2845	18	the	the	DT
25944	2845	19	tubercular	tubercular	NN
25944	2845	20	and	and	CC
25944	2845	21	the	the	DT
25944	2845	22	anæsthetic	anæsthetic	NN
25944	2845	23	.	.	.
25944	2846	1	A	a	DT
25944	2846	2	sharp	sharp	JJ
25944	2846	3	division	division	NN
25944	2846	4	-	-	HYPH
25944	2846	5	line	line	NN
25944	2846	6	can	can	MD
25944	2846	7	not	not	RB
25944	2846	8	,	,	,
25944	2846	9	however	however	RB
25944	2846	10	,	,	,
25944	2846	11	always	always	RB
25944	2846	12	be	be	VB
25944	2846	13	drawn	draw	VBN
25944	2846	14	;	;	:
25944	2846	15	not	not	RB
25944	2846	16	infrequently	infrequently	RB
25944	2846	17	the	the	DT
25944	2846	18	manifestations	manifestation	NNS
25944	2846	19	are	be	VBP
25944	2846	20	of	of	IN
25944	2846	21	a	a	DT
25944	2846	22	mixed	mixed	JJ
25944	2846	23	type	type	NN
25944	2846	24	,	,	,
25944	2846	25	or	or	CC
25944	2846	26	one	one	CD
25944	2846	27	form	form	NN
25944	2846	28	may	may	MD
25944	2846	29	pass	pass	VB
25944	2846	30	into	into	IN
25944	2846	31	or	or	CC
25944	2846	32	gradually	gradually	RB
25944	2846	33	present	present	JJ
25944	2846	34	symptoms	symptom	NNS
25944	2846	35	of	of	IN
25944	2846	36	the	the	DT
25944	2846	37	other	other	JJ
25944	2846	38	.	.	.
25944	2847	1	[	[	-LRB-
25944	2847	2	Illustration	illustration	NN
25944	2847	3	:	:	:
25944	2847	4	Fig	Fig	NNP
25944	2847	5	.	.	.
25944	2848	1	62	62	CD
25944	2848	2	.	.	.
25944	2849	1	Tubercular	Tubercular	NNP
25944	2849	2	Leprosy	Leprosy	NNP
25944	2849	3	.	.	.
25944	2850	1	(	(	-LRB-
25944	2850	2	_	_	NNP
25944	2850	3	After	after	IN
25944	2850	4	Stoddard	Stoddard	NNP
25944	2850	5	.	.	.
25944	2850	6	_	_	NNP
25944	2850	7	)	)	-RRB-
25944	2850	8	]	]	-RRB-
25944	2850	9	#	#	$
25944	2850	10	Describe	describe	VB
25944	2850	11	the	the	DT
25944	2850	12	symptoms	symptom	NNS
25944	2850	13	of	of	IN
25944	2850	14	tubercular	tubercular	JJ
25944	2850	15	leprosy	leprosy	NN
25944	2850	16	.	.	.
25944	2850	17	#	#	$
25944	2850	18	The	the	DT
25944	2850	19	formation	formation	NN
25944	2850	20	of	of	IN
25944	2850	21	tubercles	tubercle	NNS
25944	2850	22	and	and	CC
25944	2850	23	tubercular	tubercular	JJ
25944	2850	24	masses	masse	NNS
25944	2850	25	of	of	IN
25944	2850	26	infiltration	infiltration	NN
25944	2850	27	,	,	,
25944	2850	28	usually	usually	RB
25944	2850	29	of	of	IN
25944	2850	30	a	a	DT
25944	2850	31	yellowish	yellowish	JJ
25944	2850	32	-	-	HYPH
25944	2850	33	brown	brown	JJ
25944	2850	34	color	color	NN
25944	2850	35	,	,	,
25944	2850	36	with	with	IN
25944	2850	37	subsequent	subsequent	JJ
25944	2850	38	ulceration	ulceration	NN
25944	2850	39	,	,	,
25944	2850	40	constitute	constitute	VB
25944	2850	41	the	the	DT
25944	2850	42	important	important	JJ
25944	2850	43	cutaneous	cutaneous	JJ
25944	2850	44	symptoms	symptom	NNS
25944	2850	45	.	.	.
25944	2851	1	Along	along	IN
25944	2851	2	with	with	IN
25944	2851	3	,	,	,
25944	2851	4	or	or	CC
25944	2851	5	preceding	precede	VBG
25944	2851	6	these	these	DT
25944	2851	7	characteristic	characteristic	JJ
25944	2851	8	lesions	lesion	NNS
25944	2851	9	,	,	,
25944	2851	10	blebs	blebs	NN
25944	2851	11	and	and	CC
25944	2851	12	more	more	RBR
25944	2851	13	or	or	CC
25944	2851	14	less	less	RBR
25944	2851	15	infiltrated	infiltrated	JJ
25944	2851	16	,	,	,
25944	2851	17	hyperæsthetic	hyperæsthetic	JJ
25944	2851	18	or	or	CC
25944	2851	19	anæsthetic	anæsthetic	JJ
25944	2851	20	,	,	,
25944	2851	21	pinkish	pinkish	JJ
25944	2851	22	,	,	,
25944	2851	23	reddish	reddish	JJ
25944	2851	24	or	or	CC
25944	2851	25	pale	pale	JJ
25944	2851	26	-	-	HYPH
25944	2851	27	yellowish	yellowish	JJ
25944	2851	28	macules	macule	NNS
25944	2851	29	make	make	VBP
25944	2851	30	their	-PRON-	PRP$
25944	2851	31	appearance	appearance	NN
25944	2851	32	from	from	IN
25944	2851	33	time	time	NN
25944	2851	34	to	to	IN
25944	2851	35	time	time	NN
25944	2851	36	;	;	:
25944	2851	37	subsequently	subsequently	RB
25944	2851	38	fading	fade	VBG
25944	2851	39	away	away	RB
25944	2851	40	or	or	CC
25944	2851	41	remaining	remain	VBG
25944	2851	42	permanently	permanently	RB
25944	2851	43	(	(	-LRB-
25944	2851	44	_	_	NNP
25944	2851	45	lepra	lepra	NNP
25944	2851	46	maculosa	maculosa	NNP
25944	2851	47	_	_	NNP
25944	2851	48	)	)	-RRB-
25944	2851	49	.	.	.
25944	2852	1	When	when	WRB
25944	2852	2	well	well	RB
25944	2852	3	advanced	advanced	JJ
25944	2852	4	,	,	,
25944	2852	5	the	the	DT
25944	2852	6	tubercular	tubercular	JJ
25944	2852	7	or	or	CC
25944	2852	8	nodular	nodular	JJ
25944	2852	9	masses	masse	NNS
25944	2852	10	give	give	VBP
25944	2852	11	rise	rise	NN
25944	2852	12	to	to	IN
25944	2852	13	great	great	JJ
25944	2852	14	deformity	deformity	NN
25944	2852	15	;	;	:
25944	2852	16	the	the	DT
25944	2852	17	face	face	NN
25944	2852	18	,	,	,
25944	2852	19	a	a	DT
25944	2852	20	favorite	favorite	JJ
25944	2852	21	locality	locality	NN
25944	2852	22	,	,	,
25944	2852	23	becomes	become	VBZ
25944	2852	24	more	more	RBR
25944	2852	25	or	or	CC
25944	2852	26	less	less	JJR
25944	2852	27	leonine	leonine	NN
25944	2852	28	in	in	IN
25944	2852	29	appearance	appearance	NN
25944	2852	30	(	(	-LRB-
25944	2852	31	_	_	NNP
25944	2852	32	leontiasis	leontiasis	NN
25944	2852	33	_	_	NNP
25944	2852	34	)	)	-RRB-
25944	2852	35	.	.	.
25944	2853	1	The	the	DT
25944	2853	2	tubercles	tubercle	NNS
25944	2853	3	persist	persist	VBP
25944	2853	4	almost	almost	RB
25944	2853	5	indefinitely	indefinitely	RB
25944	2853	6	without	without	IN
25944	2853	7	material	material	NN
25944	2853	8	change	change	NN
25944	2853	9	,	,	,
25944	2853	10	or	or	CC
25944	2853	11	undergo	undergo	VB
25944	2853	12	absorption	absorption	NN
25944	2853	13	or	or	CC
25944	2853	14	ulceration	ulceration	NN
25944	2853	15	;	;	:
25944	2853	16	this	this	DT
25944	2853	17	last	last	JJ
25944	2853	18	takes	take	VBZ
25944	2853	19	place	place	NN
25944	2853	20	most	most	RBS
25944	2853	21	commonly	commonly	RB
25944	2853	22	about	about	IN
25944	2853	23	the	the	DT
25944	2853	24	fingers	finger	NNS
25944	2853	25	and	and	CC
25944	2853	26	toes	toe	NNS
25944	2853	27	.	.	.
25944	2854	1	The	the	DT
25944	2854	2	mucous	mucous	JJ
25944	2854	3	membrane	membrane	NN
25944	2854	4	of	of	IN
25944	2854	5	the	the	DT
25944	2854	6	mouth	mouth	NN
25944	2854	7	,	,	,
25944	2854	8	pharynx	pharynx	NN
25944	2854	9	and	and	CC
25944	2854	10	other	other	JJ
25944	2854	11	parts	part	NNS
25944	2854	12	may	may	MD
25944	2854	13	also	also	RB
25944	2854	14	become	become	VB
25944	2854	15	involved	involved	JJ
25944	2854	16	.	.	.
25944	2855	1	[	[	-LRB-
25944	2855	2	Illustration	illustration	NN
25944	2855	3	:	:	:
25944	2855	4	Fig	Fig	NNP
25944	2855	5	.	.	.
25944	2856	1	63	63	CD
25944	2856	2	.	.	.
25944	2857	1	Anæsthetic	Anæsthetic	NNP
25944	2857	2	Leprosy	Leprosy	NNP
25944	2857	3	.	.	.
25944	2857	4	]	]	-RRB-
25944	2858	1	#	#	NNP
25944	2858	2	Describe	describe	VB
25944	2858	3	the	the	DT
25944	2858	4	symptoms	symptom	NNS
25944	2858	5	of	of	IN
25944	2858	6	anæsthetic	anæsthetic	JJ
25944	2858	7	leprosy	leprosy	NN
25944	2858	8	.	.	.
25944	2858	9	#	#	NN
25944	2858	10	Following	follow	VBG
25944	2858	11	or	or	CC
25944	2858	12	along	along	RB
25944	2858	13	with	with	IN
25944	2858	14	precursory	precursory	NN
25944	2858	15	symptoms	symptom	NNS
25944	2858	16	denoting	denote	VBG
25944	2858	17	general	general	JJ
25944	2858	18	systemic	systemic	JJ
25944	2858	19	disturbance	disturbance	NN
25944	2858	20	,	,	,
25944	2858	21	or	or	CC
25944	2858	22	independently	independently	RB
25944	2858	23	of	of	IN
25944	2858	24	any	any	DT
25944	2858	25	prodromal	prodromal	JJ
25944	2858	26	indications	indication	NNS
25944	2858	27	,	,	,
25944	2858	28	a	a	DT
25944	2858	29	hyperæsthetic	hyperæsthetic	JJ
25944	2858	30	condition	condition	NN
25944	2858	31	,	,	,
25944	2858	32	in	in	IN
25944	2858	33	localized	localized	JJ
25944	2858	34	areas	area	NNS
25944	2858	35	or	or	CC
25944	2858	36	more	more	RBR
25944	2858	37	or	or	CC
25944	2858	38	less	less	RBR
25944	2858	39	general	general	JJ
25944	2858	40	,	,	,
25944	2858	41	is	be	VBZ
25944	2858	42	observed	observe	VBN
25944	2858	43	.	.	.
25944	2859	1	Lancinating	lancinating	JJ
25944	2859	2	pains	pain	NNS
25944	2859	3	along	along	IN
25944	2859	4	the	the	DT
25944	2859	5	nerves	nerve	NNS
25944	2859	6	and	and	CC
25944	2859	7	an	an	DT
25944	2859	8	irregular	irregular	JJ
25944	2859	9	pemphigoid	pemphigoid	JJ
25944	2859	10	eruption	eruption	NN
25944	2859	11	are	be	VBP
25944	2859	12	also	also	RB
25944	2859	13	commonly	commonly	RB
25944	2859	14	noted	note	VBN
25944	2859	15	.	.	.
25944	2860	1	There	there	EX
25944	2860	2	soon	soon	RB
25944	2860	3	follows	follow	VBZ
25944	2860	4	the	the	DT
25944	2860	5	special	special	JJ
25944	2860	6	eruption	eruption	NN
25944	2860	7	,	,	,
25944	2860	8	coming	come	VBG
25944	2860	9	out	out	RP
25944	2860	10	from	from	IN
25944	2860	11	time	time	NN
25944	2860	12	to	to	IN
25944	2860	13	time	time	NN
25944	2860	14	,	,	,
25944	2860	15	and	and	CC
25944	2860	16	consisting	consisting	NN
25944	2860	17	of	of	IN
25944	2860	18	several	several	JJ
25944	2860	19	or	or	CC
25944	2860	20	more	more	JJR
25944	2860	21	,	,	,
25944	2860	22	usually	usually	RB
25944	2860	23	non	non	JJ
25944	2860	24	-	-	JJ
25944	2860	25	elevated	elevated	JJ
25944	2860	26	,	,	,
25944	2860	27	well	well	RB
25944	2860	28	-	-	HYPH
25944	2860	29	defined	define	VBN
25944	2860	30	,	,	,
25944	2860	31	pale	pale	JJ
25944	2860	32	-	-	HYPH
25944	2860	33	yellowish	yellowish	JJ
25944	2860	34	patches	patch	NNS
25944	2860	35	,	,	,
25944	2860	36	one	one	CD
25944	2860	37	or	or	CC
25944	2860	38	two	two	CD
25944	2860	39	inches	inch	NNS
25944	2860	40	in	in	IN
25944	2860	41	diameter	diameter	NN
25944	2860	42	.	.	.
25944	2861	1	As	as	IN
25944	2861	2	a	a	DT
25944	2861	3	rule	rule	NN
25944	2861	4	,	,	,
25944	2861	5	they	-PRON-	PRP
25944	2861	6	are	be	VBP
25944	2861	7	at	at	IN
25944	2861	8	first	first	JJ
25944	2861	9	neither	neither	CC
25944	2861	10	hyperæsthetic	hyperæsthetic	JJ
25944	2861	11	nor	nor	CC
25944	2861	12	anæsthetic	anæsthetic	JJ
25944	2861	13	,	,	,
25944	2861	14	but	but	CC
25944	2861	15	may	may	MD
25944	2861	16	be	be	VB
25944	2861	17	the	the	DT
25944	2861	18	seat	seat	NN
25944	2861	19	of	of	IN
25944	2861	20	slight	slight	JJ
25944	2861	21	burning	burning	NN
25944	2861	22	or	or	CC
25944	2861	23	itching	itching	NN
25944	2861	24	.	.	.
25944	2862	1	They	-PRON-	PRP
25944	2862	2	spread	spread	VBP
25944	2862	3	peripherally	peripherally	RB
25944	2862	4	,	,	,
25944	2862	5	and	and	CC
25944	2862	6	tend	tend	VB
25944	2862	7	to	to	TO
25944	2862	8	clear	clear	VB
25944	2862	9	in	in	IN
25944	2862	10	the	the	DT
25944	2862	11	centre	centre	NN
25944	2862	12	.	.	.
25944	2863	1	The	the	DT
25944	2863	2	patches	patch	NNS
25944	2863	3	eventually	eventually	RB
25944	2863	4	become	become	VBP
25944	2863	5	markedly	markedly	RB
25944	2863	6	anæsthetic	anæsthetic	JJ
25944	2863	7	,	,	,
25944	2863	8	and	and	CC
25944	2863	9	the	the	DT
25944	2863	10	overlying	overlying	NN
25944	2863	11	skin	skin	NN
25944	2863	12	,	,	,
25944	2863	13	and	and	CC
25944	2863	14	the	the	DT
25944	2863	15	skin	skin	NN
25944	2863	16	on	on	IN
25944	2863	17	other	other	JJ
25944	2863	18	parts	part	NNS
25944	2863	19	as	as	RB
25944	2863	20	well	well	RB
25944	2863	21	,	,	,
25944	2863	22	becomes	become	VBZ
25944	2863	23	atrophic	atrophic	JJ
25944	2863	24	and	and	CC
25944	2863	25	of	of	IN
25944	2863	26	a	a	DT
25944	2863	27	brownish	brownish	JJ
25944	2863	28	or	or	CC
25944	2863	29	yellowish	yellowish	JJ
25944	2863	30	color	color	NN
25944	2863	31	.	.	.
25944	2864	1	The	the	DT
25944	2864	2	subcutaneous	subcutaneous	JJ
25944	2864	3	tissues	tissue	NNS
25944	2864	4	,	,	,
25944	2864	5	muscle	muscle	NN
25944	2864	6	,	,	,
25944	2864	7	hair	hair	NN
25944	2864	8	and	and	CC
25944	2864	9	nails	nail	NNS
25944	2864	10	undergo	undergo	VBP
25944	2864	11	atrophic	atrophic	JJ
25944	2864	12	or	or	CC
25944	2864	13	degenerative	degenerative	JJ
25944	2864	14	changes	change	NNS
25944	2864	15	,	,	,
25944	2864	16	and	and	CC
25944	2864	17	these	these	DT
25944	2864	18	changes	change	NNS
25944	2864	19	are	be	VBP
25944	2864	20	especially	especially	RB
25944	2864	21	noted	note	VBN
25944	2864	22	about	about	IN
25944	2864	23	the	the	DT
25944	2864	24	hands	hand	NNS
25944	2864	25	and	and	CC
25944	2864	26	feet	foot	NNS
25944	2864	27	.	.	.
25944	2865	1	These	these	DT
25944	2865	2	parts	part	NNS
25944	2865	3	become	become	VBP
25944	2865	4	crooked	crooked	JJ
25944	2865	5	,	,	,
25944	2865	6	the	the	DT
25944	2865	7	bone	bone	NN
25944	2865	8	tissues	tissue	NNS
25944	2865	9	are	be	VBP
25944	2865	10	involved	involve	VBN
25944	2865	11	,	,	,
25944	2865	12	the	the	DT
25944	2865	13	phalanges	phalanx	NNS
25944	2865	14	dropping	drop	VBG
25944	2865	15	off	off	RP
25944	2865	16	or	or	CC
25944	2865	17	disappearing	disappear	VBG
25944	2865	18	by	by	IN
25944	2865	19	disintegration	disintegration	NN
25944	2865	20	or	or	CC
25944	2865	21	absorption	absorption	NN
25944	2865	22	(	(	-LRB-
25944	2865	23	_	_	NNP
25944	2865	24	lepra	lepra	NNP
25944	2865	25	mutilans	mutilans	NNPS
25944	2865	26	_	_	NNP
25944	2865	27	)	)	-RRB-
25944	2865	28	.	.	.
25944	2866	1	Sooner	soon	RBR
25944	2866	2	or	or	CC
25944	2866	3	later	later	RBR
25944	2866	4	various	various	JJ
25944	2866	5	paralytic	paralytic	JJ
25944	2866	6	symptoms	symptom	NNS
25944	2866	7	,	,	,
25944	2866	8	showing	show	VBG
25944	2866	9	more	more	RBR
25944	2866	10	active	active	JJ
25944	2866	11	involvement	involvement	NN
25944	2866	12	of	of	IN
25944	2866	13	the	the	DT
25944	2866	14	nerve	nerve	NN
25944	2866	15	trunks	trunk	NNS
25944	2866	16	,	,	,
25944	2866	17	present	present	VB
25944	2866	18	themselves	-PRON-	PRP
25944	2866	19	.	.	.
25944	2867	1	#	#	JJR
25944	2867	2	State	state	NN
25944	2867	3	the	the	DT
25944	2867	4	cause	cause	NN
25944	2867	5	of	of	IN
25944	2867	6	leprosy	leprosy	NN
25944	2867	7	.	.	.
25944	2867	8	#	#	JJ
25944	2867	9	Present	present	JJ
25944	2867	10	knowledge	knowledge	NN
25944	2867	11	points	point	NNS
25944	2867	12	to	to	IN
25944	2867	13	a	a	DT
25944	2867	14	peculiar	peculiar	JJ
25944	2867	15	bacillus	bacillus	NN
25944	2867	16	as	as	IN
25944	2867	17	the	the	DT
25944	2867	18	active	active	JJ
25944	2867	19	factor	factor	NN
25944	2867	20	,	,	,
25944	2867	21	while	while	IN
25944	2867	22	climate	climate	NN
25944	2867	23	,	,	,
25944	2867	24	soil	soil	NN
25944	2867	25	,	,	,
25944	2867	26	heredity	heredity	NN
25944	2867	27	,	,	,
25944	2867	28	food	food	NN
25944	2867	29	and	and	CC
25944	2867	30	habits	habit	NNS
25944	2867	31	exert	exert	VBP
25944	2867	32	a	a	DT
25944	2867	33	predisposing	predisposing	NN
25944	2867	34	influence	influence	NN
25944	2867	35	.	.	.
25944	2868	1	#	#	$
25944	2868	2	Is	be	VBZ
25944	2868	3	leprosy	leprosy	NN
25944	2868	4	contagious	contagious	JJ
25944	2868	5	?	?	.
25944	2868	6	#	#	$
25944	2868	7	The	the	DT
25944	2868	8	consensus	consensus	NN
25944	2868	9	of	of	IN
25944	2868	10	opinion	opinion	NN
25944	2868	11	points	point	NNS
25944	2868	12	to	to	IN
25944	2868	13	the	the	DT
25944	2868	14	acceptance	acceptance	NN
25944	2868	15	of	of	IN
25944	2868	16	the	the	DT
25944	2868	17	possible	possible	JJ
25944	2868	18	contagiousness	contagiousness	NN
25944	2868	19	of	of	IN
25944	2868	20	leprosy	leprosy	NN
25944	2868	21	;	;	:
25944	2868	22	probably	probably	RB
25944	2868	23	by	by	IN
25944	2868	24	inoculation	inoculation	NN
25944	2868	25	,	,	,
25944	2868	26	but	but	CC
25944	2868	27	only	only	RB
25944	2868	28	under	under	IN
25944	2868	29	certain	certain	JJ
25944	2868	30	unknown	unknown	JJ
25944	2868	31	favoring	favor	VBG
25944	2868	32	conditions	condition	NNS
25944	2868	33	.	.	.
25944	2869	1	#	#	LS
25944	2869	2	What	what	WP
25944	2869	3	are	be	VBP
25944	2869	4	the	the	DT
25944	2869	5	pathological	pathological	JJ
25944	2869	6	changes	change	NNS
25944	2869	7	?	?	.
25944	2869	8	#	#	$
25944	2869	9	The	the	DT
25944	2869	10	lesions	lesion	NNS
25944	2869	11	consist	consist	VBP
25944	2869	12	essentially	essentially	RB
25944	2869	13	of	of	IN
25944	2869	14	a	a	DT
25944	2869	15	new	new	JJ
25944	2869	16	growth	growth	NN
25944	2869	17	,	,	,
25944	2869	18	made	make	VBN
25944	2869	19	up	up	RP
25944	2869	20	of	of	IN
25944	2869	21	numerous	numerous	JJ
25944	2869	22	small	small	JJ
25944	2869	23	,	,	,
25944	2869	24	more	more	RBR
25944	2869	25	or	or	CC
25944	2869	26	less	less	RBR
25944	2869	27	aggregated	aggregated	JJ
25944	2869	28	round	round	JJ
25944	2869	29	cells	cell	NNS
25944	2869	30	,	,	,
25944	2869	31	beginning	begin	VBG
25944	2869	32	in	in	IN
25944	2869	33	the	the	DT
25944	2869	34	walls	wall	NNS
25944	2869	35	of	of	IN
25944	2869	36	the	the	DT
25944	2869	37	bloodvessels	bloodvessel	NNS
25944	2869	38	.	.	.
25944	2870	1	In	in	IN
25944	2870	2	this	this	DT
25944	2870	3	way	way	NN
25944	2870	4	the	the	DT
25944	2870	5	tubercular	tubercular	JJ
25944	2870	6	masses	masse	NNS
25944	2870	7	and	and	CC
25944	2870	8	various	various	JJ
25944	2870	9	other	other	JJ
25944	2870	10	lesions	lesion	NNS
25944	2870	11	are	be	VBP
25944	2870	12	formed	form	VBN
25944	2870	13	.	.	.
25944	2871	1	As	as	IN
25944	2871	2	yet	yet	RB
25944	2871	3	,	,	,
25944	2871	4	positive	positive	JJ
25944	2871	5	involvement	involvement	NN
25944	2871	6	ot	ot	IN
25944	2871	7	the	the	DT
25944	2871	8	central	central	JJ
25944	2871	9	nervous	nervous	JJ
25944	2871	10	system	system	NN
25944	2871	11	has	have	VBZ
25944	2871	12	not	not	RB
25944	2871	13	been	be	VBN
25944	2871	14	shown	show	VBN
25944	2871	15	,	,	,
25944	2871	16	but	but	CC
25944	2871	17	some	some	DT
25944	2871	18	of	of	IN
25944	2871	19	the	the	DT
25944	2871	20	nerve	nerve	NN
25944	2871	21	trunks	trunk	NNS
25944	2871	22	are	be	VBP
25944	2871	23	found	find	VBN
25944	2871	24	to	to	TO
25944	2871	25	be	be	VB
25944	2871	26	inflamed	inflame	VBN
25944	2871	27	and	and	CC
25944	2871	28	swollen	swollen	JJ
25944	2871	29	,	,	,
25944	2871	30	with	with	IN
25944	2871	31	a	a	DT
25944	2871	32	tendency	tendency	NN
25944	2871	33	toward	toward	IN
25944	2871	34	hardening	harden	VBG
25944	2871	35	.	.	.
25944	2872	1	#	#	$
25944	2872	2	What	what	WDT
25944	2872	3	several	several	JJ
25944	2872	4	diseases	disease	NNS
25944	2872	5	are	be	VBP
25944	2872	6	to	to	TO
25944	2872	7	be	be	VB
25944	2872	8	eliminated	eliminate	VBN
25944	2872	9	in	in	IN
25944	2872	10	the	the	DT
25944	2872	11	diagnosis	diagnosis	NN
25944	2872	12	of	of	IN
25944	2872	13	leprosy	leprosy	NN
25944	2872	14	?	?	.
25944	2872	15	#	#	NNP
25944	2872	16	Syphilis	Syphilis	NNP
25944	2872	17	,	,	,
25944	2872	18	morph[oe]a	morph[oe]a	NNP
25944	2872	19	,	,	,
25944	2872	20	vitiligo	vitiligo	NNS
25944	2872	21	,	,	,
25944	2872	22	lupus	lupus	NNP
25944	2872	23	,	,	,
25944	2872	24	and	and	CC
25944	2872	25	syringomyelia	syringomyelia	NNP
25944	2872	26	.	.	.
25944	2873	1	When	when	WRB
25944	2873	2	well	well	RB
25944	2873	3	advanced	advanced	JJ
25944	2873	4	,	,	,
25944	2873	5	the	the	DT
25944	2873	6	aggregate	aggregate	JJ
25944	2873	7	symptoms	symptom	NNS
25944	2873	8	of	of	IN
25944	2873	9	leprosy	leprosy	NN
25944	2873	10	form	form	NN
25944	2873	11	a	a	DT
25944	2873	12	picture	picture	NN
25944	2873	13	which	which	WDT
25944	2873	14	can	can	MD
25944	2873	15	scarcely	scarcely	RB
25944	2873	16	be	be	VB
25944	2873	17	confused	confuse	VBN
25944	2873	18	with	with	IN
25944	2873	19	that	that	DT
25944	2873	20	of	of	IN
25944	2873	21	any	any	DT
25944	2873	22	other	other	JJ
25944	2873	23	disease	disease	NN
25944	2873	24	.	.	.
25944	2874	1	In	in	IN
25944	2874	2	doubtful	doubtful	JJ
25944	2874	3	cases	case	NNS
25944	2874	4	microscopical	microscopical	JJ
25944	2874	5	examinations	examination	NNS
25944	2874	6	of	of	IN
25944	2874	7	the	the	DT
25944	2874	8	involved	involved	JJ
25944	2874	9	tissues	tissue	NNS
25944	2874	10	,	,	,
25944	2874	11	for	for	IN
25944	2874	12	the	the	DT
25944	2874	13	bacilli	bacilli	NN
25944	2874	14	,	,	,
25944	2874	15	should	should	MD
25944	2874	16	be	be	VB
25944	2874	17	made	make	VBN
25944	2874	18	.	.	.
25944	2875	1	#	#	JJR
25944	2875	2	State	state	NN
25944	2875	3	the	the	DT
25944	2875	4	prognosis	prognosis	NN
25944	2875	5	of	of	IN
25944	2875	6	leprosy	leprosy	NN
25944	2875	7	.	.	.
25944	2875	8	#	#	$
25944	2875	9	Unfavorable	Unfavorable	NNP
25944	2875	10	;	;	:
25944	2875	11	a	a	DT
25944	2875	12	fatal	fatal	JJ
25944	2875	13	termination	termination	NN
25944	2875	14	is	be	VBZ
25944	2875	15	the	the	DT
25944	2875	16	rule	rule	NN
25944	2875	17	,	,	,
25944	2875	18	but	but	CC
25944	2875	19	may	may	MD
25944	2875	20	not	not	RB
25944	2875	21	be	be	VB
25944	2875	22	reached	reach	VBN
25944	2875	23	for	for	IN
25944	2875	24	a	a	DT
25944	2875	25	number	number	NN
25944	2875	26	of	of	IN
25944	2875	27	years	year	NNS
25944	2875	28	.	.	.
25944	2876	1	The	the	DT
25944	2876	2	tubercular	tubercular	JJ
25944	2876	3	form	form	NN
25944	2876	4	is	be	VBZ
25944	2876	5	the	the	DT
25944	2876	6	most	most	RBS
25944	2876	7	grave	grave	JJ
25944	2876	8	,	,	,
25944	2876	9	the	the	DT
25944	2876	10	mixed	mixed	JJ
25944	2876	11	variety	variety	NN
25944	2876	12	next	next	RB
25944	2876	13	,	,	,
25944	2876	14	and	and	CC
25944	2876	15	the	the	DT
25944	2876	16	anæsthetic	anæsthetic	NN
25944	2876	17	the	the	DT
25944	2876	18	least	least	JJS
25944	2876	19	.	.	.
25944	2877	1	Patients	patient	NNS
25944	2877	2	are	be	VBP
25944	2877	3	not	not	RB
25944	2877	4	infrequently	infrequently	RB
25944	2877	5	carried	carry	VBN
25944	2877	6	off	off	RP
25944	2877	7	by	by	IN
25944	2877	8	intercurrent	intercurrent	NN
25944	2877	9	disease	disease	NN
25944	2877	10	.	.	.
25944	2878	1	Proper	proper	JJ
25944	2878	2	management	management	NN
25944	2878	3	will	will	MD
25944	2878	4	often	often	RB
25944	2878	5	delay	delay	VB
25944	2878	6	the	the	DT
25944	2878	7	fatal	fatal	JJ
25944	2878	8	ending	ending	NN
25944	2878	9	,	,	,
25944	2878	10	and	and	CC
25944	2878	11	exceptionally	exceptionally	RB
25944	2878	12	,	,	,
25944	2878	13	in	in	IN
25944	2878	14	the	the	DT
25944	2878	15	anæsthetic	anæsthetic	JJ
25944	2878	16	variety	variety	NN
25944	2878	17	,	,	,
25944	2878	18	stay	stay	VB
25944	2878	19	the	the	DT
25944	2878	20	progress	progress	NN
25944	2878	21	of	of	IN
25944	2878	22	the	the	DT
25944	2878	23	disease	disease	NN
25944	2878	24	.	.	.
25944	2879	1	#	#	LS
25944	2879	2	What	what	WP
25944	2879	3	is	be	VBZ
25944	2879	4	the	the	DT
25944	2879	5	treatment	treatment	NN
25944	2879	6	of	of	IN
25944	2879	7	leprosy	leprosy	NN
25944	2879	8	?	?	.
25944	2879	9	#	#	DT
25944	2879	10	Hygienic	hygienic	JJ
25944	2879	11	measures	measure	NNS
25944	2879	12	are	be	VBP
25944	2879	13	important	important	JJ
25944	2879	14	.	.	.
25944	2880	1	Chaulmoogra	Chaulmoogra	NNP
25944	2880	2	oil	oil	NN
25944	2880	3	and	and	CC
25944	2880	4	gurjun	gurjun	JJ
25944	2880	5	oil	oil	NN
25944	2880	6	internally	internally	RB
25944	2880	7	and	and	CC
25944	2880	8	externally	externally	RB
25944	2880	9	are	be	VBP
25944	2880	10	in	in	IN
25944	2880	11	some	some	DT
25944	2880	12	instances	instance	NNS
25944	2880	13	of	of	IN
25944	2880	14	service	service	NN
25944	2880	15	.	.	.
25944	2881	1	Strychnia	Strychnia	NNP
25944	2881	2	alone	alone	RB
25944	2881	3	,	,	,
25944	2881	4	or	or	CC
25944	2881	5	with	with	IN
25944	2881	6	either	either	DT
25944	2881	7	of	of	IN
25944	2881	8	these	these	DT
25944	2881	9	oils	oil	NNS
25944	2881	10	,	,	,
25944	2881	11	is	be	VBZ
25944	2881	12	ofttimes	ofttimes	NNP
25944	2881	13	beneficial	beneficial	JJ
25944	2881	14	.	.	.
25944	2882	1	Ichthyol	Ichthyol	NNP
25944	2882	2	internally	internally	RB
25944	2882	3	,	,	,
25944	2882	4	and	and	CC
25944	2882	5	external	external	JJ
25944	2882	6	applications	application	NNS
25944	2882	7	of	of	IN
25944	2882	8	the	the	DT
25944	2882	9	same	same	JJ
25944	2882	10	drug	drug	NN
25944	2882	11	,	,	,
25944	2882	12	and	and	CC
25944	2882	13	of	of	IN
25944	2882	14	resorcin	resorcin	NNP
25944	2882	15	,	,	,
25944	2882	16	chrysarobin	chrysarobin	NNP
25944	2882	17	,	,	,
25944	2882	18	and	and	CC
25944	2882	19	pyrogallic	pyrogallic	NN
25944	2882	20	acid	acid	NN
25944	2882	21	,	,	,
25944	2882	22	have	have	VBP
25944	2882	23	been	be	VBN
25944	2882	24	extolled	extoll	VBN
25944	2882	25	.	.	.
25944	2883	1	Change	change	NN
25944	2883	2	of	of	IN
25944	2883	3	climate	climate	NN
25944	2883	4	,	,	,
25944	2883	5	especially	especially	RB
25944	2883	6	to	to	IN
25944	2883	7	a	a	DT
25944	2883	8	region	region	NN
25944	2883	9	where	where	WRB
25944	2883	10	the	the	DT
25944	2883	11	disease	disease	NN
25944	2883	12	does	do	VBZ
25944	2883	13	not	not	RB
25944	2883	14	prevail	prevail	VB
25944	2883	15	,	,	,
25944	2883	16	is	be	VBZ
25944	2883	17	often	often	RB
25944	2883	18	of	of	IN
25944	2883	19	great	great	JJ
25944	2883	20	advantage	advantage	NN
25944	2883	21	.	.	.
25944	2884	1	#	#	NNP
25944	2884	2	Pellagra	Pellagra	NNP
25944	2884	3	.	.	.
25944	2884	4	#	#	NNP
25944	2884	5	(	(	-LRB-
25944	2884	6	_	_	NNP
25944	2884	7	Synonym	Synonym	NNP
25944	2884	8	:	:	:
25944	2884	9	_	_	NNP
25944	2884	10	Lombardian	Lombardian	NNP
25944	2884	11	Leprosy	Leprosy	NNP
25944	2884	12	.	.	.
25944	2884	13	)	)	-RRB-
25944	2885	1	#	#	$
25944	2885	2	Describe	Describe	NNP
25944	2885	3	pellagra	pellagra	NNS
25944	2885	4	.	.	.
25944	2885	5	#	#	NNP
25944	2885	6	Pellagra	Pellagra	NNP
25944	2885	7	is	be	VBZ
25944	2885	8	a	a	DT
25944	2885	9	slow	slow	JJ
25944	2885	10	but	but	CC
25944	2885	11	usually	usually	RB
25944	2885	12	progressive	progressive	JJ
25944	2885	13	disease	disease	NN
25944	2885	14	occurring	occur	VBG
25944	2885	15	chiefly	chiefly	RB
25944	2885	16	in	in	IN
25944	2885	17	Italy	Italy	NNP
25944	2885	18	,	,	,
25944	2885	19	due	due	JJ
25944	2885	20	,	,	,
25944	2885	21	it	-PRON-	PRP
25944	2885	22	is	be	VBZ
25944	2885	23	thought	think	VBN
25944	2885	24	,	,	,
25944	2885	25	to	to	IN
25944	2885	26	the	the	DT
25944	2885	27	continued	continue	VBN
25944	2885	28	ingestion	ingestion	NN
25944	2885	29	of	of	IN
25944	2885	30	decomposed	decompose	VBN
25944	2885	31	or	or	CC
25944	2885	32	fermented	ferment	VBN
25944	2885	33	maize	maize	NN
25944	2885	34	.	.	.
25944	2886	1	It	-PRON-	PRP
25944	2886	2	is	be	VBZ
25944	2886	3	characterized	characterize	VBN
25944	2886	4	by	by	IN
25944	2886	5	cutaneous	cutaneous	JJ
25944	2886	6	symptoms	symptom	NNS
25944	2886	7	,	,	,
25944	2886	8	at	at	IN
25944	2886	9	first	first	RB
25944	2886	10	upon	upon	IN
25944	2886	11	exposed	exposed	JJ
25944	2886	12	parts	part	NNS
25944	2886	13	,	,	,
25944	2886	14	of	of	IN
25944	2886	15	an	an	DT
25944	2886	16	erythematous	erythematous	JJ
25944	2886	17	,	,	,
25944	2886	18	desquamative	desquamative	JJ
25944	2886	19	,	,	,
25944	2886	20	vesicular	vesicular	JJ
25944	2886	21	and	and	CC
25944	2886	22	bullous	bullous	JJ
25944	2886	23	character	character	NN
25944	2886	24	,	,	,
25944	2886	25	and	and	CC
25944	2886	26	by	by	IN
25944	2886	27	general	general	JJ
25944	2886	28	constitutional	constitutional	JJ
25944	2886	29	disturbance	disturbance	NN
25944	2886	30	of	of	IN
25944	2886	31	a	a	DT
25944	2886	32	markedly	markedly	RB
25944	2886	33	neurotic	neurotic	JJ
25944	2886	34	type	type	NN
25944	2886	35	.	.	.
25944	2887	1	A	a	DT
25944	2887	2	fatal	fatal	JJ
25944	2887	3	ending	ending	NN
25944	2887	4	,	,	,
25944	2887	5	if	if	IN
25944	2887	6	the	the	DT
25944	2887	7	disease	disease	NN
25944	2887	8	is	be	VBZ
25944	2887	9	at	at	RB
25944	2887	10	all	all	RB
25944	2887	11	severe	severe	JJ
25944	2887	12	or	or	CC
25944	2887	13	advanced	advanced	JJ
25944	2887	14	,	,	,
25944	2887	15	is	be	VBZ
25944	2887	16	to	to	TO
25944	2887	17	be	be	VB
25944	2887	18	expected	expect	VBN
25944	2887	19	.	.	.
25944	2888	1	Treatment	treatment	NN
25944	2888	2	is	be	VBZ
25944	2888	3	based	base	VBN
25944	2888	4	upon	upon	IN
25944	2888	5	general	general	JJ
25944	2888	6	principles	principle	NNS
25944	2888	7	.	.	.
25944	2889	1	#	#	NNP
25944	2889	2	Epithelioma	Epithelioma	NNP
25944	2889	3	.	.	.
25944	2889	4	#	#	NNP
25944	2889	5	(	(	-LRB-
25944	2889	6	_	_	NNP
25944	2889	7	Synonyms	Synonyms	NNP
25944	2889	8	:	:	:
25944	2889	9	_	_	NNP
25944	2889	10	Skin	Skin	NNP
25944	2889	11	Cancer	cancer	NN
25944	2889	12	;	;	,
25944	2889	13	Epithelial	Epithelial	NNP
25944	2889	14	Cancer	Cancer	NNP
25944	2889	15	;	;	,
25944	2889	16	Carcinoma	Carcinoma	NNP
25944	2889	17	Epitheliale	Epitheliale	NNP
25944	2889	18	.	.	.
25944	2889	19	)	)	-RRB-
25944	2890	1	#	#	$
25944	2890	2	What	what	WDT
25944	2890	3	several	several	JJ
25944	2890	4	varieties	variety	NNS
25944	2890	5	of	of	IN
25944	2890	6	epithelioma	epithelioma	NNP
25944	2890	7	are	be	VBP
25944	2890	8	met	meet	VBN
25944	2890	9	with	with	IN
25944	2890	10	?	?	.
25944	2890	11	#	#	$
25944	2890	12	Three	three	CD
25944	2890	13	--	--	:
25944	2890	14	the	the	DT
25944	2890	15	superficial	superficial	NN
25944	2890	16	,	,	,
25944	2890	17	the	the	DT
25944	2890	18	deep	deep	RB
25944	2890	19	-	-	HYPH
25944	2890	20	seated	seated	JJ
25944	2890	21	,	,	,
25944	2890	22	and	and	CC
25944	2890	23	the	the	DT
25944	2890	24	papillomatous	papillomatous	JJ
25944	2890	25	.	.	.
25944	2891	1	#	#	NNP
25944	2891	2	Describe	describe	VB
25944	2891	3	the	the	DT
25944	2891	4	clinical	clinical	JJ
25944	2891	5	appearances	appearance	NNS
25944	2891	6	and	and	CC
25944	2891	7	course	course	NN
25944	2891	8	of	of	IN
25944	2891	9	the	the	DT
25944	2891	10	superficial	superficial	JJ
25944	2891	11	variety	variety	NN
25944	2891	12	of	of	IN
25944	2891	13	epithelioma	epithelioma	NNP
25944	2891	14	.	.	.
25944	2891	15	#	#	$
25944	2891	16	The	the	DT
25944	2891	17	superficial	superficial	JJ
25944	2891	18	,	,	,
25944	2891	19	or	or	CC
25944	2891	20	flat	flat	JJ
25944	2891	21	variety	variety	NN
25944	2891	22	(	(	-LRB-
25944	2891	23	_	_	NNP
25944	2891	24	rodent	rodent	NN
25944	2891	25	ulcer	ulcer	NNP
25944	2891	26	_	_	NNP
25944	2891	27	)	)	-RRB-
25944	2891	28	,	,	,
25944	2891	29	begins	begin	VBZ
25944	2891	30	,	,	,
25944	2891	31	usually	usually	RB
25944	2891	32	on	on	IN
25944	2891	33	the	the	DT
25944	2891	34	face	face	NN
25944	2891	35	,	,	,
25944	2891	36	as	as	IN
25944	2891	37	a	a	DT
25944	2891	38	minute	minute	NN
25944	2891	39	,	,	,
25944	2891	40	firm	firm	JJ
25944	2891	41	,	,	,
25944	2891	42	reddish	reddish	JJ
25944	2891	43	or	or	CC
25944	2891	44	yellowish	yellowish	JJ
25944	2891	45	tubercle	tubercle	NN
25944	2891	46	,	,	,
25944	2891	47	as	as	IN
25944	2891	48	an	an	DT
25944	2891	49	aggregation	aggregation	NN
25944	2891	50	of	of	IN
25944	2891	51	such	such	JJ
25944	2891	52	,	,	,
25944	2891	53	as	as	IN
25944	2891	54	a	a	DT
25944	2891	55	warty	warty	JJ
25944	2891	56	excrescence	excrescence	NN
25944	2891	57	,	,	,
25944	2891	58	or	or	CC
25944	2891	59	as	as	IN
25944	2891	60	a	a	DT
25944	2891	61	localized	localized	JJ
25944	2891	62	degenerative	degenerative	JJ
25944	2891	63	seborrh[oe]ic	seborrh[oe]ic	NNP
25944	2891	64	patch	patch	NN
25944	2891	65	.	.	.
25944	2892	1	The	the	DT
25944	2892	2	latter	latter	JJ
25944	2892	3	lesion	lesion	NN
25944	2892	4	(	(	-LRB-
25944	2892	5	known	know	VBN
25944	2892	6	also	also	RB
25944	2892	7	as	as	IN
25944	2892	8	keratosis	keratosis	NN
25944	2892	9	senilis	senilis	NNP
25944	2892	10	,	,	,
25944	2892	11	old	old	JJ
25944	2892	12	-	-	HYPH
25944	2892	13	age	age	NN
25944	2892	14	atrophic	atrophic	JJ
25944	2892	15	patches	patch	NNS
25944	2892	16	)	)	-RRB-
25944	2892	17	,	,	,
25944	2892	18	consisting	consist	VBG
25944	2892	19	of	of	IN
25944	2892	20	a	a	DT
25944	2892	21	yellowish	yellowish	JJ
25944	2892	22	or	or	CC
25944	2892	23	yellowish	yellowish	JJ
25944	2892	24	-	-	HYPH
25944	2892	25	brown	brown	JJ
25944	2892	26	greasy	greasy	NN
25944	2892	27	or	or	CC
25944	2892	28	hardened	hardened	JJ
25944	2892	29	scurfy	scurfy	NNP
25944	2892	30	spot	spot	NN
25944	2892	31	or	or	CC
25944	2892	32	patch	patch	NN
25944	2892	33	is	be	VBZ
25944	2892	34	quite	quite	RB
25944	2892	35	frequently	frequently	RB
25944	2892	36	the	the	DT
25944	2892	37	starting	starting	NN
25944	2892	38	-	-	HYPH
25944	2892	39	point	point	NN
25944	2892	40	of	of	IN
25944	2892	41	epithelial	epithelial	JJ
25944	2892	42	growths	growth	NNS
25944	2892	43	.	.	.
25944	2893	1	Sooner	soon	RBR
25944	2893	2	or	or	CC
25944	2893	3	later	later	RBR
25944	2893	4	,	,	,
25944	2893	5	commonly	commonly	RB
25944	2893	6	after	after	IN
25944	2893	7	months	month	NNS
25944	2893	8	or	or	CC
25944	2893	9	several	several	JJ
25944	2893	10	years	year	NNS
25944	2893	11	,	,	,
25944	2893	12	the	the	DT
25944	2893	13	surface	surface	NN
25944	2893	14	becomes	become	VBZ
25944	2893	15	slightly	slightly	RB
25944	2893	16	excoriated	excoriate	VBN
25944	2893	17	,	,	,
25944	2893	18	and	and	CC
25944	2893	19	an	an	DT
25944	2893	20	insignificant	insignificant	JJ
25944	2893	21	,	,	,
25944	2893	22	yellowish	yellowish	JJ
25944	2893	23	or	or	CC
25944	2893	24	brownish	brownish	JJ
25944	2893	25	crust	crust	NN
25944	2893	26	is	be	VBZ
25944	2893	27	formed	form	VBN
25944	2893	28	.	.	.
25944	2894	1	The	the	DT
25944	2894	2	excoriation	excoriation	NN
25944	2894	3	gradually	gradually	RB
25944	2894	4	develops	develop	VBZ
25944	2894	5	into	into	IN
25944	2894	6	superficial	superficial	JJ
25944	2894	7	ulceration	ulceration	NN
25944	2894	8	,	,	,
25944	2894	9	and	and	CC
25944	2894	10	the	the	DT
25944	2894	11	diseased	diseased	JJ
25944	2894	12	area	area	NN
25944	2894	13	becomes	become	VBZ
25944	2894	14	slowly	slowly	RB
25944	2894	15	larger	large	JJR
25944	2894	16	and	and	CC
25944	2894	17	larger	large	JJR
25944	2894	18	.	.	.
25944	2895	1	New	new	JJ
25944	2895	2	lesions	lesion	NNS
25944	2895	3	may	may	MD
25944	2895	4	continue	continue	VB
25944	2895	5	,	,	,
25944	2895	6	from	from	IN
25944	2895	7	time	time	NN
25944	2895	8	to	to	IN
25944	2895	9	time	time	NN
25944	2895	10	,	,	,
25944	2895	11	to	to	TO
25944	2895	12	appear	appear	VB
25944	2895	13	about	about	IN
25944	2895	14	the	the	DT
25944	2895	15	edges	edge	NNS
25944	2895	16	and	and	CC
25944	2895	17	go	go	VB
25944	2895	18	through	through	IN
25944	2895	19	the	the	DT
25944	2895	20	same	same	JJ
25944	2895	21	changes	change	NNS
25944	2895	22	.	.	.
25944	2896	1	[	[	-LRB-
25944	2896	2	Illustration	illustration	NN
25944	2896	3	:	:	:
25944	2896	4	Fig	Fig	NNP
25944	2896	5	.	.	.
25944	2897	1	64	64	CD
25944	2897	2	.	.	.
25944	2898	1	Epithelioma	Epithelioma	NNP
25944	2898	2	.	.	.
25944	2899	1	(	(	-LRB-
25944	2899	2	_	_	NNP
25944	2899	3	After	after	IN
25944	2899	4	D.	D.	NNP
25944	2899	5	Lewis	Lewis	NNP
25944	2899	6	.	.	.
25944	2899	7	_	_	NNP
25944	2899	8	)	)	-RRB-
25944	2899	9	]	]	-RRB-
25944	2899	10	The	the	DT
25944	2899	11	ulcer	ulcer	NN
25944	2899	12	has	have	VBZ
25944	2899	13	usually	usually	RB
25944	2899	14	an	an	DT
25944	2899	15	uneven	uneven	JJ
25944	2899	16	surface	surface	NN
25944	2899	17	,	,	,
25944	2899	18	secretes	secrete	VBZ
25944	2899	19	a	a	DT
25944	2899	20	thin	thin	JJ
25944	2899	21	,	,	,
25944	2899	22	scanty	scanty	NN
25944	2899	23	,	,	,
25944	2899	24	viscid	viscid	NN
25944	2899	25	fluid	fluid	NN
25944	2899	26	,	,	,
25944	2899	27	which	which	WDT
25944	2899	28	dries	dry	VBZ
25944	2899	29	to	to	IN
25944	2899	30	a	a	DT
25944	2899	31	firm	firm	JJ
25944	2899	32	,	,	,
25944	2899	33	adherent	adherent	JJ
25944	2899	34	crust	crust	NN
25944	2899	35	.	.	.
25944	2900	1	It	-PRON-	PRP
25944	2900	2	is	be	VBZ
25944	2900	3	usually	usually	RB
25944	2900	4	defined	define	VBN
25944	2900	5	against	against	IN
25944	2900	6	the	the	DT
25944	2900	7	healthy	healthy	JJ
25944	2900	8	skin	skin	NN
25944	2900	9	by	by	IN
25944	2900	10	a	a	DT
25944	2900	11	slightly	slightly	RB
25944	2900	12	elevated	elevated	JJ
25944	2900	13	,	,	,
25944	2900	14	hard	hard	JJ
25944	2900	15	,	,	,
25944	2900	16	roll	roll	NN
25944	2900	17	-	-	HYPH
25944	2900	18	like	like	JJ
25944	2900	19	,	,	,
25944	2900	20	waxy	waxy	RB
25944	2900	21	-	-	HYPH
25944	2900	22	looking	look	VBG
25944	2900	23	border	border	NN
25944	2900	24	.	.	.
25944	2901	1	In	in	IN
25944	2901	2	rare	rare	JJ
25944	2901	3	instances	instance	NNS
25944	2901	4	there	there	EX
25944	2901	5	is	be	VBZ
25944	2901	6	a	a	DT
25944	2901	7	disposition	disposition	NN
25944	2901	8	,	,	,
25944	2901	9	at	at	IN
25944	2901	10	points	point	NNS
25944	2901	11	,	,	,
25944	2901	12	to	to	IN
25944	2901	13	spontaneous	spontaneous	JJ
25944	2901	14	involution	involution	NN
25944	2901	15	and	and	CC
25944	2901	16	scar	scar	NN
25944	2901	17	formation	formation	NN
25944	2901	18	;	;	:
25944	2901	19	as	as	IN
25944	2901	20	a	a	DT
25944	2901	21	rule	rule	NN
25944	2901	22	,	,	,
25944	2901	23	however	however	RB
25944	2901	24	,	,	,
25944	2901	25	the	the	DT
25944	2901	26	ulcerative	ulcerative	JJ
25944	2901	27	action	action	NN
25944	2901	28	slowly	slowly	RB
25944	2901	29	progresses	progress	VBZ
25944	2901	30	.	.	.
25944	2902	1	The	the	DT
25944	2902	2	general	general	JJ
25944	2902	3	health	health	NN
25944	2902	4	is	be	VBZ
25944	2902	5	unimpaired	unimpaired	JJ
25944	2902	6	,	,	,
25944	2902	7	the	the	DT
25944	2902	8	neighboring	neighboring	JJ
25944	2902	9	lymphatic	lymphatic	JJ
25944	2902	10	glands	gland	NNS
25944	2902	11	are	be	VBP
25944	2902	12	not	not	RB
25944	2902	13	involved	involve	VBN
25944	2902	14	,	,	,
25944	2902	15	and	and	CC
25944	2902	16	the	the	DT
25944	2902	17	local	local	JJ
25944	2902	18	condition	condition	NN
25944	2902	19	,	,	,
25944	2902	20	beyond	beyond	IN
25944	2902	21	the	the	DT
25944	2902	22	disfigurement	disfigurement	NN
25944	2902	23	,	,	,
25944	2902	24	gives	give	VBZ
25944	2902	25	rise	rise	NN
25944	2902	26	to	to	IN
25944	2902	27	little	little	JJ
25944	2902	28	trouble	trouble	NN
25944	2902	29	,	,	,
25944	2902	30	unless	unless	IN
25944	2902	31	,	,	,
25944	2902	32	as	as	IN
25944	2902	33	occasionally	occasionally	RB
25944	2902	34	happens	happen	VBZ
25944	2902	35	,	,	,
25944	2902	36	it	-PRON-	PRP
25944	2902	37	passes	pass	VBZ
25944	2902	38	into	into	IN
25944	2902	39	the	the	DT
25944	2902	40	more	more	RBR
25944	2902	41	malignant	malignant	JJ
25944	2902	42	,	,	,
25944	2902	43	deep	deep	JJ
25944	2902	44	-	-	HYPH
25944	2902	45	seated	seat	VBN
25944	2902	46	variety	variety	NN
25944	2902	47	.	.	.
25944	2903	1	#	#	NNP
25944	2903	2	Describe	describe	VB
25944	2903	3	the	the	DT
25944	2903	4	clinical	clinical	JJ
25944	2903	5	appearances	appearance	NNS
25944	2903	6	and	and	CC
25944	2903	7	course	course	NN
25944	2903	8	of	of	IN
25944	2903	9	the	the	DT
25944	2903	10	deep	deep	RB
25944	2903	11	-	-	HYPH
25944	2903	12	seated	seat	VBN
25944	2903	13	variety	variety	NN
25944	2903	14	of	of	IN
25944	2903	15	epithelioma	epithelioma	NN
25944	2903	16	.	.	.
25944	2903	17	#	#	$
25944	2903	18	The	the	DT
25944	2903	19	deep	deep	RB
25944	2903	20	-	-	HYPH
25944	2903	21	seated	seat	VBN
25944	2903	22	variety	variety	NN
25944	2903	23	starts	start	VBZ
25944	2903	24	from	from	IN
25944	2903	25	the	the	DT
25944	2903	26	superficial	superficial	JJ
25944	2903	27	form	form	NN
25944	2903	28	,	,	,
25944	2903	29	or	or	CC
25944	2903	30	it	-PRON-	PRP
25944	2903	31	begins	begin	VBZ
25944	2903	32	as	as	IN
25944	2903	33	a	a	DT
25944	2903	34	tubercle	tubercle	NN
25944	2903	35	or	or	CC
25944	2903	36	nodule	nodule	VB
25944	2903	37	in	in	IN
25944	2903	38	the	the	DT
25944	2903	39	skin	skin	NN
25944	2903	40	.	.	.
25944	2904	1	When	when	WRB
25944	2904	2	typically	typically	RB
25944	2904	3	developed	develop	VBN
25944	2904	4	,	,	,
25944	2904	5	a	a	DT
25944	2904	6	reddish	reddish	JJ
25944	2904	7	,	,	,
25944	2904	8	shining	shine	VBG
25944	2904	9	tubercle	tubercle	NN
25944	2904	10	or	or	CC
25944	2904	11	nodule	nodule	VB
25944	2904	12	,	,	,
25944	2904	13	or	or	CC
25944	2904	14	area	area	NN
25944	2904	15	of	of	IN
25944	2904	16	infiltration	infiltration	NN
25944	2904	17	,	,	,
25944	2904	18	forms	form	NNS
25944	2904	19	in	in	IN
25944	2904	20	the	the	DT
25944	2904	21	skin	skin	NN
25944	2904	22	or	or	CC
25944	2904	23	subcutaneous	subcutaneous	JJ
25944	2904	24	tissue	tissue	NN
25944	2904	25	.	.	.
25944	2905	1	In	in	IN
25944	2905	2	the	the	DT
25944	2905	3	course	course	NN
25944	2905	4	of	of	IN
25944	2905	5	weeks	week	NNS
25944	2905	6	or	or	CC
25944	2905	7	months	month	NNS
25944	2905	8	superficial	superficial	JJ
25944	2905	9	or	or	CC
25944	2905	10	deep	deep	JJ
25944	2905	11	-	-	HYPH
25944	2905	12	seated	seat	VBN
25944	2905	13	ulceration	ulceration	NN
25944	2905	14	takes	take	VBZ
25944	2905	15	place	place	NN
25944	2905	16	;	;	:
25944	2905	17	the	the	DT
25944	2905	18	ulcer	ulcer	NN
25944	2905	19	having	have	VBG
25944	2905	20	hardened	harden	VBN
25944	2905	21	,	,	,
25944	2905	22	and	and	CC
25944	2905	23	,	,	,
25944	2905	24	as	as	IN
25944	2905	25	a	a	DT
25944	2905	26	rule	rule	NN
25944	2905	27	,	,	,
25944	2905	28	everted	evert	VBD
25944	2905	29	edges	edge	NNS
25944	2905	30	.	.	.
25944	2906	1	The	the	DT
25944	2906	2	surface	surface	NN
25944	2906	3	is	be	VBZ
25944	2906	4	reddish	reddish	JJ
25944	2906	5	and	and	CC
25944	2906	6	granular	granular	JJ
25944	2906	7	,	,	,
25944	2906	8	and	and	CC
25944	2906	9	secretes	secrete	VBZ
25944	2906	10	an	an	DT
25944	2906	11	ichorous	ichorous	JJ
25944	2906	12	discharge	discharge	NN
25944	2906	13	.	.	.
25944	2907	1	The	the	DT
25944	2907	2	infiltration	infiltration	NN
25944	2907	3	spreads	spread	VBZ
25944	2907	4	,	,	,
25944	2907	5	the	the	DT
25944	2907	6	ulcer	ulcer	NN
25944	2907	7	enlarges	enlarge	VBZ
25944	2907	8	both	both	CC
25944	2907	9	peripherally	peripherally	RB
25944	2907	10	and	and	CC
25944	2907	11	in	in	IN
25944	2907	12	depth	depth	NN
25944	2907	13	--	--	:
25944	2907	14	muscle	muscle	NN
25944	2907	15	,	,	,
25944	2907	16	cartilage	cartilage	NN
25944	2907	17	and	and	CC
25944	2907	18	bone	bone	NN
25944	2907	19	often	often	RB
25944	2907	20	becoming	become	VBG
25944	2907	21	invaded	invade	VBN
25944	2907	22	.	.	.
25944	2908	1	The	the	DT
25944	2908	2	neighboring	neighboring	JJ
25944	2908	3	lymphatic	lymphatic	JJ
25944	2908	4	gland	gland	NN
25944	2908	5	may	may	MD
25944	2908	6	become	become	VB
25944	2908	7	implicated	implicated	JJ
25944	2908	8	,	,	,
25944	2908	9	pains	pain	NNS
25944	2908	10	of	of	IN
25944	2908	11	a	a	DT
25944	2908	12	burning	burning	JJ
25944	2908	13	or	or	CC
25944	2908	14	neuralgic	neuralgic	JJ
25944	2908	15	type	type	NN
25944	2908	16	are	be	VBP
25944	2908	17	experienced	experience	VBN
25944	2908	18	,	,	,
25944	2908	19	and	and	CC
25944	2908	20	from	from	IN
25944	2908	21	septicæmia	septicæmia	NN
25944	2908	22	,	,	,
25944	2908	23	marasmus	marasmus	NNP
25944	2908	24	,	,	,
25944	2908	25	or	or	CC
25944	2908	26	involvement	involvement	NN
25944	2908	27	of	of	IN
25944	2908	28	vital	vital	JJ
25944	2908	29	parts	part	NNS
25944	2908	30	,	,	,
25944	2908	31	death	death	NN
25944	2908	32	eventually	eventually	RB
25944	2908	33	ensues	ensue	VBZ
25944	2908	34	.	.	.
25944	2909	1	#	#	NNP
25944	2909	2	Describe	describe	VB
25944	2909	3	the	the	DT
25944	2909	4	clinical	clinical	JJ
25944	2909	5	appearances	appearance	NNS
25944	2909	6	and	and	CC
25944	2909	7	course	course	NN
25944	2909	8	of	of	IN
25944	2909	9	the	the	DT
25944	2909	10	papillomatous	papillomatous	JJ
25944	2909	11	variety	variety	NN
25944	2909	12	of	of	IN
25944	2909	13	epithelioma	epithelioma	NN
25944	2909	14	.	.	.
25944	2909	15	#	#	$
25944	2909	16	The	the	DT
25944	2909	17	papillomatous	papillomatous	JJ
25944	2909	18	type	type	NN
25944	2909	19	usually	usually	RB
25944	2909	20	arises	arise	VBZ
25944	2909	21	from	from	IN
25944	2909	22	the	the	DT
25944	2909	23	superficial	superficial	JJ
25944	2909	24	or	or	CC
25944	2909	25	deep	deep	JJ
25944	2909	26	-	-	HYPH
25944	2909	27	seated	seat	VBN
25944	2909	28	variety	variety	NN
25944	2909	29	,	,	,
25944	2909	30	or	or	CC
25944	2909	31	it	-PRON-	PRP
25944	2909	32	may	may	MD
25944	2909	33	begin	begin	VB
25944	2909	34	as	as	IN
25944	2909	35	a	a	DT
25944	2909	36	papillary	papillary	JJ
25944	2909	37	or	or	CC
25944	2909	38	warty	warty	JJ
25944	2909	39	growth	growth	NN
25944	2909	40	.	.	.
25944	2910	1	When	when	WRB
25944	2910	2	fully	fully	RB
25944	2910	3	developed	develop	VBN
25944	2910	4	,	,	,
25944	2910	5	it	-PRON-	PRP
25944	2910	6	presents	present	VBZ
25944	2910	7	an	an	DT
25944	2910	8	ulcerated	ulcerated	JJ
25944	2910	9	,	,	,
25944	2910	10	fissured	fissured	JJ
25944	2910	11	and	and	CC
25944	2910	12	papillomatous	papillomatous	JJ
25944	2910	13	surface	surface	NN
25944	2910	14	,	,	,
25944	2910	15	with	with	IN
25944	2910	16	an	an	DT
25944	2910	17	ichorous	ichorous	JJ
25944	2910	18	discharge	discharge	NN
25944	2910	19	which	which	WDT
25944	2910	20	dries	dry	VBZ
25944	2910	21	to	to	IN
25944	2910	22	crusts	crust	NNS
25944	2910	23	.	.	.
25944	2911	1	It	-PRON-	PRP
25944	2911	2	is	be	VBZ
25944	2911	3	slowly	slowly	RB
25944	2911	4	progressive	progressive	JJ
25944	2911	5	,	,	,
25944	2911	6	and	and	CC
25944	2911	7	sooner	soon	RBR
25944	2911	8	or	or	CC
25944	2911	9	later	later	RB
25944	2911	10	may	may	MD
25944	2911	11	develop	develop	VB
25944	2911	12	a	a	DT
25944	2911	13	malignant	malignant	JJ
25944	2911	14	tendency	tendency	NN
25944	2911	15	.	.	.
25944	2912	1	#	#	NN
25944	2912	2	Upon	upon	IN
25944	2912	3	what	what	WP
25944	2912	4	parts	part	NNS
25944	2912	5	is	be	VBZ
25944	2912	6	epithelioma	epithelioma	NN
25944	2912	7	commonly	commonly	RB
25944	2912	8	observed	observe	VBN
25944	2912	9	?	?	.
25944	2912	10	#	#	$
25944	2912	11	About	about	IN
25944	2912	12	the	the	DT
25944	2912	13	face	face	NN
25944	2912	14	,	,	,
25944	2912	15	especially	especially	RB
25944	2912	16	the	the	DT
25944	2912	17	nose	nose	NN
25944	2912	18	,	,	,
25944	2912	19	eyelids	eyelid	NNS
25944	2912	20	and	and	CC
25944	2912	21	lips	lip	NNS
25944	2912	22	;	;	,
25944	2912	23	and	and	CC
25944	2912	24	also	also	RB
25944	2912	25	about	about	IN
25944	2912	26	the	the	DT
25944	2912	27	genitalia	genitalia	NNP
25944	2912	28	.	.	.
25944	2913	1	It	-PRON-	PRP
25944	2913	2	may	may	MD
25944	2913	3	involve	involve	VB
25944	2913	4	any	any	DT
25944	2913	5	part	part	NN
25944	2913	6	.	.	.
25944	2914	1	#	#	$
25944	2914	2	At	at	IN
25944	2914	3	what	what	WDT
25944	2914	4	age	age	NN
25944	2914	5	is	be	VBZ
25944	2914	6	epithelioma	epithelioma	NN
25944	2914	7	usually	usually	RB
25944	2914	8	noted	note	VBN
25944	2914	9	?	?	.
25944	2914	10	#	#	$
25944	2914	11	It	-PRON-	PRP
25944	2914	12	is	be	VBZ
25944	2914	13	essentially	essentially	RB
25944	2914	14	a	a	DT
25944	2914	15	disease	disease	NN
25944	2914	16	of	of	IN
25944	2914	17	middle	middle	JJ
25944	2914	18	and	and	CC
25944	2914	19	late	late	JJ
25944	2914	20	life	life	NN
25944	2914	21	,	,	,
25944	2914	22	although	although	IN
25944	2914	23	it	-PRON-	PRP
25944	2914	24	is	be	VBZ
25944	2914	25	exceptionally	exceptionally	RB
25944	2914	26	met	meet	VBN
25944	2914	27	with	with	IN
25944	2914	28	in	in	IN
25944	2914	29	the	the	DT
25944	2914	30	young	young	JJ
25944	2914	31	.	.	.
25944	2915	1	#	#	LS
25944	2915	2	What	what	WP
25944	2915	3	is	be	VBZ
25944	2915	4	the	the	DT
25944	2915	5	cause	cause	NN
25944	2915	6	of	of	IN
25944	2915	7	epithelioma	epithelioma	NN
25944	2915	8	?	?	.
25944	2915	9	#	#	$
25944	2915	10	The	the	DT
25944	2915	11	etiology	etiology	NN
25944	2915	12	is	be	VBZ
25944	2915	13	obscure	obscure	JJ
25944	2915	14	.	.	.
25944	2916	1	It	-PRON-	PRP
25944	2916	2	is	be	VBZ
25944	2916	3	not	not	RB
25944	2916	4	,	,	,
25944	2916	5	as	as	IN
25944	2916	6	a	a	DT
25944	2916	7	rule	rule	NN
25944	2916	8	,	,	,
25944	2916	9	inherited	inherit	VBD
25944	2916	10	.	.	.
25944	2917	1	Any	any	DT
25944	2917	2	locally	locally	RB
25944	2917	3	irritated	irritated	JJ
25944	2917	4	tissue	tissue	NN
25944	2917	5	may	may	MD
25944	2917	6	be	be	VB
25944	2917	7	the	the	DT
25944	2917	8	starting	starting	NN
25944	2917	9	point	point	NN
25944	2917	10	of	of	IN
25944	2917	11	the	the	DT
25944	2917	12	disease	disease	NN
25944	2917	13	.	.	.
25944	2918	1	#	#	NNP
25944	2918	2	State	state	NN
25944	2918	3	the	the	DT
25944	2918	4	pathology	pathology	NN
25944	2918	5	.	.	.
25944	2918	6	#	#	$
25944	2918	7	The	the	DT
25944	2918	8	process	process	NN
25944	2918	9	consists	consist	VBZ
25944	2918	10	in	in	IN
25944	2918	11	the	the	DT
25944	2918	12	proliferation	proliferation	NN
25944	2918	13	of	of	IN
25944	2918	14	epithelial	epithelial	JJ
25944	2918	15	cells	cell	NNS
25944	2918	16	from	from	IN
25944	2918	17	the	the	DT
25944	2918	18	mucous	mucous	JJ
25944	2918	19	layer	layer	NN
25944	2918	20	;	;	:
25944	2918	21	the	the	DT
25944	2918	22	cell	cell	NN
25944	2918	23	-	-	HYPH
25944	2918	24	growth	growth	NN
25944	2918	25	takes	take	VBZ
25944	2918	26	place	place	NN
25944	2918	27	downward	downward	RB
25944	2918	28	,	,	,
25944	2918	29	in	in	IN
25944	2918	30	the	the	DT
25944	2918	31	form	form	NN
25944	2918	32	of	of	IN
25944	2918	33	finger	finger	NN
25944	2918	34	-	-	HYPH
25944	2918	35	like	like	JJ
25944	2918	36	prolongations	prolongation	NNS
25944	2918	37	or	or	CC
25944	2918	38	columns	column	NNS
25944	2918	39	,	,	,
25944	2918	40	or	or	CC
25944	2918	41	it	-PRON-	PRP
25944	2918	42	may	may	MD
25944	2918	43	spread	spread	VB
25944	2918	44	out	out	RP
25944	2918	45	laterally	laterally	RB
25944	2918	46	,	,	,
25944	2918	47	so	so	IN
25944	2918	48	as	as	IN
25944	2918	49	to	to	TO
25944	2918	50	form	form	VB
25944	2918	51	rounded	rounded	JJ
25944	2918	52	masses	masse	NNS
25944	2918	53	,	,	,
25944	2918	54	the	the	DT
25944	2918	55	centres	centre	NNS
25944	2918	56	of	of	IN
25944	2918	57	which	which	WDT
25944	2918	58	usually	usually	RB
25944	2918	59	undergo	undergo	VBP
25944	2918	60	horny	horny	JJ
25944	2918	61	transformation	transformation	NN
25944	2918	62	,	,	,
25944	2918	63	resulting	result	VBG
25944	2918	64	in	in	IN
25944	2918	65	the	the	DT
25944	2918	66	formation	formation	NN
25944	2918	67	of	of	IN
25944	2918	68	onion	onion	NN
25944	2918	69	-	-	HYPH
25944	2918	70	like	like	JJ
25944	2918	71	bodies	body	NNS
25944	2918	72	,	,	,
25944	2918	73	the	the	DT
25944	2918	74	so	so	RB
25944	2918	75	-	-	HYPH
25944	2918	76	called	call	VBN
25944	2918	77	cell	cell	NN
25944	2918	78	-	-	HYPH
25944	2918	79	nests	nest	NNS
25944	2918	80	or	or	CC
25944	2918	81	globes	globe	NNS
25944	2918	82	.	.	.
25944	2919	1	The	the	DT
25944	2919	2	rapid	rapid	JJ
25944	2919	3	cell	cell	NN
25944	2919	4	-	-	HYPH
25944	2919	5	growth	growth	NN
25944	2919	6	requires	require	VBZ
25944	2919	7	increased	increase	VBN
25944	2919	8	nutriment	nutriment	NN
25944	2919	9	,	,	,
25944	2919	10	and	and	CC
25944	2919	11	hence	hence	RB
25944	2919	12	the	the	DT
25944	2919	13	bloodvessels	bloodvessel	NNS
25944	2919	14	become	become	VBP
25944	2919	15	enlarged	enlarged	JJ
25944	2919	16	;	;	:
25944	2919	17	moreover	moreover	RB
25944	2919	18	,	,	,
25944	2919	19	the	the	DT
25944	2919	20	pressure	pressure	NN
25944	2919	21	of	of	IN
25944	2919	22	the	the	DT
25944	2919	23	cell	cell	NN
25944	2919	24	-	-	HYPH
25944	2919	25	masses	masse	NNS
25944	2919	26	gives	give	VBZ
25944	2919	27	rise	rise	NN
25944	2919	28	to	to	IN
25944	2919	29	irritation	irritation	NN
25944	2919	30	and	and	CC
25944	2919	31	inflammation	inflammation	NN
25944	2919	32	,	,	,
25944	2919	33	with	with	IN
25944	2919	34	corresponding	correspond	VBG
25944	2919	35	serous	serous	JJ
25944	2919	36	and	and	CC
25944	2919	37	round	round	JJ
25944	2919	38	-	-	HYPH
25944	2919	39	cell	cell	NN
25944	2919	40	infiltration	infiltration	NN
25944	2919	41	.	.	.
25944	2920	1	#	#	NNP
25944	2920	2	How	how	WRB
25944	2920	3	would	would	MD
25944	2920	4	you	-PRON-	PRP
25944	2920	5	distinguish	distinguish	VB
25944	2920	6	epithelioma	epithelioma	NNP
25944	2920	7	from	from	IN
25944	2920	8	syphilitic	syphilitic	JJ
25944	2920	9	ulceration	ulceration	NN
25944	2920	10	,	,	,
25944	2920	11	wart	wart	JJ
25944	2920	12	,	,	,
25944	2920	13	and	and	CC
25944	2920	14	lupus	lupus	NNP
25944	2920	15	vulgaris	vulgaris	NNP
25944	2920	16	?	?	.
25944	2920	17	#	#	$
25944	2920	18	From	from	IN
25944	2920	19	syphilis	syphilis	NNP
25944	2920	20	it	-PRON-	PRP
25944	2920	21	is	be	VBZ
25944	2920	22	to	to	TO
25944	2920	23	be	be	VB
25944	2920	24	differentiated	differentiate	VBN
25944	2920	25	by	by	IN
25944	2920	26	the	the	DT
25944	2920	27	history	history	NN
25944	2920	28	,	,	,
25944	2920	29	duration	duration	NN
25944	2920	30	,	,	,
25944	2920	31	character	character	NN
25944	2920	32	of	of	IN
25944	2920	33	the	the	DT
25944	2920	34	base	base	NN
25944	2920	35	and	and	CC
25944	2920	36	edges	edge	NNS
25944	2920	37	,	,	,
25944	2920	38	its	-PRON-	PRP$
25944	2920	39	comparative	comparative	JJ
25944	2920	40	slow	slow	JJ
25944	2920	41	progress	progress	NN
25944	2920	42	,	,	,
25944	2920	43	its	-PRON-	PRP$
25944	2920	44	usually	usually	RB
25944	2920	45	slight	slight	JJ
25944	2920	46	,	,	,
25944	2920	47	viscid	viscid	JJ
25944	2920	48	discharge	discharge	NN
25944	2920	49	,	,	,
25944	2920	50	often	often	RB
25944	2920	51	streaked	streak	VBD
25944	2920	52	with	with	IN
25944	2920	53	blood	blood	NN
25944	2920	54	,	,	,
25944	2920	55	and	and	CC
25944	2920	56	,	,	,
25944	2920	57	if	if	IN
25944	2920	58	necessary	necessary	JJ
25944	2920	59	,	,	,
25944	2920	60	by	by	IN
25944	2920	61	the	the	DT
25944	2920	62	therapeutic	therapeutic	JJ
25944	2920	63	test	test	NN
25944	2920	64	.	.	.
25944	2921	1	Wart	wart	JJ
25944	2921	2	or	or	CC
25944	2921	3	warty	warty	CD
25944	2921	4	growths	growth	NNS
25944	2921	5	are	be	VBP
25944	2921	6	to	to	TO
25944	2921	7	be	be	VB
25944	2921	8	differentiated	differentiate	VBN
25944	2921	9	by	by	IN
25944	2921	10	attention	attention	NN
25944	2921	11	to	to	IN
25944	2921	12	their	-PRON-	PRP$
25944	2921	13	history	history	NN
25944	2921	14	and	and	CC
25944	2921	15	course	course	NN
25944	2921	16	.	.	.
25944	2922	1	Long	long	RB
25944	2922	2	-	-	HYPH
25944	2922	3	continued	continue	VBN
25944	2922	4	observation	observation	NN
25944	2922	5	may	may	MD
25944	2922	6	be	be	VB
25944	2922	7	necessary	necessary	JJ
25944	2922	8	before	before	IN
25944	2922	9	a	a	DT
25944	2922	10	positive	positive	JJ
25944	2922	11	opinion	opinion	NN
25944	2922	12	is	be	VBZ
25944	2922	13	warrantable	warrantable	JJ
25944	2922	14	.	.	.
25944	2923	1	The	the	DT
25944	2923	2	appearance	appearance	NN
25944	2923	3	of	of	IN
25944	2923	4	any	any	DT
25944	2923	5	tendency	tendency	NN
25944	2923	6	to	to	IN
25944	2923	7	crusting	crusting	NN
25944	2923	8	,	,	,
25944	2923	9	to	to	TO
25944	2923	10	break	break	VB
25944	2923	11	down	down	RP
25944	2923	12	or	or	CC
25944	2923	13	ulcerate	ulcerate	JJ
25944	2923	14	is	be	VBZ
25944	2923	15	significant	significant	JJ
25944	2923	16	of	of	IN
25944	2923	17	epitheliomatous	epitheliomatous	JJ
25944	2923	18	degeneration	degeneration	NN
25944	2923	19	.	.	.
25944	2924	1	In	in	IN
25944	2924	2	lupus	lupus	NNP
25944	2924	3	vulgaris	vulgaris	NNP
25944	2924	4	the	the	DT
25944	2924	5	deposits	deposit	NNS
25944	2924	6	are	be	VBP
25944	2924	7	peculiar	peculiar	JJ
25944	2924	8	and	and	CC
25944	2924	9	multiple	multiple	JJ
25944	2924	10	,	,	,
25944	2924	11	the	the	DT
25944	2924	12	ulcerations	ulceration	NNS
25944	2924	13	are	be	VBP
25944	2924	14	of	of	IN
25944	2924	15	different	different	JJ
25944	2924	16	character	character	NN
25944	2924	17	,	,	,
25944	2924	18	the	the	DT
25944	2924	19	tendency	tendency	NN
25944	2924	20	to	to	IN
25944	2924	21	scar	scar	NN
25944	2924	22	-	-	HYPH
25944	2924	23	formation	formation	NN
25944	2924	24	constant	constant	NN
25944	2924	25	;	;	:
25944	2924	26	and	and	CC
25944	2924	27	,	,	,
25944	2924	28	with	with	IN
25944	2924	29	few	few	JJ
25944	2924	30	exceptions	exception	NNS
25944	2924	31	,	,	,
25944	2924	32	it	-PRON-	PRP
25944	2924	33	has	have	VBZ
25944	2924	34	,	,	,
25944	2924	35	moreover	moreover	RB
25944	2924	36	,	,	,
25944	2924	37	its	-PRON-	PRP$
25944	2924	38	beginning	beginning	NN
25944	2924	39	in	in	IN
25944	2924	40	childhood	childhood	NN
25944	2924	41	or	or	CC
25944	2924	42	early	early	JJ
25944	2924	43	adult	adult	NN
25944	2924	44	life	life	NN
25944	2924	45	.	.	.
25944	2925	1	#	#	NN
25944	2925	2	What	what	WDT
25944	2925	3	factors	factor	NNS
25944	2925	4	are	be	VBP
25944	2925	5	to	to	TO
25944	2925	6	be	be	VB
25944	2925	7	considered	consider	VBN
25944	2925	8	in	in	IN
25944	2925	9	giving	give	VBG
25944	2925	10	a	a	DT
25944	2925	11	prognosis	prognosis	NN
25944	2925	12	in	in	IN
25944	2925	13	epithelioma	epithelioma	NN
25944	2925	14	?	?	.
25944	2925	15	#	#	$
25944	2925	16	The	the	DT
25944	2925	17	variety	variety	NN
25944	2925	18	,	,	,
25944	2925	19	extent	extent	NN
25944	2925	20	,	,	,
25944	2925	21	and	and	CC
25944	2925	22	rapidity	rapidity	NN
25944	2925	23	of	of	IN
25944	2925	24	the	the	DT
25944	2925	25	process	process	NN
25944	2925	26	.	.	.
25944	2926	1	The	the	DT
25944	2926	2	superficial	superficial	JJ
25944	2926	3	form	form	NN
25944	2926	4	may	may	MD
25944	2926	5	exist	exist	VB
25944	2926	6	for	for	IN
25944	2926	7	years	year	NNS
25944	2926	8	,	,	,
25944	2926	9	and	and	CC
25944	2926	10	give	give	VB
25944	2926	11	rise	rise	NN
25944	2926	12	to	to	IN
25944	2926	13	no	no	DT
25944	2926	14	alarm	alarm	NN
25944	2926	15	;	;	:
25944	2926	16	whereas	whereas	IN
25944	2926	17	the	the	DT
25944	2926	18	deeper	deeply	RBR
25944	2926	19	-	-	HYPH
25944	2926	20	seated	seat	VBN
25944	2926	21	varieties	variety	NNS
25944	2926	22	are	be	VBP
25944	2926	23	always	always	RB
25944	2926	24	to	to	TO
25944	2926	25	be	be	VB
25944	2926	26	viewed	view	VBN
25944	2926	27	as	as	IN
25944	2926	28	serious	serious	JJ
25944	2926	29	,	,	,
25944	2926	30	and	and	CC
25944	2926	31	are	be	VBP
25944	2926	32	,	,	,
25944	2926	33	indeed	indeed	RB
25944	2926	34	,	,	,
25944	2926	35	often	often	RB
25944	2926	36	fatal	fatal	JJ
25944	2926	37	.	.	.
25944	2927	1	Involving	involve	VBG
25944	2927	2	the	the	DT
25944	2927	3	genitalia	genitalia	NNP
25944	2927	4	,	,	,
25944	2927	5	its	-PRON-	PRP$
25944	2927	6	course	course	NN
25944	2927	7	is	be	VBZ
25944	2927	8	often	often	RB
25944	2927	9	strikingly	strikingly	RB
25944	2927	10	rapid	rapid	JJ
25944	2927	11	.	.	.
25944	2928	1	Relapses	relapse	NNS
25944	2928	2	,	,	,
25944	2928	3	after	after	IN
25944	2928	4	removal	removal	NN
25944	2928	5	,	,	,
25944	2928	6	are	be	VBP
25944	2928	7	not	not	RB
25944	2928	8	uncommon	uncommon	JJ
25944	2928	9	.	.	.
25944	2929	1	#	#	LS
25944	2929	2	What	what	WP
25944	2929	3	is	be	VBZ
25944	2929	4	the	the	DT
25944	2929	5	special	special	JJ
25944	2929	6	object	object	NN
25944	2929	7	in	in	IN
25944	2929	8	view	view	NN
25944	2929	9	in	in	IN
25944	2929	10	the	the	DT
25944	2929	11	treatment	treatment	NN
25944	2929	12	of	of	IN
25944	2929	13	epithelioma	epithelioma	NN
25944	2929	14	?	?	.
25944	2929	15	#	#	$
25944	2929	16	Thorough	thorough	JJ
25944	2929	17	destruction	destruction	NN
25944	2929	18	or	or	CC
25944	2929	19	removal	removal	NN
25944	2929	20	of	of	IN
25944	2929	21	the	the	DT
25944	2929	22	epitheliomatous	epitheliomatous	JJ
25944	2929	23	tissue	tissue	NN
25944	2929	24	.	.	.
25944	2930	1	#	#	NNP
25944	2930	2	How	how	WRB
25944	2930	3	is	be	VBZ
25944	2930	4	the	the	DT
25944	2930	5	destruction	destruction	NN
25944	2930	6	or	or	CC
25944	2930	7	removal	removal	NN
25944	2930	8	of	of	IN
25944	2930	9	the	the	DT
25944	2930	10	epitheliomatous	epitheliomatous	JJ
25944	2930	11	tissue	tissue	NN
25944	2930	12	effected	effect	VBN
25944	2930	13	?	?	.
25944	2930	14	#	#	NN
25944	2930	15	By	by	IN
25944	2930	16	the	the	DT
25944	2930	17	use	use	NN
25944	2930	18	of	of	IN
25944	2930	19	such	such	JJ
25944	2930	20	caustics	caustic	NNS
25944	2930	21	as	as	IN
25944	2930	22	caustic	caustic	JJ
25944	2930	23	potash	potash	NN
25944	2930	24	,	,	,
25944	2930	25	chloride	chloride	NN
25944	2930	26	-	-	HYPH
25944	2930	27	of	of	IN
25944	2930	28	-	-	HYPH
25944	2930	29	zinc	zinc	NN
25944	2930	30	paste	paste	NN
25944	2930	31	,	,	,
25944	2930	32	pyrogallic	pyrogallic	NN
25944	2930	33	acid	acid	NN
25944	2930	34	,	,	,
25944	2930	35	arsenic	arsenic	JJ
25944	2930	36	,	,	,
25944	2930	37	and	and	CC
25944	2930	38	the	the	DT
25944	2930	39	galvano	galvano	NN
25944	2930	40	-	-	HYPH
25944	2930	41	cautery	cautery	NN
25944	2930	42	;	;	:
25944	2930	43	and	and	CC
25944	2930	44	by	by	IN
25944	2930	45	operative	operative	JJ
25944	2930	46	measures	measure	NNS
25944	2930	47	,	,	,
25944	2930	48	such	such	JJ
25944	2930	49	as	as	IN
25944	2930	50	excision	excision	NN
25944	2930	51	and	and	CC
25944	2930	52	erasion	erasion	NN
25944	2930	53	with	with	IN
25944	2930	54	the	the	DT
25944	2930	55	dermal	dermal	JJ
25944	2930	56	curette	curette	NN
25944	2930	57	,	,	,
25944	2930	58	and	and	CC
25944	2930	59	by	by	IN
25944	2930	60	the	the	DT
25944	2930	61	_	_	NNP
25944	2930	62	x_-ray	x_-ray	NN
25944	2930	63	.	.	.
25944	2931	1	(	(	-LRB-
25944	2931	2	See	see	VB
25944	2931	3	treatment	treatment	NN
25944	2931	4	of	of	IN
25944	2931	5	lupus	lupus	NNP
25944	2931	6	vulgaris	vulgaris	NNP
25944	2931	7	.	.	.
25944	2931	8	)	)	-RRB-
25944	2932	1	In	in	IN
25944	2932	2	small	small	JJ
25944	2932	3	lesions	lesion	NNS
25944	2932	4	the	the	DT
25944	2932	5	use	use	NN
25944	2932	6	of	of	IN
25944	2932	7	an	an	DT
25944	2932	8	arsenical	arsenical	JJ
25944	2932	9	paste	paste	NN
25944	2932	10	is	be	VBZ
25944	2932	11	a	a	DT
25944	2932	12	most	most	RBS
25944	2932	13	admirable	admirable	JJ
25944	2932	14	method	method	NN
25944	2932	15	of	of	IN
25944	2932	16	treatment	treatment	NN
25944	2932	17	,	,	,
25944	2932	18	although	although	IN
25944	2932	19	somewhat	somewhat	RB
25944	2932	20	painful	painful	JJ
25944	2932	21	.	.	.
25944	2933	1	The	the	DT
25944	2933	2	paste	paste	NN
25944	2933	3	is	be	VBZ
25944	2933	4	made	make	VBN
25944	2933	5	of	of	IN
25944	2933	6	one	one	CD
25944	2933	7	part	part	NN
25944	2933	8	powdered	powder	VBN
25944	2933	9	acacia	acacia	NNP
25944	2933	10	and	and	CC
25944	2933	11	one	one	CD
25944	2933	12	to	to	TO
25944	2933	13	two	two	CD
25944	2933	14	parts	part	NNS
25944	2933	15	arsenious	arsenious	JJ
25944	2933	16	acid	acid	NN
25944	2933	17	;	;	:
25944	2933	18	at	at	IN
25944	2933	19	the	the	DT
25944	2933	20	time	time	NN
25944	2933	21	of	of	IN
25944	2933	22	application	application	NN
25944	2933	23	sufficient	sufficient	JJ
25944	2933	24	water	water	NN
25944	2933	25	is	be	VBZ
25944	2933	26	added	add	VBN
25944	2933	27	to	to	TO
25944	2933	28	make	make	VB
25944	2933	29	a	a	DT
25944	2933	30	paste	paste	NN
25944	2933	31	.	.	.
25944	2934	1	This	this	DT
25944	2934	2	is	be	VBZ
25944	2934	3	applied	apply	VBN
25944	2934	4	thickly	thickly	RB
25944	2934	5	,	,	,
25944	2934	6	and	and	CC
25944	2934	7	a	a	DT
25944	2934	8	piece	piece	NN
25944	2934	9	of	of	IN
25944	2934	10	lint	lint	NN
25944	2934	11	superimposed	superimpose	VBN
25944	2934	12	.	.	.
25944	2935	1	A	a	DT
25944	2935	2	good	good	JJ
25944	2935	3	deal	deal	NN
25944	2935	4	of	of	IN
25944	2935	5	pain	pain	NN
25944	2935	6	and	and	CC
25944	2935	7	inflammatory	inflammatory	JJ
25944	2935	8	swelling	swell	VBG
25944	2935	9	ensue	ensue	NN
25944	2935	10	;	;	:
25944	2935	11	at	at	IN
25944	2935	12	the	the	DT
25944	2935	13	end	end	NN
25944	2935	14	of	of	IN
25944	2935	15	twenty	twenty	CD
25944	2935	16	-	-	HYPH
25944	2935	17	four	four	CD
25944	2935	18	hours	hour	NNS
25944	2935	19	the	the	DT
25944	2935	20	part	part	NN
25944	2935	21	is	be	VBZ
25944	2935	22	poulticed	poultice	VBN
25944	2935	23	till	till	IN
25944	2935	24	the	the	DT
25944	2935	25	slough	slough	NN
25944	2935	26	comes	come	VBZ
25944	2935	27	away	away	RB
25944	2935	28	;	;	:
25944	2935	29	the	the	DT
25944	2935	30	ulcer	ulcer	NN
25944	2935	31	is	be	VBZ
25944	2935	32	then	then	RB
25944	2935	33	treated	treat	VBN
25944	2935	34	as	as	IN
25944	2935	35	a	a	DT
25944	2935	36	simple	simple	JJ
25944	2935	37	ulcer	ulcer	NN
25944	2935	38	,	,	,
25944	2935	39	under	under	IN
25944	2935	40	which	which	WDT
25944	2935	41	healing	healing	NN
25944	2935	42	takes	take	VBZ
25944	2935	43	place	place	NN
25944	2935	44	.	.	.
25944	2936	1	Occasionally	occasionally	RB
25944	2936	2	a	a	DT
25944	2936	3	second	second	JJ
25944	2936	4	application	application	NN
25944	2936	5	is	be	VBZ
25944	2936	6	found	find	VBN
25944	2936	7	necessary	necessary	JJ
25944	2936	8	.	.	.
25944	2937	1	Upon	upon	IN
25944	2937	2	the	the	DT
25944	2937	3	whole	whole	NN
25944	2937	4	,	,	,
25944	2937	5	the	the	DT
25944	2937	6	best	good	JJS
25944	2937	7	method	method	NN
25944	2937	8	in	in	IN
25944	2937	9	the	the	DT
25944	2937	10	average	average	JJ
25944	2937	11	case	case	NN
25944	2937	12	is	be	VBZ
25944	2937	13	to	to	TO
25944	2937	14	curette	curette	VB
25944	2937	15	thoroughly	thoroughly	RB
25944	2937	16	,	,	,
25944	2937	17	and	and	CC
25944	2937	18	supplement	supplement	VB
25944	2937	19	with	with	IN
25944	2937	20	momentary	momentary	JJ
25944	2937	21	cauterization	cauterization	NN
25944	2937	22	,	,	,
25944	2937	23	with	with	IN
25944	2937	24	caustic	caustic	JJ
25944	2937	25	potash	potash	NN
25944	2937	26	,	,	,
25944	2937	27	or	or	CC
25944	2937	28	with	with	IN
25944	2937	29	several	several	JJ
25944	2937	30	days	day	NNS
25944	2937	31	'	'	POS
25944	2937	32	use	use	NN
25944	2937	33	of	of	IN
25944	2937	34	the	the	DT
25944	2937	35	pyrogallic	pyrogallic	NN
25944	2937	36	acid	acid	NNP
25944	2937	37	ointment	ointment	NNP
25944	2937	38	.	.	.
25944	2938	1	During	during	IN
25944	2938	2	the	the	DT
25944	2938	3	healing	healing	NN
25944	2938	4	process	process	NN
25944	2938	5	,	,	,
25944	2938	6	short	short	JJ
25944	2938	7	exposures	exposure	NNS
25944	2938	8	to	to	IN
25944	2938	9	the	the	DT
25944	2938	10	Röntgen	Röntgen	NNP
25944	2938	11	ray	ray	NNP
25944	2938	12	--	--	:
25944	2938	13	about	about	RB
25944	2938	14	every	every	DT
25944	2938	15	three	three	CD
25944	2938	16	to	to	TO
25944	2938	17	five	five	CD
25944	2938	18	days	day	NNS
25944	2938	19	--	--	:
25944	2938	20	is	be	VBZ
25944	2938	21	good	good	JJ
25944	2938	22	practice	practice	NN
25944	2938	23	.	.	.
25944	2939	1	The	the	DT
25944	2939	2	degenerative	degenerative	JJ
25944	2939	3	changes	change	NNS
25944	2939	4	in	in	IN
25944	2939	5	the	the	DT
25944	2939	6	beginning	beginning	NN
25944	2939	7	of	of	IN
25944	2939	8	scurfy	scurfy	NNP
25944	2939	9	,	,	,
25944	2939	10	seborrh[oe]ic	seborrh[oe]ic	NNP
25944	2939	11	spots	spot	NNS
25944	2939	12	or	or	CC
25944	2939	13	patches	patch	NNS
25944	2939	14	seen	see	VBN
25944	2939	15	in	in	IN
25944	2939	16	old	old	JJ
25944	2939	17	people	people	NNS
25944	2939	18	can	can	MD
25944	2939	19	frequently	frequently	RB
25944	2939	20	be	be	VB
25944	2939	21	lessened	lessen	VBN
25944	2939	22	or	or	CC
25944	2939	23	wholly	wholly	RB
25944	2939	24	stopped	stop	VBN
25944	2939	25	by	by	IN
25944	2939	26	the	the	DT
25944	2939	27	daily	daily	JJ
25944	2939	28	application	application	NN
25944	2939	29	of	of	IN
25944	2939	30	an	an	DT
25944	2939	31	ointment	ointment	NN
25944	2939	32	containing	contain	VBG
25944	2939	33	5	5	CD
25944	2939	34	to	to	TO
25944	2939	35	10	10	CD
25944	2939	36	per	per	NN
25944	2939	37	cent	cent	NN
25944	2939	38	.	.	.
25944	2940	1	of	of	IN
25944	2940	2	sulphur	sulphur	NNP
25944	2940	3	and	and	CC
25944	2940	4	2	2	CD
25944	2940	5	to	to	TO
25944	2940	6	5	5	CD
25944	2940	7	per	per	NN
25944	2940	8	cent	cent	NN
25944	2940	9	.	.	.
25944	2941	1	of	of	IN
25944	2941	2	salicylic	salicylic	JJ
25944	2941	3	acid	acid	NN
25944	2941	4	.	.	.
25944	2942	1	#	#	LS
25944	2942	2	What	what	WP
25944	2942	3	can	can	MD
25944	2942	4	be	be	VB
25944	2942	5	said	say	VBN
25944	2942	6	of	of	IN
25944	2942	7	the	the	DT
25944	2942	8	value	value	NN
25944	2942	9	of	of	IN
25944	2942	10	the	the	DT
25944	2942	11	x	x	NN
25944	2942	12	-	-	NN
25944	2942	13	ray	ray	NN
25944	2942	14	in	in	IN
25944	2942	15	epithelioma	epithelioma	NNP
25944	2942	16	?	?	.
25944	2942	17	#	#	$
25944	2942	18	The	the	DT
25944	2942	19	_	_	NNP
25944	2942	20	x_-ray	x_-ray	NN
25944	2942	21	method	method	NN
25944	2942	22	is	be	VBZ
25944	2942	23	now	now	RB
25944	2942	24	much	much	JJ
25944	2942	25	in	in	IN
25944	2942	26	vogue	vogue	NN
25944	2942	27	,	,	,
25944	2942	28	and	and	CC
25944	2942	29	proves	prove	VBZ
25944	2942	30	curative	curative	JJ
25944	2942	31	in	in	IN
25944	2942	32	many	many	JJ
25944	2942	33	superficial	superficial	JJ
25944	2942	34	cases	case	NNS
25944	2942	35	,	,	,
25944	2942	36	and	and	CC
25944	2942	37	of	of	IN
25944	2942	38	benefit	benefit	NN
25944	2942	39	in	in	IN
25944	2942	40	some	some	DT
25944	2942	41	of	of	IN
25944	2942	42	the	the	DT
25944	2942	43	deeper	deeply	RBR
25944	2942	44	-	-	HYPH
25944	2942	45	seated	seat	VBN
25944	2942	46	varieties	variety	NNS
25944	2942	47	.	.	.
25944	2943	1	In	in	IN
25944	2943	2	most	most	JJS
25944	2943	3	cases	case	NNS
25944	2943	4	it	-PRON-	PRP
25944	2943	5	must	must	MD
25944	2943	6	be	be	VB
25944	2943	7	pushed	push	VBN
25944	2943	8	to	to	IN
25944	2943	9	the	the	DT
25944	2943	10	point	point	NN
25944	2943	11	of	of	IN
25944	2943	12	producing	produce	VBG
25944	2943	13	a	a	DT
25944	2943	14	mild	mild	JJ
25944	2943	15	_	_	NNP
25944	2943	16	x_-ray	x_-ray	NN
25944	2943	17	erythema	erythema	NN
25944	2943	18	;	;	:
25944	2943	19	and	and	CC
25944	2943	20	in	in	IN
25944	2943	21	some	some	DT
25944	2943	22	instances	instance	NNS
25944	2943	23	benefit	benefit	VBP
25944	2943	24	or	or	CC
25944	2943	25	cure	cure	NN
25944	2943	26	only	only	RB
25944	2943	27	occurs	occur	VBZ
25944	2943	28	after	after	IN
25944	2943	29	more	more	RBR
25944	2943	30	active	active	JJ
25944	2943	31	exposure	exposure	NN
25944	2943	32	,	,	,
25944	2943	33	sufficient	sufficient	JJ
25944	2943	34	to	to	TO
25944	2943	35	cause	cause	VB
25944	2943	36	an	an	DT
25944	2943	37	_	_	NNP
25944	2943	38	x_-ray	x_-ray	NN
25944	2943	39	burn	burn	NN
25944	2943	40	of	of	IN
25944	2943	41	the	the	DT
25944	2943	42	second	second	JJ
25944	2943	43	degree	degree	NN
25944	2943	44	.	.	.
25944	2944	1	The	the	DT
25944	2944	2	method	method	NN
25944	2944	3	is	be	VBZ
25944	2944	4	not	not	RB
25944	2944	5	attended	attend	VBN
25944	2944	6	with	with	IN
25944	2944	7	much	much	JJ
25944	2944	8	risk	risk	NN
25944	2944	9	if	if	IN
25944	2944	10	properly	properly	RB
25944	2944	11	used	use	VBN
25944	2944	12	.	.	.
25944	2945	1	The	the	DT
25944	2945	2	healthy	healthy	JJ
25944	2945	3	parts	part	NNS
25944	2945	4	should	should	MD
25944	2945	5	be	be	VB
25944	2945	6	protected	protect	VBN
25944	2945	7	by	by	IN
25944	2945	8	lead	lead	NN
25944	2945	9	-	-	HYPH
25944	2945	10	foil	foil	NN
25944	2945	11	.	.	.
25944	2946	1	Exposure	exposure	NN
25944	2946	2	should	should	MD
25944	2946	3	be	be	VB
25944	2946	4	two	two	CD
25944	2946	5	to	to	TO
25944	2946	6	five	five	CD
25944	2946	7	times	time	NNS
25944	2946	8	weekly	weekly	JJ
25944	2946	9	,	,	,
25944	2946	10	at	at	IN
25944	2946	11	a	a	DT
25944	2946	12	distance	distance	NN
25944	2946	13	of	of	IN
25944	2946	14	three	three	CD
25944	2946	15	to	to	TO
25944	2946	16	eight	eight	CD
25944	2946	17	inches	inch	NNS
25944	2946	18	,	,	,
25944	2946	19	and	and	CC
25944	2946	20	from	from	IN
25944	2946	21	five	five	CD
25944	2946	22	to	to	TO
25944	2946	23	twenty	twenty	CD
25944	2946	24	minutes	minute	NNS
25944	2946	25	,	,	,
25944	2946	26	employing	employ	VBG
25944	2946	27	a	a	DT
25944	2946	28	tube	tube	NN
25944	2946	29	of	of	IN
25944	2946	30	medium	medium	JJ
25944	2946	31	vacuum	vacuum	NN
25944	2946	32	.	.	.
25944	2947	1	Unfortunately	unfortunately	RB
25944	2947	2	the	the	DT
25944	2947	3	method	method	NN
25944	2947	4	is	be	VBZ
25944	2947	5	usually	usually	RB
25944	2947	6	slow	slow	JJ
25944	2947	7	.	.	.
25944	2948	1	The	the	DT
25944	2948	2	radium	radium	NN
25944	2948	3	treatment	treatment	NN
25944	2948	4	is	be	VBZ
25944	2948	5	essentially	essentially	RB
25944	2948	6	similar	similar	JJ
25944	2948	7	to	to	IN
25944	2948	8	that	that	DT
25944	2948	9	by	by	IN
25944	2948	10	the	the	DT
25944	2948	11	_	_	NNP
25944	2948	12	x_-ray	x_-ray	NN
25944	2948	13	.	.	.
25944	2949	1	The	the	DT
25944	2949	2	much	much	RB
25944	2949	3	better	well	JJR
25944	2949	4	plan	plan	NN
25944	2949	5	,	,	,
25944	2949	6	as	as	IN
25944	2949	7	already	already	RB
25944	2949	8	intimated	intimate	VBN
25944	2949	9	,	,	,
25944	2949	10	is	be	VBZ
25944	2949	11	to	to	TO
25944	2949	12	employ	employ	VB
25944	2949	13	one	one	CD
25944	2949	14	of	of	IN
25944	2949	15	the	the	DT
25944	2949	16	several	several	JJ
25944	2949	17	operative	operative	JJ
25944	2949	18	or	or	CC
25944	2949	19	caustic	caustic	JJ
25944	2949	20	methods	method	NNS
25944	2949	21	,	,	,
25944	2949	22	and	and	CC
25944	2949	23	supplementing	supplementing	NN
25944	2949	24	,	,	,
25944	2949	25	while	while	IN
25944	2949	26	healing	healing	NN
25944	2949	27	,	,	,
25944	2949	28	with	with	IN
25944	2949	29	the	the	DT
25944	2949	30	_	_	NNP
25944	2949	31	x_-ray	x_-ray	NN
25944	2949	32	.	.	.
25944	2950	1	#	#	NNP
25944	2950	2	Paget	Paget	NNP
25944	2950	3	's	's	POS
25944	2950	4	Disease	Disease	NNP
25944	2950	5	of	of	IN
25944	2950	6	the	the	DT
25944	2950	7	Nipple	Nipple	NNP
25944	2950	8	.	.	.
25944	2950	9	#	#	NNP
25944	2950	10	(	(	-LRB-
25944	2950	11	_	_	NNP
25944	2950	12	Synonyms	Synonyms	NNP
25944	2950	13	:	:	:
25944	2950	14	_	_	NNP
25944	2950	15	Malignant	Malignant	NNP
25944	2950	16	Papillary	Papillary	NNP
25944	2950	17	Dermatitis	Dermatitis	NNP
25944	2950	18	;	;	:
25944	2950	19	Paget	Paget	NNP
25944	2950	20	's	's	POS
25944	2950	21	Disease	Disease	NNP
25944	2950	22	.	.	.
25944	2950	23	)	)	-RRB-
25944	2951	1	#	#	LS
25944	2951	2	What	what	WP
25944	2951	3	do	do	VBP
25944	2951	4	you	-PRON-	PRP
25944	2951	5	understand	understand	VB
25944	2951	6	by	by	IN
25944	2951	7	Paget	Paget	NNP
25944	2951	8	's	's	POS
25944	2951	9	disease	disease	NN
25944	2951	10	of	of	IN
25944	2951	11	the	the	DT
25944	2951	12	nipple	nipple	NN
25944	2951	13	?	?	.
25944	2951	14	#	#	$
25944	2951	15	Paget	Paget	NNP
25944	2951	16	's	's	POS
25944	2951	17	disease	disease	NN
25944	2951	18	is	be	VBZ
25944	2951	19	a	a	DT
25944	2951	20	rare	rare	JJ
25944	2951	21	,	,	,
25944	2951	22	inflammatory	inflammatory	JJ
25944	2951	23	-	-	HYPH
25944	2951	24	looking	look	VBG
25944	2951	25	,	,	,
25944	2951	26	malignant	malignant	JJ
25944	2951	27	disease	disease	NN
25944	2951	28	of	of	IN
25944	2951	29	the	the	DT
25944	2951	30	nipple	nipple	NN
25944	2951	31	and	and	CC
25944	2951	32	areola	areola	NNP
25944	2951	33	in	in	IN
25944	2951	34	women	woman	NNS
25944	2951	35	,	,	,
25944	2951	36	usually	usually	RB
25944	2951	37	of	of	IN
25944	2951	38	advancing	advance	VBG
25944	2951	39	years	year	NNS
25944	2951	40	,	,	,
25944	2951	41	eventually	eventually	RB
25944	2951	42	terminating	terminate	VBG
25944	2951	43	in	in	IN
25944	2951	44	cancerous	cancerous	JJ
25944	2951	45	involvement	involvement	NN
25944	2951	46	of	of	IN
25944	2951	47	the	the	DT
25944	2951	48	entire	entire	JJ
25944	2951	49	gland	gland	NN
25944	2951	50	.	.	.
25944	2952	1	#	#	NNP
25944	2952	2	Describe	describe	VB
25944	2952	3	the	the	DT
25944	2952	4	symptoms	symptom	NNS
25944	2952	5	of	of	IN
25944	2952	6	Paget	Paget	NNP
25944	2952	7	's	's	POS
25944	2952	8	disease	disease	NN
25944	2952	9	.	.	.
25944	2952	10	#	#	$
25944	2952	11	The	the	DT
25944	2952	12	first	first	JJ
25944	2952	13	symptoms	symptom	NNS
25944	2952	14	,	,	,
25944	2952	15	which	which	WDT
25944	2952	16	usually	usually	RB
25944	2952	17	last	last	VBP
25944	2952	18	for	for	IN
25944	2952	19	months	month	NNS
25944	2952	20	or	or	CC
25944	2952	21	years	year	NNS
25944	2952	22	,	,	,
25944	2952	23	are	be	VBP
25944	2952	24	apparently	apparently	RB
25944	2952	25	eczematous	eczematous	JJ
25944	2952	26	,	,	,
25944	2952	27	accompanied	accompany	VBN
25944	2952	28	with	with	IN
25944	2952	29	more	more	JJR
25944	2952	30	or	or	CC
25944	2952	31	less	less	RBR
25944	2952	32	burning	burning	JJ
25944	2952	33	,	,	,
25944	2952	34	itching	itching	NN
25944	2952	35	and	and	CC
25944	2952	36	tingling	tingling	NN
25944	2952	37	.	.	.
25944	2953	1	Gradually	gradually	RB
25944	2953	2	,	,	,
25944	2953	3	the	the	DT
25944	2953	4	diseased	diseased	JJ
25944	2953	5	area	area	NN
25944	2953	6	,	,	,
25944	2953	7	which	which	WDT
25944	2953	8	is	be	VBZ
25944	2953	9	sharply	sharply	RB
25944	2953	10	-	-	HYPH
25944	2953	11	defined	define	VBN
25944	2953	12	,	,	,
25944	2953	13	and	and	CC
25944	2953	14	feels	feel	VBZ
25944	2953	15	like	like	IN
25944	2953	16	a	a	DT
25944	2953	17	thin	thin	JJ
25944	2953	18	layer	layer	NN
25944	2953	19	of	of	IN
25944	2953	20	indurated	indurated	JJ
25944	2953	21	tissue	tissue	NN
25944	2953	22	,	,	,
25944	2953	23	presents	present	VBZ
25944	2953	24	a	a	DT
25944	2953	25	florid	florid	NN
25944	2953	26	,	,	,
25944	2953	27	intensely	intensely	RB
25944	2953	28	red	red	JJ
25944	2953	29	,	,	,
25944	2953	30	very	very	RB
25944	2953	31	finely	finely	RB
25944	2953	32	-	-	HYPH
25944	2953	33	granular	granular	JJ
25944	2953	34	,	,	,
25944	2953	35	raw	raw	JJ
25944	2953	36	surface	surface	NN
25944	2953	37	,	,	,
25944	2953	38	attended	attend	VBD
25944	2953	39	with	with	IN
25944	2953	40	a	a	DT
25944	2953	41	more	more	RBR
25944	2953	42	or	or	CC
25944	2953	43	less	less	RBR
25944	2953	44	copious	copious	JJ
25944	2953	45	viscid	viscid	NN
25944	2953	46	exudation	exudation	NN
25944	2953	47	.	.	.
25944	2954	1	Sooner	soon	RBR
25944	2954	2	or	or	CC
25944	2954	3	later	later	RB
25944	2954	4	retraction	retraction	NN
25944	2954	5	and	and	CC
25944	2954	6	destruction	destruction	NN
25944	2954	7	of	of	IN
25944	2954	8	the	the	DT
25944	2954	9	nipple	nipple	NN
25944	2954	10	,	,	,
25944	2954	11	followed	follow	VBN
25944	2954	12	by	by	IN
25944	2954	13	gradual	gradual	JJ
25944	2954	14	scirrhous	scirrhous	JJ
25944	2954	15	involvement	involvement	NN
25944	2954	16	of	of	IN
25944	2954	17	the	the	DT
25944	2954	18	whole	whole	JJ
25944	2954	19	breast	breast	NN
25944	2954	20	,	,	,
25944	2954	21	takes	take	VBZ
25944	2954	22	place	place	NN
25944	2954	23	.	.	.
25944	2955	1	#	#	LS
25944	2955	2	What	what	WP
25944	2955	3	is	be	VBZ
25944	2955	4	the	the	DT
25944	2955	5	pathology	pathology	NN
25944	2955	6	of	of	IN
25944	2955	7	Paget	Paget	NNP
25944	2955	8	's	's	POS
25944	2955	9	disease	disease	NN
25944	2955	10	?	?	.
25944	2955	11	#	#	$
25944	2955	12	Although	although	IN
25944	2955	13	it	-PRON-	PRP
25944	2955	14	was	be	VBD
25944	2955	15	thought	think	VBN
25944	2955	16	at	at	IN
25944	2955	17	one	one	CD
25944	2955	18	time	time	NN
25944	2955	19	to	to	TO
25944	2955	20	be	be	VB
25944	2955	21	a	a	DT
25944	2955	22	cancerous	cancerous	JJ
25944	2955	23	disease	disease	NN
25944	2955	24	resulting	result	VBG
25944	2955	25	from	from	IN
25944	2955	26	a	a	DT
25944	2955	27	continued	continue	VBN
25944	2955	28	eczematous	eczematous	JJ
25944	2955	29	inflammation	inflammation	NN
25944	2955	30	of	of	IN
25944	2955	31	the	the	DT
25944	2955	32	parts	part	NNS
25944	2955	33	,	,	,
25944	2955	34	there	there	EX
25944	2955	35	is	be	VBZ
25944	2955	36	now	now	RB
25944	2955	37	but	but	CC
25944	2955	38	little	little	JJ
25944	2955	39	doubt	doubt	NN
25944	2955	40	that	that	IN
25944	2955	41	it	-PRON-	PRP
25944	2955	42	is	be	VBZ
25944	2955	43	of	of	IN
25944	2955	44	malignant	malignant	JJ
25944	2955	45	nature	nature	NN
25944	2955	46	from	from	IN
25944	2955	47	the	the	DT
25944	2955	48	earliest	early	JJS
25944	2955	49	stages	stage	NNS
25944	2955	50	.	.	.
25944	2956	1	The	the	DT
25944	2956	2	psorosperm	psorosperm	NN
25944	2956	3	-	-	HYPH
25944	2956	4	like	like	JJ
25944	2956	5	bodies	body	NNS
25944	2956	6	found	find	VBN
25944	2956	7	,	,	,
25944	2956	8	to	to	IN
25944	2956	9	the	the	DT
25944	2956	10	presence	presence	NN
25944	2956	11	of	of	IN
25944	2956	12	which	which	WDT
25944	2956	13	the	the	DT
25944	2956	14	disease	disease	NN
25944	2956	15	has	have	VBZ
25944	2956	16	by	by	IN
25944	2956	17	some	some	DT
25944	2956	18	authorities	authority	NNS
25944	2956	19	been	be	VBN
25944	2956	20	attributed	attribute	VBN
25944	2956	21	(	(	-LRB-
25944	2956	22	psorospermosis	psorospermosis	NN
25944	2956	23	)	)	-RRB-
25944	2956	24	,	,	,
25944	2956	25	are	be	VBP
25944	2956	26	now	now	RB
25944	2956	27	known	know	VBN
25944	2956	28	to	to	TO
25944	2956	29	be	be	VB
25944	2956	30	merely	merely	RB
25944	2956	31	changed	change	VBN
25944	2956	32	and	and	CC
25944	2956	33	degenerated	degenerate	VBD
25944	2956	34	epithelia	epithelia	NNP
25944	2956	35	.	.	.
25944	2957	1	The	the	DT
25944	2957	2	morbid	morbid	NN
25944	2957	3	changes	change	NNS
25944	2957	4	consist	consist	VBP
25944	2957	5	of	of	IN
25944	2957	6	an	an	DT
25944	2957	7	inflammation	inflammation	NN
25944	2957	8	of	of	IN
25944	2957	9	the	the	DT
25944	2957	10	papillary	papillary	JJ
25944	2957	11	region	region	NN
25944	2957	12	of	of	IN
25944	2957	13	the	the	DT
25944	2957	14	derma	derma	NN
25944	2957	15	,	,	,
25944	2957	16	leading	lead	VBG
25944	2957	17	to	to	IN
25944	2957	18	[	[	-LRB-
25944	2957	19	oe]dema	oe]dema	NN
25944	2957	20	and	and	CC
25944	2957	21	vacuolation	vacuolation	NN
25944	2957	22	of	of	IN
25944	2957	23	the	the	DT
25944	2957	24	constituent	constituent	NN
25944	2957	25	cells	cell	NNS
25944	2957	26	of	of	IN
25944	2957	27	the	the	DT
25944	2957	28	epidermis	epidermis	NN
25944	2957	29	,	,	,
25944	2957	30	followed	follow	VBN
25944	2957	31	by	by	IN
25944	2957	32	their	-PRON-	PRP$
25944	2957	33	complete	complete	JJ
25944	2957	34	destruction	destruction	NN
25944	2957	35	in	in	IN
25944	2957	36	places	place	NNS
25944	2957	37	and	and	CC
25944	2957	38	their	-PRON-	PRP$
25944	2957	39	abnormal	abnormal	JJ
25944	2957	40	proliferation	proliferation	NN
25944	2957	41	in	in	IN
25944	2957	42	others	other	NNS
25944	2957	43	(	(	-LRB-
25944	2957	44	Fordyce	Fordyce	NNP
25944	2957	45	)	)	-RRB-
25944	2957	46	.	.	.
25944	2958	1	#	#	JJR
25944	2958	2	State	state	NN
25944	2958	3	the	the	DT
25944	2958	4	diagnostic	diagnostic	JJ
25944	2958	5	features	feature	NNS
25944	2958	6	of	of	IN
25944	2958	7	Paget	Paget	NNP
25944	2958	8	's	's	POS
25944	2958	9	disease	disease	NN
25944	2958	10	.	.	.
25944	2958	11	#	#	$
25944	2958	12	The	the	DT
25944	2958	13	age	age	NN
25944	2958	14	of	of	IN
25944	2958	15	the	the	DT
25944	2958	16	patient	patient	NN
25944	2958	17	;	;	:
25944	2958	18	the	the	DT
25944	2958	19	sharp	sharp	JJ
25944	2958	20	limitation	limitation	NN
25944	2958	21	;	;	:
25944	2958	22	the	the	DT
25944	2958	23	well	well	RB
25944	2958	24	-	-	HYPH
25944	2958	25	defined	define	VBN
25944	2958	26	,	,	,
25944	2958	27	indurated	indurated	JJ
25944	2958	28	film	film	NN
25944	2958	29	of	of	IN
25944	2958	30	infiltration	infiltration	NN
25944	2958	31	;	;	,
25944	2958	32	the	the	DT
25944	2958	33	peculiar	peculiar	JJ
25944	2958	34	,	,	,
25944	2958	35	red	red	JJ
25944	2958	36	,	,	,
25944	2958	37	raw	raw	JJ
25944	2958	38	,	,	,
25944	2958	39	granulating	granulate	VBG
25944	2958	40	appearance	appearance	NN
25944	2958	41	;	;	,
25944	2958	42	and	and	CC
25944	2958	43	,	,	,
25944	2958	44	later	later	RB
25944	2958	45	,	,	,
25944	2958	46	the	the	DT
25944	2958	47	retraction	retraction	NN
25944	2958	48	of	of	IN
25944	2958	49	the	the	DT
25944	2958	50	nipple	nipple	NN
25944	2958	51	;	;	:
25944	2958	52	and	and	CC
25944	2958	53	,	,	,
25944	2958	54	finally	finally	RB
25944	2958	55	,	,	,
25944	2958	56	the	the	DT
25944	2958	57	involvement	involvement	NN
25944	2958	58	of	of	IN
25944	2958	59	the	the	DT
25944	2958	60	deeper	deep	JJR
25944	2958	61	parts	part	NNS
25944	2958	62	.	.	.
25944	2959	1	#	#	LS
25944	2959	2	What	what	WP
25944	2959	3	is	be	VBZ
25944	2959	4	the	the	DT
25944	2959	5	prognosis	prognosis	NN
25944	2959	6	?	?	.
25944	2959	7	#	#	$
25944	2959	8	If	if	IN
25944	2959	9	the	the	DT
25944	2959	10	disease	disease	NN
25944	2959	11	is	be	VBZ
25944	2959	12	recognized	recognize	VBN
25944	2959	13	early	early	RB
25944	2959	14	,	,	,
25944	2959	15	and	and	CC
25944	2959	16	properly	properly	RB
25944	2959	17	treated	treat	VBN
25944	2959	18	,	,	,
25944	2959	19	a	a	DT
25944	2959	20	cure	cure	NN
25944	2959	21	may	may	MD
25944	2959	22	be	be	VB
25944	2959	23	anticipated	anticipate	VBN
25944	2959	24	;	;	:
25944	2959	25	later	later	RB
25944	2959	26	the	the	DT
25944	2959	27	outlook	outlook	NN
25944	2959	28	is	be	VBZ
25944	2959	29	that	that	DT
25944	2959	30	of	of	IN
25944	2959	31	scirrhus	scirrhu	NNS
25944	2959	32	of	of	IN
25944	2959	33	the	the	DT
25944	2959	34	breast	breast	NN
25944	2959	35	.	.	.
25944	2960	1	#	#	LS
25944	2960	2	What	what	WP
25944	2960	3	is	be	VBZ
25944	2960	4	the	the	DT
25944	2960	5	treatment	treatment	NN
25944	2960	6	of	of	IN
25944	2960	7	Paget	Paget	NNP
25944	2960	8	's	's	POS
25944	2960	9	disease	disease	NN
25944	2960	10	?	?	.
25944	2960	11	#	#	NN
25944	2960	12	Thorough	thorough	JJ
25944	2960	13	cauterization	cauterization	NN
25944	2960	14	by	by	IN
25944	2960	15	means	mean	NNS
25944	2960	16	of	of	IN
25944	2960	17	caustic	caustic	JJ
25944	2960	18	potash	potash	NN
25944	2960	19	or	or	CC
25944	2960	20	the	the	DT
25944	2960	21	galvano	galvano	NN
25944	2960	22	-	-	HYPH
25944	2960	23	cautery	cautery	NN
25944	2960	24	;	;	:
25944	2960	25	or	or	CC
25944	2960	26	,	,	,
25944	2960	27	its	-PRON-	PRP$
25944	2960	28	extirpation	extirpation	NN
25944	2960	29	by	by	IN
25944	2960	30	means	mean	NNS
25944	2960	31	of	of	IN
25944	2960	32	the	the	DT
25944	2960	33	curette	curette	NN
25944	2960	34	or	or	CC
25944	2960	35	excision	excision	NN
25944	2960	36	.	.	.
25944	2961	1	After	after	IN
25944	2961	2	extirpation	extirpation	NN
25944	2961	3	or	or	CC
25944	2961	4	cauterization	cauterization	NN
25944	2961	5	,	,	,
25944	2961	6	supplementary	supplementary	JJ
25944	2961	7	treatment	treatment	NN
25944	2961	8	by	by	IN
25944	2961	9	the	the	DT
25944	2961	10	_	_	NNP
25944	2961	11	x_-ray	x_-ray	NN
25944	2961	12	is	be	VBZ
25944	2961	13	advisable	advisable	JJ
25944	2961	14	as	as	IN
25944	2961	15	an	an	DT
25944	2961	16	additional	additional	JJ
25944	2961	17	measure	measure	NN
25944	2961	18	of	of	IN
25944	2961	19	precaution	precaution	NN
25944	2961	20	against	against	IN
25944	2961	21	relapse	relapse	NN
25944	2961	22	.	.	.
25944	2962	1	Until	until	IN
25944	2962	2	the	the	DT
25944	2962	3	diagnosis	diagnosis	NN
25944	2962	4	is	be	VBZ
25944	2962	5	thoroughly	thoroughly	RB
25944	2962	6	established	establish	VBN
25944	2962	7	,	,	,
25944	2962	8	soothing	soothe	VBG
25944	2962	9	applications	application	NNS
25944	2962	10	,	,	,
25944	2962	11	such	such	JJ
25944	2962	12	as	as	IN
25944	2962	13	are	be	VBP
25944	2962	14	employed	employ	VBN
25944	2962	15	in	in	IN
25944	2962	16	acute	acute	JJ
25944	2962	17	eczema	eczema	NN
25944	2962	18	,	,	,
25944	2962	19	are	be	VBP
25944	2962	20	to	to	TO
25944	2962	21	be	be	VB
25944	2962	22	advised	advise	VBN
25944	2962	23	.	.	.
25944	2963	1	#	#	NNP
25944	2963	2	Sarcoma	Sarcoma	NNP
25944	2963	3	.	.	.
25944	2963	4	#	#	NNP
25944	2963	5	(	(	-LRB-
25944	2963	6	_	_	NNP
25944	2963	7	Synonyms	Synonyms	NNP
25944	2963	8	:	:	:
25944	2963	9	_	_	NNP
25944	2963	10	Sarcoma	Sarcoma	NNP
25944	2963	11	Cutis	Cutis	NNP
25944	2963	12	;	;	:
25944	2963	13	Sarcoma	Sarcoma	NNP
25944	2963	14	of	of	IN
25944	2963	15	the	the	DT
25944	2963	16	Skin	skin	NN
25944	2963	17	.	.	.
25944	2963	18	)	)	-RRB-
25944	2964	1	#	#	NNP
25944	2964	2	Describe	describe	VB
25944	2964	3	the	the	DT
25944	2964	4	several	several	JJ
25944	2964	5	varieties	variety	NNS
25944	2964	6	of	of	IN
25944	2964	7	sarcoma	sarcoma	NN
25944	2964	8	.	.	.
25944	2964	9	#	#	$
25944	2964	10	Sarcoma	Sarcoma	NNP
25944	2964	11	of	of	IN
25944	2964	12	the	the	DT
25944	2964	13	skin	skin	NN
25944	2964	14	is	be	VBZ
25944	2964	15	a	a	DT
25944	2964	16	more	more	RBR
25944	2964	17	or	or	CC
25944	2964	18	less	less	RBR
25944	2964	19	malignant	malignant	JJ
25944	2964	20	new	new	JJ
25944	2964	21	growth	growth	NN
25944	2964	22	,	,	,
25944	2964	23	of	of	IN
25944	2964	24	rapid	rapid	JJ
25944	2964	25	or	or	CC
25944	2964	26	slow	slow	JJ
25944	2964	27	progress	progress	NN
25944	2964	28	,	,	,
25944	2964	29	characterized	characterize	VBN
25944	2964	30	by	by	IN
25944	2964	31	the	the	DT
25944	2964	32	appearance	appearance	NN
25944	2964	33	of	of	IN
25944	2964	34	single	single	JJ
25944	2964	35	or	or	CC
25944	2964	36	multiple	multiple	JJ
25944	2964	37	,	,	,
25944	2964	38	variously	variously	RB
25944	2964	39	-	-	HYPH
25944	2964	40	shaped	shaped	JJ
25944	2964	41	,	,	,
25944	2964	42	discrete	discrete	JJ
25944	2964	43	,	,	,
25944	2964	44	non	non	JJ
25944	2964	45	-	-	JJ
25944	2964	46	pigmented	pigmented	JJ
25944	2964	47	or	or	CC
25944	2964	48	pigmented	pigment	VBN
25944	2964	49	tubercles	tubercle	NNS
25944	2964	50	or	or	CC
25944	2964	51	tumors	tumor	NNS
25944	2964	52	,	,	,
25944	2964	53	of	of	IN
25944	2964	54	size	size	NN
25944	2964	55	varying	varying	NN
25944	2964	56	from	from	IN
25944	2964	57	that	that	DT
25944	2964	58	of	of	IN
25944	2964	59	a	a	DT
25944	2964	60	shot	shot	NN
25944	2964	61	to	to	IN
25944	2964	62	a	a	DT
25944	2964	63	hazelnut	hazelnut	NN
25944	2964	64	or	or	CC
25944	2964	65	larger	large	JJR
25944	2964	66	.	.	.
25944	2965	1	As	as	IN
25944	2965	2	a	a	DT
25944	2965	3	rule	rule	NN
25944	2965	4	the	the	DT
25944	2965	5	growths	growth	NNS
25944	2965	6	are	be	VBP
25944	2965	7	smooth	smooth	JJ
25944	2965	8	,	,	,
25944	2965	9	firm	firm	JJ
25944	2965	10	and	and	CC
25944	2965	11	elastic	elastic	JJ
25944	2965	12	,	,	,
25944	2965	13	somewhat	somewhat	RB
25944	2965	14	painful	painful	JJ
25944	2965	15	upon	upon	IN
25944	2965	16	pressure	pressure	NN
25944	2965	17	,	,	,
25944	2965	18	and	and	CC
25944	2965	19	exhibit	exhibit	VB
25944	2965	20	a	a	DT
25944	2965	21	tendency	tendency	NN
25944	2965	22	to	to	TO
25944	2965	23	ulcerate	ulcerate	VB
25944	2965	24	.	.	.
25944	2966	1	The	the	DT
25944	2966	2	overlying	overlying	NN
25944	2966	3	skin	skin	NN
25944	2966	4	is	be	VBZ
25944	2966	5	at	at	IN
25944	2966	6	first	first	JJ
25944	2966	7	normal	normal	JJ
25944	2966	8	and	and	CC
25944	2966	9	somewhat	somewhat	RB
25944	2966	10	movable	movable	JJ
25944	2966	11	,	,	,
25944	2966	12	but	but	CC
25944	2966	13	as	as	IN
25944	2966	14	the	the	DT
25944	2966	15	growths	growth	NNS
25944	2966	16	approach	approach	VBP
25944	2966	17	the	the	DT
25944	2966	18	surface	surface	NN
25944	2966	19	it	-PRON-	PRP
25944	2966	20	becomes	become	VBZ
25944	2966	21	reddened	reddened	JJ
25944	2966	22	and	and	CC
25944	2966	23	adherent	adherent	JJ
25944	2966	24	;	;	:
25944	2966	25	or	or	CC
25944	2966	26	,	,	,
25944	2966	27	if	if	IN
25944	2966	28	the	the	DT
25944	2966	29	disease	disease	NN
25944	2966	30	is	be	VBZ
25944	2966	31	of	of	IN
25944	2966	32	the	the	DT
25944	2966	33	pigmented	pigment	VBN
25944	2966	34	variety	variety	NN
25944	2966	35	,	,	,
25944	2966	36	it	-PRON-	PRP
25944	2966	37	acquires	acquire	VBZ
25944	2966	38	a	a	DT
25944	2966	39	bluish	bluish	JJ
25944	2966	40	-	-	HYPH
25944	2966	41	black	black	JJ
25944	2966	42	color	color	NN
25944	2966	43	.	.	.
25944	2967	1	It	-PRON-	PRP
25944	2967	2	is	be	VBZ
25944	2967	3	now	now	RB
25944	2967	4	generally	generally	RB
25944	2967	5	believed	believe	VBN
25944	2967	6	that	that	IN
25944	2967	7	the	the	DT
25944	2967	8	most	most	JJS
25944	2967	9	of	of	IN
25944	2967	10	the	the	DT
25944	2967	11	pigmented	pigment	VBN
25944	2967	12	cases	case	NNS
25944	2967	13	formerly	formerly	RB
25944	2967	14	thought	think	VBN
25944	2967	15	to	to	TO
25944	2967	16	be	be	VB
25944	2967	17	of	of	IN
25944	2967	18	sarcomatous	sarcomatous	JJ
25944	2967	19	nature	nature	NN
25944	2967	20	are	be	VBP
25944	2967	21	really	really	RB
25944	2967	22	carcinomatous	carcinomatous	JJ
25944	2967	23	in	in	IN
25944	2967	24	character	character	NN
25944	2967	25	.	.	.
25944	2968	1	The	the	DT
25944	2968	2	multiple	multiple	JJ
25944	2968	3	pigmented	pigment	VBN
25944	2968	4	sarcoma	sarcoma	NN
25944	2968	5	(	(	-LRB-
25944	2968	6	_	_	NNP
25944	2968	7	melano	melano	NNP
25944	2968	8	-	-	HYPH
25944	2968	9	sarcoma	sarcoma	NNP
25944	2968	10	_	_	NNP
25944	2968	11	)	)	-RRB-
25944	2968	12	appears	appear	VBZ
25944	2968	13	first	first	RB
25944	2968	14	,	,	,
25944	2968	15	usually	usually	RB
25944	2968	16	on	on	IN
25944	2968	17	the	the	DT
25944	2968	18	soles	sol	NNS
25944	2968	19	and	and	CC
25944	2968	20	dorsal	dorsal	NN
25944	2968	21	surfaces	surface	NNS
25944	2968	22	of	of	IN
25944	2968	23	the	the	DT
25944	2968	24	feet	foot	NNS
25944	2968	25	,	,	,
25944	2968	26	and	and	CC
25944	2968	27	later	later	RB
25944	2968	28	on	on	IN
25944	2968	29	the	the	DT
25944	2968	30	hands	hand	NNS
25944	2968	31	.	.	.
25944	2969	1	There	there	EX
25944	2969	2	is	be	VBZ
25944	2969	3	more	more	RBR
25944	2969	4	or	or	CC
25944	2969	5	less	less	RBR
25944	2969	6	diffuse	diffuse	NN
25944	2969	7	thickening	thickening	NN
25944	2969	8	of	of	IN
25944	2969	9	the	the	DT
25944	2969	10	integument	integument	NN
25944	2969	11	.	.	.
25944	2970	1	The	the	DT
25944	2970	2	lesions	lesion	NNS
25944	2970	3	themselves	-PRON-	PRP
25944	2970	4	manifest	manifest	VBP
25944	2970	5	a	a	DT
25944	2970	6	disposition	disposition	NN
25944	2970	7	to	to	TO
25944	2970	8	bleed	bleed	VB
25944	2970	9	.	.	.
25944	2971	1	#	#	JJR
25944	2971	2	State	state	NN
25944	2971	3	the	the	DT
25944	2971	4	prognosis	prognosis	NN
25944	2971	5	and	and	CC
25944	2971	6	treatment	treatment	NN
25944	2971	7	of	of	IN
25944	2971	8	sarcoma	sarcoma	NN
25944	2971	9	.	.	.
25944	2971	10	#	#	$
25944	2971	11	The	the	DT
25944	2971	12	disease	disease	NN
25944	2971	13	is	be	VBZ
25944	2971	14	always	always	RB
25944	2971	15	more	more	RBR
25944	2971	16	or	or	CC
25944	2971	17	less	less	RBR
25944	2971	18	malignant	malignant	JJ
25944	2971	19	and	and	CC
25944	2971	20	,	,	,
25944	2971	21	as	as	IN
25944	2971	22	a	a	DT
25944	2971	23	rule	rule	NN
25944	2971	24	,	,	,
25944	2971	25	sooner	sooner	RB
25944	2971	26	or	or	CC
25944	2971	27	later	later	RB
25944	2971	28	a	a	DT
25944	2971	29	fatal	fatal	JJ
25944	2971	30	termination	termination	NN
25944	2971	31	takes	take	VBZ
25944	2971	32	place	place	NN
25944	2971	33	.	.	.
25944	2972	1	It	-PRON-	PRP
25944	2972	2	is	be	VBZ
25944	2972	3	usually	usually	RB
25944	2972	4	slow	slow	JJ
25944	2972	5	in	in	IN
25944	2972	6	its	-PRON-	PRP$
25944	2972	7	course	course	NN
25944	2972	8	.	.	.
25944	2973	1	Excision	excision	NN
25944	2973	2	or	or	CC
25944	2973	3	extirpation	extirpation	NN
25944	2973	4	,	,	,
25944	2973	5	_	_	NNP
25944	2973	6	x_-ray	x_-ray	NN
25944	2973	7	exposures	exposure	NNS
25944	2973	8	,	,	,
25944	2973	9	and	and	CC
25944	2973	10	the	the	DT
25944	2973	11	administration	administration	NN
25944	2973	12	of	of	IN
25944	2973	13	arsenic	arsenic	NNP
25944	2973	14	in	in	IN
25944	2973	15	increasing	increase	VBG
25944	2973	16	dosage	dosage	NN
25944	2973	17	(	(	-LRB-
25944	2973	18	preferably	preferably	RB
25944	2973	19	by	by	IN
25944	2973	20	hypodermic	hypodermic	JJ
25944	2973	21	injection	injection	NN
25944	2973	22	)	)	-RRB-
25944	2973	23	now	now	RB
25944	2973	24	are	be	VBP
25944	2973	25	generally	generally	RB
25944	2973	26	considered	consider	VBN
25944	2973	27	the	the	DT
25944	2973	28	most	most	RBS
25944	2973	29	promising	promising	JJ
25944	2973	30	in	in	IN
25944	2973	31	this	this	DT
25944	2973	32	usually	usually	RB
25944	2973	33	hopeless	hopeless	RB
25944	2973	34	malady	malady	JJ
25944	2973	35	.	.	.
25944	2974	1	#	#	NNP
25944	2974	2	Granuloma	Granuloma	NNP
25944	2974	3	Fungoides	Fungoides	NNPS
25944	2974	4	.	.	.
25944	2974	5	#	#	$
25944	2974	6	#	#	$
25944	2974	7	Describe	Describe	NNP
25944	2974	8	granuloma	granuloma	NN
25944	2974	9	fungoides	fungoide	NNS
25944	2974	10	.	.	.
25944	2974	11	#	#	$
25944	2974	12	A	a	DT
25944	2974	13	rare	rare	JJ
25944	2974	14	form	form	NN
25944	2974	15	of	of	IN
25944	2974	16	disease	disease	NN
25944	2974	17	,	,	,
25944	2974	18	heretofore	heretofore	RB
25944	2974	19	looked	look	VBD
25944	2974	20	upon	upon	IN
25944	2974	21	as	as	RB
25944	2974	22	sarcomatous	sarcomatous	JJ
25944	2974	23	,	,	,
25944	2974	24	but	but	CC
25944	2974	25	now	now	RB
25944	2974	26	generally	generally	RB
25944	2974	27	recognized	recognize	VBN
25944	2974	28	as	as	IN
25944	2974	29	granuloma	granuloma	NNP
25944	2974	30	,	,	,
25944	2974	31	and	and	CC
25944	2974	32	formerly	formerly	RB
25944	2974	33	described	describe	VBN
25944	2974	34	under	under	IN
25944	2974	35	the	the	DT
25944	2974	36	names	name	NNS
25944	2974	37	_	_	NNP
25944	2974	38	mycosis	mycosis	NN
25944	2974	39	fungoides	fungoide	NNS
25944	2974	40	_	_	NNP
25944	2974	41	,	,	,
25944	2974	42	_	_	NNP
25944	2974	43	inflammatory	inflammatory	JJ
25944	2974	44	fungoid	fungoid	NN
25944	2974	45	neoplasm	neoplasm	NNP
25944	2974	46	_	_	NNP
25944	2974	47	,	,	,
25944	2974	48	and	and	CC
25944	2974	49	several	several	JJ
25944	2974	50	others	other	NNS
25944	2974	51	.	.	.
25944	2975	1	It	-PRON-	PRP
25944	2975	2	is	be	VBZ
25944	2975	3	characterized	characterize	VBN
25944	2975	4	usually	usually	RB
25944	2975	5	by	by	IN
25944	2975	6	symptoms	symptom	NNS
25944	2975	7	of	of	IN
25944	2975	8	an	an	DT
25944	2975	9	eczematous	eczematous	JJ
25944	2975	10	,	,	,
25944	2975	11	urticarial	urticarial	JJ
25944	2975	12	,	,	,
25944	2975	13	and	and	CC
25944	2975	14	erysipelatous	erysipelatous	JJ
25944	2975	15	nature	nature	NN
25944	2975	16	,	,	,
25944	2975	17	and	and	CC
25944	2975	18	by	by	IN
25944	2975	19	the	the	DT
25944	2975	20	sudden	sudden	JJ
25944	2975	21	or	or	CC
25944	2975	22	gradual	gradual	JJ
25944	2975	23	appearance	appearance	NN
25944	2975	24	of	of	IN
25944	2975	25	pinkish	pinkish	NN
25944	2975	26	or	or	CC
25944	2975	27	reddish	reddish	JJ
25944	2975	28	,	,	,
25944	2975	29	tubercular	tubercular	JJ
25944	2975	30	,	,	,
25944	2975	31	nodular	nodular	JJ
25944	2975	32	,	,	,
25944	2975	33	lobulated	lobulate	VBN
25944	2975	34	,	,	,
25944	2975	35	or	or	CC
25944	2975	36	furrowed	furrowed	JJ
25944	2975	37	tumors	tumor	NNS
25944	2975	38	or	or	CC
25944	2975	39	flat	flat	JJ
25944	2975	40	infiltrations	infiltration	NNS
25944	2975	41	,	,	,
25944	2975	42	which	which	WDT
25944	2975	43	may	may	MD
25944	2975	44	disappear	disappear	VB
25944	2975	45	by	by	IN
25944	2975	46	involution	involution	NN
25944	2975	47	or	or	CC
25944	2975	48	may	may	MD
25944	2975	49	be	be	VB
25944	2975	50	followed	follow	VBN
25944	2975	51	by	by	IN
25944	2975	52	ulceration	ulceration	NN
25944	2975	53	;	;	,
25944	2975	54	several	several	JJ
25944	2975	55	or	or	CC
25944	2975	56	a	a	DT
25944	2975	57	larger	large	JJR
25944	2975	58	number	number	NN
25944	2975	59	of	of	IN
25944	2975	60	the	the	DT
25944	2975	61	growths	growth	NNS
25944	2975	62	present	present	VBP
25944	2975	63	a	a	DT
25944	2975	64	mushroom	mushroom	NN
25944	2975	65	,	,	,
25944	2975	66	papillomatous	papillomatous	JJ
25944	2975	67	,	,	,
25944	2975	68	or	or	CC
25944	2975	69	fungoid	fungoid	JJ
25944	2975	70	appearance	appearance	NN
25944	2975	71	,	,	,
25944	2975	72	sometimes	sometimes	RB
25944	2975	73	roughly	roughly	RB
25944	2975	74	resembling	resemble	VBG
25944	2975	75	the	the	DT
25944	2975	76	cut	cut	JJ
25944	2975	77	part	part	NN
25944	2975	78	of	of	IN
25944	2975	79	a	a	DT
25944	2975	80	tomato	tomato	NN
25944	2975	81	.	.	.
25944	2976	1	In	in	IN
25944	2976	2	most	most	JJS
25944	2976	3	cases	case	NNS
25944	2976	4	the	the	DT
25944	2976	5	tumor	tumor	NN
25944	2976	6	stage	stage	NN
25944	2976	7	of	of	IN
25944	2976	8	the	the	DT
25944	2976	9	malady	malady	NN
25944	2976	10	is	be	VBZ
25944	2976	11	not	not	RB
25944	2976	12	reached	reach	VBN
25944	2976	13	for	for	IN
25944	2976	14	two	two	CD
25944	2976	15	or	or	CC
25944	2976	16	more	more	JJR
25944	2976	17	years	year	NNS
25944	2976	18	;	;	:
25944	2976	19	in	in	IN
25944	2976	20	exceptional	exceptional	JJ
25944	2976	21	instances	instance	NNS
25944	2976	22	,	,	,
25944	2976	23	however	however	RB
25944	2976	24	,	,	,
25944	2976	25	they	-PRON-	PRP
25944	2976	26	appear	appear	VBP
25944	2976	27	in	in	IN
25944	2976	28	the	the	DT
25944	2976	29	first	first	JJ
25944	2976	30	few	few	JJ
25944	2976	31	months	month	NNS
25944	2976	32	.	.	.
25944	2977	1	The	the	DT
25944	2977	2	lesions	lesion	NNS
25944	2977	3	,	,	,
25944	2977	4	especially	especially	RB
25944	2977	5	in	in	IN
25944	2977	6	their	-PRON-	PRP$
25944	2977	7	early	early	JJ
25944	2977	8	stages	stage	NNS
25944	2977	9	,	,	,
25944	2977	10	are	be	VBP
25944	2977	11	,	,	,
25944	2977	12	as	as	IN
25944	2977	13	a	a	DT
25944	2977	14	rule	rule	NN
25944	2977	15	,	,	,
25944	2977	16	accompanied	accompany	VBN
25944	2977	17	with	with	IN
25944	2977	18	more	more	JJR
25944	2977	19	or	or	CC
25944	2977	20	less	less	RBR
25944	2977	21	burning	burn	VBG
25944	2977	22	and	and	CC
25944	2977	23	itching	itching	NN
25944	2977	24	.	.	.
25944	2978	1	#	#	JJR
25944	2978	2	State	state	NN
25944	2978	3	the	the	DT
25944	2978	4	prognosis	prognosis	NN
25944	2978	5	and	and	CC
25944	2978	6	treatment	treatment	NN
25944	2978	7	of	of	IN
25944	2978	8	granuloma	granuloma	NNP
25944	2978	9	fungoides	fungoide	NNS
25944	2978	10	.	.	.
25944	2978	11	#	#	$
25944	2978	12	The	the	DT
25944	2978	13	malady	malady	JJ
25944	2978	14	may	may	MD
25944	2978	15	last	last	VB
25944	2978	16	for	for	IN
25944	2978	17	several	several	JJ
25944	2978	18	years	year	NNS
25944	2978	19	or	or	CC
25944	2978	20	much	much	RB
25944	2978	21	longer	long	JJR
25944	2978	22	,	,	,
25944	2978	23	a	a	DT
25944	2978	24	fatal	fatal	JJ
25944	2978	25	termination	termination	NN
25944	2978	26	,	,	,
25944	2978	27	with	with	IN
25944	2978	28	rare	rare	JJ
25944	2978	29	exceptions	exception	NNS
25944	2978	30	,	,	,
25944	2978	31	sooner	soon	RBR
25944	2978	32	or	or	CC
25944	2978	33	later	later	RBR
25944	2978	34	taking	take	VBG
25944	2978	35	place	place	NN
25944	2978	36	.	.	.
25944	2979	1	After	after	IN
25944	2979	2	the	the	DT
25944	2979	3	tumor	tumor	NN
25944	2979	4	stage	stage	NN
25944	2979	5	is	be	VBZ
25944	2979	6	well	well	RB
25944	2979	7	established	establish	VBN
25944	2979	8	,	,	,
25944	2979	9	the	the	DT
25944	2979	10	patient	patient	NN
25944	2979	11	usually	usually	RB
25944	2979	12	succumbs	succumb	VBZ
25944	2979	13	in	in	RB
25944	2979	14	from	from	IN
25944	2979	15	several	several	JJ
25944	2979	16	months	month	NNS
25944	2979	17	to	to	IN
25944	2979	18	one	one	CD
25944	2979	19	or	or	CC
25944	2979	20	two	two	CD
25944	2979	21	years	year	NNS
25944	2979	22	.	.	.
25944	2980	1	[	[	-LRB-
25944	2980	2	Illustration	illustration	NN
25944	2980	3	:	:	:
25944	2980	4	Fig	Fig	NNP
25944	2980	5	.	.	.
25944	2981	1	65	65	CD
25944	2981	2	.	.	.
25944	2982	1	Granuloma	Granuloma	NNP
25944	2982	2	Fungoides	Fungoides	NNPS
25944	2982	3	.	.	.
25944	2982	4	]	]	-RRB-
25944	2983	1	Treatment	treatment	NN
25944	2983	2	consists	consist	VBZ
25944	2983	3	of	of	IN
25944	2983	4	tonics	tonic	NNS
25944	2983	5	,	,	,
25944	2983	6	if	if	IN
25944	2983	7	indicated	indicate	VBN
25944	2983	8	,	,	,
25944	2983	9	and	and	CC
25944	2983	10	the	the	DT
25944	2983	11	administration	administration	NN
25944	2983	12	of	of	IN
25944	2983	13	arsenic	arsenic	JJ
25944	2983	14	,	,	,
25944	2983	15	preferably	preferably	RB
25944	2983	16	hypodermically	hypodermically	RB
25944	2983	17	,	,	,
25944	2983	18	and	and	CC
25944	2983	19	Röntgen	Röntgen	NNP
25944	2983	20	-	-	HYPH
25944	2983	21	ray	ray	NNP
25944	2983	22	exposures	exposure	NNS
25944	2983	23	,	,	,
25944	2983	24	along	along	IN
25944	2983	25	with	with	IN
25944	2983	26	the	the	DT
25944	2983	27	application	application	NN
25944	2983	28	of	of	IN
25944	2983	29	mild	mild	JJ
25944	2983	30	antiseptics	antiseptic	NNS
25944	2983	31	,	,	,
25944	2983	32	and	and	CC
25944	2983	33	operative	operative	JJ
25944	2983	34	interference	interference	NN
25944	2983	35	when	when	WRB
25944	2983	36	necessary	necessary	JJ
25944	2983	37	or	or	CC
25944	2983	38	advisable	advisable	JJ
25944	2983	39	.	.	.
25944	2984	1	#	#	$
25944	2984	2	CLASS	CLASS	NNP
25944	2984	3	VII.--NEUROSES	vii.--neuroses	XX
25944	2984	4	.	.	.
25944	2984	5	#	#	$
25944	2984	6	#	#	$
25944	2984	7	Hyperæsthesia	Hyperæsthesia	NNP
25944	2984	8	.	.	.
25944	2984	9	#	#	$
25944	2984	10	#	#	$
25944	2984	11	What	what	WP
25944	2984	12	is	be	VBZ
25944	2984	13	hyperæsthesia	hyperæsthesia	NNP
25944	2984	14	?	?	.
25944	2984	15	#	#	NNP
25944	2984	16	By	by	IN
25944	2984	17	hyperæsthesia	hyperæsthesia	NNP
25944	2984	18	is	be	VBZ
25944	2984	19	meant	mean	VBN
25944	2984	20	increased	increase	VBN
25944	2984	21	cutaneous	cutaneous	JJ
25944	2984	22	sensibility	sensibility	NN
25944	2984	23	.	.	.
25944	2985	1	It	-PRON-	PRP
25944	2985	2	is	be	VBZ
25944	2985	3	usually	usually	RB
25944	2985	4	more	more	RBR
25944	2985	5	or	or	CC
25944	2985	6	less	less	RBR
25944	2985	7	localized	localized	JJ
25944	2985	8	,	,	,
25944	2985	9	and	and	CC
25944	2985	10	is	be	VBZ
25944	2985	11	met	meet	VBN
25944	2985	12	with	with	IN
25944	2985	13	as	as	IN
25944	2985	14	a	a	DT
25944	2985	15	symptom	symptom	NN
25944	2985	16	in	in	IN
25944	2985	17	functional	functional	JJ
25944	2985	18	and	and	CC
25944	2985	19	organic	organic	JJ
25944	2985	20	nervous	nervous	JJ
25944	2985	21	diseases	disease	NNS
25944	2985	22	.	.	.
25944	2986	1	#	#	NNP
25944	2986	2	Dermatalgia	Dermatalgia	NNP
25944	2986	3	.	.	.
25944	2986	4	#	#	NNP
25944	2986	5	(	(	-LRB-
25944	2986	6	_	_	NNP
25944	2986	7	Synonyms	Synonyms	NNP
25944	2986	8	:	:	:
25944	2986	9	_	_	NNP
25944	2986	10	Neuralgia	Neuralgia	NNP
25944	2986	11	of	of	IN
25944	2986	12	the	the	DT
25944	2986	13	Skin	skin	NN
25944	2986	14	;	;	:
25944	2986	15	Rheumatism	rheumatism	NN
25944	2986	16	of	of	IN
25944	2986	17	the	the	DT
25944	2986	18	Skin	skin	NN
25944	2986	19	;	;	:
25944	2986	20	Dermalgia	Dermalgia	NNP
25944	2986	21	.	.	.
25944	2986	22	)	)	-RRB-
25944	2987	1	#	#	LS
25944	2987	2	What	what	WP
25944	2987	3	do	do	VBP
25944	2987	4	you	-PRON-	PRP
25944	2987	5	understand	understand	VB
25944	2987	6	by	by	IN
25944	2987	7	dermatalgia	dermatalgia	NN
25944	2987	8	?	?	.
25944	2987	9	#	#	$
25944	2987	10	By	by	IN
25944	2987	11	dermatalgia	dermatalgia	NN
25944	2987	12	is	be	VBZ
25944	2987	13	meant	mean	VBN
25944	2987	14	a	a	DT
25944	2987	15	tender	tender	JJ
25944	2987	16	or	or	CC
25944	2987	17	painful	painful	JJ
25944	2987	18	condition	condition	NN
25944	2987	19	of	of	IN
25944	2987	20	the	the	DT
25944	2987	21	skin	skin	NN
25944	2987	22	unattended	unattende	VBN
25944	2987	23	by	by	IN
25944	2987	24	structural	structural	JJ
25944	2987	25	change	change	NN
25944	2987	26	.	.	.
25944	2988	1	It	-PRON-	PRP
25944	2988	2	is	be	VBZ
25944	2988	3	commonly	commonly	RB
25944	2988	4	limited	limit	VBN
25944	2988	5	to	to	IN
25944	2988	6	a	a	DT
25944	2988	7	small	small	JJ
25944	2988	8	area	area	NN
25944	2988	9	,	,	,
25944	2988	10	and	and	CC
25944	2988	11	is	be	VBZ
25944	2988	12	usually	usually	RB
25944	2988	13	symptomatic	symptomatic	JJ
25944	2988	14	of	of	IN
25944	2988	15	functional	functional	JJ
25944	2988	16	or	or	CC
25944	2988	17	organic	organic	JJ
25944	2988	18	nervous	nervous	JJ
25944	2988	19	disease	disease	NN
25944	2988	20	.	.	.
25944	2989	1	As	as	IN
25944	2989	2	an	an	DT
25944	2989	3	idiopathic	idiopathic	JJ
25944	2989	4	affection	affection	NN
25944	2989	5	it	-PRON-	PRP
25944	2989	6	is	be	VBZ
25944	2989	7	looked	look	VBN
25944	2989	8	upon	upon	IN
25944	2989	9	as	as	IN
25944	2989	10	of	of	IN
25944	2989	11	a	a	DT
25944	2989	12	rheumatic	rheumatic	JJ
25944	2989	13	origin	origin	NN
25944	2989	14	.	.	.
25944	2990	1	Treatment	treatment	NN
25944	2990	2	depends	depend	VBZ
25944	2990	3	upon	upon	IN
25944	2990	4	the	the	DT
25944	2990	5	cause	cause	NN
25944	2990	6	.	.	.
25944	2991	1	#	#	NNP
25944	2991	2	Anæsthesia	Anæsthesia	NNP
25944	2991	3	.	.	.
25944	2991	4	#	#	$
25944	2991	5	#	#	$
25944	2991	6	What	what	WP
25944	2991	7	is	be	VBZ
25944	2991	8	anæsthesia	anæsthesia	JJ
25944	2991	9	?	?	.
25944	2991	10	#	#	$
25944	2991	11	Anæsthesia	Anæsthesia	NNP
25944	2991	12	is	be	VBZ
25944	2991	13	a	a	DT
25944	2991	14	diminution	diminution	NN
25944	2991	15	,	,	,
25944	2991	16	comparative	comparative	JJ
25944	2991	17	or	or	CC
25944	2991	18	complete	complete	JJ
25944	2991	19	,	,	,
25944	2991	20	of	of	IN
25944	2991	21	cutaneous	cutaneous	JJ
25944	2991	22	sensibility	sensibility	NN
25944	2991	23	.	.	.
25944	2992	1	It	-PRON-	PRP
25944	2992	2	is	be	VBZ
25944	2992	3	usually	usually	RB
25944	2992	4	localized	localize	VBN
25944	2992	5	,	,	,
25944	2992	6	and	and	CC
25944	2992	7	is	be	VBZ
25944	2992	8	met	meet	VBN
25944	2992	9	with	with	IN
25944	2992	10	in	in	IN
25944	2992	11	the	the	DT
25944	2992	12	course	course	NN
25944	2992	13	of	of	IN
25944	2992	14	certain	certain	JJ
25944	2992	15	nervous	nervous	JJ
25944	2992	16	affections	affection	NNS
25944	2992	17	.	.	.
25944	2993	1	It	-PRON-	PRP
25944	2993	2	is	be	VBZ
25944	2993	3	also	also	RB
25944	2993	4	encountered	encounter	VBN
25944	2993	5	in	in	IN
25944	2993	6	leprosy	leprosy	NN
25944	2993	7	,	,	,
25944	2993	8	morph[oe]a	morph[oe]a	NNP
25944	2993	9	and	and	CC
25944	2993	10	like	like	IN
25944	2993	11	diseases	disease	NNS
25944	2993	12	.	.	.
25944	2994	1	#	#	NNP
25944	2994	2	Pruritus	Pruritus	NNP
25944	2994	3	.	.	.
25944	2994	4	#	#	$
25944	2994	5	#	#	$
25944	2994	6	What	what	WP
25944	2994	7	do	do	VBP
25944	2994	8	you	-PRON-	PRP
25944	2994	9	understand	understand	VB
25944	2994	10	by	by	IN
25944	2994	11	pruritus	pruritus	NN
25944	2994	12	?	?	.
25944	2994	13	#	#	$
25944	2994	14	Pruritus	Pruritus	NNP
25944	2994	15	is	be	VBZ
25944	2994	16	a	a	DT
25944	2994	17	functional	functional	JJ
25944	2994	18	disease	disease	NN
25944	2994	19	of	of	IN
25944	2994	20	the	the	DT
25944	2994	21	skin	skin	NN
25944	2994	22	,	,	,
25944	2994	23	the	the	DT
25944	2994	24	sole	sole	JJ
25944	2994	25	symptom	symptom	NN
25944	2994	26	of	of	IN
25944	2994	27	which	which	WDT
25944	2994	28	is	be	VBZ
25944	2994	29	itching	itch	VBG
25944	2994	30	,	,	,
25944	2994	31	there	there	EX
25944	2994	32	being	be	VBG
25944	2994	33	no	no	DT
25944	2994	34	structural	structural	JJ
25944	2994	35	change	change	NN
25944	2994	36	.	.	.
25944	2995	1	#	#	NNP
25944	2995	2	Describe	describe	VB
25944	2995	3	the	the	DT
25944	2995	4	symptoms	symptom	NNS
25944	2995	5	of	of	IN
25944	2995	6	pruritus	pruritus	NN
25944	2995	7	.	.	.
25944	2995	8	#	#	$
25944	2995	9	The	the	DT
25944	2995	10	sole	sole	JJ
25944	2995	11	and	and	CC
25944	2995	12	essential	essential	JJ
25944	2995	13	symptom	symptom	NN
25944	2995	14	is	be	VBZ
25944	2995	15	itchiness	itchiness	JJ
25944	2995	16	,	,	,
25944	2995	17	usually	usually	RB
25944	2995	18	more	more	RBR
25944	2995	19	or	or	CC
25944	2995	20	less	less	RBR
25944	2995	21	paroxysmal	paroxysmal	JJ
25944	2995	22	,	,	,
25944	2995	23	and	and	CC
25944	2995	24	worse	bad	JJR
25944	2995	25	at	at	IN
25944	2995	26	night	night	NN
25944	2995	27	.	.	.
25944	2996	1	There	there	EX
25944	2996	2	are	be	VBP
25944	2996	3	no	no	DT
25944	2996	4	primary	primary	JJ
25944	2996	5	structural	structural	JJ
25944	2996	6	lesions	lesion	NNS
25944	2996	7	,	,	,
25944	2996	8	but	but	CC
25944	2996	9	in	in	IN
25944	2996	10	severe	severe	JJ
25944	2996	11	and	and	CC
25944	2996	12	persistent	persistent	JJ
25944	2996	13	cases	case	NNS
25944	2996	14	the	the	DT
25944	2996	15	parts	part	NNS
25944	2996	16	become	become	VBP
25944	2996	17	so	so	RB
25944	2996	18	irritated	irritated	JJ
25944	2996	19	by	by	IN
25944	2996	20	continued	continued	JJ
25944	2996	21	scratching	scratching	NN
25944	2996	22	that	that	IN
25944	2996	23	secondary	secondary	JJ
25944	2996	24	lesions	lesion	NNS
25944	2996	25	,	,	,
25944	2996	26	such	such	JJ
25944	2996	27	as	as	IN
25944	2996	28	papules	papule	NNS
25944	2996	29	and	and	CC
25944	2996	30	slight	slight	JJ
25944	2996	31	thickening	thickening	NN
25944	2996	32	and	and	CC
25944	2996	33	infiltration	infiltration	NN
25944	2996	34	,	,	,
25944	2996	35	may	may	MD
25944	2996	36	result	result	VB
25944	2996	37	.	.	.
25944	2997	1	It	-PRON-	PRP
25944	2997	2	is	be	VBZ
25944	2997	3	much	much	RB
25944	2997	4	more	more	RBR
25944	2997	5	common	common	JJ
25944	2997	6	in	in	IN
25944	2997	7	advanced	advanced	JJ
25944	2997	8	life--_pruritus	life--_pruritus	JJ
25944	2997	9	senilis	senilis	NNP
25944	2997	10	_	_	NNP
25944	2997	11	.	.	.
25944	2998	1	In	in	IN
25944	2998	2	such	such	JJ
25944	2998	3	cases	case	NNS
25944	2998	4	,	,	,
25944	2998	5	as	as	RB
25944	2998	6	well	well	RB
25944	2998	7	as	as	IN
25944	2998	8	in	in	IN
25944	2998	9	those	those	DT
25944	2998	10	cases	case	NNS
25944	2998	11	in	in	IN
25944	2998	12	younger	young	JJR
25944	2998	13	and	and	CC
25944	2998	14	middle	middle	NN
25944	2998	15	-	-	HYPH
25944	2998	16	aged	aged	JJ
25944	2998	17	individuals	individual	NNS
25944	2998	18	in	in	IN
25944	2998	19	which	which	WDT
25944	2998	20	the	the	DT
25944	2998	21	itchiness	itchiness	NN
25944	2998	22	develops	develop	VBZ
25944	2998	23	at	at	IN
25944	2998	24	the	the	DT
25944	2998	25	approach	approach	NN
25944	2998	26	of	of	IN
25944	2998	27	cold	cold	JJ
25944	2998	28	weather	weather	NN
25944	2998	29	and	and	CC
25944	2998	30	disappears	disappear	VBZ
25944	2998	31	upon	upon	IN
25944	2998	32	the	the	DT
25944	2998	33	coming	coming	NN
25944	2998	34	of	of	IN
25944	2998	35	the	the	DT
25944	2998	36	warm	warm	JJ
25944	2998	37	season	season	NN
25944	2998	38	(	(	-LRB-
25944	2998	39	_	_	NNP
25944	2998	40	pruritus	pruritus	NNP
25944	2998	41	hiemalis	hiemalis	NNP
25944	2998	42	_	_	NNP
25944	2998	43	)	)	-RRB-
25944	2998	44	,	,	,
25944	2998	45	the	the	DT
25944	2998	46	pruritus	pruritus	NN
25944	2998	47	is	be	VBZ
25944	2998	48	usually	usually	RB
25944	2998	49	more	more	RBR
25944	2998	50	or	or	CC
25944	2998	51	less	less	RBR
25944	2998	52	generalized	generalize	VBN
25944	2998	53	,	,	,
25944	2998	54	although	although	IN
25944	2998	55	not	not	RB
25944	2998	56	infrequently	infrequently	RB
25944	2998	57	in	in	IN
25944	2998	58	the	the	DT
25944	2998	59	latter	latter	JJ
25944	2998	60	the	the	DT
25944	2998	61	legs	leg	NNS
25944	2998	62	are	be	VBP
25944	2998	63	specially	specially	RB
25944	2998	64	involved	involved	JJ
25944	2998	65	.	.	.
25944	2999	1	In	in	IN
25944	2999	2	some	some	DT
25944	2999	3	individuals	individual	NNS
25944	2999	4	an	an	DT
25944	2999	5	attack	attack	NN
25944	2999	6	of	of	IN
25944	2999	7	pruritus	pruritus	NN
25944	2999	8	,	,	,
25944	2999	9	of	of	IN
25944	2999	10	variable	variable	JJ
25944	2999	11	intensity	intensity	NN
25944	2999	12	,	,	,
25944	2999	13	lasting	last	VBG
25944	2999	14	from	from	IN
25944	2999	15	five	five	CD
25944	2999	16	to	to	TO
25944	2999	17	thirty	thirty	CD
25944	2999	18	minutes	minute	NNS
25944	2999	19	,	,	,
25944	2999	20	comes	come	VBZ
25944	2999	21	on	on	RP
25944	2999	22	immediately	immediately	RB
25944	2999	23	after	after	IN
25944	2999	24	a	a	DT
25944	2999	25	bath	bath	NN
25944	2999	26	(	(	-LRB-
25944	2999	27	_	_	NNP
25944	2999	28	bath	bath	NN
25944	2999	29	-	-	HYPH
25944	2999	30	pruritus	pruritus	NNP
25944	2999	31	_	_	NNP
25944	2999	32	)	)	-RRB-
25944	2999	33	.	.	.
25944	3000	1	It	-PRON-	PRP
25944	3000	2	is	be	VBZ
25944	3000	3	usually	usually	RB
25944	3000	4	confined	confine	VBN
25944	3000	5	to	to	IN
25944	3000	6	the	the	DT
25944	3000	7	legs	leg	NNS
25944	3000	8	from	from	IN
25944	3000	9	the	the	DT
25944	3000	10	hips	hip	NNS
25944	3000	11	down	down	RP
25944	3000	12	.	.	.
25944	3001	1	#	#	$
25944	3001	2	Is	be	VBZ
25944	3001	3	pruritus	pruritus	VB
25944	3001	4	always	always	RB
25944	3001	5	more	more	RBR
25944	3001	6	or	or	CC
25944	3001	7	less	less	RBR
25944	3001	8	generalized	generalized	JJ
25944	3001	9	?	?	.
25944	3001	10	#	#	$
25944	3001	11	No	no	UH
25944	3001	12	;	;	:
25944	3001	13	not	not	RB
25944	3001	14	infrequently	infrequently	RB
25944	3001	15	the	the	DT
25944	3001	16	itching	itching	NN
25944	3001	17	is	be	VBZ
25944	3001	18	limited	limit	VBN
25944	3001	19	to	to	IN
25944	3001	20	the	the	DT
25944	3001	21	genital	genital	JJ
25944	3001	22	region	region	NN
25944	3001	23	(	(	-LRB-
25944	3001	24	_	_	NNP
25944	3001	25	pruritus	pruritus	NN
25944	3001	26	scroti	scroti	NNP
25944	3001	27	_	_	NNP
25944	3001	28	,	,	,
25944	3001	29	_	_	NNP
25944	3001	30	pruritus	pruritus	NN
25944	3001	31	vulvæ	vulvæ	NNP
25944	3001	32	_	_	NNP
25944	3001	33	)	)	-RRB-
25944	3001	34	or	or	CC
25944	3001	35	to	to	IN
25944	3001	36	the	the	DT
25944	3001	37	anus	anus	NN
25944	3001	38	(	(	-LRB-
25944	3001	39	_	_	NNP
25944	3001	40	pruritus	pruritus	NN
25944	3001	41	ani	ani	NNP
25944	3001	42	_	_	NNP
25944	3001	43	)	)	-RRB-
25944	3001	44	.	.	.
25944	3002	1	#	#	JJR
25944	3002	2	To	to	IN
25944	3002	3	what	what	WP
25944	3002	4	may	may	MD
25944	3002	5	pruritus	pruritus	VB
25944	3002	6	often	often	RB
25944	3002	7	be	be	VB
25944	3002	8	ascribed	ascribe	VBN
25944	3002	9	?	?	.
25944	3002	10	#	#	$
25944	3002	11	To	to	TO
25944	3002	12	digestive	digestive	JJ
25944	3002	13	and	and	CC
25944	3002	14	intestinal	intestinal	JJ
25944	3002	15	derangements	derangement	NNS
25944	3002	16	,	,	,
25944	3002	17	hepatic	hepatic	JJ
25944	3002	18	disorders	disorder	NNS
25944	3002	19	,	,	,
25944	3002	20	the	the	DT
25944	3002	21	uric	uric	JJ
25944	3002	22	acid	acid	NN
25944	3002	23	diathesis	diathesis	NN
25944	3002	24	,	,	,
25944	3002	25	gestation	gestation	NN
25944	3002	26	,	,	,
25944	3002	27	diabetes	diabetes	NN
25944	3002	28	mellitus	mellitus	NN
25944	3002	29	,	,	,
25944	3002	30	and	and	CC
25944	3002	31	a	a	DT
25944	3002	32	depraved	depraved	JJ
25944	3002	33	state	state	NN
25944	3002	34	of	of	IN
25944	3002	35	the	the	DT
25944	3002	36	nervous	nervous	JJ
25944	3002	37	system	system	NN
25944	3002	38	.	.	.
25944	3003	1	Pruritus	Pruritus	NNP
25944	3003	2	vulvæ	vulvæ	JJ
25944	3003	3	is	be	VBZ
25944	3003	4	at	at	IN
25944	3003	5	times	time	NNS
25944	3003	6	due	due	JJ
25944	3003	7	to	to	IN
25944	3003	8	irritating	irritate	VBG
25944	3003	9	discharges	discharge	NNS
25944	3003	10	,	,	,
25944	3003	11	and	and	CC
25944	3003	12	pruritus	pruritus	VB
25944	3003	13	ani	ani	NNP
25944	3003	14	occasionally	occasionally	RB
25944	3003	15	to	to	IN
25944	3003	16	hemorrhoids	hemorrhoid	NNS
25944	3003	17	and	and	CC
25944	3003	18	seat	seat	NN
25944	3003	19	-	-	HYPH
25944	3003	20	worms	worm	NNS
25944	3003	21	.	.	.
25944	3004	1	#	#	$
25944	3004	2	Is	be	VBZ
25944	3004	3	there	there	EX
25944	3004	4	any	any	DT
25944	3004	5	difficulty	difficulty	NN
25944	3004	6	in	in	IN
25944	3004	7	the	the	DT
25944	3004	8	diagnosis	diagnosis	NN
25944	3004	9	of	of	IN
25944	3004	10	pruritus	pruritus	NN
25944	3004	11	?	?	.
25944	3004	12	#	#	$
25944	3004	13	No	no	UH
25944	3004	14	.	.	.
25944	3005	1	The	the	DT
25944	3005	2	subjective	subjective	JJ
25944	3005	3	symptom	symptom	NN
25944	3005	4	of	of	IN
25944	3005	5	itching	itch	VBG
25944	3005	6	without	without	IN
25944	3005	7	the	the	DT
25944	3005	8	presence	presence	NN
25944	3005	9	of	of	IN
25944	3005	10	structural	structural	JJ
25944	3005	11	lesions	lesion	NNS
25944	3005	12	is	be	VBZ
25944	3005	13	diagnostic	diagnostic	JJ
25944	3005	14	.	.	.
25944	3006	1	In	in	IN
25944	3006	2	those	those	DT
25944	3006	3	severe	severe	JJ
25944	3006	4	and	and	CC
25944	3006	5	persistent	persistent	JJ
25944	3006	6	cases	case	NNS
25944	3006	7	in	in	IN
25944	3006	8	which	which	WDT
25944	3006	9	excoriations	excoriation	NNS
25944	3006	10	and	and	CC
25944	3006	11	papules	papule	NNS
25944	3006	12	have	have	VBP
25944	3006	13	resulted	result	VBN
25944	3006	14	from	from	IN
25944	3006	15	the	the	DT
25944	3006	16	scratching	scratching	NN
25944	3006	17	,	,	,
25944	3006	18	the	the	DT
25944	3006	19	history	history	NN
25944	3006	20	of	of	IN
25944	3006	21	the	the	DT
25944	3006	22	case	case	NN
25944	3006	23	,	,	,
25944	3006	24	together	together	RB
25944	3006	25	with	with	IN
25944	3006	26	its	-PRON-	PRP$
25944	3006	27	course	course	NN
25944	3006	28	,	,	,
25944	3006	29	must	must	MD
25944	3006	30	be	be	VB
25944	3006	31	considered	consider	VBN
25944	3006	32	.	.	.
25944	3007	1	Care	care	NN
25944	3007	2	should	should	MD
25944	3007	3	be	be	VB
25944	3007	4	taken	take	VBN
25944	3007	5	not	not	RB
25944	3007	6	to	to	TO
25944	3007	7	confound	confound	VB
25944	3007	8	it	-PRON-	PRP
25944	3007	9	with	with	IN
25944	3007	10	pediculosis	pediculosis	NN
25944	3007	11	.	.	.
25944	3008	1	In	in	IN
25944	3008	2	this	this	DT
25944	3008	3	latter	latter	JJ
25944	3008	4	the	the	DT
25944	3008	5	excoriations	excoriation	NNS
25944	3008	6	usually	usually	RB
25944	3008	7	have	have	VBP
25944	3008	8	a	a	DT
25944	3008	9	somewhat	somewhat	RB
25944	3008	10	peculiar	peculiar	JJ
25944	3008	11	distribution	distribution	NN
25944	3008	12	,	,	,
25944	3008	13	being	be	VBG
25944	3008	14	most	most	RBS
25944	3008	15	abundant	abundant	JJ
25944	3008	16	on	on	IN
25944	3008	17	those	those	DT
25944	3008	18	parts	part	NNS
25944	3008	19	of	of	IN
25944	3008	20	the	the	DT
25944	3008	21	body	body	NN
25944	3008	22	with	with	IN
25944	3008	23	which	which	WDT
25944	3008	24	the	the	DT
25944	3008	25	clothing	clothing	NN
25944	3008	26	lies	lie	VBZ
25944	3008	27	closely	closely	RB
25944	3008	28	in	in	IN
25944	3008	29	contact	contact	NN
25944	3008	30	.	.	.
25944	3009	1	(	(	-LRB-
25944	3009	2	See	see	VB
25944	3009	3	Pediculosis	Pediculosis	NNP
25944	3009	4	corporis	corporis	NN
25944	3009	5	.	.	.
25944	3009	6	)	)	-RRB-
25944	3010	1	In	in	IN
25944	3010	2	pruritus	pruritus	NN
25944	3010	3	of	of	IN
25944	3010	4	the	the	DT
25944	3010	5	genitocrural	genitocrural	JJ
25944	3010	6	region	region	NN
25944	3010	7	the	the	DT
25944	3010	8	possibility	possibility	NN
25944	3010	9	of	of	IN
25944	3010	10	pediculi	pediculi	NN
25944	3010	11	being	be	VBG
25944	3010	12	the	the	DT
25944	3010	13	cause	cause	NN
25944	3010	14	must	must	MD
25944	3010	15	be	be	VB
25944	3010	16	kept	keep	VBN
25944	3010	17	in	in	IN
25944	3010	18	mind	mind	NN
25944	3010	19	;	;	,
25944	3010	20	an	an	DT
25944	3010	21	examination	examination	NN
25944	3010	22	of	of	IN
25944	3010	23	the	the	DT
25944	3010	24	parts	part	NNS
25944	3010	25	for	for	IN
25944	3010	26	the	the	DT
25944	3010	27	parasite	parasite	NN
25944	3010	28	or	or	CC
25944	3010	29	for	for	IN
25944	3010	30	ova	ova	NNP
25944	3010	31	(	(	-LRB-
25944	3010	32	attached	attach	VBN
25944	3010	33	to	to	IN
25944	3010	34	the	the	DT
25944	3010	35	hairs	hair	NNS
25944	3010	36	)	)	-RRB-
25944	3010	37	would	would	MD
25944	3010	38	prevent	prevent	VB
25944	3010	39	error	error	NN
25944	3010	40	.	.	.
25944	3011	1	(	(	-LRB-
25944	3011	2	See	see	VB
25944	3011	3	Pediculosis	Pediculosis	NNP
25944	3011	4	pubis	pubi	VBD
25944	3011	5	.	.	.
25944	3011	6	)	)	-RRB-
25944	3012	1	#	#	LS
25944	3012	2	What	what	WDT
25944	3012	3	prognosis	prognosis	NN
25944	3012	4	would	would	MD
25944	3012	5	you	-PRON-	PRP
25944	3012	6	give	give	VB
25944	3012	7	in	in	IN
25944	3012	8	pruritus	pruritus	NN
25944	3012	9	?	?	.
25944	3012	10	#	#	$
25944	3012	11	In	in	IN
25944	3012	12	the	the	DT
25944	3012	13	majority	majority	NN
25944	3012	14	of	of	IN
25944	3012	15	cases	case	NNS
25944	3012	16	the	the	DT
25944	3012	17	condition	condition	NN
25944	3012	18	responds	respond	VBZ
25944	3012	19	to	to	IN
25944	3012	20	proper	proper	JJ
25944	3012	21	treatment	treatment	NN
25944	3012	22	,	,	,
25944	3012	23	but	but	CC
25944	3012	24	in	in	IN
25944	3012	25	others	other	NNS
25944	3012	26	it	-PRON-	PRP
25944	3012	27	proves	prove	VBZ
25944	3012	28	rebellious	rebellious	JJ
25944	3012	29	.	.	.
25944	3013	1	The	the	DT
25944	3013	2	prognosis	prognosis	NN
25944	3013	3	depends	depend	VBZ
25944	3013	4	,	,	,
25944	3013	5	in	in	IN
25944	3013	6	fact	fact	NN
25944	3013	7	,	,	,
25944	3013	8	upon	upon	IN
25944	3013	9	the	the	DT
25944	3013	10	removability	removability	NN
25944	3013	11	of	of	IN
25944	3013	12	the	the	DT
25944	3013	13	cause	cause	NN
25944	3013	14	.	.	.
25944	3014	1	Temporary	temporary	JJ
25944	3014	2	relief	relief	NN
25944	3014	3	may	may	MD
25944	3014	4	always	always	RB
25944	3014	5	be	be	VB
25944	3014	6	given	give	VBN
25944	3014	7	by	by	IN
25944	3014	8	external	external	JJ
25944	3014	9	applications	application	NNS
25944	3014	10	.	.	.
25944	3015	1	#	#	NNP
25944	3015	2	How	how	WRB
25944	3015	3	would	would	MD
25944	3015	4	you	-PRON-	PRP
25944	3015	5	treat	treat	VB
25944	3015	6	pruritus	pruritus	NN
25944	3015	7	?	?	.
25944	3015	8	#	#	NN
25944	3015	9	With	with	IN
25944	3015	10	systemic	systemic	JJ
25944	3015	11	remedies	remedy	NNS
25944	3015	12	directed	direct	VBN
25944	3015	13	toward	toward	IN
25944	3015	14	a	a	DT
25944	3015	15	removal	removal	NN
25944	3015	16	or	or	CC
25944	3015	17	modification	modification	NN
25944	3015	18	of	of	IN
25944	3015	19	the	the	DT
25944	3015	20	etiological	etiological	JJ
25944	3015	21	factors	factor	NNS
25944	3015	22	,	,	,
25944	3015	23	and	and	CC
25944	3015	24	,	,	,
25944	3015	25	for	for	IN
25944	3015	26	the	the	DT
25944	3015	27	temporary	temporary	JJ
25944	3015	28	relief	relief	NN
25944	3015	29	of	of	IN
25944	3015	30	the	the	DT
25944	3015	31	itching	itching	NN
25944	3015	32	,	,	,
25944	3015	33	suitable	suitable	JJ
25944	3015	34	antipruritic	antipruritic	JJ
25944	3015	35	applications	application	NNS
25944	3015	36	.	.	.
25944	3016	1	In	in	IN
25944	3016	2	obscure	obscure	JJ
25944	3016	3	cases	case	NNS
25944	3016	4	,	,	,
25944	3016	5	quinia	quinia	NNP
25944	3016	6	,	,	,
25944	3016	7	salophen	salophen	NNP
25944	3016	8	,	,	,
25944	3016	9	lithia	lithia	NNP
25944	3016	10	salts	salts	NNP
25944	3016	11	,	,	,
25944	3016	12	calcium	calcium	NN
25944	3016	13	chloride	chloride	NN
25944	3016	14	,	,	,
25944	3016	15	belladonna	belladonna	NN
25944	3016	16	,	,	,
25944	3016	17	nux	nux	NN
25944	3016	18	vomica	vomica	NNP
25944	3016	19	,	,	,
25944	3016	20	arsenic	arsenic	JJ
25944	3016	21	,	,	,
25944	3016	22	pilocarpine	pilocarpine	NN
25944	3016	23	,	,	,
25944	3016	24	and	and	CC
25944	3016	25	general	general	JJ
25944	3016	26	galvanization	galvanization	NN
25944	3016	27	may	may	MD
25944	3016	28	be	be	VB
25944	3016	29	variously	variously	RB
25944	3016	30	tried	try	VBN
25944	3016	31	.	.	.
25944	3017	1	Alkalies	alkali	NNS
25944	3017	2	prove	prove	VBP
25944	3017	3	useful	useful	JJ
25944	3017	4	in	in	IN
25944	3017	5	many	many	JJ
25944	3017	6	cases	case	NNS
25944	3017	7	.	.	.
25944	3018	1	Exceptionally	exceptionally	RB
25944	3018	2	,	,	,
25944	3018	3	the	the	DT
25944	3018	4	relief	relief	NN
25944	3018	5	furnished	furnish	VBN
25944	3018	6	by	by	IN
25944	3018	7	external	external	JJ
25944	3018	8	treatment	treatment	NN
25944	3018	9	is	be	VBZ
25944	3018	10	more	more	RBR
25944	3018	11	or	or	CC
25944	3018	12	less	less	RBR
25944	3018	13	permanent	permanent	JJ
25944	3018	14	.	.	.
25944	3019	1	#	#	$
25944	3019	2	Name	name	VB
25944	3019	3	the	the	DT
25944	3019	4	important	important	JJ
25944	3019	5	antipruritic	antipruritic	JJ
25944	3019	6	applications	application	NNS
25944	3019	7	.	.	.
25944	3019	8	#	#	JJR
25944	3019	9	Alkaline	Alkaline	NNP
25944	3019	10	baths	bath	NNS
25944	3019	11	;	;	:
25944	3019	12	lotions	lotion	NNS
25944	3019	13	of	of	IN
25944	3019	14	carbolic	carbolic	JJ
25944	3019	15	acid	acid	NN
25944	3019	16	(	(	-LRB-
25944	3019	17	[	[	-LRB-
25944	3019	18	dram]j-[dram]iij	dram]j-[dram]iij	NN
25944	3019	19	to	to	IN
25944	3019	20	Oj	oj	NN
25944	3019	21	)	)	-RRB-
25944	3019	22	,	,	,
25944	3019	23	of	of	IN
25944	3019	24	resorcin	resorcin	NNS
25944	3019	25	(	(	-LRB-
25944	3019	26	[	[	-LRB-
25944	3019	27	dram]j-[dram]iv	dram]j-[dram]iv	NN
25944	3019	28	to	to	IN
25944	3019	29	Oj	oj	NN
25944	3019	30	)	)	-RRB-
25944	3019	31	,	,	,
25944	3019	32	of	of	IN
25944	3019	33	liquor	liquor	NN
25944	3019	34	carbonis	carbonis	NN
25944	3019	35	detergens	detergen	NNS
25944	3019	36	(	(	-LRB-
25944	3019	37	[	[	-LRB-
25944	3019	38	Oz]j-[Oz]iv	oz]j-[oz]iv	JJ
25944	3019	39	to	to	IN
25944	3019	40	Oj	oj	NN
25944	3019	41	)	)	-RRB-
25944	3019	42	,	,	,
25944	3019	43	and	and	CC
25944	3019	44	liquor	liquor	NN
25944	3019	45	picis	picis	NNP
25944	3019	46	alkalinus	alkalinus	NNP
25944	3019	47	(	(	-LRB-
25944	3019	48	[	[	-LRB-
25944	3019	49	dram]j-[dram]iv	dram]j-[dram]iv	NN
25944	3019	50	to	to	IN
25944	3019	51	Oj	oj	NN
25944	3019	52	)	)	-RRB-
25944	3019	53	,	,	,
25944	3019	54	used	use	VBN
25944	3019	55	cautiously	cautiously	RB
25944	3019	56	.	.	.
25944	3020	1	One	one	CD
25944	3020	2	or	or	CC
25944	3020	3	several	several	JJ
25944	3020	4	ounces	ounce	NNS
25944	3020	5	of	of	IN
25944	3020	6	alcohol	alcohol	NN
25944	3020	7	and	and	CC
25944	3020	8	one	one	CD
25944	3020	9	or	or	CC
25944	3020	10	two	two	CD
25944	3020	11	drachms	drachm	NNS
25944	3020	12	of	of	IN
25944	3020	13	glycerin	glycerin	NN
25944	3020	14	in	in	IN
25944	3020	15	each	each	DT
25944	3020	16	pint	pint	NN
25944	3020	17	of	of	IN
25944	3020	18	these	these	DT
25944	3020	19	lotions	lotion	NNS
25944	3020	20	will	will	MD
25944	3020	21	often	often	RB
25944	3020	22	be	be	VB
25944	3020	23	of	of	IN
25944	3020	24	advantage	advantage	NN
25944	3020	25	,	,	,
25944	3020	26	as	as	IN
25944	3020	27	the	the	DT
25944	3020	28	following:--	following:--	NN
25944	3020	29	[	[	-LRB-
25944	3020	30	Rx	Rx	NNP
25944	3020	31	]	]	-RRB-
25944	3020	32	Ac	Ac	NNP
25944	3020	33	.	.	.
25944	3021	1	carbolici	carbolici	NNS
25944	3021	2	,	,	,
25944	3021	3	.......................	.......................	NFP
25944	3021	4	[	[	-LRB-
25944	3021	5	dram]j-[dram]iij	dram]j-[dram]iij	NN
25944	3021	6	Gylcerinæ	Gylcerinæ	NNP
25944	3021	7	,	,	,
25944	3021	8	...........................	...........................	NFP
25944	3021	9	f[dram]ij	f[dram]ij	NFP
25944	3021	10	Alcoholis	Alcoholis	NNP
25944	3021	11	,	,	,
25944	3021	12	...........................	...........................	.
25944	3021	13	f[oz]ij	f[oz]ij	NFP
25944	3021	14	Aquæ	Aquæ	NNP
25944	3021	15	,	,	,
25944	3021	16	.........	.........	NFP
25944	3021	17	q.s	q.s	NNP
25944	3021	18	.	.	.
25944	3022	1	ad	ad	NN
25944	3022	2	..............	..............	.
25944	3022	3	Oj	oj	UH
25944	3022	4	.	.	.
25944	3023	1	M.	M.	NNP
25944	3023	2	Various	various	JJ
25944	3023	3	dusting	dusting	NN
25944	3023	4	-	-	HYPH
25944	3023	5	powders	powder	NNS
25944	3023	6	,	,	,
25944	3023	7	alone	alone	RB
25944	3023	8	or	or	CC
25944	3023	9	in	in	IN
25944	3023	10	conjunction	conjunction	NN
25944	3023	11	with	with	IN
25944	3023	12	the	the	DT
25944	3023	13	lotions	lotion	NNS
25944	3023	14	.	.	.
25944	3024	1	And	and	CC
25944	3024	2	in	in	IN
25944	3024	3	some	some	DT
25944	3024	4	cases	case	NNS
25944	3024	5	,	,	,
25944	3024	6	especially	especially	RB
25944	3024	7	those	those	DT
25944	3024	8	in	in	IN
25944	3024	9	which	which	WDT
25944	3024	10	the	the	DT
25944	3024	11	skin	skin	NN
25944	3024	12	is	be	VBZ
25944	3024	13	unnaturally	unnaturally	RB
25944	3024	14	dry	dry	JJ
25944	3024	15	,	,	,
25944	3024	16	ointments	ointment	NNS
25944	3024	17	may	may	MD
25944	3024	18	be	be	VB
25944	3024	19	used	use	VBN
25944	3024	20	,	,	,
25944	3024	21	such	such	JJ
25944	3024	22	as	as	IN
25944	3024	23	equal	equal	JJ
25944	3024	24	parts	part	NNS
25944	3024	25	of	of	IN
25944	3024	26	lard	lard	NN
25944	3024	27	,	,	,
25944	3024	28	lanolin	lanolin	NN
25944	3024	29	,	,	,
25944	3024	30	and	and	CC
25944	3024	31	petrolatum	petrolatum	NN
25944	3024	32	,	,	,
25944	3024	33	to	to	IN
25944	3024	34	the	the	DT
25944	3024	35	ounce	ounce	NN
25944	3024	36	of	of	IN
25944	3024	37	which	which	WDT
25944	3024	38	may	may	MD
25944	3024	39	be	be	VB
25944	3024	40	added	add	VBN
25944	3024	41	from	from	IN
25944	3024	42	five	five	CD
25944	3024	43	to	to	TO
25944	3024	44	thirty	thirty	CD
25944	3024	45	grains	grain	NNS
25944	3024	46	of	of	IN
25944	3024	47	carbolic	carbolic	JJ
25944	3024	48	acid	acid	NN
25944	3024	49	,	,	,
25944	3024	50	three	three	CD
25944	3024	51	to	to	TO
25944	3024	52	twenty	twenty	CD
25944	3024	53	grains	grain	NNS
25944	3024	54	of	of	IN
25944	3024	55	thymol	thymol	NN
25944	3024	56	,	,	,
25944	3024	57	ten	ten	CD
25944	3024	58	to	to	IN
25944	3024	59	thirty	thirty	CD
25944	3024	60	minims	minim	NNS
25944	3024	61	of	of	IN
25944	3024	62	chloroform	chloroform	NN
25944	3024	63	,	,	,
25944	3024	64	or	or	CC
25944	3024	65	two	two	CD
25944	3024	66	to	to	TO
25944	3024	67	ten	ten	CD
25944	3024	68	grains	grain	NNS
25944	3024	69	of	of	IN
25944	3024	70	menthol	menthol	NNP
25944	3024	71	.	.	.
25944	3025	1	#	#	$
25944	3025	2	What	what	WDT
25944	3025	3	external	external	JJ
25944	3025	4	applications	application	NNS
25944	3025	5	are	be	VBP
25944	3025	6	to	to	TO
25944	3025	7	be	be	VB
25944	3025	8	used	use	VBN
25944	3025	9	in	in	IN
25944	3025	10	the	the	DT
25944	3025	11	local	local	JJ
25944	3025	12	varieties	variety	NNS
25944	3025	13	of	of	IN
25944	3025	14	pruritus	pruritus	NN
25944	3025	15	?	?	.
25944	3025	16	#	#	$
25944	3025	17	In	in	IN
25944	3025	18	_	_	NNP
25944	3025	19	pruritus	pruritus	NN
25944	3025	20	ani	ani	NNP
25944	3025	21	_	_	NNP
25944	3025	22	and	and	CC
25944	3025	23	_	_	NNP
25944	3025	24	pruritus	pruritus	NN
25944	3025	25	vulvæ	vulvæ	NNP
25944	3025	26	_	_	NNP
25944	3025	27	,	,	,
25944	3025	28	in	in	IN
25944	3025	29	addition	addition	NN
25944	3025	30	to	to	IN
25944	3025	31	the	the	DT
25944	3025	32	various	various	JJ
25944	3025	33	applications	application	NNS
25944	3025	34	above	above	RB
25944	3025	35	,	,	,
25944	3025	36	a	a	DT
25944	3025	37	cocaine	cocaine	NN
25944	3025	38	ointment	ointment	NN
25944	3025	39	,	,	,
25944	3025	40	one	one	CD
25944	3025	41	to	to	TO
25944	3025	42	ten	ten	CD
25944	3025	43	grains	grain	NNS
25944	3025	44	to	to	IN
25944	3025	45	the	the	DT
25944	3025	46	ounce	ounce	NN
25944	3025	47	,	,	,
25944	3025	48	a	a	DT
25944	3025	49	strong	strong	JJ
25944	3025	50	solution	solution	NN
25944	3025	51	of	of	IN
25944	3025	52	the	the	DT
25944	3025	53	same	same	JJ
25944	3025	54	(	(	-LRB-
25944	3025	55	gr	gr	FW
25944	3025	56	.	.	.
25944	3026	1	v	v	LS
25944	3026	2	-	-	:
25944	3026	3	xx	xx	NNP
25944	3026	4	to	to	IN
25944	3026	5	[	[	-LRB-
25944	3026	6	Oz]j	Oz]j	NNP
25944	3026	7	)	)	-RRB-
25944	3026	8	,	,	,
25944	3026	9	and	and	CC
25944	3026	10	an	an	DT
25944	3026	11	ointment	ointment	NN
25944	3026	12	containing	contain	VBG
25944	3026	13	ten	ten	CD
25944	3026	14	to	to	IN
25944	3026	15	thirty	thirty	CD
25944	3026	16	minims	minim	NNS
25944	3026	17	of	of	IN
25944	3026	18	the	the	DT
25944	3026	19	oil	oil	NN
25944	3026	20	of	of	IN
25944	3026	21	peppermint	peppermint	NN
25944	3026	22	to	to	IN
25944	3026	23	the	the	DT
25944	3026	24	ounce	ounce	NN
25944	3026	25	;	;	,
25944	3026	26	sponging	sponge	VBG
25944	3026	27	with	with	IN
25944	3026	28	hot	hot	JJ
25944	3026	29	water	water	NN
25944	3026	30	,	,	,
25944	3026	31	often	often	RB
25944	3026	32	affords	afford	VBZ
25944	3026	33	temporary	temporary	JJ
25944	3026	34	relief	relief	NN
25944	3026	35	.	.	.
25944	3027	1	In	in	IN
25944	3027	2	pruritus	pruritus	NN
25944	3027	3	vulvæ	vulvæ	JJ
25944	3027	4	,	,	,
25944	3027	5	moreover	moreover	RB
25944	3027	6	,	,	,
25944	3027	7	astringent	astringent	JJ
25944	3027	8	applications	application	NNS
25944	3027	9	and	and	CC
25944	3027	10	injections	injection	NNS
25944	3027	11	of	of	IN
25944	3027	12	zinc	zinc	NN
25944	3027	13	sulphate	sulphate	NN
25944	3027	14	,	,	,
25944	3027	15	alum	alum	NN
25944	3027	16	,	,	,
25944	3027	17	tannic	tannic	JJ
25944	3027	18	or	or	CC
25944	3027	19	acetic	acetic	JJ
25944	3027	20	acid	acid	NN
25944	3027	21	,	,	,
25944	3027	22	in	in	IN
25944	3027	23	the	the	DT
25944	3027	24	strength	strength	NN
25944	3027	25	commonly	commonly	RB
25944	3027	26	employed	employ	VBN
25944	3027	27	for	for	IN
25944	3027	28	vaginal	vaginal	JJ
25944	3027	29	injections	injection	NNS
25944	3027	30	,	,	,
25944	3027	31	are	be	VBP
25944	3027	32	at	at	IN
25944	3027	33	times	time	NNS
25944	3027	34	curative	curative	JJ
25944	3027	35	.	.	.
25944	3028	1	In	in	IN
25944	3028	2	bath	bath	NN
25944	3028	3	-	-	HYPH
25944	3028	4	pruritus	pruritus	NN
25944	3028	5	weak	weak	JJ
25944	3028	6	glycerine	glycerine	JJ
25944	3028	7	lotions	lotion	NNS
25944	3028	8	,	,	,
25944	3028	9	and	and	CC
25944	3028	10	an	an	DT
25944	3028	11	ointment	ointment	NN
25944	3028	12	containing	contain	VBG
25944	3028	13	a	a	DT
25944	3028	14	few	few	JJ
25944	3028	15	grains	grain	NNS
25944	3028	16	of	of	IN
25944	3028	17	thymol	thymol	NNP
25944	3028	18	and	and	CC
25944	3028	19	menthol	menthol	NNP
25944	3028	20	to	to	IN
25944	3028	21	the	the	DT
25944	3028	22	ounce	ounce	NN
25944	3028	23	sometimes	sometimes	RB
25944	3028	24	give	give	VB
25944	3028	25	moderate	moderate	JJ
25944	3028	26	relief	relief	NN
25944	3028	27	.	.	.
25944	3029	1	Turkish	turkish	JJ
25944	3029	2	baths	bath	NNS
25944	3029	3	are	be	VBP
25944	3029	4	sometimes	sometimes	RB
25944	3029	5	free	free	JJ
25944	3029	6	from	from	IN
25944	3029	7	subsequent	subsequent	JJ
25944	3029	8	pruritus	pruritus	NN
25944	3029	9	.	.	.
25944	3030	1	#	#	$
25944	3030	2	CLASS	class	NN
25944	3030	3	VIII.--PARASITIC	viii.--parasitic	NN
25944	3030	4	AFFECTIONS	affection	NNS
25944	3030	5	.	.	.
25944	3030	6	#	#	$
25944	3030	7	#	#	$
25944	3030	8	Tinea	Tinea	NNP
25944	3030	9	Favosa	Favosa	NNP
25944	3030	10	.	.	.
25944	3030	11	#	#	NNP
25944	3030	12	(	(	-LRB-
25944	3030	13	_	_	NNP
25944	3030	14	Synonym	Synonym	NNP
25944	3030	15	:	:	:
25944	3030	16	_	_	NNP
25944	3030	17	Favus	Favus	NNP
25944	3030	18	.	.	.
25944	3030	19	)	)	-RRB-
25944	3031	1	#	#	LS
25944	3031	2	What	what	WP
25944	3031	3	is	be	VBZ
25944	3031	4	tinea	tinea	NNP
25944	3031	5	favosa	favosa	NNS
25944	3031	6	?	?	.
25944	3031	7	#	#	$
25944	3031	8	Tinea	Tinea	NNP
25944	3031	9	favosa	favosa	NNS
25944	3031	10	,	,	,
25944	3031	11	or	or	CC
25944	3031	12	favus	favus	NN
25944	3031	13	,	,	,
25944	3031	14	is	be	VBZ
25944	3031	15	a	a	DT
25944	3031	16	contagious	contagious	JJ
25944	3031	17	vegetable	vegetable	NN
25944	3031	18	-	-	HYPH
25944	3031	19	parasitic	parasitic	JJ
25944	3031	20	disease	disease	NN
25944	3031	21	of	of	IN
25944	3031	22	the	the	DT
25944	3031	23	skin	skin	NN
25944	3031	24	,	,	,
25944	3031	25	characterized	characterize	VBN
25944	3031	26	by	by	IN
25944	3031	27	pin	pin	NN
25944	3031	28	-	-	HYPH
25944	3031	29	head	head	NN
25944	3031	30	to	to	IN
25944	3031	31	pea	pea	JJ
25944	3031	32	-	-	HYPH
25944	3031	33	sized	sized	JJ
25944	3031	34	,	,	,
25944	3031	35	friable	friable	JJ
25944	3031	36	,	,	,
25944	3031	37	umbilicated	umbilicated	JJ
25944	3031	38	,	,	,
25944	3031	39	cup	cup	NN
25944	3031	40	-	-	HYPH
25944	3031	41	shaped	shape	VBN
25944	3031	42	yellow	yellow	JJ
25944	3031	43	crusts	crust	NNS
25944	3031	44	,	,	,
25944	3031	45	each	each	DT
25944	3031	46	usually	usually	RB
25944	3031	47	perforated	perforate	VBN
25944	3031	48	by	by	IN
25944	3031	49	a	a	DT
25944	3031	50	hair	hair	NN
25944	3031	51	.	.	.
25944	3032	1	#	#	NN
25944	3032	2	Upon	upon	IN
25944	3032	3	what	what	WP
25944	3032	4	parts	part	NNS
25944	3032	5	and	and	CC
25944	3032	6	at	at	IN
25944	3032	7	what	what	WDT
25944	3032	8	age	age	NN
25944	3032	9	is	be	VBZ
25944	3032	10	favus	favus	RB
25944	3032	11	observed	observe	VBN
25944	3032	12	?	?	.
25944	3032	13	#	#	$
25944	3032	14	It	-PRON-	PRP
25944	3032	15	is	be	VBZ
25944	3032	16	usually	usually	RB
25944	3032	17	met	meet	VBN
25944	3032	18	with	with	IN
25944	3032	19	upon	upon	IN
25944	3032	20	the	the	DT
25944	3032	21	scalp	scalp	NN
25944	3032	22	,	,	,
25944	3032	23	but	but	CC
25944	3032	24	it	-PRON-	PRP
25944	3032	25	may	may	MD
25944	3032	26	occur	occur	VB
25944	3032	27	upon	upon	IN
25944	3032	28	any	any	DT
25944	3032	29	part	part	NN
25944	3032	30	of	of	IN
25944	3032	31	the	the	DT
25944	3032	32	integument	integument	NN
25944	3032	33	.	.	.
25944	3033	1	Occasionally	occasionally	RB
25944	3033	2	the	the	DT
25944	3033	3	nails	nail	NNS
25944	3033	4	are	be	VBP
25944	3033	5	invaded	invade	VBN
25944	3033	6	.	.	.
25944	3034	1	It	-PRON-	PRP
25944	3034	2	is	be	VBZ
25944	3034	3	seen	see	VBN
25944	3034	4	at	at	IN
25944	3034	5	all	all	DT
25944	3034	6	ages	age	NNS
25944	3034	7	,	,	,
25944	3034	8	but	but	CC
25944	3034	9	is	be	VBZ
25944	3034	10	much	much	RB
25944	3034	11	more	more	RBR
25944	3034	12	common	common	JJ
25944	3034	13	in	in	IN
25944	3034	14	children	child	NNS
25944	3034	15	.	.	.
25944	3035	1	#	#	NNP
25944	3035	2	Describe	describe	VB
25944	3035	3	the	the	DT
25944	3035	4	symptoms	symptom	NNS
25944	3035	5	of	of	IN
25944	3035	6	favus	favus	NNP
25944	3035	7	of	of	IN
25944	3035	8	the	the	DT
25944	3035	9	scalp	scalp	NN
25944	3035	10	.	.	.
25944	3035	11	#	#	$
25944	3035	12	The	the	DT
25944	3035	13	disease	disease	NN
25944	3035	14	begins	begin	VBZ
25944	3035	15	as	as	IN
25944	3035	16	a	a	DT
25944	3035	17	superficial	superficial	JJ
25944	3035	18	inflammation	inflammation	NN
25944	3035	19	or	or	CC
25944	3035	20	hyperæmic	hyperæmic	JJ
25944	3035	21	spot	spot	NN
25944	3035	22	,	,	,
25944	3035	23	more	more	RBR
25944	3035	24	or	or	CC
25944	3035	25	less	less	RBR
25944	3035	26	circumscribed	circumscribed	JJ
25944	3035	27	,	,	,
25944	3035	28	slightly	slightly	RB
25944	3035	29	scaly	scaly	NNP
25944	3035	30	,	,	,
25944	3035	31	and	and	CC
25944	3035	32	which	which	WDT
25944	3035	33	is	be	VBZ
25944	3035	34	soon	soon	RB
25944	3035	35	followed	follow	VBN
25944	3035	36	by	by	IN
25944	3035	37	the	the	DT
25944	3035	38	formation	formation	NN
25944	3035	39	of	of	IN
25944	3035	40	yellowish	yellowish	JJ
25944	3035	41	points	point	NNS
25944	3035	42	about	about	IN
25944	3035	43	the	the	DT
25944	3035	44	hair	hair	NN
25944	3035	45	follicles	follicle	NNS
25944	3035	46	,	,	,
25944	3035	47	surrounding	surround	VBG
25944	3035	48	the	the	DT
25944	3035	49	hair	hair	NN
25944	3035	50	shaft	shaft	NN
25944	3035	51	.	.	.
25944	3036	1	These	these	DT
25944	3036	2	yellowish	yellowish	JJ
25944	3036	3	points	point	NNS
25944	3036	4	or	or	CC
25944	3036	5	crusts	crust	NNS
25944	3036	6	increase	increase	NN
25944	3036	7	in	in	IN
25944	3036	8	size	size	NN
25944	3036	9	,	,	,
25944	3036	10	become	become	VBN
25944	3036	11	usually	usually	RB
25944	3036	12	as	as	RB
25944	3036	13	large	large	JJ
25944	3036	14	as	as	IN
25944	3036	15	small	small	JJ
25944	3036	16	peas	pea	NNS
25944	3036	17	,	,	,
25944	3036	18	are	be	VBP
25944	3036	19	cup	cup	NN
25944	3036	20	-	-	HYPH
25944	3036	21	shaped	shape	VBN
25944	3036	22	,	,	,
25944	3036	23	with	with	IN
25944	3036	24	the	the	DT
25944	3036	25	convex	convex	NNP
25944	3036	26	side	side	NN
25944	3036	27	pressing	press	VBG
25944	3036	28	down	down	RP
25944	3036	29	upon	upon	IN
25944	3036	30	the	the	DT
25944	3036	31	papillary	papillary	JJ
25944	3036	32	layer	layer	NN
25944	3036	33	,	,	,
25944	3036	34	and	and	CC
25944	3036	35	the	the	DT
25944	3036	36	concave	concave	NNP
25944	3036	37	side	side	NN
25944	3036	38	raised	raise	VBD
25944	3036	39	several	several	JJ
25944	3036	40	lines	line	NNS
25944	3036	41	above	above	IN
25944	3036	42	the	the	DT
25944	3036	43	level	level	NN
25944	3036	44	of	of	IN
25944	3036	45	the	the	DT
25944	3036	46	skin	skin	NN
25944	3036	47	;	;	:
25944	3036	48	they	-PRON-	PRP
25944	3036	49	are	be	VBP
25944	3036	50	umbilicated	umbilicated	JJ
25944	3036	51	,	,	,
25944	3036	52	friable	friable	JJ
25944	3036	53	,	,	,
25944	3036	54	sulphur	sulphur	NN
25944	3036	55	-	-	HYPH
25944	3036	56	colored	color	VBN
25944	3036	57	,	,	,
25944	3036	58	and	and	CC
25944	3036	59	usually	usually	RB
25944	3036	60	each	each	DT
25944	3036	61	cup	cup	NN
25944	3036	62	or	or	CC
25944	3036	63	disc	disc	NN
25944	3036	64	is	be	VBZ
25944	3036	65	perforated	perforate	VBN
25944	3036	66	by	by	IN
25944	3036	67	a	a	DT
25944	3036	68	hair	hair	NN
25944	3036	69	.	.	.
25944	3037	1	Upon	upon	IN
25944	3037	2	removal	removal	NN
25944	3037	3	or	or	CC
25944	3037	4	detachment	detachment	NN
25944	3037	5	,	,	,
25944	3037	6	the	the	DT
25944	3037	7	underlying	underlying	JJ
25944	3037	8	surface	surface	NN
25944	3037	9	is	be	VBZ
25944	3037	10	found	find	VBN
25944	3037	11	to	to	TO
25944	3037	12	be	be	VB
25944	3037	13	somewhat	somewhat	RB
25944	3037	14	excavated	excavate	VBN
25944	3037	15	,	,	,
25944	3037	16	reddened	redden	VBN
25944	3037	17	,	,	,
25944	3037	18	atrophied	atrophy	VBN
25944	3037	19	and	and	CC
25944	3037	20	sometimes	sometimes	RB
25944	3037	21	suppurating	suppurate	VBG
25944	3037	22	.	.	.
25944	3038	1	As	as	IN
25944	3038	2	the	the	DT
25944	3038	3	disease	disease	NN
25944	3038	4	progresses	progress	VBZ
25944	3038	5	the	the	DT
25944	3038	6	crusting	crusting	NN
25944	3038	7	becomes	become	VBZ
25944	3038	8	more	more	RBR
25944	3038	9	or	or	CC
25944	3038	10	less	less	RBR
25944	3038	11	confluent	confluent	JJ
25944	3038	12	,	,	,
25944	3038	13	forming	form	VBG
25944	3038	14	irregular	irregular	JJ
25944	3038	15	masses	masse	NNS
25944	3038	16	of	of	IN
25944	3038	17	thick	thick	JJ
25944	3038	18	,	,	,
25944	3038	19	yellowish	yellowish	JJ
25944	3038	20	,	,	,
25944	3038	21	mortar	mortar	NN
25944	3038	22	-	-	HYPH
25944	3038	23	like	like	JJ
25944	3038	24	crusts	crust	NNS
25944	3038	25	or	or	CC
25944	3038	26	accumulations	accumulation	NNS
25944	3038	27	,	,	,
25944	3038	28	having	have	VBG
25944	3038	29	a	a	DT
25944	3038	30	peculiar	peculiar	JJ
25944	3038	31	,	,	,
25944	3038	32	characteristic	characteristic	JJ
25944	3038	33	odor	odor	NN
25944	3038	34	--	--	:
25944	3038	35	that	that	DT
25944	3038	36	of	of	IN
25944	3038	37	mice	mouse	NNS
25944	3038	38	,	,	,
25944	3038	39	or	or	CC
25944	3038	40	stale	stale	JJ
25944	3038	41	,	,	,
25944	3038	42	damp	damp	JJ
25944	3038	43	straw	straw	NN
25944	3038	44	.	.	.
25944	3039	1	The	the	DT
25944	3039	2	hairs	hair	NNS
25944	3039	3	are	be	VBP
25944	3039	4	involved	involve	VBN
25944	3039	5	early	early	RB
25944	3039	6	in	in	IN
25944	3039	7	the	the	DT
25944	3039	8	disease	disease	NN
25944	3039	9	,	,	,
25944	3039	10	become	become	VBN
25944	3039	11	brittle	brittle	JJ
25944	3039	12	,	,	,
25944	3039	13	lustreless	lustreless	NN
25944	3039	14	,	,	,
25944	3039	15	break	break	VB
25944	3039	16	off	off	RP
25944	3039	17	and	and	CC
25944	3039	18	fall	fall	VB
25944	3039	19	out	out	RP
25944	3039	20	.	.	.
25944	3040	1	In	in	IN
25944	3040	2	some	some	DT
25944	3040	3	instances	instance	NNS
25944	3040	4	,	,	,
25944	3040	5	especially	especially	RB
25944	3040	6	near	near	IN
25944	3040	7	the	the	DT
25944	3040	8	border	border	NN
25944	3040	9	of	of	IN
25944	3040	10	the	the	DT
25944	3040	11	crusts	crust	NNS
25944	3040	12	,	,	,
25944	3040	13	are	be	VBP
25944	3040	14	seen	see	VBN
25944	3040	15	pustules	pustule	NNS
25944	3040	16	or	or	CC
25944	3040	17	suppurating	suppurating	NN
25944	3040	18	points	point	NNS
25944	3040	19	.	.	.
25944	3041	1	_	_	NNP
25944	3041	2	Atrophy	Atrophy	NNP
25944	3041	3	_	_	NNP
25944	3041	4	and	and	CC
25944	3041	5	more	more	RBR
25944	3041	6	or	or	CC
25944	3041	7	less	less	RBR
25944	3041	8	actual	actual	JJ
25944	3041	9	_	_	NNP
25944	3041	10	scarring	scar	VBG
25944	3041	11	_	_	NNP
25944	3041	12	are	be	VBP
25944	3041	13	sooner	soon	RBR
25944	3041	14	or	or	CC
25944	3041	15	later	later	RB
25944	3041	16	noted	note	VBN
25944	3041	17	.	.	.
25944	3042	1	Itching	itching	NN
25944	3042	2	,	,	,
25944	3042	3	variable	variable	JJ
25944	3042	4	as	as	IN
25944	3042	5	to	to	IN
25944	3042	6	degree	degree	NN
25944	3042	7	,	,	,
25944	3042	8	is	be	VBZ
25944	3042	9	usually	usually	RB
25944	3042	10	present	present	JJ
25944	3042	11	.	.	.
25944	3043	1	#	#	LS
25944	3043	2	What	what	WP
25944	3043	3	is	be	VBZ
25944	3043	4	the	the	DT
25944	3043	5	course	course	NN
25944	3043	6	of	of	IN
25944	3043	7	favus	favus	NN
25944	3043	8	of	of	IN
25944	3043	9	the	the	DT
25944	3043	10	scalp	scalp	NN
25944	3043	11	?	?	.
25944	3043	12	#	#	NNP
25944	3043	13	Persistent	persistent	JJ
25944	3043	14	and	and	CC
25944	3043	15	slowly	slowly	RB
25944	3043	16	progressive	progressive	JJ
25944	3043	17	.	.	.
25944	3044	1	[	[	-LRB-
25944	3044	2	Illustration	illustration	NN
25944	3044	3	:	:	:
25944	3044	4	Fig	Fig	NNP
25944	3044	5	.	.	.
25944	3045	1	66	66	CD
25944	3045	2	.	.	.
25944	3046	1	Achorion	Achorion	NNP
25944	3046	2	Schönleinii	Schönleinii	NNP
25944	3046	3	X	X	NNP
25944	3046	4	450	450	CD
25944	3046	5	.	.	.
25944	3047	1	(	(	-LRB-
25944	3047	2	_	_	NNP
25944	3047	3	After	after	IN
25944	3047	4	Duhring	Duhring	NNP
25944	3047	5	.	.	.
25944	3047	6	_	_	NNP
25944	3047	7	)	)	-RRB-
25944	3047	8	Showing	show	VBG
25944	3047	9	simple	simple	JJ
25944	3047	10	mycelium	mycelium	NN
25944	3047	11	,	,	,
25944	3047	12	in	in	IN
25944	3047	13	various	various	JJ
25944	3047	14	stages	stage	NNS
25944	3047	15	of	of	IN
25944	3047	16	development	development	NN
25944	3047	17	,	,	,
25944	3047	18	and	and	CC
25944	3047	19	free	free	JJ
25944	3047	20	spores	spore	NNS
25944	3047	21	.	.	.
25944	3047	22	]	]	-RRB-
25944	3048	1	#	#	LS
25944	3048	2	What	what	WP
25944	3048	3	are	be	VBP
25944	3048	4	the	the	DT
25944	3048	5	symptoms	symptom	NNS
25944	3048	6	of	of	IN
25944	3048	7	favus	favus	NNP
25944	3048	8	when	when	WRB
25944	3048	9	seated	seat	VBN
25944	3048	10	upon	upon	IN
25944	3048	11	the	the	DT
25944	3048	12	general	general	JJ
25944	3048	13	surface	surface	NN
25944	3048	14	?	?	.
25944	3048	15	#	#	$
25944	3048	16	The	the	DT
25944	3048	17	symptoms	symptom	NNS
25944	3048	18	are	be	VBP
25944	3048	19	essentially	essentially	RB
25944	3048	20	similar	similar	JJ
25944	3048	21	to	to	IN
25944	3048	22	those	those	DT
25944	3048	23	upon	upon	IN
25944	3048	24	the	the	DT
25944	3048	25	scalp	scalp	NN
25944	3048	26	,	,	,
25944	3048	27	modified	modify	VBN
25944	3048	28	somewhat	somewhat	RB
25944	3048	29	by	by	IN
25944	3048	30	the	the	DT
25944	3048	31	anatomical	anatomical	JJ
25944	3048	32	differences	difference	NNS
25944	3048	33	of	of	IN
25944	3048	34	the	the	DT
25944	3048	35	parts	part	NNS
25944	3048	36	.	.	.
25944	3049	1	The	the	DT
25944	3049	2	_	_	NNP
25944	3049	3	nails	nail	NNS
25944	3049	4	_	_	NNP
25944	3049	5	,	,	,
25944	3049	6	when	when	WRB
25944	3049	7	affected	affect	VBN
25944	3049	8	,	,	,
25944	3049	9	become	become	VB
25944	3049	10	yellowish	yellowish	JJ
25944	3049	11	,	,	,
25944	3049	12	more	more	RBR
25944	3049	13	or	or	CC
25944	3049	14	less	less	RBR
25944	3049	15	thickened	thicken	VBN
25944	3049	16	,	,	,
25944	3049	17	brittle	brittle	JJ
25944	3049	18	and	and	CC
25944	3049	19	opaque	opaque	JJ
25944	3049	20	(	(	-LRB-
25944	3049	21	_	_	NNP
25944	3049	22	tinea	tinea	NNP
25944	3049	23	favosa	favosa	NNP
25944	3049	24	unguium	unguium	NN
25944	3049	25	_	_	NNP
25944	3049	26	,	,	,
25944	3049	27	_	_	NNP
25944	3049	28	onychomycosis	onychomycosis	NN
25944	3049	29	favosa	favosa	NNP
25944	3049	30	_	_	NNP
25944	3049	31	)	)	-RRB-
25944	3049	32	.	.	.
25944	3050	1	#	#	JJR
25944	3050	2	To	to	IN
25944	3050	3	what	what	WP
25944	3050	4	is	be	VBZ
25944	3050	5	favus	favus	RB
25944	3050	6	due	due	JJ
25944	3050	7	?	?	.
25944	3050	8	#	#	$
25944	3050	9	Solely	solely	RB
25944	3050	10	to	to	IN
25944	3050	11	the	the	DT
25944	3050	12	invasion	invasion	NN
25944	3050	13	of	of	IN
25944	3050	14	the	the	DT
25944	3050	15	cutaneous	cutaneous	JJ
25944	3050	16	structures	structure	NNS
25944	3050	17	,	,	,
25944	3050	18	especially	especially	RB
25944	3050	19	the	the	DT
25944	3050	20	epidermal	epidermal	JJ
25944	3050	21	portion	portion	NN
25944	3050	22	,	,	,
25944	3050	23	by	by	IN
25944	3050	24	the	the	DT
25944	3050	25	vegetable	vegetable	NN
25944	3050	26	parasite	parasite	NN
25944	3050	27	,	,	,
25944	3050	28	the	the	DT
25944	3050	29	_	_	NNP
25944	3050	30	achorion	achorion	NN
25944	3050	31	Schönleinii	Schönleinii	NNP
25944	3050	32	_	_	NNP
25944	3050	33	.	.	.
25944	3051	1	It	-PRON-	PRP
25944	3051	2	is	be	VBZ
25944	3051	3	contagious	contagious	JJ
25944	3051	4	.	.	.
25944	3052	1	It	-PRON-	PRP
25944	3052	2	is	be	VBZ
25944	3052	3	a	a	DT
25944	3052	4	somewhat	somewhat	RB
25944	3052	5	rare	rare	JJ
25944	3052	6	disease	disease	NN
25944	3052	7	in	in	IN
25944	3052	8	the	the	DT
25944	3052	9	native	native	NN
25944	3052	10	-	-	HYPH
25944	3052	11	born	bear	VBN
25944	3052	12	,	,	,
25944	3052	13	being	be	VBG
25944	3052	14	chiefly	chiefly	RB
25944	3052	15	observed	observe	VBN
25944	3052	16	among	among	IN
25944	3052	17	the	the	DT
25944	3052	18	foreign	foreign	JJ
25944	3052	19	poor	poor	NN
25944	3052	20	.	.	.
25944	3053	1	The	the	DT
25944	3053	2	nails	nail	NNS
25944	3053	3	are	be	VBP
25944	3053	4	rarely	rarely	RB
25944	3053	5	affected	affect	VBN
25944	3053	6	primarily	primarily	RB
25944	3053	7	.	.	.
25944	3054	1	It	-PRON-	PRP
25944	3054	2	is	be	VBZ
25944	3054	3	also	also	RB
25944	3054	4	met	meet	VBN
25944	3054	5	with	with	IN
25944	3054	6	in	in	IN
25944	3054	7	the	the	DT
25944	3054	8	lower	low	JJR
25944	3054	9	animals	animal	NNS
25944	3054	10	,	,	,
25944	3054	11	from	from	IN
25944	3054	12	which	which	WDT
25944	3054	13	it	-PRON-	PRP
25944	3054	14	is	be	VBZ
25944	3054	15	doubtless	doubtless	RB
25944	3054	16	not	not	RB
25944	3054	17	infrequently	infrequently	RB
25944	3054	18	communicated	communicate	VBN
25944	3054	19	to	to	IN
25944	3054	20	man	man	NN
25944	3054	21	.	.	.
25944	3055	1	#	#	LS
25944	3055	2	What	what	WP
25944	3055	3	are	be	VBP
25944	3055	4	the	the	DT
25944	3055	5	diagnostic	diagnostic	JJ
25944	3055	6	features	feature	NNS
25944	3055	7	of	of	IN
25944	3055	8	favus	favus	NNP
25944	3055	9	?	?	.
25944	3055	10	#	#	$
25944	3055	11	The	the	DT
25944	3055	12	yellow	yellow	NN
25944	3055	13	,	,	,
25944	3055	14	and	and	CC
25944	3055	15	often	often	RB
25944	3055	16	cup	cup	NN
25944	3055	17	-	-	HYPH
25944	3055	18	shaped	shape	VBN
25944	3055	19	,	,	,
25944	3055	20	crusts	crust	NNS
25944	3055	21	,	,	,
25944	3055	22	brittleness	brittleness	NN
25944	3055	23	and	and	CC
25944	3055	24	loss	loss	NN
25944	3055	25	of	of	IN
25944	3055	26	hair	hair	NN
25944	3055	27	,	,	,
25944	3055	28	atrophy	atrophy	NN
25944	3055	29	,	,	,
25944	3055	30	and	and	CC
25944	3055	31	the	the	DT
25944	3055	32	history	history	NN
25944	3055	33	.	.	.
25944	3056	1	[	[	-LRB-
25944	3056	2	Illustration	illustration	NN
25944	3056	3	:	:	:
25944	3056	4	Fig	Fig	NNP
25944	3056	5	.	.	.
25944	3057	1	67	67	CD
25944	3057	2	.	.	.
25944	3058	1	Epilating	Epilating	NNP
25944	3058	2	Forceps	Forceps	NNP
25944	3058	3	.	.	.
25944	3058	4	]	]	-RRB-
25944	3059	1	#	#	NNP
25944	3059	2	How	how	WRB
25944	3059	3	would	would	MD
25944	3059	4	you	-PRON-	PRP
25944	3059	5	distinguish	distinguish	VB
25944	3059	6	favus	favus	NN
25944	3059	7	from	from	IN
25944	3059	8	eczema	eczema	NN
25944	3059	9	and	and	CC
25944	3059	10	ringworm	ringworm	VB
25944	3059	11	?	?	.
25944	3059	12	#	#	$
25944	3059	13	From	from	IN
25944	3059	14	eczema	eczema	NN
25944	3059	15	by	by	IN
25944	3059	16	the	the	DT
25944	3059	17	condition	condition	NN
25944	3059	18	of	of	IN
25944	3059	19	the	the	DT
25944	3059	20	affected	affected	JJ
25944	3059	21	hair	hair	NN
25944	3059	22	,	,	,
25944	3059	23	the	the	DT
25944	3059	24	atrophic	atrophic	JJ
25944	3059	25	and	and	CC
25944	3059	26	scar	scar	NN
25944	3059	27	-	-	HYPH
25944	3059	28	like	like	JJ
25944	3059	29	areas	area	NNS
25944	3059	30	,	,	,
25944	3059	31	the	the	DT
25944	3059	32	odor	odor	NN
25944	3059	33	,	,	,
25944	3059	34	and	and	CC
25944	3059	35	the	the	DT
25944	3059	36	history	history	NN
25944	3059	37	.	.	.
25944	3060	1	From	from	IN
25944	3060	2	ringworm	ringworm	NN
25944	3060	3	by	by	IN
25944	3060	4	the	the	DT
25944	3060	5	crusting	crusting	NN
25944	3060	6	and	and	CC
25944	3060	7	the	the	DT
25944	3060	8	atrophy	atrophy	NN
25944	3060	9	.	.	.
25944	3061	1	In	in	IN
25944	3061	2	this	this	DT
25944	3061	3	latter	latter	JJ
25944	3061	4	disease	disease	NN
25944	3061	5	there	there	EX
25944	3061	6	is	be	VBZ
25944	3061	7	usually	usually	RB
25944	3061	8	but	but	CC
25944	3061	9	slight	slight	JJ
25944	3061	10	scaliness	scaliness	NN
25944	3061	11	,	,	,
25944	3061	12	and	and	CC
25944	3061	13	rarely	rarely	RB
25944	3061	14	any	any	DT
25944	3061	15	scarring	scarring	NN
25944	3061	16	.	.	.
25944	3062	1	Finally	finally	RB
25944	3062	2	,	,	,
25944	3062	3	if	if	IN
25944	3062	4	necessary	necessary	JJ
25944	3062	5	,	,	,
25944	3062	6	a	a	DT
25944	3062	7	microscopic	microscopic	JJ
25944	3062	8	examination	examination	NN
25944	3062	9	of	of	IN
25944	3062	10	the	the	DT
25944	3062	11	crusts	crust	NNS
25944	3062	12	may	may	MD
25944	3062	13	be	be	VB
25944	3062	14	made	make	VBN
25944	3062	15	.	.	.
25944	3063	1	#	#	JJR
25944	3063	2	State	state	NN
25944	3063	3	the	the	DT
25944	3063	4	method	method	NN
25944	3063	5	of	of	IN
25944	3063	6	examination	examination	NN
25944	3063	7	for	for	IN
25944	3063	8	fungus	fungus	NN
25944	3063	9	.	.	.
25944	3063	10	#	#	$
25944	3063	11	A	a	DT
25944	3063	12	portion	portion	NN
25944	3063	13	of	of	IN
25944	3063	14	the	the	DT
25944	3063	15	crust	crust	NN
25944	3063	16	is	be	VBZ
25944	3063	17	moistened	moisten	VBN
25944	3063	18	with	with	IN
25944	3063	19	liquor	liquor	NN
25944	3063	20	potassæ	potassæ	NNS
25944	3063	21	and	and	CC
25944	3063	22	examined	examine	VBD
25944	3063	23	with	with	IN
25944	3063	24	a	a	DT
25944	3063	25	power	power	NN
25944	3063	26	of	of	IN
25944	3063	27	three	three	CD
25944	3063	28	to	to	TO
25944	3063	29	five	five	CD
25944	3063	30	hundred	hundred	CD
25944	3063	31	diameters	diameter	NNS
25944	3063	32	.	.	.
25944	3064	1	The	the	DT
25944	3064	2	fungus	fungus	NN
25944	3064	3	,	,	,
25944	3064	4	(	(	-LRB-
25944	3064	5	achorion	achorion	NN
25944	3064	6	Schönleinii	Schönleinii	NNP
25944	3064	7	)	)	-RRB-
25944	3064	8	,	,	,
25944	3064	9	consisting	consist	VBG
25944	3064	10	of	of	IN
25944	3064	11	mycelium	mycelium	NN
25944	3064	12	and	and	CC
25944	3064	13	spores	spore	NNS
25944	3064	14	,	,	,
25944	3064	15	is	be	VBZ
25944	3064	16	luxuriant	luxuriant	JJ
25944	3064	17	and	and	CC
25944	3064	18	is	be	VBZ
25944	3064	19	readily	readily	RB
25944	3064	20	detected	detect	VBN
25944	3064	21	.	.	.
25944	3065	1	#	#	JJR
25944	3065	2	State	state	NN
25944	3065	3	the	the	DT
25944	3065	4	prognosis	prognosis	NN
25944	3065	5	of	of	IN
25944	3065	6	favus	favus	NN
25944	3065	7	.	.	.
25944	3065	8	#	#	$
25944	3065	9	Upon	upon	IN
25944	3065	10	the	the	DT
25944	3065	11	scalp	scalp	NN
25944	3065	12	,	,	,
25944	3065	13	favus	favus	NNP
25944	3065	14	is	be	VBZ
25944	3065	15	extremely	extremely	RB
25944	3065	16	chronic	chronic	JJ
25944	3065	17	and	and	CC
25944	3065	18	rebellious	rebellious	JJ
25944	3065	19	to	to	IN
25944	3065	20	treatment	treatment	NN
25944	3065	21	,	,	,
25944	3065	22	and	and	CC
25944	3065	23	a	a	DT
25944	3065	24	cure	cure	NN
25944	3065	25	in	in	IN
25944	3065	26	six	six	CD
25944	3065	27	to	to	TO
25944	3065	28	twelve	twelve	CD
25944	3065	29	months	month	NNS
25944	3065	30	may	may	MD
25944	3065	31	be	be	VB
25944	3065	32	considered	consider	VBN
25944	3065	33	satisfactory	satisfactory	JJ
25944	3065	34	;	;	:
25944	3065	35	in	in	IN
25944	3065	36	neglected	neglected	JJ
25944	3065	37	cases	case	NNS
25944	3065	38	permanent	permanent	JJ
25944	3065	39	baldness	baldness	NN
25944	3065	40	,	,	,
25944	3065	41	atrophy	atrophy	NN
25944	3065	42	,	,	,
25944	3065	43	and	and	CC
25944	3065	44	scarring	scar	VBG
25944	3065	45	sooner	soon	RBR
25944	3065	46	or	or	CC
25944	3065	47	later	later	RB
25944	3065	48	result	result	NN
25944	3065	49	.	.	.
25944	3066	1	Although	although	IN
25944	3066	2	favus	favus	NN
25944	3066	3	of	of	IN
25944	3066	4	the	the	DT
25944	3066	5	scalp	scalp	NN
25944	3066	6	persists	persist	VBZ
25944	3066	7	into	into	IN
25944	3066	8	adult	adult	NN
25944	3066	9	life	life	NN
25944	3066	10	,	,	,
25944	3066	11	it	-PRON-	PRP
25944	3066	12	becomes	become	VBZ
25944	3066	13	less	less	RBR
25944	3066	14	active	active	JJ
25944	3066	15	and	and	CC
25944	3066	16	,	,	,
25944	3066	17	finally	finally	RB
25944	3066	18	,	,	,
25944	3066	19	as	as	IN
25944	3066	20	a	a	DT
25944	3066	21	rule	rule	NN
25944	3066	22	,	,	,
25944	3066	23	gradually	gradually	RB
25944	3066	24	disappears	disappear	VBZ
25944	3066	25	,	,	,
25944	3066	26	leaving	leave	VBG
25944	3066	27	behind	behind	RB
25944	3066	28	scarred	scarred	JJ
25944	3066	29	or	or	CC
25944	3066	30	atrophic	atrophic	JJ
25944	3066	31	bald	bald	JJ
25944	3066	32	areas	area	NNS
25944	3066	33	.	.	.
25944	3067	1	Upon	upon	IN
25944	3067	2	the	the	DT
25944	3067	3	general	general	JJ
25944	3067	4	surface	surface	NN
25944	3067	5	it	-PRON-	PRP
25944	3067	6	usually	usually	RB
25944	3067	7	responds	respond	VBZ
25944	3067	8	readily	readily	RB
25944	3067	9	to	to	IN
25944	3067	10	treatment	treatment	NN
25944	3067	11	,	,	,
25944	3067	12	excepting	except	VBG
25944	3067	13	favus	favus	NN
25944	3067	14	of	of	IN
25944	3067	15	the	the	DT
25944	3067	16	nails	nail	NNS
25944	3067	17	,	,	,
25944	3067	18	which	which	WDT
25944	3067	19	is	be	VBZ
25944	3067	20	always	always	RB
25944	3067	21	obstinate	obstinate	JJ
25944	3067	22	.	.	.
25944	3068	1	#	#	NNP
25944	3068	2	How	how	WRB
25944	3068	3	is	be	VBZ
25944	3068	4	favus	favus	NN
25944	3068	5	of	of	IN
25944	3068	6	the	the	DT
25944	3068	7	scalp	scalp	NN
25944	3068	8	treated	treat	VBN
25944	3068	9	?	?	.
25944	3068	10	#	#	$
25944	3068	11	Treatment	Treatment	NNP
25944	3068	12	is	be	VBZ
25944	3068	13	entirely	entirely	RB
25944	3068	14	local	local	JJ
25944	3068	15	and	and	CC
25944	3068	16	consists	consist	VBZ
25944	3068	17	in	in	IN
25944	3068	18	keeping	keep	VBG
25944	3068	19	the	the	DT
25944	3068	20	parts	part	NNS
25944	3068	21	free	free	JJ
25944	3068	22	from	from	IN
25944	3068	23	crusts	crust	NNS
25944	3068	24	,	,	,
25944	3068	25	in	in	IN
25944	3068	26	epilation	epilation	NN
25944	3068	27	and	and	CC
25944	3068	28	applications	application	NNS
25944	3068	29	of	of	IN
25944	3068	30	a	a	DT
25944	3068	31	parasiticide	parasiticide	NN
25944	3068	32	.	.	.
25944	3069	1	The	the	DT
25944	3069	2	crusts	crust	NNS
25944	3069	3	are	be	VBP
25944	3069	4	removed	remove	VBN
25944	3069	5	by	by	IN
25944	3069	6	oily	oily	JJ
25944	3069	7	applications	application	NNS
25944	3069	8	and	and	CC
25944	3069	9	soap	soap	NN
25944	3069	10	-	-	HYPH
25944	3069	11	and	and	CC
25944	3069	12	-	-	HYPH
25944	3069	13	water	water	NN
25944	3069	14	washings	washing	NNS
25944	3069	15	.	.	.
25944	3070	1	The	the	DT
25944	3070	2	hair	hair	NN
25944	3070	3	on	on	IN
25944	3070	4	and	and	CC
25944	3070	5	around	around	IN
25944	3070	6	the	the	DT
25944	3070	7	diseased	diseased	JJ
25944	3070	8	parts	part	NNS
25944	3070	9	is	be	VBZ
25944	3070	10	to	to	TO
25944	3070	11	be	be	VB
25944	3070	12	kept	keep	VBN
25944	3070	13	closely	closely	RB
25944	3070	14	cut	cut	VBN
25944	3070	15	,	,	,
25944	3070	16	and	and	CC
25944	3070	17	,	,	,
25944	3070	18	when	when	WRB
25944	3070	19	practicable	practicable	JJ
25944	3070	20	,	,	,
25944	3070	21	depilation	depilation	NN
25944	3070	22	,	,	,
25944	3070	23	or	or	CC
25944	3070	24	extraction	extraction	NN
25944	3070	25	of	of	IN
25944	3070	26	the	the	DT
25944	3070	27	affected	affected	JJ
25944	3070	28	hairs	hair	NNS
25944	3070	29	,	,	,
25944	3070	30	is	be	VBZ
25944	3070	31	advised	advise	VBN
25944	3070	32	;	;	:
25944	3070	33	this	this	DT
25944	3070	34	latter	latter	NN
25944	3070	35	is	be	VBZ
25944	3070	36	,	,	,
25944	3070	37	in	in	IN
25944	3070	38	most	most	JJS
25944	3070	39	cases	case	NNS
25944	3070	40	,	,	,
25944	3070	41	essential	essential	JJ
25944	3070	42	to	to	IN
25944	3070	43	a	a	DT
25944	3070	44	cure	cure	NN
25944	3070	45	.	.	.
25944	3071	1	Remedial	remedial	JJ
25944	3071	2	applications	application	NNS
25944	3071	3	--	--	:
25944	3071	4	the	the	DT
25944	3071	5	so	so	RB
25944	3071	6	-	-	HYPH
25944	3071	7	called	call	VBN
25944	3071	8	parasiticides	parasiticide	NNS
25944	3071	9	--	--	:
25944	3071	10	are	be	VBP
25944	3071	11	,	,	,
25944	3071	12	as	as	IN
25944	3071	13	a	a	DT
25944	3071	14	rule	rule	NN
25944	3071	15	,	,	,
25944	3071	16	to	to	TO
25944	3071	17	be	be	VB
25944	3071	18	made	make	VBN
25944	3071	19	twice	twice	RB
25944	3071	20	daily	daily	JJ
25944	3071	21	.	.	.
25944	3072	1	If	if	IN
25944	3072	2	an	an	DT
25944	3072	3	ointment	ointment	NN
25944	3072	4	is	be	VBZ
25944	3072	5	used	use	VBN
25944	3072	6	,	,	,
25944	3072	7	it	-PRON-	PRP
25944	3072	8	is	be	VBZ
25944	3072	9	to	to	TO
25944	3072	10	be	be	VB
25944	3072	11	thoroughly	thoroughly	RB
25944	3072	12	rubbed	rub	VBN
25944	3072	13	in	in	IN
25944	3072	14	;	;	:
25944	3072	15	if	if	IN
25944	3072	16	a	a	DT
25944	3072	17	lotion	lotion	NN
25944	3072	18	,	,	,
25944	3072	19	it	-PRON-	PRP
25944	3072	20	is	be	VBZ
25944	3072	21	to	to	TO
25944	3072	22	be	be	VB
25944	3072	23	dabbed	dab	VBN
25944	3072	24	on	on	IN
25944	3072	25	for	for	IN
25944	3072	26	several	several	JJ
25944	3072	27	minutes	minute	NNS
25944	3072	28	and	and	CC
25944	3072	29	allowed	allow	VBN
25944	3072	30	to	to	TO
25944	3072	31	soak	soak	VB
25944	3072	32	in	in	RP
25944	3072	33	.	.	.
25944	3073	1	#	#	JJR
25944	3073	2	Name	name	VB
25944	3073	3	the	the	DT
25944	3073	4	most	most	RBS
25944	3073	5	important	important	JJ
25944	3073	6	parasiticides	parasiticide	NNS
25944	3073	7	.	.	.
25944	3073	8	#	#	JJR
25944	3073	9	Corrosive	corrosive	JJ
25944	3073	10	sublimate	sublimate	NN
25944	3073	11	,	,	,
25944	3073	12	one	one	CD
25944	3073	13	to	to	TO
25944	3073	14	four	four	CD
25944	3073	15	grains	grain	NNS
25944	3073	16	to	to	IN
25944	3073	17	an	an	DT
25944	3073	18	ounce	ounce	NN
25944	3073	19	of	of	IN
25944	3073	20	alcohol	alcohol	NN
25944	3073	21	and	and	CC
25944	3073	22	water	water	NN
25944	3073	23	;	;	:
25944	3073	24	carbolic	carbolic	JJ
25944	3073	25	acid	acid	NN
25944	3073	26	,	,	,
25944	3073	27	one	one	CD
25944	3073	28	part	part	NN
25944	3073	29	to	to	IN
25944	3073	30	three	three	CD
25944	3073	31	or	or	CC
25944	3073	32	more	more	JJR
25944	3073	33	parts	part	NNS
25944	3073	34	of	of	IN
25944	3073	35	glycerine	glycerine	NNP
25944	3073	36	;	;	:
25944	3073	37	a	a	DT
25944	3073	38	ten	ten	CD
25944	3073	39	per	per	IN
25944	3073	40	cent	cent	NN
25944	3073	41	.	.	.
25944	3074	1	oleate	oleate	NN
25944	3074	2	of	of	IN
25944	3074	3	mercury	mercury	NNP
25944	3074	4	;	;	,
25944	3074	5	ointments	ointment	NNS
25944	3074	6	of	of	IN
25944	3074	7	ammoniated	ammoniate	VBN
25944	3074	8	mercury	mercury	NNP
25944	3074	9	,	,	,
25944	3074	10	sulphur	sulphur	NNP
25944	3074	11	and	and	CC
25944	3074	12	tar	tar	NNP
25944	3074	13	;	;	:
25944	3074	14	and	and	CC
25944	3074	15	sulphurous	sulphurous	JJ
25944	3074	16	acid	acid	NN
25944	3074	17	,	,	,
25944	3074	18	pure	pure	JJ
25944	3074	19	or	or	CC
25944	3074	20	diluted	diluted	JJ
25944	3074	21	.	.	.
25944	3075	1	The	the	DT
25944	3075	2	following	follow	VBG
25944	3075	3	is	be	VBZ
25944	3075	4	valuable:--	valuable:--	NNP
25944	3075	5	[	[	-LRB-
25944	3075	6	Rx	Rx	NNP
25944	3075	7	]	]	-RRB-
25944	3075	8	Sulphur	Sulphur	NNP
25944	3075	9	,	,	,
25944	3075	10	præcip	præcip	NN
25944	3075	11	.	.	.
25944	3075	12	,	,	,
25944	3075	13	....................	....................	NFP
25944	3075	14	[	[	-LRB-
25944	3075	15	dram]ij	dram]ij	FW
25944	3075	16	Saponis	Saponis	NNP
25944	3075	17	viridis	viridis	NN
25944	3075	18	,	,	,
25944	3075	19	Ol	old	NNP
25944	3075	20	.	.	.
25944	3076	1	cadini	cadini	NNP
25944	3076	2	,	,	,
25944	3076	3	.......	.......	NFP
25944	3076	4	[	[	-LRB-
25944	3076	5	=	=	SYM
25944	3076	6	a][=a	a][=a	CD
25944	3076	7	]	]	-RRB-
25944	3076	8	.........	.........	.
25944	3076	9	[	[	-LRB-
25944	3076	10	dram]j	dram]j	NNP
25944	3076	11	Adipis	Adipis	NNP
25944	3076	12	,	,	,
25944	3076	13	..............................	..............................	NFP
25944	3076	14	[	[	-LRB-
25944	3076	15	Oz]ss	Oz]ss	NNP
25944	3076	16	.	.	.
25944	3077	1	M.	M.	NNP
25944	3077	2	Chrysarobin	Chrysarobin	NNP
25944	3077	3	is	be	VBZ
25944	3077	4	a	a	DT
25944	3077	5	valuable	valuable	JJ
25944	3077	6	remedy	remedy	NN
25944	3077	7	,	,	,
25944	3077	8	but	but	CC
25944	3077	9	must	must	MD
25944	3077	10	be	be	VB
25944	3077	11	used	use	VBN
25944	3077	12	with	with	IN
25944	3077	13	caution	caution	NN
25944	3077	14	;	;	:
25944	3077	15	it	-PRON-	PRP
25944	3077	16	may	may	MD
25944	3077	17	be	be	VB
25944	3077	18	employed	employ	VBN
25944	3077	19	as	as	IN
25944	3077	20	an	an	DT
25944	3077	21	ointment	ointment	NN
25944	3077	22	,	,	,
25944	3077	23	five	five	CD
25944	3077	24	to	to	TO
25944	3077	25	ten	ten	CD
25944	3077	26	per	per	IN
25944	3077	27	cent	cent	NN
25944	3077	28	.	.	.
25944	3078	1	strength	strength	NN
25944	3078	2	,	,	,
25944	3078	3	as	as	IN
25944	3078	4	a	a	DT
25944	3078	5	rubber	rubber	NN
25944	3078	6	plaster	plaster	NN
25944	3078	7	,	,	,
25944	3078	8	or	or	CC
25944	3078	9	as	as	IN
25944	3078	10	a	a	DT
25944	3078	11	paint	paint	NN
25944	3078	12	,	,	,
25944	3078	13	a	a	DT
25944	3078	14	drachm	drachm	NN
25944	3078	15	to	to	IN
25944	3078	16	an	an	DT
25944	3078	17	ounce	ounce	NN
25944	3078	18	of	of	IN
25944	3078	19	gutta	gutta	NN
25944	3078	20	-	-	HYPH
25944	3078	21	percha	percha	NN
25944	3078	22	solution	solution	NN
25944	3078	23	.	.	.
25944	3079	1	Formalin	Formalin	NNP
25944	3079	2	,	,	,
25944	3079	3	weakened	weaken	VBD
25944	3079	4	or	or	CC
25944	3079	5	full	full	JJ
25944	3079	6	strength	strength	NN
25944	3079	7	,	,	,
25944	3079	8	has	have	VBZ
25944	3079	9	been	be	VBN
25944	3079	10	extolled	extoll	VBN
25944	3079	11	.	.	.
25944	3080	1	Some	some	DT
25944	3080	2	observers	observer	NNS
25944	3080	3	have	have	VBP
25944	3080	4	experimentally	experimentally	RB
25944	3080	5	tried	try	VBN
25944	3080	6	the	the	DT
25944	3080	7	effect	effect	NN
25944	3080	8	of	of	IN
25944	3080	9	_	_	NNP
25944	3080	10	x_-ray	x_-ray	NN
25944	3080	11	exposure	exposure	NN
25944	3080	12	with	with	IN
25944	3080	13	alleged	allege	VBN
25944	3080	14	good	good	JJ
25944	3080	15	results	result	NNS
25944	3080	16	,	,	,
25944	3080	17	pushing	push	VBG
25944	3080	18	the	the	DT
25944	3080	19	treatment	treatment	NN
25944	3080	20	to	to	IN
25944	3080	21	the	the	DT
25944	3080	22	point	point	NN
25944	3080	23	of	of	IN
25944	3080	24	producing	produce	VBG
25944	3080	25	depilation	depilation	NN
25944	3080	26	;	;	:
25944	3080	27	if	if	IN
25944	3080	28	used	use	VBN
25944	3080	29	great	great	JJ
25944	3080	30	caution	caution	NN
25944	3080	31	should	should	MD
25944	3080	32	be	be	VB
25944	3080	33	exercised	exercise	VBN
25944	3080	34	.	.	.
25944	3081	1	#	#	NNP
25944	3081	2	How	how	WRB
25944	3081	3	is	be	VBZ
25944	3081	4	favus	favus	NN
25944	3081	5	upon	upon	IN
25944	3081	6	the	the	DT
25944	3081	7	general	general	JJ
25944	3081	8	surface	surface	NN
25944	3081	9	to	to	TO
25944	3081	10	be	be	VB
25944	3081	11	treated	treat	VBN
25944	3081	12	?	?	.
25944	3081	13	#	#	NN
25944	3081	14	In	in	IN
25944	3081	15	the	the	DT
25944	3081	16	same	same	JJ
25944	3081	17	general	general	JJ
25944	3081	18	manner	manner	NN
25944	3081	19	as	as	IN
25944	3081	20	favus	favus	NN
25944	3081	21	of	of	IN
25944	3081	22	the	the	DT
25944	3081	23	scalp	scalp	NN
25944	3081	24	,	,	,
25944	3081	25	but	but	CC
25944	3081	26	the	the	DT
25944	3081	27	remedies	remedy	NNS
25944	3081	28	employed	employ	VBN
25944	3081	29	should	should	MD
25944	3081	30	be	be	VB
25944	3081	31	somewhat	somewhat	RB
25944	3081	32	weaker	weak	JJR
25944	3081	33	.	.	.
25944	3082	1	In	in	IN
25944	3082	2	favus	favus	NN
25944	3082	3	of	of	IN
25944	3082	4	the	the	DT
25944	3082	5	nail	nail	NN
25944	3082	6	frequent	frequent	JJ
25944	3082	7	and	and	CC
25944	3082	8	close	close	JJ
25944	3082	9	paring	paring	NN
25944	3082	10	of	of	IN
25944	3082	11	the	the	DT
25944	3082	12	affected	affected	JJ
25944	3082	13	part	part	NN
25944	3082	14	and	and	CC
25944	3082	15	the	the	DT
25944	3082	16	application	application	NN
25944	3082	17	,	,	,
25944	3082	18	twice	twice	RB
25944	3082	19	daily	daily	JJ
25944	3082	20	,	,	,
25944	3082	21	of	of	IN
25944	3082	22	one	one	CD
25944	3082	23	of	of	IN
25944	3082	24	the	the	DT
25944	3082	25	milder	milder	NN
25944	3082	26	parasiticides	parasiticide	NNS
25944	3082	27	,	,	,
25944	3082	28	will	will	MD
25944	3082	29	eventually	eventually	RB
25944	3082	30	lead	lead	VB
25944	3082	31	to	to	IN
25944	3082	32	a	a	DT
25944	3082	33	good	good	JJ
25944	3082	34	result	result	NN
25944	3082	35	.	.	.
25944	3083	1	#	#	$
25944	3083	2	Is	be	VBZ
25944	3083	3	constitutional	constitutional	JJ
25944	3083	4	treatment	treatment	NN
25944	3083	5	of	of	IN
25944	3083	6	any	any	DT
25944	3083	7	value	value	NN
25944	3083	8	in	in	IN
25944	3083	9	favus	favus	NNP
25944	3083	10	?	?	.
25944	3083	11	#	#	$
25944	3083	12	It	-PRON-	PRP
25944	3083	13	is	be	VBZ
25944	3083	14	questionable	questionable	JJ
25944	3083	15	,	,	,
25944	3083	16	but	but	CC
25944	3083	17	in	in	IN
25944	3083	18	debilitated	debilitate	VBN
25944	3083	19	subjects	subject	NNS
25944	3083	20	tonics	tonic	NNS
25944	3083	21	,	,	,
25944	3083	22	especially	especially	RB
25944	3083	23	cod	cod	NN
25944	3083	24	-	-	HYPH
25944	3083	25	liver	liver	NN
25944	3083	26	oil	oil	NN
25944	3083	27	,	,	,
25944	3083	28	may	may	MD
25944	3083	29	be	be	VB
25944	3083	30	prescribed	prescribe	VBN
25944	3083	31	with	with	IN
25944	3083	32	the	the	DT
25944	3083	33	hope	hope	NN
25944	3083	34	of	of	IN
25944	3083	35	aiding	aid	VBG
25944	3083	36	the	the	DT
25944	3083	37	external	external	JJ
25944	3083	38	applications	application	NNS
25944	3083	39	.	.	.
25944	3084	1	#	#	NNP
25944	3084	2	Tinea	Tinea	NNP
25944	3084	3	Trichophytina	Trichophytina	NNP
25944	3084	4	.	.	.
25944	3084	5	#	#	NNP
25944	3084	6	(	(	-LRB-
25944	3084	7	_	_	NNP
25944	3084	8	Synonym	Synonym	NNP
25944	3084	9	:	:	:
25944	3084	10	_	_	NNP
25944	3084	11	Ringworm	Ringworm	NNP
25944	3084	12	.	.	.
25944	3084	13	)	)	-RRB-
25944	3085	1	#	#	LS
25944	3085	2	What	what	WP
25944	3085	3	is	be	VBZ
25944	3085	4	tinea	tinea	RB
25944	3085	5	trichophytina	trichophytina	NN
25944	3085	6	?	?	.
25944	3085	7	#	#	$
25944	3085	8	Tinea	Tinea	NNP
25944	3085	9	trichophytina	trichophytina	NN
25944	3085	10	,	,	,
25944	3085	11	or	or	CC
25944	3085	12	ringworm	ringworm	NN
25944	3085	13	,	,	,
25944	3085	14	is	be	VBZ
25944	3085	15	a	a	DT
25944	3085	16	contagious	contagious	JJ
25944	3085	17	,	,	,
25944	3085	18	vegetable	vegetable	NN
25944	3085	19	-	-	HYPH
25944	3085	20	parasitic	parasitic	JJ
25944	3085	21	disease	disease	NN
25944	3085	22	due	due	IN
25944	3085	23	to	to	IN
25944	3085	24	the	the	DT
25944	3085	25	invasion	invasion	NN
25944	3085	26	of	of	IN
25944	3085	27	the	the	DT
25944	3085	28	cutaneous	cutaneous	JJ
25944	3085	29	structures	structure	NNS
25944	3085	30	by	by	IN
25944	3085	31	the	the	DT
25944	3085	32	vegetable	vegetable	NN
25944	3085	33	parasite	parasite	NN
25944	3085	34	,	,	,
25944	3085	35	the	the	DT
25944	3085	36	trichophyton	trichophyton	NNP
25944	3085	37	,	,	,
25944	3085	38	or	or	CC
25944	3085	39	the	the	DT
25944	3085	40	microsporon	microsporon	JJ
25944	3085	41	Audouinii	Audouinii	NNP
25944	3085	42	.	.	.
25944	3086	1	#	#	$
25944	3086	2	Do	do	VBP
25944	3086	3	the	the	DT
25944	3086	4	clinical	clinical	JJ
25944	3086	5	characters	character	NNS
25944	3086	6	of	of	IN
25944	3086	7	ringworm	ringworm	NN
25944	3086	8	vary	vary	VBP
25944	3086	9	according	accord	VBG
25944	3086	10	to	to	IN
25944	3086	11	the	the	DT
25944	3086	12	part	part	NN
25944	3086	13	affected	affect	VBN
25944	3086	14	?	?	.
25944	3086	15	#	#	NN
25944	3086	16	Yes	yes	UH
25944	3086	17	,	,	,
25944	3086	18	often	often	RB
25944	3086	19	considerably	considerably	RB
25944	3086	20	;	;	:
25944	3086	21	thus	thus	RB
25944	3086	22	upon	upon	IN
25944	3086	23	the	the	DT
25944	3086	24	scalp	scalp	NN
25944	3086	25	,	,	,
25944	3086	26	upon	upon	IN
25944	3086	27	the	the	DT
25944	3086	28	general	general	JJ
25944	3086	29	surface	surface	NN
25944	3086	30	,	,	,
25944	3086	31	and	and	CC
25944	3086	32	upon	upon	IN
25944	3086	33	the	the	DT
25944	3086	34	bearded	bearded	JJ
25944	3086	35	region	region	NN
25944	3086	36	,	,	,
25944	3086	37	the	the	DT
25944	3086	38	disease	disease	NN
25944	3086	39	usually	usually	RB
25944	3086	40	presents	present	VBZ
25944	3086	41	totally	totally	RB
25944	3086	42	different	different	JJ
25944	3086	43	appearances	appearance	NNS
25944	3086	44	.	.	.
25944	3087	1	#	#	NNP
25944	3087	2	Describe	describe	VB
25944	3087	3	the	the	DT
25944	3087	4	symptoms	symptom	NNS
25944	3087	5	of	of	IN
25944	3087	6	ringworm	ringworm	NN
25944	3087	7	as	as	IN
25944	3087	8	it	-PRON-	PRP
25944	3087	9	occurs	occur	VBZ
25944	3087	10	upon	upon	IN
25944	3087	11	non	non	JJ
25944	3087	12	-	-	JJ
25944	3087	13	hairy	hairy	JJ
25944	3087	14	portions	portion	NNS
25944	3087	15	of	of	IN
25944	3087	16	the	the	DT
25944	3087	17	body	body	NN
25944	3087	18	.	.	.
25944	3087	19	#	#	JJR
25944	3087	20	Ringworm	ringworm	NN
25944	3087	21	of	of	IN
25944	3087	22	the	the	DT
25944	3087	23	general	general	JJ
25944	3087	24	surface	surface	NN
25944	3087	25	(	(	-LRB-
25944	3087	26	_	_	NNP
25944	3087	27	tinea	tinea	NNP
25944	3087	28	trichophytina	trichophytina	NNP
25944	3087	29	corporis	corporis	NNP
25944	3087	30	_	_	NNP
25944	3087	31	,	,	,
25944	3087	32	_	_	NNP
25944	3087	33	tinea	tinea	NNP
25944	3087	34	circinata	circinata	NNP
25944	3087	35	_	_	NNP
25944	3087	36	)	)	-RRB-
25944	3087	37	appears	appear	VBZ
25944	3087	38	as	as	IN
25944	3087	39	one	one	CD
25944	3087	40	or	or	CC
25944	3087	41	more	more	RBR
25944	3087	42	small	small	JJ
25944	3087	43	,	,	,
25944	3087	44	slightly	slightly	RB
25944	3087	45	-	-	HYPH
25944	3087	46	elevated	elevated	JJ
25944	3087	47	,	,	,
25944	3087	48	sharply	sharply	RB
25944	3087	49	-	-	HYPH
25944	3087	50	limited	limited	JJ
25944	3087	51	,	,	,
25944	3087	52	somewhat	somewhat	RB
25944	3087	53	scaly	scaly	NNP
25944	3087	54	,	,	,
25944	3087	55	hyperæmic	hyperæmic	JJ
25944	3087	56	spots	spot	NNS
25944	3087	57	,	,	,
25944	3087	58	with	with	IN
25944	3087	59	,	,	,
25944	3087	60	rarely	rarely	RB
25944	3087	61	,	,	,
25944	3087	62	minute	minute	NN
25944	3087	63	papules	papule	NNS
25944	3087	64	,	,	,
25944	3087	65	vesico	vesico	NN
25944	3087	66	-	-	HYPH
25944	3087	67	papules	papule	NNS
25944	3087	68	,	,	,
25944	3087	69	or	or	CC
25944	3087	70	vesicles	vesicle	NNS
25944	3087	71	,	,	,
25944	3087	72	especially	especially	RB
25944	3087	73	at	at	IN
25944	3087	74	the	the	DT
25944	3087	75	circumference	circumference	NN
25944	3087	76	.	.	.
25944	3088	1	The	the	DT
25944	3088	2	patch	patch	NN
25944	3088	3	spreads	spread	VBZ
25944	3088	4	in	in	IN
25944	3088	5	a	a	DT
25944	3088	6	uniform	uniform	JJ
25944	3088	7	manner	manner	NN
25944	3088	8	peripherally	peripherally	RB
25944	3088	9	,	,	,
25944	3088	10	is	be	VBZ
25944	3088	11	slightly	slightly	RB
25944	3088	12	scaly	scaly	JJ
25944	3088	13	,	,	,
25944	3088	14	and	and	CC
25944	3088	15	tends	tend	VBZ
25944	3088	16	to	to	TO
25944	3088	17	clear	clear	VB
25944	3088	18	in	in	IN
25944	3088	19	the	the	DT
25944	3088	20	centre	centre	NN
25944	3088	21	,	,	,
25944	3088	22	assuming	assume	VBG
25944	3088	23	a	a	DT
25944	3088	24	ring	ring	NN
25944	3088	25	-	-	HYPH
25944	3088	26	like	like	JJ
25944	3088	27	appearance	appearance	NN
25944	3088	28	.	.	.
25944	3089	1	When	when	WRB
25944	3089	2	coming	come	VBG
25944	3089	3	under	under	IN
25944	3089	4	observation	observation	NN
25944	3089	5	,	,	,
25944	3089	6	the	the	DT
25944	3089	7	patches	patch	NNS
25944	3089	8	are	be	VBP
25944	3089	9	usually	usually	RB
25944	3089	10	from	from	IN
25944	3089	11	one	one	CD
25944	3089	12	-	-	HYPH
25944	3089	13	half	half	NN
25944	3089	14	to	to	IN
25944	3089	15	one	one	CD
25944	3089	16	inch	inch	NN
25944	3089	17	in	in	IN
25944	3089	18	diameter	diameter	NN
25944	3089	19	,	,	,
25944	3089	20	the	the	DT
25944	3089	21	central	central	JJ
25944	3089	22	portion	portion	NN
25944	3089	23	pale	pale	JJ
25944	3089	24	or	or	CC
25944	3089	25	pale	pale	JJ
25944	3089	26	red	red	JJ
25944	3089	27	,	,	,
25944	3089	28	and	and	CC
25944	3089	29	the	the	DT
25944	3089	30	outer	outer	JJ
25944	3089	31	portion	portion	NN
25944	3089	32	more	more	RBR
25944	3089	33	or	or	CC
25944	3089	34	less	less	RBR
25944	3089	35	elevated	elevated	JJ
25944	3089	36	,	,	,
25944	3089	37	hyperæmic	hyperæmic	JJ
25944	3089	38	and	and	CC
25944	3089	39	somewhat	somewhat	RB
25944	3089	40	scaly	scaly	NNP
25944	3089	41	.	.	.
25944	3090	1	As	as	IN
25944	3090	2	commonly	commonly	RB
25944	3090	3	noted	note	VBN
25944	3090	4	one	one	CD
25944	3090	5	,	,	,
25944	3090	6	several	several	JJ
25944	3090	7	or	or	CC
25944	3090	8	more	more	JJR
25944	3090	9	patches	patch	NNS
25944	3090	10	are	be	VBP
25944	3090	11	present	present	JJ
25944	3090	12	.	.	.
25944	3091	1	After	after	IN
25944	3091	2	reaching	reach	VBG
25944	3091	3	a	a	DT
25944	3091	4	certain	certain	JJ
25944	3091	5	size	size	NN
25944	3091	6	they	-PRON-	PRP
25944	3091	7	may	may	MD
25944	3091	8	remain	remain	VB
25944	3091	9	stationary	stationary	JJ
25944	3091	10	,	,	,
25944	3091	11	or	or	CC
25944	3091	12	in	in	IN
25944	3091	13	exceptional	exceptional	JJ
25944	3091	14	cases	case	NNS
25944	3091	15	may	may	MD
25944	3091	16	tend	tend	VB
25944	3091	17	to	to	IN
25944	3091	18	spontaneous	spontaneous	JJ
25944	3091	19	disappearance	disappearance	NN
25944	3091	20	.	.	.
25944	3092	1	At	at	IN
25944	3092	2	times	time	NNS
25944	3092	3	when	when	WRB
25944	3092	4	close	close	RB
25944	3092	5	together	together	RB
25944	3092	6	,	,	,
25944	3092	7	several	several	JJ
25944	3092	8	may	may	MD
25944	3092	9	merge	merge	VB
25944	3092	10	and	and	CC
25944	3092	11	form	form	VB
25944	3092	12	a	a	DT
25944	3092	13	large	large	JJ
25944	3092	14	,	,	,
25944	3092	15	irregular	irregular	JJ
25944	3092	16	,	,	,
25944	3092	17	gyrate	gyrate	NN
25944	3092	18	patch	patch	NN
25944	3092	19	.	.	.
25944	3093	1	Itching	itching	NN
25944	3093	2	,	,	,
25944	3093	3	usually	usually	RB
25944	3093	4	slight	slight	JJ
25944	3093	5	,	,	,
25944	3093	6	may	may	MD
25944	3093	7	or	or	CC
25944	3093	8	may	may	MD
25944	3093	9	not	not	RB
25944	3093	10	be	be	VB
25944	3093	11	present	present	JJ
25944	3093	12	.	.	.
25944	3094	1	Exceptionally	exceptionally	RB
25944	3094	2	ringworm	ringworm	VB
25944	3094	3	appears	appear	VBZ
25944	3094	4	as	as	IN
25944	3094	5	a	a	DT
25944	3094	6	markedly	markedly	RB
25944	3094	7	inflammatory	inflammatory	JJ
25944	3094	8	pustular	pustular	NN
25944	3094	9	circumscribed	circumscribe	VBN
25944	3094	10	patch	patch	NN
25944	3094	11	,	,	,
25944	3094	12	formerly	formerly	RB
25944	3094	13	thought	think	VBN
25944	3094	14	to	to	TO
25944	3094	15	be	be	VB
25944	3094	16	a	a	DT
25944	3094	17	distinct	distinct	JJ
25944	3094	18	affection	affection	NN
25944	3094	19	and	and	CC
25944	3094	20	described	describe	VBN
25944	3094	21	under	under	IN
25944	3094	22	the	the	DT
25944	3094	23	name	name	NN
25944	3094	24	of	of	IN
25944	3094	25	_	_	NNP
25944	3094	26	conglomerate	conglomerate	NN
25944	3094	27	pustular	pustular	NNP
25944	3094	28	folliculitis	folliculitis	NN
25944	3094	29	_	_	NNP
25944	3094	30	.	.	.
25944	3095	1	It	-PRON-	PRP
25944	3095	2	consists	consist	VBZ
25944	3095	3	of	of	IN
25944	3095	4	a	a	DT
25944	3095	5	flat	flat	JJ
25944	3095	6	carbuncular	carbuncular	NN
25944	3095	7	or	or	CC
25944	3095	8	kerion	kerion	NN
25944	3095	9	-	-	HYPH
25944	3095	10	like	like	JJ
25944	3095	11	inflammation	inflammation	NN
25944	3095	12	,	,	,
25944	3095	13	somewhat	somewhat	RB
25944	3095	14	elevated	elevated	JJ
25944	3095	15	,	,	,
25944	3095	16	and	and	CC
25944	3095	17	usually	usually	RB
25944	3095	18	a	a	DT
25944	3095	19	dime	dime	NN
25944	3095	20	to	to	IN
25944	3095	21	silver	silver	JJ
25944	3095	22	dollar	dollar	NN
25944	3095	23	in	in	IN
25944	3095	24	area	area	NN
25944	3095	25	.	.	.
25944	3096	1	The	the	DT
25944	3096	2	most	most	RBS
25944	3096	3	common	common	JJ
25944	3096	4	seats	seat	NNS
25944	3096	5	are	be	VBP
25944	3096	6	the	the	DT
25944	3096	7	back	back	NN
25944	3096	8	of	of	IN
25944	3096	9	the	the	DT
25944	3096	10	hands	hand	NNS
25944	3096	11	and	and	CC
25944	3096	12	the	the	DT
25944	3096	13	buttocks	buttock	NNS
25944	3096	14	.	.	.
25944	3097	1	The	the	DT
25944	3097	2	surface	surface	NN
25944	3097	3	is	be	VBZ
25944	3097	4	cribriform	cribriform	NN
25944	3097	5	,	,	,
25944	3097	6	and	and	CC
25944	3097	7	a	a	DT
25944	3097	8	purulent	purulent	NN
25944	3097	9	secretion	secretion	NN
25944	3097	10	may	may	MD
25944	3097	11	be	be	VB
25944	3097	12	pressed	press	VBN
25944	3097	13	out	out	RP
25944	3097	14	from	from	IN
25944	3097	15	follicular	follicular	JJ
25944	3097	16	openings	opening	NNS
25944	3097	17	.	.	.
25944	3098	1	[	[	-LRB-
25944	3098	2	Illustration	illustration	NN
25944	3098	3	:	:	:
25944	3098	4	Fig	Fig	NNP
25944	3098	5	.	.	.
25944	3099	1	68	68	CD
25944	3099	2	.	.	.
25944	3100	1	Tinea	Tinea	NNP
25944	3100	2	trichophytina	trichophytina	NN
25944	3100	3	cruris	cruris	NN
25944	3100	4	--	--	:
25944	3100	5	so	so	RB
25944	3100	6	-	-	HYPH
25944	3100	7	called	call	VBN
25944	3100	8	eczema	eczema	NN
25944	3100	9	marginatum	marginatum	NN
25944	3100	10	--	--	:
25944	3100	11	of	of	IN
25944	3100	12	unusually	unusually	RB
25944	3100	13	extensive	extensive	JJ
25944	3100	14	development	development	NN
25944	3100	15	.	.	.
25944	3101	1	(	(	-LRB-
25944	3101	2	_	_	NNP
25944	3101	3	After	after	IN
25944	3101	4	Piffard	Piffard	NNP
25944	3101	5	.	.	.
25944	3101	6	_	_	NNP
25944	3101	7	)	)	-RRB-
25944	3101	8	]	]	-RRB-
25944	3101	9	#	#	$
25944	3101	10	Describe	describe	VB
25944	3101	11	the	the	DT
25944	3101	12	symptoms	symptom	NNS
25944	3101	13	of	of	IN
25944	3101	14	ringworm	ringworm	NN
25944	3101	15	when	when	WRB
25944	3101	16	occurring	occur	VBG
25944	3101	17	about	about	IN
25944	3101	18	the	the	DT
25944	3101	19	thighs	thigh	NNS
25944	3101	20	and	and	CC
25944	3101	21	scrotum	scrotum	NN
25944	3101	22	.	.	.
25944	3101	23	#	#	$
25944	3101	24	In	in	IN
25944	3101	25	adults	adult	NNS
25944	3101	26	,	,	,
25944	3101	27	more	more	RBR
25944	3101	28	especially	especially	RB
25944	3101	29	males	male	NNS
25944	3101	30	,	,	,
25944	3101	31	the	the	DT
25944	3101	32	inner	inner	JJ
25944	3101	33	portion	portion	NN
25944	3101	34	of	of	IN
25944	3101	35	the	the	DT
25944	3101	36	upper	upper	JJ
25944	3101	37	part	part	NN
25944	3101	38	of	of	IN
25944	3101	39	the	the	DT
25944	3101	40	thighs	thigh	NNS
25944	3101	41	and	and	CC
25944	3101	42	scrotum	scrotum	NN
25944	3101	43	(	(	-LRB-
25944	3101	44	_	_	NNP
25944	3101	45	tinea	tinea	NNP
25944	3101	46	trichophytina	trichophytina	NNP
25944	3101	47	cruris	cruris	NNP
25944	3101	48	_	_	NNP
25944	3101	49	,	,	,
25944	3101	50	so	so	RB
25944	3101	51	-	-	HYPH
25944	3101	52	called	call	VBN
25944	3101	53	_	_	NNP
25944	3101	54	eczema	eczema	NN
25944	3101	55	marginatum	marginatum	NN
25944	3101	56	_	_	NNP
25944	3101	57	)	)	-RRB-
25944	3101	58	may	may	MD
25944	3101	59	be	be	VB
25944	3101	60	attacked	attack	VBN
25944	3101	61	,	,	,
25944	3101	62	and	and	CC
25944	3101	63	here	here	RB
25944	3101	64	the	the	DT
25944	3101	65	affection	affection	NN
25944	3101	66	,	,	,
25944	3101	67	favored	favor	VBN
25944	3101	68	by	by	IN
25944	3101	69	heat	heat	NN
25944	3101	70	and	and	CC
25944	3101	71	moisture	moisture	NN
25944	3101	72	,	,	,
25944	3101	73	develops	develop	VBZ
25944	3101	74	rapidly	rapidly	RB
25944	3101	75	and	and	CC
25944	3101	76	may	may	MD
25944	3101	77	soon	soon	RB
25944	3101	78	lose	lose	VB
25944	3101	79	its	-PRON-	PRP$
25944	3101	80	ordinary	ordinary	JJ
25944	3101	81	clinical	clinical	JJ
25944	3101	82	appearances	appearance	NNS
25944	3101	83	,	,	,
25944	3101	84	the	the	DT
25944	3101	85	inflammatory	inflammatory	JJ
25944	3101	86	symptoms	symptom	NNS
25944	3101	87	becoming	become	VBG
25944	3101	88	especially	especially	RB
25944	3101	89	prominent	prominent	JJ
25944	3101	90	.	.	.
25944	3102	1	The	the	DT
25944	3102	2	whole	whole	NN
25944	3102	3	of	of	IN
25944	3102	4	this	this	DT
25944	3102	5	region	region	NN
25944	3102	6	may	may	MD
25944	3102	7	become	become	VB
25944	3102	8	involved	involved	JJ
25944	3102	9	,	,	,
25944	3102	10	presenting	present	VBG
25944	3102	11	all	all	PDT
25944	3102	12	the	the	DT
25944	3102	13	symptoms	symptom	NNS
25944	3102	14	of	of	IN
25944	3102	15	a	a	DT
25944	3102	16	true	true	JJ
25944	3102	17	eczema	eczema	NN
25944	3102	18	;	;	:
25944	3102	19	the	the	DT
25944	3102	20	border	border	NN
25944	3102	21	,	,	,
25944	3102	22	however	however	RB
25944	3102	23	,	,	,
25944	3102	24	is	be	VBZ
25944	3102	25	sharply	sharply	RB
25944	3102	26	defined	define	VBN
25944	3102	27	,	,	,
25944	3102	28	and	and	CC
25944	3102	29	usually	usually	RB
25944	3102	30	one	one	CD
25944	3102	31	or	or	CC
25944	3102	32	more	more	RBR
25944	3102	33	outlying	outlying	JJ
25944	3102	34	patches	patch	NNS
25944	3102	35	of	of	IN
25944	3102	36	the	the	DT
25944	3102	37	ordinary	ordinary	JJ
25944	3102	38	clinical	clinical	JJ
25944	3102	39	type	type	NN
25944	3102	40	of	of	IN
25944	3102	41	the	the	DT
25944	3102	42	disease	disease	NN
25944	3102	43	may	may	MD
25944	3102	44	be	be	VB
25944	3102	45	seen	see	VBN
25944	3102	46	.	.	.
25944	3103	1	#	#	NNP
25944	3103	2	Describe	describe	VB
25944	3103	3	the	the	DT
25944	3103	4	symptoms	symptom	NNS
25944	3103	5	of	of	IN
25944	3103	6	ringworm	ringworm	NN
25944	3103	7	when	when	WRB
25944	3103	8	involving	involve	VBG
25944	3103	9	the	the	DT
25944	3103	10	nails	nail	NNS
25944	3103	11	.	.	.
25944	3103	12	#	#	$
25944	3103	13	In	in	IN
25944	3103	14	ringworm	ringworm	NN
25944	3103	15	of	of	IN
25944	3103	16	the	the	DT
25944	3103	17	nails	nail	NNS
25944	3103	18	(	(	-LRB-
25944	3103	19	_	_	NNP
25944	3103	20	tinea	tinea	NNP
25944	3103	21	trichophytina	trichophytina	NNP
25944	3103	22	unguium	unguium	NN
25944	3103	23	_	_	NNP
25944	3103	24	)	)	-RRB-
25944	3103	25	these	these	DT
25944	3103	26	structures	structure	NNS
25944	3103	27	become	become	VBP
25944	3103	28	soft	soft	JJ
25944	3103	29	or	or	CC
25944	3103	30	brittle	brittle	JJ
25944	3103	31	,	,	,
25944	3103	32	yellowish	yellowish	JJ
25944	3103	33	,	,	,
25944	3103	34	opaque	opaque	JJ
25944	3103	35	and	and	CC
25944	3103	36	thickened	thicken	VBD
25944	3103	37	the	the	DT
25944	3103	38	changes	change	NNS
25944	3103	39	taking	take	VBG
25944	3103	40	place	place	NN
25944	3103	41	mainly	mainly	RB
25944	3103	42	about	about	IN
25944	3103	43	the	the	DT
25944	3103	44	free	free	JJ
25944	3103	45	borders	border	NNS
25944	3103	46	.	.	.
25944	3104	1	Ringworm	ringworm	VB
25944	3104	2	on	on	IN
25944	3104	3	other	other	JJ
25944	3104	4	parts	part	NNS
25944	3104	5	usually	usually	RB
25944	3104	6	coexists	coexist	VBZ
25944	3104	7	.	.	.
25944	3105	1	#	#	NNP
25944	3105	2	Describe	describe	VB
25944	3105	3	the	the	DT
25944	3105	4	symptoms	symptom	NNS
25944	3105	5	of	of	IN
25944	3105	6	ringworm	ringworm	NN
25944	3105	7	as	as	IN
25944	3105	8	it	-PRON-	PRP
25944	3105	9	occurs	occur	VBZ
25944	3105	10	upon	upon	IN
25944	3105	11	the	the	DT
25944	3105	12	scalp	scalp	NN
25944	3105	13	.	.	.
25944	3105	14	#	#	$
25944	3105	15	Ringworm	ringworm	NN
25944	3105	16	of	of	IN
25944	3105	17	the	the	DT
25944	3105	18	scalp	scalp	NN
25944	3105	19	(	(	-LRB-
25944	3105	20	_	_	NNP
25944	3105	21	tinea	tinea	NNP
25944	3105	22	trichophytina	trichophytina	NNP
25944	3105	23	capitis	capitis	NN
25944	3105	24	_	_	NNP
25944	3105	25	,	,	,
25944	3105	26	_	_	NNP
25944	3105	27	tinea	tinea	NNP
25944	3105	28	tonsurans	tonsurans	NNPS
25944	3105	29	_	_	NNP
25944	3105	30	)	)	-RRB-
25944	3105	31	begins	begin	VBZ
25944	3105	32	usually	usually	RB
25944	3105	33	in	in	IN
25944	3105	34	the	the	DT
25944	3105	35	same	same	JJ
25944	3105	36	manner	manner	NN
25944	3105	37	as	as	IN
25944	3105	38	that	that	DT
25944	3105	39	upon	upon	IN
25944	3105	40	the	the	DT
25944	3105	41	general	general	JJ
25944	3105	42	surface	surface	NN
25944	3105	43	,	,	,
25944	3105	44	but	but	CC
25944	3105	45	,	,	,
25944	3105	46	as	as	IN
25944	3105	47	a	a	DT
25944	3105	48	rule	rule	NN
25944	3105	49	,	,	,
25944	3105	50	much	much	RB
25944	3105	51	more	more	RBR
25944	3105	52	insidiously	insidiously	RB
25944	3105	53	.	.	.
25944	3106	1	Sooner	soon	RBR
25944	3106	2	or	or	CC
25944	3106	3	later	later	RB
25944	3106	4	,	,	,
25944	3106	5	however	however	RB
25944	3106	6	,	,	,
25944	3106	7	the	the	DT
25944	3106	8	hair	hair	NN
25944	3106	9	and	and	CC
25944	3106	10	follicles	follicle	NNS
25944	3106	11	are	be	VBP
25944	3106	12	invaded	invade	VBN
25944	3106	13	by	by	IN
25944	3106	14	the	the	DT
25944	3106	15	fungus	fungus	NN
25944	3106	16	,	,	,
25944	3106	17	and	and	CC
25944	3106	18	in	in	IN
25944	3106	19	consequence	consequence	NN
25944	3106	20	the	the	DT
25944	3106	21	hair	hair	NN
25944	3106	22	falls	fall	VBZ
25944	3106	23	out	out	RP
25944	3106	24	or	or	CC
25944	3106	25	becomes	become	VBZ
25944	3106	26	brittle	brittle	JJ
25944	3106	27	and	and	CC
25944	3106	28	breaks	break	VBZ
25944	3106	29	off	off	RP
25944	3106	30	.	.	.
25944	3107	1	The	the	DT
25944	3107	2	follicles	follicle	NNS
25944	3107	3	,	,	,
25944	3107	4	except	except	IN
25944	3107	5	in	in	IN
25944	3107	6	long	long	RB
25944	3107	7	-	-	HYPH
25944	3107	8	standing	stand	VBG
25944	3107	9	cases	case	NNS
25944	3107	10	,	,	,
25944	3107	11	are	be	VBP
25944	3107	12	slightly	slightly	RB
25944	3107	13	elevated	elevated	JJ
25944	3107	14	and	and	CC
25944	3107	15	prominent	prominent	JJ
25944	3107	16	,	,	,
25944	3107	17	and	and	CC
25944	3107	18	the	the	DT
25944	3107	19	patch	patch	NN
25944	3107	20	may	may	MD
25944	3107	21	have	have	VB
25944	3107	22	a	a	DT
25944	3107	23	puffed	puffed	JJ
25944	3107	24	or	or	CC
25944	3107	25	goose	goose	NN
25944	3107	26	-	-	HYPH
25944	3107	27	flesh	flesh	NN
25944	3107	28	appearance	appearance	NN
25944	3107	29	.	.	.
25944	3108	1	In	in	IN
25944	3108	2	addition	addition	NN
25944	3108	3	,	,	,
25944	3108	4	there	there	EX
25944	3108	5	is	be	VBZ
25944	3108	6	slight	slight	JJ
25944	3108	7	scaliness	scaliness	NN
25944	3108	8	.	.	.
25944	3109	1	#	#	NNP
25944	3109	2	Describe	describe	VB
25944	3109	3	the	the	DT
25944	3109	4	appearances	appearance	NNS
25944	3109	5	of	of	IN
25944	3109	6	a	a	DT
25944	3109	7	typical	typical	JJ
25944	3109	8	patch	patch	NN
25944	3109	9	of	of	IN
25944	3109	10	ringworm	ringworm	NN
25944	3109	11	of	of	IN
25944	3109	12	the	the	DT
25944	3109	13	scalp	scalp	NN
25944	3109	14	.	.	.
25944	3109	15	#	#	$
25944	3109	16	The	the	DT
25944	3109	17	patch	patch	NN
25944	3109	18	is	be	VBZ
25944	3109	19	rounded	rounded	JJ
25944	3109	20	,	,	,
25944	3109	21	grayish	grayish	NN
25944	3109	22	,	,	,
25944	3109	23	somewhat	somewhat	RB
25944	3109	24	scaly	scaly	NNP
25944	3109	25	,	,	,
25944	3109	26	and	and	CC
25944	3109	27	slightly	slightly	RB
25944	3109	28	elevated	elevated	JJ
25944	3109	29	;	;	:
25944	3109	30	the	the	DT
25944	3109	31	follicles	follicle	NNS
25944	3109	32	are	be	VBP
25944	3109	33	somewhat	somewhat	RB
25944	3109	34	prominent	prominent	JJ
25944	3109	35	;	;	:
25944	3109	36	there	there	EX
25944	3109	37	is	be	VBZ
25944	3109	38	more	more	RBR
25944	3109	39	or	or	CC
25944	3109	40	less	less	JJR
25944	3109	41	alopecia	alopecia	NN
25944	3109	42	,	,	,
25944	3109	43	with	with	IN
25944	3109	44	here	here	RB
25944	3109	45	and	and	CC
25944	3109	46	there	there	RB
25944	3109	47	broken	break	VBN
25944	3109	48	,	,	,
25944	3109	49	gnawed	gnaw	VBN
25944	3109	50	-	-	HYPH
25944	3109	51	off	off	RP
25944	3109	52	-	-	HYPH
25944	3109	53	looking	look	VBG
25944	3109	54	hairs	hair	NNS
25944	3109	55	,	,	,
25944	3109	56	some	some	DT
25944	3109	57	of	of	IN
25944	3109	58	which	which	WDT
25944	3109	59	may	may	MD
25944	3109	60	be	be	VB
25944	3109	61	broken	break	VBN
25944	3109	62	off	off	RP
25944	3109	63	just	just	RB
25944	3109	64	at	at	IN
25944	3109	65	the	the	DT
25944	3109	66	outlet	outlet	NN
25944	3109	67	of	of	IN
25944	3109	68	the	the	DT
25944	3109	69	follicles	follicle	NNS
25944	3109	70	and	and	CC
25944	3109	71	more	more	RBR
25944	3109	72	or	or	CC
25944	3109	73	less	less	RBR
25944	3109	74	surrounded	surround	VBN
25944	3109	75	by	by	IN
25944	3109	76	a	a	DT
25944	3109	77	whitish	whitish	NN
25944	3109	78	or	or	CC
25944	3109	79	grayish	grayish	NN
25944	3109	80	-	-	HYPH
25944	3109	81	white	white	JJ
25944	3109	82	dust	dust	NN
25944	3109	83	.	.	.
25944	3110	1	This	this	DT
25944	3110	2	type	type	NN
25944	3110	3	is	be	VBZ
25944	3110	4	produced	produce	VBN
25944	3110	5	by	by	IN
25944	3110	6	the	the	DT
25944	3110	7	small	small	JJ
25944	3110	8	-	-	HYPH
25944	3110	9	spore	spore	NN
25944	3110	10	fungus	fungus	NN
25944	3110	11	--	--	:
25944	3110	12	microsporon	microsporon	NNP
25944	3110	13	.	.	.
25944	3111	1	#	#	NN
25944	3111	2	Does	do	VBZ
25944	3111	3	ringworm	ringworm	VB
25944	3111	4	of	of	IN
25944	3111	5	the	the	DT
25944	3111	6	scalp	scalp	NN
25944	3111	7	always	always	RB
25944	3111	8	present	present	VBP
25944	3111	9	typical	typical	JJ
25944	3111	10	appearances	appearance	NNS
25944	3111	11	?	?	.
25944	3111	12	#	#	NN
25944	3111	13	Not	not	RB
25944	3111	14	invariably	invariably	RB
25944	3111	15	.	.	.
25944	3112	1	In	in	IN
25944	3112	2	some	some	DT
25944	3112	3	cases	case	NNS
25944	3112	4	the	the	DT
25944	3112	5	patch	patch	NN
25944	3112	6	or	or	CC
25944	3112	7	patches	patch	NNS
25944	3112	8	may	may	MD
25944	3112	9	become	become	VB
25944	3112	10	almost	almost	RB
25944	3112	11	completely	completely	RB
25944	3112	12	bald	bald	JJ
25944	3112	13	,	,	,
25944	3112	14	and	and	CC
25944	3112	15	in	in	IN
25944	3112	16	others	other	NNS
25944	3112	17	a	a	DT
25944	3112	18	tendency	tendency	NN
25944	3112	19	to	to	IN
25944	3112	20	the	the	DT
25944	3112	21	formation	formation	NN
25944	3112	22	of	of	IN
25944	3112	23	pustules	pustule	NNS
25944	3112	24	,	,	,
25944	3112	25	with	with	IN
25944	3112	26	more	more	JJR
25944	3112	27	or	or	CC
25944	3112	28	less	less	JJR
25944	3112	29	crust	crust	NN
25944	3112	30	-	-	HYPH
25944	3112	31	formation	formation	NN
25944	3112	32	,	,	,
25944	3112	33	may	may	MD
25944	3112	34	be	be	VB
25944	3112	35	seen	see	VBN
25944	3112	36	.	.	.
25944	3113	1	The	the	DT
25944	3113	2	affection	affection	NN
25944	3113	3	may	may	MD
25944	3113	4	also	also	RB
25944	3113	5	appear	appear	VB
25944	3113	6	as	as	IN
25944	3113	7	small	small	JJ
25944	3113	8	scattered	scatter	VBN
25944	3113	9	spots	spot	NNS
25944	3113	10	or	or	CC
25944	3113	11	points	point	NNS
25944	3113	12	.	.	.
25944	3114	1	[	[	-LRB-
25944	3114	2	Illustration	illustration	NN
25944	3114	3	:	:	:
25944	3114	4	Fig	Fig	NNP
25944	3114	5	.	.	.
25944	3115	1	69	69	CD
25944	3115	2	.	.	.
25944	3116	1	Ringworm	Ringworm	NNP
25944	3116	2	(	(	-LRB-
25944	3116	3	rather	rather	RB
25944	3116	4	inflammatory	inflammatory	JJ
25944	3116	5	type	type	NN
25944	3116	6	,	,	,
25944	3116	7	and	and	CC
25944	3116	8	produced	produce	VBN
25944	3116	9	by	by	IN
25944	3116	10	the	the	DT
25944	3116	11	trichophyton	trichophyton	NNP
25944	3116	12	)	)	-RRB-
25944	3116	13	.	.	.
25944	3116	14	]	]	-RRB-
25944	3117	1	The	the	DT
25944	3117	2	markedly	markedly	RB
25944	3117	3	inflammatory	inflammatory	JJ
25944	3117	4	and	and	CC
25944	3117	5	pustular	pustular	JJ
25944	3117	6	types	type	NNS
25944	3117	7	are	be	VBP
25944	3117	8	produced	produce	VBN
25944	3117	9	by	by	IN
25944	3117	10	the	the	DT
25944	3117	11	large	large	JJ
25944	3117	12	-	-	HYPH
25944	3117	13	spore	spore	NN
25944	3117	14	fungus	fungus	NN
25944	3117	15	--	--	:
25944	3117	16	trichophyton	trichophyton	NNP
25944	3117	17	.	.	.
25944	3118	1	#	#	LS
25944	3118	2	What	what	WP
25944	3118	3	is	be	VBZ
25944	3118	4	tinea	tinea	JJ
25944	3118	5	kerion	kerion	NN
25944	3118	6	?	?	.
25944	3118	7	#	#	$
25944	3118	8	Tinea	Tinea	NNP
25944	3118	9	kerion	kerion	NN
25944	3118	10	(	(	-LRB-
25944	3118	11	_	_	NNP
25944	3118	12	kerion	kerion	NN
25944	3118	13	_	_	NNP
25944	3118	14	)	)	-RRB-
25944	3118	15	is	be	VBZ
25944	3118	16	a	a	DT
25944	3118	17	markedly	markedly	RB
25944	3118	18	inflammatory	inflammatory	JJ
25944	3118	19	type	type	NN
25944	3118	20	of	of	IN
25944	3118	21	ringworm	ringworm	NN
25944	3118	22	of	of	IN
25944	3118	23	the	the	DT
25944	3118	24	scalp	scalp	NN
25944	3118	25	involving	involve	VBG
25944	3118	26	the	the	DT
25944	3118	27	deeper	deep	JJR
25944	3118	28	tissues	tissue	NNS
25944	3118	29	,	,	,
25944	3118	30	appearing	appear	VBG
25944	3118	31	as	as	IN
25944	3118	32	a	a	DT
25944	3118	33	more	more	RBR
25944	3118	34	or	or	CC
25944	3118	35	less	less	RBR
25944	3118	36	bald	bald	JJ
25944	3118	37	,	,	,
25944	3118	38	rounded	rounded	JJ
25944	3118	39	,	,	,
25944	3118	40	inflammatory	inflammatory	JJ
25944	3118	41	,	,	,
25944	3118	42	[	[	-LRB-
25944	3118	43	oe]dematous	oe]dematous	UH
25944	3118	44	,	,	,
25944	3118	45	boggy	boggy	NNP
25944	3118	46	,	,	,
25944	3118	47	honeycombed	honeycombed	JJ
25944	3118	48	tumor	tumor	NN
25944	3118	49	,	,	,
25944	3118	50	discharging	discharge	VBG
25944	3118	51	from	from	IN
25944	3118	52	the	the	DT
25944	3118	53	follicular	follicular	JJ
25944	3118	54	openings	opening	NNS
25944	3118	55	a	a	DT
25944	3118	56	mucoid	mucoid	NNP
25944	3118	57	secretion	secretion	NN
25944	3118	58	.	.	.
25944	3119	1	#	#	NN
25944	3119	2	Does	do	VBZ
25944	3119	3	ringworm	ringworm	VB
25944	3119	4	of	of	IN
25944	3119	5	the	the	DT
25944	3119	6	scalp	scalp	NN
25944	3119	7	ever	ever	RB
25944	3119	8	occur	occur	VBP
25944	3119	9	in	in	IN
25944	3119	10	adults	adult	NNS
25944	3119	11	?	?	.
25944	3119	12	#	#	$
25944	3119	13	No	no	UH
25944	3119	14	.	.	.
25944	3120	1	(	(	-LRB-
25944	3120	2	Extremely	extremely	RB
25944	3120	3	rare	rare	JJ
25944	3120	4	exceptions	exception	NNS
25944	3120	5	.	.	.
25944	3120	6	)	)	-RRB-
25944	3121	1	[	[	-LRB-
25944	3121	2	Illustration	illustration	NN
25944	3121	3	:	:	:
25944	3121	4	Fig	Fig	NNP
25944	3121	5	.	.	.
25944	3122	1	70	70	CD
25944	3122	2	.	.	.
25944	3123	1	Ringworm	Ringworm	NNP
25944	3123	2	Fungus	Fungus	NNP
25944	3123	3	(	(	-LRB-
25944	3123	4	Trichophyton	Trichophyton	NNP
25944	3123	5	)	)	-RRB-
25944	3123	6	x	x	SYM
25944	3123	7	450	450	CD
25944	3123	8	.	.	.
25944	3124	1	(	(	-LRB-
25944	3124	2	_	_	NNP
25944	3124	3	After	after	IN
25944	3124	4	Duhring	Duhring	NNP
25944	3124	5	.	.	.
25944	3124	6	_	_	NNP
25944	3124	7	)	)	-RRB-
25944	3124	8	As	as	IN
25944	3124	9	found	find	VBN
25944	3124	10	in	in	IN
25944	3124	11	epidermic	epidermic	JJ
25944	3124	12	scrapings	scraping	NNS
25944	3124	13	of	of	IN
25944	3124	14	ringworm	ringworm	NN
25944	3124	15	,	,	,
25944	3124	16	showing	show	VBG
25944	3124	17	mycelium	mycelium	NN
25944	3124	18	and	and	CC
25944	3124	19	spores	spore	NNS
25944	3124	20	.	.	.
25944	3124	21	]	]	-RRB-
25944	3125	1	#	#	NNP
25944	3125	2	Describe	describe	VB
25944	3125	3	the	the	DT
25944	3125	4	symptoms	symptom	NNS
25944	3125	5	of	of	IN
25944	3125	6	ringworm	ringworm	NN
25944	3125	7	of	of	IN
25944	3125	8	the	the	DT
25944	3125	9	bearded	bearded	JJ
25944	3125	10	region	region	NN
25944	3125	11	.	.	.
25944	3125	12	#	#	JJR
25944	3125	13	Ringworm	ringworm	NN
25944	3125	14	of	of	IN
25944	3125	15	the	the	DT
25944	3125	16	bearded	bearded	JJ
25944	3125	17	region	region	NN
25944	3125	18	(	(	-LRB-
25944	3125	19	_	_	NNP
25944	3125	20	tinea	tinea	NNP
25944	3125	21	trichophytina	trichophytina	NNP
25944	3125	22	barbæ	barbæ	NNP
25944	3125	23	_	_	NNP
25944	3125	24	,	,	,
25944	3125	25	_	_	NNP
25944	3125	26	tinea	tinea	NNP
25944	3125	27	sycosis	sycosis	NN
25944	3125	28	_	_	NNP
25944	3125	29	,	,	,
25944	3125	30	_	_	NNP
25944	3125	31	parasitic	parasitic	JJ
25944	3125	32	sycosis	sycosis	NN
25944	3125	33	_	_	NNP
25944	3125	34	,	,	,
25944	3125	35	_	_	NNP
25944	3125	36	barber	barber	NN
25944	3125	37	's	's	POS
25944	3125	38	itch	itch	NN
25944	3125	39	_	_	NNP
25944	3125	40	)	)	-RRB-
25944	3125	41	begins	begin	VBZ
25944	3125	42	usually	usually	RB
25944	3125	43	in	in	IN
25944	3125	44	the	the	DT
25944	3125	45	same	same	JJ
25944	3125	46	manner	manner	NN
25944	3125	47	as	as	IN
25944	3125	48	ringworm	ringworm	NN
25944	3125	49	on	on	IN
25944	3125	50	other	other	JJ
25944	3125	51	parts	part	NNS
25944	3125	52	,	,	,
25944	3125	53	as	as	IN
25944	3125	54	one	one	CD
25944	3125	55	or	or	CC
25944	3125	56	more	more	RBR
25944	3125	57	rounded	rounded	JJ
25944	3125	58	,	,	,
25944	3125	59	slightly	slightly	RB
25944	3125	60	scaly	scaly	JJ
25944	3125	61	,	,	,
25944	3125	62	hyperæmic	hyperæmic	JJ
25944	3125	63	patches	patch	NNS
25944	3125	64	.	.	.
25944	3126	1	In	in	IN
25944	3126	2	rare	rare	JJ
25944	3126	3	instances	instance	NNS
25944	3126	4	the	the	DT
25944	3126	5	disease	disease	NN
25944	3126	6	may	may	MD
25944	3126	7	persist	persist	VB
25944	3126	8	as	as	IN
25944	3126	9	such	such	JJ
25944	3126	10	,	,	,
25944	3126	11	with	with	IN
25944	3126	12	very	very	RB
25944	3126	13	little	little	JJ
25944	3126	14	tendency	tendency	NN
25944	3126	15	to	to	TO
25944	3126	16	involve	involve	VB
25944	3126	17	the	the	DT
25944	3126	18	hairs	hair	NNS
25944	3126	19	and	and	CC
25944	3126	20	follicles	follicle	NNS
25944	3126	21	;	;	:
25944	3126	22	but	but	CC
25944	3126	23	,	,	,
25944	3126	24	as	as	IN
25944	3126	25	a	a	DT
25944	3126	26	rule	rule	NN
25944	3126	27	,	,	,
25944	3126	28	the	the	DT
25944	3126	29	hairy	hairy	JJ
25944	3126	30	structures	structure	NNS
25944	3126	31	are	be	VBP
25944	3126	32	soon	soon	RB
25944	3126	33	invaded	invade	VBN
25944	3126	34	,	,	,
25944	3126	35	many	many	JJ
25944	3126	36	of	of	IN
25944	3126	37	the	the	DT
25944	3126	38	hairs	hair	NNS
25944	3126	39	breaking	break	VBG
25944	3126	40	off	off	RP
25944	3126	41	,	,	,
25944	3126	42	and	and	CC
25944	3126	43	many	many	JJ
25944	3126	44	falling	fall	VBG
25944	3126	45	out	out	RP
25944	3126	46	.	.	.
25944	3127	1	From	from	IN
25944	3127	2	involvement	involvement	NN
25944	3127	3	of	of	IN
25944	3127	4	the	the	DT
25944	3127	5	follicles	follicle	NNS
25944	3127	6	,	,	,
25944	3127	7	more	more	RBR
25944	3127	8	or	or	CC
25944	3127	9	less	less	RBR
25944	3127	10	subcutaneous	subcutaneous	JJ
25944	3127	11	swelling	swelling	NN
25944	3127	12	ensues	ensue	NNS
25944	3127	13	,	,	,
25944	3127	14	the	the	DT
25944	3127	15	parts	part	NNS
25944	3127	16	assuming	assume	VBG
25944	3127	17	a	a	DT
25944	3127	18	distinctly	distinctly	RB
25944	3127	19	_	_	NNP
25944	3127	20	lumpy	lumpy	JJ
25944	3127	21	and	and	CC
25944	3127	22	nodular	nodular	JJ
25944	3127	23	_	_	NNP
25944	3127	24	condition	condition	NN
25944	3127	25	.	.	.
25944	3128	1	The	the	DT
25944	3128	2	skin	skin	NN
25944	3128	3	is	be	VBZ
25944	3128	4	usually	usually	RB
25944	3128	5	considerably	considerably	RB
25944	3128	6	reddened	redden	VBN
25944	3128	7	,	,	,
25944	3128	8	often	often	RB
25944	3128	9	having	have	VBG
25944	3128	10	a	a	DT
25944	3128	11	glossy	glossy	JJ
25944	3128	12	appearance	appearance	NN
25944	3128	13	,	,	,
25944	3128	14	and	and	CC
25944	3128	15	studded	stud	VBD
25944	3128	16	with	with	IN
25944	3128	17	few	few	JJ
25944	3128	18	or	or	CC
25944	3128	19	numerous	numerous	JJ
25944	3128	20	pustules	pustule	NNS
25944	3128	21	.	.	.
25944	3129	1	The	the	DT
25944	3129	2	nodules	nodule	NNS
25944	3129	3	tend	tend	VBP
25944	3129	4	,	,	,
25944	3129	5	ordinarily	ordinarily	RB
25944	3129	6	,	,	,
25944	3129	7	to	to	TO
25944	3129	8	break	break	VB
25944	3129	9	down	down	RP
25944	3129	10	and	and	CC
25944	3129	11	discharge	discharge	VB
25944	3129	12	,	,	,
25944	3129	13	at	at	IN
25944	3129	14	one	one	CD
25944	3129	15	or	or	CC
25944	3129	16	more	more	JJR
25944	3129	17	of	of	IN
25944	3129	18	the	the	DT
25944	3129	19	follicular	follicular	JJ
25944	3129	20	openings	opening	NNS
25944	3129	21	,	,	,
25944	3129	22	a	a	DT
25944	3129	23	glairy	glairy	NN
25944	3129	24	,	,	,
25944	3129	25	glutinous	glutinous	JJ
25944	3129	26	,	,	,
25944	3129	27	purulent	purulent	NN
25944	3129	28	material	material	NN
25944	3129	29	,	,	,
25944	3129	30	which	which	WDT
25944	3129	31	may	may	MD
25944	3129	32	dry	dry	VB
25944	3129	33	to	to	IN
25944	3129	34	thick	thick	JJ
25944	3129	35	,	,	,
25944	3129	36	adherent	adherent	JJ
25944	3129	37	crusts	crust	NNS
25944	3129	38	.	.	.
25944	3130	1	[	[	-LRB-
25944	3130	2	Illustration	illustration	NN
25944	3130	3	:	:	:
25944	3130	4	Fig	Fig	NNP
25944	3130	5	.	.	.
25944	3131	1	71	71	CD
25944	3131	2	.	.	.
25944	3132	1	Ringworm	Ringworm	NNP
25944	3132	2	Fungus	Fungus	NNP
25944	3132	3	(	(	-LRB-
25944	3132	4	Microsporon	Microsporon	NNP
25944	3132	5	)	)	-RRB-
25944	3132	6	x	x	NNP
25944	3132	7	500	500	CD
25944	3132	8	.	.	.
25944	3133	1	(	(	-LRB-
25944	3133	2	_	_	NNP
25944	3133	3	After	after	IN
25944	3133	4	Duhring	Duhring	NNP
25944	3133	5	.	.	.
25944	3133	6	_	_	NNP
25944	3133	7	)	)	-RRB-
25944	3133	8	Short	Short	NNP
25944	3133	9	,	,	,
25944	3133	10	broken	break	VBN
25944	3133	11	-	-	HYPH
25944	3133	12	off	off	RP
25944	3133	13	hair	hair	NN
25944	3133	14	of	of	IN
25944	3133	15	scalp	scalp	NNP
25944	3133	16	invaded	invade	VBN
25944	3133	17	with	with	IN
25944	3133	18	masses	masse	NNS
25944	3133	19	of	of	IN
25944	3133	20	free	free	JJ
25944	3133	21	spores	spore	NNS
25944	3133	22	.	.	.
25944	3133	23	]	]	-RRB-
25944	3134	1	The	the	DT
25944	3134	2	disease	disease	NN
25944	3134	3	may	may	MD
25944	3134	4	be	be	VB
25944	3134	5	limited	limit	VBN
25944	3134	6	to	to	IN
25944	3134	7	one	one	CD
25944	3134	8	patch	patch	NN
25944	3134	9	,	,	,
25944	3134	10	or	or	CC
25944	3134	11	a	a	DT
25944	3134	12	large	large	JJ
25944	3134	13	area	area	NN
25944	3134	14	,	,	,
25944	3134	15	even	even	RB
25944	3134	16	to	to	IN
25944	3134	17	the	the	DT
25944	3134	18	extent	extent	NN
25944	3134	19	of	of	IN
25944	3134	20	the	the	DT
25944	3134	21	whole	whole	JJ
25944	3134	22	bearded	bearded	JJ
25944	3134	23	region	region	NN
25944	3134	24	,	,	,
25944	3134	25	becomes	become	VBZ
25944	3134	26	involved	involved	JJ
25944	3134	27	.	.	.
25944	3135	1	The	the	DT
25944	3135	2	upper	upper	JJ
25944	3135	3	lip	lip	NN
25944	3135	4	is	be	VBZ
25944	3135	5	rarely	rarely	RB
25944	3135	6	invaded	invade	VBN
25944	3135	7	.	.	.
25944	3136	1	Ringworm	Ringworm	NNP
25944	3136	2	of	of	IN
25944	3136	3	the	the	DT
25944	3136	4	bearded	bearded	JJ
25944	3136	5	region	region	NN
25944	3136	6	is	be	VBZ
25944	3136	7	due	due	JJ
25944	3136	8	to	to	IN
25944	3136	9	the	the	DT
25944	3136	10	trichophyton	trichophyton	NNP
25944	3136	11	.	.	.
25944	3137	1	[	[	-LRB-
25944	3137	2	Illustration	illustration	NN
25944	3137	3	:	:	:
25944	3137	4	Fig	Fig	NNP
25944	3137	5	.	.	.
25944	3138	1	72	72	CD
25944	3138	2	.	.	.
25944	3139	1	Ringworm	Ringworm	NNP
25944	3139	2	Fungus	Fungus	NNP
25944	3139	3	(	(	-LRB-
25944	3139	4	Trichophyton	Trichophyton	NNP
25944	3139	5	)	)	-RRB-
25944	3139	6	x	x	SYM
25944	3139	7	300	300	CD
25944	3139	8	.	.	.
25944	3140	1	(	(	-LRB-
25944	3140	2	_	_	NNP
25944	3140	3	After	after	IN
25944	3140	4	Duhring	Duhring	NNP
25944	3140	5	.	.	.
25944	3140	6	_	_	NNP
25944	3140	7	)	)	-RRB-
25944	3140	8	Short	Short	NNP
25944	3140	9	,	,	,
25944	3140	10	stout	stout	RB
25944	3140	11	hair	hair	NN
25944	3140	12	of	of	IN
25944	3140	13	beard	beard	NNP
25944	3140	14	,	,	,
25944	3140	15	with	with	IN
25944	3140	16	the	the	DT
25944	3140	17	root	root	NN
25944	3140	18	-	-	HYPH
25944	3140	19	sheath	sheath	NN
25944	3140	20	attached	attach	VBN
25944	3140	21	,	,	,
25944	3140	22	showing	show	VBG
25944	3140	23	free	free	JJ
25944	3140	24	spores	spore	NNS
25944	3140	25	and	and	CC
25944	3140	26	chains	chain	NNS
25944	3140	27	of	of	IN
25944	3140	28	spores	spore	NNS
25944	3140	29	.	.	.
25944	3140	30	]	]	-RRB-
25944	3141	1	#	#	JJR
25944	3141	2	To	to	TO
25944	3141	3	what	what	WP
25944	3141	4	is	be	VBZ
25944	3141	5	ringworm	ringworm	JJ
25944	3141	6	due	due	JJ
25944	3141	7	?	?	.
25944	3141	8	#	#	$
25944	3141	9	To	to	IN
25944	3141	10	the	the	DT
25944	3141	11	presence	presence	NN
25944	3141	12	and	and	CC
25944	3141	13	growth	growth	NN
25944	3141	14	in	in	IN
25944	3141	15	the	the	DT
25944	3141	16	cutaneous	cutaneous	JJ
25944	3141	17	structures	structure	NNS
25944	3141	18	of	of	IN
25944	3141	19	a	a	DT
25944	3141	20	vegetable	vegetable	NN
25944	3141	21	parasite	parasite	NN
25944	3141	22	.	.	.
25944	3142	1	Although	although	IN
25944	3142	2	the	the	DT
25944	3142	3	disease	disease	NN
25944	3142	4	is	be	VBZ
25944	3142	5	contagious	contagious	JJ
25944	3142	6	,	,	,
25944	3142	7	individuals	individual	NNS
25944	3142	8	differ	differ	VBP
25944	3142	9	considerably	considerably	RB
25944	3142	10	as	as	IN
25944	3142	11	to	to	IN
25944	3142	12	susceptibility	susceptibility	NN
25944	3142	13	.	.	.
25944	3143	1	It	-PRON-	PRP
25944	3143	2	is	be	VBZ
25944	3143	3	much	much	RB
25944	3143	4	more	more	RBR
25944	3143	5	common	common	JJ
25944	3143	6	in	in	IN
25944	3143	7	children	child	NNS
25944	3143	8	than	than	IN
25944	3143	9	in	in	IN
25944	3143	10	those	those	DT
25944	3143	11	past	past	IN
25944	3143	12	the	the	DT
25944	3143	13	age	age	NN
25944	3143	14	of	of	IN
25944	3143	15	puberty	puberty	NN
25944	3143	16	,	,	,
25944	3143	17	ringworm	ringworm	NN
25944	3143	18	of	of	IN
25944	3143	19	the	the	DT
25944	3143	20	scalp	scalp	NN
25944	3143	21	being	be	VBG
25944	3143	22	limited	limit	VBN
25944	3143	23	to	to	IN
25944	3143	24	the	the	DT
25944	3143	25	former	former	JJ
25944	3143	26	(	(	-LRB-
25944	3143	27	rare	rare	JJ
25944	3143	28	exceptions	exception	NNS
25944	3143	29	)	)	-RRB-
25944	3143	30	,	,	,
25944	3143	31	and	and	CC
25944	3143	32	tinea	tinea	NN
25944	3143	33	sycosis	sycosis	NN
25944	3143	34	being	be	VBG
25944	3143	35	a	a	DT
25944	3143	36	disease	disease	NN
25944	3143	37	of	of	IN
25944	3143	38	the	the	DT
25944	3143	39	male	male	JJ
25944	3143	40	adult	adult	NN
25944	3143	41	.	.	.
25944	3144	1	Until	until	IN
25944	3144	2	recently	recently	RB
25944	3144	3	the	the	DT
25944	3144	4	ringworm	ringworm	NN
25944	3144	5	was	be	VBD
25944	3144	6	thought	think	VBN
25944	3144	7	to	to	TO
25944	3144	8	be	be	VB
25944	3144	9	due	due	JJ
25944	3144	10	to	to	IN
25944	3144	11	but	but	CC
25944	3144	12	one	one	CD
25944	3144	13	fungus	fungus	NN
25944	3144	14	--	--	:
25944	3144	15	the	the	DT
25944	3144	16	trichophyton	trichophyton	NNP
25944	3144	17	;	;	:
25944	3144	18	it	-PRON-	PRP
25944	3144	19	is	be	VBZ
25944	3144	20	now	now	RB
25944	3144	21	known	know	VBN
25944	3144	22	that	that	IN
25944	3144	23	there	there	EX
25944	3144	24	are	be	VBP
25944	3144	25	several	several	JJ
25944	3144	26	forms	form	NNS
25944	3144	27	of	of	IN
25944	3144	28	fungi	fungi	NN
25944	3144	29	,	,	,
25944	3144	30	the	the	DT
25944	3144	31	main	main	JJ
25944	3144	32	forms	form	NNS
25944	3144	33	being	be	VBG
25944	3144	34	the	the	DT
25944	3144	35	small	small	NN
25944	3144	36	-	-	HYPH
25944	3144	37	spored	spored	JJ
25944	3144	38	(	(	-LRB-
25944	3144	39	microsporon	microsporon	NNP
25944	3144	40	Audouini	Audouini	NNP
25944	3144	41	)	)	-RRB-
25944	3144	42	and	and	CC
25944	3144	43	the	the	DT
25944	3144	44	large	large	JJ
25944	3144	45	-	-	HYPH
25944	3144	46	spored	spored	JJ
25944	3144	47	(	(	-LRB-
25944	3144	48	trichophyton	trichophyton	NNP
25944	3144	49	)	)	-RRB-
25944	3144	50	.	.	.
25944	3145	1	Of	of	IN
25944	3145	2	this	this	DT
25944	3145	3	latter	latter	NN
25944	3145	4	there	there	EX
25944	3145	5	are	be	VBP
25944	3145	6	two	two	CD
25944	3145	7	main	main	JJ
25944	3145	8	subvarieties	subvarietie	NNS
25944	3145	9	--	--	:
25944	3145	10	endothrix	endothrix	NN
25944	3145	11	and	and	CC
25944	3145	12	ectothrix	ectothrix	NN
25944	3145	13	.	.	.
25944	3146	1	The	the	DT
25944	3146	2	small	small	JJ
25944	3146	3	-	-	HYPH
25944	3146	4	spored	spore	VBN
25944	3146	5	fungus	fungus	NN
25944	3146	6	is	be	VBZ
25944	3146	7	found	find	VBN
25944	3146	8	as	as	IN
25944	3146	9	the	the	DT
25944	3146	10	cause	cause	NN
25944	3146	11	in	in	IN
25944	3146	12	the	the	DT
25944	3146	13	majority	majority	NN
25944	3146	14	of	of	IN
25944	3146	15	scalp	scalp	NN
25944	3146	16	cases	case	NNS
25944	3146	17	;	;	:
25944	3146	18	the	the	DT
25944	3146	19	endothrix	endothrix	NN
25944	3146	20	also	also	RB
25944	3146	21	commonly	commonly	RB
25944	3146	22	invades	invade	VBZ
25944	3146	23	the	the	DT
25944	3146	24	scalp	scalp	NNP
25944	3146	25	integument	integument	NN
25944	3146	26	.	.	.
25944	3147	1	The	the	DT
25944	3147	2	ectothrix	ectothrix	NN
25944	3147	3	variety	variety	NN
25944	3147	4	is	be	VBZ
25944	3147	5	usually	usually	RB
25944	3147	6	derived	derive	VBN
25944	3147	7	directly	directly	RB
25944	3147	8	or	or	CC
25944	3147	9	indirectly	indirectly	RB
25944	3147	10	from	from	IN
25944	3147	11	domestic	domestic	JJ
25944	3147	12	animals	animal	NNS
25944	3147	13	,	,	,
25944	3147	14	and	and	CC
25944	3147	15	is	be	VBZ
25944	3147	16	chiefly	chiefly	RB
25944	3147	17	responsible	responsible	JJ
25944	3147	18	for	for	IN
25944	3147	19	body	body	NN
25944	3147	20	-	-	HYPH
25944	3147	21	ringworm	ringworm	NN
25944	3147	22	,	,	,
25944	3147	23	and	and	CC
25944	3147	24	for	for	IN
25944	3147	25	suppurative	suppurative	NN
25944	3147	26	ringworm	ringworm	NN
25944	3147	27	,	,	,
25944	3147	28	whether	whether	IN
25944	3147	29	upon	upon	IN
25944	3147	30	the	the	DT
25944	3147	31	bearded	bearded	JJ
25944	3147	32	region	region	NN
25944	3147	33	or	or	CC
25944	3147	34	elsewhere	elsewhere	RB
25944	3147	35	.	.	.
25944	3148	1	#	#	LS
25944	3148	2	What	what	WP
25944	3148	3	is	be	VBZ
25944	3148	4	the	the	DT
25944	3148	5	pathology	pathology	NN
25944	3148	6	of	of	IN
25944	3148	7	ringworm	ringworm	NN
25944	3148	8	?	?	.
25944	3148	9	#	#	$
25944	3148	10	On	on	IN
25944	3148	11	the	the	DT
25944	3148	12	general	general	JJ
25944	3148	13	surface	surface	NN
25944	3148	14	the	the	DT
25944	3148	15	fungus	fungus	NN
25944	3148	16	has	have	VBZ
25944	3148	17	its	-PRON-	PRP$
25944	3148	18	seat	seat	NN
25944	3148	19	in	in	IN
25944	3148	20	the	the	DT
25944	3148	21	epidermis	epidermis	NN
25944	3148	22	,	,	,
25944	3148	23	especially	especially	RB
25944	3148	24	in	in	IN
25944	3148	25	the	the	DT
25944	3148	26	corneous	corneous	JJ
25944	3148	27	layer	layer	NN
25944	3148	28	;	;	:
25944	3148	29	upon	upon	IN
25944	3148	30	the	the	DT
25944	3148	31	scalp	scalp	NN
25944	3148	32	and	and	CC
25944	3148	33	bearded	bearded	JJ
25944	3148	34	region	region	NN
25944	3148	35	the	the	DT
25944	3148	36	epidermis	epidermis	NN
25944	3148	37	,	,	,
25944	3148	38	hair	hair	NN
25944	3148	39	-	-	HYPH
25944	3148	40	shaft	shaft	NN
25944	3148	41	,	,	,
25944	3148	42	root	root	NN
25944	3148	43	and	and	CC
25944	3148	44	follicle	follicle	NN
25944	3148	45	are	be	VBP
25944	3148	46	invaded	invade	VBN
25944	3148	47	.	.	.
25944	3149	1	The	the	DT
25944	3149	2	inflammatory	inflammatory	JJ
25944	3149	3	action	action	NN
25944	3149	4	may	may	MD
25944	3149	5	vary	vary	VB
25944	3149	6	considerably	considerably	RB
25944	3149	7	in	in	IN
25944	3149	8	different	different	JJ
25944	3149	9	cases	case	NNS
25944	3149	10	,	,	,
25944	3149	11	and	and	CC
25944	3149	12	at	at	IN
25944	3149	13	different	different	JJ
25944	3149	14	times	time	NNS
25944	3149	15	in	in	IN
25944	3149	16	the	the	DT
25944	3149	17	same	same	JJ
25944	3149	18	case	case	NN
25944	3149	19	.	.	.
25944	3150	1	The	the	DT
25944	3150	2	fungus	fungus	NN
25944	3150	3	consists	consist	VBZ
25944	3150	4	of	of	IN
25944	3150	5	mycelium	mycelium	NN
25944	3150	6	and	and	CC
25944	3150	7	spores	spore	NNS
25944	3150	8	.	.	.
25944	3151	1	In	in	IN
25944	3151	2	the	the	DT
25944	3151	3	epidermic	epidermic	JJ
25944	3151	4	scrapings	scraping	NNS
25944	3151	5	it	-PRON-	PRP
25944	3151	6	is	be	VBZ
25944	3151	7	never	never	RB
25944	3151	8	to	to	TO
25944	3151	9	be	be	VB
25944	3151	10	found	find	VBN
25944	3151	11	in	in	IN
25944	3151	12	abundance	abundance	NN
25944	3151	13	,	,	,
25944	3151	14	and	and	CC
25944	3151	15	the	the	DT
25944	3151	16	mycelium	mycelium	NN
25944	3151	17	predominates	predominate	VBZ
25944	3151	18	,	,	,
25944	3151	19	while	while	IN
25944	3151	20	in	in	IN
25944	3151	21	affected	affected	JJ
25944	3151	22	hairs	hair	NNS
25944	3151	23	the	the	DT
25944	3151	24	spores	spore	NNS
25944	3151	25	and	and	CC
25944	3151	26	chains	chain	NNS
25944	3151	27	of	of	IN
25944	3151	28	spores	spore	NNS
25944	3151	29	are	be	VBP
25944	3151	30	almost	almost	RB
25944	3151	31	exclusively	exclusively	RB
25944	3151	32	seen	see	VBN
25944	3151	33	,	,	,
25944	3151	34	and	and	CC
25944	3151	35	are	be	VBP
25944	3151	36	usually	usually	RB
25944	3151	37	present	present	JJ
25944	3151	38	in	in	IN
25944	3151	39	great	great	JJ
25944	3151	40	profusion	profusion	NN
25944	3151	41	.	.	.
25944	3152	1	#	#	NNP
25944	3152	2	How	how	WRB
25944	3152	3	do	do	VBP
25944	3152	4	you	-PRON-	PRP
25944	3152	5	examine	examine	VB
25944	3152	6	for	for	IN
25944	3152	7	the	the	DT
25944	3152	8	fungus	fungus	NN
25944	3152	9	?	?	.
25944	3152	10	#	#	$
25944	3152	11	The	the	DT
25944	3152	12	scrapings	scraping	NNS
25944	3152	13	or	or	CC
25944	3152	14	hair	hair	NN
25944	3152	15	should	should	MD
25944	3152	16	be	be	VB
25944	3152	17	moistened	moisten	VBN
25944	3152	18	with	with	IN
25944	3152	19	liquor	liquor	NN
25944	3152	20	potassæ	potassæ	NNS
25944	3152	21	,	,	,
25944	3152	22	and	and	CC
25944	3152	23	examined	examine	VBN
25944	3152	24	with	with	IN
25944	3152	25	a	a	DT
25944	3152	26	power	power	NN
25944	3152	27	from	from	IN
25944	3152	28	three	three	CD
25944	3152	29	hundred	hundred	CD
25944	3152	30	diameters	diameter	NNS
25944	3152	31	upward	upward	RB
25944	3152	32	.	.	.
25944	3153	1	#	#	NNP
25944	3153	2	How	how	WRB
25944	3153	3	is	be	VBZ
25944	3153	4	ringworm	ringworm	NN
25944	3153	5	of	of	IN
25944	3153	6	the	the	DT
25944	3153	7	general	general	JJ
25944	3153	8	surface	surface	NN
25944	3153	9	to	to	TO
25944	3153	10	be	be	VB
25944	3153	11	distinguished	distinguish	VBN
25944	3153	12	from	from	IN
25944	3153	13	eczema	eczema	NN
25944	3153	14	,	,	,
25944	3153	15	psoriasis	psoriasis	NN
25944	3153	16	and	and	CC
25944	3153	17	seborrh[oe]a	seborrh[oe]a	NNP
25944	3153	18	?	?	.
25944	3153	19	#	#	NN
25944	3153	20	By	by	IN
25944	3153	21	the	the	DT
25944	3153	22	growth	growth	NN
25944	3153	23	and	and	CC
25944	3153	24	characters	character	NNS
25944	3153	25	of	of	IN
25944	3153	26	the	the	DT
25944	3153	27	patch	patch	NN
25944	3153	28	,	,	,
25944	3153	29	the	the	DT
25944	3153	30	slight	slight	JJ
25944	3153	31	scaliness	scaliness	NN
25944	3153	32	,	,	,
25944	3153	33	the	the	DT
25944	3153	34	tendency	tendency	NN
25944	3153	35	to	to	TO
25944	3153	36	disappear	disappear	VB
25944	3153	37	in	in	IN
25944	3153	38	the	the	DT
25944	3153	39	centre	centre	NN
25944	3153	40	,	,	,
25944	3153	41	by	by	IN
25944	3153	42	the	the	DT
25944	3153	43	history	history	NN
25944	3153	44	,	,	,
25944	3153	45	and	and	CC
25944	3153	46	,	,	,
25944	3153	47	if	if	IN
25944	3153	48	necessary	necessary	JJ
25944	3153	49	,	,	,
25944	3153	50	by	by	IN
25944	3153	51	a	a	DT
25944	3153	52	microscopic	microscopic	JJ
25944	3153	53	examination	examination	NN
25944	3153	54	of	of	IN
25944	3153	55	the	the	DT
25944	3153	56	scales	scale	NNS
25944	3153	57	.	.	.
25944	3154	1	#	#	NNP
25944	3154	2	How	how	WRB
25944	3154	3	is	be	VBZ
25944	3154	4	ringworm	ringworm	NN
25944	3154	5	of	of	IN
25944	3154	6	the	the	DT
25944	3154	7	scalp	scalp	NN
25944	3154	8	to	to	TO
25944	3154	9	be	be	VB
25944	3154	10	distinguished	distinguish	VBN
25944	3154	11	from	from	IN
25944	3154	12	alopecia	alopecia	NNP
25944	3154	13	areata	areata	NNP
25944	3154	14	,	,	,
25944	3154	15	favus	favus	NNP
25944	3154	16	,	,	,
25944	3154	17	eczema	eczema	NN
25944	3154	18	,	,	,
25944	3154	19	seborrh[oe]a	seborrh[oe]a	NNP
25944	3154	20	,	,	,
25944	3154	21	and	and	CC
25944	3154	22	psoriasis	psoriasis	NN
25944	3154	23	?	?	.
25944	3154	24	#	#	$
25944	3154	25	By	by	IN
25944	3154	26	the	the	DT
25944	3154	27	peculiar	peculiar	JJ
25944	3154	28	clinical	clinical	JJ
25944	3154	29	features	feature	NNS
25944	3154	30	of	of	IN
25944	3154	31	ringworm	ringworm	NN
25944	3154	32	on	on	IN
25944	3154	33	this	this	DT
25944	3154	34	region	region	NN
25944	3154	35	--	--	:
25944	3154	36	the	the	DT
25944	3154	37	slight	slight	JJ
25944	3154	38	scaliness	scaliness	NN
25944	3154	39	,	,	,
25944	3154	40	broken	broken	JJ
25944	3154	41	hair	hair	NN
25944	3154	42	and	and	CC
25944	3154	43	hair	hair	NN
25944	3154	44	stumps	stump	NNS
25944	3154	45	,	,	,
25944	3154	46	with	with	IN
25944	3154	47	a	a	DT
25944	3154	48	certain	certain	JJ
25944	3154	49	amount	amount	NN
25944	3154	50	of	of	IN
25944	3154	51	baldness	baldness	NN
25944	3154	52	--	--	:
25944	3154	53	and	and	CC
25944	3154	54	in	in	IN
25944	3154	55	doubtful	doubtful	JJ
25944	3154	56	cases	case	NNS
25944	3154	57	by	by	IN
25944	3154	58	a	a	DT
25944	3154	59	microscopical	microscopical	JJ
25944	3154	60	examination	examination	NN
25944	3154	61	of	of	IN
25944	3154	62	the	the	DT
25944	3154	63	hairs	hair	NNS
25944	3154	64	.	.	.
25944	3155	1	In	in	IN
25944	3155	2	favus	favus	NNP
25944	3155	3	,	,	,
25944	3155	4	although	although	IN
25944	3155	5	the	the	DT
25944	3155	6	same	same	JJ
25944	3155	7	condition	condition	NN
25944	3155	8	of	of	IN
25944	3155	9	the	the	DT
25944	3155	10	hair	hair	NN
25944	3155	11	is	be	VBZ
25944	3155	12	noted	note	VBN
25944	3155	13	,	,	,
25944	3155	14	the	the	DT
25944	3155	15	yellow	yellow	JJ
25944	3155	16	,	,	,
25944	3155	17	cup	cup	NN
25944	3155	18	-	-	HYPH
25944	3155	19	shaped	shape	VBN
25944	3155	20	crusts	crust	NNS
25944	3155	21	,	,	,
25944	3155	22	and	and	CC
25944	3155	23	the	the	DT
25944	3155	24	presence	presence	NN
25944	3155	25	of	of	IN
25944	3155	26	the	the	DT
25944	3155	27	atrophic	atrophic	JJ
25944	3155	28	areas	area	NNS
25944	3155	29	in	in	IN
25944	3155	30	that	that	DT
25944	3155	31	disease	disease	NN
25944	3155	32	are	be	VBP
25944	3155	33	pathognomonic	pathognomonic	JJ
25944	3155	34	.	.	.
25944	3156	1	#	#	NNP
25944	3156	2	How	how	WRB
25944	3156	3	is	be	VBZ
25944	3156	4	ringworm	ringworm	NN
25944	3156	5	of	of	IN
25944	3156	6	the	the	DT
25944	3156	7	bearded	bearded	JJ
25944	3156	8	region	region	NN
25944	3156	9	to	to	TO
25944	3156	10	be	be	VB
25944	3156	11	distinguished	distinguish	VBN
25944	3156	12	from	from	IN
25944	3156	13	eczema	eczema	NN
25944	3156	14	and	and	CC
25944	3156	15	sycosis	sycosis	NN
25944	3156	16	?	?	.
25944	3156	17	#	#	NN
25944	3156	18	By	by	IN
25944	3156	19	the	the	DT
25944	3156	20	peculiar	peculiar	JJ
25944	3156	21	lumpiness	lumpiness	NN
25944	3156	22	of	of	IN
25944	3156	23	the	the	DT
25944	3156	24	parts	part	NNS
25944	3156	25	,	,	,
25944	3156	26	the	the	DT
25944	3156	27	brittleness	brittleness	NN
25944	3156	28	of	of	IN
25944	3156	29	the	the	DT
25944	3156	30	hair	hair	NN
25944	3156	31	,	,	,
25944	3156	32	more	more	RBR
25944	3156	33	or	or	CC
25944	3156	34	less	less	JJR
25944	3156	35	hair	hair	NN
25944	3156	36	loss	loss	NN
25944	3156	37	,	,	,
25944	3156	38	and	and	CC
25944	3156	39	the	the	DT
25944	3156	40	history	history	NN
25944	3156	41	.	.	.
25944	3157	1	The	the	DT
25944	3157	2	superficial	superficial	JJ
25944	3157	3	type	type	NN
25944	3157	4	of	of	IN
25944	3157	5	ringworm	ringworm	NN
25944	3157	6	sycosis	sycosis	NN
25944	3157	7	--	--	:
25944	3157	8	those	those	DT
25944	3157	9	cases	case	NNS
25944	3157	10	in	in	IN
25944	3157	11	which	which	WDT
25944	3157	12	the	the	DT
25944	3157	13	disease	disease	NN
25944	3157	14	remains	remain	VBZ
25944	3157	15	a	a	DT
25944	3157	16	surface	surface	NN
25944	3157	17	disease	disease	NN
25944	3157	18	--	--	:
25944	3157	19	is	be	VBZ
25944	3157	20	readily	readily	RB
25944	3157	21	distinguished	distinguish	VBN
25944	3157	22	,	,	,
25944	3157	23	as	as	IN
25944	3157	24	the	the	DT
25944	3157	25	symptoms	symptom	NNS
25944	3157	26	are	be	VBP
25944	3157	27	essentially	essentially	RB
25944	3157	28	the	the	DT
25944	3157	29	same	same	JJ
25944	3157	30	as	as	IN
25944	3157	31	ringworm	ringworm	NN
25944	3157	32	of	of	IN
25944	3157	33	non	non	JJ
25944	3157	34	-	-	JJ
25944	3157	35	hairy	hairy	JJ
25944	3157	36	parts	part	NNS
25944	3157	37	,	,	,
25944	3157	38	except	except	IN
25944	3157	39	that	that	IN
25944	3157	40	some	some	DT
25944	3157	41	of	of	IN
25944	3157	42	the	the	DT
25944	3157	43	hairs	hair	NNS
25944	3157	44	in	in	IN
25944	3157	45	the	the	DT
25944	3157	46	areas	area	NNS
25944	3157	47	may	may	MD
25944	3157	48	become	become	VB
25944	3157	49	invaded	invaded	JJ
25944	3157	50	and	and	CC
25944	3157	51	break	break	VB
25944	3157	52	off	off	RP
25944	3157	53	or	or	CC
25944	3157	54	fall	fall	VB
25944	3157	55	out	out	RP
25944	3157	56	.	.	.
25944	3158	1	In	in	IN
25944	3158	2	doubtful	doubtful	JJ
25944	3158	3	cases	case	NNS
25944	3158	4	recourse	recourse	VBP
25944	3158	5	may	may	MD
25944	3158	6	be	be	VB
25944	3158	7	had	have	VBN
25944	3158	8	to	to	IN
25944	3158	9	microscopical	microscopical	JJ
25944	3158	10	examination	examination	NN
25944	3158	11	.	.	.
25944	3159	1	#	#	LS
25944	3159	2	What	what	WP
25944	3159	3	is	be	VBZ
25944	3159	4	the	the	DT
25944	3159	5	prognosis	prognosis	NN
25944	3159	6	of	of	IN
25944	3159	7	ringworm	ringworm	NN
25944	3159	8	of	of	IN
25944	3159	9	these	these	DT
25944	3159	10	several	several	JJ
25944	3159	11	parts	part	NNS
25944	3159	12	?	?	.
25944	3159	13	#	#	NN
25944	3159	14	When	when	WRB
25944	3159	15	upon	upon	IN
25944	3159	16	the	the	DT
25944	3159	17	general	general	JJ
25944	3159	18	surface	surface	NN
25944	3159	19	,	,	,
25944	3159	20	the	the	DT
25944	3159	21	disease	disease	NN
25944	3159	22	usually	usually	RB
25944	3159	23	responds	respond	VBZ
25944	3159	24	rapidly	rapidly	RB
25944	3159	25	to	to	IN
25944	3159	26	therapeutical	therapeutical	JJ
25944	3159	27	applications	application	NNS
25944	3159	28	;	;	:
25944	3159	29	upon	upon	IN
25944	3159	30	the	the	DT
25944	3159	31	scalp	scalp	NN
25944	3159	32	it	-PRON-	PRP
25944	3159	33	is	be	VBZ
25944	3159	34	always	always	RB
25944	3159	35	a	a	DT
25944	3159	36	stubborn	stubborn	JJ
25944	3159	37	affection	affection	NN
25944	3159	38	,	,	,
25944	3159	39	and	and	CC
25944	3159	40	,	,	,
25944	3159	41	as	as	IN
25944	3159	42	a	a	DT
25944	3159	43	rule	rule	NN
25944	3159	44	,	,	,
25944	3159	45	requires	require	VBZ
25944	3159	46	several	several	JJ
25944	3159	47	months	month	NNS
25944	3159	48	to	to	IN
25944	3159	49	a	a	DT
25944	3159	50	year	year	NN
25944	3159	51	of	of	IN
25944	3159	52	energetic	energetic	JJ
25944	3159	53	treatment	treatment	NN
25944	3159	54	to	to	TO
25944	3159	55	effect	effect	VB
25944	3159	56	a	a	DT
25944	3159	57	cure	cure	NN
25944	3159	58	.	.	.
25944	3160	1	In	in	IN
25944	3160	2	this	this	DT
25944	3160	3	latter	latter	JJ
25944	3160	4	region	region	NN
25944	3160	5	the	the	DT
25944	3160	6	disease	disease	NN
25944	3160	7	will	will	MD
25944	3160	8	disappear	disappear	VB
25944	3160	9	spontaneously	spontaneously	RB
25944	3160	10	as	as	IN
25944	3160	11	the	the	DT
25944	3160	12	age	age	NN
25944	3160	13	of	of	IN
25944	3160	14	fifteen	fifteen	CD
25944	3160	15	or	or	CC
25944	3160	16	sixteen	sixteen	CD
25944	3160	17	is	be	VBZ
25944	3160	18	reached	reach	VBN
25944	3160	19	.	.	.
25944	3161	1	Tinea	Tinea	NNP
25944	3161	2	sycosis	sycosis	NN
25944	3161	3	yields	yield	NNS
25944	3161	4	in	in	IN
25944	3161	5	most	most	JJS
25944	3161	6	instances	instance	NNS
25944	3161	7	in	in	IN
25944	3161	8	the	the	DT
25944	3161	9	course	course	NN
25944	3161	10	of	of	IN
25944	3161	11	several	several	JJ
25944	3161	12	weeks	week	NNS
25944	3161	13	or	or	CC
25944	3161	14	a	a	DT
25944	3161	15	few	few	JJ
25944	3161	16	months	month	NNS
25944	3161	17	.	.	.
25944	3162	1	#	#	$
25944	3162	2	Is	be	VBZ
25944	3162	3	ringworm	ringworm	NN
25944	3162	4	of	of	IN
25944	3162	5	these	these	DT
25944	3162	6	several	several	JJ
25944	3162	7	parts	part	NNS
25944	3162	8	treated	treat	VBN
25944	3162	9	with	with	IN
25944	3162	10	the	the	DT
25944	3162	11	same	same	JJ
25944	3162	12	remedies	remedy	NNS
25944	3162	13	?	?	.
25944	3162	14	#	#	$
25944	3162	15	As	as	IN
25944	3162	16	a	a	DT
25944	3162	17	rule	rule	NN
25944	3162	18	,	,	,
25944	3162	19	yes	yes	UH
25944	3162	20	;	;	:
25944	3162	21	but	but	CC
25944	3162	22	the	the	DT
25944	3162	23	strength	strength	NN
25944	3162	24	must	must	MD
25944	3162	25	be	be	VB
25944	3162	26	modified	modify	VBN
25944	3162	27	.	.	.
25944	3163	1	The	the	DT
25944	3163	2	scalp	scalp	NN
25944	3163	3	will	will	MD
25944	3163	4	stand	stand	VB
25944	3163	5	strong	strong	JJ
25944	3163	6	applications	application	NNS
25944	3163	7	,	,	,
25944	3163	8	as	as	IN
25944	3163	9	will	will	MD
25944	3163	10	likewise	likewise	VB
25944	3163	11	the	the	DT
25944	3163	12	bearded	bearded	JJ
25944	3163	13	region	region	NN
25944	3163	14	;	;	:
25944	3163	15	upon	upon	IN
25944	3163	16	non	non	JJ
25944	3163	17	-	-	JJ
25944	3163	18	hairy	hairy	JJ
25944	3163	19	portions	portion	NNS
25944	3163	20	the	the	DT
25944	3163	21	remedies	remedy	NNS
25944	3163	22	should	should	MD
25944	3163	23	be	be	VB
25944	3163	24	used	use	VBN
25944	3163	25	somewhat	somewhat	RB
25944	3163	26	weaker	weak	JJR
25944	3163	27	.	.	.
25944	3164	1	They	-PRON-	PRP
25944	3164	2	should	should	MD
25944	3164	3	be	be	VB
25944	3164	4	applied	apply	VBN
25944	3164	5	twice	twice	RB
25944	3164	6	daily	daily	JJ
25944	3164	7	;	;	:
25944	3164	8	ointments	ointment	NNS
25944	3164	9	,	,	,
25944	3164	10	if	if	IN
25944	3164	11	used	use	VBN
25944	3164	12	,	,	,
25944	3164	13	being	be	VBG
25944	3164	14	well	well	RB
25944	3164	15	rubbed	rub	VBN
25944	3164	16	in	in	RP
25944	3164	17	,	,	,
25944	3164	18	and	and	CC
25944	3164	19	lotions	lotion	NNS
25944	3164	20	thoroughly	thoroughly	RB
25944	3164	21	dabbed	dab	VBD
25944	3164	22	on	on	IN
25944	3164	23	.	.	.
25944	3165	1	#	#	NNP
25944	3165	2	How	how	WRB
25944	3165	3	would	would	MD
25944	3165	4	you	-PRON-	PRP
25944	3165	5	treat	treat	VB
25944	3165	6	ringworm	ringworm	NN
25944	3165	7	of	of	IN
25944	3165	8	the	the	DT
25944	3165	9	general	general	JJ
25944	3165	10	surface	surface	NN
25944	3165	11	?	?	.
25944	3165	12	#	#	NN
25944	3165	13	By	by	IN
25944	3165	14	applications	application	NNS
25944	3165	15	of	of	IN
25944	3165	16	the	the	DT
25944	3165	17	milder	milder	NN
25944	3165	18	parasiticides	parasiticide	NNS
25944	3165	19	,	,	,
25944	3165	20	such	such	JJ
25944	3165	21	as	as	IN
25944	3165	22	a	a	DT
25944	3165	23	ten	ten	CD
25944	3165	24	to	to	TO
25944	3165	25	fifteen	fifteen	CD
25944	3165	26	per	per	IN
25944	3165	27	cent	cent	NN
25944	3165	28	.	.	.
25944	3166	1	solution	solution	NN
25944	3166	2	of	of	IN
25944	3166	3	sodium	sodium	NN
25944	3166	4	hyposulphite	hyposulphite	NN
25944	3166	5	;	;	:
25944	3166	6	carbolic	carbolic	JJ
25944	3166	7	acid	acid	NN
25944	3166	8	,	,	,
25944	3166	9	five	five	CD
25944	3166	10	to	to	TO
25944	3166	11	thirty	thirty	CD
25944	3166	12	grains	grain	NNS
25944	3166	13	to	to	IN
25944	3166	14	the	the	DT
25944	3166	15	ounce	ounce	NN
25944	3166	16	of	of	IN
25944	3166	17	water	water	NN
25944	3166	18	,	,	,
25944	3166	19	or	or	CC
25944	3166	20	lard	lard	NN
25944	3166	21	;	;	:
25944	3166	22	a	a	DT
25944	3166	23	saturated	saturate	VBN
25944	3166	24	solution	solution	NN
25944	3166	25	of	of	IN
25944	3166	26	boric	boric	NN
25944	3166	27	acid	acid	NN
25944	3166	28	;	;	:
25944	3166	29	ointments	ointment	NNS
25944	3166	30	of	of	IN
25944	3166	31	tar	tar	NNP
25944	3166	32	,	,	,
25944	3166	33	sulphur	sulphur	NNP
25944	3166	34	and	and	CC
25944	3166	35	mercury	mercury	NNP
25944	3166	36	,	,	,
25944	3166	37	official	official	JJ
25944	3166	38	strength	strength	NN
25944	3166	39	or	or	CC
25944	3166	40	weakened	weaken	VBN
25944	3166	41	with	with	IN
25944	3166	42	lard	lard	NN
25944	3166	43	;	;	:
25944	3166	44	and	and	CC
25944	3166	45	tincture	tincture	NN
25944	3166	46	of	of	IN
25944	3166	47	iodine	iodine	JJ
25944	3166	48	,	,	,
25944	3166	49	pure	pure	JJ
25944	3166	50	or	or	CC
25944	3166	51	diluted	diluted	JJ
25944	3166	52	.	.	.
25944	3167	1	When	when	WRB
25944	3167	2	occurring	occur	VBG
25944	3167	3	upon	upon	IN
25944	3167	4	the	the	DT
25944	3167	5	upper	upper	JJ
25944	3167	6	and	and	CC
25944	3167	7	inner	inner	JJ
25944	3167	8	part	part	NN
25944	3167	9	of	of	IN
25944	3167	10	the	the	DT
25944	3167	11	thighs	thigh	NNS
25944	3167	12	(	(	-LRB-
25944	3167	13	so	so	RB
25944	3167	14	-	-	HYPH
25944	3167	15	called	call	VBN
25944	3167	16	eczema	eczema	NN
25944	3167	17	marginatum	marginatum	NN
25944	3167	18	)	)	-RRB-
25944	3167	19	,	,	,
25944	3167	20	the	the	DT
25944	3167	21	same	same	JJ
25944	3167	22	remedies	remedy	NNS
25944	3167	23	are	be	VBP
25944	3167	24	to	to	TO
25944	3167	25	be	be	VB
25944	3167	26	employed	employ	VBN
25944	3167	27	,	,	,
25944	3167	28	but	but	CC
25944	3167	29	usually	usually	RB
25944	3167	30	stronger	strong	JJR
25944	3167	31	.	.	.
25944	3168	1	Deserving	deserve	VBG
25944	3168	2	of	of	IN
25944	3168	3	special	special	JJ
25944	3168	4	mention	mention	NN
25944	3168	5	is	be	VBZ
25944	3168	6	a	a	DT
25944	3168	7	lotion	lotion	NN
25944	3168	8	of	of	IN
25944	3168	9	corrosive	corrosive	JJ
25944	3168	10	sublimate	sublimate	NN
25944	3168	11	,	,	,
25944	3168	12	one	one	CD
25944	3168	13	to	to	TO
25944	3168	14	four	four	CD
25944	3168	15	grains	grain	NNS
25944	3168	16	to	to	IN
25944	3168	17	the	the	DT
25944	3168	18	ounce	ounce	NN
25944	3168	19	;	;	:
25944	3168	20	or	or	CC
25944	3168	21	the	the	DT
25944	3168	22	same	same	JJ
25944	3168	23	remedy	remedy	NN
25944	3168	24	,	,	,
25944	3168	25	in	in	IN
25944	3168	26	the	the	DT
25944	3168	27	same	same	JJ
25944	3168	28	proportion	proportion	NN
25944	3168	29	,	,	,
25944	3168	30	may	may	MD
25944	3168	31	be	be	VB
25944	3168	32	used	use	VBN
25944	3168	33	in	in	IN
25944	3168	34	tincture	tincture	NN
25944	3168	35	of	of	IN
25944	3168	36	myrrh	myrrh	NNP
25944	3168	37	or	or	CC
25944	3168	38	benzoin	benzoin	NN
25944	3168	39	,	,	,
25944	3168	40	and	and	CC
25944	3168	41	painted	paint	VBD
25944	3168	42	on	on	IN
25944	3168	43	the	the	DT
25944	3168	44	parts	part	NNS
25944	3168	45	.	.	.
25944	3169	1	#	#	NNP
25944	3169	2	How	how	WRB
25944	3169	3	would	would	MD
25944	3169	4	you	-PRON-	PRP
25944	3169	5	treat	treat	VB
25944	3169	6	ringworm	ringworm	NN
25944	3169	7	of	of	IN
25944	3169	8	the	the	DT
25944	3169	9	scalp	scalp	NN
25944	3169	10	?	?	.
25944	3169	11	#	#	$
25944	3169	12	By	by	IN
25944	3169	13	occasional	occasional	JJ
25944	3169	14	soap	soap	NN
25944	3169	15	-	-	HYPH
25944	3169	16	and	and	CC
25944	3169	17	-	-	HYPH
25944	3169	18	hot	hot	JJ
25944	3169	19	-	-	HYPH
25944	3169	20	water	water	NN
25944	3169	21	washing	washing	NN
25944	3169	22	;	;	:
25944	3169	23	by	by	IN
25944	3169	24	extraction	extraction	NN
25944	3169	25	of	of	IN
25944	3169	26	the	the	DT
25944	3169	27	involved	involved	JJ
25944	3169	28	hairs	hair	NNS
25944	3169	29	,	,	,
25944	3169	30	when	when	WRB
25944	3169	31	practicable	practicable	JJ
25944	3169	32	;	;	:
25944	3169	33	by	by	IN
25944	3169	34	carbolic	carbolic	JJ
25944	3169	35	acid	acid	NN
25944	3169	36	or	or	CC
25944	3169	37	boric	boric	NN
25944	3169	38	acid	acid	NN
25944	3169	39	lotions	lotion	NNS
25944	3169	40	to	to	IN
25944	3169	41	the	the	DT
25944	3169	42	whole	whole	JJ
25944	3169	43	scalp	scalp	NN
25944	3169	44	,	,	,
25944	3169	45	so	so	IN
25944	3169	46	as	as	IN
25944	3169	47	to	to	TO
25944	3169	48	limit	limit	VB
25944	3169	49	,	,	,
25944	3169	50	as	as	RB
25944	3169	51	much	much	RB
25944	3169	52	as	as	IN
25944	3169	53	possible	possible	JJ
25944	3169	54	,	,	,
25944	3169	55	the	the	DT
25944	3169	56	spread	spread	NN
25944	3169	57	of	of	IN
25944	3169	58	the	the	DT
25944	3169	59	disease	disease	NN
25944	3169	60	;	;	:
25944	3169	61	and	and	CC
25944	3169	62	by	by	IN
25944	3169	63	daily	daily	JJ
25944	3169	64	(	(	-LRB-
25944	3169	65	or	or	CC
25944	3169	66	twice	twice	RB
25944	3169	67	daily	daily	JJ
25944	3169	68	)	)	-RRB-
25944	3169	69	applications	application	NNS
25944	3169	70	to	to	IN
25944	3169	71	the	the	DT
25944	3169	72	patches	patch	NNS
25944	3169	73	and	and	CC
25944	3169	74	involved	involve	VBN
25944	3169	75	areas	area	NNS
25944	3169	76	of	of	IN
25944	3169	77	a	a	DT
25944	3169	78	parasiticide	parasiticide	NN
25944	3169	79	.	.	.
25944	3170	1	The	the	DT
25944	3170	2	following	follow	VBG
25944	3170	3	are	be	VBP
25944	3170	4	the	the	DT
25944	3170	5	most	most	RBS
25944	3170	6	valuable	valuable	JJ
25944	3170	7	:	:	:
25944	3170	8	the	the	DT
25944	3170	9	oleate	oleate	NN
25944	3170	10	of	of	IN
25944	3170	11	mercury	mercury	NNP
25944	3170	12	,	,	,
25944	3170	13	with	with	IN
25944	3170	14	lard	lard	NN
25944	3170	15	or	or	CC
25944	3170	16	lanolin	lanolin	NN
25944	3170	17	,	,	,
25944	3170	18	in	in	IN
25944	3170	19	varying	varying	NN
25944	3170	20	strength	strength	NN
25944	3170	21	,	,	,
25944	3170	22	from	from	IN
25944	3170	23	ten	ten	CD
25944	3170	24	to	to	TO
25944	3170	25	twenty	twenty	CD
25944	3170	26	per	per	IN
25944	3170	27	cent	cent	NN
25944	3170	28	.	.	.
25944	3171	1	;	;	:
25944	3171	2	carbolic	carbolic	JJ
25944	3171	3	acid	acid	NN
25944	3171	4	,	,	,
25944	3171	5	with	with	IN
25944	3171	6	one	one	CD
25944	3171	7	to	to	TO
25944	3171	8	three	three	CD
25944	3171	9	or	or	CC
25944	3171	10	more	more	JJR
25944	3171	11	parts	part	NNS
25944	3171	12	of	of	IN
25944	3171	13	glycerine	glycerine	NN
25944	3171	14	or	or	CC
25944	3171	15	oil	oil	NN
25944	3171	16	;	;	,
25944	3171	17	corrosive	corrosive	JJ
25944	3171	18	sublimate	sublimate	NN
25944	3171	19	,	,	,
25944	3171	20	in	in	IN
25944	3171	21	solution	solution	NN
25944	3171	22	in	in	IN
25944	3171	23	alcohol	alcohol	NN
25944	3171	24	and	and	CC
25944	3171	25	water	water	NN
25944	3171	26	,	,	,
25944	3171	27	one	one	CD
25944	3171	28	to	to	TO
25944	3171	29	four	four	CD
25944	3171	30	grains	grain	NNS
25944	3171	31	to	to	IN
25944	3171	32	the	the	DT
25944	3171	33	ounce	ounce	NN
25944	3171	34	;	;	:
25944	3171	35	sulphur	sulphur	NNP
25944	3171	36	ointment	ointment	NNP
25944	3171	37	;	;	:
25944	3171	38	and	and	CC
25944	3171	39	citrine	citrine	NNP
25944	3171	40	ointment	ointment	NN
25944	3171	41	,	,	,
25944	3171	42	with	with	IN
25944	3171	43	one	one	CD
25944	3171	44	or	or	CC
25944	3171	45	two	two	CD
25944	3171	46	parts	part	NNS
25944	3171	47	of	of	IN
25944	3171	48	lard	lard	NN
25944	3171	49	.	.	.
25944	3172	1	Chrysarobin	Chrysarobin	NNP
25944	3172	2	is	be	VBZ
25944	3172	3	a	a	DT
25944	3172	4	valuable	valuable	JJ
25944	3172	5	remedy	remedy	NN
25944	3172	6	,	,	,
25944	3172	7	but	but	CC
25944	3172	8	is	be	VBZ
25944	3172	9	to	to	TO
25944	3172	10	be	be	VB
25944	3172	11	employed	employ	VBN
25944	3172	12	with	with	IN
25944	3172	13	care	care	NN
25944	3172	14	;	;	:
25944	3172	15	it	-PRON-	PRP
25944	3172	16	may	may	MD
25944	3172	17	be	be	VB
25944	3172	18	prescribed	prescribe	VBN
25944	3172	19	as	as	IN
25944	3172	20	a	a	DT
25944	3172	21	rubber	rubber	NN
25944	3172	22	plaster	plaster	NN
25944	3172	23	,	,	,
25944	3172	24	or	or	CC
25944	3172	25	in	in	IN
25944	3172	26	a	a	DT
25944	3172	27	solution	solution	NN
25944	3172	28	of	of	IN
25944	3172	29	gutta	gutta	NN
25944	3172	30	-	-	HYPH
25944	3172	31	percha	percha	NNS
25944	3172	32	,	,	,
25944	3172	33	or	or	CC
25944	3172	34	as	as	IN
25944	3172	35	an	an	DT
25944	3172	36	ointment	ointment	NN
25944	3172	37	,	,	,
25944	3172	38	ten	ten	CD
25944	3172	39	to	to	TO
25944	3172	40	fifteen	fifteen	CD
25944	3172	41	per	per	IN
25944	3172	42	cent	cent	NN
25944	3172	43	.	.	.
25944	3173	1	strength	strength	NN
25944	3173	2	.	.	.
25944	3174	1	[	[	-LRB-
25944	3174	2	beta]-naphthol	beta]-naphthol	NNP
25944	3174	3	in	in	IN
25944	3174	4	ointment	ointment	NN
25944	3174	5	form	form	NN
25944	3174	6	,	,	,
25944	3174	7	five	five	CD
25944	3174	8	to	to	TO
25944	3174	9	fifteen	fifteen	CD
25944	3174	10	per	per	IN
25944	3174	11	cent	cent	NN
25944	3174	12	.	.	.
25944	3175	1	strength	strength	NN
25944	3175	2	,	,	,
25944	3175	3	is	be	VBZ
25944	3175	4	also	also	RB
25944	3175	5	useful	useful	JJ
25944	3175	6	.	.	.
25944	3176	1	An	an	DT
25944	3176	2	excellent	excellent	JJ
25944	3176	3	application	application	NN
25944	3176	4	for	for	IN
25944	3176	5	beginning	begin	VBG
25944	3176	6	areas	area	NNS
25944	3176	7	on	on	IN
25944	3176	8	the	the	DT
25944	3176	9	scalp	scalp	NN
25944	3176	10	is	be	VBZ
25944	3176	11	a	a	DT
25944	3176	12	solution	solution	NN
25944	3176	13	of	of	IN
25944	3176	14	the	the	DT
25944	3176	15	red	red	NNP
25944	3176	16	iodide	iodide	NNP
25944	3176	17	of	of	IN
25944	3176	18	mercury	mercury	NNP
25944	3176	19	in	in	IN
25944	3176	20	iodine	iodine	NNP
25944	3176	21	tincture	tincture	NN
25944	3176	22	,	,	,
25944	3176	23	one	one	CD
25944	3176	24	to	to	TO
25944	3176	25	three	three	CD
25944	3176	26	grains	grain	NNS
25944	3176	27	to	to	IN
25944	3176	28	an	an	DT
25944	3176	29	ounce	ounce	NN
25944	3176	30	.	.	.
25944	3177	1	A	a	DT
25944	3177	2	compound	compound	NN
25944	3177	3	ointment	ointment	NN
25944	3177	4	,	,	,
25944	3177	5	containing	contain	VBG
25944	3177	6	several	several	JJ
25944	3177	7	of	of	IN
25944	3177	8	the	the	DT
25944	3177	9	active	active	JJ
25944	3177	10	remedies	remedy	NNS
25944	3177	11	named	name	VBN
25944	3177	12	,	,	,
25944	3177	13	is	be	VBZ
25944	3177	14	convenient	convenient	JJ
25944	3177	15	for	for	IN
25944	3177	16	dispensary	dispensary	JJ
25944	3177	17	practice	practice	NN
25944	3177	18	,	,	,
25944	3177	19	such	such	JJ
25944	3177	20	as:--	as:--	ADD
25944	3177	21	[	[	-LRB-
25944	3177	22	Rx	Rx	NNP
25944	3177	23	]	]	-RRB-
25944	3177	24	[	[	-LRB-
25944	3177	25	beta]-naphthol	beta]-naphthol	NNP
25944	3177	26	,	,	,
25944	3177	27	.................	.................	NFP
25944	3177	28	[	[	-LRB-
25944	3177	29	dram]ss-[dram]j	dram]ss-[dram]j	NNP
25944	3177	30	Ol	old	NNP
25944	3177	31	.	.	.
25944	3178	1	cadini	cadini	NNP
25944	3178	2	,	,	,
25944	3178	3	.........................	.........................	NFP
25944	3178	4	[	[	-LRB-
25944	3178	5	dram]j	dram]j	NNP
25944	3178	6	Ungt	Ungt	NNP
25944	3178	7	.	.	.
25944	3179	1	sulphuris	sulphuris	NNP
25944	3179	2	,	,	,
25944	3179	3	............	............	NFP
25944	3179	4	q.s	q.s	NNP
25944	3179	5	.	.	.
25944	3180	1	ad	ad	NN
25944	3180	2	[	[	-LRB-
25944	3180	3	Oz]j	Oz]j	NNP
25944	3180	4	.	.	.
25944	3180	5	M.	M.	NNP
25944	3180	6	In	in	IN
25944	3180	7	that	that	DT
25944	3180	8	form	form	NN
25944	3180	9	known	know	VBN
25944	3180	10	as	as	IN
25944	3180	11	tinea	tinea	NNP
25944	3180	12	kerion	kerion	NN
25944	3180	13	mild	mild	JJ
25944	3180	14	applications	application	NNS
25944	3180	15	are	be	VBP
25944	3180	16	demanded	demand	VBN
25944	3180	17	at	at	IN
25944	3180	18	first	first	RB
25944	3180	19	;	;	:
25944	3180	20	later	later	RB
25944	3180	21	the	the	DT
25944	3180	22	same	same	JJ
25944	3180	23	treatment	treatment	NN
25944	3180	24	as	as	IN
25944	3180	25	in	in	IN
25944	3180	26	the	the	DT
25944	3180	27	ordinary	ordinary	JJ
25944	3180	28	type	type	NN
25944	3180	29	.	.	.
25944	3181	1	#	#	NNP
25944	3181	2	How	how	WRB
25944	3181	3	is	be	VBZ
25944	3181	4	ringworm	ringworm	NN
25944	3181	5	of	of	IN
25944	3181	6	the	the	DT
25944	3181	7	bearded	bearded	JJ
25944	3181	8	region	region	NN
25944	3181	9	to	to	TO
25944	3181	10	be	be	VB
25944	3181	11	treated	treat	VBN
25944	3181	12	?	?	.
25944	3181	13	#	#	NN
25944	3181	14	On	on	IN
25944	3181	15	the	the	DT
25944	3181	16	same	same	JJ
25944	3181	17	general	general	JJ
25944	3181	18	plan	plan	NN
25944	3181	19	and	and	CC
25944	3181	20	with	with	IN
25944	3181	21	the	the	DT
25944	3181	22	same	same	JJ
25944	3181	23	remedies	remedy	NNS
25944	3181	24	(	(	-LRB-
25944	3181	25	excepting	except	VBG
25944	3181	26	chrysarobin	chrysarobin	NNP
25944	3181	27	)	)	-RRB-
25944	3181	28	as	as	IN
25944	3181	29	in	in	IN
25944	3181	30	ringworm	ringworm	NN
25944	3181	31	of	of	IN
25944	3181	32	the	the	DT
25944	3181	33	scalp	scalp	NN
25944	3181	34	.	.	.
25944	3182	1	Depilation	depilation	NN
25944	3182	2	is	be	VBZ
25944	3182	3	to	to	TO
25944	3182	4	be	be	VB
25944	3182	5	practised	practise	VBN
25944	3182	6	as	as	IN
25944	3182	7	an	an	DT
25944	3182	8	essential	essential	JJ
25944	3182	9	part	part	NN
25944	3182	10	of	of	IN
25944	3182	11	the	the	DT
25944	3182	12	treatment	treatment	NN
25944	3182	13	.	.	.
25944	3183	1	Special	special	JJ
25944	3183	2	mention	mention	NN
25944	3183	3	may	may	MD
25944	3183	4	be	be	VB
25944	3183	5	made	make	VBN
25944	3183	6	of	of	IN
25944	3183	7	an	an	DT
25944	3183	8	ointment	ointment	NN
25944	3183	9	of	of	IN
25944	3183	10	oleate	oleate	NN
25944	3183	11	of	of	IN
25944	3183	12	mercury	mercury	NNP
25944	3183	13	,	,	,
25944	3183	14	sulphur	sulphur	NNP
25944	3183	15	ointment	ointment	NNP
25944	3183	16	,	,	,
25944	3183	17	a	a	DT
25944	3183	18	lotion	lotion	NN
25944	3183	19	of	of	IN
25944	3183	20	sodium	sodium	NN
25944	3183	21	hyposulphite	hyposulphite	NN
25944	3183	22	(	(	-LRB-
25944	3183	23	[	[	-LRB-
25944	3183	24	dram]j-[Oz]j	dram]j-[Oz]j	NNP
25944	3183	25	)	)	-RRB-
25944	3183	26	,	,	,
25944	3183	27	and	and	CC
25944	3183	28	a	a	DT
25944	3183	29	lotion	lotion	NN
25944	3183	30	of	of	IN
25944	3183	31	corrosive	corrosive	JJ
25944	3183	32	sublimate	sublimate	NN
25944	3183	33	(	(	-LRB-
25944	3183	34	gr	gr	NNP
25944	3183	35	.	.	.
25944	3184	1	j	j	LS
25944	3184	2	-	-	HYPH
25944	3184	3	iv	iv	NNP
25944	3184	4	to	to	IN
25944	3184	5	[	[	-LRB-
25944	3184	6	Oz]j	oz]j	NN
25944	3184	7	)	)	-RRB-
25944	3184	8	.	.	.
25944	3185	1	The	the	DT
25944	3185	2	_	_	NNP
25944	3185	3	x_-ray	x_-ray	NN
25944	3185	4	has	have	VBZ
25944	3185	5	been	be	VBN
25944	3185	6	used	use	VBN
25944	3185	7	in	in	IN
25944	3185	8	ringworm	ringworm	NN
25944	3185	9	of	of	IN
25944	3185	10	this	this	DT
25944	3185	11	region	region	NN
25944	3185	12	with	with	IN
25944	3185	13	alleged	alleged	JJ
25944	3185	14	success	success	NN
25944	3185	15	,	,	,
25944	3185	16	pushing	push	VBG
25944	3185	17	it	-PRON-	PRP
25944	3185	18	to	to	IN
25944	3185	19	the	the	DT
25944	3185	20	production	production	NN
25944	3185	21	of	of	IN
25944	3185	22	a	a	DT
25944	3185	23	mild	mild	JJ
25944	3185	24	erythema	erythema	NN
25944	3185	25	and	and	CC
25944	3185	26	depilation	depilation	NN
25944	3185	27	.	.	.
25944	3186	1	The	the	DT
25944	3186	2	above	above	JJ
25944	3186	3	methods	method	NNS
25944	3186	4	are	be	VBP
25944	3186	5	,	,	,
25944	3186	6	however	however	RB
25944	3186	7	,	,	,
25944	3186	8	usually	usually	RB
25944	3186	9	successful	successful	JJ
25944	3186	10	,	,	,
25944	3186	11	and	and	CC
25944	3186	12	are	be	VBP
25944	3186	13	without	without	IN
25944	3186	14	risk	risk	NN
25944	3186	15	of	of	IN
25944	3186	16	damage	damage	NN
25944	3186	17	.	.	.
25944	3187	1	#	#	NNP
25944	3187	2	How	how	WRB
25944	3187	3	is	be	VBZ
25944	3187	4	the	the	DT
25944	3187	5	certainty	certainty	NN
25944	3187	6	of	of	IN
25944	3187	7	an	an	DT
25944	3187	8	apparent	apparent	JJ
25944	3187	9	cure	cure	NN
25944	3187	10	in	in	IN
25944	3187	11	ringworm	ringworm	NN
25944	3187	12	of	of	IN
25944	3187	13	the	the	DT
25944	3187	14	scalp	scalp	NN
25944	3187	15	or	or	CC
25944	3187	16	bearded	bearded	JJ
25944	3187	17	region	region	NN
25944	3187	18	to	to	TO
25944	3187	19	be	be	VB
25944	3187	20	determined	determine	VBN
25944	3187	21	?	?	.
25944	3187	22	#	#	NN
25944	3187	23	By	by	IN
25944	3187	24	the	the	DT
25944	3187	25	continued	continue	VBN
25944	3187	26	absence	absence	NN
25944	3187	27	of	of	IN
25944	3187	28	roughness	roughness	NN
25944	3187	29	and	and	CC
25944	3187	30	of	of	IN
25944	3187	31	broken	broken	JJ
25944	3187	32	hairs	hair	NNS
25944	3187	33	and	and	CC
25944	3187	34	stumps	stump	NNS
25944	3187	35	,	,	,
25944	3187	36	and	and	CC
25944	3187	37	by	by	IN
25944	3187	38	microscopical	microscopical	JJ
25944	3187	39	examination	examination	NN
25944	3187	40	of	of	IN
25944	3187	41	the	the	DT
25944	3187	42	new	new	RB
25944	3187	43	-	-	HYPH
25944	3187	44	growing	grow	VBG
25944	3187	45	hairs	hair	NNS
25944	3187	46	from	from	IN
25944	3187	47	time	time	NN
25944	3187	48	to	to	IN
25944	3187	49	time	time	NN
25944	3187	50	for	for	IN
25944	3187	51	several	several	JJ
25944	3187	52	weeks	week	NNS
25944	3187	53	after	after	IN
25944	3187	54	discontinuance	discontinuance	NN
25944	3187	55	of	of	IN
25944	3187	56	treatment	treatment	NN
25944	3187	57	.	.	.
25944	3188	1	Cure	cure	NN
25944	3188	2	of	of	IN
25944	3188	3	ringworm	ringworm	NN
25944	3188	4	of	of	IN
25944	3188	5	the	the	DT
25944	3188	6	general	general	JJ
25944	3188	7	surface	surface	NN
25944	3188	8	is	be	VBZ
25944	3188	9	usually	usually	RB
25944	3188	10	self	self	NN
25944	3188	11	-	-	HYPH
25944	3188	12	evident	evident	JJ
25944	3188	13	.	.	.
25944	3189	1	#	#	$
25944	3189	2	Is	be	VBZ
25944	3189	3	systemic	systemic	JJ
25944	3189	4	treatment	treatment	NN
25944	3189	5	of	of	IN
25944	3189	6	aid	aid	NN
25944	3189	7	in	in	IN
25944	3189	8	the	the	DT
25944	3189	9	cure	cure	NN
25944	3189	10	of	of	IN
25944	3189	11	ringworm	ringworm	NN
25944	3189	12	?	?	.
25944	3189	13	#	#	$
25944	3189	14	It	-PRON-	PRP
25944	3189	15	is	be	VBZ
25944	3189	16	doubtful	doubtful	JJ
25944	3189	17	,	,	,
25944	3189	18	although	although	IN
25944	3189	19	in	in	IN
25944	3189	20	children	child	NNS
25944	3189	21	in	in	IN
25944	3189	22	a	a	DT
25944	3189	23	depraved	depraved	JJ
25944	3189	24	state	state	NN
25944	3189	25	of	of	IN
25944	3189	26	health	health	NN
25944	3189	27	the	the	DT
25944	3189	28	disease	disease	NN
25944	3189	29	is	be	VBZ
25944	3189	30	often	often	RB
25944	3189	31	noted	note	VBN
25944	3189	32	to	to	TO
25944	3189	33	be	be	VB
25944	3189	34	especially	especially	RB
25944	3189	35	stubborn	stubborn	JJ
25944	3189	36	,	,	,
25944	3189	37	and	and	CC
25944	3189	38	in	in	IN
25944	3189	39	such	such	JJ
25944	3189	40	cod	cod	NN
25944	3189	41	-	-	HYPH
25944	3189	42	liver	liver	NN
25944	3189	43	oil	oil	NN
25944	3189	44	and	and	CC
25944	3189	45	similar	similar	JJ
25944	3189	46	remedies	remedy	NNS
25944	3189	47	may	may	MD
25944	3189	48	at	at	IN
25944	3189	49	times	time	NNS
25944	3189	50	prove	prove	VB
25944	3189	51	of	of	IN
25944	3189	52	benefit	benefit	NN
25944	3189	53	.	.	.
25944	3190	1	#	#	NNP
25944	3190	2	Tinea	Tinea	NNP
25944	3190	3	Imbricata	Imbricata	NNP
25944	3190	4	.	.	.
25944	3190	5	#	#	NNP
25944	3190	6	(	(	-LRB-
25944	3190	7	_	_	NNP
25944	3190	8	Synonym	Synonym	NNP
25944	3190	9	:	:	:
25944	3190	10	_	_	NNP
25944	3190	11	Tokelau	Tokelau	NNP
25944	3190	12	Ringworm	Ringworm	NNP
25944	3190	13	.	.	.
25944	3190	14	)	)	-RRB-
25944	3191	1	#	#	LS
25944	3191	2	What	what	WP
25944	3191	3	is	be	VBZ
25944	3191	4	tinea	tinea	JJ
25944	3191	5	imbricata	imbricata	NN
25944	3191	6	?	?	.
25944	3191	7	#	#	$
25944	3191	8	A	a	DT
25944	3191	9	vegetable	vegetable	JJ
25944	3191	10	parasitic	parasitic	JJ
25944	3191	11	disease	disease	NN
25944	3191	12	of	of	IN
25944	3191	13	moist	moist	JJ
25944	3191	14	tropical	tropical	JJ
25944	3191	15	countries	country	NNS
25944	3191	16	,	,	,
25944	3191	17	characterized	characterize	VBN
25944	3191	18	by	by	IN
25944	3191	19	the	the	DT
25944	3191	20	formation	formation	NN
25944	3191	21	of	of	IN
25944	3191	22	patches	patch	NNS
25944	3191	23	composed	compose	VBN
25944	3191	24	of	of	IN
25944	3191	25	concentrically	concentrically	RB
25944	3191	26	arranged	arrange	VBN
25944	3191	27	,	,	,
25944	3191	28	imbricated	imbricated	JJ
25944	3191	29	,	,	,
25944	3191	30	scaly	scaly	VB
25944	3191	31	rings	ring	NNS
25944	3191	32	.	.	.
25944	3192	1	It	-PRON-	PRP
25944	3192	2	may	may	MD
25944	3192	3	begin	begin	VB
25944	3192	4	at	at	IN
25944	3192	5	one	one	CD
25944	3192	6	or	or	CC
25944	3192	7	several	several	JJ
25944	3192	8	points	point	NNS
25944	3192	9	as	as	IN
25944	3192	10	a	a	DT
25944	3192	11	brownish	brownish	NN
25944	3192	12	,	,	,
25944	3192	13	slightly	slightly	RB
25944	3192	14	raised	raise	VBN
25944	3192	15	spot	spot	NN
25944	3192	16	,	,	,
25944	3192	17	spreading	spread	VBG
25944	3192	18	peripherally	peripherally	RB
25944	3192	19	;	;	:
25944	3192	20	the	the	DT
25944	3192	21	renewed	renew	VBN
25944	3192	22	epidermis	epidermis	NN
25944	3192	23	of	of	IN
25944	3192	24	the	the	DT
25944	3192	25	central	central	JJ
25944	3192	26	part	part	NN
25944	3192	27	of	of	IN
25944	3192	28	the	the	DT
25944	3192	29	patch	patch	NN
25944	3192	30	goes	go	VBZ
25944	3192	31	again	again	RB
25944	3192	32	through	through	IN
25944	3192	33	the	the	DT
25944	3192	34	same	same	JJ
25944	3192	35	process	process	NN
25944	3192	36	;	;	:
25944	3192	37	the	the	DT
25944	3192	38	result	result	NN
25944	3192	39	is	be	VBZ
25944	3192	40	a	a	DT
25944	3192	41	small	small	JJ
25944	3192	42	or	or	CC
25944	3192	43	large	large	JJ
25944	3192	44	area	area	NN
25944	3192	45	of	of	IN
25944	3192	46	concentrically	concentrically	RB
25944	3192	47	arranged	arrange	VBN
25944	3192	48	,	,	,
25944	3192	49	imbricated	imbricated	JJ
25944	3192	50	,	,	,
25944	3192	51	slightly	slightly	RB
25944	3192	52	scaly	scaly	VB
25944	3192	53	eruption	eruption	NN
25944	3192	54	.	.	.
25944	3193	1	Several	several	JJ
25944	3193	2	such	such	JJ
25944	3193	3	areas	area	NNS
25944	3193	4	fusing	fuse	VBG
25944	3193	5	together	together	RB
25944	3193	6	may	may	MD
25944	3193	7	cover	cover	VB
25944	3193	8	a	a	DT
25944	3193	9	large	large	JJ
25944	3193	10	part	part	NN
25944	3193	11	of	of	IN
25944	3193	12	the	the	DT
25944	3193	13	surface	surface	NN
25944	3193	14	,	,	,
25944	3193	15	the	the	DT
25944	3193	16	ring	ring	NN
25944	3193	17	-	-	HYPH
25944	3193	18	like	like	JJ
25944	3193	19	arrangement	arrangement	NN
25944	3193	20	being	be	VBG
25944	3193	21	sometimes	sometimes	RB
25944	3193	22	more	more	RBR
25944	3193	23	or	or	CC
25944	3193	24	less	less	RBR
25944	3193	25	completely	completely	RB
25944	3193	26	lost	lose	VBN
25944	3193	27	.	.	.
25944	3194	1	The	the	DT
25944	3194	2	malady	malady	JJ
25944	3194	3	is	be	VBZ
25944	3194	4	chronic	chronic	JJ
25944	3194	5	.	.	.
25944	3195	1	There	there	EX
25944	3195	2	may	may	MD
25944	3195	3	be	be	VB
25944	3195	4	a	a	DT
25944	3195	5	variable	variable	JJ
25944	3195	6	degree	degree	NN
25944	3195	7	of	of	IN
25944	3195	8	itching	itching	NN
25944	3195	9	.	.	.
25944	3196	1	The	the	DT
25944	3196	2	cause	cause	NN
25944	3196	3	of	of	IN
25944	3196	4	the	the	DT
25944	3196	5	disease	disease	NN
25944	3196	6	,	,	,
25944	3196	7	which	which	WDT
25944	3196	8	is	be	VBZ
25944	3196	9	of	of	IN
25944	3196	10	a	a	DT
25944	3196	11	contagious	contagious	JJ
25944	3196	12	nature	nature	NN
25944	3196	13	,	,	,
25944	3196	14	is	be	VBZ
25944	3196	15	a	a	DT
25944	3196	16	vegetable	vegetable	NN
25944	3196	17	parasite	parasite	NN
25944	3196	18	closely	closely	RB
25944	3196	19	similar	similar	JJ
25944	3196	20	to	to	IN
25944	3196	21	the	the	DT
25944	3196	22	trichophyton	trichophyton	NNP
25944	3196	23	.	.	.
25944	3197	1	The	the	DT
25944	3197	2	treatment	treatment	NN
25944	3197	3	is	be	VBZ
25944	3197	4	by	by	IN
25944	3197	5	the	the	DT
25944	3197	6	parasiticides	parasiticide	NNS
25944	3197	7	,	,	,
25944	3197	8	being	be	VBG
25944	3197	9	essentially	essentially	RB
25944	3197	10	the	the	DT
25944	3197	11	same	same	JJ
25944	3197	12	,	,	,
25944	3197	13	in	in	IN
25944	3197	14	fact	fact	NN
25944	3197	15	,	,	,
25944	3197	16	as	as	IN
25944	3197	17	ringworm	ringworm	NN
25944	3197	18	.	.	.
25944	3198	1	#	#	NNP
25944	3198	2	Tinea	Tinea	NNP
25944	3198	3	Versicolor	Versicolor	NNP
25944	3198	4	.	.	.
25944	3198	5	#	#	NNP
25944	3198	6	(	(	-LRB-
25944	3198	7	_	_	NNP
25944	3198	8	Synonyms	Synonyms	NNP
25944	3198	9	:	:	:
25944	3198	10	_	_	NNP
25944	3198	11	Pityriasis	Pityriasis	NNP
25944	3198	12	Versicolor	Versicolor	NNP
25944	3198	13	;	;	:
25944	3198	14	Chromophytosis	Chromophytosis	NNP
25944	3198	15	.	.	.
25944	3198	16	)	)	-RRB-
25944	3199	1	#	#	LS
25944	3199	2	What	what	WP
25944	3199	3	is	be	VBZ
25944	3199	4	tinea	tinea	JJ
25944	3199	5	versicolor	versicolor	NN
25944	3199	6	?	?	.
25944	3199	7	#	#	$
25944	3199	8	Tinea	Tinea	NNP
25944	3199	9	versicolor	versicolor	NN
25944	3199	10	is	be	VBZ
25944	3199	11	a	a	DT
25944	3199	12	vegetable	vegetable	NN
25944	3199	13	-	-	HYPH
25944	3199	14	parasitic	parasitic	JJ
25944	3199	15	disease	disease	NN
25944	3199	16	of	of	IN
25944	3199	17	the	the	DT
25944	3199	18	skin	skin	NN
25944	3199	19	,	,	,
25944	3199	20	characterized	characterize	VBN
25944	3199	21	by	by	IN
25944	3199	22	variously	variously	RB
25944	3199	23	-	-	HYPH
25944	3199	24	sized	sized	JJ
25944	3199	25	and	and	CC
25944	3199	26	shaped	shaped	JJ
25944	3199	27	,	,	,
25944	3199	28	slightly	slightly	RB
25944	3199	29	scaly	scaly	NNP
25944	3199	30	,	,	,
25944	3199	31	macular	macular	JJ
25944	3199	32	patches	patch	NNS
25944	3199	33	of	of	IN
25944	3199	34	a	a	DT
25944	3199	35	yellowish	yellowish	JJ
25944	3199	36	-	-	HYPH
25944	3199	37	fawn	fawn	NN
25944	3199	38	color	color	NN
25944	3199	39	,	,	,
25944	3199	40	and	and	CC
25944	3199	41	occurring	occur	VBG
25944	3199	42	for	for	IN
25944	3199	43	the	the	DT
25944	3199	44	most	most	JJS
25944	3199	45	part	part	NN
25944	3199	46	upon	upon	IN
25944	3199	47	the	the	DT
25944	3199	48	upper	upper	JJ
25944	3199	49	portion	portion	NN
25944	3199	50	of	of	IN
25944	3199	51	the	the	DT
25944	3199	52	trunk	trunk	NN
25944	3199	53	.	.	.
25944	3200	1	#	#	NNP
25944	3200	2	Describe	describe	VB
25944	3200	3	the	the	DT
25944	3200	4	symptoms	symptom	NNS
25944	3200	5	of	of	IN
25944	3200	6	tinea	tinea	NNP
25944	3200	7	versicolor	versicolor	NN
25944	3200	8	.	.	.
25944	3200	9	#	#	$
25944	3200	10	The	the	DT
25944	3200	11	disease	disease	NN
25944	3200	12	begins	begin	VBZ
25944	3200	13	as	as	IN
25944	3200	14	one	one	CD
25944	3200	15	or	or	CC
25944	3200	16	more	more	JJR
25944	3200	17	yellowish	yellowish	JJ
25944	3200	18	macular	macular	JJ
25944	3200	19	points	point	NNS
25944	3200	20	;	;	:
25944	3200	21	these	these	DT
25944	3200	22	,	,	,
25944	3200	23	in	in	IN
25944	3200	24	the	the	DT
25944	3200	25	course	course	NN
25944	3200	26	of	of	IN
25944	3200	27	weeks	week	NNS
25944	3200	28	or	or	CC
25944	3200	29	months	month	NNS
25944	3200	30	,	,	,
25944	3200	31	gradually	gradually	RB
25944	3200	32	extend	extend	VB
25944	3200	33	,	,	,
25944	3200	34	and	and	CC
25944	3200	35	,	,	,
25944	3200	36	together	together	RB
25944	3200	37	with	with	IN
25944	3200	38	other	other	JJ
25944	3200	39	patches	patch	NNS
25944	3200	40	that	that	WDT
25944	3200	41	arise	arise	VBP
25944	3200	42	,	,	,
25944	3200	43	may	may	MD
25944	3200	44	form	form	VB
25944	3200	45	a	a	DT
25944	3200	46	more	more	RBR
25944	3200	47	or	or	CC
25944	3200	48	less	less	RBR
25944	3200	49	continuous	continuous	JJ
25944	3200	50	sheet	sheet	NN
25944	3200	51	of	of	IN
25944	3200	52	eruption	eruption	NN
25944	3200	53	.	.	.
25944	3201	1	There	there	EX
25944	3201	2	is	be	VBZ
25944	3201	3	slight	slight	JJ
25944	3201	4	scaliness	scaliness	NN
25944	3201	5	,	,	,
25944	3201	6	always	always	RB
25944	3201	7	insignificant	insignificant	JJ
25944	3201	8	and	and	CC
25944	3201	9	furfuraceous	furfuraceous	JJ
25944	3201	10	in	in	IN
25944	3201	11	character	character	NN
25944	3201	12	,	,	,
25944	3201	13	and	and	CC
25944	3201	14	at	at	IN
25944	3201	15	times	time	NNS
25944	3201	16	,	,	,
25944	3201	17	except	except	IN
25944	3201	18	upon	upon	IN
25944	3201	19	close	close	JJ
25944	3201	20	inspection	inspection	NN
25944	3201	21	,	,	,
25944	3201	22	scarcely	scarcely	RB
25944	3201	23	perceptible	perceptible	JJ
25944	3201	24	.	.	.
25944	3202	1	The	the	DT
25944	3202	2	color	color	NN
25944	3202	3	of	of	IN
25944	3202	4	the	the	DT
25944	3202	5	patches	patch	NNS
25944	3202	6	is	be	VBZ
25944	3202	7	pale	pale	JJ
25944	3202	8	or	or	CC
25944	3202	9	brownish	brownish	NN
25944	3202	10	-	-	HYPH
25944	3202	11	yellow	yellow	NN
25944	3202	12	;	;	:
25944	3202	13	in	in	IN
25944	3202	14	rare	rare	JJ
25944	3202	15	instances	instance	NNS
25944	3202	16	,	,	,
25944	3202	17	in	in	IN
25944	3202	18	those	those	DT
25944	3202	19	of	of	IN
25944	3202	20	delicate	delicate	JJ
25944	3202	21	skin	skin	NN
25944	3202	22	,	,	,
25944	3202	23	there	there	EX
25944	3202	24	may	may	MD
25944	3202	25	be	be	VB
25944	3202	26	more	more	RBR
25944	3202	27	or	or	CC
25944	3202	28	less	less	JJR
25944	3202	29	hyperæmia	hyperæmia	NN
25944	3202	30	,	,	,
25944	3202	31	and	and	CC
25944	3202	32	in	in	IN
25944	3202	33	consequence	consequence	NN
25944	3202	34	the	the	DT
25944	3202	35	eruption	eruption	NN
25944	3202	36	is	be	VBZ
25944	3202	37	of	of	IN
25944	3202	38	a	a	DT
25944	3202	39	reddish	reddish	JJ
25944	3202	40	tinge	tinge	NN
25944	3202	41	.	.	.
25944	3203	1	The	the	DT
25944	3203	2	number	number	NN
25944	3203	3	of	of	IN
25944	3203	4	patches	patch	NNS
25944	3203	5	varies	vary	VBZ
25944	3203	6	;	;	:
25944	3203	7	there	there	EX
25944	3203	8	may	may	MD
25944	3203	9	be	be	VB
25944	3203	10	but	but	CC
25944	3203	11	a	a	DT
25944	3203	12	few	few	JJ
25944	3203	13	,	,	,
25944	3203	14	or	or	CC
25944	3203	15	,	,	,
25944	3203	16	on	on	IN
25944	3203	17	the	the	DT
25944	3203	18	other	other	JJ
25944	3203	19	hand	hand	NN
25944	3203	20	,	,	,
25944	3203	21	a	a	DT
25944	3203	22	profusion	profusion	NN
25944	3203	23	.	.	.
25944	3204	1	Slight	slight	JJ
25944	3204	2	itching	itching	NN
25944	3204	3	,	,	,
25944	3204	4	especially	especially	RB
25944	3204	5	when	when	WRB
25944	3204	6	the	the	DT
25944	3204	7	parts	part	NNS
25944	3204	8	are	be	VBP
25944	3204	9	warm	warm	JJ
25944	3204	10	,	,	,
25944	3204	11	is	be	VBZ
25944	3204	12	usually	usually	RB
25944	3204	13	present	present	JJ
25944	3204	14	.	.	.
25944	3205	1	#	#	NNP
25944	3205	2	Does	do	VBZ
25944	3205	3	the	the	DT
25944	3205	4	eruption	eruption	NN
25944	3205	5	of	of	IN
25944	3205	6	tinea	tinea	NNP
25944	3205	7	versicolor	versicolor	NNP
25944	3205	8	show	show	NN
25944	3205	9	predilection	predilection	NN
25944	3205	10	for	for	IN
25944	3205	11	any	any	DT
25944	3205	12	special	special	JJ
25944	3205	13	region	region	NN
25944	3205	14	?	?	.
25944	3205	15	#	#	NN
25944	3205	16	Yes	yes	UH
25944	3205	17	;	;	:
25944	3205	18	the	the	DT
25944	3205	19	upper	upper	JJ
25944	3205	20	part	part	NN
25944	3205	21	of	of	IN
25944	3205	22	the	the	DT
25944	3205	23	trunk	trunk	NN
25944	3205	24	,	,	,
25944	3205	25	especially	especially	RB
25944	3205	26	anteriorly	anteriorly	RB
25944	3205	27	,	,	,
25944	3205	28	is	be	VBZ
25944	3205	29	the	the	DT
25944	3205	30	usual	usual	JJ
25944	3205	31	seat	seat	NN
25944	3205	32	of	of	IN
25944	3205	33	the	the	DT
25944	3205	34	eruption	eruption	NN
25944	3205	35	,	,	,
25944	3205	36	but	but	CC
25944	3205	37	in	in	IN
25944	3205	38	exceptional	exceptional	JJ
25944	3205	39	instances	instance	NNS
25944	3205	40	the	the	DT
25944	3205	41	neck	neck	NN
25944	3205	42	,	,	,
25944	3205	43	axillæ	axillæ	RB
25944	3205	44	,	,	,
25944	3205	45	the	the	DT
25944	3205	46	arms	arm	NNS
25944	3205	47	,	,	,
25944	3205	48	the	the	DT
25944	3205	49	whole	whole	JJ
25944	3205	50	trunk	trunk	NN
25944	3205	51	,	,	,
25944	3205	52	the	the	DT
25944	3205	53	genitocrural	genitocrural	JJ
25944	3205	54	region	region	NN
25944	3205	55	and	and	CC
25944	3205	56	poplitea	poplitea	NN
25944	3205	57	,	,	,
25944	3205	58	and	and	CC
25944	3205	59	in	in	IN
25944	3205	60	rare	rare	JJ
25944	3205	61	cases	case	NNS
25944	3205	62	even	even	RB
25944	3205	63	the	the	DT
25944	3205	64	lower	low	JJR
25944	3205	65	part	part	NN
25944	3205	66	of	of	IN
25944	3205	67	the	the	DT
25944	3205	68	face	face	NN
25944	3205	69	,	,	,
25944	3205	70	may	may	MD
25944	3205	71	become	become	VB
25944	3205	72	invaded	invaded	JJ
25944	3205	73	.	.	.
25944	3206	1	#	#	LS
25944	3206	2	What	what	WDT
25944	3206	3	course	course	NN
25944	3206	4	does	do	VBZ
25944	3206	5	tinea	tinea	VB
25944	3206	6	versicolor	versicolor	NN
25944	3206	7	pursue	pursue	NN
25944	3206	8	?	?	.
25944	3206	9	#	#	NNP
25944	3206	10	Persistent	Persistent	NNP
25944	3206	11	,	,	,
25944	3206	12	but	but	CC
25944	3206	13	somewhat	somewhat	RB
25944	3206	14	variable	variable	JJ
25944	3206	15	;	;	:
25944	3206	16	as	as	IN
25944	3206	17	a	a	DT
25944	3206	18	rule	rule	NN
25944	3206	19	,	,	,
25944	3206	20	however	however	RB
25944	3206	21	,	,	,
25944	3206	22	slowly	slowly	RB
25944	3206	23	progressive	progressive	JJ
25944	3206	24	and	and	CC
25944	3206	25	lasting	last	VBG
25944	3206	26	for	for	IN
25944	3206	27	years	year	NNS
25944	3206	28	.	.	.
25944	3207	1	#	#	JJR
25944	3207	2	To	to	TO
25944	3207	3	what	what	WP
25944	3207	4	is	be	VBZ
25944	3207	5	tinea	tinea	JJ
25944	3207	6	versicolor	versicolor	NN
25944	3207	7	due	due	JJ
25944	3207	8	?	?	.
25944	3207	9	#	#	NN
25944	3207	10	To	to	IN
25944	3207	11	a	a	DT
25944	3207	12	vegetable	vegetable	JJ
25944	3207	13	fungus	fungus	NN
25944	3207	14	--	--	:
25944	3207	15	the	the	DT
25944	3207	16	_	_	NNP
25944	3207	17	microsporon	microsporon	NNP
25944	3207	18	furfur	furfur	NNP
25944	3207	19	_	_	NNP
25944	3207	20	.	.	.
25944	3208	1	The	the	DT
25944	3208	2	affection	affection	NN
25944	3208	3	is	be	VBZ
25944	3208	4	tolerably	tolerably	RB
25944	3208	5	common	common	JJ
25944	3208	6	,	,	,
25944	3208	7	and	and	CC
25944	3208	8	occurs	occur	VBZ
25944	3208	9	in	in	IN
25944	3208	10	all	all	DT
25944	3208	11	parts	part	NNS
25944	3208	12	of	of	IN
25944	3208	13	the	the	DT
25944	3208	14	world	world	NN
25944	3208	15	.	.	.
25944	3209	1	With	with	IN
25944	3209	2	rare	rare	JJ
25944	3209	3	exceptions	exception	NNS
25944	3209	4	,	,	,
25944	3209	5	it	-PRON-	PRP
25944	3209	6	is	be	VBZ
25944	3209	7	a	a	DT
25944	3209	8	disease	disease	NN
25944	3209	9	of	of	IN
25944	3209	10	adults	adult	NNS
25944	3209	11	,	,	,
25944	3209	12	and	and	CC
25944	3209	13	while	while	IN
25944	3209	14	looked	look	VBN
25944	3209	15	upon	upon	IN
25944	3209	16	as	as	IN
25944	3209	17	contagious	contagious	JJ
25944	3209	18	,	,	,
25944	3209	19	must	must	MD
25944	3209	20	be	be	VB
25944	3209	21	so	so	RB
25944	3209	22	to	to	IN
25944	3209	23	an	an	DT
25944	3209	24	extremely	extremely	RB
25944	3209	25	slight	slight	JJ
25944	3209	26	degree	degree	NN
25944	3209	27	.	.	.
25944	3210	1	[	[	-LRB-
25944	3210	2	Illustration	illustration	NN
25944	3210	3	:	:	:
25944	3210	4	Fig	Fig	NNP
25944	3210	5	.	.	.
25944	3211	1	73	73	CD
25944	3211	2	.	.	.
25944	3212	1	Microsporon	Microsporon	NNP
25944	3212	2	Furfur	Furfur	NNP
25944	3212	3	x	x	SYM
25944	3212	4	400	400	CD
25944	3212	5	.	.	.
25944	3213	1	(	(	-LRB-
25944	3213	2	_	_	NNP
25944	3213	3	After	after	IN
25944	3213	4	Duhring	Duhring	NNP
25944	3213	5	.	.	.
25944	3213	6	_	_	NNP
25944	3213	7	)	)	-RRB-
25944	3213	8	Showing	show	VBG
25944	3213	9	mycelium	mycelium	NN
25944	3213	10	in	in	IN
25944	3213	11	various	various	JJ
25944	3213	12	stages	stage	NNS
25944	3213	13	of	of	IN
25944	3213	14	development	development	NN
25944	3213	15	,	,	,
25944	3213	16	groups	group	NNS
25944	3213	17	of	of	IN
25944	3213	18	spores	spore	NNS
25944	3213	19	and	and	CC
25944	3213	20	free	free	JJ
25944	3213	21	spores	spore	NNS
25944	3213	22	.	.	.
25944	3213	23	]	]	-RRB-
25944	3214	1	#	#	LS
25944	3214	2	What	what	WP
25944	3214	3	is	be	VBZ
25944	3214	4	the	the	DT
25944	3214	5	pathology	pathology	NN
25944	3214	6	?	?	.
25944	3214	7	#	#	$
25944	3214	8	The	the	DT
25944	3214	9	fungus	fungus	NN
25944	3214	10	,	,	,
25944	3214	11	consisting	consist	VBG
25944	3214	12	of	of	IN
25944	3214	13	mycelium	mycelium	NN
25944	3214	14	and	and	CC
25944	3214	15	spores	spore	NNS
25944	3214	16	,	,	,
25944	3214	17	the	the	DT
25944	3214	18	latter	latter	JJ
25944	3214	19	showing	show	VBG
25944	3214	20	a	a	DT
25944	3214	21	marked	marked	JJ
25944	3214	22	tendency	tendency	NN
25944	3214	23	to	to	TO
25944	3214	24	aggregate	aggregate	VB
25944	3214	25	,	,	,
25944	3214	26	invades	invade	VBZ
25944	3214	27	the	the	DT
25944	3214	28	superficial	superficial	JJ
25944	3214	29	portion	portion	NN
25944	3214	30	of	of	IN
25944	3214	31	the	the	DT
25944	3214	32	epidermis	epidermis	NN
25944	3214	33	.	.	.
25944	3215	1	#	#	$
25944	3215	2	Is	be	VBZ
25944	3215	3	tinea	tinea	JJ
25944	3215	4	versicolor	versicolor	NN
25944	3215	5	readily	readily	RB
25944	3215	6	diagnosticated	diagnosticate	VBD
25944	3215	7	?	?	.
25944	3215	8	#	#	JJ
25944	3215	9	Yes	yes	UH
25944	3215	10	;	;	:
25944	3215	11	if	if	IN
25944	3215	12	the	the	DT
25944	3215	13	color	color	NN
25944	3215	14	,	,	,
25944	3215	15	peculiar	peculiar	JJ
25944	3215	16	characters	character	NNS
25944	3215	17	and	and	CC
25944	3215	18	distribution	distribution	NN
25944	3215	19	of	of	IN
25944	3215	20	the	the	DT
25944	3215	21	eruption	eruption	NN
25944	3215	22	are	be	VBP
25944	3215	23	kept	keep	VBN
25944	3215	24	in	in	IN
25944	3215	25	mind	mind	NN
25944	3215	26	.	.	.
25944	3216	1	It	-PRON-	PRP
25944	3216	2	is	be	VBZ
25944	3216	3	not	not	RB
25944	3216	4	to	to	TO
25944	3216	5	be	be	VB
25944	3216	6	confounded	confound	VBN
25944	3216	7	with	with	IN
25944	3216	8	vitiligo	vitiligo	NNS
25944	3216	9	,	,	,
25944	3216	10	chloasma	chloasma	NN
25944	3216	11	,	,	,
25944	3216	12	or	or	CC
25944	3216	13	the	the	DT
25944	3216	14	macular	macular	JJ
25944	3216	15	syphiloderm	syphiloderm	NN
25944	3216	16	.	.	.
25944	3217	1	If	if	IN
25944	3217	2	in	in	IN
25944	3217	3	doubt	doubt	NN
25944	3217	4	,	,	,
25944	3217	5	have	have	VBP
25944	3217	6	recourse	recourse	VBN
25944	3217	7	to	to	IN
25944	3217	8	the	the	DT
25944	3217	9	microscope	microscope	NN
25944	3217	10	.	.	.
25944	3218	1	#	#	JJR
25944	3218	2	State	state	NN
25944	3218	3	the	the	DT
25944	3218	4	method	method	NN
25944	3218	5	of	of	IN
25944	3218	6	examination	examination	NN
25944	3218	7	for	for	IN
25944	3218	8	fungus	fungus	NN
25944	3218	9	.	.	.
25944	3218	10	#	#	$
25944	3218	11	The	the	DT
25944	3218	12	scrapings	scraping	NNS
25944	3218	13	are	be	VBP
25944	3218	14	taken	take	VBN
25944	3218	15	from	from	IN
25944	3218	16	a	a	DT
25944	3218	17	patch	patch	NN
25944	3218	18	,	,	,
25944	3218	19	moistened	moisten	VBN
25944	3218	20	with	with	IN
25944	3218	21	liquor	liquor	NN
25944	3218	22	potassæ	potassæ	NNS
25944	3218	23	,	,	,
25944	3218	24	and	and	CC
25944	3218	25	examined	examine	VBN
25944	3218	26	with	with	IN
25944	3218	27	a	a	DT
25944	3218	28	power	power	NN
25944	3218	29	of	of	IN
25944	3218	30	three	three	CD
25944	3218	31	to	to	TO
25944	3218	32	five	five	CD
25944	3218	33	hundred	hundred	CD
25944	3218	34	diameters	diameter	NNS
25944	3218	35	.	.	.
25944	3219	1	#	#	JJR
25944	3219	2	State	state	NN
25944	3219	3	the	the	DT
25944	3219	4	prognosis	prognosis	NN
25944	3219	5	of	of	IN
25944	3219	6	tinea	tinea	NNP
25944	3219	7	versicolor	versicolor	NN
25944	3219	8	.	.	.
25944	3219	9	#	#	$
25944	3219	10	With	with	IN
25944	3219	11	proper	proper	JJ
25944	3219	12	management	management	NN
25944	3219	13	the	the	DT
25944	3219	14	disease	disease	NN
25944	3219	15	is	be	VBZ
25944	3219	16	readily	readily	RB
25944	3219	17	curable	curable	JJ
25944	3219	18	.	.	.
25944	3220	1	Relapses	relapse	NNS
25944	3220	2	are	be	VBP
25944	3220	3	not	not	RB
25944	3220	4	uncommon	uncommon	JJ
25944	3220	5	.	.	.
25944	3221	1	[	[	-LRB-
25944	3221	2	Illustration	illustration	NN
25944	3221	3	:	:	:
25944	3221	4	Fig	Fig	NNP
25944	3221	5	.	.	.
25944	3222	1	74	74	CD
25944	3222	2	.	.	.
25944	3223	1	Tinea	Tinea	NNP
25944	3223	2	versicolor	versicolor	NN
25944	3223	3	.	.	.
25944	3223	4	]	]	-RRB-
25944	3224	1	#	#	LS
25944	3224	2	What	what	WP
25944	3224	3	is	be	VBZ
25944	3224	4	the	the	DT
25944	3224	5	treatment	treatment	NN
25944	3224	6	of	of	IN
25944	3224	7	tinea	tinea	NNP
25944	3224	8	versicolor	versicolor	NN
25944	3224	9	?	?	.
25944	3224	10	#	#	NNP
25944	3224	11	It	-PRON-	PRP
25944	3224	12	consists	consist	VBZ
25944	3224	13	in	in	IN
25944	3224	14	daily	daily	JJ
25944	3224	15	washing	washing	NN
25944	3224	16	with	with	IN
25944	3224	17	soap	soap	NN
25944	3224	18	and	and	CC
25944	3224	19	hot	hot	JJ
25944	3224	20	water	water	NN
25944	3224	21	(	(	-LRB-
25944	3224	22	and	and	CC
25944	3224	23	in	in	IN
25944	3224	24	obstinate	obstinate	NN
25944	3224	25	cases	case	NNS
25944	3224	26	with	with	IN
25944	3224	27	sapo	sapo	JJ
25944	3224	28	viridis	viridi	NNS
25944	3224	29	instead	instead	RB
25944	3224	30	of	of	IN
25944	3224	31	the	the	DT
25944	3224	32	ordinary	ordinary	JJ
25944	3224	33	soap	soap	NN
25944	3224	34	)	)	-RRB-
25944	3224	35	and	and	CC
25944	3224	36	application	application	NN
25944	3224	37	of	of	IN
25944	3224	38	a	a	DT
25944	3224	39	lotion	lotion	NN
25944	3224	40	of	of	IN
25944	3224	41	--	--	:
25944	3224	42	sulphite	sulphite	NN
25944	3224	43	or	or	CC
25944	3224	44	hyposulphite	hyposulphite	NN
25944	3224	45	of	of	IN
25944	3224	46	sodium	sodium	NN
25944	3224	47	,	,	,
25944	3224	48	a	a	DT
25944	3224	49	drachm	drachm	NN
25944	3224	50	to	to	IN
25944	3224	51	the	the	DT
25944	3224	52	ounce	ounce	NN
25944	3224	53	;	;	:
25944	3224	54	sulphurous	sulphurous	JJ
25944	3224	55	acid	acid	NN
25944	3224	56	,	,	,
25944	3224	57	pure	pure	JJ
25944	3224	58	or	or	CC
25944	3224	59	diluted	diluted	JJ
25944	3224	60	;	;	:
25944	3224	61	carbolic	carbolic	JJ
25944	3224	62	acid	acid	NN
25944	3224	63	,	,	,
25944	3224	64	or	or	CC
25944	3224	65	resorcin	resorcin	NNS
25944	3224	66	,	,	,
25944	3224	67	ten	ten	CD
25944	3224	68	to	to	TO
25944	3224	69	twenty	twenty	CD
25944	3224	70	grains	grain	NNS
25944	3224	71	to	to	IN
25944	3224	72	the	the	DT
25944	3224	73	ounce	ounce	NN
25944	3224	74	of	of	IN
25944	3224	75	water	water	NN
25944	3224	76	and	and	CC
25944	3224	77	alcohol	alcohol	NN
25944	3224	78	;	;	:
25944	3224	79	or	or	CC
25944	3224	80	corrosive	corrosive	JJ
25944	3224	81	sublimate	sublimate	NN
25944	3224	82	,	,	,
25944	3224	83	one	one	CD
25944	3224	84	to	to	TO
25944	3224	85	three	three	CD
25944	3224	86	grains	grain	NNS
25944	3224	87	to	to	IN
25944	3224	88	the	the	DT
25944	3224	89	ounce	ounce	NN
25944	3224	90	of	of	IN
25944	3224	91	water	water	NN
25944	3224	92	.	.	.
25944	3225	1	Sulphur	Sulphur	NNP
25944	3225	2	and	and	CC
25944	3225	3	ammoniated	ammoniate	VBN
25944	3225	4	-	-	HYPH
25944	3225	5	mercury	mercury	NN
25944	3225	6	ointments	ointment	NNS
25944	3225	7	are	be	VBP
25944	3225	8	also	also	RB
25944	3225	9	serviceable	serviceable	JJ
25944	3225	10	.	.	.
25944	3226	1	The	the	DT
25944	3226	2	following	follow	VBG
25944	3226	3	used	use	VBN
25944	3226	4	alone	alone	RB
25944	3226	5	,	,	,
25944	3226	6	simply	simply	RB
25944	3226	7	as	as	IN
25944	3226	8	a	a	DT
25944	3226	9	soap	soap	NN
25944	3226	10	,	,	,
25944	3226	11	or	or	CC
25944	3226	12	in	in	IN
25944	3226	13	conjunction	conjunction	NN
25944	3226	14	with	with	IN
25944	3226	15	a	a	DT
25944	3226	16	lotion	lotion	NN
25944	3226	17	,	,	,
25944	3226	18	is	be	VBZ
25944	3226	19	often	often	RB
25944	3226	20	of	of	IN
25944	3226	21	special	special	JJ
25944	3226	22	value:--	value:--	''
25944	3226	23	[	[	-LRB-
25944	3226	24	Rx	Rx	NNP
25944	3226	25	]	]	-RRB-
25944	3226	26	Sulphur	Sulphur	NNP
25944	3226	27	,	,	,
25944	3226	28	præcip	præcip	NN
25944	3226	29	.	.	.
25944	3226	30	,	,	,
25944	3226	31	....................	....................	NFP
25944	3226	32	[	[	-LRB-
25944	3226	33	dram]iv	dram]iv	NNP
25944	3226	34	Saponis	Saponis	NNP
25944	3226	35	viridis	viridis	NN
25944	3226	36	,	,	,
25944	3226	37	.....................	.....................	NFP
25944	3226	38	[	[	-LRB-
25944	3226	39	dram]xii	dram]xii	NN
25944	3226	40	.	.	.
25944	3227	1	M.	M.	NNP
25944	3227	2	After	after	IN
25944	3227	3	the	the	DT
25944	3227	4	disease	disease	NN
25944	3227	5	is	be	VBZ
25944	3227	6	apparently	apparently	RB
25944	3227	7	cured	cure	VBN
25944	3227	8	,	,	,
25944	3227	9	an	an	DT
25944	3227	10	occasional	occasional	JJ
25944	3227	11	remedial	remedial	JJ
25944	3227	12	application	application	NN
25944	3227	13	should	should	MD
25944	3227	14	be	be	VB
25944	3227	15	made	make	VBN
25944	3227	16	for	for	IN
25944	3227	17	several	several	JJ
25944	3227	18	months	month	NNS
25944	3227	19	,	,	,
25944	3227	20	in	in	IN
25944	3227	21	order	order	NN
25944	3227	22	to	to	TO
25944	3227	23	guard	guard	VB
25944	3227	24	against	against	IN
25944	3227	25	the	the	DT
25944	3227	26	possibility	possibility	NN
25944	3227	27	of	of	IN
25944	3227	28	a	a	DT
25944	3227	29	relapse	relapse	NN
25944	3227	30	.	.	.
25944	3228	1	#	#	NNP
25944	3228	2	Erythrasma	Erythrasma	NNP
25944	3228	3	.	.	.
25944	3228	4	#	#	$
25944	3228	5	#	#	$
25944	3228	6	Describe	Describe	NNP
25944	3228	7	erythrasma	erythrasma	NN
25944	3228	8	.	.	.
25944	3228	9	#	#	$
25944	3228	10	Erythrasma	Erythrasma	NNP
25944	3228	11	is	be	VBZ
25944	3228	12	an	an	DT
25944	3228	13	extremely	extremely	RB
25944	3228	14	rare	rare	JJ
25944	3228	15	disease	disease	NN
25944	3228	16	,	,	,
25944	3228	17	due	due	IN
25944	3228	18	to	to	IN
25944	3228	19	the	the	DT
25944	3228	20	presence	presence	NN
25944	3228	21	and	and	CC
25944	3228	22	growth	growth	NN
25944	3228	23	in	in	IN
25944	3228	24	the	the	DT
25944	3228	25	epidermic	epidermic	JJ
25944	3228	26	structures	structure	NNS
25944	3228	27	of	of	IN
25944	3228	28	the	the	DT
25944	3228	29	vegetable	vegetable	NN
25944	3228	30	parasite	parasite	NN
25944	3228	31	--	--	:
25944	3228	32	the	the	DT
25944	3228	33	_	_	NNP
25944	3228	34	microsporon	microsporon	NNP
25944	3228	35	minutissimum	minutissimum	NNP
25944	3228	36	_	_	NNP
25944	3228	37	.	.	.
25944	3229	1	It	-PRON-	PRP
25944	3229	2	is	be	VBZ
25944	3229	3	characterized	characterize	VBN
25944	3229	4	by	by	IN
25944	3229	5	small	small	JJ
25944	3229	6	and	and	CC
25944	3229	7	large	large	JJ
25944	3229	8	,	,	,
25944	3229	9	slightly	slightly	RB
25944	3229	10	furfuraceous	furfuraceous	JJ
25944	3229	11	,	,	,
25944	3229	12	reddish	reddish	JJ
25944	3229	13	-	-	HYPH
25944	3229	14	yellow	yellow	NN
25944	3229	15	or	or	CC
25944	3229	16	reddish	reddish	JJ
25944	3229	17	-	-	HYPH
25944	3229	18	brown	brown	JJ
25944	3229	19	patches	patch	NNS
25944	3229	20	,	,	,
25944	3229	21	occurring	occur	VBG
25944	3229	22	usually	usually	RB
25944	3229	23	on	on	IN
25944	3229	24	warm	warm	JJ
25944	3229	25	and	and	CC
25944	3229	26	moist	moist	JJ
25944	3229	27	parts	part	NNS
25944	3229	28	,	,	,
25944	3229	29	such	such	JJ
25944	3229	30	as	as	IN
25944	3229	31	the	the	DT
25944	3229	32	axillary	axillary	JJ
25944	3229	33	,	,	,
25944	3229	34	inguinal	inguinal	JJ
25944	3229	35	,	,	,
25944	3229	36	anal	anal	JJ
25944	3229	37	and	and	CC
25944	3229	38	genitocrural	genitocrural	JJ
25944	3229	39	regions	region	NNS
25944	3229	40	.	.	.
25944	3230	1	It	-PRON-	PRP
25944	3230	2	is	be	VBZ
25944	3230	3	slowly	slowly	RB
25944	3230	4	progressive	progressive	JJ
25944	3230	5	and	and	CC
25944	3230	6	persistent	persistent	JJ
25944	3230	7	,	,	,
25944	3230	8	but	but	CC
25944	3230	9	is	be	VBZ
25944	3230	10	without	without	IN
25944	3230	11	disturbing	disturb	VBG
25944	3230	12	symptoms	symptom	NNS
25944	3230	13	other	other	JJ
25944	3230	14	than	than	IN
25944	3230	15	occasional	occasional	JJ
25944	3230	16	slight	slight	JJ
25944	3230	17	itching	itching	NN
25944	3230	18	.	.	.
25944	3231	1	[	[	-LRB-
25944	3231	2	Illustration	illustration	NN
25944	3231	3	:	:	:
25944	3231	4	Fig	Fig	NNP
25944	3231	5	.	.	.
25944	3232	1	75	75	CD
25944	3232	2	.	.	.
25944	3233	1	Microsporon	Microsporon	NNP
25944	3233	2	Minutissimum	Minutissimum	NNP
25944	3233	3	x	x	NNP
25944	3233	4	1000	1000	CD
25944	3233	5	.	.	.
25944	3234	1	(	(	-LRB-
25944	3234	2	_	_	NNP
25944	3234	3	After	after	IN
25944	3234	4	Riehl	Riehl	NNP
25944	3234	5	.	.	.
25944	3234	6	_	_	NNP
25944	3234	7	)	)	-RRB-
25944	3234	8	]	]	-RRB-
25944	3234	9	Treatment	Treatment	NNP
25944	3234	10	,	,	,
25944	3234	11	which	which	WDT
25944	3234	12	is	be	VBZ
25944	3234	13	rapidly	rapidly	RB
25944	3234	14	effective	effective	JJ
25944	3234	15	,	,	,
25944	3234	16	is	be	VBZ
25944	3234	17	the	the	DT
25944	3234	18	same	same	JJ
25944	3234	19	as	as	IN
25944	3234	20	that	that	DT
25944	3234	21	employed	employ	VBD
25944	3234	22	in	in	IN
25944	3234	23	tinea	tinea	NNP
25944	3234	24	versicolor	versicolor	NN
25944	3234	25	.	.	.
25944	3235	1	#	#	NNP
25944	3235	2	Dhobie	Dhobie	NNP
25944	3235	3	Itch	Itch	NNP
25944	3235	4	.	.	.
25944	3235	5	#	#	$
25944	3235	6	Dhobie	Dhobie	NNP
25944	3235	7	itch	itch	NN
25944	3235	8	is	be	VBZ
25944	3235	9	a	a	DT
25944	3235	10	name	name	NN
25944	3235	11	used	use	VBN
25944	3235	12	in	in	IN
25944	3235	13	certain	certain	JJ
25944	3235	14	tropical	tropical	JJ
25944	3235	15	countries	country	NNS
25944	3235	16	to	to	TO
25944	3235	17	designate	designate	VB
25944	3235	18	a	a	DT
25944	3235	19	somewhat	somewhat	RB
25944	3235	20	peculiar	peculiar	JJ
25944	3235	21	itching	itching	NN
25944	3235	22	eruption	eruption	NN
25944	3235	23	of	of	IN
25944	3235	24	the	the	DT
25944	3235	25	genitocrural	genitocrural	JJ
25944	3235	26	and	and	CC
25944	3235	27	axillary	axillary	JJ
25944	3235	28	regions	region	NNS
25944	3235	29	,	,	,
25944	3235	30	and	and	CC
25944	3235	31	by	by	IN
25944	3235	32	some	some	DT
25944	3235	33	also	also	RB
25944	3235	34	a	a	DT
25944	3235	35	similar	similar	JJ
25944	3235	36	eruption	eruption	NN
25944	3235	37	about	about	IN
25944	3235	38	the	the	DT
25944	3235	39	feet	foot	NNS
25944	3235	40	.	.	.
25944	3236	1	It	-PRON-	PRP
25944	3236	2	consists	consist	VBZ
25944	3236	3	of	of	IN
25944	3236	4	a	a	DT
25944	3236	5	dermatitis	dermatitis	NN
25944	3236	6	of	of	IN
25944	3236	7	variable	variable	JJ
25944	3236	8	degree	degree	NN
25944	3236	9	,	,	,
25944	3236	10	usually	usually	RB
25944	3236	11	with	with	IN
25944	3236	12	a	a	DT
25944	3236	13	festooned	festooned	JJ
25944	3236	14	,	,	,
25944	3236	15	irregular	irregular	JJ
25944	3236	16	border	border	NN
25944	3236	17	,	,	,
25944	3236	18	with	with	IN
25944	3236	19	considerable	considerable	JJ
25944	3236	20	itching	itching	NN
25944	3236	21	.	.	.
25944	3237	1	It	-PRON-	PRP
25944	3237	2	is	be	VBZ
25944	3237	3	believed	believe	VBN
25944	3237	4	that	that	IN
25944	3237	5	such	such	JJ
25944	3237	6	cases	case	NNS
25944	3237	7	are	be	VBP
25944	3237	8	variously	variously	RB
25944	3237	9	due	due	JJ
25944	3237	10	to	to	IN
25944	3237	11	the	the	DT
25944	3237	12	trichophyton	trichophyton	NN
25944	3237	13	of	of	IN
25944	3237	14	ringworm	ringworm	NN
25944	3237	15	,	,	,
25944	3237	16	to	to	IN
25944	3237	17	the	the	DT
25944	3237	18	microsporon	microsporon	NNP
25944	3237	19	furfur	furfur	NN
25944	3237	20	of	of	IN
25944	3237	21	tinea	tinea	NNP
25944	3237	22	versicolor	versicolor	NN
25944	3237	23	,	,	,
25944	3237	24	to	to	IN
25944	3237	25	the	the	DT
25944	3237	26	microsporon	microsporon	NNP
25944	3237	27	minutissimus	minutissimus	NNP
25944	3237	28	of	of	IN
25944	3237	29	erythrasma	erythrasma	NNP
25944	3237	30	,	,	,
25944	3237	31	and	and	CC
25944	3237	32	to	to	IN
25944	3237	33	other	other	JJ
25944	3237	34	parasites	parasite	NNS
25944	3237	35	.	.	.
25944	3238	1	#	#	NNP
25944	3238	2	Actinomycosis	Actinomycosis	NNP
25944	3238	3	.	.	.
25944	3238	4	#	#	$
25944	3238	5	#	#	$
25944	3238	6	Describe	Describe	NNP
25944	3238	7	actinomycosis	actinomycosis	NN
25944	3238	8	.	.	.
25944	3238	9	#	#	$
25944	3238	10	Actinomycosis	actinomycosis	NN
25944	3238	11	of	of	IN
25944	3238	12	the	the	DT
25944	3238	13	skin	skin	NN
25944	3238	14	is	be	VBZ
25944	3238	15	an	an	DT
25944	3238	16	affection	affection	NN
25944	3238	17	due	due	JJ
25944	3238	18	to	to	IN
25944	3238	19	the	the	DT
25944	3238	20	ray	ray	NN
25944	3238	21	fungus	fungus	NN
25944	3238	22	,	,	,
25944	3238	23	and	and	CC
25944	3238	24	characterized	characterize	VBN
25944	3238	25	by	by	IN
25944	3238	26	a	a	DT
25944	3238	27	sluggish	sluggish	JJ
25944	3238	28	,	,	,
25944	3238	29	red	red	JJ
25944	3238	30	,	,	,
25944	3238	31	nodular	nodular	JJ
25944	3238	32	,	,	,
25944	3238	33	or	or	CC
25944	3238	34	lumpy	lumpy	VBZ
25944	3238	35	infiltration	infiltration	NN
25944	3238	36	,	,	,
25944	3238	37	usually	usually	RB
25944	3238	38	with	with	IN
25944	3238	39	a	a	DT
25944	3238	40	tendency	tendency	NN
25944	3238	41	to	to	TO
25944	3238	42	break	break	VB
25944	3238	43	down	down	RP
25944	3238	44	and	and	CC
25944	3238	45	form	form	VB
25944	3238	46	sinuses	sinus	NNS
25944	3238	47	.	.	.
25944	3239	1	The	the	DT
25944	3239	2	affection	affection	NN
25944	3239	3	may	may	MD
25944	3239	4	involve	involve	VB
25944	3239	5	almost	almost	RB
25944	3239	6	any	any	DT
25944	3239	7	part	part	NN
25944	3239	8	,	,	,
25944	3239	9	but	but	CC
25944	3239	10	its	-PRON-	PRP$
25944	3239	11	most	most	RBS
25944	3239	12	common	common	JJ
25944	3239	13	site	site	NN
25944	3239	14	is	be	VBZ
25944	3239	15	about	about	IN
25944	3239	16	the	the	DT
25944	3239	17	jaw	jaw	NN
25944	3239	18	,	,	,
25944	3239	19	neck	neck	NN
25944	3239	20	,	,	,
25944	3239	21	and	and	CC
25944	3239	22	face	face	NN
25944	3239	23	.	.	.
25944	3240	1	As	as	IN
25944	3240	2	a	a	DT
25944	3240	3	rule	rule	NN
25944	3240	4	,	,	,
25944	3240	5	the	the	DT
25944	3240	6	first	first	JJ
25944	3240	7	evidence	evidence	NN
25944	3240	8	is	be	VBZ
25944	3240	9	a	a	DT
25944	3240	10	hard	hard	JJ
25944	3240	11	subcutaneous	subcutaneous	JJ
25944	3240	12	swelling	swelling	NN
25944	3240	13	or	or	CC
25944	3240	14	infiltration	infiltration	NN
25944	3240	15	,	,	,
25944	3240	16	which	which	WDT
25944	3240	17	may	may	MD
25944	3240	18	increase	increase	VB
25944	3240	19	slightly	slightly	RB
25944	3240	20	or	or	CC
25944	3240	21	considerably	considerably	RB
25944	3240	22	.	.	.
25944	3241	1	The	the	DT
25944	3241	2	overlying	overlying	NN
25944	3241	3	skin	skin	NN
25944	3241	4	gradually	gradually	RB
25944	3241	5	becomes	become	VBZ
25944	3241	6	of	of	IN
25944	3241	7	a	a	DT
25944	3241	8	sluggish	sluggish	JJ
25944	3241	9	or	or	CC
25944	3241	10	dark	dark	JJ
25944	3241	11	-	-	HYPH
25944	3241	12	red	red	JJ
25944	3241	13	color	color	NN
25944	3241	14	.	.	.
25944	3242	1	Softening	soften	VBG
25944	3242	2	ensues	ensue	NNS
25944	3242	3	,	,	,
25944	3242	4	and	and	CC
25944	3242	5	the	the	DT
25944	3242	6	diseased	diseased	JJ
25944	3242	7	area	area	NN
25944	3242	8	breaks	break	VBZ
25944	3242	9	down	down	RP
25944	3242	10	at	at	IN
25944	3242	11	one	one	CD
25944	3242	12	or	or	CC
25944	3242	13	more	more	JJR
25944	3242	14	points	point	NNS
25944	3242	15	,	,	,
25944	3242	16	from	from	IN
25944	3242	17	which	which	WDT
25944	3242	18	there	there	EX
25944	3242	19	oozes	ooze	VBZ
25944	3242	20	a	a	DT
25944	3242	21	discharge	discharge	NN
25944	3242	22	of	of	IN
25944	3242	23	a	a	DT
25944	3242	24	sero	sero	NN
25944	3242	25	-	-	:
25944	3242	26	purulent	purulent	NN
25944	3242	27	,	,	,
25944	3242	28	purulent	purulent	VBP
25944	3242	29	,	,	,
25944	3242	30	or	or	CC
25944	3242	31	sanguinolent	sanguinolent	NN
25944	3242	32	character	character	NN
25944	3242	33	.	.	.
25944	3243	1	In	in	IN
25944	3243	2	this	this	DT
25944	3243	3	discharge	discharge	NN
25944	3243	4	can	can	MD
25944	3243	5	be	be	VB
25944	3243	6	usually	usually	RB
25944	3243	7	noted	note	VBN
25944	3243	8	minute	minute	NN
25944	3243	9	,	,	,
25944	3243	10	friable	friable	JJ
25944	3243	11	,	,	,
25944	3243	12	yellowish	yellowish	JJ
25944	3243	13	or	or	CC
25944	3243	14	yellowish	yellowish	JJ
25944	3243	15	-	-	HYPH
25944	3243	16	gray	gray	JJ
25944	3243	17	bodies	body	NNS
25944	3243	18	representing	represent	VBG
25944	3243	19	conglomerate	conglomerate	NN
25944	3243	20	collections	collection	NNS
25944	3243	21	of	of	IN
25944	3243	22	the	the	DT
25944	3243	23	causative	causative	JJ
25944	3243	24	fungus	fungus	NN
25944	3243	25	.	.	.
25944	3244	1	The	the	DT
25944	3244	2	course	course	NN
25944	3244	3	of	of	IN
25944	3244	4	the	the	DT
25944	3244	5	malady	malady	NN
25944	3244	6	is	be	VBZ
25944	3244	7	commonly	commonly	RB
25944	3244	8	slow	slow	JJ
25944	3244	9	and	and	CC
25944	3244	10	insidious	insidious	JJ
25944	3244	11	.	.	.
25944	3245	1	Unless	unless	IN
25944	3245	2	systemic	systemic	JJ
25944	3245	3	pyemic	pyemic	JJ
25944	3245	4	infection	infection	NN
25944	3245	5	occurs	occur	VBZ
25944	3245	6	or	or	CC
25944	3245	7	the	the	DT
25944	3245	8	fungus	fungus	NN
25944	3245	9	elements	element	NNS
25944	3245	10	find	find	VBP
25944	3245	11	their	-PRON-	PRP$
25944	3245	12	way	way	NN
25944	3245	13	to	to	IN
25944	3245	14	the	the	DT
25944	3245	15	deeper	deep	JJR
25944	3245	16	organs	organ	NNS
25944	3245	17	or	or	CC
25944	3245	18	structures	structure	VBZ
25944	3245	19	the	the	DT
25944	3245	20	general	general	JJ
25944	3245	21	health	health	NN
25944	3245	22	remains	remain	VBZ
25944	3245	23	apparently	apparently	RB
25944	3245	24	undisturbed	undisturbed	JJ
25944	3245	25	.	.	.
25944	3246	1	#	#	LS
25944	3246	2	What	what	WP
25944	3246	3	is	be	VBZ
25944	3246	4	the	the	DT
25944	3246	5	treatment	treatment	NN
25944	3246	6	?	?	.
25944	3246	7	#	#	$
25944	3246	8	The	the	DT
25944	3246	9	administration	administration	NN
25944	3246	10	of	of	IN
25944	3246	11	moderate	moderate	JJ
25944	3246	12	to	to	IN
25944	3246	13	large	large	JJ
25944	3246	14	doses	dose	NNS
25944	3246	15	of	of	IN
25944	3246	16	potassium	potassium	NN
25944	3246	17	iodide	iodide	NN
25944	3246	18	,	,	,
25944	3246	19	conjointly	conjointly	RB
25944	3246	20	with	with	IN
25944	3246	21	curetting	curetting	NN
25944	3246	22	or	or	CC
25944	3246	23	excision	excision	NN
25944	3246	24	of	of	IN
25944	3246	25	the	the	DT
25944	3246	26	diseased	diseased	JJ
25944	3246	27	mass	mass	NN
25944	3246	28	.	.	.
25944	3247	1	Local	local	JJ
25944	3247	2	applications	application	NNS
25944	3247	3	of	of	IN
25944	3247	4	iodine	iodine	NN
25944	3247	5	solution	solution	NN
25944	3247	6	can	can	MD
25944	3247	7	also	also	RB
25944	3247	8	be	be	VB
25944	3247	9	tried	try	VBN
25944	3247	10	.	.	.
25944	3248	1	#	#	NNP
25944	3248	2	Blastomycetic	Blastomycetic	NNP
25944	3248	3	Dermatitis	Dermatitis	NNP
25944	3248	4	.	.	.
25944	3248	5	#	#	$
25944	3248	6	#	#	$
25944	3248	7	What	what	WP
25944	3248	8	do	do	VBP
25944	3248	9	you	-PRON-	PRP
25944	3248	10	understand	understand	VB
25944	3248	11	by	by	IN
25944	3248	12	blastomycetic	blastomycetic	JJ
25944	3248	13	dermatitis	dermatitis	NN
25944	3248	14	?	?	.
25944	3248	15	#	#	$
25944	3248	16	Blastomycetic	blastomycetic	JJ
25944	3248	17	dermatitis	dermatitis	NN
25944	3248	18	is	be	VBZ
25944	3248	19	a	a	DT
25944	3248	20	rare	rare	JJ
25944	3248	21	disease	disease	NN
25944	3248	22	beginning	begin	VBG
25944	3248	23	usually	usually	RB
25944	3248	24	as	as	IN
25944	3248	25	a	a	DT
25944	3248	26	small	small	JJ
25944	3248	27	papule	papule	NN
25944	3248	28	or	or	CC
25944	3248	29	nodule	nodule	VB
25944	3248	30	,	,	,
25944	3248	31	enlarging	enlarge	VBG
25944	3248	32	slowly	slowly	RB
25944	3248	33	,	,	,
25944	3248	34	breaking	break	VBG
25944	3248	35	down	down	RP
25944	3248	36	and	and	CC
25944	3248	37	developing	develop	VBG
25944	3248	38	into	into	IN
25944	3248	39	a	a	DT
25944	3248	40	verrucous	verrucous	JJ
25944	3248	41	or	or	CC
25944	3248	42	papillomatous	papillomatous	JJ
25944	3248	43	-	-	HYPH
25944	3248	44	looking	looking	JJ
25944	3248	45	area	area	NN
25944	3248	46	,	,	,
25944	3248	47	similar	similar	JJ
25944	3248	48	in	in	IN
25944	3248	49	appearance	appearance	NN
25944	3248	50	to	to	IN
25944	3248	51	tuberculosis	tuberculosis	NNP
25944	3248	52	cutis	cutis	NNP
25944	3248	53	verrucosa	verrucosa	NNP
25944	3248	54	.	.	.
25944	3249	1	A	a	DT
25944	3249	2	muco	muco	NN
25944	3249	3	-	-	HYPH
25944	3249	4	purulent	purulent	NN
25944	3249	5	or	or	CC
25944	3249	6	purulent	purulent	NN
25944	3249	7	secretion	secretion	NN
25944	3249	8	can	can	MD
25944	3249	9	visually	visually	RB
25944	3249	10	be	be	VB
25944	3249	11	pressed	press	VBN
25944	3249	12	out	out	RP
25944	3249	13	from	from	IN
25944	3249	14	between	between	IN
25944	3249	15	the	the	DT
25944	3249	16	papillomatous	papillomatous	JJ
25944	3249	17	elevations	elevation	NNS
25944	3249	18	.	.	.
25944	3250	1	It	-PRON-	PRP
25944	3250	2	may	may	MD
25944	3250	3	also	also	RB
25944	3250	4	present	present	VB
25944	3250	5	the	the	DT
25944	3250	6	appearance	appearance	NN
25944	3250	7	of	of	IN
25944	3250	8	a	a	DT
25944	3250	9	serpiginous	serpiginous	JJ
25944	3250	10	lupus	lupus	NNP
25944	3250	11	vulgaris	vulgaris	NN
25944	3250	12	or	or	CC
25944	3250	13	syphiloderm	syphiloderm	NNP
25944	3250	14	.	.	.
25944	3251	1	As	as	IN
25944	3251	2	a	a	DT
25944	3251	3	rule	rule	NN
25944	3251	4	it	-PRON-	PRP
25944	3251	5	is	be	VBZ
25944	3251	6	slow	slow	JJ
25944	3251	7	in	in	IN
25944	3251	8	its	-PRON-	PRP$
25944	3251	9	course	course	NN
25944	3251	10	.	.	.
25944	3252	1	Furuncular	Furuncular	NNP
25944	3252	2	or	or	CC
25944	3252	3	abscess	abscess	NN
25944	3252	4	-	-	HYPH
25944	3252	5	like	like	JJ
25944	3252	6	formations	formation	NNS
25944	3252	7	may	may	MD
25944	3252	8	develop	develop	VB
25944	3252	9	,	,	,
25944	3252	10	usually	usually	RB
25944	3252	11	from	from	IN
25944	3252	12	secondary	secondary	JJ
25944	3252	13	infection	infection	NN
25944	3252	14	.	.	.
25944	3253	1	The	the	DT
25944	3253	2	disease	disease	NN
25944	3253	3	is	be	VBZ
25944	3253	4	due	due	JJ
25944	3253	5	to	to	IN
25944	3253	6	the	the	DT
25944	3253	7	invasion	invasion	NN
25944	3253	8	of	of	IN
25944	3253	9	the	the	DT
25944	3253	10	cutaneous	cutaneous	JJ
25944	3253	11	tissues	tissue	NNS
25944	3253	12	by	by	IN
25944	3253	13	the	the	DT
25944	3253	14	blastomyces	blastomyce	NNS
25944	3253	15	.	.	.
25944	3254	1	[	[	-LRB-
25944	3254	2	Illustration	illustration	NN
25944	3254	3	:	:	:
25944	3254	4	Blastomycetic	blastomycetic	JJ
25944	3254	5	dermatitis	dermatitis	NN
25944	3254	6	.	.	.
25944	3254	7	]	]	-RRB-
25944	3255	1	Treatment	treatment	NN
25944	3255	2	consists	consist	VBZ
25944	3255	3	in	in	IN
25944	3255	4	administration	administration	NN
25944	3255	5	of	of	IN
25944	3255	6	moderate	moderate	JJ
25944	3255	7	to	to	IN
25944	3255	8	large	large	JJ
25944	3255	9	doses	dose	NNS
25944	3255	10	of	of	IN
25944	3255	11	potassium	potassium	NN
25944	3255	12	iodide	iodide	NN
25944	3255	13	,	,	,
25944	3255	14	and	and	CC
25944	3255	15	in	in	IN
25944	3255	16	the	the	DT
25944	3255	17	employment	employment	NN
25944	3255	18	of	of	IN
25944	3255	19	antiseptic	antiseptic	NN
25944	3255	20	and	and	CC
25944	3255	21	parasiticide	parasiticide	NN
25944	3255	22	applications	application	NNS
25944	3255	23	;	;	:
25944	3255	24	usually	usually	RB
25944	3255	25	,	,	,
25944	3255	26	however	however	RB
25944	3255	27	,	,	,
25944	3255	28	radical	radical	JJ
25944	3255	29	treatment	treatment	NN
25944	3255	30	,	,	,
25944	3255	31	such	such	JJ
25944	3255	32	as	as	IN
25944	3255	33	employed	employ	VBN
25944	3255	34	in	in	IN
25944	3255	35	lupus	lupus	NNP
25944	3255	36	vulgaris	vulgaris	NNP
25944	3255	37	,	,	,
25944	3255	38	may	may	MD
25944	3255	39	be	be	VB
25944	3255	40	necessary	necessary	JJ
25944	3255	41	.	.	.
25944	3256	1	#	#	NNP
25944	3256	2	Scabies	Scabies	NNP
25944	3256	3	.	.	.
25944	3256	4	#	#	NNP
25944	3256	5	(	(	-LRB-
25944	3256	6	_	_	NNP
25944	3256	7	Synonym	Synonym	NNP
25944	3256	8	:	:	:
25944	3256	9	_	_	NNP
25944	3256	10	The	the	DT
25944	3256	11	Itch	Itch	NNP
25944	3256	12	.	.	.
25944	3256	13	)	)	-RRB-
25944	3257	1	#	#	LS
25944	3257	2	What	what	WP
25944	3257	3	is	be	VBZ
25944	3257	4	scabies	scabie	NNS
25944	3257	5	?	?	.
25944	3257	6	#	#	$
25944	3257	7	Scabies	scabie	NNS
25944	3257	8	,	,	,
25944	3257	9	or	or	CC
25944	3257	10	itch	itch	NN
25944	3257	11	,	,	,
25944	3257	12	is	be	VBZ
25944	3257	13	a	a	DT
25944	3257	14	contagious	contagious	JJ
25944	3257	15	animal	animal	NN
25944	3257	16	-	-	HYPH
25944	3257	17	parasitic	parasitic	NN
25944	3257	18	disease	disease	NN
25944	3257	19	characterized	characterize	VBN
25944	3257	20	by	by	IN
25944	3257	21	a	a	DT
25944	3257	22	multiform	multiform	NN
25944	3257	23	eruption	eruption	NN
25944	3257	24	of	of	IN
25944	3257	25	a	a	DT
25944	3257	26	somewhat	somewhat	RB
25944	3257	27	peculiar	peculiar	JJ
25944	3257	28	distribution	distribution	NN
25944	3257	29	,	,	,
25944	3257	30	attended	attend	VBN
25944	3257	31	by	by	IN
25944	3257	32	intense	intense	JJ
25944	3257	33	itching	itching	NN
25944	3257	34	.	.	.
25944	3258	1	#	#	NNP
25944	3258	2	Describe	describe	VB
25944	3258	3	the	the	DT
25944	3258	4	symptoms	symptom	NNS
25944	3258	5	of	of	IN
25944	3258	6	scabies	scabie	NNS
25944	3258	7	.	.	.
25944	3258	8	#	#	$
25944	3258	9	The	the	DT
25944	3258	10	penetration	penetration	NN
25944	3258	11	and	and	CC
25944	3258	12	presence	presence	NN
25944	3258	13	of	of	IN
25944	3258	14	the	the	DT
25944	3258	15	parasites	parasite	NNS
25944	3258	16	within	within	IN
25944	3258	17	the	the	DT
25944	3258	18	cutaneous	cutaneous	JJ
25944	3258	19	structures	structure	NNS
25944	3258	20	besides	besides	IN
25944	3258	21	often	often	RB
25944	3258	22	giving	give	VBG
25944	3258	23	rise	rise	NN
25944	3258	24	to	to	IN
25944	3258	25	several	several	JJ
25944	3258	26	or	or	CC
25944	3258	27	more	more	RBR
25944	3258	28	complete	complete	JJ
25944	3258	29	or	or	CC
25944	3258	30	imperfectly	imperfectly	RB
25944	3258	31	formed	form	VBN
25944	3258	32	_	_	NNP
25944	3258	33	burrows	burrow	VBZ
25944	3258	34	_	_	NNP
25944	3258	35	,	,	,
25944	3258	36	excite	excite	JJ
25944	3258	37	varying	vary	VBG
25944	3258	38	degrees	degree	NNS
25944	3258	39	of	of	IN
25944	3258	40	irritation	irritation	NN
25944	3258	41	,	,	,
25944	3258	42	and	and	CC
25944	3258	43	in	in	IN
25944	3258	44	consequence	consequence	NN
25944	3258	45	the	the	DT
25944	3258	46	formation	formation	NN
25944	3258	47	of	of	IN
25944	3258	48	vesicles	vesicle	NNS
25944	3258	49	,	,	,
25944	3258	50	papules	papule	NNS
25944	3258	51	and	and	CC
25944	3258	52	pustules	pustule	NNS
25944	3258	53	,	,	,
25944	3258	54	accompanied	accompany	VBN
25944	3258	55	with	with	IN
25944	3258	56	more	more	JJR
25944	3258	57	or	or	CC
25944	3258	58	less	less	RBR
25944	3258	59	intense	intense	JJ
25944	3258	60	itching	itching	NN
25944	3258	61	.	.	.
25944	3259	1	Secondarily	secondarily	RB
25944	3259	2	,	,	,
25944	3259	3	crusting	crusting	NN
25944	3259	4	,	,	,
25944	3259	5	and	and	CC
25944	3259	6	at	at	IN
25944	3259	7	times	time	NNS
25944	3259	8	a	a	DT
25944	3259	9	mild	mild	JJ
25944	3259	10	or	or	CC
25944	3259	11	severe	severe	JJ
25944	3259	12	grade	grade	NN
25944	3259	13	of	of	IN
25944	3259	14	dermatitis	dermatitis	NN
25944	3259	15	,	,	,
25944	3259	16	may	may	MD
25944	3259	17	be	be	VB
25944	3259	18	brought	bring	VBN
25944	3259	19	about	about	RP
25944	3259	20	.	.	.
25944	3260	1	The	the	DT
25944	3260	2	parasite	parasite	NN
25944	3260	3	seeks	seek	VBZ
25944	3260	4	preferably	preferably	RB
25944	3260	5	tender	tender	JJ
25944	3260	6	and	and	CC
25944	3260	7	protected	protect	VBN
25944	3260	8	situations	situation	NNS
25944	3260	9	,	,	,
25944	3260	10	as	as	IN
25944	3260	11	between	between	IN
25944	3260	12	the	the	DT
25944	3260	13	fingers	finger	NNS
25944	3260	14	,	,	,
25944	3260	15	on	on	IN
25944	3260	16	the	the	DT
25944	3260	17	wrists	wrist	NNS
25944	3260	18	,	,	,
25944	3260	19	especially	especially	RB
25944	3260	20	the	the	DT
25944	3260	21	flexor	flexor	NN
25944	3260	22	surface	surface	NN
25944	3260	23	,	,	,
25944	3260	24	in	in	IN
25944	3260	25	the	the	DT
25944	3260	26	folds	fold	NNS
25944	3260	27	of	of	IN
25944	3260	28	the	the	DT
25944	3260	29	axilla	axilla	NN
25944	3260	30	,	,	,
25944	3260	31	on	on	IN
25944	3260	32	the	the	DT
25944	3260	33	abdomen	abdomen	NNP
25944	3260	34	,	,	,
25944	3260	35	about	about	IN
25944	3260	36	the	the	DT
25944	3260	37	anal	anal	JJ
25944	3260	38	fissure	fissure	NN
25944	3260	39	,	,	,
25944	3260	40	about	about	IN
25944	3260	41	the	the	DT
25944	3260	42	genitalia	genitalia	NNP
25944	3260	43	,	,	,
25944	3260	44	and	and	CC
25944	3260	45	in	in	IN
25944	3260	46	females	female	NNS
25944	3260	47	also	also	RB
25944	3260	48	about	about	IN
25944	3260	49	the	the	DT
25944	3260	50	nipples	nipple	NNS
25944	3260	51	,	,	,
25944	3260	52	and	and	CC
25944	3260	53	hence	hence	RB
25944	3260	54	the	the	DT
25944	3260	55	eruption	eruption	NN
25944	3260	56	is	be	VBZ
25944	3260	57	most	most	RBS
25944	3260	58	abundant	abundant	JJ
25944	3260	59	about	about	IN
25944	3260	60	these	these	DT
25944	3260	61	regions	region	NNS
25944	3260	62	.	.	.
25944	3261	1	The	the	DT
25944	3261	2	inside	inside	NN
25944	3261	3	of	of	IN
25944	3261	4	the	the	DT
25944	3261	5	thighs	thigh	NNS
25944	3261	6	and	and	CC
25944	3261	7	the	the	DT
25944	3261	8	feet	foot	NNS
25944	3261	9	are	be	VBP
25944	3261	10	also	also	RB
25944	3261	11	attacked	attack	VBN
25944	3261	12	,	,	,
25944	3261	13	as	as	IN
25944	3261	14	,	,	,
25944	3261	15	indeed	indeed	RB
25944	3261	16	,	,	,
25944	3261	17	may	may	MD
25944	3261	18	be	be	VB
25944	3261	19	almost	almost	RB
25944	3261	20	every	every	DT
25944	3261	21	portion	portion	NN
25944	3261	22	of	of	IN
25944	3261	23	the	the	DT
25944	3261	24	body	body	NN
25944	3261	25	.	.	.
25944	3262	1	The	the	DT
25944	3262	2	scalp	scalp	NN
25944	3262	3	and	and	CC
25944	3262	4	face	face	NN
25944	3262	5	are	be	VBP
25944	3262	6	not	not	RB
25944	3262	7	involved	involve	VBN
25944	3262	8	;	;	:
25944	3262	9	exceptionally	exceptionally	RB
25944	3262	10	,	,	,
25944	3262	11	however	however	RB
25944	3262	12	,	,	,
25944	3262	13	these	these	DT
25944	3262	14	parts	part	NNS
25944	3262	15	are	be	VBP
25944	3262	16	invaded	invade	VBN
25944	3262	17	in	in	IN
25944	3262	18	infants	infant	NNS
25944	3262	19	and	and	CC
25944	3262	20	young	young	JJ
25944	3262	21	children	child	NNS
25944	3262	22	.	.	.
25944	3263	1	#	#	$
25944	3263	2	Is	be	VBZ
25944	3263	3	the	the	DT
25944	3263	4	grade	grade	NN
25944	3263	5	of	of	IN
25944	3263	6	cutaneous	cutaneous	JJ
25944	3263	7	irritation	irritation	NN
25944	3263	8	the	the	DT
25944	3263	9	same	same	JJ
25944	3263	10	in	in	IN
25944	3263	11	all	all	DT
25944	3263	12	cases	case	NNS
25944	3263	13	of	of	IN
25944	3263	14	scabies	scabie	NNS
25944	3263	15	?	?	.
25944	3263	16	#	#	NN
25944	3263	17	No	no	UH
25944	3263	18	;	;	:
25944	3263	19	in	in	IN
25944	3263	20	those	those	DT
25944	3263	21	of	of	IN
25944	3263	22	great	great	JJ
25944	3263	23	cutaneous	cutaneous	JJ
25944	3263	24	irritability	irritability	NN
25944	3263	25	,	,	,
25944	3263	26	especially	especially	RB
25944	3263	27	in	in	IN
25944	3263	28	children	child	NNS
25944	3263	29	,	,	,
25944	3263	30	the	the	DT
25944	3263	31	skin	skin	NN
25944	3263	32	being	be	VBG
25944	3263	33	more	more	RBR
25944	3263	34	tender	tender	JJ
25944	3263	35	,	,	,
25944	3263	36	the	the	DT
25944	3263	37	type	type	NN
25944	3263	38	of	of	IN
25944	3263	39	the	the	DT
25944	3263	40	eruption	eruption	NN
25944	3263	41	is	be	VBZ
25944	3263	42	usually	usually	RB
25944	3263	43	much	much	RB
25944	3263	44	more	more	RBR
25944	3263	45	inflammatory	inflammatory	JJ
25944	3263	46	.	.	.
25944	3264	1	In	in	IN
25944	3264	2	those	those	DT
25944	3264	3	predisposed	predispose	VBD
25944	3264	4	a	a	DT
25944	3264	5	true	true	JJ
25944	3264	6	eczema	eczema	NN
25944	3264	7	may	may	MD
25944	3264	8	arise	arise	VB
25944	3264	9	,	,	,
25944	3264	10	and	and	CC
25944	3264	11	then	then	RB
25944	3264	12	,	,	,
25944	3264	13	in	in	IN
25944	3264	14	addition	addition	NN
25944	3264	15	to	to	IN
25944	3264	16	the	the	DT
25944	3264	17	characteristic	characteristic	JJ
25944	3264	18	lesions	lesion	NNS
25944	3264	19	of	of	IN
25944	3264	20	scabies	scabie	NNS
25944	3264	21	,	,	,
25944	3264	22	eczematous	eczematous	JJ
25944	3264	23	symptoms	symptom	NNS
25944	3264	24	are	be	VBP
25944	3264	25	superadded	superadde	VBN
25944	3264	26	;	;	:
25944	3264	27	in	in	IN
25944	3264	28	long	long	JJ
25944	3264	29	-	-	HYPH
25944	3264	30	persistent	persistent	JJ
25944	3264	31	cases	case	NNS
25944	3264	32	,	,	,
25944	3264	33	indeed	indeed	RB
25944	3264	34	,	,	,
25944	3264	35	the	the	DT
25944	3264	36	burrows	burrow	NNS
25944	3264	37	and	and	CC
25944	3264	38	other	other	JJ
25944	3264	39	consequent	consequent	JJ
25944	3264	40	lesions	lesion	NNS
25944	3264	41	may	may	MD
25944	3264	42	be	be	VB
25944	3264	43	more	more	RBR
25944	3264	44	or	or	CC
25944	3264	45	less	less	RBR
25944	3264	46	completely	completely	RB
25944	3264	47	masked	mask	VBN
25944	3264	48	by	by	IN
25944	3264	49	the	the	DT
25944	3264	50	eczematous	eczematous	JJ
25944	3264	51	inflammation	inflammation	NN
25944	3264	52	,	,	,
25944	3264	53	and	and	CC
25944	3264	54	the	the	DT
25944	3264	55	true	true	JJ
25944	3264	56	nature	nature	NN
25944	3264	57	of	of	IN
25944	3264	58	the	the	DT
25944	3264	59	disease	disease	NN
25944	3264	60	be	be	VB
25944	3264	61	greatly	greatly	RB
25944	3264	62	obscured	obscure	VBN
25944	3264	63	.	.	.
25944	3265	1	#	#	LS
25944	3265	2	What	what	WP
25944	3265	3	do	do	VBP
25944	3265	4	you	-PRON-	PRP
25944	3265	5	mean	mean	VB
25944	3265	6	by	by	IN
25944	3265	7	burrows	burrow	NNS
25944	3265	8	?	?	.
25944	3265	9	#	#	$
25944	3265	10	Burrows	burrow	NNS
25944	3265	11	,	,	,
25944	3265	12	or	or	CC
25944	3265	13	_	_	NNP
25944	3265	14	cuniculi	cuniculi	NNP
25944	3265	15	_	_	NNP
25944	3265	16	,	,	,
25944	3265	17	are	be	VBP
25944	3265	18	tortuous	tortuous	JJ
25944	3265	19	,	,	,
25944	3265	20	straight	straight	JJ
25944	3265	21	or	or	CC
25944	3265	22	zigzag	zigzag	NN
25944	3265	23	,	,	,
25944	3265	24	dotted	dot	VBN
25944	3265	25	,	,	,
25944	3265	26	slightly	slightly	RB
25944	3265	27	elevated	elevated	JJ
25944	3265	28	,	,	,
25944	3265	29	dark	dark	JJ
25944	3265	30	-	-	HYPH
25944	3265	31	gray	gray	JJ
25944	3265	32	or	or	CC
25944	3265	33	blackish	blackish	VB
25944	3265	34	thread	thread	NN
25944	3265	35	-	-	HYPH
25944	3265	36	like	like	JJ
25944	3265	37	linear	linear	JJ
25944	3265	38	formations	formation	NNS
25944	3265	39	,	,	,
25944	3265	40	varying	vary	VBG
25944	3265	41	in	in	RP
25944	3265	42	length	length	NN
25944	3265	43	from	from	IN
25944	3265	44	an	an	DT
25944	3265	45	eighth	eighth	NN
25944	3265	46	to	to	IN
25944	3265	47	a	a	DT
25944	3265	48	half	half	NN
25944	3265	49	an	an	DT
25944	3265	50	inch	inch	NN
25944	3265	51	.	.	.
25944	3266	1	[	[	-LRB-
25944	3266	2	Illustration	illustration	NN
25944	3266	3	:	:	:
25944	3266	4	Fig	Fig	NNP
25944	3266	5	.	.	.
25944	3267	1	76	76	CD
25944	3267	2	.	.	.
25944	3268	1	Burrow	burrow	VB
25944	3268	2	,	,	,
25944	3268	3	or	or	CC
25944	3268	4	cuniculus	cuniculus	NN
25944	3268	5	,	,	,
25944	3268	6	greatly	greatly	RB
25944	3268	7	magnified	magnify	VBN
25944	3268	8	.	.	.
25944	3269	1	(	(	-LRB-
25944	3269	2	_	_	NNP
25944	3269	3	After	after	IN
25944	3269	4	Kaposi	Kaposi	NNP
25944	3269	5	.	.	.
25944	3269	6	_	_	NNP
25944	3269	7	)	)	-RRB-
25944	3269	8	Showing	show	VBG
25944	3269	9	the	the	DT
25944	3269	10	mite	mite	NN
25944	3269	11	,	,	,
25944	3269	12	ova	ova	NNP
25944	3269	13	,	,	,
25944	3269	14	empty	empty	JJ
25944	3269	15	shells	shell	NNS
25944	3269	16	and	and	CC
25944	3269	17	excrement	excrement	NN
25944	3269	18	.	.	.
25944	3269	19	]	]	-RRB-
25944	3270	1	#	#	NNP
25944	3270	2	How	how	WRB
25944	3270	3	is	be	VBZ
25944	3270	4	a	a	DT
25944	3270	5	burrow	burrow	NN
25944	3270	6	formed	form	VBN
25944	3270	7	?	?	.
25944	3270	8	#	#	NN
25944	3270	9	By	by	IN
25944	3270	10	the	the	DT
25944	3270	11	impregnated	impregnate	VBN
25944	3270	12	female	female	JJ
25944	3270	13	parasite	parasite	NN
25944	3270	14	,	,	,
25944	3270	15	which	which	WDT
25944	3270	16	penetrates	penetrate	VBZ
25944	3270	17	the	the	DT
25944	3270	18	epidermis	epidermis	NN
25944	3270	19	obliquely	obliquely	RB
25944	3270	20	to	to	IN
25944	3270	21	the	the	DT
25944	3270	22	rete	rete	NN
25944	3270	23	,	,	,
25944	3270	24	depositing	depositing	NN
25944	3270	25	as	as	IN
25944	3270	26	it	-PRON-	PRP
25944	3270	27	goes	go	VBZ
25944	3270	28	along	along	IN
25944	3270	29	ten	ten	CD
25944	3270	30	or	or	CC
25944	3270	31	fifteen	fifteen	CD
25944	3270	32	ova	ova	NN
25944	3270	33	,	,	,
25944	3270	34	forming	form	VBG
25944	3270	35	a	a	DT
25944	3270	36	minute	minute	NN
25944	3270	37	passage	passage	NN
25944	3270	38	or	or	CC
25944	3270	39	burrow	burrow	NN
25944	3270	40	.	.	.
25944	3271	1	#	#	NN
25944	3271	2	Upon	upon	IN
25944	3271	3	what	what	WP
25944	3271	4	parts	part	NNS
25944	3271	5	are	be	VBP
25944	3271	6	burrows	burrow	NNS
25944	3271	7	most	most	RBS
25944	3271	8	commonly	commonly	RB
25944	3271	9	to	to	TO
25944	3271	10	be	be	VB
25944	3271	11	found	find	VBN
25944	3271	12	?	?	.
25944	3271	13	#	#	$
25944	3271	14	In	in	IN
25944	3271	15	the	the	DT
25944	3271	16	interdigital	interdigital	JJ
25944	3271	17	spaces	space	NNS
25944	3271	18	,	,	,
25944	3271	19	on	on	IN
25944	3271	20	the	the	DT
25944	3271	21	flexor	flexor	NN
25944	3271	22	surface	surface	NN
25944	3271	23	of	of	IN
25944	3271	24	the	the	DT
25944	3271	25	wrists	wrist	NNS
25944	3271	26	,	,	,
25944	3271	27	about	about	IN
25944	3271	28	the	the	DT
25944	3271	29	mammæ	mammæ	NN
25944	3271	30	in	in	IN
25944	3271	31	the	the	DT
25944	3271	32	female	female	NN
25944	3271	33	,	,	,
25944	3271	34	and	and	CC
25944	3271	35	on	on	IN
25944	3271	36	the	the	DT
25944	3271	37	shaft	shaft	NN
25944	3271	38	of	of	IN
25944	3271	39	the	the	DT
25944	3271	40	penis	penis	NN
25944	3271	41	in	in	IN
25944	3271	42	the	the	DT
25944	3271	43	male	male	NN
25944	3271	44	.	.	.
25944	3272	1	#	#	NN
25944	3272	2	Are	be	VBP
25944	3272	3	burrows	burrow	NNS
25944	3272	4	usually	usually	RB
25944	3272	5	present	present	JJ
25944	3272	6	in	in	IN
25944	3272	7	numbers	number	NNS
25944	3272	8	?	?	.
25944	3272	9	#	#	$
25944	3272	10	No	no	UH
25944	3272	11	.	.	.
25944	3273	1	Several	several	JJ
25944	3273	2	may	may	MD
25944	3273	3	be	be	VB
25944	3273	4	found	find	VBN
25944	3273	5	in	in	IN
25944	3273	6	a	a	DT
25944	3273	7	single	single	JJ
25944	3273	8	case	case	NN
25944	3273	9	,	,	,
25944	3273	10	but	but	CC
25944	3273	11	they	-PRON-	PRP
25944	3273	12	are	be	VBP
25944	3273	13	rarely	rarely	RB
25944	3273	14	numerous	numerous	JJ
25944	3273	15	,	,	,
25944	3273	16	as	as	IN
25944	3273	17	the	the	DT
25944	3273	18	irritation	irritation	NN
25944	3273	19	caused	cause	VBN
25944	3273	20	by	by	IN
25944	3273	21	the	the	DT
25944	3273	22	penetration	penetration	NN
25944	3273	23	of	of	IN
25944	3273	24	the	the	DT
25944	3273	25	parasites	parasite	NNS
25944	3273	26	leads	lead	VBZ
25944	3273	27	either	either	RB
25944	3273	28	to	to	IN
25944	3273	29	violent	violent	JJ
25944	3273	30	scratching	scratching	NN
25944	3273	31	and	and	CC
25944	3273	32	their	-PRON-	PRP$
25944	3273	33	destruction	destruction	NN
25944	3273	34	,	,	,
25944	3273	35	or	or	CC
25944	3273	36	gives	give	VBZ
25944	3273	37	rise	rise	NN
25944	3273	38	to	to	IN
25944	3273	39	the	the	DT
25944	3273	40	formation	formation	NN
25944	3273	41	of	of	IN
25944	3273	42	vesicles	vesicle	NNS
25944	3273	43	and	and	CC
25944	3273	44	pustules	pustule	NNS
25944	3273	45	,	,	,
25944	3273	46	and	and	CC
25944	3273	47	consequently	consequently	RB
25944	3273	48	their	-PRON-	PRP$
25944	3273	49	formation	formation	NN
25944	3273	50	is	be	VBZ
25944	3273	51	prevented	prevent	VBN
25944	3273	52	.	.	.
25944	3274	1	#	#	LS
25944	3274	2	What	what	WDT
25944	3274	3	course	course	NN
25944	3274	4	does	do	VBZ
25944	3274	5	scabies	scabie	NNS
25944	3274	6	pursue	pursue	VB
25944	3274	7	?	?	.
25944	3274	8	#	#	$
25944	3274	9	Chronic	Chronic	NNP
25944	3274	10	and	and	CC
25944	3274	11	progressive	progressive	JJ
25944	3274	12	,	,	,
25944	3274	13	showing	show	VBG
25944	3274	14	no	no	DT
25944	3274	15	tendency	tendency	NN
25944	3274	16	to	to	IN
25944	3274	17	spontaneous	spontaneous	JJ
25944	3274	18	disappearance	disappearance	NN
25944	3274	19	.	.	.
25944	3275	1	#	#	JJR
25944	3275	2	To	to	IN
25944	3275	3	what	what	WP
25944	3275	4	is	be	VBZ
25944	3275	5	scabies	scabie	NNS
25944	3275	6	due	due	JJ
25944	3275	7	?	?	.
25944	3275	8	#	#	$
25944	3275	9	To	to	IN
25944	3275	10	the	the	DT
25944	3275	11	invasion	invasion	NN
25944	3275	12	of	of	IN
25944	3275	13	the	the	DT
25944	3275	14	cutaneous	cutaneous	JJ
25944	3275	15	structures	structure	NNS
25944	3275	16	by	by	IN
25944	3275	17	an	an	DT
25944	3275	18	animal	animal	NN
25944	3275	19	parasite	parasite	NN
25944	3275	20	,	,	,
25944	3275	21	the	the	DT
25944	3275	22	sarcoptes	sarcopte	NNS
25944	3275	23	scabiei	scabiei	VBP
25944	3275	24	(	(	-LRB-
25944	3275	25	_	_	NNP
25944	3275	26	acarus	acarus	NNP
25944	3275	27	scabiei	scabiei	NN
25944	3275	28	_	_	NNP
25944	3275	29	)	)	-RRB-
25944	3275	30	.	.	.
25944	3276	1	The	the	DT
25944	3276	2	male	male	JJ
25944	3276	3	mite	mite	NN
25944	3276	4	is	be	VBZ
25944	3276	5	never	never	RB
25944	3276	6	found	find	VBN
25944	3276	7	in	in	IN
25944	3276	8	the	the	DT
25944	3276	9	skin	skin	NN
25944	3276	10	and	and	CC
25944	3276	11	apparently	apparently	RB
25944	3276	12	takes	take	VBZ
25944	3276	13	no	no	DT
25944	3276	14	direct	direct	JJ
25944	3276	15	part	part	NN
25944	3276	16	in	in	IN
25944	3276	17	the	the	DT
25944	3276	18	production	production	NN
25944	3276	19	of	of	IN
25944	3276	20	the	the	DT
25944	3276	21	symptoms	symptom	NNS
25944	3276	22	.	.	.
25944	3277	1	[	[	-LRB-
25944	3277	2	Illustration	illustration	NN
25944	3277	3	:	:	:
25944	3277	4	Fig	Fig	NNP
25944	3277	5	.	.	.
25944	3278	1	77	77	CD
25944	3278	2	.	.	.
25944	3279	1	Fig	fig	NN
25944	3279	2	.	.	.
25944	3280	1	78	78	CD
25944	3280	2	.	.	.
25944	3281	1	Sarcoptes	sarcopte	NNS
25944	3281	2	scabiei	scabiei	VBP
25944	3281	3	x	x	SYM
25944	3281	4	100	100	CD
25944	3281	5	.	.	.
25944	3282	1	(	(	-LRB-
25944	3282	2	_	_	NNP
25944	3282	3	After	after	IN
25944	3282	4	Duhring	Duhring	NNP
25944	3282	5	.	.	.
25944	3282	6	_	_	NNP
25944	3282	7	)	)	-RRB-
25944	3282	8	Female	Female	NNP
25944	3282	9	.	.	.
25944	3283	1	Ventral	ventral	JJ
25944	3283	2	surface	surface	NN
25944	3283	3	.	.	.
25944	3284	1	Male	Male	NNP
25944	3284	2	.	.	.
25944	3284	3	]	]	-RRB-
25944	3285	1	The	the	DT
25944	3285	2	disease	disease	NN
25944	3285	3	is	be	VBZ
25944	3285	4	contagious	contagious	JJ
25944	3285	5	to	to	IN
25944	3285	6	a	a	DT
25944	3285	7	marked	marked	JJ
25944	3285	8	degree	degree	NN
25944	3285	9	,	,	,
25944	3285	10	and	and	CC
25944	3285	11	is	be	VBZ
25944	3285	12	most	most	RBS
25944	3285	13	commonly	commonly	RB
25944	3285	14	contracted	contract	VBN
25944	3285	15	by	by	IN
25944	3285	16	sleeping	sleep	VBG
25944	3285	17	with	with	IN
25944	3285	18	those	those	DT
25944	3285	19	affected	affect	VBN
25944	3285	20	,	,	,
25944	3285	21	or	or	CC
25944	3285	22	by	by	IN
25944	3285	23	occupying	occupy	VBG
25944	3285	24	a	a	DT
25944	3285	25	bed	bed	NN
25944	3285	26	in	in	IN
25944	3285	27	which	which	WDT
25944	3285	28	an	an	DT
25944	3285	29	affected	affect	VBN
25944	3285	30	person	person	NN
25944	3285	31	has	have	VBZ
25944	3285	32	slept	sleep	VBN
25944	3285	33	.	.	.
25944	3286	1	It	-PRON-	PRP
25944	3286	2	occurs	occur	VBZ
25944	3286	3	,	,	,
25944	3286	4	for	for	IN
25944	3286	5	obvious	obvious	JJ
25944	3286	6	reasons	reason	NNS
25944	3286	7	,	,	,
25944	3286	8	usually	usually	RB
25944	3286	9	among	among	IN
25944	3286	10	the	the	DT
25944	3286	11	poor	poor	JJ
25944	3286	12	,	,	,
25944	3286	13	although	although	IN
25944	3286	14	it	-PRON-	PRP
25944	3286	15	is	be	VBZ
25944	3286	16	now	now	RB
25944	3286	17	quite	quite	RB
25944	3286	18	frequently	frequently	RB
25944	3286	19	met	meet	VBN
25944	3286	20	with	with	IN
25944	3286	21	among	among	IN
25944	3286	22	the	the	DT
25944	3286	23	better	well	JJR
25944	3286	24	classes	class	NNS
25944	3286	25	.	.	.
25944	3287	1	#	#	JJR
25944	3287	2	State	state	NN
25944	3287	3	the	the	DT
25944	3287	4	diagnostic	diagnostic	JJ
25944	3287	5	features	feature	NNS
25944	3287	6	of	of	IN
25944	3287	7	scabies	scabie	NNS
25944	3287	8	.	.	.
25944	3287	9	#	#	$
25944	3287	10	The	the	DT
25944	3287	11	burrows	burrow	NNS
25944	3287	12	,	,	,
25944	3287	13	the	the	DT
25944	3287	14	peculiar	peculiar	JJ
25944	3287	15	distribution	distribution	NN
25944	3287	16	and	and	CC
25944	3287	17	the	the	DT
25944	3287	18	multiformity	multiformity	NN
25944	3287	19	of	of	IN
25944	3287	20	the	the	DT
25944	3287	21	eruption	eruption	NN
25944	3287	22	,	,	,
25944	3287	23	the	the	DT
25944	3287	24	progressive	progressive	JJ
25944	3287	25	development	development	NN
25944	3287	26	,	,	,
25944	3287	27	and	and	CC
25944	3287	28	usually	usually	RB
25944	3287	29	a	a	DT
25944	3287	30	history	history	NN
25944	3287	31	of	of	IN
25944	3287	32	contagion	contagion	NN
25944	3287	33	.	.	.
25944	3288	1	#	#	NN
25944	3288	2	How	how	WRB
25944	3288	3	do	do	VBP
25944	3288	4	vesicular	vesicular	NN
25944	3288	5	and	and	CC
25944	3288	6	pustular	pustular	JJ
25944	3288	7	eczema	eczema	NN
25944	3288	8	differ	differ	VBP
25944	3288	9	from	from	IN
25944	3288	10	scabies	scabie	NNS
25944	3288	11	?	?	.
25944	3288	12	#	#	NNP
25944	3288	13	Eczema	Eczema	NNP
25944	3288	14	is	be	VBZ
25944	3288	15	usually	usually	RB
25944	3288	16	limited	limit	VBN
25944	3288	17	in	in	IN
25944	3288	18	extent	extent	NN
25944	3288	19	,	,	,
25944	3288	20	or	or	CC
25944	3288	21	irregularly	irregularly	RB
25944	3288	22	distributed	distribute	VBN
25944	3288	23	,	,	,
25944	3288	24	is	be	VBZ
25944	3288	25	distinctly	distinctly	RB
25944	3288	26	patchy	patchy	JJ
25944	3288	27	,	,	,
25944	3288	28	with	with	IN
25944	3288	29	often	often	RB
25944	3288	30	the	the	DT
25944	3288	31	formation	formation	NN
25944	3288	32	of	of	IN
25944	3288	33	large	large	JJ
25944	3288	34	diffused	diffuse	VBN
25944	3288	35	areas	area	NNS
25944	3288	36	;	;	:
25944	3288	37	it	-PRON-	PRP
25944	3288	38	is	be	VBZ
25944	3288	39	variable	variable	JJ
25944	3288	40	in	in	IN
25944	3288	41	its	-PRON-	PRP$
25944	3288	42	clinical	clinical	JJ
25944	3288	43	behavior	behavior	NN
25944	3288	44	,	,	,
25944	3288	45	better	well	JJR
25944	3288	46	and	and	CC
25944	3288	47	worse	bad	JJR
25944	3288	48	from	from	IN
25944	3288	49	time	time	NN
25944	3288	50	to	to	IN
25944	3288	51	time	time	NN
25944	3288	52	,	,	,
25944	3288	53	and	and	CC
25944	3288	54	differs	differ	NNS
25944	3288	55	,	,	,
25944	3288	56	moreover	moreover	RB
25944	3288	57	,	,	,
25944	3288	58	in	in	IN
25944	3288	59	the	the	DT
25944	3288	60	absence	absence	NN
25944	3288	61	of	of	IN
25944	3288	62	burrows	burrow	NNS
25944	3288	63	and	and	CC
25944	3288	64	of	of	IN
25944	3288	65	a	a	DT
25944	3288	66	history	history	NN
25944	3288	67	of	of	IN
25944	3288	68	contagion	contagion	NN
25944	3288	69	.	.	.
25944	3289	1	#	#	NNP
25944	3289	2	How	how	WRB
25944	3289	3	does	do	VBZ
25944	3289	4	pediculosis	pediculosis	VB
25944	3289	5	corporis	corporis	NNP
25944	3289	6	differ	differ	VB
25944	3289	7	from	from	IN
25944	3289	8	scabies	scabie	NNS
25944	3289	9	?	?	.
25944	3289	10	#	#	$
25944	3289	11	In	in	IN
25944	3289	12	the	the	DT
25944	3289	13	distribution	distribution	NN
25944	3289	14	of	of	IN
25944	3289	15	the	the	DT
25944	3289	16	eruption	eruption	NN
25944	3289	17	.	.	.
25944	3290	1	The	the	DT
25944	3290	2	pediculi	pediculi	NN
25944	3290	3	live	live	VBP
25944	3290	4	in	in	IN
25944	3290	5	the	the	DT
25944	3290	6	clothing	clothing	NN
25944	3290	7	and	and	CC
25944	3290	8	go	go	VB
25944	3290	9	to	to	IN
25944	3290	10	the	the	DT
25944	3290	11	skin	skin	NN
25944	3290	12	solely	solely	RB
25944	3290	13	for	for	IN
25944	3290	14	nourishment	nourishment	NN
25944	3290	15	,	,	,
25944	3290	16	and	and	CC
25944	3290	17	hence	hence	RB
25944	3290	18	the	the	DT
25944	3290	19	eruption	eruption	NN
25944	3290	20	in	in	IN
25944	3290	21	that	that	DT
25944	3290	22	condition	condition	NN
25944	3290	23	is	be	VBZ
25944	3290	24	upon	upon	IN
25944	3290	25	covered	covered	JJ
25944	3290	26	parts	part	NNS
25944	3290	27	,	,	,
25944	3290	28	especially	especially	RB
25944	3290	29	those	those	DT
25944	3290	30	parts	part	NNS
25944	3290	31	with	with	IN
25944	3290	32	which	which	WDT
25944	3290	33	the	the	DT
25944	3290	34	clothing	clothing	NN
25944	3290	35	lies	lie	VBZ
25944	3290	36	closely	closely	RB
25944	3290	37	in	in	IN
25944	3290	38	contact	contact	NN
25944	3290	39	,	,	,
25944	3290	40	as	as	IN
25944	3290	41	around	around	IN
25944	3290	42	the	the	DT
25944	3290	43	neck	neck	NN
25944	3290	44	,	,	,
25944	3290	45	across	across	IN
25944	3290	46	the	the	DT
25944	3290	47	upper	upper	JJ
25944	3290	48	part	part	NN
25944	3290	49	of	of	IN
25944	3290	50	the	the	DT
25944	3290	51	back	back	NN
25944	3290	52	,	,	,
25944	3290	53	about	about	IN
25944	3290	54	the	the	DT
25944	3290	55	waist	waist	NN
25944	3290	56	and	and	CC
25944	3290	57	down	down	IN
25944	3290	58	the	the	DT
25944	3290	59	outside	outside	NN
25944	3290	60	of	of	IN
25944	3290	61	the	the	DT
25944	3290	62	thighs	thigh	NNS
25944	3290	63	;	;	:
25944	3290	64	_	_	NNP
25944	3290	65	the	the	DT
25944	3290	66	hands	hand	NNS
25944	3290	67	are	be	VBP
25944	3290	68	free	free	JJ
25944	3290	69	_	_	NNP
25944	3290	70	.	.	.
25944	3291	1	#	#	JJR
25944	3291	2	State	state	NN
25944	3291	3	the	the	DT
25944	3291	4	prognosis	prognosis	NN
25944	3291	5	of	of	IN
25944	3291	6	scabies	scabie	NNS
25944	3291	7	.	.	.
25944	3291	8	#	#	$
25944	3291	9	It	-PRON-	PRP
25944	3291	10	is	be	VBZ
25944	3291	11	favorable	favorable	JJ
25944	3291	12	.	.	.
25944	3292	1	The	the	DT
25944	3292	2	disease	disease	NN
25944	3292	3	is	be	VBZ
25944	3292	4	readily	readily	RB
25944	3292	5	cured	cure	VBN
25944	3292	6	,	,	,
25944	3292	7	and	and	CC
25944	3292	8	,	,	,
25944	3292	9	as	as	RB
25944	3292	10	soon	soon	RB
25944	3292	11	as	as	IN
25944	3292	12	the	the	DT
25944	3292	13	parasites	parasite	NNS
25944	3292	14	and	and	CC
25944	3292	15	their	-PRON-	PRP$
25944	3292	16	ova	ova	NN
25944	3292	17	are	be	VBP
25944	3292	18	destroyed	destroy	VBN
25944	3292	19	,	,	,
25944	3292	20	the	the	DT
25944	3292	21	itching	itching	NN
25944	3292	22	and	and	CC
25944	3292	23	the	the	DT
25944	3292	24	secondary	secondary	JJ
25944	3292	25	symptoms	symptom	NNS
25944	3292	26	,	,	,
25944	3292	27	as	as	IN
25944	3292	28	a	a	DT
25944	3292	29	rule	rule	NN
25944	3292	30	,	,	,
25944	3292	31	rapidly	rapidly	RB
25944	3292	32	disappear	disappear	VBP
25944	3292	33	.	.	.
25944	3293	1	#	#	NNP
25944	3293	2	How	how	WRB
25944	3293	3	is	be	VBZ
25944	3293	4	scabies	scabie	NNS
25944	3293	5	treated	treat	VBN
25944	3293	6	?	?	.
25944	3293	7	#	#	$
25944	3293	8	Treatment	Treatment	NNP
25944	3293	9	is	be	VBZ
25944	3293	10	entirely	entirely	RB
25944	3293	11	external	external	JJ
25944	3293	12	,	,	,
25944	3293	13	and	and	CC
25944	3293	14	consists	consist	VBZ
25944	3293	15	of	of	IN
25944	3293	16	a	a	DT
25944	3293	17	preliminary	preliminary	JJ
25944	3293	18	soap	soap	NN
25944	3293	19	-	-	HYPH
25944	3293	20	and	and	CC
25944	3293	21	-	-	HYPH
25944	3293	22	hot	hot	JJ
25944	3293	23	-	-	HYPH
25944	3293	24	water	water	NN
25944	3293	25	bath	bath	NN
25944	3293	26	,	,	,
25944	3293	27	an	an	DT
25944	3293	28	application	application	NN
25944	3293	29	,	,	,
25944	3293	30	twice	twice	RB
25944	3293	31	daily	daily	JJ
25944	3293	32	for	for	IN
25944	3293	33	three	three	CD
25944	3293	34	days	day	NNS
25944	3293	35	,	,	,
25944	3293	36	of	of	IN
25944	3293	37	a	a	DT
25944	3293	38	remedy	remedy	NN
25944	3293	39	destructive	destructive	JJ
25944	3293	40	to	to	IN
25944	3293	41	the	the	DT
25944	3293	42	parasites	parasite	NNS
25944	3293	43	and	and	CC
25944	3293	44	ova	ova	NN
25944	3293	45	,	,	,
25944	3293	46	and	and	CC
25944	3293	47	finally	finally	RB
25944	3293	48	another	another	DT
25944	3293	49	bath	bath	NN
25944	3293	50	.	.	.
25944	3294	1	Inquiry	inquiry	NN
25944	3294	2	as	as	IN
25944	3294	3	to	to	IN
25944	3294	4	others	other	NNS
25944	3294	5	of	of	IN
25944	3294	6	the	the	DT
25944	3294	7	family	family	NN
25944	3294	8	should	should	MD
25944	3294	9	be	be	VB
25944	3294	10	made	make	VBN
25944	3294	11	,	,	,
25944	3294	12	and	and	CC
25944	3294	13	,	,	,
25944	3294	14	if	if	IN
25944	3294	15	affected	affect	VBN
25944	3294	16	,	,	,
25944	3294	17	treated	treat	VBN
25944	3294	18	at	at	IN
25944	3294	19	the	the	DT
25944	3294	20	same	same	JJ
25944	3294	21	time	time	NN
25944	3294	22	.	.	.
25944	3295	1	The	the	DT
25944	3295	2	wearing	wear	VBG
25944	3295	3	apparel	apparel	NN
25944	3295	4	should	should	MD
25944	3295	5	be	be	VB
25944	3295	6	looked	look	VBN
25944	3295	7	after	after	IN
25944	3295	8	--	--	:
25944	3295	9	boiled	boil	VBN
25944	3295	10	,	,	,
25944	3295	11	baked	bake	VBD
25944	3295	12	,	,	,
25944	3295	13	or	or	CC
25944	3295	14	sulphur	sulphur	NN
25944	3295	15	-	-	HYPH
25944	3295	16	fumigated	fumigate	VBN
25944	3295	17	.	.	.
25944	3296	1	#	#	JJS
25944	3296	2	What	what	WDT
25944	3296	3	remedial	remedial	JJ
25944	3296	4	applications	application	NNS
25944	3296	5	are	be	VBP
25944	3296	6	employed	employ	VBN
25944	3296	7	in	in	IN
25944	3296	8	scabies	scabie	NNS
25944	3296	9	?	?	.
25944	3296	10	#	#	NN
25944	3296	11	Sulphur	Sulphur	NNP
25944	3296	12	,	,	,
25944	3296	13	balsam	balsam	NN
25944	3296	14	of	of	IN
25944	3296	15	Peru	Peru	NNP
25944	3296	16	,	,	,
25944	3296	17	styrax	styrax	NN
25944	3296	18	,	,	,
25944	3296	19	and	and	CC
25944	3296	20	[	[	-LRB-
25944	3296	21	beta]-naphthol	beta]-naphthol	NNP
25944	3296	22	,	,	,
25944	3296	23	singly	singly	RB
25944	3296	24	or	or	CC
25944	3296	25	severally	severally	RB
25944	3296	26	combined	combined	JJ
25944	3296	27	.	.	.
25944	3297	1	In	in	IN
25944	3297	2	children	child	NNS
25944	3297	3	,	,	,
25944	3297	4	or	or	CC
25944	3297	5	in	in	IN
25944	3297	6	those	those	DT
25944	3297	7	of	of	IN
25944	3297	8	sensitive	sensitive	JJ
25944	3297	9	skin	skin	NN
25944	3297	10	,	,	,
25944	3297	11	the	the	DT
25944	3297	12	following:--	following:--	NN
25944	3297	13	[	[	-LRB-
25944	3297	14	Rx	Rx	NNP
25944	3297	15	]	]	-RRB-
25944	3297	16	Sulphur	Sulphur	NNP
25944	3297	17	.	.	.
25944	3298	1	præcip	præcip	NNP
25944	3298	2	.	.	.
25944	3298	3	,	,	,
25944	3298	4	....................	....................	NFP
25944	3298	5	[	[	-LRB-
25944	3298	6	dram]iv	dram]iv	NNP
25944	3298	7	Balsam	Balsam	NNP
25944	3298	8	.	.	.
25944	3299	1	Peruv	Peruv	NNP
25944	3299	2	.	.	NNP
25944	3299	3	,	,	,
25944	3299	4	......................	......................	NFP
25944	3299	5	[	[	-LRB-
25944	3299	6	dram]ij	dram]ij	IN
25944	3299	7	Adipis	Adipis	NNP
25944	3299	8	,	,	,
25944	3299	9	Petrolati	Petrolati	NNP
25944	3299	10	,	,	,
25944	3299	11	.........	.........	NFP
25944	3299	12	[	[	-LRB-
25944	3299	13	=	=	SYM
25944	3299	14	a][=a	a][=a	CD
25944	3299	15	]	]	-RRB-
25944	3299	16	........	........	.
25944	3299	17	[	[	-LRB-
25944	3299	18	Oz]iss	oz]iss	CD
25944	3299	19	.	.	.
25944	3300	1	M.	M.	NNP
25944	3300	2	And	and	CC
25944	3300	3	in	in	IN
25944	3300	4	adults	adult	NNS
25944	3300	5	,	,	,
25944	3300	6	or	or	CC
25944	3300	7	those	those	DT
25944	3300	8	of	of	IN
25944	3300	9	non	non	JJ
25944	3300	10	-	-	JJ
25944	3300	11	irritable	irritable	JJ
25944	3300	12	skin:--	skin:--	''
25944	3300	13	[	[	-LRB-
25944	3300	14	Rx	Rx	NNP
25944	3300	15	]	]	-RRB-
25944	3300	16	Sulphur	Sulphur	NNP
25944	3300	17	,	,	,
25944	3300	18	præcip	præcip	NN
25944	3300	19	.	.	.
25944	3300	20	,	,	,
25944	3300	21	....................	....................	NFP
25944	3300	22	[	[	-LRB-
25944	3300	23	Oz]j	Oz]j	NNP
25944	3300	24	Balsam	Balsam	NNP
25944	3300	25	.	.	.
25944	3301	1	Peruv	Peruv	NNP
25944	3301	2	.	.	NNP
25944	3301	3	,	,	,
25944	3301	4	......................	......................	NFP
25944	3301	5	[	[	-LRB-
25944	3301	6	Oz]ss	Oz]ss	NNP
25944	3301	7	[	[	-LRB-
25944	3301	8	beta]-Naphthol	beta]-Naphthol	NNP
25944	3301	9	,	,	,
25944	3301	10	.....................	.....................	NFP
25944	3301	11	[	[	-LRB-
25944	3301	12	dram]ij	dram]ij	NNP
25944	3301	13	Adipis	Adipis	NNP
25944	3301	14	,	,	,
25944	3301	15	Petrolati	Petrolati	NNP
25944	3301	16	,	,	,
25944	3301	17	...	...	NFP
25944	3301	18	[	[	-LRB-
25944	3301	19	=	=	SYM
25944	3301	20	a][=a	a][=a	CD
25944	3301	21	]	]	-RRB-
25944	3301	22	...	...	NFP
25944	3301	23	q.s	q.s	NNP
25944	3301	24	.	.	.
25944	3302	1	ad	ad	NN
25944	3302	2	..	..	.
25944	3302	3	[	[	-LRB-
25944	3302	4	Oz]iv	oz]iv	NN
25944	3302	5	.	.	.
25944	3303	1	M.	M.	NNP
25944	3303	2	Styrax	Styrax	NNP
25944	3303	3	is	be	VBZ
25944	3303	4	a	a	DT
25944	3303	5	remedy	remedy	NN
25944	3303	6	of	of	IN
25944	3303	7	value	value	NN
25944	3303	8	and	and	CC
25944	3303	9	is	be	VBZ
25944	3303	10	commonly	commonly	RB
25944	3303	11	employed	employ	VBN
25944	3303	12	as	as	IN
25944	3303	13	an	an	DT
25944	3303	14	ointment	ointment	NN
25944	3303	15	in	in	IN
25944	3303	16	the	the	DT
25944	3303	17	strength	strength	NN
25944	3303	18	of	of	IN
25944	3303	19	one	one	CD
25944	3303	20	part	part	NN
25944	3303	21	to	to	IN
25944	3303	22	two	two	CD
25944	3303	23	or	or	CC
25944	3303	24	three	three	CD
25944	3303	25	parts	part	NNS
25944	3303	26	of	of	IN
25944	3303	27	lard	lard	NN
25944	3303	28	.	.	.
25944	3304	1	#	#	$
25944	3304	2	Is	be	VBZ
25944	3304	3	one	one	CD
25944	3304	4	such	such	JJ
25944	3304	5	course	course	NN
25944	3304	6	of	of	IN
25944	3304	7	treatment	treatment	NN
25944	3304	8	sufficient	sufficient	JJ
25944	3304	9	to	to	TO
25944	3304	10	bring	bring	VB
25944	3304	11	about	about	RP
25944	3304	12	a	a	DT
25944	3304	13	cure	cure	NN
25944	3304	14	?	?	.
25944	3304	15	#	#	NN
25944	3304	16	Yes	yes	UH
25944	3304	17	,	,	,
25944	3304	18	in	in	IN
25944	3304	19	ordinary	ordinary	JJ
25944	3304	20	cases	case	NNS
25944	3304	21	,	,	,
25944	3304	22	if	if	IN
25944	3304	23	the	the	DT
25944	3304	24	applications	application	NNS
25944	3304	25	have	have	VBP
25944	3304	26	been	be	VBN
25944	3304	27	carefully	carefully	RB
25944	3304	28	and	and	CC
25944	3304	29	thoroughly	thoroughly	RB
25944	3304	30	made	make	VBN
25944	3304	31	;	;	:
25944	3304	32	exceptionally	exceptionally	RB
25944	3304	33	,	,	,
25944	3304	34	however	however	RB
25944	3304	35	,	,	,
25944	3304	36	some	some	DT
25944	3304	37	parasites	parasite	NNS
25944	3304	38	and	and	CC
25944	3304	39	ova	ova	VBP
25944	3304	40	escape	escape	NN
25944	3304	41	destruction	destruction	NN
25944	3304	42	,	,	,
25944	3304	43	and	and	CC
25944	3304	44	consequently	consequently	RB
25944	3304	45	itching	itch	VBG
25944	3304	46	will	will	MD
25944	3304	47	again	again	RB
25944	3304	48	begin	begin	VB
25944	3304	49	to	to	TO
25944	3304	50	show	show	VB
25944	3304	51	itself	-PRON-	PRP
25944	3304	52	at	at	IN
25944	3304	53	the	the	DT
25944	3304	54	end	end	NN
25944	3304	55	of	of	IN
25944	3304	56	a	a	DT
25944	3304	57	week	week	NN
25944	3304	58	or	or	CC
25944	3304	59	ten	ten	CD
25944	3304	60	days	day	NNS
25944	3304	61	,	,	,
25944	3304	62	and	and	CC
25944	3304	63	a	a	DT
25944	3304	64	repetition	repetition	NN
25944	3304	65	of	of	IN
25944	3304	66	the	the	DT
25944	3304	67	treatment	treatment	NN
25944	3304	68	become	become	VBP
25944	3304	69	necessary	necessary	JJ
25944	3304	70	.	.	.
25944	3305	1	#	#	NNP
25944	3305	2	Does	do	VBZ
25944	3305	3	the	the	DT
25944	3305	4	secondary	secondary	JJ
25944	3305	5	dermatitis	dermatitis	NN
25944	3305	6	which	which	WDT
25944	3305	7	is	be	VBZ
25944	3305	8	always	always	RB
25944	3305	9	present	present	JJ
25944	3305	10	in	in	IN
25944	3305	11	severe	severe	JJ
25944	3305	12	cases	case	NNS
25944	3305	13	require	require	VBP
25944	3305	14	treatment	treatment	NN
25944	3305	15	?	?	.
25944	3305	16	#	#	$
25944	3305	17	Only	only	RB
25944	3305	18	when	when	WRB
25944	3305	19	it	-PRON-	PRP
25944	3305	20	is	be	VBZ
25944	3305	21	unusually	unusually	RB
25944	3305	22	persistent	persistent	JJ
25944	3305	23	or	or	CC
25944	3305	24	severe	severe	JJ
25944	3305	25	;	;	:
25944	3305	26	in	in	IN
25944	3305	27	such	such	JJ
25944	3305	28	cases	case	NNS
25944	3305	29	the	the	DT
25944	3305	30	various	various	JJ
25944	3305	31	soothing	soothing	JJ
25944	3305	32	applications	application	NNS
25944	3305	33	,	,	,
25944	3305	34	lotions	lotion	NNS
25944	3305	35	or	or	CC
25944	3305	36	ointments	ointment	NNS
25944	3305	37	employed	employ	VBN
25944	3305	38	in	in	IN
25944	3305	39	acute	acute	JJ
25944	3305	40	eczema	eczema	NN
25944	3305	41	are	be	VBP
25944	3305	42	to	to	TO
25944	3305	43	be	be	VB
25944	3305	44	prescribed	prescribe	VBN
25944	3305	45	.	.	.
25944	3306	1	#	#	$
25944	3306	2	Is	be	VBZ
25944	3306	3	a	a	DT
25944	3306	4	dermatitis	dermatitis	NN
25944	3306	5	due	due	JJ
25944	3306	6	to	to	IN
25944	3306	7	too	too	RB
25944	3306	8	active	active	JJ
25944	3306	9	and	and	CC
25944	3306	10	prolonged	prolonged	JJ
25944	3306	11	treatment	treatment	NN
25944	3306	12	ever	ever	RB
25944	3306	13	mistaken	mistake	VBN
25944	3306	14	for	for	IN
25944	3306	15	persistence	persistence	NN
25944	3306	16	of	of	IN
25944	3306	17	the	the	DT
25944	3306	18	scabies	scabie	NNS
25944	3306	19	?	?	.
25944	3306	20	#	#	NN
25944	3306	21	Yes	yes	UH
25944	3306	22	.	.	.
25944	3307	1	#	#	NNP
25944	3307	2	Pediculosis	Pediculosis	NNP
25944	3307	3	.	.	.
25944	3307	4	#	#	NNP
25944	3307	5	(	(	-LRB-
25944	3307	6	_	_	NNP
25944	3307	7	Synonyms	Synonyms	NNP
25944	3307	8	:	:	:
25944	3307	9	_	_	NNP
25944	3307	10	Phtheiriasis	Phtheiriasis	NNP
25944	3307	11	;	;	:
25944	3307	12	Lousiness	Lousiness	NNP
25944	3307	13	.	.	.
25944	3307	14	)	)	-RRB-
25944	3308	1	#	#	NNP
25944	3308	2	Define	Define	NNP
25944	3308	3	pediculosis	pediculosis	NN
25944	3308	4	.	.	.
25944	3308	5	#	#	NNP
25944	3308	6	Pediculosis	Pediculosis	NNP
25944	3308	7	is	be	VBZ
25944	3308	8	a	a	DT
25944	3308	9	term	term	NN
25944	3308	10	applied	apply	VBN
25944	3308	11	to	to	IN
25944	3308	12	that	that	DT
25944	3308	13	condition	condition	NN
25944	3308	14	of	of	IN
25944	3308	15	local	local	JJ
25944	3308	16	or	or	CC
25944	3308	17	general	general	JJ
25944	3308	18	cutaneous	cutaneous	JJ
25944	3308	19	irritation	irritation	NN
25944	3308	20	due	due	IN
25944	3308	21	to	to	IN
25944	3308	22	the	the	DT
25944	3308	23	presence	presence	NN
25944	3308	24	of	of	IN
25944	3308	25	the	the	DT
25944	3308	26	animal	animal	NN
25944	3308	27	parasite	parasite	NN
25944	3308	28	,	,	,
25944	3308	29	the	the	DT
25944	3308	30	pediculus	pediculus	NN
25944	3308	31	,	,	,
25944	3308	32	or	or	CC
25944	3308	33	louse	louse	NN
25944	3308	34	.	.	.
25944	3309	1	#	#	$
25944	3309	2	Name	name	VB
25944	3309	3	the	the	DT
25944	3309	4	several	several	JJ
25944	3309	5	varieties	variety	NNS
25944	3309	6	met	meet	VBD
25944	3309	7	with	with	IN
25944	3309	8	.	.	.
25944	3309	9	#	#	$
25944	3309	10	Three	three	CD
25944	3309	11	varieties	variety	NNS
25944	3309	12	are	be	VBP
25944	3309	13	presented	present	VBN
25944	3309	14	,	,	,
25944	3309	15	named	name	VBN
25944	3309	16	according	accord	VBG
25944	3309	17	to	to	IN
25944	3309	18	the	the	DT
25944	3309	19	parts	part	NNS
25944	3309	20	involved	involve	VBN
25944	3309	21	,	,	,
25944	3309	22	pediculosis	pediculosis	NN
25944	3309	23	capitis	capitis	NN
25944	3309	24	,	,	,
25944	3309	25	pediculosis	pediculosis	NNP
25944	3309	26	corporis	corporis	NNP
25944	3309	27	,	,	,
25944	3309	28	and	and	CC
25944	3309	29	pediculosis	pediculosis	NN
25944	3309	30	pubis	pubi	VBD
25944	3309	31	;	;	:
25944	3309	32	the	the	DT
25944	3309	33	parasite	parasite	NN
25944	3309	34	in	in	IN
25944	3309	35	each	each	DT
25944	3309	36	being	be	VBG
25944	3309	37	a	a	DT
25944	3309	38	distinct	distinct	JJ
25944	3309	39	species	species	NN
25944	3309	40	of	of	IN
25944	3309	41	pediculus	pediculus	NN
25944	3309	42	.	.	.
25944	3310	1	#	#	NNP
25944	3310	2	Pediculosis	Pediculosis	NNP
25944	3310	3	Capitis	Capitis	NNP
25944	3310	4	.	.	.
25944	3310	5	#	#	$
25944	3310	6	#	#	$
25944	3310	7	Describe	describe	VB
25944	3310	8	the	the	DT
25944	3310	9	symptoms	symptom	NNS
25944	3310	10	of	of	IN
25944	3310	11	pediculosis	pediculosis	NN
25944	3310	12	capitis	capitis	NN
25944	3310	13	.	.	.
25944	3310	14	#	#	$
25944	3310	15	Pediculosis	Pediculosis	NNP
25944	3310	16	capitis	capitis	NN
25944	3310	17	(	(	-LRB-
25944	3310	18	_	_	NNP
25944	3310	19	pediculosis	pediculosis	NN
25944	3310	20	capillitii	capillitii	NNP
25944	3310	21	_	_	NNP
25944	3310	22	)	)	-RRB-
25944	3310	23	,	,	,
25944	3310	24	due	due	IN
25944	3310	25	to	to	IN
25944	3310	26	the	the	DT
25944	3310	27	presence	presence	NN
25944	3310	28	of	of	IN
25944	3310	29	the	the	DT
25944	3310	30	pediculus	pediculus	JJ
25944	3310	31	capitis	capitis	NN
25944	3310	32	,	,	,
25944	3310	33	occurs	occur	VBZ
25944	3310	34	much	much	RB
25944	3310	35	more	more	RBR
25944	3310	36	frequently	frequently	RB
25944	3310	37	in	in	IN
25944	3310	38	children	child	NNS
25944	3310	39	than	than	IN
25944	3310	40	in	in	IN
25944	3310	41	adults	adult	NNS
25944	3310	42	.	.	.
25944	3311	1	It	-PRON-	PRP
25944	3311	2	is	be	VBZ
25944	3311	3	characterized	characterize	VBN
25944	3311	4	by	by	IN
25944	3311	5	marked	mark	VBN
25944	3311	6	itching	itching	NN
25944	3311	7	,	,	,
25944	3311	8	and	and	CC
25944	3311	9	the	the	DT
25944	3311	10	formation	formation	NN
25944	3311	11	of	of	IN
25944	3311	12	various	various	JJ
25944	3311	13	inflammatory	inflammatory	JJ
25944	3311	14	lesions	lesion	NNS
25944	3311	15	,	,	,
25944	3311	16	such	such	JJ
25944	3311	17	as	as	IN
25944	3311	18	papules	papule	NNS
25944	3311	19	,	,	,
25944	3311	20	pustules	pustule	NNS
25944	3311	21	and	and	CC
25944	3311	22	excoriations	excoriation	NNS
25944	3311	23	--	--	:
25944	3311	24	resulting	result	VBG
25944	3311	25	from	from	IN
25944	3311	26	the	the	DT
25944	3311	27	irritation	irritation	NN
25944	3311	28	produced	produce	VBN
25944	3311	29	by	by	IN
25944	3311	30	the	the	DT
25944	3311	31	parasites	parasite	NNS
25944	3311	32	and	and	CC
25944	3311	33	from	from	IN
25944	3311	34	the	the	DT
25944	3311	35	scratching	scratching	NN
25944	3311	36	to	to	TO
25944	3311	37	which	which	WDT
25944	3311	38	the	the	DT
25944	3311	39	intense	intense	JJ
25944	3311	40	pruritus	pruritus	NN
25944	3311	41	gives	give	VBZ
25944	3311	42	rise	rise	NN
25944	3311	43	.	.	.
25944	3312	1	In	in	IN
25944	3312	2	fact	fact	NN
25944	3312	3	,	,	,
25944	3312	4	an	an	DT
25944	3312	5	eczematous	eczematous	JJ
25944	3312	6	eruption	eruption	NN
25944	3312	7	of	of	IN
25944	3312	8	the	the	DT
25944	3312	9	pustular	pustular	JJ
25944	3312	10	type	type	NN
25944	3312	11	soon	soon	RB
25944	3312	12	results	result	NNS
25944	3312	13	,	,	,
25944	3312	14	attended	attend	VBD
25944	3312	15	with	with	IN
25944	3312	16	more	more	JJR
25944	3312	17	or	or	CC
25944	3312	18	less	less	JJR
25944	3312	19	crust	crust	NN
25944	3312	20	formation	formation	NN
25944	3312	21	.	.	.
25944	3313	1	In	in	IN
25944	3313	2	consequence	consequence	NN
25944	3313	3	of	of	IN
25944	3313	4	the	the	DT
25944	3313	5	cutaneous	cutaneous	JJ
25944	3313	6	irritation	irritation	NN
25944	3313	7	the	the	DT
25944	3313	8	neighboring	neighboring	JJ
25944	3313	9	lymphatic	lymphatic	JJ
25944	3313	10	glands	gland	NNS
25944	3313	11	may	may	MD
25944	3313	12	become	become	VB
25944	3313	13	inflamed	inflamed	JJ
25944	3313	14	and	and	CC
25944	3313	15	swollen	swollen	JJ
25944	3313	16	,	,	,
25944	3313	17	and	and	CC
25944	3313	18	in	in	IN
25944	3313	19	rare	rare	JJ
25944	3313	20	cases	case	NNS
25944	3313	21	suppurate	suppurate	VBP
25944	3313	22	.	.	.
25944	3314	1	The	the	DT
25944	3314	2	occipital	occipital	JJ
25944	3314	3	region	region	NN
25944	3314	4	is	be	VBZ
25944	3314	5	the	the	DT
25944	3314	6	part	part	NN
25944	3314	7	which	which	WDT
25944	3314	8	is	be	VBZ
25944	3314	9	usually	usually	RB
25944	3314	10	most	most	RBS
25944	3314	11	profusely	profusely	RB
25944	3314	12	infested	infested	JJ
25944	3314	13	,	,	,
25944	3314	14	more	more	RBR
25944	3314	15	especially	especially	RB
25944	3314	16	in	in	IN
25944	3314	17	young	young	JJ
25944	3314	18	girls	girl	NNS
25944	3314	19	and	and	CC
25944	3314	20	women	woman	NNS
25944	3314	21	.	.	.
25944	3315	1	In	in	IN
25944	3315	2	those	those	DT
25944	3315	3	of	of	IN
25944	3315	4	delicate	delicate	JJ
25944	3315	5	skin	skin	NN
25944	3315	6	,	,	,
25944	3315	7	especially	especially	RB
25944	3315	8	in	in	IN
25944	3315	9	children	child	NNS
25944	3315	10	,	,	,
25944	3315	11	scattered	scatter	VBN
25944	3315	12	papules	papule	NNS
25944	3315	13	,	,	,
25944	3315	14	vesico	vesico	NN
25944	3315	15	-	-	HYPH
25944	3315	16	papules	papule	NNS
25944	3315	17	,	,	,
25944	3315	18	pustules	pustule	NNS
25944	3315	19	,	,	,
25944	3315	20	and	and	CC
25944	3315	21	excoriations	excoriation	NNS
25944	3315	22	may	may	MD
25944	3315	23	often	often	RB
25944	3315	24	be	be	VB
25944	3315	25	seen	see	VBN
25944	3315	26	upon	upon	IN
25944	3315	27	the	the	DT
25944	3315	28	forehead	forehead	NN
25944	3315	29	and	and	CC
25944	3315	30	neck	neck	NN
25944	3315	31	.	.	.
25944	3316	1	In	in	IN
25944	3316	2	some	some	DT
25944	3316	3	instances	instance	NNS
25944	3316	4	,	,	,
25944	3316	5	however	however	RB
25944	3316	6	,	,	,
25944	3316	7	especially	especially	RB
25944	3316	8	in	in	IN
25944	3316	9	boys	boy	NNS
25944	3316	10	,	,	,
25944	3316	11	there	there	EX
25944	3316	12	may	may	MD
25944	3316	13	be	be	VB
25944	3316	14	many	many	JJ
25944	3316	15	pediculi	pediculi	NNS
25944	3316	16	present	present	JJ
25944	3316	17	,	,	,
25944	3316	18	with	with	IN
25944	3316	19	but	but	CC
25944	3316	20	little	little	JJ
25944	3316	21	cutaneous	cutaneous	JJ
25944	3316	22	disturbance	disturbance	NN
25944	3316	23	,	,	,
25944	3316	24	the	the	DT
25944	3316	25	itching	itching	NN
25944	3316	26	being	be	VBG
25944	3316	27	the	the	DT
25944	3316	28	sole	sole	JJ
25944	3316	29	symptom	symptom	NN
25944	3316	30	.	.	.
25944	3317	1	[	[	-LRB-
25944	3317	2	Illustration	illustration	NN
25944	3317	3	:	:	:
25944	3317	4	Fig	Fig	NNP
25944	3317	5	.	.	.
25944	3318	1	79	79	CD
25944	3318	2	.	.	.
25944	3319	1	Pediculus	Pediculus	NNP
25944	3319	2	Capitis	Capitis	NNP
25944	3319	3	x	x	SYM
25944	3319	4	25	25	CD
25944	3319	5	.	.	.
25944	3320	1	(	(	-LRB-
25944	3320	2	_	_	NNP
25944	3320	3	After	after	IN
25944	3320	4	Duhring	Duhring	NNP
25944	3320	5	.	.	.
25944	3320	6	_	_	NNP
25944	3320	7	)	)	-RRB-
25944	3320	8	Female	Female	NNP
25944	3320	9	.	.	.
25944	3321	1	Dorsal	dorsal	NN
25944	3321	2	surface	surface	NN
25944	3321	3	.	.	.
25944	3321	4	]	]	-RRB-
25944	3322	1	In	in	IN
25944	3322	2	addition	addition	NN
25944	3322	3	to	to	IN
25944	3322	4	the	the	DT
25944	3322	5	pediculi	pediculi	NN
25944	3322	6	,	,	,
25944	3322	7	which	which	WDT
25944	3322	8	,	,	,
25944	3322	9	as	as	IN
25944	3322	10	a	a	DT
25944	3322	11	rule	rule	NN
25944	3322	12	,	,	,
25944	3322	13	may	may	MD
25944	3322	14	be	be	VB
25944	3322	15	readily	readily	RB
25944	3322	16	found	find	VBN
25944	3322	17	,	,	,
25944	3322	18	their	-PRON-	PRP$
25944	3322	19	_	_	NNP
25944	3322	20	ova	ova	NNP
25944	3322	21	_	_	NNP
25944	3322	22	,	,	,
25944	3322	23	or	or	CC
25944	3322	24	_	_	NNP
25944	3322	25	nits	nit	NNS
25944	3322	26	_	_	NNP
25944	3322	27	,	,	,
25944	3322	28	are	be	VBP
25944	3322	29	always	always	RB
25944	3322	30	to	to	TO
25944	3322	31	be	be	VB
25944	3322	32	seen	see	VBN
25944	3322	33	upon	upon	IN
25944	3322	34	the	the	DT
25944	3322	35	shaft	shaft	NN
25944	3322	36	of	of	IN
25944	3322	37	the	the	DT
25944	3322	38	hairs	hair	NNS
25944	3322	39	,	,	,
25944	3322	40	quite	quite	RB
25944	3322	41	firmly	firmly	RB
25944	3322	42	attached	attach	VBD
25944	3322	43	.	.	.
25944	3323	1	#	#	NNP
25944	3323	2	Describe	describe	VB
25944	3323	3	the	the	DT
25944	3323	4	appearance	appearance	NN
25944	3323	5	of	of	IN
25944	3323	6	the	the	DT
25944	3323	7	ova	ova	NNP
25944	3323	8	.	.	.
25944	3323	9	#	#	$
25944	3323	10	They	-PRON-	PRP
25944	3323	11	are	be	VBP
25944	3323	12	dirty	dirty	JJ
25944	3323	13	-	-	HYPH
25944	3323	14	white	white	JJ
25944	3323	15	or	or	CC
25944	3323	16	grayish	grayish	NN
25944	3323	17	looking	looking	NN
25944	3323	18	,	,	,
25944	3323	19	minute	minute	NN
25944	3323	20	,	,	,
25944	3323	21	pear	pear	NN
25944	3323	22	-	-	HYPH
25944	3323	23	shaped	shape	VBN
25944	3323	24	bodies	body	NNS
25944	3323	25	,	,	,
25944	3323	26	visible	visible	JJ
25944	3323	27	to	to	IN
25944	3323	28	the	the	DT
25944	3323	29	naked	naked	JJ
25944	3323	30	eye	eye	NN
25944	3323	31	,	,	,
25944	3323	32	and	and	CC
25944	3323	33	fastened	fasten	VBN
25944	3323	34	upon	upon	IN
25944	3323	35	the	the	DT
25944	3323	36	shaft	shaft	NN
25944	3323	37	of	of	IN
25944	3323	38	the	the	DT
25944	3323	39	hairs	hair	NNS
25944	3323	40	with	with	IN
25944	3323	41	the	the	DT
25944	3323	42	small	small	JJ
25944	3323	43	end	end	NN
25944	3323	44	toward	toward	IN
25944	3323	45	the	the	DT
25944	3323	46	root	root	NN
25944	3323	47	.	.	.
25944	3324	1	[	[	-LRB-
25944	3324	2	Illustration	illustration	NN
25944	3324	3	:	:	:
25944	3324	4	Fig	Fig	NNP
25944	3324	5	.	.	.
25944	3325	1	80	80	CD
25944	3325	2	.	.	.
25944	3326	1	Ova	ova	NN
25944	3326	2	of	of	IN
25944	3326	3	the	the	DT
25944	3326	4	head	head	NN
25944	3326	5	-	-	HYPH
25944	3326	6	louse	louse	NN
25944	3326	7	attached	attach	VBN
25944	3326	8	to	to	IN
25944	3326	9	a	a	DT
25944	3326	10	hair	hair	NN
25944	3326	11	.	.	.
25944	3327	1	Magnified	Magnified	NNP
25944	3327	2	.	.	.
25944	3328	1	(	(	-LRB-
25944	3328	2	_	_	NNP
25944	3328	3	After	after	IN
25944	3328	4	Kaposi	Kaposi	NNP
25944	3328	5	.	.	.
25944	3328	6	_	_	NNP
25944	3328	7	)	)	-RRB-
25944	3328	8	]	]	-RRB-
25944	3328	9	#	#	$
25944	3328	10	Is	be	VBZ
25944	3328	11	there	there	EX
25944	3328	12	any	any	DT
25944	3328	13	difficulty	difficulty	NN
25944	3328	14	in	in	IN
25944	3328	15	the	the	DT
25944	3328	16	diagnosis	diagnosis	NN
25944	3328	17	of	of	IN
25944	3328	18	pediculosis	pediculosis	NN
25944	3328	19	capitis	capitis	NN
25944	3328	20	?	?	.
25944	3328	21	#	#	$
25944	3328	22	No	no	UH
25944	3328	23	.	.	.
25944	3329	1	The	the	DT
25944	3329	2	diagnosis	diagnosis	NN
25944	3329	3	is	be	VBZ
25944	3329	4	readily	readily	RB
25944	3329	5	made	make	VBN
25944	3329	6	,	,	,
25944	3329	7	as	as	IN
25944	3329	8	the	the	DT
25944	3329	9	pediculi	pediculi	NN
25944	3329	10	are	be	VBP
25944	3329	11	usually	usually	RB
25944	3329	12	to	to	TO
25944	3329	13	be	be	VB
25944	3329	14	found	find	VBN
25944	3329	15	without	without	IN
25944	3329	16	difficulty	difficulty	NN
25944	3329	17	,	,	,
25944	3329	18	and	and	CC
25944	3329	19	even	even	RB
25944	3329	20	when	when	WRB
25944	3329	21	they	-PRON-	PRP
25944	3329	22	exist	exist	VBP
25944	3329	23	in	in	IN
25944	3329	24	small	small	JJ
25944	3329	25	numbers	number	NNS
25944	3329	26	and	and	CC
25944	3329	27	are	be	VBP
25944	3329	28	not	not	RB
25944	3329	29	readily	readily	RB
25944	3329	30	discovered	discover	VBN
25944	3329	31	,	,	,
25944	3329	32	_	_	NNP
25944	3329	33	the	the	DT
25944	3329	34	presence	presence	NN
25944	3329	35	of	of	IN
25944	3329	36	the	the	DT
25944	3329	37	ova	ova	NNP
25944	3329	38	_	_	NNP
25944	3329	39	will	will	MD
25944	3329	40	indicate	indicate	VB
25944	3329	41	the	the	DT
25944	3329	42	nature	nature	NN
25944	3329	43	of	of	IN
25944	3329	44	the	the	DT
25944	3329	45	affection	affection	NN
25944	3329	46	.	.	.
25944	3330	1	Pustular	pustular	JJ
25944	3330	2	eruptions	eruption	NNS
25944	3330	3	upon	upon	IN
25944	3330	4	the	the	DT
25944	3330	5	scalp	scalp	NN
25944	3330	6	,	,	,
25944	3330	7	especially	especially	RB
25944	3330	8	posteriorly	posteriorly	RB
25944	3330	9	,	,	,
25944	3330	10	should	should	MD
25944	3330	11	always	always	RB
25944	3330	12	arouse	arouse	VB
25944	3330	13	a	a	DT
25944	3330	14	suspicion	suspicion	NN
25944	3330	15	of	of	IN
25944	3330	16	pediculosis	pediculosis	NN
25944	3330	17	.	.	.
25944	3331	1	The	the	DT
25944	3331	2	possibility	possibility	NN
25944	3331	3	of	of	IN
25944	3331	4	the	the	DT
25944	3331	5	pediculosis	pediculosis	NN
25944	3331	6	being	be	VBG
25944	3331	7	secondary	secondary	JJ
25944	3331	8	to	to	IN
25944	3331	9	eczema	eczema	NN
25944	3331	10	must	must	MD
25944	3331	11	not	not	RB
25944	3331	12	be	be	VB
25944	3331	13	forgotten	forget	VBN
25944	3331	14	.	.	.
25944	3332	1	#	#	LS
25944	3332	2	What	what	WP
25944	3332	3	is	be	VBZ
25944	3332	4	the	the	DT
25944	3332	5	treatment	treatment	NN
25944	3332	6	of	of	IN
25944	3332	7	pediculosis	pediculosis	NN
25944	3332	8	capitis	capitis	NN
25944	3332	9	?	?	.
25944	3332	10	#	#	$
25944	3332	11	Treatment	Treatment	NNP
25944	3332	12	consists	consist	VBZ
25944	3332	13	in	in	IN
25944	3332	14	the	the	DT
25944	3332	15	application	application	NN
25944	3332	16	of	of	IN
25944	3332	17	some	some	DT
25944	3332	18	remedy	remedy	NN
25944	3332	19	destructive	destructive	JJ
25944	3332	20	to	to	IN
25944	3332	21	the	the	DT
25944	3332	22	pediculi	pediculi	NN
25944	3332	23	and	and	CC
25944	3332	24	their	-PRON-	PRP$
25944	3332	25	ova	ova	NN
25944	3332	26	.	.	.
25944	3333	1	Crude	crude	JJ
25944	3333	2	petroleum	petroleum	NN
25944	3333	3	is	be	VBZ
25944	3333	4	effective	effective	JJ
25944	3333	5	,	,	,
25944	3333	6	one	one	CD
25944	3333	7	or	or	CC
25944	3333	8	two	two	CD
25944	3333	9	thorough	thorough	JJ
25944	3333	10	applications	application	NNS
25944	3333	11	over	over	IN
25944	3333	12	night	night	NN
25944	3333	13	being	be	VBG
25944	3333	14	usually	usually	RB
25944	3333	15	sufficient	sufficient	JJ
25944	3333	16	;	;	:
25944	3333	17	in	in	IN
25944	3333	18	order	order	NN
25944	3333	19	to	to	TO
25944	3333	20	lessen	lessen	VB
25944	3333	21	its	-PRON-	PRP$
25944	3333	22	inflammability	inflammability	NN
25944	3333	23	,	,	,
25944	3333	24	and	and	CC
25944	3333	25	also	also	RB
25944	3333	26	to	to	TO
25944	3333	27	mask	mask	VB
25944	3333	28	its	-PRON-	PRP$
25944	3333	29	somewhat	somewhat	RB
25944	3333	30	disagreeable	disagreeable	JJ
25944	3333	31	odor	odor	NN
25944	3333	32	,	,	,
25944	3333	33	it	-PRON-	PRP
25944	3333	34	may	may	MD
25944	3333	35	be	be	VB
25944	3333	36	mixed	mix	VBN
25944	3333	37	with	with	IN
25944	3333	38	an	an	DT
25944	3333	39	equal	equal	JJ
25944	3333	40	part	part	NN
25944	3333	41	of	of	IN
25944	3333	42	olive	olive	JJ
25944	3333	43	oil	oil	NN
25944	3333	44	and	and	CC
25944	3333	45	a	a	DT
25944	3333	46	small	small	JJ
25944	3333	47	quantity	quantity	NN
25944	3333	48	of	of	IN
25944	3333	49	balsam	balsam	NN
25944	3333	50	of	of	IN
25944	3333	51	Peru	Peru	NNP
25944	3333	52	added	add	VBD
25944	3333	53	.	.	.
25944	3334	1	Tincture	tincture	NN
25944	3334	2	of	of	IN
25944	3334	3	cocculus	cocculus	NN
25944	3334	4	indicus	indicus	NN
25944	3334	5	,	,	,
25944	3334	6	pure	pure	JJ
25944	3334	7	or	or	CC
25944	3334	8	diluted	diluted	JJ
25944	3334	9	,	,	,
25944	3334	10	may	may	MD
25944	3334	11	also	also	RB
25944	3334	12	be	be	VB
25944	3334	13	applied	apply	VBN
25944	3334	14	with	with	IN
25944	3334	15	good	good	JJ
25944	3334	16	results	result	NNS
25944	3334	17	.	.	.
25944	3335	1	When	when	WRB
25944	3335	2	the	the	DT
25944	3335	3	parts	part	NNS
25944	3335	4	are	be	VBP
25944	3335	5	markedly	markedly	RB
25944	3335	6	eczematous	eczematous	JJ
25944	3335	7	,	,	,
25944	3335	8	an	an	DT
25944	3335	9	ointment	ointment	NN
25944	3335	10	of	of	IN
25944	3335	11	ammoniated	ammoniate	VBN
25944	3335	12	mercury	mercury	NN
25944	3335	13	or	or	CC
25944	3335	14	[	[	-LRB-
25944	3335	15	beta]-naphthol	beta]-naphthol	NNP
25944	3335	16	,	,	,
25944	3335	17	thirty	thirty	CD
25944	3335	18	to	to	TO
25944	3335	19	sixty	sixty	CD
25944	3335	20	grains	grain	NNS
25944	3335	21	to	to	IN
25944	3335	22	the	the	DT
25944	3335	23	ounce	ounce	NN
25944	3335	24	may	may	MD
25944	3335	25	be	be	VB
25944	3335	26	used	use	VBN
25944	3335	27	.	.	.
25944	3336	1	Daily	daily	JJ
25944	3336	2	shampooing	shampoo	VBG
25944	3336	3	with	with	IN
25944	3336	4	soap	soap	NN
25944	3336	5	and	and	CC
25944	3336	6	water	water	NN
25944	3336	7	,	,	,
25944	3336	8	and	and	CC
25944	3336	9	the	the	DT
25944	3336	10	twice	twice	RB
25944	3336	11	daily	daily	JJ
25944	3336	12	application	application	NN
25944	3336	13	of	of	IN
25944	3336	14	a	a	DT
25944	3336	15	five	five	CD
25944	3336	16	per	per	NN
25944	3336	17	cent	cent	NN
25944	3336	18	.	.	.
25944	3337	1	carbolic	carbolic	JJ
25944	3337	2	acid	acid	NNP
25944	3337	3	lotion	lotion	NN
25944	3337	4	,	,	,
25944	3337	5	together	together	RB
25944	3337	6	with	with	IN
25944	3337	7	the	the	DT
25944	3337	8	use	use	NN
25944	3337	9	of	of	IN
25944	3337	10	a	a	DT
25944	3337	11	fine	fine	RB
25944	3337	12	-	-	HYPH
25944	3337	13	toothed	toothed	JJ
25944	3337	14	comb	comb	NN
25944	3337	15	,	,	,
25944	3337	16	is	be	VBZ
25944	3337	17	a	a	DT
25944	3337	18	safe	safe	JJ
25944	3337	19	and	and	CC
25944	3337	20	efficient	efficient	JJ
25944	3337	21	method	method	NN
25944	3337	22	for	for	IN
25944	3337	23	dispensary	dispensary	JJ
25944	3337	24	practice	practice	NN
25944	3337	25	;	;	:
25944	3337	26	as	as	IN
25944	3337	27	it	-PRON-	PRP
25944	3337	28	is	be	VBZ
25944	3337	29	,	,	,
25944	3337	30	indeed	indeed	RB
25944	3337	31	,	,	,
25944	3337	32	for	for	IN
25944	3337	33	any	any	DT
25944	3337	34	class	class	NN
25944	3337	35	of	of	IN
25944	3337	36	patients	patient	NNS
25944	3337	37	.	.	.
25944	3338	1	#	#	NNP
25944	3338	2	How	how	WRB
25944	3338	3	are	be	VBP
25944	3338	4	the	the	DT
25944	3338	5	ova	ova	NN
25944	3338	6	or	or	CC
25944	3338	7	their	-PRON-	PRP$
25944	3338	8	shells	shell	NNS
25944	3338	9	to	to	TO
25944	3338	10	be	be	VB
25944	3338	11	removed	remove	VBN
25944	3338	12	from	from	IN
25944	3338	13	the	the	DT
25944	3338	14	hair	hair	NN
25944	3338	15	?	?	.
25944	3338	16	#	#	$
25944	3338	17	By	by	IN
25944	3338	18	the	the	DT
25944	3338	19	frequent	frequent	JJ
25944	3338	20	use	use	NN
25944	3338	21	of	of	IN
25944	3338	22	acid	acid	NN
25944	3338	23	or	or	CC
25944	3338	24	alkaline	alkaline	NN
25944	3338	25	lotions	lotion	NNS
25944	3338	26	,	,	,
25944	3338	27	such	such	JJ
25944	3338	28	as	as	IN
25944	3338	29	dilute	dilute	NN
25944	3338	30	acetic	acetic	JJ
25944	3338	31	acid	acid	NN
25944	3338	32	and	and	CC
25944	3338	33	vinegar	vinegar	NN
25944	3338	34	,	,	,
25944	3338	35	or	or	CC
25944	3338	36	solutions	solution	NNS
25944	3338	37	of	of	IN
25944	3338	38	sodium	sodium	NN
25944	3338	39	carbonate	carbonate	NN
25944	3338	40	and	and	CC
25944	3338	41	borax	borax	NNS
25944	3338	42	.	.	.
25944	3339	1	#	#	NNP
25944	3339	2	Pediculosis	Pediculosis	NNP
25944	3339	3	Corporis	Corporis	NNP
25944	3339	4	.	.	.
25944	3339	5	#	#	$
25944	3339	6	#	#	$
25944	3339	7	Describe	describe	VB
25944	3339	8	the	the	DT
25944	3339	9	symptoms	symptom	NNS
25944	3339	10	of	of	IN
25944	3339	11	pediculosis	pediculosis	NN
25944	3339	12	corporis	corporis	NNP
25944	3339	13	.	.	.
25944	3339	14	#	#	$
25944	3339	15	Pediculosis	Pediculosis	NNP
25944	3339	16	corporis	corporis	NNP
25944	3339	17	is	be	VBZ
25944	3339	18	dependent	dependent	JJ
25944	3339	19	upon	upon	IN
25944	3339	20	the	the	DT
25944	3339	21	presence	presence	NN
25944	3339	22	of	of	IN
25944	3339	23	the	the	DT
25944	3339	24	pediculus	pediculus	NNP
25944	3339	25	corporis	corporis	NNP
25944	3339	26	(	(	-LRB-
25944	3339	27	_	_	NNP
25944	3339	28	pediculus	pediculus	NN
25944	3339	29	vestimenti	vestimenti	NNP
25944	3339	30	_	_	NNP
25944	3339	31	)	)	-RRB-
25944	3339	32	,	,	,
25944	3339	33	a	a	DT
25944	3339	34	larger	large	JJR
25944	3339	35	variety	variety	NN
25944	3339	36	than	than	IN
25944	3339	37	that	that	DT
25944	3339	38	infesting	infest	VBG
25944	3339	39	the	the	DT
25944	3339	40	scalp	scalp	NN
25944	3339	41	.	.	.
25944	3340	1	It	-PRON-	PRP
25944	3340	2	is	be	VBZ
25944	3340	3	characterized	characterize	VBN
25944	3340	4	by	by	IN
25944	3340	5	more	more	RBR
25944	3340	6	or	or	CC
25944	3340	7	less	less	RBR
25944	3340	8	general	general	JJ
25944	3340	9	itching	itching	NN
25944	3340	10	,	,	,
25944	3340	11	together	together	RB
25944	3340	12	with	with	IN
25944	3340	13	various	various	JJ
25944	3340	14	inflammatory	inflammatory	JJ
25944	3340	15	lesions	lesion	NNS
25944	3340	16	and	and	CC
25944	3340	17	excoriations	excoriation	NNS
25944	3340	18	.	.	.
25944	3341	1	As	as	IN
25944	3341	2	the	the	DT
25944	3341	3	parasites	parasite	NNS
25944	3341	4	are	be	VBP
25944	3341	5	to	to	TO
25944	3341	6	be	be	VB
25944	3341	7	found	find	VBN
25944	3341	8	chiefly	chiefly	RB
25944	3341	9	in	in	IN
25944	3341	10	the	the	DT
25944	3341	11	folds	fold	NNS
25944	3341	12	and	and	CC
25944	3341	13	seams	seam	NNS
25944	3341	14	of	of	IN
25944	3341	15	the	the	DT
25944	3341	16	clothing	clothing	NN
25944	3341	17	,	,	,
25944	3341	18	visiting	visit	VBG
25944	3341	19	the	the	DT
25944	3341	20	skin	skin	NN
25944	3341	21	for	for	IN
25944	3341	22	the	the	DT
25944	3341	23	purpose	purpose	NN
25944	3341	24	of	of	IN
25944	3341	25	feeding	feeding	NN
25944	3341	26	,	,	,
25944	3341	27	the	the	DT
25944	3341	28	various	various	JJ
25944	3341	29	symptoms	symptom	NNS
25944	3341	30	--	--	:
25944	3341	31	the	the	DT
25944	3341	32	minute	minute	JJ
25944	3341	33	hemorrhagic	hemorrhagic	JJ
25944	3341	34	puncta	puncta	NN
25944	3341	35	showing	show	VBG
25944	3341	36	the	the	DT
25944	3341	37	points	point	NNS
25944	3341	38	at	at	IN
25944	3341	39	which	which	WDT
25944	3341	40	they	-PRON-	PRP
25944	3341	41	have	have	VBP
25944	3341	42	been	be	VBN
25944	3341	43	sucking	suck	VBG
25944	3341	44	,	,	,
25944	3341	45	and	and	CC
25944	3341	46	the	the	DT
25944	3341	47	consequent	consequent	JJ
25944	3341	48	papules	papule	NNS
25944	3341	49	,	,	,
25944	3341	50	pustules	pustule	NNS
25944	3341	51	and	and	CC
25944	3341	52	excoriations	excoriation	NNS
25944	3341	53	--	--	:
25944	3341	54	are	be	VBP
25944	3341	55	,	,	,
25944	3341	56	therefore	therefore	RB
25944	3341	57	,	,	,
25944	3341	58	to	to	TO
25944	3341	59	be	be	VB
25944	3341	60	found	find	VBN
25944	3341	61	most	most	RBS
25944	3341	62	abundantly	abundantly	RB
25944	3341	63	on	on	IN
25944	3341	64	those	those	DT
25944	3341	65	parts	part	NNS
25944	3341	66	with	with	IN
25944	3341	67	which	which	WDT
25944	3341	68	the	the	DT
25944	3341	69	clothing	clothing	NN
25944	3341	70	comes	come	VBZ
25944	3341	71	closely	closely	RB
25944	3341	72	in	in	IN
25944	3341	73	contact	contact	NN
25944	3341	74	,	,	,
25944	3341	75	as	as	IN
25944	3341	76	,	,	,
25944	3341	77	for	for	IN
25944	3341	78	instance	instance	NN
25944	3341	79	,	,	,
25944	3341	80	around	around	IN
25944	3341	81	the	the	DT
25944	3341	82	neck	neck	NN
25944	3341	83	,	,	,
25944	3341	84	across	across	IN
25944	3341	85	the	the	DT
25944	3341	86	shoulders	shoulder	NNS
25944	3341	87	,	,	,
25944	3341	88	around	around	IN
25944	3341	89	the	the	DT
25944	3341	90	waist	waist	NN
25944	3341	91	,	,	,
25944	3341	92	and	and	CC
25944	3341	93	down	down	IN
25944	3341	94	the	the	DT
25944	3341	95	outside	outside	NN
25944	3341	96	of	of	IN
25944	3341	97	the	the	DT
25944	3341	98	thighs	thigh	NNS
25944	3341	99	.	.	.
25944	3342	1	It	-PRON-	PRP
25944	3342	2	is	be	VBZ
25944	3342	3	uncommon	uncommon	JJ
25944	3342	4	in	in	IN
25944	3342	5	children	child	NNS
25944	3342	6	.	.	.
25944	3343	1	[	[	-LRB-
25944	3343	2	Illustration	illustration	NN
25944	3343	3	:	:	:
25944	3343	4	Fig	Fig	NNP
25944	3343	5	.	.	.
25944	3344	1	81	81	CD
25944	3344	2	.	.	.
25944	3345	1	Pediculus	Pediculus	NNP
25944	3345	2	Corporis	Corporis	NNP
25944	3345	3	x	x	SYM
25944	3345	4	25	25	CD
25944	3345	5	.	.	.
25944	3346	1	(	(	-LRB-
25944	3346	2	_	_	NNP
25944	3346	3	After	after	IN
25944	3346	4	Duhring	Duhring	NNP
25944	3346	5	.	.	.
25944	3346	6	_	_	NNP
25944	3346	7	)	)	-RRB-
25944	3346	8	Female	Female	NNP
25944	3346	9	.	.	.
25944	3347	1	Dorsal	dorsal	NN
25944	3347	2	surface	surface	NN
25944	3347	3	.	.	.
25944	3347	4	]	]	-RRB-
25944	3348	1	#	#	JJR
25944	3348	2	State	state	NN
25944	3348	3	the	the	DT
25944	3348	4	diagnostic	diagnostic	JJ
25944	3348	5	characters	character	NNS
25944	3348	6	of	of	IN
25944	3348	7	pediculosis	pediculosis	NN
25944	3348	8	corporis	corporis	NN
25944	3348	9	.	.	.
25944	3348	10	#	#	$
25944	3348	11	The	the	DT
25944	3348	12	presence	presence	NN
25944	3348	13	of	of	IN
25944	3348	14	the	the	DT
25944	3348	15	minute	minute	JJ
25944	3348	16	hemorrhagic	hemorrhagic	JJ
25944	3348	17	puncta	puncta	NN
25944	3348	18	,	,	,
25944	3348	19	the	the	DT
25944	3348	20	multiform	multiform	NN
25944	3348	21	character	character	NN
25944	3348	22	and	and	CC
25944	3348	23	peculiar	peculiar	JJ
25944	3348	24	distribution	distribution	NN
25944	3348	25	of	of	IN
25944	3348	26	the	the	DT
25944	3348	27	eruption	eruption	NN
25944	3348	28	.	.	.
25944	3349	1	Careful	careful	JJ
25944	3349	2	search	search	NN
25944	3349	3	will	will	MD
25944	3349	4	almost	almost	RB
25944	3349	5	invariably	invariably	RB
25944	3349	6	disclose	disclose	VB
25944	3349	7	one	one	CD
25944	3349	8	or	or	CC
25944	3349	9	more	more	JJR
25944	3349	10	pediculi	pediculi	NN
25944	3349	11	.	.	.
25944	3350	1	#	#	LS
25944	3350	2	What	what	WP
25944	3350	3	is	be	VBZ
25944	3350	4	the	the	DT
25944	3350	5	treatment	treatment	NN
25944	3350	6	of	of	IN
25944	3350	7	pediculosis	pediculosis	NN
25944	3350	8	corporis	corporis	NN
25944	3350	9	?	?	.
25944	3350	10	#	#	$
25944	3350	11	The	the	DT
25944	3350	12	clothing	clothing	NN
25944	3350	13	and	and	CC
25944	3350	14	bed	bed	NN
25944	3350	15	-	-	HYPH
25944	3350	16	coverings	covering	NNS
25944	3350	17	are	be	VBP
25944	3350	18	to	to	TO
25944	3350	19	be	be	VB
25944	3350	20	thoroughly	thoroughly	RB
25944	3350	21	baked	bake	VBN
25944	3350	22	or	or	CC
25944	3350	23	boiled	boil	VBN
25944	3350	24	,	,	,
25944	3350	25	the	the	DT
25944	3350	26	pediculi	pediculi	NN
25944	3350	27	and	and	CC
25944	3350	28	their	-PRON-	PRP$
25944	3350	29	ova	ova	NN
25944	3350	30	being	being	NN
25944	3350	31	in	in	IN
25944	3350	32	this	this	DT
25944	3350	33	manner	manner	NN
25944	3350	34	destroyed	destroy	VBN
25944	3350	35	;	;	:
25944	3350	36	a	a	DT
25944	3350	37	thymol	thymol	NN
25944	3350	38	or	or	CC
25944	3350	39	carbolized	carbolize	VBN
25944	3350	40	boric	boric	NN
25944	3350	41	-	-	HYPH
25944	3350	42	acid	acid	NN
25944	3350	43	lotion	lotion	NN
25944	3350	44	may	may	MD
25944	3350	45	be	be	VB
25944	3350	46	used	use	VBN
25944	3350	47	to	to	TO
25944	3350	48	relieve	relieve	VB
25944	3350	49	the	the	DT
25944	3350	50	cutaneous	cutaneous	JJ
25944	3350	51	irritation	irritation	NN
25944	3350	52	.	.	.
25944	3351	1	When	when	WRB
25944	3351	2	attention	attention	NN
25944	3351	3	to	to	IN
25944	3351	4	the	the	DT
25944	3351	5	wearing	wear	VBG
25944	3351	6	apparel	apparel	NN
25944	3351	7	is	be	VBZ
25944	3351	8	not	not	RB
25944	3351	9	immediately	immediately	RB
25944	3351	10	practicable	practicable	JJ
25944	3351	11	,	,	,
25944	3351	12	ointments	ointment	NNS
25944	3351	13	of	of	IN
25944	3351	14	sulphur	sulphur	NNP
25944	3351	15	and	and	CC
25944	3351	16	staphisagria	staphisagria	NNP
25944	3351	17	,	,	,
25944	3351	18	and	and	CC
25944	3351	19	lotions	lotion	NNS
25944	3351	20	of	of	IN
25944	3351	21	carbolic	carbolic	JJ
25944	3351	22	acid	acid	NN
25944	3351	23	,	,	,
25944	3351	24	may	may	MD
25944	3351	25	be	be	VB
25944	3351	26	advised	advise	VBN
25944	3351	27	as	as	IN
25944	3351	28	temporary	temporary	JJ
25944	3351	29	measures	measure	NNS
25944	3351	30	.	.	.
25944	3352	1	The	the	DT
25944	3352	2	wearing	wear	VBG
25944	3352	3	of	of	IN
25944	3352	4	a	a	DT
25944	3352	5	bag	bag	NN
25944	3352	6	of	of	IN
25944	3352	7	loosely	loosely	RB
25944	3352	8	woven	weave	VBN
25944	3352	9	texture	texture	NN
25944	3352	10	containing	contain	VBG
25944	3352	11	some	some	DT
25944	3352	12	lump	lump	NN
25944	3352	13	sulphur	sulphur	NNP
25944	3352	14	next	next	RB
25944	3352	15	to	to	IN
25944	3352	16	the	the	DT
25944	3352	17	skin	skin	NN
25944	3352	18	is	be	VBZ
25944	3352	19	useful	useful	JJ
25944	3352	20	in	in	IN
25944	3352	21	such	such	JJ
25944	3352	22	cases	case	NNS
25944	3352	23	;	;	:
25944	3352	24	at	at	IN
25944	3352	25	the	the	DT
25944	3352	26	temperature	temperature	NN
25944	3352	27	of	of	IN
25944	3352	28	the	the	DT
25944	3352	29	body	body	NN
25944	3352	30	the	the	DT
25944	3352	31	sulphur	sulphur	NN
25944	3352	32	undergoes	undergo	VBZ
25944	3352	33	slow	slow	JJ
25944	3352	34	oxidation	oxidation	NN
25944	3352	35	.	.	.
25944	3353	1	In	in	IN
25944	3353	2	hairy	hairy	JJ
25944	3353	3	individuals	individual	NNS
25944	3353	4	the	the	DT
25944	3353	5	malady	malady	JJ
25944	3353	6	is	be	VBZ
25944	3353	7	often	often	RB
25944	3353	8	persistent	persistent	JJ
25944	3353	9	,	,	,
25944	3353	10	due	due	IN
25944	3353	11	to	to	IN
25944	3353	12	the	the	DT
25944	3353	13	fact	fact	NN
25944	3353	14	that	that	IN
25944	3353	15	ova	ova	NNP
25944	3353	16	have	have	VBP
25944	3353	17	become	become	VBN
25944	3353	18	attached	attach	VBN
25944	3353	19	to	to	IN
25944	3353	20	the	the	DT
25944	3353	21	hair	hair	NN
25944	3353	22	and	and	CC
25944	3353	23	a	a	DT
25944	3353	24	new	new	JJ
25944	3353	25	progeny	progeny	NN
25944	3353	26	soon	soon	RB
25944	3353	27	hatched	hatch	VBD
25944	3353	28	out	out	RP
25944	3353	29	.	.	.
25944	3354	1	Continued	continued	JJ
25944	3354	2	treatment	treatment	NN
25944	3354	3	over	over	IN
25944	3354	4	a	a	DT
25944	3354	5	few	few	JJ
25944	3354	6	weeks	week	NNS
25944	3354	7	will	will	MD
25944	3354	8	usually	usually	RB
25944	3354	9	suffice	suffice	VB
25944	3354	10	to	to	TO
25944	3354	11	rid	rid	VB
25944	3354	12	the	the	DT
25944	3354	13	patient	patient	NN
25944	3354	14	of	of	IN
25944	3354	15	their	-PRON-	PRP$
25944	3354	16	presence	presence	NN
25944	3354	17	.	.	.
25944	3355	1	#	#	NNP
25944	3355	2	Pediculosis	Pediculosis	NNP
25944	3355	3	Pubis	Pubis	NNP
25944	3355	4	.	.	.
25944	3355	5	#	#	$
25944	3355	6	#	#	$
25944	3355	7	Describe	describe	VB
25944	3355	8	the	the	DT
25944	3355	9	symptoms	symptom	NNS
25944	3355	10	of	of	IN
25944	3355	11	pediculosis	pediculosis	NN
25944	3355	12	pubis	pubi	VBD
25944	3355	13	.	.	.
25944	3355	14	#	#	NNP
25944	3355	15	Pediculosis	Pediculosis	NNP
25944	3355	16	pubis	pubi	VBD
25944	3355	17	is	be	VBZ
25944	3355	18	a	a	DT
25944	3355	19	condition	condition	NN
25944	3355	20	due	due	IN
25944	3355	21	to	to	IN
25944	3355	22	the	the	DT
25944	3355	23	presence	presence	NN
25944	3355	24	of	of	IN
25944	3355	25	the	the	DT
25944	3355	26	pediculus	pediculus	NN
25944	3355	27	pubis	pubi	VBD
25944	3355	28	,	,	,
25944	3355	29	or	or	CC
25944	3355	30	crab	crab	NN
25944	3355	31	-	-	HYPH
25944	3355	32	louse	louse	NN
25944	3355	33	.	.	.
25944	3356	1	It	-PRON-	PRP
25944	3356	2	is	be	VBZ
25944	3356	3	characterized	characterize	VBN
25944	3356	4	by	by	IN
25944	3356	5	more	more	JJR
25944	3356	6	or	or	CC
25944	3356	7	less	less	RBR
25944	3356	8	itching	itch	VBG
25944	3356	9	about	about	IN
25944	3356	10	the	the	DT
25944	3356	11	genitalia	genitalia	NNP
25944	3356	12	,	,	,
25944	3356	13	together	together	RB
25944	3356	14	with	with	IN
25944	3356	15	papules	papule	NNS
25944	3356	16	,	,	,
25944	3356	17	excoriations	excoriation	NNS
25944	3356	18	,	,	,
25944	3356	19	and	and	CC
25944	3356	20	other	other	JJ
25944	3356	21	inflammatory	inflammatory	JJ
25944	3356	22	lesions	lesion	NNS
25944	3356	23	.	.	.
25944	3357	1	The	the	DT
25944	3357	2	amount	amount	NN
25944	3357	3	of	of	IN
25944	3357	4	irritation	irritation	NN
25944	3357	5	varies	varie	NNS
25944	3357	6	;	;	:
25944	3357	7	it	-PRON-	PRP
25944	3357	8	may	may	MD
25944	3357	9	be	be	VB
25944	3357	10	slight	slight	JJ
25944	3357	11	,	,	,
25944	3357	12	or	or	CC
25944	3357	13	,	,	,
25944	3357	14	on	on	IN
25944	3357	15	the	the	DT
25944	3357	16	other	other	JJ
25944	3357	17	hand	hand	NN
25944	3357	18	,	,	,
25944	3357	19	severe	severe	JJ
25944	3357	20	.	.	.
25944	3358	1	The	the	DT
25944	3358	2	parasite	parasite	NN
25944	3358	3	,	,	,
25944	3358	4	which	which	WDT
25944	3358	5	is	be	VBZ
25944	3358	6	the	the	DT
25944	3358	7	smallest	small	JJS
25944	3358	8	of	of	IN
25944	3358	9	the	the	DT
25944	3358	10	three	three	CD
25944	3358	11	varieties	variety	NNS
25944	3358	12	,	,	,
25944	3358	13	may	may	MD
25944	3358	14	be	be	VB
25944	3358	15	discovered	discover	VBN
25944	3358	16	upon	upon	IN
25944	3358	17	close	close	JJ
25944	3358	18	examination	examination	NN
25944	3358	19	seated	seat	VBN
25944	3358	20	near	near	IN
25944	3358	21	the	the	DT
25944	3358	22	roots	root	NNS
25944	3358	23	of	of	IN
25944	3358	24	the	the	DT
25944	3358	25	hairs	hair	NNS
25944	3358	26	,	,	,
25944	3358	27	clutching	clutch	VBG
25944	3358	28	the	the	DT
25944	3358	29	hair	hair	NN
25944	3358	30	,	,	,
25944	3358	31	with	with	IN
25944	3358	32	its	-PRON-	PRP$
25944	3358	33	head	head	NN
25944	3358	34	downward	downward	RB
25944	3358	35	and	and	CC
25944	3358	36	buried	bury	VBN
25944	3358	37	in	in	IN
25944	3358	38	the	the	DT
25944	3358	39	follicle	follicle	NN
25944	3358	40	.	.	.
25944	3359	1	The	the	DT
25944	3359	2	ova	ova	NN
25944	3359	3	may	may	MD
25944	3359	4	be	be	VB
25944	3359	5	seen	see	VBN
25944	3359	6	attached	attach	VBN
25944	3359	7	to	to	IN
25944	3359	8	the	the	DT
25944	3359	9	hair	hair	NN
25944	3359	10	-	-	HYPH
25944	3359	11	shafts	shaft	NNS
25944	3359	12	.	.	.
25944	3360	1	It	-PRON-	PRP
25944	3360	2	infests	infest	VBZ
25944	3360	3	adults	adult	NNS
25944	3360	4	chiefly	chiefly	RB
25944	3360	5	,	,	,
25944	3360	6	being	be	VBG
25944	3360	7	in	in	IN
25944	3360	8	many	many	JJ
25944	3360	9	instances	instance	NNS
25944	3360	10	probably	probably	RB
25944	3360	11	contracted	contract	VBN
25944	3360	12	through	through	IN
25944	3360	13	sexual	sexual	JJ
25944	3360	14	intercourse	intercourse	NN
25944	3360	15	.	.	.
25944	3361	1	#	#	$
25944	3361	2	Is	be	VBZ
25944	3361	3	the	the	DT
25944	3361	4	pediculus	pediculus	NN
25944	3361	5	pubis	pubi	VBN
25944	3361	6	found	find	VBN
25944	3361	7	upon	upon	IN
25944	3361	8	any	any	DT
25944	3361	9	other	other	JJ
25944	3361	10	part	part	NN
25944	3361	11	of	of	IN
25944	3361	12	the	the	DT
25944	3361	13	body	body	NN
25944	3361	14	?	?	.
25944	3361	15	#	#	NN
25944	3361	16	Yes	yes	UH
25944	3361	17	.	.	.
25944	3362	1	Although	although	IN
25944	3362	2	its	-PRON-	PRP$
25944	3362	3	favorite	favorite	JJ
25944	3362	4	habitat	habitat	NN
25944	3362	5	is	be	VBZ
25944	3362	6	the	the	DT
25944	3362	7	region	region	NN
25944	3362	8	of	of	IN
25944	3362	9	the	the	DT
25944	3362	10	pubes	pubis	NNS
25944	3362	11	,	,	,
25944	3362	12	it	-PRON-	PRP
25944	3362	13	may	may	MD
25944	3362	14	,	,	,
25944	3362	15	in	in	IN
25944	3362	16	exceptional	exceptional	JJ
25944	3362	17	instances	instance	NNS
25944	3362	18	,	,	,
25944	3362	19	also	also	RB
25944	3362	20	infest	infest	VBZ
25944	3362	21	the	the	DT
25944	3362	22	axillæ	axillæ	NN
25944	3362	23	,	,	,
25944	3362	24	the	the	DT
25944	3362	25	sternal	sternal	JJ
25944	3362	26	region	region	NN
25944	3362	27	of	of	IN
25944	3362	28	the	the	DT
25944	3362	29	male	male	NN
25944	3362	30	,	,	,
25944	3362	31	the	the	DT
25944	3362	32	beard	beard	NN
25944	3362	33	,	,	,
25944	3362	34	eyebrows	eyebrow	NNS
25944	3362	35	,	,	,
25944	3362	36	and	and	CC
25944	3362	37	even	even	RB
25944	3362	38	the	the	DT
25944	3362	39	eyelashes	eyelash	NNS
25944	3362	40	.	.	.
25944	3363	1	#	#	JJR
25944	3363	2	State	state	NN
25944	3363	3	the	the	DT
25944	3363	4	diagnostic	diagnostic	JJ
25944	3363	5	characters	character	NNS
25944	3363	6	of	of	IN
25944	3363	7	pediculosis	pediculosis	NN
25944	3363	8	pubis	pubi	VBD
25944	3363	9	.	.	.
25944	3363	10	#	#	$
25944	3363	11	The	the	DT
25944	3363	12	region	region	NN
25944	3363	13	involved	involve	VBN
25944	3363	14	,	,	,
25944	3363	15	itching	itching	NN
25944	3363	16	,	,	,
25944	3363	17	variable	variable	JJ
25944	3363	18	amount	amount	NN
25944	3363	19	of	of	IN
25944	3363	20	irritation	irritation	NN
25944	3363	21	,	,	,
25944	3363	22	and	and	CC
25944	3363	23	,	,	,
25944	3363	24	above	above	IN
25944	3363	25	all	all	DT
25944	3363	26	,	,	,
25944	3363	27	the	the	DT
25944	3363	28	presence	presence	NN
25944	3363	29	of	of	IN
25944	3363	30	the	the	DT
25944	3363	31	pediculi	pediculi	NN
25944	3363	32	and	and	CC
25944	3363	33	their	-PRON-	PRP$
25944	3363	34	ova	ova	NN
25944	3363	35	.	.	.
25944	3364	1	[	[	-LRB-
25944	3364	2	Illustration	illustration	NN
25944	3364	3	:	:	:
25944	3364	4	Fig	Fig	NNP
25944	3364	5	.	.	.
25944	3365	1	82	82	CD
25944	3365	2	.	.	.
25944	3366	1	Pediculus	Pediculus	NNP
25944	3366	2	Pubis	Pubis	NNP
25944	3366	3	x	x	SYM
25944	3366	4	25	25	CD
25944	3366	5	.	.	.
25944	3367	1	(	(	-LRB-
25944	3367	2	_	_	NNP
25944	3367	3	After	after	IN
25944	3367	4	Duhring	Duhring	NNP
25944	3367	5	.	.	.
25944	3367	6	_	_	NNP
25944	3367	7	)	)	-RRB-
25944	3367	8	Female	Female	NNP
25944	3367	9	.	.	.
25944	3368	1	Dorsal	dorsal	NN
25944	3368	2	surface	surface	NN
25944	3368	3	.	.	.
25944	3368	4	]	]	-RRB-
25944	3369	1	#	#	$
25944	3369	2	Name	name	VB
25944	3369	3	several	several	JJ
25944	3369	4	applications	application	NNS
25944	3369	5	prescribed	prescribe	VBN
25944	3369	6	for	for	IN
25944	3369	7	pediculosis	pediculosis	NN
25944	3369	8	pubis	pubi	VBD
25944	3369	9	.	.	.
25944	3369	10	#	#	$
25944	3369	11	A	a	DT
25944	3369	12	lotion	lotion	NN
25944	3369	13	of	of	IN
25944	3369	14	corrosive	corrosive	JJ
25944	3369	15	sublimate	sublimate	NN
25944	3369	16	,	,	,
25944	3369	17	one	one	CD
25944	3369	18	to	to	TO
25944	3369	19	four	four	CD
25944	3369	20	grains	grain	NNS
25944	3369	21	to	to	IN
25944	3369	22	the	the	DT
25944	3369	23	ounce	ounce	NN
25944	3369	24	;	;	:
25944	3369	25	infusion	infusion	NN
25944	3369	26	of	of	IN
25944	3369	27	tobacco	tobacco	NN
25944	3369	28	;	;	:
25944	3369	29	a	a	DT
25944	3369	30	ten	ten	CD
25944	3369	31	to	to	TO
25944	3369	32	twenty	twenty	CD
25944	3369	33	per	per	IN
25944	3369	34	cent	cent	NN
25944	3369	35	.	.	.
25944	3370	1	ointment	ointment	NN
25944	3370	2	of	of	IN
25944	3370	3	oleate	oleate	NN
25944	3370	4	of	of	IN
25944	3370	5	mercury	mercury	NNP
25944	3370	6	;	;	,
25944	3370	7	ammoniated	ammoniate	VBD
25944	3370	8	mercury	mercury	NNP
25944	3370	9	ointment	ointment	NNP
25944	3370	10	,	,	,
25944	3370	11	and	and	CC
25944	3370	12	a	a	DT
25944	3370	13	five	five	CD
25944	3370	14	to	to	TO
25944	3370	15	ten	ten	CD
25944	3370	16	per	per	IN
25944	3370	17	cent	cent	NN
25944	3370	18	.	.	.
25944	3371	1	[	[	-LRB-
25944	3371	2	beta]-naphthol	beta]-naphthol	NNP
25944	3371	3	ointment	ointment	NNP
25944	3371	4	.	.	.
25944	3372	1	Repeated	repeat	VBN
25944	3372	2	washings	washing	NNS
25944	3372	3	with	with	IN
25944	3372	4	vinegar	vinegar	NN
25944	3372	5	or	or	CC
25944	3372	6	dilute	dilute	NN
25944	3372	7	acetic	acetic	JJ
25944	3372	8	acid	acid	NN
25944	3372	9	,	,	,
25944	3372	10	or	or	CC
25944	3372	11	with	with	IN
25944	3372	12	alkaline	alkaline	NN
25944	3372	13	lotions	lotion	NNS
25944	3372	14	,	,	,
25944	3372	15	will	will	MD
25944	3372	16	free	free	VB
25944	3372	17	the	the	DT
25944	3372	18	hairs	hair	NNS
25944	3372	19	of	of	IN
25944	3372	20	the	the	DT
25944	3372	21	ova	ova	NNP
25944	3372	22	.	.	.
25944	3373	1	#	#	NNP
25944	3373	2	Cysticercus	Cysticercus	NNP
25944	3373	3	Cellulosæ	Cellulosæ	NNP
25944	3373	4	.	.	.
25944	3373	5	#	#	$
25944	3373	6	#	#	$
25944	3373	7	Describe	describe	VB
25944	3373	8	the	the	DT
25944	3373	9	cutaneous	cutaneous	JJ
25944	3373	10	disturbance	disturbance	NN
25944	3373	11	produced	produce	VBN
25944	3373	12	by	by	IN
25944	3373	13	the	the	DT
25944	3373	14	cysticercus	cysticercus	NNP
25944	3373	15	cellulosæ	cellulosæ	NNP
25944	3373	16	.	.	.
25944	3373	17	#	#	$
25944	3373	18	The	the	DT
25944	3373	19	presence	presence	NN
25944	3373	20	of	of	IN
25944	3373	21	cysticerci	cysticerci	NNP
25944	3373	22	in	in	IN
25944	3373	23	the	the	DT
25944	3373	24	skin	skin	NN
25944	3373	25	and	and	CC
25944	3373	26	subcutaneous	subcutaneous	JJ
25944	3373	27	tissue	tissue	NN
25944	3373	28	gives	give	VBZ
25944	3373	29	rise	rise	NN
25944	3373	30	to	to	IN
25944	3373	31	pea	pea	NN
25944	3373	32	to	to	IN
25944	3373	33	hazelnut	hazelnut	NN
25944	3373	34	-	-	HYPH
25944	3373	35	sized	sized	JJ
25944	3373	36	,	,	,
25944	3373	37	rounded	rounded	JJ
25944	3373	38	,	,	,
25944	3373	39	firm	firm	JJ
25944	3373	40	,	,	,
25944	3373	41	movable	movable	JJ
25944	3373	42	tumors	tumor	NNS
25944	3373	43	which	which	WDT
25944	3373	44	,	,	,
25944	3373	45	when	when	WRB
25944	3373	46	developed	develop	VBN
25944	3373	47	,	,	,
25944	3373	48	may	may	MD
25944	3373	49	remain	remain	VB
25944	3373	50	unchanged	unchanged	JJ
25944	3373	51	for	for	IN
25944	3373	52	months	month	NNS
25944	3373	53	.	.	.
25944	3374	1	The	the	DT
25944	3374	2	parasites	parasite	NNS
25944	3374	3	are	be	VBP
25944	3374	4	disclosed	disclose	VBN
25944	3374	5	by	by	IN
25944	3374	6	microscopic	microscopic	JJ
25944	3374	7	examination	examination	NN
25944	3374	8	.	.	.
25944	3375	1	Most	Most	JJS
25944	3375	2	of	of	IN
25944	3375	3	the	the	DT
25944	3375	4	cases	case	NNS
25944	3375	5	have	have	VBP
25944	3375	6	been	be	VBN
25944	3375	7	observed	observe	VBN
25944	3375	8	in	in	IN
25944	3375	9	Germany	Germany	NNP
25944	3375	10	.	.	.
25944	3376	1	#	#	NNP
25944	3376	2	Filaria	Filaria	NNP
25944	3376	3	Medinensis	Medinensis	NNP
25944	3376	4	.	.	.
25944	3376	5	#	#	NNP
25944	3376	6	(	(	-LRB-
25944	3376	7	_	_	NNP
25944	3376	8	Synonym	Synonym	NNP
25944	3376	9	:	:	:
25944	3376	10	_	_	NNP
25944	3376	11	Guinea	Guinea	NNP
25944	3376	12	-	-	HYPH
25944	3376	13	worm	worm	NNP
25944	3376	14	.	.	.
25944	3376	15	)	)	-RRB-
25944	3377	1	#	#	NNP
25944	3377	2	State	state	NN
25944	3377	3	the	the	DT
25944	3377	4	character	character	NN
25944	3377	5	of	of	IN
25944	3377	6	the	the	DT
25944	3377	7	lesions	lesion	NNS
25944	3377	8	produced	produce	VBN
25944	3377	9	by	by	IN
25944	3377	10	the	the	DT
25944	3377	11	filaria	filaria	JJ
25944	3377	12	medinensis	medinensis	NN
25944	3377	13	.	.	.
25944	3377	14	#	#	$
25944	3377	15	The	the	DT
25944	3377	16	young	young	JJ
25944	3377	17	microscopic	microscopic	JJ
25944	3377	18	worm	worm	NN
25944	3377	19	penetrates	penetrate	VBZ
25944	3377	20	the	the	DT
25944	3377	21	skin	skin	NN
25944	3377	22	or	or	CC
25944	3377	23	deeper	deep	JJR
25944	3377	24	tissue	tissue	NN
25944	3377	25	,	,	,
25944	3377	26	where	where	WRB
25944	3377	27	it	-PRON-	PRP
25944	3377	28	grows	grow	VBZ
25944	3377	29	gradually	gradually	RB
25944	3377	30	,	,	,
25944	3377	31	finally	finally	RB
25944	3377	32	reaching	reach	VBG
25944	3377	33	several	several	JJ
25944	3377	34	inches	inch	NNS
25944	3377	35	or	or	CC
25944	3377	36	more	more	JJR
25944	3377	37	in	in	IN
25944	3377	38	length	length	NN
25944	3377	39	and	and	CC
25944	3377	40	about	about	IN
25944	3377	41	a	a	DT
25944	3377	42	half	half	JJ
25944	3377	43	-	-	HYPH
25944	3377	44	line	line	NN
25944	3377	45	in	in	IN
25944	3377	46	thickness	thickness	NN
25944	3377	47	;	;	,
25944	3377	48	inflammation	inflammation	NN
25944	3377	49	is	be	VBZ
25944	3377	50	excited	excited	JJ
25944	3377	51	and	and	CC
25944	3377	52	a	a	DT
25944	3377	53	tumor	tumor	NN
25944	3377	54	-	-	HYPH
25944	3377	55	like	like	JJ
25944	3377	56	swelling	swelling	NN
25944	3377	57	makes	make	VBZ
25944	3377	58	its	-PRON-	PRP$
25944	3377	59	appearance	appearance	NN
25944	3377	60	,	,	,
25944	3377	61	which	which	WDT
25944	3377	62	,	,	,
25944	3377	63	sooner	soon	RBR
25944	3377	64	or	or	CC
25944	3377	65	later	later	RBR
25944	3377	66	,	,	,
25944	3377	67	breaks	break	NNS
25944	3377	68	,	,	,
25944	3377	69	disclosing	disclose	VBG
25944	3377	70	the	the	DT
25944	3377	71	worm	worm	NN
25944	3377	72	.	.	.
25944	3378	1	It	-PRON-	PRP
25944	3378	2	may	may	MD
25944	3378	3	also	also	RB
25944	3378	4	present	present	VB
25944	3378	5	a	a	DT
25944	3378	6	cord	cord	NN
25944	3378	7	-	-	HYPH
25944	3378	8	like	like	JJ
25944	3378	9	appearance	appearance	NN
25944	3378	10	.	.	.
25944	3379	1	It	-PRON-	PRP
25944	3379	2	is	be	VBZ
25944	3379	3	rarely	rarely	RB
25944	3379	4	met	meet	VBN
25944	3379	5	with	with	IN
25944	3379	6	outside	outside	NN
25944	3379	7	of	of	IN
25944	3379	8	tropical	tropical	JJ
25944	3379	9	countries	country	NNS
25944	3379	10	.	.	.
25944	3380	1	Treatment	treatment	NN
25944	3380	2	consists	consist	VBZ
25944	3380	3	in	in	IN
25944	3380	4	gradual	gradual	JJ
25944	3380	5	extraction	extraction	NN
25944	3380	6	,	,	,
25944	3380	7	or	or	CC
25944	3380	8	in	in	IN
25944	3380	9	the	the	DT
25944	3380	10	injection	injection	NN
25944	3380	11	of	of	IN
25944	3380	12	a	a	DT
25944	3380	13	corrosive	corrosive	JJ
25944	3380	14	sublimate	sublimate	NN
25944	3380	15	solution	solution	NN
25944	3380	16	(	(	-LRB-
25944	3380	17	1:1000	1:1000	CD
25944	3380	18	)	)	-RRB-
25944	3380	19	into	into	IN
25944	3380	20	the	the	DT
25944	3380	21	forming	form	VBG
25944	3380	22	tumor	tumor	NN
25944	3380	23	.	.	.
25944	3381	1	Asafetida	Asafetida	NNP
25944	3381	2	internally	internally	RB
25944	3381	3	has	have	VBZ
25944	3381	4	been	be	VBN
25944	3381	5	found	find	VBN
25944	3381	6	to	to	TO
25944	3381	7	be	be	VB
25944	3381	8	curative	curative	JJ
25944	3381	9	,	,	,
25944	3381	10	the	the	DT
25944	3381	11	parasite	parasite	NN
25944	3381	12	being	be	VBG
25944	3381	13	destroyed	destroy	VBN
25944	3381	14	and	and	CC
25944	3381	15	subsequently	subsequently	RB
25944	3381	16	absorbed	absorb	VBN
25944	3381	17	or	or	CC
25944	3381	18	discharged	discharge	VBN
25944	3381	19	.	.	.
25944	3382	1	#	#	NNP
25944	3382	2	Ixodes	Ixodes	NNP
25944	3382	3	.	.	.
25944	3382	4	#	#	NNP
25944	3382	5	(	(	-LRB-
25944	3382	6	_	_	NNP
25944	3382	7	Synonym	Synonym	NNP
25944	3382	8	:	:	:
25944	3382	9	_	_	NNP
25944	3382	10	Wood	Wood	NNP
25944	3382	11	-	-	HYPH
25944	3382	12	tick	tick	NNP
25944	3382	13	.	.	.
25944	3382	14	)	)	-RRB-
25944	3383	1	#	#	NNP
25944	3383	2	State	state	NN
25944	3383	3	the	the	DT
25944	3383	4	character	character	NN
25944	3383	5	of	of	IN
25944	3383	6	the	the	DT
25944	3383	7	cutaneous	cutaneous	JJ
25944	3383	8	disturbance	disturbance	NN
25944	3383	9	produced	produce	VBN
25944	3383	10	by	by	IN
25944	3383	11	the	the	DT
25944	3383	12	ixodes	ixode	NNS
25944	3383	13	.	.	.
25944	3383	14	#	#	$
25944	3383	15	The	the	DT
25944	3383	16	tick	tick	NN
25944	3383	17	sticks	stick	VBZ
25944	3383	18	its	-PRON-	PRP$
25944	3383	19	proboscis	proboscis	NN
25944	3383	20	into	into	IN
25944	3383	21	the	the	DT
25944	3383	22	skin	skin	NN
25944	3383	23	and	and	CC
25944	3383	24	sucks	suck	VBZ
25944	3383	25	blood	blood	NN
25944	3383	26	until	until	IN
25944	3383	27	it	-PRON-	PRP
25944	3383	28	is	be	VBZ
25944	3383	29	several	several	JJ
25944	3383	30	times	time	NNS
25944	3383	31	its	-PRON-	PRP$
25944	3383	32	natural	natural	JJ
25944	3383	33	size	size	NN
25944	3383	34	,	,	,
25944	3383	35	and	and	CC
25944	3383	36	then	then	RB
25944	3383	37	falls	fall	VBZ
25944	3383	38	off	off	RP
25944	3383	39	;	;	:
25944	3383	40	an	an	DT
25944	3383	41	urticarial	urticarial	JJ
25944	3383	42	lesion	lesion	NN
25944	3383	43	results	result	NNS
25944	3383	44	.	.	.
25944	3384	1	If	if	IN
25944	3384	2	caught	catch	VBN
25944	3384	3	in	in	IN
25944	3384	4	the	the	DT
25944	3384	5	act	act	NN
25944	3384	6	the	the	DT
25944	3384	7	animal	animal	NN
25944	3384	8	should	should	MD
25944	3384	9	not	not	RB
25944	3384	10	be	be	VB
25944	3384	11	forcibly	forcibly	RB
25944	3384	12	extracted	extract	VBN
25944	3384	13	,	,	,
25944	3384	14	as	as	IN
25944	3384	15	its	-PRON-	PRP$
25944	3384	16	proboscis	proboscis	NN
25944	3384	17	may	may	MD
25944	3384	18	be	be	VB
25944	3384	19	thus	thus	RB
25944	3384	20	broken	break	VBN
25944	3384	21	off	off	RP
25944	3384	22	and	and	CC
25944	3384	23	remain	remain	VB
25944	3384	24	in	in	IN
25944	3384	25	the	the	DT
25944	3384	26	skin	skin	NN
25944	3384	27	,	,	,
25944	3384	28	and	and	CC
25944	3384	29	give	give	VB
25944	3384	30	rise	rise	NN
25944	3384	31	to	to	IN
25944	3384	32	pain	pain	NN
25944	3384	33	and	and	CC
25944	3384	34	inflammation	inflammation	NN
25944	3384	35	.	.	.
25944	3385	1	It	-PRON-	PRP
25944	3385	2	may	may	MD
25944	3385	3	be	be	VB
25944	3385	4	made	make	VBN
25944	3385	5	to	to	TO
25944	3385	6	relinquish	relinquish	VB
25944	3385	7	its	-PRON-	PRP$
25944	3385	8	hold	hold	NN
25944	3385	9	by	by	IN
25944	3385	10	placing	place	VBG
25944	3385	11	on	on	IN
25944	3385	12	it	-PRON-	PRP
25944	3385	13	a	a	DT
25944	3385	14	drop	drop	NN
25944	3385	15	of	of	IN
25944	3385	16	an	an	DT
25944	3385	17	essential	essential	JJ
25944	3385	18	oil	oil	NN
25944	3385	19	.	.	.
25944	3386	1	A	a	DT
25944	3386	2	thymol	thymol	NN
25944	3386	3	or	or	CC
25944	3386	4	carbolized	carbolize	VBN
25944	3386	5	boric	boric	NN
25944	3386	6	-	-	HYPH
25944	3386	7	acid	acid	NN
25944	3386	8	lotion	lotion	NN
25944	3386	9	will	will	MD
25944	3386	10	relieve	relieve	VB
25944	3386	11	the	the	DT
25944	3386	12	irritation	irritation	NN
25944	3386	13	.	.	.
25944	3387	1	#	#	NNP
25944	3387	2	Leptus	Leptus	NNP
25944	3387	3	.	.	.
25944	3387	4	#	#	NNP
25944	3387	5	(	(	-LRB-
25944	3387	6	_	_	NNP
25944	3387	7	Synonym	Synonym	NNP
25944	3387	8	:	:	:
25944	3387	9	_	_	NNP
25944	3387	10	Harvest	Harvest	NNP
25944	3387	11	-	-	HYPH
25944	3387	12	mite	mite	NNP
25944	3387	13	.	.	.
25944	3387	14	)	)	-RRB-
25944	3388	1	#	#	JJR
25944	3388	2	State	state	NN
25944	3388	3	the	the	DT
25944	3388	4	characters	character	NNS
25944	3388	5	of	of	IN
25944	3388	6	the	the	DT
25944	3388	7	lesion	lesion	NN
25944	3388	8	produced	produce	VBN
25944	3388	9	by	by	IN
25944	3388	10	the	the	DT
25944	3388	11	leptus	leptus	NN
25944	3388	12	.	.	.
25944	3388	13	#	#	$
25944	3388	14	This	this	DT
25944	3388	15	minute	minute	NN
25944	3388	16	brick	brick	NN
25944	3388	17	-	-	HYPH
25944	3388	18	red	red	JJ
25944	3388	19	mite	mite	NN
25944	3388	20	buries	burie	NNS
25944	3388	21	itself	-PRON-	PRP
25944	3388	22	in	in	IN
25944	3388	23	the	the	DT
25944	3388	24	skin	skin	NN
25944	3388	25	,	,	,
25944	3388	26	especially	especially	RB
25944	3388	27	about	about	IN
25944	3388	28	the	the	DT
25944	3388	29	ankles	ankle	NNS
25944	3388	30	and	and	CC
25944	3388	31	feet	foot	NNS
25944	3388	32	,	,	,
25944	3388	33	giving	give	VBG
25944	3388	34	rise	rise	NN
25944	3388	35	to	to	IN
25944	3388	36	papules	papule	NNS
25944	3388	37	,	,	,
25944	3388	38	vesicles	vesicle	NNS
25944	3388	39	and	and	CC
25944	3388	40	pustules	pustule	NNS
25944	3388	41	.	.	.
25944	3389	1	Treatment	treatment	NN
25944	3389	2	consists	consist	VBZ
25944	3389	3	of	of	IN
25944	3389	4	the	the	DT
25944	3389	5	use	use	NN
25944	3389	6	of	of	IN
25944	3389	7	a	a	DT
25944	3389	8	mild	mild	JJ
25944	3389	9	sulphur	sulphur	NN
25944	3389	10	ointment	ointment	NN
25944	3389	11	or	or	CC
25944	3389	12	of	of	IN
25944	3389	13	a	a	DT
25944	3389	14	carbolic	carbolic	JJ
25944	3389	15	-	-	HYPH
25944	3389	16	acid	acid	NN
25944	3389	17	lotion	lotion	NN
25944	3389	18	.	.	.
25944	3390	1	#	#	NNP
25944	3390	2	[	[	-LRB-
25944	3390	3	OE]strus	OE]strus	NNP
25944	3390	4	.	.	.
25944	3390	5	#	#	NNP
25944	3390	6	(	(	-LRB-
25944	3390	7	_	_	NNP
25944	3390	8	Synonym	Synonym	NNP
25944	3390	9	:	:	:
25944	3390	10	_	_	NNP
25944	3390	11	Gad	Gad	NNP
25944	3390	12	,	,	,
25944	3390	13	or	or	CC
25944	3390	14	Bot	bot	NN
25944	3390	15	-	-	HYPH
25944	3390	16	fly	fly	NNP
25944	3390	17	.	.	.
25944	3390	18	)	)	-RRB-
25944	3391	1	#	#	NNP
25944	3391	2	Describe	describe	VB
25944	3391	3	the	the	DT
25944	3391	4	cutaneous	cutaneous	JJ
25944	3391	5	disturbance	disturbance	NN
25944	3391	6	produced	produce	VBN
25944	3391	7	by	by	IN
25944	3391	8	the	the	DT
25944	3391	9	[	[	-LRB-
25944	3391	10	oe]strus	oe]strus	UH
25944	3391	11	.	.	.
25944	3391	12	#	#	$
25944	3391	13	The	the	DT
25944	3391	14	ova	ova	NN
25944	3391	15	are	be	VBP
25944	3391	16	deposited	deposit	VBN
25944	3391	17	in	in	IN
25944	3391	18	the	the	DT
25944	3391	19	skin	skin	NN
25944	3391	20	,	,	,
25944	3391	21	develop	develop	VB
25944	3391	22	and	and	CC
25944	3391	23	give	give	VB
25944	3391	24	rise	rise	NN
25944	3391	25	to	to	IN
25944	3391	26	the	the	DT
25944	3391	27	formation	formation	NN
25944	3391	28	of	of	IN
25944	3391	29	furuncle	furuncle	NN
25944	3391	30	-	-	HYPH
25944	3391	31	like	like	JJ
25944	3391	32	tumors	tumor	NNS
25944	3391	33	with	with	IN
25944	3391	34	central	central	JJ
25944	3391	35	aperture	aperture	NN
25944	3391	36	,	,	,
25944	3391	37	through	through	IN
25944	3391	38	which	which	WDT
25944	3391	39	a	a	DT
25944	3391	40	sanious	sanious	JJ
25944	3391	41	discharge	discharge	NN
25944	3391	42	exudes	exude	NNS
25944	3391	43	;	;	:
25944	3391	44	or	or	CC
25944	3391	45	as	as	IN
25944	3391	46	the	the	DT
25944	3391	47	result	result	NN
25944	3391	48	of	of	IN
25944	3391	49	the	the	DT
25944	3391	50	burrowing	burrowing	NN
25944	3391	51	of	of	IN
25944	3391	52	the	the	DT
25944	3391	53	larvæ	larvæ	JJ
25944	3391	54	,	,	,
25944	3391	55	irregular	irregular	JJ
25944	3391	56	serpiginous	serpiginous	JJ
25944	3391	57	lines	line	NNS
25944	3391	58	or	or	CC
25944	3391	59	wheals	wheal	NNS
25944	3391	60	are	be	VBP
25944	3391	61	produced	produce	VBN
25944	3391	62	.	.	.
25944	3392	1	It	-PRON-	PRP
25944	3392	2	is	be	VBZ
25944	3392	3	chiefly	chiefly	RB
25944	3392	4	met	meet	VBN
25944	3392	5	with	with	IN
25944	3392	6	in	in	IN
25944	3392	7	Central	Central	NNP
25944	3392	8	and	and	CC
25944	3392	9	South	South	NNP
25944	3392	10	America	America	NNP
25944	3392	11	.	.	.
25944	3393	1	_	_	NNP
25944	3393	2	Larva	Larva	NNP
25944	3393	3	migrant	migrant	NN
25944	3393	4	_	_	NNP
25944	3393	5	,	,	,
25944	3393	6	or	or	CC
25944	3393	7	_	_	NNP
25944	3393	8	creeping	creep	VBG
25944	3393	9	disease	disease	NN
25944	3393	10	_	_	NNP
25944	3393	11	,	,	,
25944	3393	12	is	be	VBZ
25944	3393	13	doubtless	doubtless	RB
25944	3393	14	in	in	IN
25944	3393	15	this	this	DT
25944	3393	16	same	same	JJ
25944	3393	17	class	class	NN
25944	3393	18	.	.	.
25944	3394	1	It	-PRON-	PRP
25944	3394	2	is	be	VBZ
25944	3394	3	characterized	characterize	VBN
25944	3394	4	by	by	IN
25944	3394	5	a	a	DT
25944	3394	6	thread	thread	NN
25944	3394	7	-	-	HYPH
25944	3394	8	like	like	JJ
25944	3394	9	linear	linear	JJ
25944	3394	10	formation	formation	NN
25944	3394	11	of	of	IN
25944	3394	12	an	an	DT
25944	3394	13	erythematous	erythematous	JJ
25944	3394	14	,	,	,
25944	3394	15	erythemato	erythemato	JJ
25944	3394	16	-	-	HYPH
25944	3394	17	papular	papular	NN
25944	3394	18	,	,	,
25944	3394	19	or	or	CC
25944	3394	20	vesicular	vesicular	JJ
25944	3394	21	nature	nature	NN
25944	3394	22	that	that	WDT
25944	3394	23	gradually	gradually	RB
25944	3394	24	extends	extend	VBZ
25944	3394	25	,	,	,
25944	3394	26	the	the	DT
25944	3394	27	older	old	JJR
25944	3394	28	part	part	NN
25944	3394	29	disappearing	disappear	VBG
25944	3394	30	;	;	,
25944	3394	31	considerable	considerable	JJ
25944	3394	32	surface	surface	NN
25944	3394	33	may	may	MD
25944	3394	34	be	be	VB
25944	3394	35	covered	cover	VBN
25944	3394	36	before	before	IN
25944	3394	37	the	the	DT
25944	3394	38	parasite	parasite	NN
25944	3394	39	disappears	disappear	VBZ
25944	3394	40	or	or	CC
25944	3394	41	dies	die	VBZ
25944	3394	42	.	.	.
25944	3395	1	The	the	DT
25944	3395	2	treatment	treatment	NN
25944	3395	3	consists	consist	VBZ
25944	3395	4	in	in	IN
25944	3395	5	endeavoring	endeavor	VBG
25944	3395	6	to	to	TO
25944	3395	7	destroy	destroy	VB
25944	3395	8	the	the	DT
25944	3395	9	organism	organism	NN
25944	3395	10	by	by	IN
25944	3395	11	means	mean	NNS
25944	3395	12	of	of	IN
25944	3395	13	excision	excision	NN
25944	3395	14	or	or	CC
25944	3395	15	caustic	caustic	JJ
25944	3395	16	applications	application	NNS
25944	3395	17	at	at	IN
25944	3395	18	the	the	DT
25944	3395	19	point	point	NN
25944	3395	20	of	of	IN
25944	3395	21	its	-PRON-	PRP$
25944	3395	22	suspected	suspect	VBN
25944	3395	23	site	site	NN
25944	3395	24	which	which	WDT
25944	3395	25	is	be	VBZ
25944	3395	26	just	just	RB
25944	3395	27	ahead	ahead	RB
25944	3395	28	of	of	IN
25944	3395	29	the	the	DT
25944	3395	30	extending	extend	VBG
25944	3395	31	line	line	NN
25944	3395	32	.	.	.
25944	3396	1	#	#	NNP
25944	3396	2	Pulex	Pulex	NNP
25944	3396	3	Penetrans	Penetrans	NNPS
25944	3396	4	.	.	.
25944	3396	5	#	#	NNP
25944	3396	6	(	(	-LRB-
25944	3396	7	_	_	NNP
25944	3396	8	Synonyms	Synonyms	NNP
25944	3396	9	:	:	:
25944	3396	10	_	_	NNP
25944	3396	11	Sand	Sand	NNP
25944	3396	12	Flea	Flea	NNP
25944	3396	13	;	;	:
25944	3396	14	Jigger	Jigger	NNP
25944	3396	15	.	.	.
25944	3396	16	)	)	-RRB-
25944	3397	1	#	#	NNP
25944	3397	2	Describe	describe	VB
25944	3397	3	the	the	DT
25944	3397	4	cutaneous	cutaneous	JJ
25944	3397	5	disturbance	disturbance	NN
25944	3397	6	produced	produce	VBN
25944	3397	7	by	by	IN
25944	3397	8	the	the	DT
25944	3397	9	pulex	pulex	NN
25944	3397	10	penetrans	penetran	NNS
25944	3397	11	.	.	.
25944	3397	12	#	#	$
25944	3397	13	This	this	DT
25944	3397	14	microscopic	microscopic	JJ
25944	3397	15	animal	animal	NN
25944	3397	16	penetrates	penetrate	VBZ
25944	3397	17	the	the	DT
25944	3397	18	skin	skin	NN
25944	3397	19	,	,	,
25944	3397	20	especially	especially	RB
25944	3397	21	about	about	IN
25944	3397	22	the	the	DT
25944	3397	23	toes	toe	NNS
25944	3397	24	,	,	,
25944	3397	25	producing	produce	VBG
25944	3397	26	an	an	DT
25944	3397	27	inflammatory	inflammatory	JJ
25944	3397	28	swelling	swelling	NN
25944	3397	29	,	,	,
25944	3397	30	vesicle	vesicle	NN
25944	3397	31	or	or	CC
25944	3397	32	pustule	pustule	VB
25944	3397	33	,	,	,
25944	3397	34	or	or	CC
25944	3397	35	even	even	RB
25944	3397	36	ulceration	ulceration	NN
25944	3397	37	.	.	.
25944	3398	1	It	-PRON-	PRP
25944	3398	2	is	be	VBZ
25944	3398	3	met	meet	VBN
25944	3398	4	with	with	IN
25944	3398	5	in	in	IN
25944	3398	6	warm	warm	JJ
25944	3398	7	and	and	CC
25944	3398	8	tropical	tropical	JJ
25944	3398	9	countries	country	NNS
25944	3398	10	.	.	.
25944	3399	1	Treatment	treatment	NN
25944	3399	2	consists	consist	VBZ
25944	3399	3	in	in	IN
25944	3399	4	extraction	extraction	NN
25944	3399	5	.	.	.
25944	3400	1	Essential	essential	JJ
25944	3400	2	oils	oil	NNS
25944	3400	3	are	be	VBP
25944	3400	4	used	use	VBN
25944	3400	5	as	as	IN
25944	3400	6	a	a	DT
25944	3400	7	preventive	preventive	NN
25944	3400	8	.	.	.
25944	3401	1	A	a	DT
25944	3401	2	carbolic	carbolic	JJ
25944	3401	3	-	-	HYPH
25944	3401	4	acid	acid	NN
25944	3401	5	or	or	CC
25944	3401	6	alkaline	alkaline	NN
25944	3401	7	lotion	lotion	NN
25944	3401	8	relieves	relieve	VBZ
25944	3401	9	irritation	irritation	NN
25944	3401	10	.	.	.
25944	3402	1	#	#	NNP
25944	3402	2	Cimex	Cimex	NNP
25944	3402	3	Lectularius	Lectularius	NNP
25944	3402	4	.	.	.
25944	3402	5	#	#	NNP
25944	3402	6	(	(	-LRB-
25944	3402	7	_	_	NNP
25944	3402	8	Synonym	Synonym	NNP
25944	3402	9	:	:	:
25944	3402	10	_	_	NNP
25944	3402	11	Bed	Bed	NNP
25944	3402	12	-	-	HYPH
25944	3402	13	bug	bug	NN
25944	3402	14	.	.	.
25944	3402	15	)	)	-RRB-
25944	3403	1	#	#	NNP
25944	3403	2	Describe	describe	VB
25944	3403	3	the	the	DT
25944	3403	4	characters	character	NNS
25944	3403	5	of	of	IN
25944	3403	6	a	a	DT
25944	3403	7	bed	bed	NN
25944	3403	8	-	-	HYPH
25944	3403	9	bug	bug	NN
25944	3403	10	bite	bite	NN
25944	3403	11	.	.	.
25944	3403	12	#	#	$
25944	3403	13	An	an	DT
25944	3403	14	inflammatory	inflammatory	JJ
25944	3403	15	papule	papule	NN
25944	3403	16	or	or	CC
25944	3403	17	wheal	wheal	NN
25944	3403	18	-	-	HYPH
25944	3403	19	like	like	JJ
25944	3403	20	lesion	lesion	NN
25944	3403	21	results	result	NNS
25944	3403	22	,	,	,
25944	3403	23	somewhat	somewhat	RB
25944	3403	24	hemorrhagic	hemorrhagic	JJ
25944	3403	25	;	;	:
25944	3403	26	the	the	DT
25944	3403	27	purpuric	purpuric	NN
25944	3403	28	or	or	CC
25944	3403	29	hemorrhagic	hemorrhagic	JJ
25944	3403	30	point	point	NN
25944	3403	31	or	or	CC
25944	3403	32	spot	spot	NN
25944	3403	33	remains	remain	VBZ
25944	3403	34	after	after	IN
25944	3403	35	the	the	DT
25944	3403	36	swelling	swell	VBG
25944	3403	37	subsides	subside	NNS
25944	3403	38	,	,	,
25944	3403	39	but	but	CC
25944	3403	40	finally	finally	RB
25944	3403	41	,	,	,
25944	3403	42	in	in	IN
25944	3403	43	the	the	DT
25944	3403	44	course	course	NN
25944	3403	45	of	of	IN
25944	3403	46	several	several	JJ
25944	3403	47	days	day	NNS
25944	3403	48	or	or	CC
25944	3403	49	a	a	DT
25944	3403	50	few	few	JJ
25944	3403	51	weeks	week	NNS
25944	3403	52	,	,	,
25944	3403	53	disappears	disappear	VBZ
25944	3403	54	.	.	.
25944	3404	1	Treatment	treatment	NN
25944	3404	2	consists	consist	VBZ
25944	3404	3	in	in	IN
25944	3404	4	the	the	DT
25944	3404	5	application	application	NN
25944	3404	6	of	of	IN
25944	3404	7	alkaline	alkaline	NN
25944	3404	8	or	or	CC
25944	3404	9	acid	acid	NN
25944	3404	10	lotions	lotion	NNS
25944	3404	11	.	.	.
25944	3405	1	#	#	NNP
25944	3405	2	Culex	Culex	NNP
25944	3405	3	.	.	.
25944	3405	4	#	#	NNP
25944	3405	5	(	(	-LRB-
25944	3405	6	_	_	NNP
25944	3405	7	Synonym	Synonym	NNP
25944	3405	8	:	:	:
25944	3405	9	_	_	NNP
25944	3405	10	Gnat	Gnat	NNP
25944	3405	11	;	;	:
25944	3405	12	Mosquito	Mosquito	NNP
25944	3405	13	.	.	.
25944	3405	14	)	)	-RRB-
25944	3406	1	#	#	NNP
25944	3406	2	Describe	describe	VB
25944	3406	3	the	the	DT
25944	3406	4	cutaneous	cutaneous	JJ
25944	3406	5	disturbance	disturbance	NN
25944	3406	6	produced	produce	VBN
25944	3406	7	by	by	IN
25944	3406	8	the	the	DT
25944	3406	9	culex	culex	NN
25944	3406	10	.	.	.
25944	3406	11	#	#	$
25944	3406	12	It	-PRON-	PRP
25944	3406	13	consists	consist	VBZ
25944	3406	14	of	of	IN
25944	3406	15	an	an	DT
25944	3406	16	erythematous	erythematous	JJ
25944	3406	17	spot	spot	NN
25944	3406	18	or	or	CC
25944	3406	19	a	a	DT
25944	3406	20	wheal	wheal	NN
25944	3406	21	-	-	HYPH
25944	3406	22	like	like	JJ
25944	3406	23	lesion	lesion	NN
25944	3406	24	.	.	.
25944	3407	1	Alkaline	alkaline	NN
25944	3407	2	or	or	CC
25944	3407	3	acid	acid	JJ
25944	3407	4	lotions	lotion	NNS
25944	3407	5	usually	usually	RB
25944	3407	6	give	give	VBP
25944	3407	7	relief	relief	NN
25944	3407	8	.	.	.
25944	3408	1	#	#	NNP
25944	3408	2	Pulex	Pulex	NNP
25944	3408	3	Irritans	Irritans	NNPS
25944	3408	4	.	.	.
25944	3408	5	#	#	NNP
25944	3408	6	(	(	-LRB-
25944	3408	7	_	_	NNP
25944	3408	8	Synonym	Synonym	NNP
25944	3408	9	:	:	:
25944	3408	10	_	_	NNP
25944	3408	11	Common	Common	NNP
25944	3408	12	Flea	Flea	NNP
25944	3408	13	.	.	.
25944	3408	14	)	)	-RRB-
25944	3409	1	#	#	NNP
25944	3409	2	Describe	describe	VB
25944	3409	3	the	the	DT
25944	3409	4	cutaneous	cutaneous	JJ
25944	3409	5	disturbance	disturbance	NN
25944	3409	6	produced	produce	VBN
25944	3409	7	by	by	IN
25944	3409	8	the	the	DT
25944	3409	9	pulex	pulex	NN
25944	3409	10	irritans	irritan	NNS
25944	3409	11	.	.	.
25944	3409	12	#	#	$
25944	3409	13	It	-PRON-	PRP
25944	3409	14	consists	consist	VBZ
25944	3409	15	of	of	IN
25944	3409	16	an	an	DT
25944	3409	17	erythematous	erythematous	JJ
25944	3409	18	spot	spot	NN
25944	3409	19	with	with	IN
25944	3409	20	a	a	DT
25944	3409	21	minute	minute	JJ
25944	3409	22	central	central	JJ
25944	3409	23	hemorrhagic	hemorrhagic	JJ
25944	3409	24	point	point	NN
25944	3409	25	.	.	.
25944	3410	1	In	in	IN
25944	3410	2	irritable	irritable	JJ
25944	3410	3	skin	skin	NN
25944	3410	4	,	,	,
25944	3410	5	a	a	DT
25944	3410	6	wheal	wheal	NN
25944	3410	7	-	-	HYPH
25944	3410	8	like	like	JJ
25944	3410	9	lesion	lesion	NN
25944	3410	10	may	may	MD
25944	3410	11	result	result	VB
25944	3410	12	.	.	.
25944	3411	1	Treatment	treatment	NN
25944	3411	2	consists	consist	VBZ
25944	3411	3	of	of	IN
25944	3411	4	applications	application	NNS
25944	3411	5	of	of	IN
25944	3411	6	camphor	camphor	NNP
25944	3411	7	or	or	CC
25944	3411	8	ammonia	ammonia	NNP
25944	3411	9	-	-	HYPH
25944	3411	10	water	water	NN
25944	3411	11	;	;	:
25944	3411	12	carbolic	carbolic	JJ
25944	3411	13	acid	acid	NN
25944	3411	14	and	and	CC
25944	3411	15	thymol	thymol	NN
25944	3411	16	lotions	lotion	NNS
25944	3411	17	are	be	VBP
25944	3411	18	also	also	RB
25944	3411	19	useful	useful	JJ
25944	3411	20	.	.	.
25944	3412	1	RELATIVE	relative	NN
25944	3412	2	FREQUENCY	FREQUENCY	VBD
25944	3412	3	OF	of	IN
25944	3412	4	THE	the	DT
25944	3412	5	VARIOUS	various	NN
25944	3412	6	DISEASES	diseases	NN
25944	3412	7	OF	of	IN
25944	3412	8	SKIN	SKIN	NNP
25944	3412	9	AS	as	IN
25944	3412	10	SHOWN	show	VBN
25944	3412	11	BY	by	IN
25944	3412	12	THE	the	DT
25944	3412	13	STATISTICS	statistic	NNS
25944	3412	14	(	(	-LRB-
25944	3412	15	123,746	123,746	CD
25944	3412	16	CASES	cases	NN
25944	3412	17	)	)	-RRB-
25944	3412	18	OF	of	IN
25944	3412	19	THE	the	DT
25944	3412	20	AMERICAN	AMERICAN	NNP
25944	3412	21	DERMATOLOGICAL	DERMATOLOGICAL	NNP
25944	3412	22	ASSOCIATION	ASSOCIATION	NNP
25944	3412	23	FOR	for	IN
25944	3412	24	TEN	TEN	NNP
25944	3412	25	YEARS	year	NNS
25944	3412	26	,	,	,
25944	3412	27	1878	1878	CD
25944	3412	28	-	-	SYM
25944	3412	29	87	87	CD
25944	3412	30	.	.	.
25944	3413	1	-------------------------+-------+-------+	-------------------------+-------+-------+	:
25944	3413	2	CLASSIFICATION	classification	NN
25944	3413	3	OF	of	IN
25944	3413	4	|	|	CD
25944	3413	5	No	no	NN
25944	3413	6	.	.	.
25944	3414	1	|	|	CD
25944	3414	2	%	%	NN
25944	3414	3	|	|	CD
25944	3414	4	DISEASES	disease	NNS
25944	3414	5	.	.	.
25944	3415	1	|	|	NNS
25944	3415	2	Cases	case	NNS
25944	3415	3	|	|	NNP
25944	3415	4	Cases	case	NNS
25944	3415	5	|	|	NNP
25944	3415	6	-------------------------+-------+-------+	-------------------------+-------+-------+	:
25944	3415	7	Class	class	NN
25944	3415	8	I.	i.	NN
25944	3416	1	Disorders	disorder	NNS
25944	3416	2	of	of	IN
25944	3416	3	the|	the|	NNP
25944	3416	4	|	|	NNP
25944	3416	5	|	|	NNP
25944	3416	6	Glands	gland	NNS
25944	3416	7	.	.	.
25944	3417	1	|	|	NNP
25944	3417	2	|	|	CD
25944	3417	3	|	|	CD
25944	3417	4	1	1	CD
25944	3417	5	.	.	.
25944	3418	1	OF	of	IN
25944	3418	2	THE	the	DT
25944	3418	3	SWEAT	SWEAT	NNP
25944	3418	4	GLANDS.|	GLANDS.|	NNS
25944	3418	5	|	|	NNP
25944	3418	6	|	|	NNP
25944	3418	7	Hyperidrosis	Hyperidrosis	NNP
25944	3418	8	|	|	NNP
25944	3418	9	328	328	CD
25944	3418	10	|	|	CD
25944	3418	11	.265	.265	CD
25944	3418	12	|	|	NNP
25944	3418	13	Sudamen	Sudamen	NNP
25944	3418	14	|	|	NNP
25944	3418	15	268	268	CD
25944	3418	16	|	|	CD
25944	3418	17	.216	.216	CD
25944	3418	18	|	|	NNP
25944	3418	19	Anidrosis	Anidrosis	NNP
25944	3418	20	|	|	NNP
25944	3418	21	11	11	CD
25944	3418	22	|	|	CD
25944	3418	23	.009	.009	CD
25944	3418	24	|	|	NNP
25944	3418	25	Bromidrosis	Bromidrosis	NNP
25944	3418	26	|	|	NNP
25944	3418	27	112	112	CD
25944	3418	28	|	|	CD
25944	3418	29	.090	.090	CD
25944	3418	30	|	|	NNP
25944	3418	31	Chromidrosis	Chromidrosis	NNP
25944	3418	32	|	|	NNP
25944	3418	33	7	7	CD
25944	3418	34	|	|	CD
25944	3418	35	.005	.005	CD
25944	3418	36	|	|	NNP
25944	3418	37	Uridrosis	Uridrosis	NNP
25944	3418	38	|	|	NNP
25944	3418	39	...	...	:
25944	3418	40	|	|	NNP
25944	3418	41	....	....	CD
25944	3418	42	|	|	NNP
25944	3418	43	2	2	CD
25944	3418	44	.	.	.
25944	3419	1	OF	of	IN
25944	3419	2	THE	the	DT
25944	3419	3	SEBACEOUS	SEBACEOUS	NNP
25944	3419	4	|	|	NNP
25944	3419	5	|	|	NNP
25944	3419	6	|	|	NNP
25944	3419	7	GLANDS	GLANDS	NNP
25944	3419	8	|	|	CD
25944	3419	9	238	238	CD
25944	3419	10	|	|	CD
25944	3419	11	.193	.193	CD
25944	3419	12	|	|	HYPH
25944	3419	13	Seborrh[oe]a	seborrh[oe]a	CD
25944	3419	14	:	:	:
25944	3419	15	|	|	NNP
25944	3419	16	1812	1812	CD
25944	3419	17	|	|	CD
25944	3419	18	1.47	1.47	CD
25944	3419	19	|	|	NNP
25944	3419	20	a.	a.	NN
25944	3419	21	oleosa	oleosa	NNP
25944	3419	22	|	|	NNP
25944	3419	23	367	367	CD
25944	3419	24	|	|	CD
25944	3419	25	.296	.296	CD
25944	3419	26	|	|	CD
25944	3419	27	b.	b.	NN
25944	3419	28	sicca	sicca	NNP
25944	3419	29	|	|	NNP
25944	3419	30	395	395	CD
25944	3419	31	|	|	CD
25944	3419	32	.319	.319	CD
25944	3419	33	|	|	NNP
25944	3419	34	Comedo	Comedo	NNP
25944	3419	35	|	|	NNP
25944	3419	36	1225	1225	CD
25944	3419	37	|	|	NNP
25944	3419	38	.989	.989	CD
25944	3419	39	|	|	NNP
25944	3419	40	Cyst	Cyst	NNP
25944	3419	41	:	:	:
25944	3419	42	|	|	NNP
25944	3419	43	6	6	CD
25944	3419	44	|	|	CD
25944	3419	45	.004	.004	CD
25944	3419	46	|	|	NNP
25944	3419	47	a.	a.	NN
25944	3419	48	Milium	Milium	NNP
25944	3419	49	|	|	NNP
25944	3419	50	225	225	CD
25944	3419	51	|	|	CD
25944	3419	52	.183	.183	CD
25944	3419	53	|	|	NNP
25944	3419	54	b.	b.	NNP
25944	3419	55	Steatoma	Steatoma	NNP
25944	3419	56	|	|	NNP
25944	3419	57	151	151	CD
25944	3419	58	|	|	CD
25944	3419	59	.122	.122	CD
25944	3419	60	|	|	NNP
25944	3419	61	Asteatosis	Asteatosis	NNP
25944	3419	62	|	|	NNP
25944	3419	63	8	8	CD
25944	3419	64	|	|	CD
25944	3419	65	.006	.006	CD
25944	3419	66	|	|	CD
25944	3419	67	|	|	CD
25944	3419	68	|	|	CD
25944	3419	69	|	|	NNP
25944	3419	70	Class	Class	NNP
25944	3419	71	II	II	NNP
25944	3419	72	.	.	.
25944	3420	1	Inflammations	inflammation	NNS
25944	3420	2	.	.	.
25944	3421	1	|	|	NNP
25944	3421	2	|	|	NNP
25944	3421	3	|	|	NNP
25944	3421	4	Exanthemata	Exanthemata	NNP
25944	3421	5	|	|	NNP
25944	3421	6	1770	1770	CD
25944	3421	7	|	|	CD
25944	3421	8	1.43	1.43	CD
25944	3421	9	|	|	CD
25944	3421	10	Erythema	Erythema	NNP
25944	3421	11	simplex	simplex	NN
25944	3421	12	|	|	NNP
25944	3421	13	1064	1064	CD
25944	3421	14	|	|	NNP
25944	3421	15	.859	.859	CD
25944	3421	16	|	|	NNP
25944	3421	17	Erythema	Erythema	NNP
25944	3421	18	multiforme	multiforme	NN
25944	3421	19	:	:	:
25944	3421	20	|	|	CD
25944	3421	21	915	915	CD
25944	3421	22	|	|	CD
25944	3421	23	.730	.730	CD
25944	3421	24	|	|	HYPH
25944	3421	25	a.	a.	NN
25944	3421	26	papulosum	papulosum	NN
25944	3421	27	|	|	NNP
25944	3421	28	325	325	CD
25944	3421	29	|	|	CD
25944	3421	30	.262	.262	CD
25944	3421	31	|	|	NNP
25944	3421	32	b.	b.	NNP
25944	3421	33	bullosum	bullosum	NNP
25944	3421	34	|	|	NNP
25944	3421	35	37	37	CD
25944	3421	36	|	|	CD
25944	3421	37	.029	.029	CD
25944	3421	38	|	|	HYPH
25944	3421	39	c.	c.	NN
25944	3421	40	nodosum	nodosum	NNP
25944	3421	41	|	|	NNP
25944	3421	42	82	82	CD
25944	3421	43	|	|	CD
25944	3421	44	.066	.066	CD
25944	3421	45	|	|	NNP
25944	3421	46	Urticaria	Urticaria	NNP
25944	3421	47	|	|	NNP
25944	3421	48	2994	2994	CD
25944	3421	49	|	|	CD
25944	3421	50	2.47	2.47	CD
25944	3421	51	|	|	NNP
25944	3421	52	pigmentosa	pigmentosa	NNS
25944	3421	53	|	|	NNP
25944	3421	54	1	1	CD
25944	3421	55	|	|	CD
25944	3421	56	.0008|	.0008|	.
25944	3421	57	[	[	-LRB-
25944	3421	58	E]Dermatitis	e]dermatitis	NN
25944	3421	59	:	:	:
25944	3421	60	|	|	CD
25944	3421	61	1720	1720	CD
25944	3421	62	|	|	CD
25944	3421	63	1.39	1.39	CD
25944	3421	64	|	|	NNP
25944	3421	65	a.	a.	NN
25944	3421	66	traumatica	traumatica	NNP
25944	3421	67	|	|	NNP
25944	3421	68	468	468	CD
25944	3421	69	|	|	CD
25944	3421	70	.378	.378	CD
25944	3421	71	|	|	CD
25944	3421	72	b.	b.	NNP
25944	3421	73	venenata	venenata	NNP
25944	3421	74	|	|	NNP
25944	3421	75	616	616	CD
25944	3421	76	|	|	CD
25944	3421	77	.498	.498	CD
25944	3421	78	|	|	CD
25944	3421	79	c.	c.	NN
25944	3421	80	calorica	calorica	NNP
25944	3421	81	|	|	NNP
25944	3421	82	224	224	CD
25944	3421	83	|	|	CD
25944	3421	84	.187	.187	CD
25944	3421	85	|	|	NNP
25944	3421	86	d.	d.	NNP
25944	3421	87	medicamentosa	medicamentosa	NNP
25944	3421	88	|	|	NNP
25944	3421	89	108	108	CD
25944	3421	90	|	|	CD
25944	3421	91	.087	.087	CD
25944	3421	92	|	|	NNP
25944	3421	93	e.	e.	NNP
25944	3421	94	gangrænosa	gangrænosa	NNP
25944	3421	95	|	|	NNP
25944	3421	96	8	8	CD
25944	3421	97	|	|	CD
25944	3421	98	.006	.006	CD
25944	3421	99	|	|	NNP
25944	3421	100	Erysipelas	Erysipelas	NNP
25944	3421	101	|	|	NNP
25944	3421	102	1026	1026	CD
25944	3421	103	|	|	CD
25944	3421	104	.829	.829	CD
25944	3421	105	|	|	NNP
25944	3421	106	Furunculus	Furunculus	NNP
25944	3421	107	|	|	CD
25944	3421	108	2129	2129	CD
25944	3421	109	|	|	CD
25944	3421	110	1.72	1.72	CD
25944	3421	111	|	|	NNP
25944	3421	112	Anthrax	Anthrax	NNP
25944	3421	113	|	|	NNP
25944	3421	114	252	252	CD
25944	3421	115	|	|	CD
25944	3421	116	.203	.203	CD
25944	3421	117	|	|	CD
25944	3421	118	Phlegmona	Phlegmona	NNP
25944	3421	119	diffusa	diffusa	VBD
25944	3421	120	|	|	NNP
25944	3421	121	265	265	CD
25944	3421	122	|	|	CD
25944	3421	123	.215	.215	CD
25944	3421	124	|	|	CD
25944	3421	125	Pustula	Pustula	NNP
25944	3421	126	maligna	maligna	NNS
25944	3421	127	|	|	POS
25944	3421	128	197	197	CD
25944	3421	129	|	|	CD
25944	3421	130	.159	.159	CD
25944	3421	131	|	|	NNP
25944	3421	132	Herpes	Herpes	NNP
25944	3421	133	simplex	simplex	NN
25944	3421	134	|	|	NNP
25944	3421	135	2057	2057	CD
25944	3421	136	|	|	CD
25944	3421	137	1.66	1.66	CD
25944	3421	138	|	|	NNP
25944	3421	139	Herpes	Herpes	NNP
25944	3421	140	zoster	zoster	NN
25944	3421	141	|	|	NNP
25944	3421	142	1428	1428	CD
25944	3421	143	|	|	CD
25944	3421	144	1.15	1.15	CD
25944	3421	145	|	|	NNP
25944	3421	146	Dermatitis	Dermatitis	NNP
25944	3421	147	|	|	NNP
25944	3421	148	|	|	NNP
25944	3421	149	|	|	CD
25944	3421	150	herpetiformis	herpetiformis	NN
25944	3421	151	|	|	CD
25944	3421	152	41	41	CD
25944	3421	153	|	|	CD
25944	3421	154	.033	.033	CD
25944	3421	155	|	|	NNP
25944	3421	156	Psoriasis	Psoriasis	NNP
25944	3421	157	|	|	NNP
25944	3421	158	4131	4131	CD
25944	3421	159	|	|	CD
25944	3421	160	3.34	3.34	CD
25944	3421	161	|	|	NNP
25944	3421	162	Pityriasis	Pityriasis	NNP
25944	3421	163	maculuta	maculuta	JJ
25944	3421	164	|	|	NNP
25944	3421	165	|	|	NNP
25944	3421	166	|	|	NNP
25944	3421	167	et	et	NNP
25944	3421	168	circinata	circinata	NN
25944	3421	169	|	|	NNP
25944	3421	170	71	71	CD
25944	3421	171	|	|	CD
25944	3421	172	.057	.057	CD
25944	3421	173	|	|	NNP
25944	3421	174	Dermatitis	Dermatitis	NNP
25944	3421	175	|	|	NNP
25944	3421	176	|	|	NNP
25944	3421	177	|	|	CD
25944	3421	178	exfoliativa	exfoliativa	NN
25944	3421	179	|	|	NNP
25944	3421	180	16	16	CD
25944	3421	181	|	|	CD
25944	3421	182	.012	.012	CD
25944	3421	183	|	|	NNP
25944	3421	184	Pityriasis	Pityriasis	NNP
25944	3421	185	rubra	rubra	NNP
25944	3421	186	|	|	CD
25944	3421	187	44	44	CD
25944	3421	188	|	|	CD
25944	3421	189	.032	.032	CD
25944	3421	190	|	|	NNP
25944	3421	191	Lichen	Lichen	NNP
25944	3421	192	:	:	:
25944	3421	193	|	|	NNP
25944	3421	194	144	144	CD
25944	3421	195	|	|	CD
25944	3421	196	.116	.116	CD
25944	3421	197	|	|	CD
25944	3421	198	a.	a.	NN
25944	3421	199	planus	planus	NN
25944	3421	200	|	|	CD
25944	3421	201	154	154	CD
25944	3421	202	|	|	CD
25944	3421	203	.124	.124	CD
25944	3421	204	|	|	NNP
25944	3421	205	b.	b.	NNP
25944	3421	206	ruber	ruber	NNP
25944	3421	207	|	|	NNP
25944	3421	208	27	27	CD
25944	3421	209	|	|	CD
25944	3421	210	.021	.021	CD
25944	3421	211	|	|	NNP
25944	3421	212	Eczema	Eczema	NNP
25944	3421	213	:	:	:
25944	3421	214	|	|	NNP
25944	3421	215	37661	37661	CD
25944	3421	216	|30.43	|30.43	NNP
25944	3421	217	|	|	NNP
25944	3421	218	a.	a.	NN
25944	3421	219	erythematosum	erythematosum	NNP
25944	3421	220	|	|	NNP
25944	3421	221	....	....	NNP
25944	3421	222	|	|	NNP
25944	3421	223	....	....	NFP
25944	3421	224	|	|	NNP
25944	3421	225	b.	b.	NNP
25944	3421	226	papulosum	papulosum	NNP
25944	3421	227	|	|	NNP
25944	3421	228	....	....	SYM
25944	3421	229	|	|	NNP
25944	3421	230	....	....	NFP
25944	3421	231	|	|	NNP
25944	3421	232	c.	c.	NNP
25944	3421	233	vesiculosum	vesiculosum	NNP
25944	3421	234	|	|	NNP
25944	3421	235	....	....	SYM
25944	3421	236	|	|	NNP
25944	3421	237	....	....	NFP
25944	3421	238	|	|	NNP
25944	3421	239	d.	d.	NNP
25944	3421	240	madidans	madidans	NNPS
25944	3421	241	|	|	NNP
25944	3421	242	....	....	NNP
25944	3421	243	|	|	NNP
25944	3421	244	....	....	NFP
25944	3421	245	|	|	NNP
25944	3421	246	e.	e.	NNP
25944	3421	247	pustulosum	pustulosum	NNP
25944	3421	248	|	|	NNP
25944	3421	249	....	....	SYM
25944	3421	250	|	|	NNP
25944	3421	251	....	....	NFP
25944	3421	252	|	|	NNP
25944	3421	253	f.	f.	NNP
25944	3421	254	rubrum	rubrum	NNP
25944	3421	255	|	|	NNP
25944	3421	256	....	....	NNP
25944	3421	257	|	|	NNP
25944	3421	258	....	....	NFP
25944	3421	259	|	|	NNP
25944	3421	260	g.	g.	NNP
25944	3421	261	squamosum	squamosum	NNP
25944	3421	262	|	|	NNP
25944	3421	263	....	....	NFP
25944	3421	264	|	|	NNP
25944	3421	265	....	....	NFP
25944	3421	266	|	|	NNP
25944	3421	267	Prurigo	Prurigo	NNP
25944	3421	268	|	|	NNP
25944	3421	269	34	34	CD
25944	3421	270	|	|	CD
25944	3421	271	.027	.027	CD
25944	3421	272	|	|	NNP
25944	3421	273	Acne	Acne	NNP
25944	3421	274	|	|	CD
25944	3421	275	9077	9077	CD
25944	3421	276	|	|	CD
25944	3421	277	7.34	7.34	CD
25944	3421	278	|	|	CD
25944	3421	279	Acne	Acne	NNP
25944	3421	280	rosacea	rosacea	FW
25944	3421	281	|	|	NNP
25944	3421	282	398	398	CD
25944	3421	283	|	|	CD
25944	3421	284	.321	.321	CD
25944	3421	285	|	|	NNP
25944	3421	286	Sycosis	Sycosis	NNP
25944	3421	287	|	|	NNP
25944	3421	288	227	227	CD
25944	3421	289	|	|	CD
25944	3421	290	.185	.185	CD
25944	3421	291	|	|	NNS
25944	3421	292	Impetigo	Impetigo	NNP
25944	3421	293	|	|	NNP
25944	3421	294	1769	1769	CD
25944	3421	295	|	|	CD
25944	3421	296	1.43	1.43	CD
25944	3421	297	|	|	CD
25944	3421	298	Impetigo	Impetigo	NNP
25944	3421	299	contagiosa	contagiosa	NN
25944	3421	300	|	|	CD
25944	3421	301	600	600	CD
25944	3421	302	|	|	CD
25944	3421	303	.485	.485	CD
25944	3421	304	|	|	NNP
25944	3421	305	Impetigo	Impetigo	NNP
25944	3421	306	|	|	NNP
25944	3421	307	|	|	NNP
25944	3421	308	|	|	CD
25944	3421	309	herpetiformis	herpetiformis	NN
25944	3421	310	|	|	NNP
25944	3421	311	10	10	CD
25944	3421	312	|	|	CD
25944	3421	313	.009	.009	CD
25944	3421	314	|	|	NNP
25944	3421	315	Ecthyma	Ecthyma	NNP
25944	3421	316	|	|	NNP
25944	3421	317	726	726	CD
25944	3421	318	|	|	CD
25944	3421	319	.587	.587	CD
25944	3421	320	|	|	NNP
25944	3421	321	Pemphigus	Pemphigus	NNP
25944	3421	322	|	|	NNP
25944	3421	323	183	183	CD
25944	3421	324	|	|	CD
25944	3421	325	.148	.148	CD
25944	3421	326	|	|	NNP
25944	3421	327	Ulcers	Ulcers	NNP
25944	3421	328	|	|	NNP
25944	3421	329	3021	3021	CD
25944	3421	330	|	|	CD
25944	3421	331	2.44	2.44	CD
25944	3421	332	|	|	CD
25944	3421	333	|	|	CD
25944	3421	334	|	|	CD
25944	3421	335	|	|	NNP
25944	3421	336	Class	Class	NNP
25944	3421	337	III	III	NNP
25944	3421	338	.	.	.
25944	3422	1	Hemorrhages	Hemorrhages	NNP
25944	3422	2	.	.	.
25944	3423	1	|	|	NNP
25944	3423	2	|	|	NNP
25944	3423	3	|	|	NNP
25944	3423	4	Purpura	Purpura	NNP
25944	3423	5	:	:	:
25944	3423	6	|	|	NNP
25944	3423	7	341	341	CD
25944	3423	8	|	|	CD
25944	3423	9	.275	.275	CD
25944	3423	10	|	|	CD
25944	3423	11	a.	a.	NN
25944	3423	12	simplex	simplex	NNP
25944	3423	13	|	|	NNP
25944	3423	14	181	181	CD
25944	3423	15	|	|	CD
25944	3423	16	.145	.145	CD
25944	3423	17	|	|	HYPH
25944	3423	18	b.	b.	NNP
25944	3423	19	hæmorrhagica	hæmorrhagica	NNP
25944	3423	20	|	|	NNP
25944	3423	21	49	49	CD
25944	3423	22	|	|	CD
25944	3423	23	.039	.039	CD
25944	3423	24	|	|	CD
25944	3423	25	|	|	CD
25944	3423	26	|	|	NNP
25944	3423	27	|	|	NNP
25944	3423	28	Class	Class	NNP
25944	3423	29	IV	IV	NNP
25944	3423	30	.	.	.
25944	3424	1	Hypertrophies	hypertrophy	NNS
25944	3424	2	.	.	.
25944	3425	1	|	|	NNP
25944	3425	2	|	|	CD
25944	3425	3	|	|	CD
25944	3425	4	1	1	CD
25944	3425	5	.	.	.
25944	3426	1	OF	of	IN
25944	3426	2	PIGMENT	PIGMENT	NNP
25944	3426	3	.	.	.
25944	3427	1	|	|	NNP
25944	3427	2	|	|	NNP
25944	3427	3	|	|	NNP
25944	3427	4	Lentigo	Lentigo	NNP
25944	3427	5	|	|	NNP
25944	3427	6	127	127	CD
25944	3427	7	|	|	CD
25944	3427	8	.103	.103	CD
25944	3427	9	|	|	NNP
25944	3427	10	Chloasma	Chloasma	NNP
25944	3427	11	|	|	NNP
25944	3427	12	560	560	CD
25944	3427	13	|	|	CD
25944	3427	14	.452	.452	CD
25944	3427	15	|	|	CD
25944	3427	16	2	2	CD
25944	3427	17	.	.	.
25944	3428	1	OF	of	IN
25944	3428	2	EPIDERMAL	EPIDERMAL	NNP
25944	3428	3	AND	and	CC
25944	3428	4	|	|	NNP
25944	3428	5	|	|	NNP
25944	3428	6	|	|	NNP
25944	3428	7	PAPILLARY	PAPILLARY	NNP
25944	3428	8	LAYERS	layer	NNS
25944	3428	9	.	.	.
25944	3429	1	|	|	NNP
25944	3429	2	|	|	CD
25944	3429	3	|	|	NNP
25944	3429	4	Keratosis	keratosis	NN
25944	3429	5	:	:	:
25944	3429	6	|	|	CD
25944	3429	7	94	94	CD
25944	3429	8	|	|	CD
25944	3429	9	.076	.076	CD
25944	3429	10	|	|	NNP
25944	3429	11	a.	a.	NN
25944	3429	12	pilaris	pilaris	NNP
25944	3429	13	|	|	NNP
25944	3429	14	103	103	CD
25944	3429	15	|	|	CD
25944	3429	16	.083	.083	CD
25944	3429	17	|	|	NNP
25944	3429	18	b.	b.	NN
25944	3429	19	senilis	senilis	NNP
25944	3429	20	|	|	NNP
25944	3429	21	68	68	CD
25944	3429	22	|	|	CD
25944	3429	23	.055	.055	CD
25944	3429	24	|	|	NNP
25944	3429	25	Molluscum	Molluscum	NNP
25944	3429	26	epitheliale|	epitheliale|	NNP
25944	3429	27	172	172	CD
25944	3429	28	|	|	CD
25944	3429	29	.139	.139	CD
25944	3429	30	|	|	NNP
25944	3429	31	Callositas	Callositas	NNP
25944	3429	32	|	|	NNP
25944	3429	33	110	110	CD
25944	3429	34	|	|	CD
25944	3429	35	.090	.090	CD
25944	3429	36	|	|	NNP
25944	3429	37	Clavus	Clavus	NNP
25944	3429	38	|	|	NNP
25944	3429	39	84	84	CD
25944	3429	40	|	|	CD
25944	3429	41	.068	.068	CD
25944	3429	42	|	|	NNP
25944	3429	43	Cornu	Cornu	NNP
25944	3429	44	cutaneum	cutaneum	NN
25944	3429	45	|	|	NNP
25944	3429	46	42	42	CD
25944	3429	47	|	|	CD
25944	3429	48	.034	.034	CD
25944	3429	49	|	|	CD
25944	3429	50	Verruca	Verruca	NNP
25944	3429	51	|	|	NNP
25944	3429	52	1252	1252	CD
25944	3429	53	|	|	CD
25944	3429	54	1.09	1.09	CD
25944	3429	55	|	|	NNP
25944	3429	56	Verruca	Verruca	NNP
25944	3429	57	necrogenica	necrogenica	NNP
25944	3429	58	|	|	NNP
25944	3429	59	2	2	CD
25944	3429	60	|	|	CD
25944	3429	61	.001	.001	CD
25944	3429	62	|	|	CD
25944	3429	63	Nævus	Nævus	NNP
25944	3429	64	pigmentosus	pigmentosus	NN
25944	3429	65	|	|	CD
25944	3429	66	88	88	CD
25944	3429	67	|	|	CD
25944	3429	68	.064	.064	CD
25944	3429	69	|	|	NNP
25944	3429	70	Xerosis	Xerosis	NNP
25944	3429	71	|	|	CD
25944	3429	72	100	100	CD
25944	3429	73	|	|	CD
25944	3429	74	.080	.080	CD
25944	3429	75	|	|	NNP
25944	3429	76	Ichthyosis	Ichthyosis	NNP
25944	3429	77	|	|	NNP
25944	3429	78	309	309	CD
25944	3429	79	|	|	CD
25944	3429	80	.249	.249	CD
25944	3429	81	|	|	NNP
25944	3429	82	Onychauxis	Onychauxis	NNP
25944	3429	83	|	|	NNP
25944	3429	84	70	70	CD
25944	3429	85	|	|	CD
25944	3429	86	.056	.056	CD
25944	3429	87	|	|	NNP
25944	3429	88	Hypertrichosis	Hypertrichosis	NNP
25944	3429	89	|	|	NNP
25944	3429	90	515	515	CD
25944	3429	91	|	|	CD
25944	3429	92	.416	.416	CD
25944	3429	93	|	|	CD
25944	3429	94	3	3	CD
25944	3429	95	.	.	.
25944	3430	1	OF	of	IN
25944	3430	2	CONNECTIVE	CONNECTIVE	NNP
25944	3430	3	|	|	CD
25944	3430	4	|	|	CD
25944	3430	5	|	|	CD
25944	3430	6	TISSUE	tissue	NN
25944	3430	7	.	.	.
25944	3431	1	|	|	NNP
25944	3431	2	|	|	CD
25944	3431	3	|	|	NNP
25944	3431	4	Sclerema	Sclerema	NNP
25944	3431	5	neonatorum	neonatorum	NN
25944	3431	6	|	|	NNP
25944	3431	7	....	....	NFP
25944	3431	8	|	|	NNP
25944	3431	9	....	....	NFP
25944	3431	10	|	|	NNP
25944	3431	11	Scleroderma	Scleroderma	NNP
25944	3431	12	|	|	NNP
25944	3431	13	38	38	CD
25944	3431	14	|	|	CD
25944	3431	15	0.030	0.030	CD
25944	3431	16	|	|	CD
25944	3431	17	Morph[oe]a	morph[oe]a	CD
25944	3431	18	|	|	CD
25944	3431	19	39	39	CD
25944	3431	20	|	|	CD
25944	3431	21	0.031	0.031	CD
25944	3431	22	|	|	NNP
25944	3431	23	Elephantiasis	Elephantiasis	NNP
25944	3431	24	|	|	NNP
25944	3431	25	57	57	CD
25944	3431	26	|	|	CD
25944	3431	27	0.046	0.046	CD
25944	3431	28	|	|	CD
25944	3431	29	Rosacea	Rosacea	NNP
25944	3431	30	:	:	:
25944	3431	31	|	|	CD
25944	3431	32	785	785	CD
25944	3431	33	|	|	CD
25944	3431	34	0.634	0.634	CD
25944	3431	35	|	|	NNP
25944	3431	36	a.	a.	NN
25944	3431	37	erythematosa	erythematosa	NNP
25944	3431	38	|	|	NNP
25944	3431	39	381	381	CD
25944	3431	40	|	|	CD
25944	3431	41	0.308	0.308	CD
25944	3431	42	|	|	NNP
25944	3431	43	b.	b.	NNP
25944	3431	44	hypertrophica	hypertrophica	NNP
25944	3431	45	|	|	NNP
25944	3431	46	58	58	CD
25944	3431	47	|	|	CD
25944	3431	48	0.047	0.047	CD
25944	3431	49	|	|	NNP
25944	3431	50	Framb[oe]sia	Framb[oe]sia	NNP
25944	3431	51	|	|	NNP
25944	3431	52	22	22	CD
25944	3431	53	|	|	CD
25944	3431	54	0.018	0.018	CD
25944	3431	55	|	|	CD
25944	3431	56	|	|	CD
25944	3431	57	|	|	NNP
25944	3431	58	|	|	NNP
25944	3431	59	Class	Class	NNP
25944	3431	60	V.	V.	NNP
25944	3431	61	Atrophies	Atrophies	NNP
25944	3431	62	.	.	.
25944	3432	1	|	|	NNP
25944	3432	2	|	|	CD
25944	3432	3	|	|	CD
25944	3432	4	1	1	CD
25944	3432	5	.	.	.
25944	3433	1	OF	of	IN
25944	3433	2	PIGMENT	PIGMENT	NNP
25944	3433	3	.	.	.
25944	3434	1	|	|	NNP
25944	3434	2	|	|	NNP
25944	3434	3	|	|	NNP
25944	3434	4	Leucoderma	Leucoderma	NNP
25944	3434	5	|	|	CD
25944	3434	6	77	77	CD
25944	3434	7	|	|	CD
25944	3434	8	0.062	0.062	CD
25944	3434	9	|	|	NNP
25944	3434	10	Albinismus	Albinismus	NNP
25944	3434	11	|	|	CD
25944	3434	12	9	9	CD
25944	3434	13	|	|	CD
25944	3434	14	0.008	0.008	CD
25944	3434	15	|	|	NNP
25944	3434	16	Vitiligo	Vitiligo	NNP
25944	3434	17	|	|	CD
25944	3434	18	191	191	CD
25944	3434	19	|	|	CD
25944	3434	20	0.155	0.155	CD
25944	3434	21	|	|	NNP
25944	3434	22	Canities	Canities	NNPS
25944	3434	23	|	|	NNP
25944	3434	24	43	43	CD
25944	3434	25	|	|	CD
25944	3434	26	0.035	0.035	CD
25944	3434	27	|	|	CD
25944	3434	28	2	2	CD
25944	3434	29	.	.	.
25944	3435	1	OF	of	IN
25944	3435	2	HAIR	HAIR	NNP
25944	3435	3	.	.	.
25944	3436	1	|	|	NNP
25944	3436	2	|	|	CD
25944	3436	3	|	|	NNP
25944	3436	4	Alopecia	Alopecia	NNP
25944	3436	5	|	|	NNP
25944	3436	6	926	926	CD
25944	3436	7	|	|	CD
25944	3436	8	0.749	0.749	CD
25944	3436	9	|	|	CD
25944	3436	10	Alopecia	Alopecia	NNP
25944	3436	11	furfuracea	furfuracea	NNP
25944	3436	12	|	|	NNP
25944	3436	13	830	830	CD
25944	3436	14	|	|	CD
25944	3436	15	0.670	0.670	CD
25944	3436	16	|	|	CD
25944	3436	17	Alopecia	Alopecia	NNP
25944	3436	18	areata	areata	NNP
25944	3436	19	|	|	CD
25944	3436	20	794	794	CD
25944	3436	21	|	|	CD
25944	3436	22	0.641	0.641	CD
25944	3436	23	|	|	NNP
25944	3436	24	Atrophia	Atrophia	NNP
25944	3436	25	pilorum	pilorum	NN
25944	3436	26	|	|	NNP
25944	3436	27	|	|	CD
25944	3436	28	|	|	CD
25944	3436	29	propria	propria	VBP
25944	3436	30	|	|	CD
25944	3436	31	23	23	CD
25944	3436	32	|	|	CD
25944	3436	33	0.019	0.019	CD
25944	3436	34	|	|	NNS
25944	3436	35	Trichorexis	Trichorexis	NNP
25944	3436	36	nodosa	nodosa	NNS
25944	3436	37	|	|	NNP
25944	3436	38	3	3	CD
25944	3436	39	|	|	CD
25944	3436	40	0.002	0.002	CD
25944	3436	41	|	|	CD
25944	3436	42	3	3	CD
25944	3436	43	.	.	.
25944	3437	1	OF	of	IN
25944	3437	2	NAIL	NAIL	NNP
25944	3437	3	|	|	NNP
25944	3437	4	26	26	CD
25944	3437	5	|	|	CD
25944	3437	6	0.021	0.021	CD
25944	3437	7	|	|	NNP
25944	3437	8	Atrophia	Atrophia	NNP
25944	3437	9	unguis	unguis	NN
25944	3437	10	|	|	CD
25944	3437	11	19	19	CD
25944	3437	12	|	|	CD
25944	3437	13	0.015	0.015	CD
25944	3437	14	|	|	CD
25944	3437	15	4	4	CD
25944	3437	16	.	.	.
25944	3438	1	OF	OF	NNP
25944	3438	2	CUTIS	CUTIS	NNP
25944	3438	3	|	|	CD
25944	3438	4	6	6	CD
25944	3438	5	|	|	CD
25944	3438	6	0.005	0.005	CD
25944	3438	7	|	|	NNP
25944	3438	8	Atrophia	Atrophia	NNP
25944	3438	9	senilis	senilis	NN
25944	3438	10	|	|	CD
25944	3438	11	15	15	CD
25944	3438	12	|	|	CD
25944	3438	13	0.013	0.013	CD
25944	3438	14	|	|	NNP
25944	3438	15	Atrophia	Atrophia	NNP
25944	3438	16	maculosa	maculosa	NNP
25944	3438	17	et	et	NNP
25944	3438	18	|	|	NNP
25944	3438	19	|	|	NNP
25944	3438	20	|	|	NNP
25944	3438	21	striata	striata	NN
25944	3438	22	|	|	CD
25944	3438	23	23	23	CD
25944	3438	24	|	|	CD
25944	3438	25	0.019	0.019	CD
25944	3438	26	|	|	CD
25944	3438	27	|	|	CD
25944	3438	28	|	|	CD
25944	3438	29	|	|	NNP
25944	3438	30	Class	Class	NNP
25944	3438	31	VI	vi	NN
25944	3438	32	.	.	.
25944	3439	1	New	New	NNP
25944	3439	2	Growths	Growths	NNPS
25944	3439	3	.	.	.
25944	3440	1	|	|	NNP
25944	3440	2	|	|	CD
25944	3440	3	|	|	CD
25944	3440	4	1	1	CD
25944	3440	5	.	.	.
25944	3441	1	OF	of	IN
25944	3441	2	CONNECTIVE	CONNECTIVE	NNP
25944	3441	3	|	|	CD
25944	3441	4	|	|	CD
25944	3441	5	|	|	CD
25944	3441	6	TISSUE	tissue	NN
25944	3441	7	.	.	.
25944	3442	1	|	|	NNP
25944	3442	2	1	1	CD
25944	3442	3	|	|	CD
25944	3442	4	0.0008|	0.0008|	CD
25944	3442	5	Keloid	Keloid	NNP
25944	3442	6	|	|	NNP
25944	3442	7	152	152	CD
25944	3442	8	|	|	CD
25944	3442	9	0.124	0.124	CD
25944	3442	10	|	|	NNP
25944	3442	11	Cicatrix	Cicatrix	NNP
25944	3442	12	|	|	NNP
25944	3442	13	89	89	CD
25944	3442	14	|	|	CD
25944	3442	15	0.065	0.065	CD
25944	3442	16	|	|	NNP
25944	3442	17	Fibroma	Fibroma	NNP
25944	3442	18	|	|	NNP
25944	3442	19	93	93	CD
25944	3442	20	|	|	CD
25944	3442	21	0.075	0.075	CD
25944	3442	22	|	|	NNP
25944	3442	23	Neuroma	Neuroma	NNP
25944	3442	24	|	|	NNP
25944	3442	25	11	11	CD
25944	3442	26	|	|	CD
25944	3442	27	0.009	0.009	CD
25944	3442	28	|	|	CD
25944	3442	29	Xanthoma	Xanthoma	NNP
25944	3442	30	|	|	NNP
25944	3442	31	69	69	CD
25944	3442	32	|	|	CD
25944	3442	33	0.056	0.056	CD
25944	3442	34	|	|	CD
25944	3442	35	2	2	CD
25944	3442	36	.	.	.
25944	3443	1	OF	of	IN
25944	3443	2	MUSCULAR	MUSCULAR	NNP
25944	3443	3	TISSUE	TISSUE	NNP
25944	3443	4	.	.	.
25944	3444	1	|	|	NNP
25944	3444	2	|	|	NNP
25944	3444	3	|	|	NNP
25944	3444	4	Myoma	Myoma	NNP
25944	3444	5	|	|	NNP
25944	3444	6	1	1	CD
25944	3444	7	|	|	CD
25944	3444	8	0.0008|	0.0008|	CD
25944	3444	9	3	3	CD
25944	3444	10	.	.	.
25944	3445	1	OF	of	IN
25944	3445	2	VESSELS	VESSELS	NNP
25944	3445	3	.	.	.
25944	3446	1	|	|	NNP
25944	3446	2	|	|	CD
25944	3446	3	|	|	NNP
25944	3446	4	Angioma	Angioma	NNP
25944	3446	5	|	|	CD
25944	3446	6	462	462	CD
25944	3446	7	|	|	CD
25944	3446	8	0.373	0.373	CD
25944	3446	9	|	|	CD
25944	3446	10	Angioma	Angioma	NNP
25944	3446	11	pigmentosum	pigmentosum	NN
25944	3446	12	|	|	NNP
25944	3446	13	|	|	NNP
25944	3446	14	|	|	NNP
25944	3446	15	et	et	NNP
25944	3446	16	atrophicum	atrophicum	NN
25944	3446	17	|	|	NNP
25944	3446	18	13	13	CD
25944	3446	19	|	|	CD
25944	3446	20	0.010	0.010	CD
25944	3446	21	|	|	NNP
25944	3446	22	Angioma	Angioma	NNP
25944	3446	23	cavernosum	cavernosum	NNP
25944	3446	24	|	|	NNP
25944	3446	25	22	22	CD
25944	3446	26	|	|	CD
25944	3446	27	0.018	0.018	CD
25944	3446	28	|	|	CD
25944	3446	29	Lymphangioma	Lymphangioma	NNP
25944	3446	30	|	|	NNP
25944	3446	31	16	16	CD
25944	3446	32	|	|	CD
25944	3446	33	.012	.012	CD
25944	3446	34	|	|	CD
25944	3446	35	4	4	CD
25944	3446	36	.	.	.
25944	3447	1	Mycosis	Mycosis	NNP
25944	3447	2	fongoide	fongoide	NN
25944	3447	3	|	|	CD
25944	3447	4	1	1	CD
25944	3447	5	|	|	CD
25944	3447	6	.0008|	.0008|	.
25944	3447	7	Rhinoscleroma	Rhinoscleroma	NNP
25944	3447	8	|	|	NNP
25944	3447	9	3	3	CD
25944	3447	10	|	|	CD
25944	3447	11	.002	.002	CD
25944	3447	12	|	|	NNP
25944	3447	13	Lupus	Lupus	NNP
25944	3447	14	erythematosus	erythematosus	NN
25944	3447	15	|	|	CD
25944	3447	16	477	477	CD
25944	3447	17	|	|	CD
25944	3447	18	.385	.385	CD
25944	3447	19	|	|	NNP
25944	3447	20	Lupus	Lupus	NNP
25944	3447	21	vulgaris	vulgaris	NN
25944	3447	22	|	|	NNP
25944	3447	23	536	536	CD
25944	3447	24	|	|	CD
25944	3447	25	.433	.433	CD
25944	3447	26	|	|	NNP
25944	3447	27	Scrofuloderma	Scrofuloderma	NNP
25944	3447	28	|	|	NNP
25944	3447	29	663	663	CD
25944	3447	30	|	|	CD
25944	3447	31	.536	.536	CD
25944	3447	32	|	|	NNS
25944	3447	33	Syphiloderma	Syphiloderma	NNP
25944	3447	34	:	:	:
25944	3447	35	|	|	NNP
25944	3447	36	13888	13888	CD
25944	3447	37	|11.22	|11.22	NNP
25944	3447	38	|	|	NNP
25944	3447	39	a.	a.	NN
25944	3447	40	erythematosum	erythematosum	NNP
25944	3447	41	|	|	NNP
25944	3447	42	....	....	NNP
25944	3447	43	|	|	NNP
25944	3447	44	....	....	NFP
25944	3447	45	|	|	NNP
25944	3447	46	b.	b.	NNP
25944	3447	47	papulosum	papulosum	NNP
25944	3447	48	|	|	NNP
25944	3447	49	....	....	SYM
25944	3447	50	|	|	NNP
25944	3447	51	....	....	NFP
25944	3447	52	|	|	NNP
25944	3447	53	c.	c.	NN
25944	3447	54	pustulosum	pustulosum	NNP
25944	3447	55	|	|	NNP
25944	3447	56	....	....	SYM
25944	3447	57	|	|	NNP
25944	3447	58	....	....	NFP
25944	3447	59	|	|	NNP
25944	3447	60	d.	d.	NNP
25944	3447	61	tuberculosum	tuberculosum	NNP
25944	3447	62	|	|	NNP
25944	3447	63	....	....	NNP
25944	3447	64	|	|	NNP
25944	3447	65	....	....	NFP
25944	3447	66	|	|	NNP
25944	3447	67	e.	e.	NNP
25944	3447	68	gummatosum	gummatosum	NNP
25944	3447	69	|	|	NNP
25944	3447	70	....	....	SYM
25944	3447	71	|	|	NNP
25944	3447	72	....	....	NFP
25944	3447	73	|	|	NNP
25944	3447	74	Lepra	Lepra	NNP
25944	3447	75	:	:	:
25944	3447	76	|	|	NNP
25944	3447	77	24	24	CD
25944	3447	78	|	|	CD
25944	3447	79	.020	.020	CD
25944	3447	80	|	|	NNP
25944	3447	81	a.	a.	NN
25944	3447	82	tuberosa	tuberosa	NNP
25944	3447	83	|	|	NNP
25944	3447	84	7	7	CD
25944	3447	85	|	|	CD
25944	3447	86	.005	.005	CD
25944	3447	87	|	|	NNP
25944	3447	88	b.	b.	NNP
25944	3447	89	maculosa	maculosa	NNP
25944	3447	90	|	|	NNP
25944	3447	91	4	4	CD
25944	3447	92	|	|	CD
25944	3447	93	.003	.003	CD
25944	3447	94	|	|	CD
25944	3447	95	c.	c.	NNP
25944	3447	96	anæsthetica	anæsthetica	NNP
25944	3447	97	|	|	NNP
25944	3447	98	6	6	CD
25944	3447	99	|	|	CD
25944	3447	100	.004	.004	CD
25944	3447	101	|	|	CD
25944	3447	102	Carcinoma	Carcinoma	NNP
25944	3447	103	|	|	NNP
25944	3447	104	1068	1068	CD
25944	3447	105	|	|	CD
25944	3447	106	.863	.863	CD
25944	3447	107	|	|	NNP
25944	3447	108	Sarcoma	Sarcoma	NNP
25944	3447	109	|	|	CD
25944	3447	110	55	55	CD
25944	3447	111	|	|	CD
25944	3447	112	.044	.044	CD
25944	3447	113	|	|	CD
25944	3447	114	|	|	CD
25944	3447	115	|	|	CD
25944	3447	116	|	|	NNP
25944	3447	117	Class	Class	NNP
25944	3447	118	VII	vii	NN
25944	3447	119	.	.	.
25944	3448	1	Neuroses	neurosis	NNS
25944	3448	2	.	.	.
25944	3449	1	|	|	NNP
25944	3449	2	|	|	NNP
25944	3449	3	|	|	NNP
25944	3449	4	Hyperæsthesia	Hyperæsthesia	NNP
25944	3449	5	:	:	:
25944	3449	6	|	|	NNP
25944	3449	7	4	4	CD
25944	3449	8	|	|	CD
25944	3449	9	.003	.003	CD
25944	3449	10	|	|	CD
25944	3449	11	a.	a.	NN
25944	3449	12	Pruritus	Pruritus	NNP
25944	3449	13	|	|	NNP
25944	3449	14	2716	2716	CD
25944	3449	15	|	|	CD
25944	3449	16	2.12	2.12	CD
25944	3449	17	|	|	CD
25944	3449	18	b.	b.	NN
25944	3449	19	Dermatalgia	Dermatalgia	NNP
25944	3449	20	|	|	NNP
25944	3449	21	11	11	CD
25944	3449	22	|	|	CD
25944	3449	23	.009	.009	CD
25944	3449	24	|	|	CD
25944	3449	25	Anæsthesia	Anæsthesia	NNP
25944	3449	26	|	|	CD
25944	3449	27	22	22	CD
25944	3449	28	|	|	CD
25944	3449	29	.018	.018	CD
25944	3449	30	|	|	CD
25944	3449	31	|	|	CD
25944	3449	32	|	|	CD
25944	3449	33	|	|	CD
25944	3449	34	Class	Class	NNP
25944	3449	35	VIII	viii	NN
25944	3449	36	.	.	.
25944	3450	1	Parasitic	Parasitic	NNP
25944	3450	2	|	|	NNP
25944	3450	3	|	|	NNP
25944	3450	4	|	|	NNP
25944	3450	5	Affections	affection	NNS
25944	3450	6	.	.	.
25944	3451	1	|	|	NNP
25944	3451	2	|	|	CD
25944	3451	3	|	|	CD
25944	3451	4	1	1	CD
25944	3451	5	.	.	.
25944	3452	1	VEGETABLE	VEGETABLE	NNP
25944	3452	2	.	.	.
25944	3453	1	|	|	NNP
25944	3453	2	|	|	NNP
25944	3453	3	|	|	NNP
25944	3453	4	Tinea	Tinea	NNP
25944	3453	5	favosa	favosa	NNS
25944	3453	6	|	|	NNP
25944	3453	7	354	354	CD
25944	3453	8	|	|	CD
25944	3453	9	.286	.286	CD
25944	3453	10	|	|	NNP
25944	3453	11	Tinea	Tinea	NNP
25944	3453	12	trichophytina	trichophytina	NN
25944	3453	13	:	:	:
25944	3453	14	|	|	NNP
25944	3453	15	2289	2289	CD
25944	3453	16	|	|	CD
25944	3453	17	1.85	1.85	CD
25944	3453	18	|	|	NNP
25944	3453	19	a.	a.	NN
25944	3453	20	circinata	circinata	NN
25944	3453	21	|	|	NNP
25944	3453	22	705	705	CD
25944	3453	23	|	|	CD
25944	3453	24	.569	.569	CD
25944	3453	25	|	|	CD
25944	3453	26	b.	b.	NNP
25944	3453	27	tonsurans	tonsuran	NNS
25944	3453	28	|	|	NNP
25944	3453	29	675	675	CD
25944	3453	30	|	|	CD
25944	3453	31	.545	.545	CD
25944	3453	32	|	|	HYPH
25944	3453	33	c.	c.	NN
25944	3453	34	sycosis	sycosis	NNP
25944	3453	35	|	|	NNP
25944	3453	36	365	365	CD
25944	3453	37	|	|	CD
25944	3453	38	.295	.295	CD
25944	3453	39	|	|	NNP
25944	3453	40	Tinea	Tinea	NNP
25944	3453	41	versicolor	versicolor	NN
25944	3453	42	|	|	CD
25944	3453	43	1263	1263	CD
25944	3453	44	|	|	CD
25944	3453	45	1.02	1.02	CD
25944	3453	46	|	|	CD
25944	3453	47	2	2	CD
25944	3453	48	.	.	.
25944	3454	1	ANIMAL	ANIMAL	NNP
25944	3454	2	.	.	.
25944	3455	1	|	|	NNP
25944	3455	2	|	|	NNP
25944	3455	3	|	|	NNP
25944	3455	4	Scabies	Scabies	NNPS
25944	3455	5	|	|	NNP
25944	3455	6	3192	3192	CD
25944	3455	7	|	|	CD
25944	3455	8	2.58	2.58	CD
25944	3455	9	|	|	NNP
25944	3455	10	Pediculosis	Pediculosis	NNP
25944	3455	11	|	|	NNP
25944	3455	12	|	|	NNP
25944	3455	13	|	|	NNP
25944	3455	14	capillitii	capillitii	NNS
25944	3455	15	|	|	NNP
25944	3455	16	2579	2579	CD
25944	3455	17	|	|	CD
25944	3455	18	2.09	2.09	CD
25944	3455	19	|	|	NNP
25944	3455	20	Pediculosis	Pediculosis	NNP
25944	3455	21	corporis	corporis	NNP
25944	3455	22	|	|	POS
25944	3455	23	1704	1704	CD
25944	3455	24	|	|	CD
25944	3455	25	1.38	1.38	CD
25944	3455	26	|	|	NNS
25944	3455	27	Pediculosis	Pediculosis	NNP
25944	3455	28	pubis	pubi	VBD
25944	3455	29	|	|	CD
25944	3455	30	436	436	CD
25944	3455	31	|	|	CD
25944	3455	32	.352	.352	CD
25944	3455	33	|	|	NNP
25944	3455	34	-------------------------+-------+-------+	-------------------------+-------+-------+	:
25944	3455	35	Total	total	NN
25944	3455	36	123746	123746	CD
25944	3455	37	[	[	-LRB-
25944	3455	38	Footnote	footnote	NN
25944	3455	39	E	E	NNP
25944	3455	40	:	:	:
25944	3455	41	Indicating	indicate	VBG
25944	3455	42	affections	affection	NNS
25944	3455	43	of	of	IN
25944	3455	44	this	this	DT
25944	3455	45	class	class	NN
25944	3455	46	not	not	RB
25944	3455	47	properly	properly	RB
25944	3455	48	included	include	VBN
25944	3455	49	under	under	IN
25944	3455	50	other	other	JJ
25944	3455	51	titles	title	NNS
25944	3455	52	.	.	.
25944	3455	53	]	]	-RRB-
25944	3456	1	#	#	JJR
25944	3456	2	INDEX	INDEX	NNP
25944	3456	3	.	.	.
25944	3456	4	#	#	NNP
25944	3456	5	Acarus	Acarus	NNP
25944	3456	6	folliculorum	folliculorum	NN
25944	3456	7	,	,	,
25944	3456	8	40	40	CD
25944	3456	9	scabiei	scabiei	NN
25944	3456	10	,	,	,
25944	3456	11	269	269	CD
25944	3456	12	Achorion	Achorion	NNP
25944	3456	13	Schönleinii	Schönleinii	NNP
25944	3456	14	,	,	,
25944	3456	15	249	249	CD
25944	3456	16	Acne	Acne	NNS
25944	3456	17	,	,	,
25944	3456	18	115	115	CD
25944	3456	19	-	-	SYM
25944	3456	20	126	126	CD
25944	3456	21	artificialis	artificialis	RB
25944	3456	22	,	,	,
25944	3456	23	120	120	CD
25944	3456	24	atrophica	atrophica	NNP
25944	3456	25	,	,	,
25944	3456	26	120	120	CD
25944	3456	27	cachecticorum	cachecticorum	NN
25944	3456	28	,	,	,
25944	3456	29	120	120	CD
25944	3456	30	frontalis	frontalis	NNPS
25944	3456	31	,	,	,
25944	3456	32	129	129	CD
25944	3456	33	hypertrophica	hypertrophica	NNP
25944	3456	34	,	,	,
25944	3456	35	120	120	CD
25944	3456	36	indurata	indurata	NNP
25944	3456	37	,	,	,
25944	3456	38	120	120	CD
25944	3456	39	keloid	keloid	NN
25944	3456	40	,	,	,
25944	3456	41	135	135	CD
25944	3456	42	lupoid	lupoid	NN
25944	3456	43	,	,	,
25944	3456	44	129	129	CD
25944	3456	45	necrotica	necrotica	NN
25944	3456	46	,	,	,
25944	3456	47	129	129	CD
25944	3456	48	papulosa	papulosa	NNS
25944	3456	49	,	,	,
25944	3456	50	120	120	CD
25944	3456	51	punctata	punctata	NNS
25944	3456	52	,	,	,
25944	3456	53	120	120	CD
25944	3456	54	pustulosa	pustulosa	NNS
25944	3456	55	,	,	,
25944	3456	56	120	120	CD
25944	3456	57	rodens	roden	NNS
25944	3456	58	,	,	,
25944	3456	59	129	129	CD
25944	3456	60	rosacea	rosacea	NN
25944	3456	61	,	,	,
25944	3456	62	126	126	CD
25944	3456	63	-	-	SYM
25944	3456	64	129	129	CD
25944	3456	65	,	,	,
25944	3456	66	198	198	CD
25944	3456	67	sebacea	sebacea	NN
25944	3456	68	,	,	,
25944	3456	69	33	33	CD
25944	3456	70	tar	tar	NN
25944	3456	71	,	,	,
25944	3456	72	120	120	CD
25944	3456	73	urticata	urticata	JJ
25944	3456	74	,	,	,
25944	3456	75	130	130	CD
25944	3456	76	varioliformis	varioliformis	NN
25944	3456	77	,	,	,
25944	3456	78	129	129	CD
25944	3456	79	vulgaris	vulgaris	NN
25944	3456	80	,	,	,
25944	3456	81	119	119	CD
25944	3456	82	Acnitis	Acnitis	NNP
25944	3456	83	,	,	,
25944	3456	84	130	130	CD
25944	3456	85	Actinomycosis	actinomycosis	NN
25944	3456	86	,	,	,
25944	3456	87	266	266	CD
25944	3456	88	Addison	Addison	NNP
25944	3456	89	's	's	POS
25944	3456	90	disease	disease	NN
25944	3456	91	,	,	,
25944	3456	92	pigmentation	pigmentation	NN
25944	3456	93	of	of	IN
25944	3456	94	the	the	DT
25944	3456	95	skin	skin	NN
25944	3456	96	in	in	RP
25944	3456	97	,	,	,
25944	3456	98	149	149	CD
25944	3456	99	keloid	keloid	NN
25944	3456	100	,	,	,
25944	3456	101	172	172	CD
25944	3456	102	Ainhum	Ainhum	NNP
25944	3456	103	,	,	,
25944	3456	104	212	212	CD
25944	3456	105	Albinismus	Albinismus	NNP
25944	3456	106	,	,	,
25944	3456	107	177	177	CD
25944	3456	108	Albinos	Albinos	NNP
25944	3456	109	,	,	,
25944	3456	110	177	177	CD
25944	3456	111	Alopecia	Alopecia	NNP
25944	3456	112	,	,	,
25944	3456	113	181	181	CD
25944	3456	114	-	-	SYM
25944	3456	115	183	183	CD
25944	3456	116	areata	areata	NN
25944	3456	117	,	,	,
25944	3456	118	183	183	CD
25944	3456	119	-	-	SYM
25944	3456	120	186	186	CD
25944	3456	121	circumscripta	circumscripta	NN
25944	3456	122	,	,	,
25944	3456	123	183	183	CD
25944	3456	124	congenital	congenital	JJ
25944	3456	125	,	,	,
25944	3456	126	181	181	CD
25944	3456	127	furfuracea	furfuracea	NN
25944	3456	128	,	,	,
25944	3456	129	181	181	CD
25944	3456	130	premature	premature	JJ
25944	3456	131	,	,	,
25944	3456	132	181	181	CD
25944	3456	133	senile	senile	JJ
25944	3456	134	,	,	,
25944	3456	135	181	181	CD
25944	3456	136	Anæsthesia	Anæsthesia	NNP
25944	3456	137	,	,	,
25944	3456	138	244	244	CD
25944	3456	139	Anatomy	anatomy	NN
25944	3456	140	of	of	IN
25944	3456	141	the	the	DT
25944	3456	142	skin	skin	NN
25944	3456	143	,	,	,
25944	3456	144	17	17	CD
25944	3456	145	-	-	SYM
25944	3456	146	21	21	CD
25944	3456	147	,	,	,
25944	3456	148	28	28	CD
25944	3456	149	Angioma	Angioma	NNP
25944	3456	150	,	,	,
25944	3456	151	196	196	CD
25944	3456	152	,	,	,
25944	3456	153	197	197	CD
25944	3456	154	cavernosum	cavernosum	NN
25944	3456	155	,	,	,
25944	3456	156	197	197	CD
25944	3456	157	pigmentosum	pigmentosum	NN
25944	3456	158	et	et	NNP
25944	3456	159	atrophicum	atrophicum	NN
25944	3456	160	,	,	,
25944	3456	161	190	190	CD
25944	3456	162	simplex	simplex	NN
25944	3456	163	,	,	,
25944	3456	164	196	196	CD
25944	3456	165	Angiomyoma	Angiomyoma	NNP
25944	3456	166	,	,	,
25944	3456	167	196	196	CD
25944	3456	168	Angioneurotic	angioneurotic	JJ
25944	3456	169	[	[	-LRB-
25944	3456	170	oe]dema	oe]dema	NNS
25944	3456	171	,	,	,
25944	3456	172	54	54	CD
25944	3456	173	Anidrosis	anidrosis	NN
25944	3456	174	,	,	,
25944	3456	175	31	31	CD
25944	3456	176	Anthrax	anthrax	NN
25944	3456	177	,	,	,
25944	3456	178	70	70	CD
25944	3456	179	,	,	,
25944	3456	180	72	72	CD
25944	3456	181	Antipruritic	antipruritic	JJ
25944	3456	182	applications	application	NNS
25944	3456	183	,	,	,
25944	3456	184	246	246	CD
25944	3456	185	Antipyrin	Antipyrin	NNP
25944	3456	186	,	,	,
25944	3456	187	eruptions	eruption	NNS
25944	3456	188	from	from	IN
25944	3456	189	,	,	,
25944	3456	190	61	61	CD
25944	3456	191	Area	Area	NNP
25944	3456	192	Celsi	Celsi	NNP
25944	3456	193	,	,	,
25944	3456	194	183	183	CD
25944	3456	195	Argyria	Argyria	NNP
25944	3456	196	,	,	,
25944	3456	197	150	150	CD
25944	3456	198	Arsenic	arsenic	JJ
25944	3456	199	,	,	,
25944	3456	200	eruptions	eruption	NNS
25944	3456	201	from	from	IN
25944	3456	202	,	,	,
25944	3456	203	61	61	CD
25944	3456	204	Artificial	artificial	JJ
25944	3456	205	eruptions	eruption	NNS
25944	3456	206	(	(	-LRB-
25944	3456	207	feigned	feigned	JJ
25944	3456	208	eruptions	eruption	NNS
25944	3456	209	)	)	-RRB-
25944	3456	210	,	,	,
25944	3456	211	64	64	CD
25944	3456	212	Atrophia	Atrophia	NNP
25944	3456	213	cutis	cutis	NN
25944	3456	214	,	,	,
25944	3456	215	189	189	CD
25944	3456	216	,	,	,
25944	3456	217	190	190	CD
25944	3456	218	pilorum	pilorum	NN
25944	3456	219	propria	propria	NN
25944	3456	220	,	,	,
25944	3456	221	187	187	CD
25944	3456	222	unguis	unguis	NN
25944	3456	223	,	,	,
25944	3456	224	188	188	CD
25944	3456	225	,	,	,
25944	3456	226	189	189	CD
25944	3456	227	Atrophic	atrophic	JJ
25944	3456	228	lines	line	NNS
25944	3456	229	and	and	CC
25944	3456	230	spots	spot	NNS
25944	3456	231	,	,	,
25944	3456	232	190	190	CD
25944	3456	233	Atrophies	Atrophies	NNPS
25944	3456	234	,	,	,
25944	3456	235	177	177	CD
25944	3456	236	-	-	SYM
25944	3456	237	190	190	CD
25944	3456	238	Atrophoderma	Atrophoderma	NNP
25944	3456	239	,	,	,
25944	3456	240	189	189	CD
25944	3456	241	neuriticum	neuriticum	NN
25944	3456	242	,	,	,
25944	3456	243	189	189	CD
25944	3456	244	Atrophy	Atrophy	NNP
25944	3456	245	of	of	IN
25944	3456	246	the	the	DT
25944	3456	247	hair	hair	NN
25944	3456	248	,	,	,
25944	3456	249	187	187	CD
25944	3456	250	of	of	IN
25944	3456	251	the	the	DT
25944	3456	252	nails	nail	NNS
25944	3456	253	,	,	,
25944	3456	254	188	188	CD
25944	3456	255	of	of	IN
25944	3456	256	the	the	DT
25944	3456	257	skin	skin	NN
25944	3456	258	,	,	,
25944	3456	259	189	189	CD
25944	3456	260	general	general	JJ
25944	3456	261	idiopathic	idiopathic	NNP
25944	3456	262	,	,	,
25944	3456	263	189	189	CD
25944	3456	264	senile	senile	JJ
25944	3456	265	,	,	,
25944	3456	266	190	190	CD
25944	3456	267	Atropia	atropia	NN
25944	3456	268	,	,	,
25944	3456	269	eruptions	eruption	NNS
25944	3456	270	from	from	IN
25944	3456	271	,	,	,
25944	3456	272	61	61	CD
25944	3456	273	Autographism	autographism	NN
25944	3456	274	,	,	,
25944	3456	275	52	52	CD
25944	3456	276	Baldness	Baldness	NNP
25944	3456	277	,	,	,
25944	3456	278	181	181	CD
25944	3456	279	Barbadoes	barbadoe	NNS
25944	3456	280	leg	leg	NN
25944	3456	281	,	,	,
25944	3456	282	174	174	CD
25944	3456	283	Barbers	barber	NNS
25944	3456	284	'	'	POS
25944	3456	285	itch	itch	NN
25944	3456	286	,	,	,
25944	3456	287	255	255	CD
25944	3456	288	Bath	bath	NN
25944	3456	289	-	-	HYPH
25944	3456	290	pruritis	pruritis	NNP
25944	3456	291	,	,	,
25944	3456	292	245	245	CD
25944	3456	293	Bed	bed	NN
25944	3456	294	-	-	HYPH
25944	3456	295	bug	bug	NN
25944	3456	296	,	,	,
25944	3456	297	278	278	CD
25944	3456	298	Bed	bed	NN
25944	3456	299	-	-	HYPH
25944	3456	300	sores	sore	NNS
25944	3456	301	,	,	,
25944	3456	302	58	58	CD
25944	3456	303	Belladonna	Belladonna	NNP
25944	3456	304	,	,	,
25944	3456	305	eruptions	eruption	NNS
25944	3456	306	from	from	IN
25944	3456	307	,	,	,
25944	3456	308	61	61	CD
25944	3456	309	Blackheads	blackhead	NNS
25944	3456	310	,	,	,
25944	3456	311	38	38	CD
25944	3456	312	-	-	SYM
25944	3456	313	41	41	CD
25944	3456	314	Blanching	blanching	NN
25944	3456	315	of	of	IN
25944	3456	316	the	the	DT
25944	3456	317	hair	hair	NN
25944	3456	318	,	,	,
25944	3456	319	180	180	CD
25944	3456	320	Blastomycetic	blastomycetic	JJ
25944	3456	321	dermatitis	dermatitis	NN
25944	3456	322	,	,	,
25944	3456	323	266	266	CD
25944	3456	324	Blebs	Blebs	NNP
25944	3456	325	,	,	,
25944	3456	326	23	23	CD
25944	3456	327	Blood	blood	NN
25944	3456	328	-	-	HYPH
25944	3456	329	vessels	vessel	NNS
25944	3456	330	,	,	,
25944	3456	331	19	19	CD
25944	3456	332	Boil	Boil	NNP
25944	3456	333	,	,	,
25944	3456	334	68	68	CD
25944	3456	335	Bot	bot	NN
25944	3456	336	-	-	HYPH
25944	3456	337	fly	fly	NNP
25944	3456	338	,	,	,
25944	3456	339	278	278	CD
25944	3456	340	Bromides	bromide	NNS
25944	3456	341	,	,	,
25944	3456	342	eruptions	eruption	NNS
25944	3456	343	from	from	IN
25944	3456	344	,	,	,
25944	3456	345	61	61	CD
25944	3456	346	Bromidrosis	Bromidrosis	NNP
25944	3456	347	,	,	,
25944	3456	348	32	32	CD
25944	3456	349	Bullæ	Bullæ	NNP
25944	3456	350	,	,	,
25944	3456	351	23	23	CD
25944	3456	352	Burns	burn	NNS
25944	3456	353	,	,	,
25944	3456	354	58	58	CD
25944	3456	355	Burrows	burrow	NNS
25944	3456	356	,	,	,
25944	3456	357	268	268	CD
25944	3456	358	Calculi	Calculi	NNP
25944	3456	359	,	,	,
25944	3456	360	cutaneous	cutaneous	JJ
25944	3456	361	,	,	,
25944	3456	362	42	42	CD
25944	3456	363	Callositas	Callositas	NNP
25944	3456	364	,	,	,
25944	3456	365	155	155	CD
25944	3456	366	,	,	,
25944	3456	367	156	156	CD
25944	3456	368	Callosity	callosity	NN
25944	3456	369	,	,	,
25944	3456	370	155	155	CD
25944	3456	371	Callous	callous	JJ
25944	3456	372	,	,	,
25944	3456	373	155	155	CD
25944	3456	374	Callus	Callus	NNP
25944	3456	375	,	,	,
25944	3456	376	155	155	CD
25944	3456	377	Cancer	Cancer	NNP
25944	3456	378	,	,	,
25944	3456	379	epithelial	epithelial	NN
25944	3456	380	,	,	,
25944	3456	381	236	236	CD
25944	3456	382	skin	skin	NN
25944	3456	383	,	,	,
25944	3456	384	236	236	CD
25944	3456	385	Canities	canitie	NNS
25944	3456	386	,	,	,
25944	3456	387	180	180	CD
25944	3456	388	prematura	prematura	NNS
25944	3456	389	,	,	,
25944	3456	390	180	180	CD
25944	3456	391	senilis	senili	NNS
25944	3456	392	,	,	,
25944	3456	393	180	180	CD
25944	3456	394	Carbuncle	Carbuncle	NNP
25944	3456	395	,	,	,
25944	3456	396	70	70	CD
25944	3456	397	Carbunculus	Carbunculus	NNP
25944	3456	398	,	,	,
25944	3456	399	70	70	CD
25944	3456	400	-	-	SYM
25944	3456	401	72	72	CD
25944	3456	402	Carcinoma	Carcinoma	NNP
25944	3456	403	epitheliale	epitheliale	NN
25944	3456	404	,	,	,
25944	3456	405	236	236	CD
25944	3456	406	Carrion	carrion	NN
25944	3456	407	's	's	POS
25944	3456	408	disease	disease	NN
25944	3456	409	,	,	,
25944	3456	410	73	73	CD
25944	3456	411	Chafing	chafe	VBG
25944	3456	412	,	,	,
25944	3456	413	45	45	CD
25944	3456	414	Chapping	Chapping	NNP
25944	3456	415	,	,	,
25944	3456	416	106	106	CD
25944	3456	417	Charbon	Charbon	NNP
25944	3456	418	,	,	,
25944	3456	419	72	72	CD
25944	3456	420	Cheiro	Cheiro	NNP
25944	3456	421	-	-	HYPH
25944	3456	422	pompholyx	pompholyx	NNP
25944	3456	423	,	,	,
25944	3456	424	76	76	CD
25944	3456	425	Cheloid	Cheloid	NNP
25944	3456	426	,	,	,
25944	3456	427	191	191	CD
25944	3456	428	Chloasma	Chloasma	NNP
25944	3456	429	,	,	,
25944	3456	430	149	149	CD
25944	3456	431	-	-	SYM
25944	3456	432	151	151	CD
25944	3456	433	uterinum	uterinum	NN
25944	3456	434	,	,	,
25944	3456	435	149	149	CD
25944	3456	436	Chloral	chloral	JJ
25944	3456	437	,	,	,
25944	3456	438	eruptions	eruption	NNS
25944	3456	439	from	from	IN
25944	3456	440	,	,	,
25944	3456	441	62	62	CD
25944	3456	442	Chromidrosis	Chromidrosis	NNP
25944	3456	443	,	,	,
25944	3456	444	32	32	CD
25944	3456	445	red	red	JJ
25944	3456	446	,	,	,
25944	3456	447	33	33	CD
25944	3456	448	Chromophytosis	chromophytosis	NN
25944	3456	449	,	,	,
25944	3456	450	262	262	CD
25944	3456	451	Chrysarobin	Chrysarobin	NNP
25944	3456	452	,	,	,
25944	3456	453	93	93	CD
25944	3456	454	Chrysophanic	chrysophanic	JJ
25944	3456	455	acid	acid	NN
25944	3456	456	(	(	-LRB-
25944	3456	457	chrysarobin	chrysarobin	NNP
25944	3456	458	)	)	-RRB-
25944	3456	459	,	,	,
25944	3456	460	93	93	CD
25944	3456	461	Cicatrices	cicatrix	NNS
25944	3456	462	,	,	,
25944	3456	463	24	24	CD
25944	3456	464	Cimex	Cimex	NNP
25944	3456	465	lectularius	lectularius	NN
25944	3456	466	,	,	,
25944	3456	467	278	278	CD
25944	3456	468	Clavus	clavu	NNS
25944	3456	469	,	,	,
25944	3456	470	156	156	CD
25944	3456	471	,	,	,
25944	3456	472	157	157	CD
25944	3456	473	Comedo	Comedo	NNP
25944	3456	474	,	,	,
25944	3456	475	38	38	CD
25944	3456	476	-	-	SYM
25944	3456	477	41	41	CD
25944	3456	478	extractor	extractor	NN
25944	3456	479	,	,	,
25944	3456	480	40	40	CD
25944	3456	481	Condyloma	Condyloma	NNS
25944	3456	482	,	,	,
25944	3456	483	flat	flat	JJ
25944	3456	484	(	(	-LRB-
25944	3456	485	or	or	CC
25944	3456	486	broad	broad	RB
25944	3456	487	)	)	-RRB-
25944	3456	488	,	,	,
25944	3456	489	217	217	CD
25944	3456	490	pointed	point	VBD
25944	3456	491	,	,	,
25944	3456	492	161	161	CD
25944	3456	493	Configuration	Configuration	NNP
25944	3456	494	,	,	,
25944	3456	495	24	24	CD
25944	3456	496	Conglomerate	conglomerate	NN
25944	3456	497	pustular	pustular	NN
25944	3456	498	folliculitis	folliculitis	NN
25944	3456	499	,	,	,
25944	3456	500	252	252	CD
25944	3456	501	Contagious	contagious	JJ
25944	3456	502	impetigo	impetigo	NNS
25944	3456	503	,	,	,
25944	3456	504	136	136	CD
25944	3456	505	Contagiousness	Contagiousness	NNP
25944	3456	506	,	,	,
25944	3456	507	27	27	CD
25944	3456	508	Copaiba	Copaiba	NNP
25944	3456	509	,	,	,
25944	3456	510	eruptions	eruption	NNS
25944	3456	511	from	from	IN
25944	3456	512	,	,	,
25944	3456	513	62	62	CD
25944	3456	514	Corn	corn	NN
25944	3456	515	,	,	,
25944	3456	516	156	156	CD
25944	3456	517	Cornu	Cornu	NNP
25944	3456	518	cutaneum	cutaneum	NN
25944	3456	519	,	,	,
25944	3456	520	158	158	CD
25944	3456	521	,	,	,
25944	3456	522	159	159	CD
25944	3456	523	humanum	humanum	NN
25944	3456	524	,	,	,
25944	3456	525	159	159	CD
25944	3456	526	Crab	crab	NN
25944	3456	527	-	-	HYPH
25944	3456	528	louse	louse	NN
25944	3456	529	,	,	,
25944	3456	530	275	275	CD
25944	3456	531	Creeping	creeping	NN
25944	3456	532	disease	disease	NN
25944	3456	533	,	,	,
25944	3456	534	278	278	CD
25944	3456	535	Crusta	Crusta	NNP
25944	3456	536	lactea	lactea	NN
25944	3456	537	,	,	,
25944	3456	538	104	104	CD
25944	3456	539	Crustæ	Crustæ	NNP
25944	3456	540	,	,	,
25944	3456	541	24	24	CD
25944	3456	542	Crusts	crust	NNS
25944	3456	543	,	,	,
25944	3456	544	24	24	CD
25944	3456	545	Cubebs	Cubebs	NNP
25944	3456	546	,	,	,
25944	3456	547	eruptions	eruption	NNS
25944	3456	548	from	from	IN
25944	3456	549	,	,	,
25944	3456	550	62	62	CD
25944	3456	551	Culex	Culex	NNP
25944	3456	552	,	,	,
25944	3456	553	279	279	CD
25944	3456	554	Cuniculus	Cuniculus	NNP
25944	3456	555	,	,	,
25944	3456	556	268	268	CD
25944	3456	557	Curette	Curette	NNP
25944	3456	558	,	,	,
25944	3456	559	208	208	CD
25944	3456	560	Cutaneous	cutaneous	JJ
25944	3456	561	calculi	calculus	NNS
25944	3456	562	,	,	,
25944	3456	563	42	42	CD
25944	3456	564	horn	horn	NN
25944	3456	565	,	,	,
25944	3456	566	158	158	CD
25944	3456	567	Cutis	Cutis	NNP
25944	3456	568	anserina	anserina	NNP
25944	3456	569	,	,	,
25944	3456	570	152	152	CD
25944	3456	571	pendula	pendula	NN
25944	3456	572	,	,	,
25944	3456	573	176	176	CD
25944	3456	574	Cyst	Cyst	NNP
25944	3456	575	,	,	,
25944	3456	576	sebaceous	sebaceous	JJ
25944	3456	577	,	,	,
25944	3456	578	43	43	CD
25944	3456	579	Cysticercus	Cysticercus	NNP
25944	3456	580	cellulosæ	cellulosæ	NN
25944	3456	581	,	,	,
25944	3456	582	276	276	CD
25944	3456	583	Dandruff	Dandruff	NNP
25944	3456	584	,	,	,
25944	3456	585	33	33	CD
25944	3456	586	,	,	,
25944	3456	587	34	34	CD
25944	3456	588	Darier	Darier	NNP
25944	3456	589	's	's	POS
25944	3456	590	disease	disease	NN
25944	3456	591	,	,	,
25944	3456	592	153	153	CD
25944	3456	593	Defluvium	Defluvium	NNP
25944	3456	594	capillorum	capillorum	NN
25944	3456	595	,	,	,
25944	3456	596	181	181	CD
25944	3456	597	Demodex	Demodex	NNP
25944	3456	598	folliculorum	folliculorum	NN
25944	3456	599	,	,	,
25944	3456	600	40	40	CD
25944	3456	601	Depilatories	depilatory	NNS
25944	3456	602	,	,	,
25944	3456	603	169	169	CD
25944	3456	604	Dermalgia	dermalgia	NN
25944	3456	605	,	,	,
25944	3456	606	244	244	CD
25944	3456	607	Dermatalgia	Dermatalgia	NNP
25944	3456	608	,	,	,
25944	3456	609	244	244	CD
25944	3456	610	Dermatitis	dermatitis	NN
25944	3456	611	,	,	,
25944	3456	612	58	58	CD
25944	3456	613	-	-	SYM
25944	3456	614	64	64	CD
25944	3456	615	acute	acute	NN
25944	3456	616	general	general	NN
25944	3456	617	,	,	,
25944	3456	618	96	96	CD
25944	3456	619	ambustionis	ambustionis	NN
25944	3456	620	,	,	,
25944	3456	621	58	58	CD
25944	3456	622	blastomycetic	blastomycetic	NN
25944	3456	623	,	,	,
25944	3456	624	266	266	CD
25944	3456	625	calorica	calorica	NN
25944	3456	626	,	,	,
25944	3456	627	58	58	CD
25944	3456	628	congelationis	congelationis	NN
25944	3456	629	,	,	,
25944	3456	630	58	58	CD
25944	3456	631	contusiformis	contusiformis	NN
25944	3456	632	,	,	,
25944	3456	633	50	50	CD
25944	3456	634	exfoliativa	exfoliativa	NN
25944	3456	635	,	,	,
25944	3456	636	96	96	CD
25944	3456	637	,	,	,
25944	3456	638	97	97	CD
25944	3456	639	general	general	NN
25944	3456	640	,	,	,
25944	3456	641	96	96	CD
25944	3456	642	neonatorum	neonatorum	NN
25944	3456	643	,	,	,
25944	3456	644	97	97	CD
25944	3456	645	recurrent	recurrent	NN
25944	3456	646	,	,	,
25944	3456	647	96	96	CD
25944	3456	648	factitia	factitia	NN
25944	3456	649	,	,	,
25944	3456	650	64	64	CD
25944	3456	651	gangrænosa	gangrænosa	NNS
25944	3456	652	,	,	,
25944	3456	653	65	65	CD
25944	3456	654	herpetiformis	herpetiformis	NN
25944	3456	655	,	,	,
25944	3456	656	83	83	CD
25944	3456	657	-	-	SYM
25944	3456	658	86	86	CD
25944	3456	659	iodoform	iodoform	NN
25944	3456	660	,	,	,
25944	3456	661	59	59	CD
25944	3456	662	malignant	malignant	JJ
25944	3456	663	papillary	papillary	NN
25944	3456	664	,	,	,
25944	3456	665	240	240	CD
25944	3456	666	medicamentosa	medicamentosa	NNP
25944	3456	667	,	,	,
25944	3456	668	60	60	CD
25944	3456	669	papillaris	papillaris	NNP
25944	3456	670	capillitii	capillitii	NNP
25944	3456	671	,	,	,
25944	3456	672	135	135	CD
25944	3456	673	repens	repen	NNS
25944	3456	674	,	,	,
25944	3456	675	81	81	CD
25944	3456	676	traumatica	traumatica	NN
25944	3456	677	,	,	,
25944	3456	678	58	58	CD
25944	3456	679	vegetans	vegetan	NNS
25944	3456	680	,	,	,
25944	3456	681	142	142	CD
25944	3456	682	venenata	venenata	NN
25944	3456	683	,	,	,
25944	3456	684	59	59	CD
25944	3456	685	_	_	NN
25944	3456	686	x_-ray	x_-ray	NNS
25944	3456	687	,	,	,
25944	3456	688	63	63	CD
25944	3456	689	Dermatographism	Dermatographism	NNP
25944	3456	690	,	,	,
25944	3456	691	52	52	CD
25944	3456	692	Dermatolysis	Dermatolysis	NNP
25944	3456	693	,	,	,
25944	3456	694	176	176	CD
25944	3456	695	Dermatomyoma	Dermatomyoma	NNP
25944	3456	696	,	,	,
25944	3456	697	196	196	CD
25944	3456	698	Dermatosclerosis	dermatosclerosis	NN
25944	3456	699	,	,	,
25944	3456	700	172	172	CD
25944	3456	701	Dermatosyphilis	Dermatosyphilis	NNP
25944	3456	702	,	,	,
25944	3456	703	213	213	CD
25944	3456	704	Dhobi	Dhobi	NNP
25944	3456	705	itch	itch	NN
25944	3456	706	,	,	,
25944	3456	707	265	265	CD
25944	3456	708	Digitalis	Digitalis	NNP
25944	3456	709	,	,	,
25944	3456	710	eruptions	eruption	NNS
25944	3456	711	from	from	IN
25944	3456	712	,	,	,
25944	3456	713	62	62	CD
25944	3456	714	Disorders	disorder	NNS
25944	3456	715	of	of	IN
25944	3456	716	the	the	DT
25944	3456	717	glands	gland	NNS
25944	3456	718	,	,	,
25944	3456	719	28	28	CD
25944	3456	720	-	-	SYM
25944	3456	721	44	44	CD
25944	3456	722	Dissection	Dissection	NNP
25944	3456	723	wound	wound	NN
25944	3456	724	,	,	,
25944	3456	725	73	73	CD
25944	3456	726	Distribution	distribution	NN
25944	3456	727	and	and	CC
25944	3456	728	configuration	configuration	NN
25944	3456	729	,	,	,
25944	3456	730	24	24	CD
25944	3456	731	-	-	SYM
25944	3456	732	26	26	CD
25944	3456	733	Drug	Drug	NNP
25944	3456	734	eruptions	eruption	NNS
25944	3456	735	(	(	-LRB-
25944	3456	736	dermatitis	dermatitis	NNP
25944	3456	737	medicamentosa	medicamentosa	NNP
25944	3456	738	)	)	-RRB-
25944	3456	739	,	,	,
25944	3456	740	60	60	CD
25944	3456	741	Duhring	Duhring	NNP
25944	3456	742	's	's	POS
25944	3456	743	disease	disease	NN
25944	3456	744	,	,	,
25944	3456	745	83	83	CD
25944	3456	746	Dysidrosis	dysidrosis	NN
25944	3456	747	,	,	,
25944	3456	748	76	76	CD
25944	3456	749	Ecthyma	ecthyma	NN
25944	3456	750	,	,	,
25944	3456	751	138	138	CD
25944	3456	752	,	,	,
25944	3456	753	139	139	CD
25944	3456	754	Eczema	Eczema	NNP
25944	3456	755	,	,	,
25944	3456	756	100	100	CD
25944	3456	757	-	-	SYM
25944	3456	758	119	119	CD
25944	3456	759	erythematosum	erythematosum	NN
25944	3456	760	,	,	,
25944	3456	761	102	102	CD
25944	3456	762	fissum	fissum	NN
25944	3456	763	,	,	,
25944	3456	764	106	106	CD
25944	3456	765	impetiginosum	impetiginosum	NN
25944	3456	766	,	,	,
25944	3456	767	104	104	CD
25944	3456	768	madidans	madidan	NNS
25944	3456	769	,	,	,
25944	3456	770	105	105	CD
25944	3456	771	marginatum	marginatum	NN
25944	3456	772	,	,	,
25944	3456	773	253	253	CD
25944	3456	774	papulosum	papulosum	NN
25944	3456	775	,	,	,
25944	3456	776	103	103	CD
25944	3456	777	pustulosum	pustulosum	NN
25944	3456	778	,	,	,
25944	3456	779	104	104	CD
25944	3456	780	rimosum	rimosum	NN
25944	3456	781	,	,	,
25944	3456	782	106	106	CD
25944	3456	783	rubrum	rubrum	NN
25944	3456	784	,	,	,
25944	3456	785	105	105	CD
25944	3456	786	sclerosum	sclerosum	NN
25944	3456	787	,	,	,
25944	3456	788	106	106	CD
25944	3456	789	seborrhoicum	seborrhoicum	NN
25944	3456	790	,	,	,
25944	3456	791	33	33	CD
25944	3456	792	,	,	,
25944	3456	793	34	34	CD
25944	3456	794	,	,	,
25944	3456	795	91	91	CD
25944	3456	796	,	,	,
25944	3456	797	95	95	CD
25944	3456	798	,	,	,
25944	3456	799	109	109	CD
25944	3456	800	squamosum	squamosum	NN
25944	3456	801	,	,	,
25944	3456	802	104	104	CD
25944	3456	803	verrucosum	verrucosum	NN
25944	3456	804	,	,	,
25944	3456	805	106	106	CD
25944	3456	806	vesiculosum	vesiculosum	NN
25944	3456	807	,	,	,
25944	3456	808	104	104	CD
25944	3456	809	Electrolysis	electrolysis	NN
25944	3456	810	in	in	IN
25944	3456	811	removal	removal	NN
25944	3456	812	of	of	IN
25944	3456	813	hair	hair	NN
25944	3456	814	,	,	,
25944	3456	815	169	169	CD
25944	3456	816	Elephant	Elephant	NNP
25944	3456	817	leg	leg	NN
25944	3456	818	,	,	,
25944	3456	819	174	174	CD
25944	3456	820	Elephantiasis	Elephantiasis	NNP
25944	3456	821	,	,	,
25944	3456	822	174	174	CD
25944	3456	823	-	-	SYM
25944	3456	824	176	176	CD
25944	3456	825	Arabum	Arabum	NNP
25944	3456	826	,	,	,
25944	3456	827	174	174	CD
25944	3456	828	Græcorum	Græcorum	NNP
25944	3456	829	,	,	,
25944	3456	830	231	231	CD
25944	3456	831	Epidermis	Epidermis	NNP
25944	3456	832	,	,	,
25944	3456	833	18	18	CD
25944	3456	834	Epidermolysis	Epidermolysis	NNP
25944	3456	835	bullosa	bullosa	NNP
25944	3456	836	,	,	,
25944	3456	837	80	80	CD
25944	3456	838	Epilating	Epilating	NNP
25944	3456	839	forceps	forceps	NNS
25944	3456	840	,	,	,
25944	3456	841	249	249	CD
25944	3456	842	Epithelial	epithelial	JJ
25944	3456	843	cancer	cancer	NN
25944	3456	844	,	,	,
25944	3456	845	236	236	CD
25944	3456	846	Epithelioma	Epithelioma	NNP
25944	3456	847	,	,	,
25944	3456	848	236	236	CD
25944	3456	849	-	-	SYM
25944	3456	850	240	240	CD
25944	3456	851	benign	benign	JJ
25944	3456	852	cystic	cystic	NN
25944	3456	853	,	,	,
25944	3456	854	198	198	CD
25944	3456	855	molluscum	molluscum	NN
25944	3456	856	,	,	,
25944	3456	857	153	153	CD
25944	3456	858	Equinia	Equinia	NNP
25944	3456	859	,	,	,
25944	3456	860	74	74	CD
25944	3456	861	Erasion	erasion	NN
25944	3456	862	,	,	,
25944	3456	863	208	208	CD
25944	3456	864	Eruptions	eruption	NNS
25944	3456	865	,	,	,
25944	3456	866	feigned	feigned	JJ
25944	3456	867	(	(	-LRB-
25944	3456	868	artificial	artificial	JJ
25944	3456	869	)	)	-RRB-
25944	3456	870	,	,	,
25944	3456	871	64	64	CD
25944	3456	872	medicinal	medicinal	JJ
25944	3456	873	(	(	-LRB-
25944	3456	874	dermatitis	dermatitis	NNP
25944	3456	875	medicamentosa	medicamentosa	NNP
25944	3456	876	)	)	-RRB-
25944	3456	877	,	,	,
25944	3456	878	60	60	CD
25944	3456	879	Erysipelas	Erysipelas	NNP
25944	3456	880	,	,	,
25944	3456	881	66	66	CD
25944	3456	882	,	,	,
25944	3456	883	67	67	CD
25944	3456	884	ambulans	ambulan	NNS
25944	3456	885	,	,	,
25944	3456	886	67	67	CD
25944	3456	887	migrans	migran	NNS
25944	3456	888	,	,	,
25944	3456	889	67	67	CD
25944	3456	890	Erysipeloid	Erysipeloid	NNP
25944	3456	891	,	,	,
25944	3456	892	67	67	CD
25944	3456	893	Erythema	Erythema	NNP
25944	3456	894	,	,	,
25944	3456	895	44	44	CD
25944	3456	896	annulare	annulare	NNP
25944	3456	897	,	,	,
25944	3456	898	48	48	CD
25944	3456	899	bullosum	bullosum	NN
25944	3456	900	,	,	,
25944	3456	901	48	48	CD
25944	3456	902	caloricum	caloricum	NN
25944	3456	903	,	,	,
25944	3456	904	44	44	CD
25944	3456	905	desquamative	desquamative	JJ
25944	3456	906	scarlatiniform	scarlatiniform	NN
25944	3456	907	,	,	,
25944	3456	908	96	96	CD
25944	3456	909	gangrenosum	gangrenosum	NN
25944	3456	910	,	,	,
25944	3456	911	65	65	CD
25944	3456	912	gyratum	gyratum	NN
25944	3456	913	,	,	,
25944	3456	914	48	48	CD
25944	3456	915	induratum	induratum	NN
25944	3456	916	,	,	,
25944	3456	917	51	51	CD
25944	3456	918	scrofulosorum	scrofulosorum	NN
25944	3456	919	,	,	,
25944	3456	920	51	51	CD
25944	3456	921	intertrigo	intertrigo	NNS
25944	3456	922	,	,	,
25944	3456	923	45	45	CD
25944	3456	924	,	,	,
25944	3456	925	46	46	CD
25944	3456	926	iris	iri	NNS
25944	3456	927	,	,	,
25944	3456	928	48	48	CD
25944	3456	929	marginatum	marginatum	NN
25944	3456	930	,	,	,
25944	3456	931	48	48	CD
25944	3456	932	multiforme	multiforme	NN
25944	3456	933	,	,	,
25944	3456	934	46	46	CD
25944	3456	935	nodosum	nodosum	NN
25944	3456	936	,	,	,
25944	3456	937	50	50	CD
25944	3456	938	,	,	,
25944	3456	939	51	51	CD
25944	3456	940	recurrent	recurrent	NN
25944	3456	941	exfoliative	exfoliative	JJ
25944	3456	942	,	,	,
25944	3456	943	96	96	CD
25944	3456	944	simplex	simplex	NN
25944	3456	945	,	,	,
25944	3456	946	44	44	CD
25944	3456	947	solare	solare	NN
25944	3456	948	,	,	,
25944	3456	949	44	44	CD
25944	3456	950	traumaticum	traumaticum	NN
25944	3456	951	,	,	,
25944	3456	952	44	44	CD
25944	3456	953	venenatum	venenatum	NN
25944	3456	954	,	,	,
25944	3456	955	44	44	CD
25944	3456	956	vesiculosum	vesiculosum	NN
25944	3456	957	,	,	,
25944	3456	958	48	48	CD
25944	3456	959	Erythrasma	Erythrasma	NNP
25944	3456	960	,	,	,
25944	3456	961	265	265	CD
25944	3456	962	Excessive	excessive	JJ
25944	3456	963	sweating	sweating	NN
25944	3456	964	(	(	-LRB-
25944	3456	965	hyperidrosis	hyperidrosis	NN
25944	3456	966	)	)	-RRB-
25944	3456	967	,	,	,
25944	3456	968	28	28	CD
25944	3456	969	Excoriationes	Excoriationes	NNP
25944	3456	970	,	,	,
25944	3456	971	24	24	CD
25944	3456	972	Excoriations	excoriation	NNS
25944	3456	973	,	,	,
25944	3456	974	24	24	CD
25944	3456	975	Farcy	Farcy	NNP
25944	3456	976	,	,	,
25944	3456	977	74	74	CD
25944	3456	978	Favus	Favus	NNP
25944	3456	979	,	,	,
25944	3456	980	247	247	CD
25944	3456	981	of	of	IN
25944	3456	982	general	general	JJ
25944	3456	983	surface	surface	NN
25944	3456	984	,	,	,
25944	3456	985	248	248	CD
25944	3456	986	of	of	IN
25944	3456	987	nails	nail	NNS
25944	3456	988	,	,	,
25944	3456	989	249	249	CD
25944	3456	990	of	of	IN
25944	3456	991	scalp	scalp	NNP
25944	3456	992	,	,	,
25944	3456	993	247	247	CD
25944	3456	994	Feigned	feigned	JJ
25944	3456	995	eruptions	eruption	NNS
25944	3456	996	,	,	,
25944	3456	997	64	64	CD
25944	3456	998	Fever	Fever	NNP
25944	3456	999	blisters	blister	NNS
25944	3456	1000	,	,	,
25944	3456	1001	78	78	CD
25944	3456	1002	Fibroma	Fibroma	NNP
25944	3456	1003	,	,	,
25944	3456	1004	192	192	CD
25944	3456	1005	-	-	SYM
25944	3456	1006	194	194	CD
25944	3456	1007	molluscum	molluscum	NN
25944	3456	1008	,	,	,
25944	3456	1009	192	192	CD
25944	3456	1010	Fibromyoma	Fibromyoma	NNP
25944	3456	1011	,	,	,
25944	3456	1012	196	196	CD
25944	3456	1013	Filaria	filaria	JJ
25944	3456	1014	,	,	,
25944	3456	1015	175	175	CD
25944	3456	1016	medinensis	medinensis	NN
25944	3456	1017	,	,	,
25944	3456	1018	277	277	CD
25944	3456	1019	Fish	fish	NN
25944	3456	1020	-	-	HYPH
25944	3456	1021	skin	skin	NN
25944	3456	1022	disease	disease	NN
25944	3456	1023	,	,	,
25944	3456	1024	165	165	CD
25944	3456	1025	Fissures	fissure	NNS
25944	3456	1026	,	,	,
25944	3456	1027	24	24	CD
25944	3456	1028	Flea	Flea	NNP
25944	3456	1029	,	,	,
25944	3456	1030	common	common	JJ
25944	3456	1031	,	,	,
25944	3456	1032	279	279	CD
25944	3456	1033	sand	sand	NN
25944	3456	1034	,	,	,
25944	3456	1035	278	278	CD
25944	3456	1036	Flesh	Flesh	NNP
25944	3456	1037	worms	worm	NNS
25944	3456	1038	,	,	,
25944	3456	1039	38	38	CD
25944	3456	1040	-	-	SYM
25944	3456	1041	41	41	CD
25944	3456	1042	Folliclis	Folliclis	NNPS
25944	3456	1043	,	,	,
25944	3456	1044	130	130	CD
25944	3456	1045	Folliculitis	Folliculitis	NNP
25944	3456	1046	barbæ	barbæ	NN
25944	3456	1047	,	,	,
25944	3456	1048	130	130	CD
25944	3456	1049	decalvans	decalvan	NNS
25944	3456	1050	,	,	,
25944	3456	1051	131	131	CD
25944	3456	1052	pustular	pustular	NN
25944	3456	1053	,	,	,
25944	3456	1054	conglomerate	conglomerate	NN
25944	3456	1055	,	,	,
25944	3456	1056	252	252	CD
25944	3456	1057	Forceps	Forceps	NNPS
25944	3456	1058	,	,	,
25944	3456	1059	epilating	epilating	NN
25944	3456	1060	,	,	,
25944	3456	1061	249	249	CD
25944	3456	1062	Fragilitas	Fragilitas	NNP
25944	3456	1063	crinium	crinium	NN
25944	3456	1064	,	,	,
25944	3456	1065	187	187	CD
25944	3456	1066	Framb[oe]sia	framb[oe]sia	CD
25944	3456	1067	,	,	,
25944	3456	1068	73	73	CD
25944	3456	1069	Freckle	Freckle	NNP
25944	3456	1070	,	,	,
25944	3456	1071	148	148	CD
25944	3456	1072	Frost	frost	NN
25944	3456	1073	-	-	HYPH
25944	3456	1074	bite	bite	NN
25944	3456	1075	,	,	,
25944	3456	1076	58	58	CD
25944	3456	1077	Fungous	fungous	JJ
25944	3456	1078	foot	foot	NN
25944	3456	1079	of	of	IN
25944	3456	1080	India	India	NNP
25944	3456	1081	,	,	,
25944	3456	1082	212	212	CD
25944	3456	1083	Furuncle	Furuncle	NNP
25944	3456	1084	,	,	,
25944	3456	1085	68	68	CD
25944	3456	1086	Furunculosis	furunculosis	NN
25944	3456	1087	,	,	,
25944	3456	1088	69	69	CD
25944	3456	1089	Furunculus	Furunculus	NNP
25944	3456	1090	,	,	,
25944	3456	1091	68	68	CD
25944	3456	1092	-	-	SYM
25944	3456	1093	70	70	CD
25944	3456	1094	Gad	Gad	NNP
25944	3456	1095	-	-	HYPH
25944	3456	1096	fly	fly	NNP
25944	3456	1097	,	,	,
25944	3456	1098	278	278	CD
25944	3456	1099	Galvano	Galvano	NNP
25944	3456	1100	-	-	HYPH
25944	3456	1101	cautery	cautery	NNP
25944	3456	1102	,	,	,
25944	3456	1103	208	208	CD
25944	3456	1104	instruments	instrument	NNS
25944	3456	1105	,	,	,
25944	3456	1106	206	206	CD
25944	3456	1107	Gangrene	gangrene	NN
25944	3456	1108	of	of	IN
25944	3456	1109	the	the	DT
25944	3456	1110	skin	skin	NN
25944	3456	1111	(	(	-LRB-
25944	3456	1112	dermatitis	dermatitis	NNP
25944	3456	1113	gangrænosa	gangrænosa	NNP
25944	3456	1114	)	)	-RRB-
25944	3456	1115	,	,	,
25944	3456	1116	65	65	CD
25944	3456	1117	spontaneous	spontaneous	JJ
25944	3456	1118	,	,	,
25944	3456	1119	65	65	CD
25944	3456	1120	symmetric	symmetric	JJ
25944	3456	1121	,	,	,
25944	3456	1122	66	66	CD
25944	3456	1123	Gelatin	Gelatin	NNP
25944	3456	1124	dressing	dressing	NN
25944	3456	1125	,	,	,
25944	3456	1126	116	116	CD
25944	3456	1127	Giant	giant	JJ
25944	3456	1128	urticaria	urticaria	JJ
25944	3456	1129	,	,	,
25944	3456	1130	54	54	CD
25944	3456	1131	Glanders	Glanders	NNPS
25944	3456	1132	,	,	,
25944	3456	1133	74	74	CD
25944	3456	1134	Glands	gland	NNS
25944	3456	1135	,	,	,
25944	3456	1136	sebaceous	sebaceous	JJ
25944	3456	1137	,	,	,
25944	3456	1138	33	33	CD
25944	3456	1139	sweat	sweat	NN
25944	3456	1140	,	,	,
25944	3456	1141	28	28	CD
25944	3456	1142	Glossy	glossy	JJ
25944	3456	1143	skin	skin	NN
25944	3456	1144	,	,	,
25944	3456	1145	189	189	CD
25944	3456	1146	Gnat	Gnat	NNP
25944	3456	1147	,	,	,
25944	3456	1148	279	279	CD
25944	3456	1149	Goose	Goose	NNP
25944	3456	1150	-	-	HYPH
25944	3456	1151	flesh	flesh	NNP
25944	3456	1152	,	,	,
25944	3456	1153	152	152	CD
25944	3456	1154	Granuloma	Granuloma	NNP
25944	3456	1155	fungoides	fungoide	NNS
25944	3456	1156	,	,	,
25944	3456	1157	242	242	CD
25944	3456	1158	necroticum	necroticum	NNS
25944	3456	1159	,	,	,
25944	3456	1160	129	129	CD
25944	3456	1161	Grayness	grayness	NN
25944	3456	1162	of	of	IN
25944	3456	1163	the	the	DT
25944	3456	1164	hair	hair	NN
25944	3456	1165	,	,	,
25944	3456	1166	180	180	CD
25944	3456	1167	Grutum	Grutum	NNP
25944	3456	1168	,	,	,
25944	3456	1169	42	42	CD
25944	3456	1170	Guinea	Guinea	NNP
25944	3456	1171	-	-	HYPH
25944	3456	1172	worm	worm	NNP
25944	3456	1173	,	,	,
25944	3456	1174	277	277	CD
25944	3456	1175	Gumma	Gumma	NNP
25944	3456	1176	,	,	,
25944	3456	1177	225	225	CD
25944	3456	1178	Gun	Gun	NNP
25944	3456	1179	-	-	HYPH
25944	3456	1180	powder	powder	NN
25944	3456	1181	marks	mark	NNS
25944	3456	1182	,	,	,
25944	3456	1183	151	151	CD
25944	3456	1184	Gutta	Gutta	NNP
25944	3456	1185	-	-	HYPH
25944	3456	1186	percha	percha	NNP
25944	3456	1187	plaster	plaster	NN
25944	3456	1188	,	,	,
25944	3456	1189	117	117	CD
25944	3456	1190	Hair	hair	NN
25944	3456	1191	,	,	,
25944	3456	1192	21	21	CD
25944	3456	1193	atrophy	atrophy	NN
25944	3456	1194	of	of	IN
25944	3456	1195	,	,	,
25944	3456	1196	187	187	CD
25944	3456	1197	graying	graying	NN
25944	3456	1198	of	of	IN
25944	3456	1199	,	,	,
25944	3456	1200	180	180	CD
25944	3456	1201	hypertrophy	hypertrophy	NN
25944	3456	1202	of	of	IN
25944	3456	1203	,	,	,
25944	3456	1204	168	168	CD
25944	3456	1205	superfluous	superfluous	JJ
25944	3456	1206	,	,	,
25944	3456	1207	168	168	CD
25944	3456	1208	Hair	Hair	NNP
25944	3456	1209	-	-	HYPH
25944	3456	1210	follicle	follicle	NNP
25944	3456	1211	,	,	,
25944	3456	1212	21	21	CD
25944	3456	1213	Hairy	hairy	JJ
25944	3456	1214	people	people	NNS
25944	3456	1215	,	,	,
25944	3456	1216	168	168	CD
25944	3456	1217	Harvest	Harvest	NNP
25944	3456	1218	mite	mite	NN
25944	3456	1219	,	,	,
25944	3456	1220	277	277	CD
25944	3456	1221	Heat	Heat	NNP
25944	3456	1222	rash	rash	NN
25944	3456	1223	,	,	,
25944	3456	1224	74	74	CD
25944	3456	1225	Hemorrhages	Hemorrhages	NNP
25944	3456	1226	,	,	,
25944	3456	1227	144	144	CD
25944	3456	1228	-	-	SYM
25944	3456	1229	146	146	CD
25944	3456	1230	Henoch	Henoch	NNP
25944	3456	1231	's	's	POS
25944	3456	1232	purpura	purpura	NN
25944	3456	1233	,	,	,
25944	3456	1234	145	145	CD
25944	3456	1235	,	,	,
25944	3456	1236	146	146	CD
25944	3456	1237	Hereditary	hereditary	JJ
25944	3456	1238	infantile	infantile	NN
25944	3456	1239	syphilis	syphili	NNS
25944	3456	1240	,	,	,
25944	3456	1241	228	228	CD
25944	3456	1242	cutaneous	cutaneous	JJ
25944	3456	1243	manifestations	manifestation	NNS
25944	3456	1244	of	of	IN
25944	3456	1245	,	,	,
25944	3456	1246	221	221	CD
25944	3456	1247	Herpes	herpe	NNS
25944	3456	1248	,	,	,
25944	3456	1249	78	78	CD
25944	3456	1250	facialis	facialis	NNP
25944	3456	1251	,	,	,
25944	3456	1252	78	78	CD
25944	3456	1253	gestationis	gestationis	NN
25944	3456	1254	,	,	,
25944	3456	1255	83	83	CD
25944	3456	1256	iris	iri	NNS
25944	3456	1257	,	,	,
25944	3456	1258	48	48	CD
25944	3456	1259	labialis	labialis	JJ
25944	3456	1260	,	,	,
25944	3456	1261	78	78	CD
25944	3456	1262	præputialis	præputialis	NNP
25944	3456	1263	,	,	,
25944	3456	1264	79	79	CD
25944	3456	1265	progenitalis	progenitalis	NNP
25944	3456	1266	,	,	,
25944	3456	1267	78	78	CD
25944	3456	1268	simplex	simplex	NN
25944	3456	1269	,	,	,
25944	3456	1270	78	78	CD
25944	3456	1271	-	-	SYM
25944	3456	1272	80	80	CD
25944	3456	1273	zoster	zoster	NN
25944	3456	1274	,	,	,
25944	3456	1275	81	81	CD
25944	3456	1276	-	-	SYM
25944	3456	1277	83	83	CD
25944	3456	1278	Hirsuties	hirsutie	NNS
25944	3456	1279	,	,	,
25944	3456	1280	168	168	CD
25944	3456	1281	Hives	hive	NNS
25944	3456	1282	,	,	,
25944	3456	1283	52	52	CD
25944	3456	1284	Homines	Homines	NNPS
25944	3456	1285	pilosi	pilosi	NN
25944	3456	1286	,	,	,
25944	3456	1287	168	168	CD
25944	3456	1288	Horn	Horn	NNP
25944	3456	1289	,	,	,
25944	3456	1290	cutaneous	cutaneous	JJ
25944	3456	1291	,	,	,
25944	3456	1292	158	158	CD
25944	3456	1293	Hydradenitis	Hydradenitis	NNP
25944	3456	1294	suppurativa	suppurativa	NN
25944	3456	1295	,	,	,
25944	3456	1296	130	130	CD
25944	3456	1297	Hydroa	Hydroa	NNP
25944	3456	1298	æstivale	æstivale	NN
25944	3456	1299	,	,	,
25944	3456	1300	80	80	CD
25944	3456	1301	herpetiforme	herpetiforme	NN
25944	3456	1302	,	,	,
25944	3456	1303	83	83	CD
25944	3456	1304	puerorum	puerorum	NN
25944	3456	1305	,	,	,
25944	3456	1306	80	80	CD
25944	3456	1307	vacciniforme	vacciniforme	NN
25944	3456	1308	,	,	,
25944	3456	1309	80	80	CD
25944	3456	1310	Hydrocystoma	Hydrocystoma	NNP
25944	3456	1311	,	,	,
25944	3456	1312	31	31	CD
25944	3456	1313	Hyperesthesia	Hyperesthesia	NNP
25944	3456	1314	,	,	,
25944	3456	1315	244	244	CD
25944	3456	1316	Hyperidrosis	Hyperidrosis	NNP
25944	3456	1317	,	,	,
25944	3456	1318	28	28	CD
25944	3456	1319	-	-	SYM
25944	3456	1320	30	30	CD
25944	3456	1321	Hypertrichosis	hypertrichosis	NN
25944	3456	1322	,	,	,
25944	3456	1323	168	168	CD
25944	3456	1324	-	-	SYM
25944	3456	1325	170	170	CD
25944	3456	1326	Hypertrophic	hypertrophic	JJ
25944	3456	1327	scar	scar	NN
25944	3456	1328	,	,	,
25944	3456	1329	192	192	CD
25944	3456	1330	Hypertrophies	hypertrophy	NNS
25944	3456	1331	,	,	,
25944	3456	1332	148	148	CD
25944	3456	1333	-	-	SYM
25944	3456	1334	177	177	CD
25944	3456	1335	Hypertrophy	Hypertrophy	NNP
25944	3456	1336	of	of	IN
25944	3456	1337	the	the	DT
25944	3456	1338	hair	hair	NN
25944	3456	1339	,	,	,
25944	3456	1340	168	168	CD
25944	3456	1341	of	of	IN
25944	3456	1342	the	the	DT
25944	3456	1343	nail	nail	NN
25944	3456	1344	,	,	,
25944	3456	1345	167	167	CD
25944	3456	1346	Ichthyosis	Ichthyosis	NNP
25944	3456	1347	,	,	,
25944	3456	1348	165	165	CD
25944	3456	1349	-	-	SYM
25944	3456	1350	167	167	CD
25944	3456	1351	congenita	congenita	NN
25944	3456	1352	,	,	,
25944	3456	1353	165	165	CD
25944	3456	1354	follicularis	follicularis	NN
25944	3456	1355	,	,	,
25944	3456	1356	153	153	CD
25944	3456	1357	hystrix	hystrix	NNP
25944	3456	1358	,	,	,
25944	3456	1359	165	165	CD
25944	3456	1360	sebacea	sebacea	NN
25944	3456	1361	,	,	,
25944	3456	1362	33	33	CD
25944	3456	1363	cornea	cornea	NN
25944	3456	1364	,	,	,
25944	3456	1365	153	153	CD
25944	3456	1366	simplex	simplex	NN
25944	3456	1367	,	,	,
25944	3456	1368	165	165	CD
25944	3456	1369	Impetigo	Impetigo	NNPS
25944	3456	1370	contagiosa	contagiosa	NNS
25944	3456	1371	,	,	,
25944	3456	1372	136	136	CD
25944	3456	1373	,	,	,
25944	3456	1374	138	138	CD
25944	3456	1375	herpetiformis	herpetiformis	NN
25944	3456	1376	,	,	,
25944	3456	1377	138	138	CD
25944	3456	1378	simplex	simplex	NN
25944	3456	1379	,	,	,
25944	3456	1380	137	137	CD
25944	3456	1381	Infantile	Infantile	NNP
25944	3456	1382	syphilis	syphili	NNS
25944	3456	1383	,	,	,
25944	3456	1384	hereditary	hereditary	JJ
25944	3456	1385	,	,	,
25944	3456	1386	228	228	CD
25944	3456	1387	Inflammations	Inflammations	NNPS
25944	3456	1388	,	,	,
25944	3456	1389	44	44	CD
25944	3456	1390	-	-	SYM
25944	3456	1391	143	143	CD
25944	3456	1392	Inflammatory	Inflammatory	NNP
25944	3456	1393	fungoid	fungoid	NN
25944	3456	1394	neoplasm	neoplasm	NN
25944	3456	1395	,	,	,
25944	3456	1396	242	242	CD
25944	3456	1397	Iodides	iodide	NNS
25944	3456	1398	,	,	,
25944	3456	1399	eruptions	eruption	NNS
25944	3456	1400	from	from	IN
25944	3456	1401	,	,	,
25944	3456	1402	62	62	CD
25944	3456	1403	Iodoform	Iodoform	NNP
25944	3456	1404	dermatitis	dermatitis	NN
25944	3456	1405	,	,	,
25944	3456	1406	59	59	CD
25944	3456	1407	Itch	itch	NN
25944	3456	1408	,	,	,
25944	3456	1409	267	267	CD
25944	3456	1410	barbers	barber	NNS
25944	3456	1411	'	'	POS
25944	3456	1412	,	,	,
25944	3456	1413	255	255	CD
25944	3456	1414	dhobie	dhobie	NNS
25944	3456	1415	,	,	,
25944	3456	1416	265	265	CD
25944	3456	1417	mite	mite	NN
25944	3456	1418	,	,	,
25944	3456	1419	269	269	CD
25944	3456	1420	Ivy	Ivy	NNP
25944	3456	1421	poisoning	poisoning	NN
25944	3456	1422	,	,	,
25944	3456	1423	59	59	CD
25944	3456	1424	Ixodes	ixode	NNS
25944	3456	1425	,	,	,
25944	3456	1426	277	277	CD
25944	3456	1427	Jigger	Jigger	NNP
25944	3456	1428	,	,	,
25944	3456	1429	278	278	CD
25944	3456	1430	Keloid	Keloid	NNP
25944	3456	1431	,	,	,
25944	3456	1432	172	172	CD
25944	3456	1433	,	,	,
25944	3456	1434	192	192	CD
25944	3456	1435	cicatricial	cicatricial	NN
25944	3456	1436	,	,	,
25944	3456	1437	191	191	CD
25944	3456	1438	false	false	JJ
25944	3456	1439	,	,	,
25944	3456	1440	191	191	CD
25944	3456	1441	of	of	IN
25944	3456	1442	Addison	Addison	NNP
25944	3456	1443	,	,	,
25944	3456	1444	172	172	CD
25944	3456	1445	of	of	IN
25944	3456	1446	Alibert	Alibert	NNP
25944	3456	1447	,	,	,
25944	3456	1448	191	191	CD
25944	3456	1449	spontaneous	spontaneous	JJ
25944	3456	1450	,	,	,
25944	3456	1451	191	191	CD
25944	3456	1452	true	true	JJ
25944	3456	1453	,	,	,
25944	3456	1454	191	191	CD
25944	3456	1455	Keratodermia	Keratodermia	NNP
25944	3456	1456	,	,	,
25944	3456	1457	symmetric	symmetric	JJ
25944	3456	1458	,	,	,
25944	3456	1459	155	155	CD
25944	3456	1460	Keratoma	Keratoma	NNP
25944	3456	1461	,	,	,
25944	3456	1462	155	155	CD
25944	3456	1463	Keratosis	Keratosis	NNP
25944	3456	1464	follicularis	follicularis	NN
25944	3456	1465	,	,	,
25944	3456	1466	153	153	CD
25944	3456	1467	palmaris	palmaris	NNP
25944	3456	1468	et	et	NNP
25944	3456	1469	plantaris	plantaris	NNP
25944	3456	1470	,	,	,
25944	3456	1471	155	155	CD
25944	3456	1472	pigmentosa	pigmentosa	NNS
25944	3456	1473	,	,	,
25944	3456	1474	160	160	CD
25944	3456	1475	pilaris	pilaris	NNP
25944	3456	1476	,	,	,
25944	3456	1477	151	151	CD
25944	3456	1478	,	,	,
25944	3456	1479	152	152	CD
25944	3456	1480	senilis	senili	NNS
25944	3456	1481	,	,	,
25944	3456	1482	236	236	CD
25944	3456	1483	Kerion	Kerion	NNP
25944	3456	1484	,	,	,
25944	3456	1485	255	255	CD
25944	3456	1486	Land	land	NN
25944	3456	1487	scurvy	scurvy	NN
25944	3456	1488	,	,	,
25944	3456	1489	145	145	CD
25944	3456	1490	Larva	Larva	NNP
25944	3456	1491	nigrans	nigran	NNS
25944	3456	1492	,	,	,
25944	3456	1493	278	278	CD
25944	3456	1494	Lentigo	Lentigo	NNP
25944	3456	1495	,	,	,
25944	3456	1496	148	148	CD
25944	3456	1497	Leontiasis	leontiasis	NN
25944	3456	1498	,	,	,
25944	3456	1499	233	233	CD
25944	3456	1500	Lepra	Lepra	NNP
25944	3456	1501	,	,	,
25944	3456	1502	231	231	CD
25944	3456	1503	-	-	SYM
25944	3456	1504	235	235	CD
25944	3456	1505	Leprosy	Leprosy	NNP
25944	3456	1506	,	,	,
25944	3456	1507	231	231	CD
25944	3456	1508	anæsthetic	anæsthetic	NN
25944	3456	1509	,	,	,
25944	3456	1510	233	233	CD
25944	3456	1511	Lombardian	Lombardian	NNP
25944	3456	1512	,	,	,
25944	3456	1513	235	235	CD
25944	3456	1514	tubercular	tubercular	JJ
25944	3456	1515	,	,	,
25944	3456	1516	232	232	CD
25944	3456	1517	Leptus	Leptus	NNP
25944	3456	1518	,	,	,
25944	3456	1519	277	277	CD
25944	3456	1520	Lesions	Lesions	NNP
25944	3456	1521	,	,	,
25944	3456	1522	22	22	CD
25944	3456	1523	configuration	configuration	NN
25944	3456	1524	of	of	IN
25944	3456	1525	,	,	,
25944	3456	1526	24	24	CD
25944	3456	1527	consecutive	consecutive	JJ
25944	3456	1528	,	,	,
25944	3456	1529	23	23	CD
25944	3456	1530	distribution	distribution	NN
25944	3456	1531	of	of	IN
25944	3456	1532	,	,	,
25944	3456	1533	24	24	CD
25944	3456	1534	elementary	elementary	JJ
25944	3456	1535	,	,	,
25944	3456	1536	22	22	CD
25944	3456	1537	primary	primary	JJ
25944	3456	1538	,	,	,
25944	3456	1539	22	22	CD
25944	3456	1540	secondary	secondary	JJ
25944	3456	1541	,	,	,
25944	3456	1542	23	23	CD
25944	3456	1543	Leucoderma	Leucoderma	NNP
25944	3456	1544	,	,	,
25944	3456	1545	178	178	CD
25944	3456	1546	Leucopathia	Leucopathia	NNP
25944	3456	1547	,	,	,
25944	3456	1548	178	178	CD
25944	3456	1549	Lichen	Lichen	NNP
25944	3456	1550	moniliformis	moniliformis	NNP
25944	3456	1551	,	,	,
25944	3456	1552	98	98	CD
25944	3456	1553	pilaris	pilaris	NNP
25944	3456	1554	,	,	,
25944	3456	1555	151	151	CD
25944	3456	1556	planus	planus	NN
25944	3456	1557	,	,	,
25944	3456	1558	98	98	CD
25944	3456	1559	hypertrophicus	hypertrophicus	NN
25944	3456	1560	,	,	,
25944	3456	1561	98	98	CD
25944	3456	1562	ruber	ruber	NN
25944	3456	1563	,	,	,
25944	3456	1564	99	99	CD
25944	3456	1565	acuminatus	acuminatus	NN
25944	3456	1566	,	,	,
25944	3456	1567	99	99	CD
25944	3456	1568	scrofulosus	scrofulosus	NN
25944	3456	1569	,	,	,
25944	3456	1570	100	100	CD
25944	3456	1571	tropicus	tropicus	NN
25944	3456	1572	,	,	,
25944	3456	1573	74	74	CD
25944	3456	1574	urticatus	urticatus	NN
25944	3456	1575	,	,	,
25944	3456	1576	53	53	CD
25944	3456	1577	Linæ	Linæ	NNP
25944	3456	1578	albicantes	albicante	VBZ
25944	3456	1579	,	,	,
25944	3456	1580	190	190	CD
25944	3456	1581	Linear	linear	JJ
25944	3456	1582	nævus	nævu	NNS
25944	3456	1583	,	,	,
25944	3456	1584	163	163	CD
25944	3456	1585	scarification	scarification	NN
25944	3456	1586	,	,	,
25944	3456	1587	208	208	CD
25944	3456	1588	Liomyoma	Liomyoma	NNP
25944	3456	1589	cutis	cutis	NN
25944	3456	1590	,	,	,
25944	3456	1591	196	196	CD
25944	3456	1592	Liquor	Liquor	NNP
25944	3456	1593	carbonic	carbonic	JJ
25944	3456	1594	detergens	detergen	NNS
25944	3456	1595	,	,	,
25944	3456	1596	113	113	CD
25944	3456	1597	picis	picis	NN
25944	3456	1598	alkalinus	alkalinus	JJ
25944	3456	1599	,	,	,
25944	3456	1600	116	116	CD
25944	3456	1601	Lombardian	lombardian	JJ
25944	3456	1602	leprosy	leprosy	NN
25944	3456	1603	,	,	,
25944	3456	1604	235	235	CD
25944	3456	1605	Louse	louse	NN
25944	3456	1606	,	,	,
25944	3456	1607	body	body	NN
25944	3456	1608	(	(	-LRB-
25944	3456	1609	pediculus	pediculus	NNP
25944	3456	1610	corporis	corporis	NNP
25944	3456	1611	)	)	-RRB-
25944	3456	1612	,	,	,
25944	3456	1613	274	274	CD
25944	3456	1614	clothes	clothe	NNS
25944	3456	1615	(	(	-LRB-
25944	3456	1616	pediculus	pediculus	NNP
25944	3456	1617	corporis	corporis	NNP
25944	3456	1618	)	)	-RRB-
25944	3456	1619	,	,	,
25944	3456	1620	274	274	CD
25944	3456	1621	crab	crab	NN
25944	3456	1622	,	,	,
25944	3456	1623	275	275	CD
25944	3456	1624	head	head	NN
25944	3456	1625	(	(	-LRB-
25944	3456	1626	pediculus	pediculus	NNP
25944	3456	1627	capitis	capitis	NN
25944	3456	1628	)	)	-RRB-
25944	3456	1629	,	,	,
25944	3456	1630	272	272	CD
25944	3456	1631	Lousiness	Lousiness	NNP
25944	3456	1632	,	,	,
25944	3456	1633	271	271	CD
25944	3456	1634	Lupoid	Lupoid	NNP
25944	3456	1635	acne	acne	NNS
25944	3456	1636	,	,	,
25944	3456	1637	129	129	CD
25944	3456	1638	sycosis	sycosis	NN
25944	3456	1639	,	,	,
25944	3456	1640	131	131	CD
25944	3456	1641	Lupus	Lupus	NNP
25944	3456	1642	,	,	,
25944	3456	1643	203	203	CD
25944	3456	1644	erythematodes	erythematode	NNS
25944	3456	1645	,	,	,
25944	3456	1646	199	199	CD
25944	3456	1647	erythematosus	erythematosus	NN
25944	3456	1648	,	,	,
25944	3456	1649	199	199	CD
25944	3456	1650	-	-	SYM
25944	3456	1651	203	203	CD
25944	3456	1652	exedens	exeden	NNS
25944	3456	1653	,	,	,
25944	3456	1654	203	203	CD
25944	3456	1655	exfoliativus	exfoliativu	VBD
25944	3456	1656	,	,	,
25944	3456	1657	203	203	CD
25944	3456	1658	exulcerans	exulceran	NNS
25944	3456	1659	,	,	,
25944	3456	1660	203	203	CD
25944	3456	1661	hypertrophicus	hypertrophicus	NN
25944	3456	1662	,	,	,
25944	3456	1663	204	204	CD
25944	3456	1664	sebaceous	sebaceous	JJ
25944	3456	1665	,	,	,
25944	3456	1666	199	199	CD
25944	3456	1667	ulcerations	ulceration	NNS
25944	3456	1668	,	,	,
25944	3456	1669	203	203	CD
25944	3456	1670	verrucosus	verrucosu	NNS
25944	3456	1671	,	,	,
25944	3456	1672	204	204	CD
25944	3456	1673	vorax	vorax	NN
25944	3456	1674	,	,	,
25944	3456	1675	203	203	CD
25944	3456	1676	vulgaris	vulgaris	NN
25944	3456	1677	,	,	,
25944	3456	1678	203	203	CD
25944	3456	1679	-	-	SYM
25944	3456	1680	208	208	CD
25944	3456	1681	Lymphangiectodes	Lymphangiectodes	NNPS
25944	3456	1682	,	,	,
25944	3456	1683	198	198	CD
25944	3456	1684	Lymphangioma	Lymphangioma	NNP
25944	3456	1685	,	,	,
25944	3456	1686	198	198	CD
25944	3456	1687	tuberosum	tuberosum	NN
25944	3456	1688	multiplex	multiplex	NN
25944	3456	1689	,	,	,
25944	3456	1690	198	198	CD
25944	3456	1691	Lymphangiomyoma	Lymphangiomyoma	NNP
25944	3456	1692	,	,	,
25944	3456	1693	196	196	CD
25944	3456	1694	Maculæ	Maculæ	NNP
25944	3456	1695	,	,	,
25944	3456	1696	22	22	CD
25944	3456	1697	et	et	NN
25944	3456	1698	striæ	striæ	NN
25944	3456	1699	atrophicæ	atrophicæ	NN
25944	3456	1700	,	,	,
25944	3456	1701	190	190	CD
25944	3456	1702	Macules	Macules	NNP
25944	3456	1703	,	,	,
25944	3456	1704	22	22	CD
25944	3456	1705	Madura	Madura	NNP
25944	3456	1706	foot	foot	NN
25944	3456	1707	,	,	,
25944	3456	1708	212	212	CD
25944	3456	1709	Malignant	malignant	JJ
25944	3456	1710	papillary	papillary	JJ
25944	3456	1711	dermatitis	dermatitis	NN
25944	3456	1712	,	,	,
25944	3456	1713	240	240	CD
25944	3456	1714	pustule	pustule	NN
25944	3456	1715	,	,	,
25944	3456	1716	72	72	CD
25944	3456	1717	Medicinal	medicinal	JJ
25944	3456	1718	eruptions	eruption	NNS
25944	3456	1719	(	(	-LRB-
25944	3456	1720	dermatitis	dermatitis	NNP
25944	3456	1721	medicamentosa	medicamentosa	NNP
25944	3456	1722	)	)	-RRB-
25944	3456	1723	,	,	,
25944	3456	1724	60	60	CD
25944	3456	1725	Melanoderma	Melanoderma	NNP
25944	3456	1726	,	,	,
25944	3456	1727	149	149	CD
25944	3456	1728	Melanosarcoma	Melanosarcoma	NNP
25944	3456	1729	,	,	,
25944	3456	1730	242	242	CD
25944	3456	1731	Melasma	Melasma	NNP
25944	3456	1732	,	,	,
25944	3456	1733	149	149	CD
25944	3456	1734	Mercury	Mercury	NNP
25944	3456	1735	,	,	,
25944	3456	1736	eruptions	eruption	NNS
25944	3456	1737	from	from	IN
25944	3456	1738	,	,	,
25944	3456	1739	62	62	CD
25944	3456	1740	Microsporon	Microsporon	NNP
25944	3456	1741	audouini	audouini	NNP
25944	3456	1742	,	,	,
25944	3456	1743	258	258	CD
25944	3456	1744	Microsporon	Microsporon	NNP
25944	3456	1745	furfur	furfur	NN
25944	3456	1746	,	,	,
25944	3456	1747	262	262	CD
25944	3456	1748	minutissimum	minutissimum	NN
25944	3456	1749	,	,	,
25944	3456	1750	265	265	CD
25944	3456	1751	Miliaria	Miliaria	NNP
25944	3456	1752	,	,	,
25944	3456	1753	74	74	CD
25944	3456	1754	-	-	SYM
25944	3456	1755	76	76	CD
25944	3456	1756	alba	alba	NN
25944	3456	1757	,	,	,
25944	3456	1758	75	75	CD
25944	3456	1759	crystallina	crystallina	NN
25944	3456	1760	,	,	,
25944	3456	1761	30	30	CD
25944	3456	1762	rubra	rubra	NN
25944	3456	1763	,	,	,
25944	3456	1764	74	74	CD
25944	3456	1765	Milium	Milium	NNP
25944	3456	1766	,	,	,
25944	3456	1767	42	42	CD
25944	3456	1768	,	,	,
25944	3456	1769	43	43	CD
25944	3456	1770	needle	needle	NN
25944	3456	1771	,	,	,
25944	3456	1772	42	42	CD
25944	3456	1773	Milk	milk	NN
25944	3456	1774	crust	crust	NN
25944	3456	1775	,	,	,
25944	3456	1776	104	104	CD
25944	3456	1777	Mite	Mite	NNP
25944	3456	1778	,	,	,
25944	3456	1779	harvest	harvest	NN
25944	3456	1780	,	,	,
25944	3456	1781	277	277	CD
25944	3456	1782	itch	itch	NN
25944	3456	1783	,	,	,
25944	3456	1784	269	269	CD
25944	3456	1785	Moist	Moist	NNP
25944	3456	1786	papule	papule	NN
25944	3456	1787	,	,	,
25944	3456	1788	216	216	CD
25944	3456	1789	,	,	,
25944	3456	1790	217	217	CD
25944	3456	1791	Mole	Mole	NNP
25944	3456	1792	,	,	,
25944	3456	1793	162	162	CD
25944	3456	1794	Molluscum	Molluscum	NNP
25944	3456	1795	contagiosum	contagiosum	NNP
25944	3456	1796	,	,	,
25944	3456	1797	153	153	CD
25944	3456	1798	epitheliale	epitheliale	NN
25944	3456	1799	,	,	,
25944	3456	1800	153	153	CD
25944	3456	1801	-	-	SYM
25944	3456	1802	155	155	CD
25944	3456	1803	fibrosum	fibrosum	NN
25944	3456	1804	,	,	,
25944	3456	1805	192	192	CD
25944	3456	1806	sebaceum	sebaceum	NN
25944	3456	1807	,	,	,
25944	3456	1808	153	153	CD
25944	3456	1809	Morphia	Morphia	NNS
25944	3456	1810	,	,	,
25944	3456	1811	eruptions	eruption	NNS
25944	3456	1812	from	from	IN
25944	3456	1813	,	,	,
25944	3456	1814	63	63	CD
25944	3456	1815	Morph[oe]a	morph[oe]a	CD
25944	3456	1816	,	,	,
25944	3456	1817	172	172	CD
25944	3456	1818	Mosquito	Mosquito	NNP
25944	3456	1819	,	,	,
25944	3456	1820	279	279	CD
25944	3456	1821	Mucous	mucous	JJ
25944	3456	1822	patch	patch	NN
25944	3456	1823	,	,	,
25944	3456	1824	217	217	CD
25944	3456	1825	Mycetoma	Mycetoma	NNP
25944	3456	1826	,	,	,
25944	3456	1827	212	212	CD
25944	3456	1828	Mycosis	Mycosis	NNP
25944	3456	1829	fungoides	fungoide	NNS
25944	3456	1830	,	,	,
25944	3456	1831	242	242	CD
25944	3456	1832	Myoma	Myoma	NNP
25944	3456	1833	,	,	,
25944	3456	1834	196	196	CD
25944	3456	1835	cutis	cutis	JJ
25944	3456	1836	,	,	,
25944	3456	1837	196	196	CD
25944	3456	1838	telangiectodes	telangiectode	NNS
25944	3456	1839	,	,	,
25944	3456	1840	196	196	CD
25944	3456	1841	Nævus	Nævus	NNP
25944	3456	1842	araneus	araneu	NNS
25944	3456	1843	,	,	,
25944	3456	1844	198	198	CD
25944	3456	1845	capillary	capillary	JJ
25944	3456	1846	,	,	,
25944	3456	1847	196	196	CD
25944	3456	1848	flammeus	flammeu	NNS
25944	3456	1849	,	,	,
25944	3456	1850	196	196	CD
25944	3456	1851	linear	linear	JJ
25944	3456	1852	,	,	,
25944	3456	1853	163	163	CD
25944	3456	1854	lipomatodes	lipomatode	NNS
25944	3456	1855	,	,	,
25944	3456	1856	164	164	CD
25944	3456	1857	pigmentosus	pigmentosus	NN
25944	3456	1858	,	,	,
25944	3456	1859	162	162	CD
25944	3456	1860	pilosus	pilosus	NN
25944	3456	1861	,	,	,
25944	3456	1862	163	163	CD
25944	3456	1863	,	,	,
25944	3456	1864	168	168	CD
25944	3456	1865	sanguineus	sanguineus	NN
25944	3456	1866	,	,	,
25944	3456	1867	196	196	CD
25944	3456	1868	simplex	simplex	NN
25944	3456	1869	,	,	,
25944	3456	1870	196	196	CD
25944	3456	1871	spider	spider	NN
25944	3456	1872	,	,	,
25944	3456	1873	198	198	CD
25944	3456	1874	spilus	spilus	NN
25944	3456	1875	,	,	,
25944	3456	1876	163	163	CD
25944	3456	1877	tuberosus	tuberosus	NN
25944	3456	1878	,	,	,
25944	3456	1879	197	197	CD
25944	3456	1880	vasculosus	vasculosus	NN
25944	3456	1881	,	,	,
25944	3456	1882	196	196	CD
25944	3456	1883	venous	venous	JJ
25944	3456	1884	,	,	,
25944	3456	1885	197	197	CD
25944	3456	1886	verrucosus	verrucosus	NN
25944	3456	1887	,	,	,
25944	3456	1888	163	163	CD
25944	3456	1889	Nail	nail	NN
25944	3456	1890	,	,	,
25944	3456	1891	atrophy	atrophy	NN
25944	3456	1892	of	of	IN
25944	3456	1893	,	,	,
25944	3456	1894	188	188	CD
25944	3456	1895	hypertrophy	hypertrophy	NN
25944	3456	1896	of	of	IN
25944	3456	1897	,	,	,
25944	3456	1898	167	167	CD
25944	3456	1899	Necrotic	necrotic	JJ
25944	3456	1900	granuloma	granuloma	NN
25944	3456	1901	,	,	,
25944	3456	1902	129	129	CD
25944	3456	1903	Neoplasm	Neoplasm	NNP
25944	3456	1904	,	,	,
25944	3456	1905	inflammatory	inflammatory	JJ
25944	3456	1906	fungoid	fungoid	NN
25944	3456	1907	,	,	,
25944	3456	1908	242	242	CD
25944	3456	1909	Neoplasmata	Neoplasmata	NNP
25944	3456	1910	(	(	-LRB-
25944	3456	1911	new	new	JJ
25944	3456	1912	growths	growth	NNS
25944	3456	1913	)	)	-RRB-
25944	3456	1914	,	,	,
25944	3456	1915	191	191	CD
25944	3456	1916	,	,	,
25944	3456	1917	241	241	CD
25944	3456	1918	Nettlerash	Nettlerash	NNP
25944	3456	1919	,	,	,
25944	3456	1920	52	52	CD
25944	3456	1921	Neuralgia	Neuralgia	NNP
25944	3456	1922	of	of	IN
25944	3456	1923	the	the	DT
25944	3456	1924	skin	skin	NN
25944	3456	1925	,	,	,
25944	3456	1926	244	244	CD
25944	3456	1927	Neuroma	Neuroma	NNP
25944	3456	1928	,	,	,
25944	3456	1929	194	194	CD
25944	3456	1930	Neuroses	neurosis	NNS
25944	3456	1931	,	,	,
25944	3456	1932	244	244	CD
25944	3456	1933	-	-	HYPH
25944	3456	1934	247	247	CD
25944	3456	1935	New	new	JJ
25944	3456	1936	growths	growth	NNS
25944	3456	1937	,	,	,
25944	3456	1938	191	191	CD
25944	3456	1939	-	-	SYM
25944	3456	1940	243	243	CD
25944	3456	1941	Nits	nit	NNS
25944	3456	1942	,	,	,
25944	3456	1943	273	273	CD
25944	3456	1944	Objective	objective	JJ
25944	3456	1945	symptoms	symptom	NNS
25944	3456	1946	,	,	,
25944	3456	1947	22	22	CD
25944	3456	1948	[	[	-LRB-
25944	3456	1949	OE]dema	OE]dema	NNP
25944	3456	1950	,	,	,
25944	3456	1951	acute	acute	JJ
25944	3456	1952	circumscribed	circumscribe	VBN
25944	3456	1953	,	,	,
25944	3456	1954	54	54	CD
25944	3456	1955	neonatorum	neonatorum	NN
25944	3456	1956	,	,	,
25944	3456	1957	170	170	CD
25944	3456	1958	[	[	-LRB-
25944	3456	1959	OE]strus	OE]strus	NNP
25944	3456	1960	,	,	,
25944	3456	1961	278	278	CD
25944	3456	1962	Ointment	ointment	NN
25944	3456	1963	bases	basis	NNS
25944	3456	1964	,	,	,
25944	3456	1965	27	27	CD
25944	3456	1966	Onychatrophia	Onychatrophia	NNP
25944	3456	1967	,	,	,
25944	3456	1968	188	188	CD
25944	3456	1969	Onychauxis	Onychauxis	NNP
25944	3456	1970	,	,	,
25944	3456	1971	167	167	CD
25944	3456	1972	,	,	,
25944	3456	1973	168	168	CD
25944	3456	1974	Onychomycosis	Onychomycosis	NNP
25944	3456	1975	,	,	,
25944	3456	1976	188	188	CD
25944	3456	1977	favosa	favosa	NNS
25944	3456	1978	,	,	,
25944	3456	1979	249	249	CD
25944	3456	1980	Opium	Opium	NNP
25944	3456	1981	,	,	,
25944	3456	1982	eruptions	eruption	NNS
25944	3456	1983	from	from	IN
25944	3456	1984	,	,	,
25944	3456	1985	63	63	CD
25944	3456	1986	Oroya	Oroya	NNP
25944	3456	1987	fever	fever	NN
25944	3456	1988	,	,	,
25944	3456	1989	73	73	CD
25944	3456	1990	Osmidrosis	Osmidrosis	NNP
25944	3456	1991	,	,	,
25944	3456	1992	32	32	CD
25944	3456	1993	Ova	ova	NN
25944	3456	1994	of	of	IN
25944	3456	1995	pediculi	pediculi	NN
25944	3456	1996	,	,	,
25944	3456	1997	273	273	CD
25944	3456	1998	Pachydermia	Pachydermia	NNP
25944	3456	1999	,	,	,
25944	3456	2000	174	174	CD
25944	3456	2001	Paget	Paget	NNP
25944	3456	2002	's	's	POS
25944	3456	2003	disease	disease	NN
25944	3456	2004	of	of	IN
25944	3456	2005	the	the	DT
25944	3456	2006	nipple	nipple	NN
25944	3456	2007	,	,	,
25944	3456	2008	240	240	CD
25944	3456	2009	Papillæ	papillæ	NN
25944	3456	2010	,	,	,
25944	3456	2011	nervous	nervous	JJ
25944	3456	2012	and	and	CC
25944	3456	2013	vascular	vascular	JJ
25944	3456	2014	,	,	,
25944	3456	2015	20	20	CD
25944	3456	2016	Papulæ	Papulæ	NNP
25944	3456	2017	,	,	,
25944	3456	2018	23	23	CD
25944	3456	2019	Papule	Papule	NNP
25944	3456	2020	,	,	,
25944	3456	2021	moist	moist	NN
25944	3456	2022	,	,	,
25944	3456	2023	216	216	CD
25944	3456	2024	,	,	,
25944	3456	2025	217	217	CD
25944	3456	2026	Papules	Papules	NNPS
25944	3456	2027	,	,	,
25944	3456	2028	23	23	CD
25944	3456	2029	Parasitic	parasitic	JJ
25944	3456	2030	affections	affection	NNS
25944	3456	2031	,	,	,
25944	3456	2032	247	247	CD
25944	3456	2033	-	-	SYM
25944	3456	2034	279	279	CD
25944	3456	2035	sycosis	sycosis	NN
25944	3456	2036	,	,	,
25944	3456	2037	255	255	CD
25944	3456	2038	Parasiticides	Parasiticides	NNPS
25944	3456	2039	,	,	,
25944	3456	2040	250	250	CD
25944	3456	2041	,	,	,
25944	3456	2042	259	259	CD
25944	3456	2043	Parchment	Parchment	NNP
25944	3456	2044	skin	skin	NN
25944	3456	2045	,	,	,
25944	3456	2046	190	190	CD
25944	3456	2047	Paronychia	Paronychia	NNS
25944	3456	2048	,	,	,
25944	3456	2049	167	167	CD
25944	3456	2050	Patch	Patch	NNP
25944	3456	2051	,	,	,
25944	3456	2052	mucous	mucous	NN
25944	3456	2053	,	,	,
25944	3456	2054	217	217	CD
25944	3456	2055	Pediculosis	Pediculosis	NNP
25944	3456	2056	,	,	,
25944	3456	2057	271	271	CD
25944	3456	2058	capillitii	capillitii	NNS
25944	3456	2059	,	,	,
25944	3456	2060	272	272	CD
25944	3456	2061	capitis	capitis	NN
25944	3456	2062	,	,	,
25944	3456	2063	272	272	CD
25944	3456	2064	,	,	,
25944	3456	2065	273	273	CD
25944	3456	2066	corporis	corpori	NNS
25944	3456	2067	,	,	,
25944	3456	2068	274	274	CD
25944	3456	2069	,	,	,
25944	3456	2070	275	275	CD
25944	3456	2071	pubis	pubi	VBD
25944	3456	2072	,	,	,
25944	3456	2073	275	275	CD
25944	3456	2074	,	,	,
25944	3456	2075	276	276	CD
25944	3456	2076	Pediculus	pediculus	JJ
25944	3456	2077	capitis	capitis	NN
25944	3456	2078	,	,	,
25944	3456	2079	272	272	CD
25944	3456	2080	corporis	corpori	NNS
25944	3456	2081	,	,	,
25944	3456	2082	274	274	CD
25944	3456	2083	pubis	pubi	VBD
25944	3456	2084	,	,	,
25944	3456	2085	275	275	CD
25944	3456	2086	vestimenti	vestimenti	NN
25944	3456	2087	,	,	,
25944	3456	2088	274	274	CD
25944	3456	2089	Peliosis	Peliosis	NNP
25944	3456	2090	rheumatica	rheumatica	NN
25944	3456	2091	,	,	,
25944	3456	2092	144	144	CD
25944	3456	2093	Pellagra	Pellagra	NNP
25944	3456	2094	,	,	,
25944	3456	2095	235	235	CD
25944	3456	2096	Pemphigus	Pemphigus	NNP
25944	3456	2097	,	,	,
25944	3456	2098	140	140	CD
25944	3456	2099	-	-	SYM
25944	3456	2100	144	144	CD
25944	3456	2101	foliaceus	foliaceu	NNS
25944	3456	2102	,	,	,
25944	3456	2103	141	141	CD
25944	3456	2104	neonatorum	neonatorum	NN
25944	3456	2105	,	,	,
25944	3456	2106	140	140	CD
25944	3456	2107	pruriginosus	pruriginosus	NN
25944	3456	2108	,	,	,
25944	3456	2109	83	83	CD
25944	3456	2110	vegetans	vegetan	NNS
25944	3456	2111	,	,	,
25944	3456	2112	142	142	CD
25944	3456	2113	vulgaris	vulgaris	NN
25944	3456	2114	,	,	,
25944	3456	2115	140	140	CD
25944	3456	2116	Perforating	perforate	VBG
25944	3456	2117	ulcer	ulcer	NN
25944	3456	2118	of	of	IN
25944	3456	2119	the	the	DT
25944	3456	2120	foot	foot	NN
25944	3456	2121	,	,	,
25944	3456	2122	213	213	CD
25944	3456	2123	Peruvian	peruvian	JJ
25944	3456	2124	warts	wart	NNS
25944	3456	2125	,	,	,
25944	3456	2126	73	73	CD
25944	3456	2127	Phlegmona	Phlegmona	NNP
25944	3456	2128	diffusa	diffusa	VBD
25944	3456	2129	,	,	,
25944	3456	2130	68	68	CD
25944	3456	2131	Phosphorescent	phosphorescent	NN
25944	3456	2132	sweat	sweat	NN
25944	3456	2133	,	,	,
25944	3456	2134	33	33	CD
25944	3456	2135	Phosphoridrosis	Phosphoridrosis	NNP
25944	3456	2136	,	,	,
25944	3456	2137	33	33	CD
25944	3456	2138	Phtheiriasis	Phtheiriasis	NNP
25944	3456	2139	,	,	,
25944	3456	2140	271	271	CD
25944	3456	2141	Plan	plan	NN
25944	3456	2142	,	,	,
25944	3456	2143	73	73	CD
25944	3456	2144	Pityriasis	Pityriasis	NNP
25944	3456	2145	capitis	capitis	NN
25944	3456	2146	,	,	,
25944	3456	2147	34	34	CD
25944	3456	2148	maculata	maculata	NNP
25944	3456	2149	et	et	NNP
25944	3456	2150	circinata	circinata	NN
25944	3456	2151	,	,	,
25944	3456	2152	95	95	CD
25944	3456	2153	pilaris	pilaris	NNP
25944	3456	2154	,	,	,
25944	3456	2155	151	151	CD
25944	3456	2156	rosea	rosea	NN
25944	3456	2157	,	,	,
25944	3456	2158	95	95	CD
25944	3456	2159	,	,	,
25944	3456	2160	96	96	CD
25944	3456	2161	rubra	rubra	NN
25944	3456	2162	,	,	,
25944	3456	2163	97	97	CD
25944	3456	2164	Pityriasis	Pityriasis	NNP
25944	3456	2165	rubra	rubra	NN
25944	3456	2166	pilaris	pilaris	NNP
25944	3456	2167	,	,	,
25944	3456	2168	99	99	CD
25944	3456	2169	versicolor	versicolor	NN
25944	3456	2170	,	,	,
25944	3456	2171	261	261	CD
25944	3456	2172	Plasment	Plasment	NNP
25944	3456	2173	,	,	,
25944	3456	2174	117	117	CD
25944	3456	2175	Plaster	Plaster	NNP
25944	3456	2176	-	-	HYPH
25944	3456	2177	mull	mull	NN
25944	3456	2178	,	,	,
25944	3456	2179	117	117	CD
25944	3456	2180	Podelcoma	Podelcoma	NNP
25944	3456	2181	,	,	,
25944	3456	2182	212	212	CD
25944	3456	2183	Poison	poison	NN
25944	3456	2184	dogwood	dogwood	NN
25944	3456	2185	,	,	,
25944	3456	2186	dermatitis	dermatitis	NN
25944	3456	2187	from	from	IN
25944	3456	2188	,	,	,
25944	3456	2189	59	59	CD
25944	3456	2190	ivy	ivy	NN
25944	3456	2191	,	,	,
25944	3456	2192	dermatitis	dermatitis	NN
25944	3456	2193	from	from	IN
25944	3456	2194	,	,	,
25944	3456	2195	59	59	CD
25944	3456	2196	sumach	sumach	NN
25944	3456	2197	,	,	,
25944	3456	2198	dermatitis	dermatitis	NN
25944	3456	2199	from	from	IN
25944	3456	2200	,	,	,
25944	3456	2201	59	59	CD
25944	3456	2202	vine	vine	NN
25944	3456	2203	,	,	,
25944	3456	2204	dermatitis	dermatitis	NN
25944	3456	2205	from	from	IN
25944	3456	2206	,	,	,
25944	3456	2207	59	59	CD
25944	3456	2208	Pomphi	Pomphi	NNP
25944	3456	2209	,	,	,
25944	3456	2210	23	23	CD
25944	3456	2211	Pompholyx	Pompholyx	NNP
25944	3456	2212	,	,	,
25944	3456	2213	76	76	CD
25944	3456	2214	-	-	SYM
25944	3456	2215	78	78	CD
25944	3456	2216	Port	Port	NNP
25944	3456	2217	-	-	HYPH
25944	3456	2218	wine	wine	NN
25944	3456	2219	mark	mark	NN
25944	3456	2220	,	,	,
25944	3456	2221	197	197	CD
25944	3456	2222	Post	post	JJ
25944	3456	2223	-	-	JJ
25944	3456	2224	mortem	mortem	JJ
25944	3456	2225	pustule	pustule	NN
25944	3456	2226	,	,	,
25944	3456	2227	73	73	CD
25944	3456	2228	Prickly	prickly	JJ
25944	3456	2229	heat	heat	NN
25944	3456	2230	,	,	,
25944	3456	2231	74	74	CD
25944	3456	2232	Primary	primary	JJ
25944	3456	2233	lesions	lesion	NNS
25944	3456	2234	,	,	,
25944	3456	2235	22	22	CD
25944	3456	2236	,	,	,
25944	3456	2237	23	23	CD
25944	3456	2238	Prurigo	Prurigo	NNS
25944	3456	2239	,	,	,
25944	3456	2240	118	118	CD
25944	3456	2241	,	,	,
25944	3456	2242	119	119	CD
25944	3456	2243	Pruritus	Pruritus	NNP
25944	3456	2244	,	,	,
25944	3456	2245	244	244	CD
25944	3456	2246	-	-	SYM
25944	3456	2247	247	247	CD
25944	3456	2248	ani	ani	NN
25944	3456	2249	,	,	,
25944	3456	2250	245	245	CD
25944	3456	2251	hiemalis	hiemalis	NN
25944	3456	2252	,	,	,
25944	3456	2253	245	245	CD
25944	3456	2254	scroti	scroti	NN
25944	3456	2255	,	,	,
25944	3456	2256	245	245	CD
25944	3456	2257	senilis	senili	NNS
25944	3456	2258	,	,	,
25944	3456	2259	245	245	CD
25944	3456	2260	vulvæ	vulvæ	VBN
25944	3456	2261	,	,	,
25944	3456	2262	245	245	CD
25944	3456	2263	Pseudochromidrosis	Pseudochromidrosis	NNP
25944	3456	2264	,	,	,
25944	3456	2265	33	33	CD
25944	3456	2266	Psoriasis	psoriasis	NN
25944	3456	2267	,	,	,
25944	3456	2268	86	86	CD
25944	3456	2269	-	-	SYM
25944	3456	2270	95	95	CD
25944	3456	2271	circinata	circinata	NN
25944	3456	2272	,	,	,
25944	3456	2273	88	88	CD
25944	3456	2274	diffusa	diffusa	VBD
25944	3456	2275	,	,	,
25944	3456	2276	88	88	CD
25944	3456	2277	guttata	guttata	NN
25944	3456	2278	,	,	,
25944	3456	2279	88	88	CD
25944	3456	2280	gyrata	gyrata	NN
25944	3456	2281	,	,	,
25944	3456	2282	88	88	CD
25944	3456	2283	inveterata	inveterata	NN
25944	3456	2284	,	,	,
25944	3456	2285	88	88	CD
25944	3456	2286	nummularis	nummularis	NNP
25944	3456	2287	,	,	,
25944	3456	2288	88	88	CD
25944	3456	2289	punctata	punctata	NNP
25944	3456	2290	,	,	,
25944	3456	2291	88	88	CD
25944	3456	2292	syphilitica	syphilitica	NN
25944	3456	2293	,	,	,
25944	3456	2294	218	218	CD
25944	3456	2295	Psorospermosis	Psorospermosis	NNP
25944	3456	2296	,	,	,
25944	3456	2297	153	153	CD
25944	3456	2298	,	,	,
25944	3456	2299	154	154	CD
25944	3456	2300	,	,	,
25944	3456	2301	240	240	CD
25944	3456	2302	Pulex	Pulex	NNP
25944	3456	2303	irritans	irritan	NNS
25944	3456	2304	,	,	,
25944	3456	2305	279	279	CD
25944	3456	2306	penetrans	penetran	NNS
25944	3456	2307	,	,	,
25944	3456	2308	278	278	CD
25944	3456	2309	Punctate	Punctate	NNP
25944	3456	2310	scarification	scarification	NN
25944	3456	2311	,	,	,
25944	3456	2312	208	208	CD
25944	3456	2313	Purpura	Purpura	NNP
25944	3456	2314	,	,	,
25944	3456	2315	144	144	CD
25944	3456	2316	-	-	SYM
25944	3456	2317	146	146	CD
25944	3456	2318	hæmorrhagica	hæmorrhagica	NNP
25944	3456	2319	,	,	,
25944	3456	2320	145	145	CD
25944	3456	2321	Henoch	Henoch	NNP
25944	3456	2322	's	's	POS
25944	3456	2323	,	,	,
25944	3456	2324	145	145	CD
25944	3456	2325	,	,	,
25944	3456	2326	146	146	CD
25944	3456	2327	rheumatica	rheumatica	NN
25944	3456	2328	,	,	,
25944	3456	2329	144	144	CD
25944	3456	2330	scorbutica	scorbutica	NNP
25944	3456	2331	,	,	,
25944	3456	2332	146	146	CD
25944	3456	2333	simplex	simplex	NN
25944	3456	2334	,	,	,
25944	3456	2335	144	144	CD
25944	3456	2336	urticans	urtican	NNS
25944	3456	2337	,	,	,
25944	3456	2338	144	144	CD
25944	3456	2339	Pustula	Pustula	NNP
25944	3456	2340	maligna	maligna	NNS
25944	3456	2341	,	,	,
25944	3456	2342	72	72	CD
25944	3456	2343	Pustulæ	Pustulæ	NNP
25944	3456	2344	,	,	,
25944	3456	2345	23	23	CD
25944	3456	2346	Pustules	Pustules	NNPS
25944	3456	2347	,	,	,
25944	3456	2348	23	23	CD
25944	3456	2349	Quinine	quinine	JJ
25944	3456	2350	,	,	,
25944	3456	2351	eruptions	eruption	NNS
25944	3456	2352	from	from	IN
25944	3456	2353	,	,	,
25944	3456	2354	63	63	CD
25944	3456	2355	Rapidity	rapidity	NN
25944	3456	2356	of	of	IN
25944	3456	2357	cure	cure	NN
25944	3456	2358	,	,	,
25944	3456	2359	27	27	CD
25944	3456	2360	Raynaud	Raynaud	NNP
25944	3456	2361	's	's	POS
25944	3456	2362	disease	disease	NN
25944	3456	2363	,	,	,
25944	3456	2364	66	66	CD
25944	3456	2365	Recurrent	recurrent	JJ
25944	3456	2366	summer	summer	NN
25944	3456	2367	eruption	eruption	NN
25944	3456	2368	,	,	,
25944	3456	2369	80	80	CD
25944	3456	2370	Red	red	JJ
25944	3456	2371	chromidrosis	chromidrosis	NN
25944	3456	2372	,	,	,
25944	3456	2373	33	33	CD
25944	3456	2374	gum	gum	NN
25944	3456	2375	,	,	,
25944	3456	2376	74	74	CD
25944	3456	2377	Relative	relative	JJ
25944	3456	2378	frequency	frequency	NN
25944	3456	2379	,	,	,
25944	3456	2380	26	26	CD
25944	3456	2381	Rhagades	rhagade	NNS
25944	3456	2382	,	,	,
25944	3456	2383	24	24	CD
25944	3456	2384	Rheumatism	rheumatism	NN
25944	3456	2385	of	of	IN
25944	3456	2386	the	the	DT
25944	3456	2387	skin	skin	NN
25944	3456	2388	,	,	,
25944	3456	2389	244	244	CD
25944	3456	2390	Rhinophyma	Rhinophyma	NNP
25944	3456	2391	,	,	,
25944	3456	2392	127	127	CD
25944	3456	2393	Rhinoscleroma	Rhinoscleroma	NNP
25944	3456	2394	,	,	,
25944	3456	2395	198	198	CD
25944	3456	2396	,	,	,
25944	3456	2397	199	199	CD
25944	3456	2398	Rhus	rhu	NNS
25944	3456	2399	poisoning	poisoning	NN
25944	3456	2400	,	,	,
25944	3456	2401	59	59	CD
25944	3456	2402	Ringworm	ringworm	NN
25944	3456	2403	,	,	,
25944	3456	2404	251	251	CD
25944	3456	2405	of	of	IN
25944	3456	2406	bearded	bearded	JJ
25944	3456	2407	region	region	NN
25944	3456	2408	,	,	,
25944	3456	2409	255	255	CD
25944	3456	2410	of	of	IN
25944	3456	2411	general	general	JJ
25944	3456	2412	surface	surface	NN
25944	3456	2413	,	,	,
25944	3456	2414	251	251	CD
25944	3456	2415	of	of	IN
25944	3456	2416	the	the	DT
25944	3456	2417	nail	nail	NN
25944	3456	2418	,	,	,
25944	3456	2419	253	253	CD
25944	3456	2420	of	of	IN
25944	3456	2421	the	the	DT
25944	3456	2422	scalp	scalp	NN
25944	3456	2423	,	,	,
25944	3456	2424	253	253	CD
25944	3456	2425	of	of	IN
25944	3456	2426	the	the	DT
25944	3456	2427	thighs	thigh	NNS
25944	3456	2428	and	and	CC
25944	3456	2429	scrotum	scrotum	NN
25944	3456	2430	,	,	,
25944	3456	2431	252	252	CD
25944	3456	2432	Tokelau	Tokelau	NNP
25944	3456	2433	,	,	,
25944	3456	2434	261	261	CD
25944	3456	2435	Rodent	rodent	NN
25944	3456	2436	ulcer	ulcer	NN
25944	3456	2437	,	,	,
25944	3456	2438	236	236	CD
25944	3456	2439	Rosacea	Rosacea	NNP
25944	3456	2440	,	,	,
25944	3456	2441	198	198	CD
25944	3456	2442	acne	acne	NNS
25944	3456	2443	,	,	,
25944	3456	2444	126	126	CD
25944	3456	2445	Rubber	Rubber	NNP
25944	3456	2446	plaster	plaster	NN
25944	3456	2447	,	,	,
25944	3456	2448	117	117	CD
25944	3456	2449	Rupia	Rupia	NNP
25944	3456	2450	,	,	,
25944	3456	2451	221	221	CD
25944	3456	2452	,	,	,
25944	3456	2453	222	222	CD
25944	3456	2454	Salicylic	salicylic	JJ
25944	3456	2455	acid	acid	NN
25944	3456	2456	,	,	,
25944	3456	2457	eruptions	eruption	NNS
25944	3456	2458	from	from	IN
25944	3456	2459	,	,	,
25944	3456	2460	63	63	CD
25944	3456	2461	paste	paste	NN
25944	3456	2462	,	,	,
25944	3456	2463	113	113	CD
25944	3456	2464	Salt	Salt	NNP
25944	3456	2465	rheum	rheum	NN
25944	3456	2466	,	,	,
25944	3456	2467	100	100	CD
25944	3456	2468	Sand	sand	NN
25944	3456	2469	flea	flea	NN
25944	3456	2470	,	,	,
25944	3456	2471	278	278	CD
25944	3456	2472	Sarcoma	Sarcoma	NNP
25944	3456	2473	,	,	,
25944	3456	2474	241	241	CD
25944	3456	2475	,	,	,
25944	3456	2476	242	242	CD
25944	3456	2477	cutis	cutis	NN
25944	3456	2478	,	,	,
25944	3456	2479	241	241	CD
25944	3456	2480	Sarcoptes	Sarcoptes	NNPS
25944	3456	2481	scabiei	scabiei	VBP
25944	3456	2482	,	,	,
25944	3456	2483	269	269	CD
25944	3456	2484	Scabies	scabie	NNS
25944	3456	2485	,	,	,
25944	3456	2486	267	267	CD
25944	3456	2487	-	-	SYM
25944	3456	2488	271	271	CD
25944	3456	2489	Scales	Scales	NNPS
25944	3456	2490	,	,	,
25944	3456	2491	24	24	CD
25944	3456	2492	Scarification	Scarification	NNP
25944	3456	2493	,	,	,
25944	3456	2494	linear	linear	JJ
25944	3456	2495	,	,	,
25944	3456	2496	208	208	CD
25944	3456	2497	punctate	punctate	NN
25944	3456	2498	,	,	,
25944	3456	2499	208	208	CD
25944	3456	2500	Scarifier	scarifi	JJR
25944	3456	2501	,	,	,
25944	3456	2502	multiple	multiple	NN
25944	3456	2503	,	,	,
25944	3456	2504	202	202	CD
25944	3456	2505	single	single	JJ
25944	3456	2506	,	,	,
25944	3456	2507	202	202	CD
25944	3456	2508	Scars	scar	NNS
25944	3456	2509	,	,	,
25944	3456	2510	24	24	CD
25944	3456	2511	hypertrophic	hypertrophic	JJ
25944	3456	2512	,	,	,
25944	3456	2513	192	192	CD
25944	3456	2514	Schönlein	Schönlein	NNP
25944	3456	2515	's	's	POS
25944	3456	2516	disease	disease	NN
25944	3456	2517	,	,	,
25944	3456	2518	145	145	CD
25944	3456	2519	,	,	,
25944	3456	2520	146	146	CD
25944	3456	2521	Sclerema	Sclerema	NNP
25944	3456	2522	,	,	,
25944	3456	2523	172	172	CD
25944	3456	2524	neonatorum	neonatorum	NN
25944	3456	2525	,	,	,
25944	3456	2526	171	171	CD
25944	3456	2527	of	of	IN
25944	3456	2528	the	the	DT
25944	3456	2529	newborn	newborn	JJ
25944	3456	2530	,	,	,
25944	3456	2531	171	171	CD
25944	3456	2532	Scleriasis	scleriasis	NN
25944	3456	2533	,	,	,
25944	3456	2534	172	172	CD
25944	3456	2535	Scleroderma	Scleroderma	NNP
25944	3456	2536	,	,	,
25944	3456	2537	172	172	CD
25944	3456	2538	,	,	,
25944	3456	2539	173	173	CD
25944	3456	2540	neonatorum	neonatorum	NN
25944	3456	2541	,	,	,
25944	3456	2542	171	171	CD
25944	3456	2543	Scorbutus	Scorbutus	NNP
25944	3456	2544	,	,	,
25944	3456	2545	146	146	CD
25944	3456	2546	Scrofuloderma	Scrofuloderma	NNP
25944	3456	2547	,	,	,
25944	3456	2548	209	209	CD
25944	3456	2549	pustular	pustular	NN
25944	3456	2550	,	,	,
25944	3456	2551	small	small	JJ
25944	3456	2552	,	,	,
25944	3456	2553	210	210	CD
25944	3456	2554	Scurvy	Scurvy	NNP
25944	3456	2555	,	,	,
25944	3456	2556	146	146	CD
25944	3456	2557	land	land	NN
25944	3456	2558	,	,	,
25944	3456	2559	145	145	CD
25944	3456	2560	sea	sea	NN
25944	3456	2561	,	,	,
25944	3456	2562	146	146	CD
25944	3456	2563	Sebaceous	sebaceous	JJ
25944	3456	2564	cyst	cyst	NN
25944	3456	2565	,	,	,
25944	3456	2566	43	43	CD
25944	3456	2567	gland	gland	NN
25944	3456	2568	,	,	,
25944	3456	2569	33	33	CD
25944	3456	2570	tumor	tumor	NN
25944	3456	2571	,	,	,
25944	3456	2572	43	43	CD
25944	3456	2573	Seborrh[oe]a	seborrh[oe]a	CD
25944	3456	2574	,	,	,
25944	3456	2575	33	33	CD
25944	3456	2576	-	-	SYM
25944	3456	2577	38	38	CD
25944	3456	2578	congestiva	congestiva	NN
25944	3456	2579	,	,	,
25944	3456	2580	199	199	CD
25944	3456	2581	oleosa	oleosa	NNS
25944	3456	2582	,	,	,
25944	3456	2583	34	34	CD
25944	3456	2584	sicca	sicca	JJS
25944	3456	2585	,	,	,
25944	3456	2586	34	34	CD
25944	3456	2587	Secondary	secondary	JJ
25944	3456	2588	lesions	lesion	NNS
25944	3456	2589	,	,	,
25944	3456	2590	23	23	CD
25944	3456	2591	,	,	,
25944	3456	2592	24	24	CD
25944	3456	2593	Shingles	shingle	NNS
25944	3456	2594	,	,	,
25944	3456	2595	81	81	CD
25944	3456	2596	Skin	skin	NN
25944	3456	2597	,	,	,
25944	3456	2598	anatomy	anatomy	NN
25944	3456	2599	of	of	IN
25944	3456	2600	,	,	,
25944	3456	2601	17	17	CD
25944	3456	2602	cancer	cancer	NN
25944	3456	2603	,	,	,
25944	3456	2604	236	236	CD
25944	3456	2605	general	general	JJ
25944	3456	2606	idiopathic	idiopathic	JJ
25944	3456	2607	atrophy	atrophy	NN
25944	3456	2608	of	of	IN
25944	3456	2609	,	,	,
25944	3456	2610	189	189	CD
25944	3456	2611	glossy	glossy	JJ
25944	3456	2612	,	,	,
25944	3456	2613	189	189	CD
25944	3456	2614	looseness	looseness	NN
25944	3456	2615	of	of	IN
25944	3456	2616	,	,	,
25944	3456	2617	176	176	CD
25944	3456	2618	Skin	skin	NN
25944	3456	2619	,	,	,
25944	3456	2620	parchment	parchment	NN
25944	3456	2621	,	,	,
25944	3456	2622	190	190	CD
25944	3456	2623	Spider	Spider	NNP
25944	3456	2624	nævus	nævu	NNS
25944	3456	2625	,	,	,
25944	3456	2626	198	198	CD
25944	3456	2627	Spiradenitis	Spiradenitis	NNP
25944	3456	2628	,	,	,
25944	3456	2629	130	130	CD
25944	3456	2630	Spontaneous	spontaneous	JJ
25944	3456	2631	gangrene	gangrene	NN
25944	3456	2632	,	,	,
25944	3456	2633	65	65	CD
25944	3456	2634	Spots	spot	NNS
25944	3456	2635	,	,	,
25944	3456	2636	22	22	CD
25944	3456	2637	Squamæ	Squamæ	NNP
25944	3456	2638	,	,	,
25944	3456	2639	24	24	CD
25944	3456	2640	Stains	stain	NNS
25944	3456	2641	,	,	,
25944	3456	2642	24	24	CD
25944	3456	2643	Statistics	statistic	NNS
25944	3456	2644	,	,	,
25944	3456	2645	280	280	CD
25944	3456	2646	,	,	,
25944	3456	2647	281	281	CD
25944	3456	2648	Steatoma	Steatoma	NNP
25944	3456	2649	,	,	,
25944	3456	2650	43	43	CD
25944	3456	2651	Steatorrh[oe]a	steatorrh[oe]a	CD
25944	3456	2652	,	,	,
25944	3456	2653	33	33	CD
25944	3456	2654	Stramonium	stramonium	NN
25944	3456	2655	,	,	,
25944	3456	2656	eruptions	eruption	NNS
25944	3456	2657	from	from	IN
25944	3456	2658	,	,	,
25944	3456	2659	63	63	CD
25944	3456	2660	Striæ	Striæ	NNP
25944	3456	2661	et	et	NN
25944	3456	2662	maculæ	maculæ	NN
25944	3456	2663	atrophicæ	atrophicæ	NN
25944	3456	2664	,	,	,
25944	3456	2665	190	190	CD
25944	3456	2666	Strophulus	Strophulus	NNP
25944	3456	2667	,	,	,
25944	3456	2668	74	74	CD
25944	3456	2669	albidus	albidus	NN
25944	3456	2670	,	,	,
25944	3456	2671	42	42	CD
25944	3456	2672	Subjective	subjective	JJ
25944	3456	2673	symptoms	symptom	NNS
25944	3456	2674	,	,	,
25944	3456	2675	22	22	CD
25944	3456	2676	Sudamen	sudaman	NNS
25944	3456	2677	,	,	,
25944	3456	2678	30	30	CD
25944	3456	2679	,	,	,
25944	3456	2680	31	31	CD
25944	3456	2681	Superfluous	superfluous	JJ
25944	3456	2682	hair	hair	NN
25944	3456	2683	,	,	,
25944	3456	2684	168	168	CD
25944	3456	2685	Sweat	Sweat	NNP
25944	3456	2686	,	,	,
25944	3456	2687	colored	colored	JJ
25944	3456	2688	(	(	-LRB-
25944	3456	2689	chromidrosis	chromidrosis	NN
25944	3456	2690	)	)	-RRB-
25944	3456	2691	,	,	,
25944	3456	2692	32	32	CD
25944	3456	2693	glands	gland	NNS
25944	3456	2694	,	,	,
25944	3456	2695	28	28	CD
25944	3456	2696	phosphorescent	phosphorescent	NN
25944	3456	2697	,	,	,
25944	3456	2698	33	33	CD
25944	3456	2699	Sweating	sweating	NN
25944	3456	2700	,	,	,
25944	3456	2701	excessive	excessive	JJ
25944	3456	2702	,	,	,
25944	3456	2703	28	28	CD
25944	3456	2704	Sycosis	Sycosis	NNP
25944	3456	2705	,	,	,
25944	3456	2706	130	130	CD
25944	3456	2707	-	-	SYM
25944	3456	2708	135	135	CD
25944	3456	2709	coccogenica	coccogenica	NN
25944	3456	2710	,	,	,
25944	3456	2711	130	130	CD
25944	3456	2712	non	non	JJ
25944	3456	2713	-	-	NN
25944	3456	2714	parasitica	parasitica	JJ
25944	3456	2715	,	,	,
25944	3456	2716	130	130	CD
25944	3456	2717	parasitic	parasitic	JJ
25944	3456	2718	,	,	,
25944	3456	2719	255	255	CD
25944	3456	2720	vulgaris	vulgaris	NN
25944	3456	2721	,	,	,
25944	3456	2722	130	130	CD
25944	3456	2723	Symmetric	symmetric	JJ
25944	3456	2724	gangrene	gangrene	NN
25944	3456	2725	,	,	,
25944	3456	2726	66	66	CD
25944	3456	2727	keratodermia	keratodermia	NN
25944	3456	2728	,	,	,
25944	3456	2729	155	155	CD
25944	3456	2730	Symptomatology	symptomatology	NN
25944	3456	2731	,	,	,
25944	3456	2732	22	22	CD
25944	3456	2733	-	-	SYM
25944	3456	2734	26	26	CD
25944	3456	2735	Symptoms	Symptoms	NNPS
25944	3456	2736	,	,	,
25944	3456	2737	objective	objective	JJ
25944	3456	2738	,	,	,
25944	3456	2739	22	22	CD
25944	3456	2740	subjective	subjective	JJ
25944	3456	2741	,	,	,
25944	3456	2742	22	22	CD
25944	3456	2743	systemic	systemic	NN
25944	3456	2744	,	,	,
25944	3456	2745	22	22	CD
25944	3456	2746	Syphilis	Syphilis	NNP
25944	3456	2747	cutanea	cutanea	NN
25944	3456	2748	,	,	,
25944	3456	2749	213	213	CD
25944	3456	2750	-	-	SYM
25944	3456	2751	231	231	CD
25944	3456	2752	early	early	JJ
25944	3456	2753	eruptions	eruption	NNS
25944	3456	2754	of	of	IN
25944	3456	2755	,	,	,
25944	3456	2756	213	213	CD
25944	3456	2757	late	late	JJ
25944	3456	2758	eruptions	eruption	NNS
25944	3456	2759	of	of	IN
25944	3456	2760	,	,	,
25944	3456	2761	214	214	CD
25944	3456	2762	papillomatosa	papillomatosa	NNS
25944	3456	2763	,	,	,
25944	3456	2764	225	225	CD
25944	3456	2765	hereditary	hereditary	JJ
25944	3456	2766	,	,	,
25944	3456	2767	227	227	CD
25944	3456	2768	eruptions	eruption	NNS
25944	3456	2769	of	of	IN
25944	3456	2770	,	,	,
25944	3456	2771	227	227	CD
25944	3456	2772	of	of	IN
25944	3456	2773	the	the	DT
25944	3456	2774	skin	skin	NN
25944	3456	2775	,	,	,
25944	3456	2776	213	213	CD
25944	3456	2777	-	-	SYM
25944	3456	2778	231	231	CD
25944	3456	2779	Syphiloderm	Syphiloderm	NNP
25944	3456	2780	,	,	,
25944	3456	2781	213	213	CD
25944	3456	2782	acne	acne	NN
25944	3456	2783	-	-	HYPH
25944	3456	2784	form	form	NN
25944	3456	2785	,	,	,
25944	3456	2786	220	220	CD
25944	3456	2787	annular	annular	NN
25944	3456	2788	,	,	,
25944	3456	2789	219	219	CD
25944	3456	2790	bullous	bullous	JJ
25944	3456	2791	,	,	,
25944	3456	2792	222	222	CD
25944	3456	2793	,	,	,
25944	3456	2794	228	228	CD
25944	3456	2795	circinate	circinate	NN
25944	3456	2796	,	,	,
25944	3456	2797	219	219	CD
25944	3456	2798	ecthyma	ecthyma	NN
25944	3456	2799	-	-	HYPH
25944	3456	2800	form	form	NN
25944	3456	2801	,	,	,
25944	3456	2802	221	221	CD
25944	3456	2803	erythematous	erythematous	JJ
25944	3456	2804	,	,	,
25944	3456	2805	214	214	CD
25944	3456	2806	,	,	,
25944	3456	2807	227	227	CD
25944	3456	2808	gummatous	gummatous	JJ
25944	3456	2809	,	,	,
25944	3456	2810	225	225	CD
25944	3456	2811	impetigo	impetigo	NN
25944	3456	2812	-	-	HYPH
25944	3456	2813	form	form	NN
25944	3456	2814	,	,	,
25944	3456	2815	220	220	CD
25944	3456	2816	large	large	JJ
25944	3456	2817	acuminated	acuminate	VBN
25944	3456	2818	-	-	HYPH
25944	3456	2819	pustular	pustular	NN
25944	3456	2820	,	,	,
25944	3456	2821	220	220	CD
25944	3456	2822	flat	flat	JJ
25944	3456	2823	-	-	HYPH
25944	3456	2824	pustular	pustular	JJ
25944	3456	2825	,	,	,
25944	3456	2826	221	221	CD
25944	3456	2827	papular	papular	JJ
25944	3456	2828	,	,	,
25944	3456	2829	216	216	CD
25944	3456	2830	lenticular	lenticular	NN
25944	3456	2831	,	,	,
25944	3456	2832	216	216	CD
25944	3456	2833	macular	macular	JJ
25944	3456	2834	,	,	,
25944	3456	2835	214	214	CD
25944	3456	2836	,	,	,
25944	3456	2837	227	227	CD
25944	3456	2838	miliary	miliary	JJ
25944	3456	2839	papular	papular	NN
25944	3456	2840	,	,	,
25944	3456	2841	215	215	CD
25944	3456	2842	pustular	pustular	NN
25944	3456	2843	,	,	,
25944	3456	2844	219	219	CD
25944	3456	2845	non	non	JJ
25944	3456	2846	-	-	JJ
25944	3456	2847	ulcerating	ulcerating	JJ
25944	3456	2848	tubercular	tubercular	NN
25944	3456	2849	,	,	,
25944	3456	2850	224	224	CD
25944	3456	2851	palmar	palmar	NN
25944	3456	2852	,	,	,
25944	3456	2853	217	217	CD
25944	3456	2854	,	,	,
25944	3456	2855	218	218	CD
25944	3456	2856	papular	papular	NN
25944	3456	2857	,	,	,
25944	3456	2858	215	215	CD
25944	3456	2859	,	,	,
25944	3456	2860	227	227	CD
25944	3456	2861	papulo	papulo	JJ
25944	3456	2862	-	-	HYPH
25944	3456	2863	squamous	squamous	JJ
25944	3456	2864	,	,	,
25944	3456	2865	218	218	CD
25944	3456	2866	plantar	plantar	NN
25944	3456	2867	,	,	,
25944	3456	2868	218	218	CD
25944	3456	2869	pustular	pustular	NN
25944	3456	2870	,	,	,
25944	3456	2871	219	219	CD
25944	3456	2872	serpiginous	serpiginous	JJ
25944	3456	2873	tubercular	tubercular	NN
25944	3456	2874	,	,	,
25944	3456	2875	224	224	CD
25944	3456	2876	small	small	JJ
25944	3456	2877	acuminated	acuminate	VBN
25944	3456	2878	-	-	HYPH
25944	3456	2879	pustular	pustular	NN
25944	3456	2880	,	,	,
25944	3456	2881	219	219	CD
25944	3456	2882	flat	flat	JJ
25944	3456	2883	-	-	HYPH
25944	3456	2884	pustular	pustular	NN
25944	3456	2885	,	,	,
25944	3456	2886	220	220	CD
25944	3456	2887	papular	papular	JJ
25944	3456	2888	,	,	,
25944	3456	2889	215	215	CD
25944	3456	2890	squamous	squamous	JJ
25944	3456	2891	,	,	,
25944	3456	2892	218	218	CD
25944	3456	2893	tubercular	tubercular	NN
25944	3456	2894	,	,	,
25944	3456	2895	223	223	CD
25944	3456	2896	,	,	,
25944	3456	2897	224	224	CD
25944	3456	2898	ulcerating	ulcerating	NN
25944	3456	2899	tubercular	tubercular	NN
25944	3456	2900	,	,	,
25944	3456	2901	224	224	CD
25944	3456	2902	variola	variola	NN
25944	3456	2903	-	-	HYPH
25944	3456	2904	form	form	NN
25944	3456	2905	,	,	,
25944	3456	2906	220	220	CD
25944	3456	2907	vegetating	vegetate	VBG
25944	3456	2908	,	,	,
25944	3456	2909	218	218	CD
25944	3456	2910	Syphiloderma	Syphiloderma	NNP
25944	3456	2911	,	,	,
25944	3456	2912	213	213	CD
25944	3456	2913	Syphiloma	Syphiloma	NNP
25944	3456	2914	,	,	,
25944	3456	2915	225	225	CD
25944	3456	2916	Tar	tar	NN
25944	3456	2917	acne	acne	NNS
25944	3456	2918	,	,	,
25944	3456	2919	120	120	CD
25944	3456	2920	Tattoo	Tattoo	NNP
25944	3456	2921	-	-	HYPH
25944	3456	2922	marks	mark	NNS
25944	3456	2923	,	,	,
25944	3456	2924	removal	removal	NN
25944	3456	2925	of	of	IN
25944	3456	2926	,	,	,
25944	3456	2927	151	151	CD
25944	3456	2928	Telangiectasis	Telangiectasis	NNP
25944	3456	2929	,	,	,
25944	3456	2930	127	127	CD
25944	3456	2931	,	,	,
25944	3456	2932	197	197	CD
25944	3456	2933	,	,	,
25944	3456	2934	198	198	CD
25944	3456	2935	Tetter	Tetter	NNP
25944	3456	2936	,	,	,
25944	3456	2937	100	100	CD
25944	3456	2938	Tinea	Tinea	NNP
25944	3456	2939	circinata	circinata	NN
25944	3456	2940	,	,	,
25944	3456	2941	251	251	CD
25944	3456	2942	favosa	favosa	NNS
25944	3456	2943	,	,	,
25944	3456	2944	247	247	CD
25944	3456	2945	-	-	HYPH
25944	3456	2946	251	251	CD
25944	3456	2947	fungus	fungus	NN
25944	3456	2948	of	of	IN
25944	3456	2949	,	,	,
25944	3456	2950	249	249	CD
25944	3456	2951	unguium	unguium	NN
25944	3456	2952	,	,	,
25944	3456	2953	249	249	CD
25944	3456	2954	imbricata	imbricata	NN
25944	3456	2955	,	,	,
25944	3456	2956	261	261	CD
25944	3456	2957	kerion	kerion	NN
25944	3456	2958	,	,	,
25944	3456	2959	255	255	CD
25944	3456	2960	sycosis	sycosis	NN
25944	3456	2961	,	,	,
25944	3456	2962	255	255	CD
25944	3456	2963	tonsurans	tonsuran	NNS
25944	3456	2964	,	,	,
25944	3456	2965	253	253	CD
25944	3456	2966	trichophytina	trichophytina	NN
25944	3456	2967	,	,	,
25944	3456	2968	251	251	CD
25944	3456	2969	-	-	SYM
25944	3456	2970	261	261	CD
25944	3456	2971	barbæ	barbæ	NN
25944	3456	2972	,	,	,
25944	3456	2973	255	255	CD
25944	3456	2974	capitis	capitis	NN
25944	3456	2975	,	,	,
25944	3456	2976	253	253	CD
25944	3456	2977	corporis	corpori	NNS
25944	3456	2978	,	,	,
25944	3456	2979	251	251	CD
25944	3456	2980	cruris	cruris	NN
25944	3456	2981	,	,	,
25944	3456	2982	252	252	CD
25944	3456	2983	fungus	fungus	NN
25944	3456	2984	of	of	IN
25944	3456	2985	,	,	,
25944	3456	2986	258	258	CD
25944	3456	2987	unguium	unguium	NN
25944	3456	2988	,	,	,
25944	3456	2989	253	253	CD
25944	3456	2990	versicolor	versicolor	NN
25944	3456	2991	,	,	,
25944	3456	2992	262	262	CD
25944	3456	2993	-	-	SYM
25944	3456	2994	265	265	CD
25944	3456	2995	fungus	fungus	NN
25944	3456	2996	of	of	IN
25944	3456	2997	,	,	,
25944	3456	2998	262	262	CD
25944	3456	2999	Tokelau	Tokelau	NNP
25944	3456	3000	ringworm	ringworm	NN
25944	3456	3001	,	,	,
25944	3456	3002	261	261	CD
25944	3456	3003	Traumaticin	Traumaticin	NNPS
25944	3456	3004	,	,	,
25944	3456	3005	94	94	CD
25944	3456	3006	Trichophyton	Trichophyton	NNP
25944	3456	3007	,	,	,
25944	3456	3008	258	258	CD
25944	3456	3009	Trichorrhexis	Trichorrhexis	NNP
25944	3456	3010	nodosa	nodosa	NN
25944	3456	3011	,	,	,
25944	3456	3012	187	187	CD
25944	3456	3013	Tubercles	Tubercles	NNPS
25944	3456	3014	,	,	,
25944	3456	3015	23	23	CD
25944	3456	3016	Tubercula	Tubercula	NNP
25944	3456	3017	,	,	,
25944	3456	3018	23	23	CD
25944	3456	3019	Tuberculosis	tuberculosis	NN
25944	3456	3020	cutis	cutis	JJ
25944	3456	3021	,	,	,
25944	3456	3022	209	209	CD
25944	3456	3023	-	-	SYM
25944	3456	3024	211	211	CD
25944	3456	3025	of	of	IN
25944	3456	3026	the	the	DT
25944	3456	3027	skin	skin	NN
25944	3456	3028	,	,	,
25944	3456	3029	203	203	CD
25944	3456	3030	Tuberculosis	Tuberculosis	NNP
25944	3456	3031	verrucosa	verrucosa	NN
25944	3456	3032	cutis	cutis	NN
25944	3456	3033	,	,	,
25944	3456	3034	209	209	CD
25944	3456	3035	,	,	,
25944	3456	3036	210	210	CD
25944	3456	3037	Tumor	Tumor	NNP
25944	3456	3038	,	,	,
25944	3456	3039	sebaceous	sebaceous	JJ
25944	3456	3040	,	,	,
25944	3456	3041	43	43	CD
25944	3456	3042	Tumors	tumor	NNS
25944	3456	3043	,	,	,
25944	3456	3044	23	23	CD
25944	3456	3045	Turpentine	turpentine	NN
25944	3456	3046	,	,	,
25944	3456	3047	eruptions	eruption	NNS
25944	3456	3048	from	from	IN
25944	3456	3049	,	,	,
25944	3456	3050	63	63	CD
25944	3456	3051	Tyloma	Tyloma	NNP
25944	3456	3052	,	,	,
25944	3456	3053	155	155	CD
25944	3456	3054	Tylosis	Tylosis	NNP
25944	3456	3055	,	,	,
25944	3456	3056	155	155	CD
25944	3456	3057	Ulcer	Ulcer	NNP
25944	3456	3058	,	,	,
25944	3456	3059	perforating	perforate	VBG
25944	3456	3060	,	,	,
25944	3456	3061	of	of	IN
25944	3456	3062	foot	foot	NN
25944	3456	3063	,	,	,
25944	3456	3064	213	213	CD
25944	3456	3065	rodent	rodent	NN
25944	3456	3066	,	,	,
25944	3456	3067	236	236	CD
25944	3456	3068	Ulcera	Ulcera	NNP
25944	3456	3069	,	,	,
25944	3456	3070	24	24	CD
25944	3456	3071	Ulerythema	Ulerythema	NNP
25944	3456	3072	sycosiforme	sycosiforme	NN
25944	3456	3073	,	,	,
25944	3456	3074	131	131	CD
25944	3456	3075	Uridrosis	Uridrosis	NNP
25944	3456	3076	,	,	,
25944	3456	3077	33	33	CD
25944	3456	3078	Urticaria	Urticaria	NNP
25944	3456	3079	,	,	,
25944	3456	3080	52	52	CD
25944	3456	3081	-	-	SYM
25944	3456	3082	56	56	CD
25944	3456	3083	bullosa	bullosa	NNS
25944	3456	3084	,	,	,
25944	3456	3085	54	54	CD
25944	3456	3086	chronic	chronic	NN
25944	3456	3087	,	,	,
25944	3456	3088	53	53	CD
25944	3456	3089	factitia	factitia	NNS
25944	3456	3090	,	,	,
25944	3456	3091	52	52	CD
25944	3456	3092	hæmorrhagica	hæmorrhagica	NNS
25944	3456	3093	,	,	,
25944	3456	3094	54	54	CD
25944	3456	3095	[	[	-LRB-
25944	3456	3096	oe]dematosa	oe]dematosa	NNP
25944	3456	3097	,	,	,
25944	3456	3098	54	54	CD
25944	3456	3099	papulosa	papulosa	NNS
25944	3456	3100	,	,	,
25944	3456	3101	54	54	CD
25944	3456	3102	tuberosa	tuberosa	NNS
25944	3456	3103	,	,	,
25944	3456	3104	54	54	CD
25944	3456	3105	giant	giant	NN
25944	3456	3106	,	,	,
25944	3456	3107	54	54	CD
25944	3456	3108	pigmentosa	pigmentosa	NNS
25944	3456	3109	,	,	,
25944	3456	3110	59	59	CD
25944	3456	3111	vesicular	vesicular	JJ
25944	3456	3112	,	,	,
25944	3456	3113	54	54	CD
25944	3456	3114	Venereal	Venereal	NNP
25944	3456	3115	wart	wart	JJ
25944	3456	3116	,	,	,
25944	3456	3117	161	161	CD
25944	3456	3118	Verruca	Verruca	NNP
25944	3456	3119	,	,	,
25944	3456	3120	160	160	CD
25944	3456	3121	-	-	SYM
25944	3456	3122	162	162	CD
25944	3456	3123	acuminata	acuminata	NN
25944	3456	3124	,	,	,
25944	3456	3125	161	161	CD
25944	3456	3126	digitata	digitata	NN
25944	3456	3127	,	,	,
25944	3456	3128	160	160	CD
25944	3456	3129	filiformis	filiformis	NN
25944	3456	3130	,	,	,
25944	3456	3131	160	160	CD
25944	3456	3132	necrogenica	necrogenica	NN
25944	3456	3133	,	,	,
25944	3456	3134	211	211	CD
25944	3456	3135	plana	plana	NNS
25944	3456	3136	,	,	,
25944	3456	3137	160	160	CD
25944	3456	3138	juvenilis	juvenilis	NNPS
25944	3456	3139	,	,	,
25944	3456	3140	160	160	CD
25944	3456	3141	senilis	senili	NNS
25944	3456	3142	,	,	,
25944	3456	3143	160	160	CD
25944	3456	3144	vulgaris	vulgaris	NN
25944	3456	3145	,	,	,
25944	3456	3146	160	160	CD
25944	3456	3147	Verruga	Verruga	NNP
25944	3456	3148	peruana	peruana	NNS
25944	3456	3149	,	,	,
25944	3456	3150	73	73	CD
25944	3456	3151	Vesicles	vesicle	NNS
25944	3456	3152	,	,	,
25944	3456	3153	23	23	CD
25944	3456	3154	Vesiculæ	Vesiculæ	NNP
25944	3456	3155	,	,	,
25944	3456	3156	23	23	CD
25944	3456	3157	Vitiligo	Vitiligo	NNS
25944	3456	3158	,	,	,
25944	3456	3159	178	178	CD
25944	3456	3160	-	-	SYM
25944	3456	3161	180	180	CD
25944	3456	3162	Vitiligoidea	Vitiligoidea	NNP
25944	3456	3163	,	,	,
25944	3456	3164	195	195	CD
25944	3456	3165	Vleminckx	Vleminckx	NNP
25944	3456	3166	's	's	POS
25944	3456	3167	solution	solution	NN
25944	3456	3168	,	,	,
25944	3456	3169	129	129	CD
25944	3456	3170	Wart	wart	NN
25944	3456	3171	,	,	,
25944	3456	3172	160	160	CD
25944	3456	3173	Peruvian	Peruvian	NNP
25944	3456	3174	,	,	,
25944	3456	3175	73	73	CD
25944	3456	3176	pointed	point	VBD
25944	3456	3177	,	,	,
25944	3456	3178	161	161	CD
25944	3456	3179	venereal	venereal	JJ
25944	3456	3180	,	,	,
25944	3456	3181	161	161	CD
25944	3456	3182	Wen	Wen	NNP
25944	3456	3183	,	,	,
25944	3456	3184	43	43	CD
25944	3456	3185	Wheals	wheal	NNS
25944	3456	3186	,	,	,
25944	3456	3187	23	23	CD
25944	3456	3188	Wood	wood	NN
25944	3456	3189	-	-	HYPH
25944	3456	3190	tick	tick	NN
25944	3456	3191	,	,	,
25944	3456	3192	277	277	CD
25944	3456	3193	Wound	Wound	NNP
25944	3456	3194	dissection	dissection	NN
25944	3456	3195	,	,	,
25944	3456	3196	73	73	CD
25944	3456	3197	Xanthelasma	Xanthelasma	NNP
25944	3456	3198	,	,	,
25944	3456	3199	195	195	CD
25944	3456	3200	Xanthelasmoidea	Xanthelasmoidea	NNP
25944	3456	3201	,	,	,
25944	3456	3202	56	56	CD
25944	3456	3203	Xanthoma	Xanthoma	NNP
25944	3456	3204	,	,	,
25944	3456	3205	195	195	CD
25944	3456	3206	,	,	,
25944	3456	3207	196	196	CD
25944	3456	3208	diabeticorum	diabeticorum	NN
25944	3456	3209	,	,	,
25944	3456	3210	195	195	CD
25944	3456	3211	multiplex	multiplex	NN
25944	3456	3212	,	,	,
25944	3456	3213	195	195	CD
25944	3456	3214	planum	planum	NN
25944	3456	3215	,	,	,
25944	3456	3216	195	195	CD
25944	3456	3217	tuberculatum	tuberculatum	NN
25944	3456	3218	,	,	,
25944	3456	3219	195	195	CD
25944	3456	3220	tuberosum	tuberosum	NN
25944	3456	3221	,	,	,
25944	3456	3222	195	195	CD
25944	3456	3223	Xeroderma	Xeroderma	NNP
25944	3456	3224	,	,	,
25944	3456	3225	165	165	CD
25944	3456	3226	Xeroderma	Xeroderma	NNP
25944	3456	3227	pigmentosum	pigmentosum	NN
25944	3456	3228	,	,	,
25944	3456	3229	190	190	CD
25944	3456	3230	_	_	NNP
25944	3456	3231	X_-ray	x_-ray	NN
25944	3456	3232	dermatitis	dermatitis	NN
25944	3456	3233	,	,	,
25944	3456	3234	63	63	CD
25944	3456	3235	Yaws	yaw	NNS
25944	3456	3236	,	,	,
25944	3456	3237	73	73	CD
25944	3456	3238	Zona	Zona	NNP
25944	3456	3239	,	,	,
25944	3456	3240	81	81	CD
25944	3456	3241	Zoster	zoster	NN
25944	3456	3242	,	,	,
25944	3456	3243	81	81	CD
25944	3456	3244	SAUNDERS	saunder	NNS
25944	3456	3245	'	'	POS
25944	3456	3246	BOOKS	books	NN
25944	3456	3247	---------	---------	NFP
25944	3456	3248	on	on	IN
25944	3456	3249	---------	---------	NFP
25944	3456	3250	GYNECOLOGY	GYNECOLOGY	NNP
25944	3456	3251	and	and	CC
25944	3456	3252	OBSTETRICS	obstetrics	NN
25944	3456	3253	*	*	NFP
25944	3456	3254	*	*	NFP
25944	3456	3255	*	*	NFP
25944	3456	3256	*	*	NFP
25944	3456	3257	*	*	NFP
25944	3456	3258	W.	W.	NNP
25944	3456	3259	B.	B.	NNP
25944	3456	3260	SAUNDERS	SAUNDERS	NNP
25944	3456	3261	COMPANY	COMPANY	NNP
25944	3456	3262	925	925	CD
25944	3456	3263	Walnut	Walnut	NNP
25944	3456	3264	Street	Street	NNP
25944	3456	3265	Philadelphia	Philadelphia	NNP
25944	3456	3266	9	9	CD
25944	3456	3267	,	,	,
25944	3456	3268	Henrietta	Henrietta	NNP
25944	3456	3269	Street	Street	NNP
25944	3456	3270	Covent	Covent	NNP
25944	3456	3271	Garden	Garden	NNP
25944	3456	3272	,	,	,
25944	3456	3273	London	London	NNP
25944	3456	3274	=	=	SYM
25944	3456	3275	=	=	SYM
25944	3456	3276	=	=	SYM
25944	3456	3277	=	=	SYM
25944	3456	3278	=	=	SYM
25944	3456	3279	=	=	SYM
25944	3456	3280	=	=	SYM
25944	3456	3281	=	=	SYM
25944	3456	3282	=	=	SYM
25944	3456	3283	=	=	SYM
25944	3456	3284	=	=	SYM
25944	3456	3285	=	=	SYM
25944	3456	3286	=	=	SYM
25944	3456	3287	=	=	SYM
25944	3456	3288	=	=	SYM
25944	3456	3289	=	=	SYM
25944	3456	3290	=	=	SYM
25944	3456	3291	=	=	SYM
25944	3456	3292	=	=	SYM
25944	3456	3293	=	=	SYM
25944	3456	3294	=	=	SYM
25944	3456	3295	=	=	SYM
25944	3456	3296	=	=	SYM
25944	3456	3297	=	=	SYM
25944	3456	3298	=	=	SYM
25944	3456	3299	=	=	SYM
25944	3456	3300	=	=	SYM
25944	3456	3301	=	=	SYM
25944	3456	3302	=	=	SYM
25944	3456	3303	=	=	SYM
25944	3456	3304	=	=	SYM
25944	3456	3305	=	=	SYM
25944	3456	3306	=	=	SYM
25944	3456	3307	=	=	SYM
25944	3456	3308	=	=	SYM
25944	3456	3309	=	=	SYM
25944	3456	3310	=	=	SYM
25944	3456	3311	=	=	SYM
25944	3456	3312	=	=	SYM
25944	3456	3313	=	=	SYM
25944	3456	3314	=	=	SYM
25944	3456	3315	=	=	SYM
25944	3456	3316	=	=	SYM
25944	3456	3317	=	=	SYM
25944	3456	3318	=	=	SYM
25944	3456	3319	=	=	SYM
25944	3456	3320	=	=	SYM
25944	3456	3321	=	=	SYM
25944	3456	3322	=	=	SYM
25944	3456	3323	=	=	SYM
25944	3456	3324	=	=	SYM
25944	3456	3325	=	=	SYM
25944	3456	3326	=	=	SYM
25944	3456	3327	=	=	SYM
25944	3456	3328	=	=	SYM
25944	3456	3329	=	=	SYM
25944	3456	3330	=	=	SYM
25944	3456	3331	=	=	SYM
25944	3456	3332	=	=	SYM
25944	3456	3333	=	=	SYM
25944	3456	3334	=	=	SYM
25944	3456	3335	=	=	SYM
25944	3456	3336	=	=	SYM
25944	3456	3337	=	=	SYM
25944	3456	3338	=	=	SYM
25944	3456	3339	=	=	SYM
25944	3456	3340	=	=	SYM
25944	3456	3341	=	=	SYM
25944	3456	3342	=	=	SYM
25944	3456	3343	=	=	SYM
25944	3456	3344	=	=	SYM
25944	3456	3345	=	=	NFP
25944	3456	3346	=	=	SYM
25944	3456	3347	SAUNDERS	SAUNDERS	NNP
25944	3456	3348	'	'	POS
25944	3456	3349	TEXT	text	NN
25944	3456	3350	-	-	HYPH
25944	3456	3351	BOOKS	books	NN
25944	3456	3352	CONTINUE	CONTINUE	NNP
25944	3456	3353	TO	to	TO
25944	3456	3354	GAIN	gain	VB
25944	3456	3355	The	the	DT
25944	3456	3356	list	list	NN
25944	3456	3357	of	of	IN
25944	3456	3358	text	text	NN
25944	3456	3359	-	-	HYPH
25944	3456	3360	books	book	NNS
25944	3456	3361	recommended	recommend	VBN
25944	3456	3362	in	in	IN
25944	3456	3363	the	the	DT
25944	3456	3364	various	various	JJ
25944	3456	3365	colleges	college	NNS
25944	3456	3366	again	again	RB
25944	3456	3367	shows	show	VBZ
25944	3456	3368	a	a	DT
25944	3456	3369	#	#	$
25944	3456	3370	decided	decide	VBN
25944	3456	3371	gain	gain	NN
25944	3456	3372	for	for	IN
25944	3456	3373	the	the	DT
25944	3456	3374	Saunders	Saunders	NNPS
25944	3456	3375	publications	publication	NNS
25944	3456	3376	#	#	$
25944	3456	3377	.	.	.
25944	3457	1	During	during	IN
25944	3457	2	the	the	DT
25944	3457	3	present	present	JJ
25944	3457	4	college	college	NN
25944	3457	5	year	year	NN
25944	3457	6	,	,	,
25944	3457	7	in	in	IN
25944	3457	8	the	the	DT
25944	3457	9	list	list	NN
25944	3457	10	of	of	IN
25944	3457	11	recommended	recommend	VBN
25944	3457	12	books	book	NNS
25944	3457	13	published	publish	VBN
25944	3457	14	by	by	IN
25944	3457	15	164	164	CD
25944	3457	16	colleges	college	NNS
25944	3457	17	(	(	-LRB-
25944	3457	18	the	the	DT
25944	3457	19	other	other	JJ
25944	3457	20	23	23	CD
25944	3457	21	have	have	VBP
25944	3457	22	not	not	RB
25944	3457	23	published	publish	VBN
25944	3457	24	lists	list	NNS
25944	3457	25	)	)	-RRB-
25944	3457	26	,	,	,
25944	3457	27	the	the	DT
25944	3457	28	Saunders	Saunders	NNPS
25944	3457	29	books	book	NNS
25944	3457	30	are	be	VBP
25944	3457	31	mentioned	mention	VBN
25944	3457	32	3278	3278	CD
25944	3457	33	times	time	NNS
25944	3457	34	,	,	,
25944	3457	35	as	as	IN
25944	3457	36	against	against	IN
25944	3457	37	3054	3054	CD
25944	3457	38	the	the	DT
25944	3457	39	previous	previous	JJ
25944	3457	40	year--#an	year--#an	NNP
25944	3457	41	increase	increase	NN
25944	3457	42	of	of	IN
25944	3457	43	224	224	CD
25944	3457	44	#	#	$
25944	3457	45	.	.	.
25944	3458	1	In	in	IN
25944	3458	2	other	other	JJ
25944	3458	3	words	word	NNS
25944	3458	4	,	,	,
25944	3458	5	in	in	IN
25944	3458	6	each	each	DT
25944	3458	7	of	of	IN
25944	3458	8	the	the	DT
25944	3458	9	medical	medical	JJ
25944	3458	10	colleges	college	NNS
25944	3458	11	in	in	IN
25944	3458	12	this	this	DT
25944	3458	13	country	country	NN
25944	3458	14	an	an	DT
25944	3458	15	average	average	NN
25944	3458	16	of	of	IN
25944	3458	17	20	20	CD
25944	3458	18	(	(	-LRB-
25944	3458	19	18	18	CD
25944	3458	20	-	-	SYM
25944	3458	21	2/5	2/5	CD
25944	3458	22	the	the	DT
25944	3458	23	previous	previous	JJ
25944	3458	24	year	year	NN
25944	3458	25	)	)	-RRB-
25944	3458	26	of	of	IN
25944	3458	27	the	the	DT
25944	3458	28	teaching	teaching	NN
25944	3458	29	books	book	NNS
25944	3458	30	employed	employ	VBN
25944	3458	31	are	be	VBP
25944	3458	32	publications	publication	NNS
25944	3458	33	issued	issue	VBN
25944	3458	34	by	by	IN
25944	3458	35	W.	W.	NNP
25944	3458	36	B.	B.	NNP
25944	3458	37	Saunders	Saunders	NNP
25944	3458	38	Company	Company	NNP
25944	3458	39	.	.	.
25944	3459	1	That	that	IN
25944	3459	2	this	this	DT
25944	3459	3	increase	increase	NN
25944	3459	4	is	be	VBZ
25944	3459	5	not	not	RB
25944	3459	6	due	due	JJ
25944	3459	7	alone	alone	RB
25944	3459	8	to	to	IN
25944	3459	9	the	the	DT
25944	3459	10	publication	publication	NN
25944	3459	11	of	of	IN
25944	3459	12	new	new	JJ
25944	3459	13	text	text	NN
25944	3459	14	-	-	HYPH
25944	3459	15	books	book	NNS
25944	3459	16	,	,	,
25944	3459	17	but	but	CC
25944	3459	18	rather	rather	RB
25944	3459	19	to	to	IN
25944	3459	20	a	a	DT
25944	3459	21	most	most	RBS
25944	3459	22	gratifying	gratifying	JJ
25944	3459	23	increase	increase	NN
25944	3459	24	in	in	IN
25944	3459	25	the	the	DT
25944	3459	26	recommendation	recommendation	NN
25944	3459	27	of	of	IN
25944	3459	28	text	text	NN
25944	3459	29	-	-	HYPH
25944	3459	30	books	book	NNS
25944	3459	31	recognized	recognize	VBN
25944	3459	32	as	as	IN
25944	3459	33	standards	standard	NNS
25944	3459	34	,	,	,
25944	3459	35	is	be	VBZ
25944	3459	36	at	at	IN
25944	3459	37	once	once	RB
25944	3459	38	evident	evident	JJ
25944	3459	39	from	from	IN
25944	3459	40	the	the	DT
25944	3459	41	following	follow	VBG
25944	3459	42	:	:	:
25944	3459	43	Ashton	Ashton	NNP
25944	3459	44	's	's	POS
25944	3459	45	Gynecology	gynecology	NN
25944	3459	46	shows	show	VBZ
25944	3459	47	an	an	DT
25944	3459	48	increase	increase	NN
25944	3459	49	of	of	IN
25944	3459	50	19	19	CD
25944	3459	51	;	;	:
25944	3459	52	DaCosta	DaCosta	NNP
25944	3459	53	's	's	POS
25944	3459	54	Surgery	Surgery	NNP
25944	3459	55	,	,	,
25944	3459	56	an	an	DT
25944	3459	57	increase	increase	NN
25944	3459	58	of	of	IN
25944	3459	59	12	12	CD
25944	3459	60	;	;	:
25944	3459	61	Hirst	Hirst	NNP
25944	3459	62	's	's	POS
25944	3459	63	Obstetrics	Obstetrics	NNP
25944	3459	64	,	,	,
25944	3459	65	14	14	CD
25944	3459	66	;	;	:
25944	3459	67	Howell	Howell	NNP
25944	3459	68	's	's	POS
25944	3459	69	Physiology	Physiology	NNP
25944	3459	70	,	,	,
25944	3459	71	25	25	CD
25944	3459	72	;	;	:
25944	3459	73	Jackson	Jackson	NNP
25944	3459	74	on	on	IN
25944	3459	75	the	the	DT
25944	3459	76	Eye	Eye	NNP
25944	3459	77	,	,	,
25944	3459	78	16	16	CD
25944	3459	79	;	;	:
25944	3459	80	Sahli	Sahli	NNP
25944	3459	81	's	's	POS
25944	3459	82	Diagnostic	Diagnostic	NNP
25944	3459	83	Methods	Methods	NNPS
25944	3459	84	,	,	,
25944	3459	85	11	11	CD
25944	3459	86	;	;	:
25944	3459	87	Scudder	Scudder	NNP
25944	3459	88	's	's	POS
25944	3459	89	Fractures	Fractures	NNPS
25944	3459	90	,	,	,
25944	3459	91	11	11	CD
25944	3459	92	;	;	:
25944	3459	93	Stengel	Stengel	NNP
25944	3459	94	's	's	POS
25944	3459	95	Pathology	Pathology	NNP
25944	3459	96	,	,	,
25944	3459	97	13	13	CD
25944	3459	98	;	;	:
25944	3459	99	Stelwagon	Stelwagon	NNP
25944	3459	100	on	on	IN
25944	3459	101	the	the	DT
25944	3459	102	Skin	skin	NN
25944	3459	103	,	,	,
25944	3459	104	11	11	CD
25944	3459	105	.	.	.
25944	3460	1	These	these	DT
25944	3460	2	are	be	VBP
25944	3460	3	but	but	IN
25944	3460	4	examples	example	NNS
25944	3460	5	of	of	IN
25944	3460	6	similar	similar	JJ
25944	3460	7	remarkable	remarkable	JJ
25944	3460	8	gains	gain	NNS
25944	3460	9	throughout	throughout	IN
25944	3460	10	the	the	DT
25944	3460	11	entire	entire	JJ
25944	3460	12	list	list	NN
25944	3460	13	,	,	,
25944	3460	14	and	and	CC
25944	3460	15	is	be	VBZ
25944	3460	16	undoubted	undoubted	JJ
25944	3460	17	evidence	evidence	NN
25944	3460	18	that	that	IN
25944	3460	19	the	the	DT
25944	3460	20	#	#	$
25944	3460	21	Saunders	Saunders	NNPS
25944	3460	22	text	text	NN
25944	3460	23	-	-	HYPH
25944	3460	24	books	book	NNS
25944	3460	25	are	be	VBP
25944	3460	26	recognized	recognize	VBN
25944	3460	27	as	as	IN
25944	3460	28	the	the	DT
25944	3460	29	best	good	JJS
25944	3460	30	#	#	$
25944	3460	31	.	.	.
25944	3461	1	#	#	$
25944	3461	2	A	a	DT
25944	3461	3	Complete	complete	JJ
25944	3461	4	Catalogue	Catalogue	NNP
25944	3461	5	of	of	IN
25944	3461	6	our	-PRON-	PRP$
25944	3461	7	Publications	publication	NNS
25944	3461	8	will	will	MD
25944	3461	9	be	be	VB
25944	3461	10	Sent	send	VBN
25944	3461	11	upon	upon	IN
25944	3461	12	Request	Request	NNP
25944	3461	13	#	#	NNP
25944	3461	14	Bandler	Bandler	NNP
25944	3461	15	's	's	POS
25944	3461	16	Medical	Medical	NNP
25944	3461	17	Gynecology	Gynecology	NNP
25944	3461	18	*	*	NFP
25944	3461	19	*	*	NFP
25944	3461	20	*	*	NFP
25944	3461	21	*	*	NFP
25944	3461	22	*	*	NFP
25944	3461	23	#	#	NNP
25944	3461	24	Medical	Medical	NNP
25944	3461	25	Gynecology	Gynecology	NNP
25944	3461	26	#	#	NNP
25944	3461	27	.	.	.
25944	3462	1	By	by	IN
25944	3462	2	S.	S.	NNP
25944	3462	3	Wyllis	Wyllis	NNP
25944	3462	4	Bandler	Bandler	NNP
25944	3462	5	,	,	,
25944	3462	6	M.D.	M.D.	NNP
25944	3462	7	,	,	,
25944	3462	8	Adjunct	Adjunct	NNP
25944	3462	9	.	.	.
25944	3463	1	Professor	Professor	NNP
25944	3463	2	of	of	IN
25944	3463	3	Diseases	Diseases	NNPS
25944	3463	4	of	of	IN
25944	3463	5	Women	Women	NNP
25944	3463	6	,	,	,
25944	3463	7	New	New	NNP
25944	3463	8	York	York	NNP
25944	3463	9	Post	Post	NNP
25944	3463	10	-	-	NNP
25944	3463	11	Graduate	Graduate	NNP
25944	3463	12	Medical	Medical	NNP
25944	3463	13	School	School	NNP
25944	3463	14	and	and	CC
25944	3463	15	Hospital	Hospital	NNP
25944	3463	16	.	.	.
25944	3464	1	Octavo	Octavo	NNP
25944	3464	2	of	of	IN
25944	3464	3	680	680	CD
25944	3464	4	pages	page	NNS
25944	3464	5	,	,	,
25944	3464	6	with	with	IN
25944	3464	7	135	135	CD
25944	3464	8	original	original	JJ
25944	3464	9	illustrations	illustration	NNS
25944	3464	10	.	.	.
25944	3465	1	Cloth	cloth	NN
25944	3465	2	,	,	,
25944	3465	3	$	$	$
25944	3465	4	5.00	5.00	CD
25944	3465	5	net	net	NN
25944	3465	6	;	;	:
25944	3465	7	Half	Half	NNP
25944	3465	8	Morocco	Morocco	NNP
25944	3465	9	,	,	,
25944	3465	10	$	$	$
25944	3465	11	6.50	6.50	CD
25944	3465	12	net	net	NN
25944	3465	13	.	.	.
25944	3466	1	#	#	NN
25944	3466	2	JUST	just	RB
25944	3466	3	READY	ready	JJ
25944	3466	4	--	--	:
25944	3466	5	EXCLUSIVELY	exclusively	NN
25944	3466	6	MEDICAL	MEDICAL	NNP
25944	3466	7	GYNECOLOGY	gynecology	VBP
25944	3466	8	#	#	$
25944	3466	9	This	this	DT
25944	3466	10	new	new	JJ
25944	3466	11	work	work	NN
25944	3466	12	by	by	IN
25944	3466	13	Dr.	Dr.	NNP
25944	3466	14	Bandler	Bandler	NNP
25944	3466	15	is	be	VBZ
25944	3466	16	just	just	RB
25944	3466	17	the	the	DT
25944	3466	18	book	book	NN
25944	3466	19	that	that	WDT
25944	3466	20	the	the	DT
25944	3466	21	physician	physician	NN
25944	3466	22	engaged	engage	VBD
25944	3466	23	in	in	IN
25944	3466	24	general	general	JJ
25944	3466	25	practice	practice	NN
25944	3466	26	has	have	VBZ
25944	3466	27	long	long	RB
25944	3466	28	needed	need	VBN
25944	3466	29	.	.	.
25944	3467	1	It	-PRON-	PRP
25944	3467	2	is	be	VBZ
25944	3467	3	truly	truly	RB
25944	3467	4	_	_	NNP
25944	3467	5	the	the	DT
25944	3467	6	practitioner	practitioner	NN
25944	3467	7	's	's	POS
25944	3467	8	gynecology_--planned	gynecology_--planne	VBN
25944	3467	9	for	for	IN
25944	3467	10	him	-PRON-	PRP
25944	3467	11	,	,	,
25944	3467	12	written	write	VBN
25944	3467	13	for	for	IN
25944	3467	14	him	-PRON-	PRP
25944	3467	15	,	,	,
25944	3467	16	and	and	CC
25944	3467	17	illustrated	illustrate	VBN
25944	3467	18	for	for	IN
25944	3467	19	him	-PRON-	PRP
25944	3467	20	.	.	.
25944	3468	1	There	there	EX
25944	3468	2	are	be	VBP
25944	3468	3	many	many	JJ
25944	3468	4	gynecologic	gynecologic	JJ
25944	3468	5	conditions	condition	NNS
25944	3468	6	that	that	WDT
25944	3468	7	do	do	VBP
25944	3468	8	not	not	RB
25944	3468	9	call	call	VB
25944	3468	10	for	for	IN
25944	3468	11	operative	operative	JJ
25944	3468	12	treatment	treatment	NN
25944	3468	13	;	;	:
25944	3468	14	yet	yet	CC
25944	3468	15	,	,	,
25944	3468	16	because	because	IN
25944	3468	17	of	of	IN
25944	3468	18	lack	lack	NN
25944	3468	19	of	of	IN
25944	3468	20	that	that	DT
25944	3468	21	special	special	JJ
25944	3468	22	knowledge	knowledge	NN
25944	3468	23	required	require	VBN
25944	3468	24	for	for	IN
25944	3468	25	their	-PRON-	PRP$
25944	3468	26	diagnosis	diagnosis	NN
25944	3468	27	and	and	CC
25944	3468	28	treatment	treatment	NN
25944	3468	29	,	,	,
25944	3468	30	the	the	DT
25944	3468	31	general	general	JJ
25944	3468	32	practitioner	practitioner	NN
25944	3468	33	has	have	VBZ
25944	3468	34	been	be	VBN
25944	3468	35	unable	unable	JJ
25944	3468	36	to	to	TO
25944	3468	37	treat	treat	VB
25944	3468	38	them	-PRON-	PRP
25944	3468	39	intelligently	intelligently	RB
25944	3468	40	.	.	.
25944	3469	1	This	this	DT
25944	3469	2	work	work	NN
25944	3469	3	gives	give	VBZ
25944	3469	4	just	just	RB
25944	3469	5	the	the	DT
25944	3469	6	information	information	NN
25944	3469	7	the	the	DT
25944	3469	8	practitioner	practitioner	NN
25944	3469	9	needs	need	VBZ
25944	3469	10	.	.	.
25944	3470	1	It	-PRON-	PRP
25944	3470	2	not	not	RB
25944	3470	3	only	only	RB
25944	3470	4	deals	deal	VBZ
25944	3470	5	with	with	IN
25944	3470	6	those	those	DT
25944	3470	7	conditions	condition	NNS
25944	3470	8	amenable	amenable	JJ
25944	3470	9	to	to	IN
25944	3470	10	non	non	JJ
25944	3470	11	-	-	JJ
25944	3470	12	operative	operative	JJ
25944	3470	13	treatment	treatment	NN
25944	3470	14	,	,	,
25944	3470	15	but	but	CC
25944	3470	16	it	-PRON-	PRP
25944	3470	17	also	also	RB
25944	3470	18	tells	tell	VBZ
25944	3470	19	how	how	WRB
25944	3470	20	to	to	TO
25944	3470	21	recognize	recognize	VB
25944	3470	22	those	those	DT
25944	3470	23	diseases	disease	NNS
25944	3470	24	demanding	demand	VBG
25944	3470	25	operative	operative	JJ
25944	3470	26	treatment	treatment	NN
25944	3470	27	,	,	,
25944	3470	28	so	so	IN
25944	3470	29	that	that	IN
25944	3470	30	the	the	DT
25944	3470	31	practitioner	practitioner	NN
25944	3470	32	will	will	MD
25944	3470	33	be	be	VB
25944	3470	34	enabled	enable	VBN
25944	3470	35	to	to	TO
25944	3470	36	advise	advise	VB
25944	3470	37	his	-PRON-	PRP$
25944	3470	38	patient	patient	NN
25944	3470	39	at	at	IN
25944	3470	40	a	a	DT
25944	3470	41	time	time	NN
25944	3470	42	when	when	WRB
25944	3470	43	operation	operation	NN
25944	3470	44	will	will	MD
25944	3470	45	be	be	VB
25944	3470	46	attended	attend	VBN
25944	3470	47	with	with	IN
25944	3470	48	the	the	DT
25944	3470	49	most	most	RBS
25944	3470	50	favorable	favorable	JJ
25944	3470	51	results	result	NNS
25944	3470	52	.	.	.
25944	3471	1	The	the	DT
25944	3471	2	chapter	chapter	NN
25944	3471	3	on	on	IN
25944	3471	4	Pessaries	pessary	NNS
25944	3471	5	is	be	VBZ
25944	3471	6	especially	especially	RB
25944	3471	7	full	full	JJ
25944	3471	8	and	and	CC
25944	3471	9	excellent	excellent	JJ
25944	3471	10	,	,	,
25944	3471	11	the	the	DT
25944	3471	12	proper	proper	JJ
25944	3471	13	manner	manner	NN
25944	3471	14	of	of	IN
25944	3471	15	introducing	introduce	VBG
25944	3471	16	the	the	DT
25944	3471	17	pessary	pessary	NN
25944	3471	18	being	be	VBG
25944	3471	19	clearly	clearly	RB
25944	3471	20	described	describe	VBN
25944	3471	21	and	and	CC
25944	3471	22	illustrated	illustrate	VBN
25944	3471	23	with	with	IN
25944	3471	24	original	original	JJ
25944	3471	25	pictures	picture	NNS
25944	3471	26	that	that	WDT
25944	3471	27	show	show	VBP
25944	3471	28	plainly	plainly	RB
25944	3471	29	the	the	DT
25944	3471	30	correct	correct	JJ
25944	3471	31	technic	technic	NN
25944	3471	32	of	of	IN
25944	3471	33	this	this	DT
25944	3471	34	procedure	procedure	NN
25944	3471	35	.	.	.
25944	3472	1	The	the	DT
25944	3472	2	chapters	chapter	NNS
25944	3472	3	on	on	IN
25944	3472	4	Vaginal	Vaginal	NNP
25944	3472	5	and	and	CC
25944	3472	6	Abdominal	Abdominal	NNP
25944	3472	7	Massage	Massage	NNP
25944	3472	8	,	,	,
25944	3472	9	and	and	CC
25944	3472	10	particularly	particularly	RB
25944	3472	11	that	that	DT
25944	3472	12	on	on	IN
25944	3472	13	Artificial	Artificial	NNP
25944	3472	14	Hyperemia	Hyperemia	NNP
25944	3472	15	and	and	CC
25944	3472	16	Anemia	Anemia	NNP
25944	3472	17	,	,	,
25944	3472	18	are	be	VBP
25944	3472	19	extremely	extremely	RB
25944	3472	20	valuable	valuable	JJ
25944	3472	21	to	to	IN
25944	3472	22	the	the	DT
25944	3472	23	practitioner	practitioner	NN
25944	3472	24	.	.	.
25944	3473	1	They	-PRON-	PRP
25944	3473	2	express	express	VBP
25944	3473	3	the	the	DT
25944	3473	4	very	very	RB
25944	3473	5	latest	late	JJS
25944	3473	6	advances	advance	NNS
25944	3473	7	in	in	IN
25944	3473	8	these	these	DT
25944	3473	9	methods	method	NNS
25944	3473	10	of	of	IN
25944	3473	11	treatment	treatment	NN
25944	3473	12	.	.	.
25944	3474	1	Hydrotherapy	Hydrotherapy	NNP
25944	3474	2	,	,	,
25944	3474	3	especially	especially	RB
25944	3474	4	the	the	DT
25944	3474	5	Ferguson	Ferguson	NNP
25944	3474	6	and	and	CC
25944	3474	7	Nauheim	Nauheim	NNP
25944	3474	8	baths	bath	NNS
25944	3474	9	,	,	,
25944	3474	10	are	be	VBP
25944	3474	11	treated	treat	VBN
25944	3474	12	_	_	NNP
25944	3474	13	in	in	IN
25944	3474	14	extenso	extenso	NNP
25944	3474	15	_	_	NNP
25944	3474	16	,	,	,
25944	3474	17	and	and	CC
25944	3474	18	Electrotherapy	Electrotherapy	NNP
25944	3474	19	receives	receive	VBZ
25944	3474	20	the	the	DT
25944	3474	21	full	full	JJ
25944	3474	22	consideration	consideration	NN
25944	3474	23	its	-PRON-	PRP$
25944	3474	24	importance	importance	NN
25944	3474	25	merits	merit	NNS
25944	3474	26	.	.	.
25944	3475	1	Pain	pain	NN
25944	3475	2	as	as	IN
25944	3475	3	a	a	DT
25944	3475	4	symptom	symptom	NN
25944	3475	5	and	and	CC
25944	3475	6	its	-PRON-	PRP$
25944	3475	7	alleviation	alleviation	NN
25944	3475	8	is	be	VBZ
25944	3475	9	dealt	deal	VBN
25944	3475	10	with	with	IN
25944	3475	11	in	in	IN
25944	3475	12	an	an	DT
25944	3475	13	unusually	unusually	RB
25944	3475	14	practical	practical	JJ
25944	3475	15	way	way	NN
25944	3475	16	,	,	,
25944	3475	17	its	-PRON-	PRP$
25944	3475	18	value	value	NN
25944	3475	19	as	as	IN
25944	3475	20	an	an	DT
25944	3475	21	aid	aid	NN
25944	3475	22	in	in	IN
25944	3475	23	diagnosis	diagnosis	NN
25944	3475	24	being	be	VBG
25944	3475	25	emphasized	emphasize	VBN
25944	3475	26	.	.	.
25944	3476	1	Gonorrhea	Gonorrhea	NNP
25944	3476	2	and	and	CC
25944	3476	3	Syphilis	Syphilis	NNP
25944	3476	4	and	and	CC
25944	3476	5	their	-PRON-	PRP$
25944	3476	6	many	many	JJ
25944	3476	7	complications	complication	NNS
25944	3476	8	are	be	VBP
25944	3476	9	treated	treat	VBN
25944	3476	10	in	in	IN
25944	3476	11	detail	detail	NN
25944	3476	12	,	,	,
25944	3476	13	every	every	DT
25944	3476	14	care	care	NN
25944	3476	15	being	be	VBG
25944	3476	16	taken	take	VBN
25944	3476	17	to	to	TO
25944	3476	18	have	have	VB
25944	3476	19	these	these	DT
25944	3476	20	sections	section	NNS
25944	3476	21	--	--	:
25944	3476	22	of	of	IN
25944	3476	23	special	special	JJ
25944	3476	24	interest	interest	NN
25944	3476	25	to	to	IN
25944	3476	26	the	the	DT
25944	3476	27	practitioner	practitioner	NN
25944	3476	28	--	--	:
25944	3476	29	complete	complete	JJ
25944	3476	30	in	in	IN
25944	3476	31	every	every	DT
25944	3476	32	particular	particular	NN
25944	3476	33	.	.	.
25944	3477	1	Other	other	JJ
25944	3477	2	chapters	chapter	NNS
25944	3477	3	of	of	IN
25944	3477	4	great	great	JJ
25944	3477	5	importance	importance	NN
25944	3477	6	are	be	VBP
25944	3477	7	those	those	DT
25944	3477	8	on	on	IN
25944	3477	9	Constipation	Constipation	NNP
25944	3477	10	,	,	,
25944	3477	11	Sterility	Sterility	NNP
25944	3477	12	,	,	,
25944	3477	13	Associated	Associated	NNP
25944	3477	14	Nervous	Nervous	NNP
25944	3477	15	Conditions	Conditions	NNPS
25944	3477	16	in	in	IN
25944	3477	17	Gynecology	Gynecology	NNP
25944	3477	18	,	,	,
25944	3477	19	and	and	CC
25944	3477	20	Pregnancy	Pregnancy	NNP
25944	3477	21	and	and	CC
25944	3477	22	Abortion	Abortion	NNP
25944	3477	23	.	.	.
25944	3478	1	Kelly	Kelly	NNP
25944	3478	2	and	and	CC
25944	3478	3	Noble	Noble	NNP
25944	3478	4	's	's	POS
25944	3478	5	Gynecology	Gynecology	NNP
25944	3478	6	and	and	CC
25944	3478	7	Abdominal	Abdominal	NNP
25944	3478	8	Surgery	Surgery	NNP
25944	3478	9	#	#	NNP
25944	3478	10	Gynecology	Gynecology	NNP
25944	3478	11	and	and	CC
25944	3478	12	Abdominal	Abdominal	NNP
25944	3478	13	Surgery	Surgery	NNP
25944	3478	14	#	#	NNP
25944	3478	15	.	.	.
25944	3479	1	Edited	edit	VBN
25944	3479	2	by	by	IN
25944	3479	3	Howard	Howard	NNP
25944	3479	4	A.	a.	NN
25944	3479	5	Kelly	Kelly	NNP
25944	3479	6	,	,	,
25944	3479	7	M.D.	M.D.	NNP
25944	3479	8	,	,	,
25944	3479	9	Professor	Professor	NNP
25944	3479	10	of	of	IN
25944	3479	11	Gynecology	Gynecology	NNP
25944	3479	12	in	in	IN
25944	3479	13	Johns	Johns	NNP
25944	3479	14	Hopkins	Hopkins	NNP
25944	3479	15	University	University	NNP
25944	3479	16	;	;	:
25944	3479	17	and	and	CC
25944	3479	18	Charles	Charles	NNP
25944	3479	19	P.	P.	NNP
25944	3479	20	Noble	Noble	NNP
25944	3479	21	,	,	,
25944	3479	22	M.D.	M.D.	NNP
25944	3479	23	,	,	,
25944	3479	24	Clinical	Clinical	NNP
25944	3479	25	Professor	Professor	NNP
25944	3479	26	of	of	IN
25944	3479	27	Gynecology	Gynecology	NNP
25944	3479	28	in	in	IN
25944	3479	29	the	the	DT
25944	3479	30	Woman	Woman	NNP
25944	3479	31	's	's	POS
25944	3479	32	Medical	Medical	NNP
25944	3479	33	College	College	NNP
25944	3479	34	,	,	,
25944	3479	35	Philadelphia	Philadelphia	NNP
25944	3479	36	.	.	.
25944	3480	1	Two	two	CD
25944	3480	2	imperial	imperial	JJ
25944	3480	3	octavo	octavo	NN
25944	3480	4	volumes	volume	NNS
25944	3480	5	of	of	IN
25944	3480	6	900	900	CD
25944	3480	7	pages	page	NNS
25944	3480	8	each	each	DT
25944	3480	9	,	,	,
25944	3480	10	containing	contain	VBG
25944	3480	11	650	650	CD
25944	3480	12	illustrations	illustration	NNS
25944	3480	13	,	,	,
25944	3480	14	mostly	mostly	RB
25944	3480	15	original	original	JJ
25944	3480	16	.	.	.
25944	3481	1	Per	per	IN
25944	3481	2	volume	volume	NN
25944	3481	3	:	:	:
25944	3481	4	Cloth	cloth	NN
25944	3481	5	,	,	,
25944	3481	6	$	$	$
25944	3481	7	8.00	8.00	CD
25944	3481	8	net	net	NN
25944	3481	9	;	;	:
25944	3481	10	Half	Half	NNP
25944	3481	11	Morocco	Morocco	NNP
25944	3481	12	,	,	,
25944	3481	13	$	$	$
25944	3481	14	9.50	9.50	CD
25944	3481	15	net	net	NN
25944	3481	16	.	.	.
25944	3482	1	BOTH	both	DT
25944	3482	2	VOLUMES	volume	NNS
25944	3482	3	NOW	now	RB
25944	3482	4	READY	ready	JJ
25944	3482	5	WITH	with	IN
25944	3482	6	650	650	CD
25944	3482	7	ORIGINAL	original	JJ
25944	3482	8	ILLUSTRATIONS	illustration	NNS
25944	3482	9	BY	by	NN
25944	3482	10	HERMANN	hermann	NN
25944	3482	11	BECKER	BECKER	NNS
25944	3482	12	AND	and	CC
25944	3482	13	MAX	MAX	NNP
25944	3482	14	BRÖDEL	BRÖDEL	NNP
25944	3482	15	In	in	IN
25944	3482	16	view	view	NN
25944	3482	17	of	of	IN
25944	3482	18	the	the	DT
25944	3482	19	intimate	intimate	NNP
25944	3482	20	association	association	NNP
25944	3482	21	of	of	IN
25944	3482	22	gynecology	gynecology	NN
25944	3482	23	with	with	IN
25944	3482	24	abdominal	abdominal	JJ
25944	3482	25	surgery	surgery	NN
25944	3482	26	the	the	DT
25944	3482	27	editors	editor	NNS
25944	3482	28	have	have	VBP
25944	3482	29	combined	combine	VBN
25944	3482	30	these	these	DT
25944	3482	31	two	two	CD
25944	3482	32	important	important	JJ
25944	3482	33	subjects	subject	NNS
25944	3482	34	in	in	IN
25944	3482	35	one	one	CD
25944	3482	36	work	work	NN
25944	3482	37	.	.	.
25944	3483	1	For	for	IN
25944	3483	2	this	this	DT
25944	3483	3	reason	reason	NN
25944	3483	4	the	the	DT
25944	3483	5	work	work	NN
25944	3483	6	will	will	MD
25944	3483	7	be	be	VB
25944	3483	8	doubly	doubly	RB
25944	3483	9	valuable	valuable	JJ
25944	3483	10	,	,	,
25944	3483	11	for	for	IN
25944	3483	12	not	not	RB
25944	3483	13	only	only	RB
25944	3483	14	the	the	DT
25944	3483	15	gynecologist	gynecologist	JJ
25944	3483	16	and	and	CC
25944	3483	17	general	general	JJ
25944	3483	18	practitioner	practitioner	NN
25944	3483	19	will	will	MD
25944	3483	20	find	find	VB
25944	3483	21	it	-PRON-	PRP
25944	3483	22	an	an	DT
25944	3483	23	exhaustive	exhaustive	JJ
25944	3483	24	treatise	treatise	NN
25944	3483	25	,	,	,
25944	3483	26	but	but	CC
25944	3483	27	the	the	DT
25944	3483	28	surgeon	surgeon	NN
25944	3483	29	also	also	RB
25944	3483	30	will	will	MD
25944	3483	31	find	find	VB
25944	3483	32	here	here	RB
25944	3483	33	the	the	DT
25944	3483	34	latest	late	JJS
25944	3483	35	technic	technic	NN
25944	3483	36	of	of	IN
25944	3483	37	the	the	DT
25944	3483	38	various	various	JJ
25944	3483	39	abdominal	abdominal	JJ
25944	3483	40	operations	operation	NNS
25944	3483	41	.	.	.
25944	3484	1	It	-PRON-	PRP
25944	3484	2	possesses	possess	VBZ
25944	3484	3	a	a	DT
25944	3484	4	number	number	NN
25944	3484	5	of	of	IN
25944	3484	6	valuable	valuable	JJ
25944	3484	7	features	feature	NNS
25944	3484	8	not	not	RB
25944	3484	9	to	to	TO
25944	3484	10	be	be	VB
25944	3484	11	found	find	VBN
25944	3484	12	in	in	IN
25944	3484	13	any	any	DT
25944	3484	14	other	other	JJ
25944	3484	15	publication	publication	NN
25944	3484	16	covering	cover	VBG
25944	3484	17	the	the	DT
25944	3484	18	same	same	JJ
25944	3484	19	fields	field	NNS
25944	3484	20	.	.	.
25944	3485	1	It	-PRON-	PRP
25944	3485	2	contains	contain	VBZ
25944	3485	3	a	a	DT
25944	3485	4	chapter	chapter	NN
25944	3485	5	upon	upon	IN
25944	3485	6	the	the	DT
25944	3485	7	bacteriology	bacteriology	NN
25944	3485	8	and	and	CC
25944	3485	9	one	one	CD
25944	3485	10	upon	upon	IN
25944	3485	11	the	the	DT
25944	3485	12	pathology	pathology	NN
25944	3485	13	of	of	IN
25944	3485	14	gynecology	gynecology	NN
25944	3485	15	,	,	,
25944	3485	16	dealing	deal	VBG
25944	3485	17	fully	fully	RB
25944	3485	18	with	with	IN
25944	3485	19	the	the	DT
25944	3485	20	scientific	scientific	JJ
25944	3485	21	basis	basis	NN
25944	3485	22	of	of	IN
25944	3485	23	gynecology	gynecology	NN
25944	3485	24	.	.	.
25944	3486	1	In	in	IN
25944	3486	2	no	no	DT
25944	3486	3	other	other	JJ
25944	3486	4	work	work	NN
25944	3486	5	can	can	MD
25944	3486	6	this	this	DT
25944	3486	7	information	information	NN
25944	3486	8	,	,	,
25944	3486	9	prepared	prepare	VBN
25944	3486	10	by	by	IN
25944	3486	11	specialists	specialist	NNS
25944	3486	12	,	,	,
25944	3486	13	be	be	VB
25944	3486	14	found	find	VBN
25944	3486	15	as	as	IN
25944	3486	16	separate	separate	JJ
25944	3486	17	chapters	chapter	NNS
25944	3486	18	.	.	.
25944	3487	1	There	there	EX
25944	3487	2	is	be	VBZ
25944	3487	3	a	a	DT
25944	3487	4	large	large	JJ
25944	3487	5	chapter	chapter	NN
25944	3487	6	devoted	devote	VBN
25944	3487	7	entirely	entirely	RB
25944	3487	8	to	to	IN
25944	3487	9	_	_	NNP
25944	3487	10	medical	medical	JJ
25944	3487	11	gynecology	gynecology	NN
25944	3487	12	_	_	NNP
25944	3487	13	,	,	,
25944	3487	14	written	write	VBN
25944	3487	15	especially	especially	RB
25944	3487	16	for	for	IN
25944	3487	17	the	the	DT
25944	3487	18	physician	physician	NN
25944	3487	19	engaged	engage	VBN
25944	3487	20	in	in	IN
25944	3487	21	general	general	JJ
25944	3487	22	practice	practice	NN
25944	3487	23	.	.	.
25944	3488	1	Heretofore	heretofore	RB
25944	3488	2	the	the	DT
25944	3488	3	general	general	JJ
25944	3488	4	practitioner	practitioner	NN
25944	3488	5	was	be	VBD
25944	3488	6	compelled	compel	VBN
25944	3488	7	to	to	TO
25944	3488	8	search	search	VB
25944	3488	9	through	through	IN
25944	3488	10	an	an	DT
25944	3488	11	entire	entire	JJ
25944	3488	12	work	work	NN
25944	3488	13	in	in	IN
25944	3488	14	order	order	NN
25944	3488	15	to	to	TO
25944	3488	16	obtain	obtain	VB
25944	3488	17	the	the	DT
25944	3488	18	information	information	NN
25944	3488	19	desired	desire	VBN
25944	3488	20	.	.	.
25944	3489	1	_	_	NNP
25944	3489	2	Abdominal	Abdominal	NNP
25944	3489	3	surgery	surgery	NN
25944	3489	4	_	_	NNP
25944	3489	5	proper	proper	JJ
25944	3489	6	,	,	,
25944	3489	7	as	as	RB
25944	3489	8	distinct	distinct	JJ
25944	3489	9	from	from	IN
25944	3489	10	gynecology	gynecology	NN
25944	3489	11	,	,	,
25944	3489	12	is	be	VBZ
25944	3489	13	fully	fully	RB
25944	3489	14	treated	treat	VBN
25944	3489	15	,	,	,
25944	3489	16	embracing	embrace	VBG
25944	3489	17	operations	operation	NNS
25944	3489	18	upon	upon	IN
25944	3489	19	the	the	DT
25944	3489	20	stomach	stomach	NN
25944	3489	21	,	,	,
25944	3489	22	upon	upon	IN
25944	3489	23	the	the	DT
25944	3489	24	intestines	intestine	NNS
25944	3489	25	,	,	,
25944	3489	26	upon	upon	IN
25944	3489	27	the	the	DT
25944	3489	28	liver	liver	NN
25944	3489	29	and	and	CC
25944	3489	30	bile	bile	NN
25944	3489	31	-	-	HYPH
25944	3489	32	ducts	duct	NNS
25944	3489	33	,	,	,
25944	3489	34	upon	upon	IN
25944	3489	35	the	the	DT
25944	3489	36	pancreas	pancrea	NNS
25944	3489	37	and	and	CC
25944	3489	38	spleen	spleen	NN
25944	3489	39	,	,	,
25944	3489	40	upon	upon	IN
25944	3489	41	the	the	DT
25944	3489	42	kidney	kidney	NN
25944	3489	43	,	,	,
25944	3489	44	ureter	ureter	NN
25944	3489	45	,	,	,
25944	3489	46	bladder	bladder	NN
25944	3489	47	,	,	,
25944	3489	48	and	and	CC
25944	3489	49	the	the	DT
25944	3489	50	peritoneum	peritoneum	NN
25944	3489	51	.	.	.
25944	3490	1	Special	special	JJ
25944	3490	2	attention	attention	NN
25944	3490	3	has	have	VBZ
25944	3490	4	been	be	VBN
25944	3490	5	given	give	VBN
25944	3490	6	to	to	IN
25944	3490	7	_	_	NNP
25944	3490	8	modern	modern	JJ
25944	3490	9	technic	technic	NN
25944	3490	10	_	_	NN
25944	3490	11	and	and	CC
25944	3490	12	illustrations	illustration	NNS
25944	3490	13	of	of	IN
25944	3490	14	the	the	DT
25944	3490	15	very	very	RB
25944	3490	16	highest	high	JJS
25944	3490	17	order	order	NN
25944	3490	18	have	have	VBP
25944	3490	19	been	be	VBN
25944	3490	20	used	use	VBN
25944	3490	21	to	to	TO
25944	3490	22	make	make	VB
25944	3490	23	clear	clear	JJ
25944	3490	24	the	the	DT
25944	3490	25	various	various	JJ
25944	3490	26	steps	step	NNS
25944	3490	27	of	of	IN
25944	3490	28	the	the	DT
25944	3490	29	operations	operation	NNS
25944	3490	30	.	.	.
25944	3491	1	Indeed	indeed	RB
25944	3491	2	,	,	,
25944	3491	3	the	the	DT
25944	3491	4	illustrations	illustration	NNS
25944	3491	5	are	be	VBP
25944	3491	6	truly	truly	RB
25944	3491	7	magnificent	magnificent	JJ
25944	3491	8	,	,	,
25944	3491	9	being	be	VBG
25944	3491	10	the	the	DT
25944	3491	11	work	work	NN
25944	3491	12	of	of	IN
25944	3491	13	_	_	NNP
25944	3491	14	Mr.	Mr.	NNP
25944	3492	1	Hermann	Hermann	NNP
25944	3492	2	Becker	Becker	NNP
25944	3492	3	_	_	NNP
25944	3492	4	and	and	CC
25944	3492	5	_	_	NNP
25944	3492	6	Mr.	Mr.	NNP
25944	3493	1	Max	Max	NNP
25944	3493	2	Brödel	Brödel	NNP
25944	3493	3	_	_	NNP
25944	3493	4	,	,	,
25944	3493	5	of	of	IN
25944	3493	6	the	the	DT
25944	3493	7	Johns	Johns	NNP
25944	3493	8	Hopkins	Hopkins	NNP
25944	3493	9	Hospital	Hospital	NNP
25944	3493	10	.	.	.
25944	3494	1	Ashton	Ashton	NNP
25944	3494	2	's	's	POS
25944	3494	3	Practice	Practice	NNP
25944	3494	4	of	of	IN
25944	3494	5	Gynecology	gynecology	NN
25944	3494	6	*	*	NFP
25944	3494	7	*	*	NFP
25944	3494	8	*	*	NFP
25944	3494	9	*	*	NFP
25944	3494	10	*	*	NFP
25944	3494	11	#	#	NN
25944	3494	12	The	the	DT
25944	3494	13	Practice	Practice	NNP
25944	3494	14	of	of	IN
25944	3494	15	Gynecology	Gynecology	NNP
25944	3494	16	#	#	NN
25944	3494	17	.	.	.
25944	3495	1	By	by	IN
25944	3495	2	W.	W.	NNP
25944	3495	3	Easterly	Easterly	NNP
25944	3495	4	Ashton	Ashton	NNP
25944	3495	5	,	,	,
25944	3495	6	M.D.	M.D.	NNP
25944	3495	7	,	,	,
25944	3495	8	LL.D.	LL.D.	NNP
25944	3495	9	,	,	,
25944	3495	10	Professor	Professor	NNP
25944	3495	11	of	of	IN
25944	3495	12	Gynecology	Gynecology	NNP
25944	3495	13	in	in	IN
25944	3495	14	the	the	DT
25944	3495	15	Medico	Medico	NNP
25944	3495	16	-	-	HYPH
25944	3495	17	Chirurgical	Chirurgical	NNP
25944	3495	18	College	College	NNP
25944	3495	19	,	,	,
25944	3495	20	Philadelphia	Philadelphia	NNP
25944	3495	21	.	.	.
25944	3496	1	Handsome	handsome	JJ
25944	3496	2	octavo	octavo	JJ
25944	3496	3	volume	volume	NN
25944	3496	4	of	of	IN
25944	3496	5	1096	1096	CD
25944	3496	6	pages	page	NNS
25944	3496	7	,	,	,
25944	3496	8	containing	contain	VBG
25944	3496	9	1057	1057	CD
25944	3496	10	original	original	JJ
25944	3496	11	line	line	NN
25944	3496	12	drawings	drawing	NNS
25944	3496	13	.	.	.
25944	3497	1	Cloth	cloth	NN
25944	3497	2	,	,	,
25944	3497	3	$	$	$
25944	3497	4	6.50	6.50	CD
25944	3497	5	net	net	NN
25944	3497	6	;	;	:
25944	3497	7	Half	Half	NNP
25944	3497	8	Morocco	Morocco	NNP
25944	3497	9	,	,	,
25944	3497	10	$	$	$
25944	3497	11	8.00	8.00	CD
25944	3497	12	net	net	NN
25944	3497	13	.	.	.
25944	3498	1	RECENTLY	recently	JJ
25944	3498	2	ISSUED	ISSUED	NNS
25944	3498	3	--	--	:
25944	3498	4	NEW	NEW	NNP
25944	3498	5	(	(	-LRB-
25944	3498	6	3d	3d	NNP
25944	3498	7	)	)	-RRB-
25944	3498	8	EDITION	edition	NN
25944	3498	9	THREE	three	CD
25944	3498	10	EDITIONS	edition	NNS
25944	3498	11	IN	in	IN
25944	3498	12	EIGHTEEN	EIGHTEEN	NNP
25944	3498	13	MONTHS	MONTHS	NNP
25944	3498	14	Three	three	CD
25944	3498	15	editions	edition	NNS
25944	3498	16	of	of	IN
25944	3498	17	this	this	DT
25944	3498	18	work	work	NN
25944	3498	19	have	have	VBP
25944	3498	20	been	be	VBN
25944	3498	21	demanded	demand	VBN
25944	3498	22	in	in	IN
25944	3498	23	eighteen	eighteen	CD
25944	3498	24	months	month	NNS
25944	3498	25	.	.	.
25944	3499	1	Among	among	IN
25944	3499	2	the	the	DT
25944	3499	3	new	new	JJ
25944	3499	4	additions	addition	NNS
25944	3499	5	are	be	VBP
25944	3499	6	:	:	:
25944	3499	7	Colonic	colonic	JJ
25944	3499	8	lavage	lavage	NN
25944	3499	9	and	and	CC
25944	3499	10	flushing	flush	VBG
25944	3499	11	,	,	,
25944	3499	12	Hirst	Hirst	NNP
25944	3499	13	's	's	POS
25944	3499	14	treatment	treatment	NN
25944	3499	15	for	for	IN
25944	3499	16	vaginismus	vaginismus	NN
25944	3499	17	,	,	,
25944	3499	18	Dudley	Dudley	NNP
25944	3499	19	's	's	POS
25944	3499	20	treatment	treatment	NN
25944	3499	21	of	of	IN
25944	3499	22	cystocele	cystocele	NNP
25944	3499	23	,	,	,
25944	3499	24	Montgomery	Montgomery	NNP
25944	3499	25	's	's	POS
25944	3499	26	round	round	JJ
25944	3499	27	ligament	ligament	JJ
25944	3499	28	operation	operation	NN
25944	3499	29	,	,	,
25944	3499	30	Chorio	Chorio	NNP
25944	3499	31	-	-	HYPH
25944	3499	32	epithelioma	epithelioma	NNP
25944	3499	33	of	of	IN
25944	3499	34	the	the	DT
25944	3499	35	Uterus	Uterus	NNP
25944	3499	36	,	,	,
25944	3499	37	Passive	Passive	NNP
25944	3499	38	Incontinence	Incontinence	NNP
25944	3499	39	of	of	IN
25944	3499	40	the	the	DT
25944	3499	41	Urine	Urine	NNP
25944	3499	42	,	,	,
25944	3499	43	and	and	CC
25944	3499	44	Moynihan	Moynihan	NNP
25944	3499	45	's	's	POS
25944	3499	46	methods	method	NNS
25944	3499	47	in	in	IN
25944	3499	48	Intestinal	Intestinal	NNP
25944	3499	49	Anastomosis	Anastomosis	NNP
25944	3499	50	.	.	.
25944	3500	1	Nothing	nothing	NN
25944	3500	2	is	be	VBZ
25944	3500	3	left	leave	VBN
25944	3500	4	to	to	TO
25944	3500	5	be	be	VB
25944	3500	6	taken	take	VBN
25944	3500	7	for	for	IN
25944	3500	8	granted	grant	VBN
25944	3500	9	,	,	,
25944	3500	10	the	the	DT
25944	3500	11	author	author	NN
25944	3500	12	not	not	RB
25944	3500	13	only	only	RB
25944	3500	14	telling	tell	VBG
25944	3500	15	his	-PRON-	PRP$
25944	3500	16	readers	reader	NNS
25944	3500	17	in	in	IN
25944	3500	18	every	every	DT
25944	3500	19	instance	instance	NN
25944	3500	20	what	what	WP
25944	3500	21	should	should	MD
25944	3500	22	be	be	VB
25944	3500	23	done	do	VBN
25944	3500	24	,	,	,
25944	3500	25	but	but	CC
25944	3500	26	also	also	RB
25944	3500	27	precisely	precisely	RB
25944	3500	28	_	_	VB
25944	3500	29	how	how	WRB
25944	3500	30	to	to	TO
25944	3500	31	do	do	VB
25944	3500	32	it	-PRON-	PRP
25944	3500	33	_	_	RP
25944	3500	34	.	.	.
25944	3501	1	A	a	DT
25944	3501	2	distinctly	distinctly	RB
25944	3501	3	original	original	JJ
25944	3501	4	feature	feature	NN
25944	3501	5	of	of	IN
25944	3501	6	the	the	DT
25944	3501	7	book	book	NN
25944	3501	8	is	be	VBZ
25944	3501	9	the	the	DT
25944	3501	10	illustrations	illustration	NNS
25944	3501	11	,	,	,
25944	3501	12	numbering	number	VBG
25944	3501	13	about	about	RB
25944	3501	14	one	one	CD
25944	3501	15	thousand	thousand	CD
25944	3501	16	line	line	NN
25944	3501	17	drawings	drawing	NNS
25944	3501	18	made	make	VBN
25944	3501	19	especially	especially	RB
25944	3501	20	under	under	IN
25944	3501	21	the	the	DT
25944	3501	22	author	author	NN
25944	3501	23	's	's	POS
25944	3501	24	personal	personal	JJ
25944	3501	25	supervision	supervision	NN
25944	3501	26	from	from	IN
25944	3501	27	actual	actual	JJ
25944	3501	28	apparatus	apparatus	NN
25944	3501	29	,	,	,
25944	3501	30	living	living	NN
25944	3501	31	models	model	NNS
25944	3501	32	,	,	,
25944	3501	33	and	and	CC
25944	3501	34	dissections	dissection	NNS
25944	3501	35	on	on	IN
25944	3501	36	the	the	DT
25944	3501	37	cadaver	cadaver	NN
25944	3501	38	.	.	.
25944	3502	1	These	these	DT
25944	3502	2	line	line	NN
25944	3502	3	drawings	drawing	NNS
25944	3502	4	show	show	VBP
25944	3502	5	in	in	IN
25944	3502	6	detail	detail	NN
25944	3502	7	the	the	DT
25944	3502	8	procedures	procedure	NNS
25944	3502	9	and	and	CC
25944	3502	10	operations	operation	NNS
25944	3502	11	without	without	IN
25944	3502	12	obscuring	obscure	VBG
25944	3502	13	their	-PRON-	PRP$
25944	3502	14	purpose	purpose	NN
25944	3502	15	by	by	IN
25944	3502	16	unnecessary	unnecessary	JJ
25944	3502	17	and	and	CC
25944	3502	18	unimportant	unimportant	JJ
25944	3502	19	anatomic	anatomic	JJ
25944	3502	20	surroundings	surrounding	NNS
25944	3502	21	.	.	.
25944	3503	1	#	#	NNP
25944	3503	2	Howard	Howard	NNP
25944	3503	3	A.	a.	NN
25944	3503	4	Kelly	Kelly	NNP
25944	3503	5	,	,	,
25944	3503	6	M.D.	M.D.	NNP
25944	3503	7	#	#	NNP
25944	3503	8	_	_	NNP
25944	3503	9	Professor	Professor	NNP
25944	3503	10	of	of	IN
25944	3503	11	Gynecology	Gynecology	NNP
25944	3503	12	,	,	,
25944	3503	13	Johns	Johns	NNP
25944	3503	14	Hopkins	Hopkins	NNP
25944	3503	15	University	University	NNP
25944	3503	16	.	.	.
25944	3503	17	_	_	NNP
25944	3503	18	"	"	``
25944	3503	19	It	-PRON-	PRP
25944	3503	20	is	be	VBZ
25944	3503	21	different	different	JJ
25944	3503	22	from	from	IN
25944	3503	23	anything	anything	NN
25944	3503	24	that	that	WDT
25944	3503	25	has	have	VBZ
25944	3503	26	as	as	RB
25944	3503	27	yet	yet	RB
25944	3503	28	appeared	appear	VBN
25944	3503	29	.	.	.
25944	3504	1	The	the	DT
25944	3504	2	illustrations	illustration	NNS
25944	3504	3	are	be	VBP
25944	3504	4	particularly	particularly	RB
25944	3504	5	clear	clear	JJ
25944	3504	6	and	and	CC
25944	3504	7	satisfactory	satisfactory	JJ
25944	3504	8	.	.	.
25944	3505	1	One	one	CD
25944	3505	2	specially	specially	RB
25944	3505	3	good	good	JJ
25944	3505	4	feature	feature	NN
25944	3505	5	is	be	VBZ
25944	3505	6	the	the	DT
25944	3505	7	pains	pain	NNS
25944	3505	8	with	with	IN
25944	3505	9	which	which	WDT
25944	3505	10	you	-PRON-	PRP
25944	3505	11	describe	describe	VBP
25944	3505	12	so	so	RB
25944	3505	13	many	many	JJ
25944	3505	14	_	_	NNP
25944	3505	15	details	detail	NNS
25944	3505	16	_	_	NNP
25944	3505	17	so	so	RB
25944	3505	18	often	often	RB
25944	3505	19	left	leave	VBD
25944	3505	20	to	to	IN
25944	3505	21	the	the	DT
25944	3505	22	imagination	imagination	NN
25944	3505	23	.	.	.
25944	3505	24	"	"	''
25944	3506	1	#	#	NNP
25944	3506	2	Charles	Charles	NNP
25944	3506	3	B.	B.	NNP
25944	3506	4	Penrose	Penrose	NNP
25944	3506	5	,	,	,
25944	3506	6	M.D.	M.D.	NNP
25944	3506	7	,	,	,
25944	3506	8	#	#	NNP
25944	3506	9	_	_	NNP
25944	3506	10	Formerly	Formerly	NNP
25944	3506	11	Professor	Professor	NNP
25944	3506	12	of	of	IN
25944	3506	13	Gynecology	Gynecology	NNP
25944	3506	14	,	,	,
25944	3506	15	University	University	NNP
25944	3506	16	of	of	IN
25944	3506	17	Pennsylvania	Pennsylvania	NNP
25944	3506	18	.	.	.
25944	3506	19	_	_	NNP
25944	3506	20	"	"	``
25944	3506	21	I	-PRON-	PRP
25944	3506	22	know	know	VBP
25944	3506	23	of	of	IN
25944	3506	24	no	no	DT
25944	3506	25	book	book	NN
25944	3506	26	that	that	WDT
25944	3506	27	goes	go	VBZ
25944	3506	28	so	so	RB
25944	3506	29	thoroughly	thoroughly	RB
25944	3506	30	and	and	CC
25944	3506	31	satisfactorily	satisfactorily	RB
25944	3506	32	into	into	IN
25944	3506	33	all	all	PDT
25944	3506	34	the	the	DT
25944	3506	35	_	_	NNP
25944	3506	36	details	detail	NNS
25944	3506	37	_	_	NNP
25944	3506	38	of	of	IN
25944	3506	39	everything	everything	NN
25944	3506	40	connected	connect	VBN
25944	3506	41	with	with	IN
25944	3506	42	the	the	DT
25944	3506	43	subject	subject	NN
25944	3506	44	.	.	.
25944	3507	1	In	in	IN
25944	3507	2	this	this	DT
25944	3507	3	respect	respect	NN
25944	3507	4	your	-PRON-	PRP$
25944	3507	5	book	book	NN
25944	3507	6	differs	differ	VBZ
25944	3507	7	from	from	IN
25944	3507	8	the	the	DT
25944	3507	9	others	other	NNS
25944	3507	10	.	.	.
25944	3507	11	"	"	''
25944	3508	1	#	#	NNP
25944	3508	2	George	George	NNP
25944	3508	3	M.	M.	NNP
25944	3508	4	Edebohls	Edebohls	NNP
25944	3508	5	,	,	,
25944	3508	6	M.D.	M.D.	NNP
25944	3508	7	#	#	NNP
25944	3508	8	_	_	NNP
25944	3508	9	Professor	Professor	NNP
25944	3508	10	of	of	IN
25944	3508	11	Diseases	Diseases	NNPS
25944	3508	12	of	of	IN
25944	3508	13	Women	Women	NNP
25944	3508	14	,	,	,
25944	3508	15	New	New	NNP
25944	3508	16	York	York	NNP
25944	3508	17	Post	Post	NNP
25944	3508	18	-	-	NNP
25944	3508	19	Graduate	Graduate	NNP
25944	3508	20	Medical	Medical	NNP
25944	3508	21	School	School	NNP
25944	3508	22	.	.	.
25944	3508	23	_	_	NNP
25944	3508	24	"	"	``
25944	3508	25	I	-PRON-	PRP
25944	3508	26	have	have	VBP
25944	3508	27	looked	look	VBN
25944	3508	28	it	-PRON-	PRP
25944	3508	29	through	through	RP
25944	3508	30	and	and	CC
25944	3508	31	must	must	MD
25944	3508	32	congratulate	congratulate	VB
25944	3508	33	you	-PRON-	PRP
25944	3508	34	upon	upon	IN
25944	3508	35	having	have	VBG
25944	3508	36	produced	produce	VBN
25944	3508	37	a	a	DT
25944	3508	38	text	text	NN
25944	3508	39	-	-	HYPH
25944	3508	40	book	book	NN
25944	3508	41	most	most	RBS
25944	3508	42	admirably	admirably	RB
25944	3508	43	adapted	adapt	VBN
25944	3508	44	to	to	IN
25944	3508	45	_	_	NNP
25944	3508	46	teach	teach	VB
25944	3508	47	_	_	NNP
25944	3508	48	gynecology	gynecology	NN
25944	3508	49	to	to	IN
25944	3508	50	those	those	DT
25944	3508	51	who	who	WP
25944	3508	52	must	must	MD
25944	3508	53	get	get	VB
25944	3508	54	their	-PRON-	PRP$
25944	3508	55	knowledge	knowledge	NN
25944	3508	56	,	,	,
25944	3508	57	even	even	RB
25944	3508	58	to	to	IN
25944	3508	59	the	the	DT
25944	3508	60	minutest	minute	JJS
25944	3508	61	and	and	CC
25944	3508	62	most	most	RBS
25944	3508	63	elementary	elementary	JJ
25944	3508	64	details	detail	NNS
25944	3508	65	,	,	,
25944	3508	66	from	from	IN
25944	3508	67	books	book	NNS
25944	3508	68	.	.	.
25944	3508	69	"	"	''
25944	3509	1	Webster	Webster	NNP
25944	3509	2	's	's	POS
25944	3509	3	Diseases	Diseases	NNP
25944	3509	4	_	_	NNP
25944	3509	5	of	of	IN
25944	3509	6	_	_	NNP
25944	3509	7	Women	Women	NNP
25944	3509	8	*	*	NFP
25944	3509	9	*	*	NFP
25944	3509	10	*	*	NFP
25944	3509	11	*	*	NFP
25944	3509	12	*	*	NFP
25944	3509	13	#	#	NN
25944	3509	14	Diseases	Diseases	NNPS
25944	3509	15	of	of	IN
25944	3509	16	Women	Women	NNPS
25944	3509	17	.	.	.
25944	3509	18	#	#	NNP
25944	3509	19	By	by	IN
25944	3509	20	J.	J.	NNP
25944	3509	21	Clarence	Clarence	NNP
25944	3509	22	Webster	Webster	NNP
25944	3509	23	,	,	,
25944	3509	24	M.D.	M.D.	NNP
25944	3510	1	(	(	-LRB-
25944	3510	2	Edin	Edin	NNP
25944	3510	3	.	.	.
25944	3511	1	)	)	-RRB-
25944	3511	2	,	,	,
25944	3511	3	F.R.C.P.E.	f.r.c.p.e.	CD
25944	3511	4	,	,	,
25944	3511	5	Professor	Professor	NNP
25944	3511	6	of	of	IN
25944	3511	7	Gynecology	Gynecology	NNP
25944	3511	8	and	and	CC
25944	3511	9	Obstetrics	Obstetrics	NNPS
25944	3511	10	in	in	IN
25944	3511	11	Rush	Rush	NNP
25944	3511	12	Medical	Medical	NNP
25944	3511	13	College	College	NNP
25944	3511	14	.	.	.
25944	3512	1	Octavo	Octavo	NNP
25944	3512	2	of	of	IN
25944	3512	3	712	712	CD
25944	3512	4	pages	page	NNS
25944	3512	5	,	,	,
25944	3512	6	with	with	IN
25944	3512	7	372	372	CD
25944	3512	8	illustrations	illustration	NNS
25944	3512	9	.	.	.
25944	3513	1	Cloth	cloth	NN
25944	3513	2	,	,	,
25944	3513	3	$	$	$
25944	3513	4	7.00	7.00	CD
25944	3513	5	net	net	NN
25944	3513	6	;	;	:
25944	3513	7	Half	Half	NNP
25944	3513	8	Morocco	Morocco	NNP
25944	3513	9	,	,	,
25944	3513	10	$	$	$
25944	3513	11	8.50	8.50	CD
25944	3513	12	net	net	NN
25944	3513	13	.	.	.
25944	3514	1	RECENTLY	recently	JJ
25944	3514	2	ISSUED	ISSUED	NNS
25944	3514	3	--	--	:
25944	3514	4	FOR	for	IN
25944	3514	5	THE	the	DT
25944	3514	6	PRACTITIONER	PRACTITIONER	NNP
25944	3514	7	Dr.	Dr.	NNP
25944	3514	8	Webster	Webster	NNP
25944	3514	9	has	have	VBZ
25944	3514	10	written	write	VBN
25944	3514	11	this	this	DT
25944	3514	12	work	work	NN
25944	3514	13	_	_	IN
25944	3514	14	especially	especially	RB
25944	3514	15	for	for	IN
25944	3514	16	the	the	DT
25944	3514	17	general	general	JJ
25944	3514	18	practitioner	practitioner	NN
25944	3514	19	_	_	NNP
25944	3514	20	,	,	,
25944	3514	21	discussing	discuss	VBG
25944	3514	22	the	the	DT
25944	3514	23	clinical	clinical	JJ
25944	3514	24	features	feature	NNS
25944	3514	25	of	of	IN
25944	3514	26	the	the	DT
25944	3514	27	subject	subject	NN
25944	3514	28	in	in	IN
25944	3514	29	their	-PRON-	PRP$
25944	3514	30	widest	wide	JJS
25944	3514	31	relations	relation	NNS
25944	3514	32	to	to	IN
25944	3514	33	general	general	JJ
25944	3514	34	practice	practice	NN
25944	3514	35	rather	rather	RB
25944	3514	36	than	than	IN
25944	3514	37	from	from	IN
25944	3514	38	the	the	DT
25944	3514	39	standpoint	standpoint	NN
25944	3514	40	of	of	IN
25944	3514	41	specialism	specialism	NN
25944	3514	42	.	.	.
25944	3515	1	The	the	DT
25944	3515	2	magnificent	magnificent	JJ
25944	3515	3	illustrations	illustration	NNS
25944	3515	4	,	,	,
25944	3515	5	three	three	CD
25944	3515	6	hundred	hundred	CD
25944	3515	7	and	and	CC
25944	3515	8	seventy	seventy	CD
25944	3515	9	-	-	HYPH
25944	3515	10	two	two	CD
25944	3515	11	in	in	IN
25944	3515	12	number	number	NN
25944	3515	13	,	,	,
25944	3515	14	are	be	VBP
25944	3515	15	nearly	nearly	RB
25944	3515	16	all	all	RB
25944	3515	17	original	original	JJ
25944	3515	18	.	.	.
25944	3516	1	Drawn	draw	VBN
25944	3516	2	by	by	IN
25944	3516	3	expert	expert	JJ
25944	3516	4	anatomic	anatomic	JJ
25944	3516	5	artists	artist	NNS
25944	3516	6	under	under	IN
25944	3516	7	Dr.	Dr.	NNP
25944	3516	8	Webster	Webster	NNP
25944	3516	9	's	's	POS
25944	3516	10	direct	direct	JJ
25944	3516	11	supervision	supervision	NN
25944	3516	12	,	,	,
25944	3516	13	they	-PRON-	PRP
25944	3516	14	portray	portray	VBP
25944	3516	15	the	the	DT
25944	3516	16	anatomy	anatomy	NN
25944	3516	17	of	of	IN
25944	3516	18	the	the	DT
25944	3516	19	parts	part	NNS
25944	3516	20	and	and	CC
25944	3516	21	the	the	DT
25944	3516	22	steps	step	NNS
25944	3516	23	in	in	IN
25944	3516	24	the	the	DT
25944	3516	25	operations	operation	NNS
25944	3516	26	with	with	IN
25944	3516	27	rare	rare	JJ
25944	3516	28	clearness	clearness	NN
25944	3516	29	and	and	CC
25944	3516	30	exactness	exactness	NN
25944	3516	31	.	.	.
25944	3517	1	#	#	NNP
25944	3517	2	Howard	Howard	NNP
25944	3517	3	A.	a.	NN
25944	3517	4	Kelly	Kelly	NNP
25944	3517	5	,	,	,
25944	3517	6	M.D.	M.D.	NNP
25944	3517	7	#	#	NNP
25944	3517	8	,	,	,
25944	3517	9	_	_	NNP
25944	3517	10	Professor	Professor	NNP
25944	3517	11	of	of	IN
25944	3517	12	Gynecology	Gynecology	NNP
25944	3517	13	,	,	,
25944	3517	14	Johns	Johns	NNP
25944	3517	15	Hopkins	Hopkins	NNP
25944	3517	16	University	University	NNP
25944	3517	17	.	.	.
25944	3517	18	_	_	NNP
25944	3517	19	"	"	``
25944	3517	20	It	-PRON-	PRP
25944	3517	21	is	be	VBZ
25944	3517	22	undoubtedly	undoubtedly	RB
25944	3517	23	one	one	CD
25944	3517	24	of	of	IN
25944	3517	25	the	the	DT
25944	3517	26	best	good	JJS
25944	3517	27	works	work	NNS
25944	3517	28	which	which	WDT
25944	3517	29	has	have	VBZ
25944	3517	30	been	be	VBN
25944	3517	31	put	put	VBN
25944	3517	32	on	on	IN
25944	3517	33	the	the	DT
25944	3517	34	market	market	NN
25944	3517	35	within	within	IN
25944	3517	36	recent	recent	JJ
25944	3517	37	years	year	NNS
25944	3517	38	,	,	,
25944	3517	39	showing	show	VBG
25944	3517	40	from	from	IN
25944	3517	41	start	start	NN
25944	3517	42	to	to	IN
25944	3517	43	finish	finish	NN
25944	3517	44	Dr.	Dr.	NNP
25944	3517	45	Webster	Webster	NNP
25944	3517	46	's	's	POS
25944	3517	47	well	well	RB
25944	3517	48	-	-	HYPH
25944	3517	49	known	know	VBN
25944	3517	50	thoroughness	thoroughness	NN
25944	3517	51	.	.	.
25944	3518	1	The	the	DT
25944	3518	2	illustrations	illustration	NNS
25944	3518	3	are	be	VBP
25944	3518	4	also	also	RB
25944	3518	5	of	of	IN
25944	3518	6	the	the	DT
25944	3518	7	highest	high	JJS
25944	3518	8	order	order	NN
25944	3518	9	.	.	.
25944	3518	10	"	"	''
25944	3519	1	*	*	NFP
25944	3519	2	*	*	NFP
25944	3519	3	*	*	NFP
25944	3519	4	*	*	NFP
25944	3519	5	*	*	NFP
25944	3519	6	#	#	NN
25944	3519	7	Webster	Webster	NNP
25944	3519	8	's	's	POS
25944	3519	9	Obstetrics	Obstetrics	NNPS
25944	3519	10	#	#	$
25944	3519	11	#	#	$
25944	3519	12	A	a	DT
25944	3519	13	Text	Text	NNP
25944	3519	14	-	-	HYPH
25944	3519	15	Book	Book	NNP
25944	3519	16	of	of	IN
25944	3519	17	Obstetrics	Obstetrics	NNPS
25944	3519	18	#	#	$
25944	3519	19	.	.	.
25944	3520	1	By	by	IN
25944	3520	2	J.	J.	NNP
25944	3520	3	Clarence	Clarence	NNP
25944	3520	4	Webster	Webster	NNP
25944	3520	5	,	,	,
25944	3520	6	M.D.	M.D.	NNP
25944	3521	1	(	(	-LRB-
25944	3521	2	Edin	Edin	NNP
25944	3521	3	.	.	.
25944	3522	1	)	)	-RRB-
25944	3522	2	,	,	,
25944	3522	3	Professor	Professor	NNP
25944	3522	4	of	of	IN
25944	3522	5	Obstetrics	Obstetrics	NNPS
25944	3522	6	and	and	CC
25944	3522	7	Gynecology	Gynecology	NNP
25944	3522	8	in	in	IN
25944	3522	9	Rush	Rush	NNP
25944	3522	10	Medical	Medical	NNP
25944	3522	11	College	College	NNP
25944	3522	12	.	.	.
25944	3523	1	Octavo	Octavo	NNP
25944	3523	2	of	of	IN
25944	3523	3	767	767	CD
25944	3523	4	pages	page	NNS
25944	3523	5	,	,	,
25944	3523	6	illustrated	illustrate	VBN
25944	3523	7	.	.	.
25944	3524	1	Cloth	cloth	NN
25944	3524	2	,	,	,
25944	3524	3	$	$	$
25944	3524	4	5.00	5.00	CD
25944	3524	5	net	net	NN
25944	3524	6	;	;	:
25944	3524	7	Half	Half	NNP
25944	3524	8	Morocco	Morocco	NNP
25944	3524	9	,	,	,
25944	3524	10	$	$	$
25944	3524	11	6.50	6.50	CD
25944	3524	12	net	net	NN
25944	3524	13	.	.	.
25944	3525	1	RECENTLY	recently	JJ
25944	3525	2	ISSUED	ISSUED	NNS
25944	3525	3	#	#	$
25944	3525	4	Medical	Medical	NNP
25944	3525	5	Record	Record	NNP
25944	3525	6	,	,	,
25944	3525	7	New	New	NNP
25944	3525	8	York	York	NNP
25944	3525	9	#	#	NN
25944	3525	10	"	"	``
25944	3525	11	The	the	DT
25944	3525	12	author	author	NN
25944	3525	13	's	's	POS
25944	3525	14	remarks	remark	NNS
25944	3525	15	on	on	IN
25944	3525	16	asepsis	asepsis	NN
25944	3525	17	and	and	CC
25944	3525	18	antisepsis	antisepsis	NN
25944	3525	19	are	be	VBP
25944	3525	20	admirable	admirable	JJ
25944	3525	21	,	,	,
25944	3525	22	the	the	DT
25944	3525	23	chapter	chapter	NN
25944	3525	24	on	on	IN
25944	3525	25	eclampsia	eclampsia	NNP
25944	3525	26	is	be	VBZ
25944	3525	27	full	full	JJ
25944	3525	28	of	of	IN
25944	3525	29	good	good	JJ
25944	3525	30	material	material	NN
25944	3525	31	,	,	,
25944	3525	32	and	and	CC
25944	3525	33	...	...	:
25944	3525	34	the	the	DT
25944	3525	35	book	book	NN
25944	3525	36	can	can	MD
25944	3525	37	be	be	VB
25944	3525	38	cordially	cordially	RB
25944	3525	39	recommended	recommend	VBN
25944	3525	40	as	as	IN
25944	3525	41	a	a	DT
25944	3525	42	safe	safe	JJ
25944	3525	43	guide	guide	NN
25944	3525	44	.	.	.
25944	3525	45	"	"	''
25944	3526	1	Cullen	Cullen	NNP
25944	3526	2	's	's	POS
25944	3526	3	Uterine	Uterine	NNP
25944	3526	4	Adenomyoma	Adenomyoma	NNP
25944	3526	5	*	*	NFP
25944	3526	6	*	*	NFP
25944	3526	7	*	*	NFP
25944	3526	8	*	*	NFP
25944	3526	9	*	*	NFP
25944	3526	10	#	#	NN
25944	3526	11	Uterine	Uterine	NNP
25944	3526	12	Adenomyoma	Adenomyoma	NNP
25944	3526	13	#	#	$
25944	3526	14	.	.	.
25944	3527	1	By	by	IN
25944	3527	2	Thomas	Thomas	NNP
25944	3527	3	S.	S.	NNP
25944	3527	4	Cullen	Cullen	NNP
25944	3527	5	,	,	,
25944	3527	6	M.D.	M.D.	NNP
25944	3527	7	,	,	,
25944	3527	8	Associate	Associate	NNP
25944	3527	9	Professor	Professor	NNP
25944	3527	10	of	of	IN
25944	3527	11	Gynecology	Gynecology	NNP
25944	3527	12	,	,	,
25944	3527	13	Johns	Johns	NNP
25944	3527	14	Hopkins	Hopkins	NNP
25944	3527	15	University	University	NNP
25944	3527	16	.	.	.
25944	3528	1	Octavo	Octavo	NNP
25944	3528	2	of	of	IN
25944	3528	3	275	275	CD
25944	3528	4	pages	page	NNS
25944	3528	5	,	,	,
25944	3528	6	with	with	IN
25944	3528	7	original	original	JJ
25944	3528	8	illustrations	illustration	NNS
25944	3528	9	by	by	IN
25944	3528	10	Hermann	Hermann	NNP
25944	3528	11	Becker	Becker	NNP
25944	3528	12	and	and	CC
25944	3528	13	August	August	NNP
25944	3528	14	Horn	Horn	NNP
25944	3528	15	.	.	.
25944	3529	1	Cloth	cloth	NN
25944	3529	2	,	,	,
25944	3529	3	$	$	$
25944	3529	4	5.00	5.00	CD
25944	3529	5	net	net	NN
25944	3529	6	.	.	.
25944	3530	1	JUST	just	RB
25944	3530	2	READY	ready	JJ
25944	3530	3	Dr.	Dr.	NNP
25944	3530	4	Cullen	Cullen	NNP
25944	3530	5	's	's	POS
25944	3530	6	large	large	JJ
25944	3530	7	clinical	clinical	JJ
25944	3530	8	experience	experience	NN
25944	3530	9	and	and	CC
25944	3530	10	his	-PRON-	PRP$
25944	3530	11	extensive	extensive	JJ
25944	3530	12	original	original	JJ
25944	3530	13	work	work	NN
25944	3530	14	along	along	IN
25944	3530	15	the	the	DT
25944	3530	16	lines	line	NNS
25944	3530	17	of	of	IN
25944	3530	18	gynecologic	gynecologic	JJ
25944	3530	19	pathology	pathology	NN
25944	3530	20	have	have	VBP
25944	3530	21	enabled	enable	VBN
25944	3530	22	him	-PRON-	PRP
25944	3530	23	to	to	TO
25944	3530	24	present	present	VB
25944	3530	25	his	-PRON-	PRP$
25944	3530	26	subject	subject	NN
25944	3530	27	with	with	IN
25944	3530	28	originality	originality	NN
25944	3530	29	and	and	CC
25944	3530	30	precision	precision	NN
25944	3530	31	.	.	.
25944	3531	1	The	the	DT
25944	3531	2	work	work	NN
25944	3531	3	gives	give	VBZ
25944	3531	4	the	the	DT
25944	3531	5	early	early	JJ
25944	3531	6	literature	literature	NN
25944	3531	7	on	on	IN
25944	3531	8	adenomyoma	adenomyoma	NNP
25944	3531	9	,	,	,
25944	3531	10	traces	trace	VBZ
25944	3531	11	the	the	DT
25944	3531	12	disease	disease	NN
25944	3531	13	through	through	IN
25944	3531	14	its	-PRON-	PRP$
25944	3531	15	various	various	JJ
25944	3531	16	stages	stage	NNS
25944	3531	17	,	,	,
25944	3531	18	and	and	CC
25944	3531	19	then	then	RB
25944	3531	20	gives	give	VBZ
25944	3531	21	the	the	DT
25944	3531	22	detailed	detailed	JJ
25944	3531	23	findings	finding	NNS
25944	3531	24	in	in	IN
25944	3531	25	a	a	DT
25944	3531	26	large	large	JJ
25944	3531	27	number	number	NN
25944	3531	28	of	of	IN
25944	3531	29	cases	case	NNS
25944	3531	30	personally	personally	RB
25944	3531	31	examined	examine	VBN
25944	3531	32	by	by	IN
25944	3531	33	the	the	DT
25944	3531	34	author	author	NN
25944	3531	35	.	.	.
25944	3532	1	Formerly	formerly	RB
25944	3532	2	the	the	DT
25944	3532	3	physician	physician	NN
25944	3532	4	and	and	CC
25944	3532	5	surgeon	surgeon	NN
25944	3532	6	were	be	VBD
25944	3532	7	unable	unable	JJ
25944	3532	8	to	to	TO
25944	3532	9	determine	determine	VB
25944	3532	10	the	the	DT
25944	3532	11	cause	cause	NN
25944	3532	12	of	of	IN
25944	3532	13	uterine	uterine	JJ
25944	3532	14	bleeding	bleeding	NN
25944	3532	15	,	,	,
25944	3532	16	but	but	CC
25944	3532	17	after	after	IN
25944	3532	18	following	follow	VBG
25944	3532	19	closely	closely	RB
25944	3532	20	the	the	DT
25944	3532	21	clinical	clinical	JJ
25944	3532	22	course	course	NN
25944	3532	23	of	of	IN
25944	3532	24	the	the	DT
25944	3532	25	disease	disease	NN
25944	3532	26	,	,	,
25944	3532	27	Dr.	Dr.	NNP
25944	3532	28	Cullen	Cullen	NNP
25944	3532	29	has	have	VBZ
25944	3532	30	found	find	VBN
25944	3532	31	that	that	IN
25944	3532	32	the	the	DT
25944	3532	33	majority	majority	NN
25944	3532	34	of	of	IN
25944	3532	35	these	these	DT
25944	3532	36	cases	case	NNS
25944	3532	37	can	can	MD
25944	3532	38	be	be	VB
25944	3532	39	diagnosed	diagnose	VBN
25944	3532	40	clinically	clinically	RB
25944	3532	41	.	.	.
25944	3533	1	The	the	DT
25944	3533	2	results	result	NNS
25944	3533	3	of	of	IN
25944	3533	4	these	these	DT
25944	3533	5	observations	observation	NNS
25944	3533	6	he	-PRON-	PRP
25944	3533	7	presents	present	VBZ
25944	3533	8	in	in	IN
25944	3533	9	this	this	DT
25944	3533	10	work	work	NN
25944	3533	11	.	.	.
25944	3534	1	The	the	DT
25944	3534	2	entire	entire	JJ
25944	3534	3	subject	subject	NN
25944	3534	4	of	of	IN
25944	3534	5	adenomyoma	adenomyoma	NNP
25944	3534	6	is	be	VBZ
25944	3534	7	dealt	deal	VBN
25944	3534	8	with	with	IN
25944	3534	9	from	from	IN
25944	3534	10	the	the	DT
25944	3534	11	standpoint	standpoint	NN
25944	3534	12	of	of	IN
25944	3534	13	the	the	DT
25944	3534	14	pathologist	pathologist	NN
25944	3534	15	,	,	,
25944	3534	16	the	the	DT
25944	3534	17	clinician	clinician	NNP
25944	3534	18	,	,	,
25944	3534	19	and	and	CC
25944	3534	20	the	the	DT
25944	3534	21	surgeon	surgeon	NN
25944	3534	22	.	.	.
25944	3535	1	The	the	DT
25944	3535	2	superb	superb	JJ
25944	3535	3	illustrations	illustration	NNS
25944	3535	4	are	be	VBP
25944	3535	5	the	the	DT
25944	3535	6	work	work	NN
25944	3535	7	of	of	IN
25944	3535	8	Mr.	Mr.	NNP
25944	3535	9	Hermann	Hermann	NNP
25944	3535	10	Becker	Becker	NNP
25944	3535	11	and	and	CC
25944	3535	12	Mr.	Mr.	NNP
25944	3535	13	August	August	NNP
25944	3535	14	Horn	Horn	NNP
25944	3535	15	,	,	,
25944	3535	16	of	of	IN
25944	3535	17	the	the	DT
25944	3535	18	Johns	Johns	NNP
25944	3535	19	Hopkins	Hopkins	NNP
25944	3535	20	Hospital	Hospital	NNP
25944	3535	21	.	.	.
25944	3536	1	*	*	NFP
25944	3536	2	*	*	NFP
25944	3536	3	*	*	NFP
25944	3536	4	*	*	NFP
25944	3536	5	*	*	NFP
25944	3536	6	The	the	DT
25944	3536	7	American	American	NNP
25944	3536	8	Text	Text	NNP
25944	3536	9	-	-	HYPH
25944	3536	10	Book	Book	NNP
25944	3536	11	_	_	NNP
25944	3536	12	of	of	IN
25944	3536	13	_	_	NNP
25944	3536	14	Obstetrics	Obstetrics	NNP
25944	3536	15	Recently	recently	RB
25944	3536	16	Issued	issue	VBD
25944	3536	17	--	--	:
25944	3536	18	New	New	NNP
25944	3536	19	(	(	-LRB-
25944	3536	20	2d	2d	NNP
25944	3536	21	)	)	-RRB-
25944	3536	22	Edition	edition	NN
25944	3536	23	#	#	NN
25944	3536	24	The	the	DT
25944	3536	25	American	American	NNP
25944	3536	26	Text	Text	NNP
25944	3536	27	-	-	HYPH
25944	3536	28	Book	Book	NNP
25944	3536	29	of	of	IN
25944	3536	30	Obstetrics	Obstetrics	NNPS
25944	3536	31	#	#	$
25944	3536	32	.	.	.
25944	3537	1	In	in	IN
25944	3537	2	two	two	CD
25944	3537	3	volumes	volume	NNS
25944	3537	4	.	.	.
25944	3538	1	Edited	edit	VBN
25944	3538	2	by	by	IN
25944	3538	3	Richard	Richard	NNP
25944	3538	4	C.	C.	NNP
25944	3538	5	Norris	Norris	NNP
25944	3538	6	,	,	,
25944	3538	7	M.D.	M.D.	NNP
25944	3539	1	;	;	:
25944	3539	2	Art	Art	NNP
25944	3539	3	Editor	Editor	NNP
25944	3539	4	,	,	,
25944	3539	5	Robert	Robert	NNP
25944	3539	6	L.	L.	NNP
25944	3539	7	Dickinson	Dickinson	NNP
25944	3539	8	,	,	,
25944	3539	9	M.D.	M.D.	NNP
25944	3540	1	Two	two	CD
25944	3540	2	octavos	octavos	NN
25944	3540	3	of	of	IN
25944	3540	4	about	about	RB
25944	3540	5	600	600	CD
25944	3540	6	pages	page	NNS
25944	3540	7	each	each	DT
25944	3540	8	;	;	:
25944	3540	9	nearly	nearly	RB
25944	3540	10	900	900	CD
25944	3540	11	illustrations	illustration	NNS
25944	3540	12	,	,	,
25944	3540	13	including	include	VBG
25944	3540	14	49	49	CD
25944	3540	15	colored	color	VBN
25944	3540	16	and	and	CC
25944	3540	17	half	half	JJ
25944	3540	18	-	-	HYPH
25944	3540	19	tone	tone	NN
25944	3540	20	plates	plate	NNS
25944	3540	21	.	.	.
25944	3541	1	Per	per	IN
25944	3541	2	volume	volume	NN
25944	3541	3	:	:	:
25944	3541	4	Cloth	cloth	NN
25944	3541	5	,	,	,
25944	3541	6	$	$	$
25944	3541	7	3.50	3.50	CD
25944	3541	8	net	net	NN
25944	3541	9	;	;	:
25944	3541	10	Half	Half	NNP
25944	3541	11	Morocco	Morocco	NNP
25944	3541	12	,	,	,
25944	3541	13	$	$	$
25944	3541	14	4.50	4.50	CD
25944	3541	15	net	net	NN
25944	3541	16	.	.	.
25944	3542	1	#	#	NNP
25944	3542	2	American	American	NNP
25944	3542	3	Journal	Journal	NNP
25944	3542	4	of	of	IN
25944	3542	5	the	the	DT
25944	3542	6	Medical	Medical	NNP
25944	3542	7	Sciences	Sciences	NNPS
25944	3542	8	#	#	NN
25944	3542	9	"	"	``
25944	3542	10	As	as	IN
25944	3542	11	an	an	DT
25944	3542	12	authority	authority	NN
25944	3542	13	,	,	,
25944	3542	14	as	as	IN
25944	3542	15	a	a	DT
25944	3542	16	book	book	NN
25944	3542	17	of	of	IN
25944	3542	18	reference	reference	NN
25944	3542	19	,	,	,
25944	3542	20	as	as	IN
25944	3542	21	a	a	DT
25944	3542	22	'	'	``
25944	3542	23	working	working	NN
25944	3542	24	book	book	NN
25944	3542	25	'	'	''
25944	3542	26	for	for	IN
25944	3542	27	the	the	DT
25944	3542	28	student	student	NN
25944	3542	29	or	or	CC
25944	3542	30	practitioner	practitioner	NN
25944	3542	31	,	,	,
25944	3542	32	we	-PRON-	PRP
25944	3542	33	commend	commend	VBP
25944	3542	34	it	-PRON-	PRP
25944	3542	35	because	because	IN
25944	3542	36	we	-PRON-	PRP
25944	3542	37	believe	believe	VBP
25944	3542	38	there	there	EX
25944	3542	39	is	be	VBZ
25944	3542	40	no	no	RB
25944	3542	41	better	well	JJR
25944	3542	42	.	.	.
25944	3542	43	"	"	''
25944	3543	1	Hirst	Hirst	NNP
25944	3543	2	's	's	POS
25944	3543	3	Diseases	Diseases	NNPS
25944	3543	4	of	of	IN
25944	3543	5	Women	woman	NNS
25944	3543	6	*	*	NFP
25944	3543	7	*	*	NFP
25944	3543	8	*	*	NFP
25944	3543	9	*	*	NFP
25944	3543	10	*	*	NFP
25944	3543	11	#	#	NN
25944	3543	12	A	a	DT
25944	3543	13	Text	Text	NNP
25944	3543	14	-	-	HYPH
25944	3543	15	Book	Book	NNP
25944	3543	16	of	of	IN
25944	3543	17	Diseases	Diseases	NNPS
25944	3543	18	of	of	IN
25944	3543	19	Women	Women	NNP
25944	3543	20	#	#	$
25944	3543	21	.	.	.
25944	3544	1	By	by	IN
25944	3544	2	Barton	Barton	NNP
25944	3544	3	Cooke	Cooke	NNP
25944	3544	4	Hirst	Hirst	NNP
25944	3544	5	,	,	,
25944	3544	6	M.D.	M.D.	NNP
25944	3544	7	,	,	,
25944	3544	8	Professor	Professor	NNP
25944	3544	9	of	of	IN
25944	3544	10	Obstetrics	Obstetrics	NNP
25944	3544	11	,	,	,
25944	3544	12	University	University	NNP
25944	3544	13	of	of	IN
25944	3544	14	Pennsylvania	Pennsylvania	NNP
25944	3544	15	;	;	:
25944	3544	16	Gynecologist	gynecologist	JJ
25944	3544	17	to	to	IN
25944	3544	18	the	the	DT
25944	3544	19	Howard	Howard	NNP
25944	3544	20	,	,	,
25944	3544	21	the	the	DT
25944	3544	22	Orthopedic	orthopedic	JJ
25944	3544	23	,	,	,
25944	3544	24	and	and	CC
25944	3544	25	the	the	DT
25944	3544	26	Philadelphia	Philadelphia	NNP
25944	3544	27	Hospitals	Hospitals	NNPS
25944	3544	28	.	.	.
25944	3545	1	Octavo	Octavo	NNP
25944	3545	2	of	of	IN
25944	3545	3	745	745	CD
25944	3545	4	pages	page	NNS
25944	3545	5	,	,	,
25944	3545	6	701	701	CD
25944	3545	7	illustrations	illustration	NNS
25944	3545	8	,	,	,
25944	3545	9	many	many	JJ
25944	3545	10	in	in	IN
25944	3545	11	colors	color	NNS
25944	3545	12	.	.	.
25944	3546	1	Cloth	cloth	NN
25944	3546	2	,	,	,
25944	3546	3	$	$	$
25944	3546	4	5.00	5.00	CD
25944	3546	5	net	net	NN
25944	3546	6	;	;	:
25944	3546	7	Half	Half	NNP
25944	3546	8	Morocco	Morocco	NNP
25944	3546	9	,	,	,
25944	3546	10	$	$	$
25944	3546	11	6.50	6.50	CD
25944	3546	12	net	net	NN
25944	3546	13	.	.	.
25944	3547	1	RECENTLY	recently	JJ
25944	3547	2	ISSUED	ISSUED	NNS
25944	3547	3	--	--	:
25944	3547	4	NEW	NEW	NNP
25944	3547	5	(	(	-LRB-
25944	3547	6	2d	2d	NNP
25944	3547	7	)	)	-RRB-
25944	3547	8	EDITION	edition	NN
25944	3547	9	WITH	with	IN
25944	3547	10	701	701	CD
25944	3547	11	ORIGINAL	original	JJ
25944	3547	12	ILLUSTRATIONS	illustration	VBD
25944	3547	13	The	the	DT
25944	3547	14	new	new	JJ
25944	3547	15	edition	edition	NN
25944	3547	16	of	of	IN
25944	3547	17	this	this	DT
25944	3547	18	work	work	NN
25944	3547	19	has	have	VBZ
25944	3547	20	just	just	RB
25944	3547	21	been	be	VBN
25944	3547	22	issued	issue	VBN
25944	3547	23	after	after	IN
25944	3547	24	a	a	DT
25944	3547	25	careful	careful	JJ
25944	3547	26	revision	revision	NN
25944	3547	27	.	.	.
25944	3548	1	As	as	IN
25944	3548	2	diagnosis	diagnosis	NN
25944	3548	3	and	and	CC
25944	3548	4	treatment	treatment	NN
25944	3548	5	are	be	VBP
25944	3548	6	of	of	IN
25944	3548	7	the	the	DT
25944	3548	8	greatest	great	JJS
25944	3548	9	importance	importance	NN
25944	3548	10	in	in	IN
25944	3548	11	considering	consider	VBG
25944	3548	12	diseases	disease	NNS
25944	3548	13	of	of	IN
25944	3548	14	women	woman	NNS
25944	3548	15	,	,	,
25944	3548	16	particular	particular	JJ
25944	3548	17	attention	attention	NN
25944	3548	18	has	have	VBZ
25944	3548	19	been	be	VBN
25944	3548	20	devoted	devote	VBN
25944	3548	21	to	to	IN
25944	3548	22	these	these	DT
25944	3548	23	divisions	division	NNS
25944	3548	24	.	.	.
25944	3549	1	To	to	IN
25944	3549	2	this	this	DT
25944	3549	3	end	end	NN
25944	3549	4	,	,	,
25944	3549	5	also	also	RB
25944	3549	6	,	,	,
25944	3549	7	the	the	DT
25944	3549	8	work	work	NN
25944	3549	9	has	have	VBZ
25944	3549	10	been	be	VBN
25944	3549	11	magnificently	magnificently	RB
25944	3549	12	illuminated	illuminate	VBN
25944	3549	13	with	with	IN
25944	3549	14	701	701	CD
25944	3549	15	illustrations	illustration	NNS
25944	3549	16	,	,	,
25944	3549	17	for	for	IN
25944	3549	18	the	the	DT
25944	3549	19	most	most	JJS
25944	3549	20	part	part	NN
25944	3549	21	original	original	JJ
25944	3549	22	photographs	photograph	NNS
25944	3549	23	and	and	CC
25944	3549	24	water	water	NN
25944	3549	25	-	-	HYPH
25944	3549	26	colors	color	NNS
25944	3549	27	of	of	IN
25944	3549	28	actual	actual	JJ
25944	3549	29	clinical	clinical	JJ
25944	3549	30	cases	case	NNS
25944	3549	31	accumulated	accumulate	VBN
25944	3549	32	during	during	IN
25944	3549	33	the	the	DT
25944	3549	34	past	past	JJ
25944	3549	35	fifteen	fifteen	CD
25944	3549	36	years	year	NNS
25944	3549	37	.	.	.
25944	3550	1	The	the	DT
25944	3550	2	palliative	palliative	JJ
25944	3550	3	treatment	treatment	NN
25944	3550	4	,	,	,
25944	3550	5	as	as	RB
25944	3550	6	well	well	RB
25944	3550	7	as	as	IN
25944	3550	8	the	the	DT
25944	3550	9	radical	radical	JJ
25944	3550	10	operative	operative	NN
25944	3550	11	,	,	,
25944	3550	12	is	be	VBZ
25944	3550	13	fully	fully	RB
25944	3550	14	described	describe	VBN
25944	3550	15	,	,	,
25944	3550	16	enabling	enable	VBG
25944	3550	17	the	the	DT
25944	3550	18	general	general	JJ
25944	3550	19	practitioner	practitioner	NN
25944	3550	20	to	to	TO
25944	3550	21	treat	treat	VB
25944	3550	22	many	many	JJ
25944	3550	23	of	of	IN
25944	3550	24	his	-PRON-	PRP$
25944	3550	25	own	own	JJ
25944	3550	26	patients	patient	NNS
25944	3550	27	without	without	IN
25944	3550	28	referring	refer	VBG
25944	3550	29	them	-PRON-	PRP
25944	3550	30	to	to	IN
25944	3550	31	a	a	DT
25944	3550	32	specialist	specialist	NN
25944	3550	33	.	.	.
25944	3551	1	The	the	DT
25944	3551	2	author	author	NN
25944	3551	3	's	's	POS
25944	3551	4	extensive	extensive	JJ
25944	3551	5	experience	experience	NN
25944	3551	6	renders	render	VBZ
25944	3551	7	this	this	DT
25944	3551	8	work	work	NN
25944	3551	9	of	of	IN
25944	3551	10	unusual	unusual	JJ
25944	3551	11	value	value	NN
25944	3551	12	.	.	.
25944	3552	1	*	*	NFP
25944	3552	2	*	*	NFP
25944	3552	3	*	*	NFP
25944	3552	4	*	*	NFP
25944	3552	5	*	*	NFP
25944	3552	6	OPINIONS	opinions	NN
25944	3552	7	OF	of	IN
25944	3552	8	THE	the	DT
25944	3552	9	MEDICAL	MEDICAL	NNP
25944	3552	10	PRESS	PRESS	NNP
25944	3552	11	*	*	NFP
25944	3552	12	*	*	NFP
25944	3552	13	*	*	NFP
25944	3552	14	*	*	NFP
25944	3552	15	*	*	NFP
25944	3552	16	#	#	NNP
25944	3552	17	Medical	Medical	NNP
25944	3552	18	Record	Record	NNP
25944	3552	19	,	,	,
25944	3552	20	New	New	NNP
25944	3552	21	York	York	NNP
25944	3552	22	#	#	NN
25944	3552	23	"	"	``
25944	3552	24	Its	-PRON-	PRP$
25944	3552	25	merits	merit	NNS
25944	3552	26	can	can	MD
25944	3552	27	be	be	VB
25944	3552	28	appreciated	appreciate	VBN
25944	3552	29	only	only	RB
25944	3552	30	by	by	IN
25944	3552	31	a	a	DT
25944	3552	32	careful	careful	JJ
25944	3552	33	perusal	perusal	NN
25944	3552	34	....	....	.
25944	3552	35	Nearly	nearly	RB
25944	3552	36	one	one	CD
25944	3552	37	hundred	hundred	CD
25944	3552	38	pages	page	NNS
25944	3552	39	are	be	VBP
25944	3552	40	devoted	devoted	JJ
25944	3552	41	to	to	IN
25944	3552	42	technic	technic	JJ
25944	3552	43	,	,	,
25944	3552	44	this	this	DT
25944	3552	45	chapter	chapter	NN
25944	3552	46	being	be	VBG
25944	3552	47	in	in	IN
25944	3552	48	some	some	DT
25944	3552	49	respects	respect	NNS
25944	3552	50	superior	superior	JJ
25944	3552	51	to	to	IN
25944	3552	52	the	the	DT
25944	3552	53	descriptions	description	NNS
25944	3552	54	in	in	IN
25944	3552	55	many	many	JJ
25944	3552	56	text	text	NN
25944	3552	57	-	-	HYPH
25944	3552	58	books	book	NNS
25944	3552	59	.	.	.
25944	3552	60	"	"	''
25944	3553	1	#	#	NNP
25944	3553	2	Boston	Boston	NNP
25944	3553	3	Medical	Medical	NNP
25944	3553	4	and	and	CC
25944	3553	5	Surgical	Surgical	NNP
25944	3553	6	Journal	Journal	NNP
25944	3553	7	#	#	$
25944	3553	8	"	"	``
25944	3553	9	The	the	DT
25944	3553	10	author	author	NN
25944	3553	11	has	have	VBZ
25944	3553	12	given	give	VBN
25944	3553	13	special	special	JJ
25944	3553	14	attention	attention	NN
25944	3553	15	to	to	IN
25944	3553	16	diagnosis	diagnosis	NN
25944	3553	17	and	and	CC
25944	3553	18	treatment	treatment	NN
25944	3553	19	throughout	throughout	IN
25944	3553	20	the	the	DT
25944	3553	21	book	book	NN
25944	3553	22	,	,	,
25944	3553	23	and	and	CC
25944	3553	24	has	have	VBZ
25944	3553	25	produced	produce	VBN
25944	3553	26	a	a	DT
25944	3553	27	practical	practical	JJ
25944	3553	28	treatise	treatise	NN
25944	3553	29	which	which	WDT
25944	3553	30	should	should	MD
25944	3553	31	be	be	VB
25944	3553	32	of	of	IN
25944	3553	33	the	the	DT
25944	3553	34	greatest	great	JJS
25944	3553	35	value	value	NN
25944	3553	36	to	to	IN
25944	3553	37	the	the	DT
25944	3553	38	student	student	NN
25944	3553	39	,	,	,
25944	3553	40	the	the	DT
25944	3553	41	general	general	JJ
25944	3553	42	practitioner	practitioner	NN
25944	3553	43	,	,	,
25944	3553	44	and	and	CC
25944	3553	45	the	the	DT
25944	3553	46	specialist	specialist	NN
25944	3553	47	.	.	.
25944	3553	48	"	"	''
25944	3554	1	#	#	NNP
25944	3554	2	Medical	Medical	NNP
25944	3554	3	News	News	NNP
25944	3554	4	,	,	,
25944	3554	5	New	New	NNP
25944	3554	6	York	York	NNP
25944	3554	7	#	#	$
25944	3554	8	"	"	``
25944	3554	9	Office	office	NN
25944	3554	10	treatment	treatment	NN
25944	3554	11	is	be	VBZ
25944	3554	12	given	give	VBN
25944	3554	13	a	a	DT
25944	3554	14	due	due	JJ
25944	3554	15	amount	amount	NN
25944	3554	16	of	of	IN
25944	3554	17	consideration	consideration	NN
25944	3554	18	,	,	,
25944	3554	19	so	so	IN
25944	3554	20	that	that	IN
25944	3554	21	the	the	DT
25944	3554	22	work	work	NN
25944	3554	23	will	will	MD
25944	3554	24	be	be	VB
25944	3554	25	as	as	RB
25944	3554	26	useful	useful	JJ
25944	3554	27	to	to	IN
25944	3554	28	the	the	DT
25944	3554	29	non	non	JJ
25944	3554	30	-	-	NN
25944	3554	31	operator	operator	NN
25944	3554	32	as	as	IN
25944	3554	33	to	to	IN
25944	3554	34	the	the	DT
25944	3554	35	specialist	specialist	NN
25944	3554	36	.	.	.
25944	3554	37	"	"	''
25944	3555	1	Hirst	Hirst	NNP
25944	3555	2	's	's	POS
25944	3555	3	Text	Text	NNP
25944	3555	4	-	-	HYPH
25944	3555	5	Book	Book	NNP
25944	3555	6	of	of	IN
25944	3555	7	Obstetrics	Obstetrics	NNP
25944	3555	8	New	New	NNP
25944	3555	9	(	(	-LRB-
25944	3555	10	5th	5th	NN
25944	3555	11	)	)	-RRB-
25944	3555	12	Edition	Edition	NNP
25944	3555	13	,	,	,
25944	3555	14	Revised	revise	VBN
25944	3555	15	*	*	NFP
25944	3555	16	*	*	NFP
25944	3555	17	*	*	NFP
25944	3555	18	*	*	NFP
25944	3555	19	*	*	NFP
25944	3555	20	#	#	NN
25944	3555	21	A	a	DT
25944	3555	22	Text	Text	NNP
25944	3555	23	-	-	HYPH
25944	3555	24	Book	Book	NNP
25944	3555	25	of	of	IN
25944	3555	26	Obstetrics	Obstetrics	NNPS
25944	3555	27	#	#	$
25944	3555	28	.	.	.
25944	3556	1	By	by	IN
25944	3556	2	Barton	Barton	NNP
25944	3556	3	Cooke	Cooke	NNP
25944	3556	4	Hirst	Hirst	NNP
25944	3556	5	,	,	,
25944	3556	6	M.D.	M.D.	NNP
25944	3556	7	,	,	,
25944	3556	8	Professor	Professor	NNP
25944	3556	9	of	of	IN
25944	3556	10	Obstetrics	Obstetrics	NNPS
25944	3556	11	in	in	IN
25944	3556	12	the	the	DT
25944	3556	13	University	University	NNP
25944	3556	14	of	of	IN
25944	3556	15	Pennsylvania	Pennsylvania	NNP
25944	3556	16	.	.	.
25944	3557	1	Handsome	handsome	JJ
25944	3557	2	octavo	octavo	NNP
25944	3557	3	,	,	,
25944	3557	4	899	899	CD
25944	3557	5	pages	page	NNS
25944	3557	6	,	,	,
25944	3557	7	with	with	IN
25944	3557	8	746	746	CD
25944	3557	9	illustrations	illustration	NNS
25944	3557	10	,	,	,
25944	3557	11	39	39	CD
25944	3557	12	in	in	IN
25944	3557	13	colors	color	NNS
25944	3557	14	.	.	.
25944	3558	1	Cloth	cloth	NN
25944	3558	2	,	,	,
25944	3558	3	$	$	$
25944	3558	4	5.00	5.00	CD
25944	3558	5	net	net	NN
25944	3558	6	;	;	:
25944	3558	7	Sheep	Sheep	NNS
25944	3558	8	or	or	CC
25944	3558	9	Half	Half	NNP
25944	3558	10	Morocco	Morocco	NNP
25944	3558	11	,	,	,
25944	3558	12	$	$	$
25944	3558	13	6.50	6.50	CD
25944	3558	14	net	net	NN
25944	3558	15	.	.	.
25944	3559	1	RECENTLY	recently	JJ
25944	3559	2	ISSUED	ISSUED	NNS
25944	3559	3	Immediately	immediately	RB
25944	3559	4	on	on	IN
25944	3559	5	its	-PRON-	PRP$
25944	3559	6	publication	publication	NN
25944	3559	7	this	this	DT
25944	3559	8	work	work	NN
25944	3559	9	took	take	VBD
25944	3559	10	its	-PRON-	PRP$
25944	3559	11	place	place	NN
25944	3559	12	as	as	IN
25944	3559	13	the	the	DT
25944	3559	14	leading	lead	VBG
25944	3559	15	text	text	NN
25944	3559	16	-	-	HYPH
25944	3559	17	book	book	NN
25944	3559	18	on	on	IN
25944	3559	19	the	the	DT
25944	3559	20	subject	subject	NN
25944	3559	21	.	.	.
25944	3560	1	Both	both	DT
25944	3560	2	in	in	IN
25944	3560	3	this	this	DT
25944	3560	4	country	country	NN
25944	3560	5	and	and	CC
25944	3560	6	abroad	abroad	RB
25944	3560	7	it	-PRON-	PRP
25944	3560	8	is	be	VBZ
25944	3560	9	recognized	recognize	VBN
25944	3560	10	as	as	IN
25944	3560	11	the	the	DT
25944	3560	12	most	most	RBS
25944	3560	13	satisfactorily	satisfactorily	RB
25944	3560	14	written	write	VBN
25944	3560	15	and	and	CC
25944	3560	16	clearly	clearly	RB
25944	3560	17	illustrated	illustrate	VBN
25944	3560	18	work	work	NN
25944	3560	19	on	on	IN
25944	3560	20	obstetrics	obstetric	NNS
25944	3560	21	in	in	IN
25944	3560	22	the	the	DT
25944	3560	23	language	language	NN
25944	3560	24	.	.	.
25944	3561	1	The	the	DT
25944	3561	2	illustrations	illustration	NNS
25944	3561	3	form	form	VBP
25944	3561	4	one	one	CD
25944	3561	5	of	of	IN
25944	3561	6	the	the	DT
25944	3561	7	features	feature	NNS
25944	3561	8	of	of	IN
25944	3561	9	the	the	DT
25944	3561	10	book	book	NN
25944	3561	11	.	.	.
25944	3562	1	They	-PRON-	PRP
25944	3562	2	are	be	VBP
25944	3562	3	numerous	numerous	JJ
25944	3562	4	and	and	CC
25944	3562	5	the	the	DT
25944	3562	6	most	most	JJS
25944	3562	7	of	of	IN
25944	3562	8	them	-PRON-	PRP
25944	3562	9	are	be	VBP
25944	3562	10	original	original	JJ
25944	3562	11	.	.	.
25944	3563	1	In	in	IN
25944	3563	2	this	this	DT
25944	3563	3	edition	edition	NN
25944	3563	4	the	the	DT
25944	3563	5	book	book	NN
25944	3563	6	has	have	VBZ
25944	3563	7	been	be	VBN
25944	3563	8	thoroughly	thoroughly	RB
25944	3563	9	revised	revise	VBN
25944	3563	10	.	.	.
25944	3564	1	More	More	JJR
25944	3564	2	attention	attention	NN
25944	3564	3	has	have	VBZ
25944	3564	4	been	be	VBN
25944	3564	5	given	give	VBN
25944	3564	6	to	to	IN
25944	3564	7	the	the	DT
25944	3564	8	diseases	disease	NNS
25944	3564	9	of	of	IN
25944	3564	10	the	the	DT
25944	3564	11	genital	genital	JJ
25944	3564	12	organs	organ	NNS
25944	3564	13	associated	associate	VBN
25944	3564	14	with	with	IN
25944	3564	15	or	or	CC
25944	3564	16	following	follow	VBG
25944	3564	17	childbirth	childbirth	NN
25944	3564	18	.	.	.
25944	3565	1	Many	many	JJ
25944	3565	2	of	of	IN
25944	3565	3	the	the	DT
25944	3565	4	old	old	JJ
25944	3565	5	illustrations	illustration	NNS
25944	3565	6	have	have	VBP
25944	3565	7	been	be	VBN
25944	3565	8	replaced	replace	VBN
25944	3565	9	by	by	IN
25944	3565	10	better	well	JJR
25944	3565	11	ones	one	NNS
25944	3565	12	,	,	,
25944	3565	13	and	and	CC
25944	3565	14	there	there	EX
25944	3565	15	have	have	VBP
25944	3565	16	been	be	VBN
25944	3565	17	added	add	VBN
25944	3565	18	a	a	DT
25944	3565	19	number	number	NN
25944	3565	20	entirely	entirely	RB
25944	3565	21	new	new	JJ
25944	3565	22	.	.	.
25944	3566	1	The	the	DT
25944	3566	2	work	work	NN
25944	3566	3	treats	treat	VBZ
25944	3566	4	the	the	DT
25944	3566	5	subject	subject	NN
25944	3566	6	from	from	IN
25944	3566	7	a	a	DT
25944	3566	8	clinical	clinical	JJ
25944	3566	9	standpoint	standpoint	NN
25944	3566	10	.	.	.
25944	3567	1	*	*	NFP
25944	3567	2	*	*	NFP
25944	3567	3	*	*	NFP
25944	3567	4	*	*	NFP
25944	3567	5	*	*	NFP
25944	3567	6	OPINIONS	opinions	NN
25944	3567	7	OF	of	IN
25944	3567	8	THE	the	DT
25944	3567	9	MEDICAL	MEDICAL	NNP
25944	3567	10	PRESS	PRESS	NNP
25944	3567	11	*	*	NFP
25944	3567	12	*	*	NFP
25944	3567	13	*	*	NFP
25944	3567	14	*	*	NFP
25944	3567	15	*	*	NFP
25944	3567	16	#	#	,
25944	3567	17	British	British	NNP
25944	3567	18	Medical	Medical	NNP
25944	3567	19	Journal	Journal	NNP
25944	3567	20	#	#	$
25944	3567	21	"	"	``
25944	3567	22	The	the	DT
25944	3567	23	popularity	popularity	NN
25944	3567	24	of	of	IN
25944	3567	25	American	american	JJ
25944	3567	26	text	text	NN
25944	3567	27	-	-	HYPH
25944	3567	28	books	book	NNS
25944	3567	29	in	in	IN
25944	3567	30	this	this	DT
25944	3567	31	country	country	NN
25944	3567	32	is	be	VBZ
25944	3567	33	one	one	CD
25944	3567	34	of	of	IN
25944	3567	35	the	the	DT
25944	3567	36	features	feature	NNS
25944	3567	37	of	of	IN
25944	3567	38	recent	recent	JJ
25944	3567	39	years	year	NNS
25944	3567	40	.	.	.
25944	3568	1	The	the	DT
25944	3568	2	popularity	popularity	NN
25944	3568	3	is	be	VBZ
25944	3568	4	probably	probably	RB
25944	3568	5	chiefly	chiefly	RB
25944	3568	6	due	due	JJ
25944	3568	7	to	to	IN
25944	3568	8	the	the	DT
25944	3568	9	great	great	JJ
25944	3568	10	superiority	superiority	NN
25944	3568	11	of	of	IN
25944	3568	12	their	-PRON-	PRP$
25944	3568	13	illustration	illustration	NN
25944	3568	14	over	over	IN
25944	3568	15	those	those	DT
25944	3568	16	of	of	IN
25944	3568	17	the	the	DT
25944	3568	18	English	english	JJ
25944	3568	19	text	text	NN
25944	3568	20	-	-	HYPH
25944	3568	21	books	book	NNS
25944	3568	22	.	.	.
25944	3569	1	The	the	DT
25944	3569	2	illustrations	illustration	NNS
25944	3569	3	in	in	IN
25944	3569	4	Dr.	Dr.	NNP
25944	3569	5	Hirst	Hirst	NNP
25944	3569	6	's	's	POS
25944	3569	7	volume	volume	NN
25944	3569	8	are	be	VBP
25944	3569	9	far	far	RB
25944	3569	10	more	more	RBR
25944	3569	11	numerous	numerous	JJ
25944	3569	12	and	and	CC
25944	3569	13	far	far	RB
25944	3569	14	better	well	RBR
25944	3569	15	executed	execute	VBN
25944	3569	16	,	,	,
25944	3569	17	and	and	CC
25944	3569	18	therefore	therefore	RB
25944	3569	19	more	more	RBR
25944	3569	20	instructive	instructive	JJ
25944	3569	21	,	,	,
25944	3569	22	than	than	IN
25944	3569	23	those	those	DT
25944	3569	24	commonly	commonly	RB
25944	3569	25	found	find	VBN
25944	3569	26	in	in	IN
25944	3569	27	the	the	DT
25944	3569	28	works	work	NNS
25944	3569	29	of	of	IN
25944	3569	30	writers	writer	NNS
25944	3569	31	on	on	IN
25944	3569	32	obstetrics	obstetric	NNS
25944	3569	33	in	in	IN
25944	3569	34	our	-PRON-	PRP$
25944	3569	35	own	own	JJ
25944	3569	36	country	country	NN
25944	3569	37	.	.	.
25944	3569	38	"	"	''
25944	3570	1	#	#	NNP
25944	3570	2	Bulletin	Bulletin	NNP
25944	3570	3	of	of	IN
25944	3570	4	Johns	Johns	NNP
25944	3570	5	Hopkins	Hopkins	NNP
25944	3570	6	Hospital	Hospital	NNP
25944	3570	7	#	#	$
25944	3570	8	"	"	``
25944	3570	9	The	the	DT
25944	3570	10	work	work	NN
25944	3570	11	is	be	VBZ
25944	3570	12	an	an	DT
25944	3570	13	admirable	admirable	JJ
25944	3570	14	one	one	NN
25944	3570	15	in	in	IN
25944	3570	16	every	every	DT
25944	3570	17	sense	sense	NN
25944	3570	18	of	of	IN
25944	3570	19	the	the	DT
25944	3570	20	word	word	NN
25944	3570	21	,	,	,
25944	3570	22	concisely	concisely	RB
25944	3570	23	but	but	CC
25944	3570	24	comprehensively	comprehensively	RB
25944	3570	25	written	write	VBN
25944	3570	26	.	.	.
25944	3570	27	"	"	''
25944	3571	1	#	#	$
25944	3571	2	The	the	DT
25944	3571	3	Medical	Medical	NNP
25944	3571	4	Record	Record	NNP
25944	3571	5	,	,	,
25944	3571	6	New	New	NNP
25944	3571	7	York	York	NNP
25944	3571	8	#	#	NN
25944	3571	9	"	"	``
25944	3571	10	The	the	DT
25944	3571	11	illustrations	illustration	NNS
25944	3571	12	are	be	VBP
25944	3571	13	numerous	numerous	JJ
25944	3571	14	and	and	CC
25944	3571	15	are	be	VBP
25944	3571	16	works	work	NNS
25944	3571	17	of	of	IN
25944	3571	18	art	art	NN
25944	3571	19	,	,	,
25944	3571	20	many	many	JJ
25944	3571	21	of	of	IN
25944	3571	22	them	-PRON-	PRP
25944	3571	23	appearing	appear	VBG
25944	3571	24	for	for	IN
25944	3571	25	the	the	DT
25944	3571	26	first	first	JJ
25944	3571	27	time	time	NN
25944	3571	28	.	.	.
25944	3572	1	The	the	DT
25944	3572	2	author	author	NN
25944	3572	3	's	's	POS
25944	3572	4	style	style	NN
25944	3572	5	,	,	,
25944	3572	6	though	though	IN
25944	3572	7	condensed	condense	VBN
25944	3572	8	,	,	,
25944	3572	9	is	be	VBZ
25944	3572	10	singularly	singularly	RB
25944	3572	11	clear	clear	JJ
25944	3572	12	,	,	,
25944	3572	13	so	so	IN
25944	3572	14	that	that	IN
25944	3572	15	it	-PRON-	PRP
25944	3572	16	is	be	VBZ
25944	3572	17	never	never	RB
25944	3572	18	necessary	necessary	JJ
25944	3572	19	to	to	TO
25944	3572	20	re	re	VB
25944	3572	21	-	-	VB
25944	3572	22	read	read	VB
25944	3572	23	a	a	DT
25944	3572	24	sentence	sentence	NN
25944	3572	25	in	in	IN
25944	3572	26	order	order	NN
25944	3572	27	to	to	TO
25944	3572	28	grasp	grasp	VB
25944	3572	29	the	the	DT
25944	3572	30	meaning	meaning	NN
25944	3572	31	.	.	.
25944	3573	1	As	as	IN
25944	3573	2	a	a	DT
25944	3573	3	true	true	JJ
25944	3573	4	model	model	NN
25944	3573	5	of	of	IN
25944	3573	6	what	what	WP
25944	3573	7	a	a	DT
25944	3573	8	modern	modern	JJ
25944	3573	9	text	text	NN
25944	3573	10	-	-	HYPH
25944	3573	11	book	book	NN
25944	3573	12	on	on	IN
25944	3573	13	obstetrics	obstetric	NNS
25944	3573	14	should	should	MD
25944	3573	15	be	be	VB
25944	3573	16	,	,	,
25944	3573	17	we	-PRON-	PRP
25944	3573	18	feel	feel	VBP
25944	3573	19	justified	justified	JJ
25944	3573	20	in	in	IN
25944	3573	21	affirming	affirming	NN
25944	3573	22	that	that	IN
25944	3573	23	Dr.	Dr.	NNP
25944	3573	24	Hirst	Hirst	NNP
25944	3573	25	's	's	POS
25944	3573	26	book	book	NN
25944	3573	27	is	be	VBZ
25944	3573	28	without	without	IN
25944	3573	29	a	a	DT
25944	3573	30	rival	rival	NN
25944	3573	31	.	.	.
25944	3573	32	"	"	''
25944	3574	1	Penrose	Penrose	NNP
25944	3574	2	's	's	POS
25944	3574	3	Diseases	Diseases	NNPS
25944	3574	4	of	of	IN
25944	3574	5	Women	Women	NNP
25944	3574	6	Sixth	Sixth	NNP
25944	3574	7	Revised	Revised	NNP
25944	3574	8	Edition	Edition	NNP
25944	3574	9	*	*	NFP
25944	3574	10	*	*	NFP
25944	3574	11	*	*	NFP
25944	3574	12	*	*	NFP
25944	3574	13	*	*	NFP
25944	3574	14	#	#	NN
25944	3574	15	A	a	DT
25944	3574	16	Text	Text	NNP
25944	3574	17	-	-	HYPH
25944	3574	18	Book	Book	NNP
25944	3574	19	of	of	IN
25944	3574	20	Diseases	Diseases	NNPS
25944	3574	21	of	of	IN
25944	3574	22	Women	Women	NNP
25944	3574	23	#	#	$
25944	3574	24	.	.	.
25944	3575	1	By	by	IN
25944	3575	2	Charles	Charles	NNP
25944	3575	3	B.	B.	NNP
25944	3575	4	Penrose	Penrose	NNP
25944	3575	5	,	,	,
25944	3575	6	M.D.	M.D.	NNP
25944	3575	7	,	,	,
25944	3575	8	Ph.D.	ph.d.	NN
25944	3575	9	,	,	,
25944	3575	10	formerly	formerly	RB
25944	3575	11	Professor	Professor	NNP
25944	3575	12	of	of	IN
25944	3575	13	Gynecology	Gynecology	NNP
25944	3575	14	in	in	IN
25944	3575	15	the	the	DT
25944	3575	16	University	University	NNP
25944	3575	17	of	of	IN
25944	3575	18	Pennsylvania	Pennsylvania	NNP
25944	3575	19	;	;	:
25944	3575	20	Surgeon	Surgeon	NNP
25944	3575	21	to	to	IN
25944	3575	22	the	the	DT
25944	3575	23	Gynecean	Gynecean	NNP
25944	3575	24	Hospital	Hospital	NNP
25944	3575	25	,	,	,
25944	3575	26	Philadelphia	Philadelphia	NNP
25944	3575	27	.	.	.
25944	3576	1	Octavo	octavo	JJ
25944	3576	2	volume	volume	NN
25944	3576	3	of	of	IN
25944	3576	4	550	550	CD
25944	3576	5	pages	page	NNS
25944	3576	6	,	,	,
25944	3576	7	with	with	IN
25944	3576	8	225	225	CD
25944	3576	9	fine	fine	JJ
25944	3576	10	original	original	JJ
25944	3576	11	illustrations	illustration	NNS
25944	3576	12	.	.	.
25944	3577	1	Cloth	cloth	VB
25944	3577	2	$	$	$
25944	3577	3	3.75	3.75	CD
25944	3577	4	net	net	NN
25944	3577	5	.	.	.
25944	3578	1	JUST	just	RB
25944	3578	2	ISSUED	issue	VBZ
25944	3578	3	Regularly	regularly	RB
25944	3578	4	every	every	DT
25944	3578	5	year	year	NN
25944	3578	6	a	a	DT
25944	3578	7	new	new	JJ
25944	3578	8	edition	edition	NN
25944	3578	9	of	of	IN
25944	3578	10	this	this	DT
25944	3578	11	excellent	excellent	JJ
25944	3578	12	text	text	NN
25944	3578	13	-	-	HYPH
25944	3578	14	book	book	NN
25944	3578	15	is	be	VBZ
25944	3578	16	called	call	VBN
25944	3578	17	for	for	IN
25944	3578	18	,	,	,
25944	3578	19	and	and	CC
25944	3578	20	it	-PRON-	PRP
25944	3578	21	appears	appear	VBZ
25944	3578	22	to	to	TO
25944	3578	23	be	be	VB
25944	3578	24	in	in	IN
25944	3578	25	as	as	RB
25944	3578	26	great	great	JJ
25944	3578	27	favor	favor	NN
25944	3578	28	with	with	IN
25944	3578	29	physicians	physician	NNS
25944	3578	30	as	as	IN
25944	3578	31	with	with	IN
25944	3578	32	students	student	NNS
25944	3578	33	.	.	.
25944	3579	1	Indeed	indeed	RB
25944	3579	2	,	,	,
25944	3579	3	this	this	DT
25944	3579	4	book	book	NN
25944	3579	5	has	have	VBZ
25944	3579	6	taken	take	VBN
25944	3579	7	its	-PRON-	PRP$
25944	3579	8	place	place	NN
25944	3579	9	as	as	IN
25944	3579	10	the	the	DT
25944	3579	11	ideal	ideal	JJ
25944	3579	12	work	work	NN
25944	3579	13	for	for	IN
25944	3579	14	the	the	DT
25944	3579	15	general	general	JJ
25944	3579	16	practitioner	practitioner	NN
25944	3579	17	.	.	.
25944	3580	1	The	the	DT
25944	3580	2	author	author	NN
25944	3580	3	presents	present	VBZ
25944	3580	4	the	the	DT
25944	3580	5	best	good	JJS
25944	3580	6	teaching	teaching	NN
25944	3580	7	of	of	IN
25944	3580	8	modern	modern	JJ
25944	3580	9	gynecology	gynecology	NN
25944	3580	10	,	,	,
25944	3580	11	untrammeled	untrammele	VBN
25944	3580	12	by	by	IN
25944	3580	13	antiquated	antiquated	JJ
25944	3580	14	ideas	idea	NNS
25944	3580	15	and	and	CC
25944	3580	16	methods	method	NNS
25944	3580	17	.	.	.
25944	3581	1	In	in	IN
25944	3581	2	every	every	DT
25944	3581	3	case	case	NN
25944	3581	4	the	the	DT
25944	3581	5	most	most	RBS
25944	3581	6	modern	modern	JJ
25944	3581	7	and	and	CC
25944	3581	8	progressive	progressive	JJ
25944	3581	9	technique	technique	NN
25944	3581	10	is	be	VBZ
25944	3581	11	adopted	adopt	VBN
25944	3581	12	,	,	,
25944	3581	13	and	and	CC
25944	3581	14	the	the	DT
25944	3581	15	main	main	JJ
25944	3581	16	points	point	NNS
25944	3581	17	are	be	VBP
25944	3581	18	made	make	VBN
25944	3581	19	clear	clear	JJ
25944	3581	20	by	by	IN
25944	3581	21	excellent	excellent	JJ
25944	3581	22	illustrations	illustration	NNS
25944	3581	23	.	.	.
25944	3582	1	The	the	DT
25944	3582	2	new	new	JJ
25944	3582	3	edition	edition	NN
25944	3582	4	has	have	VBZ
25944	3582	5	been	be	VBN
25944	3582	6	carefully	carefully	RB
25944	3582	7	revised	revise	VBN
25944	3582	8	,	,	,
25944	3582	9	much	much	JJ
25944	3582	10	new	new	JJ
25944	3582	11	matter	matter	NN
25944	3582	12	has	have	VBZ
25944	3582	13	been	be	VBN
25944	3582	14	added	add	VBN
25944	3582	15	,	,	,
25944	3582	16	and	and	CC
25944	3582	17	a	a	DT
25944	3582	18	number	number	NN
25944	3582	19	of	of	IN
25944	3582	20	new	new	JJ
25944	3582	21	original	original	JJ
25944	3582	22	illustrations	illustration	NNS
25944	3582	23	have	have	VBP
25944	3582	24	been	be	VBN
25944	3582	25	introduced	introduce	VBN
25944	3582	26	.	.	.
25944	3583	1	In	in	IN
25944	3583	2	its	-PRON-	PRP$
25944	3583	3	revised	revise	VBN
25944	3583	4	form	form	NN
25944	3583	5	this	this	DT
25944	3583	6	volume	volume	NN
25944	3583	7	continues	continue	VBZ
25944	3583	8	to	to	TO
25944	3583	9	be	be	VB
25944	3583	10	an	an	DT
25944	3583	11	admirable	admirable	JJ
25944	3583	12	exposition	exposition	NN
25944	3583	13	of	of	IN
25944	3583	14	the	the	DT
25944	3583	15	present	present	JJ
25944	3583	16	status	status	NN
25944	3583	17	of	of	IN
25944	3583	18	gynecologic	gynecologic	JJ
25944	3583	19	practice	practice	NN
25944	3583	20	.	.	.
25944	3584	1	*	*	NFP
25944	3584	2	*	*	NFP
25944	3584	3	*	*	NFP
25944	3584	4	*	*	NFP
25944	3584	5	*	*	NFP
25944	3584	6	PERSONAL	personal	NN
25944	3584	7	AND	and	CC
25944	3584	8	PRESS	press	NN
25944	3584	9	OPINIONS	opinions	NN
25944	3584	10	*	*	NFP
25944	3584	11	*	*	NFP
25944	3584	12	*	*	NFP
25944	3584	13	*	*	NFP
25944	3584	14	*	*	NFP
25944	3584	15	#	#	$
25944	3584	16	Howard	Howard	NNP
25944	3584	17	A.	a.	NN
25944	3584	18	Kelly	Kelly	NNP
25944	3584	19	,	,	,
25944	3584	20	M.D.	M.D.	NNP
25944	3584	21	,	,	,
25944	3584	22	#	#	NNP
25944	3584	23	_	_	NNP
25944	3584	24	Professor	Professor	NNP
25944	3584	25	of	of	IN
25944	3584	26	Gynecology	Gynecology	NNP
25944	3584	27	and	and	CC
25944	3584	28	Obstetrics	Obstetrics	NNP
25944	3584	29	,	,	,
25944	3584	30	Johns	Johns	NNP
25944	3584	31	Hopkins	Hopkins	NNP
25944	3584	32	University	University	NNP
25944	3584	33	,	,	,
25944	3584	34	Baltimore	Baltimore	NNP
25944	3584	35	.	.	.
25944	3584	36	_	_	NNP
25944	3584	37	"	"	``
25944	3584	38	I	-PRON-	PRP
25944	3584	39	shall	shall	MD
25944	3584	40	value	value	VB
25944	3584	41	very	very	RB
25944	3584	42	highly	highly	RB
25944	3584	43	the	the	DT
25944	3584	44	copy	copy	NN
25944	3584	45	of	of	IN
25944	3584	46	Penrose	Penrose	NNP
25944	3584	47	's	's	POS
25944	3584	48	'	'	``
25944	3584	49	Diseases	Diseases	NNPS
25944	3584	50	of	of	IN
25944	3584	51	Women	woman	NNS
25944	3584	52	'	'	POS
25944	3584	53	received	receive	VBD
25944	3584	54	.	.	.
25944	3585	1	I	-PRON-	PRP
25944	3585	2	have	have	VBP
25944	3585	3	already	already	RB
25944	3585	4	recommended	recommend	VBN
25944	3585	5	it	-PRON-	PRP
25944	3585	6	to	to	IN
25944	3585	7	my	-PRON-	PRP$
25944	3585	8	class	class	NN
25944	3585	9	as	as	IN
25944	3585	10	The	the	DT
25944	3585	11	Best	good	JJS
25944	3585	12	book	book	NN
25944	3585	13	.	.	.
25944	3585	14	"	"	''
25944	3586	1	#	#	NNP
25944	3586	2	L.E.	L.E.	NNP
25944	3587	1	Montgomery	Montgomery	NNP
25944	3587	2	,	,	,
25944	3587	3	M.D.	M.D.	NNP
25944	3587	4	,	,	,
25944	3587	5	#	#	NNP
25944	3587	6	_	_	NNP
25944	3587	7	Professor	Professor	NNP
25944	3587	8	of	of	IN
25944	3587	9	Gynecology	Gynecology	NNP
25944	3587	10	,	,	,
25944	3587	11	Jefferson	Jefferson	NNP
25944	3587	12	Medical	Medical	NNP
25944	3587	13	College	College	NNP
25944	3587	14	,	,	,
25944	3587	15	Philadelphia	Philadelphia	NNP
25944	3587	16	.	.	.
25944	3587	17	_	_	NNP
25944	3587	18	"	"	``
25944	3587	19	The	the	DT
25944	3587	20	copy	copy	NN
25944	3587	21	of	of	IN
25944	3587	22	'	'	``
25944	3587	23	A	a	DT
25944	3587	24	Text	Text	NNP
25944	3587	25	-	-	HYPH
25944	3587	26	Book	Book	NNP
25944	3587	27	of	of	IN
25944	3587	28	Diseases	Diseases	NNPS
25944	3587	29	of	of	IN
25944	3587	30	Women	Women	NNPS
25944	3587	31	'	'	POS
25944	3587	32	by	by	IN
25944	3587	33	Penrose	Penrose	NNP
25944	3587	34	received	receive	VBD
25944	3587	35	to	to	IN
25944	3587	36	-	-	HYPH
25944	3587	37	day	day	NN
25944	3587	38	.	.	.
25944	3588	1	I	-PRON-	PRP
25944	3588	2	have	have	VBP
25944	3588	3	looked	look	VBN
25944	3588	4	over	over	IN
25944	3588	5	it	-PRON-	PRP
25944	3588	6	and	and	CC
25944	3588	7	admire	admire	VB
25944	3588	8	it	-PRON-	PRP
25944	3588	9	very	very	RB
25944	3588	10	much	much	RB
25944	3588	11	.	.	.
25944	3589	1	I	-PRON-	PRP
25944	3589	2	have	have	VBP
25944	3589	3	no	no	DT
25944	3589	4	doubt	doubt	NN
25944	3589	5	it	-PRON-	PRP
25944	3589	6	will	will	MD
25944	3589	7	have	have	VB
25944	3589	8	a	a	DT
25944	3589	9	large	large	JJ
25944	3589	10	sale	sale	NN
25944	3589	11	,	,	,
25944	3589	12	as	as	IN
25944	3589	13	it	-PRON-	PRP
25944	3589	14	justly	justly	RB
25944	3589	15	merits	merit	VBZ
25944	3589	16	.	.	.
25944	3589	17	"	"	''
25944	3590	1	#	#	NN
25944	3590	2	Bristol	Bristol	NNP
25944	3590	3	Medico	Medico	NNP
25944	3590	4	-	-	HYPH
25944	3590	5	Chirurgical	Chirurgical	NNP
25944	3590	6	Journal	Journal	NNP
25944	3590	7	#	#	$
25944	3590	8	"	"	``
25944	3590	9	This	this	DT
25944	3590	10	is	be	VBZ
25944	3590	11	an	an	DT
25944	3590	12	excellent	excellent	JJ
25944	3590	13	work	work	NN
25944	3590	14	which	which	WDT
25944	3590	15	goes	go	VBZ
25944	3590	16	straight	straight	RB
25944	3590	17	to	to	IN
25944	3590	18	the	the	DT
25944	3590	19	mark	mark	NN
25944	3590	20	....	....	.
25944	3591	1	The	the	DT
25944	3591	2	book	book	NN
25944	3591	3	may	may	MD
25944	3591	4	be	be	VB
25944	3591	5	taken	take	VBN
25944	3591	6	as	as	IN
25944	3591	7	a	a	DT
25944	3591	8	trustworthy	trustworthy	JJ
25944	3591	9	exposition	exposition	NN
25944	3591	10	of	of	IN
25944	3591	11	modern	modern	JJ
25944	3591	12	gynecology	gynecology	NN
25944	3591	13	.	.	.
25944	3591	14	"	"	''
25944	3592	1	GET	get	VB
25944	3592	2	THE	the	DT
25944	3592	3	NEW	new	JJ
25944	3592	4	THE	the	DT
25944	3592	5	BEST	best	JJ
25944	3592	6	American	american	JJ
25944	3592	7	STANDARD	STANDARD	NNP
25944	3592	8	Illustrated	Illustrated	NNP
25944	3592	9	Dictionary	Dictionary	NNP
25944	3592	10	Recently	recently	RB
25944	3592	11	Issued	issue	VBN
25944	3592	12	--	--	:
25944	3592	13	New	New	NNP
25944	3592	14	(	(	-LRB-
25944	3592	15	4th	4th	JJ
25944	3592	16	)	)	-RRB-
25944	3592	17	Edition	edition	NN
25944	3592	18	*	*	NFP
25944	3592	19	*	*	NFP
25944	3592	20	*	*	NFP
25944	3592	21	*	*	NFP
25944	3592	22	*	*	NFP
25944	3592	23	#	#	NN
25944	3592	24	The	the	DT
25944	3592	25	American	American	NNP
25944	3592	26	Illustrated	Illustrated	NNP
25944	3592	27	Medical	Medical	NNP
25944	3592	28	Dictionary	Dictionary	NNP
25944	3592	29	#	#	NNP
25944	3592	30	.	.	.
25944	3593	1	A	a	DT
25944	3593	2	new	new	JJ
25944	3593	3	and	and	CC
25944	3593	4	complete	complete	JJ
25944	3593	5	dictionary	dictionary	NN
25944	3593	6	of	of	IN
25944	3593	7	the	the	DT
25944	3593	8	terms	term	NNS
25944	3593	9	used	use	VBN
25944	3593	10	in	in	IN
25944	3593	11	Medicine	Medicine	NNP
25944	3593	12	,	,	,
25944	3593	13	Surgery	Surgery	NNP
25944	3593	14	,	,	,
25944	3593	15	Dentistry	Dentistry	NNP
25944	3593	16	,	,	,
25944	3593	17	Pharmacy	Pharmacy	NNP
25944	3593	18	,	,	,
25944	3593	19	Chemistry	Chemistry	NNP
25944	3593	20	,	,	,
25944	3593	21	and	and	CC
25944	3593	22	kindred	kindred	JJ
25944	3593	23	branches	branch	NNS
25944	3593	24	;	;	:
25944	3593	25	with	with	IN
25944	3593	26	over	over	IN
25944	3593	27	100	100	CD
25944	3593	28	new	new	JJ
25944	3593	29	and	and	CC
25944	3593	30	elaborate	elaborate	JJ
25944	3593	31	tables	table	NNS
25944	3593	32	and	and	CC
25944	3593	33	many	many	JJ
25944	3593	34	handsome	handsome	JJ
25944	3593	35	illustrations	illustration	NNS
25944	3593	36	.	.	.
25944	3594	1	By	by	IN
25944	3594	2	W.A.	W.A.	NNP
25944	3595	1	Newman	Newman	NNP
25944	3595	2	Dorland	Dorland	NNP
25944	3595	3	,	,	,
25944	3595	4	M.D.	M.D.	NNP
25944	3595	5	,	,	,
25944	3595	6	Editor	Editor	NNP
25944	3595	7	of	of	IN
25944	3595	8	"	"	``
25944	3595	9	The	the	DT
25944	3595	10	American	American	NNP
25944	3595	11	Pocket	Pocket	NNP
25944	3595	12	Medical	Medical	NNP
25944	3595	13	Dictionary	Dictionary	NNP
25944	3595	14	.	.	.
25944	3595	15	"	"	''
25944	3596	1	Large	large	JJ
25944	3596	2	octavo	octavo	NN
25944	3596	3	,	,	,
25944	3596	4	850	850	CD
25944	3596	5	pages	page	NNS
25944	3596	6	,	,	,
25944	3596	7	bound	bind	VBN
25944	3596	8	in	in	IN
25944	3596	9	full	full	JJ
25944	3596	10	flexible	flexible	JJ
25944	3596	11	leather	leather	NN
25944	3596	12	.	.	.
25944	3597	1	Price	price	NN
25944	3597	2	,	,	,
25944	3597	3	$	$	$
25944	3597	4	4.50	4.50	CD
25944	3597	5	net	net	NN
25944	3597	6	;	;	:
25944	3597	7	with	with	IN
25944	3597	8	thumb	thumb	NN
25944	3597	9	index	index	NN
25944	3597	10	,	,	,
25944	3597	11	$	$	$
25944	3597	12	5.00	5.00	CD
25944	3597	13	net	net	NN
25944	3597	14	.	.	.
25944	3598	1	Gives	give	VBZ
25944	3598	2	a	a	DT
25944	3598	3	Maximum	Maximum	NNP
25944	3598	4	Amount	Amount	NNP
25944	3598	5	of	of	IN
25944	3598	6	Matter	Matter	NNP
25944	3598	7	in	in	IN
25944	3598	8	a	a	DT
25944	3598	9	Minimum	Minimum	NNP
25944	3598	10	Space	Space	NNP
25944	3598	11	,	,	,
25944	3598	12	and	and	CC
25944	3598	13	at	at	IN
25944	3598	14	the	the	DT
25944	3598	15	Lowest	low	JJS
25944	3598	16	Possible	possible	JJ
25944	3598	17	Cost	cost	NN
25944	3598	18	WITH	with	IN
25944	3598	19	2000	2000	CD
25944	3598	20	NEW	new	JJ
25944	3598	21	TERMS	term	NNS
25944	3598	22	The	the	DT
25944	3598	23	immediate	immediate	JJ
25944	3598	24	success	success	NN
25944	3598	25	of	of	IN
25944	3598	26	this	this	DT
25944	3598	27	work	work	NN
25944	3598	28	is	be	VBZ
25944	3598	29	due	due	JJ
25944	3598	30	to	to	IN
25944	3598	31	the	the	DT
25944	3598	32	special	special	JJ
25944	3598	33	features	feature	NNS
25944	3598	34	that	that	WDT
25944	3598	35	distinguish	distinguish	VBP
25944	3598	36	it	-PRON-	PRP
25944	3598	37	from	from	IN
25944	3598	38	other	other	JJ
25944	3598	39	books	book	NNS
25944	3598	40	of	of	IN
25944	3598	41	its	-PRON-	PRP$
25944	3598	42	kind	kind	NN
25944	3598	43	.	.	.
25944	3599	1	It	-PRON-	PRP
25944	3599	2	gives	give	VBZ
25944	3599	3	a	a	DT
25944	3599	4	maximum	maximum	NN
25944	3599	5	of	of	IN
25944	3599	6	matter	matter	NN
25944	3599	7	in	in	IN
25944	3599	8	a	a	DT
25944	3599	9	minimum	minimum	JJ
25944	3599	10	space	space	NN
25944	3599	11	and	and	CC
25944	3599	12	at	at	IN
25944	3599	13	the	the	DT
25944	3599	14	lowest	low	JJS
25944	3599	15	possible	possible	JJ
25944	3599	16	cost	cost	NN
25944	3599	17	.	.	.
25944	3600	1	Though	though	IN
25944	3600	2	it	-PRON-	PRP
25944	3600	3	is	be	VBZ
25944	3600	4	practically	practically	RB
25944	3600	5	unabridged	unabridged	JJ
25944	3600	6	,	,	,
25944	3600	7	yet	yet	CC
25944	3600	8	by	by	IN
25944	3600	9	the	the	DT
25944	3600	10	use	use	NN
25944	3600	11	of	of	IN
25944	3600	12	thin	thin	JJ
25944	3600	13	bible	bible	NNP
25944	3600	14	paper	paper	NN
25944	3600	15	and	and	CC
25944	3600	16	flexible	flexible	JJ
25944	3600	17	morocco	morocco	NN
25944	3600	18	binding	bind	VBG
25944	3600	19	it	-PRON-	PRP
25944	3600	20	is	be	VBZ
25944	3600	21	only	only	RB
25944	3600	22	1	1	CD
25944	3600	23	-	-	SYM
25944	3600	24	1/4	1/4	CD
25944	3600	25	inches	inch	NNS
25944	3600	26	thick	thick	JJ
25944	3600	27	.	.	.
25944	3601	1	In	in	IN
25944	3601	2	this	this	DT
25944	3601	3	new	new	JJ
25944	3601	4	edition	edition	NN
25944	3601	5	the	the	DT
25944	3601	6	book	book	NN
25944	3601	7	has	have	VBZ
25944	3601	8	been	be	VBN
25944	3601	9	thoroughly	thoroughly	RB
25944	3601	10	revised	revise	VBN
25944	3601	11	,	,	,
25944	3601	12	and	and	CC
25944	3601	13	upward	upward	RB
25944	3601	14	of	of	IN
25944	3601	15	two	two	CD
25944	3601	16	thousand	thousand	CD
25944	3601	17	new	new	JJ
25944	3601	18	terms	term	NNS
25944	3601	19	have	have	VBP
25944	3601	20	been	be	VBN
25944	3601	21	added	add	VBN
25944	3601	22	,	,	,
25944	3601	23	thus	thus	RB
25944	3601	24	bringing	bring	VBG
25944	3601	25	the	the	DT
25944	3601	26	book	book	NN
25944	3601	27	absolutely	absolutely	RB
25944	3601	28	up	up	IN
25944	3601	29	to	to	IN
25944	3601	30	date	date	NN
25944	3601	31	.	.	.
25944	3602	1	The	the	DT
25944	3602	2	book	book	NN
25944	3602	3	contains	contain	VBZ
25944	3602	4	hundreds	hundred	NNS
25944	3602	5	of	of	IN
25944	3602	6	terms	term	NNS
25944	3602	7	not	not	RB
25944	3602	8	to	to	TO
25944	3602	9	be	be	VB
25944	3602	10	found	find	VBN
25944	3602	11	in	in	IN
25944	3602	12	any	any	DT
25944	3602	13	other	other	JJ
25944	3602	14	dictionary	dictionary	NN
25944	3602	15	,	,	,
25944	3602	16	over	over	IN
25944	3602	17	100	100	CD
25944	3602	18	original	original	JJ
25944	3602	19	tables	table	NNS
25944	3602	20	,	,	,
25944	3602	21	and	and	CC
25944	3602	22	many	many	JJ
25944	3602	23	handsome	handsome	JJ
25944	3602	24	illustrations	illustration	NNS
25944	3602	25	.	.	.
25944	3603	1	*	*	NFP
25944	3603	2	*	*	NFP
25944	3603	3	*	*	NFP
25944	3603	4	*	*	NFP
25944	3603	5	*	*	NFP
25944	3603	6	PERSONAL	personal	JJ
25944	3603	7	OPINIONS	opinions	NN
25944	3603	8	*	*	NFP
25944	3603	9	*	*	NFP
25944	3603	10	*	*	NFP
25944	3603	11	*	*	NFP
25944	3603	12	*	*	NFP
25944	3603	13	#	#	$
25944	3603	14	Howard	Howard	NNP
25944	3603	15	A.	a.	NN
25944	3603	16	Kelly	Kelly	NNP
25944	3603	17	,	,	,
25944	3603	18	M.D.	M.D.	NNP
25944	3603	19	,	,	,
25944	3603	20	#	#	NNP
25944	3603	21	_	_	NNP
25944	3603	22	Professor	Professor	NNP
25944	3603	23	of	of	IN
25944	3603	24	Gynecology	Gynecology	NNP
25944	3603	25	,	,	,
25944	3603	26	Johns	Johns	NNP
25944	3603	27	Hopkins	Hopkins	NNP
25944	3603	28	University	University	NNP
25944	3603	29	,	,	,
25944	3603	30	Baltimore	Baltimore	NNP
25944	3603	31	.	.	.
25944	3603	32	_	_	NNP
25944	3603	33	"	"	``
25944	3603	34	Dr.	Dr.	NNP
25944	3603	35	Borland	Borland	NNP
25944	3603	36	's	's	POS
25944	3603	37	dictionary	dictionary	NN
25944	3603	38	is	be	VBZ
25944	3603	39	admirable	admirable	JJ
25944	3603	40	.	.	.
25944	3604	1	It	-PRON-	PRP
25944	3604	2	is	be	VBZ
25944	3604	3	so	so	RB
25944	3604	4	well	well	RB
25944	3604	5	gotten	get	VBN
25944	3604	6	up	up	RP
25944	3604	7	and	and	CC
25944	3604	8	of	of	IN
25944	3604	9	such	such	JJ
25944	3604	10	convenient	convenient	JJ
25944	3604	11	size	size	NN
25944	3604	12	.	.	.
25944	3605	1	No	no	DT
25944	3605	2	errors	error	NNS
25944	3605	3	have	have	VBP
25944	3605	4	been	be	VBN
25944	3605	5	found	find	VBN
25944	3605	6	in	in	IN
25944	3605	7	my	-PRON-	PRP$
25944	3605	8	use	use	NN
25944	3605	9	of	of	IN
25944	3605	10	it	-PRON-	PRP
25944	3605	11	.	.	.
25944	3605	12	"	"	''
25944	3606	1	#	#	NNP
25944	3606	2	J.	J.	NNP
25944	3606	3	Collins	Collins	NNP
25944	3606	4	Warren	Warren	NNP
25944	3606	5	,	,	,
25944	3606	6	M.D.	M.D.	NNP
25944	3606	7	,	,	,
25944	3606	8	LL.D.	LL.D.	NNP
25944	3606	9	,	,	,
25944	3606	10	F.R.C.S.	F.R.C.S.	.
25944	3607	1	(	(	-LRB-
25944	3607	2	Hon	hon	UH
25944	3607	3	.	.	.
25944	3608	1	)	)	-RRB-
25944	3608	2	#	#	$
25944	3608	3	_	_	NNP
25944	3608	4	Professor	Professor	NNP
25944	3608	5	of	of	IN
25944	3608	6	Surgery	Surgery	NNP
25944	3608	7	,	,	,
25944	3608	8	Harvard	Harvard	NNP
25944	3608	9	Medical	Medical	NNP
25944	3608	10	School	School	NNP
25944	3608	11	.	.	.
25944	3608	12	_	_	NNP
25944	3608	13	"	"	``
25944	3608	14	I	-PRON-	PRP
25944	3608	15	regard	regard	VBP
25944	3608	16	it	-PRON-	PRP
25944	3608	17	as	as	IN
25944	3608	18	a	a	DT
25944	3608	19	valuable	valuable	JJ
25944	3608	20	aid	aid	NN
25944	3608	21	to	to	IN
25944	3608	22	my	-PRON-	PRP$
25944	3608	23	medical	medical	JJ
25944	3608	24	literary	literary	JJ
25944	3608	25	work	work	NN
25944	3608	26	.	.	.
25944	3609	1	It	-PRON-	PRP
25944	3609	2	is	be	VBZ
25944	3609	3	very	very	RB
25944	3609	4	complete	complete	JJ
25944	3609	5	and	and	CC
25944	3609	6	of	of	IN
25944	3609	7	convenient	convenient	JJ
25944	3609	8	size	size	NN
25944	3609	9	to	to	TO
25944	3609	10	handle	handle	VB
25944	3609	11	comfortably	comfortably	RB
25944	3609	12	.	.	.
25944	3610	1	I	-PRON-	PRP
25944	3610	2	use	use	VBP
25944	3610	3	it	-PRON-	PRP
25944	3610	4	in	in	IN
25944	3610	5	preference	preference	NN
25944	3610	6	to	to	IN
25944	3610	7	any	any	DT
25944	3610	8	other	other	JJ
25944	3610	9	.	.	.
25944	3610	10	"	"	''
25944	3611	1	Garrigues	Garrigues	NNPS
25944	3611	2	'	'	POS
25944	3611	3	Diseases	Diseases	NNPS
25944	3611	4	of	of	IN
25944	3611	5	Women	Women	NNP
25944	3611	6	Third	Third	NNP
25944	3611	7	Edition	Edition	NNP
25944	3611	8	,	,	,
25944	3611	9	Thoroughly	Thoroughly	NNP
25944	3611	10	Revised	revise	VBN
25944	3611	11	*	*	NFP
25944	3611	12	*	*	NFP
25944	3611	13	*	*	NFP
25944	3611	14	*	*	NFP
25944	3611	15	*	*	NFP
25944	3611	16	#	#	NN
25944	3611	17	A	a	DT
25944	3611	18	Text	Text	NNP
25944	3611	19	-	-	HYPH
25944	3611	20	Book	Book	NNP
25944	3611	21	of	of	IN
25944	3611	22	Diseases	Diseases	NNPS
25944	3611	23	of	of	IN
25944	3611	24	Women	Women	NNP
25944	3611	25	#	#	$
25944	3611	26	.	.	.
25944	3612	1	By	by	IN
25944	3612	2	Henry	Henry	NNP
25944	3612	3	J.	J.	NNP
25944	3612	4	Garrigues	Garrigues	NNP
25944	3612	5	,	,	,
25944	3612	6	A.M.	A.M.	NNP
25944	3612	7	,	,	,
25944	3612	8	M.D.	M.D.	NNP
25944	3612	9	,	,	,
25944	3612	10	Gynecologist	gynecologist	JJ
25944	3612	11	to	to	IN
25944	3612	12	St.	St.	NNP
25944	3612	13	Mark	Mark	NNP
25944	3612	14	's	's	POS
25944	3612	15	Hospital	Hospital	NNP
25944	3612	16	and	and	CC
25944	3612	17	to	to	IN
25944	3612	18	the	the	DT
25944	3612	19	German	German	NNP
25944	3612	20	Dispensary	Dispensary	NNP
25944	3612	21	,	,	,
25944	3612	22	New	New	NNP
25944	3612	23	York	York	NNP
25944	3612	24	City	City	NNP
25944	3612	25	.	.	.
25944	3613	1	Handsome	handsome	JJ
25944	3613	2	octavo	octavo	NN
25944	3613	3	,	,	,
25944	3613	4	756	756	CD
25944	3613	5	pages	page	NNS
25944	3613	6	,	,	,
25944	3613	7	with	with	IN
25944	3613	8	367	367	CD
25944	3613	9	engravings	engraving	NNS
25944	3613	10	and	and	CC
25944	3613	11	colored	colored	JJ
25944	3613	12	plates	plate	NNS
25944	3613	13	.	.	.
25944	3614	1	Cloth	cloth	NN
25944	3614	2	,	,	,
25944	3614	3	$	$	$
25944	3614	4	4.50	4.50	CD
25944	3614	5	net	net	NN
25944	3614	6	;	;	:
25944	3614	7	Sheep	Sheep	NNS
25944	3614	8	or	or	CC
25944	3614	9	Half	Half	NNP
25944	3614	10	Morocco	Morocco	NNP
25944	3614	11	,	,	,
25944	3614	12	$	$	$
25944	3614	13	6.00	6.00	CD
25944	3614	14	net	net	NN
25944	3614	15	.	.	.
25944	3615	1	The	the	DT
25944	3615	2	first	first	JJ
25944	3615	3	two	two	CD
25944	3615	4	editions	edition	NNS
25944	3615	5	of	of	IN
25944	3615	6	this	this	DT
25944	3615	7	work	work	NN
25944	3615	8	met	meet	VBD
25944	3615	9	with	with	IN
25944	3615	10	a	a	DT
25944	3615	11	most	most	RBS
25944	3615	12	appreciative	appreciative	JJ
25944	3615	13	reception	reception	NN
25944	3615	14	by	by	IN
25944	3615	15	the	the	DT
25944	3615	16	medical	medical	JJ
25944	3615	17	profession	profession	NN
25944	3615	18	both	both	CC
25944	3615	19	in	in	IN
25944	3615	20	this	this	DT
25944	3615	21	country	country	NN
25944	3615	22	and	and	CC
25944	3615	23	abroad	abroad	RB
25944	3615	24	.	.	.
25944	3616	1	In	in	IN
25944	3616	2	this	this	DT
25944	3616	3	edition	edition	NN
25944	3616	4	the	the	DT
25944	3616	5	entire	entire	JJ
25944	3616	6	work	work	NN
25944	3616	7	has	have	VBZ
25944	3616	8	been	be	VBN
25944	3616	9	carefully	carefully	RB
25944	3616	10	and	and	CC
25944	3616	11	thoroughly	thoroughly	RB
25944	3616	12	revised	revise	VBN
25944	3616	13	,	,	,
25944	3616	14	and	and	CC
25944	3616	15	considerable	considerable	JJ
25944	3616	16	new	new	JJ
25944	3616	17	matter	matter	NN
25944	3616	18	added	add	VBN
25944	3616	19	,	,	,
25944	3616	20	bringing	bring	VBG
25944	3616	21	the	the	DT
25944	3616	22	work	work	NN
25944	3616	23	precisely	precisely	RB
25944	3616	24	down	down	IN
25944	3616	25	to	to	IN
25944	3616	26	date	date	NN
25944	3616	27	.	.	.
25944	3617	1	Many	many	JJ
25944	3617	2	new	new	JJ
25944	3617	3	illustrations	illustration	NNS
25944	3617	4	have	have	VBP
25944	3617	5	been	be	VBN
25944	3617	6	introduced	introduce	VBN
25944	3617	7	,	,	,
25944	3617	8	thus	thus	RB
25944	3617	9	greatly	greatly	RB
25944	3617	10	increasing	increase	VBG
25944	3617	11	the	the	DT
25944	3617	12	value	value	NN
25944	3617	13	of	of	IN
25944	3617	14	the	the	DT
25944	3617	15	book	book	NN
25944	3617	16	both	both	CC
25944	3617	17	as	as	IN
25944	3617	18	a	a	DT
25944	3617	19	text	text	NN
25944	3617	20	-	-	HYPH
25944	3617	21	book	book	NN
25944	3617	22	and	and	CC
25944	3617	23	book	book	NN
25944	3617	24	of	of	IN
25944	3617	25	reference	reference	NN
25944	3617	26	.	.	.
25944	3618	1	#	#	$
25944	3618	2	Thad	Thad	NNP
25944	3618	3	.	.	.
25944	3619	1	A.	A.	NNP
25944	3619	2	Reamy	Reamy	NNP
25944	3619	3	,	,	,
25944	3619	4	M.D.	M.D.	NNP
25944	3619	5	,	,	,
25944	3619	6	#	#	NNP
25944	3619	7	_	_	NNP
25944	3619	8	Professor	Professor	NNP
25944	3619	9	of	of	IN
25944	3619	10	Gynecology	Gynecology	NNP
25944	3619	11	,	,	,
25944	3619	12	Medical	Medical	NNP
25944	3619	13	College	College	NNP
25944	3619	14	of	of	IN
25944	3619	15	Ohio	Ohio	NNP
25944	3619	16	.	.	.
25944	3619	17	_	_	NNP
25944	3619	18	"	"	``
25944	3619	19	One	one	CD
25944	3619	20	of	of	IN
25944	3619	21	the	the	DT
25944	3619	22	best	good	JJS
25944	3619	23	text	text	NN
25944	3619	24	-	-	HYPH
25944	3619	25	books	book	NNS
25944	3619	26	for	for	IN
25944	3619	27	students	student	NNS
25944	3619	28	and	and	CC
25944	3619	29	practitioners	practitioner	NNS
25944	3619	30	which	which	WDT
25944	3619	31	has	have	VBZ
25944	3619	32	been	be	VBN
25944	3619	33	published	publish	VBN
25944	3619	34	in	in	IN
25944	3619	35	the	the	DT
25944	3619	36	English	english	JJ
25944	3619	37	language	language	NN
25944	3619	38	;	;	:
25944	3619	39	it	-PRON-	PRP
25944	3619	40	is	be	VBZ
25944	3619	41	condensed	condense	VBN
25944	3619	42	,	,	,
25944	3619	43	clear	clear	JJ
25944	3619	44	,	,	,
25944	3619	45	and	and	CC
25944	3619	46	comprehensive	comprehensive	JJ
25944	3619	47	.	.	.
25944	3620	1	The	the	DT
25944	3620	2	profound	profound	JJ
25944	3620	3	learning	learning	NN
25944	3620	4	and	and	CC
25944	3620	5	great	great	JJ
25944	3620	6	clinical	clinical	JJ
25944	3620	7	experience	experience	NN
25944	3620	8	of	of	IN
25944	3620	9	the	the	DT
25944	3620	10	distinguished	distinguished	JJ
25944	3620	11	author	author	NN
25944	3620	12	find	find	VBP
25944	3620	13	expression	expression	NN
25944	3620	14	in	in	IN
25944	3620	15	this	this	DT
25944	3620	16	book	book	NN
25944	3620	17	.	.	.
25944	3620	18	"	"	''
25944	3621	1	*	*	NFP
25944	3621	2	*	*	NFP
25944	3621	3	*	*	NFP
25944	3621	4	*	*	NFP
25944	3621	5	*	*	NFP
25944	3621	6	American	American	NNP
25944	3621	7	Text	Text	NNP
25944	3621	8	-	-	HYPH
25944	3621	9	Book	Book	NNP
25944	3621	10	of	of	IN
25944	3621	11	Gynecology	Gynecology	NNP
25944	3621	12	#	#	,
25944	3621	13	American	American	NNP
25944	3621	14	Text	Text	NNP
25944	3621	15	-	-	HYPH
25944	3621	16	Book	Book	NNP
25944	3621	17	of	of	IN
25944	3621	18	Gynecology	Gynecology	NNP
25944	3621	19	#	#	NNP
25944	3621	20	.	.	.
25944	3622	1	Medical	medical	JJ
25944	3622	2	and	and	CC
25944	3622	3	Surgical	surgical	JJ
25944	3622	4	.	.	.
25944	3623	1	Edited	edit	VBN
25944	3623	2	by	by	IN
25944	3623	3	J.M.	J.M.	NNP
25944	3624	1	Baldy	Baldy	NNP
25944	3624	2	,	,	,
25944	3624	3	M.D.	M.D.	NNP
25944	3624	4	,	,	,
25944	3624	5	Professor	Professor	NNP
25944	3624	6	of	of	IN
25944	3624	7	Gynecology	Gynecology	NNP
25944	3624	8	,	,	,
25944	3624	9	Philadelphia	Philadelphia	NNP
25944	3624	10	Polyclinic	Polyclinic	NNP
25944	3624	11	.	.	.
25944	3625	1	Imperial	imperial	JJ
25944	3625	2	octavo	octavo	NN
25944	3625	3	of	of	IN
25944	3625	4	718	718	CD
25944	3625	5	pages	page	NNS
25944	3625	6	,	,	,
25944	3625	7	with	with	IN
25944	3625	8	341	341	CD
25944	3625	9	text	text	NN
25944	3625	10	-	-	HYPH
25944	3625	11	illustrations	illustration	NNS
25944	3625	12	and	and	CC
25944	3625	13	38	38	CD
25944	3625	14	plates	plate	NNS
25944	3625	15	.	.	.
25944	3626	1	Cloth	cloth	NN
25944	3626	2	,	,	,
25944	3626	3	$	$	$
25944	3626	4	6.00	6.00	CD
25944	3626	5	net	net	NN
25944	3626	6	;	;	:
25944	3626	7	Half	Half	NNP
25944	3626	8	Morocco	Morocco	NNP
25944	3626	9	,	,	,
25944	3626	10	$	$	$
25944	3626	11	7.50	7.50	CD
25944	3626	12	net	net	NN
25944	3626	13	.	.	.
25944	3627	1	SECOND	second	JJ
25944	3627	2	REVISED	revised	NN
25944	3627	3	EDITION	EDITION	VBD
25944	3627	4	This	this	DT
25944	3627	5	volume	volume	NN
25944	3627	6	is	be	VBZ
25944	3627	7	thoroughly	thoroughly	RB
25944	3627	8	practical	practical	JJ
25944	3627	9	in	in	IN
25944	3627	10	its	-PRON-	PRP$
25944	3627	11	teachings	teaching	NNS
25944	3627	12	,	,	,
25944	3627	13	and	and	CC
25944	3627	14	is	be	VBZ
25944	3627	15	intended	intend	VBN
25944	3627	16	to	to	TO
25944	3627	17	be	be	VB
25944	3627	18	a	a	DT
25944	3627	19	working	work	VBG
25944	3627	20	text	text	NN
25944	3627	21	-	-	HYPH
25944	3627	22	book	book	NN
25944	3627	23	for	for	IN
25944	3627	24	physicians	physician	NNS
25944	3627	25	and	and	CC
25944	3627	26	students	student	NNS
25944	3627	27	.	.	.
25944	3628	1	Many	many	JJ
25944	3628	2	of	of	IN
25944	3628	3	the	the	DT
25944	3628	4	most	most	RBS
25944	3628	5	important	important	JJ
25944	3628	6	subject	subject	NN
25944	3628	7	are	be	VBP
25944	3628	8	considered	consider	VBN
25944	3628	9	from	from	IN
25944	3628	10	an	an	DT
25944	3628	11	entirely	entirely	RB
25944	3628	12	new	new	JJ
25944	3628	13	standpoint	standpoint	NN
25944	3628	14	,	,	,
25944	3628	15	and	and	CC
25944	3628	16	are	be	VBP
25944	3628	17	grouped	group	VBN
25944	3628	18	together	together	RB
25944	3628	19	in	in	IN
25944	3628	20	a	a	DT
25944	3628	21	manner	manner	NN
25944	3628	22	somewhat	somewhat	RB
25944	3628	23	foreign	foreign	JJ
25944	3628	24	to	to	IN
25944	3628	25	the	the	DT
25944	3628	26	accepted	accepted	JJ
25944	3628	27	custom	custom	NN
25944	3628	28	.	.	.
25944	3629	1	#	#	NNP
25944	3629	2	Boston	Boston	NNP
25944	3629	3	Medical	Medical	NNP
25944	3629	4	and	and	CC
25944	3629	5	Surgical	Surgical	NNP
25944	3629	6	Journal	Journal	NNP
25944	3629	7	#	#	$
25944	3629	8	"	"	``
25944	3629	9	The	the	DT
25944	3629	10	most	most	RBS
25944	3629	11	complete	complete	JJ
25944	3629	12	exponent	exponent	NN
25944	3629	13	of	of	IN
25944	3629	14	gynecology	gynecology	NN
25944	3629	15	that	that	IN
25944	3629	16	we	-PRON-	PRP
25944	3629	17	have	have	VBP
25944	3629	18	.	.	.
25944	3630	1	No	no	DT
25944	3630	2	subject	subject	NN
25944	3630	3	seems	seem	VBZ
25944	3630	4	to	to	TO
25944	3630	5	have	have	VB
25944	3630	6	been	be	VBN
25944	3630	7	neglected	neglect	VBN
25944	3630	8	.	.	.
25944	3630	9	"	"	''
25944	3631	1	Dorland	Dorland	NNP
25944	3631	2	's	's	POS
25944	3631	3	Modern	Modern	NNP
25944	3631	4	Obstetrics	Obstetrics	NNPS
25944	3631	5	*	*	NFP
25944	3631	6	*	*	NFP
25944	3631	7	*	*	NFP
25944	3631	8	*	*	NFP
25944	3631	9	*	*	NFP
25944	3631	10	#	#	NN
25944	3631	11	Modern	Modern	NNP
25944	3631	12	Obstetrics	Obstetrics	NNPS
25944	3631	13	:	:	:
25944	3631	14	General	General	NNP
25944	3631	15	and	and	CC
25944	3631	16	Operative	Operative	NNP
25944	3631	17	#	#	NNP
25944	3631	18	.	.	.
25944	3632	1	By	by	IN
25944	3632	2	W.A.	W.A.	NNP
25944	3633	1	Newman	Newman	NNP
25944	3633	2	Dorland	Dorland	NNP
25944	3633	3	,	,	,
25944	3633	4	A.M.	A.M.	NNP
25944	3633	5	,	,	,
25944	3633	6	M.D.	M.D.	NNP
25944	3633	7	,	,	,
25944	3633	8	Assistant	Assistant	NNP
25944	3633	9	Instructor	Instructor	NNP
25944	3633	10	in	in	IN
25944	3633	11	Obstetrics	Obstetrics	NNP
25944	3633	12	,	,	,
25944	3633	13	University	University	NNP
25944	3633	14	of	of	IN
25944	3633	15	Pennsylvania	Pennsylvania	NNP
25944	3633	16	;	;	:
25944	3633	17	Associate	Associate	NNP
25944	3633	18	in	in	IN
25944	3633	19	Gynecology	gynecology	NN
25944	3633	20	in	in	IN
25944	3633	21	the	the	DT
25944	3633	22	Philadelphia	Philadelphia	NNP
25944	3633	23	Polyclinic	Polyclinic	NNP
25944	3633	24	.	.	.
25944	3634	1	Handsome	handsome	JJ
25944	3634	2	octavo	octavo	JJ
25944	3634	3	volume	volume	NN
25944	3634	4	of	of	IN
25944	3634	5	797	797	CD
25944	3634	6	pages	page	NNS
25944	3634	7	,	,	,
25944	3634	8	with	with	IN
25944	3634	9	201	201	CD
25944	3634	10	illustrations	illustration	NNS
25944	3634	11	.	.	.
25944	3635	1	Cloth	cloth	NN
25944	3635	2	,	,	,
25944	3635	3	$	$	$
25944	3635	4	4.00	4.00	CD
25944	3635	5	net	net	NN
25944	3635	6	.	.	.
25944	3636	1	Second	Second	NNP
25944	3636	2	Edition	Edition	NNP
25944	3636	3	,	,	,
25944	3636	4	Revised	Revised	NNP
25944	3636	5	and	and	CC
25944	3636	6	Greatly	greatly	RB
25944	3636	7	Enlarged	enlarge	VBN
25944	3636	8	In	in	IN
25944	3636	9	this	this	DT
25944	3636	10	edition	edition	NN
25944	3636	11	the	the	DT
25944	3636	12	book	book	NN
25944	3636	13	has	have	VBZ
25944	3636	14	been	be	VBN
25944	3636	15	entirely	entirely	RB
25944	3636	16	rewritten	rewrite	VBN
25944	3636	17	and	and	CC
25944	3636	18	very	very	RB
25944	3636	19	greatly	greatly	RB
25944	3636	20	enlarged	enlarged	JJ
25944	3636	21	.	.	.
25944	3637	1	Among	among	IN
25944	3637	2	the	the	DT
25944	3637	3	new	new	JJ
25944	3637	4	subjects	subject	NNS
25944	3637	5	introduced	introduce	VBN
25944	3637	6	are	be	VBP
25944	3637	7	the	the	DT
25944	3637	8	surgical	surgical	JJ
25944	3637	9	treatment	treatment	NN
25944	3637	10	of	of	IN
25944	3637	11	puerperal	puerperal	JJ
25944	3637	12	sepsis	sepsis	NN
25944	3637	13	,	,	,
25944	3637	14	infant	infant	NN
25944	3637	15	mortality	mortality	NN
25944	3637	16	,	,	,
25944	3637	17	placental	placental	JJ
25944	3637	18	transmission	transmission	NN
25944	3637	19	of	of	IN
25944	3637	20	diseases	disease	NNS
25944	3637	21	,	,	,
25944	3637	22	serum	serum	NN
25944	3637	23	-	-	HYPH
25944	3637	24	therapy	therapy	NN
25944	3637	25	of	of	IN
25944	3637	26	puerperal	puerperal	JJ
25944	3637	27	sepsis	sepsis	NN
25944	3637	28	,	,	,
25944	3637	29	etc	etc	FW
25944	3637	30	.	.	.
25944	3638	1	#	#	NNP
25944	3638	2	Journal	Journal	NNP
25944	3638	3	of	of	IN
25944	3638	4	the	the	DT
25944	3638	5	American	American	NNP
25944	3638	6	Medical	Medical	NNP
25944	3638	7	Association	Association	NNP
25944	3638	8	#	#	$
25944	3638	9	"	"	``
25944	3638	10	This	this	DT
25944	3638	11	work	work	NN
25944	3638	12	deserves	deserve	VBZ
25944	3638	13	commendation	commendation	NN
25944	3638	14	,	,	,
25944	3638	15	and	and	CC
25944	3638	16	that	that	IN
25944	3638	17	it	-PRON-	PRP
25944	3638	18	has	have	VBZ
25944	3638	19	received	receive	VBN
25944	3638	20	what	what	WP
25944	3638	21	it	-PRON-	PRP
25944	3638	22	deserves	deserve	VBZ
25944	3638	23	at	at	IN
25944	3638	24	the	the	DT
25944	3638	25	hands	hand	NNS
25944	3638	26	of	of	IN
25944	3638	27	the	the	DT
25944	3638	28	profession	profession	NN
25944	3638	29	is	be	VBZ
25944	3638	30	attested	attest	VBN
25944	3638	31	by	by	IN
25944	3638	32	the	the	DT
25944	3638	33	fact	fact	NN
25944	3638	34	that	that	IN
25944	3638	35	a	a	DT
25944	3638	36	second	second	JJ
25944	3638	37	edition	edition	NN
25944	3638	38	is	be	VBZ
25944	3638	39	called	call	VBN
25944	3638	40	for	for	IN
25944	3638	41	within	within	IN
25944	3638	42	such	such	PDT
25944	3638	43	a	a	DT
25944	3638	44	short	short	JJ
25944	3638	45	time	time	NN
25944	3638	46	.	.	.
25944	3639	1	Especially	especially	RB
25944	3639	2	deserving	deserving	NN
25944	3639	3	of	of	IN
25944	3639	4	praise	praise	NN
25944	3639	5	is	be	VBZ
25944	3639	6	the	the	DT
25944	3639	7	chapter	chapter	NN
25944	3639	8	on	on	IN
25944	3639	9	puerperal	puerperal	JJ
25944	3639	10	sepsis	sepsis	NN
25944	3639	11	.	.	.
25944	3639	12	"	"	''
25944	3640	1	*	*	NFP
25944	3640	2	*	*	NFP
25944	3640	3	*	*	NFP
25944	3640	4	*	*	NFP
25944	3640	5	*	*	NFP
25944	3640	6	Davis	Davis	NNP
25944	3640	7	'	'	POS
25944	3640	8	Obstetric	Obstetric	NNP
25944	3640	9	and	and	CC
25944	3640	10	Gynecologic	Gynecologic	NNP
25944	3640	11	Nursing	Nursing	NNP
25944	3640	12	#	#	$
25944	3640	13	Obstetric	Obstetric	NNP
25944	3640	14	and	and	CC
25944	3640	15	Gynecologic	Gynecologic	NNP
25944	3640	16	Nursing	Nursing	NNP
25944	3640	17	#	#	$
25944	3640	18	.	.	.
25944	3641	1	By	by	IN
25944	3641	2	Edward	Edward	NNP
25944	3641	3	P.	P.	NNP
25944	3641	4	Davis	Davis	NNP
25944	3641	5	,	,	,
25944	3641	6	A.M.	A.M.	NNP
25944	3641	7	,	,	,
25944	3641	8	M.D.	M.D.	NNP
25944	3641	9	,	,	,
25944	3641	10	Professor	Professor	NNP
25944	3641	11	of	of	IN
25944	3641	12	Obstetrics	Obstetrics	NNPS
25944	3641	13	in	in	IN
25944	3641	14	the	the	DT
25944	3641	15	Jefferson	Jefferson	NNP
25944	3641	16	Medical	Medical	NNP
25944	3641	17	College	College	NNP
25944	3641	18	and	and	CC
25944	3641	19	Philadelphia	Philadelphia	NNP
25944	3641	20	Polyclinic	Polyclinic	NNP
25944	3641	21	;	;	:
25944	3641	22	Obstetrician	Obstetrician	NNP
25944	3641	23	and	and	CC
25944	3641	24	Gynecologist	Gynecologist	NNP
25944	3641	25	,	,	,
25944	3641	26	Philadelphia	Philadelphia	NNP
25944	3641	27	Hospital	Hospital	NNP
25944	3641	28	.	.	.
25944	3642	1	12mo	12mo	JJ
25944	3642	2	of	of	IN
25944	3642	3	436	436	CD
25944	3642	4	pages	page	NNS
25944	3642	5	,	,	,
25944	3642	6	illustrated	illustrate	VBN
25944	3642	7	.	.	.
25944	3643	1	Buckram	Buckram	NNP
25944	3643	2	,	,	,
25944	3643	3	$	$	$
25944	3643	4	1.75	1.75	CD
25944	3643	5	net	net	NN
25944	3643	6	.	.	.
25944	3644	1	JUST	just	RB
25944	3644	2	ISSUED	ISSUED	NNS
25944	3644	3	--	--	:
25944	3644	4	THIRD	third	JJ
25944	3644	5	REVISED	revised	NN
25944	3644	6	EDITION	EDITION	VBD
25944	3644	7	This	this	DT
25944	3644	8	volume	volume	NN
25944	3644	9	gives	give	VBZ
25944	3644	10	a	a	DT
25944	3644	11	very	very	RB
25944	3644	12	clear	clear	JJ
25944	3644	13	and	and	CC
25944	3644	14	accurate	accurate	JJ
25944	3644	15	idea	idea	NN
25944	3644	16	of	of	IN
25944	3644	17	the	the	DT
25944	3644	18	manner	manner	NN
25944	3644	19	to	to	TO
25944	3644	20	meet	meet	VB
25944	3644	21	the	the	DT
25944	3644	22	conditions	condition	NNS
25944	3644	23	arising	arise	VBG
25944	3644	24	during	during	IN
25944	3644	25	obstetric	obstetric	NN
25944	3644	26	and	and	CC
25944	3644	27	gynecologic	gynecologic	JJ
25944	3644	28	nursing	nursing	NN
25944	3644	29	.	.	.
25944	3645	1	The	the	DT
25944	3645	2	third	third	JJ
25944	3645	3	edition	edition	NN
25944	3645	4	has	have	VBZ
25944	3645	5	been	be	VBN
25944	3645	6	thoroughly	thoroughly	RB
25944	3645	7	revised	revise	VBN
25944	3645	8	.	.	.
25944	3646	1	#	#	$
25944	3646	2	The	the	DT
25944	3646	3	Lancet	Lancet	NNP
25944	3646	4	,	,	,
25944	3646	5	London	London	NNP
25944	3646	6	#	#	:
25944	3646	7	"	"	``
25944	3646	8	Not	not	RB
25944	3646	9	only	only	RB
25944	3646	10	nurses	nurse	VBZ
25944	3646	11	,	,	,
25944	3646	12	but	but	CC
25944	3646	13	even	even	RB
25944	3646	14	newly	newly	RB
25944	3646	15	qualified	qualify	VBN
25944	3646	16	medical	medical	JJ
25944	3646	17	men	man	NNS
25944	3646	18	,	,	,
25944	3646	19	would	would	MD
25944	3646	20	learn	learn	VB
25944	3646	21	a	a	DT
25944	3646	22	great	great	JJ
25944	3646	23	deal	deal	NN
25944	3646	24	by	by	IN
25944	3646	25	a	a	DT
25944	3646	26	perusal	perusal	NN
25944	3646	27	of	of	IN
25944	3646	28	this	this	DT
25944	3646	29	book	book	NN
25944	3646	30	.	.	.
25944	3647	1	It	-PRON-	PRP
25944	3647	2	is	be	VBZ
25944	3647	3	written	write	VBN
25944	3647	4	in	in	IN
25944	3647	5	a	a	DT
25944	3647	6	clear	clear	JJ
25944	3647	7	and	and	CC
25944	3647	8	pleasant	pleasant	JJ
25944	3647	9	style	style	NN
25944	3647	10	,	,	,
25944	3647	11	and	and	CC
25944	3647	12	is	be	VBZ
25944	3647	13	a	a	DT
25944	3647	14	work	work	NN
25944	3647	15	we	-PRON-	PRP
25944	3647	16	can	can	MD
25944	3647	17	recommend	recommend	VB
25944	3647	18	.	.	.
25944	3647	19	"	"	''
25944	3648	1	Schäffer	Schäffer	NNP
25944	3648	2	_	_	NNP
25944	3648	3	and	and	CC
25944	3648	4	_	_	NNP
25944	3648	5	Edgar	Edgar	NNP
25944	3648	6	's	's	POS
25944	3648	7	Labor	Labor	NNP
25944	3648	8	and	and	CC
25944	3648	9	Operative	Operative	NNP
25944	3648	10	Obstetrics	Obstetrics	NNPS
25944	3648	11	*	*	NFP
25944	3648	12	*	*	NFP
25944	3648	13	*	*	NFP
25944	3648	14	*	*	NFP
25944	3648	15	*	*	NFP
25944	3648	16	#	#	NN
25944	3648	17	Atlas	Atlas	NNP
25944	3648	18	and	and	CC
25944	3648	19	Epitome	Epitome	NNP
25944	3648	20	of	of	IN
25944	3648	21	Labor	Labor	NNP
25944	3648	22	and	and	CC
25944	3648	23	Operative	Operative	NNP
25944	3648	24	Obstetrics	Obstetrics	NNPS
25944	3648	25	#	#	$
25944	3648	26	.	.	.
25944	3649	1	By	by	IN
25944	3649	2	Dr.	Dr.	NNP
25944	3649	3	O.	O.	NNP
25944	3649	4	Schäffer	Schäffer	NNP
25944	3649	5	,	,	,
25944	3649	6	of	of	IN
25944	3649	7	Heidelberg	Heidelberg	NNP
25944	3649	8	.	.	.
25944	3650	1	_	_	NNP
25944	3650	2	From	from	IN
25944	3650	3	the	the	DT
25944	3650	4	Fifth	Fifth	NNP
25944	3650	5	Revised	revised	JJ
25944	3650	6	and	and	CC
25944	3650	7	Enlarged	enlarged	JJ
25944	3650	8	German	German	NNP
25944	3650	9	Edition	Edition	NNP
25944	3650	10	.	.	.
25944	3650	11	_	_	NNP
25944	3650	12	Edited	Edited	NNP
25944	3650	13	,	,	,
25944	3650	14	with	with	IN
25944	3650	15	additions	addition	NNS
25944	3650	16	,	,	,
25944	3650	17	by	by	IN
25944	3650	18	J.	J.	NNP
25944	3650	19	Clifton	Clifton	NNP
25944	3650	20	Edgar	Edgar	NNP
25944	3650	21	,	,	,
25944	3650	22	M.D.	M.D.	NNP
25944	3650	23	,	,	,
25944	3650	24	Professor	Professor	NNP
25944	3650	25	of	of	IN
25944	3650	26	Obstetrics	Obstetrics	NNP
25944	3650	27	and	and	CC
25944	3650	28	Clinical	Clinical	NNP
25944	3650	29	Midwifery	Midwifery	NNP
25944	3650	30	,	,	,
25944	3650	31	Cornell	Cornell	NNP
25944	3650	32	University	University	NNP
25944	3650	33	Medical	Medical	NNP
25944	3650	34	School	School	NNP
25944	3650	35	,	,	,
25944	3650	36	New	New	NNP
25944	3650	37	York	York	NNP
25944	3650	38	.	.	.
25944	3651	1	With	with	IN
25944	3651	2	14	14	CD
25944	3651	3	lithographic	lithographic	JJ
25944	3651	4	plates	plate	NNS
25944	3651	5	in	in	IN
25944	3651	6	colors	color	NNS
25944	3651	7	,	,	,
25944	3651	8	139	139	CD
25944	3651	9	other	other	JJ
25944	3651	10	illustrations	illustration	NNS
25944	3651	11	,	,	,
25944	3651	12	and	and	CC
25944	3651	13	111	111	CD
25944	3651	14	pages	page	NNS
25944	3651	15	of	of	IN
25944	3651	16	text	text	NN
25944	3651	17	.	.	.
25944	3652	1	Cloth	cloth	NN
25944	3652	2	,	,	,
25944	3652	3	$	$	$
25944	3652	4	2.00	2.00	CD
25944	3652	5	net	net	NN
25944	3652	6	.	.	.
25944	3653	1	_	_	NNP
25944	3653	2	In	in	IN
25944	3653	3	Saunders	Saunders	NNPS
25944	3653	4	'	'	POS
25944	3653	5	Hand	Hand	NNP
25944	3653	6	-	-	HYPH
25944	3653	7	Atlas	Atlas	NNP
25944	3653	8	Series	Series	NNP
25944	3653	9	.	.	.
25944	3653	10	_	_	NNP
25944	3653	11	This	this	DT
25944	3653	12	book	book	NN
25944	3653	13	presents	present	VBZ
25944	3653	14	the	the	DT
25944	3653	15	act	act	NN
25944	3653	16	of	of	IN
25944	3653	17	parturition	parturition	NN
25944	3653	18	and	and	CC
25944	3653	19	the	the	DT
25944	3653	20	various	various	JJ
25944	3653	21	obstetric	obstetric	JJ
25944	3653	22	operations	operation	NNS
25944	3653	23	in	in	IN
25944	3653	24	a	a	DT
25944	3653	25	series	series	NN
25944	3653	26	of	of	IN
25944	3653	27	easily	easily	RB
25944	3653	28	understood	understand	VBN
25944	3653	29	illustrations	illustration	NNS
25944	3653	30	,	,	,
25944	3653	31	accompanied	accompany	VBN
25944	3653	32	by	by	IN
25944	3653	33	a	a	DT
25944	3653	34	text	text	NN
25944	3653	35	treating	treat	VBG
25944	3653	36	the	the	DT
25944	3653	37	subject	subject	NN
25944	3653	38	from	from	IN
25944	3653	39	a	a	DT
25944	3653	40	practical	practical	JJ
25944	3653	41	standpoint	standpoint	NN
25944	3653	42	.	.	.
25944	3654	1	#	#	NNP
25944	3654	2	American	American	NNP
25944	3654	3	Medicine	Medicine	NNP
25944	3654	4	#	#	NN
25944	3654	5	"	"	``
25944	3654	6	The	the	DT
25944	3654	7	method	method	NN
25944	3654	8	of	of	IN
25944	3654	9	presenting	present	VBG
25944	3654	10	obstetric	obstetric	JJ
25944	3654	11	operations	operation	NNS
25944	3654	12	is	be	VBZ
25944	3654	13	admirable	admirable	JJ
25944	3654	14	.	.	.
25944	3655	1	The	the	DT
25944	3655	2	drawings	drawing	NNS
25944	3655	3	,	,	,
25944	3655	4	representing	represent	VBG
25944	3655	5	original	original	JJ
25944	3655	6	work	work	NN
25944	3655	7	,	,	,
25944	3655	8	have	have	VBP
25944	3655	9	the	the	DT
25944	3655	10	commendable	commendable	JJ
25944	3655	11	merit	merit	NN
25944	3655	12	of	of	IN
25944	3655	13	illustrating	illustrate	VBG
25944	3655	14	instead	instead	RB
25944	3655	15	of	of	IN
25944	3655	16	confusing	confusing	JJ
25944	3655	17	.	.	.
25944	3655	18	"	"	''
25944	3656	1	*	*	NFP
25944	3656	2	*	*	NFP
25944	3656	3	*	*	NFP
25944	3656	4	*	*	NFP
25944	3656	5	*	*	NFP
25944	3656	6	Schäffer	Schäffer	NNP
25944	3656	7	_	_	NNP
25944	3656	8	and	and	CC
25944	3656	9	_	_	NNP
25944	3656	10	Edgar	Edgar	NNP
25944	3656	11	's	's	POS
25944	3656	12	Obstetric	Obstetric	NNP
25944	3656	13	Diagnosis	Diagnosis	NNP
25944	3656	14	and	and	CC
25944	3656	15	Treatment	Treatment	NNP
25944	3656	16	#	#	$
25944	3656	17	Atlas	Atlas	NNP
25944	3656	18	and	and	CC
25944	3656	19	Epitome	Epitome	NNP
25944	3656	20	of	of	IN
25944	3656	21	Obstetric	Obstetric	NNP
25944	3656	22	Diagnosis	Diagnosis	NNP
25944	3656	23	and	and	CC
25944	3656	24	Treatment	Treatment	NNP
25944	3656	25	#	#	NNP
25944	3656	26	.	.	.
25944	3657	1	By	by	IN
25944	3657	2	Dr.	Dr.	NNP
25944	3657	3	O.	O.	NNP
25944	3657	4	Schäffer	Schäffer	NNP
25944	3657	5	,	,	,
25944	3657	6	of	of	IN
25944	3657	7	Heidelberg	Heidelberg	NNP
25944	3657	8	.	.	.
25944	3658	1	_	_	NNP
25944	3658	2	From	from	IN
25944	3658	3	the	the	DT
25944	3658	4	Second	Second	NNP
25944	3658	5	Revised	revised	JJ
25944	3658	6	German	German	NNP
25944	3658	7	Edition._Edited	Edition._Edited	NNP
25944	3658	8	,	,	,
25944	3658	9	with	with	IN
25944	3658	10	additions	addition	NNS
25944	3658	11	,	,	,
25944	3658	12	by	by	IN
25944	3658	13	J.	J.	NNP
25944	3658	14	Clifton	Clifton	NNP
25944	3658	15	Edgar	Edgar	NNP
25944	3658	16	,	,	,
25944	3658	17	M.D.	M.D.	NNP
25944	3658	18	,	,	,
25944	3658	19	Professor	Professor	NNP
25944	3658	20	of	of	IN
25944	3658	21	Obstetrics	Obstetrics	NNP
25944	3658	22	and	and	CC
25944	3658	23	Clinical	Clinical	NNP
25944	3658	24	Midwifery	Midwifery	NNP
25944	3658	25	,	,	,
25944	3658	26	Cornell	Cornell	NNP
25944	3658	27	University	University	NNP
25944	3658	28	Medical	Medical	NNP
25944	3658	29	School	School	NNP
25944	3658	30	,	,	,
25944	3658	31	N.Y.	New York	NNP
25944	3658	32	With	with	IN
25944	3658	33	122	122	CD
25944	3658	34	colored	color	VBN
25944	3658	35	figures	figure	NNS
25944	3658	36	on	on	IN
25944	3658	37	56	56	CD
25944	3658	38	plates	plate	NNS
25944	3658	39	,	,	,
25944	3658	40	38	38	CD
25944	3658	41	text	text	NN
25944	3658	42	-	-	HYPH
25944	3658	43	cuts	cut	NNS
25944	3658	44	,	,	,
25944	3658	45	and	and	CC
25944	3658	46	315	315	CD
25944	3658	47	pages	page	NNS
25944	3658	48	of	of	IN
25944	3658	49	text	text	NN
25944	3658	50	.	.	.
25944	3659	1	Cloth	cloth	NN
25944	3659	2	,	,	,
25944	3659	3	$	$	$
25944	3659	4	3.00	3.00	CD
25944	3659	5	net	net	NN
25944	3659	6	.	.	.
25944	3660	1	_	_	NNP
25944	3660	2	In	in	IN
25944	3660	3	Saunders	Saunders	NNPS
25944	3660	4	'	'	POS
25944	3660	5	Hand	Hand	NNP
25944	3660	6	-	-	HYPH
25944	3660	7	Atlas	Atlas	NNP
25944	3660	8	Series	Series	NNP
25944	3660	9	.	.	.
25944	3660	10	_	_	NNP
25944	3660	11	This	this	DT
25944	3660	12	book	book	NN
25944	3660	13	treats	treat	VBZ
25944	3660	14	particularly	particularly	RB
25944	3660	15	of	of	IN
25944	3660	16	obstetric	obstetric	JJ
25944	3660	17	operations	operation	NNS
25944	3660	18	,	,	,
25944	3660	19	and	and	CC
25944	3660	20	,	,	,
25944	3660	21	besides	besides	IN
25944	3660	22	the	the	DT
25944	3660	23	wealth	wealth	NN
25944	3660	24	of	of	IN
25944	3660	25	beautiful	beautiful	JJ
25944	3660	26	lithographic	lithographic	JJ
25944	3660	27	illustrations	illustration	NNS
25944	3660	28	,	,	,
25944	3660	29	contains	contain	VBZ
25944	3660	30	an	an	DT
25944	3660	31	extensive	extensive	JJ
25944	3660	32	text	text	NN
25944	3660	33	of	of	IN
25944	3660	34	great	great	JJ
25944	3660	35	value	value	NN
25944	3660	36	.	.	.
25944	3661	1	This	this	DT
25944	3661	2	text	text	NN
25944	3661	3	deals	deal	VBZ
25944	3661	4	with	with	IN
25944	3661	5	the	the	DT
25944	3661	6	practical	practical	JJ
25944	3661	7	,	,	,
25944	3661	8	clinical	clinical	JJ
25944	3661	9	side	side	NN
25944	3661	10	of	of	IN
25944	3661	11	the	the	DT
25944	3661	12	subject	subject	NN
25944	3661	13	.	.	.
25944	3662	1	#	#	NNP
25944	3662	2	New	New	NNP
25944	3662	3	York	York	NNP
25944	3662	4	Medical	Medical	NNP
25944	3662	5	Journal	Journal	NNP
25944	3662	6	#	#	$
25944	3662	7	"	"	``
25944	3662	8	The	the	DT
25944	3662	9	illustrations	illustration	NNS
25944	3662	10	are	be	VBP
25944	3662	11	admirably	admirably	RB
25944	3662	12	executed	execute	VBN
25944	3662	13	,	,	,
25944	3662	14	as	as	IN
25944	3662	15	they	-PRON-	PRP
25944	3662	16	are	be	VBP
25944	3662	17	in	in	IN
25944	3662	18	all	all	DT
25944	3662	19	of	of	IN
25944	3662	20	these	these	DT
25944	3662	21	atlases	atlas	NNS
25944	3662	22	,	,	,
25944	3662	23	and	and	CC
25944	3662	24	the	the	DT
25944	3662	25	text	text	NN
25944	3662	26	can	can	MD
25944	3662	27	safely	safely	RB
25944	3662	28	be	be	VB
25944	3662	29	commended	commend	VBN
25944	3662	30	,	,	,
25944	3662	31	not	not	RB
25944	3662	32	only	only	RB
25944	3662	33	as	as	IN
25944	3662	34	elucidatory	elucidatory	NN
25944	3662	35	of	of	IN
25944	3662	36	the	the	DT
25944	3662	37	plates	plate	NNS
25944	3662	38	,	,	,
25944	3662	39	but	but	CC
25944	3662	40	as	as	IN
25944	3662	41	expounding	expound	VBG
25944	3662	42	the	the	DT
25944	3662	43	scientific	scientific	JJ
25944	3662	44	midwifery	midwifery	NN
25944	3662	45	of	of	IN
25944	3662	46	to	to	IN
25944	3662	47	-	-	HYPH
25944	3662	48	day	day	NN
25944	3662	49	.	.	.
25944	3662	50	"	"	''
25944	3663	1	Schäffer	Schäffer	NNP
25944	3663	2	and	and	CC
25944	3663	3	Norris	Norris	NNP
25944	3663	4	'	'	POS
25944	3663	5	Gynecology	gynecology	NN
25944	3663	6	*	*	NFP
25944	3663	7	*	*	NFP
25944	3663	8	*	*	NFP
25944	3663	9	*	*	NFP
25944	3663	10	*	*	NFP
25944	3663	11	#	#	NN
25944	3663	12	Atlas	Atlas	NNP
25944	3663	13	and	and	CC
25944	3663	14	Epitome	Epitome	NNP
25944	3663	15	of	of	IN
25944	3663	16	Gynecology	Gynecology	NNP
25944	3663	17	#	#	NN
25944	3663	18	.	.	.
25944	3664	1	By	by	IN
25944	3664	2	Dr.	Dr.	NNP
25944	3664	3	O.	O.	NNP
25944	3664	4	Schäffer	Schäffer	NNP
25944	3664	5	,	,	,
25944	3664	6	of	of	IN
25944	3664	7	Heidelberg	Heidelberg	NNP
25944	3664	8	.	.	.
25944	3665	1	_	_	NNP
25944	3665	2	From	from	IN
25944	3665	3	the	the	DT
25944	3665	4	Second	Second	NNP
25944	3665	5	Revised	revised	JJ
25944	3665	6	and	and	CC
25944	3665	7	Enlarged	Enlarged	NNP
25944	3665	8	German	German	NNP
25944	3665	9	Edition	Edition	NNP
25944	3665	10	.	.	.
25944	3665	11	_	_	NNP
25944	3665	12	Edited	Edited	NNP
25944	3665	13	,	,	,
25944	3665	14	with	with	IN
25944	3665	15	additions	addition	NNS
25944	3665	16	,	,	,
25944	3665	17	by	by	IN
25944	3665	18	Richard	Richard	NNP
25944	3665	19	C.	C.	NNP
25944	3665	20	Norris	Norris	NNP
25944	3665	21	,	,	,
25944	3665	22	A.M.	A.M.	NNP
25944	3665	23	,	,	,
25944	3665	24	M.D.	M.D.	NNP
25944	3665	25	,	,	,
25944	3665	26	Assistant	Assistant	NNP
25944	3665	27	Professor	Professor	NNP
25944	3665	28	of	of	IN
25944	3665	29	Obstetrics	Obstetrics	NNPS
25944	3665	30	in	in	IN
25944	3665	31	the	the	DT
25944	3665	32	University	University	NNP
25944	3665	33	of	of	IN
25944	3665	34	Pennsylvania	Pennsylvania	NNP
25944	3665	35	.	.	.
25944	3666	1	207	207	CD
25944	3666	2	colored	colored	JJ
25944	3666	3	figures	figure	NNS
25944	3666	4	on	on	IN
25944	3666	5	90	90	CD
25944	3666	6	plates	plate	NNS
25944	3666	7	,	,	,
25944	3666	8	65	65	CD
25944	3666	9	text	text	NN
25944	3666	10	-	-	HYPH
25944	3666	11	cuts	cut	NNS
25944	3666	12	,	,	,
25944	3666	13	and	and	CC
25944	3666	14	308	308	CD
25944	3666	15	pages	page	NNS
25944	3666	16	of	of	IN
25944	3666	17	text	text	NN
25944	3666	18	.	.	.
25944	3667	1	Cloth	cloth	NN
25944	3667	2	,	,	,
25944	3667	3	$	$	$
25944	3667	4	3.50	3.50	CD
25944	3667	5	net	net	NN
25944	3667	6	.	.	.
25944	3668	1	_	_	NNP
25944	3668	2	In	in	IN
25944	3668	3	Saunders	Saunders	NNPS
25944	3668	4	'	'	POS
25944	3668	5	Hand	Hand	NNP
25944	3668	6	-	-	HYPH
25944	3668	7	Atlas	Atlas	NNP
25944	3668	8	Series	Series	NNP
25944	3668	9	.	.	.
25944	3668	10	_	_	NNP
25944	3668	11	American	American	NNP
25944	3668	12	Journal	Journal	NNP
25944	3668	13	of	of	IN
25944	3668	14	the	the	DT
25944	3668	15	Medical	Medical	NNP
25944	3668	16	Sciences	Sciences	NNPS
25944	3668	17	"	"	''
25944	3668	18	Of	of	IN
25944	3668	19	the	the	DT
25944	3668	20	illustrations	illustration	NNS
25944	3668	21	it	-PRON-	PRP
25944	3668	22	is	be	VBZ
25944	3668	23	difficult	difficult	JJ
25944	3668	24	to	to	TO
25944	3668	25	speak	speak	VB
25944	3668	26	in	in	IN
25944	3668	27	too	too	RB
25944	3668	28	high	high	JJ
25944	3668	29	terms	term	NNS
25944	3668	30	of	of	IN
25944	3668	31	approval	approval	NN
25944	3668	32	.	.	.
25944	3669	1	They	-PRON-	PRP
25944	3669	2	are	be	VBP
25944	3669	3	so	so	RB
25944	3669	4	clear	clear	JJ
25944	3669	5	and	and	CC
25944	3669	6	true	true	JJ
25944	3669	7	to	to	IN
25944	3669	8	nature	nature	NN
25944	3669	9	that	that	IN
25944	3669	10	the	the	DT
25944	3669	11	accompanying	accompanying	JJ
25944	3669	12	explanations	explanation	NNS
25944	3669	13	are	be	VBP
25944	3669	14	almost	almost	RB
25944	3669	15	superfluous	superfluous	JJ
25944	3669	16	.	.	.
25944	3670	1	We	-PRON-	PRP
25944	3670	2	commend	commend	VBP
25944	3670	3	it	-PRON-	PRP
25944	3670	4	most	most	RBS
25944	3670	5	earnestly	earnestly	RB
25944	3670	6	.	.	.
25944	3670	7	"	"	''
25944	3671	1	*	*	NFP
25944	3671	2	*	*	NFP
25944	3671	3	*	*	NFP
25944	3671	4	*	*	NFP
25944	3671	5	*	*	NFP
25944	3671	6	Galbraith	Galbraith	NNP
25944	3671	7	's	's	POS
25944	3671	8	Four	Four	NNP
25944	3671	9	Epochs	Epochs	NNPS
25944	3671	10	of	of	IN
25944	3671	11	Woman	Woman	NNP
25944	3671	12	's	's	POS
25944	3671	13	Life	Life	NNP
25944	3671	14	Second	Second	NNP
25944	3671	15	Revised	Revised	NNP
25944	3671	16	Edition	Edition	NNP
25944	3671	17	--	--	:
25944	3671	18	Recently	recently	RB
25944	3671	19	Issued	issue	VBD
25944	3671	20	#	#	$
25944	3671	21	The	the	DT
25944	3671	22	Four	Four	NNP
25944	3671	23	Epochs	Epochs	NNPS
25944	3671	24	of	of	IN
25944	3671	25	Woman	Woman	NNP
25944	3671	26	's	's	POS
25944	3671	27	Life	life	NN
25944	3671	28	:	:	:
25944	3671	29	#	#	$
25944	3671	30	A	a	DT
25944	3671	31	Study	Study	NNP
25944	3671	32	in	in	IN
25944	3671	33	Hygiene	Hygiene	NNP
25944	3671	34	.	.	.
25944	3672	1	By	by	IN
25944	3672	2	Anna	Anna	NNP
25944	3672	3	M.	M.	NNP
25944	3672	4	Galbraith	Galbraith	NNP
25944	3672	5	,	,	,
25944	3672	6	M.D.	M.D.	NNP
25944	3672	7	,	,	,
25944	3672	8	Fellow	Fellow	NNP
25944	3672	9	of	of	IN
25944	3672	10	the	the	DT
25944	3672	11	New	New	NNP
25944	3672	12	York	York	NNP
25944	3672	13	Academy	Academy	NNP
25944	3672	14	of	of	IN
25944	3672	15	Medicine	Medicine	NNP
25944	3672	16	,	,	,
25944	3672	17	etc	etc	FW
25944	3672	18	.	.	.
25944	3673	1	With	with	IN
25944	3673	2	an	an	DT
25944	3673	3	Introductory	Introductory	NNP
25944	3673	4	Note	Note	NNP
25944	3673	5	by	by	IN
25944	3673	6	John	John	NNP
25944	3673	7	M.	M.	NNP
25944	3673	8	Musser	Musser	NNP
25944	3673	9	,	,	,
25944	3673	10	M.D.	M.D.	NNP
25944	3674	1	Professor	Professor	NNP
25944	3674	2	of	of	IN
25944	3674	3	Clinical	Clinical	NNP
25944	3674	4	Medicine	Medicine	NNP
25944	3674	5	,	,	,
25944	3674	6	University	University	NNP
25944	3674	7	of	of	IN
25944	3674	8	Pennsylvania	Pennsylvania	NNP
25944	3674	9	.	.	.
25944	3675	1	12	12	CD
25944	3675	2	mo	mo	NN
25944	3675	3	of	of	IN
25944	3675	4	247	247	CD
25944	3675	5	pages	page	NNS
25944	3675	6	.	.	.
25944	3676	1	Cloth	cloth	VB
25944	3676	2	$	$	$
25944	3676	3	1.50	1.50	CD
25944	3676	4	net	net	NN
25944	3676	5	.	.	.
25944	3677	1	MAIDENHOOD	maidenhood	NN
25944	3677	2	,	,	,
25944	3677	3	MARRIAGE	marriage	NN
25944	3677	4	,	,	,
25944	3677	5	MATERNITY	MATERNITY	NNP
25944	3677	6	,	,	,
25944	3677	7	MENOPAUSE	MENOPAUSE	NNP
25944	3677	8	In	in	IN
25944	3677	9	this	this	DT
25944	3677	10	instructive	instructive	JJ
25944	3677	11	work	work	NN
25944	3677	12	are	be	VBP
25944	3677	13	stated	state	VBN
25944	3677	14	,	,	,
25944	3677	15	in	in	IN
25944	3677	16	a	a	DT
25944	3677	17	modest	modest	JJ
25944	3677	18	,	,	,
25944	3677	19	pleasing	pleasing	JJ
25944	3677	20	,	,	,
25944	3677	21	and	and	CC
25944	3677	22	conclusive	conclusive	JJ
25944	3677	23	manner	manner	NN
25944	3677	24	,	,	,
25944	3677	25	those	those	DT
25944	3677	26	truths	truth	NNS
25944	3677	27	of	of	IN
25944	3677	28	which	which	WDT
25944	3677	29	every	every	DT
25944	3677	30	woman	woman	NN
25944	3677	31	should	should	MD
25944	3677	32	have	have	VB
25944	3677	33	a	a	DT
25944	3677	34	thorough	thorough	JJ
25944	3677	35	knowledge	knowledge	NN
25944	3677	36	.	.	.
25944	3678	1	Written	write	VBN
25944	3678	2	,	,	,
25944	3678	3	as	as	IN
25944	3678	4	it	-PRON-	PRP
25944	3678	5	is	be	VBZ
25944	3678	6	,	,	,
25944	3678	7	for	for	IN
25944	3678	8	the	the	DT
25944	3678	9	laity	laity	NN
25944	3678	10	,	,	,
25944	3678	11	the	the	DT
25944	3678	12	subject	subject	NN
25944	3678	13	is	be	VBZ
25944	3678	14	discussed	discuss	VBN
25944	3678	15	in	in	IN
25944	3678	16	language	language	NN
25944	3678	17	readily	readily	RB
25944	3678	18	grasped	grasp	VBD
25944	3678	19	even	even	RB
25944	3678	20	by	by	IN
25944	3678	21	those	those	DT
25944	3678	22	most	most	RBS
25944	3678	23	unfamiliar	unfamiliar	JJ
25944	3678	24	with	with	IN
25944	3678	25	medical	medical	JJ
25944	3678	26	subjects	subject	NNS
25944	3678	27	.	.	.
25944	3679	1	#	#	NNP
25944	3679	2	Birmingham	Birmingham	NNP
25944	3679	3	Medical	Medical	NNP
25944	3679	4	Review	Review	NNP
25944	3679	5	,	,	,
25944	3679	6	England	England	NNP
25944	3679	7	#	#	NN
25944	3679	8	"	"	``
25944	3679	9	We	-PRON-	PRP
25944	3679	10	do	do	VBP
25944	3679	11	not	not	RB
25944	3679	12	as	as	IN
25944	3679	13	a	a	DT
25944	3679	14	rule	rule	NN
25944	3679	15	care	care	NN
25944	3679	16	for	for	IN
25944	3679	17	medical	medical	JJ
25944	3679	18	books	book	NNS
25944	3679	19	written	write	VBN
25944	3679	20	for	for	IN
25944	3679	21	the	the	DT
25944	3679	22	instruction	instruction	NN
25944	3679	23	of	of	IN
25944	3679	24	the	the	DT
25944	3679	25	public	public	NN
25944	3679	26	.	.	.
25944	3680	1	But	but	CC
25944	3680	2	we	-PRON-	PRP
25944	3680	3	must	must	MD
25944	3680	4	admit	admit	VB
25944	3680	5	that	that	IN
25944	3680	6	the	the	DT
25944	3680	7	advice	advice	NN
25944	3680	8	in	in	IN
25944	3680	9	Dr.	Dr.	NNP
25944	3680	10	Galbraith	Galbraith	NNP
25944	3680	11	's	's	POS
25944	3680	12	work	work	NN
25944	3680	13	is	be	VBZ
25944	3680	14	in	in	IN
25944	3680	15	the	the	DT
25944	3680	16	main	main	JJ
25944	3680	17	wise	wise	JJ
25944	3680	18	and	and	CC
25944	3680	19	wholesome	wholesome	JJ
25944	3680	20	.	.	.
25944	3680	21	"	"	''
25944	3681	1	Schäffer	Schäffer	NNP
25944	3681	2	and	and	CC
25944	3681	3	Webster	Webster	NNP
25944	3681	4	's	's	POS
25944	3681	5	Operative	Operative	NNP
25944	3681	6	Gynecology	Gynecology	NNP
25944	3681	7	#	#	NN
25944	3681	8	Atlas	Atlas	NNP
25944	3681	9	and	and	CC
25944	3681	10	Epitome	Epitome	NNP
25944	3681	11	of	of	IN
25944	3681	12	Operative	Operative	NNP
25944	3681	13	Gynecology	Gynecology	NNP
25944	3681	14	#	#	NNP
25944	3681	15	.	.	.
25944	3682	1	By	by	IN
25944	3682	2	Dr.	Dr.	NNP
25944	3682	3	O.	O.	NNP
25944	3682	4	Schäffer	Schäffer	NNP
25944	3682	5	,	,	,
25944	3682	6	of	of	IN
25944	3682	7	Heidelberg	Heidelberg	NNP
25944	3682	8	.	.	.
25944	3683	1	Edited	edit	VBN
25944	3683	2	,	,	,
25944	3683	3	with	with	IN
25944	3683	4	additions	addition	NNS
25944	3683	5	,	,	,
25944	3683	6	by	by	IN
25944	3683	7	J.	J.	NNP
25944	3683	8	Clarence	Clarence	NNP
25944	3683	9	Webster	Webster	NNP
25944	3683	10	,	,	,
25944	3683	11	M.D.	M.D.	NNP
25944	3684	1	(	(	-LRB-
25944	3684	2	Edin	Edin	NNP
25944	3684	3	.	.	.
25944	3685	1	)	)	-RRB-
25944	3685	2	,	,	,
25944	3685	3	F.R.C.P.E.	f.r.c.p.e.	CD
25944	3685	4	,	,	,
25944	3685	5	Professor	Professor	NNP
25944	3685	6	of	of	IN
25944	3685	7	Obstetrics	Obstetrics	NNPS
25944	3685	8	and	and	CC
25944	3685	9	Gynecology	Gynecology	NNP
25944	3685	10	in	in	IN
25944	3685	11	Rush	Rush	NNP
25944	3685	12	Medical	Medical	NNP
25944	3685	13	College	College	NNP
25944	3685	14	,	,	,
25944	3685	15	in	in	IN
25944	3685	16	affiliation	affiliation	NN
25944	3685	17	with	with	IN
25944	3685	18	the	the	DT
25944	3685	19	University	University	NNP
25944	3685	20	of	of	IN
25944	3685	21	Chicago	Chicago	NNP
25944	3685	22	.	.	.
25944	3686	1	42	42	CD
25944	3686	2	colored	colored	JJ
25944	3686	3	lithographic	lithographic	JJ
25944	3686	4	plates	plate	NNS
25944	3686	5	,	,	,
25944	3686	6	many	many	JJ
25944	3686	7	text	text	NN
25944	3686	8	-	-	HYPH
25944	3686	9	cuts	cut	NNS
25944	3686	10	,	,	,
25944	3686	11	a	a	DT
25944	3686	12	number	number	NN
25944	3686	13	in	in	IN
25944	3686	14	colors	color	NNS
25944	3686	15	,	,	,
25944	3686	16	and	and	CC
25944	3686	17	138	138	CD
25944	3686	18	pages	page	NNS
25944	3686	19	of	of	IN
25944	3686	20	text	text	NN
25944	3686	21	.	.	.
25944	3687	1	_	_	NNP
25944	3687	2	In	in	IN
25944	3687	3	Saunders	Saunders	NNPS
25944	3687	4	'	'	POS
25944	3687	5	Hand	Hand	NNP
25944	3687	6	-	-	HYPH
25944	3687	7	Atlas	Atlas	NNP
25944	3687	8	Series	Series	NNP
25944	3687	9	.	.	.
25944	3687	10	_	_	NNP
25944	3687	11	Cloth	Cloth	NNP
25944	3687	12	,	,	,
25944	3687	13	$	$	$
25944	3687	14	3.00	3.00	CD
25944	3687	15	net	net	NN
25944	3687	16	.	.	.
25944	3688	1	RECENTLY	RECENTLY	NNS
25944	3688	2	ISSUED	ISSUED	NNS
25944	3688	3	Much	much	JJ
25944	3688	4	patient	patient	JJ
25944	3688	5	endeavor	endeavor	NN
25944	3688	6	has	have	VBZ
25944	3688	7	been	be	VBN
25944	3688	8	expended	expend	VBN
25944	3688	9	by	by	IN
25944	3688	10	the	the	DT
25944	3688	11	author	author	NN
25944	3688	12	,	,	,
25944	3688	13	the	the	DT
25944	3688	14	artist	artist	NN
25944	3688	15	,	,	,
25944	3688	16	and	and	CC
25944	3688	17	the	the	DT
25944	3688	18	lithographer	lithographer	NN
25944	3688	19	in	in	IN
25944	3688	20	the	the	DT
25944	3688	21	preparation	preparation	NN
25944	3688	22	of	of	IN
25944	3688	23	the	the	DT
25944	3688	24	plates	plate	NNS
25944	3688	25	for	for	IN
25944	3688	26	this	this	DT
25944	3688	27	Atlas	Atlas	NNP
25944	3688	28	.	.	.
25944	3689	1	They	-PRON-	PRP
25944	3689	2	are	be	VBP
25944	3689	3	based	base	VBN
25944	3689	4	on	on	IN
25944	3689	5	hundreds	hundred	NNS
25944	3689	6	of	of	IN
25944	3689	7	photographs	photograph	NNS
25944	3689	8	taken	take	VBN
25944	3689	9	from	from	IN
25944	3689	10	nature	nature	NN
25944	3689	11	,	,	,
25944	3689	12	and	and	CC
25944	3689	13	illustrate	illustrate	VB
25944	3689	14	most	most	RBS
25944	3689	15	faithfully	faithfully	RB
25944	3689	16	the	the	DT
25944	3689	17	various	various	JJ
25944	3689	18	surgical	surgical	JJ
25944	3689	19	situations	situation	NNS
25944	3689	20	.	.	.
25944	3690	1	Dr.	Dr.	NNP
25944	3690	2	Schäffer	Schäffer	NNP
25944	3690	3	has	have	VBZ
25944	3690	4	made	make	VBN
25944	3690	5	a	a	DT
25944	3690	6	specialty	specialty	NN
25944	3690	7	of	of	IN
25944	3690	8	demonstrating	demonstrating	NN
25944	3690	9	by	by	IN
25944	3690	10	illustrations	illustration	NNS
25944	3690	11	.	.	.
25944	3691	1	#	#	NNP
25944	3691	2	Medical	Medical	NNP
25944	3691	3	Record	Record	NNP
25944	3691	4	,	,	,
25944	3691	5	New	New	NNP
25944	3691	6	York	York	NNP
25944	3691	7	#	#	NN
25944	3691	8	"	"	``
25944	3691	9	The	the	DT
25944	3691	10	volume	volume	NN
25944	3691	11	should	should	MD
25944	3691	12	prove	prove	VB
25944	3691	13	most	most	RBS
25944	3691	14	helpful	helpful	JJ
25944	3691	15	to	to	IN
25944	3691	16	students	student	NNS
25944	3691	17	and	and	CC
25944	3691	18	others	other	NNS
25944	3691	19	in	in	IN
25944	3691	20	grasping	grasp	VBG
25944	3691	21	details	detail	NNS
25944	3691	22	usually	usually	RB
25944	3691	23	to	to	TO
25944	3691	24	be	be	VB
25944	3691	25	acquired	acquire	VBN
25944	3691	26	only	only	RB
25944	3691	27	in	in	IN
25944	3691	28	the	the	DT
25944	3691	29	amphitheater	amphitheater	NN
25944	3691	30	itself	-PRON-	PRP
25944	3691	31	.	.	.
25944	3691	32	"	"	''
25944	3692	1	*	*	NFP
25944	3692	2	*	*	NFP
25944	3692	3	*	*	NFP
25944	3692	4	*	*	NFP
25944	3692	5	*	*	NFP
25944	3692	6	DeLee	DeLee	NNP
25944	3692	7	's	's	POS
25944	3692	8	Obstetrics	Obstetrics	NNPS
25944	3692	9	for	for	IN
25944	3692	10	Nurses	Nurses	NNP
25944	3692	11	#	#	$
25944	3692	12	Obstetrics	obstetric	NNS
25944	3692	13	for	for	IN
25944	3692	14	Nurses	nurse	NNS
25944	3692	15	#	#	NN
25944	3692	16	.	.	.
25944	3693	1	By	by	IN
25944	3693	2	Joseph	Joseph	NNP
25944	3693	3	B.	B.	NNP
25944	3693	4	DeLee	DeLee	NNP
25944	3693	5	,	,	,
25944	3693	6	M.D.	M.D.	NNP
25944	3693	7	,	,	,
25944	3693	8	Professor	Professor	NNP
25944	3693	9	of	of	IN
25944	3693	10	Obstetrics	Obstetrics	NNPS
25944	3693	11	in	in	IN
25944	3693	12	the	the	DT
25944	3693	13	Northwestern	Northwestern	NNP
25944	3693	14	University	University	NNP
25944	3693	15	Medical	Medical	NNP
25944	3693	16	School	School	NNP
25944	3693	17	,	,	,
25944	3693	18	Chicago	Chicago	NNP
25944	3693	19	;	;	:
25944	3693	20	Lecturer	lecturer	NN
25944	3693	21	in	in	IN
25944	3693	22	the	the	DT
25944	3693	23	Nurses	Nurses	NNPS
25944	3693	24	'	'	POS
25944	3693	25	Training	Training	NNP
25944	3693	26	Schools	Schools	NNPS
25944	3693	27	of	of	IN
25944	3693	28	Mercy	Mercy	NNP
25944	3693	29	,	,	,
25944	3693	30	Wesley	Wesley	NNP
25944	3693	31	,	,	,
25944	3693	32	Provident	Provident	NNP
25944	3693	33	,	,	,
25944	3693	34	Cook	Cook	NNP
25944	3693	35	County	County	NNP
25944	3693	36	,	,	,
25944	3693	37	and	and	CC
25944	3693	38	Chicago	Chicago	NNP
25944	3693	39	Lying	Lying	NNP
25944	3693	40	-	-	HYPH
25944	3693	41	in	in	RP
25944	3693	42	Hospitals	hospital	NNS
25944	3693	43	.	.	.
25944	3694	1	12mo	12mo	JJ
25944	3694	2	of	of	IN
25944	3694	3	512	512	CD
25944	3694	4	pages	page	NNS
25944	3694	5	,	,	,
25944	3694	6	fully	fully	RB
25944	3694	7	illustrated	illustrate	VBN
25944	3694	8	.	.	.
25944	3695	1	Cloth	cloth	NN
25944	3695	2	,	,	,
25944	3695	3	$	$	$
25944	3695	4	2.50	2.50	CD
25944	3695	5	net	net	NN
25944	3695	6	.	.	.
25944	3696	1	JUST	just	RB
25944	3696	2	ISSUED	ISSUED	NNP
25944	3696	3	--	--	:
25944	3696	4	NEW	NEW	NNP
25944	3696	5	(	(	-LRB-
25944	3696	6	3d	3d	NNP
25944	3696	7	)	)	-RRB-
25944	3696	8	EDITION	EDITION	NNP
25944	3696	9	While	while	IN
25944	3696	10	Dr.	Dr.	NNP
25944	3696	11	DeLee	DeLee	NNP
25944	3696	12	has	have	VBZ
25944	3696	13	written	write	VBN
25944	3696	14	his	-PRON-	PRP$
25944	3696	15	work	work	NN
25944	3696	16	especially	especially	RB
25944	3696	17	for	for	IN
25944	3696	18	nurses	nurse	NNS
25944	3696	19	,	,	,
25944	3696	20	the	the	DT
25944	3696	21	practitioner	practitioner	NN
25944	3696	22	will	will	MD
25944	3696	23	also	also	RB
25944	3696	24	find	find	VB
25944	3696	25	it	-PRON-	PRP
25944	3696	26	useful	useful	JJ
25944	3696	27	and	and	CC
25944	3696	28	instructive	instructive	JJ
25944	3696	29	,	,	,
25944	3696	30	since	since	IN
25944	3696	31	the	the	DT
25944	3696	32	duties	duty	NNS
25944	3696	33	of	of	IN
25944	3696	34	a	a	DT
25944	3696	35	nurse	nurse	NN
25944	3696	36	often	often	RB
25944	3696	37	devolve	devolve	VBP
25944	3696	38	upon	upon	IN
25944	3696	39	him	-PRON-	PRP
25944	3696	40	in	in	IN
25944	3696	41	the	the	DT
25944	3696	42	early	early	JJ
25944	3696	43	years	year	NNS
25944	3696	44	of	of	IN
25944	3696	45	his	-PRON-	PRP$
25944	3696	46	practice	practice	NN
25944	3696	47	.	.	.
25944	3697	1	The	the	DT
25944	3697	2	illustrations	illustration	NNS
25944	3697	3	are	be	VBP
25944	3697	4	nearly	nearly	RB
25944	3697	5	all	all	RB
25944	3697	6	original	original	JJ
25944	3697	7	and	and	CC
25944	3697	8	represent	represent	VB
25944	3697	9	photographs	photograph	NNS
25944	3697	10	taken	take	VBN
25944	3697	11	from	from	IN
25944	3697	12	actual	actual	JJ
25944	3697	13	scenes	scene	NNS
25944	3697	14	.	.	.
25944	3698	1	The	the	DT
25944	3698	2	text	text	NN
25944	3698	3	is	be	VBZ
25944	3698	4	the	the	DT
25944	3698	5	result	result	NN
25944	3698	6	of	of	IN
25944	3698	7	the	the	DT
25944	3698	8	author	author	NN
25944	3698	9	's	's	POS
25944	3698	10	many	many	JJ
25944	3698	11	years	year	NNS
25944	3698	12	'	'	POS
25944	3698	13	experience	experience	NN
25944	3698	14	in	in	IN
25944	3698	15	lecturing	lecture	VBG
25944	3698	16	to	to	IN
25944	3698	17	the	the	DT
25944	3698	18	nurses	nurse	NNS
25944	3698	19	of	of	IN
25944	3698	20	five	five	CD
25944	3698	21	different	different	JJ
25944	3698	22	training	training	NN
25944	3698	23	schools	school	NNS
25944	3698	24	.	.	.
25944	3699	1	#	#	$
25944	3699	2	J.	J.	NNP
25944	3699	3	Clifton	Clifton	NNP
25944	3699	4	Edgar	Edgar	NNP
25944	3699	5	,	,	,
25944	3699	6	M.D.	M.D.	NNP
25944	3699	7	,	,	,
25944	3699	8	#	#	NNP
25944	3699	9	_	_	NNP
25944	3699	10	Professor	Professor	NNP
25944	3699	11	of	of	IN
25944	3699	12	Obstetrics	Obstetrics	NNP
25944	3699	13	and	and	CC
25944	3699	14	Clinical	Clinical	NNP
25944	3699	15	Midwifery	Midwifery	NNP
25944	3699	16	,	,	,
25944	3699	17	Cornell	Cornell	NNP
25944	3699	18	University	University	NNP
25944	3699	19	,	,	,
25944	3699	20	New	New	NNP
25944	3699	21	York	York	NNP
25944	3699	22	.	.	.
25944	3699	23	_	_	NNP
25944	3699	24	"	"	``
25944	3699	25	It	-PRON-	PRP
25944	3699	26	is	be	VBZ
25944	3699	27	far	far	RB
25944	3699	28	and	and	CC
25944	3699	29	away	away	RB
25944	3699	30	the	the	DT
25944	3699	31	best	good	JJS
25944	3699	32	that	that	WDT
25944	3699	33	has	have	VBZ
25944	3699	34	come	come	VBN
25944	3699	35	to	to	IN
25944	3699	36	my	-PRON-	PRP$
25944	3699	37	notice	notice	NN
25944	3699	38	,	,	,
25944	3699	39	and	and	CC
25944	3699	40	I	-PRON-	PRP
25944	3699	41	shall	shall	MD
25944	3699	42	take	take	VB
25944	3699	43	great	great	JJ
25944	3699	44	pleasure	pleasure	NN
25944	3699	45	in	in	IN
25944	3699	46	recommending	recommend	VBG
25944	3699	47	it	-PRON-	PRP
25944	3699	48	to	to	IN
25944	3699	49	my	-PRON-	PRP$
25944	3699	50	nurses	nurse	NNS
25944	3699	51	,	,	,
25944	3699	52	and	and	CC
25944	3699	53	students	student	NNS
25944	3699	54	as	as	RB
25944	3699	55	well	well	RB
25944	3699	56	.	.	.
25944	3699	57	"	"	''
25944	3700	1	#	#	NNP
25944	3700	2	American	American	NNP
25944	3700	3	Pocket	Pocket	NNP
25944	3700	4	Dictionary	Dictionary	NNP
25944	3700	5	#	#	$
25944	3700	6	Recently	recently	RB
25944	3700	7	issued--5th	issued--5th	NNP
25944	3700	8	Ed	Ed	NNP
25944	3700	9	.	.	.
25944	3701	1	The	the	DT
25944	3701	2	American	American	NNP
25944	3701	3	Pocket	Pocket	NNP
25944	3701	4	Medical	Medical	NNP
25944	3701	5	Dictionary	Dictionary	NNP
25944	3701	6	.	.	.
25944	3702	1	Edited	edit	VBN
25944	3702	2	by	by	IN
25944	3702	3	W.A.	W.A.	NNP
25944	3703	1	Newman	Newman	NNP
25944	3703	2	Dorland	Dorland	NNP
25944	3703	3	,	,	,
25944	3703	4	A.M.	A.M.	NNP
25944	3703	5	,	,	,
25944	3703	6	M.D.	M.D.	NNP
25944	3703	7	,	,	,
25944	3703	8	Assistant	Assistant	NNP
25944	3703	9	Obstetrician	Obstetrician	NNP
25944	3703	10	to	to	IN
25944	3703	11	the	the	DT
25944	3703	12	Hospital	Hospital	NNP
25944	3703	13	of	of	IN
25944	3703	14	the	the	DT
25944	3703	15	University	University	NNP
25944	3703	16	of	of	IN
25944	3703	17	Pennsylvania	Pennsylvania	NNP
25944	3703	18	;	;	:
25944	3703	19	Fellow	Fellow	NNP
25944	3703	20	of	of	IN
25944	3703	21	the	the	DT
25944	3703	22	American	American	NNP
25944	3703	23	Academy	Academy	NNP
25944	3703	24	of	of	IN
25944	3703	25	Medicine	Medicine	NNP
25944	3703	26	.	.	.
25944	3704	1	With	with	IN
25944	3704	2	578	578	CD
25944	3704	3	pages	page	NNS
25944	3704	4	.	.	.
25944	3705	1	Full	full	JJ
25944	3705	2	leather	leather	NN
25944	3705	3	,	,	,
25944	3705	4	limp	limp	JJ
25944	3705	5	,	,	,
25944	3705	6	with	with	IN
25944	3705	7	gold	gold	JJ
25944	3705	8	edges	edge	NNS
25944	3705	9	,	,	,
25944	3705	10	$	$	$
25944	3705	11	1.00	1.00	CD
25944	3705	12	net	net	NN
25944	3705	13	;	;	:
25944	3705	14	with	with	IN
25944	3705	15	patent	patent	NN
25944	3705	16	thumb	thumb	NN
25944	3705	17	index	index	NN
25944	3705	18	,	,	,
25944	3705	19	$	$	$
25944	3705	20	1.25	1.25	CD
25944	3705	21	net	net	NN
25944	3705	22	.	.	.
25944	3706	1	#	#	NNP
25944	3706	2	James	James	NNP
25944	3706	3	W.	W.	NNP
25944	3706	4	Holland	Holland	NNP
25944	3706	5	.	.	.
25944	3707	1	M.D.	M.D.	NNP
25944	3707	2	,	,	,
25944	3707	3	#	#	NNP
25944	3707	4	_	_	NNP
25944	3707	5	Professor	Professor	NNP
25944	3707	6	of	of	IN
25944	3707	7	Chemistry	Chemistry	NNP
25944	3707	8	and	and	CC
25944	3707	9	Toxicology	Toxicology	NNP
25944	3707	10	,	,	,
25944	3707	11	at	at	IN
25944	3707	12	the	the	DT
25944	3707	13	Jefferson	Jefferson	NNP
25944	3707	14	Medical	Medical	NNP
25944	3707	15	College	College	NNP
25944	3707	16	,	,	,
25944	3707	17	Philadelphia	Philadelphia	NNP
25944	3707	18	.	.	.
25944	3707	19	_	_	NNP
25944	3707	20	"	"	``
25944	3707	21	I	-PRON-	PRP
25944	3707	22	am	be	VBP
25944	3707	23	struck	strike	VBN
25944	3707	24	at	at	IN
25944	3707	25	once	once	RB
25944	3707	26	with	with	IN
25944	3707	27	admiration	admiration	NN
25944	3707	28	at	at	IN
25944	3707	29	the	the	DT
25944	3707	30	compact	compact	JJ
25944	3707	31	size	size	NN
25944	3707	32	and	and	CC
25944	3707	33	attractive	attractive	JJ
25944	3707	34	exterior	exterior	NN
25944	3707	35	.	.	.
25944	3708	1	I	-PRON-	PRP
25944	3708	2	can	can	MD
25944	3708	3	recommend	recommend	VB
25944	3708	4	it	-PRON-	PRP
25944	3708	5	to	to	IN
25944	3708	6	our	-PRON-	PRP$
25944	3708	7	students	student	NNS
25944	3708	8	without	without	IN
25944	3708	9	reserve	reserve	NN
25944	3708	10	.	.	.
25944	3708	11	"	"	''
25944	3709	1	#	#	NNP
25944	3709	2	Cragin	Cragin	NNP
25944	3709	3	's	's	POS
25944	3709	4	Gynecology	gynecology	NN
25944	3709	5	#	#	NN
25944	3709	6	Recently	recently	RB
25944	3709	7	Issued	issue	VBN
25944	3709	8	--	--	:
25944	3709	9	New	New	NNP
25944	3709	10	(	(	-LRB-
25944	3709	11	6th	6th	NN
25944	3709	12	)	)	-RRB-
25944	3709	13	Ed	Ed	NNP
25944	3709	14	.	.	.
25944	3710	1	Essentials	Essentials	NNP
25944	3710	2	of	of	IN
25944	3710	3	Gynecology	Gynecology	NNP
25944	3710	4	.	.	.
25944	3711	1	By	by	IN
25944	3711	2	Edwin	Edwin	NNP
25944	3711	3	B.	B.	NNP
25944	3711	4	Cragin	Cragin	NNP
25944	3711	5	,	,	,
25944	3711	6	M.D.	M.D.	NNP
25944	3711	7	,	,	,
25944	3711	8	Professor	Professor	NNP
25944	3711	9	of	of	IN
25944	3711	10	Obstetrics	Obstetrics	NNP
25944	3711	11	,	,	,
25944	3711	12	College	College	NNP
25944	3711	13	of	of	IN
25944	3711	14	Physicians	Physicians	NNPS
25944	3711	15	and	and	CC
25944	3711	16	Surgeons	Surgeons	NNPS
25944	3711	17	,	,	,
25944	3711	18	New	New	NNP
25944	3711	19	York	York	NNP
25944	3711	20	.	.	.
25944	3712	1	Crown	Crown	NNP
25944	3712	2	octavo	octavo	NNP
25944	3712	3	,	,	,
25944	3712	4	240	240	CD
25944	3712	5	pages	page	NNS
25944	3712	6	,	,	,
25944	3712	7	62	62	CD
25944	3712	8	illustrations	illustration	NNS
25944	3712	9	.	.	.
25944	3713	1	Cloth	cloth	NN
25944	3713	2	,	,	,
25944	3713	3	$	$	$
25944	3713	4	1.00	1.00	CD
25944	3713	5	net	net	NN
25944	3713	6	.	.	.
25944	3714	1	_	_	NNP
25944	3714	2	In	in	IN
25944	3714	3	Saunders	Saunders	NNPS
25944	3714	4	'	'	POS
25944	3714	5	Question	Question	NNP
25944	3714	6	-	-	HYPH
25944	3714	7	Compend	Compend	NNP
25944	3714	8	Series	Series	NNP
25944	3714	9	.	.	.
25944	3714	10	_	_	NNP
25944	3714	11	#	#	$
25944	3714	12	The	the	DT
25944	3714	13	Medical	Medical	NNP
25944	3714	14	Record	Record	NNP
25944	3714	15	,	,	,
25944	3714	16	New	New	NNP
25944	3714	17	York	York	NNP
25944	3714	18	#	#	NN
25944	3714	19	"	"	``
25944	3714	20	A	a	DT
25944	3714	21	handy	handy	JJ
25944	3714	22	volume	volume	NN
25944	3714	23	and	and	CC
25944	3714	24	a	a	DT
25944	3714	25	distinct	distinct	JJ
25944	3714	26	improvement	improvement	NN
25944	3714	27	on	on	IN
25944	3714	28	students	student	NNS
25944	3714	29	'	'	POS
25944	3714	30	compends	compend	NNS
25944	3714	31	in	in	IN
25944	3714	32	general	general	JJ
25944	3714	33	.	.	.
25944	3715	1	No	no	DT
25944	3715	2	author	author	NN
25944	3715	3	who	who	WP
25944	3715	4	was	be	VBD
25944	3715	5	not	not	RB
25944	3715	6	himself	-PRON-	PRP
25944	3715	7	a	a	DT
25944	3715	8	practical	practical	JJ
25944	3715	9	gynecologist	gynecologist	NN
25944	3715	10	could	could	MD
25944	3715	11	have	have	VB
25944	3715	12	consulted	consult	VBN
25944	3715	13	the	the	DT
25944	3715	14	student	student	NN
25944	3715	15	's	's	POS
25944	3715	16	needs	need	NNS
25944	3715	17	so	so	RB
25944	3715	18	thoroughly	thoroughly	RB
25944	3715	19	as	as	IN
25944	3715	20	Dr.	Dr.	NNP
25944	3715	21	Cragin	Cragin	NNP
25944	3715	22	has	have	VBZ
25944	3715	23	done	do	VBN
25944	3715	24	.	.	.
25944	3715	25	"	"	''
25944	3716	1	#	#	NNP
25944	3716	2	Boisliniere	Boisliniere	NNP
25944	3716	3	's	's	POS
25944	3716	4	Obstetric	Obstetric	NNP
25944	3716	5	Accidents	Accidents	NNPS
25944	3716	6	,	,	,
25944	3716	7	Emergencies	Emergencies	NNPS
25944	3716	8	,	,	,
25944	3716	9	and	and	CC
25944	3716	10	Operations	operation	NNS
25944	3716	11	#	#	NNP
25944	3716	12	Obstetric	Obstetric	NNP
25944	3716	13	Accidents	Accidents	NNPS
25944	3716	14	,	,	,
25944	3716	15	Emergencies	Emergencies	NNPS
25944	3716	16	,	,	,
25944	3716	17	and	and	CC
25944	3716	18	Operations	operation	NNS
25944	3716	19	.	.	.
25944	3717	1	By	by	IN
25944	3717	2	the	the	DT
25944	3717	3	late	late	JJ
25944	3717	4	L.	L.	NNP
25944	3717	5	Ch	Ch	NNP
25944	3717	6	.	.	.
25944	3718	1	Boisliniere	Boisliniere	NNP
25944	3718	2	,	,	,
25944	3718	3	M.D.	M.D.	NNP
25944	3718	4	,	,	,
25944	3718	5	Emeritus	Emeritus	NNP
25944	3718	6	Professor	Professor	NNP
25944	3718	7	of	of	IN
25944	3718	8	Obstetrics	Obstetrics	NNPS
25944	3718	9	,	,	,
25944	3718	10	St.	St.	NNP
25944	3718	11	Louis	Louis	NNP
25944	3718	12	Medical	Medical	NNP
25944	3718	13	College	College	NNP
25944	3718	14	;	;	:
25944	3718	15	Consulting	Consulting	NNP
25944	3718	16	Physician	Physician	NNP
25944	3718	17	,	,	,
25944	3718	18	St.	St.	NNP
25944	3718	19	Louis	Louis	NNP
25944	3718	20	Female	Female	NNP
25944	3718	21	Hospital	Hospital	NNP
25944	3718	22	.	.	.
25944	3719	1	381	381	CD
25944	3719	2	pages	page	NNS
25944	3719	3	,	,	,
25944	3719	4	illustrated	illustrate	VBN
25944	3719	5	.	.	.
25944	3720	1	Cloth	cloth	NN
25944	3720	2	,	,	,
25944	3720	3	$	$	$
25944	3720	4	2.00	2.00	CD
25944	3720	5	net	net	NN
25944	3720	6	.	.	.
25944	3721	1	#	#	$
25944	3721	2	British	British	NNP
25944	3721	3	Medical	Medical	NNP
25944	3721	4	Journal	Journal	NNP
25944	3721	5	#	#	$
25944	3721	6	"	"	``
25944	3721	7	It	-PRON-	PRP
25944	3721	8	is	be	VBZ
25944	3721	9	clearly	clearly	RB
25944	3721	10	and	and	CC
25944	3721	11	concisely	concisely	RB
25944	3721	12	written	write	VBN
25944	3721	13	,	,	,
25944	3721	14	and	and	CC
25944	3721	15	is	be	VBZ
25944	3721	16	evidently	evidently	RB
25944	3721	17	the	the	DT
25944	3721	18	work	work	NN
25944	3721	19	of	of	IN
25944	3721	20	a	a	DT
25944	3721	21	teacher	teacher	NN
25944	3721	22	and	and	CC
25944	3721	23	practitioner	practitioner	NN
25944	3721	24	of	of	IN
25944	3721	25	large	large	JJ
25944	3721	26	experience	experience	NN
25944	3721	27	.	.	.
25944	3722	1	Its	-PRON-	PRP$
25944	3722	2	merit	merit	NN
25944	3722	3	lies	lie	VBZ
25944	3722	4	in	in	IN
25944	3722	5	the	the	DT
25944	3722	6	judgment	judgment	NN
25944	3722	7	which	which	WDT
25944	3722	8	comes	come	VBZ
25944	3722	9	from	from	IN
25944	3722	10	experience	experience	NN
25944	3722	11	.	.	.
25944	3722	12	"	"	''
25944	3723	1	#	#	NNP
25944	3723	2	Ashton	Ashton	NNP
25944	3723	3	's	's	POS
25944	3723	4	Obstetrics	obstetric	NNS
25944	3723	5	#	#	NN
25944	3723	6	Recently	recently	RB
25944	3723	7	Issued	issue	VBN
25944	3723	8	--	--	:
25944	3723	9	New	New	NNP
25944	3723	10	(	(	-LRB-
25944	3723	11	6th	6th	NN
25944	3723	12	)	)	-RRB-
25944	3723	13	Ed	Ed	NNP
25944	3723	14	.	.	.
25944	3724	1	Essentials	Essentials	NNP
25944	3724	2	of	of	IN
25944	3724	3	Obstetrics	Obstetrics	NNPS
25944	3724	4	.	.	.
25944	3725	1	By	by	IN
25944	3725	2	W.	W.	NNP
25944	3725	3	Easterly	Easterly	NNP
25944	3725	4	Ashton	Ashton	NNP
25944	3725	5	,	,	,
25944	3725	6	M.D.	M.D.	NNP
25944	3725	7	,	,	,
25944	3725	8	Professor	Professor	NNP
25944	3725	9	of	of	IN
25944	3725	10	Gynecology	Gynecology	NNP
25944	3725	11	in	in	IN
25944	3725	12	the	the	DT
25944	3725	13	Medico	Medico	NNP
25944	3725	14	-	-	HYPH
25944	3725	15	Chirurgical	Chirurgical	NNP
25944	3725	16	College	College	NNP
25944	3725	17	,	,	,
25944	3725	18	Philadelphia	Philadelphia	NNP
25944	3725	19	.	.	.
25944	3726	1	Crown	Crown	NNP
25944	3726	2	octavo	octavo	NNP
25944	3726	3	,	,	,
25944	3726	4	252	252	CD
25944	3726	5	pages	page	NNS
25944	3726	6	,	,	,
25944	3726	7	75	75	CD
25944	3726	8	illustrations	illustration	NNS
25944	3726	9	.	.	.
25944	3727	1	Cloth	cloth	NN
25944	3727	2	,	,	,
25944	3727	3	$	$	$
25944	3727	4	1.00	1.00	CD
25944	3727	5	net	net	NN
25944	3727	6	.	.	.
25944	3728	1	_	_	NNP
25944	3728	2	In	in	IN
25944	3728	3	Saunders	Saunders	NNPS
25944	3728	4	'	'	POS
25944	3728	5	Question	Question	NNP
25944	3728	6	-	-	HYPH
25944	3728	7	Compend	Compend	NNP
25944	3728	8	Series	Series	NNP
25944	3728	9	.	.	.
25944	3728	10	_	_	NNP
25944	3728	11	#	#	NNP
25944	3728	12	Southern	Southern	NNP
25944	3728	13	Practitioner	Practitioner	NNP
25944	3728	14	#	#	$
25944	3728	15	"	"	``
25944	3728	16	An	an	DT
25944	3728	17	excellent	excellent	JJ
25944	3728	18	little	little	JJ
25944	3728	19	volume	volume	NN
25944	3728	20	,	,	,
25944	3728	21	containing	contain	VBG
25944	3728	22	correct	correct	JJ
25944	3728	23	and	and	CC
25944	3728	24	practical	practical	JJ
25944	3728	25	knowledge	knowledge	NN
25944	3728	26	.	.	.
25944	3729	1	An	an	DT
25944	3729	2	admirable	admirable	JJ
25944	3729	3	compend	compend	NN
25944	3729	4	,	,	,
25944	3729	5	and	and	CC
25944	3729	6	the	the	DT
25944	3729	7	best	good	JJS
25944	3729	8	condensation	condensation	NN
25944	3729	9	we	-PRON-	PRP
25944	3729	10	have	have	VBP
25944	3729	11	seen	see	VBN
25944	3729	12	.	.	.
25944	3729	13	"	"	''
25944	3730	1	#	#	NNP
25944	3730	2	Barton	Barton	NNP
25944	3730	3	and	and	CC
25944	3730	4	Wells	Wells	NNP
25944	3730	5	'	'	POS
25944	3730	6	Medical	Medical	NNP
25944	3730	7	Thesaurus	Thesaurus	NNP
25944	3730	8	#	#	NN
25944	3730	9	A	a	DT
25944	3730	10	Thesaurus	Thesaurus	NNP
25944	3730	11	of	of	IN
25944	3730	12	Medical	medical	JJ
25944	3730	13	Words	Words	NNPS
25944	3730	14	and	and	CC
25944	3730	15	Phrases	Phrases	NNPS
25944	3730	16	.	.	.
25944	3731	1	By	by	IN
25944	3731	2	Wilfred	Wilfred	NNP
25944	3731	3	M.	M.	NNP
25944	3731	4	Barton	Barton	NNP
25944	3731	5	,	,	,
25944	3731	6	M.D.	M.D.	NNP
25944	3731	7	,	,	,
25944	3731	8	Assistant	Assistant	NNP
25944	3731	9	to	to	IN
25944	3731	10	Professor	Professor	NNP
25944	3731	11	of	of	IN
25944	3731	12	Materia	Materia	NNP
25944	3731	13	Medica	Medica	NNP
25944	3731	14	and	and	CC
25944	3731	15	Therapeutics	Therapeutics	NNP
25944	3731	16	,	,	,
25944	3731	17	Georgetown	Georgetown	NNP
25944	3731	18	University	University	NNP
25944	3731	19	,	,	,
25944	3731	20	Washington	Washington	NNP
25944	3731	21	,	,	,
25944	3731	22	D.C.	D.C.	NNP
25944	3731	23	;	;	:
25944	3731	24	and	and	CC
25944	3731	25	WALTER	WALTER	NNP
25944	3731	26	A.	A.	NNP
25944	3732	1	WELLS	WELLS	NNP
25944	3732	2	,	,	,
25944	3732	3	M.D.	M.D.	NNP
25944	3732	4	,	,	,
25944	3732	5	Demonstrator	Demonstrator	NNP
25944	3732	6	of	of	IN
25944	3732	7	Laryngology	Laryngology	NNP
25944	3732	8	,	,	,
25944	3732	9	Georgetown	Georgetown	NNP
25944	3732	10	University	University	NNP
25944	3732	11	,	,	,
25944	3732	12	Washington	Washington	NNP
25944	3732	13	,	,	,
25944	3732	14	D.C.	D.C.	NNP
25944	3732	15	12mo	12mo	NN
25944	3732	16	of	of	IN
25944	3732	17	534	534	CD
25944	3732	18	pages	page	NNS
25944	3732	19	.	.	.
25944	3733	1	Flexible	flexible	JJ
25944	3733	2	leather	leather	NN
25944	3733	3	,	,	,
25944	3733	4	$	$	$
25944	3733	5	2.50	2.50	CD
25944	3733	6	net	net	NN
25944	3733	7	;	;	:
25944	3733	8	with	with	IN
25944	3733	9	thumb	thumb	NN
25944	3733	10	index	index	NN
25944	3733	11	,	,	,
25944	3733	12	$	$	$
25944	3733	13	3.00	3.00	CD
25944	3733	14	net	net	NN
25944	3733	15	.	.	.
25944	3734	1	*	*	NFP
25944	3734	2	*	*	NFP
25944	3734	3	*	*	NFP
25944	3734	4	*	*	NFP
25944	3734	5	*	*	NFP
25944	3734	6	Transcriber	Transcriber	NNP
25944	3734	7	's	's	POS
25944	3734	8	note	note	NN
25944	3734	9	:	:	:
25944	3734	10	Changed	change	VBN
25944	3734	11	"	"	``
25944	3734	12	dioxid	dioxid	NN
25944	3734	13	"	"	''
25944	3734	14	to	to	TO
25944	3734	15	"	"	``
25944	3734	16	dioxide	dioxide	VB
25944	3734	17	"	"	''
25944	3734	18	in	in	IN
25944	3734	19	several	several	JJ
25944	3734	20	places	place	NNS
25944	3734	21	Made	make	VBD
25944	3734	22	hyphenation	hyphenation	NN
25944	3734	23	of	of	IN
25944	3734	24	various	various	JJ
25944	3734	25	words	word	NNS
25944	3734	26	consistent	consistent	JJ
25944	3734	27	Page	Page	NNP
25944	3734	28	74	74	CD
25944	3734	29	:	:	:
25944	3734	30	Corrected	correct	VBN
25944	3734	31	misspelling	misspelling	NN
25944	3734	32	of	of	IN
25944	3734	33	Phlegmona	Phlegmona	NNP
25944	3734	34	Page	Page	NNP
25944	3734	35	135	135	CD
25944	3734	36	:	:	:
25944	3734	37	Corrected	correct	VBN
25944	3734	38	misspelling	misspelling	NN
25944	3734	39	of	of	IN
25944	3734	40	quantity	quantity	NN
25944	3734	41	Page	Page	NNP
25944	3734	42	138	138	CD
25944	3734	43	:	:	:
25944	3734	44	changed	change	VBN
25944	3734	45	'	'	''
25944	3734	46	,	,	,
25944	3734	47	'	'	''
25944	3734	48	to	to	IN
25944	3734	49	'	'	''
25944	3734	50	.	.	.
25944	3734	51	'	'	''
25944	3735	1	at	at	IN
25944	3735	2	end	end	NN
25944	3735	3	of	of	IN
25944	3735	4	sentence	sentence	NN
25944	3735	5	Page	Page	NNP
25944	3735	6	208	208	CD
25944	3735	7	:	:	:
25944	3735	8	aquæ	aquæ	NNP
25944	3735	9	rosae	rosae	NNP
25944	3735	10	changed	change	VBN
25944	3735	11	to	to	IN
25944	3735	12	aquæ	aquæ	JJ
25944	3735	13	rosæ	rosæ	NN
25944	3735	14	Page	Page	NNP
25944	3735	15	210	210	CD
25944	3735	16	:	:	:
25944	3735	17	Fixed	fix	VBN
25944	3735	18	typographical	typographical	JJ
25944	3735	19	error	error	NN
25944	3735	20	"	"	``
25944	3735	21	symptyms	symptyms	NN
25944	3735	22	"	"	''
25944	3735	23	into	into	IN
25944	3735	24	"	"	``
25944	3735	25	symptoms	symptom	NNS
25944	3735	26	"	"	''
25944	3735	27	Page	page	NN
25944	3735	28	212	212	CD
25944	3735	29	:	:	:
25944	3735	30	Fixed	fix	VBN
25944	3735	31	typographical	typographical	JJ
25944	3735	32	error	error	NN
25944	3735	33	"	"	``
25944	3735	34	Decribe	decribe	JJ
25944	3735	35	mycetoma	mycetoma	NN
25944	3735	36	"	"	''
25944	3735	37	into	into	IN
25944	3735	38	"	"	``
25944	3735	39	Describe	describe	JJ
25944	3735	40	mycetoma	mycetoma	NN
25944	3735	41	"	"	''
25944	3735	42	Page	page	NN
25944	3735	43	213	213	CD
25944	3735	44	:	:	:
25944	3735	45	Fixed	fix	VBN
25944	3735	46	typographical	typographical	JJ
25944	3735	47	error	error	NN
25944	3735	48	"	"	``
25944	3735	49	iodid	iodid	VBD
25944	3735	50	"	"	''
25944	3735	51	into	into	IN
25944	3735	52	"	"	``
25944	3735	53	iodide	iodide	NN
25944	3735	54	"	"	''